5,649 Matching Annotations
  1. Jan 2025
    1. Author response:

      We thank the three reviewers for their insightful feedback. We look forward to addressing the raised concerns in a revised version of the manuscript. There were a few common themes among the reviews that we will briefly touch upon now, and we will provide more details in the revised manuscript. 

      First, the reviewers asked for the reasoning behind the task ratios we implemented for the different attentional width conditions. The different ratios were selected to be as similar as possible given the size and spacing of our stimuli (aside from the narrowest cue width of one bin, the ratios for the others were 0.67, 0.60, and 0.67). As Figure 1b shows, task accuracy showed small and non-monotonic changes across the three larger cue widths, dissociable from the monotonic pattern seen for the model-estimated width of the attentional field. Furthermore, prior work has indicated that there is a relationship between task difficulty and the overall magnitude of the BOLD response, however we don’t suspect that this will influence the width of the modulation. How task difficulty influences the BOLD response is an important topic, and we hope that future work will investigate this relationship more directly.   

      Second, reviewers expressed interest in the distribution of spatial attention in higher visual areas. In our study we focus only on early visual regions (V1-V3). This was primarily driven by pragmatic considerations, in that we only have retinotopic estimates for our participants in these early visual areas. Our modeling approach is dependent on having access to the population receptive field estimates for all voxels, and while the main experiment was scanned using whole brain coverage, retinotopy was measured in a separate session using a field of view only covering the occipital cortex.  

      Lastly, we appreciate the opportunity to clarify the purpose of the temporal interval analysis. The reviewer is correct in assuming we set out to test how much data is needed to recover the cortical modulation and how dynamic a signal the method can capture. This analysis does show that more data provided more reliable estimates. The more important finding, however, is that the model was still able to recover the location and width of the attentional cue at shorter timescales of as few as two TRs. This has implications for the potential applicability of our approach to paradigms that involve more dynamic adaptation of the attentional field.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      This a comprehensive study that sheds light on how Wag31 functions and localises in mycobacterial cells. A clear link to interactions with CL is shown using a combination of microscopy in combination with fusion fluorescent constructs, and lipid specific dyes. Furthermore, studies using mutant versions of Wag31 shed light on the functionalities of each domain in the protein. My concerns/suggestions for the manuscript are minor:

      (1) Ln 130. A better clarification/discussion is required here. It is clear that both depletion and overexpression have an effect on levels of various lipids, but subsequent descriptions show that they affect different classes of lipids.

      We thank the reviewer for the comments. We will improve Ln130 in the manuscript. The lipid classes that get impacted by the depletion of Wag31 vs overexpression are different. Wag31 is an adaptor protein that interacts with proteins of the ACCase complex (Meniche et al., 2014; Xu et al., 2014) that synthesize fatty acid precursors and regulate their activity (Habibi Arejan et al., 2022).

      The varied response to lipid homeostasis could be attributed to a change in the stoichiometry of these interactions with Wag31. While Wag31 depletion would prevent such interactions from occurring and might affect lipid synthesis that directly depends on Wag31-protein partner interactions, its overexpression would lead to promiscuous interactions and a change in the stoichiometry of native interactions, ultimately modulating lipid synthesis pathways.

      (2) The pulldown assays results are interesting, but links are tentative.

      The interactome of Wag31 was identified through the immunoprecipitation of Flag-tagged Wag31 complemented at an integrative locus in Wag31 mutant background to avoid overexpression artifacts. We used Msm::gfp expressing an integrative copy (at L5 locus) of FLAG-GFP as a control to subtract non-specific interactions. The experiment was performed in biological triplicates, and interactors that appeared in all replicates were selected for further analysis. Although we identified more than 100 interactors of Wag31, we analyzed only the top 25 hits, with a PSM cut-off ≥18 and unique peptides≥5. Additionally, two of Wag31's established interactors, AccD5 and Rne, were among the top five hits, thus validating our data.

      Though we agree that the interactions can either be direct or through a third partner, the fact that we obtained known interactors of Wag31 makes us believe these interactions are genuine. Moreover, we performed pulldown experiments for validation by mixing E. coli lysates expressing His-Wag31 full-length or truncated protein with M. smegmatis lysates expressing FLAG-tagged interacting proteins. The wash conditions used were quite stringent for these pull-down assays—the wash buffer contained 1% Triton X100, eliminating all non-specific and indirect interactions.  However, we agree that we cannot conclusively state that the interactions are direct without purifying the proteins and performing the experiment. We will describe this caveat in the revised manuscript. 

      (3) The authors may perhaps like to rephrase claims of effects lipid homeostasis, as my understanding is that lipid localisation rather than catabolism/breakdown is affected.

      In this manuscript, we are trying to convey that Wag31 is a spatiotemporal regulator of lipid metabolism. It is a peripheral protein that is hooked to the membrane via Cardiolipin and forms a scaffold at the poles, which helps localize several enzymes involved in lipid metabolism.

      Homeostasis is the process by which an organism maintains a steady-state of balance and stability in response to changes.  Depletion of Wag31 not only results in delocalisation of lipids in intracellular lipid inclusions but also leads to changes in the levels of various lipid classes. Advancement in the field of spatial biology underscores the importance of native localization of various biological molecules crucial for maintaining a steady-cell of the cell. Hence, we have used the word “homeostasis” to describe both the changes observed in lipid metabolism.

      Reviewer #2 (Public review):

      Summary

      Kapoor et. al. investigated the role of the mycobacterial protein Wag31 in lipid and peptidoglycan synthesis and sought to delineate the role of the N- and C- terminal domains of Wag31. They demonstrated that modulating Wag31 levels influences lipid homeostasis in M. smegmatis and cardiolipin (CL) localisation in cells. Wag31 was found to preferentially bind CL-containing liposomes, and deleting the N-terminus of the protein significantly decreased this interaction. Novel interactions between Wag31 and proteins involved in lipid metabolism and cell wall synthesis were identified, suggesting that Wag31 recruits proteins to the intracellular membrane domain by direct interaction.

      Strengths:

      (1) The importance of Wag31 in maintaining lipid homeostasis is supported by several lines of evidence.

      (2) The interaction between Wag31 and cardiolipin, and the role of the N-terminus in this interaction was convincingly demonstrated.

      Weaknesses:

      (1) MS experiments provide some evidence for novel protein-protein interactions. However, the pull-down experiments lack a valid negative control.

      We thank the reviewer for the comments. We will include a valid negative control in the experiment. We would choose ~2 mycobacterial proteins that are not a part of our interactome study and perform a similar pull-down experiment with them and a positive control (known interactor of Wag31).

      (2) The role of the N-terminus in the protein-protein interaction has not been ruled out.

      Previously, we attempted to express the N-terminal (1-60 aa) and the C-terminal (60-212 aa) proteins in various mycobacterial shuttle vectors to perform MS/MS experiments. Despite numerous efforts, neither was expressed with the N/C-terminal FLAG tag nor without any tag in episomal or integrative vectors due to the instability of the protein. Eventually, we successfully expressed the C-terminal Wag31 with an N and C-terminal hexa-His tag. However, this expression was not sufficient or stable enough for us to perform Ni affinity pull-down experiments for mass spectrometry.  The N-terminal of Wag31 could not be expressed in M. smegmatis even with N and C-terminal Hexa-His tags.

      To rule out the role of the N-terminal in mediating protein-protein interactions, we plan to attempt to express N-terminal of Wag31with N and C-terminal hexa-His tag in E. coli. If this clone successfully expresses in E. coli, we will perform pull-down experiments as described in Figure 7.

      Reviewer #3 (Public review):

      Summary:

      This manuscript describes the characterization of mycobacterial cytoskeleton protein Wag31, examining its role in orchestrating protein-lipid and protein-protein interactions essential for mycobacterial survival. The most significant finding is that Wag31, which directs polar elongation and maintains the intracellular membrane domain, was revealed to have membrane tethering capabilities.

      Strengths:

      The authors provided a detailed analysis of Wag31 domain architecture, revealing distinct functional roles: the N-terminal domain facilitates lipid binding and membrane tethering, while the C-terminal domain mediates protein-protein interactions. Overall, this study offers a robust and new understanding of Wag31 function.

      Weaknesses:

      The following major concerns should be addressed.

      • Authors use 10-N-Nonyl-acridine orange (NAO) as a marker for cardiolipin localization. However, given that NAO is known to bind to various anionic phospholipids, how do the authors know that what they are seeing is specifically visualizing cardiolipin and not a different anionic phospholipid? For example, phosphatidylinositol is another abundant anionic phospholipid in mycobacterial plasma membrane.

      We thank the reviewer for the comments. Despite its promiscuous binding to other anionic phospholipids, 10-N-Nonyl-acridine orange is widely used to stain Cardiolipin and determine its localisation in bacterial cells and mitochondria of eukaryotes (Garcia Fernandez et al., 2004; Mileykovskaya & Dowhan, 2000; Renner & Weibel, 2011).  This is because it has a stronger affinity for Cardiolipin than other anionic phospholipids with the affinity constant being 2 × 10<sup>6</sup> M<sup>−1</sup> for Cardiolipin association and 7 × 10<sup>4</sup> M<sup>−1</sup> for that of phosphatidylserine and phosphatidylinositol association (Petit et al., 1992). Additionally, there is not yet another stain available for detecting Cardiolipin. Our protein-lipid binding assays suggest that Wag31 preferentially binds to Cardiolipin over other anionic phospholipids (Fig. 4b), hence it is likely that the majority of redistribution of NAO fluorescence that we observe might be contributed by Cardiolipin mislocalization due to altered Wag31 levels, with smaller degree of NAO redistribution intensity coming indirectly from other anionic phospholipids displaced from the membrane due to the loss of membrane integrity and cell shape changes due to Wag31.

      • Authors' data show that the N-terminal region of Wag31 is important for membrane tethering. The authors' data also show that the N-terminal region is important for sustaining mycobacterial morphology. However, the authors' statement in Line 256 "These results highlight the importance of tethering for sustaining mycobacterial morphology and survival" requires additional proof. It remains possible that the N-terminal region has another unknown activity, and this yet-unknown activity rather than the membrane tethering activity drives the morphological maintenance. Similarly, the N-terminal region is important for lipid homeostasis, but the statement in Line 270, "the maintenance of lipid homeostasis by Wag31 is a consequence of its tethering activity" requires additional proof. The authors should tone down these overstatements or provide additional data to support their claims.

      We agree with the reviewer that there exists a possibility for another function of the N-terminal that may contribute to sustaining mycobacterial physiology and survival. We would revise our statements in the paper to accurately reflect the data. Results shown suggest that the tethering activity of the N-terminal region may contribute to mycobacterial morphology and survival. However, additional functions of this region can’t be ruled out. Similarly, the maintenance of lipid homeostasis by Wag31 may be associated with its tethering activity, although other mechanisms could also contribute to this process. 

      • Authors suggest that Wag31 acts as a scaffold for the IMD (Fig. 8). However, Meniche et. al. has shown that MurG as well as GlfT2, two well-characterized IMD proteins, do not colocalize with Wag31 (DivIVA) (https://doi.org/10.1073/pnas.1402158111). IMD proteins are always slightly subpolar while Wag31 is located to the tip of the cell. Therefore, the authors' biochemical data cannot be easily reconciled with microscopic observations in the literature. This raises a question regarding the validity of protein-protein interaction shown in Figure 7. Since this pull-down assay was conducted by mixing E. coli lysate expressing Wag31 and Msm lysate expression Wag31 interactors like MurG, it is possible that the interactions are not direct. Authors should interpret their data more cautiously. If authors cannot provide additional data and sufficient justifications, they should avoid proposing a confusing model like Figure 8 that contradicts published observations.

      In the literature, MurG and GlfT2 have been shown to have polar localization (Freeman et al., 2023; Hayashi et al., 2016; Kado et al., 2023), and two groups have shown slightly sub-polar localization of MurG (García-Heredia et al., 2021; Meniche et al., 2014). Additionally, (Freeman et al., 2023) they showed SepIVA to be a spatio-temporal regulator of MurG. MS/MS analysis of Wag31 immunoprecipitation data yielded both MurG and SepIVA to be interactors of Wag31 (Fig. 3). Given Wag31 also displays polar localisation, it likely associates with the polar MurG. However, since a sub-polar localization of MurG has also been reported, it is possible that they do not interact directly, and another protein mediates their interaction. We will modify the model proposed in Fig. 8 based on the above.

      We agree that for validation of interaction, we performed pulldown experiments by mixing E. coli lysates expressing His-Wag31 full-length or truncated protein with M. smegmatis lysates expressing FLAG-tagged interacting proteins. The wash conditions used were quite stringent for these pull-down assays—the wash buffer containing 1% Triton X100, which eliminates all non-specific and indirect interactions.  However, we agree that we cannot conclusively state that the interactions are direct without purifying the proteins and performing the experiment. We will describe this caveat in the revised manuscript and propose a model reflecting our results.

      References:

      Freeman, A. H., Tembiwa, K., Brenner, J. R., Chase, M. R., Fortune, S. M., Morita, Y. S., & Boutte, C. C. (2023). Arginine methylation sites on SepIVA help balance elongation and septation in Mycobacterium smegmatis. Mol Microbiol, 119(2), 208-223. https://doi.org/10.1111/mmi.15006

      Garcia Fernandez, M. I., Ceccarelli, D., & Muscatello, U. (2004). Use of the fluorescent dye 10-N-nonyl acridine orange in quantitative and location assays of cardiolipin: a study on different experimental models. Anal Biochem, 328(2), 174-180. https://doi.org/10.1016/j.ab.2004.01.020

      García-Heredia, A., Kado, T., Sein, C. E., Puffal, J., Osman, S. H., Judd, J., Gray, T. A., Morita, Y. S., & Siegrist, M. S. (2021). Membrane-partitioned cell wall synthesis in mycobacteria. eLife, 10. https://doi.org/10.7554/eLife.60263

      Habibi Arejan, N., Ensinck, D., Diacovich, L., Patel, P. B., Quintanilla, S. Y., Emami Saleh, A., Gramajo, H., & Boutte, C. C. (2022). Polar protein Wag31 both activates and inhibits cell wall metabolism at the poles and septum. Front Microbiol, 13, 1085918. https://doi.org/10.3389/fmicb.2022.1085918

      Hayashi, J. M., Luo, C. Y., Mayfield, J. A., Hsu, T., Fukuda, T., Walfield, A. L., Giffen, S. R., Leszyk, J. D., Baer, C. E., Bennion, O. T., Madduri, A., Shaffer, S. A., Aldridge, B. B., Sassetti, C. M., Sandler, S. J., Kinoshita, T., Moody, D. B., & Morita, Y. S. (2016). Spatially distinct and metabolically active membrane domain in mycobacteria. Proc Natl Acad Sci U S A, 113(19), 5400-5405. https://doi.org/10.1073/pnas.1525165113

      Kado, T., Akbary, Z., Motooka, D., Sparks, I. L., Melzer, E. S., Nakamura, S., Rojas, E. R., Morita, Y. S., & Siegrist, M. S. (2023). A cell wall synthase accelerates plasma membrane partitioning in mycobacteria. eLife, 12, e81924. https://doi.org/10.7554/eLife.81924

      Meniche, X., Otten, R., Siegrist, M. S., Baer, C. E., Murphy, K. C., Bertozzi, C. R., & Sassetti, C. M. (2014). Subpolar addition of new cell wall is directed by DivIVA in mycobacteria. Proc Natl Acad Sci U S A, 111(31), E3243-3251. https://doi.org/10.1073/pnas.1402158111

      Mileykovskaya, E., & Dowhan, W. (2000). Visualization of phospholipid domains in Escherichia coli by using the cardiolipin-specific fluorescent dye 10-N-nonyl acridine orange. J Bacteriol, 182(4), 1172-1175. https://doi.org/10.1128/JB.182.4.1172-1175.2000

      Petit, J. M., Maftah, A., Ratinaud, M. H., & Julien, R. (1992). 10N-nonyl acridine orange interacts with cardiolipin and allows the quantification of this phospholipid in isolated mitochondria. Eur J Biochem, 209(1), 267-273. https://doi.org/10.1111/j.1432-1033.1992.tb17285.x

      Renner, L. D., & Weibel, D. B. (2011). Cardiolipin microdomains localize to negatively curved regions of Escherichia coli membranes. Proc Natl Acad Sci U S A, 108(15), 6264-6269. https://doi.org/10.1073/pnas.1015757108

      Xu, W. X., Zhang, L., Mai, J. T., Peng, R. C., Yang, E. Z., Peng, C., & Wang, H. H. (2014). The Wag31 protein interacts with AccA3 and coordinates cell wall lipid permeability and lipophilic drug resistance in Mycobacterium smegmatis. Biochem Biophys Res Commun, 448(3), 255-260. https://doi.org/10.1016/j.bbrc.2014.04.116

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In the manuscript by Su et al., the authors present a massively parallel reporter assay (MPRA) measuring the stability of in vitro transcribed mRNAs carrying wild-type or mutant 5' or 3' UTRs transfected into two different human cell lines. The goal presented at the beginning of the manuscript was to screen for effects of disease-associated point mutations on the stability of the reporter RNAs carrying partial human 5' or 3' UTRs. However, the majority of the manuscript is dedicated to identifying sequence components underlying the differential stability of reporter constructs. This shows that TA dinucleotides are the most predictive feature of RNA stability in both cell lines and both UTRs.

      The effect of AU rich elements (AREs) on RNA stability is well established in multiple systems, and the present study confirms this general trend but points out variability in the consequence of seemingly similar motifs on RNA stability. For example, the authors report that a long stretch of Us has extreme opposite effects on RNA stability depending on whether it is preceded by an A (strongly destabilizing) or followed by an A (strongly stabilizing). While the authors interpretation of a context- dependence of the effect is certainly well-founded, it seems counterintuitive that the preceding or following A would be the (only) determining factor. This points to a generally reductionist approach taken by the authors in the analysis of the data and in their attempt to dissect the contribution of "AU rich sequences" to RNA stability, with a general tendency to reduce the size and complexity of the features (e.g. to dinucleotides). While this certainly increases the statistical power of the analysis due to the number of occurrences of these motifs, it limits the interpretability of the results. How do TA dinucleotides per se contribute to destabilizing the RNA, both in 5' and 3' UTRs, but (according to limited data presented) not in coding sequences? What is the mechanism? RBPs binding to TA dinucleotide containing sequences are suggested to "mask" the destabilizing effect, thereby leading to a more stable RNA. Gain of TA dinucleotides is reported to have a destabilizing effect, but again no hypothesis is provided as to the underlying molecular mechanism. In addition to reducing the motif length to dinucleotides, the notion of "context dependence" is used in a very narrow sense; especially when focusing on simple and short motifs, a more extensive analysis of the interdependence of these features (beyond the existing analysis of the relationship between TA- diNTs and GC content) could potentially reveal more of the context dependence underlying the seemingly opposite behavior of very similar motifs.

      (We have used UA instead of TA, as per the reviewer's suggestion)

      The contribution of coding region sequence to RNA stability has been extensively discussed (For example: doi.org/10.1016/j.molcel.2022.03.032; doi.org/10.1186/s13059-020-02251-5; doi.org/10.15252/embr.201948220; doi.org/10.1371/journal.pone.0228730; doi.org/10.7554/eLife.45396). While UA content at the third codon position (wobble position) has been implicated as a pro-degradation signal, codon optimality has emerged as the most prominent determinant for RNA stability. This indicates that the role of coding regions in RNA stability differs from that of UTRs due to the involvement of translation elongation. We did not intend to suggest that UA-dinucleotides in UTRs and coding regions have the same effect. 

      To ensure the representativeness of the features entered into the LASSO model, we pre-selected those with an occurrence greater than 10% among all UTRs. As a result, while motifs with very low occurrences were excluded from the analysis, there is no evidence to indicate a preference for dinucleotides by the LASSO model.

      We hypothesize that UA-dinucleotide may recruit endonucleases RNase A family, whose catalytic pockets exhibit a strong bias for UA dinucleotide (doi.org/10.1016/j.febslet.2010.04.018). Structures or protein bindings that block this recognition might stabilize RNAs. To gain further insight into the motif interactions, we investigated the interactions between UA and other 15 dinucleotides through more detailed analyses. We conducted a linear regression analysis investigating interactions between UA and the other 15 dinucleotides. The formula used below includes UA:

      , where all 𝛽 terms represent the regression coefficients, and , , and represent the number of UA dinucleotides, the number of other dinucleotides (other than UA), and the GC content of the i<sup>th</sup> UTR, respectively, and 𝜖<sub>i</sub> denotes the error term. For each dinucleotide, we tested the significance of 𝛽<sub>UAxGC%</sub> and 𝛽<sub>UAxDiNT</sub>, and compared their p-values using a quantile-quantile (QQ) plot. Author response image 1 shows that the interaction effect of UA dinucleotides with GC% is much more significant than interactions with the other 15 dinucleotides, as indicated by the inflated QQ plot of p-values. This suggests that GC content is a more critical contextual factor influencing UA dinucleotides' impact on RNA stability.

      Author response image 1.

      The present MPRAs measures the effect of UTR sequences in one specific reporter context and using one experimental approach (following the decay of in vitro transcribed and transfected RNAs). While this approach certainly has its merits compared to other approaches, it also comes with some caveats: RNA is delivered naked, without bound RBPs and no nuclear history, e.g. of splicing (no EJCs), editing and modifications. One way to assess the generalizability of the results as well as the context dependence of the effects is to perform the same analysis on existing datasets of RNA stability measurements obtained through other methods (e.g. transcription inhibition). Are TA dinucleotides universally the most predictive feature of RNA half-lives?

      Our system studies the stability control of RNA synthesized in vitro and delivered into human cells. While we did not intend to generalize our conclusions to endogenous RNAs, our approach contributes to the understanding of in vitro synthesized RNA used for cellular expression, such as in vaccines. It is known that endogenous RNAs undergo very different regulation. The most prominent factors controlling endogenous RNA stability are the density of splice junctions and the length of UTRs (doi.org/10.1186/s13059-022-02811-x; doi.org/10.1186/s12915-021-00949-x). To decipher the sequence regulation, these factors are controlled in our experiments. Therefore, we do not expect the dinucleotide features found by our approach to be generalized as the most predictive feature of RNA half-life in vivo. 

      The authors conclude their study with a meta-analysis of genes with increased TA dinucleotides in 5' and 3'UTRs, showing that specific functional groups are overrepresented among these genes. In addition, they provide evidence for an effect of disease-associated UTR mutations on endogenous RNA stability. While these elements link back to the original motivation of the study (screening for effects of point mutations in 5' and 3' UTRs), they provide only a limited amount of additional insights.

      We utilized the Taiwan Biobank to investigate whether mutations significantly affecting RNA stability also impact human biochemical measurements. Our findings indicate that these mutations indeed have a significant effect on various biochemical indices. This highlights the importance of our study, as it bridges basic science with potential applications in precision medicine. By linking specific UTR mutations with measurable changes in biochemical indices, our research underscores the potential for these findings to inform targeted medical interventions in the future.

      In summary, this manuscript presents an interesting addition to the long-standing attempts at dissecting the sequence basis of RNA stability in human cells. The analysis is in general very comprehensive and sound; however, at times the goal of the authors to find novelty and specificity in the data overshadows some analyses. One example is the case where the authors try to show that TA-dinucleotides and GC content are decoupled and not merely two sides of the same coin.

      They claim that the effect of TA dinucleotides is different between high- and low-GC content contexts but do not control for the fact that low GC-content regions naturally will contain more TA dinucleotides and therefore the effect sizes and the resulting correlation between TA-diNT rate and stability will be stronger (Fig. 5A). A more thorough analysis and greater caution in some of the claims could further improve the credibility of the conclusions.

      Low GC content implies a higher UA content but does not directly equate to a high UA-dinucleotide ratio. For instance, the sequence AUUGAACCUU has a lower GC content (0.3) compared to UAUAGGCCGC (0.6), yet it also has a lower UA-dinucleotide ratio (0 vs. 0.22). To address this concern more rigorously, we performed a stratified analysis based on UA-diNT rate. As shown in our Fig. S7C, even after stratifying by UA- dinucleotide ratio (upper panel high UA- dinucleotide ratio / lower panel low UA- dinucleotide ratio), we still observe that the destabilizing effect of UA is stronger in the low GC content group.

      Reviewer #2 (Public Review):

      Summary of goals:

      Untranslated regions are key cis-regulatory elements that control mRNA stability, translation, and translocation. Through interactions with small RNAs and RNA binding proteins, UTRs form complex transcriptional circuitry that allows cells to fine-tune gene expression. Functional annotation of UTR variants has been very limited, and improvements could offer insights into disease relevant regulatory mechanisms. The goals were to advance our understanding of the determinants of UTR regulatory elements and characterize the effects of a set of "disease-relevant" UTR variants.

      Strengths:

      The use of a massively parallel reporter assay allowed for analysis of a substantial set (6,555 pairs) of 5' and 3' UTR fragments compiled from known disease associated variants. Two cell types were used.

      The findings confirm previous work about the importance of AREs, which helps show validity and adds some detailed comparisons of specific AU-rich motif effects in these two cell types.

      Using a Lasso regression, TA-dinucleotide content is identified as a strong regulator of RNA stability in a context dependent manner based on GC content and presence of RNA binding protein binding motifs. The findings have potential importance, drawing attention to a UTR feature that is not well characterized.

      The use of complementary datasets, including from half-life analyses of RNAs and from random sequence library MRPA's, is a useful addition and supports several important findings. The finding the TA dinucleotides have explanatory power separate from (and in some cases interacting with) GC content is valuable.

      The functional enrichment analysis suggests some new ideas about how UTRs may contribute to regulation of certain classes of genes.

      Weaknesses:

      It is difficult to understand how the calculations for half-life were performed. The sequencing approach measures the relative frequency of each sequence at each time point (less stable sequences become relatively less frequent after time 0, whereas more stable sequences become relatively more frequent after time 0). Since there is no discussion of whether the abundance of the transfected RNA population is referenced to some external standard (e.g., housekeeping RNAs), it is not clear how absolute (rather than relative) half-lives were determined.

      We estimated decay constant λ and half-life (t<sub>1/2</sub>) by the following equations:

      where C<sub>i(t)</sub> and C<sub>i(t=0)</sub> are read count values of the ith replicate at time points 𝑡 and 0 (see also Methods). The absolute abundance was not required for the half-life calculation. 

      Fig. S1A and B are used to assess reproducibility. They show that read counts at a given time point correlate well across replicate experiments. However, this is not a good way to assess reproducibility or accuracy of the measurements of t1/2 are. (The major source of variability in read counts in these plots - especially at early time points - is likely the starting abundance of each RNA sequence, not stability.) This creates concerns about how well the method is measuring t1/2. Also creating concern is the observation that many RNAs are associated with half-lives that are much longer than the time points analyzed in the study. For example, based upon Figure S1 and Table S1 correctly, the median t1/2 for the 5' UTR library in HEK cells appears to be >700 minutes. Given that RNA was collected at 30, 75, and 120 minutes, accurate measurements of RNAs with such long half lives would seem to be very difficult.

      We estimated the half-life based on the following equations:

      where C<sub>i(t)</sub> and C<sub>i(t=0)</sub> are read count values of the ith replicate at time points 𝑡 and 0 (see also Methods). The calculation of the half-life involves first determining the decay constant 𝜆, which represents a constant rate of decay. Since 𝜆 is a constant, it is possible to accurately calculate it without needing data over the entire decay range. Our experimental design considers this by selecting appropriate time points to ensure a reliable estimation of 𝜆, and thus, the half-life. To determine the most suitable time points, we conducted preliminary experiments using RT-PCR.

      These experiments indicated that 30, 75, and 120 minutes provided an effective range for capturing the decay dynamics of the transcripts.

      There is no direct comparison of t1/2 between the two cell types studied for the full set of sequences studied. This would be helpful in understanding whether the regulatory effects of UTRs are generally similar across cell lines (as has been shown in some previous studies) or whether there are fundamental differences. The distribution of t1/2's is clearly quite different in the two cell lines, but it is important to know if this reflects generally slow RNA turnover in HEK cells or whether there are a large number of sequence-specific effects on stability between cell lines. A related issue is that it is not clear whether the relatively small number of significant variant effects detected in HEK cells versus SH-SY5Y cells is attributable to real biological differences between cell types or to technical issues (many fewer read counts and much longer half lives in HEK cells).

      For both cell lines, we selected oligonucleotides with R<sup>2</sup> > 0.5 and mean squared error (MSE) < 1 for analysis when estimating half-life (λ) by linear regression. This selection criterion was implemented to minimize the effect of experimental noise. After quality control, we selected common UTRs and compared the RNA half-lives of the two cell lines using a scatter plot. Author response image 2 shows that RNA half-lives are quite different between the cell lines, with a moderate similarity observed in the 5' UTRs (R = 0.21), while the correlation in the 3' UTRs is non-significant.

      Author response image 2.

      Despite the low correlation of mRNA half-life between the two cell lines, UA-dinucleotide and UA-rich sequences consistently emerge as the most significant destabilizing features, suggesting a shared regulatory mechanism across diverse cellular environments.

      The general assertion is made in many places that TA dinucleotides are the most prominent destabilizing element in UTRs (e.g., in the title, the abstract, Fig. 4 legend, and on p. 12). This appears to be true for only one of the two cell lines tested based on Fig. 3.

      UA-dinucleotides and other UA-rich sequences exhibit similar effects on RNA stability, as illustrated in Fig. S5A-C. In two cell lines, UA-dinucleotide and WWWWWW sequences were representatives of the same stability-affecting cluster. While the impact of UA-dinucleotides can be generalized, we have rephrased some statements for clarification to avoid any potential misunderstanding. For examples: 

      Abstract: “...We found that UA dinucleotides and UA-rich motifs are the most prominent destabilizing element.“

      p.10: “UA dinucleotides and UA-rich motifs are the most common and effective RNA destabilizing factor” 

      Figure 4: “The UTR UA dinucleotides and UA-rich motifs are the most common and influential RNA destabilizing factor.”

      Appraisal and impact:

      The work adds to existing studies that previously identified sequence features, including AREs and other RNA binding protein motifs, that regulate stability and puts a new emphasis on the role of "TA" (better "UA") dinucleotides. It is not clear how potential problems with the RNA stability measurements discussed above might influence the overall conclusions, which may limit the impact unless these can be addressed.

      It is difficult to understand whether the importance of TA dinucleotides is best explained by their occurrence in a related set of longer RBP binding motifs (see Fig 5J, these motifs may be encompassed by the "WWWWWW cluster") or whether some other explanation applies. Further discussion of this would be helpful. Does the LASSO method tend to collapse a more diverse set of longer motifs that are each relatively rare compared to the dinucleotide? It remains unclear whether TA dinucleotides are associated with less stability independent of the presence of the known larger WWWWWWW motif. As noted above, the importance of TA dinucleotides in the HEK experiments appears to be less than is implied in the text.

      To ensure the representativeness of the features entered into the LASSO model, we pre-selected those with an occurrence greater than 10% among all UTRs. There is no evidence to support a preference for dinucleotides by LASSO. To address whether the destabilizing effect of UA dinucleotides is part of the broader WWWWWW motif, we divided UA dinucleotides into two groups: those within the WWWWWW motif and those outside of it. Specifically, we divided UTRs into two categories: 'at least one UA within a WWWWWW motif' and 'no UA within a WWWWWW motif,' and visualized the results using a boxplot. As shown in Author response image 3, the destabilizing trend still remains for UA dinucleotides outside of the WWWWWW motif, although the effect appears to be more pronounced when UA is within the WWWWWW motif. This suggests that while UA dinucleotides have a destabilizing effect independently, their impact is amplified when they are part of the broader WWWWWW motif.

      Author response image 3.

      The inclusion of more than a single cell type is an acknowledgement of the importance of evaluating cell type-specific effects. The work suggests a number of cell type-specific differences, but due to technical issues (especially with the HEK data, as outlined above) and the use of only two cell lines, it is difficult to understand cell type effects from the work.

      The inclusion of both 3' and 5' UTR sequences distinguishes this work from most prior studies in the field. Contrasting the effects of these regions on stability is of interest, although the role of these UTRs (especially the 5' UTR) in translational regulation is not assessed here.

      We examined the role of UTR and UTR variants in translation regulation using polysome profiling. By both univariate analysis and an elastic regression model, we identified motifs of short repeated sequences, including SRSF2 binding sites, as mutation hotspots that lead to aberrant translation. Furthermore, these polysome-shifting mutations had a considerable impact on RNA secondary structures, particularly in upstream AUG-containing 5’ UTRs. Integrating these features, our model achieved high accuracy (AUROC > 0.8) in predicting polysome-shifting mutations in the test dataset. Additionally, metagene analysis indicated that pathogenic variants were enriched at the upstream open reading frame (uORF) translation start site, suggesting changes in uORF usage underlie the translation deficiencies caused by these mutations. Illustrating this, we demonstrated that a pathogenic mutation in the IRF6 5’ UTR suppresses translation of the primary open reading frame by creating a uORF. Remarkably, site-directed ADAR editing of the mutant mRNA rescued this translation deficiency. Because the regulation of translation and stability does not converge, we illustrate these two mechanisms in two separate manuscripts (this one and doi.org/10.1101/2024.04.11.589132).

      Reviewer #3 (Public Review):

      Summary:

      In their manuscript titled "Multiplexed Assays of Human Disease‐relevant Mutations Reveal UTR

      Dinucleotide Composition as a Major Determinant of RNA Stability" the authors aim to investigate the effect of sequence variations in 3'UTR and 5'UTRs on the stability of mRNAs in two different human cell lines.

      To do so, the authors use a massively parallel reporter assay (MPRA). They transfect cells with a set of mRNA reporters that contain sequence variants in their 3' or 5' UTRs, which were previously reported in human diseases. They follow their clearance from cells over time relative to the matching non-variant sequence. To analyze their results, they define a set of factors (RBP and miRNA binding sites, sequence features, secondary structure etc.) and test their association with differences in mRNA stability. For features with a significant association, they use clustering to select a subset of factors for LASSO regression and identify factors that affect mRNA stability.

      They conclude that the TA dinucleotide content of UTRs is the strongest destabilizing sequence feature. Within that context, elevated GC content and protein binding can protect susceptible mRNAs from degradation. They also show that TA dinucleotide content of UTRs affects native mRNA stability, and that it is associated with specific functional groups. Finally, they link disease associated sequence variants with differences in mRNA stability of reporters.

      Strengths:

      This work introduces a different MPRA approach to analyze the effect of genetic variants. While previous works in tissue culture use DNA transfections that require normalization for transcription efficiency, here the mRNA is directly introduced into cells at fixed amounts, allowing a more direct view of the mRNA regulation.

      The authors also introduce a unique analysis approach, which takes into account multiple factors that might affect mRNA stability. This approach allows them to identify general sequence features that affect mRNA stability beyond specific genetic variants, and reach important insights on mRNA stability regulation. Indeed, while the conclusions to genetic variants identified in this work are interesting, the main strength of the work involve general effect of sequence features rather than specific variants.

      The authors provide adequate supports for their claims, and validate their analysis using both their reporter data and native genes. For the main feature identified, TA di-nucleotides, they perform follow-up experiments with modified reporters that further strengthen their claims, and also validate the effect on native cellular transcripts (beyond reporters), demonstrating its validity also within native scenarios.

      The work provides a broad analysis of mRNA stability, across two mRNA regulatory segments (3'UTR and 5'UTR) and is performed in two separate cell-types. Comparison between two different cell-types is adequate, and the results demonstrate, as expected, the dependence of mRNA stability on the cellular context. Analysis of 3'UTR and 5'UTR regulatory effects also shows interesting differences and similarities between these two regulatory regions.

      Weaknesses:

      (1) The authors fail to acknowledge several possible confounding factors of their MPRA approach in the discussion.

      First, while transfection of mRNA directly into cells allows to avoid the need to normalize for differences in transcription, the introduction of naked mRNA molecules is different than native cellular mRNAs and could introduce biases due to differences in mRNA modifications, protein associations etc. that may occur co-transcriptionally.

      Second, along those lines, the authors also use in-vitro polyadenylation. The length of the polyA tail of the transfected transcripts could potentially be very different than that of native mRNAs and also affect stability.

      The transcripts used in our study were polyadenylated in vitro with approximately 100 nucleotides 

      (Fig. S1C), similar to the polyA tail lengths typically observed in vivo (dx.doi.org/10.1016/j.molcel.2014.02.007).  Additionally, these transcripts were capped to emulate essential mRNA characteristics and to minimize immune responses in recipient cells. This design allows us to study RNA decay for in vitro-synthesized RNA delivered into human cells, akin to RNA vaccines, but it does not necessarily extend to endogenous RNAs. As mentioned, endogenous RNAs undergo nuclear processing and are decorated by numerous trans factors, resulting in distinct regulatory mechanisms. We therefore provided a more discussion on these differences and their implications in the revised manuscript: “However, while our approach effectively assesses the stability of synthesized RNA in human cells, it may not fully capture the decay dynamics of nuclear-synthesized RNA, which can be influenced by endogenous modifications and trans-acting RNA binding factors. (p. 18)”

      (2) The analysis approach used in this work for identifying regulatory features in UTRs was not previously used. As such, lack of in-depth details of the methodology, and possibly also more general validation of the approach, is a drawback in convincing the reader in the validity of this approach and its results.

      In particular, a main point that is not addressed is how the authors decide on the set of "factors" used in their analysis? As choosing different sets of factors might affect the results of the analysis. 

      In our study, we employed the calculation of the Variance Inflation Factor (VIF) as a basis for selecting variables. This well-established method is widely used to detect variables with high collinearity, thus ensuring the robustness and reliability of our analysis. By identifying and excluding highly collinear variables, we aimed to minimize multicollinearity and improve the accuracy of our regression models. For more detailed information on the use of VIF in regression analysis, please refer to Akinwande, M., Dikko, H., and Samson, A. (2015). Variance Inflation Factor: As a Condition for the Inclusion of Suppressor Variable(s) in Regression Analysis. Open Journal of Statistics, 5, 754-767. doi: 10.4236/ojs.2015.57075. We have included the method details in the revised manuscript (p. 28) :”… to avoid multicollinearity caused by similar features that perturb feature selection, all features were clustered using single-linkage hierarchical clustering with the distance metric defined as one minus the absolute value of the Spearman correlation coefficient. We cut the tree at a specific height, and the feature that had the greatest influence on RNA stability, which was examined using a simple linear regression model, was selected to be the representative of each cluster. Then we calculated the variance inflation factor (VIF) value of the representative features. The VIFs were obtained by the following linear model and equations:

      where and are the estimated value of the jth feature and the value of the kth feature of the ith UTR (note that the kth feature is a feature other than the jth feature), and are the intercept and the regression coefficients of the linear model that regressed the jth feature on the other remaining features, and is the mean level of the jth feature of all UTRs.”

      For example, the choice to use 7-mer sequences within the factors set is not explained, particularly when almost all motifs that are eventually identified (Figure 3B-E) are shorter.

      The known RBP motifs are primarily 6-mer. To explore the possibility of discovering novel motifs that could significantly impact our model, we started with 7-mer sequences. However, our analysis revealed that including these additional variables did not improve the explanatory power of the model; instead, it reduced it. Consequently, our final model focuses on motifs shorter than 7-mer. We explained the motif selections in the revised manuscript (p. 9): “Given our discovery that the effect of AREs is heavily dependent on sequence content, we decided to further explore the effects of other sequence elements, i.e., beyond known regulatory motifs, in more detail. Since most reported RBP motifs are 6-mers, we initiated a search for novel motifs by analyzing the presence of all 7-mers in our massively parallel reporter assay (MPRA) library, correlating their occurrence with mRNA half-life.”

      In addition, the authors do not perform validations to demonstrate the validity of their approach on simulated data or well-established control datasets. Such analysis would be helpful to further convince the reader in the usefulness and robustness of the analysis.

      We acknowledge the importance of validating our approach on simulated data or well-established control datasets to demonstrate its robustness and reliability. However, to the best of our knowledge, there are currently no well-established control datasets available that perfectly correspond to our specific study context. Despite this, we will continue to search for any relevant datasets that could be utilized for this purpose in future work. This effort will help to further reinforce the confidence in our methodology and its findings.

      (3) The analysis and regression models built in this work are not thoroughly investigated relative to native genes within cells. The effect of sequence "factors" on native cellular transcripts' stability is not investigated beyond TA di-nucleotides, and it is unclear to what degree do other predicted factors also affect native transcripts.

      Our system studies the stability control of RNA synthesized in vitro and delivered into human cells. While we validated the UTR UA-dinucleotide effect in vivo, we did not intend to conclude that this is the most influential regulation for endogenous RNAs. It is known that endogenous RNAs undergo very different regulation. The most prominent factors controlling endogenous RNA stability are the density of splice junctions and the length of UTRs (doi.org/10.1186/s13059-022-02811-x; doi.org/10.1186/s12915-021-00949-x). To decipher the sequence regulation, we controlled for these factors in our experiments. Therefore, we acknowledge that several endogenous features, which were excluded by our approach, may serve as predictive features of RNA half-life in vivo. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Specific comments:  

      Some references are missing, e.g for the sentence:

      Please see the response below.

      "Similarly, point mutation of the GFPT1 3' UTR results in congenital myasthenic syndrome." (p5)

      The reference has been added to the text:

      Dusl, M., Senderek, J., Muller, J. S., Vogel, J. G., Pertl, A., Stucka, R., Lochmuller, H., David, R., & Abicht, A. (2015). A 3'-UTR mutation creates a microRNA target site in the GFPT1 gene of patients with congenital myasthenic syndrome. Human Molecular Genetics, 24(12), 34183426. https://doi.org/10.1093/hmg/ddv090 

      "...but there have been no systematic assessments of the explicit effects of variants of both UTRs on stability regulation." (not true in the current phrasing; e.g. PMIDs 32719458, 36156153, 34849835)

      These references have been added to the text. However, we have to point out that these studies do not focus on the effects of the disease-relevant variants. To clarify, we modified the sentence to "... systematic assessments of the explicit effects of disease-relevant variants in both UTRs on stability regulation are still absent."

      "Multiple approaches have revealed AREs as exerting a destabilizing effect on RNA stability (Barreau et al., 2005). (p8)

      The reference has been added to the text:

      Barreau, C., Paillard, L., & Osborne, H. B. (2005). AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Research, 33(22), 7138-7150. https://doi.org/10.1093/nar/gki1012 

      "This effect is specific, as such ratios in the coding region are inconsequential." (p12)

      This refers to our findings of Fig. 4G and Supplemental Fig. S5F.

      What are the sequences at the 5' and 3'UTR without insertion of a library? 5'UTR library (especially in SH) has much longer half-life compared to 3'utr library (Fig S1D).

      There is no designed 5’UTR of the 3’UTR library, only the Kozak sequence derived from the pEGFPC1 vector. This may partially underlie the shorter half-life of the 3’ UTR library.

      Fig2A: What are the units? "half-life (log)" Do the numbers correspond to log10(min)?

      It represents ln (min). To clarify, we now use ‘ln t<sub>1/2</sub> (min)’ in all figures.

      Fig 2 and 3: This was done only on the wild-type sequences? Or all tested sequences together, wt and mut?

      It was done only on the wild-type sequences. To clarify, we modified the text to “we examined the effect of AREs on RNA stability of the ref alleles according to specific sequence content….(p.8)” and “We considered as many factors as possible to explain the half-life of our ref UTR libraries,…. (p.9)”. ‘ref’ stands for reference.

      "Furthermore, to avoid collinearity confounding our model, e.g., the effects of very similar factors (such as 'AA' and 'AAA' sequences), we clustered the factors according to their properties, and then only one representative factor from within a cluster (i.e., the one with the highest correlation to halflife within a cluster) was subjected to LASSO regression": Given the observed context dependence, e.g. in the case of poly-U stretches: Isn't this clustering leading to similar/identical motifs with different context being grouped together (such as polyU preceded by an A (strongly destabilizing, according to Fig 2B) or followed by one (strongly stabilizing, according to Fig 2B), resulting in ignoring the context or using one potential outcome while a motif from the same cluster can have the opposite effect?

      Thank you very much for pointing this out. To determine if considering different contextual effects within each feature cluster would enhance model performance, we modified our feature selection by choosing both the feature with the largest positive and the largest negative effect on RNA half-life in Step III of Figure 3A. We then split the data into a 2:1 training and testing set and repeated this process 100 times. Model performance was evaluated using mean average error (MAE), root mean squared error (RMSE), and adjusted R-squared. From Author response image 4, we observed no significant improvement in model performance using this new approach. Notably, in the SH-SY5Y 5' UTR model, our original method even outperformed the modified one, with statistically lower MAE and RMSE and a higher adjusted R-squared. Therefore, we believe our current approach remains appropriate.

      Author response image 4.

      "Overall, motifs that are at least two nucleotides long proved critical for RNA stability, supporting the sequence specificity of the decay process." Unclear why this supports the "sequence specificity"

      No monomers were selected as an explanatory factor. On the contrary, specific sequence combinations and order are important for the regulation. These findings suggest sequence-specific recognition for the decay process.

      Fig3: The same features were used in both cell lines? If yes: Since they were selected for their highest correlation with half-life, how was a common set chosen? If no: problematic to compare.

      Thank you for your question regarding feature selection across cell lines. Initially, the features were collected uniformly for both cell lines. However, subsequent feature selection steps were cell-type specific, focusing on identifying features with the greatest impact on RNA half-life in each context. This approach allows us to still compare model performance and discuss the similarities and differences in selected features across cell types. By maintaining a consistent starting point, we ensure that any observed differences reflect cell-specific regulatory dynamics.

      uORFs were not used as features?

      Thank you for pointing this out. At the beginning of our study, we investigated the impact of Kozak sequence strength (categorized as weak, moderate, strong, or optimal) on RNA half-life. However, we found that this feature performed poorly in predicting RNA stability, and as a result, we decided not to include upstream open reading frames (uORFs) or Kozak sequences in our subsequent analyses.

      Experimental reproducibility: Only correlations between replicates for the same time point is shown, but no comparison between time points or between decay rates. How reproducible were the paired differences between mut/wt?

      The decay rate was calculated by modeling the slope of a linear regression of all time points. Therefore, there is only one decay rate associated with a genotype. To rule out inconsistent data, we excluded any regression with a mean square error greater than 1, as this indicates a poor fit of the data points. 

      Fig 7C/p17: This does not establish a "causal relationship" as the authors claim.

      We agree with the reviewer’s suggestion. We have modified the text on p.17 to “to establish a correlation between UTR variants and health outcomes,…..”

      In the discussion, the authors claim that TA-diNTs are not only an opposite of the GC percentage and base this on Fig 5A.

      Fig 5A: The range of TA-diNTs is naturally much higher in the low GC group. To make the high and low GC content comparable (as the authors aim to do), the correlation should be assessed for the same range of TA dint in both cases.

      To address this concern more rigorously, we performed a stratified analysis based on UA-diNT rate. As shown in our Fig. S7C, even after stratifying by UA- dinucleotide ratio (upper panel high UA- dinucleotide ratio / lower panel low UA- dinucleotide ratio), we still observe that the destabilizing effect of UA is stronger in the low GC content group.

      Supplemental Figure S7. Interplay of GC content and TA dinucleotide on stability regulation, related to Figure 5. (C) Stratifications of both TA dinucleotide ratio and GC content showed that the destabilizing effect of TA dinucleotide is the most prominent under conditions of low TA dinucleotide ratio and low GC content. The same trend was observed for 5’ UTR (left) and 3’ UTR (right).

      The injection of in vitro transcribed and polyA/capped RNA certainly has advantages over other methods, but delivering naked mRNA without nuclear history might also lead to artifacts. The caveats of the approach should be discussed more extensively.

      We appreciate the suggestion and have hence added the following in the Discussion (p.18): “However, while our approach effectively assesses the stability of synthesized RNA in human cells, it may not fully capture the decay dynamics of nuclear-synthesized RNA, which can be influenced by endogenous modifications and trans-acting RNA binding factors.”

      "We unexpectedly identified many crucial regulatory features in 5' UTRs." Why was this unexpected?

      We initially thought the 3’ UTR would play a major role in stability regulation. To avoid confusion, we have removed the word ‘unexpected’ from the text (p. 20): "We identified many crucial regulatory features in 5' UTRs."

      "...a massively parallel reporter assay in which coding regions and human 5'/3' UTRs with diseaserelevant mutations were generated in vitro and then directly transfected into human cell lines to assess their decay patterns by next‐generation sequencing": also coding regions?

      Thanks for the question. Indeed, the coding region was not synthesized together with the UTR library. Therefore, we modified the text of p. 6 to “…we developed a massively parallel reporter assay in which human 5’/3’ UTRs with disease-relevant mutations were generated in vitro, ligated with the enhanced green fluorescence protein (EGFP) coding region, and then directly transfected into human cell lines to assess their decay patterns by next-generation sequencing.”

      Reviewer #2 (Recommendations For The Authors):

      Nomenclature: When discussing RNA sequences, "U" should be used in place of "T" (e.g., "UA dinucleotide").

      We have replaced the RNA sequence “T” with “U” of the text and figures.

      Abstract: "We examined the RNA degradation patterns mediated by the UTR library in multiple cell lines" - It would be clearer to state that two cell lines (rather than multiple) were used.

      We appreciate the suggestion. We have modified the abstract as suggested: “We examined the RNA degradation patterns mediated by the UTR library in two cell lines…"

      The manuscript refers to "wild-type (WT) and mutant (mt) alleles." (p. 7 and elsewhere). It would be better to use "reference" instead of "wild type" given that these are human populations.

      We appreciate the suggestion. All instances of ‘wild-type’ or ‘WT’ in the text and figures have been replaced with ‘reference’ or ‘ref’.

      In the introduction, it is stated that traditional MPRAs "cannot differentiate the effect of the UTRs on transcription, stability and, in some cases, even protein production, greatly limiting scientific interpretation." This is confusing, since these assays can and have been used in association with both RNA decay measurements and measurements of reporter protein levels that allow assessment of effects on stability and protein production (including in the cited references).

      We reason that the RNA steady-state level (e.g., sequencing the overall RNA normalized to DNA) or protein steady-state level (e.g., detecting the fluorescence signal) does not precisely reveal the decay kinetics of the RNA. Steady-state level is a result of production and decay, both of which UTRs contribute to. Similarly, the protein level is not a perfect estimate of the RNA decay.

      To clarify, we have modified the introduction (p. 5) to “Nevertheless, because the steady-state level is a result of production and decay, these approaches cannot differentiate the effect of the UTRs on transcription, stability and, in some cases, even protein production, greatly limiting scientific interpretation.” 

      Adding raw and normalized read count data from individual experiments (e.g., to Table S1) would make it more likely for others to use this dataset to address additional questions.

      All raw and processed sequencing data generated in this study have been submitted to the NCBI Gene Expression Omnibus (GEO; https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE217518 (reviewer token snspaakujtsdpcv).

      The manuscript would benefit from further clarification about model selection. Additional details regarding how the features were clustered, and the actual clusters themselves should be included.

      It should be discussed why Lasso was chosen vs Ridge or Elastic Net, in the context of handling multicollinearity. Often, data is subsetted for training and validation, and model performance metrics are presented.

      Thank you for pointing out the need for further clarification on model selection. The features were clustered using single-linkage hierarchical clustering with the distance metric defined as one minus the absolute value of the Spearman correlation coefficient (this information has been added to the manuscript on p. 28: “…to avoid multicollinearity caused by similar features that perturb feature selection, all features were clustered using single-linkage hierarchical clustering with the distance metric defined as one minus the absolute value of the Spearman correlation coefficient.”). The resulting feature clusters are available in Supplemental Table S3. 

      Regarding model selection, we chose LASSO over ridge and elastic net primarily for feature selection, as ridge does not perform feature selection. Elastic net is essentially a hybrid of ridge regression and LASSO regularization, but we opted for LASSO for its simplicity and effectiveness in selecting a sparse set of important features.

      We also performed a 2:1 training and testing set analysis and have included these details in the manuscript. Model performance metrics, including correlation coefficient between observed and predicted values in the testing set, mean absolute error (MAE), root mean squared error (RMSE), mean absolute percentage error (MAPE), and R-squared, are provided in new Supplemental Table S4.

      Recommend reviewing and correcting verb tenses in the methods section.

      We appreciate the reviewer’s suggestion. We have corrected verb tenses in the methods section, which includes “The UTRs were defined by NCBI RefSeq and ENCODE V27. (p.21)”, “The variant was placed in the middle of the sequence….(p.22)”, and “eCLIP signals with value < 1 or p value > 0.05 were removed. (p.26)”

      Please add information about which cell type(s) are being used in each of the figure legends (e.g., in Figs. 2B and 5).

      We appreciate the reviewer’s suggestion. We have added the cell type information in the figure legends: “Figure 2…. (B) The ten most influential AREs in terms of RNA stability in SH-SY5Y cells.” And “Figure 5…..(A) MPRA data of SH-SY5Y cells stratified according to the GC content (GC%) of UTRs.”

      Recommend review of axis labels and consistency in formatting the log(half-lives) and including the base of the log and the time unit (minutes). Even better, converting axis labels from log minutes to minutes would make this easier to understand.

      Thank you for the suggestion regarding axis labels and consistency. We have unified the half-life label to ‘ln t<sub>1/2</sub> (min)’ in all figures. We chose not to convert the axis from logarithmic minutes to minutes because the original scale is highly skewed, which would hinder clear data visualization.

      The discussion refers to Figure 1D but Figure 1 only has A-C

      Thank you for pointing out this mistake. ‘Fig. 1D’ has been changed to ‘Fig. 1B’ in the text (p. 7 and p. 20).

      The analyses in Fig. 2 are interpreted as demonstrating that AREs destabilize RNAs. These analyses are examining associations, so it would be more appropriate to say that AREs are associated with destabilization (since it is formally possible that other sequences that are present in these UTR fragment cause destabilization). A similar issue arises on p. 10: "TA dinucleotides alone can negatively regulate RNA stability, with a Pearson's correlation coefficient of ‐0.287 for 5' UTRs and ‐0.377 for 3' UTRs (Fig. 4A,C)." This is an association and does not establish causation. Again on p. 17: "We identified several SNPs in UTRs that induce aberrant RNA expression and/or protein expression (Supplemental Table S7)." These may be causal but may simply be in LD with other variants that are causal.

      We agree that the association observed is not proven to be causal. Therefore, we modified the text as suggested: 

      “AUUUA/AUUA-containing AREs are associated with RNA destabilization.” (p. 8)

      “UA dinucleotides alone present a negative correlation with RNA stability, with a Pearson’s correlation coefficient of -0.287 for 5’ UTRs and -0.377 for 3’ UTRs.”  (p.10)

      “We identified several SNPs in UTRs that correlated with aberrant RNA expression and/or protein expression.”  (p. 17)

      Figure 4C is important in that it examines whether variant sequences that differ in a manner that changes the number of dinucleotide repeats affect stability. Please show the number (not just the percentage) of sequences in each category.

      Thank you for your insightful comment. We believe the figure you referred to is Figure 4E. We have updated the figure to include the number of sequences in each category.

      Figure 6A and B: The horizontal axes appear to be misaligned since the dotted vertical lines do not cross at 0. ?

      The dotted vertical lines represent the genomic background of the UA-diNT ratio. To clarify it, we have modified the legend to: “Figure 6……(A) The top ten biological processes for which the 5’ UTR UA-dinucleotide ratio most significantly deviated from the genomic background (dashed line).”

      It may be helpful to state what the dashed and solid lines represent on Figure 6 E/F. Please correct spelling of "Biological" in 6E.

      As per the reviewer’s suggestions, we have modified the legend of Figure 6 to: “………..(E) Biological processes for RNAs in which the UA-dinucleotide ratios of both 5’ and 3’ UTRs are significantly different from the genomic background (dashed lines). (F) Molecular functions for RNAs in which the UA-dinucleotide ratios of both 5’ and 3’ UTRs are significantly different from the genomic background (dashed lines). The thin solid lines represent the standard deviation of the UAdinucleotide ratio within the gene group.” 

      In addition, the spelling of “Biological” in Fig. 6E has been corrected.

      Reviewer #3 (Recommendations For The Authors):

      I have 3 points that I think could improve science and its presentation within the manuscript.

      (1) Most importantly, how well do LASSO regression models predict the stability of native transcripts? Such analysis can also be useful for comparison between two different cell-types. How well does the regression model learned (on reporters) within one cell-type predict mRNA stability (of reporters and native genes) in this cell-type and in the other cell-type? Similarly, models can also help to analyze the effects of 5'UTR and 3'UTR sequences on mRNA stability. In particular, how well does the regression model of each separate regulatory sequence (3'UTR or 5'UTR) is able to predict the stability of native genes in the cell? Can the predictions be improved by combining both 3'UTR and 5'UTR sequence features within the regression models?

      The decay model for native transcripts has been established in prior research (doi.org/10.1186/s13059-022-02811-x; doi.org/10.1186/s12915-021-00949-x), which indicates that exon junction density and transcript length are the primary determinants of RNA stability. Based on these findings, we designed the MPRA with fixed length and without splicing to focus on the contribution of primary sequences. We validated the destabilizing effect of UA dinucleotide on endogenous RNAs (Fig. 4G and Supplemental Fig. S5F) but do not recommend using our model to fully explain or predict the stability of native transcripts.

      To assess the model's cross-cell type predictive performance for RNA half-life, we employed the Regression Error Characteristic (REC) curve (Bi & Bennett, 2003). Similar to the receiver operating characteristic (ROC) curve, the REC curve illustrates the trade-off between error tolerance and accuracy, with better performance indicated by curves trending toward the upper left. We also computed the Area Over the Curve (AOC) as a performance metric, where lower values indicate better predictive ability. From Author response image 5, the REC curves reveal that cross-cell type prediction performance is suboptimal. The y-axis represents prediction accuracy, while the x-axis denotes error tolerance for the natural logarithm of RNA half-life (ln(𝑡<sub>1/2</sub>), in minutes).

      Author response image 5.

      In response to the suggestion of combining 5' and 3' UTR sequence features in the regression model, we believe this approach may not be ideal. As shown in Figure S1D, the distribution of RNA half-lives between 5' and 3' UTRs is significantly different, reflecting their distinct regulatory roles. Additionally, the base composition differs, with 5' UTRs having a higher GC content compared to 3' UTRs. Combining these datasets would likely make the origin of the sequence (5' or 3' UTR) the most predictive feature, thereby reducing the model's interpretability. Furthermore, our MPRA results, derived from separate 5’ or 3’ UTR library, do not support a combined model, further suggesting this approach may not be suitable with our data.

      The conclusions regarding genetic variants are interesting, yet the main strength of the work involves identifying general sequence features that affect mRNA stability rather than specific variants. I wonder if the authors have considered to shift the focus of the motivation part to reflect that?

      We appreciated the reviewer’s suggestion. We have revised the abstract and introductions to emphasize the general UTR regulation. Here is the revised abstract:

      UTRs contain crucial regulatory elements for RNA stability, translation and localization, so their integrity is indispensable for gene expression. Approximately 3.7% of genetic variants associated with diseases occur in UTRs, yet a comprehensive understanding of UTR variant functions remains limited due to inefficient experimental and computational assessment methods. To systematically evaluate the effects of UTR variants on RNA stability, we established a massively parallel reporter assay on 6,555 UTR variants reported in human disease databases. We examined the RNA degradation patterns mediated by the UTR library in two cell lines, and then applied LASSO regression to model the influential regulators of RNA stability. We found that UA dinucleotides and UA-rich motifs are the most prominent destabilizing element. Gain of UA dinucleotide outlined mutant UTRs with reduced stability. Studies on endogenous transcripts indicate that high UA-dinucleotide ratios in UTRs promote RNA degradation. Conversely, elevated GC content and protein binding on UA dinucleotides protect high-UA RNA from degradation. Further analysis reveals polarized roles of UA-dinucleotide-binding proteins in RNA protection and degradation. Furthermore, the UA-dinucleotide ratio of both UTRs is a common characteristic of genes in innate immune response pathways, implying a coordinated stability regulation through UTRs at the transcriptomic level. We also demonstrate that stability-altering UTRs are associated with changes in biobank-based health indices, underscoring the importance of precise UTR regulation for wellness. Our study highlights the importance of RNA stability regulation through UTR primary sequences, paving the way for further exploration of their implications in gene networks and precision medicine.

      Plots presenting correlations (e.g., Figure 4A, 4C) are more informative when plotted as density plots (i.e., using colorscale to show density of the dots at each part of the plot).

      We greatly appreciate the reviewer's insightful suggestion regarding the use of density plots for presenting correlations. We have modified Figures 4A and 4C in the revised manuscript to implement density plotting. The updated figures now utilize a colorscale that highlights areas of high and low data density.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Recommendations for the authors):

      I am generally satisfied with the authors' revisions and response to my previous comments. I have amended my previous review.

      We thank Reviewer #1 for his valuable comments and suggestions, which improved this manuscript.

      Thank you for considering the comments in your revised version. I still feel a strong mismatch between the claims of optimal foraging behaviour and the results with little compelling evidence.

      On terminology: MTR means Migration Traffic Rates. The authors responded that in their study, MTR is defined as Movement traffic rates. I have two problems with this definition: i) it creates confusion in the literature on the definition of MTR, ii) a traffic inherently describes a movement, and this pleonasm is not necessary.

      We revised the acronyms in this article, replacing MTR with MoTR to clearly distinguish between Migration Traffic Rate (MTR) and Movement Traffic Rate (MoTR).

      Minimal size of insects: Please detail radar settings (power sent, STC; detection thresholds). These parameters define the minimal size of the detected animals.

      We added the following paragraph to provide additional information regarding the radar's detection capabilities:

      " with decreasing detection probability at increasing altitudes. The detection threshold, defined by the STC setting, was 93 dBm, and the transmit power was 25 kW."

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This study asks whether the phenomenon of crossmodal temporal recalibration, i.e. the adjustment of time perception by consistent temporal mismatches across the senses, can be explained by the concept of multisensory causal inference. In particular, they ask whether the explanation offered by causal inference better explains temporal recalibration better than a model assuming that crossmodal stimuli are always integrated, regardless of how discrepant they are.

      The study is motivated by previous work in the spatial domain, where it has been shown consistently across studies that the use of crossmodal spatial information is explained by the concept of multisensory causal inference. It is also motivated by the observation that the behavioral data showcasing temporal recalibration feature nonlinearities that, by their nature, cannot be explained by a fixed integration model (sometimes also called mandatory fusion).

      To probe this the authors implemented a sophisticated experiment that probed temporal recalibration in several sessions. They then fit the data using the two classes of candidate models and rely on model criteria to provide evidence for their conclusion. The study is sophisticated, conceptually and technically state-of-the-art, and theoretically grounded. The data clearly support the authors’ conclusions.

      I find the conceptual advance somewhat limited. First, by design, the fixed integration model cannot explain data with a nonlinear dependency on multisensory discrepancy, as already explained in many studies on spatial multisensory perception. Hence, it is not surprising that the causal inference model better fits the data.

      We have addressed this comment by including an asynchrony-contingent model, which is capable of predicting the nonlinearity of recalibration effects by employing a heuristic approximation of the causal-inference process (Fig. 3). We also updated the previous competitor model with a more reasonable asynchrony-correction model as the baseline of model comparison, which assumes recalibration aims to restore synchrony whenever the sensory measurement of SOA indicates an asynchrony. The causal-inference model outperformed both models, as indicated by model evidence (Fig. 4A). Furthermore, model predictions show that the causal-inference model more accurately captures recalibration at large SOAs at both the group (Fig. 4B) and the individual levels (Fig. S4).

      Second, and again similar to studies on spatial paradigms, the causal inference model fails to predict the behavioral data for large discrepancies. The model predictions in Figure 5 show the (expected) vanishing recalibration for large delta, while the behavioral data don’t decay to zero. Either the range of tested SOAs is too small to show that both the model and data converge to the same vanishing effect at large SOAs, or the model's formula is not the best for explaining the data. Again, the studies using spatial paradigms have the same problem, but in my view, this poses the most interesting question here.

      We included an additional simulation (Fig. 5B) to show that the causal-inference model can predict non-zero recalibration for long adapter SOAs, especially in observers with a high common-cause prior and low sensory precision. This ability to predict a non-zero recalibration effect even at large SOA, such as 0.7 s, is one key feature of the causal-inference model that distinguishes it from the asynchrony-contingent model.

      In my view there is nothing generally wrong with the study, it does extend the 'known' to another type of paradigm. However, it covers little new ground on the conceptual side.

      On that note, the small sample size of n=10 is likely not an issue, but still, it is on the very low end for this type of study.

      This study used a within-subject design, which included 3 phases each repeated in 9 sessions, totaling 13.5 hours per participant. This extensive data collection allows us to better constrain the model for each participant. Our conclusions are based on the different models’ ability to fit individual data.

      Reviewer #2 (Public Review):

      Summary:

      Li et al.’s goal is to understand the mechanisms of audiovisual temporal recalibration. This is an interesting challenge that the brain readily solves in order to compensate for real-world latency differences in the time of arrival of audio/visual signals. To do this they perform a 3-phase recalibration experiment on 9 observers that involves a temporal order judgment (TOJ) pretest and posttest (in which observers are required to judge whether an auditory and visual stimulus were coincident, auditory leading or visual leading) and a conditioning phase in which participants are exposed to a sequence of AV stimuli with a particular temporal disparity. Participants are required to monitor both streams of information for infrequent oddballs, before being tested again in the TOJ, although this time there are 3 conditioning trials for every 1 TOJ trial. Like many previous studies, they demonstrate that conditioning stimuli shift the point of subjective simultaneity (pss) in the direction of the exposure sequence.

      These shifts are modest - maxing out at around -50 ms for auditory leading sequences and slightly less than that for visual leading sequences. Similar effects are observed even for the longest offsets where it seems unlikely listeners would perceive the stimuli as synchronous (and therefore under a causal inference model you might intuitively expect no recalibration, and indeed simulations in Figure 5 seem to predict exactly that which isn't what most of their human observers did). Overall I think their data contribute evidence that a causal inference step is likely included within the process of recalibration.

      Strengths:

      The manuscript performs comprehensive testing over 9 days and 100s of trials and accompanies this with mathematical models to explain the data. The paper is reasonably clearly written and the data appear to support the conclusions.

      Weaknesses:

      While I believe the data contribute evidence that a causal inference step is likely included within the process of recalibration, this to my mind is not a mechanism but might be seen more as a logical checkpoint to determine whether whatever underlying neuronal mechanism actually instantiates the recalibration should be triggered.

      We have addressed this comment by replacing the fixed-update model with an asynchrony-correction model, which assumes that the system first evaluates whether the measurement of SOA is asynchronous, thus indicating a need for recalibration (Fig. 3). If it does, it shifts the audiovisual bias by a proportion of the measured SOA. We additionally included an asynchrony-contingent model, which is capable of replicating the nonlinearity of recalibration effects by a heuristic approximation of the causal-inference process.

      Model comparisons indicate that the causal-inference model of temporal recalibration outperforms both alternative models (Fig. 4A). Furthermore, the model predictions demonstrate that the causal-inference model more accurately captures recalibration at large SOAs at both the group level (Fig. 4B) and individual level (Fig. S4).

      The authors’ causal inference model strongly predicts that there should be no recalibration for stimuli at 0.7 ms offset, yet only 3/9 participants appear to show this effect. They note that a significant difference in their design and that of others is the inclusion of longer lags, which are unlikely to originate from the same source, but don’t offer any explanation for this key difference between their data and the predictions of a causal inference model.

      We added further simulations to show that the causal-inference model can predict non-zero recalibration also for longer adapter SOAs, especially in observers with a large common-cause prior (Fig. 5A) and low sensory precision (Fig. 5B). This ability to predict a non-zero recalibration effect even at longer adapter SOAs, such as 0.7 s, is a key feature of the causal-inference model that distinguishes it from the asynchrony-contingent model.

      I’m also not completely convinced that the causal inference model isn’t ‘best’ simply because it has sufficient free parameters to capture the noise in the data. The tested models do not (I think) have equivalent complexity - the causal inference model fits best, but has more parameters with which to fit the data. Moreover, while it fits ‘best’, is it a good model? Figure S6 is useful in this regard but is not completely clear - are the red dots the actual data or the causal inference prediction? This suggests that it does fit the data very well, but is this based on predicting held-out data, or is it just that by having more parameters it can better capture the noise? Similarly, S7 is a potentially useful figure but it's not clear what is data and what are model predictions (what are the differences between each row for each participant; are they two different models or pre-test post-test or data and model prediction?!).

      I'm not an expert on the implementation of such models but my reading of the supplemental methods is that the model is fit using all the data rather than fit and tested on held-out data. This seems problematic.

      We recognize the risk of overfitting with the causal-inference model. We now rely on Bayesian model comparisons, which use model evidence for model selection. This method automatically incorporates a penalty for model complexity through the marginalization over the parameter space (MacKay, 2003).

      Our design is not suitable for cross-validation because the model-fitting process is computationally intensive and time-consuming. Each fit of the causal-inference model takes approximately 30 hours, and multiple fits with different initial starting points are required to rule out that the parameter estimates correspond to local minima.

      I would have liked to have seen more individual participant data (which is currently in the supplemental materials, albeit in a not very clear manner as discussed above).

      We have revised Supplementary Figures S4-S6 to show additional model predictions of the recalibration effect for individual participants, and participants’ temporal-order judgments are now shown in Supplement Figure S7. These figures confirm the better performance of the causal-inference model.

      The way that S3 is described in the text (line 141) makes it sound like everyone was in the same direction, however, it is clear that 2 /9 listeners show the opposite pattern, and 2 have confidence intervals close to zero (albeit on the -ve side).

      We have revised the text to clarify that the asymmetry occurs in both directions and is idiosyncratic (lines 168-171). We summarized the distribution of the individual asymmetries of the recalibration effect across visual-leading and auditory-leading adapter SOAs in Supplementary Figure S2.

      Reviewer #3 (Public Review):

      Summary:

      Li et al. describe an audiovisual temporal recalibration experiment in which participants perform baseline sessions of ternary order judgments about audiovisual stimulus pairs with various stimulus-onset asynchronies (SOAs). These are followed by adaptation at several adapting SOAs (each on a different day), followed by post-adaptation sessions to assess changes in psychometric functions. The key novelty is the formal specification and application/fit of a causal-inference model for the perception of relative timing, providing simulated predictions for the complete set of psychometric functions both pre and post-adaptation.

      Strengths:

      (1) Formal models are preferable to vague theoretical statements about a process, and prior to this work, certain accounts of temporal recalibration (specifically those that do not rely on a population code) had only qualitative theoretical statements to explain how/why the magnitude of recalibration changes non-linearly with the stimulus-onset asynchrony of the adapter.

      (2) The experiment is appropriate, the methods are well described, and the average model prediction is a fairly good match to the average data (Figure 4). Conclusions may be overstated slightly, but seem to be essentially supported by the data and modelling.

      (3) The work should be impactful. There seems a good chance that this will become the go-to modelling framework for those exploring non-population-code accounts of temporal recalibration (or comparing them with population-code accounts).

      (4) A key issue for the generality of the model, specifically in terms of recalibration asymmetries reported by other authors that are inconsistent with those reported here, is properly acknowledged in the discussion.

      Weaknesses:

      (1) The evidence for the model comes in two forms. First, two trends in the data (non-linearity and asymmetry) are illustrated, and the model is shown to be capable of delivering patterns like these. Second, the model is compared, via AIC, to three other models. However, the main comparison models are clearly not going to fit the data very well, so the fact that the new model fits better does not seem all that compelling. I would suggest that the authors consider a comparison with the atheoretical model they use to first illustrate the data (in Figure 2). This model fits all sessions but with complete freedom to move the bias around (whereas the new model constrains the way bias changes via a principled account). The atheoretical model will obviously fit better, but will have many more free parameters, so a comparison via AIC/BIC or similar should be informative

      In the revised manuscript, we switched from AIC to Bayesian model selection, which approximates and compares model evidence. This method incorporates a strong penalty for model complexity through marginalization over the parameter space (MacKay, 2003).

      We have addressed this comment by updating the former competitor model into a more reasonable version that induces recalibration only for some measured SOAs and by including another (asynchrony-contingent) model that is capable of predicting the nonlinearity and asymmetry of recalibration (Fig. 3) while heuristically approximating the causal inference computations. The causal-inference model outperformed the asynchrony-contingent model, as indicated by model evidence (Fig. 4A). Furthermore, model predictions show that the causal-inference model more accurately captures recalibration at large SOAs at both the group (Fig. 4B) and the individual level (Fig. S4).

      (2) It does not appear that some key comparisons have been subjected to appropriate inferential statistical tests. Specifically, lines 196-207 - presumably this is the mean (and SD or SE) change in AIC between models across the group of 9 observers. So are these differences actually significant, for example via t-test?

      We statistically compared the models using Bayes factors (Fig. 4A). The model evidence for each model was approximated using Variational Bayesian Monte Carlo. Bayes factors provided strong evidence in support of the causal-inference model relative to the other models.

      (3) The manuscript tends to gloss over the population-code account of temporal recalibration, which can already provide a quantitative account of how the magnitude of recalibration varies with adapter SOA. This could be better acknowledged, and the features a population code may struggle with (asymmetry?) are considered.

      We simulated a population-code model to examine its prediction of the recalibration effect for different adapter SOAs (lines 380–388, Supplement Section 8). The population-code model can predict the nonlinearity of recalibration, i.e., a decreasing recalibration effect as the adapter SOA increases. However, to capture the asymmetry of recalibration effects across auditory-leading and visual-leading adapter stimuli, we would need to assume that the auditory-leading and visual-leading SOAs are represented by neural populations with unequal tuning curves.

      (4) The engagement with relevant past literature seems a little thin. Firstly, papers that have applied causal inference modeling to judgments of relative timing are overlooked (see references below). There should be greater clarity regarding how the modelling here builds on or differs from these previous papers (most obviously in terms of additionally modelling the recalibration process, but other details may vary too). Secondly, there is no discussion of previous findings like that in Fujisaki et al.’s seminal work on recalibration, where the spatial overlap of the audio and visual events didn’t seem to matter (although admittedly this was an N = 2 control experiment). This kind of finding would seem relevant to a causal inference account.

      References:

      Magnotti JF, Ma WJ and Beauchamp MS (2013) Causal inference of asynchronous audiovisual speech. Front. Psychol. 4:798. doi: 10.3389/fpsyg.2013.00798

      Sato, Y. (2021). Comparing Bayesian models for simultaneity judgement with different causal assumptions. J. Math. Psychol., 102, 102521.

      We have revised the Introduction and Discussion to better situate our study within the existing literature. Specifically, we have incorporated the suggested references (lines 66–69) and provided clearer distinctions on how our modeling approach builds on or differs from previous work on causal-inference models, particularly in terms of modeling the recalibration process (lines 75–79). Additionally, we have discussed findings that might contradict the assumptions of the causal-inference model (lines 405–424).

      (5) As a minor point, the model relies on simulation, which may limit its take-up/application by others in the field.

      Upon acceptance, we will publicly share the code for all models (simulation and parameter fitting) to enable researchers to adapt and apply these models to their own data.

      (6) There is little in the way of reassurance regarding the model’s identifiability and recoverability. The authors might for example consider some parameter recovery simulations or similar.

      We conducted a model recovery for each of the six models described in the main text and confirmed that the asynchrony-contingent and causal-inference models are identifiable (Supplement Section 11). Simulations of the asynchrony-correction model were sometimes best fit by causal-inference models, because the latter behaves similarly when the prior of a common cause is set to one.

      We also conducted a parameter recovery for the winning model, the causal-inference model with modality-specific precision (Supplement Section 13).

      Key parameters, including audiovisual bias  , amount of auditory latency noise  , amount of visual latency noise  , criterion, lapse rate  showed satisfactory recovery performance. The less accurate recovery of  is likely due to a tradeoff with learning rate  .

      (7) I don't recall any statements about open science and the availability of code and data.

      Upon acceptance of the manuscript, all code (simulation and parameter fitting) and data will be made available on OSF and publicly available.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      In addition to the comments below, we would like to offer the following summary based on the discussion between reviewers:

      The major shortcoming of the work is that there should ideally be a bit more evidence to support the model, over and above a demonstration that it captures important trends and beats an account that was already known to be wrong. We suggest you:

      (1) Revise the figure legends (Figure 5 and Figure 6E).

      We revised all figures and figure legends.

      (2) Additionally report model differences in terms of BIC (which will favour the preferred model less under the current analysis);

      We now base the model comparison on Bayesian model selection, which approximates and compares model evidence. This method incorporates a strong penalty for model complexity through marginalization over the parameter space (MacKay, 2003).

      (3) Move to instead fitting the models multiple times in order to get leave-one-out estimates of best-fitting loglikelihood for each left-out data point (and then sum those for the comparison metric).

      Unfortunately, our design is not suitable for cross-validation methods because the model-fitting process is computationally intensive and time-consuming. Each fit of the causal-inference model takes approximately 30 hours, and multiple fits with different initial starting points are required to rule out local minima.

      (4) Offering a comparison with a more convincing model (for example an atheoretical fit with free parameters for all adapters, e.g. as suggested by Reviewer 3.

      We updated the previous competitor model and included an asynchrony-contingent model, which is capable of predicting the nonlinearity of recalibration (Fig. 3). The causal-inference model still outperformed the asynchrony-contingent model (Fig. 4A). Furthermore, model predictions show that only the causal-inference model captures non-zero recalibration effects for long adapter SOAs at both the group level (Fig. 4B) and individual level (Figure S4).

      Reviewer #1 (Recommendations For The Authors):

      A larger sample size would be better.

      This study used a within-subject design, which included 9 sessions, totaling 13.5 hours per participant. This extensive data collection allows us to better constrain the model for each participant. Our conclusions are based on the different models’ ability to fit individual data rather than on group statistics.

      It would be good to better put the study in the context of spatial ventriloquism, where similar model comparisons have been done over the last ten years and there is a large body of work to connect to.

      We now discuss our model in relation to models of cross-modal spatial recalibration in the Introduction (lines 70–78) and Discussion (lines 324–330).

      Reviewer #2 (Recommendations For The Authors):

      Previous authors (e.g. Yarrow et al.,) have described latency shift and criterion change models as providing a good fit of experimental data. Did the authors attempt a criterion shift model in addition to a shift model?

      We have considered criterion-shift variants of our atheoretical recalibration models in Supplement Section 1. To summarize the results, we varied two model assumptions: 1) the use of either a Gaussian or an exponential measurement distribution, and 2) recalibration being implemented either as a shift of bias or a criterion. We fit each model variant separately to the ternary TOJ responses of all sessions. Bayesian model comparisons indicated that the bias-shift model with exponential measurement distributions best captured the data of most participants.

      Figure 4B - I'm not convinced that the modality-independent uncertainty is anything but a straw man. Models not allowed to be asymmetric do not show asymmetry? (the asymmetry index is irrelevant in the fixed update model as I understand it so it is not surprising the model is identical?).

      We included the assumption that temporal uncertainty might be modality-independent for several reasons. First, there is evidence suggesting that a central mechanism governs the precision of temporal-order judgments (Hirsh & Sherrick, 1961), indicating that precision is primarily limited by a central mechanism rather than the sensory channels themselves. Second, from a modeling perspective, it was necessary to test whether an audio-visual temporal bias alone, i.e., assuming modality-independent uncertainty, could introduce asymmetry across adapter SOAs. Additionally, most previous studies implicitly assumed symmetric likelihoods, i.e., modality-independent latency noise, by fitting cumulative Gaussians to the psychometric curves derived from 2AFC-TOJ tasks (Di Luca et al., 2009; Fujisaki et al., 2004; Harrar & Harris, 2005; Keetels & Vroomen, 2007; Navarra et al., 2005; Tanaka et al., 2011; Vatakis et al., 2007, 2008; Vroomen et al., 2004).

      Why does a zero SOA adapter shift the pss towards auditory leading? Is this a consequence of the previous day’s conditioning - it’s not clear from the methods whether all listeners had the same SOA conditioning sequence across days.

      The auditory-leading recalibration effect for an adapter SOA of zero has been consistently reported in previous studies (e.g., Fujisaki et al., 2004; Vroomen et al., 2004). This effect symbolizes the asymmetry in recalibration. This asymmetry can be explained by differences across modalities in the noisiness of the latencies (Figure 5C) in combination with audiovisual temporal bias (Figure S8).

      We added details about the order of testing to the Methods section (lines 456–457).

      Reviewer #3 (Recommendations For The Authors):

      Abstract

      “Our results indicate that human observers employ causal-inference-based percepts to recalibrate cross-modal temporal perception” Your results indicate this is plausible. However, this statement (basically repeated at the end of the intro and again in the discussion) is - in my opinion - too strong.

      We have revised the statement as suggested.

      Intro and later

      Within the wider literature on relative timing perception, the temporal order judgement (TOJ) task refers to a task with just two response options. Tasks with three response options, as employed here, are typically referred to as ternary judgments. I would suggest language consistent with the existing literature (or if not, the contrast to standard usage could be clarified).

      Ref: Ulrich, R. (1987). Threshold models of temporal-order judgments evaluated by a ternary response task. Percept. Psychophys., 42, 224-239.

      We revised the term for the task as suggested throughout the manuscript.

      Results, 2.2.2

      “However, temporal precision might not be due to the variability of arrival latency.” Indeed, although there is some recent evidence that it might be.

      Ref: Yarrow, K., Kohl, C, Segasby, T., Kaur Bansal, R., Rowe, P., & Arnold, D.H. Neural-latency noise places limits on human sensitivity to the timing of events. Cognition, 222, 105012 (2022).

      We included the reference as suggested (lines 245–248).

      Methods, 4.3.

      Should there be some information here about the order of adaptation sessions (e.g. random for each observer)?

      We added details about the order of testing to the Methods section (lines 456–457).

      Supplemental material section 1.

      Here, you test whether the changes resulting from recalibration look more like a shift of the entire psychometric function or an expansion of the psychometric function on one side (most straightforwardly compatible with a change of one decision criterion). Fine, but the way you have done this is odd, because you have introduced a further difference in the models (Gaussian vs. exponential latency noise) so that you cannot actually conclude that the trend towards a win for the bias-shift model is simply down to the bias vs. criterion difference. It could just as easily be down to the different shapes of psychometric functions that the two models can predict (with the exponential noise model permitting asymmetry in slopes). There seems to be no reason that this comparison cannot be made entirely within the exponential noise framework (by a very simple reparameterization that focuses on the two boundaries rather than the midpoint and extent of the decision window). Then, you would be focusing entirely on the question of interest. It would also equate model parameters, removing any reliance on asymptotic assumptions being met for AIC.

      We revised our exploration of atheoretical recalibration models. To summarize the results, we varied two model assumptions: 1) the use of either a Gaussian or an exponential measurement distribution, and 2) recalibration being implemented either as a shift of the cross-modal temporal bias or as a shift of the criterion. We fit each model separately to the ternary TOJ responses of all sessions. Bayesian model comparisons indicated that the bias-shift model with exponential measurement distributions best described the data of most participants.

      References

      Di Luca, M., Machulla, T.-K., & Ernst, M. O. (2009). Recalibration of multisensory simultaneity:

      cross-modal transfer coincides with a change in perceptual latency. Journal of Vision, 9(12), Article 7.

      Fujisaki, W., Shimojo, S., Kashino, M., & Nishida, S. ’ya. (2004). Recalibration of audiovisual simultaneity. Nature Neuroscience, 7(7), 773–778.

      Harrar, V., & Harris, L. R. (2005). Simultaneity constancy: detecting events with touch and vision. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale, 166(3-4), 465–473.

      Hirsh, I. J., & Sherrick, C. E., Jr. (1961). Perceived order in different sense modalities. Journal of Experimental Psychology, 62(5), 423–432.

      Keetels, M., & Vroomen, J. (2007). No effect of auditory-visual spatial disparity on temporal recalibration. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale, 182(4), 559–565.

      MacKay, D. J. (2003). Information theory, inference and learning algorithms.https://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=201b835c3f3a3626ca07b e68cc28cf7d286bf8d5

      Navarra, J., Vatakis, A., Zampini, M., Soto-Faraco, S., Humphreys, W., & Spence, C. (2005). Exposure to asynchronous audiovisual speech extends the temporal window for audiovisual integration. Brain Research. Cognitive Brain Research, 25(2), 499–507.

      Tanaka, A., Asakawa, K., & Imai, H. (2011). The change in perceptual synchrony between auditory and visual speech after exposure to asynchronous speech. Neuroreport, 22(14), 684–688.

      Vatakis, A., Navarra, J., Soto-Faraco, S., & Spence, C. (2007). Temporal recalibration during asynchronous audiovisual speech perception. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale, 181(1), 173–181.

      Vatakis, A., Navarra, J., Soto-Faraco, S., & Spence, C. (2008). Audiovisual temporal adaptation of speech: temporal order versus simultaneity judgments. Experimental Brain Research. Experimentelle Hirnforschung. Experimentation Cerebrale, 185(3), 521–529.

      Vroomen, J., Keetels, M., de Gelder, B., & Bertelson, P. (2004). Recalibration of temporal order perception by exposure to audio-visual asynchrony. Brain Research. Cognitive Brain Research, 22(1), 32–35.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1 (Public Review):

      Summary:

      In this manuscript by Bimbard et al., a new method to perform stable recordings over long periods of time with neuropixels, as well as the technical details on how the electrodes can be explanted for follow-up reuse, is provided. I think the description of all parts of the method is very clear, and the validation analyses (n of units per day over time, RMS over recording days...) are very convincing. I however missed a stronger emphasis on why this could provide a big impact on the ephys community, by enabling new analyses, new behavior correlation studies, or neurophysiological mechanisms across temporal scales.

      Strengths:

      Open source method. Validation across laboratories. Across species (mice and rats) demonstration of its use and in different behavioral conditions (head-fixed and freely moving).

      Weaknesses:

      Weak emphasis on what can be enabled with this new method that didn't exist before.

      We thank the reviewer for highlighting the limited discussion around scientific impact. Our implant has several advantages which combine to make it much more accessible than previous solutions. This enables a variety of recording configurations that would not have been possible with previous designs, facilitating recordings from a wider range of brain regions, animals, and experimental setups. In short, there are three key advances which we now emphasise in the manuscript:

      Adaptability: The CAD files can be readily adapted to a wide range of configurations (implantation depth, angle, position of headstage, etc.). Labs have already modified the design for their needs, and re-shared with the community (Discussion, Para 5).

      Weight: Because of the lightweight design, experimenters can i) perform complex and demanding freely moving tasks as we exemplify in the manuscript, and ii) implant female and water restricted mice while respecting animal welfare weight limitations (Flexible design, Para 1).

      Cost: At ~$10, our implant is significantly cheaper than published alternatives, which makes it affordable to more labs and means that testing modifications is cost-effective (Discussion, Para 4).

      Reviewer 1 (Recommendations For The Authors):

      - Differences between mice and rats seem very significant. Although this is probably not surprising, I suggest that the authors comment on this to make it clear to anyone trying to use in different species that are not quantified in the main figures.

      The reviewer is correct—there are qualitative differences between mice and rats, particularly with respect to the unit median amplitude. We have added a comment in the discussion to highlight these inter-species variations (Discussion, Para 7)

      - Another comment that would be useful to have would be how to tackle the problem of tracking the same neuron across days. Even if currently impossible, it could be useful to provide discussion along those lines as to where future improvements (either in hardware or software) can be made.

      We thank the reviewer for highlighting this. Figure. 5 does show data from tracking the same neuron across days (and even months). We have modified the language to make this clear.

      Reviewer 2 (Public Review):  

      Summary:

      This work by Bimbard et al., introduces a new implant for Neuropixels probes. While Neuropixels probes have critically improved and extended our ability to record the activity of a large number of neurons with high temporal resolution, the use of these expensive devices in chronic experiments has so far been hampered by the difficulty of safely implanting them and, importantly, to explant and reuse them after conclusion of the experiment. The authors present a newly designed two-part implant, consisting of a docking and a payload module, that allows for secure implantation and straightforward recovery of the probes. The implant is lightweight, making it amenable for use in mice and rats, and customizable. The authors provide schematics and files for printing of the implants, which can be easily modified and adapted to custom experiments by researchers with little to no design experience. Importantly, the authors demonstrate the successful use of this implant across multiple use cases, in head-fixed and freely moving experiments, in mice and rats, with different versions of Neuropixels probes, and across 8 different labs. Taken together, the presented implants promise to make chronic Neuropixel recordings and long-term studies of neuronal activity significantly easier and attainable for both current and future Neuropixels users.

      Strengths:

      The implants have been successfully tested across 8 different laboratories, in mice and rats, in headfixed and freely moving conditions, and have been adapted in multiple ways for a number of distinct experiments.

      Implants are easily customizable and the authors provide a straightforward approach for customization across multiple design dimensions even for researchers not experienced in design.

      The authors provide clear and straightforward descriptions of the construction, implantation, and explant of the described implants.

      The split of the implant into a docking and payload module makes reuse even in different experiments (using different docking modules) easy.

      The authors demonstrate that implants can be re-used multiple times and still allow for high-quality recordings.

      The authors show that the chronic implantations allow for the tracking of individual neurons across days and weeks (using additional software tracking solutions), which is critical for a large number of experiments requiring the description of neuronal activity, e.g. throughout learning processes.

      The authors show that implanted animals can even perform complex behavioral tasks, with no apparent reduction in their performance.

      Weaknesses:

      While implanted animals can still perform complex behavioral tasks, the authors describe that the implants may reduce the animals' mobility, as measured by prolonged reaction times. However, the presented data does not allow us to judge whether this effect is specifically due to the presented implant or whether any implant or just tethering of the animals per se would have the same effects.

      The reviewer is correct: some of the differences in mouse reaction time could be due to the tether rather than the implant. As these experiments were also performed in water-restricted female mice with the heavier Neuropixels 1.0 implant, our data represent the maximal impact of the implant, and we have highlighted this point in the revision (Freely behaving animals, Para 2).  

      While the authors make certain comparisons to other, previously published approaches for chronic implantation and re-use of Neuropixels probes, it is hard to make conclusive comparisons and judge the advantages of the current implant. For example, while the authors emphasize that the lower weight of their implant allows them to perform recordings in mice (and is surely advantageous), the previously described, heavier implants they mention (Steinmetz et al., 2021; van Daal et al., 2021), have also been used in mice. Whether the weight difference makes a difference in practice therefore remains somewhat unclear.

      The reviewer is correct: without a direct comparison, we cannot be certain that our smaller, lighter implant improves behavioural results (although this is supported by the literature, e.g. Newman et al, 2023). However, the reduced weight of our implant is critical for several laboratories represented in this manuscript due to animal welfare requirements. Indeed, in van Daal et al the authors “recommend a [mouse] weight of >25 g for implanting Neuropixels 1.0 probes.” This limit precludes using (the vast majority of) female mice, or water-restricted animals. Conversely, our implant can be routinely used with lighter, water-restricted male and female mice. We emphasised this point in the revision (Discussion, Para 2).

      The non-permanent integration of the headstages into the implant, while allowing for the use of the same headstage for multiple animals in parallel, requires repeated connections and does not provide strong protection for the implant. This may especially be an issue for the use in rats, requiring additional protective components as in the presented rat experiments.

      We apologise for not clarifying the various headstage holder options in the manuscript and we have now addressed this in the revision (Freely behaving animals, Para 1&2). Our repository has headstage holder designs (in the XtraModifications/Mouse_FreelyMoving folder). This allows leaving the headstage on the implant, and thus minimize the number of connections (albeit increasing the weight for the mouse). Indeed, mice recorded while performing the task described in our manuscript had the head-stage semi-permanently integrated to the implant, and we now highlight this in the revision (Freely behaving animals, Para 1).

      Reviewer 2 (Recommendations For The Authors): 

      The description of the different versions of the head-stage holders should be more clear, listing also advantages/disadvantages of the different solutions. It would be also useful if the authors could comment on the use of these head-stage holders in rats, since they do not seem to offer much protection.

      We thank the reviewer for this point, and we have added notes to the manuscript to clarify the various advantages of the different headstage-holders, and that the headstage can be permanently attached to the implant (Freely behaving animals, Para 1&2). This is the primary advantage of these solutions compared with the minimal implant—at the expense of increasing the implant weight.  

      The reviewer’s concerns regarding the lack of protection for implants in rats is well-placed, and we now emphasise that these experiments benefited from the additional protection of an external 3D casing, which is likely critical for use in larger animals (Freely behaving animals, Para 1).

      While re-used probes seem to show similar yields across multiple uses (Figure 4C), it seems as if there is a much higher variability of the yield for probes that are used for the first (maybe also second) time. There are probes with much higher than average yields, but it seems none of the re-used probes show such high yields. Is this a real effect? Is this because the high-yield probes happened to have not been used multiple times? Is there an analysis the authors could provide to reduce the concern that yields may generally be lower for re-used probes/that there are no very high yields for re-used probes?

      We understand the reviewer’s concern with respect to Figure 4C, however, the re-use of any given probe was determined only by the experimental needs of the project. It is therefore not possible that there is a relationship between probes selected for re-use and unit-yield. We now specify this in the revised legend of Figure 4C. This variability (and the consistency in yield across uses) likely stems from differences between labs, brain region, and implantation protocol.

      The authors claim that a 'large fraction' of units could be tracked for the entire duration of the experiment (Figure 5A,B). They mention in the discussion that quantification can be found in a different manuscript (van Beest et al., 2023), but this should also be quantified here in at least some more detail, also for other animals in addition to the one mouse which was recorded for ~100 days. What fraction can be held for different durations? What is the average holding time, etc.?

      We agree with the reviewer, and have now added new panels quantifying the probability and reliability of tracking a neuron across days (Figure 5E-F). We also comment on the change in tracking probability across time, and its variability across recordings (Stability, Para 4).

      Reviewer 3 (Public Reviews):

      Summary:

      In this manuscript, Bimbard and colleagues describe a new implant apparatus called "Apollo Implant", which should facilitate recording in freely moving rodents (mice and rats) using Neuropixels probes. The authors collected data from both mice and rats, they used 3 different versions of Neuropixels, multiple labs have already adopted this method, which is impressive. They openly share their CAD designs and surgery protocol to further facilitate the adaptation of their method.

      Strengths:

      Overall, the "Apollo Implant" is easy to use and adapt, as it has been used in other laboratories successfully and custom modifications are already available. The device is reproducible using common 3D printing services and can be easily modified thanks to its CAD design (the video explaining this is extremely helpful). The weight and price are amazing compared to other systems for rigid silicon probes allowing a wide range of use of the "Apollo Implant".

      Weaknesses:

      The "Apollo Implant" can only handle Neuropixels probes. It cannot hold other widely used and commercially available silicon probes. Certain angles and distances are not possible in their current form (distance between probes 1.8 to 4mm, implantation depth 2-6.5 mm, or angle of insertion up to 20 degrees).

      As we now discuss in the manuscript (Discussion, Para 4), one implant accommodating the diversity of the existing probes is beyond the scope of this project. However, because the design is adaptable, groups should be able to modify the current version of the implant to adapt to their electrodes’ size and format (and can highlight any issues in the Github “Discussions” area).

      With Neuropixels, the current range of depths covers practically all trajectories in the mouse brain. In rats, where deeper penetrations may be useful, the experimenter can attach the probe at a lower point in the payload module to expose more of the shank. We now specify this in the Github repository.  

      We have now extended the range of inter-probe distances from a maximum of 4 mm to 6.5 mm. Distances beyond this may be better served by 2 implants, and smaller distances could be achieved by attaching two probes on the same side of the docking module. These points are now specified in the revised manuscript (Flexible design, Para 2).

      Reviewer 3 (Recommendations For The Authors):

      I have only a few questions and suggestions:

      Is it possible to create step-by-step instructions for explantation (similar to Figure-1 with CAD schematics)? You mention that payload holder is attached to a micromanipulator, but it is unclear how this is achieved. How was the payload secured with a screw (which screw)? My understanding is that as you turn the screw in the payload holder, it will grab onto the payload module from both sides, but the screw is not in contact with the payload module, correct? I found the screw type on your GitHub, but it would be great if you could add a bill of materials in a table format, so readers don't have to jump between GitHub and article.

      We have now added a bill of materials to the revised manuscript (Implant design and materials, Para 2), although up-to-date links are still provided on the Github repository due to changing availability.

      What happens if you do a dual probe implant and cannot avoid blood vessels in one or both of the craniotomies due to the pre-defined geometry? Is this a frequent issue? How can you overcome this during the surgery?

      Blood vessels can be difficult to avoid in some cases, but we are typically able to rotate/reposition the probes to solve this issue. In some cases, with 4-shank probes, the blood vessel can be positioned between individual probe shanks. We now detail this in the revised manuscript (Assembly and implantation, Para 3).

      I assume if the head is not aligned (line-332) the probe can break during recovery. Have you experienced this during explanation?

      As we now specify in the manuscript (Explantation, Para 2), we are careful when explanting the probe to avoid this issue, and due to the flexibility of the shanks, it does not appear to be a major concern.

      Why did you remove the UV glue (line 435)? How can you level the skull? I assume you have covered bregma and lambda in the first surgery which can create an uneven surface to measure even after you remove the UV glue.

      We thank the reviewer for highlighting this omission from the methods. We now explain (Implantation, Carandini-Harris laboratory) that the UV-glue is completely removed during the second surgery, and the skull is cleaned and scored. This improves the adhesion of the dental cement, and allows for reliable levelling of the skull.

      In line 112 you mentioned that the number of recorded neurons was stable; however, you found a 3% mean decrease in unit count per day (line 120). Stability is great until day 10 (in Figure 4A), but it deteriorates quickly after that. I think it would help readers if you could add the mean{plus minus}SEM of recorded units in the text for days 1-10, days 11-50, and days 51-100 (using the data from Figure 4A).

      We have now added Supplementary Figure 4 to show unit count across bins of days, and a corresponding comment in the text (Stability, Para 2).

      A full survey of the probe (Figure 4B) means that you recorded neuronal activity across 4-5000 channels (depending on how many channels were in the brain). While it is clear that a full probe survey can reduce the number of animals needed for a study, it is also clear in this figure that by day 25 you can record ~300 neurons on 4000 channels. It would be great to discuss this in the discussion and give a balanced view of the long-term stability of these recordings.

      Overall, keeping a large number of units for a long time still remains a challenge. Here, we could record on average 85 neurons per bank during the first 10 days, and then only 45 after 50 days. It is important to note that our quantification averages across all banks recorded, including those in a ventricle or partly outside of the brain. Thus, our results represent a lower estimate of the total neurons recorded. Our new Supplementary Figure 4 helps to highlight the diversity of neuron number recorded per animal. Further improvements in surgical techniques and spike sorting will likely improve stability further and we have now added this comment in the manuscript (Stability, Para 2). For example, we observed excellent stability in a mouse where the craniotomy was stabilized with KwikSil (Supplementary Figure 5).

      The RMS value was around 20 uV in some of the recordings, and according to Figure 4G it is around 16 uV on average. Is it safe to accept putative single units with 20 uV amplitudes, when the baseline noise level is this close to the spike peak-to-peak amplitude?

      On average, less than 1% of the units selected using all the other metrics except the amplitude had an amplitude below 30 µV, and 2.6% below 50 µV. Increasing the threshold to 30 µV, or even 50 µV, did not affect the results. We have now added this comment in the Methods (Data processing, Para 3).

      Can you add the waveform and ISIH of the example unit from day 106 to Figure 5?

      We have now added 4 units tracked up to day 106 in Figure 5.  

      Could you move Supplementary Figure 3A to Figure 4? The number of units is more valuable information than the RMS noise level. I understand that you don't have such a nice coverage of all the days as in Figure 3 and 4, but you might be able to group for the first 3 days and the last 3 days (and if data is available, the middle 3 days) as a boxplot. The goal would be for the reader to be able to see whether there is any change in the number of single units over time.

      We agree with the reviewer, the number of units is more valuable. We had included this information in Figure 4A-F, but we have made edits to the text to make it clearer that this is what is being shown. The data from Figure 3A is already contained within Figure 4, but in 3A the data is separated by individual labs.

      Product numbers are missing in multiple places: line-285 (screw), line-288 (screw), line-290 (screw), line-309 (manipulator), line-374 (gold pin and silver wire), line-384 (Mill-Max), line-394 (silver wire), and many more. It would be great if you could add all these details, so people can replicate your protocol.

      We thank the reviewer for highlighting this, and we have added details of screw thread-size and length to relevant parts of the manuscript, although any type of screw can be used. Similarly, other components are non-specific (e.g. multiple silver-wire diameters were used across labs), so we have not included specific product numbers for general consumer items (like screws and silver wires) to avoid indicating that a specific part must be purchased.

      While it is great to see lab-specific methods, I am not sure in their current form it helps to understand the protocol better. The information is conveyed in different ways (I assume these were written by different people), in different orders, and in different depths (some mention probe implant location relative to bregma and midline, some don't). There are many different glues, epoxies, cement, wires, and pins. I would recommend rewriting these methods sections under a unified template, so it is easier to follow.

      We thank the reviewer for this suggestion and we have rewritten this section of the methods accordingly. We now use a template structure to simplify the comparisons between labs: the same template is used for each lab in each section (payload module assembly, implantation, and data acquisition).

      Line-307: why is a skull screw optional for grounding? What did you use for ground and reference if not a ground screw?

      We now specify in the manuscript that during head-fixed experiments, the animal’s headplate can be used for grounding, and combined with internal referencing provided by the Neuropixels, yielded lownoise recordings (Implantation protocol, Methods).

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the three reviewers for their positive comments and useful suggestions. We have implemented most of the reviewers’ recommendations and hope the manuscript is clearer now.

      The main modifications are:

      - A revision of the introduction to better explain what Transitional Probabilities are and clarify the rationale of the experimental design

      - A revision of the discussion

      - To tune down and better explain the interpretation of the different responses between duplets after a stream with phonetic or voice regularities (possibly an N400).

      - To better clarify the framing of statistical learning as a universal learning mechanism that might share computational principles across features (or domains).

      Below, we provide detailed answers to each reviewer's point.

      Response to Reviewer 1:

      There are no significant weaknesses to signal in the manuscript. However, in order to fully conclude that there is no obvious advantage for the linguistic dimension in neonates, it would have been most useful to test a third condition in which the two dimensions were pitted against each other, that is, in which they provide conflicting information as to the boundaries of the words comprised in the artificial language.

      This last condition would have allowed us to determine whether statistical learning weighs linguistic and non-linguistic features equally, or whether phonetic content is preferentially processed.

      We appreciate the reviewers' suggestion that a stream with conflicting information would provide valuable insights. In the present study, we started with a simpler case involving two orthogonal features (i.e., phonemes and voices), with one feature being informative and the other uninformative, and we found similar learning capacities for both. Future work should explore whether infants—and humans more broadly—can simultaneously track regularities in multiple speech features. However, creating a stream with two conflicting statistical structures is challenging. To use neural entrainment, the two features must lead to segmentation at different chunk sizes so that their effects lead to changes in power/PLV at different frequencies—for instance, using duplets for the voice dimension and triplets for the linguistic dimension (or vice versa). Consequently, the two dimensions would not be directly comparable within the same participant in terms of the number of distinguishable syllables/voices, memory demand, or SNR given the 1/F decrease in amplitude of background EEG activity. This would involve comparisons between two distinct groups counter-balancing chunk size and linguistic non-linguistic dimension. Considering the test phase, words for one dimension would have been part-words for the other dimension. As we are measuring differences and not preferences, interpreting the results would also have been difficult. Additionally, it may be difficult to find a sufficient number of clearly discriminable voices for such a design (triplets imply 12 voices). Therefore, an entirely different experimental paradigm would need to be developed.

      If such a design were tested, one possibility is that the regularities for the two dimensions are calculated in parallel, in line with the idea that the calculation of statistical regularities is a ubiquitous implicit mechanism (see Benjamin et al., 2024, for a proposed neural mechanism). Yet, similar to our present study, possibly only phonetic features would be used as word candidates. Another possibility is that only one informative feature would be explicitly processed at a time due to the serial nature of perceptual awareness, which may prioritise one feature over the other.

      We added one sentence in the discussion stating that more research is needed to understand whether infants can track both regularities simultaneously (p.13, l.270 “Future work could explore whether they can simultaneously track multiple regularities.”).

      Note: The reviewer’s summary contains a typo: syllabic rate (4 Hz) –not 2 Hz, and word rate (2 Hz) –not 4 Hz.

      Response to Reviewer 2:

      N400: I am skeptical regarding the interpretation of the phoneme-specific ERP effect as a precursor of the N400 and would suggest toning it down. While the authors are correct in that infant ERP components are typically slower and more posterior compared to adult components, and the observed pattern is hence consistent with an adult N400, at the same time, it could also be a lot of other things. On a functional level, I can't follow the author's argument as to why a violation in phoneme regularity should elicit an N400, since there is no evidence for any semantic processing involved. In sum, I think there is just not enough evidence from the present paradigm to confidently call it an N400.

      The reviewer is correct that we cannot definitively determine the type of processing reflected by the ERP component that appears when neonates hear a duplet after exposure to a stream with phonetic regularities. We interpreted this component as a precursor to the N400, based on prior findings in speech segmentation tasks without semantic content, where a ~400 ms component emerged when adult participants recognised pseudowords (Sander et al., 2002) or during structured streams of syllables (Cunillera et al., 2006, 2009). Additionally, the component we observed had a similar topography and timing to those labelled as N400 in infant studies, where semantic processing was involved (Parise et al., 2010; Friedrich & Friederici, 2011).

      Given our experimental design, the difference we observed must be related to the type of regularity during familiarisation (either phonemes or voices). Thus, we interpreted this component as reflecting lexical search— a process which could be triggered by a linguistic structure but which would not be relevant to a non-linguistic regularity such as voices. However, we are open to alternative interpretations. In any case, this difference between the two streams reveals that computing regularities based on phonemes versus voices does not lead to the same processes.

      We revised the abstract (p.2, l.33) and the discussion of this result (p.15, l.299), toning them down. We hope the rationale of the interpretation is clearer now, as is the fact that it is just one possible interpretation of the results.

      Female and male voices: Why did the authors choose to include male and female voices? While using both female and male stimuli of course leads to a higher generalizability, it also introduces a second dimension for one feature that is not present for this other (i.e., phoneme for Experiment 1 and voice identity plus gender for Experiment 2). Hence, couldn't it also be that the infants extracted the regularity with which one gender voice followed the other? For instance, in List B, in the words, one gender is always followed by the other (M-F or F-M), while in 2/3 of the part-words, the gender is repeated (F-F and M-M). Wouldn't you expect the same pattern of results if infants learned regularities based on gender rather than identity?

      We used three female and three male voices to maximise acoustic variability. The streams were synthesised using MBROLA, which provides a limited set of artificial voices. Indeed, there were not enough French voices of acceptable quality, so we also used two Italian voices (the phonemes used existed in both Italian and French).

      Voices differ in timbre, and female voices tend to be higher pitched. However, it is sometimes difficult to categorise low-pitched female voices and high-pitched male voices. Given that gender may be an important factor in infants' speech perception (newborns, for instance, prefer female voices at birth), we conducted tests to assess whether this dimension could have influenced our results.

      We report these analyses in SI and referred to them in the methods section (p.25, l.468 “We performed post-hoc tests to ensure that the results were not driven by a perception of two voices: female and male (see SI).”).

      We first quantified the transitional probabilities matrices during the structured stream of Experiment 2, considering that there are only two types of voices: Female and Male.

      For List A, all transition probabilities are equal to 0.5 (P(M|F), P(F|M), P(M|M), P(F|F)), resulting in flat TPs throughout the stream (see Author response image 1, top). Therefore, we would not expect neural entrainment at the word rate (2 Hz), nor would we anticipate ERP differences between the presented duplets in the test phase.

      For List B, P(M|F)=P(F|M)=0.66 while P(M|M)=P(F|F)=0.33. However, this does not produce a regular pattern of TP drops throughout the stream (see Author response image 1, bottom). As a result, strong neural entrainment at 2 Hz was unlikely, although some degree of entrainment might have occasionally occurred due to some drops occurring at a 2 Hz frequency. Regarding the test phase, all three Words and only one Part-word presented alternating patterns (TP=0.6). Therefore, the difference in the ERPs between Words and Part- words in List B might be attributed to gender alternation.

      However, it seems unlikely that gender alternation alone explains the entire pattern of results, as the effect is inconsistent and appears in only one of the lists. To rule out this possibility, we analysed the effects in each list separately.

      Author response image 1.

      Transition probabilities (TPs) across the structured stream in Experiment 2, considering voices processed by gender (Female or Male). Top: List A. Bottom: List B.

      We computed the mean activation within the time windows and electrodes of interest and compared the effects of word type and list using a two-way ANOVA. For the difference between Words and Part-words over the positive cluster, we observed a main effect of word type (F(1,31) = 5.902, p = 0.021), with no effects of list or interactions (p > 0.1). Over the negative cluster, we again observed a main effect of word type (F(1,31) = 10.916, p = 0.0016), with no effects of list or interactions (p > 0.1). See Author response image 2.

      Author response image 2:

      Difference in ERP voltage (Words – Part-words) for the two lists (A and B); W=Words; P=Part-Words,

      We conducted a similar analysis for neural entrainment during the structured stream on voices. A comparison of entrainment at 2 Hz between participants who completed List A and List B showed no significant differences (t(30) = -0.27, p = 0.79). A test against zero for each list indicated significant entrainment in both cases (List A: t(17) = 4.44, p = 0.00036; List B: t(13) = 3.16, p = 0.0075). See Author response image 3.

      Author response image 3.

      Neural entrainment at 2Hz during the structured stream of Experiment 2 for Lists A and B.

      Words entrainment over occipital electrodes: Do you have any idea why the duplet entrainment effect occurs over the electrodes it does, in particular over the occipital electrodes (which seems a bit unintuitive given that this is a purely auditory experiment with sleeping neonates).

      Neural entrainment might be considered as a succession of evoked response induced by the stream. After applying an average reference in high-density EEG recordings, the auditory ERP in neonates typically consists of a central positivity and a posterior negativity with a source located at the electrical zero in a single-dipole model (i.e. approximately in the superior temporal region (Dehaene-Lambertz & Dehaene, 1994). In adults, because of the average reference (i.e. the sum of voltages is equal to zero at each time point) and because the electrodes cannot capture the negative pole of the auditory response, the negativity is distributed around the head. In infants, however, the brain is higher within the skull, allowing for a more accurate recording of the negative pole of the auditory ERP (see Figure 4 for the location of electrodes in an infant head model).

      Besides the posterior electrodes, we can see some entrainment on more anterior electrodes that probably corresponds to the positive pole of the auditory ERP.

      We added a phrase in the discussion to explain why we can expect phase-locked activity in posterior electrodes (p.14, l.277: “Auditory ERPs, after reference-averaged, typically consist of a central positivity and posterior negativity”).

      Author response image 4:

      International 10–20 sensors' location on the skull of an infant template, with the underlying 3-D reconstruction of the grey-white matter interface and projection of each electrode to the cortex. Computed across 16 infants (from Kabdebon et al, Neuroimage, 2014). The O1, O2, T5, and T6 electrodes project lower than in adults.

      Response to Reviewer 3:

      (1) While it's true that voice is not essential for language (i.e., sign languages are implemented over gestures; the use of voices to produce non-linguistic sounds, like laughter), it is a feature of spoken languages. Thus I'm not sure if we can really consider this study as a comparison between linguistic and non-linguistic dimensions. In turn, I'm not sure that these results show that statistical learning at birth operates on non-linguistic features, being voices a linguistic dimension at least in spoken languages. I'd like to hear the authors' opinions on this.

      On one hand, it has been shown that statistical learning (SL) operates across multiple modalities and domains in human adults and animals. On the other hand, SL is considered essential for infants to begin parsing speech. Therefore, we aimed to investigate whether SL capacities at birth are more effective on linguistic dimensions of speech, potentially as a way to promote language learning.

      We agree with the reviewer that voices play an important role in communication (e.g., for identifying who is speaking); however, they do not contribute to language structure or meaning, and listeners are expected to normalize across voices to accurately perceive phonemes and words. Thus, voices are speech features but not linguistic features. Additionally, in natural speech, there are no abrupt voice changes within a word as in our experiment; instead, voice changes typically occur on a longer timescale and involve only a limited number of voices, such as in a dialogue. Therefore, computing regularities based on voice changes would not be useful in real-life language learning. We considered that contrasting syllables and voices was an elegant way to test SL beyond its linguistic dimension, as the experimental paradigm is identical in both experiments.

      We have rephrased the introduction to make this point clearer. See p.5, l.88-92: “To test this, we have taken advantage of the fact that syllables convey two important pieces of information for humans: what is being said and who is speaking, i.e. linguistic content and speaker’s identity. While statistical learning…”.

      Along the same line, in the Discussion section, the present results are interpreted within a theoretical framework showing statistical learning in auditory non-linguistic (string of tones, music) and visual domains as well as visual and other animal species. I'm not sure if that theoretical framework is the right fit for the present results.

      (2) I'm not sure whether the fact that we see parallel and independent tracking of statistics in the two dimensions of speech at birth indicates that newborns would be able to do so in all the other dimensions of the speech. If so, what other dimensions are the authors referring to?

      The reviewer is correct that demonstrating the universality of SL requires testing additional modalities and acoustic dimensions. However, we postulate that SL is grounded in a basic mechanism of long-term associative learning, as proposed in Benjamin et al. (2024), which relies on a slow decay in the representation of a given event. This simple mechanism, capable of operating on any representational output, accounts for many types of sequence learning reported in the literature (Benjamin et al., in preparation).

      We have revised the discussion to clarify this theoretical framework.

      In p.13, l.264: “This mechanism might be rooted in associative learning processes relying on the co- existence of event representations driven by slow activation decays (Benjamin et al., 2024). ”

      In p., l. 364: “Altogether, our results show that statistical learning works similarly on different speech features in human neonates with no clear advantage for computing linguistically relevant regularities in speech. This supports the idea that statistical learning is a general learning mechanism, probably operating on common computational principles across neural networks (Benjamin et al., 2024)…”.

      (3) Lines 341-345: Statistical learning is an evolutionary ancient learning mechanism but I do not think that the present results are showing it. This is a study on human neonates and adults, there are no other animal species involved therefore I do not see a connection with the evolutionary history of statistical learning. It would be much more interesting to make claims on the ontogeny (rather than philogeny) of statistical learning, and what regularities newborns are able to detect right after birth. I believe that this is one of the strengths of this work.

      We did not intend to make claims about the phylogeny of SL. Since SL appears to be a learning mechanism shared across species, we use it as a framework to suggest that SL may arise from general operational principles applicable to diverse neural networks. Thus, while it is highly useful for language acquisition, it is not specific to it.

      We have removed the sentence “Statistical learning is an evolutionary ancient learning mechanism.”, and replaced it by (p.18, l.364) “Altogether, our results show that statistical learning works similarly on different speech features in human neonates with no clear advantage for computing linguistically relevant regularities in speech.” We now emphasise in the discussion that infants compute regularities on both features and propose that SL might be a universal learning mechanism sharing computational principles (Benjamin et al., 2024) (see point 2).

      (4) The description of the stimuli in Lines 110-113 is a bit confusing. In Experiment 1, e.g., "pe" and "tu" are both uttered by the same voice, correct? ("random voice each time" is confusing). Whereas in Experiment 2, e.g., "pe" and "tu" are uttered by different voices, for example, "pe" by yellow voice and "tu" by red voice. If this is correct, then I recommend the authors to rephrase this section to make it more clear.

      To clarify, in Experiment 1, the voices were randomly assigned to each syllable, with the constraint that no voice was repeated consecutively. This means that syllables within the same word were spoken by different voices, and each syllable was heard with various voices throughout the stream. As a result, neonates had to retrieve the words based solely on syllabic patterns, without relying on consistent voice associations or specific voice relationships.

      In Experiment 2, the design was orthogonal: while the syllables were presented in a random order, the voices followed a structured pattern. Similar to Experiment 1, each syllable (e.g., “pe” and “tu”) was spoken by different voices. The key difference is that in Experiment 2, the structured regularities were applied to the voices rather than the syllables. In other words, the “green” voice was always followed by the “red” voice for example but uttered different syllables.

      We have revised the description of the stimuli and the legend of Figure 1 to clarify these important points.

      See p.6, l. 113: “The structure consisted of the random concatenation of three duplets (i.e., two-syllable units) defined only by one of the two dimensions. For example, in Experiment 1, one duplet could be petu with each syllable uttered by a random voice each time they appear in the stream (e.g pe is produced by voice1 and tu by voice6 in one instance and in another instance pe is produced by voice3 and tu by

      voice2). In contrast, in Experiment 2, one duplet could be the combination [voice1- voice6], each uttering randomly any of the syllables.”

      p.20, l. 390 (Figure 1 legend): “For example, the two syllables of the word “petu” were produced by different voices, which randomly changed at each presentation of the word (e.g. “yellow” voice and “green” voice for the first instance, “blue” and “purple” voice for the second instance, etc..). In Experiment 2, the statistical structure was based on voices (TPs alternated between 1 and 0.5), while the syllables changed randomly (uniform TPs of 0.2). For example, the “green” voice was always followed by the “red” voice, but they were randomly saying different syllables “boda” in the first instance, “tupe” in the second instance, etc... “

      (5) Line 114: the sentence "they should compute a 36 x 36 TPs matrix relating each acoustic signal, with TPs alternating between 1/6 within words and 1/12 between words" is confusing as it seems like there are different acoustic signals. Can the authors clarify this point?

      Thank you for highlighting this point. To clarify, our suggestion is that neonates might not track regularities between phonemes and voices as separate features. Instead, they may treat each syllable-voice combination as a distinct item—for example, "pe" spoken by the "yellow" voice is one item, while "pe" spoken by the "red" voice is another. Under this scenario, there would be a total of 36 unique items (6 syllables × 6 voices), and infants would need to track regularities between these 36 combinations.

      We have modified this sentence in the manuscript to make it clearer.

      See p.7, l. 120: “If infants at birth compute regularities based on a neural representation of the syllable as a whole, i.e. comprising both phonetic and voice content, this would require computing a 36 × 36 TPs matrix relating each token.”

      Reviewer #1 (Recommendations for the authors):

      (1) The acronym TP should be spelled out, and a brief description of the fact that dips in TPs signal boundaries while high TPs signal a cohesive unit could be useful for non-specialist readers.

      We have added it at the beginning of the introduction (lines 52-60)

      (2) p.5, l.76: "Here, we aimed to further characterise the characteristics of this mechanism...". I suggest this is rephrased as "to further characterise this mechanism".

      We have changed it as suggested by the reviewer (now p.5, l.81)

      (3) p.9, l.172: "[...] this contribution is unlikely since the electrodes differ from the electrodes, showing enhanced word-rate activity at 2 Hz."

      It is unclear which electrodes differ from which electrodes. I figure that the authors mean that the electrodes showing stronger activity at 2 Hz differ from those showing it at 4 Hz, but the sentence could use rephrasing.

      This part has been rephrased (p.9, l.177-181)

      (4) p.10, l.182: "[...] the entrainment during the first minute of the structure stream [… ]".

      Structured stream.

      It has been corrected (p.10, l.190)

      (5) p.12, l.234: "we compared STATISTICAL LEARNING"

      Why the use of capitals?

      This was an error and it was corrected (p.12, l.242).

      (6) p.15, l.298: "[...] suggesting that such negativity might be related to semantic."

      The sentence feels incomplete. To semantics? To the processing of semantic information?

      The phrase has been corrected (p.15, l.314). Additionally, the discussion of the posterior negativity observed for duplets after familiarisation with a stream with regularities over phonemes has been rephrased (p.15, l.)

      (7) Same page, l.301: "3-mo-olds" 3-month-olds.

      It has been corrected (now in p.16, l.333)

      (8) Same page, l.307: "(see also (Bergelson and Aslin, 2017)" (see also Bergelson and Aslin, 2017).

      It has been corrected (now in p.17, l.340)

      (9) Same page, l.310: "[...] would be considered as possible candidate" As possible candidates.

      This has been rephrased and corrected (now in p.17, l.343)

      Reviewer #2 (Recommendations for the authors):

      (1) Figure 2: The authors mention a "thick orange line", which I think should be a "thick black line".

      We are sorry for this. It has been corrected.

      (2) Ln 166: Should be Figure 2C rather than 3C.

      It has been corrected (now in p.9, l.173)

      (3) Figure 4 is not referenced in the manuscript.

      We referred to it now on p. 12, l.236

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews: 

      Reviewer #1 Comments on revisions: 

      The authors have addressed my concerns so I am fine with revision in principle.

      Thank you for taking the time to review our work and for your thoughtful feedback. We’re glad to hear that your concerns have been addressed.

      Reviewer #2 Comments on revisions:

      The authors have addressed many of the concerns raised in the initial review and provided alternative analytical approaches to address the relevant questions in this revision. Some of these are useful; however, they have not fully addressed one critical point. 

      In my original critique, I noted that the maternal KO might not be suitable as a control, given that there is no significant phenotypic difference between the maternal-only KO and the maternal-zygotic KO. While we did not dispute the molecular differences presented in Figure 2, so how the authors conclude in the Response "embryos with a maternal KO or zygotic heterozygous KO of Oct4 or Sox2 show no noticeable ... molecular difference (Figure 2-figure supplement 4A)"? The authors should recheck whether this is a typographical error or a valid statement. 

      Additionally, I recommend the removal of phrases such as "absolutely priority" and "pivotal" throughout the manuscript, as these terms are overly assertive without sufficient supporting evidence.

      We sincerely appreciate the reviewer’s feedback and would like to take this opportunity to provide further clarification, as there might have been a misunderstanding.

      We respectfully disagree with the reviewer’s statement that “there is no significant phenotypic difference between the maternal-only KO and the maternal-zygotic KO.” Based on privious publications, there is clear evidence that maternal-zygotic KO embryos exhibit significant defects: they fail to form a healthy primitive endoderm, are unable to give rise to embryonic stem cells (ESCs) in vitro, and die shortly after implantation (Frum et al., Dev Cell 2013; Wu et al., Nat Cell Biol 2013; Le Bin et al., Development 2014; Wicklow et al., PLoS Genet 2014). In contrast, maternal-only KO embryos develop as healthy as wild-type (WT) embryos and do not display any of these phenotypic abnormalities. We believe that this distinction validates our use of maternal KO embryos as proper controls in our experiments. 

      To address the reviewer’s concerns and ensure clarity, we have also revised the following statement in the manuscript.

      Original manuscript: “Mouse embryos with a maternal KO or zygotic heterozygous KO of either factor show no noticeable phenotype or molecular difference (Figure 2-figure supplement 4A) (Avilion et al., 2003; Frum et al., 2013; Kehler et al, 2004; Nichols et al., 1998; Wicklow et al., 2014; Wu et al., 2013).” 

      Revised manuscript: “Maternal KO embryos (circles in Figure 2—figure supplement 4A) clustered together with wildtype embryos (triangles and squares) in the PCA analysis, consistent with previous studies reporting no observable phenotype in maternal KO embryos (Avilion et al., 2003; Frum et al., 2013; Kehler et al, 2004; Nichols et al., 1998; Wicklow et al., 2014; Wu et al., 2013).”

      While we acknowledge the potential for using maternal-only KO controls to underestimate differences between control and KO samples, we believe this approach does not introduce false positives in our RNA-seq and ATAC-seq experiments, only the possibility of more conservative conclusions. This minimizes the risk of overestimating the molecular impact.

      We appreciate the reviewer’s recommendation regarding the use of overly assertive terms. Upon careful review of the manuscript and response letter, we could not find instances of the term “absolutely priority.” However, we do use the term “pivotal” and would prefer to retain it as we believe it accurately reflects the importance of the findings presented in our manuscript.

      Thank you for your thoughtful comments and suggestions! We hope this response clarifies our rationale and addresses the concerns.

      ---

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review)

      Summary:

      Numerous mechanism and structural studies reported the cooperative role of Oct4 and Sox2 during the establishment of pluripotency during reprogramming. Due to the difficulty in sample collection and RNA-seq with low-number cells, the precise mechanisms remain in early embryos. This manuscript reported the role of OCT4 and SOX2 in mouse early embryos using knockout models with low-input ATAC-seq and RNA-seq. Compared to the control, chromatin accessibility and transcriptome were affected when Oct4 and Sox2 were deleted in early ICM. Specifically, decreased ATAC-seq peaks showed enrichment of Motifs of TF such as OCT, SOX, and OCT-SOX, indicating their importance during early development. Moreover, by deep analysis of ATAC-seq and RNA-seq data, they found Oct4 and Sox2 target enhancer to activate their downstream genes. In addition, they also uncovered the role of OS during development from the morula to ICM, which provided the scientific community with a more comprehensive understanding.

      Strengths:

      On the whole, the manuscript is innovative, and the conclusions of this paper are mostly well supported by data, however, there are some issues that need to be addressed.

      Weaknesses:

      Major Points:

      (1) In Figure 1, a more detailed description of the knockout strategy should be provided to clarify itself. The knockout strategy in Fig1 is somewhat obscure, such as how is OCT4 inactivated in Oct4mKO2 heterozygotes. As shown in Figure 1, the exon of OCT4 is not deleted, and its promoter is not destroyed. Therefore, how does OCT4 inactivate to form heterozygotes?

      Thank you for helping clarify this. We will add a detailed description of the knockout strategy in the legends for Figure 1A and 1B, as shown below. Note that the same strategy was used by Nichols et al (Cell, 1998).

      Figure 1A. Schemes of mKO2-labeled Oct4 KO (Oct4<sup>mKO2</sup>) and Oct4<sup>flox</sup> alleles. In the Oct4<sup>mKO2</sup> allele, a PGK-pac∆tk-P2A-mKO2-pA cassette was inserted 3.6 kb upstream of the Oct4 transcription start site (TSS) and a promoter-less FRT-SA-IRES-hph-P2A-Venus-pA cassette was inserted into Oct4 intron 1. The inclusion of a stop codon followed by three sets of polyadenylation signal sequences (pA) after the Venus cassette ensures both transcriptional and translational termination, effectively blocking the expression of Oct4 exons 2–5.

      Figure 1B. Schemes of EGFP-labeled Sox2 KO (Sox2<sup>EGFP</sup>) and Sox2 <sup>flox</sup> alleles. In the Sox2 Sox2<sup>EGFP</sup> allele, the 5’ untranslated region (UTR), coding sequence and a portion of the 3’ UTR of Sox2 were deleted and replaced with a PGK-EGFP-pA cassette. Notably, 1,023 bp of the Sox2 3’UTR remain intact.

      (2) Is ZP3-Cre expressed in the zygotes? Is there any residual protein?

      This is indeed a very important issue. Here is why we think we are on the safe side. ZP3 is specifically expressed in growing oocytes, thus making ZP3-Cre a widely used tool for deleting maternally inherited alleles. When we crossed Oct4<sup>flox/flox</sup>; ZP3-Cre<sup>-</sup>_females with _Oct4<sup>flox/flox</sup>; ZP3-Cre<sup>+</sup> males, we got ZP3-Cre<sup>+</sup> Oct4<sup>flox/flox</sup> but no Oct4<sup> flox/∆</sup> or Oct4<sup> ∆/∆</sup> pups, suggesting that the paternally inherited ZP3-Cre allele is not functionally active in zygotes, which is consistent with reports from other researchers (e.g. Frum, et al., Dev Cell 2013; Wu, et al., Nat Cell Biol 2013).

      (3) What motifs are enriched in the rising ATAC-seq peaks after knocking out of OCT4 and SOX2?

      The enriched motifs in the rising ATAC-seq peaking in Oct4 KO and Sox2 KO ICMs are the GATA, TEAD, EOMES and KLF motifs, as shown in Figure 4A and Figure supplement 7.

      (4) The ordinate of Fig4c is lost.

      Thank you for pointing this out. The y-axis is average normalized signals (reads per million-normalized pileup signals). We will add it in the revised version.

      (5) Signals of H3K4me1, H3K27ac, and so on are usually used to define enhancers, and the loci of enhancers vary greatly in different cells. In the manuscript, the authors defined ATAC-seq peaks far from the TSS as enhancers. The definition in this manuscript is not strictly an enhancer.

      Thank you for this insightful comment. We analyzed the published H3K27ac ChIP-seq data of mouse ICM at 94-96 h post hCG (B. Liu, et al., Nat Cell Biol 2024) to assess the enrichment of H3K27ac around our ATAC-seq peaks. Unfortunately, the data quality is poor, e.g., inconsistent across replicates (Author response image 1A), and shows little enrichment around the well-defined enhancers (Author response image 1B). Nevertheless, as we admit not all the distal ATAC-seq peaks or open chromatin regions are enhancers, we have replaced “enhancers” with “open chromatin regions”, “ATAC-seq peaks” or “putative enhancers”.

      Author response image 1.

      Analysis of the published H3K27ac ChIP-seq dataset of mouse ICM at 94-96 h post hCG (B. Liu, et al., Nat Cell Biol 2024). A. ChIP-seq profiles of H3K27ac over the decreased, unchanged and increased ATAC-seq peaks in our Oct4-KO late ICMs. To exclude spurious peaks, only strong unchanged peaks (57,512 out of 142,096) were used in the analysis. B. IGV tracks displaying ATAC-seq and H3K27ac ChIP-seq profiles around Dppa3 and Oct4. Red boxes mark the known OCT-SOX enhancers.

      (6) If Oct4 and Sox2 truly activate sap 30 and Uhrf 1, what effect does interfere with both genes have on gene expression and chromatin accessibility?

      This is indeed an interesting question. Unfortunately, we have not conducted this specific experiment, so we do not have direct results. However, Sap30 is a key component of the mSin3A corepressor complex, while Uhrf1 regulates the establishment and maintenance of DNA methylation. Both proteins are known to function as repressors. Therefore, we hypothesize that interfering with these two genes could alleviate repression of some genes, such as trophectoderm markers, similar to what we have observed in Oct4 KO and Sox2 KO ICMs.

      Reviewer #2 (Public review):

      In this manuscript, Hou et al. investigate the interplay between OCT4 and SOX2 in driving the pluripotent state during early embryonic lineage development. Using knockout (KO) embryos, the authors specifically analyze the transcriptome and chromatin state within the ICM-to-EPI developmental trajectory. They emphasize the critical role of OCT4 and the supportive function of SOX2, along with other factors, in promoting embryonic fate. Although the paper presents high-quality data, several key claims are not well-supported, and direct evidence is generally lacking.

      Major Points:

      (1) Although the authors claim that both maternal KO and maternal KO/zygotic hetero KO mice develop normally, the molecular changes in these groups appear overestimated. A wildtype control is recommended for a more robust comparison. (a complementary comment from the reviewer: “Both maternal KO and maternal-zygotic KO in this study exhibited phenotypic consistency but molecular disparity. Specifically, both KO and control groups could develop normally; however, their chromatin landscapes and transcriptomic profiles showed different. This raises the question of whether the molecular differences are real. We suggest that inclusion of a completely wild-type control group would make the comparison more robust.”)

      Thank you for your feedback as this point was obviously not clear in the manuscript. Here is our explanation: Mouse embryos with a maternal KO or zygotic heterozygous KO of Oct4 or Sox2 show no noticeable phenotype or molecular difference (Figure 2-figure supplement 4A) (Avilion et al., 2003; Frum et al., 2013; Kehler et al, 2004; Nichols et al., 1998; Wicklow et al., 2014; Wu et al., 2013). We have clarified this point in the revised manuscript.

      (2) The authors assert that OCT4 and SOX2 activate the pluripotent network via the OCT-SOX enhancer. However, the definition of this enhancer is based solely on proximity to TSSs, which is a rough approximation. Canonical enhancers are typically located in intronic and intergenic regions and marked by H3K4me1 or H3K27ac. Re-analyzing enhancer regions with these standards could be beneficial. Additionally, the definitions of "close to" or "near" in lines 183-184 are unclear and not defined in the legends or methods.

      Thank you for this insightful and helpful comment. As stated in the response to Reviewer #1’s point (5), we have replaced “enhancers” with “open chromatin regions”, “ATAC-seq peaks” or “putative enhancers”.

      The definition of "close to" or "near" in lines 183-184 is in the legend of Figure 2E and Methods. In the GSEA analysis, Ensembl protein-coding genes with TSSs located within 10 kb of ATAC-seq peak centers were included, so that some of the intronic ATAC-seq peaks were taken into consideration. We have also added the information in the main text of the revised manuscript.

      (3) There is no evidence that the decreased peaks/enhancers could be the direct targets of Oct4 and Sox2 throughout this manuscript. Figures 2 and 4 show only minimal peak annotations related to OCT and SOX motifs, and there is a lack of chromatin IP data. Therefore, claims about direct targets are not substantiated and should be appropriately revised.

      Yes indeed, you have a point. In Figure Supplement 3C, we analyzed the published Sox2 CUT&RUN data from E4.5 ICMs (Li et al., Science, 2023), which demonstrates that the reduced ATAC-seq peaks in our Sox2 KO ICMs are enriched with the Sox2 CUT&RUN signals. Unfortunately, we did not to find similar published data for Oct4 in embryos. We have removed the statement indicating that these are the direct targets in the revised manuscript.

      (4) Lines 143-146 lack direct data to support the claim. Actually, the main difference in cluster 1, 11 and 3, 8, 14 is whether the peak contains OCT-SOX motif. However, the reviewer cannot get any information of peaks activated by OCT4 rather than SOX2 in cluster 1, 11.

      Thank you for the comment that we hope we can clarify.

      Lines 143-146 are: “Notably, the peaks activated by Oct4 but not by Sox2 in the ICM tended to be already open at the morula stage (Figure 2B, clusters 1 and 11), whereas those dependent on both Oct4 and Sox2 became open in the ICM (Figure 2B, clusters 3, 8 and 14).”

      We agree with you that clusters 3/8/14 are more enriched in OCT-SOX motifs than clusters 1/11. However, this is consistent with our observation that accessibility of peaks in clusters 1 and 11 relies mainly on Oct4, while accessibility in clusters 3, 8, 14 depends on both Oct4 and Sox2. But maybe the term “activate” is misleading. We have rephrased the text as below:

      “Notably, compared to the peaks that depend on Oct4 but not Sox2 (Figure 2B, clusters 1 and 11), those reliant on both Oct4 and Sox2 show greater enrichment of the OCT-SOX motif (Figure 2B, clusters 3, 8 and 14). The former group was generally already open in the morula, while the latter group only became open in the ICM. “

      Minor Points:

      (1) Lines 153-159: The figure panel does not show obvious enrichment of SOX2 signals or significant differences in H3K27ac signals across clusters, thus not supporting the claim.

      We hope to be able to explain this.

      Line 153-159 refer to two datasets:  Figure Supplement 3C and 3D.

      In Figure Supplement 3C, the average plots above the heatmaps show that the decreased ATAC-seq peaks (the indigo lines) have higher enrichment with Sox2 CUT&RUN signals than the increased or unchanged peaks (the yellow and light blue lines, respectively).

      In Figure Supplement 3D, the average plots indicate that H3K27ac signals around the center of the decreased ATAC-seq peaks (the indigo line) show higher enrichment compared to the unaltered and decreased groups (the light blue and yellow lines, respectively). Notably, H3K27ac enrichment appears slightly offset from the central nucleosome-free regions.

      (2) Lines 189-190: The term "identify" is overstated for the integrative analysis of RNA-seq and ATAC-seq, which typically helps infer TF targets rather than definitively identifying them.

      You are right. We have replaced “identify” with “infer” in the revised manuscript.

      (3) The Discussion is lengthy and should be condensed.

      We have shortened the discussion in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The manuscript by Oleh et al. uses in vitro electrophysiology and compartmental modeling (via NEURON) to investigate the expression and function of HCN channels in mouse L2/3 pyramidal neurons. The authors conclude that L2/3 neurons have developmentally regulated HCN channels, the activation of which can be observed when subjected to large hyperpolarizations. They further conclude via blockade experiments that HCN channels in L2/3 neurons influence cellular excitability and pathway-specific EPSP kinetics, which can be neuromodulated. While the authors perform a wide range of slice physiology experiments, concrete evidence that L2/3 cells express functionally relevant HCN channels is limited. There are serious experimental design caveats and confounds that make drawing strong conclusions from the data difficult. Furthermore, the significance of the findings is generally unclear, given modest effect sizes and a lack of any functional relevance, either directly via in vivo experiments or indirectly via strong HCN-mediated changes in known operations/computations/functions of L2/3 neurons.

      Specific points:

      (1) The interpretability and impact of this manuscript are limited due to numerous methodological issues in experimental design, data collection, and analysis. The authors have not followed best practices in the field, and as such, much of the data is ambiguous and/or weak and does not support their interpretations (detailed below). Additionally, the authors fail to appropriately explain their rationale for many of their choices, making it difficult to understand why they did what they did. Furthermore, many important references appear to be missing, both in terms of contextualizing the work and in terms of approach/method. For example, the authors do not cite Kalmbach et al 2018, which performed a directly comparable set of experiments on HCN channels in L2/3 neurons of both humans and mice. This is an unacceptable omission. Additionally, the authors fail to cite prior literature regarding the specificity or lack thereof of Cs+ in blocking HCN. In describing a result, the authors state "In line with previous reports, we found that L2/3 PCs exhibited an unremarkable amount of sag at 'typical' current commands" but they then fail to cite the previous reports.

      We thank the reviewer for the thorough examination of our manuscript; however, we disagree with many of the raised concerns for several reasons, as detailed here:

      To address the lack of certain citations, we would like to emphasize that in the introduction section, we did initially focus on the several decades-long line of investigation into the HCN channel content of layer 2/3 pyramidal cells (L2/3 PCs), where there has undoubtedly been some controversy as to their functional contribution. We did not explicitly cite papers that claimed to find no/little HCN channels/sag- although this would be a significant list of publications from some excellent investigators, as methods used may have differed from ours leading to different interpretations. Simply stated, unless one was explicitly looking for HCN in L2/3 PCs, it might go unobserved. However, we now addressed this more clearly in the revision:

      Just to take one example: in the publication mentioned by the reviewer (Kalmbach et al 2018), the investigators did not carry out voltage clamp or dynamic clamp recordings, as we did in our work here. Furthermore, the reported input resistance values in the aforementioned paper were far above other reports in mice (Routh et al. 2022, Brandalise et al 2022, Hedrick et al 2012; which were similar to our findings here), suggesting that recordings in Kalmbach were carried out at membrane potentials where HCN activation may be less available (Routh, Brager and Johnston 2022).

      Another reason for some mixed findings in the field is undoubtedly due to the small/nonexistent sag in L2/3 current clamp recordings (in mice). We also observed a very small sag, which can be explained by the following:  The ‘sag’ potential is a biphasic voltage response emerging from a relatively fast passive membrane response and a slower Ih activation. In L2/3 PCs, hyperpolarization-activated currents are apparently faster than previously described, and are located proximally (Figure 2 & Figure 5). Therefore, their recruitment in mouse L2/3 PCs is on a similar timescale to the passive membrane response, resulting in a more monophasic response. We now include a more full set of citations in the updated introduction section, to highlight the importance of HCN channels in L2/3 PCs in mice (and other species).

      The justification for using cesium (i.e., ‘best practices’) is detailed below.

      (2) A critical experimental concern in the manuscript is the reliance on cesium, a nonspecific blocker, to evaluate HCN channel function. Cesium blocks HCN channels but also acts at potassium channels (and possibly other channels as well). The authors do not acknowledge this or attempt to justify their use of Cs+ and do not cite prior work on this subject. They do not show control experiments demonstrating that the application of Cs+ in their preparation only affects Ih. Additionally, the authors write 1 mM cesium in the text but appear to use 2 mM in the figures. In later experiments, the authors switch to ZD7288, a more commonly used and generally accepted more specific blocker of HCN channels. However, they use a very high concentration, which is also known to produce off-target effects (see Chevaleyre and Castillo, 2002). To make robust conclusions, the authors should have used both blockers (at accepted/conservative concentrations) for all (or at least most) experiments. Using one blocker for some experiments and then another for different experiments is fraught with potential confounds.

      To address the concerns regarding the usage of cesium to block HCN channels, we would like to state that neither cesium nor ZD-7288 are without off-target effects, however in our case the potential off-target effects of external cesium were deemed less impactful, especially concerning AP firing output experiments. Extracellular cesium has been widely accepted as a blocker of HCN channels (Lau et al. 2010, Wickenden et al. 2009, Rateau and Ropert 2005, Hemond et al. 2009, Yang et al. 2015, Matt et al. 2010). However, it is well known to act on potassium channels as well at higher concentrations, which has been demonstrated with intracellular and extracellular application (Puil et al. 1981, Fleidervish et al. 2008, Williams et al. 1991, 2008).

      Although we initially performed ‘internal’ control experiments to ensure the cesium concentration was unlikely to greatly block voltage gated K+ channels during our recordings, we recognize these were not included in the original manuscript. These are detailed as follows: during our recordings cesium had no significant effect on action potential halfwidth, ruling out substantial blocking of potassium channels, nor did it affect any other aspects of suprathreshold activity (now reported in results, page 4 - line 113). Furthermore, we observed similar effects on passive properties (resting membrane potential, input resistance) following ZD-7288 as with cesium, which we now also updated in our figures (Supplementary Figure 1). We did acknowledge that ZD-7288 is a widely accepted blocker of HCN, and for this reason we carried out some of our experiments using this pharmacological agent instead of cesium.

      On the other hand, ZD-7288 suffers from its own side effects, such as potential effects on sodium channels (Wu et al. 2012) and calcium channels (Sánchez-Alonso et al. 2008, Felix et al. 2003). As our aim was to provide functional evidence for the importance of HCN channels, we initially deemed these potential effects unacceptable in experiments where AP firing output (e.g., in cell-attached experiments) was measured. Nonetheless, in new experiments now included here, we found the effects of ZD and cesium on AP output were similar as shown in new Supplemental Figure 1.

      Many experiments were supported by complementary findings using external cesium and ZD-7288. For example, the effect of ZD-7288 on EPSPs was confirmed by similar synaptic stimulation experiments using cesium. This is important, as synaptic inputs of L2/3 PCs are modulated by both dendritic sodium (Ferrarese et al. 2018) and calcium channels (Landau 2022), therefore the application of ZD-7288 alone may have been difficult to interpret in isolation. We thank the reviewer for bringing up this important point.

      (3) A stronger case could be made that HCN is expressed in the somatic compartment of L2/3 cells if the authors had directly measured HCN-isolated currents with outside-out or nucleated patch recording (with appropriate leak subtraction and pharmacology). Whole-cell voltage-clamp in neurons with axons and/or dendrites does not work. It has been shown to produce erroneous results over and over again in the field due to well-known space clamp problems (see Rall, Spruston, Williams, etc.). The authors could have also included negative controls, such as recordings in neurons that do not express HCN or in HCN-knockout animals. Without these experiments, the authors draw a false equivalency between the effects of cesium and HCN channels, when the outcomes they describe could be driven simply by multiple other cesium-sensitive currents. Distortions are common in these preparations when attempting to study channels (see Williams and Womzy, J Neuro, 2011). In Fig 2h, cesium-sensitive currents look too large and fast to be from HCN currents alone given what the authors have shown in their earlier current clamp data. Furthermore, serious errors in leak subtraction appear to be visible in Supplementary Figure 1c. To claim that these conductances are solely from HCN may be misleading.

      We disagree with the argument that “Whole-cell voltage-clamp in neurons with axons and/or dendrites does not work”. Although this method is not without its confounds (i.e. space clamp), it is still a useful initial measure as demonstrated countless times in the literature. However, the reviewer is correct that the best approach to establish the somatodendritic distribution of ion channels is by direct somatic and dendritic outside-out patches. Due to the small diameter of L2/3 PC dendrites, these experiments haven’t been carried out yet in the literature for any other ion channel either to our knowledge. Mapping this distribution electrophysiologically may be outside the scope of the current manuscript, but it was hard for us to ignore the sheer size of the Cs<sup>+</sup> sensitive hyperpolarizing currents in whole cell. Thus, we will opt to report this data.

      Also, we should point out that space clamp-related errors manifest in the overestimation of frequency-dependent features, such as activation kinetics, and underestimation of steady-state current amplitudes. The activation time constant of our measured currents are somewhat faster than previously reported; reducing major concerns regarding space clamp errors. Furthermore, we simply do not understand what “too large… to be from HCN currents” means. Our voltage-clamp measured currents are similar to previously reported HCN currents (Meng et al. 2011, Li 2011, Zhao et al. 2019, Yu et al. 2004, Zhang et al. 2008, Spinelli et al. 2018, Craven et al. 2006, Ying et al. 2012, Biel et al. 2009).

      Furthermore, we should point out that our measured currents activated at hyperpolarized voltages, had the same voltage dependence as HCN currents, did not show inactivation, influenced both input resistance and resting membrane potential, and are blocked by low concentration extracellular cesium. Each of these features would point to HCN.

      (4) The authors present current-clamp traces with some sag, a primary indicator of HCN conductance, in Figure 2. However, they do not show example traces with cesium or ZD7288 blockade. Additionally, the normalization of current injected by cellular capacitance and the lack of reporting of input resistance or estimated cellular size makes it difficult to determine how much current is actually needed to observe the sag, which is important for assessing the functional relevance of these channels. The sag ratio in controls also varies significantly without explanation (Figure 6 vs Figure 7). Could this variability be a result of genetically defined subgroups within L2/3? For example, in humans, HCN expression in L2/3 varies from superficial and deep neurons. The authors do not make an effort to investigate this. Regardless of inconsistencies in either current injection or cell type, the sag ratio appears to be rather modest and similar to what has already been reported previously in other papers.

      We thank the reviewer for pointing out that our explanation for the modest sag ratio might have not been sufficient to properly understand why this measurement cannot be applied to layer 2/3 pyramidal cells. Briefly: sag potential emerges from a relatively (compared to I<sub>h</sub>) fast passive membrane response and a slower HCN recruitment. The opposing polarity and different timescales of these two mechanisms results in a biphasic response called “sag” potential. However, if the timescale of these two mechanisms is similar, the voltage response is not predicted to be biphasic. We have shown that hyperpolarization activated currents in our preparations are fast and proximal, therefore they are recruited during the passive response (see Figure 2g.). This means that although a substantial amount of HCN currents are activated during hyperpolarization, their activation will not result in substantial sag. Therefore, sag ratio measurement is not necessarily applicable to approximate the HCN content of mouse L2/3 PCs. We would like to emphasize that sag ratio measurements are correct in case of other cell types (i.e. L5 and CA1 PCs_,_ and our aim is not to discredit the method, but rather to show that it cannot be applied similarly in the case of mouse L2/3 PCs.

      Our own measurements, similar to others in the literature show that L2/3 PCs exhibit modest sag ratios, however, this does not mean that HCN is not relevant. I<sub>h</sub> activation in L2/3 PCs does not manifest in large sag potential but rather in a continuous distortion of steady-state responses (Figure 2b.). The reviewer is correct that L2/3 PCs are non-homogenous, therefore we sampled along the entire L2/3 axis. This yielded some potential variability in our results (i.e., passive properties); yet we did not observe any cells where hyperpolarizing-activated/Cs<sup>+</sup>-sensitive currents could not be resolved. As structural variability of L2/3 cells does result in variability in cellular capacitance, we compensated for this variability by injecting cellular capacitance-normalized currents. Our measured cellular capacitances were in accordance with previously published values, in the range of 50-120 pF. Therefore, the injected currents were not outside frequently used values. Together, we would like to state that whether substantial sag potential is present or not, initial estimates of the HCN content for each L2/3 PC should be treated with caution.

      (5) In the later experiments with ZD7288, the authors measured EPSP half-width at greater distances from the soma. However, they use minimal stimulation to evoke EPSPs at increasingly far distances from the soma. Without controlling for amplitude, the authors cannot easily distinguish between attenuation and spread from dendritic filtering and additional activation and spread from HCN blockade. At a minimum, the authors should share the variability of EPSP amplitude versus the change in EPSP half-width and/or stimulation amplitudes by distance. In general, this kind of experiment yields much clearer results if a more precise local activation of synapses is used, such as dendritic current injection, glutamate uncaging, sucrose puff, or glutamate iontophoresis. There are recording quality concerns here as well: the cell pictured in Figure 3a does not have visible dendritic spines, and a substantial amount of membrane is visible in the recording pipette. These concerns also apply to the similar developmental experiment in 6f-h, where EPSP amplitude is not controlled, and therefore, attenuation and spread by distance cannot be effectively measured. The outcome, that L2/3 cells have dendritic properties that violate cable theory, seems implausible and is more likely a result of variable amplitude by proximity.

      To resolve this issue, we made a supplementary figure showing elicited amplitudes, which showed no significant distance dependence and minimal variability (new Supplementary Figure 6). We thank the reviewer for suggesting an amplitude-halfwidth comparison control (now included as new Supplementary Figure 6).). To address the issue of the non-visible spines, we would like to note that these images are of lower magnification and power to resolve them. The presence of dendritic spines was confirmed in every recorded pyramidal cell observed using 2P microscopy at higher magnification.

      We would like to emphasize that although our recordings “seemingly” violated the cable theory, this is only true if we assume a completely passive condition. As shown in our manuscript, cable theory was not violated, as the presence of NMDA receptor boosting explained the observed ‘non-Rallian’ phenomenon.

      (6) Minimal stimulation used for experiments in Figures 3d-i and Figures 4g-h does not resolve the half-width measurement's sensitivity to dendritic filtering, nor does cesium blockade preclude only HCN channel involvement. Example traces should be shown for all conditions in 3h; the example traces shown here do not appear to even be from the same cell. These experiments should be paired (with and without cesium/ZD). The same problem appears in Figure 4, where it is not clear that the authors performed controls and drug conditions on the same cells. 4g also lacks a scale bar, so readers cannot determine how much these measurements are affected by filtering and evoked amplitude variability. Finally, if we are to believe that minimal stimulation is used to evoke responses of single axons with 50% fail rates, NMDA receptor activation should be minimal to begin with. If the authors wish to make this claim, they need to do more precise activation of NMDA-mediated EPSPs and examine the effects of ZD7288 on these responses in the same cell. As the data is presented, it is not possible to draw the conclusion that HCN boosts NMDA-mediated responses in L2/3 neurons.

      As stated in the figure legends, the control and drug application traces are from the same cell, both in figure 3 and figure 4, and the scalebar is not included as the amplitudes were normalized for clarity. We have address the effects of dendritic filtering above in answer (5), and cesium blockade above in answer (2). To reiterate, dendritic filtering alone cannot explain our observations, and cesium is often a better choice for blocking HCN channels compared to ZD-7288, which blocks sodium channels as well.

      When an excitatory synaptic signal arrives onto a pyramidal cell in typical conditions, neurotransmitter sensitive receptors transmit a synaptic current to the dendritic spine. This dendritic spine is electrically isolated by the high resistance of the spine neck and due to the small membrane surface of the spine, the synaptic current can elicit remarkably large voltage changes. These voltage changes can be large enough to depolarize the spine close to zero millivolts upon even single small inputs (Jayant et al. 2016). Therefore, to state that single inputs arriving to dendritic spines cannot be large enough to recruit NMDA receptor activation is incorrect. This is further exemplified by the substantial literature showing ‘miniature’ NMDA recruitment via stochastic vesicle release alone.

      (7) The quality of recordings included in the dataset has concerning variability: for example, resting membrane potentials vary by >15-20 mV and the AP threshold varies by 20 mV in controls. This is indicative of either a very wide range of genetically distinct cell types that the authors are ignoring or the inclusion of cells that are either unhealthy or have bad seals.

      Although we are aware of the diversity of L2/3 PCs, resolving further layer depth differences is outside the scope of our current manuscript. However, as shown in Kalmbech et al, resting membrane potential can greatly vary (>15-20 mV) in L2/3 PCs depending on distance from pia. We acknowledge that the variance in AP threshold is large and could be due to genetically distinct cell types.

      (8) The authors make no mention of blocking GABAergic signaling, so it must be assumed that it is intact for all experiments. Electrical stimulation can therefore evoke a mixture of excitatory and inhibitory responses, which may well synapse at very different locations, adding to interpretability and variability concerns.

      We thank the reviewer for pointing out our lack of detail regarding the GABAergic signaling blocker SR 95531. We did include this drug in our recordings of (50Hz stim.) signal summation, so GABAergic responses did not contaminate our recordings. We now included this information in the results section (page 5) and the methods section (page 15)

      (9) The investigation of serotonergic interaction with HCN channels produces modest effect sizes and suffers the same problems as described above.

      We do not agree with the reviewer that 50% drop in neuronal AP firing responses (Figure 7b) was a modest effect size. Thus, we opted to keep this data in the manuscript.

      (10) The computational modeling is not well described and is not biologically plausible. Persistent and transient K channels are missing. Values for other parameters are not listed. The model does not seem to follow cable theory, which, as described above, is not only implausible but is also not supported by the experimental findings.

      The model was downloaded from the Cell Type Database from the Allen Institute, with only minor modifications including the addition of dendritic HCN channels and NDMA receptors- which were varied along a wide parameter space to find a ‘best fit’ to our observations. These additions were necessary to recapitulate our experimental findings. We agree the model likely does not fully recapitulate all aspects of the dendrites, which as we hope to convey in this manuscript, are not fully resolved in mouse L2/3 PCs. This is a previously published neuronal model, and despite its potential shortcomings, is one among a handful of open-source neuronal models of a fully reconstructed L2/3 PC.

      Reviewer #2 (Public Review):

      Summary:

      This paper by Olah et al. uncovers a previously unknown role of HCN channels in shaping synaptic inputs to L2/3 cortical neurons. The authors demonstrate using slice electrophysiology and computational modeling that, unlike layer 5 pyramidal neurons, L2/3 neurons have an enrichment of HCN channels in the proximal dendrites. This location provides a locus of neuromodulation for inputs onto the proximal dendrites from L4 without an influence on distal inputs from L1. The authors use pharmacology to demonstrate the effect of HCN channels on NMDA-mediated synaptic inputs from L4. The authors further demonstrate the developmental time course of HCN function in L2/3 pyramidal neurons. Taken together, this a well-constructed investigation of HCN channel function and the consequences of these channels on synaptic integration in L2/3 pyramidal neurons.

      Strengths:

      The authors use careful, well-constrained experiments using multiple pharmacological agents to asses HCN channel contributions to synaptic integrations. The authors also use a voltage clamp to directly measure the current through HCN channels across developmental ages. The authors also provide supplemental data showing that their observation is consistent across multiple areas of the cerebral cortex.

      Weaknesses:

      The gradient of the HCN channel function is based almost exclusively on changes in EPSP width measured at the soma. While providing strong evidence for the presence of HCN current in L2/3 neurons, there are space clamp issues related to the use of somatic whole-cell voltage clamps that should be considered in the discussion.

      We thank the reviewer for pointing out our careful and well-constrained experiments and for making suggestions. The potential effects of space clamp errors are detailed in the extended explanations under Reviewer 1, Specific points (3).

      Reviewer #3 (Public Review):

      Summary:

      The authors study the function of HCN channels in L2/3 pyramidal neurons, employing somatic whole-cell recordings in acute slices of visual cortex in adult mice and a bevy of technically challenging techniques. Their primary claim is a non-uniform HCN distribution across the dendritic arbor with a greater density closer to the soma (roughly opposite of the gradient found in L5 PT-type neurons). The second major claim is that multiple sources of long-range excitatory input (cortical and thalamic) are differentially affected by the HCN distribution. They further describe an interesting interplay of NMDAR and HCN, serotonergic modulation of HCN, and compare HCN-related properties at 1, 2 and 6 weeks of age. Several results are supported by biophysical simulations.

      Strengths:

      The authors collected data from both male and female mice, at an age (6-10 weeks) that permits comparison with in vivo studies, in sufficient numbers for each condition, and they collected a good number of data points for almost all figure panels. This is all the more positive, considering the demanding nature of multi-electrode recording configurations and pipette-perfusion. The main strength of the study is the question and focus.

      Weaknesses:

      Unfortunately, in its present form, the main claims are not adequately supported by the experimental evidence: primarily because the evidence is indirect and circumstantial, but also because multiple unusual experimental choices (along with poor presentation of results) undermine the reader's confidence. Additionally, the authors overstate the novelty of certain results and fail to cite important related publications. Some of these weaknesses can be addressed by improved analysis and statistics, resolving inconsistent data across figures, reorganizing/improving figure panels, more complete methods, improved citations, and proofreading. In particular, given the emphasis on EPSPs, the primary data (for example EPSPs, overlaid conditions) should be shown much more.

      However, on the experimental side, addressing the reviewer's concerns would require a very substantial additional effort: direct measurement of HCN density at different points in the dendritic arbor and soma; the internal solution chosen here (K-gluconate) is reported to inhibit HCN; bath-applied cesium at the concentrations used blocks multiple potassium channels, i.e. is not selective for HCN (the fact that the more selective blocker ZD7288 was used in a subset of experiments makes the choice of Cs+ as the primary blocker all the more curious); pathway-specific synaptic stimulation, for example via optogenetic activation of specific long-range inputs, to complement / support / verify the layer-specific electrical stimulation.

      We thank the reviewer for their very careful examination of our manuscript and helpful suggestions. We addressed the concerns raised in the review and presented more raw traces in our figures. Although direct dendritic HCN mapping measurements are outside the scope of the current manuscript due to the morphological constraints presented by L2/3 PCs (which explains why no other full dendritic nonlinearity distribution has been described in L2/3 PCs with this method), we nonetheless supplemented our manuscript with additional suggested experiments as suggested. For example, we included the excellent suggestion of pathway-specific optogenetic stimulation to further validate the disparate effect of HCN channels for distal and proximal inputs. We agree that ZD-7288 is a widely accepted blocker of HCN channels. However, the off-target effects on sodium channels may have significantly confounded our measurements of AP output using extracellular stimulation. Therefore, we chose low concentration cesium as the primary blocker for those experiments, but now validated several other Cs<sup>+</sup>-based results with ZD-7288 as well.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      I have some issues that need clarification or correction.

      (1) On page 3, line 90, the authors state "We found that bath application of Cs+ (1mM)..." but the methods and Figure 1 state "2mM Cs+". Please check and correct.

      Correct, typo corrected.

      (2) Related to Cs+ application, the methods state that "CsMeSO4 (2mM) was bath applied..." Is this correct? CsMeSO4 is typically used intracellularly while CsCl is used extracellularly. If so, please justify. If not, please correct.

      It is correct. The justification for not using CsCl selectively extracellularly is that introducing intracellular chloride ions can significantly alter basic biophysical properties, unrelated to the cesium effect. However, no similar distinction has been made for CsMeSO4, which would exclude the use of this drug extracellularly.

      (3) The authors normalize the current injections by cell capacitance (pA/pF). Was this done because there is a significant variance in cell morphology? A bit of justification for why the authors chose to normalize the current injection this way would help. If there is significant variation in cell capacitance across cells (or developmental ages), the authors could also include these data.

      Indeed, we choose to normalize current injection to cellular capacitance due to the markedly different morphology of deep and superficial L2/3 PCs. Deeper L2/3 PCs have a pronounced apical branch, closely resembling other pyramidal cell types such as L5 PCs, while superficial L2/3 PC lack a thick main apical branch and instead are equipped with multiple, thinner apical dendrites. This morphological variation would yield an inherent bias in several of the reported measurements, therefore we corrected for it by normalizing current injection to cellular capacitance, similar to our previous recent publications (Olah, Goettemoeller et al., 2022, Goettemoeller et al. 2024, Kumar et al. 2024).

      (4) On page 15, line 445, the section heading is "PV cell NEURON modeling". Is this a typo? The models are of L2/3 pyramidal neurons, correct?  

      Correct, typo corrected.

      (5) Figures 3F and 3I are plots of the voltage integral for different inputs before and after Cs+. The y-axis label units are "pA*ms". This should be "mV*ms" for a voltage integral.  

      Correct, typo corrected.

      (6) On page 9, line 273, the text reads "Voltage clamp experiments revealed that the rectification of steady-state voltage responses to hyperpolarizing current injection was amplified with 5-CT (Fig. 7c)". Both the text and Figure 7C describe current clamp, not voltage clamp, recordings. Please check and correct.

      Correct, typo corrected.

      (7) Figure 2i looks to be a normalized conductance vs voltage (i.e. activation) plot. The y-axis shows 0-1 but the units are in nS. Is that a coincidence or an error?

      Correct, typo corrected.

      Reviewer #3 (Recommendations For The Authors):

      This is your paper. My comments are my own opinion, I don't expect you to agree or to respond. But I hope that what I wrote below will help you to understand my perspective.

      Please pardon my directness (and sheer volume) in this section - I have a lot of notes/thoughts and hope you may find some of them helpful. My high-level comments are unfortunately rather critical, and in (small) part that is because I encountered too many errors/typos/ambiguities in figures, legend, and text. I expect many would be caught with good proofreading, but uncorrected caused confusion on my part, or an inability to interpret your figures with confidence, given some ambiguity.

      The paper reads a bit like patchwork - likely a result of many "helpful" reviewers who came before me. Consider starting with and focusing on the synaptic findings, expanding the number of figures and panels dedicated to that, showing example traces for all conditions, and giving yourself the space to portray these complex experiments and results. While I'm not a fan of a large number of supplemental figures, I feel you could move the "extra" results to the supplementals to improve the focus and get right to the meat of it.

      For me, the main concern is that the evidence you present for the non-uniform HCN distribution is rather indirect. Ideally, I'd like to see patch recordings from various dendritic locations (as others have done in rats, at least; I'm not sure if L2/3 mice have had such conductance density measurements made in basal and apical dendrites). Otherwise, perhaps optical mapping, either functional or via staining. I also mention some concerns about the choice of internal and cesium. More generally, I want to see more primary data (traces), in particular for the big synaptic findings (non-uniform, L1-vs-L4 differences, NMDAR).

      We thank the reviewer for the helpful suggestions. Indeed, direct patch clamp recording is widely considered to be the best method to identify dendritic ion channel distribution, however, we choose an in silico approach instead, for several reasons. Undoubtedly, one of the main reasons to omit direct dendritic recordings was that due to the uniquely narrow apical dendrites this method is extremely challenging, with no previous examples in the literature where isolated dendritic outside-out patch recordings were achieved from this cell type. However, there are theoretical considerations as well. In primates, it has been demonstrated that HCN1 channels are concentrated on dendritic spines (Datta et al., 2023) therefore direct outside-out recordings are not adequate in these circumstances. In future experiments we could directly target L2/3 PC dendrites for outside out recordings in order to resolve dendritic nonlinearity distribution, although a cell-attached methodology may be better suited due to the HCN biophysical properties being closely regulated by intracellular signaling pathways.

      The introduction and Figures 1 and 2 are not so interesting and not entirely accurate: L2/3 do not have "abundant" HCN, nor is there an actual controversy about whether they have HCN. It's been clear (published) for years that they have about the same as all other non-PT neocortical pyramidal neurons (see e.g. Larkum 2007; Sheets 2011). Your own Figure 1A has a logarithmic scale and shows L2/3 as having the lowest expression (?) of all pyramidals and roughly 10x lower than L5 PT, but the text says "comparable", which is misleading.

      We thank the reviewer for this comment. Although there are sporadic reports in the literature about the HCN content of L2/3 PCs, most of these publications arrive to the same conclusion from the negligible sag potential (as the mentioned Larkum et al., 2007 publication); namely that L2/3 PCs do not contain significant amount of HCN channels. We have shown with voltage and current clamp recordings that this assumption is false, as sag potential is not a reliable indicator of HCN content in L2/3 PCs. With the term “controversial” we aimed to highlight the different conclusions of functional investigations (e.g. Sheets et al., 2011) and sag potential recordings (e.g. Larkum et al., 2007), regarding the importance of HCN channels in L2/3 PCs.

      Non-uniform HCN with distal lower density has already been published for a (rare) pyramidal neuron in CA1 (Bullis 2007), similar to what you found in L2/3, and different from the main CA1 population.

      We thank the reviewer for this suggestion. We have now included the mentioned citation in the introduction section (page 3).

      Express sag as a ratio or percentage, consistently. Figure out why in Figure 7 the average sag ratio is 0.02 while in Fig. S1 it is 0.07 (for V1) - that is a massive difference.

      The calculation of sag ratio is consistent across the manuscript (at -6pA.pF), except for experiments depicted in Fig. 7 where sag ratio was calculated from -2pA/pF steps. Explanation below:

      Sag should be measured at a common membrane potential, with each neuron receiving a current pulse appropriate to reach that potential. Your approach of capacitance-based may allow for the same, but it is not clear which responses are used to calculate a single sag value per cell (as in Figure 2d).

      Thank you, we now included this info in the methods section. Sag potential was measured at the -6 pA/pF step peak voltage, except for Fig. 7 as noted above. We have now included this discrepancy detail in the methods section (page 14 ). These recordings in Fig. 7 took significantly longer than any other recording in the manuscript, as it took a considerable time to reach steady-state response from 5-CT application. -6pA/pF is a current injection in the range of 400-800 pA, which was proven to be too severe for continued application in cells after more than an hour of recording. Accordingly, we decided to lower the hyperpolarizing current step in these recordings. The absolute value of sag is thus different in Fig. 7, but nonetheless the 5-CT effect was still significant. Notably, we probably wouldn’t have noticed the small sag in L2/3 here (and thus the entire study), save for the fact that we looked at -6pA/pF to begin.

      In a paper focused on HCN, I would have liked to see resonance curves in the passive characterization.

      We thank the reviewer for the suggestion. Resonance curves can indeed provide useful insights into the impact of HCN on a cell’s physiological behavior, however, these experiments are outside the scope of our current manuscript as without in vivo recordings, resonance curves do not contribute to the manuscript in our opinion.

      How did you identify L2/3? Did you target cells in L2 or L3 or in the middle, or did you sample across the full layer width for each condition? A quantitative diagram showing where you patched (soma) and where you stimulated (L1, L4) with actual measurements, would be helpful (supplemental perhaps). You mention in the text that some L2/3 don't have a tuft, suggesting some variability in morphology - some info on this would be useful, i.e. since you did fill at least some of the neurons (eg 3A), how similar/different are the dendritic arbors?

      We sampled the entire L2/3 region during our recordings. It has been published that deep and superficial L2/3  PCs are markedly different in their morphology, and a recent publication (Brandelise et al. 2023) has even separated these two subpopulations to broad-tufted and slender tufted pyramidal cells, which receive distinct subcortical inputs. Although this differentiation opens exciting avenues for future research, examining potential layer gradients in our dataset would warrant significantly higher sample numbers and is currently out of the scope of our manuscript.

      Distal vs proximal: this could use more clarification, considering how central it is to your results. What about a synapse on a basal dendrite, but 150 or 200 um from the soma, is that considered proximal? Is the distance to the soma you report measured along the 3D dendrite, along the 2D dendrite, as a straight line to the soma, or just relative to some layers or cortical markers? (I apologize if I missed this).

      We thank the reviewer for pointing out the missing description in the results section. We have amended this oversight (p15).  Furthermore, although deeper L3 PCs have characteristic apical and basal dendritic branches, when recordings were made from more superficial L2 cells, a large portion of their dendrites extended radially, which made their classification ambiguous. Therefore, we did not use “apical” and “basal” terminology in the paper to avoid confusion. Distances were measured along the 3D reconstructed surface of the recovered pyramidal cells. This information is now included in the methods.

      Line 445, "PV cell NEURON modeling" ... hmm. Everyone re-uses methods sections to some degree, but this is not confidence-inspiring, and also not from a proofreading perspective.

      We have corrected the typo.

      It seems that you constructed a new HCN NEURON mechanism when several have been published/reviewed already. Please explain your reasons or at least comment on the differences.

      There are slight differences in our model compared to previously published models. Nevertheless, we took a previously published HCN model as a base (Gasparini et al, 2004), and created our own model to fit our whole-cell voltage clamp recordings.

      Bath-applied Cs+ can change synaptic transmission (in the hippocampus; Chevaleyre 2002). But also ZD7288 has some such effects. Also, see (Harris 1995) for a Cs+ and ZD7288 comparison. As well as (Harris 1994) for more Cs+ side-effects (it broadens APs, etc). Bath-applied blockers may affect both long-range and local synapses in your recordings, via K-channels or perhaps presynaptic HCN (though I am aware of your Fig. 1e). Since you can do intracellular perfusion, you could apply ZD7288 postsynaptically (Sheets 2011), an elegant solution.

      We thank the reviewer for the suggestion. We were aware of the potential presynaptic effects of cesium (i.e., presynaptic Kv or other channel effects) and did measure PPR after cesium application (Fig. 1h), noting no effect. At Cs<sup>+</sup> concentrations used here, we now also include new data in the results showing no effect on somatically recorded AP waveform (i.e., representative of a Kv channel effect). As stated earlier for reviewer 1, we now performed additional experiments using either cesium or ZD-7288 for comparison (e.g., see updated Fig. 1; Supplementary Figure 1; Fig. 3b-e). Intracellular ZD re-perfusion is an elegant solution which we will absolutely consider in future experiments.

      K-Gluconate is reported to inhibit Ih (Velumian 1997), consider at least some control experiments with a different internal for the main synaptic finding - maybe you'll find no big change ...

      We thank the reviewer for the suggestion. Although K-Gluconate can inhibit HCN current, the use of this intracellular solution is often used in the literature to measure this current (Huang & Trussel 2014). We have chosen this intracellular solution to improve recording stability.  

      (Biel 2009) is a very comprehensive HCN review, you may find it useful.

      We thank the reviewer for bringing this to our attention, we have now included the citation in the introduction.

      "Hidden" in your title seems too much.

      We changed the title to more accurately describe our findings and removed ‘hidden’.

      While I'm glad you didn't record at room temperature, the choice of 30C seems a bit unfortunate - if you go to the trouble to heat the bath, why not at least 34C, which is reasonably standard as an approximation for physiological temperature?

      We thank the reviewer for pointing this out. The choice of 30C was made to approach physiological temperature levels, while preserving the slices for extended amounts of time which is a standard approach. Future experiments in vivo be performed to further understand the naturalistic relevance at ~37C.

      Line 506: do you mean "Hz" here? It's not a frequency, is it? I think it's a unitless ratio?

      Correct, we have amended the typo.

      Line 95: you have not shown that HCN is "essential" for "excess" AP firing.

      We have corrected the phrasing, we agree.

      Fig. 2b,c: is this data from a single example neuron, maybe the same neuron as in 2a? Or from all recorded neurons pooled?

      The data is from several recorded cells pooled.

      Fig. 3 (important figure):

      Why did you not use a paired test for panels e and f? You have the same number of neurons for each condition and the expectation is that you record each neuron in control and then in cesium condition, which would be a paired comparison. Or did you record only 1 condition per neuron?

      This figure presents your main finding (in my opinion). You should show examples of the synaptic responses, i.e. raw traces, for each condition and panel, and overlaid in such a way that the reader can immediately see the relevant comparison - it's worth the space it requires.

      We thank the reviewer for the suggestions. Traces are only overlaid in the paper when they come from the same cell. For Fig. 3d-i, EPSPs in every neuron were evoked in 2-3 different locations (i.e., 1-2 ‘L4’ locations for Type-I and Type-II synapses, and one ‘L1’ location in each) with the same stimulation pipette and one pharmacological condition per cell. Therefore two-sample t-test were used since the control and cesium conditions came from separate cells (i.e., separate observations). This was necessary, as we can never assume that the stimulating electrode can return back to the same synapse after moving it. We were not comfortable with showing overlaid traces from different cells, however, we did show representative traces from control and the Cs<sup>+</sup> conditions in Fig. 3h. Complementary ZD-7288 experiments can be found on panel b and c, where we did perform within-cell pharmacology (and thus used paired t-tests) from one stimulation area/cell. We hope these complementary experiments increase overall confidence as neither pharmacological approach is 100% without off-target effects. We now also included more overlaid traces where appropriate (i.e., Fig. 3b, and in the new  Fig. 3k experiments using within-cell pharmacology comparisons). We do realize these complementary approaches could cause confusion to the reader, and have now done our best to make the slightly different approaches in this Figure clearer in the results section.

      Consider repeating at least some of these critical experiments with ZD7288 instead of Cs+ (and not K-gluc), or even with ZD7288 pipette perfusion, if it's technically feasible here.

      We thank the reviewer for the suggestions. Although many of our recordings using Cs<sup>+</sup> already had complementary experiments (such as synaptic experiments Figure 3e vs Figure 3b), we recognize the need to extend the manuscript with more ZD-7288 experiments. We have now extended Figure 1 with three panels (Figure 1 c,d,e), which recapitulates a fundamental finding, the change in overall excitability upon HCN channel blockade, using ZD-7288 as well.

      Fig. 3a, why show a schematic (and weirdly scaled) stimulating electrode? Don't you have a BF photo showing the actual stimulating electrode, which you could trace to scale or overlay? Could you use this panel to indicate what counts as "distal" and what as "proximal", visually?

      The stimulating electrode was unfortunately not filled with florescent materials, therefore it was not captured during the z-stack.

      Fig. 3b: is the y-axis labeled correctly? A "100% change" would mean a doubling, but based on the data points here I think y=100% means "no change"?

      The scale is labeled correctly, 100% means doubling.

      Fig. 3b, c: again, show traces representing distal and proximal, not just one example (without telling us how far it was). And use those traces to illustrate the half-width measurement, which may be non-trivial.

      We have extended Figure 3b with an inset showing the effect of ZD-7288 on a proximal stimulating site. The legend now includes additional information indicating stimulating location 28 µm away from the soma in control conditions (black trace) and upon Z-7288 application (green trace).  

      Line 543, 549: it seems you swapped labels "h" and "i"?

      Typo corrected.

      Fig. 4b: to me, MK-801 only *partially* blocks amplification, but in the text L198 you write "abolish".

      We thank the reviewer for pointing this out. Indeed, there are several other subthreshold mechanisms that are still intact after pipette perfusion, which can cause amplification. We have now clarified this in the text (p7).

      Fig. 4e,f: what is the message? Uniform NMDAR? The red asterisk in (e) is at a proximal/distal ratio of roughly 1. I don't understand the meaning of the asterisk (the legend is too basic) and I'm surprised to see a ratio of 1 as the best fit, and also that the red asterisk is at a dendritic distance of 0 um in (f). This could use more explanation (if you feel it's relevant).

      We thank the reviewer for pointing this out. We have now included a better explanation in the results and figure legend. We have also updated the figure to make it clearer and added model traces in Fig. 4f, which correspond to example data from slices in Fig. 4g (both green). The graph suggests nonuniform, proximally abundant NMDA distribution. The color coding corresponds to the proximal EPSP halfwidth divided by distal EPSP halfwidth. It is true that the dendritic distance ‘center’ was best-fit very close to the soma, but also note the dispersion (distribution) half-width was >150mm, so there is quite a significant dendritic spread despite the proximal bias prediction. Based on this model there is likely NMDA spread throughout the entire dendrite, but biased proximally. Naturally, future work will need to map this at the spine level so this is currently an oversimplification. Nonetheless, a proximal NMDA bias was necessary to recapitulate findings from Fig. 3, and additional slice recordings in Fig. 4 were consistent with this interpretation.

      Fig. 4g: I feel your choice of which traces to overlay is focusing on the wrong question. As the reader, what I want to see here is an overlay of all 4 conditions for one pathway. If this is a sequential recording in a single cell (Cs, Cs+MK801, wash out Cs, MK801), then the overlay would be ideal and need not be scaled. Otherwise, you can scale it. But the L1/L4 comparison does not seem appropriate to me. I find myself trying to imagine what all the dark lines would look like overlaid, and all the light lines overlaid separately. Also, the time axis is missing from this panel. Consider a subtraction of traces (if appropriate).

      In these recordings, all EPSPs cells were measured using a stimulating electrode that was moved between L1 and L4 (only once, to keep the exact input consistent) to measure the different inputs in a single neuron. In separate sets of experiments, the same method was used but in the presence of Cs<sup>+</sup>, Cs<sup>+</sup> + MK-801, or MK-801 alone. This was the most controlled method in our hands for this type of approach, as drug wash outs were either impractical or not possible.  Overlaying four traces would have presented a more cluttered image, and were not actually performed experimentally. As our aim was to resolve the proximal-distal halfwidth relationship, therefore we deemed the within-cell L1 vs. L4 comparison appropriate. We have nonetheless added model traces in Fig. 4f, which correspond to example data from slices in Fig. 4g (both green). The bar graphs should serve also serve to illustrate the input-specific  relationship- i.e., that the only time the L1 and L4 EPSP relationship was inverted was in the presence of Cs<sup>+</sup> (green bars) and that this effect was occluded with simultaneous MK-801 in the pipette (red bars).

      Line 579: should "hyperpolarized" be depolarized?

      Corrected

      Fig. 5a: it looks like the HCN density is high in the most basal dendrites (black curve above), then drops towards the soma, then rises again in the apicals (red curve). Is that indeed how the density was modeled? If so, this is completely at odds with the impression I received from reading your text and experimental data - there, "proximal" seems to mean where the L4 axons are, and "distal" seems to mean where the L1 axons are, in other words, high HCN towards the pia and low HCN towards the white matter. But this diagram suggests a biphasic hill-valley-hill distribution of HCN (meaning there is a second "distal" region below the soma). In that case, would the laterally-distant basal dendrites also be considered distal? How does the model implement the distribution - is it 1D, 2D or 3D? As you can probably tell, this figure raised more questions for me and made me wonder why I don't have a better understanding yet of your definitions.

      We thank the reviewer for pointing this out. We agree our initial cartoon of the parameter fitting procedure was not accurate and should have just been depicted a single ‘curve’. We have now simplified it to better demonstrate what the model is testing, and also made the terms more consistent and accurate. There is no ‘second’ region in the model. We hope this better illustrates it now. We also edited the legend to be clearer. Because the model description in Fig. 4d suffered from similar shortcomings, we also modified it accordingly as well as the figure legend there.

      Fig. 5b: why is the best fit at a proximal/distal ratio of 1, yet sigma is 50 um?

      Proximal/distal bias on this figure was fitted to 0.985 (prox/distal ratio) as we modeled control conditions, with intact NDMA and HCN channels,  which closely approximated the control recording comparisons.

      Fig. 6h, Line 662: "vs CsMeSO4 ... for putative LGN events" The panel shows proximal vs distal, not control vs Cs+. What's going on here?

      Typo corrected.

      Fig. 7e: the ctrl sag ratio here averages 0.02, while in Fig. S1 the average (for V1 and others) is about 0.07.  Please refer to our answer given to the previous question regarding sag ratio measurements. Briefly, recordings made with 5-CT application were made using a less severe, -2 pA/pF current injection to test seg responses. This more modest hyperpolarization activated less HCN channels, therefore the sag ratio is lower compared to previously reported datapoints.

      We have included this explanation in the methods section (page 14)

      Now hear you are using a paired test for this pharmacology, but you didn't previously (see my earlier comments/questions).

      Paired t-test were used for these experiments as these control and test datapoints came from the same cell. Cells were recorded in control conditions, and after drug application.

      Line 137: single-axon activation: but cortical axons make multi-synaptic contacts, at least for certain types of pre- and post-synaptic neurons, and (e.g. in L5-L5 pairs) those contacts can be distributed across the entire dendritic arbor. In other words, it's possible that when you stimulate in L1, you activate local axons, and the signal could then propagate to multiple synaptic contact locations, some being distal and some proximal. Maybe you have reasons to believe you're able to avoid this?

      We thank the reviewer for this question. Cortical axons often make distributed contacts, however, top-down and bottom-up pathways innervating L2/3 PCs are at least somewhat restricted to L2/3/L4 and L1, respectively (Shen et al. 2022, Sermet et al. 2019). Therefore, due to the lack evidence suggesting a heavily mixed topographical distribution for top-down and bottom-up inputs, we have reason to believe that L1 stimulation will result in mainly distal input recruitment, while L4 stimulation will mainly excite proximal dendritic regions. The resolution of our experiments was also improved by the minimal stimulation and visual guidance (subset of experiments) of the stimulation. Furthermore, new optogenetic experiments stimulating LGN and LM axons, which have been anatomically defined previously as biased to deeper layers and L1, respectively, were now also performed (Fig. 3j-l) with analogous cesium effects as our local electrical stimulation experiments. Future work using varying optogenetic stimulation parameters will expand on this.

      L140: "previous reports" ==> citation needed.

      We have inserted the citation needed.

      L149: "arriving to layer 1"; but I think earlier you noted that some or many L2/3 neurons lack a dendritic tuft; do they all nevertheless have dendrites in L1? Note that cortico-cortical long-range axons still need to pass through all cortical layers on their way up to L1.

      We thank the reviewer for the question. Although the more superficial L2/3 PCs lack distinct apical tuft, their dendrites reach the pia similarly to deeper L2/3 PCs. All of our recorded and post-hoc recovered cells had dendrites in L1, except in cases where they were clearly cut during the slicing procedure, which cells were occluded from the study.

      When you write "L4 axons" or "L4 inputs", do you specifically mean long-range thalamic axons? Or axons from local L4 neurons? What about axons in L4 that originate from L5 pyramidal neurons?

      In case of ‘L4’ axons, we cannot disambiguate these inputs a priori, as they are both part of the bottom-up pathway, and are possibly experimentally indistinguishable. Even with restricted opto LGN stimulation, disynaptic inputs via L4 PCs cannot be completely ruled out under our conditions. On the other hand, the probability of L5 PC axons to terminate on L2/3 PCs is exceedingly low (single reported connection out of 1145 potential connections; Hage et al. 2022). We did find two clearly different synaptic subpopulations (Supp. Fig 3) in L4- which was tempting to classify as one or the other. However we felt there was not enough evidence in the literature as well as our additional optogenetic experiments to make a classification on the source of these different L4 inputs. Thus we deemed them as Type-I or Type-II for now.

      Do you inject more holding current to compensate for the resting membrane potential when Cs+ or ZD7288 is in the bath?

      We thank the reviewer for the question. We did not inject a compensatory current, as we wanted to investigate the dual, physiologically relevant action of HCN channels (George et al. 2009)

      I'd like to see distributions (histograms) of L4 and L1 EPSP amplitudes, under control conditions and ideally also under HCN block.

      We have now extended the manuscript with a supplementary figure (Supplementary Figure 6) to show that EPSP peak was not distance dependent in control conditions, and there was no relationship between peak and halfwidth in our dataset.

      Line 186, custom pipette perfusion: why not use this for internal ZD7288, to make it cell-specific?

      We thank the reviewer for the question, this is a good point. In future work we will consider this when applicable. It is certainly a way to control for bath application confounds in many ways.

      L205: "recapitulate our experimental findings" - which findings do you mean? I think a bit of explanation/referencing would help.

      Corrected.

      Line 210: L4-evoked were narrower than L1-evoked: is this not expected based on filtering?

      We thank the reviewer for pointing this out, the word “Intriguingly” has been omitted.

      Line 231 and 235: "in L5 PCs" should be restricted to L5 PT-type PCs.

      We have corrected this throughout the manuscript.

      Neuromodulation, Fig. 7, L263-282: the neuromodulation finding is interesting. However, a bit like the developmental figure, it feels "tacked on" and the transition feels a bit awkward. I think you may want to discuss/cite more of the existing literature on neuromodulatory interactions with HCN (not just L2/3). Most importantly, what I feel is missing is a connection to your main finding, namely L1 and L4 inputs. Does serotonergic neuromodulation put L1 and L4 back on equal footing, or does it exaggerate the differences?

      We thank the reviewer for the question. We agree with the reviewer that Figure 7 does not give a complete picture about how the adult brain can capitalize on this channel distribution, as our intention was to show that HCN channels are not a stationary feature of L2/3 PC, but a feature which can be regulated developmentally and even in the adult brain via neuromodulation. In other words, the subthreshold NMDA boosting we observed can be gated by HCN, depending on developmental stage and/or neuromodulatory state of the system. We have now added some brief language to better introduce the transition and its relevance to the current study in the results (p8), and discussed the implications in the discussion section of the original manuscript.

      General comment: different types/sources of synapses may have different EPSP kinetics. I feel this is not mentioned/discussed adequately, considering your emphasis on EPSPs/HCN.

      See points above on input-specific synaptic diversity.

      Line 319/320: enriched distal HCN is found in L5 PT-type, not in all L5 PCs.

      Corrected

      L320: CA1 reportedly has a subset of pyramidal neurons that have higher proximal HCN than distal (I gave the citation above). In light of that, I think "unprecedented" is an overstatement.

      Corrected.

      Methods:

      L367: What form of anesthesia was used?

      Amended.

      Which brain areas, and how?

      Amended.

      Why did you first hold slices at 34C, but during recording hold at 30C?

      We held the slices at 34C to accelerate the degradation of superficial damaged parts of the slice, which is in line with currently used acute slice preparation methodologies, regardless of the subsequent recording temperature.

      Pipette resistance/tip size?

      Amended.

      Cell-attached recordings (L385): provide details of recordings. What was the command potential (fixed value, or did you adjust it per neuron by some criteria)?

      Amended.

      What type of stimulating electrode did you use? If glass, what solution is inside, and what tip size?

      We thank the reviewer for pointing these out, the specific points were added to the methods section.

      L392/393: you adjusted the holding (bias) current to sit at -80 mV. What were the range and max values of holding current? Was -80 mV the "raw" potential, or did it account for liquid junction? If you did not account for liquid junction potential, then would -80 in your hands effectively be between -95 and -90 mV? That seems unusually hyperpolarized.

      All cells were held with bias holding currents between -50 pA and 150 pA. To be clear, as mentioned below, we did not change the bias current after any drug applications. We did not correct for liquid junction potential, and cells were ‘held‘ with bias current at -80 mV as during our recordings, as 1) this value was apparently close to the RMP (i.e. little bias current needed at this voltage on average) (Fig. 2e) and 2) to keep consistent conditions across recordings. The uncorrected -80 mV is in the range of previously reported membrane potential values both in vivo and in vitro (Svoboda et al. 1999, Oswald et al. 2008, Luo et al. 2017), which found the (corrected) RMP to be below -80mV. Naturally this will not reflect every in vivo condition completely and further investigation using naturalistic conditions in the future are warranted.  

      Did you adjust the bias current during/after pharmacology?

      Bias current was not adjusted in order to resolve the effect on resting membrane potential.

      L398: sag calculation could use better explanation: how did you combine/analyze multiple steps from a single neuron when calculating sag? Did you choose one level (how) or did you average across step sizes or ...?

      Sag ratio was measured at -6 pA/pF current step except for one set of experiments in Fig. 7. Methods section was amended.

      L400, 401: 10 uM Alexa-594 or 30 um Alexa-594, which is correct?

      10 µM is correct, typo was corrected

      L445: "PV cell" seems like a typo?

      Typo is corrected.

      L450: "altered", please describe the algorithm or manual process.

      Alterations were made manually.

      L474: NDMA, typo.

      Typo is fixed.

      L474: "were adjusted", again please describe the process.

      Adjustments were made by a grid-search algorithm.

      Biel, M., Wahl-Schott, C., Michalakis, S., & Zong, X. (2009). Hyperpolarization-activated cation channels: from genes to function. Physiological reviews, 89(3), 847-885. https://journals.physiology.org/doi/full/10.1152/physrev.00029.2008 - (very comprehensive review of HCN)

      Bullis JB, Jones TD, Poolos NP. Reversed somatodendritic I(h) gradient in a class of rat hippocampal neurons with pyramidal morphology. J Physiol. 2007 Mar 1;579(Pt 2):431-43. doi: 10.1113/jphysiol.2006.123836. Epub 2006 Dec 21. PMID: 17185334; PMCID: PMC2075407. https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/jphysiol.2006.123836 - (CA1 subset (PLPs) have a reversed HCN gradient; cell-attached patches, NMDAR)

      Velumian AA, Zhang L, Pennefather P, Carlen PL. Reversible inhibition of IK, IAHP, Ih, and ICa currents by internally applied gluconate in rat hippocampal pyramidal neurones. Pflugers Arch. 1997 Jan;433(3):343-50. doi: 10.1007/s004240050286. PMID: 9064651. https://link.springer.com/article/10.1007/s004240050286 - (K-Gluc internal inhibits HCN)

      Sheets, P. L., Suter, B. A., Kiritani, T., Chan, C. S., Surmeier, D. J., & Shepherd, G. M. (2011). Corticospinal-specific HCN expression in mouse motor cortex: I h-dependent synaptic integration as a candidate microcircuit mechanism involved in motor control. Journal of neurophysiology, 106(5), 2216-2231. https://journals.physiology.org/doi/full/10.1152/jn.00232.2011 - (L2/3 IT have same sag ratio as all other non-PT pyramidals, roughly 5% (vs 20% PT); intracellular ZD7288 used at 10 or 25 um)

      Harris NC, Constanti A. Mechanism of block by ZD 7288 of the hyperpolarization-activated inward rectifying current in guinea pig substantia nigra neurons in vitro. J Neurophysiol. 1995 Dec;74(6):2366-78. doi: 10.1152/jn.1995.74.6.2366. PMID: 8747199. https://journals.physiology.org/doi/abs/10.1152/jn.1995.74.6.2366 - (comparison Cs+ and ZD7288)

      Harris, N. C., Libri, V., & Constanti, A. (1994). Selective blockade of the hyperpolarization-activated cationic current (Ih) in guinea pig substantia nigra pars compacta neurones by a novel bradycardic agent, Zeneca ZM 227189. Neuroscience letters, 176(2), 221-225. https://www.sciencedirect.com/science/article/abs/pii/0304394094900876 - (Cs+ is not HCN-selective; it also broadens APs, reduces the AHP)

      Chevaleyre, V., & Castillo, P. E. (2002). Assessing the role of Ih channels in synaptic transmission and mossy fiber LTP. Proceedings of the National Academy of Sciences, 99(14), 9538-9543. https://pnas.org/doi/abs/10.1073/pnas.142213199 - (Cs+ blocks K channels, increases transmitter release; but also ZD7288 affects synaptic transmission)

      Thank you

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      Early-life adversity or stress can enhance stress susceptibility by causing changes in emotion, cognition, and reward-seeking behaviors. This important manuscript highlights the involvement of lateral amygdala astrocytes in fear generalization and the associated synaptic plasticity, which are parallel to the effects of early life stress. With an elegant combination of behavioral models, morphological and functional assessments using immunostaining, electrophysiology, and viral-mediated loss-of-function approaches, the authors provide solid correlational and causal evidence that is consistent with the hypothesis that early life stress produces neural and behavioral dysfunction via perturbing lateral amygdala astrocytic function.

      We would like to thank the authors and editors for taking the time to review our work, and re-review it now. Also, we are grateful for this very positive assessment of our work. In this revised manuscript we made a strong effort to address comments made by all reviewers, providing clarification where required and new data to our manuscript in order to further support our observations.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript asks the question of whether astrocytes contribute to behavioral deficits triggered by early life stress. This question is tested by experiments that monitor the effects of early life stress on anxiety-like behaviors, long-term potentiation in the lateral amygdala, and immunohistochemistry of astrocyte-specific (GFAP, Cx43, GLT-1) and general activity (c-Fos ) markers. Secondarily, astrocyte activity in the lateral amygdala is impaired by viruses that suppress gap-junction coupling or reduce astrocyte Ca2+ followed by behavioral, synaptic plasticity, and c-Fos staining. Early life stress is found to reduce the expression of GFAP and Cx43 and to induce translocation of the glucocorticoid receptor to astrocytic nuclei. Both early life stress and astrocyte manipulations are found to result in the generalization of fear to neutral auditory cues. All of the experiments are done well with appropriate statistics and control groups. The manuscript is very well-written and the data are presented clearly. The authors' conclusion that lateral amygdala astrocytes regulate amygdala-dependent behaviors is strongly supported by the data. However, the extent to which astrocytes contribute to behavioral and neuronal consequences of early life stress remains open to debate.

      Strengths:

      A strong combination of behavioral, electrophysiology, and immunostaining approaches is utilized and possible sex differences in behavioral data are considered. The experiments clearly demonstrate that disruption of astrocyte networks or reduction of astrocyte Ca2+ provokes generalization of fear and impairs long-term potentiation in the lateral amygdala. The provocative finding that astrocyte dysfunction accounts for a subset of behavioral effects of early life stress (e.g. not elevated plus or distance traveled observations) is also perceived as a strength.

      Weaknesses:

      The main weakness is the absence of more direct evidence that behavioral and neuronal plasticity after early life stress can be attributed to astrocytes. It remains unknown what would happen if astrocyte activity were disrupted concurrently with early life stress or if the facilitation of astrocyte Ca2+ would attenuate early life stress outcomes. As is, the only evidence that early life stress involves astrocytes is nuclear translocation of GR and downregulation of GFAP and Cx43 in Figure 3 which may or may not provoke astrocyte Ca2+ or astrocyte network activity changes.

      We would like to thank the reviewer for their constructive feedback on our work. In the revised version we have added new experiments that further support a role of astrocytes in ELS-induced behavioural dysfunction. Specifically, we carried out two-photon calcium imaging in lateral amygdala astrocytes using viral overexpression of membrane tethered GCaMP6f. These experiments revealed a decrease in astrocyte calcium activity following ELS (Figure 4). Interestingly these data also showed an important number of sex differences (Figure 4 - Figure supplement 1).

      These new data allow us to strengthen the link between ELS-induced astrocyte hypofunction and behavioural changes. Indeed, we validated the impact of CalEx on astrocyte calcium activity in the lateral amygdala, again using two-photon microscopy, and show that CalEx resulted in an astrocyte calcium signature that very closely resembled that of ELS, i.e. reduced frequency and amplitude of events (Figure 5 - Figure supplement 2). As such, we feel like these data, while still correlative in nature, strengthen our findings and conclusion that astrocyte dysfunction alone is sufficient to recapitulate the effects of stress on excitability, synaptic function, and behaviour.

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, Guayasamin et al. show that early-life stress (ELS) can induce a shift in fear generalisation in mice. They took advantage of a fear conditioning paradigm followed by a discrimination test and complemented learning and memory findings with measurements for anxiety-like behaviors. Next, astrocytic dysfunction in the lateral amygdala was investigated at the cellular level by combining staining for c-Fos with astrocyte-related proteins. Changes in excitatory neurotransmission were observed in acute brains slices after ELS suggesting impaired communication between neurons and astrocytes. To confirm the causality of astrocytic-neuronal dysfunction in behavioral changes, viral manipulations were performed in unstressed mice. Occlusion of functional coupling with a dominant negative construct for gap junction connexin 43 or reduction in astrocytic calcium with CalEx mimicked the behavioral changes observed after ELS suggesting that dysfunction of the astrocytic network underlies ELS-induced memory impairments.

      Strengths:

      Overall, this well-written manuscript highlights a key role for astrocytes in regulating stress-induced behavioral and synaptic deficits in the lateral amygdala in the context of ELS. Results are innovative, and methodological approaches relevant to decipher the role of astrocytes in behaviors. As mentioned by the authors, non-neuronal cells are receiving increasing attention in the neuroscience, stress, and psychiatry fields.

      Weaknesses:

      I do have several suggestions and comments to address that I believe will improve the clarity and impact of the work. For example, there is currently a lack of information on the timeline for behavioral experiments, tissue collection, etc.

      We thank the reviewer for their kind comments and constructive feedback on our manuscript. We agree that certain aspects could have been made more clear and we have revised the manuscript and figures to be more explicit regarding timelines. Including the addition of timelines on figures and improved clarity in the text where possible. We have also addressed the private comments provided by the reviewers alluded to in this public review.

      Reviewer #3 (Public Review):

      Summary

      The authors show that ELS induces a number of brain and behavioral changes in the adult lateral amygdala. These changes include enduring astrocytic dysfunction, and inducing astrocytic dysfunction via genetic interventions is sufficient to phenocopy the behavioral and neural phenotypes. This suggests that astrocyte dysfunction may play a causal role in ELS-associated pathologies.

      Strengths:

      A strength is the shift in focus to astrocytes to understand how ELS alters adult behavior.

      Weaknesses:

      The mechanistic links between some of the correlates - altered astrocytic function, changes in neural excitability, and synaptic plasticity in the lateral amygdala and behaviour - are underdeveloped.

      We thank the reviewer for their comments. We are happy that they found our shift in focus towards astrocytes to be a strength of our work. Regarding mechanistic links being underdeveloped, we have attempted to address this by placing more effort into understanding the functional changes in astrocytes and how this relates to behaviour.

      To address this comment we have used two-photon calcium imaging to quantify the impact of ELS on astrocyte calcium activity. As such, the revised manuscript contains several new figures including a detailed characterisation of the effects of ELS on astrocyte calcium activity (Figure 4), including sex differences in naive and the effects of stress (Figure 4 - Figure supplement 1), and an important validation of the impact of CalEx on astrocyte calcium activity. CalEx mirrors the impact of stress on astrocyte calcium activity reducing the frequency and amplitude of individual events (Figure 5 - Figure supplement 2).

      Considering the strong overlap of the effects of ELS and CalEx on synapses, excitability, behaviour, and now astrocyte calcium activity, we hope that this added detail addresses some of the points highlighted by the reviewer.

      Recommendations for the authors:

      The reviewers all agree on one major issue for the authors to address. There is a bit of a lack of mechanistic linking between the astrocyte function and the early life stress and these data are more correlational than causal in nature. This could either be addressed by scaling back the data interpretation and title to be more reflective of the data at hand or if the authors would consider, doing the causal experiment of examining the manipulation of astrocyte activity following early life stress to see if this does influence the phenotype.

      We agree with reviewers on this issue and realise that we have overstated our findings somewhat. As an immediate fix, suggested by reviewers, we have changed the title to more closely align with our data stating that astrocyte dysfunction is “associated with” rather than “induces” as well as adjusting our interpretations.

      In addition to this one major comment, there are a list of minor comments that the authors should consider to improve the manuscript.

      (1) A major caveat is the lack of information on the timeline for behavioral experiments, tissue collection, etc. The authors mention "Mice between ages P45-70' but considering the developmental changes occurring between late adolescence and young adulthood, I recommend adding timelines on all Figures clearly indicating when behavioral tests were performed, and tissue collected for electrophysiology or immunostaining. With corticosterone (CORT) back at baseline at P70 vs a difference observed at P45 was this time point favored? It should be clarified throughout.

      We apologise for the lack of clarity on this and have added more timelines on figures.

      The age range favoured (p45-p70), relates to adolescence a time when latent psychiatric disorders tend to manifest in humans following early-life adversity. We have clarified this choice in the text.

      (2) Given the transient increase in corticosterone levels in early-life stress mice, peaking at P45 and declining to control levels by P70, it would be informative to know whether the reported behavioral and synaptic changes differ within this time window. This may not be doable in the current approach, but this should be addressed nonetheless. Furthermore, it wasn't clear why the increase in blood corticosterone was delayed. Was this expected? How does this relate to earlier work? Wouldn't it be expected to be elevated at P17 (end of ELS period)?

      We agree that this observation was very unexpected. Initially, we expected CORT to be elevated at P17, end of ELS period. We believe that low CORT levels during the ELS paradigm can be attributed to this paradigm coinciding with the stress hyporesponsive period (SHRP) which in rodents lasts until roughly postnatal day 14. During this period, mild stressors fail to elicit CORT responses. Considering our ELS paradigm lasts from P10-P17, there is a significant overlap with the SHRP.

      This point is now included in the discussion with several citations regarding this biological phenomenon, as well as other studies that report similar findings to our own, i.e. a delayed increase in blood corticosterone levels following early-life stress.

      (3) It is mentioned that behavioral tests were performed in both sexes with no sex differences observed. Were animals of both sexes also included in other experiments (ephys, immunostaining, blood CORT analysis)? Behavioral outcomes could be the same but underlying biological processes different. This is a topic that should be discussed. Identification of males vs females on graphs would be helpful.

      We apologise for not having provided this data in the previous version of the manuscript. In the revised manuscript we provide analysis of sex differences for our initial behavioural observations (Figure 2 - Figure supplement 1), c-Fos (Figure 2 - Figure supplement 2), for GFAP and Cx43 (Figure 3 - Figure supplement 1), calcium signalling (Figure 4 - Figure supplement 1), and for CalEx and dnCx43 experiments across behaviour (Figure 5 - Figure supplement 4) and c-Fos (Figure 5 - Figure supplement 5).

      (4) How long-lasting are the generalization phenotypes? Do they outlast the transient increase in blood corticosterone? Showing this would provide a more solid foundation for future explorations.

      The reviewers raise a very important point. It remains unclear as to how long these effects last and this is something we are keen to address in future studies, with careful experiments designed to explicitly test this question, as well as subsequent questions regarding whether long-lasting effects are due to impaired brain development or whether these effects emerge due to CORT changes, or other changes, or a combination of them all?

      As an aside, an additional manuscript from our lab (Depaauw-Holt et al. 2024 bioRxiv) which uses the same stressor but focuses on distinct brain regions and behaviours uses a prolonged time window in which the effects of stress are readily observable all the way to P90.

      So while we do provide the answers in this work, it is a really great idea that we would like to follow up subsequently.

      (5) With the ELS-induced change in locomotion, I would recommend presenting open field (center, periphery) and elevated plus maze (open, closed arms) data independently. It could also be interesting to analyze corner time in the open field as well as center time in the elevated plus maze.

      We now provide data for the open field and elevated plus maze as requested. Our findings remain unchanged, but we agree with the reviewer that this way of representing the data is more clear.

      (6) For Figure 2C, the ideal stats would be an ANOVA with CS (+/-) as a within-subject variable and treatment (naive/ELS) as a between-subjects variable. Then the best support for the generalization claim would be a CS x treatment interaction. I encourage the authors to do these stats. I note that this point is mitigated by the discrimination analysis presented in 2D (where they compare naive and ELS groups directly).

      We have carried out the analysis as requested and these data further support the notion of fear generalisation in ELS mice (Figure 2 - Figure supplement 2A, B). Additionally, the analyses are included in a supplementary table. We hope that we have understood correctly, and this figure accurately reflects the reviewer’s suggestion.

      (7) In Figure 2H, why not evaluate c-Fos levels after the discrimination test which is the main behavioral outcome? This statement in the Discussion should be modified if, as per my understanding, c-Fos was measured after the fear paradigm only "We find that both ELS and astrocyte dysfunction both enhance neuronal excitability, assessed by local c-Fos staining in the lateral amygdala following auditory discriminative fear conditioning. One interpretation of these data is that astrocytes might tune engram formation, with astrocyte dysfunction, genetically or after stress, increasing c-Fos expression resulting in a loss of specificity of the memory trace and generalisation of fear.'

      We agree that further evaluation of c-Fos levels following the discrimination test would be insightful. We honestly did not consider this time point in our initial experimental design, as we considered previous reports in the literature that investigated how the numbers of cells recruited to the engram (c-Fos density) could influence memory accuracy at a later time point. As such, investigating c-Fos levels following training was our initial target. We have modified the text to be more explicit in our experimental approach.

      This is nevertheless a fascinating point that we are keen to pursue in future studies.

      (8) Some thoughts on why dnCx43 suppression of astrocyte network activity is less effective at inducing fear generalization than CalEx suppression of astrocyte Ca2+ are warranted. One might predict that both manipulations should result in similar effects, as seen in fEPSP and cFos data in Figure 4.

      We agree that this is an interesting observation and the fact we did not observe the same behavioural phenotype despite fEPSP and c-Fos data to be the same is puzzling.

      Nevertheless, we do see increased fear generalisation in both dnCx43 and CalEx. We hypothesise that CalEx had a more profound effect due to the wide range of processes that are presumably affected by reduced astrocyte calcium activity, whereas blocking gap junction channels still leaves a large number of astrocyte functions intact.

      Overall, our conclusion is that behaviour is a more sensitive assay compared to the cellular phenotypes, which highlights the importance of answering these questions from multiple angles.

      (9) Ideally changes in functional coupling following the dnCx43 manipulation) should be shown here (line 169).

      We, unfortunately, did not directly evaluate functional coupling in dnCx43 mice in this manuscript. This would have been a useful experiment, but we rely on our previous data where we extensively characterised this tool (Murphy-Royal et al. 2020 Nat Comms).

      (10) It would be relevant to perform c-Fos staining with markers for astrocytes or neuronal cells. Is an increase in activity expected for both cell types?

      This is a fascinating question, given recent work on this topic showing that astrocytes can indeed express c-Fos and may be recruited into engrams. We analysed our existing tissue, we found that indeed astrocytes were labelled with c-Fos following our behavioural conditioning paradigm. Our data align with recent reports, and we demonstrate a small percentage of astrocytes expressing c-Fos (Figure 2 - figure supplement 3). This modest number of astrocytes expressing c-Fos is discussed in the text and placed into context of very recent papers that have been published since our submission to eLife.

      (11) Were the same mice subjected to behavior analysis than immunostaining?

      We generated separate cohorts of mice for immunostaining and behaviour, and have made this more clear in the text.

      (12) Language describing learning paradigm. The CS+ (line 73) isn't in itself aversive (and shouldn't be described as such). It acquires that value after pairing with the US (which is aversive).

      We agree that this is poorly worded and have modified the text from “aversive cue” to “conditioned cue”.

      (13) It is hard to appreciate the glucocorticoid receptor translocation with the images provided. Would it be possible to increase magnification or at least, provide small inserts at higher magnification?

      We have re-imaged our brain sections to get more detailed images. These are provided in revised manuscript (Figure 3)

      (14) For the viral injection experiment, for how long is the virus expressed before running behavior/recording/c-Fos staining? Is the age of the tested mice the same as Figures1-3 or they were injected at P45 and tested weeks later?

      We age-matched all mice for all experiments and tried to keep our experimental window as tight as possible (p45-70). All mice were injected at P25-30 in order to meet the experimental time window. To be more precise we have added timelines on all figures.

      (15) A validation of the virus is missing to confirm the reduction of Cx43 expression at mRNA and protein levels when compared to controls. A reference is provided but to my understanding age of the animals might be different.

      Here, I believe the reviewer is referring to dnCx43. In this experiment we used a viral approach to overexpress a non-functional connexin 43 protein (Murphy-Royal et al. 2020 Nat Comms). As such, a PCR or immuno against this protein would be expected to reveal higher expression levels. We have tried to clarify this approach in the text.

      It is true that we did not fully characterise this tool in the lateral amygdala which would have been useful but considering our extensive experience with this tool and in it’s development with our collaborators Baljit Khakh, Randy Stout, David Spray (see Murphy-Royal et al. 2020) we are confident in these data, despite the limitation of validation in this manuscript.

      (16) Same comment for the CalEx, a validation would be appreciated. Based on Yu et al. could a GCaMP6f virus be more appropriate as control?

      We agree this is an important experiment as our lab has not fully validated this tool in house (compared to dnCx43, which we previously validated).

      Importantly, we now have the capacity to do these experiments. Until very recently our two-photon microscope was not fully functional due to dodgy PMTs sent from the company we purchased our equipment from… Troubleshooting this issue took many months before we were convinced that we were not at fault and that the problem was the equipment.

      As such, mice were injected with both a membrane tethered GCaMP6f under the control of the short GFAP promoter - AAV2/5-gfaABC1D-lck-GCaMP6f and CalEx - AAV2/5-gfaABC1D-hPMCA2w/b-mCherry. Using this approach we were able to record calcium activity from CalEx positive and CalEx negative astrocytes in the same tissue (Figure 5 - figure supplement 2).

      We report that this approach does indeed reduce astrocyte calcium but does not entirely eliminate it. In fact, CalEx expressing astrocytes displayed similar calcium activity dynamics to that we observed following ELS. Together, this further strengthens our rationale to use CalEx in order to mimic the effects of stress on astrocytes, and determine downstream effects on excitability, synapses, and behaviour.

      (17) Have previous studies found ELS--> generalization phenotypes in adulthood? If so, these should be discussed in more detail. If not, perhaps this point can be made more explicit.

      This is a great point. After looking deeper into the literature in more depth we found an example of this in which ELS resulted in context fear generalisation in adult rats. This work is cited in the discussion in the context of our findings.

      (18) A paper by Krugers et al (Biol Psychiatry 2020) seems especially relevant (glucocorticoids, fear generalization, engram size) and should be discussed.

      Thank you for bringing this work to our attention. This is certainly important work that we had unfortunately overlooked. We have added a citation and discussed the manuscript Lesuis et al. Biol. Psychiatry 2021, which contains the data discussed in the conference proceeding by Krugers et al. Biol. Psychiatry 2020.

      Additionally, we added another great manuscript by Lesuis et al. recently published in Cell in which they investigated the cellular mechanisms by which acute stress results in fear generalisation via endocannabinoids.

      (19) Minor text revisions are necessary at lines 101 and 264 as well as p.5, line 58: "ratio" and p.10, line 128: "region of interest".

      Thank you for pointing out these typos and errors. We have corrected them.

      Editor's note:

      Should you choose to revise your manuscript, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors attempt to validate Fisher Kernels on the top of HMM as a way to better describe human brain dynamics at resting state. The objective criterion was the better prediction of the proposed pipeline of the individual traits.

      Strengths:

      The authors analyzed rs-fMRI dataset from the HCP providing results also from other kernels.

      The authors also provided findings from simulation data.

      Weaknesses:

      (1) The authors should explain in detail how they applied cross-validation across the dataset for both optimization of parameters, and also for cross-validation of the models to predict individual traits.

      Indeed, there were details about the cross-validation for hyperparameter tuning and prediction missing. This problem was also raised by Reviewer #2. We have now rephrased this section in 4.4 and added details: ll. 804-813:

      “We used k-fold nested cross-validation (CV) to select and evaluate the models. We used 10 folds for both the outer loop (used to train and test the model) and the inner loop (used to select the optimal hyperparameters) such that 90% were used for training and 10% for testing. The optimal hyperparameters λ (and τ in the case of the Gaussian kernels) were selected using grid-search from the vectors λ=[0.0001,0.001,0.01,0.1,0.3,0.5,0.7,0.9,1] and . In both the outer and the inner loop, we accounted for family structure in the HCP dataset so that subjects from the same family were never split across folds (Winkler et al., 2015). Within the CV, we regressed out sex and head motion confounds, i.e., we estimated the regression coefficients for the confounds on the training set and applied them to the test set (Snoek et al., 2019).“ and ll. 818-820: “We generated the 100 random repetitions of the 10 outer CV folds once, and then used them for training and prediction of all methods, so that all methods were fit to the same partitions.”

      (2) They discussed throughout the paper that their proposed (HMM+Fisher) kernel approach outperformed dynamic functional connectivity (dFC). However, they compared the proposed methodology with just static FC.

      We would like to clarify that the HMM is itself a method for estimating dynamic (or time-varying) FC, just like the sliding window approach, see also Vidaurre, 2024 (https://direct.mit.edu/imag/article/doi/10.1162/imag_a_00363/124983) for an overview of terminology.

      See also our response to Q3.

      (3) If the authors wanted to claim that their methodology is better than dFC, then they have to demonstrate results based on dFC with the trivial sliding window approach.

      We would like to be clear that we do not claim in the manuscript that our method outperforms other dynamic functional connectivity (dFC) approaches, such as sliding window FC. We have now made changes to the manuscript to make this clearer.

      First, we have clarified our use of the term “brain dynamics” to signify “time-varying amplitude and functional connectivity patterns” in this context, as Reviewer #2 raised the point that the former term is ambiguous (ll.33-35: “One way of describing brain dynamics are state-space models, which allow capturing recurring patterns of activity and functional connectivity (FC) across the whole brain.”).

      Second, our focus is on our method being a way of using dFC for predictive modelling, since there currently is no widely accepted way of doing this. One reason why dFC is not usually considered in prediction studies is that it is mathematically not trivial how to use the parameters from estimators of dynamic FC for a prediction. This includes the sliding window approach. We do not aim at comparing across different dFC estimators in this paper. To make these points clearer, we have revised the introduction to now say:

      Ll. 39-50:

      “One reason why brain dynamics are not usually considered in this context pertains to their representation: They are represented using models of varying complexity that are estimated from modalities such as functional MRI or MEG. Although there exists a variety of methods for estimating time-varying or dynamic FC (Lurie et al., 2019), like the commonly used sliding-window approach, there is currently no widely accepted way of using them for prediction problems. This is because these models are usually parametrised by a high number of parameters with complex mathematical relationships between the parameters that reflect the model assumptions. How to leverage these parameters for prediction is currently an open question.

      We here propose the Fisher kernel for predicting individual traits from brain dynamics, using information from generative models that do not assume any knowledge of task timings. We focus on models of brain dynamics that capture within-session changes in functional connectivity and amplitude from fMRI scans, in this case acquired during wakeful rest, and how the parameters from these models can be used to predict behavioural variables or traits. In particular, we use the Hidden Markov Model (HMM), which is a probabilistic generative model of time-varying amplitude and functional connectivity (FC) dynamics (Vidaurre et al., 2017).”

      Reviewer #2 (Public Review):

      Summary:

      The manuscript presents a valuable investigation into the use of Fisher Kernels for extracting representations from temporal models of brain activity, with the aim of improving regression and classification applications. The authors provide solid evidence through extensive benchmarks and simulations that demonstrate the potential of Fisher Kernels to enhance the accuracy and robustness of regression and classification performance in the context of functional magnetic resonance imaging (fMRI) data. This is an important achievement for the neuroimaging community interested in predictive modeling from brain dynamics and, in particular, state-space models.

      Strengths:

      (1) The study's main contribution is the innovative application of Fisher Kernels to temporal brain activity models, which represents a valuable advancement in the field of human cognitive neuroimaging.

      (2) The evidence presented is solid, supported by extensive benchmarks that showcase the method's effectiveness in various scenarios.

      (3) Model inspection and simulations provide important insights into the nature of the signal picked up by the method, highlighting the importance of state rather than transition probabilities.

      (4) The documentation and description of the methods are solid including sufficient mathematical details and availability of source code, ensuring that the study can be replicated and extended by other researchers.

      Weaknesses:

      (1) The generalizability of the findings is currently limited to the young and healthy population represented in the Human Connectome Project (HCP) dataset. The potential of the method for other populations and modalities remains to be investigated.

      As suggested by the reviewer, we have added a limitations paragraph and included a statement about the dataset: Ll. 477-481: “The fMRI dataset we used (HCP 1200 Young Adult) is a large sample taken from a healthy, young population, and it remains to be shown how our findings generalise to other datasets, e.g. other modalities such as EEG/MEG, clinical data, older populations, different data quality, or smaller sample sizes both in terms of the number of participants and the scanning duration”.

      We would like to emphasise that this is a methodological contribution, rather than a basic science investigation about cognition and brain-behaviour associations. Therefore, the method would be equally usable on different populations, even if the results vary.

      (2) The possibility of positivity bias in the HMM, due to the use of a population model before cross-validation, needs to be addressed to confirm the robustness of the results.

      As pointed out by both Reviewers #2 and #3, we did not separate subjects into training and test set before fitting the HMM. To address this issue, we have now repeated the predictions for HMMs fit only to the training subjects. We show that this has no effect on the results. Since this question has consequences for the Fisher kernel, we have also added simulations showing how the different kernels react to increasing heterogeneity between training and test set. These new results are added as results section 2.4 (ll. 376-423).

      (3) The statistical significance testing might be compromised by incorrect assumptions about the independence between cross-validation distributions, which warrants further examination or clearer documentation.

      We have now replaced the significance testing with repeated k-fold cross-validated corrected tests. Note that this required re-running the models to be able to test differences in accuracies on the level of individual folds, resulting in different plots throughout the manuscript and different statistical results. This does not, however, change the main conclusions of our manuscript.

      (4) The inclusion of the R^2 score, sensitive to scale, would provide a more comprehensive understanding of the method's performance, as the Pearson correlation coefficient alone is not standard in machine learning and may not be sufficient (even if it is common practice in applied machine learning studies in human neuroimaging).

      We have now added the coefficient of determination to the results figures.

      (5) The process for hyperparameter tuning is not clearly documented in the methods section, both for kernel methods and the elastic net.

      As mentioned above in the response to Reviewer #1, we have now added details about hyperparameter tuning for the kernel methods and the non-kernelised static FC regression models (see also Reviewer #1 comment 1): Ll.804-813: “We used k-fold nested cross-validation (CV) to select and evaluate the models. We used 10 folds for both the outer loop (used to train and test the model) and the inner loop (used to select the optimal hyperparameters) such that 90% were used for training and 10% for testing. The optimal hyperparameters  (and  in the case of the Gaussian kernels) were selected using grid-search from the vectors λ=[0.0001,0.001,0.01,0.1,0.3,0.5,0.7,0.9,1] and . In both the outer and the inner loop, we accounted for family structure in the HCP dataset so that subjects from the same family were never split across folds (Winkler et al., 2015). Within the CV, we regressed out sex and head motion confounds, i.e., we estimated the regression coefficients for the confounds on the training set and applied them to the test set (Snoek et al., 2019).” and ll. 818-820: “We generated the 100 random repetitions of the 10 outer CV folds once, and then used them for training and prediction of all methods, so that all methods were fit to the same partitions.”, as well as ll.913-917: “All time-averaged FC models are fitted using the same (nested) cross-validation strategy as described above (10-fold CV using the outer loop for model evaluation and the inner loop for model selection using grid-search for hyperparameter tuning, accounting for family structure in the dataset, and repeated 100 times with randomised folds).”

      (6) For the time-averaged benchmarks, a comparison with kernel methods using metrics defined on the Riemannian SPD manifold, such as employing the Frobenius norm of the logarithm map within a Gaussian kernel, would strengthen the analysis, cf. Jayasumana (https://arxiv.org/abs/1412.4172) Table 1, log-euclidean metric.

      We have now added the log-Euclidean Gaussian kernel proposed by the reviewer to the model comparisons. The additional model does not change our conclusions.

      (7) A more nuanced and explicit discussion of the limitations, including the reliance on HCP data, lack of clinical focus, and the context of tasks for which performance is expected to be on the low end (e.g. cognitive scores), is crucial for framing the findings within the appropriate context.

      We have now revised the discussion section and added an explicit limitations paragraph: Ll. 475-484:

      “We here aimed to show the potential of the HMM-Fisher kernel approach to leverage information from patterns of brain dynamics to predict individual traits in an example fMRI dataset as well as simulated data. The fMRI dataset we used (HCP 1200 Young Adult) is a large sample taken from a healthy, young population, and it remains to be shown how the exhibited performance generalises to other datasets, e.g. other modalities such as EEG/MEG, clinical data, older populations, different data quality, or smaller sample sizes both in terms of the number of participants and the scanning duration. Additionally, we only tested our approach for the prediction of a specific set of demographic items and cognitive scores; it may be interesting to test the framework in also on clinical variables, such as the presence of a disease or the response to pharmacological treatment.”

      (8) While further benchmarks could enhance the study, the authors should provide a critical appraisal of the current findings and outline directions for future research, considering the scope and budget constraints of the work.

      In addition to the new limitations paragraph (see previous comment), we have now rephrased our interpretation of the results and extended the outlook paragraph: Ll. 485-507:

      “There is growing interest in combining different data types or modalities, such as structural, static, and dynamic measures, to predict phenotypes (Engemann et al., 2020; Schouten et al., 2016). While directly combining the features from each modality can be problematic, modality-specific kernels, such as the Fisher kernel for time-varying amplitude and/or FC, can be easily combined using approaches such as stacking (Breiman, 1996) or Multi Kernel Learning (MKL) (Gönen & Alpaydın, 2011). MKL can improve prediction accuracy of multimodal studies (Vaghari et al., 2022), and stacking has recently been shown to be a useful framework for combining static and time-varying FC predictions (Griffin et al., 2024). A detailed comparison of different multimodal prediction strategies including kernels for time-varying amplitude/FC may may be the focus of future work.

      In a clinical context, while there are nowadays highly accurate biomarkers and prognostics for many diseases, others, such as psychiatric diseases, remain poorly understood, diagnosed, and treated. Here, improving the description of individual variability in brain measures may have potential benefits for a variety of clinical goals, e.g., to diagnose or predict individual patients’ outcomes, find biomarkers, or to deepen our understanding of changes in the brain related to treatment responses like drugs or non-pharmacological therapies (Marquand et al., 2016; Stephan et al., 2017; Wen et al., 2022; Wolfers et al., 2015). However, the focus so far has mostly been on static or structural information, leaving the potentially crucial information from brain dynamics untapped. Our proposed approach provides one avenue of addressing this by leveraging individual patterns of time-varying amplitude and FC, and it can be flexibly modified or extended to include, e.g., information about temporally recurring frequency patterns (Vidaurre et al., 2016).”

      Reviewer #3 (Public Review):

      Summary:

      In this work, the authors use a Hidden Markov Model (HMM) to describe dynamic connectivity and amplitude patterns in fMRI data, and propose to integrate these features with the Fisher Kernel to improve the prediction of individual traits. The approach is tested using a large sample of healthy young adults from the Human Connectome Project. The HMM-Fisher Kernel approach was shown to achieve higher prediction accuracy with lower variance on many individual traits compared to alternate kernels and measures of static connectivity. As an additional finding, the authors demonstrate that parameters of the HMM state matrix may be more informative in predicting behavioral/cognitive variables in this data compared to state-transition probabilities.

      Strengths:

      - Overall, this work helps to address the timely challenge of how to leverage high-dimensional dynamic features to describe brain activity in individuals.

      - The idea to use a Fisher Kernel seems novel and suitable in this context.

      - Detailed comparisons are carried out across the set of individual traits, as well as across models with alternate kernels and features.

      - The paper is well-written and clear, and the analysis is thorough.

      Potential weaknesses:

      - One conclusion of the paper is that the Fisher Kernel "predicts more accurately than other methods" (Section 2.1 heading). I was not certain this conclusion is fully justified by the data presented, as it appears that certain individual traits may be better predicted by other approaches (e.g., as shown in Figure 3) and I found it hard to tell if certain pairwise comparisons were performed -- was the linear Fisher Kernel significantly better than the linear Naive normalized kernel, for example?

      We have revised the abstract and the discussion to state the results more appropriately. For instance, we changed the relevant section in the abstract to (ll. 24-26):

      “We show here, in fMRI data, that the HMM-Fisher kernel approach is accurate and reliable. We compare the Fisher kernel to other prediction methods, both time-varying and time-averaged functional connectivity-based models.”,

      and in the discussion, removing the sentence

      “resulting in better generalisability and interpretability compared to other methods”,

      and adding (given the revised statistical results) ll. 435-436:

      “though most comparisons were not statistically significant given the narrow margin for improvements.”

      In conjunction with the new statistical approach (see Reviewer #2, comment 3), we have now streamlined the comparisons. We explained which comparisons were performed in the methods ll.880-890:

      “For the main results, we separately compare the linear Fisher kernel to the other linear kernels, and the Gaussian Fisher kernel to the other Gaussian kernels, as well as to each other. We also compare the linear Fisher kernel to all time-averaged methods. Finally, to test for the effect of tangent space projection for the time-averaged FC prediction, we also compare the Ridge regression model to the Ridge Regression in Riemannian space. To test for effects of removing sets of features, we use the approach described above to compare the kernels constructed from the full feature sets to their versions where features were removed or reduced. Finally, to test for effects of training the HMM either on all subjects or only on the subjects that were later used as training set, we compare each kernel to the corresponding kernel constructed from HMM parameters, where training and test set were kept separate.“

      Model performance evaluation is done on the level of all predictions (i.e., across target variables, CV folds, and CV iterations) rather than for each of the target variables separately. That means different best-performing methods depending on the target variables are to be expected.

      - While 10-fold cross-validation is used for behavioral prediction, it appears that data from the entire set of subjects is concatenated to produce the initial group-level HMM estimates (which are then customized to individuals). I wonder if this procedure could introduce some shared information between CV training and test sets. This may be a minor issue when comparing the HMM-based models to one another, but it may be more important when comparing with other models such as those based on time-averaged connectivity, which are calculated separately for train/test partitions (if I understood correctly).

      The lack of separation between training and test set before fitting the HMM was also pointed out by Reviewer #2. We are addressing this issue in the new Results section 2.4 (see also our response to Reviewer #2, comment 2).

      Recommendations for the authors:

      The individual public reviews all indicate the merits of the study, however, they also highlight relatively consistent questions or issues that ought to be addressed. Most significantly, the authors ought to provide greater clarity surrounding the use of the cross-validation procedures they employ, and the use of a common atlas derived outside the cross-validation loop. Also, the authors should ensure that the statistical testing procedures they employ accommodate the dependencies induced between folds by the cross-validation procedure and give care to ensuring that the conclusions they make are fully supported by the data and statistical tests they present.

      Reviewer #1 (Recommendations For The Authors):

      Overall, the study is interesting but demands further improvements. Below, I summarize my comments:

      (1) The authors should explain in detail how they applied cross-validation across the dataset for both optimization of parameters, and also for cross-validation of the models to predict individual traits.

      How did you split the dataset for both parameters optimization, and for the CV of the prediction of behavioral traits?

      A review and a summary of various CVs that have been applied on the same dataset should be applied.

      We apologise for the oversight and have now added more details to the CV section of the methods, see our response to Reviewer #1 comment 1:

      In ll. 804-813:

      “We used k-fold nested cross-validation (CV) to select and evaluate the models. We used 10 folds for both the outer loop (used to train and test the model) and the inner loop (used to select the optimal hyperparameters) such that 90% were used for training and 10% for testing. The optimal hyperparameters  (and  in the case of the Gaussian kernels) were selected using grid-search from the vectors λ=[0.0001,0.001,0.01,0.1,0.3,0.5,0.7,0.9,1] and . In both the outer and the inner loop, we accounted for family structure in the HCP dataset so that subjects from the same family were never split across folds (Winkler et al., 2015). Within the CV, we regressed out sex and head motion confounds, i.e., we estimated the regression coefficients for the confounds on the training set and applied them to the test set (Snoek et al., 2019).“ and ll. 818-820: “We generated the 100 random repetitions of the 10 outer CV folds once, and then used them for training and prediction of all methods, so that all methods were fit to the same partitions.”

      (2) The authors should explain in more detail how they applied ICA-based parcellation at the group-level.

      A. Did you apply it across the whole group? If yes, then this is problematic since it rejects the CV approach. It should be applied within the folds.

      B. How did you define the representative time-source per ROI?

      A: How group ICA was applied was stated in the Methods section (4.1 HCP imaging and behavioural data), ll. 543-548:

      “The parcellation was estimated from the data using multi-session spatial ICA on the temporally concatenated data from all subjects.”

      We have now added a disclaimer about the divide between training and test set:

      “Note that this means that there is no strict divide between the subjects used for training and the subjects for testing the later predictive models, so that there is potential for leakage of information between training and test set. However, since this step does not concern the target variable, but only the preprocessing of the predictors, the effect can be expected to be minimal (Rosenblatt et al., 2024).”

      We understand that in order to make sure we avoid data leakage, it would be desirable to estimate and apply group ICA separately for the folds, but the computational load of this would be well beyond the constraints of this particular work, where we have instead used the parcellation provided by the HCP consortium.

      B: This was also stated in 4.1, ll. 554-559: “Timecourses were extracted using dual regression (Beckmann et al., 2009), where group-level components are regressed onto each subject’s fMRI data to obtain subject-specific versions of the parcels and their timecourses. We normalised the timecourses of each subject to ensure that the model of brain dynamics and, crucially, the kernels were not driven by (averaged) amplitude and variance differences between subjects.”

      (3) The authors discussed throughout the paper that their proposed (HMM+Fisher) kernel approach outperformed dynamic functional connectivity (dFC). However, they compared the proposed methodology with just static FC.

      A. The authors didn't explain how static and dFC have been applied.

      B. If the authors wanted to claim that their methodology is better than dFC, then they have to demonstrate results based on dFC with the trivial sliding window approach.

      C. Moreover, the static FC networks have been constructed by concatenating time samples that belong to the same state across the time course of resting-state activity.

      So, it's HMM-informed static FC analysis, which is problematic since it's derived from HMM applied over the brain dynamics.

      I don't agree that connectivity is derived exclusively from the clustering of human brain dynamics!

      D. A static approach of using the whole time course, and a dFC following the trivial sliding-window approach should be adopted and presented for comparison with (HMM+Fisher) kernel.

      We do not intend to claim our manuscript that our method outperforms other methods for doing dynamic FC. Indeed, we would like to be clear that the HMM itself is a method for capturing dynamic FC. Please see our responses to public review comments 2 and 3 by reviewer #1, copied below, which is intended to clear up this misunderstanding:

      We would like to clarify that the HMM is itself a method for estimating dynamic (or time-varying) FC, just like the sliding window approach, see also Vidaurre, 2024 (https://direct.mit.edu/imag/article/doi/10.1162/imag_a_00363/124983) for an overview of terminology.

      We would like to be clear that we do not claim in the manuscript that our method outperforms other dynamic functional connectivity (dFC) approaches, such as sliding window FC. We have now made changes to the manuscript to make this clearer.

      First, we have clarified our use of the term “brain dynamics” to signify “time-varying amplitude and functional connectivity patterns” in this context, as Reviewer #2 raised the point that the former term is ambiguous.

      Second, our focus is on our method being a way of using dFC for predictive modelling, since there currently is no widely accepted way of doing this. One reason why dFC is not usually considered in prediction studies is that it is mathematically not trivial how to use the parameters from estimators of dynamic FC for a prediction. This includes the sliding window approach. We do not aim at comparing across different dFC estimators in this paper. To make these points clearer, we have revised the introduction to now say:

      Ll. 39-50:

      “One reason why brain dynamics are not usually considered in this context pertains to their representation: They are represented using models of varying complexity that are estimated from modalities such as functional MRI or MEG. Although there exists a variety of methods for estimating time-varying or dynamic FC (Lurie et al., 2019), like the commonly used sliding-window approach, there is currently no widely accepted way of using them for prediction problems. This is because these models are usually parametrised by a high number of parameters with complex mathematical relationships between the parameters that reflect the model assumptions. How to leverage these parameters for prediction is currently an open question.

      We here propose the Fisher kernel for predicting individual traits from brain dynamics, using information from generative models that do not assume any knowledge of task timings. We focus on models of brain dynamics that capture within-session changes in functional connectivity and amplitude from fMRI scans, in this case acquired during wakeful rest, and how the parameters from these models can be used to predict behavioural variables or traits. In particular, we use the Hidden Markov Model (HMM), which is a probabilistic generative model of time-varying amplitude and functional connectivity (FC) dynamics (Vidaurre et al., 2017).”

      To the additional points raised here:

      A: How static and dynamic FC have been estimated is explicitly stated in the relevant Methods sections 4.2 (The Hidden Markov Model), which explains the details of using the HMM to estimate dynamic functional connectivity; and 4.5 (Regression models based on time-averaged FC features), which explains how static FC was computed.

      B: We are not making this claim. We have now modified the Introduction to avoid further misunderstandings, as per ll. 33-36: “One way of describing brain dynamics are state-space models, which allow capturing recurring patterns of activity and functional connectivity (FC) across the whole brain.”

      C: This is not how static FC networks were constructed; we apologise for the confusion. We also do not perform any kind of clustering. The only “HMM-informed static FC analysis” is the static FC KL divergence model to allow for a more direct comparison with the time-varying FC KL divergence model, but we have included several other static FC models (log-Euclidean, Ridge regression, Ridge regression Riem., Elastic Net, Elastic Net Riem., and Selected Edges), which do not use HMMs. This is explained in Methods section 4.5.

      D: As explained above, we have included four (five in the revised manuscript) static approaches using the whole time course, and we do not claim that our method outperforms other dynamic FC models. We also disagree that using the sliding window approach for predictive modelling is trivial, as explained in the introduction of the manuscript and under public review comment 3.

      (4) Did you correct for multiple comparisons across the various statistical tests?

      All statistical comparisons have been corrected for multiple comparisons. Please find the relevant text in Methods section 4.4.1.

      (5) Do we expect that behavioral traits are encapsulated in resting-state human brain dynamics, and on which brain areas mostly? Please, elaborate on this.

      While this is certainly an interesting question, our paper is a methodological contribution about how to predict from models of brain dynamics, rather than a basic science study about the relation between resting-state brain dynamics and behaviour. The biological aspects and interpretation of the specific brain-behaviour associations are a secondary point and out of scope for this paper. Our approach uses whole-brain dynamics, which does not require selecting brain areas of interest.

      Reviewer #2 (Recommendations For The Authors):

      Beyond the general principles included in the public review, here are a few additional pointers to minor issues that I would wish to see addressed.

      Introduction:

      - The term "brain dynamics" encompasses a broad spectrum of phenomena, not limited to those captured by state-space models. It includes various measures such as time-averaged connectivity and mean EEG power within specific frequency bands. To ensure clarity and relevance for a diverse readership, it would be beneficial to adopt a more inclusive and balanced approach to the terminology used.

      The reviewer rightly points out the ambiguity of the term “brain dynamics”, which we use in the interest of readability. The HMM is one of several possible descriptions of brain dynamics. We have now included a statement early in the introduction to narrow this down:

      Ll. 32-35:

      “… the patterns in which brain activity unfolds over time, i.e., brain dynamics. One way of describing brain dynamics are state-space models, which allow capturing recurring patterns of activity and functional connectivity (FC) across the whole brain.”

      And ll. 503-507:

      “Our proposed approach provides one avenue of addressing this by leveraging individual patterns of time-varying amplitude and FC, as one of many possible descriptions of brain dynamics, and it can be flexibly modified or extended to include, e.g., information about temporally recurring frequency patterns (Vidaurre et al., 2016).”

      Figures:

      - The font sizes across the figures, particularly in subpanels 2B and 2C, are quite small and may challenge readability. It is advisable to standardize the font sizes throughout all figures to enhance legibility.

      We have slightly increased the overall font sizes, while we are generally following figure recommendations set out by Nature. The font sizes are the same throughout the figures.

      - When presenting performance comparisons, a horizontal layout is often more intuitive for readers, as it aligns with the natural left-to-right reading direction. This is not just a personal preference; it is supported by visualization best practices as outlined in resources like the NVS Cheat Sheet (https://github.com/GraphicsPrinciples/CheatSheet/blob/master/NVSCheatSheet.pdf) and Kieran Healy's book (https://socviz.co/lookatdata.html).

      We have changed all figures to use horizontal layout, hoping that this will ease visual comparison between the different models.

      - In the kernel density estimation (KDE) and violin plot representations, it appears that the data displays may be truncated. It is crucial to indicate where the data distribution ends. Overplotting individual data points could provide additional clarity.

      To avoid confusion about the data distribution in the violin plots, we have now overlaid scatter plots, as suggested by the reviewer. Overlaying the fold-level accuracies was not feasible (since this would result in ~1.5 million transparent points for a single figure), so we instead show the accuracies averaged over folds but separate for target variables and CV iterations. Only the newly added coefficient of determination plots had to be truncated, which we have noted in the figure legend.

      - Figure 3 could inadvertently suggest that time-varying features correspond to panel A and time-averaged features to panel B. To avoid confusion, consider reorganizing the labels at the bottom into two rows for clearer attribution.

      We have changed the layout of the time-varying and time-averaged labels in the new version of the plots to avoid this issue.

      Discussion:

      - The discussion on multimodal modeling might give the impression that it is more effective with multiple kernel learning (MKL) than with other methods. To present a more balanced view, it would be appropriate to rephrase this section. For instance, stacking, examples of which are cited in the same paragraph, has been successfully applied in practice. The text could be adjusted to reflect that Fisher Kernels via MKL adds to the array of viable options for multimodal modeling. As a side thought: additionally, a well-designed comparison between MKL and stacking methods, conducted by experts in each domain, could greatly benefit the field. In certain scenarios, it might even be demonstrated that the two approaches converge, such as when using linear kernels.

      We would like to thank the reviewer for the suggestion about the discussion concerning multimodal modelling. We agree that there are other relevant methods that may lead to interesting future work and have now included stacking and refined the section: ll. 487-494:

      “While directly combining the features from each modality can be problematic, modality-specific kernels, such as the Fisher kernel for time-varying amplitude and/or FC, can be easily combined using approaches such as stacking (Breiman, 1996) or Multi Kernel Learning (MKL) (Gönen & Alpaydın, 2011). MKL can improve prediction accuracy of multimodal studies (Vaghari et al., 2022), and stacking has recently been shown to be a useful framework for combining static and time-varying FC predictions (Griffin et al., 2024). A detailed comparison of different multimodal prediction strategies including kernels for time-varying amplitude/FC may be the focus of future work.”

      - The potential clinical applications of brain dynamics extend beyond diagnosis and individual outcome prediction. They play a significant role in the context of biomarkers, including pharmacodynamics, prognostic assessments, responder analysis, and other uses. The current discussion might be misinterpreted as being specific to hidden Markov model (HMM) approaches. For diagnostic purposes, where clinical assessment or established biomarkers are already available, the need for new models may be less pressing. It would be advantageous to reframe the discussion to emphasize the potential for gaining deeper insights into changes in brain activity that could indicate therapeutic effects or improvements not captured by structural brain measures. However, this forward-looking perspective is not the focus of the current work. A nuanced revision of this section is recommended to better reflect the breadth of applications.

      We appreciate the reviewer’s thoughtful suggestions regarding the discussion of potential clinical applications. We have included the suggestions and refined this section of the discussion: Ll. 495-507:

      “In a clinical context, while there are nowadays highly accurate biomarkers and prognostics for many diseases, others, such as psychiatric diseases, remain poorly understood, diagnosed, and treated. Here, improving the description of individual variability in brain measures may have potential benefits for a variety of clinical goals, e.g., to diagnose or predict individual patients’ outcomes, find biomarkers, or to deepen our understanding of changes in the brain related to treatment responses like drugs or non-pharmacological therapies (Marquand et al., 2016; Stephan et al., 2017; Wen et al., 2022; Wolfers et al., 2015). However, the focus so far has mostly been on static or structural information, leaving the potentially crucial information from brain dynamics untapped. Our proposed approach provides one avenue of addressing this by leveraging individual patterns of time-varying amplitude and FC, and it can be flexibly modified or extended to include, e.g., information about temporally recurring frequency patterns (Vidaurre et al., 2016).”

      Reviewer #3 (Recommendations For The Authors):

      - I wondered if the authors could provide, within the Introduction, an intuitive description for how the Fisher Kernel "preserves the structure of the underlying model of brain dynamics" / "preserves the mathematical structure of the underlying HMM"? Providing more background may help to motivate this study to a general audience.

      We agree that this would be helpful and have now added this to the introduction: Ll.61-67:

      “Mathematically, the HMM parameters lie on a Riemannian manifold (the structure). This defines, for instance, the relation between parameters, such as: how changing one parameter, like the probabilities of transitioning from one state to another, would affect the fitting of other parameters, like the states’ FC. It also defines the relative importance of each parameter; for example, how a change of 0.1 in the transition probabilities would not be the same as a change of 0.1 in one edge of the states’ FC matrices.”

      To communicate the intuition behind the concept, the idea was also illustrated in Figure 1, panel 4 by showing Euclidean distances as straight lines through a curved surface (4a, Naïve kernel), as opposed to the tangent space projection onto the curved manifold (4b, Fisher kernel).

      - Some clarifications regarding Figure 2a would be helpful. Was the linear Fisher Kernel significantly better than the linear Naive normalized kernel? I couldn't find whether this comparison was carried out. Apologies if I have missed it in the text. For some of the brackets indicating pairwise tests and their significance values, the start/endpoints of the bracket fall between two violins; in this case, were the results of the linear and Gaussian Fisher Kernels pooled together for this comparison?

      We have now streamlined the statistical comparisons and avoided plotting brackets falling between two violin plots. The comparisons that were carried out are stated in the methods section 4.4.1. Please see also our response to above to Reviewer #3 public review, potential weaknesses, point 1, relevant point copied below:

      In conjunction with the new statistical approach (see Reviewer #2, comment 3), we have now streamlined the comparisons. We explained which comparisons were performed in the methods ll.880-890:

      “For the main results, we separately compare the linear Fisher kernel to the other linear kernels, and the Gaussian Fisher kernel to the other Gaussian kernels, as well as to each other. We also compare the linear Fisher kernel to all time-averaged methods. Finally, to test for the effect of tangent space projection for the time-averaged FC prediction, we also compare the Ridge regression model to the Ridge Regression in Riemannian space. To test for effects of removing sets of features, we use the approach described above to compare the kernels constructed from the full feature sets to their versions where features were removed or reduced. Finally, to test for effects of training the HMM either on all subjects or only on the subjects that were later used as training set, we compare each kernel to the corresponding kernel constructed from HMM parameters, where training and test set were kept separate”.

      - The authors may wish to include, in the Discussion, some remarks on the use of all subjects in fitting the group-level HMM and the implications for the cross-validation performance, and/or try some analysis to ensure that the effect is minor.

      As suggested by reviewers #2 and #3, we have now performed the suggested analysis and show that fitting the group-level HMM to all subjects compared to only to the training subjects has no effect on the results. Please see our response to Reviewer #2, public review, comment 2.

      - The decision to use k=6 states was made here, and I wondered if the authors may include some support for this choice (e.g., based on findings from prior studies)?

      We have now refined and extended our explanation and rationale behind the number of states: Ll. 586-594: “The number of states can be understood as the level of detail or granularity with which we describe the spatiotemporal patterns in the data, akin to a dimensionality reduction, where a small number of states will lead to a very general, coarse description and a large number of states will lead to a very detailed, fine-grained description. Here, we chose a small number of states, K=6, to ensure that the group-level HMM states are general enough to be found in all subjects, since a larger number of states increases the chances of certain states being present only in a subset of subjects. The exact number of states is less relevant in this context, since the same HMM estimation is used for all kernels.”

      - (minor) Abstract: "structural aspects" - do you mean structural connectivity?

      With “structural aspects”, we refer to the various measures of brain structure that are used in predictive modelling. We have now specified: Ll. 14-15: “structural aspects, such as structural connectivity or cortical thickness”.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      The modeling and experimental work described provide solid evidence that this model is capable of qualitatively predicting alterations to the swing and stance phase durations during locomotion at different speeds on intact or split-belt treadmills, but a revision of the figures to overlay the model predictions with the experimental data would facilitate the assessment of this qualitative agreement. This paper will interest neuroscientists studying vertebrate motor systems, including researchers investigating motor dysfunction after spinal cord injury.

      Figures showing the overlay of the experimental data with the modeling predictions have been included as figure supplements for Figures 5-7. This highlights how accurate the model predictions were.

      Public Reviews:

      Reviewer #1 (Public review):

      We thank the reviewer for the positive evaluation of our paper and emphasizing its strengths in the Summary.

      Weaknesses:

      (1) Could the authors provide a statement in the methods or results to clarify whether there were any changes in synaptic weight or other model parameters of the intact model to ensure locomotor activity in the hemisected model?

      Such a statement has been inserted in Materials and Methods, section “Modeling”. Also, in the 1st paragraph of section “Spinal sensorimotor network architecture and operation after a lateral spinal hemisection”, we stated that no “additional changes or adjustments” were made.

      (2) The authors should remind the reader what the main differences are between state-machine, flexor-driven, and classical half-center regimes (lines 77-79).

      Short explanations/reminders have been inserted (see lines 80-83 of tracked changes document).

      (3) There may be changes in the wiring of spinal locomotor networks after the hemisection. Yet, without applying any sort of plasticity, the model is able to replicate many of the experimental data. Based on what was experimentally replicated or not, what does the model tell us about possible sites of plasticity after hemisection?

      Quantitative correspondence of changes in locomotor characteristics predicted by the model and those obtained experimentally provide additional validation of the model proposed in the preceding paper and used in this paper. This was our ultimate goal. None of the plastic changes during recovery were modeled because of a lack of precise information on these changes. The absence of possible plastic changes may explain the small discrepancies between our simulations and experimental data (see Supplemental Figures that have been added). However, the model only has a simplified description of spinal circuits without motoneurons and without real simulation of leg biomechanics. This limits our analysis or predictions of possible plastic changes within a reasonable degree of speculation. This issue is discussed in section: “Limitations and future directions” in the Discussion. We have also inserted a sentence: “The lack of possible plastic changes in spinal sensorimotor circuits of our model may explain the absence of exact/quantitative correspondences between simulated and experimental data.

      (4) Why are the durations on the right hemisected (fast) side similar to results in the full spinal transected model (Rybak et al. 2024)? Is it because the left is in slow mode and so there is not much drive from the left side to the right side even though the latter is still receiving supraspinal drive, as opposed to in the full transection model? (lines 202-203).

      This is correct. We have included this explanation in the text (lines 210-211 of tracked changes document).

      (5) There is an error with probability (line 280).

      This typo was corrected.

      Reviewer #2 (Public review):

      This is a nice article that presents interesting findings. One main concern is that I don't think the predictions from the simulation are overlaid on the animal data at any point - I understand the match is qualitative, which is fine, but even that is hard to judge without at least one figure overlaying some of the data.

      We thank the Reviewer for the constructive comments. Figures showing the overlay of the experimental data with the modeling predictions have been included as figure supplements for Figures 5-7. This highlights how accurate the model predictions were.

      Second is that it's not clear how the lateral coupling strengths of the model were trained/set, so it's hard to judge how important this hemi-split-belt paradigm is. The model's predictions match the data qualitatively, which is good; but does the comparison using the hemi-split-belt paradigm not offer any corrections to the model? The discussion points to modeling plasticity after SCI, which could be good, but does that mean the fit here is so good there's no point using the data to refine?

      The model has not been trained or retrained, but was used as it was described in the preceding paper. Response: Quantitative correspondence of changes in locomotor characteristics predicted by the model and those obtained experimentally provide additional validation of the model proposed in the preceding paper and used in this paper. This was our ultimate goal. None of the plastic changes during recovery were modeled because of a lack of precise information on these changes. The absence of possible plastic changes may explain the small discrepancies between our simulations and experimental data (see figure supplements that have been added). However, the model only has a simplified description of spinal circuits without motoneurons and without real simulation of leg biomechanics. This limits our analysis or predictions of possible plastic changes within a reasonable degree of speculation. This issue is discussed in section: “Limitations and future directions” in the Discussion.

      The manuscript is well-written and interesting. The putative neural circuit mechanisms that the model uncovers are great, if they can be tested in an animal somehow.

      We agree and we are considering how we can do this in an animal model.

      Page 2, lines 75-6: Perhaps it belongs in the other paper on the model, but it's surprising that in the section on how the model has been revised to have different regimes of operation as speed increases, there is no reference to a lot of past literature on this idea. Just one example would be Koditschek and Full, 1999 JEB Figure 3, where they talk about exactly this idea, or similarly Holmes et al., 2006 SIAM review Figure 7, but obviously many more have put this forward over the years (Daley and Beiwener, etc). It's neat in this model to have it tied down to a detailed neural model that can be compared with the vast cat literature, but the concept of this has been talked about for at least 25+ years. Maybe a review that discusses it should be cited?

      We have revised the Introduction to include the suggested references.

      Page 2, line 88: While it makes sense to think of the sides as supraspinal vs afferent driven, respectively, what is the added insight from having them coupled laterally in this hemisection model? What does that buy you beyond complete transection (both sides no supra) compared with intact?

      We are trying to make one model that could reproduce multiple experimental data in quadrupedal locomotion, including genetic manipulations with (silencing/removal) particular neuron types (and commissural interneurons), as pointed out in the section “Model Description” in the Results. These lateral connections are critical for reproducing and explaining other locomotor behaviors demonstrated experimentally. However, even in this study, these lateral interactions are necessary to maintain left-right coordination and equal left-right frequency (step period) during split-belt locomotion and after hemisection.

      I can see how being able to vary cycle frequencies separately of the two limbs is a good "knob" to vary when perturbing the system in order to refine the model. But there isn't a ton of context explaining how the hemi-section with split belt paradigm is important for refining the model, and therefore the science. Is it somehow importantly related to the new "regimes" of operation versus speed idea for the model?  

      We did not refine the model in this paper. We just used it for new simulations. The predictions strengthen the organization and operation of the model we recently proposed.

      Page 5, line 212: For the predictions from the model, a lot depends on how strong the lateral coupling of the model is, which, in turn, depends on the data the model was trained on. Were the model parameters (especially for lateral coupling of the limbs) trained on data in a context where limbs were pushed out of phase and neuronal connectivity was likely required to bring the limbs back into the same phase relationship? Because if the model had no need for lateral coupling, then it's not so surprising that the hemisected limbs behave like separate limbs, one with surpaspinal intact and one without.

      Please see our response above concerning the need for lateral interactions incorporated to the model.

      Page 8, line 360: The discussion of the mechanisms (increased influence of afferents, etc) that the model reveals could be causing the changes is exciting, though I'm not sure if there is an animal model where it can be tested in vivo in a moving animal.

      We agree it may be difficult to test right now but we are considering experimental approaches.

      Page 9, line 395: There are some interesting conclusions that rely on the hemi-split-belt paradigm here.

      We agree with this comment. Thanks.

      Reviewer #2 (Recommendations for the authors):

      Figures: Why aren't there any figures with the simulation results overlaid on the animal data?

      We followed this suggestion. Figures showing the overlay of the experimental data with the modeling predictions have been included as figure supplements.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      A nice study trying to identify the relationship between E. coli O157 from cattle and humans in Alberta, Canada.

      Strengths:

      (1) The combined human and animal sampling is a great foundation for this kind of study.

      (2) Phylogenetic analyses seem to have been carried out in a high-quality fashion.

      Weaknesses:

      I think there may be a problem with the selection of the isolates for the primary analysis. This is what I'm thinking:

      (1) Transmission analyses are strongly influenced by the sampling frame.

      (2) While the authors have randomly selected from their isolate collections, which is fine, the collections themselves are not random.

      (3) The animal isolates are likely to represent a broad swathe of diversity, because of the structured sampling of animal reservoirs undertaken (as I understand it).

      (4) The human isolates are all from clinical cases. Clinical cases of the disease are likely to be closely related to other clinical cases, because of outbreaks (either detected, or undetected), and the high ascertainment rate for serious infections.

      (5) Therefore, taking an equivalent number of animal and clinical isolates, will underestimate the total diversity in the clinical isolates because the sampling of the clinical isolates is less "independent" (in the statistical sense) than sampling from the animal isolates.

      (6) This could lead to over-estimating of transmission from cattle to humans.

      We appreciate the reviewer’s careful thoughts about our sampling strategy. We agree with points (1) and (2), and we have provided additional details on the animal collections as requested (lines 95-101).

      We agree with point (3) in theory but not in fact. As shown in Figure 3, the cattle isolates were very closely related, despite the temporal and geographic breadth of sampling within Alberta. The median SNP distance between cattle sequences was 45 (IQR 36-56), compared to 54 (IQR 43-229) SNPs between human sequences from cases in Alberta during the same years. Additionally, as shown in Figure 2, only clade A and B isolates – clades that diverge substantially from the rest of the tree – were dominated by human cases in Alberta. We have better highlight this evidence in the revision (lines 234-236 and 247-249).

      We agree with the reviewer in point (4) that outbreaks can be an important confounder of phylogenetic inference. This is why we down-sampled outbreaks (based on genetic relatedness, not external designation) in our extended analyses. We did not do this in the primary analysis, because there were no large clusters of identical isolates. Figure 3b shows a limited number of small clusters; however, clustered cattle isolates outnumbered clustered human isolates, suggesting that any bias would be in the opposite direction the reviewer suggests. In the revision, we down-sampled all analyses and, indeed, the proportion of human lineages descending from cattle lineages increased (lines 259-261). Regarding severe cases being oversampled among the clinical isolates, this is absolutely true and a limitation of all studies utilizing public health reporting data. We made this limitation to generalizability clearer in the discussion. However, as noted above, clinical isolates were more variable than cattle isolates, so it does not appear to have heavily biased the analysis (lines 490-495).

      We disagree with the reviewer on point (5). While the bias toward severe cases could make the human isolates less independent, the relative sampling proportions are likely to induce greater distance between clinical isolates than cattle isolates, which is exactly what we observe (see response to point (3) above). Cattle are E. coli O157:H7’s primary reservoir, and humans are incidental hosts not able to sustain infection chains long-term. Not only is the bacteria prevalent among cattle, cattle are also highly prevalent in Alberta. Thus, even with 89 sampling points, we are still capturing a small proportion of the E. coli O157:H7 in the province. Being able to sample only a small proportion of cattle’s E. coli O157:H7 increases the likelihood of only sampling from the center of the distribution, making extreme cases such as that shown at the very bottom of the tree in Figure 4, rare and important. In comparison, sampling from human cases constitutes a higher proportion of human infections relative to cattle, and is therefore more representative of the underlying distribution, including extremes. We added this point to the limitations (lines 495-504). As with the clustering above, if anything, this outcome would have biased the study away from identifying cattle as the primary reservoir. Additionally, the relatively small proportion of cattle sampled makes our finding that 15.7% of clinical isolates were within 5 SNPs of a cattle isolate, the distance most commonly used to indicate transmission for E. coli O157:H7, all the more remarkable.

      Because of the aforementioned points, we disagree with the reviewer’s conclusion in point (6). If a bias exists, we believe transmission from cattle-to-humans is likely underestimated for the reasons given above. Not only do all prior studies indicate ruminants as the primary reservoirs of E. coli O157:H7, and humans as only incidental hosts, our specific data do not support the reviewer’s individual contentions. The results of the sensitivity analysis the reviewer recommended is consistent with the points we outlined above, estimating that 94.3% of human lineages arose from cattle lineages (vs. 88.5% in the primary analysis). We have opted to retain the more conservative estimate of the primary analysis, which includes a more representative number of clinical cases.

      (7) We hypothesize that the large proportion of disease associated with local transmission systems is a principal cause of Alberta's high E. coli O157:H7 incidence" - this seems a bit tautological. There is a lot of O157 because there's a lot of transmission. What part of the fact it is local means that it is a principal cause of high incidence? It seems that they've observed a high rate of local transmission, but the reasons for this are not apparent, and hence the cause of Alberta's incidence is not apparent. Would a better conclusion not be that "X% of STEC in Alberta is the result of transmission of local variants"? And then, this poses a question for future epi studies of what the transmission pathway is.

      The reviewer is correct, and the suggestion for the direction of future studies was our intent with this statement. We have removed this sentence.

      Reviewer #1 (Recommendations For The Authors):

      (1) To address my concerns about the different sampling frames in humans and animals, I would suggest a sensitivity analysis, using something like the following strategy. Make a phylogeny of all the available genome sequences from humans and cattle from Alberta. Phylogenetically sub-sample the tree, using something like Treemer (https://github.com/fmenardo/Treemmer), to remove phylogenetically redundant isolates from the same host type. Randomly select 100 human and 100 animal isolates from this non-redundant tree, and re-do your analysis.

      Although we originally down-sampled outbreaks for our analysis of the extended Alberta tree (2007-2019), we had not done this systematically for all analyses. We were not able to use the recommended Treemer tool, because we did not see a way to incorporate the timing of sequences. Because the objective of our study was to evaluate persistence, we did not want to exclude identical sequences that were separated in time and thus could be indicating persistence. To accomplish this, we developed a utility that allowed us to incorporate the temporality of sequences. Using this utility, we systematically down-sampled all sequences that met the following conditions: 1) within 0-2 SNPs of another sequence and 2) no gaps in sequence set >2 months. The second condition means that for any set of sequences within 0-2 SNPs of one another, there can be no more than 2 months without a sequence from the set. Similar sequences that occur beyond this 2-month-cutoff would be considered a separate set for down-sampling. This cutoff was chosen based on the epidemiology of E. coli O157 outbreaks, which are generally either point-source or continuous-source outbreaks. Intermittent outbreaks of a single strain are believed to arise from distinct contamination events and are exactly the type of phenomena we are seeking to identify. We have added details on down-sampling to the Methods (lines 178-180).

      After down-sampling, our primary analysis included 115 human and 84 cattle isolates. T conduct the recommended sensitivity analysis, we further randomly subsampled the human isolates, selecting 84 to match the number of cattle isolates. As we suggested in our initial response, and contrary to the reviewer’s concern, subsampling in this way accentuated the results, with 94.3% of human lineages inferred as arising from cattle lineages, compared to 88.5% in the primary analysis. This sensitivity analysis also identified 10 of the 11 LPLs identified in the primary analysis. The LPL not identified had 5 isolates in the primary analysis, the minimum for definition as an LPL, and was reduced to 4 isolates through subsampling. This sensitivity analysis is shown in Suppl. Figure S3.

      (2) This is the first time I've seen target diagrams used for SNP distances, I'm not sure of their value compared with histograms. They seem to emphasise the maximum distance, rather than the largest number of isolates. I.e. most isolates are closely related, but the diagram emphasises the small number of divergent ones.

      In using the target diagrams, we sought to emphasize the bimodal distribution of human-to-closest-cattle SNP differences. However, this is still mostly visible in a histogram, so we have replaced the target diagrams with a histogram as suggested (Figure 3).

      (3) L130 - fastqc doesn't trim adapters and read ends, there will be something else like trimmomatic which does.

      The reviewer is correct, and we appreciate them catching this error. Trimmomatic is incorporated into the Shovill pipeline, which was the assembler we used through the Bactopia pipeline. We have updated the Methods to indicate this (lines 142-144).

      (4) I find the flow of the article a bit confusing. You have your primary analysis, but Figure 2, which is a secondary analysis, comes before Figure 3. Which is the primary analysis? For me, primary analysis results should come first, or at least signpost a bit better.

      Figure 2 is not a secondary analysis. It is intended to provide an overview of the isolates used from the phylogenetic perspective, just as the diagram in Figure 1 provides an overview of the isolates by analysis. The secondary analyses are shown in Figures 5-7. We have added a sub-header, “Description of Isolates”, to the section referring to Figure 2, to clarify (line 232).

      (5) Locally persistent lineage definition. What is the rationale for the different criteria signifying locally persistent lineages? There is nothing in some of your criteria e.g. all isolates <30 SNPs from each other, which indicates that it is locally persistent - could have been transmitted to Japan (just to pick a place at random), causing a bunch of cases there, and then come back for all we know. Would that be a locally persistent lineage? Did you use the MCC tree here? That is a sub-sample of your full dataset, I am not sure what exactly you're trying to say with the LPLs, but maybe using a larger dataset would be better? Also, there are lots of STEC genomes available from e.g. UK and USA, by only including a fraction of these, you limit the strength of the inferences you can make about locally persistent lineages unless you know that they don't see the G sub-lineage that you observe.

      The reviewer raises multiple points here. First, regarding our definition of LPLs, it is intended to identify those lineages that pose a threat to populations in the specific geographic area (“local”) for at least 1 year (“persistent”) that are likely to be harbored in local reservoirs. Each of the criteria contributes to this definition.

      (1) A single lineage of the MCC tree with a most recent common ancestor (MRCA) with ≥95% posterior probability: This criterion provides confidence in the given isolates being part of a single, defined lineage. The posterior probability gives the probability that the topology of the tree is accurate, based on the data provided and the chosen model of evolution. In other words, we required at least 95% probability that the lineage was correct, and in practice the posterior probability of the lineages we defined as LPLs was 99.7-100% (we have added this detail to the text, lines 269-270). We also added a sensitivity analysis, shown in Suppl. Figure S4, which shows all sampled trees. We find that the essential structure of the tree around the LPLs we defined is well-supported.

      (2) All isolates ≤30 core SNPs from one another: This criterion limited LPLs to those lineages where the isolates were closely related. We did not want to limit LPLs to those that might define an outbreak, for example using a 5-10 SNP threshold, because the point of the study is to identify lineages that persistently cause disease over longer periods than a normal outbreak. Pathogens evolve over time in their reservoirs, leading to greater SNP distances, and we wanted to allow for this. The U.S. CDC has acknowledged a similar concern for such persistent lineages in its definition of REP strains, which it has defined based on ranges of 13-104 allele differences by cgMLST. Thus, our choice of 30 core SNPs as the threshold is in line with current practice in the emerging science on persistence of enteric pathogens. We have also added a sensitivity analysis examining alternate SNP thresholds, shown in Suppl. Figure S5, which results in clusters of LPLs identified in the primary analysis being grouped into larger lineages. Additionally, in the tree showing our primary analysis (Figure 4), we now note the minimum number of SNPs all isolates within the lineage differ by.

      (3) Contained at least 1 cattle isolate: This criterion increases confidence that the lineage is indeed “local”. Unlike humans, cattle are not known to be routinely infected by imported food products, and they do not make roundtrip journeys to other locations, as humans infected during travel do. Cattle themselves may be imported into Alberta while infected, and cattle in Alberta can be infected by other imported animals. In these cases, if the STEC strains the cattle harbor persist for ≥1 year, they become the type of lineages we are interested in as LPLs, regardless where they previously came from, because they are now potential persistent sources of infection in Alberta. By including at least one cattle isolate in each LPL, the only way an identified LPL is not actually local is if cattle are imported from the lineage’s reservoir community elsewhere (e.g., in Japan, as the reviewer suggested), the lineage is persisting in that non-Alberta reservoir, and newly infected cattle are imported repeatedly over 1 or more years. This could feasibly explain G(vi)-AB LPL 5 (Figure 4), which is entirely composed of cattle. Indeed, such an explanation would be consistent with the lack of new cases from this LPL after 2015 in the extended analysis (Figure 5). However, for all other LPLs, which contain both cattle and human isolates, for the LPL to not be local, both cattle and human cases would have to be imported from the same non-Alberta reservoir. While this is possible, the probability of such a scenario is low, and it decreases the more isolates are in an LPL. For the average LPL, this means 4 human and 6 cattle cases would need to be imported from a non-Alberta reservoir over several years. Given that our study is only a random sample of the total STEC cases and cattle in Alberta from 2007-2015, these numbers are underestimates of the true absolute number of cases and cattle associated with LPLs that would have to be explained by importation if the LPL were not local. We have added some explanation of the possibility of importation in the Discussion where we discuss the LPL criteria (lines 376-380).

      (4) Contained ≥5 isolates: In concert with criterion 3, this criterion guards against anomalies being counted as LPLs. By requiring at least 5 isolates in an LPL after down-sampling, at least 5 infection events must have occurred from the LPL, reducing the likelihood of importation explaining the LPL and emphasizing more significant LPLs.

      (5) The isolates were collected at sampling events (for cattle) or reported (for humans) over a period of at least 1 year: This criterion defines the persistence aspect of the LPL. In the primary analysis, the LPLs we identified persisted for an average of 8 years, with the shortest persisting for 5 years (these details have been added to the text, lines 268-269). Incorporating the extended analysis, several LPLs persisted for the full 13 years of the study.

      Regarding using additional non-Alberta isolates to help rule out importation, we have expanded the number of U.S. and global isolates included in the importation analysis, over-sampling clade G isolates from the U.S. (Figure 7). As cattle trade is substantially more common with the U.S. than other countries, we felt it most important to focus on the U.S. as a potential source of both imported cattle and human cases. Our results from this analysis show that only 9 of 494 (1.8%) U.S. isolates occurred in the LPLs we defined in the primary analysis, and all occurred after Alberta isolates (lines 313-317). Although we also added more global isolates, we still found that none were associated with the Alberta LPLs.

      (6) Given the importance of sampling for a study like this, some more information on animal sampling studies should be included here.

      We have added details on the cattle sampling to the Methods (lines 95-101).

      (7) L172 - do you mean an MRCA with >- 95% probability of location in Alberta?

      Location in Alberta was not determined from the primary analysis, which defined the LPLs, as only Alberta isolates were included in that analysis. As described above, this criterion meant that we required at least 95% probability that the tree topology at the lineage’s MRCA was correct, and in practice the posterior probability of the lineages we defined as LPLs was 99.7-100%.

      (8) Need a supplementary figure of just clade G from Figure 2.

      We have added a sub-tree diagram of clade G(vi) as Figure 2b.

      Reviewer #2 (Public Review):

      This study identified multiple locally evolving lineages transmitted between cattle and humans persistently associated with E. coli O157:H7 illnesses for up to 13 years. Furthermore, this study mentions a dramatic shift in the local persistent lineages toward strains with the more virulent stx2a-only profile. The authors hypothesized that this phenomenon is the large proportion of disease associated with local transmission systems is a principal cause of Alberta's high E. coli O157:H7 incidence. These opinions more effectively explain the role of the cattle reservoir in the dynamics of E. coli O157:H7 human infections.

      (1) The authors acknowledge the possibility of intermediate hosts or environmental reservoirs playing a role in transmission. Further discussion on the potential roles of other animal species commonly found in Alberta (e.g., sheep, goats, swine) could enhance the understanding of the transmission dynamics. Were isolates from these species available for analysis? If not, the authors should clearly state this limitation.”

      We have expanded the discussion of other species in Alberta, as suggested, including other livestock, wildlife, and the potential role of birds and flies (lines 353-360). Unfortunately, we did not have sequences available from other species, which we have added to the limitations (lines 487-490).

      (2) The focus on E. coli O157:H7 is understandable given its prominence in Alberta and the availability of historical data. However, a brief discussion on the potential applicability of the findings to non-O157 STEC serogroups, and the limitations therein, would be beneficial. Are there reasons to believe the transmission dynamics would be similar or different for other serogroups?

      We appreciate this comment and have expanded our discussion of relevance to non-O157 STEC (lines 452-460). Other authors have proposed that transmission dynamics differ, and studies of STEC risk factors, including our own, support this. However, there has been very little direct study of non-O157 transmission dynamics and there is even less cross-species genomic and metadata available for non-O157 isolates of concern.

      (3) The authors briefly mention the need for elucidating local transmission systems to inform management strategies. A more detailed discussion on specific public health interventions that could be targeted at the identified LPLs and their potential reservoirs would strengthen the paper's impact.

      We agree with the reviewer that this would be a good addition to the manuscript. The public health implications for control are several and extend to non-STEC reportable zoonotic enteric infections, such as Campylobacter and Salmonella. We have added a discussion of these (lines 460-465, 467-485).

      (4) Understanding the relationship between specific risk factors and E. coli O157:H7 infections is essential for developing effective prevention strategies. Have case-control or cohort studies been conducted to assess the correlation between identified risk factors and the incidence of E. coli O157:H7 infections? What methodologies were employed to control for potential confounders in these studies?

      Yes, there have been several case-control studies of reported cases. Many of these are referenced in the discussion in terms of the contribution of different sources to infection. As risk factors were not the focus of the current study, we believe a thorough discussion of the literature on the aspects of these various studies is beyond our scope. However, we have added some details on the risk factors themselves (lines 72-79).

      (5) The study's findings are noteworthy, particularly in the context of E. coli O157:H7 epidemiology. However, the extent to which these results can be replicated across different temporal and geographical settings remains an open question. It would be constructive for the authors to provide additional data that demonstrate the replication of their sampling and sequencing experiments under varied conditions. This would address concerns regarding the specificity of the observed patterns to the initial study's parameters.

      We appreciate the reviewer’s comment, as we are currently building on this analysis with an American dataset with different types of data available than were used in this study. Aligned with this work, we have added a comment on the adaptation of our method to other settings with different types of data (lines 448-450). We also added a sensitivity analysis to the manuscript simulating a different sampling approach (Suppl. Fig. S3), which should be informative to this question.

      Reviewer #2 (Recommendations For The Authors):

      Minor comments.

      (1) Figure 1: The figure is a critical visual representation of the study's findings and should be given prominent emphasis. It is essential that the key discoveries of the research are clearly depicted and explained in this visual format. The authors should ensure that Figure 1 is detailed and informative enough to stand out as a central piece of the study.

      Figure 1 is the diagram of sample numbers, locations, and corresponding analyses. We assume that the reviewer means to refer to Figure 2. Although the inclusion of >1,200 isolates makes the tree difficult to see in detail, we have made some modifications to make the findings clearer. First, we changed the clade coloration such that the only subclade differentiated is G(vi). We have removed the stx metadata ring to focus attention on the location and species of the isolates, as stx data are described in Table 1. Finally, we have added a sub-tree diagram of clade G(vi), colored by location. This makes clear the large sections of the subclade dominated by isolates from one location or another, and the limited areas where they overlap.

      (2) Figures 2 and 4: While these figures contribute to the presentation of the data, they appear to be somewhat rudimentary in their current form. The lack of detailed annotations regarding the clustering of different strains is a notable omission. I recommend that the authors refine these figures to include comprehensive labeling that clearly delineates the various bacterial clusters. Enhanced graphical representation with clear annotations will aid readers in better understanding the study's findings.

      We appreciate this suggestion. We have remade all trees generated by the BEAST 2 analyses in R, rather than FigTree. This has allowed us to annotate the trees with additional information on the LPLs and we believe provides a clearer picture of each LPL.

      (3) Supplemental Table S1: The supplemental tables are an excellent opportunity to showcase additional data and findings that support the study's conclusions. For Supplemental Table S1, it is recommended that the authors highlight the innovative aspects or novel discoveries presented in this table.

      Suppl. Table S1 shows the modeling specifications and priors used in the analyses. These decisions were not in and of themselves novel. The innovation in our methods is due to the development of the LPLs based on the trees resulting from the analyses detailed in Suppl. Table S1, as well as from the application of these models to E. coli O157:H7 for the first time. However, we understand the reviewers point and have emphasized the importance of the results shown in Suppl. Table S2 (lines 391-395).

      (4) Line 35: "We assessed the role of persistent cross-species transmission systems in Alberta's E. coli O157:H7 epidemiology." change to "We assessed the impact of persistent cross-species transmission systems on the epidemiology of E. coli O157:H7 in Alberta."

      We have made this change.

      (5) To facilitate a deeper understanding of the core findings of the manuscript and to enable the development of effective response strategies, I suggest that the authors provide more information regarding the sequencing data used in the study. This information should at least include aspects such as data accessibility and quality control measures.

      We have included a Supplemental Data File that lists all isolates used in the analysis, and the QC measures are detailed in the Methods.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      Can a plastic RNN serve as a basis function for learning to estimate value. In previous work this was shown to be the case, with a similar architecture to that proposed here. The learning rule in previous work was back-prop with an objective function that was the TD error function (delta) squared. Such a learning rule is non-local as the changes in weights within the RNN, and from inputs to the RNN depends on the weights from the RNN to the output, which estimates value. This is non-local, and in addition, these weights themselves change over learning. The main idea in this paper is to examine if replacing the values of these non-local changing weights, used for credit assignment, with random fixed weights can still produce similar results to those obtained with complete bp. This random feedback approach is motivated by a similar approach used for deep feed-forward neural networks.

      This work shows that this random feedback in credit assignment performs well but is not as well as the precise gradient-based approach. When more constraints due to biological plausibility are imposed performance degrades. These results are not surprising given previous results on random feedback. This work is incomplete because the delay times used were only a few time steps, and it is not clear how well random feedback would operate with longer delays. Additionally, the examples simulated with a single cue and a single reward are overly simplistic and the field should move beyond these exceptionally simple examples.

      Strengths:

      • The authors show that random feedback can approximate well a model trained with detailed credit assignment.

      • The authors simulate several experiments including some with probabilistic reward schedules and show results similar to those obtained with detailed credit assignments as well as in experiments.

      • The paper examines the impact of more biologically realistic learning rules and the results are still quite similar to the detailed back-prop model.

      Weaknesses:

      • The authors also show that an untrained RNN does not perform as well as the trained RNN. However, they never explain what they mean by an untrained RNN. It should be clearly explained. These results are actually surprising. An untrained RNN with enough units and sufficiently large variance of recurrent weights can have a high-dimensionality and generate a complete or nearly complete basis, though not orthonormal (e.g: Rajan&Abbott 2006). It should be possible to use such a basis to learn this simple classical conditioning paradigm. It would be useful to measure the dimensionality of network dynamics, in both trained and untrained RNN's.

      Thank you for pointing out the lack of explanation about untrained RNN. Untrained RNN in our simulations (except Fig. 6D/6E-gray-dotted) was randomly initialized RNN (i.e., connection weights were drawn from a pseudo normal distribution) that was used as initial RNN for training of value-RNNs. As you suggested, the performance of untrained RNN indeed improved as the number of units increased (Fig. 2J), and its highest part was almost comparable to the highest performance of trained value-RNNs (Fig. 2I). In the revision we will show the dimensionality of network dynamics (as you have suggested), and eigenvalue spectrum of the network.

      • The impact of the article is limited by using a network with discrete time-steps, and only a small number of time steps from stimulus to reward. What is the length of each time step? If it's on the order of the membrane time constant, then a few time steps are only tens of ms. In the classical conditioning experiments typical delays are of the order to hundreds of milliseconds to seconds. Authors should test if random feedback weights work as well for larger time spans. This can be done by simply using a much larger number of time steps.

      Thank you for pointing out this important issue, for which our explanation was lacking and our examination was insufficient. We do not consider that single time step in our models corresponds to the neuronal membrane time constant. Rather, for the following reasons, we assume that the time step corresponds to several hundreds of milliseconds:

      - We assume that single RNN unit corresponds to a small neuron population that intrinsically (for genetic/developmental reasons) share inputs/outputs and are mutually connected via excitatory collaterals.

      - Cortical activity is suggested to be sustained not only by fast synaptic transmission and spiking but also, even predominantly, by slower synaptic neurochemical dynamics (Mongillo et al., 2008, Science "Synaptic Theory of Working Memory" https://www.science.org/doi/10.1126/science.1150769).

      - In line with such theoretical suggestion, previous research examining excitatory interactions between pyramidal cells, to which one of us (the corresponding author Morita) contributed by conducting model fitting (Morishima, Morita, Kubota, Kawaguchi, 2011, J Neurosci, https://www.jneurosci.org/content/31/28/10380), showed that mean recovery time constant from facilitation for recurrent excitation among one of the two types of cortico-striatal pyramidal cells was around 500 milliseconds.

      If single time step corresponds to 500 milliseconds, three time steps from cue to reward in our simulations correspond to 1.5 sec, which matches the delay in the conditioning task used in Schultz et al. 1997 Science. Nevertheless, as you pointed out, it is necessary to examine whether our random feedback models can work for longer delays, and we will examine it in our revision.

      • In the section with more biologically constrained learning rules, while the output weights are restricted to only be positive (as well as the random feedback weights), the recurrent weights and weights from input to RNN are still bi-polar and can change signs during learning. Why is the constraint imposed only on the output weights? It seems reasonable that the whole setup will fail if the recurrent weights were only positive as in such a case most neurons will have very similar dynamics, and the network dimensionality would be very low. However, it is possible that only negative weights might work. It is unclear to me how to justify that bipolar weights that change sign are appropriate for the recurrent connections and inappropriate for the output connections. On the other hand, an RNN with excitatory and inhibitory neurons in which weight signs do not change could possibly work.

      Our explanation and examination about this issue were insufficient, and thank you for pointing it out and giving us helpful suggestion. In the Discussion (Line 507-510) of the original manuscript, we described "Regarding the connectivity, in our models, recurrent/feed-forward connections could take both positive and negative values. This could be justified because there are both excitatory and inhibitory connections in the cortex and the net connection sign between two units can be positive or negative depending on whether excitation or inhibition exceeds the other." However, we admit that the meaning of this description was not clear, and more explicit modeling will be necessary as you suggested.

      Therefore in our revision, we will examine models, in which inhibitory units (modeling fast-spiking (FS) GABAergic cells) will be incorporated, and neuron will follow Dale’s law.

      • Like most papers in the field this work assumes a world composed of a single cue. In the real world there many more cues than rewards, some cues are not associated with any rewards, and some are associated with other rewards or even punishments. In the simplest case, it would be useful to show that this network could actually work if there are additional distractor cues that appear at random either before the CS, or between the CS and US. There are good reasons to believe such distractor cues will be fatal for an untrained RNN, but might work with a trained RNN, either using BPPT or random feedback. Although this assumption is a common flaw in most work in the field, we should no longer ignore these slightly more realistic scenarios.

      Thank you very much for this insightful comment. In our revision, we will examine situations where there exist not only reward-associated cue but also randomly appeared distractor cues.

      Reviewer #2 (Public review):

      Summary:

      Tsurumi et al. show that recurrent neural networks can learn state and value representations in simple reinforcement learning tasks when trained with random feedback weights. The traditional method of learning for recurrent network in such tasks (backpropagation through time) requires feedback weights which are a transposed copy of the feed-forward weights, a biologically implausible assumption. This manuscript builds on previous work regarding "random feedback alignment" and "value-RNNs", and extends them to a reinforcement learning context. The authors also demonstrate that certain non-negative constraints can enforce a "loose alignment" of feedback weights. The author's results suggest that random feedback may be a powerful tool of learning in biological networks, even in reinforcement learning tasks.

      Strengths:

      The authors describe well the issues regarding biologically plausible learning in recurrent networks and in reinforcement learning tasks. They take care to propose networks which might be implemented in biological systems and compare their proposed learning rules to those already existing in literature. Further, they use small networks on relatively simple tasks, which allows for easier intuition into the learning dynamics.

      Weaknesses:

      The principles discovered by the authors in these smaller networks are not applied to deeper networks or more complicated tasks, so it remains unclear to what degree these methods can scale up, or can be used more generally.

      In our revision, we will examine more biologically realistic models with excitatory and inhibitory units, as well as more complicated tasks with distractor cues. We will also consider whether/how the depth of networks can be increased, though we do not currently have concrete idea on this last point. Thank you also for giving us the detailed insightful 'recommendations for authors'. We will address also them in our revision.

      Reviewer #3 (Public review):

      Summary:

      The paper studies learning rules in a simple sigmoidal recurrent neural network setting. The recurrent network has a single layer of 10 to 40 units. It is first confirmed that feedback alignment (FA) can learn a value function in this setting. Then so-called bio-plausible constraints are added: (1) when value weights (readout) is non-negative, (2) when the activity is non-negative (normal sigmoid rather than downscaled between -0.5 and 0.5), (3) when the feedback weights are non-negative, (4) when the learning rule is revised to be monotic: the weights are not downregulated. In the simple task considered all four biological features do not appear to impair totally the learning.

      Strengths:

      (1) The learning rules are implemented in a low-level fashion of the form: (pre-synaptic-activity) x (post-synaptic-activity) x feedback x RPE. Which is therefore interpretable in terms of measurable quantities in the wet-lab.

      (2) I find that non-negative FA (FA with non negative c and w) is the most valuable theoretical insight of this paper: I understand why the alignment between w and c is automatically better at initialization.

      (3) The task choice is relevant since it connects with experimental settings of reward conditioning with possible plasticity measurements.

      Weaknesses:

      (4) The task is rather easy, so it's not clear that it really captures the computational gap that exists with FA (gradient-like learning) and simpler learning rule like a delta rule: RPE x (pre-synpatic) x (post-synaptic). To control if the task is not too trivial, I suggest adding a control where the vector c is constant c_i=1.

      Thank you for this insightful comment. We have realized that this is actually an issue that would need multilateral considerations. A previous study of one of us (Wärnberg & Kumar, 2023 PNAS) assumed that DA represents a vector error rather than a scalar RPE, and thus homogeneous DA was considered as negative control because it cannot represent vector error other than the direction of (1, 1, .., 1). In contrast, the present work assumed that DA represents a scalar RPE, and then homogeneous DA (i.e., constant feedback) would not be said as a failure mode because it can actually represent a scalar RPE and FA to the direction of (1, 1, .., 1) should in fact occur. And this FA to (1, 1, ..., 1) may actually be interesting because it means that if heterogeneity of DA inputs is not large and the feedback is not far from (1, 1, ..., 1), states are learned to be represented in such a way that simple summation of cortical neuronal activity approximates value, thereby potentially explaining why value is often correlated with regional activation (fMRI BOLD signal) of not only striatal but also cortical regions (which I have been considering as an unresolved mystery). But on the other hand, the case with constant feedback is the same as the simple delta rule, as you pointed out, and then what could be obtained from the present analyses would be that FA is actually occurring behind the successful operation of such a simple rule. Anyway we will make further examinations and considerations on this issue.

      (5) Related to point 3), the main strength of this paper is to draw potential connection with experimental data. It would be good to highlight more concretely the prediction of the theory for experimental findings. (Ideally, what should be observed with non-negative FA that is not expected with FA or a delta rule (constant global feedback) ?).

      In response to this insightful comment, we considered concrete predictions of our models. In the FA model, the feedback vector c and the value-weight vector w are initially at random (on average orthogonal) relationships and become gradually aligned, whereas in the non-negative model, the vectors c and w are loosely aligned from the beginning. We considered how the vectors c and w can be experimentally measured. Each element of the feedback vector c is multiplied with TD-RPE, modulating the degree of update in each pyramidal cell (more accurately, pyramidal cell population that corresponds to single RNN unit). Thus each element of c could be measured as the magnitude of response of each pyramidal cell to DA stimulation. The element of the value-weight vector w corresponding to a given pyramidal cell could be measured, if striatal neuron that receives input from that pyramidal cell can be identified (although technically demanding), as the magnitude of response of the striatal neuron to activation of the pyramidal cell.

      Then, the abovementioned predictions can be tested by (i) identify cortical, striatal, and VTA regions that are connected by meso-cortico-limbic pathway and cortico-striatal-VTA pathway, (ii) identify pairs of cortical pyramidal cells and striatal neurons that are connected, (iii) measure the responses of identified pyramidal cells to DA stimulation, as well as the responses of identified striatal neurons to activation of the connected pyramidal cells, and (iv) test whether the DA->pyramidal responses and the pyramidal->striatal responses are associated across pyramidal cells, and whether such associations develop through learning. We will elaborate this tentative idea, and also other ideas, in our revision.

      (6a) Random feedback with RNN in RL have been studied in the past, so it is maybe worth giving some insights how the results and the analyzes compare to this previous line of work (for instance in this paper [https://www.nature.com/articles/s41467-020-17236-y]). For instance, I am not very surprised that FA also works for value prediction with TD error. It is also expected from the literature that the RL + RNN + FA setting would scale to tasks that are more complex than the conditioning problem proposed here, so is there a more specific take-home message about non-negative FA? or benefits from this simpler toy task?

      In reply to this suggestion, we will explore how our results compare to the previous studies including the paper [https://www.nature.com/articles/s41467-020-17236-y], and explore benefits of our models. At preset, we think of one possible direction. According to our results (Fig. 6E), under the non-negativity constraint, the model with random feedback and monotonic plasticity rule (bioVRNNrf) performed better, on average, than the model with backprop and non-monotonic plasticity rule (revVRNNbp) when the number of units was large, though the difference in the performance was not drastic. We will explore reasons for this, and examine if this also applies to cases with more realistic models, e.g., having separate excitatory and inhibitory units (as suggested by other reviewer).

      (6b) Related to task complexity, it is not clear to me if non-negative value and feedback weights would generally scale to harder tasks. If the task in so simple that a global RPE signal is sufficient to learn (see 4 and 5), then it could be good to extend the task to find a substantial gap between: global RPE, non-negative FA, FA, BP. For a well chosen task, I expect to see a performance gap between any pair of these four learning rules. In the context of the present paper, this would be particularly interesting to study the failure mode of non-negative FA and the cases where it does perform as well as FA.

      In reply to this comment and also other reviewer's comment, we will examine the performance of the different models in more complex tasks, e.g., having distractor cues or longer delays. We will also see whether or not the better performance of bioVRNNrf than revVRNNbp mentioned in the previous point applies to the different tasks.

      (7) I find that the writing could be improved, it mostly feels more technical and difficult than it should. Here are some recommendations:

      (7a) for instance the technical description of the task (CSC) is not fully described and requires background knowledge from other paper which is not desirable.

      (7b) Also the rationale for the added difficulty with the stochastic reward and new state is not well explained.

      (7c) In the technical description of the results I find that the text dives into descriptive comments of the figures but high-level take home messages would be helpful to guide the reader. I got a bit lost, although I feel that there is probably a lot of depth in these paragraphs.

      Thank you for your helpful suggestions. We will thoroughly revise our writings.

      (8) Related to the writing issue and 5), I wished that "bio-plausibility" was not the only reason to study positive feedback and value weights. Is it possible to develop a bit more specifically what and why this positivity is interesting? Is there an expected finding with non-negative FA both in the model capability? or maybe there is a simpler and crisp take-home message to communicate the experimental predictions to the community would be useful?

      We will make considerations on whether/how the non-negative constraints could have any benefits other than biological plausibility, in particular, in theoretical aspects or applications using neuro-morphic hardware, while we will also elaborate the links to biology and concretize the model's predictions.

    1. Author response:

      Reviewer #1 (Evidence, reproducibility and clarity):

      This is an interesting manuscript where the authors systematically measure rG4 levels in brain samples at different ages of patients affected by AD. To the best of my knowledge this is the first time that BG4 staining is used in this context and the authors provide compelling evidence to show an association with BG4 staining and age or AD progression, which interestingly indicates that such RNA structure might play a role in regulating protein homeostasis as previously speculated. The methods used and the results reported seem robust and reproducible.

      In terms of the conclusions, however, I think that there are 2 main things that need addressing prior to publication:

      (1) Usually in BG4 staining experiments to ensure that the signal detected is genuinely due to rG4 an RNase treatment experiment is performed. This does not have to be extended to all the samples presented but having a couple of controls where the authors observe loss of staining upon RNase treatment will be key to ensure with confidence that rG4s are detected under the experimental conditions. This is particularly relevant for this brain tissue samples where BG4 staining has never been performed before.

      With what is now known about RNA rG4s and the recent reconciliation of the controversy on rG4 formation (Kharel, Nature Communications 2023), this experiment is no longer strictly required for demonstration of rG4 formation. Despite this change, we did attempt this experiment at the reviewer’s suggestion, but the controls were not successful, suggesting it may not be feasible with our fixing and staining conditions. That said, we agree that despite the G4 staining appearing primarily outside the nucleus, it would be helpful to have some direct indication of whether we were observing primarily RNA or DNA G4s, and so we performed an alternate experiment to determine this.

      In our previous submission, we had performed ribosomal RNA staining  (Figure S7), and the staining patterns were similar to that of BG4, especially the punctate pattern near the nuclei. Therefore, we directly asked whether the BG4 was largely binding to rRNA and have now shown the resulting co-stain in Figure 3b. These results show that at least a large amount of the BG4 staining does arise from rG4s in ribosomes. At high magnification, we observe that the BG4 stains a subset of the ribosomes, consistent with previous observations of high rG4 levels in ribosomes both in vitro and in cells (Mestre-Fos, 2019 J Mol Biol, Mestre-Fos 2019 PLoS One, Mestre-Fos 2020 J Biol Chem), but this had never been demonstrated in tissue. This experiment has therefore both answered the primary question of whether we are primarily observing rG4s, as well as provided more detailed information on the cellular sublocalization of rG4 formation, and provided the first evidence of rG4 formation on ribosomes in tissue.

      (2) The authors have an association between rG4-formation and age/disease progression. They also observe distribution dependency of this, which is great. However, this is still an association which does not allow the model to be supported. This is not something that can be fixed with an easy experiment and it is what it is, but my point is that the narrative of the manuscript should be more fair and reflect the fact that, although interesting, what the authors are observing is a simple correlation. They should still go ahead and propose a model for it, but they should be more balanced in the conclusion and do not imply that this evidence is sufficient to demonstrate the proposed model. It is absolutely fine to refer to the literature and comment on the fact that similar observations have been reported and this is in line with those, but still this is not an ultimate demonstration.

      We agree that these are correlative studies (of necessity when studying human tissue), but recent experiments have shown that rG4s affect the aggregation of Tau in vitro – and we have now better clarified this in the text itself. We have now also been more careful in drawing causative conclusions as shown in the revised text.

      Minor point:

      (3) rG4s themselves have been shown to generate aggregates in ALS models in the absence of any protein (Ragueso et al. Nat Commun 2023). I think this is also important in the light of my comment on the model, could well be that these rG4s are causing aggregates themselves that act as nucleation point for the proteins as reported in the paper I mentioned. Providing a broader and more unbiased view of the current literature on the topic would be fair, rather than focusing on reports more in line with the model proposed.

      We agree and have modified the discussion and added a broader context, including the Ragueso report described above.

      Reviewer #1 (Significance):

      This is a significant novel study, as per my comments above. I believe that such a study will be of impact in the G4 and neurodegenerative fields. Providing that the authors can address the criticisms above, I strongly believe that this manuscript would be of value to the scientific community. The main strength is the novelty of the study (never done before) the main weakness is the lack of the RNase control at the moment and the slightly over interpretation of the findings (see comments above).

      Reviewer #2 (Evidence, reproducibility and clarity):

      RNA guanine-rich G-quadruplexes (rG4s) are non-canonical higher order nucleic acid structures that can form under physiological conditions. Interestingly, cellular stress is positively correlated with rG4 induction.  In this study, the authors examined human hippocampal postmortem tissue for the formation ofrG4s in aging and Alzheimer Disease (AD). rG4 immunostaining strongly increased in the hippocampus with both age and with AD severity. 21 cases were used in this study (age range 30-92).  This immunostaining co-localized with hyper-phosphorylated tau immunostaining in neurons. The BG4 staining levels were also impacted by APOE status. rG4 structure was previously found to drive tau aggregation. Based on these observations, the authors propose a model of neurodegeneration in which chronic rG4 formation drives proteostasis collapse.

      This model is interesting, and would explain different observations (e.g., RNA is present in AD aggregates and rG4s can enhance protein oligomerization and tau aggregation).

      Main issue:

      There is indeed a positive correlation between Braak stage severity and BG4 staining, but this correlation is relatively weak and borderline significant ((R = 0.52, p value = 0.028). This is probably the main limitation of this study, which should be clearly acknowledged (together with a reminder that "correlation is not causality”.

      We believe that we had not explained this clearly enough in the text (based on the reviewer’s comment), as the correlation mentioned by the Reviewer was for the CA4 region only, and not the OML, which was substantially more correlated and statistically significant (Spearman R= 0.72, p = 0.00086). As a result, we believe this was a miscommunication that is rectified by the revised text:

      “In the OML, plotting BG4 percent area versus Braak stage demonstrated a strong correlation (Spearman R= 0.72) with highly significantly increased BG4 staining with higher Braak stages (p = 0.00086) (Fig. 2b).”

      Related to this, here is no clear justification to exclude the four individuals in Fig 1d (without them R increases to 0.78). Please remove this statement. On the other hand, the difference based on APOE status is more striking.

      We did not mean to imply that deleting these outliers was correct, but merely were demonstrating that they were in fact outliers. To avoid this misinterpretation, we have now deleted the sentence in the Figure 1d caption mentioning the outliers.

      Minor suggestions

      - "BG4 immunostaining was in many cases localized in the cytoplasm near the nucleus in a punctate pattern". Define "many"

      This is seen in nearly every cells and this is now altered in the text and is now identified as ribosomes containing rG4s using the rRNA antibody (Fig. 3b).

      - Specify that MABE917 corresponds to the specific single-chain version of the BG4 antibody

      Yes, this is correct, and this clarification has been added to the manuscript

      - Define PMI, Braak, CERAD (add a list of acronyms or insert these definitions in Fig 1b legend)

      These definitions have all been added when they first appear.

      - Fig 3: scale bar legend missing (50 micrometers?)

      This has been added, and the reviewer was correct that it was 50 micrometers.

      - Supplementary data Table 1: indicate target for all antibodies

      The target for each antibody has been added to supplementary Table 1.

      - Supplementary data Table 2: why give ages with different levels of precision? (e.g. 90.15 vs 63)

      We apologize for this oversight and have altered the ages to the same (whole years) in the figure.

      - Supplementary data Fig 1 X-axis legend: add "(nm)" after wavelength. Sequence can also be added in the legend. Why this one? Max/Min Wavelengths in the figure do not match indications in the experimental part. Not sure if that part is actually relevant for this study.

      The CD spectrum in Sup Fig 1 is the sequence that had previously been shown to aid in tau aggregation seeding, but had not been suspected by those authors to be a quadruplex. So we tested that here and showed it is a quadruplex, as described at the end of the introduction. We have added wording to the figure legend to clarify where its corresponding description in the main text can be found. We have also checked and corrected the wavelength and units.

      - Supplementary data Fig 7: Which ribosomal antibody was used?

      The details of this antibody have now been added to Supplementary Table 2 which lists all the antibodies used.

      Reviewer #2 (Significance):

      Provide a link between Alzheimer disease and RNA G-quadruplexes.

      Reviewer #3 (Evidence, reproducibility and clarity):

      This study investigated the formation of RNA G quadruplexes (rG4) in aging and AD in human hippocampal postmortem tissue. The rG4 immunostaining in the hippocampus increases strongly with age and with the severity of AD. Furthermore, rG4 is present in neurons with an accumulation of phosphorylated tau immunostaining.

      Major comments

      (1) The method used in this study is primarily immunostaining of BG4, and the results cannot be considered correct without additional data from more multifaceted analyses (biochemical analysis, RNA expression analysis, etc.).

      We respectfully disagree with the Reviewer’s assessment of the value of these experiments. The most relevant biochemical experiments at the cellular and molecular level showing the role of G4s in aggregation in general and Tau in particular have been done and are referenced in the text. The results here stand on their own and are highly novel and significant, as evaluated by both of the other reviewers. There has been no previous work demonstrating the presence of rG4s in human brain – either in controls or in patients with AD. AD is a complex condition that only occurs spontaneously in the human brain and no other species; because of this complexity, novel aspects are best first studied in human brain tissue using the methods employed here.

      (2) Overall, the quality of the stained images is poor, and detailed quantitative analysis using further high quality data is essential to conclude the authors' conclusions.

      We have again looked at our images and they are not poor quality -they are confocal images taken at recommended resolution of the confocal microscope. It is possible the poor quality came from pdf compression by the manuscript submission portal, which is beyond our control as they were uploaded at high resolution. These data were quantified by scientists who were blinded to the diagnosis of each case. The level of description on the detailed quantification is higher than we have observed in similar studies. We therefore disagree with the reviewer’s conclusion.

      Reviewer #3 (Significance):

      Overall, this study is not a deeply analyzed study. In addition, the authors of this study need further understanding regarding G4.

      It is also unclear why the reviewer believes that we do not have sufficient understanding of G4s, and would request that the reviewer instead provides specific comments regarding what is lacking in terms of knowledge on G4s, as we respectfully disagree with this judgement of our knowledge-base (see other G4 papers from the Horowitz lab, Begeman, 2020, Litberg 2023, Son, 2023 referenced below).

      Litberg TJ, Sannapureddi RKR, Huang Z, Son A, Sathyamoorthy B, Horowitz S. Why are G-quadruplexes good at preventing protein aggregation? Jan;20(1):495-509. doi: 10.1080/15476286.2023.2228572. RNA Biol. (2023)

      Son A, Huizar Cabral V, Huang Z, Litberg TJ, Horowitz S. G-quadruplexes rescuing protein folding. May 16;120(20):e2216308120. doi: 10.1073/pnas.2216308120. Proc Natl Acad Sci U S A (2023)

      Guzman BB, Son A, Litberg TJ, Huang Z, Dominguez , Horowitz S. Emerging Roles for G-Quadruplexes in Proteostasis FEBS J.doi: 10.1111/febs.16608. (2022)

      Begeman A, Son A, Litberg TJ, Wroblewski TH, Gehring T, Huizar Cabral V, Bourne J, Xuan Z, Horowitz S. G-Quadruplexes Act as Sequence Dependent Protein Chaperones. EMBO Reports Sep 18;e49735. doi: 10.15252/embr.201949735. (2020)

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The use of antalarmin, a selective CRF1 receptor antagonist, prevents the deficits in sociability in (acutely) morphine-treated males, but not in females. In addition, cell-attached experiments show a rescue to control levels of the morphine-induced increased firing in PVN neurons from morphine-treated males. Similar results are obtained in CRF receptor 1-/- male mice, confirming the involvement of CRF receptor 1-mediated signaling in both sociability deficits and neuronal firing changes in morphine-treated male mice.

      Strengths:

      The experiments and analyses appear to be performed to a high standard, and the manuscript is well written and the data clearly presented. The main finding, that CRF-receptor plays a role in sociability deficits occurring after acute morphine administration, is an important contribution to the field.

      Weaknesses:

      The link between the effect of pharmacological and genetic modulation of CRF 1 receptor on sociability and on PVN neuronal firing, is less well supported by the data presented. No evidence of causality is provided.

      Major points:

      (1) The results of behavioral tests and the neural substrate are purely correlative. To find causality would be important to selectively delete or re-express CRF1 receptor sequence in the VPN. Re-expressing the CRF1 receptor in the VPN of male mice and testing them for social behavior and for neuronal firing would be the easier step in this direction.

      We agree with this comment and have acknowledged that further studies, such as genetic or pharmacological inactivation of CRF<sub>1</sub> receptors selectively in the paraventricular nucleus of the hypothalamus (PVN), are warranted to address this issue (page 17, line 25 to page 18, line 1).

      We would also like to mention that our manuscript title intentionally presented our findings separately without implying causality. Our idea was simply to pair the behavioral data to neural activity within a network of interest, i.e., the PVN CRF-oxytocin (OXY)/arginine-vasopressin (AVP) network, which is thought to play a critical role at the interface of substance use disorders and social behavior. Accordingly, we previously reported that genetic CRF<sub>2</sub> receptor deficiency reliably eliminated sociability deficits and hypothalamic OXY and AVP expression induced by cocaine withdrawal (Morisot et al., 2018). Thus, the present manuscript reliably shows that CRF<sub>1</sub> receptor-mediated effects of acute morphine administration upon social behavior are consistently mirrored by neural activity changes within the PVN, and particularly within its OXY<sup>+</sup>/AVP<sup>+</sup> neuronal populations. In addition, we demonstrate that the latter effects are sex-linked, which is in line with previous reports of sex-biased CRF<sub>1</sub> receptor roles in rodents (Rosinger et al., 2019; Valentino et al., 2013) and humans (Roy et al., 2018; Weber et al., 2016).

      (2) It would be interesting to discuss the relationship between morphine dose and CRF1 receptor expression.

      We are not aware of studies reporting CRF<sub>1</sub> receptor expression following acute morphine administration. However, repeated heroin self-administration was shown to increase CRF<sub>1</sub> receptor expression in the ventral tegmental area (VTA). We have mentioned the latter study in the present revised version of our manuscript at page 18, lines 1-2.

      (3) It would be important to show the expression levels of CRF1 receptors in PVN neurons in controls and morphine-treated mice, both males and females.

      We agree with this reviewer comment and, in the present version of the manuscript, have mentioned that examination of CRF<sub>1</sub> receptor expression in the PVN might help to understand the brain mechanisms underlying morphine effects upon social behavior (page 18, lines 2-6). Moreover, at page 15, lines 11-19 we have mentioned studies showing higher levels of the CRF<sub>1</sub> receptor in the PVN of adult (2 months) and old (20-24 months) male mice, as compared to adult and old female mice (Rosinger et al., 2019). Thus, differences in PVN CRF<sub>1</sub> receptor expression between male and female mice might underlie the sex-linked effects of CRF<sub>1</sub> receptor antagonism by antalarmin reported in our manuscript.

      (4) It would be important to discuss the mechanisms by which CRF1 receptor controls the firing frequency of APV+/OXY+ neurons in the VPN of male mice.

      Using the in situ hybridization technique, studies reported relatively low expression of the CRF<sub>1</sub> receptor in the PVN (Van Pett et al., 2000). However, more recent studies using genetic approaches identified a substantial population of CRF<sub>1</sub> receptor-expressing neurons within the PVN (Jiang et al., 2019, 2018). These CRF<sub>1</sub> receptor-expressing neurons are believed to respond to local CRF release and likely form bidirectional connections with both CRF and OXY+/AVP+ neurons (Jiang et al., 2019, 2018). Thus, one proposed mechanism of action is that morphine increases intra-PVN release of CRF, which may act on intra-PVN CRF<sub>1</sub> receptor-expressing neurons. The latter neurons might in turn influence the activity of PVN OXY+/AVP+ neurons, which largely project to the VTA and the bed nucleus of the stria terminalis (BNST) to modulate social behavior. Within this framework, pharmacological or genetic inactivation of CRF<sub>1</sub> receptors might deregulate the activity of intra-PVN CRF-OXY/AVP interactions and thus interfere with opiate-induced social behavior deficits. In particular, the latter phenomenon might be more pronounced in male mice since they express more CRF<sub>1</sub> receptor-positive neurons in the PVN, as compared to female mice (Rosinger et al., 2019). The putative mechanisms of action described herein are also mentioned at page 16, lines 12 to page 17, line 7 of the present revised version of the manuscript.

      Minor points:

      (1) The phase of the estrous cycles in which females are analyzed for both behavior and electrophysiology should be stated.

      The normal estrous cycle of laboratory mice is 4-5 days in length, and it is divided into four phases (proestrus, estrus, metestrus and diestrus). The three-chamber experiments were generally carried out over a 5-day period, thus spanning across the entire estrous cycle. In particular, on each test day approximately the same number of mice was assigned to each experimental group. Thus, within each group the number of female mice tested on each phase of the estrous cycle was likely similar. Moreover, except for firing frequency displayed by vehicle/morphine-treated mice, female and male mice showed similar results variability, indicating a marginal role for the estrous cycle in the spread of data. We would also like to mention relatively recent studies indicating no significant difference over different phases of the estrous cycle in the social interaction test as well as in anxiety-like and anhedonia-like behavioral tests in C57BL/6J female mice (Zhao et al., 2021). Accordingly, similar findings were also reported by other authors who found no difference across the diestrus and estrus phases of the estrous cycle in C57BL/6J female mice tested in behavioral assays of anxiety-like, depression-like and social interaction (Zeng et al., 2023).

      A paragraph has been added to page 20, lines 1-9 of the present version of the manuscript to explain why we did not monitor the estrous cycle in female mice.

      (2) It would be important to show the statistical analysis between sexes.

      Following this reviewer comment, we examined the sociability ratio results by a three-way ANOVA with sex (males vs. females), pretreatment (vehicle vs. antalarmin) and treatment (saline vs. morphine) as between-subjects factors. The latter analysis revealed an almost significant sex X pretreatment X treatment interaction effect (F<sub>1,53</sub>=3.287, P=0.075), which could not allow for post-hoc individual group comparisons. Nevertheless, Newman-Keuls post-hoc comparisons revealed that male mice treated with antalarmin/morphine showed higher sociability ratio than female mice treated with antalarmin/morphine (P<0.05). The latter statistical results have been added to the present revised version of the manuscript at page 7, lines 2-8.

      We also examined neuronal firing frequency by a three-way ANOVA with sex (males vs. females), pretreatment (vehicle vs. antalarmin) and treatment (saline vs. morphine) as between-subjects factors. Analysis of firing frequency of all of the recorded cells in C57BL/6J mice revealed a sex X pretreatment X treatment interaction effect (F<sub>1,195</sub>=4.765, P<0.05). Newman-Keuls post-hoc individual group comparisons revealed that male mice treated with vehicle/morphine showed higher firing frequency than all other male and female groups (P<0.0005). Moreover, male mice treated with antalarmin/morphine showed lower firing frequency than male mice treated with vehicle/morphine (P<0.0005). In net contrast, female mice treated with antalarmin/morphine did not differ from female mice treated with vehicle/morphine (P=0.914). The latter statistical results have been added to the present revised version of the manuscript at page 8, lines 4-12. Finally, similar results were obtained following the three-way ANOVA (sex X pretreatment X treatment) of firing frequency recorded in the subset of neurons co-expressing OXY and AVP (data not shown).

      Thus, sex-linked responses to morphine were detected also by three-way ANOVAs including sex as a variable. However, in the revised version of the manuscript we did not include novel figures combining the two sexes because it would have been largely redundant with the figures already reported, especially with Fig. 1D, Fig. 1G, Fig. 2B and Fig. 2D.

      Reviewer #2 (Public review):

      This manuscript reports a series of studies that sought to identify a biological basis for morphine-induced social deficits. This goal has important translational implications and is, at present, incompletely understood in the field. The extant literature points to changes in periventricular CRF and oxytocin neurons as critical substrates for morphine to alter social behavior. The experiments utilize mice, administered morphine prior to a sociability assay. Both male and female mice show reduced sociability in this procedure. Pretreatment with the CRF1 receptor antagonist, antalarmin, clearly abolished the morphine effect in males, and the data are compelling. Consistently, CRF1-/- male mice appeared to be spared of the effect of morphine (while wild-type and het mice had reduced sociability). The same experiment was reported as non-feasible in females due to the effect of dose on exploratory behavior per se. Seeking a neural correlate of the behavioral pharmacology, acute cell-attached recordings of PVN neurons were made in acute slices from mice pretreated with morphine or anatalarmin. Morphine increased firing frequencies, and both antalarmin and CRF1-/- mice were spared of this effect. Increasing confidence that this is a CRF1 mediated effect, there is a gene deletion dose effect where het's had an intermediate response to morphine. In general, these experiments are well-designed and sufficiently powered to support the authors' inferences. A final experiment repeated the cell-attached recordings with later immunohistochemical verification of the recorded cells as oxytocin or vasopressin positive. Here the data are more nuanced. The majority of sampled cells were positive for both oxytocin and vasopressin, in cells obtained from males, morphine pretreatment increased firing in this population and was CRF1 dependent, however in females the effect of morphine was more modest without sensitivity to CRF1. Given that only ~8 cells were only immunoreactive for oxytocin, it may be premature to attribute the changes in behavior and physiology strictly to oxytocinergic neurons.

      In sum, the data provide convincing behavioral pharmacological evidence and a regional (and possibly cellular) correlation of these effects suggesting that morphine leads to sociality deficits via CRF interacting with oxytocin in the hypothalamus. While this hypothesis remains plausible, the current data do not go so far as directly testing this mechanism in a site or cell-specific way.

      We agree with this reviewer’s comment and acknowledge that further studies are needed to better understand the neural substrates of CRF<sub>1</sub> receptor-mediated sociability deficits induced by morphine. This has been mentioned at page 17, line 25 to page 18, line 6 of the present revised version of the manuscript.

      With regard to the presentation of these data and their interpretation, the manuscript does not sufficiently draw a clear link between mu-opioid receptors, their action on CRF neurons of the PVN, and the synaptic connectivity to oxytocin neurons. Importantly, sex, cell, and site-specific variations in the CRF are well established (see Valentino & Bangasser) yet these are not reviewed nor are hypotheses regarding sex differences articulated at the outset. The manuscript would have more impact on the field if the implications of the sex-specific effects evident here were incorporated into a larger literature.

      At page 15, line 19 to page 16, line 2 of the present version of the manuscript, we have mentioned prior studies reporting differences in CRF<sub>1</sub> receptor signaling or cellular compartmentalization between male and female rodents (Bangasser et al., 2013, 2010). However, the latter studies were conducted in cortical or locus coeruleus brain tissues. Thus, more studies are needed to examine CRF<sub>1</sub> receptor signaling or cellular compartmentalization in the PVN and their relationship to the sex-linked results reported in our manuscript.

      With regards to the model proposed in the discussion, it seems that there is an assumption that ip morphine or antalarmin have specific effects on the PVN and that these mediate behavior - but this is impossible to assume and there are many meaningful alternatives (for example, both MOR and CRF modulation of the raphe or accumbens are worth exploration).

      We focused our discussion on PVN OXY/AVP systems because ourelectrophysiology studies examined neurons expressing OXY and/or AVP in this brain area. However, we understand that other brain areas/systems might mediate the effect of systemic administration of the CRF<sub>1</sub> receptor antagonist antalarmin or whole-body genetic disruption of the CRF<sub>1</sub> receptor upon morphine-induced social behavior deficits. For this reason, at page 16, line 12 to page 17, line 7 of the present version of the manuscript we have mentioned the possible involvement of BNST OXY or VTA dopamine systems in the CRF<sub>1</sub> receptor-mediated social behavior effects of morphine reported herein. Indeed, literature suggests important CRF-OXY and CRF-dopamine interactions in the BNST and the VTA, which might be relevant to the expression of social behavior. Nevertheless, to date the implication of the latter brain systems interactions in social behavior alterations induced by substances of abuse remains to be elucidated.

      While it is up to the authors to conduct additional studies, a demonstration that the physiology findings are in fact specific to the PVN would greatly increase confidence that the pharmacology is localized here. Similarly, direct infusion of antalarmin to the PVN, or cell-specific manipulation of OT neurons (OT-cre mice with inhibitory dreadds) combined with morphine pre-exposure would really tie the correlative data together for a strong mechanistic interpretation.

      We agree with this reviewer’s comment that the suggested experiments would greatly increase the understanding of the brain mechanisms underlying the social behavior deficits induced by opiate substances. We have acknowledged this at page 17, line 25 to page 18, line 6.

      Because the work is framed as informing a clinical problem, the discussion might have increased impact if the authors describe how the acute effects of CRF1 antagonists and morphine might change as a result of repeated use or withdrawal.

      Prior studies reported behavioral and neuroendocrine (hypothalamus-pituitary-adrenal axis) effects of chronic systemic administration of CRF<sub>1</sub> receptor antagonists, such as R121919 and antalarmin (Ayala et al., 2004; Dong et al., 2018). However, to our knowledge, no studies have directly compared the behavioral effects of acute vs. repeated administration of CRF<sub>1</sub> receptor antagonists. We previously reported that acute administration of antalarmin increased the expression of somatic opiate withdrawal in mice, indicating that this compound is effective following withdrawal from repeated morphine administration (Papaleo et al., 2007). Nevertheless, further studies are needed to specifically address this reviewer’s comment.

      Reviewer #3 (Public review):

      Summary:

      In the current manuscript, Piccin et al. identify a role for CRF type 1 receptors in morphine-induced social deficits using a 3-chamber social interaction task in mice. They demonstrate that pre-treatment with a CRFR1 antagonist blocks morphine-induced social deficits in male, but not female, mice, and this is associated with the CRF R1 antagonist blocking morphine-induced increases in PVN neuronal excitability in male but not female mice. They followed up by using a transgenic mouse CRFR1 knockout mouse line. CRFR1 genetic deletion also blocked morphine-induced social deficits, similar to the pharmacological approach, in male mice. This was also associated with morphine-induced increases in PVN neuronal excitability being blocked in CRFR1 knockout mice. Interestingly they found that the pharmacological antagonism of the CRFR1 specifically blocked morphine-induced increases in oxytocin/AVP neurons in the PVN in male mice.

      Strengths:

      The authors used both male and female mice where possible and the studies were fairly well controlled. The authors provided sufficient methodological detail and detailed statistical information. They also examined measures of locomotion in all of the behavioral tasks to separate changes in sociability from overall changes in locomotion. The experiments were well thought out and well controlled. The use of both the pharmacological and genetic approaches provides converging lines of evidence for the role of CRFR1 in morphine-induced social deficits. Additionally, they have identified the PVN as a potential site of action for these CRFR1 effects.

      Weaknesses:

      While the authors included both sexes they analyzed them independently. This was done for simplicity's sake as they have multiple measures but there are several measures where the number of factors is reduced and the inclusion of sex as a factor would be possible.

      Please, see above our response to the same comment made by Reviewer 1.

      Additionally, single doses of both the CRFR1 antagonist and morphine are used within an experiment without justification for the doses. In fact, a lower dose of morphine was needed for the genetic CRFR1 mouse line. This would suggest that the dose of morphine being used is likely causing some aversion that may be more present in the females, as they have lower overall time in the ROI areas of both the object and the mouse following morphine exposure.

      The morphine dose was chosen based on our prior study showing that morphine (2.5 mg/kg) impaired sociability in male and female C57BL/6J mice, without affecting locomotor activity (Piccin et al., 2022). Also, the antalarmin dose (20 mg/kg) and the route of administration (per os) was chosen based on our prior studies demonstrating behavioral effects of this CRF<sub>1</sub> receptor antagonist administered per os (Contarino et al., 2017; Ingallinesi et al., 2012; Piccin and Contarino, 2020). This is now mentioned in the “materials and methods” section of the present revised version of the manuscript at page 23, lines 6-13. We also agree with this reviewer that female mice seemed more sensitive to morphine than male mice. Indeed, during the habituation phase of the three-chamber test female mice treated with morphine (2.5 mg/kg) spent less time in the ROIs containing the empty wire cages, as compared to saline-treated female mice (Fig. 1E). However, morphine did not affect locomotor activity in female mice (Fig. S1B), suggesting independency between social approach and ambulation.

      As for the discussion, the authors do not sufficiently address why CRFR1 has an effect in males but not females and what might be driving that difference, or why male and female mice have different distribution of PVN cell types during the recordings.

      At page 15, line 11 to page 16, line 2, we have mentioned possible mechanisms that might underlie the sex-linked results reported in our manuscript. Moreover, at page 16, lines 6-9 we have mentioned a seminal review reporting sex-linked expression of PVN OXY and AVP in a variety of animal species that is similar to the present results. Nevertheless, as mentioned in the “discussion” section, further studies are needed to elucidate the neural substrates underlying sex-linked effects of opiate substances upon social behavior.

      Additionally, the authors attribute their effect to CRF and CRFR1 within the PVN but do not consider the role of extrahypothalamic CRF and CRFR1. While the PVN does contain the largest density of CRF neurons there are other CRF neurons, notably in the central amygdala and BNST, that have been shown to play important roles in the impact of stress on drug-related behavior. This also holds true for the expression of CRFR1 in other regions of the brain, including the VTA, which is important for drug-related behavior and social behavior. The treatments used in the current manuscript were systemic or brain-wide deletion of CRFR1. Therefore, the authors should consider that the effects could be outside the PVN.

      Even if they suggest a role for PVN CRF<sub>1</sub>-OXY circuits, we are aware that the present data do not support a direct link between behavior and PVN CRF<sub>1</sub> receptors. Thus, at page 16, line 12 to page 17, line 7 of the present version of the manuscript we have mentioned some studies showing a role for PVN OXY, BNST OXY or VTA dopamine systems in social behavior. Interestingly, the latter brain systems are thought to interact with the CRF system. However, more studies are warranted to understand the implication of CRF-OXY or CRF-dopamine interactions in social behavior deficits induced by substances of abuse.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      I commend the authors on crafting a well-written and clear manuscript with excellent figures. Furthermore, the data analysis and rigor are quite high. I have a few suggestions in the order they appear in the manuscript:

      The introduction has a number of abrupt transitions. For example, the sentence beginning with "Besides," in paragraph 2 jumps from CRF to oxytocin and vasopressin without a transition or justification. In all, vasopressin may be better removed from the introduction. There is sufficient evidence in the literature to support the CRF-OT circuit that might mediate behavioral pharmacology and this should be clearly described in the introduction.

      We have added a sentence at page 3, lines 22-23 to introduce possible interactions of the CRF system with other brain systems implicated in social behavior. Also, in the “introduction” section both OXY and AVP systems are mentioned because our electrophysiology studies examined the effect of morphine upon the activity of OXY- and AVP-positive neurons.

      Our interest in the PVN CRF-OXY/AVP network also stems from previous findings from our laboratory showing that genetic inactivation of the CRF<sub>2</sub> receptor eliminated both sociability deficits and increased hypothalamic OXY and AVP expression associated with long-term cocaine withdrawal in male mice (Morisot et al., 2018). Moreover, evidence suggests the implication of AVP systems in opiate effects. In particular, pharmacological antagonism of AVP-V1b receptors decreased the acquisition of morphine-induced conditioned place preference in male C57BL/6N mice housed with morphine-treated mice (Bates et al., 2018).

      Throughout the manuscript, it seems that there is an assumption that ip morphine or antalarmin have specific effects on the PVN and that these mediate behavior - this is impossible to assume and there are many meaningful alternatives (for example, both MOR and CRF modulation of the raphe or accumbens are worth exploration). While it is up to the authors to conduct additional studies, a demonstration that the physiology findings are in fact specific to the PVN would greatly increase confidence that the pharmacology is localized here. Similarly, direct infusion of antalarmin to the PVN, or cell-specific manipulation of OT neurons (OT-cre mice with inhibitory dreadds) combined with morphine pre-exposure would really tie the correlative data together for a strong mechanistic interpretation.

      We agree that the suggested experiments would greatly increase the understanding of the brain mechanisms underlying the social behavior deficits induced by opiate substances. This has been acknowledged at page 17, line 25 to page 18, line 6 of the present version of the manuscript.

      Also in the introduction, the reference to shank3b mice is not the most direct evidence of oxytocin involvement in sociability. It may be helpful to point reviewers to studies with direct manipulation of these populations (Grinevich group, for example).

      At page 4, lines 4-6 of the “introduction” section, we have added a sentence to mention a seminal paper by the Grinevich group demonstrating an important role for OXY-expressing PVN parvocellular neurons in social behavior (Tang et al., 2020). Moreover, at page 4, lines 8-10 we have mentioned a recent study showing that targeted chemogenetic silencing of PVN OXY neurons in male rats impaired short- and long-term social recognition memory (Thirtamara Rajamani et al., 2024).

      It would be helpful in the figures to indicate which panels contain male or female data.

      The sex of the mice is mentioned above each panel of the main and supplemental figures, except for the studies with CRF<sub>1</sub> receptor-deficient mice wherein only experiments carried out with male mice were illustrated. In the latter case, the sex (male) of the mice is mentioned in the related legend.

      The discussion itself departs from the central data in a few ways - the passages suggesting that morphine produces a stress response and that CRF1 antagonists would block the stress state are highly speculative (although testable). The manuscript would have more impact if the sex-specific effects and alternative hypotheses were enhanced in the discussion.

      At page 16, line 12 to page 17, line 7 of the “discussion” section, we have suggested that interaction of the CRF system with other brain systems implicated in social behavior (i.e., OXY, dopamine) might underlie the sex-linked CR<sub>1</sub> receptor-mediated effects of morphine reported in our manuscript. Also, at page 15, line 19 to page 16, line 2 we have mentioned studies showing sex-linked CRF<sub>1</sub> receptor signaling and cellular compartmentalization that might be relevant to the present findings. Finally, to further support the notion of morphine-induced PVN CRF activity, at page 15, lines 4-6 we have mentioned a study suggesting that activation of presynaptic mu-opioid receptors located on PVN GABA terminals might reduce GABA release (and related inhibitory effects) onto PVN CRF neurons (Wamsteeker Cusulin et al., 2013). Nevertheless, we believe that more work is needed to better understand the role for the CRF<sub>1</sub> receptor in opiate-induced stress responses and activity of OXY and dopamine systems implicated in social behavior.

      Reviewer #3 (Recommendations for the authors):

      (1) You should provide justification for the doses selected for treatments and the route of administration for the CRFR1 antagonist, especially for females.

      This has been added at page 23, lines 6-13 of the present version of the manuscript. In particular, the doses and routes of administration for morphine and antalarmin used in the present study were chosen based on previous work from our laboratory. Indeed, the intraperitoneal administration of morphine (2.5 mg/kg) impaired social behavior in male and female mice, without affecting locomotor activity (Piccin et al., 2022). Moreover, the oral route of administration for antalarmin was chosen for its translational relevance, as it could be easily employed in clinical trials assessing the therapeutic value of pharmacological CRF<sub>1</sub> receptor antagonists.

      (2) For the electrophysiology data you should include the number of cells per animal that were obtained. It appears that fewer cells from more females were obtained than in males and so the distribution of individual animals to the overall variance may be different between males and females.

      The number of cells examined and animals used in the electrophysiology experiments are reported above each panel of the related Figures 2, 3 and 4 as well as in the supplementary tables S1B and S1C. Overall, the number of cells examined in male and female mice was quite similar. Also, the number of male and female mice used was comparable. Standard errors of the mean (SEM) were quite similar across the different male and female groups (Fig. 2B and 2D), except for vehicle/morphine-treated male mice. Indeed, in the latter group a considerable number of cells displayed elevated firing responses to morphine, which accounted for the higher spread of the data. Accordingly, as mentioned above, the three-way ANOVA with sex (males vs. females), pretreatment (vehicle vs. antalarmin) and treatment (saline vs. morphine) as between-subjects factors revealed that male mice treated with vehicle/morphine showed higher firing frequency than all other male and female groups (P<0.0005). Finally, a similar pattern of firing frequency was observed also in neurons co-expressing OXY and AVP, wherein vehicle/morphine-treated male mice displayed higher SEM, as compared to all other male and female groups (Fig. 4C and 4F). Thus, except for vehicle/morphine-treated mice, distribution of the firing frequency data did not seem to be linked to the sex of the animal.

      (3) You should consider using a nested analysis for the slice electrophysiology data as that is more appropriate.

      We thank the reviewer for this suggestion. However, after careful consideration, we have decided to keep the current statistical analyses. In particular, given the relatively low variability of our data, we believe that the use of parametric ANOVA tests is appropriate. Moreover, additional details supporting our choice are provided just above in our response to the comment #2.

      (4) While it makes sense to not want to directly compare male and female data that results in needing to run a 4-way ANOVA, there are many measures, such as sociability, firing rate, etc., that if including sex as a factor would result in running a 3-way ANOVA and would allow for direct comparison of male and female mice.

      Please, see above our response to the same comment made by Reviewer 1. Notably, the results of our new statistical analyses including sex as a variable further support sex-linked effects of the CRF<sub>1</sub> receptor antagonist antalarmin upon morphine-induced sociability deficits and PVN neuronal firing. Nevertheless, we would like to keep the figures illustrating our findings as they are since it easily allows detecting the observed sex-linked results. Finally, we hope that this reviewer agrees with our choice, which is consistent with the wording of the title (i.e., “in male mice”).

      (5) There are grammatical and phrasing issues throughout the manuscript and the manuscript would benefit from additional thorough editing.

      We appreciate this reviewer’s feedback. Thus, upon revising, we have carefully edited the manuscript with regard to possible grammatical and phrasing errors. We hope that our changes have made the manuscript clearer in order to facilitate readability by the audience.

      (6) The discussion should be edited to include consideration of an explanation for the presence of the effect in male, but not female, mice more clearly. The discussion should also include some discussion as to why the distribution of cell types used in the electrophysiology recordings was different between males and females and whether the distribution of CRFR1 is different between males and females. Lastly, the authors need to include consideration of extrahypothalamic CRF and CRFR1 as a possible explanation for their effects. While they have PVN neuron recordings, the treatments that they used are brain-wide and therefore the possibility that the critical actions of CRFR1 could be outside the PVN.

      At page 15, line 11 to page 16, line 2 of the “discussion” section, we have suggested several mechanisms that might underlie the sex-linked behavioral and brain effects of CR<sub>1</sub> receptor antagonism reported in our manuscript. With regard to the distribution of cell types examined in the electrophysiology studies, at page 16, lines 6-9 we have mentioned a seminal review reporting sex-linked expression of PVN OXY and AVP in a variety of animal species that is similar to our results. Moreover, at page 18, lines 2-6 we mentioned that more studies are needed to examine PVN CRF<sub>1</sub> receptor expression in male and female animals, an issue that is still poorly understood. Finally, at page 16, line 12 to page 17, line 7 of the “discussion” section we also suggest that CRF<sub>1</sub> receptor-expressing brain areas other than the PVN, such as the BNST or the VTA, might contribute to the sex-linked effects of morphine reported in our manuscript. Thus, in agreement with this reviewer’s suggestion, in the present version of the manuscript we have further emphasized the possible implication of CRF<sub>1</sub> receptor-expressing extrahypothalamic brain areas in social behavior deficits induced by opiate substances.

      References

      Ayala AR, Pushkas J, Higley JD, Ronsaville D, Gold PW, Chrousos GP, Pacak K, Calis KA, Gerald M, Lindell S, Rice KC, Cizza G. 2004. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm. J Clin Endocrinol Metab 89:5729–5737. doi:10.1210/jc.2003-032170

      Bangasser DA, Curtis A, Reyes B a. S, Bethea TT, Parastatidis I, Ischiropoulos H, Van Bockstaele EJ, Valentino RJ. 2010. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol Psychiatry 15:877, 896–904. doi:10.1038/mp.2010.66

      Bangasser DA, Reyes B a. S, Piel D, Garachh V, Zhang X-Y, Plona ZM, Van Bockstaele EJ, Beck SG, Valentino RJ. 2013. Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol Psychiatry 18:166–173. doi:10.1038/mp.2012.24

      Bates MLS, Hofford RS, Emery MA, Wellman PJ, Eitan S. 2018. The role of the vasopressin system and dopamine D1 receptors in the effects of social housing condition on morphine reward. Drug Alcohol Depend 188:113–118. doi:10.1016/j.drugalcdep.2018.03.021

      Contarino A, Kitchener P, Vallée M, Papaleo F, Piazza P-V. 2017. CRF1 receptor-deficiency increases cocaine reward. Neuropharmacology 117:41–48. doi:10.1016/j.neuropharm.2017.01.024

      Dong H, Keegan JM, Hong E, Gallardo C, Montalvo-Ortiz J, Wang B, Rice KC, Csernansky J. 2018. Corticotrophin releasing factor receptor 1 antagonists prevent chronic stress-induced behavioral changes and synapse loss in aged rats. Psychoneuroendocrinology 90:92–101. doi:10.1016/j.psyneuen.2018.02.013

      Ingallinesi M, Rouibi K, Le Moine C, Papaleo F, Contarino A. 2012. CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping. Mol Psychiatry 17:1283–1294. doi:10.1038/mp.2011.119

      Jiang Z, Rajamanickam S, Justice NJ. 2019. CRF signaling between neurons in the paraventricular nucleus of the hypothalamus (PVN) coordinates stress responses. Neurobiol Stress 11:100192. doi:10.1016/j.ynstr.2019.100192

      Jiang Z, Rajamanickam S, Justice NJ. 2018. Local Corticotropin-Releasing Factor Signaling in the Hypothalamic Paraventricular Nucleus. J Neurosci 38:1874–1890. doi:10.1523/JNEUROSCI.1492-17.2017

      Morisot N, Monier R, Le Moine C, Millan MJ, Contarino A. 2018. Corticotropin-releasing factor receptor 2-deficiency eliminates social behaviour deficits and vulnerability induced by cocaine. Br J Pharmacol 175:1504–1518. doi:10.1111/bph.14159

      Papaleo F, Kitchener P, Contarino A. 2007. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron 53:577–589. doi:10.1016/j.neuron.2007.01.022

      Piccin A, Contarino A. 2020. Sex-linked roles of the CRF1 and the CRF2 receptor in social behavior. J Neurosci Res 98:1561–1574. doi:10.1002/jnr.24629

      Piccin A, Courtand G, Contarino A. 2022. Morphine reduces the interest for natural rewards. Psychopharmacology (Berl) 239:2407–2419. doi:10.1007/s00213-022-06131-7

      Rosinger ZJ, Jacobskind JS, De Guzman RM, Justice NJ, Zuloaga DG. 2019. A sexually dimorphic distribution of corticotropin-releasing factor receptor 1 in the paraventricular hypothalamus. Neuroscience 409:195–203. doi:10.1016/j.neuroscience.2019.04.045

      Roy A, Laas K, Kurrikoff T, Reif A, Veidebaum T, Lesch K-P, Harro J. 2018. Family environment interacts with CRHR1 rs17689918 to predict mental health and behavioral outcomes. Prog Neuropsychopharmacol Biol Psychiatry 86:45–51. doi:10.1016/j.pnpbp.2018.05.004

      Tang Y, Benusiglio D, Lefevre A, Hilfiger L, Althammer F, Bludau A, Hagiwara D, Baudon A, Darbon P, Schimmer J, Kirchner MK, Roy RK, Wang S, Eliava M, Wagner S, Oberhuber M, Conzelmann KK, Schwarz M, Stern JE, Leng G, Neumann ID, Charlet A, Grinevich V. 2020. Social touch promotes interfemale communication via activation of parvocellular oxytocin neurons. Nat Neurosci 23:1125–1137. doi:10.1038/s41593-020-0674-y

      Thirtamara Rajamani K, Barbier M, Lefevre A, Niblo K, Cordero N, Netser S, Grinevich V, Wagner S, Harony-Nicolas H. 2024. Oxytocin activity in the paraventricular and supramammillary nuclei of the hypothalamus is essential for social recognition memory in rats. Mol Psychiatry 29:412–424. doi:10.1038/s41380-023-02336-0

      Valentino RJ, Van Bockstaele E, Bangasser D. 2013. Sex-specific cell signaling: the corticotropin-releasing factor receptor model. Trends Pharmacol Sci 34:437–444. doi:10.1016/j.tips.2013.06.004

      Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. 2000. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428:191–212. doi:10.1002/1096-9861(20001211)428:2<191::aid-cne1>3.0.co;2-u

      Wamsteeker Cusulin JI, Füzesi T, Inoue W, Bains JS. 2013. Glucocorticoid feedback uncovers retrograde opioid signaling at hypothalamic synapses. Nat Neurosci 16:596–604. doi:10.1038/nn.3374

      Weber H, Richter J, Straube B, Lueken U, Domschke K, Schartner C, Klauke B, Baumann C, Pané-Farré C, Jacob CP, Scholz C-J, Zwanzger P, Lang T, Fehm L, Jansen A, Konrad C, Fydrich T, Wittmann A, Pfleiderer B, Ströhle A, Gerlach AL, Alpers GW, Arolt V, Pauli P, Wittchen H-U, Kent L, Hamm A, Kircher T, Deckert J, Reif A. 2016. Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing. Mol Psychiatry 21:813–822. doi:10.1038/mp.2015.125

      Zeng P-Y, Tsai Y-H, Lee C-L, Ma Y-K, Kuo T-H. 2023. Minimal influence of estrous cycle on studies of female mouse behaviors. Front Mol Neurosci 16:1146109. doi:10.3389/fnmol.2023.1146109

      Zhao W, Li Q, Ma Y, Wang Z, Fan B, Zhai X, Hu M, Wang Q, Zhang M, Zhang C, Qin Y, Sha S, Gan Z, Ye F, Xia Y, Zhang G, Yang L, Zou S, Xu Z, Xia S, Yu Y, Abdul M, Yang J-X, Cao J-L, Zhou F, Zhang H. 2021. Behaviors Related to Psychiatric Disorders and Pain Perception in C57BL/6J Mice During Different Phases of Estrous Cycle. Front Neurosci 15:650793. doi:10.3389/fnins.2021.650793

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public review):

      Comment 1: This manuscript from Clayton and co-authors, entitled ”Mechanism of dimer selectivity and binding cooperativity of BRAF inhibitors”, aims to clarify the molecular mechanism of BRAF dimer selectivity. Indeed, first-generation BRAF inhibitors, targeting monomeric BRAFV600E, are ineffective in treating resistant dimeric BRAF isoforms. Here, the authors employed molecular dynamics simulations to study the conformational dynamics of monomeric and dimeric BRAF, in the presence and absence of inhibitors. Multi-microsecond MD simulations showed an inward shift of the αC helix in the BRAFV600E mutant dimer. This helped in identifying a hydrogen bond between the inhibitors and the BRAF residue Glu501 as critical for dimer compatibility. The stability of the aforementioned interaction seems to be important to distinguish between dimer-selective and equipotent inhibitors.

      The study is overall valuable and robust. The authors used the recently developed particle mesh Ewald constant pH molecular dynamics, a state-of-the-art method, to investigate the correct histidine protonation considering the dynamics of the protein. Then, multi-microsecond simulations showed differences in the flexibility of the αC helix and DFG motif. The dimerization restricts the αC position in the inward conformation, in agreement with the result that dimer-compatible inhibitors can stabilize the αC-in state. Noteworthy, the MD simulations were used to study the interactions between the inhibitors and the protein, suggesting a critical role for a hydrogen bond with Glu501. Finally, simulations of a mixed state of BRAF (one protomer bound to the inhibitor and the other apo) indicate that the ability to stabilize the inward αC state of the apo protomer could be at the basis of the positive cooperativity of PHI1.

      We thank the reviewer for the positive evaluation of our work.

      Comment 2a: Regarding the analyses of the mixed state simulations, the DFG dihedral probability densities for the apo protomer (Fig. 5a right) are highly overlapping. It is not convincing that a slight shift can support the conclusion that the binding in one protomer is enough to shift the DFG motif outward allosterically. Moreover, the DFG dihedral time-series for the apo protomer (Supplementary Figure 9) clearly shows that the measured quantities are affected by significant fluctuations and poor consistency between the three replicates. The apo protomer of the mixed state simulations could be affected by the same problem that the authors pointed out in the case of the apo dimer simulations, where the amount of sampling is insufficient to model the DFG-out/-in transition properly.

      While the reviewer is correct there are large fluctuations in the DFG pseudo dihedral over the course of the apo simulations, these fluctuations occur primarily in the first 2 µs of the simulations, which were removed from our analysis. The reviewer is also correct that these simulations do not sufficiently model the DFG-out/-in transition; however, a full transition is not necessary for our analysis, as we are only interested in the shift of the DFG pseudo dihedral. As to the reviewer’s comment on the overlapping DFG distributions, we agree that the difference is very subtle. We revised the text.

      On page 9, second paragraph from the bottom:

      “While PHI1 or LY binding clearly perturbs the αC helix of the opposite apo protomer, the effect on the DFG conformation is less clear when comparing the DFG dihedral distribution of the the apo protomer in the PHI1 or LY-mixed dimer with that of the apo dimer (blue, orange, and grey, Figure 5a right). All three distributions are broad, covering a range of 160-330°. It appears that, relative to the apo dimer, the DFG of the apo protomer in the PHI1-mixed dimer is slightly shifted to the right, whereas that of the LY-mixed dimer is slightly shifted to the left; however, these differences are very subtle and warrant further investigation in future studies.”

      Comment 2b: There is similar concern with the Lys483-Glu501 salt bridge measured for the apo protomers of the mixed simulations. As it can be observed from the probabilities bar plot (Fig. 5a middle), the standard deviation is too high to support a significant role for this interaction in the allosteric modulation of the apo protomer.

      As for the salt bridge, the fluctuation in the apo dimer and LY-mixed dimer is indeed large, and together with the lower average probability suggests that the salt bridge is weaker, which is consistent with the αC helix moving outward. To clarify this, we revised the text.

      On page 9, second paragraph from the bottom:

      “Consistent with the inward shift of the αC helix, the Glu501–Lys483 salt bridge has a lower average probability and a larger fluctuation in the apo dimer and the apo protomer of the LY-mixed dimer, as compared to the apo protomer of the PHI1-mixed dimer.”

      Reviewer #2 (Public review):

      Comment 1: The authors employ molecular dynamics simulations to understand the selectivity of FDA approved inhibitors within dimeric and monomeric BRAF species. Through these comprehensive simulations, they shed light on the selectivity of BRAF inhibitors by delineating the main structural changes occurring during dimerization and inhibitor action. Notably, they identify the two pivotal elements in this process: the movement and conformational changes involving the alpha-C helix and the formation of a hydrogen bond involving the Glu-501 residue. These findings find support in the analyses of various structures crystallized from dimers and co-crystallized monomers in the presence of inhibitors. The elucidation of this mechanism holds significant potential for advancing our understanding of kinase signalling and the development of future BRAF inhibitor drugs.

      The authors employ a diverse array of computational techniques to characterize the binding sites and interactions between inhibitors and the active site of BRAF in both dimeric and monomeric forms. They combine traditional and advanced molecular dynamics simulation techniques such as CpHMD (all-atom continuous constant pH molecular dynamics) to provide mechanistic explanations. Additionally, the paper introduces methods for identifying and characterizing the formation of the hydrogen bond involving the Glu501 residue without the need for extensive molecular dynamics simulations. This approach facilitates the rapid identification of future BRAF inhibitor candidates.

      We thank the reviewer for the positive evaluation of our work.

      Comment 2: Despite the use of molecular dynamics yields crucial structural insights and outlines a mechanism to elucidate dimer selectivity and cooperativity in these systems, the authors could consider adoption of free energy methods to estimate the values of hydrogen bond energies and hydrophobic interactions, thereby enhancing the depth of their analysis.

      As mentioned in our previous response, current free energy methods are capable of giving accurate estimates of the relative binding free energies of similar ligands; however, accurate calculations of the absolute free energies of hydrogen bond and hydrophobic interactions are not feasible yet. Thus, we decided not to pursue the calculations.

      Reviewer #1 (Recommendations to author):

      Comment 1: It would be useful to cite all supplementary figures in the main text (where relevant). In the present version, only Supplementary Figures 2,3, and 4 are cited in the main text.

      This was an oversight; supplementary figures 5 through 9 are now cited in the text, to point to the time-series of the quantity discussed. We note that supplementary figures 10 and 11 show the time-series of the root mean squared deviation (RMSD) of each protomer in both all monomeric and dimeric simulations; these quantities are not discussed in the manuscript but are provided for further insight.

      Comment 2: It is unclear whether the present data could support a direct involvement of the DFG movement in the allosteric mechanism proposed. The same argument applies to the Lys483Glu501 interaction in the apo protomer of the mixed state simulations. The current simulation data could only support a different stabilization of the αC-helix position. The authors should either remove/tone down the claim or extend the simulations to sample a ”converged” distribution of the DFG dihedral and the Lys483-Glu501 salt bridge of the apo protomers.

      We agree that the DFG change in the apo protomer of the PH1-mixed dimer is very subtle (see our response and revision to comment 2); however, the allosteric involvement of DFG is clearly demonstrated in Figure 5 (right panel in 5a and 5b). We compare three states: apo protomer in the mixed dimer, PHI1-bound protomer in the mixed dimer, and holo dimer (i.e., with two PHI1) Binding of the first PHI1 restricts the DFG conformation to the larger DFG dihedrals (blue curves in the top and bottom right panels). This effect (DFG outward and more restricted) is even strong when the second PHI1 binds, locking the DFG in both protomers to a narrow dihedral range 270–330 degree (green and blue curves in Figure 5b, right panel). These are allosteric effects, demonstrating that the second PH1 binding induces conformational change of the DFG in the first protomer. This is why in Figure 6, the DFG of the PHI1-bound protomer in the mixed dimer is labeled as “almost out”, while the DFG in the holo dimer is labeled as “fully out”.

      The effect of second PHI1 on the DFG of the first protomer is consistent with that the αC helix position, in which case, the second PH1 induces an inward movement of the αC of the first protomer (illustrated as “fully in” in the schematic Figure 6). Through the aC movement, the salt-bridge strength is affected, as we discussed in our response and revision to Reviewer’s comment 2a. To clarify these points, we revised the discussion of Figure 5. We made the x axis range of the DFG dihedral distributions the same between the top and bottom panels in Figure 5. To remove the claim of priming effect on DFG, we revised Figure 6.

      Page 10, Figure 5:

      we made the x axis range of the DFG dihedral distributions on the top and bottom panels the same to facilitate comparison.

      Page 11, second and third paragraphs:

      “Consistent with the change in the DFG conformation between the holo (two inhibitor) and apo dimers (Figure 3c,3f), DFG is rigidified upon binding of the first inhibitor, as evident from the narrower DFG dihedral distribution of the PHI1 or LY-bound protomer in the mixed protomer (Figure 5b right) compared to the apo protomer in the mixed dimer (Figure 5a right). Importantly, the DFG dihedral is right shifted in the occupied vs. apo protomer, demonstrating that the inhibitor pushes the DFG outward.”

      “Consistent with the effect of the second PHI1 on the αC position of the first PHI1-bound protomer, binding of the second PHI1 shifts the peak of the DFG distribution for both protomers further outward, as shown by the 30° larger DFG pseudo dihedral in the holo dimer relative to the mixed dimer (green and blue in Figure 5b right; Supplementary Figures 6,9). In contrast, there is no significant difference in the DFG pseudo dihedral between the LY-mixed and holo dimers. These data suggest that while the binding of the first PHI1 pushes the DFG outward, binding of the second PHI1 has an allosteric effect, shifting the DFG of the opposite protomer further outward.”

      On page 12, the last paragraph of Conclusion, we remove the claim of the priming effect for DFG:

      “The first PHI1 binding in the BRAF<sup>V600E</sup> dimer restricts the motion of the αC helix and DFG, shifting them slightly inward and outward, respectively (Figure 6, bottom right panel). Intriguingly, the first PHI1 binding primes the apo protomer by making the αC more favorable for binding, i.e., shifting the αC inward (Figure 6, bottom right panel). Importantly, upon binding the second PHI1, the αC helix is shifted further inward and the DFG is shifted further outward in both protomers.”

      On page 13, Figure 6:

      we removed the label “slightly outward” for DFG.

      Comment 3: An alternative approach could be using enhanced sampling methods to enhance the diffusion along these coordinates.

      We thank the reviewer for bringing up this point. While that the allostery and cooperativity effects are apparent from our simulation data, we agree that enhanced sampling methods in principle could be used to further converge the conformational sampling; however, these approaches face significant challenges. First, BRAF dimer is weakly associated, with αC helix forming a part of the dimer interface. Enhanced sampling of αC helix would likely result in dimer dissociation. On the other hand, simply using RMSD as a reaction coordinate or progress variable would not necessarily enhance the motion of αC helix or DFG or activation loop, which are all coupled. Second, our extensive simulations of a monomer kinase with metadynamics demonstrated that the kinase conformation becomes distorted when a biasing potential is placed to enhance the motion of DFG. This is likely because the other parts of the protein do not have enough time to relax to accommodate the conformational change. To our knowledge, this aspect has not been discussed in the current metadynamics literature, which focuses on the free energy differences and (local) conformational changes along the reaction coordinate. To clarify these points, we added a discussion.

      Page 6, end of the first paragraph:

      “We note that enhanced sampling methods were not used due to several challenges. First, the BRAF dimer is weakly associated, with αC helix forming a part of the dimer interface (Figure 1a). Enhanced sampling (particularly of αC helix) would likely lead to dimer dissociation. Second, biased sampling methods such as metadynamics may lead to unrealistic conformational states due to the slow relaxation of some parts of the protein to accommodate the conformational change directed by the reaction coordinate. For example, our unpublished metadynamics simulations of a monomer kinase showed that enhancing the DFG conformational change resulted in distortion of the kinase structure.”

      We thank the reviewers again for their valuable comments. We believe our revision has further elevated the quality of the manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public review):

      Summary:

      The authors test the "OHC-fluid-pump" hypothesis by assaying the rates of kainic acid dispersal both in quiet and in cochleae stimulated by sounds of different levels and spectral content. The main result is that sound (and thus, presumably, OHC contractions and expansions) result in faster transport along the duct. OHC involvement is corroborated using salicylate, which yielded results similar to silence. Especially interesting is the fact that some stimuli (e.g., tones) seem to provide better/faster pumping than others (e.g., noise), ostensibly due to the phase profile of the resulting cochlear traveling-wave response.

      Strengths:

      The experiments appear well controlled and the results are novel and interesting. Some elegant cochlear modeling that includes coupling between the organ of Corti and the surrounding fluid as well as advective flow supports the proposed mechanism.

      The current limitations and future directions of the study, including possible experimental tests, extensions of the modeling work, and practical applications to drug delivery, are thoughtfully discussed.

      Weaknesses:

      Although the authors provide compelling evidence that OHC motility can usefully pump fluid, their claim (last sentence of the Abstract) that wideband OHC motility (i.e., motility in the "tail" region of the traveling wave) evolved for the purposes of circulating fluid---rather then emerging, say, as a happy by-product of OHC motility that evolved for other reasons---seems too strong.

      We adjusted our tone to be less assertive.

      Our measurements and simulations coherently suggest that active outer hair cells in the tail region of cochlear traveling waves drive cochlear fluid circulation.

      Reviewer #2 (Public review):

      Although recent cochlear micromechanical measurements in living animals have shown that outer hair cells drive broadband vibration of the reticular lamina, the role of this vibration in cochlear fluid circulation remains unknown. The authors hypothesized that motile outer hair cells may facilitate cochlear fluid circulation. To test this hypothesis, they investigated the effects of acoustic stimuli and salicylate, an outer hair cell motility blocker, on kainic acid-induced changes in the cochlear nucleus activities. The results demonstrated that acoustic stimuli reduced the latency of the kainic acid effect, with low-frequency tones being more effective than broadband noise. Salicylate reduced the effect of acoustic stimuli on kainic acid-induced changes. The authors also developed a computational model to provide a physical framework for interpreting experimental results. Their combined experimental and simulated results indicate that broadband outer hair cell action serves to drive cochlear fluid circulation.

      The major strengths of this study lie in its high significance and the synergistic use of electrophysiological recording of the cochlear nucleus responses alongside computational modeling. Cochlear outer hair cells have long been believed to be responsible for the exceptional sensitivity, sharp tuning, and huge dynamic range of mammalian hearing. However, recent observations of the broadband reticular lamina vibration contradict widely accepted view of frequency-specific cochlear amplification. Furthermore, there is currently no effective noninvasive method to deliver the drugs or genes to the cochlea, a crucial need for treating sensorineural hearing loss, one of the most common auditory disorders. This study addresses these important questions by observing outer hair cells' roles in the cochlear transport of kainic acid. The well-established electrophysiological method used to record cochlear nucleus responses produced valuable new data, and the custom-developed developed computational model greatly enhanced the interpretation of the experimental results.

      The authors successfully tested their hypothesis, with both the experimental and modeling results supporting the conclusion that active outer hair cells can enhance cochlear fluid circulation in the living cochlea.

      The findings from this study can potentially be applied for treating sensorineural hearing loss and advance our understanding of how outer hair cells contribute to cochlear amplification and normal hearing.

      Reviewer #3 (Public review):

      Summary:

      This study reveals that sound exposure enhances drug delivery to the cochlea through the nonselective action of outer hair cells. The efficiency of sound-facilitated drug delivery is reduced when outer hair cell motility is inhibited. Additionally, low-frequency tones were found to be more effective than broadband noise for targeting substances to the cochlear apex. Computational model simulations support these findings.

      Strengths:

      The study provides compelling evidence that the broad action of outer hair cells is crucial for cochlear fluid circulation, offering a novel perspective on their function beyond frequency-selective amplification. Furthermore, these results could offer potential strategies for targeting and optimizing drug delivery throughout the cochlear spiral.

      Weaknesses:

      The primary weakness of this paper lies in the surgical procedure used for drug administration through the round window. Opening the cochlea can alter intracochlear pressure and disrupt the traveling wave from sound, a key factor influencing outer hair cell activity. However, the authors do not provide sufficient details on how they managed this issue during surgery. Additionally, the introduction section needs further development to better explain the background and emphasize the significance of the work.

      Comments on revisions:

      Thank you for addressing the comments and concerns. The author has responded to all points thoroughly and clarified them well. However, please include the key points from the responses to the comments (Introduction ((3), (5)) and Results ((5)) into the manuscript. While the explanations in the response letter are reasonable, the current descriptions in the manuscript may limit the reader's understanding. Expanding on these points in the Introduction, Results, or Discussion sections would enhance clarity and comprehensiveness.

      Introduction (3): As inner-ear fluid homeostasis is maintained locally, longitudinal electro-chemical gradients, including the endocochlear potential, may vary along the cochlear length (Schulte and Schmiedt 1992; Sadanaga and Morimitsu 1995; Hirose and Liberman 2003).

      Introduction (5): We do not want to distract the readers from the primary message by discussing different drug delivery methods into the inner ear. This paper is regarding active outer hair cells’ new role as the title suggests. An extensive discussion of drug delivery can confuse the theme of this work.

      Results (5): High frequencies were not tested because they would not affect drug delivery to the apex of the cochlea (i.e., the traveling waves stop near the CF location.)

    1. Author response:

      We thank the three anonymous reviewers who took the time to read and evaluate our work. We look forward to submitting a revised version of  the manuscript that addresses their comments. 

      We agree with the reviewers that missing genes and incomplete genome assemblies can be challenges when trying to make interspecies comparisons in a complex and repetitive region like the MHC. Our revised manuscript will include more discussion of this topic, and we look forward to future work on this region that considers the next generation of complete telomere-to-telomere genomes with long-read sequencing.

      Repeating this analysis with other gene families—immune and non-immune—is a great idea. While outside of the scope of this work, this will provide many opportunities for comparison and help tease apart the features that make this family unique.

      We also point readers to our companion paper, Ancient Trans-Species Polymorphism at the Major Histocompatibility Complex in Primates, which tackles different (but related) questions about long-term balancing selection in the primate MHC and also summarizes relevant past work in the area. This second paper addresses some questions raised by reviewers here.

    1. Author response:

      Reviewer #1 (Public review):

      The authors present their new bioinformatic tool called TEKRABber, and use it to correlate expression between KRAB ZNFs and TEs across different brain tissues, and across species. While the aims of the authors are clear and there would be significant interest from other researchers in the field for a program that can do such correlative gene expression analysis across individual genomes and species, the presented approach and work display significant shortcomings. In the current state of the analysis pipeline, the biases and shortcomings mentioned below, for which I have seen no proof that they are accounted for by the authors, are severely impacting the presented results and conclusions. It is therefore essential that the points below are addressed, involving significant changes in the TEKRABber program as well as the analysis pipeline, to prevent the identification of false positive and negative signals, that would severely affect the conclusions one can raise about the analysis.

      Thank you very much for the insightful review of our manuscript.

      My main concerns are provided below:

      (1) One important shortcoming of the biocomputational approach is that most TEs are not actually expressed, and others (Alus) are not a proxy of the activity of the TE class at all. I will explain: While specific TE classes can act as (species-specific) promoters for genes (such as LTRs) or are expressed as TE derived transcripts (LINEs, SVAs), the majority of other older TE classes do not have such behavior and are either neutral to the genome or may have some enhancer activity (as mapped in the program they refer to 'TEffectR'. A big focus is on Alus, but Alus contribute to a transcriptome in a different way too: They often become part of transcripts due to alternative splicing. As such, the presence of Alu derived transcripts is not a proxy for the expression/activity of the Alu class, but rather a result of some Alus being part of gene transcripts (see also next point). The bottom line is that the TEKRABber software/approach is heavily prone to picking up both false positives (TEs being part of transcribed loci) and false negatives (TEs not producing any transcripts at all), which has a big implication for how reads from TEs as done in this study should be interpreted: The TE expression used to correlate the KRAB ZNF expression is simply not representing the species-specific influences of TEs where the authors are after.

      With the strategy as described, a lot of TE expression is misinterpreted: TEs can be part of gene-derived transcripts due to alternative splicing (often happens for Alus) or as a result of the TE being present in an inefficiently spliced out intron (happens a lot) which leads to TE-derived reads as a result of that TE being part of that intron, rather than that TE being actively expressed. As a result, the data as analysed is not reliably indicating the expression of TEs (as the authors intend to) and should be filtered for any reads that are coming from the above scenarios: These reads have nothing to do with KRAB ZNF control, and are not representing actively expressed TEs and therefore should be removed. Given that from my lab's experience in the brain (and other) tissues, the proportion of RNA sequencing reads that are actually derived from active TEs is a stark minority compared to reads derived from TEs that happen to be in any of the many transcribed loci, applying this filtering is expected to have a huge impact on the results and conclusions of this study.

      We sincerely thank the reviewer for highlighting the potential issues of false positives and negatives in TE quantification. The reviewer provided valuable examples of how different TE classes, such as Alus, LTRs, LINEs, and SVAs, exhibit distinct behaviors in the genome. To our knowledge, specific tools like ERVmap (Tokuyama et al., 2018), which annotates ERVs, and LtrDetector (Joseph et al., 2019), which uses k-mer distributions to quantify LTRs, could indeed enhance precision by treating specific TE classes individually. We acknowledge that such approaches may yield more accurate results and appreciate the suggestion.

      In our study, we used TEtranscripts (Jin et al., 2015) prior to TEKRABber. TEtranscripts applies the Expectation Maximization (EM) algorithm to assign ambiguous reads as the following steps. Uniquely mapped reads are first assigned to genes, and reads overlapping genes and TEs are assigned to TEs only if they do not uniquely match an annotated gene. The remaining ambiguous reads are distributed based on EM iterations. While this approach may not be as specialized as the latest tools for specific TE classes, it provides a general overview of TE activity. TEtranscripts outputs subfamily-level TE expression data, which we used as input for TEKRABber to perform downstream analyses such as differential expression and correlation studies.

      We understand the importance of adapting tools to specific research objectives, including focusing on particular TE classes. TEKRABber is designed not to refine TE quantification at the mapping stage but to flexibly handle outputs from various TE quantification tools. It accepts raw TE counts as input in the form of dataframes, enabling diverse analytical pipelines. In the revised version of our manuscript, we will emphasize this distinction in the discussion and provide examples of how TEKRABber can integrate with other tools to enhance specificity and accuracy.

      (2) Another potential problem that I don't see addressed is that due to the high level of similarity of the many hundreds of KRAB ZNF genes in primates and the reads derived from them, and the inaccurate annotations of many KZNFs in non-human genomes, the expression data derived from RNA-seq datasets cannot be simply used to plot KZNF expression values, without significant work and manual curation to safeguard proper cross species ortholog-annotation: The work of Thomas and Schneider (2011) has studied this in great detail but genome-assemblies of non-human primates tend to be highly inaccurate in appointing the right ortholog of human ZNF genes. The problem becomes even bigger when RNA-sequencing reads are analyzed: RNA-sequencing reads from a human ZNF that emerged in great apes by duplication from an older parental gene (we have a decent number of those in the human genome) may be mapped to that older parental gene in Macaque genome: So, the expression of human-specific ZNF-B, that derived from the parental ZNF-A, is likely to be compared in their DESeq to the expression of ZNF-A in Macaque RNA-seq data. In other words, without a significant amount of manual curation, the DE-seq analysis is prone to lead to false comparisons which make the strategy and KRABber software approach described highly biased and unreliable.

      There is no doubt that there are differences in expression and activity of KRAB-ZNFs and TEs respectively that may have had important evolutionary consequences. However, because all of the network analyses in this paper rely on the analyses of RNA-seq data and the processing through the TE-KRABber software with the shortcomings and potential biases that I mentioned above, I need to emphasize that the results and conclusions are likely to be significantly different if the appropriate measures are taken to get more accurate and curated TE and KRAB ZNF expression data.

      We thank the reviewer for raising the important issue of accurately annotating the expanded repertoire of KRAB-ZNFs in primates, particularly the challenges of cross-species orthology and potential biases in RNA-seq data analysis. Indeed, we have also addressed this challenge in some of our previous papers (Nowick et al., 2010, Nowick et al., 2011 and Jovanovic et al., 2021).

      In the revised manuscript, we will include more details about our two-step strategy to ensure accurate KRAB-ZNF ortholog assignments. First, we employed the Gene Order Conservation (GOC) score from Ensembl BioMart as a primary filter, selecting only one-to-one orthologs with a GOC score above 75% across primates. This threshold, recommended in Ensembl’s ortholog quality control guidelines, ensures high-confidence orthology relationships, (http://www.ensembl.org/info/genome/compara/Ortholog_qc_manual.html#goc).

      Second, we incorporated data from Jovanovic et al. (2021), which independently validated KRAB-ZNF orthologs across 27 primate genomes. This additional layer of validation allowed us to refine our dataset, resulting in the identification of 337 orthologous KRAB-ZNFs for differential expression analysis (Figure S2).

      We acknowledge that different annotation methods or criteria may for some genes yield variations in the identified orthologs. However, we believe that this combination provides a robust starting point for addressing the challenges raised, while we remain open to additional refinements in future analyses.

      (3) The association with certain variations in ZNF genes with neurological disorders such as AD, as reported in the introduction is not entirely convincing without further functional support. Such associations could merely happen by chance, given the high number of ZNF genes in the human genome and the high chance that variations in these loci happen to associate with certain disease-associated traits. So using these associations as an argument that changes in TEs and KRAB ZNF networks are important for diseases like AD should be used with much more caution.

      There are a number of papers where KRAB ZNF and TE expression are analysed in parallel in human brain tissues. So the novelty of that aspect of the presented study may be limited.

      We fully acknowledge the concern that, given the large number of KRAB-ZNFs and their inherent variability, some associations with AD or other neurological disorders could occur by chance. This highlights the importance of additional functional studies to validate the causal role of KRAB-ZNF and TE interactions in disease contexts. While previous studies have indeed analyzed KRAB-ZNF and TE expression in human brain tissues, our study seeks to expand on this foundation by incorporating interspecies comparisons across primates. This approach enabled us to identify TE:KRAB-ZNF pairs that are uniquely present in healthy human brains, which may provide insights into their potential evolutionary significance and relevance to diseases like AD.

      In addition to analyzing RNA-seq data (GSE127898 and syn5550404), we have cross-validated our findings using ChIP-exo data for 159 KRAB-ZNF proteins and their TE binding regions in human (Imbeault et al., 2017). This allowed us to identify specific binding events between KRAB-ZNF and TE pairs, providing further support for the observed associations. We agree with the reviewer that additional experimental validations, such as functional studies, are critical to further establish the role of KRAB-ZNF and TE networks in AD. We hope that future research can build upon our findings to explore these associations in greater detail.

      Reviewer #2 (Public review):

      Summary:

      The aim was to decipher the regulatory networks of KRAB-ZNFs and TEs that have changed during human brain evolution and in Alzheimer's disease.

      Strengths:

      This solid study presents a valuable analysis and successfully confirms previous assumptions, but also goes beyond the current state of the art.

      Weaknesses:

      The design of the analysis needs to be slightly modified and a more in-depth analysis of the positive correlation cases would be beneficial. Some of the conclusions need to be reinterpreted.

      We sincerely thank the reviewer for the thoughtful summary, positive evaluation of our study, and constructive feedback. We appreciate the recognition of the strengths in our analysis and the valuable suggestions for improving its design and interpretation.

      We would like to briefly comment on the suggested modifications to the design here, and will provide a detailed point-by-point review later with our revised manuscript.

      The reviewer recommended considering a more recent timepoint, such as less than 25 million years ago (mya), to define the "evolutionary young group" of KRAB-ZNF genes and TEs when discussing the arms-race theory. This is indeed a valuable perspective, as the TE repressing functions by KRAB-ZNF proteins may have evolved more recently than the split between Old World Monkeys (OWM) and New World Monkeys (NWM) at 44.2 mya we used.

      Our rationale for selecting 44.2 mya is based on certain primate-specific TEs such as the Alu subfamilies, which emerged after the rise of Simiiformes and have been used in phylogenetic studies (Xing et al., 2007 and Williams et al., 2010). This timeframe allowed us to investigate the potential co-evolution of KRAB-ZNFs and TEs in species that emerged after the OWM-NWM split (e.g., human, chimpanzee, bonobos, and macaques used for this study). However, focusing only on KRAB-ZNFs and TEs younger than 25 million years would limit the analysis to just 9 KRAB-ZNFs and 92 TEs expressed in our datasets. While we will not conduct a reanalysis using this more recent timepoint, we will integrate the recommendation into the discussion section of the revised manuscript.

      Furthermore, we greatly appreciate the reviewer's detailed insights and suggestions for refining specific descriptions and interpretations in our manuscript. We will address these points in the revised version to ensure the content is presented with greater precision and clarity.

      Once again, we thank both reviewers for their valuable feedback, which provides significant input for strengthening our study.

    1. Author response:

      eLife Assessment

      This study provides useful insights into the ways in which germinal center B cell metabolism, particularly lipid metabolism, affects cellular responses. The authors use sophisticated mouse models to demonstrate that ether lipids are relevant for B cell homeostasis and efficient humoral responses. Although the data were collected from in vitro and in vivo experiments and analyzed using solid and validated methodology, more careful experiments and extensive revision of the manuscript will be required to strengthen the authors' conclusions.

      In addition to praise for the eLife system and transparency (public posting of the reviews; along with an opportunity to address them), we are grateful for the decision of the Editors to select this submission for in-depth peer review and to the referees for the thoughtful and constructive comments.

      In overview, we mostly agree with the specific comments and evaluation of strengths of what the work adds as well as with indications of limitations and caveats that apply to the breadth of conclusions. One can view these as a combination of weaknesses, of instances of reading more into the work than what it says, and of important future directions opened up by the findings we report. Regarding the positives, we appreciate the reviewers' appraisal that our work unveils a novel mechanism in which the peroxisomal enzyme PexRAP mediates B cell intrinsic ether lipid synthesis and promotes a humoral immune response. We are gratified by a recognition that a main contribution of the work is to show that a spatial lipidomic analysis can set the stage for discovery of new molecular processes in biology that are supported by using 2-dimensional imaging mass spectrometry techniques and cell type specific conditional knockout mouse models.

      By and large, the technical issues are items we will strive to improve. Ultimately, an over-arching issue in research publications in this epoch are the questions "when is enough enough?" and "what, or how much, advance will be broadly important in moving biological and biomedical research forward?" It appears that one limitation troubling the reviews centers on whether the mechanism of increased ROS and multi-modal death - supported most by the in vitro evidence - applies to germinal center B cells in situ, versus either a mechanism for decreased GC that mostly applies to the pre-GC clonal amplification (or recruitment into GC). Overall, we agree that this leap could benefit from additional evidence - but as resources ended we instead leave that question for the future other than the findings with S1pr2-CreERT2-driven deletion leading to less GC B cells. While we strove to be very careful in framing such a connection as an inference in the posted manuscript, we will revisit the matter via rechecking the wording when revising the text after trying to get some specific evidence.  

      In the more granular part of this provisional response (below), we will outline our plan prompted by the reviewers but also comment on a few points of disagreement or refinement (longer and more detailed explanation). The plan includes more detailed analysis of B cell compartments, surface level of immunoglobulin, Tfh cell population, a refinement of GC B cell markers, and the ex vivo GC B cell analysis for ROS, proliferation, and cell death. We will also edit the text to provide more detailed information and clarify our interpretation to prevent the confusion of our results.  At a practical level, some evidence likely is technologically impractical, and an unfortunate determinant is the lack of further sponsored funding for further work. The detailed point-by-point response to the reviewer’s comments is below.  

      Public Reviews:

      Reviewer #1 (Public review):

      In this manuscript, Sung Hoon Cho et al. presents a novel investigation into the role of PexRAP, an intermediary in ether lipid biosynthesis, in B cell function, particularly during the Germinal Center (GC) reaction. The authors profile lipid composition in activated B cells both in vitro and in vivo, revealing the significance of PexRAP. Using a combination of animal models and imaging mass spectrometry, they demonstrate that PexRAP is specifically required in B cells. They further establish that its activity is critical upon antigen encounter, shaping B cell survival during the GC reaction.

      Mechanistically, they show that ether lipid synthesis is necessary to modulate reactive oxygen species (ROS) levels and prevent membrane peroxidation.

      Highlights of the Manuscript:

      The authors perform exhaustive imaging mass spectrometry (IMS) analyses of B cells, including GC B cells, to explore ether lipid metabolism during the humoral response. This approach is particularly noteworthy given the challenge of limited cell availability in GC reactions, which often hampers metabolomic studies. IMS proves to be a valuable tool in overcoming this limitation, allowing detailed exploration of GC metabolism.

      The data presented is highly relevant, especially in light of recent studies suggesting a pivotal role for lipid metabolism in GC B cells. While these studies primarily focus on mitochondrial function, this manuscript uniquely investigates peroxisomes, which are linked to mitochondria and contribute to fatty acid oxidation (FAO). By extending the study of lipid metabolism beyond mitochondria to include peroxisomes, the authors add a critical dimension to our understanding of B cell biology.

      Additionally, the metabolic plasticity of B cells poses challenges for studying metabolism, as genetic deletions from the beginning of B cell development often result in compensatory adaptations. To address this, the authors employ an acute loss-of-function approach using two conditional, cell-type-specific gene inactivation mouse models: one targeting B cells after the establishment of a pre-immune B cell population (Dhrs7b^f/f, huCD20-CreERT2) and the other during the GC reaction (Dhrs7b^f/f; S1pr2-CreERT2). This strategy is elegant and well-suited to studying the role of metabolism in B cell activation.

      Overall, this manuscript is a significant contribution to the field, providing robust evidence for the fundamental role of lipid metabolism during the GC reaction and unveiling a novel function for peroxisomes in B cells.

      We appreciate these positive reactions and response, and agree with the overview and summary of the paper's approaches and strengths.

      However, several major points need to be addressed:

      Major Comments:

      Figures 1 and 2

      The authors conclude, based on the results from these two figures, that PexRAP promotes the homeostatic maintenance and proliferation of B cells. In this section, the authors first use a tamoxifen-inducible full Dhrs7b knockout (KO) and afterwards Dhrs7bΔ/Δ-B model to specifically characterize the role of this molecule in B cells. They characterize the B and T cell compartments using flow cytometry (FACS) and examine the establishment of the GC reaction using FACS and immunofluorescence. They conclude that B cell numbers are reduced, and the GC reaction is defective upon stimulation, showing a reduction in the total percentage of GC cells, particularly in the light zone (LZ).

      The analysis of the steady-state B cell compartment should also be improved. This includes a more detailed characterization of MZ and B1 populations, given the role of lipid metabolism and lipid peroxidation in these subtypes.

      Suggestions for Improvement:

      B Cell compartment characterization: A deeper characterization of the B cell compartment in non-immunized mice is needed, including analysis of Marginal Zone (MZ) maturation and a more detailed examination of the B1 compartment. This is especially important given the role of specific lipid metabolism in these cell types. The phenotyping of the B cell compartment should also include an analysis of immunoglobulin levels on the membrane, considering the impact of lipids on membrane composition.

      Although the manuscript is focused on post-ontogenic B cell regulation in Ab responses, we believe we will be able to polish a revised manuscript through addition of results of analyses suggested by this point in the review: measurement of surface IgM on and phenotyping of various B cell subsets, including MZB and B1 B cells, to extend the data in Supplemental Fig 1H and I. Depending on the level of support, new immunization experiments to score Tfh and analyze a few of their functional molecules as part of a B cell paper may be feasible.  

      - GC Response Analysis Upon Immunization: The GC response characterization should include additional data on the T cell compartment, specifically the presence and function of Tfh cells. In Fig. 1H, the distribution of the LZ appears strikingly different. However, the authors have not addressed this in the text. A more thorough characterization of centroblasts and centrocytes using CXCR4 and CD86 markers is needed.

      The gating strategy used to characterize GC cells (GL7+CD95+ in IgD− cells) is suboptimal. A more robust analysis of GC cells should be performed in total B220+CD138− cells.

      We first want to apologize the mislabeling of LZ and DZ in Fig 1H. The greenish-yellow colored region (GL7<sup>+</sup> CD35<sup>+</sup>) indicate the DZ and the cyan-colored region (GL7<sup>+</sup> CD35<sup>+</sup>) indicates the LZ.

      As a technical note, we experienced high background noise with GL7 staining uniquely with PexRAP deficient (Dhrs7b<sup>f/f</sup>; Rosa26-CreER<sup>T2</sup>) mice (i.e., not WT control mice). The high background noise of GL7 staining was not observed in B cell specific KO of PexRAP (Dhrs7b<sup>f/f</sup>; huCD20-CreER<sup>T2</sup>). Two formal possibilities to account for this staining issue would be if either the expression of the GL7 epitope were repressed by PexRAP or the proper positioning of GL7<sup>+</sup> cells in germinal center region were defective in PexRAP-deficient mice (e.g., due to an effect on positioning cues from cell types other than B cells). In a revised manuscript, we will fix the labeling error and further discuss the GL7 issue, while taking care not to be thought to conclude that there is a positioning problem or derepression of GL7 (an activation antigen on T cells as well as B cells).

      While the gating strategy for an overall population of GC B cells is fairly standard even in the current literature, the question about using CD138 staining to exclude early plasmablasts (i.e., analyze B220<sup>+</sup> CD138<sup>neg</sup> vs B220<sup>+</sup> CD138<sup>+</sup>) is interesting. In addition, some papers like to use GL7<sup>+</sup> CD38<sup>neg</sup> for GC B cells instead of GL7<sup>+</sup> Fas (CD95)<sup>+</sup>, and we thank the reviewer for suggesting the analysis of centroblasts and centrocytes. For the revision, we will try to secure resources to revisit the immunizations and analyze them for these other facets of GC B cells (including CXCR4/CD86) and for their GL7<sup>+</sup> CD38<sup>neg</sup>. B220<sup>+</sup> CD138<sup>-</sup> and B220<sup>+</sup> CD138<sup>+</sup> cell populations. 

      We agree that comparison of the Rosa26-CreERT2 results to those with B cell-specific loss-of-function raise a tantalizing possibility that Tfh cells also are influenced by PexRAP. Although the manuscript is focused on post-ontogenic B cell regulation in Ab responses, we hope to add a new immunization experiments that scores Tfh and analyzes a few of their functional molecules could be added to this B cell paper, depending on the ability to wheedle enough support / fiscal resources.

      - The authors claim that Dhrs7b supports the homeostatic maintenance of quiescent B cells in vivo and promotes effective proliferation. This conclusion is primarily based on experiments where CTV-labeled PexRAP-deficient B cells were adoptively transferred into μMT mice (Fig. 2D-F). However, we recommend reviewing the flow plots of CTV in Fig. 2E, as they appear out of scale. More importantly, the low recovery of PexRAP-deficient B cells post-adoptive transfer weakens the robustness of the results and is insufficient to conclusively support the role of PexRAP in B cell proliferation in vivo.

      In the revision, we will edit the text and try to adjust the digitized cytometry data to allow more dynamic range to the right side of the upper panels in Fig. 2E, and otherwise to improve the presentation of the in vivo CTV result. However, we feel impelled to push back respectfully on some of the concern raised here. First, it seems to gloss over the presentation of multiple facets of evidence. The conclusion about maintenance derives primarily from Fig. 2C, which shows a rapid, statistically significant decrease in B cell numbers (extending the finding of Fig. 1D, a more substantial decrease after a bit longer a period). As noted in the text, the rate of de novo B cell production does not suffice to explain the magnitude of the decrease.

      In terms of proliferation, we will improve presentation of the Methods but the bottom line is that the recovery efficiency is not bad (comparing to prior published work) inasmuch as transferred B cells do not uniformly home to spleen. In a setting where BAFF is in ample supply in vivo, we transferred equal numbers of cells that were equally labeled with CTV and counted B cells.  The CTV result might be affected by lower recovered B cell with PexRAP deficiency, generally, the frequencies of CTV<sup>low</sup> divided population are not changed very much. However, it is precisely because of the pitfalls of in vivo analyses that we included complementary data with survival and proliferation in vitro. The proliferation was attenuated in PexRAP-deficient B cells in vitro; this evidence supports the conclusion that proliferation of PexRAP knockout B cells is reduced. It is likely that PexRAP deficient B cells also have defect in viability in vivo as we observed the reduced B cell number in PexRAP-deficient mice. As the reviewer noticed, the presence of a defect in cycling does, in the transfer experiments, limit the ability to interpret a lower yield of B cell population after adoptive transfer into µMT recipient mice as evidence pertaining to death rates. We will edit the text of the revision with these points in mind.

      - In vitro stimulation experiments: These experiments need improvement. The authors have used anti-CD40 and BAFF for B cell stimulation; however, it would be beneficial to also include anti-IgM in the stimulation cocktail. In Fig. 2G, CTV plots do not show clear defects in proliferation, yet the authors quantify the percentage of cells with more than three divisions. These plots should clearly display the gating strategy. Additionally, details about histogram normalization and potential defects in cell numbers are missing. A more in-depth analysis of apoptosis is also required to determine whether the observed defects are due to impaired proliferation or reduced survival.

      As suggested by reviewer, testing additional forms of B cell activation can help explore the generality (or lack thereof) of findings. We plan to test anti-IgM stimulation together with anti-CD40 + BAFF as well as anti-IgM + TLR7/8, and add the data to a revised and final manuscript.

      With regards to Fig. 2G (and 2H), in the revised manuscript we will refine the presentation (add a demonstration of the gating, and explicate histogram normalization of FlowJo).

      It is an interesting issue in bioscience, but in our presentation 'representative data' really are pretty representative, so a senior author is reminded of a comment Tak Mak made about a reduction (of proliferation, if memory serves) to 0.7 x control. [His point in a comment to referees at a symposium related that to a salary reduction by 30% :) A mathematical alternative is to point out that across four rounds of division for WT cells, a reduction to 0.7x efficiency at each cycle means about 1/4 as many progeny.] 

      We will try to edit the revision (Methods, Legends, Results, Discussion] to address better the points of the last two sentences of the comment, and improve the details that could assist in replication or comparisons (e.g., if someone develops a PexRAP inhibitor as potential therapeutic).

      For the present, please note that the cell numbers at the end of the cultures are currently shown in Fig 2, panel I. Analogous culture results are shown in Fig 8, panels I, J, albeit with harvesting at day 5 instead of day 4. So, a difference of ≥ 3x needs to be explained. As noted above, a division efficiency reduced to 0.7x normal might account for such a decrease, but in practice the data of Fig. 2I show that the number of PexRAP-deficient B cells at day 4 is similar to the number plated before activation, and yet there has been a reasonable amount of divisions. So cell numbers in the culture of  mutant B cells are constant because cycling is active but decreased and insufficient to allow increased numbers ("proliferation" in the true sense) as programmed death is increased. In line with this evidence, Fig 8G-H document higher death rates [i.e., frequencies of cleaved caspase3<sup>+</sup> cell and Annexin V<sup>+</sup> cells] of PexRAP-deficient B cells compared to controls. Thus, the in vitro data lead to the conclusion that both decreased division rates and increased death operate after this form of stimulation.

      An inference is that this is the case in vivo as well - note that recoveries differed by ~3x (Fig. 2D), and the decrease in divisions (presentation of which will be improved) was meaningful but of lesser magnitude (Fig. 2E, F).  

      Reviewer #2 (Public review):

      Summary:

      In this study, Cho et al. investigate the role of ether lipid biosynthesis in B cell biology, particularly focusing on GC B cell, by inducible deletion of PexRAP, an enzyme responsible for the synthesis of ether lipids.

      Strengths:

      Overall, the data are well-presented, the paper is well-written and provides valuable mechanistic insights into the importance of PexRAP enzyme in GC B cell proliferation.

      We appreciate this positive response and agree with the overview and summary of the paper's approaches and strengths.

      Weaknesses:

      More detailed mechanisms of the impaired GC B cell proliferation by PexRAP deficiency remain to be further investigated. In the minor part, there are issues with the interpretation of the data which might cause confusion for the readers.

      Issues about contributions of cell cycling and divisions on the one hand, and susceptibility to death on the other, were discussed above, amplifying on the current manuscript text. The aggregate data support a model in which both processes are impacted for mature B cells in general, and mechanistically the evidence and work focus on the increased ROS and modes of death. Although the data in Fig. 7 do provide evidence that GC B cells themselves are affected, we agree that resource limitations had militated against developing further evidence about cycling specifically for GC B cells. We will hope to be able to obtain sufficient data from some specific analysis of proliferation in vivo (e.g., Ki67 or BrdU) as well as ROS and death ex vivo when harvesting new samples from mice immunized to analyze GC B cells for CXCR4/CD86, CD38, CD138 as indicated by Reviewer 1.  As suggested by Reviewer 2, we will further discuss the possible mechanism(s) by which proliferation of PexRAP-deficient B cells is impaired. We also will edit the text of a revision where to enhance clarity of data interpretation - at a minimum, to be very clear that caution is warranted in assuming that GC B cells will exhibit the same mechanisms as cultures in vitro-stimulated B cells.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors present an interesting study using RL and Bayesian modelling to examine differences in learning rate adaptation in conditions of high and low volatility and noise respectively. Through "lesioning" an optimal Bayesian model, they reveal that apparently a suboptimal adaptation of learning rates results from incorrectly detecting volatility in the environment when it is not in fact present.

      Strengths:

      The experimental task used is cleverly designed and does a good job of manipulating both volatility and noise. The modelling approach takes an interesting and creative approach to understanding the source of apparently suboptimal adaptation of learning rates to noise, through carefully "lesioning" and optimal Bayesian model to determine which components are responsible for this behaviour.

      We thank the reviewer for this assessment.

      Weaknesses:

      The study has a few substantial weaknesses; the data and modelling both appear robust and informative, and it tackles an interesting question. The model space could potentially have been expanded, particularly with regard to the inclusion of alternative strategies such as those that estimate latent states and adapt learning accordingly.

      We thank the reviewer for this suggestion. We agree that it would be interesting to assess the ability of alternative models to reproduce the sub-optimal choices of participants in this study. The Bayesian Observer Model described in the paper is a form of Hierarchical Gaussian Filter, so we will assess the performance of a different class of models that are able to track uncertainty-- RL based models that are able to capture changes of uncertainty (the Kalman filter, and the model described by Cochran and Cisler, Plos Comp Biol 2019). We will assess the ability of the models to recapitulate the core behaviour of participants (in terms of learning rate adaption) and, if possible, assess their ability to account for the pupillometry response.

      Reviewer #2 (Public review):

      Summary:

      In this study, the authors aimed to investigate how humans learn and adapt their behavior in dynamic environments characterized by two distinct types of uncertainty: volatility (systematic changes in outcomes) and noise (random variability in outcomes). Specifically, they sought to understand how participants adjust their learning rates in response to changes in these forms of uncertainty.

      To achieve this, the authors employed a two-step approach:

      (1) Reinforcement Learning (RL) Model: They first used an RL model to fit participants' behavior, revealing that the learning rate was context-dependent. In other words, it varied based on the levels of volatility and noise. However, the RL model showed that participants misattributed noise as volatility, leading to higher learning rates in noisy conditions, where the optimal strategy would be to be less sensitive to random fluctuations.

      (2) Bayesian Observer Model (BOM): To better account for this context dependency, they introduced a Bayesian Observer Model (BOM), which models how an ideal Bayesian learner would update their beliefs about environmental uncertainty. They found that a degraded version of the BOM, where the agent had a coarser representation of noise compared to volatility, best fit the participants' behavior. This suggested that participants were not fully distinguishing between noise and volatility, instead treating noise as volatility and adjusting their learning rates accordingly.

      The authors also aimed to use pupillometry data (measuring pupil dilation) as a physiological marker to arbitrate between models and understand how participants' internal representations of uncertainty influenced both their behavior and physiological responses. Their objective was to explore whether the BOM could explain not just behavioral choices but also these physiological responses, thereby providing stronger evidence for the model's validity.

      Overall, the study sought to reconcile approximate rationality in human learning by showing that participants still follow a Bayesian-like learning process, but with simplified internal models that lead to suboptimal decisions in noisy environments.

      Strengths:

      The generative model presented in the study is both innovative and insightful. The authors first employ a Reinforcement Learning (RL) model to fit participants' behavior, revealing that the learning rate is context-dependent-specifically, it varies based on the levels of volatility and noise in the task. They then introduce a Bayesian Observer Model (BOM) to account for this context dependency, ultimately finding that a degraded BOM - in which the agent has a coarser representation of noise compared to volatility - provides the best fit for the participants' behavior. This suggests that participants do not fully distinguish between noise and volatility, leading to the misattribution of noise as volatility. Consequently, participants adopt higher learning rates even in noisy contexts, where an optimal strategy would involve being less sensitive to new information (i.e., using lower learning rates). This finding highlights a rational but approximate learning process, as described in the paper.

      We thank the reviewer for their assessment of the paper.

      Weaknesses:

      While the RL and Bayesian models both successfully predict behavior, it remains unclear how to fully reconcile the two approaches. The RL model captures behavior in terms of a fixed or context-dependent learning rate, while the BOM provides a more nuanced account with dynamic updates based on volatility and noise. Both models can predict actions when fit appropriately, but the pupillometry data offers a promising avenue to arbitrate between the models. However, the current study does not provide a direct comparison between the RL framework and the Bayesian model in terms of how well they explain the pupillometry data. It would be valuable to see whether the RL model can also account for physiological markers of learning, such as pupil responses, or if the BOM offers a unique advantage in this regard. A comparison of the two models using pupillometry data could strengthen the argument for the BOM's superiority, as currently, the possibility that RL models could explain the physiological data remains unexplored.

      We thank the reviewer for this suggestion. In the current version of the paper, we use an extremely simple reinforcement learning model to simply measure the learning rate in each task block (as this is the key behavioural metric we are interested in). As the reviewer highlights, this simple model doesn’t estimate uncertainty or adapt to it. Given this, we don’t think we can directly compare this model to the Bayesian Observer Model—for example, in the current analysis of the pupillometry data we classify individual trials based on the BOM’s estimate of uncertainty and show that participants adapt their learning rate as expected to the reclassified trials, this analysis would not be possible with our current RL model. However, there are more complex RL based models that do estimate uncertainty (as discussed above in response to Reviewer #1) and so may more directly be compared to the BOM. We will attempt to apply these models to our task data and describe their ability to account for participant behaviour and physiological response as suggested by the Reviewer.

      The model comparison between the Bayesian Observer Model and the self-defined degraded internal model could be further enhanced. Since different assumptions about the internal model's structure lead to varying levels of model complexity, using a formal criterion such as Bayesian Information Criterion (BIC) or Akaike Information Criterion (AIC) would allow for a more rigorous comparison of model fit. Including such comparisons would ensure that the degraded BOM is not simply favored due to its flexibility or higher complexity, but rather because it genuinely captures the participants' behavioral and physiological data better than alternative models. This would also help address concerns about overfitting and provide a clearer justification for using the degraded BOM over other potential models.

      Thank you, we will add this.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The study dissects distinct pools of diacylglycerol (DAG), continuing a line of research on the central concept that there is a major lipid metabolism DAG pool in cells, but also a smaller signaling DAG pool. It tests the hypothesis that the second pool is regulated by Dip2, which influences Pkc1 signaling. The group shows that stressed yeast increase specific DAG species C36:0 and 36:1, and propose this promotes Pkc1 activation via Pck1 binding 36:0. The study also examines how perturbing the lipid metabolism DAG pool via various deletions such as lro1, dga1, and pah1 deletion impacts DAG and stress signaling. Overall this is an interesting study that adds new data to how different DAG pools influence cellular signaling.

      Strengths:

      The study nicely combined lipidomic profiling with stress signaling biochemistry and yeast growth assays.

      We thank the reviewer for finding this study of interest and appreciating our multi-pronged approach to prove our hypothesis that a distinct pool of Dip2 regulated by DAGs activate PKC signalling.

      Weaknesses:

      One suggestion to improve the study is to examine the spatial organization of Dip2 within cells, and how this impacts its ability to modulate DAG pools. Dip2 has previously been proposed to function at mitochondria-vacuole contacts (Mondal 2022). Examining how Dip2 localization is impacted when different DAG pools are manipulated such as by deletion Pah1 (also suggested to work at yeast contact sites such as the nucleus-vacuole junction), or with Lro1 or Dga1 deletion would broaden the scope of the study.

      We thank the reviewer for the valuable suggestions regarding the spatial organization of Dip2 in cells under the influence of different DAG pools. As suggested, we will probe the localization of Dip2 in the absence of Pah1. We would also trace the localization of Dip2 in LRO1 and DGA1 deletion where the bulk DAGs are accumulated and present the data in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The authors use yeast genetics, lipidomic and biochemical approaches to demonstrate the DAG isoforms (36:0 and 36:1) can specifically activate PKC. Further, these DAG isoforms originate from PI and PI(4,5)P2. The authors propose that the Psi1-Plc1-Dip2 functions to maintain a normal level of specific DAG species to modulate PKC signalling.

      Strengths:

      Data from yeast genetics are clear and strong. The concept is potentially interesting and novel.

      We would like to thank the reviewer for the positive comments on our work. We are happy to know that the reviewer finds the study novel and interesting.

      Weaknesses:

      More evidence is needed to support the central hypothesis. The authors may consider the following:

      (1) Figure 2: the authors should show/examine C36:1 DAG. Also, some structural evidence would be highly useful here. What is the structural basis for the assertion that the PKC C1 domain can only be activated by C36:0/1 DAG but not other DAGs? This is a critical conclusion of this work and clear evidence is needed.

      We agree with the reviewer that PKC activated by C36:0 and C36:1 DAGs is a critical conclusion of our work. While we understand that there is no obvious structural explanation as to how the DAG binding C1 domain of PKC attains the acyl chain specificity for DAGs, our conclusion that yeast Pkc1 is selective for C36:0 and C36:1 DAGs is supported by a combination of robust in vitro and in vivo data

      1. In Vitro Evidence: The liposome binding assays demonstrate that the Pkc1 C1 domain only binds the selective DAG and does not interact with bulk DAGs.

      2. In Vivo Evidence: Lipidomic analyses of wild-type cells subjected to cell wall stress reveal increased levels of C36:0 and C36:1 DAGs, while levels of bulk DAGs remain unaffected. This clearly parallels the Dip2 knockout scenario in which the levels of the same set of DAGs go up and Pkc1 gets hyperactivated.

      These findings collectively indicate that Pkc1 neither binds nor is activated by bulk DAGs, reinforcing its specificity for C36:0 and C36:1 DAGs. It is also further corroborated by DGA1 and LRO1 knockouts wherein the increase of the bulk DAGs does not result in a significant increase in Pkc1 signalling.

      Moreover, elucidating the structural basis of this selectivity would require a specific DAG-bound C1 domain structure of Pkc1, which is difficult owing to the flexibility of the longer acyl chains present in C36:0 and C36:1 DAGs. Furthermore, capturing the full-length Pkc1 structure that might provide deeper insights has been challenging for several other groups for a long time. Additionally, we believe that the DAG selectivity by Pkc1 is more of a membrane-associated phenomenon wherein these DAGs might create a specific microdomain or a particular curvature which are required for Pkc1’s ability to bind DAG followed by activation. Investigating this would require extensive structural and biophysical studies, which are beyond the scope of the current work but are planned for future research.

      (2) Does Dip2 colocalize with Plc1 or Pkc1? Does Dip2 reach the plasma membrane upon Plc activation?

      Thank you for your questions regarding the colocalization and potential translocation of Dip2 upon Plc1 or Pkc1 activation.

      In the wild-type scenario, Dip2 does not colocalize with Pkc1. Dip2 predominantly localizes to the mitochondria and mitochondria-vacuole contact sites, while Pkc1 is found in the cytosol, plasma membrane and bud site. Moreover, the localization of Plc1 has not yet been studied in yeast and therefore we currently lack data on the colocalisation of Dip2 and Plc1.

      However, to investigate whether Dip2 translocates to the plasma membrane under conditions requiring Plc1 or Pkc1 activation, we plan to probe the localization of Dip2 under cell wall stress condition. This would provide a better understanding of the spatial crosstalk between Dip2 and Pkc1. We will include the results in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public review): 

      In this manuscript, the role of orexin receptors in dopamine transmission is studied. It extends previous findings suggesting an interplay of these two systems in regulating behaviour by first characterising the expression of orexin receptors in the midbrain and then disrupting orexin transmission in dopaminergic neurons by deleting its predominant receptor, OX1R (Ox1R fl/fl, DatCre tg/wt mice). Electrophysiological and calcium imaging data suggest that orexin A acutely and directly stimulates SN and VTA dopaminergic neurons, but does not seem to induce c-Fos expression. Behavioural effects of depleting OX1R from dopaminergic neurons includes enhanced noveltyinduced locomotion and exploration, relative to littermate controls (Ox1R fl/fl, Dat-Cre wt/wt). However, no difference between groups is observed in tests that measure reward processing, anxiety, and energy homeostasis. To test whether depletion of OX1R alters overall orexin-triggered activation across the brain, PET imaging is used in OX1R∆DAT knockout and control mice. This analysis reveals that several regions show a higher neuronal activation after orexin injection in OX1R∆DAT mice, but the authors focus their follow up study on the dorsal bed nucleus of the stria terminalis (BNST) and lateral paragigantocellular nucleus (LPGi). Dopaminergic inputs and expression of dopamine receptors type-1 and -2 (DRD1 & DRD2) is assessed and compared to control demonstrating moderate decrease of DRD1 and DRD2 expression in BNST of OX1R∆DAT mice and unaltered expression of DRD2, with absence of DRD1 expression in LPGi of both groups. Overall, this study is valuable for the information it provides on orexin receptor expression and function on behaviour and for the new tools it generated for the specific study of this receptor in dopaminergic circuits. 

      Strengths: 

      The use of a transgenic line that lacks OX1R in dopamine-transporter expressing neurons is a strong approach to dissect the direct role of orexin in modulating dopamine signalling in the brain. The battery of behavioural assays to study this line provides a valuable source of information for researchers interested in the role of orexin in animal physiology. 

      We thank the reviewer for summarizing the importance and significance of our study. 

      Weaknesses: 

      This study falls short in providing evidence for an anatomical substrate of the altered behaviour observed in mice lacking orexin receptor subtype 1 in dopaminergic neurons. How orexin transmission in dopaminergic neurons regulates the expression of postsynaptic dopamine receptors (as observed in BNST of OX1R<sup>∆DAT</sup> mice) is an intriguing question poorly discussed. Whether disruption of orexin activity alters dopamine release in target areas is an important point not addressed. 

      We identified dopaminergic fibers and dopamine receptors in the dBNST and LPGi, suggesting anatomical basis for dopamine neurons to regulate neural activity and receptor expression levels in these areas. PET imaging scan and c-Fos staining revealed that Ox1R signaling in dopaminergic cells regulates neuronal activity in dBNST and LPGi. The expression levels of Th were unchanged in both regions. Dopamine receptor 2 (DRD2), but not DRD1, is expressed in LPGi. The deletion of Ox1R in DAT-expressing cells did not affect DRD2 expression in LPGi. The expression levels of DRD1 and DRD2 were decreased or showed a tendency to decrease in dBNST. 

      We included the comments in the discussion in this revised manuscript (lines 308-312): ‘The expression levels of Th were not altered in dBNST or LPGi by Ox1R deletion in dopaminergic neurons. It remains unclear whether dopamine release is affected in these regions. It is possible that either the dopaminergic regulation of neuronal activity or the changes in dopamine release could lead to the decreased expression of dopamine receptors in dBNST.’

      Reviewer #2 (Public review): 

      Summary: 

      This manuscript examines expression of orexin receptors in midbrain - with a focus on dopamine neurons - and uses several fairly sophisticated manipulation techniques to explore the role of this peptide neurotransmitter in reward-related behaviors. Specifically, in situ hybridization is used to show that dopamine neurons predominantly express orexin receptor 1 subtype and then go on to delete this receptor in dopamine transporter-expressing using a transgenic strategy. Ex vivo calcium imaging of midbrain neurons is used to show that, in the absence of this receptor, orexin is no longer able to excite dopamine neurons of the substantia nigra. 

      The authors proceed to use this same model to study the effect of orexin receptor 1 deletion on a series of behavioral tests, namely, novelty-induced locomotion and exploration, anxiety-related behavior, preference for sweet solutions, cocaine-induced conditioned place preference, and energy metabolism. Of these, the most consistent effects are seen in the tests of novelty-induced locomotion and exploration in which the mice with orexin 1 receptor deletion are observed to show greater levels of exploration, relative to wild-type, when placed in a novel environment, an effect that is augmented after icv administration of orexin. 

      In the final part of the paper, the authors use PET imaging to compare brain-wide activity patterns in the mutant mice compared to wildtype. They find differences in several areas both under control conditions (i.e., after injection of saline) as well as after injection of orexin. They focus in on changes in dorsal bed nucleus of stria terminalis (dBNST) and the lateral paragigantocellular nucleus (LPGi) and perform analysis of the dopaminergic projections to these areas. They provide anatomical evidence that these regions are innervated by dopamine fibers from midbrain, are activated by orexin in control, but not mutant mice, and that dopamine receptors are present. Thus, they argue these anatomical data support the hypothesis that behavioral effects of orexin receptor 1 deletion in dopamine neurons are due to changes in dopamine signaling in these areas.

      Strengths: 

      Understanding how orexin interacts with the dopamine system is an important question and this paper contains several novel findings along these lines. Specifically:

      (1) Distribution of orexin receptor subtypes in VTA and SN is explored thoroughly.

      (2) Use of the genetic model that knocks out a specific orexin receptor subtype from dopaminetransporter-expressing neurons is a useful model and helps to narrow down the behavioral significance of this interaction.  

      (3) PET studies showing how central administration of orexin evokes dopamine release across the brain is intriguing, especially that two key areas are pursued - BNST and LPGi - where the dopamine projection is not as well described/understood. 

      We thank the reviewer for summarizing the importance and significance of our study. 

      Weaknesses: 

      The role of the orexin-dopamine interaction is not explored in enough detail. The manuscript presents several related findings, but the combination of anatomy and manipulation studies do not quite tell a cogent story. Ideally, one would like to see the authors focus on a specific behavioral parameter and show that one of their final target areas (dBNST or LPGi) was responsible or at least correlated with this behavioral readout. 

      We agree that exploring the orexin-dopamine interactions in more detail and focusing on the behavioral impact of their final target areas (e.g., dBNST or LPGi), would provide valuable data. While we are very interested in pursuing these studies, the aim of the present manuscript is to provide an overview of the behavioral roles of orexin-dopamine interaction and to propose some promising downstream pathways in a relatively broad and systematic manner. 

      In many places in the Results, insufficient explanation and statistical reporting is provided. Throughout the Results - especially in the section on behavior although not restricted to this part - statements are made without statistical tests presented to back up the claims, e.g., "Compared to controls, Ox1R<sup>ΔDAT</sup> 143 mice did not show significant changes in spontaneous locomotor activity in home cages" (L143) and "In a hole-board test, female Ox1RΔDAT mice showed increased nose pokes into the holes in early (1st and 2nd) sessions compared to control mice" (L151). In other places, ANOVAs are mentioned but full results including main effects and interactions are not described in detail, e.g., in F3-S3, only a single p-value is presented and it is difficult to know if this is the interaction term or a post hoc test (L205). These and all other statements need statistics included in the text as support. Addition of these statistical details was also requested by the editor. 

      We submitted all our source data as Excel spreadsheets to eLife during our first-round revision, and the full statistics, such as main effects and interactions, are presented alongside the source data in the respective spreadsheets. We thank the reviewer for pointing out our lack of clarity in the manuscript. In this revised manuscript, we included the statistical details of ANOVAs mentioned above in the figure legends. In the figure legends, we also explained that the full statistics were provided alongside the source data in the supplementary materials.

      In the presentation of reward processing this is particularly important as no statistical tests are shown to demonstrate that controls show a cocaine-induced preference or a sucrose preference. Here, one option would be to perform one-sample t-tests showing that the data were different to zero (no preference). As it is, the claim that "Both of the control and Ox1RΔDAT groups showed a preference for cocaine injection" is not yet statistically supported. 

      We thank the reviewer for the suggestions. We have added the one-sample t-test results in this revised manuscript (Figure 2–figure supplement 4, lines 171 - 183). 

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors): 

      Can the authors comment on overlap between DAT and Ox1R in brain areas outside VTA/SN? Is there any? 

      We only focused on the expression patterns of orexin receptors in VTA/SN, and we did not examine other brain regions. Additionally, little is known from the literature about the expression of Ox1R in DAT-expressing cells in brain areas outside VTA/SN. Further analysis is necessary to answer this question. We have added the comment in our discussion (lines 243 - 344).

      For the Ca2+ imaging experiment, it is unclear to me why the authors do not show all the neurons (almost 160 in total) and just select 5 neurons to show for each condition. 

      Heat maps of all recorded neurons are now shown in Figure 1—figure supplement 4.

      There are other claims that still require a statistical justification to be included in addition to the passages on behavior mentioned above, e.g., "Increasing the orexin A concentration to 300 nM further increased [Ca2+]i" (L118). 

      Authors should ensure that all such claims are either presented with a statistical test or are phrased differently, e.g. "Visual inspection of data suggested that there was a further increase...". In addition, when an ANOVA is conducted, full results including main effects and interactions should be described. 

      We emphasize now our statement that ALREADY 100 nM orexin A significantly increased [Ca<sup>2+</sup>]i levels (lines 117 - 118).

      We submitted all our source data as Excel spreadsheets to eLife during our first-round revision, and the full statistics, such as main effects and interactions, are presented alongside the source data in the respective spreadsheets. For clarity, we chose to include only the key statistical information in the main text and figures. We thank the reviewer for pointing this out. In this revised manuscript, we have emphasized in each figure legend: ‘Source data and full statistics are provided in the supplementary materials’.

      Typos in figure captions  

      F2-S1 - spontanous 

      F3-S2 - intrest 

      We apologize for the typos. We have corrected them in this revised manuscript.

      Editor's note: 

      Should you choose to revise your manuscript, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05. 

      We submitted all our source data as Excel spreadsheets to eLife during our first-round revision, and the full statistics, such as test statistics, df and 95% confidence intervals, are presented alongside the source data in the respective spreadsheets. We thank the editor’s note. In this revised manuscript, we have included more statistical information in the main text and figure legends (see our response to reviewer #2). In the figure legends, we also explained that the full statistics were provided alongside the source data in the supplementary materials. In addition, we also uploaded the source data and full statistics in the bioRxiv before we upload this revised manuscript to eLife.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This study sought to reveal the potential roles of m6A RNA methylation in gene dosage regulatory mechanisms, particularly in the context of aneuploid genomes in Drosophila. Specifically, this work looked at the relationships between the expression of m6A regulatory factors, RNA methylation status, classical and inverse dosage effects, and dosage compensation. Using RNA sequencing and m6A mapping experiments, an in-depth analysis was performed to reveal changes in m6A status and expression changes across multiple aneuploid Drosophila models. The authors propose that m6A methylation regulates MOF and, in turn, deposition of H4K16Ac, critical regulators of gene dosage in the context of genomic imbalance.

      Strengths:

      This study seeks to address an interesting question with respect to gene dosage regulation and the possible roles of m6A in that process. Previous work has linked m6A to X-inactivation in humans through the Xist lncRNA, and to the regulation of the Sxl in flies. This study seeks to broaden that understanding beyond these specific contexts to more broadly understand how m6A impacts imbalanced genomes in other contexts.

      Weaknesses:

      The methods being used particularly for analysis of m6A at both the bulk and transcript-specific level are not sufficiently specific or quantitative to be able to confidently draw the conclusions the authors seek to make. MeRIP m6A mapping experiments can be very valuable, but differential methylation is difficult to assess when changes are small (as they often are, in this study but also m6A studies more broadly). For instance, based on the data presented and the methods described, it is not clear that the statement that "expression levels at m6A sites in aneuploidies are significantly higher than that in wildtype" is supported. MeRIP experiments are not quantitative, and since there are far fewer peaks in aneuploidies, it stands to reason that more antibody binding sites may be available to enrich those fewer peaks to a larger extent. But based on the data as presented (figure 2D) this conclusion was drawn from RPKM in IP samples, which may not fully account for changing transcript abundances in absolute (expression level changes) and relative (proportion of transcripts in input RNA sample) terms.

      Methylated RNA immunoprecipitation followed by sequencing (MeRIP-seq) is a commonly used strategy of genome-wide mapping of m6A modification. This method uses anti-m6A antibody to immunoprecipitate RNA fragments, which results in selective enrichment of methylated RNA. Then the RNA fragments were subjected to deep sequencing, and the regions enriched in the immunoprecipitate relative to input samples are identified as m6A peaks using the peak calling algorithm. We identified m6A peaks in different samples by the exomePeak2 program and determined common m6A peaks for each genotype based on the intersection of biological replicates. Figure 2D shows the RPM values of m6A peaks in MeRIP samples for each genotype, indicating that the levels of reads in the m6A peak regions were significantly higher in the aneuploid IP samples than in wildtypes. When the enrichment of IP samples relative to Input samples (RPM.IP/RPM.Input) was taken into account, the statistics for all three aneuploidies were still significantly higher than those of the wildtypes (Mann Whitney U test p-values < 0.001). This analysis is not about changes in the abundance of transcripts, but from the MeRIP perspective, showing that there are relatively more m6A-modified reads mapped to the m6A peaks in aneuploidies than that in wildtypes. We hope to provide a possible explanation for the phenomenon that the quantitative changes of m6A peaks are not consistent with the overall m6A abundance trend. We have added the results of IP/Input in the main text, and revised the description in the manuscript to make it more precise to reduce possible misunderstandings.

      The bulk-level m6A measurements as performed here also cannot effectively support these conclusions, as they are measured in total RNA. The focus of the work is mRNA m6A regulators, but m6A levels measured from total RNA samples will not reflect mRNA m6A levels as there are other abundance RNAs that contain m6A (including rRNA). As a result, conclusions about mRNA m6A levels from these measurements are not supported.

      According to published articles, m6A levels of mRNA or total RNA can be detected by different methods (such as mass spectrometry, 2D thin-layer chromatography, etc.) in Drosophila cells or tissues [1-3]. We used the EpiQuik m6A RNA Methylation Quantification Kit, which is suitable for detecting m6A methylation status directly using total RNA isolated from any species such as mammals, plants, fungi, bacteria, and viruses. This kit has previously been used by researchers to detect the m6A/A ratio in total RNA [4, 5] or purified mRNA [6] from different species. Our pre-experiments showed that the enrichment of mRNA from total RNA did not appear to significantly affect the results of the detection of m6A levels.

      We extracted and purified mRNA from the heads of the control and MSL2 transgenic Drosophila to verify our conclusion. mRNA was isolated from total RNA using the Dynabeads mRNA purification kit (Invitrogen, Carlsbad, CA, USA, 61006). It was showing a heightened abundance of m6A modification on mRNA as opposed to total RNA (Figure 7E,F; Figure 7—figure supplement 1G,H). Compared with control Drosophila, the abundance changes of m6A in mRNA and total RNA in MSL2 transgenic Drosophila are basically the same. These results supported the conclusions in our manuscript. In the MSL2 knockdown Drosophila, the m6A modification levels on mRNA mirrored those observed on total RNA, exhibiting a significant downregulation (Figure 7E; Figure 7—figure supplement 1G). The only difference is that no substantial difference in the m6A abundance on mRNA was detected between MSL2 overexpressed female and the control Drosophila (Figure 7F; Figure 7—figure supplement 1H). It is suggested that m6A modification in other types of RNA other than mRNA (e.g., lncRNA, rRNA) is not necessarily meaningless, which is the future research direction. We will also add discussions of this issue in the manuscript.

      (1) Lence T, et al. (2016) m6A modulates neuronal functions and sex determination in Drosophila. Nature 540(7632):242-247.

      (2) Haussmann IU, et al. (2016) m(6)A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature 540(7632):301-304.

      (3) Kan L, et al. (2017) The m(6)A pathway facilitates sex determination in Drosophila. Nat Commun 8:15737.

      (4) Zhu C, et al. (2023) RNA Methylome Reveals the m(6)A-mediated Regulation of Flavor Metabolites in Tea Leaves under Solar-withering. Genomics Proteomics Bioinformatics 21(4):769-787.

      (5) Song H, et al. (2021) METTL3-mediated m(6)A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nat Commun 12(1):5522.

      (6) Yin H, et al. (2021) RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun 12(1):1394.

      Reviewer #2 (Public Review):

      Summary:

      The authors have tested the effects of partial- or whole-chromosome aneuploidy on the m6A RNA modification in Drosophila. The data reveal that overall m6A levels trend up but that the number of sites found by meRIP-seq trend down, which seems to suggest that aneuploidy causes a subset of sites to become hyper-methylated. Subsequent bioinformatic analysis of other published datasets establish correlations between the activity of the H4K16 acetyltransferase dosage compensation complex (DCC) and the expression of m6A components and m6A abundance, suggesting that DCC and m6A can act in a feedback loop on each other. Overall, this paper uses bioinformatic trends to generate a candidate model of feedback between DCC and m6A. It would be improved by functional studies that validate the effect in vivo.

      Strengths:

      • Thorough bioinformatic analysis of their data.

      • Incorporation of other published datasets that enhance scope and rigor.

      • Finds trends that suggest that a chromosome counting mechanism can control m6A, as fits with pub data that the Sxl mRNA is m6A modified in XX females and not XY males.

      • Suggests this counting mechanism may be due to the effect of chromatin-dependent effects on the expression of m6A components.

      Weaknesses:

      • The linkage between H4K16 machinery and m6A is indirect and based on bioinformatic trends with little follow-up to test the mechanistic bases of these trends.

      Western blots were performed to detect H4K16Ac in Ythdc1 knockdown Drosophila and control Drosophila. Through quantitative analysis, it is demonstrated that H4K16Ac levels changed significantly in Ythdc1 knockdown Drosophila. Combined with the results of polytene chromosome immunostaining in third instar larvae, we found that Ythdc1 affects the expression of H4K16Ac in tissue- and developmental stage-specific manners. This specificity may be associated with the onuniformity and heterogeneity of RNA m6A modification characteristics, encompassing the tissue specificity, the developmental specificity, the different numbers of m6A sites in one transcript, the different proportions of methylated transcripts, et cetera [1-3].

      In addition, we found a set of ChIP-seq data (GSE109901) of H4K16ac in female and male Drosophila larvae from the public database, and analyzed whether H4K16ac is directly associated with m6A regulator genes. ChIP-seq is a standard method to study transcription factor binding and histone modification by using efficient and specific antibodies for immunoprecipitation. The results showed that there were H4K16ac peaks at the 5' region in gene of m6A reader Ythdc1 in both males and females. In addition, most of the genome sites where the other m6A regulator genes located are acetylated at H4K16 in both sexes, except that Ime4 shows sexual dimorphism and only contains H4K16ac peak in females. These results indicate that the m6A regulator gene itself is acetylated at H4K16, so there is a direct relationship between H4K16ac and m6A regulators. We have added these contents to the text.

      Our analysis of experimental outcomes and public sequencing data has shed light on the interaction of the m6A reader protein Ythdc1 with H4K16Ac. We appreciate your interest in the complex interplay between H4K16Ac and m6A modifications. We acknowledge the intricacy of this interaction and concur that it merits further investigation, potentially supported by additional experiments.

      In current submitted manuscript, it is mainly focused on the role of RNA m6A modification in genomes experiencing imbalance, and we are going to explore this complex interplay in subsequent work for sure.

      (1) Meyer, K. D., et al. (2012). Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell, 149(7), 1635-1646.

      (2) Meyer, K. D., & Jaffrey, S. R. (2014). The dynamic epitranscriptome: N6-methyladenosine and gene expression control. Nature Reviews: Molecular Cell Biology, 15(5), 313-326.

      (3) Zaccara, S., Ries, R. J., & Jaffrey, S. R. (2019). Reading, writing and erasing mRNA methylation. Nature Reviews: Molecular Cell Biology, 20(10), 608-624.

      • The paper lacks sufficient in vivo validation of the effects of DCC alleles on m6A and vice versa. For example, Is the Ythdc1 genomic locus a direct target of the DCC component Msl-2 ? (see Figure 7).

      In order to study whether Ythdc1 genomic locus is a direct target of DCC component, we first analyzed a published MSL2 ChIP-seq data of Drosophila (GSE58768). Since MSL2 is only expressed in males under normal conditions, this set of data is from male Drosophila. According to the results, the majority (99.1%) of MSL2 peaks are located on the X chromosome, while the MSL2 peaks on other chromosomes are few. This is consistent with the fact that MSL2 is enriched on the X chromosome in male Drosophila [1, 2]. Ythdc1 gene is located on chromosome 3L, and there is no MSL2 peak near it. Similarly, other m6A regulator genes are not X-linked, and there is no MSL2 peak. Then we analyzed the MOF ChIP-seq data (GSE58768) of male Drosophila. It was found that 61.6% of MOF peaks were located on the X chromosome, which was also expected [3, 4]. Although there are more MOF peaks on autosomes than MSL2 peaks, MOF peaks are absent on m6A regulator genes on autosomes. Therefore, at present, there is no evidence that the gene locus of m6A regulators are the direct targets of DCC component MSL2 and MOF, which may be due to the fact that most MSL2 and MOF are tethered to the X chromosome by MSL complex under physiological conditions. Whether there are other direct or indirect interactions between Ythdc1 and MSL2 is an issue worthy of further study in the future.

      (1) Bashaw GJ & Baker BS (1995) The msl-2 dosage compensation gene of Drosophila encodes a putative DNA-binding protein whose expression is sex specifically regulated by Sex-lethal. Development 121(10):3245-3258.

      (2) Kelley RL, et al. (1995) Expression of msl-2 causes assembly of dosage compensation regulators on the X chromosomes and female lethality in Drosophila. Cell 81(6):867-877.

      (3) Kind J, et al. (2008) Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila. Cell 133(5):813-828.

      (4) Conrad T, et al. (2012) The MOF chromobarrel domain controls genome-wide H4K16 acetylation and spreading of the MSL complex. Dev Cell 22(3):610-624.

      Quite a bit of technical detail is omitted from the main text, making it difficult for the reader to interpret outcomes.

      (1) Please add the tissues to the labels in Figure 1D.

      Figure 1D shows the subcellular localization of FISH probe signals in Drosophila embryos. Arrowheads indicate the foci of probe signals. The corresponding tissue types are (1) blastoderm nuclei; (2) yolk plasm and pole cells; (3) brain and midgut; (4) salivary gland and midgut; (5) blastoderm nuclei and yolk cortex; (6) blastoderm nuclei and pole cells; (7) blastoderm nuclei and yolk cortex; (8) germ band. We have added these to the manuscript.

      (2) In the main text, please provide detail on the source tissues used for meRIP; was it whole larvae? adult heads? Most published datasets are from S2 cells or adult heads and comparing m6A across tissues and developmental stages could introduce quite a bit of variability, even in wt samples. This issue seems to be what the authors discuss in lines 197-199.

      In this article, the material used to perform MeRIP-seq was the whole third instar larvae. Because trisomy 2L and metafemale Drosophila died before developing into adults, it was not possible to use the heads of adults for MeRIP-seq detection of aneuploidy. For other experiments described here, the m6A abundance was measured using whole larvae or adult heads; material used for RT-qPCR analysis was whole larvae, larval brains, or adult heads; Drosophila embryos at different developmental stages were used for fluorescence in situ hybridization (FISH) experiments. We provide a detailed description of the experimental material for each assay in the manuscript.

      (3) In the main text, please identify the technique used to measure "total m6A/A" in Fig 2A. I assume it is mass spec.

      We used the EpiQuik m6A RNA Methylation Quantification Kit (Colorimetric) (Epigentek, NY, USA, Cat # P-9005) to measure the m6A/A ratio in RNA samples. This kit is commercially available for quantification of m6A RNA methylation, which used colorimetric assay with easy-to-follow steps for convenience and speed, and is suitable for detecting m6A methylation status directly using total RNA isolated from any species such as mammals, plants, fungi, bacteria, and viruses.

      (4) Line 190-191: the text describes annotating m6A sites by "nearest gene" which is confusing. The sites are mapped in RNAs, so the authors must unambiguously know the identity of the gene/transcript, right?

      When the m6A peaks were annotated using the R package ChIPseeker, it will include two items: "genomic annotation" and "nearest gene annotation". "Genomic annotation" tells us which genomic features the peak is annotated to, such as 5’UTR, 3’UTR, exon, etc. "Nearest gene annotation" indicates which specific gene/transcript the peak is matched to. We modified the description in the main text to make it easier to understand.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      While I believe this study aims to address a very interesting question and demonstrates intriguing evidence suggesting a role for m6A in unbalanced genomes, technical limitations in the methods being used limited my confidence in the overall conclusions. In addition, some of the analyses seemed to distract a bit from the main question of the work, which made thoroughly reading and reviewing the work challenging at times due to the length and lack of cohesion. Some specific points and suggestions are detailed below.

      (1) Some specific points/recommendations for the bulk m6A measurements: for Figure 2A, the authors refer to m6A/A ratio in the text, but based on the methods section and axis labels in Figure 2A (as well as other figures), it may represent m6A% in total RNA. The authors should just clarify which one it is and make the text and figures consistent. The methods description also seems to specify that m6A is quantified in total RNA, and yet the factors being discussed (Ime4, Ythdc1, etc) are associated with m6A in mRNA. Since m6A is present in non-mRNAs (including highly abundant rRNAs), m6A analysis of total RNA may be masking some of the effects due to the relatively low abundance of mRNA relative to rRNA. It is possible that the above point contributes to the discrepancy between the overall m6A abundance in aneuploidies and the changing methylase expression levels (which does seem to correlate better with m6A sequencing data). On a related note, though the authors suggest in Figures 7E and F that m6A level changes are different in males and females, the levels and trends of m6A% in these panels seem quite similar, and the absence of the presence of statistical significance seems driven by higher variation (larger error bars) in the measurements in 7F (and again effects may be masked if total RNA is being quantified). This may be a very addressable issue, as m6A analysis of mRNA-enriched samples should be feasible, and in fact, may show clearer changes to better support the authors' conclusions.

      Thank you for your helpful comments.

      As suggested, the abundance of m6A on mRNA were detected (Figure 7E, F). Total RNA was extracted from the heads of the control and MSL2 transgenic Drosophila and mRNA was isolated using the Dynabeads mRNA purification kit (Invitrogen, Carlsbad, CA, USA, 61006). 300-600 ng mRNA can be purified from 40 μg total RNA (200-300 heads per sample). We used the EpiQuik m6A RNA Methylation Quantification Kit (Colorimetric) (Epigentek, NY, USA, Cat # P-9005) to measure the abundance of m6A in mRNA samples (200ng). The results obtained by this method represent the m6A/A ratio (%), which is also written as m6A% on the user guide of the kit. We made corresponding revisions in the main text and figures to made them consistent.

      It is showing a heightened abundance of m6A modification on mRNA as opposed to total RNA including some other types of RNA such as mRNA, lncRNA, and rRNA (Figure 7E,F; Figure 7—figure supplement 1G,H). Consistently, in the MSL2 knockdown Drosophila, the m6A modification levels on mRNA mirrored those observed on total RNA, exhibiting a significant downregulation (Figure 7E; Figure 7—figure supplement 1G). In contrast, no substantial difference in the m6A abundance on mRNA was detected between MSL2 overexpressed Drosophila and the control Drosophila (Figure 7F; Figure 7—figure supplement 1H). The differences of m6A abundance between males and females were not statistically significant (Figure 7E,F), prompting us to make revisions to the manuscript.

      (2) The analyses in Figures 5 and 6 describe a lot of different comparisons derived from these datasets, and while there seem to be many interesting new hypotheses to be tested, the authors do not make any definitive conclusions from these analyses. These figures also seem to diverge a bit from the main conclusion of the work, and from this reviewer's perspective made it more difficult to read and review the work. Overall streamlining the narrative may help readers appreciate the main conclusions of the work (though this is of course up to the author's discretion).

      As indicated in Figure 5, the results demonstrated a sexually dimorphic role of m6A modification in the regulation of gene expression in aneuploid Drosophila, suggesting its potential involvement in the gene regulatory network through interactions with dosage-sensitive regulators. Furthermore, Figure 6 illustrated the intricate interplay between RNA m6A modification, gene expression, and alternative splicing under genomic imbalance, with RNA splicing being more intimately associated with m6A methylation than gene transcription itself.

      This manuscript also discussed the correlation between methylation status and classical dosage effects, dosage compensation effects, and inverse dosage effects. We have initially demonstrated that RNA m6A methylation could influence dosage-dependent gene regulation via multiple avenues, such as interactions with dosage-sensitive modifiers, alternative splicing mechanisms, the MSL complex, and other related processes. Indeed, our study primarily utilizes m6A methylated RNA immunoprecipitation sequencing (MeRIP-Seq) to comprehensively investigate the role of RNA m6A modification in genomes experiencing imbalance. We agree that more specific and in-depth research on these factors will be instrumental in elucidating the precise mechanisms by which m6A modification regulates expression in unbalanced genomes, which we acknowledge as a significant avenue for our future research.

      We are grateful for your suggestions and, should it be necessary, we might to simplify the volume of the whole manuscript by removing or condensing the data analyse and description to enhance the prominence of the central theme.

      Reviewer #2 (Recommendations For The Authors):

      Overall, please provide enough technical detail in the main text so that the reader understands what was done, and does not have to repeatedly dig into figure legends and materials and methods to understand each data statement.

      Thank you for your suggestions. We have added some technical details to the manuscript and made some modifications as suggested.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      How reconsolidation works - particularly in humans - remains largely unknown. With an elegant, 3-day design, combining fMRI and psychopharmacology, the authors provide evidence for a certain role for noradrenaline in the reconsolidation of memory for neutral stimuli. All memory tasks were performed in the context of fMRI scanning, with additional resting-state acquisitions performed before and after recall testing on Day 2. On Day 1, 3 groups of healthy participants encoded word-picture associates (with pictures being either scenes or objects) and then performed an immediate cued recall task to presentation of the word (answering is the word old or new, and whether it was paired with a scene or an object). On Day 2, the cued recall task was repeated using half of the stimulus set words encoded on Day 1 (only old words were presented, with subjects required to indicate prior scene vs object pairing). This test was immediately preceded by the oral administration of placebo, cortisol, or yohimbine (to raise noradrenaline levels) depending on group assignment. On Day 3, all words presented on Day 1 were presented. As expected, on Day 3, memory was significantly enhanced for associations that were cued and successfully retrieved on Day 2 compared to uncued associations. However, for associative d', there was no Cued × Group interaction nor a main effect of Group, i.e., on the standard measure of memory performance, post-retrieval drug presence on Day 2 did not affect memory reconsolidation. As further evidence for a null result, fMRI univariate analyses showed no Cued × Group interactions in whole-brain or ROI activity.

      Strengths:

      There are some aspects of this study that I find impressive. The study is well-designed and the fMRI analysis methodology is innovative and sound. The authors have made meticulous and thorough physiological measurements, and assays of mood, throughout the experiment. By doing so, they have overcome, to a considerable extent, the difficulties inherent in the timing of human oral drug delivery in reconsolidation tasks, where it is difficult to have the drug present in the immediate recall period without affecting recall itself. This is beautifully shown in Figure 3. I also think that having some neurobiological assay of memory reactivation when studying reconsolidation in humans is critical, and the authors provide this. While multi-voxel patterns of hemodynamic responses are, in my view, very difficult to equate with an "engram", these patterns do have something to do with memory.

      We thank the reviewer for considering aspects of our work impressive, the study to be well-designed, and the methodology to be innovative and sound.

      Weaknesses:

      I have major issues regarding the behavioral results and the framing of the manuscript.

      (1) To arrive at group differences in memory performance, the authors performed median splitting of Day 3 trials by short and long reaction times during memory cueing on Day 2, as they took this as a putative measure of high/low levels of memory reactivation. Associative category hits on Day 3 showed a Group by Day 2 Reaction time (short, long) interaction, with post-hocs showing (according to the text) worse memory for short Day 2 RTs in the Yohimbine group. These post-hocs should be corrected for multiple comparisons, as the result is not what would be predicted (see point 2). My primary issue here is that we are not given RT data for each group, nor is the median splitting procedure described in the methods. Was this across all groups, or within groups? Are short RTs in the yohimbine group any different from short RTs in the other two groups? Unfortunately, we are not given Day 2 picture category memory levels or reaction times for each group. This is relevant because (as given in Supplemental Table S1) memory performance (d´) for the Yohimbine group on Day 1 immediate testing is (roughly speaking) 20% lower than the other 2 groups (independently of whether the pairs will be presented again the following day). I appreciate that this is not significant in a group x performance ANOVA but how does this relate to later memory performance? What were the group-specific RTs on Day 1? So, before the reader goes into the fMRI results, there are questions regarding the supposed drug-induced changes in behavior. Indeed, in the discussion, there is repeated mention of subsequent memory impairment produced by yohimbine but the nature of the impairment is not clear.

      Thank you for the opportunity to clarify these important issues.

      Reaction times are well established proxies (correlates) of memory strength and memory confidence in previous research, as they reflect cognitive processes involved in retrieving information. Faster reaction times indicate stronger mnemonic evidence and higher confidence in the accuracy of a memory decision, while slower responses suggest weaker evidence and decision uncertainty or doubt. This relationship is supported by an extensive literature (e.g., Starns 2021; Robinson et al., 1997; Ratcliff & Murdock, 1976; amongst others). Importantly, distinguishing between high and low confidence choices in a memory task serves the purpose of differentiating between particularly strong memory evidence (e.g., in associative cued recall, when remembering is particularly vivid) and weaker memory evidence. Separating low from high confidence responses based on participants’ reaction times was especially important in the current analyses, because previous research demonstrates that reaction times during cued recall tasks inversely correlate with hippocampal involvement (Heinbockel et al., 2024; Gagnon et al. 2019) and that stress-effects on human memory may be particularly pronounced for high-confidence memories (Gagnon et al., 2019).

      In response to the Reviewer 1’s comments, we have elaborated on our rationale for the distinction between short and long reaction times in the introduction, results, and methods. Please see page 4, lines 144 to 148:

      “We distinguished between responses with short and long reaction times indicative of high and low confidence responses because previous research showed that reaction times are inversely correlated with hippocampal memory involvement(58-60) and memory strength(61,62), and that high confidence memories associated with short reaction times may be particularly sensitive to stress effects(63).”

      On page 13, lines 520 to 523:

      “Reaction times in the Day 2 Memory cueing task revealed a trial-specific gradient in reactivation strength. Thus, we turned to single-trial analyses, differentiating Day 3 trials by short and long reaction times during memory cueing on Day 2 (median split), indicative of high vs. low memory confidence(58–60) and hippocampal reactivation(26,63).”

      And on page 26, lines 1046 to 1053:

      “Reaction times serve as a proxy for memory confidence and memory strength, with faster responses reflecting higher confidence/strength and slower responses suggesting greater uncertainty/weaker memory. The association between reaction times and memory confidence has been established by previous research(58–60), suggesting that the distinction between high from low confidence responses differentiates vividly recalled associations from decisions based on weaker memory evidence. Reaction times are further linked to hippocampal activity during recall tasks(26,53), and stress effects on memory are particularly pronounced for high-confidence memories(53).”

      With respect to behavioral data reporting, we agree that the critical median-split procedure was not sufficiently clear in the original manuscript. We elaborate on this important aspect of the analysis now on page 26, lines 1053 to 1057:

      “We conducted a median-split within each participant to categorize trials as fast vs. slow reaction time trials during Day 2 memory cueing. We conducted this split on the participant- and not group-level because there is substantial inter-individual variability in overall reaction times. This approach also results in an equal number of trials in the low and high confidence conditions.”

      We completely agree that the relevant post-hoc test should be corrected for multiple comparisons. Please note that all reported post-hoc tests had been Bonferroni-corrected already. We clarify this now by explicitly referring to corrected p-values (P<sub>corr</sub>) and indicate in the methods that P<sub>corr</sub> refers to Bonferroni-corrected p-values. (please see page 25, lines 1036 to 1038).

      We further agree that for a comprehensive overview of the behaviour in terms of memory performance and RTs, these data need to be provided for each group and experimental day. Therefore, we now extended Supplementary Table S1 to include descriptive indices of memory performance (hits, dprime) and RTs for each group for each day. Moreover, we now report ANOVAs for reaction times for each of the experimental days in the main text.

      The ANOVA for Day 1 is now reported on page 6, lines 200 to 204: “To test for potential group differences in reaction times for correctly remembered associations on Day 1, we fit a linear model including the factors Group and Cueing. Critically, we did not observe a significant Group x Cueing interaction, suggesting no RT difference between groups for later cued and not cued items (F(2,58) = 1.41, P = .258, η<sup>2</sup> = 0.01; Supplemental Table S1).”

      The ANOVA for Day 2 is now reported on page 7, lines 243 to 248: “To test for potential group differences in reaction times for correctly remembered associations on Day 2, we fit a linear model including the factors Group and Reaction time (slow/fast) following the subject specific median split. The model did not reveal any main effect or interaction including the factor Group (all Ps > .535; Supplemental Table S1), indicating that there was no RT difference between groups, nor between low and high RT trials in the groups.”

      The ANOVA for Day 3 is reported on page 13 lines 487 to 494: “To test for potential group differences in reaction times for correctly remembered associations on Day 3 we fit a linear model including the factors Group and Cueing. This model did not reveal any main effect or interaction including the factor Group (all Ps > .267), indicating that there was no average RT difference between groups. As expected we observed a main effect of the factor Cueing, indicating a significant difference of reaction times across groups between trials that were successfully cued and those not cued on Day 2 (F(2,58) = 153.07, P < .001, η<sup>2</sup> = 0.22; Supplemental Table S1).”

      (2) The authors should be clearer as to what their original hypotheses were, and why they did the experiment. Despite being a complex literature, I would have thought the hypotheses would be reconsolidation impairment by cortisol and enhancement by yohimbine. Here it is relevant to point out that - only when the reader gets to the Methods section - there is mention of a paper published by this group in 2024. In this publication, the authors used the same study design but administered a stress manipulation after Day 2 cued recall, instead of a pharmacological one. They did not find a difference in associative hit rate between stress and control groups, but - similar to the current manuscript - reported that post-retrieval stress disrupts subsequent remembering (Day 3 performance) depending on neural memory reinstatement during reactivation (specifically driven by the hippocampus and its correlation with neocortical areas).

      Instead of using these results, and other human studies, to motivate the current work, reference is made to a recent animal study: Line 169 "Building on recent findings in rodents (Khalaf et al. 2018), we hypothesized that the effects of post-retrieval noradrenergic and glucocorticoid activation would critically depend on the reinstatement of the neural event representation during retrieval". It is difficult to follow that a rodent study using contextual fear conditioning and examining single neuron activity to remote fear recall and extinction would be relevant enough to motivate a hypothesis for a human psychopharmacological study on emotionally neutral paired associates.

      We agree that our recent publication utilizing a very similar experimental design including three days is highly relevant in the context of the current study and we now refer to this recent study earlier in our manuscript. Please see page 3, lines 89 to 94:  

      “Recently, we showed a detrimental impact of post-retrieval stress on subsequent memory that was contingent upon reinstatement dynamics in the Hippocampus, VTC and PCC during memory reactivation26. While this study provided initial insights into the potential brain mechanisms involved in the effects of post-retrieval stress on subsequent memory, the underlying neuroendocrine mechanisms remained elusive.”

      Moreover, we explicitly state our hypothesis regarding the neural mechanism, with reference to our recent work, on page 5, lines 166 to 169:

      “Building on our recent findings in humans(26) as well as current insights from rodents(47), we hypothesized that the effects of post-retrieval noradrenergic and glucocorticoid activation would critically depend on the reinstatement of the neural event representation during retrieval.”

      Concerning the potential direction of the effects of post-retrieval cortisol and noradrenaline, the literature is indeed mixed with partially contradicting results, which made it, in our view, difficult to derive a clear hypothesis of potentially opposite effects of cortisol and yohimbine. We summarize the relevant evidence in the introduction on pages 3 to 4, lines 100 to 113:

      “Some studies, using emotional recognition memory or fear conditioning in healthy humans, suggest enhancing effects of post-retrieval glucocorticoids on subsequent memory(30,31). However, rodent studies on neutral recognition memory(21), fear conditioning(32), as well as evidence from humans on episodic recognition memory(33) report impairing effects of glucocorticoid receptor activation on post-retrieval memory dynamics. For noradrenaline, post-retrieval blockade of noradrenergic activity impairs putative reconsolidation or future memory accessibility in human fear conditioning(34), as well as drug (alcohol) memory(35) and spatial memory in rodents(36). However, this effect is not consistently observed in human studies on fear conditioning(40), speaking anxiety(37), inhibitory avoidance(39), traumatic mental imagination (PTSD patients)(38), and might depend on the arousal state of the individual(21) or the exact timing of drug administration as suggested by studies in humans(41) and rodents(42). Thus, while there is evidence that glucocorticoid and noradrenergic activation after retrieval can affect subsequent memory, the direction of these effects remains elusive.”

      In addition to these reviewer comments and in response to the eLife assessment, we would like to emphasize that the present findings are in our view not only relevant for a subfield but may be of considerable interest for researchers from various fields, beyond experimental memory research, including Neurobiology, Psychiatry, Clinical Psychology, Educational Psychology, or Law Psychology. We highlight the relevance of the topic and our findings now more explicitly in the introduction and discussion. Please see page 3:

      “The dynamics of memory after retrieval, whether through reconsolidation of the original trace or interference with retrieval-related traces, have fundamental implications for educational settings, eyewitness testimony, or mental disorders(5,11,12). In clinical contexts, post-retrieval changes of memory might offer a unique opportunity to retrospectively modify or render less accessible unwanted memories, such as those associated with posttraumatic stress disorder (PTSD) or anxiety disorders(13–15). Given these potential far reaching implications, understanding the mechanisms underlying post-retrieval dynamics of memory is essential.”

      On page 17:

      “Upon their retrieval, memories can become sensitive to modification(1,2). Such post-retrieval changes in memory may be fundamental for adaptation to volatile environments and have critical implications for eyewitness testimony, clinical or educational contexts(5,11–15). Yet, the brain mechanisms involved in the dynamics of memory after retrieval are largely unknown, especially in humans.”

      And on page 19:

      “Beyond their theoretical relevance, these findings may have relevant implications for attempts to employ post-retrieval manipulations to modify unwanted memories in anxiety disorders or PTSD(97,98). Specifically, the present findings suggest that such interventions may be particularly promising if combined with cognitive or brain stimulation techniques ensuring a sufficient memory reactivation.“

      Reviewer #1 (Recommendations for the authors):

      (1) Related to major issue 2 in the Public Review. In the introduction, it would be helpful to be specific about the type of memory being probed in the different studies referenced (episodic vs conditioning). For the former, please make it clear whether stimuli to be remembered were emotional or neutral, and for which stimulus class drug effects were observed. This is particularly important given that in the first paragraph, you describe memory reactivation in the context of traumatic memories via mention of PTSD. It would also be helpful to know to which species you refer. For example, in line 115, "timing of drug administration..." a rodent and a human study are cited.

      We completely agree that these aspects are important. We have therefore rewritten the corresponding paragraph in the introduction to clarify the type of memory probed, the emotionality of the stimuli and the species tested. Please see pages 3 to 4, lines 100 to 113:

      “Some studies, using emotional recognition memory or fear conditioning in healthy humans, suggest enhancing effects of post-retrieval glucocorticoids on subsequent memory(30,31). However, rodent studies on neutral recognition memory(21), fear conditioning(32), as well as evidence from humans on episodic recognition memory(33) report impairing effects of glucocorticoid receptor activation on post-retrieval memory dynamics. For noradrenaline, post-retrieval blockade of noradrenergic activity impairs putative reconsolidation or future memory accessibility in human fear conditioning(34), as well as drug (alcohol) memory(35) and spatial memory in rodents(36). However, this effect is not consistently observed in human studies on fear conditioning(40), speaking anxiety(37), inhibitory avoidance(39), traumatic mental imagination (PTSD patients)(38), and might depend on the arousal state of the individual(21) or the exact timing of drug administration as suggested by studies in humans(41) and rodents(42). Thus, while there is evidence that glucocorticoid and noradrenergic activation after retrieval can affect subsequent memory, the direction of these effects remains elusive.”

      (2) The Bos 2014 reference appears incorrect. I think you mean the Frontiers paper of the same year.

      Thank you for noticing this mistake, which has been corrected.

      (3) Line 734 "The study employed a fully crossed, placebo-controlled, double-blind, between-subjects design". What is a fully crossed design?

      A fully-crossed design refers to studies in which all possible combinations of multiple between-subjects factors are implemented. However, because the factor reactivation/cueing was manipulated within-subject in the present study and there is only one between-subjects factor (group/drug), “fully-crossed” may be misleading here. We removed it from the manuscript.

      (4) Supplemental Table S3. Are these ordered in terms of significance? A t- or Z-value for each cluster (either of the peak or a summed value) would be helpful.

      We agree that the ordering of the clusters was not clearly described. In the revised Supplemental Table S3, we have now added a column with the cluster-peak specific T-values and added an explanation in the table caption: “Depicted clusters are ordered by cluster-peak T-values.”

      (5) Please provide the requested memory performance and reaction time data, and relevant group comparisons.

      In response to general comment #1 above, we now provide all relevant accuracy and reaction time data for all groups and experimental days in the revised Supplemental Table S1. Moreover, we now report the relevant group comparisons in the main text on page 6, lines 200 to 204, on page 7, lines 243 to 248, and on page 13, lines 487 to 494.

      (6) Please rewrite the introduction with specific hypotheses, mention your recent results published in Science Advances, and attend to suggestions made in the first comment above.

      We have rewritten parts of the introduction to make the link to our recent publication clearer and to clarify the types of memories and species tested, as suggested by the reviewer (please see pages 3 to 4, lines 100 to 113). Moreover, we explicitly state our hypothesis regarding the neural mechanism on page 5, lines 166 to 169:

      “Building on our recent findings in humans(26) as well as current insights from rodents(47), we hypothesized that the effects of post-retrieval noradrenergic and glucocorticoid activation would critically depend on the reinstatement of the neural event representation during retrieval.”

      In terms of the direction of the potential cortisol and yohimbine effects, we have elaborated on the relevant literature, which in our view does not allow a clear prediction regarding the nature of the drug effects. We have made this explicit by stating that “… while there is evidence that glucocorticoid and noradrenergic activation after retrieval can affect subsequent memory, the direction of these effects remains elusive.” (please see page 4, lines 111 to 113). It would be, in our view, inappropriate to retrospectively add another, more specific “hypothesis”.

      Reviewer #2 (Public review):

      Summary:

      The authors aimed to investigate how noradrenergic and glucocorticoid activity after retrieval influence subsequent memory recall with a 24-hour interval, by using a controlled three-day fMRI study involving pharmacological manipulation. They found that noradrenergic activity after retrieval selectively impairs subsequent memory recall, depending on hippocampal and cortical reactivation during retrieval.

      Overall, there are several significant strengths of this well-written manuscript.

      Strengths:

      (1) The study is methodologically rigorous, employing a well-structured three-day experimental design that includes fMRI imaging, pharmacological interventions, and controlled memory tests.

      (2) The use of pharmacological agents (i.e., hydrocortisone and yohimbine) to manipulate glucocorticoid and noradrenergic activity is a significant strength.

      (3) The clear distinction between online and offline neural reactivation using MVPA and RSA approaches provides valuable insights into how memory dynamics are influenced by noradrenergic and glucocorticoid activity distinctly.

      We thank the reviewer for these very positive and encouraging remarks.

      Weaknesses:

      (1) One potential limitation is the reliance on distinct pharmacodynamics of hydrocortisone and yohimbine, which may complicate the interpretation of the results.

      We agree that the pharmacodynamics of hydrocortisone and yohimbine are different. However, we took these pharmacodynamics into account when designing the experiment and have made an effort to accurately track the indicators for noradrenergic arousal and glucocorticoids across the experiment. As shown in Figure 2, these indicators confirm that both drugs are active within the time window of approximately 40-90 minutes after reactivation. This time window corresponds to the proposed reconsolidation window, which is assumed to open around 10 minutes post-reactivation and to remain open for a few hours (approximately 90 minutes; Monfils & Holmes, 2018; Lee et al., 2017; Monfils et al., 2009).

      We have now acknowledged the distinct pharmacodynamics of hydrocortisone and yohimbine on page 21, lines 845 to 847: “We note that yohimbine and hydrocortisone follow distinct pharmacodynamics(104,105), yet selected the administration timing to ensure that both substances are active within the relevant post-retrieval time window.”

      In the results section, on page 11, lines 437 to 439, we further emphasize this differential dynamic: “Our data demonstrate that, despite the distinct pharmacodynamics of CORT and YOH, both substances are active within the time window that is critical for potential reconsolidation effects(3,4,43).”

      (2) Another point related above, individual differences in pharmacological responses, physiological and cortisol measures may contribute to memory recall on Day 3.

      The administered drugs elicit a pronounced adrenergic and glucocorticoid response, respectively. Specifically, the cortisol levels reached by 20mg of hydrocortisone correspond to those observed after a significant stressor exposure. Moreover, individual variation in stress system activation following drug intake tends to be less pronounced than in response to a natural stressor. Nevertheless, we fully agree that individual factors, such as metabolism or body weight, can influence the drug's action.

      We therefore re-analysed the reported Day 3 models, now including individual measures of baseline-to-peak changes in cortisol and systolic blood pressure, respectively. We report these additional analyses in the supplement and refer the interested reader to these analyses on page 15, lines 580 to 586:

      “As individual factors, such as metabolism or body weight, can influence the drug's action, we ran an additional analysis in which we included individual (baseline-to-peak) differences in salivary cortisol and (systolic) blood pressure, respectively. This analysis did not show any group by baseline-to-peak difference interaction suggesting that the observed memory effects were mainly driven by the pharmacological intervention group per se and less by individual variation in responses to the drug (see Supplemental Results).”

      And in the Supplemental Results:

      “To account for individual differences in cortisol responses after pill intake, we fit additional GLMMs predicting Day 3 subsequent memory of cued and correct trials including the factors Individual baseline-to-peak cortisol and Group. Doing so allowed us to account for variation in Day 3 performance, which might have resulted from within-group variation in cortisol responses, in particular in the CORT group. Importantly, none of the models predicting Day 3 memory performance by Day 2 cortisol-increase and Group, median-split RTs (high/low), hippocampal activity and RTs, or hippocampal activity and VTC category reinstatement revealed a significant group x baseline-to-peak cortisol interaction (all Ps > .122). These results suggest that inter-individual differences in cortisol responses did not have a significant impact on subsequent memory, beyond the influence of group per se. The same analyses were repeated for systolic blood pressure employing GLMMs predicting Day 3 subsequent memory of cued and correct trials including the factors Individual baseline-to-peak systolic blood pressure and Group to account for variation in Day 3 performance, which might have resulted from within-group variation in blood pressure response, in particular in the YOH group. While the model predicting Day 3 memory performance revealed a significant Individual baseline-to-peak systolic blood pressure × Group × median-split RTs (high/low) interaction (β = -0.05 ± 0.02, z = -2.04, P = .041, R<sup>2</sup><sub>conditional</sub> = 0.01), post-hoc slope tests, however, did not show any significant difference between groups (all P<sub>Corr</sub> > .329). The remaining models including hippocampal activity and RTs, or hippocampal activity and VTC category reinstatement did not reveal a significant Group × Individual baseline-to-peak systolic blood pressure interaction (all Ps > .101). These results suggest that inter-individual differences in systolic blood pressure responses did not have a significant impact on subsequent memory, beyond the influence of group per se.”

      Although we acknowledge that our study may not have been sufficiently powered for an analysis of individual differences, these data suggest that our memory effects were mainly driven by the pharmacological intervention group per se and less by individual variation in responses. It is to be noted, however, that all participants of the respective groups showed a pronounced increase in cortisol concentrations (on average > 1000% in the CORT group) and autonomic arousal (on average > 10% in the YOH group), respectively. These increases appeared to be sufficient to drive the observed memory effects, irrespective of some individual variation in the magnitude of the response.

      (3) Median-splitting approach for reaction times and hippocampal activity should better be justified.

      Reaction times are well established proxies (correlates) of memory strength and memory confidence in previous research, as they reflect cognitive processes involved in retrieving information. Faster reaction times indicate stronger mnemonic evidence and higher confidence in the accuracy of a memory decision, while slower responses suggest weaker evidence and decision uncertainty or doubt. This relationship is supported by an extensive literature (e.g., Starns 2021; Robinson et al., 1997; Ratcliff & Murdock, 1976; amongst others). Importantly, distinguishing between high and low confidence choices in a memory task serves the purpose to differentiating between particularly strong memory evidence (e.g., is associative cued recall, when remembering is particularly vivid) and weaker memory evidence. Separating low from high confidence responses based on participants’ reaction times was especially important in the current analyses, because previous research demonstrates that reaction times during cued recall tasks inversely correlate with hippocampal involvement  Heinbockel et al., 2024; Gagnon et al. 2019) and that stress-effects on human memory may be particularly pronounced for high-confidence memories (Gagnon et al., 2019).

      In response to the Reviewer comments, we have elaborated on our rationale for the distinction between short and long reaction times in the introduction, results, and methods. Please see page 4, lines 144 to 148:

      “We distinguished between responses with short and long reaction times indicative of high and low confidence responses because previous research showed that reaction times are inversely correlated with hippocampal memory involvement(58–60) and memory strength(61,62), and that high confidence memories associated with short reaction times may be particularly sensitive to stress effects(63).”

      On page 13, lines 520 to 523:

      “Reaction times in the Day 2 Memory cueing task revealed a trial-specific gradient in reactivation strength. Thus, we turned to single-trial analyses, differentiating Day 3 trials by short and long reaction times during memory cueing on Day 2 (median split), indicative of high vs. low memory confidence(58–60) and hippocampal reactivation(26,63).”

      And on page 26, lines 1046 to 1053:

      “Reaction times serve as a proxy for memory confidence and memory strength, with faster responses reflecting higher confidence/strength and slower responses suggesting greater uncertainty/weaker memory. The association between reaction times and memory confidence has been established by previous research(58–60), suggesting that the distinction between high from low confidence responses differentiates vividly recalled associations from decisions based on weaker memory evidence. Reaction times are further linked to hippocampal activity during recall tasks(26,53), and stress effects on memory are particularly pronounced for high-confidence memories(53).”

      We agree that the critical median-split procedure was not sufficiently clear in the original manuscript. We elaborate on this important aspect of the analysis now on page 26, lines 1053 to 1057:

      “We conducted a median-split within each participant to categorize trials as slow vs. fast reaction time trials during Day 2 memory cueing. We chose to conduct this split on the participant- and not group-level because there is substantial inter-individual variability in overall reaction times and to retain an equal number of trials in the low and high confidence conditions.”

      In addition to these reviewer comments and in response to the eLife assessment, we would like to emphasize that the present findings are in our view not only relevant for a subfield but may be of considerable interest for researchers from various fields, beyond experimental memory research, including Neurobiology, Psychiatry, Clinical Psychology, Educational Psychology, or Law Psychology. We highlight the relevance of the topic and our findings now more explicitly in the introduction and discussion. Please see page 3:

      “The dynamics of memory after retrieval, whether through reconsolidation of the original trace or interference with retrieval-related traces, have fundamental implications for educational settings, eyewitness testimony, or mental disorders5,11,12. In clinical contexts, post-retrieval changes of memory might offer a unique opportunity to retrospectively modify or render less accessible unwanted memories, such as those associated with posttraumatic stress disorder (PTSD) or anxiety disorders(13–15). Given these potential far reaching implications, understanding the mechanisms underlying post-retrieval dynamics of memory is essential.”

      On page 17:

      “Upon their retrieval, memories can become sensitive to modification(1,2). Such post-retrieval changes in memory may be fundamental for adaptation to volatile environments and have critical implications for eyewitness testimony, clinical or educational contexts(5,11–15), Yet, the brain mechanisms involved in the dynamics of memory after retrieval are largely unknown, especially in humans.”

      And on page 19:

      “Beyond their theoretical relevance, these findings may have relevant implications for attempts to employ post-retrieval manipulations to modify unwanted memories in anxiety disorders or PTSD(97,98). Specifically, the present findings suggest that such interventions may be particularly promising if combined with cognitive or brain stimulation techniques ensuring a sufficient memory reactivation.“

      Reviewer #2 (Recommendations for the authors):

      My comments and/or questions for the authors to improve this well-written manuscript.

      (1) This study identifies the modulatory role of the hippocampus and VTC in the effects of norepinephrine on subsequent memory. Are there functional interactions between these ROIs and other brain regions that could be wise to consider for a more comprehensive understanding of the underlying neural mechanisms?

      We agree that functional interactions of hippocampus and VTC and other regions that were active during Day 2 memory cueing are relevant for our understanding of the underlying mechanisms. We therefore now performed connectivity analyses using general psycho-physiological interaction analysis (gPPI; as implemented in SPM) and report the results of this analysis on page 16, lines 635 to 644, and added Supplemental Table S4 including gPPI statistics.

      “We conducted general psycho-physiological interaction analysis (gPPI) analyses on the Day 2 memory cueing task (remembered – forgotten), which revealed that successful cueing was accompanied by significant functional connectivity between the left hippocampus, VTC, PCC and MPFC (see Supplemental Table S4). However, using these connectivity estimates to predict Day 3 subsequent memory performance (dprime) via regression did not reveal any significant Group × Connectivity interactions, indicating that the pharmacological manipulation (i.e. noradrenergic stimulation) did not modulate subsequent memory based on functional connectivity during memory cueing (all P<sub>Corr</sub> > .228). The same pattern of results was observed when including single trial beta estimates from multiple ROIs during memory cueing to predict Day 3 memory (all interaction effects P<sub>Corr</sub> > .288).”

      (2) In theory, noradrenergic activity would have a profound impact on activity in widespread brain regions that are closely related to memory function. It would be interesting to know other possible effects beyond the hippocampus and VTC.

      We agree and included in our analysis additional ROIs beyond the HC and VTC; we now report these explorative results on page 16, lines 616 to 633:

      “Beyond hippocampal and VTC activity during memory cueing (Day 2), we exploratively reanalysed the GLMMs predicting Day 3 memory performance including the PCC, which was relevant during memory cueing in the current study and in our previous work(26).  Predicting Day 3 memory performance by the factors Group and Single trial beta activity during memory cueing in the PCC did not reveal a significant interaction (P<sub>Corr</sub>  = 1); adding the factor Reaction time to the model also did not result in a significant interaction (P<sub>Corr</sub> = 1). We also included the Medial Prefrontal Cortex (MPFC) to predict Day 3 memory performance, as the MPFC has been shown to be sensitive to noradrenergic modulation in previous work(75). Predicting Day 3 memory performance by the factors Group and Single trial beta activity during memory cueing in the MPFC did not reveal a significant interaction (P<sub>Corr</sub>  = 1); adding the factor Reaction time to the model also did not result in a significant interaction (P<sub>Corr</sub> = 1), which indicates that the MPFC was not modulated by either pharmacological intervention. Finally, we investigated memory cueing from all remaining ROIs that were significantly activated during the Day 2 memory cueing task (Day 2 whole-brain analysis; correct-incorrect; Supplemental Table S3). We again fit GLMMs predicting Day 3 memory performance by the factors Group and Single trial beta activity during memory cueing. Again, we did not observe any significant interaction effect any of the ROIs (all interaction P<sub>Corr</sub> > .060) and these results did not change when adding the factor Reaction time to the respective models (all  P<sub>Corr</sub> > .075).”

      (3) There are substantial individual differences in pharmacological responses, physiological and cortisol measures, as shown in Figure 3A&B. If such individual differences are taken into account, are there any potential effects on subsequent recall on Day 3 pertaining to the hydrocortisone group?

      In response to this comment (and the General comment #1 of this reviewer), we now re-analyzed the respective models including individual measures of baseline-to-peak cortisol and systolic blood pressure.

      We re-analysed the reported Day 3 models, now including individual measures of baseline-to-peak changes in cortisol and systolic blood pressure, respectively. We report these additional analyses in the supplement and refer the interested reader to these analyses on page 15, lines 580 to 586:

      “As individual factors, such as metabolism or body weight, can influence the drug's action, we ran an additional analysis in which we included individual (baseline-to-peak) differences in salivary cortisol and (systolic) blood pressure, respectively. This analysis did not show any group by baseline-to-peak difference interaction suggesting that the observed memory effects were mainly driven by the pharmacological intervention group per se and less by individual variation in responses to the drug (see Supplemental Results).”

      And in the Supplemental Results:

      “To account for individual differences in cortisol responses after pill intake, we fit additional GLMMs predicting Day 3 subsequent memory of cued and correct trials including the factors Individual baseline-to-peak cortisol and Group. Doing so allowed us to account for variation in Day 3 performance, which might have resulted from within-group variation in cortisol responses, in particular in the CORT group. Importantly, none of the models predicting Day 3 memory performance by Day 2 cortisol-increase and Group, median-split RTs (high/low), hippocampal activity and RTs, or hippocampal activity and VTC category reinstatement revealed a significant group x baseline-to-peak cortisol interaction (all Ps > .122). These results suggest that inter-individual differences in cortisol responses did not have a significant impact on subsequent memory, beyond the influence of group per se. The same analyses were repeated for systolic blood pressure employing GLMMs predicting Day 3 subsequent memory of cued and correct trials including the factors Individual baseline-to-peak systolic blood pressure and Group to account for variation in Day 3 performance, which might have resulted from within-group variation in blood pressure response, in particular in the YOH group. While the model predicting Day 3 memory performance revealed a significant Individual baseline-to-peak systolic blood pressure × Group × median-split RTs (high/low) interaction (β = -0.05 ± 0.02, z = -2.04, P = .041, R<sup>2</sup><sub>conditional</sub> = 0.01), post-hoc slope tests, however, did not show any significant difference between groups (all P<sub>Corr</sub> > .329). The remaining models including hippocampal activity and RTs, or hippocampal activity and VTC category reinstatement did not reveal a significant Group × Individual baseline-to-peak systolic blood pressure interaction (all Ps > .101). These results suggest that inter-individual differences in systolic blood pressure responses did not have a significant impact on subsequent memory, beyond the influence of group per se.”

      (4) Median-splitting approach for reaction times and hippocampal activity should better be justified.

      Reaction times are well established proxies (correlates) of memory strength and memory confidence in previous research, as they reflect cognitive processes involved in retrieving information. Faster reaction times indicate stronger mnemonic evidence and higher confidence in the accuracy of a memory decision, while slower responses suggest weaker evidence and decision uncertainty or doubt. This relationship is supported by an extensive literature (e.g., Starns 2021; Robinson et al., 1997; Ratcliff & Murdock, 1976; amongst others). Importantly, distinguishing between high and low confidence choices in a memory task serves the purpose to differentiating between particularly strong memory evidence (e.g., is associative cued recall, when remembering is particularly vivid) and weaker memory evidence. Separating low from high confidence responses based on participants’ reaction times was especially important in the current analyses, because previous research demonstrates that reaction times during cued recall tasks inversely correlate with hippocampal involvement ( Heinbockel et al., 2024; Gagnon et al. 2019) and that stress-effects on human memory may be particularly pronounced for high-confidence memories (Gagnon et al., 2019).

      In response to the Reviewer comments, we have elaborated on our rationale for the distinction between short and long reaction times in the introduction, results, and methods. Please see page 4, lines 144 to 148:

      “We distinguished between responses with short and long reaction times indicative of high and low confidence responses because previous research showed that reaction times are inversely correlated with hippocampal memory involvement(58–60) and memory strength(61,62), and that high confidence memories associated with short reaction times may be particularly sensitive to stress effects(63).”

      On page 13, lines 520 to 523:

      “Reaction times in the Day 2 Memory cueing task revealed a trial-specific gradient in reactivation strength. Thus, we turned to single-trial analyses, differentiating Day 3 trials by short and long reaction times during memory cueing on Day 2 (median split), indicative of high vs. low memory confidence(58–60) and hippocampal reactivation(26,63).”

      And on page 26, lines 1046 to 1053:

      “Reaction times serve as a proxy for memory confidence and memory strength, with faster responses reflecting higher confidence/strength and slower responses suggesting greater uncertainty/weaker memory. The association between reaction times and memory confidence has been established by previous research(58–60), suggesting that the distinction between high from low confidence responses differentiates vividly recalled associations from decisions based on weaker memory evidence. Reaction times are further linked to hippocampal activity during recall tasks(26,53), and stress effects on memory are particularly pronounced for high-confidence memories(53).”

      Minor comments:

      (5) Please include the full names of key abbreviations in the figure legends, such as "ass.cat.hit" and among others.

      We now include the full names of key abbreviations in all figure legends (e.g., ass.cat.hit = associative category hit).

      (6) Please introduce various metrics used in the study to aid readers in better understanding the measurements they utilized.

      We agree that various measures that were included in our analyses had not been described clearly enough before, especially concerning the multivariate analyses. We therefore added short explanations across the results section.

      Page 8, lines 279 to 280: “Classifier accuracy is derived from the sum of correct predictions the trained classifier made in the test-set, relative to the total amount of predictions.”

      Page 8, lines 290 to 292:  “Neural reinstatement reflects the extent to which a neural activity pattern (i.e., for objects) that was present during encoding is reactivated during retrieval (e.g., memory cueing).”

      Page 8, lines 299 to 301:  “The logits here reflect the log-transformed trial-wise probability of a pattern either representing a scene or an object.”

      Page 10, lines 378 to 380:  “Beyond category-level reinstatement, we assessed event-level memory trace reinstatement from initial encoding (Day 1) to memory cueing (Day 2), via RSA, correlating neural patterns in each region (hippocampus, VTC, and PCC) across days.”

      (7) Please explain what the different colors represent in Figures 5B and 5C to avoid confusion. It would be good to indicate significant differences in the figures if applicable.

      We now added line legends to the figure and also the caption to clarify what exactly is depicted. We added asterisks to mark significant differences.

      References:

      Monfils, M. H., Cowansage, K. K., Klann, E., & LeDoux, J. E. (2009). Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories. science324(5929), 951-955.

      Monfils, M. H., & Holmes, E. A. (2018). Memory boundaries: opening a window inspired by reconsolidation to treat anxiety, trauma-related, and addiction disorders. The Lancet Psychiatry5(12), 1032-1042.

      Lee, J. L. C., Nader, K. & Schiller, D. An Update on Memory Reconsolidation Updating. Trends Cogn. Sci. 21, 531–545 (2017).

      Radley, J. J., Williams, B., & Sawchenko, P. E. (2008). Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress. Journal of Neuroscience28(22), 5806-5816.

      Heinbockel, H., Wagner, A. D., & Schwabe, L. (2024). Post-retrieval stress impairs subsequent memory depending on hippocampal memory trace reinstatement during reactivation. Science Advances10(18), eadm7504.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Jin, Briggs, and colleagues use light sheet imaging to reconstruct the islet threedimensional Ca2+ network. The authors find that early/late responding (leader) cells are dynamic over time, and located at the islet periphery. By contrast, highly connected or hub cells are stable and located toward the islet center. Suggesting that the two subpopulations are differentially regulated by fuel input, glucokinase activation only influences leader cell phenotype, whereas hubs remain stable.

      Strengths:

      The studies are novel in providing the first three-dimensional snapshot of the beta cell functional network, as well as determining the localization of some of the different subpopulations identified to date. The studies also provide some consensus as to the origin, stability, and role of such subpopulations in islet function.

      We thank the reviewers for their positive assessment.

      Weaknesses:

      Experiments with metabolic enzyme activators do not take into account the influence of cell viability on the observed Ca2+ network data. Limitations of the imaging approach used need to be recognized and evaluated/discussed.

      We worked very hard to make sure the islets remained stable and healthy over the duration of imaging time course. We imaged the islet in 3D and observed that all betacells displayed glucose-dependent oscillations, which can only arise from functioning cells. From the raw calcium traces (displayed in the figures) we observed no detectable loss of signal over 60 min of continuous imaging regardless of drug treatment; this is because the laser excitation is below the bleach threshold for GCaMP6s, and it is bleaching that generates phototoxicity. To demonstrate this clearly, we performed a bleach test using 6x laser power; in this case calcium amplitude dropped 30% over a 60 min of imaging, however islet calcium oscillatory behavior was preserved. Light-sheet is well documented to be 1000x more gentle than other optical sectioning techniques, which is why it was chosen for this application.

      Regarding the limitations of imaging approach, we recognized studying islets ex vivo is necessarily performed in the absence of native surrounding tissue, as highlighted in the discussion.

      Reviewer #2 (Public Review):

      The manuscript by Erli Jin, Jennifer Briggs et al. utilizes light sheet microscopy to image islet beta cell calcium oscillations in 3D and determine where beta cell populations are located that begin and coordinate glucose-stimulated calcium oscillations. The light sheet technique allowed clear 3D mapping of beta cell calcium responses to glucose, glucokinase activation, and pyruvate kinase activation. The manuscript finds that synchronized beta-cells are found at the islet center, that leader beta cells showing the first calcium responses are located on the islet periphery, that glucokinase activation helped maintain beta cells that lead calcium responses, and that pyruvate kinase activation primarily increases islet calcium oscillation frequency. The study is well-designed, contains a significant amount of high-quality data, and the conclusions are largely supported by the results.

      It has recently been shown that beta cells within islets containing intact vasculature (such as those in a pancreatic slice) show different calcium responses compared to isolated islets (such as that shown in PMID: 35559734). It would be important to include some discussion about the potential in vitro artifacts in calcium that arise following islet isolation (this could be included in the discussion about the limitations of the study).

      Although isolated islets reproduce the slow oscillatory calcium behavior observed in vivo, we agree that missing elements such as blood flow, cholinergic innervation, and surrounding tissues may each impact islet calcium responses. Pancreatic regional blood flow also links the endocrine and exocrine signaling which can directly influence the behavior of beta cells. We have highlighted some of these issues in the discussion “In addition to α-cells, vasculature may also impact islet Ca2+ responses, and may induce additional heterogeneity in vivo.” (see line 375, Ref. 46).

      Reviewer #3 (Public Review):

      Summary:

      Jin, Briggs et al. made use of light-sheet 3D imaging and data analysis to assess the collective network activity in isolated mouse islets. The major advantage of using whole islet imaging, despite compromising on the speed of acquisition, is that it provides a complete description of the network, while 2D networks are only an approximation of the islet network. In static-incubation conditions, excluding the effects of perfusion, they assessed two subpopulations of beta cells and their spatial consistency and metabolic dependence.

      Strengths:

      The authors confirmed that coordinated Ca2+ oscillations are important for glycemic control. In addition, they definitively disproved the role of individual privileged cells, which were suggested to lead or coordinate Ca²⁺ oscillations. They provided evidence for differential regional stability, confirming the previously described stochastic nature of the beta cells that act as strongly connected hubs as well as beta cells in initiating regions (doi.org/10.1103/PhysRevLett.127.168101).

      The fact that islet cores contain beta cells that are more active and more coordinated has also been readily observed in high-frequency 2D recordings (e.g. DOI: 10.2337/db22-0952), suggesting that the high-speed capture of fast activity can partially compensate for incomplete topological information.

      They also found an increased metabolic sensitivity of mantle regions of an islet with a subpopulation of beta cells with a high probability of leading the islet activity which can be entrained by fuel input. They discuss a potential role of alpha/delta cell interaction, however relative lack of beta cells in the islet border region could also be a factor contributing to less connectivity and higher excitability.

      The Methods section contains a useful series of direct instructions on how to approach fast 3D imaging with currently available hardware and software.

      The Discussion is clear and includes most of the issues regarding the interpretation of the presented results.

      Some issues concerning inconsistencies between data presented and statements made as well as statistical analysis need to be addressed.

      Taken together it is a strong technical paper to demonstrate the stochasticity regarding the functions subpopulations of beta cells in the islets may have and how less well-resolved approaches (both missing spatial resolution as well as missing temporal resolution) led us to jump to unjustified conclusions regarding the fixed roles of individual beta cells within an islet.

      We thank the reviewers for the comments on the many strengths of the manuscript and address the specific critiques below.

      Recommendations for the authors:

      Reviewing Editor Comments:

      Essential revisions:

      (1) How useful is GK activation as a subpopulation-level perturbation, given that all beta cells would be affected? Previous studies by the authors have shown that GK gradients likely dictate subpopulation behaviour, so the concern here is that GK activation across all cells might mask the influence of such gradients i.e. a U-shaped effect. Also, does the GK activator differentially penetrate the islet such that first responders/leaders are more vulnerable than hubs?

      As we previously published, non-saturating concentrations of GK activator (as used here) have the same effect on calcium oscillations as raising glucose (PMID:33147484). In other words, the activator boosts the activity of the endogenous GK. To the second point, recent ex vivo islet studies (PMID: 28380380) document the islet penetration of a fluorescent glucose analogue within seconds even under static conditions, and in our study the islets calcium oscillations reached steady state, so we are not concerned about drug penetration. The real limitation with any drug study in the islet is that non-beta cells are also activated; this limitation is included in the discussion along with the recommendation that genetic tools are needed to assess the effect of GK activation in the various endocrine subpopulations. 

      An additional concern with the GK activation experiment is that GK activation might push beta cells into a more stressed state such that they are more susceptible to phototoxicity. Although the authors state that photobleaching is low, they provide no data to support such a statement. Given the long duration of imaging and acquisition rate, phototoxicity might be more of an issue, especially with GK activation. Some further analysis (e.g. apoptosis) would be useful here to exclude an effect of beta cell viability versus GK activation on the observed phenotype of the different subpopulations.

      Acute GK activation (for 30min) does not stress the islet; the drug has the same effect as raising glucose (PMID: 33147484). To determine whether photobleaching was impacted by GK activation, we examined the peak of consecutive oscillations in response to vehicle and GK activator. The average photobleaching was less than 2% of the calcium fluorescence over 30min of continuous imaging. Furthermore, GKa activation did not significantly increase photobleaching (see Author response image 1). 

      Author response image 1.

      To the reviewer’s second point, apoptosis cannot occur on the timescale of the drug treatment (30min), and raw calcium traces are included showing that all beta cells display oscillatory behavior throughout the course of the experiment.

      (2) The authors show that glucokinase activation increases the duration of islet calcium oscillations and in some islets (3 of 15 islets) causes "a Ca2+ plateau." The authors indicate that "Glucokinase, as the 'glucose sensor' for the β-cell, controls the input of glucose carbons into glycolysis, and opens KATP channels." It would be nice to have some experimental evidence that the change in oscillation rate caused by the glucokinase activator is due to KATP activation. This could be accomplished by treating islets with subthreshold KATP activators (e.g., diazoxide) or subthreshold KATP inhibitors (e.g., tolbutamide).

      The statement that glucokinase activation opens KATP channels was a typo; glucose metabolism closes KATP channels by raising the ATP/ADP ratio. We now include additional citations that document the relationship between GK and KATP and the oscillatory behavior. See Ref 22 (PMID: 33147484) and Ref 34 (PMID: 33147484).

      The manuscript finds that "Early phase cells were maintained to a greater degree upon GKa application." Yet GKa is proposed to activate KATP. Some discussion about how the early phase is maintained in cell populations by GKa activation in the context of KATP activity would be useful.

      As discussed above, we meant to say that GKa will close KATP and apologize for the confusion. As we mentioned in the discussion, early phase cells are most likely maintained to a great degree following GK activation as result of enhanced GK gradient and reduced effect of stochastic alpha cell input. 

      (3) Membrane potential depolarization precedes calcium channel activation and subsequent calcium entry. In many cases, electrical coupling across beta cells happens on millisecond timescale. It would be good to confirm that the calcium is showing the same time scale in terms of elevation following beta cell membrane potential depolarization. One concern is that the islet beta cells could be depolarizing at the same speed and lagging in terms of calcium channel activation and calcium entry.

      We thank the reviewer for making this point, which is almost certainly true, particularly since plasma membrane calcium influx is not the sole source of intracellular calcium. Previously published “simultaneous” recordings of Vm and calcium show their same phase relationship but do not have sufficient time resolution to capture depolarization of each cell. A quantification of phase lag would require the field to generate mice with voltage sensors expressed in beta cells; these tools are not yet available.  

      A related issue: in the text, the authors discuss changes in membrane potential (not been measured in this study), while in the figures they exclusively describe Ca2+ oscillations (which were measured). Examples are on lines 149, 150, 153, 154, 263. It is recommended that the silent and active phases in the Results section describe processes actually measured in this study as shown in 6A.

      To clarify, we did not use the term ‘membrane potential’ anywhere in the manuscript. We do sometimes refer to calcium influx as a proxy for membrane depolarization; we think this is valid given the abundant evidence that these processes are interdependent in beta cells.

      (4) It would be good to include the timing of the phases of calcium entry. When was the beta cell calcium entry monitored for the response time? Were the response times between the late and early phases consistent for each oscillation? It looks as if the start of the calcium upstroke was similar for many beta cells (such as for the Figure 2I traces). It would be nice to include a shorter time duration graph of calcium oscillation traces right when the upstroke starts. This would allow the community to observe the differences in the start time of calcium entry. 

      We agree this is an important point. We now include an inset showing the expanded time scale of the calcium upstroke in Fig.2I. The response time spread between early and late phase cells is now shown in Fig.7F (and in Author response image 2). We also quantified the coefficient of variation in the response time spread (0 = no variation and 1 = maximal variation) and found no significant differences between metabolic activators (Author response image 2). 

      Author response image 2.

      Also, for most of the GCaMP6s traces shown, the authors indicate that they are plotted as F/F0. However, this normalization (F/F0) is not done for the actual traces shown. For example, Figure 2D shows the traces starting from what looks to be 0 to 0.3 F/F0, but the traces for an F/F0 group should all start at 1. Please change this for all representative oscillations so the start of calcium entry for example traces all line up.

      This has been corrected in Fig. 2D, I and Fig. 3B. Also Fig.6 should be F not F/F0

      Reviewer #1 (Recommendations for the authors):

      (1) Line 53: "Silencing the electrical activity of these hub cells with optogenetics was found to abolish the coordination within that plane of the islet". The authors should acknowledge that studies also showed that beta cell transcription factor (Pdx1/Mafa) dosage was important for hub cell phenotype and islet function.

      Thank you, this reference to Nasteska et al. (PMID: 33514698, Ref. 16) has been added to the discussion.

      (2) Light sheet imaging is used to image the 3D islet volume. Whilst speed is undoubtedly an advantage of this technique, axial resolution is ~1.1 µm over 4 µm z-step size. How confident are the authors that single nuclei can be reliably identified given their ~6 µm size in a beta cell (e.g. do some elongated nuclear appear, which could be "doublets")?

      The axial resolution of 1.1 µm exceeds the resolution needed for the Nyquist criterion (i.e. sampling every 2-3 µm). As a practical matter, it is not possible to doublecount nuclei because the software will exclude nuclei that occupy the same volume. Only a very elongated nucleus (>10 µm) would be double counted and this does not occur.

      (3) The authors discuss the advantages of the light sheet imaging approach used, including speed and phototoxicity. Some more balance is needed here since other approaches such as two-photon excitation achieve similar speeds with much better axial resolution (see dozens of neural circuit studies).

      We are careful to point out that two-photon excitation has better axial resolution, better tissue penetration, and often higher speeds (kHz using linescans) – however these neuronal studies are limited to the cells in a few planes and the laser power is orders of magnitude higher than lightsheet. For this reason, two photon imaging has not been used to image islet calcium in three dimensions. The bottom line is lightsheet trades axial resolution for gentle volumetric imaging. 

      (4) Line 340: "Laser ablation or optogenetic inactivation of these early phase cells would be predicted to have little impact on islet function, as suggested previously by electrophysiological studies in which surface β-cells have been voltage-clamped with no impact on β-cell oscillations". This statement is slightly ambiguous since the authors showed in their previous studies that laser ablation of first responder cells/leaders was able to influence the Ca2+ network. Do the authors mean that laser ablation would only temporarily influence islet function before another cell picked up the role of a first responder/leader? As written, the sentence seems to imply that first responders/leaders are unimportant for the islet function.

      We intended to imply that the oscillatory system is sufficiently robust that a new cell take over when leader cells are ablated. We also cite Korosak et al. (PMID:34723613, Ref. 40) and Dwulet et al. (PMID: 33939712, Ref. 15) to make this point, although to clarify we are not examining first responders in this study.

      (5) Line 369: "In contrast with leader cells, we found that the highly synchronized cells are both spatially and temporally stable." The sentence needs qualifying- what would spatiotemporal stability be expected to confer on such a subpopulation?

      We believe that the spatiotemporal stability of highly synchronized cells is a consequence of beta cells in the center of the islet lacking the stochastic input of nearby alpha cells; we raise this point in the discussion: “The preponderance of α-cells on the periphery of mouse islets, which influence β-cell oscillation frequency, would be expected to disrupt β-cell synchronization on the periphery and stabilize it in the islet center – which is precisely the pattern of network activity we observed.” (see line 372). 

      (6) Line 370: "However, in conflict with the description of hub cells as intermingled with other cells throughout the islet, the location of such cells in 3D space is close to the center." The study by Johnston et al did not have the axial resolution to exclude that some cells might have been grouped together.

      We agree and have included the reviewer’s comment in the text (See line 384); that’s an important reason for conducting this 3D study.  

      (7) Line 380: "One explanation may be that paracrine communication within the islet determines which region of cells will show high or low degree. For example, more peripheral cells that are in contact with nearby δ-cells may show some suppression in their Ca2+ dynamics, and thus reduced synchronization." A potentially exciting future study. Should however probably cite DOI s41467-022-31373-6 here.

      We thank the reviewer for their input. This reference to Ren et al. (PMID:35764654) was previously included as Ref. 42 (now Ref. 45)

      Reviewer #3 (Recommendations for the authors):

      (1) There are in fact no radially oriented networks in the core of an islet (l. 130, Figure 4) apart from the fact that every hub has somewhat radially oriented edges. For radiality to have some general meaning, the normalized distance from the geometric center would need to be lower than 0.4. The networks are centrally located, which does not change the major conclusions of the study.

      Thank you for pointing out this imprecise language. We did not intend to imply that the functional network is orientated radially. We corrected the text (see line 131, 145) to indicate that the cells with high and low synchronization are distributed in a radial pattern. 

      (2) The study would benefit from acknowledging that Ca2+ influx is not a sole mechanism to drive insulin secretion and that KATP channels are not the sole target sensitive to changes in the cytosolic (global or local) ADP and ATP concentration or that there is an absolute concentration-dependence of these ligands on KATP channels. The relatively small conductance changes that have been found to be associated with active and silent phases (closing and opening of the KATP channels as interpreted by the authors, respectively, doi: 10.1152/ajpendo.00046.2013) and should be due to metabolic factors, could be also associated to desensitization of KATP channels to ATP due to the increase in cytosolic Ca2+ changes after intracellular Ca2+ flux (DOI: 10.1210/endo.143.2.8625) as they have been found to operate also at time scales, significantly faster (DOI: 10.2337/db22-0952) than reported before (refs. 21,22). Metabolic changes influence intracellular Ca2+ flux as well.

      The reviewer is absolutely correct that there are amplifying factors and other sources of calcium beyond plasma membrane influx and there are other mechanisms that regulate insulin secretion beyond calcium levels. These alternative mechanisms are introduced in Refs. 1-2, however they are not the focus of this study. 

      (3) There is no explanation for why KL divergence is so different between the pre-test regional consistency of the islets used to test the vehicle compared to those where GKa and PKa have been tested.

      We thank the reviewer for their careful observation. This arises because there are larger differences between preparations than within a preparation. This has been described previously (PMID: 16306370 and 20037650) and could be expected to account for the differences in KL divergence between animals. 

      (4) Statistical analysis would profit from testing the normality of the data distribution before choosing the statistical test and then learning the difference between parametric and nonparametric tests. For example, in Figures 3CD and 5EF, the data density is lower at the calculated mean than below and above this value and there are other examples in other figures too.

      We thank the reviewer for this very important comment, and we apologize for the oversight on our part. To address this comment, we conducted two normality tests: Anderson-Darling and Kolmogorov-Smirnov on all statistical analyses in the manuscript. If the data were not normally distributed, we changed the analysis to Wilcoxon matchedpairs signed rank test (non-parametric version of t-tests) or the Friedman test (nonparametric version of ANOVA). Three results were changed based on this statistical correction: Figure 4D, also 5F 3D (from P=0.01 to P=0.0526), Figure 5F  ¼ z-depth (P = 0.005 to P = 0.012). We have updated the manuscript methods, results, and figures accordingly. Importantly, these results did not change the main points of the paper.

    1. Author response:

      Reviewer #1 (Public review):

      We thank Reviewer #1 for their thoughtful assessment. We especially agree that AVI-4206 will be a valuable tool to help understand the host immune response to viral infection.

      Reviewer #2 (Public review):

      We thank Reviewer #2 for their comments and will address PARP9/14 selectivity with in vitro experiments and alignments/modeling. For ADP-ribosylation of PARP14, we will attempt experiments patterned after Kar et al, EMBO Journal, 2024, but note that detection of ADPr by IF and western has been relatively inconsistent and detection-reagent dependent in our hands. Regardless of the outcome, we will expand the discussion of the prior literature on this point.

      Reviewer #3 (Public review):

      We thank Reviewer #3 for their comments, especially noting that we had the “chutzpah” to go for the in vivo experiment. We share the concern about potential off target effects, which is why we prioritized so many selectivity experiments prior to testing. Ongoing chemistry efforts are focused on developing next-generation inhibitors that are orally bioavailable, but this work is in its early stages.

    1. Author response:

      We thank the reviewers for the thoughtful comments, and we hope to address these issues in a future revision. We will clarify that chaos only serves to generate barcodes, and show that once they are formed and assigned the memory mechanism is stable to initial conditions.  We will also clarify the model's assumptions and its connections to indexing theory and to experimental results.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Reviews):  

      First, the metabolic network in this study is incomplete. For example, amino acid synthesis and lipid synthesis are important for biomass and growth, but they4 are not included in the three models used in this study. NADH and NADPH are as important as ATP/ADP/AMP, but they are not included in the models. In the future, a more comprehensive metabolic and biosynthesis model is required.  

      Thank you for the critical comment on the weakness of the present study. We actually tried to study a larger model like Turnborg et al (2021), which is a model of JCVI-syn3A, but we give up to include it in our model list to study in depth. This is because we noticed that the concentration of ATP in the model can be negative (we confirmed this with one of the authors of the paper). Another "big" kinetic model of metabolism that we could list would be Khodayari et al (2017). However, we could not find the models to compare the dynamics of this big model with. Therefore, we decided to use the model only for the central carbon metabolism for now. We would like to leave a more extended study for the near future.  

      We would like to mention that NADH and NADPH are included in Khodayari model and Boecker model, while NADH and NADPH are ramped up to NADH in the latter model.  

      Second, this work does not provide a mathematical explanation of the perturbation response χ. Since the perturbation analysis is performed close to the steady state (or at least belongs to the attractor of single-steady-state), local linear analysis would provide useful information. By complementing with other analysis in dynamical systems (described below) we can gain more logical insights about perturbation response.  

      We tried a linear stability analysis. However, with the perturbation strength we used here, the linearization of the model is no longer valid, in the sense that the linearized model

      leads to negative concentrations of the metabolites (xst+Δx < 0 for some metabolites). We have added a scatter plot of the response coefficient of trajectories sharing the initial condition, while the dynamics are computed by the original model and the linearized model, respectively. (Fig. S1). 

      Since the response coefficient is based on the logarithm of the concentrations, as the metabolite concentrations approach zero, the response coefficient becomes larger. The high response coefficient in the Boecker and Chassagnole model would be explained by this artifact.  The linearized Khodayari model shows either χ~1 or χ = 0 (one or more metabolite concentrations become negative). This could be due to the number of variables in the model. For the response coefficient to have a larger value, the perturbation should be along the eigenvector that leads to oscillatory dynamics with long relaxation time (i.e., the corresponding eigenvalue has a small real part in terms of absolute value and a non-zero imaginary part). However, since the Khodayari model has about 800 variables, if perturbations are along such directions, there is a high probability that one or more metabolite concentrations will become negative.

      We fully agree that if the perturbations on the metabolite concentrations are in the linear regime, the response to the perturbations can be estimated by checking the eigenvalues and eigenvectors. However, we would say that the relationship between the linearized model (and thus the spectrum of eigenvalues) and the original model is unclear in this regime.  We remarked this in Lines 158160.

      Recommendations for the authors:

      My major suggestion is about understanding the key quantity in this study: the response coefficient χ. When the perturbed state is close to the fixed point, one could adopt local stability analysis and consider the linearized system. For a linear system with one stable fixed point P, we consider the Jacobian matrix M on P. If all eigenvalues of M are real and negative, the perturbed trajectory will return to P with each component monotonically varies. If some eigenvalues have negative real part and nonzero imaginary part, then the perturbed trajectory will spiral inward to the fixed point. Depending on the spiral trajectory and the initially perturbed state, some components would deviate furthermore (transiently) from the fixed point on the spiral trajectory. This explains why the response coefficient χ can be greater than 1. 

      Mathematically, a locally linearized system has similar behavior to the linear system, and the examples in this study can be analyzed in the similar way. Specifically, if a system has many complex eigenvalues, then the perturbed trajectory is more likely to have further deviation. The metabolic network models investigated in this work are not extremely large, and hence the author could analyze its spectrum of the Jacobian matrix at the steady state. Since the steady state is stable, I expect the spectrum located in the left half of the complex plane. If the spectrum spread out away from the real axis, we expect to see more spiral trajectories under perturbation. I think the spectrum analysis will provide a complementary view with respect to analysis on χ.  The authors' major findings, about the network sparsity and cofactors, can also be investigated under the framework of the spectrum analysis.  

      Of course, when the nonlinear system is perturbed far away from the fixed point, there are other geometrical properties of the vector field that can cause the response coefficient χ to be greater than 1. This could also be investigated in the future by testing the behavior of small and large perturbations and observing if the systems have signatures of nonlinearity.  

      Since all perturbed states return to the steady state, the eigenvalues of the Jacobi matrix accompanying the linearized system around the steady state are in the left half complex plane (negative real value). Also, some eigenvalues have non-zero imaginary parts.    

      The reason we emphasize the "nonlinear regime" is that the linearization is no longer valid in this regime, i.e. the metabolite concentrations can be negative when we calculate the linearized system. Certainly, there are complex eigenvalues in the Jacobi matrix of any model. However, we would say that there is no clear relationship between the eigenvalues and the response coefficient.      

      Minor suggestions:  

      Line 127: Regarding the source of perturbation, cell division also generates unequal concentration of proteins and metabolites for two daughter cells, and it is an interesting mechanism to create metabolic perturbation. 

      Thank you for the insightful suggestion. We mentioned the cell division as another source of perturbation (Lines 130-131).

      Line 175: I do not quite understand the statement "fixing each metabolite concentration...", since the metabolite concentration in the ODE simulation would change immediately after this fixing.  

      We meant in the sentence that we fixed the concentration of the selected metabolite as the steady state concentration and set the dx/dt of that metabolite to zero. We have rewritten the sentences to avoid confusion (Lines 180-181).

      Figure 2: There are a lot of inconsistencies between the three models. Could we learn which model is more reasonable, or the conclusion here is that the cellular response under perturbation is model-specific? The latter explanation may not be quite satisfactory since we expect the overall cellular property should not be sensitive to the model details. 

      Ideally, the overall cellular property should be insensitive to model details. However, the reality is that the behavior of the models (e.g., steady-state properties, relaxation dynamics, etc.) depends on the specific parameter choices, including what regulation is implemented. I think this situation is part of the motivation for the ensemble modeling (by J. Liao and colleague) that has been developed.  

      Detailed responsiveness would be model specific. For example, FBP has a fairly strong effect in the Boecker model, but less so in the Khodayari model, and the opposite effect in the Chassagnole model (Fig. 2). Our question was whether there are common tendencies among kinetic models that tend to show model-specific behavior.  

      Reviewer 2 (Public Review):

      (1) In the study on determining key metabolites affecting responses to perturbations (starting from line 171), the authors fix the values of individual concentrations to their steady-state values and observe the responses. Such a procedure adds artificial constraints to the network because, in the natural responses of cells (and models) to perturbations, it is highly unlikely that metabolites will not evolve in time. By fixing the values of specific metabolites, the authors prohibit the metabolic network from evolving in the most optimal way to compensate for the perturbation. Instead of this procedure, have the authors considered for this task applying techniques from variance-based sensitivity analysis (Sobol, global sensitivity analysis), where they can calculate the first-order sensitivity index and total effect index? Using this technique, the authors would be able to determine the key metabolites while allowing for metabolic responses to perturbations without unnatural constraints. 

      Thank you for the useful suggestion for studying the roles of each metabolite for responsiveness. We have computed the total sensitivity index (Homma and Salteli, 1996) for each metabolite of each model (Fig.S5). The total sensitivity indices of ATP are high-ranked in Khodayari- and Chassagnole model, while it is middle-ranked in the Boecker model. We believe that the importance of the adenyl cofactors is highlighted also in terms of the Sobol’ sensitivity analysis (the figure is referred in Lines 193-195). 

      We have encountered a minor difficulty for computing the sensitivity index. For the computation of the sensitivity index, we need to carry out the following Monte Carlo integral, 

      where the superscript (m) is the sample number index. The subscript i represents the ith element of the vector x, and ~i represents the vector x except for the ith element. The tilde stands for resampling.  

      There are several conserved quantities in each model. For independent resampling, we need to deal with the conserved quantities. For the Boecker and Chassagnole models, we picked a single metabolite from each conservation law and solved its concentration algebraically to make the metabolite concentration the dependent variable. Then, we can resample the metabolite concentration of one metabolite without changing the concentrations of other metabolites, which are independent variables.  

      However, in the Khodayari model, it was difficult to solve the dependent variables because the model has about 800 variables. Therefore, we gave up the computations of the sensitivity indices of the metabolites whose concentration is part of any conserved quantities, namely NAD, NADH, NADP, NADPH, Q8, and Q8H2.

      (2) To follow up on the previous remark, the authors state that the metabolites that augment the response coefficient when their concentration is fixed tend to be allosteric regulators. The authors should report which allosteric regulations are implemented in each of the models so that one can compare against Figure 2. Again, the effect of allosteric regulation by a specific metabolite that is quantified the way the authors did is biased by fixing the concentration value - it is true that negative feedback is broken when the metabolite concentration is fixed, however, in the rate law, there is still the fixed inhibition term with its value corresponding to the inhibition at the steady state. To see the effect of allosteric regulation by a metabolite, one can change the inhibition constants instead of constraining the responses with fixed concentrations.  

      We have listed the substrate-level regulations (Table S1-3). Also, we re-ran the simulation with reduced the effect of the substrate-level regulations for the reactions that are suspected to influence the change of the response coefficient. Instead of fixing the concentrations (Fig. S6). 

      The impact of substrate-level regulations is discussed in Lines 203-212.   

      We replaced "allosteric regulation" with "substrate-level regulation" because we noticed that some regulations are not necessarily allosteric.

      (3) Given the role of ATP in metabolic processes, the authors' finding of the sensitivity of the three networks' responses to perturbations in the AXP concentrations seems reasonable. However, drawing such firm conclusions from only three models, with each of them built around one steady state and having one kinetic parameter set despite that they were built for different physiologies, raises some questions. It is well-known in studies related to basins of attraction of the steady states that the nonlinear responses also depend on the actual steady states, the values of kinetic parameters, and implemented kinetic rate law, i.e., not only on the topology of the underlying systems. In the population of only three models, we cannot exclude the possibility of overlaps and strong similarities in the values of kinetic parameters, steady states, and enzyme saturations that all affect and might bias the observed responses. Ideally, to eliminate the possibility of such biases, one should simulate responses of a large population of models for multiple physiologies (and the corresponding steady states) and multiple parameter sets per physiology. This can be a difficult task, but having more kinetic models in this work would go a long way toward more convincing results. Recently, E. coli nonlinear kinetic models from several groups appeared that might help in this task, e.g., Haiman et al., PLoS Comput Biol, 17(1): e1008208, (2021), Choudhury et al., Nat Mach Intell, 4, 710-719, (2022); Hu et al., Metab Eng, 82, 123-133 (2024), Narayanan et al., Nat Commun, 15:723, (2024). 

      We have computed the responsiveness of 215 models generated by the MASSpy package (Haiman et al, 2021). Several model realizations showed a strong responsiveness, i.e. a broader distribution of the response coefficient (Fig.S8), and mentioned in Lines 339-341.

      We would like to mention that the three models studied in the present manuscript have limited overlap in terms of kinetic rate law and, accordingly, parameter values. In the Khodayari model, all reactions are bi-uni or uni-uni reactions implemented by mass-action kinetics, while the Boecker and Chassagnole models use the generalized Michaelis-Menten type rate laws. Also, the relationship between the response coefficients of the original model and the linearized model highlights the differences between the models (Fig. S1). If the models were somewhat effectively similar, the scatter plots of the response coefficient of the original- and linearized model should look similar among the three models. However, the three panels show completely different trends. Thus, the three models have less similarity even when they are linearized around the steady states. 

      (4) Can the authors share their insights on what could be the underlying reasons for the bimodal distribution in Figure 1E? Even after adding random reactions, the distribution still has two modes - why is that?  

      We have not yet resolved why only the Khodayari model shows the bimodal distribution of the response coefficient. However, by examining the time courses, the dynamics of the Khodayari model look like those of the excitable systems. This feature may contribute to the bimodal distribution of the response coefficient. In the future, we would like to show whether the system is indeed the excitable system and whcih reactions contribute to such dynamics.

      (5) Considering the effects of the sparsity of the networks on the perturbation responses (from line 223 onwards), when we compare the three analyzed models, it is clear that the Khodayari et al. model is a superset of the other two models. Therefore, this model can be considered as, e.g., Chassagnole model with Nadd reactions (though not randomly added). Based on Figures 1b and S2, one can observe that the responses of the Khodayari models have stronger responses, which is exactly opposite to the authors' conclusion that adding the reactions weakens the responses.

      The authors should comment on this.  

      The sparsity of the network is defined by the ratio of the number of metabolites to the number of reactions. Note that the Khodayari model is a superset of the Boecker and Chassagnole models in terms of the number of reactions, but also in terms of the number of metabolites (Boecker does not have the pentose phosphate pathway, Chassagnole does not have the TCA cycle, and neither has oxyative phosphorylation). Thus, even if we manually add reactions to the Boecker model, for example, we cannot obtain a network that is equivalent to the Khodayari model.  We added one sentence to clarify the point (Lines 254-255).

      Recommendations for the authors: 

      (1) Some typos: Line 57, remove ?; Line 134, correct "relaxation". 

      Thank you for pointing out. We fixed the typos.

      (2) Lines 510-515, please rewrite/clarify, it is confusing what are you doing. 

      We rewrote the sentences (Lines 529-532). We are sorry for the confusion.

      (3) Line 522, where are the expressions above Leq and K*? 

      Leq appears in the original paper of the Boecker model, but we decided not to use Leq. We apologize for not removing Leq from the present manuscript. The * in K* is the wildcard for representing the subscripts. We added a description for the role of “*”. 

      (4) Lines 525-530, based on the wording, it seems like you test first for 128 initial concentrations if the models converge back to the steady state and then you generate another set of 128 initial concentrations - is this what you are doing, or you simply use the 128 initial concentrations that have passed the test? 

      We apologize for the confusion. We did the first thing. We have rewritten the sentence to make it clearer. 

      (5) Figure 3, caption, by "broken line," did the authors mean "dashed line"? 

      We meant dashed line. We changed “broken line” to “dashed line”.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Review: 

      Summary: 

      The authors present a new application of the high-content image-based morphological profiling Cell Painting (CP) to single cell type classification in mixed heterogeneous induced pluripotent stem cell-derived mixed neural cultures. Machine learning models were trained to classify single cell types according to either "engineered" features derived from the image or from the raw CP multiplexed image. The authors systematically evaluated experimental (e.g., cell density, cell types, fluorescent channels) and computational (e.g., different models, different cell regions) parameters and convincingly demonstrated that focusing on the nucleus and its surroundings contain sufficient information for robust and accurate cell type classification. Models that were trained on mono-cultures (i.e., containing a single cell type) could generalize for cell type prediction in mixed co-cultures, and to describe intermediate states of the maturation process of iPSC-derived neural progenitors to differentiation neurons.

      Strengths:

      Automatically identifying single cell types in heterogeneous mixed cell populations hold great promise to characterize mixed cell populations and to discover new rules of spatial organization and cell-cell communication. Although the current manuscript focuses on the application of quality control of iPSC cultures, the same approach can be extended to a wealth of other applications including in depth study of the spatial context. The simple and high-content assay democratizes use and enables adoption by other labs.

      The manuscript is supported by comprehensive experimental and computational validations that raises the bar beyond the current state of the art in the field of highcontent phenotyping and makes this manuscript especially compelling. These include (i) Explicitly assessing replication biases (batch effects); (ii) Direct comparison of featurebased (a la cell profiling) versus deep-learning-based classification (which is not trivial/obvious for the application of cell profiling); (iii) Systematic assessment of the contribution of each fluorescent channel; (iv) Evaluation of cell-density dependency; (v) explicit examination of mistakes in classification; (vi) Evaluating the performance of different spatial contexts around the cell/nucleus; (vii) generalization of models trained on cultures containing a single cell type (mono-cultures) to mixed co-cultures; (viii) application to multiple classification tasks.

      Comments on latest version:

      I have consulted with Reviewer #3 and both of us were impressed by revised manuscript, especially by the clear and convincing evidence regarding the nucleocentric model use of the nuclear periphery and its benefit for the case of dense cultures. However, there are two issues that are incompletely addressed (see below). Until these are resolved, the "strength of evidence" was elevated to "compelling".

      First, the analysis of the patch size is not clearly indicating that the 12-18um range is a critical factor (Fig. 4E). On the contrary, the performance seems to be not very sensitive to the patch size, which is actually a desired property for a method. Still, Fig. 4B convincingly shows that the nucleocentric model is not sensitive to the culture density, while the other models are. Thus, the authors can adjust their text saying that the nucleocentric approach is not sensitive to the patch size and that the patch size is selected to capture the nucleus and some margins around it, making it less prone to segmentation errors in dense cultures.

      We agree that there is a significant tolerance to different patch sizes, and have therefore reformulated the conclusion as suggested in the results and the discussion sections (page 10 and 16). As very large patch sizes (>40µm) do increase the variability of the predictions and the imbalance between recall and precision, we have left this observation in the results section, as it also motivates for using smaller patch sizes.  

      Second, the GitHub does not contain sufficient information to reproduce the analysis. Its current state is sparse with documentation that would make reproducing the work difficult. What versions of the software were used? Where should data be downloaded? The README contains references to many different argparse CLI arguments, but sparse details on what these arguments actually are, and which parameters the authors used to perform their analyses. Links to images are broken. Ideally, all of these details would be present, and the authors would include a step-by-step tutorial on how to reproduce their work. Fixing this will lead to an "exceptional" strength of evidence.

      We have added additional information to the GitHub to increase the reproducibility of the analysis.  

      • The README now contains additional documentation and more extensive explanations. A flowchart has been added, making the dataflow and order of analyses more clear.  

      • The accompanying dataset is 20GB in size and can be downloaded as a .zip-file from https://figshare.com/articles/dataset/Nucleocentric-Profiling/27141441?file=49522557. This file contains 2x480 raw images and a layout file.  

      • The used software versions are included in the manuscript in table 4. To increase the reproducibility, a Conda environment file (.yaml) has been added to the GitHub. This can be installed and contains the correct package versions.

      • The README now contains for each script and its arguments a short description on its meaning, on whether it is required or optional and its default setting.  

      • A step-by-step tutorial on the use of the test dataset has been included. This tutorial includes the arguments used to run the code from the command line terminal.

      Recommendations for the authors:

      There are no reference from the text to Fig. 2D and to Fig. 3C.

      This has been changed. The text has been added to the manuscript at page 6 (fig. 2D) and the reference to Fig. 3C has been included at page 8.

    1. Author response:

      We thank the reviewers for the constructive suggestions made in the Public Reviews and the Recommendations to Authors. We intend to address these comments in a revised manuscript as follows:

      (1) We will revise the text according to the reviewer suggestions with regards to specific RBM20-dependent mRNAs and providing more detailed explanations in results and discussion.

      (2) We will upload higher resolution images of several figures (resolution had been reduced to achieve lower file sizes) to address the comment regarding “data quality”.

      (3) We will include data on eCLIP control experiments.

      (4) We will add information on replication and new data for the western blot analysis.

    1. Author response:

      We are grateful for the thorough and constructive feedback provided on our manuscript.

      Regarding the main concern about power law behavior and scale invariance, we would like to clarify that our study does not aim to establish criticality. Instead, we focus on describing and understanding a specific scale-invariant property: the collapsed eigenspectra in neural activity under random sampling. Indeed, we tested Morrell et al.’s latent-variable model (eLife 12, RP89337, 2024, [1]), where a slowly varying latent factor drives population activity. Although it produces a seemingly power-law-like spectrum, random sampling does not replicate the strict spectral collapse observed in our data (second row in Author response image 1). This highlights that simply adding latent factors does not fully recapitulate the scale invariance we measure, suggesting richer or more intricate processes may be involved in real neural recordings.

      Author response image 1.

      Morrell et al.’s latent variable model [1, 2]. A-D: Functional sampled (RSap) eigenspectral of the Morrell et al. model. E-H: Random sampled (RSap) eigenspectra of the same model. Briefly, in Morrell et al.’s latent variable model [1, 2], neural activity is driven by Nf latent fields and a place fields. The latent fields are modeled as Ornstein-Uhlenbeck processes with a time constant τ . The parameters ϵ and η control the mean and variance of individual neurons’ firing rates, respectively. The following are the parameter values used. A,E: Using the same parameters as in [1]: N<sub>f</sub> = 10, ϵ = −2.67, η = 6, τ = 0.1. Half of the cells are also coupled to the place field. B,C,D,F,G,H: Using parameters from [2]: N<sub>f</sub> = 5, ϵ = −3, η = 4. There is no place field. The time constant τ = 0.1, 1, 10 for B,F, C,G, and D,H, respectively.

      We decided to make 5 key revisions.

      • As mentioned, we have evaluated the latent variable model proposed by Morrell et al. and found that they fail to reproduce the scale-invariant eigenspectra observed in our data; these results will be presented in the Discussion section and supported by a new Supplementary Figure.

      • We will include a discussion on the findings of Manley et al. (2024, [2]) regarding the issue of saturating dimensionality in the Discussion section, highlighting the methodological differences and their implications.

      • We will add a new mathematical derivation in the Methods section, elucidating the bounded dimensionality using the spectral properties of our model.

      • We will elaborate in the Discussion section to further emphasize the robustness of our findings by demonstrating their consistency across diverse datasets and experimental techniques.

      • We will incorporate a brief discussion on the implications for neural coding. In particular, Fisher information can become unbounded when the slope of the power-law rank plot is less than one, as highlighted in the recent work by Moosavi et al. (bioRxiv 2024.08.23.608710, Aug, 2024 [3]) in the Discussion section.

      We believe these revisions will address the concerns raised by you and collectively strengthen our manuscript to provide a more comprehensive and robust understanding of the geometry and dimensionality of brain-wide activity.

      References

      (1) M. C. Morrell, A. J. Sederberg, I. Nemenman, Latent dynamical variables produce signatures of spatiotemporal criticality in large biological systems. Physical Review Letters 126, 118302 (2021).

      (2) M. C. Morrell, I. Nemenman, A. Sederberg, Neural criticality from effective latent variables. eLife 12, RP89337 (2024).

    1. Author response:

      Reviewer #1 (Public review):

      This work regards the role of Aurora Kinase A (AurA) in trained immunity. The authors claim that AurA is essential to the induction of trained immunity. The paper starts with a series of experiments showing the effects of suppressing AurA on beta-glucan-trained immunity. This is followed by an account of how AurA inhibition changes the epigenetic and metabolic reprogramming that are characteristic of trained immunity. The authors then zoom in on specific metabolic and epigenetic processes (regulation of S-adenosylmethionine metabolism & histone methylation). Finally, an inhibitor of AurA is used to reduce beta-glucan's anti-tumour effects in a subcutaneous MC-38 model.

      Strengths:

      With the exception of my confusion around the methods used for relative gene expression measurements, the experimental methods are generally well-described. I appreciate the authors' broad approach to studying different key aspects of trained immunity (from comprehensive transcriptome/chromatin accessibility measurements to detailed mechanistic experiments). Approaching the hypothesis from many different angles inspires confidence in the results (although not completely - see weaknesses section). Furthermore, the large drug-screening panel is a valuable tool as these drugs are readily available for translational drug-repurposing research.

      We thank the reviewer for the positive and encouraging comments.

      Weaknesses:

      (1) The manuscript contains factual inaccuracies such as: (a) Intro: the claim that trained cells display a shift from OXPHOS to glycolysis based on the paper by Cheng et al. in 2014; this was later shown to be dependent on the dose of stimulation and actually both glycolysis and OXPHOS are generally upregulated in trained cells (pmid 32320649).

      We appreciate the reviewer for pointing out this inaccuracy, and we will revise our statement to ensure accurate and updated description. We are aware that trained immunity involves different metabolic pathways, including both glycolysis and oxidative phosphorylation[1, 2]. We also detected Oxygen Consumption Rate (OCR, as detailed in comment#8) but observed no increase of oxygen consumption in trained BMDMs while previous study reported decreased oxidative phosphorylation[3]. We will discuss the potential reasons underlying such different results.

      (b) Discussion: Trained immunity was first described as such in 2011, not decades ago.

      We are sorry for the inaccurate description, and we will correct the statement in our revised manuscript as “Despite the fact that the concept of “trained immunity” has been proposed since 2011, the mechanisms that regulate trained immunity are still not completely understood.”

      (2) The authors approach their hypothesis from different angles, which inspires a degree of confidence in the results. However, the statistical methods and reporting are underwhelming.

      (a) Graphs depict mean +/- SEM, whereas mean +/- SD is almost always more informative. (b) The use of 1-tailed tests is dubious in this scenario. Furthermore, in many experiments/figures the case could be made that the comparisons should be considered paired (the responses of cells from the same animal are inherently not independent due to their shared genetic background and, up until cell isolation, the same host factors like serum composition/microbiome/systemic inflammation etc). (c) It could be explained a little more clearly how multiple testing correction was done and why specific tests were chosen in each instance.

      Thank you for the suggestions and we will revise all data presented as mean ± SEM in the manuscript to mean ± SD, and provide a detailed description of how multiple comparisons were performed and explain the rationale behind the different comparison methods used. Previous studies have shown that knockdown of GNMT increases intracellular SAM level and knockdown of GNMT is commonly used as a method to upregulate SAM[4-6]. Thus we used 1-tailed test in Figure 3J.

      (d) Most experiments are done with n = 3, some experiments are done with n = 5. This is not a lot. While I don't think power analyses should be required for simple in vitro experiments, I would be wary of drawing conclusions based on n = 3. It is also not indicated if the data points were acquired in independent experiments. ATAC-seq/RNA-seq was, judging by the figures, done on only 2 mice per group. No power calculations were done for the in vivo tumor model.

      We are sorry for the confusion in our description in figure legends. As for in vitro studies, we performed at least three independent experiments (BMs isolated from different mice) but we only display technical replicates data from one experiment in our manuscript. As for seq data, we acknowledge the reviewer's concern regarding the small sample size (n=2) in our RNA-seq/ATAC-seq experiment. We consider the sequencing experiment mainly as an exploratory approach, and performed rigorous quality control and normalization of the sequencing data to ensure the reliability of our findings. While we understand that a larger sample size would be ideal for drawing more definitive conclusions, we believe that the current data offer valuable preliminary insights that can inform future studies with larger cohorts. As a complementary method, we conducted ChIP PCR for detecting active histone modification enrichment in Il6 and Tnf region to further verify the increased accessibility of trained immunity induced inflammatory genes and reliability of our conclusions despite the small sample size. We hope this clarifies our approach, and we would be happy to further acknowledge and discuss the limitations of the current study.

      For the in vivo experiment, we determined the sample size by referring to the animal numbers used for similar experiments in literatures. And according to a reported resource equation approach for calculating sample size in animal studies[7], n=5-7 is suitable for most of our mouse experiments. We will describe the details in the revised methods part.

      (e) Furthermore, the data spread in many experiments (particularly BMDM experiments) is extremely small. I wonder if these are true biological replicates, meaning each point represents BMDMs from a different animal? (disclaimer: I work with human materials where the spread is of course always much larger than in animal experiments, so I might be misjudging this.).

      We are sorry for the confusion in our description in figure legends. In vivo experiments represent individual mice as biological replicates, the exact values of n are reported in figure legends and each point represents data from a different animal (Figure 1I, and Figure 6). The in vitro cell assay was performed in triplicates, each experiment was independently replicated at least three times and points represents technical replicates.

      (3) Maybe the authors are reserving this for a separate paper, but it would be fantastic if the authors would report the outcomes of the entire drug screening instead of only a selected few. The field would benefit from this as it would save needless repeat experiments. The list of drugs contains several known inhibitors of training (e.g. mTOR inhibitors) so there must have been more 'hits' than the reported 8 Aurora inhibitors.

      Thank you for your suggestion and we will report the outcomes of the entire drug screening in the revised manuscript.

      (4) Relating to the drug screen and subsequent experiments: it is unclear to me in supplementary figure 1B which concentrations belong to secondary screens #1/#2 - the methods mention 5 µM for the primary screen and "0.2 and 1 µM" for secondary screens, is it in this order or in order of descending concentration?

      Thank you for your comments and we are sorry for unclear labelled results in supplementary 1B. We performed secondary drug screen at two concentrations, and drug concentrations corresponding to secondary screen#1 and #2 are 0.2, 1 μM respectively. That is to say, it is just in this order, not in an order of descending concentration.

      (a) It is unclear if the drug screen was performed with technical replicates or not - the supplementary figure 1B suggests no replicates and quite a large spread (in some cases lower concentration works better?)

      Thank you for your question. The drug screen was performed without technical replicates. Actually, we observed s a lower concentration works better in some cases. This might be due to the fact that the drug's effect correlates positively with its concentration only within a specific range (as seen in comment#4).

      (5) The methods for (presumably) qPCR for measuring gene expression in Figure 1C are missing. Which reference gene was used and is this a suitably stable gene?

      We are sorry for the omission for the qPCR method. The mRNA expression of Il6 and Tnf in trained BMDMs was normalized to untrained BMDMs and β-actin served as a reference gene. And we will describe in detail in our revised manuscript.

      (6) From the complete unedited blot image of Figure 1D it appears that the p-Aurora and total Aurora are not from the same gel (discordant number of lanes and positioning). This could be alright if there are no/only slight technical errors, but I find it misleading as it is presented as if the actin (loading control to account for aforementioned technical errors!) counts for the entire figure.

      Thanks for this comment. In the original data, p-Aurora and total Aurora were from different gels. In this experiment the membrane stripping/reprobing after p-Aurora antibody did now work well, so we couldn’t get all results from one gel, and we had to run another gel using the same samples to blot with anti-aurora antibody. Yes we should have provided separated actin blots as loading controls for this experiment. We will repeat the experiment and provide original data of three biological replicates to confirm the experiment result.

      Figure 2: This figure highlights results that are by far not the strongest ones - I think the 'top hits' deserve some more glory. A small explanation on why the highlighted results were selected would have been fitting.

      We appreciate the valuable suggestion. We will make a discussion in our revised manuscript.

      (7) Figure 3 incl supplement: the carbon tracing experiments show more glucose-carbon going into TCA cycle (suggesting upregulated oxidative metabolism), but no mito stress test was performed on the seahorse.

      We appreciate this question raised by the reviewer. We previously performed seahorse XF analyze to measure mito stress in β-glucan trained BMDMs in combination with alisertib (data not shown in our submitted manuscript). The results showed no increase in oxidative phosphorylation under β-glucan stimulation.

      Author response image 1.

      (8) Inconsistent use of an 'alisertib-alone' control in addition to 'medium', 'b-glucan', 'b-glucan + alisertib'. This control would be of great added value in many cases, in my opinion.

      Thank you for your comment. We appreciate that including “alisertib-alone” group throughout all the experiments may add more value to the findings. We set the aim of the current study to investigate the role of Aurora kinase A in trained immunity. Therefore, in most settings, we did not focus on the role of aurora kinase A without β-glucan stimulation. Initially, we showed in Figure 1B and 1C that alisertib alone in a concentration lower than 1μM (included) does not affect the response to secondary stimulus. In a previous report, the authors showed that Aurora A inhibitor alone did not affect trained immunity[8]. Thus, we did not include this control group in all of the experiments.

      (9) Figure 4A: looking at the unedited blot images, the blot for H3K36me3 appears in its original orientation, whereas other images appear horizontally mirrored. Please note, I don't think there is any malicious intent but this is quite sloppy and the authors should explain why/how this happened (are they different gels and the loading sequence was reversed?)

      Thank you for pointing out this error. After checking the original data, we found that we indeed misassembled the orientation of several blots. We went through the assembling process and figured out that some orientations were assembled according to the loading sequences but not saved, so that the orientations in Figure 4A were not consistent with the unedited blot image. We are sorry for the careless mistake, and we will double check to make sure all the blots are correctly assembled in the revised manuscript.

      (10) For many figures, for example prominently figure 5, the text describes 'beta-glucan training' whereas the figures actually depict acute stimulation with beta-glucan. While this is partially a semantic issue (technically, the stimulation is 'the training-phase' of the experiment), this could confuse the reader.

      Thanks for the reviewer’s suggestion and we will reorganize our language to ensure clarity and avoid any inconsistencies that might lead to misunderstanding.

      (11) Figure 6: Cytokines, especially IL-6 and IL-1β, can be excreted by tumour cells and have pro-tumoral functions. This is not likely in the context of the other results in this case, but since there is flow cytometry data from the tumour material it would have been nice to see also intracellular cytokine staining to pinpoint the source of these cytokines.

      Thanks for the reviewer’s suggestion. To address potential concerns raised by the reviewers, we will perform intracellular cytokines staining in tumor experiments with mice trained with β-glucan or in combination with alisertib followed MC38 inoculation.

      Reviewer #2 (Public review):

      Summary:

      This manuscript investigates the inhibition of Aurora A and its impact on β-glucan-induced trained immunity via the FOXO3/GNMT pathway. The study demonstrates that inhibition of Aurora A leads to overconsumption of SAM, which subsequently impairs the epigenetic reprogramming of H3K4me3 and H3K36me3, effectively abolishing the training effect.

      Strengths:

      The authors identify the role of Aurora A through small molecule screening and validation using a variety of molecular and biochemical approaches. Overall, the findings are interesting and shed light on the previously underexplored role of Aurora A in the induction of β-glucan-driven epigenetic change.

      We thank the reviewer for the positive and encouraging comments.

      Weaknesses:

      Given the established role of histone methylations, such as H3K4me3, in trained immunity, it is not surprising that depletion of the methyl donor SAM impairs the training response. Nonetheless, this study provides solid evidence supporting the role of Aurora A in β-glucan-induced trained immunity in murine macrophages. The part of in vivo trained immunity antitumor effect is insufficient to support the final claim as using Alisertib could inhibits Aurora A other cell types other than myeloid cells.

      We appreciate the question raised by the reviewer. Though SAM generally acts as methyl donor, whether the epigenetic reprogram in trained immunity is directly linked to SAM metabolism is not known. In our study, we provided evidence suggesting the necessity of SAM maintenance in supporting trained immunity. As for in vivo tumor model, tumor cells were subcutaneously inoculated 24 h after oral administration of alisertib. Previous studies showed alisertib administered orally had a half-life of 10 h and 90% concentration reduction in serum after 24 h [9, 10]. Therefore, we suppose that tumor cells are more susceptible to long-term effects of drugs on the immune system rather than directly affected by alisertib. To further address the reviewer’s concern, we will perform bone marrow transplantation (trained mice as donor and naïve mice as recipient) to clarify the mechanistic contribution of trained immunity versus off-target effects.

      Cited references

      (1) Ferreira, A.V., et al., Metabolic Regulation in the Induction of Trained Immunity. Semin Immunopathol, 2024. 46(3-4): p. 7.

      (2) Keating, S.T., et al., Rewiring of glucose metabolism defines trained immunity induced by oxidized low-density lipoprotein. J Mol Med (Berl), 2020. 98(6): p. 819-831.

      (3) Li, X., et al., Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell, 2022. 185(10): p. 1709-1727.e18.

      (4) Luka, Z., S.H. Mudd, and C. Wagner, Glycine N-methyltransferase and regulation of S-adenosylmethionine levels. J Biol Chem, 2009. 284(34): p. 22507-11.

      (5) Hughey, C.C., et al., Glycine N-methyltransferase deletion in mice diverts carbon flux from gluconeogenesis to pathways that utilize excess methionine cycle intermediates. J Biol Chem, 2018. 293(30): p. 11944-11954.

      (6) Simile, M.M., et al., Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase. Transl Oncol, 2022. 15(1): p. 101239.

      (7) Arifin, W.N. and W.M. Zahiruddin, Sample Size Calculation in Animal Studies Using Resource Equation Approach. Malays J Med Sci, 2017. 24(5): p. 101-105.

      (8) Benjaskulluecha, S., et al., Screening of compounds to identify novel epigenetic regulatory factors that affect innate immune memory in macrophages. Sci Rep, 2022. 12(1): p. 1912.

      (9) Yang, J.J., et al., Preclinical drug metabolism and pharmacokinetics, and prediction of human pharmacokinetics and efficacious dose of the investigational Aurora A kinase inhibitor alisertib (MLN8237). Drug Metab Lett, 2014. 7(2): p. 96-104.

      (10) Palani, S., et al., Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase. Cancer Chemother Pharmacol, 2013. 72(6): p. 1255-64.

    1. Author response:

      Public Reviews:<br /> Reviewer #1 (Public review):

      Summary:

      The manuscript discusses the role of phosphorylated ubiquitin (pUb) by PINK1 kinase in neurodegenerative diseases. It reveals that elevated levels of pUb are observed in aged human brains and those affected by Parkinson's disease (PD), as well as in Alzheimer's disease (AD), aging, and ischemic injury. The study shows that increased pUb impairs proteasomal degradation, leading to protein aggregation and neurodegeneration. The authors also demonstrate that PINK1 knockout can mitigate protein aggregation in aging and ischemic mouse brains, as well as in cells treated with a proteasome inhibitor. While this study provided some interesting data, several important points should be addressed before being further considered.

      Strengths:

      (1) Reveals a novel pathological mechanism of neurodegeneration mediated by pUb, providing a new perspective on understanding neurodegenerative diseases.

      (2) The study covers not only a single disease model but also various neurodegenerative diseases such as Alzheimer's disease, aging, and ischemic injury, enhancing the breadth and applicability of the research findings.

      Weaknesses:

      (1) PINK1 has been reported as a kinase capable of phosphorylating Ubiquitin, hence the expected outcome of increased p-Ub levels upon PINK1 overexpression. Figures 5E-F do not demonstrate a significant increase in Ub levels upon overexpression of PINK1 alone, whereas the evident increase in Ub expression upon overexpression of S65A is apparent. Therefore, the notion that increased Ub phosphorylation leads to protein aggregation in mouse hippocampal neurons is not yet convincingly supported.

      Indeed, overexpression of sPINK1* alone caused little change in Ub levels in the soluble fraction (Figure 5E), which is expected. Ub in the soluble fraction is in a relatively stable, buffered state. However, overexpression of sPINK1* resulted in an increase in Ub levels in the insoluble fraction, indicating protein aggregation. The molecular weight of Ub in the insoluble fraction was predominantly below 70 kDa, implying that phosphorylation inhibits Ub chain elongation.

      To further examine this, we used the Ub/S65A mutant to antagonize Ub phosphorylation, and found that the aggregation at low molecular weight was significantly reduced, indicating a partial restoration of proteasomal activity. The increase in Ub levels in both the soluble and insoluble fractions likely results from the high rate of ubiquitination driven by the elevated levels of Ub. Notably, the overexpressed Ub/S65A was detected in the Western blot using the wild-type Ub antibody, which accounts for the apparently increased Ub level.

      When overexpressing Ub/S65E, we again saw an increase in Ub levels in the insoluble fraction (but no increase in the soluble fraction), with low molecular weight bands even more prominent than those observed with sPINK1* transfection. These findings collectively support the conclusion that sPINK1* promotes protein aggregation through Ub phosphorylation.

      (2) The specificity of PINK1 and p-Ub antibodies requires further validation, as a series of literature indicate that the expression of the PINK1 protein is relatively low and difficult to detect under physiological conditions.

      We acknowledge the challenges in achieving optimal specificity for commercially available and custom-generated antibodies targeting PINK1 and pUb, particularly given the low endogenous levels of these proteins under physiological conditions. Despite these limitations, we observed robust immunofluorescent staining for PINK1 (Figures 1A, 1C, and 1G) and pUb (Figures 1B, 1D, and 1G) in human brain samples from Alzheimer's disease (AD) patients, as well as in mouse brains from models of AD and cerebral ischemia. The significant elevation of PINK1 and pUb under these pathological conditions likely accounts for the clear visualization. To validate antibody specificity, we have included images from pink1-/- mice as negative controls in the revised manuscript (Figure 1C and 1D, third panel).

      In addition, we detected a significant increase in pUb levels in aged mouse brains compared to young ones (Figures 1E and 1F). Notably, in pink1-/- mice, pUb levels remained unchanged between young and aged groups, despite some background signal, further supporting the conclusion that pUb accumulation during aging is PINK1-dependent.

      In HEK293 cells, pink1-/- cells served as a negative control for PINK1 (Figure 2B and 2C) and for pUb (Figure 2D and 2E). While the Western blot using the pUb antibody displayed some nonspecific background, pUb levels in pink1-/- cells remained unchanged across all MG132 treatment conditions (Figures 2D and 2E), further attesting the reliability of our findings.

      (3) In Figure 6, relying solely on Western blot staining and Golgi staining under high magnification is insufficient to prove the impact of PINK1 overexpression on neuronal integrity and cognitive function. The authors should supplement their findings with immunostaining results for MAP2 or NeuN to demonstrate whether neuronal cells are affected.

      Thank you for raising this important point. We included NeuN immunofluorescent staining in Figure 5—figure supplement 2 of the original manuscript. The results demonstrate a significant loss of NeuN-positive cells in the hippocampus following Ub/S65E overexpression, while no apparent change in NeuN-positive cells was observed with sPINK1* transfection alone. These findings provide evidence of neuronal loss in response to Ub/S65E, further supporting the impact of pUb elevation on neuronal integrity.

      While we did not perform MAP2 immunostaining, we included complementary analyses to assess neuronal integrity. Specifically, we performed Western blotting to determine MAP2 protein levels and used Golgi staining to study neuronal morphology and synaptic structure in greater detail. These analyses revealed that overexpression of sPINK1* or Ub/S65E decreased MAP2 levels and caused damage to synaptic structures (Figures 6F and 6H). Importantly, the deleterious effects of sPINK1* overexpression could be rescued by co-expression of Ub/S65A, further underscoring the role of pUb in mediating these changes.

      Together, our NeuN immunostaining, MAP2 analysis, and Golgi staining provide strong evidence for the impact of PINK1 overexpression and pUb elevation on neuronal integrity and synaptic health. We believe these complementary approaches sufficiently address the reviewer’s concern and highlight the pathological consequences of elevated pUb levels.

      (4) The authors should provide more detailed figure captions to facilitate the understanding of the results depicted in the figures.

      Figure captions will be updated with more details in the revised manuscript.

      (5) While the study proposes that pUb promotes neurodegeneration by affecting proteasomal function, the specific molecular mechanisms and signaling pathways remain to be elucidated.

      The specific molecular mechanisms and signaling pathways through which pUb promotes neurodegeneration are likely multifaceted and interconnected. Mitochondrial dysfunction appears to be a central contributor to neurodegeneration following sPINK1* overexpression. This is supported by (1) an observed increase in full-length PINK1, indicative of impaired mitochondrial quality control, and (2) proteomic data revealing enhanced mitophagy at 30 days post-transfection and substantial mitochondrial injury by 70 days post-transfection. The progressive damage to mitochondria caused by protein aggregates can cause further neuronal injury and degeneration.

      In addition, reduced proteasomal activity may result in the accumulation of inhibitory proteins that are normally degraded by the ubiquitin-proteasome system. Our proteomics analysis identified a >54-fold increase in CamK2n1 (UniProt ID: Q6QWF9), an endogenous inhibitor of CaMKII activation, following sPINK1* overexpression. This is particularly significant because the accumulation of CamK2n1 could suppress CaMKII activation and, subsequently, inhibit the CREB signaling pathway (illustrated below). As CREB is essential for synaptic plasticity and neuronal survival, its inhibition may further amplify neurodegenerative processes.

      While our study identifies proteasomal dysfunction and mitochondrial damage as key initial triggers, downstream effects—such as disruptions in signaling pathways like CaMKII-CREB—likely contribute to a broader cascade of pathological events. These findings highlight the complexity of pUb-mediated neurodegeneration and suggest that further exploration of downstream mechanisms is necessary to fully elucidate the pathways involved.

      We plan to include the proteomics data, in the revised manuscript, of mouse brain tissues at 30 days and 70 days post-transfection, to further highlight this downstream effect upon proteasomal dysfunction.

      Author response image 1.

      Reviewer #2 (Public review):

      Summary:

      The manuscript makes the claim that pUb is elevated in a number of degenerative conditions including Alzheimer's Disease and cerebral ischemia. Some of this is based on antibody staining which is poorly controlled and difficult to accept at this point. They confirm previous results that a cytosolic form of PINK1 accumulates following proteasome inhibition and that this can be active. Accumulation of pUb is proposed to interfere with proteostasis through inhibition of the proteasome. Much of the data relies on over-expression and there is little support for this reflecting physiological mechanisms.

      Weaknesses:

      The manuscript is poorly written. I appreciate this may be difficult in a non-native tongue, but felt that many of the problems are organisational. Less data of higher quality, better controls and incision would be preferable. Overall the referencing of past work is lamentable.

      Methods are also very poor and difficult to follow.<br /> Until technical issues are addressed I think this would represent an unreliable contribution to the field.

      (1) Antibody specificity and detection under pathological conditions

      We acknowledge the limitations of commercially available antibodies for detecting PINK1 and pUb. Despite these challenges, our findings demonstrate a significant increase in PINK1 and pUb levels under pathological conditions, such as Alzheimer's disease (AD) and ischemia. Additionally, we observed an increase in pUb level during brain aging, further highlighting its relevance in this particular physiological process. To ensure reliable quantification of PINK1 and pUb levels, we used pink1-/- mice and HEK293 cells as negative controls. For example, PINK1 levels were extremely low in control cells but increased dramatically after 2 hours of oxygen-glucose deprivation (OGD) and 6 hours of reperfusion (Figure 1H). Together, these controls validate that the observed elevations in PINK1 and pUb are specific and linked to pathological or certain physiological conditions.

      (2)  Overexpression as a model for pathological conditions

      To investigate whether the inhibitory effects of sPINK1* on the ubiquitin-proteasome system (UPS) are dependent on its kinase activity, we utilized a kinase-dead version of sPINK1* as a negative control. Since PINK1 has multiple substrates, we further explored whether its effects on UPS inhibition were mediated specifically by ubiquitin phosphorylation. For this, we used Ub/S65A (a phospho-null mutant) to antagonize Ub phosphorylation by sPINK1*, and Ub/S65E (a phospho-mimetic mutant) to mimic phosphorylated Ub. These well-defined controls ensured the robustness of our conclusions.

      While overexpression does not perfectly replicate physiological conditions, it serves as a valuable model for studying pathological scenarios such as neurodegeneration and brain aging, where pUb levels are known to increase. For example, we observed a 30.4% increase in pUb levels in aged mouse brains compared to young brains (Figure 1F). Similarly, in our sPINK1* overexpression model, pUb levels increased by 43.8% and 59.9% at 30- and 70-days post-transfection, respectively, compared to controls (Figures 5A and 5C). Notably, co-expression of sPINK1* with Ub/S65A almost entirely prevented sPINK1* accumulation (Figure 5B), indicating that an active UPS can efficiently degrade sPINK1*. Collectively, these findings show that sPINK1* accumulation inhibits UPS activity, a defect that can be rescued by the phospho-null Ub mutant. Thus, this overexpression model closely mimics pathological conditions and offers valuable insights into pUb-mediated proteasomal dysfunction.

      (3) Organization of the manuscript

      We believe the structure of the manuscript is justified and systematically addresses the key aspects of the study in a logic flow:

      (a) Evidence for the increase of PINK1 and pUb in multiple pathological and physiological conditions.

      (b) Identification of the sources and consequences of sPINK1 and pUb elevation.

      (c) Mechanistic insights into how pUb inhibits UPS-mediated degradation.

      (d) Validation of these findings using pink1-/- mice and cells.

      (e) Evidence of the reciprocal relationship between proteasomal inhibition and pUb elevation, culminating in neurodegeneration.

      (f) Demonstration of elevated pUb levels and protein aggregation in the hippocampus following sPINK1* overexpression, supported by proteomic analyses, behavioral tests, Western blotting, and Golgi staining.

      Thus, this organization provides a clear and cohesive narrative, culminating in the demonstration that sPINK1* overexpression induces hippocampal neuron degeneration.

      (4) Revisions to writing, referencing, and methodology

      We will improve the clarity and flow of the manuscript, add more references to properly acknowledge prior work, and incorporate additional details into the Methods section to enhance readability and reproducibility. These improvements should address the organizational and technical concerns raised, while strengthen the overall quality of the manuscript.

      Reviewer #3 (Public review):

      Summary:

      This study aims to explore the role of phosphorylated ubiquitin (pUb) in proteostasis and its impact on neurodegeneration. By employing a combination of molecular, cellular, and in vivo approaches, the authors demonstrate that elevated pUb levels contribute to both protective and neurotoxic effects, depending on the context. The research integrates proteasomal inhibition, mitochondrial dysfunction, and protein aggregation, providing new insights into the pathology of neurodegenerative diseases.

      Strengths:

      - The integration of proteomics, molecular biology, and animal models provides comprehensive insights.

      - The use of phospho-null and phospho-mimetic ubiquitin mutants elegantly demonstrates the dual effects of pUb.

      - Data on behavioral changes and cognitive impairments establish a clear link between cellular mechanisms and functional outcomes.

      Weaknesses:

      - While the study discusses the reciprocal relationship between proteasomal inhibition and pUb elevation, causality remains partially inferred.

      The reciprocal cycle between proteasomal inhibition and pUb elevation can be initiated by various factors that impair proteasomal activity. These factors include Aβ accumulation, ATP depletion, reduced expression of proteasome components, and covalent modifications of proteasomal subunits—all well-established contributors to the progressive decline in proteasome function. Once initiated, this cycle would become self-perpetuating, with the accumulation of sPINK1 and pUb driving a feedback loop of deteriorating proteasomal activity.

      In the current study, this reciprocal relationship between sPINK1/pUb elevation and proteasomal dysfunction is depicted in Figure 4A. Our results demonstrate that increased sPINK1 or PINK1 levels, such as through overexpression, can initiate this cycle. Crucially, co-expression of Ub/S65A effectively rescues the cells from this cycle, highlighting the pivotal role of pUb in driving proteasomal inhibition and establishing causality in this relationship. At the animal level, pink1 knockout could prevent protein aggregation upon aging and cerebral ischemia (Figures 1E and 1G).

      Mitochondrial injury is a likely source of elevated PINK1 and pUb levels. A recent study showed that efficient mitophagy is necessary to prevent pUb accumulation (bioRxiv 2023.02.14.528378), suggesting that mitochondrial damage can trigger this cycle. In another study (bioRxiv 2024.07.03.601901), the authors found that mitochondrial damage could enhance PINK1 transcription, further increasing cytoplasmic PINK1 levels and exacerbating the cycle.

      - The role of alternative pathways, such as autophagy, in compensating for proteasomal dysfunction is underexplored.

      Elevated sPINK1 has been reported to enhance autophagy (Autophagy 2016, 12: 632-647), potentially compensating for the impaired UPS. One mechanism involves the phosphorylation of p62 by sPINK1, which enhances autophagy activity. In our study, we did observe increased autophagic activity upon sPINK1* overexpression, as shown in Figure 2I (middle panel, without BALA). This increased autophagy may help degrade ubiquitinated proteins induced by puromycin, partially compensating for the proteasomal dysfunction.

      This compensation might explain why protein aggregation only increased slightly, though statistically significant, at 70 days post sPINK1* transfection (Figure 5F). Additionally, we observed a slight, though statistically insignificant, increase in LC3II levels in the hippocampus of mouse brains at 70 days post sPINK1* transfection (Figure 5—figure supplement 6), further supporting the notion of autophagy activation.

      However, while autophagy may provide some compensation, its effect is likely limited. Autophagy and UPS differ significantly in their roles and mechanisms of degradation. Autophagy is a bulk degradation pathway that is generally non-selective, targeting long-lived proteins, damaged organelles, and intracellular pathogens. In contrast, the UPS is highly selective, primarily degrading short-lived regulatory proteins, misfolded proteins, and proteins tagged for degradation.

      Together, we found that sPINK1* overexpression enhanced autophagy-mediated protein degradation while simultaneously impairing UPS-mediated degradation. This suggests that while autophagy may provide partial compensation for proteasomal dysfunction, it is not sufficient to fully counterbalance the selective degradation functions of the UPS.

      - The immunofluorescence images in Figure 1A-D lack clarity and transparency. It is not clear whether the images represent human brain tissue, mouse brain tissue, or cultured cells. Additionally, the DAPI staining is not well-defined, making it difficult to discern cell nuclei or staging. To address these issues, lower-magnification images that clearly show the brain region should be provided, along with improved DAPI staining for better visualization. Furthermore, the Results section and Figure legends should explicitly indicate which brain region is being presented. These concerns raise questions about the reliability of the reported pUb levels in AD, which is a critical aspect of the study's findings.

      We will include low-magnification images in the supplementary figures of the revised manuscript to provide a broader context for the immunofluorescence data presented in Figure 1. DAPI staining at higher magnifications will also be provided to improve visualization of cell nuclei and overall tissue structure. Additionally, we will indicate the brain regions examined in the corresponding figure legends, and incorporate more details in the Results section to provide clearer descriptions of the samples and brain regions analyzed.

      The human brain samples presented in Figure 1 are from the cingulate gyrus region of Alzheimer's disease (AD) patients. Our analysis revealed that PINK1 is primarily localized within cell bodies, while pUb is more abundant around Aβ plaques, likely in nerve terminals. These additional clarifications and supplementary figures should provide greater transparency and improve the reliability of our findings.

      - Figure 4B should also indicate which brain region is being presented.

      The images were taken for layer III-IV in the neocortex of mouse brains, which information will be incorporated in the figure legend of the revised manuscript.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review):

      Previous experimental studies demonstrated that membrane association drives avidity for several potent broadly HIV-neutralizing antibodies and its loss dramatically reduces neutralization. In this study, the authors present a tour de force analysis of molecular dynamics (MD) simulations that demonstrate how several HIV-neutralizing membrane-proximal external region (MPER)-targeting antibodies associate with a model lipid bilayer.

      First, the authors compared how three MPER antibodies, 4E10, PGZL1, and 10E8, associated with model membranes, constructed with two lipid compositions similar to native viral membranes. They found that the related antibodies 4E10 and PGZL1 strongly associate with a phospholipid near heavy chain loop 1, consistent with prior crystallographic studies. They also discovered that a previously unappreciated framework region between loops 2-3 in the 4E10/PGZL1 heavy chain contributes to membrane association. Simulations of 10E8, an antibody from a different lineage, revealed several differences from published X-ray structures. Namely, a phosphatidylcholine binding site was offset and includes significant interaction with a nearby framework region. The revised manuscript demonstrates that these lipid interactions are robust to alterations in membrane composition and rigidity. However, it does not address the reverse-that phospholipids known experimentally not to associate with these antibodies (if any such lipids exist) also fail to interact in MD simulations.

      Next, the authors simulate another MPER-targeting antibody, LN01, with a model HIV membrane either containing or missing an MPER antigen fragment within. Of note, LN01 inserts more deeply into the membrane when the MPER antigen is present, supporting an energy balance between the lowest energy conformations of LN01, MPER, and the complex. These simulations recapitulate lipid binding interactions solved in published crystallographic studies but also lead to the discovery of a novel lipid binding site the authors term the "Loading Site", which could guide future experiments with this antibody.

      The authors next established course-grained (CG) MD simulations of the various antibodies with model membranes to study membrane embedding. These simulations facilitated greater sampling of different initial antibody geometries relative to membrane. These CG simulations , which cannot resolve atomistic interactions, are nonetheless compelling because negative controls (ab 13h11, BSA) that should not associate with membrane indeed sample significantly less membrane.

      Distinct geometries derived from CG simulations were then used to initialize all-atom MD simulations to study insertion in finer detail (e.g., phospholipid association), which largely recapitulate their earlier results, albeit with more unbiased sampling. The multiscale model of an initial CG study with broad geometric sampling, followed by all-atom MD, provides a generalized framework for such simulations.

      Finally, the authors construct velocity pulling simulations to estimate the energetics of antibody membrane embedding. Using the multiscale modelling workflow to achieve greater geometric sampling, they demonstrate that their model reliably predicts lower association energetics for known mutations in 4E10 that disrupt lipid binding. However, the model does have limitations: namely, its ability to predict more subtle changes along a lineage-intermediate mutations that reduce lipid binding are indistinguishable from mutations that completely ablate lipid association. Thus, while large/binary differences in lipid affinity might be predictable, the use of this method as a generative model are likely more limited.

      The MD simulations conducted throughout are rigorous and the analysis are extensive, creative, and biologically inspired. Overall, these analyses provide an important mechanistic characterization of how broadly neutralizing antibodies associate with lipids proximal to membrane-associated epitopes to drive neutralization.

      Reviewer #2 (Public review):

      In this study, Maillie et al. have carried out a set of multiscale molecular dynamics simulations to investigate the interactions between the viral membrane and four broadly neutralizing antibodies that target the membrane proximal exposed region (MPER) of the HIV-1 envelope trimer. The simulation recapitulated in several cases the binding sites of lipid head groups that were observed experimentally by X-ray crystallography, as well as some new binding sites. These binding sites were further validated using a structural bioinformatics approach. Finally, steered molecular dynamics was used to measure the binding strength between the membrane and variants of the 4E10 and PGZL1 antibodies.

      The use of multiscale MD simulations allows for a detailed exploration of the system at different time and length scales. The combination of MD simulations and structural bioinformatics provides a comprehensive approach to validate the identified binding sites. Finally, the steered MD simulations offer quantitative insights into the binding strength between the membrane and bnAbs.

      While the simulations and analyses provide qualitative insights into the binding interactions, they do not offer a quantitative assessment of energetics. The coarse-grained simulations exhibit artifacts and thus require careful analysis.

      This study contributes to a deeper understanding of the molecular mechanisms underlying bnAb recognition of the HIV-1 envelope. The insights gained from this work could inform the design of more potent and broadly neutralizing antibodies.

      Recommendations for the authors:

      Reviewing Editor:

      We recommend the authors remove the figure and section related to bnAb LN01, perform additional analysis (e.g., further expanding on the differences in antibody binding in the presence or absence of antigen), and present this as a separate manuscript in a follow-up study.

      We consider the analysis of a bnAb with a transmembrane antigen and of LN01 as essential to the manuscript and novel results.  Study of LN01 provides many insights unique from the other MPER bnAbs in this study.  We agree further characterization of LN01 and bnAbs with transmembrane antigen or full-length Env are intriguing and necessary to complete the full mechanistic understanding of lipid-associated antibodies.  LN01 section in this paper is novel in the field and demonstrates the preliminary evidence motivating further work, which we agree are beyond the scope of this already long detailed study.

      Reviewer #1 (Recommendations for the authors):

      I appreciate the degree to which the authors responded to my previous points raised in the private review, including edits where I might have missed something in the manuscript or relevant literature. I imagine such a point-by-point response was quite onerous. Thank you also for balancing presentation/clarity with content/rigor considering the large information content of this manuscript; in silico results are inherently hard to present given the delicate balance between rigorous validation and novel information content. I apologize if I repeat points raised and addressed previously and commend the authors on their revised study, which is much improved in clarity; any additional revisions are of course entirely at your discretion.

      "...now having more diversity in lipid headgroup chemistries" references the wrong figure-it should be: Figure 2-figure supplement 2A-C. The incorrect figure is also referenced again several sentences down: "...relevant CDR and framework surface loops..."

      Thank you for pointing out this error. We have corrected figure references.

      "One shared conformational difference observed for these bnAbs the higher cholesterol bilayers was slightly more extensive and broader interaction profiles as well as modestly deeper embedding of the relevant CDR and framework surfaces loops" please rephrase

      Thank you for this suggestion.  We rephrased this for improved clarity and flow. 

      "These results bolster the feasibility for using all-atom MD as an in silico platform to explore differential phospholipid affinity at these sites (i.e., specificity studies) and influence on antibody preferred conformation as membrane composition and lipid chemistry are systematically varied" Please tone down these speculations-you have demonstrated that simulations are robust to different headgroup chemistries but have not provided evidence for the exclusion of lipids that are known not to associate with these antibodies.

      We rephrased this speculation to highlight the potential of this application. We also emphasize future studies that would be required to achieve this application in the following sentence.

      “These results motivate use of all-atom MD as an in silico approach for exploring differential phospholipid affinity at these sites…”

      Figure 2A: Specify which PDB entry corresponds to the displayed crystal structures in the main figure or caption.

      We clarified these PDB entries in the figure caption. 

      Check reference formatting in supplemental figures when generating VOR.

      I am not sure how relevant this might be to the claims of Figure 2-figure supplement 3, but AlphaFold3-based phospholigand docking might provide an additional orthogonal approach if relevant ligand(s) are available for such analysis (particularly for the newly proposed 10E8 POPC complex).

      Thank you for this suggestion.  AI/ML based prediction methods like AF3 and RoseTTAFold All-Atom (RFAA) are interesting new methods that have come since our initial submission.   We’ve decided these experiments are beyond the scope of this already long and detailed study. We have added a sentence suggesting use of these methods in future work.

      "We next studied bnAb LN01 to interrogate differences" --> this transition still reads a bit unclear. Why shift gears and change antibodies? Also, while you do go into its interactions both +/- antigen, there's no lead into the simulation initialization with and without antigen to guide the reader into the comparisons you will draw in the figure. Also, the order of information presentation is a bit strange, where the rationale for choosing a single monomeric helix is brought up in the middle of the paragraph instead of at the beginning of the section. In the next paragraph, it goes back to the initialization of the membrane composition again, which feels a bit disorganized-I do appreciate the unique challenge of having to weave through so much quality data! In fact, if you were to conduct simulations of membrane + antigen vs. membrane + LN01 vs. membrane + LN01 + antigen, I am tempted to say that this could be removed from this manuscript and flow better as a paper in and of itself.

      We thank the reviewer for the suggestion to improve the writing style.  We feel this section adds a lot of value to the manuscript, so we will keep it in the paper and improved the transition as well as rationale.  

      We selected to study the additional antibody LN01 and the monomeric MPER-TM antigen conformation because of the existing structural evidence available without additional creative model building.  This rationale has been updated in the new text.  

      We changd the order of information as suggested, moving the rationale for antigen fragment earlier in the paragraph followed by the background of the lipids sites from the crystal that can lead into simulation set-up.  We clarified the simulation initialization was similar for systems with and without antigen in the opening sentence of the paragraph

      "previously observed snorkeling and hydration of TM Arg686" --> Is this R696 (numbering could be different based on the particular Env)?

      Thank you for noting this typo, we have corrected the numbering.

      Potential font color issue with Figure 3-Figure supplement 1 B and part of A text-could be fixed in typesetting.

      The discussion reads very well. Is it possible to direct antibody maturation, even in an engineered context, towards membrane affinity without increasing immunogenic polyreactivity? This is mentioned very briefly and cited with ref 36, but I would be interested in the author's thoughts on this topic.

      We thank the reviewer for the insightful idea to explore in future work.  Our conclusion alludes to possibly artificially evolving membrane affinity studied by MD, as done in vitro by Nieva and co-workers.  Because the hypothetical nature, we’ve chosen not to elaborate on those ideas from this manuscript.

      Reviewer #2 (Recommendations for the authors):

      To ensure reproducibility and facilitate further research, the authors should publicly deposit the code for running the MD simulations and analyses (e.g., on GitHub) along with the underlying data used in the study (e.g., on Zenodo.org).

      We appreciate the consideration for open-source code and analysis. Representative code and simulation trajectories were uploaded to the following repositories:

      https://github.com/cmaillie98/mper_bnAbs.git

      https://zenodo.org/records/13830877

      —-

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Previous experimental studies demonstrated that membrane association drives avidity for several potent broadly HIV-neutralizing antibodies and its loss dramatically reduces neutralization. In this study, the authors present a tour de force analysis of molecular dynamics (MD) simulations that demonstrate how several HIV-neutralizing membrane-proximal external region (MPER)-targeting antibodies associate with a model lipid bilayer.

      First, the authors compared how three MPER antibodies, 4E10, PGZL1, and 10E8, associated with model membranes, constructed with a lipid composition similar to the native virion. They found that the related antibodies 4E10 and PGZL1 strongly associate with a phospholipid near heavy chain loop 1, consistent with prior crystallographic studies. They also discovered that a previously unappreciated framework region between loops 2-3 in the 4E10/PGZL1 heavy chain contributes to membrane association. Simulations of 10E8, an antibody from a different lineage, revealed several differences from published X-ray structures. Namely, a phosphatidylcholine binding site was offset and includes significant interaction with a nearby framework region.

      Next, the authors simulate another MPER-targeting antibody, LN01, with a model HIV membrane either containing or missing an MPER antigen fragment within. Of note, LN01 inserts more deeply into the membrane when the MPER antigen is present, supporting an energy balance between the lowest energy conformations of LN01, MPER, and the complex. Additional contacts and conformational restraints imposed by ectodomain regions of the envelope glycoprotein, however, remain unaddressed-the size of such simulations likely runs into technical limitations including sampling and compute time.

      The authors next established course-grained (CG) MD simulations of the various antibodies with model membranes to study membrane embedding. These simulations facilitated greater sampling of different initial antibody geometries relative to membrane. Distinct geometries derived from CG simulations were then used to initialize all-atom MD simulations to study insertion in finer detail (e.g., phospholipid association), which largely recapitulate their earlier results, albeit with more unbiased sampling. The multiscale model of an initial CG study with broad geometric sampling, followed by all-atom MD, provides a generalized framework for such simulations.

      Finally, the authors construct velocity pulling simulations to estimate the energetics of antibody membrane embedding. Using the multiscale modelling workflow to achieve greater geometric sampling, they demonstrate that their model reliably predicts lower association energetics for known mutations in 4E10 that disrupt lipid binding. However, the model does have limitations: namely, its ability to predict more subtle changes along a lineage-intermediate mutations that reduce lipid binding are indistinguishable from mutations that completely ablate lipid association. Thus, while large/binary differences in lipid affinity might be predictable, the use of this method as a generative model are likely more limited.

      The MD simulations conducted throughout are rigorous and the analysis are extensive. However, given the large amount of data presented within the manuscript, the text would benefit from clearer subsections that delineate discrete mechanistic discoveries, particularly for experimentalists interested in antibody discovery and design. One area the paper does not address involves the polyreactivity associated with membrane binding antibodies-MD simulations and/or pulling velocity experiments with model membranes of different compositions, with and without model antigens, would be needed. Finally, given the challenges in initializing these simulations and their limitations, the text regarding their generalized use for discovery, rather than mechanism, could be toned down.

      Overall, these analyses provide an important mechanistic characterization of how broadly neutralizing antibodies associate with lipids proximal to membrane-associated epitopes to drive neutralization.

      Reviewer #2 (Public Review):

      In this study, Maillie et al. have carried out a set of multiscale molecular dynamics simulations to investigate the interactions between the viral membrane and four broadly neutralizing antibodies that target the membrane proximal exposed region (MPER) of the HIV-1 envelope trimer. The simulation recapitulated in several cases the binding sites of lipid head groups that were observed experimentally by X-ray crystallography, as well as some new binding sites. These binding sites were further validated using a structural bioinformatics approach. Finally, steered molecular dynamics was used to measure the binding strength between the membrane and variants of the 4E10 and PGZL1 antibodies.

      The conclusions from the paper are mostly well supported by the simulations, however, they remain very descriptive and the key findings should be better described and validated. In particular:

      It has been shown that the lipid composition of HIV membrane is rich in cholesterol [1], which accounts for almost 50% molar ratio. The authors use a very different composition and should therefore provide a reference. It has been shown for 4E10 that the change in lipid composition affects dynamics of the binding. The robustness of the results to changes of the lipid composition should also be reported.

      The real advantage of the multiscale approach (coarse grained (CG) simulation followed by a back-mapped all atom simulation) remains unclear. In most cases, the binding mode in the CG simulations seem to be an artifact.

      The results reported in this study should be better compared to available experimental data. For example how does the approach angle compare to cryo-EM structure of the bnAbs engaging with the MPER region, e.g. [2-3]? How do these results from this study compare to previous molecular dynamics studies, e.g.[4-5]?

      References<br /> (1) Brügger, Britta, et al. "The HIV lipidome: a raft with an unusual composition." Proceedings of the National Academy of Sciences 103.8 (2006): 2641-2646.<br /> (2) Rantalainen, Kimmo, et al. "HIV-1 envelope and MPER antibody structures in lipid assemblies." Cell Reports 31.4 (2020).<br /> (3) Yang, Shuang, et al. "Dynamic HIV-1 spike motion creates vulnerability for its membrane-bound tripod to antibody attack." Nature Communications 13.1 (2022): 6393.<br /> (4) Carravilla, Pablo, et al. "The bilayer collective properties govern the interaction of an HIV-1 antibody with the viral membrane." Biophysical Journal 118.1 (2020): 44-56.<br /> (5) Pinto, Dora, et al. "Structural basis for broad HIV-1 neutralization by the MPER-specific human broadly neutralizing antibody LN01." Cell host & microbe 26.5 (2019): 623-637.

      Considering reviewer suggestions, we slightly reorganized the results section into specific sub-sections with headings and changed the order in which key results were presented to allow the subsequent analysis more accessible for readers.  Supplemental materials were redistributed into eLife format, having each supplemental item grouped to a corresponding main figure. Many slightly detail modifications were made to figures (mostly supplemental items) without changing their character, such as clearer axes labels or revised annotations within panels.

      The major additions within the results sections based on the reviews were:

      (1) An expanded the comparison between our simulation analyses to previous simulations and to existing cryo-EM structural evidence for MPER antibodies’ membrane orientation the context of full-length antigen, resulting in new supplemental figure panels.

      (2) New atomistic simulations of 10E8, PGZL1, and 4E10 evaluating the phospholipid binding predictions in a different lipid composition more closely modeling HIV membranes.

      Minor edits to the analyses and interpretations include:

      (1) Outlining the geometric components contributing to variance in substates after clustering the atomistic 10E8, 4E10, and PGZL1 simulations.

      (2) Better defining the variance and durability of membrane interactions within and across systems in the coarse grain methods section.

      (3) Removed interpretations in the original results sections regarding polyreactivity and energetics for MPER bnAbs that were not explicitly supported by data.   

      (4) More context of the prevenance of bnAb loop geometries in structural informatics section

      (5) Rationale for the choice of the continuous helix MPER-TM conformation in LN01-antigen conformations, and citations to previous gp41 TM simulations.

      (6) Removed language on the novelty of the coarse grain and steered pulling simulations as newly developed approaches; tempering the potential discriminating power and applications of those approaches, in light of their limitations.

      The discussion was revised to provide more novel context of the results within the field, including discussing direct relevance of the simulation methods for evaluating immune tolerance mechanisms and into antibody engineering.   We have shared custom scripts used for molecular dynamics analysis on github (https://github.com/cmaillie98/mper_bnAbs.git) and uploaded trajectories to a public repository hosted on Zenodo (https://zenodo.org/records/13830877).

      Recommendations for the authors:

      Below, I provide an extensive list of minor edits associated with the text and figures for the authors to consider. I provide these with the hope of increasing the accessibility of the manuscript to broader audiences but leave changes to the discretion of the authors.

      Text/clarity

      Figure 1 main text

      The main text discussing Figure 1 is disorganized, making the analysis difficult to follow. I would suggest the following: moving the sentence, "4E10 and PG2L1 are structurally homologous" immediately after the paragraph discussing the simulation initiation. Then, add a sentence that directly compares their experimental affinity, neutralization, and polyreactivity of 4E10 and PG2L1 (later, an unintroduced idea pops up, "These patterns may in part explain 4E10's greater polyreactivity"). Next, lead into the discussion of the MD simulation data with something to the effect of: "Given these similarities, we first compared mechanisms of membrane insertion between 4E10 and PG2L1 to bolster confidence in our predictions". Later, the sentence "Across 4E10 and PGZL1 simulations, the bound lipid phosphates"

      We thank the reviewer for the suggestion and we have restructured the beginning of the results to implement this style: to first introduce then discuss the comparative PGZL1 & 4E10 results, i.e. Figure 1 plus associated supplements.

      In the background and the introduction text leading up to Figure 1, CDR-H3 is discussed at length, however, the first figure focuses almost entirely on how CDR-H1 coordinates a lipid phosphate headgroup. Are there experimental mutations in this loop that do not affect affinity (e.g., to a soluble gp41 peptide), but do affect neutralization (like the WAWA mutation for CDR-H3, discussed later)?

      We have altered the Introduction (para 2) and Results (4E10/PGZL1 sub-section) to give more balanced discussion of CDRs H1 & H3.  That includes referencing experimental data addressing the reviewer’s question; a PGZL1 clone H4K3 where mutations to CDRH1 were introduced and shown have minimal impact on affinity to MPER peptide via ELISA and BLI, but those mutant bnAbs had significantly reduced neutralization efficacy (PMC6879610).

      The sentence "These phospholipid binding events were highly stable, typically persisting for hundreds of nanoseconds" should be moved down to immediately precede, "[However], in a PGZL1 simulation, we observed a". This would be a good place for a paragraph break following, "Thus, these bnABs constitutively", since this block of text is very long.

      Similarly, the sentence and parts of the section, "Likewise, the interactions coordinating the lipid phosphate oxygens at CDR-H1" more appropriately belongs immediately before or after the sentence, "Our simulations uncover the CDR-lipid interactions that are the most feasible".

      Thank you for the detailed guidance in reorganizing the Figure 1 results.  We followed the advice to directly compare 4E10 and PGZL1 results separately from 10E8, moving those sections of text appropriately.  New paragraph breaks were added to improve accessibility and flow of concepts throughout the Results.

      In the sentence, "our simulations uncover CDR-lipid interactions that are the most feasible and biologically relevant in the context of a full [HIV] lipid bilayer... validation to which of the many possible ions" à have you confidently determined lipid binding and positioning outside of the site validated in figure 1? Which site(s) are these referencing? The next two sentences then introduce two new ideas on the loop backbone stability then lead into lipid exchange, which is a bit jarring.

      We have adjusted the language concerning the putative ions/lipids electron density across the many PGZL1 and 4E10 crystal structures, and additionally make the explicit point that we confidently determined the lack of lipid binding outside of the site focused on in Figure 1.

      “… both bnAbs showed strong hotspots for a lipid phosphate bound within the CDR-H1 loops, with minimal phospholipid or cholesterol ordering around the proteins elsewhere.  The simulated lipid phosphates bound within CDR-H1 have exceptional overlap with electron densities and atomic details of modelled headgroups from respective lipid-soaked co-crystal structures…”

      Figure 2 main text

      "We similarly investigated bnAb 10E8" - Please make this a separate subheader, the block text is very long up to this point.

      Thank you for the suggestion. We introduced a sub-header to separate work on 10E8 all-atom simulations.

      "we observed a POPC complexed with... modelled as headgroup phosphoglycerol anions..." - please cite the references within the text.

      Thank you for pointing out this missing reference, we added the appropriate reference.

      "One striking and novel observation" - please remove the phrase "striking" throughout, for following best practices in scientific writing (PMC10212555)-this is generally well-done throughout.

      We removed “striking” from our text per your suggestion.

      "This CDR-L1 site highlights... (>500 fold) across HIV strains" - How much do R29 and Y32 also contribute to antigen binding and the conformation of this loop? These mutants also decreased Kd by approximately 20X, and based on the co-crystal structure with the TM antigen (PDB: 4XCC), seem to play a more direct role in antigen contact. Additionally, these residues should be highlighted on a figure, otherwise it's difficult to understand why they are important for membrane association.

      We thank the reviewer for deep engagement to these supporting experimental details.  The R29A+Y32A 10E8 mutant referenced in the text showed only 4-fold Kd increase, a modest change for an SPR binding experiment.  Whereas R29E+Y32E 10E8 mutant resulted in 40x Kd increase, the “20x” the reviewer refers to.  Both 10E8 mutants showed similar drastically reduced breadth and potency of over 2 orders of magnitude on average.

      These mutated CDR-L1 residues are not directly involved in antigen contact and adopt the same loop helix conformation when antigen is bound.  A minor impact on antigen binding affinity could be due altering pre-organization of CDR loops upon losing interactions from the Tyr & Arg sidechains - particularly Tyr31 in contact with CDR-H3.

      As per the suggestion, clearer annotated figure panel denoting these sidechains has been added to Figure 2-Figure Supplement 1 for 10E8 analysis.

      "Structural searches querying... identified between 10^5 and 2*10^6..." - why is this value represented as such a large range? Does this depend on the parameters used for analysis? Please clarify.

      Additionally, how prevalent are any random loop conformations compared to the ones you searched? It's otherwise difficult to attribute number of occurrences within the 2 A cutoff to biological significance, as this number is not put in context.

      We appreciate the reviewers comment to contextualize the range and relative frequency of the bnAb loop conformations.   RMSD and length of loop are the key parameters, which can be controlled by searching reference loops of similar length.  The main point of the backbone-level searching is simply to imply the bnAb loops are not particularly rare when comparing loops of similar length.   

      We did as was suggested and added comparison to random loops of the same length to the main text, including a new Supplementary Table 4.   

      “…identified between 105 to 2∙106 geometrically similar sub-segments within natural proteins (<2 Å RMSD)40, reflecting they are relatively prevalent (not rare) in the protein universe, comparing well with frequency of other surface loops of similar length in antibodies (Supplementary Table 3).”

      "We next examined the geometries" could start after its own new subheading. Moreover, while there's an emphasis on tilt for neutralization, there is not a figure clearly modelling the proposed Env tilt compared to the relatively planar bilayer. It would be helpful to have an additional panel somewhere that shows the orientation of the antibody (e.g., a representative pose) in the simulations relative to an appropriately curved membrane, Env, the binding conformation of the antibody to Env, and apo Env, given the tilting observed in PMID: 32348769 and theorized in PMC5338832. What additional conformational changes or tilting need to occur between the antibodies and Env to accomplish binding to their respective epitopes?

      Thank you for outlining an interesting element to consider in our analysis of a multi-step binding mechanism for MPER antibodies. We added additional figure panels in the supplement to outline the similarities and differences between our simulations and Fabs with the inferred membranes in cryo-EM experiments of full-length HIV Env.  The simulated Fabs’ angles are very similar with only minor tilting to match the cryo-EM antibody-membrane geometries. 

      We added Figure 1-figure supplement 1A & Figure 2-figure supplement 2A, and alter to text to reflect this:

      “The primary difference is Env-bound Fabs in cryo-EM adopt slightly more shallow approach angles (~15_°_) relative to the bilayer normal.  The simulated bnAbs in isolation prefer orientations slightly more upright, but presenting CDRs at approximately the same depth and orientation.  Thus, these bnAbs appear pre-disposed in their membrane surface conformations, needing only a minor tilt to form the membrane-antibody-antigen neutralization complex.”   

      Env tilt dynamics and membrane curvature of natural virions may reconcile some of these differences.  Recent in situ tomography of Full-length Env in pseudo-virions corroborates our approximation of flat bilayers over the short length scales around Env.

      The sentence "we next examined the geometries" mentions "potential energy cost, if any, for reorienting...". However, there's no further discussions of geometry or energy cost within this section. Please rephrase, or move this figure to main and increase discussion associated with the various conformational ensembles, their geometry, and their phospholipid association.

      As the reviewer highlights, the unbiased simulations and our analysis do not explicitly evaluate energetics.  We removed this phrase, and now only allude to the minimal energy barrier between the similar geometric conformations, relative to the tilting & access requirements for antigen binding mechanism.

      “The apparent barrier for re-orientation is likely much less energetically constraining than shielding glycans and accessibility of MPER”

      ".. describing the spectrum of surface-bound conformations" cites the wrong figure.

      Thank you for noticing this error; we correct the figure reference to (Figure 2-figure supplement 4).

      Please comment on the significance of how global clustering (Fig. S5A-C) was similar for 4E10 and PGZL1, but different for 10E8 (e.g., blue, orange, and yellow clusters for 4E10 and PHZL1 versus cyan, red, and green clusters for 10E8). As the cyan cluster seems to be much closer in Euclidian space to the 4E10/PGZL1 clusters, it might warrant additional analysis. What do these clusters represent in terms of structure/conformation? How do these clusters differ in membrane insertion as in (A)?

      We are grateful you identify analysis in the geometric clustering section that may be of interest to other readers. We have added additional supplementary table (Table 2) to detail the CDR loop membrane insertion and global Fab angles which describe each cluster, to demonstrate their similarities and differences.  We also better describe how global clustering was similar for 4E10 and PGZL1, but different for 10E8 in the relevant results section<br /> The cyan cluster is not close in structure to 4E10/PGZL1 clusters.  We note the original figure panel had an error.  The updated Figure 2-supplement 4B shows the correct Euclidian distance hierarchy with an early split between 4e10/pgzl1 and 10e8 clusters.

      Figure 3 main text

      The start of this section, "We next studied bnAb LN01...", is a good place for a new subheader.

      We have added an additional subheader here: Antigen influence on membrane bound conformations and lipid binding sites for LN01

      There should be a sentence in the main text defining the replicate setup and production MD run time. Is the apo and complex based on a published structure? How do you embed the MPER? Is the apo structure docked to membrane like in 4E10? The MD setup could also be better delineated within the methods.

      The first two paragraphs in this section have been updated to clarify the relevant simulations configuration and Fab membrane docking prediction details. 

      The procedure was the same for predicting an initial membrane insertion, albeit now we use the LN01-TM complex and the calculation will account for the membrane burial of the the TM domain and MPER fragment.  As mentioned, LN01 is predicted as inserted with CDR loops insert similarly with or without the TM-MPER fragment.  The geometry differs from PGZL1/4E10 and 10E8, denoted by the text.

      Please comment on the oligomerization state of the antigen used in the MD simulation: how does the simulation differ from a crossed MPER as observed in an MPER antibody-bound Env cryo-EM structure (PMID: 32348769), a three-helix bundle (PMC7210310), or single transmembrane helix (PMC6121722)? How does the model MPER monomer embed in the membrane compared to simulations with a trimeric MPER (PMC6035291, PMID: 33882664)-namely, key arginine residues such as R696?

      We thank the reviewer for pointing out critical underlying rationale for modeling this TM-MPER-LN01 complex which we have corrected in the revised draft. The range of potential conformations and display of MPER based on TM domain organization could easily be its own paper – we in fact have a manuscript in preparation on the topic.  

      The updated text expands the rationale for choosing the monomeric uninterrupted helix form of the MPER-TM model antigen (para 1 of LN01 section). The alternative conformations we did not to explore are called out, with references provided by the reviewer.

      The discussion qualified that the MPER presentation is likely oversimplified here, noting MPER display in the full-length Env trimer will vary in different conformational states or membrane environments. However, the only cryo-EM structures of full-length ENV with TM domains resolved have this continuous helix MPER-TM conformation – seen both within crossing TM dimers or dissociated TM monomers.

      Are there additional analyses that can validate the dynamics of the MPER monomer in the membrane and relative to LN01? Such as key contacts you would expect to maintain over the duration of the MD simulation?

      We also increased description of this TM domain’s behavior, dynamics (tilt, orientation, Arg696 snorkeling, and complex w LN01) to provide a clearer picture of the simulation results – which aligns with past MD of the gp41 TM domain as a monomer (para 2 of LN01 section).  As well, we noted key LN01-MPER contacts that were maintained.

      How does the model MPER modulate membrane properties like lipid density and lipid proximities near LN01?

      We checked and didn’t notice differences for the types of lipids (chol, etc) proximal to the MPER-TM or the CDR loops versus the bulk lipid bilayer distributions.  Due to the already long & detailed nature of this manuscript, we elect not to include discussion on this topic.

      Supplemental figure 1H-I would be better positioned as a figure 3-associated supplemental figure.

      We rearranged to follow the eLife format and have paired supplemental panels with their most relevant main figures.

      Figure 3F/H reference a "loading site" but this site is defined much later in the text, which was confusing.

      Thank you for pointing out this source of confusion, we rearranged our discussion to reflect the order in which we present data in figures.

      What evidence suggests that lipids "quickly exchange from the Loading site into the X-ray site by diffusion"? I do not gather this from Figure S1H/I.

      We have rearranged the loading side and x-ray site RMSD maps in Figure 3-Figure supplement 1 to better illustrate how a lipid exchanges between these sites.

      Figure 4 main text

      The authors assert that in the CG simulations, restraints, "[maintain] Fab tertiary and quaternary structure". However, backbone RMSD does not directly assert this claim-an additional analysis of the key interfacial residues between chains, or geometric analysis between the chains, would better support this claim.

      Thank you for pointing this point.  We rephrased to add that the major sidechain contacts between heavy and light chain persist, in addition to backbone RMSD, to describe how these Fabs maintain the fold stably in CG representation. 

      In several cases, CG models sample and then dissociate from the membrane. In the text, the authors mention, "course-grained models can distinguishing unfavorable and favorable membrane-bound conformations". Is there a particular orientation that causes/favors membrane association and dissociation? This analysis could look at conformations immediately preceding association and dissociation to give clues as to what orientation(s) favor each state.

      Thank you for suggesting this interesting analysis.  Clustering analysis of associated states are presented in Figure 5, Figure 5-Figure Supplement 1, and Figure 6, which show all CDR and framework loop directed insertion.  This feature is currently described in the main text.  

      We did not find strong correlation of specific orientations as “pre-dissociation” states or ineffective non-inserting “scanning” events.  We revised the key sentence to reflect the major take away – that non-CDR alternative conformations did not insert and most of those having CDRs inserted in a different manner than all-atom simulations also were prone to dissociate:

      “Given that non-CDR directed and alternative CDR-embedded orientations readily dissociate, we conclude that course-grained models can distinguish unfavorable and favorable membrane-bound conformations to an extent that provides utility for characterizing antibody-bilayer interaction mechanisms.”

      Figure 6 main text

      "For 4E10, trajectories initiated from all three geometries..." only two geometries are shown for each antibody. Please include all three on the plot.

      The plots include markers for all three geometries for 4E10, highlighted in stars or with letters on the density plots of angles sampled (Figure 6B,C)

      "Aligning a full-length IgG... unlikely that two Fabs simultaneously..." Are there theoretical conformations in which two Fabs could simultaneously associate with membrane? If this was physiological or could be designed rationally, could an antibody benefit further from avidity?

      Our modeling suggests the theoretical conformations having two Fabs on the membrane are infeasible.  It’s even less likely multiple Env antigens could be engaged by one IgG.  We have revised the text to express this more clearly.

      Figure 7 main text

      "An intermediate... showed a modest reduction in affinity..." what affinity does PGZL1 have for this antigen?

      The preceding sentence for this information: “Mature PGZL1 has relatively high affinity to the MPER epitope peptide (Kd = 10 nM) and demonstrates great breadth and potency, neutralizing 84% of a 130 strain panel “

      Figures

      Figure 1

      It would be helpful to have an additional panel at the top of this figure further zoomed out showing the orientation of the antibody (e.g., a representative pose) in the simulations relative to an appropriately curved membrane, Env, the binding conformation of the antibody to Env, and apo Env, given the tilting observed in PMID: 32348769 and theorized in PMC5338832. What additional conformational changes or tilting need to occur between the antibodies and Env to accomplish binding to their respective epitopes?

      Thank you for the suggestion to include this analysis.  We have added to the text reflecting this information, as well as making new supplemental panels for 4E10 and 10E8 that we compare simulated 4E10 and 10E8 Fab conformations to cryoEM density maps with Fabs bound to full-length HIV Env. Figure 1-figure supplement 1A & Figure 2-figure supplement 2A

      In Figure 1, space permitting, it would be helpful to annotate the distances between the phosphates and side chains (similarly, for Figure S1A).

      To avoid the overloading the Main figure panels with text, those relevant distances are listed in the methods sections.  Those distances are used to define the “bound” lipid phosphate state.  Generally, we note the interactions are within hydrogen bonding distance.

      Annotating "Replicate 1" and "Replicate 2" on the left side of Figure 1C/D would make this figure immediately intuitive.

      We have added these labels.

      Figure caption 1C: Please clarify the threshold/definition of a contact used to binarize "bound" versus "unbound" (for example, "mean distance cutoff of 2A between the phosphate oxygen and the COM of CDR-H1") [on further reading of the methods section, this criterion is quite involved and might benefit from: a sentence that includes "see methods"]. Additionally, C could use a sentence explaining the bar such as in E, "Phosphate binding is mapped to above each MD trajectory" Please define FR-H3 in the figure caption for E/F.

      We have added these details to the figure caption.

      Because Figure 1 is aggregated simulation time, it would be helpful to also represent the data as individual replicates or incorporate this information to calculate standard deviations/statistics (e.g., 1 microsecond max using the replicates to compute a standard deviation).

      We believe the current quantification & display of data via sharing all trajectories is sufficient to convey the major point for how often each CDR-phosholipid binding site it occupied.  Further tracking and statistics of inter-atomic distances will likely be too tedious & add minimal value. There is some dynamics of the phosphate oxygens between the polar within the CDR site but our “bound” state definitions sufficiently describe the key participating interactions are made.

      Figure 2

      For A, it would be helpful to annotate the yellow and blue mesh on the figure itself.

      We have defined the orange phosphate and blue choline densities.

      Also, where are R29 and Y32 relative to this site? In the X-ray panels, Y38 is not shown, and the box delineating the zoom-in is almost imperceptible.

      Thank you for this suggestion to include those amino acids which are referenced in the text as critical sites where mutation impacts function. To clarify, Y32 is the pdb numbering for residue Y38 in IMGT numbering. We have added a panel to Figure 2-Figure Supplement 1 having a cartoon graphic of 10E8 loop groove with sidechains & annotating R29 and Y38, staying consistent with out use of IMGT numbering in the manuscript.

      Figure 3

      It might read clearer to have "LN01+MPER-TM" and "LN01-Apo" in the middle of A/B and C/D, respectively, and a dotted line delineating the left and right side of the figure panels.

      We have added these details to the figure for clarity for readers.

      It would be helpful to show some critical interactions that are discussed in the text, such as the salt bridge with K31, by labeling these on the figure (e.g., in E-H).

      We drafted figure panels with dashed lines to indicate those key interactions.  However, they became almost imperceptible and overloaded with annotations that distracted from the overall details.  For K31, the interaction occurs in LN01 crystal structures readers can refer to.

      Why are axes cut off for J?

      We corrected this.

      Please re-define K/L plots as in Figure 1, and explain abbreviations.

      We updated the figure caption to reflect these changes.

      Figure 4

      The caption for panel A states that the Fab begins in solvent 1-2 nm above the bilayer, but the main text states 0.5-2 nm.

      We have reconciled this difference and listed the correct distances: 0.5-2nm.

      Please label the y-axis as "Replicate" for relevant figure panels so that they are more immediately interpretable.

      This label has been added.

      A legend with "membrane-associated" and "non-associated" within the figure would be helpful. Additionally, the average percent membrane associated, with a standard deviation, should be shown (Similar to 1C, albeit with the statistics).

      This legend has been added.  We also added the additional statistical metrics requested to strengthen our analysis.

      The text references "10, 14, and 12 extended insertion events" for the three antibody-based simulations. How do you define "extended insertion events"? Would breaking this into average insertion time and standard deviation better highlight the association differences between MPER antibodies and controls, in addition to the variability due to difference random initialization?

      We thank the reviewer for the insightful suggestion on how to better organize quantitative analysis to support the method. Supplemental Table 3 includes these numbers.

      Figure 5

      The analysis in Fig. S6C could be included here as a main figure.

      The drafted revised figure adding S6C to Figure 5 made for too much information.  Likewise, putting this panel S6C separated it from the parent clustering data of S6B, so we decided to keep these figures separated.  The S6 figure is now Figure 5-figure supplement 1.

      Figure 6

      Please annotate membrane insertion on E as %.

      These are phosphate binding RMSD/occupancy vs time.  The panels are now too small to annotate by %.  The qualitative presentation is sufficient at this stage.  The quantitative % are listed in-line within text when relevant to support assertions made. 

      Please use the figure caption to explain why certain clusters (e.g., 10E8 cluster A, artifact, Fig. S6E) are not included in panel E.

      We have added this information in the figure caption.

      Figure 7

      Please show all points on the box and whisker plots (panels E and F), and perform appropriate statistical tests to see if means are significantly different (these are mentioned in the text, but should be annotated on the graph and mentioned within the figure caption).

      We have changed these plots to show all data points along with relevant statistical comparisons. The figure captions describe unpaired t-test statistical tests used.

      Figure S1

      G, H, and I do not belong here-they should be moved to accompany their relevant text section, which associates with Figure 3. It would be helpful to associate this with Figure 3 in the eLife format, "Figure 3-Supplemental Figure 1" or its equivalent.

      It's very difficult to distinguish the green and blue circles on panel G.

      We darkened the shading and added outline for better visualization

      Subfigure I is missing a caption, could be included with H: "(H,I) Additional replicates for LN01+TM (H) and LN01 (I)".

      We corrected this as suggested.

      Why is H only 3 simulations and not 4? Does it not have a lipid in the x-ray site? Also, the caption states "(top, green)" and "(bottom, cyan)", but the green vs. cyan figures are organized on the left and right. Additional labels within the figure would help make this more intuitive.

      If the point of H and I is to illustrate that POPC exchanges between the X-ray and loading sites, this is unclear from the figure. Consider clarifying these figures.

      Thank you for describing the confusion in this figure, we have added labels to clarify.

      Figure S2 (panels split between revised Figure 4 associated figure supplements)

      The LN01 figures should likely follow later so that they can associate with Figure 3, despite being a similar analysis.

      We corrected supplements to eLife format so supplements are associated with relevant main figures.

      Figure S3 (panels split between revised Figure 1 & 2 associated figure supplements)

      As hydrophobicity is discussed as a driving factor for residue insertion, it would be helpful to have a rolling hydrophobicity chart underneath each plot to make this claim obvious.

      We prefer the current format, due to the worry of having too much information in these already data-rich panels.  As well, residues are not apolar but are deeply inserted.

      Figure S4 (panels split between revised Figure 1 & 2 associated figure supplements)

      It would be helpful to label the relevant loops on these figures.

      We have labeled loops for clarity.

      Do any of these loops have minor contacts with Env in the structure?

      The 4E10 and PGZL1 CDRH-1 loop does not directly contact bound MPER peptides bound in crystal structures. 

      FRL-3 and CDR-H1 in 10E8 do not contact the MPER peptide antigen component based on x-ray crystal structures.

      Do motif contacts with lipid involve minor contacts with additional loops other than those displayed in this figure?

      The phosphate-loop interactions in motifs used as query bait here are mediated solely by the backbone and side chain interactions of the loops displayed. We visually inspected most matches and did not see any “consensus” additional peripheral interactions common across each potential instance in the unrelated proteins.  The supplied Supplemental Table 2 contains the information if a reader wanted to conduct a detailed search. 

      Why is there such a difference between the loop conformation adopted in the X-ray structure and that in the MD simulation, and why does this lead to the large observed differences in ligand-binding structure matches?

      We thank the reviewer for carefully noting our error in labeling of CDR loop and framework region input queries. We revised the labeling to clarify the issue.

      The is minimal structural difference between the loops in x-ray and MD.

      Figure S5 (Figure 2-Figure supplement 4)

      This figure is not colorblind friendly-it would be helpful to change to such a pallet as the data are interesting, but uninterpretable to some.

      We have left this figure the same.

      "Susbstates" - "Substates"

      Corrected, thank you.

      Panel B is uninterpretable-please break the axis so that the Euclidian distances can be represented accurately but the histograms can be interpreted.

      We have adjusted axis for this plot to better illustrate the cluster thresholds.

      The clusters in D-H should be analyzed in greater depth. What is the structural relevance of these clusters other than differences in phospholipid occupancy in (I)? Snapshots of representative poses for each cluster could help clarify these differences.

      We have adjusted the text to describe the geometric differences in each of those clusters that result in the different exceptionally lower propensities for forming the key phospholipid interaction.  

      The figure caption should make it clear that 3 μS of aggregate simulation time is being used here instead of 4 μS to start with unique tilt initializations. E.g., "unique starting membrane-bound conformations (0 degrees, -15 degrees, 15 degrees initialization relative to the docked pose)". Further, why was the particular 0-degree replicate chosen while the other was thrown out? Or was this information averaged? Why is the full 4 μS then used for D-I?

      We thank the reviewer for noting these details.  We didn’t want to bias the differential between 10E8 and 4E10/PGZL1 by including the replicate simulations.  The analysis was mainly intended to achieve more coarse resolution distinction between 10E8 and the similar PGZL1/4E10.  

      In the subsequent clustering of individual bnAb simulation groups, the replicate 0 degree simulations had sufficiently different geometric sampling and unique lipid binding behavior that we though it should be used (4 us total) to achieve finer conformational resolution for each bnAb.

      Figure S6 (now Figure 5-Figure Supplement 1)

      Please label the CDRs in C and provide a color key like in other figures. Also, please label the y-axes. This figure could move to main below 5B with the clusters "A,B,C" labeled on 5B.

      We have added the axes labels and color key legend.  We retained a minimal CDR loop labeling scheme for the more throughput interaction profiles here where colored sections in the residue axes denote CDR loop regions.

      Figure S7 (Figure 7 Figure Supplement 1)

      Panels A and B would likely read better if swapped.

      We have swapped these panels for a better flow.

      For panel C, please display mean and standard deviation, and compare these values with an appropriate statistical test.

      This is already displayed in main figure, we have removed it from supplement.

      For E and F, please clarify from which trajectory(s) you are extracting this conformation from. Are these the global mean/representative poses? How do they compare to other geometrically distinct clusters?

      The requested information was added to supplemental figure caption.  These are frames from 2 distinct time points selected phosphate bound frames from 0-degree tilt replicates for both 4E10 and 10E8, representing at least 2 distinct macroscopic substates differing in global light chain and heavy chain orientation towards the membrane. 

      Table S2 (now Supplementary Table 3)

      Please add details for the 13h11 simulation.

      Additionally, please add average contact time and their standard deviation to the table, rather than just the aggregated total time. This will highlight the variability associated with the random initializations of each simulation.

      We have added the details for 13h11 and the requested analysis (average aggregated time +/- standard deviation and average time per association event +- standard deviation) to supplement our summary statistics for this method.

      Reviewer #2 (Recommendations For The Authors):

      (1) The structure of the manuscript should be improved. For example, almost half of the introduction (three paragraphs) summarize the results. I found it hard to navigate all the data and specific interactions described in the result section. Furthermore, the claims at the end of several sections seem unsupported. Especially for the generalization of the approach. This should be moved to the discussion section. The discussion is pretty general and does not provide much context to the results presented in this study.

      We have significantly reorganized the results section to improve the flow of the manuscript and accessibility for readers, especially the first sections of all-atom simulations. We also removed claims not directly supported by data from our results, and expanded on some of these concepts in the discussion to make some more novel context to the result.

      (2) The author should cite more rigorously previous work and refrain from using the term "develop" to describe the simple use of a well established method. E.g. Several studies have investigated membrane protein interactions e.g. [1], membrane protein-bilayer self-assembly [2], steered molecular dynamics [3], etc.

      Thank you for identifying relevant work for the simulations that set precedent for our novel application to antibody-membrane interactions.  We have removed language about development of simulation methods from the text and now better reference the precedent simulation methods used here.

      (3) Have the authors considered estimating the PMF by combining the steered MD simulation through the application of Jarzynski's equality?

      We performed from preliminary PMFs for Fab-membrane binding, but saw it was taking upward of 40 us to reach convergence.  Steered simulations focus on a key lipid may be easier.

      Although PMFs are beyond the scope of this work, we added proposals & allusion to their utility as the next steps for more rigorous quantification of fab-membrane interactions.

      Minor

      (4) The term "integrative modeling" is usually used for computational pipelines which incorporate experimental data. Multiscale modeling would be more appropriate for this study.

      We altered descriptions throughout the manuscript to reflect this comment.

      (5) Units to report the force in the steered molecular dynamics are incorrect. They should be 98.

      We changed axes and results to correctly report this unit.

      (6) Labels for axes of several graphs are not missing.

      We added labels to all axes of graphs, except for a few where stacked labels can be easily interpreted to save space and reduce complexity in figures.

      (7) Figure 3 K & L is this really < 1% of total? The term "total" should also be clarified.

      Thank you for pointing this out, we changed the % labels to be correct with axes from 0-100%. We clarified total in the figure caption.

      (8) The font size in figures should be uniformized.

      This suggestion has been applied

      (9) Time needed for steered MD should be reported in CPUh and not hours (page 17).

      We removed comments on explicit time measurements for our simulations.

      (10) Version of Martini force field is missing in methods section

      We used Martini 2.6 and added this to the methods.

      References

      (1) Prunotto, Alessio, et al. "Molecular bases of the membrane association mechanism potentiating antibiotic resistance by New Delhi metallo-β-lactamase 1." ACS infectious diseases 6.10 (2020): 2719-2731.

      (2) Scott, Kathryn A., et al. "Coarse-grained MD simulations of membrane protein-bilayer self-assembly." Structure 16.4 (2008): 621-630.

      (3) Izrailev, S., et al. "Computational molecular dynamics: challenges, methods, ideas. Chapter 1. Steered molecular dynamics." (1997).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In this work, the authors examine the mechanism of action of MOTS-c and its impact on monocyte-derived macrophages. In the first part of the study, they show that MOTS-c acts as a host defense peptide with direct antibacterial activity. In the second part of the study, the authors aim to demonstrate that MOTS-c influences monocyte differentiation into macrophages via transcriptional regulation.

      Major strengths.

      Methods used to study the bactericidal activity of MOTS-c are appropriate and the results are convincing.

      Major weaknesses.

      Methods used to study the impact on monocyte differentiation are inappropriate and the conclusions are not supported by the data shown. A major issue is the use of the THP-1 cell line, a transformed monocytic line which does not mimic physiological monocyte biology. In particular, THP-1 differentiation is induced by PMA, which is a completely artificial system and conclusions from this approach cannot be generalized to monocyte differentiation. The authors would need to perform this series of experiments using freshly isolated monocytes, either from mouse or human. The read-out used for macrophage differentiation (adherence to plastic) is also not very robust, and the authors would need to analyze other parameters such as cell surface markers. It is also not clear whether MOTS-c could act in a cell-intrinsic fashion, as the authors have exposed cells to exogenous MOTS-c in all their experiments. The authors did not perform complementary experiments using MOTS-c deficient monocytes. The authors have also analyzed the transcriptomic changes induced by MOTS-c exposure in macrophages derived from young or old mice. While the results are potentially interesting, the differences observed seem independent from MOTS-c and mainly related to age, therefore the conclusions from this figure are not clear. Another concern is the reproducibility of the experiments, as the authors do not indicate the number of biological replicates analyzed nor the number of independent experiments performed.

      In this study, we employed the THP-1 cell line as a proof-of-principle to elucidate the existence of a firstin-class mitochondrial-encoded host defense peptide. This peptide is expressed in monocytes and serves dual functions: i) direct targeting of bacteria, and ii) regulation of monocyte differentiation. It is noteworthy that THP-1 cells differentiated by PMA have been widely utilized as a model for monocyte differentiation by numerous research groups.  While we acknowledge the significance of utilizing primary monocytes to fully comprehend the translational implications of our findings, conducting a complete replication of our experiments in primary monocytes falls beyond the scope of this study. However, we have conducted several pivotal experiments in primary monocytes, including:  

      i) Demonstration of the induction of endogenous MOTS-c in primary human monocytes during differentiation by M-CSF (Fig 3A).

      ii) Observation of an increased number of adhered monocytes during monocyte differentiation following MOTS-c treatment (Fig 5A).

      iii) Examination of the transcriptional regulation in mouse primary bone marrow-derived macrophages (BMDMs) by MOTS-c, seven days after a single treatment at the onset of differentiation (Fig 6).

      In addition to assessing adherence to plastic, we performed RNA-seq of THP-1 cells during early differentiation with MOTS-c as a measure of accelerated differentiation (Fig 4). The positive correlation between the effects of PMA and PMA+MOTS-c suggests that MOTS-c accelerates the transcriptional changes that occur during differentiation (Fig 4G). We consider this method a more comprehensive evaluation of differentiation as it encompasses the expression of thousands of genes rather than relying on a limited selection of cell surface markers. Future investigations should explore additional indicators of differentiation, including potential epigenetic effects of MOTS-c.

      Our findings indicate that endogenous MOTS-c is induced during monocyte stimulation and translocates into the nucleus (Figs 3-4), implying a cell-intrinsic role for MOTS-c during monocyte differentiation. Although examining MOTS-c deficient monocytes would offer valuable insights, technical limitations currently hinder the production of such monocytes due to the mitochondrial genomic encoding of MOTSc within the 12S rRNA.

      Furthermore, our study reveals that MOTS-c alters gene expression in macrophages similarly across age and sex groups. This observation, illustrated in Fig 6E where the fold changes in clusters 5 and 6 in response to MOTS-c were consistent across all groups, suggests that MOTS-c modulates macrophage gene expression in an age-related manner. We postulate this to be an adaptive response to age-related alterations in the monocyte and macrophage microenvironment.

      The number of biological replicates performed for each experiment is indicated.

      The different parts of the manuscript do not appear well connected and it is not clear what the main message from the manuscript would be. The physiological relevance of this study is also unclear.

      The main message of our manuscript is that the mitochondrial genome encodes for a previously unknown host defense peptide that has physiological roles in modulating immune responses during infection and during aging. We have edited the ‘introduction’ to clarify this.

      Reviewer #2 (Public Review):

      The research study presented by Rice et al. set out to further profile the host defense properties of the mitochondrial protein MOTS-c. To do this they studied i. the potential antimicrobial effects of MOTS-c on common bacterial pathogens E.coli and MRSA, ii. the effects of MOTS-c on the stimulation and differentiation of monocytes into macrophages. This is a well performed study that utilizes relevant methods and cell types to base their conclusions on. However, there appear to be a few weaknesses to the current study that hold it back from more broad application.

      Comment 1: From reading the manuscript methods and results, it is unclear exactly what the synthetic MOTS-c source is. Therefore it is hard to determine whether there may be any impurities in the production of this synthetic protein that may interfere with the results presented throughout the manuscript. Though, the data presented in Supplemental Figure 4F, where E.coli expressing intracellular MOTS-c inhibited bacterial growth certainly support MOTS-c specific effects. Similarly with the experiments showing endogenous MOTS-c levels rising in stimulation and differentiated macrophages (Figure 3).

      We have edited our manuscript to include the source and purity of our synthetic MOTS-c peptide. The MOTS-c peptide used was synthesized by New England Peptides (now Biosynth) with a purity >95% by mass spectrometry.

      Comment 2: It is interesting that the mice receiving bacteria coupled with MOTS-c lost about 10% of their body weight. It would have been interesting to demonstrate the cause of this weight loss since the effect appears to be separate from mere PAMPs as shown by using heat-killed MRSA in Supplemental Figure 5. Was inflammation changed? Is this due to changes in systemic metabolism? Would have been interesting to have seen CRP levels or circulating liver enzymes.

      As suggested, we repeated this experiment to include both the heat-killed and MOTS-c-MRSA groups in the same controlled experiment for comparison (Fig 2; see below). Blood was collected from these mice for evaluation of cytokine levels and markers of organ damage. While only 1/6 controls survived, all MOTSc and heat-killed MRSA-treated mice survived. However, compared to the heat-killed group, the MOTS-cMRSA group lost more weight and had a higher inflammatory profile, but still significantly less than in the control group. We hypothesize that this is due to only partial killing of MRSA by MOTS-c, as suggested by the CFU plated after overnight incubation, leading to a non-lethal infection in these mice. Others have shown that in this peritonitis model, α-hemolysin production by live MRSA is a key factor in toxicity, rather than PAMP-induced shock (PMID: 8975909; 22802349), which is consistent with the absence of death following heat-killed MRSA inoculation.

      Despite these concerns, the data are well suited to answering their research question, and they open up the door to studying how mitochondrial peptides like MOTS-c could have roles outside of the mitochondria.

      Reviewer #1 (Recommendations For The Authors):

      Suggestions for improvement

      (1) The authors need to indicate in each legend the number of biological replicates analyzed and the number of independent experiments performed. This is essential.

      We have included the number of biological replicates analyzed.

      (2) The authors need to repeat the key experiments using freshly isolated monocytes, either human or mouse. THP-1 cells are abnormal cells and findings from these cells cannot be generalized to monocytes. For instance, in Figures 3A and B, it is clear that the kinetics of MOTS-c expression are different between THP-1 cells and human blood monocytes.

      The kinetics of THP-1 cells compared to human monocytes are slightly different, as expected by using different cells and different differentiation cues (M-CSF vs PMA). However, our findings collectively demonstrate the same effect, that each stimulus transiently induces the expression of MOTS-c within 24 hours in monocytes.

      In Figure 3A, the authors should show what happens in the absence of MCSF. Is MOTS-c expression upregulated by culture alone?

      There is some degree of baseline expression of MOTS-c in a resting state, and MOTS-c expression is significantly increased upon stimulation. This expression may be higher in primary monocytes than THP-1 cells, given that these monocytes are inevitably stressed by being removed from the native environment and put through the purification process.

      (3) In Figure 4A, a control for cytoplasmic contamination in the nuclear fraction is missing.

      We now include GAPDH detection in the nuclear fraction.  

      Author response image 1.

      (4) The RNA-seq analysis shown in Figure 4 is not very informative. What genes are differentially expressed? The authors should provide a list of these genes as supplementary information and highlight some key genes in the figure and text.

      The complete list of these genes is provided in Tables S1 and S2. We chose not to highlight specific genes in this paper due to the lack of sufficient evidence identifying any particular genes as key factors at this time.

      (5) In Figure 5A, a control is missing: the authors should treat the monocytes with the same volume of 'vehicle' (presumably it is water).

      In all experiments with MOTS-c treatment, the controls were treated with the same volume of vehicle (water). We have edited legends to state this.

      (6) In Figure 6, the differences observed seem independent on MOTS-c. The conclusions from this figure are overstated and need to be rephrased and clarified.

      MOTS-c shifted gene expression in macrophages in a similar manner regardless of age and sex, as shown in Fig 6E where the fold changes in clusters 5 and 6 in response to MOTS-c were similar in all groups. Independently, aging alone increases the expression of these same genes related to antigen presentation and interferon signaling, suggesting that MOTS-c shifts macrophage gene expression in an age-related manner – the expression of antigen presentation and interferon-related genes have been shown to be highly age-related (PMID: 36040389, 32669714, 36622281, 31754020). We hypothesize this to be an adaptive response to age-related changes in the monocyte and macrophage microenvironment.

      (7) Adherence to plastic is not a robust read-out for monocyte differentiation into macrophages. The authors need to examine other parameters, for instance characteristic cell surface markers for macrophages.

      As a read-out of accelerated differentiation, in addition to adherence to plastic we performed RNA-seq of THP-1 cells during early differentiation with MOTS-c (Fig 4). The positive correlation between the effects of PMA and effects of PMA+MOTS-c suggest MOTS-c is accelerating the transcriptional changes that occur during differentiation (Fig 4G). We believe this to be a more robust assessment of differentiation as it relies on the expression of thousands of genes rather than a limited selection of cell surface markers. Further studies are needed to assess other read-outs of differentiation, including possible epigenetic effects of MOTS-c.

      (8) It is not clear whether MOTS-c could have a cell-intrinsic effect in monocytes. The results should be strengthened by examining the differentiation of monocytes deficient for MOTS-c (without addition of exogenous MOTS-c).

      We have shown that endogenous MOTS-c is induced during monocyte stimulation and translocates into the nucleus (Figs 3-4), suggesting that MOTS-c does have a cell-intrinsic role during monocyte differentiation.

      While having MOTS-c deficient monocytes would certainly be insightful, because MOTS-c is encoded within the mitochondrial genome in the 12S rRNA there are currently technical limitations in producing these monocytes.

      Other points

      (1) The paper would benefit from a more extended discussion to understand the physiological relevance of these findings. What cells would release MOTS-c in vivo, and how would that affect monocytes ? Is there a cell-intrinsic of MOTS-c in monocytes, and if so what would be the signals inducing its expression during differentiation ? These aspects should be discussed by the authors so that the readers can understand their views.

      We thank the reviewer for their suggestion and have edited the discussion in our revised manuscript.  

      MOTS-c has been detected in various tissue and cell types, including the liver, muscle, T cells, monocytes/macrophages, and epithelial cells. This aligns with MOTS-c being referred to in literature as a cytokine, which are typically expressed by a broad range of cell types. Consistent with this, we also propose that MOTS-c would be expressed in cells known to express HDPs.

      We hypothesize that MOTS-c acts in both a cell-intrinsic and extrinsic manner in vivo, consistent with known HDPs, to both target bacteria directly and modulate immune cell responses. In vitro, M-CSF, PMA, LPS, and IFNγ each induced MOTS-c expression. In vivo, monocytes respond to a range of stimuli that influence their differentiation, and these stimuli may induce MOTS-c as well. We have previously published that MOTS-c acts primarily under conditions of cell stress, such as nutrient deprivation and oxidative stress, to help restore homeostasis. While MOTS-c did regulate macrophage gene expression in resting “M0-like” macrophages, we hypothesize that the physiological role of MOTS-c is to regulate cell adaptation to stress, therefore the context under which monocytes differentiate will be an important factor determining the functional effects of MOTS-c. In future studies, we plan to test whether the immuno-modulatory effects of MOTS-c are dependent on the environment during differentiation.

      (2) Scale bar appear to be missing from Figure 1G.

      We apologize for the poor resolution of the scale bar. We have made it easily recognizable in the revised figure.  

      (3) It is not very clear what is shown in Figure S2. The authors should better explain what the images represent.

      Figure S2 is related to Figure 1D and Figure S1. In this experiment, E. coli, S. typhimurium, and P. aeruginosa cultures were treated with MOTS-c (100uM). We observed that only E. coli aggregated immediately, while

      S. typhimurium and P. aeruginosa did not show aggregation. This suggests that MOTS-c exhibits specificity in targeting certain types of bacteria, although the underlying basis of this specificity is currently unknown.  

      We have revised the legend as follows: 'MOTS-c exhibits specificity in bacterial targeting. MOTS-c (100 μM) treatment causes immediate aggregation of E. coli but not S. typhimurium or P. aeruginosa (n=6). Representative image shown. See Figure 1D'.

      Reviewer #2 (Recommendations For The Authors):

      This is a beautifully executed study and a well written manuscript. I generally don't have much critical feedback to give based on my reading. The only recommendation I have to improve the completeness of the data would be in relation to Figure 5E and F. The metabolic phenotype of LPS stimulated monocytes/macrophages is more typically the Warburg effect where oxidative phosphorylation is reduced (as you show with a lowered OCR), but with a concomitant elevation in lactate production. It would have been nice to see either i. the ECAR levels from your seahorse data, or ii. separate lactate measurements on your supernatants. This would go a long way to further explaining the phenotype described in the figure.

      We greatly appreciate the reviewer's positive feedback. The data provided below are ECAR measurements obtained from the Seahorse assay. However, it's important to note that the assays were originally designed for OCR measurement (e.g. buffered media unsuitable for ECAR measurements, use of mitochondrial complex inhibitors, etc.), thus rendering the ECAR data unreliable for accurately assessing glycolysis. Consequently, while we share this data with the reviewer, we believe it is inappropriate to include it in the manuscript (hence omitted in the original submission).

      Author response image 2.

      Furthermore, we are currently engaged in a separate manuscript focusing on elucidating the immunometabolic mechanisms of MOTS-c in macrophages. We intend for this manuscript to stand alone, providing a comprehensive exploration of metabolic pathways, including a detailed untargeted metabolomics map spanning multiple time-points.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper examines patterns of diversity and divergence in two closely related sub-species of Zea mays. While the data are interesting and the authors have tried to exclude multiple confounding factors, many patterns cannot clearly be ascribed to one cause or another.

      Strengths:

      The paper presents interesting data from sets of sympatric populations of the two sub-species, maize and teosinte. This sampling offers unique insights into the diversity and divergence between the two, as well as the geographic structure of each. Many analyses and simulations to check analyses have been carried out.

      Weaknesses:

      The strength of conclusions that can be drawn from the analyses was low, partly because there are many strange patterns. The authors have done a good job of adding caveats, but clearly, these species do not meet many assumptions of our methods.

      Thank you for the comments. We appreciate the multiple rounds of revision the manuscript has undergone and the work has improved as a consequence. Overall we disagree that the patterns are strange, and have made considerable efforts to explain in the text and in our responses why the patterns make sense based on what we know about the history of Zeamays from previous research. We agree that currently available methods are not capable of answering all questions we propose adequately. This reflects both limitations with the available data for these populations (i.e. phenotypes and spatially explicit sampling), and limitations in available methods tailored to the questions at hand (spatially explicit inference of the range over which an allele is adaptive). We have made considerable effort to point out the places where our inferences are likely to have low accuracy or limited resolution. These limitations are in many ways inherent to all inferential based science and should not be considered a weak point specific to this work, nor do they take away from the fundamental conclusions, which have changed quantitatively but not qualitatively over the course of peer review.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      -The manuscript should say something about the fact that range-wide PSMC does not show a decline.

      We did not use PSMC methods but instead mushi as described in the methods. On line 356 we described how the lower sample size and strong regularization are the most likely explanations for the lack of a population size decline in the rangewide samples.

      - The manuscript should explain how rdmc was run and what "overlapping" means.

      We described how sweep intervals were inferred starting on line 823 (Methods subsection “Identifying Selective Sweeps”). Sweep regions were defined as the outermost coordinates from all populations that shared any overlap in their respectively defined sweep intervals. The details of how we ran rdmc, including all of the parameters, is described starting on line 895 (methods subsection “Inferring modes of convergent adaptation”).

      - Figure 4: "Negative log10" is messed up

      Thank you. This has been fixed for the Version Of Record.

      - Line 318: "accruacy"

      Thank you. We have edited this typo for the Version Of Record.

      - New Table S3: why don't the proportions add to 1?

      These values represent what proportion of fixed differences at 0 fold sites are unique to each population. The denominator is the total number of fixed differences for each population separately, so each proportion is distinct for each population and thus should not sum to one across them. The table caption has been reworded in efforts to clarify for the Version Of Record.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This paper examines patterns of diversity and divergence in two closely related sub-species of Zea mays. While the patterns are interesting, the strength of evidence in support of the conclusions drawn from these patterns is weak overall. Most of the main conclusions are not supported by convincing analyses.

      Strengths:

      The paper presents interesting data from sets of sympatric populations of the two sub-species, maize and teosinte. This sampling offers unique insights into the diversity and divergence between the two, as well as the geographic structure of each.

      Weaknesses:

      There were issues with many parts of the paper, especially with the strength of conclusions that can be drawn from the analyses. I list the major issues in the order in which they appear in the paper.

      (1) Gene flow and demography.

      The f4 tests of introgression (Figure 1E) are not independent of one another. So how should we interpret these: as gene flow everywhere, or just one event in an ancestral population? More importantly, almost all the significant points involve one population (Crucero Lagunitas), which suggests that the results do not simply represent gene flow between the sub-species. There was also no signal of increased migration between sympatric pairs of populations. Overall, the evidence for gene flow presented here is not convincing. Can some kind of supporting evidence be presented?

      We agree that the standard approach to f4 tests that we employed here is not without limitations, namely, that the tests are conducted independently, while the true evolutionary history is not. While a joint demographic inference across all populations would be useful, it did not seem tractable to perform over all of our populations with currently available methods, given the number of populations being analyzed, nor does it directly address the question of interest. Our purpose for including the f4 was testing if there was more gene flow between sympatric pairs than in other comparisons (we have made that point more clear in the text near line 174. As described in the text, the distribution of Z scores is generated by pairing focal populations with all other non-focal populations across both subspecies, which means the gene flow signal of interest is marginalized over the effects of gene flow in the other non-focal populations. This is not nearly as rich as inferring the full history, but it gives us some sense of the average amount of gene flow experienced between populations and allows us to address one of our primary questions of interest when conceiving this paper - do sympatric pairs show more geneflow than other pairs? We agree with the reviewer that that answer is largely no, and the writing reflects this.

      Overall, we think both points mentioned by the reviewer here; finding that most but not all tests involved Crucero Lagunitas maize, and that sympatric pairs don’t show higher gene flow; nicely contributes to the overall theme in the paper - the history of both subspecies is idiosyncratic and impacted by humans in ways that do not reflect geographic proximity that we did not anticipate (see expectations near line 110). We have emphasized the connection between f4 tests and the revised rdmc results near line 653.

      The paper also estimates demographic histories (changes in effective population sizes) for each population, and each sub-species together. The text (lines 191-194) says that "all histories estimated a bottleneck that started approximately 10 thousand generations ago" but I do not see this. Figure 2C (not 2E, as cited in the text) shows that teosinte had declines in all populations 10,000 generations ago, but some of these declines were very minimal. Maize has a similar pattern that started more recently, but the overall species history shows no change in effective size at all. There's not a lot of signal in these figures overall.

      I am also curious: how does the demographic model inferred by mushi address inbreeding and homozygosity by descent (lines 197-202)? In other words, why does a change in Ne necessarily affect inbreeding, especially when all effective population sizes are above 10,000?

      All maize populations show a decline beginning 10,000 generations ago. The smallest decline for maize is from 100,000 to 30,000. All teosinte populations show a reduction in population size. The smallest of these drops more than 70% from around 300,000 to 100,000. Three of the teosinte populations showed a reduction in population size from ~10^5 to ~10^3, which is well below 10,000. Thus all populations show declines.

      These large reductions should lead to inbreeding and increased homozygosity by descent. Mushi does not specifically model these features of the data, yet as we show, simulations under the model estimated by Mushi matched the true HBD levels fairly well (Figure 2D).

      The rangewide sample does not show declines, likely because there is enough isolation between populations that the reduction in variation at any given locus is not shared, and is maintained in the populations that did not experience the population decline.

      (2) Proportion of adaptive mutations.

      The paper estimates alpha, the proportion of nonsynonymous substitutions fixed by positive selection, using two different sampling schemes for polymorphism. One uses range-wide polymorphism data and one uses each of the single populations. Because the estimates using these two approaches are similar, the authors conclude that there is little local adaptation. However, this conclusion is not justified.

      There is little information as to how the McDonald-Kreitman test is carried out, but it appears that polymorphism within either teosinte or maize (using either sampling scheme) is compared to fixed differences with an outgroup. These species might be Z. luxurians or Z. diploperennis, as both are mentioned as outgroups. Regardless of which is used, this sampling means that almost all the fixed differences in the MK test will be along the ancestral branch leading to the ancestor of maize or teosinte, and on the branch leading to the outgroup. Therefore, it should not be surprising that alpha does not change based on the sampling scheme, as this should barely change the number of fixed differences (no numbers are reported).

      The lack of differences in results has little to do with range-wide vs restricted adaptation, and much more to do with how MK tests are constructed. Should we expect an excess of fixed amino acid differences on very short internal branches of each sub-species tree? It makes sense that there is more variation in alpha in teosinte than maize, as these branches are longer, but they all seem quite short (it is hard to know precisely, as no Fst values or similar are reported).

      The section “Genetic Diversity” in the methods provides details about how luxurians and diploperennis were used as outgroups. The section “Estimating the Rate of Positive Selection, α”, in the methods includes the definition of α and full joint non-linear regression equation and the software used to estimate it (brms), and the relevant citations crediting the authors of the original method. However, some of the relevant information about the SFS construction is provided in the previous section entitled, “Genetic Diversity”. We added reference to this in results near line 800.

      While we appreciate the concern that “almost all the fixed differences in the MK test will be along the ancestral branch leading to the ancestor of maize or teosinte”, this is only a problem if there aren’t enough fixed differences that are unshared between populations. This is more of a concern for maize than teosinte, which we make clear as a caveat in the manuscript in several places already. The fact that there is variation in alpha among teosinte populations is evidence that these counts do differ among pops. As we can see in the population trees in Figure 1, there is a considerable amount of terminal branch length for all the populations. Indeed if we look at the number of fixed differences at 0 fold sites across populations:

      The variation in the number of fixed differences, particularly across teosinte means that a large number cannot be shared between populations. We can estimate the fixed differences unique to each subpopulation (and total count) demonstrating that, in general, there are a large number of substitutions unique to each population. This is good evidence the rangewide estimates do not reflect a lack of variation within populations, at least not for teosinte. This is now included in the supplement (Table S3).

      Finally, we note that the branches leading to outgroups are likely not substantially longer than those among populations. Given our estimates of Ne, the coalescent within maize and teosinte should be relatively deep (with Ne of 30K it should be ~120K years). The divergence time between Zea mays and these outgroup taxa has been estimated at ~150K years (Chen et al. 2022). This is now mentioned in the text on line 407.

      We have added a caveat about the reviewers concern for the non-independence of fixed difference for maize near line 386.

      (3) Shared and private sweeps.

      In order to make biological inferences from the number of shared and private sweeps, there are a number of issues that must be addressed.

      One issue is false negatives and false positives. If sweeps occur but are missed, then they will appear to be less shared than they really are. Table S3 reports very high false negative rates across much of the parameter space considered, but is not mentioned in the main text. How can we make strong conclusions about the scale of local adaptation given this? Conversely, while there is information about the false positive rate provided, this information doesn't tell us whether it's higher for population-specific events. It certainly seems likely that it would be. In either case, we should be cautious saying that some sweeps are "locally restricted" if they can be missed more than 85% of the time in a second population or falsely identified more than 25% of the time in a single population.

      The reviewer brings up a worthwhile point. The simulation results indeed call into question how many of the sweeps we claim are exclusive to one population actually are. This caveat is already made, but we now make clearer the reviewer’s concern regarding the high false negative rate (near line 299). However, if anything this suggests sweeps are shared even more often than what is reported. One of the major takeaways from the paper is that convergent adaptation is more common than we expected. The most interesting part about the unique sweeps is the comparison between maize and teosinte. While the true proportions may vary, the relatively higher proportion of sweeps exclusive to one population in teosinte compared to maize is unlikely to be affected by false negatives, since the accuracy to identify sweeps pretty similar across subspecies (though perhaps with some exceptions for the populations with stronger bottlenecks). Further, these criticisms are specific to the raisd results. All sweeps shared across multiple populations were analyzed using rdmc. After adjustments made to the number of proposed sites for selection (see response below), there is good agreement between the raisd and rdmc results - the regions we proposed as selective sweeps with raisd all show evidence convergence using rdmc. Recall too that rdmc uses a quite different approach to inference - all populations are used jointly, labelling those that did and did not experience the sweep. If sweeps were present in populations that were labeled as neutral (or vice versa), this would weaken the power to infer selection at the locus. Much of the parameter space we explored is for quite weak selection, and the simulated analysis shows we are likely to miss those instances, often entirely. For strong sweeps, however, our simulations show we have appreciable accuracy.

      Together, there is reason to be optimistic about our detection of strong shared sweeps and that the main conclusions we make are sound.

      Finally, we note that we are unaware of any other empirical study that has performed similar estimates of the accuracy of the sweep calling in their data (as opposed to using simulations). We thus see these analyses as a significant contribution towards transparency that is completely lacking from most papers.

      A second, opposite, issue is shared ancestral events. Maize populations are much more closely related than teosinte (Figure 2B). Because of this, a single, completed sweep in the ancestor of all populations could much more readily show a signal in multiple descendant populations. This is consistent with the data showing more shared events (and possibly more events overall). There also appear to be some very closely (phylogenetically) related teosinte populations. What if there's selection in their shared ancestor? For instance, Los Guajes and Palmar Chico are the two most closely related populations of teosinte and have the fewest unique sweeps (Figure 4B). How do these kinds of ancestrally shared selective events fit into the framework here?

      The reviewer brings up another interesting point and one that likely impacts some of our results.

      As the reviewer describes, this is an issue that is of more concern to the more closely related populations and is less likely to explain results across the subspecies. We have added this as a caveat (near line 456). As is clear in the writing, sharing across subspecies is our primary interest for the rdmc results.

      These analyses of shared sweeps are followed by an analysis of sweeps shared by sympatric pairs of teosinte and maize. Because there are not more events shared by these pairs than expected, the paper concludes that geography and local environment are not important. But wouldn't it be better to test for shared sweeps according to the geographic proximity of populations of the same sub-species? A comparison of the two sub-species does not directly address the scale of adaptation of one organism to its environment, and therefore it is hard to know what to conclude from this analysis.

      We did not intend to conclude that local adaptation is not important. Especially for teosinte, we report and interpret evidence that many sweeps are happening exclusively to one population, which is consistent with the action of location adaptation and consistent with some of our expectations.

      More directly, this is another instance of us having clear hypotheses going into the paper and constructing specific analyses to test them. As we explain in the paper, we expected the scale of local adaptation to be very small, such that subspecies growing next to each other have more opportunities to exchange alleles that are locally adapted to their shared environment. The analysis we conducted makes sense in light of this expectation. We considered conducting tests regarding geographic proximity, but there is limited power with the number of populations we have within subspecies, and the meaning of the tests is unclear if all populations of both subspecies are naively included together. This analysis shows that, at least for sweeps and fixations, adaptation is larger than a single location. While it may not be a complete description on its own, the work here does provide information about the scale of adaptation and is useful to our overall claims and objectives of the paper. As mentioned in the paper, the story might be very different if we were to study through a lens of polygenic adaptation. We also now include in the discussion in several places mention of where broader sampling could improve inference.

      (4) Convergent adaptation

      My biggest concern involves the apparent main conclusion of the paper about the sources of "convergent adaptations". I believe the authors are misapplying the method of Lee and Coop (2017), and have not seriously considered the confounding factors of this method as applied. I am unconvinced by the conclusions that are made from these analyses.

      The method of Lee and Coop (referred to as rdmc) is intended to be applied to a single locus (or very tightly linked loci) that shows adaptation to the same environmental factor in different populations. From their paper: "Geographically separated populations can convergently adapt to the same selection pressure. Convergent evolution at the level of a gene may arise via three distinct modes." However, in the current paper, we are not considering such a restricted case. Instead, genome-wide scans for sweep regions have been made, without regard to similar selection pressures or to whether events are occurring in the same gene. Instead, the method is applied to large genomic regions not associated with known phenotypes or selective pressures.

      I think the larger worry here is whether we are truly considering the "same gene" in these analyses. The methods applied here attempt to find shared sweep regions, not shared genes (or mutations). Even then, there are no details that I could find as to what constitutes a shared sweep. The only relevant text (lines 802-803) describes how a single region is called: "We merged outlier regions within 50,000 Kb of one another and treated as a single sweep region." (It probably doesn't mean "50,000 kb", which would be 50 million bases.) However, no information is given about how to identify overlap between populations or sub-species, nor how likely it is that the shared target of selection would be included in anything identified as a shared sweep. Is there a way to gauge whether we are truly identifying the same target of selection in two populations?

      The question then is, what does rdmc conclude if we are simply looking at a region that happened to be a sweep in two populations, but was not due to shared selection or similar genes? There is little testing of this application here, especially its accuracy. Testing in Lee and Coop (2017) is all carried out assuming the location of the selected site is known, and even then there is quite a lot of difficulty distinguishing among several of the non-neutral models. This was especially true when standing variation was only polymorphic for a short time, as is estimated here for many cases, and would be confused for migration (see Lee and Coop 2017). Furthermore, the model of Lee and Coop (2017) does not seem to consider a completed ancestral sweep that has signals that persist into current populations (see point 3 above). How would rdmc interpret such a scenario?

      Overall, there simply doesn't seem to be enough testing of this method, nor are many caveats raised in relation to the strange distributions of standing variation times (bimodal) or migration rates (opposite between maize and teosinte). It is not clear what inferences can be made with confidence, and certainly the Discussion (and Abstract) makes conclusions about the spread of beneficial alleles via introgression that seem to outstrip the results.

      We have fixed the “50,000 Kb” typo.

      There are several important points the reviewer makes here worth considering. First and most importantly, the method of Lee and Coop (2017) actually does include sites as part of the composite likelihood calculation. For computational feasibility, the number of positions we initially considered was 20 (20 different positions along the input sequence were proposed as the site of the shared beneficial mutation). In efforts to further address the reviewer’s concern about adaptive mutations at distinct loci, we have increased the number of proposed selected sites to 200. This fact should greatly diminish the reviewer’s concern that we are picking up independent sweeps that happened at different nucleotide positions in the same region - evidence for a beneficial mutation must be shared by the selected populations at a proposed site. As the revisions show, this has modified the results of our paper in a number of ways, including changing all of the previous neutral regions to shared via standing variation or migration. Despite these changes, our previous conclusions are intact, including the pattern that migration rates are high when maize populations share the sweep. Relatedly, we disagree with the reviewer’s characterization of the migration results. The pattern is quite clear and makes sense - when a maize population is involved in the sweep, migration rate is inferred to be high. Sweeps exclusive to teosinte are rarer and are inferred to have a low migration rate. This relates directly to the idea that humans have moved maize relatively rapidly across the landscape.

      We have now included a plot showing how the difference between the maximum composite likelihood (CLE) site compares to the next highest CLE site varies across our inferences (Figure S8), which strongly suggests that patterns are not muddled across multiple loci, but are centered at a focal region where the beneficial allele is inferred to be located. While there are too many to show in the manuscript across all sweeps, here is a nice example of what inference looks like for one of the proposed sweep regions.

      Author response image 1.

      Furthermore, the situation the reviewer is describing would be selection acting on independent mutations (mutations at different loci), which would not create an increase in the amount of allele frequency covariance above and beyond what would be expected by drift under the migration and standing variation models.

      We also note that we are not alone in applying this approach to shared outlier signals in the absence of known genes; indeed the authors of the DMC method have applied it to regions of shared outlier signal themselves (e.g. https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1008593).

      Reviewer #2 (Public Review):

      Summary:

      The authors sampled multiple populations of maize and teosinte across Mexico, aiming to characterise the geographic scale of local adaptation, patterns of selective sweeps, and modes of convergent evolution between populations and subspecies.

      Strengths & Weaknesses:

      The population genomic methods are standard and appropriate, including Fst, Tajima's D, α, and selective sweep scans. The whole genome sequencing data seems high quality. However, limitations exist regarding limited sampling, potential high false-positive sweep detection rates, and weak evidence for some conclusions, like the role of migration in teosinte adaptation.

      Aims & Conclusions:

      The results are interesting in supporting local adaptation at intermediate geographic scales, widespread convergence between populations, and standing variation/gene flow facilitating adaptation. However, more rigorous assessments of method performance would strengthen confidence. Connecting genetic patterns to phenotypic differences would also help validate associations with local adaptation.

      Impact & Utility:

      This work provides some of the first genomic insights into local adaptation and convergence in maize and teosinte. However, the limited sampling and need for better method validation currently temper the utility and impact. Broader sampling and connecting results to phenotypes would make this a more impactful study and valuable resource. The population genomic data itself provides a helpful resource for the community.

      Additional Context:

      Previous work has found population structure and phenotypic differences consistent with local adaptation in maize and teosinte. However, genomic insights have been lacking. This paper takes initial steps to characterise genomic patterns but is limited by sampling and validation. Additional work building on this foundation could contribute to understanding local adaptation in these agriculturally vital species.

      We appreciate the reviewer’s thoughtful reading of the paper and scrutiny. We hope that the added caveats made in response to reviewer 1 (as well as the previous rounds of peer review) will provide readers with the proper amount of skepticism in the accuracy of some of our initial sweep results, while also demonstrating that many of our conclusions are robust to the concerns raised over the various stages of review.

      We agree with the reviewer that better sampling and the incorporation inference about phenotypic data would be excellent additions, but the information is not available for the studied populations, and is outside scope of this paper.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      - Sometimes alpha is described as a rate, and sometimes as a proportion. The latter is correct.

      We have updated this. Thanks.

      - Line 79: are they really "discrete" populations?

      The teosinte populations sampled are all clearly separated from each other and are physically discrete. The maize population samples came from individual farmer fields. Traditional maize is grown as open-pollinated (outcrossing) populations, and farmers save seed for subsequent generations. An individual farmer’s field thus behaves as a discrete population for our purposes, impacted of course by gene flow, selection, and other evolutionary processes.

      - Lines 418-420: "Large genomes may lead to more soft sweeps, where no single mutation driving adaptive evolution would fix (Mei et al. 2018)." I'm not sure I understand this statement. Why is this a property of genome size?

      Mei et al. 2018 lay out the logic, but essentially they present data arguing that the total number of functionally relevant base pairs increases with genome size (less than linearly). If true, genomes with a large number of potentially functional bp are more likely to undergo soft sweeps (see theory by Hermisson and Pennings cited in Mei et al. 2018).

      - Lines 500-1: selection does not cause one to underestimate effective population sizes. Selection directly affects Ne. I'm not sure what biases the sentences on lines 502-508 are trying to explain.

      We have simplified this section. Not accounting for linked selection (especially positive selection) results in a biased inference of demographic history. See Marsh and Johri (2024) for another example. https://doi.org/10.1093/molbev/msae118

      - Line 511-3: does Uricchio et al. (2019) show any difference in the estimate of alpha from Messer and Petrov (2013) when taking background selection into account?

      What we initially wrote was incorrect. The aMK method of Messer and Petrov (2013) accounts for weakly deleterious polymorphisms, but it does not account for positively selected ones. We have updated this text and suggested our method may underestimate alpha if positively selected segregating alleles are common (near line 539).

      - Lines 598-599: "which would limit the rate of new and beneficial mutations." I don't understand this - shouldn't a bottleneck only affect standing variation? Why would a bottleneck affect new mutations?

      This is simply to say that during the low Ne period of a bottleneck, fewer total mutations (and therefore beneficial mutations) will be generated since there are fewer individuals for mutations to occur in. We have changed “rate” to amount to clarify we do not mean the mutation rate itself.

      Reviewer #2 (Recommendations For The Authors):

      Experiments/Analyses:

      (1) Consider simulating polygenic adaptation in addition to hard and soft sweeps to see if this improves the power to detect adaptive signatures shared between populations. This could involve simulating the coordinated change in allele frequencies across many loci to match a specified shift in trait value due to selection. The ability to detect shared polygenic adaptation between population replicates could be assessed using methods tailored to polygenic signals, such as the Polygenic Selection Score approach. Comparing the power to detect shared polygenic adaptation versus shared hard and soft sweeps would provide further insight into what adaptive modes current methods can uncover. If the power to detect shared polygenic adaptation is very low, the extent of shared adaptation between populations may be even more common than currently inferred. Adding simulations of polygenic adaptation would strengthen the study.

      While this would be a worthwhile undertaking in general, it would be a considerable amount of work outside of the scope and aims of this paper.

      (2) Explore using machine learning approaches like S/HIC to improve power over summary statistic methods potentially.

      We in fact put considerable effort into applying diplo S/HIC before switching to raisd for this project. While predictions on simulations had good power to detect sweeps, we found that applying to our actual data had a dubious number of windows classified as sweeps (e.g. >90% of the genome), which we believed to be false positives. We speculated that this may have to do with sensitivity to demographic or other types of misspecification in the simulations, such as our choice of window sizes compared to local recombination rates. It would likely be fruitful to our further efforts into using machine learning methods for maize and teosinte, but a deeper exploration of the right hyper parameters and simulation choices is likely needed to apply them effectively.

      (3) Increase geographic sampling density, if possible, especially near population pairs showing high differentiation, to better understand the scale of local adaptation.

      We agree this would be valuable research. Hopefully this work inspires further efforts into the question of the spatial and temporal scales of local adaptation with more ambitious spatial sampling designed at the onset

      Writing/Presentation:

      (1) Provide more intuition about the biological interpretation of the migration rates inferred under the migration model of convergence. What do the rates imply about the amount or timing of gene flow?

      We have expanded the discussion sections (starting near line 653) to elaborate on the migration results and connect the rdmc and f4 tests more explicitly. The timing of gene flow is more challenging to address directly with the approaches we used, but we agree it would be interesting to explore more in future papers.

      (2a) Expand the discussion of power limitations and the need for simulation tests. Consider adding ROC curves for sweep detection on simulated data. The relatively low proportion of shared selective sweeps between population replicates highlights limitations in the power to detect sweeps, especially incomplete or soft sweeps. I think it would be a good idea to expand the discussion of the power tradeoffs shown in the simulation analyses. In particular, the ROC curves in Figure S4 clearly show how power declines for weaker selection coefficients across the different sweep types. I suggest making these ROC curves part of the main figures to feature the issue of power limitations more prominently.

      (2b) The discussion would benefit from commenting on how power changes across the sweep simulation scenarios. Adding a summary figure to visualise the effects of sweep type, selection strength, and frequency on detectability could further clarify the power constraints. Stating the proportion of sweeps likely missed strengthens the argument that sharing adaptive alleles is likely even more common than inferred. Discussing power will also motivate the need for developing methods with improved abilities to uncover incomplete and soft sweeps.

      While these are useful suggestions (2a and 2b), the aim of this paper at its core is empirical, and was not intended to give an exhaustive analysis of the power to detect sweeps. We report what parts of the analysis may be impacted by low power and what aspects of our inferences have higher uncertainty due to power. We agree that there is more work to be done to improve methods to detect selection given our findings (see below concerning our efforts to use machine learning as well). While we do not highlight this in the paper, we also note that ours is one of extremely few empirical studies that actually perform power analyses on real data (as opposed to simulations). We think this extra transparency by itself is of substantial utility to the community in demonstrating that the results from simulation studies performed in publications describing a method do not necessarily translate well to empirical data.

      (3) Improve clarity in describing f4 test results. Consider visualising results on a map to show spatial patterns.

      We have expanded the discussion concerning f4 tests (see several comments to reviewer 1). We are not clear on how to effectively visualize f4 spatially, but hope the updates have made the results more clear.

      Minor:

      -  Increase the font size of figure axis labels for improved readability.

      We have looked over and figures and increased font sizes where possible.

      -  Add units to selection coefficient axis labels in Figure 5.

      Selection coefficients are derived in Lee and Coop (2017) from classical population genetics theory. They do not have units, but denote the relative fitness advantage of the heterozygous genotype carrying the beneficial mutation of interest.

      -  Fix the typo 'cophenetic' in Figure S3 caption.

      Fixed. Thank you.

    1. Author Response:

      We greatly appreciate invaluable and constructive comments from Editors and Reviewers. We also thank for their time and patience. We are pleased for our manuscript to have been assessed valuable and solid.

      One of most critical concerns was a possible involvement of Ca2+ channel inactivation in the strong paired pulse depression (PPD). Meanwhile, we have already measured total (free plus buffered) calcium increments induced by each of first four APs in a 40 Hz train at axonal boutons of prelimbic layer 2/3 pyramidal cells. We found that first four Ca2+ increments were not different each other, arguing against possible contribution of Ca2+ channel inactivation to PPD. Please see our reply to the 2nd issue in the Weakness section of Reviewer #3.

      The second critical issue was on the definition of ‘vesicular probability’. Previously, vesicular probability (pv) has been used with reference to the releasable vesicle pool which includes not only tightly docked vesicles but also reluctant vesicles. On the other hand, the meaning of pv in the present study was release probability of tightly docked vesicles. We clarified this point in our replies to the 1st issues in the Weakness sections of Reviewer #2 and Reviewer #3.

      To other Reviews’ comments, we below described our point-by-point replies.

      Reviewer #2 (Public review):

      Summary:

      Shin et al aim to identify in a very extensive piece of work a mechanism that contributes to dynamic regulation of synaptic output in the rat cortex at the second time scale. This mechanism is related to a new powerful model is well versed to test if the pool of SV ready for fusion is dynamically scaled to adjust supply demand aspects. The methods applied are state-of-the-art and both address quantitative aspects with high signal to noise. In addition, the authors examine both excitatory output onto glutamatergic and GABAergic neurons, which provides important information on how general the observed signals are in neural networks, The results are compellingly clear and show that pool regulation may be predominantly responsible. Their results suggests that a regulation of release probability, the alternative contender for regulation, is unlikely to be involved in the observed short term plasticity behavior (but see below). Besides providing a clear analysis pof the underlying physiology, they test two molecular contenders for the observed mechanism by showing that loss of Synaptotagmin7 function and the role of the Ca dependent phospholipase activity seems critical for the short term plasticity behavior. The authors go on to test the in vivo role of the mechanism by modulating Syt7 function and examining working memory tasks as well as overall changes in network activity using immediate early gene activity. Finally, they model their data, providing strong support for their interpretation of TS pool occupancy regulation.

      Strengths:

      This is a very thorough study, addressing the research question from many different angles and the experimental execution is superb. The impact of the work is high, as it applies recent models of short term plasticity behavior to in vivo circuits further providing insights how synapses provide dynamic control to enable working memory related behavior through nonpermanent changes in synaptic output.

      Weaknesses:

      While this work is carefully examined and the results are presented and discussed in a detailed manner, the reviewer is still not fully convinced that regulation of release provability is not a putative contributor to the observed behavior. No additional work is needed but in the moment I am not convinced that changes in release probability are not in play. One solution may be to extend the discussion of changes in rules probability as an alternative.

      Quantal content (m) depends on n * pv, where n = RRP size and pv =vesicular release probability. The value for pv critically depends on the definition of RRP size. Recent studies revealed that docked vesicles have differential priming states: loosely or tightly docked state (LS or TS, respectively). Because the RRP size estimated by hypertonic solution or long presynaptic depolarization is larger than that by back extrapolation of a cumulative EPSC plot (Moulder & Mennerick, 2005; Sakaba, 2006) in glutamatergic synapses, the former RRP (denoted as RRPhyper) may encompass not only AP-evoked fast-releasing vesicles (TS vesicle) but also reluctant vesicles (LS vesicles). Because we measured pv based on AP-evoked EPSCs such as strong paired pulse depression (PPD) and associated failure rates, pv in the present study denotes vesicular fusion probability of TS vesicles not that of LS plus TS vesicles.

      Recent studies suggest that release sites are not fully occupied by TS vesicles in the baseline (Miki et al., 2016; Pulido and Marty, 2018; Malagon et al., 2020; Lin et al., 2022). Instead the occupancy (pocc) by TS vesicles is subject to dynamic regulation by reversible rate constants (denoted by k1 and b1, respectively). The number of TS vesicles (n) can be factored into the number of release sites (N) and pocc, among which N is a fixed parameter but pocc depends on k1/(k1+b1) under the framework of the simple refilling model (see Methods). Because these refilling rate constants are regulated by Ca2+ (Hosoi, et al., 2008), pocc is not a fixed parameter. Therefore, release probability should be re-defined as pocc x pv. In this regard, the increase in release probability is a major player in STF. Our study asserts that STF by 2.3 times can be attributed to an increase in pocc rather than pv, because pv is close to unity (Fig. S8). Moreover, strong PPD was observed not only in the baseline but also at the early and in the middle of a train (Fig. 2 and 7) and during the recovery phase (Fig. 3), arguing against a gradual increase in pv of reluctant vesicles.

      If the Reviewer meant vesicular release or fusion probability (pv) by ‘release provability’, pv (of TS vesicles) is not a major player in STF, because the baseline pv is already higher than 0.8 even if it is most parsimoniously estimated (Fig. 2). Moreover, considering very high refilling rate (23/s), the high double failure rate cannot be explained without assuming that pv is close to unity (Fig. S8).

      Conventional models for facilitation assume a post-AP residual Ca2+-dependent step increase in pv of RRP (Dittman et al., 2000) or reluctant vesicles (Turecek et al., 2016). Given that pv of TS vesicles is close to one, an increase in pv of TS vesicles cannot account for facilitation. The possibility for activity-dependent increase in fusion probability of LS vesicles (denoted as pv,LS) should be considered in two ways depending on whether LS and TS vesicles reside in distinct pools or in the same pool. Notably, strong PPD at short ISI implies that pv,LS is near zero at the resting state. Whereas LS vesicles do not contribute to baseline transmission, short-term facilitation (STF) may be mediated by cumulative increase in pv, LS that reside in a distinct pool. Because the increase in pv,LS during facilitation recruits new release sites (increase in N), the variance of EPSCs should become larger as stimulation frequency increases, resulting in upward deviation from a parabola in the V-M plane, as shown in recent studies (Valera et al., 2012; Kobbersmed et al., 2020). This prediction is not compatible with our results of V-M analysis (Fig. 3), showing that EPSCs during STF fell on the same parabola regardless of stimulation frequencies. Therefore, it is unlikely that an increase in fusion probability of reluctant vesicles residing in a distinct release pool mediates STF in the present study.

      For the latter case, in which LS and TS vesicles occupy in the same release sites, it is hard to distinguish a step increase in fusion probability of LS vesicles from a conversion of LS vesicles to TS. Nevertheless, our results do not support the possibility for gradual increase in pv,LS that occurs in parallel with STF. Strong PPD, indicative of high pv, was consistently found not only in the baseline (Fig. 2 and Fig. S6) but also during post-tetanic augmentation phase (Fig. 3D) and even during the early development of facilitation (Fig. 2D-E and Fig. 7), arguing against gradual increase in pv,LS. One may argue that STF may be mediated by a drastic step increase of pv,LS from zero to one, but it is not distinguishable from conversion of LS to TS vesicles.

      To address the reviewer’s concern, we will incorporate these perspectives into the discussion and further clarify the reasoning behind our conclusions.

      <References>

      Moulder KL, Mennerick S (2005) Reluctant vesicles contribute to the total readily releasable pool in glutamatergic hippocampal neurons. J Neurosci 25:3842–3850.

      Sakaba, T (2006) Roles of the fast-releasing and the slowly releasing vesicles in synaptic transmission at the calyx of Held. J Neurosci 26(22): 5863-5871.

      Fig 3 I am confused about the interpretation of the Mean Variance analysis outcome. Since the data points follow the curve during induction of short term plasticity, aren't these suggesting that release probability and not the pool size increases? Related, to measure the absolute release probability and failure rate using the optogenetic stimulation technique is not trivial as the experimental paradigm bias the experiment to a given output strength, and therefore a change in release probability cannot be excluded.

      Under the recent definition of release probability, it can be factored into pv and pocc, which are fusion probability of TS vesicles and the occupancy of release sites by TS vesicles, respectively. With this regard, our interpretation of the Variance-Mean results is consistent with conventional one: different data points along a parabola represent a change in release probability (= pocc x pv). Our novel finding is that the increase in release probability should be attributed to an increase in pocc, not to that in pv.

      Fig4B interprets the phorbol ester stimulation to be the result of pool overfilling, however, phorbol ester stimulation has also been shown to increase release probability without changing the size of the readily releasable pool. The high frequency of stimulation may occlude an increased paired pulse depression in presence of OAG, which others have interpreted in mammalian synapses as an increase in release probability.

      To our experience in the calyx of Held synapses, OAG, a DAG analogue, increased the fast releasing vesicle pool (FRP) size (Lee JS et al., 2013), consistent with our interpretation (pool overfilling). Once the release sites are overfilled in the presence of OAG, it is expected that the maximal STF (ratio of facilitated to baseline EPSCs) becomes lower as long as the number of release sites (N) are limited. As aforementioned, the baseline pv is already close to one, and thus it cannot be further increased by OAG. Instead, the baseline pocc seems to be increased by OAG.

      <Reference>

      Lee JS, et al., Superpriming of synaptic vesicles after their recruitment to the readily releasable pool. Proc Natl Acad Sci U S A, 2013. 110(37): 15079-84.

      The literature on Syt7 function is still quite controversial. An observation in the literature that loss of Syt7 function in the fly synapse leads to an increase of release probability. Thus the observed changes in short term plasticity characteristics in the Syt7 KD experiments may contain a release probability component. Can the authors really exclude this possibility? Figure 5 shows for the Syt7 KD group a very prominent depression of the EPSC/IPSC with the second stimulus, particularly for the short interpulse intervals, usually a strong sign of increased release probability, as lack of pool refilling can unlikely explain the strong drop in synaptic output.

      The reviewer raises an interesting point regarding the potential link between Syt7 KD and increased initial pv, particularly in light of observations in Drosophila synapses (Guan et al., 2020; Fujii et al., 2021), in which Syt7 mutants exhibited elevated initial pv. However, it is important to note that these findings markedly differ from those in mammalian systems, where the role of Syt7 in regulating initial pv has been extensively studied. In rodents, consistent evidence indicates that Syt7 does not significantly affect initial pv, as demonstrated in several studies (Jackman et al., 2016; Chen et al., 2017; Turecek and Regehr, 2018). Furthermore, in our study of excitatory synapses in the mPFC layer 2/3, we observed an initial pv already near its maximal level, approaching a value of 1. Consequently, it is unlikely that the loss of Syt7 could further elevate the initial pv. Instead, such effects are more plausibly explained by alternative mechanisms, such as alterations in vesicle replenishment dynamics, rather than a direct influence on pv.

      <References>

      Chen, C., et al., Triple Function of Synaptotagmin 7 Ensures Efficiency of High-Frequency Transmission at Central GABAergic Synapses. Cell Rep, 2017. 21(8): 2082-2089.

      Fujii, T., et al., Synaptotagmin 7 switches short-term synaptic plasticity from depression to facilitation by suppressing synaptic transmission. Scientific reports, 2021. 11(1): 4059.

      Guan, Z., et al., Drosophila Synaptotagmin 7 negatively regulates synaptic vesicle release and replenishment in a dosage-dependent manner. Elife, 2020. 9: e55443.

      Jackman, S.L., et al., The calcium sensor synaptotagmin 7 is required for synaptic facilitation. Nature, 2016. 529(7584): 88-91.

      Turecek, J. and W.G. Regehr, Synaptotagmin 7 mediates both facilitation and asynchronous release at granule cell synapses. Journal of Neuroscience, 2018. 38(13): 3240-3251.

      Reviewer #3 (Public review):

      Summary:

      The report by Shin, Lee, Kim, and Lee entitled "Progressive overfilling of readily releasable pool underlies short-term facilitation at recurrent excitatory synapses in layer 2/3 of the rat prefrontal cortex" describes electrophysiological experiments of short-term synaptic plasticity during repetitive presynaptic stimulation at synapses between layer 2/3 pyramidal neurons and nearby target neurons. Manipulations include pharmacological inhibition of PLC and actin polymerization, activation of DAG receptors, and shRNA knockdown of Syt7. The results are interpreted as support for the hypothesis that synaptic vesicle release sites are vacant most of the time at resting synapses (i.e., p_occ is low) and that facilitation (and augmentation) components of short-term enhancement are caused by an increase in occupancy, presumably because of acceleration of the transition from not-occupied to occupied. The report additionally describes behavioural experiments where trace fear conditioning is degraded by knocking down syt7 in the same synapses.

      Strengths:

      The strength of the study is in the new information about short-term plasticity at local synapses in layer 2/3, and the major disruption of a memory task after eliminating short-term enhancement at only 15% of excitatory synapses in a single layer of a small brain region. The local synapses in layer 2/3 were previously difficult to study, but the authors have overcome a number of challenges by combining channel rhodopsins with in vitro electroporation, which is an impressive technical advance.

      Weaknesses:

      The question of whether or not short-term enhancement causes an increase in p_occ (i.e., "readily releasable pool overfilling") is important because it cuts to the heart of the ongoing debate about how to model short term synaptic plasticity in general. However, my opinion is that, in their current form, the results do not constitute strong support for an increase in p_occ, even though this is presented as the main conclusion. Instead, there are at least two alternative explanations for the results that both seem more likely. Neither alternative is acknowledged in the present version of the report.

      The evidence presented to support overfilling is essentially two-fold. The first is strong paired pulse depression of synaptic strength when the interval between action potentials is 20 or 25 ms, but not when the interval is 50 ms. Subsequent stimuli at frequencies between 5 and 40 Hz then drive enhancement. The second is the observation that a slow component of recovery from depression after trains of action potentials is unveiled after eliminating enhancement by knocking down syt7. Of the two, the second is predicted by essentially all models where enhancement mechanisms operate independently of release site depletion - i.e., transient increases in p_occ, p_v, or even N - so isn't the sort of support that would distinguish the hypothesis from alternatives (Garcia-Perez and Wesseling, 2008, https://doi.org/10.1152/jn.01348.2007).

      The apparent discrepancy in interpretation of post-tetanic augmentation between the present and previous papers [Sevens Wesseling (1999), Garcia-Perez and Wesseling (2008)] is an important issue that should be clarified. We noted that different meanings of ‘vesicular release probability’ in these papers are responsible for the discrepancy. We will add an explanation to Discussion on the difference in the meaning of ‘vesicular release probability’ between the present study and previous studies [Sevens Wesseling (1999), Garcia-Perez and Wesseling (2008)]. In summary, the pv in the present study was used for vesicular release probability of TS vesicles, while previous studies used it as vesicular release probability of vesicles in the RRP, which include LS and TS vesicles. Accordingly, pocc in the present study is occupancy of release sites by TS vesicles.

      Not only double failure rate but also other failure rates upon paired pulse stimulation were best fitted at pv close to 1 (Fig. S8 and associated text). Moreover, strong PPD, indicating release of vesicles with high pv, was observed not only at the beginning of a train but also in the middle of a 5 Hz train (Fig. 2D), during the augmentation phase after a 40 Hz train (Fig 3D), and in the recovery phase after three pulse bursts (Fig. 7). Given that pv is close to 1 throughout the EPSC trains and that N does not increase during a train (Fig. 3), synaptic facilitation can be attained only by the increase in pocc (occupancy of release sites by TS vesicles). In addition, it should be noted that Fig. 7 demonstrates strong PPD during the recovery phase after depletion of TS vesicles by three pulse bursts, indicating that recovered vesicles after depletion display high pv too. Knock-down of Syt7 slowed the recovery of TS vesicles after depletion of TS vesicles, highlighting that Syt7 accelerates the recovery of TS vesicles following their depletion.

      As addressed in our reply to the first issue raised by Reviewer #2 and the third issue raised by Reviewer #3, our results do not support possibilities for recruitment of new release sites (increase in N) having low pv or for a gradual increase in pv of reluctant vesicles during short-term facilitation.  

      <Following statement will be added to _Discussion_ in the revised manuscript>

      Previous studies suggested that an increase in pv is responsible for post-tetanic augmentation (Stevens and Wesseling, 1999; Garcia-Perez and Wesseling, 2008) by observing invariance of the RRP size after tetanic stimulation. In these studies, the RRP size was estimated by hypertonic sucrose solution or as the sum of EPSCs evoked 20 Hz/60 pulses train (denoted as ‘RRPhyper’). Because reluctant vesicles (called LS vesicles) can be quickly converted to TS vesicles (16/s) and are released during a train (Lee et al., 2012), it is likely that the RRP size measured by these methods encompasses both LS and TS vesicles. In contrast, we assert high pv based on the observation of strong PPD and failure rates upon paired stimulations at ISI of 20 ms (Fig. 2 and Fig. S8). Given that single AP-induced vesicular release occurs from TS vesicles but not from LS vesicles, pv in the present study indicates the fusion probability of TS vesicles. From the same reasons, pocc denotes the occupancy of release sites by TS vesicles. Note that our study does not provide direct clue whether release sites are occupied by LS vesicles that are not tapped by a single AP, although an increase in the LS vesicle number may accelerate the recovery of TS vesicles. As suggested in Neher (2024), even if the number of LS plus TS vesicles are kept constant, an increase in pocc (occupancy by TS vesicles) would be interpreted as an increase in ‘vesicular release probability’ as in the previous studies (Stevens and Wesseling (1999); Garcia-Perez and Wesseling (2008)) as long as it was measured based on RRPhyper.

      Regarding the paired pulse depression: The authors ascribe this to depletion of a homogeneous population of release sites, all with similar p_v. However, the details fit better with the alternative hypothesis that the depression is instead caused by quickly reversing inactivation of Ca2+ channels near release sites, as proposed by Dobrunz and Stevens to explain a similar phenomenon at a different type of synapse (1997, PNAS,<br /> https://doi.org/10.1073/pnas.94.26.14843). The details that fit better with Ca2+ channel inactivation include the combination of the sigmoid time course of the recovery from depression (plotted backwards in Fig1G,I) and observations that EGTA (Fig2B) increases the paired-pulse depression seen after 25 ms intervals. That is, the authors ascribe the sigmoid recovery to a delay in the activation of the facilitation mechanism, but the increased paired pulse depression after loading EGTA indicates, instead, that the facilitation mechanism has already caused p_r to double within the first 25 ms (relative to the value if the facilitation mechanism was not active). Meanwhile, Ca2+ channel inactivation would be expected to cause a sigmoidal recovery of synaptic strength because of the sigmoidal relationship between Ca2+-influx and exocytosis (Dodge and Rahamimoff, 1967, https://doi.org/10.1113/jphysiol.1967.sp008367).

      The Ca2+-channel inactivation hypothesis could probably be ruled in or out with experiments analogous to the 1997 Dobrunz study, except after lowering extracellular Ca2+ to the point where synaptic transmission failures are frequent. However, a possible complication might be a large increase in facilitation in low Ca2+ (Fig2B of Stevens and Wesseling, 1999, https://doi.org/10.1016/s0896-6273(00)80685-6).

      We appreciate the reviewer's thoughtful comment regarding the potential role of Ca2+ channel inactivation in the observed paired-pulse depression (PPD). As noted by the Reviewer, the Dobrunz and Stevens (1997) suggested that the high double failure rate at short ISIs in synapses exhibiting PPD can be attributed to Ca2+ channel inactivation. This interpretation seems to be based on a premise that the number of RRP vesicles are not varied trial-by-trial. The number of TS vesicles, however, can be dynamically regulated depending on the parameters k1 and b1, as shown in Fig. S8, implying that the high double failure rate at short ISIs cannot be solely attributed to Ca2+ channel inactivation. Nevertheless, we acknowledge the possibility that Ca2+ channel inactivation may contribute to PPD, and therefore, we have further investigated this possibility. Specifically, we measured action potential (AP)-evoked Ca2+ transients at individual axonal boutons of layer 2/3 pyramidal cells in the mPFC using two-dye ratiometry techniques. Our analysis revealed no evidence for Ca2+ channel inactivation during a 40 Hz train of APs. This finding indicates that voltage-gated Ca2+ channel inactivation is unlikely to contribute to the pronounced PPD.

      Author response image 1 below shows how we measured the total Ca2+ increments at axonal boutons. First we estimated endogenous Ca2+-binding ratio from analyses of single AP-induced Ca2+ transients at different concentrations of Ca2+ indicator dye (panels A to E). And then, using the Ca2+ buffer properties, we converted free [Ca2+] amplitudes to total calcium increments for the first four AP-evoked Ca2+ transients in a 40 Hz train (panels G-I). We will incorporate these results into the revised version of reviewed preprint to provide evidence against the Ca2+ channel inactivation.

      Author response image 1.

      On the other hand, even if the paired pulse depression is caused by depletion of release sites rather than Ca2+-channel inactivation, there does not seem to be any support for the critical assumption that all of the release sites have similar p_v. And indeed, there seems to be substantial emerging evidence from other studies for multiple types of release sites with 5 to 20-fold differences in p_v at a wide variety of synapse types (Maschi and Klyachko, eLife, 2020, https://doi.org/10.7554/elife.55210; Rodriguez Gotor et al, eLife, 2024, https://doi.org/10.7554/elife.88212 and refs. therein). If so, the paired pulse depression could be caused by depletion of release sites with high p_v, whereas the facilitation could occur at sites with much lower p_v that are still occupied. It might be possible to address this by eliminating assumptions about the distribution of p_v across release sites from the variance-mean analysis, but this seems difficult; simply showing how a few selected distributions wouldn't work - such as in standard multiple probability fluctuation analyses - wouldn't add much.

      We appreciate the reviewer’s insightful comments regarding the potential increase in pfusion of reluctant vesicles. It should be noted, however, that Maschi and Klyachko (2020) showed a distribution of release probability (pr) within a single active zone rather than a heterogeneity in pfusion of individual docked vesicles. Therefore both pocc and pv of TS vesicles would contribute to the pr distribution shown in Maschi and Klyachko (2020). 

      The Reviewer’s concern aligns closely with the first issue raised by Reviewer #2, to which we addressed in detail. Briefly, new release site may not be recruited during facilitation or post-tetanic augmentation, because variance of EPSCs during and after a train fell on the same parabola (Fig. 3). Secondly, strong PPD was observed not only in the baseline but also during early and late phases of facilitation, indicating that vesicles with very high pv contribute to EPSC throughout train stimulations (Fig. 2, 3, and 7). These findings argue against the possibilities for recruitment of new release sites harboring low pv vesicles and for a gradual increase in fusion probability of reluctant vesicles.

      To address the reviewers’ concern, we will incorporate the perspectives into Discussion and further clarify the reasoning behind our conclusions.

      In any case, the large increase - often 10-fold or more - in enhancement seen after lowering Ca2+ below 0.25 mM at a broad range of synapses and neuro-muscular junctions noted above is a potent reason to be cautious about the LS/TS model. There is morphological evidence that the transitions from a loose to tight docking state (LS to TS) occur, and even that the timing is accelerated by activity. However, 10-fold enhancement would imply that at least 90 % of vesicles start off in the LS state, and this has not been reported. In addition, my understanding is that the reverse transition (TS to LS) is thought to occur within 10s of ms of the action potential, which is 10-fold too fast to account for the reversal of facilitation seen at the same synapses (Kusick et al, 2020, https://doi.org/10.1038/s41593-020-00716-1).

      As the reviewer suggested, low external Ca2+ concentration can lower release probability (pr). Given that both pv and pocc are regulated by [Ca2+]i, low external [Ca2+] may affect not only pv but also pocc, both of which would contribute to low pr. Under such conditions, it would be plausible that the baseline pr becomes much lower than 0.1 due to low pv and pocc (for instance, pv decreases from 1 to 0.5, and pocc from 0.3 to 0.1, then pr = 0.05), and then pr (= pv x pocc) has a room for an increase by a factor of ten (0.5, for example) by short-term facilitation as cytosolic [Ca2+] accumulates during a train.

      If pv is close to one, pr depends pocc, and thus facilitation depends on the number of TS vesicles just before arrival of each AP of a train. Thus, post-train recovery from facilitation would depend on restoration of equilibrium between TS and LS vesicles to the baseline. Even if transition between LS and TS vesicles is very fast (tens of ms), the equilibrium involved in de novo priming (reversible transitions between recycling vesicle pool and partially docked LS vesicles) seems to be much slower (13 s in Fig. 5A of Wu and Borst 1999). Thus, we can consider a two-step priming model (recycling pool -> LS -> TS), which is comprised of a slow 1st step (-> LS) and a fast 2nd step (-> TS). Under the framework of the two-step model, the slow 1st step (de novo priming step) is the rate limiting step regulating the development and recovery kinetics of facilitation. Given that on and off rate for Ca2+ binding to Syt7 is slow, it is plausible that Syt7 may contribute to short-term facilitation (STF) by Ca2+-dependent acceleration of the 1st step (as shown in Fig. 9). During train stimulation, the number of LS vesicles would slowly accumulate in a Syt7 and Ca2+-dependent manner, and this increase in LS vesicles would shift LS/TS equilibrium towards TS, resulting in STF. After tetanic stimulation, the recovery kinetics from facilitation would be limited by slow recovery of LS vesicles.

      <Reference>

      Wu, L.-G. and Borst J.G.G. (1999) The reduced release probability of releasable vesicles during recovery from short-term synaptic depression. Neuron, 23(4): 821-832.

      Individual points:

      (1) An additional problem with the overfilling hypothesis is that syt7 knockdown increases the estimate of p_occ extracted from the variance-mean analysis, which would imply a faster transition from unoccupied to occupied, and would consequently predict faster recovery from depression. However, recovery from depression seen in experiments was slower, not faster. Meanwhile, the apparent decrease in the estimate of N extracted from the mean-variance analysis is not anticipated by the authors' model, but fits well with alternatives where p_v varies extensively among release sites because release sites with low p_v would essentially be silent in the absence of facilitation.

      Slower recovery from depression observed in the Syt7 knockdown (KD) synapses (Fig. 7) may results from a deficiency in activity-dependent acceleration of TS vesicle recovery. Although basal occupancy was higher in the Syt7 KD synapses, this does not indicate a faster activity-dependent recovery.

      Higher baseline occupancy does not always imply faster recovery of PPR too. Actually PPR recovery was slower in Syt7 KD synapses than WT one (18.5 vs. 23/s). Under the framework of the simple refilling model (Fig. S8Aa), the baseline occupancy and PPR recovery rate are calculated as k1 / (k1 + b1) and (k1 + b1), respectively. The baseline occupancy depends on k1/b1, while the PPR recovery on absolute values of k1 and b1. Based on pocc and PPR recovery time constant of WT and KD synapses, we expect higher k1/b1 but lower values for (k1 +b1) in Syt7 KD synapses compared to WT ones.

      Lower release sites (N) in Syt7-KD synapses was not anticipated. As you suggested, such low N might be ascribed to little recruitment of release sites during a train in KD synapses. But our results do not support this model. If silent release sites are recruited during a train, the variance should upwardly deviate from the parabola predicted under a fixed N (Valera et al., 2012; Kobbersmed et al. 2020). Our result was not the case (Fig. 3). In the first version of Ms, we have argued against this possibility in line 203-208.

      As discussed in both the Results and Discussion sections, the baseline EPSC was unchanged by KD (Fig. S3) because of complementary changes in the number of docking sites and their baseline occupancy (Fig. 6). These findings suggest that Syt7 may be involved in maintaining additional vacant docking sites, which could be overfilled during facilitation. It remains to be determined whether the decrease in docking sites in Syt7 KD synapses is related to its specific localization of Syt7 at the plasma membrane of active zones, as proposed in previous studies (Sugita et al., 2001; Vevea et al., 2021).

      (2) Figure S4A: I like the TTX part of this control, but the 4-AP part needs a positive control to be meaningful (e.g., absence of TTX).

      The reason why we used 4-AP in the presence of TTX was to increase the length constant of axon fibers and to facilitate the conduction of local depolarization in the illumination area to axon terminals. The lack of EPSC in the presence of 4-AP and TTX indicates that illumination area is distant from axon terminals enough for optic stimulation-induced local depolarization not to evoke synaptic transmission. This methodology has been employed in previous studies including the work of Little and Carter (2013).

      <Reference>

      Little JP and Carter AG (2013) Synaptic mechanisms underlying strong reciprocal connectivity between the medial prefrontal cortex and basolateral amygdala. J Neurosci, 33(39): 15333-15342.

      (3) Line 251: At least some of the previous studies that concluded these drugs affect vesicle dynamics used logic that was based on some of the same assumptions that are problematic for the present study, so the reasoning is a bit circular.

      (4) Line 329 and Line 461: A similar problem with circularity for interpreting earlier syt7 studies.

      (Reply to #3 and #4) We selected the target molecules as candidates based on their well-characterized roles in vesicle dynamics, and aimed to investigate what aspects of STP are affected by these molecules in our experimental context. For example, we could find that the baseline pocc and short-term facilitation (STF) are enhanced by the baseline DAG level and train stimulation-induced PLC activation, respectively. Notably, the effect of dynasore informed us that slow site clearing is responsible for the late depression of 40 Hz train EPSC. The knock-down experiments also provided us with information on the critical role of Syt7 in replenishment of TS vesicles. These approaches do not deviate from standard scientific reasoning but rather builds upon prior knowledge to formulate and test hypotheses.

      Importantly, our conclusions do not rely solely on the assumption that altering the target molecule impacts synaptic transmission. Instead, our conclusions are derived from a comprehensive analysis of diverse outcomes obtained through both pharmacological and genetic manipulations. These interpretations align closely with prior literature, further validating our conclusions.

      Therefore, the use of established studies to guide candidate selection and the consistency of our findings with existing knowledge do not represent a logical circularity but rather a reinforcement of the proposed mechanism through converging lines of evidence.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this study, the authors explore a novel mechanism linking aging to chromosome mis-segregation and aneuploidy in yeast cells. They reveal that, in old yeast mother cells, chromosome loss occurs through asymmetric partitioning of chromosomes to daughter cells, a process coupled with the inheritance of an old Spindle Pole Body. Remarkably, the authors identify that remodeling of the nuclear pore complex (NPC), specifically the displacement of its nuclear basket, triggers these asymmetric segregation events. This disruption also leads to the leakage of unspliced pre-mRNAs into the cytoplasm, highlighting a breakdown in RNA quality control. Through genetic manipulation, the study demonstrates that removing introns from key chromosome segregation genes is sufficient to prevent chromosome loss in aged cells. Moreover, promoting pre-mRNA leakage in young cells mimics the chromosome mis-segregation observed in old cells, providing further evidence for the critical role of nuclear envelope integrity and RNA processing in aging-related genome instability.

      Strengths:

      The findings presented are not only intriguing but also well-supported by robust experimental data, highlighting a previously unrecognized connection between nuclear envelope integrity, RNA processing, and genome stability in aging cells, deepening our understanding of the molecular basis of chromosome loss in aging.

      We thank the reviewer for this very positive assessment of our work

      Weaknesses:

      Further analysis of yeast aging data from microfluidic experiments will provide important information about the dynamic features and prevalence of the key aging phenotypes, e.g. pre-mRNA leakage and chromosome loss, reported in this work.

      We thank the reviewer for bringing this point, which we will address indeed in the revised version of the manuscript.  In short, chromosome loss is an abrupt, late event in the lifespan of the cells.  Its prevalence is more complex to assess and will require correlated loss rate of several chromosomes concomitantly. The prevalence of the pre-mRNA leakage phenotype is easier to assess and we will provide data about this in the revised manuscript as well.  Our data show that the prevalence is quite high (well above 50%), even if not every cell is affected.

      In addition, a discussion would be needed to clarify the relationship between "chromosome loss" in this study and "genomic missegregation" reported previously in yeast aging.

      The genomic missegregation mentioned by the reviewer is a process distinct from the chromosome loss that we report.  Genomic missegregation is characterized by the entry of both SPBs and all the chromosomes into the daughter cell compartment (PMID: 31714209).  We do observed these events in our movies as well.  In contrast, the chromosome loss phenotype is takes place under proper elongation of the spindle and proper segregation of the two SPBs between mother and bud, as shown in figure 2 of the manuscript.  In our movies, chromosome loss is at least three fold more frequent (for a single chromosome) than full genome missegregation.  Furthermore, whereas chromosome loss is alleviated by the removal of the introns of MCM21, NBL1 and GLC7, genomic missegregation is not.

      Nevertheless, we thank the reviewer for bringing up the possible confusion between the two phenotypes.  We will explain and illustrate the difference between the two processes in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The authors make the interesting discovery of increased chromosome non-dysjunction in aging yeast mother cells. The phenotype is quite striking and well supported with solid experimental evidence. This is quite significant to a haploid cell (as used here) - loss of an essential chromosome leads to death soon thereafter. The authors then work to tie this phenotype to other age-associated phenotypes that have been previously characterized: accumulation of extrachromosomal rDNA circles that then correlate with compromised nuclear pore export functions, which correlates with "leaky" pores that permit unspliced mRNA messages to be inappropriately exported to the cytoplasm. They then infer that three intron containing mRNAs that encode portions in resolving sister chromatid separation during mitosis, are unspliced in this age-associated defect and thus lead to the non-dysjunction problem.

      Strengths: The discovery of age-associated chromosome non-dysjunction is an interesting discovery, and it is demonstrated in a convincing fashion with "classic" microscopy-based single cell fluorescent chromosome assays that are appropriate and seem robust. The correlation of this phenotype with other age-associated phenotypes - specifically extrachromosomal rDNA circles and nuclear pore dysfunction - is supported by in vivo genetic manipulations that have been well-characterized in the past.

      In addition, the application of the single cell mRNA splicing defect reporter showed very convincingly that general mRNA splicing is compromised in aged cells. Such a pleiotropic event certainly has big implications.

      We thank the reviewer for this assessment of our work.  To avoid confusion, we would like to stress out, however, that our data do not show that splicing per se is defective in old cells.  We only show that unspliced mRNAs tend to leak out of the nucleus of old cells.

      Weaknesses:

      The biggest weakness is "connecting all the dots" of causality and linking the splicing defect to chromosome disjunction. I commend the authors for making a valiant effort in this regard, but there are many caveats to this interpretation. While the "triple intron" removal suppressed the non-dysjunction defect in aged cells, this could simply be a kinetic fix, where a slowdown in the relevant aspects of mitosis, could give the cell time to resolve the syntelic attachment of the chromatids.

      The possibility that intron-removal leads to a kinetic fix is an interesting idea that we will address in the revised manuscript.  So far we have no observed that removing these introns slows down mitosis but we will test the idea by doing precise measurements.

      To this point, I note that the intron-less version of GLC7, which affects the most dramatic suppression of the three genes, is reported by one of the authors to have a slow growth rate (Parenteau et al, 2008 - https://doi.org/10.1091/mbc.e07-12-1254)

      The reviewer is right, removing the intron of GLC7 reduces the expression levels of the gene product (PMID: 16816425) to about 50% of the original value and causes a slow growth phenotype.  However, the cells revert fairly rapidly through duplication of the GLC7 gene.  As a consequence, neither the GLC7-∆i nor the 3x∆i mutant strains show noticeable growth phenotypes by spot assays.  We will document these findings and provide a measurement of the growth rate of the mutant strain in the revised manuscript. 

      In addition, the lifespan curve containing the 3∆i in Figure 5E has a very unusual shape, suggesting a growth problem/"sickness" in this strain.

      To be accurate the strain plotted in Figure 5E is not the 3x∆i triple mutant strain but the 3x∆i mlp1∆  quadruple mutant strain.  The 3x∆i triple mutant strain is plotted in Figure 4D and its shape is similar to that of the wild type cells.  The strain in Figure 5E is indeed sick ,due to the removal of the nuclear basket. However, the 3x∆i mutations partially rescue the replicative lifespan shortening due the mlp1∆ mutation (see text).  Illustrating the fact that the 3x∆i mutant strain is not particularly sick, it shows a prolonged lifespan and a fairly standard aging curve.

      Lastly, the Herculean effort to perform FISH of the introns in the cytoplasm is quite literally at the statistical limit of this assay. The data were not as robust as the other assays employed through this study. The data show either "no" signal for the young cells or a signal of 0, 1,or 2 FISH foci in the aged cells. In a Poisson distribution, which this follows, it is improbable to distinguish between these differences.

      This is correct, this experiment was not the easiest of the manuscript... However, despite the limitations of the assay, the data presented in figure 6B are quite clear.  300 cells aged by MEP were analysed, divided in the cohorts of 100 each, and the distribution of foci (nuclear vs cytoplasmic) in these aged cells were compared to the distribution in three cohorts of young cells.  For all 3 aged cohorts, over 70% of the visible foci were cytoplasmic, while in the young cells, this figure was around 3%.  A t-test was conducted to compare these frequencies between young and old cells (Figure 6B).  The difference is highly significant.  The reviewer refers to the supplementary Figure 4, where we were simply asking i) is the signal lost in cells lacking the intron of GLC7 (the response is unambiguously yes) and ii) what is the general number of dots per cells between young and old wild type cells (without distinguishing between nuclear and cytoplasmic) and the information to be taken from this last quantification is indeed that there is no clearly distinguishable difference between these two population of cells.  In other word, the reason why there are more dots in the cytoplasm of the old cells in the Figure 6B is not because the old cells have much more dots in general.  We hope that these clarifications help understand the data better.  We will make sure that this is clearer in the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      Mirkovic et al explore the cause underlying development of aneuploidy during aging. This paper provides a compelling insight into the basis of chromosome missegregation in aged cells, tying this phenomenon to the established Nuclear Pore Complex architecture remodeling that occurs with aging across a large span of diverse organisms. The authors first establish that aged mother cells exhibit aberrant error correction during mitosis. As extrachromosomal rDNA circles (ERCs) are known to increase with age and lead to NPC dysfunction that can result in leakage of unspliced pre-mRNAs, Mirkovic et al search for intron-containing genes in yeast that may be underlying chromosome missegregation, identifying three genes in the aurora B-dependent error correction pathway: MCM21, NBL1, and GLC7. Interestingly, intron-less mutants in these genes suppress chromosome loss in aged cells, with a significant impact observed when all three introns were deleted (3x∆i). The 3x∆i mutant also suppresses the increased chromosome loss resulting from nuclear basket destabilization in a mlp1∆ mutant. The authors then directly test if aged cells do exhibit aberrant mRNA export, using RNA FISH to identify that old cells indeed leak intron-containing pre-mRNA into the cytoplasm, as well as a reporter assay to demonstrate translation of leaked pre-mRNA, and that this is suppressed in cells producing less ERCs. Mutants causing increased pre-mRNA leakage are sufficient to induce chromosome missegregation, which is suppressed by the 3x∆i.

      Strengths:

      The finding that deleting the introns of 3 genes in the Aurora B pathway can suppress age-related chromosome missegregation is highly compelling. Additionally, the rationale behind the various experiments in this paper is well-reasoned and clearly explained.

      We thank the reviewer for their very positive assessment of our work

      Weaknesses:

      In some cases, controls for experiments were not presented or were depicted in other figures.

      We are sorry about this confusion.  We will improve our presentation of the controls, make sure that they are brought back again each time they are relevant (we wanted to limit the cases of replotting the same controls several times).  We will also add those that are missing (such as those mentioned by reviewer 2, see above)

      High variability was seen in chromosome loss data, leading to large error bars.

      We thank the reviewer for this comment. The variance in those two figures (3A and 5D) comes from the suboptimal plotting of this data. This will be corrected in the revised version of the manuscript. 

      The text could have been more polished.

      Thank you for this comment.  We will go through the manuscript again in details

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The topic of nanobody-based PET imaging is important and holds great potential for real-world applications since nanobodies have many advantages over full sized immunoglobulins and small molecules.

      Strengths:

      The submitted manuscript contains quite a bit of interesting data from a collaborative team of well-respected researchers. The authors are to be congratulated for presenting results that may not have turned out the way they had hoped, and doing so in a transparent fashion.

      Weaknesses:

      However, the manuscript could be considered to be a collection of exploratory findings rather than a complete and mature scientific exposition. Most of the sample sizes were 3 per group, which is fine for exploratory work, but insufficient to draw strong statistically robust conclusions for definitive results.

      We thank reviewer #1 for the  review of our work. We appreciate reviewer’s #1 comment on our intent to publish our results in the most transparent fashion, which is the case. We would point out that due to the technical challenges and cost of generating all the different nanobody-radiometal tracer conjugates, we included 3 repeats per group, which is the minimum required  to perform statistical comparisons. We plan to add additional controls to the manuscript that were not initially included to limit the length of the manuscript. These additional controls  will lend more weight to our conclusions.

      Reviewer #2 (Public review):

      Summary:

      This is a strong and well-described study showing for the first time the use and publicly available resources to use a specific PET tracer to track proliferating transplanted cells in vivo, in a full murine immunecompetent environment.

      In this study the authors described a previously developed set of VHH-based PET tracers to track transplants (cancer cells, embryo's) in a murine immune-competent environment.

      Strengths:

      Unique set of PET tracer and mouse strain to track transplanted cells in vivo without genetic modification of the transplanted cells. This is a unique asset, and a first-in-kind.

      Weaknesses:

      - Some methodological aspects and controls are missing

      - No clinical relevance?

      We thank reviewer #2 for their review of our work. We support reviewer’s 2 view on the strength of being able to track transplanted cells in vivo without the need of any sort of manipulation of the transferred cells.  We plan to add additional controls to the manuscript that were not initially included to limit the length of the manuscript. These additional controls will lend more weight to our conclusions. We emphasize that although no clear clinical applications immediately derive  from our studies, this work  still offers better-suited tools for pre-clinical studies that require the ability to track transplanted cells in in vivo . We will resubmit a revised version shortly.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This work made a lot of efforts to explore the multifaceted roles of the inferior colliculus (IC) in auditory processing, extending beyond traditional sensory encoding. The authors recorded neuronal activitity from the IC at single unit level when monkeys were passively exposed or actively engaged in behavioral task. They concluded that 1)IC neurons showed sustained firing patterns related to sound duration, indicating their roles in temporal perception, 2) IC neuronal firing rates increased as sound sequences progress, reflecting modulation by behavioral context rather than reward anticipation, 3) IC neurons encode reward prediction error and their capability of adjusting responses based on reward predictability, 4) IC neural activity correlates with decision-making. In summary, this study tried to provide a new perspective on IC functions by exploring its roles in sensory prediction and reward processing, which are not traditionally associated with this structure.

      Strengths:

      The major strength of this work is that the authors performed electrophysiological recordings from the IC of behaving monkeys. Compared with the auditory cortex and thalamus, the IC in monkeys has not been adequately explored.

      We appreciate the reviewer’s acknowledgment of the efforts and strengths of our study. Indeed, our goal was to provide a comprehensive exploration of the multifaceted roles of the inferior colliculus (IC) in auditory processing and beyond, particularly in sensory prediction and reward processing. The use of electrophysiological recordings in behaving monkeys was central to our approach, as we sought to uncover the underexplored aspects of IC function in these complex cognitive domains. We are pleased that the reviewer recognizes the value of investigating the IC, a structure that has not been adequately explored in primates compared to other auditory regions like the cortex and thalamus. This feedback reinforces our belief that our work contributes significantly to advancing the understanding of the IC's roles in cognitive processing.

      We look forward to addressing any further points the reviewers may have and refining our manuscript accordingly. Thank you for your constructive feedback and for recognizing the strengths of our research approach.

      Weaknesses:

      (1) The authors cited several papers focusing on dopaminergic inputs in the IC to suggest the involvement of this brain region in cognitive functions. However, all those cited work were done in rodents. Whether monkey's IC shares similar inputs is not clear.

      We appreciate the reviewer's insightful comment on the limitations of extrapolating findings from rodent models to monkeys, particularly concerning dopaminergic inputs to the Inferior Colliculus (IC). While it is true that most studies on dopaminergic inputs to the IC have been conducted in rodents, to our knowledge, no studies have been conducted specifically in primates. To address the reviewer's concern, we have added a statement in both the introduction and discussion sections of our manuscript:

      • Introduction: "However, these studies were conducted in rodents, and the existence and role of dopaminergic inputs in the primate IC remain underexplored." (P.5, Line. 16-17)

      • Discussion: "However, the exact mechanisms and functions of dopamine modulation in the inferior colliculus are still not fully understood, particularly in primates. " (P.21, Line. 7-9)

      (2) The authors confused the two terms, novelty and deviation. According to their behavioral paradigm, deviation rather than novelty should be used in the paper because all the stimuli have been presented to the monkeys during training. Therefore, there is actually no novel stimuli but only deviant stimuli. This reflects that the author has misunderstood the basic concept.

      We appreciate the reviewer's clarification regarding the distinction between "novelty" and "deviation" in the context of our behavioral paradigm. We agree that, given the nature of our experimental design where all stimuli were familiar to the monkeys during training, the term "deviation" more accurately describes the stimuli used in our study rather than "novelty."

      To address this, we have revised the manuscript to replace the term "novelty" with "deviation" wherever applicable. This change has been made to ensure accurate terminology is used throughout the paper, thereby eliminating any potential misunderstanding of the concepts involved in our study.

      We thank the reviewer for pointing out this important distinction, which has improved the clarity and precision of our manuscript.

      (3) Most of the conclusions were made based on correlational analysis or speculation without providing causal evidences.

      We appreciate the reviewer’s concern regarding the reliance on correlational analyses in our study. Indeed, we acknowledge that the conclusions drawn primarily reflect correlations between neuronal activity and behavioral outcomes, rather than direct causal evidence. This limitation is common in many electrophysiological studies, particularly those conducted in behaving primates, where directly manipulating specific neural circuits to establish causality presents significant challenges, especially in comparison to research in mice.

      This complexity is further compounded when considering the IC’s role as a key lower-level relay station in the auditory pathway. Manipulating IC activity could have a widespread impact on auditory responses in downstream pathways, potentially influencing sensory prediction and decision-making processes.

      Despite this limitation, our study provides novel evidence suggesting that the IC may exhibit multiple facets of cognitive signaling, which could inspire future research aimed at exploring the underlying mechanisms and broader functional implications of these signals.

      To address the reviewer's concerns, we have made the following adjustments to the manuscript:

      (1) Clarified the Scope of Conclusions: We have revised the language in the Results and Discussion sections to explicitly state that our findings represent correlational relationships rather than causal mechanisms. For example, we have referred to the associations observed between IC activity and behavioral outcomes as "correlational" and have refrained from making definitive causal claims without supporting experimental evidence.

      “Finally, to determine whether the IC plays a role in decision-making processes related to auditory perception, we analyzed the correlation between neuronal activity and behavioral choices in the duration deviation detection task.” (P.14, Line. 4-6)

      (2) Proposed Future Directions: In the Discussion section, we have included suggestions for future studies to directly test the causality of the observed relationships.

      “Further research is required to explore the underlying neuronal mechanisms and functional significance of this dynamic change comprehensively.” (P.18, Line. 11-12)

      We believe these revisions provide a more balanced interpretation of our findings while emphasizing the importance of future research to build on our results and establish causal relationships. Thank you for raising this critical point, which has led to a more rigorous and transparent presentation of our study.

      (4) Results are presented in a very "straightforward" manner with too many detailed descriptions of phenomena but lack of summary and information synthesis. For example, the first section of Results is very long but did not convey clear information.

      We appreciate the reviewer’s feedback regarding the presentation of our results. We understand that the detailed descriptions of phenomena may have made it difficult to discern the key findings and overarching themes in the study. We recognize the importance of balancing detailed reporting with clear summaries and synthesis to effectively communicate our findings.

      To address this concern, we have made the following revisions to the manuscript:

      (1) Condensed and Synthesized Key Findings: We have streamlined the presentation of the Results section by condensing overly detailed descriptions and focusing on the most critical aspects of the data. Key findings are now summarized at the end of each subsection to ensure that the main points are clearly conveyed.

      “The accumulation of the climbing effect alongside repetitive sound presentations suggests a potential linkage to reward prediction or sensory prediction, reflecting an increased probability of receiving a reward and the strengthening of sound prediction as the sound sequence progresses.” (P.10, Line. 17-20)

      “The distinct response in the control condition, where the reward was unpredictable, contrasted sharply with the predictable reward scenario in the deviant condition, underscoring the ability of auditory IC neurons to encode reward prediction errors.” (P.13, Line. 21-22; P.14, Line. 1-2)

      (2) Improved Flow and Clarity: We have revised the structure and organization of the Results section to improve the flow of information. By rearranging certain paragraphs and refining the language, we aim to present the results in a more cohesive and coherent manner.

      “Deviant Response dynamics in duration deviation detection” (P.6, Line. 12)

      “Standard Response dynamics in duration deviation detection” (P.9, Line. 4)

      We believe these changes will make the Results section more accessible and informative, allowing readers to more easily grasp the significance of our findings. Thank you for your valuable suggestion, which has significantly improved the clarity and impact of our manuscript.

      (5) The logic between different sections of Results is not clear.

      We appreciate the reviewer’s observation regarding the lack of clear logical connections between different sections of the Results. We acknowledge that a coherent flow is essential for effectively communicating the progression of findings and their implications.

      To address this concern, we have made the following revisions:

      (1) Enhanced Transitions Between Sections: We have introduced clearer transitional statements between sections of the Results. These transitions explicitly state how each new section builds upon or relates to the previous findings, creating a more cohesive narrative.

      “Building upon the findings from the deviant responses, we next explored whether the climbing effect also manifested in responses to preceding standard stimuli, thereby examining the influence of sensory prediction and repetition on IC neuronal activity.” (P.9, Line. 5-7)

      “To determine whether the observed climbing effect was driven by reward anticipation, we designed an experiment controlling for reward effects, thereby clarifying the underlying factors influencing IC neuronal activity.” (P.10, Line. 22; P.11, Line. 1-2)

      “Recognizing that some IC neurons responded to reward delivery, we investigated whether these responses reflected reward prediction errors, thereby further elucidating the IC's role in reward processing.” (P.12, Line. 9-11)

      “Finally, to determine whether the IC plays a role in decision-making processes related to auditory perception, we analyzed the correlation between neuronal activity and behavioral choices in the duration deviation detection task.” (P.14, Line. 4-6)

      (2) Integration of Findings: In several places within the Results, we have added brief synthesis paragraphs that integrate findings across sections. These integrative summaries help to tie together the different aspects of our study, demonstrating how they collectively contribute to our understanding of the Inferior Colliculus’s (IC) role in sensory prediction, decision-making, and reward processing.

      “These results demonstrate that reward anticipation does not drive the climbing effect, thereby reinforcing the idea that sensory prediction is the primary factor influencing the accumulation of the climbing effect in the IC.” (P.12, Line. 4-7)

      “The distinct response in the control condition, where the reward was unpredictable, contrasted sharply with the predictable reward scenario in the deviant condition, underscoring the ability of auditory IC neurons to encode reward prediction errors.” (P.13, Line. 21-22; P.14, Line. 1-2)

      (3) Clarified Rationale: At the beginning of each major section, we have clarified the rationale behind why certain experiments were conducted, connecting them more clearly to the overarching goals of the study. This should help the reader understand the purpose of each set of results in the context of the broader research objectives.

      “Building upon the findings from the deviant responses, we next explored whether the climbing effect also manifested in responses to preceding standard stimuli, thereby examining the influence of sensory prediction and repetition on IC neuronal activity.” (P.9, Line. 5-7)

      “To determine whether the observed climbing effect was driven by reward anticipation, we designed an experiment controlling for reward effects, thereby clarifying the underlying factors influencing IC neuronal activity.” (P.10, Line. 22; P.11, Line. 1-2)

      “Recognizing that some IC neurons responded to reward delivery, we investigated whether these responses reflected reward prediction errors, thereby further elucidating the IC's role in reward processing.” (P.12, Line. 9-11)

      “Finally, to determine whether the IC plays a role in decision-making processes related to auditory perception, we analyzed the correlation between neuronal activity and behavioral choices in the duration deviation detection task.” (P.14, Line. 4-6)

      We believe these changes improve the overall coherence and readability of the Results section, allowing readers to better follow the logical progression of our study. We are grateful for this constructive feedback and believe it has significantly enhanced the manuscript.

      (6) In the Discussion, there is excessive repetition of results, and further comparison with and discussion of potentially related work are very insufficient. For example, Metzger, R.R., et al. (J Neurosc, 2006) have shown similar firing patterns of IC neurons and correlated their findings with reward.

      We appreciate the reviewer's insightful critique regarding the excessive repetition in the Discussion and the lack of sufficient comparison with related work. We acknowledge that a well-balanced Discussion should not only interpret findings but also place them in the context of existing literature to highlight the novelty and significance of the study.

      To address these concerns, we have made the following revisions:

      (1) Reduction of Repetition: We have carefully revised the Discussion to minimize redundant repetition of the Results. Instead of restating the findings, we now focus more on their implications, limitations, and how they advance the current understanding of the Inferior Colliculus (IC) and its broader cognitive roles.

      “We demonstrated that the climbing effect is dynamically modulated (Figure 2D-G), and this modulation is driven primarily by sensory prediction rather than reward anticipation, as controlling for reward effects showed minimal impact on the response profile (Figure 3D, E). This modulation by preceding sensory experiences indicates that the IC is more than merely a relay station, suggesting a more intricate role in auditory processing influenced by both ascending and descending neural pathways.” (P.17, Line. 1-5)

      (2) Incorporation of Related Work: We have expanded the Discussion to include a more comprehensive comparison with existing literature, specifically highlighting studies that have reported similar findings. For example, we now discuss the work by Metzger et al. (2006), which demonstrated similar firing patterns of IC neurons and correlated these with reward-related processes. This comparison helps contextualize our results and emphasizes the novel contributions our study makes to the field.

      “Metzger and colleagues reported a gradual increase in neural activity—termed late-trial ramping—in the IC during an auditory saccade task. Similar to our results, they observed no climbing effect in the absence of a behavioral task. Both studies support the idea that the climbing effect depends on both behavioral engagement and reward. While both pieces of research emphasize the IC's complex role in integrating auditory processing with cognitive functions related to reward and behavior, our findings provide further insight by distinguishing between the effects of sensory prediction and reward anticipation on IC neuronal activity.” (P.16, Line. 16-24)

      We believe these revisions have significantly improved the quality of the Discussion by reducing unnecessary repetition and providing a more thorough engagement with the relevant literature. We are grateful for the reviewer's valuable feedback, which has helped us refine and strengthen the manuscript.

      Reviewer #2 (Public review):

      Summary:

      The inferior colliculus (IC) has been explored for its possible functions in behavioral tasks and has been suggested to play more important roles rather than simple sensory transmission. The authors revealed the climbing effect of neurons in IC during decision-making tasks, and tried to explore the reward effect in this condition.

      Strengths:

      Complex cognitive behaviors can be regarded as simple ideals of generating output based on information input, which depends on all kinds of input from sensory systems. The auditory system has hierarchic structures no less complex than those areas in charge of complex functions. Meanwhile, IC receives projections from higher areas, such as auditory cortex, which implies IC is involved in complex behaviors. Experiments in behavioral monkeys are always time-consuming works with hardship, and this will offer more approximate knowledge of how the human brain works.

      We greatly appreciate the reviewer's positive summary of our work and recognition of the effort involved in conducting experiments on behaving monkeys. We agree with the reviewer that the inferior colliculus (IC) plays a significant role beyond mere sensory transmission, particularly in integrating sensory inputs with higher cognitive functions. Our study aims to shed light on these complex functions by revealing the climbing effect of IC neurons during decision-making tasks and exploring how reward influences this dynamic.

      We are encouraged that the reviewer acknowledges the importance of investigating the IC's role within the broader framework of complex cognitive behaviors and appreciates the hierarchical nature of the auditory system. The reviewer's comments reinforce the value of our research in contributing to a more nuanced understanding of how the IC might contribute to sensory-cognitive integration.

      We thank the reviewer for highlighting the significance of using behavioral monkey models to approximate human brain function. We are hopeful that our findings will serve as a stepping stone for further research exploring the multifaceted roles of the IC in cognition and behavior.

      We will now proceed to address the specific concerns and suggestions provided by the reviewer in the following sections.

      Weaknesses:

      These findings are more about correlation but not causality of IC function in behaviors. And I have a few major concerns.

      We appreciate the reviewer’s concern regarding the reliance on correlational analyses in our study. We fully acknowledge the importance of distinguishing between correlation and causality. As outlined in our response to Question 3 from Reviewer #1, we recognize the limitations of relying on correlational data and the inherent challenges in establishing direct causal links, particularly in electrophysiological studies involving behaving primates, and given the lower-level role of the IC in the auditory pathway.

      We have taken steps to clarify this distinction throughout our manuscript. Specifically, we have revised the Results and Discussion sections to ensure that the findings are presented as correlational, not causal, and we have proposed future studies utilizing more direct manipulation techniques to assess causality. We hope these revisions adequately address your concerns.

      “Finally, to determine whether the IC plays a role in decision-making processes related to auditory perception, we analyzed the correlation between neuronal activity and behavioral choices in the duration deviation detection task.” (P.14, Line. 4-6)

      “Further research is required to explore the underlying neuronal mechanisms and functional significance of this dynamic change comprehensively.” (P.18, Line. 11-12)

      Comparing neurons' spike activities in different tests, a 'climbing effect' was found in the oddball paradigm. The effect is clearly related to training and learning process, but it still requires more exploration to rule out a few explanations. First, repeated white noise bursts with fixed inter-stimulus-interval of 0.6 seconds was presented, so that monkeys might remember the sounds by rhymes, which is some sort of learned auditory response. It is interesting to know monkeys' responses and neurons' activities if the inter-stimuli-interval is variable. Second, the task only asked monkeys to press one button and the reward ratio (the ratio of correct response trials) was around 78% (based on the number from Line 302). so that, in the sessions with reward, monkeys had highly expected reward chances, does this expectation cause the climbing effect?

      We thank the reviewer for raising these insightful points regarding the 'climbing effect' observed in the oddball paradigm and its potential relationship with training, learning processes, and reward expectation. Below, we address each of the reviewer's specific concerns:

      (1) Inter-Stimulus Interval (ISI) and Rhythmic Auditory Response:

      The reviewer suggests that the fixed inter-stimulus interval (ISI) of 0.6 seconds might lead to a rhythmic auditory response, where monkeys could anticipate the sounds. We appreciate this perspective and recognize its relevance. However, we believe that rhythm is unlikely to be a significant contributor to the 'climbing effect' for two key reasons:

      a) The 'climbing effect' begins as early as the second sound in the block (as shown in Fig. 2D and Fig. 3B), before any rhythm or pattern could be fully established, since rhythm generally requires at least three repetitions to form.

      b) In our reward experiment (Figs. 4-5), the sounds were also presented at regular ISIs, which could have facilitated rhythmic learning, yet the observed climbing effect was comparatively small in those conditions.

      Unfortunately, we did not explore variable ISIs in this current study, so we cannot directly address this concern with the available data.

      (2) Reward Expectation and Climbing Effect:

      The reviewer raises a valid concern regarding whether the 'climbing effect' might be influenced by the monkeys' high reward expectation, especially given the high reward ratio (~78%) in the sessions. While it is plausible that reward expectation could contribute to the observed increase in neuronal firing rates, we believe the results from our reward experiment (Fig. 4) suggest otherwise.

      In this experiment, even though reward expectation was likely formed due to the consistent pairing of sounds with rewards (100% reward delivery), we did not observe a significant climbing effect in the auditory response. Additionally, the presence of reward prediction error (Fig. 4D) further supports the idea that while the monkeys may indeed form reward expectations, these expectations do not directly drive the climbing effect in the IC.

      To make this distinction clearer, we have added sentences in the revised manuscript explicitly discussing the relationship between reward expectation and the climbing effect.

      “Within the oddball paradigm, both sensory and reward predictions intensify alongside the recurrence of standard sounds, suggesting that the strength of these predictions could significantly influence neuronal responses. Our experimentation with rewards has effectively dismissed the role of reward prediction (Figures 3 and 4), highlighting the potential significance of sensory prediction in molding the climbing effect.” (P.17, Line. 14-19)

      We believe these revisions provide a clearer understanding of the factors contributing to the climbing effect and effectively address the reviewer's concerns. We sincerely thank the reviewer for these valuable suggestions, which have allowed us to improve the clarity and depth of our manuscript.

      "Reward effect" on IC neurons' responses were shown in Fig. 4. Is this auditory response caused by physical reward action or not? In reward sessions, IC neurons have obvious response related to the onset of water reward. The electromagnetic valve is often used in water-rewarding system and will give out a loud click sound every time when the reward is triggered. IC neurons' responses may be simply caused by the click sound if the electromagnetic valve is used. It is important to find a way to rule out this simple possibility.

      We appreciate the reviewer’s concern regarding the potential confounding factor introduced by the electromagnetic valve’s click sound during water reward delivery, which could be misinterpreted as an auditory response rather than a response to the reward itself. Anticipating this possibility, we took measures to eliminate it by placing the electromagnetic valve outside the soundproof room where the neuronal recordings were performed.

      To address your concern more explicitly, we have added sentences in the Methods section of the revised manuscript detailing this setup, ensuring that readers are aware of the steps we took to eliminate this potential confound. By doing so, we believe that the observed reward-related neural activity in the IC is attributable to the reward processing itself rather than an auditory response to the valve click. We appreciate you bringing this important aspect to our attention, and we hope our clarification strengthens the interpretation of our findings.

      “The reward was controlled electronically by a valve located outside the sound-proof room to prevent any noise interference from the valve.” (P.24, Line. 6-7)

      Reviewer #3 (Public review):

      Summary:

      The authors aimed to investigate the multifaceted roles of the Inferior Colliculus (IC) in auditory and cognitive processes in monkeys. Through extracellular recordings during a sound duration-based novelty detection task, the authors observed a "climbing effect" in neuronal firing rates, suggesting an enhanced response during sensory prediction. Observations of reward prediction errors within the IC further highlight its complex integration in both auditory and reward processing. Additionally, the study indicated IC neuronal activities could be involved in decision-making processes.

      Strengths:

      This study has the potential to significantly impact the field by challenging the traditional view of the IC as merely an auditory relay station and proposing a more integrative role in cognitive processing. The results provide valuable insights into the complex roles of the IC, particularly in sensory and cognitive integration, and could inspire further research into the cognitive functions of the IC.

      We appreciate the reviewer’s positive summary of our work and recognition of its potential impact on the field. We are pleased that the reviewer acknowledges the significance of our findings in challenging the traditional view of the Inferior Colliculus (IC) as merely an auditory relay station and in proposing its integrative role in cognitive processing.

      Our study indeed aims to provide new insights into the multifaceted roles of the IC, particularly in the context of sensory and cognitive integration. We believe that this research could pave the way for future studies that further explore the cognitive functions of the IC and its involvement in complex behavioral processes.

      We are encouraged by the reviewer’s positive assessment and are committed to continuing to refine our work in response to the constructive feedback provided. We hope that our findings will contribute to advancing the understanding of the IC’s role in the broader context of neuroscience.

      We will now proceed to address the specific concerns and suggestions provided by the reviewer in the following sections.

      Weaknesses:

      Major Comments:

      (1) Structural Clarity and Logic Flow:

      The manuscript investigates three intriguing functions of IC neurons: sensory prediction, reward prediction, and cognitive decision-making, each of which is a compelling topic. However, the logical flow of the manuscript is not clearly presented and needs to be well recognized. For instance, Figure 3 should be merged into Figure 2 to present population responses to the order of sounds, thereby focusing on sensory prediction. Given the current arrangement of results and figures, the title could be more aptly phrased as "Beyond Auditory Relay: Dissecting the Inferior Colliculus's Role in Sensory Prediction, Reward Prediction, and Cognitive Decision-Making."

      We appreciate the reviewer’s detailed feedback on the structural clarity and logical flow of the manuscript. We understand the importance of presenting our findings in a clear and cohesive manner, especially when addressing multiple complex topics such as sensory prediction, reward prediction, and cognitive decision-making.

      To address the reviewer's concerns, we have made the following revisions:

      (1) Reorganization of Figures and Results:

      We agree with the suggestion to merge Figure 3 into Figure 2. By doing so, we can present the population responses to the order of sounds more effectively, thereby streamlining the focus on sensory prediction. This will allow readers to more easily follow the progression of the results related to this key function of the IC.

      We have reorganized the Results section to ensure a smoother transition between the different aspects of IC function that we are investigating. The new structure will better guide the reader through the narrative, aligning with the themes of sensory prediction, reward prediction, and cognitive decision-making.

      “Deviant Response dynamics in duration deviation detection” (P.6, Line. 12)

      “Standard Response dynamics in duration deviation detection” (P.9, Line. 4)

      (2) Revised Title:

      In line with the reviewer's suggestion, we have revised the title to "Beyond Auditory Relay: Dissecting the Inferior Colliculus's Role in Sensory Prediction, Reward Prediction, and Cognitive Decision-Making." We believe this title more accurately reflects the scope and focus of our study, as it highlights the three core functions of the IC that we are investigating.

      (3) Improved Logic Flow:

      We have added introductory statements at the beginning of each section within the Results to clarify the rationale behind the experiments and the logical connections between them. This should help to improve the overall flow of the manuscript and make the progression of our findings more intuitive for readers.

      “Building upon the findings from the deviant responses, we next explored whether the climbing effect also manifested in responses to preceding standard stimuli, thereby examining the influence of sensory prediction and repetition on IC neuronal activity.” (P.9, Line. 5-7)

      “To determine whether the observed climbing effect was driven by reward anticipation, we designed an experiment controlling for reward effects, thereby clarifying the underlying factors influencing IC neuronal activity.” (P.10, Line 22; P.11, Line. 1-2)

      “Recognizing that some IC neurons responded to reward delivery, we investigated whether these responses reflected reward prediction errors, thereby further elucidating the IC's role in reward processing.” (P.12, Line. 9-11)

      “Finally, to determine whether the IC plays a role in decision-making processes related to auditory perception, we analyzed the correlation between neuronal activity and behavioral choices in the duration deviation detection task.” (P.14, Line. 4-6)

      We believe these changes significantly enhance the clarity and logical structure of the manuscript, making it easier for readers to understand the sequence and importance of our findings. Thank you for your valuable suggestion, which has led to a more coherent and focused presentation of our work.

      (2) Clarification of Data Analysis:

      Key information regarding data analysis is dispersed throughout the results section, which can lead to confusion. Providing a more detailed and cohesive explanation of the experimental design would significantly enhance the interpretation of the findings. For instance, including a detailed timeline and reward information for the behavioral paradigms shown in Figures 1C and D would offer crucial context for the study. More importantly, clearly presenting the analysis temporal windows and providing comprehensive statistical analysis details would greatly improve reader comprehension.

      We appreciate the reviewer’s insightful comment regarding the need for clearer and more cohesive explanations of the data analysis and experimental design. We recognize that a well-structured presentation of this information is essential for the reader to fully understand and interpret our findings. To address this, we have made the following revisions:

      (1) Detailed Explanation of Experimental Design:

      We have included a more detailed explanation of the experimental design, particularly for the behavioral paradigms shown in Figures 1C and 1D. This includes a comprehensive timeline of the experiments, along with explicit information about the reward structure and timing. By providing this context upfront, we aim to give readers a clearer understanding of the conditions under which the neuronal recordings were obtained.

      (2) Cohesive Presentation of Data Analysis:

      Key information regarding data analysis, which was previously dispersed throughout the Results section, has been consolidated and moved to a dedicated subsection within the Methods. This subsection now provides a step-by-step description of the analysis process, including the temporal windows used for examining neuronal activity, as well as the specific statistical methods employed.

      We have also ensured that the temporal windows used for different analyses (e.g., onset window, late window, etc.) are clearly defined and consistently referenced throughout the manuscript. This will help readers track the use of these windows across different figures and analyses.

      (3) Enhanced Statistical Analysis Details:

      We have expanded the description of the statistical analyses performed in the study, including the rationale behind the choice of tests, the criteria for significance, and any corrections for multiple comparisons. This relevant information is highlighted in the Results section or figure legends to facilitate understanding.

      We believe these changes will significantly improve the clarity and comprehensibility of the manuscript, allowing readers to better follow the experimental design, data analysis, and the conclusions drawn from our findings. Thank you for this valuable feedback, which has helped us to enhance the rigor and transparency of our presentation.

      (3) Reward Prediction Analysis:

      The conclusion regarding the IC's role in reward prediction is underdeveloped. While the manuscript presents evidence that IC neurons can encode reward prediction, this is only demonstrated with two example neurons in Figure 6. A more comprehensive analysis of the relationship between IC neuronal activity and reward prediction is necessary. Providing population-level data would significantly strengthen the findings concerning the IC's complex functionalities. Additionally, the discussion of reward prediction in lines 437-445, which describes IC neuron responses in control experiments, does not sufficiently demonstrate that IC neurons can encode reward expectations. It would be valuable to include the responses of IC neurons during trials with incorrect key presses or no key presses to better illustrate this point.

      We deeply appreciate the detailed feedback provided regarding the conclusions on the inferior colliculus (IC)'s role in reward prediction within our manuscript. We acknowledge the importance of a robust and comprehensive presentation of our findings, particularly when discussing complex neural functionalities.

      In response to the reviewers' concerns, we have made the following revisions to strengthen our manuscript:

      (1) Inclusion of Population-Level Data for IC Neurons:

      In the revised manuscript, we have included population-level results for IC neurons in a supplementary figure. Initially, we focused on two example neurons that did not exhibit motor-related responses to key presses to isolate reward-related signals. However, most IC neurons exhibit motor responses during key presses (as indicated in Fig.6), which can complicate distinguishing between reward-related activity and motor responses. This complexity is why we initially presented neurons without motor responses. To clarify this point, we have added sentences in the Results section to explain the rationale behind our selection of neurons and to address the potential overlap between motor and reward responses in the IC.

      “This phenomenon was further supported by examining the responses in the duration deviation detection task. Since most IC neurons exhibit motor responses during key presses (Supplementary Figure 6), which can complicate distinguishing between reward-related activity and motor responses, we specifically selected two neurons without motor responses during key presses (Figure 5).” (P.13, Line. 10-15)

      (2) Addition of Data on Key Press Errors and No-Response Trials:

      In response to the reviewer’s suggestion, we have demonstrated Peri-Stimulus Time Histograms (PSTHs) for two example neurons during error trials as below, including incorrect key presses and no-response trials. Given that the monkeys performed the task with high accuracy, the number of error trials is relatively small, especially for the control condition (as shown in the top row of the figure below). While we remain cautious in drawing definitive conclusions from this limited trials, we observed that no clear reward signals were detected during the corresponding window (typically centered around 150 ms after the end of the sound). It is important to note that the experiment was initially designed to explore decision-making signals in the IC, rather than focusing specifically on reward processing. However, the data in Fig. 6 demonstrated intriguing signals of reward prediction error, which is why we believe it is important to present them.

      When combined with the results from our reward experiment (Fig. 5), we believe these findings provide compelling evidence of reward prediction errors being processed by IC neurons.

      Author response image 1.

      (A)  PSTH of the neuron from Figure 5A during a key press trial under control condition. The number in the parentheses in the legend represents the number of trials for control condition. (B) PSTHs of the neuron from Figure 5A during non-key press trials under experimental conditions. The numbers in the parentheses in the legend represent the number of trials for experimental conditions. (C-D) Equivalent PSTHs as in A-B but from the neuron in Figure 5B.

      We are grateful for the reviewer's insightful suggestions, which have allowed us to improve the depth and rigor of our analysis. We believe these revisions significantly enhance our manuscript's conclusions regarding the complex functionalities of IC.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      One of the major issues of this work is that its writing fails to convey the focus and significance of the work. Sentences are too long and multiple pieces of information are often integrated in one sentence, causing great confusion.

      We appreciate the reviewer's feedback regarding the clarity and structure of the manuscript. We agree that scientific writing should be clear and concise to effectively communicate the significance of the work. In response to this comment, we have undertaken the following revisions to improve the readability and focus of the manuscript:

      (1) Simplified Sentence Structure:<br /> We have revisited the manuscript and revised sentences that were overly complex or contained multiple pieces of information. Long sentences have been broken into shorter, more digestible statements to improve clarity and readability. Each sentence now conveys a single, focused idea.

      (2) Improved Flow and Focus:<br /> We have restructured certain paragraphs to ensure that the narrative flows logically and highlights the key findings. This restructuring includes placing the most significant results in prominent positions within paragraphs and ensuring that each section begins with a clear statement of purpose.

      “Building upon the findings from the deviant responses, we next explored whether the climbing effect also manifested in responses to preceding standard stimuli, thereby examining the influence of sensory prediction and repetition on IC neuronal activity.” (P.9, Line. 5-7)

      “To determine whether the observed climbing effect was driven by reward anticipation, we designed an experiment controlling for reward effects, thereby clarifying the underlying factors influencing IC neuronal activity.” (P.10, Line. 22; P.11, Line. 1-2)

      “Recognizing that some IC neurons responded to reward delivery, we investigated whether these responses reflected reward prediction errors, thereby further elucidating the IC's role in reward processing.” (P.12, Line. 9-11)

      “Finally, to determine whether the IC plays a role in decision-making processes related to auditory perception, we analyzed the correlation between neuronal activity and behavioral choices in the duration deviation detection task.” (P.14, Line. 4-6)

      (3) Refined Significance of the Work:<br /> In response to the reviewer's concern that the manuscript fails to clearly convey the significance of the work, we have revised the Introduction and Discussion sections to better emphasize the focus and impact of our findings. We now explicitly highlight the novel contributions of this research to the understanding of the multifaceted role of the IC in sensory prediction, decision-making, and reward processing.

      “In this research, we embarked on a deviation detection task centered around sound duration with trained monkeys, performing extracellular recordings in the IC. Our observations unveiled a 'climbing effect'—a progressive increase in firing rate after sound onset, not attributable to reward but seemingly linked to sensory experience such as sensory prediction. Moreover, we identified signals of reward prediction error and decision-making. These findings propose that the IC's role in auditory processing extends into the realm of complex perceptual and cognitive tasks, challenging previous assumptions about its functionality.” (P.6, Line. 1-8)

      “Overall, our results strongly suggest that the inferior colliculus is actively engaged in sensory experience, reward prediction and decision making, shedding light on its intricate functions in these processes.” (P.16, Line. 10-12)

      We believe these revisions address the reviewer's concern and will make the manuscript more accessible to readers. Thank you for the valuable suggestion, which has led to a more precise and effective presentation of our work.

      Reviewer #2 (Recommendations for the authors):

      (1) In oddball paradigm, inter-stimuli-interval of 0.6 seconds was used. Vary the inter-stimulus-interval should prove whether this effect is rhyme learning. It is better to choose random inter-stimuli-interval and inter-trial-interval for each experiment across whole experiment in case monkeys try to remember the rhythm.

      The reviewer suggests that the fixed inter-stimulus interval (ISI) of 0.6 seconds may lead to a rhythmic auditory response, allowing monkeys to anticipate sounds. This is a valuable suggestion, and we appreciate this perspective. However, we believe that rhythm is unlikely to play a significant role in driving the 'climbing effect.' The 'climbing effect' starts as early as the second sound in the block (as shown in Fig. 2D and Fig. 3B), which is before any rhythm or pattern could be fully established. Typically, rhythm learning requires at least three repetitions to form a predictable sequence.

      Unfortunately, we did not vary the inter-stimuli-interval in the current study, so we cannot directly test this hypothesis with the current dataset. However, we agree with the reviewer that using random ISIs would be an effective way to rule out any potential contribution of rhythm learning to the climbing effect directly.

      (2) Regarding "reward effect" on IC neurons' responses, we should rule out the possibility of simple auditory response to the switching of electromagnetic valve.

      We appreciate the reviewer’s concern about the potential confounding factor of the electromagnetic valve's click sound during water reward delivery, which could be interpreted as an auditory response rather than a true reward-related response. Anticipating this issue, we took measures to eliminate this possibility by placing the electromagnetic valve outside the soundproof room where neuronal recordings were conducted. This setup ensured that any potential auditory noise from the valve was minimized and unlikely to influence the IC neuronal activity.

      To address this concern more explicitly, we have added a description in the Methods section detailing this setup. This revision clarifies the steps we took to rule out this potential confound, strengthening the validity of our claim that the observed IC activity is genuinely related to reward processing and not a simple auditory response to the valve's operation.

      We thank the reviewer for bringing attention to this critical aspect of our experimental design, and we hope this clarification enhances the interpretation of our findings.

      “The reward was controlled electronically by a valve located outside the sound-proof room to prevent any noise interference from the valve.” (P.24, Line. 6-7)

      (3) Since monkeys are smart, simple Go/NoGo design is not a good strategy. The task with more buttons to press, such as 2-AFC or 4-AFC task, may prevent artificial effect of unwanted behaviors and offer us more reliable and useful data.

      We appreciate the reviewer’s suggestion to implement a more complex behavioral task, such as a 2-Alternative Forced Choice (2-AFC) or 4-AFC design, to reduce the possibility of unwanted behaviors and to gather more reliable data. We agree that such paradigms could offer additional insights and help control the monkeys’ decision-making processes by reducing potential confounding factors related to the simplicity of Go/NoGo responses.

      In our current study, we chose the Go/NoGo task because it aligns with our primary experimental goal: investigating the relationship between IC activity and sensory prediction, decision-making, and reward processing in a simplified manner. This task allowed us to focus on reward prediction and sensory responses without introducing additional complexity that could increase the cognitive load on the monkeys and affect their performance. It is worth noting that training monkeys to perform auditory tasks is generally more challenging compared to visual tasks, though they are indeed capable of complex learning.

      Moreover, this novelty detection task was initially designed as an oddball paradigm to explore predictive coding along the auditory pathway. Our lab has concentrated on this topic for several years, with the majority of current research focusing on non-behavioral subjects such as rodents. Implementing a more advanced paradigm like 2-AFC would have increased training time and required a different approach than our core objective.

      That said, we agree that future studies would benefit from using more sophisticated tasks, such as 2-AFC or 4-AFC paradigms, as they could offer a more refined understanding of decision-making processes while enhancing the quality of data by minimizing unwanted behaviors. We believe that incorporating more advanced behavioral paradigms in future work will further enhance the rigor and reliability of our findings.

      (4) Line 52, "challenges...", sounds a little bit too much. The authors tried to sell the ideal that IC is more than simple sensory relay point. I agree with that and I know the experiments on monkeys are not easy to gain too much comprehensive data. But to support authors' further bold opinions, more analysis is need to be done.

      We appreciate the reviewer’s feedback on the tone of the statement in Line 52, where we describe the findings as “challenging” conventional views of the IC as a simple sensory relay point. We agree that while our data provides intriguing insights into the multifunctionality of the IC, especially in sensory prediction, decision-making, and reward processing.

      To address this, we have toned down the language in the revised manuscript to better reflect the current state of our findings. Rather than presenting the results as a direct challenge to existing knowledge, we now describe them as contributing to a growing body of evidence that suggests the IC plays a more integrative role in auditory processing and cognitive functions.

      “This research highlights a more complex role for the IC than traditionally understood, showcasing its integral role in cognitive and sensory processing and emphasizing its importance in integrated brain functions.” (Abstract, P.3, Line.12-15)

      “This modulation by preceding sensory experiences indicates that the IC is more than merely a relay station, suggesting a more intricate role in auditory processing influenced by both ascending and descending neural pathways.” (P.17, Line. 3-5)

      (5) Line 143, "peak response", it is better not to refer this transient response as "peak response". How about "transient response" or "transient peak response"?

      Thank you for your suggestion regarding the terminology used in Line 143. We agree with the reviewer that referring to this as simply a "peak response" could be misleading. To improve clarity and precision, we have revised the term to "transient peak response" as recommended.

      We believe this adjustment better captures the nature of the neuronal activity observed and avoids confusion. The manuscript has been updated accordingly, and we appreciate the reviewer’s valuable input.

      (6) Is it possible to manipulate IC area and check the affection in behavior task?

      We appreciate the reviewer’s suggestion to manipulate the IC area and observe its effect on behavior during the task. Indeed, this would provide valuable causal evidence regarding the role of the IC in sensory prediction, decision-making, and reward processing, which would complement the correlational findings we have presented.

      However, in this particular study, we focused on electrophysiological recordings to observe naturally occurring neuronal activity in behaving monkeys. While it is certainly feasible to manipulate IC activity, such as through pharmacological inactivation, optogenetics, or electrical stimulation, these techniques pose technical challenges in primates. Moreover, manipulating the IC, given its role as a lower-level relay station in the auditory pathway, could potentially disrupt auditory processing more broadly, complicating the interpretation of behavioral outcomes.

      That said, we agree that introducing such manipulations in future studies would significantly enhance our understanding of the causal role of the IC in cognitive and sensory functions. We have now emphasized this as a key future research direction in the revised manuscript’s discussion section. Thank you for this insightful suggestion.

      “Further research is required to explore the underlying neuronal mechanisms and functional significance of this dynamic change comprehensively.” (P.18, Line. 11-12)

      Reviewer #3 (Recommendations for the authors):

      Minor Comments:

      (1) Figure Labeling:

      The figures require more precise labeling, particularly concerning the analysis time windows, to facilitate reader understanding of the results.

      We thank the reviewer for highlighting the importance of precise figure labeling, particularly regarding the analysis time windows. We understand that clear labeling is critical for conveying our findings effectively.

      In response to your suggestion, we have revised the figures to include more precise and detailed labels, especially for the analysis time windows. These changes will help guide readers through the experimental design and clarify the interpretation of the results. We hope these improvements enhance the overall clarity and accessibility of the figures.

      (2) Discrepancies in Figures and Text:

      There are discrepancies in the manuscript that could confuse readers. For example, on line 154, what was referred to as Supplementary Figure 1 seemed to actually be Supplementary Figure 2. Similar issues were noted on lines 480 and 606.

      We appreciate the reviewer bringing this issue to our attention. We apologize for the discrepancies between the figures referenced in the text and their actual labels in the manuscript, as this could indeed confuse readers.

      We have carefully reviewed the entire manuscript and corrected all discrepancies between the figures and their corresponding references in the text, including the issues noted on lines 154, 480, and 606. We have ensured that the figure and supplementary figure references are now consistent and accurate throughout the manuscript.

      (3) Inconsistent Formatting in Figure legends:

      Ensuring a more professional and uniform presentation throughout the manuscript would be appreciated. There was inconsistent use of uppercase and lowercase letters in legends.

      We appreciate the reviewer’s attention to detail regarding the formatting of figure legends. Ensuring a professional and consistent presentation is crucial for enhancing the readability and overall quality of the manuscript.

      We have carefully reviewed all figure legends and made the necessary corrections to ensure consistent use of uppercase and lowercase letters, as well as uniform formatting throughout the manuscript. This includes ensuring that all abbreviations and terminology are used consistently across the text and legends.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      In this manuscript, the authors recorded cerebellar unipolar brush cells (UBCs) in acute brain slices. They confirmed that mossy fiber (MF) inputs generate a continuum of UBC responses. Using systematic and physiological trains of MF electrical stimulation, they demonstrated that MF inputs either increased or decreased UBC firing rates (UBC ON vs. OFF) or induced complex, long-lasting modulation of their discharges. The MF influence on UBC firing was directly associated with a specific combination of metabotropic glutamate receptors, mGluR2/3 (inhibitory) and mGluR1 (excitatory). Ultimately, the amount and ratio of these two receptors controlled the time course of the effect, yielding specific temporal transformations such as phase shifts.

      Overall, the topic is compelling, as it broadens our understanding of temporal processing in the cerebellar cortex. The experiments are well-executed and properly analyzed.

      Strengths:

      (1) A wide range of MF stimulation patterns was explored, including burst duration and frequency dependency, which could serve as a valuable foundation for explicit modeling of temporal transformations in the granule cell layer.

      (2) The pharmacological blockade of mGluR2/3, mGluR1, AMPA, and NMDA receptors helped identify the specific roles of these glutamate receptors.

      (3) The experiments convincingly demonstrate the key role of mGluR1 receptors in temporal information processing by UBCs.

      Weaknesses:

      (1) This study is largely descriptive and represents only a modest incremental advance from the previous work (Guo et al., Nat. Commun., 2021). 

      We feel that the present study is a major advance.  It builds on (Guo et al., Nat. Commun., 2021) in which we examined the effects of bursts of 20 stimuli at 100 spk/s.  In that study we found that differential expression of mGluR1 and mGluR2 let to a continuum of temporal responses in UBCs, but AMPARs make a minimal contribution for such bursts. It was not known how UBCs transform realistic mossy fiber input patterns. Here we provide a comprehensive evaluation of a wide range of input patterns that include a range of bursts comprised of 1-20 stimuli, sustained stimulation with stimulation of 1 spk/s to 60 spk/s. This more thorough assessment of UBC transformations combined with a pharmacological assessment of the contributions of different glutamate receptor subtypes provided many new insights: 

      • We found that UBC transformations are comprised of two different components: a slow temporally filtered component controlled by an interplay of mGluR1 and mGluR2, and a second component mediated by AMPARs that can convey spike timing information. NMDARs do not make a major contribution to UBC firing. The finding that UBCs simultaneously convey two types of signals, a slow filtered response and responses to single stimuli, has important implications for the computational potential of UBCs and fundamentally changes the way we think about UBCs.  

      • We found that with regard to the slow filtered component mediated by mGluR1 and mGluR2, we could extend the concept of a continuum of responses evoked by 20 stimuli at 100 spk/s (Guo et al., Nat. Commun., 2021) to a wide range of stimuli. It was not a given that this would be the case.   

      • The contributions of AMPARs was surprising. Even though snRNAseq data did not reveal a gradient of AMPAR expression across the population of UBCs (Guo et al., Nat. Commun., 2021), we found that there was a gradient of AMPA-mediated responses, and that the AMPA component was also most prominent in cells with a large mGluR1 component. Our finding that AMPAR accessory proteins exhibit a gradient across the population, which could account for the gradient of AMPAR responses, will prompt additional studies to test their involvement. 

      (2) The MF activity used to mimic natural stimulation was previously collected in primates, while the recordings were conducted in mice.

      Our first task was to determine the firing properties of mossy fibers under physiological conditions in UBC rich cerebellar regions. Previous studies have estimated this in anesthetized mice using whole cell granule cell recordings (Arenz et al., 2008; Witter & De Zeeuw 2015). However, for assessing firing patterns during awake behavior, we felt that the most comprehensive data set available in a UBC rich cerebellar region was for mossy fibers involved in smooth pursuit in monkeys (David J. Herzfeld and Stephen G. Lisberger). This revealed the general features of mossy fiber firing that helped us design stimulus patterns to thoroughly probe the properties of MF to UBC transformations. The firing patterns are designed to investigate the transformations for a wide range of activity patterns and have important general implications for UBC transformations that are likely applicable to UBCs in different species that are activated in different ways.   

      (3) Inhibition was blocked throughout the study, reducing its physiological relevance.

      The reviewer correctly brings up the very important issue of inhibition in shaping UBC responses.  It is well established that UBCs are inhibited by Golgi cells (Rousseau et al., 2012), and we recently showed that some UBCs are also inhibited by PCs (Guo et al., eLife, 2021). This will undoubtedly influence the firing of UBCs in vivo. We considered examining this issue, but felt that brain slice experiments are not well suited to this. In contrast to MF inputs that can be activated with a realistic activity pattern, it is exceedingly difficult to know how Golgi cells and Purkinje cells are activated under physiological conditions. Each UBC is activated by a single mossy fiber, but inhibition is provided by Golgi cells that are activated by many mossy fibers and granule cells, and PCs that are controlled by many granule cells and many other PCs. In addition, we found that many Golgi cells do not survive very well in slices, and the axons of many PCs are severed in brain slice. Although limitations of the slice preparation prevent us from determining the role of inhibition in shaping UBC responses, we have added a section to the discussion in which we address the important issue of inhibition and UBC responses.   

      Reviewer #2 (Public review):

      This study addresses the question of how UBCs transform synaptic input patterns into spiking output patterns and how different glutamate receptors contribute to their transformations. The first figure utilizes recorded patterns of mossy fiber firing during eye movements in the flocculus of rhesus monkeys obtained from another laboratory. In the first figure, these patterns are used to stimulate mossy fibers in the mouse cerebellum during extracellular recordings of UBCs in acute mouse brain slices. The remaining experiments stimulate mossy fiber inputs at different rates or burst durations, which is described as 'mossy-fiber like', although they are quite simpler than those recorded in vivo. As expected from previous work, AMPA mediates the fast responses, and mGluR1 and mGluR2/3 mediate the majority of longer-duration and delayed responses. The manuscript is well organized and the discussion contextualizes the results effectively.

      The authors use extracellular recordings because the washout of intracellular molecules necessary for metabotropic signaling may occur during whole-cell recordings. These cell-attached recordings do not allow one to confirm that electrical stimulation produces a postsynaptic current on every stimulus. Moreover, it is not clear that the synaptic input is monosynaptic, as UBCs synapse on one another. This leaves open the possibility that delays in firing could be due to disynaptic stimulation. Additionally, the result that AMPAmediated responses were surprisingly small in many UBCs, despite apparent mRNA expression, suggests the possibility that spillover from other nearby synapses activated the higher affinity extrasynaptic mGluRs and that that main mossy fiber input to the UBC was not being stimulated. For these reasons, some whole-cell recordings (or perforated patch) would show that when stimulation is confirmed to be monosynaptic and reliable it can produce the same range of spiking responses seen extracellularly and that AMPA receptormediated currents are indeed small or absent in some UBCs.

      We appreciate the reviewer’s concerns regarding the reliability of mossy fiber activation, the possibility of glutamate spillover from other synapses, and the possibility of disynaptic activation involving stimulation of MFàUBCàUBC connections. We examined these issues in a previous study (Guo et al., Nat. Commun., 2021).  We did on-cell recordings and followed that up with whole cell voltage clamp recordings from the same cell (Guo et al., Nat. Commun., 2021, Fig. 5), and there was good agreement with the amplitude and timing of spiking and the time course and amplitudes of the synaptic currents.  We also compared responses evoked by focal glutamate uncaging over the brush and MF stimulation (Guo et al., Nat. Commun., 2021, Fig. 4). We found that the time courses and amplitudes of the responses were remarkably similar. This strongly suggests that the responses we observe do not reflect disynaptic activation (MFàUBCàUBC connections). We also showed that the responses were all-or-none: at low intensities no response was evoked, as the intensity of extracellular stimulation was increased a large response was suddenly evoked at a threshold intensity and further increases in intensity did not increase the amplitude of the response (Guo et al., Nat. Commun., 2021, Extended data Fig. 1).  We can be well above threshold and still excite the same response, and as a result we do not see stereotyped indications of an inability to stimulate during prolonged high frequency activation.  We recognize the importance of these issues, so we have  added a section dealing explicitly with these issues (pp. 15-16).  

      A discussion of whether the tested glutamate receptors affected the spontaneous firing rates of these cells would be informative as standing currents have been reported in UBCs. It is unclear whether the firing rate was normalized for each stimulation, each drug application, or each cell. It would also be informative to report whether UBCs characterized as responding with Fast, Mid-range, Slow, and OFF responses have different spontaneous firing rates or spontaneous firing patterns (regular vs irregular).

      The spontaneous firing of UBCs is indeed an interesting issue that is deserving of further investigation. It is not currently known how spontaneous firing at rest is regulated in UBCs, however, in previous work we have shown that there is great diversity in the rates across the population of UBCs in the dorsal cochlear nucleus (Huson & Regehr, JNeurosci, 2023, Fig. 4). Unfortunately, during the kind of sustained high-frequency stimulation protocols (as used in this study) spontaneous firing rates tend to increase. This is likely an effect of residual receptor activation. As such, our current dataset is not suitable to performing in depth analysis of the effects of the different glutamate receptors on spontaneous firing rates. As this study aims to explore UBC responses to MF inputs we feel that specific experiments to address the issue of spontaneous firing rates are outside of the scope.

      As the reviewers points out there are indeed different ways the firing rates can be normalized for display in the heatmaps, and different normalizations have been used in different figures. We have made sure that the method for normalization is clearly indicated in the figure legends for each of the heatmaps on display, specifying the protocol and drug application used for normalization.

      Figure 1 shows examples of how Fast, Mid-range, Slow, and OFF UBCs respond to in vivo MF firing patterns, but lacks a summary of how the input is transformed across a population of UBCs. In panel d, it looks as if the phase of firing becomes more delayed across the examples from Fast to OFF UBCs. Quantifying this input/output relationship more thoroughly would strengthen these results.

      The UBC responses to in vivo MF firing patterns are intriguing and we agree that there appears to be increasing delays for slower UBCs visible in Figure 1. However, we feel that the true in vivo MF firing patterns are too complex and irregular for rigorous interpretation. Therefore, we only tested simplified burst and smooth pursuit-like input patterns on the full population of UBCs. Here we indeed do see increasingly delayed responses as UBCs get slower (Fig. 4).

      Inhibition was pharmacologically blocked in these studies. Golgi cells and other inhibitory interneurons likely contribute to how UBCs transform input signals. Speculation of how GABAergic and glycinergic synaptic inhibition may contribute additional context to help readers understand how a circuit with intact inhibition may behave. 

      As indicated in our response to reviewer 1, we have added a section discussing the very important issue of inhibition and UBC responses in vivo.   

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Including recordings without inhibition blocked would strengthen the study and provide a more comprehensive view of the transformations made by UBCs at the input stage of the cerebellar cortex.

      See response to public comments.   

      (2) The authors claim that a continuum of temporal responses was observed in UBCs, but they also distinguish between fast, mid-range, slow, and OFF UBCs. While some UBCs fire spontaneously, others are activated by MF inputs. A more thorough classification effort would clarify the various response profiles observed under specific MF stimulation regimes. Have the authors considered using machine learning algorithms to aid in classification? 

      We fundamentally feel that these response properties do not conform to rigid categories. In our previous work we have shown that UBC population constitutes a continuum in terms of gene expression, and in terms of spontaneous and evoked firing patterns. While in order to answer some questions empirically it may still be useful to apply advanced algorithms to enforce separate groups to be compared, in this work we aimed to present the full range of UBC responses without introducing any additional biases that such methods would produce.

      (3) A robust classification could assist in quantifying the temporal shifts observed during smooth pursuit-like MF stimulation, a critical outcome of the study.

      As stated above, we prefer to present an unbiased overview of the continuous nature of the UBC population, as we believe that this is fundamentally the most accurate representation. While it is true that this prevents us from providing a quantification in the different temporal shifts, we believe that the range of shifts across the population is sufficiently large and continuously varying the be convincing (see Figure 4d).  

      (4) In Figure 5, contrary to what is described on page 10, Cells 10 and 11 (OFF UBCs) appear to behave differently, as mGluR1 does not seem to affect their firing rates. A specific case should be made for OFF UBCs. 

      Indeed, cells 10 and 11 do not show clear increases in firing and are not strongly affected by blocking of mGluR1. However, as discussed above and explored in our previous work, we feel that the range of UBC increases in firing is best described as a continuum, including the extreme where increases in firing are no longer clearly observable. As the aim in this work is to describe this continuum of responses for physiologically relevant inputs, we do not feel there is a benefit to creating a specific case for OFF UBCs here. It should be pointed out that the number of “pure” OFF UBCs completely lacking an mGluR1 component is very small.  

      (5) A summary diagram should be added at the end of the manuscript to highlight the key temporal features observed in this study. 

      This is a great suggestion and we have prepared such a summary diagram (Figure 6).

      Reviewer #2 (Recommendations for the authors):

      (1) Page 3- "Assed" should be "assessed"

      (2) Page 19- "by integrating" is repeated twice

      (3) It was not noted whether the data would be made available. It could be useful for those interested in implementing UBCs in models of the cerebellar cortex.

      We agree that this data set is invaluable to those interested in implementing UBCs in models of the cerebellar cortex.  We will make the dataset available as described in the text.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      (1) “…Given that the focus in the paper is on tissue-specific immune training, it would be helpful to know whether the ongoing presence of BCG at low levels in the profiled tissue contributes to the trained immunity phenotypes observed.”….“To address point 1, the authors could treat with anti-BCG antibiotics at 2 or 4 weeks post-BCG exposure and profile the impact on trained immunity phenotypes.”

      We thank the reviewer for this important comment. The experiment suggested by the reviewer is to treat with abx to remove BCG from the tissue from the first week post challenge for the duration of four weeks. In previous work, Kaufmann et al (PMID: 29328912) showed that after a month of antibiotics, BCG levels are reduced, but residual BCG levels still remains. Accroding to their results, while antibiotic treatment reduces the training phenotype of LKS<sup>+</sup> HSC expansion in the bone marrow, protection against TB was maintained during ex-vivo challenge of BMDMs.

      In our experiments, we are concerned that antibiotic treatment will only change the dynamics of BCG clearance, but residual BCG will remain and will limit our interpretation. Furthermore, examining the transcriptional changes we observed at early timeponts after BCG may not be relavant at 1 month post antibiotics.

      As an alternative approach, we refer to our results with an antibody to block early IFNg signaling (1-5 days; Figure S4 K-M). Here, although BCG levels are comparable between treatment and control groups, we were unable to detect any TI-related transcriptional signatures upon early aIFNg treatment. This indicates that that residual BCG is not sufficient for the TI phenotype in the spleen. We now emphasize this point in the revised version of the manuscript (see lines 335-339).

      (2) “Related to the point about BCG above, it would be helpful to understand whether this is a specifically time-limited requirement when trained immunity is first induced, or whether ongoing signaling through this axis is required for maintenance of the observed trained immunity phenotypes.”… “To address point 2, authors could treat with the inhibitor at 2 weeks and/or 4 weeks post-BCG and profiling later transcriptional and/or salmonella growth phenotypes.”

      We thank the reviewer for his comment, but respectfully claim that this experiment might not be feasible. As IFNg signaling is directly required for control of Salmonella infection,  we are concerned that late IFNg inhibition will also directly affect the response to Salmonella challenge and control. Thus, in our experiments, to ensure that treatment only affects the response to BCG challenge, we were careful to limit aIFNg treatment to the early time points and allowed long resting period before Salmonella challenge.

      Furthermore, inhibition of IFNg at late time point was already tested in both Lee et al, and Tran et al. (PMID: 38036767, 38302603). The authors show that late blockage of IFNg signalling (days 14-21) is sufficient to prevent protection during a viral challenge. This would indeed imply that ongoing signalling is necessary in this context to generate protection, specifically also late signalling events. Furthermore, Lee at al., also observed a biphasic activation pattern of cytokines and recruited cells, suggesting that rather than continuous activation, sequential cell activation and signalling may be occurring.

      Respectfully, in our experiments we focus on the early time points based on our observations of early recruitment of CM-T cells (Figure S2. C-D). This was our main findings of this paper. We agree with the reviewer that future experiments are required to compare the differences in cell populations that are invovled in the early vs. late trained phenotpe dynamics.

      Minor points:

      Experimental conditions for the shown data are not consistently clear from the figure legends- would add more detail about the biological conditions.

      OK – done

      Figure 3E missing units on the legend

      OK – done

      Figure 4C middle panel missing y-axis label

      OK – done

      Line 40- remove "both"

      OK- done

      Line 156- Language could be clearer about what was described previously in contrast to the results shown in this work

      We have modified the text accordingly in the revised manuscript

      Reviewer #2:

      “A significant amount of work has already been performed for this study. The work is rich with data and description.”

      We thank the reviewer for acknowledging the importance of our work.

      Minor comments for the authors to consider:

      “BCG is widely recognised to induce trained immunity. In this study, Salmonella is used as secondary infection event. Why? What is role of Salmonella in this study? Does this study contribute to our understanding of the Salmonella infection process? What does this tell us about Salmonella/vaccines? Is there any evidence that BCG protects against Salmonella infection? “

      We thank the reviewer for this important comment. We now added to the introduction and the discussion the relevance of our study to the potential of BCG and trained immunity as an alternative heterologous vaccine approach to traditional vaccines that require strain-specific vaccine for each pathogen (lines 49-55 of the revised manuscript).

      “Figure 1E. RPM cannot be detected by scRNAseq?”

      The reviewer is correct. we excluded RPMs from the scRNA-seq analysis. As we discuss in the manuscript (lines 94-96), and in our previous publication (PMID: 34788598), RPM activation involves rapid cell death. As we are analyzing by scRNA-seq two weeks after BCG challenge, we only measured scRNA-seq of CD11b+ cells, which exclude RPMs, as we were worried that our transcriptional data would represent transcriptional signatures of dying cells, making interpretation of the data difficult.

      “Figures 1H and I. The CM-T macrophages are not represented? Are they contemplated within the CM population? Would be useful to see the contribution of CM-T to the total CM DEGs/pathways.”

      The reviewer is correct. CM-T cells are evident only after BCG challenge. Because of this, our analysis of DEGs induced in monocytes by BCG requires analysis of all monocytes together. Thus, we were careful throughout the manuscript to refer to CM when analyzing bulk RNA-seq data.

      “Lines 104-117. Can the authors summarise or move the text in this paragraph to discussion? Although it provides important context, it cuts the line of thought and reduces comprehension of this section. “

      OK – we moved this section to the discussion in the revised manuscript.

      “Line 127. Is it Fig 1I or 1F that the authors are referring to? “

      The reviewer is correct, and we changed the text in the revised manuscipt accordingly.

      “Figure 1J. x-axis labels CM cells but both text and figure legend refer to this panel as CM-T. If this is the case, please show data for CM and CM-T separately.”

      Please see our earlier point above that limits these analyses. As such we have also edited the text and figure legend to reflect this.

      “Lines 136-139. Please indicate that this can be found in Fig 1J.”

      OK – indicated in the revised manuscript

      “Line 152. Please add that STm infection occurred at 14 and 60 days post training.”

      OK – added

      “Lines 162-163. This is repeated from lines 89-90, maybe the reduction of RPMs can be only highlighted in this section so that the previous section can be just focused on the new CM-T population?”

      The reviewer is correct - we removed the mention of RPMs here, and mention them only later in the revised manuscript.

      “Line 163. The recruitment is CM or CM-T cells? Since they express CXCL9 (line 165 and Fig1J) could this be used as a marker for the CM-T population at this time point?”

      The reviewer is correct, and we thank him for this important comment. We now indicate that CXCL9+ is a marker for the CM-Ts population here and throughout the revised manuscript (lines 153-155 of the revised manuscript).

      “Line 173. The loss of CXCL9 at 60 dpi means that CM-T population disappears/reduces or returns to CM only? If the population is reduced, could it be related to the reduced STm infection control at 60 days?”

      OK– done. Referred to these cells as CM-Ts and suggested a correlation with protection loss in the text (lines 160-162 of the revised manuscript).

      “Figure 2D. Can the authors show if there is variation in the myeloid populations after PBS injection at different time points? Are the percentages shown only at 3 dpi? It is curious that at 30 dpi the transcriptome has a significant change for certain genes.”

      There are indeed variations across the PBS time points samples, which we demonstrate in Figure S2B. The percentages shown in the main figure for PBS reflect the mean of all time points, this is now stated in greater clarity in the revised manuscript (lines 151-152). We also noted an increase in the cell cycling genes at D30 for the control mice as well, and while still significant in BCG, we limited interpretation accordingly.

      “Line 208. The authors can highlight that the expression of STAT1 follows the same pattern as IFNg. Maybe even present the graphs side by side?”

      The reviewer is correct, and we have implemented their suggestion as such in the updated text (lines 192-195) and figure (Fig. 2H).

      “Line 213. Authors mention a replenishment of the RPM population - what time point are you referring to? At 60 dpi the population seems to be halved compared to 14 dpi. Later (line 230), authors refer to the replenishment as a repopulation by other cell types - is repopulation more correct than replenishment?”

      The reviewer is correct, and we thank the reviewer for this important comment. We now changed replenishment to repopulation (lines 95, 201), which is more accurate given the continued decreased percentage at later time points.

      Lines 214-222. It is not clear what is the conclusion from these experiments: is the recruitment of progenitors from the BM or by local signals?

      The reviewer is correct, we agree that the wording in the initial manuscript was imprecise. This experiment specifically tests whether trained bone marrow progenitors can sustain the observed TI signatures in a naive environment. By transplanting trained bone marrow into naive hosts, we demonstrate that progenitor programming alone is sufficient to maintain long-term SCA-1 expression in NCMs, without requiring ongoing local tissue signals. We now better clarify this text in the revised manuscript (lines 202-212).

      “Line 333-334. Where is the data that shows that upon Fedratinib RPMs have enhanced survival?”

      OK – We now indicate the figure in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Chemogenetics validation

      Little validation is provided for the chemogenetic manipulations. The authors report that animals were excluded due to lack of expression but do not quantify/document the extent of expression in the animals that were included in the study.

      We thank the reviewer for raising this oversight. We have added additional examples of virus expression in sections from included and excluded animals in Figure 1 – Supplement 1. We also added additional comments on the extent of expression we observed in lines 92-95: “Post-experiment histology confirmed overlapping virus expression and TH-positive neurons in putative VTA near the injection site (-5.6 mm AP from bregma), as well as approximately 0.5 mm anterior and posterior (-5 to -6 mm AP).”

      There's no independent verification that VTA was actually inhibited by the chemogenetic manipulation besides the experimental effects of interest.

      While we did include animals expressing control virus to control for any effect of CNO administration itself, the reviewer is correct that we did not independently verify VTA neurons were inhibited. We have noted this limitation of the current study on lines 513-522 in the Discussion: “We did not directly measure the suppression of VTA neurons after CNO injection. Previous work in other brain areas found hM4Di activation suppressed firing rates to around 60% of baseline (Mahler et al., 2014; Chang et al., 2015), in addition to diminishing synaptic transmission even when spikes occurred (Stachniak et al., 2014). Combined with the incomplete expression of hM4Di in TH-positive neurons in our animals, we expect VTA activity was significantly but not completely suppressed. Because our results depend only on any degree of blunting differences in dopamine release at different reward locations, rather than the total absence of dopamine signaling, measuring the magnitude of suppression was not essential for our conclusions.”

      The authors report a range of CNO doses. What determined the dose that each rat received? Was it constant for an individual rat? If not, how was the dose determined? The authors may wish to examine whether any of their CNO effects were dependent on dose.

      The reviewer is completely correct that we omitted sufficient information regarding the dosage of CNO used in each animal and each session. We have included more details in the Methods lines 676-694, detailing both the doses and the rationale.

      The authors tested the same animal multiple times per day with relatively little time between recording sessions. Can they be certain that the effect of CNO wore off between sessions? Might successive CNO injections in the same day have impacted neural activity in the VTA differently? Could the chemogenetic manipulation have grown stronger with each successive injection (or maybe weaker due to something like receptor desensitization)? The authors could test statistically whether the effects of CNO that they report do not depend on the number of CNO injections a rat received over a short period of time.

      We thank the reviewer for bringing up the question of whether the order of sessions had an influence on the efficacy of CNO in inactivating VTA activity. To address this, we split our dataset in Experiment 1 into two based on what number session of the particular day it was: 1st sessions of the day vs. all subsequent sessions (2nd+ session of the day). Then, we examined the difference in sharp-wave ripple rate between the reward ends in Epoch 2, as in Figure 2D of the manuscript. Though the resulting number of sessions in each split of the dataset is too low to draw strong statistical conclusions, particularly for novel sessions, we see little evidence there is any systematic change in the effect of VTA inactivation as a function of session number in the day. We include this in the revised manuscript as Figure 2 – Supplement 3 and in the Results lines 255-258.

      Motivational considerations

      In a similar vein, running multiple sessions per day raises the possibility that rats' motivation was not constant across all data collection time points. The authors could test whether any measures of motivation (laps completed, running speed) changed across the sessions conducted within the same day.

      We thank the reviewer for this suggestion. We examined behavioral measures of motivation across sessions conducted within the same day. First, we calculated how many total laps each animal completed each session as a function of the session number of the day. In individual animals, this ranged from -2.8 to 4.1 laps per additional session number (mean 2.01), with an average total laps per session of 43.2 laps. Second, we calculated the median running velocity per session, across both running directions and all epochs, and checked how it varied across session number of the day. Per additional session in the day, this ranged from -3.6 to 8.6 cm/s difference across animals (mean 2.7 cm/s), with an average running velocity of 34.1 cm/s in total. Taken together, while we found little behavioral evidence of strong motivational changes across session, our animals may have been slightly more motivated in later sessions in the day, which also corresponded to later in the light cycle and closer to the dark cycle. We mention this information in Results lines 255-258, related to Figure 2 – Supplement 3.

      This is a particularly tricky issue, because my read of the methods is that saline sessions were only conducted as the first session of any recording day, which means there's a session order/time of day and potential motivational confound in comparing saline to CNO sessions.

      We have clarified the ordering of CNO and saline sessions in the Methods lines 697-702. Briefly, we avoided running CNO sessions before saline sessions in the same day, but either could be the first session of a day. That is, saline -> saline, saline -> CNO, and CNO -> CNO were all valid orderings. On days with more than two sessions, any number of repeated saline and CNO sessions was permitted, provided that as soon as a CNO session occurred, any subsequent sessions were also CNO.

      More generally, we shared this reviewer’s concern about potential confounds between drug and motivation. For novel sessions in Experiment 1, each animal had equal numbers of saline and CNO 1st and 2nd sessions of the day. For familiar sessions, animals had similar counts for 1st sessions of the day (experimental rats: 20 saline, 16 CNO; control rats: 17 saline, 15 CNO) but more CNO 2nd sessions of the day (experimental rats: 5 saline, 13 CNO; control rats: 5 saline, 10 CNO). There were occasionally 3rd or 4th sessions in a given day for some rats, and these were also approximately equal (experimental rat 2, 3rd sessions: 2 each of saline and CNO, 4th session: 1 saline; experimental rat 3 and 4, 3rd sessions: 1 each of saline and CNO; control rat 2, 3rd session: 1 saline).

      Statistics, statistical power, and effect sizes

      Throughout the manuscript, the authors employ a mixture of t-tests, ANOVAs, and mixed-effects models. Only the mixed effects models appropriately account for the fact that all of this data involves repeated measurements from the same subject. The t-tests are frequently doubly inappropriate because they both treat repeated measures as independent and are not corrected for multiple comparisons.

      We thank the reviewer for pointing out these issues with our statistical analyses in places. We have made the following improvements:

      Figure 1F-I, S1, reward end visit durations: We now use a linear mixed-effects model to analyze the difference in stopping period durations between epochs. For each session, we calculated the mean stopping duration for each reward end in each epoch, then modeled the difference between epochs as a function of drug and novelty, with animal-specific intercepts. For example, related to Figure 1F and also described in the Results, we modeled the stopping duration difference at the Unchanged reward end, Epoch 2 – Epoch 1, and found experimental rats had a significant intercept (Epoch 2 stops shorter than Epoch 1) and the drug × novelty interaction, while control rats had a significant intercept and novelty main effect. The other visit duration analysis shown in Figure 1 – Supplement 1 have similarly been updated.

      Figure 2D-E, ripple rate difference between reward ends in Epoch 2: We now use a linear mixed-effects model to analyze the difference between ripple rates at the Incr. and Unch. reward ends in Epoch 2. For each session, we calculated the mean ripple rate at each end in Epoch 2, then modeled the difference as a function of drug and novelty, with animal-specific intercepts. With the full stopping periods, for experimental rats, there was a significant intercept (ripple rate at Incr. greater than Unch.) and the model with drug included performed significantly better than the one without it (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = 5.22). Control rats had a significant intercept and effect of novelty (greater difference with novelty), and the model excluding drug terms performed better (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = -3.54). Results with the trimmed stopping periods were similar. These analyses are described in Results lines 253-266.   

      Figure 3D-E, ripple rate as a function of reward history: We now use a mixed-effects model that incorporates animal-specific intercepts. The results remained similar and have been updated in the text and legend.

      Figure 4D-K, replay rates as a function of drug, novelty, and directionality: We now use mixed-effects models that incorporate animal-specific intercepts rather than three-way ANOVA. The results remained similar and have been updated in the text and legend.

      The number of animals in these studies is on the lower end for this sort of work, raising questions about whether all of these results are statistically reliable and likely to generalize. This is particularly pronounced in the reward volatility experiment, where the number of rats in the experimental group is halved to just two. The results of this experiment are potentially very exciting, but the sample size makes this feel more like pilot data than a finished product.

      We have added additional emphasis in the text that the experimental group results of CNO inactivation in the volatile reward task should be confirmed with future work, in Discussion line 529-533. Because these experiments were performed on familiar tracks, we see them as corroborating/complementing the results from Experiment 1. Although the analysis assumes VTA inactivation had no effect, our pooling of all Experiment 2 data to display in Figure 3 – Supplement 2 maximized our ability to analyze the effects of volatile reward deliveries on sharp-wave ripple rates, lending further support to the main results shown in Figure 3.

      The effect sizes of the various manipulations appear to be relatively modest, and I wonder if the authors could help readers by contextualizing the magnitude of these results further. For instance, when VTA inactivation increases mis-localization of SWRs to the unchanged end of the track, roughly how many misplaced sharp-waves are occurring within a session, and what would their consequence be? On this particular behavioral task, it's not clear that the animals are doing worse in any way despite the mislocalization of sharp-waves. And it seems like the absolute number of extra sharp-waves that occur in some of these conditions would be quite small over the course of a session, so it would be helpful if the authors could speculate on how these differences might translate to meaningful changes in processes like consolidation, for instance.

      We thank the reviewer for this helpful suggestion to give some context to the difference in sharp-wave ripple numbers and the functional consequence of these changes. We agree completely that this task is almost certainly too simple for animals to show any performance deficit from these changes. We chose this precisely so we could examine the consequences of VTA inactivation to the sharp-wave ripple response to reward changes per se, without any confound of performance or memory changes that could also conceivably alter sharp-wave ripples. We have added both more context about the magnitude and consequence of these sharp-wave ripple changes as well as comments about the choice of this particular task (Discussion lines 522-529).  

      How directly is reward affecting sharp-wave rate?

      Changes in reward magnitude on the authors' task cause rats to reallocate how much time they spent at each end. Coincident with this behavioral change, the authors identify changes in the sharp-wave rate, and the assumption is that changing reward is altering the sharp-wave rate. But it also seems possible that by inducing longer pauses, increased reward magnitude is affecting the hippocampal network state and creating an occasion for more sharp-waves to occur. It's possible that any manipulation so altering rats' behavior would similarly affect the sharp-wave rate.

      For instance, in the volatility experiment, on trials when no reward is given sharp-wave rate looks like it is effectively zero. But this rate is somewhat hard to interpret. If rats hardly stopped moving on trials when no reward was given, and the hippocampus remained in a strong theta network state for the full duration of the rat's visit to the feeder, the lack of sharp-waves might not reflect something about reward processing so much as the fact that the rat's hippocampus didn't have the occasion to emit a sharp-wave. A better way to compute the sharp-wave rate might be to use not the entire visit duration in the denominator, but rather the total amount of time the hippocampus spends in a non-theta state during each visit. Another approach might be to include visit duration as a covariate with reward magnitude in some of the analyses. Increasing reward magnitude seems to increase visit duration, but these probably aren't perfectly correlated, so the authors might gain some leverage by showing that on the rare long visit to a low-reward end sharp-wave rate remains reliably low. This would help exclude the explanation that sharp-wave rate follows increases in reward magnitude simply because longer pauses allow a greater opportunity for the hippocampus to settle into a non-theta state.

      We thank the reviewer for these important comments. We have better clarified the analysis of sharp-wave ripple rate in the Results (lines 172-173). To speak to the main concern of the reviewer, we do only consider times during “stopping periods” when the rat is actually stationary. That is, ripple rate for each visit is calculated as (# of ripples / total stationary time), rather than the full duration the rat is at the track end. With respect to including visit duration as a covariate, the Poisson model takes the total stationary time of each visit into account, so that it is effectively predicting the number of events (ripples) per unit of time (seconds) given the particular experimental variables (reward condition, drug condition, etc.). We have added additional clarification of this in the Methods (line 834-836).

      The authors seem to acknowledge this issue to some extent, as a few analyses have the moments just after the rat's arrival at a feeder and just before departure trimmed out of consideration. But that assumes these sorts of non-theta states are only occurring at the very beginning and very end of visits when in fact rats might be doing all sorts of other things during visits that could affect the hippocampus network state and the propensity to observe sharp-waves.

      We hope that with the clarification provided above, this control analysis helps remove any potential effects of approaching/leaving behavior or differences in movement at the reward end that could alter sharp-wave ripple rates. 

      Minor issues

      The title/abstract should reflect that only male animals were used in this study.

      We have added this important information to the Abstract line 21.

      The title refers to hippocampal replay, but for much of the paper the authors are measuring sharp-wave rate and not replay directly, so I would favor a more nuanced title.

      We thank the reviewer for this suggestion. In the context of our work, we consider sharp-wave ripples as more-easily-detected markers for the occurrence of replay. Previous work from our lab (Ambrose et al., 2016) showed the effect of reward changes had very similar effects to both sharp-wave ripple rate and replay rate. We try to be explicit about viewing ripples as markers of replay content in both the Introduction and Discussion. Nevertheless, we do also demonstrate the title claim directly – by measuring replay and its spatial localization – therefore we feel comfortable with the title as it is.

      Relatedly, the interpretation of the mislocalization of sharp-waves following VTA inactivation suggests that the hippocampus is perhaps representing information inappropriately/incorrectly for consolidation, as the increased rate is observed both for a location that has undergone a change in reward and one that has not. However, the authors are measuring replay rate, not replay content. It's entirely possible that the "mislocalized" replays at the unchanged end are, in fact, replaying information about the changed end of the track. A bit more nuance in the discussion of this effect would be helpful.

      While we do show that replay content, in the form of reverse vs. forward replays, is altered with VTA inactivation, we take the reviewers point and completely agree. Especially in the context of the linear track, replays at either end could certainly be updating/consolidating information about both ends. We would argue our results suggest VTA is critical to localizing ripples and replay in more complex environments where this is not the case, but this is a hypothesis. We have added clarification and discussion of this point (Discussion lines 522-529).

      However, in response to the reviewer’s comment, we have now also examined non-locally-initiated replays specifically to determine whether the increased ripple rate at the Unch. reward end in novel CNO sessions was likely due to more non-local replay, but found no significant increases in non-local replay at either reward end in either drug condition or novelty condition. We have included this result as Figure 4 – Supplement 3, and note it in the Results lines 487-488.

      The authors use decoding accuracy during movement to determine which sessions should be included for decoding of replay direction. Details on cross-validation are omitted and would be appreciated. Also, the authors assume that sessions failed to meet inclusion criteria because of ensemble size, but this information is not reported anywhere directly. More info on the ensemble size of included/excluded sessions would be helpful.

      We have added additional information about the run decoding procedure and related session inclusion criteria, as well as about recorded ensemble sizes (lines 417-421). Briefly, mean ensemble sizes were significantly smaller for excluded sessions (cell count, mean±sem; included sessions: 26.1±1.1, excluded sessions: 9.5±1.6; two-sample t-test, t(133)=5.3, p<10<sup>-5</sup>). The average field size, defined as the number of spatial bins with greater than 1 hz firing rate, in excluded sessions was also larger (mean±sem, included sessions: 47.7±1.3, excluded sessions: 57.7±5.8; two-sample t-test, t(133)=-2.33, p<0.05), though the difference was less dramatic. Using a mixed effects model to predict position decoding error (as in Figure 4 – Supplement 2A) as a function of drug, novelty, cell count, and mean place field size, in both experimental and control groups cell count and field size were significant predictors: more cells and smaller average field size led to lower error. A similar model that instead predicted the fraction of running bins with correctly decoded running direction (as in Figure 4 – Supplement 2B), in neither group was field size significant, while cell count remained so: more cells led to more bins with running direction correctly classified. We include these analyses in the legend for the figure. With respect to cross validation of run decoding, because both the contribution of spikes in any single time bin to a neuron’s place field is extremely small and because we used run decoding accuracy simply to filter out sessions with poorer decoding, we did not use cross validation here.

      For most of the paper, the authors detect sharp-waves using ripple power in the LFP, but for the analysis of replay direction, they use a different detection procedure based on the population firing rate of recorded neurons. Was there a reason for this switch? It's somewhat difficult to compare reported sharpwave/replay rates of the analyses given that different approaches were used.

      We have added clarification for this change in detecting candidate events (lines 787-789). Briefly, sharp-wave ripples and spike density events are often but not always overlapping, such that there can be strong ripples with little spiking in the recorded ensemble or weak/absent ripples during vigorous spiking in the recorded ensemble. Because the decoding of replay content relies on spiking, our lab and others often use spike density or population burst events as candidate events. We have confirmed that the main results of Experiment 1 (e.g., Figure 2) remain the same if we use spike density events rather than sharp-wave ripples, but prefer to keep the use of sharp-wave ripples here for better comparison with Experiment 2 and to allow the inclusion of animals and sessions with low cell yield but clear ripples in the LFP.  

      Reviewer #2 (Recommendations For The Authors):

      Include additional histological data to confirm the extent of viral spread and precise tetrode placements. Providing detailed figures that clearly illustrate these aspects would strengthen the validity of the neural recordings and the specificity of the chemogenetic silencing.

      We thank the reviewer for this suggestion and have added additional information regarding virus expression in Figure 1 – Supplement 1. We also added additional comments on the extent of expression we observed in lines 92-95: “Post-experiment histology confirmed overlapping virus expression and TH-positive neurons in putative VTA near the injection site (-5.6 mm AP from bregma), as well as approximately 0.5 mm anterior and posterior (-5 to -6 mm AP).”

      While we do not show histological confirmation of hippocampal recording sites, the presence of sharp-wave ripples with upward deflections, presence of place cells, and recording coordinates and depth typical of dorsal CA1 made us confident in our recording location. We have noted these characteristics of our recordings in lines 128-131 in the Results: “Tetrodes were lowered to the pyramidal cell layer of dCA1, using the presence of sharp-wave ripples with upward deflections in the LFP, recording depth characteristic of dCA1, and spatially-restricted firing of place cells to confirm the recording location.”

      Address the variability in CNO dosing and timing before recordings. It is recommended to standardize the dose and ensure a consistent timing interval between CNO administration and the start of recordings to minimize variability in the effects observed across different subjects. Instead of collecting new data, the authors could report the data for each animal, indicating the dose and interval between the injection and the recording.

      We have further clarified the CNO dosing and timings in lines 676-702.

      In Figure 1F, explicitly state whether the data represent averages across multiple sessions and confirm if these observations are primarily from the initial novel sessions. This clarification will help in accurately interpreting the effects of novelty on the measured neural activities.

      We have changed the analyses shown in Figure 1F-I and Figure 1 – Supplement 1 thanks to the suggestions of Reviewer #1, but also more clearly spell out the analysis. Briefly, we average the durations for each condition within session (e.g., take the mean Unch. duration in Epoch 1), then perform the analysis across sessions. These data come from all sessions in Experiment 1, as described in lines 141-147, meaning there are around 2-3 times as many familiar sessions as novel sessions.

      Reconsider the reporting of marginal p-values (e.g., p=0.055). If the results are borderline significant, either more data should be collected to robustly demonstrate the effects or a statistical discussion should be included to address the implications of these marginal findings.

      We have removed the reporting of marginal p-values.

      Ensure that the axes and scales are consistent across similar figures (specifically mentioned for Figure 2A) to prevent misinterpretation of the data. Consider showing the average across all animals in 2A, similar to 2B and 2C.

      We have adjusted these axes to be consistent across all panels.

      Add a legend to the heatmap in Figure 4A to facilitate understanding of the data presented.

      We have added a heatmap to the figure and legend.

      Provide a detailed examination and discussion of the apparent contradictions observed in control data, particularly where experimental conditions with saline show increased reverse replay in novel environments, which is absent in familiar sessions. See Figures 4E and 4I.

      We thank the reviewer for noting that this feature of our data deserved discussion. We confirmed that the lack of an effect of reward on reverse replay rates in familiar sessions in control rats was due to generally low replay rates in these sessions. Replay rates have been observed to decrease as the familiarity of an environment or behavior increases, and the presence of the reward-related modulation of reverse replay in novel sessions in these animals is consistent with this observation. We now report in the Results lines 458-459 and 485-486 the low replay rates in this group in familiar sessions, and the likelihood that this is preventing any reward-related modulation from being detected.

      Include a more detailed analysis of place cell properties, such as firing rates and field sizes, especially in novel environments where VTA inactivation appears to alter spatial coding. Decoding error is lower during CNO administration - does this mean place fields are smaller/more accurate? This analysis could offer deeper insights into the mechanisms by which dopamine influences hippocampal neural representations and memory processes.

      We thank the reviewer for this helpful suggestion. We have expanded on our analysis of place field properties and decoding accuracy, describing properties of sessions with good enough decoding to be included compared to those that were excluded (lines 417-421). We also directly tested how decoding quality depended on several factors, including drug condition, novelty, number of cells recorded, and the average place field size of recorded cells (see legend for Figure 4 – Supplement 2). We found a small but significant effect of drug in experimental rats, but larger effects of number of recorded cells and average field size, that were also present in control animals.

      Correct the typo on line 722 from "In ANOVA" to "An ANOVA".

      We reworded this section and have corrected this error.

      Reviewer #3 (Recommendations For The Authors):

      The manuscript is clear and exciting. As a main criticism, I would have liked to see the effects on ripple duration not just the rate.

      We thank the reviewer for this interesting idea. We performed a new analysis, similar to our analysis on SWR rate, probing the effect of our experimental manipulations on SWR duration in experimental rats. We have added the results in Figure 2 – Supplement 4, and note them in the main text lines 195-198: “SWR duration was reduced in novel sessions, consistent with replays becoming longer with increased familiarity  (Berners-Lee et al., 2021), as well as in Epoch 2, but was otherwise unaffected by reward or drug (Figure 2 – Supplement 4).”

      I have a few other minor comments:

      (1) I find it a little disturbing and counterintuitive that statistical differences are not always depicted in the figure graphs (for example Figures 2A-E). If the authors don't like to use the traditional *, ** or *** they could either just use one symbol to depict significance or simply depict the actual p values.

      We thank the reviewer for this suggestion. We struggled with indicating significance values graphically in an intuitive way for interaction terms in the figures. We now added significance indicators in Figures 1F-I, added the significant model coefficients directly into Figure 2B-C, changed the analysis depicted in Figure 2D-E per Reviewer 1’s suggestions, and added significance indicators where previously missing in Figures 3 and 4.

      (2) Related to the point above: in the page 7 legend D and E, it would be advantageous for clarity of the experimental results to also perform post-hoc analyses as depicted in the graphs, rather than just describe the p-value of the 3way ANOVA;

      We thank the reviewer for this suggestion. Because the figure includes the mean and standard error of each condition, in addition to the significant effects of the mixed-effects model, we prefer the current format as it makes clearer the statistical tests that were performed while still allowing visual appreciation of differences between specific experimental conditions of interest to the reader.

      (3) According to Figure 1H, the duration of the reward visits can go up to 15s (or more). Yet in Figure 2A only the first 10sec were analyzed. While I understand the rationale for using the initial 10 seconds where there is a lot more data, the results of graphs of Figures A to C will not have the same data/rate as Figures D-F where I assume the entire duration of the visit is taken into account.

      A figure showing what happening to the ripple rate during the visits >10sec would help interpret the results of Figure 2.

      We thank the reviewer for these interesting suggestions. We clarify now that all these analyses of Experiment 1 use only the first 10 s of each stopping period in Method line 758-764. However, examining the longer stopping periods is an excellent suggestion, and we re-analyzed the Experiment 1 dataset using up to the first 20 s of each stopping period. The main results (e.g., Figure 2) remain the same:

      (1) Related to Figure 2B-C: For experimental rats, a mixed-effects generalized linear model predicting sharp-wave ripple rate as a function of reward end, block, drug, novelty, and interactions, had the following significant terms: drug (p<10<sup>-5</sup>), novelty (p<10<sup>-10</sup>), reward end × block (p<10<sup>-10</sup>), and reward end × block × drug (p<0.05). The same model in control rats had significant terms: reward end (p<0.05), novelty (p<10<sup>-4</sup>), reward end × block (p<10<sup>-10</sup>).

      (2) Related to Figure 2D-E: For experimental rats, we used a mixed-effects generalized linear model predicting the difference in sharp-wave ripple rate between the Incr. and Unch. reward ends in Epoch 2 as a function of novelty, drug, and their interaction. Model comparison found the full model performed better than a model removing the drug terms (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = 2.94), while a model with only the intercept performed even worse (AIC<sub>intercept</sub> – AIC<sub>full</sub> = 13.76). For control rats, model comparison found the full model was equivalent to a model with only the intercept (AICintercept – AICfull = -0.36), with both modestly better than a model with no drug terms (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = 1.38).

      We have added a remark that results remain the same using this longer time window in Methods line 758-764.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The paper proposes an interesting perspective on the spatio-temporal relationship between FC in fMRI and electrophysiology. The study found that while similar network configurations are found in both modalities, there is a tendency for the networks to spatially converge more commonly at synchronous than asynchronous time points. However, my confidence in the findings and their interpretation is undermined by an apparent lack of justification for the expected outcomes for each of the proposed scenarios, and in the analysis pipeline itself.

      Main Concerns

      (1) Figure 1 makes sense to me conceptually, including the schematics of the trajectories, i.e.

      Scenario 1: Temporally convergent, same trajectories through connectome state space

      Scenario 2: Temporally divergent, different trajectories through connectome state space

      However, based on my understanding I am concerned that these scenarios do not necessarily translate into the schematic CRP plots shown in Figure 2C, or the statements in the main text:

      For Scenario 1: "epochs of cross-modal spatial similarity should occur more frequently at on-diagonal (synchronous) than off-diagonal (asynchronous) entries, resulting in an on-/off-diagonal ratio larger than unity"

      For Scenario 2: "epochs of spatial similarity could occur equally likely at on-diagonal and off-diagonal entries (ratio≈1)"

      Where do the authors get these statements and the schematics in Figure 2C from? Are they based on previous literature, theory, or simulations?

      I am not convinced based on the evidence currently in the paper, that the ratio of off- to on-diagonal entries (and under what assumptions) is a definitive way to discriminate between scenarios 1 and 2.

      For example, what about the case where the same network configuration reoccurs in both modalities at multiple time points? It seems to me that one would get a CRP with entries occurring equally on the on-diagonal as on the off-diagonal, regardless of whether the dynamics are matched between the two modalities or not (i.e. regardless of scenario 1 or 2 being true).

      This thought experiment example might have a flaw in it, and the authors might ultimately be correct, but nonetheless, a systematic justification needs to be provided for using the ratio of off- to on-diagonal entries to discriminate between scenarios 1 and 2 (and under what assumptions it is valid).

      In the absence of theory, a couple of ways I can think of to gain insight into this key aspect are:

      (1) Use surrogate data for scenarios 1 and 2:

      a. For scenario 1: Run the CRP using a single modality. E.g. feed in the EEG into the analysis as both modality 1 AND modality 2. This should provide at least one example of CRP under scenario 1 (although it does not ensure that all CRPs under this scenario will look like this, it is at least a useful sanity check)

      b. For scenario 2: Run the CRP using a single modality plus a shuffled version. E.g. feed in the EEG into the analysis as both modality 1 AND a temporally shuffled version of the EEG as modality 2. The temporal shuffling of the EEG could be done by simply splitting the data into blocks of say ~10s and then shuffling them into a new order. This should provide a version of the CRP under scenario 2 (although it does not ensure that all CRPs under this scenario will look like this, it is at least a useful sanity check).

      (2) Do simulations, with clearly specified assumptions, for scenarios 1 and 2. One way of doing this is to use a simplified (state-space) setup and randomly simulate N spatially fixed networks that are independently switching on and off over time (i.e. "activation" is 0 or 1). Note that this would result in a N-dimensional connectome state space.

      The authors would only need to worry about simulating the network activation time courses, i.e. they would not need to bother with specifying the spatial configuration of each network, instead, they would make the implied assumption that each of these networks has the same spatial configuration in modality 1 and modality 2.

      With that assumption, the CRP calculation should simply correspond to calculating, at each time i in modality 1 and time j in modality 2, the number of networks that are activating in both modality 1 and modality 2, by using their activation time courses. Using this, one can simulate and compute the CRPs for the two scenarios:

      a. Scenario 1: where the simulated activation timecourses are set to be the same between both modalities

      b. Scenario 2: where the simulated activation timecourses are simulated separately for each of the modalities

      We thank the reviewer for raising this important matter as it directly relates to our study hypothesis. To address this point, we chose to focus on the first of the two alternative suggestions of the reviewer, as it provides evidence based on empirical data. In line with the reviewer’s suggestion 1, recurrence plots have indeed been previously applied to connectome dynamics data from the same modality [Hansen et al., NeuroImage 2015; Fig. 2B]. As shown in the referenced study, where the recurrence plot has been estimated within fMRI connectome dynamics, the on-diagonal entries have noticeably larger correlation values in comparison to off-diagonal entries. As the authors state, this contrast emphasizes the autocorrelation of connectome dynamics in their single modality recurrence plot. Extending these findings to our cross-modal recurrence plots, more synchronicity of connectome dynamics across fMRI and EEG will -by theory- translate into stronger correlation values along the diagonal axis as it represents neighboring timepoints in the data. On the other hand, less cross-modal synchronicity translates to a lack of such correlation prevalence along the diagonal axis.

      Complementing these statements with empirical data, Author response image 1 shows the fMRI-to-iEEG and fMRI-to-fMRI CRPs side by side as suggested by the reviewer. For simplicity, we thresholded each CRP at the top 5% of entries and calculated their corresponding on-/off-diagonal ratios. The on/off-diagonal ratio for fMRI-to-fMRI CRP was 4.32 ± 6.26 across -5 to +5 TR lags (with a maximum of 16.56 at a lag of one TR), while this value was 1.00 ± 0.31 for fMRI-to-iEEG CRP. Thus, it becomes apparent that synchronicity of connectome dynamics directly translates to the on-/off-diagonal ratio in CRP.

      Author response image 1.

      Sample CRP shown for a subject for comparing two cases: fMRI-to-iEEG (left) and fMRI-to-fMRI (right). The comparison shows that in the presence of genuine synchronous connectome dynamics, as expected for the within-molality case (right panel), the on-/off-diagonal ratio is expected to show noticeably higher values. This figure establishes a strong link between our proposed metric of on-/off-diagonal ratio and the extent of synchronicity of connectome dynamics.

      Author response image 2.

      On-/off-diagonal ratio in the fMRI-to-fMRI recurrence plot is considerably higher than the cross-modal fMRI-to-iEEG case. Horizontal axis shows the lag where the metric was calculated in the CRP. The bars reflect the group average metric while the whickers show standard deviation. Note that for the within-modality case, ratio is not defined at lag zero because of identical connectome frames.

      (2) Choices in the analysis pipeline leading up to the computation of FC in fMRI or EEG will affect the quality of information available in the FC. For example, but not only, the choice of parcellation (in the study, the number of parcels is very high given the number of EEG sensors). I think it is important that we see the impact of the chosen pipeline on the time-averaged connectomes, an output that the field has some idea about what is sensible. This would give confidence that the information being used in the main analyses in the paper is based on a sensible footing and relates to what the field is used to thinking about in terms of FC. This should be trivial to compute, as it is just a case of averaging the time-varying FCs being used for the CRP over all time points. Admittedly, this approach is less useful for the intracranial EEG.

      We agree with the reviewer on ensuring that the time-averaged FC aligns with expectations of the field and prior work. For this reason, our supplementary analysis already included an analysis that replicates the well-established (albeit modest) spatial similarity between fMRI static connectome and EEG/iEEG static connectomes:

      “In scalp EEG-fMRI data, cross-modal spatial (2D) Pearson correlation of group-level time-averaged connectomes between fMRI and EEG-FCAmp or fMRI and EEG-FCPhase were calculated across all frequency bands. The average spatial correlation value across frequency bands r = 0.28 and r = 0.28 for EEG-FCAmp and EEG-FCPhase, respectively. The spatial correlation values across all frequency bands and connectivity measures were significantly higher than the corresponding null distributions generated by phase-permuted group-level fMRI-FC spatial organization (p<0.005; 200 repetitions; FDR-corrected at q<0.05 for the number of frequency bands). …. Of note, the small effect sizes are strongly in line with prior literature (Hipp and Siegel, 2015; Wirsich et al., 2017; Betzel et al., 2019) and may point to possible divergence in the dynamic domain as investigated in the main manuscript.”

      This replication directly confirms the validity of our selected atlas for further investigations into the connectome dynamics. We acknowledge that with 64 EEG channels, one can only estimate a relatively coarse connectome. Among the well-known coarse atlases, we chose the Desikan-Killiany atlas as it is based on anatomical features, eliminating possible biases towards a particular functional data modality. Moreover, this atlas has been commonly used for multimodal functional connectivity studies, facilitating the confirmation of prior findings in the time-averaged domain [Deligianni et al. Front. Neurosci 2104, Wirsich et al. NeuroImage, 2020, Wirsich et al., NeuroImage 2021].

      (3) Leakage correction. The paper states: "To mitigate this issue, we provide results from source-localized data both with and without leakage correction (supplementary and main text, respectively)." Given that FC in EEG is dominated by spatial leakage (see Hipp paper), then I cannot see how it can be justified to look at non-spatial leakage correction results at all, let alone put them up front as the main results. All main results/figures for the scalp EEG should be done using spatial leakage-corrected EEG data.

      We agree that relying on leakage-uncorrected scalp EEG alone would be problematic. It is for this reason that the intracranial data constructs the core of our results, emphasizing that the observed multiplex architecture of connectomes is indeed present in the absence of source leakage. Only when this finding is established in the intracranial EEG, do we provide the scalp EEG data as a generalization to whole-cortex coverage connectomes of healthy subjects. Moreover, it is known that existing source-leakage correction algorithms may inadvertently remove some of the genuine zero-lag connectivity. For instance, Finger and colleagues have shown that the similarity of functional connectivity to structural connectivity diminishes after correction for source-leakage (Finger et. al, PLOS Comp. Biol. 2016). Therefore, we have deliberately chosen to include our generalization findings before source-leakage correction (main text) as well as after source-leakage correction reflecting a more stringent approach (supplementary analysis). Importantly, our conclusions hold true for both before and after source-leakage correction.

      Reviewer #2 (Public Review):

      Summary:

      The study investigates the brain's functional connectivity (FC) dynamics across different timescales using simultaneous recordings of intracranial EEG/source-localized EEG and fMRI. The primary research goal was to determine which of three convergence/divergence scenarios is the most likely to occur.

      The results indicate that despite similar FC patterns found in different data modalities, the time points were not aligned, indicating spatial convergence but temporal divergence.

      The researchers also found that FC patterns in different frequencies do not overlap significantly, emphasizing the multi-frequency nature of brain connectivity. Such asynchronous activity across frequency bands supports the idea of multiple connectivity states that operate independently and are organized into a multiplex system.

      Strengths:

      The data supporting the authors' claims are convincing and come from simultaneous recordings of fMRI and iEEG/EEG, which has been recently developed and adapted.

      The analysis methods are solid and involve a novel approach to analyzing the co-occurrence of FC patterns across modalities (cross-modal recurrence plot, CRP) and robust statistics, including replication of the main results using multiple operationalizations of the functional connectome (e.g., amplitude, orthogonalized, and phase-based coupling).

      In addition, the authors provided a detailed interpretation of the results, placing them in the context of recent advances and understanding of the relationships between functional connectivity and cognitive states.

      Weaknesses:

      Despite the impressive work, the paper still lacks some analyses to make it complete.

      Firstly, the effect of the window size is unclear, especially in the case of different frequencies where the number of cycles that fall in a window will vary drastically. A typical oscillation lasts just a few cycles (see Myrov et al., 2024), and brain states are usually short-lived because of meta-stability (see Roberts et al., 2019).

      We now replicate our results with an additional window size. Please see section “Recommendations for the authors”.

      Secondly, the authors didn't examine frequencies lower than 1Hz despite similarities between fMRI and infra-slow oscillations found in prior literature (see Palva et al., 2014; Zhang et al., 2023).

      We address this issue below. Please see section “Recommendations for the authors”.

      On a minor note, the phase-locking value (PLV) is positively biased for EEG data (see Palva et al., 2018) and a different metric for phase coupling could be a more appropriate choice (e.g., iPLV/wPLI, see Vinck et al., 2011).

      While iPLV and wPLI are not positively biased, they may reduce genuine zero-phase connectivity as they were initially designed to address spurious zero-phase connectivity from source leakage in scalp EEG. Indeed, PLV connectivity is shown to be more strongly correlated with structural connectivity than wPLI and other phase coupling methods [Finger et al., PLOS Comp. Biol. 2016], emphasizing that it contains genuine connectivity that may be lacking when zero-phase connectivity is removed. We chose PLV because it is a widely used functional connectivity metric, particularly in intracranial data where source leakage is not a critical concern. Thus, using PLV facilitates cross-study comparisons including to our prior work [e.g. Mostame et al. NeuroImage 2020, Mostame et al. J Neurosci 2021].

      The repository with the code is also unavailable.

      Thank you for bringing this to our attention. We have now made our repository publicly accessible at: https://github.com/connectlab/Mostame2024_Multiplex_iEEG_fMRI.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      The window widths used to compute FC as a function of time are an important aspect, so I feel that this should be briefly described up-front in the main Results text.

      Methods. "Finally, to compensate for the time lag between hemodynamic and neural responses of the brain (Logothetis et al., 2001), we shifted the fMRI-FC time course 6 seconds backwards in time." What about the effects of temporal blurring from the HRF? Do we need to care about that?

      We agree with the importance to investigate the effect if temporal blurring of the HRF. The main text already included a replication of findings from CRPs generated using fMRI data and EEG amplitude signals convolved with the canonical HRF. This method serves as an alternative to the 6-second shifting. Both approaches produced similar results.

      Methods. In fMRI connectome computation it is common to look at partial correlation rather than full correlation. Partial correlation focuses more on direct connections. It would be good if the paper acknowledged and justified why it is OK to use full correlation.

      We have now added a brief explanation in this regard in the main text (Methods section) as follows:

      “In fMRI connectome computation, some prior work has used partial correlation instead of full correlation. Partial correlation emphasizes direct connections by calculating correlation between any pair of bran regions after regressing out the timeseries of all other regions. However, we have opted to use full correlation because this permits interpretation of our outcomes in the context of the vast existing literature that uses full correlations in fMRI including the majority of bimodal (EEG-fMRI) connectome studies (e.g. Tagliazucchi et al., 2012; Deligianni et al., 2014; Wirsich et al., 2017b, 2020, 2021; Allen et al., 2018).”

      The paper should relate the results to findings showing clear links between simultaneously recorded EEG and fMRI beyond FC. E.g. Mantini (PNAS) 2007 and Van De Ville (PNAS) 2010 to name two.

      In line with this important point, we have extended the existing discussion section that compares our outcomes to EEG-fMRI beyond functional connectivity:

      “Prior multi-modal studies of neural dynamics have predominantly aimed at methodologically cross-validating hemodynamic and electrophysiological observations, thus focusing on their convergence. These important foundational studies include e.g., the cross-modal comparison of region-wise (Mukamel et al., 2005; Nir et al., 2007) or ICN-wise (Mantini et al., 2007) activity fluctuations, instantaneous activity maps (Hunyadi et al., 2019; Zhang et al., 2020) or EEG microstates (Van de Ville 2010), infraslow connectome states (Abreu et al., 2020), or connection-wise FC including studies in the iEEG-fMRI and scalp EEG-fMRI data used in the current study (Ridley et al., 2017; and Wirsich et al., 2020, respectively). In contrast to this prior work, the current study investigated the highly time-resolved cross-modal temporal relationship at the level of FC patterns distributed over all available pairwise connections, and found a connectome-level temporal divergence. The discrepancy between temporal divergence in our study and convergence in prior studies implies that infraslow fluctuations of activity in individual regions or of FC in individual region-pairs observable in both modalities (prior studies) are neurally distinct from connectome-wide FC dynamics observable separately in each modality (current study). Indeed, we confirmed the existence of infraslow electrophysiological FC dynamics driving cross-modal temporal associations at the level of individual connections (Fig. S3) …”

      Reviewer #2 (Recommendations For The Authors):

      (1) Check different window sizes and stability of the FC patterns as a function of it.

      We thank the reviewer for the helpful feedback. We agree that the window size could possibly affect the estimation of individual connectome frames, particularly given that neural processes unfold at hundreds of milliseconds rather than seconds. However, we expect that the asynchronous nature of cross-modal convergence observed in our data would remain intact regardless of the specific window length used for FC calculations. To confirm this, we replicated some of our main analyses in the iEEG-fMRI data with a window length of 500ms (as opposed to 3s, equivalent to one TR) as follows:

      First, we showed that changing the window length does not substantially impact the overall architecture of the connectomes (Author response image 3). Particularly, the time-averaged connectome patterns across different frequency bands were all strongly correlated between the two analyses (500ms and 3s window lengths).

      Author response image 3.

      Time-averaged connectome patterns are highly replicable when calculated using 3s or 500ms window lengths. Horizontal axis represents frequency bands, while each dot represents a subject. Vertical axis shows 2D Pearson correlation of the two connectomes. The group average within each frequency band is marked by a horizontal line.

      Second, we replicated our major findings of CRP and its on-/off-diagonal ratio in the iEEG-fMRI dataset using a window length of 500ms for FC calculations. Indeed, the data does not show a substantial difference in the on-/off-diagonal ratios of the CRP entries between the 3s and 500ms window lengths. Specifically, the ratio was equal to 1.02 ± 0.07 for 500ms window length, emphasizing absence of significant temporal convergence of the connectome dynamics (see Author response image 4). A paired t-test between group-averaged ratios across different lags confirms a lack of significant difference between the two analyses (p= 0.50). This finding further emphasizes the genuine asynchronous nature of connectome dynamics across the neural timescales measured in fMRI and electrophysiology. We have added this analysis to the supplementary data.

      Author response image 4.

      On-/off-diagonal ratio is shown across lags for both analyses: 3s window length (blue) and 500ms window length (red). Each bar shows the mean across subjects, while the whiskers show the corresponding standard deviations.

      (2) Try to decrease the lowest frequency of the analysis below 1Hz or just compute it for multiple log-spaced frequencies from infra-slow delta to high-gamma band.

      Thank you for pointing out this matter. We do not expect considerable signal in the frequency range below the current lower bound of delta (1Hz) because as in most other EEG recordings, EEG was not recorded in DC setting and has a hardware high-pass filter of 0.1Hz. Nonetheless, we investigated the power spectral density of our iEEG-fMRI data and found that there is indeed little signal power left in the available infraslow range [0.5 – 1 Hz] after the preprocessing steps (Author response image 5).

      Author response image 5.

      Power spectral density of all subjects in the fMRI-iEEG dataset shows lack of sufficient power in the infraslow range. Infraslow range signals are almost always filtered out during recording unless the recording setup includes a DC amplifier. The infraslow signal of EEG that is often considered correlated with the fMRI signals in the literature most commonly are extracted from the slow-changing envelope of the bandlimited signals, like envelope of gamma oscillations.

      Accordingly, when the iEEG signals are filtered within the range of [0.5, 1], there is little signal variation observed in the signal timeseries, contrasting the adjacent delta band signal (Author response image 6). Importantly, the power envelope of the delta band (and all other canonical bands not shown here) comprise major fluctuations in the infraslow range, as expected. We would like to emphasize that the existing studies addressing infraslow EEG signal dynamics typically consider the infraslow envelope fluctuations of band-limited signals in traditional frequency bands [e.g. Nir et. al, Nat Neurosci 2008] rather than direct recordings in the infraslow frequency range. Investigating HRF-convolved EEG signals similarly captures the infraslow characteristics of the timeseries [e.g. Mantini et al. PNAS 2007, Sadaghiani et al., J Neurosci 2010] (and note that HRF-convolved analyses are included as supplementary investigation in the current study). To the best of our knowledge, very few studies have investigated direct infraslow EEG signals using DC EEG, and we are aware of only two DC-EEG studies with concurrent fMRI [Hiltunen et al., J Neurosci 2014, Grooms et al., Brain Connectivity 2017]. The infraslow correlates of fMRI in electrophysiological signals reported in prior work therefore reflect the slow changes in faster activity or connectivity of traditional frequency bands, which is indeed already included in the current study.

      Author response image 6.

      Sample timeseries of the iEEG signal of the nine subjects (nine rows) for a 400 second interval. Blue signals show the bandlimited delta with its envelope shown as darker blue. The red signal represents the infraslow signal component left in the data, which is much lower in power.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #2 (Public review):

      Summary:

      Yamawaki et al., conducted a series of neuroanatomical tracing and whole cell recording experiments to elucidate and characterise a relatively unknown pathway between the endopiriform (EN) and CA1 of the ventral hippocampus (vCA1) and to assess its functional role in social and object recognition using fibre photometry and dual vector chemogenetics. The main findings were that the EN sends robust projections to the vCA1 that collateralise to the prefrontal cortex, lateral entorhinal cortex and piriform cortex, and these EN projection neurons terminate in the stratum lacunosum-moleculare (SLM) layer of distal vCA1, synapsing onto GABAergic neurons that span across the Pyramidal-Stratum Radiatum (SR) and SR-SML borders. It was also demonstrated that EN input disynaptically inhibits vCA1 pyramidal neurons. vCA1 projecting EN neurons receive afferent input from piriform cortex, and from within EN. Finally, fibre photometry experiments revealed that vCA1 projecting EN neurons are most active when mice explore novel objects or conspecifics, and pathway-specific chemogenetic inhibition led to an impairment in the ability to discriminate between novel vs. familiar objects and conspecifics.

      The authors have addressed most of my concerns, but a few weaknesses remain :<br /> (1) I expected to see the addition of raw interaction times with objects and conspecifics for each phase of social testing (pre-test, sociability test, social discrimination), as per my comment on including raw data. However, the authors only provided total distance traveled and velocity, and total interaction time in Figure S9, which is less informative.

      We apologies for missing the request. We have added the raw interaction times in Fig. S9G.

      (2) The authors observed increased activity in vCA1-projecting EN neurons tracking with the preferred object during the pre-test (object-object exploration) phase of the social tests, and the summary schematic (Figure 9A) depicts animals as showing a preference for one object over the other (although they are identical) in both the social and object recognition tests. However, in the chemogenetic experiment, the data (Fig S9B) indicate that animals did not show this preference for one object over another, making the expected baseline for this task unclear. This also raises an important question of whether the lack of effect from chemogenetic inhibition of vCA1-projecting EN neurons could be attributed to the absence of this baseline preference.

      We appreciate the comments. In Fig. S9B, although the group median at baseline (pretest) showed no preference for one object, individual subjects displayed a preference for one object (i.e., each data point deviated positively or negatively from 0.5) in saline condition. Therefore, we do not think that a lack of baseline preference accounts for the absence of the inhibition effect in the pretest.

      Additionally, the finding that vCA1-projecting EN activity is associated with the preferred object exploration appears to counter the authors' argument that novelty engages this circuit (since both objects are novel in this instance). This discrepancy warrants further discussion.

      This is an interesting point. One possibility is that during the pretest, EN activity simply "reports" or "represents" the interaction time without driving exploratory preference. This aligns with our DREADD experiment data, which show that inhibition of EN neurons produced no overall behavioral effect. Innate exploratory behavior has been attributed to various circuits, including the medial preoptic area → PAG circuit (Ryoo et al., 2021, Front. Neuro.) and the Septal → VTA circuit (Mocellin et al., 2024, Neuron). We found no direct projection from these areas to EN (Fig. 6), but such connections could be established di- or polysynaptically. Moreover, these circuits could be driven by common inputs, such as the locus coeruleus or the cholinergic system for arousal, with only specific downstream targets, excluding EN, playing a key role in driving innate exploration and preference.

      We have inserted the following sentence in discussion (line 253-255):

      “The correlation of ENvCA1-proj. activity with novel object preference in the pretest nevertheless suggests that these neurons 'represent' the innate preference without driving it.”

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      Line 209: Please remove the reference to neural activity 'predicting' behavior, as correlation analysis does not imply predictive power.

      We now have changed the phrase to “Although EN<sup>vCA1-proj.</sup> activity was correlated with the behavior…”

      Line 236: It is unclear what is meant by: 'This circuit motif may predict the predominant role of ENvCA1-proj. neurons in social recognition memory'

      We have changed the sentence to the following for the clarity:

      “Since social odor information is crucial for discriminating conspecifics in rodents, this circuit motif may predict the predominant role of ENvCA1-proj. neurons in social recognition memory, given that social odor can engage multiple olfactory pathways innervating the piriform cortex.”

      Fig 7 title: insert 'with' after correlates: 'Activity of ENvCA1-proj. neurons correlates social/object discrimination performance'

      Corrected.

      Fig S1 title: 'Projecing' typo.

      Corrected.

      Fig S8: Please rephrase for clarity: 'In pretest, the object was aligned by longer interaction time (preferred object is plotted in right side)'

      We now have rephrased the sentence to:

      “In the pretest plot, the object that the mice interacted with more is placed on the right side.”

      References:

      A septal-ventral tegmental area circuit drives exploratory behavior. Mocellin, Petra et al. Neuron, Volume 112, Issue 6, 1020-1032.e7

      An inhibitory medial preoptic circuit mediates innate exploration. Ryoo, Jia et al. Front. Neurosci., 23 August 221. Volume 15- 2021

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary: 

      Liu and colleagues applied the hidden Markov model on fMRI to show three brain states underlying speech comprehension. Many interesting findings were presented: brain state dynamics were related to various speech and semantic properties, timely expression of brain states (rather than their occurrence probabilities) was correlated with better comprehension, and the estimated brain states were specific to speech comprehension but not at rest or when listening to non-comprehensible speech. 

      Strengths: 

      Recently, the HMM has been applied to many fMRI studies, including movie watching and rest. The authors cleverly used the HMM to test the external/linguistic/internal processing theory that was suggested in comprehension literature. I appreciated the way the authors theoretically grounded their hypotheses and reviewed relevant papers that used the HMM on other naturalistic datasets. The manuscript was well written, the analyses were sound, and the results had clear implications. 

      Weaknesses: 

      Further details are needed for the experimental procedure, adjustments needed for statistics/analyses, and the interpretation/rationale is needed for the results. 

      For the Experimental Procedure, we will provide a more detailed description about stimuli, and the comprehension test, and upload the audio files and corresponding transcriptions as the supplementary dataset. 

      For statistics/analyses, we have reproduced the states' spatial maps using unnormalized activity pattern. For the resting state, we observed a state resembling the baseline state described in Song, Shim, & Rosenberg (2023). However, for the speech comprehension task, all three states were characterized by network activities varying largely from zero. In addition, we have re-generated the null distribution for behaviorbrain state correlations using circular shift. The results are largely consistent with the previous findings. We have also made some other adjustment to the analyses or add some new analyses as recommended by the reviewer. We will revise the manuscript to incorporate these changes.

      For the interpretation/rationale: We will add a more detailed interpretation for the association between state occurrence and semantic coherence. Briefly speaking, higher semantic coherence may allow for the brain to better accumulate information over time.

      State #2 seems to be involved in the integration of information at shorter timescales (hundreds of milliseconds) while State #3 seems to be involved in the longer timescales (seconds). 

      We greatly appreciate the reviewer for the insightful comments and constructive suggestions.  

      Reviewer #2 (Public review): 

      Liu et al. applied hidden Markov models (HMM) to fMRI data from 64 participants listening to audio stories. The authors identified three brain states, characterized by specific patterns of activity and connectivity, that the brain transitions between during story listening. Drawing on a theoretical framework proposed by Berwick et al. (TICS 2023), the authors interpret these states as corresponding to external sensory-motor processing (State 1), lexical processing (State 2), and internal mental representations (State 3). States 1 and 3 were more likely to transition to State 2 than between one another, suggesting that State 2 acts as a transition hub between states. Participants whose brain state trajectories closely matched those of an individual with high comprehension scores tended to have higher comprehension scores themselves, suggesting that optimal transitions between brain states facilitated narrative comprehension. 

      Overall, the conclusions of the paper are well-supported by the data. Several recent studies (e.g., Song, Shim, and Rosenberg, eLife, 2023) have found that the brain transitions between a small number of states; however, the functional role of these states remains under-explored. An important contribution of this paper is that it relates the expression of brain states to specific features of the stimulus in a manner that is consistent with theoretical predictions. 

      (1) It is worth noting, however, that the correlation between narrative features and brain state expression (as shown in Figure 3) is relatively low (~0.03). Additionally, it was unclear if the temporal correlation of the brain state expression was considered when generating the null distribution. It would be helpful to clarify whether the brain state expression time courses were circularly shifted when generating the null. 

      In the revision, we generated the null distribution by circularly shifting the state time courses. The results remain consistent with our previous findings: p = 0.002 for the speech envelope, p = 0.007 for word-level coherence, and p = 0.001 for clause-level coherence.

      We note that in other studies which examined the relationship between brain activity and word embedding features, the group-mean correlation values are similarly low but statistically significant and theoretically meaningful (e.g., Fernandino et al., 2022; Oota et al., 2022). We think these relatively low correlations are primarily due to the high level of noise inherent in neural data. Brain activity fluctuations are shaped by a variety of factors, including task-related cognitive processing, internal thoughts, physiological states, as well as arousal and vigilance. Additionally, the narrative features we measured may account for only a small portion of the cognitive processes occurring during the task. As a result, the variance in narrative features can only explain a limited portion of the overall variance in brain activity fluctuations.

      We will replace Figure 3 and the related supplementary figures with new ones, in which the null distribution is generated via circular shift. Furthermore, we will expand our discussion to address why the observed brain-stimuli correlations are relatively small, despite their statistical significance.

      (2) A strength of the paper is that the authors repeated the HMM analyses across different tasks (Figure 5) and an independent dataset (Figure S3) and found that the data was consistently best fit by 3 brain states. However, it was not entirely clear to me how well the 3 states identified in these other analyses matched the brain states reported in the main analyses. In particular, the confusion matrices shown in Figure 5 and Figure S3 suggests that that states were confusable across studies (State 2 vs. State 3 in Fig. 5A and S3A, State 1 vs. State 2 in Figure 5B). I don't think this takes away from the main results, but it does call into question the generalizability of the brain states across tasks and populations. 

      We identified matching states across analyses based on similarity in the activity patterns of the nine networks. For each candidate state identified in other analyses, we calculate the correlation between its network activity pattern and the three predefined states from the main analysis, and set the one it most closely resembled to be its matching state. For instance, if a candidate state showed the highest correlation with State #1, it was labelled State #1 accordingly. 

      Each column in the confusion matrix depicts the similarity of each candidate state with the three predefined states. In Figure S3 (analysis for the replication dataset), the highest similarity occurred along the diagonal of the confusion matrix. This means that each of the three candidate states was best matched to State #1, State #2, and State #3, respectively, maintaining a one-to-one correspondence between the states from two analyses.

      For the comparison of speech comprehension task with the resting and the incomprehensible speech condition, there was some degree of overlap or "confusion."

      In Figure 5A, there were two candidate states showing the highest similarity to State #2. In this case, we labelled the candidate state with the strongest similarity as State #2, while the other candidate state is assigned as State #3 based on the ranking of similarity. This strategy was also applied to naming of states for the incomprehensible condition. The observed confusion supports the idea that the tripartite-state space is not an intrinsic, task-free property. To make the labeling clearer in the presentation of results, we will use a prime symbol (e.g., State #3') to indicate cases where such confusion occurred, helping to distinguish these ambiguous matches.

      (3) The three states identified in the manuscript correspond rather well to areas with short, medium, and long temporal timescales (see Hasson, Chen & Honey, TiCs, 2015).

      Given the relationship with behavior, where State 1 responds to acoustic properties, State 2 responds to word-level properties, and State 3 responds to clause-level properties, the authors may want to consider a "single-process" account where the states differ in terms of the temporal window for which one needs to integrate information over, rather than a multi-process account where the states correspond to distinct processes. 

      The temporal window hypothesis provides a more fitting explanation for our results. Based on the spatial maps and their modulation by speech features, States #1, #2, and #3 seem to correspond to short, medium, and long processing timescales, respectively. We will update the discussion to reflect this interpretation.

      We sincerely appreciate the constructive suggestions from the two anonymous reviewers, which have been highly valuable in improving the quality of the manuscript.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      (1) The "Participants and experimental procedure" section deserves more details. I've checked Liu et al. (2020), and the dataset contained 43 participants aged 20-75 years, whereas this study contained data from 64 young adults and 30 old adult samples. The previous dataset seems to have two stories, whereas this study seems to have three. Please be specific, given that the dataset does not seem the same. Could the authors also include more descriptions of what the auditory stories were? For example, what were the contents, and how were they recorded? 

      The citation is partially incorrect. The dataset of young adults is shared with our work published in (2022). The 64 participants listened to one of three stories told by a female college student in Mandarin, recounting her real-life experience of hiking, a graduate admission interview, and her first time taking a flight, respectively. The sample of older adults is from our work published in (2020), which includes 30 older adults and additionally 13 young adults. The stimuli in this case were two stories told by an older woman in a Chinese dialect, describing her experience in Thailand and riding a warship, respectively. Since we aim to explore whether the main results can be replicated on a different age group, we excluded the 13 young adults from the analysis. 

      All the stories were recorded during fMRI scanning using a noise-canceling microphone (FOMRI-III; Optoacoustics Ltd, Or-Yehuda, Israel) positioned above the speaker’s mouth. The audio recordings were subsequently processed offline with Adobe Audition 3.0 (Adobe Systems Inc., USA) to further eliminate MRI scanner noise.

      In the revised manuscript, we have updated the citation, and provided a more detailed description of the stimuli in the supplementary material. We have also uploaded the audio files along with their corresponding transcriptions to GitHub.

      (2) I am curious about individual differences in comprehension scores. Did participants have less comprehension of the audio-narrated story because the story was a hard-tocomprehend narrative or because the audio quality was low? Could the authors share examples of comprehension tests? 

      We believe two factors contribute to the individual differences in comprehension scores. First, the audio quality is indeed moderately lower than in dailylife story-listening conditions. This is because those stories were recorded and played during fMRI scanning. Although a noise-canceling equipment was used, there were still some noises accompanying the speech, which may have made speech perception and comprehension more difficult than usual.

      Second, the comprehension test measured how much information about the story (including both main themes and details) participants could recall. Specifically, participants were asked to retell the stories in detail immediately after the scanning session. Following this free recall, the experimenters posed a few additional questions drawn from a pre-prepared list, targeting information not mentioned in their recall. If participants experienced lapses of attention or did not store the incoming information into memory promptly, they might fail to recall the relevant content. In several studies, such a task has been called a narrative recall test. However, memory plays a crucial role in real-time speech comprehension, while comprehension affects the depth of processing during memory encoding, thereby influencing subsequent recall performance. To align with prior work (e.g., Stephens et al., 2010) and our previous publications, we chose to referred to this task as narrative comprehension. 

      In the revised manuscript, we have provided a detailed description about the comprehension test (Line 907-933) and share the examples on GitHub. 

      (3) Regarding Figure 3, what does it mean for a state occurrence to follow semantic coherence? Is there a theoretical reason why semantic coherence was measured and related to brain state dynamics? A related empirical question is: is it more likely for the brain states to transition from one state to another when nearby time points share low semantic similarity compared to chance? 

      We analyzed semantic coherence and sound envelope as they capture different layers of linguistic and acoustic structure that unfold over varying temporal scales. Changes in the sound envelope typically occur on the order of milliseconds to a few hundred milliseconds, changes in word-level semantic coherence span approximately 0.24 ± 0.15 seconds, and changes in clause-level semantic coherence extend to 3.2 ± 1.7 seconds. Previous theory and empirical studies suggest that the timescales of information accumulation vary hierarchically, progressing from early sensory areas to higher-order areas (Hasson et al., 2015; Lerner et al., 2011). Based on this work, we anticipate that the three brain states, which are respectively associated with the auditory and sensory motor network, the language network and the DMN, would be selectively modulated by these speech properties corresponding to distinct timescales. 

      Accordingly, when a state occurrence aligns with (clause-level) semantic coherence, it suggests that this state is engaged in processing information accumulated at the clause level (i.e., its semantic relationship). Higher coherence facilitates better accumulation, making it more likely for the associated brain state to be activated. 

      We analyzed the relationship between state transition probability and semantic coherence, but did not find significant results. Here, the transition probability was calculated as Gamma(t) – Gamma(t-1), where Gamma refers to the state occurrence probability. The lack of significant findings may be because brain state transitions are driven primarily by more slowly changing factors. Indeed, we found the average dwell time of the three states ranges from 9.66 to 15.29s, which is a much slower temporal dynamics compared to the relatively rapid shifts in acoustic/semantic properties. 

      In the revised version, we have updated the Introduction to clarify the rational for selecting the three speech properties and to explore their relationship with brain dynamics (Line 111-118)

      (4) When running the HMM, the authors iterated K of 2 to 10 and K = 4, 10, and 12. However, the input features of the model consist of only 9 functional networks. Given that the HMM is designed to find low-dimensional latent state sequences, the choice of the number of latent states being higher than the number of input features sounds odd to me - to my speculation, it is bound to generate almost the exact same states as 9 networks and/or duplicates of the same state. I suggest limiting the K iterations from 2 to 8. For replication with Yeo et al.'s 7 networks, K iteration should also be limited to K of less than 7, or optionally, Yeo's 7 network scheme could be replaced with a 17network scheme. 

      We understand your concern. However, the determination of the number (K) of hidden states is not directly related to the number of features (in this case, the number of networks), but rather depends on the complexity of the time series and the number of underlying patterns. Given that each state corresponds to a distinct combination of the features, even a small number of features can be used to model a system with complex temporal behaviors and multiple states. For instance, for a system with n features, assuming each is a binary variable (0 or 1), there are maximally 2<sup>n</sup> possible underlying states. 

      In our study, we recorded brain activity over 300 time points and used the 9 networks as features. At different time points, the brain can exhibit distinct spatial configurations, reflected in the relative activity levels of the nine networks and their interactions. To accurately capture the temporal dynamics of brain activity, it is essential to explore models that allow for more states than the number of features. We note that in other HMM studies, researchers have also explored states more than the number of networks to find the best number of hidden states (e.g., Ahrends et al., 2022; Stevner et al., 2019). 

      Furthermore, Ahrends et al. (2022) suggested that “Based on the HCP-dataset, we estimate as a rule of thumb that the ratio of observations to free parameters per state should not be inferior to 200”, where free parameters per state is [𝐾 ∗(𝐾 −1)+ (𝐾 −1)+𝐾 ∗𝑁 ∗(𝑁 +1)/2]/𝐾. According to this, there should be above 10, 980 observations when the number of states (K) is 10 (the maximal number in our study) and the number of networks (N) is 9. In our group-level HMM model, there were 64 (valid runs) * 300 (TR) = 19200 observations for young adults, and 50 (valid runs) * 210 (TR) = 10500 observations for older adults. Aside from the older adults' data being slightly insufficient (4.37% less than the suggestion), all other hyperparameter combinations in this study meet the recommended number of observations. 

      (5) In Figure 2, the authors write that the states' spatial maps were normalized for visualization purposes. Could the authors also show visualization of brain states that are not normalized? The reason why I ask is, for example, in Song, Shim, & Rosenberg (2023), the base state was observed which had activity levels all close to the mean (which is 0 because the BOLD activity was normalized). If the activity patterns of this brain state were to be normalized after state estimation, the base state would have looked drastically different than what is reported. 

      We derived the spatial maps of the states using unnormalized activity patterns, with the BOLD signals Z-score normalized to a mean of zero. Under the speech comprehension task, the three states exhibited relatively large fluctuations in network activity levels. The activity ranges were as follows: [-0.71 to 0.51] for State #1, [-0.26 to 0.30] for State #2, and [-0.82 to 0.40] for State #3. For the resting state, we observed a state resembling the baseline state as described in Song, Shim, & Rosenberg (2023), with activity values ranging from -0.133 to 0.09. 

      In the revision, we have replaced the states' spatial maps with versions showing unnormalized activity patterns. 

      (6) In line 297, the authors speculate that "This may be because there is too much heterogeneity among the older adults". To support this speculation, the authors can calculate the overall ISC of brain state dynamics among older adults and compare it to the ISC estimated from younger adults.  

      We analyzed the overall ISC of brain state dynamics, and found the ISC was indeed significantly lower among the older adults than that among the younger adults. We have revised this statement as follows:

      These factors can diminish the inter-subject correlation of brain state dynamics— indeed, ISCs among older adults were significantly lower than those among younger adults (Figure S5)—and reduce ISC's sensitivity to individual differences in task performance (Line 321-326).

      Other comments: 

      (7) In Figure 4, the authors showed a significant positive correlation between head movement ISC with the best performer and comprehension scores. Does the average head movement of all individuals negatively correlate with comprehension scores, given that the authors argue that "greater task engagement is accompanied by decreased movement"? 

      We examined the relationship between participants' average head movement across the comprehension task and their comprehension scores. There was no significant correlation (r = 0.041, p = 0.74). In the literature (e.g. ,Ballenghein et al., 2019) , the relationship between task engagement and head movement was also assessed at the moment-by-moment level, rather than by using time-averaged data.

      Real-time head movements reflect fluctuations in task engagement and cognitive state. In contrast, mean head movement, as a static measure, fails to capture these changes, and thus is not effective in predicting task performance.

      (8) The authors write the older adults sample, the "independent dataset". Technically, however, this dataset cannot be independent because they were collected at the same time by the same research group. I would advise replacing the word independent to something like second dataset or replication dataset. 

      We have replaced the phrase “independent dataset” with “replication dataset”. 

      (9) Pertaining to a paragraph starting in line 586: For non-parametric permutation tests, the authors note that the time courses of brain state expression were "randomly shuffled". How was this random shuffling done: was this circular-shifted randomly, or were the values within the time course literally shuffled? The latter approach, literal shuffling of the values, does not make a fair null distribution because it does not retain temporal regularities (autocorrelation) that are intrinsic to the fMRI signals. Thus, I suggest replacing all non-parametric permutation tests with random circular shifting of the time series (np. roll in python).  

      In the original manuscript, the time course was literally shuffled. In the revised version, we circular-shifted the time course randomly (circshift.m in Matlab) to generate the null distribution. The results remain consistent with our previous findings: p = 0.002 for the speech envelope, p = 0.007 for word-level coherence, and p = 0.001 for clause-level coherence (Line 230-235). 

      (10) The p value calculation should be p = (1+#(chance>=observed))/(1+#iterations) for one-tailed test and p = (1+#(abs(chance)>=abs(observed)))/(1+#iterations) for twotailed test. Thus, if 5,000 iterations were run and none of the chances were higher than the actual observation, the p-value is p = 1/5001, which is the minimal value it can achieve. 

      Have corrected. 

      (11) State 3 in Figure S2 does not resemble State 3 of the main result. Could the authors explain why they corresponded State 3 of the Yeo-7 scheme to State 3 of the nineparcellation scheme, perhaps using evidence of spatial overlap? 

      The correspondence of states between the two schemes was established using evidence of state expression time course. 

      To assess temporal overlap, we calculated Pearson’s correlation between each candidate state obtained by the Yeo-7 scheme and the three predefined states obtained by the nine-network parcellation scheme in terms of state expression probabilities. The time courses of the 64 participants were concatenated, resulting in 19200 (300*64) time points for each state. The one that the candidate state most closely resembled was set to be its corresponding state. For instance, if a candidate state showed the highest correlation with State #1, it was labelled State #1 accordingly. As demonstrated in the confusion matrix, each of the three candidate states was best matched to State #1, State #2, and State #3, respectively, maintaining a one-to-one correspondence between the states from the two schemes.

      We also assessed the spatial overlap between the two schemes. First, a state activity value was assigned to each voxel across the whole brain (including a total of 34,892 voxels covered by both parcellation schemes). This is done for each brain state. Next, we calculated Spearman’s correlation between each candidate state obtained by the Yeo-7 scheme and the three predefined states obtained by the nine-network scheme in terms of whole-brain activities. The pattern of spatial overlap is consistent with the pattern of temporal overlap, such that each of the three candidate states was best matched to State #1, State #2, and State #3, respectively.

      Author response image 1.

      We noted that the networks between the two schemes are not well aligned in their spatial location, especially for the DMN (as shown below). This may lead to the low spatial overlap of State #3, which is dominated by DMN activity. Consequently, establishing state correspondence based on temporal information is more appropriate in this context. We therefore only reported the results of temporal overlap in the manuscript. 

      We have added a paragraph in the main text for “Establishing state correspondence between analyses” (Line 672-699). We have also updated the associated figures (Fig.S2, Fig.S3 and Fig.5)

      Author response image 2.

      (12) Line 839: gamma parameter, on a step size of? 

      (16) Figure 3. Please add a legend in the "Sound envelope" graph what green and blue lines indicate. The authors write Coh(t) and Coh(t, t+1) at the top and Coh(t) and Coh(t+1) at the bottom. Please be consistent with the labeling. Shouldn't they be Coh(t-1, t) and Coh(t, t+1) to be exact for both? 

      Have corrected. 

      (17) In line 226, is this one-sample t-test compared to zero? If so, please write it inside the parentheses. In line 227, the authors write "slightly weaker"; however, since this is not statistically warranted, I suggest removing the word "slightly weaker" and just noting significance in both States 1 and 2.  

      Have corrected.

      (18) In line 288, please fix "we also whether". 

      Have corrected. 

      (19) In Figure 2C, what do pink lines in the transition matrix indicate? Are they colored just to show authors' interests, or do they indicate statistical significance? Please write it in the figure legend.   

      Yes, the pink lines indicate a meaningful trend, showing that the between-state transition probabilities are significantly higher than those in permutation.

      We have added this information to the figure legend. 

      Reviewer #2 (Recommendations for the authors):

      (1) It is unclear how the correspondence between states across different conditions and datasets was computed. Given the spatial autocorrelation of brain maps, I recommend reporting the Dice coefficient along with a spin-test permutation to test for statistical significance.  

      The state correspondence between different conditions and between the two datasets are established using evidence of spatial overlap. The spatial overlap between states was quantified by Pearson’s correlation using the activity values (derived from HMM) of the nine networks. For each candidate state identified in other analyses (for the Rest, MG and older-adult datasets), we calculate the correlation between its network activity pattern and the three predefined states from the main analysis (for the young-adults dataset), and set the one it most closely resembled to be its matching state. For instance, if a candidate state showed the highest correlation with State #1, it was labelled State #1 accordingly. 

      For the comparison between the young and older adults’ datasets (as shown below), the largest spatial overlap occurred along the diagonal of the confusion matrix, with high correlation values. This means that each of the three candidate states was best matched to State #1, State #2, and State #3, respectively, maintaining a one-to-one correspondence between the states from the two datasets. As the HMM is modelled at the level of networks which lack accurate coordinates, we did not apply the spin-test to assess the statistical significance of overlap. Instead, we extracted the state activity patterns from the 1000 permutations (wherein the original BOLD time courses were circularly shifted and an HMM was conducted) for the older-adults dataset. Applying the similar state-correspondence strategy, we generated a null distribution of spatial overlap. The real overlap of the three states was greater than and 97.97%, 95.34% and 92.39% instances from the permutation (as shown below). 

      Author response image 3.

      For the comparison of main task with the resting and the incomprehensible speech condition, there was some degree of confusion: there were two candidate states showing the highest similarity to State #2. In this case, we labeled the most similar candidate as State #2. The other candidate was then assigned to the predefined state with which it had the second-highest correlation. We used a prime symbol (e.g., State #3') to denote cases where such confusion occurred. These findings support our conclusion that the tripartite-organization of brain states is not a task-free, intrinsic property.

      When establishing the correspondence between the Yeo-7 network and the ninenetwork parcellation schemes, we primarily relied on evidence from temporal overlap measures, as a clear network-level alignment between the two parcellation schemes is lacking. Temporal overlap was quantified by calculating the correlation of state occurrence probabilities between the two schemes. To achieve this, we concatenated the time courses of 64 participants, resulting in a time series consisting of 19,200 time points (300 time points per participant) for each state. Each of the three candidate states from the Yeo-7 network scheme was best matched to State #1, State #2, and State #3 from the main analyses, respectively. To determine the statistical significance of the temporal overlap, we circular shifted each participant’s time course of state expression obtained from the Yeo-7network scheme for 1000 times. Applying the same strategy to find the matching states, we generated a null distribution of overlap. The real overlap was much higher than the instances from permutation. 

      Author response image 4.

      In the revision, we have provided detailed description for how the state correspondence is established and reported the statistical significance of those correspondence (Line 671-699). The associated figures have also been updated (Fig.5, Fig. S2 and Fig.S3).  

      (2) Please clarify if circle-shifting was applied to the state expression time course when generating the null distribution for behavior-brain state correlations reported in Figure (3). This seems important to control for the temporal autocorrelation in the time courses.  

      We have updated the results by using circle-shifting to generated the null distribution. The results are largely consistent with the previous on without circular shifting (Line 230-242). 

      (3) Figure 3: What does the green shaded area around the sound envelope represent? In the caption, specify whether the red line in the null distributions indicates the mean or median R between brain state expression and narrative features. It would also be beneficial to report this value in the main text. 

      The green shaded area indicated the original amplitude of speech signal, while blue line indicates the smoothed, low-frequency contour of amplitude changes over time (i.e., speech envelope). We have updated the figure and explained this in the figure caption. 

      The red line in the null distributions indicates the R between brain state expression and narrative features for the real data. and reported the mean R of the permutation in the main text. 

      (4) The manuscript is missing a data availability statement (https://elifesciences.org/inside-elife/51839f0a/for-authors-updates-to-elife-s-datasharing-policies). 

      We have added a statement of data availability in the revision, as follows: 

      “The raw and processed fMRI data are available on OpenNeuro: https://openneuro.org/datasets/ds005623. The experimental stimuli, behavioral data and main scripts used in the analyses are provided on Github. ”

      (5) There is a typo in line 102 ("perceptual alalyses"). 

      Have corrected. 

      We sincerely thank the two reviewers for their constructive feedback, thorough review, and the time they dedicated to improving our work.

      Reference: 

      Ahrends, C., Stevner, A., Pervaiz, U., Kringelbach, M. L., Vuust, P., Woolrich, M. W., & Vidaurre, D. (2022). Data and model considerations for estimating timevarying functional connectivity in fMRI. Neuroimage, 252, 119026. 

      Ballenghein, U., Megalakaki, O., & Baccino, T. (2019). Cognitive engagement in emotional text reading: concurrent recordings of eye movements and head motion. Cognition and Emotion. 

      Fernandino, L., Tong, J.-Q., Conant, L. L., Humphries, C. J., & Binder, J. R. (2022). Decoding the information structure underlying the neural representation of concepts. Proceedings of the national academy of sciences, 119(6), e2108091119. https://doi.org/10.1073/pnas.2108091119  

      Hasson, U., Chen, J., & Honey, C. J. (2015). Hierarchical process memory: memory as an integral component of information processing. Trends in Cognitive Sciences, 19(6), 304-313. 

      Lerner, Y., Honey, C. J., Silbert, L. J., & Hasson, U. (2011). Topographic mapping of a hierarchy of temporal receptive windows using a narrated story [Article]. Journal of Neuroscience, 31(8), 2906-2915. https://doi.org/10.1523/JNEUROSCI.3684-10.2011  

      Liu, L., Li, H., Ren, Z., Zhou, Q., Zhang, Y., Lu, C., Qiu, J., Chen, H., & Ding, G. (2022). The “two-brain” approach reveals the active role of task-deactivated default mode network in speech comprehension. Cerebral Cortex, 32(21), 4869-4884. 

      Liu, L., Zhang, Y., Zhou, Q., Garrett, D. D., Lu, C., Chen, A., Qiu, J., & Ding, G. (2020). Auditory–Articulatory Neural Alignment between Listener and Speaker during Verbal Communication. Cerebral Cortex, 30(3), 942-951. https://doi.org/10.1093/cercor/bhz138

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      The authors in this paper investigate the nature of the activity in the rodent EPN during a simple freely moving cue-reward association task. Given that primate literature suggests movement coding whereas other primate and rodent studies suggest mainly reward outcome coding in the EPNs, it is important to try to tease apart the two views. Through careful analysis of behavior kinematics, position, and neural activity in the EPNs, the authors reveal an interesting and complex relationship between the EPN and mouse behavior.

      Strengths:

      (1) The authors use a novel freely moving task to study EPN activity, which displays rich movement trajectories and kinematics. Given that previous studies have mostly looked at reward coding during head-fixed behavior, this study adds a valuable dataset to the literature. (2) The neural analysis is rich and thorough. Both single neuron level and population level (i.e. PCA) analysis are employed to reveal what EPN encodes.

      Thank you very much for this appreciation.

      Weaknesses:

      (1) One major weakness in this paper is the way the authors define the EPN neurons. Without a clear method of delineating EPN vs other surrounding regions, it is not convincing enough to call these neurons EPNs solely from looking at the electrode cannula track from Figure 2B. Indeed, EPN is a very small nucleus and previous studies like Stephenson-Jones et al (2016) have used opto-tagging of Vglut2 neurons to precisely label EPN single neurons. Wallace et al (2017) have also shown the existence of SOM and PV-positive neurons in the EPN. By not using transgenic lines and cell-type specific approaches to label these EPN neurons, the authors miss the opportunity to claim that the neurons recorded in this study do indeed come from EPN. The authors should at least consider showing an analysis of neurons slightly above or below EPN and show that these neurons display different waveforms or firing patterns.

      We thank the reviewer for their comment, and we thank the opportunity to expand on the inclusion criteria of studied units after providing an explanation. 

      As part of another study, we performed experiments recording in EPN with optrodes and photoidentification in PV-Cre animals. We found optoidentified units in both: animals with correct placement (within the EPN) and on those with off-target placement (within the thalamus or medial to the EPN). Thus, despite the use of Cre animals, we relied on histology to ensure correct EPN recording. We believe that the optotagging based purely on neural makers such as PV, SOM, VGLUT, VGAT would not provide a better anatomical delineation of the EPN since adjacent structures are rich in those same markers. The thalamic reticular nucleus is just dorsal to the EPN and it has been shown to express both SOM and PV (Martinez-Garcia et al., 2020). 

      On the other hand, the lateral hypothalamus (just medial to the EPN) also expresses vGlut2 and SOM. Stephenson-Jones (2016), Extended Data Figure 1, panel g, shows vGluT2 and somatostatin labeling of neurons, with important expression of neurons dorsal, ventral and medial to the EPN. Thus, we believe that viral strategies relying on single neuronal markers still depend on careful histological analysis of recording sites.

      A combination of neural markers or more complex viral strategies might be more suitable to delineate the EPN. As an example, for anatomical tracing Stephenson-Jones et al. 2016 performed a rabies-virus based approach involving retrogradely transported virus making use of projection sites through two injections. Two step viral approaches were also performed in Wallace, M. et al. 2017. We attempted to perform a two-step viral approach, using an anterogradely transported Cre-expressing virus (AAV1.hSyn.Cre.WPRE.hGH) injected into the striatum and a second Cre dependent ChR2 into the EPN. However, our preliminary experiments showed that this double viral approach had a stark effect decreasing the performance of animals during the task (we attempted re-training 2-3 weeks after viral infections and animals failed to turn to the contralateral side of the injections). We believe that this approach might have had a toxic effect (Zingg et al., 2017). 

      To this point, a recent paper (Lazaridis et al., 2019) repeated an optogenetic experiment performed in the Stephenson-Jones et al. study, using a set of different viral approaches and concluded that increasing the activity of GPi-LHb is not aversive, as it had been previously reported. Thus, future studies attempting to increase anatomical specificity are a must, but they will require using viral approaches amenable to the behavioral paradigm.

      We attempted to find properties regarding waveforms, firing rate, and firing patterns from units above or below, however, we did not find a marker that could generate a clear demarcation. We show here a figure that includes the included units in this study as well as excluded ones to show that there is a clear overlap.

      Author response image 1.

      Finally, we completely agree with the reviewer in that there is still room for improvement. We have further expanded the Methods section to explain better our efforts to include units recorded within the EPN. Further, we have added a paragraph within the Discussion section to point out this limitation (lines 871-876).

      Methods (lines 116-131):

      “Recordings. Movable microwire bundles (16 microwires, 32 micrometers in diameter, held inside a cannula, Innovative Neurophysiology, Durham, NC)] were stereotaxtically implanted just above the entopeduncular nucleus (-0.8 AP, 1.7 ML, 3.9 DV). Post surgical care included antibiotic, analgesic and antiinflammatory pharmacological treatment. After 5 days of recovery, animals were retrained for 1-2 weeks. Unitary activity was recorded for 2-6 days at each dorsoventral electrode position and the session with the best electrophysiological (signal to noise ratio (>2), stability across time) and behavioral [performance, number of trials (>220)] quality was selected. Microwire electrodes were advanced in 50 micrometer dorsoventral steps for 500 micrometers in total. After experiment completion, animals were perfused with a 4% paraformaldehyde solution. Brains were extracted, dehydrated with a 30% sucrose solution and sectioned in a cryostat into 30micron thick slices. Slices were mounted and photographed using a light microscope. Microwire tracks of the 16-microwire bundle were analyzed (Fig. 2A-B) and only animals with tracks traversing the EPN were selected (6 out of 10). Finally, we located the final position of microwire tips and inferred the dorsoventral recording position of each of the recording sessions. Only units recorded within the EPN were included.” 

      Discussion (lines 871-876):

      “A weakness of the current study is the lack of characterization of neuronal subtypes. An area of opportunity for future research could be to perform photo-identification of neuronal subtypes within the EPN which could contribute to the overall description of the information representation. Further, detailed anatomical viral vector strategies could aid to improve anatomical localization of recordings, reduce reliance on histological examination, and solve some current controversies (Lazaridis et al., 2019).” 

      (2) The authors fail to replicate the main finding about EPN neurons which is that they encode outcome in a negative manner. Both Stephenson-Jones et al (2016) and Hong and Hikosaka (2008) show a reward response during the outcome period where firing goes down during reward and up during neutral or aversive outcome. However, Figure 2 G top panel shows that the mean population is higher during correct trials and lower during incorrect trials. This could be interesting given that the authors might try recording from another part of EPN that has not been studied before. However, without convincing evidence that the neurons recorded are from EPN in the first place (point 1), it is hard to interpret these results and reconcile them with previous studies.

      We really thank the reviewer for pointing out that we need to better explain how EPN units encode outcome. We now provide an additional panel in Figure 4, its corresponding text in the results section (lines 544-562) and a new paragraph in the discussion related to this comment.

      We believe that we do indeed recapitulate findings of both of Stephenson-Jones et al (2016) and Hong and Hikosaka (2008). Both studies focus on a specific subpopulation of GPi/EPN neurons that project to the lateral habenula (LHb). Stephenson-Jones et al (2016) posit that GPi-LHb neurons (which they opto-tag as vGluT2) exhibit a decreased firing rate during rewarding outcomes. Hong and Hikosaka (2008) antidromically identified LHb projecting neurons through within the GPi and found reward positive and reward negative neurons, which were respectively modulated either by increasing or decreasing their firing rate with a rewarding outcome (red and green dots on the x-axis of Figure 5A in their paper).

      As the reviewer pointed out the zScore may be misleading. Therefore, in our study we also decomposed population activity on reward axis through dPCA. When marginalizing for reward in Figure 3F, we find that the weights of individual units on this axis are centered around zero, with positive and negative values (Figure 3F, right panel). Thus, units can code a rewarding outcome as either an increase or a decrease of activity. We show example units of such modulation in Figure 3-1g and h.

      We had segregated our analysis of spatio-temporal and kinematic coding upon the reward coding of units in Figure 4L-M. Yet, following this comment and in an effort of further clarifying this segregation, we introduced panels with the mean zScore of units during outcome evaluation in Figure 4L.

      We amended the main text to better explain these findings (lines 544-562).

      “Previous reports suggest that EPN units that project to the lateral habenula encode reward as a decrease in firing rate. Thus, we wished to ask whether reward encoding units can code kinematic and spatio-temporal variables as well.

      To this end, we first segregated units upon their reward coding properties: reward positive (which increased activity with reward) and reward negative units (which decreased activity with reward). We performed auROC on the 250ms after head entry comparing rewarded trials and incorrect trails (p<0.001, permutation test). Mean activity of reward insensitive, positive and negative units is shown in Fig. 4L. Next, we performed a dimensionality reduction on the coefficients of the model that best explained both contexts (kinematic + spatio-temporal model on pooled data) using UMAP (McInnes et al., 2018). We observe a continuum rather than discrete clusters (Fig. 4L). Note that individual units are color coded according to their responsivity to reward. We did not find a clear clustering either.”  

      Paragraph added in the discussion (lines 749-755):

      “In this study, we found that rewarding outcomes can be represented by EPN units through either an increase or a decrease in firing rate (Fig. 3F, 3-1g-h, 4L). While Stephenson-Jones et al., 2016 found that lateral habenula (LHb)-projecting neurons within the EPN of mice primarily encoded rewarding outcomes by a decrease in firing rate, Hong and Hikosaka, 2008 observed that in primates, LHb-projecting units could encode reward through either a decrease or an increase in firing rate. Thus, our results align more closely with the latter study, which also employed an operant conditioning task.”

      (3) The authors say that: 'reward and kinematic doing are not mutually exclusive, challenging the notion of distinct pathways and movement processing'. However, it is not clear whether the data presented in this work supports this statement. First, the authors have not attempted to record from the entire EPN. Thus it is possible that the coding might be more segregated in other parts of EPN. Second, EPNs have previously been shown to display positive firing for negative outcomes and vice versa, something which the authors do not find here. It is possible that those neurons might not encode kinematic and movement variables. Thus, the authors should point out in the main text the possibility that the EPN activity recorded might be missing some parts of the whole EPN.

      We thank the reviewer for the opportunity to expand on this topic. We believe it is certainly possible that other not-recorded regions of the EPN might exhibit greater segregation of reward and kinematics. However, we considered it worthwhile pointing out that from the dataset collected in this study reward-sensitive units encode kinematics in a similar fashion to reward-insensitive ones (Fig. 4L,M). Moreover, we asked specifically whether reward-negative units (that decrease firing rate with rewarding outcomes, as previously reported) could encode kinematics and spatio-temporal variables with different strength than reward-insensitive ones and could not find significant differences (Fig. 4M).

      We did indeed find units that displayed decreased firing rate upon rewarding outcomes, as has been previously reported. We have addressed this fact more thoroughly in point (2). 

      Finally, we agree with the reviewer that the dataset collected in this study is by no means exhaustive of the entire EPN and have thus included a sentence pointing this out in the Discussion section (lines 805-806):

      “Given that we did not record from the entire EPN, it is still possible that another region of the nucleus might exhibit more segregation.”

      (4) The authors use an IR beam system to record licks and make a strong claim about the nature of lick encoding in the EPN. However, the authors should note that IR beam system is not the most accurate way of detecting licks given that any object blocking the path (paw or jaw-dropping) will be detected as lick events. Capacitance based, closed-loop detection, or video capturing is better suited to detect individual licks. Given that the authors are interested in kinematics of licking, this is important. The authors should either point this out in the main text or verify in the system if the IR beam is correctly detecting licks using a combination of those methods.

      We thank the reviewer for the opportunity of clarifying the lick event acquisition. We have experience using electrical alternatives to lickometers; however, we believe they were not best suited to this application. Closed-loop lickometers generally use a metallic grid upon which animals stand so that the loop can be closed; however, we wanted to have a transparent floor. We have found capacitance based lickometers to be useful in head-fixed conditions but have noticed that they are very dependent on animal position and proximity of other bodyparts such as limbs. Given the freely moving aspect of the task this was difficult to control. Finally, both electric alternatives for lickometers are more prone to noise and may introduce electrical artifacts that might contaminate the spiking signal. This is why we opted to use a slit in combination with an IR beam that would only fit the tongue and that forced enough protrusion such that individual licks could be monitored. Further, the slit could not fit other body-parts like the paw or jaw. We have now included a video (Supp. Video 2) showing a closeup of this behavior that better conveys how the jaw and paw do not fit inside the slit. The following text has been added in the corresponding methods section (lines 97-98):

      “The lickometer slit was just wide enough to fit the tongue and deep enough to evoke a clear tongue protrusion.”

      Reviewer #1 (Recommendations For The Authors):

      (1)The authors should verify using opto-tagging of either Vglut2, SOM, or PV neurons whether they can see the same firing pattern. If not, the authors should address this weakness in the paper.

      We thank the reviewer for this important point, we have provided a more detailed reply above.

      (2)The way dPCA or PCA is applied to the data is not stated at all in the main text. Are all units from different mice combined? Or applied separately for each mouse? How does that affect the interpretation of the data? At least a brief text should be included in the main text to guide the readers.

      We thank the reviewer for pointing out this important omission. We have included an explanation in the Methods section and in the Main text.

      Methods (lines 182-184):

      “For all population level analyses individual units recorded from all sessions and all animals were pooled to construct pseudo-simultaneous population response of combined data mostly recorded separately.”

      Main text (lines 397-399):

      “For population level analyses throughout the study, we pooled recorded units from all animals to construct a pseudo-simultaneous population.”

      Discussion (lines 729-730):

      “…(from pooled units from all animals to construct a pseudo-simultaneous population, which assumes homogeneity across subjects)”

      (3) The authors argue that they do not find 'value coding' in this study. However, the authors never manipulate reward size or probability, but only the uncertainty or difficulty of the task. This might be better termed 'difficulty', and it is difficult to say whether this correlates with value in this task. For instance, mice might be very confident about the choice, even for an intermediate frequency sweep, if the mouse had waited long enough to hear the full sweep. In that case, the difficulty would not correlate with value, given that the mouse will think the value of the port it is going to is high. Thus, authors should avoid using the term value.

      We agree with the reviewer. We have modified the text to specify that difficulty was the variable being studied and added the following sentence in the Discussion (lines 747-748):

      “It is still possible that by modifying reward contingencies such as droplet size value coding could be evidenced.”

      (4) How have the authors obtained Figure 7D bottom panel? It is unclear at all what this correlation represents. Are the authors looking at a correlation between instantaneous firing rate and lick rate during a lick bout?

      We thank the reviewer for pointing out that omission. It is indeed correlation coefficient between the instantaneous firing rate and the instantaneous lick rate for a lick bout. We have included labeling in Figure 7D and pointed this out in the main text [lines 680-681]:

      “Fig.7D, lower panel shows the correlation coefficient between the instantaneous firing rate and the instantaneous lick rate within a lick bout for all units.”

      Reviewer #2 (Public Review):

      This paper examined how the activity of neurons in the entopeduncular nucleus (EPN) of mice relates to kinematics, value, and reward. The authors recorded neural activity during an auditory-cued two-alternative choice task, allowing them to examine how neuronal firing relates to specific movements like licking or paw movements, as well as how contextual factors like task stage or proximity to a goal influence the coding of kinematic and spatiotemporal features. The data shows that the firing of individual neurons is linked to kinematic features such as lick or step cycles. However, the majority of neurons exhibited activity related to both movement types, suggesting that EPN neuronal activity does not merely reflect muscle-level representations. This contradicts what would be expected from traditional action selection or action specification models of the basal ganglia.

      The authors also show that spatiotemporal variables account for more variability compared to kinematic features alone. Using demixed Principal Component Analysis, they reveal that at the population level, the three principal components explaining the most variance were related to specific temporal or spatial features of the task, such as ramping activity as mice approached reward ports, rather than trial outcome or specific actions. Notably, this activity was present in neurons whose firing was also modulated by kinematic features, demonstrating that individual EPN neurons integrate multiple features. A weakness is that what the spatiotemporal activity reflects is not well specified. The authors suggest some may relate to action value due to greater modulation when approaching a reward port, but acknowledge action value is not well parametrized or separated from variables like reward expectation.

      We thank the reviewer for the comment. We indeed believe that further exploring these spatiotemporal signals is important and will be the subject of future studies.

      A key goal was to determine whether activity related to expected value and reward delivery arose from a distinct population of EPN neurons or was also present in neurons modulated by kinematic and spatiotemporal features. In contrast to previous studies (Hong & Hikosaka 2008 and Stephenson-Jones et al., 2016), the current data reveals that individual neurons can exhibit modulation by both reward and kinematic parameters. Two potential differences may explain this discrepancy: First, the previous studies used head-fixed recordings, where it may have been easier to isolate movement versus reward-related responses. Second, those studies observed prominent phasic responses to the delivery or omission of expected rewards - responses largely absent in the current paper. This absence suggests a possibility that neurons exhibiting such phasic "reward" responses were not sampled, which is plausible since in both primates and rodents, these neurons tend to be located in restricted topographic regions. Alternatively, in the head-fixed recordings, kinematic/spatial coding may have gone undetected due to the forced immobility.

      Thank you for raising this point. Nevertheless, there is some phasic activity associated with reward responses, which can be seen in the new panel in Figure 4L.

      Overall, this paper offers needed insight into how the basal ganglia output encodes behavior. The EPN recordings from freely moving mice clearly demonstrate that individual neurons integrate reward, kinematic, and spatiotemporal features, challenging traditional models. However, the specific relationship between spatiotemporal activity and factors like action value remains unclear.

      We really appreciate this reviewer for their valuable comments.

      Reviewer #2 (Recommendations For The Authors):

      One small suggestion is to make sure that all the panels in the figures are well annotated. I struggled in places to know what certain alignments or groupings meant because they were not labelled. An example would be what do the lines correspond to in the lower panels of Figure 2D and E. I could figure it out from other panels but it would have helped if each panel had better labelling.

      Thanks for pointing this out, we have improved labelling across the figures and corrected the specific example you have pointed out.

      The paper is very nice though. Congratulations!

      Thank you very much.

      Editor's note:

      Should you choose to revise your manuscript, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript.

      We thank the editor for the comment. A statistics table has been added.

      References:

      Lazaridis, I., Tzortzi, O., Weglage, M., Märtin, A., Xuan, Y., Parent, M., Johansson, Y., Fuzik, J., Fürth, D., Fenno, L. E., Ramakrishnan, C., Silberberg, G., Deisseroth, K., Carlén, M., & Meletis, K. (2019). A hypothalamus-habenula circuit controls aversion. Molecular Psychiatry, 24(9), 1351–1368. https://doi.org/10.1038/s41380-019-0369-5

      Martinez-Garcia, R. I., Voelcker, B., Zaltsman, J. B., Patrick, S. L., Stevens, T. R., Connors, B. W., & Cruikshank, S. J. (2020). Two dynamically distinct circuits drive inhibition in the sensory thalamus. Nature, 583(7818), 813–818. https://doi.org/10.1038/s41586-0202512-5

      McInnes, L., Healy, J., Saul, N., & Großberger, L. (2018). UMAP: Uniform Manifold Approximation and Projection. Journal of Open Source Software, 3(29), 861. https://doi.org/10.21105/joss.00861

      Zingg, B., Chou, X. lin, Zhang, Z. gang, Mesik, L., Liang, F., Tao, H. W., & Zhang, L. I. (2017). AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors. Neuron, 93(1), 33–47. https://doi.org/10.1016/j.neuron.2016.11.045

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment

      This valuable work analyzes how specialized cells in the auditory cells, known as the octopus cells, can detect coincidences in their inputs at the submillisecond time scale. While previous work indicated that these cells receive no inhibitory inputs, the present study unambiguously demonstrates that these cells receive inhibitory glycinergic inputs. The physiologic impact of these inputs needs to be studied further. It remains incomplete at present but could be made solid by addressing caveats related to similar sizes of excitatory postsynaptic potentials and spikes in the octopus neurons.

      We apologize for not explicitly describing our experimental methods and analyses procedures that ensure the discrimination between action potentials and EPSPs. This has been addressed in responses to reviewer comments and amended in the manuscript.

      Reviewer #1 (Public Review):

      Kreeger and colleagues have explored the balance of excitation and inhibition in the cochlear nucleus octopus cells of mice using morphological, electrophysiological, and computational methods. On the surface, the conclusion, that synaptic inhibition is present, does not seem like a leap. However, the octopus cells have been in the past portrayed as devoid of inhibition. This view was supported by the seeming lack of glycinergic fibers in the octopus cell area and the lack of apparent IPSPs. Here, Kreeger et al. used beautiful immunohistochemical and mouse genetic methods to quantify the inhibitory and excitatory boutons over the complete surface of individual octopus cells and further analyzed the proportions of the different subtypes of spiral ganglion cell inputs. I think the analysis stands as one of the most complete descriptions of any neuron, leaving little doubt about the presence of glycinergic boutons.

      Kreeger et al then examined inhibition physiologically, but here I felt that the study was incomplete. Specifically, no attempt was made to assess the actual, biological values of synaptic conductance for AMPAR and GlyR. Thus, we don't really know how potent the GlyR could be in mediating inhibition. Here are some numbered comments:

      (1) "EPSPs" were evoked either optogenetically or with electrical stimulation. The resulting depolarizations are interpreted to be EPSPs. However previous studies from Oertel show that octopus cells have tiny spikes, and distinguishing them from EPSPs is tricky. No mention is made here about how or whether that was done. Thus, the analysis of EPSP amplitude is ambiguous.

      We agree that large EPSPs can be difficult to distinguish from an octopus cell’s short spikes during experiments. During analysis, we distinguished spikes from EPSPs by generating phase plots, which allow us to visualize the first derivative of the voltage trace on the y-axis and the value of the voltage on the x-axis at each moment in time. In the example shown below, four depolarizing events were electrically evoked in an octopus cell (panel A). The largest of these events (shown in orange in panels B-D) has an amplitude of ~9mV and could be a small spike. The first derivative of the voltage (panel C) reveals a bi-phasic response in the larger orange trace, where during the rising phase (mV/ms > 0) of the EPSP there is a second, sharper rising phase for the spike. Like more traditionally sized action potentials, phase plots for octopus cell spikes also reveal a sharp change in the rate of voltage change over time (Author response image 1 panel D, ✱) after the rising action of the EPSP begins to slow. EPSPs (shown in blue in panels B-D) lack the deflection in the phase plot. Not all cases were as unambiguous as this example. Therefore, our analysis only included subthreshold stimulation that unambiguously evoked EPSPs, not spikes. A brief description of this analysis has been added to the methods text (lines 625-627) and we have noted in the results section that both ChR2-evoked and electrically-evoked stimulation can produce small action potentials, which were excluded from analysis (lines 156-158).

      Author response image 1.

      (2) For this and later analysis, a voltage clamp of synaptic inputs would have been a simple alternative to avoid contaminating spikes or shunts by background or voltage-gated conductances. Yet only the current clamp was employed. I can understand that the authors might feel that the voltage clamp is 'flawed' because of the failure to clamp dendrites. But that may have been a good price to pay in this case. The authors should have at least justified their choice of method and detailed its caveats.

      We agree that data collected using voltage-clamp would have eliminated the confound of short action potentials and avoided the influence of voltage-gated conductances. The large-diameter, and comparatively simple dendritic trees of octopus cells make them good morphological candidates for reliable voltage clamp. However, as suggested, we were concerned that the abundance of channels open at the neuron’s resting potential would make it difficult to sufficiently clamp dendrites. Ultimately, given the low input resistances of octopus cells and the fast kinetics of excitatory inputs, we determined that bad voltage clamp conditions were likely to result in unclamped synaptic events with unpredicted distortions in kinetics and attenuation (To et al. 2022; PMID: 34480986; DOI: 10.1016/j.neuroscience.2021.08.024). We therefore chose to focus our efforts on current-clamp.

      Beyond the limits of both current-clamp and voltage-clamp, we chose to leave all conductances that influence EPSP dendritic propagation intact because our model demonstrates that active Kv and leak conductances shape and attenuate synaptic inputs as they travel through the dendritic tree (Supp. Fig. 4F-G). The addition of voltage-clamp recordings would not impact the conclusions we make about EPSP summation at the soma. Future studies will need to focus on a dendrite-centric view of local excitatory and inhibitory summation. For dendrite-centric experiments, dendritic voltage-clamp recordings are well suited to answer that set of questions.

      (3) The modeling raised several concerns. First, there is little presentation of assumptions, and of course, a model is entirely about its assumptions. For example, what excitatory conductance amplitudes were used? The same for inhibitory conductance? How were these values arrived at? The authors note that EPSGs and IPSGs had peaks at 0.3 and 3 ms. On what basis were these numbers obtained? The model's conclusions entirely depend on these values, and no measurements were made here that could have provided them. Parenthetical reference is made to Figure S5 where a range of values are tested, but with little explanation or justification.

      We apologize for not providing this information. We used our octopus neuron model to fit both EPSP and IPSP parameters to match experimental data. We have expanded the methods to include final values for the conductances (lines 649-651), which were adjusted to match experimental values seen in current-clamp recordings. We have also expanded the results section to describe each of the parameters we tuned (lines 203-222). An example of these adjustments is illustrated in Fig. 4F where the magnitude of inhibitory potentials at different conductances (100nS and 1nS) was compared to experimental data over a range of octopus cell input resistance conditions. Kinetic parameters were determined by aligning modeled PSPs to the rise times and full width at half maximum (FWHM) measurements from experiments under control and Kv block conditions. The experimental data for EPSPs and IPSPs that was used to fit the model is shown in Author response image 2 below.

      Author response image 2.

      (4) In experiments that combined E and I stimulation, what exactly were time courses of the conductance changes, and how 'synchronous' were they, given the different methods to evoke them? (had the authors done voltage clamp they would know the answers).

      We chose to focus data collection on voltage changes at the soma under physiological conditions to better understand how excitation and inhibition integrate at the somatic compartment. Our conclusions in the combined E and I stimulation experiments require the resting membrane properties of octopus cells to be intact to make physiologically-relevant conclusions. Our current-clamp data includes the critical impact of leak, Kv, and HCN conductances on this computation. Reliable voltage-clamp would necessitate the removal of the Kv and HCN conductances that shape PSP magnitude, shape, and speed. Because it was not necessary to measure the conductances and kinetics of specific channels, we chose to use current-clamp.

      Evoked IPSPs and EPSPs had cell-to-cell variability in their latencies to onset. Somatically-recorded optically-evoked inhibition under pharmacological conditions that changed cable properties had onset latencies between 2.5 and 4.3ms; electrically-evoked excitation under control conditions had latencies between 0.8 and 1.4ms. To overcome cell-to-cell timing variabilities, we presented a shuffled set of stimulation pairings that had a 3ms range of timings with 200µs intervals. As the evoked excitation and inhibition become more ‘synchronous’, the impact on EPSP magnitude and timing is greatest. Data presented in this paper was for the stimulation pairings that evokes a maximal shift in EPSP timing. On average, this occurred when the optical stimulation began ~1.2ms before electrical stimulation. Stimulation pairing times ranged between a 0ms offset and a 1.8ms offset at the extremes. An example of the shuffled stimulation pairings is shown in Author response image 3 below, and we have included information about the shuffled stimulus in the methods (lines 627-630)

      Author response image 3.

      (5) Figure 4G is confusing to me. Its point, according to the text, is to show that changes in membrane properties induced by a block of Kv and HCN channels would not be expected to alter the amplitudes of EPSCs and IPSCs across the dendritic expanse. Now we are talking about currents (not shunting effects), and the presumption is that the blockers would alter the resting potential and thus the driving force for the currents. But what was the measured membrane potential change in the blockers? Surely that was documented. To me, the bigger concern (stated in the text) is whether the blockers altered exocytosis, and thus the increase in IPSP amplitude in blockers is due BOTH to loss of shunting and increase in presynaptic spike width. Added to this is that 4AP will reduce the spike threshold, thus allowing more ChR2-expressing axons to reach the threshold. Figure 4G does not address this point.

      These are valuable points that motivated us to improve the clarity of this figure and the corresponding text. We discussed two separate points in this paragraph and were not clear. Our intention with Figure 4G was to address concerns that using pharmacological blockers changes driving forces and may confound the measured change in magnitude of postsynaptic potentials. Membrane potentials hyperpolarized by approximately 8-10 mV after application of blockers. We corrected for this effect by adding a holding current to depolarize the neuron to its baseline resting potential. Text in the results (lines 187-190) and figure legends have been changed to clarify these points.

      We also removed any discussion of presynaptic effects from this portion of the text because our description was incomplete and we did not directly collect data related to these claims. We originally wrote, “While blocking Kv and HCN allowed us to reveal IPSPs at the soma, 4-AP increases the duration of the already unphysiological ChR2-evoked presynaptic action potential (Jackman et al., 2014; DOI: 10.1523/jneurosci.4694-13.2014), resulting in altered release probabilities and synaptic properties, amongst other caveats (Mathie et al., 1998; DOI: 10.1016/S0306-3623(97)00034-7)”. Ultimately, effects on exocytosis, presynaptic excitability, or release probability are only relevant for the experiments presented in Figure 4. Figure 4 serves as evidence that synaptic release of glycine elicits strychnine-sensitive inhibitory postsynaptic potentials in octopus cells. Concerns of presynaptic effects do not carry over to the data presented in Figure 5, as Kv and HCN were not blocked in these experiments. Therefore, we have removed this portion of the text.

      (6) Figure 5F is striking as the key piece of biological data that shows that inhibition does reduce the amplitude of "EPSPs" in octopus cells. Given the other uncertainties mentioned, I wondered if it makes sense as an example of shunting inhibition. Specifically, what are the relative synaptic conductances, and would you predict a 25% reduction given the actual (not modeled) values?

      We agree that both shunting and hyperpolarizing inhibition could play a role in the measured EPSP changes. Because we focused data collection on voltage changes at the soma under physiological conditions, we cannot calculate the relative synaptic conductances. Together, our experimental current-clamp results paired with estimates from the model provide compelling evidence for the change we observe in EPSPs. Regardless, the relative weights of the synaptic conductances is a very interesting question, but this information is not necessary to answer the questions posed in this study, namely the impact of dendritic inhibition on the arrival of EPSPs in the soma.

      (7) Some of the supplemental figures, like 4 and 5, are hardly mentioned. Few will glean anything from them unless the authors direct attention to them and explain them better. In general, the readers would benefit from more complete explanations of what was done.

      We apologize for not fully discussing these figures in the results text. We have fully expanded the results section to detail the experiments and results presented in the supplement (lines 203-238).

      Reviewer #2 (Public Review):

      Summary:

      Kreeger et.al provided mechanistic evidence for flexible coincidence detection of auditory nerve synaptic inputs by octopus cells in the mouse cochlear nucleus. The octopus cells are specialized neurons that can fire repetitively at very high rates (> 800 Hz in vivo), yield responses dominated by the onset of sound for simple stimuli, and integrate auditory nerve inputs over a wide frequency span. Previously, it was thought that octopus cells received little inhibitory input, and their integration of auditory input depended principally on temporally precise coincidence detection of excitatory auditory nerve inputs, coupled with a low input resistance established by high levels of expression of certain potassium channels and hyperpolarization-activated channels.

      In this study, the authors used a combination of numerous genetic mouse models to characterize synaptic inputs and enable optogenetic stimulation of subsets of afferents, fluorescent microscopy, detailed reconstructions of the location of inhibitory synapses on the soma and dendrites of octopus cells, and computational modeling, to explore the importance of inhibitory inputs to the cells. They determined through assessment of excitatory and inhibitory synaptic densities that spiral ganglion neuron synapses are densest on the soma and proximal dendrite, while glycinergic inhibitory synaptic density is greater on the dendrites compared to the soma of octopus cells. Using different genetic lines, the authors further elucidated that the majority of excitatory synapses on the octopus cells are from type 1a spiral ganglion neurons, which have low response thresholds and high rates of spontaneous activity. In the second half of the paper, the authors employed electrophysiology to uncover the physiological response of octopus cells to excitatory and inhibitory inputs. Using a combination of pharmacological blockers in vitro cellular and computational modeling, the authors conclude that glycine in fact evokes IPSPs in octopus cells; these IPSPs are largely shunted by the high membrane conductance of the cells under normal conditions and thus were not clearly evident in prior studies. Pharmacological experiments point towards a specific glycine receptor subunit composition. Lastly, Kreeger et. al demonstrated with in vitro recordings and computational modeling that octopus cell inhibition modulates the amplitude and timing of dendritic spiral ganglion inputs to octopus cells, allowing for flexible coincidence detection.

      Strengths:

      The work combines a number of approaches and complementary observations to characterize the spatial patterns of excitatory and inhibitory synaptic input, and the type of auditory nerve input to the octopus cells. The combination of multiple mouse lines enables a better understanding of and helps to define, the pattern of synaptic convergence onto these cells. The electrophysiology provides excellent functional evidence for the presence of the inhibitory inputs, and the modeling helps to interpret the likely functional role of inhibition. The work is technically well done and adds an interesting dimension related to the processing of sound by these neurons. The paper is overall well written, the experimental tests are well-motivated and easy to follow. The discussion is reasonable and touches on both the potential implications of the work as well as some caveats.

      Weaknesses:

      While the conclusions presented by the authors are solid, a prominent question remains regarding the source of the glycinergic input onto octopus cells. In the discussion, the authors claim that there is no evidence for D-stellate, L-stellate, and tuberculoventral cell (all local inhibitory neurons of the ventral and dorsal cochlear nucleus) connections to octopus cells, and cite the relevant literature. An experimental approach will be necessary to properly rule out (or rule in) these cell types and others that may arise from other auditory brainstem nuclei. Understanding which cells provide the inhibitory input will be an essential step in clarifying its roles in the processing of sound by octopus cells.

      We are glad that the reviewer agrees with the conclusions we have made and is interested in learning more about how these findings impact sound processing. We agree that defining the source of inhibition will dramatically shape our understanding of the computation octopus cells are making. However, this is not an easy task, given the small size of the octopus cell area, and will involve considerable additional work. Since the overall findings do not depend on knowing the source of inhibition, we have instead re-written the discussion to clarify the lack of evidence for intrinsic inhibitory inputs to octopus cells, in addition to presenting likely candidates. As genetic profiles of cochlear nucleus and other auditory brainstem neurons become available, we intend to make and utilize genetic mouse models to answer questions like this.

      The authors showed that type 1a SGNs are the most abundant inputs to octopus cells via microscopy. However, in Figure 3 they compare optical stimulation of all classes of ANFs, then compare this against stimulation of type 1b/c ANFs. While a difference in the paired-pulse ratio (and therefore, likely release probability) can be inferred by the difference between Foxg1-ChR2 and Ntng1-ChR2, it would have been preferable to have specific data with selective stimulation of type 1a neurons.

      We agree that complete genetic access to only the Ia population would have been the preferable approach, but we did not have an appropriate line when beginning these experiments. Because our results did not suggest a meaningful difference between the populations, we did not pursue further investigation once a line was available.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Besides the points mentioned in the main review:

      Minor

      (1) I really like the graphics and the immunohistological presentation.

      (2) Lines 316-319 say that octopus cells lack things like back-propagating spikes and dendritic Ca spikes. How do you know this?

      This statement was intended to be a summary of suggestions from the literature and lacked references and context as written. We have rewritten this section and clarified that our hypothesis was formed from data found in the literature (lines 334-337).

      (3) Spectrograms of Figure 6A...where were these data obtained?

      We recorded and visualized human-generated rhythmic tapping and high-frequency squeaking sounds using Audacity. The visualizations of rhythmic tapping and imitated vocalizations are meant to show two different types of multi-frequency stimuli we hypothesize would result in somatic summation within an octopus cell’s spike integration window, despite differences in timing. We rewrote the figure legend to explain more clearly what is shown and how it relates to the model in Figure 6.

      (4) 'on-path' and 'off-path' seem like jargon that may not be clear to the average reader.

      Thank you for pointing out our use of unapproachable jargon. We have replaced the term from the figure with “proximal” and “distal” inhibition. In the main text, we now describe on-path and off-path together as the effect of location of dendritic inhibition on somatically recorded EPSPs.

      (5) The paper could benefit from a table of modeled values.

      We have added specific details about the modelling in the text and clarified which modeled values were referenced from previous computational models and which were tuned to fit experimental data. Since most values were taken from a referenced publication, we did not add a table and instead point readers towards that source.

      (6) Figure S4A-C what currents were delivered to the modeled cells?

      The model cells were injected with a -0.8 nA DC current for 300 ms in current clamp mode. This information has been added to the figure legend.

      (7) In that figure "scaling factors" scale exactly which channels?

      Scaling factor is used to scale low-voltage activated K<sup>+</sup> (ḡ<sub>KLT</sub>), high threshold K<sup>+</sup> (ḡ<sub>KHT</sub>), fast transient K<sup>+</sup> (ḡ<sub>KA</sub>), hyperpolarization-activated cyclic nucleotide-gated HCN (ḡ<sub>h</sub>) but not fast Na<sup>+</sup> (ḡ<sub>Na</sub>) and leak K<sup>+</sup> (ḡ<sub>leak</sub>). This information has been added to the text (lines 205-208 and 646-653).

      (8) In performing and modeling Kv/HCN block, do you know how complete the level of the block is?

      Since we cannot assess how complete the level of block is, we have changed the language in the text to clarify that we are reducing Kv and HCN channel conductance to the degree needed to increase resistance of the neuron (line 185).

      (9) More on this Figure S4. It is hardly referred to in the text except to say that it supports that blocking the Kv/HCN channels will enhance the IPSP. Given how large the figure is, can you offer more of a conclusion than that? Also, in the synaptic model in that figure, the IPSCs are presumably happening in current-clamp conditions, and the reduction in amplitude of the IPSC (as opposed to the increase in IPSP) is due to hyperpolarization. Can you simply state that so readers can track what this figure is showing? Other similar things: what is a transfer impedance? How is it measured? What do we take from the analysis?

      We have elaborated on our description of both Supp. Fig. 4 and Supp. Fig. 5 in the results section of the text (lines 203-238).

      (10) Figure S5 also needs a better explanation. E.g., in C-D, what does 'average' mean? The gray is an SD of this average? You modeled a range of values...but which ones are physiological? To me, this is a key point.

      We have elaborated on our description of both Supp. Fig. 4 and Supp. Fig. 5 in the results section of the text (lines 203-238).

      Reviewer #2 (Recommendations For The Authors):

      General:

      The images and 3-D reconstructions are visually stunning, but they are not colorblind-friendly and in some cases, hard to distinguish. This shows up particularly in the green and blue colors used in Figure 1. Also, better representative images could be used for Figure 1B.

      Thank you for pointing out that blue and green were difficult to distinguish in Figure 1H. We have outlined the green inhibitory puncta in this image to make them more distinguishable. We have also increased the resolution of the image in Figure 1B for better clarity. All other colors are selected from Wong, 2011 (PMID: 21850730; DOI: https://doi.org/10.1038/nmeth.1618).

      Supplemental Figure 1D: The low-power view is good to have, but the CN is too small and the image appears a bit noisy. An inset showing the CN on a larger scale (higher resolution image?) would be more convincing. In this image, I see what appear to be cells in the DCN labeled, which calls into question the purity of the source of optogenetic synaptic activation. It is also difficult to tell whether there are other cells labeled in the VCN. Such inputs would still be minor, but it would be good to be very clear about the expression pattern.

      To offer more information about the activity of the Ntng1<sup>Cre</sup> line in other regions of the auditory system, we increased the resolution of the image included in Supp. Fig. 1D and have also included an additional image (Supp. Fig. 1E) of a coronal section of the cochlear nucleus complex with Ntng1-tdT labelling. This image provides additional context for the cells labeled in the DCN. The text in the figure legend has been changed to clarify that some cells in the DCN were labeled (lines 118-120).

      We agree that in the Ntng1<sup>Cre</sup> experiments, there is the possibility of minor contamination from excitatory cells that express ChR2 outside of the spiral ganglion. This is also true for our Foxg1<sup>Cre</sup> and Foxg1<sup>Flp</sup> experiments, because these lines label cortical cells in addition to cochlear cells. However, we do not observe direct descending inputs from the cortex into the PVCN, making contamination from other Foxg1<sup>Cre</sup>-positive neurons unlikely. While non-cochlear inputs from the Ntng1<sup>Cre</sup> line are possible, evidence from both lines gives us confidence that we are not capturing inputs to octopus cells outside the cochlea. Central axons from Type I spiral ganglion neurons have VGLUT1+ synaptic terminals. When comparing the overlap between VGLUT1+ terminals and Foxg1-tdT labelling, we see full coverage. That is, all VGLUT+ terminals on octopus cells are co-labelled by Foxg1<sup>Cre</sup>-mediated expression of tdTomato. An example image is shown below. Here, an octopus cell soma is labeled with blue fluorescent Nissl stain and inputs to the cochlear nucleus complex are labeled with Foxg1<sup>Cre</sup>-dependent tdTomato (Foxg1-tdT; magenta). We have also immunolabeled for VGLUT1 puncta in green. This eliminates the possibility that VGLUT+ cells from outside the cochlea and cortex are sources of excitation to octopus cells.

      Author response image 4.

      Further, we have looked at expression of Ntng1-tdT and Foxg1-EYFP together in the octopus cell area.  An example image is shown below. All Ntng1-tdT+ fibers (magenta) are also Foxg1-EYFP+ (green), suggesting that all Ntng1<sup>Cre</sup>-targeted inputs to octopus cells are a part of the Foxg1<sup>Cre</sup>-targeted input population, which are very likely to only be from the cochlea. We have expanded the results section to include information about the overlap in expression driven by the Ntng1<sup>Cre</sup> and Foxg1<sup>Flp</sup> lines.

      Author response image 5.

      Supplemental Figure 2 G: These are a bit hard to read. Perhaps use a different image, or provide a reference outline drawing telling us what is what.

      We have used a different image with a Thy1-YFP labeled octopus cell for clarity.

      In some places, the term "SGN" is used when referencing the axons and terminals within the CN, and without some context, this was occasionally confusing (SGN would seem to refer to the cell bodies). In some places in the text, it may be preferable to separate SGN, auditory nerve fibers (ANFs), and terminals, as entities for clarity.

      In order to make the study accessible to a broad neuroscience audience, we refer to the neurons of the spiral ganglion and their central axon projections using one name. We understand why, for those well acquainted with the auditory periphery, condensing terminology may feel awkward. However, for those readers unfamiliar with the anatomy of the cochlea and auditory nerve, we feel that the use of “SGN central axon” makes it clear that the “auditory nerve fibers” come from neurons in the spiral ganglion. This is clarified in the first paragraph of the introduction (lines 29-31) and in the methods (line 533).

      Specific: Numbers refer to the line numbers on the manuscript.

      L29-31: Cochlear nucleus neurons are more general in their responses than this sentence indicates. While we can all agree that they are specialized to carry (or improve upon) the representation of these specific features of sound, they also respond more generally to sounds that might not have specific information in any of these domains. They are not silos of neural computation, and their outputs become mixed and "re-represented" well before they reach the auditory cortex. Octopus cells are no exception to this. I suggest striking most of the first paragraph, and instead using the first sentence to lead into the second paragraph, and putting the last sentence (of the current first paragraph) at the end of the second (now first) paragraph.

      We agree with this assessment and have made major changes to the introduction in line with these suggestions.

      L33-46: A number of points in this paragraph need references (exp. line 41).

      We agree and have added references accordingly.

      L43: Not sure what is meant by "fire at the onset of the sound, breaking it up into its frequency components"?

      We changed this text as part of a major reworking of the introduction.

      L47-66: Again more citations are needed (at the end of sentence at line 55, probably moving some of the citations from the next sentence up).

      We agree and have added references accordingly.

      L51: The consistent orientation of octopus cell dendrites across the ANFs has been claimed in the literature (as mentioned here), but there are some (perhaps problematic - plane of sectioning?) counterexamples from the older Golgi-stained images, and even amongst intracellularly stained cells (for example see Reccio-Spinoza and Rhode, 2020). This is important with regards to the broader hypothesis regarding traveling-wave compensation (e.g., McGinley et al; but also many others); if the cells are not all in the appropriate orientation then such compensation may be problematic. Likewise, the data from Lu et al., 2022, points towards a range of sensitivity to frequency-swept stimuli, some of which work in opposition to the traveling wave compensation hypothesis. It would seem that with the Thy1 mice, you have an opportunity to clarify the orientation. Figures 1A and 2A show a consistent dendritic orientation, assuming that these drawings are reconstructions of the cells as they were actually oriented in the tissue. Can you either comment on this or provide clearer evidence?

      We are happy to offer more information about the appearances of octopus cells in our preparations. In our hands, sparsely labeled octopus cells in Thy1-YFP-H mice show consistent dendritic orientation when visualized in a 15 degree parasaggital plane, with the most diversity apparent in cells with somas located more dorsally in the octopus cell area. We hypothesize that this is due to the limited area through which the central projections of spiral ganglion neurons (i.e. ANFs) must pass through before they enter the dorsal cochlear nucleus and continue their tonotopic organization in that area.

      A caveat to studies without physiological or genetic identification of octopus cells is the assumption that all neurons in the octopus cell area are octopus cells. We find, especially along the borders of the octopus cell area, that stellate cells can be seen amongst octopus cells. Because stellate cell dendrites are not oriented like octopus cell dendrites, any stellate cells misidentified as octopus cells would appear to have poorly-oriented dendrites. This may explain why some studies report this finding. In addition, it can be difficult to assess tonotopic organization because of the 3D trajectory of tightly bundled axons, which is not capturable by a single section plane. Although a parasaggital plane of sectioning captures the tonotopic axis in one part of the octopus cell area, that same plane may be perpendicular at the opposing end.

      L67: canonical -> exceptional.

      Thank you for the suggestion. We have made this change in the introduction.

      L127: This paragraph was confusing on first reading. I don't think Supplemental Figure 1D shows the restricted pattern of expression very clearly. The "restricted to SGNs" might be better as "restricted to auditory nerve fibers" (except in the DCN, where there seem to be some scattered small cells?). A higher magnification image of the CN, but lower magnification than in panel E, would be helpful here.

      To avoid confusion, we have re-written this paragraph (lines 117-127) and included a higher magnification image of the CN in a revised Supp. Fig. 1.

      L168: Here, perhaps say ANFs instead of SGNs.

      As above, we have decided to describe ANFs as SGN central axons to make the anatomy more accessible to people unfamiliar with cochlear anatomy.

      L201-204: The IPSPs are surprisingly slow (Figures 5B, C), especially given the speed of the EPSPs/EPSCs in these cells. This is reminiscent of the asymmetry between EPSC and IPSC kinetics in bushy cells (Xie and Manis, 2014). The kinetics used in the model (3 ms; mentioned on line 624) however seem a bit arbitrary and no data is provided for the selection of that value. Were there any direct measurements of the IPSC kinetics (all of the traces in the paper are in the current clamp) that were used to justify this value?

      The kinetics of the somatically-recorded IPSPs are subject to the effects of our pharmacological manipulations. EPSPs measured at the soma under control conditions are small amplitude and rapid. With pharmacological reduction of HCN and Kv channels, EPSPs are larger and slower (please see figure in response to a similar question posed by Reviewer #1). We expect that this change also occurs with the IPSP kinetics under pharmacological conditions. Our justification of kinetics has been expanded and justified in the methods section (lines 641-661).

      L594: Technically, this is a -11 mV junction potential, but thanks for including the information.

      We have corrected this in the text (line 618). Thank you for the close reading of all experimental and methodological details.

      L595: The estimated power of the LED illumination at the focal plane should be measured and indicated here.

      We measured the power of the LED illumination at the focal plane using a PM100D Compact Power and Energy Meter Console (Thorlabs), a S120C Photodiode Power Sensor (Thorlabs), and a 1000µm diameter Circular Precision Pinhole (Thorlabs). Light intensity at the focal plane ranged between 1.9 and 4.1mW/mm<sup>2</sup>, corresponding to 6% and 10% intensity on the Colibri5 system. We have reported these measurements in the results section (Lines 621-622).

      L609: One concern about the model is that the integration time of 25 microseconds is rather close to the relative shifts in latency. While I doubt it will make a difference (except in the number), it may be worth verifying (spot checks, at least) that running the model with a 5 or 10-microsecond step yields a similar pattern of latency shifts (e.g., Supplementary Figure 5, Figure 5).

      Also, it is not clear what temperature the model was executed at (I would presume 35C); this needs to be given, and channel Q10's listed.

      We realize that additional information is needed to fully understand the model and have added this to the results and the methods. The synaptic mechanism (.mod) files were obtained from Manis and Campagnola (2018) (PMID: 29331233; DOI: https://doi.org/10.1016/j.heares.2017.12.017). Q10 (3) and temperature (22°C) were also matched to parameters from Manis and Campagnola (2018). Because temperature is a critical factor for channel kinetics, we verified that our primary results remain consistent under conditions using a temperature of 35°C and a time step of 5µs, depicted below. Panel A illustrates the increase in IPSP as a function of glycine conductance under Kv+HCN block conditions at 35°C. As at 22°C, an increase in IPSP magnitude is absent in the control condition at 35°C. Panels B and C provide a direct comparison between the initial (i.e. 22°C) and suggested (i.e. 35°C) simulation conditions. Again we found that temperature does not have a major impact on the amplitude of IPSPs. Thus, results at 35°C do not change the conclusions we make from the model.

      Author response image 6.

      The nominal conductance densities should at least be provided in a table (supplemental, in addition to including them in the deposited code). The method for "optimization" of the conductance densities to match the experimental recordings needs to be described; the parameter space can be quite large in a model such as this. The McGinley reference needs a number.

      We added a more thorough description of modeling parameters and justification of choices in the methods section of the text (lines 641-661). We have also added a reference number to the McGinley 2012 reference in the text.

      I think this is required by the journal:

      The model code, test results, and simulation results should be deposited in a public resource (Github would be preferable, but dryad, Zenodo, or Figshare could work), and the URL/doi for the resource provided in the manuscript. This includes the morphology swc/hoc file. The code should be in a form, and with a description, that readily allows an interested party with appropriate skills to download it and run it to generate the figures.

      We will upload the code and all associated simulation files to the ModelDB repository upon publication.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:  

      Reviewer #1 (Public Review): 

      Summary: 

      The authors use an innovative behavior assay (chamber preference test) and standard calcium imaging experiments on cultured dorsal root ganglion (DRG) neurons to evaluate the consequences of global knockout of TRPV1 and TRPM2, and overexpression of TRPV1, on warmth detection. They find a profound effect of TRPM2 elimination in the behavioral assay, whereas elimination of TRPV1 has the largest effect on neuronal responses. These findings are of importance, as there is still substantial discussion in the field regarding the contribution of TRP channels to different aspects of thermosensation. 

      Strengths: 

      The chamber preference test is an important innovation compared to the standard two-plate test, as it depends on thermal information sampled from the entire skin, as opposed to only the plantar side of the paws. With this assay, and the detailed analysis, the authors provide strong supporting evidence for the role of TRPM2 in warmth avoidance. The conceptual framework using the Drift Diffusion Model provides a first glimpse of how this decision of a mouse to change between temperatures can be interpreted and may form the basis for further analysis of thermosensory behavior. 

      Weaknesses: 

      The authors juxtapose these behavioral data with calcium imaging data using isolated DRG neurons. Here, there are a few aspects that are less convincing. 

      (1) The authors study warmth responses using DRG neurons after three days of culturing. They propose that these "more accurately reflect the functional properties and abundance of warm-responsive sensory neurons that are found in behaving animals." However, the only argument to support this notion is that the fraction of neurons responding to warmth is lower after three days of culture. This could have many reasons, including loss of specific subpopulations of neurons, or any other (artificial?) alterations to the neurons' transcriptome due to the culturing. The isolated DRGs are not selected in any way, so also include neurons innervating viscera not involved in thermosensation. If the authors wish to address actual changes in sensory nerves involved in warmth sensing in TRPM2 or TRPV1 KO mice without disturbing the response profile as a result of the isolation procedure, other approaches would be needed (e.g. skin-nerve recordings or in vivo DRG imaging).  

      We agree that there could be several reasons as to why the responses of cultured DRGs are reduced compared to the acute/short-term cultures. It is possible ––and likely–– that transcriptional changes happen over the course of the culturing period. It is also possible that it is a mere coincidence that the 3-day cultures have a response profile more similar to the in vivo situation than the acute cultures. In the revised manuscript, we have therefore toned down the claim that the 3-day cultures mirror the native conditions more appropriately and included the sentence “However, whether 3-day cultures resemble native sensory neurons more closely than acute cultures in terms of their (transcriptional) identity is currently unknown.” (page 5). 

      We now also included a section “Limitations of the study” and bring this point up there as well and acknolwedge that longer culturing periods may cause changes in the neurons and may result in a drift away from their native state. 

      Nevertheless, our results clearly show that acute cultures have a response profile that is much more similar to damaged/”inflamed” neurons, irrespective of any comparison to the 3 daycultures. Therefore, we believe, it is helpful to include this data to make scientists aware that acute cultures are very different to non-inflamed native/in vivo DRG neurons that many researchers use in their experiments.

      (2) The authors state that there is a reduction in warmth-sensitive DRG neurons in the TRPM2 knockout mice based on the data presented in Figure 2D. This is not convincing for the following reasons. First, the authors used t-tests (with FDR correction - yielding borderline significance) whereas three groups are compared here in three repetitive stimuli. This would require different statistics (e.g. ANOVA), and I am not convinced (based on a rapid assessment of the data) that such an analysis would yield any significant difference between WT and TRPM2 KO. Second, there seems to be a discrepancy between the plot and legend regarding the number of LOV analysed (21, 17, and 18 FOV according to the legend, compared to 18, 10, and 12 dots in the plot). Therefore, I would urge the authors to critically assess this part of the study and to reconsider whether the statement (and discussion) that "Trpm2 deletion reduces the proportion of warmth responders" should be maintained or abandoned. . 

      Yes, we agree that the statistical tests indicated by the referee are more appropriate/robust for the data shown in Figures 1F, 2D, and 4G.

      When we perform 2-way repeated measures ANOVA and subsequent multiple comparison test (with Dunnets correction) against Wildtype, for data shown in Fig. 2D, both the main effect (Genotype) and the interaction term (Stimulus x Genotype) are significant. The multiple comparison yields very similar result as in the current manuscript, with the difference that the TRPM2-KO data for the second stimulus (~36°C) is borderline significant (with a p-value of p=0.050).

      Due to the possible dependence of the repeated temperature stimuli and the variability of each stimulus between FOVs (Fig. 2C), it is possible that a mixed-effect model that accounts for these effects is more appropriate. 

      Similarly, for plots 1F and 4G, Genotype (either as main effect or as interaction with Time) is significant after a repeated measures two-way ANOVA. The multiple comparisons (with Bonferroni correction) only changed the results marginally at individual timepoints, without affecting the overall conclusions. The exception is Fig. 4G at 38°C, where the interaction of Time and Genotype is significant, but no individual timepoint-comparison is significant after Bonferroni correction.

      The main difference between the results presented above and the ones presented in the manuscript is the choice of the multiple comparison correction. We originally opted for the falsediscovery rate (FDR) approach as it is less prone to Type II errors (false negatives) than other methods such as Sidaks or Bonferroni, particularly when correcting for a large number of tests.

      However, we are mainly interested in whether the genotypes differ in their behavior in each temperature combination and the significant ANOVA tests for Fig. 1F and 4G support that point. The statistical test and comparison used in the original/previous version of the manuscript, comparing behavior at individual/distinct timepoints, are interesting, but less relevant (and potentially distracting), as we do not go into the details about the behavior at any given/distinct timepoint in the assay.

      Therefore, and per suggestion of the reviewer, we have updated the statistics in the revised version of the manuscript. Also, we now report the correct number of FOVs in the legend. The statistical details are now found in the legends of the respective figures.

      (3) It remains unclear whether the clear behavioral effect seen in the TRPM2 knockout animals is at all related to TRPM2 functioning as a warmth sensor in sensory neurons. As discussed above, the effects of the TRPM2 KO on the proportion of warmth-sensing neurons are at most very subtle, and the authors did not use any pharmacological tool (in contrast to the use of capsaicin to probe for TRPV1 in Figures S3 and S4) to support a direct involvement of TRPM2 in the neuronal warmth responses. Behavioral experiments on sensory-neuron-specific TRPM2 knockout animals will be required to clarify this important point

      As mentioned above, we have toned down the correlation between the cellular and behavioral data. 

      In the discussion we now clearly describe three possibilities as to why the Trpm2 knockout animals only show a subtle cellular thermal phenotype but a strong behavioral thermal preference phenotype: (i) permanent deletion of Trpm2 may result in developmental defects and/or compensatory mechanisms; (ii) The DRG population expressing Trpm2 may be more relevant for autonomic thermoregulation rather than behavioral responses to temperature; (iii) Trpm2 expression outside DRGs (possibly in the hypothalamic POA) may account for the altered thermal behavior. 

      (4) The authors only use male mice, which is a significant limitation, especially considering known differences in warmth sensing between male and female animals and humans. The authors state "For this study, only male animals were used, as we aimed to compare our results with previous studies which exclusively used male animals (7, 8, 17, 43)." This statement is not correct: all four mentioned papers include behavioral data from both male and female mice! I recommend the authors to either include data from female mice or to clearly state that their study (in comparison with these other studies) only uses male mice.  

      This is a valid point -- when our study started 7-8 years ago, we only used male mice (as did many other researchers) and this we would now do differently. We have now newly included a statement concerning this limitation in the “Limitations of this study” section of the manuscript. 

      Nevertheless, in the studies by Tan et al. And Vandevauw et al. only male animals were used for the behavioral experiments. Yarmolinsky et al.  And Paricio-Montesinons et al. used both males and females while, as far as we can tell, only Paricio-Montesions et al. Reported that no difference was observed between the sexes. 

      Wildtypes are all C57bl/6N from the provider Janvier. Generally, all lines are backcrossed to C57bl/6 mice and additionally inbreeding was altered every 4-6 generations by crossing to C57bl/6. Exactly how many times the Trp channel KOs have been backcrossed to C57bl/6 mice we cannot exactly state.

      Reviewer #2 (Public Review): 

      Summary: 

      The authors of the study use a technically well-thought-out approach to dissect the question of how far TRPV1 and TRPM2 are involved in the perception of warm temperatures in mice. They supplement the experimental data with a drift-diffusion model. They find that TRPM2 is required to trigger the preference for 31{degree sign}C over warmer temperatures while TRPV1 increases the fidelity of afferent temperature information. A lack of either channel leads to a depletion of warm-sensing neurons and in the case of TRPV1 to a deficit in rapid responses to temperature changes. The study demonstrates that mouse phenotyping can only produce trustworthy results if the tools used to test them measure what we believe they are measuring. 

      Strengths: 

      The authors tackle a central question in physiology to which we have not yet found sufficient answers. They take a pragmatic approach by putting existing experimental methods to the test and refining them significantly. 

      Weaknesses: 

      It is difficult to find weaknesses. Not only the experimental methods but also the data analysis have been refined meticulously. There is no doubt that the authors achieved their aims and that the results support their conclusions. 

      There will certainly be some lasting impact on the future use of DRG cultures with respect to (I) the incubation periods, (II) how these data need to be analyzed, and (III) the numbers of neurons to be looked at. 

      As for the CPT assay, the future will have to show if mouse phenotyping results are more accurate with this technique. I'm more fond of full thermal gradient environments. However, behavioural phenotyping is still one of the most difficult fields in somatosensory research.  

      We thank the referee and were happy to read that the referee finds our study valuable and insightful. 

      Reviewer #3 (Public Review):  

      Summary and strengths: 

      In the manuscript, Abd El Hay et al investigate the role of thermally sensitive ion channels TRPM2 and TRPV1 in warm preference and their dynamic response features to thermal stimulation. They develop a novel thermal preference task, where both the floor and air temperature are controlled, and conclude that mice likely integrate floor with air temperature to form a thermal preference. They go on to use knockout mice and show that TRPM2-/- mice play a role in the avoidance of warmer temperatures. Using a new approach for culturing DRG neurons they show the involvement of both channels in warm responsiveness and dynamics. This is an interesting study with novel methods that generate important new information on the different roles of TRPV1 and TRPM2 on thermal behavior. 

      Open questions and weaknesses: 

      (1) Differences in the response features of cells expressing TRPM2 and TRPV1 are central and interesting findings but need further validation (Figures 3 and 4). To show differences in the dynamics and the amplitude of responses across different lines and stimulus amplitudes more clearly, the authors should show the grand average population calcium response from all responsive neurons with error bars for all 3 groups for the different amplitudes of stimuli (as has been presented for the thermal stimuli traces). The authors should also provide a population analysis of the amplitude of the responses in all groups to all stimulus amplitudes. Prior work suggests that thermal detection is supported by an enhancement or suppression of the ongoing activity of sensory fibers innervating the skin. The authors should present any data on cells with ongoing activity. 

      We have now included grand average population analysis of the different groups in the revised version, this is found in Figure 2E and F. Based on the referee’s suggestion and the new analysis, we now can report a (subtle) cellular phenotype observed in DRG cultures of Trpm2 deficient animals: when averaging all warmth responses, the new analysis suggests that Trpm2-deficient cultures lack modulation of the response magnitude across the three increasing consecutive warmth stimuli (33°C, 36°C and 39°C).

      Concerning the point about ongoing activity: We are not sure if it is possible in neuronal cultures to faithfully recapitulate ongoing activity. Ongoing activity has been mostly recorded in skinnerve preparations (or in older studies in other types of nerve recordings) and there are only very few studies that show ongoing activity in cultured neurons and in those instances the ongoing activity only starts in sensory neuron cultures when cultured for even longer time periods than 3 days (Ref.: doi: 10.1152/jn.00158.2018). We have very few cells that show some spontaneous activity, but these are too few to draw any conclusions. In any case, nerve fibers might be necessary to drive ongoing activity which are absent from our cultures.

      (2) The authors should better place their findings in context with the literature and highlight the novelty of their findings. The introduction builds a story of a 'disconnect' or 'contradictory' findings about the role of TRPV1 and TRPM2 in warm detection. While there are some disparate findings in the literature, Tan and McNaughton (2016) show a role for TRPM2 in the avoidance of warmth in a similar task, Paricio et al. (2020) show a significant reduction in warm perception in TRPM2 and TRPV1 knock out lines and Yarmolinksy et al. (2016) show a reduction in warm perception with TRPV1 inactivation. All these papers are therefore in agreement with the authors finding of a role for these channels in warm behavior. The authors should change their introduction and discussion to more correctly discuss the findings of these studies and to better pinpoint the novelty of their own work.  

      Paricio-Montesinos et al. argue that TRPM8 is crucial for the detection of warmth, as TRPM8KO animals are incapable of learning the operant task. TRPM2-KO animals and, to a smaller extent TRPV1-KO animals, have reduced sensitivity in the task, but are still capable of learning/performing the task. However, in our chamber preference assay this is reversed: TRPM2-KO animals lose the ability to differentiate warm temperatures while TRPM8 appears to play no major role. A commonality between the two studies is that while TRPV1 affects the detection of warm temperatures in the different assays, this ion channel appears not to be crucial. 

      Similarly, Yarmolinsky et al. show that Trpv1-inactivation only increases the error rate in their operant assay (from ~10% to ~30%), without testing TRPM2. And Tan et al. show the importance of TRPM2 in the preference task, without testing for TRPV1. 

      More generally, the choice of the assay, being either an operant task (Paricio-Montesinos et al. and Yarmolinsky et al.) or a preference assay without training of the mice (Tan et al. and our data here), might be important and different TRP receptors may be relevant for different types of temperature assays, which we have now included at the end of the discussion section in the revised manuscript. While our results generally agree with the previous studies, they add a different perspective on the analysis of the behavior (with correlation to cellular data). We now edited the manuscript to highlight the advances more clearly. 

      Nevertheless, we believe that a discrepancy between cellular and behavioral data in the former studies exists and we kept this in the introduction. We hope that our data and suggestions of more nuanced analysis of cellular and behavioral responses, in particular also differences in their kinetics, may be helping to guide future studies.  

      (3) The responses of 60 randomly selected cells are shown in Figure 2B. But, looking at the TRPM2-/- data, warm responses appear more obvious than in WTs and the weaker responders of the WT group appear weaker than the equivalent group in the TRPV1-/- and TRPM2-/- data. This does not necessarily invalidate the results, but it may suggest a problem in the data selection. Because the correct classification of warm-sensitive neurons is central to this part of the study more validation of the classifier should be presented. For example, the authors could state if they trained the classifier using equal amounts of cells, show some randomly selected cells that are warm-insensitive for all genotypes, and show the population average responses of warm-insensitive neurons.  

      The classifier was trained on a balanced dataset of 1000 (500 responders and 500 nonresponders), manually labelled traces across all 5 temperature stimuli. The prediction accuracy was 98%. We have now described more clearly how the classifier was trained (See Materials and Methods) and include examples of responders and non-responders, the population averages of each class as well as a confusion matrix of the classification in the revised manuscript (Suppl. Figure 4A and B).

      (4) The interpretation of the main behavioral results and justification of the last figure is presented as the result of changes in sensing but differences in this behavior could be due to many factors and this needs clarification and discussion. (i) The authors mention that 'crucially temperature perception is not static' and suggest that there are fluctuating changes in perception over time and conclude that their modelling approach helps show changes in temperature detection. They imply that temperature perceptual threshold changes over time, but the mouse could just as easily have had exactly the same threshold throughout the task but their motivation (or some other cognitive variable) might vary causing them to change chamber. The authors should correct this. (ii) Likewise, from their fascinating and high-profile prior work the authors suggest a model of internal temperature sensing whereby TRPM2 expression in the hypothalamus acts as an internal sensory of body temperature. Given this, and the slow time course of the behavior in chambers with different ambient temperatures, couldn't the reason for the behavioral differences be due to central changes in hypothalamic processing rather than detection by skin temperature? If TRPM2-/- were selectively ablated from the skin or the hypothalamus (these experiments are not necessary for this paper) it might be possible to conclude whether sensation or body temperature is more likely the root cause of these effects but, without further experiments it is tough to conclude either way. (iii) Because the ambient temperature is controlled in this behavior, another hypothesis is that warm avoidance could be due to negative valence associated with breathing warm air, i.e. a result of sensation within the body in internal pathways, rather than sensing from the external skin. Overall, the authors should tone down conclusions about sensation and present a more detailed discussion of these points.  

      We are sorry that the statement including the phrase “crucially temperature perception is not static” was ambiguous; We have now deleted this statement and instead included different possibilities as to why mice may switch from one chamber to the other stochastically. 

      As the referee mentioned, it is possible that some other variable (motivation etc.) makes the mouse change the chamber; Nevertheless, we hypothesize that this variable (whatever it might be) is still modulated by temperature (at least this would be the likeliest explanation that we see).

      As for the aspect of internal/hypothalamic temperature sensing and its dependence on Trpm2: we have included this possibility in the discussion in the manuscript. 

      As for the point of negative valence mediated by breathing in warm air: yes, presumably this could also be possible. The aspect of valence is in interesting aspect by itself: would the mice be rather repelled from the (uncomfortable) hot plate or more attracted to the (more comfortable) thermoneutral plate, or both? Something to elucidate in a different study.

      (5) It is an excellent idea to present a more in-depth analysis of the behavioral data collected during the preference task, beyond 'the mouse is on one side or the other'. However, the drift-diffusion approach is complex to interpret from the text in the results and the figures. The results text is not completely clear on which behavioral parameters are analyzed and terms like drift, noise, estimate, and evidence are not clearly defined. Currently, this section of the paper slightly confuses and takes the paper away from the central findings about dynamics and behavioral differences. It seems like they could come to similar conclusions with simpler analysis and simpler figures. 

      We have now reassessed the description of the drift diffusion model and explain it more clearly, this can be found on page 5 – 8. We have considered whether it will be better to introduce the drift diffusion model at the beginning of the study, subsequent to Figure 1 but we believe this to better suited at the end, because, indeed, the cellular results (and differences in kinetic response parameters observed in DRG cultures of Trpv1 KO mice) prompted us to assess the behavior in this way. Thus, the order of experiments presented here, represents also more the natural path the study took. 

      (6) In Figure 2D the % of warm-sensitive neurons are shown for each genotype. Each data point is a field of view, however, reading the figure legend there appear to be more FOVs than data points (eg 10 data points for the TRPV1-/- but 17 FOVs). The authors should check this. 

      We have checked and corrected the number of FOVs mentioned in the legend, and the number shown in the Figure 2D and its legend are now in agreement. 

      (7) Can the authors comment on why animals with over-expression of TRPV1 spend more time in the warmest chamber to start with at 38C and not at 34C?  

      This is an interesting observation that we did not consider before. A closer look at Figure 4H reveals that the majority of the TRPV1-OX animals, have a proportionally long first visit to the 38°C room. We can only speculate why this is the case. We cannot rule out that this a technical shortcoming of the assay and how we conduced it – but we did not observe this for the wildtype mice, thus it is rather unlikely a technical problem. It is possible that this is a type of “freezing-” (or “startle-“) behavior when the animals first encounter the 38°C temperature. Freezing behaviors in mice can be observed when sudden/threatening stimuli are applied. It is possible that, in the TRPV1-overexpressing animals, the initial encounter with 38°C leads to activation of a larger proportion of cells (compared to WT controls), possibly signaling a “threatening” stimulus, and thus leading to this startle effect. However, such a claim would require additional experiments to test such a hypothesis more rigorously.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      eLife Assessment

      This study presents valuable findings on the potential of short-movie viewing fMRI protocol to explore the functional and topographical organization of the visual system in awake infants and toddlers. Although the data are compelling given the difficulty of studying this population, the evidence presented is incomplete and would be strengthened by additional analyses to support the authors' claims. This study will be of interest to cognitive neuroscientists and developmental psychologists, especially those interested in using fMRI to investigate brain organisation in pediatric and clinical populations with limited fMRI tolerance.

      We are grateful for the thorough and thoughtful reviews. We have provided point-bypoint responses to the reviewers’ comments, but first, we summarize the major revisions here. We believe these revisions have substantially improved the clarity of the writing and impact of the results.

      Regarding the framing of the paper, we have made the following major changes in response to the reviews:

      (1) We have clarified that our goal in this paper was to show that movie data contains topographic, fine-grained details of the infant visual cortex. In the revision, we now state clearly that our results should not be taken as evidence that movies could replace retinotopy and have reworded parts of the manuscript that could mislead the reader in this regard.

      (2) We have added extensive details to the (admittedly) complex methods to make them more approachable. An example of this change is that we have reorganized the figure explaining the Shared Response Modelling methods to divide the analytic steps more clearly.

      (3) We have clarified the intermediate products contributing to the results by adding 6 supplementary figures that show the gradients for each IC or SRM movie and each infant participant.

      In response to the reviews, we have conducted several major analyses to support our findings further:

      (1) To verify that our analyses can identify fine-grained organization, we have manually traced and labeled adult data, and then performed the same analyses on them. The results from this additional dataset validate that these analyses can recover fine-grained organization of the visual cortex from movie data.

      (2) To further explore how visual maps derived from movies compare to alternative methods, we performed an anatomical alignment control analysis. We show that high-quality maps can be predicted from other participants using anatomical alignment.

      (3) To test the contribution of motion to the homotopy analyses, we regressed out the motion effects in these analyses. We found qualitatively similar results to our main analyses, suggesting motion did not play a substantial role.

      (4) To test the contribution of data quantity to the homotopy analyses, we correlated the amount of movie data collected from each participant with the homotopy results. We did not find a relationship between data quantity and the homotopy results. 

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Ellis et al. investigated the functional and topographical organization of the visual cortex in infants and toddlers, as evidenced by movie-viewing data. They build directly on prior research that revealed topographic maps in infants who completed a retinotopy task, claiming that even a limited amount of rich, naturalistic movie-viewing data is sufficient to reveal this organization, within and across participants. Generating this evidence required methodological innovations to acquire high-quality fMRI data from awake infants (which have been described by this group, and elsewhere) and analytical creativity. The authors provide evidence for structured functional responses in infant visual cortex at multiple levels of analyses; homotopic brain regions (defined based on a retinotopy task) responded more similarly to one another than to other brain regions in visual cortex during movie-viewing; ICA applied to movie-viewing data revealed components that were identifiable as spatial frequency, and to a lesser degree, meridian maps, and shared response modeling analyses suggested that visual cortex responses were similar across infants/toddlers, as well as across infants/toddlers and adults. These results are suggestive of fairly mature functional response profiles in the visual cortex in infants/toddlers and highlight the potential of movie-viewing data for studying finer-grained aspects of functional brain responses, but further evidence is necessary to support their claims and the study motivation needs refining, in light of prior research.

      Strengths:

      - This study links the authors' prior evidence for retinotopic organization of visual cortex in human infants (Ellis et al., 2021) and research by others using movie-viewing fMRI experiments with adults to reveal retinotopic organization (Knapen, 2021).

      - Awake infant fMRI data are rare, time-consuming, and expensive to collect; they are therefore of high value to the community. The raw and preprocessed fMRI and anatomical data analyzed will be made publicly available.

      We are grateful to the reviewer for their clear and thoughtful description of the strengths of the paper, as well as their helpful outlining of areas we could improve.

      Weaknesses:

      - The Methods are at times difficult to understand and in some cases seem inappropriate for the conclusions drawn. For example, I believe that the movie-defined ICA components were validated using independent data from the retinotopy task, but this was a point of confusion among reviewers. 

      We acknowledge the complexity of the methods and wish to clarify them as best as possible for the reviewers and the readers. We have extensively revised the methods and results sections to help avoid potential misunderstandings. For instance, we have revamped the figure and caption describing the SRM pipeline (Figure 5).

      To answer the stated confusion directly, the ICA components were derived from the movie data and validated on the (completely independent) retinotopy data. There were no additional tasks. The following text in the paper explains this point:

      “To assess the selected component maps, we correlated the gradients (described above) of the task-evoked and component maps. This test uses independent data: the components were defined based on movie data and validated against task-evoked retinotopic maps.” Pg. 11

      In either case: more analyses should be done to support the conclusion that the components identified from the movie reproduce retinotopic maps (for example, by comparing the performance of movie-viewing maps to available alternatives (anatomical ROIs, group-defined ROIs). 

      Before addressing this suggestion, we want to restate our conclusions: features of the retinotopic organization of infant visual cortex could be predicted from movie data. We did not conclude that movie data could ‘reproduce’ retinotopic maps in the sense that they would be a replacement. We recognize that this was not clear in our original manuscript and have clarified this point throughout, including in this section of the discussion:

      “To be clear, we are not suggesting that movies work well enough to replace a retinotopy task when accurate maps are needed. For instance, even though ICA found components that were highly correlated with the spatial frequency map, we also selected some components that turned out to have lower correlations. Without knowing the ground truth from a retinotopy task, there would be no way to weed these out. Additionally, anatomical alignment (i.e., averaging the maps from other participants and anatomically aligning them to a held-out participant) resulted in maps that were highly similar to the ground truth. Indeed, we previously[23] found that adult-defined visual areas were moderately similar to infants. While functional alignment with adults can outperform anatomical alignment methods in similar analyses[27], here we find that functional alignment is inferior to anatomical alignment. Thus, if the goal is to define visual areas in an infant that lacks task-based retinotopy, anatomical alignment of other participants’ retinotopic maps is superior to using movie-based analyses, at least as we tested it.” Pg. 21

      As per the reviewer’s suggestion and alluded to in the paragraph above, we have created anatomically aligned visual maps, providing an analogous test to the betweenparticipant analyses like SRM. We find that these maps are highly similar to the ground truth. We describe this result in a new section of the results:

      “We performed an anatomical alignment analog of the functional alignment (SRM) approach. This analysis serves as a benchmark for predicting visual maps using taskbased data, rather than movie data, from other participants. For each infant participant, we aggregated all other infant or adult participants as a reference. The retinotopic maps from these reference participants were anatomically aligned to the standard surface template, and then averaged. These averages served as predictions of the maps in the test participant, akin to SRM, and were analyzed equivalently (i.e., correlating the gradients in the predicted map with the gradients in the task-based map). These correlations (Table S4) are significantly higher than for functional alignment (using infants to predict spatial frequency, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.44, CI=[0.32–0.58], p<.001; using infants to predict meridians, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.61, CI=[0.47–0.74], p<.001; using adults to predict spatial frequency, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.31, CI=[0.21–0.42], p<.001; using adults to predict meridians, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.49, CI=[0.39–0.60], p<.001). This suggests that even if SRM shows that movies can be used to produce retinotopic maps that are significantly similar to a participant, these maps are not as good as those that can be produced by anatomical alignment of the maps from other participants without any movie data.” Pg. 16–17

      Also, the ROIs used for the homotopy analyses were defined based on the retinotopic task rather than based on movie-viewing data alone - leaving it unclear whether movie-viewing data alone can be used to recover functionally distinct regions within the visual cortex.

      We agree with the reviewer that our approach does not test whether movie-viewing data alone can be used to recover functionally distinct regions. The goal of the homotopy analyses was to identify whether there was functional differentiation of visual areas in the infant brain while they watch movies. This was a novel question that provides positive evidence that these regions are functionally distinct. In subsequent analyses, we show that when these areas are defined anatomically, rather than functionally, they also show differentiated function (e.g., Figure 2). Nonetheless, our intention was not to use the homotopy analyses to define the regions. We have added text to clarify the goal and novelty of this analysis.

      “Although these analyses cannot define visual maps, they test whether visual areas have different functional signatures.” Pg. 6

      Additionally, even if the goal were to define areas based on homotopy, we believe the power of that analysis would be questionable. We would need to use a large amount of the movie data to define the areas, leaving a low-powered dataset to test whether their function is differentiated by these movie-based areas.

      - The authors previously reported on retinotopic organization of the visual cortex in human infants (Ellis et al., 2021) and suggest that the feasibility of using movie-viewing experiments to recover these topographic maps is still in question. They point out that movies may not fully sample the stimulus parameters necessary for revealing topographic maps/areas in the visual cortex, or the time-resolution constraints of fMRI might limit the use of movie stimuli, or the rich, uncontrolled nature of movies might make them inferior to stimuli that are designed for retinotopic mapping, or might lead to variable attention between participants that makes measuring the structure of visual responses across individuals challenging. This motivation doesn't sufficiently highlight the importance or value of testing this question in infants. Further, it's unclear if/how this motivation takes into account prior research using movie-viewing fMRI experiments to reveal retinotopic organization in adults (e.g., Knapen, 2021). Given the evidence for retinotopic organization in infants and evidence for the use of movie-viewing experiments in adults, an alternative framing of the novel contribution of this study is that it tests whether retinotopic organization is measurable using a limited amount of movie-viewing data (i.e., a methodological stress test). The study motivation and discussion could be strengthened by more attention to relevant work with adults and/or more explanation of the importance of testing this question in infants (is the reason to test this question in infants purely methodological - i.e., as a way to negate the need for retinotopic tasks in subsequent research, given the time constraints of scanning human infants?).

      We are grateful to the reviewer for giving us the opportunity to clarify the innovations of this research. We believe that this research contributes to our understanding of how infants process dynamic stimuli, demonstrates the viability and utility of movie experiments in infants, and highlights the potential for new movie-based analyses (e.g., SRM). We have now consolidated these motivations in the introduction to more clearly motivate this work:

      “The primary goal of the current study is to investigate whether movie-watching data recapitulates the organization of visual cortex. Movies drive strong and naturalistic responses in sensory regions while minimizing task demands[12, 13, 24] and thus are a proxy for typical experience. In adults, movies and resting-state data have been used to characterize the visual cortex in a data-driven fashion[25–27]. Movies have been useful in awake infant fMRI for studying event segmentation[28], functional alignment[29], and brain networks[30]. However, this past work did not address the granularity and specificity of cortical organization that movies evoke. For example, movies evoke similar activity in infants in anatomically aligned visual areas[28], but it remains unclear whether responses to movie content differ between visual areas (e.g., is there more similarity of function within visual areas than between31). Moreover, it is unknown whether structure within visual areas, namely visual maps, contributes substantially to visual evoked activity. Additionally, we wish to test whether methods for functional alignment can be used with infants. Functional alignment finds a mapping between participants using functional activity – rather than anatomy – and in adults can improve signal-to-noise, enhance across participant prediction, and enable unique analyses[27, 32–34].” Pg. 3-4

      Furthermore, the introduction culminates in the following statement on what the analyses will tell us about the nature of movie-driven activity in infants:

      “These three analyses assess key indicators of the mature visual system: functional specialization between areas, organization within areas, and consistency between individuals.” Pg. 5

      Furthermore, in the discussion we revisit these motivations and elaborate on them further:

      [Regarding homotopy:] “This suggests that visual areas are functionally differentiated in infancy and that this function is shared across hemispheres[31].” Pg. 19

      [Regarding ICA:] “This means that the retinotopic organization of the infant brain accounts for a detectable amount of variance in visual activity, otherwise components resembling these maps would not be discoverable.” Pg. 19–20

      [Regarding SRM:] “This is initial evidence that functional alignment may be useful for enhancing signal quality, like it has in adults[27,32,33], or revealing changing function over development[45].” Pg. 21

      Additionally, we have expanded our discussion of relevant work that uses similar methods such as the excellent research from Knapen (2021) and others:

      “In adults, movies and resting-state data have been used to characterize the visual cortex in a data-driven fashion[25-27].” Pg. 4

      “We next explored whether movies can reveal fine-grained organization within visual areas by using independent components analysis (ICA) to propose visual maps in individual infant brains[25,26,35,42,43].” Pg. 9

      Reviewer #2 (Public Review):

      Summary:

      This manuscript shows evidence from a dataset with awake movie-watching in infants, that the infant brain contains areas with distinct functions, consistent with previous studies using resting state and awake task-based infant fMRI. However, substantial new analyses would be required to support the novel claim that movie-watching data in infants can be used to identify retinotopic areas or to capture within-area functional organization.

      Strengths:

      The authors have collected a unique dataset: the same individual infants both watched naturalistic animations and a specific retinotopy task. These data position the authors to test their novel claim, that movie-watching data in infants can be used to identify retinotopic areas.

      Weaknesses:

      To claim that movie-watching data can identify retinotopic regions, the authors should provide evidence for two claims:

      - Retinotopic areas defined based only on movie-watching data, predict retinotopic responses in independent retinotopy-task-driven data.

      - Defining retinotopic areas based on the infant's own movie-watching response is more accurate than alternative approaches that don't require any movie-watching data, like anatomical parcellations or shared response activation from independent groups of participants.

      We thank the reviewer for their comments. Before addressing their suggestions, we wish to clarify that we do not claim that movie data can be used to identify retinotopic areas, but instead that movie data captures components of the within and between visual area organization as defined by retinotopic mapping. We recognize that this was not clear in our original manuscript and have clarified this point throughout, including in this section of the discussion:

      “To be clear, we are not suggesting that movies work well enough to replace a retinotopy task when accurate maps are needed. For instance, even though ICA found components that were highly correlated with the spatial frequency map, we also selected some components that turned out to have lower correlations. Without knowing the ground truth from a retinotopy task, there would be no way to weed these out. Additionally, anatomical alignment (i.e., averaging the maps from other participants and anatomically aligning them to a held-out participant) resulted in maps that were highly similar to the ground truth. Indeed, we previously[23] found that adult-defined visual areas were moderately similar to infants. While functional alignment with adults can outperform anatomical alignment methods in similar analyses[27], here we find that functional alignment with infants is inferior to anatomical alignment. Thus, if the goal is to define visual areas in an infant that lacks task-based retinotopy, anatomical alignment of other participants’ retinotopic maps is superior to using movie-based analyses, at least as we tested it.” Pg. 21

      In response to the reviewer’s suggestion, we compare the maps identified by SRM to the averaged, anatomically aligned maps from infants. We find that these maps are highly similar to the task-based ground truth and we describe this result in a new section:

      “We performed an anatomical alignment analog of the functional alignment (SRM) approach. This analysis serves as a benchmark for predicting visual maps using taskbased data, rather than movie data, from other participants. For each infant participant, we aggregated all other infant or adult participants as a reference. The retinotopic maps from these reference participants were anatomically aligned to the standard surface template, and then averaged. These averages served as predictions of the maps in the test participant, akin to SRM, and were analyzed equivalently (i.e., correlating the gradients in the predicted map with the gradients in the task-based map). These correlations (Table S4) are significantly higher than for functional alignment (using infants to predict spatial frequency, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.44, CI=[0.32–0.58], p<.001; using infants to predict meridians, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.61, CI=[0.47–0.74], p<.001; using adults to predict spatial frequency, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.31, CI=[0.21–0.42], p<.001; using adults to predict meridians, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.49, CI=[0.39–0.60], p<.001). This suggests that even if SRM shows that movies can be used to produce retinotopic maps that are significantly similar to a participant, these maps are not as good as those that can be produced by anatomical alignment of the maps from other participants without any movie data.” Pg. 16–17

      Note that we do not compare the anatomically aligned maps with the ICA maps statistically. This is because these analyses are not comparable: ICA is run withinparticipant whereas anatomical alignment is necessarily between-participant — either infant or adults. Nonetheless, an interested reader can refer to the Table where we report the results of anatomical alignment and see that anatomical alignment outperforms ICA in terms of the correlation between the predicted and task-based maps.

      Both of these analyses are possible, using the (valuable!) data that these authors have collected, but these are not the analyses that the authors have done so far. Instead, the authors report the inverse of (1): regions identified by the retinotopy task can be used to predict responses in the movies. The authors report one part of (2), shared responses from other participants can be used to predict individual infants' responses in the movies, but they do not test whether movie data from the same individual infant can be used to make better predictions of the retinotopy task data, than the shared response maps.

      So to be clear, to support the claims of this paper, I recommend that the authors use the retinotopic task responses in each individual infant as the independent "Test" data, and compare the accuracy in predicting those responses, based on:

      -  The same infant's movie-watching data, analysed with MELODIC, when blind experimenters select components for the SF and meridian boundaries with no access to the ground-truth retinotopy data.

      -  Anatomical parcellations in the same infant.

      -  Shared response maps from groups of other infants or adults.

      -  (If possible, ICA of resting state data, in the same infant, or from independent groups of infants).

      Or, possibly, combinations of these techniques.

      If the infant's own movie-watching data leads to improved predictions of the infant's retinotopic task-driven response, relative to these existing alternatives that don't require movie-watching data from the same infant, then the authors' main claim will be supported.

      These are excellent suggestions for additional analyses to test the suitability for moviebased maps to replace task-based maps. We hope it is now clear that it was never our intention to claim that movie-based data could replace task-based methods. We want to emphasize that the discoveries made in this paper — that movies evoke fine-grained organization in infant visual cortex — do not rely on movie-based maps being better than alternative methods for producing maps, such as the newly added anatomical alignment.

      The proposed analysis above solves a critical problem with the analyses presented in the current manuscript: the data used to generate maps is identical to the data used to validate those maps. For the task-evoked maps, the same data are used to draw the lines along gradients and then test for gradient organization. For the component maps, the maps are manually selected to show the clearest gradients among many noisy options, and then the same data are tested for gradient organization. This is a double-dipping error. To fix this problem, the data must be split into independent train and test subsets.

      We appreciate the reviewer’s concern; however, we believe it is a result of a miscommunication in our analytic strategy. We have now provided more details on the analyses to clarify how double-dipping was avoided. 

      To summarize, a retinotopy task produced visual maps that were used to trace both area boundaries and gradients across the areas. These data were then fixed and unchanged, and we make no claims about the nature of these maps in this paper, other than to treat them as the ground truth to be used as a benchmark in our analyses. The movie data, which are collected independently from the same infant in the session, used the boundaries from the retinotopy task (in the case of homotopy) or were compared with the maps from the retinotopy task (in the case of ICA and SRM). In other words, the statement that “the data used to generate maps is identical to the data used to validate those maps” is incorrect because we generated the maps with a retinotopy task and validated the maps with the movie data. This means no double dipping occurred.

      Perhaps a cause of the reviewer’s interpretation is that the gradients used in the analysis are not clearly described. We now provide this additional description:  “Using the same manually traced lines from the retinotopy task, we measured the intensity gradients in each component from the movie-watching data. We can then use the gradients of intensity in the retinotopy task-defined maps as a benchmark for comparison with the ICA-derived maps.” Pg. 10

      Regarding the SRM analyses, we take great pains to avoid the possibility of data contamination. To emphasize how independent the SRM analysis is, the prediction of the retinotopic map from the test participant does not use their retinotopy data at all; in fact, the predicted maps could be made before that participant’s retinotopy data were ever collected. To make this prediction for a test participant, we need to learn the inversion of the SRM, but this only uses the movie data of the test participant. Hence, there is no double-dipping in the SRM analyses. We have elaborated on this point in the revision, and we remade the figure and its caption to clarify this point:

      We also have updated the description of these results to emphasize how double-dipping was avoided:

      “We then mapped the held-out participant's movie data into the learned shared space without changing the shared space (Figure 5c). In other words, the shared response model was learned and frozen before the held-out participant’s data was considered.

      This approach has been used and validated in prior SRM studies[45].” Pg. 14

      The reviewer suggests that manually choosing components from ICA is double-dipping. Although the reviewer is correct that the manual selection of components in ICA means that the components chosen ought to be good candidates, we are testing whether those choices were good by evaluating those components against the task-based maps that were not used for the ICA. Our statistical analyses evaluate whether the components chosen were better than the components that would have been chosen by random chance. Critically: all decisions about selecting the components happen before the components are compared to the retinotopic maps. Hence there is no double-dipping in the selection of components, as the choice of candidate ICA maps is not informed by the ground-truth retinotopic maps. We now clarify what the goal of this process is in the results:

      “Success in this process requires that 1) retinotopic organization accounts for sufficient variance in visual activity to be identified by ICA and 2) experimenters can accurately identify these components.” Pg. 10

      The reviewer also alludes to a concern that the researcher selecting the maps was not blind to the ground-truth retinotopic maps from participants and this could have influenced the results. In such a scenario, the researcher could have selected components that have the gradients of activity in the places that the infant has as ground truth. The researcher who made the selection of components (CTE) is one of the researchers who originally traced the areas in the participants approximately a year prior to the identification of ICs. The researcher selecting the components didn’t use the ground-truth retinotopic maps as reference, nor did they pay attention to the participant IDs when sorting the IC components. Indeed, they weren’t trying to find participant specific maps per se, but rather aimed to find good candidate retinotopic maps in general. In the case of the newly added adult analyses, the ICs were selected before the retinotopic mapping was reviewed or traced; hence, no knowledge about the participant-specific ground truth could have influenced the selection of ICs. Even with this process from adults, we find results of comparable strength as we found in infants, as shown below. Nonetheless, there is a possibility that this researcher’s previous experience of tracing the infant maps could have influenced their choice of components at the participant-specific level. If so, it was a small effect since the components the researcher selected were far from the best possible options (i.e., rankings of the selected components averaged in the 64th percentile for spatial frequency maps and the 68th percentile for meridian maps). We believe all reasonable steps were taken to mitigate bias in the selection of ICs.

      Reviewer #3 (Public Review):

      The manuscript reports data collected in awake toddlers recording BOLD while watching videos. The authors analyse the BOLD time series using two different statistical approaches, both very complex but do not require any a priori determination of the movie features or contents to be associated with regressors. The two main messages are that 1) toddlers have occipital visual areas very similar to adults, given that an SRM model derived from adult BOLD is consistent with the infant brains as well; 2) the retinotopic organization and the spatial frequency selectivity of the occipital maps derived by applying correlation analysis are consistent with the maps obtained by standard and conventional mapping.

      Clearly, the data are important, and the author has achieved important and original results. However, the manuscript is totally unclear and very difficult to follow; the figures are not informative; the reader needs to trust the authors because no data to verify the output of the statistical analysis are presented (localization maps with proper statistics) nor so any validation of the statistical analysis provided. Indeed what I think that manuscript means, or better what I understood, may be very far from what the authors want to present, given how obscure the methods and the result presentation are.

      In the present form, this reviewer considers that the manuscript needs to be totally rewritten, the results presented each technique with appropriate validation or comparison that the reader can evaluate.

      We are grateful to the reviewer for the chance to improve the paper. We have broken their review into three parts: clarification of the methods, validation of the analyses, and enhancing the visualization.

      Clarification of the methods

      We acknowledge that the methods we employed are complex and uncommon in many fields of neuroimaging. That said, numerous papers have conducted these analyses on adults (Beckman et al., 2005; Butt et al., 2015; Guntupalli et al., 2016; Haak & Beckman, 2018; Knapen, 2021; Lu et al., 2017) and non-human primates (Arcaro & Livingstone, 2017; Moeller et al., 2009). We have redoubled our efforts in the revision to make the methods as clear as possible, expanding on the original text and providing intuitions where possible. These changes have been added throughout and are too vast in number to repeat here, especially without context, but we hope that readers will have an easier time following the analyses now. 

      Additionally, we updated Figures 3 and 5 in which the main ICA and SRM analyses are described. For instance, in Figure 3’s caption we now add details about how the gradient analyses were performed on the components: 

      “We used the same lines that were manually traced on the task-evoked map to assess the change in the component’s response. We found a monotonic trend within area from medial to lateral, just like we see in the ground truth.” Pg. 11

      Regarding Figure 5, we reconsidered the best way to explain the SRM analyses and decided it would be helpful to partition the diagram into steps, reflecting the analytic process. These updates have been added to Figure 5, and the caption has been updated accordingly.

      We hope that these changes have improved the clarity of the methods. For readers interested in learning more, we encourage them to either read the methods-focused papers that debut the analyses (e.g., Chen et al., 2015), read the papers applying the methods (e.g., Guntupalli et al., 2016), or read the annotated code we publicly release which implements these pipelines and can be used to replicate the findings.

      Validation of the analyses

      One of the requests the reviewer makes is to validate our analyses. Our initial approach was to lean on papers that have used these methods in adults or primates (e.g., Arcaro, & Livingstone, 2017; Beckman et al., 2005; Butt et al., 2015; Guntupalli et al., 2016; Haak & Beckman, 2018; Knapen, 2021; Moeller et al., 2009) where the underlying organization and neurophysiology is established. However, we have made changes to these methods that differ from their original usage (e.g., we used SRM rather than hyperalignment, we use meridian mapping rather than traveling wave retinotopy, we use movie-watching data rather than rest). Hence, the specifics of our design and pipeline warrant validation. 

      To add further validation, we have rerun the main analyses on an adult sample. We collected 8 adult participants who completed the same retinotopy task and a large subset of the movies that infants saw. These participants were run under maximally similar conditions to infants (i.e., scanned using the same parameters and without the top of the head-coil) and were preprocessed using the same pipeline. Given that the relationship between adult visual maps and movie-driven (or resting-state) analyses has been shown in many studies (Beckman et al., 2005; Butt et al., 2015; Guntupalli et al., 2016; Haak & Beckman, 2018; Knapen, 2021; Lu et al., 2017), these adult data serve as a validation of our analysis pipeline. These adult participants were included in the original manuscript; however, they were previously only used to support the SRM analyses (i.e., can adults be used to predict infant visual maps). The adult results are described before any results with infants, as a way to engender confidence. Moreover, we have provided new supplementary figures of the adult results that we hope will be integrated with the article when viewing it online, such that it will be easy to compare infant and adult results, as per the reviewer’s request. 

      As per the figures and captions below, the analyses were all successful with the adult participants: 1) Homotopic correlations are higher than correlations between comparable areas in other streams or areas that are more distant within stream. 2) A multidimensional scaling depiction of the data shows that areas in the dorsal and ventral stream are dissimilar. 3) Using independent components analysis on the movie data, we identified components that are highly correlated with the retinotopy task-based spatial frequency and meridian maps. 4) Using shared response modeling on the movie data, we predicted maps that are highly correlated with the retinotopy task-based spatial frequency and meridian maps.

      These supplementary analyses are underpowered for between-group comparisons, so we do not statistically compare the results between infants and adults. Nonetheless, the pattern of adult results is comparable overall to the infant results. 

      We believe these adult results provide a useful validation that the infant analyses we performed can recover fine-grained organization.

      Enhancing the visualization

      The reviewer raises an additional concern about the lack of visualization of the results. We recognize that the plots of the summary statistics do not provide information about the intermediate analyses. Indeed, we think the summary statistics can understate the degree of similarity between the components or predicted visual maps and the ground truth. Hence, we have added 6 new supplementary figures showing the intensity gradients for the following analyses: 1. spatial frequency prediction using ICA, 2. meridian prediction using ICA, 3. spatial frequency prediction using infant SRM, 4. meridian prediction using infant SRM, 5. spatial frequency prediction using adult SRM, and 6. meridian prediction using adult SRM.

      We hope that these visualizations are helpful. It is possible that the reviewer wishes us to also visually present the raw maps from the ICA and SRM, akin to what we show in Figure 3A and 3B. We believe this is out of scope of this paper: of the 1140 components that were identified by ICA, we selected 36 for spatial frequency and 17 for meridian maps. We also created 20 predicted maps for spatial frequency and 20 predicted meridian maps using SRM. This would result in the depiction of 93 subfigures, requiring at least 15 new full-page supplementary figures to display with adequate resolution. Instead, we encourage the reader to access this content themselves: we have made the code to recreate the analyses publicly available, as well as both the raw and preprocessed data for these analyses, including the data for each of these selected maps.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) As mentioned in the public review, the authors should consider incorporating relevant adult fMRI research into the Introduction and explain the importance of testing this question in infants.

      Our public response describes the several citations to relevant adult research we have added, and have provided further motivation for the project.

      (2) The authors should conduct additional analyses to support their conclusion that movie data alone can generate accurate retinotopic maps (i.e., by comparing this approach to other available alternatives).

      We have clarified in our public response that we did not wish to conclude that movie data alone can generate accurate retinotopic maps, and have made substantial edits to the text to emphasize this. Thus, because this claim is already not supported by our analyses, we do not think it is necessary to test it further.

      (3) The authors should re-do the homotopy analyses using movie-defined ROIs (i.e., by splitting the movie-viewing data into independent folds for functional ROI definition and analyses).

      As stated above, defining ROIs based on the movie content is not the intended goal of this project. Even if that were the general goal, we do not believe that it would be appropriate to run this specific analysis with the data we collected. Firstly, halving the data for ROI definition (e.g., using half the movie data to identify and trace areas, and then use those areas in the homotopy analysis to run on the other half of data) would qualitatively change the power of the analyses described here. Secondly, we would be unable to define areas beyond hV4/V3AB with confidence, since our retinotopic mapping only affords specification of early visual cortex. Thus we could not conduct the MDS analyses shown in Figure 2.

      (4) If the authors agree that a primary contribution of this study and paper is to showcase what is possible to do with a limited amount of movie-viewing data, then they should make it clearer, sooner, how much usable movie data they have from infants. They could also consider conducting additional analyses to determine the minimum amount of fMRI data necessary to reveal the same detailed characteristics of functional responses in the visual cortex.

      We agree it would be good to highlight the amount of movie data used. When the infant data is first introduced in the results section, we now state the durations:

      “All available movies from each session were included (Table S2), with an average duration of 540.7s (range: 186--1116s).” Pg. 5

      Additionally, we have added a homotopy analysis that describes the contribution of data quantity to the results observed. We compare the amount of data collected with the magnitude of same vs. different stream effect (Figure 1B) and within stream distance effect (Figure 1C). We find no effect of movie duration in the sample we tested, as reported below:

      “We found no evidence that the variability in movie duration per participant correlated with this difference [of same stream vs. different stream] (r=0.08, p=.700).” Pg. 6-7

      “There was no correlation between movie duration and the effect (Same > Adjacent: r=-0.01, p=.965, Adjacent > Distal: r=-0.09, p=.740).” Pg. 7

      (5) If any of the methodological approaches are novel, the authors should make this clear. In particular, has the approach of visually inspecting and categorizing components generated from ICA and movie data been done before, in adults/other contexts?

      The methods we employed are similar to others, as described in the public review.

      However, changes were necessary to apply them to infant samples. For instance, Guntupalli et al. (2016) used hyperalignment to predict the visual maps of adult participants, whereas we use SRM. SRM and hyperalignment have the same goal — find a maximally aligned representation between participants based on brain function — but their implementation is different. The application of functional alignment to infants is novel, as is their use in movie data that is relatively short by comparison to standard adult data. Indeed, this is the most thorough demonstration that SRM — or any functional alignment procedure — can be usefully applied to infant data, awake or sleeping. We have clarified this point in the discussion.

      “This is initial evidence that functional alignment may be useful for enhancing signal quality, like it has in adults[27,32,33], or revealing changing function over development[45], which may prove especially useful for infant fMRI[52].” Pg. 21

      (6) The authors found that meridian maps were less identifiable from ICA and movie data and suggest that this may be because these maps are more susceptible to noise or gaze variability. If this is the case, you might predict that these maps are more identifiable in adult data. The authors could consider running additional analyses with their adult participants to better understand this result.

      As described in the manuscript, we hypothesize that meridian maps are more difficult to identify than spatial frequency maps because meridian maps are a less smooth, more fine-grained map than spatial frequency. Indeed, it has previously been reported (Moeller et al., 2009) that similar procedures can result in meridian maps that are constituted by multiple independent components (e.g., a component sensitive to horizontal orientations, and a separate component sensitive to vertical components). Nonetheless, we have now conducted the ICA procedure on adult participants and again find it is easier to identify spatial frequency components compared to meridian maps, as reported in the public review.

      Minor corrections:

      (1) Typo: Figure 3 title: "Example retintopic task vs. ICA-based spatial frequency maps.".

      Fixed

      (2) Given the age range of the participants, consider using "infants and toddlers"? (Not to diminish the results at all; on the contrary, I think it is perhaps even more impressive to obtain awake fMRI data from ~1-2-year-olds). Example: Figure 3 legend: "A) Spatial frequency map of a 17.1-monthold infant.".

      We agree with the reviewer that there is disagreement about the age range at which a child starts being considered a toddler. We have changed the terms in places where we refer to a toddler in particular (e.g., the figure caption the reviewer highlights) and added the phrase “infants and toddlers” in places where appropriate. Nonetheless, we have kept “infants” in some places, particularly those where we are comparing the sample to adults. Adding “and toddlers” could imply three samples being compared which would confuse the reader.

      (3) Figure 6 legend: The following text should be omitted as there is no bar plot in this figure: "The bar plot is the average across participants. The error bar is the standard error across participants.".

      Fixed

      (4) Table S1 legend: Missing first single quote: Runs'.

      Fixed

      Reviewer #2 (Recommendations For The Authors):

      I request that this paper cite more of the existing literature on the fMRI of human infants and toddlers using task-driven and resting-state data. For example, early studies by (first authors) Biagi, Dehaene-Lambertz, Cusack, and Fransson, and more recent studies by Chen, Cabral, Truzzi, Deen, and Kosakowski.

      We have added several new citations of recent task-based and resting state studies to the second sentence of the main text:

      “Despite the recent growth in infant fMRI[1-6], one of the most important obstacles facing this research is that infants are unable to maintain focus for long periods of time and struggle to complete traditional cognitive tasks[7].”

      Reviewer #3 (Recommendations For The Authors):

      In the following, I report some of my main perplexities, but many more may arise when the material is presented more clearly.

      The age of the children varies from 5 months to about 2 years. While the developmental literature suggests that between 1 and 2 years children have a visual system nearly adult-like, below that age some areas may be very immature. I would split the sample and perhaps attempt to validate the adult SRM model with the youngest children (and those can be called infants).

      We recognize the substantial age variability in our sample, which is why we report participant-specific data in our figures. While splitting up the data into age bins might reveal age effects, we do not think we can perform adequately powered null hypothesis testing of the age trend. In order to investigate the contribution of age, larger samples will be needed. That said, we can see from the data that we have reported that any effect of age is likely small. To elaborate: Figures 4 and 6 report the participant-specific data points and order the participants by age. There are no clear linear trends in these plots, thus there are no strong age effects.

      More broadly, we do not think there is a principled way to divide the participants by age. The reviewer suggests that the visual system is immature before the first year of life and mature afterward; however, such claims are the exact motivation for the type of work we are doing here, and the verdict is still out. Indeed, the conclusion of our earlier work reporting retinotopy in infants (Ellis et al., 2021) suggests that the organization of the early visual cortex in infants as young as 5 months — the youngest infant in our sample — is surprisingly adult-like.

      The title cannot refer to infants given the age span.

      There is disagreement in the field about the age at which it is appropriate to refer to children as infants. In this paper, and in our prior work, we followed the practice of the most attended infant cognition conference and society, the International Congress of Infant Studies (ICIS), which considers infants as those aged between 0-3 years old, for the purposes of their conference. Indeed, we have never received this concern across dozens of prior reviews for previous papers covering a similar age range. That said, we understand the spirit of the reviewer’s comment and now refer to the sample as “infants and toddlers” and to older individuals in our sample as “toddlers” wherever it is appropriate (the younger individuals would fairly be considered “infants” under any definition).

      Figure 1 is clear and an interesting approach. Please also show the average correlation maps on the cortical surface.

      While we would like to create a figure as requested, we are unsure how to depict an area-by-area correlation map on the cortical surface. One option would be to generate a seed-based map in which we take an area and depict the correlation of that seed (e.g., vV1) with all other voxels. This approach would result in 8 maps for just the task-defined areas, and 17 maps for anatomically-defined areas. Hence, we believe this is out of scope of this paper, but an interested reader could easily generate these maps from the data we have released.

      Figure 2 results are not easily interpretable. Ventral and dorsal V1-V3 areas represent upper or lower VF respectively. Higher dorsal and ventral areas represent both upper and lower VF, so we should predict an equal distance between the two streams. Again, how can we verify that it is not a result of some artifacts?

      In adults, visual areas differ in their functional response properties along multiple dimensions, including spatial coding. The dorsal/ventral stream hypothesis is derived from the idea that areas in each stream support different functions, independent of spatial coding. The MDS analysis did not attempt to isolate the specific contribution of spatial representations of each area but instead tested the similarity of function that is evoked in naturalistic viewing. Other covariance-based analyses specifically isolate the contribution of spatial representations (Haak et al., 2013); however, they use a much more constrained analysis than what was implemented here. The fact that we find broad differentiation of dorsal and ventral visual areas in infants is consistent with adults (Haak & Beckman, 2018) and neonate non-human primates (Arcaro & Livingstone, 2017). 

      Nonetheless, we recognize that we did not mention the differences in visual field properties across areas and what that means. If visual field properties alone drove the functional response then we would expect to see a clustering of areas based on the visual field they represent (e.g., hV4 and V3AB should have similar representations). Since we did not see that, and instead saw organization by visual stream, the result is interesting and thus warrants reporting. We now mention this difference in visual fields in the manuscript to highlight the surprising nature of the result.

      “This separation between streams is striking when considering that it happens despite differences in visual field representations across areas: while dorsal V1 and ventral V1 represent the lower and upper visual field, respectively, V3A/B and hV4 both have full visual field maps. These visual field representations can be detected in adults[41]; however, they are often not the primary driver of function[39]. We see that in infants too: hV4 and V3A/B represent the same visual space yet have distinct functional profiles.” Pg. 8

      The reviewer raises a concern that the MDS result may be spurious and caused by noise. Below, we present three reasons why we believe these results are not accounted for by artifacts but instead reflect real functional differentiation in the visual cortex. 

      (1) Figure 2 is a visualization of the similarity matrix presented in Figure S1. In Figure S1, we report the significance testing we performed to confirm that the patterns differentiating dorsal and ventral streams — as well as adjacent areas from distal areas — are statistically reliable across participants. If an artifact accounted for the result then it would have to be a kind of systematic noise that is consistent across participants.

      (2) One of the main sources of noise (both systematic and non-systematic) with infant fMRI is motion. Homotopy is a within-participant analysis that could be biased by motion. To assess whether motion accounts for the results, we took a conservative approach of regressing out the framewise motion (i.e., how much movement there is between fMRI volumes) from the comparisons of the functional activity in regions. Although the correlations numerically decreased with this procedure, they were qualitatively similar to the analysis that does not regress out motion:

      “Additionally, if we control for motion in the correlation between areas --- in case motion transients drive consistent activity across areas --- then the effects described here are negligibly different (Figure S5).” Pg. 7

      (3) We recognize that despite these analyses, it would be helpful to see what this pattern looks like in adults where we know more about the visual field properties and the function of dorsal and ventral streams. This has been done previously (e.g., Haak & Beckman, 2018), but we have now run those analyses on adults in our sample, as described in the public review. As with infants, there are reliable differences in the homotopy between streams (Figure S1). The MDS results show that the adult data was more complex than the infant data, since it was best described by 3 dimensions rather than 2. Nonetheless, there is a rotation of the MDS such that the structure of the ventral and dorsal streams is also dissociable. 

      Figure 3 also raises several alternative interpretations. The spatial frequency component in B has strong activity ONLY at the extreme border of the VF and this is probably the origin of the strong correlation. I understand that it is only one subject, but this brings the need to show all subjects and to report the correlation. Also, it is important to show the putative average ICA for retinotopy and spatial frequencies across subjects and for adults. All methods should be validated on adults where we have clear data for retinotopy and spatial frequency.

      The reviewer notes that the component in Figure 3 shows strong negative response in the periphery. It is often the case, as reported elsewhere (Moeller et al., 2009), that ICA extracts portions of visual maps. To make a full visual map would require combining components into a composite (e.g., a component that has a high response in the periphery and another component that has a high response in the fovea). If we were to claim that this component, or others like it, could replace the need for retinotopic mapping, then we would want to produce these composite maps; however, our conclusion in this project is that the topographic information of retinotopic maps manifest in individual components of ICA. For this purpose, the analysis we perform adequately assesses this topography.

      Regarding the request to show the results for all subjects, we address this in the public response and repeat it here briefly: we have added 6 new figures to show results akin to Figure 3C and D. It is impractical to show the equivalent of Figure 3A and B for all participants, yet we do release the data necessary to see to visualize these maps easily.

      Finally, the reviewer suggests that we validate the analyses on adult participants. As shown in Figure S3 and reported in the public response, we now run these analyses on adult participants and observe qualitatively similar results to infants.

      How much was the variation in the presumed spatial frequency map? Is it consistent with the acuity range? 5-month-old infants should have an acuity of around 10c/deg, depending on the mean luminance of the scene.

      The reviewer highlights an important weakness of conducting ICA: we cannot put units on the degree of variation we see in components. We now highlight this weakness in the discussion:

      “Another limitation is that ICA does not provide a scale to the variation: although we find a correlation between gradients of spatial frequency in the ground truth and the selected component, we cannot use the component alone to infer the spatial frequency selectivity of any part of cortex. In other words, we cannot infer units of spatial frequency sensitivity from the components alone.” Pg. 20

      Figure 5 pipeline is totally obscure. I presumed that I understood, but as it is it is useless. All methods should be clearly described, and the intermediate results should be illustrated in figures and appropriately discussed. Using such blind analyses in infants in principle may not be appropriate and this needs to be verified. Overall all these techniques rely on correlation activities that are all biased by head movement, eye movement, and probably the dummy sucking. All those movements need to be estimated and correlated with the variability of the results. It is a strong assumption that the techniques should work in infants, given the presence of movements.

      We recognize that the SRM methods are complex. Given this feedback, we remade Figure 5 with explicit steps for the process and updated the caption (as reported in the public review).

      Regarding the validation of these methods, we have added SRM analyses from adults and find comparable results. This means that using these methods on adults with comparable amounts of data as what we collected from infants can predict maps that are highly similar to the real maps. Even so, it is not a given that these methods are valid in infants. We present two considerations in this regard. 

      First, as part of the SRM analyses reported in the manuscript, we show that control analyses are significantly worse than the real analyses (indicated by the lines on Figure 6). To clarify the control analysis: we break the mapping (i.e., flip the order of the data so that it is backwards) between the test participant and the training participants used to create the SRM. The fact that this control analysis is significantly worse indicates that SRM is learning meaningful representations that matter for retinotopy. 

      Second, we believe that this paper is a validation of SRM for infants. Infant fMRI is a nascent field and SRM has the potential to increase the signal quality in this population. We hope that readers will see these analyses as a proof of concept that SRM can be used in their work with infants. We have stated this contribution in the paper now.

      “Additionally, we wish to test whether methods for functional alignment can be used with infants. Functional alignment finds a mapping between participants using functional activity -- rather than anatomy -- and in adults can improve signal-to-noise, enhance across participant prediction, and enable unique analyses[27,32-34].” Pg. 4

      “This is initial evidence that functional alignment may be useful for enhancing signal quality, like it has in adults[27,32,33], or revealing changing function over development[45].” Pg. 21

      Regarding the reviewer’s concern that motion may bias the results, we wish to emphasize the nature of the analyses being conducted here: we are using data from a group of participants to predict the neural responses in a held-out participant. For motion to explain consistency between participants, the motion would need to be timelocked across participants. Even if motion was time-locked during movie watching, motion will impair the formation of an adequate model that can contain retinotopic information. Thus, motion should only hurt the ability for a shared response to be found that can be used for predicting retinotopic maps. Hence, the results we observed are despite motion and other sources of noise.

      What is M??? is it simply the mean value??? If not, how it is estimated?

      M is an abbreviation for mean. We have now expanded the abbreviation the first time we use it.

      Figure 6 should be integrated with map activity where the individual area correlation should be illustrated. Probably fitting SMR adult works well for early cortical areas, but not for more ventral and associative, and the correlation should be evaluated for the different masks.

      With the addition of plots showing the gradients for each participant and each movie (Figures S10–S13) we hope we have addressed this concern. We additionally want to clarify that the regions we tested in the analysis in Figure 6 are only the early visual areas V1, V2, V3, V3A/B, and hV4. The adult validation analyses show that SRM works well for predicting the visual maps in these areas. Nonetheless, it is an interesting question for future research with more extensive retinotopic mapping in infants to see if SRM can predict maps beyond extrastriate cortex.

      Occipital masks have never been described or shown.

      The occipital mask is from the MNI probabilistic structural atlas (Mazziotta et al., 2001), as reported in the original version and is shared with the public data release. We have added the additional detail that the probabilistic atlas is thresholded at 0% in order to be liberally inclusive. 

      “We used the occipital mask from the MNI structural atlas[63] in standard space -- defined liberally to include any voxel with an above zero probability of being labelled as the occipital lobe -- and used the inverted transform to put it into native functional space.” Pg. 27–28

      Methods lack the main explanation of the procedures and software description.

      We hope that the additions we have made to address this reviewer’s concerns have provided better explanations for our procedures. Additionally, as part of the data and code release, we thoroughly explain all of the software needed to recreate the results we have observed here.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      My main concern is the use of the 700K SNP dataset. This set of SNPs suffers from a heavy ascertainment bias, which can be seen in the PCA in the supplementary material where all the aurochs cluster in the center within the variation of cattle. Given the coverage of some of the samples, multiple individuals would have less than 10K SNP covered. The majority of these are unlikely to be informative here given that they would just represent fixed positions between taurine and indicine or SNPs mostly variable in milk cattle breeds. The authors would get a much better resolution (i.e. many more SNPs to work with their very low genome coverage data) using the 1000 bull genome project VCF data set:

      https://www.ebi.ac.uk/ena/browser/view/PRJEB42783 which based on whole genome resequencing data from many cattle. This will certainly help with improving the resolution of qpAdm and f4 analysis, which have huge confidence intervals in most cases. Right now some individuals have huge confidence intervals ranging from 0 to 80% auroch ancestry...

      We thank the reviewer for this suggestion. We repeated our analyses with a SNP panel from Run 6 of the 1000 Bulls project presented in Naval-Sanchez et al 2020. This panel reduced standard errors and narrowed down confidence intervals for the ancient samples. Another consequence is that more single-source qpAdm models can now be rejected highlighting the abundance of hybridization. For our comparison to modern breeds, we still use the 700K dataset as it provides a set of different modern European cattle breeds.

      I agree with the authors that qpAdm is likely to give quite a noisy estimate of ancestry here (likely explain part of the issue I mentioned above). Although qpAdm is good for model testing here for ancestry proportion the authors instead could use an explicit f4 ratio - this would allow them to specify a model which would make the result easier to interpret.

      We have added ancestry estimates from f4 ratios to the manuscript and display them together with qpAdm and Struct-f4 (as suggested by reviewer #3) in our new Table 1. We decided to keep all three different estimates to illustrate that results are not consistent for all analyses. An additional feature of qpAdm is the possibility that two source models can be rejected and additional ancestries can be identified.

      The interpretation of the different levels of allele sharing on X vs autosome being the result of sex-bias admixture is not very convincing. Could these differences simply be due to a low recombination rate on the X chromosome and/or lower effective population size, which would lead to less efficient purifying selection?

      Following this comment (and another comment referring to the X chromosome analysis by reviewer #2), we decided to remove sex bias from the title of our study and add more information on the caveats of this analysis. While estimating ancestry on the X chromosome can be difficult, we also add that our patterns are consistent with what has been suggested based on ancient mitochondrial data (Verdugo et al 2019). For Neolithic Anatolia, it has been suggested that the insemination of domestic cows by auroch bulls has been intentional or even ritual (Peters et al 2012). A recent parallel archaeogenomic study also concluded sex-biased introgression from autosomal, X-chromosomal and Y-chromosomal data (Rossi et al 2024). As our results are consistent with these previous studies as well as the lower differentiation of modern breeds on the X chromosome (da Fonseca et al 2019), we still consider the general pattern of our results valid even if the exact extent of sex bias is difficult to assess.

      The authors suggest that 2 pop model rejection in some domestic population might be due to indicine ancestry, this seems relatively straightforward to test.

      We had already performed this analysis of modeling their ancestry from three sources using qpAdm. The results are shown in Supplementary Table S6 and we now refer to this more explicitly in the text: “The presence of indicine ancestry can be confirmed in a qpAdm analysis using three sources resulting in fitting models for all breeds (Supplementary Table S6).”

      The first sentence of the paper is a bit long-winded, also dogs were domesticated before the emergence of farming societies.

      We rephrased the first sentence to “Domestication of livestock and crops has been the dominant and most enduring innovation of the transition from a hunter-gathering lifestyle to farming societies.”

      It would be good to be specific about the number of genomes and coverage info in the last paragraph of the intro.

      This information is included in the first paragraph of the results section and we decided to not duplicate the numbers in the preceding introduction paragraph to retain a flow for the readers.

      Reviewer #2 (Public Review):

      Summary:

      In this paper, the authors investigated the admixture history of domestic cattle since they were introduced into Iberia, by studying genomic data from 24 ancient samples dated to ~2000-8000 years ago and comparing them to modern breeds. They aimed to (1) test for introgression from (local) wild aurochs into domestic cattle; (2) characterize the pattern of admixture (frequency, extent, sex bias, directionality) over time; (3) test for correlation between genetic ancestry and stable isotope levels (which are indicative of ecological niche); and (4) test for the hypothesized higher aurochs ancestry in a modern breed of fighting bulls.

      Strengths:

      Overall, this study collects valuable new data that are useful for testing interesting hypotheses, such as admixture between domestic and wild populations, and correlation between genome-wide aurochs ancestry and aggressiveness.

      Thank you for highlighting the importance of our study and the potential of our dataset.

      Weaknesses:

      Most conclusions are partially supported by the data presented. The presence of admixed individuals in prehistorical periods supports the hypothesized introgression, although this conclusion needs to be strengthened with an analysis of potential contamination. The frequency, sex-bias, and directionality of admixture remain highly uncertain due to limitations of the data or issues with the analysis. There is considerable overlap in stable isotope values between domestic and wild groups, indicating a shared ecological niche, but variation in classification criteria for domestic vs wild groups and in skeletal elements sampled for measurements significantly weakens this claim. Lastly, the authors presented convincing evidence for relatively constant aurochs ancestry across all modern breeds, including the Lidia breed which has been bred for aggressiveness for centuries. My specific concerns are outlined below.

      Contamination is a common concern for all ancient DNA studies. Contamination by modern samples is perhaps unlikely for this specific study of ancient cattle, but there is still the possibility of cross-sample contamination. The authors should estimate and report contamination estimates for each sample (based on coverage of autosomes and sex chromosomes, or heterozygosity of Y or MT DNA). Such contamination estimates are particularly important to support the presence of individuals with admixed ancestry, as a domestic sample contaminated with a wild sample (or vice versa) could appear as an admixed individual.

      We thank the reviewer for this suggestion. Due to our low coverage data, we focused on estimating contamination from the mitochondrial data by implementing the approach used by Green et al (2008). We make the code for this step available on Github. While most samples displayed low levels of contamination, we identified one sample (moo013a) with a surprisingly high (~50%) level of contamination which was excluded from further analysis.

      A major limitation of this study is uncertainty in the "population identity" for most sampled individuals (i.e., whether an individual belonged to the domesticated or wild herd when they were alive). Based on chronology, morphology, and genetic data, it is clear the Mesolithic samples from the Artusia and Mendandia sites are bona fide aurochs, but the identities of individuals from the other two sites are much less certain. Indeed, archeological and morphological evidence from El Portalon supports the presence of both domestic animals and wild aurochs, which is echoed by the inter-individual heterogeneity in genetic ancestry. Based on results shown in Fig 1C and Fig 2 it seems that individuals moo017, moo020, and possibly moo012a are likely wild aurochs that had been hunted and brought back to the site by humans. Although the presence of individuals (e.g., moo050, moo019) that can only be explained by two-source models strongly supports that interbreeding happened (if cross-contamination is ruled out), it is unclear whether these admixed individuals were raised in the domestic population or lived in the wild population and hunted.

      The reviewer is pointing out an important topic, the unknown identity of the studied individuals. We have revised the text making clear that we do not know whether the individuals were hunted or herded. At the same time, their genomic ancestry speaks for itself showing that there was hybridization between wild and domestic and that different individuals carried different degrees of wild ancestry. In the revised version, we have added the unknown identity as well as the fact that our results can be affected by both, changes in human hunting and herding practices over time. Regardless of the exact identity of the individuals, our results can still be seen as (a) evidence for hybridization and (b) changes in human practices (hunting and/or herding) and their relationship to bovids over time.

      Such uncertainty in "population identity" limits the authors' ability to make conclusions regarding the frequency, sex bias, and directionality of gene flow between domestic and wild populations. For instance, the wide range of ancestry estimates in Neolithic and Chalcolithic samples could be interpreted as evidence of (1) frequent recent gene flow or (2) mixed practices of herding and hunting and less frequent gene flow. Similarly, the statement about "bidirection introgression" (on pages 8 and 11) is not directly supported by data. As the genomic, morphological, and isotope data cannot confidently classify an individual as belonging to the domesticated or wild population, it seems impossible to conclude the direction of gene flow (if by "bidirection introgression" the authors mean something other than "bidirectional gene flow", they need to clearly explain this before reaching the conclusion.)

      We have removed “bidirectional introgression” from the text and replaced it with the more neutral term “hybridization”. Furthermore, we used the revision to mention at several places in the text that it is not clear whether the sequenced individuals were hunted and herded and that the observed pattern likely reflects changes in both hunting and herding practices.

      The f4 statistics shown in Fig 3B are insufficient to support the claim regarding sex-biased hybridization, as the f4 statistic values are not directly comparable between the X chromosome and autosomes. Because the effective population size is different for the X chromosome and autosomes (roughly 3:4 for populations with equal numbers of males and females), the expected amount of drift is different, hence the fraction of allele sharing (f4) is expected to be different. In fact, the observation that moo004 whose autosomal genome can be modeled as 100% domestic ancestry still shows a higher f4 value for the X chromosome than autosomes hints at this issue. A more robust metric to test for sex-biased admixture is the admixture proportion itself, which can be estimated by qpAdm or f4-ratio (see Patterson et al 2012). However, even with this method, criticism has been raised (e.g., Lazaridis and Reich 2017; Pfennig and Lachance, 2023). In general, detecting sex-bias admixture is a tough problem.

      In response to this comment and another comment by reviewer #1, we decided to remove sex bias from the title. In the revised version of our study, we have now switched this analysis from f4 statistics to comparing f4 ratios between the X chromosome and autosomes (Figure 3). Furthermore, we have added more information on the caveats of this analysis citing the articles mentioned by the reviewer. At the same time, we highlight that our patterns are consistent with what has been suggested based on ancient mitochondrial data (Verdugo et al 2019). Unfortunately, the low coverage data does not allow to call Y chromosomal haplotypes which would also allow an analysis of the paternal lineage. But our results are consistent with additional examples from the literature: For Neolithic Anatolia, it has been suggested that the insemination of domestic cows by auroch bulls has been intentional or even ritual (Peters et al 2012) and there is a lower differentiation of modern breeds on the X chromosome (da Fonseca et al 2019). A recent parallel archaeogenomic study also concluded sex-biased introgression from autosomal, X-chromosomal and Y-chromosomal data (Rossi et al 2024). Similar to the broader hybridization signal, our interpretation does not depend on the estimates for single individuals as we describe the broader pattern. As our results are consistent with previous results based on other types of data, we still consider the general pattern of our results valid even if the exact extent of sex bias is difficult to assess.

      In general, the stable isotope analysis seems to be very underpowered, due to the issues of variation in classification criteria and skeletal sampling location discussed by the authors in supplementary material. The authors claimed a significant difference in stable nitrogen isotope between (inconsistently defined) domestic cattle and wild aurochs, but no figures or statistics are presented to support this claim. Please describe the statistical method used and the corresponding p-values. The authors can consider including a figure to better show the stable isotope results.

      In combination with updated tables, we have added a supplementary figure showing the stable isotope results (S9). In light of the reanalysis of the genetic data, we have reassessed the genetic models used to assign species in the stable isotope analysis. We have provided more details of the statistical methods used and the p-values are given in the supplementary materials. There is a significant difference in the nitrogen isotope values when comparing B. taurus and B. primigenius (identified on morphology) but no other comparisons are significant at the p = 0.05 threshold. The reviewer highlights what we have mentioned in the supplementary material regarding the varied skeletal elements used for stable isotope analysis and the difficulty of assigning a species identity (as this depends on what criteria are used; morphological or some kind of genetic threshold of ancestry). Indeed, how to identify the species is at the heart of the paper. Given that identity could be defined in many ways, we have used 3 different genetic models to reflect this and the morphological categories, to help explore different possible scenarios. The reviewer is correct to point out that some of this analysis is not helped by the variety of skeletal elements used, but we have been careful not to over-interpret the results. The only samples that have nitrogen values higher than one standard deviation from the mean are domestic cattle, so it is not unreasonable to suggest that only domestic cattle have high nitrogen isotope values.

      Reviewer #3 (Public Review):

      Summary:

      Günther and colleagues leverage ancient DNA data to track the genomic history of one of the most important farm animals (cattle) in Iberia, a region showing peculiarities both in terms of cultural practices as well as a climatic refugium during the LGM, the latter of which could have allowed the survival of endemic lineages. They document interesting trends of hybridisation with wild aurochs over the last 8-9 millennia, including a stabilisation of auroch ancestry ~4000 years ago, at ~20%, a time coincidental with the arrival of domestic horses from the Pontic steppe. Modern breeds such as the iconic Lidia used in bullfighting or bull running retain a comparable level of auroch ancestry.

      Strengths:

      The generation of ancient DNA data has been proven crucial to unravel the domestication history of traditional livestock, and this is challenging due to the environmental conditions of the Iberian peninsula, less favourable to DNA preservation. The authors leverage samples unearthed from key archaeological sites in Spain, including the karstic system of Atapuerca. Their results provide fresher insights into past management practices, and permit characterisation of significant shifts in hybridization with wild aurochs.

      We thank the reviewer for their positive assessment of our work and for highlighting the strength and potential of the study.

      Weaknesses:

      - Treatment of post-mortem damage: the base quality of nucleotide transitions was recalibrated down to a quality score of 2, but for 5bp from the read termini only. In some specimens (e.g. moo022), the damage seems to extend further. Why not use dedicated tools (e.g. mapDamage), or check the robustness by conditioning on nucleotide transversions?

      We agree that using such a non-standard data preparation approach requires some testing. Since our main analyses are all based on f statistics, we compared f4 statistics and f4 ratios of our rescaled base quality data with data only using transversion sites. While estimates are highly correlated, the data set reduced to transversions produces larger confidence intervals in f4 ratios due to the lower number of sites. Consequently, we decided to use the rescaled data for all analyses displayed in main figures. We also prefer not to perform reference based rescaling as implemented in mapDamage as it might be sensitive to mapping bias (Günther & Nettelblad 2019).

      - Their more solid analyses are based on qpAdm, but rely on two single-sample donor populations. As the authors openly discuss, it is unclear whether CPC98 is a good proxy for Iberian aurochs despite possibly forming a monophyletic clade (the number of analysed sites is simply too low to assess this monophyly; Supplementary Table S2). Additionally, it is also unclear whether Sub1 was a fully unadmixed domestic specimen, depleted of auroch ancestry. The authors seem to suggest themselves that sex-biased introgression may have already taken place in Anatolia ("suggesting that sex-biased processes already took place prior to the arrival of cattle to Iberia").

      We expanded the discussion on this topic but removed the analysis of whether European aurochs form a clade due to the low number of sites. We do highlight that a recent parallel study on aurochs genomes confirmed that Western European aurochs form a clade, probably even originating from an Iberian glacial refugium (Rossi et al 2024). Even if minor structure in the gene pool of European aurochs might affect our quantitative results, it should not drive the qualitative pattern. The same should be the case for Sub1 as our tests would detect additional European aurochs ancestry that was not present in Sub1. The corresponding paragraph now reads:

      “A limitation of this analysis is the availability of genomes that can be used as representatives of the source populations as we used German and British aurochs to represent western European aurochs ancestry and a single Anatolian Neolithic to represent the original domestic cattle that was introduced into Europe. Our Mesolithic Iberian aurochs contained too little endogenous DNA to be used as a proxy aurochs reference and all Neolithic and Chalcolithic samples estimated with predominantly aurochs ancestry (including the 2.7x genome of moo014) already carry low (but significant) levels of domestic ancestry. However, the fact that all of these aurochs samples carried P mitochondria strongly suggests that western European aurochs can be considered monophyletic. Furthermore, a recent parallel study also concluded that Western European aurochs all form a clade (27). The Anatolian Sub1 might also not be depleted of any European aurochs ancestry and could not fully represent the original European Neolithic gene pool as also indicated by qpAdm and Struct-f4 identifying small proportions of other Asian ancestries in some Iberian individuals.

      While these caveats should affect our quantitative estimates of European aurochs ancestry, they should not drive the qualitative pattern as our tests would still detect any excess European aurochs ancestry that was not present in Neolithic Anatolia.”

      Alternatively, I recommend using Struct-f4 as it can model the ancestry of all individuals together based on their f4 permutations, including outgroups and modern data, and without the need to define pure "right" and "left" populations such as CPC98 and Sub1. It should work with low-coverage data, and allows us to do f4-based MDS plots as well as to estimate ancestry proportions (including from ghost populations).

      We thank the reviewer for this suggestion. We added Struct-f4 as an analysis but observed that it would not converge in an individual-based analysis due to the low coverage of most of our samples. We added Struct-f4 results for samples with >0.1X to the new Table 1, the results are similar to the results obtained using f4 ratios and (to a lower degree) the qpAdm results.

      - In the admixture graph analyses (supplementary results), the authors use population groups based on a single sample. If these samples are pseudohaploidised (or if coverage is insufficient to estimate heterozygosity - and it is at least for moo004 and moo014), f3 values are biased, implying that the fitted graph may be wrong. The graph shown in Fig S7 is in fact hard to interpret. For example, the auroch Gyu2 from Anatolia but not the auroch CPC98 also from Anatolia received 62% of ancestry from North Africa? The Neolithic samples moo004 and moo014 also show the same shocking disparity. I would consider re-doing this analysis with more than a sample per population group

      There seems to be some confusion relating to the sample identity in these figures. CPC98 is British and not Anatolian while Gyu2 is from the Caucasus and not Anatolia which would explain why they are different. Furthermore, moo004 is mostly of domestic ancestry while, moo014 is mostly of European aurochs ancestry according to our other analyses, which should explain why they also behave differently in this analysis. To avoid confusion and since this is a supplementary analysis from which we are not drawing any major conclusions, we decided to remove the graphs and the analysis from the study.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      Fig 3A: The red regression line is misleading. It seems to show that the average aurochs ancestry fraction has been steadily decreasing since ~8000 years ago, but the "averaging" is not meaningful as not all samples necessarily represent domestic cattle remains and the sample size is rather small. In other words, the samples are just a small, random collection of domestic and wild animals, and the average ancestry is subject to large sampling noise. I would suggest removing the regression line (along with the associated confidence interval) in this figure. It would also be helpful to label the samples with their IDs and morphology in the plot for cross-reference with other figures. Also, it is said in the legend that "Modern Iberian breeds... are added around date 0 with some vertical jitter". Do the authors mean "horizontal jitter" instead?

      Thank you for noticing this! We have removed the regression line and corrected the figure legend.

      Fig 2 vs Fig 3A: are the error bars the same in these two plots? They seem to be highly similar, if not identical, but the legends read very differently ("95% confidence interval by block-jackknife vs. on standard error"). Please explain.

      The figure legends have been corrected.

      Fig 3B: What do the error bars in Fig 3B mean? 95% confidence interval or one standard error? Please clarify in the legend.

      We have removed this figure and replaced it with a different way of displaying the results (now Figure 3). We ensured that the error bars are displayed consistently across figures.

      According to the f4 statistics shown in Fig 1C and Fig 3B, moo012b carries a relatively high amount of domestic ancestry. How is this compatible with the observation in Fig 2 that this individual can be modeled with 100% aurochs (i.e., aurochs as the single source)? Does this simply reflect the low genome coverage?

      moo012b is indeed one of the lowest coverage samples in our has at <0.02x sequencing depth. Even in our revised analysis using more sites, there is a discrepancy between the results of f4 statistics and qpAdm (suggesting mostly domestic ancestry) and f4 ratio suggesting mostly aurochs ancestry (Figure 1C and Table 1). We believe that this highlights the sensitivity of different methods to assumptions about the relationships of sources and potential “outgroups” which might not be well resolvable with low coverage data and in the presence of potentially complex admixture. Our general results, however, do not depend on the estimates for single individuals as our interpretations are based on the general pattern.

      I don't fully understand the rationale behind the statement "However, at some point, the herding practices must have changed since modern Iberian breeds show approximately 20-25% aurochs ancestry". Can the stable ancestry fraction from 4000 years to the present (relative to the highly variable ancestry before) reflect of discontinuation of hunting rather than changes in herding practices?

      We agree that this statement was not justified here, we rephrased the sentence to “In fact, from the Bronze Age onwards, most estimates overlap with the approximately 25% aurochs ancestry in modern Iberian cattle” and generally tried to make the text more nuanced on the issue of herding and hunting practices.

      Reviewer #3 (Recommendations For The Authors):

      Thanks for this interesting piece of work. The results are clearly presented, and I have no additional concerns other than those reflected in the public report, except perhaps:

      (i) trying to use more informative sample names (eg. including the date and location). It may facilitate reading without going back and forth to the table "Sample List".

      We have now added a main table listing our post-Mesolithic samples together with their age, site and estimated aurochs ancestry proportions. We hope that his table makes it easier for readers to follow our sample IDs.

      (ii) Briefly describe in the main the age of aurochs and Sub1 not generated in this study.

      Fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Meissner et al describe an update on the collection of split-GAL4 lines generated by a consortium led by Janelia Research Campus. This follows the same experimental pipeline described before and presents as a significant increment to the present collection. This will strengthen the usefulness and relevance of "splits" as a standard tool for labs that already use this tool and attract more labs and researchers to use it.

      Strengths:

      This manuscript presents a solid step to establish Split-GAL4 lines as a relevant tool in the powerful Drosophila toolkit. Not only does the raw number of available lines contribute to the relevance of this tool in the "technical landscape" of genetic tools, but additional features of this effort contribute to the successful adoption. These include:

      (1) A description of expression patterns in the adult and larvae, expanding the "audience" for these tools

      (2) A classification of line combination according to quality levels, which provides a relevant criterion while deciding to use a particular set of "splits".

      (3) Discrimination between male and female expression patterns, providing hints regarding the potential role of these gender-specific circuits.

      (4) The search engine seems to be user-friendly, facilitating the retrieval of useful information.

      Overall, the authors employed a pipeline that maximizes the potential of the Split-GAL4 collection to the scientific community.

      Weaknesses:

      The following aspects apply:

      The use of split-GAL4 lines has improved tremendously the genetic toolkit of Drosophila and this manuscript is another step forward in establishing this tool in the genetic repertoire that laboratories use. Thus, this would be a perfect opportunity for the authors to review the current status of this tool, addressing its caveats and how to effectively implement it into the experimental pipeline.

      (1) While the authors do bring up a series of relevant caveats that the community should be aware of while using split-GAL4 lines, the authors should take the opportunity to address some of the genetic issues that frequently arise while using the described genetic tools. This is particularly important for laboratories that lack the experience using split-GAL4 lines and wish to use them. Some of these issues are covertly brought up, but not entirely clarified.

      First, why do the authors (wisely) rescreen the lines using UAS-CsChrimson-mVenus? One reason is that using another transgene (such as UAS-GFP) and/or another genomic locus can drive a different expression pattern or intensities. Although this is discussed, this should be made more explicit and the readers should be aware of this.

      Second, it would be important to include a discussion regarding the potential of hemidriver lines to suffer from transvection effects whenever there is a genetic element in the same locus. These are serious issues that prevent a more reliable use of split-GAL4 lines that, once again, should be discussed.

      We added additional explanatory text to the discussion.

      (2) The authors simply mention that the goal of the manuscript is to "summarize the results obtained over the past decade.". A better explanation would be welcomed in order to understand the need of a dedicated manuscript to announce the availability of a new batch of lines when previous publications already described the Split-GAL4 lines. At the extreme, one might question why we need a manuscript for this when a simple footnote on Janelia's website would suffice.

      We added an additional mention of the cell type split-GAL4 collection at the relevant section and added more emphasis on the curation process adding value to the final selections. We feel that the manuscript is useful to document the methods used for the contained analysis and datasets and gives a starting point to the reader to go through the many split-GAL4 publications and images.

      Reviewer #2 (Public Review):

      Summary: This manuscript describes the creation and curation of a collection of genetic driver lines that specifically label small numbers of neurons, often just a single to handful of cell types, in the central nervous system of the fruit fly, Drosophila melanogaster. The authors screened over 77,000 split hemidriver combinations to yield a collection of 3060 lines targeting a range of cell types in the adult Drosophila central nervous system and 1373 lines characterized in third-instar larvae. These genetic driver lines have already contributed to several important publications and will no doubt continue to do so. It is a truly valuable resource that represents the cooperation of several labs throughout the Drosophila community.

      Strengths:

      The authors have thoughtfully curated and documented the lines that they have created, so that they may be maximally useful to the greater community. This documentation includes confocal images of neurons labeled by each driver line and when possible, a list of cell types labeled by the genetic driver line and their identity in an EM connectome dataset. The authors have also made available some information from the other lines they created and tested but deemed not specific or strong enough to be included as part of the collection. This additional resource will be a valuable aid for those seeking to label cell types that may not be included in the main collection.

      Weaknesses:

      None, this is a valuable set of tools that took many years of effort by several labs. This collection will continue to facilitate important science for years to come.

      We thank the reviewer for their positive feedback.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Meissner et al. describes a collection of 3060 Drosophila lines that can be used to genetically target very small numbers of brain cells. The collection is the product of over a decade of work by the FlyLight Project Team at the Janelia Research Campus and their collaborators. This painstaking work has used the intersectional split-Gal4 method to combine pairs of so-called hemidrivers into driver lines capable of highly refined expression, often targeting single cell types. Roughly one-third of the lines have been described and characterized in previous publications and others will be described in manuscripts still in preparation. They are brought together here with many new lines to form one high-quality collection of lines with exceptional selectivity of expression. As detailed in the manuscript, all of the lines described have been made publicly available accompanied by an online database of images and metadata that allow researchers to identify lines containing neurons of interest to them. Collectively, the lines include neurons in most regions of both the adult and larval nervous systems, and the imaging database is intended to eventually permit anatomical searching that can match cell types targeted by the lines to those identified at the EM level in emerging connectomes. In addition, the manuscript introduces a second, freely accessible database of raw imaging data for many lower quality, but still potentially useful, split-Gal4 driver lines made by the FlyLight Project Team.

      Strengths:

      Both the stock collection and the image databases are substantial and important resources that will be of obvious interest to neuroscientists conducting research in Drosophila. Although many researchers will already be aware of the basic resources generated at Janelia, the comprehensive description provided in this manuscript represents a useful summary of past and recent accomplishments of the FlyLight Team and their collaborators and will be very valuable to newcomers in the field. In addition, the new lines being made available and the effort to collect all lines that have been generated that have highly specific expression patterns is very useful to all.

      Weaknesses:

      The collection of lines presented here is obviously somewhat redundant in including lines from previously published collections. Potentially confusing is the fact that previously published split-Gal4 collections have also touted lines with highly selective expression, but only a fraction of those lines have been chosen for inclusion in the present manuscript. For example, the collection of Shuai et al. (2023) describes some 800 new lines, many with specificity for neurons with connectivity to the mushroom body, but only 168 of these lines were selected for inclusion here. This is presumably because of the more stringent criteria applied in selecting the lines described in this manuscript, but it would be useful to spell this out and explain what makes this collection different from those previously published (and those forthcoming).

      We added more description of how this collection is focused on the best cell-type-specific lines across the CNS. An important requirement for inclusion was this degree of specificity across the CNS, while many prior publications had a greater emphasis on lines with a narrower focus of specificity.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Luckily for us, genetics is for the most part an exact science. However, there's still some "voodoo" in a lot of genetic combinations that the authors should disclose and be as clear as possible in the manuscript. This allows for the potential users to gauge expectations and devise a priori alternative plans.

      We attempted to comprehensively cover the caveats inherent in our genetic targeting approach.

      Minor points:

      (1) The authors mention that fly age should be controlled as expression can vary. Is there any reference to support this claim?

      We added a reference describing driver expression changes over development.

      (2) There should be a citation for "Flies were typically 1-5 days old at dissection for the cell type collection rescreening, 1-8 days old for other non-MCFO crosses and 3-8 days old for MCFO".

      We clarified that these descriptions were of our experimental preparations, not describing other citable work.

      Reviewer #3 (Recommendations For The Authors):

      General Points:

      Overall, the manuscript is very clear, but there are a couple of points where more explicit information would be useful. One of these is with respect to the issue of selectivity of targeting. The cell type specificity of lines is often referred to, but cell types can range from single pairs of neurons to hundreds of indistinguishable neurons with similar morphology and function. It would be useful if the authors explained whether their use of the term "cell type" distinguishes cell type from cell number. It would also be useful if lines that target many neurons of a single cell type were identified.

      We added further discussion of cell types vs. cell numbers. Our labeling strategy was not optimized for counting cell numbers labeled by each line. We believe EM studies are best positioned to comprehensively evaluate the number of cells making up each type.

      The second point relates to vagueness about the intended schedule for providing resources that will match (or allow matching of) neurons to the connectome. For example, on pp. 5-6 it is stated that: "In the future all of the neurons in these lines will be uniquely identified and linked to neurons reconstructed in the electron microscopy volume of the larva" but no timeline is provided. Similarly, for the adult neurons it is stated on p. 4 that: "Anatomical searching for comparison to other light microscopy (LM) and EM data is being made available." A more explicit statement about what resources are and are not yet available, a timeline for full availability, and an indication of how many lines currently have been matched to EM data would be helpful.

      During the review and revision period we have made progress on processing the images in the collection. We updated the text with the current status and anticipated timeline for completion.

      Specific Points:

      p. 4 "Although the lines used for these comparisons are not a random sample, the areas of greatest difference are in the vicinity of previously described sexual dimorphisms..." In the vicinity of is a very vague statement of localization. A couple of examples of what is meant here would be useful.

      We added example images to Figure 3.

      p. 5 "...may have specific expression outside our regions of interest." It's not clear what "our regions of interest" refers to here. Please clarify.

      We clarified that we were referring to the regions studied in the publications listed in Table 1.

      p. 5 "...lines that were sparse in VNC but dirty in the brain or SEZ..." A more quantitative descriptor than "dirty" would be helpful.

      We unfortunately did not quantify the extent of undesired brain/SEZ expression, but attempted to clarify the statement.

      p. 6 "...the images are being made instantly searchable for LM and EM comparisons at NeuronBridge..." Here again it is hard to know what is meant by "being made instantly searchable." How many have been made searchable and what is the bottleneck in making the rest searchable?

      We updated the text as described above. The bottleneck has been available processing capacity for the hundreds of thousands of included images.

      Figure 1 Supplemental File 2: The movie is beautiful, but it seems more useful as art than as a reference. Perhaps converting it to a pdf of searchable images for each line would make it more useful.

      We replaced the movie with a searchable PDF.

      Fig. 2(B) legend: "Other lines may have more than two types." It is not clear what "other lines" are being referred to.

      As part of making the quality evaluation more robust, we scored lines for the clear presence of three or more cell types. We updated the text accordingly.

      Fig. 2(C): Presumably the image shown is an example of variability in expression rather than weakness, but it is hard to know without a point of comparison. Perhaps show the expression patterns of other samples? Or describe briefly in the legend what other samples looked like?

      We added Figure 2 - figure supplement 1 with examples of variable expression in a split-GAL4 line.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      The authors identify new mechanisms that link a PIK3R1 mutant to cellular signaling and division in Activated PI3 Kinase Delta Syndrome 1 and 2 (APDS1/2). The conclusion that this mutant serves as a dominant negative form of the protein, impacting PI3K complex assembly and IRS/AKT signaling, is important, and the evidence from constitutive and inducible systems in cultured cells is convincing. Nevertheless, there are several limitations relating to differences between cell lines and expression systems, as well as more global characterization of the protein interaction landscape, which would further enhance the work.

      We are pleased by this fair assessment, while noting that this work relates to APDS2 (PIK3R1-related) rather than APDS1 (PIK3CD-related). Our findings we believe are clear, but the observation that studies including more global proteomics/phosphoproteomics in cells expressing mutants at endogenous levels would add further insight is well made. We hope that this report may motivate such studies by laboratories with wider access to primary cells from patients and knock-in mice.

      Public Reviews

      Reviewer #1 (Public Review):

      Summary:

      This study provides convincing data showing that expression of the PIK3R1(delta Exon11) dominant negative mutation in Activated PI3K Delta Syndrome 1/2 (APDS1/2) patient-derived cells reduces AKT activation and p110δ protein levels. Using a 3T3-L1 model cell system, the authors show that overexpressed p85α delta Exon 11) displays reduced association with the p110α catalytic subunit but strongly interacts with Irs1/2. Overexpression of PIK3R1 dominant negative mutants inhibits AKT phosphorylation and reduces cellular differentiation of preadipocytes. The strength of this article is the clear results derived from Western blots analysis of cell signaling markers (e.g. pAKT1), and co-immunoprecipitation of PI3K holoenzyme complexes and associated regulatory factors (e.g. Irs1/2). The experimental design, interpretation, and quantification broadly support the authors' conclusions.

      Strengths:

      The authors analyze a variety of PIK3R1 mutants (i.e. delta Exon11, E489K, R649W, and Y657X), which reveals a range of phenotypes that support the proposed model for dominant negative activity. The use of clonal cell lines with doxycycline-induced expression of the PIK3R1 mutants (DExon 11, R649W, and Y657X) provides convincing experimental data concerning the relationship between p85α mutant expression and AKT phosphorylation in vivo. The authors convincingly show that p85α delta Exon11, R649W, or Y657X) is unable to associate with p110α but instead more strongly associates with Irs1/2 compared to wild type p85α. This helps explain why the authors were unable to purify the recombinant p110α/p85α delta Exon 11) heterodimeric complex from insect cells.

      Weaknesses:

      Future experimentation will be needed to reconcile the cell type specific differences (e.g. APDS2 patient-derived cells vs. the 3T3-L1 cell model system) in PIK3R1 mutant behavior reported by the authors.

      This is a fair comment. It has been established for many years that relative protein levels even of wild type PIK3CA and PIK3R1 gene products influence sensitivity of PI3K to growth factor stimulation. Such issues of stoichiometry become exponentially more complicated when the numerous potential interactions among the full repertoire of Class 1 PI3K regulatory subunits (3 splice variants of PIK3R1, and also PIK3R2 and PIK3R3) and corresponding catalytic subunits (PIK3CA, PIK3CB, PIK3CD) are considered, and when different activities and stabilities of PIK3R1 mutants are added to the mix. It thus seems obvious to us that different levels of expression of different mutants in different cellular contexts will have different signalling consequences. We establish a paradigm in this paper using an overexpression system, and we strongly agree that this merits further investigation in a wider variety of primary cells (or cells with knock in at the endogenous locus), where available.

      An unbiased proteomic study that broadly evaluates the cell signaling landscape could provide a more holistic understanding of the APDS2 and SHORT mutants compared to a candidate-based approach.

      We agree. This would be highly informative, but we think would best be carried out in both “metabolic” and “immune” cells with endogenous levels of expression of SHORT or APDS2 PIK3R1 mutants. These are not all currently available to us, and require follow up studies.

      Additional biochemical analysis of p110α/p85α delta Exon 11 complex is needed to explain why this mutant regulatory subunit does not strongly associate with the p110 catalytic subunit.

      We agree. We present this observation in our overexpression system, which is clear and reproducible, even though somewhat surprising. The failure to bind p110a is likely not absolute, as sufficient p110a-p85a<sup>DEx11</sup> was synthesised in vitro in a prior study to permit structural and biochemical studies, although a series of technical workarounds were required to generate enough heterodimeric PI3K to study in vitro given the manifest instability of the complex, particularly when concentrated (PMID 28167755). We already note in discussion that p85a can homodimerize and bind PTEN, likely among other partners, and it may be that the APDS2 deletion strongly favours binding to proteins that effectively compete with p110a. However this requires further study of the wider interactome of the mutant PIK3R1, which, as noted above, are beyond the scope of the current study.

      It remains unclear why p85α delta Exon 11 expression reduces p110δ protein levels in APDS2 patient-derived dermal fibroblasts.

      We caution that we only had the opportunity to study dermal fibroblasts cultured from a single APDS2 patient, as noted in the paper, and so replication of this finding in future will be of interest. Nevertheless the observation is robust and reproducible in these cells, and we agree that this apparently selective effect on p110d  is not fully explained. Having said that, it has been observed previously that heterodimers of the DEx11 p85a variant with either p110a or p110d are unstable, and when the unstable complexes were eventually synthesised, p110a and p110d were demonstrated to show differences in engagement with the mutant p85, with greater disruption of inhibitory interactions observed for p110d (PMID 28167755). It is thus not a great stretch to imagine that as well as disinhibiting p110d more, the DEx11 p85a variant also destabilises the p85a-p110d complex more, potentially explaining its near disappearance in cells with low baseline p110d expression. Following on from the preceding question and response, however, is an alternative explanation, based on the 3T3-L1 overexpression studies in this paper, wherein we were unable to demonstrate binding of p110a by DEx11 p85a. If, in any given cellular context, the mutant p85 could bind p110d but not p110a, then the destabilising effect would be observed only for p110d. So in summary, we believe the selective effect on p110d is explained by differences in binding kinetics and heterodimer stability for different DEx11 p85a-containing complexes. The net effect of these differences may vary among cell types depending on relative levels of subunit expression.

      This study would benefit from a more comprehensive biochemical analysis of the described p110α/p85α, p110β/p85α, and p110δ/p85α mutant protein complexes. The current limitation of this study to the use of a single endpoint assay to measure PI3K lipid kinase activity in the presence of a single regulatory input (i.e. RTK-derived pY peptide). A broader biochemical analysis of the mutant PI3K complexes across the canonical signaling landscape will be important for establishing how competition between wild-type and mutant regulatory subunits is regulated in different cell signaling pathways.

      We agree that a wider analysis of upstream inputs and downstream network would be of interest, though as noted above the ultimate functional consequences of mutants will be an amalgam of any differential signalling effects of complexes that are stable enough to function, and differential effects of mutant p85a on the kinetics of distinct heterodimer assembly and stability. In this paper we seek to suggest a paradigm worthy of further, deeper assessment. We note that the search space here is large indeed (A. different cell types with differing profiles of PI3K subunit expression B. Multiple upstream stimuli and C. Multiple downstream outputs, with timecourse of responses an additional important factor to consider). These studies are realistically beyond the scope of the current work, but we hope that further studies, as suggested by the reviewer, follow.

      Reviewer #2 (Public Review)

      Summary:

      Patsy R. Tomlinson et al; investigated the impact of different p85alpha variants associated with SHORT syndrome or APDS2 on insulin-mediated signaling in dermal fibroblasts and preadipocytes. They find no evidence of hyperactive PI3K signalling monitored by pAKT in APDS2 patient-derived dermal fibroblast cells. In these cells p110alpha protein levels were comparable to levels in control cells, however, the p110delta protein levels were strongly reduced. Remarkably, the truncated APDS2-causal p85alpha variant was less abundant in these cells than p85alpha wildtype. Afterwards, they studied the impact of ectopically expressed p85alpha variants on insulin-mediated PI3K signaling in 3T3-L1 preadipocytes. Interestingly they found that the truncated APDS2-causal p85alpha variant impaired insulin-induced signaling. Using immunoprecipitation of p110alpha they did not find truncated APDS2-causal p85alpha variant in p110alpha precipitates. Furthermore, by immunoprecipitating IRS1 and IRS2, they observed that the truncated APDS2-causal p85alpha variant was very abundant in IRS1 and IRS2 precipitates, even in the absence of insulin stimulation. These important findings add in an interesting way possible mechanistic explanation for the growing number of APDS2 patients described with features of SHORT syndrome.

      Strengths:

      Based on state-of-the-art functional investigation the authors propose indicating a loss-of-function activity of the APDS2-disease causing p85alpha variant in preadipocytes providing a possible mechanistic explanation for the growing number of APDS2 patients described with features of SHORT syndrome.

      Weaknesses:

      Related to Figure 1: PIK3R1 expression not only by Western blotting but also by quantifying the RNA transcripts, e.g. mutant and wildtype transcripts, was not performed. RNA expression analysis would further strengthen the suggested impaired stabilization/binding.

      It is not completely clear to us how further PIK3R1 mRNA analysis would enhance the points we seek to make. Perhaps the reviewer’s point is that changes in protein expression could be explained by reduced transcription rather than having anything to do with altered protein turnover? As shown in Figure 1 supplemental figure 1, sequencing cDNA from each of the primary cell lines studied indicates that both mutant and WT alleles are expressed at or close to 50% of the total mRNA for PIK3CA or PIK3R1 as relevant. While this is not strictly quantitative, allied to prior evidence that these are dominant alleles which require to be expressed to exert their effect, with no evidence for altered mRNA expression of these variants in prior studies, we don’t believe any further quantification of mRNA expression would add value.

      Related to Figure 2

      As mentioned by the authors in the manuscript the expression of p110delta but also p110beta in 3T3-L1 preadipocytes ectopically expressing p85alpha variants has not been analyzed.

      We agree that such determination would have been a useful addition to the study, but regretfully it was not undertaken in these modified 3T3-L1 cells at the time of study. However independent bulk RNAseq studies of the founder 3T3-L1 cells from which the stably transduced cells were generated, undertaken as part of an unrelated study, revealed the following relative levels of endogenous expression of PI3K subunit mRNA:

      Author response table 1.

      We have not determined endogenous protein expression, and so have left the text of the discussion unchanged, simply noting that we have not formally assessed protein expression of p110d/p110b. However these transcriptomic findings suggest that p110d protein is likely either undetectable, or else present at extremely low levels compared to endogenous p110a. p110b also appears to be expressed at a much lower level than p110a. In our studies overexpressing mutant PIK3R1 and assessing insulin action, we believe we are largely or perhaps entirely assaying the effect of the mutants on p110a, in keeping with the fact that genetic and pharmacological studies have firmly established that it is p110a that is responsible for mediating the metabolic actions of insulin in adipose tissue and preadipocytes including 3T3-L1 (e.g. PMID 16647110). Indeed, to quote from this study, in 3T3-L1 “… inhibitors of p110b (TGX-115 and TGX-286) and p110d (IC87114 and PIK-23) had no effect on the insulin-stimulated phosphorylation of any protein in the PI3-K pathway.”

      We have added the following sentence to the discussion:

      “The current study has limitations. We have studied primary cells from only a single APDS2 patient, and in the 3T3-L1 cell model, we did not determine whether p110d protein could be detected. If not, this could explain the lack of detectable AKT phosphorylation with induction of Pik3r1 DEx11.  Indeed, previous pharmacological studies in 3T3-L1 adipocytes has shown that selective inhibition of p110d or p110b does not alter insulin-induced phosphorylation of any protein studied in the PI3-K pathway, attesting to the dominance of p110a in insulin action in this cell model (Knight et al, 2006).” 

      Furthermore, a direct comparison of the truncated APDS2-causal p85alpha variant with SHORT syndrome-causal p85alpha variants in regard to pAKT level, and p85alpha expression level has not been performed.

      These investigations would further strengthen the data.

      The cell lines conditionally expressing SHORT syndrome variants have been reported already, as cited (PMID: 27766312). Remarkably, the degree of inhibition of insulin-stimulated signalling is actually less pronounced for the SHORT syndrome variants than for the overexpressed APDS2 variant, as seen in the excerpt from the prior paper below. In this prior paper the maximum insulin concentration used, 100nM, was the concentration used in the current study. While overexpression of the APDS2 p85a variant ablated the response to insulin entirely, it is still seen in the prior study, albeit at a clearly reduced level.

      Related to Figure 3

      The E489K and Y657X p85alpha variants should be also tested in combination with p110delta in the PI3K activity in vitro assay. This would help to further decipher the overall impact, especially of the E489K variant.

      We agree that this would make our data more complete, but for logistical reasons (primarily available personnel) we were compelled to constrain the number of p85-p110 combinations we studied. We elected to prioritise the PIK3R1 R649W variant as by far the most common causal SHORT syndrome variant, and as the variant showing the “cleanest” functional perturbation, namely severely impaired or absent ability to dock to phosphotyrosines in cognate proteins.  The paradox that we sought to explain in this paper, namely the phenotypic combination of gain-of-function APDS2 with loss-of-function SHORT syndrome features holds only for APDS2 PIK3R1 variants, and so while it is interesting to document that the canonical SHORT syndrome variant also inhibits PI3Kb and PI3Kd activation in vitro, this was not the main purpose of our study.

      Reviewer #1 (Recommendations For The Authors):

      Points of clarification and suggestions for improving the manuscript:

      (1) Explain whether there are any PIK3R1-independent genetic alterations in the APDS2 and PROS-derived cell lines. For example, are there differences in the karyotype of mutant cell lines compared to wild-type cells?

      Karyotypic abnormalities are not an established feature of either PROS or APDS2, and the patients from whom cells were derived were documented to be of normal karyotype. Karyotypic abnormalities acquired during cell culture would not be unprecedented, but confirming normal karyotypes in primary cell lines where there is no specific reason to suppose any alteration exceeds normal expectations for primary cell studies, and so this has not been undertaken.

      (2) When introducing the APDS2-associated PIK3R1 mutation (lines 126-128), the authors describe both the exon 11 skipping and in-frame deletions. I recommend rewording this sentence to say exon 11 skipping results in an in-frame deletion of PIK3R1. The current wording makes it seem like APDS2-derived cells contain two genetic perturbations: (1) exon 11 skipping and (2) in-frame deletion. Include a diagram in Figure 1 to help explain the location of the mutations being studied in relationship to the PIK3R1 gene sequence and domains (i.e. nSH2, iSH2, cSH2). The description of the exon 11 skipping and in-frame deletions (lines 126-128) would benefit from having a complementary figure that diagrams the location of these mutations in the PIK3R1 gene.

      On review we agree that clarity of description could be enhanced. We have now edited these lines as follows:

      “We began by assessing dermal fibroblasts cultured from a previously described woman with APDS2 due to the common causal PIK3R1 mutation. This affects a splice donor site and causes skipping of exon 11, leading to an in-frame deletion of 42 amino acids (434-475 inclusive) in the inter-SH2 domain, which is shared by all PIK3R1 isoforms (Patient A.1 in (Lucas et al., 2014b))(Figure 1 figure supplement 1).”

      We have moreover introduced a further figure element including a schematic of all PIK3R1 mutations reported in the current study (new Figure 1 figure supplement 1)

      (3) For Figure 2, I recommend including a cartoon that illustrates the experimental design showing the induced expression of PIK3R1 mutants, R649W and Y657X, in the background of the wild-type endogenous gene expression.

      Such a figure element has now been generated and included as Figure 2 figure supplement 1, duly called out in the results section where appropriate.

      (4) For the data plotted in Figure 1B-1C, please clarify whether the experiments represent a single patient or all 3-4 patients shown in Figure 1A.

      Each datapoint shown represents one of the patients in the immunoblots, with all patients included. Each point in turn is the mean from 3 independent experiments. We have added the following to the Figure legend:

      “(B)-(E) quantification of immunoblot bands from 3 independent experiments shown for phosphoAKT-S473, phosphoAKT-T308, p110d and p110a respectively. Each point represents data from one of the patient cell lines in the immunoblots. Paired datapoints +/- insulin are shown in (B) and (C), and dotted lines mark means.”

      (5) I recommend rewording the following sentence: "Given this evidence that APDS2-associated PIK3R1 delta Exon 11 potently inhibits PI3Kα when overexpressed in 3T3-L1 preadipocytes," to say "... potently inhibits PI3Kα signaling when overexpressed in 3T3-L1 preadipocytes." The data shown in Figures 1 and 2 do not support a direct biochemical inhibition of PI3Kα lipid kinase activity by p85α (delta Exon 11).

      This edit has been made.

      (6) Provide more discussion concerning the percentage of humans with APDS2 or SHORT syndrome that contain the mutations discussed in this paper. How strong is the genotype-phenotype link for these diseases? Are these diseases inherited or acquired through environmental stresses?

      Both APDS2 and SHORT syndrome are very well established, highly penetrant and stereotyped monogenic disease. APDS is defined by the presence of activating PIK3R1 mutations such as the one studied here (by far the commonest causal mutation).  SHORT syndrome clinically has some superficial resemblance to other human genetic syndrome including short stature, but when careful attention is paid to characteristic features it is nearly universally attributable to loss-of-function PIK3R1 mutations with the single exception of one case in which a putatively pathogenic PKCE mutation was described (PMID: 28934384). Although both syndromes are monogenic it is often not accurate to refer to them as inherited, as, particularly in SHORT syndrome, de novo mutations (i.e. not found in either parent) are common. Environmental modifiers of phenotypes have not been described. To the introduction has now been added the comment that both conditions are highly penetrant and monogenic.

      (7) The data presented in Figure 5 would benefit from additional discussion and citations that describe the molecular basis of the interaction between PI3K and Irs1/2. What studies have previously established this is a direct protein-protein interactions? Are there PI3K mutants that don't interact with Irs1/2 that can be included as a negative control? Alternatively, the authors can simply reference other papers to support the mechanism of interaction.

      There is a voluminous literature dating back to the early 1990s documenting the mode of interaction of PI3K with Irs1/2. Relevant papers have now been cited as requested:

      p85-Irs1 binding: PMID 1332046 (White lab, PNAS 1992)

      p85-Irs2 binding: PMID 7675087 (White lab, Nature 1995)

      “This may be important, as p85a mediates recruitment of PI3K to activated tyrosine kinase receptors and their tyrosine phosphorylated substrates, including the insulin-receptor substrate proteins Irs1 (PMID 1332046) and Irs2 (PMID 7675087).”

      Regarding PI3K mutants that don't interact with Irs1/2, the SHORT syndrome mutant R649W which we include in this study is perhaps the best example of this, so it is both disease-causing and functions as such a negative control.

      (8) To see the effect of the dominant negative delta Exon 11, the truncated p85α needs to be super stoichiometric to the full-length p85α (Figure 2 - Supplemental Figure 2). This is distinct from the results in Figure 1 showing the ADPS2-derived dermal fibroblast express 5-10x lower levels of p85α delta Exon 11 compared to full-length p85α (Figure 1A), but still strongly inhibits pAKT S473 and T308 (Figure 1B-1C). The manuscript would benefit from more discussion concerning the cell type specific differences in phenotypes. Alternatively, do the APDS2-derived dermal fibroblasts have other genetic perturbations that are not accounted for that potentially modulate cell signaling differently compared to 3T3-L1 preadipocytes?

      The reviewer is astute to point out this apparent contrast. First of all, we have no reason to suppose there is any specific, PI3K-modifying genetic perturbation present in the primary dermal fibroblasts studied, although of course the genetic background of these cells is very distinct to that of 3T3-L1 mouse embryo fibroblasts. Related to such background differences, however, substantial variability is usually apparent in insulin-responsiveness even of healthy control dermal fibroblasts. This means that caution should be exercised in extrapolating from studies of the primary cells of a single individual. To illustrate this, we point the reviewer to our 2016 study in which we extensively studied the dermal fibroblasts of a proband with SHORT syndrome due to PIK3R1 Y657X:

      From this study we conclude that A. WT controls show quite substantial variation in insulin-stimulated AKT phosphorylation and B. even the SHORT syndrome p85a Y657X variant, expressed at higher levels that WT p85a in dermal fibroblasts, does not produce an obvious decrease in insulin-stimulated AKT phosphorylation, despite extensive evidence from other human cell studies and knock-in mice that it does indeed impaired insulin action in metabolic tissues. For both these reasons we are not convinced that the lower insulin-induced AKT phosphorylation we described in Figure 1 should be overinterpreted until reproduced in other studies with primary cells from further APDS2 patients. This is why we did not comment more extensively on this. We now add the following qualifier in results:

      “Despite this, no increase in basal or insulin-stimulated AKT phosphorylation was seen in APDS2 cells compared to cells from wild-type volunteers or from people with PROS and activating PIK3CA mutations H1047L or H1047R (Fig 1A-C, Fig 1 figure supplement 3A,B). Although insulin-induced AKT phosphorylation was lower in fibroblasts from the one APDS2 patient studied compared to controls, we have previously reported extensive variability in insulin-responsiveness of primary dermal fibroblasts from WT controls. Moreover even primary cells from a patient expressing high levels of the SHORT syndrome-associated p85a Y657X did not show attenuated insulin action, so we do not believe the reduced insulin action in APDS2 cells in the current study should be overinterpreted until reproduced in further APDS2 cells.”

      Nevertheless we remind the reviewer that the main purpose of our primary cell experiment was to determine if there were any INCREASE in basal PI3K activity, or any difference in p110a or p110d protein levels, and we regard our findings in these regards to be clear.

      The manuscript would benefit from additional explanation concerning why the E489K, R649W, and Y657X are equivalent substitutes for the characterization of p110α/p85α delta Exon 11). Perhaps a more explicit description of these mutations in relationship to the location of p85α delta Exon 11) mutation would help. I recommend including a diagram in Figure 3 showing the position of the delta Exon 11, E489K, R649W, and Y657X mutations in the PIK3R1 coding sequence. B. Also, please clarify whether all three holoenzyme complexes were biochemically unstable (i.e. p110α/p85α, p110β/p85α, p110δ/p85α) when p85α delta Exon 11) was expressed in insect cells.

      A. Whether or not E489K, R649W and Y657X are “equivalent” to the APDS2 mutant is not really a meaningful issue here. These mutants are being studied because they cause SHORT syndrome without immunodeficiency, while the APDS2 mutant causes APDS2 often with features of SHORT syndrome. That is, it is naturally occurring mutations and the associated genotype-phenotype correlation that we seek to understand. Of the 3 SHORT syndrome causal mutations chosen, R649W is by far the commonest, effectively preventing phosphotyrosine binding, Y657X has the interesting attribute that it can be discriminated from full length p85 on immunoblots due to its truncation, and is moreover a variant that we have studied in cells and mice before, while the rarer E489K is an interesting SHORT syndrome variant as it is positioned more proximally in the p85a protein than most SHORT syndrome causal variants. All variants studied are now illustrated in the new Figure 1 figure supplement 1. B. Regarding stability of PI3K heterodimers containing the APDS2 p85a variant, we tried extensively to purify p110a and p110d complexes without success despite several approaches to optimise production. We did not try to synthesise the p110b-containing complex.

      (10) I recommend presenting the results in Figure 4 before Figure 3 because it provides a good rationale for why it's difficult to purify the p110α/p85α delta Exon 11) holoenzyme from insect cells.

      This would be true of p110d were studied in Figure 4 but it is not. Figure 4 looks instead at effects on p110a of heterologous overexpression of mutant p85, is a natural lead in to the ensuing figures 5 and 6, and we do not agree it would add value or enhance flow to swap Figures 3 and 4.

      (11) The authors show that overexpression of the p85α delta Exon 11) did not result in p110α/p85α delta Exon 11) complex formation based on co-immunoprecipitation. Do the authors get the same result when they co-immunoprecipitation p110α/p85α and p110δ/p85α in the APDS2-derived dermal fibroblasts used in Figure 1A?

      This is an interesting question but not an experiment we have done. It is not unfeasible, but generating enough cells to undertake IP experiments of this nature in dermal fibroblasts is a significant undertaking, and with finite resources available and only one primary cell line to study we elected not to pursue this.

      Details in Methods section:

      (1) Include catalog numbers and vendors for reagents (e.g. lipids, PhosSTOP, G-Dynabeads, etc.). There is not enough information provided to reproduce this work.

      We have now added all vendors and catalogue numbers where relevant.

      (2) Concerning the stated lipid composition (5/10/15/45/20/5 %) in the liposome preparation protocol. Please clarify whether these numbers represent molar percentages or mg/mL percentages.

      We have now added that this is expressed as “(wt/vol)”

      (3) What is the amino acid sequence of the PDGFR (pY2) peptide used for the PI3K activity assay?

      This assay has been published and references with detailed methods are cited. For clarity, however we now say:

      “PI(3,4,5)P3 production was measured by modified PI3-Kinase activity fluorescence polarisation assay (Echelon Biosciences, Salt Lake City, UT, USA). 10μL reactions in 384-well black microtitre plates used 1mM liposomes containing 50μM PI(4,5)P2, optimised concentrations of purified PI3K proteins, 100μM ATP, 2mM MgCl2, with or without 1μM tyrosine bisphosphorylated 33-mer peptide derived from mouse PDGFRβ residues 735-767, including phosphotyrosine at positions 740 and 751 (“pY2”; 735-ESDGGYMDMSKDESIDYVPMLDMKGDIKYADIE-767;  Cambridge peptides).”

      (4) Include a Supplemental file containing a comprehensive description of the plasmids and coding sequencing used in this study.

      Such a supplemental file has been created and is included as Table 2

      Minor points of clarification, citations, and typos:

      (1) Clarify why Activated PI3K Delta Syndrome 1 (APDS1) is thus named APDS2. See lines 71-72 of the introduction. Also see line 89: "...is common in APDS2, but not in APDS1." Briefly describe the difference between APDS1 and APDS2?

      This is described in the introduction, but we apologise if our wording was not sufficiently clear. We have tried now to remove any ambiguity:

      “Some PIK3R1 mutations reduce basal inhibition of catalytic subunits, usually due to disruption of the inhibitory inter-SH2 domain, and are found in cancers (Philp et al, 2001) and vascular malformations with overgrowth(Cottrell et al, 2021). In both diseases, hyperactivated PI3Ka, composed of heterodimers of PIK3R1 products and p110a, drives pathological growth. Distinct inter-SH2 domain PIK3R1 mutations, mostly causing skipping of exon 11 and deletion of residues 434-475, hyperactivate PI3Kd in immune cells, causing highly penetrant monogenic immunodeficiency (Deau et al, 2014; Lucas et al, 2014b). This phenocopies the immunodeficiency caused by genetic activation of p110d itself, which is named Activated PI3K Delta Syndrome 1 (APDS1) (Angulo et al, 2013; Lucas et al, 2014a). The PIK3R1-related syndrome, discovered shortly afterwards, is thus named APDS2.”

      (2) Figure legend 1. Clarify reference to "Figure EV2".

      (3) Figure legend 2. Clarify reference to "Figure EV3".

      (4) Figure legend 3. Clarify reference to "Figure EV5".

      Thank you for pointing out this oversight, arising from failure to update nomenclature fully between versions. “EV” figures actually are the figure supplements in the submission. All labels have now been updated.

      (5) For Figure 1 - supplemental figure 1C, indicate experimental conditions on the blot (e.g. -/+ insulin).

      This is now added

      (6) Figure 4B, y-axis. Clarify how data was quantified. Perhaps reword "(% WT without DOX)" for clarity.

      We have left the Y axis label as it is, but have added the following to the figure legend:

      “(B) Quantification of immunoblot bands from immunoprecipitates from 3 independent experiments, expressed as a percentage relative to the intensity of the band in WT cells without doxycycline exposure.”

      (7) In the results section (lines 117-124), please explicitly state whether the described mutations are homo- or heterozygous.

      All mutations are heterozygous, as now explicitly stated

      (8) I recommend spelling out the SHORT and APDS2 acronyms in the abstract to make this study more accessible.

      We respectfully disagree that such spelling out in the abstract would improve accessibility. Both acronyms are clunky and wordy and are more likely to obscure meaning by squeezing out other words in the abstract. APDS is already spelled out in the introduction, and we now add the following for SHORT syndrome:

      “More surprisingly, phenotypic overlap is reported between APDS2 and SHORT syndrome. SHORT syndrome, named for the characteristic developmental features (Short stature, Hyperextensibility, Hernia, Ocular depression, Rieger anomaly, and Teething delay) is caused by loss of PI3Ka function due to disruption of the phosphotyrosine-binding C-terminal SH2 domain (Chudasama et al, 2013; Dyment et al, 2013; Thauvin-Robinet et al, 2013).”

      (9) I recommend explaining in more detail or rewording the following jargon/terms to make the writing more accessible to a broad audience: "reduced linear growth" (line 83) and "larger series" (line 86). I assume "reduced linear growth" is height.

      Edited as follows:

      “It  features short stature, insulin resistance, and dysmorphic features (Avila et al, 2016). In recent years, both individual case reports (Bravo Garcia-Morato et al, 2017; Petrovski et al, 2016; Ramirez et al, 2020; Szczawinska-Poplonyk et al, 2022) and larger case series (Elkaim et al, 2016; Jamee et al, 2020; Maccari et al, 2023; Nguyen et al, 2023; Olbrich et al, 2016; Petrovski et al., 2016) have established that many people with APDS2 have overt features of SHORT syndrome, while, more generally, linear growth impairment is common in APDS2, but not in APDS1.”

      (10) For clarity, reword lines 214-215 to read, "No increase in p110α levels was seen on conditional overexpression of wild-type or R649W p85α."

      Change made, thank you

      (11) Figure 6A - Western blot label says, "657X" instead of "Y657X."

      Now corrected

      (12) Lines 214-215: For clarity, reword the sentence to say, "No increase in p110α was seen on conditional overexpression...".

      REPEAT OF POINT 10 ABOVE

      (13) Clarify what interactions are being competed for in the following statement: "... delta Ex11 may exert its inhibitory action by competing with PI3K holoenzyme" (lines 237-238). Are you referring to the interaction between p110α and p85α or the interaction between p110α/p85α and another protein?

      We have endeavoured to clarify by editing as follows:

      “As APDS2 p85a DEx11 does not appear to displace wild-type p85a from p110a despite strong overexpression, it is likely that there are high levels of truncated p85a unbound to p110a in the cell. This may be important, as p85a mediates recruitment of PI3K to activated tyrosine kinase receptors and their tyrosine phosphorylated substrates, including the insulin-receptor substrate proteins Irs1 and Irs2. Excess free regulatory subunits compete with heterodimeric PI3K holoenzyme for binding to these phosphotyrosines (Ueki et al., 2002), raising the possibility that excess free, truncated APDS2 p85a DEx11 may exert its inhibitory action similarly by outcompeting PI3K holoenzyme for phosphotyrosine binding.”

      (14) Provide more information about the following statement and how it relates to the mutations in this study: "Homozygous truncating PIK3R1 mutations abolishing p85α expression while preserving p55α and p50α produce agammaglobulinaemia" (lines 271-272). The manuscript would benefit from a more explicit description of the nature of these mutations.

      This wording seems to us to be explicit, however we agree that a schematic of PIK3R1 genotype-phenotype correlation, as requested elsewhere, would help readers. Such a schematic is now included as Figure 1 figure supplement 1.

      (15) Typo on line 299: "unclike".

      Corrected.

      (16) The data presented in this study support a model in which p85α (DExon 11) expression functions as a dominant negative. Please clarify why in the discussion section you explain that p85α (DExon 11) activates PI3K. For example, "...skipping of exon 11, were shown in 2014 to activate PI3K..." (lines 290-291), "...activate PI3Kδ on one hand..." (line 309); "...APDS2 mutations in PIK3R1 has mixed consequences, producing greater hyperactivation of p110δ than p110α" (lines 354-355).

      We do not entirely understand the reviewer’s question and thus request here. p85α (DExon 11) activates PI3Kd in immune cells and in vitro, and this is accepted, based on numerous reports, to be the mechanism underlying immunodeficiency. We do not challenge this, and cite evidence for any such claims in our report. The dominant negative activity we describe here towards PI3Ka activation is based not on inhibition of mutant-containing heterodimer, but rather on destabilisation of and/or competition with heterodimeric WT holoenzyme. This is the basis of the model we present; that is, a finely balanced competition between enzymic activation and mutant holoenzyme destabilisation and competition of mutant free p85a with WT holoenzyme, whose net effect likely differs among cells and tissues, most likely based on the repertoire and proportions of PI3K subunit expression. If the reviewer has specific suggestions for us that will make this point clearer still we should be happy to consider them.

      (17) Provide references for the statements in lines 349-353 of the discussion.

      This brief closing paragraph is a succinct recap and summary of the key points made throughout the manuscript and thoroughly referenced therein. We prefer to keep this section clean to maximise clarity, but are happy to copy references from the various other places in the manuscript to back up these assertions if this is preferred by the editorial team. Current text:

      “In summary, it is already established that: A. genetic activation of PIK3CD causes immunodeficiency without disordered growth, while B. inhibition of PIK3R1 recruitment to RTKs and their substrates impairs growth and insulin action, without immunodeficiency, despite all catalytic subunits being affected and C. loss of p85 alone causes immunodeficiency.”

      Reviewer #2 (Recommendations For The Authors):

      In the abstract line 42 I would rather talk from SHORT syndrome like features.

      Some patients do indeed meet the criteria for SHORT syndrome, but there is a spectrum. We have thus added this qualification and removed “short stature” to maintain the word count, as this is itself a SHORT syndrome-like feature.

      Line 74 It would be helpful for the reader to give the amino-acid exchange and affected position of this single case.

      We agree. Now added.

      Furthermore, an illustration indicating the location of the different PIK3R1 variants on the p85 alpha level would be helpful for the reader.

      As noted above such a figure element is now included as Figure 1 figure supplement 1 and duly called out in the text

      The sentence in lines 298-300 makes no sense to me. Do you mean, unlike APDS1 murine models?

      We agree, on review, that this paragraph is convoluted and makes a simple observation complex. We have rewritten now in what we hope is a more accessible style:

      “Thus, study of distinct PIK3R1-related syndromes shows that established loss-of-function PIK3R1 mutations produce phenotypes attributable selectively to impaired PI3Ka hypofunction, while activating mutations produce phenotypes attributable to selectively increased PI3Kd signalling. Indeed, not only do such activating mutations not produce phenotypes attributable to PI3Ka activation, but they surprisingly have features characteristic of impaired PI3Ka function.”

      Line 321 I propose including the notion of different cells: “The balance between expression and signalling in different cells may be a fine one ...”

      This change has been made

      Line 352 C. loss replace with complete loss.

      “C.” actually denotes the last in a list after “A.” and “B.”. We have now used bold to emphasise this, but we imagine house style may dictate how we approach this.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      The study presents valuable findings on the role of RIPK1 in maintaining liver homeostasis under metabolic stress. Strengths include the intriguing findings that RIPK1 deficiency sensitizes the liver to acute liver injury and apoptosis, but because the conclusions require additional experimental support, the evidence is incomplete.

      We are truly grateful, and wish to express our sincere acknowledgement to the reviewer and the editor for the time and effort spent in reviewing our manuscript. We highly appreciate the thorough and constructive comments, which can greatly improve our manuscript. We have conducted new experiments to address the reviewer’s concerns. We also carefully checked and changed our manuscript according to the constructive suggestions by the reviewer. Hopefully we have adequately addressed all the concerns. In the revised manuscript version, changes are highlighted in yellow. Please find the detailed point-to-point responses below. 

      Public Reviews:

      Reviewer #1 (Public Review):

      This study presents an investigation into the physiological functions of RIPK1 within the context of liver physiology, particularly during short-term fasting. Through the use of hepatocyte-specific Ripk1-deficient mice (Ripk1Δhep), the authors embarked on an examination of the consequences of Ripk1 deficiency in hepatocytes under fasting conditions. They discovered that the absence of RIPK1 sensitized the liver to acute injury and hepatocyte apoptosis during fasting, a finding of significant interest given the crucial role of the liver in metabolic adaptation. Employing a combination of transcriptomic profiling and single-cell RNA sequencing techniques, the authors uncovered intricate molecular mechanisms underlying the exacerbated proinflammatory response observed in Ripk1Δhep mice during fasting. While the investigation offers valuable insights into the consequences of Ripk1 deficiency in hepatocytes during fasting conditions, there appears to be a primarily descriptive nature to the study with a lack of clear connection between the experiments. Thus, a stronger focus is warranted, particularly on understanding the dialogue between hepatocytes and macrophages. Moreover, the data would benefit from reinforcement through additional experiments such as Western blotting, flow cytometry, and rescue experiments, which would offer a more quantitative aspect to the findings. By incorporating these enhancements, the study could achieve a more comprehensive understanding of the underlying mechanisms and ultimately strengthen the overall impact of the research.

      We thank the reviewer for the encouraging comments and helpful suggestions. We agree with the reviewer that additional experiments could reinforce our findings. Therefore, we conducted additional experiments including flow cytometry, western blotting, and using kinase-dead mutant mice to further investigate the underlying mechanisms. We carefully addressed every comment by the reviewer as indicated below.

      Detailed major concerns:

      (1) Related to Figure 1.

      It is imperative to ensure consistency in the number of animals analyzed across the different graphs. The current resolution of the images appears to be low, resulting in unsharp visuals that hinder the interpretation of data beyond the presence of "white dots". To address this issue, it is recommended to enhance the resolution of the images and consider incorporating zoom-in features to facilitate a clearer visualization of the observed differences. Moreover, it would be beneficial to include a complete WB analysis for the cell death pathways analyzed. These adjustments will significantly improve the clarity and interpretability of Figure 1.

      Thanks very much for the constructive advice. We carefully checked the number of animals and make sure that the animal number were consistent within different figures. We further updated the figures with incorporating zoom-in features in updated Figure 1, and the resolution of the figures were greatly improved. Western blot analysis were also included in updated Supplementary Figure 1.

      (2) Related to Figure 2.

      It is essential to ensure consistency in the number of animals analyzed across the different graphs, as indicated by n=6 in the figure legend (similar to Figure 1). Additionally, it is crucial to distinguish between male and female subjects in the dot plots to assess any potential gender-based differences, which should be consistent throughout the paper. To achieve this, the dots plot should be harmonized to clearly differentiate between males and females and investigate if there are any disparities between the genders. Moreover, it is imperative to correlate hepatic inflammation with the activation of Kupffer cells, infiltrating monocytes, and/or hepatic stellate cells (HSCs). Therefore, conducting flow cytometry would be instrumental in achieving this correlation. Additionally, the staining for Ki67 appears to be non-specific, showing a granular pattern reminiscent of bile crystals rather than the expected nuclear staining of hepatocytes or immune cells. It is crucial to ensure specific staining for Ki67, and conducting in vitro experiments on primary hepatocytes could further elucidate the proliferation process. These experiments are relatively straightforward to implement and would provide valuable insights into the mechanisms underlying hepatic inflammation and proliferation.

      Thanks very much for the helpful advice. First, we corrected the number of animals analyzed in different graphs and make sure that the number of animals listed in the figure legend were consistent with the graphs in all figures. Second, to distinguish the results between male and female mice, blue represents male mice, pink represents female mice, and green represents RIPK1 kinase inactivated mice. The majority of results were obtained from male mice, and our results indicated that there was no difference between male and female mice herein.

      The percentages of immune cell subpopulations isolated from mouse liver tissue were determined. The results were consistent with single cell analysis that greater number of  macrophages were recruited into the liver tissue in Ripk1<sup>Δhep</sup> upon 12-hour fasting (updated Figure 4F&G).

      To confirm the results of Ki67, we first detected the transcriptional expression of Ki67 using real-time qPCR, and the results were consistent with the protein expression measured by immunohistochemical analysis. The percentage of Ki67<sup>+</sup> cells in liver cells were also detected, and there was significantly more Ki67<sup>+</sup> cells in Ripk1<sup>Δhep</sup> mouse liver than WT control mouse upon 12-hour fasting. Taken together, our transcriptional analysis, immunohistochemical analysis as well as flow cytometry data indicated that Ki67 expression was higher in Ripk1<sup>Δhep</sup> mice than Ripk1<sup>fl/fl</sup> mice. (updated Figure 2). 

      (3) Related to Figure 3 & related to Figure 4.

      The immunofluorescence data presented are not entirely convincing and are insufficient to conclusively demonstrate the recruitment of monocytes. Previous suggestions for flow cytometry studies remain pertinent and are indeed necessary to bolster the robustness of the data and conclusions. Conducting flow cytometry analyses would provide more accurate and quantitative assessments of monocyte recruitment, ensuring the reliability of the findings and strengthening the overall conclusions of the study. Regarding the single-cell RNA sequencing analysis presented in the manuscript, it's worth questioning its relevance and depth of information provided. While it successfully identifies a quantitative difference in the cellular composition of the liver between control and knockout mice, it may fall short in elucidating the intricate interactions between different cell populations, which are crucial for understanding the underlying mechanisms of hepatic inflammation. Therefore, I propose considering alternative bioinformatic analyses, such as CellPhone-CellChat, which could potentially provide a more comprehensive understanding of the cellular dynamics and interactions within the liver microenvironment. By examining the dialogue between different cell clusters, these analyses could offer deeper insights into the functional consequences of Ripk1 deficiency in hepatocytes and its impact on hepatic inflammation during fasting.

      Thanks very much for the constructive suggestion. We agree with the reviewer that conducting flow cytometry analyses would provide accurate and quantitative assessments of monocyte recruitment, ensuring the reliability of the findings. Following the advice, both WT and Ripk1<sup>Δhep</sup> mice were fasted for 12 hour and then single hepatic cells were isolated and analyzed by flow cytometry. As indicated in updated Figure 4F&G, the percentage of F4/80<sup>+</sup>CD11b<sup>+</sup> cells were significantly higher in Ripk1<sup>Δhep</sup> compared with WT control mice, confirming that more monocytes were recruited into the liver.

      Additionally, we performed CellChat analysis on the single-cell transcriptomic data. As shown in updated Figures 4H-J, both the number of ligand-receptor pairs and the interaction strength among the eight cell types were significantly increased in Ripk1<sup>Δhep</sup> mice, particularly the interactions between macrophages and other cell types. Network analysis indicated that inflammation and proliferation signals were amplified in Ripk1<sup>Δhep</sup> mice. Consistent with the bulk RNA sequencing data, SAA signaling was upregulated in the hepatocytes of Ripk1<sup>Δhep</sup> mice (updated Figure 4K). SAA has been found to play a role in regulating immune responses and tumor development. Based on these findings, we speculate that fasting-induced liver injury in RIPK1 knockout mice may exacerbate the inflammatory response in liver tissue through enhanced SAA signaling. The above data analysis and interpretation were included in the updated Figure 4&S4 and line 421 - 443.

      (4) Related to Figure 5.

      What additional insights do the data from Figure 5 provide compared to the study published in Nat Comms, which demonstrated that RIPK1 regulates starvation resistance by modulating aspartate catabolism (PMID: 34686667)?

      Thank you very much for your constructive suggestion. As noted by the reviewer, this study (PMID: 34686667) primarily focuses on metabolomic analyses of Ripk1<sup>-/-</sup> neonatal mouse brain tissue and Ripk1<sup>-/-</sup> MEF cells. The authors propose that Ripk1 regulates starvation resistance by modulating aspartate catabolism.

      In our study, the global metabolic changes induced by fasting were monitored. Fastinginduced lipolysis in peripheral adipose tissue leads to hepatic lipid accumulation, and excessive deposition of free fatty acids has been shown to induce endoplasmic reticulum (ER) stress in the liver. Data from Figure 5 demonstrate that administering the ER stress inhibitor 4-PBA effectively mitigated fasting-induced liver injury and inflammatory responses in Ripk1<sup>Δhep</sup> mice. Our findings suggest that ER stress plays a critical role in fasting-induced liver injury and inflammation in Ripk1<sup>Δhep</sup> mice.

      (5) Related to Figure 6.

      The data presented in Figure 7 are complementary and do not introduce new mechanistic insights.

      Thank you very much for your insightful suggestion. As you mentioned, the AAV-TBG-Cre-mediated liver-specific RIPK1 knockout mice offer complementary validation of the results obtained from Ripk1<sup>Δhep</sup> mice. Moreover, TBG is a promoter that is exclusively expressed in mature hepatocytes, while the ALB promoter is active not only in mature hepatocytes but also in precursor cells and cholangiocytes. Therefore, we think that the inclusion of AAV-TBG-Cre further strengthens our finding that RIPK1 in hepatocytes is responsible for fasting-induced liver injury and inflammatory responses.

      (6) Related to Figure 7.

      The data from Figure 7 suggest that RIPK1 in hepatocytes is responsible for the observed damage. However, it has been previously demonstrated that inhibition of RIPK1 activity in macrophages protects against the development of MASLD (PMID: 33208891). One possible explanation for these findings could be that the overreaction of macrophages to fasting, coupled with the absence of RIPK1 in hepatocytes (an indirect effect), contributes to the observed damage. Considering this, complementing hepatocytes with a kinase-dead version of RIPK1 could be a valuable approach to further refine the molecular aspect of the study. This would allow for a more precise investigation into the specific role of RIPK1's scaffolding or kinase function in response to starvation in hepatocytes. Such experiments could provide additional insights into the mechanisms underlying the observed effects and help delineate the contributions of RIPK1 in different cell types to metabolic stress responses.

      Thank you very much for the constructive suggestion. We fully agree with the reviewer that employing a RIPK1 kinase-inactive mutant mice could precisely investigate the specific roles of RIPK1's scaffolding and kinase functions in hepatocyte responses to starvation, respectively. In accordance with this advice, we established a 12-hour fasting model using Ripk1<sup>WT/WT</sup> and Ripk1<sup>K45A/K45A</sup> mice, which were previously established and confirmed with the inactivity of RIPK1 kinase activity. As demonstrated in updated Supplementary Figure 2, these mice did not show significant liver damage or inflammatory responses after 12 hours of fasting. These findings suggest that the liver damage and inflammatory response induced by fasting in Ripk1<sup>Δhep</sup> mice may not be contributed by the kinase activity of RIPK1.  

      Reviewer #2 (Public Review):

      Summary:

      Zhang et al. analyzed the functional role of hepatocyte RIPK1 during metabolic stress, particularly its scaffold function rather than kinase function. They show that Ripk1 knockout sensitizes the liver to cell death and inflammation in response to short-term fasting, a condition that would not induce obvious abnormality in wild-type mice.

      Strengths:

      The findings are based on a knockout mouse model and supported by bulk RNA-seq and scRNA-seq. The work consolidates the complex role of RIPK1 in metabolic stress.

      Weaknesses:

      However, the findings are not novel enough because the pro-survival role of RIPK1 scaffold is well-established and several similar pieces of research already exist. Moreover, the mechanism is not very clear and needs additional experiments.

      We thank the reviewer for the encouraging comments and helpful suggestions. Here we conducted additional experiments including flow cytometry, western blotting, and using kinase-dead mutant mice to further investigate the underlying mechanisms. We carefully addressed every comment by the reviewer as indicated below.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (7) I recommend that the authors consider reassessing their results, particularly with regards to elucidating the dialogue between macrophages and hepatocytes, as this could further strengthen the study's conclusions.

      Thank you very much for your constructive suggestion. We conducted additional experiments, including flow cytometry and western blotting, to reassess our findings. Furthermore, to clarify the interactions between cells, we employed CellChat for a more in-depth analysis of the single-cell sequencing results. In the revised manuscript version, changes are highlighted in yellow. In this study, we demonstrated that the specific deletion of RIPK1 in hepatocytes exacerbated the liver's vulnerability to metabolic disturbances, such as short-term fasting and high-fat diet feeding, resulting in increased liver damage, apoptosis, inflammation, and compensatory proliferation. The data indicate that fasting-induced liver injury in RIPK1 knockout mice of hepatic parenchymal cells may exacerbate the inflammatory response in liver tissue through enhanced SAA signaling. In summary, we revealed a novel physiological role of RIPK1 as a scaffold in maintaining liver homeostasis during fasting and other nutritional disturbances.

      (8) It would be beneficial for the authors to address the minor weaknesses identified in the study, such as ensuring consistency in the number of animals analyzed across different graphs and enhancing the resolution of images to improve data clarity.

      Thank you for the suggestion. In the revised manuscript, we have addressed these minor weaknesses, and we checked the consistency in the number of animals in different graphs, as well as enhanced the resolution of all images.

      (9) I encourage the authors to incorporate additional experiments, such as Western blotting and flow cytometry, to provide a more quantitative assessment of the observed effects and enhance the robustness of their conclusions.

      Thank you for your insightful suggestion. We completely agree with the reviewer that incorporating flow cytometry and western blotting would strengthen the robustness of our conclusions. We conducted flow cytometry analysis and western blotting and the results were listed in updated Supplementary Figure 1, Figure 2, Figure 4 and Supplementary Figure 4.

      (10) Furthermore, the authors may consider conducting complementary experiments, such as rescue experiments involving complementing hepatocytes with a kinase-dead version of RIPK1, to further refine the molecular aspect of the study and elucidate the specific roles of RIPK1's scaffolding or kinase function in response to starvation.

      Thank you very much for your constructive suggestion. As shown in updated Supplementary Figure 2, we conducted fasting experiments using RIPK1 kinase-dead mice. These findings suggest that the liver damage and inflammatory response induced by fasting in Ripk1<sup>Δhep</sup> mice may not contributed by the kinase activity of RIPK1.

      Reviewer #2 (Recommendations For The Authors):

      Major:

      (11) What is the upsteam signal for RIPK1? The study investigated the change induced by short-term fasting which is metabolic stress. Although RIPK1 knockout promotes cell death and inflammation, how it is involved in this condition is unclear. RIPK1 is never reported as a metabolic sensor and its function is typically downstream of TNFR1 as well as other death receptors such as Fas, TRAIL-R1, TRAIL-R2. Thus, it's probable that metabolic stress induces the expression and secretion of some ligand of the above receptors. Although TNFα expression is upregulated on both mRNA and protein levels, it could not be concluded that TNFα is the upsteam signal for RIPK1 because expression difference does not always lead to fuctional role. In addition, a recent study, which is also reference 33, reports that knockout of TNFR1/2 does not protect against 18 h liver ischemia, a condition that is similar to the present study. Therefore, the link between the metabolic fluctuation and RIPK1 function is elusive and should be addressed. The expression difference analysis should be extended to other relevant ligands. A functional study using neutralizing antibodies in RIPK1ΔHep mice is encouraged. At least, this should be discussed in the discussion section.

      Thank you very much for your insightful comments. The upstream signals of RIPK1 remains a significant area of scientific inquiry. Fasting, as one of the main causes of metabolic stress, is known to trigger a series of physiological changes, including but not limited to decreased blood glucose levels, hepatic glycogen depletion, increased production of hepatic glucose and ketone bodies, adipose tissue lipolysis, and the influx and accumulation of free fatty lipids in the liver. It is well-established that the elevated lipid influx and hepatic accumulation during fasting may cause lipotoxicity stress for liver. To investigate whether the elevated free fatty acids influx might act as the signal to induce cytotoxicity, we isolated primary hepatocytes but observed that a significant number of cells underwent spontaneous death during the isolation and perfusion processes. To address this question, we utilized CRISPR-Cas9 technology to generate Ripk1<sup>-/-</sup> AML12 cells, as illustrated in Author response image 1A.

      To mimic hepatic lipid accumulation induced by short-term fasting, we treated the cells with palmitic acid (PA) or oleic acid (OA) for 12 hours in vitro. Our results indicated a significant increase in cell death among Ripk1<sup>-/-</sup> AML12 cells after PA treatment compared to WT control cells (Author response image 1B). As shown in Author response image 1C, we also observed a marked increase in caspase-3 activity in Ripk1<sup>-/-</sup> AML12 cells following PA treatment.

      Collectively, our results highlight the crucial role of RIPK1 in hepatocytes in maintaining the liver's adaptive capacity to counteract lipotoxicity induced by metabolic stress. These in vitro results were not included in the manuscript; however, we addressed them in the discussion section (line 593 - 597). If the reviewer suggest, we would like to incorporate in our manuscript.

      Author response image 1.

      (12) What is the exact relationship between ER stress and RIPK1? In Figure 5A and Figure 6B, Ripk1 knockout only slightly promotes the expression of ER stress markers. The evidence of RIPK1 leading to ER stress is limited in the literature and poorly supported in this study. Also in reference 33, the hypothesis is proposed that ER stress leads to death receptor upregulation and activation, which induces RIPK1 activation. Although the ER stress inhibitor showed good efficacy in rescue experiments, it could not determine whether RIPK1 deficiency leads to ER stress-associated phenotype or ER stress leads to death receptor activation and RIPK1 deficiency-associated phenotype. If RIPK1 deficiency leads to ER stress, the possible mechanism should be investigated.

      Thank you very much for your insightful comments. As the reviewer noted, the specific relationship between endoplasmic reticulum (ER) stress and RIPK1 remains unclear. However, our data, along with findings from other studies (Piccolis M et al., Mol Cell. 2019; Geng Y et al., Hepatol Int. 2021), suggest that fasting-induced lipolysis in peripheral adipose tissue leads to hepatic lipid accumulation. Additionally, excessive deposition of free fatty acids has been shown to induce ER stress in the liver. One possible explanation is that ER stress may trigger the upregulation and activation of death receptors, and the scaffold function of RIPK1 may play a protective and checkpoint role in this process. ER stress during the fasting might locate upstream of RIPK1. This could help explain why short-term fasting results in liver damage in Ripk1<sup>Δhep</sup> mice while control mice remain unaffected. Moreover, the inhibition of ER stress using 4-PBA can effectively alleviate this damage.

      Minor:  

      (13) The study starts directly from functional experiments. However, it should be firstly explored whether RIPK1 expression or activation is modulated in wild-type mice.

      Thank you very much for your insightful observation. Previous studies showed that RIPK1 deficiency in hepatocytes does not impact the growth and development of mice, indicating that RIPK1 is dispensable for proper liver development and homeostasis (Filliol A et al., Cell Death Dis. 2016). Furthermore, we did not observe any changes in RIPK1 levels in wild-type mice induced by fasting across different experimental batches. In our bulk transcriptomic analysis, the expression of RIPK1 was not changed before and after 12-hour fasting in Ripk1<sup>fl/fl</sup> mice. Therefore, we focused our attention on the function of RIPK1 and started our study directly with functional experiments.

      (14) Knockout of RIPK1 deprived both its scaffold function and kinase function. It is encouraged to explore whether blocking RIPK1 kinase activity influences the outcome of metabolic stress.

      Thank you for your insightful suggestion. To investigate the role of RIPK1 kinase activity in response to metabolic stress, we added fasting experiments using RIPK1 kinaseinactive mice in the updated Supplementary Figure 2, in which blocking RIPK1 kinase activity does not affect the outcome of metabolic stress.

      (15) In Figure 1, the number of TUNEL+ cells is about 2 times of c-casp3. What is the possible reason?

      Thank you for your careful reading. Indeed, the number of TUNEL<sup>+</sup> cells in Figure 1 is twice that of cleaved-caspase-3<sup>+</sup> cells. There are two possible reasons. First, we speculate that this discrepancy may be attributed to the higher sensitivity of the TUNEL assay compared to the cleaved-caspase-3 assay. Secondly, TUNEL assay detects DNA fragmentation, indicating that these cells are in a pre-apoptotic state or poised to undergo apoptosis. In contrast, cleaved-caspase-3 specifically identifies cells that have already committed to the apoptotic pathway, whereas TUNEL assay could detects all types of apoptosis, but the mechanisms of apoptosis may involve more than just cleaved-caspase3.

      (16) Infiltrated innate immune cells could lead to hepatocyte death. Is the hepatocyte death in this study partially caused by immune cells?

      Many thanks for the advice. As outlined in the response to the 11th comment from the second reviewer, our findings indicate that metabolic stress induced by short-term fasting is the primary cause of hepatocyte death. Additionally, we demonstrate that infiltrated innate immune cells may also play a partial role in hepatocyte death through subsequent cascade reactions.

      (17) Could the in vivo results be consolidated by in vitro experiments on primary mouse hepatocytes? This would be helpful to answer question 4.

      Thank you for your helpful comments. As demonstrated in the response to the 11th comment by the second reviewer, we attempted to conduct in vitro experiments using primary hepatocytes. However, during the isolation and perfusion processes, we observed that a significant number of cells underwent spontaneous death. To address this issue, we utilized CRISPR-Cas9 technology to generate Ripk1<sup>-/-</sup> AML12 cells, in which a significant increase in cell death among Ripk1<sup>-/-</sup> AML12 cells after palmitic acid (PA) treatment compared to WT control cells. We also observed a marked increase in caspase-3 activity in Ripk1<sup>-/-</sup> AML12 cells following PA treatment.

      (18) RIPK1 scaffold function is associated with NF-kB signal. Is NF-kB signal transduction influenced by Ripk1 deficiency? If so, to what extent does it contribute to the observed phynotype? If not, what is the direct downstream effect of Ripk1 deficiency?

      Thank you very much for your insightful perspective. As reported by Clucas J et al., RIPK1 serves as a scaffold for downstream NF-κB signaling through the ubiquitin chains generated by its ubiquitination (Clucas J et al., Nat Rev Mol Cell Biol. 2023). The deficiency of RIPK1 in hepatic parenchymal cells can disrupt NF-κB signaling and impair its pro-survival functions, resulting in increased cell death in response to stress. Our current findings suggest that the RIPK1-NF-κB axis serves as a crucial scaffold platform essential for the liver's adaptation to metabolic fluctuations. Any inappropriate inactivation or deletion of components within this scaffold disrupts the delicate balance between cell death, inflammation, and normal function, making the liver susceptible to metabolic changes, ultimately leading to liver damage, hepatic inflammation, and compensatory proliferation.

      (19) In Figure 6B, the 'RIP' should be changed to 'RIPK1'.

      Thank you for your careful observation. We have corrected "RIP" to "RIPK1" in updated Figure 6B.

      (20) For Western blot results, the blot height should be at least the lane width to reveal additional signals and the molecular weight as well as unspecific signals should be denoted.

      Thank you for your valuable advice. We appreciate your suggestions regarding the western blot results. We went through the previous western blot results and did not find any additional nonspecific signals. We added the molecular weights in the updated figures Figure 5, Figure 6 and Supplementary Figure 1.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Comments on revised version: 

      Overall, I thought the authors addressed my comments well with the possible exception of what is actually new here. This was the most important thing that I thought should be included in the revision. Although the authors rewrote the paragraph describing the lines presented in the paper, I still can't tell exactly which ones haven't been previously published. Their revised paragraph says that 40 lines have been "previously used," but Supplemental Table 1 shows references for over 200 of the lines, which sounds more reasonable based on papers that have come out. 

      We have modified the text in line 112-120 as below.

      “Supplementary File 1 lists 859 lines (including split-LexA) and their detailed information, such as genotype, expression specificity, matched EM cell type(s), and recommended driver for each cell type. A small subset of 47 lines from this collection have been previously used in studies (Aso et al., 2023; Dolan et al., 2019; Gao et al., 2019; Scaplen et al., 2021; Schretter et al., 2020; Takagi et al., 2017; Xie et al., 2021; Yamada et al., 2023).”

      For 842 lines among the 859 lines listed in Supplementary File 1, this study is the primary citation for future papers for the following reason: 

      In 2021 December, we deposited the confocal images of new split-GAL4 lines at Janelia Flylight website (http://www.janelia.org/split-gal4) without a publication to describe annotation of expression patterns, and we already started sharing the lines without restrictions. In 2023 September, we released the preprint of this study at bioRxiv (doi: https://doi.org/10.1101/2023.09.15.557808). Up to this point, 47 lines have been used in other studies. In Supplementary File 1, 30 of them attribute the citation credit to both this study and other papers, because this 2023 preprint was cited as the primary citation in those papers. Similarly, the omni paper to summarize all the eWort of generating split-GAL4 lines by Janelia Flylight team (https://doi.org/10.7554/eLife.98405.1) cite many lines from this paper. However, since this summary paper did not provide additional information such as functional characterization by behavioral experiments, we did not include it in Supplementary File 1 to clarify that this study is the primary citation for these lines. The remaining 17 lines were published before 2021. We included them for the convenience of users, and we attributed the primary citation to the already published papers. 

      Also, in the revised paragraph they state that "All transgenic lines newly generated in this study are listed in Supplementary File 2" but that table lists only the 36 LexA hemidriver lines! Confusingly, this comment cites the same 8 references as are cited for the 40 line that they say were previously published. I am thus only more confused about how many previously uncharacterized lines are presented in this paper. 

      We modified the text as below to clarify that “new lines” indicate LexA or DBD lines but not new combination of already published AD and DBD lines. We removed the 8 citations, which were mistakenly placed in the previous manuscript.

      “The newly generated LexA, Gal4DBD and LexADBD lines are listed in Supplementary File 2. “

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1:

      (1) All analyses were performed on trial-averaged neural responses that were pooled across mice. Owing to differences between subjects in behavior, experimental preparation quality, and biological variability, it seems important to perform at least some analyses on individual analyses to assess how behavioral training might differently affect each animal.

      In order to image at a relatively fast rate (30Hz) appropriate to the experimental conditions, we restricted our imaging to a relatively small field of view (412x412um with 512x512 pixels). This entails a smaller number of ROIs per animal, which can lead to an unbalanced distribution of cells responsive to different stimuli for individual fields-of-view. We used the common approach of pooling across animals (Homann et al., 2021; Kim et al., 2019) to overcome limitations imposed by sampling a smaller number of cells per animal. In response to this comment, we included supplemental analyses (Sup.Fig. 6) showing that representational drift (which was not performed on trial-averaged data) looks substantially the same (albeit nosier) for individual animals as at the population level. Additional analyses (PE ratio, etc.) were difficult since the distribution of cells selective for individual stimuli is unbalanced between individual animals and few mice have multiple cells representing all of the different stimuli.

      (2) The correlation analyses presented in Figure 3 (labeled the second Figure 2 in the text) should be conducted on a single-animal basis. Studying population codes constructed by pooling across mice, particularly when there is no behavioral readout to assess whether learning has had similar effects on all animals, appears inappropriate to me. If the results in Figure 3 hold up on single animals, I think that is definitely an interesting result.

      We repeated the correlation analysis performed on mice individually and included them in the supplement (Supp. Fig. 6). The overall result generally mirrors the result found by pooling across animals.

      (3) On Day 0 and Day 5, the reordered stimuli are presented in trial blocks where each image sequence is shown 100 times. Why wasn't the trial ordering randomized as was done in previous studies (e.g. Gavornik and Bear 2014)? Given this lack of reordering, did neurons show reduced predictive responses because the unexpected sequence was shown so many times in quick succession? This might change the results seen in Figure 2, as well as the decoder results where there is a neural encoding of sequence order (Figure 4). It would be interesting if the Figure 4 decoder stopped working when the higher-order block structure of the task was disrupted.

      Our work builds primarily on previous studies (Gavornik & Bear, 2014; Price et al., 2023) that demonstrated clear changes in neural responses over days while employing a similar block structure. Notably, Price et al. found that trial number (within a block) was not a significant factor in the generation of prediction-error responses which strongly suggests short-term plasticity does not play a significant role in shaping responses within the block structure. This finding is consistent with our previous LFP recordings which have not revealed any significant plasticity occurring within a training session, a conclusion bolstered by a collaborative work currently in press (Hosmane et al. 2024, Sleep) revealing the requirement for sleep in sequence plasticity expression.

      It is possible that layer 2/3 adapts to sequences more rapidly than layer 4/5. While manual inspection does not reveal an obvious difference between early and late blocks in this dataset, the n for this subset is too small to draw firm conclusions. It is our view that the block structure provides the strongest comparison to previous work, but agree it would be interesting to randomize or fully interleave sequences in future studies to determine what effect, if any, short-term changes might have. 

      (4) A primary advantage of using two-photon calcium imaging over other techniques like extracellular electrophysiology is that the same neurons can be tracked over many days. This is a standard approach that can be accomplished by using many software packages-including Suite2P (Pachitariu et al. 2017), which is what the authors already used for the rest of their data preprocessing. The authors of this paper did not appear to do this. Instead, it appears that different neurons were imaged on Day 0 (baseline) and Day 5 (test). This is a significant weakness of the current dataset.

      The hypothesis being tested was whether expectation violations, as described in Keller & Mrsic-Flogel 2018, exist under a multi-day sequence learning paradigm. For this, tracking cells across days is not necessary as our PE metric compared responses of individual neurons to multiple stimuli within a single session. Given the speed/FOV tradeoff discussed above, we wanted to consider all cells irrespective of whether they were visible/active or trackable across days, especially since we would expect cells that learn to signal prediction errors to be inactive on day 0 and not selected by our segmentation algorithm. Though we did not compare the responses of single cells before/after training, we did analyze cells from the same field of view on days 0 and 5 (see Supp.Fig. 1) and not distinct populations.

      Reviewer #2:

      (1) There appears to be some confusion regarding the conceptual framing of predictive coding.

      Assuming the mouse learns to expect the sequence ABCD, then ABBD does not probe just for negative prediction errors, and ACBD is not just for positive prediction errors. With ABBD, there is a combination of a negative prediction error for the missing C in the 3rd position, and a positive prediction error for B in the 3rd. Likewise, with ACBD, there is a negative prediction error for the missing B at 2nd and missing C at 3rd, and a positive prediction error for the C in 2nd and B in 3rd. Thus, the authors' experimental design does not have the power to isolate either negative or positive prediction errors. Moreover, looking at the raw data in Figure 2C, this does not look like an "omission" response to C, but more like a stronger response to a longer B. The pitch of the paper as investigating prediction error responses is probably not warranted - we see no way to align the authors' results with this interpretation.

      The reviewer has identified a real problem with the framing of “positive” and “negative” prediction errors in context of sensory stimuli where substitution simultaneously introduces unexpected “positive” violation and “negative” omission. Simply put, even if there are separate mechanisms to represent positive and negative errors, there may be no way to isolate the positive response experimentally since an unexpected input always replaces the unseen expected input. For example, had a cell fired solely to ACBD (and not during either ABCD or ABCD), then whether it was signaling the unexpected occurrence of C or the unexpected absence of B would be inherently ambiguous. In either case, such a cell would have been labeled as C-responsive, and its activity would have been elevated compared with ABCD and would have been included in our substitution-type analysis of prediction errors. We accept that there is some ambiguity regarding the description in this particular case, but overall, this cell’s activity pattern would have informed the PE analysis for which the result was essentially null for the substitution-type violation ACBD.

      Omission, in which the sensory input does not change, may experimentally isolate the negative response though this is only true if there is a temporal expectation of when the change should have occurred. If A is predicting B in an ordinal sense but there is no expectation of when B will occur with respect to A, changing the duration of A would not be expected to produce an error signal since at any point in time B might still be coming and the expectation is not broken until something other than B occurs. With respect specifically to ABBD in our experiments, it is correct that the learned error responses take the form of stronger, sustained responses to B during the time C was expected. This is still in contrast to day 0 in which activation decays after a transient response to ABBD. The data shows that responses during an omitted element are altered with training and take the form of elevated responses to ABBD on day 5.As we say in our discussion, this is somewhat ambiguous evidence of prediction errors since it does emerges only with training and is generally consistent with the hypothesis being tested though it takes a different form than we expected it to.

      (2) Related to the interpretation of the findings, just because something can be described as a prediction error does not mean it is computed in (or even is relevant to) the visual cortex. To the best of our knowledge, it is still unclear where in the visual stream the responses described here are computed. It is possible that this type of computation happens before the signals reach the visual cortex, similar to mechanisms predicting moving stimuli already in the retina (https://pubmed.ncbi.nlm.nih.gov/10192333/). This would also be consistent with the authors' finding (in previous work) that single-cell recordings in V1 exhibit weaker sequence violation responses than the author's earlier work using LFP recordings.

      Our work was aimed at testing the specific hypothesis that PE responses, at the very least, exist in L2/3—a hypothesis that is well-supported under different experimental paradigms (often multisensory mismatch). Our aim was to test this idea under a sequence learning paradigm and connect it with previously found PE responses in L4. We don’t claim that it is the only place in which prediction errors may be computed or useful, especially since (as you mentioned), there is evidence for such responses in layer 4. But it is fundamentally important to predictive processing that we determine whether PE responses can be found in layer 2/3 under this passive sequence learning paradigm, whether or not they reflect upstream processes, feedback from higher areas, or entirely local computations. Our aim was to establish some baseline evidence for or against predictive processing accounts of L2/3 activity during passive exposure to visual sequences.

      (3) Recording from the same neurons over the course of this paradigm is well within the technical standards of the field, and there is no reason not to do this. Given that the authors chose to record from different neurons, it is difficult to distinguish representational drift from drift in the population of neurons recorded.

      Our discussion of drift refers to changes occurring within a population of neurons over the course of a single imaging session. We have added clarifying language to the manuscript to make this clear. Changes to the population-level encoding of stimuli over days are treated separately and with different analytical tools. Re. tracking single across days, please see the response to Reviewer #1, comment 4.

      (4) The block paradigm to test for prediction errors appears ill-chosen. Why not interleave oddball stimuli randomly in a sequence of normal stimuli? The concern is related to the question of how many repetitions it takes to learn a sequence. Can the mice not learn ACBD over 100x repetitions? The authors should definitely look at early vs. late responses in the oddball block. Also, the first few presentations after the block transition might be potentially interesting. The authors' analysis in the paper already strongly suggests that the mice learn rather rapidly. The authors conclude: "we expected ABCD would be more-or-less indistinguishable from ABBD and ACBD since A occurs first in each sequence and always preceded by a long (800 ms) gray period.

      This was not the case. Most often, the decoder correctly identified which sequence stimulus A came from." This would suggest that whatever learning/drift could happen within one block did indeed happen and responses to different sequences are harder to interpret.

      This work builds on previous studies that used a block structure to drive plasticity across days. We previously tested whether there are intra-block effects and found no indication of changes occurring within a block or withing a session (please see the response to Reviewer #1, comment 3 for further discussion). Observed drift does complicate comparison between blocks. There is no indication in our data that this is a learned effect, though future experiments could test this directly.

      (5) Throughout the manuscript, many of the claims are not statistically tested, and where they are the tests do not appear to be hierarchical (https://pubmed.ncbi.nlm.nih.gov/24671065/), even though the data are likely nested.

      We have modified language throughout the manuscript to be more precise about our claims. We used pooled data between mice and common parametric statistics in line with published literature. The referenced paper offers a broad critique of this approach, arguing that it increases the possibility of type 1 errors, though it is not clear to us that our experimental design carries this risk particularly since most of our results were negative. To address the specific concern, however we performed a non-parametric hierarchical bootstrap analysis (https://pmc.ncbi.nlm.nih.gov/articles/PMC7906290/) that re-confirmed the statistical significance of our positive results, see Supplemental Figure 8.

      (6) The manuscript would greatly benefit from thorough proofreading (not just in regard to figure references).

      We apologize for the errors in the manuscript. We caught the issue and passed on a corrected draft, but apparently the uncorrected draft was sent for review. The re-written manuscript addresses all identified issues.

      (7) With a sequence of stimuli that are 250ms in length each, the use of GCaMP6s appears like a very poor choice.

      We started our experiments using GCaMP6f but ultimately switched to GCaMP6s due to its improved sensitivity, brightness, and accuracy in spike detection (Huang et al., 2021). When combined with deconvolution (Pachitariu et al., 2018; Pnevmatikakis et al., 2016), we found GCaMP6s provides the most complete and accurate view of spiking within 40ms time bins. The inherent limitations of calcium imaging are more likely to be addressed using electrophysiology rather than a faster sensor in future studies.

      (8) The data shown are unnecessarily selective. E.g. it would probably be interesting to see how the average population response evolves with days. The relevant question for most prediction error interpretations would be whether there are subpopulations of neurons that selectively respond to any of the oddballs. E.g. while the authors state they "did" not identify a separate population of omission-responsive neurons, they provide no evidence for this. However, it is unclear whether the block structure of the experiments allows the authors to analyze this.

      We concluded that there is no clear dedicated subpopulation of omission-responding cells by inspecting cells with large PE responses (i.e., ABBD, see supplemental figure 3). Out of the 107 B-responsive cells on day 5, only one appeared to fire exclusively during the omitted stimulus. Average traces for all B-responsive cells are included in the supplement and we have updated the manuscript accordingly. Similarly, a single C-responsive cell was found with an apparently unique substitution error profile (ABCD and ACBD , supplemental figure 4).

      Our primary concern was to make sure that days 0 and 5 had the highest quality fields-of-view. In work leading up to this study, there were concerns that imaging on all intermediate days resulted in a degradation of quality due to photobleaching. We agree that an analysis of intermediate days would be interesting, but it was excluded due to these concerns. 

      Reviewer #3:

      (1) Experimental design using a block structure. The use of a block structure on test days (0 and 5) in which sequences were presented in 100 repetition blocks leads to several potential confounds. First, there is the potential for plasticity within blocks, which could alter the responses and induce learned expectations. The ability of the authors to clearly distinguish blocks 1 and 2 on Day 0 with a decoder suggests this change over time may be meaningful.

      Repeating the experiments with fully interleaved sequences on test days would alleviate this concern. With the existing data, the authors should compare responses from the first trials in a block to the last trials in a block.

      This block design likely also accounts for the ability of a decoder to readily distinguish stimulus A in ABCD from A in ABBD. As all ABCD sequences were run in a contiguous block separate from ABBD, the recent history of experience is different for A stimuli in ABCD versus ABBD. Running fully interleaved sequences would also address this point, and would also potentially mitigate the impact of drift over blocks (discussed below).

      As described in other responses, the block structure was chosen to align more closely with previous studies. We take the overall point though, and future studies will employ the suggested randomized or interleaved structure in addition to block structures to investigate the effects of short-term plasticity.

      (2) The computation of prediction error differs significantly for omission as opposed to substitutions, in meaningful ways the authors do not address. For omission errors, PE compares the responses of B1 and B2 within ABBD blocks. These responses are measured from the same trial, within tens of milliseconds of each other. In contrast, substitution PE is computed by comparing C in ABCD to C in ACBD. As noted above, the block structure means that these C responses were recorded in different blocks, when the state of the brain could be different. This may account for the authors' detection of prediction error for omission but not substitution. To address this, the authors should calculate PE for omission using B responses from ABCD.

      We performed the suggested analysis (i.e., ABBD vs ABCD) prior to submission but omitted it from the draft for brevity (the effect was the same as with ABBD vs ABBD). We have added the results of standardizing with ABCD as supplementary figure 3.

      (3) The behavior of responses to B and C within the trained sequence ABCD differs considerably, yet is not addressed. Responses to B in ABCD potentiate from d0-> d5, yet responses to C in the same sequence go down. This suggests there may be some difference in either the representation of B vs C or position 2 vs 3 in the sequence that may also be contributing to the appearance of prediction errors in ABBD but not ACBD. The authors do not appear to consider this point, which could potentially impact their results. Presenting different stimuli for A,B,C,D across mice would help (in the current paper B is 75 deg and C is 165 deg in all cases). Additionally, other omissions or substitutions at different sequence positions should be tested (eg ABCC or ABDC).

      We appreciate the suggestion. Ideally, we could test many different variants, but practical concerns regarding the duration of the imaging sessions prevented us from testing other interesting variations (such as ABCC) in the current study. We are uncertain as to how we should interpret the overall depressed response to element C seen on day 5, but since the effect is shared in both ABCD and ACBD, we don’t think it affected our PE calculations. 

      (4) The authors' interpretation of their PCA results is flawed. The authors write "Experience simplifies activity in principal component space". This is untrue based on their data. The variance explained by the first set of PCs does not change with training, indicating that the data is not residing in a lower dimensional ("simpler") space. Instead, the authors show that the first 5 PCs better align with their a priori expectations of the stimulus structure, but that does not mean these PCs necessarily represent more information about the stimulus (and the fact that the authors fail to see an improvement in decoding performance argues against this case). Addressing such a question would be highly interesting, but is lacking in the current manuscript. Without such analysis, referring to the PCs after training as "highly discretized" and "untangled" are largely meaningless descriptions that lack analytical support.

      We meant the terms “simpler”, “highly-discretized”, and “untangled” as qualitative descriptions of changes in covariance structure that occurred despite the maintenance of overall dimensionality. As the reviewer notes, the obvious changes in PC space appear to have had practically no effect on decodability or dimensionality, and we found this surprising and worth describing.

      (5) The authors report that activity sparsifies, yet provide only the fraction of stimulus-selective cells. Given that cell detection was automated in a manner that takes into account neural activity (using Suite2p), it is difficult to interpret these results as presented. If the authors wish to claim sparsification, they need to provide evidence that the total number of ROIs drawn on each day (the denominator for sparseness in their calculation) is unbiased. Including more (or less) ROIs can dramatically change the calculated sparseness.

      The authors mention sparsification as contributing to coding efficiency but do not test this. Training a decoder on variously sized subsets of their data on days 0 and 5 would test whether redundant information is being eliminated in the network over training.

      First, we provide evidence for sparseness using a visual responsiveness metric in addition to stimulus-selectivity. Second, it is true that Suite2p’s segmentation is informed by activity and therefore may possibly omit cells with very minimal activity. However, we detected a comparable number of cells on day 5 (n=1500) to day 0 (1368). We reportedly roughly half as many cells are stimulus-selective on day 5 compared with day 0. In order for that to have been a result of biased ROI segmentation, we would have needed to have detected closer to 2600 cells on day 5 rather than 1500.  Therefore, we consider any bias in the segmentation to have had little effect on the main findings.

      (6) The authors claim their results show representational drift, but this isn't supported in the data. Rather they show that there is some information in the structure of activity that allows a decoder to learn block ID. But this does not show whether the actual stimulus representations change, and could instead reflect an unrelated artifact that changes over time (responsivity, alertness, bleaching, etc). To actually assess representational drift, the authors should directly compare representations across blocks (one could train a decoder on block 1 and test on blocks 2-5). In the absence of this or other tests of representational drift over blocks, the authors should remove the statement that "These findings suggest that there is a measurable amount of representational drift".

      “To actually assess representational drift, the authors should directly compare representations across blocks (one could train a decoder on block 1 and test on blocks 25)”: This is the exact analysis that was performed. Additionally, our analysis of pairwise correlations directly measures representational drift.

      “But this does not show whether the actual stimulus representations change, and could instead reflect an unrelated artifact that changes over time (responsivity, alertness, bleaching, etc)”: We have repeated the decoder analysis using normalized population vectors (Supplementary Figure 5) which we believe directly addresses whether the observed drift is due to photobleaching or alertness that would affect the overall magnitudes of response vectors.

      Our analysis of block decoding reflects decoders trained on individual stimulus elements, and we show the average over all such decodings (we have clarified this in the text). For example, we trained a decoder on ABCD presentations from block 1 and tested only against ABCD from other blocks, which I believe is the test being suggested by the reviewer. Furthermore, we do show that representational similarity for all stimulus elements reduces gradually and more-or-less monotonically as the time between presentations increases. We believe this is a fairly straightforward test of representational drift as has been reported and used elsewhere (Deitch et al., 2021).

      (7) The authors allude to "temporal echoes" in a subheading. This term is never defined, or substantiated with analysis, and should be removed.

      We hoped the term ‘temporal echo’ would be understood in the context of rebounding activity during gray periods as supported by analysis in figure 6a. We have eliminated the wording in the updated manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, the authors provide a method aiming to accurately reflect the individual deviation of longitudinal/temporal change compared to the normal temporal change characterized based on pre-trained population normative model (i.e., a Bayesian linear regression normative model), which was built based on cross-sectional data. This manuscript aims at solving a recently identified problem of using normative models based on cross-sectional data to make inferences about longitudinal change.

      Strengths:

      The efforts of this work make a good contribution to addressing an important question of normative modeling. With the greater availability of cross-sectional studies for normative modeling than longitudinal studies, and the inappropriateness of making inferences about longitudinal subject-specific changes using these cross-sectional data-based normative models, it's meaningful to try to address this gap from the aspect of methodological development.

      In the 1st revision, the authors added a simulation study to show how the performance of the classification based on z-diff scores relatively changes with different disruptions (and autocorrelation). Unfortunately, in my view this is insufficient as it only shows how the performance of using z-diff score relatively changes in different scenarios. I would suggest adding the comparison of performance to using the naïve difference in two simple z-scores to first show its better performance, which should also further highlight the inappropriate use of simple z-scores in inferring within-subject longitudinal changes.

      Thank you for the suggestion for additional comparison, which we have now implemented in the simulated methods comparison, see Figure 2 and the extended text of Section 2.1.4 Simulation study.

      Specifically, we have revised the simulation section to not only illustrate the performance of our z-diff method under various scenarios but also to include a direct comparison with a naïve approach that subtracts two z-scores.

      The updated results demonstrate that, compared to the naïve method, the z-diff score consistently maintains a fixed false-positive rate, making it a more robust and controllable approach. Additionally, we show that under conditions of high autocorrelation, the z-diff method is significantly more sensitive in detecting smaller changes than the subtraction method. Importantly, our analysis of a sample from our dataset indicates that high autocorrelation is a prevalent characteristic in real-world data, further supporting the utility of the z-diff method.

      We believe that these findings strengthen the case for adopting the z-diff method and underscore the limitations of more intuitive approaches, which, while simple, lack mathematical rigour.

      Additionally, Figure 1 is hard to read and obtain the actual values of the performance measure. I would suggest reducing it to several 2-dimensional figures. For example, for several fixed values of rho, how the performance changes with different values of the true disruption (and also adding the comparison to the naïve method (difference in two z-scores)).

      We believe that the Reviewer meant Figure 2; indeed, the 3-dimensional visualization, while attractive to some, may have been difficult to read, so we have now replaced it with several 2-dimensional figures as requested.

      I would also suggest changing the title to reflect that the evaluation of "intra-subject" longitudinal change is the method's focus.

      Thanks for the suggestion. We have now implemented it by changing the title to Using normative models pre-trained on cross-sectional data to evaluate intra-individual longitudinal changes in neuroimaging data.

      We hope the changes implemented fulfill the expectations of the Reviewer.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This work aims to understand the role of thalamus POm in dorsal lateral striatum (DLS) projection in learning a sensorimotor associative task. The authors first confirm that POm forms "en passant" synapses with some of the DLS neuronal subtypes. They then perform a go/no-go associative task that consists of the mouse learning to discriminate between two different textures and to associate one of them with an action. During this task, they either record the activity of the POm to DLS axons using endoscopy or silence their activity. They report that POm axons in the DLS are activated around the sensory stimulus but that the activity is not modulated by the reward. Last, they showed that silencing the POm axons at the level of DLS slows down learning the task.

      The authors show convincing evidence of projections from POm to DLS and that POm inputs to DLS code for whisking whatever the outcome of the task is. However, their results do not allow us to conclude if more neurons are recruited during the learning process or if the already activated fibres get activated more strongly. Last, because POm fibres in the DLS are also projecting to S1, silencing the POm fibres in the DLS could have affected inputs in S1 as well and therefore, the slowdown in acquiring the task is not necessarily specific to the POm to DLS pathway.

      We thank the reviewer for these constructive comments. The points are addressed below.  

      Strengths:

      One of the main strengths of the paper is to go from slice electrophysiology to behaviour to get an in-depth characterization of one pathway. The authors did a comprehensive description of the POm projections to the DLS using transgenic mice to unambiguously identify the DLS neuronal population. They also used a carefully designed sensorimotor association task, and they exploited the results in depth.

      It is a very nice effort to have measured the activity of the axons in the DLS not only after the mice have learned the task but throughout the learning process. It shows the progressive increase of activity of POm axons in the DLS, which could imply that there is a progressive strengthening of the pathway. The results show convincingly that POm axons in the DLS are not activated by the outcome of the task but by the whisker activity, and that this activity on average increases with learning.

      Weaknesses:

      One of the main targets of the striatum from thalamic input are the cholinergic neurons that weren't investigated here, is there information that could be provided?

      This is true of the parafascicular (Pf) thalamic nucleus, which has been well studied in this context. However, there is much less known about the striatal projections of other thalamic nuclei, including POm, and their inputs to cholinergic neurons. Anatomical tracing evidence from Klug et al. (2018), which mapped brain-wide inputs to striatal cholinergic (ChAT) interneurons, suggests that Pf provides the majority of thalamic innervation of striatal ChAT neurons compared to other thalamic nuclei. Many other thalamic nuclei, including POm, showed very little of no labeling, suggesting weak innervation of ChAT interneurons. However, it is possible that these thalamic nuclei, including POm, do provide functional innervation of ChAT interneurons that is not sufficiently assessed by anatomical tracing. Understanding the innervation patterns of POm-striatal projections beyond the three cell types we have studied here would be an important area of further study.

      It is interesting to know that the POm projects to all neuronal types in the DLS, but this information is not used further down the manuscript so the only take-home message of Figure 1 is that the axons that they image or silence in the DLS are indeed connected to DLS neurons and not just passing fibres. In this line, are these axons the same as the ones projecting to S1? If this is the case, why would we expect a different behaviour of the axon activity at the DLS level compared to S1?

      Tracing of single POm axons by Ohno et al. (2012) indicated that POm axons form a branched collateral that innervates striatum, while the main axon continues in the rostral-dorsal direction to innervate cortex. We think it is reasonable, based on the morphology, that our optogenetic suppression experiment restricted the suppression of glutamate release to this branch and avoided the other branches of the axon that project to cortex. However, testing this would require monitoring S1 activity during the POm-striatal axon suppression, which we did not do in this study.

      It is a very interesting question whether there could be different axon activity behavior in striatum versus S1. There is surprising evidence that POm synaptic terminals are different sizes in S1 and M1 and show different synaptic physiological properties depending on these cortical projection targets (Casas-Torremocha et al., 2022). Based on this, it is possible that POm-striatal synapses show distinct properties compared to cortex; however, this will need to be tested in future work.

      The authors used endoscopy to measure the POm axons in the DLS activity, which makes it impossible to know if the progressive increase of POm response is due to an increase of activity from each individual neuron or if new neurons are progressively recruited in the process.

      This is a good point. It would be necessary to perform chronic two-photon imaging of POm neurons (or chronic electrophysiological recordings) to determine whether the activity of individual neurons increased versus whether individual neuron activity levels remained similar but new neurons became active with learning. Even under baseline conditions, it is not known in detail what fraction of the population of POm neurons is active during sensory processing or behavior, highlighting how much is still to be discovered in this exciting area of neuroscience.

      The picture presented in Figure 4 of the stimulation site is slightly concerning as there are hardly any fibres in neocortical layer 1 while there seems to be quite a lot of them in layer 4, suggesting that the animal here was injected in the VB. This is especially striking as the implantation and projection sites presented in Figures 1 and 2 are very clean and consistent with POm injection.

      Although this image was selected to demonstrate the position of the POm injection site and optical fiber implant above striatal axons, the reviewer is correct that there appears to be mixed labeling of axons in L4 and L5a. In some cases, there was expression slightly outside the border of POm (see Fig. 1B, right), which might explain the cortical innervation pattern in this figure. While cortically bound VPM axons pass through the striatum, they do not form synaptic terminals until reaching the cortex (Hunnicutt et al., 2016). If, as may be the case, inhibitory opsins suppress release of neurotransmitter at synaptic terminals more effectively than action potential propagation in axons, it may be likely that optogenetic suppression of POm-striatal terminals is more effective than suppression of action potentials in off-target-labelled VPM axons of passage. Ideally, we could compare effects of suppression of POm-striatal synapses with POm-cortical synapses and VPM-cortical synapses, but this was outside the bandwidth of the present study.

      Reviewer #2 (Public Review):

      Summary:

      Yonk and colleagues show that the posterior medial thalamus (POm), which is interconnected with sensory and motor systems, projects directly to major categories of neurons in the striatum, including direct and indirect pathway MSNs, and PV interneurons. Activity in POm-striatal neurons during a sensory-based learning task indicates a relationship between reward expectation and arousal. Inhibition of these neurons slows reaction to stimuli and overall learning. This circuit is positioned to feed salient event activation to the striatum to set the stage for effective learning and action selection.

      Strengths:

      The results are well presented and offer interesting insight into an understudied thalamostriatal circuit. In general, this work is important as part of a general need for an increased understanding of thalamostriatal circuits in complex learning and action selection processes, which have generally received less attention than corticostriatal systems.

      Weaknesses:

      There could be a stronger connection between the connectivity part of the data - showing that POm neurons context D1, D2, and PV neurons in the striatum but with some different properties - and the functional side of the project. One wonders whether the POm neurons projecting to these subtypes or striatal neurons have unique signaling properties related to learning, or if there is a uniform, bulk signal sent to the striatum. This is not a weakness per se, as it's reasonable for these questions to be answered in future papers.

      We are very interested to understand the potentially distinct learning-related synaptic and circuit changes that potentially occur at the POm synapses with D1- and D2-SPNs and PV interneurons, and other striatal cell types. We agree that this would be an important topic for further investigation.

      All the in vivo activity-related conclusions stem from data from just 5 mice, which is a relatively small sample set. Optogenetic groups are also on the small side.

      We appreciate this point and agree that higher N can be important for observing robust effects. A factor of our experiments that helped reduce the number of animals used was the longitudinal design, with repeated measures in the same subjects. This allowed for the internal control of comparing learning effects in the same subject from naïve to expert stages and therefore increased robustness. Even with relatively small group sizes, results were statistically significant, suggesting that the use of more mice was unnecessary, which we considered consistent with best practice in the use of animals in research. We also note that our group sizes were consistent with other studies in the field.  

      Reviewer #3 (Public Review):

      Yonk and colleagues investigate the role of the thalamostriatal pathway. Specifically, they studied the interaction of the posterior thalamic nucleus (PO) and the dorsolateral striatum in the mouse. First, they characterize connectivity by recording DLS neurons in in-vitro slices and optogenetically activating PO terminals. PO is observed to establish depressing synapses onto D1 and D2 spiny neurons as well as PV neurons. Second, the image PO axons are imaged by fiber photometry in mice trained to discriminate textures. Initially, no trial-locked activity is observed, but as the mice learn PO develops responses timed to the audio cue that marks the start of the trial and precedes touch. PO does appear to encode the tactile stimulus type or outcome. Optogenetic suppression of PO terminals in striatum slow task acquisition. The authors conclude that PO provides a "behaviorally relevant arousal-related signal" and that this signal "primes" striatal circuitry for sensory processing.

      A great strength of this paper is its timeliness. Thalamostriatal processing has received almost no attention in the past, and the field has become very interested in the possible functions of PO. Additionally, the experiments exploit multiple cutting-edge techniques.

      There seem to be some technical/analytical weaknesses. The in vitro experiments appear to have some contamination of nearby thalamic nuclei by the virus delivering the opsin, which could change the interpretation. Some of the statistical analyses of these data also appear inappropriate. The correlative analysis of Pom activity in vivo, licking, and pupil could be more convincingly done.

      The bigger weakness is conceptual - why should striatal circuitry need "priming" by the thalamus in order to process sensory stimuli? Why would such circuitry even be necessary? Why is a sensory signal from the cortex insufficient? Why should the animal more slowly learn the task? How does this fit with existing ideas of striatal plasticity? It is unclear from the experiments that the thalamostriatal pathway exists for priming sensory processing. In fact, the optogenetic suppression of the thalamostriatal pathway seems to speak against that idea.

      We thank the reviewer for these constructive comments. The points are addressed below.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      Do POm neurons innervate CINs also? The connection between the PF thalamus and CINs is mentioned in a couple of places - one question is how unique are the input patterns for the POm versus adjacent sensorimotor thalamic regions, including the PF? This isn't a weakness per se but knowing the answer to that question would help in forming a more complete picture of how these different thalamostriatal circuits do or do not contribute uniquely to learning and action selection.

      Anatomical tracing evidence from Klug et al. (2018), which mapped brain-wide inputs to striatal cholinergic (ChAT) interneurons, suggests that Pf provides the majority of thalamic innervation of striatal ChAT neurons compared to other thalamic nuclei. Many other thalamic nuclei, including POm, showed very little or no labeling, suggesting weak innervation of ChAT interneurons. However, it is possible that these thalamic nuclei, including POm, do provide functional innervation of ChAT interneurons that is not sufficiently assessed by anatomical tracing.

      Another difference between Pf and other thalamic nuclei (likely including POm) comes from anatomical tracing evidence (Smith et al., 2014; PMID: 24523677) which indicates that Pf inputs form the majority of their synapses onto dendritic shafts of SPNs, while other thalamic nuclei form synapses onto dendritic spines. Understanding the innervation patterns of POm-striatal projections beyond the three cell types we have studied here, including ChAT neurons and subcellular localization, would be an important area of further study.

      It would be useful to know to what extent these POm-striatum neurons are activated generally during movement, versus this discrimination task specifically.

      We agree that distinguishing general movement-related activity from task-specific activity would be very useful. Earlier work (Petty et al., 2021) showed a close relationship between POm neuron activity, spontaneous (task-free) whisker movements, and pupil-indexed arousal in head-restrained mice. Oram et al. (2024; PMID: 39003286) recently recorded VPM and POm in freely moving mice during natural movements, finding that activity of both nuclei correlated with head and whisker movements. These studies indicate that POm is generally coactive with exploratory head and whisker movements.

      During task performance, the situation may change with training and attentional effects. For example, Petty and Bruno (2024) (https://elifesciences.org/reviewed-preprints/97188) showed that POm activity correlates more closely with task demands than tactile or visual stimulus modality. Our data indicate that POm axonal signals are increased at trial start during anticipation of tactile stimulus delivery and through the sensory discrimination period, then decrease to baseline levels during licking and water reward collection (Fig. 3). Results of Petty and Bruno (2024) together with ours suggest that POm is particularly active during the context of behaviorally relevant task performance. Thus, we think it is likely that, while pupil dilation indexes general movement and arousal, POm activity is more specific to movement and arousal associated with task engagement and behavioral performance. We have strengthened this point in the Discussion.

      Many of the data panels and text for legends/axes are quite small, and the stroke on line art is quite faint - overall figures could be improved from a readability standpoint.

      We thank the reviewer for their careful attention to the figures. 

      Reviewer #3 (Recommendations For The Authors):

      Major

      (1) Page 4, the Results regarding PSP and distance from injection site. The r-squared is the wrong thing to look at to test for a relationship. One should look at the p-value on the coefficient corresponding to the slope. The p-value is probably significant given the figures, in which case there may be a relationship contrary to what is stated. All the low r-squared value says is that, if there is a relationship, it does not explain a lot of the PSP variability.

      We thank the reviewer for alerting us this oversight. We have included the p value (p = 0.0293) in the figure and legend, and indicated that the relationship is “small but significant”.

      (2) Figure 1B suggests that the virus injections extend beyond POm and into other thalamic structures. Do any of the results change if the injections contaminating other nuclei are excluded from the analysis? I am not suggesting the authors change the figures/analyses. I am simply suggesting they double-check.

      We selected for injections that were predominantly expressing in POm as determined by post-hoc histological analysis (see Fig. 1, right). As above, we think that axons of passage that do not form striatal synapses are less likely to be suppressed than axons with terminals; however, this would need to be determined in further experiments. Because the preponderance of expression is within POm, we think the results would be similar even with a stricter selection criterion. 

      (3) The authors conclude that POm and licking are not correlated (bottom of page 6 pertaining to Figures 3A-F). The danger of these analyses is that they assume that GCaMP8 is a perfect linear reporter of POm spikes. The reliability of GCaMP8 has been quantified in some cell types, but not thalamic neurons, which have relatively higher firing rates.

      The reviewer is correct that the relationship between GCaMP8 fluorescence changes and spiking has not been sufficiently characterized in thalamic neurons, and that this would be important to do.

      What if the indicator is simply saturated late into the trial (after the average reaction time)? It would look like there is no response and one would conclude no correlation, but there could be a very strong correlation.

      While saturation is worthy of concern, the signal dynamics here argue against this possibility. The reason is that the signal increased in the early part of the trial and decreased by the end. If saturation was an issue, this would have been apparent during the initial increase. When the signal decreased in amplitude at the end of the trial, this indicates that the signal is not saturated because it is returning from a point closer to its maximum (and is becoming less saturated).

      Also, what happens between trials? Are the correlations the same, stronger, weaker? Ideally, the authors would analyze the data during and between trials.

      Between trials the signal did not show further changes in baseline beyond what was displayed at the start and end of behavioral trials. There were no consistent increases or decreases in signals between trials, except perhaps during strong whisking bouts. This is anecdotal because we did not analyze between-trial data. However, it is interesting and important to note that signals increased dramatically in amplitude from naïve, early learning to expert behavioral performance (Fig. 3), highlighting that POm-axonal signals relate to behavioral engagement and performance rather than spontaneous behaviors.  

      (4) Axonal activity could also appear more correlated with the pupil than licking because pupil dynamics are slow like the dynamics of calcium indicators. These kernels could artificially inflate the correlation. Ideally, the authors could consider these temporal effects. Perhaps they could deconvolve the temporal profiles of calcium and pupil before correlating? Or equivalently incorporate the profiles into their analysis?

      We analyzed the lick probability histograms, which had a temporal profile similar to the calcium signals (Fig. 3D,E), ruling out concerns about effects of temporal effects on correlations. It is also worth noting that we observed changes in correlations between calcium signals and pupil with learning stage (Fig. 3I), even though the temporal profiles (signal dynamics) are not changing. Thus, temporal effects of the signals themselves are not the driver of correlations, but rather the changes in relative timing between calcium signals and pupil, as occur with learning.

      (5) The authors conclude that PO provides a "behaviorally relevant arousal-related signal" and that this signal "primes" striatal circuitry for sensory processing. The data here support the first part. It is not clear that the data support the second part, largely because it is vague what "priming" of sensory processing or "a key role in the initial stages of action selection (p.9) even means here. Why would such circuitry even be necessary? Why is a sensory signal from the cortex insufficient? Why should the animal more slowly learn the task? How does this fit with existing ideas of striatal plasticity? Some conceptual proposals from the authors, even if speculative and not offered as a conclusion, would be helpful.

      We appreciate these good points and have added further consideration and revision of the concept of priming and potential roles in an extensively revised Discussion section.

      (6) The photometry shows that PO turns on about 2 seconds before the texture presentation. PO's activity seems locked to the auditory cue, not the texture (Figure 2). This means that the attempt to suppress the thalamostriatal pathway with JAWS (Figure 4) is rather late, isn't it? Some PO signals surely go through. This seems to contradict the idea of priming above. It would be good if the authors could factor this into their narrative. Perhaps labelling the time of the auditory cue in Figure 4C would also be helpful.

      The start of texture presentation (movement of the texture panel toward the mouse) and auditory cue occur at the same time. To clarify this, we added a label “start tone” in Figure 4C and also in Figure 2C.

      For optogenetic (JAWS) suppression, we intentionally chose a time window between start tone onset and texture presentation, because our photometry experiments showed that this was when the preponderance of the signal occurred. However, the reviewer is correct that our chosen optogenetic suppression (JAWS) onset occurs shortly after the photometry signal has already started, potentially leaving the early photometry signal un-suppressed. Our motivation for choosing a restricted time window surrounding the texture presentation time was 1) to minimize illumination and potential heating of brain tissue; 2) to target a time window that avoids the auditory cue but covers stimulus presentation. We did not want to extend the duration of the suppression to before the trial started, because this could produce task-non-specific effects, such as distraction or loss of attention before the start of the trial.

      Even if some signal were getting through before suppression, we don’t think this contradicts the possibility of ‘priming’, because the process underlying priming would still be disrupted even if not totally suppressed. This would alter the temporal relationship between POm-striatal inputs and further corticostriatal inputs (from S1 and M1 cortex, for example). We have included further consideration of these points and possible relation to the priming concept in the Discussion.

      Minor

      (1) Page 5, "the sensitivity metric is artificially increased". What do you mean "artificially"? The mice are discriminating better. It is true that either a change in HR or FAR can cause the sensitivity metric to change, but there is nothing artificial or misleading about this.

      We removed the word artificial and clarified our definition of behaviorally Expert in this context:

      “Mice were considered Expert once they had reached ≥ 0.80 Hit Rate and ≤ 0.30 FA Rate for two consecutive sessions in lieu of a strict sensitivity (d’) threshold; we found this definition more intuitive because d’ is enhanced as Hit Rate and FA Rate approach their extremes (0 or 1)”

      (2) Page 7, "Upon segmentation (Figure S4G-J)". Do you mean "segregation by trial outcome"?

      Corrected.

      (3) Page 9, "POm projections may have discrete target-specific functions, such that POm-striatal inputs may play a distinct role in sensorimotor behavior compared to POm-cortical inputs". Would POm-cortical inputs not also be sensorimotor? The somatosensory cortex contains a lot of corticostriatal cells. It also has various direct and indirect links to the motor cortex as well.

      We have clarified the wording here to convey the possibility that POm signals could be received and processed differently by striatal versus cortical circuitry, and have moved this statement to later in the discussion for better elaboration.

      (4) The Methods state that male and female mice were used. Why not say how many of each and whether or not there are any sex-specific differences?

      We added the following information to the Methods:

      The number of male and female mice were as follows, by experiment type: 6 male, 4 female (electrophysiology); 3 male, 2 female (fiber photometry); 4 male, 5 female (optogenetics). Data were not analyzed for sex differences.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this series of studies, Locantore et al. investigated the role of SST-expressing neurons in the entopeduncular nucleus (EPNSst+) in probabilistic switching tasks, a paradigm that requires continued learning to guide future actions. In prior work, this group had demonstrated EPNSst+ neurons co-release both glutamate and GABA and project to the lateral habenula (LHb), and LHb activity is also necessary for outcome evaluation necessary for performance in probabilistic decision-making tasks. Previous slice physiology works have shown that the balance of glutamate/GABA co-release is plastic, altering the net effect of EPN on downstream brain areas and neural circuit function. The authors used a combination of in vivo calcium monitoring with fiber photometry and computational modeling to demonstrate that EPNSst+ neural activity represents movement, choice direction, and reward outcomes in their behavioral task. However, viral-genetic manipulations to synaptically silence these neurons or selectively eliminate glutamate release had no effect on behavioral performance in well-trained animals. The authors conclude that despite their representation of task variables, EPN Sst+ neuron synaptic output is dispensable for task performance.

      Strengths and Weaknesses:

      Overall, the manuscript is exceptionally scholarly, with a clear articulation of the scientific question and a discussion of the findings and their limitations. The analyses and interpretations are careful and rigorous. This review appreciates the thorough explanation of the behavioral modeling and GLM for deconvolving the photometry signal around behavioral events, and the transparency and thoroughness of the analyses in the supplemental figures. This extra care has the result of increasing the accessibility for non-experts, and bolsters confidence in the results.

      (1) To bolster a reader's understanding of results, we suggest it would be interesting to see the same mouse represented across panels (i.e. Figures 1 F-J, Supplementary Figures 1 F, K, etc i.e via the inclusion of faint hash lines connecting individual data points across variables.

      Thank you for the suggestion. The same mouse is now represented in Fig 1 and Fig 1—Figure Supplement 1 as a darkened circle so it can be followed across different panels. Photometry from this mouse was used as sample date in Figure 2b and Figure 2—figure supplement 1a-b.

      (2) Additionally, Figure 3E demonstrates that eliminating the 'reward' and 'choice and reward' terms from the GLM significantly worsens model performance; to demonstrate the magnitude of this effect, it would be interesting to include a reconstruction of the photometry signal after holding out of both or one of these terms, alongside the 'original' and 'reconstructed' photometry traces in panel D. This would help give context for how the model performance degrades by exclusion of those key terms.

      We have now added analyses and reconstructed photometry signals from GLMs excluding important predictors in Figure 3—figure supplement 1 and 2. We use the model where both “Direction and reward” were omitted as predictors for the GLM and showed photometry reconstructions aligned to behavioral events used for the full model (Figure 3—figure supplement 1) and partial model (Figure 3—figure supplement 2) to compare model performance.  

      (3) Finally, the authors claimed calcium activity increased following ipsilateral movements. However, Figure 3C clearly shows that both SXcontra and SXipsi increase beta coefficients. Instead, the choice direction may be represented in these neurons, given that beta coefficients increase following CXipsi and before SEipsi, presumably when animals make executive decisions. Could the authors clarify their interpretation on this point?

      We observe that calcium activity increases during ipsilateral choices as the animal moves toward the ipsilateral side port (e.g. CX<sub>ipsi</sub> to SE<sub>ipsi</sub>; Fig 2C and Fig 3C). The animal also makes other ipsiversive movements not during the “choice” phase of a trial such as when it is returning to the center port following a contralateral choice (e.g. SX<sub>Contra</sub> to CE; Fig 2—figure supplement 1F and Fig 3C). We also observe an increase in calcium activity during these ipsiversive movements (e.g. SX<sub>Contra</sub> to CE), but they are not as large as those observed during the choice phase (Fig 2—figure supplement 1G). Therefore, during the choice phase of a trial, activity contains signals related to ipsilateral movement and additional factors (e.g. executive decision making).    

      (4) Also, it is not clear if there is a photometry response related to motor parameters (i.e. head direction or locomotion, licking), which could change the interpretation of the reward outcome if it is related to a motor response; could the authors show photometry signal from representative 'high licking' or 'low licking' reward trials, or from spontaneous periods of high vs. low locomotor speeds (if the sessions are recorded) to otherwise clarify this point?

      Unfortunately, neither licks nor locomotion were recorded during the behavioral sessions when photometry was recorded. In Figure 2—figure supplement 1a we now show individual trials sorted by trial duration (time elapsed between CE and SE) to illustrate the dynamics of the photometry signal on fast vs slow trials within a session.  

      (5) There are a few limitations with the design and timing of the synaptic manipulations that would improve the manuscript if discussed or clarified. The authors take care to validate the intersectional genetic strategies: Tetanus Toxin virus (which eliminates synaptic vesicle fusion) or CRISPR editing of Slc17a6, which prevents glutamate loading into synaptic vesicles. The magnitude of effect in the slice physiology results is striking. However, this relies on the co-infection of a second AAV to express channelrhodopsin for the purposes of validation, and it is surely the case that there will not be 100% overlap between the proportion of cells infected.

      For the Tet-tox experiments in Figure 4 we estimate approximately 70±15% of EP<sup>Sst+</sup> neurons expressed Tet-tox based on our histological counts and published stereological counts in EP (Miyamoto and Fukuda, 2015). It is true that channelrhodopsin expression will not overlap 100% with cells infected by the other virus, indeed our in vitro synaptic physiology shows small residual postsynaptic currents following optogenetic stimulation either from incomplete blockade of synaptic release or neurons that expressed channelrhodopsin but not Tettx (Figure 4—figure supplement 1J-K). The same is shown for CRISPR mediated deletion of Slc17a6 (Fig 5 – Fig supplement 1J-K).  

      (6) Alternative means of glutamate packaging (other VGluT isoforms, other transporters, etc) could also compensate for the partial absence of VGluT2, which should be discussed.

      While single cell sequencing (Wallace et al, 2017) has shown EP<sup>Sst+</sup> neurons do not express Slc17a7/8 (vGlut1 or vGlut3) it is possible that these genes could be upregulated following CRISPR mediated deletion of Slc17a6, however we do not see evidence of this with our in vitro synaptic physiology (EPSCs are significant suppressed, Figure 5 – Fig supplement 1J-K) and therefore can conclude it is highly unlikely to occur to a significant degree in our experiments. This is now included in the Discussion.

      (7) The authors do not perform a complimentary experiment to delete GABA release (i.e. via VGAT editing), which is understandable, given the absence of an effect with the pan-synaptic manipulation. A more significant concern is the timing of these manipulations as the authors acknowledge. The manipulations are all done in well-trained animals, who continue to perform during the length of viral expression. Moreover, after carefully showing that mice use different strategies on the 70/30 version vs the 90/10 version of the task, only performance on the 90/10 version is assessed after the manipulation. Together, the observation that EPNsst activity does not alter performance on a well-learned, 90/10 switching task decreases the impact of the findings, as this population may play a larger role during task acquisition or under more dynamic task conditions. Additional experiments could be done to strengthen the current evidence, although the limitation is transparently discussed by the authors.

      As mentioned above, it is possible that a requirement for EP<sup>Sst+</sup> neurons could be revealed if the experiment was conducted with different parameters (either different reward probabilities, fluctuating reward probabilities within a session, or withholding additional training during viral expression). It is difficult to predict which version of the task, if any, would be most likely to reveal a requirement for EP<sup>Sst+</sup> neurons based on our results. We favor testing for EP<sup>Sst+</sup> function using a new behavioral paradigm that allows us to carefully examine task learning following EP manipulations in an independent study.

      (8) Finally, intersectional strategies target LHb-projecting neurons, although in the original characterization, it is not entirely clear that the LHb is the only projection target of EPNsst neurons. A projection map would help clarify this point.

      In a previous study we confirmed that EP<sup>Sst+</sup> neurons project exclusively to the LHb using cell-type specific rabies infection and examining all reported downstream regions for axon collaterals (Wallace et al 2017, Suppl. Fig 6F-G). When EP<sup>Sst+</sup> neurons were labeled we did not observe axon collaterals in known targets of EP such as ventro-antero lateral thalamus, red nucleus, parafasicular nucleus of the thalamus, or the pedunculopontine tegmental nucleus, only in the LHb. Additionally, using single cell tracing techniques, others have shown EP neurons that exclusively project to the LHb (Parent et al, 2001).

      Overall, the authors used a pertinent experimental paradigm and common cell-specific approaches to address a major gap in the field, which is the functional role of glutamate/GABA co-release from the major basal ganglia output nucleus in action selection and evaluation. The study is carefully conducted, their analyses are thorough, and the data are often convincing and thought-provoking. However, the limitations of their synaptic manipulations with respect to the behavioral assays reduce generalizability and to some extent the impact of their findings.

      Reviewer #2 (Public Review):

      Summary:

      This paper aimed to determine the role EP sst+ neurons play in a probabilistic switching task.

      Strengths:

      The in vivo recording of the EP sst+ neuron activity in the task is one of the strongest parts of this paper. Previous work had recorded from the EP-LHb population in rodents and primates in head-fixed configurations, the recordings of this population in a freely moving context is a valuable addition to these studies and has highlighted more clearly that these neurons respond both at the time of choice and outcome.

      The use of a refined intersectional technique to record specifically the EP sst+ neurons is also an important strength of the paper. This is because previous work has shown that there are two genetically different types of glutamatergic EP neurons that project to the LHb. Previous work had not distinguished between these types in their recordings so the current results showing that the bidirectional value signaling is present in the EP sst+ population is valuable.

      Weaknesses:

      (1) One of the main weaknesses of the paper is to do with how the effect of the EP sst+ neurons on the behavior was assessed.

      (a) All the manipulations (blocking synaptic release and blocking glutamatergic transmission) are chronic and more importantly the mice are given weeks of training after the manipulation before the behavioral effect is assessed. This means that as the authors point out in their discussion the mice will have time to adjust to the behavioral manipulation and compensate for the manipulations. The results do show that mice can adapt to these chronic manipulations and that the EP sst+ are not required to perform the task. What is unclear is whether the mice have compensated for the loss of EP sst+ neurons and whether they play a role in the task under normal conditions. Acute manipulations or chronic manipulations without additional training would be needed to assess this.

      Unfortunately, when mice are given a three week break from behavioral training (the time required to allow for adequate viral expression) behavioral performance on the task (p(highport), p(switch), trial number, trial time, etc.) is significantly degraded. Animals do eventually recover to previous performance levels, but this takes place during a 4-5 day “relearning” period. Here we sought to examine if EP<sup>Sst+</sup> neurons are required for continued task performance and chose to continue to train the animals following viral injection to avoid the “relearning” period that occurs following an extended break from behavioral training which may have made it difficult to interpret changes in behavioral performance due to the viral manipulation vs relearning.  

      Acute manipulations were not used because we planned to compare complete synaptic ablation (Tettx) and single neurotransmitter ablation (CRISPR Slc17a6) over similar time courses and we know of no acute manipulation that could achieve single neurotransmitter ablation. 

      (b) Another weakness is that the effect of the manipulations was assessed in the 90/10 contingency version of the task. Under these contingencies, mice integrate past outcomes over fewer trials to determine their choice and animals act closer to a simple win-stay-lose switch strategy. Due to this, it is unclear if the EP sst+ neurons would play a role in the task when they must integrate over a larger number of conditions in the less deterministic 70/30 version of the task.

      It is possible that a requirement for EP<sup>Sst+</sup> neurons could be revealed if the experiment was conducted with different parameters (either different reward probabilities, fluctuating reward probabilities within a session, or withholding additional training during viral expression). It is difficult to predict which version of the task, if any, would be most likely to reveal a requirement for EP<sup>Sst+</sup> neurons based on our results. We favor testing for EP<sup>Sst+</sup> function using a new behavioral paradigm that allows us to carefully examine task learning following EP manipulations in an independent study.

      The authors show an intriguing result that the EP sst+ neurons are excited when mice make an ipsilateral movement in the task either toward or away from the center port. This is referred to as a choice response, but it could be a movement response or related to the predicted value of a specific action. Recordings while mice perform movement outside the task or well-controlled value manipulations within the session would be needed to really refine what these responses are related to.

      If activity of EP<sup>Sst+</sup> neurons included a predicted value component, we would expect to see a change in activity during ipsilateral movements when the previous trial was rewarded vs unrewarded. This is examined in Fig 2—figure suppl. 2C, where we compare EP<sup>Sst+</sup> responses during ipsilateral trials when the previous trials were either rewarded (blue) or unrewarded (gray). We show that EP<sup>Sst+</sup> activity prior to side port entry (SE) is identical in these two trial types indicating that EP<sup>Sst+</sup> neurons do not show evidence of predicted value of an action in this context. Therefore, we conclude that increased EP<sup>Sst+</sup> activity during ipsilateral trials is primarily related to ipsilateral movement following CX (we call this the “choice” phase of the trial). We also show that other ipsiversive movements outside of the “choice” phase of a trial (such as the return to center port following a contralateral trial) show a smaller but significant increase in activity (Figure 2—figure supplement 1F-G). Therefore, whereas the activity observed during ipsilateral choice contains signals related to ipsilateral movement and additional factors, our data suggest that predicted value is not one of those factors. We will clarify this point and our definition of “choice” in the narrative.  

      (2) The authors conclude that they do not see any evidence for bidirectional prediction errors. It is not possible to conclude this. First, they see a large response in the EP sst+ neurons to the omission of an expected reward. This is what would be expected of a negative reward prediction error. There are much more specific well-controlled tests for this that are commonplace in head-fixed and freely moving paradigms that could be tested to probe this. The authors do look at the effect of previous trials on the response and do not see strong consistent results, but this is not a strong formal test of what would be expected of a prediction error, either a positive or negative. The other way they assess this is by looking at the size of the responses in different recording sessions with different reward contingencies. They claim that the size of the reward expectation and prediction error should scale with the different reward probabilities. If all the reward probabilities were present in the same session this should be true as lots of others have shown for RPE. Because however this data was taken from different sessions it is not expected that the responses should scale, this is because reward prediction errors have been shown to adaptively scale to cover the range of values on offer (Tobler et al., Science 2005). A better test of positive prediction error would be to give a larger-than-expected reward on a subset of trials. Either way, there is already evidence that responses reflect a negative prediction error in their data and more specific tests would be needed to formally rule in or out prediction error coding especially as previous recordings have shown it is present in previous primate and rodent recordings.

      We do not conclude that we see no evidence for RPE and the reviewer is correct in stating that a large increase in EP<sup>Sst+</sup> activity following omission of an expected reward would be expected of a negative reward prediction error. However, this observation alone is not strong enough evidence that EP<sup>Sst+</sup> neurons signal RPE. When we looked for additional evidence of RPE within our experiments we did not find consistent demonstrations of its existence in our data. When performing photometry measurements of dopamine release in the striatum, RPE signals are readily observed with a task identical to ours using trial history to as a modifier of reward prediction (Chantranupong, et al 2023). Of course, there could be a weaker more heterogeneous RPE signal in EP<sup>Sst+</sup> neurons that we cannot detect with our methods. As we state in the discussion, RPE signals may be present in a subset of individual neurons (as observed in Stephenson-Jones et al, 2016 and Hong and Hikosaka, 2008) which are below our detection threshold using fiber photometry. Additionally, Hong and Hikosaka, 2008 show that LHb-projecting GPi neurons show both positive and negative reward modulations which may obscure observation of RPE signals with photometry recordings that arise from population activity of genetically defined neurons.   

      (3) There are a lot of variables in the GLM that occur extremely close in time such as the entry and exit of a port. If two variables occur closely in time and are always correlated it will be difficult if not impossible for a regression model to assign weights accurately to each event. This is not a large issue, but it is misleading to have regression kernels for port entry and exits unless the authors can show these are separable due to behavioral jitter or a lack of correlation under specific conditions, which does not seem to be the case.

      It is true that two variables that are always correlated are redundant in a GLM. For example, center entry (CE) and center exit (CX) occur in quick succession in most trials and are highly correlated (Figure 1C). For this reason, when only one is removed as a predictor from the model but not the other there is a very small change in the MSE of the fit (Figure 3E, -CE or -CX). However, when both are removed model performance decreases further indicating that center-port nose-pokes do contribute to model performance (Figure 3E, -CE/CX). Due to the presence/absence of reward following side port entry there is substantial behavioral jitter (due to water consumption in rewarded trials) that the SE and SX are not always correlated, therefore the model performs worse when either are omitted alone, but even worse still when both SE/SX are omitted together (Figure 3E, -SE/SX). We will update Figure 3 and the narrative to make this more explicit.

      Reviewer #3 (Public Review):

      Summary:

      The authors find that Sst-EPN neurons, which project to the lateral habenula, encode information about response directionality (left vs right) and outcome (rewarded vs unrewarded). Surprisingly, impairment of vesicular signaling in these neurons onto their LHb targets did not impair probabilistic choice behavior.

      Strengths:

      Strengths of the current work include extremely detailed and thorough analysis of data at all levels, not only of the physiological data but also an uncommonly thorough analysis of behavioral response patterns.

      Weaknesses:

      Overall, I saw very few weaknesses, with only two issues, both of which should be possible to address without new experiments:

      (1) The authors note that the neural response difference between rewarded and unrewarded trials is not an RPE, as it is not affected by reward probability. However, the authors also show the neural difference is partly driven by the rapid motoric withdrawal from the port. Since there is also a response component that remains different apart from this motoric difference (Figure 2, Supplementary Figure 1E), it seems this is what needs to be analyzed with respect to reward probability, to truly determine whether there is no RPE component. Was this done?

      We thank the reviewer for this comment, we believe this is particularly important for unrewarded trials as SE and SX occur in rapid succession. In Figure 2—figure supplement 2A-B we now show the photometry signal from Rewarded and Unrewarded ipsilateral trials aligned to SX for different reward probabilities. We quantify the signals for different reward probabilities during a 500ms window immediately prior to SX but find no differences between groups.  

      (2) The current study reaches very different conclusions than a 2016 study by Stephenson-Jones and colleagues despite using a similar behavioral task to study the same Sst-EPN-LHb circuit. This is potentially very interesting, and the new findings likely shed important light on how this circuit really works. Hence, I would have liked to hear more of the authors' thoughts about possible explanations of the differences. I acknowledge that a full answer might not be possible, but in-depth elaboration would help the reader put the current findings in the context of the earlier work, and give a better sense of what work still needs to be done in the future to fully understand this circuit.

      For example, the authors suggest that the Sst-EPN-LHb circuit might be involved in initial learning, but play less of a role in well-trained animals, thereby explaining the lack of observed behavioral effect. However, it is my understanding that the probabilistic switching task forces animals to continually update learned contingencies, rendering this explanation somewhat less persuasive, at least not without further elaboration (e.g. maybe the authors think it plays a role before the animals learn to switch?).

      Also, as I understand it, the 2016 study used manipulations that likely impaired phasic activity patterns, e.g. precisely timed optogenetic activation/inhibition, and/or deletion of GABA/glutamate receptors. In contrast, the current study's manipulations - blockade of vesicle release using tetanus toxin or deletion of VGlut2, would likely have blocked both phasic and tonic activity patterns. Do the authors think this factor, or any others they are aware of, could be relevant?

      We have added further discussion of the Stephenson-Jones, et al 2016 study as well as the Lazaridis, et al 2019 study which shows no effect of phasic stimulation of EP when specifically manipulating EP<sup>Sst+</sup> (vGat+/vGlut2+) neurons rather than vGlut2+ neurons as in the Stephenson-Jones study.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      In some places, there seems to be a mismatch between referenced figures and texts. For example:

      (1) The authors described that 'This increase in activity was seen for all three reward probabilities tested (90/10, 80/20, and 70/30) and occurred while the animal was engaged in ipsiversive movements as similar increases were observed following side exit (SX) on contralateral trials as the animal was moving from the contralateral side port back to the center port (Figure 2-Figure Supplement 1c)', but supplement 1c is not about calcium dynamics around the SX event. I presume they mean Figure 2-Figure Supplement 1d.

      Yes, this will be corrected in the revised manuscript.

      (2) The authors explained that increased EPSst+ neuronal activity following an unrewarded outcome was partially due to the rapid withdrawal of the animal's snout following an unrewarded outcome however, differences in rewarded and unrewarded trials were still distinguishable when signals were aligned to side port exit indicating that these increases in EPSst+ neuronal activity on unrewarded trials were a combination of outcome evaluation (unrewarded) and side port withdrawal occurring in quick succession (SX, Figure 2 - Figure Supplement 1d). I presume that they mean Figure 2 - Figure Supplement 1e.

      Yes, this will be corrected in the revised manuscript.

      Minor suggestions related to specific figure presentation are below:

      Figure 2 and supplement figures:

      (1) Figure 2B: the authors may consider presenting outcome-related signals recorded from all trials, including both ipsilateral and contralateral events, and align signals to SE when reward consumption presumably begins, rather than aligning to CE.

      We have added sample recordings from ipsilateral and contralateral trials and sorted them by trial duration to allow for clearer presentation of activity following CE and SE (Figure 2—figure supplement 1a-b).

      (2) The authors described that 'This increase in activity was seen for all three reward probabilities tested (90/10, 80/20, and 70/30) and occurred while the animal was engaged in ipsiversive movements as similar increases were observed following side exit (SX) on contralateral trials as the animal was moving from the contralateral side port back to the center port (Figure 2-Figure Supplement 1c)', but supplement 1c is not about calcium dynamics around the SX event. I presume they mean Figure 2-Figure Supplement 1d.

      Yes, this will be corrected in the revised manuscript.

      (3) The authors explained that increased EPSst+ neuronal activity following an unrewarded outcome was partially due to the rapid withdrawal of the animal's snout following an unrewarded outcome however, differences in rewarded and unrewarded trials were still distinguishable when signals were aligned to side port exit indicating that these increases in EPSst+ neuronal activity on unrewarded trials were a combination of outcome evaluation (unrewarded) and side port withdrawal occurring in quick succession (SX, Figure 2 -Figure Supplement 1d). I presume that they mean Figure 2 -Figure Supplement 1e.

      Yes, this will be corrected in the revised manuscript.

      Figure 3 and supplement figures:

      (1) Figure 3C-F: it is hard to compare the amplitude of calcium signals between different behaviour events without a uniform y-axis.

      The scale for the y-axis on Figure 3C-D is uniform for all panels. Figure 3E is also uniform for all boxplots. The reviewer may be referring to Figure 2C-F, but the y-axis for all of the photometry data is uniform for all panels and the horizontal line represents zero. The y-axis for the quantification on the right of each panel is scaled to the max/min for each comparison.

      (2) Figure 3E is difficult to follow. The authors explained that the 'SE' variable is generated by collapsing the ipsilateral and contralateral port entries, and hence the variable has no choice of direction information. I assumed that the 'SX', 'CE', and 'CX' variables are generated similarly. It is not clear if this is the case for the 'side', 'centre' and 'choice' variables. The authors explained that 'omitting center port entry/exit together or individually also resulted in decreased GLM performance but to a smaller degree than the omission of choice direction (Figure 3e, "-Center")'. My understanding is that they created the Centre variable by collapsing ipsilateral and contralateral centre port entry/exit together. The Centre variable should have no choice of direction information. How is the Center variable generated differently from omitting centre port entry/exit together? I would ask the authors to explain the model and different variables a bit more thoroughly in the text.

      We apologize for the confusion. All ten variables used to train the full GLM are listed in Fig. 3C. In Figure 3E variable(s) were omitted to test how they contributed to GLM performance (data labeled “None” is the full model with all variables). Omitted variables are now defined as follows: -Rew = Rew+Unrew removed, -Direction = Ipsi/Contra designation removed and collapsed into CE, CX, SE, SX, -Direction & Rew = Ipsi/Contra info removed from all variables + Rew/Unrew removed, -CE/CX = Ipsi/Contra CE and CX removed, -CE = Ipsi/contra CE removed, -CX = Ipsi/contra CX removed, -SE/SX = Ipsi/Contra SE and SX removed, -SE = Ipsi/contra SE removed, -SX = Ipsi/contra SX removed. This clarification has also been added to the Generalized Linear Model section of Materials and Methods.

      Figure 5 and supplement figures:

      There are no representative and summary figures show the specificity and efficiency of oChief-tdTomato or Tetx-GFP expression. Body weight changes following virus injection are not well described.

      A representative image of Tettx GFP expression are shown in Fig. 4A and percent of infected EP<sup>Sst+</sup> neurons is described in the text (70±15.1% (mean±SD), 1070±230 neurons/animal, n=6 mice). Most oChief-tdTom animals were used for post-hoc electrophysiology experiments and careful quantification of viral expression was not possible. However, Slc17a6 deletion was confirmed in these animals (Fig. 5 – Fig supplement 1J-K) to confirm the manipulation was effective in the experimental group. A representative image of oChief-tdTom expression is shown in Fig. 5A.

      We now mention the body weight changes observed following Tettx injection in the narrative.

      Reviewer #2 (Recommendations For The Authors):

      (1) In the RFLR section you state that "this variable decays...", a variable can't decay only the value of a variable can change. Also, it is not mentioned what variable is being discussed. There are lots of variables in the model so this should be made clear.

      We now state, “This variable (β) changes over trials and is updated with new evidence from each new trial’s choice and outcome with an additional bias towards or away from its most recent choice (Figure 1-figure supplement 2A-C).”

      (2) I couldn't find in the results section, or the methods section the details for the Tet tx experiments, were mice trained and tested on 90/10 only? Were they trained while the virus was expressing etc? This should be added.

      In the methods section we state, ”For experiments where we manipulated synaptic release in EP<sup>Sst+</sup> neurons (Figures 4-5) we trained mice (reward probabilities 90/10, no transparent barrier present) to the following criteria for the 5 days prior to virus injection: 1) p(highport) per session was greater than or equal to 0.80 with a variance less than 0.003, 2) p(switch) per session was less than or equal to 0.15 with a variance less than 0.001, 3) the p(left port) was between 0.45-0.55 with a variance less than 0.005, and 4) the animal performed at least 200 trials in a session. The mean and variance for these measurements was calculated across the five session immediately preceding surgery. The criterion were determined by comparing performance profiles in separate animals and chosen based on when animals first showed stable and plateaued behavioral performance. Following surgery, mice were allowed to recover for 3 days and then continued to train for 3 weeks during viral expression. Data collected during the 5 day pre-surgery period was then compared to data collected for 10 sessions following the 3 weeks allotted for viral expression (i.e. days 22-31 post-surgery).”

      Reviewer #3 (Recommendations For The Authors):

      (1) The kernel in Figure 3C shows an activation prior to CE on "contra" trials that is not apparent in Figure 2C which shows no activation prior to CE on either contra or ipsi trials. Given that movement directionality prior to CE is dictated by the choice on the PREVIOUS trial, is the "contra" condition in 3C actually based on the previous trial? If so, this should be clarified.

      On most “contra” trials the animal is making an ipsiversive movement just prior to CE as it returns to the center from the contralateral side-port (as most trials are no “switch” trials). Therefore, an increase in activity is expected and shown most clearly following SX for contralateral trials in Fig 2 –Fig suppl 1F. A significant increase in activity prior to CE on contra trials compared to ipsi trials can also be seen in Fig 2C, its just not as large a change as the increase observed following CE for ipsi. trials. The comparison between activity observed during the two types of ipsiversive movements is now shown directly in Figure 2—figure supplement 1G.

      (2) Paragraph 7 of the discussion uses a phrase "by-in-large", which probably should be "by and large".

      Thank you for the correction.

      Editor's note:

      Should you choose to revise your manuscript, if you have not already done so, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript.

      Readers would also benefit from coding individual data points by sex and noting N/sex.

      Sex breakdown has been added to figure legends for each experiment, full statistical reporting is now also include in the figure legends.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript by Bell et. al. describes an analysis of the effects of removing one of two mutually exclusive splice exons at two distinct sites in the Drosophila CaV2 calcium channel Cacophony (Cac). The authors perform imaging and electrophysiology, along with some behavioral analysis of larval locomotion, to determine whether these alternatively spliced variants have the potential to diversify Cac function in presynaptic output at larval neuromuscular junctions. The author provided valuable insights into how alternative splicing at two sites in the calcium channel alters its function.

      Strengths:

      The authors find that both of the second alternatively spliced exons (I-IIA and I-IIB) that are found in the intracellular loop between the 1st and second set of transmembrane domains can support Cac function. However, loss of the I-IIB isoform (predicted to alter potential beta subunit interactions) results in 50% fewer channels at active zones and a decrease in neurotransmitter release and the ability to support presynaptic homeostatic potentiation. Overall, the study provides new insights into Cac diversity at two alternatively spliced sites within the protein, adding to our understanding of how regulation of presynaptic calcium channel function can be regulated by splicing.

      Weaknesses:

      The authors find that one splice isoform (IS4B) in the first S4 voltage sensor is essential for the protein's function in promoting neurotransmitter release, while the other isoform (IS4A) is dispensable. The authors conclude that IS4B is required to localize Cac channels to active zones. However, I find it more likely that IS4B is required for channel stability and leads to the protein being degraded, rather than any effect on active zone localization. More analysis would be required to establish that as the mechanism for the unique requirement for IS4B.

      (1) We thank the reviewer for this important point. In fact, all three reviewers raised the same question, and the reviewing editor pointed out that caution or additional experiments were required to distinguish between IS4 splicing being important for cac channel localization versus channel stability/degradation. We provide multiple sets of experiments as well as text and figure revisions to strengthen our claim that the IS4B exon is required for cacophony channels to enter motoneuron presynaptic boutons and localize to active zones.

      a. If IS4B was indeed required for cac channel stability (and not for localization to active zones) IS4A channels should be instable wherever they are. This is not the case because we have recorded somatodendritic cacophony currents from IS4A expressing adult motoneurons that were devoid of cac channels with the IS4B exon. Therefore, IS4A cac channels are not instable but underlie somatodendritic voltage dependent calcium currents in these motoneurons. These new data are now shown in the revised figure 3C and referred to in the text on page 7, line 42 to page 8 line 9.

      b. Similarly, if IS4B was required for channel stability, it should not be present anywhere in the nervous system. We tested this by immunohistochemistry for GFP tagged IS4A channels in the larval CNS. Although IS4A channels are sparsely expressed, which is consistent with low expression levels seen in the Western blots (Fig. 1E), there are always defined and reproducible patterns of IS4A label in the larval brain lobes as well as in the anterior part of the VNC. This again shows that the absence of IS4A from presynaptic active zones is not caused by channel instability, because the channel is expressed in other parts of the nervous system. These data are shown in the new supplementary figure 1 and referred to in the text on page 15, lines 3 to 8.

      c. As suggested in a similar context by reviewers 1 and 2, we now show enlargements of the presence of IS4B channels in presynaptic active zones as well as enlargements of the absence of IS4A channels in presynaptic active zones in the revised figures 2A-C and 3A. In these images, no IS4A label is detectable in active zones or anywhere else throughout the axon terminals, thus indicating that IS4B is required for expressing cac channels in the axon terminal boutons and localizing it to active zones. Text and figure legends have been adjusted accordingly.

      d. Related to this, reviewer 1 also recommended to quantify the IS4A and ISB4 channel intensity and co-localization with the active zone marker brp (recommendation for authors). After following the reviewers’ suggestion to adjust the background values in IS4A and IS4B immunolabels to identical (revised Figs. 2A-C), it becomes obvious that IS4A channel are not detectable above background in presynaptic terminals or active zones, thus intensity is close to zero. We still calculated the Pearsons co-localization coefficient for both IS4 variants with the active zone marker brp. For IS4B channels the Pearson’s correlation coefficient is control like, just above 0.6, whereas for IS4A channels we do not find colocalization with brp (Pearson’s below 0.25). These new analyses are now shown in the revised figure 2D and referred to on page 6, lines 33 to 38.

      e. Consistent with our finding that IS4B is required for cac channel localization to presynaptic active zones, upon removal of IS4B we find no evoked synaptic transmission (Fig. 2 in initial submission, now Fig. 3B).

      Together these data are in line with a unique requirement of IS4B at presynaptic active zones (not excluding additional functions of IS4B), whereas IS4A containing cac isoforms are not found in presynaptic active zones and mediate different functions.

      Reviewer #2 (Public Review):

      This study by Bell et al. focuses on understanding the roles of two alternatively spliced exons in the single Drosophila Cav2 gene cac. The authors generate a series of cac alleles in which one or the other mutually exclusive exons are deleted to determine the functional consequences at the neuromuscular junction. They find alternative splicing at one exon encoding part of the voltage sensor impacts the activation voltage as well as localization to the active zone. In contrast, splicing at the second exon pair does not impact Cav2 channel localization, but it appears to determine the abundance of the channel at active zones.

      Together, the authors propose that alternative splicing at the Cac locus enables diversity in Cav2 function generated through isoform diversity generated at the single Cav2 alpha subunit gene encoded in Drosophila.

      Overall this is an excellent, rigorously validated study that defines unanticipated functions for alternative splicing in Cav2 channels. The authors have generated an important toolkit of mutually exclusive Cac splice isoforms that will be of broad utility for the field, and show convincing evidence for distinct consequences of alternative splicing of this single Cav2 channel at synapses. Importantly, the authors use electrophysiology and quantitative live sptPALM imaging to determine the impacts of Cac alternative splicing on synaptic function. There are some outstanding questions regarding the mechanisms underlying the changes in Cac localization and function, and some additional suggestions are listed below for the authors to consider in strengthening this study. Nonetheless, this is a compelling investigation of alternative splicing in Cav2 channels that should be of interest to many researchers.

      (2) We believe that the additional data on cac IS4A isoform localization and function as detailed above (response to public review 1) has strengthened the manuscript and answered some of the remaining questions the reviewer refers to. We are also grateful for the specific additional reviewer suggestions which we have addressed point-by-point and refer to below (section recommendations for authors).

      Reviewer #3 (Public Review):

      Summary:

      Bell and colleagues studied how different splice isoforms of voltage-gated CaV2 calcium channels affect channel expression, localization, function, synaptic transmission, and locomotor behavior at the larval Drosophila neuromuscular junction. They reveal that one mutually exclusive exon located in the fourth transmembrane domain encoding the voltage sensor is essential for calcium channel expression, function, active zone localization, and synaptic transmission. Furthermore, a second mutually exclusive exon residing in an intracellular loop containing the binding sites for Caβ and G-protein βγ subunits promotes the expression and synaptic localization of around ~50% of CaV2 channels, thereby contributing to ~50% of synaptic transmission. This isoform enhances release probability, as evident from increased short-term depression, is vital for homeostatic potentiation of neurotransmitter release induced by glutamate receptor impairment, and promotes locomotion. The roles of the two other tested isoforms remain less clear.

      Strengths:

      The study is based on solid data that was obtained with a diverse set of approaches. Moreover, it generated valuable transgenic flies that will facilitate future research on the role of calcium channel splice isoforms in neural function.

      Weaknesses:

      (1) Based on the data shown in Figures 2A-C, and 2H, it is difficult to judge the localization of the cac isoforms. Could they analyze cac localization with regard to Brp localization (similar to Figure 3; the term "co-localization" should be avoided for confocal data), as well as cac and Brp fluorescence intensity in the different genotypes for the experiments shown in Figure 2 and 3 (Brp intensity appears lower in the dI-IIA example shown in Figure 3G)? Furthermore, heterozygous dIS4B imaging data (Figure 2C) should be quantified and compared to heterozygous cacsfGFP/+.

      According to the reviewer’s suggestion, we have quantified cac localization relative to brp localization by computing the Pearson’s correlation coefficient for controls and IS4A as well as IS4B animals. These new data are shown in the revised Fig. 2D and referred to on page 6, lines 33-38. Furthermore, we now confirm control-like Pearson’s correlation coefficients for all exon out variants except ΔIS4B and show Pearson’s correlation coefficients for all genotypes side-by-side in the revised Fig. 4D (legend has been adjusted accordingly). In addition, in response to the recommendations to authors, we now provide selective enlargements for the co-labeling of Brp and each exon out variant in the revised figures 2-4. We have also adjusted the background in Fig. 2C (ΔIS4B) to match that in Figs. 2A and B (control and ΔIS4A). This allows a fair comparison of cac intensities following excision of IS4B versus excision of IS4A and control (see also Fig 3). Together, this demonstrates the absence of IS4A label in presynaptic active zones much clearer. As suggested, we have also quantified brp puncta intensity on m6/7 across homozygous exon excision mutants and found no differences (this is now stated for IS4A/IS4B in the results text on page 6, lines 37/38 and for I-IIA/I-IIB on page 8, lines 42-44.). We did not quantify the intensity of cacophony puncta upon excision of IS4B because the label revealed no significant difference from background (which can be seen much better in the images now), but the brp intensities remained control-like even upon excision of IS4B.

      (2) They conclude that I-II splicing is not required for cac localization (p. 13). However, cac channel number is reduced in dI-IIB. Could the channels be mis-localized (e.g., in the soma/axon)? What is their definition of localization? Could cac be also mis-localized in dIS4B? Furthermore, the Western Blots indicate a prominent decrease in cac levels in dIS4B/+ and dI-IIB (Figure 1D). How do the decreased protein levels seen in both genotypes fit to a "localization" defect? Could decreased cac expression levels explain the phenotypes alone?

      We have now precisely defined what we mean by cac localization, namely the selective label of cac channels in presynaptic active zones that are defined as brp puncta, but no cac label elsewhere in the presynaptic bouton (page 6, lines 18 to 20). On the level of CLSM microscopy this corresponds to overlapping cac puncta and brp puncta, but no cac label elsewhere in the bouton. Based on the additional analysis and data sets outlined in our response 1 (see above) we conclude that excision of IS4B does not cause channel mislocalization because we find reproducible expression patterns elsewhere in the nervous system as well as somatodendritic cac current in ΔIS4B (for detail see above). Therefore, the isoforms containing the mutually exclusive IS4A exon are expressed and mediate other functions, but cannot substitute IS4B containing isoforms at the presynaptic AZ. In fact, our Western blots are in line with reduced cac expression if all isoforms that mediate evoked release are missing, again indicating that the presynapse specific cac isoforms cannot be replaced by other cac isoforms. This is also in line with the sparse expression of IS4A throughout the CNS as seen in the new supplementary figure 1 (for detail see above).

      (3) Cac-IS4B is required for Cav2 expression, active zone localization, and synaptic transmission. Similarly, loss of cac-I-IIB reduces calcium channel expression and number. Hence, the major phenotype of the tested splice isoforms is the loss of/a reduction in Cav2 channel number. What is the physiological role of these isoforms? Is the idea that channel numbers can be regulated by splicing? Is there any data from other systems relating channel number regulation to splicing (vs. transcription or post-transcriptional regulation)?

      Our data are not consistent with the idea that splicing regulates channel numbers. Rather, splicing can be used to generate channels with specific properties that match the demand at the site of expression. For the IS4 exon pair we find differences in activation voltage between IS4A and IS4B channels (revised Fig. 3C), with IS4B being required for sustained HVA current. IS4A does not localize to presynaptic active zones at the NMJ and is only sparsely expressed elsewhere in the NS (new supplementary Fig. 1). By contrast, IS4B is abundantly expressed in many neuropils. Therefore, taking out IS4B takes out the more abundant IS4 isoform. This is consistent with different expression levels for IS4 isoforms that have different functions, but we do not find evidence for splicing regulating expression levels per se.

      Similarly, the I-II mutually exclusive exon pair differs markedly in the presence or absence of G-protein βγ binding sites that play a role in acute channel regulation as well the conservation of the sequence for β-subunit binding (see page 5, lines 9-17). Channel number reduction in active zones occurs specifically if expression of the cac channels with the G<sub>βγ</sub>-binding site as well as the more conserved β-subunit binding is prohibited by excision of the I-IIB exon (see Fig. 5F). Vice versa, excision of I-IIA does not result in reduced channel numbers. This scenario is consistent with the hypothesis that conserved β-subunit binding affects channel number in the active zone (see page 17, lines 3 to 6 and lines 33-36), but we have no evidence that I-II splicing per se affects channel number.

      (4) Although not supported by statistics, and as appreciated by the authors (p. 14), there is a slight increase in PSC amplitude in dIS4A mutants (Figure 2). Similarly, PSC amplitudes appear slightly larger (Figure 3J), and cac fluorescence intensity is slightly higher (Figure 3H) in dI-IIA mutants. Furthermore, cac intensity and PSC amplitude distributions appear larger in dI-IIA mutants (Figures 3H, J), suggesting a correlation between cac levels and release. Can they exclude that IS4A and/or I-IIA negatively regulate release? I suggest increasing the sample size for Canton S to assess whether dIS4A mutant PSCs differ from controls (Figure 2E). Experiments at lower extracellular calcium may help reveal potential increases in PSC amplitude in the two genotypes (but are not required). A potential increase in PSC amplitude in either isoform would be very interesting because it would suggest that cac splicing could negatively regulate release.

      There are several possibilities to explain this, but as none of the effects is statistically significant, we prefer to not investigate this in further depth. However, given that we cannot find IS4A in presynaptic active zones (revised figures 2C and 3A plus the new enlargements 2Ci and 3Ai, revised text page 6, lines 22 to 24 and 29 to 31, and page 7, second paragraph, same as public response 1D) IS4A channels cannot have a direct negative effect on release probability. Nonetheless, given that IS4A containing cac isoforms mediate functions in other neuronal compartments (see revised Fig. 3C) it may regulate release indirectly by affecting e.g. action potential shape. Moreover, in response to the more detailed suggestions to authors we provide new data that give additional insight.

      (5) They provide compelling evidence that IS4A is required for the amplitude of somatic sustained HVA calcium currents. However, the evidence for effects on biophysical properties and activation voltage (p. 13) is less convincing. Is the phenotype confined to the sustained phase, or are other aspects of the current also affected (Figure 2J)? Could they also show the quantification of further parameters, such as CaV2 peak current density, charge density, as well as inactivation kinetics for the two genotypes? I also suggest plotting peaknormalized HVA current density and conductance (G/Gmax) as a function of Vm. Could a decrease in current density due to decreased channel expression be the only phenotype? How would changes in the sustained phase translate into altered synaptic transmission in response to AP stimulation?

      Most importantly, sustained HVA current is abolished upon excision of IS4B (not IS4A, we think the reviewer accidentally mixed up the genotype) and presynaptic active zones at the NMJ contain only cac isoforms with the IS4B exon. This indicates that the cac isoforms that mediate evoked release encode HVA channels. The somatodendritic currents shown in the revised figure 3C (previously 2J) that remain upon excision of IS4B are mediated by IS4A containing cac isoforms. Please note that these never localize to the presynaptic active zone, and thus do not contribute to evoked release. Therefore, the interpretation is that specifically sustained HVA current encoded by IS4B cac isoforms is required for synaptic transmission. Reduced cac current density due to decreased channel expression is not the cause for impaired evoked release upon IS4B excision, but instead, the cause is the absence of any cac channels in active zones. IS4B-containing cac isoforms encode sustained HVA current, and we speculate that this might be a well suited current to minimize cacophony channel inactivation in the presynaptic active zone. Given that HVA current shows fast voltage dependent activation and fast inactivation upon repolarization, it is useful at large intraburst firing frequencies as observed during crawling (Kadas et al., 2017) without excessive cac inactivation (see page 15, Kadas, lines 16 to 20).

      However, we agree with the reviewer that a deeper electrophysiological analysis of splice isoform specific cac currents will be instructive. We have now added traces of control and ΔIS4B from a holding potential of -90 mv (revised Fig. 3C, bottom traces and revised text on page 7, line 43 to page 8, lines 1 to 10), and these are also consistent with IS4B mediating sustained HVA cac current. However, further analysis of activation and inactivation voltages and kinetics suffers form space clamp issues in recordings from the somata of such complex neurons (DLM motoneurons of the adult fly contain roughly 6000 µm of dendrites with over 4000 branches, Ryglewski et al., 2017, Neuron 93(3):632-645). Therefore, we will analyze the currents in a heterologous expression system and present these data to the scientific community as a separate study at a later time point.

      (6) Why was the STED data analysis confined to the same optical section, and not to max. intensity z-projections? How many and which optical sections were considered for each active zone? What were the criteria for choosing the optical sections? Was synapse orientation considered for the nearest neighbor Cac - Brp cluster distance analysis? How do the nearest-neighbor distances compare between "planar" and "side-view" Brp puncta?

      Maximum intensity z-projections would be imprecise because they can artificially suggest close proximity of label that is close by in x and y but far away in z. Therefore, the analysis was executed in xy-direction of various planes of entire 3D image stacks. We considered active zones of different orientations (Figs. 5C, D) to account for all planes. In fact, we searched the entire z-stacks until we found active zones of all orientations within the same boutons, as shown in figures 5C1-C6. The same active zone orientations were analyzed for all exon-out mutants with cac localization in active zones. The distance between cac and brp did not change if viewed from the side or any other orientation. We now explain this in more clarity in the results text on page 9, lines 23/24.

      (7) Cac clusters localize to the Brp center (e.g., Liu et al., 2011). They conclude that Cav2 localization within Brp is not affected in the cac variants (p. 8). However, their analysis is not informative regarding a potential offset between the central cac cluster and the Brp "ring". Did they/could they analyze cac localization with regard to Brp ring center localization of planar synapses, as well as Brp-ring dimensions?

      In the top views (planar) we did not find any clear offset in cac orientation to brp between genotypes. In such planar synapses (top views, Fig. 5D, left row) we did not find any difference in Brp ring dimensions. We did not quantify brp ring dimensions rigorously, because this study focusses on cac splice isoform-specific localization and function. Possible effects of different cac isoforms on brp-ring dimensions or other aspects of scaffold structure are not central to our study, in particular given that brp puncta are clearly present even if cac is absent from the synapse (Fig. 3A), indicating that cac is not instructive for the formation of the brp scaffold.

      (8) Given the accelerated PSC decay/ decreased half width in dI-IIA (Fig. 5Q), I recommend reporting PSC charge in Figure 3, and PPR charge in Figures 5A-D. The charge-based PPRs of dI-IIA mutants likely resemble WT more closely than the amplitude-based PPR. In addition, miniature PSC decay kinetics should be reported, as they may contribute to altered decay kinetics. How could faster cac inactivation kinetics in response to single AP stimulation result in a decreased PSC half-width? Is there any evidence for an effect of calcium current inactivation on PSC kinetics? On a similar note, is there any evidence that AP waveform changes accelerate PSC kinetics? PSC decay kinetics are mainly determined by GluR decay kinetics/desensitization. The arguments supporting the role of cac splice isoforms in PSC kinetics outlined in the discussion section are not convincing and should be revised.

      We agree that reporting charge in figure 3 is informative and do so in the revised text. Since the result (no significant difference in the PSCs between between CS, cac<sup>GFP</sup>, <sup>ΔI-IIA</sup>, and transheterozygous I-IIA/I-IIB, but significantly smaller values in ΔI-IIB) remained unchanged no matter whether charge or amplitude were analyzed, we decided to leave the figure as is and report the additional analysis in the text (page 8, lines 40 to 42). This way, both types of analysis are reported. Please note that EPSC amplitude is slightly but not significantly increased upon excision of I-IIA (Fig. 4J), whereas EPSC half amplitude width is significantly smaller (Fig. 5Q, now revised Fig 6R). Together, a tendency of increased EPSC amplitudes and smaller half amplitude width result in statistically insignificant changes in EPSC in ∆I-IIA (now discussed on page 15, lines 37 to 40). We also understand the reviewer’s concern attributing altered EPSC kinetics to presynaptic cac channel properties. We have toned down our interpretation in the discussion and list possible alterations in presynaptic AP shape or cac channel kinetics as alternative explanations (not conclusions; see revised discussion on page 15, line 40 to page 16, line 2). Moreover, we have quantified postsynaptic GluRIIA abundance to test whether altered PSC kinetics are caused by altered GluRIIA expression. In our opinion, the latter is more instructive than mini decay kinetic analysis because this depends strongly on the distance of the recording electrode to the actual site of transmission in these large muscle cells. Although we find no difference in GluRIIA expression levels we now clearly state that we cannot exclude other changes in GluR receptor fields, which of course, could also explain altered PSC kinetics. We have updated the discussion on page 16, lines 2/3 accordingly.

      (9) Paired-pulse ratios (PPRs): On how many sweeps are the PPRs based? In which sequence were the intervals applied? Are PPR values based on the average of the second over the first PSC amplitudes of all sweeps, or on the PPRs of each sweep and then averaged? The latter calculation may result in spurious facilitation, and thus to the large PPRs seen in dI-IIB mutants (Kim & Alger, 2001; doi: 10.1523/JNEUROSCI.21-2409608.2001).

      We agree that the PP protocol and analyses had to be described more precisely in the methods and have done so on page 23, lines 31 to 37 in the methods. Mean PPR values are based on the PPRs of each sweep and then averaged. We are aware of the study of Kim and Alger 2001 and have re-analyzed the PP data in both ways outlined by the reviewer. We get identical results with either analyses method. Spurious facilitation is thus not an issue in our data. We now explain this in the methods section along with the PPR protocol. The large spread seen in dI-IIB is indeed caused by reduced calcium influx into active zones with fewer channels, as anticipated by the reviewer (see next point).

      (10) Could the dI-IIB phenotype be simply explained by a decrease in channel number/ release probability? To test this, I propose investigating PPRs and short-term dynamics during train stimulation at lower extracellular Ca2+ concentration in WT. The Ca2+ concentration could be titrated such that the first PSC amplitude is similar between WT and dI-IIB mutants. This experiment would test if the increased PPR/depression variability is a secondary consequence of a decrease in Ca2+ influx, or specific to the splice isoform.

      In fact, the interpretation that decreased PSC amplitude upon I-IIB excision is caused mainly by reduced channel number is precisely our interpretation (see discussion page 14, last paragraph to page 15, first paragraph in the original submission, now page 16, second paragraph paragraph). In addition, we are grateful for the reviewer’s suggestion to triturate the external calcium such that the first PSC amplitude in matches in ∆I-IIB and control. This experiment tests whether altered short term plasticity is solely a function of altered channel number or whether additional causes, such as altered channel properties, also play into this. We triturated the first pulse amplitude in ∆I-IIB to match control and find that paired pulse ratio and the variance thereof are not different anymore. Therefore, the differences observed in identical external calcium can be fully explained by altered channel numbers. This additional dataset is shown in the revised figures 6D and E and referred to in the results section on page 10, lines 14 to 25 and the discussion on page16, lines 36 to 38.

      (11) How were the depression kinetics analyzed? How many trains were used for each cell, and how do the tau values depend on the first PSC amplitude? Time constants in the range of a few (5-10) milliseconds are not informative for train stimulations with a frequency of 1 or 10 Hz (the unit is missing in Figure 5H). Also, the data shown in Figures 5E-K suggest slower time constants than 5-10 ms. Together, are the data indeed consistent with the idea that dIIIB does not only affect cac channel number, but also PPR/depression variability (p. 9)?

      For each animal the amplitudes of all subsequent PSCs in each train were plotted over time and fitted with a single exponential. For depression at 1 and 10 Hz, we used one train per animal, and 5-6 animals per genotype (as reflected in the data points in Figs. 6I, M). This is now explained in more detail in the revised methods section (page 23, lines 39 to 41). The tau values are not affected by the amplitude of the first PSC. First, we carefully re-fitted new and previously presented depression data and find that the taus for depression at low stimulation frequencies (1 and 10Hz) are not affected by exon excisions at the I-II site. We thank the reviewer for detecting our error in units and tau values in the previous figure panels 5H and L (this has now been corrected in the revised figure panels 6I and M). Given that PSC amplitude upon I-IIB excision is significantly smaller than in controls and following I-IIA excision, we suspected that the time course of depression at low stimulation frequency is not significantly affected by the amount of calcium influx during the first PSC. To further test this, we followed the reviewer ’s suggestion and re-measured depression at 1 and 10 Hz for cac-GFP controls and for delta I-IIB in a higher external calcium concentration (1.8 mM), so that the first PSC was increased in amplitude in both genotypes (1.8 mM external calcium triturates the PSC amplitude in delta I-IIB to match that of controls measured in 0.5 mM external calcium, see revised Figs. 6H, L). Neither in control, nor in delta I-IIB did this affect the time course of synaptic depression (see revised Figs. 6I, M). This indicates that at low stimulation frequencies (1 and 10Hz) the time course of depression is not affected by mean quantal content. This is consistent with the paired pulse ratio at 100 ms interpulse interval shown in figures 6A-D. However, for synaptic depression at 1 Hz stimulation the variability of the data is higher for delta I-IIB (independent of external calcium concentration, see rev. Fig. 6I), which might also be due to reduced channel number in this genotype. Taken together, the data are in line with the idea that altered cac channel numbers in active zones are sufficient to explain all effects that we observe upon I-IIB excision on PPRs and synaptic depression at low stimulation frequencies. This is now clarified in the revised text on page 12, lines 3 to 7.

      (12) The GFP-tagged I-IIA and mEOS4b-tagged I-IIB cac puncta shown in Figure 6N appear larger than the Brp puncta. Endogenously tagged cac puncta are typically smaller than Brp puncta (Gratz et al., 2019). Also, the I-IIA and I-IIB fluorescence sometimes appear to be partially non-overlapping. First, I suggest adding panels that show all three channels merged. Second, could they analyze the area and area overlap of I-IIA and I-IIB with regard to each other and to Brp, and compare it to cac-GFP? Any speculation as to how the different tags could affect localization? Finally, I recommend moving the dI-IIA and dI-IIB localization data shown in Figure 6N to an earlier figure (Figure 1 or Figure 3).

      We now show panels with the two I-II cac isoforms merged in the revised figure 7H (previously 6N). We also tested merging all three labels as suggested, but found this not instructive for the reader. We thank the reviewer for pointing out that the Brp puncta appeared smaller than the cac puncta in some panels. We carefully went through the data and found that the Brp puncta are not systematically smaller than the cac puncta. Please note that punctum size can appear quite differently, depending on different staining qualities as well as different laser intensities and different point spread in different imaging channels. The purpose of this figure was not to analyze punctum size and labeling intensity, but instead, to demonstrate that I-IIA and I-IIB are both present in most active zones, but some active zones show only I-IIB labeling, as quantified in figure 7I. We did not follow the suggestion to conduct additional co-localization analyses and compare it with cac-GFP controls, because Pearson co-localization coefficients for cac-GFP and all exon-out variants analyzed, including delta I-IIA and delta I-IIB are presented in the revised figure 4D. Moreover, delta I-IIA and delta I-IIB show similar Manders 1 and 2 co-localization coefficients with Brp (see Figs. 4E, F). We do not want to speculate whether the different tags have any effect on localization precision. Artificial differences in localization precision can also be suggested by different antibodies, but we know from our STED analyses with identical tags and antibodies for all isoforms that I-IIA and I-IIB co-localize identically with Brp (see Figs. 5A-E). Finally, we prefer to not move the figure because we believe it is informative to show our finding that active zones usually contain both splice I-II variants together with the finding that only I-IIB is required for PHP.

      Recommendations for the authors:

      Reviewing Editor Comments:

      We thank you for your submission. All three reviewers urge caution in interpreting the S4 splice variant playing a role specifically in Cac localization, as opposed to just leading to instability and degradation. There are other issues with the electrophysiological experiments, a need for improved imaging and analyses, and some areas of interpretation detailed in the reviews.

      We agree that additional data was required to conclude that IS4 splicing plays a specific role in cac channel localization and is not just leading to channel instability and degradation. As outlined in detail in our response to reviewer 1, comment 1, we conducted several sets of experiments to support our interpretation. First, electrophysiological experiments show that upon removal of IS4B, which eliminates synaptic transmission at the larval NMJ and cac positive label in presynaptic active zones, somatodendritic cac current is reliably recorded (new data in revised figure 3C). This is not in line with a channel instability or degradation effect, but instead with IS4B containing isoforms being required and sufficient for evoked release from NMJ motor terminals, whereas IS4A isoforms are not sufficient for evoked release from axon terminals, but IS4A isoforms alone can mediate a distinct component of somatodendritic calcium current. Second, immunohostochemical analyses reveal that IS4A, which is not present in NMJ presynaptic active zones, is expressed sparsely, but in reproducible patterns in the larval brain lobes and in specific regions of the anterior VNC parts (new supplementary figure 1). Again, the absence of a IS4A-containing cac isoform from presynaptic active zones but their simultaneous presence in other parts of the nervous system is in accord with isoform specific localization, but not with general channel isoform instability. Third, enlargements of NMJ boutons with brp positive presynaptic active zones confirm the absence of IS4A and the presence of IS4B in active zones (these enlargements are now shown in the revised figures 2A-C, 3A, and 4A-C). Fourth, as suggested we have quantified the Pearson co-localization of IS4 isoforms with Brp in presynaptic active zones (revised Fig. 2D). This confirms quantitatively similar co-localization of IS4B and control with Brp, but no co-localization of IS4A with Brp. In fact, the labeling intensity of IS4A in presynaptic active zones is quantitatively not significantly different from background, no IS4A label is detected anywhere in the axon terminals at the NMJ, but we find IS4 label in the CNS. Together, these data strongly support our interpretation that the IS4 splice site plays a distinct role in cac channel localization. Figure legends as well as results and discussion section have been modified accordingly (the respective page and line numbers are listed in our-point-by-point responses).

      In addition, we have carefully addressed all other public comments as well as all other recommendations for authors by providing multiple new data sets, new image analyses, and revising text. Addressing the insightful comments of all three reviewers and the reviewing editor has greatly helped to make the manuscript better.

      Reviewer #1 (Recommendations For The Authors):

      The conclusion that the IS4B exon controls Cac localization to active zones versus simply being required for channel abundance is not well supported. The authors need to either mention both possibilities or provide stronger support for the active zone localization model if they want to emphasize this point.

      We agree and have included several additional data sets as outlined in our response to point 1 of reviewer 1 and to the reviewing editor (see above). These new data strongly support our interpretation that the IS4B exon controls Cac localization to active zones and is not simply required for channel abundance. The additions to the figures and accompanying text (including the respective figure panel, page, and line numbers) are listed in the point-bypoint responses to the reviewers’ public suggestions.

      Figure 2C staining for Cac localization in the delta 4B line is difficult to compare to the others, as the background staining is so high (muscles are green for example). As such, it is hard to determine whether the arrows in C are just background.

      We had over-emphasized the green label to show that there really is no cacophony label in active zones. However, we agree that this hampered image interpretation. Thus, we have adjusted brightness such that it matches the other genotypes (see new figure panel 2C, and figure 3A, bottom). Revising the figure as suggested by the reviewer shows much more clearly that IS4B puncta are detected exclusively in presynaptic active zones, whereas IS4A channels are not detectable in active zones or anywhere else in the axon terminal boutons. Quantification of IS4A label in brp positive active zones confirms that labeling intensity is not significantly above background (page 6, lines 29 to 31 and page 7, lines 19 to 21). Therefore, IS4A is not detectable in active zones at the NMJ.

      It seems more likely that the removal of the 4B exon simply destabilizes the protein and causes it to be degraded (as suggested by the Western), rather than mislocalizing it away from active zones. It's hard to imagine how some residue changes in the S4 voltage sensor would control active zone localization to begin with. The authors should note that the alternative explanation is that the protein is just degraded when the 4B exon is removed.

      Based on additional data and analyses, we disagree with the interpretation that removal of IS4B disrupts protein integrity and present multiple lines of evidence that support sparse expression of IS4A channels (ΔIS4B). As outlined in our response to reviewer 1 and to the reviewing editor, we show (1) in new immunohistochemical stainings (new supplementary figure 1) that upon removal of IS4B, sparse label is detectable in the VNC and the brain lobes (for detail see above). (2) In our new figure 3C, we show cacophony-mediated somatodendritic calcium currents recorded from adult flight motoneurons in a control situation and upon removal of IS4B that leaves only IS4A channels. This clearly demonstrates that IS4A underlies a substantial component of the HVA somatodendritic calcium current, although it is absence from axon terminals. This is in line with isoform specific functions at different locations, but not with IS4A instability/degradation. (3) We do not agree with the reviewer’s interpretation of the Western Blot data in figure 1E (formerly figure 1D). Together with our immunohistochemical data that show sparse cacophony IS4A expression, we think that the faint band upon removal of IS4B in a heterozygous background (that reduces labeled channels even further) reflects the sparseness of IS4A expression. This sparseness is not due to channel instability, but to IS4A functions that are less abundant than the ubiquitously expressed cac<sup>IS4B</sup> channels at presynaptic active zones of fast chemical synapses (see page 15, lines 24 to 29).

      If they really want to claim the 4B exon governs active zone localization, much higher quality imaging is required (with enlarged views of individual boutons and their AZs, rather than the low-quality full NMJ imaging provided). Similarly, higher resolution imaging of Cac localization at Muscle 12 (Figure 2H) boutons would be very useful, as the current images are blurry and hard to interpret. Figure 6N shows beautiful high-resolution Cac and Brp imaging in single boutons for the I-II exon manipulations - the authors should do the same for the 4B line. For all immuno in Figure 2, it is important to quantify Cac intensity as well. There is no quantification provided, just a sample image. The authors should provide quantification as they do for the delta I-II exons in Figure 3.

      We did as suggested and added figure panels to figure 2A-C and to new figures 3A (formerly part of figure 2 and 4A-C (formerly figure 3) showing magnified label at the NMJ AZs to better judge on cacophony expression after exon excision. These data are now referred to in the results section on page 6, lines 22 to 24, page 7, lines 18 to 21 and page 8, lines 17/18.

      As suggested, we now also provide quantification of co-localization with brp puncta as Pearson’s correlation coefficient for control, IS4B, and IS4A in the new figure panel 2D (text on page 6, lines 34 to 38). This further underscores control-like active zone localization of IS4B but no significant active zone localization of IS4A. As suggested, we quantified now also the intensity of IS4B label in active zones, and it was not different from control (see revised figure 4H and text on page 8, lines 38/39). We did not quantify the intensity of IS4A label, because it was not over background (text, page 6, lines 30/31).

      Reviewer #2 (Recommendations For The Authors):

      (1a) Questions about the engineered Cac splice isoform alleles:

      The authors using CRISPR gene editing to selectively remove the entire alternatively spliced exons of interest. Do the authors know what happens to the cac transcript with the deleted exon? Is the deleted exon just skipped and spliced to the next exon? Or does the transcript instead undergo nonsense-mediated decay?

      We do not believe that there is nonsense mediated mRNA decay, because for all exon excisions the respective mRNA and protein are made. Protein has been detected on the level of Western blotting and immunocytochemistry. Therefore, we are certain that the mRNA is viable for each exon excision (and we have confirmed this for low abundance cac protein isoforms by rt-PCR), but only subsets of cac isoforms can be made from mRNAs that are lacking specific exons. However, we can not make any statements as to whether the lack of specific protein isoforms exerts feedback on mRNA stability, the rate of transcription and translation, or other unknown effects.

      (1b) While it is clear that the IS4 exons encode part of the voltage sensor in the first repeat, are there studies in Drosophila to support the putative Ca-beta and G-protein beta-gamma binding sites in the I-II loop? Or are these inferred from Mammalian studies?

      To the best of our knowledge, there are no studies in Drosophila that unambiguously show Caβ and Gβγ binding sites in the I-II loop of cacophony. However, sequence analysis strongly suggests that I-IIB contains both, a Caβ as well as a Gβγ binding site (AID: α-interacting domain) because the binding motif QXXER is present. In mouse Cav2.1 and Ca<sub>v</sub>2.2 channels the sequence is QQIER, while in Drosophila cacophony I-IIB it is QQLER. In the alternative IIIA, this motif is not present, strongly suggesting that G<sub>βγ</sub> subunits cannot interact at the AID. However, as already suggested by Smith et al. (1998), based on sequence analysis, Ca<sub>β</sub> should still be able to bind, although possibly with a lower affinity. We agree that this information should be given to the reader and have revised the text accordingly on page 5, lines 9 to 17.

      (1c) The authors assert that splicing of Cav2/cac in flies is a means to encode diversity, as mammals obviously have 4 Cav2 genes vs 1 in flies. However, as the authors likely know, mammalian Cav2 channels also have various splice isoforms encoded in each of the 4 Cav2 genes. The authors should discuss in more detail what is known about the splicing of individual mammalian Cav2 channels and whether there are any homologous properties in mammalian channels controlled by alternative splicing.

      We agree and now provide a more comprehensive discussion of vertebrate Ca<sub>v</sub>2 splicing and its impact on channel function. In line to what we report in Drosophila, properties like G<sub>βγ</sub> binding and activation voltage can also be affected by alternative splicing in vertebrate Ca<sub>v</sub>2 channel, through the exon patterns are quite different from Drosophila. We integrated this part on page 14, first paragraph) in the revised discussion. The respective text is below for the reviewer’s convenience:

      “However, alternative splicing increases functional diversity also in mammalian Ca<sub>v</sub>2 channels. Although the mutually exclusive splice site in the S4 segment of the first homologous repeat (IS4) is not present in vertebrate Cav channels, alternative splicing in the extracellular linker region between S3 and S4 is at a position to potentially change voltage sensor properties (Bezanilla 2002). Alternative splice sites in rat Ca<sub>v</sub>2.1 exon 24 (homologous repeat III) and in exon 31 (homologous repeat IV) within the S3-S4 loop modulate channel pharmacology, such as differences in the sensitivity of Ca<sub>v</sub>2.1 to Agatoxin. Alternative splicing is thus a potential cause for the different pharmacological profiles of P- and Q-channels (both Ca<sub>v</sub>2.1; Bourinet et al. 1999). Moreover, the intracellular loop connecting homologous repeats I and II is encoded by 3-5 exons and provides strong interaction with G<sub>βγ</sub>-subunits (Herlitze et al. 1996). In Ca<sub>v</sub>2.1 channels, binding to G<sub>βγ</sub> subunits is potentially modulated by alternative splicing of exon 10 (Bourinet et al. 1999). Moreover, whole cell currents of splice forms α1A-a (no Valine at position 421) and α1A-b (with Valine) represent alternative variants for the I-II intracellular loop in rat Ca<sub>v</sub>2.1 and Ca<sub>v</sub>2.2 channels. While α1A-a exhibits fast inactivation and more negative activation, α1A-b has delayed inactivation and a positive shift in the IV-curve (Bourinet et al. 1999). This is phenotypically similar to what we find for the mutually exclusive exons at the IS4 site, in which IS4B mediates high voltage activated cacophony currents while IS4A channels activate at more negative potentials and show transient current (Fig. 3; see also Ryglewski et al. 2012). Furthermore, altered Ca<sub>β</sub> interaction have been shown for splice isoforms in loop III (Bourinet et al. 1999), similar to what we suspect for the I-II site in cacophony. Finally, in mammalian VGCCs, the C-terminus presents a large splicing hub affecting channel function as well as coupling distance to other proteins. Taken together, Ca<sub>v</sub>2  channel diversity is greatly enhanced by alternative splicing also in vertebrates, but the specific two mutually exclusive exon pairs investigated here are not present in vertebrate Ca<sub>v</sub>2 genes.”

      (1d) In Figure 1, it would be helpful to see the entire cac genomic locus with all introns/exons and the 4 specific exons targeted for deletion.

      We agree and have changed figure 1 accordingly.

      (2a) Cav2.IS4B deletion alleles:

      More work is necessary to explain the localization of Cac controlled by the IS4B exon. First, can the authors determine whether actual Cac channels are present at NMJ boutons? The authors seem to indicate that in the IS4B deletion mutants, some Cac (GFP) signal remains in a diffuse pattern across NMJ boutons. However, from the imaging of wild-type Cac-GFP (and previous studies), there is no Cac signal outside of active zones defined by the BRP signal. It would benefit the study to a) take additional, higher resolution images of the remaining Cac signal at NMJs in IS4B deletion mutants, and b) comment on whether the apparent remaining signal in these mutants is only observed in the absence of IS4Bcontaining Cac channels, or if the IS4A-positive channels are normally observed (but perhaps mis-localized?).

      We have conducted additional analyses to show convincingly that IS4A channels (that remain upon IS4B deletion) are absent from presynaptic active zone. Please see also responses to reviewers 1 and 3. By adjusting the background values in of CLSM images to identical values in control, delta IS4A, and delta IS4B, as well as by providing selective enlargements as suggested, the figure panels 2C, Ci and 3A now show much clearer, that upon deletion of IS4B no cac label remains in active zones or anywhere else in the axon terminal boutons (see text on page 6, lines 22 to 24). This is further confirmed by quantification showing the in IS4B mutants cac labeling intensity in active zones is not above background (see text on page 6, lines 27 to 31). We never intended to indicate that there was cac signal outside of active zones defined by the brp signal, and we now carefully went through the text to not indicate this possibility unintentionally anywhere in the manuscript.

      (2b) Do the authors know whether any presynaptic Ca2+ influx is contributed by IS4Apositive Cac channels at boutons, given the potential diffuse localization? There are various approaches for doing presynaptic Ca2+ imaging that could provide insight into this question.

      We agree that this is an interesting question. However, based on the revisions made, we now show with more clarity that IS4A channels are absent from the presynaptic terminal at the NMJ. IS4A labeling intensities within active zones and anywhere else in the axon terminals are not different from background (see text on page 6, lines 27 to 31 and revised Figs. 2C, Ci, and 3A with new selective enlargements in response to comments of both other reviewers). This is in line with our finding that evoked synaptic transmission from NMJ axon terminals to muscle cells is mostly absent upon excision of IS4B (see Fig. 3B). The very small amplitude EPSC (below 5 % of the normal amplitude of evoked EPSCs) that can still be recorded in the absence of IS4B is similar to what is observed in cac null mutant junctions and is mediated by calcium influx through another voltage gated calcium channels, a Ca<sub>v</sub>1 homolog named Dmca1D, as we have previously published (Krick et al., 2021, PNAS 118(28):e2106621118. Gathering additional support for the absence of IS4A from presynaptic terminals by calcium imaging experiments would suffer significantly from the presence of additional types of VGCCs in presynaptic terminals (for sure Dmca1D (Krick et al., 2021) and potentially also the Ca<sub>v</sub>3 homolog DmαG or Dm-α1T). Such experiments would require mosaic null mutants for cac and DmαG channels in a mosaic IS4B excision mutant, which, if feasible at all, would be very hard and time consuming to generate. In the light of the additional clarification that IS4A is not located in NMJ axon terminal boutons, as shown by additional labeling intensity analysis, revised figures with selective enlargement, and revised text, we feel confident to state that IS4A is not sufficient for evoked SV release.

      (2c) Mechanistically, how are amino acid changes in one of the voltage sensing domains in Cac related to trafficking/stabilization/localization of Cac to AZs?

      This is an exciting question that has occupied our discussions a lot. Some sorting mechanism must exist that recognizes the correct protein isoforms, just as sorting and transport mechanisms exist that transport other synaptic proteins to the synapse. We do not think that the few amino acid changes in the voltage sensor are directly involved in protein targeting. We rather believe that the cacophony variants that happen to contain this specific voltage sensor are selected for transport out to the synapse. There are possibilities to achieve this cell biological, but we have not further addressed potential mechanisms because we do not want enter the realms of speculation.

      (3) How are auxiliary subunits impacted in the Cac isoform mutants?

      Recent work by Kate O'Connor-Giles has shown that both Stj and Ca-Beta subunits localize to active zones along with Cac at the Drosophila NMJ. Endogenously tagged Stj and CaBeta alleles are now available, so it would be of interest to determine if Stj and particular Cabeta levels or localization change in the various Cac isoform alleles. This would be particularly interesting given the putative binding site for Ca-beta encoded in the I-II linker.

      We agree that the synthesis of the work of Kate O'Connor-Giles group and our study open up new avenues to explore exciting hypotheses about differential coupling of specific cacophony splice isoforms with distinct accessory proteins such as Caβ and α<sub>2</sub>δ subunits. However, this requires numerous full sets of additional experiments and is beyond the scope of this study.

      (4a) Interpretation of short-term plasticity in the I-IIB exon deletion:

      The changes in short-term plasticity presented in Figure 5 are interpreted as an additional phenotype due to the loss of the I-IIB exon, but it seems this might be entirely explained simply due to the reduced Cac levels. Reduced Cac levels at active zones will obviously reduce Ca2+ influx and neurotransmitter release. This may be really the only phenotype/function of the I-IIB exon. Hence, to determine whether loss of the I-IIB exon encodes any functions in short-term plasticity, separate from reduced Cac levels, the authors should compare short-term plasticity in I-IIB loss alleles compared to wild type with starting EPSC amplitudes are equal (for example by reducing extracellular Ca2+ levels in wild type to achieve the same levels at in Cac I-IIB exon deleted alleles). Reduced release probability, simply by reduced Ca2+ influx (either by reduced Cac abundance or extracellular Ca2+) should result in more variability in transmission, so I am not sure there is any particular function of the I-IIB exon in maintaining transmission variability beyond controlling Cac abundance at active zones.

      For two reasons we are particularly grateful for this comment. First, it shows us that we needed to explain much clearer that our interpretation is that changes in paired pulse ratios (PPRs) and in depression at low stimulation frequencies are a causal consequence of lower channel numbers upon I-IIB exon deletion, precisely as pointed out by the reviewer. We have carefully revised the text accordingly on page 10, lines 14-25, page 11, lines 3-7 and 22-28; page 16, lines 36-38. Second, the experiment suggested by the reviewer is superb to provide additional evidence that the cause of altered PPRs is in fact reduced channel number, but not altered channel properties. Accordingly, we have conducted additional TEVC recordings in elevated external calcium (1.8 mM) so that the single PSC amplitudes in I-IIB excision animals match those of controls in 0.5 mM extracellular calcium. This makes the amplitudes and the variance of PPR for all interpulse intervals tested control-like (see revised Figs. 6D, E). This strongly indicates that differences observed in PPRs as well as the variance thereof were caused by the amount of calcium influx during the first EPSC, and thus by different channel numbers in active zones.

      (4b) Another point about the data in Figure 5: If "behaviorally relevant" motor neuron stimulation and recordings are the goal, the authors should also record under physiological Ca2+ conditions (1.8 mM), rather than the highly reduced Ca2+ levels (0.5 mM) they are using in their protocols.

      Although we doubt that the effective extracellular calcium concentration that determines the electromotoric force for calcium to enter the ensheathed motoneuron terminals in vivo during crawling is known, we followed the reviewer’s suggestion partly and have repeated the high frequency stimulation trains for ΔI-IIB in 1.8 mM calcium. As for short-term plasticity this brings the charge conducted to values as observed in control and in ΔI-IIA in 0.5 mM calcium. Therefore, all difference observed in previous figure 5 (now revised figure 6) can be accounted to different channel numbers in presynaptic active zones. This is now explained on page 11, lines 19-28. For controls recordings at high frequency stimulation in higher external calcium (e.g. 2 mM) have previously been published and show significant synaptic depression (e.g. Krick et al., 2021, PNAS). Given that in the exon out variants we do not expect any differences except from those caused by different channel numbers, we did not repeat these experiments for control and ΔI-IIA.

      (5a) Mechanism of Cac's role in PHP :

      As the authors likely know, mutations in Cac were previously reported to disrupt PHP expression (see Frank et al., 2006 Neuron). Inexplicably, this finding and publication were not cited anywhere in this manuscript (this paper should also be cited when introducing PhTx, as it was the first to characterize PhTx as a means of acutely inducing PHP). In the Frank et al. paper (and in several subsequent studies), PHP was shown to be blocked in mutations in Cac, namely the CacS allele. This allele, like the I-IIB excision allele, reduces baseline transmission presumably due to reduced Ca2+ influx through Cac. The authors should at a minimum discuss these previous findings and how they relate to what they find in Figure 6 regarding the block in PHP in the Cac I-IIB excision allele.

      We thank the reviewer for pointing this out and apologize for this oversight. We agree that it is imperative to cite the 2006 paper by Frank et al. when introducing PhTx mediated PHP as well as when discussing cac the effects of cac mutants on PHP together with other published work. We have revised the text accordingly on page 12, lines 9-11 and 21-23 and on page 17, lines 29-33.

      In terms of data presentation in Fig. 6, as is typical in the field, the authors should normalize their mEPSC/QC data as a percentage of baseline (+PhTx/-PhTx). This makes it easier to see the reduction in mEPSC values (the "homeostatic pressure" on the system) and then the homeostatic enhancement in QC. Similarly, in Fig. 6M, the authors should show both mEPSC and QC as a percentage of baseline (wild type or non-GluRIIA mutant background).

      We agree and have changed figure presentation accordingly. Figure 7 (formerly figure 6) was updated as was the accompanying results text on page 12, lines 23-40.

      (6) Cac I-IIA and I-IIB excision allele colocalization at AZs:

      These are very nice and important experiments shown in Figures 6N and O, which I suggest the authors consider analyzing in further detail. Most significantly:

      (6i) The authors nicely show that most AZs have a mix of both Cac IIA and IIB isoforms. Using simple intensity analysis, can the authors say anything about whether there is a consistent stoichiometric ratio of IIA vs IIB at single AZs? It is difficult to extract actual numbers of IIA vs IIB at individual AZs without having both isoforms labeled mEOS4b, but as a rough estimate can the authors say whether the immunofluorescence intensity of IIA:IIB is similar across each AZ? Or is there broad heterogeneity, with some AZs having low vs high ratios of each isoform (as the authors suggest across proximal to distal NMJ AZs)?

      We agree and have conducted experiments and analyses to provide these data. We measured the cac puncta fluorescence intensities for heterozygous cac<sup>sfGFP</sup>/cac, cacIIIA<sup>sfGFP</sup>/cacI-IIB, and cacI-IIB<sup>sfGFP</sup>/cacI-IIA animals. We preferred this strategy, because intensity was always measured from cac puncta with the same GFP tag. Next, we normalized all values to the intensities obtained in active zones from heterozygous cac<sup>sfGFP</sup>/cac controls and then plotted the intensities of I-IIA versus I-IIB containing active zones side by side. Across junctions and animals, we find a consistent ratio 2:1 in the relative intensities of I-IIB and I-IIA, thus indicating on average roughly twice as many I-IIB as compared to I-IIA channels across active zones. This is consistent with the counts in our STED analysis (see Fig. 5F). These new data are shown in the new figure panel 7J and referred to on page 13, lines 10-16 in the revised text.

      (6ii) Intensity analysis of Cac IIA vs IIB after PHP: Previous studies have shown Cac abundance increases at NMJ AZs after PHP. Can the authors determine whether both Cac IIA vs IIB isoforms increase after PHP or whether just one isoform is targeted for this enhancement?

      We already show that PHP is not possible in the absence of I-IIB channels (see figure 7). However, we agree that it is an interesting question to test whether I-IIA channel are added in the presence of I-IIB channels during PHP, but we consider this a detail beyond the scope of this study.

      Minor points:

      (1) Including line numbers in the manuscript would help to make reviewing easier.

      We agree and now provide line numbers.

      (2) Several typos (abstract "The By contrast", etc).

      We carefully double checked for typos.

      (3) Throughout the manuscript, the authors refer to Cac alleles and channels as "Cav2", which is unconventional in the field. Unless there is a compelling reason to deviate, I suggest the authors stick to referring to "Cac" (i.e. cacdIS4B, etc) rather than Cav2. The authors make clear in the introduction that Cac is the sole fly Cav2 channel, so there shouldn't be a need to constantly reinforce that cac=Cav2.

      We agree and have changed all fly Ca<sub>v</sub>2 reference to cac.

      (4) In some figures/text the authors use "PSC" to refer to "postsynaptic current", while in others (i.e. Figure 6) they switch to the more conventional terms of mEPSC or EPSC. I suggest the authors stick to a common convention (mEPSC and EPSC).

      We have changed PSC to EPSC throughout.

      Reviewer #3 (Recommendations For The Authors):

      (1) The abstract could focus more on the results at the expense of the background.

      We agree and have deleted the second introductory background sentence and added information on PPRs and depression during low frequency stimulation.

      (2) What does "strict" active zone localization refer to? Could they please define the term strict?

      Strict active zone localization means that cac puncta are detected in active zones but no cac label above background is found anywhere else throughout the presynaptic terminal, now defined on page 6, lines 27-29.

      (3) Single boutons/zoomed versions of the confocal images shown in Figures 2A-C, 2H, and 3A-C would be very helpful.

      We have provided these panels as suggested (see above and revised figures 2-4). Figure 3 is now figure 4.

      (4) The authors cite Ghelani et al. (2023) for increased cac levels during homeostatic plasticity. I recommend citing earlier work making similar observations (Gratz et al., 2019; DOI: 10.1523/JNEUROSCI.3068-18.2019), and linking them to increased presynaptic calcium influx (Müller & Davis, 2012; DOI: 10.1016/j.cub.2012.04.018).

      We agree and have added Gratz et al. 2019 and Davis and Müller 2012 to the results section on page 12, lines 17/18 and lines 21-23, in the discussion on page 17, lines 29-33.

      (5) The data shown in Figure 3 does not directly support the conclusion of altered release probability in dI-IIB. I therefore suggest changing the legend's title.

      We have reworded to “Excisions at the I-II exon do not affect active zone cacophony localization but can alter cacsfGFP label intensity in active zones and PSC amplitude” as this is reflecting the data shown in the figure panels more directly.

      (6) It would be helpful to specify "adult flight muscle" in Figure 2J.

      We agree that it is helpful to specify in the figure (now revised figure 3C) that the voltage clamp recordings of somatodendritic calcium current were conducted in adult flight motoneurons and have revised the headline of figure panel 3C and the legend accordingly. Please note, these are not muscle cells but central neurons.

      (7) Do dIS4B/Cav2null MNs indeed show an inward or outward current at -90 to -70 mV/-40 and -50 mV, or is this an analysis artifact?

      No, this is due to baseline fluctuations as typical for voltage clamp in central neurons with more than 6000 µm dendritic length and more than 4000 dendritic branches.

      (8) Loss of several presynaptic proteins, including Brp (Kittel et al., 2006), and RBP (Liu et al., 2011), induce changes in GluR field size (without apparent changes in miniature amplitude). The statement regarding the Cav2 isoform and possible effects on GluR number (p. 8) should be revised accordingly.

      We understand and have done two things. First, we measured the intensity of GluRIIA immunolabel in ΔI-IIA, ΔI-IIB, and controls and found no differences. Second, we reworded the statement. It now reads on page 9, lines 1-6: “It seems unlikely that presynaptic cac channel isoform type affects glutamate receptor types or numbers, because the amplitude of spontaneous miniature postsynaptic currents (mEPSCs, Fig. 4K) and the labeling intensity of postsynaptic GluRIIA receptors are not significantly different between controls, I-IIA, and I-IIB junctions (see suppl. Fig. 2, p = 0.48, ordinary one-way ANOVA, mean and SD intensity values are 61.0 ± 6.9 (control), 55.8 ± 8.5 (∆I-IIA), 61.1 ± 17.3 (∆I-IIB)). However, we cannot exclude altered GluRIIB numbers and have not quantified GluR receptor field sizes.”

      (9) The statement relating miniature frequency to RRP size is unclear (p. 8). Is there any evidence for a correlation between miniature frequency to RRP size? Could the authors please clarify?

      We agree that this statement requires caution. Although there is some published evidence for a correlation of RRP size and mini frequency (Neuron, 2009 61(3):412-24. doi: 10.1016/j.neuron.2008.12.029 and Journal of Neuroscience 44 (18) e1253232024; doi: 10.1523/JNEUROSCI.1253-23.2024), which we now refer to on page 9, it is not clear whether this is true for all synapses and how linear such a relationship may be. Therefore, we have revised the text on page 9, lines 6-9. It now reads: “Similarly, the frequency of miniature postsynaptic currents (mEPSCs) remains unaltered. Since mEPSCs frequency has been related to RRP size at some synapses (Pan et al., 2009; Ralowicz et al., 2024) this indicates unaltered RRP size upon I-IIB excision, but we have not directly measured RRP size.”

      (10) Please define the "strict top view" of synapses (p. 8).

      Top view is what this reviewer referred to as “planar view” in the public review points 6 and 7. In our responses to these public review points we now also define “strict top view”, see page 9, lines 17-19.

      (11) Two papers are cited regarding a linear relationship between calcium channel number and release probability (p. 15). Many more papers could be cited to demonstrate a supralinear relationship (e.g., Dodge & Rahaminoff, 1967; Weyhersmüller et al., 2011 doi: 10.1523/JNEUROSCI.6698-10.2011). The data of the present study were collected at an extracellular calcium concentration of 0.5 mM, whereas Meideiros et al. (2023) used 1.5 mM. The relationship between calcium and release is supra-linear around 0.5 mM extracellular calcium (Weyhersmüller et al. 2011). This should be discussed/the statements be revised. Also, the reference to Meideiros et al. (2023) should be included in the reference list.

      We have now updated the Medeiros reference (updated version of that paper appeared in eLife in 2024) in the text and reference list. We agree that the relationship of the calcium concentration and P<sub>r</sub> can also be non-linear and refer to this on page 16, lines 26-32, but the point we want to make is to relate defined changes in calcium channel number (not calcium influx) as assessed by multiple methods (CLSM intensity measures and sptPALM channel counting) to release probability. We now also clearly state that we measured at 0.5 mM external calcium (page 16, lines 27/28) whereas Medeiros et al. 2024 measured at 1.5 mM calcium (page 16, lines 31/32).

      (12) Figure 6: Quantal content does not have any units - please remove "n vesicles".

      We have revised this figure in response to reviewer 2 (comment 5) and quantal content is now expressed as percent baseline, thus without units (see revised figure 7).

      (13) Figure 6C should be auto-scaled from zero.

      This has been fixed by revising that figure in response to reviewer 2 (comment 5)

      (14) The data supporting the statement on impaired motor behavior and reduced vitality of adult IS4A should be either shown, or the statement should be removed (p. 13). Any hypotheses as to why IS4A is important for behavior and or viability?

      As suggested, we have removed that statement.

      (15) They do not provide any data supporting the statement that changes in PSC decay kinetics "counteract" the increase in PSC amplitude (p. 14). The sentence should be changed accordingly.

      We agree and have down toned. It now reads on page 16, lines 7-9: “During repetitive firing, the median increase of PSC amplitude by ~10 % is potentially counteracted by the significant decrease in PSC half amplitude width by ~25 %...”.

      (16) How do they explain the net locomotion speed increase in dI    -IIA larvae? Although the overall charge transfer is not affected during the stimulus protocols used, could the accelerated PSC decay affect PSP summation (I would actually expect a decrease in summation/slower speed)? Independent of the voltage-clamp data, is muscle input resistance changed in dI-IIA mutants?

      Muscle input resistance is not altered in I-II mutants. We refer to potential causes of the locomotion effects of I-IIA excision in the discussion. On page 16, lines 12 to 21 it reads: “there is no difference in charge transfer from the motoneuron axon terminal to the postsynaptic muscle cell between ∆I-IIA and control. Surprisingly, crawling is significantly affected by the removal of I-IIA, in that the animals show a significantly increased mean crawling speed but no significant change in the number of stops. Given that the presynaptic function at the NMJ is not strongly altered upon I-IIA excision, and that I-IIA likely mediates also Ca<sub>v</sub>2 functions outside presynaptic AZs (see above) and in other neuron types than motoneurons, and that the muscle calcium current is mediated by Ca<sub>v</sub>1>/i> and Ca<sub>v</sub>3, the effects of I-IIA excision of increasing crawling speed is unlikely caused by altered pre- or postsynaptic function at the NMJ. We judge it more likely that excision of I-IIA has multiple effects on sensory and pre-motor processing, but identification of these functions is beyond the scope of this study.”

    1. Author response:

      Provisional Responses to Review #1's comments:

      We thank the reviewer for the comments, which highlight both strengths and weaknesses.

      We acknowledge that the optimized parameter values are somewhat specific to Plasmodium, as demographic and mutation/recombination rates can vary across species. However, we would like to emphasize that our simulation and benchmarking framework, along with associated tools like the efficient ibdutils, should be broadly applicable to many species, such as Apicomplexan parasites and other high-recombining eukaryotes, especially when their demographic and evolutionary parameters can be provided or estimated. We will update relevant paragraphs in the disucssion to highlight this point.

      Results related to Refined IBD may not seem unexpected, but our work demonstrates that its direct application to malaria parasites without species-specific optimization can be suboptimal, as has previously occurred in malaria research with their validity not formally evaluated. We believe it is crucial for the research community focusing on non-standard model organisms to validate assumptions made in methods developed for standard models, such as humans, before they are applided to new species.

      Although standard deviations (SDs) are not provided for many analyses, we argue that simulating 14 chromosomes independently serves as repeats (data were shown as means over chromosomes), particularly when assessing the accuracy of IBD segments or scanning for selection signals. For analyses that aggregate information across chromosomes, we are planning to conduct additional repeated simulations or analyses to quantify the uncertainty of estimates. In the upcoming revised version, we will provide SDs where appropriate and explanations when repeated simulation are not necessary given a large number of data points have well captured their empirical distributions.

      Provisional response to review #2's comment:

      Thank you to the reviewer for the suggestions. We agree with the comments, and addressing the mentioned weakness will improve the manuscript's clarity and impact. We plan to enhance the introduction by highlighting the significance of studying malaria and specifically focusing on P. falciparum in this work. We will also update the discussion to reinforce the connection between our findings and malaria research and control and further emphasize the broader implications for the field.

    1. Author response:

      The following is the authors’ response to the original reviews.

      (1) Reviewer 3: Moreover, the conclusion that preBötC NMBR and GRPR activations are unnecessary for sighing is not fully supported by the current experimental design. While the study shows that sighing can still be induced despite pharmacological inhibition of NMBR and GRPR, this does not conclusively prove that these receptors are not required under natural conditions. 

      We concluded that “NMBR and GRPR receptors are not necessary for sigh generation”. We acknowledge that under normal conditions these receptors almost certainly play a role; in fact, microinjection of saporin conjugated to bombesin, which presumably ablates NMBR<sup>+</sup> and GRPR<sup>+</sup> preBötC neurons, completely eliminated endogenous sighing activity in awake mice (Li et al., Nature, 2015). However, that study did not establish that the receptors per se are essential in this context, since the protocol ablated not just the receptors but also the preBötC neurons that happened to express these receptors. Here, we show that we could evoke sighs AFTER complete pharmacological blockade of NMBRs and GRPRs. Also, we show that sighs can be elicited by stimulation of a distinct subpopulation of preBötC neurons expressing the peptide somatostatin (SST<sup>+</sup>). These results demonstrate that sighs can be evoked in absence of activation of NMBRs and/or GRPRs, leading to the conclusion that NMBRs and/or GRPRs are not required for sighs but rather contribute to periodic sigh generation under normal conditions.

      (2) Reviewer 1: To make such a novel (and quite surprising) claim requires many more studies and the conclusion is dependent on how the authors have defined a sigh. Moreover, some data within the paper conflicts with this idea.

      Our definition of sighs was carefully chosen so that it applied across different experimental conditions, including in vitro slices, anesthetized or awake in vivo. We defined sighs as transient changes in minute ventilation on a time scale slower than eupneic breathing period, to avoid classifying breathing after vagotomy or under isoflurane anesthesia as “all-sigh breathing”. This is why induction of persistent large amplitude breaths (such as in Figures 5-6) were not counted as sighs.

      (3) Reviewer 2: Several key technical aspects of the study require further clarification to aid in interpreting the experimental results, including issues relating to the validation of the transgenic mouse lines and virally transduced expressions of proteins utilized for optogenetic and chemogenetic experiments, as well as justifying the optogenetic photostimulation paradigms used to evoke sighs.

      The rationale for using SPP and LPP stems from our published observations of the effects of optogenetic stimulation of various preBötC neuronal subpopulations. Thus, SPP and LPP evoke the same responses in GlyT2 (Sherman et al., 2015) and Dbx1 (Cui et al., 2016) neurons, while for other subpopulations, e.g., SST (Cui et al., 2015), the effects of SPP are markedly different from LPP. Hence, in this study we examined both. As effects of SPP and LPP of SST neurons were examined previously (Cui et al., 2016), these protocols were not repeated except for evoking sighs after blockade of NMBR/GRPRs. SPP of pF NMB or GRP did not evoke any respiratory responses and hence were not presented in any figures (see Results, section “Activation of Nmb- or Grp-expressing pF neurons induces sighs”).

      (4) Reviewer 3: however, the rationale and experimental details require further explanation, and their impacts on the conclusion require clarification. For instance, how and why the variability in optogenetic activation conditions could impact the experimental outcomes. 

      Refractory periods reported here for pF NMB, pF GRP, preBötC NMBR and preBötC GRPR were all obtained using the same intensity LPP. We acknowledge the possibility, even the likelihood that higher intensity LPP would shorten refractory periods. In line with this, we observed that ectopic sighs were evoked earlier during the LPP as the sigh phase progressed. As described in RESULTS, such effects were observed for pF NMB, pF GRP, preBötC NMBR and preBötC GRPR only and not for preBötC SST, which might suggest that timing of intrinsically generated sighs depends on the NMB-GRP signaling pathway, yet sigh production depends on the SST pathway.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      This is an elegant didactic exposition showing how dendritic plateau potentials can enable neurons to perform reliable 'binary' computations in the face of realistic spike time jitter in cortical networks. The authors make many good arguments, and the general concept underlying the paper is sound. A strength is their systematic progression from biophiysical to simplified models of single neurons, and their parallel investigation of spiking and binary neural networks, with training happening in the binary neural network.

      Reviewer #2 (Public Review):

      Summary:

      Artificial intelligence (AI) could be useful in some applications and could help humankind. Some forms of AI work on the platform of artificial neural networks (ANN). ANNs are inspired by real brains and real neurons. Therefore understanding the repertoire and logic of real neurons could potentially improve AANs. Cell bodies of real neurons, and axons of real neurons, fire nerve impulses (nerve impulses are very brief ~2 ms, and very tall ~100 mV). Dendrites, which comprise ~80% of the total neuronal membrane (80% of the total neuronal apparatus) typically generate smaller (~50 mV amplitude) but much longer (~100 ms duration) electrical transients, called glutamate-mediated dendritic plateau potentials. The authors have built artificial neurons capable of generating such dendritic plateau potentials, and through computer simulations the authors concluded that long-lasting dendritic signals

      (plateau potentials) reduce negative impact of temporal jitter occurring in real brain, or in

      AANs. The authors showed that in AANs equipped with neurons whose dendrites are capable of generating local dendritic plateau potentials, the sparse, yet reliable spiking computations may not require precisely synchronized inputs. That means, the real world can impose notable fluctuations in the network activity and yet neurons could still recognize and pair the related network events. In the AANs equipped with dendritic plateaus, the computations are very robust even when inputs are only partially synchronized. In summary, dendritic plateau potentials endow neurons with ability to hold information longer and connect two events which did not happen at the same moment of time. Dendritic plateaus circumvent the negative impact, which the short membrane time constants arduously inflict on the action potential generation (in both real neurons and model neurons). Interestingly, one of the indirect conclusions of the current study is that neurons equipped with dendritic plateau potentials may reduce the total number of cells (nodes, units) required to perform robust computations.

      Strengths:

      The majority of published studies are descriptive in nature. Researchers report what they see or measure. A smaller number of studies embark on a more difficult task, which is to explain the logic and rationale of a particular natural design. The current study falls into that second category. The authors first recognize that conduction delays and noise make asynchrony unavoidable in communication between circuits in the real brain. This poses a fundamental problem for the integration of related inputs in real (noisy) world. Neurons with short membrane time constants can only integrate coincident inputs that arrive simultaneously within 2-3 ms of one another. Then the authors considered the role for dendritic plateau potentials. Glutamate-mediated depolarization events within individual dendritic branches, can remedy the situation by widening the integration time window of neurons. In summary, the authors recognized that one important feature of neurons, their dendrites, are built-in to solve the major problems of rapid signal processing: [1] temporal jitter, [2] variation, [3] stochasticity, and [4] reliability of computation. In one word, the dendritic plateau potentials have evolved in the central nervous systems to make rapid CNS computations robust.

      Weaknesses:

      The authors made some unsupported statements, which should either be deleted, or thoroughly defended in the manuscript. But first of all, the authors failed to bring this study to the readers who are not experts in computational modeling or Artificial Neural Networks. Critical terms (syntax) and ideas have not been explained. For example: [1] binary feature space? [2] 13 dimensions binary vectors? [3] the binary network could still cope with the loss of information due to the binarization of the continuous coordinates? [4] accurate summation?

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      However, I have a number of specific points, listed below, that should be addressed. Most of them are relatively minor, but the authors should especially address point 10, which is a major point, by redoing the simulations affected by the erroneous value of the time constant, and by remaking the relevant figures based on the new simulations.

      Specific comments:

      (1) 7f "This feature is conspicuous because it is an order of magnitude longer than unitary synaptic inputs and axonal spikes.": — It is an order of magnitude longer than AMPA receptor-mediated synaptic currents (EPSCs), but more similar in time course to synaptic potentials (EPSPs) whose decay is governed by the passive membrane time constant (about 10 to 20 ms in pyramidal neurons in vivo) and which determines the lifetime of the 'memory' of the neuron for synaptic inputs under conditions of subthreshold, non-spiking dendritic integration. The quoted sentence should be rewritten accordingly.

      Following this suggestion, we have rewritten the sentence (l. 7) to: "This timescale is conspicuous, being many times longer than the fastest signalling processes in the nervous systems, including Excitatory Post-Synaptic Potentials (EPSPs) and axonal spikes."

      (2) 16ff "This is especially relevant to integration of inputs during high conductance states that are prevalent in-vivo. In these states the effective time constant of the neuronal membrane is extremely short and varies substantially depending on synaptic drive [13, 34, 49].": — The time-averaged synaptic conductance driven by sensory input in vivo is much less high than implied by this statement (e.g. see Fig. 4 of Haider et al. 2013 https://www.nature.com/articles/nature11665 ), and reduces the passive membrane time constant only by a small percentage. The energy cost of a high prevalence of highconductance states and extremely short membrane time constants would also exceed the energy budget of the brain (ref. 4). I would therefore suggest dropping this sentence.

      We have clarified this sentence thanks to the reviewer's suggestion. We meant that the instantaneous, rather than the time-averaged, conductance can be very big. To clarify this we have rewritten this section (l. 15): This is especially relevant to integration of inputs during high conductance states that are prevalent in vivo, where a typical neuron receives significant synaptic drive. In these states, the effective membrane time constant can be extremely short, and varies substantially depending on synaptic input.

      (3) l. 17f "As a consequence, computations that rely on passive summation of multiple inputs place punishing constraints on spike timing precision.": — Again, the passive membrane time constant is on the order of 10 ms and I would tone down this statement accordingly, removing the word 'punishing' for example.

      Following the suggestion, we have rewritten the sentence to (l. 18): "As a consequence, computations that rely on passive summation of multiple inputs would place strong constraints on spike timing precision."

      (4) l. 18ff "Dendritic action potentials, by contrast, have a consistently long duration that is ensured by the kinetic properties of voltage gated ion channels and NMDA receptors [54, 47, 10, 3]. These properties are largely determined by the amino acid sequence of receptor and channel proteins that are specifically expressed in dendrites [45, 44, 40]. This suggests dendritic properties are specifically tuned to produce localised, suprathreshold events that outlive rapid membrane fluctuations.": — Yes, but see also Attwell & Gibb 2005 ( https://www.nature.com/articles/nrn1784 ), especially the last two of their key points. The slow NMDA receptor decay kinetics (and therefore their high affinity for binding glutamate) may also be the consequence of a design goal to set the temporal coherence window for NMDA receptor-mediated synaptic plasticity such as STDP to be on the order of tens of milliseconds, somewhat longer than the membrane time constant.

      The reviewer is correct; other functions (e.g. synaptic plasticity) are also part of the dendrite's repertoire. To acknowledge this, we added a section (l. 34) where we mention that our idea does not conflict with, for example, synaptic plasticity.

      (5) l. 32f "Numerous studies point out that nonlinear summation in dendrites can make neurons computationally equivalent to entire networks of simplified point models, or 'units' in a traditional neural network [9, 21, 38, 40, 45, 48, 50, 51].": — See also Beniaguev et al. 2021 ( https://www.cell.com/neuron/pdf/S0896-6273(21)00501-8.pdf ), which also speaks to the next sentence.

      We thank the reviewer for the suggestion; the citation has been added.

      (6) Fig. 2E and F: the top of panel F corresponds to the top of panel E, but the bottom ofpanel F does not correspond to the bottom of panel E - it corresponds to a dendritic neuron with passive dendrites, not a point neuron. Panel E should be changed to reflect this fact.

      We have followed the suggestion to change the figure.

      (7) l. 49f "Despite these dendritic spikes being initiated at different times, they still sum in the soma, leading to a sodium spike there (Figure 2E).": — You probably mean Fig. 2D, and instead of a sodium spike (which could be misunderstood as local and dendritic) you triggered a sodium action potential. Likewise, Fig. 2B (right) shows the timescale of sodium action potentials at the soma (cf. l. 46).

      The error in the referencing to the figure has been corrected. The phrasing has also been changed to "a sodium action potential" (l. 56), following the reviewer's suggestion.

      (8) Please check the scale bars in Fig. 2D. Do they also apply to panel F below? If yes thatshould be stated.

      The scale bars are indeed the same; I have repeated them in the figure to avoid any confusion.

      (9) l. 68 "This time constant is consistent with the high-conductance state of pyramidalneurons in the cortex [6]":

      You do not need to invoke a high-conductance state to justify this time constant, which is indeed typical for the membrane time constant of pyramidal neurons in vivo.

      On a related note, Fig. 3B and its legend seem to assume that tau = 1 ms, and calls that one EPSP duration in the legend. An EPSC may have a decay time constant of 1 ms, but an EPSP will have a decay time constant of about 10 ms, similar to the membrane time constant. Fig. 3B (and therefore also the rest of Figure 3) seems to have been constructed with a value of tau that is too small by a factor of 10, and this should be corrected by remaking the figure. If tau = 1 ms was used also in Figure 4 then this figure also needs to be remade.

      Section 3.3 and Table 1 also use tau = 1 ms. This is unrealistic and needs to be changed an appropriate value of tau = 10 ms is given by the authors themselves in line 67. The incorrect value of tau in Table 1 causes other entries of the Table to be terribly wrong; a leak conductance of 1 µS would imply an input resistance of the neuron of 1 MOhm, but somatic input resistances of pyramidal neurons in vivo are on the order of 20 to 50 MOhm. The total capacitance of 1 nF is slightly too large, and should be adjusted to yield a membrane time constant of 10 ms given an appropriate leak conductance leading to an input resistance of about 20 to 50 MOhm. These are key numbers to get right for both Figures 3 and 4, especially if you want to be able to say "We have been careful to respect the essence of basic physiological facts while trying to build an abstraction of how elementary spiking computations might occur." (l. 215f).

      We thank the reviewer for catching this. We had actually already used tau = 10 ms, but had not yet updated the paper. Moreover, the somatic input resistance was indeed off. To rectify this, we have used the values: $Cm = 0.5 nF$, $\taum = 10 ms$, $Rm = 20 M \Ohm$, $gl = 0.05 \mu S$. Figure 3 was remade using these values, and Table 1 updated accordingly.

      (10) l. 158ff "The assumption that each neuron connects to one dendrite of an upstream neuron is actually grounded in physiology, although it may appear like a strong assumption at first glance: related inputs arrive at local clusters of spines synchronously [60].": — You probably mean "each neuron connects to one dendrite of a downstream neuron." And I would add "But see Beniaguev et al. 2022 https://www.biorxiv.org/content/10.1101/2022.01.28.478132v2.abstract " - your restrictive arrangement of inputs is probably not really needed, especially if postsynaptic neurons have more dendrites.

      The suggested wording was correct, and has been now incorporated (l. 166). I have also added the suggested citation.

      (11) I note that the plateaus in Fig. 4D are much shorter than those in Fig. 2D and F, but thisis a good thing: The experimental and simulation results in Fig. 2 are based on ref. 18, which used microiontophoresis of glutamate, leading to much slower glutamate concentration time courses at the dendritic NMDA receptors than synaptic release of glutamate would. The time courses of plateaus in Fig. 4 are much more in line with the NMDA plateau durations shown in ref. 21, especially their Figure 2B. These faster NMDA plateaus (or NMDA spikes as they are called in ref. 21) are based on synaptic release of glutamate in vivo, and on the faster NMDA receptor kinetics at physiological temperature compared to the old models with room temperature kinetics used in ref. 18.

      Here are two additional references that the authors might find interesting:

      Fisek et al. 2023 https://www.nature.com/articles/s41586-023-06007-6 Dudai et al. 2022 https://www.jneurosci.org/content/42/7/1184.full

      We thank the reviewer for the suggested references. The first has been added to the references in the introduction, on l. 28. The second has been added on l. 78.

      Reviewer #2 (Recommendations For The Authors):

      (1) In Fig. 3A, we observed some animal pictures, which were never explained in the figurecaption, or text of the manuscript. These pictures were probably explained at the lab meeting, so it is unnecessary to waste effort on these pictures in the manuscript draft.

      We agree with the reviewer; the figures have been removed.

      (2) Figure 1 has not been referenced anywhere in the manuscript text!

      Indeed, this had to be corrected, figure is now references on l. 9.

      (3) Line 45. "[18] triggered two NMDA spikes by glutamate uncaging at the indicated (red,blue) sites". [18] triggered one NMDA spike while recording at three locations simultaneously (two locations in dendrite and one location in the soma).

      The reviewer is correct here. The sentence has now been rephrased to "(ref.) triggered an NMDA spike by glutamate microiontophoresis while recording at the soma and the indicated (red, blue) sites in the dendrite." (l. 49)

      (4) Fig. 2B. The two labels, "Dendrite 2" and "Dendrite 1" incorrectly suggest that two traceswere recorded in two dendrites. These two traces were recorded in the same dendrite.

      We agree with the reviewer; labels have now been changed to "Dendrite site".

      (5) Line 45. "[18] triggered two NMDA spikes by glutamate uncaging at the indicated (red,blue) sites". - - One NMDA spike by "glutamate microiontophoresis".

      This is correct, the phrasing on (l. 50) has been changed accordingly.

      (6) Line 47. "... simulated glutamate releases 50 ms apart in the three dendritic sites indicatedin Figure 2C, thereby triggering three NMDA spikes at those sites. Despite these dendritic spikes being initiated at different times, they still sum in the soma, leading to a sodium spike there (Figure 2E)". A similar experiment has been performed in real cortical neurons (KD Oikonomu et al., 2012, PMID: 22934081), and could potentially be cited here. Briefly, Oikonomou et al. generated two dendritic plateau potentials in two dendritic branches and monitored the summation of these dendritic plateau potentials in the cell body.

      The reference has been added, on l. 54

      (7) Line 63. "We compared the behaviour of our simplified model with that of the full, detailedbiophysical model". Which detailed biophysical model? Please cite here the detailed biophysical model that you used for comparisons with your simplified abstract model.

      The reference to the paper has been added.

      (8) Line 65. "Figure 2F shows that spikes arriving at different times are summed in anintegrate and hold-like manner". In Fig. 2F, I am unable to see that spikes arriving at different times are summed in an integrate and hold-like manner. Which feature of Fig. 2F refers to the "hold-like manner"? Please explain in the manuscript.

      To clarify we have added "Figure 2F, top" in the text (l. 71).

      (9) Figure 2 caption. "(F) The voltage traces of the abstract model, with and without plateaus.Because of the extended time duration of the plateau potentials, they sum accurately to produce a somatic spike". I am unable to understand what an "accurate summation" in Fig. 2 is. Could the authors provide an illustrative example of a situation in which the neuronal potentials DID NOT sum accurately?

      To address this confusion, we have changed the wording to "...they are summed to reach threshold."

      (10) Line 75. "This is an important issue we intend to return to in future work". The authorspersonal plans should not be in the text discussing scientific results.

      We believe it is entirely reasonable to discuss scientific plans that are part of ongoing work, and this is quite common throughout the literature. Nonetheless, we have now reworded this to "This is an important issue for future work." (l. 81)

      (11) In Fig. 4F, the full-line and the dashed-line have not been identified! The readers are leftto guess.

      This has now been addressed both with text inserts in the figure, and specification in the figure caption.

      (12) Line 247. "would amount to scaling up the number of cells in a network to performcomputations that could, in principle, be performed by more robust single units". Did the authors mean to say: "would amount to scaling up the number of cells in a network to perform computations that could, in principle, be performed by a fewer (but more robust) single units"?

      We have replaced the sentence with the reviewer's suggestion (l. 259)

      (13) In the abstract, the authors repeat sentences: "the timescale of dendritic potentialsallows reliable integration of asynchronous inputs" and "nonlinear dendritic plateau potentials allow reliable integration of asynchronous spikes". Besides this being a bad writing style, the authors cannot decide if inputs to the model neuron are asynchronous, or spiking of the model neuron is asynchronous. Are these asynchronous spikes occurring in the neuron experiencing dendritic plateau potentials, or these asynchronous spikes occur in the neuronal network? This confusion of terms and ideas must be removed from the abstract.

      We have rewritten the second sentence, which now reads: "Using this model, we show that long-lived, nonlinear dendritic plateau potentials allow neurons to spike reliably when confronted with asynchronous input spikes."

      (14) In the abstract, the authors claim: "Our results provide empirically testable hypothesesfor the role of dendritic action potentials in cortical function". With great anticipation, I read throughout the manuscript, but I was unable to find one single experimental design that could support the authors' bald statement. In the text of the manuscript, the authors must carefully reveal the precise experimental outline that would test their specific hypothesis, or delete the untrue statement.

      We respectfully challenge the rather critical tone of the reviewer. The central hypothesis that plateaus enable robust summation, and that circuit level computations rely on this is an experimentally testable hypothesis. The precise experimental design of how to test such a hypothesis is always best left to an experimentalist to determine, as there are many possible means of doing this and each will depend on the preparation and methodology at hand. At the same time, we understand that there is an increasing culture of expecting explicit "testable hypotheses" spelled out to the reader. To satisfy this expectation while avoiding overly prescriptive ideas for how future work should proceed, we have now added more explicit descriptions of possible experimental tests in l. 231 and onwards.

      (15) Fig. 2F was submitted for review without a time scale, while at the same time the authorsheavily discuss specific numerical values for time intervals. Namely, the authors instruct readers to pay attention to a 10 ms time constant and 2-3 ms input decay (Fig. 2F), but they do not show the time scale in Fig. 2F.

      "We compared this to a situation where all inputs arrive at a soma with standard LIF dynamics and a 10 ms membrane time constant. This time constant is consistent with the high-conductance state of pyramidal neurons in the cortex [6]: Inputs decay after 2-3 ms, and fail to sum to spike threshold (Figure 2F, lower)".

      The time (and voltage) bars have now been added to Fig. 2F.

      (16) Line 75. "In the scope of what remains here we want to ask if integrate-and-hold isminimally feasible". This reviewer is unable to understand the meaning of the syntaxes "integrate-and-hold" and "minimally feasible" in the context of dendritic integration. This reviewer is worried that the majority of the journal readers would feel exactly the same. To alleviate this problem, the authors should explain both terms right here, in line 77.

      Integrate-and-hold is defined on line 57 (to be exact we write: "We refer to this behavior as “Leaky Integrate-and-Hold” (LIH)." To be more clear we could reuse the acronym LIH here, to emphasise that we are referring to the same thing. By 'minimally feasible' we mean biologically plausible given assumptions that are not strong. Can use another term, e.g. "biologically plausible under lenient assumptions".

      To address this point, we have rephrased the sentence as "In the scope of what remains here we want to ask if Leaky-Integrate-and-Hold (LIH) can easily and plausibly facilitate network computations with spikes." (l. 81), repeating the LIH definition.

      (17) Line 91. "Spikes arriving even slightly out of sync with each other introduces noise in themembrane potential ..." Introduce.

      The sentence has been fixed using the reviewer's correction.

      (18) The caption of the Fig. 3B was submitted for review without any explanation of thenormalization procedure used. Also, in the caption of the same figure, one cannot find explanation of the light-gray area surrounding the black curves. Also, the readers are left to wonder how the results of a simulation could possibly be greater than 1 in some simulation trials.

      We have added a description of the normalization and the shaded area to the caption of Fig. 3B.

      (19) Line 117. "We assumed that inputs to a network arrive at the dendrites within some timewindow, and their combined depolarisations are either sufficient to either elicit a dendritic spike or not, as shown in Figure 3". We could potentially compact the current text by deleting one instance of "either".

      We agree this is better writing; one of the occurrences of 'either' has been removed.

      (20) Line 127. "where incoming connections can be represented with a 1 (a spike arrives)..."Did you mean "a presynaptic spike arrives"?

      The sentence has been rewritten following the suggestion.

      (21) Line 134. "with each unit only having ..." Dendrite can be a unit. Dendritic spine can be aunit. Did you mean "with each unit (i.e. neuron) having ..."

      We have incorporated the suggestion.

      (22) Fig. 4, Caption. "Each point is a 2D input vector x, the colors represent the differentclasses". An effort was made to introduce 3 different classes. But then, no mention of "classes" thereafter. The three input vectors, mentioned in Line 170, perhaps represent the remnants of the class concept mentioned in the previous paragraph.

      We have now rewritten the sentence beginning with "These three input vectors ..." on l. 182 to emphasise that a correct answer means a correct classification.

      (23) Line 152. "The 2D input points were first projected onto a binary feature space, to obtain13D binary vectors". Did you mean to say: "The 2D input points (three classes, Fig. A) were first projected onto a binary feature space, to obtain three binary vectors; each 13D binary vector responding to a specific class".

      The sentence has been replaced with the reviewer's suggestion (l. 159).

      (24) Line 163. "Because our focus is to account for how transient signals can be summed andthresholded robustly, we are assuming that inhibition is implicitly accounted for in the lumped abstraction". Could you please explain your two ideas: [1] "inhibition is implicitly accounted for" and [2] "lumped abstraction", because this reviewer did not get neither idea.

      The reviewer is right that as it stood, the sentence was unclear. To clarify the point we have decided to expand upon that sentence and break it out as an individual paragraph (starting l. 171).

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer 1:

      This study is one in a series of excellent papers by the Forstmann group focusing on the ability of fMRI to reliably detect activity in small subcortical nuclei - in this case, specifically those purportedly involved in the hyper- and indirect inhibitory basal ganglia pathways. I have been very fond of this work for a long time, beginning with the demonstration of De Hollander, Forstmann et al. (HBM 2017) of the fact that 3T fMRI imaging (as well as many 7T imaging sequences) do not afford sufficient signal to noise ratio to reliably image these small subcortical nuclei. This work has done a lot to reshape my view of seminal past studies of subcortical activity during inhibitory control, including some that have several thousand citations.

      Comments on revised version:

      This is my second review of this article, now entitled "Multi-study fMRI outlooks on subcortical BOLD responses in the stop-signal paradigm" by Isherwood and colleagues.

      The authors have been very responsive to the initial round of reviews.

      I still think it would be helpful to see a combined investigation of the available 7T data, just to really drive the point home that even with the best parameters and a multi-study sample size, fMRI cannot detect any increases in BOLD activity on successful stop compared to go trials. However, I agree with the authors that these "sub samples still lack the temporal resolution seemingly required for looking at the processes in the SST." As such, I don't have any more feedback.

      We thank the reviewer for their positive feedback, and for their thorough and constructive comments on our initial submission. 

      Reviewer 2:

      This work aggregates data across 5 openly available stopping studies (3 at 7 tesla and 2 at 3 tesla) to evaluate activity patterns across the common contrasts of Failed Stop (FS) > Go, FS > stop success (SS), and SS > Go. Previous work has implicated a set of regions that tend to be positively active in one or more of these contrasts, including the bilateral inferior frontal gyrus, preSMA, and multiple basal ganglia structures. However, the authors argue that upon closer examination, many previous papers have not found subcortical structures to be more active on SS than FS trials, bringing into question whether they play an essential role in (successful) inhibition. In order to evaluate this with more data and power, the authors aggregate across five datasets and find many areas that are *more* active for FS than SS, including bilateral preSMA, GPE, thalamus, and VTA. They argue that this brings into question the role of these areas in inhibition, based upon the assumption that areas involved in inhibition should be more active on successful stop than failed stop trials, not the opposite as they observed.

      Since the initial submission, the authors have improved their theoretical synthesis and changed their SSRT calculation method to the more appropriate integration method with replacement for go omissions. They have also done a better job of explaining how these fMRI results situate within the broader response inhibition literature including work using other neuroscience methods.

      They have also included a new Bayes Factor analysis. In the process of evaluating this new analysis, I recognized the following comments that I believe justify additional analyses and discussion:

      First, if I understand the author's pipeline, for the ROI analyses it is not appropriate to run FSL's FILM method on the data that were generated by repeating the same time series across all voxels of an ROI. FSL's FILM uses neighboring voxels in parts of the estimation to stabilize temporal correlation and variance estimates and was intended and evaluated for use on voxelwise data. Instead, I believe it would be more appropriate to average the level 1 contrast estimates over the voxels of each ROI to serve as the dependent variables in the ROI analysis.

      We agree with the reviewer’s assertion that this approach could create estimation problems. However, in this instance, we turned off the spatial smoothing procedure that FSL’s FILM normally uses for estimating the amount of autocorrelation – thus, the autocorrelation was estimated based on each voxel’s timeseries individually. We also confirmed that all voxels within each ROI had identical statistics, which would not be the case if the autocorrelation estimates differed per voxel. We have added the following text to the Methods section under fMRI analysis: ROI-wise:

      Note that the standard implementation of FSL FILM uses a spatial smoothing procedure prior to estimating temporal autocorrelations which is suitable for use only on voxelwise data (Woolrich et al., 2001). We therefore turned this spatial smoothing procedure off and instead estimated autocorrelation using each voxel’s individual timeseries.

      Second, for the group-level ROI analyses there seems to be inconsistencies when comparing the z-statistics (Figure 3) to the Bayes Factors (Figure 4) in that very similar zstatistics have very different Bayes Factors within the same contrast across different brain areas, which seemed surprising (e.g., a z of 6.64 has a BF of .858 while another with a z of 6.76 has a BF of 3.18). The authors do briefly discuss some instances in the frequentist and Bayesian results differ, but they do not ever explain by similar z-stats yield very different bayes factors for a given contrast across different brain areas. I believe a discussion of this would be useful.

      We thank the reviewer for their keen observation, and agree that this is indeed a strange inconsistency. Upon reviewing this issue, we came across an error in our analysis pipeline, which led to inconsistent scaling of the parameter estimates between datasets. We corrected this error, and included new tables (Figures 3, 4, and Supplementary Figure 5) which now show improved correspondence between the frequentist results from FSL and the Bayesian results.

      We have updated the text of the Results section accordingly. In this revision, we have also updated all BFs to be expressed in log<sub>10</sub> form, to ensure consistency for the reader. Updates to the manuscript are given below.

      Results: Behavioural Analyses:

      Consistent with the assumptions of the standard horse-race model (Logan & Cowan, 1984), the median failed stop RT is significantly faster within all datasets than the median go RT (Aron_3T: p < .001, BF<sub>log10</sub> = 2.77; Poldrack_3T: p < .001, BF<sub>log10</sub> = 23.49; deHollander_7T: p < .001, B BF<sub>log10</sub> = 8.88; Isherwood_7T: p < .001, BF<sub>log10</sub> = 2.95; Miletic_7T: p = .0019, BF<sub>log10</sub> = 1.35). Mean SSRTs were calculated using the integration method and are all within normal range across the datasets.

      Results: ROI-wise GLMS: 

      To further statistically compare the functional results between datasets, we then fit a set of GLMs using the canonical HRF with a temporal derivative to the timeseries extracted from each ROI. Below we show the results of the group-level ROI analyses over all datasets using z-scores (Fig. 3) and log-transformed Bayes Factors (BF; Fig. 4). Note that these values were time-locked to the onset of the go signal. See Supplementary Figure 5 for analyses where the FS and SS trials were time-locked to the onset of the stop signal. To account for multiple comparisons, threshold values were set using the FDR method for the frequentist analyses. 

      For the FS > GO contrast, the frequentist analysis found significant positive z-scores in all regions bar left and right M1, and the left GPi. The right M1 showed a significant negative z-score; left M1 and GPi showed no significant effect in this contrast. The BFs showed moderate or greater evidence for the alternative hypothesis in bilateral IFG, preSMA, caudate, STN, Tha, and VTA, and right GPe. Bilateral M1 and left GPi showed moderate evidence for the null. Evidence for other ROIs was anecdotal (see Fig 4). 

      For the FS > SS contrast, we found significant positive z-scores in in all regions except the left GPi. The BFs showed moderate or greater evidence for right IFG, right GPi, and bilateral M1, preSMA, Tha, and VTA, and moderate evidence for the null in left GPi. Evidence for other ROIs was anecdotal (see Fig 4). 

      For the SS > GO contrast we found a significant positive z-scores in bilateral IFG, right Tha, and right VTA, and significant negative z-scores in bilateral M1, left GPe, right GPi, and bilateral putamen. The BFs showed moderate or greater evidence for the alternative hypothesis in bilateral M1 and right IFG, and moderate or greater evidence for the null in left preSMA, bilateral caudate, bilateral GPe, left GPi, bilateral putamen, and bilateral SN. Evidence for other ROIs was anecdotal (see Fig 4). 

      Although the frequentist and Bayesian analyses are mostly in line with one another, there were also some differences, particularly in the contrasts with FS. In the FS > GO contrast, the interpretation of the GPi, GPe, putamen, and SN differ. The frequentist models suggests significantly increased activation for these regions (except left GPi) in FS trials. In the Bayesian model, this evidence was found to be anecdotal in the SN and right GPi, and moderate in the right GPe, while finding anecdotal or moderate evidence for the null hypothesis in the left GPe, left GPi, and putamen. For the FS > SS contrast, the frequentist analysis showed significant activation in all regions except for the left GPi, whereas the Bayesian analysis found this evidence to be only anecdotal, or in favour of the null for a large number of regions (see Fig 4 for details).  

      Since the Bayes Factor analysis appears to be based on repeated measures ANOVA and the z-statistics are from Flame1+2, the BayesFactor analysis model does not pair with the frequentist analysis model very cleanly. To facilitate comparison, I would recommend that the same repeated measures ANOVA model should be used in both cases. My reading of the literature is that there is no need to be concerned about any benefits of using Flame being lost, since heteroscedasticity does not impact type I errors and will only potentially impact power.

      We agree with the reviewer that there are differences between the two analyses. The advantage of the z-statistics from FSL’s flame 1+2 is that these are based on a multi-level model in which measurement error in the first level (i.e., subject level) is taken into account in the group-level analysis. This is an advantage especially in the current paper since the datasets differ strongly in the degree of measurement error, both due to the differences in field strength and in the number of trials (and volumes). Although multilevel Bayesian approaches exist, none (except by use of custom code) allow for convolution with the HRF of a design matrix like typical MRI analyses. Thus, we extracted the participant-level parameter estimates (converted to percent signal change), and only estimated the dataset and group level parameters with the BayesFactor package. As such, this approach effectively ignores measurement error. However, despite these differences in the analyses, the general conclusions from the Bayesian and frequentist analyses are very aligned after we corrected for the error described above. The Bayesian results are more conservative, which can be explained by the unfiltered participantlevel measurement error increasing the uncertainty of the group-level parameter estimates. At worst, the BFs represent the lower bounds of the true effect, and are thus safe to interpret. 

      We have also included an additional figure (Supplementary Figure 7) that shows the correspondence between the BFs and the z scores. 

      Though frequentist statistics suggest that many basal ganglia structures are significantly more active in the FS > SS contrast (see 2nd row of Figure 3), the Bayesian analyses are much more equivocal, with no basal ganglia areas showing Log10BF > 1 (which would be indicative of strong evidence). The authors suggest that "the frequentist and Bayesian analyses are monst in line with one another", but in my view, this frequentist vs. Bayesian analysis for the FS > SS contrast seems to suggest substantially different conclusions. More specifically, the frequentist analyses suggest greater activity in FS than SS in most basal ganglia ROIs (all but 2), but the Bayesian analysis did not find *any* basal ganglia ROIs with strong evidence for the alternative hypothesis (or a difference), and several with more evidence for the null than the alternative hypothesis. This difference between the frequentist and Bayesian analyses seems to warrant discussion, but unless I overlooked it, the Bayesian analyses are not mentioned in the Discussion at all. In my view, the frequentist analyses are treated as the results, and the Bayesian analyses were largely ignored.

      The original manuscript only used frequentist statistics to assess the results, and then added Bayesian analyses later in response to a reviewer comment. We agree that the revised discussion did not consider the Bayesian results in enough detail, and have updated the manuscript throughout to more thoroughly incorporate the Bayesian analyses and improve overall readability. 

      In the Methods section, we have updated the fMRI analysis – general linear models (GLMs): ROIwise GLMs section to more thoroughly incorporate the Bayesian analyses as follows: 

      We compared the full model (H1) comprising trial type, dataset and subject as predictors to the null model (H0) comprising only the dataset and subject as predictor. Datasets and subjects were modeled as random factors in both cases. Since effect sizes in fMRI analyses are typically small, we set the scaling parameter on the effect size prior for fixed effects to 0.25, instead of the default of 0.5, which assumes medium effect sizes (note that the same qualitative conclusions would be reached with the default prior setting; Rouder et al., 2009). We divided the resultant BFs from the full model by the null model to provide evidence for or against a difference in beta weights for each trial type. To interpret the BFs, we used a modified version of Jeffreys’ scale (Andraszewicz et al., 2014; Jeffreys, 1939). To facilitate interpretation of the BFs, we converted them to the logarithmic scale. The approximate conversion between the interpretation of logarithmic BFs and standard interpretation on the adjusted Jeffreys’ scale can be found in Table 3.   

      The Bayesian results are also more incorporated into the Discussion as follows: 

      Evidence for the role of the basal ganglia in response inhibition comes from a multitude of studies citing significant activation of either the SN, STN or GPe during successful inhibition trials (Aron, 2007; Aron & Poldrack, 2006; Mallet et al., 2016; Nambu et al., 2002; Zhang & Iwaki, 2019). Here, we re-examined activation patterns in the subcortex across five different datasets, identifying differences in regional activation using both frequentist and Bayesian approaches. Broadly, the frequentist approach found significant differences between most ROIs in FS>GO and FS>SS contrasts, and limited differences in the SS>GO contrast. The Bayesian results were more conservative; while many of the ROIs showed moderate or strong evidence, some with small but significant z scores were considered only anecdotal by the Bayesian analysis. In our discussion, where the findings between analytical approaches differ, we focus mainly on the more conservative Bayesian analysis.

      Here, our multi-study results found limited evidence that the canonical inhibition pathways (the indirect and hyperdirect pathways) are recruited during successful response inhibition in the SST. We expected to find increased activation in the nodes of the indirect pathway (e.g., the preSMA, GPe, STN, SN, GPi, and thalamus) during successful stop compared to go or failed stop trials. We found strong evidence for activation pattern differences in the preSMA, thalamus, and right GPi between the two stop types (failed and successful), and limited evidence, or evidence in favour of the null hypothesis, in the other regions, such as the GPe, STN, and SN. However, we did find recruitment of subcortical nodes (VTA, thalamus, STN, and caudate), as well as preSMA and IFG activation during failed stop trials. We suggest that these results indicate that failing to inhibit one’s action is a larger driver of the utilisation of these nodes than action cancellation itself. 

      These results are in contention to many previous fMRI studies of the stop signal task as well as research using other measurement techniques such as local field potential recordings, direct subcortical stimulation, and animal studies, where activation of particularly the STN has consistently been observed (Alegre et al., 2013b; Aron & Poldrack, 2006; Benis et al., 2014; Fischer et al., 2017; Mancini et al., 2019; Wessel et al., 2016).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The authors set out to define the molecular basis for LP as the origin of BRCA1deficient breast cancers. They showed that LPs have the highest level of replicative stress, and hypothesise that this may account for their tendency to transform. They went on to identify ELF3 as a candidate driver of LP transformation and showed that ELF3 expression is up-regulated in response to replicative stress as well as BRCA1 deficiency. They went on to show that ELF3 inactivation led to a higher level of DNA damage, which may result from compromised replicative stress responses.

      While the manuscript supports the interesting idea wherein ELF3 may fuel LP cell transformation, it remains obscure how ELF3 promotes cell tolerance to DNA damage. Interestingly the authors proposed that ELF3 suppresses excessive genomic instability, but in my opinion, I do not see any evidence that supports this claim. In fact, one might think that genomic instability is key to cell transformation.

      We greatly appreciate your thorough review and insightful comments on our manuscript. We have taken your feedback seriously and have made several key revisions to address your concerns.

      To your primary point about how ELF3 helps cells tolerate DNA damage, we have expanded our discussion to clarify the role of ELF3 in the context of BRCA1 deficiency and high replicative stress. We clarified that while ELF3 may not directly suppress excessive genomic instability, it plays a role in maintaining a balance that prevents catastrophic damage in BRCA1-deficient cells. Both BRCA1 deficiency and increased replication stress induce up-regulation of ELF3, which acts as a transcription factor, and it’s up-regulation leads to up-regulation of the expression of a variety of DNA replication-associated proteins that help to maintain homeostasis in the DNA replication process (Figure 5 E and F). Defects in ELF3 also do lead to disruption of the DNA replication process (Figure 5 G-I). While ELF3 cannot completely eliminate genomic instability, ELF3 essentially maintains genomic instability within a dangerous yet non-lethal range: higher than in normal cells, but not so high as to cause cell death.

      This precarious balance can facilitate the transformation of LPs into a malignant state, as you pointed out.

      In the revised manuscript, we emphasized that in cells with inherently low replicative stress, such as other non-LP mammary cells, the ELF3-associated mechanism might help cells endure the high replicative stress caused by BRCA1 deficiency without leading to cancerous changes. However, in LP cells, which naturally experience higher replicative stress, this ELF3-related mechanism may make them more susceptible to transformation into cancer cells. This supports our hypothesis that the combination of high replicative stress and BRCA1 deficiency specifically predisposes LP cells to tumorigenesis.

      We have modified the working model to make it clearer.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript focuses on a persistent question of why germline mutations in BRCA1 which impair homology-directed repair of DNA double-strand breaks predispose to primarily breast and ovarian cancers but not other tissues. The authors propose that replication stress is elevated in the luminal progenitor (LP) cells and apply the gene signature from Dreyer et al as a measure of replication stress in populations of cells selected by FACS previously (published by Lim et al.) and suggest an enrichment of replication stress among the LP cells. This is followed by single-cell RNA seq data from a small number of breast tissues from a small number of BRCA1 mutation carriers but the pathogenic variants are not listed. The authors perform an elegant analysis of the effects of BRCA1 knockdown in MCF10A cells, but these cells are not considered a model of LP cells.

      Overall, the manuscript suffers from significant gaps and leaps in logic among the datasets used. The connection to luminal progenitor cells is not adequately established because the models used are not representative of this population of cells. Therefore, the central hypothesis is not sufficiently justified.

      Strengths:

      The inducible knockdown of BRCA1 provided compelling data pointing to an upregulation of ELF3 in this setting as well as a small number of other genes. It would be useful to discuss the other genes for completeness and explain the logic for focusing on ELF3. Nonetheless, the connection with ELF 3 is reasonable. The authors provide significant data showing a role for ELF3 in breast epithelial cells and its role in cell survival.

      Weaknesses:

      The initial observations in primary breast cells have small sample sizes. The mutations in BRCA1 seem to be presumed to be all the same, but we know that pathogenic variants differ among individuals and range from missense mutations affecting interactions with one critical partner to large-scale truncations of the protein.

      The figure legends are missing critical details that make it difficult for the reader to evaluate the data. The data support the notion that ELF3 may participate in relieving replication stress, but does not appear to be limited to LP cells as proposed in the hypothesis.

      We would like to sincerely thank you for your thorough review and constructive feedback on our manuscript. Your insightful comments and suggestions have been invaluable in guiding our revisions.

      (1) Acknowledgment of Data Set Limitations and Additional Analyses:    We fully acknowledge the importance of the concerns raised regarding the datasets used in our study. We have supplemented our manuscript with the missing information you pointed out and conducted additional analyses as suggested. These efforts have

      (2) Challenges in LP Cell Experiments:

      One of the most critical issues you raised was the lack of validation in LP cells, particularly concerning the role of ELF3 in these cells. We are acutely aware of the significance of this point. Following your review, we made extensive efforts to isolate and culture LP cells from both BRCA1-proficient and BRCA1-deficient patient samples. We tried various methods and invested substantial resources, including time, manpower, and materials, to establish a reliable protocol for isolating and cultivating LP cells in vitro. Unfortunately, despite our best efforts, we were unable to obtain a sufficient number of high-quality cells to generate solid and reproducible results.

      The challenges we faced included the limited availability of patient tissues and the technical difficulties in consistently obtaining viable LP cells. Given the already extended timeline for the revision of this manuscript, we regretfully decided to forgo further attempts to perform these critical experiments with LP cells. In the revised manuscript, we have explicitly addressed the limitations of our cell models and provided a detailed discussion of the challenges faced in isolating LP cells. Despite these limitations, we believe that the consistency between our results and LP cell sequencing data provides valuable insights and a solid foundation for future studies.

      (3) Data Presentation Improvements:

      In response to your feedback, we have also made significant improvements to the data presentation in our manuscript. We updated and optimized figure legends and narrative sections to ensure that the data are clearly and accurately conveyed. These changes aim to enhance the readability and comprehensibility of our findings.

      We greatly appreciate your valuable feedback, which has significantly contributed to the improvement of our manuscript. Your suggestions have helped us refine our arguments and present a more robust and nuanced interpretation of our data. 

      Thank you once again for your critical and constructive review. We look forward to your feedback on our revised manuscript.

      Recommendations for the authors:  

      Reviewer #1 (Recommendations For The Authors):  

      As such, in addition to consolidating the role of ELF3 in promoting cell tolerance to replicative stress (or in suppressing genomic instability), I have a few comments the authors should consider to improve their manuscript.  

      (1) I am not sure how cells have gained a growth advantage if they were arrested (Line 105-106). Perhaps the authors can elaborate.

      Thanks for pointing this out and we are sorry for the misleading statement. We have revised the manuscript and would like to clarify that “survival advantage” may be more accurate than “growth advantage”, and since long-term DOX treatment led to decreased cell survival indicated by decreased number of colonies in Supplemental Fig. S1D, thus many cells died during DOX treatment. Therefore, the cells able to survive throughout DOX treatment and being collected for sequencing may have gained survival advantage compared to their counterparts who fail to survive.  

      (2) Figure 3D - From Western blotting of ELF3, forced expression of E2F6 does not appear to "block" HU-induced ELF3 up-regulation, but merely down-regulate basal level of ELF3, with the effect of HU still notable.

      Thanks for the comment and we agree that E2F6 down-regulate ELF3 baseline expression levels and did not fully block ELF3 up-regulation. After calculating the foldchange after E2F6 overexpression, we did confirm that E2F6 overexpression still partially block HU-induced ELF3 up-regulation, with foldchange from 3.32 to 2.40, supporting our conclusion that HU-induced ELF3 upregulation is regulated by ATRChk1-E2F axis. It does, however, cannot be excluded that E2F6 also regulates ELF3 expression in other replication stress-independent ways, and we have revised the manuscript accordingly. 

      (3) Figure 3J & K - In my opinion, if BRCA1 knockdown were more efficient it remains formally possible that co-depletion of BRCA1 and GATA3 may exhibit additive effects in up-regulating ELF3 mRNA level.

      Thank you for the comment. Actually, the BRCA1 knockdown efficiency in Figure 3J was shown in Supplemental Fig. S3B, and notably both BRCA1 and GATA3 knockdown were numerically more efficient in the double-knockdown group than in the single-knockdown group, individually. Thus, the higher ELF3 up-regulation in double-knockdown group in Figure 3J could be cause by the superior knockdown efficiency of both BRCA1 and GATA3. Nonetheless, we agree that it might be possible that BRCA1 and GATA3 still have separate functions in this experimental setting and marginal additive effect may exist, and the manuscript was revised accordingly.

      (4) Figure 4 - Perhaps the authors can change its title to better summarise the findings. Cell sensitivity assays and xenograph experimentations may not necessarily relate to genomic instability.

      Thank you for the great suggestion. To summarize the results more accurately, we have revised the title as “ELF3 can help cells tolerate replication stress and sustain cell survival”.

      (5) Figure 5B&C - It would be important to document the time-dependent resolution of HU-induced DNA lesions by including additional time-points before, during, and after HU treatment.

      We appreciate the suggestion to include additional time points to document the timedependent resolution of HU-induced DNA lesions. In our experiments, we observed that ELF3 knockdown leads to genomic instability both in the presence and absence of HU treatment. Specifically, Figure 5A and Figure S5 demonstrate that ELF3 knockdown increases genomic instability without HU treatment, indicating its role in maintaining genomic stability under normal conditions. On the other hand, Figure 5B, 5C, and 5D show that ELF3 knockdown under HU-induced replication stress further exacerbates genomic instability. This observation aligns with our finding that ELF3 expression increases in response to replication stress, suggesting its critical role in maintaining replication homeostasis under such conditions. 

      6) Figure 5F&I - Which ELF3 siRNA was used in these experimentations? Since the authors did not exclude off-target effects perhaps it may be worthwhile to include both ELF3 siRNAs for Panel F.

      Thanks for your advice. The qPCR (Figure 5F) and DNA fiber assay (Figure 5I) were using siELF3-4 siRNA. And we repeat the qPCR experiments for Panel F using siELF3-5 siRNA (Supplement Fig. S5B).

      We sincerely thank you for your thoughtful feedback and constructive suggestions. Addressing these points has strengthened our manuscript, and we are grateful for the opportunity to refine and clarify our work. We appreciate your critical evaluation and look forward to further constructive dialogue.

      Reviewer #2 (Recommendations For The Authors):  

      (1) The data driving the hypothesis uses gene expression signatures as an indirect measure of replication stress. This is a critical concern.

      a. At this time, numerous gene expression signatures have been reported to be biomarkers of replication stress. Therefore, it would be valuable to apply additional gene expression signatures to examine the performance and the overlap in the results.

      The recent work by Takahashi et al., 2022 (https://pubmed.ncbi.nlm.nih.gov/36381660/) provides a signature that was derived independently and offers one that can be used to assess the performance of the signatures and stability of the conclusions.

      Thank you for the valuable suggestion. We have done the replication stress evaluation of mammary cell subgroups using the Repstress score developed in the work you mentioned. The result showed that LP cells have trends of higher replication stress compared with other subgroups, though no statistical significance. This result, consistent with our previous analysis, indicated that LP cells have higher trends of replication stress levels. And we have added this data as the last line of Figure 1A in revised vision.

      Author response image 1.

      Replication stress pathway scores of different human normal mammary cell  populations. The gene expression data were from Lim et al. (3).

      b. A direct measure of replication stress in LP cells would be important to confirm the gene expression signature. Therefore, performing immunostaining for markers of replication stress (eg gamma-H2AX foci, DNA fiber assays) would provide more direct data to support the assertions.

      Thank you for this suggestion and we totally agree that experiments revealing replication stress levels by investigating common markers, e.g., gamma-H2AX foci, DNA fiber assays, will provide vital evidence for our hypothesis. However, since our last response, we have been diligently trying to obtain LP cells for these experiments but encountered technical challenges while attempting to isolate and culture LP cells in vitro. 

      In the discussion part, we have revised the manuscript to emphasize that the data obtained from MCF10A should be interpreted with caution and there are certain gaps between the cell models and LP cells.

      (2) The depth of single-cell sequencing can often be limiting. Therefore, a supplementary table listing the genes used for the replication stress signature and the frequency that they are observed in the single-cell sequencing data. This is needed to ensure that the replication stress score does not reflect a small subset of the replication stress signature genes.

      Thanks very much for this evaluable suggestion. We have provided an expression matrix of genes for the replication stress signature in the revised version (Supplementary Table S1), And we also calculated the average expression level of each gene in the cells. As shown in Author response image 2, these genes expressed relatively low at the single-cell level (with counts≤10), The expression differences among genes are relatively small. Thus, we excluded the possibility that several high-expressed genes significantly affect the replicative stress score.

      Author response image 2.

      Average counts of Top 50 genes for the replication stress signature

      (3) As only 4 BRCA mutation carriers are analyzed, it is critical that the mutations be reported for these individuals because pathogenic variants differ in their effects and interactions with the DNA repair machinery in cells.

      Thanks for the suggestion and the information of 4 BRCA1 mutant carriers were added in Supplemental Table S2.

      (4) The figures throughout lack critical details making it difficult to evaluate. Figure 1A states that these are "replication stress pathway scores..." but there is no evaluation of levels of statistical differences. The heat map has what appears to be a log unit score between +2 and -2 but it is unclear whether it is log2 or log10 or some other unit. In 1B, the replication stress scores are visualized as relative values between 0 and 0.1, but there is no indication of what this means or whether there is a statistically significant difference in the levels among the populations. As tumors are composed of multiple cell types, it should be stated how the "tumor cells" are uniquely identified in the figure legend. The lack of critical information is common across many of the figures making review frustratingly difficult.

      Thanks for the suggestion. We have added the statistical analysis and scale in Figure 1A legend. For Figure 1B, replication stress was calculated by sum of replication stress gene expression and presented as ln value. We have provided a quantitative figure and statistical tests (by Mann-Whitney) of replication stress scores for various cell types (Supplementary Figure 1A). 

      In addition, we added details of identification of tumor cells in the method section in the revised manuscript. Briefly, the adjacent normal breast sample served as a control to filter various types of normal cells from tumor samples. the normal cells from the tumor sample were merged with the same types of normal cells from adjacent normal breast samples, leaving one cell cluster only generalized by tumor sample. These tumor specific clusters were considered as malignant cell populations. We further found that the malignant cell population showed higher UMI counts than the normal cell populations, consistent with active metabolism in the malignant cells. More importantly, ER, PR, and HER2 expression of the malignant cells in each case were exactly matched with the clinical records. Finally, we utilized InferCNV to validate malignant cells subset as higher copy number alterations (CNAs) detected in the malignant cells compared with normal cells.

      (5) The hypothesis states that the LP cells are uniquely sensitive to deficiency in BRCA1 compared to other cells. However, the authors use knockdown of BRCA1 in MCF10A cells which are generally considered to be basal cells and not LP cells.

      Thanks for the comment. We totally agree that MCF10A cannot reflect the LP features and was mainly used as a normal mammary cell line model. We have tried to obtain human LP to perform some experiments but have all failed due to the cell vulnerability and difficult to be passed on in vitro. The gap between MCF10A and LP cells was stressed in the discussion part.

      (6) Figure 2, the number of samples being compared is not listed for most of the panels. It appears that ELF3 is enriched in subsets of breast cancers, but much of the data is not focused on BRCA1-deficient tumors. Therefore, the data appears to show that ELF3 expression is more of a generalized feature of TNBCs (which has been reported previously) and dilutes the support for the hypothesis. Therefore, panels C-G raise concerns regarding the overall hypothesis that LP cells are the cell type that is affected.

      Thanks for the suggestion. We have added the number of samples in Figure 2 legends.

      Our analysis focus on basal subtype because of the well-known relationship between BRCA1 deficiency and this subtype. Our results demonstrate the association between ELF3 expression and basal, TNBC, as well as HER2+ subtype, consistent with previous reports. Since TNBC also has high replication stress levels (NPJ Breast Cancer. 2020 Sep 7;6:40.), ELF3 upregulation in this subtype may not be solely due to BRCA1 deficiency, and we totally agree that this analysis may dilute the relationship between ELF3 and BRCA1. We have revised the discussion part to be more precise on this. 

      (7) Figure 3 provides experimental support for the hypothesis. While panel A is of interest, the legend lacks any description beyond "normal mammary tissue" and that there are non-carriers and carriers of BRCA1 mutations. Is this from bulk RNAseq data or single-cell RNAseq data? How many carriers and how many noncarriers? Panel E is ENCODE data from MCF7 cells that are ER+ luminal subtype so it is unclear if this is relevant to the LP cells that are the focus of the hypothesis.

      Thanks for the comments. Figure 3 panel A was from single-cell RNAseq data, including 3 BRCA1 WT patients and 4 BRCA1 mutant patients. All cells (normal cells and tumor cells) are involving, and ELF3 expression was normalized by reads in each cell. We have added this information in the figure legend. 

      It has been difficult to obtain ENCODE data in LP cells. The effect of E2F1 on regulation of ELF3 was validated in MCF10A cells by experiment and consistent with MCF7 ENCODE data, thus we suggest this effect can be conserve in mammary cells, but further confirmation in LP cells is needed. We have revised the manuscript to note that.

      (8) In Figure 4, the authors use BRCA1-deficient breast cancer cells to show the reliance on ELF3 and suggest that this is specific to this genetic lesion and not other subtypes. However, there is no data to show that this is not observed using ER+ cells or TNBC that are not BRCA1-deficient cell lines or models.

      Thanks for pointing this out. As ELF3 knockdown in MCF10A resulted in increased genomic instability (Supplement Fig S5) and less capability to resolve replication stress (Figure 5B), we believe that ELF3 can help deal with replication stress not specifically in BRCA1-mutant cells, but also normal mammary cells, and also multiple cell lines with distinct backgrounds as suggested in Figure 4G, 4H and Supplement Fig S4G. The special link between ELF3 and BRCA1 is reflected by ELF3 significant upregulation upon BRCA1 deficiency, but not ELF3 downstream functions. 

      (9) Figure 5 provides the first direct evaluation of biomarkers of replication stress (gamma H2AX, 53BP1). DNA fiber assays provide the most direct evaluation of replication fork kinetics, and therefore, replication stress. The knockdown of BRCA1 and ELF3 appear to phenocopy one another in the HCC1937, but there is no other cell type to show whether this is specific for BRCA1-deficient cells. For example, the MCF7 cells show E2F1 binding to ELF3 (Figure 3E) and may show replication stress upon knockdown of ELF3. Without testing this, the authors cannot suggest that the effect is linked to BRCA1 status. The authors do not identify the BRCA1 mutation in these cells and whether there is homozygous loss. Similarly, the mutational status in the SUM149PT cells should also be stated. These need to be added to aid interpretation of the results.

      Thank you for the constructive advice. We have added information regarding BRCA1 status of HCC1937 and SUM149PT. As discussed before, the results from Figure 4G and 4H suggest that ELF3 expression is associated with sensitivity to replicationstress-inducing-drugs across many cell lines. Thus ELF3 can maintain the stability of DNA replication is not specific to BRCA1-deficient cells. The reliance of ELF3 in BRCA1-deficiency we proposed is mainly focus on the fact that ELF3 is upregulated in BRCA1 deficient conditions, plus ELF3 may help cells tolerate replication stress during the transformation, therefore the resulted tumor cells-that is BRCA1-deficient breast cancer cells-may be more sensitive when losing ELF3 expression.

      (10) While the data in Figure 6 are valuable extensions of the gene signature derived from the MCF10A cells with BRCA1 knockdown, only 2 BRCA1 carriers are reported. As carriers bear heterozygous mutations in BRCA1, haplo-insufficiency would be necessary to generate the signature. The authors do note the publication by Panthania et al, but there are relatively few examples of haploinsufficiency. It should be noted that Sedic et al., 2015 also suggested haploinsufficiency in breast epithelial cell cultures from BRCA1 heterozygotes which appears to cause premature senescence, possibly via replication stress. However, this was observed in the basal epithelial cells. Therefore, this appears to be a feature of the breast epithelium more generally and is not enriched or limited to the LP cells.

      Thanks very much for your valuable suggestion. We have revised the discussion part to involve this important work and we fully agree that BRCA1 deficiency can cause replication stress not limited to LP cells. While in fact, the point we would like to address in Figure 6 is that BRCA1 deficiency modules the transcription profile towards LP-like cells, but not other-subtype-like cells, in normal mammary cells. We observed surprisingly similar profile between BRCA1-deficient cells and LP cells, suggesting there might be an inherent function of BRCA1 to mediate LP genes transcription. Furthermore, the data indicate that ELF3 has a tighter association with LP genes than other recognized LP-specific transcription factors like ELF5 and EHF, which are of the same family of ELF3. This result is intriguing since ELF3 can be upregulated by BRCA1 deficiency and replication stress. We assume that ELF3 could be a transcription node downstream of BRCA1 deficiency and modulate LP genes expression, and this process might be limited to LP cells since ELF3 has the highest expression levels in LP. Nonetheless, this hypothesis is also needed to be validated in LP cells by experiments. 

      We would like to express our deepest gratitude to the reviewers for their thorough and constructive feedback. Their insightful comments have been invaluable in guiding the revisions of our manuscript, helping us to clarify our hypotheses and strengthen the presentation of our findings. While we encountered some challenges, particularly with the isolation and culturing of LP cells, we made significant efforts to address the reviewers' concerns to the best of our ability. We have updated our manuscript accordingly, ensuring that all issues raised have been addressed comprehensively. We believe that these revisions have substantially improved the quality and clarity of our work, and we are excited to share our findings with the scientific community. Thank you once again for the opportunity to revise our manuscript, and we look forward to your feedback on the updated version.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This study analyzed biomarker data from 28 subjects with geographic atrophy (GA) in a Phase I/II clinical trial of PPY988, a subretinal AAV2 complement factor I (CFI) gene therapy, to evaluate pharmacokinetics and pharmacodynamics. Post-treatment, a 2-fold increase in the vitreous humor (VH) FI was observed, correlating with a reduction in FB breakdown product Ba but minimal changes in other complement factors. The aqueous humor (AH) was found to be an unreliable proxy for VH in assessing complement activation. In vitro assays showed that the increase in FI had a minor effect on the complement amplification loop compared to the more potent C3 inhibitor pegcetacoplan. These findings suggest that PPY988 may not provide enough FI protein to effectively modulate complement activation and slow GA progression, highlighting the need for a thorough biomarker review to determine optimal dosing in future studies.

      Strengths:

      This manuscript provides critical data on the efficacy of gene therapy for the eye, specifically introducing complement FI expression. It presents the results from a halted clinical trial, making sharing this data essential for understanding the outcomes of this gene therapy approach. The findings offer valuable insights and lessons for future gene therapy attempts in similar contexts.

      Weaknesses:

      No particular weaknesses. The study was carefully performed and limitations are discussed.

      I have just some concerns about the methodology used. The authors use the MILLIPLEX assays, which allow for multiplexed detection of complement proteins and they mention extensive validation. How are the measurements with this assay correlating with gold standard methods? Is the specificity and the expected normal ranges preserved with this assay? This also stands for the Olink assay. Some of the proteins are measured by both assay and/or by standard ELISA. How do these measurements correlate?

      The authors thank the reviewer for the positive response. Regarding the ELISA assays used to measure the array of complement proteins described, these were extensively validated for the following parameters: specificity, intra-assay and inter-assay precision, accuracy, stability, reference range, and parallelism. All assays were validated in plasma, vitreous and aqueous humour. Due to the limited volume and availability of ocular fluids from individuals in the study, validation in vitreous and aqueous matrices was performed using a pool of several samples from post-mortem donors. At the time this study was initiated, the Millipore Luminex complement panels and the Quidel C3a and Ba EIA were the most sensitive assays and the only commercially available options capable of measuring the proteins of interest in the context of limited vitreous and aqueous humor sample. The concentrations measured were observed at similar ranges as those published in the literature using assays in distinct patient populations e.g. in (Mandava et al, Invest Ophthalmol Vis Sci, 2020).

      Measurements from vitreous and aqueous from subject samples were deemed reportable if they were within the quantifiable ranges defined for these sample types during the validation (coefficient of variation of 20%, or 30% when results were below the lower limit of quantification but above limit of detection). Notably, given the limited amount of biomarker data due to small sample size, we share results from outlier biomarker measurements, to illustrate the heterogeneity in sample quality. We further publish plasma sample biomarker results in supplemental table 5 wherein complement protein concentrations can be observed and compared to normal ranges in the literature.

      Adding confidence to the robustness of our assays was the observation that some of the complement proteins quantified by standard assay (e.g. plate and bead-based ELISAs) were also measured by the OLINK assay, and there was a general trend observed for positive correlation between results from both assays for FI levels post-treatment. However, we did not provide detailed correlative statistical analyses for further complement proteins as OLINK findings were deemed highly exploratory and hypothesis generating, and because the OLINK assay produced normalised results which are challenging to directly compare to ELISA results that were absolute.

      Reviewer #2 (Public Review):

      Summary:

      The results presented demonstrate that AAV2-CFI gene therapy delivers long-term and marginally higher FI protein in vitreous humor that results in a concomitant reduction in the FB activation product Ba. However, the lack of clinical efficacy in the phase I/II study, possibly due to lower in vitro potency when compared to currently approved pegcetacoplan, raises important considerations for the utility of this therapeutic approach. Despite the early termination of the PPY988 clinical development program, the study achieved significant milestones, including the implementation of subretinal gene therapy delivery in older adults, complement biomarker comparison between serial vitreous humor and aqueous humor samples and vitreous humor proteomic assessment via Olink.

      Strengths:

      Long-term augmentation of FI protein in vitreous humor over 96 weeks and reduction of FB breakdown product Ba in vitreous humor suggests modulation of the complement system. Developed a novel in vitro assay suggesting FI's ability to reduce C3 convertase activity is weaker than pegcetacoplan and FH and may suggest a higher dose of FI will be required for clinical efficacy. Warn of the poor correlation between vitreous humor and aqueous humor biomarkers and suggest aqueous humor may not be a reliable proxy for vitreous humor with regard to complement activation/inhibition studies.

      Weaknesses:

      The vitrectomy required for the subretinal route of administration causes a long-term loss of total protein and may influence the interpretation of complement biomarker results even with normalization. The modified in vitro assay of complement activation suggests a several hundred-fold increase in FI protein is required to significantly affect C3a levels. Interestingly, the in vitro assay demonstrates 100% inhibition of C3a with pegcetacoplan and FH therapeutics, but only a 50% reduction with FI even at the highest concentrations tested. This observation suggests FI may not be rate-limiting for negative complement regulation under the in vitro conditions tested and potentially in the eye. It is unclear if pharmacokinetic and pharmacodynamic properties in aqueous humor and vitreous humor compartments are reliable predictors of FI level/activity after subretinal delivery AAV2-CFI gene therapy.

      The authors thank the reviewer for the positive response and we agree that a limitation of the biomarker strategy for ocular gene therapy delivered to the retinal tissues is inferring PK/PD from vitreous and aqueous samples, which are the fluid sample compartments accessible from subjects available to measure molecular treatment response. We agree that these compartments may not accurately represent sub-retinal and tissue level complement turnover. In the discussion, line 508, we state: ‘Overall, the data suggests that fully functional FI is being secreted into the VH, but the regulatory effects on the level of Ba may be representative of convertase formation in the VH and not the macula retina/RPE nor the choroid. To validate this hypothesis, one approach would be to conduct vitreal sampling using an effective drug targeting C3 for GA in a larger cohort’.

      However, the observation of elevation of FI in VH (and AH) post treatment, and changes in levels of downstream complement proteins that align with prior knowledge of control of alternative pathway activation, is compelling evidence that these measurements reflect modest but direct consequences of an FI-gene therapy that was delivered to the subretinal space. We add to the discussion, line 479: ‘the findings of elevated FI in the VH after sub-retinally delivered CFI gene therapy and changes in complement pathway proteins post-treatment build confidence that VH matrix is at least partially reflecting the complement system at the retinal layers and treatment site, and is a valid biomarker for PK/PD insights in response to treatment.’

      Furthermore, the observation of moderately raised FI levels in modelled VH post treatment being insufficient to control CS activation in vitro accords with the lack of clinical response observed at phase II. We note that measuring FI and complement biomarkers in retinal tissues from treated eyes at post-mortem would be one way to explore the PK/PD effects from AAV2-FI gene therapy.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Hallam et al describes the analysis of various biomarkers in patients undergoing complement factor I supplementation treatment (PPY988 gene therapy) as part of the FOCUS Phase I/II clinical trial. The authors used validated methods (multiplexed assays and OLINK proteomics) for measuring multiple soluble complement proteins in the aqueous humour (AH) and vitreous humour (VH) of 28 patients over a series of time points, up to and including 96 weeks. Based on biomarker comparisons, the levels of FI synthesised by PPY988 were believed to be insufficient to achieve the desired level of complement inhibition. Subsequent comparative experiments showed that PPY988-delivered FI was much less efficacious than Pegceptacoplan (FDA-approved complement inhibitor under the name SYFORVE) when tested in an artificial VH matrix.

      Strengths:

      The manuscript is well written with data clearly presented and appropriate statistics used for the analysis itself. It's great to see data from real clinical samples that can help support future studies and therapeutic design. The identification that complement biomarker levels present in the AH do not represent the levels found in the VH is an important finding for the field, given the number of complement-targeting therapies in development and the desperate need for good biomarkers for target engagement. This study also provides a wealth of baseline complement protein measurements in both human AH and VH (and companion measurements in plasma) that will prove useful for future studies.

      Weaknesses:

      Perhaps the conclusions drawn regarding the lack of observed efficacy are not fully justified. The authors focus on the hypothesis that not enough FI was synthesised in these patients receiving the PPY988 gene therapy, suggesting a delivery/transduction/expression issue. But beyond rare CFI genetic variants, most genetic associations with AMD imply that it is a FI-cofactor disease. A hypothesis supported by the authors' own experiments when they supplement their artificial VH matrix with FH and achieve a significantly greater breakdown of C3b than achieved with PPY988 treatment alone. Justification around doubling FI levels driving complement turnover refers to studies conducted in blood, which has an entirely different complement protein profile than VH. In Supplemental Table 5 we see there is approx. 10-fold more FH than FI (533ug/ml vs 50ug/ml respectively) so increasing FI levels will have a direct effect. Yet in Supplemental Table 3 we see there is more FI than FH in VH (608ng/ml vs 466ng/ml respectively). Therefore, adding more FI without more co-factors would have a very limited effect. Surely this demonstrates that the study was delivering the wrong payload, i.e. FI, which hit a natural ceiling of endogenous co-factors within the eye?

      See response to reviewer 3’s review after reviewer 3 recommendations section below.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      The authors present strong evidence using validated complement biomarker assays and comprehensive proteomic profiling that support their findings. The presentation of complement biomarker data in vitreous humor and aqueous humor after FI augmentation is presented in a clear and concise format. The direct comparison of complement biomarkers in vitreous humor and aqueous humor from the same patients and demonstrating similarities and differences is important for the nascent complement gene therapy field. Developing a novel in vitro complement model and comparing pegcetacoplan, FH, and FI inhibitors provides the field with a valuable assay to benchmark other complement therapeutics. As currently designed, the in vitro assay supports why FI augmentation did not contribute to clinical success. It also suggests that non-physiological concentrations of FI protein (over 100 µg/mL) maximally inhibit C3a signal by ~50%, whereas both pegcetacoplan and FH reduce the signal by 100%. Does this suggest that CFI is not an appropriate therapeutic target to control complement overactivation in the eye?

      We agree with the reviewer that the new data from the novel in vitro assay coupled with the clinical findings from the phase II gene therapy trial does now suggest FI is less attractive as a therapeutic target for controlling complement activation in the retinal tissues of subjects with Geographic Atrophy.

      Reviewer #3 (Recommendations For The Authors):

      I think the authors have done a great job collecting and analysing these clinical samples and elucidating the baseline complement protein profile in both the AH and VH. I only have minimal suggested changes.

      Perhaps a more direct discussion around the limitations of adding more FI into environments where there is no excess of FI-cofactors present? And a discussion around the limitations of VH (and VA for that matter) biomarker sampling for a disease that primarily affects the neurosensory retina and outer blood/retinal barrier: perhaps the landscape of complement proteins is different yet again (although, admittedly, impossible to sample in a patient)? Finally, would it not have been better to perform complement activation experiments using the VH of treated patients directly rather than creating an artificial VH matrix (there may, or may not, be a couple of things in human VH that directly affect complement turnover...)?

      We thank the reviewer for the supportive comments. This study is the first to describe FI and FH levels and respective ratios in vitreous humour (plus aqueous and plasma) from GA subjects, before and after sub-retinal gene therapy. It is compelling to observe that in the VH the levels of FI are greater than FH, the primary fluid phase co-factor for FI enzymatic activity. This new information does indeed argue against further FI supplementation (using gene therapy) being of added benefit to controlling the complement system in the broader population in individuals with Geographic Atrophy. We note that at the start of the clinical development of GT005/PPY988 AAV2-FI gene therapy, there was limited information on FI and FH levels in AMD in ocular fluids to inform the pharmacodynamics of complement activation. Now, by running the FOCUS phase I clinical trial and measuring the complement biomarker data using validated assays we have added to our understanding on the levels and ratio of FI to FH and other complement proteins in a larger number of GA subjects’ ocular samples.  We report the levels of complement proteins measured in ocular and systemic samples, to show the ranges and also the differences in ratios between the different matrices.   

      Regarding the statement that FI supplementation could likely be ineffective due to limited FH cofactor; FH is not the only co-factor that FI may partner with at cell surfaces to become enzymatically active (others include MCP (CD46) and CR1 (CD35), although the latter is known to be of limited expression in the eye), as such, it is certainly true that other proteins may be present in the tissue altering the kinetics of FI’s activity after sub-retinal gene-therapy. In addition, the ratio between FI and FH detected in the VH may not be the same as in retinal tissue. As such, we agree that drawing insights from biomarkers in the VH may not fully reflect the disease processes and treatment response at the retinal cell layers, but it is the closest fluid sample available to sample tissue released soluble proteins. We acknowledge that VH biomarkers will not fully capture retinal disease processes and treatment responses, but due to their proximity, will reflect retina-released soluble proteins. The findings of elevated FI in the VH after sub-retinally delivered CFI gene therapy and changes in complement pathway proteins post-treatment build confidence that VH matrix is at least partially reflecting the complement system at the retinal layers and treatment site, and is a valid biomarker for PK/PD insights in response to treatment. We agree modelling different inhibitor effects on complement activation directly using subject’s vitreous would be informative, but this was not possible due to the limitations of very small sample volume.

      We add several sentences to the discussion regarding the points above. Line 473: ‘Notably, that FI does not reduce C3a breakdown to baseline even at supermolecular concentrations suggests cofactor limitation that might be more pronounced in VH given FH is not in excess of FI as is the case in blood 27. Moreover, there are additional cell-bound cofactors for FI that may be present in retinal tissue that are not present in the VH and could further alter the kinetics of the assay, such as MCP (CD46) albeit with disease related changes observed 37. However, the findings of elevated FI in the VH after sub-retinally delivered CFI gene therapy and changes in complement pathway proteins post-treatment build confidence that VH matrix is at least partially reflecting the complement system at the retinal layers and treatment site, and is a valid biomarker for PK/PD insights in response to treatment.’

      Minor comments:

      Line 237: Missing parenthesis at the end of the sentence

      Manuscript updated.

      Line 435: Missing secondary parenthesis after .....Figure 3A)......

      Manuscript updated.

      Line 536: I don't think suggesting the addition of FHR proteins into the neurosensory retina/VH is such a good idea

      The reference to FHRs has been clarified in the manuscript, line 558. The authors note that FHR dimerization domains have been engineered to dimerize Factor H constructs increasing half-life and potency for drugs currently in development.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Chlamydia spp. has a biphasic developmental cycle consisting of an extracellular, infectious form called an elementary body (EB) and an intracellular, replicative form known as a reticular body (RB). The structural stability of EBs is maintained by extensive cross-linking of outer membrane proteins while the outer membrane proteins of RBs are in a reduced state. The overall redox state of EBs is more oxidized than RBs. The authors propose that the redox state may be a controlling factor in the developmental cycle. To test this, alkyl hydroperoxide reductase subunit C (ahpC) was overexpressed or knocked down to examine effects on developmental gene expression. KD of ahpC induced increased expression of EB-specific genes and accelerated EB production. Conversely, overexpression of ahpC delayed differentiation to EBs. The results suggest that chlamydial redox state may play a role in differentiation.

      Strengths:

      Uses modern genetic tools to explore the difficult area of temporal gene expression throughout the chlamydial developmental cycle.

      Weaknesses:

      The environmental signals triggering ahpC expression/activity are not determined.

      Thank you for your comments. Our data and those of others have shown that ahpC is expressed as a mid-developmental cycle gene (i.e., when RBs predominate in the population). This is true of most chlamydial genes, and the factors that determine developmental expression are not fully understood. As we noted in the Discussion, Chlamydia lacks AhpF/D orthologs, so it is not clear how AhpC activity is regulated. Related to determining environmental signals that trigger activity of AhpC, then this is a non-trivial issue in an obligate intracellular bacterium. Our assumption is that AhpC is constitutively active and that the increasing metabolic production of ROS eventually overcomes the innate (and stochastic) activity of AhpC to handle it, hence the threshold hypothesis. Importantly, the stochasticity is consistent with what we know about secondary differentiation in Chlamydia. We have tried to clarify these points in the Discussion.

      Reviewer #2 (Public Review):

      The factors that influence the differentiation of EBs and RBs during Chlamydial development are not clearly understood. A previous study had shown a redox oscillation during the Chlamydial developmental cycle. Based on this observation, the authors hypothesize that the bacterial redox state may play a role in regulating the differentiation in Chlamydia. To test their hypothesis, they make knock-down and overexpression strains of the major ROS regulator, ahpC. They show that the knock-down of ahpC leads to a significant increase in ROS levels leading to an increase in the production of elementary bodies and overexpression leads to a decrease in EB production likely caused by a decrease in oxidation. From their observations, they present an interesting model wherein an increase in oxidation favors the production of EBs.

      Major concern:

      In the absence of proper redox potential measurements, it is not clear if what they observe is a general oxidative stress response, especially when the knock-down of ahpC leads to a significant increase in ROS levels. Direct redox potential measurement in the ahpC overexpression and knock-down cells is required to support the model. This can be done using the roGFP-based measurements mentioned in the Wang et al. 2014 study cited by the authors.

      Thank you for this suggestion. It is definitely something that we are looking to implement. However, our current vectors don’t allow for roGFP2 in combination with inducible expression of a gene of interest. We will need to completely redesign our vectors, and, in Chlamydia, the validation of such new vectors together with ahpC OE or KD may literally take a year or longer.

      In lieu of this, we used the CellRox redox reactive dye to image live chlamydiae during normal growth or ahpC KD. During ahpC KD, these organisms are clearly much brighter than the control, uninduced conditions. These data are included as new Figure 5 to go along with the data we previously reported from the plate reader measurements. These data also clearly indicate that the readings we observed are from Chlamydia and not the host cell.

      As far as a general oxidative stress response, Chlamydia lacks any transcriptional regulators akin to OxyR. The response we’ve measured, earlier expression of genes associated with secondary differentiation, would be an odd stress response not consistent with a focused program to respond to oxidative stress. We added new RNAseq data further showing this effect of a global earlier increase in late gene transcripts.

      Reviewer #3 (Public Review):

      Summary:

      The study reports clearly on the role of the AhpC protein as an antioxidant factor in Chlamydia trachomatis and speculates on the role of AhpC as an indirect regulator of developmental transcription induced by redox stress in this differentiating obligate intracellular bacterium.

      Strengths:

      The question posed and the concluding model about redox-dependent differentiation in chlamydia is interesting and highly relevant. This work fits with other propositions in which redox changes have been reported during bacterial developmental cycles, potentially as triggers, but have not been cited (examples PMID: 2865432, PMID: 32090198, PMID: 26063575). Here, AhpC over-expression is shown to protect Chlamydia towards redox stress imposed by H2O2, CHP, TBHP, and PN, while CRISPRi-mediated depletion of AhpC curbed intracellular replication and resulted in increased ROS levels and sensitivity to oxidizing agents. Importantly, the addition of ROS scavengers mitigated the growth defect caused by AhpC depletion. These results clearly establish the role of AhpC affects the redox state and growth in Ct (with the complicated KO genetics and complementation that are very nicely done).

      Weaknesses:

      However, with respect to the most important implication and claims of this work, the role of redox in controlling the chlamydial developmental cycle rather than simply being a correlation/passenger effect, I am less convinced about the impact of this work. First, the study is largely observational and does not resolve how this redox control of the cell cycle could be achieved, whereas in the case of _Caulobacte_r, a clear molecular link between DNA replication and redox has been proposed. How would progressive oxidation in RBs eventually trigger the secondary developmental genes to induce EB differentiation? Is there an OxyR homolog that could elicit this change and why would the oxidation stress in RBs gradually accumulate during growth despite the presence of AhpC? In other words, the role of AhpC is simply to delay or dampen the redox stress response until the trigger kicks in, again, what is the trigger? Is this caused by increasing oxidative respiration of RBs in the inclusion? But what determines the redox threshold?

      Thank you for your comments. As the reviewer notes, our work clearly demonstrates that AhpC acts as an antioxidant in Chlamydia trachomatis. Further, we have shown that transcription of the late cycle genes is altered upon altered activity of AhpC, which acts as a proof of concept that redox is (one of) the key factor(s) controlling developmental cycle progression in Chlamydia. Our new RNAseq data indicate that a broad swath of well characterized late genes is activated, which contradicts the argument that what we’ve measured is a stress response (unless activation of late genes in Chlamydia is generally a stress response (not the case based on other models of stress) – in which case we would not be able to differentiate between these effects). We hypothesize that ROS production from the metabolic activities of RBs serves as a signal to trigger secondary differentiation from RBs to EBs. How this exact threshold is determined is currently unknown as Chlamydia does not have any annotated homolog for OxyR. It is beyond the scope of the present manuscript to identify and then characterize what specific factor(s) control(s) this response. We fully anticipate that multiple factors are likely impacted by increasing oxidation, so dissecting the exact contributions of any one factor will represent (a) potential separate manuscript(s). Nonetheless, this remains an overarching goal of the lab yet remains challenging given the obligate intracellular nature of Chlamydia. Strategies that would work in a model system, like Caulobacter, that can be grown in axenic media are not easily implemented in Chlamydia.

      As we noted above in another response, ahpC is transcribed as a mid-cycle gene with a peak of transcription corresponding to the RB phase of growth. We hypothesize that the gradual accumulation of ROS from metabolic activity will eventually supercede the ability of AhpC to detoxify it. This would result in any given RB asynchronously and stochastically passing this threshold (and triggering EB formation), which is consistent with what we know about secondary differentiation in Chlamydia.

      I also find the experiment with Pen treatment to have little predictive power. The fact that transcription just proceeds when division is blocked is not unprecedented. This also happens during the Caulobacter cell cycle when FtsZ is depleted for most developmental genes, except for those that are activated upon completion of the asymmetric cell division and that is dependent on the completion of compartmentalization. This is a smaller subset of developmental genes in caulobacter, but if there is a similar subset that depends on division on chlamydia and if these are affected by redox as well, then the argument about the interplay between developmental transcription and redox becomes much stronger and the link more intriguing. Another possibility to strengthen the study is to show that redox-regulated genes are under the direct control of chlamydial developmental regulators such as Euo, HctA, or others and at least show dual regulation by these inputs -perhaps the feed occurs through the same path.

      Comparisons to other model systems are generally of limited value with Chlamydia. All chlamydial cell division genes are mid-cycle (RB-specific) genes, just like ahpC. There is no evidence of a redox-responsive transcription factor (whether EUO, HctA, or another) that activates or represses a subset of genes in Chlamydia. Similarly, there is no evidence that redox directly and specifically impacts transcription of cell division genes based on our new RNAseq data. The types of experiments suggested are not easily implemented in Chlamydia, but we would certainly like to be able to do them.

      As it pertains to penicillin specifically, we and others have shown that treating chlamydiae with Pen blocks secondary differentiation (meaning late genes are not transcribed). Effectively, Pen treatment freezes the organism in an RB state with continued transcription of RB genes. What we have shown is that, even during Pen treatment (which blocks late gene transcription), ahpC KD can overcome this block, which shows that elevated oxidation is able to trigger late gene expression even when the organisms are phenotypically blocked from progressing to EBs. The comparison from our perspective to Caulobacter is of limited value.

      This redox-transcription shortcoming is also reflected in the discussion where most are about the effects and molecular mitigation of redox stress in various systems, but there is little discussion on its link with developmental transcription in bacteria in general and chlamydia.

      We have edited the Discussion to include a broader description of the results and included additional citations as suggested by the reviewer (PMID: 32090198, PMID: 26063575). However, we found one suggested article (PMID: 2865432) is not relevant to our study, so we didn’t cite it in our present manuscript. There may have been a typo, so feel free to provide us the correct PMID that can be cited.

      Reviewer #1 (Recommendations For The Authors):

      (1) Line 146. A minor point, but inclusion-forming units directly measure infectious EBs. In some cases, the particle-to-infectivity ratio approaches unity. I don't believe IFUs are a "proxy".

      Following reviewers comment we have modified the statement.

      (2) Figure 2E. Results are normalized to uninduced. The actual number of IFUs in the uninduced should be provided.

      In the revised version of the manuscript, we have provided actual number of IFUs at 24 and 48 hpi in the uninduced condition of both ahpC OE and EV.

      (3) Figures 3B&D. The shades of gray are not possible to distinguish. I'd suggest color or direct labeling.

      Following reviewer’s suggestion, in the latest version of the manuscript we have replaced gray shaded graphs with RGB colored graphs for better visualization and understanding.

      (4) Lines 217-224, Figure 4. Is it possible to get micrographs of the reporter retention in chlamydiae to demonstrate that it is chlamydial ROS levels that are being measured and not cellular?

      Following reviewer’s comment, we performed live-cell microscopy using uninfected HeLa cells and ahpC KD in the uninduced and induced conditions at 24 and 40 hpi. We have created new Fig. 5A with the quantitative ROS measurement graph done by the plate reader (old figure 4 E) and these new 24 hpi/40 hpi microscopy images (Fig 5B and S4).

      (5) The Discussion is overly long and redundant. Large portions of the discussion are simply a rehash of the Results listing by figure number the relevant conclusions.

      Following reviewer’s suggestion, the discussion is modified.

      Reviewer #2 (Recommendations For The Authors):

      (1) In Figure 2, ahpC is significantly overexpressed at 14 hpi. An IFA as in 2B for 14hpi will be useful. This will help to understand how quick the effect of ahpC overexpression is on development.

      We have added 14 hpi IFA of ahpC and EV as part of Fig 2B.

      (2) In Figure 2E, is there a reason that there is no increase in recoverable IFUs between 24h and 48h for the EV?

      The graph in 2E is % of uninduced. For more clarity, we have mentioned absolute IFUs of uninduced samples in the revised manuscript and IFU level at 48 hpi IFU is higher than the 24 hpi.

      (3) In Figure 3, Can relative levels of RB vs EB measured? This will provide a convincing case for the production of more EBs even when only less/more RBs are present. The same stands for Figure 4.

      We assumed that the comment is for Fig. 2 not the Fig. 3 and following reviewer’s constructive suggestion, we have attempted to resolve the issue. We normalized log10 IFUs/ml with log10 gDNA for 24 hpi and added as figure 2F and 4E. This may resolve the reviewer’s concern about the levels of RBs and EBs.

      (4) A colour-coded Figure 3B and D, instead of various shades of grey, will be easy for the reader to interpret.

      Agreed with the reviewer. For better visualization and understanding of the data, we have replaced gray shaded graphs with RGB colored graphs in the latest version of the manuscript.

      Reviewer #3 (Recommendations For The Authors):

      Other comments:

      (1) The first paragraph of the discussion should be deleted. It's not very useful or revealing and just delivers self-citations.

      Following reviewer’s suggestion, we rewrote the discussion.

      (2) The first paragraph of the results section does not present results. It's an intro.

      We incorporated this information into the Intro as suggested.

      (3) Has the redox difference between RBs and EBs been experimentally verified by these authors as depicted and claimed in Figure 1A with the cell-permeable, fluorogenic dye CellROX Deep Red for example? It is important to confirm this for EBs and RBs in this setup.

      The difference between redox status of RBs and EBs is studied and established before by previous studies such as Wang et al., 2014.

      (4) l77. Obligate intracellular alpha-proteobacteria also differentiate ... not only chlamydiae.

      We have modified the sentence.

      (5) l127. Is the redox state altered upon ahpC overexpression?

      The ahpC overexpression strain showed hyper resistance for the tested oxidizing agents (including the highest concentration tested) indicating highly reduced conditions as a result of higher activity of AhpC.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We sincerely thank the Editor and the Reviewers for their time and effort in thoroughly reviewing our manuscript and providing valuable feedback. We hope we have addressed their comments effectively and improved the clarity of our manuscript as a result.

      The major revisions in the updated manuscript are as follows:

      (1) Immunization experiments using mRNA in Syrian hamsters were performed (Supplementary figures 2A, B and C).

      (2) An ELISPOT assay to evaluate cellular immunity in Syrian hamsters inoculated with BK2102 was conducted (Figure 2F).

      (3) IgA titers in BK2102-inoculated Syrian hamsters were successfully measured (Supplementary figure 2B).

      (4) New immunogenicity data for BK2102 in monkeys was additionally included (Supplementary figure 3B).

      (5) The discussion section has been thoroughly revised to integrate the new data.

      These results have been incorporated into the manuscript, and additional text has been added accordingly.

      Below, we provide point-by-point responses to the reviewers’ comments and concerns.

      Public Reviews:

      Reviewer #1:

      (1) A comparative safety assessment of the available m-RNA and live attenuated vaccines will be necessary. The comparison should include details of the doses, neutralizing antibody titers with duration of protection, tissue damage in the various organs, and other risks, including virulence reversal.

      We agree with the Reviewer’s comment regarding the lack of data to compare BK2102 with an mRNA vaccine. Unfortunately, we were unable to obtain commercially available mRNA vaccines for research purposes and could not produce mRNA vaccines of equivalent quality. As a result, a direct comparison of the safety profiles of BK2102 and mRNA vaccines was not possible. To address this, we conducted a GLP study with an additional twelve monkeys to evaluate the safety of BK2102. Following three intranasal inoculations of BK2102 at two-week intervals, no toxic effects were observed in any of the parameters assessed, including tissue damage, respiratory rate, functional observational battery (FOB), hematology, or fever. These results are detailed in lines 115-117.

      Furthermore, we compared the immunogenicity of BK2102 with that of an in-house prepared mRNA vaccine. The mRNA vaccine was designed to target the spike protein of SARS-CoV-2, and its immunogenicity was evaluated in hamsters. When serum neutralizing antibody titers were found to be comparable between the two, intranasal inoculation of BK2102 induced higher IgA levels in nasal wash samples compared to those from hamsters injected intramuscularly with the self-made mRNA vaccine (Supplementary figures. 2A and B, respectively). Additionally, while the mRNA vaccine induced Th1 and Th2 immune responses, as indicated by the detection of IgG1 and IgG2/3 (Supplementary figure. 2C), BK2102 mainly induced a Th1 response in hamsters. These explanatory sentences have been added to the manuscript (lines 140-150).

      (2) The vaccine's effect on primates is doubtful. The study fails to explain why only two of four monkeys developed neutralizing antibodies. Information about the vaccine's testing in monkeys is also missing: What was the level of protection and duration of the persistence of neutralizing antibodies in monkeys? Were the tissue damages and other risks assessed?

      We believe that the reason neutralizing antibody titers were observed in only 2 out of 4 monkeys in the immunogenicity study reported in the original manuscript is that only a single-dose was administered. We measured the neutralizing antibody titers in sera collected from monkeys used in the GLP study and confirmed the induction of neutralizing antibody in all 6 monkeys that received three inoculations of BK2102. This data has been included in a new figure (Supplementary figure 3B). While we would have liked to evaluate the persistence of immunity and conduct a protection study in monkeys, limitations related to facility availability and cost prevented us from doing so. As noted in (1), tissue injury and other risk assessments were evaluated in the GLP study, which showed no evidence of tissue injury or other toxic effects. These results are described in lines 113-117.

      (3) The vaccine's safety in immunosuppressed individuals or individuals with chronic diseases should be assessed. Authors should make specific comments on this aspect.

      In general, live-attenuated vaccines are contraindicated for immunosuppressed individuals or those with chronic conditions, and therefore BK2102 is also not intended for use in these patients.

      This information has been added to the Discussion section (lines 309-311).

      (4) The candidate vaccine has been tested with a limited number of SARS-CoV-2 strains. Of note, the latest Omicron variants have lesser virulence than many early variants, such as the alfa, beta, and delta strains.

      We have added the results of a protection study against the SARS-CoV-2 gamma strain to Supplementary figures 5A and B. No weight loss was observed in BK2102-inoculated hamsters following infection with the gamma strain. These results are described in lines 109-111, 158-162.

      (5) Limitations of the study have not been discussed.

      We apologize for the ambiguity in the description of the Limitations of this paper. One major limitation of this study is that, despite observing high immunogenicity in hamsters, it remains uncertain whether the same positive results would be achieved in humans. Differences in susceptibility exist between species, which are not solely attributed to weight differences. For instance, while a single dose of 10<sup>3</sup> PFU of BK2102 was sufficient to induce neutralizing antibodies in hamsters, a higher dose of 10<sup>7</sup> PFU in monkeys was required to induce antibodies in only about 50% of the monkeys. Additionally, two more challenges in development of BK2102 were added to the discussion. The first was the limited availability of analytical reagents for hamster models, which restricted the detailed immunological characterization of the response. Second, it took time to gather preclinical data due to the space-related restrictions of BSL3 facilities, which delayed the clinical trials for BK2102 until many individuals had already acquired immunity against SARS-CoV-2. It remains to be seen whether our candidate will be optimal for human use, as the immunogenicity of live-attenuated vaccines is generally influenced by pre-existing immunity.

      We added these considerations to the discussion section (lines 300-309).

      Reviewer #2:

      No major weaknesses were identified, however, this reviewer notes the following:

      The authors missed the opportunity to include a mRNA vaccine to demonstrate that the immunity and protection efficacy of their live attenuated vaccine BK2102 is better than a mRNA vaccine.

      One of the potential advantages of live-attenuated vaccines is their ability to induce mucosal

      immunity. It would be great if the authors included experiments to assess the mucosal immunity of their live-attenuated vaccine BK2102.

      We agree with the Reviewer’s suggestion regarding the importance of comparing BK2102 with the mRNA vaccine modality and evaluating the mucosal immunity induced by BK2102. In hamsters, under conditions where serum neutralizing antibody titers were equivalent, intranasal inoculation of BK2102 induced higher levels of antigen-specific IgA in nasal wash compared to intramuscular injection of the conventional mRNA vaccine. This new data has been added in Supplementary figures 2A and B, and corresponding sentences have been included in the Results and Discussion sections (lines 140-145, 292-299).

      Reviewer #3:

      Lack of a more detailed discussion of this new vaccine approach in the context of reported live-attenuated SARS-CoV-2 vaccines in terms of its advantages and/or weaknesses.

      sCPD9 and CoviLiv<sup>TM</sup>, two previously reported live-attenuated vaccines, achieve attenuation through codon deoptimization or a combination of codon deoptimization and FCS deletion. These two strategies affect viral proliferation but do not directly impact virulence. In contrast, the temperature sensitivity-related substitutions in NSP14 included in BK2102 selectively restrict the infection site, reducing the likelihood of lung infection and providing a safety advantage over the other live-attenuated vaccines. As mentioned in the response to comment (5) of Reviewer #1, a limitation of BK2102 is that its development began later than that of the previously reported live-attenuated vaccines. Consequently, we must consider the impact of pre-existing immunity in future human trials. Based on these points, we have added sentences discussing the advantages and disadvantages to the Discussion section (lines 302-305, 312-319).

      Antibody endpoint titers could be presented.

      Thank you for your suggestion. We calculated the antibody endpoint titers for Figure 2A and included the results in lines 105-107 of the revised manuscript.

      Lack of elaboration on immune mechanisms of protection at the upper respiratory tract (URT) against an immune evasive variant in the absence of detectable neutralizing antibodies.

      We appreciate the comment. The potential role of cellular and mucosal immunity in protection has been discussed in more detail in the revised manuscript, specifically in lines 283-295. According to the reference we initially cited, Hasanpourghadi et al. evaluated their adenovirus vector vaccine candidates and reported that the protection was enhanced by co-expression of the nucleocapsid protein rather than relying solely on the spike protein (Hasanpourghadi et al., Microbes Infect, 2023). Therefore, cellular immunity against the nucleocapsid and/or other viral proteins induced by BK2102 may also contribute to protection, as evidenced by more pronounced cellular immunity to the nucleocapsid detected through ELISPOT assay. Moreover, antigen-specific mucosal immunity was successfully detected in additional studies. The involvement of mucosal immunity in protection against mutant strains has been documented in the previously cited reference (Thwaites et al., Nat Commun, 2023). We have included these new data in Figure 2F and Supplementary figure 2B. Additionally, the results and discussion regarding the mechanisms of protection in the upper respiratory tract, in the absence of detectable neutralizing antibodies, have been incorporated into the revised lines 136-139, 143-145 and 283-295, respectively.

      Recommendations for the authors:

      Reviewer #2:

      Figure 1: Please include the LOD and statistical analysis in both panels. Please consider passaging the virus in Vero cell s, approved for human vaccine production, to assess the stability of BK2102 after serial passage in vitro, which is important for its implementation as a live-attenuated vaccine. The authors should consider evaluating viral replication in different cell lines, and also assessing the plaque phenotype.

      Thank you for your valuable comments. First, we have added the statistical analysis and the limit of detection (LOD) to Figure 1. In response to the comments regarding the stability of BK2102 after serial passage in Vero cells, as well as its replication and plaque phenotype in different cell lines, we manufactured test substances for GLP studies and clinical trials by passaging BK2102 in Vero cells, which are approved for human vaccine production. We confirmed that BK2102 is stable (data not shown). Additionally, we verified that BK2102 replicates in BHK, Vero E6, and Vero E6/TMPRSS2 cells, in addition to Vero cells. Among these options, we selected Vero cells due to their high proliferative capacity and ability to produce clear plaques.

      Figure 2: Please, include statistical analysis in panels A, B, and D. Please, include the LOD in panels A and D. Please, include viral titers from these experiments in hamsters and NHPs.

      First, we would like to note that Figure 2D has been replaced by Figure 2C in the revised manuscript, and the data on neutralizing antibody titers in non-human primates (NHPs), originally presented as Figure 2C, have been moved to the Supplementary figure 3A.

      We have added the statistical analysis to Figure 2B and C, as well as the LOD to Figure 2C. Figure 2A (Spike-specific IgG ELISA) was intended for qualitative evaluation based on OD values, so the LOD was not defined. We have also added a detailed description of virus titer in the Methods section under the headings “Evaluation of Immunogenicity in Hamsters” and “Evaluation of Immunogenicity in Monkeys”, and updated the information in the Figure legends of the revised manuscript (lines 451, 459, 468-474, 566-567, 576-578, 582-584, 661-662).

      Figure 3: Please, include the viral titers of the challenge virus in the NT and lungs.

      We have added the virus titers for the challenge experiments to the Results section under the heading “BK2102 induced protective immunity against SARS-CoV-2 infection” (lines 168-174).

      Figure 4: Please, include statistical analysis in panels B and C and evaluate viral titers.

      We have added the statistical analysis to Figure 4B and C. Unfortunately, all samples in Figure 4 were fixed in formalin for histopathological examination, so virus titers could not be measured. However, in past experiments, we measured viral titers in the nasal wash samples and lungs of hamsters three days post-infection with D614G and BK2102. We confirmed that infectious virus was detected in both the nasal wash and lungs of the hamsters infected with D614G strain (2.9 log10 PFU/mL and 5.3 log10 PFU/g, respectively), but not in the lungs of the hamsters with BK2102. The viral titers in the nasal wash of BK2102-infected hamsters were equivalent to those of the hamsters infected with the D614G wild-type strain (3.0 log10 PFU/mL). However, we did not include this data to the revised manuscript.

      Figure 5: Please, include viral titers in different tissues with the different vaccines (panels A and B). Please, include the body weight changes.  Finally, please, consider the possibility of challenging the vaccinated mice with the same SARS-CoV-2 strains used in the manuscript to demonstrate similar protection efficacy in this new ACE2 transgenic mice.

      The different tissues of Tg mice were not sampled, as no gross abnormalities were observed in organs other than lungs and brains during necropsy. We have added new data on the body weight of Tg mice after infection to Supplementary figures 9B and 9C in the revised manuscript, along with additional lines in the Results section (lines 228-230 and 247-248). Although we do not know the reason, we have observed that immunization of this animal model does not lead to an increase in antibody titers. Therefore, we do not consider this animal model suitable for the protection study as you suggested. However, it could be useful in passive immunization experiments.

      Supplementary Figure 1: Since most of the manuscript focuses on BK2102, the authors should consider removing the other live-attenuated vaccines (Supplementary Figure 1A).

      We agree with the Reviewer’s suggestion and have simplified the description for Supplementary Figure 1A (lines 93-97).

      Supplementary Figure 3: Please, include statistical analysis.

      In the revised manuscript, Supplementary Figure 3 from the original manuscript has been moved to Supplementary Figure 2D. The IgG subclass ELISA was intended for a qualitative evaluation based on OD values, and therefore the results were included in the Supplementary figure. However, we realized the description was not clear, so we added further clarification in the Results section (lines 145-147).

      Supplementary Figure 4: Please, include the viral titers in both infected and contact hamsters from this experiment.

      In the revised manuscript, Supplementary Figure 4 in the original manuscript has been moved to Supplementary Figure 6. Unfortunately, due to limited breeding space for the hamsters, we were unable to prepare groups for the evaluation of viral titer, and instead prioritized evaluation by body weight.

      Reviewer #3:

      (1) It would be helpful to discuss this new vaccine in the context of other reported live-attenuated vaccines in terms of its advantages and/or disadvantages.

      Please refer to our response to the Reviewer’s “first comment” above, as well as to the response in Public comment (5) of Reviewer #1. The modifications made in the manuscript are described in lines 302-305 and 312-319.

      (2) Figure 2A: end-point titers could be presented, other than OD values.

      This comment is addressed in the reviewer’s second public comment. The endpoint titer has been included in lines 105-107 of the revised manuscript.

      (3) Figure 2C: it is unclear why only 2 out of 4 NHPs show neutralization titers. This could be moved to a supplementary figure.

      As suggested by the Reviewer, Figure 2C of the original manuscript has been moved to Supplementary Figure 3A in the revised manuscript. In response Public comment (2) from Reviewer #1, we have also added new data on neutralizing antibodies in the monkeys as Supplementary figure 3B.

      (4) Figures 2E-F: bulk measurement of cytokine production in supernatants is not an optimal way to measure vaccine-induced Ag-specific T cells. ELISPOT or ICS are better. T-cell ELSIPOT for hamsters is available. This should at least be discussed.

      Please refer to our response to this Reviewer’s third public comment. We have added the new results in Figure 2F of the revised manuscript.

      (5) It is quite interesting that no N-specific cellular response was observed, given that it is a live-attenuated vaccine. What about N-specific binding Abs?

      We conducted the ELISPOT assay as suggested by the Reviewer and detected cellular immunity against both spike and nucleocapsid proteins (Figure 2F). We did not examine nucleocapsid-specific antibodies, as they do not contribute to the neutralizing activity; however, nucleocapsid-specific cellular immunity was confirmed.

      (6) Figure 3: limit of detection for virological assays could be labeled.

      We have added the LOD in Figures 3C, D, F and G.

      (7) Figures 3E-F: it is interesting to see that the vaccine elicits almost complete protection at URT against BA.5, despite no BA.5 neutralizing titers being detected at all. What mechanism of URT protection by BK2102 would the authors speculate? T cells or other Ab effector functions?

      Please refer to the response to this Reviewer’s third public comment. We have added new results regarding cellular and mucosal immunity (Figure 2F and Supplementary figure 2B) and discussed the mechanisms of protection in the upper respiratory tract in the absence of detectable neutralizing antibodies (lines 136-139, 143-145 and 283-295, respectively).

      (8) Figure 3I: the durability of protection is a strength of the study. Other than body weight changes, what about viral loads in the animals after the challenge?

      We primarily assessed the effect of the vaccine by monitoring changes in body weight, as the differences compared to the naïve group were clear. Unfortunately, we did not collect samples at different time points throughout the study, which prevented us from evaluating the viral titers.

      In addition, we made corrections to several other sections identified during the revision process. The revised parts are as follows:

      - In the Methods section under the title “Evaluation of BK2102 pathogenicity in hamsters”, the infectious virus titer of D614G strain has been corrected (line 478).

      - In the Methods section under the title “In vivo passage of BK2102 in hamsters”, infectious virus titer of BK2102 and A50-18 strain has been corrected (line 487).

      - The collection time of splenocytes after inoculation has been corrected in the figure legend of Figure 2D, (line 583).

      - There was an error in Figure 2D. The figure has been replaced with the appropriate version.

      - A new reference on NSP1 deletion (Ueno et al., Virology, 2024) has been added to the references.

      - Several methods have been described more clearly.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Comments on the revised version:

      Concerns flagged about using CRISPR -guide RNA mediated knockdown of viral has yet to be addressed entirely. I understand that the authors could not get knock out despite attempts and hence they have guide RNA mediated knockdown strategy. However, I wondered if the authors looked at the levels of the downstream genes in this knockdown.

      We thank the reviewer for bringing this up since it is known that certain artifacts derived from this approach may be related with changes in expression of downstream genes. We run a qPCR of Rv0432 and Rv0433 and confirmed that no significant differences in expression of virR downstream genes were detected in the virR mutant or the complemented strains relative to WT. This is now indicated in the method section on Generation of the CRISPR mutants. The data is now presented as Supplementary Figure 13.

      Authors have used the virmut-Comp strain for some of the experiments. However, the materials and methods must describe how this strain was generated. Given the mutant is a CRISPR-guide RNA mediated knockdown. The CRISPR construct may have taken up the L5 loci. Did authors use episomal construct for complementation? If so, what is the expression level of virR in the complementation construct? What are the expression levels of downstream genes in mutant and complementation strains? This is important because the transcriptome analysis was redone by considering complementation strain. The complemented strain is written as virmut-C or virmut-Comp. This has to be consistent.

      We apologize for not having included the information about the generation of the complemented strain in our last version of the manuscript. We took the complementing vector from a previous paper on VirR (Rath et al., (2013) PNAS 110(49):E4790). This vector was constructed as follows: Complementation plasmids were cloned using Gateway® Cloning Technology (Invitrogen). E. coli strains expressing the following Gateway vectors were kindly provided by Dirk Schnappinger and Sabine Ehrt: pDO221A, pDO23A, pEN23A-linker1, pEN41A-TO2, pEN21A-Hsp60, pDE43-MEH. PCR was used to amplify the following target sequences from H37Rvgenomic DNA: coding sequence of Rv0431, coding sequence of Rv0431 with a FLAG tag either in its C-terminus or its N-terminus, and the predicted cytosolic sequence of Rv0431 with a FLAG tag in its new C-terminus. The primers used for PCR were designed such that the amplicons would be flanked with Gateway® cloning- specific attachment (att) sites. These PCR products were recombined into Gateway® donor vectors using bacteriophage-derived integrase and integration host factor, resulting in entry vectors. The recombination events are specific to the attB sites on the PCR products and to the attP sequences on the donor vectors, such that the orientation of the target sequence is maintained during the recombination reaction, also known as the BP reaction, for attB-attP recombination. Using the MultiSite Gateway® system, three DNA fragments, derived from each of three distinct entry vectors, can be simultaneously inserted into a final complementation vector called the destination vector in a specific order and orientation. Multisite recombination events are mediated by Integrase and Integrase Host Factor, in a process called the LR reaction (for the attL and attR sites in the entry and destination vectors). The Gateway® entry vectors thus generated were recombined with another entry vector containing either the Hsp60 promoter, an empty entry vector, and a complementation vector (episomal) to give rise to the final destination vector. The destination vector (episomal) was engineered to contain a hygromycin resistance cassette. These vectors were used to transform competent Rv0431-deficient Mtb. The transformation mixture was plated on 7H11 plates containing OADC and hygromycin (50 μg/ml). Colonies, typically observed 3-5 weeks later, were isolated and grown in 7H9 media and characterized.

      For simplicity, we have just referenced our previous paper to indicate that the complementing plasmid is the same used in that study.

      Regarding the virR expression levels in the WT, virR<sup>mut</sup> and complemented virR strains please see previous Figure 6 C.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors have revised the manuscript in light of previous reviews. The authors have addressed some of my concerns appropriately. However, the specific dataset remains unchanged and unclear.

      Fig 8G and H: In response to a comment on the mechanism of how VirR mediates EV release, the authors have added new data showing an increase in the abundance of deacetylated muropeptides in the mutant. This observation is linked to altered lysozyme activity or PG fragility. In my opinion, this is another indirect observation. More concerning is the complemented strain, which also showed a comparable increase in deacetylated muropeptides, indicating that the altered muropeptides could be unrelated to VirR.

      We must disagree here with the reviewer assessment about the fact that the abundance of deacetylated muropeptides is an indirect indication of PG fragility. We consider that this observation and quantitative fact is another additional evidence that indicate a more fragile PG. We believe that considering each of the supporting facts individually may be seen as indirect, but we would like that the reviewer take all the evidence together: (i) sensitivity to lysozyme; (ii) enlargement and altered physicochemical morphological characteristics including porosity or thickness; (iii) altered penetrance of FDAAs; and (iv) increased released of muropeptides. In this later fact, the complemented strain may not display the WT features, but this may be due to some artifacts derived from the complementation.

      Taking all together, we believe that the PG of virR<sup>mut</sup> is more fragile than that of the WT and the complemented strains based on a series of evidence. We hope the reviewer may consider this perspective when analyzing such a complex feature like PG fragility. So far, there is not a direct method to assess this condition.

      Lipid analyses are not comprehensive. The issue related to the need for more clarity of DIMA and DIMB still needs to be addressed. I understand that the authors do not have facilities to perform radioactive assays. However, they could have repeated the experiment to generate a better-quality image. Similarly, the newly generated SL-1, PAT, and DAT TLC could be of better quality. Bands still need to be resolved. The solvent front is irregular. The same is true for PIMs and DPG TLCs. With the evidence provided, the deregulation of cell wall lipids is incomplete.

      We agree with the reviewer that the quality of the TLC is not appropriate. We have no repeated the PDIM TLC (new Fig 7D). In addition, we have repeated the TLCs resolving sulfolipids in a 2D mode. For simplicity we just run the glycerol condition including the three strains. This is now part of a new Supplementary figure 8 B. For PIMs, we have a 1D and a 2D analysis that, after checking previous papers using similar approaches with no radioactivity, we consider that it has the desired quality to identify the indicated lipids.

      We hope this new data and repeated experiments satisfy the reviewer concerns.

      Thank you very much for your assessment and time to review this paper.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer # 1 (Public Review):

      Summary:

      Inthispreprint, theauthorssystematicallyandrigorouslyinvestigatehowspecificclassesofresiduemutations alter the critical temperature as a proxy for the driving forces for phase separation. The work is well executed, the manuscript well-written, and the results reasonable and insightful.

      Strengths:

      The introductory material does an excellent job of being precise in language and ideas while summarizing the state of the art. The simulation design, execution, and analysis are exceptional and set the standard for these types of large-scale simulation studies. The results, interpretations, and Discussion are largely nuanced, clear, and well-motivated.

      We thank the reviewer for their assessment of our work and for highlighting the key strengths of the paper.

      Weaknesses:

      This is not exactly a weakness, but I think it would future-proof the authors’ conclusions to clarify a few key caveats associated with this work. Most notably, given the underlying implementation of the Mpipi model, temperature dependencies for intermolecular interactions driven by solvent effects (e.g., hydrophobic effect and charge-mediated interactions facilitated by desolvation penalties) are not captured. This itself is not a “weakness” per se, but it means I would imagine CERTAIN types of features would not be wellcaptured; notably, my expectation is that at higher temperatures, proline-rich sequences drive intermolecular interactions, but at lower temperatures, they do not. This is likely also true for the aliphatic residues, although these are found less frequently in IDRs. As such, it may be worth the authors explicitly discussing.

      We also thank the reviewer for pointing out that a more detailed discussion of the model limitations is needed. The original Mpipi model was designed to probe UCST-type transitions (that are associative in nature) of disordered sequences. The reviewer is correct, that in its current form, the model does not capture LCST-type transitions that depend on changes in solvation of hydrophobic residues with temperature. We have amended the discussion to highlight this fact.

      Similarly, prior work has established the importance of an alpha-helical region in TDP-43, as well as the role of aliphatic residues in driving TDP-43’s assembly (see Schmidt et al 2019). I recognize the authors have focussed here on a specific set of mutations, so it may be worth (in the Discussion) mentioning [1] what impact, if any, they expect transient or persistent secondary structure to have on their conclusions and [2] how they expect aliphatic residues to contribute. These can and probably should be speculative as opposed to definitive.

      Again - these are not raised as weaknesses in terms of this work, but the fact they are not discussed is a minor weakness, and the preprint’s use and impact would be improved on such a discussion.

      We agree with the reviewer that the effects of structural changes/propensities on these scaling behaviors would be an interesting and important angle to probe. We also comment on this in the discussion.

      Reviewer # 2 (Public Review):

      This is an interesting manuscript where a CA-only CG model (Mpipi) was used to examine the critical temperature (Tc) of phase separation of a set of 140 variants of prion-like low complexity domains (PLDs). The key result is that Tc of these PLDs seems to have a linear dependence on substitutions of various sticker and space residues. This is potentially useful for estimating the Tc shift when making novel mutations of a PLD. However, I have strong reservations about the significance of this observation as well as some aspects of the technical detail and writing of the manuscript.

      We thank the reviewer for their thoughtful and detailed feedback on the manuscript.

      (1) Writing of the manuscript: The manuscript can be significantly shortened with more concise discussions. The current text reads as very wordy in places. It even appears that the authors may be trying a bit too hard to make a big deal out of the observed linear dependence.

      The manuscript needs to be toned done to minimize self-promotion throughout the text. Some of the glaring examples include the wording “unprecedented”, “our research marks a significant milestone in the field of computational studies of protein phase behavior ..”, “Our work explores a new framework to describe, quantitatively, the phase behavior ...”, and others.

      We thank the reviewer for their suggestions on the writing of the manuscript. We understand the concern regarding the length and tone of the manuscript, and in response to their feedback, we have revised the language throughout the manuscript.

      There is really little need to emphasize the need to manage a large number of simulations for all 140 variants. Yes, some thoughts need to go into designing and managing the jobs and organizing the data, but it is pretty standard in computational studies. For example, large-scale protein ligand-free energy calculations can require one to a few orders of magnitude larger number of runs, and it is pretty routine.

      We fully agree with the reviewer that this aspect of the study is relatively standard in computational research and does not require special emphasis. In response, we have revised the manuscript to shorten the aforementioned section, focusing instead on the scientific insights gained from the simulations rather than the logistical challenges of managing them.

      When discussing the agreement with experimental results on Tm, it should be noted that the values of R > 0.93 and RMSD < 14 K are based on only 16 data points. I am not sure that one should refer to this as “extended validation”. It is more like a limited validation given the small data size.

      We thank the reviewer for their consideration of our validation set. Indeed, the agreement with experimental results is based on 16 data points, as this set represents the available published data at the time of writing of this manuscript. The term “extended validation” is used to signify that our current dataset builds upon previous validations (in Joseph, Reinhardt et al. Nat Comput. Sci. 2021), incorporating additional variants not previously examined. The metrics of an r>0.93 and a low RMSD indicate a strong agreement between the model and experiments, and an improvement with respect to other reported models. We are committed to continue validating our methods.

      Results of linear fitting shown in Eq 4-12 should be summarized in a single table instead of scattering across multiple pages.

      We considered the reviewer’s suggestion to compile all the laws into a single table. However, we believe it would be more effective for readers to reference each relationship directly where it is first discussed in the text. That said, we do include Table 1 in the original manuscript, which provides a summary of all the laws.

      The title may also be toned down a bit given the limited significance of the observed linear dependence.

      We respectfully disagree with the reviewer and believe that the current title accurately captures the scope of the manuscript.

      (2) Significance and reliability of Tc: Given the simplicity of Mpipi (a CA-only model that can only describe polymerchaindimension)andthelowcomplexitynatureofPLDs, thesequencecompositionitselfisexpected to be the key determinant of Tc. This is also reflected in various mean-field theories. It is well known that other factors will contribute, such as patterning (examined in this work as well), residual structures, and conformational preferences in dilute and dense phases. The observed roughly linear dependence is a nice confirmation but really unsurprising by itself. It appears how many of the constructs deviate from the expected linear dependence (e.g., Figure 4A) may be more interesting to explore.

      While linear dependencies in critical solution temperatures may appear expected for certain systems, for example, symmetric hard spheres, the heterogeneity of intrinsically disordered regions (IDRs), like prion-like domains (PLDs), make this finding notable. The simplicity of our linear scaling law belies the underlying complexity of multivalent interactions and sequence-dependent behaviors in a certain sequence regime, which has not been quantitatively characterized in this manner before. Likewise, although linear dependencies may be expected in simplified models, the real-world applicability and empirical validation of these laws in biologically relevant systems are not guaranteed. Our chemically based model provides the robustness needed to do that. The linear relationship observed is significant because it provides a predictive framework for understanding how specific mutations affect a diverse set of PLDs. The framework presented can be extended to other protein families upon the application of a validated model, which might or might not yield linear relationships depending on the cooperative effects of their collective behavior. This extends beyond confirming known theories—it offers a practical tool for predicting phase behavior based on sequence composition

      We agree with the reviewer that, while the overarching linear trend is clear, deviations from linearity observed in constructs like those in Figure 4A point to additional, and interesting, layers of complexity. These deviations offer interesting avenues for future research and suggest that while linearity might dominate PLD critical behavior, other factors may modulate this behavior under specific conditions.

      This is an excellent suggestion from the reviewer that, while it falls outside the scope of the current study, we are interested in exploring in the future.

      Finally, the relationships are all linear, they have been normalized in different ways—the strength of the study also lies in that. Instead of focusing solely on linearity, our study explores the physical mechanisms that underlie these relationships. This approach provides a more complete understanding of how sequence composition and the underlying chemistry of the mutated residues influence T<sub>c</sub.

      The assumption that all systems investigated here belong to the same universality class as a 3D Ising model and the use of Eqn 20 and 21 to derive Tc is poorly justified. Several papers have discussed this issue, e.g., see Pappu Chem Rev 2023 and others. Muthukumar and coworkers further showed that the scaling of the relevant order parameters, including the conserved order parameter, does not follow the 3D Ising model. More appropriate theoretical models including various mean field theories can be used to derive binodal from their data, such as using Rohit Pappu’s FIREBALL toolset. Imposing the physics of the 3D Ising model as done in the current work creates challenges for equivalence relationships that are likely unjustified.

      We thank the reviewer for raising this point and for highlighting the FIREBALL toolset. Based on our understanding, FIREBALL is designed to fit phase diagrams using mean-field theories, such as Flory–Huggins and Gaussian Cluster Theory. Our experience with this toolset suggests that it places a higher weight on the dilute arm of the binodal. However, in our slab simulations, we observe greater uncertainty in the density of the dilute arm. This leads to only a moderate fit of the data to the mean-field theories employed in the toolset. While we agree that there is no reason to assume the phase behavior of these systems is fully captured by the 3D Ising model, we expect that such a model will describe the behavior near the critical point better than mean-field theories. Testing our results further with different critical exponents would be valuable in assessing how these predictions compare to a broader set of experimental data. Additionally, we have made the raw data points for the phase diagrams available on our GitHub, enabling practitioners to apply alternative fitting methods.

      While it has been a common practice to extract Tc when fitting the coexistence densities, it is not a parameter that is directly relevant physiologically. Instead, Csat would be much more relevant to think about if phase separation could occur in cells.

      WhileitistruethatCsatisdirectlyrelevanttowhetherphaseseparationcanoccurincellsunder physiological conditions, T<sub>c</sub> should not be dismissed as irrelevant.T<sub>c</sub> provides fundamental insights into the thermodynamics of phase separation, reflecting the overall stability and strength of interactions driving condensate formation. This stability is crucial for understanding how environmental factors, such as temperature or mutations, might affect phase behavior. In Figure 2C and D we compare experimental C<sub>sat</sub> values with our predicted T<sub>c</sub> from simulations. These quantities are roughly inversely proportional to each other and so we expect that, to a first approximation, the relationships recovered for T<sub>c</sub> should hold when consideringC<sub>sat</sub> at a fixed temperature.

      Reviewer # 3 (Public Review):

      Summary:

      “Decoding Phase Separation of Prion-Like Domains through Data-Driven Scaling Laws” by Maristany et al. offers a significant contribution to the understanding of phase separation in prion-like domains (PLDs). The study investigates the phase separation behavior of PLDs, which are intrinsically disordered regions within proteins that have a propensity to undergo liquid-liquid phase separation (LLPS). This phenomenon is crucial in forming biomolecular condensates, which play essential roles in cellular organization and function. The authors employ a data-driven approach to establish predictive scaling laws that describe the phase behavior of these domains.

      Strengths:

      The study benefits from a robust dataset encompassing a wide range of PLDs, which enhances the generalizability of the findings. The authors’ meticulous curation and analysis of this data add to the study’s robustness. The scaling laws derived from the data provide predictive insights into the phase behavior of PLDs, which can be useful in the future for the design of synthetic biomolecular condensates.

      We thank the reviewer for highlighting the importance of our work and for their critical feedback.

      Weaknesses:

      While the data-driven approach is powerful, the study could benefit from more experimental validation. Experimental studies confirming the predictions of the scaling laws would strengthen the conclusions. For example, in Figure 1, the Tc of TDP-43 is below 300 K even though it can undergo LLPS under standard conditions. Figure 2 clearly highlights the quantitative accuracy of the model for hnRNPA1 PLD mutants, but its applicability to other systems such as TDP-43, FUS, TIA1, EWSR1, etc., may be questionable.

      In the manuscript, we have leveraged existing experimental data for the A1-LCD variants, extracting critical temperatures and saturation concentrations to compare with our model and scaling law predictions. We acknowledge that a larger set of experiments would be beneficial. By selecting sequences that are related, we hypothesize that the scaling laws described herein should remain robust. In the case of TDP-43, to our knowledge this protein does not phase separate on its own under standard conditions. In vitro experiments that report phase separation at/above 300 K involve either the use of crowding agents (such as dextran or PEG) or multicomponent mixtures that include RNA or other proteins. Therefore, our predictions for TDP-43 are consistent with experiments. In general, we hope that the scaling laws presented in our work will inspire other researchers to further test their validity.

      The authors may wish to consider checking if the scaling behavior is only observed for Tc or if other experimentally relevant quantities such as Csat also show similar behavior. Additionally, providing more intuitive explanations could make the findings more broadly accessible.

      In Figure 2C and D we compare experimental C<sub>sat</sub> values with our predicted T<sub>c</sub> from simulations. These quantities are roughly inversely proportional to each other and so we expect that, to a first approximation, the relationships recovered for T<sub>c</sub> should hold when considering C<sub>sat</sub> at a fixed temperature.

      The study focuses on a particular subset of intrinsically disordered regions. While this is necessary for depth, it may limit the applicability of the findings to other types of phase-separating biomolecules. The authors may wish to discuss why this is not a concern. Some statements in the paper may require careful evaluation for general applicability, and I encourage the authors to exercise caution while making general conclusions. For example, “Therefore, our results reveal that it is almost twice more destabilizing to mutate Arg to Lys than to replace Arg with any uncharged, non-aromatic amino acid...” This may not be true if the protein has a lot of negative charges.

      A significant number of proteins, in addition to those mentioned in the manuscript, that contain prion-like low complexity domains have been reported to exhibit phase separation behaviors and/or are constituents of condensates inside cells. We therefore expect these laws to be applicable to such systems and have further revised the text to emphasize this point. As the reviewer suggests, we have also clarified that the reported scaling of various mutations applies to these systems.

      I am surprised that a quarter of a million CPU hours are described as staggering in terms of computational requirements.

      We have removed the note on CPU hours from the manuscript. However, we would like to clarify that the amount of CPU hours was incorrectly reported. The correct estimate is 1.25 million hours, but this value was unfortunately misrepresented during the editing process. We thank the reviewer for catching this mistake on our part.

      Reviewer # 1 (Recommendations For The Authors):

      Some minor points here:

      “illustrating that IDPs indeed behave like a polymer in a good solvent [43]. ” Whether or not an IDP depends as a polymer in a good solvent depends on the amino acid sequence - the referenced paper selected a set of sequences that do indeed appear on average to map to a good-solvent-like polymer, but lest we forget SAXS experiments require high protein concentrations and until the recent advent of SEC-SAXS, your protein essentially needed to be near infinitely soluble to be measured. As such, this paper’s conclusions are, apparently, ignorant of the limitations associated with the data they are describing, drawing sweeping generalizations that are clearly not supported by a multitude of studies in which sequence-dependencies have led to ensembles with a scaling exponent far below 0.59 (See Riback et al 2017, Peng et al 2019, Martin et al 2020, etc).

      We thank the reviewer for raising this point. To avoid making incorrect generalizations and potentially misleading readers, we have removed the quoted statement from our manuscript.

      As of right now, the sequences are provided in a convenient multiple-sequence alignment figure. However, it would be important also to provide all sequences in an Excel table to make it easy for folks to compare.

      In addition to the sequence alignment figure, we now provide all tested sequences in an Excel table format in the GitHub repository.

      Maybe I’m missing it, but it would be extremely valuable if the coexistence points plot in all the figures were provided as so-called source data; this could just be on the GitHub repository, but I’m envisaging a scenario where for each sequence you have a 4 column file where Col1=concentration and Col2=temperature, col3=fit concentration and col4=fit temperature, such that someone could plot col1 vs. col2 and col3 vs. col4 and reproduce the binodals in the various figures. Given the tremendous amount of work done to achieve binodals:

      The coexistence points used to plot the figures are now provided in the GitHub, in a format similar to that suggested by the reviewer.

      It would be nice to visually show how finite size effects are considered/tested for (which they are very nicely) because I think this is something the simulation field should be thinking about more than they are.

      Thank you for highlighting this point. In our previous work (supporting information of the original Mpipi paper), we demonstrated a thorough approach by varying both the cross-sectional area of the box and the long axis while keeping the overall density constant. In this work, we verified that the cross-sectional area was larger than the average R<sub>g</sub> of the protein. We then maintained a fixed cross-sectional area to long-axis ratio, varying the number of proteins while keeping the overall density constant. We have updated Appendix 1–Figure 2 to clarify our procedure and revised the caption to better explain how we ensured the number of proteins was adequate.

      When explaining the law of reticular diameters, it would be good to explain where the 3.06 exponent comes from.

      Based on the reviewer’s suggestion, we have added to the text: “The constant 3.06 in the equation is a dimensionless empirical factor that was derived from simulations of the 3D Ising model.”

      The NCPR scale in Figure 5 being viridis is not super intuitive and may benefit from being seismic or some other r-w-b colormap just to make it easier for a reader to map the color to meaning.

      We thank the reviewer for this suggestion and have replaced the scale with a r-w-b colormap.

      The “sticker and spacer” framework has received critiques recently given its perceived simplicity. However, this work seems to clearly illustrate that certain types of residues have a large effect on Tc when mutated, whereas others have a smaller effect. It may be worth re-phrasing the sticker-spacer introduction not as “everyone knows aromatic/arginine residues are stickers” but as “aromatic and arginine residues have been proposed to be stickers, yet other groups have argued all residues matter equally” and then go on to make the point that while a black-and-white delineation is probably not appropriate, based on the data, certain residues ARE demonstrably more impactful on Tc than others, which is the definition of stickers. With this in mind, it may be useful to separate out a sticker and a spacer distribution in Figure 1D, because the different distribution between the two residues types is not particularly obvious from the overlapping points.

      We have revised the introduction of the sticker–spacer model in the manuscript for clarity. As the reviewer suggests, we have also separated the sticker and spacer distribution, which is now summarized in new Appendix 0–figure 8.

      Reviewer # 3 (Recommendations For The Authors):

      Figure 2 clearly highlights the quantitative accuracy of the model for hnRNPA1 PLD mutants, but its applicability to other systems such as TDP-43, FUS, TIA1, EWSR1, etc., may be questionable. The following sentence may be revised to reflect this: “Our extended validation set confirms that the Mpipi potential can ...”

      Based on the reviewer’s suggestion, we have revised the text: “Our validation set, which expands the range of proteins variants originally tested [32], highlights that the Mpipi potential can effectively capture the thermodynamic behavior of a wide range of hnRNPA1-PLD variants, and suggests that Mpipi is adequate for proteins with similar sequence compositions, as in the set of proteins analyzed in this study. In recent work by others [66], Mpipi was tested against experimental radius of gyration data for 137 disordered proteins and the model produced highly accurate results, which further suggests the applicability of the approach to a broad range of sequences.”

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public review):

      As a starting point, the authors discuss the so-called "additive partitioning" (AP) method proposed by Loreau & Hector in 2001. The AP is the result of a mathematical rearrangement of the definition of overyielding, written in terms of relative yields (RY) of species in mixtures relative to monocultures. One term, the so-called complementarity effect (CE), is proportional to the average RY deviations from the null expectations that plants of both species "do the same" in monocultures and mixtures. The other term, the selection effect (SE), captures how these RY deviations are related to monoculture productivity. Overall, CE measures whether relative biomass gains differ from zero when averaged across all community members, and SE, whether the "relative advantage" species have in the mixture, is related to their productivity. In extreme cases, when all species benefit, CE becomes positive.

      This is not true; positive CE does not require positive RY deviations of all species. CE is positive as long as average RY deviation is greater than 0. In a 2-species mixture, for example, if the RY deviation of one species is -0.2 and that of the other species is +0.3, CE would be still positive. Positive CE can be associated with negative NE (net biodiversity effects) when more productivity species have smaller negative RY deviation compared to positive RY deviation of less productive species. Therefore, the suggestion by the reviewer “This is intuitively compatible with the idea that niche complementarity mitigates competition (CE>0)” is not correct.   

      When large species have large relative productivity increases, SE becomes positive. This is intuitively compatible with the idea that niche complementarity mitigates competition (CE>0), or that competitively superior species dominate mixtures and thereby driver overyielding (SE>0).

      The use of word “mitigate” indicates that the effects of niche complementarity and competition are in opposite directions, which is not true with biodiversity experiments based on replacement design. We have explained this in detail in our first responses to reviewers.    

      However, it is very important to understand that CE and SE capture the "statistical structure" of RY that underlies overyielding. Specifically, CE and SE are not the ultimate biological mechanisms that drive overyielding, and never were meant to be. CE also does not describe niche complementarity. Interpreting CE and SE as directly quantifying niche complementarity or resource competition, is simply wrong, although it sometimes is done. The criticism of the AP method thus in large part seems unwarranted. The alternative methods the authors discuss (lines 108-123) are based on very similar principles.

      Agree. However, If CE and SE are not meant to be biological mechanisms, as suggested by the reviewer, the argument “This is intuitively compatible with the idea that niche complementarity mitigates competition (CE>0), or that competitively superior species dominate mixtures and thereby driver overyielding (SE>0)” would be invalid.  

      Lines 108-123 are not on our method.   

      The authors now set out to develop a method that aims at linking response patterns to "more true" biological mechanisms.

      Assuming that "competitive dominance" is key to understanding mixture productivity, because "competitive interactions are the predominant type of interspecific relationships in plants", the authors introduce "partial density" monocultures, i.e. monocultures that have the same planting density for a species as in a mixture. The idea is that using these partial density monocultures as a reference would allow for isolating the effect of competition by the surrounding "species matrix".

      The authors argue that "To separate effects of competitive interactions from those of other species interactions, we would need the hypothesis that constituent species share an identical niche but differ in growth and competitive ability (i.e., absence of positive/negative interactions)." - I think the term interaction is not correctly used here, because clearly competition is an interaction, but the point made here is that this would be a zero-sum game.

      We did not say that competition is not an interaction.

      The authors use the ratio of productivity of partial density and full-density monocultures, divided by planting density, as a measure of "competitive growth response" (abbreviated as MG). This is the extra growth a plant individual produces when intraspecific competition is reduced.

      Here, I see two issues: first, this rests on the assumption that there is only "one mode" of competition if two species use the same resources, which may not be true, because intraspecific and interspecific competition may differ. Of course, one can argue that then somehow "niches" are different, but such a niche definition would be very broad and go beyond the "resource set" perspective the authors adopt. Second, this value will heavily depend on timing and the relationship between maximum initial growth rates and competitive abilities at high stand densities.

      True. Research findings indicate that biodiversity effect detected with AP is not constant.    

      The authors then progress to define relative competitive ability (RC), and this time simply uses monoculture biomass as a measure of competitive ability. To express this biomass in a standardized way, they express it as different from the mean of the other species and then divide by the maximum monoculture biomass of all species.

      I have two concerns here: first, if competitive ability is the capability of a species to preempt resources from a pool also accessed by another species, as the authors argued before, then this seems wrong because one would expect that a species can simply be more productive because it has a broader niche space that it exploits. This contradicts the very narrow perspective on competitive ability the authors have adopted. This also is difficult to reconcile with the idea that specialist species with a narrow niche would outcompete generalist species with a broad niche.

      Competitive ability is not necessarily associated with species niche space. Both generalist and specialist species can be more productive at a particular study site, as long as they are more capable of obtaining resources from a local pool. Remember, biodiversity experiments are conducted at a site of particular conditions, not across a range of species niche space at landscape level.

      Second, I am concerned by the mathematical form. Standardizing by the maximum makes the scaling dependent on a single value.

      As explained in lines 370-376, the mathematical form is a linear approximation as the relationship between competitive growth responses and species relative competitive ability is generally unknow but would be likely nonlinear. Once the relationship is determined in future research, the scaling factor is not needed.    

      As a final step, the authors calculate a "competitive expectation" for a species' biomass in the mixture, by scaling deviations from the expected yield by the product MG ⨯ RC. This would mean a species does better in a mixture when (1) it benefits most from a conspecific density reduction, and (2) has a relatively high biomass.

      Put simply, the assumption would be that if a species is productive in monoculture (high RC), it effectively does not "see" the competitors and then grows like it would be the sole species in the community, i.e. like in the partial density monoculture.

      Overall, I am not very convinced by the proposed method.

      Comments on revised version:

      Only minimal changes were made to the manuscript, and they do not address the main points that were raised.

      Reviewer #2 (Public review):

      This manuscript by Tao et al. reports on an effort to better specify the underlying interactions driving the effects of biodiversity on productivity in biodiversity experiments. The authors are especially concerned with the potential for competitive interactions to drive positive biodiversity-ecosystem functioning relationships by driving down the biomass of subdominant species. The authors suggest a new partitioning schema that utilizes a suite of partial density treatments to capture so-called competitive ability. While I agree with the authors that understanding the underlying drivers of biodiversity-ecosystem functioning relationships is valuable - I am unsure of the added value of this specific approach for several reasons.

      No responses.

      Comments on revised version:

      The authors changed only one minor detail in response to the last round of reviews.

      Reviewer #3 (Public review):

      Summary:

      This manuscript claims to provide a new null hypothesis for testing the effects of biodiversity on ecosystem functioning. It reports that the strength of biodiversity effects changes when this different null hypothesis is used. This main result is rather inevitable. That is, one expects a different answer when using a different approach. The question then becomes whether the manuscript's null hypothesis is both new and an improvement on the null hypothesis that has been in use in recent decades.

      Our approach adopts two hypotheses, null hypothesis that is also with the additive partitioning model and competitive hypothesis that is new. Null hypothesis assumes that inter- and intra-specie interactions are the same, while competitive hypothesis assumes that species differ in competitive ability and growth rate. Therefore, our approach is an extension of current approach. Our approach separates effects of competitive interactions from those of other species interactions, while the current approach does not.      

      Strengths:

      In general, I appreciate studies like this that question whether we have been doing it all wrong and I encourage consideration of new approaches.

      Weaknesses:

      Despite many sweeping critiques of previous studies and bold claims of novelty made throughout the manuscript, I was unable to find new insights. The manuscript fails to place the study in the context of the long history of literature on competition and biodiversity and ecosystem functioning.

      We have explained in our first responses that competition and biodiversity effects are studied in different experimental approaches, i.e., additive and replacement designs. Results from one approach are not compatible with those from the other. For example, competition effect with additive design is negative but generally positive with replacement design that is used extensively in biodiversity experiments. We have considered species competitive ability, density-growth relationship, and different effects of competitive interactions between additive and replacement design, while the current method does not reflect any of those.        

      The Introduction claims the new approach will address deficiencies of previous approaches, but after reading further I see no evidence that it addresses the limitations of previous approaches noted in the Introduction. Furthermore, the manuscript does not reproducibly describe the methods used to produce the results (e.g., in Table 1) and relies on simulations, claiming experimental data are not available when many experiments have already tested these ideas and not found support for them.

      We used simulation data, as partial density monocultures are generally not available in previous biodiversity experiments.

      Finally, it is unclear to me whether rejecting the 'new' null hypothesis presented in the manuscript would be of interest to ecologists, agronomists, conservationists, or others.

      Our null hypothesis is the same as the null hypothesis with the additive partitioning assuming that inter- and intra-species interactions are the same, while our competitive hypothesis assumes that species differ in competitive ability and growth rate. Rejecting null hypothesis means that inter- and intra-species interactions are different, whereas rejecting competitive hypothesis indicates existence of positive/negative species interactions. This would be interesting to everyone.       

      Comments on revised version:

      Please see review comments on the previous version of this manuscript. The authors have not revised their manuscript to address most of the issues previously raised by reviewers.

      No responses.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Do take reviews seriously. Even if you think the reviewers all are wrong and did not understand your work, then this seems to indicate that it was not clearly presented.

      Reviewer #2 (Recommendations for the authors):

      I can understand that the authors are perhaps frustrated with what they perceive as a basic misunderstanding of their goals and approach. This misunderstanding however, provides with it an opportunity to clarify. I believe that the authors have tried to clarify in rebutting our statements but would do better to clarify in the manuscript itself. If we reviewers, who are deeply invested in this field, don't understand the approach and its value, then it is likely that many readers will not as well.

      The additive partitioning has been publicly questioned at least for serval times since the conception of the method in 2001. Our work provides an alternative.

    1. Author response:

      The following is the authors’ response to the current reviews.

      eLife Assessment

      This neuroimaging and electrophysiology study in a small cohort of congenital cataract patients with sight recovery aims to characterize the effects of early visual deprivation on excitatory and inhibitory balance in visual cortex. While contrasting sight-recovery with visually intact controls suggested the existence of persistent alterations in Glx/GABA ratio and aperiodic EEG signals, it provided only incomplete evidence supporting claims about the effects of early deprivation itself. The reported data were considered valuable, given the rare study population. However, the small sample sizes, lack of a specific control cohort and multiple methodological limitations will likely restrict usefulness to scientists working in this particular subfield.

      We thank the reviewing editors for their consideration and updated assessment of our manuscript after its first revision.

      In order to assess the effects of early deprivation, we included an age-matched, normally sighted control group recruited from the same community, measured in the same scanner and laboratory. This study design is analogous to numerous studies in permanently congenitally blind humans, which typically recruited sighted controls, but hardly ever individuals with a different, e.g. late blindness history. In order to improve the specificity of our conclusions, we used a frontal cortex voxel in addition to a visual cortex voxel (MRS). Analogously, we separately analyzed occipital and frontal electrodes (EEG).

      Moreover, we relate our findings in congenital cataract reversal individuals to findings in the literature on permanent congenital blindness. Note, there are, to the best of our knowledge, neither MRS nor resting-state EEG studies in individuals with permanent late blindness.

      Our participants necessarily have nystagmus and low visual acuity due to their congenital deprivation phase, and the existence of nystagmus is a recruitment criterion to diagnose congenital cataracts.

      It might be interesting for future studies to investigate individuals with transient late blindness. However, such a study would be ill-motivated had we not found differences between the most “extreme” of congenital visual deprivation conditions and normally sighted individuals (analogous to why earlier research on permanent blindness investigated permanent congenitally blind humans first, rather than permanently late blind humans, or both in the same study). Any result of these future work would need the reference to our study, and neither results in these additional groups would invalidate our findings.

      Since all our congenital cataract reversal individuals by definition had visual impairments, we included an eyes closed condition, both in the MRS and EEG assessment. Any group effect during the eyes closed condition cannot be due to visual acuity deficits changing the bottom-up driven visual activation.

      As we detail in response to review 3, our EEG analyses followed the standards in the field.

      Public Reviews:

      Reviewer (1 (Public review):

      Summary

      In this human neuroimaging and electrophysiology study, the authors aimed to characterise effects of a period of visual deprivation in the sensitive period on excitatory and inhibitory balance in the visual cortex. They attempted to do so by comparing neurochemistry conditions ('eyes open', 'eyes closed') and resting state, and visually evoked EEG activity between ten congenital cataract patients with recovered sight (CC), and ten age-matched control participants (SC) with normal sight.

      First, they used magnetic resonance spectroscopy to measure in vivo neurochemistry from two locations, the primary location of interest in the visual cortex, and a control location in the frontal cortex. Such voxels are used to provide a control for the spatial specificity of any effects, because the single-voxel MRS method provides a single sampling location. Using MR-visible proxies of excitatory and inhibitory neurotransmission, Glx and GABA+ respectively, the authors report no group effects in GABA+ or Glx, no difference in the functional conditions 'eyes closed' and 'eyes open'. They found an effect of group in the ratio of Glx/GABA+ and no similar effect in the control voxel location. They then perform multiple exploratory correlations between MRS measures and visual acuity, and report a weak positive correlation between the 'eyes open' condition and visual acuity in CC participants.

      The same participants then took part in an EEG experiment. The authors selected two electrodes placed in the visual cortex for analysis and report a group difference in an EEG index of neural activity, the aperiodic intercept, as well as the aperiodic slope, considered a proxy for cortical inhibition. Control electrodes in the frontal region did not present with the same pattern. They report an exploratory correlation between the aperiodic intercept and Glx in one out of three EEG conditions.

      The authors report the difference in E/I ratio, and interpret the lower E/I ratio as representing an adaptation to visual deprivation, which would have initially caused a higher E/I ratio. Although intriguing, the strength of evidence in support of this view is not strong. Amongst the limitations are the low sample size, a critical control cohort that could provide evidence for higher E/I ratio in CC patients without recovered sight for example, and lower data quality in the control voxel. Nevertheless, the study provides a rare and valuable insight into experience-dependent plasticity in the human brain.

      Strengths of study

      How sensitive period experience shapes the developing brain is an enduring and important question in neuroscience. This question has been particularly difficult to investigate in humans. The authors recruited a small number of sight-recovered participants with bilateral congenital cataracts to investigate the effect of sensitive period deprivation on the balance of excitation and inhibition in the visual brain using measures of brain chemistry and brain electrophysiology. The research is novel, and the paper was interesting and well written.

      Limitations

      Low sample size. Ten for CC and ten for SC, and further two SC participants were rejected due to lack of frontal control voxel data. The sample size limits the statistical power of the dataset and increases the likelihood of effect inflation.

      In the updated manuscript, the authors have provided justification for their sample size by pointing to prior studies and the inherent difficulties in recruiting individuals with bilateral congenital cataracts. Importantly, this highlights the value the study brings to the field while also acknowledging the need to replicate the effects in a larger cohort.

      Lack of specific control cohort. The control cohort has normal vision. The control cohort is not specific enough to distinguish between people with sight loss due to different causes and patients with congenital cataracts with co-morbidities. Further data from a more specific populations, such as patients whose cataracts have not been removed, with developmental cataracts, or congenitally blind participants, would greatly improve the interpretability of the main finding. The lack of a more specific control cohort is a major caveat that limits a conclusive interpretation of the results.

      In the updated version, the authors have indicated that future studies can pursue comparisons between congenital cataract participants and cohorts with later sight loss.

      MRS data quality differences. Data quality in the control voxel appears worse than in the visual cortex voxel. The frontal cortex MRS spectrum shows far broader linewidth than the visual cortex (Supplementary Figures). Compared to the visual voxel, the frontal cortex voxel has less defined Glx and GABA+ peaks; lower GABA+ and Glx concentrations, lower NAA SNR values; lower NAA concentrations. If the data quality is a lot worse in the FC, then small effects may not be detectable.

      In the updated version, the authors have added more information that informs the reader of the MRS quality differences between voxel locations. This increases the transparency of their reporting and enhances the assessment of the results.

      Because of the direction of the difference in E/I, the authors interpret their findings as representing signatures of sight improvement after surgery without further evidence, either within the study or from the literature. However, the literature suggests that plasticity and visual deprivation drives the E/I index up rather than down. Decreasing GABA+ is thought to facilitate experience dependent remodelling. What evidence is there that cortical inhibition increases in response to a visual cortex that is over-sensitised to due congenital cataracts? Without further experimental or literature support this interpretation remains very speculative.

      The updated manuscript contains key reference from non-human work to justify their interpretation.

      Heterogeneity in patient group. Congenital cataract (CC) patients experienced a variety of duration of visual impairment and were of different ages. They presented with co-morbidities (absorbed lens, strabismus, nystagmus). Strabismus has been associated with abnormalities in GABAergic inhibition in the visual cortex. The possible interactions with residual vision and confounds of co-morbidities are not experimentally controlled for in the correlations, and not discussed.

      The updated document has addressed this caveat.

      Multiple exploratory correlations were performed to relate MRS measures to visual acuity (shown in Supplementary Materials), and only specific ones shown in the main document. The authors describe the analysis as exploratory in the 'Methods' section. Furthermore, the correlation between visual acuity and E/I metric is weak, not corrected for multiple comparisons. The results should be presented as preliminary, as no strong conclusions can be made from them. They can provide a hypothesis to test in a future study.

      This has now been done throughout the document and increases the transparency of the reporting.

      P.16 Given the correlation of the aperiodic intercept with age ("Age negatively correlated with the aperiodic intercept across CC and SC individuals, that is, a flattening of the intercept was observed with age"), age needs to be controlled for in the correlation between neurochemistry and the aperiodic intercept. Glx has also been shown to negatively correlates with age.

      This caveat has been addressed in the revised manuscript.

      Multiple exploratory correlations were performed to relate MRS to EEG measures (shown in Supplementary Materials), and only specific ones shown in the main document. Given the multiple measures from the MRS, the correlations with the EEG measures were exploratory, as stated in the text, p.16, and in Fig.4. yet the introduction said that there was a prior hypothesis "We further hypothesized that neurotransmitter changes would relate to changes in the slope and intercept of the EEG aperiodic activity in the same subjects." It would be great if the text could be revised for consistency and the analysis described as exploratory.

      This has been done throughout the document and increases the transparency of the reporting.

      The analysis for the EEG needs to take more advantage of the available data. As far as I understand, only two electrodes were used, yet far more were available as seen in their previous study (Ossandon et al., 2023). The spatial specificity is not established. The authors could use the frontal cortex electrode (FP1, FP2) signals as a control for spatial specificity in the group effects, or even better, all available electrodes and correct for multiple comparisons. Furthermore, they could use the aperiodic intercept vs Glx in SC to evaluate the specificity of the correlation to CC.

      This caveat has been addressed. The authors have added frontal electrodes to their analysis, providing an essential regional control for the visual cortex location.

      Comments on the latest version:

      The authors have made reasonable adjustments to their manuscript that addressed most of my comments by adding further justification for their methodology, essential literature support, pointing out exploratory analyses, limitations and adding key control analyses. Their revised manuscript has overall improved, providing valuable information, though the evidence that supports their claims is still incomplete.

      We thank the reviewer for suggesting ways to improve our manuscript and carefully reassessing our revised manuscript.

      Reviewer 2 (Public review):

      Summary:

      The study examined 10 congenitally blind patients who recovered vision through the surgical removal of bilateral dense cataracts, measuring neural activity and neuro chemical profiles from the visual cortex. The declared aim is to test whether restoring visual function after years of complete blindness impacts excitation/inhibition balance in the visual cortex.

      Strengths:

      The findings are undoubtedly useful for the community, as they contribute towards characterising the many ways in which this special population differs from normally sighted individuals. The combination of MRS and EEG measures is a promising strategy to estimate a fundamental physiological parameter - the balance between excitation and inhibition in the visual cortex, which animal studies show to be heavily dependent upon early visual experience. Thus, the reported results pave the way for further studies, which may use a similar approach to evaluate more patients and control groups.

      Weaknesses:

      The main methodological limitation is the lack of an appropriate comparison group or condition to delineate the effect of sight recovery (as opposed to the effect of congenital blindness). Few previous studies suggested that Excitation/Inhibition ratio in the visual cortex is increased in congenitally blind patients; the present study reports that E/I ratio decreases instead. The authors claim that this implies a change of E/I ratio following sight recovery. However, supporting this claim would require showing a shift of E/I after vs. before the sight-recovery surgery, or at least it would require comparing patients who did and did not undergo the sight-recovery surgery (as common in the field).

      We thank the reviewer for suggesting ways to improve our manuscript and carefully reassessing our revised manuscript.

      Since we have not been able to acquire longitudinal data with the experimental design of the present study in congenital cataract reversal individuals, we compared the MRS and EEG results of congenital cataract reversal individuals  to published work in congenitally permanent blind individuals. We consider this as a resource saving approach. We think that the results of our cross-sectional study now justify the costs and enormous efforts (and time for the patients who often have to travel long distances) associated with longitudinal studies in this rare population.

      There are also more technical limitations related to the correlation analyses, which are partly acknowledged in the manuscript. A bland correlation between GLX/GABA and the visual impairment is reported, but this is specific to the patients group (N=10) and would not hold across groups (the correlation is positive, predicting the lowest GLX/GABA ratio values for the sighted controls - opposite of what is found). There is also a strong correlation between GLX concentrations and the EEG power at the lowest temporal frequencies. Although this relation is intriguing, it only holds for a very specific combination of parameters (of the many tested): only with eyes open, only in the patients group.

      Given the exploratory nature of the correlations, we do not base the majority of our conclusions on this analysis. There are no doubts that the reported correlations need replication; however, replication is only possible after a first report. Thus, we hope to motivate corresponding analyses in further studies.

      It has to be noted that in the present study significance testing for correlations were corrected for multiple comparisons, and that some findings replicate earlier reports (e.g. effects on EEG aperiodic slope, alpha power, and correlations with chronological age).

      Conclusions:

      The main claim of the study is that sight recovery impacts the excitation/inhibition balance in the visual cortex, estimated with MRS or through indirect EEG indices. However, due to the weaknesses outlined above, the study cannot distinguish the effects of sight recovery from those of visual deprivation. Moreover, many aspects of the results are interesting but their validation and interpretation require additional experimental work.

      We interpret the group differences between individuals tested years after congenital visual deprivation and normally sighted individuals as supportive of the E/I ratio being impacted by congenital visual deprivation. In the absence of a sensitive period for the development of an E/I ratio, individuals with a transient phase of congenital blindness might have developed a visual system indistinguishable  from normally sighted individuals. As we demonstrate, this is not so. Comparing the results of congenitally blind humans with those of congenitally permanently blind humans (from previous studies) allowed us to identify changes of E/I ratio, which add to those found for congenital blindness.  

      We thank the reviewer for the helpful comments and suggestions related to the first submission and first revision of our manuscript. We are keen to translate some of them into future studies.

      Reviewer 3 (Public review):

      This manuscript examines the impact of congenital visual deprivation on the excitatory/inhibitory (E/I) ratio in the visual cortex using Magnetic Resonance Spectroscopy (MRS) and electroencephalography (EEG) in individuals whose sight was restored. Ten individuals with reversed congenital cataracts were compared to age-matched, normally sighted controls, assessing the cortical E/I balance and its interrelationship and to visual acuity. The study reveals that the Glx/GABA ratio in the visual cortex and the intercept and aperiodic signal are significantly altered in those with a history of early visual deprivation, suggesting persistent neurophysiological changes despite visual restoration.

      First of all, I would like to disclose that I am not an expert in congenital visual deprivation, nor in MRS. My expertise is in EEG (particularly in the decomposition of periodic and aperiodic activity) and statistical methods.

      Although the authors addressed some of the concerns of the previous version, major concerns and flaws remain in terms of methodological and statistical approaches along with the (over)interpretation of the results. Specific concerns include:

      (1 3.1 Response to Variability in Visual Deprivation<br /> Rather than listing the advantages and disadvantages of visual deprivation, I recommend providing at least a descriptive analysis of how the duration of visual deprivation influenced the measures of interest. This would enhance the depth and relevance of the discussion.

      Although Review 2 and Review 3 (see below) pointed out problems in interpreting multiple correlational analyses in small samples, we addressed this request by reporting such correlations between visual deprivation history and measured EEG/MRS outcomes.

      Calculating the correlation between duration of visual deprivation and behavioral or brain measures is, in fact, a common suggestion. The existence of sensitive periods, which are typically assumed to not follow a linear gradual decline of neuroplasticity, does not necessary allow predicting a correlation with duration of blindness. Daphne Maurer has additionally worked on the concept of “sleeper effects” (Maurer et al., 2007), that is, effects on the brain and behavior by early deprivation which are observed only later in life when the function/neural circuits matures.

      In accordance with this reasoning, we did not observe a significant correlation between duration of visual deprivation and any of our dependent variables.

      (2 3.2) Small Sample Size

      The issue of small sample size remains problematic. The justification that previous studies employed similar sample sizes does not adequately address the limitation in the current study. I strongly suggest that the correlation analyses should not feature prominently in the main manuscript or the abstract, especially if the discussion does not substantially rely on these correlations. Please also revisit the recommendations made in the section on statistical concerns.

      In the revised manuscript, we explicitly mention that our sample size is not atypical for the special group investigated, but that a replication of our results in larger samples would foster their impact. We only explicitly mention correlations that survived stringent testing for multiple comparisons in the main manuscript.

      Given the exploratory nature of the correlations, we have not based the majority of our claims on this analysis.

      (3 3.3) Statistical Concerns

      While I appreciate the effort of conducting an independent statistical check, it merely validates whether the reported statistical parameters, degrees of freedom (df), and p-values are consistent. However, this does not address the appropriateness of the chosen statistical methods.

      We did not intend for the statcheck report to justify the methods used for statistics, which we have done in a separate section with normality and homogeneity testing (Supplementary Material S9), and references to it in the descriptions of the statistical analyses (Methods, Page 13, Lines 326-329 and Page 15, Lines 400-402).

      Several points require clarification or improvement:

      (4) Correlation Methods: The manuscript does not specify whether the reported correlation analyses are based on Pearson or Spearman correlation.

      The depicted correlations are Pearson correlations. We will add this information to the Methods.

      (5) Confidence Intervals: Include confidence intervals for correlations to represent the uncertainty associated with these estimates.

      We will add the confidence intervals to the second revision of our manuscript.

      (6) Permutation Statistics: Given the small sample size, I recommend using permutation statistics, as these are exact tests and more appropriate for small datasets.

      Our study focuses on a rare population, with a sample size limited by the availability of participants. Our findings provide exploratory insights rather than make strong inferential claims. To this end, we have ensured that our analysis adheres to key statistical assumptions (Shapiro-Wilk as well as Levene’s tests, Supplementary Material S9),and reported our findings with effect sizes, appropriate caution and context.

      (7) Adjusted P-Values: Ensure that reported Bonferroni corrected p-values (e.g., p > 0.999) are clearly labeled as adjusted p-values where applicable.

      In the revised manuscript, we will change Figure 4 to say ‘adjusted p,’  which we indeed reported.

      (8) Figure 2C

      Figure 2C still lacks crucial information that the correlation between Glx/GABA ratio and visual acuity was computed solely in the control group (as described in the rebuttal letter). Why was this analysis restricted to the control group? Please provide a rationale.

      Figure 2C depicts the correlation between Glx/GABA+ ratio and visual acuity in the congenital cataract reversal group, not the control group. This is mentioned in the Figure 2 legend, as well as in the main text where the figure is referred to (Page 18, Line 475).

      The correlation analyses between visual acuity and MRS/EEG measures were only performed in the congenital cataract reversal group since the sighed control group comprised of individuals with vision in the normal range; thus this analyses would not make sense. Table 1 with the individual visual acuities for all participants, including the normally sighted controls, shows the low variance in the latter group.  

      For variables in which no apiori group differences in variance were predicted, we performed the correlation analyses across groups (see Supplementary Material S12, S15).

      We will highlight these motivations more clearly in the Methods of the revised manuscript.

      (9 3.4) Interpretation of Aperiodic Signal

      Relying on previous studies to interpret the aperiodic slope as a proxy for excitation/inhibition (E/I) does not make the interpretation more robust.

      How to interpret aperiodic EEG activity has been subject of extensive investigation. We cite studies which provide evidence from multiple species (monkeys, humans) and measurements (EEG, MEG, ECoG), including studies which pharmacologically manipulated E/I balance.

      Whether our findings are robust, in fact, requires a replication study. Importantly, we analyzed the intercept of the aperiodic activity fit as well, and discuss results related to the intercept.

      Quote:

      “3.4 Interpretation of aperiodic signal:

      - Several recent papers demonstrated that the aperiodic signal measured in EEG or ECoG is related to various important aspects such as age, skull thickness, electrode impedance, as well as cognition. Thus, currently, very little is known about the underlying effects which influence the aperiodic intercept and slope. The entire interpretation of the aperiodic slope as a proxy for E/I is based on a computational model and simulation (as described in the Gao et al. paper).

      Response: Apart from the modeling work from Gao et al., multiple papers which have also been cited which used ECoG, EEG and MEG and showed concomitant changes in aperiodic activity with pharmacological manipulation of the E/I ratio (Colombo et al., 2019; Molina et al., 2020; Muthukumaraswamy & Liley, 2018). Further, several prior studies have interpreted changes in the aperiodic slope as reflective of changes in the E/I ratio, including studies of developmental groups (Favaro et al., 2023; Hill et al., 2022; McSweeney et al., 2023; Schaworonkow & Voytek, 2021) as well as patient groups (Molina et al., 2020; Ostlund et al., 2021).

      - The authors further wrote: We used the slope of the aperiodic (1/f) component of the EEG spectrum as an estimate of E/I ratio (Gao et al., 2017; Medel et al., 2020; Muthukumaraswamy & Liley, 2018). This is a highly speculative interpretation with very little empirical evidence. These papers were conducted with ECoG data (mostly in animals) and mostly under anesthesia. Thus, these studies only allow an indirect interpretation by what the 1/f slope in EEG measurements is actually influenced.

      Response: Note that Muthukumaraswamy et al. (2018) used different types of pharmacological manipulations and analyzed periodic and aperiodic MEG activity in humans, in addition to monkey ECoG (Muthukumaraswamy & Liley, 2018). Further, Medel et al. (now published as Medel et al., 2023) compared EEG activity in addition to ECoG data after propofol administration. The interpretation of our results are in line with a number of recent studies in developing (Hill et al., 2022; Schaworonkow & Voytek, 2021) and special populations using EEG. As mentioned above, several prior studies have used the slope of the 1/f component/aperiodic activity as an indirect measure of the E/I ratio (Favaro et al., 2023; Hill et al., 2022; McSweeney et al., 2023; Molina et al., 2020; Ostlund et al., 2021; Schaworonkow & Voytek, 2021), including studies using scalp-recorded EEG from humans.

      In the introduction of the revised manuscript, we have made more explicit that this metric is indirect (Page 3, Line 91), (additionally see Discussion, Page 24, Lines 644-645, Page 25, Lines 650-657).

      While a full understanding of aperiodic activity needs to be provided, some convergent ideas have emerged. We think that our results contribute to this enterprise, since our study is, to the best of our knowledge, the first which assessed MRS measured neurotransmitter levels and EEG aperiodic activity.“

      (10) Additionally, the authors state:

      "We cannot think of how any of the exploratory correlations between neurophysiological measures and MRS measures could be accounted for by a difference e.g. in skull thickness."

      (11) This could be addressed directly by including skull thickness as a covariate or visualizing it in scatterplots, for instance, by representing skull thickness as the size of the dots.

      We are not aware of any study that would justify such an analysis.

      Our analyses were based on previous findings in the literature.

      Since to the best of our knowledge, no evidence exists that congenital cataracts go together with changes in skull thickness, and that skull thickness might selectively modulate visual cortex Glx/GABA+ but not NAA measures, we decided against following this suggestion.

      Notably, the neurotransmitter concentration reported here is after tissue segmentation of the voxel region. The tissue fraction was shown to not differ between groups in the MRS voxels (Supplementary Material S4). The EEG electrode impedance was lowered to <10 kOhm in every participant (Methods, Page 13, Line 344), and preparation was identical across groups.

      (12 3.5) Problems with EEG Preprocessing and Analysis

      Downsampling: The decision to downsample the data to 60 Hz "to match the stimulation rate" is problematic. This choice conflates subsequent spectral analyses due to aliasing issues, as explained by the Nyquist theorem. While the authors cite prior studies (Schwenk et al., 2020; VanRullen & MacDonald, 2012) to justify this decision, these studies focused on alpha (8-12 Hz), where aliasing is less of a concern compared of analyzing aperiodic signal. Furthermore, in contrast, the current study analyzes the frequency range from 1-20 Hz, which is too narrow for interpreting the aperiodic signal as E/I. Typically, this analysis should include higher frequencies, spanning at least 1-30 Hz or even 1-45 Hz (not 20-40 Hz).

      As mentioned in the Methods (Page 15 Line 376) and the previous response, the pop_resample function used by EEGLAB applies an anti-aliasing filter, at half the resampling frequency (as per the Nyquist theorem https://eeglab.org/tutorials/05_Preprocess/resampling.html). The upper cut off of the low pass filter set by EEGlab prior to down sampling (30 Hz) is still far above the frequency of interest in the current study  (1-20 Hz), thus allowing us to derive valid results.

      Quote:

      “- The authors downsampled the data to 60Hz to "to match the stimulation rate". What is the intention of this? Because the subsequent spectral analyses are conflated by this choice (see Nyquist theorem).

      Response: This data were collected as part of a study designed to evoke alpha activity with visual white-noise, which ranged in luminance with equal power at all frequencies from 1-60 Hz, restricted by the refresh rate of the monitor on which stimuli were presented (Pant et al., 2023). This paradigm and method was developed by VanRullen and colleagues (Schwenk et al., 2020; Vanrullen & MacDonald, 2012), wherein the analysis requires the same sampling rate between the presented frequencies and the EEG data. The downsampling function used here automatically applies an anti-aliasing filter (EEGLAB 2019) .”

      Moreover, the resting-state data were not resampled to 60 Hz. We will make this clearer in the Methods of the revised manuscript.

      Our consistent results of group differences across all three  EEG conditions, thus, exclude any possibility that they were driven by aliasing artifacts.

      The expected effects of this anti-aliasing filter can be seen in the attached Figure R1, showing an example participant’s spectrum in the 1-30 Hz range (as opposed to the 1-20 Hz plotted in the manuscript), clearly showing a 30-40 dB drop at 30 Hz. Any aliasing due to, for example, remaining line noise, would additionally be visible in this figure (as well as Figure 3) as a peak.

      Author response image 1.

      Power spectral density of one congenital cataract-reversal (CC) participant in the visual stimulation condition across all channels. The reduced power at 30 Hz shows the effects of the anti-aliasing filter applied by EEGLAB’s pop_resample function.

      As we stated in the manuscript, and in previous reviews, so far there has been no consensus on the exact range of measuring aperiodic activity. We made a principled decision based on the literature (showing a knee in aperiodic fits of this dataset at 20 Hz) (Medel et al., 2023; Ossandón et al., 2023), data quality (possible contamination by line noise at higher frequencies) and the purpose of the visual stimulation experiment (to look at the lower frequency range by stimulating up to 60 Hz, thereby limiting us to quantifying below 30 Hz), that 1-20 Hz would be the fit range in this dataset.

      Quote:

      “(3) What's the underlying idea of analyzing two separate aperiodic slopes (20-40Hz and 1-19Hz). This is very unusual to compute the slope between 20-40 Hz, where the SNR is rather low.

      "Ossandón et al. (2023), however, observed that in addition to the flatter slope of the aperiodic power spectrum in the high frequency range (20-40 Hz), the slope of the low frequency range (1-19 Hz) was steeper in both, congenital cataract-reversal individuals, as well as in permanently congenitally blind humans."

      Response: The present manuscript computed the slope between 1-20 Hz. Ossandón et al. as well as Medel et al. (2023) found a “knee” of the 1/f distribution at 20 Hz and describe further the motivations for computing both slope ranges. For example, Ossandón et al. used a data driven approach and compared single vs. dual fits and found that the latter fitted the data better. Additionally, they found the best fit if a knee at 20 Hz was used. We would like to point out that no standard range exists for the fitting of the 1/f component across the literature and, in fact, very different ranges have been used (Gao et al., 2017; Medel et al., 2023; Muthukumaraswamy & Liley, 2018).“

      (13) Baseline Removal: Subtracting the mean activity across an epoch as a baseline removal step is inappropriate for resting-state EEG data. This preprocessing step undermines the validity of the analysis. The EEG dataset has fundamental flaws, many of which were pointed out in the previous review round but remain unaddressed. In its current form, the manuscript falls short of standards for robust EEG analysis. If I were reviewing for another journal, I would recommend rejection based on these flaws.

      The baseline removal step from each epoch serves to remove the DC component of the recording and detrend the data. This is a standard preprocessing step (included as an option in preprocessing pipelines recommended by the EEGLAB toolbox, FieldTrip toolbox and MNE toolbox), additionally necessary to improve the efficacy of ICA decomposition (Groppe et al., 2009).

      In the previous review round, a clarification of the baseline timing was requested, which we added. Beyond this request, there was no mention of the appropriateness of the baseline removal and/or a request to provide reasons for why it might not undermine the validity of the analysis.

      Quote:

      “- "Subsequently, baseline removal was conducted by subtracting the mean activity across the length of an epoch from every data point." The actual baseline time segment should be specified.

      Response: The time segment was the length of the epoch, that is, 1 second for the resting state conditions and 6.25 seconds for the visual stimulation conditions. This has been explicitly stated in the revised manuscript (Page 13, Line 354).”

      Prior work in the time (not frequency) domain on event-related potential (ERP) analysis has suggested that the baselining step might cause spurious effects (Delorme, 2023) (although see (Tanner et al., 2016)). We did not perform ERP analysis at any stage. One recent study suggests spurious group differences in the 1/f signal might be driven by an inappropriate dB division baselining method (Gyurkovics et al., 2021), which we did not perform.

      Any effect of our baselining procedure on the FFT spectrum would be below the 1 Hz range, which we did not analyze.  

      Each of the preprocessing steps in the manuscript match pipelines described and published in extensive prior work. We document how multiple aspects of our EEG results replicate prior findings (Supplementary Material S15, S18, S19), reports of other experimenters, groups and locations, validating that our results are robust.

      We therefore reject the claim of methodological flaws in our EEG analyses in the strongest possible terms.

      Quote:

      “3.5 Problems with EEG preprocessing and analysis:

      - It seems that the authors did not identify bad channels nor address the line noise issue (even a problem if a low pass filter of below-the-line noise was applied).

      Response: As pointed out in the methods and Figure 1, we only analyzed data from two occipital channels, O1 and O2 neither of which were rejected for any participant. Channel rejection was performed for the larger dataset, published elsewhere (Ossandón et al., 2023; Pant et al., 2023). As control sites we added the frontal channels FP1 and Fp2 (see Supplementary Material S14)

      Neither Ossandón et al. (2023) nor Pant et al. (2023) considered frequency ranges above 40 Hz to avoid any possible contamination with line noise. Here, we focused on activity between 0 and 20 Hz, definitely excluding line noise contaminations (Methods, Page 14, Lines 365-367). The low pass filter (FIR, 1-45 Hz) guaranteed that any spill-over effects of line noise would be restricted to frequencies just below the upper cutoff frequency.

      Additionally, a prior version of the analysis used spectrum interpolation to remove line noise; the group differences remained stable (Ossandón et al., 2023). We have reported this analysis in the revised manuscript (Page 14, Lines 364-357).

      Further, both groups were measured in the same lab, making line noise (~ 50 Hz) as an account for the observed group effects in the 1-20 Hz frequency range highly unlikely. Finally, any of the exploratory MRS-EEG correlations would be hard to explain if the EEG parameters would be contaminated with line noise.

      - What was the percentage of segments that needed to be rejected due to the 120μV criteria? This should be reported specifically for EO & EC and controls and patients.

      Response: The mean percentage of 1 second segments rejected for each resting state condition and the percentage of 6.25 long segments rejected in each group for the visual stimulation condition have been added to the revised manuscript (Supplementary Material S10), and referred to in the Methods on Page 14, Lines 372-373).

      - The authors downsampled the data to 60Hz to "to match the stimulation rate". What is the intention of this? Because the subsequent spectral analyses are conflated by this choice (see Nyquist theorem).

      Response: This data were collected as part of a study designed to evoke alpha activity with visual white-noise, which changed in luminance with equal power at all frequencies from 1-60 Hz, restricted by the refresh rate of the monitor on which stimuli were presented (Pant et al., 2023). This paradigm and method was developed by VanRullen and colleagues (Schwenk et al., 2020; VanRullen & MacDonald, 2012), wherein the analysis requires the same sampling rate between the presented frequencies and the EEG data. The downsampling function used here automatically applies an anti-aliasing filter (EEGLAB 2019) .

      - "Subsequently, baseline removal was conducted by subtracting the mean activity across the length of an epoch from every data point." The actual baseline time segment should be specified.

      The time segment was the length of the epoch, that is, 1 second for the resting state conditions and 6.25 seconds for the visual stimulation conditions. This has now been explicitly stated in the revised manuscript (Page 14, Lines 379-380).<br /> - "We excluded the alpha range (8-14 Hz) for this fit to avoid biasing the results due to documented differences in alpha activity between CC and SC individuals (Bottari et al., 2016; Ossandón et al., 2023; Pant et al., 2023)." This does not really make sense, as the FOOOF algorithm first fits the 1/f slope, for which the alpha activity is not relevant.

      Response: We did not use the FOOOF algorithm/toolbox in this manuscript. As stated in the Methods, we used a 1/f fit to the 1-20 Hz spectrum in the log-log space, and subtracted this fit from the original spectrum to obtain the corrected spectrum. Given the pronounced difference in alpha power between groups (Bottari et al., 2016; Ossandón et al., 2023; Pant et al., 2023), we were concerned it might drive differences in the exponent values. Our analysis pipeline had been adapted from previous publications of our group and other labs (Ossandón et al., 2023; Voytek et al., 2015; Waschke et al., 2017).

      We have conducted the analysis with and without the exclusion of the alpha range, as well as using the FOOOF toolbox both in the 1-20 Hz and 20-40 Hz ranges (Ossandón et al., 2023). The findings of a steeper slope in the 1-20 Hz range as well as lower alpha power in CC vs SC individuals remained stable. In Ossandón et al., the comparison between the piecewise fits and FOOOF fits led the authors to use the former, as it outperformed the FOOOF algorithm for their data.

      - The model fits of the 1/f fitting for EO, EC, and both participant groups should be reported.

      Response: In Figure 3 of the manuscript, we depicted the mean spectra and 1/f fits for each group.

      In the revised manuscript, we added the fit quality metrics (average R<sup>2</sup> values > 0.91 for each group and condition) (Methods Page 15, Lines 395-396; Supplementary Material S11) and additionally show individual subjects’ fits (Supplementary Material S11).“

      (14) The authors mention:

      "The EEG data sets reported here were part of data published earlier (Ossandón et al., 2023; Pant et al., 2023)." Thus, the statement "The group differences for the EEG assessments corresponded to those of a larger sample of CC individuals (n=38) " is a circular argument and should be avoided."

      The authors addressed this comment and adjusted the statement. However, I do not understand, why not the full sample published earlier (Ossandón et al., 2023) was used in the current study?

      The recording of EEG resting state data stated in 2013, while MRS testing could only be set up by the end of 2019. Moreover, not all subjects who qualify for EEG recording qualify for being scanned (e.g. due to MRI safety, claustrophobia)

      References

      Bottari, D., Troje, N. F., Ley, P., Hense, M., Kekunnaya, R., & Röder, B. (2016). Sight restoration after congenital blindness does not reinstate alpha oscillatory activity in humans. Scientific Reports. https://doi.org/10.1038/srep24683

      Colombo, M. A., Napolitani, M., Boly, M., Gosseries, O., Casarotto, S., Rosanova, M., Brichant, J. F., Boveroux, P., Rex, S., Laureys, S., Massimini, M., Chieregato, A., & Sarasso, S. (2019). The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine. NeuroImage, 189(September 2018), 631–644. https://doi.org/10.1016/j.neuroimage.2019.01.024

      Delorme, A. (2023). EEG is better left alone. Scientific Reports, 13(1), 2372. https://doi.org/10.1038/s41598-023-27528-0

      Favaro, J., Colombo, M. A., Mikulan, E., Sartori, S., Nosadini, M., Pelizza, M. F., Rosanova, M., Sarasso, S., Massimini, M., & Toldo, I. (2023). The maturation of aperiodic EEG activity across development reveals a progressive differentiation of wakefulness from sleep. NeuroImage, 277. https://doi.org/10.1016/J.NEUROIMAGE.2023.120264

      Gao, R., Peterson, E. J., & Voytek, B. (2017). Inferring synaptic excitation/inhibition balance from field potentials. NeuroImage, 158(March), 70–78. https://doi.org/10.1016/j.neuroimage.2017.06.078

      Groppe, D. M., Makeig, S., & Kutas, M. (2009). Identifying reliable independent components via split-half comparisons. NeuroImage, 45(4), 1199–1211. https://doi.org/10.1016/j.neuroimage.2008.12.038

      Gyurkovics, M., Clements, G. M., Low, K. A., Fabiani, M., & Gratton, G. (2021). The impact of 1/f activity and baseline correction on the results and interpretation of time-frequency analyses of EEG/MEG data: A cautionary tale. NeuroImage, 237. https://doi.org/10.1016/j.neuroimage.2021.118192

      Hill, A. T., Clark, G. M., Bigelow, F. J., Lum, J. A. G., & Enticott, P. G. (2022). Periodic and aperiodic neural activity displays age-dependent changes across early-to-middle childhood. Developmental Cognitive Neuroscience, 54, 101076. https://doi.org/10.1016/J.DCN.2022.101076

      Maurer, D., Mondloch, C. J., & Lewis, T. L. (2007). Sleeper effects. In Developmental Science. https://doi.org/10.1111/j.1467-7687.2007.00562.x

      McSweeney, M., Morales, S., Valadez, E. A., Buzzell, G. A., Yoder, L., Fifer, W. P., Pini, N., Shuffrey, L. C., Elliott, A. J., Isler, J. R., & Fox, N. A. (2023). Age-related trends in aperiodic EEG activity and alpha oscillations during early- to middle-childhood. NeuroImage, 269, 119925. https://doi.org/10.1016/j.neuroimage.2023.119925

      Medel, V., Irani, M., Crossley, N., Ossandón, T., & Boncompte, G. (2023). Complexity and 1/f slope jointly reflect brain states. Scientific Reports, 13(1), 21700. https://doi.org/10.1038/s41598-023-47316-0

      Molina, J. L., Voytek, B., Thomas, M. L., Joshi, Y. B., Bhakta, S. G., Talledo, J. A., Swerdlow, N. R., & Light, G. A. (2020). Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 5(6), 562–568. https://doi.org/10.1016/j.bpsc.2020.02.004

      Muthukumaraswamy, S. D., & Liley, D. T. (2018). 1/F electrophysiological spectra in resting and drug-induced states can be explained by the dynamics of multiple oscillatory relaxation processes. NeuroImage, 179(November 2017), 582–595. https://doi.org/10.1016/j.neuroimage.2018.06.068

      Ossandón, J. P., Stange, L., Gudi-Mindermann, H., Rimmele, J. M., Sourav, S., Bottari, D., Kekunnaya, R., & Röder, B. (2023). The development of oscillatory and aperiodic resting state activity is linked to a sensitive period in humans. NeuroImage, 275, 120171. https://doi.org/10.1016/J.NEUROIMAGE.2023.120171

      Ostlund, B. D., Alperin, B. R., Drew, T., & Karalunas, S. L. (2021). Behavioral and cognitive correlates of the aperiodic (1/f-like) exponent of the EEG power spectrum in adolescents with and without ADHD. Developmental Cognitive Neuroscience, 48, 100931. https://doi.org/10.1016/j.dcn.2021.100931

      Pant, R., Ossandón, J., Stange, L., Shareef, I., Kekunnaya, R., & Röder, B. (2023). Stimulus-evoked and resting-state alpha oscillations show a linked dependence on patterned visual experience for development. NeuroImage: Clinical, 103375. https://doi.org/10.1016/J.NICL.2023.103375

      Schaworonkow, N., & Voytek, B. (2021). Longitudinal changes in aperiodic and periodic activity in electrophysiological recordings in the first seven months of life. Developmental Cognitive Neuroscience, 47. https://doi.org/10.1016/j.dcn.2020.100895

      Schwenk, J. C. B., VanRullen, R., & Bremmer, F. (2020). Dynamics of Visual Perceptual Echoes Following Short-Term Visual Deprivation. Cerebral Cortex Communications, 1(1). https://doi.org/10.1093/TEXCOM/TGAA012

      Tanner, D., Norton, J. J. S., Morgan-Short, K., & Luck, S. J. (2016). On high-pass filter artifacts (they’re real) and baseline correction (it’s a good idea) in ERP/ERMF analysis. Journal of Neuroscience Methods, 266, 166–170. https://doi.org/10.1016/j.jneumeth.2016.01.002

      Vanrullen, R., & MacDonald, J. S. P. (2012). Perceptual echoes at 10 Hz in the human brain. Current Biology. https://doi.org/10.1016/j.cub.2012.03.050

      Voytek, B., Kramer, M. A., Case, J., Lepage, K. Q., Tempesta, Z. R., Knight, R. T., & Gazzaley, A. (2015). Age-related changes in 1/f neural electrophysiological noise. Journal of Neuroscience, 35(38). https://doi.org/10.1523/JNEUROSCI.2332-14.2015

      Waschke, L., Wöstmann, M., & Obleser, J. (2017). States and traits of neural irregularity in the age-varying human brain. Scientific Reports 2017 7:1, 7(1), 1–12. https://doi.org/10.1038/s41598-017-17766-4


      The following is the authors’ response to the original reviews.

      eLife Assessment

      This potentially useful study involves neuro-imaging and electrophysiology in a small cohort of congenital cataract patients after sight recovery and age-matched control participants with normal sight. It aims to characterize the effects of early visual deprivation on excitatory and inhibitory balance in the visual cortex. While the findings are taken to suggest the existence of persistent alterations in Glx/GABA ratio and aperiodic EEG signals, the evidence supporting these claims is incomplete. Specifically, small sample sizes, lack of a specific control cohort, and other methodological limitations will likely restrict the usefulness of the work, with relevance limited to scientists working in this particular subfield.

      As pointed out in the public reviews, there are very few human models which allow for assessing the role of early experience on neural circuit development. While the prevalent research in permanent congenital blindness reveals the response and adaptation of the developing brain to an atypical situation (blindness), research in sight restoration addresses the question of whether and how atypical development can be remediated if typical experience (vision) is restored. The literature on the role of visual experience in the development of E/I balance in humans, assessed via Magnetic Resonance Spectroscopy (MRS), has been limited to a few studies on congenital permanent blindness. Thus, we assessed sight recovery individuals with a history of congenital blindness, as limited evidence from other researchers indicated that the visual cortex E/I ratio might differ compared to normally sighted controls.

      Individuals with total bilateral congenital cataracts who remained untreated until later in life are extremely rare, particularly if only carefully diagnosed patients are included in a study sample. A sample size of 10 patients is, at the very least, typical of past studies in this population, even for exclusively behavioral assessments. In the present study, in addition to behavioral assessment as an indirect measure of sensitive periods, we investigated participants with two neuroimaging methods (Magnetic Resonance Spectroscopy and electroencephalography) to directly assess the neural correlates of sensitive periods in humans. The electroencephalography data allowed us to link the results of our small sample to findings documented in large cohorts of both, sight recovery individuals and permanently congenitally blind individuals. As pointed out in a recent editorial recommending an “exploration-then-estimation procedure,” (“Consideration of Sample Size in Neuroscience Studies,” 2020), exploratory studies like ours provide crucial direction and specific hypotheses for future work.

      We included an age-matched sighted control group recruited from the same community, measured in the same scanner and laboratory, to assess whether early experience is necessary for a typical excitatory/inhibitory (E/I) ratio to emerge in adulthood. The present findings indicate that this is indeed the case. Based on these results, a possible question to answer in future work, with individuals who had developmental cataracts, is whether later visual deprivation causes similar effects. Note that even if visual deprivation at a later stage in life caused similar effects, the current results would not be invalidated; by contrast, they are essential to understand future work on late (permanent or transient) blindness.

      Thus, we think that the present manuscript has far reaching implications for our understanding of the conditions under which E/I balance, a crucial characteristic of brain functioning, emerges in humans.

      Finally, our manuscript is one of the first few studies that relate MRS neurotransmitter concentrations to parameters of EEG aperiodic activity. Since present research has been using aperiodic activity as a correlate of the E/I ratio, and partially of higher cognitive functions, we think that our manuscript additionally contributes to a better understanding of what might be measured with aperiodic neurophysiological activity.

      Public Reviews:<br /> Reviewer #1 (Public Review):

      Summary:

      In this human neuroimaging and electrophysiology study, the authors aimed to characterize the effects of a period of visual deprivation in the sensitive period on excitatory and inhibitory balance in the visual cortex. They attempted to do so by comparing neurochemistry conditions ('eyes open', 'eyes closed') and resting state, and visually evoked EEG activity between ten congenital cataract patients with recovered sight (CC), and ten age-matched control participants (SC) with normal sight.

      First, they used magnetic resonance spectroscopy to measure in vivo neurochemistry from two locations, the primary location of interest in the visual cortex, and a control location in the frontal cortex. Such voxels are used to provide a control for the spatial specificity of any effects because the single-voxel MRS method provides a single sampling location. Using MR-visible proxies of excitatory and inhibitory neurotransmission, Glx and GABA+ respectively, the authors report no group effects in GABA+ or Glx, no difference in the functional conditions 'eyes closed' and 'eyes open'. They found an effect of the group in the ratio of Glx/GABA+ and no similar effect in the control voxel location. They then performed multiple exploratory correlations between MRS measures and visual acuity, and reported a weak positive correlation between the 'eyes open' condition and visual acuity in CC participants.

      The same participants then took part in an EEG experiment. The authors selected only two electrodes placed in the visual cortex for analysis and reported a group difference in an EEG index of neural activity, the aperiodic intercept, as well as the aperiodic slope, considered a proxy for cortical inhibition. They report an exploratory correlation between the aperiodic intercept and Glx in one out of three EEG conditions.

      The authors report the difference in E/I ratio, and interpret the lower E/I ratio as representing an adaptation to visual deprivation, which would have initially caused a higher E/I ratio. Although intriguing, the strength of evidence in support of this view is not strong. Amongst the limitations are the low sample size, a critical control cohort that could provide evidence for a higher E/I ratio in CC patients without recovered sight for example, and lower data quality in the control voxel.

      Strengths of study:

      How sensitive period experience shapes the developing brain is an enduring and important question in neuroscience. This question has been particularly difficult to investigate in humans. The authors recruited a small number of sight-recovered participants with bilateral congenital cataracts to investigate the effect of sensitive period deprivation on the balance of excitation and inhibition in the visual brain using measures of brain chemistry and brain electrophysiology. The research is novel, and the paper was interesting and well-written.

      Limitations:

      (1.1) Low sample size. Ten for CC and ten for SC, and a further two SC participants were rejected due to a lack of frontal control voxel data. The sample size limits the statistical power of the dataset and increases the likelihood of effect inflation.

      Applying strict criteria, we only included individuals who were born with no patterned vision in the CC group. The population of individuals who have remained untreated past infancy is small in India, despite a higher prevalence of childhood cataract than Germany. Indeed, from the original 11 CC and 11 SC participants tested, one participant each from the CC and SC group had to be rejected, as their data had been corrupted, resulting in 10 participants in each group.

      It was a challenge to recruit participants from this rare group with no history of neurological diagnosis/intake of neuromodulatory medications, who were able and willing to undergo both MRS and EEG. For this study, data collection took more than 2.5 years.

      We took care of the validity of our results with two measures; first, we assessed not just MRS, but additionally, EEG measures of E/I ratio. The latter allowed us to link results to a larger population of CC individuals, that is, we replicated the results of a larger group of 28 additional individuals (Ossandón et al., 2023) in our sub-group.

      Second, we included a control voxel. As predicted, all group effects were restricted to the occipital voxel.

      (1.2) Lack of specific control cohort. The control cohort has normal vision. The control cohort is not specific enough to distinguish between people with sight loss due to different causes and patients with congenital cataracts with co-morbidities. Further data from more specific populations, such as patients whose cataracts have not been removed, with developmental cataracts, or congenitally blind participants, would greatly improve the interpretability of the main finding. The lack of a more specific control cohort is a major caveat that limits a conclusive interpretation of the results.

      The existing work on visual deprivation and neurochemical changes, as assessed with MRS, has been limited to permanent congenital blindness. In fact, most of the studies on permanent blindness included only congenitally blind or early blind humans (Coullon et al., 2015; Weaver et al., 2013), or, in separate studies, only late-blind individuals (Bernabeu et al., 2009). Thus, accordingly, we started with the most “extreme” visual deprivation model, sight recovery after congenital blindness. If we had not observed any group difference compared to normally sighted controls, investigating other groups might have been trivial. Based on our results, subsequent studies in late blind individuals, and then individuals with developmental cataracts, can be planned with clear hypotheses.

      (1.3) MRS data quality differences. Data quality in the control voxel appears worse than in the visual cortex voxel. The frontal cortex MRS spectrum shows far broader linewidth than the visual cortex (Supplementary Figures). Compared to the visual voxel, the frontal cortex voxel has less defined Glx and GABA+ peaks; lower GABA+ and Glx concentrations, lower NAA SNR values; lower NAA concentrations. If the data quality is a lot worse in the FC, then small effects may not be detectable.

      Worse data quality in the frontal than the visual cortex has been repeatedly observed in the MRS literature, attributable to magnetic field distortions (Juchem & Graaf, 2017) resulting from the proximity of the region to the sinuses (recent example: (Rideaux et al., 2022)). Nevertheless, we chose the frontal control region rather than a parietal voxel, given the potential neurochemical changes in multisensory regions of the parietal cortex due to blindness. Such reorganization would be less likely in frontal areas associated with higher cognitive functions. Further, prior MRS studies of the visual cortex have used the frontal cortex as a control region as well (Pitchaimuthu et al., 2017; Rideaux et al., 2022). In the revised manuscript, we more explicitly inform the reader about this data quality difference between regions in the Methods (Pages 11-12, MRS Data Quality/Table 2) and Discussion (Page 25, Lines 644- 647).

      Importantly, while in the present study data quality differed between the frontal and visual cortex voxel, it did not differ between groups (Supplementary Material S6).  

      Further, we checked that the frontal cortex datasets for Glx and GABA+ concentrations were of sufficient quality: the fit error was below 8.31% in both groups (Supplementary Material S3). For reference, Mikkelsen et al. reported a mean GABA+ fit error of 6.24 +/- 1.95% from a posterior cingulate cortex voxel across 8 GE scanners, using the Gannet pipeline. No absolute cutoffs have been proposed for fit errors. However, MRS studies in special populations (I/E ratio assessed in narcolepsy (Gao et al., 2024), GABA concentration assessed in Autism Spectrum Disorder (Maier et al., 2022) have used frontal cortex data with a fit error of <10% to identify differences between cohorts (Gao et al., 2024; Pitchaimuthu et al., 2017). Based on the literature, MRS data from the frontal voxel of the present study would have been of sufficient quality to uncover group differences.

      In the revised manuscript, we added the recently published MRS quality assessment form to the supplementary materials (Supplementary Excel File S1). Additionally, we would like to allude to our apriori prediction of group differences for the visual cortex, but not for the frontal cortex voxel. Finally, EEG data quality did not differ between frontal and occipital electrodes; therefore, lower sensitivity of frontal measures cannot easily explain the lack of group differences for frontal measures.

      (1.4) Because of the direction of the difference in E/I, the authors interpret their findings as representing signatures of sight improvement after surgery without further evidence, either within the study or from the literature. However, the literature suggests that plasticity and visual deprivation drive the E/I index up rather than down. Decreasing GABA+ is thought to facilitate experience-dependent remodelling. What evidence is there that cortical inhibition increases in response to a visual cortex that is over-sensitised due to congenital cataracts? Without further experimental or literature support this interpretation remains very speculative.

      Indeed, higher inhibition was not predicted, which we attempt to reconcile in our discussion section. We base our discussion mainly on the non-human animal literature, which has shown evidence of homeostatic changes after prolonged visual deprivation in the adult brain (Barnes et al., 2015). It is also interesting to note that after monocular deprivation in adult humans, resting GABA+ levels decreased in the visual cortex (Lunghi et al., 2015). Assuming that after delayed sight restoration, adult neuroplasticity mechanisms must be employed, these studies would predict a “balancing” of the increased excitatory drive following sight restoration by a commensurate increase in inhibition (Keck et al., 2017). Additionally, the EEG results of the present study allowed for speculation regarding the underlying neural mechanisms of an altered E/I ratio. The aperiodic EEG activity suggested higher spontaneous spiking (increased intercept) and increased inhibition (steeper aperiodic slope between 1-20 Hz) in CC vs SC individuals (Ossandón et al., 2023).

      In the revised manuscript, we have more clearly indicated that these speculations are based primarily on non-human animal work, due to the lack of human studies on the subject (Page 23, Lines 609-613).

      (1.5) Heterogeneity in the patient group. Congenital cataract (CC) patients experienced a variety of duration of visual impairment and were of different ages. They presented with co-morbidities (absorbed lens, strabismus, nystagmus). Strabismus has been associated with abnormalities in GABAergic inhibition in the visual cortex. The possible interactions with residual vision and confounds of co-morbidities are not experimentally controlled for in the correlations, and not discussed.

      The goal of the present study was to assess whether we would observe changes in E/I ratio after restoring vision at all. We would not have included patients without nystagmus in the CC group of the present study, since it would have been unlikely that they experienced congenital patterned visual deprivation. Amongst diagnosticians, nystagmus or strabismus might not be considered genuine “comorbidities” that emerge in people with congenital cataracts. Rather, these are consequences of congenital visual deprivation, which we employed as diagnostic criteria. Similarly, absorbed lenses are clear signs that cataracts were congenital. As in other models of experience dependent brain development (e.g. the extant literature on congenital permanent blindness, including anophthalmic individuals (Coullon et al., 2015; Weaver et al., 2013), some uncertainty remains regarding whether the (remaining, in our case) abnormalities of the eye, or the blindness they caused, are the factors driving neural changes. In case of people with reversed congenital cataracts, at least the retina is considered to be intact, as they would otherwise not receive cataract removal surgery.

      However, we consider it unlikely that strabismus caused the group differences, because the present study shows group differences in the Glx/GABA+ ratio at rest, regardless of eye opening or eye closure, for which strabismus would have caused distinct effects. By contrast, the link between GABA concentration and, for example, interocular suppression in strabismus, have so far been documented during visual stimulation (Mukerji et al., 2022; Sengpiel et al., 2006), and differed in direction depending on the amblyopic vs. non-amblyopic eye. Further, one MRS study did not find group differences in GABA concentration between the visual cortices of 16 amblyopic individuals and sighted controls (Mukerji et al., 2022), supporting that the differences in Glx/GABA+ concentration which we observed were driven by congenital deprivation, and not amblyopia-associated visual acuity or eye movement differences. 

      In the revised manuscript, we discussed the inclusion criteria in more detail, and the aforementioned reasons why our data remains interpretable (Page 5, Lines 143 – 145, Lines 147-149). 

      (1.6) Multiple exploratory correlations were performed to relate MRS measures to visual acuity (shown in Supplementary Materials), and only specific ones were shown in the main document. The authors describe the analysis as exploratory in the 'Methods' section. Furthermore, the correlation between visual acuity and E/I metric is weak, and not corrected for multiple comparisons. The results should be presented as preliminary, as no strong conclusions can be made from them. They can provide a hypothesis to test in a future study.

      In the revised manuscript, we have clearly indicated that the exploratory correlation analyses are reported to put forth hypotheses for future studies (Page 4, Lines 118-128; Page 5, Lines 132-134; Page 25, Lines 644- 647).

      (1.7) P.16 Given the correlation of the aperiodic intercept with age ("Age negatively correlated with the aperiodic intercept across CC and SC individuals, that is, a flattening of the intercept was observed with age"), age needs to be controlled for in the correlation between neurochemistry and the aperiodic intercept. Glx has also been shown to negatively correlate with age.

      The correlation between chronological age and aperiodic intercept was observed across groups, but the correlation between Glx and the intercept of the aperiodic EEG activity was seen only in the CC group, even though the SC group was matched for age. Thus, such a correlation was very unlikely to be predominantly driven by an effect of chronological age.

      In the revised manuscript, we added the linear regressions with age as a covariate (Supplementary Material S16, referred to in the main Results, Page 21, Lines 534-537), demonstrating the significant relationship between aperiodic intercept and Glx concentration in the CC group. 

      (1.8) Multiple exploratory correlations were performed to relate MRS to EEG measures (shown in Supplementary Materials), and only specific ones were shown in the main document. Given the multiple measures from the MRS, the correlations with the EEG measures were exploratory, as stated in the text, p.16, and in Figure 4. Yet the introduction said that there was a prior hypothesis "We further hypothesized that neurotransmitter changes would relate to changes in the slope and intercept of the EEG aperiodic activity in the same subjects." It would be great if the text could be revised for consistency and the analysis described as exploratory.

      In the revised manuscript, we improved the phrasing (Page 5, Lines 130-132) and consistently reported the correlations as exploratory in the Methods and Discussion. We consider the correlation analyses as exploratory due to our sample size and the absence of prior work. However, we did hypothesize that both MRS and EEG markers would concurrently be altered in CC vs SC individuals.

      (1.9) The analysis for the EEG needs to take more advantage of the available data. As far as I understand, only two electrodes were used, yet far more were available as seen in their previous study (Ossandon et al., 2023). The spatial specificity is not established. The authors could use the frontal cortex electrode (FP1, FP2) signals as a control for spatial specificity in the group effects, or even better, all available electrodes and correct for multiple comparisons. Furthermore, they could use the aperiodic intercept vs Glx in SC to evaluate the specificity of the correlation to CC.

      The aperiodic intercept and slope did not differ between CC and SC individuals for Fp1 and Fp2, suggesting the spatial specificity of the results. In the revised manuscript, we added this analysis to the Supplementary Material (Supplementary Material S14) and referred to it in our Results (Page 20, Lines 513-514).

      Further, Glx concentration in the visual cortex did not correlate with the aperiodic intercept in the SC group (Figure 4), suggesting that this relationship was indeed specific to the CC group.

      The data from all electrodes has been analyzed and published in other studies as well (Pant et al., 2023; Ossandón et al., 2023). 

      Reviewer #2 (Public Review):

      Summary:

      The manuscript reports non-invasive measures of activity and neurochemical profiles of the visual cortex in congenitally blind patients who recovered vision through the surgical removal of bilateral dense cataracts. The declared aim of the study is to find out how restoring visual function after several months or years of complete blindness impacts the balance between excitation and inhibition in the visual cortex.

      Strengths:

      The findings are undoubtedly useful for the community, as they contribute towards characterising the many ways this special population differs from normally sighted individuals. The combination of MRS and EEG measures is a promising strategy to estimate a fundamental physiological parameter - the balance between excitation and inhibition in the visual cortex, which animal studies show to be heavily dependent upon early visual experience. Thus, the reported results pave the way for further studies, which may use a similar approach to evaluate more patients and control groups.

      Weaknesses:

      (2.1) The main issue is the lack of an appropriate comparison group or condition to delineate the effect of sight recovery (as opposed to the effect of congenital blindness). Few previous studies suggested an increased excitation/Inhibition ratio in the visual cortex of congenitally blind patients; the present study reports a decreased E/I ratio instead. The authors claim that this implies a change of E/I ratio following sight recovery. However, supporting this claim would require showing a shift of E/I after vs. before the sight-recovery surgery, or at least it would require comparing patients who did and did not undergo the sight-recovery surgery (as common in the field).

      Longitudinal studies would indeed be the best way to test the hypothesis that the lower E/I ratio in the CC group observed by the present study is a consequence of sight restoration.

      We have now explicitly stated this in the Limitations section (Page 25, Lines 654-655).

      However, longitudinal studies involving neuroimaging are an effortful challenge, particularly in research conducted outside of major developed countries and dedicated neuroimaging research facilities. Crucially, however, had CC and SC individuals, as well as permanently congenitally blind vs SC individuals (Coullon et al., 2015; Weaver et al., 2013), not differed on any neurochemical markers, such a longitudinal study might have been trivial. Thus, in order to justify and better tailor longitudinal studies, cross-sectional studies are an initial step.

      (2.2) MR Spectroscopy shows a reduced GLX/GABA ratio in patients vs. sighted controls; however, this finding remains rather isolated, not corroborated by other observations. The difference between patients and controls only emerges for the GLX/GABA ratio, but there is no accompanying difference in either the GLX or the GABA concentrations. There is an attempt to relate the MRS data with acuity measurements and electrophysiological indices, but the explorative correlational analyses do not help to build a coherent picture. A bland correlation between GLX/GABA and visual impairment is reported, but this is specific to the patients' group (N=10) and would not hold across groups (the correlation is positive, predicting the lowest GLX/GABA ratio values for the sighted controls - the opposite of what is found). There is also a strong correlation between GLX concentrations and the EEG power at the lowest temporal frequencies. Although this relation is intriguing, it only holds for a very specific combination of parameters (of the many tested): only with eyes open, only in the patient group.

      We interpret these findings differently, that is, in the context of experiments from non-human animals and the larger MRS literature (Page 23, Lines 609-611).

      Homeostatic control of E/I balance assumes that the ratio of excitation (reflected here by Glx) and inhibition (reflected here by GABA+) is regulated. Like prior work (Gao et al., 2024, 2024; Narayan et al., 2022; Perica et al., 2022; Steel et al., 2020; Takado et al., 2022; Takei et al., 2016), we assumed that the ratio of Glx/GABA+ is indicative of E/I balance rather than solely the individual neurotransmitter levels. One of the motivations for assessing the ratio vs the absolute concentration is that as per the underlying E/I balance hypothesis, a change in excitation would cause a concomitant change in inhibition, and vice versa, which has been shown in non-human animal work (Fang et al., 2021; Haider et al., 2006; Tao & Poo, 2005) and modeling research (Vreeswijk & Sompolinsky, 1996; Wu et al., 2022). Importantly, our interpretation of the lower E/I ratio is not just from the Glx/GABA+ ratio, but additionally, based on the steeper EEG aperiodic slope (1-20 Hz). 

      As stated in the Discussion section and Response 1.4, we did not expect to see a lower Glx/GABA+ ratio in CC individuals. We discuss the possible reasons for the direction of the correlation with visual acuity and aperiodic offset during passive visual stimulation, and offer interpretations and (testable) hypotheses.

      We interpret the direction of the Glx/GABA+ correlation with visual acuity to imply that patients with highest (compensatory) balancing of the consequences of congenital blindness (hyperexcitation), in light of visual stimulation, are those who recover best. Note, the sighted control group was selected based on their “normal” vision. Thus, clinical visual acuity measures are not expected to sufficiently vary, nor have the resolution to show strong correlations with neurophysiological measures. By contrast, the CC group comprised patients highly varying in visual outcomes, and thus were ideal to investigate such correlations.

      This holds for the correlation between Glx and the aperiodic intercept, as well. Previous work has suggested that the intercept of the aperiodic activity is associated with broadband spiking activity in neural circuits (Manning et al., 2009). Thus, an atypical increase of spiking activity during visual stimulation, as indirectly suggested by “old” non-human primate work on visual deprivation (Hyvärinen et al., 1981) might drive a correlation not observed in healthy populations.

      In the revised manuscript, we have more clearly indicated in the Discussion that these are possible post-hoc interpretations (Page 23, Lines 584-586; Page 24, Lines 609-620; Page 24, Lines 644-647; Pages 25, Lines 650 - 657). We argue that given the lack of such studies in humans, it is all the more important that extant data be presented completely, even if the direction of the effects are not as expected.

      (2.3) For these reasons, the reported findings do not allow us to draw firm conclusions on the relation between EEG parameters and E/I ratio or on the impact of early (vs. late) visual experience on the excitation/inhibition ratio of the human visual cortex.

      Indeed, the correlations we have tested between the E/I ratio and EEG parameters were exploratory, and have been reported as such.

      We have now made this clear in all the relevant parts of the manuscript (Introduction, Page 5, Lines 132-135; Methods, Page 16, Line 415; Results, Page 21, Figure 4; Discussion, Page 22, Line 568, Page 25, Lines 644-645, Page 25, Lines 650-657).

      The goal of our study was not to compare the effects of early vs. late visual experience. The goal was to study whether early visual experience is necessary for a typical E/I ratio in visual neural circuits. We provided clear evidence in favor of this hypothesis. Thus, the present results suggest the necessity of investigating the effects of late visual deprivation. In fact, such research is missing in permanent blindness as well.

      Reviewer #3 (Public Review):

      This manuscript examines the impact of congenital visual deprivation on the excitatory/inhibitory (E/I) ratio in the visual cortex using Magnetic Resonance Spectroscopy (MRS) and electroencephalography (EEG) in individuals whose sight was restored. Ten individuals with reversed congenital cataracts were compared to age-matched, normally sighted controls, assessing the cortical E/I balance and its interrelationship to visual acuity. The study reveals that the Glx/GABA ratio in the visual cortex and the intercept and aperiodic signal are significantly altered in those with a history of early visual deprivation, suggesting persistent neurophysiological changes despite visual restoration.

      My expertise is in EEG (particularly in the decomposition of periodic and aperiodic activity) and statistical methods. I have several major concerns in terms of methodological and statistical approaches along with the (over)interpretation of the results. These major concerns are detailed below.

      (3.1) Variability in visual deprivation:

      - The document states a large variability in the duration of visual deprivation (probably also the age at restoration), with significant implications for the sensitivity period's impact on visual circuit development. The variability and its potential effects on the outcomes need thorough exploration and discussion.

      We work with a rare, unique patient population, which makes it difficult to systematically assess the effects of different visual histories while maintaining stringent inclusion criteria such as complete patterned visual deprivation at birth. Regardless, we considered the large variance in age at surgery and time since surgery as supportive of our interpretation: group differences were found despite the large variance in duration of visual deprivation. Moreover, the existing variance was used to explore possible associations between behavior and neural measures, as well as neurochemical and EEG measures.

      In the revised manuscript, we have detailed the advantages (Methods, Page 5, Lines 143 – 145, Lines 147-149; Discussion, Page 26, Lines 677-678) and disadvantages (Discussion, Page 25, Lines 650-657) of our CC sample, with respect to duration of congenital visual deprivation.

      (3.2) Sample size:

      - The small sample size is a major concern as it may not provide sufficient power to detect subtle effects and/or overestimate significant effects, which then tend not to generalize to new data. One of the biggest drivers of the replication crisis in neuroscience.

      We address the small sample size in our Discussion, and make clear that small sample sizes were due to the nature of investigations in special populations. In the revised manuscript, we added the sample sizes of previous studies using MRS in permanently blind individuals (Page 4, Lines 108 - 109). It is worth noting that our EEG results fully align with those of larger samples of congenital cataract reversal individuals (Page 25, Lines 666-676, Supplementary Material S18, S19) (Ossandón et al., 2023), providing us confidence about their validity and reproducibility. Moreover, our MRS results and correlations of those with EEG parameters were spatially specific to occipital cortex measures.

      The main problem with the correlation analyses between MRS and EEG measures is that the sample size is simply too small to conduct such an analysis. Moreover, it is unclear from the methods section that this analysis was only conducted in the patient group (which the reviewer assumed from the plots), and not explained why this was done only in the patient group. I would highly recommend removing these correlation analyses.

      In the revised manuscript, we have more clearly marked the correlation analyses as exploratory (Introduction, Page 4, Lines 118-128 and Page 5, Lines 132-134; Methods Page 16, Line 415; Discussion Page 22, Line 568, Page 24, Lines 644-645, Page 25, Lines 650-657); note that we do not base most of our discussion on the results of these analyses.

      As indicated by Reviewer 1, reporting them allows for deriving more precise hypothesis for future studies. It has to be noted that we investigate an extremely rare population, tested outside of major developed economies and dedicated neuroimaging research facilities. In addition to being a rare patient group, these individuals come from poor communities. Therefore, we consider it justified to report these correlations as exploratory, providing direction for future research.

      (3.3) Statistical concerns:

      - The statistical analyses, particularly the correlations drawn from a small sample, may not provide reliable estimates (see https://www.sciencedirect.com/science/article/pii/S0092656613000858, which clearly describes this problem).

      It would undoubtedly be better to have a larger sample size. We nonetheless think it is of value to the research community to publish this dataset, since 10 multimodal data sets from a carefully diagnosed, rare population, representing a human model for the effects of early experience on brain development, are quite a lot. Sample sizes in prior neuroimaging studies in transient blindness have most often ranged from n = 1 to n = 10. They nevertheless provided valuable direction for future research, and integration of results across multiple studies provides scientific insights. 

      Identifying possible group differences was the goal of our study, with the correlations being an exploratory analysis, which we have clearly indicated in the methods, results and discussion.

      - Statistical analyses for the MRS: The authors should consider some additional permutation statistics, which are more suitable for small sample sizes. The current statistical model (2x2) design ANOVA is not ideal for such small sample sizes. Moreover, it is unclear why the condition (EO & EC) was chosen as a predictor and not the brain region (visual & frontal) or neurochemicals. Finally, the authors did not provide any information on the alpha level nor any information on correction for multiple comparisons (in the methods section). Finally, even if the groups are matched w.r.t. age, the time between surgery and measurement, the duration of visual deprivation, (and sex?), these should be included as covariates as it has been shown that these are highly related to the measurements of interest (especially for the EEG measurements) and the age range of the current study is large.

      In our ANOVA models, the neurochemicals were the outcome variables, and the conditions were chosen as predictors based on prior work suggesting that Glx/GABA+ might vary with eye closure (Kurcyus et al., 2018). The study was designed based on a hypothesis of group differences localized to the occipital cortex, due to visual deprivation. The frontal cortex voxel was chosen to indicate whether these differences were spatially specific. Therefore, we conducted separate ANOVAs based on this study design.

      We have now clarified the motivation for these conditions in the Introduction (Page 4, Lines 122-125) and the Methods (Page 9, Lines 219-224).

      In the revised manuscript, we added the rationale for parametric analyses for our outcomes (Shapiro-Wilk as well as Levene’s tests, Supplementary Material S9). Note that in the Supplementary Materials (S12, S14), we have reported the correlations between visual history metrics and MRS/EEG outcomes, thereby investigating whether the variance in visual history might have driven these results. Specifically, we found a (negative) correlation between visual cortex Glx/GABA+ concentration during eye closure and the visual acuity in the CC group (Figure 2c). None of the other exploratory correlations between MRS/EEG outcomes vs time since surgery, duration of blindness or visual acuity were significant in the CC group (Supplementary Material S12, S15).  

      The alpha level used for the ANOVA models specified in the Methods section was 0.05. The alpha level for the exploratory analyses reported in the main manuscript was 0.008, after correcting for (6) multiple comparisons using the Bonferroni correction, also specified in the Methods. Note that the p-values following correction are expressed as multiplied by 6, due to most readers assuming an alpha level of 0.05 (see response regarding large p-values).

      We used a control group matched for age, recruited and tested in the same institutes, using the same setup. We feel that we followed the gold standards for recruiting a healthy control group for a patient group.

      - EEG statistical analyses: The same critique as for the MRS statistical analyses applies to the EEG analysis. In addition: was the 2x3 ANOVA conducted for EO and EC independently? This seems to be inconsistent with the approach in the MRS analyses, in which the authors chose EO & EC as predictors in their 2x2 ANOVA.

      The 2x3 ANOVA was not conducted independently for the eyes open/eyes closed condition. The ANOVA conducted on the EEG metrics was 2x3 because it had two groups (CC, SC) and three conditions (eyes open (EO), eyes closed (EC) and visual stimulation (LU)) as predictors.

      - Figure 4: The authors report a p-value of >0.999 with a correlation coefficient of -0.42 with a sample size of 10 subjects. This can't be correct (it should be around: p = 0.22). All statistical analyses should be checked.

      As specified in the Methods and Figure legend, the reported p values in Figure 4 have been corrected using the Bonferroni correction, and therefore multiplied by the number of comparisons, leading to the seemingly large values.

      Additionally, to check all statistical analyses, we put the manuscript through an independent Statistics Check (Nuijten & Polanin, 2020) (https://michelenuijten.shinyapps.io/statcheck-web/) and have uploaded the consistency report with the revised Supplementary Material (Supplementary Report 1).

      - Figure 2c. Eyes closed condition: The highest score of the *Glx/GABA ratio seems to be ~3.6. In subplot 2a, there seem to be 3 subjects that show a Glx/GABA ratio score > 3.6. How can this be explained? There is also a discrepancy for the eyes-closed condition.

      The three subjects that show the Glx/GABA+ ratio > 3.6 in subplot 2a are in the SC group, whereas the correlations plotted in figure 2c are only for the CC group, where the highest score is indeed ~3.6.

      (3.4) Interpretation of aperiodic signal:

      - Several recent papers demonstrated that the aperiodic signal measured in EEG or ECoG is related to various important aspects such as age, skull thickness, electrode impedance, as well as cognition. Thus, currently, very little is known about the underlying effects which influence the aperiodic intercept and slope. The entire interpretation of the aperiodic slope as a proxy for E/I is based on a computational model and simulation (as described in the Gao et al. paper).

      Apart from the modeling work from Gao et al., multiple papers which have also been cited which used ECoG, EEG and MEG and showed concomitant changes in aperiodic activity with pharmacological manipulation of the E/I ratio (Colombo et al., 2019; Molina et al., 2020; Muthukumaraswamy & Liley, 2018). Further, several prior studies have interpreted changes in the aperiodic slope as reflective of changes in the E/I ratio, including studies of developmental groups (Favaro et al., 2023; Hill et al., 2022; McSweeney et al., 2023; Schaworonkow & Voytek, 2021) as well as patient groups (Molina et al., 2020; Ostlund et al., 2021).

      In the revised manuscript, we have cited those studies not already included in the Introduction (Page 3, Lines 92-94).

      - Especially the aperiodic intercept is a very sensitive measure to many influences (e.g. skull thickness, electrode impedance...). As crucial results (correlation aperiodic intercept and MRS measures) are facing this problem, this needs to be reevaluated. It is safer to make statements on the aperiodic slope than intercept. In theory, some of the potentially confounding measures are available to the authors (e.g. skull thickness can be computed from T1w images; electrode impedances are usually acquired alongside the EEG data) and could be therefore controlled.

      All electrophysiological measures indeed depend on parameters such as skull thickness and electrode impedance. As in the extant literature using neurophysiological measures to compare brain function between patient and control groups, we used a control group matched in age/sex, recruited in the same region, tested with the same devices, and analyzed with the same analysis pipeline. For example, impedance was kept below 10 kOhm for all subjects.

      This is now mentioned in the Methods, Page 13, Line 344.

      There is no evidence available suggesting that congenital cataracts are associated with changes in skull thickness that would cause the observed pattern of group results. Moreover, we cannot think of how any of the exploratory correlations between neurophysiological measures and MRS measures could be accounted for by a difference e.g. in skull thickness.

      - The authors wrote: "Higher frequencies (such as 20-40 Hz) have been predominantly associated with local circuit activity and feedforward signaling (Bastos et al., 2018; Van Kerkoerle et al., 2014); the increased 20-40 Hz slope may therefore signal increased spontaneous spiking activity in local networks. We speculate that the steeper slope of the aperiodic activity for the lower frequency range (1-20 Hz) in CC individuals reflects the concomitant increase in inhibition." The authors confuse the interpretation of periodic and aperiodic signals. This section refers to the interpretation of the periodic signal (higher frequencies). This interpretation cannot simply be translated to the aperiodic signal (slope).

      Prior work has not always separated the aperiodic and periodic components, making it unclear what might have driven these effects in our data. The interpretation of the higher frequency range was intended to contrast with the interpretations of lower frequency range, in order to speculate as to why the two aperiodic fits might go in differing directions. Note that Ossandón et al. reported highly similar results (group differences for CC individuals and for permanently congenitally blind humans) for the aperiodic activity between 20-40 Hz and oscillatory activity in the gamma range.

      In the revised Discussion, we removed this section. We primarily interpret the increased offset and prior findings from fMRI-BOLD data (Raczy et al., 2023) as an increase in broadband neuronal firing.

      - The authors further wrote: We used the slope of the aperiodic (1/f) component of the EEG spectrum as an estimate of E/I ratio (Gao et al., 2017; Medel et al., 2020; Muthukumaraswamy & Liley, 2018). This is a highly speculative interpretation with very little empirical evidence. These papers were conducted with ECoG data (mostly in animals) and mostly under anesthesia. Thus, these studies only allow an indirect interpretation by what the 1/f slope in EEG measurements is actually influenced.

      Note that Muthukumaraswamy et al. (2018) used different types of pharmacological manipulations and analyzed periodic and aperiodic MEG activity in humans, in addition to monkey ECoG (Muthukumaraswamy & Liley, 2018). Further, Medel et al. (now published as Medel et al., 2023) compared EEG activity in addition to ECoG data after propofol administration. The interpretation of our results are in line with a number of recent studies in developing (Hill et al., 2022; Schaworonkow & Voytek, 2021) and special populations using EEG. As mentioned above, several prior studies have used the slope of the 1/f component/aperiodic activity as an indirect measure of the E/I ratio (Favaro et al., 2023; Hill et al., 2022; McSweeney et al., 2023; Molina et al., 2020; Ostlund et al., 2021; Schaworonkow & Voytek, 2021), including studies using scalp-recorded EEG from humans.

      In the introduction of the revised manuscript, we have made more explicit that this metric is indirect (Page 3, Line 91), (additionally see Discussion, Page 24, Lines 644-645, Page 25, Lines 650-657).

      While a full understanding of aperiodic activity needs to be provided, some convergent ideas have emerged. We think that our results contribute to this enterprise, since our study is, to the best of our knowledge, the first which assessed MRS measured neurotransmitter levels and EEG aperiodic activity.

      (3.5) Problems with EEG preprocessing and analysis:

      - It seems that the authors did not identify bad channels nor address the line noise issue (even a problem if a low pass filter of below-the-line noise was applied).

      As pointed out in the methods and Figure 1, we only analyzed data from two occipital channels, O1 and O2 neither of which were rejected for any participant. Channel rejection was performed for the larger dataset, published elsewhere (Ossandón et al., 2023; Pant et al., 2023). As control sites we added the frontal channels FP1 and Fp2 (see Supplementary Material S14)

      Neither Ossandón et al. (2023) nor Pant et al. (2023) considered frequency ranges above 40 Hz to avoid any possible contamination with line noise. Here, we focused on activity between 0 and 20 Hz, definitely excluding line noise contaminations (Methods, Page 14, Lines 365-367). The low pass filter (FIR, 1-45 Hz) guaranteed that any spill-over effects of line noise would be restricted to frequencies just below the upper cutoff frequency.

      Additionally, a prior version of the analysis used spectrum interpolation to remove line noise; the group differences remained stable (Ossandón et al., 2023). We have reported this analysis in the revised manuscript (Page 14, Lines 364-357).

      Further, both groups were measured in the same lab, making line noise (~ 50 Hz) as an account for the observed group effects in the 1-20 Hz frequency range highly unlikely. Finally, any of the exploratory MRS-EEG correlations would be hard to explain if the EEG parameters would be contaminated with line noise.

      - What was the percentage of segments that needed to be rejected due to the 120μV criteria? This should be reported specifically for EO & EC and controls and patients.

      The mean percentage of 1 second segments rejected for each resting state condition and the percentage of 6.25 long segments rejected in each group for the visual stimulation condition have been added to the revised manuscript (Supplementary Material S10), and referred to in the Methods on Page 14, Lines 372-373).

      - The authors downsampled the data to 60Hz to "to match the stimulation rate". What is the intention of this? Because the subsequent spectral analyses are conflated by this choice (see Nyquist theorem).

      This data were collected as part of a study designed to evoke alpha activity with visual white-noise, which changed in luminance with equal power at all frequencies from 1-60 Hz, restricted by the refresh rate of the monitor on which stimuli were presented (Pant et al., 2023). This paradigm and method was developed by VanRullen and colleagues (Schwenk et al., 2020; VanRullen & MacDonald, 2012), wherein the analysis requires the same sampling rate between the presented frequencies and the EEG data. The downsampling function used here automatically applies an anti-aliasing filter (EEGLAB 2019) .

      - "Subsequently, baseline removal was conducted by subtracting the mean activity across the length of an epoch from every data point." The actual baseline time segment should be specified.

      The time segment was the length of the epoch, that is, 1 second for the resting state conditions and 6.25 seconds for the visual stimulation conditions. This has now been explicitly stated in the revised manuscript (Page 14, Lines 379-380).

      - "We excluded the alpha range (8-14 Hz) for this fit to avoid biasing the results due to documented differences in alpha activity between CC and SC individuals (Bottari et al., 2016; Ossandón et al., 2023; Pant et al., 2023)." This does not really make sense, as the FOOOF algorithm first fits the 1/f slope, for which the alpha activity is not relevant.

      We did not use the FOOOF algorithm/toolbox in this manuscript. As stated in the Methods, we used a 1/f fit to the 1-20 Hz spectrum in the log-log space, and subtracted this fit from the original spectrum to obtain the corrected spectrum. Given the pronounced difference in alpha power between groups (Bottari et al., 2016; Ossandón et al., 2023; Pant et al., 2023), we were concerned it might drive differences in the exponent values. Our analysis pipeline had been adapted from previous publications of our group and other labs (Ossandón et al., 2023; Voytek et al., 2015; Waschke et al., 2017).

      We have conducted the analysis with and without the exclusion of the alpha range, as well as using the FOOOF toolbox both in the 1-20 Hz and 20-40 Hz ranges (Ossandón et al., 2023). The findings of a steeper slope in the 1-20 Hz range as well as lower alpha power in CC vs SC individuals remained stable. In Ossandón et al., the comparison between the piecewise fits and FOOOF fits led the authors to use the former, as it outperformed the FOOOF algorithm for their data.

      - The model fits of the 1/f fitting for EO, EC, and both participant groups should be reported.

      In Figure 3 of the manuscript, we depicted the mean spectra and 1/f fits for each group.

      In the revised manuscript, we added the fit quality metrics (average R<sup>2</sup> values > 0.91 for each group and condition) (Methods Page 15, Lines 395-396; Supplementary Material S11) and additionally show individual subjects’ fits (Supplementary Material S11).

      (3.6) Validity of GABA measurements and results:

      - According the a newer study by the authors of the Gannet toolbox (https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/nbm.5076), the reliability and reproducibility of the gamma-aminobutyric acid (GABA) measurement can vary significantly depending on acquisition and modeling parameter. Thus, did the author address these challenges?

      We took care of data quality while acquiring MRS data by ensuring appropriate voxel placement and linewidth prior to scanning (Page 9, Lines 229-237). We now address this explicitly in the Methods in the “MRS Data Quality” section. Acquisition as well as modeling parameters were constant for both groups, so they cannot have driven group differences.

      The linked article compares the reproducibility of GABA measurement using Osprey (Oeltzschner et al., 2020), which was released in 2020 and uses linear combination modeling to fit the peak, as opposed to Gannet’s simple peak fitting (Hupfeld et al., 2024). The study finds better test-retest reliability for Osprey compared to Gannet’s method.

      As the present work was conceptualized in 2018, we used Gannet 3.0, which was the state-of-the-art edited-spectrum analysis toolbox at the time, and still is widely used.

      In the revised manuscript, we re-analyzed the data using linear combination modeling with Osprey (Oeltzschner et al., 2020), and reported that the main findings remained the same, i.e. the Glx/GABA+ concentration ratio was lower in the visual cortex of congenital cataract reversal individuals compared to normally sighted controls, regardless of whether participants were scanned with eyes open or with eyes closed. Further, NAA concentration did not differ between groups (Supplementary Material S3). Thus, we demonstrate that our findings were robust to analysis pipelines, and state this in the Methods (Page 9, Lines 242-246) and Results (Page 19, Lines 464-467).

      - Furthermore, the authors wrote: "We confirmed the within-subject stability of metabolite quantification by testing a subset of the sighted controls (n=6) 2-4 weeks apart. Looking at the supplementary Figure 5 (which would be rather plotted as ICC or Blant-Altman plots), the within-subject stability compared to between-subject variability seems not to be great. Furthermore, I don't think such a small sample size qualifies for a rigorous assessment of stability.

      Indeed, we did not intend to provide a rigorous assessment of within-subject stability. Rather, we aimed to confirm that data quality/concentration ratios did not systematically differ between the same subjects tested longitudinally; driven, for example, by scanner heating or time of day. As with the phantom testing, we attempted to give readers an idea of the quality of the data, as they were collected from a primarily clinical rather than a research site.

      In the revised manuscript, we have removed the statement regarding stability and the associated section.

      - "Why might an enhanced inhibitory drive, as indicated by the lower Glx/GABA ratio" Is this interpretation really warranted, as the results of the group differences in the Glx/GABA ratio seem to be rather driven by a decreased Glx concentration in CC rather than an increased GABA (see Figure 2).

      We used the Glx/GABA+ ratio as a measure, rather than individual Glx or GABA+ concentration, which did not significantly differ between groups. As detailed in Response 2.2, we think this metric aligns better with an underlying E/I balance hypothesis and has been used in many previous studies (Gao et al., 2024; Liu et al., 2015; Narayan et al., 2022; Perica et al., 2022).

      Our interpretation of an enhanced inhibitory drive additionally comes from the combination of aperiodic EEG (1-20 Hz) and MRS measures, which, when considered together, are consistent with a decreased E/I ratio.

      In the revised manuscript, we have rewritten the Discussion and removed this section.   

      - Glx concentration predicted the aperiodic intercept in CC individuals' visual cortices during ambient and flickering visual stimulation. Why specifically investigate the Glx concentration, when the paper is about E/I ratio?

      As stated in the methods, we exploratorily assessed the relationship between all MRS parameters (Glx, GABA+ and Glx/GABA+ ratio) with the aperiodic parameters (slope, offset), and corrected for multiple comparisons accordingly. We think this is a worthwhile analysis considering the rarity of the dataset/population (see 1.2, 1.6, 2.1 and Reviewer 1’s comments about future hypotheses). We only report the Glx – aperiodic intercept correlation in the main manuscript as it survived correction for multiple comparisons.

      (3.7) Interpretation of the correlation between MRS measurements and EEG aperiodic signal:

      - The authors wrote: "The intercept of the aperiodic activity was highly correlated with the Glx concentration during rest with eyes open and during flickering stimulation (also see Supplementary Material S11). Based on the assumption that the aperiodic intercept reflects broadband firing (Manning et al., 2009; Winawer et al., 2013), this suggests that the Glx concentration might be related to broadband firing in CC individuals during active and passive visual stimulation." These results should not be interpreted (or with very caution) for several reasons (see also problem with influences on aperiodic intercept and small sample size). This is a result of the exploratory analyses of correlating every EEG parameter with every MRS parameter. This requires well-powered replication before any interpretation can be provided. Furthermore and importantly: why should this be specifically only in CC patients, but not in the SC control group?

      We have indicated clearly in all parts of the manuscript that these correlations are presented as exploratory. Further, we interpret the Glx-aperiodic offset correlation, and none of the others, as it survived the Bonferroni correction for multiple comparisons. We offer a hypothesis in the Discussion as to why such a correlation might exist in the CC but not the SC group (see response 2.2), and do not speculate further.

      (3.8) Language and presentation:

      - The manuscript requires language improvements and correction of numerous typos. Over-simplifications and unclear statements are present, which could mislead or confuse readers (see also interpretation of aperiodic signal).

      In the revised manuscript, we have checked that speculations are clearly marked, and typos are removed.

      - The authors state that "Together, the present results provide strong evidence for experience-dependent development of the E/I ratio in the human visual cortex, with consequences for behavior." The results of the study do not provide any strong evidence, because of the small sample size and exploratory analyses approach and not accounting for possible confounding factors.

      We disagree with this statement and allude to convergent evidence of both MRS and neurophysiological measures. The latter link to corresponding results observed in a larger sample of CC individuals (Ossandón et al., 2023). In the revised manuscript, we have rephrased the statement as “to provide initial evidence” (Page 22, Line 676).

      - "Our results imply a change in neurotransmitter concentrations as a consequence of *restoring* vision following congenital blindness." This is a speculative statement to infer a causal relationship on cross-sectional data.

      As mentioned under 2.1, we conducted a cross-sectional study which might justify future longitudinal work. In order to advance science, new testable hypotheses were put forward at the end of a manuscript.

      In the revised manuscript, we rephrased the sentence and added “might imply” to better indicate the hypothetical character of this idea (Page 22, Lines 586-587).

      - In the limitation section, the authors wrote: "The sample size of the present study is relatively high for the rare population , but undoubtedly, overall, rather small." This sentence should be rewritten, as the study is plein underpowered. The further justification "We nevertheless think that our results are valid. Our findings neurochemically (Glx and GABA+ concentration), and anatomically (visual cortex) specific. The MRS parameters varied with parameters of the aperiodic EEG activity and visual acuity. The group differences for the EEG assessments corresponded to those of a larger sample of CC individuals (n=38) (Ossandón et al., 2023), and effects of chronological age were as expected from the literature." These statements do not provide any validation or justification of small samples. Furthermore, the current data set is a subset of an earlier published paper by the same authors "The EEG data sets reported here were part of data published earlier (Ossandón et al., 2023; Pant et al., 2023)." Thus, the statement "The group differences for the EEG assessments corresponded to those of a larger sample of CC individuals (n=38) " is a circular argument and should be avoided.

      Our intention was not to justify having a small sample, but to justify why we think the results might be valid as they align with/replicate existing literature.

      In the revised manuscript, we added a figure showing that the EEG results of the 10 subjects considered here correspond to those of the 28 other subjects of Ossandón et al (Supplementary Material S18). We adapted the text accordingly, clearly stating that the pattern of EEG results of the ten subjects reported here replicate those of the 28 additional subjects of Ossandón et al. (2023) (Page 25, Lines 671-672).

      References (Public Review)

      Barnes, S. J., Sammons, R. P., Jacobsen, R. I., Mackie, J., Keller, G. B., & Keck, T. (2015). Subnetwork-specific homeostatic plasticity in mouse visual cortex in vivo. Neuron, 86(5), 1290–1303. https://doi.org/10.1016/J.NEURON.2015.05.010

      Bernabeu, A., Alfaro, A., García, M., & Fernández, E. (2009). Proton magnetic resonance spectroscopy (1H-MRS) reveals the presence of elevated myo-inositol in the occipital cortex of blind subjects. NeuroImage, 47(4), 1172–1176. https://doi.org/10.1016/j.neuroimage.2009.04.080

      Bottari, D., Troje, N. F., Ley, P., Hense, M., Kekunnaya, R., & Röder, B. (2016). Sight restoration after congenital blindness does not reinstate alpha oscillatory activity in humans. Scientific Reports. https://doi.org/10.1038/srep24683

      Colombo, M. A., Napolitani, M., Boly, M., Gosseries, O., Casarotto, S., Rosanova, M., Brichant, J. F., Boveroux, P., Rex, S., Laureys, S., Massimini, M., Chieregato, A., & Sarasso, S. (2019). The spectral exponent of the resting EEG indexes the presence of consciousness during unresponsiveness induced by propofol, xenon, and ketamine. NeuroImage, 189(September 2018), 631–644. https://doi.org/10.1016/j.neuroimage.2019.01.024

      Consideration of Sample Size in Neuroscience Studies. (2020). Journal of Neuroscience, 40(21), 4076–4077. https://doi.org/10.1523/JNEUROSCI.0866-20.2020

      Coullon, G. S. L., Emir, U. E., Fine, I., Watkins, K. E., & Bridge, H. (2015). Neurochemical changes in the pericalcarine cortex in congenital blindness attributable to bilateral anophthalmia. Journal of Neurophysiology. https://doi.org/10.1152/jn.00567.2015

      Fang, Q., Li, Y. T., Peng, B., Li, Z., Zhang, L. I., & Tao, H. W. (2021). Balanced enhancements of synaptic excitation and inhibition underlie developmental maturation of receptive fields in the mouse visual cortex. Journal of Neuroscience, 41(49), 10065–10079. https://doi.org/10.1523/JNEUROSCI.0442-21.2021

      Favaro, J., Colombo, M. A., Mikulan, E., Sartori, S., Nosadini, M., Pelizza, M. F., Rosanova, M., Sarasso, S., Massimini, M., & Toldo, I. (2023). The maturation of aperiodic EEG activity across development reveals a progressive differentiation of wakefulness from sleep. NeuroImage, 277. https://doi.org/10.1016/J.NEUROIMAGE.2023.120264

      Gao, Y., Liu, Y., Zhao, S., Liu, Y., Zhang, C., Hui, S., Mikkelsen, M., Edden, R. A. E., Meng, X., Yu, B., & Xiao, L. (2024). MRS study on the correlation between frontal GABA+/Glx ratio and abnormal cognitive function in medication-naive patients with narcolepsy. Sleep Medicine, 119, 1–8. https://doi.org/10.1016/j.sleep.2024.04.004

      Haider, B., Duque, A., Hasenstaub, A. R., & McCormick, D. A. (2006). Neocortical network activity in vivo is generated through a dynamic balance of excitation and inhibition. Journal of Neuroscience. https://doi.org/10.1523/JNEUROSCI.5297-05.2006

      Hill, A. T., Clark, G. M., Bigelow, F. J., Lum, J. A. G., & Enticott, P. G. (2022). Periodic and aperiodic neural activity displays age-dependent changes across early-to-middle childhood. Developmental Cognitive Neuroscience, 54, 101076. https://doi.org/10.1016/J.DCN.2022.101076

      Hupfeld, K. E., Zöllner, H. J., Hui, S. C. N., Song, Y., Murali-Manohar, S., Yedavalli, V., Oeltzschner, G., Prisciandaro, J. J., & Edden, R. A. E. (2024). Impact of acquisition and modeling parameters on the test–retest reproducibility of edited GABA+. NMR in Biomedicine, 37(4), e5076. https://doi.org/10.1002/nbm.5076

      Hyvärinen, J., Carlson, S., & Hyvärinen, L. (1981). Early visual deprivation alters modality of neuronal responses in area 19 of monkey cortex. Neuroscience Letters, 26(3), 239–243. https://doi.org/10.1016/0304-3940(81)90139-7

      Juchem, C., & Graaf, R. A. de. (2017). B0 magnetic field homogeneity and shimming for in vivo magnetic resonance spectroscopy. Analytical Biochemistry, 529, 17–29. https://doi.org/10.1016/j.ab.2016.06.003

      Keck, T., Hübener, M., & Bonhoeffer, T. (2017). Interactions between synaptic homeostatic mechanisms: An attempt to reconcile BCM theory, synaptic scaling, and changing excitation/inhibition balance. Current Opinion in Neurobiology, 43, 87–93. https://doi.org/10.1016/J.CONB.2017.02.003

      Kurcyus, K., Annac, E., Hanning, N. M., Harris, A. D., Oeltzschner, G., Edden, R., & Riedl, V. (2018). Opposite Dynamics of GABA and Glutamate Levels in the Occipital Cortex during Visual Processing. Journal of Neuroscience, 38(46), 9967–9976. https://doi.org/10.1523/JNEUROSCI.1214-18.2018

      Liu, B., Wang, G., Gao, D., Gao, F., Zhao, B., Qiao, M., Yang, H., Yu, Y., Ren, F., Yang, P., Chen, W., & Rae, C. D. (2015). Alterations of GABA and glutamate-glutamine levels in premenstrual dysphoric disorder: A 3T proton magnetic resonance spectroscopy study. Psychiatry Research - Neuroimaging, 231(1), 64–70. https://doi.org/10.1016/J.PSCYCHRESNS.2014.10.020

      Lunghi, C., Berchicci, M., Morrone, M. C., & Russo, F. D. (2015). Short‐term monocular deprivation alters early components of visual evoked potentials. The Journal of Physiology, 593(19), 4361. https://doi.org/10.1113/JP270950

      Maier, S., Düppers, A. L., Runge, K., Dacko, M., Lange, T., Fangmeier, T., Riedel, A., Ebert, D., Endres, D., Domschke, K., Perlov, E., Nickel, K., & Tebartz van Elst, L. (2022). Increased prefrontal GABA concentrations in adults with autism spectrum disorders. Autism Research, 15(7), 1222–1236. https://doi.org/10.1002/aur.2740

      Manning, J. R., Jacobs, J., Fried, I., & Kahana, M. J. (2009). Broadband shifts in local field potential power spectra are correlated with single-neuron spiking in humans. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 29(43), 13613–13620. https://doi.org/10.1523/JNEUROSCI.2041-09.2009

      McSweeney, M., Morales, S., Valadez, E. A., Buzzell, G. A., Yoder, L., Fifer, W. P., Pini, N., Shuffrey, L. C., Elliott, A. J., Isler, J. R., & Fox, N. A. (2023). Age-related trends in aperiodic EEG activity and alpha oscillations during early- to middle-childhood. NeuroImage, 269, 119925. https://doi.org/10.1016/j.neuroimage.2023.119925

      Medel, V., Irani, M., Crossley, N., Ossandón, T., & Boncompte, G. (2023). Complexity and 1/f slope jointly reflect brain states. Scientific Reports, 13(1), 21700. https://doi.org/10.1038/s41598-023-47316-0

      Molina, J. L., Voytek, B., Thomas, M. L., Joshi, Y. B., Bhakta, S. G., Talledo, J. A., Swerdlow, N. R., & Light, G. A. (2020). Memantine Effects on Electroencephalographic Measures of Putative Excitatory/Inhibitory Balance in Schizophrenia. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 5(6), 562–568. https://doi.org/10.1016/j.bpsc.2020.02.004

      Mukerji, A., Byrne, K. N., Yang, E., Levi, D. M., & Silver, M. A. (2022). Visual cortical γ−aminobutyric acid and perceptual suppression in amblyopia. Frontiers in Human Neuroscience, 16. https://doi.org/10.3389/fnhum.2022.949395

      Muthukumaraswamy, S. D., & Liley, D. T. (2018). 1/F electrophysiological spectra in resting and drug-induced states can be explained by the dynamics of multiple oscillatory relaxation processes. NeuroImage, 179(November 2017), 582–595. https://doi.org/10.1016/j.neuroimage.2018.06.068

      Narayan, G. A., Hill, K. R., Wengler, K., He, X., Wang, J., Yang, J., Parsey, R. V., & DeLorenzo, C. (2022). Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial. Molecular Psychiatry, 27(9), 3833—3841. https://doi.org/10.1038/s41380-022-01730-4

      Nuijten, M. B., & Polanin, J. R. (2020). “statcheck”: Automatically detect statistical reporting inconsistencies to increase reproducibility of meta-analyses. Research Synthesis Methods, 11(5), 574–579. https://doi.org/10.1002/jrsm.1408

      Oeltzschner, G., Zöllner, H. J., Hui, S. C. N., Mikkelsen, M., Saleh, M. G., Tapper, S., & Edden, R. A. E. (2020). Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. Journal of Neuroscience Methods, 343, 108827. https://doi.org/10.1016/j.jneumeth.2020.108827

      Ossandón, J. P., Stange, L., Gudi-Mindermann, H., Rimmele, J. M., Sourav, S., Bottari, D., Kekunnaya, R., & Röder, B. (2023). The development of oscillatory and aperiodic resting state activity is linked to a sensitive period in humans. NeuroImage, 275, 120171. https://doi.org/10.1016/J.NEUROIMAGE.2023.120171

      Ostlund, B. D., Alperin, B. R., Drew, T., & Karalunas, S. L. (2021). Behavioral and cognitive correlates of the aperiodic (1/f-like) exponent of the EEG power spectrum in adolescents with and without ADHD. Developmental Cognitive Neuroscience, 48, 100931. https://doi.org/10.1016/j.dcn.2021.100931

      Pant, R., Ossandón, J., Stange, L., Shareef, I., Kekunnaya, R., & Röder, B. (2023). Stimulus-evoked and resting-state alpha oscillations show a linked dependence on patterned visual experience for development. NeuroImage: Clinical, 103375. https://doi.org/10.1016/J.NICL.2023.103375

      Perica, M. I., Calabro, F. J., Larsen, B., Foran, W., Yushmanov, V. E., Hetherington, H., Tervo-Clemmens, B., Moon, C.-H., & Luna, B. (2022). Development of frontal GABA and glutamate supports excitation/inhibition balance from adolescence into adulthood. Progress in Neurobiology, 219, 102370. https://doi.org/10.1016/j.pneurobio.2022.102370

      Pitchaimuthu, K., Wu, Q. Z., Carter, O., Nguyen, B. N., Ahn, S., Egan, G. F., & McKendrick, A. M. (2017). Occipital GABA levels in older adults and their relationship to visual perceptual suppression. Scientific Reports, 7(1). https://doi.org/10.1038/S41598-017-14577-5

      Rideaux, R., Ehrhardt, S. E., Wards, Y., Filmer, H. L., Jin, J., Deelchand, D. K., Marjańska, M., Mattingley, J. B., & Dux, P. E. (2022). On the relationship between GABA+ and glutamate across the brain. NeuroImage, 257, 119273. https://doi.org/10.1016/J.NEUROIMAGE.2022.119273

      Schaworonkow, N., & Voytek, B. (2021). Longitudinal changes in aperiodic and periodic activity in electrophysiological recordings in the first seven months of life. Developmental Cognitive Neuroscience, 47. https://doi.org/10.1016/j.dcn.2020.100895

      Schwenk, J. C. B., VanRullen, R., & Bremmer, F. (2020). Dynamics of Visual Perceptual Echoes Following Short-Term Visual Deprivation. Cerebral Cortex Communications, 1(1). https://doi.org/10.1093/TEXCOM/TGAA012

      Sengpiel, F., Jirmann, K.-U., Vorobyov, V., & Eysel, U. T. (2006). Strabismic Suppression Is Mediated by Inhibitory Interactions in the Primary Visual Cortex. Cerebral Cortex, 16(12), 1750–1758. https://doi.org/10.1093/cercor/bhj110

      Steel, A., Mikkelsen, M., Edden, R. A. E., & Robertson, C. E. (2020). Regional balance between glutamate+glutamine and GABA+ in the resting human brain. NeuroImage, 220. https://doi.org/10.1016/J.NEUROIMAGE.2020.117112

      Takado, Y., Takuwa, H., Sampei, K., Urushihata, T., Takahashi, M., Shimojo, M., Uchida, S., Nitta, N., Shibata, S., Nagashima, K., Ochi, Y., Ono, M., Maeda, J., Tomita, Y., Sahara, N., Near, J., Aoki, I., Shibata, K., & Higuchi, M. (2022). MRS-measured glutamate versus GABA reflects excitatory versus inhibitory neural activities in awake mice. Journal of Cerebral Blood Flow & Metabolism, 42(1), 197. https://doi.org/10.1177/0271678X211045449

      Takei, Y., Fujihara, K., Tagawa, M., Hironaga, N., Near, J., Kasagi, M., Takahashi, Y., Motegi, T., Suzuki, Y., Aoyama, Y., Sakurai, N., Yamaguchi, M., Tobimatsu, S., Ujita, K., Tsushima, Y., Narita, K., & Fukuda, M. (2016). The inhibition/excitation ratio related to task-induced oscillatory modulations during a working memory task: A multtimodal-imaging study using MEG and MRS. NeuroImage, 128, 302–315. https://doi.org/10.1016/J.NEUROIMAGE.2015.12.057

      Tao, H. W., & Poo, M. M. (2005). Activity-dependent matching of excitatory and inhibitory inputs during refinement of visual receptive fields. Neuron, 45(6), 829–836. https://doi.org/10.1016/J.NEURON.2005.01.046

      Vanrullen, R., & MacDonald, J. S. P. (2012). Perceptual echoes at 10 Hz in the human brain. Current Biology. https://doi.org/10.1016/j.cub.2012.03.050

      Voytek, B., Kramer, M. A., Case, J., Lepage, K. Q., Tempesta, Z. R., Knight, R. T., & Gazzaley, A. (2015). Age-related changes in 1/f neural electrophysiological noise. Journal of Neuroscience, 35(38). https://doi.org/10.1523/JNEUROSCI.2332-14.2015

      Vreeswijk, C. V., & Sompolinsky, H. (1996). Chaos in neuronal networks with balanced excitatory and inhibitory activity. Science, 274(5293), 1724–1726. https://doi.org/10.1126/SCIENCE.274.5293.1724

      Waschke, L., Wöstmann, M., & Obleser, J. (2017). States and traits of neural irregularity in the age-varying human brain. Scientific Reports 2017 7:1, 7(1), 1–12. https://doi.org/10.1038/s41598-017-17766-4

      Weaver, K. E., Richards, T. L., Saenz, M., Petropoulos, H., & Fine, I. (2013). Neurochemical changes within human early blind occipital cortex. Neuroscience. https://doi.org/10.1016/j.neuroscience.2013.08.004

      Wu, Y. K., Miehl, C., & Gjorgjieva, J. (2022). Regulation of circuit organization and function through inhibitory synaptic plasticity. Trends in Neurosciences, 45(12), 884–898. https://doi.org/10.1016/J.TINS.2022.10.006

      Recommendations for the Authors:

      Reviewer #1 (Recommendations for The Authors):

      Thank you for the interesting submission. I have inserted my comments to the authors here. Some of them will be more granular comments related to the concerns raised in the public review.

      (1) Introduction:

      Could you please justify the rationale for using eyes open and eyes closed in the MRS condition, and the use of the three different conditions in the EEG experiment? If these resulted in negative findings, then the implications should be discussed.

      Previous work with MRS in sighted individuals has suggested that eye opening in darkness results in a decrease of visual cortex GABA+ concentration, while visual stimulation results in an increase of Glx concentration, compared to a baseline concentration at eye closure (Kurcyus et al., 2018). Moreover visual stimulation/eye opening is known to result in an alpha desynchronization (Adrian & Matthews, 1934).

      While previous work of our group has shown significantly reduced alpha oscillatory activity in congenital cataract reversal individual, desynchronization following eye opening was indistinguishable when compared to normally sighted controls (Ossandón et al., 2023; Pant et al., 2023).

      Thus, we decided to include both conditions to test whether a similar pattern of results would emerge for GABA+/Glx concentration.

      We added our motivation to the Introduction of the revised manuscript (Page 4, Lines 122-125) along with the Methods (Page 9, Lines 219-223).

      It does not become clear from the introduction why a higher intercept is predicted in the EEG measure. The rationale for this hypothesis needs to be explained better.

      Given the prior findings suggesting an increased E/I ratio in CC individuals and the proposed link between neuronal firing (Manning et al., 2009) and the aperiodic intercept, we expected a higher intercept for the CC compared to the SC group.

      We have now added this explanation to the Introduction (Page 4, Lines 126-128).

      (2) Participants

      Were participants screened for common MRS exclusion criteria such as history of psychiatric conditions or antidepressant medication, which could alter neurochemistry? If not, then this needs to be pointed out.

      All participants were clinically screened at the LV Prasad Eye Institute, and additionally self-reported no neurological or psychiatric conditions or medications. Moreover, all subjects were screened based exclusion criteria for being scanned using the standard questionnaire of the radiology center.

      We have now made this clear in the Methods (Page 7, Lines 168-171).

      Table 1 needs to show the age of the participant, which can only be derived by adding the columns 'duration of deprivation' and 'time since surgery'. Table 1 also needs to include the controls.

      We have accordingly modified Table 1 in the revised manuscript and added age for the patients as well as the controls (Table 1, Pages 6-7).

      The control cohort is not specific enough to exclude reduced visual acuity, or co-morbidities, as the primary driver of the differences between groups. Ideally, a cohort with developmental cataracts is recruited. Normally sighted participants as a control cohort cannot distinguish between different types of sight loss, or stages of plasticity.

      The goal of this study was not to distinguish between different types of sight loss or stages of plasticity. We aimed to assess whether the most extreme forms of visual deprivation (i.e. congenital and total patterned vision loss) affected the E/I ratio. Low visual acuity and nystagmus are genuine diagnostic criteria (Methods, Page 5, Lines 142-145). Visual acuity cannot solely explain the current findings, since the MRS data were acquired both with eyes closed or diffuse visual stimulation in a dimly lit room, without any visual task.

      With the awareness of the present results, we consider it worthwhile for the future to investigate additional groups such as developmental cataract-reversal individuals, to narrow down the contribution of the age of onset and degree of visual deprivation to the observed group differences.

      (3) Data collection and analysis

      - More detail is needed: how long were the sessions, how long was each part?

      We have added this information on Page 7, Lines 178-181 of the Methods. MRS scanning took between 45 and 60 minutes, EEG testing took 20 minutes excluding the time for capping, and visual acuity testing took 3-5 minutes.

      - It should be mentioned here that the EEG data is a reanalysis of a subset of legacy data, published previously in Ossandón et al., 2023; Pant et al., 2023.

      In the revised manuscript, we explicitly state at the beginning of the “Electrophysiology recordings” section of the Methods (Page 13, Lines 331-334) that the EEG datasets were a subset of previously published data.

      (4) MRS Spectroscopy

      - Please fill out the minimum reporting standards form (Lin et al., 2021), or report all the requested measures in the main document https://pubmed.ncbi.nlm.nih.gov/33559967/

      We have now filled out this form and added it as Supplementary Material (Supplementary Excel File 1). Additionally, all the requested information has been moved to the Methods section of the main document (MRS Data Quality, Pages 10-12).

      - Information on how the voxels were placed is missing. The visual cortex voxel is not angled parallel to the calcarine, as is a common way to capture processing in the early visual cortex. Describe in the paper what the criteria for successful placement were, and how was it ensured that non-brain tissue was avoided in a voxel of this size.

      Voxel placement was optimized in each subject to avoid the meninges, ventricles, skull and subcortical structures, ensured by examining the voxel region across slices in the acquired T1 volume for each subject. Saturation bands were placed to nullify the skull signal during MRS acquisition, at the anterior (frontal) and posterior (visual) edge of the voxel for every subject. Due to limitations in the clinical scanner rotated/skewed voxels were not possible, and thus voxels were not always located precisely parallel to the calcarine.

      We have added this information to Page 9 (Lines 229-237) of the revised manuscript.

      - Figure 1. shows voxels that are very close to the edge of the brain (frontal cortex) or to the tentorium (visual cortex). Could the authors please calculate the percentage overlap between the visual cortex MRS voxel and the visual cortex, and compare them across groups to ensure that there is no between-group bias from voxel placement?

      We have now added the requested analysis to Supplementary Material S2 and referred to it in the main manuscript on Page 9, Lines 236-237.

      Briefly, the percentage overlap with areas V1-V6 in every individual subject’s visual cortex voxel was 60% or more; the mean overlap in the CC group was 67% and the SC group 70%. The percentage overlap did not differ between groups ( t-test (t(18) = -1.14, p = 0.269)).

      - Figure 1. I would recommend displaying data on a skull-stripped image to avoid identifying information from the participant's T1 profile.

      We have now replaced the images in Figure 1 with skull-stripped images. Note that images from SPM12 were used instead of GannetCoregister, as GannetCoregister only displays images with the skull.

      - Please show more rigor with the MRS quality measures. Several examples of inconsistency and omissions are below.

      • SNR was quantified and shows a difference in SNR between voxel positions, with lower SNR in the frontal cortex. No explanation or discussion of the difference was provided.

      • Looking at S1, the linewidth of NAA seems to be a lot broader in the frontal cortex than in the visual cortex. The figures suggest that acquisition quality was very different between voxel locations, making the comparison difficult.

      • Linewidth of NAA is a generally agreed measure of shim quality in megapress acquisitions (Craven et al., 2022).

      The data quality difference between the frontal and visual cortices has been observed in the literature (Juchem & Graaf, 2017; Rideaux et al., 2022). We nevertheless chose a frontal cortex voxel as control site instead of the often-chosen sensorimotor cortex. The main motivation was to avoid any cortical region linked to sensory processing since crossmodal compensation as a consequence of visual deprivation is a well-documented phenomenon.

      We now make this clearer in the Methods (Page 11, Lines 284 – 299), in the Discussion/Limitations (Page 25, Lines 662 - 665).  

      - To get a handle on the data quality, I would recommend that the authors display their MRS quality measures in a separate section 'MRS quality measure', including NAA linewidth, NAA SNR, GABA+ CRLB, Glx CRLB, and test for the main effects and interaction of voxel location (VC, FC) and group (SC, CC) and discuss any discrepancies.

      We have moved all the quality metric values for GABA+, Glx and NAA from the supplement to the Methods section (see Table 2), and added the requested section titled “MRS Data quality.”

      We have conducted the requested analyses and reported them in Supplementary Material S6: there was a strong effect of region confirming that data quality was better in the visual than frontal region. We have referred to this in the main manuscript on Page 11, Line 299.

      In the revised manuscript, we discuss the data quality in the frontal cortex, and how we ensured it was comparable to prior work. Moreover, there were no significant group effects, or group-by-region interactions, suggesting that group differences observed for the visual cortex voxel cannot be accounted for by differences in data quality. We now included a section on data quality, both in the Methods (Page 11, Lines 284 – 299), and the limitations section of the Discussion (Page 25, Lines 662 - 665).

      Please clarify the MRS acquisition, "Each MEGA- PRESS scan lasted for 8 minutes and was acquired with the following specifications: TR = 2000 ms, TE = 68 ms, Voxel size = 40 mm x 30 mm x 25mm, 192 averages (each consists of two TRs). "192 averages x 2 TRs x 2s TR = 12.8 min, not 8 min, apologies if I have misunderstood these details.

      We have corrected this error in the revised manuscript and stated the parameters more clearly – there were a total of 256 averages, resulting in an (256 repetitions with 1 TR * 2 s/60) 8.5-minute scan (Page 8, Lines 212-213).

      - What was presented to participants in the eyes open MRS? Was it just normal room illumination or was it completely dark? Please add details to your methods.

      The scans were conducted in regular room illumination, with no visual stimulation.

      We have now clarified this on Page 9 (Lines 223-224) of the Methods.

      (5) MRS analysis

      How was the tissue fraction correction performed? Please add or refer to the exact equation from Harris et al., 2015.

      We have clarified that the reported GABA+/Glx values are water-normalized alpha corrected values (Page 10, Line 249), and cited Harris et al., 2015 on Page 10 (Line 251) of the Methods.

      (6) Statistical approach

      How was the sample size determined? Please add your justification for the sample size

      We collected as many qualifying patients as we were able to recruit for this study within 2.5 years of data collection (commencing August 2019, ending February 2022), given the constraints of the patient population and the pandemic. We have now made this clear in the Discussion (Page 25, Lines 650-652).

      Please report the tests for normality.

      We have now reported the Shapiro-Wilk test results for normality as well as Levene’s test for homogeneity of variance between groups for every dependent variable in our dataset in Supplementary Material S9, and added references to it in the descriptions of the statistical analyses (Methods, Page13, Lines 326-329 and Page 15, Lines 400-402).

      Calculate the Bayes Factor where possible.

      As our analyses are all frequentist, instead of re-analyzing the data within a Bayesian framework, we added partial eta squared values for all the reported ANOVAs (η<sub>p</sub><sup>²</sup>) for readers to get an idea of the effect size (Results).

      I recommend partial correlations to control for the influence of age, duration, and time of surgery, rather than separate correlations.

      Given the combination of small sample size and the expected multicollinearity in our variables (duration of blindness, for example, would be expected to correlate with age, as well as visual acuity post-surgery), partial correlations could not be calculated on this data.

      We are aware of the limits of correlational analyses. Given the unique data set of a rare population we had exploratorily planned to relate behavioral, EEG and MRS parameters by calculating correlations. Since no similar data existed when we started (and to the best of our knowledge our data set is still unique), these correlation analyses were explorative, but the most transparent to run.

      We have now clearly outlined these limitations in our Introduction (Page 5, Lines 133-135), Methods (Page 15, Lines 408-410) and Discussion section (Page 24, Line 634, Page 25, Lines 652-65) to ensure that the results are interpreted with appropriate caution.

      (7) Visual acuity

      Is the VA monocular average, from the dominant eye, or bilateral?

      We have now clarified that the VA reported here is bilateral (Methods, Page 7 Line 165 and Page 15, Line 405). Bilateral visual acuity in congenital cataract-reversal individuals typically corresponds to the visual acuity of the best eye.

      It is mentioned here that correlations with VA are exploratory, please be consistent as the introduction mentions that there was a hypothesis that you sought to test.

      We have now accordingly modified the Introduction (Page 5, Lines 133-135) and added the appropriate caveats in the discussion with regards to interpretations (Page 25, Lines 652-665).

      (8) Correlation analyses between MRS and EEG

      It is mentioned here that correlations between EEG and MRS are exploratory, please consistently point out the exploratory nature, as these results are preliminary and should not be overinterpreted ("We did not have prior hypotheses as to the best of our knowledge no extant literature has tested the correlation between aperiodic EEG activity and MRS measures of GABA+,Glx and Glx/GABA+." ).

      In the revised manuscript, we explicitly state the reported associations between EEG (aperiodic component) and MRS parameters allow for putting forward directed / more specific hypotheses for future studies (Introduction, Page 5, Lines 133-135; Methods, Page 15, Line 415. Discussion, Page 25, Lines 644-645 and Lines 652-665).

      (9) Results

      Figure 2 uses the same y-axis for the visual cortex and frontal cortex to facilitate a comparison between the two locations. Comparing Figure 2 a with b demonstrates poorer spectral peaks and reduced amplitudes. Lower spectral quality in the frontal cortex voxel could contribute to the absence of a group effect in the control voxel location. The major caveat that spectral quality differs between voxels needs to be pointed out and the limitations thereof discussed.

      We have now explicitly pointed out this issue in the Methods (MRS Data Quality, Supplementary Material S6) and Discussion in the Limitations section (Page 25, Lines 662-665). While data quality was lower for the frontal compared to the visual cortex voxels, as has been observed previously (Juchem & Graaf, 2017; Rideaux et al., 2022), this was not an issue for the EEG recordings. Thus, lower sensitivity of frontal measures cannot easily explain the lack of group differences for frontal measures. Crucially, data quality did not differ between groups.

      The results in 2c are the result of multiple correlations with metabolite values ("As in previous studies, we ran a number of exploratory correlation analyses between GABA+, Glx, and Glx/GABA+ concentrations, and visual acuity at the date of testing, duration of visual deprivation, and time since surgery respectively in the CC group"), it seems at least six for the visual acuity measure (VA vs Glx, VA vs GABA+, VA vs Glx/GABA+ x 2 conditions). While the trends are interesting, they should be interpreted with caution because of the exploratory nature, small sample size, the lack of multiple comparison correction, and the influence of two extreme data points. The authors should not overinterpret these results and should point out the need for replication.

      See response to (6) last section, which we copy here for convenience:

      We are aware of the limits of correlational analyses. Given the unique data set of a rare population we exploratorily related behavioral, EEG and MRS parameters by calculating correlations. Since no similar data existed when we started (and to the best of our knowledge our data set is still unique), these correlation analyses were explorative, but the most transparent to run.

      We have now clearly outlined these limitations in our Discussion section to ensure that the results are interpreted with appropriate caution (Discussion, Page 25, Lines 644-645 and Lines 652-665).

      (10) Discussion:

      Please explain the decrease in E/I balance from MRS in view of recent findings on an increase in E/I balance in CC using RSN-fMRI (Raczy et al., 2022) and EEG (Ossandon et al. 2023).

      We have edited our Abstract (Page 1-2, Lines 31-35) and Discussion (Page 23, Lines 584-590; Page 24, Lines 613-620). In brief, we think our results reflect a homeostatic regulation of E/I balance, that is, an increase in inhibition due to an increase in stimulus driven excitation following sight restoration.

      Names limitations but does nothing to mitigate concerns about spatial specificity. The limitations need to be rewritten to include differences in SNR between the visual cortex and frontal lobe. Needs to include caveats of small samples, including effect inflation.

      We have now discussed the data quality differences between the visual and frontal cortex voxel in MRS data quality, which we find irrespective of group (MRS Data Quality, Supplementary Material S6). We also reiterate why this might not explain our results; data quality was comparable to prior studies which have found group differences in frontal cortex (Methods Page 11, Lines 284 – 299), and data quality did not differ between groups. Further, EEG data quality did not differ across frontal and occipital regions, but group differences in EEG datasets were localized to the occipital cortex.

      Reviewer #2 (Recommendations for The Authors):

      To address the main weakness, the authors could consider including data from a third group, of congenitally blind individuals. Including this would go a very long way towards making the findings interpretable and relating them to the rest of the literature.

      Unfortunately, recruitment of these groups was not possible due to the pandemic. Indeed, we would consider a pre- vs post- surgery approach the most suitable design in the future, which, however, will require several years to be completed. Such time and resource intensive longitudinal studies are justified by the present cross-sectional results.

      We have explicitly stated our contribution and need for future studies in the Limitations section of the Discussion (Page 25, Lines 650-657).

      Analysing the amplitude of alpha rhythms, as well as the other "aperiodic" components, would be useful to relate the profile of the tested patients with previous studies. Visual inspection of Figure 3 suggests that alpha power with eyes closed is not reduced in the patients' group compared to the controls. This would be inconsistent with previous studies (including research from the same group) and it could suggest that the small selected sample is not really representative of the sight-recovery population - certainly one of the most heterogeneous study populations. This further highlights the difficulty of drawing conclusions on the effects of visual experience merely based on this N=10 set of patients.

      Alpha power was indeed reduced in the present subsample of 10 CC individuals (Supplementary Material S19). A possible source of the confusion (that the graphs of the CC and SC group look so similar for the EC condition in Figure 3) likely is that the spectra are shown with aperiodic components not yet removed, and scales to accommodate very different alpha power values. As documented in Supplementary Material S18 and S19, alpha power and the aperiodic intercept/slope results of the resting state data in the present 10 CC individuals correspond to the results from a larger sample of CC individuals (n = 28) in Ossandón et al., 2023. We explicitly highlight this “replication” in the main manuscript (Page 25 -26, Lines 671-676). Thus, the present sub-sample of CC individuals are representative for their population.

      To further characterise the MRS results, the authors may consider an alternative normalisation scheme. It is not clear whether the lack of significant GABA and GLX differences in the face of a significant group difference in the GLX/GABA ratio is due to the former measures being noisier since taking the ratio between two metabolites often helps reduce inter-individual variability and thereby helps revealing group differences. It remains an open question whether the GABA or GLX concentrations would show significant group differences after appropriate normalisation (e.g. NAA?).

      We repeated the analysis with Creatine-normalized values of GABA+ and Glx, and the main results i.e. reduced Glx/GABA+ concentration in the visual cortex of CC vs SC individuals, and no such difference in the frontal cortex, remained the same (Supplementary Material S5).

      Further, we re-analyzed the data using Osprey, an open-source toolbox that uses linear combination modeling, and found once more that our results did not change (Supplementary Material S3). We refer to these findings in the Methods (Page 10, Lines 272-275) and Results (Page 10, Lines 467-471) of the main manuscript.

      In fact, the Glx concentration in the visual cortex of CC vs SC individuals was significantly decreased when Cr-normalized values were used (which was not significant in the original analysis). However, we do not interpret this result as it was not replicated with the water-normalized values from Gannet or Osprey.

      I suggest revising the discussion to present a more balanced picture of the existent evidence of the relation between E/I and EEG indices. Although there is evidence that the 1/f slope changes across development, in a way that could be consistent with a higher slope reflecting more immature and excitable tissue, the link with cortical E/I is far from established, especially when referring to specific EEG indices (intercept vs. slope, measured in lower vs. higher frequency ranges).

      We have revised the Introduction (Page 4, Line 91, Lines 101-102) and Discussion (Page 22, Lines 568-569, Page 24, Lines 645-647 and Lines 654-657) in the manuscript accordingly; we allude to the fact that the links between cortical E/I and aperiodic EEG indices have not yet been unequivocally established in the literature.

      Minor:

      - The authors estimated NAA concentration with different software than the one used to estimate GLX and GABA; this examined the OFF spectra only; I suggest that the authors consider running their analysis with LCModel, which would allow a straightforward approach to estimate concentrations of all three metabolites from the same edited spectrum and automatically return normalised concentrations as well as water-related ones.

      We re-analyzed all of the MRS datasets using Osprey, which uses linear combination modelling and has shown quantification results similar to LCModel for NAA (Oeltzschner et al., 2020). The results of a lower Glx/GABA+ concentration in the visual cortex of CC vs SC individuals, and no difference in NAA concentration, were replicated using this pipeline.

      We have now added these analyses to the Supplementary Material S3 and referred to them in the Methods (Page 9, Lines 242-246) and Results (Page 18, Lines 464-467).

      - Of course the normalisation used to estimate GABA and GLX values is completely irrelevant when the two values are expressed as ratio GLX/GABA - this may be reflected in the text ("water normalised GLX/GABA concentration" should read "GLX/GABA concentration" instead).

      We have adapted the text on Page 16 (Line 431) and have ensured that throughout the manuscript the use of “water-normalized” is in reference to Glx or GABA+ concentration, and not the ratio.

      - Please specify which equation was used for tissue correction - is it alpha-correction?

      We have clarified that the reported GABA+/Glx values are water-normalized alpha corrected values (Page 10, Line 249), and cited Harris et al., 2015 on Page 10 (Line 251) of the Methods.

      - Since ANOVA was used, the assumption is that values are normally distributed. Please report evidence supporting this assumption.

      We have now reported the Shapiro-Wilk test results for normality as well as Levene’s test for homogeneity of variance between groups for every dependent variable in our dataset in Supplementary Material S9, and added references to it in the Methods (Page 13, Lines 326-329 and Page 15, Lines 400-402).

      Reviewer #3 (Recommendations for The Authors):

      In addition to addressing major comments listed in my Public Review, I have the following, more granular comments, which should also be addressed:

      (1) The paper's structure could be improved by presenting visual acuity data before diving into MRS and EEG results to better contextualize the findings.

      We now explicitly state in the Methods (Page 5, Line 155) that lower visual acuity is expected in a cohort of CC individuals with long lasting congenital visual deprivation.

      We have additionally included a plot of visual acuities of the two groups (Supplementary Material S1).

      (2) The paper should better explain the differences between CC for which sight is restored and congenitally blind patients. The authors write in the introduction that there are sensitive periods/epochs during the lifespan for the development of local inhibitory neural circuits. and "Human neuroimaging studies have similarly demonstrated that visual experience during the first weeks and months of life is crucial for the development of visual circuits. If human infants born with dense bilateral cataracts are treated later than a few weeks from birth, they suffer from a permanent reduction of not only visual acuity (Birch et al., 1998; Khanna et al., 2013) and stereovision (Birch et al., 1993; Tytla et al., 1993) but additionally from impairments in higher-level visual functions, such as face perception (Le Grand et al., 2001; Putzar et al., 2010; Röder et al., 2013)...".

      Thus it seems that the current participants (sight restored after a sensitive period) seem to be similarly affected by the development of the local inhibitory circuits as congenitally blind. To assess the effect of plasticity and sight restoration longitudinal data would be necessary.

      In the Introduction (Page 2, Lines 59-64; Page 3, Lines 111-114) we added that in order to identify sensitive periods e.g. for the elaboration of visual neural circuits, sight recovery individuals need to be investigated. The study of permanently blind individuals allows for investigating the role of experience (whether sight is necessary to introduce the maturation of visual neural circuits), but not whether visual input needs to be available at early epochs in life (i.e. whether sight restoration following congenital blindness could nevertheless lead to the development of visual circuits).

      This is indeed the conclusion we make in the Discussion section. We have now highlighted the need for longitudinal assessments in the Discussion (Page 25, Lines 654-656).

      (3) What's the underlying idea of analyzing two separate aperiodic slopes (20-40Hz and 1-19Hz). This is very unusual to compute the slope between 20-40 Hz, where the SNR is rather low.

      "Ossandón et al. (2023), however, observed that in addition to the flatter slope of the aperiodic power spectrum in the high frequency range (20-40 Hz), the slope of the low frequency range (1-19 Hz) was steeper in both, congenital cataract-reversal individuals, as well as in permanently congenitally blind humans."

      The present manuscript computed the slope between 1-20 Hz. Ossandón et al. as well as Medel et al. (2023) found a “knee” of the 1/f distribution at 20 Hz and describe further the motivations for computing both slope ranges. For example, Ossandón et al. used a data driven approach and compared single vs. dual fits and found that the latter fitted the data better. Additionally, they found the best fit if a knee at 20 Hz was used. We would like to point out that no standard range exists for the fitting of the 1/f component across the literature and, in fact, very different ranges have been used (Gao et al., 2017; Medel et al., 2023; Muthukumaraswamy & Liley, 2018).

      (4) "For this scan, participants were instructed to keep their eyes closed and stay as still as possible." Why should it be important to have the eyes closed during a T1w data acquisition? This statement at this location does not make sense.

      To avoid misunderstandings, we removed this statement in this context.

      (5) "Two SC subjects did not complete the frontal cortex scan for the EO condition and were excluded from the statistical comparisons of frontal cortex neurotransmitter concentrations."<br /> Why did the authors not conduct whole-brain MRS, which seems to be on the market for quite some time (e.g. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590062/) ?

      Similar to previous work (Coullon et al., 2015; Weaver et al., 2013) our hypothesis was related to the visual cortex, and we chose the frontal cortex voxel as a control. This has now been clarified in the Introduction (Page 4, Lines 103-114), Methods (Page 9, Lines 225-227) and Discussion (Page 25, Lines 662-665).

      (6) In "....during visual stimulation with stimuli that changed in luminance (LU) (Pant et al., 2023)." the authors should provide a link on the visual stimulation, which is provided further below

      In the revised manuscript, we have moved up the description of the visual stimulation (Page 13, Line 336).

      (7) "During the EO condition, participants were asked to fixate on a blank screen." This is not really possible. Typically, resting state EO conditions include a fixation cross, as the participants would not be able to fixate on a blank screen and move their eyes, which would impact the recordings.

      We have now rephrased this as “look towards” with the goal of avoiding eye movements (Page 14, Line 347).

      (8) "Components corresponding to horizontal or vertical eye movements were identified via visual inspection and removed (Plöchl et al., 2012)." It is unclear what the Plöchl reference should serve for. Is the intention of the authors to state that manual (and subjective) visual inspection of the ICA components is adequate? I would recommend removing this reference.

      The intention was to provide the basis for classification during the visual inspection, as opposed to an automated method such as ICLabel.

      We stated this clearly in the revised manuscript (Page 14 Lines 368-370).

      (9) "The datasets were divided into 6.25 s long epochs corresponding to each trial." This is a bit inaccurate, as the trial also included some motor response task. Thus, I assume the 6.25 s are related to the visual stimulation.

      We have modified the sentence accordingly (Page 15, Line 378).

      (10) Figure 2. a & b. Just an esthetic suggestion: I would recommend removing the lines between the EC and EO conditions, as they suggest some longitudinal changes. Unless it is important to highlight the changes between EC and EO within each subject.

      In fact, EC vs. EO was a within-subject factor with expected changes for the EEG and possible changes in the MRS parameters. To allow the reader to track changes due to EC vs. EO for individual subjects (rather than just comparing the change in the mean scores), we use lines.  

      (11) Figure 3A: I would plot the same y-axis range for both groups to make it more comparable.

      We have changed Figure 3A accordingly.

      (12) " flattening of the intercept" replaces flattening, as it is too related to slope.

      We have replaced “flattening” with “reduction” (Page 20, Line 517).

      (13) The plotting of only the significant correlation between MRS measures and EEG measures seems to be rather selective reporting. For this type of exploratory analysis, I would recommend plotting all of the scatter plots and moving the entire exploratory analysis to the supplementary (as this provides the smallest evidence of the results).

      We have made clear in the Methods (Page 16, Lines 415-426), Results and Discussion (page 24, Lines 644-645), as well as in the Supplementary material, that the reason for only reporting the significant correlation was that this correlation survived correction for multiple comparisons, while all other correlations did not. We additionally explicitly allude to the Supplementary Material where the plots for all correlations are shown (Results, Page 21, Lines 546-552).

      (14) "Here, we speculate that due to limited structural plasticity after a phase of congenital blindness, the neural circuits of CC individuals, which had adapted to blindness after birth, employ available, likely predominantly physiological plasticity mechanisms (Knudsen, 1998; Mower et al., 1985; Röder et al., 2021), in order to re-adapt to the newly available visual excitation following sight restoration."

      I don't understand the logic here. The CC individuals are congenitally blind, thus why should there be any physiological plasticity mechanism to adapt to blindness, if they were blind at birth?

      With “adapt to blindness” we mean adaptation of a brain to an atypical or unexpected condition when taking an evolutionary perspective (i.e. the lack of vision). We have made this clear in the revised manuscript (Introduction, Page 4, Lines 111-114; Discussion, Page 23, Lines 584-591).

      (15) "An overall reduction in Glx/GABA ratio would counteract the aforementioned adaptations to congenital blindness, e.g. a lower threshold for excitation, which might come with the risk of runaway excitation in the presence of restored visually-elicited excitation."

      This could be tested by actually investigating the visual excitation by visual stimulation studies.

      The visual stimulation condition in the EEG experiment of the present study found a higher aperiodic intercept in CC compared to SC individuals. Given the proposed link between the intercept and spontaneous neural firing (Manning et al., 2009), we interpreted the higher intercept in CC individuals as increased broadband neural firing during visual stimulation (Results Figure 3; Discussion Page 24, Lines 635-640). This idea is compatible with enhanced BOLD responses during an EO condition in CC individuals (Raczy et al., 2022). Future work should systematically manipulate visual stimulation to test this idea.

      (16) As the authors also collected T1w images, the hypothesis of increased visual cortex thickness in CC. Was this investigated?

      This hypothesis was investigated in a separate publication which included this subset of participants (Hölig et al., 2023), and found increased visual cortical thickness in the CC group. We refer to this publication, and related work (Feng et al., 2021) in the present manuscript.

      (17) The entire discussion of age should be omitted, as the current data set is too small to assess age effects.

      We have removed this section and just allude to the fact that we replicated typical age trends to underline the validity of the present data (Page 26, Lines 675-676).

      (18) Table1: should include the age and the age at the time point of surgery.

      We added age to the revised Table 1. We clarified that in CC individuals, duration of blindness is the same as age at the time point of surgery (Page 6, Line 163).

      (19) Why no group comparisons of visual acuity are reported?

      Lower visual acuity in CC than SC individuals is a well-documented fact.

      We have now added the visual acuity plots for readers (Supplementary Material S1, referred to in the Methods, Page 5, Line 155) which highlight this common finding.

      References (Recommendations to the Authors)

      Adrian, E. D., & Matthews, B. H. C. (1934). The berger rhythm: Potential changes from the occipital lobes in man. Brain. https://doi.org/10.1093/brain/57.4.355

      Coullon, G. S. L., Emir, U. E., Fine, I., Watkins, K. E., & Bridge, H. (2015). Neurochemical changes in the pericalcarine cortex in congenital blindness attributable to bilateral anophthalmia. Journal of Neurophysiology. https://doi.org/10.1152/jn.00567.2015

      Feng, Y., Collignon, O., Maurer, D., Yao, K., & Gao, X. (2021). Brief postnatal visual deprivation triggers long-lasting interactive structural and functional reorganization of the human cortex. Frontiers in Medicine, 8, 752021. https://doi.org/10.3389/FMED.2021.752021/BIBTEX

      Gao, R., Peterson, E. J., & Voytek, B. (2017). Inferring synaptic excitation/inhibition balance from field potentials. NeuroImage, 158(March), 70–78. https://doi.org/10.1016/j.neuroimage.2017.06.078

      Hölig, C., Guerreiro, M. J. S., Lingareddy, S., Kekunnaya, R., & Röder, B. (2023). Sight restoration in congenitally blind humans does not restore visual brain structure. Cerebral Cortex, 33(5), 2152–2161. https://doi.org/10.1093/CERCOR/BHAC197

      Juchem, C., & Graaf, R. A. de. (2017). B0 magnetic field homogeneity and shimming for in vivo magnetic resonance spectroscopy. Analytical Biochemistry, 529, 17–29. https://doi.org/10.1016/j.ab.2016.06.003

      Kurcyus, K., Annac, E., Hanning, N. M., Harris, A. D., Oeltzschner, G., Edden, R., & Riedl, V. (2018). Opposite Dynamics of GABA and Glutamate Levels in the Occipital Cortex during Visual Processing. Journal of Neuroscience, 38(46), 9967–9976. https://doi.org/10.1523/JNEUROSCI.1214-18.2018

      Manning, J. R., Jacobs, J., Fried, I., & Kahana, M. J. (2009). Broadband shifts in local field potential power spectra are correlated with single-neuron spiking in humans. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 29(43), 13613–13620. https://doi.org/10.1523/JNEUROSCI.2041-09.2009

      Medel, V., Irani, M., Crossley, N., Ossandón, T., & Boncompte, G. (2023). Complexity and 1/f slope jointly reflect brain states. Scientific Reports, 13(1), 21700. https://doi.org/10.1038/s41598-023-47316-0

      Muthukumaraswamy, S. D., & Liley, D. T. (2018). 1/F electrophysiological spectra in resting and drug-induced states can be explained by the dynamics of multiple oscillatory relaxation processes. NeuroImage, 179(November 2017), 582–595. https://doi.org/10.1016/j.neuroimage.2018.06.068

      Oeltzschner, G., Zöllner, H. J., Hui, S. C. N., Mikkelsen, M., Saleh, M. G., Tapper, S., & Edden, R. A. E. (2020). Osprey: Open-source processing, reconstruction & estimation of magnetic resonance spectroscopy data. Journal of Neuroscience Methods, 343, 108827. https://doi.org/10.1016/j.jneumeth.2020.108827

      Ossandón, J. P., Stange, L., Gudi-Mindermann, H., Rimmele, J. M., Sourav, S., Bottari, D., Kekunnaya, R., & Röder, B. (2023). The development of oscillatory and aperiodic resting state activity is linked to a sensitive period in humans. NeuroImage, 275, 120171. https://doi.org/10.1016/J.NEUROIMAGE.2023.120171

      Pant, R., Ossandón, J., Stange, L., Shareef, I., Kekunnaya, R., & Röder, B. (2023). Stimulus-evoked and resting-state alpha oscillations show a linked dependence on patterned visual experience for development. NeuroImage: Clinical, 103375. https://doi.org/10.1016/J.NICL.2023.103375

      Raczy, K., Holig, C., Guerreiro, M. J. S., Lingareddy, S., Kekunnaya, R., & Roder, B. (2022). Typical resting-state activity of the brain requires visual input during an early sensitive period. Brain Communications, 4(4). https://doi.org/10.1093/BRAINCOMMS/FCAC146

      Rideaux, R., Ehrhardt, S. E., Wards, Y., Filmer, H. L., Jin, J., Deelchand, D. K., Marjańska, M., Mattingley, J. B., & Dux, P. E. (2022). On the relationship between GABA+ and glutamate across the brain. NeuroImage, 257, 119273. https://doi.org/10.1016/J.NEUROIMAGE.2022.119273

      Weaver, K. E., Richards, T. L., Saenz, M., Petropoulos, H., & Fine, I. (2013). Neurochemical changes within human early blind occipital cortex. Neuroscience. https://doi.org/10.1016/j.neuroscience.2013.08.004

    1. Author response:

      We thank the editor and the three reviewers for the positive assessment and constructive feedback on how to improve our manuscript. We greatly appreciate that our work is considered valuable to the field, the recognition of the high-resolution model we presented, and the comments on our investigation of CisA’s role in the attachment and firing mechanism of the extended assembly. It is truly gratifying to know that our study contributes to expanding the current understanding of the biology of Streptomyces and the role of these functionally diverse and fascinating bacterial nanomachines.

      We have provided specific responses to each reviewer's comments below. In summary, we intend to address the following requested revisions:

      We will expand our bioinformatic analysis of CisA and provide additional information on the oligomeric state of CisA. We will also modify the text, figures, and figure legends to improve the clarity of our work and experimental procedures.

      Some reviewer comments would require additional experimental work, some of which would involve extensive optimization of experimental conditions. Because both lead postdoctoral researchers involved in this work have now left the lab, we currently do not have the capability to perform additional experimental work.

      Reviewer #1 (Public review):

      Contractile Injection Systems (CIS) are versatile machines that can form pores in membranes or deliver effectors. They can act extra or intracellularly. When intracellular they are positioned to face the exterior of the cell and hence should be anchored to the cell envelope. The authors previously reported the characterization of a CIS in Streptomyces coelicolor, including significant information on the architecture of the apparatus. However, how the tubular structure is attached to the envelope was not investigated. Here they provide a wealth of evidence to demonstrate that a specific gene within the CIS gene cluster, cisA, encodes a membrane protein that anchors the CIS to the envelope. More specifically, they show that:

      - CisA is not required for assembly of the structure but is important for proper contraction and CIS-mediated cell death

      - CisA is associated to the membrane (fluorescence microscopy, cell fractionation) through a transmembrane segment (lacZ-phoA topology fusions in E. coli)

      - Structural prediction of interaction between CisA and a CIS baseplate component<br /> - In addition they provide a high-resolution model structure of the >750-polypeptide Streptomyces CIS in its extended conformation, revealing new details of this fascinating machine, notably in the baseplate and cap complexes.

      All the experiments are well controlled including trans-complemented of all tested phenotypes.

      One important information we miss is the oligomeric state of CisA.

      While it would have been great to test the interaction between CisA and Cis11, to perform cryo-electron microscopy assays of detergent-extracted CIS structures to maintain the interaction with CisA, I believe that the toxicity of CisA upon overexpression or upon expression in E. coli render these studies difficult and will require a significant amount of time and optimization to be performed. It is worth mentioning that this study is of significant novelty in the CIS field because, except for Type VI secretion systems, very few membrane proteins or complexes responsible for CIS attachment have been identified and studied.

      We thank this reviewer for their highly supportive and positive comments on our manuscript. We are grateful for this reviewer’s recognition of the novelty of our study, particularly in the context of membrane proteins and complexes involved in CIS attachment.

      We agree that further experimental evidence on the direct interaction between CisA and Cis11 would have strengthened our model of CisA function. However, as noted by this reviewer, this additional work is technically challenging and currently beyond the scope of this study.

      We thank Reviewer #1 for suggesting discussing the potential oligomeric state of CisA. We will perform additional AlphaFold modelling of CisA and discuss the result of this analysis in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The overall question that is addressed in this study is how the S. coelicolor contractile injection system (CISSc) works and affects both cell viability and differentiation, which it has been implicated to do in previous work from this group and others. The CISSc system has been enigmatic in the sense that it is free-floating in the cytoplasm in an extended form and is seen in contracted conformation (i.e. after having been triggered) mainly in dead and partially lysed cells, suggesting involvement in some kind of regulated cell death. So, how do the structure and function of the CISSc system compare to those of related CIS from other bacteria, does it interact with the cytoplasmic membrane, how does it do that, and is the membrane interaction involved in the suggested role in stress-induced, regulated cell death? The authors address these questions by investigating the role of a membrane protein, CisA, that is encoded by a gene in the CIS gene cluster in S. coelicolor. Further, they analyse the structure of the assembled CISSc, purified from the cytoplasm of S. coelicolor, using single-particle cryo-electron microscopy.

      Strengths:

      The beautiful visualisation of the CIS system both by cryo-electron tomography of intact bacterial cells and by single-particle electron microscopy of purified CIS assemblies are clearly the strengths of the paper, both in terms of methods and results. Further, the paper provides genetic evidence that the membrane protein CisA is required for the contraction of the CISSc assemblies that are seen in partially lysed or ghost cells of the wild type. The conclusion that CisA is a transmembrane protein and the inferred membrane topology are well supported by experimental data. The cryo-EM data suggest that CisA is not a stable part of the extended form of the CISSc assemblies. These findings raise the question of what CisA does.

      We thank Reviewer #2 for the overall positive evaluation of our manuscript and the constructive criticism. 

      Weaknesses:

      The investigations of the role of CisA in function, membrane interaction, and triggering of contraction of CIS assemblies, are important parts of the paper and are highlighted in the title. However, the experimental data provided to answer these questions appear partially incomplete and not as conclusive as one would expect.

      We acknowledge that some aspects of our work have not been fully answered. We believe that providing additional experimental data is currently beyond the scope of this study. To improve this study, we will modify the text and clarify experimental procedures and figures where possible in the revised version of our manuscript.

      The stress-induced loss of viability is only monitored with one method: an in vivo assay where cytoplasmic sfGFP signal is compared to FM5-95 membrane stain. Addition of a sublethal level of nisin lead to loss of sfGFP signal in individual hyphae in the WT, but not in the cisA mutant (similarly to what was previously reported for a CIS-negative mutant). Technically, this experiment and the example images that are shown give rise to some concern. Only individual hyphal fragments are shown that do not look like healthy and growing S. coelicolor hyphae. Under the stated growth conditions, S. coelicolor strains would normally have grown as dense hyphal pellets. It is therefore surprising that only these unbranched hyphal fragments are shown in Fig. 4ab.

      We thank Reviewer #2 for their thoughtful criticism regarding our stress-induced viability assay and the data presented in Figure 4. We acknowledge the importance of ensuring that the presented images should reflect the physiological state of S. coelicolor under the stated growth conditions and recognize that hyphal fragments shown in Figure 4 do not fully capture the typical morphology of S. coelicolor. As pointed out by this reviewer, S. coelicolor grows in large hyphal clumps when cultured in liquid media, making the quantification of fluorescence intensities in hyphae expressing cytoplasmic GFP and stained with the membrane dye FM5-95 particularly challenging. To improve the image analysis and quantification of GFP and FM5-95-fluorescent intensities across the three S. coelicolor strains (wildtype, cisA deletion mutant and the complemented cisA mutant), we vortexed the cell samples briefly before imaging to break up hyphal clumps, increasing hyphal fragments. The hyphae shown in our images were selected as representative examples across three biological replicates. 

      Further, S. coelicolor would likely be in a stationary phase when grown 48 h in the rich medium that is stated, giving rise to concern about the physiological state of the hyphae that were used for the viability assay. It would be valuable to know whether actively growing mycelium is affected in the same way by the nisin treatment, and also whether the cell death effect could be detected by other methods.

      The reasoning behind growing S. coelicolor for 48 h before performing the fluorescence-based viability assay was that we (DOI: 10.1038/s41564-023-01341-x ) and others (e.g.: DOI: 10.1038/s41467-023-37087-7 ) previously showed that the levels of CIS particles peak at the transition from vegetative to reproductive/stationary growth, thus indicating that CIS activity is highest during this growth stage. The obtained results in this manuscript are in agreement with our previous study, in which we showed a similar effect on the viability of wildtype versus cis-deficient S. coelicolor strains (DOI: 10.1038/s41564-023-01341-x ) using nisin, the protonophore CCCP and UV light, and supported by biological replicate experiments and appropriate controls. Furthermore, our results are in agreement with the findings reported in a complementary study by Vladimirov et al. (DOI: 10.1038/s41467-023-37087-7 ) that used a different approach (SYTO9/PI staining of hyphal pellets) to demonstrate that CIS-deficient mutants exhibit decreased hyphal death. We agree that it would be interesting to test if actively growing hyphae respond differently to nisin treatment, and such experiments will be considered in future work. 

      Taken together, we believe that the results obtained from our fluorescence-based viability assay are consistent with data reported by others and provide strong experimental evidence that functional CIS mediate hyphal cell death. 

      The model presented in Fig. 5 suggests that stress leads to a CisA-dependent attachment of CIS assemblies to the cytoplasmic membrane, and then triggering of contraction, leading to cell death. This model makes testable predictions that have not been challenged experimentally. Given that sublethal doses of nisin seem to trigger cell death, there appear to be possibilities to monitor whether activation of the system (via CisA?) indeed leads to at least temporally increased interaction of CIS with the membrane.

      We thank this reviewer for their suggestions on how to test our model further. In the meantime, we have performed co-immunoprecipitation experiments using S. coelicolor cells that produced CisA-FLAG as bait and were treated with a sub-lethal nisin concentration for 0/15/45 min.  Mass spectrometry analysis of co-eluted peptides did not show the presence of CIS-associated peptides. While we cannot exclude the possibility that our experimental assay requires further optimization to successfully demonstrate a CisA-CIS interaction (e.g. optimization of the use of detergents to improve the solubilization of CisA from Streptomyces membrane, which is currently not an established method), an alternative and equally valid hypothesis is that the interaction between CIS particles and CisA is transient and therefore difficult to capture. We would like to mention that we did detect CisA peptides in crude purifications of CIS particles from nisin-stressed cells (Supplementary Table 2, manuscript: line 265/266), supporting our model that CisA associates with CIS particles in vivo.

      Further, would not the model predict that stress leads to an increased number of contracted CIS assemblies in the cytoplasm? No clear difference in length of the isolated assemblies if Fig. S7 is seen between untreated and nisin-exposed cells, and also no difference between assemblies from WT and cisA mutant hyphae.

      The reviewer is correct that there is no clear difference in length in the isolated CIS particles shown in Figure S7. This is in line with our results, which show that CisA is not required for the correct assembly of CIS particles and their ability to contract in the presence and absence of nisin treatment. The purpose of Figure S7 was to support this statement. We would like to note that the particles shown in Figure S7 were purified from cell lysates using a crude sheath preparation protocol, during which CIS particles generally contract irrespective of the presence or absence of CisA. Thus, we cannot comment on whether there is an increased number of contracted CIS assemblies in the cytoplasm of nisin-exposed cells. To answer this point, we would need to acquire additional cryo-electron tomograms (cyroET) of the different strains treated with nisin. We appreciate this reviewer's suggestions. However, cryoET is an extremely time and labour-intensive task, and given that we currently don’t know the exact dynamics of the CIS-CisA interaction following exogenous stress, we believe this experiment is beyond the scope of this work.

      The interaction of CisA with the CIS assembly is critical for the model but is only supported by Alphafold modelling, predicting interaction between cytoplasmic parts of CisA and Cis11 protein in the baseplate wedge. An experimental demonstration of this interaction would have strengthened the conclusions.

      We agree that direct experimental evidence of this interaction would have further strengthened the conclusions of our study, and we have extensively tried to provide additional experimental evidence. Unfortunately, due to the toxicity of CisA expression in E. coli and the transient nature of the interaction under our experimental conditions, we were unable to pursue direct biochemical or biophysical validation methods, such as co-purification or bacterial two-hybrid assays. While these challenges limited our ability to experimentally confirm the interaction, the AlphaFold predictions provided a valuable hypothesis and mechanistic insight into the role of CisA.

      The cisA mutant showed a similarly accelerated sporulation as was previously reported for CIS-negative strains, which supports the conclusion that CisA is required for function of CISSc. But the results do not add any new insights into how CIS/CisA affects the progression of the developmental life cycle and whether this effect has anything to do with the regulated cell death that is caused by CIS. The same applies to the effect on secondary metabolite production, with no further mechanistic insights added, except reporting similar effects of CIS and CisA inactivations.

      We thank this reviewer for their thoughtful feedback and for highlighting the connections between CisA, CIS function, and their effects on the developmental life cycle and secondary metabolite production in S. coelicolor. The main focus of this study was to provide further insight into how CIS contraction and firing are mediated in Streptomyces, and we used the analysis of accelerated sporulation and secondary metabolite production to assess the functionality of CIS in the presence or absence of CisA.

      We agree that we still don’t fully understand the nature of the signals that trigger CIS contraction, but we do know that the production of CIS assemblies seems to be an integral part of the Streptomyces multicellular life cycle as demonstrated in two independent previous studies (DOI: 10.1038/s41564-023-01341-x and DOI: 10.1038/s41467-023-37087-7 ). We propose that the assembly and firing of Streptomyces CIS particles could present a molecular mechanism to sacrifice only a part of the mycelium to either prevent the spread of local cellular damage or to provide additional nutrients for the rest of the mycelium and delay the terminal differentiation into spores and affect the production of secondary metabolites.

      We recognize the importance of understanding the regulation and mechanistic details underpinning the proposed CIS-mediated regulated cell death model. This will be further explored in future studies.

      Concluding remarks:

      The work will be of interest to anyone interested in contractile injection systems, T6SS, or similar machineries, as well for people working on the biology of streptomycetes. There is also a potential impact of the work in the understanding of how such molecular machineries could have been co-opted during evolution to become a mechanism for regulated cell death. However, this latter aspect remains still poorly understood. Even though this paper adds excellent new structural insights and identifies a putative membrane anchor, it remains elusive how the Streptomyces CIS may lead to cell death. It is also unclear what the advantage would be to trigger death of hyphal compartments in response to stress, as well as how such cell death may impact (or accelerate) the developmental progression. Finally, it is inescapable to wonder whether the Streptomyces CIS could have any role in protection against phage infection.

      We thank Reviewer #2 for their supportive assessment of our work. In the revised manuscript, we will briefly discuss the impact of functional CIS assemblies on Streptomyces development. We previously tested if Streptomyces could defend against phages but have not found any experimental evidence to support this idea. The analysis of phage defense mechanisms is an underdeveloped area in Streptomyces research, partly due to the currently limited availability of a diverse phage panel.

      Reviewer #3 (Public review):

      Summary:

      In this work, Casu et al. have reported the characterization of a previously uncharacterized membrane protein CisA encoded in a non-canonical contractile injection system of Streptomyces coelicolor, CISSc, which is a cytosolic CISs significantly distinct from both intracellular membrane-anchored T6SSs and extracellular CISs. The authors have presented the first high-resolution structure of extended CISSc structure. It revealed important structural insights in this conformational state. To further explore how CISSc interacted with cytoplasmic membrane, they further set out to investigate CisA that was previously hypothesized to be the membrane adaptor. However, the structure revealed that it was not associated with CISSc. Using fluorescence microscope and cell fractionation assay, the authors verified that CisA is indeed a membrane-associated protein. They further determined experimentally that CisA had a cytosolic N-terminal domain and a periplasmic C-terminus. The functional analysis of cisA mutant revealed that it is not required for CISSc assembly but is essential for the contraction, as a result, the deletion significantly affects CISSc-mediated cell death upon stress, timely differentiation, as well as secondary metabolite production. Although the work did not resolve the mechanistic detail how CisA interacts with CISSc structure, it provides solid data and a strong foundation for future investigation toward understanding the mechanism of CISSc contraction, and potentially, the relation between the membrane association of CISSc, the sheath contraction and the cell death.

      Strengths:

      The paper is well-structured, and the conclusion of the study is supported by solid data and careful data interpretation was presented. The authors provided strong evidence on (1) the high-resolution structure of extended CISSc determined by cryo-EM, and the subsequent comparison with known eCIS structures, which sheds light on both its similarity and different features from other subtypes of eCISs in detail; (2) the topological features of CisA using fluorescence microscopic analysis, cell fractionation and PhoA-LacZα reporter assays, (3) functions of CisA in CISSc-mediated cell death and secondary metabolite production, likely via the regulation of sheath contraction.

      Weaknesses:

      The data presented are not sufficient to provide mechanistic details of CisA-mediated CISSc contraction, as authors are not able to experimentally demonstrate the direct interaction between CisA with baseplate complex of CISSc (hypothesized to be via Cis11 by structural modeling), since they could not express cisA in E. coli due to its potential toxicity. Therefore, there is a lack of biochemical analysis of direct interaction between CisA and baseplate wedge. In addition, there is no direct evidence showing that CisA is responsible for tethering CISSc to the membrane upon stress, and the spatial and temporal relation between membrane association and contraction remains unclear. Further investigation will be needed to address these questions in future.

      We thank Reviewer #3 for the supportive evaluation and constructive criticism of our study in the public and non-public review. We appreciate your recognition of the technical limitations of experimentally demonstrating a direct interaction between CisA and CIS baseplate complex, and we agree that further investigations in the future will hopefully provide a full mechanistic understanding of the spatiotemporal interaction of CisA and CIS particular and the subsequent CIS firing.

      To further improve the manuscript, we will revise the text and clarify figures and figure legends as suggested in the non-public review.

      Discussion:

      Overall, the work provides a valuable contribution to our understanding on the structure of a much less understood subtype of CISs, which is unique compared to both membrane-anchored T6SSs and host-membrane targeting eCISs. Importantly, the work serves as a good foundation to further investigate how the sheath contraction works here. The work contributes to expanding our understanding of the diverse CIS superfamilies.

      Thank you.

    1. Author response:

      Both reviewers made thoughtful and constructive comments, suggesting improvements that we are keen to provide. The comments fall under 3 headings (1) Further validation of the design, regarding both optical performance and utility, for both education and research (2) Further description and facilitation of the build process and (3) Further description of future plans, in particular plans for dissemination and long-term support. We think these requirements will be best served by adding new content to our Github site and our YouTube channel. We will create this new content and provide a revised manuscript in which these materials are linked from our existing narrative.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors showed the presence of Mtb in human liver biopsy samples of TB patients and reported that chronic infection of Mtb causes immune-metabolic dysregulation. Authors showed that Mtb replicates in hepatocytes in a lipid rich environment created by up regulating transcription factor PPARγ. Authors also reported that Mtb protects itself from anti-TB drugs by inducing drug metabolising enzymes.

      Strengths:

      It has been shown that Mtb induces storage of triacylglycerol in macrophages by induction of WNT6/ACC2 which helps in its replication and intracellular survival, however, creation of favorable replicative niche in hepatocytes by Mtb is not reported. It is known that Mtb infects macrophages and induces formation of lipid-laden foamy macrophages which eventually causes tissue destruction in TB patients. In a recent article it has been reported that "A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages" that shows how Mtb manipulates host defense mechanisms for its survival. In this manuscript, authors reported the enhancement of lipid droplets in Mtb infected hepatocytes and convincingly showed that fatty acid synthesis and triacylglycerol formation is important for growth of Mtb in hepatocytes. The authors also showed the molecular mechanism for accumulation of lipid and showed that the transcription factor associated with lipid biogenesis, PPARγ and adipogenic genes were upregulated in Mtb infected cells.

      The comparison of gene expression data between macrophages and hepatocytes by authors is important which indicates that Mtb modulates different pathways in different cell type as in macrophages it is related to immune response whereas, in hepatocytes it is related to metabolic pathways.

      Authors also reported that Mtb residing in hepatocytes showed drug tolerance phenotype due to up regulation of enzymes involved in drug metabolism and showed that cytochrome P450 monooxygenase that metabolize rifampicin and NAT2 gene responsible for N-acetylation of isoniazid were up regulated in Mtb infected cells.

      We thank the reviewer for the positive feedback and for highlighting the strengths of our study.

      Weaknesses:

      There are reports of hepatic tuberculosis in pulmonary TB patients especially in immune-compromised patients, therefore finding granuloma in human liver biopsy samples is not surprising.

      Mtb infected hepatic cells showed induced DME and NAT and this could lead to enhanced metabolism of drug by hepatic cells as a result Mtb in side HepG2 cells get exposed to reduced drug concentration and show higher tolerance to drug. The authors mentioned that " hepatocyte resident Mtb may display higher tolerance to rifampicin". In my opinion higher tolerance to drugs is possible only when DME of Mtb inside is up regulated or the target is modified. Although, in the end authors mentioned that drug tolerance phenotype can be better attributed to host intrinsic factors rather than Mtb efflux pumps. It may be better if the Drug tolerant phenotype section can be rewritten to clarify the facts.

      We agree that several case studies regarding liver infection in pulmonary TB patients have been reported in the literature, however this report is the first comprehensive study that establishes hepatocytes to be a favourable niche for Mtb survival and growth.

      Drug tolerance is a phenomenon that is exhibited by the bacteria and in the course of host-pathogen interactions, can be influenced by both intrinsic (bacterial) and extrinsic (host-mediated) factors. Multiple examples of tolerance being attributed to host driven factors can be found in literature (PMID 32546788, PMID: 28659799, PMID: 32846197). Our studies demonstrate that Mtb infected hepatocytes create a drug tolerant environment by modulating the expression of Drug modifying enzymes (DMEs) in the hepatocytes.

      As suggested by the reviewer we will rewrite the drug tolerant phenotype section.

      Reviewer #2 (Public review):

      The manuscript by Sarkar et al has demonstrated the infection of liver cells/hepatocytes with Mtb and the significance of liver cells in the replication of Mtb by reprogramming lipid metabolism during tuberculosis. Besides, the present study shows that similar to Mtb infection of macrophages (reviewed in Chen et al., 2024; Toobian et al., 2021), Mtb infects liver cells but with a greater multiplication owing to consumption of enhanced lipid resources mediated by PPARg that could be cleared by its inhibitors. The strength of the study lies in the clinical evaluation of the presence of Mtb in human autopsied liver samples from individuals with miliary tuberculosis and the presence of a clear granuloma-like structure. The interesting observation is of granuloma-like structure in liver which prompts further investigations in the field.

      The modulation of lipid synthesis during Mtb infection, such as PPARg upregulation, appears generic to different cell types including both liver cells and macrophage cells. It is also known that infection affect PPARγ expression and activity in hepatocytes. It is also known that this can lead to lipid droplet accumulation in the liver and the development of fatty liver disease (as shown for HCV). This study is in a similar line for M.tb infection. As the liver is the main site for lipid regulation, the availability of lipid resources is greater and higher is the replication rate. In short, the observations from the study confirm the earlier studies with these additional cell types. It is known that higher the lipid content, the greater are Lipid Droplet-positive Mtb and higher is the drug resistance (Mekonnen et al., 2021). The DMEs of liver cells add further to the phenotype.

      We thank the reviewer for emphasizing on the strengths of our study and how it can lead to further investigations in the field.

      Reviewer #3 (Public review):

      This manuscript by Sarkar et al. examines the infection of the liver and hepatocytes during M. tuberculosis infection. They demonstrate that aerosol infection of mice and guinea pigs leads to appreciable infection of the liver as well as the lung. Transcriptomic analysis of HepG2 cells showed differential regulation of metabolic pathways including fatty acid metabolic processing. Hepatocyte infection is assisted by fatty acid synthesis in the liver and inhibiting this caused reduced Mtb growth. The nuclear receptor PPARg was upregulated by Mtb infection and inhibition or agonism of its activity caused a reduction or increase in Mtb growth, respectively, supporting data published elsewhere about the role of PPARg in lung macrophage Mtb infection. Finally, the authors show that Mtb infection of hepatocytes can cause upregulation of enzymes that metabolize antibiotics, resulting in increased tolerance of these drugs by Mtb in the liver.

      Overall, this is an interesting paper on an area of TB research where we lack understanding. However, some additions to the experiments and figures are needed to improve the rigor of the paper and further support the findings. Most importantly, although the authors show that Mtb can infect hepatocytes in vitro, they fail to describe how bacteria get from the lungs to the liver in an aerosolized infection. They also claim that "PPARg activation resulting in lipid droplets formation by Mtb might be a mechanism of prolonging survival within hepatocytes" but do not show a direct interaction between PPARg activation and lipid droplet formation and lipid metabolism, only that PPARg promotes Mtb growth. Thus, the correlations with PPARg appear to be there but causation, implied in the abstract and discussion, is not proven.

      The human photomicrographs are important and overall, well done (lung and liver from the same individuals is excellent). However, in lines 120-121, the authors comment on the absence of studies on the precise involvement of different cells in the liver. In this study there is no attempt to immunophenotype the nature of the cells harboring Mtb in these samples (esp. hepatocytes). Proving that hepatocytes specifically harbor the bacteria in these human samples would add significant rigor to the conclusions made.

      We thank the reviewer for nicely summarizing our manuscript.

      Our study establishes the involvement of liver and hepatocytes in pulmonary TB infection in mice. Understanding the mechanism of bacterial dissemination from the lung to the liver in aerosol infections demands a detailed separate study.

      Figure 6E and 6F shows how PPARγ agonist and antagonist modulate (increase and decrease respectively) bacterial growth in hepatocytes (further supported by the CFU data in Supplementary Figure 9B). Again, the number of lipid droplets in hepatocytes increase and decrease with the application of PPARγ agonist and antagonist respectively as shown in Figure 6G and 6H. Collectively, these studies provide strong evidence that PPARγ activation leads to more lipid droplets that support better Mtb growth.

      We thank the reviewer for finding our human photomicrographs convincing. In the manuscript, we provide evidence for the direct involvement of the hepatocytes (and liver) in Mtb infection. We perform detailed immunophenotyping of hepatocyte cells in the mice model with ASPGR1 (asialoglycoprotein receptor 1) and in the revised version of record, we will further stain the infected hepatocytes with anti-albumin antibody.

  2. Dec 2024
    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #3:

      Concerns and comments on current version:

      The revision has improved the manuscript but, in my opinion, remains inadequate. While most of my requested changes have been made, I do not see an expansion of Fig1A legend to incorporate more details about the analysis. Lacking details of methodology was a concern from all reviewers.

      To address this concern, we expanded Fig.1A legend, and also significantly expanded the text describing experimental design, to also include the description of the data analysis approach.

      “BCR repertoires libraries were obtained using the 5’-RACE (Rapid Amplification of cDNA Ends) protocol as previously described21 and sequenced with 150+150 bp read length. This approach allowed us to achieve high coverage for the obtained libraries (Table S1) to reveal information on clonal composition, CDR-H3 properties, IgM/IgG/IgA isotypes and somatic hypermutation load within CDR-H3. For B cell clonal lineage reconstruction and phylogenetic analysis, however, 150+150 bp read length is suboptimal because it does not cover V-gene region outside CDR-H3, where hypermutations also occur. Therefore, to verify our conclusions based on the data obtained by 150+150 bp sequencing (“short repertoires”), for some of our samples we also generated BCR libraries by IG RNA Multiplex protocol (See Materials and Methods) and sequenced them at 250+250 bp read length (“long repertoires”). Libraries obtained by this protocol cover V gene sequence starting from CDR-H1 and capture most of the hypermutations in the V gene. Conclusions about clonal lineage phylogeny were drawn only when they were corroborated by “long repertoire” analysis.

      For BCR repertoire reconstruction from sequencing data, we first performed unique molecular identifier (UMI) extraction and error correction (reads/UMI threshold = 3 for 5`RACE and 4 for IG Multiplex libraries). Then, we used MIXCR58 software to assemble reads into clonotypes, determine germline V, D, and J genes, isotypes, and find the boundaries of target regions, such as CDR-H3. Only

      UMI counts, and not read counts, were used for quantitative analysis. Clonotypes derived from only one UMI were excluded from the analysis of individual clonotype features but were used to analyze clonal lineages and hypermutation phylogeny, where sample size was crucial. Samples with 50 or less clonotypes left after preprocessing were excluded from the analysis.”

      Similarly, the 'fragmented' narrative was a concern of all reviewers. These matters have not been dealt with adequately enough - there are parts of the manuscript which remain fragmented and confusing.

      Unfortunately, the reviewers do not give us a hint as to which parts of the text are the most problematic in their opinion. We identified the parts describing physicochemical properties of CDR3s, Intratumoral heterogeneity and Intra-LN heterogeneity as the most problematic, and edited these parts significantly. Also, we significantly edited the Discussion section (please see the Comparison file for details). Other parts sections were also edited to improve readability and clarity.

      The narrative and analysis does not explain how the plasma cell bias has been dealt with adequately and in fact is simply just confusing. There is a paragraph at the beginning of the discussion re the plasma cell bias, which should be re-written to be clearer and moved to have a prominent place early in the results. Why are these results not properly presented? They are key for interpretation of the manuscript. Furthermore, the sorted plasma cell sequencing analysis also has only been performed on two patients.

      In response to this concern, we moved the section describing plasma cell bias in the bulk BCR repertoires to the main text.

      Another issue is that some disease cohorts are entirely composed of patients with metastasis, some without but metastasis is not mentioned. Metastasis has been shown to impact the immune landscape.

      Intrinsic heterogeneity of the cohort is indeed one of the weaknesses of our work, which could negatively impact the statistical significance of our results and, as a consequence, mask certain observations or make them less statistically significant. We mention this in the discussion section. It should not, in our understanding, lead to any false conclusions. We did not, however, pool data from primary and metastatic tumor samples, and all tumor samples that we mention are primary tumors.

      The following part of a sentence was added to the discussion:

      “...which could negatively impact the statistical significance of our results and, as a consequence, mask certain observations or make them less statistically significant.”

      A reviewer brought up a concern about the overlap analysis and I also asked for an explanation on why this F2 metric was chosen. Part of the rebuttal argues that another metric was explored showing similar results, thus the conclusion reached is reasonable. Remarkably, these data are not only omitted from the manuscript, but are not even provided for the reviewers.

      We did not intend to conceal any data from the reviewers, and we now added the panel for D metric to the S1 figure. We would also like to point out that the panel describing R metric for repertoire overlaps (a measure of similarity of overlapping clonotype frequencies), was included in the first version of the S2 Figure (now S1 Figure), and it also showed a similar trend. We hope that now the data are fully conclusive.

      This manuscript certainly includes some interesting and useful work. Unfortunately, a comprehensive re-write was required to make the work much clearer and easier to understand and this has not been realized.

      Again, we thank the reviewers for their thorough evaluation, and hopefully we could make the text clearer in the second reviewed version.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this work, a screening platform is presented for rapid and cost-effective screening of candidate genes involved in Fragile Bone Disorders. The authors validate the approach of using crispants, generating FO mosaic mutants, to evaluate the function of specific target genes in this particular condition. The design of the guide RNAs is convincingly described, while the effectiveness of the method is evaluated to 60% to 92% of the respective target genes being presumably inactivated. Thus, injected F0 larvae can be directly used to investigate the consequences of this inactivation.

      Skeletal formation is then evaluated at 7dpf and 14dpf, first using a transgenic reporter line revealing fluorescent osteoblasts, and second using alizarin-red staining of mineralized structures. In general, it appears that the osteoblast-positive areas are more often affected in the crispants compared to the mineralized areas, an observation that appears to correlate with the observed reduced expression of bglap, a marker for mature osteoblasts, and the increased expression of col1a1a in more immature osteoblasts.

      Finally, the injected fish (except two lines that revealed high mortality) are also analyzed at 90dpf, using alizarin red staining and micro-CT analysis, revealing an increased incidence of skeletal deformities in the vertebral arches, fractures, as well as vertebral fusions and compressions for all crispants except those for daam2. Finally, the Tissue Mineral Density (TMD) as determined by micro-CT is proposed as an important marker for investigating genes involved in osteoporosis.

      Taken together, this manuscript is well presented, the data are clear and well analyzed, and the methods are well described. It makes a compelling case for using the crispant technology to screen the function of candidate genes in a specific condition, as shown here for bone disorders.

      Strengths:

      Strengths are the clever combination of existing technologies from different fields to build a screening platform. All the required methods are comprehe Zebrafish tanks_13062024nsively described.

      We would like to thank the reviewer for highlighting the strengths of our paper.  

      Weaknesses:

      One may have wished to bring one or two of the crispants to the stage of bona fide mutants, to confirm the results of the screening, however, this is done for some of the tested genes as laid out in the discussion.

      We thank the reviewer for their comment. We would like to point out that indeed similar phenotypes have been observed in existing models, as mentioned in the discussion section.

      Reviewer #2 (Public review):

      Summary:

      More and more genes and genetic loci are being linked to bone fragility disorders like osteoporosis and osteogenesis imperfecta through GWAS and clinical sequencing. In this study, the authors seek to develop a pipeline for validating these new candidate genes using crispant screening in zebrafish. Candidates were selected based on GWAS bone density evidence (4 genes) or linkage to OI cases plus some aspect of bone biology (6 genes). NGS was performed on embryos injected with different gRNAs/Cas9 to confirm high mutagenic efficacy and off-target cutting was verified to be low. Bone growth, mineralization, density, and gene expression levels were carefully measured and compared across crispants using a battery of assays at three different stages.

      Strengths:

      (1) The pipeline would be straightforward to replicate in other labs, and the study could thus make a real contribution towards resolving the major bottleneck of candidate gene validation.

      (2) The study is clearly written and extensively quantified.

      (3) The discussion attempts to place the phenotypes of different crispant lines into the context of what is already known about each gene's function.

      (4) There is added value in seeing the results for the different crispant lines side by side for each assay.

      We would like to thank the reviewer for highlighting the strengths of our paper.  

      Weaknesses:

      (1) The study uses only well-established methods and is strategy-driven rather than question/hypothesis-driven.

      We thank the reviewer for this correct remark. The mayor aim of this study was to establish a workflow for rapid in vivo functional screening of candidate genes across a broad range of FBDs. 

      (2) Some of the measurements are inadequately normalized and not as specific to bone as suggested:

      (a) The measurements of surface area covered by osteoblasts or mineralized bone (Figure 1) should be normalized to body size. The authors note that such measures provide "insight into the formation of new skeletal tissue during early development" and reflect "the quantity of osteoblasts within a given structure and [is] a measure of the formation of bone matrix." I agree in principle, but these measures are also secondarily impacted by the overall growth and health of the larva. The surface area data are normalized to the control but not to the size/length of each fish - the esr1 line in particular appears quite developmentally advanced in some of the images shown, which could easily explain the larger bone areas. The fact that the images in Figure S5 were not all taken at the same magnification further complicates this interpretation.

      We thank the reviewer for this detailed and insightful remark. We agree with the reviewer and recognize that the results may be influenced by size differences. However, we do not normalize for size, as variations in growth were considered as part of the phenotypic outcome. This consideration has been addressed in the discussion section.

      Line 335-338: ‘Although the measurements of osteoblast-positive and mineralized surface areas may be influenced by size differences among some of the crispants, normalization to size parameters was not conducted, as variations in growth were considered integral to the phenotypic outcome.’

      Line 369: ‘Phenotypic variability in these zebrafish larvae can be attributed to several factors, including crispant mosaicism, allele heterogeneity, environmental factors, differences in genomic background and development, and slightly variable imaging positioning.’

      (b) Some of the genes evaluated by RT-PCR in Figure 2 are expressed in other tissues in addition to bone (as are the candidate genes themselves); because whole-body samples were used for these assays, there is a nonzero possibility that observed changes may be rooted in other, non-skeletal cell types.

      We thank the reviewer for this valuable comment. We acknowledge that the genes assessed by RT-PCR are expressed in other tissues beyond bone. This consideration has been addressed in the discussion section.

      Line 362-365: “However, it is important to note that the genes evaluated by RT-PCR are not exclusively expressed in bone tissue. Since whole-body samples were used for expression analysis, there is a possibility that the observed changes in gene expression may be influenced by other non-skeletal cell types”.

      (3) Though the assays evaluate bone development and quality at several levels, it is still difficult to synthesize all the results for a given gene into a coherent model of its requirement.

      We appreciate the reviewer’s  remark. We acknowledge that the results for the larval stages exhibit variability, making it challenging to synthesize them into a coherent model. However, it is important to emphasize that all adult crispant consistently display a skeletal phenotype. Consequently, the feasibility and reproducibility of this screening method are primarily focusing on the adult stages. This consideration has been addressed in the discussion section of the manuscript.

      Line 391-399: ‘In adult crispants, the skeletal phenotype was generally more penetrant. All crispants showed malformed arches, a majority displayed vertebral fractures and fusions and some crispants exhibited distinct quantitative variations in vertebral body measurements. This confirmed the role of the selected genes in skeletal development and homeostasis and their involvement in skeletal disease and established the crispant approach as a valid approach for rapidly providing in vivo gene function data to support candidate gene identification.’

      (4) Several additional caveats to crispant analyses are worth noting:

      (a) False negatives, i.e. individual fish may not carry many (or any!) mutant alleles. The crispant individuals used for most assays here were not directly genotyped, and no control appears to have been used to confirm successful injection. The authors therefore cannot rule out that some individuals were not, in fact, mutagenized at the loci of interest, potentially due to human error. While this doesn't invalidate the results, it is worth acknowledging the limitation.

      We thank the reviewer for this valuable remark. We recognize the fact that working with crispants has certain limitations, including the possibility that some individuals may carry few or no mutant alleles. To address this issue, we use 10 individual crispants during the larval stage and 5 during the adult stage. Although some individuals may lack the mutant alleles, using multiple fish helps reduce the risk of false negatives.

      Furthermore, we perform NGS analysis on pools of 10 embryos from the same injection clutch as the fish used in the various assays to assess the indel efficiency. While there remains a possibility of false negatives, the overall indel efficiency, as indicated by our NGS analysis,  is high (>90%), thereby reducing the likelihood of having crispants with very low indel efficiency. We included this in the discussion.

      Line 387-390: ‘While there remains a possibility of false negatives, the overall indel efficiency, as indicated by our NGS analysis,  is high (>90%), thereby reducing the likelihood of having crispants with very low indel efficiency.’

      (b) Many/most loci identified through GWAS are non-coding and not easily associated with a nearby gene. The authors should discuss whether their coding gene-focused pipeline could be applied in such cases and how that might work.

      The authors thank the reviewer for this insightful comment. Our study is focused on strong candidate genes rather than non-coding variants. We recognize that the use of this workflow poses challenges for analyzing non-coding variants, which represents a limitation of the crispant approach. We have addressed this issue in the discussion section of the manuscript.

      Line 131: ‘Gene-based’

      Line 453: ‘Gene-based’

      Line 311-314: ‘It is important to note that this study focused on candidate genes for osteoporosis, not on the role of specific variants identified in GWAS studies. Non-coding variants for instance, which are often identified in GWAS studies,  present significant challenges in terms of functional validation and interpretation.’

      Reviewer #3 (Public review):

      Summary:

      The manuscript "Crispant analysis in zebrafish as a tool for rapid functional screening of disease-causing genes for bone fragility" describes the use of CRISPR gene editing coupled with phenotyping mosaic zebrafish larvae to characterize functions of genes implicated in heritable fragile bone disorders (FBDs). The authors targeted six high-confident candidate genes implicated in severe recessive forms of FBDs and four Osteoporosis GWAS-implicated genes and observed varied developmental phenotypes across all crispants, in addition to adult skeletal phenotypes.

      A major strength of the paper is the streamlined method that produced significant phenotypes for all candidate genes tested.

      We would like to thank the reviewer for highlighting the strengths of our paper.  

      A major weakness is a lack of new insights into underlying mechanisms that may contribute to disease phenotypes, nor any clear commonalities across gene sets. This was most evident in the qRT-PCR analysis of select skeletal developmental genes, which all showed varied changes in fold and direction, but with little insight into the implications of the results.

      We thank the reviewer for this insightful remark. We want to emphasize that this study focusses on establishing a new screening method for candidate genes involved in FBDs, rather than investigating the underlying mechanisms contributing to disease phenotypes. However, to investigate the underlying mechanisms in these crispants, the creation of bona fide mutants is necessary. We have included this consideration in the discussion.

      Furthermore, we acknowledge that the results for the larval stages exhibit variability, which can complicate the interpretation of these findings. This is particularly true for the RT-PCR analysis, where whole-body samples were used, raising the possibility that other tissues may influence the expression results. Therefore, our primary focus is on the adult stages, as all crispants display a skeletal phenotype at this age. We have elaborated on this point in the discussion.

      Line 462-463: ‘Moreover, to explore the underlying mechanisms contributing to disease phenotypes, it is essential to establish stable knockout mutants derived from the crispants’.

      Line 391-399: ‘In adult crispants, the skeletal phenotype was generally more penetrant. All crispants showed malformed arches, a majority displayed vertebral fractures and fusions and some crispants exhibited distinct quantitative variations in vertebral body measurements. This confirmed the role of the selected genes in skeletal development and homeostasis and their involvement in skeletal disease and established the crispant approach as a valid approach for rapidly providing in vivo gene function data to support candidate gene identification.’

      Ultimately, the authors were able to show their approach is capable of connecting candidate genes with perturbation of skeletal phenotypes. It was surprising that all four GWAS candidate genes (which presumably were lower confidence) also produced a result.

      We appreciate the reviewer’s comment. We would like to direct attention to the discussion section, where we offer a possible explanation for the observation that all four GWAS candidate genes produce a skeletal phenotype.

      Line 460-410: 'The more pronounced and earlier phenotypes in these zebrafish crispants are most likely attributed to the quasi knock-out state of the studied genes, while more common less impactful variants in the same genes result in typical late-onset osteoporosis (Laine et al., 2013) . This phenomenon is also observed in knock-out mouse models for these genes (Melville et al., 2014)(Coughlin et al., 2019).’

      These authors have previously demonstrated that crispants recapitulate skeletal phenotypes of stable mutant lines for a single gene, somewhat reducing the novelty of the study.

      We thank the reviewer for this comment and appreciate their concern. We have indeed demonstrated that crispants can recapitulate the skeletal phenotypes observed in stable mutant lines for the osteoporosis gene LRP5. However, we would like to highlight that the current study represents the first large-scale screening of candidate genes associated with bone disorders, including genes related to both OI and osteoporosis. We have included this information in both the abstract and the discussion

      Line 60-62: ‘We advocate for a novel comprehensive approach that integrates various techniques and evaluates distinct skeletal and molecular profiles across different developmental and adult stages.’

      Line 456-457: ‘While this work represents a pioneering effort in establishing a screening platform for skeletal diseases, it offers opportunities for future improvement and refinement.’

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Figure 1a: what does the differential shading of the bone elements represent? Explain in the legend.

      The differential shading doesn't represent anything specific. It's simply used to enhance the visual appeal and to help distinguish between the different structures. We removed the shading in the figure.

      (2) Supplementary Figures 2-5: should the numbering of these figures be also in order of appearance in the text? I understand that the authors prefer to associate the transgenic and the alizarin red-stained specimens, however, the reading would be easier that way.

      We changed this accordingly.

      (3) Lines 275-276: "no significant differences in standard length (Figure 4a)": should be Figure 4b.

      The suggested changes are incorporated in the manuscript.

      Line 276-277: ‘Among the eight crispants that successfully matured into adulthood, none exhibited significant differences in standard length and head size (n=5 fish per crispant) (Figure 4b).’

      (4) Line 277 "larger eye diameter": should be Figure 4b.

      The suggested changes are incorporated in the manuscript.

      Line 378: ‘However, esr1 crispants were observed to have notably larger eye diameters (Figure 4b).’

      (5) Line 280: "no obvious abnormalities were detected (Figure 4b,c)": should be Figure 4a, c. Note that the authors may reconsider the a, b, c numbering in Figure 4 by inverting a and b.

      The suggested changes are incorporated in the manuscript.

      Line 278-281: ‘All these crispants demonstrated various abnormalities in the caudal part of the vertebral column such as fusions, compressions, fractures, or arch malformations, except for daam2 crispants where no obvious abnormalities were detected (Figure 4a,c; Supplementary Figure 6).’

      (6) Table 2: This table, which recapitulates all the results presented in the manuscript, is in the end the centerpiece of the work. It is however difficult to read in its present form. Three suggestions:

      - Transpose it such that each gene has its own column, and the lines give the results for the different measurements

      - Place the measurements that result in "ns" for all crispants at the end (bottom) of the table.

      - Maybe bring the measurements at 7dpf, 14dpf, and 90 dpf together.

      We agree with the reviewer and have added a new table where we transposed the data. However, we chose not to place the measurements that resulted in 'ns' for all crispants at the end of the table, as we believe it is important to track the evolution of the phenotype over time. Where possible, we have grouped the measurements for 7 dpf and 14 dpf together.

      Reviewer #2 (Recommendations for the authors):

      (1) It would help to justify why these particular area measurements are appropriate for this set of candidate genes, which were selected based on putative links to bone quality rather than bone development.

      The selected methods are among the most commonly used to evaluate bone phenotypes. They are straightforward to reproduce, as well as cost- and time-effective. The strength of this approach lies in its use of simple, reproducible techniques that form the foundation for characterizing bone development.  Although the candidate genes were chosen based on their putative links to bone quality, early skeletal phenotypes can already be observed during bone development.

      The mineralized surface area of the total head and specific head structures was selected to evaluate the degree of mineralization in early skeletal development, as mineralization is a direct indicator of bone formation. Additionally, the osteoblast-positive surface areas were measured to provide insight into the formation of new skeletal tissue during early development. Osteoblasts, as active bone-forming cells, are essential for understanding bone growth and the dynamics of skeletal phenotypes.

      Examples in the manuscript:

      Line 212-214: ‘The osteoblast-positive areas in both the total head and the opercle were then quantified to gain insight into the formation of new skeletal tissue during early development.’

      Line 221-223: ‘Subsequently, Alizarin Red S (ARS) staining was conducted on the same 7 and 14 dpf crispant zebrafish larvae in order to evaluate the degree of mineralization in the early skeletal structures.’

      (2) Reword: The opercle bone is the earliest forming bone of the opercular series, and appears to be what the authors are referring to as the "operculum" at 7-14 dpf. The operculum is the larger structure (gill cover) in which the opercle is embedded. It would be more accurate to simply refer to the opercle at these stages.

      We agree with this comment and changed the text accordingly.

      (3) Define BMD and TMD at first usage.

      BMD and TMD are now defined in the manuscript.

      Line 41-43: ‘Six genes associated with severe recessive forms of Osteogenesis Imperfecta (OI) and four genes associated with bone mineral density (BMD), a key osteoporosis indicator, identified through genome-wide association studies (GWAS) were selected.’

      Line 286-288: ‘For each of the vertebral centra, the length, tissue mineral density (TMD), volume, and thickness were determined and tested for statistical differences between groups using a regression-based statistical test (Supplementary Figure 7).’

      (4) It would be helpful to note the grouping of candidates into OI vs. BMD GWAS throughout the figures.

      We agree with this comment and added this to all figure legends.

      ‘The first four genes are associated with the pathogenesis of osteoporosis, while the last six are linked to osteogenesis imperfecta’

      Reviewer #3 (Recommendations for the authors):

      Major points:

      (1) For the Results, it would be useful to the Reader to justify the selection of human candidate genes and their associated zebrafish orthologs to model skeletal functions. For example, what are variants identified from human studies, and do they impact functional domains? Are these domains and/or proteins conserved between humans/zebrafish? Is there evidence of skeletal expression in humans/zebrafish?

      Supplementary Table 4 lists the selected human candidate genes with reported mutations and/or polymorphisms associated with both skeletal and non-skeletal phenotypes. The table also includes additional findings from studies in mice and zebrafish. An extra column was now added to indicate gene conservation between human and zebrafish. We consulted UniProt (https://www.uniprot.org) and ZFIN (https://zfin.org) to assess the skeletal expression of these genes in human and zebrafish. All genes showed expression in the trabecular bone and/or bone marrow in humans, as well as in bone elements in zebrafish. We added this in the discussion.

      Line 309: ‘All selected genes show skeletal expression in both human and zebrafish.’

      Supplemental table 4 legend: ‘The conservation between human and zebrafish is reported in the last column.’

      As part of this, some version of Supplementary Table 4 might be included as a main display to introduce the targeted genes, ideally separated by rare (recessive OI) vs. common disease (osteoporosis). In the case of common disease and GWAS hits, how did authors narrow in on candidate genes (which often have Mbp-scale associated regions spanning multiple genes)? Further, what is the evidence that the mechanism of action of the GWAS variant is haploinsufficiency modeled by their crispant zebrafish?

      We have kept Supplementary Table 4 in the supplementary material but have referred to it earlier in the manuscript’s introduction. Consequently, the table has been renumbered from ‘Supplementary Table 4’  to ‘Supplementary Table 1’.

      The selection of genes potentially involved in the pathogenesis of osteoporosis is based on the data from the GWAS catalog, which annotates SNPs using the Ensemble mapping pipeline. The available annotation on their online search interface includes any Ensemble genes to which a SNP maps, or the closest upstream and downstream gene within a 50kb window. Four genes were selected for this screening method based on the criteria outlined in the results section. In this study, we aim to evaluate the general involvement of specific genes in bone metabolism, rather than to model a specific variant.

      Line 135-136 and 309-311: ‘An overview of the selected genes with observed mutant phenotypes in human, mice and zebrafish is provided in Supplementary Table 1.’

      (2) Using the crispant approach does not impact maternally-deposited RNAs that would dampen early developmental phenotypes. Considering the higher variability in larval phenotypes, perhaps the maternal effect plays a role. The authors might investigate developmental expression profiles of their genes using existing RNA-seq datasets such as from White et al (doi: 10.7554/eLife.30860).

      We thank the reviewer for this comment and agree with the possibility that maternally-deposited RNAs might have an impact on early developmental phenotypes. We included this in the discussion.

      Line 369-372: ‘Phenotypic variability in these zebrafish larvae can be attributed to several factors, including crispant mosaicism, allele heterogeneity, environmental factors, differences in genomic background and development, maternally-deposited RNAs, and slightly variable imaging positioning.’

      (3) While making comparisons within a clutch of mutant vs scrambled control is crucial, it is also important to ensure phenotypes are not specific to a single clutch. Do phenotypes remain consistent across different crosses/clutches?

      Yes, phenotypes remain consistent across different crosses and clutches. We included images from a second clutch in the Supplementary material (Supplementary Figure 8) and refereed to it in the discussion.

      Line 394-397: ‘Additionally, these skeletal malformations were consistently observed in a second clutch of crispants (Supplementary Figure 8), underscoring the reproducibility of these phenotypic features across independent clutches.’

      (4) Understanding that antibodies may not exist for many of the selected genes for zebrafish, authors should verify haploinsufficiency using an RT-qPCR of targeted genes in crispants vs. controls.

      We appreciate the reviewer’s suggestion to use RT-qPCR to examine expression levels of the targeted genes in crispants. However, previous experience suggests that relying on RNA expression to verify haploinsufficiency in zebrafish can be challenging. In zebrafish KO mutants, RT-qPCR often still detects gene transcripts, potentially due to incomplete nonsense-mediated decay (NMD) of the mutated mRNA, which may allow residual expression even in the absence of functional protein. As a more definitive approach, we prefer to use antibodies to confirm haploinsufficiency at the protein level. However, as the reviewer noted, generating and applying specific antibodies in zebrafish remains challenging.

      (5) Please indicate how parametric vs. non-parametric statistical tests were selected for datasets.

      We initially selected the parametric unpaired t-test, assuming the data were normally distributed with similar variances between groups. We verified the assumption of equal variances using the F-test, which was not significant across all assays. However, we did not assess the normality of the data directly, meaning we cannot confirm the normality assumption required for the t-test. Given this, we have opted to use the non-parametric Mann-Whitney U test, which does not require assumptions of normality, to ensure the robustness of our statistical analyses. We changed the Figures, the figure legends and the text accordingly.

      (6) In the figures and tables, I recommend adding notation showing the grouping of the first four genes as GWAS osteoporosis, the next three genes as osteoblast differentiation, the next two genes as bone mineralization, and the final gene as collagen transport to orient the reader. One might expect there to be a clustering of phenotypic outcomes based on the selection of genes, and it would be easier to follow this. This would be particularly useful to include in Table 2.

      Our primary objective is to assess the feasibility and reproducibility of the crispant screen rather than performing an in-depth pathway analysis or categorizing genes by biological processes. For this purpose, we have organized candidate genes based on their relevance to osteoporosis and Osteogenesis Imperfecta, without subdividing them further. We have clarified this focus in the figure legends, as suggested in an earlier recommendation.

      (7) For Figure 1, consider adding a smaller zoomed version of 1a embedded in each sub-figure with each measured element highlighted to improve readability.

      We agree with this comment and changed the figure accordingly.

      Minor points:

      (1) Table 2 could be simplified to improve readability. The headers have redundancies across columns with varied time points and could be merged.

      The suggested changes are incorporated in the manuscript (see earlier comment about this).

      (2) "BMD" is not defined in the Abstract. This is a personal preference, but there were numerous abbreviations in the text that made it difficult to follow at times.

      The suggested changes are incorporated in the manuscript (see earlier comment about this).

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study reveals how a rhizobial effector protein cleaves and inhibits a key plant receptor for symbiosis signaling, while the host plant counters by phosphorylating the effector. The molecular evidence for the protein-protein interaction and modification is solid, though biological evidence directly linking effector cleavage to rhizobial infection is incomplete. With additional functional data, this work could have implications for understanding intricate plant-microbe dynamics during mutualistic interactions.

      Thank you for this positive comment. Our data strongly support the view that NFR5 cleavage by NopT impairs Nod factor signaling resulting in reduced rhizobial infection. However, other mechanisms may also have an effect on the symbiosis, as NopT targets other proteins in addition to NFR5. In our revised manuscript version, we discuss the possibility that negative NopT effects on symbiosis could be due to NopT-triggered immune responses. As mentioned in our point-by-point answers to the Reviewers, we included additional data into our manuscript. We would also like to point out that we are generally more cautious in our revised version in order to avoid over-interpreting the data obtained.

      Public Reviews:

      Reviewer #1 (Public Review):

      Bacterial effectors that interfere with the inner molecular workings of eukaryotic host cells are of great biological significance across disciplines. On the one hand they help us to understand the molecular strategies that bacteria use to manipulate host cells. On the other hand they can be used as research tools to reveal molecular details of the intricate workings of the host machinery that is relevant for the interaction/defence/symbiosis with bacteria. The authors investigate the function and biological impact of a rhizobial effector that interacts with and modifies, and curiously is modified by, legume receptors essential for symbiosis. The molecular analysis revealed a bacterial effector that cleaves a plant symbiosis signaling receptor to inhibit signaling and the host counterplay by phosphorylation via a receptor kinase. These findings have potential implications beyond bacterial interactions with plants.

      Thank you for highlighting the broad significance of rhizobial effectors in understanding legume-rhizobia interactions. We fully agree with your assessment and have expanded our Discussion (and Abstract) regarding the potential implications of our findings beyond bacterial interactions with plants. We mention the prospect of developing specific kinase-interacting proteases to fine-tune cellular signaling processes in general.

      Bao and colleagues investigated how rhizobial effector proteins can regulate the legume root nodule symbiosis. A rhizobial effector is described to directly modify symbiosis-related signaling proteins, altering the outcome of the symbiosis. Overall, the paper presents findings that will have a wide appeal beyond its primary field.

      Out of 15 identified effectors from Sinorhizobium fredii, they focus on the effector NopT, which exhibits proteolytic activity and may therefore cleave specific target proteins of the host plant. They focus on two Nod factor receptors of the legume Lotus japonicus, NFR1 and NFR5, both of which were previously found to be essential for the perception of rhizobial nod factor, and the induction of symbiotic responses such as bacterial infection thread formation in root hairs and root nodule development (Madsen et al., 2003, Nature; Tirichine et al., 2003; Nature). The authors present evidence for an interaction of NopT with NFR1 and NFR5. The paper aims to characterize the biochemical and functional consequences of these interactions and the phenotype that arises when the effector is mutated.

      Thank you for your positive feedback.  We have now emphasized the interdisciplinary significance of our work in the Introduction and Discussion of our revised manuscript. We highlight how the insights gained from our study can contribute to a better understanding of microbial interactions with eukaryotic hosts in general, and hope that our findings could benefit future research in the fields of pathogenesis, immunity, and symbiosis.

      We appreciate your detailed summary of our work, which is focused on NopT and its interaction with Nod factor receptors. To ensure that the readers can easily follow the rationale behind our work, we have included a more detailed explanation of how NopT was identified to target Nod factor receptors. In particular, we now better describe the test system (Nicotiana benthamiana cells co-expressing NFR1/NFR5 with a given effector of Sinorhizobium fredii NGR234). In addition, we provide now a more thorough background on the roles of NFR1 and NFR5 in symbiotic signaling and refer to the two Nature papers from 2003 on NFR1 and NFR5 (Madsen et al., 2003; Radutoiu et al., 2003).

      Evidence is presented that in vitro NopT can cleave NFR5 at its juxtamembrane region. NFR5 appears also to be cleaved in vivo. and NFR1 appears to inhibit the proteolytic activity of NopT by phosphorylating NopT. When NFR5 and NFR1 are ectopically over-expressed in leaves of the non-legume Nicotiana benthamiana, they induce cell death (Madsen et al., 2011, Plant Journal). Bao et al., found that this cell death response is inhibited by the coexpression of nopT. Mutation of nopT alters the outcome of rhizobial infection in L. japonicus. These conclusions are well supported by the data.

      We appreciate your recognition of the robustness of our conclusions. In the context of your comments, we made the following improvements to our manuscript:

      We included a more detailed description of the experimental conditions under which the cleavage of NFR5 by NopT was observed in vitro and in vivo. Furthermore, additional experiments were added to strengthen the evidence for NFR5 cleavage by NopT (Fig 3, S3, S6, and S14).

      We provided more comprehensive data on the phosphorylation of NopT by NFR1, including phosphorylation assays (Fig. 4) and mass spectrometry results (Fig. S7 and Table S1). These data provide additional information on the mechanism by which NFR1 inhibits the proteolytic activity of NopT.

      We expanded the discussion on the cell death response induced by ectopic expression of NFR1 and NFR5 in Nicotiana benthamiana. We also included further details from Madsen et al. (2011) to contextualize our findings within the known literature.

      We believe that these additions and clarifications have improved the significance and impact of our study.

      The authors present evidence supporting the interaction of NopT with NFR1 and NFR5. In particular, there is solid support for cleavage of NFR5 by NopT (Figure 3) and the identification of NopT phosphorylation sites that inhibit its proteolytic activity (Figure 4C). Cleavage of NFR5 upon expression in N. benthamiana (Figure 3A) requires appropriate controls (inactive mutant versions) that have been provided, since Agrobacterium as a closely rhizobia-related bacterium, might increase defense related proteolytic activity in the plant host cells.

      We appreciate your recognition of the importance of appropriate controls in our experimental design. In response to your comments, we revised our manuscript to ensure that the figures and legends provide a clear description of the controls used. We also included a more detailed description of our experimental design at several places. In particular, we have highlighted the use of the protease-dead version of NopT as a control (NopT<sup>C93S</sup>). Therefore, NFR5-GFP cleavage in N. benthamiana clearly depended on protease activity of NopT and not on Agrobacterium (Fig. 3A). In the revised text, we are now more cautious in our wording and don’t conclude at this stage that NopT proteolyzes NFR5. However, our subsequent experiments, including in vitro experiments, clearly show that NopT is able to proteolyze NFR5.

      We are convinced that these changes have improved the quality of our work.

      Key results from N. benthamiana appear consistent with data from recombinant protein expression in bacteria. For the analysis in the host legume L. japonicus transgenic hairy roots were included. To demonstrate that the cleavage of NFR5 occurs during the interaction in plant cells the authors build largely on western blots. Regardless of whether Nicotiana leaf cells or Lotus root cells are used as the test platform, the Western blots indicate that only a small proportion of NFR5 is cleaved when co-expressed with nopT, and most of the NFR5 persists in its full-length form (Figures 3A-D). It is not quite clear how the authors explain the loss of NFR5 function (loss of cell death, impact on symbiosis), as a vast excess of the tested target remains intact. It is also not clear why a large proportion of NFR5 is unaffected by the proteolytic activity of NopT. This is particularly interesting in Nicotiana in the absence of Nod factor that could trigger NFR1 kinase activity.

      Thank you for your comments regarding the cleavage of NFR5 by NopT and its functional implications. We acknowledge that our immunoblots indicate only a relatively small proportion of  the NFR5 cleavage product.  Possible explanations could be as follows:

      (1) The presence of full-length NFR5 does not preclude a significant impact of NopT on function of NFR5, as NopT is able to bind to NFR5. In other words, the NopT-NFR5 and NopT-NFR1 interactions at the plasmamembrane might influence the function of the NFR1/NFR5 receptor without proteolytic cleavage of NFR5. In fact, protease-dead NopT<sup>C93S</sup> expressed in NGR234Δ_nopT_ showed certain effects in L. japonicus (less infection foci were formed compared to NGR234Δ_nopT_ Fig. 5E).  In this context, it is worth mentioning that the non-acylated NopT<sup>C93S</sup> (Fig. 1B) and not<sub>USDA257</sub> (Fig. 6B) proteins were unable to suppress NFR1/NFR5-induced cell death in N. benthamina, but this could be explained by the lack of acylation and altered subcellular localization.

      (2) The cleaved NFR5 fraction, although small, may be sufficient to disrupt signaling pathways, leading to the observed phenotypic changes  (loss of cell death in N. benthamiana; altered infection in L. japonicus).

      (3) The used expression systems produce high levels of proteins in the cell. This may not reflect the natural situation in L. japonicus cells.

      (4) Cellular conditions could impair cleavage of NFR5 by NopT.  Expression of proteins in E. coli may partially result in formation of protein aggregates (inactive NopT; NFR5 resistant to proteolysis).

      (5) In N. benthamiana co-expressing NFR1/NFR5, the NFR1 kinase activity is constitutively active (i.e., does not require Nod factors), suggesting an altered protein conformation of the receptor complex, which may influence the proteolytic susceptibility of NFR5.

      (6) The proteolytic activity of NopT may be reduced by the interaction of NopT with other proteins such as NFR1, which phosphorylates NopT and inactivates its protease activity.

      In our revised manuscript version, we provide now quantitative data for the efficiency of NFR5 cleavage by NopT in different expression systems used (Supplemental Fig.  14).  We have also improved our Discussion in this context. Future research will be necessary to better understand loss of NFR5 function by NopT. 

      It is also difficult to evaluate how the ratios of cleaved and full-length protein change when different versions of NopT are present without a quantification of band strengths normalized to loading controls (Figure 3C, 3D, 3F). The same is true for the blots supporting NFR1 phosphorylation of NopT (Figure 4A).

      Thank you for pointing out this. Following your suggestions, we quantified the band intensities for cleaved and full-length NFR5 in our different expression systems (N. benthamiana, L. japonicus and E. coli). The protein bands were normalized to loading controls. The data are shown in the new Supplemental Fig. 14. Similarly, the bands of immunoblots supporting phosphorylation of NopT by NFR1 were quantified. The data on band intensities are shown in Fig.  4B of our revised manuscript. These improvements provide a clearer understanding of how the ratios of cleaved to full-length proteins change in different protein expression systems, and to which extent NopT was phosphorylated by NFR1.

      Nodule primordia and infection threads are still formed when L. japonicus plants are inoculated with ∆nopT mutant bacteria, but it is not clear if these primordia are infected or develop into fully functional nodules (Figure 5). A quantification of the ratio of infected and non-infected nodules and primordia would reveal whether NopT is only active at the transition from infection focus to thread or perhaps also later in the bacterial infection process of the developing root nodule.

      Thank you for highlighting this aspect of our study. In response to your comment, we have conducted additional inoculation experiments with L. japonicus plants inoculated with NGR234 and NGR234_ΔnopT_ mutant. The new data are shown in Fig 5A, 5E, and 5G. However, we could not find any uninfected nodules (empty) nodules when roots were inoculated with these strains and mention this observation in the Results section of our revised manuscript.

      Reviewer #2 (Public Review):

      Summary:

      This manuscript presents data demonstrating NopT's interaction with Nod Factor Receptors NFR1 and NFR5 and its impact on cell death inhibition and rhizobial infection. The identification of a truncated NopT variant in certain Sinorhizobium species adds an interesting dimension to the study. These data try to bridge the gaps between classical Nod-factor-dependent nodulation and T3SS NopT effector-dependent nodulation in legume-rhizobium symbiosis. Overall, the research provides interesting insights into the molecular mechanisms underlying symbiotic interactions between rhizobia and legumes.

      Strengths:

      The manuscript nicely demonstrates NopT's proteolytic cleavage of NFR5, regulated by NFR1 phosphorylation, promoting rhizobial infection in L. japonicus. Intriguingly, authors also identify a truncated NopT variant in certain Sinorhizobium species, maintaining NFR5 cleavage but lacking NFR1 interaction. These findings bridge the T3SS effector with the classical Nod-factor-dependent nodulation pathway, offering novel insights into symbiotic interactions.

      Weaknesses:

      (1) In the previous study, when transiently expressed NopT alone in Nicotiana tobacco plants, proteolytically active NopT elicited a rapid hypersensitive reaction. However, this phenotype was not observed when expressing the same NopT in Nicotiana benthamiana (Figure 1A). Conversely, cell death and a hypersensitive reaction were observed in Figure S8. This raises questions about the suitability of the exogenous expression system for studying NopT proteolysis specificity.

      We appreciate your attention to these plant-specific differences. Previous studies showed that NopT expressed in tobacco (N. tabacum) or in specific Arabidopsis ecotypes (with PBS1/RPS5 genes) causes rapid cell death (Dai et al. 2008; Khan et al. 2022). Khan et al. 2022 reported recently that cell death does not occur in N. benthamiana unless the leaves were transformed with PBS1/RPS5 constructs. Our data shown in Fig. S15 confirm these findings. As cell death (effector triggered immunity) is usually associated with induction of plant protease activities, we considered N. tabacum and A. thaliana plants as not suitable for testing NFR5 cleavage by NopT. In fact, no NopT/NFR5 experiments were not performed with these plants in our study.  In response to your comment, we now better describe the N. benthamiana expression system and cite the previous articles_. Furthermore,  We have revised the Discussion section to better emphasize effector-induced immunity in non-host plants and the negative effect of rhizobial effectors during symbiosis. Our revisions certainly provide a clearer understanding of the advantages and limitations of the _N.  benthamiana expression system.

      (2) NFR5 Loss-of-function mutants do not produce nodules in the presence of rhizobia in lotus roots, and overexpression of NFR1 and NFR5 produces spontaneous nodules. In this regard, if the direct proteolysis target of NopT is NFR5, one could expect the NGR234's infection will not be very successful because of the Native NopT's specific proteolysis function of NFR5 and NFR1. Conversely, in Figure 5, authors observed the different results.

      Thank you for this comment, which points out that we did not address this aspect precisely enough in the original manuscript version.  We improved our manuscript and now write that nfr1 and nfr5 mutants do not produce nodules (Madsen et al., 2003; Radutoiu et al., 2003) and that over-expression of either NFR1 or NFR5 can activate NF signaling, resulting in formation of spontaneous nodules in the absence of rhizobia (Ried et al., 2014). In fact, compared to the nopT knockout mutant NGR234_ΔnopT_, wildtype NGR234 (with NopT) is less successful in inducing infection foci in root hairs of L. japonicus (Fig. 5). With respect to formation of nodule primordia, we repeated our inoculation experiments with NGR234_ΔnopT_ and wildtype NGR234 and also included a nopT over-expressing NGR234 strain into the analysis. Our data clearly showed that nodule primordium formation was negatively affected by NopT. The new data are shown in Fig. 5 of our revised version. Our data show that NGR234's infection is not really successful, especially when NopT is over-expressed. This is consistent  with our observations that NopT targets Nod factor receptors in L. japonicus and inhibits NF signaling (NIN promoter-GUS experiments). Our findings indicate that NopT is an “Avr effector” for L. japonicus.  However, in other host plants of NGR234, NopT possesses a symbiosis-promoting role (Dai et al. 2008; Kambara et al. 2009). Such differences could be explained by different NopT targets in different plants (in addition to Nod factor receptors), which may influence the outcome of the infection process. Indeed, our work shows hat NopT can interact with various kinase-dead LysM domain receptors, suggesting a role of NopT in suppression or activation of plant immunity responses depending on the host plant. We discuss such alternative mechanisms in our revised manuscript version and emphasize the need for further investigation to elucidate the precise mechanisms underlying the observed infection phenotype and the role of NopT in modulating symbiotic signaling pathways. In this context, we would also like to mention the two new figures of our manuscript which are showing (i) the efficiency of NFR5 cleavage by NopT in different expression systems, (ii) the interaction between NopT<sup>C93S</sup> and His-SUMO-NFR5<sup>JM</sup>-GFP, and (iii) cleavage of His-SUMO-NFP<sup>JM</sup>-GFP by NopT (Supplementary Figs. S8 and S9).

      (3) In Figure 6E, the model illustrates how NopT digests NFR5 to regulate rhizobia infection. However, it raises the question of whether it is reasonable for NGR234 to produce an effector that restricts its own colonization in host plants.

      Thank you for mentioning this point. We are aware of the possible paradox that the broad-host-range strain NGR234 produces an effector that appears to restrict its infection of host plants. As mentioned in our answer to the previous comment, NopT could have additional functions beyond the regulation of Nod factor signaling. In our revised manuscript version, we have modified our text as follows:

      (1) We mention the potential evolutionary aspects of NopT-mediated regulation of rhizobial infection and discuss the possibility that interactions between NopT and Nod factor receptors may have evolved to fine-tune Nod factor signaling to avoid rhizobial hyperinfection in certain host legumes.

      (2) We also emphasize that the presence of NopT may confer selective advantages in other host plants than L. japonicus due to interactions with proteins related to plant immunity. Like other effectors, NopT could suppress activation of immune responses (suppression of PTI) or cause effector-triggered immunity (ETI) responses, thereby modulating rhizobial infection and nodule formation. Interactions between NopT and proteins related to the plant immune system may represent an important evolutionary driving force for host-specific nodulation and explain why the presence of NopT in NGR234 has a negative effect on symbiosis with L. japonicus but a positive one with other legumes.

      (4) The failure to generate stable transgenic plants expressing NopT in Lotus japonicus is surprising, considering the manuscript's claim that NopT specifically proteolyzes NFR5, a major player in the response to nodule symbiosis, without being essential for plant development.

      We also thank for this comment. We have revised the Discussion section of our manuscript and discuss now our failure to generate stable transgenic L. japonicus plants expressing NopT. We observed that the protease activity of NopT in aerial parts of L. japonicus had a negative effect on plant development, whereas NopT expression in hairy roots was possible. Such differences may be explained by different NopT substrates in roots and aerial parts of the plant. In this context, we also discuss our finding that NopT not only cleaves NFR5 but is also able to proteolyze other proteins of L. japonicus such as LjLYS11, suggesting that NopT not only suppresses Nod factor signaling, but may also interfere with signal transduction pathways related to plant immunity. We speculate that, depending on the host legume species, NopT could suppress PTI or induce ETI, thereby modulating rhizobial infection and nodule formation.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Overall the text and figure legends must be double-checked for correctness of scientific statements. The few listed here are just examples. There are more that are potentially damaging the perception by the readers and thus the value of the manuscript.

      The nopT mutant leads to more infections. In line 358 the statement: "...and the proteolysis of NFR5 are important for rhizobial infection", is wrong, as the infection works even better without it. It is, according to my interpretation of the results, important for the regulation of infection. Sounds a small difference, but it completely changes the meaning.

      We appreciate your thorough review and have taken the opportunity to correct this error. Following your suggestions, we carefully rephrased the whole text and figure legends to ensure that the scientific statements accurately reflect the findings of our study. We are convinced that these changed have increased the value of this study.

      In line 905 the authors state that NopTC indicates the truncated version of NopT after autocleavage by releasing about 50 a.a. at its N-terminus.

      They do not analyse this cleavage product to support this claim. So better rephrase.

      According to Dai et al. (2008), NopT expressed in E. coli is autocleaved. The N-terminal sequence GCCA obtained by Edman sequencing suggests that NopT was cleaved between M49 and G50.  We improved our manuscript and now write:

      (1) “A previous study has shown that NopT is autocleaved at its N-terminus to form a processed protein that lacks the first 49 amino acid residues (Dai et al., 2008)”

      (2) “However, NopT<sup>ΔN50</sup>, which is similar to autocleaved NopT, retained the ability to interact with NFR5 but not with NFR1 (Fig. S2D).”.

      In line 967: "Both NopT and NopTC after autocleavage exert proteolytic activities" This is confusing as it was suggested earlier that NopTc is a product of the autocleavage. There is no indication of another round of NopTc autocleavage or did I miss something?

      Thank you for bringing this inaccuracy to our attention. There is no second round of NopT autocleavage. We have corrected the text and write: “NopT and not<sup>C</sup> (autocleaved NopT) proteolytically cleave NFR5 at the juxtamembrane domain to release the intracellular domain of NFR5”

      Given the amount of work that went into the research, the presentation of the figures should be considerably improved. For example, in Figure 3F the mutant is not correctly annotated. In figure 5 the term infection foci and IT occur but it is not explained in the legend what these are, where they can be seen in the figure and how the researchers discriminated between the two events.

      In general, the labeling of the figure panels should be improved to facilitate the understanding. For example, in Figure 3 the panels switch between different host plant systems. The plant could be clarified for each panel to aid the reader. The asterisks are not in line with the signal that is supposed to be marked. And so on. I strongly advise to improve the figures.

      Thank you for your valuable suggestions. We acknowledge the importance of clear and informative figure presentation to enhance the understanding of our research findings. In response to your comments, we made a comprehensive revision of the figures to address the mentioned issues:

      (1) We corrected annotations of the mutant in Figure 3F to accurately represent the experimental conditions.

      (2) We revised the legend of Figure 5 and provide clear explanations of the terms "infection foci" and "IT" (infection threads) in the Methods section.

      (3) We improved the labeling of figure panels and improved the writing of the figure legend specifying the protein expression system (N. benthamiana, L. japonicus and E. coli, respectively). . We ensured that the asterisks indicating statistically significant results are properly aligned.

      Furthermore, we carefully reviewed each figure to enhance clarity and readability, including optimizing font size and line thickness. Captions and annotations were also revised.

      Figure 1

      • To verify that the lack of observed cell death is not linked to differential expression levels, an expression control Western blot is essential. In the expression control Western blot given in the supplemental materials (Supplemental fig. 1E), NFR5 is not visible in the first lane.

      We appreciate your comments on the control immunoblot which were made to verify the presence of NFR1, NFR5 and NopT in N. benthamiana.  However, as shown in Supplemental Fig. 1E, the intact NFR5 could not be immuno-detected when co-expressed with NFR1 and NopT. To ensure co-expression of NFR1/NFR5, A. tumefaciens carrying a binary vector with both NFR1 and NFR5 was used. In the revised version, we modified the figure legend accordingly and also included a detailed description of the procedure at lines 165-166

      • Labeling of NFR1/LjNFR1 should be kept consistent between the text and the figures. Currently, the text refers to both NFR1 and LjNFR1 and figures are labelled NFR1. The same is true for NFR5.

      Thank you for pointing out this inconsistency. We revised our manuscript and use now consistently NFR1 and NFR5 without a prefix to avoid any confusions.

      • A clearer description of how cell death was determined would be useful. In the selected pictures in panel D, leaves coexpressing nopT with Bax1 or Cerk1 appear very different from the pictures selected for NopM and AVr3a/R3a.

      We agree that a clearer description of our cell death experiments with N. benthamiana was necessary. We have re-worded the figure legend to provide more detailed information on the criteria used for assessing cell death. Additionally, we show now our images at higher resolution.

      • In panel D, the "Death/Total" ratio is only shown for leaf discs where nopT was coexpressed with the cell-death triggering proteins. Including the ratio for leaf discs where only the cell-death triggering protein (without nopT ) was expressed would make the figure more clear.

      Thank you for this suggestion. To provide a more comprehensive comparison, we included the "Cell death/Total" ratio for all leaf disc images shown in Fig. 1D. 

      Figure 2:

      • A: Split-YFP is not ideal as evidence for colocalization because of the chemical bond formed between the YFP fragments that may lead to artificial trapping/accumulation outside the main expression domains. Overall, the authors should revise if this figure aims to show colocalization or interaction. In the current text, both terms are used, but these are different interpretations.

      We appreciate your concern regarding the use of Split-YFP for colocalization analysis. We carefully reviewed the figure and corresponding text to ensure clarity in the interpretation of the results. The primary aim of this figure was to explore protein-protein interactions rather than strict colocalization. Protein-protein interactions have also been validated by other experiments of our work. We have revised the text accordingly and no longer emphasize on “co-localization”.

      • Given the focus on proteolytic activity in this paper, all blots need to be clearly labeled with size markers, and it would be good to include a supplemental figure with all other bands produced in the Western blot, regardless of their size. Without this, the results in panel 2D seem inconsistent with results presented in figure 3A, since NFR5 does not appear to be cleaved in the Western blot in 2D, but 3A shows cleavage when the same proteins (with different tags) are coexpressed in the same system.

      Thank you for bringing up this point. We ensured that all immunoblots are clearly labeled with size markers in our revised manuscript. We also carefully checked the consistency of the results presented in Figures 2D and Figure 3A and included appropriate clarifications in the revised manuscript. In Figure 2D, we show the bands at around 75 kD  (multi-bands would be detected below, including cleaved NFR5 by NopT, but also other non-specific bands).

      Figure 3:

      • In panel E, NopTC93S cannot cleave His-Sumo-NFR5JM-GFP, but it would be interesting to also show if NopTC93S can bind the NFR5JM fragment. It would also be useful to see this experiment done with the JM of NFP.

      Thank you for the suggestion. We agree that investigating the binding of NopT<sup>C93S</sup> to the NFR5<sup>JM</sup> fragment provides valuable insights into the interaction between NopT and NFR5. In our revised version, we show in the new Supplemental Fig. S4 that NopT interacts with NFR5JM and cleaves NFP<sup>JM</sup>. The Results section has been modified accordingly.

      • The panels in this figure require better labeling. In many panels, asterisks are misplaced relative to the bands they should highlight, and not all blots have size markers or loading controls.

      Thank you for bringing this to our attention. We carefully reviewed the labeling of all panels in Figure 3 to ensure accuracy and clarity. We ensured that asterisks are correctly placed in the figures. We also included size markers and loading controls to improve the quality of the shown immunoblots.

      • Since there is no clear evidence in this figure that the smear in the blot in panel C is phosphorylated NopT, it is recommended to provide a less interpretative label on the blot, and explain the label in the text.

      We appreciate your suggestion regarding the labeling of the blot in panel C of Fig. 3. We revised the label and provided a less interpretative designation in Fig. 3C. We also rephrased the figure legend and the text in the Results section as recommended.

      Figure 4

      • In B, a brief introduction in the text to the function of the Zn-phostag would make the figure easier to understand for more readers.

      Thank you for the suggestion. We agree and have provided a brief explanation in the Results section: “On such gels, a Zn<sup>2+</sup>-Phos-tag bound phosphorylated protein migrates slower than its unbound nonphosphorylated form. Furthermore, we have included the reference (Kato & Sakamoto, 2019) into the Methods section.

      Figure 5:

      • Change "Scar bar" to "Scale bar" in the figure captions

      Thank you for spotting that typo. We have corrected it.

      • Correct the references to the figures in the text

      We carefully reviewed the Figure 5 and made corresponding corrections to improve the quality of our manuscript Please check line 394-451.

      • It should be clarified what was quantified as "infection foci" (C, F, G)

      We revised the legend of Figure 5 and provide now explanations of the terms "infection foci" and "IT" (infection threads) in the Methods section.  Please check line 399-451.

      • It is recommended to use pictures that are from the same region of the plant root (the susceptible zone). The pictures in panel A appear to be from different regions, since the density of root hairs is different.

      Thank you for bringing this to our attention. We ensured that the images selected for panel A were from the same region of the plant root to guarantee consistency and accuracy of the comparison.

      • Panel G should be labeled so it is clearer that nopT is being expressed in L. japonicus transgenic roots.

      We have labeled this panel more clearly to help the reader understand that nopT was expressed in transgenic L. japonicus roots.

      • Panel F is missing statistical tests for ITs

      We apologize and have included the results of our statistical tests for ITs.

      Figure 6:

      • The model presented in panel E misrepresents the role of NFR5 according to the results in the paper. From the evidence presented, it is not clear if the observed rhizobial infection phenotype is due to reduced abundance of full-length NFR5, or if the cleaved NFR5 fragment is suppressing infection. Additionally, S. fredii should not be drawn so close to the plasma membrane, since the bacteria are located outside the cell wall when the T3SS is active.

      We appreciate your comment which helps us to improve the interpretation of our results. We agree that the model should accurately reflect the uncertainties regarding the role of NFR5. We revised the model (positioning of S. fredii etc.) and write in the Discussion:

      “NopT impairs the function of the NFR1/NFR5 receptor complex. Cleavage of NFR5 by NopT reduces its protein levels. Possible inhibitory effects of NFR5 cleavage products on NF signaling are unknown but cannot be excluded.”

      Reviewer #2 (Recommendations For The Authors):

      (1) Some minor weaknesses need addressing: In Figure 5A, the root hair density in the two images appears significantly different. Are these images representative of each treatment?

      We appreciate your attention to detail and the importance of ensuring that the images in Figure 5A are representative. We carefully reviewed our image selection process and confirm that the shown images are indeed representative of each treatment group. In our revised version, we show additional images and also improved the text in the figure legend. Furthermore, we performed additional GUS staining tests and the new data are shown in Fig 5A abd 5B.

      (2) Additionally, please ensure consistency in the format of genotype names throughout the manuscript. For instance, in Line 897, "Italy" should be used in place of "N. benthamiana."

      We thank you for pointing out the format of genotype names and corrected our manuscript as requested.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public Review): 

      Summary: 

      The authors introduced their previous paper with the concise statement that "the relationships between lineage-specific attributes and genotypic differences of tumors are not understood" (Chen et al., JEM 2019, PMID: 30737256). For example, it is not clear why combined loss of RB1 and TP53 is required for tumorigenesis in SCLC or other aggressive neuroendocrine (NE) cancers, or why the oncogenic mutations in KRAS or EGFR that drive NSCLC tumorigenesis are found so infrequently in SCLC. This is the main question addressed by the previous and current papers. 

      One approach to this question is to identify a discrete set of genetic/biochemical manipulations that are sufficient to transform non-malignant human cells into SCLC-like tumors. One group reported the transformation of primary human bronchial epithelial cells into NE tumors through a complex lentiviral cocktail involving the inactivation of pRB and p53 and activation of AKT, cMYC, and BCL2 (PARCB) (Park et al., Science 2018, PMID: 30287662). The cocktail previously reported by Chen and colleagues to transform human pluripotent stem-cell (hPSC)-derived lung progenitors (LPs) into NE xenografts was more concise: DAPT to inactivate NOTCH signaling combined with shRNAs against RB1 and TP53. However, the resulting RP xenografts lacked important characteristics of SCLC. Unlike SCLC, these tumors proliferated slowly and did not metastasize, and although small subpopulations expressed MYC or MYCL, none expressed NEUROD1. 

      MYC is frequently amplified or expressed at high levels in SCLC, and here, the authors have tested whether inducible expression of MYC could increase the resemblance of their hPSC-derived NE tumors to SCLC. These RPM cells (or RPM T58A with stabilized cMYC) engrafted more consistently and grew more rapidly than RP cells, and unlike RP cells, formed liver metastases when injected into the renal capsule. Gene expression analyses revealed that RPM tumor subpopulations expressed NEUROD1, ASCL1, and/or YAP1. 

      The hPSC-derived RPM model is a major advance over the previous RP model. This may become a powerful tool for understanding SCLC tumorigenesis and progression and for discovering gene dependencies and molecular targets for novel therapies. However, the specific role of cMYC in this model needs to be clarified. 

      cMYC can drive proliferation, tumorigenesis, or apoptosis in a variety of lineages depending on concurrent mutations. For example, in the Park et al., study, normal human prostate cells could be reprogrammed to form adenocarcinoma-like tumors by activation of cMYC and AKT alone, without manipulation of TP53 or RB1. In their previous manuscript, the authors carefully showed the role of each molecular manipulation in NE tumorigenesis. DAPT was required for NE differentiation of LPs to PNECs, shRB1 was required for expansion of the PNECs, and shTP53 was required for xenograft formation. cMYC expression could influence each of these steps, and importantly, could render some steps dispensable. For example, shRB1 was previously necessary to expand the DAPT-induced PNECs, as neither shTP53 nor activation of KRAS or EGFR had no effect on this population, but perhaps cMYC overexpression could expand PNECs even in the presence of pRB, or even induce LPs to become PNECs without DAPT. Similarly, both shRB1 and shTP53 were necessary for xenograft formation, but maybe not if cMYC is overexpressed. If a molecular hallmark of SCLC, such as loss of RB1 or TP53, has become dispensable with the addition of cMYC, this information is critically important in interpreting this as a model of SCLC tumorigenesis.  

      The reviewer’s suggestion may be possible; indeed, in a recent report from our group (Gardner EE, et al., Science 2024) we have shown, using genetically engineered mouse modeling coupled with lineage tracing, that the cMyc oncogene can selectively expand Ascl1+ PNECs in the lung.

      We agree with the reviewer that not having a better understanding of the individual components necessary and/or sufficient to transform hESC-derived LPs is an important shortcoming of this current work. However, we would like to stress three important points about the comments:  1) tumors were reviewed and the histological diagnoses were certified by a practicing pulmonary pathologist at WCM (our co-author, C. Zhang); 2 )the observed  transcriptional programs were consistent with primary human SCLC; and 3) RB1-proficient SCLC is now recognized as a rare presentation of SCLC (Febrese-Aldana CA, et al., Clin. Can. Res. 2022. PMID: 35792876).

      To interpret the role of cMYC expression in hPSC-derived RPM tumors, we need to know what this manipulation does without manipulation of pRB, p53, or NOTCH, alone or in combination. Seven relevant combinations should be presented in this manuscript: (1) cMYC alone in LPs, (2) cMYC + DAPT, (3) cMYC + shRB1, (4) cMYC + DAPT + shRB1, (5) cMYC + shTP53, (6) cMYC + DAPT + shTP53, and (7) cMYC + shRB1 + shTP53. Wildtype cMYC is sufficient; further exploration with the T58A mutant would not be necessary. 

      We respectfully disagree that an interrogation of the differences between the phenotypes produced by wildtype and Myc(T58A) would not be informative. (Our view is confirmed by the second reviewer; see below.)    It is well established that Myc gene or protein dosage can have profound effects on in vivo phenotypes (Murphy DJ, et al., Cancer Cell 2008. PMID: 19061836). The “RPM” model of variant SCLC developed by Trudy Oliver’s lab relied on the conditional T58A point mutant of cMyc, originally made by Rob Wechsler-Reya. While we do not discuss the differences between Myc and Myc(T58A), it is nonetheless important to present our results with both the WT and mutant MYC constructs, as we are aware of others actively investigating differences between them in GEMM models of SCLC tumor development.

      We agree with the reviewer about the virtues of trying to identify the effects of individual gene manipulations; indeed our original paper (Chen et al., J. Expt. Med. 2019), describing the RUES2derived model of SCLC did just that, carefully dissecting events required to transform LPs towards a SCLC-like state. The central  purpose of the current study was to determine the effects of adding cMyc on the behavior of weakly tumorigenic SCLC-like cells cMyc.  Presenting data with these two alleles to seek effects of different doses of MYC protein seems reasonable.

      This reviewer considers that there should be a presentation of the effects of these combinations on LP differentiation to PNECs, expansion of PNECs as well as other lung cells, xenograft formation and histology, and xenograft growth rate and capacity for metastasis. If this could be clarified experimentally, and the results discussed in the context of other similar approaches such as the Park et al., paper, this study would be a major addition to the field.  

      Reviewer #2 (Public Review): 

      Summary: 

      Chen et al use human embryonic stem cells (ESCs) to determine the impact of wildtype MYC and a point mutant stable form of MYC (MYC-T58A) in the transformation of induced pulmonary neuroendocrine cells (PNEC) in the context of RB1/P53 (RP) loss (tumor suppressors that are nearly universally lost in small cell lung cancer (SCLC)). Upon transplant into immune-deficient mice, they find that RP-MYC and RP-MYC-T58A cells grow more rapidly, and are more likely to be metastatic when transplanted into the kidney capsule, than RP controls. Through single-cell RNA sequencing and immunostaining approaches, they find that these RPM tumors and their metastases express NEUROD1, which is a transcription factor whose expression marks a distinct molecular state of SCLC. While MYC is already known to promote aggressive NEUROD1+ SCLC in other models, these data demonstrate its capacity in a human setting that provides a rationale for further use of the ESC-based model going forward. Overall, these findings provide a minor advance over the previous characterization of this ESC-based model of SCLC published in Chen et al, J Exp Med, 2019. 

      We consider the findings more than a “minor” advance in the development of the model, since any useful model for SCLC would need to form aggressive and metastatic tumors.

      The major conclusion of the paper is generally well supported, but some minor conclusions are inadequate and require important controls and more careful analysis. 

      Strengths:

      (1) Both MYC and MYC-T58A yield similar results when RP-MYC and RP-MYCT58A PNEC ESCs are injected subcutaneously, or into the renal capsule, of immune-deficient mice, leading to the conclusion that MYC promotes faster growth and more metastases than RP controls. 

      (2) Consistent with numerous prior studies in mice with a neuroendocrine (NE) cell of origin (Mollaoglu et al, Cancer Cell, 2017; Ireland et al, Cancer Cell, 2020; Olsen et al, Genes Dev, 2021), MYC appears sufficient in the context of RB/P53 loss to induce the NEUROD1 state. Prior studies also show that MYC can convert human ASCL1+ neuroendocrine SCLC cell lines to a NEUROD1 state (Patel et al, Sci Advances, 2021); this study for the first time demonstrates that RB/P53/MYC from a human neuroendocrine cell of origin is sufficient to transform a NE state to aggressive NEUROD1+ SCLC. This finding provides a solid rationale for using the human ESC system to better understand the function of human oncogenes and tumor suppressors from a neuroendocrine origin. 

      Weaknesses:

      (1) There is a major concern about the conclusion that MYC "yields a larger neuroendocrine compartment" related to Figures 4C and 4G, which is inadequately supported and likely inaccurate. There is overwhelming published data that while MYC can promote NEUROD1, it also tends to correlate with reduced ASCL1 and reduced NE fate (Mollaoglu et al, Cancer Cell, 2017; Zhang et al, TLCR, 2018; Ireland et al, Cancer Cell, 2020; Patel et al, Sci Advances, 2021). Most importantly, there is a lack of in vivo RP tumor controls to make the proper comparison to judge MYC's impact on neuroendocrine identity. RPM tumors are largely neuroendocrine compared to in vitro conditions, but since RP control tumors (in vivo) are missing, it is impossible to determine whether MYC promotes more or less neuroendocrine fate than RP controls. It is not appropriate to compare RPM tumors to in vitro RP cells when it comes to cell fate. Upon inspection of the sample identity in S1B, the fibroblast and basal-like cells appear to only grow in vitro and are not well represented in vivo; it is, therefore, unclear whether these are transformed or even lack RB/P53 or express MYC. Indeed, a close inspection of Figure S1B shows that RPM tumor cells have little ASCL1 expression, consistent with lower NE fate than expected in control RP tumors. 

      We would like to clarify two points related to the conclusions that we draw about MYC’s ability to promote an increase in the neuroendocrine fraction in hESC-derived cultures:  1) The comparisons in Figures 4C were made between cells isolated in culture following the standard 50 day differentiation protocol, where, following generation of LPs around day 25, MYC was added to the other factors previously shown to enrich for a PNEC phenotype (shRB1, shTP53, and DAPT). Therefore, the argument that MYC increased the frequency of “neuroendocrine cells” (which we define by a gene expression signature) is a reasonable conclusion in the system we are using; and 2) following injection of these cells into immunocompromised mice, an ASCL1-low / NEUROD1-high presentation is noted (Supplemental Figures 1F-G). In the few metastases that we were able use to sequence bulk RNA, there is an even more pronounced increase in expression of NEUROD1 with a decrease in ASCL1.

      Some confusion may have arisen from our previous characterization of neuroendocrine (NE) cells using either ASCL1 or NEUROD1 as markers. To clarify, we have now designated cells positive for ASCL1 as classical NE cells and those positive for NEUROD1 as the NE variant. According to this revised classification, our findings indicate that MYC expression leads to an increase in the NEUROD1+ NE variant and a decrease in ASCL1+ classical NE cells. This adjustment has been reflected on the results section titled, “Inoculation of the renal capsule facilitates metastasis of the RUES2-derived RPM tumors” of the manuscript.  

      From the limited samples in hand, we compared the expression of ASCL1 and NEUROD1 in the weakly tumorigenic hESC RP cells after successful primary engraftment into immunocompromised mice. As expected, the RP tumors were distinguished by the lack of expression of NEUROD1, compared to levels observed in the RPM tumors.

      In addition, since MYC appears to require Notch signaling to induce  NE fate (cf Ireland et al), the presence of DAPT in culture could enrich for NE fate despite MYC's presence. It's important to clarify in the legend of Fig 4A which samples are used in the scRNA-seq data and whether they were derived from in vitro or in vivo conditions (as such, Supplementary Figure S1B should be provided in the main figure). Given their conclusion is confusing and challenges robustly supported data in other models, it is critical to resolve this issue properly. I suspect when properly resolved, MYC actually consistently does reduce NE fate compared to RP controls, even though tumors are still relatively NE compared to completely distinct cellular identities such as fibroblasts.

      We have clarified the source of tumor sequencing data and the platform (single cell or bulk) in Figure 4 and Supplemental Figure 1. To reiterate – the RNA sequencing results from paired metastatic and primary tumors from the RPM model are derived from bulk RNA;  the single cell RNA data in RP or RPM datasets are from cells in culture.  These distinctions are clarified in the legend to Supplemental Figure 1.

      (2) The rigor of the conclusions in Figure 1 would be strengthened by comparing an equivalent number of RP animals in the renal capsule assay, which is n = 6 compared to n = 11-14 in the MYC conditions.

      As we did not perform a power calculation to determine a sample size required to draw a level of statistical significance from our conclusions, this comment is not entirely accurate. Our statistical rigor was limited by the availability of samples from the RP tumor model.

      (3) Statistical analysis is not provided for Figures 2A-2B, and while the results are compelling, may be strengthened by additional samples due to the variability observed. 

      We acknowledge that the cohorts are relatively small but we have added statistical comparisons in Figure 2B. 

      (4a) Related to Figure 3, primary tumors and liver metastases from RPM or RPM-T58A-expressing cells express NEUROD1 by immunohistochemistry (IHC) but the putative negative controls (RP) are not shown, and there is no assessment of variability from tumor to tumor, ie, this is not quantified across multiple animals. 

      The results of H&E and IF staining for ASCL1, NEUROD1, CGRP, and CD56 in negative control (RP tumors) are presented in the updated Figure 3F-G.

      (4b) Relatedly, MYC has been shown to be able to push cells beyond NEUROD1 to a double-negative or YAP1+ state (Mollaoglu et al, Cancer Cell, 2017; Ireland et al, Cancer Cell, 2020), but the authors do not assess subtype markers by IHC. They do show subtype markers by mRNA levels in Fig 4B, and since there is expression of ASCL1, and potentially expression of YAP1 and POU2F3, it would be valuable to examine the protein levels by IHC in control RP vs. RPM samples.

      YAP1 positive SCLC is still somewhat controversial, so it is not clear what value staining for YAP1 offers beyond showing the well-established markers, ASCL1 and NEUROD1.  

      (5) Given that MYC has been shown to function distinctly from MYCL in SCLC models, it would have raised the impact and value of the study if MYC was compared to MYCL or MYCL fusions in this context since generally, SCLC expresses a MYC family member. However, it is quite possible that the control RP cells do express MYCL, and as such, it would be useful to show. 

      We now include Supplemental Figure S2 to illustrate four important points raised by this reviewer and others:  1) expression of MYC family members in the merged dataset (RP and RPM) is low or undetectable in the basal/fibroblast cultures; 2) MYC does have a weak correlation with EGFP in the neuroendocrine cluster when either WT MYC or T58A MYC is overexpressed; 3) MYCL and MYCN are detectable, but at low levels compared to CMYC; and 4) Expression of  ASCL1 is anticorrelated with MYC expression across the merged single cell datasets using RP and RPM models.

      Reviewer #3 (Public Review): 

      Summary: 

      The authors continue their study of the experimental model of small cell lung cancer (SCLC) they created from human embryonic stem cells (hESCs) using a protocol for differentiating the hESCs into pulmonary lineages followed by NOTCH signaling inactivation with DAPT, and then knockdown of TP53 and RB1 (RP models) with DOX inducible shRNAs. To this published model, they now add DOX-controlled activation of expression of a MYC or T58A MYC transgenes (RPM and RPMT58A models) and study the impact of this on xenograft tumor growth and metastases. Their major findings are that the addition of MYC increased dramatically subcutaneous tumor growth and also the growth of tumors implanted into the renal capsule. In addition, they only found liver and occasional lung metastases with renal capsule implantation. Molecular studies including scRNAseq showed that tumor lines with MYC or T58A MYC led surprisingly to more neuroendocrine differentiation, and (not surprisingly) that MYC expression was most highly correlated with NEUROD1 expression. Of interest, many of the hESCs with RPM/RPMT58A expressed ASCL1. Of note, even in the renal capsule RPM/RPMT58A models only 6/12 and 4/9 mice developed metastases (mainly liver with one lung metastasis) and a few mice of each type did not even develop a renal sub capsule tumor. The authors start their Discussion by concluding: " In this report, we show that the addition of an efficiently expressed transgene encoding normal or mutant human cMYC can convert weakly tumorigenic human PNEC cells, derived from a human ESC line and depleted of tumor suppressors RB1 and TP53, into highly malignant, metastatic SCLC-like cancers after implantation into the renal capsule of immunodeficient mice.". 

      Strengths: 

      The in vivo study of a human preclinical model of SCLC demonstrates the important role of c-Myc in the development of a malignant phenotype and metastases. Also the role of c-Myc in selecting for expression of NEUROD1 lineage oncogene expression. 

      Weaknesses: 

      There are no data on results from an orthotopic (pulmonary) implantation on generation of metastases; no comparative study of other myc family members (MYCL, MYCN); no indication of analyses of other common metastatic sites found in SCLC (e.g. brain, adrenal gland, lymph nodes, bone marrow); no studies of response to standard platin-etoposide doublet chemotherapy; no data on the status of NEUROD1 and ASCL1 expression in the individual metastatic lesions they identified. 

      We have acknowledged from the outset that our study has significant limitations, as noted by this reviewer, and we explained in our initial letter of response why we need to present this limited, but still consequential, story at this time. 

      In particular, while we have attempted orthotopic transplantations of RPM tumor cells into NSG mice (by tail vein or intra-pulmonary injection, or intra-tracheal instillation of tumor cells), these methods were not successful in colonizing the lung. Additionally, we have compared the efficacy of platinum/etoposide to that of removing DOX in established RPM subcutaneous tumors, but we chose not to include these data as we lacked a chemotherapy responsive tumor model, and thus could not say with confidence that the chemotherapeutic agants were active and that the RPM models were truly resistant to standard SCLC chemotherapy. In a discussion about other metastatic sites, we have now included the following text: 

      “In animals administered DOX, histological examinations showed that approximately half developed metastases in distant organs, including the liver or lung (Figure 1D). No metastases were observed in the bone, brain, or lymph nodes. For a more detailed assessment, future studies could employ more sensitive imaging methods, such as luciferase imaging.”

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors): 

      Technical points related to Major Weakness #1: 

      For Figure 4: Cells were enriched for EGFP-high cells only, under the hypothesis that cells with lower EGFP may have silenced expression of the integrated vector. Since EGFP is expressed only in the shRB1 construct, selection for high EGFP may inadvertently alter/exclude heterogeneity within the transformed population for the other transgenes (shP53, shMYC/MYC-T58A). Can authors include data to show the expression of MYC/MYC T58A in EGFP-high v -med v-low cells? MYC levels may alter the NEdifferentiation status of tumor cells. 

      Please now refer to Supplemental Figure S2.

      Related to the appropriateness of the methods for Figure 4C, the authors state, "We performed differential cluster abundance analysis after accounting for the fraction of cells that were EGFP+". If only EGFP+ cells were accounted for in the analysis for 4C, the majority of RP cells in the "Neuroendocrine differentiated" cluster would not be included in the analysis (according to EGFP expression in Fig S1A-B), and therefore inappropriately reduce NE identity compared to RPM samples that have higher levels of EGFP. 

      There is no consideration or analysis of cell cycling/proliferation until after the conclusion is stated. Yet, increased proliferation of MYC-high vs MYC-low cultures would enhance selection for more tumors (termed "NE-diff") than non-tumors (basal/fibroblast) in 2D cultures. 

      The expression of MYC itself isn't assessed for this analysis but assumed, and whether higher levels of MYC/MYC-T58A may be present in EGFP+ tumor cells that are in the NE-low populations isn't clear. Can MYC-T58A/HA also be included in the reference genome? 

      We did not include an HA tag in our reference transcriptome. For [some] answers to this and other related questions, please refer to Supplemental Figure S2.

      Reviewer #3 (Recommendations For The Authors): 

      (1) The experiments are all technically well done and clearly presented and represent a logical extension exploring the role of c-Myc in the hESC experimental model system. 

      We appreciate this supportive comment!

      (2) It is of great interest that both the initial RP model only forms "benign" tumors and that with the addition of a strong oncogene like c-myc, where expression is known to be associated with a very bad prognosis in SCLC, that while one gets tumor formation there are still occasional mice both for subcutaneous and renal capsule test sites that don't get tumors even with the injection of 500,000 RPM/RPMT58A cells. In addition, of the mice that do form tumors, only ~50% exhibit metastases from the renal sub-capsule site. The authors need to comment on this further in their Discussion. To me, this illustrates both how incredibly resistant/difficult it is to form metastases, thus indicating the need for other pathways to be activated to achieve such spread, and also represents an opportunity for further functional genomic tests using their preclinical model to systematically attack this problem. Obvious candidate genes are those recently identified in genetically engineered mouse models (GEMMs) related to neuronal behavior. In addition, we already know that full-fledged patient-derived SCLC when injected subcutaneously into immune-deprived mice don't exhibit metastases - thus, while the hESC RPM result is not surprising, it indicates to me the power of their model (logs less complicated genetically than a patient SCLC) to sort through a mechanism that would allow metastases to develop from subcutaneous sites. The authors can point these things out in their Discussion section to provide a "roadmap" for future research. 

      Although we remain mindful of the relatively small cohorts we have studied, the thrust of Reviewer #3’s comments is now included in the Discussion. And there is, of course, a lot more to do, and it has taken several years already to get to this point. Additional information about the prolonged gestation of this project and about the difficulties of doing more in the near future was described in our initial response to reviewers/Editor, included near the start of this letter.    

      (3) I will state the obvious that this paper would be much more valuable if they had compared and contrasted at least one of the myc family members (MYCL or MYCN) with the CMYC findings whatever the results would be. Most SCLC patients develop metastases, and most of their tumors don't express high levels of CMYC (and often use MYCL). In any event, as the authors Discuss, this will be an important next stage to test.

      We have acknowledged and explained the limitations of the work in several ways. Further, we were unaware of the relationship between metastases and the expression of MYC and MYCL1 noted by the reviewer; we will look for confirmation of this association in any future studies, although we have not encountered it in current literature.

      (4) Their assays for metastases involved looking for anatomically "gross" lesions. While that is fine, particularly given that the "gross" lesions they show in figures are actually pretty small, we still need to know if they performed straightforward autopsies on mice and looked for other well-known sites of metastases in SCLC patients besides liver and lung - namely lymph nodes, adrenal, bone marrow, and brain. I would guess these would probably not show metastatic growth but with the current report, we don't know if these were looked for or not. Again, while this could be a "negative" result, the paper's value would be increased by these simple data. Let's assume no metastases are seen, then the authors could further strengthen the case for the value of their hESC model in systematically exploring with functional genomics the requirements to achieve metastases to these other sites.

      We have included descriptions of what we found and didn’t find at other potential sites of metastasis in the results section, with the following sentences: 

      “In animals administered DOX, histological examinations showed that approximately half developed metastases in distant organs, including the liver or lung (Figure 1D). No metastases were observed in the bone, brain, or lymph nodes. For a more detailed assessment, future studies could employ more sensitive imaging methods, such as luciferase imaging.”

      (5) Related to this, we have no idea if the mice that developed liver metastases (or the one mouse with lung metastasis) had more than one metastatic site. They will know this and should report it. Again, my guess is that these were isolated metastases in each mouse. Again, they can indicate the value of their model in searching for programs that would increase the number of the various organs. 

      We appreciate the suggestion. We observed that one of the mice developed metastatic tumors in both the liver and lungs. This information has been incorporated into the Results section.

      (6) While renal capsule implantation for testing growth and metastatic behavior is reasonable and based on substantial literature using this site for implantation of patient tumor specimens, what would have increased the value of the paper is knowing the results from orthotopic (lung implantation). Whatever the results were (they occurred or did not occur) they will be important to know. I understand the "future experiments" argument, but in reading the manuscript this jumped out at me as an obvious thing for the authors to try. 

      We conducted orthotopic implantation several ways, including via intra-tracheal instillation of 0.5 million RP or RPM cells in PBS per mouse. However, none of the subjects (0/5 mice) developed tumor-like growths and the number of animals used was small. Further, this outcome could be attributed to biological or physical factors. For instance, the conducting airway is coated with secretory cells producing protective mucins and may not have retained the 0.5 million cells. This is one example that may have hindered effective colonization. Future adjustments, such as increasing the number of cells, embedding them in Matrigel, or damaging the airway to denude secretory cells and trigger regeneration might alter the outcomes. These ideas might guide future work to strengthen the utility of the models.

      (7) Another obvious piece of data that would have improved the value of this manuscript would be to know whether the RPM tumors responded to platin-etoposide chemotherapy. Such data was not presented in their first RP hESC notch inhibition paper (which we now know generated what the authors call "benign" tumors). While I realize chemotherapy responses represent other types of experiments, as the authors point out one of the main reasons they developed their new human model was for therapy testing. Two papers in and we are all still asking - does their model respond or not respond dramatically to platin-etoposide therapy? Whatever the results are they are a vital next step in considering the use of their model. 

      Please see the comments above regarding our decision not to include data from a clinical trial that lacked appropriate controls.

      (8) The finding of RPM cells that expressed NEUROD1, ASCL1, or both was interesting. From the way the data were presented, I don't have a clear idea which of these lineage oncogenes the metastatic lesions from ~11 different mice expressed. Whatever the result is it would be useful to know - all NEUROD1, some ASCL1, some mixed etc.

      Based on the bulk RNA-sequencing of a few metastatic sites (Figure 4H), what we can demonstrate is that all sites were NEUROD1 and expressed low or no detectable  ASCL1.

      (9) While several H&E histologic images were presented, even when I enlarged them to 400% I couldn't clearly see most of them. For future reference, I think it would be important to have several high-quality images of the RP, RPM, RPMT58A subcutaneous tumors, sub-renal capsule tumors, and liver and lung metastatic lesions. If there is heterogeneity in the primary tumors or the metastases it would be important to show this. The quality of the images they have in the pdf file is suboptimal. If they have already provided higher-quality images - great. If not, I think in the long run as people come back to this paper, it will help both the field and the authors to have really great images of their tumors and metastases. 

      We have attempted to improve the quality of the embedded images. Digital resolution is a tradeoff with data size – higher resolution images are always available upon request, but may not be suitable  for generation of figures in a manuscript viewed on-line.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1 (Public Review):

      Summary:

      Here the authors convincingly identify and characterize the SERBP1 interactome and further define its role in the nucleus, where it is associated with complexes involved in splicing, cell division, chromosome structure, and ribosome biogenesis. Many of the SERBP1-associated proteins are RNA-binding proteins and SERBP1 exerts its impact, at least in part, through these players. SERBP1 is mostly disordered but along with its associated proteins displays a preference for G4 binding and can bind to PAR and be PARylated. They present data that strongly suggest that complexes in which SERBP1 participates are assembled through G4 or PAR binding. The authors suggest that because SERBP1 lacks traditional functional domains yet is clearly involved in distinct regulatory complexes, SERBP1 likely acts in the early steps of assembly through the recognition of interacting sites present in RNA, DNA, and proteins.

      Strengths:

      The data is very convincing and demonstrated through multiple approaches.

      Weaknesses:

      No weaknesses were identified by this reviewer.

      Reviewer #2 (Public Review):

      Summary:

      In this study the authors have used pull-down experiments in a cell line overexpressing tagged SERPINE1 mRNA binding protein 1 (SERBP1) followed by mass spectrometry-based proteomics, to establish its interactome. Extensive analyses are performed to connect the data to published resources. The authors attempt to connect SERBP1 to stress granules and Alzheimer's disease-associated tau pathology. Based on the interactome, the authors propose a cross-talk between SERBP1 and PARP1 functions.

      Strengths:

      The main strength of this study lies in the proteomics data analysis, and its effort to connect the data to published studies.

      Weaknesses:

      While the authors propose a feedback regulatory model for SERBP1 and PARP1 functions, strong evidence for PARylation modulating SERBP1 functions is lacking. PARP inhibition decreasing the amount of PARylated proteins associated with SERBP1 and likely all other PARylated proteins is expected. This study is also incomplete in its attempt to establish a connection to Alzheimer's disease related tauopathy. A single AD case is not sufficient, and frozen autopsy tissue shows unexplained punctate staining likely due to poor preservation of cellular structures for immunohistochemistry. There is a lack of essential demographic data, source of the tissue, brain regions shown, and whether there was an IRB protocol for the human brain tissue. The presence of phase-separated transient stress granules in an autopsy brain is unlikely, even if G3BP1 staining is present. Normally, stress granule proteins move to the cytoplasm under cellular stress, whereas SERBP1 becomes nuclear. The co-localization of abundant cytoplasmic G3BP1 and SERBP1 under normal conditions does not indicate an association with stress granules.

      Reviewer #3 (Public Review):

      Summary:

      A survey of SERBP1-associated functions and their impact on the transcriptome upon gene depletion, as well as the identification of chemical inhibitors upon gene over-expression.

      Strengths:

      (1) Provides a valuable resource for the community, supported by statistical analyses.

      (2) Offers a survey of different processes with correlation data, serving as a good starting point for the community to follow up.

      Weaknesses:

      (1) The authors provided numerous correlations on diverse topics, from cell division to RNA splicing and PARP1 association, but did not follow up their findings with experiments, offering little mechanistic insight into the actual role of SERBP1. The model in Figure 5D is entirely speculative and lacks data support in the manuscript.

      Our article includes several pieces of evidence that support SERBP1’s role in splicing, translation, cell division and association with PARP1. We respectfully disagree that the model in Figure 5D is speculative. The goal of our study was to generate initial evidence of SERBP1 involvement in different biological processes based on its interactome. The characterization of molecular mechanisms in all these scenarios requires a substantial amount work and will the topic of follow up manuscripts. 

      (2) Following up with experiments to demonstrate that their findings are real (e.g., those related to splicing defects and the PARylation/PAR-binding association) would be beneficial. For example, whether the association between PARP1 and SERBP1 is sensitive to PAR-degrading enzymes is unclear.

      We included experiments showing the interaction between endogenous SERBP1 and PARP1. Additionally, we demonstrated that SERBP1 interaction with PARP1 was disrupted when cells are treated with PARP inhibitors.

      (3) They did not clearly articulate how experiments were performed. For instance, the drug screen and even the initial experiment involving the pull-down were poorly described. Many in the community may not be familiar with vectors such as pSBP or pUltra without looking up details.

      We provided additional details about the vectors and expanded the description of experiments in results and figure legends.

      (4) The co-staining of SERBP1 with pTau, PARP1, and G3BP1 in the brain is interesting, but it would be beneficial to follow up with immunoprecipitation in normal and patient samples to confirm the increased physical association.

      Thank you for this suggestion. We performed instead a Proximity Ligation Assay (PLA) on human tissue. Data was included in Fig. 7B and C. PLA between pTau and SERBP1 confirmed interaction in AD cortices as well as SERBP1 with PARP1.

      (5) The combination index of 0.7-0.9 for PJ34 + siSERBP1 is weak. Could this be due to the non-specific nature of the drug against other PARPs? Have the authors looked into this possibility?

      The combination index could be considered weak in the case of U251 cells but not in the case of U343 cells. PJ34 has been shown to be mainly a PARP-1 inhibitor. Different PJ34 concentrations and different drugs will be examined in future studies. It is worth mentioning that in a genetic screening, SERBP1 has been shown to increase sensitivity to different PARP inhibitors (PMID: 37160887). This information is included in the manuscript.

      Reviewer #1 (Recommendations For The Authors):

      This is a really well-done piece of research that is written very well. The data are very convincing and the conclusions are well supported. Some wording in Figures 2B and D is pixelated and hard to read. All the figure legends could benefit from being expanded but this is especially true for Figures 2, 3, 7, and 8. There is a ton of data being presented and a very limited description of what was done and what is being concluded. Some of the content may not be fully comprehended by some readers with limited descriptions.

      We revised all figures to assure images are clear and their resolution is high. We expanded all figure legends to provide a better explanation of the experimental design.

      Reviewer #2 (Recommendations For The Authors):

      The "merged" pdf file is the same as the "article".

      Individual files were uploaded this time.

      The abstract should spell out acronyms, such as the name of the protein Serpine1 mRNA-binding protein 1 (SERBP1).

      This was not included since the abstract has a word limit.

      "SERBP1 (Serpine1 mRNA-binding protein 1) is a unique member of this group of RBPs". In what way is it unique?

      The text was modified to better explain SERBP1’s singularities.

      "RBPs containing IDRs and RGG motifs are particularly relevant in the nervous system. Their misfolding contributes to the formation of pathological protein aggregates in Alzheimer's disease (AD), Frontotemporal Lobar Dementia (FTLD), Amyotrophic Lateral Sclerosis (ALS), and Parkinson's disease (PD)" -> while TDP-43 and FUS in ALS/FTD may fit this description, it is not true for tau and amyloid-beta (AD) and alpha-synuclein (PD).

      "SERBP1 is a unique RBPs containing IDRs and RGG motifs yet lacks other readily recognizable, canonical or structured RNA binding motifs. Moreover, SERBP1 has been observed by our study and others as common Tau interactor in Alzheimer’s Disease (AD) brains. RBPs containing IDRs (e.g. TDP-43, FUS, hnRNPs, TIA1) have been shown self-aggregate and co-aggregate with pathogenic amyloids (Tau, Aβ-amyloid and α-Synuclein)  in AD, Frontotemporal Lobar Dementia (FTLD), Amyotrophic Lateral Sclerosis (ALS), and Parkinson's disease (PD) and this suggest that, like other IDRs RBPs, SERBP1 contributes to RNA dysmetabolism in neurodegenerative diseases”.

      While the authors propose a feedback regulatory model for SERBP1 and PARP1 functions, strong evidence for PARylation modulating SERBP1 functions is lacking. The fact that PARP inhibition decreases the amount of PARylated proteins associated with SERBP1 and likely all other PARylated proteins is expected and cannot count as evidence.

      We included data showing that treatment with PJ34 (PARP inhibitor) decreases SERBP1 interaction with PARP1 and G3BP1. We are currently conducting a more extensive analysis to identify SERBP1 PAR binding domain and the impact of PARP inhibition on its interactions and functions. These experiments will be included in a new manuscript.

      A single AD case is not sufficient.

      Sorry for the poor clarity. We included in the study 6 cases from age-matched controls and 6 cases of AD. We summarize all cases demographics, and the experimental application assigned to each case in Table 1. Moreover, we included a paragraph regarding Human tissue harvesting.

      Most western blot data are not quantified from multiple replicates, as required.

      Quantifications are now provided.

      FTLD - frontotemporal lobar degeneration (not dementia).

      This was corrected.

      Frozen autopsy tissue is problematic due to poor preservation. The staining presented here shows unexplained punctate staining likely due to poor preservation of cellular structures for immunohistochemistry.

      We included a paragraph regarding human tissue harvesting. We have successfully used frozen tissues in our previous studies, observing a well preserved neuronal and tissue structure (PMIDs: 32855391, 31532069 and 30367664)

      The presence of phase-separated stress granules in tissue is controversial since these are transient structures.

      Normally, stress granule proteins move to the cytoplasm under cellular stress, whereas SERBP1 becomes nuclear. The co-localization of abundant (and partially overexposed) cytoplasmic G3BP1 and SERBP1 under normal conditions is not evidence for association with stress granules. Does induction of stress granule formation lead to colocalization in stress granules? The H2O2 experiment suggests otherwise.

      RBPs implicated in stress response move to stress granules when cells are exposed to stress. SERBP1 has been shown to shuttle to stress granules and nucleus in stress conditions (PMID: 24205981). Our results are in agreement.

      Using co-IF, we observed some overlap between G3BP1 and SERBP1 in AD tissues. As shown in Fig. S6A and B, 50% of stress granules overlap with SERBP1 signal. On the contrary, it is hard to assess their relationship in aged-matched control brains where stress granules form and accumulate with a lower rate than in AD. SERBP1 is not very abundant in normal brains.  It is known that RNA-Binding Proteins aggregation and/or dysfunctional LLPS dysregulate stress granules formation and accumulation in AD and other proteinopathies (PMIDs 30853299, 27256390 and 31911437). However, it is too early to determine the role of SERBP1 and its contribution to stress granules formation and accumulation. We will examine this topic in future studies.

      There is a lack of essential demographics data (age, clinical diagnosis, path diagnosis, co-pathologies, Braak stage, etc.), source of the tissue (what brain bank?), brain regions shown, and whether there was informed consent for the collection and use of human brain tissue.

      We included the information requested in materials and methods section.

      Reviewer #3 (Recommendations For The Authors):

      The authors need to better explain their experimental rationale and approach in the main text, not just in the supplementary materials.

      We have extensively revised the text to provide a better description of experiments in the results section and figure legends.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      In cells undergoing Flavivirus infection, cellular translation is impaired but the viruses themselves escape this inhibition and are efficiently translated. In this study, the authors use very elegant and direct approaches to identify the regions in the 5' and 3' UTRs that are important for this phenomenon and then use them to retrieve two cellular proteins that associate with them and mediate translational shutoff evasion (DDX3 and PABP1). A number of experimental approaches are used with a series of well-controlled experiments that fully support the authors' conclusions.

      Strengths:

      The work identifies the regions in the 5' and 3' UTRs of the viral genome that mediate the escape of JEV from cellular transcriptional shutoff, they evaluate the infectivity of the mutant viruses bearing or not these structures and even explore their pathogenicity in mice. They then identify the cellular proteins that bind to these regions (DDX3 and PABP1) and determine their role in translation blockade escape, in addition to examining and assessing the conservation of the stem-loop identified in JEV in other Flaviviridae.

      In almost all of their systematic analyses, translational effects are put in parallel with the replication kinetics of the different mutant viruses. The experimental thread followed in this study is rigorous and direct, and all experiments are truly well-controlled, fully supporting the authors' conclusions.

      We greatly appreciate the reviewer's recognition of this study. We elucidated the role of UTR in translation blockade escape of JEV from the perspective of the RNA structure of the UTR and its interaction with host proteins (DDX3 and PABP1), and we hope that this study could gain wider recognition.

      Reviewer #2 (Public review):

      Summary:

      The authors use a combination of techniques including viral genetics, in vitro reporters, and purified proteins and RNA to interrogate how the Japanese encephalitis virus maintains translation of its RNA to produce viral proteins after the host cell has shut down general translation as a means to block viral replication. They report a role for the RNA helicase DDX3 in promoting virus translation in a cap-independent manner through binding a dumbbell RNA structure in the 3' untranslated region previously reported to drive Japanese encephalitis virus cap-independent translation and a stem-loop at the viral RNA 5' end.

      Strengths:

      The authors clearly show that the Japanese encephalitis virus does not possess an IRES activity to initiate translation using a range of mono- and bi-cistronic mRNAs. Surprisingly, using a replicon system, the translation of a capped or uncapped viral RNA is reported to have the same translation efficiency when transfected into cells. The authors have applied a broad range of techniques to support their hypotheses.

      We are grateful for the reviewer’s recognition of the thoroughness and multi-faceted nature of our study.

      Weaknesses:

      (1) The authors' original experiments in Figure 1 where the virus is recovered following transfection of in vitro transcribed viral RNA with alternative 5' ends such as capped or uncapped ignore that after a single replication cycle of that transfected RNA, the subsequent viral RNA will be capped by the viral capping proteins making the RNA in all conditions the same.

      Thank you for your suggestion. We share the same viewpoint as the reviewer. After the first round of translation of the uncapped viral RNA, the subsequent viral RNA will inevitably be capped by the viral capping proteins. However, there is no doubt that the transfected cells do not contain viral capping proteins in the initial transfection stage, which directly proved that JEV possesses a cap-independent translation initiation mechanism.

      (2) The authors report that deletion of the dumbbell and the large 3' stem-loop RNA reduce replication of a Japanese encephalitis virus replicon. These structures have been reported for other flaviviruses to be important respectively for the accumulation of short flaviviral RNAs that can regulate replication and stability of the viral RNA that lacks a polyA tail. The authors don't show any assessment of RNA stability or degradation state.

      Thank you for your suggestion. We agree that a rigorous supplementary experiment for the assessment of RNA stability or degradation state is desirable. To address this, the relative amounts of viral RNA with the deletion of DB2 or sHP-SL will be determined by real-time RT-PCR analysis in transfected cells at multiple time points, which will allow us to test whether the deletion of the dumbbell and the large 3' stem-loop RNA reduce the RNA stability of JEV.

      (3) The authors propose a model for DDX3 to drive 5'-3' end interaction of the Japanese encephalitis virus viral genome but no direct evidence for this is presented.

      Thank you for your suggestion. In this study, we did not have direct evidence to suggest that DDX3 can drive the 5'-3' end interaction of the Japanese encephalitis virus viral genome, which is indeed a limitation of our research. In the revision, we will more explicitly discuss the interrelationship between DDX3 and 5'-3' UTR, as well as incorporate a discussion of these points into the main text, acknowledging the limitations of our current models.

      (4) The authors' final model in Figure 10 proposes a switch from a cap-dependent translation system in early infection to cap-independent DDX3-driven translation system late in infection. The replicon data that measures translation directly however shows identical traces for capped and uncapped RNAs in all untreated conditions so that which mechanism is used at different stages of the infection is not clear.

      Thank you for your suggestion. The replicon transfection system was used to evaluate the key viral element for cap-independent translation. We only monitored reporter gene expression from 2 hpt to 12 hpt, which can’t fully recapitulate the different stages of JEV infection. In the experimental results Figure 1 and Figure 1-figure supplement 1, we demonstrated that JEV significantly induced the host translational shutoff at 36 hpi, while the expression level of viral protein gradually increased as infection went on, suggesting that JEV translation could evade the shutoff of cap-dependent translation initiation at the late stage of infection. As shown in the growth curves in Figure 5Q, JEV replicated to similar virus titers in WT and DDX3-KO cells from 12 hpi to 36 hpi, but higher level virus yields were observed in WT cells from 48 hpi, suggesting that DDX3 is important for JEV infection at the late stage. DDX3 was demonstrated to be critical for JEV cap-independent translation. Based on these data, we proposed that the DDX3-dependent cap-independent translation is employed by JEV to maintain efficient infection at the late stage when the cap-dependent translation imitation was suppressed.

      Reviewer #3 (Public review):

      Summary:

      This work is a valuable study that aims to decipher the molecular mechanisms underlying the translation process in Japanese encephalitis virus (JEV), a relevant member of the genus Flavivirus. The authors provide evidence that cap-independent translation, which has already been demonstrated for other flaviviruses, could also account in JEV. This process depends on the genomic 3' UTR, as previously demonstrated in other flaviviruses. Further, the authors find that cellular proteins such as DDX3 or PABP1 could contribute to JEV translation in a cap-independent way. Both DDX3 and PABP1 had previously been described to have a role in cellular protein synthesis and also in the translation step of other flaviviruses distinct from JEV; therefore, this work would expand the cap-independent translation in flaviviruses as a general mechanism to bypass the translation repression exerted by the host cell during viral infection. Further, the findings can be relevant for the development of specific drugs that could interfere with flaviviral translation in the future. Nevertheless, the conclusions are not fully supported by the provided results.

      Strengths:

      The results provide a good starting point to investigate the molecular mechanism underlying the translation in flaviviruses, which even today is an area of knowledge with many limitations.

      Thank you to the reviewer for providing positive feedback. The research on the molecular mechanism underlying cap-independent translation is still a limited field in the flaviviruses, and its mechanism has not been well elucidated at present. We only hope that this study could reveal a novel mechanism of translation initiation for flaviviruses.

      Weaknesses:

      The main limit of the work is related to the fact that the role of the 3' UTR structural elements and DDX3 is not only circumscribed to translation, but also to replication and encapsidation. In fact, some of the provided results suggest this idea. Particularly, it is intriguing why the virus titer can be completely abrogated while the viral protein levels are only partially affected by the knockdown of DDX3. This points to the fact that many of the drawn conclusions could be overestimated or, at least, all the observed effect cannot be attributed only to the DDX3 effect on translation. Finally, it is noteworthy that the use of uncapped transcripts could be misleading, since this is not the natural molecular context of the viral genome.

      Thank you for your suggestion. We agree with the reviewer's comments that the role of the 3' UTR structural elements and DDX3 may not only be circumscribed to translation. However, not as described by the reviewer, DDX3 knockdown did not completely abrogate JEV infection. As indicated in Figure 5E-5F, the recombinant virus was successfully rescued at 36 hpt and 48 hpt using the uncapped viral genomic RNA, although the viral titer rescued with the uncapped genomic RNA at 24 hpt was below the limit of detection. We have confirmed that the DB2 and sHP-SL elements in 3' UTR play a decisive role in the replication of viral RNA in our research (Figure 2G and Figure 2-figure supplement 4C), and we will further analyze the role of DDX3 in viral RNA replication and encapsidation, thereby clarifying the multiple functions of DDX3 in JEV life cycle. Meanwhile, we will incorporate a discussion of these points into the main text, acknowledging the limitations of our current research.

      To eliminate the misleading effects of using uncapped transcripts, we will use a natural molecular background of the viral genome with cap methylation deficiency. The methyltransferase (MTase) of the flavivirus NS5 protein catalyzes  N-7 and 2’-O methylations in the formation of the 5’-end cap of the genome, and the E218 amino acid of the NS5 protein MTase domain is one of the active sites of flavivirus methyltransferase (PLoS Pathogens. 2012. PMID:22496660; Journal of Virology. 2007. PMID: 1866096). We will construct a mutant virus of the E218A mutation to abolish 2'-O methylation activity and significantly reduce N-7 methylation activity and then analyze the roles of UTR structure and DDX3 in recombinant viruses with the type-I cap structure functional deficiency.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors revealed the cellular heterogeneity of companion cells (CCs) and demonstrated that the florigen gene FT is highly expressed in a specific subpopulation of these CCs in Arabidopsis. Through a thorough characterization of this subpopulation, they further identified NITRATE-INDUCIBLE GARP-TYPE TRANSCRIPTIONAL REPRESSOR 1 (NIGT1)-like transcription factors as potential new regulators of FT. Overall, these findings are intriguing and valuable, contributing significantly to our understanding of florigen and the photoperiodic flowering pathway. However, there is still room for improvement in the quality of the data and the depth of the analysis. I have several comments that may be beneficial for the authors.

      Strengths:

      The usage of snRNA-seq to characterize the FT-expressing companion cells (CCs) is very interesting and important. Two findings are novel: 1) Expression of FT in CCs is not uniform. Only a subcluster of CCs exhibits high expression level of FT. 2) Based on consensus binding motifs enriched in this subcluster, they further identify NITRATE-INDUCIBLE GARP-TYPE TRANSCRIPTIONAL REPRESSOR 1 (NIGT1)-like transcription factors as potential new regulators of FT.

      We are pleased to hear that reviewer 1 noted the novelty and importance of our work. As reviewer 1 mentioned, we are also excited about the identification of a subcluster of companion cells with very high FT expression. We believe that this work is an initial step to describe the molecular characteristics of these FT-expressing cells. We are also excited to share our new findings on NIGT1_s as potential _FT regulators. We think that this finding attracts broader audiences, as the molecular factor that coordinates plant nutrition status with flowering time remains largely unknown despite its well-known plant phenomenon.

      Weaknesses:

      (1) Title: "A florigen-expressing subpopulation of companion cells". It is a bit misleading. The conclusion here is that only a subset of companion cells exhibit high expression of FT, but this does not imply that other companion cells do not express it at all.

      We agree with this comment, as we also did not intend to say that FT is not produced in other companion cells than the subpopulation we identified. We will revise the title to more accurately reflect the point.

      (2) Data quality: Authors opted for fluorescence-activated nuclei sorting (FANS) instead of traditional cell sorting method. What is the rationale behind this decision? Readers may wonder, especially given that RNA abundance in single nuclei is generally lower than that in single cells. This concern also applies to snRNA-seq data. Specifically, the number of genes captured was quite low, with a median of only 149 genes per nucleus. Additionally, the total number of nuclei analyzed was limited (1,173 for the pFT:NTF and 3,650 for the pSUC2:NTF). These factors suggest that the quality of the snRNA-seq data presented in this study is quite low. In this context, it becomes challenging for the reviewer to accurately assess whether this will impact the subsequent conclusions of the paper. Would it be possible to repeat this experiment and get more nuclei?

      We appreciate this comment; we noticed that we did not clearly explain the rationale of using single-nucleus RNA sequencing (snRNA-seq) instead of single-cell RNA-seq (scRNA-seq). As reviewer 1 mentioned, RNA abundance in scRNA-seq is higher than in snRNA-seq. To conduct scRNA-seq using plant cells, protoplasting is the necessary step. However, in our study, protoplasting has many drawbacks in isolating our target cells from the phloem. It is technically challenging to efficiently isolate protoplasts from highly embedded phloem companion cells from plant tissues. Usually, it requires a minimum of several hours of enzymatic incubation to protoplast companion cells and the efficiencies of protoplasting these cells are still low. For our analysis, restoring the time information within a day is also crucial. Therefore, we performed more speedy isolation method. In the revision, we will explain our rationale of choosing snRNA-seq due to the technical limitations.

      Here, reviewer 1 raised a concern about the quality of our snRNA-seq data, referring to the relatively low readcounts per nucleus. Although we believe that shallow reads do not necessaryily indicate low quality and are confident in the accuracy of our snRNA-seq data, as supported by the detailed follow-up experiments (e.g., imaging analysis in Fig. 4B), we agree that it is important to address this point in the revision and alleviate readers’ concerns regarding the data quality.

      (3) Another disappointment is that the authors did not utilize reporter genes to identify the specific locations of the FT-high expressing cells (cluster 7 cells) within the CC population in vivo. Are there any discernible patterns that can be observed?

      As we previously showed only limited spatial images of overlap between FT-expressing cells and other cluster 7 gene-expressing cells in Fig. 4B, this comment is understandable. To respond to it, we will include whole leaf images of FT- and cluster 7 gene-expressing cells to assess the spatial overlaps between FT and cluster 7 genes within a leaf.

      (4) The final disappointment is that the authors only compared FT expression between the nigtQ mutants and the wild type. Does this imply that the mutant does not have a flowering time defect particularly under high nitrogen conditions?

      To answer this question, we will include the flowering time measurement data of the nigtQ mutants grown on the soil with sufficient nitrogen sources.

      Reviewer #2 (Public review):

      This manuscript submitted by Takagi et al. details the molecular characterization of the FT-expressing cell at a single-cell level. The authors examined what genes are expressed specifically in FT-expressing cells and other phloem companion cells by exploiting bulk nuclei and single-nuclei RNA-seq and transgenic analysis. The authors found the unique expression profile of FT-expressing cells at a single-cell level and identified new transcriptional repressors of FT such as NIGT1.2 and NIGT1.4.

      Although previous researchers have known that FT is expressed in phloem companion cells, they have tended to neglect the molecular characterization of the FT-expressing phloem companion cells. To understand how FT, which is expressed in tiny amounts in phloem companion cells that make up a very small portion of the leaf, can be a key molecule in the regulation of the critical developmental step of floral transition, it is important to understand the molecular features of FT-expressing cells in detail. In this regard, this manuscript provides insight into the understanding of detailed molecular characteristics of the FT-expressing cell. This endeavor will contribute to the research field of flowering time.

      We are grateful that reviewer 2 recognizes the importance of transcriptome profiling of FT-expressing cells at the single-cell level.

      Here are my comments on how to improve this manuscript.

      (1) The most noble finding of this manuscript is the identification of NTGI1.2 as the upstream regulator of FT-expressing cluster 7 gene expression. The flowering phenotypes of the nigtQ mutant and the transgenic plants in which NIGT1.2 was expressed under the SUC2 gene promoter support that NIGT1.2 functions as a floral repressor upstream of the FT gene. Nevertheless, the expression patterns of NIGT1.2 genes do not appear to have much overlap with those of NIGT1.2-downstream genes in the cluster 7 (Figs S14 and F3). An explanation for this should be provided in the discussion section.

      We agree reviewer 2 that spatial expression patterns of NIGT1.2 and cluster 7 genes do not overlap much, and some discussion should be provided in the manuscript. Although we do not have a concrete answer for this phenomenon, NIGT1.2 may suppress FT gene expression in non-cluster 7 cells to prevent the misexpression of FT. Another possible explanation is that NIGT1.2 negatively affects the formation of cluster 7 cells. If so, cells with high NIGT1.2 gene expression hardly become cluster 7 cells. We will discuss it further in the discussion section in our revised manuscript.

      (2) To investigate gene expression in the nuclei of specific cell populations, the authors generated transgenic plants expressing a fusion gene encoding a Nuclear Targeting Fusion protein (NTF) under the control of various cell type-specific promoters. Since the public audience would not know about NTF without reading reference 16, some explanation of NTF is necessary in the manuscript. Please provide a schematic of constructs the authors used to make the transformants.

      As reviewer 2 pointed out, we lacked a clear explanation why we used NTF in this study. NTF is the fusion protein that consists of a nuclear envelope targeting domain, GFP, and biotin acceptor peptide. It was originally designed for the INTACT (isolation of nuclei tagged in specific cell types) method that enables us to isolate bulk nuclei from specific tissues. Although our original intention was profiling the bulk transcriptome of mRNAs that exist in nuclei of the FT-expressing cells using INTACT, we utilized our NTF transgenic lines for snRNA-seq analysis. To explain what NTF is to readers, we will include a schematic diagram of NTF.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      We have carefully addressed all the reviewers' suggestions, and detailed responses are provided at the end of this letter. In summary:

      • We conducted two additional replicates of the study to obtain more robust and reliable data.

      • The Introduction has been revised for greater clarity and conciseness.

      • The Results section was shortened and reorganized to highlight the key findings more effectively.

      • The Discussion was modified according to the reviewers' suggestions, with a focus on reorganization and conciseness.

      We hope you find this revised version of the manuscript satisfactory.

      Reviewer #1 (Public Review):

      Summary:

      This study examines the role of host blood meal source, temperature, and photoperiod on the reproductive traits of Cx. quinquefasciatus, an important vector of numerous pathogens of medical importance. The host use pattern of Cx. quinquefasciatus is interesting in that it feeds on birds during spring and shifts to feeding on mammals towards fall. Various hypotheses have been proposed to explain the seasonal shift in host use in this species but have provided limited evidence. This study examines whether the shifting of host classes from birds to mammals towards autumn offers any reproductive advantages to Cx. quinquefasciatus in terms of enhanced fecundity, fertility, and hatchability of the offspring. The authors found no evidence of this, suggesting that alternate mechanisms may drive the seasonal shift in host use in Cx. quinquefasciatus.

      Strengths:

      Host blood meal source, temperature, and photoperiod were all examined together.

      Weaknesses:

      The study was conducted in laboratory conditions with a local population of Cx. quinquefasciatus from Argentina. I'm not sure if there is any evidence for a seasonal shift in the host use pattern in Cx. quinquefasciatus populations from the southern latitudes.

      Comments on the revision: 

      Overall, I am not quite convinced about the possible shift in host use in the Argentinian populations of Cx. quinquefasciatus. The evidence from the papers that the authors cite is not strong enough to derive this conclusion. Therefore, I think that the introduction and discussion parts where they talk about host shift in Cx. quinquefasciatus should be removed completely as it misleads the readers. I suggest limiting the manuscript to talking only about the effects of blood meal source and seasonality on the reproductive outcomes of Cx. quinquefasciatus

      As mentioned in the previous revision, we agree on the reviewer observation about the lack of evidence on seasonal shift in the host use pattern in Cx. quinquefasciatus populations from Argentina. We include this topic in the discussion.

      Additionally, we also added a paragraph in the discussion section to include the limitations of our study and conclusions. One of them is the fact that our results are based on controlled conditions experiments. Future studies are needed to elucidate if the same trend is found in the field.

      Reviewer #1 (Recommendations for the authors): 

      Abstract

      Line 73: shift in feeding behavior

      Accepted as suggested. 

      Discussion

      Line 258: addressed that Accepted as suggested.

      Line 263: blood is nutritionally richer

      Accepted as suggested.

      Reviewer #2 (Public Review): 

      Summary:

      Conceptually, this study is interesting and is the first attempt to account for the potentially interactive effects of seasonality and blood source on mosquito fitness, which the authors frame as a possible explanation for previously observed host-switching of Culex quinquefasciatus from birds to mammals in the fall. The authors hypothesize that if changes in fitness by blood source change between seasons, higher fitness on birds in the summer and on mammals in the autumn could drive observed host switching. To test this, the authors fed individuals from a colony of Cx. quinquefasciatus on chickens (bird model) and mice (mammal model) and subjected each of these two groups to two different environmental conditions reflecting the high and low temperatures and photoperiod experienced in summer and autumn in Córdoba, Argentina (aka seasonality). They measured fecundity, fertility, and hatchability over two gonotrophic cycles. The authors then used a generalized linear model to evaluate the impact of host species, seasonality, and gonotrophic cycle on fecundity, fertility, and hatchability. The authors were trying to test their hypothesis by determining whether there was an interactive effect of season and host species on mosquito fitness. This is an interesting hypothesis; if it had been supported, it would provide support for a new mechanism driving host switching. While the authors did report an interactive impact of seasonality and host species, the directionality of the effect was the opposite from that hypothesized. The authors have done a very good job of addressing many of the reviewer concerns, with several exception that continue to cause concern about the conclusions of the study. 

      Strengths:

      (1) Using a combination of laboratory feedings and incubators to simulate seasonal environmental conditions is a good, controlled way to assess the potentially interactive impact of host species and seasonality on the fitness of Culex quinquefasciatus in the lab.

      (2) The driving hypothesis is an interesting and creative way to think about a potential driver of host switching observed in the field. 

      (3) The manuscript has become a lot clearer and easier to read with the revisions - thank you to the authors for working hard to make many of the suggested changes. 

      Weaknesses:

      (1) The authors have decided not to follow the suggestion of conducting experimental replicates of the study. This is understandable given the significant investment of resources and time necessary, however, it leaves the study lacking support. Experimental replication is an important feature of a strong study and helps to provide confidence that the observed patterns are real and replicable. Without replication, I continue to lack confidence in the conclusions of the study. 

      We included replicates as suggested.  

      (2) The authors have included some additional discussion about the counterintuitive nature of their results, but the paragraph discussing this in the discussion was confusing. I believe that this should be revised. This is a key point of the paper and needs to be clear to the reader.

      Revised as suggested. 

      (3) There should be more discussion of the host switching observed in the two studies conducted in Argentina referenced by the authors. Since host switching is the foundation for the hypothesis tested in this paper, it is important to fully explain what is currently known in Argentina. 

      Accepted as suggested.

      (4) In some cases, the explanations of referenced papers are not entirely accurate. For example, when referencing Erram et al 2022, I think the authors misrepresented the paper's discussion regarding pre-diuresis- Erram et al. are suggesting that pre-diuresis might be the mechanism by which C. furens compensates for the lower nutritional value of avian blood, leading to no significant difference between avian/mammal blood on fecundity/fertility (rather than leading to higher fecundity on birds, as stated in this manuscript). The study performed by Erram et al. also didn't prove this phenomenon, they just suggest it as a possible mechanism to explain their results, so that should be made clear when referencing the paper. 

      Changed as suggested.

      (5) In some cases, the conclusions continue to be too strongly worded for the evidence available. For example, lines 322-324: I don't think the data is sufficient to conclude that a different physiological state is induced, nor that they are required to feed on a blood source that results in higher fitness. 

      Redaction was modified as suggested to tight our discussion with results.

      (6) There is limited mention of the caveat that this experiment performed with simulated seasonality that does not perfectly replicate seasonality in the field. I think this caveat should be discussed in the discussion (e.g. that humidity is held constant).

      This topic is now included in the discussion as suggested. 

      Reviewer #2 (Recommendations for the authors): 

      59-60: These terms should end with -phagic instead of -philic. These papers study blood feeding patterns, not preference. I understand that the Janssen papers calls it "mammalophilic" in their title, but this was an incorrect use of the term in their paper. There are some review papers that explain the difference in this terminology if it's helpful.

      Accepted as suggested. 

      73: edit to "in" feeding behavior 

      Accepted as suggested.

      77-78: Given that the premise of your study is based on the phenomenon of host switching, I suggest that you expand your discussion of these two papers. What did they observe? Which hosts did they switch from / to and how dramatic was the shift?

      Accepted as suggested. 

      79: replace acknowledged with experienced 

      Accepted as suggested.

      79-80: the way that this is written is misleading. It suggests that Spinsanti showed that seasonal variation in SLEV could be attributed to a host shift, which isn't true. This citation should come before the comma and then you should use more cautious language in the second half. E.g which MIGHT be possible to attribute to .... 

      Accepted as suggested.

      80-82: this is not convincing. Even if the Robin isn't in Argentina, Argentina does have migrating birds, so couldn't this be the case for other species of birds? Do any of the birds observed in previous blood meal analyses in Argentina migrate? If so, couldn't this hypothesis indeed play a role? 

      A paragraph about this topic was added to the discussion as suggested.

      90: hypotheses for what? The fall peak in cases? Or host switching? 

      Changed to be clearer.

      98: where was this mentioned before? I think "as mentioned before" can be removed. 

      Accepted as suggested.

      101: edit to "whether an interaction effect exists" 

      Accepted as suggested.

      104: edit to "We hypothesize that..." 

      Accepted as suggested.

      106: reported host USE changes, not host PREFERENCE changes, right? 

      All the terminology was change to host pattern and not preference to avoid confusion.

      200: Briefly reading Carsey and Harden, it looks like the methodology was developed for social science. Is there anything you can cite to show this applied to other types of data? If not, I think this requires more explanation in your MS. 

      This was removed as replicates were included.

      237-239: I think it is best not to make a definitive statement about greater/higher if it isn't statistically significant; I suggest modifying the sentences to state that the differences you are listing were not significantly different up front rather than at the end, otherwise if people aren't reading carefully, they may get the wrong impression. 

      Accepted as suggested.

      245: you only use the term MS-I once before and I forgot what it meant since it wasn't repeated, so I had to search back through with command-F. I suggest writing this out rather than using the acronym. 

      Accepted as suggested.

      249: edit to: "an interaction exists between the effect of..." 

      Accepted as suggested.

      253-254: greater compared to what? 

      Change for clearness. 258-260: edit for grammar 

      Accepted as suggested.

      260-262: edit for grammar; e.g. "However, this assumption lacks solid evidence; there is a scarcity of studies regarding nutritional quality of avian blood and its impact on mosquito fitness." 

      Accepted as suggested.

      263: edit: blood is nutritionally... 

      Accepted as suggested.

      264-267: This doesn't sound like an accurate interpretation of what the paper suggests regarding pre-diuresis in their discussion - they are suggesting that pre-diuresis might be the mechanism by which C. furens compensates for the lower nutritional value of avian blood, leading to no significant difference between avian/mammal blood on fecundity/fertility. They also don't show this, they just suggest it as a possible mechanism to explain their results. 

      This topic was removed given the restructuring of discussion.

      253-269: You should tie this paragraph back to your results to explicitly compare/contrast your findings with the previous literature. 

      Accepted as suggested.

      270-282: This paragraph would be a good place to explain the caveat of working in the laboratory - for example, humidity was the same across the two seasons which I'm guessing isn't the case in the field in Argentina. You can discuss what aspects of laboratory season simulation do not accurately replicate field conditions and how this can impact your findings. You said in your response to the reviewers that you weren't interested in measuring other variables (which is fair, and not expected!), but the beauty of the discussion section is to be able to think about how your experimental design might impact your results - one possibility is that your season simulation may not have produced the results produced by true seasonal shifts. 

      Accepted as suggested.

      279-281: You say your experiment was conducted within the optimal range, which would suggest that both summer and autumn were within that range, but then you only talk about summer as optimal in the following sentence. 

      Changed for clearness.

      281-282: You should clarify this sentence - state what the interaction has an effect on. 

      Accepted as suggested.

      283-291: I appreciate that your discussion now acknowledges the small sample size and the questions that remain unanswered due to the results being opposite to that of the hypothesis, but this paragraph lacks some details and in places doesn't make sense. 

      I think you need to emphasize which groups had small sample size and which conclusions that might impact. I also think you need to explain why the sample size was substantially smaller for some groups (e.g. did they refuse to feed on the mouse in the autumn?). I appreciate that sample sizes are hard to keep high across many groups and two gonotrophic periods, but unfortunately, that is why fitness experiments are so hard to do and by their nature, take a long time. I understand that other papers have even lower sample size, but I was not asked to review those papers and would have had the same critique of them. I don't believe that creating simulated data via a Monte Carlo approach can make up for generating real data. As I understand it from your explanation, you are parametrizing the Monte Carlo simulations with your original data, which was small to begin with for autumn mouse. Using this simulation doesn't seem like a satisfactory replacement for an experimental replicate in my opinion. I maintain that at least a second replicate is necessary to see whether the patterns that you have observed hold. 

      The performing of a power analysis and addition of more replicates tried to solve the issue of sample size. More about this critic is added in the discussion. The simulation approach was totally removed.

      Regarding the directionality of the interaction effect, I think this warrants more discussion. Lines 287-291 don't make sense to me. You suggest that feeding on birds in the autumn may confer a reproductive advantage when conditions are more challenging. But then why wouldn't they preferentially feed on birds in the autumn, rather than mammals? I suggest rewriting this paragraph to make it clearer. 

      Accepted as suggested.

      297: earlier mentioned treatments? Do you mean compared to the first gonotrophic cycle? This isn't clear. 

      Changed for clearness.

      302-303: Did you clarify whether you are allowed to reference unpublished data in eLife? 

      This was removed to follow the guidelines of eLife.

      316-317: "it becomes apparent" sounds awkward, I suggest rewording and also explaining how this conclusion was made. 

      Accepted as suggested.

      322-324: I think that this statement is too strongly worded. I don't think your data is sufficient to conclude that a different physiological state is induced, nor that they are required to feed on a blood source that results in higher fitness. Please modify this and make your conclusions more cautious and closely linked to what you actually demonstrated. 

      Accepted as suggested.

      325: change will perform to would have 

      Accepted as suggested.

      326: add to the sentence: "and vice versa in the summer" 

      Accepted as suggested.

      330: possible explanations, not explaining scenarios. 

      Accepted as suggested.

      517: I think you should repeat the abbreviation definitions in the caption to make it easier for readers, otherwise they have to flip back and forth which can be difficult depending on formatting.

      Accepted as suggested. 

      In general, I think that your captions need more information. I think the best captions explain the figure relatively thoroughly such that the reader can look at the figure and caption and understand without reading the paper in depth. (e.g. the statistical test used).

      Data availability: The eLife author instructions do say that data must be made available, so there should be a statement on data availability in your MS. I also suggest you make the code available.

      Accepted as suggested.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The aim of this paper is to describe a novel method for genetic labelling of animals or cell populations, using a system of DNA/RNA barcodes.

      Strengths:

      • The author's attempt at providing a straightforward method for multiplexing Drosophila samples prior to scRNA-seq is commendable. The perspective of being able to load multiple samples on a 10X Chromium without antibody labelling is appealing.

      • The authors are generally honest about potential issues in their method, and areas that would benefit from future improvement.

      • The article reads well. Graphs and figures are clear and easy to understand.

      We thank the reviewer for these positive comments.

      Weaknesses:

      • The usefulness of TaG-EM for phototaxis, egg laying or fecundity experiments is questionable. The behaviours presented here are all easily quantifiable, either manually or using automated image-based quantification, even when they include a relatively large number of groups and replicates. Despite their claims (e.g., L311-313), the authors do not present any real evidence about the cost- or time-effectiveness of their method in comparison to existing quantification methods.

      While the behaviors that were quantified in the original manuscript were indeed relatively easy to quantify through other methods, they nonetheless demonstrated that sequencing-based TaG-EM measurements faithfully recapitulated manual behavioral measurements. In response to the reviewer’s comment, we have added additional experiments that demonstrate the utility of TaG-EM-based behavioral quantification in the context of a more labor-intensive phenotypic assay (measuring gut motility via food transit times in Drosophila larvae, Figure 4, Supplemental Figure 7). We found that food transit times in the presence and absence of caffeine are subtly different and that, as with larger effect size behaviors, TaG-EM data recapitulates the results of the manual assay. This experiment demonstrates both that TaG-EM can be used to streamline labor-intensive behavioral assays (we have included an estimate of the savings in hands-on labor for this assay by using a multiplexed sequencing approach, Supplemental Figure 8) and that TaG-EM can quantify small differences between experimental groups. We also note in the discussion that an additional benefit of TaGEM-based behavioral assays is that the observed is blinded as to the experimental conditions as they are intermingled in a single multiplexed assay. We have added the following text to the paper describing these experiments.

      Results:

      “Quantifying food transit time in the larval gut using TaG-EM

      Gut motility defects underlie a number of functional gastrointestinal disorders in humans (Keller et al., 2018). To study gut motility in Drosophila, we have developed an assay based on the time it takes a food bolus to transit the larval gut (Figure 4A), similar to approaches that have been employed for studying the role of the microbiome in human gut motility (Asnicar et al., 2021). Third instar larvae were starved for 90 minutes and then fed food containing a blue dye. After 60 minutes, larvae in which a blue bolus of food was visible were transferred to plates containing non-dyed food, and food transit (indicated by loss of the blue food bolus) was scored every 30 minutes for five hours (Supplemental Figure 7). 

      Because this assay is highly labor-intensive and requires hands-on effort for the entire five-hour observation period, there is a limit on how many conditions or replicates can be scored in one session (~8 plates maximum). Thus, we decided to test whether food transit could be quantified in a more streamlined and scalable fashion by using TaG-EM (Figure 4B). Using the manual assay, we observed that while caffeinecontaining food is aversive to larvae, the presence of caffeine reduces transit time through the gut (Figure 4C, Supplemental Figure 7). This is consistent with previous observations in adult flies that bitter compounds (including caffeine) activate enteric neurons via serotonin-mediated signaling and promote gut motility (Yao and Scott, 2022). We tested whether TaG-EM could be used to measure the effect of caffeine on food transit time in larvae. As with prior behavioral tests, the TaG-EM data recapitulated the results seen in the manual assay (Figure 4D). Conducting the transit assay via TaGEM enables several labor-saving steps. First, rather than counting the number of larvae with and without a food bolus at each time point, one simply needs to transfer nonbolus-containing larvae to a collection tube. Second, because the TaG-EM lines are genetically barcoded, all the conditions can be tested at once on a single plate, removing the need to separately count each replicate of each experimental condition. This reduces the hands-on time for the assay to just a few minutes per hour.  A summary of the anticipated cost and labor savings for the TaG-EM-based food transit assay is shown in Supplemental Figure 8.”

      Discussion:

      “While the utility of TaG-EM barcode-based quantification will vary based on the number of conditions being analyzed and the ease of quantifying the behavior or phenotype by other means, we demonstrate that TaG-EM can be employed to cost-effectively streamline labor-intensive assays and to quantify phenotypes with small effect sizes (Figure 4, Supplemental Figure 8). An additional benefit of multiplexed TaG-EM behavioral measurements is that the experimental conditions are effectively blinded as the multiplexed conditions are intermingled in a single assay.”

      Methods:

      “Larval gut motility experiments

      Preparing Yeast Food Plates

      Yeast agar plates were prepared by making a solution containing 20% Red Star Active Dry Yeast 32oz (Red Star Yeast) and 2.4% Agar Powder/Flakes (Fisher) and a separate solution containing 20% Glucose (Sigma-Aldrich). Both mixtures were autoclaved with a 45-minute liquid cycle and then transferred to a water bath at 55ºC. After cooling to 55ºC, the solutions were combined and mixed, and approximately 5 mL of the combined solution was transferred into 100 x 15 mm petri dishes (VWR) in a PCR hood or contamination-free area. For blue-dyed yeast food plates, 0.4% Blue Food Color (McCormick) was added to the yeast solution. For the caffeine assays, 300 µL of a solution of 100 mM 99% pure caffeine (Sigma-Aldrich) was pipetted onto the blue-dyed yeast plate and allowed to absorb into the food during the 90-minute starvation period.

      Manual Gut Motility Assay

      Third instar Drosophila larvae were transferred to empty conical tubes that had been misted with water to prevent the larvae from drying out. After a 90-minute starvation period the larvae were moved from the conical to a blue-dyed yeast plate with or without caffeine and allowed to feed for 60 minutes. Following the feeding period, the larvae were transferred to an undyed yeast plate. Larvae were scored for the presence or absence of a food bolus every 30 minutes over a 5-hour period. Up to 8 experimental replicates/conditions were scored simultaneously. 

      TaG-EM Gut Motility Assay

      Third instar larvae were starved and fed blue dye-containing food with or without caffeine as described above. An equal number of larvae from each experimental condition/replicate were transferred to an undyed yeast plate. During the 5-hour observation period, larvae were examined every 30 minutes and larvae lacking a food bolus were transferred to a microcentrifuge tube labeled for the timepoint. Any larvae that died during the experiment were placed in a separate microcentrifuge tube and any larvae that failed to pass the food bolus were transferred to a microcentrifuge tube at the end of the experiment. DNA was extracted from the larvae in each tube and TaG-EM barcode libraries were prepared and sequenced as described above.”

      • Behavioural assays presented in this article have clear outcomes, with large effect sizes, and therefore do not really challenge the efficiency of TaG-EM. By showing a Tmaze in Fig 1B, the authors suggest that their method could be used to quantify more complex behaviours. Not exploring this possibility in this manuscript seems like a missed opportunity.

      See the response to the previous point.

      • Experiments in Figs S3 and S6 suggest that some tags have a detrimental effect on certain behaviours or on GFP expression. Whereas the authors rightly acknowledge these issues, they do not investigate their causes. Unfortunately, this question the overall suitability of TaG-EM, as other barcodes may also affect certain aspects of the animal's physiology or behaviour. Revising barcode design will be crucial to make sure that sequences with potential regulatory function are excluded.

      We have determined that the barcode (BC#8) that had no detectable Gal4induced gene expression in Figure S6 (now Supplemental Figure 9) has a deletion in the GFP coding region that ablates GFP function. Interestingly, the expressed TaG-EM barcode transcript is still detectable in single cell sequencing experiments, but obviously this line cannot be used for cell enrichment (at least based solely on GFP expression from the TaG-EM construct). While it is unclear how this line came to have a lesion in the GFP gene, we have subsequently generated >150 additional TaG-EM stocks and we have tested the GFP expression of these newly established stocks by crossing them to Mhc-Gal4. All of the additional stocks had GFP expression in the expected pattern, indicating that the BC#8 construct is an outlier with respect to inducibility of GFP. We have added the following text to the results section to address this point:

      “No GFP expression was visible for TaG-EM barcode number 8, which upon molecular characterization had an 853 bp deletion within the GFP coding region (data not shown). We generated and tested GFP expression of an additional 156 TaG-EM barcode lines (Alegria et al., 2024), by crossing them to Mhc-Gal4 and observing expression in the adult thorax. All 156 additional TaG-EM lines had robust GFP expression (data not shown).”

      It is certainly the case that future improvements to the construct design may be necessary or desirable and that back-crossing could likely be used to alleviate line-toline differences for specific phenotypes, we also address this point in the discussion with the following text:

      “We excluded this poor performing barcode line from the fecundity tests, however, backcrossing is often used to bring reagents into a consistent genetic background for behavioral experiments and could also potentially be used to address behavior-specific issues with specific TaG-EM lines. In addition, other strategies such as averaging across multiple barcode lines or permutation of barcode assignment across replicates could also mitigate such deficiencies.”

      • For their single-cell experiments, the authors have used the 10X Genomics method, which relies on sequencing just a short segment of each transcript (usually 50-250bp - unknown for this study as read length information was not provided) to enable its identification, with the matching paired-end read providing cell barcode and UMI information (Macosko et al., 2015). With average fragment length after tagmentation usually ranging from 300-700bp, a large number of GFP reads will likely not include the 14bp TaG-EM barcode. 

      The 10x Genomics 3’ workflows that were used for sequencing TaG-EM samples reads the cell barcode and UMI in read one and the expressed RNA sequence in read two. We sequenced the samples shown in Figure 5 in the initial manuscript using a run configuration that generated 150 bp for read two. The TaG-EM barcodes are located just upstream of the poly-adenylation sites (based on the sequencing data, we observe two different poly-A sites and the TaG-EM barcode is located 35 and 60 bp upstream of these sites). Based on the location of the TaG-EM barcodes,150 bp reads is sufficient to see the barcode in any GFP-associated read (when using the 3’ gene expression workflow). In addition to detecting the expression of the TaG-EM barcodes in the 10x Genomics gene expression library, it is possible to make a separate library that enriches the barcode sequence (similar to hashtag or CITE-Seq feature barcode libraries). We have added experimental data where we successfully performed an enrichment of the TaG-EM barcodes and sequenced this as a separate hashtag library (Supplemental Figure 18). We have added text to the results describing this work and also included a detailed information in the methods for performing TaG-EM barcode enrichment during 10x library prep. 

      Results:

      “In antibody-conjugated oligo cell hashing approaches, sparsity of barcode representation is overcome by spiking in an additional primer at the cDNA amplification step and amplifying the hashtag oligo by PCR. We employed a similar approach to attempt to enrich for TaG-EM barcodes in an additional library sequenced separately from the 10x Genomics gene expression library. Our initial attempts at barcode enrichment using spike-in and enrichment primers corresponding to the TaG-EM PCR handle were unsuccessful (Supplemental Figure 18). However, we subsequently optimized the TaG-EM barcode enrichment by 1) using a longer spike-in primer that more closely matches the annealing temperature used during the 10x Genomics cDNA creation step, and 2) using a nested PCR approach to amplify the cell-barcode and unique molecular identifier (UMI)-labeled TaG-EM barcodes (Supplemental Figure 18). Using the enriched library, TaG-EM barcodes were detected in nearly 100% of the cells at high sequencing depths (Supplemental Figure 19). However, although we used a polymerase that has been engineered to have high processivity and that has been shown to reduce the formation of chimeric reads in other contexts (Gohl et al., 2016), it is possible that PCR chimeras could lead to unreliable detection events for some cells. Indeed, many cells had a mixture of barcodes detected with low counts and single or low numbers of associated UMIS. To assess the reliability of detection, we analyzed the correlation between barcodes detected in the gene expression library and the enriched TaG-EM barcode library as a function of the purity of TaG-EM barcode detection for each cell (the percentage of the most abundant detected TaG-EM barcode, Supplemental Figure 19). For TaG-EM barcode detections where the most abundance barcode was a high percentage of the total barcode reads detected (~75%-99.99%), there was a high correlation between the barcode detected in the gene expression library and the enriched TaG-EM barcode library. Below this threshold, the correlation was substantially reduced. 

      In the enriched library, we identified 26.8% of cells with a TaG-EM barcode reliably detected, a very modest improvement over the gene expression library alone (23.96%), indicating that at least for this experiment, the main constraint is sufficient expression of the TaG-EM barcode and not detection. To identify TaG-EM barcodes in the combined data set, we counted a positive detection as any barcode either identified in the gene expression library or any barcode identified in the enriched library with a purity of >75%. In the case of conflicting barcode calls, we assigned the barcode that was detected directly in the gene expression library. This increased the total fraction of cells where a barcode was identified to approximately 37% (Figure 6B).”

      Methods:

      “The resulting pool was prepared for sequencing following the 10x Genomics Single Cell 3’ protocol (version CG000315 Rev C), At step 2.2 of the protocol, cDNA amplification, 1 µl of TaG-EM spike-in primer (10 µM) was added to the reaction to amplify cDNA with the TaG-EM barcode. Gene expression cDNA and TaG-EM cDNA were separated using a double-sided SPRIselect (Beckman Coulter) bead clean up following 10x Genomics Single Cell 3’ Feature Barcode protocol, step 2.3 (version CG000317 Rev E). The gene expression cDNA was created into a library following the CG000315 Rev C protocol starting at section 3. Custom nested primers were used for enrichment of TaG-EM barcodes after cDNA creation using PCR.  The following primers were tested (see Supplemental Figure 18):

      UMGC_IL_TaGEM_SpikeIn_v1:

      GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCTTCCAACAACCGGAAGT*G*A UMGC_IL_TaGEM_SpikeIn_v2:

      GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCAGCTTATAACTTCCAACAACCGGAAGT*G*A

      UMGC_IL_TaGEM_SpikeIn_v3:

      TGTGCTCTTCCGATCTGCAGCTTATAACTTCCAACAACCGGAAGT*G*A D701_TaGEM:

      CAAGCAGAAGACGGCATACGAGATCGAGTAATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCAGC*T*T

      SI PCR Primer:

      AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGC*T*C

      UMGC_IL_DoubleNest:

      GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGCAGCTTATAACTTCCAACAACCGG*A*A

      P5: AATGATACGGCGACCACCGA

      D701:

      GATCGGAAGAGCACACGTCTGAACTCCAGTCACATTACTCGATCTCGTATGCCGTCTTCTGCTTG

      D702:

      GATCGGAAGAGCACACGTCTGAACTCCAGTCACTCCGGAGAATCTCGTATGCCGTCTTCTGCTTG

      After multiple optimization trials, the following steps yielded ~96% on-target reads for the TaG-EM library (Supplemental Figure 18, note that for the enriched barcode data shown in Figure 6 and Supplemental Figure 19, a similar amplification protocol was used TaG-EM barcodes were amplified from the gene expression library cDNA and not the SPRI-selected barcode pool). TaG-EM cDNA was amplified with the following PCR reaction: 5 µl purified TaG-EM cDNA, 50 µl 2x KAPA HiFi ReadyMix (Roche), 2.5 µl UMGC_IL_DoubleNest primer (10 µM), 2.5 µl SI_PCR primer (10 µM), and 40 µl nuclease-free water. The reaction was amplified using the following cycling conditions: 98ºC for 2 minutes, followed by 15 cycles of 98ºC for 20 seconds, 63ºC for 30 seconds, 72ºC for 20 seconds, followed by 72ºC for 5 minutes. After the first PCR, the amplified cDNA was purified with a 1.2x SPRIselect (Beckman Coulter) bead cleanup with 80% ethanol washes and eluted into 40 µL of nuclease-water. A second round of PCR was run with following reaction: 5 µl purified TaG-EM cDNA, 50 µl 2x KAPA HiFi ReadyMix (Roche), 2.5 µl D702 primer (10 µM), 2.5 µl p5 Primer (10 µM), and 40 µl nuclease-free water. The reaction was amplified using the following cycling conditions: 98ºC for 2 minutes, followed by 10 cycles of 98ºC for 20 seconds, 63ºC for 30 seconds, 72ºC for 20 seconds, followed by 72ºC for 5 minutes. After the second PCR, the amplified cDNA was purified with a 1.2x SPRIselect (Beckman Coulter) bead cleanup with 80% ethanol washes and eluted into 40uL of nuclease-water. The resulting 3’ gene expression library and TaG-EM enrichment library were sequenced together following Scenario 1 of the BioLegend “Total-Seq-A Antibodies and Cell Hashing with 10x Single Cell 3’ Reagents Kit v3 or v3.1” protocol. Additional sequencing of the enriched TaG-EM library also done following Scenario 2 from the same protocol.” 

      When a given cell barcode is not associated with any TaG-EM barcode, then demultiplexing is impossible. This is a major problem, which is particularly visible in Figs 5 and S13. In 5F, BC4 is only detected in a couple of dozen cells, even though the Jon99Ciii marker of enterocytes is present in a much larger population (Fig 5C). Therefore, in this particular case, TaG-EM fails to detect most of the GFP-expressing cells. 

      Figure 5 in the original manuscript represented data from an experiment in which there were eight different TaG-EM barcoded samples present, including four replicates of the pan-midgut driver (each of which included enterocyte populations). One would not expect the BC4 enterocyte driver expression to be observed in all of the Jon99Ciii cells, since the majority of the GFP+ cells shown in the UMAP plot were likely derived from and are labeled by the pan-midgut driver-associated barcodes. Thus, the design and presentation of this particular experiment (in particular, the presence of eight distinct samples in the data set) is making the detection of the TaG-EM barcodes look sparser than it actually is. We have added a panel in both Figure 6B and Supplemental Figure 17B that shows the overall detection of barcodes in the enriched barcode library and gene expression library or the gene expression library only, respectively, for this experiment.

      However, the reviewer’s overall point regarding barcode detection is still valid in that if we consider all eight barcodes, we only see TaG-EM barcode labeling associated with about a quarter of all the cells in this gene expression library, or about 37% of cells when we include the enriched TaG-EM barcode library. While improving barcode detection will improve the yield and is necessary for some applications (such as robust detection of multiplets), we would argue that even at the current level of success this approach has significant utility. First, if one’s goal is to unambiguously label a cell cluster and trace it to a defined cell population in vivo, sparse labeling may be sufficient. Second, demultiplexing is still possible (as we demonstrate) but involves a trade off in yield (not every cell is recovered and there is some extra sequencing cost as some sequenced cells cannot be assigned to a barcode). 

      Similarly, in S13, most cells should express one of the four barcodes, however many of them (maybe up to half - this should be quantified) do not. Therefore, the claim (L277278) that "the pan-midgut driver were broadly distributed across the cell clusters" is misleading. Moreover, the hypothesis that "low expressing driver lines may result in particularly sparse labelling" (L331-333) is at least partially wrong, as Fig S13 shows that the same Gal4 driver can lead to very different levels of barcode coverage.

      As described above, since this experiment included eight different TaG-EM barcodes expressed by five different drivers, the expectation is that only about half of the cells in Figure S13 (now Figure S20) should express a TaG-EM barcode. It is not clear why BC2 is underrepresented in terms of the number of cells labeled and BC7 is overrepresented. We agree with the reviewer that this should be described more accurately in the paper and that it does impact our interpretation related to driver strength and barcode detection. We have revised this sentence in the discussion and also added additional text in the results describing the within driver variability seen in this experiment.

      Results text:

      “As expected, the barcodes expressed by the pan-midgut driver were broadly distributed across the cell clusters (Supplemental Figure 20). However, the number of cells recovered varied significantly among the four pan-midgut driver associated barcodes.”

      Discussion text:

      “It is likely that the strength of the Gal4 driver contributes to the labeling density. However, we also observed variable recovery of TaG-EM barcodes that were all driven by the same pan-midgut Gal4 driver (Supplemental Figure 20).”

      • Comparisons between TaG-EM and other, simpler methods for labelling individual cell populations are missing. For example, how would TaG-EM compare with expression of different fluorescent reporters, or a strategy based on the brainbow/flybow principle?

      The advantage of TaG-EM is that an arbitrarily large number of DNA barcodes can be used (contingent upon the availability of transgenic lines – we described 20 barcoded lines in our initial manuscript and we have now extended this collection to over 170 lines), while the number of distinguishable FPs is much lower. Brainbow/Flybow uses combinatorial expression of different FPs, but because this combinatorial expression is stochastic, tracing a single cell transcriptome to a defined cell population in vivo based on the FP signature of a Brainbow animal would likely not be possible (and would almost certainly be impossible at scale).

      • FACS data is missing throughout the paper. The authors should include data from their comparative flow cytometry experiment of TaG-EM cells with or without additional hexameric GFP, as well as FSC/SSC and fluorescence scatter plots for the FACS steps that they performed prior to scRNA-seq, at least in supplementary figures.

      We have added Supplemental Figures with the FACS data for all of the single cell sequencing data presented in the manuscript (Supplemental Figures 12 and 14).

      • The authors should show the whole data described in L229, including the cluster that they chose to delete. At least, they should provide more information about how many cells were removed. In any case, the fact that their data still contains a large number of debris and dead cells despite sorting out PI negative cells with FACS and filtering low abundance barcodes with Cellranger is concerning.

      This description was referring to the unprocessed Cellranger output (not filtered for low abundance barcodes). Prior to filtering for cell barcodes with high mitochondria or rRNA (or other processing in Seurat/Scanpy), we saw two clusters, one with low UMI counts and enrichment of mitochondrial genes (see Cellranger report below). 

      Author response image 1.

      These cell barcodes were removed by downstream quality filtering and the remaining cells showed expression of expected intestinal stem cell and enteroblast marker genes.

      Overall, although a method for genetic tagging cell populations prior to multiplexing in single-cell experiments would be extremely useful, the method presented here is inadequate. However, despite all the weaknesses listed above, the idea of barcodes expressed specifically in cells of interest deserves more consideration. If the authors manage to improve their design to resolve the major issues and demonstrate the benefits of their method more clearly, then TaG-EM could become an interesting option for certain applications.

      We thank the reviewer for this comment and hope that the above responses and additional experiments and data that we have added have helped to alleviate the noted weaknesses.

      Reviewer #2 (Public Review):

      In this manuscript, Mendana et al developed a multiplexing method - Targeted Genetically-Encoded Multiplexing or TaG-EM - by inserting a DNA barcode upstream of the polyadenylation site in a Gal4-inducible UAS-GFP construct. This Multiplexing method can be used for population-scale behavioral measurements or can potentially be used in single-cell sequencing experiments to pool flies from different populations. The authors created 20 distinctly barcoded fly lines. First, TaG-EM was used to measure phototaxis and oviposition behaviors. Then, TaG-EM was applied to the fly gut cell types to demonstrate its applications in single-cell RNA-seq for cell type annotation and cell origin retrieving.

      This TaG-EM system can be useful for multiplexed behavioral studies from nextgeneration sequencing (NGS) of pooled samples and for Transcriptomic Studies. I don't have major concerns for the first application, but I think the scRNA-seq part has several major issues and needs to be further optimized.

      Major concerns:

      (1) It seems the barcode detection rate is low according to Fig S9 and Fig 5F, J and N. Could the authors evaluate the detection rate? If the detection rate is too low, it can cause problems when it is used to decode cell types.

      See responses to Reviewer #1 on this topic above.  

      (2) Unsuccessful amplification of TaG-EM barcodes: The authors attempted to amplify the TaG-EM barcodes in parallel to the gene expression library preparation but encountered difficulties, as the resulting sequencing reads were predominantly offtarget. This unsuccessful amplification raises concerns about the reliability and feasibility of this amplification approach, which could affect the detection and analysis of the TaG-EM barcodes in future experiments.

      As noted above, we have now established a successful amplification protocol for the TaG-EM barcodes. This data is shown in Figure 6, and Supplemental Figures 18-19 and we have included a detailed information in the methods for performing TaG-EM barcode enrichment during 10x library prep. We have also included code in the paper’s Github repository for assigning TaG-EM barcodes from the enriched library to the associated 10x Genomics cell barcodes.

      (3) For Fig 5, the singe-cell clusters are not annotated. It is not clear what cell types are corresponding to which clusters. So, it is difficult to evaluate the accuracy of the assignment of barcodes.

      We have added annotation information for the cell clusters based on expression of cell-type-specific marker genes (Figure 6A, Supplemental Figures 16-17).

      (4) The scRNA-seq UMAP in Fig 5 is a bit strange to me. The fly gut epithelium contains only a few major cell types, including ISC, EB, EC, and EE. However, the authors showed 38 clusters in fig 5B. It is true that some cell types, like EE (Guo et al., 2019, Cell Reports), have sub-populations, but I don't expect they will form these many subtypes. There are many peripheral small clusters that are not shown in other gut scRNAseq studies (Hung et al., 2020; Li et al., 2022 Fly Cell Atlas; Lu et al., 2023 Aging Fly Cell Atlas). I suggest the authors try different data-processing methods to validate their clustering result.

      For all of the single cell experiments, after doublet and ambient RNA removal (as suggested below), we have reclustered the datasets and evaluated different resolutions using Clustree. As the Reviewer points out, there are different EE subtypes, as well as regionalized expression differences in EC and other cell populations, so more than four clusters are expected (an analysis of the adult midgut identified 22 distinct cell types). With this revised analysis our results more closely match the cell populations observed in other studies (though it should be noted that the referenced studies largely focus on the adult and not the larval stage).  

      (5) Different gut drivers, PMC-, PC-, EB-, EC-, and EE-GAL4, were used. The authors should carefully characterize these GAL4 expression in larval guts and validate sequencing data. For example, does the ratio of each cell type in Fig 5B reflect the in vivo cell type ratio? The authors used cell-type markers mostly based on the knowledge from adult guts, but there are significant morphological and cell ratio differences between larval and adult guts (e.g., Mathur...Ohlstein, 2010 Science).

      We have characterized the PC driver which is highlighted in Supplemental Figure 13, and the EC and EE drivers which are highlighted in Figure 6G-N in detail in larval guts and have added this data to the paper (Supplemental Figure 21). The EB driver was not characterized histologically as EB-specific antibodies are not currently available. The PMG-Gal4 line exhibits strong expression throughout the larval gut (Figure 5B and barcodes are recovered from essentially all of the larval gut cell clusters using this driver (Supplemental Figure 20). We don’t necessarily expect the ratios of cells observed in the scRNA-Seq data to reflect the ratios typically observed in the gut as we performed pooled flow sorting on a multiplexed set of eight genotypes and driver expression levels, flow sorting, and possibly other processing steps could all influence the relative abundance of different cell types. However, detailed characterization of these driver lines did reveal spatial expression patterns that help explain aspects of the scRNA-Seq data. We have also added the following text to the paper to further describe the characterization of the drivers:

      Results:

      “Detailed characterization of the EC-Gal4 line indicated that although this line labeled a high percentage of enterocytes, expression was restricted to an area at the anterior and middle of the midgut, with gaps between these regions and at the posterior (Supplemental Figure 21). This could explain the absence of subsets of enterocytes, such as those labeled by betaTry, which exhibits regional expression in R2 of the adult midgut (Buchon et al., 2013).”

      “Detailed characterization of the EE-Gal4 driver line indicated that ~80-85% of Prospero-positive enteroendocrine cells are labeled in the anterior and middle of the larval midgut, with a lower percentage (~65%) of Prospero-positive cells labeled in the posterior midgut (Supplemental Figure 21). As with the enterocyte labeling, and consistent with the Gal4 driver expression pattern, the EE-Gal4 expressed TaG-EM barcode 9 did not label all classes of enteroendocrine cells and other clusters of presumptive enteroendocrine cells expressing other neuropeptides such as Orcokinin, AstA, and AstC, or neuropeptide receptors such as CCHa2 (not shown) were also observed.”

      Methods:

      “Dissection and immunostaining

      Midguts from third instar larvae of driver lines crossed to UAS-GFP.nls or UAS-mCherry were dissected in 1xPBS and fixed with 4% paraformaldehyde (PFA) overnight at 4ºC. Fixed samples were washed with 0.1% PBTx (1xPBS + 0.1% Triton X-100) three times for 10 minutes each and blocked in PBTxGS (0.1% PBTx + 3% Normal Goat Serum) for 2–4 hours at RT. After blocking, midguts were incubated in primary antibody solution overnight at 4ºC. The next day samples were washed with 0.1% PBTx three times for 20 minutes each and were incubated in secondary antibody solution for 2–3 hours at RT (protected from light) followed by three washes with 0.1% PBTx for 20 minutes each. One µg/ml DAPI solution prepared in 0.1% PBTx was added to the sample and incubated for 10 minutes followed by washing with 0.1% PBTx three times for 10 minutes each. Finally, samples were mounted on a slide glass with 70% glycerol and imaged using a Nikon AX R confocal microscope. Confocal images were processed using Fiji software. 

      The primary antibodies used were rabbit anti-GFP (A6455,1:1000 Invitrogen), mouse anti-mCherry (3A11, 1:20 DSHB), mouse anti-Prospero (MR1A, 1:50 DSHB) and mouse anti-Pdm1 (Nub 2D4, 1:30 DSHB). The secondary antibodies used were goat antimouse and goat anti-rabbit IgG conjugated to Alexa 647 and Alexa 488 (1:200) (Invitrogen), respectively. Five larval gut specimens per Gal4 line were dissected and examined.”

      (6) Doublets are removed based on the co-expression of two barcodes in Fig 5A. However, there are also other possible doublets, for example, from the same barcode cells or when one cell doesn't have detectable barcode. Did the authors try other computational approaches to remove doublets, like DoubleFinder (McGinnis et al., 2019) and Scrublet (Wolock et al., 2019)?

      We have included DoubleFinder-based doublet removal in our data analysis pipeline. This is now described in the methods (see below).

      (7) Did the authors remove ambient RNA which is a common issue for scRNA-seq experiments?

      We have also used DecontX to remove ambient RNA. This is now described in the methods:

      “Datasets were first mapped and analyzed using the Cell Ranger analysis pipeline (10x Genomics). A custom Drosophila genome reference was made by combining the BDGP.28 reference genome assembly and Ensembl gene annotations. Custom gene definitions for each of the TaG-EM barcodes were added to the fasta genome file and .gtf gene annotation file. A Cell Ranger reference package was generated with the Cell Ranger mkref command. Subsequent single-cell data analysis was performed using the R package Seurat (Satija et al., 2015). Cells expressing less than 200 genes and genes expressed in fewer than three cells were filtered from the expression matrix. Next, percent mitochondrial reads, percent ribosomal reads cells counts, and cell features were graphed to determine optimal filtering parameters. DecontX (Yang et al., 2020) was used to identify empty droplets, to evaluate ambient RNA contamination, and to remove empty cells and cells with high ambient RNA expression. DoubletFinder (McGinnis et al., 2019) to identify droplet multiplets and remove cells classified as multiplets. Clustree (Zappia and Oshlack, 2018) was used to visualize different clustering resolutions and to determine the optimal clustering resolution for downstream analysis. Finally, SingleR (Aran et al., 2019) was used for automated cell annotation with a gut single-cell reference from the Fly Cell Atlas (Li et al., 2022). The dataset was manually annotated using the expression patterns of marker genes known to be associated with cell types of interest. To correlate TaG-EM barcodes with cell IDs in the enriched TaG-EM barcode library, a custom Python script was used (TaGEM_barcode_Cell_barcode_correlation.py), which is available via Github: https://github.com/darylgohl/TaG-EM.”

      (8) Why does TaG-EM barcode #4, driven by EC-GAL4, not label other classes of enterocyte cells such as betaTry+ positive ECs (Figures 5D-E)? similarly, why does TaG-EM barcode #9, driven by EE-GAL4, not label all EEs? Again, it is difficult to evaluate this part without proper data processing and accurate cell type annotation.

      As noted in the response to a comment by Reviewer #1 above, part of this apparent sparsity of labeling is due to the way that this experiment was designed and visualized. We have added a new Figure panel in both Figure 6B and Supplemental Figure 17B that shows the overall detection of barcodes in the enriched barcode library and gene expression library or the gene expression library only, respectively, to better illustrate the efficacy of barcode detection. See also the response to point 5 above. Both the lack of labelling of betaTry+ ECs and subsets of EEs is consistent with the expression patterns of the EC-Gal4 and EE-Gal4 drivers.

      (9) For Figure 2, when the authors tested different combinations of groups with various numbers of barcodes. They found remarkable consistency for the even groups. Once the numbers start to increase to 64, barcode abundance becomes highly variable (range of 12-18% for both male and female). I think this would be problematic because the differences seen in two groups for example may be due to the barcode selection rather than an actual biologically meaningful difference.

      While there is some barcode-to-barcode variability for different amplification conditions, the magnitude of this variation is relatively consistent across the conditions tested. We looked at the coefficient of variation for the evenly pooled barcodes or for the staggered barcodes pooled at different relative levels. While the absolute magnitude of the variation is higher for the highly abundant barcodes in the staggered conditions, the CVs for these conditions (0.186 for female flies and for 0.163 male flies) were only slightly above the mean CV (0.125) for all conditions (see Supplemental Figure 3):

      We have added this analysis as Supplemental Figure 3 and added the following text to the paper:(

      “The coefficients of variation were largely consistent for groups of TaG-EM barcodes pooled evenly or at different levels within the staggered pools (Supplemental Figure 3).”

      (10) Barcode #14 cannot be reliably detected in oviposition experiment. This suggests that the BC 14 fly line might have additional mutations in the attp2 chromosome arm that affects this behavior. Perhaps other barcode lines also have unknown mutations and would cause issues for other untested behaviors. One possible solution is to backcross all 20 lines with the same genetic background wild-type flies for >7 generations to make all these lines to have the same (or very similar) genetic background. This strategy is common for aging and behavior assays.

      See response to Reviewer #1 above on this topic.

      Reviewer #3 (Public Review):

      The work addresses challenges in linking anatomical information to transcriptomic data in single-cell sequencing. It proposes a method called Targeted Genetically-Encoded Multiplexing (TaG-EM), which uses genetic barcoding in Drosophila to label specific cell populations in vivo. By inserting a DNA barcode near the polyadenylation site in a UASGFP construct, cells of interest can be identified during single-cell sequencing. TaG-EM enables various applications, including cell type identification, multiplet droplet detection, and barcoding experimental parameters. The study demonstrates that TaGEM barcodes can be decoded using next-generation sequencing for large-scale behavioral measurements. Overall, the results are solid in supporting the claims and will be useful for a broader fly community. I have only a few comments below:

      We thank the reviewer for these positive comments.

      Specific comments:

      (1) The authors mentioned that the results of structure pool tests in Fig. 2 showed a high level of quantitative accuracy in detecting the TaG-EM barcode abundance. Although the data were generally consistent with the input values in most cases, there were some obvious exceptions such as barcode 1 (under-represented) and barcodes 15, 20 (overrepresented). It would be great if the authors could comment on these and provide a guideline for choosing the appropriate barcode lines when implementing this TaG-EM method.

      See the response to point 9 from Reviewer 2. Although there seem to be some systematic differences in barcode amplification, the coefficient of variation was relatively consistent across all of the barcode combinations and relative input levels that we examined. Our recommendation (described in the text) is to average across 3-4 independent barcodes (which yielded a R2 values of >0.99 with expected abundance in the structured pooled tests).  

      (2) In Supplemental Figure 6, the authors showed GFP antibody staining data with 20 different TaG-EM barcode lines. The variability in GFP antibody staining results among these different TaG-EM barcode lines concerns the use of these TaG-EM barcode lines for sequencing followed by FACS sorting of native GFP. I expected the native GFP expression would be weaker and much more variable than the GFP antibody staining results shown in Supplemental Figure 6. If this is the case, variation of tissue-specific expression of TaG-EM barcode lines will likely be a confounding factor.

      Aside from barcode 8, which had a mutation in the GFP coding sequence, we did not see significant variability in expression levels either in the wing disc. Subtle differences seen in this figure most likely result from differences in larval staging. Similar consistent native (unstained) GFP expression of the TaG-EM constructs was seen in crosses with Mhc-Gal4 (described above). 

      (3) As the authors mentioned in the manuscript, multiple barcodes for one experimental condition would be a better experimental design. Could the authors suggest a recommended number of barcodes for each experiential condition? 3? 4? Or more? 

      See response to Reviewer #3, point number 1 above.

      (3b) Also, it would be great if the authors could provide a short discussion on the cost of such TaG-EM method. For example, for the phototaxis assay, if it is much more expensive to perform TaG-EM as compared to manually scoring the preference index by videotaping, what would be the practical considerations or benefits of doing TaG-EM over manual scoring?

      While this will vary depending on the assay and the scale at which one is conducting experiments, we have added an analysis of labor savings for the larval gut motility assay (Supplemental Figure 8). We have also added the following text to the Discussion describing some of the trade-offs to consider in assessing the potential benefit of incorporating TaG-EM into behavioral measurements:

      “While the utility of TaG-EM barcode-based quantification will vary based on the number of conditions being analyzed and the ease of quantifying the behavior or phenotype by other means, we demonstrate that TaG-EM can be employed to cost-effectively streamline labor-intensive assays and to quantify phenotypes with small effect sizes (Figure 4, Supplemental Figure 8).”

      Recommendations for the authors:  

      While recognising the potential of the TaG-EM methodology, we had a few major concerns that the authors might want to consider addressing:

      As stated above, we are grateful to the reviewers and editor for their thoughtful comments. We have addressed many of the points below in our responses above, so we will briefly respond to these points and where relevant direct the reader to comments above.

      (1) We were concerned about the efficacy of TaG-EM in assessing more complex behaviours than oviposition and phototaxis. We note that Barcode #14 cannot be reliably detected in oviposition experiment. This suggests that the BC 14 fly line might have additional mutations in the attp2 chromosome arm that affects this behavior. Perhaps other barcode lines also have unknown mutations and would cause issues for other untested behaviors. One possible solution is to back-cross all 20 lines with the same genetic background wild-type flies for >7 generations to make all these lines to have the same (or very similar) genetic background. This strategy is common for aging and behavior assays.

      See response to Reviewer #1 and Reviewer #2, item 10, above.

      (2) We were unable to assess the drop-out rates of the TaG-EM barcode from the sequencing. The barcode detection rate is low (Fig S9 and Fig 5F, J and N). This would be a considerable drawback (relating to both experimental design and cost), if a large proportion of the cells could not be assigned an identity.

      See comments above addressing this point.

      (3) The effectiveness of TaG-EM scRNA-seq on the larvae gut is not very effective - the cells are not well annotated, the barcodes seem not to have labelled expected cell types (ECs and EEs), and there is no validation of the Gal4 drivers in vivo.

      See previous comments. We have addressed specific comments above on data processing and annotation, included a visualization of the overall effectiveness of labeling, added a protocol and data on enriched TaG-EM barcode libraries, and have added detailed characterization of the Gal4 drivers in the larval gut (Figure 6, Supplemental Figures 17-21).

      (4) A formal assessment of the cost-effectiveness would be an important consideration in broad uptake of the methodology.

      While this is difficult to do in a comprehensive manner given the breadth of potential applications, we have included estimates of labor savings for one of the behavioral assays that we tested (Supplemental Figure 8). We have also included a discussion of some of the factors that would make TaG-EM useful or cost-effective to apply for behavioral assays (see response to Reviewer #3, comment 3b, above). We have also added the following text to the discussion to address the cost considerations in applying TaG-EM for scRNA-Seq:

      “For single cell RNA-Seq experiments, the cost savings of multiplexing is roughly the cost of a run divided by the number of independent lines multiplexed, plus labor savings by also being able to multiplex upstream flow cytometry, minus loss of unbarcoded cells. Our experiments indicated that for the specific drivers we tested TaG-EM barcodes are detected in around one quarter of the cells if relying on endogenous expression in the gene expression library, though this fraction was higher (~37%) if sequencing an enriched TaG-EM barcode library in parallel (Figure 6, Supplemental Figures 18-19).”

      (5) Similarly, a formal assessment of the effect of the insertion on the variability in GFP expression and the behaviour needs to be documented.

      See responses to Reviewer #1, Reviewer #2, item 9, and Reviewer #3, item 2 above.

      Reviewer #1 (Recommendations For The Authors):

      (in no particular order of importance)

      • L84-85: the authors should either expand, or remove this statement. Indeed, lack of replicates is only true if one ignores that each cell in an atlas is indeed a replicate. Therefore, depending on the approach or question, this statement is inaccurate.

      This sentence was meant to refer to experiments where different experimental conditions are being compared and not to more descriptive studies such as cell atlases. We have revised this sentence to clarify.

      “Outside of descriptive studies, these costs are also a barrier to including replicates to assess biological variability; consequently, a lack of biological replicates derived from independent samples is a common shortcoming of single-cell sequencing experiments.”

      • L103-104: this sentence is unclear.

      We have revised this sentence as follows:

      “Genetically barcoded fly lines can also be used to enable highly multiplexed behavioral assays which can be read out using high throughput sequencing.”

      • In Fig S1 it is unclear why there are more than 20 different sequences in panel B where the text and panel A only mention the generation of 20 distinct constructs. This should be better explained.

      The following text was added to the Figure legend to explain this discrepancy:

      “Because the TaG-EM barcode constructs were injected as a pool of 29 purified plasmids, some of the transgenic lines had inserts of the same construct. In total 20 unique lines were recovered from this round of injection.”

      • It would be interesting to compare the efficiency of TaG-EM driven doublet removal (Fig 5A) with standard doublet-removing software (e.g., DoubletFinder, McGinnis et al., 2019).

      We have done this comparison, which is now shown in Supplemental Figure 15.

      • I would encourage the authors to check whether barcode representation in Fig S13  can be correlated to average library size, as one would expect libraries with shorter reads to be more likely to include the 14-bp barcode and therefore more accurately recapitulate TaG-EM barcode expression.

      These are not independent sequencing libraries, but rather data from barcodes that were multiplexed in a single flow sort, 10x droplet capture, and sequencing library. Thus, there must be some other variable that explains the differential recovery of these barcodes.

      • Fig 4A should appear earlier in the paper.

      We have moved Figure 4A from the previous manuscript (a schematic showing the detailed design of the TaG-EM construct) to Figure 1A in the revised version.

      Reviewer #2 (Recommendations For The Authors):

      Minor:

      (1) There is a typo for Fig S13 figure legends: BC1, BC1, BC3... should be BC1, BC2, BC3.

      Fixed.

      Reviewer #3 (Recommendations For The Authors):

      Comments to authors:

      (1) It would be great if the authors could provide an additional explanation on how these 29 barcode sequences were determined.

      Response: This information is in the Methods section. For the original cloned plasmids:

      “Expected construct size was verified by diagnostic digest with _Eco_RI and _Apa_LI. DNA concentration was determined using a Quant-iT PicoGreen dsDNA assay (Thermo Fisher Scientific) and the randomer barcode for each of the constructs was determined by Sanger sequencing using the following primers:

      SV40_post_R: GCCAGATCGATCCAGACATGA

      SV40_5F: CTCCCCCTGAACCTGAAACA”

      For transgenic flies, after DNA extraction and PCR enrichment (details also in the Methods section):

      “The barcode sequence for each of the independent transgenic lines was determined by Sanger sequencing using the SV40_5F and SV40_PostR primers.”

      (2) Why did the authors choose myr-GFP as the backbone instead of nls-GFP if the downstream application is to perform sequencing?

      We initially chose myr::GFP as we planned to conduct single cell and not single nucleus sequencing and myr::GFP has the advantage of labeling cell membranes which could facilitate the characterization or confirmation of cell type-specific expression, particularly in the nervous system. However, we have considered making a version of the TaG-EM construct with a nuclear targeted GFP (thereby enabling “NucEM”). In the Discussion, we mention this possibility as well as the possibility of using a second nuclear-GFP construct in conjunction with TaG-EM lines is nuclear enrichment is desired:

      “In addition, while the original TaG-EM lines were made using a membrane-localized myr::GFP construct, variants that express GFP in other cell compartments such as the cytoplasm or nucleus could be constructed to enable increased expression levels or purification of nuclei. Nuclear labeling could also be achieved by co-expressing a nuclear GFP construct with existing TaG-EM lines in analogy to the use of hexameric GFP described above.”

      Minor comments:

      (1) Line 193, Supplemental Figure 4 should be Supplemental Figure 5

      Fixed.

      (2) Scale bars should be added in Figure 4, Supplemental Figures 6, 7, and 8A.

      We have added scale bars to these figures and also included scale bars in additional Supplemental Figures detailing characterization of the gut driver lines.

      (3) Were Figure 4C and Supplemental Figure 7 data stained with a GFP antibody?

      No, this is endogenous GFP signal. This is now noted in the Figure legends.

      (4) Line 220, specify the three barcode lines (lines #7, 8, 9) in the text. 

      Added this information.

      Same for Lines 251-254. Line 258, which 8 barcode Gal4 line combinations?

      (5) Line 994, typo: (BC1, BC1, BC3, and BC7)-> (BC1, BC2, BC3, and BC7)

      Fixed.

      (6) Figure 5 F, J and N, add EC-Gal4, EB-Gal4, and EE-Gal4 above each panel to improve readability.

      We have added labels of the cell type being targeted (leftmost panels), the barcode, and the marker gene name to Figure 6 C-N.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      BMP signaling is, arguably, best known for its role in the dorsoventral patterning, but not in nematodes, where it regulates body size. In their paper, Vora et al. analyze ChIP-Seq and RNA-Seq data to identify direct transcriptional targets of SMA-3 (Smad) and SMA-9 (Schnurri) and understand the respective roles of SMA-3 and SMA-9 in the nematode model Caenorhabditis elegans. The authors use publicly available SMA-3 and SMA-9 ChIP-Seq data, own RNA-Seq data from SMA-3 and SMA-9 mutants, and bioinformatic analyses to identify the genes directly controlled by these two transcription factors (TFs) and find approximately 350 such targets for each. They show that all SMA-3-controlled targets are positively controlled by SMA-3 binding, while SMA-9-controlled targets can be either up or downregulated by SMA-9. 129 direct targets were shared by SMA-3 and SMA-9, and, curiously, the expression of 15 of them was activated by SMA-3 but repressed by SMA-9. Since genes responsible for cuticle collagen production were eminent among the SMA-3 targets, the authors focused on trying to understand the body size defect known to be elicited by the modulation of BMP signaling. Vora et al. provide compelling evidence that this defect is likely to be due to problems with the BMP signaling-dependent collagen secretion necessary for cuticle formation.

      We thank the reviewer for this supportive summary. We would like to clarify the status of the publicly available ChIP-seq data. We generated the GFP tagged SMA-3 and SMA‑9 strains and submitted them to be entered into the queue for ChIP-seq processing by the modENCODE (later modERN) consortium. Thus, the publicly available SMA-3 and SMA-9 ChIP-seq datasets used here were derived from our efforts.  Due to the nature of the consortium’s funding, the data were required to be released publicly upon completion. Nevertheless, our current manuscript provides the first comprehensive analysis of these datasets. We have updated the text to clarify this point.

      Strengths:

      Vora et al. provide a valuable analysis of ChIP-Seq and RNA-Seq datasets, which will be very useful for the community. They also shed light on the mechanism of the BMP-dependent body size control by identifying SMA-3 target genes regulating cuticle collagen synthesis and by showing that downregulation of these genes affects body size in C. elegans.

      Weaknesses:

      (1) Although the analysis of the SMA-3 and SMA-9 ChIP-Seq and RNA-Seq data is extremely useful, the goal "to untangle the roles of Smad and Schnurri transcription factors in the developing C. elegans larva", has not been reached. While the role of SMA-3 as a transcriptional activator appears to be quite straightforward, the function of SMA-9 in the BMP signaling remains obscure. The authors write that in SMA-9 mutants, body size is affected, but they do not show any data on the mechanism of this effect.

      We thank the reviewer for directing our attention to the lack of clarity about SMA-9’s function. We have revised the text to highlight what this study and others demonstrate about SMA-9’s role in body size. Simply stated, SMA-9 is needed together with SMA-3 to promote the expression of genes involved in one-carbon metabolism, collagens, and chaperones, all of which are required for body size. SMA-3 has additional, SMA-9-independent transcriptional targets, including chaperones and ER secretion factors, that also contribute to body size. Finally, SMA-9 regulates additional targets independent of SMA-3 that likely have a minimal role in body size. We have adjusted Figure 5 with new graphs of the original data to make these points more clear.

      (2) The authors clearly show that both TFs can bind independently of each other, however, by using distances between SMA-3 and SMA-9 ChIP peaks, they claim that when the peaks are close these two TFs act as complexes. In the absence of proof that SMA-3 and SMA-9 physically interact (e.g. that they co-immunoprecipitate - as they do in Drosophila), this is an unfounded claim, which should either be experimentally substantiated or toned down.

      We acknowledge that we have not demonstrated a physical interaction between SMA-3 and SMA-9 through a co-immunoprecipitation, and we have indicated in the text that a formal biochemical demonstration would be required to make this point. Moreover, we toned down the text by stating that our results suggest that either SMA-3 and SMA-9 frequently bind as either subunits in a complex or in close vicinity to each other along the DNA. As the reviewer has indicated, a physical interaction between Smads and Schnurris has been amply demonstrated in other systems. A limitation in these previous studies is that only a small number of target genes were analyzed. Our goal in this study was to determine how widespread this interaction is on a genomic scale. Our analyses demonstrate for the first time that a Schnurri transcription factor has significant numbers of both Smad-dependent and Smad-independent target genes. We have revised the text to clarify this point.

      (3) The second part of the paper (the collagen story) is very loosely connected to the first part. dpy-11 encodes an enzyme important for cuticle development, and it is a differentially expressed direct target of SMA-3. dpy-11 can be bound by SMA-9, but it is not affected by this binding according to RNA-Seq. Thus, technically, this part of the paper does not require any information about SMA-9. However, this can likely be improved by addressing the function of the 15 genes, with the opposing mode of regulation by SMA-3 and SMA-9.

      We appreciate this suggestion and have clarified in the text how SMA-9 contributes to collagen organization and body size regulation.

      (4) The Discussion does not add much to the paper - it simply repeats the results in a more streamlined fashion.

      We thank the reviewer for this suggestion. We have added more context to the Discussion.

      Reviewer #2 (Public Review):

      In the present study, Vora et al. elucidated the transcription factors downstream of the BMP pathway components Smad and Schnurri in C. elegans and their effects on body size. Using a combination of a broad range of techniques, they compiled a comprehensive list of genome-wide downstream targets of the Smads SMA-3 and SMA-9. They found that both proteins have an overlapping spectrum of transcriptional target sites they control, but also unique ones. Thereby, they also identified genes involved in one-carbon metabolism or the endoplasmic reticulum (ER) secretory pathway. In an elaborate effort, the authors set out to characterize the effects of numerous of these targets on the regulation of body size in vivo as the BMP pathway is involved in this process. Using the reporter ROL-6::wrmScarlet, they further revealed that not only collagen production, as previously shown, but also collagen secretion into the cuticle is controlled by SMA-3 and SMA-9. The data presented by Vora et al. provide in-depth insight into the means by which the BMP pathway regulates body size, thus offering a whole new set of downstream mechanisms that are potentially interesting to a broad field of researchers.

      The paper is mostly well-researched, and the conclusions are comprehensive and supported by the data presented. However, certain aspects need clarification and potentially extended data.

      (1) The BMP pathway is active during development and growth. Thus, it is logical that the data shown in the study by Vora et al. is based on L2 worms. However, it raises the question of if and how the pattern of transcriptional targets of SMA-3 and SMA-9 changes with age or in the male tail, where the BMP pathway also has been shown to play a role. Is there any data to shed light on this matter or are there any speculations or hypotheses?

      We agree that these are intriguing questions, and we are interested in the roles of transcriptional targets at other developmental stages and in other physiological functions, but these analyses are beyond the scope of the current study.

      (2) As it was shown that SMA-3 and SMA-9 potentially act in a complex to regulate the transcription of several genes, it would be interesting to know whether the two interact with each other or if the cooperation is more indirect.

      A physical interaction between Smads and Schnurri has been amply demonstrated in other systems. Our goal in this study was not to validate this physical interaction, but to analyze functional interactions on a genome-wide scale.

      (3) It would help the understanding of the data even more if the authors could specifically state if there were collagens among the genes regulated by SMA-3 and SMA-9 and which.

      We thank the reviewer for this suggestion. col-94 and col-153 were identified as direct targets of both SMA-3 and SMA-9. We noted this in the Discussion.

      (4) The data on the role of SMA-3 and SMA-9 in the regulation of the secretion of collagens from the hypodermis is highly intriguing. The authors use ROL-6 as a reporter for the secretion of collagens. Is ROL-6 a target of SMA-9 or SMA-3? Even if this is not the case, the data would gain even more strength if a comparable quantification of the cuticular levels of ROL-6 were shown in Figure 6, and potentially a ratio of cuticular versus hypodermal levels. By that, the levels of secretion versus production can be better appreciated.

      We previously showed that rol-6 mRNA levels are reduced in dbl-1 mutants at L2, but RNA-seq analysis did not find enough of a statistically significant change in rol-6 to qualify it as a transcriptional target and total levels of protein are also not significantly reduced in mutants. We added this information in the text.

      (5) It is known that the BMP pathway controls several processes besides body size. The discussion would benefit from a broader overview of how the identified genes could contribute to body size. The focus of the study is on collagen production and secretion, but it would be interesting to have some insights into whether and how other identified proteins could play a role or whether they are likely to not be involved here (such as the ones normally associated with lipid metabolism, etc.).

      We have added more information to the Discussion.

      Reviewer #1 (Recommendations For The Authors):

      Figure 1 - Figure 3: The authors might want to think about condensing this into two figures.

      To avoid confusion with the different workflows, we prefer to keep these as three separate figures.

      Figure 1a-b: Measurement unit missing on X.

      We added the unit “bps” to these graphs.

      Line 244-246: The authors should stress in the Results that they analyzed publicly available ChIP-Seq data, which was not generated by them, - not just by providing a reference to Kudron et al., 2018. As far as I understood, ChIP was performed with an anti-GFP antibody. Please mention this, and specify the information about the vendor and the catalog number in the Methods.

      We would like to clarify the status of the publicly available ChIP-seq data. We generated the GFP tagged SMA-3 and SMA‑9 strains and submitted them to be entered into the queue for ChIP-seq processing by the modENCODE (later modERN) consortium. Thus, the publicly available SMA-3 and SMA-9 ChIP-seq datasets used here were derived from our efforts.  Due to the nature of the consortium’s funding, the data were required to be released publicly upon completion. Nevertheless, our current manuscript provides the first comprehensive analysis of these datasets. We have clarified these issues in the text.  We have also added information regarding the anti-GFP antibody to the Methods.

      Line 267-270: The authors should either provide experimental evidence that SMA-3 and SMA-9 form complexes or write something like "significant overlap between SMA-3 and SMA-9 peaks may indicate complex formation between these two transcription factors as shown in Drosophila" - but in the absence of proof, this must be a point for the Discussion, not for the Results. Moreover, similar behavior of fat-6 (overlapping ChIP peaks) and nhr-114 (non-overlapping ChIP peaks) in SMA-3 and SMA-9 mutants may be interpreted as a circumstantial argument against SMA-3/SMA-9 complex formation (see Lines 342-348). Importantly, since ChIP-Seq data are available for a wide array of C. elegans TFs, it would be very useful to have an estimate of whether SMA-3/SMA-9 peak overlap is significantly higher than the peak overlap between SMA-3 and several other TFs expressed at the same L2 stage.

      We have clarified our goals regarding SMA-3 and SMA-9 interactions and softened our conclusions by indicating in the text that a formal biochemical demonstration would be required to demonstrate a physical interaction. Moreover, we toned down the text by stating that our results suggest that either SMA-3 and SMA-9 frequently bind as either subunits in a complex or in close vicinity to each other along the DNA. We have added an analysis of HOT sites to address overlap of binding with other transcription factors. We disagree with the interpretation that transcription factors with non-overlapping sites cannot act together to regulate gene expression; however, nhr-114 also has an overlapping SMA-3 and SMA-9 site, so this point becomes less relevant. We have clarified the categorization of nhr-114 in the text.

      Lines 272-292: The authors do not comment on the seemingly quite small overlap between the RNA-Seq and the ChIP-Seq dataset, but I think they should. They have 3205 SMA-3 ChIP peaks and 1867 SMA-3 DEGs, but the amount of directly regulated targets is 367. It is important that the authors provide information on the number of genes to which their peaks have been assigned. Clearly, this will not be one gene per peak, but if it were, this would mean that just 11.5% of bound targets are really affected by the binding. The same number would be 4.7% for the SMA-9 peaks.

      We have added a discussion of the discrepancy between binding sites and DEGs. The high number of additional sites classified as non-functional could represent the detection of weak affinity targets that do not have an actual biological purpose. Alternatively, these sites could have an additional role in DBL-1 signaling besides transcriptional regulation of nearby genes, or they could be regulating the expression of target genes at a far enough distance to not be detected by our BETA analysis as per the constraints chosen for the analysis. The difference between total binding sites and those associated with changes in gene expression underscores the importance of combining RNA-seq with ChIP-seq to identify the most biologically relevant targets. And as the reviewer indicated, more than one gene can be assigned to a single neighboring peak.

      Lines 294-323: I feel like there is a terminology problem, which makes reading very difficult. The authors use "direct targets" as bound genes with significant expression change, but then run into a problem when the gene is bound by SMA-9 and SMA-3, but significant expression change is only associated with one of the two factors. I am not sure this is consistent with the idea of the SMA3/SMA9 complex. Also, different modalities of the SMA3 and SMA9 effect in 15 cases can be explained by co-factors. Reading would be also simplified if the order of the panels in Figure 3 were different. Currently, the authors start their explanation by referring to the shared SMA-3/SMA-9 targets (Figures 3c-d), and only later come to Figure 3b. In general, the authors should start with a clear explanation of what is on the figure (currently starting on Line 313), otherwise, it is unclear why, if the authors only discuss common targets, it is not just 114+15=129 targets, but more.

      We have re-ordered the columns in Figure 3 to match the order discussed in the text. We also incorporated more precise language about regulation by SMA-3 and/or SMA-9 in the text.

      Lines 325-355: The chapter has a rather unfortunate name "Mechanisms of integration of SMA-3 and SMA-9 function", although the authors do not provide any mechanism. Using 3 target genes, they show that if the regulatory modality of SMA-3 and SMA-9 is the same (2 examples), there is no difference in the expression of the targets, but if the modalities are opposing (1 example), SMA-9 repressive action is epistatic to the SMA-3 activating action. Can this be generalized? The authors should test all their 15 targets with opposite regulations. Moreover, it seems obvious to ask whether the intermediate phenotype of the double-mutants can be attributed to the action of these 15 genes activated by SMA-3 and repressed by SMA-9. I would suggest testing this by RNAi. I would also suggest renaming the chapter to something better reflecting its content.

      We have removed the word “mechanism” from the title of this section. We also performed additional RT-PCR experiments on another 5 targets with opposing directions of regulation. The results from these genes are consistent with the result from C54E4.5, demonstrating that the epistasis of sma-9 is generalizable.

      Figure 4b: Why was a two-way ANOVA performed here? With the small number of measurements, I would consider using a non-parametric test.

      These data are parametric and the distribution of the data is normal, so we chose to use a parametric test (ANOVA).

      Lines 354-355. The authors offer two suggestions for the mechanism of the epistatic action of SMA-9 on SMA-3 in the case of C54E4.5, but this is something for the Discussion. If they want to keep it in the Results they should address this experimentally by performing SMA-3 ChIP-seq in the SMA-9 mutants and SMA-9 ChIP-Seq in the SMA-3 mutants.

      We moved these models to the discussion as suggested.

      Lines 365-367: "We expect that clusters of genes involved in fatty acid metabolism and innate immunity mediate the physiological functions of BMP signaling in fat storage and pathogen resistance, respectively." - This is pretty confusing since the Authors claim in the previous sentence that regulation of immunity by SMA-9 is TGF-beta independent.

      Co-regulation of immunity by BMP signaling and SMA-9 is already known. The novel insight is that SMA-9 may have an additional independent role in immunity. We have clarified the language to address this confusion.

      Lines 377, and 380: Please explain in non-C. elegans-specific terminology, what rrf-3 and LON-2 are (e.g. write "glypican LON-2" instead of just "LON-2") and add relevant references.

      We added information on the proteins encoded by these genes.

      Lines 382-384: I am not sure what the Authors mean here by "more limiting".

      We substituted the phrase “might have a more prominent requirement in mediating the exaggerated growth defect of a lon-2 mutant”.

      Lines 388-392: I found this very confusing. What were these 36 genes? Were these direct targets of SMA-3, SMA-9, or both? Top 36 targets? 36 targets for which mutants are available?

      The new Figure 5 clarifies whether target genes are SMA-3-exclusive, SMA-9-exclusive, or co-regulated. The text was also updated for clarity.

      Line 397: This is the first time the authors mention dpy-11 but they do not say what it is until later, and they do not say whether it is a target of SMA3/SMA9. Checking Figure 3, I found that it is among the 238 genes bound by both but upregulated only by SMA3. The authors need to explicitly state this - from this point on, they have a section for which SMA-9 appears to be irrelevant.

      We added the molecular function of dpy-11 at its first mention. Furthermore, we included the hypothesis that SMA-3 may regulate collagen secretion independently of SMA-9. Our subsequent results with sma-9 mutants disprove this hypothesis.

      Line 402: Is ROL-6 a SMA-3/SMA-9 target or just a marker gene?

      We previously showed that rol-6 mRNA levels are reduced in dbl-1 mutants at L2, but RNA-seq analysis did not find enough of a statistically significant change in rol-6 to qualify it as a transcriptional target and total levels of protein are also not significantly reduced in mutants. We added this information in the text.

      Line 421: I am not sure what "more skeletonized" means.

      Replaced with “thinner and skeletonized”

      Figure 2b and 2d legends: "Non-target genes nevertheless showing differential expression are indicated with green squares." (l. 581-582 and again l. 588-589) I think should be "Non-direct target genes...".

      Changed to “non-direct target genes”

      Figure 7 legend: Please indicate the scale bar size in the legend.

      Indicated the scale bar size in the legend.

      Figure 7: The ER marker is referred to as "ssGFP::KDEL" (in the image and Line 700), however in the text it is called "KDEL::oxGFP" (Line 419). Please use consistent naming.

      We fixed the inconsistent naming.

      All the experiment suggestions made are optional and can, in principle, be ignored if the authors tone down their claims (for example, the SMA-3/SMA-9 complex formation).

      Reviewer #2 (Recommendations For The Authors):

      (1) As a control: Have the authors found the known regulated genes among the differentially regulated ones?

      Previously known target genes such as fat-6 and zip-10 were identified here. We have added this information in the text.

      (2) How many repetitions were performed in Figure 4b? I am wondering as the deviation for C54E4.5 is quite large and that makes me worry that the significant differences stated are not robust.

      There were two biologically independent collections from which three cDNA syntheses were analyzed using two technical replicates per point.

      (3) Lines 333-336: Can you really make this claim that the antagonistic effects seen in the regulation of body size can be correlated with some targets being regulated in the opposite direction? I would assume that the situation is far more complex as SMADs also regulate other processes.

      We agree with the reviewer that multiple models could explain this antagonism, and we have added distinct alternatives in the text.

      (4) Lines 367-369: Add the respective reference please.

      We have added the relevant references.

    1. Author response:

      We are both honored and humbled by the high praise our work received from all three reviewers. Below, we address the common comments made by the reviewers:

      (1) Value and Impact of the Resource: We are grateful for the recognition of our dataset as a valuable and high-quality resource. Our primary goal was to generate a comprehensive dataset on protein abundance and phosphorylation dynamics during Xenopus oocyte maturation. We are pleased that this work has been seen as a solid foundation for future studies in Xenopus research and beyond, with broader implications for oocyte and cell cycle biology.

      (2) Focus on Functional Validation and Contextualization with Prior Studies: The manuscript was submitted as a Tools and Resources article, a format that emphasizes the creation and presentation of datasets, tools, and methodological advances to facilitate future discoveries. In alignment with this format, we ensured that the information is accessible and deployable for the broader scientific community. While we did not include functional validation of specific pathways, the dataset provides a robust framework for generating numerous testable hypotheses. We plan to pursue some of these follow-up studies in our labs and encourage the community to explore these further.

      (3) Contextualization with Prior Studies: We appreciate the recognition of our efforts to integrate our findings with the existing body of literature. In conclusion, we would like to thank the reviewers for their evaluation and thoughtful suggestions. We look forward to seeing how this dataset contributes to future discoveries in the field.

    1. Author response:

      eLife Assessment:

      In this important study, the authors combine innovative experimental approaches, including direct compressibility measurements and traction force analyses, with theoretical modeling to propose that wild-type cells exert compressive forces on softer HRasV12-transformed cells, influencing competition outcomes. The data generally provide solid evidence that transformed epithelial cells exhibit higher compressibility than wild-type cells, a property linked to their compaction during mechanical cell competition. However, the study would benefit from further characterization of how compression affects the behavior of HRasV12 cells and clearer causal links between compressibility and competition outcomes.

      We thank the reviewers and the editor for their thoughtful and encouraging feedback on our study and for appreciating the innovation in our experimental and theoretical approaches. We acknowledge the importance of further clarifying the mechanistic links between the compressibility of HRas<sup>V12</sup>-transformed cells, their compaction, and the outcomes of mechanical cell competition. In the revised manuscript, we will include additional experiments and analyses to assess how compression influences the cellular behavior and fate of HRas<sup>V12</sup>-transformed cells during competition. In addition, to strengthen the connection between collective compressibility and competition outcomes, we will integrate quantitative analyses of cell dynamics and additional modeling to explicitly correlate the mechanical properties with the spatial and temporal aspects of cell elimination. These additions will address the reviewer’s concerns comprehensively, further enriching the mechanistic understanding presented in the manuscript.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this article, Gupta and colleagues explore the parameters that could promote the elimination of active Ras cells when surrounded by WT cells. The elimination of active Ras cells by surrounding WT cells was previously described extensively and associated with a process named cell competition, a context dependant elimination of cells. Several mechanisms have been associated with competition, including more recently elimination processes based on mechanical stress. This was explored theoretically and experimentally and was either associated with differential growth and sensitivity to pressure and/or differences in homeostatic density/pressure. This was extensively validated for the case of Scribble mutant cells which are eliminated by WT MDCK cells due to their higher homeostatic density. However, there has been so far very little systematic characterisation of the mechanical parameters and properties of these different cell types and how this could contribute to mechanical competition.

      Here, the authors used the context of active Ras cells in MDCK cells (with some observations in vivo in mice gut which are a bit more anecdotal) to explore the parameters causal to Ras cell elimination. Using for the first time traction force microscopy, stress microscopy combined with Bayesian inference, they first show that clusters of active Ras cells experience higher pressure compared to WT. Interestingly, this occurs in absence of differences in growth rate, and while Ras cells seems to have lower homeostatic density, in contractions with the previous models associated with mechanical cell competition. Using a self-propelled Voronoi model, they explored more systematically the conditions that will promote the compression of transformed cells, showing globally that higher Area compressibility and/or lower junctional tension are associated with higher compressibility. Using then an original and novel experimental method to measure bulk compressibility of cell populations, they confirmed that active Ras cells are globally twice more compressible than WT cells. This compressibility correlates with a disruption of adherens junctions. Accordingly, the higher pressure near transformed Ras cells can be completely rescued by increasing cell-cell adhesion through E-cad overexpression, which also reduces the compressibility of the transformed cells. Altogether, these results go along the lines of a previous theoretical work (Gradeci et al. eLife 2021) which was suggesting that reduced stiffness/higher compressibility was essential to promote loser cell elimination. Here, the authors provide for the first time a very convincing experimental measurement and validation of this prediction. Moreover, their modelling approach goes far beyond what was performed before in terms of exploration of conditions promoting compressibility, and their experimental data point at alternative mechanisms that may contribute to mechanical competition.

      Strengths:

      - Original methodologies to perform systematic characterisation of mechanical properties of Ras cells during cell competition, which include a novel method to measure bulk compressibility.<br /> - A very extensive theoretical exploration of the parameters promoting cell compaction in the context of competition.

      We thank the reviewer for their detailed and thoughtful assessment of our study and for recognizing the originality of our methodologies, including the novel bulk compressibility measurement technique and the extensive theoretical exploration of parameters influencing mechanical competition. We are pleased that the reviewer finds our experimental validation and modeling approach convincing and acknowledges the relevance of our findings in advancing the understanding of mechanical cell competition. We will carefully address all the points raised to further clarify and strengthen the manuscript.

      Weaknesses:

      - Most of the theoretical focus is centred on the bulk compressibility, but so far does not really explain the final fate of the transformed cells. Classic cell competition scenario (including the one involving active Ras cells) lead to the elimination of one cell population either by cell extrusion/cell death or global delamination. This aspect is absolutely not explored in this article, experimentally or theoretically, and as such it is difficult to connect all the observables with the final outcome of cell competition. For instance, higher compressibility may not lead to loser status if the cells can withstand high density without extruding compared to the WT cells (and could even completely invert the final outcome of the competition). Down the line, and as suggested in most of the previous models/experiments, the relationship between pressure/density and extrusion/death will be the key factor that determine the final outcome of competition. However, there is absolutely no characterisation of cell death/cell extrusion in the article so far.

      We thank the reviewer for highlighting this important point. We agree that understanding the relationship between pressure, density, and the final outcomes of cell competition, such as extrusion and cell death, is crucial to connecting the mechanical properties to competition outcomes. While extrusion and cell death have been extensively characterized in previous works (e.g., https://www.nature.com/articles/s41467-021-27896-z; https://www.nature.com/articles/ncb1853), we nevertheless recognize the need to address this aspect more explicitly in our study. To this end, we have indeed performed experiments to characterize cell extrusion and cell death under varying conditions of pressure and density. We will incorporate these data into the revised manuscript. These additions will provide a more comprehensive understanding of how mechanical imbalance drives cell competition and determine the final fate of transformed cells.

      - While the compressibility measurement are very original and interesting, this bulk measurement could be explained by very different cellular processes, from modulation of cell shape, to cell extrusion and tissue multilayering (which by the way was already observed for active Ras cells, see for instance https://pubmed.ncbi.nlm.nih.gov/34644109/). This could change a lot the interpretation of this measurement and to which extend it can explain the compression observed in mixed culture. This compressibility measurement could be much more informative if coupled with an estimation of the change of cell aspect ratio and the rough evaluation of the contribution of cell shape changes versus alternative mechanisms.

      We thank the reviewer for raising this important concern. In our model system and within the experimental timescale of our studies involving gel compression microscopy (GCM) experiments, we do not observe tissue multilayering and cell extrusion, as these measurements are performed on homogeneous populations (pure wild-type or pure transformed cell monolayer). However, to address the reviewer’s suggestion, we will include measurements of cell aspect ratio as well as images eliminating the possibility of multilayering/extrusion in the revised manuscript. These results will provide additional insights into the plausible contributions of cell shape changes. Furthermore, our newer results indicate that the compressibility differences arise from variations in the intracellular organization (changed in nuclear and cytoskeletal organization) between wild-type and transformed cells. While a detailed molecular characterization of these underlying mechanisms is beyond the scope of the current manuscript, we acknowledge its importance and plan to explore it in a future study. These revisions will clarify and strengthen the interpretation of our findings.

      - So far, there is no clear explanation of why transformed Ras cells get more compacted in the context of mixed culture compared to pure Ras culture. Previously, the compaction of mutant Scribble cells could be explained by the higher homeostatic density of WT cells which impose their prefered higher density to Scribble mutant (see Wagstaff et al. 2016 or Gradeci et al 2021), however that is not the case of the Ras cells (which have even slightly higher density at confluency). If I understood properly, the Voronoid model assumes some directional movement of WT cell toward transformed which will actively compact the Ras cells through self-propelled forces (see supplementary methods), but this is never clearly discussed/described in the results section, while potentially being one essential ingredient for observing compaction of transformed cells. In fact, this was already described experimentally in the case of Scribble competition and associated with chemoattractant secretion from the mutant cells promoting directed migration of the WT (https://pubmed.ncbi.nlm.nih.gov/33357449/). It would be essential to show what happens in absence of directional propelled movement in the model and validate experimentally whether there is indeed directional movement of the WT toward the transformed cells. Without this, the current data does not really explain the competition process.

      We introduced directional movement of wild-type cells towards neighbouring transformed cells (and a form of active force to be exerted by them), motivated by the tissue compressibility measurements from the Gel Compression Microscopy experiments (Fig. 4E-L). This allowed us to devise an equivalent method of measuring the material response to isotropic compression within the SPV model framework. While the role of directional propelled movement is an area of ongoing investigation and has not been explored extensively within the current study, we emphasize that even without directional propulsion in the model, our results demonstrate compressive stress or elevated pressure, and increased compaction within the transformed population under suitable conditions reported in this work (when k<1), exhibiting a greater tissue-level compressibility in the transformed cells compared to WT cells (Figs. 4C-D), thereby laying the ground for competition. To clarify these concerns, we will provide additional results as well as detailed discussions on the effect of cell movements in compression.

      - Some of the data lack a bit of information on statistic, especially for all the stress microscopy and traction forces where we do no really know how representative at the stress patterns (how many experiment, are they average of several movies ? integrated on which temporal window ?)

      We thank the reviewer for highlighting the need for additional details regarding the statistical representation of our stress microscopy and traction force data. We will address these concerns in the revised manuscript by providing clear descriptions of the number of experiments, the averaging methodology, and the temporal windows used for analysis. Currently, Figs. 2A and 2C represent data from single time points, as the traction and stress landscapes evolve dynamically as transformed cells begin extruding (as shown in Supplementary movie 1). In contrast, Fig. 2H represents data collected from several samples across three independent experiments, all measured at the 3-hour time point following doxycycline induction. This specific time point is critical because it captures the emergence of compressive stresses before extrusion begins, simplifying the analysis and ensuring consistency. We will ensure these details are clearly articulated in the revised text and figure legends.

      Reviewer #2 (Public review):

      The work by Gupta et al. addresses the role of tissue compressibility as a driver of cell competition. The authors use a planar epithelial monolayer system to study cell competition between wild type and transformed epithelial cells expressing HRasV12. They combine imaging and traction force measurements from which the authors propose that wild type cells generate compressive forces on transformed epithelial cells. The authors further present a novel setup to directly measure the compressibility of adherent epithelial tissues. These measurements suggest a higher compressibility of transformed epithelial cells, which is causally linked to a reduction in cell-cell adhesion in transformed cells. The authors support their conclusions by theoretical modelling using a self-Propelled Voronoi model that supports differences in tissue compressibility can lead to compression of the softer tissue type.

      The experimental framework to measure tissue compressibility of adherent epithelial monolayers establishes a novel tool, however additional controls of this measurement appear required. Moreover, the experimental support of this study is mostly based on single representative images and would greatly benefit from additional data and their quantitative analysis to support the authors' conclusions. Specific comments are also listed in the following:

      Major points:

      It is not evident in Fig2A that traction forces increase along the interface between wild type and transformed populations and stresses in Fig2C also seem to be similar at the interface and surrounding cell layer. Only representative examples are provided and a quantification of sigma_m needs to be provided.

      In Figure 1-3 only panel 2G and 2H provide a quantitative analysis, but it is not clear how many regions of interest and clusters of transform cells were quantified.

      We thank the reviewer for their detailed comments and for highlighting the importance of additional quantitative analyses to support our conclusions. We appreciate their recognition of our novel experimental framework to measure tissue compressibility and the overall approach of our study. Regarding Fig. 2A and Fig. 2C, we acknowledge the need for further clarity. While the traction forces and stress patterns may not appear uniformly distinct at the interface in the representative images, these differences are more evident at specific time points before extrusion begins. Please note that the traction and stress landscapes evolve dynamically as transformed cells begin extruding (as shown in Supplementary movie 1). We will include a quantification of σ<sub>m</sub>​ and additional data from multiple experiments to substantiate the observations and address this concern in the revised manuscript. Currently, the data in Fig. 2G and Fig. 2H represent several regions of interest and transformed cell clusters collected from three independent experiments, all analyzed at the 3-hour time point after doxycycline induction. This time point was chosen because it captures the compressive stress emergence without interference from extrusion processes, simplifying the analysis. We will expand these sections with detailed descriptions of the sample sizes and statistical analyses to ensure greater transparency and reproducibility. These revisions will provide a stronger quantitative foundation for our findings and address the reviewer's concerns.

      Several statements appear to be not sufficiently justified and supported by data.<br /> For example the statement on pg 3. line 38 seems to lack supportive data 'This comparison revealed that the thickness of HRasV12-expressing cells was reduced by more than 1.7-fold when they were surrounded by wild type cells. These observations pointed towards a selective, competition-dependent compaction of HRasV12-expressing transformed cells but not control cells, in the intestinal villi of mice.'  Similarly, the statement about a cell area change of 2.7 fold (pg 3 line 47) lacks support by measurements.

      We thank the reviewer for pointing out the need for more supportive data to justify several statements in the manuscript. Specifically, the observation regarding the reduction in the thickness of HRas<sup>V12</sup>-expressing cells by more than 1.7-fold when surrounded by wild-type cells, and the statement about a 2.7-fold change in cell area, will be supported by detailed measurements. In the revised manuscript, we will include quantitative analyses with additional figures that clearly document these changes. These figures will provide representative images, statistical summaries, and detailed descriptions of the measurements to substantiate these claims. We appreciate the reviewer highlighting these areas and will ensure that all statements are robustly backed by data.

      What is the rationale for setting 𝐾p = 1 in the model assumptions if clear differences in junctional membranes of transformed versus wild type cells occur, including dynamic ruffling? This assumption does not seem to be in line with biological observations.

      While the specific role of K<sub>p</sub> in the differences observed in the junctional membranes of transformed versus WT cells, including dynamical ruffling, is not directly studied in this work, our findings indicate that the lower junctional tension (weaker and less stable cellular junctions) in mutant cells is influenced primarily by competition in the dimensionless cell shape index within the model. This also suggests a larger preferred cell perimeter (P<sub>0</sub>) for mutant cells, corresponding to their softer, unjammed state. Huang et al. (https://doi.org/10.1039/d3sm00327b) have previously argued that a high P<sub>0</sub> may, in some cases, result from elevated cortical tension along cell edges, or reflect weak membrane elasticity, implying a smaller K<sub>p</sub>. While this connection could be an intriguing avenue for future exploration, we emphasize that K<sub>p</sub> is not expected to alter any of the key findings or conclusions reported in this work. We will include any required analysis and corresponding discussions in the revised manuscript.

      The novel approach to measure tissue compressibility is based on pH dependent hydrogels. As the pH responsive hydrogel pillar is placed into a culture medium with different conditions, an important control would be if the insertion of this hydrogel itself would change the pH or conditions of the culture assays and whether this alters tissue compressibility or cell adhesion. The authors could for example insert a hydrogel pillar of a smaller diameter that would not lead to compression or culture cells in a larger ring to assess the influence of the pillar itself.

      We appreciate the reviewer’s insightful comment regarding the potential effects of the pH-responsive hydrogel pillar on the culture conditions and tissue compressibility. In our experiments, the expandable hydrogels are kept separate from the cells until the pH of the hydrogel is elevated to 7.4, ensuring that the hydrogel does not impact the culture environment. However, we acknowledge the concern and will include additional controls in the revised manuscript. Specifically, we will insert a hydrogel pillar with a smaller diameter that would not induce compression on culture cells in a larger ring to assess any potential influence of the hydrogel pillar itself. This will help to further validate our experimental setup.

      The authors focus on the study of cell compaction of the transformed cells, but how does this ultimately lead to a competitive benefit of wild type cells? Is a higher rate of extrusion observed and associated with the compaction of transformed cells or is their cell death rate increased? While transformed cells seem to maintain a proliferative advantage it is not clear which consequences of tissue compression ultimately drive cell competition between wild type and transformed cells.

      We thank the reviewer for highlighting this important point. We agree that understanding how tissue compression leads to a competitive advantage for wild type cells is crucial. While our current study focuses on the mechanical properties of transformed cells leading to the compaction and subsequent extrusion of the transformed cells, we recognize the need to explicitly connect these properties to the final outcomes of cell competition, such as extrusion or cell death. Although extrusion and cell death have been extensively characterized in previous studies (e.g., https://www.nature.com/articles/s41467-021-27896-z; https://www.nature.com/articles/ncb1853), we have indeed performed additional experiments to investigate the relationship between pressure, density, and these processes in our system. In the revised manuscript, we will include these new data, which will help to clarify how mechanical stress, driven by tissue compression, contributes to the competition between wild type and transformed cells and influences their eventual fate.

      The argumentation that softer tissues would be more easily compressed is plausible. However, which mechanism do the authors suggest is generating the actual compressive stress to drive the compaction of transformed cells? They exclude a proliferative advantage of wild type cells, which other mechanisms will generate the compressive forces by wild type cells?

      We thank the reviewer for raising this important question. As rightly pointed out by the reviewer indeed in our model system, we do not observe a proliferative advantage for the wild-type cells, and the compressive forces exerted by the wild-type cells are due to their intrinsic mechanical properties, such as lesser compressibility compared to the transformed cells. This difference in compressibility results in wild-type cells generating compressive stress at the interface with the transformed cells. Regarding the mechanism underlying the increased compressibility of the transformed cells, our newer findings indicate that the differences in compressibility arise from variations in the intracellular organization, specifically changes in nuclear and cytoskeletal organization between wild-type and transformed cells. While a detailed molecular characterization of these mechanisms is beyond the scope of the current manuscript, we acknowledge its significance and plan to investigate it in future work. We will, nevertheless, include a detailed discussion on the mechanism underlying the differential compressibility of wild-type and transformed cells in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      The revised manuscript contains new results and additional text. Major revisions:

      (1) Additional simulations and analyses of networks with different biophysical parameters and with identical time constants for E and I neurons (Methods, Supplementary Fig. 5).

      (2) Additional simulations and analyses of networks with modifications of connectivity parameters to further analyze effects of E/I assemblies on manifold geometry (Supplementary Fig. 6).

      (3) Analysis of synaptic current components (Figure 3 D-F; to analyze mechanism of modest amplification in Tuned networks). 

      (4) More detailed explanation of pattern completion analysis (Results).

      (5) Analysis of classification performance of Scaled networks (Supplementary Fig.8).

      (6) Additional analysis (Figure 5D-F) and discussion (particularly section “Computational functions of networks with E/I assemblies”) of functional benefits of continuous representations in networks with E-I assemblies. 

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Meissner-Bernard et al present a biologically constrained model of telencephalic area of adult zebrafish, a homologous area to the piriform cortex, and argue for the role of precisely balanced memory networks in olfactory processing. 

      This is interesting as it can add to recent evidence on the presence of functional subnetworks in multiple sensory cortices. It is also important in deviating from traditional accounts of memory systems as attractor networks. Evidence for attractor networks has been found in some systems, like in the head direction circuits in the flies. However, the presence of attractor dynamics in other modalities, like sensory systems, and their role in computation has been more contentious. This work contributes to this active line of research in experimental and computational neuroscience by suggesting that, rather than being represented in attractor networks and persistent activity, olfactory memories might be coded by balanced excitation-inhibitory subnetworks. 

      Strengths: 

      The main strength of the work is in: (1) direct link to biological parameters and measurements, (2) good controls and quantification of the results, and (3) comparison across multiple models. 

      (1) The authors have done a good job of gathering the current experimental information to inform a biological-constrained spiking model of the telencephalic area of adult zebrafish. The results are compared to previous experimental measurements to choose the right regimes of operation. 

      (2) Multiple quantification metrics and controls are used to support the main conclusions and to ensure that the key parameters are controlled for - e.g. when comparing across multiple models.  (3) Four specific models (random, scaled I / attractor, and two variant of specific E-I networks - tuned I and tuned E+I) are compared with different metrics, helping to pinpoint which features emerge in which model. 

      Weaknesses: 

      Major problems with the work are: (1) mechanistic explanation of the results in specific E-I networks, (2) parameter exploration, and (3) the functional significance of the specific E-I model. 

      (1) The main problem with the paper is a lack of mechanistic analysis of the models. The models are treated like biological entities and only tested with different assays and metrics to describe their different features (e.g. different geometry of representation in Fig. 4). Given that all the key parameters of the models are known and can be changed (unlike biological networks), it is expected to provide a more analytical account of why specific networks show the reported results. For instance, what is the key mechanism for medium amplification in specific E/I network models (Fig. 3)? How does the specific geometry of representation/manifolds (in Fig. 4) emerge in terms of excitatory-inhibitory interactions, and what are the main mechanisms/parameters? Mechanistic account and analysis of these results are missing in the current version of the paper. 

      We agree that further mechanistic insights would be of interest and addressed this issue at different levels:

      (1) Biophysical parameters: to determine whether network behavior depends on specific choices of biophysical parameters in E and I neurons we equalized biophysical parameters across neuron types. The main observations are unchanged, suggesting that the observed effects depend primarily on network connectivity (see also response to comment [2]).

      (2) Mechanism of modest amplification in E/I assemblies: analyzing the different components of the synaptic currents demonstrate that the modest amplification of activity in Tuned networks results from an “imperfect” balance of recurrent excitation and inhibition within assemblies (see new Figures 3D-F and text p.7). Hence, E/I co-tuning substantially reduces the net amplification in Tuned networks as compared to Scaled networks, thus preventing discrete attractor dynamics and stabilizing network activity, but a modest amplification still occurs, consistent with biological observations.

      (3) Representational geometry: to obtain insights into the network mechanisms underlying effects of E/I assemblies on the geometry of population activity we tested the hypothesis that geometrical changes depend, at least in part, on the modest amplification of activity within E/I assemblies (see Supplementary Figure 6). We changed model parameters to either prevent the modest amplification in Tuned networks (increasing I-to-E connectivity within assemblies) or introduce a modest amplification in subsets of neurons by other mechanisms (concentration-dependent increase in the excitability of pseudo-assembly neurons; Scaled I networks with reduced connectivity within assemblies). Manipulations that introduced a modest, input-dependent amplification in neuronal subsets had geometrical effects similar to those observed in Tuned networks, whereas manipulations that prevented a modest amplification abolished these effects (Supplementary Figure 6). Note however that these manipulations generated different firing rate distributions. These results provide a starting point for more detailed analyses of the relationship between network connectivity and representational geometry (see p.12).

      In summary, our additional analyses indicate that effects of E/I assemblies on representational geometry depend primarily on network connectivity, rather than specific biophysical parameters, and that the resulting modest amplification of activity within assemblies makes an important contribution. Further analyses may reveal more specific relationships between E/I assemblies and representational geometry, but such analyses are beyond the scope of this study.

      (2) The second major issue with the study is a lack of systematic exploration and analysis of the parameter space. Some parameters are biologically constrained, but not all the parameters. For instance, it is not clear what the justification for the choice of synaptic time scales are (with E synaptic time constants being larger than inhibition: tau_syn_i = 10 ms, tau_syn_E = 30 ms). How would the results change if they are varying these - and other unconstrained - parameters? It is important to show how the main results, especially the manifold localisation, would change by doing a systematic exploration of the key parameters and performing some sensitivity analysis. This would also help to see how robust the results are, which parameters are more important and which parameters are less relevant, and to shed light on the key mechanisms.  

      We thank the reviewer for raising this point. We chose a relatively slow time constant for excitatory synapses because experimental data indicate that excitatory synaptic currents in Dp and piriform cortex contain a prominent NMDA component. Nevertheless, to assess whether network behavior depends on specific choices of biophysical parameters in E and I neurons, we have performed additional simulations with equal synaptic time constants and equal biophysical parameters for all neurons. Each neuron also received the same number of inputs from each population (see revised Methods). Results were similar to those observed previously (Supplementary Fig.5 and p.9 of main text). We therefore conclude that the main effects observed in Tuned networks cannot be explained by differences in biophysical parameters between E and I neurons but is primarily a consequence of network connectivity.

      (3) It is not clear what the main functional advantage of the specific E-I network model is compared to random networks. In terms of activity, they show that specific E-I networks amplify the input more than random networks (Fig. 3). But when it comes to classification, the effect seems to be very small (Fig. 5c). Description of different geometry of representation and manifold localization in specific networks compared to random networks is good, but it is more of an illustration of different activity patterns than proving a functional benefit for the network. The reader is still left with the question of what major functional benefits (in terms of computational/biological processing) should be expected from these networks, if they are to be a good model for olfactory processing and learning. 

      One possibility for instance might be that the tasks used here are too easy to reveal the main benefits of the specific models - and more complex tasks would be needed to assess the functional enhancement (e.g. more noisy conditions or more combination of odours). It would be good to show this more clearly - or at least discuss it in relation to computation and function. 

      In the previous manuscript, the analysis of potential computational benefits other than pattern classification was limited and the discussion of this issue was condensed into a single itemized paragraph to avoid excessive speculation. Although a thorough analysis of potential computational benefits exceeds the scope of a single paper, we agree with the reviewer that this issue is of interest and therefore added additional analyses and discussion.

      In the initial manuscript we analyzed pattern classification primarily to investigate whether Tuned networks can support this function at all, given that they do not exhibit discrete attractor states. We found this to be the case, which we consider a first important result.

      Furthermore, we found that precise balance of E/I assemblies can protect networks against catastrophic firing rate instabilities when assemblies are added sequentially, as in continual learning. Results from these simulations are now described and discussed in more detail (see Results p.11 and Discussion p.13).

      In the revised manuscript, we now also examine additional potential benefits of Tuned networks and discuss them in more detail (see new Figure 5D-F and text p.11). One hypothesis is that continuous representations provide a distance metric between a given input and relevant (learned) stimuli. To address this hypothesis, we (1) performed regression analysis and (2) trained support vector machines (SVMs) to predict the concentration of a given odor in a mixture based on population activity. In both cases, Tuned E+I networks outperformed Scaled and _rand n_etworks in predicting the concentration of learned odors across a wide range mixtures (Figure 5D-F).  E/I assemblies therefore support the quantification of learned odors within mixtures or, more generally, assessments of how strongly a (potentially complex) input is related to relevant odors stored in memory. Such a metric assessment of stimulus quality is not well supported by discrete attractor networks because inputs are mapped onto discrete network states.

      The observation that Tuned networks do not map inputs onto discrete outputs indicates that such networks do not classify inputs as distinct items. Nonetheless, the observed geometrical modifications of continuous representations support the classification of learned inputs or the assessment of metric relationships by hypothetical readout neurons. Geometrical modifications of odor representations may therefore serve as one of multiple steps in multi-layer computations for pattern classification (and/or other computations). In this scenario, the transformation of odor representations in Dp may be seen as related to transformations of representations between different layers in artificial networks, which collectively perform a given task (notwithstanding obvious structural and mechanistic differences between artificial and biological networks). In other words, geometrical transformations of representations in Tuned networks may overrepresent learned (relevant) information at the expense of other information and thereby support further learning processes in other brain areas. An obvious corollary of this scenario is that Dp does not perform odor classification per se based on inputs from the olfactory bulb but reformats representations of odor space based on experience to support computational tasks as part of a larger system. This scenario is now explicitly discussed (p.14).

      Reviewer #2 (Public Review): 

      Summary: 

      The authors conducted a comparative analysis of four networks, varying in the presence of excitatory assemblies and the architecture of inhibitory cell assembly connectivity. They found that co-tuned E-I assemblies provide network stability and a continuous representation of input patterns (on locally constrained manifolds), contrasting with networks with global inhibition that result in attractor networks. 

      Strengths: 

      The findings presented in this paper are very interesting and cutting-edge. The manuscript effectively conveys the message and presents a creative way to represent high-dimensional inputs and network responses. Particularly, the result regarding the projection of input patterns onto local manifolds and continuous representation of input/memory is very Intriguing and novel. Both computational and experimental neuroscientists would find value in reading the paper. 

      Weaknesses: 

      that have continuous representations. This could also be shown in Figure 5B, along with the performance of the random and tuned E-I networks. The latter networks have the advantage of providing network stability compared to the Scaled I network, but at the cost of reduced network salience and, therefore, reduced input decodability. The authors may consider designing a decoder to quantify and compare the classification performance of all four networks. 

      We have now quantified classification by networks with discrete attractor dynamics (Scaled) along with other networks. However, because the neuronal covariance matrix for such networks is low rank and not invertible, pattern classification cannot be analyzed by QDA as in Figure 5B. We therefore classified patterns from the odor subspace by template matching, assigning test patterns to one of the four classes based on correlations (see Supplementary Figure 8). As expected, Scaled networks performed well, but they did not outperform Tuned networks. Moreover, the performance of Scaled networks, but not Tuned networks, depended on the order in which odors were presented to the network. This hysteresis effect is a direct consequence of persistent attractor states and decreased the general classification performance of Scaled networks (see Supplementary Figure 8 for details). These results confirm the prediction that networks with discrete attractor states can efficiently classify inputs, but also reveal disadvantages arising from attractor dynamics. Moreover, the results indicate that the classification performance of Tuned networks is also high under the given task conditions, which simulate a biologically realistic scenario.

      We would also like to emphasize that classification may not be the only task, and perhaps not even a main task, of Dp/piriform cortex or other memory networks with E/I assemblies. Conceivably, other computations could include metric assessments of inputs relative to learned inputs or additional learning-related computations. Please see our response to comment (3) of reviewer 1 for a further discussion of this issue. 

      Networks featuring E/I assemblies could potentially represent multistable attractors by exploring the parameter space for their reciprocal connectivity and connectivity with the rest of the network. However, for co-tuned E-I networks, the scope for achieving multistability is relatively constrained compared to networks employing global or lateral inhibition between assemblies. It would be good if the authors mentioned this in the discussion. Also, the fact that reciprocal inhibition increases network stability has been shown before and should be cited in the statements addressing network stability (e.g., some of the citations in the manuscript, including Rost et al. 2018, Lagzi & Fairhall 2022, and Vogels et al. 2011 have shown this).  

      We thank the reviewer for this comment. We now explicitly discuss multistability (see p. 12) and refer to additional references in the statements addressing network stability.

      Providing raster plots of the pDp network for familiar and novel inputs would help with understanding the claims regarding continuous versus discrete representation of inputs, allowing readers to visualize the activity patterns of the four different networks. (similar to Figure 1B). 

      We thank the reviewer for this suggestion. We have added raster plots of responses to both familiar and novel inputs in the revised manuscript (Figure 2D and Supplementary Figure 4A).

      Reviewer #3 (Public Review): 

      Summary: 

      This work investigates the computational consequences of assemblies containing both excitatory and inhibitory neurons (E/I assembly) in a model with parameters constrained by experimental data from the telencephalic area Dp of zebrafish. The authors show how this precise E/I balance shapes the geometry of neuronal dynamics in comparison to unstructured networks and networks with more global inhibitory balance. Specifically, E/I assemblies lead to the activity being locally restricted onto manifolds - a dynamical structure in between high-dimensional representations in unstructured networks and discrete attractors in networks with global inhibitory balance. Furthermore, E/I assemblies lead to smoother representations of mixtures of stimuli while those stimuli can still be reliably classified, and allow for more robust learning of additional stimuli. 

      Strengths: 

      Since experimental studies do suggest that E/I balance is very precise and E/I assemblies exist, it is important to study the consequences of those connectivity structures on network dynamics. The authors convincingly show that E/I assemblies lead to different geometries of stimulus representation compared to unstructured networks and networks with global inhibition. This finding might open the door for future studies for exploring the functional advantage of these locally defined manifolds, and how other network properties allow to shape those manifolds. 

      The authors also make sure that their spiking model is well-constrained by experimental data from the zebrafish pDp. Both spontaneous and odor stimulus triggered spiking activity is within the range of experimental measurements. But the model is also general enough to be potentially applied to findings in other animal models and brain regions. 

      Weaknesses: 

      I find the point about pattern completion a bit confusing. In Fig. 3 the authors argue that only the Scaled I network can lead to pattern completion for morphed inputs since the output correlations are higher than the input correlations. For me, this sounds less like the network can perform pattern completion but it can nonlinearly increase the output correlations. Furthermore, in Suppl. Fig. 3 the authors show that activating half the assembly does lead to pattern completion in the sense that also non-activated assembly cells become highly active and that this pattern completion can be seen for Scaled I, Tuned E+I, and Tuned I networks. These two results seem a bit contradictory to me and require further clarification, and the authors might want to clarify how exactly they define pattern completion. 

      We believe that this comment concerns a semantic misunderstanding and apologize for any lack of clarity. We added a definition of pattern completion in the text: “…the retrieval of the whole memory from noisy or corrupted versions of the learned input.”. Pattern completion may be assessed using different procedures. In computational studies, it is often analyzed by delivering input to a subset of the assembly neurons which store a given memory (partial activation). Under these conditions, we find recruitment of the entire assembly in all structured networks, as demonstrated in Supplementary Figure 3. However, these conditions are unlikely to occur during odor presentation because the majority of neurons do not receive any input.

      Another more biologically motivated approach to assess pattern completion is to gradually modify a realistic odor input into a learned input, thereby gradually increasing the overlap between the two inputs. This approach had been used previously in experimental studies (references added to the text p.6). In the presence of assemblies, recurrent connectivity is expected to recruit assembly neurons (and thus retrieve the stored pattern) more efficiently as the learned pattern is approached. This should result in a nonlinear increase in the similarity between the evoked and the learned activity pattern. This signature was prominent in Scaled networks but not in Tuned or rand networks. Obviously, the underlying procedure is different from the partial activation of the assembly described above because input patterns target many neurons (including neurons outside assemblies) and exhibit a biologically realistic distribution of activity. However, this approach has also been referred to as “pattern completion” in the neuroscience literature, which may be the source of semantic confusion here. To clarify the difference between these approaches we have now revised the text and explicitly described each procedure in more detail (see p.6). 

      The authors argue that Tuned E+I networks have several advantages over Scaled I networks. While I agree with the authors that in some cases adding this localized E/I balance is beneficial, I believe that a more rigorous comparison between Tuned E+I networks and Scaled I networks is needed: quantification of variance (Fig. 4G) and angle distributions (Fig. 4H) should also be shown for the Scaled I network. Similarly in Fig. 5, what is the Mahalanobis distance for Scaled I networks and how well can the Scaled I network be classified compared to the Tuned E+I network? I suspect that the Scaled I network will actually be better at classifying odors compared to the E+I network. The authors might want to speculate about the benefit of having networks with both sources of inhibition (local and global) and hence being able to switch between locally defined manifolds and discrete attractor states. 

      We agree that a more rigorous comparison of Tuned and Scaled networks would be of interest. We have added the variance analysis (Fig 4G) and angle distributions (Fig. 4H) for both Tuned I and Scaled networks. However, the Mahalanobis distances and Quadratic Discriminant Analysis cannot be applied to Scaled networks because their neuronal covariance matrix is low rank and not invertible_. To nevertheless compare these networks, we performed template matching by assigning test patterns to one of the four odor classes based on correlations to template patterns (Supplementary Figure 8; see also response to the first comment of reviewer 2). Interestingly, _Scaled networks performed well at classification but did not outperform Tuned networks, and exhibited disadvantages arising from attractor dynamics (Supplementary Figure 8; see also response to the first comment of reviewer 2). Furthermore, in further analyses we found that continuous representational manifolds support metric assessments of inputs relative to learned odors, which cannot be achieved by discrete representations. These results are now shown in Figure 5D-E and discussed explicitly in the text on p.11 (see also response to comment 3 of reviewer 1).

      We preferred not to add a sentence in the Discussion about benefits of networks having both sources of inhibition_,_ as we find this a bit too speculative.

      At a few points in the manuscript, the authors use statements without actually providing evidence in terms of a Figure. Often the authors themselves acknowledge this, by adding the term "not shown" to the end of the sentence. I believe it will be helpful to the reader to be provided with figures or panels in support of the statements.  

      Thank you for this comment. We have provided additional data figures to support the following statements:

      “d<sub>M</sub> was again increased upon learning, particularly between learned odors and reference classes representing other odors (Supplementary Figure 9)”

      “decreasing amplification in assemblies of Scaled networks changed transformations towards the intermediate behavior, albeit with broader firing rate distributions than in Tuned networks (Supplementary Figure 6 B)”  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Meissner-Bernard et al present a biologically constrained model of telencephalic area of adult zebrafish, a homologous area to the piriform cortex, and argue for the role of precisely balanced memory networks in olfactory processing. 

      This is interesting as it can add to recent evidence on the presence of functional subnetworks in multiple sensory cortices. It is also important in deviating from traditional accounts of memory systems as attractor networks. Evidence for attractor networks has been found in some systems, like in the head direction circuits in the flies. However, the presence of attractor dynamics in other modalities, like sensory systems, and their role in computation has been more contentious. This work contributes to this active line of research in experimental and computational neuroscience by suggesting that, rather than being represented in attractor networks and persistent activity, olfactory memories might be coded by balanced excitation-inhibitory subnetworks. 

      The paper is generally well-written, the figures are informative and of good quality, and multiple approaches and metrics have been used to test and support the main results of the paper. 

      The main strength of the work is in: (1) direct link to biological parameters and measurements, (2) good controls and quantification of the results, and (3) comparison across multiple models. 

      (1) The authors have done a good job of gathering the current experimental information to inform a biological-constrained spiking model of the telencephalic area of adult zebrafish. The results are compared to previous experimental measurements to choose the right regimes of operation. 

      (2) Multiple quantification metrics and controls are used to support the main conclusions and to ensure that the key parameters are controlled for - e.g. when comparing across multiple models.   (3) Four specific models (random, scaled I / attractor, and two variant of specific E-I networks - tuned I and tuned E+I) are compared with different metrics, helping to pinpoint which features emerge in which model. 

      Major problems with the work are: (1) mechanistic explanation of the results in specific E-I networks, (2) parameter exploration, and (3) the functional significance of the specific E-I model. 

      (1) The main problem with the paper is a lack of mechanistic analysis of the models. The models are treated like biological entities and only tested with different assays and metrics to describe their different features (e.g. different geometry of representation in Fig. 4). Given that all the key parameters of the models are known and can be changed (unlike biological networks), it is expected to provide a more analytical account of why specific networks show the reported results. For instance, what is the key mechanism for medium amplification in specific E/I network models (Fig. 3)? How does the specific geometry of representation/manifolds (in Fig. 4) emerge in terms of excitatory-inhibitory interactions, and what are the main mechanisms/parameters? Mechanistic account and analysis of these results are missing in the current version of the paper. 

      Precise balancing of excitation and inhibition in subnetworks would lead to the cancellation of specific dynamical modes responsible for the amplification of responses (hence, deviating from the attractor dynamics with an unstable specific mode). What is the key difference in the specific E/I networks here (tuned I or/and tuned E+I) which make them stand between random and attractor networks? Excitatory and inhibitory neurons have different parameters in the model (Table 1). Time constants of inhibitory and excitatory synapses are also different (P. 13). Are these parameters causing networks to be effectively more excitation dominated (hence deviating from a random spectrum which would be expected from a precisely balanced E/I network, with exactly the same parameters of E and I neurons)? It is necessary to analyse the network models, describe the key mechanism for their amplification, and pinpoint the key differences between E and I neurons which are crucial for this. 

      To address these comments we performed additional simulations and analyses at different levels. Please see our reply to comment (1) of the public review (reviewer 1) for a detailed description. We thank the reviewer for these constructive comments.

      (2) The second major issue with the study is a lack of systematic exploration and analysis of the parameter space. Some parameters are biologically constrained, but not all the parameters. For instance, it is not clear what the justification for the choice of synaptic time scales are (with E synaptic time constants being larger than inhibition: tau_syn_i = 10 ms, tau_syn_E = 30 ms). How would the results change if they are varying these - and other unconstrained - parameters? It is important to show how the main results, especially the manifold localisation, would change by doing a systematic exploration of the key parameters and performing some sensitivity analysis. This would also help to see how robust the results are, which parameters are more important and which parameters are less relevant, and to shed light on the key mechanisms.  

      We thank the reviewer for this comment. We have now carried out additional simulations with equal time constants for all neurons. Please see our reply to the public review for more details (comment 2 of reviewer 1).

      (3) It is not clear what the main functional advantage of the specific E-I network model is compared to random networks. In terms of activity, they show that specific E-I networks amplify the input more than random networks (Fig. 3). But when it comes to classification, the effect seems to be very small (Fig. 5c). Description of different geometry of representation and manifold localization in specific networks compared to random networks is good, but it is more of an illustration of different activity patterns than proving a functional benefit for the network. The reader is still left with the question of what major functional benefits (in terms of computational/biological processing) should be expected from these networks, if they are to be a good model for olfactory processing and learning. 

      One possibility for instance might be that the tasks used here are too easy to reveal the main benefits of the specific models - and more complex tasks would be needed to assess the functional enhancement (e.g. more noisy conditions or more combination of odours). It would be good to show this more clearly - or at least discuss it in relation to computation and function.

      Please see our reply to the public review (comment 3 of reviewer 1).

      Specific comments: 

      Abstract: "resulting in continuous representations that reflected both relatedness of inputs and *an individual's experience*" 

      It didn't become apparent from the text or the model where the role of "individual's experience" component (or "internal representations" - in the next line) was introduced or shown (apart from a couple of lines in the Discussion) 

      We consider the scenario that that assemblies are the outcome of an experience-dependent plasticity process. To clarify this, we have now made a small addition to the text: “Biological memory networks are thought to store information by experience-dependent changes in the synaptic connectivity between assemblies of neurons.”.

      P. 2: "The resulting state of "precise" synaptic balance stabilizes firing rates because inhomogeneities or fluctuations in excitation are tracked by correlated inhibition" 

      It is not clear what the "inhomogeneities" specifically refers to - they can be temporal, or they can refer to the quenched noise of connectivity, for instance. Please clarify what you mean. 

      The statement has been modified to be more precise: “…“precise” synaptic balance stabilizes firing rates because inhomogeneities in excitation across the population or temporal variations in excitation are tracked by correlated inhibition…”.

      P. 3 (and Methods): When odour stimulus is simulated in the OB, the activity of a fraction of mitral cells is increased (10% to 15 Hz) - but also a fraction of mitral cells is suppressed (5% to 2 Hz). What is the biological motivation or reference for this? It is not provided. Is it needed for the results? Also, it is not explained how the suppressed 5% are chosen (e.g. randomly, without any relation to the increased cells?). 

      We thank the reviewer for this comment. These changes in activity directly reflect experimental observations. We apologize that we forgot to include the references reporting these observations (Friedrich and Laurent, 2001 and 2004); this is now fixed.

      In our simulation, OB neurons do not interact with each other, and the suppressed 5% were indeed randomly selected. We changed the text in Methods accordingly to read: “An additional 75 randomly selected mitral cells were inhibited” 

      P. 4, L. 1-2: "... sparsely connected integrate-and-fire neurons with conductance-based synapses (connection probability {less than or equal to}5%)." 

      Specify the connection probability of specific subtypes (EE, EI, IE, II).  

      We now refer to the Methods section, where this information can be found. 

      “... conductance-based synapses (connection probability ≤5%, Methods)”  

      P. 4, L. 6-7: "Population activity was odor-specific and activity patterns evoked by uncorrelated OB inputs remained uncorrelated in Dp (Figure 1H)" 

      What would happen to correlated OB inputs (e.g. as a result of mixture of two overlapping odours) in this baseline state of the network (before memories being introduced to it)? It would be good to know this, as it sheds light on the initial operating regime of the network in terms of E/I balance and decorrelation of inputs.  

      This information was present in the original manuscript at (Figure 3) but we improved the writing to further clarify this issue: “ (…) we morphed a novel odor into a learned odor (Figure 3A), or a learned odor into another learned odor (Supplementary Figure 3B), and quantified the similarity between morphed and learned odors by the Pearson correlation of the OB activity patterns (input correlation). We then compared input correlations to the corresponding pattern correlations among E neurons in Dp (output correlation). In rand networks, output correlations increased linearly with input correlations but did not exceed them (Figure 3B and Supplementary Figure 3B)”

      P. 4, L. 12-13: "Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of ~80%, .."   Where is this shown? 

      (There are other occasions too in the paper where references to the supporting figures are missing). 

      We now provide the statistics: “Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of 0.79 ± 0.20”

      P. 4: "In each network, we created 15 assemblies representing uncorrelated odors. As a consequence, ~30% of E neurons were part of an assembly ..." 

      15 x 100 / 4000 = 37.5% - so it's closer to 40% than 30%. Unless there is some overlap? 

      Yes: despite odors being uncorrelated and connectivity being random, some neurons (6 % of E neurons) belong to more than one assembly.

      P. 4: "When a reached a critical value of ~6, networks became unstable and generated runaway activity (Figure 2B)." 

      Can this transition point be calculated or estimated from the network parameters, and linked to the underlying mechanisms causing it? 

      We thank the reviewer for this interesting question. The unstability arises when inhibitions fails to counterbalance efficiently the increased recurrent excitation within Dp. The transition point is difficult to estimate, as it can depend on several parameters, including the probability of E to E connections, their strength, assembly size, and others. We have therefore not attempted to estimate it analytically.

      P. 4: "Hence, non-specific scaling of inhibition resulted in a divergence of firing rates that exhausted the dynamic range of individual neurons in the population, implying that homeostatic   global inhibition is insufficient to maintain a stable firing rate distribution." 

      I don't think this is justified based on the results and figures presented here (Fig. 2E) - the interpretation is a bit strong and biased towards the conclusions the authors want to draw. 

      To more clearly illustrate the finding that in Scaled networks, assembly neurons are highly active (close to maximal realistic firing rates) whereas non-assembly neurons are nearly silent we have now added Supplementary Fig. 2B. Moreover, we have toned down the text: “Hence, non-specific scaling of inhibition resulted in a large and biologically unrealistic divergence of firing rates (Supplementary Figure 2B) that nearly exhausted the dynamic range of individual neurons in the population, indicating that homeostatic global inhibition is insufficient to maintain a stable firing rate distribution”

      P. 5, third paragraph: Description of Figure 2I, inset is needed, either in the text or caption. 

      The inset is now referred to in the text: ”we projected synaptic conductances of each neuron onto a line representing the E/I ratio expected in a balanced network (“balanced axis”) and onto an orthogonal line (“counter-balanced axis”; Figure 2I inset, Methods).”

      P. 5, last paragraph: another example of writing about results without showing/referring to the corresponding figures: 

      "In rand networks, firing rates increased after stimulus onset and rapidly returned to a low baseline after stimulus offset. Correlations between activity patterns evoked by the same odor at different time points and in different trials were positive but substantially lower than unity, indicating high variability ..." 

      And the continuation with similar lack of references on P. 6: 

      "Scaled networks responded to learned odors with persistent firing of assembly neurons and high pattern correlations across trials and time, implying attractor dynamics (Hopfield, 1982; Khona and Fiete, 2022), whereas Tuned networks exhibited transient responses and modest pattern correlations similar to rand networks." 

      Please go through the Results and fix the references to the corresponding figures on all instances. 

      We thank the reviewer for pointing out these overlooked figure references, which are now fixed.

      P. 8: "These observations further support the conclusion that E/I assemblies locally constrain neuronal dynamics onto manifolds." 

      As discussed in the general major points, mechanistic explanation in terms of how the interaction of E/I dynamics leads to this is missing. 

      As discussed in the reply to the public review (comment 3 of reviewer 1), we have now provided more mechanistic analyses of our observations.

      P. 9: "Hence, E/I assemblies enhanced the classification of inputs related to learned patterns."   The effect seems to be very small. Also, any explanation for why for low test-target correlation the effect is negative (random doing better than tuned E/I)? 

      The size of the effect (plearned – pnovel = 0.074; difference of means; Figure 5C) may appear small in terms of absolute probability, but it is substantial relative to the maximum possible increase (1 – p<sub>novel</sub> =  0.133; Figure 5C). The fact that for low test-target correlations the effect is negative is a direct consequence of the positive effect for high test-target correlations and the presence of 2 learned odors in the 4-way forced choice task. 

      P. 9: "In Scaled I networks, creating two additional memories resulted in a substantial increase   in firing rates, particularly in response to the learned and related odors"   Where is this shown? Please refer to the figure. 

      We thank the reviewer again for pointing this out. We forgot to include a reference to the relevant figure which has now been added in the revised manuscript (Figure 6C).

      P. 10: "The resulting Tuned networks reproduced additional experimental observations that were not used as constraints including irregular firing patterns, lower output than input correlations, and the absence of persistent activity" 

      It is difficult to present these as "additional experimental observations", as all of them are negative, and can exist in random networks too - hence cannot be used as biological evidence in favour of specific E/I networks when compared to random networks. 

      We agree with the reviewer that these additional experimental observations cannot be used as biological evidence favouring Tuned E+I networks over random networks. We here just wanted to point out that additional observations which we did not take into account to fit the model are not invalidating the existence of E-I assemblies in biological networks. As assemblies tend to result in persistent activity in other types of networks, we feel that this observation is worth pointing out.

      Methods: 

      P. 13: Describe the parameters of Eq. 2 after the equation. 

      Done.

      P. 13: "The time constants of inhibitory and excitatory synapses were 10 ms and 30 ms, respectively." 

      What is the (biological) justification for the choice of these parameters? 

      How would varying them affect the main results (e.g. local manifolds)? 

      We chose a relatively slow time constant for excitatory synapses because experimental data indicate that excitatory synaptic currents in Dp and piriform cortex contain a prominent NMDA component. We have now also simulated networks with equal time constants for excitatory and inhibitory synapses and equal biophysical parameters for excitatory and inhibitory neurons, which did not affect the main results (see also reply to the public review: comment 2 of reviewer 1).

      P. 14: "Care was also taken to ensure that the variation in the number of output connections was low across neurons"   How exactly?

      More detailed explanations have now been added in the Methods section: “connections of a presynaptic neuron y to postsynaptic neurons x were randomly deleted when their total number exceeded the average number of output connections by ≥5%, or added when they were lower by ≥5%.“

      Reviewer #2 (Recommendations For The Authors): 

      Congratulations on the great and interesting work! The results were nicely presented and the idea of continuous encoding on manifolds is very interesting. To improve the quality of the paper, in addition to the major points raised in the public review, here are some more detailed comments for the paper: 

      (1) Generally, citations have to improve. Spiking networks with excitatory assemblies and different architectures of inhibitory populations have been studied before, and the claim about improved network stability in co-tuned E-I networks has been made in the following papers that need to be correctly cited: 

      • Vogels TP, Sprekeler H, Zenke F, Clopath C, Gerstner W. 2011. Inhibitory Plasticity Balances Excitation and Inhibition in Sensory Pathways and Memory Networks. Science 334:1-7. doi:10.1126/science.1212991 (mentions that emerging precise balance on the synaptic weights can result in the overall network stability) 

      • Lagzi F, Bustos MC, Oswald AM, Doiron B. 2021. Assembly formation is stabilized by Parvalbumin neurons and accelerated by Somatostatin neurons. bioRxiv doi: https://doi.org/10.1101/2021.09.06.459211 (among other things, contrasts stability and competition which arises from multistable networks with global inhibition and reciprocal inhibition)   • Rost T, Deger M, Nawrot MP. 2018. Winnerless competition in clustered balanced networks: inhibitory assemblies do the trick. Biol Cybern 112:81-98. doi:10.1007/s00422-017-0737-7 (compares different architectures of inhibition and their effects on network dynamics) 

      • Lagzi F, Fairhall A. 2022. Tuned inhibitory firing rate and connection weights as emergent network properties. bioRxiv 2022.04.12.488114. doi:10.1101/2022.04.12.488114 (here, see the eigenvalue and UMAP analysis for a network with global inhibition and E/I assemblies) 

      Additionally, there are lots of pioneering work about tracking of excitatory synaptic inputs by inhibitory populations, that are missing in references. Also, experimental work that show existence of cell assemblies in the brain are largely missing. On the other hand, some references that do not fit the focus of the statements have been incorrectly cited. 

      The authors may consider referencing the following more pertinent studies on spiking networks to support the statement regarding attractor dynamics in the first paragraph in the Introduction (the current citations of Hopfield and Kohonen are for rate-based networks): 

      • Wong, K.-F., & Wang, X.-J. (2006). A recurrent network mechanism of time integration in perceptual decisions. Journal of Neuroscience, 26(4), 1314-1328. https://doi.org/10.1523/JNEUROSCI.3733-05.2006 

      • Wang, X.-J. (2008). Decision making in recurrent neuronal circuits. Neuron, 60(2), 215-234. https://doi.org/10.1016/j.neuron.2008.09.034  

      • F. Lagzi, & S. Rotter. (2015). Dynamics of competition between subnetworks of spiking neuronal networks in the balanced state. PloS One. 

      • Goldman-Rakic, P. S. (1995). Cellular basis of working memory. Neuron, 14(3), 477-485. 

      • Rost T, Deger M, Nawrot MP. 2018. Winnerless competition in clustered balanced networks: inhibitory assemblies do the trick. Biol Cybern 112:81-98. doi:10.1007/s00422-017-0737-7. 

      • Amit DJ, Tsodyks M (1991) Quantitative study of attractor neural network retrieving at low spike rates: I. substrate-spikes, rates and neuronal gain. Network 2:259-273. 

      • Mazzucato, L., Fontanini, A., & La Camera, G. (2015). Dynamics of Multistable States during Ongoing and Evoked Cortical Activity. Journal of Neuroscience, 35(21), 8214-8231. 

      We thank the reviewer for the references suggestions. We have carefully reviewed the reference list and made the following changes, which we hope address the reviewer’s concerns:

      (1) We adjusted References about network stability in co-tuned E-I networks.

      (2) We added the Lagzi & Rotter (2015), Amit et al. (1991), Mazzucato et al. (2015) and GoldmanRakic (1995) papers in the Introduction as studies on attractor dynamics in spiking neural networks. We preferred to omit the two X.J Wang papers, as they describe attractors in decision making rather than memory processes.

      (3) We added the Ko et al. 2011 paper as experimental evidence for assemblies in the brain. In our view, there are few experimental studies showing the existence of cell assemblies in the brain, which we distinguish from cell ensembles, group of coactive neurons. 

      (4) We also included Hennequin 2018, Brunel 2000, Lagzi et al. 2021 and Eckmann et al. 2024, which we had not cited in the initial manuscript.

      (5) We removed the Wiechert et al. 2010 reference as it does not support the statement about geometry-preserving transformation by random networks.

      (2) The gist of the paper is about how the architecture of inhibition (reciprocal vs. global in this case) can determine network stability and salient responses (related to multistable attractors and variations) for classification purposes. It would improve the narrative of the paper if this point is raised in the Introduction and Discussion section. Also see a relevant paper that addresses this point here: 

      Lagzi F, Bustos MC, Oswald AM, Doiron B. 2021. Assembly formation is stabilized by Parvalbumin neurons and accelerated by Somatostatin neurons. bioRxiv doi: https://doi.org/10.1101/2021.09.06.459211 

      Classification has long been proposed to be a function of piriform cortex and autoassociative memory networks in general, and we consider it important. However, the computational function of Dp or piriform cortex is still poorly understood, and we do not focus only on odor classification as a possibility. In fact, continuous representational manifolds also support other functions such as the quantification of distance relationships of an input to previously memorized stimuli, or multi-layer network computations (including classification). In the revised manuscript, we have performed additional analyses to explore these notions in more detail, as explained above (response to public reviews, comment 3 of reviewer 1). Furthermore, we have now expanded the discussion of potential computational functions of Tuned networks and explicitly discuss classification but also other potential functions. 

      (3) A plot for the values of the inhibitory conductances in Figure 1 would complete the analysis for that section. 

      In Figure 1, we decided to only show the conductances that we use to fit our model, namely the afferent and total synaptic conductances. As the values of the inhibitory conductances can be derived from panel E, we refrained from plotting them separately for the sake of simplicity. 

      (4) How did the authors calculate correlations between activity patterns as a function of time in Figure 2E, bottom row? Does the color represent correlation coefficient (which should not be time dependent) or is it a correlation function? This should be explained in the Methods section. 

      The color represents the Pearson correlation coefficient between activity patterns within a narrow time window (100 ms). We updated the Figure legend to clarify this: “Mean correlation between activity patterns evoked by a learned odor at different time points during odor presentation. Correlation coefficients were calculated between pairs of activity vectors composed of the mean firing rates of E neurons in 100 ms time bins. Activity vectors were taken from the same or different trials, except for the diagonal, where only patterns from different trials were considered.”

      (5) Figure 3 needs more clarification (both in the main text and the figure caption). It is not clear what the axes are exactly, and why the network responses for familiar and novel inputs are different. The gray shaded area in panel B needs more explanation as well.  

      We thank the reviewer for the comment. We have improved Figure 3A, the figure caption, as well as the text (see p.6). We hope that the figure is now clearer.

      (6) The "scaled I" network, known for representing input patterns in discrete attractors, should exhibit clear separation between network responses in the 2D PC space in the PCA plots. However, Figure 4D and Figure 6D do not reflect this, as all network responses are overlapped. Can the authors explain the overlap in Figure 4D? 

      In Figure 4D, activity of Scaled networks is distributed between three subregions in state space that are separated by the first 2 PCs. Two of them indeed correspond to attractor states representing the two learned odors while the third represents inputs that are not associated with these attractor states. To clarify this, please see also the density plot in Figure 4E. The few datapoints between these three subregions are likely outliers generated by the sequential change in inputs, as described in Supplementary Figure 8C.

      (7) The reason for writing about the ISN networks is not clear. Co-tuned E-I assemblies do not necessarily have to operate in this regime. Also, the results of the paper do not rely on any of the properties of ISNs, but they are more general. Authors should either show the paradoxical effect associated with ISN (i.e., if increasing input to I neurons decreases their responses) or show ISN properties using stability analysis (See computational research conducted at the Allen Institute, namely Millman et al. 2020, eLife ). Currently, the paper reads as if being in the ISN regime is a necessary requirement, which is not true. Also, the arguments do not connect with the rest of the paper and never show up again. Since we know it is not a requirement, there is no need to have those few sentences in the Results section. Also, the choice of alpha=5.0 is extreme, and therefore, it would help to judge the biological realism if the raster plots for Figs 2-6 are shown.

      We have toned down the part on ISN and reduced it to one sentence for readers who might be interested in knowing whether activity is inhibition-stabilized or not. We have also added the reference to the Tsodyks et al. 1997 paper from which we derive our stability analysis. The text now reads “Hence, pDp<sub>sim</sub> entered a balanced state during odor stimulation (Figure 1D, E) with recurrent input dominating over afferent input, as observed in pDp (Rupprecht and Friedrich, 2018). Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of 0.79 ± 0.20, demonstrating that activity was inhibition-stabilized (Sadeh and Clopath, 2020b, Tsodyks et al., 1997).”  

      We have now also added the raster plots as suggested by the reviewer (see Figure 2D, Supplementary Figure 1 G, Supplementary Figure 4). We thank the reviewer for this comment.

      (8) In the abstract, authors mention "fast pattern classification" and "continual learning," but in the paper, those issues have not been addressed. The study does not include any synaptic plasticity. 

      Concerning “continual learning” we agree that we do not simulate the learning process itself. However, Figure 6 show results of a simulation where two additional patterns were stored in a network that already contained assemblies representing other odors. We consider this a crude way of exploring the end result of a “continual learning” process. “Fast pattern classification” is mentioned because activity in balanced networks can follow fluctuating inputs with high temporal resolution, while networks with stable attractor states tend to be slow. This is likely to account for the occurrence of hysteresis effects in Scaled but not Tuned networks as shown in Supplementary

      Fig. 8.

      (9) In the Introduction, the first sentence in the second paragraph reads: "... when neurons receive strong excitatory and inhibitory synaptic input ...". The word strong should be changed to "weak".

      Also, see the pioneering work of Brunel 2000. 

      In classical balanced networks, strong excitatory inputs are counterbalanced by strong inhibitory inputs, leading to a fluctuation-driven regime. We have added Brunel 2000.

      (10) In the second paragraph of the introduction, the authors refer to studies about structural co-tuning (e.g., where "precise" synaptic balance is mentioned, and Vogels et al. 2011 should be cited there) and functional co-tuning (which is, in fact, different than tracking of excitation by inhibition, but the authors refer to that as co-tuning). It makes it easier to understand which studies talk about structural co-tuning and which ones are about functional co-tuning. The paper by Znamenski 2018, which showed both structural and functional tuning in experiments, is missing here. 

      We added the citation to the now published paper by Znamenskyi et al. (2024).  

      (11) The third paragraph in the Introduction misses some references that address network dynamics that are shaped by the inhibitory architecture in E/I assemblies in spiking networks, like Rost et al 2018 and Lagzi et al 2021. 

      These references have been added.

      (12) The last sentence of the fourth paragraph in the Introduction implies that functional co-tuning is due to structural co-tuning, which is not necessarily true. While structural co-tuning results in functional co-tuning, functional co-tuning does not require structural co-tuning because it could arise from shared correlated input or heterogeneity in synaptic connections from E to I cells.  

      We generally agree with the reviewer, but we are uncertain which sentence the reviewer refers to.

      We assume the reviewer refers to the last sentence of the second (rather than the fourth paragraph), which explicitly mentions the “…structural basis of E/I co-tuning…”. If so, we consider this sentence still correct because the “structural basis” refers not specifically to E/I assemblies, but also includes any other connectivity that may produce co-tuning, including the connectivity underlying the alternative possibilities mentioned by the reviewer (shared correlated input or heterogeneity of synaptic connections).

      (13) In order to ensure that the comparison between network dynamics is legit, authors should mention up front that for all networks, the average firing rates for the excitatory cells were kept at 1 Hz, and the background input was identical for all E and I cells across different networks.

      We slightly revised the text to make this more clear “We (…) uniformly scaled I-to-E connection weights by a factor of χ until E population firing rates in response to learned odors matched the corresponding firing rates in rand networks, i.e., 1 Hz”

      (14) In the last paragraph on page 5, my understanding was that an individual odor could target different cells within an assembly in different trials to generate trial to trail variability. If this is correct, this needs to be mentioned clearly. 

      This is not correct, an odor consists of 150 activated mitral cells with defined firing rates. As now mentioned in the Methods, “Spikes were then generated from a Poisson distribution, and this process was repeated to create trial-to-trial variability.”

      (15) The last paragraph on page 6 mentions that the four OB activity patterns were uncorrelated but if they were designed as in Figure 4A, dues to the existing overlap between the patterns, they cannot be uncorrelated. 

      This appears to be a misunderstanding. We mention in the text (and show in Figure 4B) that the four odors which “… were assigned to the corners of a square…” are uncorrelated.  The intermediate odors are of course not uncorrelated. We slightly modified the corresponding paragraph (now on page 7) to clarify this: “The subspace consisted of a set of OB activity patterns representing four uncorrelated pure odors and mixtures of these pure odors. Pure odors were assigned to the corners of a square and mixtures were generated by selecting active mitral cells from each of the pure odors with probabilities depending on the relative distances from the corners (Figure 4A, Methods).”

      (16) The notion of "learned" and "novel" odors may be misleading as there was no plasticity in the network to acquire an input representation. It would be beneficial for the authors to clarify that by "learned," they imply the presence of the corresponding E assembly for the odor in the network, with the input solely impacting that assembly. Conversely, for "novel" inputs, the input does not target a predefined assembly. In Figure 2 and Figure 4, it would be especially helpful to have the spiking raster plots of some sample E and I cells.  

      As suggested by the reviewer, we have modified the existing spiking raster plots in Figure 2, such that they include examples of responses to both learned and novel odors. We added spiking raster plots showing responses of I neurons to the same odors in Supplementary Figure 1F, as well as spiking raster plots of E neurons in Supplementary Figure 4A. To clarify the usage of “learned” and “novel”, we have added a sentence in the Results section: “We thus refer to an odor as “learned” when a network contains a corresponding assembly, and as “novel” when no such assembly is present.”.

      (17) In the last paragraph of page 8, can the authors explain where the asymmetry comes from? 

      As mentioned in the text, the asymmetry comes from the difference in the covariance structure of different classes. To clarify, we have rephrased the sentence defining the Mahalanobis distance: 

      “This measure quantifies the distance between the pattern and the class center, taking into account covariation of neuronal activity within the class. In bidirectional comparisons between patterns from different classes, the mean dM may be asymmetric if neural covariance differs between classes.”

      (18) The first paragraph of page 9: random networks are not expected to perform pattern classification, but just pattern representation. It would have been better if the authors compared Scaled I network with E/I co-tuned network. Regardless of the expected poorer performance of the E/I co-tuned networks, the result would have been interesting. 

      Please see our reply to the public review (reviewer 2).

      (19) Second paragraph on page 9, the authors should provide statistical significance test analysis for the statement "... was significantly higher ...". 

      We have performed a Wilcoxon signed-rank test, and reported the p-value in the revised manuscript (p < 0.01). 

      (20) The last sentence in the first paragraph on page 11 is not clear. What do the authors mean by "linearize input-output functions", and how does it support their claim? 

      We have now amended this sentence to clarify what we mean: “…linearize the relationship between the mean input and output firing rates of neuronal populations…”.

      (21) In the first sentence of the last paragraph on page 11, the authors mentioned “high variability”, but it is not clear compared with which of the other 3 networks they observed high variability.

      Structurally co-tuned E/I networks are expected to diminish network-level variability. 

      “High variability” refers to the variability of spike trains, which is now mentioned explicity in the text. We hope this more precise statement clarifies this point.

      (22) Methods section, page 14: "firing rates decreased with a time constant of 1, 2 or 4 s". How did they decrease? Was it an implementation algorithm? The time scale of input presentation is 2 s and it overlaps with the decay time constant (particularly with the one with 4 s decrease).  

      Firing rates decreased exponentially. We have added this information in the Methods section.

      Reviewer #3 (Recommendations For The Authors): 

      In the following, I suggest minor corrections to each section which I believe can improve the manuscript. 

      - There was no github link to the code in the manuscript. The code should be made available with a link to github in the final manuscript. 

      The code can be found here: https://github.com/clairemb90/pDp-model. The link has been added in the Methods section.

      Figure 1: 

      - Fig. 1A: call it pDp not Dp. Please check if this name is consistent in every figure and the text. 

      Thank you for catching this. Now corrected in Figure 1, Figure 2 and in the text.

      - The authors write: "Hence, pDpsim entered an inhibition-stabilized balanced state (Sadeh and Clopath, 2020b) during odor stimulation (Figure 1D, E)." and then later "Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of ~80%, demonstrating that activity was indeed inhibition-stabilized. These results were robust against parameter variations (Methods)." I would suggest moving the second sentence before the first sentence, because the fact that the network is in the ISN regime follows from the shuffled spike timing result. 

      Also, I'd suggest showing this as a supplementary figure. 

      We thank the reviewer for this comment. We have removed “inhibition-stabilized” in the first sentence as there is no strong evidence of this in Rupprecht and Friedrich, 2018. And removed “indeed” in the second sentence. We also provided more detailed statistics. The text now reads “Hence, pDpsim entered a balanced state during odor stimulation (Figure 1D, E) with recurrent input dominating over afferent input, as observed in pDp (Rupprecht and Friedrich, 2018). Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of 0.79 ± 0.20, demonstrating that activity was inhibition-stabilized (Sadeh and Clopath, 2020b).”

      Figure 2: 

      - "... Scaled I networks (Figure 2H." Missing ) 

      Corrected.

      - The authors write "Unlike in Scaled I networks, mean firing rates evoked by novel odors were indistinguishable from those evoked by learned odors and from mean firing rates in rand networks (Figure 2F)." 

      Why is this something you want to see? Isn't it that novel stimuli usually lead to high responses? Eg in the paper Schulz et al., 2021 (eLife) which is also cited by the authors it is shown that novel responses have high onset firing rates. I suggest clarifying this (same in the context of Fig. 3C). 

      In Dp and piriform cortex, firing rates evoked by learned odors are not substantially different from firing rates evoked by novel odors. While small differences between responses to learned versus novel odors cannot be excluded, substantial learning-related differences in firing rates, as observed in other brain areas, have not been described in Dp or piriform cortex. We added references in the last paragraph of p.5. Note that the paper by Schulz et al. (2021) models a different type of circuit.  

      - Fig. 2B: Indicate in figure caption that this is the case "Scaled I" 

      This is not exactly the case “Scaled I”, as the parameter 𝝌𝝌 (increased I to E strength) is set to 1.

      - Suppl Fig. 2I: Is E&F ever used in the manuscript? I couldn't find a reference. I suggest removing it if not needed. 

      Suppl. Fig 2I E&F is now Suppl Fig.1G&H. We now refer to it in the text: “Activity of networks with E assemblies could not be stabilized around 1 Hz by increasing connectivity from subsets of I neurons receiving dense feed-forward input from activated mitral cells (Supplementary Figure 1GH; Sadeh and Clopath, 2020).”

      Figure 3: 

      - As mentioned in my comment in the public review section, I find the arguments about pattern completion a little bit confusing. For me it's not clear why an increase of output correlations over input correlations is considered "pattern completion" (this is not to say that I don't find the nonlinear increase of output correlations interesting). For me, to test pattern completion with second-order statistics one would need to do a similar separation as in Suppl Fig. 3, ie measuring the pairwise correlation at cells in the assembly L that get direct input from L OB with cells in the assembly L that do not get direct input from OB. If the pairwise correlations of assembly cells which do not get direct input from OB increase in correlations, I would consider this as pattern completion (similar to the argument that increase in firing rate in cells which are not directly driven by OB are considered a sign of pattern completion). 

      Also, for me it now seems like that there are contradictory results, in Fig. 3 only Scaled I can lead to pattern completion while in the context of Suppl. Fig. 3 the authors write "We found that assemblies were recruited by partial inputs in all structured pDpsim networks (Scaled and Tuned) without a significant increase in the overall population activity (Supplementary Figure 3A)."   I suggest clarifying what the authors exactly mean by pattern completion, why the increase of output correlations above input correlations can be considered as pattern completion, and why the results differs when looking at firing rates versus correlations. 

      Please see our reply to the public review (reviewer 3).

      - I actually would suggest adding Suppl. Fig. 3 to the main figure. It shows a more intuitive form of pattern completion and in the text there is a lot of back and forth between Fig. 3 and Suppl. Fig. 3 

      We feel that the additional explanations and panels in Fig.3 should clarify this issue and therefore prefer to keep Supplementary Figure 3 as part of the Supplementary Figures for simplicity.  

      - In the whole section "We next explored effects of assemblies ... prevented strong recurrent amplification within E/I assemblies." the authors could provide a link to the respective panel in Fig. 2 after each statement. This would help the reader follow your arguments. 

      We thank the reviewer for pointing this out. The references to the appropriate panels have been added. 

      - Fig. 3A: I guess the x-axis has been shifted upwards? Should be at zero. 

      We have modified the x-axis to make it consistent with panels B and C.  

      - Fig. 3B: In the figure caption, the dotted line is described as the novel odor but it is actually the unit line. The dashed lines represent the reference to the novel odor. 

      Fixed.

      - Fig. 3C: The " is missing for Pseudo-Assembly N

      Fixed.

      - "...or a learned odor into another learned odor." Have here a ref to the Supplementary Figure 3B.

      Added.

      Figure 4:   

      - "This geometry was largely maintained in the output of rand networks, consistent with the notion that random networks tend to preserve similarity relationships between input patterns (Babadi and Sompolinsky, 2014; Marr, 1969; Schaffer et al., 2018; Wiechert et al., 2010)." I suggest adding here reference to Fig. 4D (left). 

      Added.

      - Please add a definition of E/I assemblies. How do the authors define E/I assemblies? I think they consider both, Tuned I and Tuned E+I as E/I assemblies? In Suppl. Fig. 2I E it looks like tuned feedforward input is defined as E/I assemblies. 

      We thank the reviewer for pointing this out. E/I assemblies are groups of E and I neurons with enhanced connectivity. In other words, in E/I assemblies, connectivity is enhanced not only between subsets of E neurons, but also between these E neurons and a subset of I neurons. This is now clarified in the text: “We first selected the 25 I neurons that received the largest number of connections from the 100 E neurons of an assembly. To generate E/I assemblies, the connectivity between these two sets of neurons was then enhanced by two procedures.”. We removed “E/I assemblies” in Suppl. Fig.2, where the term was not used correctly, and apologize for the confusion.

      - Suppl. Fig. 4: Could the authors please define what they mean by "Loadings" 

      The loadings indicate the contribution of each neuron to each principal component, see adjusted legend of Suppl. Fig. 4: “G. Loading plot: contribution of neurons to the first two PCs of a rand and a Tuned E+I network (Figure 4D).”

      - Fig. 4F: The authors might want to normalize the participation ratio by the number of neurons (see e.g. Dahmen et al., 2023 bioRxiv, "relative PR"), so the PR is bound between 0 and 1 and the dependence on N is removed. 

      We thank the reviewer for the suggestion, but we prefer to use the non-normalized PR as we find it more easily interpretable (e.g. number of attractor states in Scaled networks).

      - Fig. 4G&H: as mentioned in the public review, I'd add the case of Scaled I to be able to compare it to the Tuned E+I case. 

      As already mentioned in the public review, we thank the reviewer for this suggestion, which we have implemented.

      - Figure caption Fig. 4H "Similar results were obtained in the full-dimensional space." I suggest showing this as a supplemental panel. 

      Since this only adds little information, we have chosen not to include it as a supplemental panel to avoid overloading the paper with figures.

      Figure 5: 

      - As mentioned in the public review, I suggest that the authors add the Scaled I case to Fig. 5 (it's shown in all figures and also in Fig. 6 again). I guess for Scaled I the separation between L and M will be very good? 

      Please see our reply to the public review (reviewer 3).

      - Fig. 5A&B: I am a bit confused about which neurons are drawn to calculate the Mahalanobis distance. In Fig. 5A, the schematic indicates that the vector B from which the neurons are drawn is distinct from the distribution Q. For the example of odor L, the distribution Q consists of pure odor L with odors that have little mixtures with the other odors. But the vector v for odor L seems to be drawn only from odors that have slightly higher mixtures (as shown in the schematic in Fig. 5A). Is there a reason to choose the vector v from different odors than the distribution Q? 

      The distribution Q and the vector v consist of activity patterns across the same neurons in response to different odors. The reason to choose a different odor for v was to avoid having this test datapoint being included in the distribution Q. We also wanted Q to be the same for all test datapoints. 

      What does "drawn from whole population" mean? Does this mean that the vectors are drawn from any neuron in pDp? If yes, then I don't understand how the authors can distinguish between different odors (L,M,O,N) on the y-axis. Or does "whole population" mean that the vector is drawn across all assemblies as shown in the schematic in Fig. 5A and the case "neurons drawn from (pseudo-) assembly" means that the authors choose only one specific assembly? In any case, the description here is a bit confusing, I think it would help the reader to clarify those terms better.  

      Yes, “drawn from whole population” means that we randomly draw 80 neurons from the 4000 E neurons in pDp. The y-axis means that we use the activity patterns of these neurons evoked by one of the 4 odors (L, M, N, O) as reference. We have modified the Figure legend to clarify this: “d<sub>M</sub> was computed based on the activity patterns of 80 E neurons drawn from the four (pseudo-) assemblies (top) or from the whole population of 4000 E neurons (bottom). Average of 50 draws.”

      - Suppl Fig. 5A: In the schematic the distance is called d_E(\bar{Q},\bar{V}) while the colorbar has d_E(\bar{Q},\bar{Q}) with the Qs in different color. The green Q should be a V. 

      We thank the reviewer for spotting this mistake, it is now fixed.

      - Fig. 5: Could the authors comment on the fact that a random network seems to be very good in classifying patterns on it's own. Maybe in the Discussion? 

      The task shown in Figure 5 is a relatively easy one, a forced-choice between four classes which are uncorrelated. In Supplementary Figure 9, we now show classification for correlated classes, which is already much harder.

      Figure 6: 

      - Is the correlation induced by creating mixtures like in the other Figures? Please clarify how the correlations were induced. 

      We clarified this point in the Methods section: “The pixel at each vertex corresponded to one pure odor with 150 activated and 75 inhibited mitral cells (…) and the remaining pixels corresponded to mixtures. In the case of correlated pure odors (Figure 6), adjacent pure odors shared half of their activated and half of their inhibited cells.”. An explicit reference to the Methods section has also been added to the figure legend.

      - Fig. 6C (right): why don't we see the clear separation in PC space as shown in Fig. 4? Is this related to the existence of correlations? Please clarify. 

      Yes. The assemblies corresponding to the correlated odors X and Y overlap significantly, and therefore responses to these odors cannot be well separated, especially for Scaled networks. We added the overlap quantification in the Results section to make this clear. “These two additional assemblies had on average 16% of neurons in common due to the similarity of the odors.”

      - "Furthermore, in this regime of higher pattern similarity, dM was again increased upon learning, particularly between learned odors and reference classes representing other odors (not shown)." Please show this (maybe as a supplemental figure). 

      We now show the data in Supplementary Figure 9.

      Discussion: 

      - The authors write: "We found that transformations became more discrete map-like when amplification within assemblies was increased and precision of synaptic balance was reduced. Likewise, decreasing amplification in assemblies of Scaled networks changed transformations towards the intermediate behavior, albeit with broader firing rate distributions than in Tuned networks (not shown)." 

      Where do I see the first point? I guess when I compare in Fig. 4D the case of Scaled I vs Tuned E+I, but the sentence above sounds like the authors showed this in a more step-wise way eg by changing the strength of \alpha or \beta (as defined in Fig. 1). 

      Also I think if the authors want to make the point that decreasing amplification in assemblies changes transformation with a different rate distribution in scaled vs tuned networks, the authors should show it (eg adding a supplemental figure). 

      The first point is indeed supported by data from different figures. Please note that the revised manuscript now contains further simulations that reinforce this statement, particularly those shown in Supplementary Figure 6, and that this point is now discussed more extensively in the Discussion. We hope that these revisions clarify this general point.

      The data showing effects of decreasing amplification in assemblies is now shown in Supplementary Figure 6 (Scaled[adjust])

      - I suggest adding the citation Znamenskiy et al., 2024 (Neuron; https://doi.org/10.1016/j.neuron.2023.12.013), which shows that excitatory and inhibitory (PV) neurons with functional similarities are indeed strongly connected in mouse V1, suggesting the existence of E/I assembly structure also in mammals.

      Done.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      It is evident that studying leukocyte extravasation in vitro is a challenge. One needs to include physiological flow, culture cells and isolate primary immune cells. Timing is of utmost importance and a reproducible setup essential. Extra challenges are met when extravasation kinetics in different vascular beds is required, e.g., across the blood-brain barrier. In this study, the authors describe a reliable and reproducible method to analyze leukocyte TEM under physiological flow conditions, including this analysis. That the software can also detect reverse TEM is a plus.

      Strengths:

      It is quite a challenge to get this assay reproducible and stable, in particular as there is flow included. Also for the analysis, there is currently no clear software analysis program, and many labs have their own methods. This paper gives the opportunity to unify the data and results obtained with this assay under label-free conditions. This should eventually lead to more solid and reproducible results.

      Also, the comparison between manual and software analysis is appreciated.

      Weaknesses:

      The authors stress that it can be done in BBB models, but I would argue that it is much more broadly applicable. This is not necessarily a weakness of the study but more an opportunity to strengthen the method. So I would encourage the authors to rewrite some parts and make it more broadly applicable.

      We thank the Reviewer for this suggestion. The barrier properties of the BBB influence the dynamic behavior of T cells during their multi-step extravasation cascade. The crawling of CD4 T cells against the direction of blood-flow is e.g. a unique behavior of T cells on the BBB  that is also observed in vivo(1-3). Nevertheless we fully agree that in principle UFMTrack is usable for studying in general immune cell interactions with endothelial monolayers under physiological flow. We have thus added a statement in the abstract and expanded the discussion to highlight availability of the framework and the potential necessary adaptations required when using UFMTrack for analyzing different experimental setups. Please also note, UFMTrack has been established as basic framework using the example of brain endothelial monolayers and one flow chamber devices while studying different immune cell subsets. The purpose of the publication is to make UFMTrack available to the community to address their specific questions.

      (1) Kawakami, N., Bartholomäus, I., Pesic, M. & Kyratsous, N. I. Intravital Imaging of Autoreactive T Cells in Living Animals. Methods Cell Biol. 113, 149–168 (2013).

      (2) Schläger, C., Litke, T., Flügel, A. & Odoardi, F. In Vivo Visualization of (Auto)Immune Processes in the Central Nervous System of Rodents. in 117–129 (Humana Press, New York, NY, 2014). doi:10.1007/7651_2014_150

      (3) Haghayegh Jahromi, N. et al. Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis. Front. Immunol. 10, 3056 (2020).

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment:

      Developing a reliable method to record ancestry and distinguish between human somatic cells presents significant challenges. I fully acknowledge that my current evidence supporting the claim of lineage tracing with fCpG barcodes is inadequate. I agree with Reviewer 1 that fCpG barcodes are essentially a cellular division clock that diverges over time. A division clock could potentially document when cells cease to divide during development, with immediate daughter cells likely exhibiting more similar barcodes than those that are less related. Although it remains uncertain whether the current fCpG barcodes capture useful biological information, refinement of this type of tool could complement other approaches that reconstruct human brain function, development, and aging.

      Due to my lack of clarity, the fCpG barcode was perceived to be a new type of cell classifier. However, it is fundamentally different. fCpG sites are selected based on their differences between cells of the same type, while traditional cell classifiers focus on sites with consistent methylation patterns in cells of the same type. Despite these opposing criteria, fCpG barcodes and traditional cell classifiers may align because neuron subtypes often share common progenitors. As a result, cells of the same phenotype are also closely related by ancestry, and ex post facto, have similar fCpG barcodes. fCpG barcodes are complementary to cell type classifiers, and potentially provide insights into aspects such as mitotic ages, diversity within a clade, and migration of immediate daughters---information which is otherwise difficult to obtain. The title has been modified to “Human Brain Ancestral Barcodes” to better reflect the function of the fCpG barcodes. The manuscript is edited to correct errors, and a new Supplement is added to further explain fCpG barcode mechanics and present new supporting data.

      Reviewer #1 (Public review):

      I thank Reviewer 1 for his constructive comments. Major noted weaknesses were 1) insufficient clarity and brevity of the methodology, 2) inconsistent or erroneous use of neurodevelopmental concepts, and 3) lack of consideration for alternative explanations.

      (1) The methodology is now outlined in detailed in a new Supplement, including simulations that indicate that the error rate consistent with the experimental data is about 0.01 changes in methylation per fCpG site per division.

      (2) Conceptual and terminology errors noted by the Reviewers are corrected in the manuscript.

      (3) I agree completely with the alternative explanation of Reviewer 1 that fCpGs are “a cellular division clock that diverges over 'time'”. Differences between more traditional cell type classifiers and fCpG barcodes are more fully outlined in the new Supplement.  Ancestry recorded by fCpGs and cell type classifiers are confounded because cells of the same phenotype typically have common progenitors---cells within a clade have similar fCpG barcodes because they are closely related. fCpG barcodes can compliment cell type classifiers with additional information such as mitotic ages, ancestry within a clade, and daughter cell migration.

      Reviewer #1 (Recommendations for the authors):

      (1) A lot of the interpretations suffer from an extremely loose/erroneous use of developmental concepts and a lack of transparency. For instance:

      a) The thalamus is not part of the brain stem

      Corrected.

      b) The pons contains cells other than inhibitory neurons in the data; the same is true for the hippocampus which contains multiple cell types

      Corrected to refer to the specific cell types in these regions.

      c) The author talks about the rostral-caudal timing a lot which is not really discussed to this degree in the cited references. Thus, it is also unclear how interneurons fit in this model as they are distinguished by a ventral-dorsal difference from excitatory neurons. Also, it is unclear whether the timing is really as distinct as claimed. For instance, inhibitory neurons and excitatory neurons significantly overlap in their birth timing. Finally, conceptually, it does not make sense to go by developmental timing as the author proposes that it is the number of divisions that is relevant. While they are somewhat correlated there are potentially stark differences.

      The manuscript attempts to describe what might be broadly expected when barcodes are sampled from different cell types and locations. As a proposed mitotic clock, the fCpG barcode methylation level could time when each neuron ceased division and differentiated. The wide ranges of fCpG barcode methylation of each cell type (Fig 2A) would be consistent with significant overlap between cell types. The manuscript is edited to emphasize overlapping rather than distinct sequential differentiation of the cell types.

      d) Neocortical astrocytes and some oligodendrocytes share a lineage, whereas a subset of oligodendrocytes in the cortex shares an origin with interneurons. This could confound results but is never discussed.

      The manuscript does not assess glial lineages in detail because neurons were preferentially included in the sampling whereas glial cells were non-systematically excluded. This sampling information is now included in the section “fCpG barcode identification”.

      e) Neocortical interneurons should be more closely related in terms of lineage-to-excitatory neurons than other inhibitory neurons of, for instance, the pons. This is not clearly discussed and delineated.

      This is not discussed. It may not be possible analyze these details with the current data. The ancestral tree reconstructions indicate that excitatory neurons that appear earlier in development (and are more methylated) are more often more closely related to inhibitory neurons.

      f) While there is some spread of excitatory neurons tangentially, there is no tangential migration at the scale of interneurons as (somewhat) suggested/implied here.

      The abstract and results have been modified to indicate greater inhibitory than excitatory neuron tangential migration, but that the extent of excitatory neuron tangential migration cannot be determined because of the sparse sampling and that barcodes may be similar by chance.

      g) The nature of the NN cells is quite important as cells not derived from the neocortical anlage are unlikely to share a developmental origin (e.g., microglia, endothelial cells). This should be clarified and clearly stated.

      The manuscript is modified to indicate that NN cells are microglial and endothelial cells. These cells have different developmental origins, and their data are present in Fig 2A, but are not further used for ancestral analysis.  

      (2) The presentation is often somewhat confusing to me and lacks detail. For instance:

      a) The methods are extremely short and I was unable to find a reference for a full pipeline, so other researchers can replicate the work and learn how to use the pipeline.

      The pipeline including python code is outlined in the new Supplement

      b) Often numbers are given as ~XX when the actual number with some indication of confidence or spread would be more appropriate.

      Data ranges are often indicated with the violin plots.

      c) Many figure legends are exceedingly short and do not provide an appropriate level of detail.

      Figure legends have been modified to include more detail

      d) Not defining groups in the figure legends or a table is quite unacceptable to me. I do not think that referring to a prior publication (that does not consistently use these groups anyway) is sufficient.

      The cell groups are based on the annotations provided with each single cell in the public databases.

      e) The used data should be better defined and introduced (number of cells, different subtypes across areas, which cells were excluded; I assume the latter as pons and hippocampus are only mentioned for one type of neuronal cells, see also above).

      The data used are present in Supplemental File 2 under the tab “cell summary H01, H02, H04”.

      f) Why were different upper bounds used for filtering for H01 and H02, and H04 is not mentioned? Why are inhibitory and excitatory neurons specifically mentioned (Lines 61-66)?

      The filtering is used to eliminate, as much as possible, cell type specific methylation, or CpG sites with skewed neuron methylation. The filtering eliminates CpG sites with high or low methylation within each of the three brains, and within the two major neuron subtypes. The goal is to enrich for CpG sites with polymorphic but not cell type specific methylation. This process is ad hoc as success criteria are currently uncertain. The extent of filtering is balanced by the need to retain sufficient numbers of fCpGs to allow comparisons between the neurons.

      g) What 'progenitor' does the author refer to? The Zygote? If yes, can the methylation status be tested directly from a zygote? There is no single progenitor for these cells other than the zygote. Does the assumption hold true when taking this into account? See, for instance, PMID 33737485 for some estimation of lineage bottlenecks.

      A brain progenitor cell can be defined as the common ancestor of all adult neurons, and is the first cell where each of its immediate daughter cell lineages yield adult neurons. The zygote is a progenitor cell to all adult cells, and barcode methylation at the start of conception, from the oocyte to the ICM, was analyzed in the new Supplement. The proposed brain progenitor cell with a fully methylated barcode was not yet evident even in the ICM.

      (3) I am generally not convinced that the fCpGs represent anything but a molecular clock of cell divisions and that many of the similarities are a function of lower division numbers where the state might be more homogenous. This mainly derives from the issues cited above, the lack of convincing evidence to the contrary, and the sparsity of the assessed data.

      Agree that the fCpG barcode is a mitotic clock that becomes polymorphic with divisions. As outlined in the new Supplement, ancestry and cell type are confounded because cells of the same type typically have a common progenitor.

      a) There appears little consideration or modeling of what the ability to switch back does to the lineage reconstruction.

      fCpG methylation flipping is further analyzed and discussed in the new Supplement.

      b) None of the data convinced me that the observations cannot be explained by the aforementioned molecular clock and systematic methylation similarities of cell types due to their cell state.

      See above

      (4) Uncategorized minor issues:

      a) The author should explain concepts like 'molecular clock hypothesis' (line 27) or 'radial unit hypothesis' (line 154), as they are somewhat complex and might not be intuitive to readers.

      The molecular clock hypothesis is deleted and the radial unit hypothesis is explained in more detail in the manuscript.

      b) Line 32: '[...] replication errors are much higher compared to base replication [...]'. I think this is central to the method and should be better explained and referenced. Maybe even through a schematic, as this is a central concept for the entire manuscript.

      The fCpG barcode mechanics are better explained in the new Supplement. With simulations, the fCpG flip rate is about 0.01 per division per fCpG.

      c) Line 41: 'neonatal'. Does the author mean to say prenatal? Most of the cells discussed are postmitotic before birth.

      Corrected to prenatal.

      d) Line 96: what does 'flip' mean in this context? Please also see the comment on Figure 2C.

      Edited to “chage”

      e) Lines 134-135: I am not sure whether the author claims to provide evidence for this question, and I would be careful with claims that this work does resolve the question here.

      Have toned down claims as evidence for my analysis is currently inadequate.

      f) Lines 192-193: I disagree as the fCpGs can switch back and the current data does not convince me that this is an improvement upon mosaic mutation analysis. In my mind, the main advantage is the re-analysis of existing data and the parallel functional insights that can be obtained.

      Lineage analysis is more straightforward with DNA sequencing, but with an error rate of ~10-9 per base per division, one needs to sequence a billion base pairs to distinguish between immediate daughter cells. By contrast, with an inferred error rate of ~10-2 per fCpG per division, much less sequencing (about a million-fold less) is needed to find differences between daughter cells.

      g) Lines 208-209: I would be careful with claims of complexity resolution given many of the limitations and inherent systematic similarities, as well as the potential of fCpGs to change back to an ancestral state later in the lineage.

      Have modified the manuscript to indicate the analysis would be more challenging due to back changes.

      h) There seem to be few figures that assess phenomena across the three brains. Even when they exist there is no attempt to provide any statistical analyses to support the conclusions or permutations to assess outlier status relative to expectations.

      The analysis could be more extensive, but with only three brains, any results, like this study itself, would be rightly judged inadequate.

      Figure 2B: there appears to be a higher number of '0s' for, for instance, inhibitory neurons compared to excitatory neurons. Is that correct and worth mentioning? The changing axes scales also make it hard to assess.

      Inhibitory neurons do appear to have more unmethylated fCpGs compared to excitatory neurons, but in general, most inhibitory fCpGs are methylated with a skew to fully methylated fCpGs, consistent with the barcode starting predominately methylated and inhibitory neurons generally appearing earlier in development relative to excitatory neurons.

      j) Figure 2C: I have several issues with this. A minor one is the use of 'Glial' which, I believe, does not appear anywhere else before this, so I am unclear what this curve represents. Generally, however, I am not sure what the y-axis represents, as it is not described in the methods or figure legend. I initially thought it was the cumulative frequency, but I do not think that this squares with the data shown in B. I appreciate the overall idea of having 'earlier'/samples with fewer divisions being shifted to the left, but it is very confusing to me when I try to understand the details of the plot.

      This graph is now better described in the legend. “Glial” cells are defined as oligodendrocytes and astrocytes. Other non-neuronal cells (such a microglial cells) have now been removed from the graph.

      This graph attempts to illustrate how it may be possible to reconstruct brain development from adult neurons, assuming barcodes are mitotic clocks that become polymorphic with cell division. The X axis is “time”, and the Y axis indicates when different cell types reach their adult levels. The cartoon indicates what is visually present along the X axis during development--- brainstem, then ganglionic eminences with a thin cortex, and finally the mature brain with a robust cortex. Time for the X axis is barcode methylation and starts at 100% and ends at 50% or greater methylation. The fCpG barcode methylation of each cell places it on this timeline and indicates when it ceased dividing and differentiated.

      The Y axis indicates the progressive accumulation of the final adult contents of each cell type during this timeline. Early in development, the brain is rudimentary and adult cells are absent. At 90% methylation, only the inhibitory neurons in the pons are present. At 80% methylation, some excitatory neurons are beginning to appear. Inhibitory neurons in the pons have reached their final adult levels and many other inhibitory neuron types are reaching adult levels. By 70% methylation, most inhibitory neurons have reached their adult levels, and more adult excitatory neurons (mainly low cortical neurons, L4-6) and glial cells are beginning to appear. By 60% methylation, inhibitory neurogenesis has largely finished. Adult excitatory neurons and glial cells are more abundant and reach their adult levels by 50% or greater cell barcode methylation levels.

      The graph illustrates a rough alignment between mitotic ages inferred by barcode methylation levels and the physical appearances of different neuronal types during development. Many neurons die during development, and this graph, if valid, indicates when neurons that survive to adulthood appear during development.

      k) Figure 4Bff: it is confusing to me that the text jumps to these panels after introducing Figure 5. This makes it very hard to read this section of the text.

      The Figures appear in the order they are first referred to in the text.

      l) Figure 5A: could any of this difference be explained by the shared lineage of excitatory neurons and dorsal neocortical glia?

      Not sure

      m) Figure 5B: after stating that interneurons have a higher lineage fidelity, the figure legend here states the opposite and I am somewhat confused by this statement.

      The legend and text have been clarified. Fig 5A restricts fidelity to within inhibitory cell types. Fig 5B compares between neuron subtypes, and illustrates more apparent inhibitory subtype switching, albeit there are more interneuron subtypes than excitatory subtypes.

      n) Figure 5E: generally, the use of tSNE for large pairwise distance analysis is often frowned upon (e.g., PMID 37590228), and I would reconsider this argument.

      This analysis was an attempt to illustrate that cells of the same phenotype based on their tSNE metrics can be either closely or more distantly related. Although the tSNE comparisons were restricted to subtypes (and not to the entire tSNE graph), tSNE are not designed for such comparisons. This graph and discussion are deleted. 

      Reviewer #2 (Public review):

      The manuscript by Shibata proposed a potentially interesting idea that variation in methylcytosine across cells can inform cellular lineage in a way similar to single nucleotide variants (SNVs). The work builds on the hypothesis that the "replication" of methylcytosine, presumably by DNMT1, is inaccurate and produces stochastic methylation variants that are inherited in a cellular lineage. Although this notion can be correct to some extent, it does not account for other mechanisms that modulate methylcytosines, such as active gain of methylation mediated by DNMT3A/B activity and activity demethylation mediated by TET activity. In some cases, it is known that the modulation of methylation is targeted by sequence-specific transcription factors. In other words, inaccurate DNMT1 activity is only one of the many potential ways that can lead to methylation variants, which fundamentally weakens the hypothesis that methylation variants can serve as a reliable lineage marker. With that being said (being skeptical of the fundamental hypothesis), I want to be as open-minded as possible and try to propose some specific analyses that might better convince me that the author is correct. However, I suspect that the concept of methylation-based lineage tracing cannot be validated without some kind of lineage tracing experiment, which has been successfully demonstrated for scRNA-seq profiling but not yet for methylation profiling (one example is Delgado et al., nature. 2022).

      I thank Reviewer 2 for the careful evaluation. The validation experiment example (Delgado et al.) introduced sequence barcodes in mice, which is not generally feasible for human studies.

      (1) The manuscript reported that fCpG sites are predominantly intergenic. The author should also score the overlap between fCpG sites and putative regulatory elements and report p-values. If fCpG sites commonly overlap with regulatory elements, that would increase the possibility that these sites being actively regulated by enhancer mechanisms other than maintenance methyltransferase activity.

      As mentioned for Reviewer 1, fCpGs are filtered to eliminate cell type specific methylation.

      (2) The overlap between fCpG and regulatory sequence is a major alternative explanation for many of the observations regarding the effectiveness of using fCpG sites to classify cell types correctly. One would expect the methylation level of thousands of enhancers to be quite effective in distinguishing cell types based on the published single-cell brain methylome works.

      As mentioned above, the manuscript did not clearly indicate that the fCpG barcode is not a cell type classifier. The distinctions between fCpG barcodes and cell type classifiers are better explained in the new Supplement.

      (3) The methylation level of fCpG sites is higher in hindbrain structures and lower in forebrain regions. This observation was interpreted as the hindbrain being the "root" of the methylation barcodes and, through "progressive demethylation" produced the methylation states in the forebrain. This interpretation does not match what is known about methylation dynamics in mammalian brains, in particular, there is no data supporting the process of "progressive demethylation". In fact, it is known that with the activation of DNMT3A during early postnatal development in mice or humans (Lister et al., 2013. Science), there is a global gain of methylation in both CH and CG contexts. This is part of the broader issue I see in this manuscript, which is that the model might be correct if "inaccurate mC replication" is the only force that drives methylation dynamics. But in reality, active enzymatic processes such as the activation of DNMT3A have a global impact on the methylome, and it is unclear if any signature for "inaccurate mC replication" survives the de novo methylation wave caused by DNMT3A activity.

      Reviewer 2 highlights a critical potential flaw in that any ancestral signal recorded by random replication errors could be overwritten by other active methylation processes. I cannot present data that indicates fCpG replication errors are never overwritten, but new data indicate barcode reproducibility and stability with aging.

      New data are also present where barcodes are compared between daughter cells (zygote to ICM) in the setting of active and passive demethylation, when germline methylation is erased. This new analysis shows that daughter cells in 2 to 8 cell embryos have more related barcodes than morula or ICM cells. The subsequent active remethylation by a wave of DNMT3A activity may underlie the observation that the barcode appears to start predominately methylated in brain progenitors.

      (3) Perhaps one way the author could address comment 3 is to analyze methylome data across several developmental stages in the same brain region, to first establish that the signal of "inaccurate mC replication" is robust and does not get erased during early postnatal development when DNMT3A deposits a large amount of de novo methylation.

      See above

      (4) The hypothesis that methylation barcodes are homogeneous among progenitor cells and more polymorphic in derived cells is an interesting one. However, in this study, the observation was likely an artifact caused by the more granular cell types in the brain stem, intermediate granularity in inhibitory cells, and highly continuous cell types in cortical excitatory cells. So, in other words, single-cell studies typically classify hindbrain cell types that are more homogenous, and cortical excitatory cells that are much more heterogeneous. The difference in cell type granularity across brain structures is documented in several whole-brain atlas papers such as Yao et al. 2023 Nature part of the BICCN paper package.

      As noted above, fCpG barcode polymorphisms and cell type differentiation are confounded because cells of the same phenotype tend to have common progenitors. The fCpG barcode is not a cell type classifier but more a cell division clock that becomes polymorphic with time. Although fCpG barcodes could be more polymorphic in cortical excitatory cells because there are many more types, fCpG barcodes would inherently become more polymorphic in excitatory cells because they appear later in development.

      (5) As discussed in comment 2, the author needs to assess whether the successful classification of cell types (brain lineage) using fCpG was, in fact, driven by fCpG sites overlapping with cell-type specific regulatory elements.

      Although unclear in the manuscript, the fCpG is not a cell classifier and the barcode is polymorphic between cells of the same type. fCpG barcodes can appear to be cell classifiers because cell types appear at different times during development, and therefore different cell types have characteristic average barcode methylation levels.

      (6) In Figure 5E, the author tried to address the question of whether methylation barcodes inform lineage or post-mitotic methylation remodeling. The Y-axis corresponds to distances in tSNE. However, tSNE involves non-linear scaling, and the distances cannot be interpreted as biological distances. PCA distances or other types of distances computed from high-dimensional data would be more appropriate.

      The Figure and discussion are deleted (similar comment by Reviewer 1)

      Reviewer #3 (Public review):

      Summary:

      In the manuscript entitled "Human Brain Barcodes", the author sought to use single-cell CpG methylation information to trace cell lineages in the human brain.

      Strengths:

      Tracing cell lineages in the human brain is important but technically challenging. Lineage tracing with single-cell CpG methylation would be interesting if convincing evidence exists.

      Weaknesses:

      As the author noted, "DNA methylation patterns are usually copied between cell division, but the replication errors are much higher compared to base replication". This unstable nature of CpG methylation would introduce significant problems in inferring the true cell lineage. The unreliable CpG methylation status also raises the question of what the "Barcodes" refer to in the title and across this study. Barcodes should be stable in principle and not dynamic across cell generations, as defined in Reference#1. It is not convincing that the "dynamic" CpG methylation fits the "barcodes" terminology. This problem is even more concerning in the last section of results, where CpG would fluctuate in post-mitotic cells.

      I thank Reviewer 3 for his thoughtful and careful evaluation. I think the “barcode” terminology is appropriate. Dynamic engineered barcodes such as CRISPR/Cas9 mutable barcodes are used in biology to record changes over time. The fCpG barcode appears to start with a single state in a progenitor cell and changes with cell division to become polymorphic in adult cells. Therefore, I think the description of a dynamic fCpG barcode is appropriate.

      Reviewer #3 (Recommendations for the authors):

      (1) As the author noted, "DNA methylation patterns are usually copied between cell division, but the replication errors are much higher compared to base replication". This unstable nature of CpG methylation would introduce significant problems in inferring the true cell lineage. To establish DNA methylation as a means for lineage tracing, one control experiment would be testing whether the DNA methylation patterns can faithfully track cell lineages for in vitro differentiated & visibly tracked cell lineages. Has this kind of experiment been done in the field?

      These types of experiments have not been performed to my knowledge and an appropriate tissue culture model is uncertain. New single cell WGBS data from the zygote to ICM indicate that more immediate daughter cells have more related barcodes even in the setting of active DNA demethylation.

      (2) The study includes assumptions that should be backed with solid rationale, supporting evidence, or reference. Here are a couple of examples:

      a) the author discarded stable CpG sites with <0.2 or >0.8 average methylation without a clear rationale in H02, and then used <0.3 and >0.7 for a specific sample H01.

      The filtering was ad hoc and was used to remove, as much as possible, CpG sites with cell type specific or patient specific methylation. CpG sites with skewed methylation are more likely cell type specific, whereas X chromosome CpG sites with methylation closer to 0.5 in male cells are more likely to be unstable. The ad hoc filtering attempted to remove cell specific CpGs sites while still retaining enough CpG sites to allow comparisons between cells.

      b) The author assumed that the early-formed brain stem would resemble progenitors better and have a higher average methylation level than the forebrain. However, this difference in DNA methylation status could reflect developmental timing or cell type-specific gene expression changes.

      This observation that brain stem neurons that appear early in development have highly methylated fCpG barcodes in all 3 brains supports the idea that the fCpG barcode starts predominately methylated. Alternative explanations are possible.

      (3) The conclusion that excitatory neurons undergo tangential migration is unclear - how far away did the author mean for the tangential direction? Lateral dispersion is known, but it would be striking that the excitatory neurons travel across different brain regions. The question is, how would the author interpret shared or divergent methylation for the same cell type across different brain regions?

      As noted with Reviewer 1, this analysis is modified to indicate that evidence of tangential migration is greater for inhibitory than excitatory neurons, but the extent of excitatory neuron migration is uncertain because of sparse sampling, and because fCpG barcodes can be similar by chance.

      (4) The sparsity and resolution of the single-cell DNA methylation data. The methylation status is detected in only a small fraction (~500/31,000 = 1.6%) of fCpGs per cell, with only 48 common sites identified between cell pairs. Given that the human genome contains over 28 million CpG sites, it is important to evaluate whether these fCpGs are truly representative. How many of these sites were considered "barcodes"?

      fCpG barcodes are distinct from traditional cell type classifiers, and how fCpGs are identified are better outlined in the new Supplement.

      (5) While focusing on the X-chromosome may simplify the identification of polymorphic fCpGs, the confidence in determining its methylation status (0 or 1) is questionable when a CpG site is covered by only one read. Did the author consider the read number of detected fCpGs in each cell when calculating methylation levels? Certain CpG sites on autosomes may also have sufficient coverage and high variability across cells, meeting the selection criteria applied to X-chromosome CpGs.

      In most cases, a fCpG site was covered by only a single read

      (6) The overall writing in the Title, the Main text, Figure legends, and Methods sections are overly simplified, making it difficult to follow. For instance, how did the author perform PWD analysis? How did they handle missing values when constructing lineage trees?

      There is not much introduction to lineage tracing in the human brain or the use of DNA methylation to trace cell lineage.

      These shortcomings are improved in the manuscript and with the new Supplement. The analysis pipeline including the Python programs are outlined and included as new Supplemental materials. IQ tree can handle the binary fCpG barcode data and skips missing values with its standard settings.

      Line 80: it is unclear: "Brain patterns were similar"

      Clarified

      Line 98: The meaning is unclear here: "Outer excitatory and glial progenitor cells are present" What are these glial progenitor cells and when/how they stop dividing?

      The glial cells are the oligodendrocytes and astrocytes. The main take away point is that these glial cells have low barcode methylation, consistent with their appearances later in development.

      Line 104: It is unclear if this is a conclusion or assumption -- "A progenitor cell barcode should become increasingly polymorphic with subsequent divisions." The "polymorphic" happens within the progenitors, their progenies, or their progenies at different time points.

      The statement is now clarified as an assumption in the manuscript.

      Similarly line 134 "Barcodes would record neuronal differentiation and migration." Is this a conclusion from this study or a citation? How is the migration part supported?

      The reasoning is better explained in the manuscript.  Migration can be documented if immediate daughter cells with similar barcodes are found in different parts of the adult brain, albeit analysis is confounded by sparse sampling and because barcodes may be similar by chance.

      Line 148 and 150: "Nearest neighbor ... neuron pairs" in DNA methylation status would conceivably reflect their cell type-specific gene expression, how did the author distinguish this from cell lineage?

      As noted above, because cells with similar phenotypes usually arise from common progenitors, cells within a clade are also usually related. However, the barcodes are still polymorphic within a clade and potentially add complementary information on mitotic ages, ancestry within a clade, and possible cell migration.

      Figure 3C: "Cells that emerge early in development" Where are they on the figure?

      Hindbrain neurons differentiate early in development and their barcodes are more methylated. The figure has been modified to label some of the values with their neuron types. Also, the older figure mistakenly included data from all 3 brains and now the data are only from brain H01.

      Figures 4D and 4E, distinguishing cell subtypes is challenging, as the same color palette is used for both excitatory and inhibitory neurons.

      Unfortunate limitations due to complexity and color limitations

      Figures 4 and 5, what are these abbreviations?

      The abbreviations are presented in Figure 1 and maintained in subsequent figures.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors intended to investigate the earliest mechanisms enabling self-prioritization, especially in the attention. Combining a temporal order judgement task with computational modelling based on the Theory of Visual Attention (TVA), the authors suggested that the shapes associated with the self can fundamentally alter the attentional selection of sensory information into awareness. This self-prioritization in attentional selection occurs automatically at early perceptual stages. Furthermore, the processing benefits obtained from attentional selection via self-relatedness and physical salience were separated from each other.

      Strengths:

      The manuscript is written in a way that is easy to follow. The methods of the paper are very clear and appropriate.

      Thank you for your valuable feedback and helpful suggestions. Please see specific answers below.

      Weaknesses:

      There are two main concerns:

      (1) The authors had a too strong pre-hypothesis that self-prioritization was associated with attention. They used the prior entry to consciousness (awareness) as an index of attention, which is not appropriate. There may be other processing that makes the stimulus prior to entry to consciousness (e.g. high arousal, high sensitivity), but not attention. The self-related/associated stimulus may be involved in such processing but not attention to make the stimulus easily caught. Perhaps the authors could include other methods such as EEG or MEG to answer this question.

      We found the possibility of other mechanisms to be responsible for “prior entry” interesting too, but believe there are solid grounds for the hypothesis that it is indicative of attention:

      First, prior entry has a long-standing history as in index of attention (e.g., Titchener, 1903; Shore et al., 2001; Yates and Nicholls, 2009; Olivers et al. 2011; see Spence & Parise, 2010, for a review.) Of course, other factors (like the ones mentioned) can contribute to encoding speed. However, for the perceptual condition, we systematically varied a stimulus feature that is associated with selective attention (salience, see e.g. Wolfe, 2021) and kept other features that are known to be associated with other factors such as arousal and sensitivity constant across the two variants (e.g. clear over threshold visibility) or varied them between participants (e.g. the colours / shapes used).

      Second, in the social salience condition we used a manipulation that has repeatedly been used to establish social salience effects in other paradigms (e.g., Li et al., 2022; Liu & Sui, 2016; Scheller et al., 2024; Sui et al., 2015; see Humphreys & Sui, 2016, for a review). We assume that the reviewer’s comment suggests that changes in arousal or sensitivity may be responsible for social salience effects, specifically. We have several reasons to interpret the social salience effects as an alteration in attentional selection, rather than a result of arousal or sensitivity:

      Arousal and attention are closely linked. However, within the present model, arousal is more likely linked to the availability of processing resources (capacity parameter C). That is, enhanced arousal is typically not stimulus-specific, and therefore unlikely affects the *relative* advantage in processing weights/rates of the self-associated (vs other-associated) stimuli. Indeed, a recent study showed that arousal does not modulate the relative division of attentional resources (as modelled by the Theory of Visual Attention; Asgeirsson & Nieuwenhuis, 2017). As such, it is unlikely that arousal can explain the observed results in relative processing changes for the self and other identities.

      Further, there is little reason to assume that presenting a different shape enhances perceptual sensitivity. Firstly, all stimuli were presented well above threshold, which would shrink any effects that were resulting from increases in sensitivity alone. Secondly, shape-associations were counterbalanced across participants, reducing the possibility that specific features, present in the stimulus display, lead to the measurable change in processing rates as a result of enhanced shape-sensitivity.

      Taken together, both, the wealth of literature that suggests prior entry to index attention and the specific design choices within our study, strongly support the notion that the observed changes in processing rates are indicative of changes in attentional selection, rather than other mechanisms (e.g. arousal, sensitivity).

      (2) The authors suggested that there are two independent attention processes. I suspect that the brain needs two attention systems. Is there a probability that the social and perceptual (physical properties of the stimulus) salience fired the same attention processing through different processing?

      We appreciate this thought-provoking comment. We conceptualize attention as a process that can facilitate different levels of representation, rather than as separate systems tuned to specific types of information. Different forms of representation, such as the perceptual shape, or the associated social identity, may be impacted by the same attentional process at different levels of representation. Indeed, our findings suggest that both social and perceptual salience effects may result from the same attentional system, albeit at different levels of representation. This is further supported by the additivity of perceptual and social salience effects and the negative correlation of processing facilitations between perceptually and socially salient cues. These results may reflect a trade-off in how attentional resources are distributed between either perceptually or socially salient stimuli.

      Reviewer #2 (Public review):

      Summary:

      The main aim of this research was to explore whether and how self-associations (as opposed to other associations) bias early attentional selection, and whether this can explain well-known self-prioritization phenomena, such as the self-advantage in perceptual matching tasks. The authors adopted the Visual Attention Theory (VAT) by estimating VAT parameters using a hierarchical Bayesian model from the field of attention and applied it to investigate the mechanisms underlying self-prioritization. They also discussed the constraints on the self-prioritization effect in attentional selection. The key conclusions reported were:

      (1) Self-association enhances both attentional weights and processing capacity

      (2) Self-prioritization in attentional selection occurs automatically but diminishes when active social decoding is required, and

      (3) Social and perceptual salience capture attention through distinct mechanisms.

      Strengths:

      Transferring the Theory of Visual Attention parameters estimated by a hierarchical Bayesian model to investigate self-prioritization in attentional selection was a smart approach. This method provides a valuable tool for accessing the very early stages of self-processing, i.e., attention selection. The authors conclude that self-associations can bias visual attention by enhancing both attentional weights and processing capacity and that this process occurs automatically. These findings offer new insights into self-prioritization from the perspective of the early stage of attentional selection.

      Thank you for your valuable feedback and helpful suggestions. Please see specific answers below.

      Weaknesses:

      (1) The results are not convincing enough to definitively support their conclusions. This is due to inconsistent findings (e.g., the model selection suggested condition-specific c parameters, but the increase in processing capacity was only slight; the correlations between attentional selection bias and SPE were inconsistent across experiments), unexpected results (e.g., when examining the impact of social association on processing rates, the other-associated stimuli were processed faster after social association, while the self-associated stimuli were processed more slowly), and weak correlations between attentional bias and behavioral SPE, which were reported without any p-value corrections. Additionally, the reasons why the attentional bias of self-association occurs automatically but disappears during active social decoding remain difficult to explain. It is also possible that the self-association with shapes was not strong enough to demonstrate attention bias, rather than the automatic processes as the authors suggest. Although these inconsistencies and unexpected results were discussed, all were post hoc explanations. To convince readers, empirical evidence is needed to support these unexpected findings.

      Thank you for outlining the specific points that raise your concern. We were happy to address these points as follows:

      a. Replications and Consistency: In our study, we consistently observed trends (relative reduction in processing speed of the self-associated stimulus) in the social salience conditions across experiments. While Experiment 2 demonstrated a significant reduction in processing rate towards self-stimuli, there was a notable trend in Experiment 1 as well.

      b. Condition-specific parameters: The condition-specific C parameters, though presenting a small effect size, significantly improved model fit. Inspecting the HDI ranges of our estimated C parameters indicates a high probability (85-89%) that processing capacity increased due to social associations, suggesting that even small changes (~2Hz) can hold meaningful implications within the context attentional selection.

      Please also note that the main conclusions about relative salience (self/other, salient/non-salient) are based on the relative processing rates. Processing rates are the product of the processing capacity (condition- but not stimulus dependent) and the attentional weight (condition and stimulus dependent). The latter is crucial to judge the *relative* advantage of the salient stimulus. Hence, the self-/salient stimulus advantage that is reflected in the ‘processing rate difference’ is automatically also reflected in the relative attentional weights attributed to the self/other and salient/non-salient stimuli. As such, the overall results of an automatic relative advantage of self-associated stimuli hold, independently of the change in overall processing capacity.

      c. Correlations: Regarding the correlations the reviewer noted, we wish to clarify that these were exploratory, and not the primary focus of our research. The aim of these exploratory analyses was to gauge the contribution of attentional selection to matching-based SPEs. As SPEs measured via the matching task are typically based on multiple different levels of processing, the contribution of early attentional selection to their overall magnitude was unclear. Without being able to gauge the possible effect sizes, corrected analyses may prevent detecting small but meaningful effects. As such, the effect sizes reported serve future studies to estimate power a priori and conduct well-powered replications of such exploratory effects. Additionally, Bayes factors were provided to give an appreciation of the strength of the evidence, all suggesting at least moderate evidence in favour of a correlation. Lastly, please note that effects that were measured within individuals and task (processing rate increase in social and perceptual decision dimensions in the TOJ task) showed consistent patterns, suggesting that the modulations within tasks were highly predictive of each other, while the modulations between tasks were not as clearly linked. We will add this clarification to the revised manuscript.

      d. Unexpected results: The unexpected results concerning the processing rates of other-associated versus self-associated stimuli certainly warrant further discussion. We believe that the additional processing steps required for social judgments, reflected in enhanced reaction times, may explain the slower processing of self-associated stimuli in that dimension. We agree that not all findings will align with initial hypotheses, and this variability presents avenues for further research. We have added this to the discussion of social salience effects.

      e. Whether association strength can account for the findings: We appreciate the scepticism regarding the strength of self-association with shapes. However, our within-participant design and control matching task indicate that the relative processing advantage for self-associated stimuli holds across conditions. This makes the scenario that “the self-association with shapes was not strong enough to demonstrate attention bias” very unlikely. Firstly, the relative processing advantage of self-associated stimuli in the perceptual decision condition, and the absence of such advantage in the social decision condition, were evidenced in the same participants. Hence, the strength of association between shapes and social identities was the same for both conditions. However, we only find an advantage for the self-associated shape when participants make perceptual (shape) judgements. It is therefore highly unlikely that the “association strength” can account for the difference in the outcomes between the conditions in experiment 1. Also, note that the order in which these conditions were presented was counter-balanced across participants, reducing the possibility that the automatic self-advantage was merely a result of learning or fatigue. Secondly, all participants completed the standard matching task to ascertain that the association between shapes and identities did indeed lead to processing advantages (across different levels).

      In summary, we believe that the evidence we provide supports the final conclusions. We do, of course, welcome any further empirical evidence that could enhance our understanding of the contribution of different processing levels to the SPE and are committed to exploring these areas in future work.

      (2) The generalization of the findings needs further examination. The current results seem to rely heavily on the perceptual matching task. Whether this attentional selection mechanism of self-prioritization can be generalized to other stimuli, such as self-name, self-face, or other domains of self-association advantages, remains to be tested. In other words, more converging evidence is needed.

      The reviewer indicates that the current findings heavily rely on the perceptual matching task, and it would be more convincing to include other paradigm(s) and different types of stimuli. We are happy to address these points here: first, we specifically used a temporal order paradigm to tap into specific processes, rather than merely relying on the matching task. Attentional selection is, along with other processes, involved in matching, but the TOJ-TVA approach allows tapping into attentional selection specifically.  Second, self-prioritization effects have been replicated across a wide range of stimuli (e.g. faces: Wozniak et al., 2018; names or owned objects: Scheller & Sui, 2022a, or even fully unfamiliar stimuli: Wozniak & Knoblich, 2019) and paradigms (e.g. matching task: Sui et al., 2012; cross-modal cue integration: e.g. Scheller & Sui, 2022b; Scheller et al., 2023; continuous flash suppression: Macrae et al., 2017; temporal order judgment: Constable et al., 2019; Truong et al., 2017). Using neutral geometric shapes, rather than faces and names, addresses a key challenge in self research: mitigating the influence of stimulus familiarity on results. In addition, these newly learned, simple stimuli can be combined with other paradigms, such as the TOJ paradigm in the current study, to investigate the broader impact of self-processing on perception and cognition.

      To the best of our knowledge, this is the first study showing evidence about the mechanisms that are involved in early attentional selection of socially salient stimuli. Future replications and extensions would certainly be useful, as with any experimental paradigm.

      (3) The comparison between the "social" and "perceptual" tasks remains debatable, as it is challenging to equate the levels of social salience and perceptual salience. In addition, these two tasks differ not only in terms of social decoding processes but also in other aspects such as task difficulty. Whether the observed differences between the tasks can definitively suggest the specificity of social decoding, as the authors claim, needs further confirmation.

      Equating the levels of social and perceptual salience is indeed challenging, but not an aim of the present study. Instead, the present study directly compares the mechanisms and effects of social and perceptual salience, specifically experiment 2. By manipulating perceptual salience (relative colour) and social salience (relative shape association) independently and jointly, and quantifying the effects on processing rates, our study allows to directly delineate the contributions of each of these types of salience. The results suggest additive effects (see also Figure 7). Indeed, the possibility remains that these effects are additive because of the use of different perceptual features, so it would be helpful for future studies to explore whether similar perceptual features lead to (supra-/sub-) additive effects. In either case, the study design allows to directly compare the effects and mechanisms of social and perceptual salience.

      Regarding the social and perceptual decision dimensions, they were not expected to be equated. Indeed, the social decision dimension requires additional retrieval of the associated identity, making it likely more challenging. This additional retrieval is also likely responsible for the slower responses towards the social association compared to the shape itself. However, the motivation to compare the effects of these two decisional dimensions lies in the assumption that the self needs to be task relevant. Some evidence suggests that the self needs to be task-relevant to induce self-prioritization effects (e.g., Woźniak & Knoblich, 2022). However, these studies typically used matching tasks and were powered to detect large effects only (e.g. f = 0.4, n = 18). As it is likely that lacking contribution of decisional processing levels (which interact with task-relevance) will reduce the SPE, smaller self-prioritization effects that result from earlier processing levels may not be detected with sufficient statistical power. Targeting specific processing levels, especially those with relatively early contributions or small effect sizes, requires larger samples (here: n = 70) to provide sufficient power. Indeed, by contrasting the relative attentional selection effects in the present study we find that the self does not need to be task-relevant to produce self-prioritization effects. This is in line with recent findings of prior entry of self-faces (Jubile & Kumar, 2021)

      Reviewer #2 (Recommendations for the authors):

      Suggestions:

      (1) The research questions should be revised to better align with the conclusions. For example, Q2 is phrased as "Does self-relatedness bias attentional selection at the level of the perceptual feature representation (shape) or at the level of the associated identity (social association)," which is unclear in its reference to "levels." A more appropriate phrasing would be whether the self-association bias occurs automatically or whether it depends on explicit social decoding.

      Thank you for this suggestion – we have revised the phrasing accordingly: “Does self-relatedness bias attentional selection automatically or does it require explicit social decoding?”

      (2) After presenting the data, it would be helpful to include one or two sentences summarizing the conclusions drawn from the data and how they relate to the research questions. Currently, readers are left to guess whether the results are consistent with the hypotheses.

      Thank you for this suggestion, which we think will enhance the clarity of the manuscript – we have added summary sentences when presenting the results:<br /> “This cross-experimental parameter inspection revealed that participants exhibited an attentional selection bias towards socially associated information. Interestingly, enhanced processing speed was observed for other-associated rather than self-associated information, a pattern that diverged from our prediction.”

      (1) “Results from experiment 2 demonstrated a faster, more automatic attentional selection for self-associated information when the decision did not require explicit social decoding. When the social identity had to be judged, processing speed for self-associated information decreased. Contrary to the hypothesis that social decoding is necessary for self-prioritization to emerge, these findings suggest that attentional selection can operate automatically to prioritize self-associated information. “

      (2) “Taken together, as also confirmed in the cross-experimental analysis, attentional selection favoured the other-related information when social identity had to be judged. In contrast, perceptual salience, as predicted, led to increased processing speed for the more salient stimulus. “

      (3) The identity of the "other" used in the experiments is unclear, making it uncertain whether the results are self-specific. It would be beneficial to compare the self condition with a control condition, such as a close friend vs. an unfamiliar other. Alternatively, the results may reflect attentional bias for familiar vs. unfamiliar individuals rather than self-specific bias.

      Thank you for this comment. Firstly, we would like to clarify that we have provided participants with a description of who the “other” is (see methods: “At the beginning of this task, participants were told that one of the two geometric shapes that was used in the TOJ task has been assigned to them, and the other shape has been assigned to another participant in the experiment – someone they did not know, but who was of similar age and gender”). We aimed to make the ‘other’ as concrete as possible, while maintaining a ‘stranger’ identity.

      Secondly, this specification is in line with the vast majority of the literature, which typically measures the effects of self-prioritization relative to the association with an unfamiliar other (stranger), or an unfamiliar and familiar other (e.g. friend, family member). They find that processing advantages that affect friend-related stimuli (friend-stimuli being processed faster than stranger-associated stimuli) are likely mediated by self-extension, that is, an association of the friend with the self. As such, SPEs, relative to familiar others, are typically smaller in size (see, e.g., Sui et al., 2012). They, however, are less stable and more variable than the self-prioritization effects measured relative to a stranger (see Scheller & Sui, 2022 JEP:HPP). Importantly, this is driven by the variability of the friend-associated stimulus, rather than the self or other-associated stimulus (see Figure 4 in main text and S5 in supplementary material in Scheller & Sui, 2022: https://durham-repository.worktribe.com/output/1210478/the-power-of-the-self-anchoring-information-processing-across-contexts). Effectively, this would suggest that choosing a familiar other as a reference would not only (a) lead to a smaller effect size, but also (b) be a less stable effect, which likely depends on the association the individual has to the other familiar person. In contrast, by associating the other shape with another participant in this experiment, we provide participants not only with a concrete representation of a stranger, but also maximise our ability to detect true effects, as these are likely to be larger and more stable.

      (4) The key aspects of the procedure (e.g., the order of different conditions) and its rationale need to be clearly explained before or during the presentation of the results. Currently, readers are left to infer certain details.

      Thank you for pointing this out. The methods that provide these details are outlined at the end of the document, however, we agree it would be useful to bring some of these details up. We have therefore revised the methods figure (Figure 3) to include an outline of the task type, order, and trial numbers. Task boxes are colour coded by the conditions that are listed in the results figures of the manuscript. We also added these details to the caption of Figure 3.

      “Task structures of Experiments 1 and 2. Both experiments started with a TOJ baseline task. In Experiment 1, only non-salient targets were presented, while in Experiment 2, perceptually salient and non-salient trials were included. These were presented in randomly intermixed order. Next, targets were associated with social identities. Associations were practiced using the matching task. Following association learning, which attaches social salience to the shapes, participants completed the same TOJ task as before. In Experiment 1, they completed one block using a social decision dimension, and one block using a perceptual decision dimension. The order of these blocks was counterbalanced across participants to reduce the influence of order effects in the results. In Experiment 2, perceptually salient and non-salient stimuli were presented in an intermixed fashion, and participants responded within the social decision dimension. Each task block was preceded by 8 (matching) to 14 (TOJ) practice trials.”

      (5) Certain imprecise terms used to describe the results, such as "slightly," "roughly," and "loosely," create confusion for the readers. The authors should take a clearer stance on the results and provide an explanation for why the data only "slightly," "roughly," or "loosely" support the findings.

      Thank you for highlighting this. We have provided a more concrete wording and details throughout (e.g., “target shapes’ were 30% bigger than the ‘background shapes”).

      Lastly, we have updated the formatting of the manuscript to provide higher fidelity figures, which were previously compromised by file conversion.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This provocative manuscript from presents valuable comparisons of the morphologies of Archaean bacterial microfossils to those of microbes transformed under environmental conditions that mimic those present on Earth during the same Eon, although the evidence in support of the conclusions is currently incomplete. The reasons include that taphonomy is not presently considered, and a greater diversity of experimental environmental conditions is not evaluated -- which is important because we ultimately do not know much about Earth's early environments. The authors may want to reframe their conclusions to reflect this work as a first step towards an interpretation of some microfossils as 'proto-cells,' and less so as providing strong support for this hypothesis. 

      Regarding the taphonomic alterations: The editor and reviewers are correct in pointing out this issue. Taphonomic alteration of the microfossils attains special significance in the case of microorganisms, as they lack rigid structures and are prone to morphological alterations during or after their fossilization. We are acutely aware of this issue and have conducted long-term experiments (lasting two years) to observe how cells die, decay, and get preserved. A large section of the manuscript (pages 11 to 20) and a substantial portion of the supplementary information is dedicated to understanding the taphonomic alterations. To the best of our knowledge, these are among the longest experiments done to understand the taphonomic alterations of the cells within laboratory conditions. 

      Recent reports by Orange et al. (1,2)  showed that under favorable environmental conditions, cells could be fossilized rather rapidly with little morphological modifications. We observed a similar phenomenon in this work. Cells in our study underwent rapid encrustation with cations from the growth media. We have analyzed the morphological changes over a period of 18 months. After 18 months, the softer biofilms got encrusted entirely in salt and turned solid (Fig. ). Despite this transformation, morphologically intact cells could still be observed within these structures. This suggests that the cells inhabiting Archaean coastal marine environments could undergo rather rapid encrustation, and their morphological features could be preserved in the geological record with little taphonomic alteration.    

      Regarding the environmental conditions: We are in total agreement with the reviewers that much is unknown about Archaean geology and its environmental conditions. Like the present-day Earth, Archaean Earth certainly had regions that greatly differed in their environmental conditions—volcanic freshwater ponds, brines, mildly halophilic coastal marine environments, and geothermal and hydrothermal vents, to name a few. Our experimental design focuses on one environment we have a relatively good understanding of rather than the rest of the planet, of which we know little. Below, we list our reasons for restricting to coastal marine environments and studying cells under mildly halophilic experimental conditions.  

      (1) Very little continental crust from Haden and early Archaean Eon exists on the presentday Earth. Much of our geochemical understanding of this time period was a result of studying the Pilbara Iron Formations and the Barberton Greenstone Belt. Geological investigations suggest that these sites were coastal marine environments. The salinity of coastal marine environments is higher than that of open oceans due to the greater water evaporation within these environments. Moreover, brines were discovered within pillow basalts within the Barberton greenstone belt, suggesting that the salinity within these sites is higher or similar to marine environments. 

      (2) We are not certain about the environmental conditions that could have supported the origin of life. However, all currently known Archaean microfossils were reported from coastal marine environments (3.8-2.4Ga). This suggests that proto-life likely flourished in mildly halophilic environments, similar to the experimental conditions employed in our study. 

      (3) The chemical analysis of Archaean microfossils also suggests that they lived in saltrich environments, as most, if not all, microfossils are closely associated, often encrusted in a thin layer of salt.  

      However, we concur with the reviewers that our interpretations should be reassessed if Archaean microfossils that greatly differ from the currently known microfossils are to be discovered or if new microfossils are to be reported from environments other than coastal marine sites.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Microfossils from the Paleoarchean Eon represent the oldest evidence of life, but their nature has been strongly debated among scientists. To resolve this, the authors reconstructed the lifecycles of Archaean organisms by transforming a Gram-positive bacterium into a primitive lipid vesicle-like state and simulating early Earth conditions. They successfully replicated all morphologies and life cycles of Archaean microfossils and studied cell degradation processes over several years, finding that encrustation with minerals like salt preserved these cells as fossilized organic carbon. Their findings suggest that microfossils from 3.8 to 2.5 billion years ago were likely liposome-like protocells with energy conservation pathways but without regulated morphology. 

      Strengths: 

      The authors have crafted a compelling narrative about the morphological similarities between microfossils from various sites and proliferating wall-deficient bacterial cells, providing detailed comparisons that have never been demonstrated in this detail before. The extensive number of supporting figures is impressive, highlighting numerous similarities. While conclusively proving that these microfossils are proliferating protocells morphologically akin to those studied here is challenging, we applaud this effort as the first detailed comparison between microfossils and morphologically primitive cells. 

      Weaknesses: 

      Although the species used in this study closely resembles the fossils morphologically, it would be beneficial to provide a clearer explanation for its selection. The literature indicates that many bacteria, if not all, can be rendered cell wall-deficient, making the rationale for choosing this specific species somewhat unclear. While this manuscript includes clear morphological comparisons, we believe the authors do not adequately address the limitations of using modern bacterial species in their study. All contemporary bacteria have undergone extensive evolutionary changes, developing complex and intertwined genetic pathways unlike those of early life forms. Consequently, comparing existing bacteria with fossilized life forms is largely hypothetical, a point that should be more thoroughly emphasized in the discussion. 

      Another weak aspect of the study is the absence of any quantitative data. While we understand that obtaining such data for microfossils may be challenging, it would be helpful to present the frequencies of different proliferative events observed in the bacterium used. Additionally, reflecting on the chemical factors in early life that might cause these distinct proliferation modes would provide valuable context. 

      Regarding our choice of using modern organisms or this particular bacterial species: 

      Based on current scientific knowledge, it is logical to infer that cellular life originated as protocells; nevertheless, there has been no direct geological evidence for the existence of such cells on early Earth. Hence, protocells remain an entirely theoretical concept. Moreover, protocells are considered to have been far more primitive than present-day cells. Surprisingly, this lack of sophistication was the biggest challenge in understanding protocells. Designing experiments in which cells are primitive (but not as primitive as non-living lipid vesicles) and still retain a functional resemblance to a living cell does pose some practical challenges. Laboratory experiments with substitute (proxy) protocells almost always come with some limitations. Although not a perfect proxy, we believe protocells and protoplasts share certain characteristics. Having said that, we would like to reemphasize that protoplasts are not protocells. Our reasons for using protoplasts as model organisms and working with this bacterial species (Exiguobacterium Strain-Molly) are based on several scientific and practical criteria listed below.

      (1) Irrespective of cell physiology and intracellular complexity, we believe that protoplasts and protocells share certain similarities in the biophysical properties of their cytoplasm. We explained our reasoning in the manuscript introduction and in our previous manuscripts (Kanaparthi et al., 2024 & Kanaparthi et al., 2023). In short, to be classified as a cell, even a protocell should possess minimal biosynthetic pathways, a physiological mechanism of harvesting free energy from the surrounding (energy-yielding pathways), and a means of replicating its genetic material and transferring it to the daughter cells. These minimal physiological processes could incorporate considerable cytoplasmic complexity. Hence, the biophysical properties of the protocell cytoplasm could have resembled those of the cytoplasm of protoplasts, irrespective of the genomic complexity. 

      (2) Irrespective of their physiology, protoplasts exhibit several key similarities to protocells, such as their inherent inability to regulate their morphology or reproduction. This similarity was pointed out in previous studies (3). Despite possessing all the necessary genetic information, protoplasts undergo reproduction through simple physiochemical processes independent of canonical molecular biological processes. This method of reproduction is considered to have been erratic and rather primitive, akin to the theoretical propositions on protocells. Although protoplasts are fully evolved cells with considerable physiological complexity, the above-mentioned biophysical similarities suggest that the protoplast life cycle could morphologically resemble that of protocells (in no other aspect except for their morphology and reproduction).  

      (3) Physiologically or genomically different species of Gram-positive protoplasts are shown to exhibit similar morphologies. This suggests that when Gram-positive bacteria lose their cell wall and turn into a protoplast,  they reproduce in a similar manner independent of physiological or genome-based differences. As morphology and only morphology is key to our study, at least from the scope of this study, intracellular complexity is not a key consideration. 

      (4) This specific strain was isolated from submerged freshwater springs in the Dead Sea. This isolate and members of this bacterial genus are known to have been well acclimatized to growing in a wide range of salt concentrations and in different salt species. This is important for our study (this and previous manuscript), in which cells must be grown not only at high salt concentrations (1-15%) but in different salts like NaCl, MgCl<sub>2</sub>, and KCl. 

      (5) Our initial interest in this isolate was due to its ability to reduce iron at high salt concentrations. Given that most spherical microfossils are found in Archaean-banded iron formations covered in pyrite, this suggests that these microfossils could have been reducing oxidized iron species like Fe(III). Nevertheless, over the course of our study, we realized the complexities of live cell staining and imaging under anoxic conditions. Given that the scope of the manuscript is restricted only to comparing the morphologies, not the physiology, we abandoned the idea of growing cells under anoxic conditions.  

      Based on these observations, cell physiology may not be a key consideration, at least within the scope of studying microfossil morphology. However, we want to emphasize again that “We do not claim present-day protoplasts are protocells.”  

      Regarding the absence of quantitative data:

      We are unsure what the reviewer meant by the absence of quantitative data. Is it from the cell size/reproductive pathways perspective or from a microfossil/ecological perspective? At the risk of being portrayed in a bad light, we admit that we did not present quantitative data from either of these perspectives. In our defense, this was not due to our lack of effort but due to the practical limitations imposed by our model organism. 

      If the reviewer means the quantitative data regarding cell sizes and morphology: In our previous work, we studied the relationship between protoplast morphology, growth rate, and environmental conditions. In that study, we proposed that the growth rate is one factor that regulates protoplast morphology. Nevertheless, we did not observe uniformity in the sizes of the cells. This lack of uniformity was not just between the replicates but even among the cells grown within the same culture flask or the cells within the same microscopic field. Moreover, cells are often observed to be reproducing either by forming internal or external or by both these processes at the same time. The size and morphological differences among cells within a growth stage could be explained by the physiological and growth rate heterogenicity among cells. 

      Bacterial growth curves and their partition into different stages (lag, log & stationary), in general, represent the growth dynamics of an entire bacterial population. Nevertheless, averaging the data obscures the behavior of individual cells (4,5). It is known that genetically identical cells within a single bacterial population could exhibit considerable cell-to-cell variation in gene expression (6,7) and growth rates (8). The reason for such stochastic behavior among monoclonal cells has not been well understood. In the case of normal cells, morphological manifestation of these variations is restricted by a rigid cell wall. Given the absence of a cell wall in protoplasts, we assume such cell-to-cell variations in growth rate is manifested in cell morphology. This makes it challenging to quantitatively determine variations in cell sizes or the size increase in a statically robust manner, even in monoclonal cells. 

      Although this lack of uniformity in cell sizes should not be perceived as a limitation, this behavior is consistently observed among microfossils. Spherical microfossils of similar morphology but different sizes were reported from different microfossil sites (9,10). In this regard, both protoplasts and microfossils are very similar. 

      If the reviewer means the quantitative data from an ecological perspective: 

      Based on the elemental composition and the isotopic signatures of the organic carbon, we can deduce if these structures are of biological origin or not. However, any further interpretation of this data to annotate these microfossils to a particular physiology group is fraught with errors. Hence, we refrain from making any inferences about the physiology and ecological function of these microfossils. This lack of clarity on the physiology of microfossils reduces the chance of quantitative studies on their ecological functions. Moreover, we would like to re-emphasize that the scope of this work is restricted to morphological comparison and is not targeted at understanding the ecological function of these microfossils. This narrow objective also limits the nature of the quantitative data we could present.

      Moreover, developing a quantitative understanding of some phenomena could be technically challenging. Many theories on the origin of life, like chemical evolution, started with the qualitative observation that lightning could mediate the synthesis of biologically relevant organic carbon. Our quantitative understanding of this process is still being explored and debated even to this day.     

      Reviewer #2 (Public Review): 

      Summary: 

      In summary, the manuscript describes life-cycle-related morphologies of primitive vesiclelike states (Em-P) produced in the laboratory from the Gram-positive bacterium Exiguobacterium Strain-Molly) under assumed Archean environmental conditions. Em-P morphologies (life cycles) are controlled by the "native environment". In order to mimic Archean environmental conditions, soy broth supplemented with Dead Sea salt was used to cultivate Em-Ps. The manuscript compares Archean microfossils and biofilms from selected photos with those laboratory morphologies. The photos derive from publications on various stratigraphic sections of Paleo- to Neoarchean ages. Based on the similarity of morphologies of microfossils and Em-Ps, the manuscript concludes that all Archean microfossils are in fact not prokaryotes, but merely "sacks of cytoplasm". 

      Strengths: 

      The approach of the authors to recognize the possibility that "real" cells were not around in the Archean time is appealing. The manuscript reflects the very hard work by the authors composing the Em-Ps used for comparison and selecting the appropriate photo material of fossils. 

      Weaknesses: 

      While the basic idea is very interesting, the manuscript includes flaws and falls short in presenting supportive data. The manuscript makes too simplistic assumptions on the "Archean paleoenvironment". First, like in our modern world, the environmental conditions during the Archean time were not globally the same. Second, we do not know much about the Archean paleoenvironment due to the immense lack of rock records. More so, the Archean stratigraphic sections from where the fossil material derived record different paleoenvironments: shelf to tidal flat and lacustrine settings, so differences must have been significant. Finally, the Archean spanned 2.500 billion years and it is unlikely that environmental conditions remained the same. Diurnal or seasonal variations are not considered. Sediment types are not considered. Due to these reasons, the laboratory model of an Archean paleoenvironment and the life therein is too simplistic. Another aspect is that eucaryote cells are described from Archean rocks, so it seems unlikely that prokaryotes were not around at the same time. Considering other fossil evidence preserved in Archean rocks except for microfossils, the many early Archean microbialites that show baffling and trapping cannot be explained without the presence of "real cells". With respect to lithology: chert is a rock predominantly composed of silica, not salt. The formation of Em-Ps in the "salty" laboratory set-up seems therefore not a good fit to evaluate chert fossils. Formation of structures in sediment is one step. The second step is their preservation. However, the second aspect of taphonomy is largely excluded in the manuscript, and the role of fossilization (lithification) of Em-Ps is not discussed. This is important because Archean rock successions are known for their tectonic and hydrothermal overprint, as well as recrystallization over time. Some of the comparisons of laboratory morphologies with fossil microfossils and biofilms are incorrect because scales differ by magnitudes. In general, one has to recognize that prokaryote cell morphologies do not offer many variations. It is possible to arrive at the morphologies described in various ways including abiotic ones. 

      Regarding the simplistic presumptions on the Archaean Eon environmental conditions, we provided a detailed explanation of this issue in our response to the eLife evaluation. In short, we agree with the reviewer that little is known about the Archaean Eon environmental conditions at a planetary scale. Hence, we restricted our study to one particular environment of which we had a comparatively good understanding. The Archaean Eon spanned 2.5 billion years. However, most of the microfossil sites we discussed in the manuscript are older than 3 billion years, with one exception (2.4 billion years old Turee Creek microfossils). We presume that conditions within this niche (coastal marine) environment could not have changed greatly until 2Ga, after which there have been major changes in the ocean salt composition and salinities.

      In the manuscript, we discussed extensively the reasons for restricting our study to these particular environmental conditions. Further explanations of these choices are presented in our response to the eLife evaluation (also see our previous manuscript). In short, the fact that all known microfossils are restricted to coastal marine environments justifies the experimental conditions employed in our study. Nevertheless, we agree with the reviewer that all lab-based studies involve some extent of simplification. This gap/mismatch is even wider when it comes to studies involving origin or early life on Earth.

      We are not arguing that prokaryotes are not around at this time. The key message of the manuscript is that they are present, but they have not developed intracellular mechanisms to regulate their morphology and remained primitive in this aspect.  

      The sizes of the microfossils and cells from our study were similar in most cases. However, we agree with the reviewer that they deviated considerably in some cases, for example, S70, S73, and S83. These size variations are limited to sedimentary structures like laminations rather than cells. These differences should be expected as we try to replicate the real-life morphologies of biofilms that could have extended over large swats of natural environments in a 2ml volume chamber slide. More specifically, in Fig. S70, there is a considerable size mismatch. But, in Fig. S73, the sizes were comparable between A & C (of course, the size of our reproduction did not match B). In the case of Fig. S83, we do not see a huge size mismatch.      

      Reviewer #1 (Recommendations For The Authors): 

      We would like to provide several suggestions for changes in text and additions to data analysis. 

      39-41: It has been stated that reconstructing the lifecycle is the only way of understanding the nature of these microfossils. First of all, I would rephrase this to 'the most promising way', as there are always multiple approaches to comparing phenomena. 

      We agree with the reviewer's suggestion. The suggested changes have been made (line 41). 

      125: Please rephrase "under the environmental condition of early Earth" to "under experimental conditions possibly resembling the conditions of the Paleoarchean Eon". Now it sounds like the exact environmental conditions have been produced, which has already been debated in the discussion. 

      We agree with the reviewer's suggestion. The suggested changes have been made (line 127). 

      125: Please mention the fold change in size, the original size in numbers, and whether this change is statistically significant. 

      In the above sections of this document, we explained our reservations about presenting the exact number.

      128: Have you found a difference in the relative percentages of modes of reproduction? In other words, is there a difference in percentage between forming internal daughter cells or a string of external daughter cells? 

      We explained our reservations about presenting the exact number above. But this has been extensively discussed in our accompaining manuscript. We want to reemphasize that the scope of this manuscript is restricted to comparing morphologies rather than providing a mechanistic explanation of the reproduction process. 

      151: A similar model for endocytosis has already been described in proliferating wall-less cells (Kapteijn et al., 2023). In the discussion, please compare your results with the observations made in that paper. 

      This is an oversight on our part. The manuscript suggested by the reviewer has now been added (line 154 & 155).  

      163: Please use another word for uncanny. We suggest using 'strong resemblance'. 

      We changed this according to the reviewers' suggestion (line 168). 

      433: Please elaborate on why the results are not shown. This sounds like a statement that should be substantiated further. 

      To observe growth and simultaneously image the cells, we conducted these experiments in chamber slides (2ml volume). Over time, we observed cells growing and breaking out of the salt crust (Fig. S86, S87 & Movie 22) and a gradual increase in the turbidity of the media. Although not quantitative, this is a qualitative indication of growth. We did not take precise measurements for several reasons. This sample is precious; it took us almost two years to solidify the biofilm completely, as shown in Fig. S84A. Hence, it was in limited supply, which prevented us from inoculating these salt crusts into large volumes of fresh media. Given a long period of starvation, these cells often exhibited a long lag phase (several days), and there wasn't enough volume to do OD measurements over time. 

      We also crushed the solidified biofilm with a sterile spatula before transferring it into the chamber slide with growth media. This resulted in debris in the form of small solid particles, which interfered with our OD measurements. These practical considerations made it challenging to determine the growth precisely. Despite these challenges, we measured an OD of 4 in some chamber slides after two weeks of incubation. Given that these measurements were done haphazardly, we chose not to present this data. 

      456: Could you please double-check whether the description is correct for the figure? 8C and 8D are part of Figure 8B, but this is stated otherwise in the description. 

      We thank the reviewer for pointing it out. It has now been rectified (line 461-472).

      Reviewer #2 (Recommendations For The Authors): 

      We thank Reviewer #2  for carefully reading the manuscript and such an elaborate list of questions. The revisions suggested have definitely improved the quality of the manuscript. Here, we would like to address some of the questions that came up repeatedly below. One frequently asked question is regarding the letters denoting the individual figures within the images. For comparison purposes, we often reproduced previously published images. To maintain a consistent figure style, we often have to block the previous denotations with an opaque square and give a new letter. 

      The second question that appeared repeatedly below is the missing scale bars in some of the images within a figure. We often did not include a scale bar in the images when this image is an enlarged section of another image within the same figure.     

      Title: Please consider being more precise in the title. Microfossils are only one fossil group of "oldest life". Perhaps better: "On the nature of some microfossils in Archean rocks". (see also Line 37).  

      Authors’ response: The title conveys a broader message without quantitative insinuations. If our manuscript had been titled "On the nature of all known Archaean microfossils,” we should have agreed with the reviewer's suggestion and changed it to "On the nature of some microfossils in Archean rocks". As it is not, we respectfully decline to make this modification.     

      Abstract:  

      Line 41: "one way", not "the only way" 

      We agree with the reviewer’s comment, and necessary changes have been made (line 41).  

      Introduction: 

      Line 58f: "oldest sedimentary rock successions", not "oldest known rock formations". There are rocks of much older ages, but those are not well preserved due to metamorphic overprint, or the rocks are igneous to begin with. Minor issue: please note that "formations" are used as stratigraphic units, not so much to describe a rock succession in the field. 

      We agree with the reviewer’s comment and have made necessary changes (line 58).

      Line 67: Microfossils are widely accepted as evidence of life. Please rephrase. 

      We agree with the reviewer’s comment, and necessary changes have been made.

      Line 71 - 74: perhaps add a sentence of information here.

      We agree with the reviewer’s comment, and necessary changes have been made (line 71).

      Line 76: which "chemical and mineralogical considerations"? 

      This has been rephrased to “Apart from the chemical and δ<sup>13</sup>C-biomass composition” (line 76).

      Line 84ff: This is a somewhat sweeping statement. Please remember that there are microbialites in such rocks that require already a high level of biofilm organization. The existence of cyanobacteria-type microbes in the Archean is also increasingly considered. 

      We are aware of literature that labeled the clusters of Archaean microfossils as biofilms and layered structures as microbialites or stromatolite-like structures. However, the use of these terms is increasingly being discouraged. A more recent consensus among researchers suggests annotating these structures simply as sedimentary structures, as microbially induced sedimentary structures (MISS). 

      We respectfully disagree with the reviewer’s comment that Archaean microfossils exhibit a high level of biofilm organization. We are not aware of any studies that have conducted such comprehensive research on the architecture of Archaean biofilms. We are not even certain if these clusters of Archaean cells could even be labeled as biofilms in the true sense of the term. We presently lack an exact definition of a biofilm. In our study, we do see sedimentation and bacteria and their encapsulation in cell debris. From a broader perspective, any such aggregation of cells enclosed in cell debris could be annotated as a biofilm. However, more in-depth studies show that biofilm is not a random but a highly organized structure. Different bacterial species have different biofilm architectures and chemical composition. The multispecies biofilms in natural environments are even more complex. We do agree with the reviewer that these structures could broadly be labeled as biofilms, but we presently lack a good, if any, understanding of the Archaean biofilm architecture. 

      Regarding the annotation of microfossils as cyanobacteria, we respectfully disagree with the reviewer. This is not a new concept. Many of the Archaean microfossils were annotated as cyanobacteria at the time of their discovery. This annotation is not without controversy. With the advent of genome-based studies, researchers are increasingly moving away from this school of thought.  

      Line 101ff: The conditions on early Earth are unknown - there are many varying opinions. Perhaps simply state that this laboratory model simulates an Archean Earth environment of these conditions outlined. 

      This is a good idea. We thank the reviewer for this suggestion, and we made appropriate changes. 

      Line 112: manuscript to be replaced by "paper"? 

      This change has been made (line 114).

      Line 116: "spanned years" - how many years? 

      We now added the number of years in the brackets (line 118).

      Results: 

      Line 125: see comment for 101ff. 

      we made appropriate changes. 

      Figure 1: Caption: Please write out ICV the first time this abbreviation is used. Images: Note that some lettering appears to not fit their white labels underneath. (G, H, I, J0, and M). 

      We apologize; this is an oversight on our part. We now spell complete expansion of ICV, the first time we used this abbreviation. 

      We took these images from previously published work (references in the figure legend), so we must block out the previous figure captions. This is necessary to maintain a uniform style throughout the manuscript. 

      Line 152ff.: here would be a great opportunity to show in a graph the size variations of modern ICVs and to compare the variations with those in the fossil material. 

      In the above sections of this document, we explained our reservations about presenting the exact number.

      Line 159f.: Fig.1K - what is to see here? Maybe a close-up or - better - a small sketch would help? 

      Fig. 1K shows the surface depressions formed during the vesicle formation. The surface characteristics of EM-P and microfossils is very similar.   

      Line 161f.: reference?  

      The paragraph spanning lines 159 to 172 discusses the morphological similarities between EM-P and SPF microfossils. We rechecked the reference no 35 (Delarue 2019). This is the correct reference. We do not see a mistake if the reviewer meant the reference to the figures.    

      Line 164ff.: A question may be asked, how many fossils of the Strelley Pool population would look similar to the "modeled" ones. Questions may rise in which way the environmental conditions control such morphology variations. Perhaps more details? 

      This relationship between the environmental conditions and the morphology is discussed extensively in our previous work (11).  

      Line 193: what is meant by "similar discontinuous distribution of organic carbon"?

      This statement highlights similarities between EM-P and microfossils. The distribution of cytoplasm within the cells is not uniform. There are regions with and devoid of cytoplasm, which is quite unusual for bacteria. Some previous studies argued that this could indicate that these organic structures are of abiotic origin. Here, we show that EMP-like cells could exhibit such a patchy distribution of cytoplasm within the cell.    

      Line 218 - 291: The observations are very nice, however, the figures of fossil material in Figures 3 A, B, and C appear not to conform. Perhaps use D, E and I to K. Also, S48 does not show features as described here (see below).  

      We did not completely understand the reviewer’s question. As mentioned in the figure legend, both the microfossils and the cells exhibit string with spherical daughter cells within them. Moreover, there are also other similarities like the presence of hollow spherical structures devoid of organic carbon. We also saw several mistakes in the Fig. S48 legend. We have rectified them, and we thank the reviewer for pointing them out.   

      Line 293f: Title with "." at end?

      This change has been made.

      Line 298: predominantly in chert. In clastic material preservation of cells and pores is unlikely due to the common lack of in situ entombment by silica. 

      We rephrased this entire paragraph to better convey our message. Either way, we are not arguing that hollow pore spaces exist. As the reviewer mentioned, they will, of course, be filled up with silica. In this entire paragraph, we did not refer to hollow spaces. So, we are not entirely sure what the question was.     

      Line 324, 328-349: Please see below comments on the supplementary figures 51-62. Some of the interpretations of morphologies may be incorrect. 

      Please find our response to the reviewer’s comments on individual figures below.  

      Figure 5 A to D look interesting, however E to J appear to be unconvincing. What is the grey frame in D (not the white insert). 

      The grey color is just the background that was added during the 3D rendering process.  

      Figure 6 does not appear to be convincing. - Erase? 

      We did not understand the reviewer’s reservations regarding this figure. Images A-F within the figure show the gradual transformation of cells into honeycomb-like structures, and images G-J show such structures from the Archaean that are closely associated with microfossils. Moreover, we did not come up with this terminology (honeycomb-like). Previous manuscripts proposed it.  

      Line 379ff: S66 and 69, please see my comments below. Microfossils "were often discovered" in layers of organic carbon. 

      Please see our response below.   

      Line 393-403: Laminae? There are many ways to arrive at C-rich laminae, especially, if the material was compressed during burial. Basically, any type of biofilm would appear as laminae, if compressed. The appearance of thin layers is a mere coincidence. Note that the scale difference in S70, S73, as well as S83, is way too high (cm versus μm!) to allow any such sweeping conclusions. What are α- and β- laminations, the one described by Tice et al.? The arguments are not convincing.

      We propose that cells be compressed to form laminae. We answered this question above about the differences in the scale bars. Yes, we are referring to α- and β- laminations described by Tice et al.       

      Figure 7: This is an interesting figure, but what are the arguments for B and C, the fossil material, being a membrane? Debris cannot be distinguished with certainty at this scale in the insert of C. B could also be a shriveled-up set of trichomes.  

      We agree with the reviewer that debris cannot be definitely differentiated. Traditionally, annotations given to microfossil structures such as biofilm, intact cells, or laminations were all based on morphological similarities with existing structures observed in microorganisms. Given that the structures observed in our study are very similar to the microfossil structures, it is logical to make such inferences. Scales in A & B match perfectly well. The structure in C is much larger, but, as we mentioned in reply to one of the reviewer’s earlier questions, some of the structures from natural environments could not be reproduced at scale in lab experiments. Working in a 2 ml chamber slides does impose some restrictions.   

      Figure 8: The figure does not show any honeycomb patterns. The "gaps" in the Moodies laminae are known as lenticular particles in biofilms. They form by desiccated and shriveledup biofilm that mineralizes in situ. Sometimes also entrapped gases induce precipitation. Note also that the modelled material shows a kind of skin around the blobs that are not present in the Moodies material.  

      We agree that entrapped gas bubbles could have formed lenticular gaps. In the manuscript, we did not discount this possibility. However, if that is the case, one should explain why we often find clumps of organic carbon within these gaps. As we presented a step-by-step transformation of parallel layers of cells into laminations, which also had similar lenticular gaps, we believe this is a more plausible way such structures could have formed. In the end, there could have been more than one way such structures could have been formed. 

      We do see the honeycomb pattern in the hollow gaps. Often, the 3D-rendering of the STED images obscures some details. Hence, in the figure legend, we referred to the supplementary figures also show the sequence of steps involved in the formation of such a pattern.      

      Line 405-417: During deposition of clastic sediment any hollow space would be compressed during burial and settling. It is rare that additional pore space (except between the graingrain-contacts) remains visible, especially after consolidation. The exception would be if very early silicification took place filling in any pore space. What about EPS being replaced by mineralic substance? The arguments are not convincing. 

      We are suggesting that EPS or cell debris is rapidly encrusted by cations from the surrounding environment and gets solidified into rigid structures. This makes it possible for the structures to be preserved in the fossil record. We believe that hollow structures like the lenticular gaps will be filled up with silica. 

      We do not agree with the reviewer’s comment that all biological structures will be compressed. If this is true, there should be no intact microfossils in the Archaean sedimentary structures, which is definitely not the case.      

      Line 419-430: Lithification takes place within the sediment and therefore is commonly controlled by the chemistry of pore water and chemical compounds that derive from the dissolution of minerals close by. Another aspect to consider is whether "desiccation cracks" on that small scale may be artefacts related to sample preparation (?).  

      We agree that desiccation cracks could have formed during the sample preparation for SEM imaging, as this involves drying the biofilms. However, we observed that the sample we used for SEM is a completely solidified biofilm (Fig. S84), so we expect little change in its morphology during drying. Moreover, visible cracks and pointy edges were also observed in wet samples, as shown in Fig. S87.        

      Line 432 - 439: Please see comments on the supplementary material below.

      Please find our response to the reviewer’s comments on individual figures below.  

      Discussion:  

      Line 477f: "all known microfossil morphologies" - is this a correct statement? Also, would the Archean world provide only one kind of "EM-P type"? Morphologies of prokaryote cells (spherical, rod-shaped, filamentous) in general are very simple, and any researcher of Precambrian material will appreciate the difficulties in concluding on taxonomy. There are papers that investigate putative microfossils in chert as features related to life cycles. Microfossil-papers commonly appear not to be controversial give and take some specific cases.  

      We made a mistake in using the term “all known microfossil morphologies.” We have now changed it to “all known spherical microfossils” from this statement (line 483). However, we do not agree with the statement that microfossil manuscripts tend not to be controversial. Assigning taxonomy to microfossils is anything but controversial. This has been intensely debated among the scientific community.     

      Line 494-496: This statement should be in the Introduction.

      We agree with the reviewer’s comment. In an earlier version of the manuscript this statement was in the introduction. To put this statement in its proper context, it needs to be associated with a discussion about the importance of morphology in the identification of microfossils. The present version of the manuscript do not permit moving an entire paragraph into the introduction. Hence, we think making this statement in the discussion section is appropriate. 

      Line 484ff. The discussion on biogenicity of microfossils is long-standing (e.g., biogenicity criteria by Buick 1990 and other papers), and nothing new. In paleontology, modern prokaryotes may serve as models but everyone working on Archean microfossils will agree that these cannot correspond to modern groups. An example is fossil "cyanobacteria" that is thought to have been around already in the early Archean. While morphologically very similar to modern cyanobacteria, their genetic information certainly differed - how much will perhaps remain undisclosed by material of that high age.  

      Yes, we agree with the reviewer that there has been a longstanding conflict on the topic of biogenicity of microfossils. However, we have never come across manuscripts suggesting that modern microorganisms should only be used as models. If at all, there have been numerous manuscripts suggesting that these microfossils represent cyanobacteria, streptomycetes, and methanotrophs. Regarding the annotation of microfossils as cyanobacteria, we addressed this issue in one of the previous questions raised by the reviewer.    

      Line 498ff: Can the variation of morphology and sizes of the EM-Ps be demonstrated statistically? Line 505ff are very speculative statements. Relabeling of what could be vesicles as "microfossils" appears inappropriate. Contrary to what is stated in the manuscript, the morphologies of the Dresser Formation vesicles do not resemble the S3 to S14 spheroids from the Strelley Pool, the Waterfall, and Mt Goldsworthy sites listed in the manuscript. The spindle-shaped vesicles in Wacey et al are not addressed by this manuscript. What roles in mineral and element composition would have played diagenetic alteration and the extreme hydrothermal overprint and weathering typical for Dresser material? S59, S60 do not show what is stated, and the material derives from the Barberton Greenstone Belt, not the Pilbara.

      Please see the comments below regarding the supplementary images. 

      We did not observe huge variations in the cell morphology. Morphologies, in most cases, were restricted to spherical cells with intracellular vesicles or filamentous extensions. Regarding the sizes of the cells, we see some variations. However, we are reluctant to provide exact numbers. We have presented our reasons above.

      We respectfully disagree with the reviewer’s comments. We see quite some similarities between Dresser formation microfossils and our cells. Not just the similarities, we have provided step-by-step transformation of cells that resulted in these morphologies. We fail to see what exactly is the speculation here. The argument that they should be classified as abiotic structures is based on the opinion that cells do form such structures. We clearly show here that they can, and these biological structures resemble Dresser formation microfossils more closely than the abiotic structures. 

      Regarding the figures S3-S14. We think they are morphologically very similar. Often, it's not just comparing both images or making exact reproductions (which is not possible). We should focus on reproducing the distinctive morphological features of these microfossils.  

      We agree with the reviewer that we did not reproduce all the structures reported by Wacey’s original manuscript, such as spherical structures. We are currently preparing another manuscript to address the filamentous microfossils. These spindle-like structures will be addressed in this subsequent work. 

      We agree with the reviewer, we often have difficulties differentiating between cells and vesicles. This is not a problem in the early stages of growth. During the log phase, a significant volume of the cell consists of the cytoplasm, with hollow vesicles constituting only a minor volume (Fig. 1B or S1A). During the later growth stages (Fig. 1E7F or S11), cells were almost hollow, with numerous daughter cells within them. These cells often resemble hollow vesicles rather than cells. However, given these are biologically formed structures, and one could argue that these vesicles are still alive as there is still a minimal amount of cytoplasm (Fig. S27). Hence, we should consider them as cells until they break apart to release daughter cells. 

      Regarding Figures S59 and S60, we did not claim either of these microfossils is from Pilbara Iron Formations. The legend of Figure S59 clearly states that these structures are from Buck Reef Chert, originally reported by Tice et al., 2006 (Figure 16 in the original manuscript). The legend of Figure S60 says these structures were originally reported by Barlow et al., 2018, from the Turee Creek Formation. 

      Line 546f and 552: The sites including microfossils in the Archean represent different paleoenvironments ranging from marine to terrestrial to lacustrine. References 6 and 66 are well-developed studies focusing on specific stratigraphic successions, but cannot include information covering other Archean worlds of the over 2.5 Ga years Archean time.  

      All the Archaean microfossils reported to date are from volcanic coastal marine environments. We are aware that there are rocky terrestrial environments, but no microfossils have been reported from these sites. We are unaware of any Archaean microfossils reported from freshwater environments. 

      Line 570ff: The statements may represent a hypothesis, but the data presented are too preliminary to substantiate the assumptions.

      We believe this is a correct inference from an evolutionary, genomic, and now from a morphological perspective. 

      Figures:  

      Please check all text and supplementary figures, whether scale bars are of different styles within the figure (minor quibble). 

      S3 (no scale in C, D); S4, S5: Note that scale bars are of different styles. 

      We believe we addressed this issue above. 

      S6 D: depressions here are well visible - perhaps exchange with a photo in the main text? Note that scale bars are of different styles.  

      We agree that depressions are well visible in E. The same image of EM-P cell in E is also present in Fig. 1D in the main text.   

      S7: Scale bars should all be of the same style, if anyhow possible. Scale in D? 

      We believe we addressed this issue above. 

      S9: F appears to be distorted. Is the fossil like this? The figure would need additional indicators (arrows) pointing toward what the reader needs to see - not clear in this version. More explanation in the figure caption could be offered. 

      We rechecked the figure from the original publication to check if by mistake the figure was distorted during the assembly of this image. We can assure you that this is not the case. We are not sure what further could be said in the figure legend.     

      S13: What is shown in the inserts of D and E that is also visible in A and B? Here a sketch of the steps would help. 

      We did not understand the question.  

      S14: Scale in A, B? 

      We believe we addressed this issue above. 

      S15: Scales in A, E, C, D 

      We believe we addressed this issue above. 

      S16: scales in D, E, G, H, I, J?  

      We believe we addressed this issue above. 

      S17: "I" appears squeezed, is that so? If morphology is an important message, perhaps reduce the entire figure so it fits the layout. Note that labels A, B, C, and D are displaced. 

      As shown in several subsequent figures, the hollow spherical vesicles are compressed first into honeycomb-like structures, and they often undergo further compression to form lamination-like structures. Such images often give the impression that the entire figure is squashed, but this is not the case. If one examines the figure closely, you could see perfectly spherical vesicles together with laterally sqeezed structures. Regarding the figure labels, we addressed this issue above. 

      S18: The filamentous feature in C could also be the grain boundaries of the crystals. Can this be excluded as an interpretation? Are there microfossils with the cell membranes? That would be an excellent contribution to this figure. Note that scale bars are of different styles.

      If this is a one-off observation, we could have arrived at the reviewer's opinion. But spherical cells in a “string of beads” configuration were frequently reported from several sites, to be discounted as mere interpretation.    

      S19: The morphologies in A - insert appear to be similar to E - insert in the lower left corner. The chain of cells in A may look similar to the morphologies in E - insert upper right of the image. B - what is to see here? D - the inclusions do not appear spherical (?). Does C look similar to the cluster with the arrow in the lower part of image E? Note that scale bars are of different styles (minor quibble). A, B, C, and D appear compressed. Perhaps reduce the size of the overall image?  

      The structures highlighted (yellow box) in C are similar to the highlighted regions in E—the agglomeration of hollow vesicles. It is hard to get understand this similarity in one figure. The similarities are apparent when one sees the Movie 4 and Fig. S12, clearly showing the spherical daughter cells within the hollow vesicle. We now added the movie reference to the figure legend.    

      S20: A appears not to contribute much. The lineations in B appear to be diagenetic. However, C is suitable. Perhaps use only C, D, E? 

      We believe too many unrecognizable structures are being labeled as diagenetic. Nevertheless, we do not subscribe to the notion that these are too lenient interpretations. These interpretations are justified as such structures have not been reported from live cells. This is the first study to report that cells could form such structures. As we now reproduced these structures, an alternate interpretation that these are organic structures derived from microfossils should be entertained. 

      S 21: Note that scale bars are of different styles.  

      We believe we addressed this issue above. 

      S22: Perhaps add an arrow in F, where the cell opened, and add "see arrow" in the caption? Is this the same situation as shown in C (white arrow)? What is shown by the white arrow in A? Note that scale bars are of different styles.

      We did the necessary changes.  

      S23: In the caption and main text, please replace "&" with "and" (please check also the other figure captions, e.g. S24). Note that scale bars are of different styles. What is shown in F? A, D - what is shown here?

      We replaced “&” with “and.”  

      S24: Note that scale bars are of different styles. Note that Wacey et al. describe the vesicles as abiotic not as "microfossils"; please correct in figure caption [same also S26; 25; 28].

      We are aware of Prof. Dr. Wacey’s interpretations. We discuss it at length in the discussion section our manuscript. Based on the similarities between the Dresser formation structures and structures formed by EM-P, we contest that these are abiotic structures.  

      S25: Appears compressed; note different scale bars. 

      We believe we addressed this issue above. 

      S28: The label in B is still in the upper right corner; scale in D? What is to see in rectangles (blue and red) in A, B? In fossil material, this could be anything. 

      These figures are taken from a previous manuscript cited in the figure legend. We could not erase or modify these figures.  

      S33: "L"ewis; G appears a bit too diffuse - erase? Note that scale bars are of different styles.

      We believe we addressed this issue above. 

      S34: This figure appears unconvincing. Erase? 

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we can address his reservations.    

      S35: It would be more convincing to show only the morphological similarities between the cell clusters. B and C are too blurry to distinguish much. Scales in D to F and in sketches? A appears compressed (?). 

      We rechecked the original manuscript to see if image A was distorted while making this figure, but this is not the case. Regarding B & C, cells in this image are faint as they are hollow vesicles and, by nature, do not generate too much contrast when imaged with a phase-contrast microscope. There are some limitations on how much we can improve the contrast. We now added scale bars for D-I. Similarly, faint hollow vesicles can be seen in Fig. S21 C & D, and Fig. 3H.  

      S36: Very nice; in B no purple arrow is visible. Note that scale bars are of different styles. S37 and S36 are very much the same - fuse, perhaps?  

      We are sorry for the confusion. There are purple arrows in Fig. S37B-D. 

      S38: this is a more unconvincing figure - erase? 

      Unconvincing in wahy sense. There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we can address his reservations.

      S39: white rectangle in A? Arrow in A? Note that scale bars are of different styles.

      These are some of the unavoidable remnants from the image from the original publication. 

      S40: in F: CM, V = ?; Note that scale bars are of different style. 

      It’s an oversite on our part. We now added the definitions to the figure legaend. We thank the reviewer for pointing it out.  

      S41: Rectangles in D, E, F, G can be deleted? Scales and labels missing in photos lower right. 

      Those rectangles are added by the image processing software to the 3Drendered images. Regarding the missing scale bars in H & I they are the magnified regions of F. The scale bar is already present in F.   

      S42: appears compressed. G could be trimmed. Labels too small; scale in G? 

      This is a curled-up folded membrane. We needed to lower the resolution of some images to restrict the size of the supplement to journal size restrictions. It is not possible to present 85 figures in high resolution. But we assure you that the image is not laterally compressed in any manner.   

      S43: This figure appears to be unconvincing. Reducing to pairing B, C, D with L, K? Spherical inclusions in B? Scales in E to G? Similar in S44: A, B, E only? Note that scale bars are of different styles. 

      Figures I to K are important. They show not just the morphological similarities but also the sequence of steps through which such structures are formed. We addressed the issue of the scale bars above.  

      S45: A, B, and C appear to show live or subrecent material. How was this isolated of a rock? Note that scale bars are of different styles.  

      It is common to treat rocks with acids to dissolve them and then retrieve organic structures within them. This technique is becoming increasingly common. The procedure is quite extensively discussed in the original manuscript. We don’t see much differences in the scale bars of microfossils and EM-P cells, they are quite similar. 

      S46: A: what is to see here? Note that scale bars are of different styles. 

      There are considerable similarities between the folded fabric like organic structures with spherical inclusions and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we can address his reservations.    

      S47: Perhaps enlarge B and erase A. Note that scale bars are of different styles. 

      S48: Image B appears to show the fossil material - is the figure caption inconsistent? There are no aggregations visible in the boxes in A. H is described in the figure caption but missing in the figure. Overall, F and G do not appear to mirror anything in A to E (which may be fossil material?). 

      S51; S52 B, C, E; S53: these figures appear unconvincing - erase? 

      Unconvincing in what sense? The structures from our study are very similar to the microfossils.   

      S54: North "Pole; scale bars in A to C =? 

      These figures were borrowed from an earlier publication referenced in the figure legend. That is the reason for the differences in the styles of scale bars.  

      S55: D and E appear not to contribute anything. Perhaps add arrow(s) and more explanation? Check the spelling in the caption, please. 

      D & E show morphological similarities between cells from our study and microfossils (A).   

      S56: Hexagonal morphologies may also be a consequence of diagenesis. Overall, perhaps erase this figure?  

      I certainly agree that could be one of the reasons for the hexagonal morphologies. Such geometric polygonal morphologies have not been observed in living organisms. Nevertheless, as you can see from the figure, such morphologies could also be formed by living organisms. Hence, this alternate interpretation should not be discounted.   

      S57: The figure caption needs improvement. Please add more description. What show arrows in A, what are the numbers in A? What is the relation between the image attached to the right side of A? Is this a close-up? Note that scale bars are of different styles. 

      We expanded a bit on our original description of the figure. However, we request the reviewer to keep in mind that the parts of the figure are taken from previous publication. We are not at liberty to modifiy them, like removing the arrows. This imposes some constrains. 

      S58: There are no honeycomb-shaped features visible. What is to see here? Erase this figure? 

      Clearly, one can see spherical and polygonal shapes within the Archaean organic structures and mat-like structures formed by EM-P.  

      S59 and S60: What is to see here? - Erase? 

      Clearly, one can see spherical and polygonal shapes within the Archaean organic structures and mat-like structures formed by EM-P in Fig. S59. Further disintegration of these honeycomb shaped mats into filamentous struructures with spherical cells attached to them can be seen in both Archaean organic structures and structures formed by EM-P.   

      S61: This figure appears to be unconvincing. B and F may be a good pairing. Note that scale bars are of different styles.  

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we might be able to address his reservations.     

      S62: This figure appears to be unconvincing - erase?

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we might be able to address his reservations.     

      S66: This figure is unconvincing - erase? 

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we might be able to address his reservations.    

      S68: Scale in B, D, and E? 

      Image B is just a magnified image of a small portion of image A. Hence, there is no need for an additional scale bar. The same is true for images D and E. 

      S69: This figure appears to be unconvincing, at least the fossil part. Filamentous features are visible in fossil material as well, but nothing else. 

      We are not sure what filamentous features the reviewer is referring to. Both the figures show morphologically similar spherical cells covered in membrane debris.    

      S70 [as well as S82]: Good thinking here, but scales differ by magnitudes (cm to μm). Erase this figure? Very similar to Figure S73: Insert in C has which scale in comparison to B? Note that scale bars are of different styles.  

      We realize the scale bars are of different sizes. In our defense, our experiments are conducted in 1ml volume chamber slides. We don’t have the luxury of doing these experiments on a scale similar to the natural environments. The size differences are to be expected. 

      S71: Scale in E? 

      Image E is just a magnified image of a small portion of image D. Hence, we believe a scale bar is unnecessary. 

      S72: Scale in insert?  

      The insert is just a magnified region of A & C

      S75: This figure appears to be unconvincing. This is clastic sediment, not chert. Lenticular gaps would collapse during burial by subsequent sediment. - Erase? 

      Regarding the similarities, we see similar lenticular gaps within the parallel layers of organic carbon in both microfossils, and structures formed by EM-P.

      S76: A, C, D do not look similar to B - erase? Similar to S79, also with respect to the differences in scale. Erase? 

      Regarding the similarities, we see similar lenticular gaps within the parallel layers of organic carbon in both microfossils, and structures formed by EM-P. We believe we addressed the issue of scale bars above. 

      S80: A appears to be diagenetic, not primary. Erase? 

      These two structures share too many resemblances to ignore or discount just as diagenic structures - Raised filamentous structures originate out of parallel layers of organic carbon (laminations), with spherical cells within this filamentous organic carbon.  

      S85: What role would diagenesis play here? This figure appears unconvincing. Erase?

      We do believe that diagenesis plays a major role in microfossil preservation. However, we also do not suscribe to the notion that we should by default assign diagenesis to all microfossil features. Our study shows that there could be an alternate explanation to some of the observations.  

      S86 and S87: These appear unconvincing. What is to see here? Erase? 

      The morphological similarities between these two structures. Stellarshaped organic structures with strings of spherical daughter cells growing out of them.  

      S88: Does this image suggest the preservation of "salt" in organic material once preserved in chert?  

      That is one inference we conclude from this observation. Crystaline NaCl was previously reported from within the microfossil cells.    

      S89: What is to see here? Spherical phenomena in different materials? 

      At present, the presence of honeycomb-like structures is often considered to have been an indication of volcanic pumice. We meant to show that biofilms of living organisms could result in honeycomb-shaped patterns similar to volcanic pumice.

      References 

      Please check the spelling in the references. 

      We found a few references that required corrention. We now rectified them. 

      References  

      (1) Orange F, Westall F, Disnar JR, Prieur D, Bienvenu N, Le Romancer M, et al. Experimental silicification of the extremophilic archaea pyrococcus abyssi and methanocaldococcus jannaschii: Applications in the search for evidence of life in early earth and extraterrestrial rocks. Geobiology. 2009;7(4). 

      (2) Orange F, Disnar JR, Westall F, Prieur D, Baillif P. Metal cation binding by the hyperthermophilic microorganism, Archaea Methanocaldococcus Jannaschii, and its effects on silicification. Palaeontology. 2011;54(5). 

      (3) Errington J. L-form bacteria, cell walls and the origins of life. Open Biol. 2013;3(1):120143. 

      (4) Cooper S. Distinguishing between linear and exponential cell growth during the division cycle: Single-cell studies, cell-culture studies, and the object of cell-cycle research. Theor Biol Med Model. 2006; 

      (5) Mitchison JM. Single cell studies of the cell cycle and some models. Theor Biol Med Model. 2005; 

      (6) Kærn M, Elston TC, Blake WJ, Collins JJ. Stochasticity in gene expression: From theories to phenotypes. Nat Rev Genet. 2005; 

      (7) Elowitz MB, Levine AJ, Siggia ED, Swain PS. Stochastic gene expression in a single cell. Science. 2002; 

      (8) Strovas TJ, Sauter LM, Guo X, Lidstrom ME. Cell-to-cell heterogeneity in growth rate and gene expression in Methylobacterium extorquens AM1. J Bacteriol. 2007; 

      (9) Knoll AH, Barghoorn ES. Archean microfossils showing cell division from the Swaziland System of South Africa. Science. 1977;198(4315):396–8. 

      (10) Sugitani K, Grey K, Allwood A, Nagaoka T, Mimura K, Minami M, et al. Diverse microstructures from Archaean chert from the Mount Goldsworthy–Mount Grant area, Pilbara Craton, Western Australia: microfossils, dubiofossils, or pseudofossils? Precambrian Res. 2007;158(3–4):228–62. 

      (11) Kanaparthi D, Lampe M, Krohn JH, Zhu B, Hildebrand F, Boesen T, et al. The reproduction process of Gram-positive protocells. Sci Rep. 2024 Mar 25;14(1):7075.

    1. Author response:

      We genuinely appreciate the reviewer critiques of our submitted paper, “Otoacoustic emissions but not behavioral measurements predict cochlear-nerve frequency tuning in an avian vocal-communication specialist.” We are planning a number of changes based on the reviewers’ helpful comments that we feel will substantially improve the manuscript and clarify its implications.

      We will add more support for the claim that budgerigars show unusual patterns of behavioral frequency tuning compared to other species. The original manuscript relied on previously published studies of budgerigar critical bands and psychophysical tuning curve to make this point (e.g., Fig. 1). Critical bands and psychophysical tuning curves have unfortunately not been studied in many bird species. Consequently, it was somewhat unclear (based on the information originally presented) whether the “unusual” behavioral tuning results shown in Fig. 1 reflect a hearing specialization in budgerigars or perhaps simply a general avian pattern attributable to declining audibility above 3-4 kHz (a point raised by both reviewers). Fortunately, behavioral critical-ratio results are available from a broader range of species. Albeit a less direct correlate of tuning, the results clearly highlight the unique hearing abilities of budgerigars in relation to other bird species as elaborated upon below.

      The critical ratio is the threshold signal-to-noise ratio for tone detection in wideband noise and partly depends on peripheral tuning bandwidth. Critical ratios have been studied in over a dozen bird species, the vast majority of which show similar thresholds to one another and monotonically increasing critical ratios for higher frequencies (by 2-3 dB/octave, similar to most mammals; reviewed by Dooling et al., 2000). By contrast, budgerigar critical ratios diverge markedly from other species at mid-to-high frequencies, with ~8 dB lower (more sensitive) thresholds from 3-4 kHz (Dooling & Saunders, 1975; Okanoya & Dooling, 1987; Farabaugh 1988; see Figs 5 & 6 in Okanoya & Dooling, 1987). The unusual critical-ratio function in budgerigars is not attributable to the audiogram and was hypothesized by Okanoya and Dooling (1987) to reflect specialized cochlear tuning or perhaps central processing mechanisms. A brief discussion of these studies will be added to the introduction, along with a new figure panel (for Fig. 1) illustrating these intriguing species differences in critical ratios.

      Another question was raised as to whether the simultaneous-masking paradigms and classic methods used to estimate behavioral tuning in budgerigars should be considered as valid, given newer forward-masking and notched-noise alternatives. We will expand the discussion of this issue in the revised manuscript. First, many of the methods from the classic budgerigar studies remain widely used in animal behavioral research (e.g., critical bands and ratios: Yost & Shofner, 2009; King et al., 2015; simultaneous masking: Burton et al., 2018). We therefore believe that it remains highly relevant to test and report whether these methods can accurately predict cochlear tuning. While forward-masking behavioral results are hypothesized to more accurately predict cochlear tuning humans (Shera et al., 2002; Joris et al., 2011; Sumner et al., 2018), evidence from nonhumans is controversial, with one study showing a closer match of forward-masking results to auditory-nerve tuning (ferret: Sumner et al., 2018), but several others showing a close match for simultaneous masking results (e.g., guinea pig, chinchilla, macaque; reviewed by Ruggero & Temchin, 2005; see Joris et al., 2011 for macaque auditory-nerve tuning). Moreover, forward- and simultaneous-masking results can often be equated with a simple scaling factor (e.g., Sumner et al., 2018). Given no real consensus on an optimal behavioral method, and seemingly limited potential for the “wrong” method to fundamentally transform the shape of the behavioral tuning quality function, it seems reasonable to accept previously published behavioral tuning estimates as essentially valid while also discussing limitations and remaining open to alternative interpretations.

      We will add clarification throughout the revision as to the specific behavioral measures used to quantify tuning in budgerigars (i.e., critical bands, psychophysical tuning curve, and critical ratios). This avoids potentially disparaging alternative behavioral methods that have not been tested. That the budgerigar behavioral data are “old” seems not particularly relevant considering that the methods are still used in animal behavioral research as noted previously. Rather, it seems important to clarify the specific behavioral techniques used to estimate budgerigar’s frequency tuning in the revised paper.

      Finally, we plan to add discussion of the apical-basal transition from the mammalian otoacoustic-emission literature, as suggested by reviewer 1, including how this concept might apply in budgerigars and other birds.

      References not already cited in the preprint:

      Burton JA, Dylla ME, Ramachandran R. Frequency selectivity in macaque monkeys measured using a notched-noise method. Hear Res. 2018 Jan;357:73-80. doi: 10.1016/j.heares.2017.11.012.

      King J, Insanally M, Jin M, Martins AR, D'amour JA, Froemke RC. Rodent auditory perception: Critical band limitations and plasticity. Neuroscience. 2015 Jun 18;296:55-65. doi: 10.1016/j.neuroscience.2015.03.053.

      Yost WA, Shofner WP. Critical bands and critical ratios in animal psychoacoustics: an example using chinchilla data. J Acoust Soc Am. 2009 Jan;125(1):315-23. doi: 10.1121/1.3037232. PMID: 19173418; PMCID: PMC2719489.

    1. Author response:

      (1) We do not know that the mechanism mediating the behavioral changes observed involves acetylcholine at all. (Reviewer 1)

      The reviewer rightly pointed out the co-release of acetylcholine (ACh) and GABA from cholinergic terminals. We believe that the detected behavioral changes are because of the augmentation of this innate mixed chemical signal. We agree that identifying the receptor specificity is an essential next step; however, addressing this point requires a currently unavailable research tool to block cholinergic receptors for a few hundred milliseconds. This temporal specificity is vital because acetylcholine is released in the medial prefrontal cortex (mPFC) on two distinct timescales, the slow release over tens of minutes from the task onset and the fast release time-locked to salient stimuli (TelesGrilo Ruivo et al., 2017). Moreover, the former slow signal is far more robust than the latter phasic signal. The pharmacological experiments suggested by the reviewer will suppress both the tonic and phasic signals, making it difficult to interpret the results. Given the rapid technological advancement in this field, we hope to investigate the underlying mechanisms in detail in the future. 

      (2) It is unclear whether mPFC cells are signaling predictions versus prediction errors. (Reviewer 2)

      As the reviewer pointed out, mPFC cells signal the prediction of imminent outcomes (Baeg et al., 2001; Mulder et al., 2003; Takehara-Nishiuchi and McNaughton, 2008; Kyriazi et al., 2020).

      However, the key difference between prediction signals and prediction error signals is their time course. The prediction signals begin to arise before the actual outcome occurs, whereas the prediction error signals are emitted after subjects experience the presence or absence of the expected outcome. In all our analyses, cell activity was normalized by the activity during the 1-second window before the threat site entry (i.e., the reveal of actual outcome; Lines 655-659). Also, all the statistical comparisons were made on the normalized activity during the 500-msec window, starting from the threat site entry (Lines 669670). Because this approach isolated the change in cell activity after the actual outcome, we interpret the data in Figure 4C as prediction error signals. 

      (3) The task does not fully dissociate place field coding. (Reviewer 2)

      The present analysis included several strategies to dissociate outcome selectivity from location selectivity (Figure 4). First, we collapsed cell activity on two threat sites to suppress the difference in cell activity between the sites. Second, our analysis compared how cell activity at the same location differed depending on whether outcomes were expected or surprising (Figure 4C). Nevertheless, we can use the present data to investigate the spatial tuning of mPFC cells. Indeed, an earlier version of this manuscript included some characterizations of spatial tuning. However, these data were deemed irrelevant and distracting when this manuscript was reviewed for publication in a different journal. As such, these data were removed from the current version. We are in the process of publishing another paper focusing on the spatial tuning of mPFC cells and their learning-dependent changes. 

      (4) The basic effects of cholinergic terminal stimulation on mPFC cell activity are unclear. (Reviewers 1, 3)

      We acknowledge the lack of characterization of the optogenetic manipulation of cholinergic terminals on mPFC cell activity outside the task context. As outlined in the discussion section (Lines 309-321), cholinergic modulation of mPFC cell activity is highly complex and most likely varies depending on behavioral states. In addition, because we intended to augment naturally occurring threatevoked cholinergic terminal responses (Tu et al., 2022), our optogenetic stimulation parameters were 3-5 times weaker than those used to evoke behavioral changes solely by the optogenetic stimulation of cholinergic terminals (Gritton et al., 2016). Based on these points, we validated the optogenetic stimulation based on its effects on air-puff-evoked cell activity during the task (Figure 2C, 2D). 

      (5) Some choices of statistical analyses are questionable (Reviewers 1, 3)

      We used the Kolmogorov-Smirnov (KS) test to investigate whether the distribution of cell responses differed between the two groups (Figure 2D) or changed with learning (Figure 3Ac, 3Bc). As seen in Figure 3Aa, some mPFC cells increased calcium activity in response to air-puffs, while others decreased. We expected that the manipulation or learning would alter these responses. If they are strengthened, the increased responses will become more positive, while the decreased responses will become more negative. If they are weakened, both responses will become closer to 0. Under such conditions, the shape of the distribution of cell response will change but not the median. The KS test can detect this, but not other tests sensitive to the difference in medians, such as Wilcoxon rank-sum tests. In Figure 2D, KS tests were applied to the independently sampled data from the control and ChrimsonRexpressing mice. In Figure 3Ac and 3Bc, we used all cells imaged in the first and fifth sessions. Considering that ~50% of them were longitudinally registered on both days, we acknowledge the violation in the assumption of independent sampling. In Figure 1D, we detected significant interaction between the group and sessions. Several approaches are appropriate to demonstrate the source of this interaction. We chose to conduct one-way ANOVA separately in each group to demonstrate the significant change in % adaptive choice across the sessions in the control group but not the ChrimsonR group. The cutoff for significance was adjusted with the Bonferroni correction in follow-up paired t-tests used in Figure 1F.

    1. Author response:

      Reviewer #1 (Public review):

      This manuscript presents an interesting exploration of the potential activation mechanisms of DLK following axonal injury. While the experiments are beautifully conducted and the data are solid, I feel that there is insufficient evidence to fully support the conclusions made by the authors.

      In this manuscript, the authors exclusively use the puc-lacZ reporter to determine the activation of DLK. This reporter has been shown to be induced when DLK is activated. However, there is insufficient evidence to confirm that the absence of reporter activation necessarily indicates that DLK is inactive. As with many MAP kinase pathways, the DLK pathway can be locally or globally activated in neurons, and the level of DLK activation may depend on the strength of the stimulation. This reporter might only reflect strong DLK activation and may not be turned on if DLK is weakly activated. The results presented in this manuscript support this interpretation. Strong stimulation, such as axotomy of all synaptic branches, caused robust DLK activation, as indicated by puc-lacZ expression. In contrast, weak stimulation, such as axotomy of some synaptic branches, resulted in weaker DLK activation, which did not induce the puc-lacZ reporter. This suggests that the strength of DLK activation depends on the severity of the injury rather than the presence of intact synapses. Given that this is a central conclusion of the study, it may be worthwhile to confirm this further. Alternatively, the authors may consider refining their conclusion to better align with the evidence presented.

      We wish to further clarify a striking aspect of puc-lacZ induction following injury: it is bimodal. It is either induced (in various injuries that remove all synaptic boutons), or not induced, including in injuries that spared only 1-2 remaining boutons. This was particularly evident for injuries that spared the NMJ on muscle 29, which is comprised of only a few boutons. In some instances, only a single bouton was evident on muscle 29. While our injuries varied enormously in the number of branches and boutons that were lost, we did not see a comparable variability in puc-lacZ induction.  In the revision we will include additional images to better demonstrate this observation.

      The reviewer (and others) fairly point out that our current study focuses on puc-lacZ as a reporter of Wnd signaling in the cell body. We consider this to be a downstream integration of events in axons that are more challenging to detect. It is striking that this integration appears strongly sensitized to the presence of spared synaptic boutons. Examination of Wnd’s activation in axons and synapses is a goal for our future work.

      As noted by the authors, DLK has been implicated in both axon regeneration and degeneration. Following axotomy, DLK activation can lead to the degeneration of distal axons, where synapses are located. This raises an important question: how is DLK activated in distal axons? The authors might consider discussing the significance of this "synapse connection-dependent" DLK activation in the broader context of DLK function and activation mechanisms.

      While it has been noted that inhibition of DLK can mildly delay Wallerian degeneration (Miller et al., 2009), this does not appear to be the case for retinal ganglion cell axons following optic nerve crush (Fernandes et al., 2014). It is also not the case for Drosophila motoneurons and NMJ terminals following peripheral nerve injury (Xiong et al., 2012; Xiong and Collins, 2012). Instead, overexpression of Wnd or activation of Wnd by a conditioning injury leads to an opposite phenotype - an increase in resiliency to Wallerian degeneration for axons that have been previously injured (Xiong et al., 2012; Xiong and Collins, 2012). The downstream outcome of Wnd activation is highly dependent on the context; it may be an integration of the outcomes of local Wnd/DLK activation in axons with downstream consequences of nuclear/cell body signaling.  The current study suggests some rules for the cell body signaling, however, how Wnd is regulated at synapses and why it promotes degeneration in some circumstances but not others are important future questions.

      For the reviewer’s suggestion, it is interesting to consider DLK’s potential contributions to the loss of NMJ synapses in a mouse model of ALS (Le Pichon et al., 2017; Wlaschin et al., 2023). Our findings suggest that the synaptic terminal is an important locus of DLK regulation, while dysfunction of NMJ terminals is an important feature of the ‘dying back’ hypothesis of disease etiology (Dadon-Nachum et al., 2011; Verma et al., 2022). We propose that the regulation of DLK at synaptic terminals is an important area for future study, and may reveal how DLK might be modulated to curtail disease progression. Of note, DLK inhibitors are in clinical trials (Katz et al., 2022; Le et al., 2023; Siu et al., 2018), but at least some have been paused due to safety concerns (Katz et al., 2022). Further understanding of the mechanisms that regulate DLK are needed to understand whether and how DLK and its downstream signaling can be tuned for therapeutic benefit.

      Reviewer #2 (Public review):

      Summary:

      The authors study a panel of sparsely labeled neuronal lines in Drosophila that each form multiple synapses. Critically, each axonal branch can be injured without affecting the others, allowing the authors to differentiate between injuries that affect all axonal branches versus those that do not, creating spared branches. Axonal injuries are known to cause Wnd (mammalian DLK)-dependent retrograde signals to the cell body, culminating in a transcriptional response. This work identifies a fascinating new phenomenon that this injury response is not all-or-none. If even a single branch remains uninjured, the injury signal is not activated in the cell body. The authors rule out that this could be due to changes in the abundance of Wnd (perhaps if incrementally activated at each injured branch) by Wnd, Hiw's known negative regulator. Thus there is both a yet-undiscovered mechanism to regulate Wnd signaling, and more broadly a mechanism by which the neuron can integrate the degree of injury it has sustained. It will now be important to tease apart the mechanism(s) of this fascinating phenomenon. But even absent a clear mechanism, this is a new biology that will inform the interpretation of injury signaling studies across species.

      Strengths:

      (1) A conceptually beautiful series of experiments that reveal a fascinating new phenomenon is described, with clear implications (as the authors discuss in their Discussion) for injury signaling in mammals.

      (2) Suggests a new mode of Wnd regulation, independent of Hiw.

      Weaknesses:

      (1) The use of a somatic transcriptional reporter for Wnd activity is powerful, however, the reporter indicates whether the transcriptional response was activated, not whether the injury signal was received. It remains possible that Wnd is still activated in the case of a spared branch, but that this activation is either local within the axons (impossible to determine in the absence of a local reporter) or that the retrograde signal was indeed generated but it was somehow insufficient to activate transcription when it entered the cell body. This is more of a mechanistic detail and should not detract from the overall importance of the study

      We agree. The puc-lacZ reporter tells us about signaling in the cell body, but whether and how Wnd is regulated in axons and synaptic branches, which we think occurs upstream of the cell body response, remains to be addressed in future studies.

      (2) That the protective effect of a spared branch is independent of Hiw, the known negative regulator of Wnd, is fascinating. But this leaves open a key question: what is the signal?

      This is indeed an important future question, and would still be a question even if Hiw were part of the protective mechanism by the spared synaptic branch. Our current hypothesis (outlined in Figure 4) is that regulation of Wnd is tied to the retrograde trafficking of a signaling organelle in axons. The Hiw-independent regulation complements other observations in the literature that multiple pathways regulate Wnd/DLK (Collins et al., 2006; Feoktistov and Herman, 2016; Klinedinst et al., 2013; Li et al., 2017; Russo and DiAntonio, 2019; Valakh et al., 2013). It is logical for this critical stress response pathway to have multiple modes of regulation that may act in parallel to tune and restrain its activation.

      Reviewer #3 (Public review):

      Summary:

      This manuscript seeks to understand how nerve injury-induced signaling to the nucleus is influenced, and it establishes a new location where these principles can be studied. By identifying and mapping specific bifurcated neuronal innervations in the Drosophila larvae, and using laser axotomy to localize the injury, the authors find that sparing a branch of a complex muscular innervation is enough to impair Wallenda-puc (analogous to DLK-JNK-cJun) signaling that is known to promote regeneration. It is only when all connections to the target are disconnected that cJun-transcriptional activation occurs.

      Overall, this is a thorough and well-performed investigation of the mechanism of spared-branch influence on axon injury signaling. The findings on control of wnd are important because this is a very widely used injury signaling pathway across species and injury models. The authors present detailed and carefully executed experiments to support their conclusions. Their effort to identify the control mechanism is admirable and will be of aid to the field as they continue to try to understand how to promote better regeneration of axons.

      Strengths:

      The paper does a very comprehensive job of investigating this phenomenon at multiple locations and through both pinpoint laser injury as well as larger crush models. They identify a non-hiw based restraint mechanism of the wnd-puc signaling axis that presumably originates from the spared terminal. They also present a large list of tests they performed to identify the actual restraint mechanism from the spared branch, which has ruled out many of the most likely explanations. This is an extremely important set of information to report, to guide future investigators in this and other model organisms on mechanisms by which regeneration signaling is controlled (or not).

      Weaknesses:

      The weakest data presented by this manuscript is the study of the actual amounts of Wallenda protein in the axon. The authors argue that increased Wnd protein is being anterogradely delivered from the soma, but no support for this is given. Whether this change is due to transcription/translation, protein stability, transport, or other means is not investigated in this work. However, because this point is not central to the arguments in the paper, it is only a minor critique.

      We agree and are glad that the reviewer considers this a minor critique; this is an area for future study. In Supplemental Figure 1 we present differences in the levels of an ectopically expressed GFP-Wnd-kinase-dead transgene, which is strikingly increased in axons that have received a full but not partial axotomy. We suspect this accumulation occurs downstream of the cell body response because of the timing. We observed the accumulations after 24 hours (Figure S1F) but not at early (1-4 hour) time points following axotomy (data not shown). Further study of the local regulation of Wnd protein and its kinase activity in axons is an important future direction.

      As far as the scope of impact: because the conclusions of the paper are focused on a single (albeit well-validated) reporter in different types of motor neurons, it is hard to determine whether the mechanism of spared branch inhibition of regeneration requires wnd-puc (DLK/cJun) signaling in all contexts (for example, sensory axons or interneurons). Is the nerve-muscle connection the rule or the exception in terms of regeneration program activation?

      DLK signaling is strongly activated in DRG sensory neurons following peripheral nerve injury (Shin et al., 2012), despite the fact that sensory neurons have bifurcated axons and their projections in the dorsal spinal cord are not directly damaged by injuries to the peripheral nerve. Therefore it is unlikely that protection by a spared synapse is a universal rule for all neuron types. However the molecular mechanisms that underlie this regulation may indeed be shared across different types of neurons but utilized in different ways. For instance, nerve growth factor withdrawal can lead to activation of DLK (Ghosh et al., 2011), however neurotrophins and their receptors are regulated and implemented differently in different cell types. We suspect that the restraint of Wnd signaling by the spared synaptic branch shares a common underlying mechanism with the restraint of DLK signaling by neurotrophin signaling. Further elucidation of the molecular mechanism is an important next step towards addressing this question.

      Because changes in puc-lacZ intensity are the major readout, it would be helpful to better explain the significance of the amount of puc-lacZ in the nucleus with respect to the activation of regeneration. Is it known that scaling up the amount of puc-lacZ transcription scales functional responses (regeneration or others)? The alternative would be that only a small amount of puc-lacZ is sufficient to efficiently induce relevant pathways (threshold response).

      While induction of puc-lacZ expression correlates with Wnd-mediated phenotypes, including sprouting of injured axons (Xiong et al., 2010), protection from Wallerian degeneration (Xiong et al., 2012; Xiong and Collins, 2012) and synaptic overgrowth (Collins et al., 2006), we have not observed any correlation between the degree of puc-lacZ induction (eg modest, medium or high) and the phenotypic outcomes (sprouting, overgrowth, etc). Rather, there appears to be a striking all-or-none difference in whether puc-lacZ is induced or not induced. There may indeed be a threshold that can be restrained through multiple mechanisms. We posit in figure 4 that restraint may take place in the cell body, where it can be influenced by the spared bifurcation.

      References Cited:

      Collins CA, Wairkar YP, Johnson SL, DiAntonio A. 2006. Highwire restrains synaptic growth by attenuating a MAP kinase signal. Neuron 51:57–69.

      Dadon-Nachum M, Melamed E, Offen D. 2011. The “dying-back” phenomenon of motor neurons in ALS. J Mol Neurosci 43:470–477.

      Feoktistov AI, Herman TG. 2016. Wallenda/DLK protein levels are temporally downregulated by Tramtrack69 to allow R7 growth cones to become stationary boutons. Development 143:2983–2993.

      Fernandes KA, Harder JM, John SW, Shrager P, Libby RT. 2014. DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury. Neurobiol Dis 69:108–116.

      Ghosh AS, Wang B, Pozniak CD, Chen M, Watts RJ, Lewcock JW. 2011. DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity. J Cell Biol 194:751–764.

      Hao Y, Frey E, Yoon C, Wong H, Nestorovski D, Holzman LB, Giger RJ, DiAntonio A, Collins C. 2016. An evolutionarily conserved mechanism for cAMP elicited axonal regeneration involves direct activation of the dual leucine zipper kinase DLK. Elife 5. doi:10.7554/eLife.14048

      Huntwork-Rodriguez S, Wang B, Watkins T, Ghosh AS, Pozniak CD, Bustos D, Newton K, Kirkpatrick DS, Lewcock JW. 2013. JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis. J Cell Biol 202:747–763.

      Katz JS, Rothstein JD, Cudkowicz ME, Genge A, Oskarsson B, Hains AB, Chen C, Galanter J, Burgess BL, Cho W, Kerchner GA, Yeh FL, Ghosh AS, Cheeti S, Brooks L, Honigberg L, Couch JA, Rothenberg ME, Brunstein F, Sharma KR, van den Berg L, Berry JD, Glass JD. 2022. A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Ann Clin Transl Neurol 9:50–66.

      Klinedinst S, Wang X, Xiong X, Haenfler JM, Collins CA. 2013. Independent pathways downstream of the Wnd/DLK MAPKKK regulate synaptic structure, axonal transport, and injury signaling. J Neurosci 33:12764–12778.

      Le K, Soth MJ, Cross JB, Liu G, Ray WJ, Ma J, Goodwani SG, Acton PJ, Buggia-Prevot V, Akkermans O, Barker J, Conner ML, Jiang Y, Liu Z, McEwan P, Warner-Schmidt J, Xu A, Zebisch M, Heijnen CJ, Abrahams B, Jones P. 2023. Discovery of IACS-52825, a potent and selective DLK inhibitor for treatment of chemotherapy-induced peripheral neuropathy. J Med Chem 66:9954–9971.

      Le Pichon CE, Meilandt WJ, Dominguez S, Solanoy H, Lin H, Ngu H, Gogineni A, Sengupta Ghosh A, Jiang Z, Lee S-H, Maloney J, Gandham VD, Pozniak CD, Wang B, Lee S, Siu M, Patel S, Modrusan Z, Liu X, Rudhard Y, Baca M, Gustafson A, Kaminker J, Carano RAD, Huang EJ, Foreman O, Weimer R, Scearce-Levie K, Lewcock JW. 2017. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med 9. doi:10.1126/scitranslmed.aag0394

      Li J, Zhang YV, Asghari Adib E, Stanchev DT, Xiong X, Klinedinst S, Soppina P, Jahn TR, Hume RI, Rasse TM, Collins CA. 2017. Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104. Elife 6. doi:10.7554/eLife.24271

      Miller BR, Press C, Daniels RW, Sasaki Y, Milbrandt J, DiAntonio A. 2009. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat Neurosci 12:387–389.

      Nihalani D, Merritt S, Holzman LB. 2000. Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation. J Biol Chem 275:7273–7279.

      Russo A, DiAntonio A. 2019. Wnd/DLK is a critical target of FMRP responsible for neurodevelopmental and behavior defects in the Drosophila model of fragile X syndrome. Cell Rep 28:2581–2593.e5.

      Shin JE, Cho Y, Beirowski B, Milbrandt J, Cavalli V, DiAntonio A. 2012. Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration. Neuron 74:1015–1022.

      Siu M, Sengupta Ghosh A, Lewcock JW. 2018. Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration. J Med Chem 61:8078–8087.

      Valakh V, Walker LJ, Skeath JB, DiAntonio A. 2013. Loss of the spectraplakin short stop activates the DLK injury response pathway in Drosophila. J Neurosci 33:17863–17873.

      Verma S, Khurana S, Vats A, Sahu B, Ganguly NK, Chakraborti P, Gourie-Devi M, Taneja V. 2022. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol Neurobiol 59:1502–1527.

      Wlaschin JJ, Donahue C, Gluski J, Osborne JF, Ramos LM, Silberberg H, Le Pichon CE. 2023. Promoting regeneration while blocking cell death preserves motor neuron function in a model of ALS. Brain 146:2016–2028.

      Xiong X, Collins CA. 2012. A conditioning lesion protects axons from degeneration via the Wallenda/DLK MAP kinase signaling cascade. J Neurosci 32:610–615.

      Xiong X, Hao Y, Sun K, Li J, Li X, Mishra B, Soppina P, Wu C, Hume RI, Collins CA. 2012. The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein. PLoS Biol 10:e1001440.

      Xiong X, Wang X, Ewanek R, Bhat P, Diantonio A, Collins CA. 2010. Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury. J Cell Biol 191:211–223.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      We thank the reviewer for their comments and suggestions. We have made several edits to the paper to address these comments, including the addition of several new control experiments, corrections to mislabeled figures in Fig 2, and other additions to improve the clarity of several figures.

      This work is missing several controls that are necessary to substantiate their claims. My most important concern is that the optogenetic screen for neurons that alter pathogenic lawn occupancy does not have an accompanying control on non-pathogenic OP50 bacteria. Hence, it remains unclear whether these neuronal inhibition experiments lead to pathogen-specific or generalized lawn-leaving alterations. For strains that show statistical differences between - and + ATR conditions, the authors should perform follow-up validation experiments on non-pathogenic OP50 lawns to ensure that the observed effect is PA14-specific. Similarly, neuronal inhibition experiments in Figures 5E and H are only performed with naïve animals on PA14 - we need to see the latency to re-entry on OP50 as well, to make general conclusions about these neurons' role in pathogen-specific avoidance.

      We have added data from new control experiments to Fig. S1 (subfigures B, C) for both exit and re-entry dynamics on OP50. We find that inhibition of neurons produces different effects on both lawn entry and exit on PA14 compared to OP50. We observed that inhibition of neurons failed to change the re-entry dynamics for any of the lines which showed delayed latency to re-entry on PA14. Our results suggest that the neural control of re-entry dynamics we see are PA14 specific.

      My second major concern is regarding the calcium imaging experiments of candidate neurons involved in lawn re-entry behavior. Although the data shows that AIY, AVK, and SIA/SIB neurons all show reduced activity following pathogen exposure, the authors do not relate these activity changes to changes in behavior. Given the well-established links between these cells and forward locomotion, it is essential to not only report differences in activity but also in the relationship between this activity and locomotory behavior. If animals are paused outside of the pathogen lawn, these neurons may show low activity simply because the animals are not moving forward. Other forward-modulated neurons may also show this pattern of reduced activity if the animals remain paused. Given that the authors have recorded neural activity before and after contact with pathogenic bacteria in freely moving animals, they should also provide an analysis of the relationship between proximity to the lawn and the activity of these neurons.

      In response, we added an additional supplementary figure S7 to illustrate the role of each neuron in navigational control and added text to the discussion to better explain the role of each neuron type in the regulation of re-entry, in light of our previously published work on SIA in speed control.

      This work is missing methodological descriptions that are necessary for the correct interpretation of the results shown here. Figure 2 suggests that the determination of statistical significance across the optogenetic inhibition screen will be found in the Methods, but this information is not to be found there. At various points in the text, authors refer to "exit rate", "rate constant", and "entry rate". These metrics seem derived from an averaged measurement across many individual animals in one lawn evacuation assay plate. However "latency to re-entry" is only defined on a per-animal basis in the lawn re-exposure assay. These differences should be clearly stated in the methods section to avoid confusion and to ensure that statistics are computed correctly.

      Additional details have been added to the methods section to provide more in depth information on the statistical analysis performed. In brief, the latency to re-entry is calculated in the same way across all assays – re-entry events across replicate experiments for a given experimental condition are aggregated together and used to calculate relevant statistics.

      This work also contains mislabeled graphs and incorrect correspondence with the text, which make it difficult to follow the authors 'claims. The text suggests that Pdop-2::Arch3 and Pmpz-1::Arch3 show increased exit rates, whereas Figure 2 shows that Pflp-4::Arch3 but not Pmpz-1::Arch3 has increased exit rate. The authors should also make a greater effort to correctly and clearly label which type of behavioral experiment is used to generate each figure and describe the differences in experimental design in the main text, figure legends, and methods. Figure 2E depicts trajectories of animals leaving a lawn over a 2.5-minute interval but it is unclear when this time window occurs within the 18-hour lawn leaving assay. Likewise, Figure 2H depicts a 30-minute time window which has an unclear relationship to the overall time course of lawn leaving. This figure legend is also mislabeled as "Infected/Healthy", whereas it should be labeled "-/+ ATR".

      In Figures 2C and F, the x-axis labels are in a different order, making it difficult to compare between the 2 plots. Promoter names should be italicized. What does the red ring mean in Figure 2A? Figure 2 legend incorrectly states that four lines showed statistically significant changes for the Exist rate constant - only 2 lines are significant according to the figure.

      We thank the reviewer for identifying this embarrassing error. Figure 2C and F were flipped, and we have corrected this, we are sorry for the error. Promoter names have been italicized, and we have added additional text in the captions that the red ring is a ring light for background illumination of the worms. In addition, we have corrected the error in the figure legends from “Infected/Healthy” to “+/- ATR”.

      Lines in figure 2C and 2F are ordered by significance rather than keeping the same order in both. Majority feedback from colleagues suggested that this ordering was preferred.

      This work raises the interesting possibility that different sets of neurons control lawn exit and lawn re-entry behaviors following pathogen exposure. However, the authors never directly test this claim. To rigorously show this, the authors would need to show that lawn-exit-promoting neurons (CEPs, HSNs, RIAs, RIDs, SIAs) are dispensable for lawn re-entry behavior and that lawn re-entry promoting neurons (AVK, SIA, AIY, MI) are dispensable for lawn exit behavior in pathogen-exposed animals.

      We agree with the reviewer’s comments that there is insufficient evidence to show a complete decoupling of lawn exit and lawn re-entry. However, we note that our screen results show that only 1 line (dop-2) shows changes in both exit and re-entry dynamics upon neural inhibition (Fig. 2). This seems to suggest that at least some degree of neural control of re-entry is decoupled from exit.

      Please label graph axes with units in Figure 1 - instead of "Exit Rate" make it #exits per worm per hour, and make it more clear that Figures 1C and E have a different kind of assay than Figures 1A, B and D. There should be more consistency between the meaning of "pre/post" and "naive/infected/healthy" - and how many hours constitutes post.

      We have edited Figure 1 and made additions to the captions of figure 1 to make both points clearer. We have also standardized our language for subsequent figures (such as figure 5) to provide less ambiguity in pre/post and naïve/infected/healthy.

      Figure 5 - it should be made more clear when the stimulation/inhibition occurred in these experiments and how long they were recorded/analyzed.

      We have added additional details to the figure captions to make it clearer when the data was collected.

      Workspaces and code have been added under a data availability section in the manuscript.

      Reviewer 2:

      However, the paper's main weakness lies in its lack of a detailed mechanism explaining how the delayed reentry process directly influences the actual locomotor output that results in avoidance. The term 'delayed reentry' is used as a dynamic metric for quantifying the screening, yet the causal link between this metric and the mechanistic output remains unclear. Despite this, the study is well-structured, with comprehensive control experiments, and is very well constructed.

      We thank the reviewer for their comments and suggestions. We have added additional data and details to our work to cover these weaknesses, as can be seen in our responses to the suggestions below.

      (1) A key issue in the manuscript is the mechanistic link between the delayed process and locomotor output. AIY is identified as a crucial neuron in this process, but the specifics of how AIY influences this delay are not clear. For instance, does AIY decrease the reversal rate, causing animals to get into long-range search when they leave the bacterial lawn? Is there any relationship between pdf-2 expression and reversal rates? Given that AIY typically promotes long-range motion when activated, the suppression of this function and its implications on motion warrants further clarification.

      We have included additional data to explain how AIY might be able to regulate lawn entry behaviors and have added more to the discussion to explain how neural suppression might lead to changes in the behavior (new figure S7). Both AIY and SIA dynamics have been linked to worm navigation. In previous work (Lee 2019), we have demonstrated that SIA can control locomotory speed. Inhibition of SIA decreases locomotory speed, and as a result may serve to drive the increased latency of re-entry.

      AIY’s role in navigation has been previously established (Zhaoyu 2014), but we have added an additional supplementary figure and edited our discussion to further illustrate this point. As can be seen in the new figure S7, AIY neural activity undergoes a transition after removal from a bacterial lawn, going from low activity to high activity. This activity increase is correlated with a transition from a high reversal rate local search state to a long range search state characterized by longer runs. Inhibition of AIY during this long range search state increased the reversal rate resulting in a higher rate of re-orientations. This might serve as a part of the mechanistic explanation for AIY’s role in preventing lawn re-entry, as inhibition dramatically increased the rate of re-orientation, preventing worms from making directed runs into the bacterial lawn. However, there is an additional effect of the inhibition of AIY, not seen during food search. Inhibition of AIY in the context of a pathogenic bacterial lawn leads to stalling at the edge. Therefore, re-entry AIY could have an additional role in governing the animals movement, post exposure, upon contact with a pathogenic lawn.

      (2) I recommend including supplementary videos to visually demonstrate the process. These videos might help others identify aspects of the mechanism that are currently missing or unclear in the text.

      (4) The authors mention that the worms "left the lawn," but the images suggest that the worms do not stray far and remain around the perimeter. Providing videos could help clarify this observation and strengthen the argument by visually connecting these points

      Additional supplementary videos (1-3) taken at several stages of lawn evacuation have been added to visually demonstrate the process.

      (3) Regarding the control experiments (Figure 1E-G), the manuscript describes testing animals picked from a PA14-seeded plate and retesting them on different plates. It's crucial to clarify the differences between these plates. Specifically, the region just outside the lawn should be considered, as it is not empty and worms can spread bacteria around. Testing animals on a new plate with a pristine proximity region might introduce variables that affect their behavior.

      We have reworded the paper to make it clearer that these new conditions on a fresh PA14 lawn represent a different type of assay from the lawn evacuation assay. Fresh PA14 plates will indeed have a pristine proximity region compared to plates where the worms have spread the bacteria.

      These experiments were done to test if the evacuation effect is purely due to aversive signals left on the lawn or attractive signals left outside of the lawn. Given that worms are known to be able to leave compounds such as ascarosides to communicate with each other, we wanted to test that this lawn re-entry defect was not simply the result of deposited pheromones. Without any other method to remove such compounds, we relied on using fresh PA14 lawns instead to test this. We have updated the manuscript to clarify this point.

      (5) The manuscript notes that the PA14 strain was grown without shaking. Typically, growing this strain without agitation leads to biofilm formation. Clarifying whether there is a link between biofilm formation and avoidance behavior would add depth to the understanding of the experimental conditions and their impact on the observed behaviors.

      As the reviewer has noted, growth of PA14 without shaking might indeed lead to biofilm formation. This does represent a legitimate concern, as evidence from previous work has suggested that biofilm formation could be linked to pathogen avoidance as worms make use of mechanosensation to avoid pathogenic bacteria (Chang et al. 2011).  However, we do not observe substantial formation of biofilm in our cultured bacteria, likely since our growth time might be insufficient for sufficient biofilm formation to occur. We also note that our evacuation dynamics appear to be of similar timescale to results reported in previous work which used different growth conditions. As such, we believe that our growth conditions thus represent similar conditions as to those historically used in the lawn evacuation literature.

      Reviewer 3:

      Weaknesses:

      My only concern is that the authors should be more careful about describing their "compressed sensing-based approach". Authors often cite their previous Nature Methods paper, but should explain more because this method is critical for this manuscript. Also, this analysis is based on the hypothesis that only a small number of neurons are responsible for a given behavior. Authors should explain more about how to determine scarcity parameters, for example.

      We have added more details to our paper outlining some of the details involved in our compressed sensing approach. We go into more detail about how we chose sparsity parameters and note that our discovered neurons for re-entry appear to be robust over choice of sparsity parameters. These additional details can be found in both the paper body and the methods section.

      Line 45: This paragraph tries to mention that there should be "small sets of neurons" that can play key roles in integrating previous information to influence subsequent behavior. Is it valid as an assumption in the nervous systems?

      We want to clarify that what is important is not that there are ‘small sets of neurons’, but rather that these key neurons make up a small fraction of the total number of neurons in the nervous system. More correctly: the compressed sensing approach identifies information bottlenecks in the neural circuits, and the assumption is that the number of neurons in these bottlenecks are small. This is the underlying sparsity assumption being made here that allows us to utilize a compressed sensing based approach to identify these neurons. We have reworded this section to make it clear that what is important is not that the total number of neurons is small, but that they must be a small fraction of the total number of neurons in the nervous system.

      Line 125: "These approaches…" Authors repeatedly mentioned this statement to emphasize that their compressed sensing-based approach is the best choice. Are you really sure?

      We agree that there are several approaches that might allow for faster screening of the nervous system. For example, many studies approach the problem by looking at neurons with synapses onto a neuron already known to be implicated in the behavior or find neurons that express a key gene known to regulate the behavior of interest. These approaches utilize prior information to greatly reduce the pool of candidate neurons needed to be screened.

      In the absence of such prior information, we believe that our compressed sensing based approach allows a rapid way to perform an unbiased interrogation of the entire nervous system to identify key neurons at bottlenecks of neural circuits. Once these key neurons are identified, neurons upstream and downstream of these key neurons can be investigated in the future.  This approach gives us the added advantage of being able to identify neurons that do not connect to neurons that are already implicated in the behavior, or that don’t have clear genetic signatures in the behavior of interest. Our approach further allows for screening of neurons with no clear single genetic marker without the next to utilize intersectional genetic strategies.  We should not use the phrase “best choice” which might not be justified. We have reworded these statements, and we believe that compressed sensing based methods provide a complementary approach to those in the literature.

      Line 42: If authors refer to mushroom bodies and human hippocampus in relation to the significance of their work, authors should go back to these references in the Discussion and explain how their work is important.

      We thank the reviewer for this feedback, and we have added to our discussion to expand upon these points.

      Line 151: "the accelerated pathogen avoidance" Accelerated pathogen avoidance does not necessarily indicate the existence of the neural mechanism that inhibits the association of pathogenicity with microbe-specific cues (during early stages: first two hours).

      We agree with the reviewer’s statements that these results alone do not indicate the presence of an early avoidance mechanism. Other evidence for early avoidance mechanisms exists as seen in two choice assay experiments (Zhang 2005), and our results do seem to support this. However, we agree that early neural inhibition is insufficient evidence towards such a mechanism. We have thus removed this statement for accuracy.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript by Lopez-Blanch and colleagues, 21 microexons are selected for a deep analysis of their impacts on behavior, development, and gene expression. The authors begin with a systematic analysis of microexon inclusion and conservation in zebrafish and use these data to select 21 microexons for further study. The behavioral, transcriptomic, and morphological data presented are for the most part convincing. Furthermore, the discussion of the potential explanations for the subtle impacts of individual microexon deletions versus loss-of-function in srrm3 and/or srrm4 is quite comprehensive and thoughtful. One major weakness: data presentation, methods, and jargon at times affect readability / might lead to overstated conclusions. However, overall this manuscript is well-written, easy to follow, and the results are of broad interest.

      We thank the Reviewer for their positive comments on our manuscript. In the revised version, we will try to improve readability, reduce jargon and avoid overstatements. 

      Strengths:

      (1) The study uses a wide variety of techniques to assess the impacts of microexon deletion, ranging from assays of protein function to regulation of behavior and development.

      (2) The authors provide comprehensive analyses of the molecular impact of their microexon deletions, including examining how host-gene and paralog expression is affected.

      Weaknesses / Major Points:

      (1) According to the methods, it seems that srrm3 social behavior is tested by pairing a 3mpf srrm3 mutant with a 30dpf srrm3 het. Is this correct? The methods seem to indicate that this decision was made to account for a slower growth rate of homozygous srrm3 mutant fish. However, the difference in age is potentially a major confound that could impact the way that srrm3 mutants interact with hets and the way that srrm3 mutants interact with one another (lower spread for the ratio of neighbour in front value, higher distance to neighbour value). This reviewer suggests testing het-het behavior at 3 months to provide age-matched comparisons for del-del, testing age-matched rather than size-matched het-del behavior, and also suggests mentioning this in the main text / within the figure itself so that readers are aware of the potential confound.

      Thank you for bringing up this point. For the tests shown in Figure 5, we indeed decided to match the srrm3 pairs by fish size since we thought this would be more comparable to the other lines both biologically and methodologically (in terms of video tracking, etc.). However, we are confident the results would be very similar if matched by age, since the differences in social interactions between the srrm3 homozygous mutants and their control siblings are very dramatic at any age. For example, this can be appreciated, in line with the Reviewer's suggestion, in Videos S2 and S3, which show groups of five 5 mpf fish that are either srrm3 mutants or controls. It can be observed that the behavior of 5 mpf control fish is very similar to those of 1 mpf fish pairs, with very small interindividual distances. We will nonetheless agree that this decision on the experimental design should be clearly stated in the text and figure legend and we will do so in the revised version.

      (2) Referring to srrm3+/+; srrm4-/- controls for double mutant behavior as "WT for simplicity" is somewhat misleading. Why do the authors not refer to these as srrm4 single mutants?

      We thought it made the interpretation of plots easier, but we will change this in the revised version.

      (3) It's not completely clear how "neurally regulated" microexons are defined / how they are different from "neural microexons"? Are these terms interchangeable?

      Yes, they are interchangeable. We will double check the wording to avoid confusion.

      (4) Overexpression experiments driving srrm3 / srrm4 in HEK293 cells are not described in the methods.

      Apologies for this omission. We will briefly described the methods; however, please note that the data was obtained from a previous publication (Torres-Mendez et al, 2019), where the detailed methodology is reported.

      (5) Suggest including more information on how neurite length was calculated. In representative images, it appears difficult to determine which neurites arise from which soma, as they cross extensively. How was this addressed in the quantification?

      We will add further details to the revised version. With regards to the specific question, we would like to mention that this has not been a very common problem for the time points used in the manuscript (10 hap and 24 hap). At those stages, it was nearly always evident how to track each individual neurite. Dubious cases were simply discarded. Of course, such cases become much more common at later time points (48 and 72 hap), not sure in this study.

      Reviewer #2 (Public review):

      Summary:

      This manuscript explores in zebrafish the impact of genetic manipulation of individual microexons and two regulators of microexon inclusion (Srrm3 and Srrm4). The authors compare molecular, anatomical, and behavioral phenotypes in larvae and juvenile fish. The authors test the hypothesis that phenotypes resulting from Srrm3 and 4 mutations might in part be attributable to individual microexon deletions in target genes.

      The authors uncover substantial alterations in in vitro neurite growth, locomotion, and social behavior in Srrm mutants but not any of the individual microexon deletion mutants. The individual mutations are accompanied by broader transcript level changes which may resemble compensatory changes. Ultimately, the authors conclude that the severe Srrm3/4 phenotypes result from additive and/or synergistic effects due to the de-regulation of multiple microexons.

      Strengths:

      The work is carefully planned, well-described, and beautifully displayed in clear, intuitive figures. The overall scope is extensive with a large number of individual mutant strains examined. The analysis bridges from molecular to anatomical and behavioral read-outs. Analysis appears rigorous and most conclusions are well-supported by the data.

      Overall, addressing the function of microexons in an in vivo system is an important and timely question.

      Weaknesses:

      The main weakness of the work is the interpretation of the social behavior phenotypes in the Srrm mutants. It is difficult to conclude that the mutations indeed impact social behavior rather than sensory processing and/or vision which precipitates apparent social alterations as a secondary consequence. Interpreting the phenotypes as "autism-like" is not supported by the data presented.

      The Reviewer is absolutely right and we apologize for this omission, since it was not our intention to imply that these social defects should be interpreted simply as autistic-like. It is indeed very likely that the main reason for the social alterations displayed by the srrm3's mutants are due to their impaired vision. We will add this discussion explicitly in the revised version. 

      Reviewer #3 (Public review):

      Summary:

      Microexons are highly conserved alternative splice variants, the individual functions of which have thus far remained mostly elusive. The inclusion of microexons in mature mRNAs increases during development, specifically in neural tissues, and is regulated by SRRM proteins. Investigation of individual microexon function is a vital avenue of research since microexon inclusion is disrupted in diseases like autism. This study provides one of the first rigorous screens (using zebrafish larvae) of the functions of individual microexons in neurodevelopment and behavioural control. The authors precisely excise 21 microexons from the genome of zebrafish using CRISPR-Cas9 and assay the downstream impacts on neurite outgrowth, larvae motility, and sociality. A small number of mild phenotypes were observed, which contrasts with the more dramatic phenotypes observed when microexon master regulators SRRM3/4 are disrupted. Importantly, this study attempts to address the reasons why mild/few phenotypes are observed and identify transcriptomic changes in microexon mutants that suggest potential compensatory gene regulatory mechanisms.

      Strengths:

      (1) The manuscript is well written with excellent presentation of the data in the figures.

      (2) The experimental design is rigorous and explained in sufficient detail.

      (3) The identification of a potential microexon compensatory mechanism by transcriptional alterations represents a valued attempt to begin to explain complex genetic interactions.

      (4) Overall this is a study with a robust experimental design that addresses a gap in knowledge of the role of microexons in neurodevelopment.

      Thank you very much for your positive comments to our manuscript.

    1. Author response:

      eLife Assessment

      This descriptive manuscript builds on prior research showing that the elimination of Origin Recognition Complex (ORC) subunits does not halt DNA replication. The authors use various methods to genetically remove one or two ORC subunits from specific tissues and observe continued replication, though it may be incomplete. The replication appears to be primarily endoreduplication, indicating that ORC-independent replication may promote genome reduplication without mitosis. Despite similar findings in previous studies, the paper provides convincing genetic evidence in mice that liver cells can replicate and undergo endoreduplication even with severely depleted ORC levels. While the mechanism behind this ORC-independent replication remains unclear, the study lays the groundwork for future research to explore how cells compensate for the absence of ORC and to develop functional approaches to investigate this process. The reviewers agree that this valuable paper would be strengthened significantly if the authors could delve a bit deeper into the nature of replication initiation, potentially using an origin mapping experiment. Such an exciting contribution would help explain the nature of the proposed new type of Mcm loading, thereby increasing the impact of this study for the field at large.<br />

      We appreciate the reviewers’ suggestion. Till now we know of only one paper that mapped origins of replication in regenerating mouse liver, and that was published two months back in Cell (PMID: 39293447).  We want to adopt this method, but we do not need it to answer the question asked.  We have mapped origins of replication in ORC-deleted cancer cell lines and compared to wild-type cells in Shibata et al., BioRXiv (PMID: 39554186) (it is under review).  We report the following:  Mapping of origins in cancer cell lines that are wild type or engineered to delete three of the subunits, ORC1, ORC2 or ORC5 shows that specific origins are still used and are mostly at the same sites in the genome as in wild type cells. Of the 30,197 origins in wild type cells (with ORC), only 2,466 (8%) are not used in any of the three ORC deleted cells and 18,319 (60%) are common between the four cell types. Despite the lack of ORC, excess MCM2-7 is still loaded at comparable rates in G1 phase to license reserve origins and is also repeatedly loaded in the same S phase to permit re-replication. 

      Citation: Specific origin selection and excess functional MCM2-7 loading in ORC-deficient cells. Yoshiyuki Shibata, Mihaela Peycheva, Etsuko Shibata, Daniel Malzl, Rushad Pavri, Anindya Dutta. bioRxiv 2024.10.30.621095; doi: https://doi.org/10.1101/2024.10.30.621095 (PMID: 39554186)

      Public Reviews:

      Reviewer #1 (Public review):

      The origin recognition complex (ORC) is an essential loading factor for the replicative Mcm2-7 helicase complex. Despite ORC's critical role in DNA replication, there have been instances where the loss of specific ORC subunits has still seemingly supported DNA replication in cancer cells, endocycling hepatocytes, and Drosophila polyploid cells. Critically, all tested ORC subunits are essential for development and proliferation in normal cells. This presents a challenge, as conditional knockouts need to be generated, and a skeptic can always claim that there were limiting but sufficient ORC levels for helicase loading and replication in polyploid or transformed cells. That being said, the authors have consistently pushed the system to demonstrate replication in the absence or extreme depletion of ORC subunits.

      Here, the authors generate conditional ORC2 mutants to counter a potential argument with prior conditional ORC1 mutants that Cdc6 may substitute for ORC1 function based on homology. They also generate a double ORC1 and ORC2 mutant, which is still capable of DNA replication in polyploid hepatocytes. While this manuscript provides significantly more support for the ability of select cells to replicate in the absence or near absence of select ORC subunits, it does not shed light on a potential mechanism.

      The strengths of this manuscript are the mouse genetics and the generation of conditional alleles of ORC2 and the rigorous assessment of phenotypes resulting from limiting amounts of specific ORC subunits. It also builds on prior work with ORC1 to rule out Cdc6 complementing the loss of ORC1.

      The weakness is that it is a very hard task to resolve the fundamental question of how much ORC is enough for replication in cancer cells or hepatocytes. Clearly, there is a marked reduction in specific ORC subunits that is sufficient to impact replication during development and in fibroblasts, but the devil's advocate can always claim minimal levels of ORC remaining in these specialized cells.

      The significance of the work is that the authors keep improving their conditional alleles (and combining them), thus making it harder and harder (but not impossible) to invoke limiting but sufficient levels of ORC. This work lays the foundation for future functional screens to identify other factors that may modulate the response to the loss of ORC subunits.

      This work will be of interest to the DNA replication, polyploidy, and genome stability communities.

      Thank you.

      Reviewer #2 (Public review):

      This manuscript proposes that primary hepatocytes can replicate their DNA without the six-subunit ORC. This follows previous studies that examined mice that did not express ORC1 in the liver. In this study, the authors suppressed expression of ORC2 or ORC1 plus ORC2 in the liver.

      Comments:

      (1) I find the conclusion of the authors somewhat hard to accept. Biochemically, ORC without the ORC1 or ORC2 subunits cannot load the MCM helicase on DNA. The question arises whether the deletion in the ORC1 and ORC2 genes by Cre is not very tight, allowing some cells to replicate their DNA and allow the liver to develop, or whether the replication of DNA proceeds via non-canonical mechanisms, such as break-induced replication. The increase in the number of polyploid cells in the mice expressing Cre supports the first mechanism, because it is consistent with few cells retaining the capacity to replicate their DNA, at least for some time during development.

      In our study, we used EYFP as a marker for Cre recombinase activity. ~98% of the hepatocytes in tissue sections and cells in culture express EYFP, suggesting that the majority of hepatocytes successfully expressed the Cre protein to delete the ORC1 or ORC2 genes. To assess deletion efficiency, we employed sensitive genotyping and Western blotting techniques to confirm the deletion of ORC1 and ORC2 in hepatocytes isolated from Alb-Cre mice. Results in Fig. 2C and Fig. 6D demonstrate the near-complete absence of ORC2 and ORC1 proteins, respectively, in these hepatocytes.

      The mutant hepatocytes underwent at least 15–18 divisions during development. The inherited ORC1 or ORC2 protein present during the initial cell divisions, would be diluted to less than 1.5% of wild-type levels within six divisions, making it highly unlikely to support DNA replication, and yet we observe hepatocyte numbers that suggest there was robust cell division even after that point.

      Furthermore, the EdU incorporation data confirm DNA synthesis in the absence of ORC1 and ORC2. Specifically, immunofluorescence showed that both in vitro and in vivo, EYFP-positive hepatocytes (indicating successful ORC1 and ORC2 deletion) incorporated EdU, demonstrating that DNA synthesis can occur without ORC1 and ORC2.

      Finally, the Alb-ORC2f/f mice have 25-37.5% of the number of hepatocyte nuclei compared to WT mice (Table 2).  If that many cells had an undeleted ORC2 gene, that would have shown up in the genotyping PCR and in the Western blots.

      (2) Fig 1H shows that 5 days post infection, there is no visible expression of ORC2 in MEFs with the ORC2 flox allele. However, at 15 days post infection, some ORC2 is visible. The authors suggest that a small number of cells that retained expression of ORC2 were selected over the cells not expressing ORC2. Could a similar scenario also happen in vivo?

      This would not explain the significant incorporation of EdU in hepatocytes that do not have detectable ORC by Western blots and that are EYFP positive.  Also note that for MEFs we are delivering the Cre by AAV infection in vitro, so there is a finite probability that a cell will not receive Cre and will not delete ORC2.  However, in vivo, the Alb-Cre will be expressed in every cell that turns on albumin.  There is no escaping the expression of Cre.

      (3) Figs 2E-G shows decreased body weight, decreased liver weight and decreased liver to body weight in mice with recombination of the ORC2 flox allele. This means that DNA replication is compromised in the ALB-ORC2f/f mice.

      It is possible that DNA replication is partially compromised or may slow down in the absence of ORC2. However, it is important to emphasize that livers with ORC2 deletion remain capable of DNA replication, so much so that liver function and life span are near normal. Therefore, some kind of DNA replication has to serve as a compensatory mechanism in the absence of ORC2 to maintain liver function and support regeneration.

      (4) Figs 2I-K do not report the number of hepatocytes, but the percent of hepatocytes with different nuclear sizes. I suspect that the number of hepatocytes is lower in the ALB-ORC2f/f mice than in the ORC2f/f mice. Can the authors report the actual numbers?

      We show in Table 2 that the Alb-Orc2f/f mice have about 25-37.5% of the hepatocytes compared to the WT mice.

      (5) Figs 3B-G do not report the number of nuclei, but percentages, which are plotted separately for the ORC2-f/f and ALB-ORC2-f/f mice. Can the authors report the actual numbers?

      In all the FACS experiments in Fig. 3B-G we collect data for a total of 10,000 nuclei (or cells).  For Fig. 3E-G we divide the 10,000 nuclei into the bottom 40% on the EYFP axis (EYFP low, which is mostly EYFP negative) as the control group, and EYFP high (top 20% on the EYFP axis) test group.  We will mention this in the revision and label EYFP negative and positive as EYFP low and high.

      (6) Fig 5 shows the response of ORC2f/f and ALB-ORC2f/f mice after partial hepatectomy. The percent of EdU+ nuclei in the ORC2-f/f (aka ALB-CRE-/-) mice in Fig 5H seems low. Based on other publications in the field it should be about 20-30%. Why is it so low here? The very low nuclear density in the ALB-ORC2-f/f mice (Fig 5F) and the large nuclei (Fig 5I) could indicate that cells fire too few origins, proceed through S phase very slowly and fail to divide.

      The percentage of EdU+ nuclei in the ORC2f/f without Alb-Cre mice is 8%, while in PMID 10623657, the 10% of wild type nuclei incorporate  EdU at 42 hr post partial hepatectomy (mid-point between the 36-48 hr post hepatectomy that was used in our study).  The important result here is that in the ORC2f/f mice with Alb-Cre (+/-) we are seeing significant EdU incorporation. We will also correct the X-axis labels in 5F, 5I, 7E and 7F to reflect that those measurements were not made at 36 hr post-resection but later (as was indicated in the schematic in Fig. 5A).

      (7) Fig 6F shows that ALB-ORC1f/f-ORC2f/f mice have very severe phenotypes in terms of body weight and liver weight (about on third of wild-type!!). Fig 6H and 6I, the actual numbers should be presented, not percentages. The fact that there are EYFP negative cells, implies that CRE was not expressed in all hepatocytes.

      The liver to body weight ratio is what one has to look at, and it is 70% of the WT.  In females the liver and body weight are low (although in proportion to each other), which maybe is what the reviewer is talking about.  However, the fact that liver weight and body weight are not as low in males, suggest that this is a gender (hormone?) specific effect and not a DNA replication defect.  We have another paper also in BioRXiv (Su et al.) that suggests that ORC subunits have significant effect on gene expression, so it is possible that that is what leads to this sexual dimorphism in phenotype.

      The bottom 40% of nuclei on the EYFP axis in the FACS profiles (what was labeled EYFP negative but will now be called EYFP low) contains mostly non-hepatocytes that are genuinely EYFP negative.   Non-hepatocytes (bile duct cells, endothelial cells, Kupffer cells, blood cells) are a significant part of cells in the dissociated liver (as can be seen in the single cell sequencing results in PMID: 32690901).  Their presence does not mean that hepatocytes are not expressing Cre.  Hepatocytes mostly are EYFP positive, as can be seen in the tissue sections (where the hepatocytes take up most of visual field) and in cells in culture.  Also if there are EYFP negative hepatocyte nuclei in the FACS, that still does not rule out EYFP presence in the cytoplasm.  The important point from the FACS is that the EYFP high nuclei (which have expressed Cre for the longest period) are polyploid relative to the EYFP low nuclei.

      (8) Comparing the EdU+ cells in Fig 7G versus 5G shows very different number of EdU+ cells in the control animals. This means that one of these images is not representative. The higher fraction of EdU+ cells in the double-knockout could mean that the hepatocytes in the double-knockout take longer to complete DNA replication than the control hepatocytes. The control hepatocytes may have already completed DNA replication, which can explain why the fraction of EdU+ cells is so low in the controls. The authors may need to study mice at earlier time points after partial hepatectomy, i.e. sacrifice the mice at 30-32 hours, instead of 40-52 hours.

      The apparent difference that the reviewer comments on stems from differences in nuclear density in the images in Fig. 7G and 5G (also quantitated in Fig. 7F and 5F).  The quantitation in Fig. 7H and 5H show that the % of EdU plus cells are comparable (5-8%). 

      (9) Regarding the calculation of the number of cell divisions during development: the authors assume that all the hepatocytes in the adult liver are derived from hepatoblasts that express Alb. Is it possible to exclude the possibility that pre-hepatoblast cells that do not express Alb give rise to hepatocytes? For example the cells that give rise to hepatoblasts may proliferate more times than normal giving rise to a higher number of hepatoblasts than in wild-type mice.

      Single cell sequencing of mouse liver at e11 shows hepatoblasts expressing hepatocyte specific markers (PMID: 32690901).  All the cells annotated from the single-cell seq analysis are differentiated cells arguing against the possibility that undifferentiated endodermal cells (what the reviewer probably means by pre-hepatoblasts) exist at e11.  The following review (https://www.ncbi.nlm.nih.gov/books/NBK27068/) says: “The differentiation of bi-potential hepatoblasts into hepatocytes or BECs begins around e13 of mouse development. Initially hepatoblasts express genes associated with both adult hepatocytes (Hnf4α, Albumin) ...”  Thus, we can be certain that undifferentiated endodermal cells are unlikely to persist on e11 and that hepatoblasts at e11 express albumin.  Our calculation of number of cell divisions in Table 2 begins from e12.

      The reviewer maybe suggesting that ORC deletion leads to the immediate demise of hepatoblasts (despite having inherited ORC protein from the endodermal cells) causing undifferentiated endodermal cells to persist and proliferate much longer than in normal development.  We consider it unlikely, but if true it will be amazing new biology, both by suggesting that deletion of ORC immediately leads to the death of the hepatoblasts (despite a healthy reserve of inherited ORC protein) and by suggesting that there is a novel feedback mechanism from the death/depletion of hepatoblasts leading to the persistence and proliferation of undifferentiated endodermal cells.

      (10) My interpretation of the data is that not all hepatocytes have the ORC1 and ORC2 genes deleted (eg EYFP-negative cells) and that these cells allow some proliferation in the livers of these mice.

      Please see the reply in question #1.  Particularly relevant: “Finally, the Alb-ORC2f/f mice have 25-37.5% of the number of hepatocyte nuclei compared to WT mice (Table 2).  If that many cells had an undeleted ORC2 gene, that would have shown up in the genotyping PCR and in the Western blots.

      Reviewer #3 (Public review):

      Summary:

      The authors address the role of ORC in DNA replication and that this protein complex is not essential for DNA replication in hepatocytes. They provide evidence that ORC subunit levels are substantially reduced in cells that have been induced to delete multiple exons of the corresponding ORC gene(s) in hepatocytes. They evaluate replication both in purified isolated hepatocytes and in mice after hepatectomy. In both cases, there is clear evidence that DNA replication does not decrease at a level that corresponds with the decrease in detectable ORC subunit and that endoreduplication is the primary type of replication observed. It remains possible that small amounts of residual ORC are responsible for the replication observed, although the authors provide arguments against this possibility. The mechanisms responsible for DNA replication in the absence of ORC are not examined.

      Strengths:

      The authors clearly show that there are dramatic reductions in the amount of the targeted ORC subunits in the cells that have been targeted for deletion. They also provide clear evidence that there is replication in a subset of these cells and that it is likely due to endoreduplication. Although there is no replication in MEFs derived from cells with the deletion, there is clearly DNA replication occurring in hepatocytes (both isolated in culture and in the context of the liver). Interestingly, the cells undergoing replication exhibit enlarged cell sizes and elevated ploidy indicating endoreduplication of the genome. These findings raise the interesting possibility that endoreduplication does not require ORC while normal replication does.

      Weaknesses:

      There are two significant weaknesses in this manuscript. The first is that although there is clearly robust reduction of the targeted ORC subunit, the authors cannot confirm that it is deleted in all cells. For example, the analysis in Fig. 4B would suggest that a substantial number of cells have not lost the targeted region of ORC2. Although the western blots show stronger effects, this type of analysis is notorious for non-linear response curves and no standards are provided. The second weakness is that there is no evaluation of the molecular nature of the replication observed. Are there changes in the amount of location of Mcm2-7 loading that is usually mediated by ORC? Does an associated change in Mcm2-7 loading lead to the endoreduplication observed? After numerous papers from this lab and others claiming that ORC is not required for eukaryotic DNA replication in a subset of cells, we still have no information about an alternative pathway that could explain this observation.

      We do not see a significant deficit in MCM2-7 loading (amount and rate) in cancer cell lines where we have deleted ORC1, ORC2 or ORC5 genes separately in Shibata et al. bioRxiv 2024.10.30.621095; doi: https://doi.org/10.1101/2024.10.30.621095 (PMID: 39554186)

      The authors frequently use the presence of a Cre-dependent eYFP expression as evidence that the ORC1 or ORC2 genes have been deleted. Although likely the best visual marker for this, it is not demonstrated that the presence of eYFP ensures that ORC2 has been targeted by Cre. For example, based on the data in Fig. 4B, there seems to be a substantial percentage of ORC2 genes that have not been targeted while the authors report that 100% of the cells express eYFP.

      The PCR reactions in Fig. 4B are still contaminated by DNA from non-hepatocyte cells:  bile duct cells, endothelial, Kupfer cells and blood cells.  Under the microscope  culture we can recognize the hepatocytes unequivocally from their morphology. <2% of the hepatocyte cells in culture in Fig. 4C are EYFP-.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer #1 (public review):

      (1) The link between the background in the introduction and the actual study and findings is often tenuous or not clearly explained. A re-working of the intro to better set up and link to the study questions would be beneficial.

      We have rewritten the introduction of the manuscript and clearly stated the study questions we were aiming for:

      In paragraph 1-we have stated clearly that we need to study why ADC type of cervical cancer is more aggressive. (Line 58 - 77)

      In paragraph 2- we have stated clearly that we need to find valuable biomarkers to help diagnose lymph node metastasis, which may compensate the shortage of radiological imaging tools and reduce the rate of misdiagnosis. (Line 78 - 100)

      In paragraph 3- we have stated clearly that HPV negative cases is a special group of cervical cancer and we aim to study its cellular features. (Line 101 - 108)

      In paragraph 4- we have stated clearly that we need to decode cell-to-cell interaction mode in the tumor immune microenvironment of ADC using scRNA-seq. (Line 109 - 123)

      (2) For the sequencing, which kit was used on the Novaseq6000?

      For sequencing, we used the Chromium Controller and Chromium Single Cell 3’Reagent Kits (v3 chemistry CG000183) on the Novaseq6000. We feel sorry for lacking this quite important part and have already add the information in Methods section. (Line 196- 197)

      (3) Additional details are needed for the analysis pipeline. How were batch effects identified/dealt with, what were the precise functions and settings for each step of the analysis, how was clustering performed and how were clusters validated etc. Currently, all that is given is software and sometimes function names which are entirely inadequate to be able to assess the validity of the analysis pipeline. This could alternatively be answered by providing annotated copies of the scripts used for analysis as a supplement.

      We apologize for the inadequacy of descriptions of data analysis process. We have already provided a new part of “data processing” with more details in the Methods section (Line 202 - 221). In addition, we have also provided annotated copies of scripts in the supplementary data as Supplementary Data 1.

      (4) For Cell type annotation, please provide the complete list of "selected gene markers" that were used for annotation.

      We have already added the list of marker genes for cell type annotation in the revised manuscript as Supplementary Table 3.

      (5) No statistics are given for the claims on cell proportion differences throughout the paper (for cell types early, epithelial sub-clusters later, and immune cell subsets further on). This should be a multivariate analysis to account for ADC/SCC, HPV+/- and Early/Late stage.

      We feel sorry for lacking statistics when performing analyses of comparisons. In the revision, we have already used statistic approaches to analyze the differences between each set of group comparison. As a result, the corresponding figures have been revised, accordingly.

      For examle, Fig. 1F, Fig. 2D, Fig. 4E, Fig. 5D, Fig. 6D had been re-analyzed to compare ADC/SCC;Supplementary Fig. 1A, Supplementary Fig. 2A, Supplementary Fig. 4A, Supplementary Fig. 5A, Supplementary Fig. 6A had been re-analyzed to compare HPV+/HPV-; Supplementary Fig. 1B, Supplementary Fig. 2B, Supplementary Fig. 4B, Supplementary Fig. 5B, Supplementary Fig. 6B had been re-analyzed to compare Early/Late stage. All P values have been listed in the figure legends.

      (6) The Y-axis label is missing from the proportion histograms in Figure 2D. In these same panels, the bars change widths on the right side. If these are exclusively in ADC, show it with a 0 bar for SCC, not doubling the width which visually makes them appear more important by taking up more area on the plot.

      We feel sorry for impreciseness when presenting histograms of Fig. 2D and we have also revised other figures with similar mistakes, such as Fig. 1F,  Fig. 5D. As for the width of bars, which is due to output style of data processing, we have already corrected all similar mistakes alongside the whole manuscript, for example, Fig. 2D and Supplementary Fig. 2A-B.

      (7) Throughout the manuscript, informatic predictions (differentiation potential, malignancy score, stemness, and trajectory) are presented as though they're concrete facts rather than the predictions they are. Strong conclusions are drawn on the basis of these predictions which do not have adequate data to support. These conclusions which touch on essentially all of the major claims made in the manuscript would need functional data to validate, or the claims need to be very substantially softened as they lack concrete support. Indeed, the fact that most of the genes examined that were characteristic of a given cluster did not show the expected expression patterns in IHC highlights the fact that such predictions require validation to be able to draw proper inferences.

      Thank you for your insightful comments. As you noted, several conclusions were initially based on bioinformatics predictions. Thus in the revised manuscript, we have rewritten all relevant descriptions in a more softened way, particularly in the paragraph of “epithelial cells” in Results section, as well as the conclusions derived from bioinformatics predictions in other paragraphs throughout the manuscript. We hope our revised descriptions will enhance the precision of our work.

      For example, in paragraph “The sub-clusters of epithelial cells in ADC exhibit elevated stem-like features (from Line 353)”, many over-affirmative disriptions had been re-written in Line 353, 362, 371, 375, 379, 383, 390, 392. From Line 395 to 399, the conclusion had been revised as “The observation of cluster Epi_10_CYSTM1 and its possible specificity to ADC makes us question whether or not it may be related to the aggressiveness of ADC” compared to the previous “This observation may partially indicate that high stemness cluster Epi_10_CYSTM1 is essential for ADC to present more aggressive features”. From Line 400 to 408, conclusions from GO analyses had also been rewritten.

      In paragraph “ADC-specific epithelial cluster-derived gene SLC26A3 is a potential prognostic marker for lymph node metastasis (from Line 422)”, many conclusions based on predictions had been revises, such as Line 424 - 428, Line 439 - 441, Line 451 - 453, Line 455 - 457, Line 458 - 459, Line 471 - 473, Line 478 - 481, Line 484 - 486, Line 489, etc.

      In paragraph “Tumor associated neutrophils (TANs) surrounding ADC tumor area may contribute to the formation of a malignant microenvironment (from Line 536)”, we have changed the descriptions based on bio-infomative predictions, such as Line 560, Line 561, Line 565, Line 566, Line 572, Line 576 - 577, etc.

      In paragraph “Crosstalk among tumor cells, Tregs and neutrophils establishes the immunosuppressive TIME in ADC (from Line 601)”, we have already corrected the all the affirmative descriptions, such as Line 604, Line 612, Line 614, Line 626, Line 628 - 629, Line 641, Line 654 – 655, etc.

      All the changes have also been listed in Revision Notes in detail.

      (8) The cluster Epi_10_CYSTM1 which is the basis for much of the paper is present in a single individual (with a single cell coming from another person), and heavily unconnected from the rest of the epithelial populations. If so much emphasis is placed on it, the existence of this cluster as a true subset of cells requires validation.

      We appreciate this suggestion. We agree that the majority of Epi_10_CYSTM1 cells are derived from sample S7. The fact that we have detected this cluster in only one patient may be due to sampling differences and the inherent heterogeneity of tumor specimens. However, the relatively high number of cells in this cluster from one stage III patient suggests its presence in ADC patients and highlights its potential as a diagnostic marker for clinical staging. To further investigate whether this cluster is generally existing in ADC patients, we have identified and selected candidate genes, such as SLC26A3, ORM1, and ORM2, as representative markers of this cluster, which demonstrated high specificity (as shown in Fig. 3B). We then performed IHC staining on a total of 56 tissue samples, and the results showed positive expressions of these markers in the majority of stage IIIC tumor tissues, confirming the existence of this cell cluster (as shown in Supplementary Fig. 3E). In our revised manuscript, we have included an in-depth discussion of this issue in the seventh paragraph of the Discussion section (From Line 801).

      (9) Claims based on survival analysis of TCGA for Epi_10_CYSTM1 are based on a non-significant p-value, though there is a slight trend in that direction.

      Thank you for your insightful comment. From the data of TCGA survival analysis for Epi_10, we found a not-so-slight trend of difference between groups (with a small P value). As a result, we presented this data and hoped to add more strength to the clinical significance of this cluster. However, this indeed caused controversy because the P value is non-significant. As a result, we have already deleted this data in the revised manuscript.

      (10) The claim "The identification of Epi_10_CYSTM1 as the only cell cluster found in patients with stage IIICp raises the possibility that this cluster may be a potential marker to diagnose patients with lymph node metastasis." This is incorrect according to the sample distributions which clearly show cells from the patient who has EPI_10_CYSTM1 in multiple other clusters. This is then used as justification for SLC26A3 which appears to be associated with associated with late stage, however, in the images SLC26A3 appears to be broadly expressed in later tumours rather than restricted to a minor subset as it should be if it were actually related to the EPI_10_CYSTM1 cluster.

      We feel thankful for this question. The conclusion that “The identification of Epi_10_CYSTM1 as the only cell cluster found in patients with stage IIICp raises the possibility that this cluster may be a potential marker to diagnose patients with lymph node metastasis” has indeed been written too concrete according to the sample distribution. We feel sorry for this and have already corrected the description into “As one of stage IIIC-specific cell clusters, the cluster of Epi_10_CYSTM1, with its representative marker gene SLC26A3, presents potential diagnostic value to predict lymph node metastasis” from Line 478-481.

      However, based on our results, we do think this cluster is a potential diagnostic marker and the hypothesis is right. As for SLC26A3, we have specifically added a new paragraph (from Line 801 - 822) in Discussion section to discuss the rationality and necessity of selecting this gene as our central focus, and the reasons why SLC26A3 should be the representative of cluster Epi_10_CYSTM1. As you noted, SLC26A3 appears to be broadly expressed in later tumors rather than restricted to a minor subset in the images. We apologize for any misunderstanding caused. When presenting the IHC data, we only showed the strongly positive areas of each slide to emphasize the differences. In our revision, we have included whole slide scanning images of the IHC samples, clearly showing that SLC26A3 is restricted to a part of the tumors (Supplementary Fig.9).

      (11) The authors claim that cytotoxic T cells express KRT17, and KRT19. This likely represents a mis-clustering of epithelial cells.

      We apologize for using data without noticing the contamination of T cells with few epithelial cells. We have re-performed quality control to exclude contamination and re-analyzed all data of T cells. In the reviesed manuscript, we have therefore updated completely new data for T cells in both Fig. 4 and Supplementary Fig. 4.

      (12) Multiple claims are made for specific activities based on GO term biological process analysis which while not contradictory to the data, certainly are by no means the only explanation for it, nor directly supported.

      Our initial purpose was to use GO analysis as supports for our conclusions. However, we know these are only claims but not evidence, which is also the problem of our writing techniques as in question (7). Therefore, in our revised manuscript, we have already deleted GO data and descriptions in the paragraphs of “T cell (Fig.4)”(from Line 495) and “B/plasma cell (Fig.6)” (from Line 579), because the predictions are quite irrelevant to our conclusions.

      However, in the sections of “epithelial cell (Fig.2)” (from Line 352) and “neutrophils (Fig.5)” (from Line 536), we retained the GO data and rewrote the conclusions, because these analyses have provided us with valuable information regarding the role of specific cell clusters in ADC progression. Furthermore, our subsequent analyses, such as CellChat, have further validated the accuracy of the findings from the GO analysis. We do think this logically supports the whole storyline of the study.

      Reviewer #2 (public review):

      (1) I believe that many of the proposed conclusions are over-interpretations or unwarranted generalizations of the single-cell analysis. These conclusions are often based on populations in the scRNA-seq data that are described as enriched or specific to a given group of samples (eg. ADC). This conclusion is based on the percentage of cells in that population belonging to the given group; for example, a cluster of cells that dominantly come from ADC. The data includes multiple samples for each group, but statistical approaches are never used to demonstrate the reproducibility of these claims.

      We feel sorry that many of the conclusions have been written in an over-affirmative way but lack profound supporting evidences. In our revision, we have already optimized the writing techniques and re-written all conclusions or descriptions related to only bio-informatic predictions. Moreover, we have performed statistical re-analyses on all data and rearranged the related figures.

      For example, in Line 352, we have changed the sub-title “The sub-clusters of epithelial cells exhibit elevated stem-like features to promote the aggressiveness of ADC” into “The sub-clusters of epithelial cells in ADC exhibit elevated stem-like features”. In this paragraph, many over-affirmative discriptions such as “exclusively”, “significant”, “overwhelmingly”, “remarkably” have been deleted. From Line 486-493, the conclusion of “Moreover, SLC26A3 could be employed as a marker for the Epi_10_CYSTM1 cluster, aiding in the diagnosis of lymph node metastasis to prevent post-surgical upstaging in ADC patients in the future” have been changed into “our results propose that SLC26A3 might be considered as a diagnostic marker to predict lymph node metastasis in ADC patients”. Similar over-affirmative descriptions and conclusions had also been re-written in the other paragraphs, which has been refered to question (7) above.

      (2) This leads to problematic conclusions. For example, the "ADC-specific" Epi_10_CYSTM1 cluster, which is a central focus of the paper, only contains cells from one of the 11 ADC samples and represents only a small fraction of the malignant cells from that sample (Sample 7, Figure 2A). Yet, this population is used to derive SLC26A3 as a potential biomarker. SLC26A3 transcripts were only detected in this small population of cells (none of the other ADC samples), which makes me question the specificity of the IHC staining on the validation cohort.

      We sincerely feel grateful for this question. This is a quite important question as it is also pointed out by reviewer#1 in question (8) above. In the revised manuscript, we have already optimized our descriptions and have added detailed explanation for the importance of SLC26A3 in the Discussion section  (from Line 802 - 823). We agree that the majority of Epi_10_CYSTM1 cells are derived from sample S7. The fact that we detected this cluster in only one patient may be due to sampling differences and the inherent heterogeneity of tumor specimens. However, the relatively high number of cells in this cluster from one stage III patient suggests its presence in ADC and highlights its potential as a diagnostic marker for staging ADC. To further investigate whether this cluster is generally present in ADC patients, we identified and selected candidate genes, such as SLC26A3, ORM1, and ORM2, as representative markers of this cluster, which demonstrated high specificity (as shown in Fig. 3B). We then performed IHC staining on 56 cases of tissue samples, and the results showed positive expression of these markers in the majority of stage III tumor tissues, confirming the existence of this cell cluster (as shown in Supplementary Fig. 3E). In our revised manuscript, we have included an in-depth discussion of this issue in the seventh paragraph of the Discussion section.

      (3) This is compounded by technical aspects of the analysis that hinder interpretation. For example, it is clear that the clustering does not perfectly segregate cell types. In Figures 2B and D, it is evident that C4 and C5 contain mixtures of cell type (eg. half of C4 is EPCAM+/CD3-, the other half EPCAM-/CD3+). These contaminations are carried forward into subclustering and are not addressed. Rather, it is claimed that there is a T cell population that is CD3- and EPCAM+, which does not seem likely.

      Thank you for your insightful comment. This important point is also raised by reviewer#1 above. In the revised manuscript, we have reanalyzed our scRNA-seq data and listed the canonical marker genes for cell type annotation. Most importantly, as for T cells and its sub-clustering, we have performed quality control and re-analyzed all data for T cells, with contamination excluded. In the reviesed manuscript, we have added the re-analyzed data for T cells in both Fig. 4 and Supplementary Fig. 4.

      Recommendations for the authors:

      Reviewer #1 (recommendations for the authors):

      The text would substantially benefit from an editorial revision of language usage.

      We sincerely feel grateful for this suggestion. In our revision, we have conducted language editing and carefully rewritten our manuscript. The changes have been clearly marked in the tracked version of the revised manuscript.

      Reviewer #2 (recommendations for the authors):

      (1) Use statistical approaches to claim enrichment/specificity of populations to given groups (ADC, HPV, etc). Analysis packages like Milo for differential abundance testing would be very helpful.

      We feel grateful for this suggestion. In our revision, we have performed statistical analyses for all groups of comparison data. Meanwhile, we have rearranged the figures based on these statistical results, for example, Fig. 1F, Fig. 2D, Fig. 4E, Fig. 5D, Fig. 6D, Supplementary Fig. 1A-B, Supplementary Fig. 2A-B, Supplementary Fig. 4A-B, Supplementary Fig. 5A-B, Supplementary Fig. 6A-B.

      (2) In the subclustering, consider a round of quality control to ensure that all cells are of the cell type they are claimed to be. Contaminant clusters/cells could be filtered out or reassigned. This could be supplemented with an automated annotation approach using cell-type references.

      We feel thankful for this suggestion. As a result, we have provided copies of scripts in the supplementary data to ensure the quality control of cell type annotation.

      (3) An explanation for why SLC26A3 is so rare in the scRNA-seq data, but seemingly common in the IHC staining would be helpful. I am concerned about the specificity of the stain.

      We apologize for lacking adequate explanation of SLC26A3 and cluster Epi_10_CYSTM1. This is a quite crucial question as it has been listed above in question (8) of reviewer #1 and question (2) of reviewer #2 (public review section). In the revised manuscript, we have added intenstive discussion about this question in the seventh paragraph of Disccusion section (from Line 801 - 822). In fact, because of the heterogeneity among different individuals and different tumor regions even within one sample, Epi_10_CYSTM1 seemed to be derived from only one sample. However, the relatively high number of cells in this cluster from one late-stage (stage IIIC) patient suggests its presence in ADC and highlights its potential as a diagnostic marker for staging ADC. Furthermore, we have identified SLC26A3, ORM1 and ORM2 as specific markers of this cluser and performed IHC staining. With a positive expression of these markers, the existence of this cluster has been indirectly proved (as shown in Fig. 3B).

    1. Author response:

      The following is the authors’ response to the current reviews.

      The authors agree with the reviewers that future studies are needed to dissect the mechanisms of eIF3 binding to 3'UTRs and their impact on translation, and the impact of this binding on cellular fate.


      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study reveals extensive binding of eukaryotic translation initiation factor 3 (eIF3) to the 3' untranslated regions (UTRs) of efficiently translated mRNAs in human pluripotent stem cell-derived neuronal progenitor cells. The authors provide solid evidence to support their conclusions, although this study may be enhanced by addressing potential biases of techniques employed to study eIF3:mRNA binding and providing additional mechanistic detail. This work will be of significant interest to researchers exploring post-transcriptional regulation of gene expression, including cellular, molecular, and developmental biologists, as well as biochemists.

      We thank the reviewers for their positive views of the results we present, along with the constructive feedback regarding the strengths and weaknesses of our manuscript, with which we generally agree. We acknowledge our results will require a deeper exploration of the molecular mechanisms behind eIF3 interactions with 3'-UTR termini and experiments to identify the molecular partners involved. Additionally, given that NPC differentiation toward mature neurons is a process that takes around 3 weeks, we recognize the importance of examining eIF3-mRNA interactions in NPCs that have undergone differentiation over longer periods than the 2-hr time point selected in this study. Finally, considering the molecular complexity of the 13subunit human eIF3, we agree that a direct comparison between Quick-irCLIP and PAR-CLIP will be highly beneficial and will determine whether different UV crosslinking wavelengths report on different eIF3 molecular interactions. Additional comments are given below to the identified weaknesses.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors perform irCLIP of neuronal progenitor cells to profile eIF3-RNA interactions upon short-term neuronal differentiation. The data shows that eIF3 mostly interacts with 3'-UTRs - specifically, the poly-A signal. There appears to be a general correlation between eIF3 binding to 3'-UTRs and ribosome occupancy, which might suggest that eIF3 binding promotes protein

      Strengths:

      The study provides a wealth of new data on eIF3-mRNA interactions and points to the potential new concept that eIF3-mRNA interactions are polyadenylation-dependent and correlate with ribosome occupancy.

      Weaknesses:

      (1) A main limitation is the correlative nature of the study. Whereas the evidence that eIF3 interacts with 3-UTRs is solid, the biological role of the interactions remains entirely unknown. Similarly, the claim that eIF3 interactions with 3'-UTR termini require polyadenylation but are independent of poly(A) binding proteins lacks support as it solely relies on the absence of observable eIF3 binding to poly-A (-) histone mRNAs and a seeming failure to detect PABP binding to eIF3 by co-immunoprecipitation and Western blotting. In contrast, LC-MS data in Supplementary File 1 show ready co-purification of eIF3 with PABP.

      We agree the molecular mechanisms underlying the crosslinking between eIF3 and the end of mRNA 3’-UTRs remains to be determined. We also agree that the lack of interaction seen between eIF3 and PABP in Westerns, even from HEK293T cells, is a puzzle. The low sequence coverage in the LC-MS data gave us pause about making a strong statement that these represent direct eIF3 interactions, given the similar background levels of some ribosomal proteins.

      (2) Another question concerns the relevance of the cellular model studied. irCLIP is performed on neuronal progenitor cells subjected to neuronal induction for 2 hours. This short-term induction leads to a very modest - perhaps 10% - and very transient 1-hour-long increase in translation, although this is not carefully quantified. The cellular phenotype also does not appear to change and calling the cells treated with differentiation media for 2 hours "differentiated NPCs" seems a bit misleading. Perhaps unsurprisingly, the minor "burst" of translation coincides with minor effects on eIF3-mRNA interactions most of which seem to be driven by mRNA levels. Based on the ~15-fold increase in ID2 mRNA coinciding with a ~5-fold increase in ribosome occupancy (RPF), ID2 TE actually goes down upon neuronal induction.

      We agree that it will be interesting to look at eIF3-mRNA interactions at longer time points after induction of NPC differentiation. However, the pattern of eIF3 crosslinking to the end of 3’-UTRs occurs in both time points reported here, which is likely to be the more general finding in what we present.

      (3) The overlap in eIF3-mRNA interactions identified here and in the authors' previous reports is minimal. Some of the discrepancies may be related to the not well-justified approach for filtering data prior to assessing overlap. Still, the fundamentally different binding patterns - eIF3 mostly interacting with 5'-UTRs in the authors' previous report and other studies versus the strong preference for 3'-UTRs shown here - are striking. In the Discussion, it is speculated that the different methods used - PAR-CLIP versus irCLIP - lead to these fundamental differences. Unfortunately, this is not supported by any data, even though it would be very important for the translation field to learn whether different CLIP methodologies assess very different aspects of eIF3-mRNA interactions.

      We agree the more interesting aspect of what we observe is the difference in location of eIF3 crosslinking, i.e. the end of 3’-UTRs rather than 5’-UTRs or the pan-mRNA pattern we observed in T cells. The reviewer is right that it will be important in the future to compare PAR-CLIP and Quick-irCLIP side-by-side to begin to unravel the differences we observe with the two approaches.

      Reviewer #2 (Public review):

      Summary:

      The paper documents the role of eIF3 in translational control during neural progenitor cell (NPC) differentiation. eIF3 predominantly binds to the 3' UTR termini of mRNAs during NPC differentiation, adjacent to the poly(A) tails, and is associated with efficiently translated mRNAs, indicating a role for eIF3 in promoting translation.

      Strengths:

      The manuscript is strong in addressing molecular mechanisms by using a combination of nextgeneration sequencing and crosslinking techniques, thus providing a comprehensive dataset that supports the authors' claims. The manuscript is methodologically sound, with clear experimental designs.

      Weaknesses:

      (1) The study could benefit from further exploration into the molecular mechanisms by which eIF3 interacts with 3' UTR termini. While the correlation between eIF3 binding and high translation levels is established, the functionality of these interactions needs validation. The authors should consider including experiments that test whether eIF3 binding sites are necessary for increased translation efficiency using reporter constructs.

      We agree with the reviewer that the molecular mechanism by which eIF3 interacts with the 3’UTR termini remains unclear, along with its biological significance, i.e. how it contributes to translation levels. We think it could be useful to try reporters in, perhaps, HEK293T cells in the future to probe the mechanism in more detail.

      (2) The authors mention that the eIF3 3' UTR termini crosslinking pattern observed in their study was not reported in previous PAR-CLIP studies performed in HEK293T cells (Lee et al., 2015) and Jurkat cells (De Silva et al., 2021). They attribute this difference to the different UV wavelengths used in Quick-irCLIP (254 nm) and PAR-CLIP (365 nm with 4-thiouridine). While the explanation is plausible, it remains a caveat that different UV crosslinking methods may capture different eIF3 modules or binding sites, depending on the chemical propensities of the amino acid-nucleotide crosslinks at each wavelength. Without addressing this caveat in more detail, the authors cannot generalize their findings, and thus, the title of the paper, which suggests a broad role for eIF3, may be misleading. Previous studies have pointed to an enrichment of eIF3 binding at the 5' UTRs, and the divergence in results between studies needs to be more explicitly acknowledged.

      We agree with the reviewer that the two methods of crosslinking will require a more detailed head-to-head comparison in the future. However, we do think the title is justified by the fact that we see crosslinking to the termini of 3’-UTRs across thousands of transcripts in each condition. Furthermore, the 3’-UTR crosslinking is enriched on mRNAs with higher ribosome protected fragment counts (RPF) in differentiated cells, Figure 3F.

      (3) While the manuscript concludes that eIF3's interaction with 3' UTR termini is independent of poly(A)-binding proteins, transient or indirect interactions should be tested using assays such as PLA (Proximity Ligation Assay), which could provide more insights.

      This is a good idea, but would require a substantial effort better suited to a future publication. We think our observations are interesting enough to the field to stimulate future experimentation that we may or may not be most capable of doing in our lab.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript by Mestre-Fos and colleagues, authors have analyzed the involvement of eIF3 binding to mRNA during differentiation of neural progenitor cells (NPC). The authors bring a lot of interesting observations leading to a novel function for eIF3 at the 3'UTR.

      During the translational burst that occurs during NPC differentiation, analysis of eIF3-associated mRNA by Quick-irCLIP reveals the unexpected binding of this initiation factor at the 3'UTR of most mRNA. Further analysis of alternative polyadenylation by APAseq highlights the close proximity of the eIF3-crosslinking position and the poly(A) tail. Furthermore, this interaction is not detected in Poly(A)-less transcripts. Using Riboseq, the authors then attempted to correlate eIF3 binding with the translation efficacy of mRNA, which would suggest a common mechanism of translational control in these cells. These observations indicate that eIF3-binding at the 3'UTR of mRNA, near the poly(A) tail, may participate to the closed-loop model of mRNA translation, bridging 5' and 3', and allowing ribosomes recycling. However, authors failed to detect interactions of eIF3, with either PABP or Paip1 or 40S subunit proteins, which is quite unexpected.

      Strength:

      The well-written manuscript presents an attractive concept regarding the mechanism of eIF3 function at the 3'UTR. Most mRNA in NPC seems to have eIF3 binding at the 3'UTR and only a few at the 5'end where it's commonly thought to bind. In a previous study from the Cate lab, eIF3 was reported to bind to a small region of the 3'UTR of the TCRA and TCRB mRNA, which was responsible for their specific translational stimulation, during T cell activation. Surprisingly in this study, the eIF3 association with mRNA occurs near polyadenylation signals in NPC, independently of cell differentiation status. This compelling evidence suggests a general mechanism of translation control by eIF3 in NPC. This observation brings back the old concept of mRNA circularization with new arguments, independent of PABP and eIF4G interaction. Finally, the discussion adequately describes the potential technical limitations of the present study compared to previous ones by the same group, due to the use of Quick-irCLIP as opposed to the PAR-CLIP/thiouridine.  

      Weaknesses:

      (1) These data were obtained from an unusual cell type, limiting the generalizability of the model.

      We agree that unraveling the mechanism employed by eIF3 at the mRNA 3’-UTR termini might be better studied in a stable cell line rather than in primary cells.

      (2) This study lacks a clear explanation for the increased translation associated with NPC differentiation, as eIF3 binding is observed in both differentiated and undifferentiated NPC. For example, I find a kind of inconsistency between changes in Riboseq density (Figure 3B) and changes in protein synthesis (Figure 1D). Thus, the title overstates a modest correlation between eIF3 binding and important changes in protein synthesis.

      We thank the reviewer for this question. Riboseq data and RNASeq data are not on absolute scales when comparing across cell conditions. They are normalized internally, so increases in for example RPF in Figure 3B are relative to the bulk RPF in a given condition. By contrast, the changes in protein synthesis measured in Figure 1D is closer to an absolute measure of protein synthesis. 

      (3) This is illustrated by the candidate selection that supports this demonstration. Looking at Figure 3B, ID2, and SNAT2 mRNA are not part of the High TE transcripts (in red). In contrast, the increase in mRNA abundance could explain a proportionally increased association with eIF3 as well as with ribosomes. The example of increased protein abundance of these best candidates is overall weak and uncertain.

      We agree that using TE as the criterion for defining increased eIF3 association would not be correct. By “highly translated” we only mean to convey the extent of protein synthesis, i.e. increases in ribosome protected fragments (RPF), rather than the translational efficiency.

      (4) Despite several attempts (chemical and UV cross-linking) to identify eIF3 partners in NPC such as PABP, PAIP1, or proteins from the 40S, the authors could not provide any evidence for such a mechanism consistent with the closed-loop model. Overall, this rather descriptive study lacks mechanistic insight (eIF3 binding partners).

      We agree that it will be important to identify the molecular mechanism used by eIF3 to engage the termini of mRNA 3’-UTRs. Nevertheless, the identification of eIF3 crosslinking to that location in mRNAs is new, and we think will stimulate new experiments in the field.

      (5) Finally, the authors suspect a potential impact of technical improvement provided by QuickirCLIP, that could have been addressed rather than discussed.

      We agree a side-by-side comparison of eIF3 crosslinks captured by PAR-CLIP versus QuickirCLIP will be an important experiment to do. However, NPCs or other primary cells may not be the best system for the comparison. We think using an established cell line might be more informative, to control for effects such as 4-thiouridine toxicity.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The Western blot signals for SLC38A2 and ID2 are close to the membrane background and little convincing. Size markers are missing.

      We agree these antibodies are not great. They are the best we could find, unfortunately. We have included originals of all western blots and gels as supplementary information. It’s important to note that the Riboseq data for ID2 and SLC38A2 are consistent with the western blots. See Figure 3C and Figure 3–figure supplement 3B.

      (2) Figure 1 - Figure Supplement 1 appears to present data from a single experiment. This is far less than ideal considering the minor differences measured.

      Thanks for the comment. This is a representative experiment showing the early time course. We have added a second experiment with two different treatments that show the same pattern in the puromycin assay, in Figure 1–figure supplement 1.

      (3) Figure 3F: One wonders what this would look like if TE was plotted instead of RPF. Figure 3 - Figure Supplement 4 seems to show something along those lines. However, the data are not mentioned in the main results section are quite unclear. Why are data separated into TE high and low? Doesn't TE high in differentiated cells equal TE low in undifferentiated cells?

      This is an interesting question. Note that in Figure 3B, n=6300 genes show no change in TE upon differentiation, compared to a total of n=2127 that show a change in TE, with most of those changes not very large. We have now replotted Figure 3F comparing irCLIP read counts in 3’-UTRs to RPF read counts, which shows a significant positive correlation, regardless of whether we look at undifferentiated or differentiated NPCs (See Figure 3F and a new Figure 3– figure supplement 4A). We also compare irCLIP reads in 3’-UTRs to TE values, which show no correlation (See Figure 3G and Figure 3–figure supplement 4B).

      Figure 3-figure supplement 4 was actually a response to a previous round of review (at PLOS Biology) to a rather technical question from a reviewer. We think this figure and associated text should be removed. Instead, we now include supplementary tables with the processed RPF and TE values, for reference (Supplemental files 4-6). We omitted these in the original submission when they should have been included. We also abandoned comparing undifferentiated and differentiated NPCs, and instead look directly at irCLIP reads vs. RPFs or TE, regardless of NPC state, as noted above (Figure 3F, G, and Figure 3–figure supplement 4).

      (4) Figure 3C: The data should be plotted on the same y-axis scale. This would make a visual assessment of the differences in mRNA and RFP levels more intuitive.

      Thanks for this suggestion. We have rescaled the plots as requested.

      Reviewer #2 (Recommendations for the authors):

      (1) The quality of the Western blots in several figures is quite poor. Notably, Figure 1C seems to be a composite gel, as each blot appears to come from a different gel. Additionally, in Supplementary Figure 1A, there is only a single data point, yet the authors indicate that this image is representative of multiple assays. The lack of error bars in this figure raises a question vis-a-vis the reproducibility of the experiments.

      Thanks for the comments. We now include all the original gels as supplementary information. As noted above, the antibodies for ID2 and SLC38A2 are not great, we agree. And as we noted above, the Riboseq data for ID2 and SLC38A2 are consistent with the western blots.

      (2) For the top 500 targets of undifferentiated and differentiated NPCs in the Quick-irCLIP assay, the manuscript does not clarify how many targets are common and how many are unique to each condition. This information is important for understanding the extent of overlap and differentiation-specific interactions of eIF3 with mRNAs. Providing this data would strengthen the interpretation of the results.

      There are 449 of the top 500 hits in common between undifferentiated and differentiated NPCs. We have now added this information to the text, to add clarity. 

      (3) The manuscript does not provide detailed percentages or numbers regarding the overlap between iCLIP and APA-Seq peaks. Clarifying this overlap, particularly in terms of how many of the APA sites are also targets of eIF3, would bolster the understanding of how these two datasets converge to support the authors' conclusions.

      This is a difficult calculation to make, due to the fact that APA-Seq reads are generally much longer than the Quick-irCLIP reads. This is why we focused instead on quantifying the percent of Quick-irCLIP peaks (which are more narrow) overlap with predicted polyadenylation sequences, in Figure 2-figure supplement 1.

      Reviewer #3 (Recommendations for the authors):

      (1) Perform Quick-irCLIP in HEK293 cells to infer technical limitations and/or to generalize the model. The authors will then compare again eIF3 binding site in Jurkat, HEK293, and NPC.

      This is an experiment we plan to do for a future publication, given that we would want to repeat both Quick-irCLIP and PAR-CLIP at the same time.

      (2) Select mRNA candidates with high or low TE changes and analyze eIF3 binding and RPF density and protein abundance along NPC differentiation to support the role of eIF3 binding in stimulating translation.

      We agree looking at time courses in more depth would be interesting. However, this would require substantial experimentation, which is better suited to a future study. Furthermore, now that we have moved away from comparing undifferentiated NPCs and differentiated NPCs when examining TE and RPF values (Figure 3 and Figure 3–figure supplement 4), we think the results now support a more general mechanism of translation reflected in the irCLIP 3’-UTR vs. RPF correlation, independent of NPC state.

      (3) Analyze the interaction of eIF3 with eIF4G and other known partners. This will really provide an improvement to the manuscript. The lack of interaction between eIF3 and the 40S is quite surprising.

      We agree more work needs to be done on the mechanistic side. These are experiments we think would be best to carry out in a stable cell line in the future, rather than primary cells.

      (4) Perform Oligo-dT pulldown (or cap column if possible) and analyze the relative association of PABP, eIF3, and eIF4F on mRNA in NPC versus HEK293. This will clarify whether this mechanism of mRNA translation is specific to NPC or not.

      Thanks for this suggestion. We are uncertain how it would be possible to deconvolute all the possible ways to interpret results from such an experiment. We agree thinking about ways to study the mechanism will keep us occupied for a while.

      (5) Citations in the text indicate the first author, whereas the references are numbered! 

      Our apologies for this oversight. This was a carryover from previous formatting, and has been fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      (1) In my opinion, the major weakness is the selection of IVs, the same IVs should be used for each exposure, especially when the outcomes (IA, SAH, and uIA) are closely related. The removal of IVs was inconsistent, for example, why was LPA rs10455872 removed for SAH but not for uIA? (significantly more IVs were used for uIA). The authors should provide more details for the justification of the removal of IVs other than only indicating "confounder" in supplementary tables. The authors should also perform additional analyses including all IVs and IVs from other PUFA GWAS.

      We apologized for our negligence. We reconducted a two-sample MR analysis following the removal of rs10455872 from the uIA, which yielded unaltered ORs and 95% confidence intervals. The P-value was once again found to be statistically insignificant. These results demonstrate the robustness of our MR analyses and indicate that this SNP does not exert an influence on the overall results. (see Figure 4)

      For SNP selection, we adhered rigorously to the established Mendelian randomization analysis process for the screening of instrumental variables. "Confounder" is mean that a current explicit influencer that is explicitly associated with the outcome variable. Following the removal of such confounding SNPs, the analysis of heterogeneity and pleiotropy is repeated on several occasions in MR analysis using radical MR, MRPRESSO, IVW-radical and Egger-radical, with each iteration involving the removal of the corresponding anomalous SNPs until all instances of pleiotropy and heterogeneity have been eliminated, it can be observed that the final single-nucleotide polymorphism (SNP) for each group is not identical. Therefore, It can be observed that the final SNPs for each group is not identical.

      (2) In addition, it seems that the SNPs in the FADS locus were driving the MR association, while FADS is a very pleiotropic locus associated with many lipid traits, removing FADS could attenuate the MR effect. The authors should perform a sensitivity analysis to remove this locus.

      Thanks for the reviewer’s suggestion. In our revised manuscript, We reconducted MR analysis of the positive results after the removal of the FADS2 and its SNPs within 500 kb of the FADS2 locus. This analysis demonstrated that there was no significant causal pathogenic association between PUFA and IA, aSAH. This result validated that SNP: rs174564 was a significant factor driving the causal association between PUFAs and CA. (See page 6, line155-157 and Figure 8)

      (3) Instead of removing multiple "confounder" IVs which I think may bias the MR results due to very closely related lipid traits, the authors should perform multivariable MR to identify independent effects of PUFAs to IA, conditioning on other PUFAs and/or other lipids.

      Thanks for the reviewer’s suggestion. In our revised manuscript, we employed MVMR through adjust for HDL cholesterol, LDL cholesterol, total cholesterol and triglycerides, to remove bias from closely related lipid traits. The application of MVMR analysis serves to reinforce the robustness of our conclusions. (See page 6, line151-153 and Figure5-7)

      (4) Colocalization was not well described, the authors should include the colocalization results for each locus in a supplementary table. They also mentioned "a large PP for H4 (PP.H4 above 0.75) strongly supports shared causal variants affecting both gene expression and phenotype". The authors should make sure that the colocalization was performed using the expression data of each gene or using the GWAS summary of each PUFA locus.

      I apologize for our negligence. We have added the detailed results of the COLOC for each locus in the supplementary table. (See supplementary table 6)

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) I suggest the authors consult Borges et al., 2022 (doi: 10.1186/s12916-022-02399-w) for PUFA IV selection, and perform sensitivity analysis based on Borges et al., 2022 IVs and another PUFA GWAS (such as J Kettunen et al., 2016, doi: 10.1038/ncomms11122).

      Thanks for the reviewer’s suggestion. In order to provide further evidence of the robustness of the results of our analyses, we conducted MVMR and a sensitivity analysis after excluding SNPs within 500 kb of the FADS2 locus, as recommended by Borges et al. (2022). (See page 6, line151-157 and Figure 5-8)

      In regard to the article by J. Kettunen et al. (2016), we found that the validation dataset from which the article was sourced was insufficient in terms of sample size and lacked the requisite statistical efficacy to be used for validation purposes.

      (2) The authors justified that colocalization is to determine if "PUFAs are mediators in the hereditary causative route of cerebral aneurysm", which I don't think is the case.

      Colocalization is to determine whether an MR estimate is not confounded by LD.

      I apologize for our incorrect description. We have made careful modification in our revised manuscript, as follows: “There is consistent evidence that PUFAs have a beneficial causal effect on cerebral aneurysm. In order to determine an MR estimate is not confounded by LD, we used COLOC to identify shared causal SNP between PUFAs and cerebral aneurysms”. (See page 7-8, line 215-217)

      (3) Supplementary tables 2-4 were a bit confusing to me, I suggest the authors provide one supplementary table for each exposure.

      Thanks for the reviewer’s suggestion. Supplementary tables 2_1-2_5 shows the exposure data for the five PUFAs associated with IA, supplementary tables 3_1-3_5 shows the exposure data for the five PUFAs associated with aSAH and supplementary tables 4_1-4_5 shows the exposure data for the five PUFAs associated with UIA. Each exposure is represented by a distinct table.

      (4) Figure 1 legend: I can't find multivariable MR in the figure/method.

      I apologize for our negligence. In our revised manuscript, we have added the MVMR methodology. We also have modified Figure 1 and Figure 1 legend. (See Figure 1, Figure 1 legend and page 6, line 151-153)

      (5) LOO analysis was mentioned in methods and results but I could not find the results for LOO.

      I apologize for our negligence. In our revised manuscript, we have described the results of the LOO, as follows: “The leave-one-out plot demonstrates that there is a potentially influential SNP (rs174564) driving the causal link between PUFA and cerebral aneurysm.” (See page 7, line 209-210)

      (6) Finally, the authors should proofread their manuscript as many sentences are difficult to read, such as:

      Line 183: "...MR methods revealed consistency", "However, there was no any causal relationship..."

      Line 200: "For achieve that..."

      I apologize for our incorrect description. We have modified these descriptions in our revised manuscript, as follows: “The results demonstrated consistency in the outcomes and directionality of the various MR methods employed” and “In order to determine an MR estimate is not confounded by LD, we used COLOC to identify shared causal SNP between PUFAs and cerebral aneurysms”. (See page 7, line 187-188 and line 215-217).

      Reviewer #2 (Recommendations For The Authors):

      (1) Are there any previous epidemiological studies on the association between PUFA and cerebral aneurysm? It will be helpful to introduce this background.

      Thanks for the reviewer’s suggestion. The epidemiology of PUFA with aneurysm in other sites, such as the abdominal aorta, are described in the Introduction section. Although there is a paucity of large-scale multicenter clinical epidemiological studies examining the relationship between PUFAs and cerebral aneurysms, we are endeavoring to infer a prior association between PUFAs and cerebral aneurysms with the aid of Mendelian randomization analysis.

      (2) The authors performed a leave-one-out analysis but did not explain much about the results. The leave-one-out analysis seems to provide some evidence that some SNP is driving the results, like rs174564 in Supplementary Figure 5-1.

      I apologize for our negligence. In our revised manuscript, we have described the results of the leave-one-out analysis, as follows: “The leave-one-out plot demonstrates that there is a potentially influential SNP (rs174564) driving the causal link between PUFA and cerebral aneurysm”. (See page 7, line209-214)”.

      (3) In the discussion (line 211), the authors mentioned omega-6 fatty acids increased the risk of IA and aSAH, omega-3 fatty acids decreased the risk for IA and aSAH, but omega-6 by omega-3 decreased the risk of IA and aSAH. This seems to be different from the figures.

      I apologize for our incorrect description. We have modified this description in our revised manuscript, as follows: “We demonstrated that the omega-3 fatty acids, DHA and, omega-3-pct causally decreased the risk for IA and aSAH. And omega-6 by omega-3 causally increased the risk of IA and aSAH”. (See page 8, line228-230)

      Minor:

      (4) Some grammar errors need to be checked, such as:

      In line 200, "For achieve that, we tested for shared causative SNPs between PUFAs and cerebral aneurysm using COLOC".

      In line 123, "Fourth, to eliminate unclear, palindromic and associated with known confounding factors (body mass index (McDowell et 125 al., 2018), blood pressure (Sun et al., 2022), type 2 diabetes (Tian et al., 2022), high-density lipoprotein (Huang et al., 2018)) SNPs."

      I apologize for our incorrect description. We have modified these descriptions in our revised manuscript, as follows: “Fourth, remove SNPs that are obscure, palindromic, and linked to recognized confounding variables (body mass index (McDowell et al., 2018), blood pressure (Sun et al., 2022), type 2 diabetes (Tian et al., 2022), high-density lipoprotein (Huang et al., 2018))” and “In order to determine an MR estimate is not confounded by LD, we used COLOC to identify shared causal SNP between PUFAs and cerebral aneurysms”. (See page 5, line 124-127 and page 7 line215-217)

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      The findings of Ziolkowska and colleagues show that a specific projection from the nucleus reuniens of the thalamus (RE) to dorsal hippocampal CA1 neurons plays an important role in fear extinction learning in male and female mice. In and of itself, this is not a particularly new finding, although the authors' identification of structural alterations from within dorsal CA1 stratum lacunosum moleculare (SLM) as a candidate mechanism for the learning-related plasticity is potentially novel and exciting. The authors use a range of anatomical and functional approaches to demonstrate structural synaptic changes in dorsal CA1 that parallel the necessary role of RE inputs in modulating extinction learning. Yet, the significance of these findings is substantially limited by several technical shortcomings in the experimental design, and the authors' central interpretation. Otherwise, there remain several strengths in the design and interpretation that offset some of these concerns.

      Given that much is already known about the role of RE and hippocampus in modulating fear learning and extinction, it remains unclear whether addressing these concerns would substantially increase the impact of this study beyond the specific area of speciality. Below, several major weaknesses will be highlighted, followed by several miscellaneous comments.

      Methodological:

      (1) One major methodological weakness in the experimental design involves the widespread misapplication of Ns used for the statistical analyses. Much of the anatomical analyses of structural synaptic changes in the RE-CA1 pathway use N = number of axons (Figs. 1, 2), N = number of dendrites (Figs. 3, 4), and N = number of sections (Fig. 7; note that there are 7 figures in total). In every instance, N = animal number should be used. It is unclear which of these results would remain significant if N = animal number were used in each or how many more animals would be required. This is problematic since these data comprise the main evidence for the authors' central conclusion that specific structural synaptic changes are associated with fear extinction learning.

      We do agree with the reviewer that N = animal number is the preferred way to present data in most of our experiments. However, in some experimental groups we observed a very low number of entries. For example, in the 5US group we found RE+/+ spines only in 3 out of 6 analyzed animals. We believe that this observation is not due to technical problems as mCherry virus transduction required to find RE+/+ spines is similar in all experimental groups and we analyzed similar volumes of tissue. While this result still allows the calculation of density of RE+/+ spines per animal it generates no entries for spine area and PSD95 mean gray value if N = animal number. Hence, we decided to use N=animals to calculate spines and boutons densities, and N=dendritic spines/boutons to calculate other spine/bouton parameters. 

      (2) There is a lack of specific information regarding what constitutes learning with respect to behavioral freezing. It is never clearly stated what specific intervals are used over which freezing is measured during acquisition, extinction, and in extinction retrieval tests. Additionally, assessment of freezing during retrieval at 5- and 30-min time points doesn't lay to rest the possibility that there were differences in the decay rate over the 30-min period (also see below).

      We added a detailed description of how learning was assessed.

      ln 125-134: “For assessment of learning we used percent of time spent by animals freezing (% freezing). Freezing behavior was defined as complete lack of movement, except respiration. To assess within-session learning (working memory) we compared pre- and post-US freezing frequency (the first 148 sec vs last 30 sec) during the CFC session (day 1). To assess formation of long-term contextual fear memory, we compared pre-US freezing (day 1) and the first 5 minutes of the Extinction session (day 2). To assess within session contextual fear extinction we ran 2-way ANOVA to assess the effect of time and manipulation on freezing frequency. Freezing data were analyzed in 5-minute bins. To assess formation of long-term contextual fear extinction memory we compared the first 5 minutes of the Extinction session (day 2) and Test session (day 3).”

      As suggested by the reviewer, we also added data for all six 5-minut bins of Extinction sessions.

      (3) A minor-to-moderate methodological weakness concerns the authors' decision to utilize saline injected groups as controls for the chemogenetics experiments (Figs. 5, 6). The correct design is to have a CNO-only group with the same viral procedure sans hM4Di. This concern is partly mitigated by the inclusion of a CNO vs. saline injection control experiment (Fig. 6).

      Figure 5 does not describe a chemogenetic experiment.

      We added new groups with control virus (CNO vs saline) to Figure 6 (now Fig. 6D and H).

      The chemogenetic experiment shown on Figure 7 has all 4 experimental groups (Control vs hM4Di and saline vs CNO).

      (4) In the electron microscopic analyses of dendritic spines (Fig. 5), comparison of only the fear acquisition versus extinction training, and the lack of inclusion of a naïve control group, makes it difficult to understand how these structural synaptic changes are occurring relative to baseline. It is noteworthy that the authors utilize the tripartite design in other anatomical analyses (Fig. 2-4).

      We added data for the Naive mice to Figure 5.

      (5) Interpretation:

      The main interpretive weakness in the study is the authors' claim that their data shows a role for the RE-CA1 pathway in memory consolidation (i.e., see Abstract). This claim is based on the premise that, although RE-CA1 pathway inactivation with CNO treatment 30 min prior to contextual fear extinction did not affect freezing at 5- and 30-min time points relative to saline controls, these rats showed greater freezing when tested on extinction retrieval 24 h thereafter. First, the data do not rule out possible differences in the decay rate of freezing during extinction training due to CNO administration. Next, the fact that CNO is given prior to training still leaves open the possibility that acquisition was affected, even if there were not any frank differences in freezing. Support for this latter possibility derives from the fact that mice tested for extinction retrieval as early as 5 min after extinction training (Fig. 6C) showed the same impairments as mice tested 24 h later (Figs. 6A). Further, all the structural synaptic changes argued to underlie consolidation were based on analysis at a time point immediately following extinction training, which is too early to allow for any long-term changes that would underlie memory consolidation, but instead would confer changes associated with the extinction training event.

      We do agree with the reviewer that our data do not allow us to conclude whether RE-CA1 pathway is involved in acquisition or consolidation of CFE memory. Therefore, we avoid those terms in the manuscript. We just conclude that RE→CA1 participates in the CFE.

      Reviewer #2 (Public review):

      Summary:

      Ziółkowska et al. characterize the synaptic mechanisms at the basis of the REdCA1 contribution to the consolidation of fear memory extinction. In particular, they describe a layer specific modulation of RE-dCA1 excitatory synapses modulation associated to contextual fear extinction which is impaired by transient chemogenetic inhibition of this pathway. These results indicate that RE activity-mediated modulation of synaptic morphology contributes to the consolidation of contextual fear extinction

      Strengths:

      The manuscript is well conceived, the statistical analysis is solid and methodology appropriate. The strength of this work is that it nicely builds up on existing literature and provides new molecular insight on a thalamo-hippocampal circuit previously known for its role in fear extinction. In addition, the quantification of pre- and post-synapses is particularly thorough.

      Weaknesses:

      The findings in this paper are well supported by the data more detailed description of the methods is needed.

      (1) In the paragraph Analysis of dCA1 synapses after contextual fear extinction (CFE), more experimental and methodological data should be given in the text:

      - how was PSD95 used for the analysis, what was the difference between RE. Even if Thy1-GFP mice were used in Fig.2, it appears they were not used for bouton size analysis. To improve clarity, I suggest moving panel 2C to Figure 3. It is not clear whether all RE axons were indiscriminately analysed in Fig. 2 or if only the ones displaying colocalization with both PSD95 and GFP were analysed. If GFP was not taken into account here, analysed boutons could reflect synapses onto inhibitory neurons and this potential scenario should be discussed.

      PSD-95 immunostaining in close apposition to boutons was used to identify RE buttons innervating CA1 (Fig 1 and 2). In these cases PSD-95 signal was not quantified. PSD-95 in close apposition to dendritic spines was used as a proxy of PSDs in CA1 (Figure 3, 4 and 7). In these cases we assessed the integrated mean gray value of PSD-95 signal per dendritic spine (Figure 3, 4) or per ROI (Figure 7). This is explained in detail in the section Confocal microscopy and image quantification (ln 149-172).

      GFP signal was not taken into account during boutons analysis. This is explained in the materials and methods section Confocal microscopy and image quantification (ln 149-172).

      We indicate that PSD-95 is a marker of excitatory synapses located both on excitatory and inhibitory neurons.

      Ln 258: RE boutons were identified in SO and SLM as axonal thickenings in close apposition to PSD-95-positive puncta (a synaptic scaffold used as a marker of excitatory synapses located both on excitatory and inhibitory neurons (Kornau et al., 1995; El-Husseini et al., 2000; Chen et al., 2011; Dharmasri et al., 2024).

      We also cite literature demonstrating that RE projects to the hippocampal formation and forms asymmetric synapses with dendritic spines and dendrites, suggesting innervation of excitatory synapses on both excitatory and aspiny inhibitory neurons (ln 673).

      As advised by the reviewer the Figure 2C panel was moved to Figure 3 (now it is Fig 3A).

      (2) in the methods: The volume of intra-hippocampal CNO injections should be indicated. The concentration of 3 uM seems pretty low in comparison with previous studies. CNO source is missing.

      This section has been rewritten to be more clear. The concentration of CNO was chosen based on the previous studies (Stachniak et al., 2014).

      ln 103: “Cannula placement. Mice were anesthetized by inhalation of 3–5% isoflurane (IsoFlo; Abbott Animal Health) in oxygen and positioned in a stereotaxic frame (51503, Stoelting, Wood Dale, IL, USA). Two holes were drilled in the skull, and a double guide cannulae (2 mm apart and 2 mm long; 26GA, Plastics One) was lowered into the holes such that the cannula tip was located over dorsal CA1 area (2 mm posterior to bregma, ±1 mm lateral, and −1.3 mm vertical). Cannulae were kept patent by using 33-gauge internal dummy cannulae (Plastics One). The animals were used in contextual fear conditioning 21 days after the cannulation. Animals received bilateral CNO (3 μM, 0.2 μl per side for 1 min; Tocris Bioscience, Cat. No. 4936) (Stachniak et al., 2014) or saline injections (0.2 μl per side) 30 minutes before Extinction session via intrahippocampal injection cannulae (33-gauge). After the infusion, the cannula was left in place for 30 seconds. The cannula placement was verified by histology, and only data from animals with correct cannula implants were included in statistical analyses.”

      (3) More details of what software/algorithm was used to score freezing should be included.

      Freezing was automatically scored with VideoFreeze™ Software (Med Associates Inc.).

      (4) Antibody dilutions for IHC should be indicated. Secondary antibody incubation time should be indicated.

      The missing information is added.

      ln 144: “Next, sections were incubated in 4°C overnight with primary antibodies directed against PSD-95 (1:500, Millipore, MAB 1598), washed three times in 0.3% Triton X-100 in PBS and incubated in room temperature for 90 minutes with a secondary antibody bound with Alexa Fluor 647 (1:500, Invitrogen, A31571).”

      (5) No statement about code and data availability is present.

      The statements are added.

      ln 785: Row data and the code used for analysis of confocal data is available at OSF (https://osf.io/bnkpx/).

      Reviewer #3 (Public review):

      Summary:

      This paper examined the role of nucleus reuniens (RE) projections to dorsal CA1 neurons in context fear extinction learning. First, they show that RE neurons send excitatory projections to the stratum oriens (SO) and the stratum lacunosum moleculare (SLM), but not the stratum radiatum (SR). After context fear conditioning, the synaptic connections between RE and dCA1 neurons in the SLM (but not the SO) are weakened (reduced bouton and spine density) after mice undergo context fear conditioning. This weakening is reversed by extinction learning, which leads to enhanced synaptic connectivity between RE inputs and dendrites in the SLM. Control experiments demonstrate that the observed changes are due to extinction and not caused by simple exposure to the context. Extinction learning also induced increases in the size (volume and surface area) of the post-synaptic density (PSD) in SLM. To establish the functional role of RE inputs to dCA1, the researchers used an inhibitory DREADD to silence this pathway during extinction learning. They observe that extinction memory (measured 2-hours or 24-hours later) is impaired by this inhibition. Control experiments show that the extinction memory deficit is not simply due to increased freezing caused by inactivation of the pathway or injections of CNO. Inhibiting the RO projection during extinction learning also reduced the levels of PSD-95 protein levels in the spines of dCA1 neurons.

      Strengths:

      Based on their results, the authors conclude that, "the RE→SLM pathway participates in the updating of fearful context value by actively regulating CFE-induced molecular and structural synaptic plasticity in the SLM.". I believe the data are generally consistent with this hypothesis, although there is an important control condition missing from the behavioral experiments.

      Weaknesses:

      (1) A defining feature of extinction learning is that it is context specific (Bouton, 2004). It is expressed where it was learned, but not in other environments. Similarly, it has been shown that internal contexts (or states) also modulate the expression of extinction (Bouton, 1990). For example, if a drug is administered during extinction learning, it can induce a specific internal state. If this state is not present during subsequent testing, the expression of extinction is impaired just as it is when the physical context is altered (Bouton, 2004). It is possible that something similar is happening in Figure 6. In these experiments, CNO is administered to inactivate the RE-dCA1 projection during extinction learning. The authors observe that this manipulation impairs the expression of extinction the next day (or 2-hours later). However, the drug is not given again during the test. Therefore, it is possible that CNO (and/or inactivation of the RE-dCA1 pathway) induces a state change during extinction that is not present during subsequent testing. Based on the literature cited above, this would be expected to disrupt fear extinction as the authors observed. To determine if this alternative explanation is correct, the researchers need to add groups that receive CNO during extinction training and subsequent extinction testing. If the deficits in extinction expression reported in Figure 6 result from a state change, then these groups should not exhibit an impairment. In contrast, if the authors' account is correct, then the expression of extinction should still be disrupted in mice that receive CNO during training and testing.

      We do agree with the reviewer that such an experiment would be interesting. However, it could be also confusing as we could not distinguish whether the possible behavioral effects are related to the state-dependent aspects of CFE or impaired recall of CFE. Importantly, previous studies showed that RE is crucial for extinction recall (Totty et al., 2023). We also show that CFE memory is impaired not only when the animals recall CFE without CNO (day 3) but also with CNO (day 4) (Figure 6C). Moreover, we do not see the effects of CNO on CFE in the control groups (Figure 6D and H). So we believe that it is unlikely that CNO results in state-dependent CFE.

      (2) In their analysis of dCA1 synapses after contextual fear extinction (CFE) (Figure 4), the authors should have compared Ctx and Ctx-Ctx animals against naïve animals (as they did in Figure 3) when comparing 5US and Ext with naïve animals. Otherwise, the authors cannot make the following conclusion; "since changes of SLM synapses were not observed in the animals exposed to the familiar context that was not associated with the USs, our data support the role of the described structural plasticity at the RE→SLM synapses in CFE, rather than in processing contextual information in general.".

      We assume that the key experimental groups to conclude about synaptic plasticity related to particular behavior are the groups that differ just by one factor/experience. For CFE that would be mice sacrificed immediately before and after CFE session (Figure 2 & 3); on the other hand to conclude about the effects of the re-exposure to the neutral context mice sacrificed before and after second exposure to the neutral context are needed (Figure 4). The naive group, as it differs by at least two manipulations from the Ext and Ctx-Ctx groups, is interesting but not crucial in both cases. This group would be necessary if we focused on the memories of FC or novel context. However, these topics are not the main focus of the current manuscript. Still, the naive group is shown on Figures 2 & 3 to check if CFE brings spine parameters to the levels observed in mice with low freezing.

      We have re-written the cited paragraph to be more precise in our conclusions.

      "Overall, our data demonstrate that synapses in all dCA1 strata undergo structural or molecular changes relevant to CFC and/or CFE. However, only in SLM CFE-induced synaptic changes are likely to be directly regulated by RE inputs as they appear on RE+ dendrites and spines. Since such changes of SLM synapses were not observed in the animals re-exposed to the neutral context, our data support the role of the described structural plasticity at the RE→SLM synapses in CFE, rather than in processing contextual information in general."

      (3) In the materials and methods section, the description of cannula placements is confusing and needs to be rewritten.

      This section has been rewritten.

      ln 103: “Cannula placement. Mice were anesthetized by inhalation of 3–5% isoflurane (IsoFlo; Abbott Animal Health) in oxygen and positioned in a stereotaxic frame (51503, Stoelting, Wood Dale, IL, USA). Two holes were drilled in the skull, and a double guide cannulae (2 mm apart and 2 mm long; 26GA, Plastics One) was lowered into the holes such that the cannula tip was located over dorsal CA1 area (2 mm posterior to bregma, ±1 mm lateral, and −1.3 mm vertical). Cannulae were kept patent by using 33-gauge internal dummy cannulae (Plastics One). The animals were used in contextual fear conditioning 21 days after the cannulation. Animals received bilateral CNO (3 μM, 0.2 μl per side for 1 min; Tocris Bioscience, Cat. No. 4936) (Stachniak et al., 2014) or saline injections (0.2 μl per side) 30 minutes before Extinction session via intrahippocampal injection cannulae (33-gauge). After the infusion, the cannula was left in place for 30 seconds. The cannula placement was verified by histology, and only data from animals with correct cannula implants were included in statistical analyses.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Other/ Minor:

      In the beginning of the second paragraph on p. 21 of the Results section, it states that "RE-dCA1 has no effect on working memory," although it was not clear what data the authors were referring to support this conclusion.

      We refer there to the changes of freezing behavior within the CFE session. This is explained now.

      Reviewer #2 (Recommendations for the authors):

      No statement about code and data availability is present.

      The statements are added.

      ln 785: “Row data and the code used for analysis of confocal data is available at OSF (https://osf.io/bnkpx/).”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      Summary: 

      The authors are trying to develop a microscopy system that generates data output exceeding the previous systems based on huge objectives. 

      Strengths: 

      They have accomplished building such a system, with a field of view of 1.5x1.0 cm2 and a resolution of up to 1.2 um. They have also demonstrated their system performance on samples such as organoids, brain sections, and embryos. 

      Weaknesses: 

      To be used as a volumetric imaging technique, the authors only showcase the implementation of multi-focal confocal sectioning. On the other hand, most of the real biological samples were acquired under wide-field illumination, and processed with so-called computational sectioning. Despite the claim that it improves the contrast, sometimes I felt that the images were oversharpened and the quantitative nature of these fluorescence images may be perturbed. 

      Reviewer #2 (Public Review): 

      Summary: 

      This manuscript introduced a volumetric trans-scale imaging system with an ultra-large field-of-view (FOV) that enables simultaneous observation of millions of cellular dynamics in centimeter-wide 3D tissues and embryos. In terms of technique, this paper is just a minor improvement of the authors' previous work, which is a fluorescence imaging system working at visible wavelength region (https://www.nature.com/articles/s41598-021-95930-7). 

      Strengths: 

      In this study, the authors enhanced the system's resolution and sensitivity by increasing the numerical aperture (NA) of the lens. Furthermore, they achieved volumetric imaging by integrating optical sectioning and computational sectioning. This study encompasses a broad range of biological applications, including imaging and analysis of organoids, mouse brains, and quail embryos, respectively. Overall, this method is useful and versatile. 

      Weaknesses: 

      The unique application that only can be done by this high-throughput system remains vague. Meanwhile, there are also several outstanding issues in this paper, such as the lack of technical advances, unclear method details, and nonstandardized figures. 

      Here, we address the first part of the Weaknesses concerning the unique application, and will respond to the latter part in the Reply to the Recommendations.

      We are developing 'large field of view with cellular resolution' imaging technique, aiming to apply it to the observation of multicellular systems consisting of a large number of cells. Our proposed optical system has achieved optical performance that enables simultaneous observation of more than one million cells in a single field of view. In this paper, we have succeeded in adding three-dimensional imaging capability while maintaining the size of this two-dimensional field of view. By simultaneously observing the dynamics of a large number of cells, we can reveal spatio-temporal sequences in state transitions (pattern formation, pathogenesis, embryogenesis, etc.) in multicellular systems and discover cells that serve as a starting point. These were mentioned in the 1st and 2nd paragraphs of the Introduction section (Line 48-, 58-) and discussed in the 4th paragraph of Discussion section (Line 398-) of the main text. While our previous work on two-dimensional specimens has shown its validity, the present work demonstrated that temporal changes of multicellular systems in three-dimensional specimens can be observed at the single-cell level.

      Ideally, we aim to achieve the same level of depth observation capability as the FOV size in the lateral direction. However, at present, the penetration depth for living specimens is limited to a few hundred micrometers due to non-transparency, while the lateral FOV size exceeds 1 cm. The current optical performance is well-suited for systems where development occurs within a thin volume but a large area, such as the quail embryo presented in this paper (Fig. 6 in the revised manuscript). In addition to quail embryos, this technique can also be applied to the developmental systems of highly transparent model organisms, such as zebrafish. Furthermore, for chemically cleared specimens, even those thicker than 1.5 mm, as shown in this paper (Fig. 5 in the revised manuscript), can be observed. Besides organs other than the brain, it could also be applied to imaging entire living organisms. However, for observation depths up to 10 mm, such as in the whole mouse brain, a mechanism to compensate for spherical aberration is required, which we consider the next step in our technological development.

      Recommendations for the authors: 

      Reviewer #1 (Recommendations For The Authors): 

      (1) I suggest that authors shall re-examine the quantitative nature of their image processing algorithm. Also, I wonder whether there are parameters that could be adjusted, as images in Figure 3D and 4E seem to be oversharpened with potential loss of information. 

      As the reviewer pointed out, we recognized that there was an insufficient explanation of the image processing.

      Therefore, descriptions on the quantitative nature and parameter adjustments have been added to the text (Materials and Methods, Line 552) and the Supplementary File (Fig. S4-5, Note 2), and these have been referenced in the main text. A summary is given below.

      The adjustable parameters in our method include the cutoff frequency of the smoothing filter used in the background light estimation. If the cutoff frequency is too high, the focal plane component will be included in the “background”; if it is too low, background light will remain in the focal plane. The cutoff frequency needs to be optimized within this range. In this optimization, neither the size of the cell itself nor the performance of the optical system was considered; instead, we utilized the concept of independent component analysis (ICA). This approach is taken because the size and structure of cells vary from sample to sample, and the optical properties also vary with wavelength and location, making it impractical to consider each factor for every case. ICA employs a blind separation method, which is based on the principle that individual signals deviate from the normal (Gaussian) distribution, while the superimposition of signals tends to bring the distribution closer to the Gaussian distribution. Several indices have been proposed to quantify the non-Gaussian nature of the distribution, including kurtosis, skewness, negentropy, and mutual information. Among these measures, we empirically found skewness to be the most suitable and robust, and therefore adopted it for our algorithm. The optimal parameters were selected using a subset of the data before applying the calculations of the entire dataset. The determined values were then applied to the entire dataset.

      Regarding the oversharpening, we believe that it rarely occurs in the image data shown in the manuscript. In a case where low-frequency structures and high-frequency structures are mixed in the focal plane, oversharpeninglike effect can occur because of the disappearance of low-frequency structures, which is discussed in Supplementary File (Note 2, Figs. S5D). However, in the case of a sample with nearly uniform spatial frequency, such as the nucleus observed in this study, oversharpening is unlikely to occur by setting appropriate parameters as described above. If it appears that some images are oversharpened in the figures, it is due to the contrast of the image.

      (2) On the other hand, I am curious how a wide-field fluorescence system may reliably extract information from a denselylabeled sample within axial volume of 200 um, as they showed in the mouse brain in Figure 4. Thus I am skeptical regarding the fidelity and completeness of the signals and cells recorded there. It would be ideal if the authors could benchmark their system performance with a two-photon microscope system, which serves as the ground truth. 

      The reviewer's suggestion is reasonable; however, we are unfortunately unable to observe the same sample using a two-photon microscope. Instead, we will explain these differences from a theoretical perspective. Two-photon microscopes used for brain imaging typically employ objective lenses with a numerical aperture (NA) of at least 0.5, allowing for 3D imaging with depth resolution ranging from several micrometers down to sub-micrometer levels. In contrast, our method uses a lens system with NA of 0.25, and the optical configuration (focusing NA, pinhole size) are not optimized for resolution (Note 2 in Supplementary File), thus the longitudinal resolution (FWHM) is about 14 microns (Fig. 3E in the revised manuscript). This difference is significant in the brain imaging, where our method may not fully separate all cells in close proximity along the depth axis, as shown in the bottom panels (xz-plane) of Fig. 5F of the revised manuscript. Nevertheless, we believe that cell nuclei can be accurately detected in this 3D image using appropriate cell detection methods based on deep learning. To support this claim, we conducted cell detection using the state-of-the-art cell detection platform ELEPHANT and incorporated the results into Fig. 5 (Fig. 5G-I). This figure demonstrates that even with the current spatial resolution, accurate detection of cell nuclei is achievable.

      We accordingly added one paragraph (Line 285) in the main text to explain the cell detection method and discuss the results. We also added one section into Materials and Methods for more detail of the cell detection (Line 650).

      In conjunction with the revision, the developer of ELEPHANT (K. Sugawara) has been included as a co-author.

      Reviewer #2 (Recommendations For The Authors): 

      In my opinion, the following concerns need to be addressed. 

      Major comments: 

      (1) The proposed system's crucial element involves the development of a giant lens system with a numerical aperture (NA) of 0.25. However, a comprehensive introduction and explanation of this significant giant lens system are missing from the manuscript. I strongly suggest that the authors supplement the relevant content to provide a clearer understanding of this integral component. 

      A detailed description of the giant lens system has been added to the main text (Optical Configuration and Performance, Line 83) and the Materials and Methods section (Wide -field imaging system (AMATERAS-2w) configuration, Line 446). A diagram of the lens configuration has also been included in Fig. 1A. In conjunction with these additions, two engineers from SIGMAKOKI CO. LTD., who made significant contributions to the design and manufacturing of the lens system, have been included as co-authors.

      (2) The manuscript introduces a computational sectioning technique, based on iteratively filtering technology. However, the accuracy of this algorithm is not sufficiently validated. 

      It is challenging to discuss accuracy of the processing results compared to the ground truth, because the ground truth is unknown for any of the experiments. Instead, in the Supplementary File (Notes 2, Figures S4-5), we show how the processing results for the measured and simulated data vary with the parameter (cutoff frequency), illustrating the characteristics of our method. The results suggest that by optimally pre-selecting the parameter, it is possible to successfully separate the in-focus and out-of-focus components. This discussion is related to our response to the first recommendation made by the reviewer #1. Please review our response to Reviewer #1 regarding parameter optimization and oversharpening. Here, as an addition, we describe a discussion of the conditions that must be met in order to perform the calculation correctly, as described below (also included in Note 2, Limitation of the computational sectioning).

      To apply this method, certain requirements must be met regarding cutoff spatial frequency and intensity. Regarding cutoff spatial frequency, the algorithm utilizes a low-pass filter with a single cutoff frequency, which can make it challenging to accurately extract structures in the focal plane when structures of varying sizes and shapes are mixed within the sample. This is illustrated by the simulation shown in Fig. S5 and described in Note 2. Conversely, regarding intensity, if the structure’s intensity in the focal plane is weak compared to the Gaussian fluctuations in the background intensity, it becomes difficult to extract the structure. However, intensity fluctuations can be reduced by applying a 3x3 moving average filter to the entire image as a pre-processing step before applying the baseline estimation algorithm. 

      In the experimental data presented in this paper (Figs. 4-6 in the revised manuscript), the spatial frequency issue was not significant because the target structures, which are stained nuclei, appear to be of nearly uniform size in the focal plane. The second issue, related to intensity, is also addressed in Fig. 4, as the signal intensity from the focal plane is sufficient to overcome background light in almost all regions. In the mouse brain example, the use of confocal imaging suppresses background light, allowing the structures in the focal plane to be accurately extracted.

      (3) I didn't see a detailed description of the confocal imaging in the manuscript. If it adheres to conventional confocal technology, then the question arises: what truly constitutes the novel aspect of this technique? 

      The principle of confocal imaging and optics is based on the use of a pinhole array, a system also employed commercially by CrestOptics (X-Light, Italy). Prior to the 1990s, when the configuration utilizing Yokogawa Electric's pinhole array and microlens array pairs became popular, pinhole array-only setups were the norm, and are now considered somewhat traditional. We do not claim novelty in the optical configuration itself, but rather in the design of a confocal optical system tailored for our original large-field (low-magnification) imaging system with a relatively high NA. The pinhole array disk we designed features significantly smaller pinholes and correspondingly tighter pinhole spacing than those used for high-magnification observation purposes. We believe that this unique size and arrangement provides sufficient novelty.

      We have revised the manuscript to clearly emphasize what we believe constitutes the novelty of this technique (paragraphs starting from Line 166 and Line 183). We have also added a discussion on our confocal optical configuration and its spatial resolution in the Supplementary File (Note 1, Fig. S2-3).

      (4) Light-sheet and light-field microscopy, as two emerging 3D microscopy techniques which has theoretically higher throughput than confocal, are not sufficiently introduced in this manuscript. 

      In the previous version, we briefly mentioned light-sheet and light-field microscopy, but we recognized that more detailed explanations were necessary and should be included in the manuscript. We have added several sentences to the main text (Line 159-165). A summary is provided below. 

      Light-sheet microscopy requires the illumination light to propagate over long distances within the specimen, and many applications necessitate the use of transparency-enhanced tissue. Even when the sample is highly transparent, no existing technique can form thin optical sections as long as 1 cm. Therefore, light-sheet microscopy is not an effective method for the thin, wide, three-dimensional objects that are the focus of this project. Regarding light-field microscopy, it features a trade-off where the number of pixels in the two-dimensional plane is reduced in exchange for the ability to record three-dimensional fluorescence distribution information in a single shot. In our imaging system, the pixel spacing is set to be comparable to the Nyquist Frequency to observe as many cells as possible, meaning that no more additional pixels can be sacrificed. Therefore, the light-field microscopy technique is not suitable for our imaging system.

      (5) The fluorescence images of cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs) stained with Rhodamine phalloidin, as presented in Figure 1(E), exhibit suboptimal quality. This may hinder the effective use of the image for biological research. It is imperative that the authors address and explain this aspect, shedding light on the limitations and potential implications of the research findings. 

      We acknowledge the reviewer’s concern regarding the suboptimal quality of the fluorescence image. Upon further examination, we recognized that the resolution and clarity of the image could potentially limit its utility for detailed biological analysis. To address this, we have re-examined the image size and quality to enhance its presentation in Fig. 2C-E in the revised manuscript, which allows for finer structures to be recognized within the large image size.

      Regarding the effective use of the image for biological research, the results shown in the images indicated the capability of observing subcellular structures, such as myofibrils, in cell sheets with a large area, such as myocardial sheets. This would enable us to simultaneously investigate micro-level structures (orientation and density of myofibrils) and macro-level multicellular dynamics (performance of myocardial sheet). We added the above explanation in the manuscript (Line 146). We hope this revision clarifies the quality and utility of the presented image.

      (6) The imaging quality difference between the two techniques shown in Figure 1F, G is relatively small, and the signal distribution difference shown in Figure H is significant, unlike the effects expected from an improvement in resolution. 

      We acknowledge the reviewer's concern regarding the minimal apparent difference in imaging quality between the two images. Upon re-evaluation, we recognized that the original presentation may not have clearly demonstrated the improvements intended by the different techniques. Figure 1H, which showed the line profile of Figs. 1F and G, may have been impacted by the resolution and compression settings of the image file, leading to a less pronounced distinction between the two techniques. To address this, we have enlarged Figs 1F and 1G

      (renumbered as Fig. 2D and 2E in the revised manuscript) and carefully reviewed the resolution and compression ratio to ensure that the differences are more clearly visible. 

      (7) The chart in Figure 2(C) lacks axis titles and numerical labels, making it challenging for readers to comprehend. To enhance reader convenience, it is recommended that the authors incorporate axis titles and numerical labels, providing a clearer context for interpreting the chart. 

      We appreciate the reviewer’s observation regarding the lack of axis titles and numerical labels in the figure. The vertical axis represents fluorescence intensity, which we initially omitted, assuming it was self-evident. However, as the reviewer correctly pointed out, it is crucial to ensure that figures are clear and accessible to readers from diverse backgrounds. In response, we have added the vertical axis title to Fig. 2C (renumbered as Fig. 3C in the revised manuscript) to enhance clarity, while the numerical labels remain omitted as the unit is arbitrary (a.u.). We have also reviewed all other figures in the manuscript to ensure that no similar errors are present.

      (8) In Figures 2(D) and (E), where the authors present the point spread function for quantifying the lateral and axial resolution of the system, I would recommend increasing the number of fluorescent microspheres to more than 10 for statistical averaging. This adjustment would strengthen the persuasiveness of the data and contribute to a more robust analysis. 

      We appreciate the reviewer’s recommendation to increase the number of fluorescent microspheres for statistical averaging in Figs. 2D and E (renumbered as Fig. 3D-E in the revised manuscript). In response, we have revised the graphs to present the point spread function with the statistical mean and standard deviation (SD) of fluorescent images obtained from a large sample size (N = 100), and accordingly revised the main text to mention the statistics (Line 118, Line 132). We also recognized that a similar adjustment was necessary for Figs 1C and D (renumbered as Fig. 2A-B in the revised manuscript), and have accordingly made the same modifications to those figures as well. We believe these changes enhance the robustness and persuasiveness of our data.

      (9) Figure 4(C) visually represents the characteristic 3D structures of several regions. However, discerning the 3D structural information in the images poses a challenge. To address this issue, I recommend that the authors optimize the 3D visualization to improve clarity and facilitate a more effective interpretation of the depicted structures. 

      We appreciate the reviewer’s suggestion regarding the challenges in discerning the 3D structural information in Fig. 4C. To address this, we have added representative images from the xy-plane and xz-plane of the cortex, medial habenula, and choroid plexus (Fig. 5G-I) in the revised manuscript. These additions provide a clearer visualization of the 3D distribution in each region, making it easier for readers to interpret the structures. Additionally, we have overlaid the results of deep-learning based cell detection on these images, further enhancing the visibility of the cells. This adjustment also aligns with our response to Reviewer #1's second comment.

      Minor comments: 

      (1) The labelling of ROI is missing in Figure 1(e). 

      We appreciate the reviewer’s observation regarding the missing labeling of the ROI in Fig. 1E. Upon review, we confirmed that the ROI was indeed labeled with a white square in the previous manuscript; however, it was difficult to discern due to its small size and the black-and-white contrast. To improve visibility, we have recolored the square in magenta, ensuring that it stands out more clearly in the figure (Fig. 2C in the revised manuscript).

      (2) The subfigure order and labeling in Fig. 1 and Fig. 2 are not consistent.

      We appreciate the reviewer’s attention to the subfigure order and labeling in Fig. 1 and 2 (Fig. 1-3 in the revised manuscript). To accommodate subfigures of varying sizes without leaving gaps, we arranged the subfigures in a non-sequential order. However, we have ensured that the text refers to the figures in the correct order. We acknowledge the importance of consistency and will work with the editorial team to explore the best way to present the figures while maintaining clarity and alignment with standard practices.

      (3) Figure 1B reappears in Figure 2.  

      We appreciate the reviewer’s observation regarding the repetition of Figure 1B in Figure 2. While the central part of the optical system (custom lens system) is common to both figures, the illumination system, pinhole array disk, and detection optics for the confocal set up differ. To provide a complete understanding of the optical system, we opted to include the full diagram in Fig. 2B (renumbered as Fig. 3B in the revised manuscript). We considered highlighting only the different components, but we felt that doing so might complicate the reader’s comprehension of the overall system. Therefore, we chose to include the common elements twice to ensure clarity.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Strengths:

      The three experiments are well designed and the various conditions are well controlled. The rationale of the study is clear, and the manuscript is pleasant to read. The analysis choices are easy to follow, and mostly appropriate.

      We are grateful to the reviewer’s thoughtful comments.

      Weaknesses:

      I only have one potential worry. The analysis for gait tracking (1 Hz) in Experiment 2 (Figures 3a/b) starts by computing a congruency effect (A/V stimulation congruent (same frequency) versus A/V incongruent (V at 1 Hz, A at either 0.6 or 1.4 Hz), separately for the Upright and Inverted conditions. Then, this congruency effect is contrasted between Upright and Inverted, in essence computing an interaction score (Congruent/Incongruent X Upright/Inverted). Then, the channels in which this interaction score is significant (by cluster-based permutation test; Figure 3a) are subselected for further analysis. This further analysis is shown in Figure 3b and described in lines 195-202. Critically, the further analysis exactly mirrors the selection criteria, i.e. it is aimed at testing the effect of Congruent/Incongruent and Upright/Inverted. This is colloquially known as "double dipping", the same contrast is used for selection (of channels, in this case) as for later statistical testing. This should be avoided, since in this case even random noise might result in a significant effect. To strengthen the evidence, either the authors could use a selection contrast that is orthogonal to the subsequent statistical test, or they could skip either the preselection step or the subsequent test. (It could be argued that the test in Figure 3b and related text is not needed to make the point - that same point is already made by the cluster-based permutation test.)

      Thanks for the helpful suggestions. In Experiment 2, to investigate whether the multisensory integration effect was specialized for biological motion perception, we contrasted the congruency effect between the upright and inverted conditions to search for clusters showing a significant interaction effect. We performed further analyses based on neural responses from this cluster to examine whether the congruency effect was significant in the upright and the inverted conditions, respectively, following the logic of post hoc comparisons after identifying an interaction effect. However, we agree with the reviewer that comparing the congruency effects between the upright and inverted conditions again based on data from this cluster was redundant and resulted in doubledipping. Therefore, we have removed this comparison from the main text and optimized the way to present our results in the revised Fig. 3).

      Related to the above: the test for the three-way interaction (lines 211-216) is reported as "marginally significant", with a p-value of 0.087. This is not very strong evidence.

      As shown in Fig.3b & e, the magnitude of amplitude differs between the gaitcycle frequency (mean = 0.008, SD = 0.038) and the step-cycle frequency (mean = 0.052; SD =0.056), which might influence the statistical results of the interaction effect. To reduce such influence, we converted the amplitude data at each frequency condition into Z-scores, separately. The repeated-measures ANOVA analysis on these normalized amplitude data revealed a significant three-way interaction (F (1,23) = 7.501, p = 0.012, ƞ<sub>p</sub><sup>2</sup> \= 0.246). We have updated the results in the revised manuscript (lines 218-225).

      Reviewer #1 (Recommendations For The Authors):

      -  Which variable caused one data point to be classified as outlier? (line 221).

      The outlier is a participant whose audiovisual congruency effect (Upright – Inverted) in neural responses at the frequency of interest exceeds 3 SD from the group mean. It is marked by a red diamond in Author response 2. Before removing the data, the correlation between the AQ score and the congruency effect is r \= -0.396, p \= 0.055. For comparison, the results after removing the outlier are shown in Fig. 3c of the revised manuscript. We have added more information about the variable causing the outlier in the revised manuscript (lines 231-232).

      Author response image 1.

      The correlation between AQ score and congruency effect

      -  The authors cite Maris & Oostenveld (2007) in line 415 as the main reference for the FieldTrip toolbox, but the correct reference here is different, see https://www.fieldtriptoolbox.org/faq/how_should_i_refer_to_fieldtrip_in_my_p ublication/

      Thank you for pointing out this issue. Citation corrected.

      -  The authors could consider giving some more background on the additive vs superadditive distinction in the Introduction, which may increase the impact; as it stands the reader might not know why this is particularly interesting. Summarize some of the takeaways of the Stevenson et al. (2014) review in this respect.

      Thanks for the suggestion and we have added the following relevant information in the Introduction (lines 80-90):

      “Moreover, we adopted an additive model to classify multisensory integration based on the AV vs A+V comparison. This model assumes independence between inputs from each sensory modality and distinguishes among sub-additive (AV < A+V), additive (AV = A+V), and super-additive (AV > A+V) response modes (see a review by Stevenson et al., 2014). The additive mode represents a linear combination between two modalities. In contrast, the super-additive and subadditive modes indicate non-linear interaction processing, either with potentiated neural activation to facilitate the perception or detection of nearthreshold signals (super-additive) or a deactivation mechanism to minimize the processing of redundant information cross-modally (sub-additive) (Laurienti et al., 2005; Metzger et al., 2020; Stanford et al., 2005; Wright et al., 2003).”

      Reviewer #2 (Public Review):

      Strengths:

      The manuscript is well-written, with a concise and clear writing style. The visual presentation is largely clear. The study involves multiple experiments with different participant groups. Each experiment involves specific considered changes to the experimental paradigm that both replicate the previous experiment's finding yet extend it in a relevant manner.

      We thank the reviewer for the valuable feedback.

      Weaknesses:

      The manuscript interprets the neural findings using mechanistic and cognitive claims that are not justified by the presented analyses and results.

      First, entrainment and cortical tracking are both invoked in this manuscript, sometimes interchangeably so, but it is becoming the standard of the field to recognize their separate evidential requirements. Namely, step and gate cycles are striking perceptual or cognitive events that are expected to produce event-related potentials (ERPs). The regular presentation of these events in the paradigm will naturally evoke a series of ERPs that leave a trace in the power spectrum at stimulation rates even if no oscillations are at play. Thus, the findings should not be interpreted from an entrainment framework except if it is contextualized as speculation, or if additional analyses or experiments are carried out to support the assumption that oscillations are present. Even if oscillations are shown to be present, it is then a further question whether the oscillations are causally relevant toward the integration of biological motion and for the orchestration of cognitive processes.

      Second, if only a cortical tracking account is adopted, it is not clear why the demonstration of supra-additivity in spectral amplitude is cognitively or behaviorally relevant. Namely, the fact that frequency-specific neural responses to the [audio & visual] condition are stronger than those to [audio] and [visual] combined does not mean this has implications for behavioral performance. While the correlation to autism traits could suggest some relation to behavior and is interesting in its own right, this correlation is a highly indirect way of assessing behavioral relevance. It would be helpful to test the relevance of supra-additive cortical tracking on a behavioral task directly related to the processing of biological motion to justify the claim that inputs are being integrated with the service of behavior. Under either framework, cortical tracking or entrainment, the causal relevance of neural findings toward cognition is lacking.

      Overall, I believe this study finds neural correlates of biological motion, and it is possible that such neural correlates relate to behaviorally relevant neural mechanisms, but based on the current task and associated analyses this has not been shown.

      Thanks for raising the important concerns regarding the interpretation of our results within the entrainment or the cortical tracking frame. A strict neural entrainment account emphasizes the alignment of endogenous neural oscillations with external rhythms, rather than a mere regular repetition of stimulus-evoked responses. However, it is challenging to fully dissociate these components, given that rhythmic stimulation can shape intrinsic neural oscillations, resulting in an intricate interplay between endogenous neural oscillations and stimulus-evoked responses (Duecker et al., 2024; Herrmann et al., 2016; Hosseinian et al., 2021). Therefore, some research, including the current study, use the term “entrainment” to refer to the alignment of brain activity to rhythmic stimulation in a broader context, without isolating the intrinsic oscillations and evoked responses (e.g., Ding et al., 2016; Nozaradan et al., 2012; Obleser & Kayser, 2019). Nevertheless, we agree with the reviewer that since the current results did not examine or provide direct evidence for endogenous oscillations, it is better to contextualize the oscillation view as speculations. Hence, we have replaced most of the expressions about “entrainment” with a more general term “tracking” in the revised manuscript (as well as in the title of the manuscript). We only briefly mentioned the entrainment account in the Discussion to facilitate comparison with the literature (lines 307-312).

      Regarding the relevance between neural findings and cognition or behavioral performance, the first supporting evidence comes from the inversion effect in Experiment 2. For the neural responses at gait-cycle frequency, we observed a significantly enhanced audiovisual congruency effect in the upright condition compared with the inverted condition. Inversion disrupts the distinctive kinematic features of biological motion (e.g., gravity-compatible ballistic movements) and significantly impairs biological motion processing, but it does not change the basic visual properties of the stimuli, including the rhythmic signals generated by low-level motion cues. Therefore, the inversion effect has long been regarded as an indicator of the specificity of biological motion processing in numerous behavioral and neuroimaging studies (Bardi et al., 2014; Grossman & Blake, 2001; Shen, Lu, Yuan, et al., 2023; Simion et al., 2008; Troje & Westhoff, 2006; Vallortigara & Regolin, 2006; Wang et al., 2014; Wang & Jiang, 2012; Wang et al., 2022). Here, our finding of the cortical tracking of higher-order rhythmic structures (gait cycles) present in the upright but not in the inverted condition suggests that this cortical tracking effect can not be explained by ERPs evoked by regular onsets of rhythmic events. Rather, it is closely linked with the specialized cognitive processing of biological motion. Furthermore, we found that the BM-specific cortical tracking effect at gait-cycle frequency (rather than the non-selective tracking effect at step-cycle frequency) correlates with observers’ autistic traits, indicating its functional relevance to social cognition. These findings convergingly suggest that the cortical tracking effect that we currently observed engages cognitively relevant neural mechanisms. In addition, our recent behavioral study showed that listening to frequency-congruent footstep sounds, compared with incongruent sounds, enhanced the visual search for human walkers but not for non-biological motion stimuli containing the same rhythmic signals (Shen, Lu, Wang, et al., 2023). These results suggest that audiovisual correspondence specifically enhances the perceptual and attentional processing of biological motion. Future research could examine whether the cortical tracking of rhythmic structures plays a functional role in this process, which may shed more light on the behavioral relevance of the cortical tracking effect to biological motion perception. We have incorporated the above information into the Discussion (lines 268-293).

      Reviewer #2 (Recommendations For The Authors):

      In Figure 1c, it could be helpful to add the word "static" in the illustration for the auditory condition so that readers understand without reading the subtext that it is a static image without biological motion.

      Suggestion taken.

      In the Discussion, I believe it is important to justify an oscillation and entrainment account, or if it cannot be justified based on the current results and analyses (which is my opinion), it could be helpful to explicitly frame it as speculation.

      We agree with the reviewer. For more clarification, please refer to our response to the public review.

      L335, I did not understand this sentence - a reformulation would be helpful.

      The point-light stimuli were created by capturing the motion of a walking actor (Vanrie & Verfaillie, 2004). The global motion of the walking sequences was eliminated so that the point-light walker looks like walking on a treadmill without translational motion. We have reformulated the sentence as follows: “The point-light walker was presented at the center of the screen without translational motion.”

      The results in Figure 2a and 2d are derived by performing a t-test between the amplitude at the frequency of gait and step cycles and zero. Comparison against amplitude of zero is too liberal; the possibility for a Type-I error is inflated because even EEG data with only noise will not have amplitudes of zero at all frequencies. A better baseline (H0) is either the 1/frequency trend in the power spectrum derived using methods like FOOOF (https://fooof-tools.github.io/fooof/) or by performing non-parametric shuffling based methods (https://doi.org/10.1016/j.jneumeth.2007.03.024).

      In our data analysis, instead of performing the t-test between raw amplitude with zero, we compared the normalized amplitude at each frequency bin (by subtracting the average amplitude measured at the neighboring frequency bins from the original amplitude data) against zero. Such analysis is equal to contrasting the raw amplitude to its neighboring frequency bins, allowing us to test whether the neural response in each frequency bin showed a significant enhancement compared with its neighbors. The multiple comparisons on each frequency bin were controlled by false discovery rate (FDR) correction, reducing the Type-I error. Such analysis procedures help reduce (though not totally remove) the influence of the 1/f trend and have been widely used in this field (Cirelli et al., 2016; Henry & Obleser, 2012; Lenc et al., 2018; Nozaradan et al., 2012; Peter et al., 2023).

      To further verify our findings, we adopted the reviewer’s suggestion and created a baseline by performing a non-parametric shuffling-based analysis. More specifically, to establish the statistical significance of amplitude peaks, we carried out a surrogate analysis on each condition. For each participant, a single control surrogate dataset was derived from their actual dataset by jittering the onset of each step-cycle relative to the actual original onset by a randomly selected integer value ranging between − 490–490 ms. This procedure removed the consistent relationship between the EEG signal and the stimuli while preserving each epoch’s general timing within the exposure period. Then, epochs were extracted based on surrogate stimuli onset, and amplitude was computed across frequencies through FFT under a null model of non-entrainment (Moreau et al., 2022). This entire procedure was performed 100 times, producing a surrogate amplitude distribution of 100 group-averaged values for each condition. If the observed amplitude values at the frequency of interest exceeded the value corresponding to the 95th percentile of the surrogate distribution (p < .05) within a given condition (e.g., AV), the amplitude peak was considered significant (Batterink, 2020). As shown in Author response image 2, the statistical results from these analyses are similar to those reported in the manuscript, confirming the significant amplitude peaks at the frequencies of interest.

      Author response image 2.

      Non-parametric analysis for spectral peak. The dotted lines represent the random data based on shuffling analysis. The solid lines represent the observed data in measured EEG signals. All conditions induced significant peaks at step-cycle frequency and its harmonic, while only the AV condition induced a significant peak at gait-cycle frequency.

      Reviewer #3 (Public Review):

      Strengths:

      The main strengths of the paper relate to the conceptualization of BM and the way it is operationalized in the experimental design and analyses. The use of entrainment, and the tracking of different, nested aspects of BM result in seemingly clean data that demonstrate the basic pattern. The first experiments essentially provide the basic utility of the methodological innovation and the second experiment further hones in on the relevant interpretation of the findings by the inclusion of better control stimuli sets.

      Another strength of the work is that it includes at a conceptual level two replications.

      We appreciate the reviewer for the comprehensive review and positive comments.

      Weaknesses:

      The statistical analysis is misleading and inadequate at times. The inclusion of the autism trait is not foreshadowed and adequately motivated and is likely underpowered. Finally, a broader discussion over other nested frequencies that might reside in the point-light walker stimuli would also be important to fully interpret the different peaks in the spectra.

      (1) Regarding the nested frequency peaks in the spectra, we did observe multiple significant amplitude peaks at 1f (1/0.83 Hz), 2f (2/1.67 Hz), and 4f (4/3.33 Hz) relative to the gait-cycle frequency (Fig. 2 a&d). To further test the functional roles of the neural activity at different frequencies, we analyzed the audiovisual integration modes at each frequency. Note that we collapsed the data from Experiments 1a & 1b in the analysis as they yielded similar results. Overall, results show a similar additive audiovisual integration mode at 2f and 4f and a super-additive integration mode only at 1f (Figure S1), suggesting that the cortical tracking effects at 2f and 4f may be functionally linked but independent of that at 1f. We have reported the detailed results in the Supplementary Information.

      (2) For the reviewer’s other concerns about statistical analysis and autism traits, please refer to our responses below to the Recommendations for the authors.

      Reviewer #3 (Recommendations For The Authors):

      The description of the analyses performed for experiment 2 comes across as double dipping. Congruency effects for BM and non-BM motion (inverted) were compared using cluster-based statistics. Then identified clusters informed an averaging of signals which then were subjected to a paired comparison. At this point, it is no surprise that these paired comparisons are highly significant seeing that the channels were selected based on a cluster analysis of the same exact contrast. This approach should be avoided.

      In the analysis of the repeated measures ANOVA reporting a trend as marginally significant is misleading. Reporting the statistical results whilst indicating that those do not reach significance is the appropriate way to communicate this finding. Other statistics can be used in order to provide the likelihood of those findings supporting H1 or H0 if the authors would like to state something more precise (Bayesian).

      Thanks for the comments. We have addressed these two points in our response to the public review of Reviewer #1.

      The authors perform a correlation along "autistic trait" scores in an individual differences approach. Individual differences are typically investigated in larger samples (>n=40). In addition, the range of AQ scores seems limited to mostly average or lower-than-average AQs (barring a couple). These points make the conclusions on the possible role of BM in the autistic phenotype very tentative. I would recommend acknowledging this.

      An alternative analysis approach that might better suit the smaller sample size is a comparison between high and low AQ participants, defined based on a median split.

      Many thanks for the suggestion. We agree with the reviewer that the sample size (n = 24) in the current study is not large for exploring the correlation between BM and autistic traits. The narrow range of AQ scores was due to the fact that all participants were non-clinical populations and we did not pre-select participants by AQ scores. To further confirm our findings, we adopted your suggestion to compare the BM-specific cortical tracking effect (i.e., audiovisual congruency effect (Upright - Inverted)) between high and low AQ participants split by the median AQ score (20) of this sample. Similar to correlation analysis, one outlier, whose audiovisual congruency effect (Upright – Inverted) in neural responses at 1 Hz exceeds 3 SD from the group mean, was removed from the following analysis. As shown in Figure S3, at 1 Hz, participants with low AQ showed a greater cortical tracking effect compared with high AQ participants (t (21) = 2.127, p \= 0.045). At 2 Hz, low and high AQ participants showed comparable neural responses (t (22) = 0.946, p \= 0.354). These results are in line with the correlation analysis, providing further support to the functional relevance between social cognition and cortical tracking of biological motion as well as its dissociation at the two temporal scales. We have added these results to the main text (lines 238-244) and the supplementary information.

      Writing

      The narrative could be better unfolded and studies better motivated. The transition from basic science research on BM to possibly delineating a mechanistic understanding of autism was a surprise at the end of the intro. Once the authors consider the suggestions and comments above it would be good to have this detail and motivation more obviously foreshadowed in the text.

      Thanks for the great suggestion and we have provided an introduction about how audiovisual BM processing links with social cognition and ASD in the first paragraph of the revised manuscript (lines 46-56). In particular, integrating multisensory BM cues is foundational for perceiving and attending to other people and developing further social interaction. However, such ability is usually compromised in people with social deficits, such as individuals with autism spectrum disorder (ASD) (Feldman et al., 2018), and even in non-clinical populations with high autistic traits (Ujiie et al., 2015). These behavioral findings underline the close relationship between multisensory BM processing and one’s social cognitive capability, motivating us to further explore this issue at the neural level in the current study. We have also modified the relevant content in the last paragraph of the Introduction (lines 100-108), briefly mentioning the methods that we used to investigate this issue.

      The use of terminology related to neural oscillations which are entraining to the BM seems to suggest that the rhythmic tracking inevitably stems from the shaping of existing intrinsic dynamics of the brain. I am not sure this is necessarily the case. I would therefore adopt a more concrete jargon for the description of the entrainment seen in this study. If a discussion over internal dynamics shaped by external stimuli should be invoked, it should be done explicitly with appropriate references (but in my opinion, it isn't quite required).

      Please refer to our response to a similar point raised in the public review of Reviewer #2.

      References

      Bardi, L., Regolin, L., & Simion, F. (2014). The First Time Ever I Saw Your Feet: Inversion Effect in Newborns’ Sensitivity to Biological Motion. Developmental Psychology, 50. https://doi.org/10.1037/a0034678

      Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The autism-spectrum quotient (AQ): Evidence from Asperger syndrome/highfunctioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17. https://doi.org/10.1023/a:1005653411471

      Batterink, L. (2020). Syllables in Sync Form a Link: Neural Phase-locking Reflects Word Knowledge during Language Learning. Journal of Cognitive Neuroscience, 32(9), 1735–1748. https://doi.org/10.1162/jocn_a_01581

      Cirelli, L. K., Spinelli, C., Nozaradan, S., & Trainor, L. J. (2016). Measuring Neural Entrainment to Beat and Meter in Infants: Effects of Music Background. Frontiers in Neuroscience, 10. https://doi.org/10.3389/fnins.2016.00229

      Ding, N., Melloni, L., Zhang, H., Tian, X., & Poeppel, D. (2016). Cortical tracking of hierarchical linguistic structures in connected speech. Nature Neuroscience, 19(1), 158–164. https://doi.org/10.1038/nn.4186

      Duecker, K., Doelling, K. B., Breska, A., Coffey, E. B. J., Sivarao, D. V., & Zoefel, B. (2024). Challenges and approaches in the study of neural entrainment. Journal of Neuroscience, 44(40). https://doi.org/10.1523/JNEUROSCI.1234-24.2024

      Falck-Ytter, T., Nyström, P., Gredebäck, G., Gliga, T., Bölte, S., & the EASE team. (2018). Reduced orienting to audiovisual synchrony in infancy predicts autism diagnosis at 3 years of age. Journal of Child Psychology and Psychiatry, 59(8), 872–880. https://doi.org/10.1111/jcpp.12863

      Feldman, J. I., Dunham, K., Cassidy, M., Wallace, M. T., Liu, Y., & Woynaroski, T. G. (2018). Audiovisual multisensory integration in individuals with autism spectrum disorder: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 95, 220–234. https://doi.org/10.1016/j.neubiorev.2018.09.020

      Grossman, E. D., & Blake, R. (2001). Brain activity evoked by inverted and imagined biological motion. Vision Research, 41(10), 1475–1482. https://doi.org/10.1016/S0042-6989(00)00317-5

      Henry, M. J., & Obleser, J. (2012). Frequency modulation entrains slow neural oscillations and optimizes human listening behavior. Proceedings of the National Academy of Sciences, 109(49), 20095–20100. https://doi.org/10.1073/pnas.1213390109

      Herrmann, C. S., Murray, M. M., Ionta, S., Hutt, A., & Lefebvre, J. (2016). Shaping Intrinsic Neural Oscillations with Periodic Stimulation. Journal of Neuroscience, 36(19), 5328–5337. https://doi.org/10.1523/JNEUROSCI.0236-16.2016

      Hosseinian, T., Yavari, F., Biagi, M. C., Kuo, M.-F., Ruffini, G., Nitsche, M. A., & Jamil, A. (2021). External induction and stabilization of brain oscillations in the human. Brain Stimulation, 14(3), 579–587. https://doi.org/10.1016/j.brs.2021.03.011

      Klin, A., Lin, D. J., Gorrindo, P., Ramsay, G., & Jones, W. (2009). Two-year-olds with autism orient to non-social contingencies rather than biological motion. Nature, 459(7244), 257–261. https://doi.org/10.1038/nature07868

      Laurienti, P. J., Perrault, T. J., Stanford, T. R., Wallace, M. T., & Stein, B. E. (2005). On the use of superadditivity as a metric for characterizing multisensory integration in functional neuroimaging studies. Experimental Brain Research, 166(3), 289–297. https://doi.org/10.1007/s00221-005-2370-2

      Lenc, T., Keller, P. E., Varlet, M., & Nozaradan, S. (2018). Neural tracking of the musical beat is enhanced by low-frequency sounds. Proceedings of the National Academy of Sciences, 115(32), 8221–8226. https://doi.org/10.1073/pnas.1801421115

      Metzger, B. A., Magnotti, J. F., Wang, Z., Nesbitt, E., Karas, P. J., Yoshor, D., & Beauchamp, M. S. (2020). Responses to Visual Speech in Human Posterior Superior Temporal Gyrus Examined with iEEG Deconvolution. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 40(36), 6938–6948. https://doi.org/10.1523/JNEUROSCI.0279-20.2020

      Moreau, C. N., Joanisse, M. F., Mulgrew, J., & Batterink, L. J. (2022). No statistical learning advantage in children over adults: Evidence from behaviour and neural entrainment. Developmental Cognitive Neuroscience, 57, 101154. https://doi.org/10.1016/j.dcn.2022.101154

      Nozaradan, S., Peretz, I., & Mouraux, A. (2012). Selective Neuronal Entrainment to the Beat and Meter Embedded in a Musical Rhythm. Journal of Neuroscience, 32(49), 17572–17581. https://doi.org/10.1523/JNEUROSCI.3203-12.2012

      Obleser, J., & Kayser, C. (2019). Neural Entrainment and Attentional Selection in the Listening Brain. Trends in Cognitive Sciences, 23(11), 913–926. https://doi.org/10.1016/j.tics.2019.08.004

      Peter, V., Goswami, U., Burnham, D., & Kalashnikova, M. (2023). Impaired neural entrainment to low frequency amplitude modulations in English-speaking children with dyslexia or dyslexia and DLD. Brain and Language, 236, 105217. https://doi.org/10.1016/j.bandl.2022.105217

      Shen, L., Lu, X., Wang, Y., & Jiang, Y. (2023). Audiovisual correspondence facilitates the visual search for biological motion. Psychonomic Bulletin & Review, 30(6), 2272–2281. https://doi.org/10.3758/s13423-023-02308-z

      Shen, L., Lu, X., Yuan, X., Hu, R., Wang, Y., & Jiang, Y. (2023). Cortical encoding of rhythmic kinematic structures in biological motion. NeuroImage, 268, 119893. https://doi.org/10.1016/j.neuroimage.2023.119893

      Simion, F., Regolin, L., & Bulf, H. (2008). A predisposition for biological motion in the newborn baby. Proceedings of the National Academy of Sciences, 105(2), 809–813. https://doi.org/10.1073/pnas.0707021105

      Stanford, T. R., Quessy, S., & Stein, B. E. (2005). Evaluating the Operations Underlying Multisensory Integration in the Cat Superior Colliculus. Journal of Neuroscience, 25(28), 6499–6508. https://doi.org/10.1523/JNEUROSCI.5095-04.2005

      Stevenson, R. A., Ghose, D., Fister, J. K., Sarko, D. K., Altieri, N. A., Nidiffer, A. R., Kurela, L. R., Siemann, J. K., James, T. W., & Wallace, M. T. (2014). Identifying and Quantifying Multisensory Integration: A Tutorial Review. Brain Topography, 27(6), 707–730. https://doi.org/10.1007/s10548-014-0365-7

      Troje, N. F., & Westhoff, C. (2006). The Inversion Effect in Biological Motion Perception: Evidence for a “Life Detector”? Current Biology, 16(8), 821–824. https://doi.org/10.1016/j.cub.2006.03.022

      Ujiie, Y., Asai, T., & Wakabayashi, A. (2015). The relationship between level of autistic traits and local bias in the context of the McGurk effect. Frontiers in Psychology, 6. https://doi.org/10.3389/fpsyg.2015.00891

      Vallortigara, G., & Regolin, L. (2006). Gravity bias in the interpretation of biological motion by inexperienced chicks. Current Biology, 16(8), R279–R280. https://doi.org/10.1016/j.cub.2006.03.052

      Vanrie, J., & Verfaillie, K. (2004). Perception of biological motion: A stimulus set of human point-light actions. Behavior Research Methods, Instruments, & Computers, 36(4), 625–629. https://doi.org/10.3758/BF03206542

      Wang, L., & Jiang, Y. (2012). Life motion signals lengthen perceived temporal duration. Proceedings of the National Academy of Sciences of the United States of America, 109(11), E673-677. https://doi.org/10.1073/pnas.1115515109

      Wang, L., Yang, X., Shi, J., & Jiang, Y. (2014). The feet have it: Local biological motion cues trigger reflexive attentional orienting in the brain. NeuroImage, 84, 217–224. https://doi.org/10.1016/j.neuroimage.2013.08.041

      Wang, Y., Zhang, X., Wang, C., Huang, W., Xu, Q., Liu, D., Zhou, W., Chen, S., & Jiang, Y. (2022). Modulation of biological motion perception in humans by gravity. Nature Communications, 13(1), Article 1. https://doi.org/10.1038/s41467-022-30347-y

      Wright, T. M., Pelphrey, K. A., Allison, T., McKeown, M. J., & McCarthy, G. (2003). Polysensory Interactions along Lateral Temporal Regions Evoked by Audiovisual Speech. Cerebral Cortex, 13(10), 1034–1043. https://doi.org/10.1093/cercor/13.10.1034

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The manuscript by Griesius et al. addresses the dendritic integration of synaptic input in cortical GABAergic interneurons (INs). Dendritic properties, passive and active, of principal cells have been extensively characterized, but much less is known about the dendrites of INs. The limited information is particularly relevant in view of the high morphological and physiological diversity of IN types. The few studies that investigated IN dendrites focused on parvalbumin-expressing INs. In fact, in a previous study, the authors examined dendritic properties of PV INs, and found supralinear dendritic integration in basal, but not in apical dendrites (Cornford et al., 2019 eLife).

      In the present study, complementary to the prior work, the authors investigate whether dendrite-targeting IN types, NDNF-expressing neurogliaform cells, and somatostatin(SOM)-expressing O-LM neurons, display similar active integrative properties by combining clustered glutamate-uncaging and pharmacological manipulations with electrophysiological recording and calcium imaging from genetically identified IN types in mouse acute hippocampal slices.

      The main findings are that NDNF IN dendrites show strong supralinear summation of spatially- and temporally-clustered EPSPs, which is changed into sublinear behavior by bath application of NMDA receptor antagonists, but not by Na+-channel blockers. L-type calcium channel blockers abolished the supralinear behavior associated calcium transients but had no or only weak effect on EPSP summation. SOM IN dendrites showed similar, albeit weaker NMDA-dependent supralinear summation, but no supralinear calcium transients were detected in these INs. In summary, the study demonstrates that different IN types are endowed with active dendritic integrative mechanisms, but show qualitative and quantitative divergence in these mechanisms.

      While the research is conceptionally not novel, it constitutes an important incremental gain in our understanding of the functional diversity of GABAergic INs. In view of the central roles of IN types in network dynamics and information processing in the cortex, results and conclusions are of interest to the broader neuroscience community.

      The experiments are well designed, and closely follow the approach from the previous publication in parts, enabling direct comparison of the results obtained from the different IN types. The data is convincing and the conclusions are well-supported, and the manuscript is very well-written.

      I see only a few open questions and some inconsistencies in the presentation of the data in the figures (see details below).

      We thank the reviewer for the evaluation and address the detailed points below.

      Reviewer #2 (Public review):

      Summary:

      Griesius et al. investigate the dendritic integration properties of two types of inhibitory interneurons in the hippocampus: those that express NDNF+ and those that express somatostatin. They found that both neurons showed supralinear synaptic integration in the dendrites, blocked by NMDA receptor blockers but not by blockers of Na+ channels. These experiments are critically overdue and very important because knowing how inhibitory neurons are engaged by excitatory synaptic input has important implications for all theories involving these inhibitory neurons.

      Strengths:

      (1) Determined the dendritic integration properties of two fundamental types of inhibitory interneurons.

      (2) Convincing demonstration that supra-threshold integration in both cell types depends on NMDA receptors but not on Na+ channels.

      Weaknesses:

      It is unknown whether highly clustered synaptic input, as used in this study (and several previous studies), occurs physiologically.

      We are grateful to the reviewer for the critique. Indeed, the degree to which clustered inputs belonging to a functional neuronal assembly occur on interneuron dendrites is an open question. However, Chen et al (2013, Nature 499:295-300) reported that dendritic domains of PV-positive interneurons in visual cortex, unlike their somata, exhibit calcium transients in vivo which are highly tuned to stimulus orientation. This suggests that clustered inputs to dendritic segments may well belong to functional assemblies, much as in principal cells (e.g. Wilson et al, 2016, Nature Neuroscience 19:1003–1009; Iacaruso et al, 2017, Nature 547;449–452). In our earlier work reporting NMDAR-dependent supralinear summation of glutamate uncaging-evoked responses at a subset of dendrites on PV-positive interneurons, we demonstrated how this arrangement in an oscillating feedback circuit could be exploited to stabilise neuronal assemblies.

      Reviewer #3 (Public review):

      Summary:

      The authors study the temporal summation of caged EPSPs in dendrite-targeting hippocampal CA1 interneurons. There are some descriptive data presented, indicating non-linear summation, which seems to be larger in dendrites of NDNF expressing neurogliaform cells versus OLM cells. However, the underlying mechanisms are largely unclear.

      Strengths:

      Focal 2-photon uncaging of glutamate is a nice and detailed method to study temporal summation of small potentials in dendritic segments.

      Weaknesses:

      (1) NMDA-receptor signaling in NDNF-IN. The authors nicely show that temporal summation in dendrites of NDNF-INs is to a certain extent non-linear. However, this non-linearity varies massively from cell to cell (or dendrite to dendrite) from 0% up to 400% (Figure S2). The reason for this variability is totally unclear. Pharmacology with AP5 hints towards a contribution of NMDA receptors. However, the authors claim that the non-linearity is not dependent on EPSP amplitude (Figure S2), which should be the case if NMDA-receptors are involved. Unfortunately, there are no voltage-clamp data of NMDA currents similar to the previous study. This would help to see whether NMDA-receptor contribution varies from synapse to synapse to generate the observed variability? Furthermore, the NMDA- and AMPA-currents would help to compare NDNF with the previously characterized PV cells and would help to contribute to our understanding of interneuron function.

      We thank the reviewer for the helpful comments.

      We did not actually claim that EPSP amplitude has no role in determining the magnitude of non-linearity: “Among possible sources of variability for voltage supralinearity, we did not observe a systematic dependence on the average amplitude of individual uEPSPs […] (Fig. S2)”. Whilst we fully agree that, at first sight, a positive dependence of supralinearity on uEPSP amplitude might be expected simply from the voltage-dependent kinetics of NMDARs, there are two main reasons why this could have been obscured. First, the expected relationship is non-monotonic, because with large local depolarizations the driving force collapses, as seen in the overall sigmoid shape of the average relationship between the scaled observed response and arithmetic sum (e.g. Figs 2a & c; 4c & e). Therefore, we would arguably expect a parabolic relationship rather than a simple positive slope relating the degree of supralinearity to the average amplitude of individual uEPSPs. Second, given that the uncaging distance varied substantially, the average amplitudes of the individual uEPSPs recorded at the soma would have undergone different degrees of electrotonic attenuation and further distortion by active conductances before they were measured. Ultimately, the plots in Fig. S2 show too much scatter to be able to exclude a positive or parabolic relationship of nonlinearity to uEPSP amplitude. To avoid misunderstanding, we have changed the sentence in the Results that refers to Fig. S2 to: “Among possible sources of variability for voltage supralinearity, we did not observe a significant monotonic dependence on the average amplitude of individual uEPSPs, distance from the uncaging location along the dendrite to the soma, [or] the dendrite order (Fig. S2)”.

      As for the relative contributions of NMDARs and AMPARs, voltage clamp recordings from both neurogliaform and OLM interneurons have already been reported, with the conclusion that neurogliaform cells exhibit relatively larger NMDAR-mediated currents (e.g. Chittajallu et al. 2017; Booker et al. 2021; Mercier et al. 2022), entirely in keeping with the conclusions of our study. Repeating these measurements would add little to the study. Furthermore, because the mean baseline uEPSP amplitude was <0.5 mV (Fig S2), it would be difficult to obtain reliable meaurements of isolated NMDAR-mediated uEPSCs.

      Turning to the high variability of supralinearity, indeed, the 95% confidence interval for the data in Fig. 2d is 73%, 213%. This degree of variability is consistent with the wide range of NMDAR/AMPAR ratios reported by Chittajallu et al. 2017 (their Fig. 1g), compounded by the expected non-monotonic relationship alluded to above.

      (2) Sublinear summation in NDNF-INs. In the presence of AP5, the temporal summation of caged EPSPs is sublinear. That is potentially interesting. The authors claim that this might be dependent on the diameter of dendrites. Many voltage-gated channels can mediate such things as well. To conclude the contribution of dendritic diameter, it would be helpful to at least plot the extent of sublinearity in single NDNF dendrites versus the dendritic diameter. Otherwise, this statement should be deleted.

      We have plotted the degree of nonlinearity against dendritic diameter for neurogliaform cells (under baseline conditions and in D-AP5) in Fig S2h-k. We did not observe any significant linear correlations, other than between amplitude nonlinearity and dendrite diameter post D-AP5. This does not negate the possibility that the significant difference in average dendritic diameters between neurogliaform and OLM cells contributes to differences in impedance (which we have rephrased as “Among possible explanations is that the local dendritic impedance is greater in neurogliaform cells, lowering the threshold for recruitment of regenerative currents”).

      (3) Nonlinear EPSP summation in OLM-IN. The authors do similar experiments in dendrite-targeting OLM-INs and show that the non-linear summation is smaller than in NDNF cells. The reason for this remains unclear. The authors claim that this is due to the larger dendritic diameter in OLM cells. However, there is no analysis. The minimum would be to correlate non-linearity with dendritic diameter in OLM-cells. Very likely there is an important role of synapse density and glutamate receptor density, which was shown to be very low in proximal dendrites of OLM cells and strongly increase with distance (Guirado et al. 2014, Cerebral Cortex 24:3014-24, Gramuntell et al. 2021, Front Aging Neurosci 13:782737). Therefore, the authors should perform a set of experiments in more distal dendrites of OLM cells with diameters similar to the diameters of the NDNF cells. Even better would be if the authors would quantify synapse density by counting spines and show how this density compares with non-linearity in the analyzed NDNF and OLM dendrites.

      The difference in average dendritic diameters between OLM and neurogliaform cells is highly significant (Fig. 8q, P<0.001). We do not claim that dendritic diameter (and by implication local impedance) is the only determinant of the degree of non-linearity. The suggestion that a gradient of glutamate receptor density contributes is interesting. However, the results of uncaging experiments targeting more distal OLM dendrites of similar diameter as neurogliaform dendrites would be subject to numerous confounds, not least the very different electrotonic attenuation, likely differences in various active conductances, and the presence of spines in OLM dendrites (which are generally sparse and were not reliably imaged in our experiments). Moreover, the cell would have to remain patched for longer in order for the fluorescent dyes to invade the distal dendrites. This alone could potentially result in systematic biases among groups. We now cite Guirrado et al (2014) and Gramuntell et al (2021) to highlight that factors other than dendritic diameter per se, such as inhomogeneity in spine and NMDA receptor density may also contribute to the heterogeneity of nonlinear summation in OLM cells.

      (4) NMDA in OLM. Similar to the NDNF cells, the authors claim the involvement of NMDA receptors in OLM cells. Again there seems to be no dependence on EPSP amplitude, which is not understandable at this point (Figure S3). Even more remarkable is the fact that the authors claim that there is no dendritic calcium increase after activation of NMDA receptors. Similar to NDNF-cell analysis there are no NMDA currents in OLMs. Unfortunately, even no calcium imaging experiments were shown. Why? Are there calcium-impermeable NNDA receptors in OLM cells? To understand this phenomenon the minimum is to show some physiological signature of NMDA-receptors, for example, voltage-clamp currents. Furthermore, it would be helpful to systematically vary stimulus intensity to see some calcium signals with larger stimulation. In case there is still no calcium signal, it would be helpful to measure reversal potentials with different ion compositions to characterize the potentially 'Ca2+ impermeable' voltage-dependent NMDA receptors in OLM cells.

      The same response to point 1) above applies to OLM cells. As with neurogliaform cells, mean OLM baseline asynchronous (separate response) amplitudes were <0.5 mV, making it very difficult to record an isolated NMDAR-mediated uEPSC. Having said that, NMDARs do contribute to EPSCs elicited by stimulation of multiple afferents (e.g. Booker et al, 2021). We do not claim that dendritic calcium transients cannot be elicited following activation of NMDARs in OLM cells. We simply reported that the evoked uEPSPs, designed to approximate individual synaptic signals, were sub-threshold for detectable dendritic calcium signals under conditions that were suprathreshold in neurogliaform cells. The statement has been amended to specify that there were no detectable signals under our recording conditions. There is no evidence presented in the manuscript to suggest that OLM NMDARs are calcium impermeable and indeed no such claim was made.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      There is a large variability in the observed dendritic nonlinearity, in NDNF IN dendrites e.g. the uEPSP amplitude nonlinearity measure varies from as low as 10-20% to over 200%. As only single dendrites were recorded from each IN, it is unclear if this variability is among the cells or between individual dendrites. While the authors analyzed some potential factors, such as distance along the dendrites, branch order, or response magnitude (amplitude and integral), they did not find any substantial correlation. It remains open if different dendrites of NDNF INs, located in the str. moleculare vs. those in or projecting towards str. radiatum, have divergent properties. Similarly, for SOM INs an important question is if axon-carrying dendrites show distinct properties.

      In this context, it would be interesting to see not only values for the mean nonlinearity but also the maximal nonlinearity and its distribution.

      Nonlinearity as defined in the manuscript is a cumulative measurement. The final value per dendritic segment is therefore the sum of nonlinearities at 1 to 12 near-synchronous uncaging locations. The data for the individual dendritic segments are shown in the slopegraphs as in Fig 2b, with their distribution visible. The averages referred to in the results correspond to the paired mean difference plots, which are the group summaries. The method section has been amended to clarify the analysis method. We did not address specifically whether dendrites projecting in different directions behaved differently. This is an interesting question beyond the scope of this study. Nor did we compare axon-carrying OLM dendrites to other dendrites.

      Figures:

      Figure 1: The gray line in plots g and h is not explained. While it looks like an identity line, the legend in plot i ("asynchronous") interferes.

      In plots g and h the gray line is the line of identity. In plot i it is an estimate of the linear summation. In plot i it is not the line of identity as it does not start at the origin with a slope of 1. The figure legend has been amended to clarify.

      In the same panels (Figure 1g,h, and subsequent figures) consider changing the title from "soma (voltage)" to uEPSP.

      The titles have been amended.

      In panel Figure 1i note the missing "(" in the title.

      Title amended.

      In panel Figure 1h: Shouldn't the X-axis label and legend text read "Arithmetic sum of (EPSP) integrals" instead of "Integral of arithmetic sum").

      The wording more accurately reflects the analytical operations. The asynchronous (separate) responses were summed arithmetically first, and then the integral was taken of each cumulative sum. We have therefore left the axis title and legend unchanged.

      Figure 2a,c: Could you please describe how the scaling was performed for the two axes?

      Method section amended.

      In the same panels (Figure 2a,c, and subsequent figures), the legend seems to be misleading: the plot is NS Amplitude/Integral vs Arithmetic sum, and the black line is the identity line (or scaled interpolation of the arithmetic sum, which is essentially the same).

      The scaled arithmetic sums (uEPSP amplitude, integral) represent linear summation and so overlap with the line of identity. The interpolation estimate of the asynchronous (separate) calcium transient response does not overlap with the line of identity as this estimate does not start at the origin with a slope of 1. The legends throughout the manuscript have been amended to clarify this.

      Figure 2b,d,f (and subsequent figures) slope plots: Please indicate that this is the average amplitude supralinearity for the individual recorded dendrites. Note here that the Results text mentions only the average amplitude supralinearity, but not the slop plots, paired mean difference, or Gardner-Altman estimation, illustrated in the figures.

      Nonlinearity as defined in the manuscript is a cumulative measurement. The final value per dendritic segment is therefore the sum of nonlinearities at 1 to 12 near-synchronous uncaging locations. The data for the individual dendritic segments are shown in the slopegraphs as in fig 2b, with their distribution visible. The averages referred to in the results correspond to the paired mean difference plots, which are the group summaries. The method section has been amended to clarify.

      Fig 2e: The legend (both text and figure, also in the following figures) is confusing, as the gray line and diamonds are defined as separate 12(?) responses, but it seems to represent a linear interpolation of the scaled arithmetic sums (ultimately nothing else but an identity line).

      The grey line shows the linear interpolation output between the calcium transient measurements at 1 uncaging location and at 12 uncaging locations. The 12th uncaging location is indicated in the key as “separate 12”. The linear interpolation in these plots does represent linear summation but is not the line of identity as it does not begin at the origin and does not have a slope of 1.

      Reviewer #2 (Recommendations for the authors):

      This study is well-developed and technically executed. I only have minor comments for the authors:

      (1) To target NDNF+ neurons, the authors use the NDNF-Cre mouse line and a Cre-dependent AAV using the mDLX promotor. Why the mDLX promotor? Would it have been sufficient to use any Cre-dependent fluorophore?

      Pilot experiments revealed leaky expression when a virus driving flexed ChR2 under a non-specific promoter (EF1a) was injected in the neocortex of Ndnf-Cre mice (Author response image 1). In our hands, and in line with Dimidschtein et al (2016),  the use of the mDLX enhancer reduced off-target expression.

      Author response image 1.

      A. AAV2/5-EF1a-DIO-hChR2(H134R)-mCherry injected into superficial neocortex of Ndnf-Cre mice led to expression in a few pyramidal neurons in addition to layer 1 neurogliaform cells. B. Patch-clamp recording from a non-labelled pyramidal cell showed that an optogenetically evoked glutamatergic current remained after blockade of GABAA and GABAB receptors, further confirming limited specificity of expression of ChR2. (Data from M Muller, M Mercier and V Magloire, Kullmann lab.)

      (2) The distance of the uncaring sites from the soma plays a key role. The authors should indicate the mean distance of the cluster and its variance.

      Uncaging distance from soma is indicated for both NGF and OLM interneurons in the supplementary figures S2 and S3 respectively.

      (3) Martina et al., in Science 2000, showed high levels of Na+ channels in the dendrites of OLM cells and hinted that spikes could occur in them. The authors should discuss this possible discrepancy.

      Discussion amended.

      (4) Looking at Figure 1d, the EPSPs look exceptionally long-lasting, longer than those observed by stimulating axonal inputs. Could this indicate spill-over excitation? If so, how could this affect the outcome of this study?

      The asynchronous (separate responses) decay to baseline within 100 ms, similar to the neurogliaform EPSPs evoked by electrical stimulation of axons in the SLM in Mercier et al. 2022. We observed clear plateau potentials in a minority of cells (e.g. Fig. S1b). Such plateau potentials can be generated by dendritic calcium channels and we do not consider that glutamate spillover needs to be invoked to account for them.

      (5) In the legend of Figure 2: "n=11 dendrites in 11 cells from 9 animals". Why do the authors only study 11 dendrites from 11 cells? Isn't it possible to repeatedly stimulate clusters of synaptic inputs onto the same cells? In principle, could one test many dendrites of the same cell at different distances from the soma? It is also remarkable that there were very few cells per animal.

      The goal always was to record from as many dendrites as possible from the same cells whilst maintaining high standards of cell health. When cell health indicators such as blebbing, input resistance change or resting voltage change were detected, no further dendritic location could be tested with reasonable confidence. In a given 400 um slice there would be relatively few healthy candidate cells at a suitable depth to attempt to patch-clamp.

    1. Author response:

      We would like to extend our sincere thanks to you and reviewers at eLife for their thoughtful handling of our manuscript and their valuable feedback, which will greatly improve our study.

      We are committed to performing the additional experiments as recommended by the reviewers. However, we would like to clarify our study's focus. 

      The novelty of our study lies in the highlights of our manuscript:

      • The formation of HIV-induced CPSF6 puncta is critical for restoring HIV-1 nuclear reverse transcription (RT).

      • CPSF6 protein lacking the FG peptide cannot bind to the viral core, thereby failing to form HIVinduced CPSF6 puncta.

      • The FG peptide, rather than low-complexity regions (LCRs) or the mixed charge domains (MCDs) of the CPSF6 protein, drives the formation of HIV-induced CPSF6 puncta.

      • HIV-induced CPSF6 puncta form individually and later fuse with nuclear speckles (NS) via the intrinsically disordered region (IDR) of SRRM2.

      By focusing on these processes, we believe our study provides a critical perspective on the molecular interactions that mediate the formation of HIV-induced CPSF6 puncta and broadens the understanding of how HIV manipulates host nuclear architecture.

      Public Reviews: 

      Reviewer #1 (Public review): 

      In recent years, our understanding of the nuclear steps of the HIV-1 life cycle has made significant advances. It has emerged that HIV-1 completes reverse transcription in the nucleus and that the host factor CPSF6 forms condensates around the viral capsid. The precise function of these CPSF6 condensates is under investigation, but it is clear that the HIV-1 capsid protein is required for their formation. This study by Tomasini et al. investigates the genesis of the CPSF6 condensates induced by HIV-1 capsid, what other co-factors may be required, and their relationship with nuclear speckels (NS). The authors show that disruption of the condensates by the drug PF74, added post-nuclear entry, blocks HIV-1 infection, which supports their functional role. They generated CPSF6 KO THP-1 cell lines, in which they expressed exogenous CPSF6 constructs to map by microscopy and pull down assays of the regions critical for the formation of condensates. This approach revealed that the LCR region of CPSF6 is required for capsid binding but not for condensates whereas the FG region is essential for both. Using SON and SRRM2 as markers of NS, the authors show that CPSF6 condensates precede their merging with NS but that depletion of SRRM2, or SRRM2 lacking the IDR domain, delays the genesis of condensates, which are also smaller. 

      The study is interesting and well conducted and defines some characteristics of the CPSF6-HIV-1 condensates. Their results on the NS are valuable. The data presented are convincing. 

      I have two main concerns. Firstly, the functional outcome of the various protein mutants and KOs is not evaluated. Although Figure 1 shows that disruption of the CPSF6 puncta by PF74 impairs HIV-1 infection, it is not clear if HIV-1 infection is at all affected by expression of the mutant CPSF6 forms (and SRRM2 mutants) or KO/KD of the various host factors. The cell lines are available, so it should be possible to measure HIV-1 infection and reverse transcription. Secondly, the authors have not assessed if the effects observed on the NS impact HIV-1 gene expression, which would be interesting to know given that NS are sites of highly active gene transcription. With the reagents at hand, it should be possible to investigate this too. 

      We thank the reviewer for her/his valuable feedback on our manuscript. We are pleased to see her/his appreciation of our results, and we will do our utmost to address the highlighted points to further improve our work.

      Reviewer #2 (Public review): 

      Summary: 

      HIV-1 infection induces CPSF6 aggregates in the nucleus that contain the viral protein CA. The study of the functions and composition of these nuclear aggregates have raised considerable interest in the field, and they have emerged as sites in which reverse transcription is completed and in the proximity of which viral DNA becomes integrated. In this work, the authors have mutated several regions of the CPSF6 protein to identify the domains important for nuclear aggregation, in addition to the alreadyknown FG region; they have characterized the kinetics of fusion between CPSF6 aggregates and SC35 nuclear speckles and have determined the role of two nuclear speckle components in this process (SRRM2, SUN2). 

      Strengths: 

      The work examines systematically the domains of CPSF6 of importance for nuclear aggregate formation in an elegant manner in which these mutants complement an otherwise CPSF6-KO cell line. In addition, this work evidences a novel role for the protein SRRM2 in HIV-induced aggregate formation, overall advancing our comprehension of the components required for their formation and regulation. 

      Weaknesses: 

      Some of the results presented in this manuscript, in particular the kinetics of fusion between CPSF6aggregates and SC35 speckles have been published before (PMID: 32665593; 32997983). 

      The observations of the different effects of CPSF6 mutants, as well as SRRM2/SUN2 silencing experiments are not complemented by infection data which would have linked morphological changes in nuclear aggregates to function during viral infection. More importantly, these functional data could have helped stratify otherwise similar morphological appearances in CPSF6 aggregates. 

      Overall, the results could be presented in a more concise and ordered manner to help focus the attention of the reader on the most important issues. Most of the figures extend to 3-4 different pages and some information could be clearly either aggregated or moved to supplementary data. 

      First, we thank the reviewer for her/his appreciation of our study and to give to us the opportunity to better explain our results and to improve our manuscript. We appreciate the reviewer’s positive feedback on our study, and we will do our best to address her/his concerns. In the meantime, we would like to clarify the focus of our study. Our research does not aim to demonstrate an association between CPSF6 condensates (we use the term "condensates" rather than "aggregates," as aggregates are generally non-dynamic (Alberti & Hyman, 2021; Banani et al., 2017), and our work specifically examines the dynamic behavior of CPSF6 during infection, as shown in Scoca et al., JMCB 2022) and SC35 nuclear speckles. This association has already been established in previous studies, as noted in the manuscript.

      About the point highlighted by the reviewer: "Kinetics of fusion between CPSF6-aggregates and SC35 speckles have been published before (PMID: 32665593; 32997983)."

      Our study differs from prior work PMID 32665593 because we utilize a full-length HIV genome and we did not follow the integrase (IN) fluorescence in trans and its association with CPSF6 but we specifically assess if CPSF6 clusters form in the nucleus independently of NS factors and next to fuse with them. In the current study we evaluated the dynamics of formation of CPSF6/NS puncta, which it has not been explored before. Given this focus, we believe that our work offers a novel perspective on the molecular interactions that facilitate HIV / CPSF6-NS fusion.

      For better clarity, we would like to specify that our study focuses on the role of SON, a scaffold factor of nuclear speckles, rather than SUN2 (SUN domain-containing protein 2), which is a component of the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex.

      As suggested by the reviewer, we will keep key information in the main figure and move additional details to the supplementary material.

      Reviewer #3 (Public review): 

      In this study, the authors investigate the requirements for the formation of CPSF6 puncta induced by HIV-1 under a high multiplicity of infection conditions. Not surprisingly, they observe that mutation of the Phe-Gly (FG) repeat responsible for CPSF6 binding to the incoming HIV-1 capsid abrogates CPSF6 punctum formation. Perhaps more interestingly, they show that the removal of other domains of CPSF6, including the mixed-charge domain (MCD), does not affect the formation of HIV-1-induced CPSF6 puncta. The authors also present data suggesting that CPSF6 puncta form individual before fusing with nuclear speckles (NSs) and that the fusion of CPSF6 puncta to NSs requires the intrinsically disordered region (IDR) of the NS component SRRM2. While the study presents some interesting findings, there are some technical issues that need to be addressed and the amount of new information is somewhat limited. Also, the authors' finding that deletion of the CPSF6 MCD does not affect the formation of HIV-1-induced CPSF6 puncta contradicts recent findings of Jang et al. (doi.org/10.1093/nar/gkae769). 

      We thank the reviewer for her/his thoughtful feedback and the opportunity to elaborate on why our findings provide a distinct perspective compared to those of Jang et al. (doi.org/10.1093/nar/gkae769), while aligning with the results of Rohlfes et al. (doi.org/10.1101/2024.06.20.599834).

      One potential reason for the differences between our findings and those of Jang et al. could be the choice of experimental systems. Jang et al. conducted their study in HEK293T cells with CPSF6 knockouts, as described in Sowd et al., 2016 (doi.org/10.1073/pnas.1524213113). In contrast, our work focused on macrophage-like THP-1 cells, which share closer characteristics with HIV-1’s natural target cells. 

      Our approach utilized a complete CPSF6 knockout in THP-1 cells, enabling us to reintroduce untagged versions of CPSF6, such as wild-type and deletion mutants, to avoid potential artifacts from tagging. Jang et al. employed HA-tagged CPSF6 constructs, which may lead to subtle differences in experimental outcomes due to the presence of the tag.

      Finally, our investigation into the IDR of SRRM2 relied on CRISPR-PAINT to generate targeted deletions directly in the endogenous gene (Lester et al., 2021, DOI: 10.1016/j.neuron.2021.03.026). This approach provided a native context for studying SRRM2’s role.

      We will incorporate these clarifications into the discussion section of the revised manuscript.

    1. Author response:

      Reviewer #1 (Public review):

      The study examines how pyruvate, a key product of glycolysis that influences TCA metabolism and gluconeogenesis, impacts cellular metabolism and cell size. It primarily utilizes the Drosophila liver-like fat body, which is composed of large post-mitotic cells that are metabolically very active. The study focuses on the key observations that over-expression of the pyruvate importer MPC complex (which imports pyruvate from the cytoplasm into mitochondria) can reduce cell size in a cell-autonomous manner. They find this is by metabolic rewiring that shunts pyruvate away from TCA metabolism and into gluconeogenesis. Surprisingly, mTORC and Myc pathways are also hyper-active in this background, despite the decreased cell size, suggesting a non-canonical cell size regulation signaling pathway. They also show a similar cell size reduction in HepG2 organoids. Metabolic analysis reveals that enhanced gluconeogenesis suppresses protein synthesis. Their working model is that elevated pyruvate mitochondrial import drives oxaloacetate production and fuels gluconeogenesis during late larval development, thus reducing amino acid production and thus reducing protein synthesis.

      Strengths:

      The study is significant because stem cells and many cancers exhibit metabolic rewiring of pyruvate metabolism. It provides new insights into how the fate of pyruvate can be tuned to influence Drosophila biomass accrual, and how pyruvate pools can influence the balance between carbohydrate and protein biosynthesis. Strengths include its rigorous dissection of metabolic rewiring and use of Drosophila and mammalian cell systems to dissect carbohydrate:protein crosstalk.

      Weaknesses:

      However, questions on how these two pathways crosstalk, and how this interfaces with canonical Myc and mTORC machinery remain. There are also questions related to how this protein:carbohydrate crosstalk interfaces with lipid biosynthesis. Addressing these will increase the overall impact of the study.

      We thank the reviewer for recognizing the significance of our work and for providing constructive feedback. Our findings indicate that elevated pyruvate transport into mitochondria acts independently of canonical pathways, such as mTORC1 or Myc signaling, to regulate cell size. To investigate these pathways, we utilized immunofluorescence with well-validated surrogate measures (p-S6 and p-4EBP1) in clonal analyses of MPC expression, as well as RNA-seq analyses in whole fat body tissues expressing MPC. These methods revealed hyperactivation of mTORC1 and Myc signaling in fat body cells expressing MPC in Drosophila, which are dramatically smaller than control cells. One explanation of these seemingly contradictory observations could be an excess of nutrients that activate mTORC1 or Myc pathways. However, our data is inconsistent with a nutrient surplus that could explain this hyperactivation. Instead, we observed reduced amino acid abundance upon MPC expression, which is very surprising given the observed hyperactivation of mTORC1. This led us to hypothesize the existence of a feedback mechanism that senses inappropriate reductions in cell size and activates signaling pathways to promote cell growth. The best characterized “sizer” pathway for mammalian cells is the CycD/CDK4 complex which has been well studied in the context of cell size regulation of the cell cycle (PMID 10970848, 34022133). However, the mechanisms that sense cell size in post-mitotic cells, such as fat body cells and hepatocytes, remain poorly understood. Investigating the hypothesized size-sensing mechanisms at play here is a fascinating direction for future research.

      For the current study, we conducted epistatic analyses with mTOR pathway members by overexpressing PI3K and knocking down the TORC1 inhibitor Tuberous Sclerosis Complex 1 (Tsc1). These manipulations increased the size of control fat body cells but not those over-expressing the MPC (Supplementary Fig. 3c, 3d). Regarding Myc, its overexpression increased the size of both control and MPC+ clones (Supplementary Fig. 3e), but Myc knockdown had no additional effect on cell size in MPC+ clones (Supplementary Fig. 3f). These results suggest that neither mTORC1, PI3K, nor Myc are epistatic to the cell size effects of MPC expression. Consequently, we shifted our focus to metabolic mechanisms regulating biomass production and cell size.

      When analyzing cellular biomolecules contributing to biomass, we observed a significant impact on protein levels in Drosophila fat body cells and mammalian MPC-expressing HepG2 spheroids. TAG abundance in MPC-expressing HepG2 spheroids and whole fat body cells showed a statistically insignificant decrease compared to controls. Furthermore, lipid droplets in fat body cells were comparable in MPC-expressing clones when normalized to cell size.

      Interestingly, RNA-seq analysis revealed increased expression of fatty acid and cholesterol biosynthesis pathways in MPC-expressing fat body cells. Upregulated genes included major SREBP targets, such as ATPCL (2.08-fold), FASN1 (1.15-fold), FASN2 (1.07-fold), and ACC (1.26-fold). Since mTOR promotes SREBP activation and MPC-expressing cells showed elevated mTOR activity and upregulation of SREBP targets, we hypothesize that SREBP is activated in these cells. Nonetheless, our data on amino acid abundance and its impact on protein synthesis activity suggest that protein abundance, rather than lipids, is likely to play a larger causal role in regulating cell size in response to increased pyruvate transport into mitochondria.

      Reviewer #2 (Public review):

      In this manuscript, the authors leverage multiple cellular models including the drosophila fat body and cultured hepatocytes to investigate the metabolic programs governing cell size. By profiling gene programs in the larval fat body during the third instar stage - in which cells cease proliferation and initiate a period of cell growth - the authors uncover a coordinated downregulation of genes involved in mitochondrial pyruvate import and metabolism. Enforced expression of the mitochondrial pyruvate carrier restrains cell size, despite active signaling of mTORC1 and other pathways viewed as traditional determinants of cell size. Mechanistically, the authors find that mitochondrial pyruvate import restrains cell size by fueling gluconeogenesis through the combined action of pyruvate carboxylase and phosphoenolpyruvate carboxykinase. Pyruvate conversion to oxaloacetate and use as a gluconeogenic substrate restrains cell growth by siphoning oxaloacetate away from aspartate and other amino acid biosynthesis, revealing a tradeoff between gluconeogenesis and provision of amino acids required to sustain protein biosynthesis. Overall, this manuscript is extremely rigorous, with each point interrogated through a variety of genetic and pharmacologic assays. The major conceptual advance is uncovering the regulation of cell size as a consequence of compartmentalized metabolism, which is dominant even over traditional signaling inputs. The work has implications for understanding cell size control in cell types that engage in gluconeogenesis but more broadly raise the possibility that metabolic tradeoffs determine cell size control in a variety of contexts.

      We thank the reviewer for their thoughtful recognition of our efforts, and we are honored by the enthusiasm the reviewer expressed for the findings and the significance of our research. We share the reviewer’s opinion that our work might help to unravel metabolic mechanisms that regulate biomass gain independent of the well-known signaling pathways.

      Reviewer #3 (Public review):

      Summary:

      In this article, Toshniwal et al. investigate the role of pyruvate metabolism in controlling cell growth. They find that elevated expression of the mitochondrial pyruvate carrier (MPC) leads to decreased cell size in the Drosophila fat body, a transformed human hepatocyte cell line (HepG2), and primary rat hepatocytes. Using genetic approaches and metabolic assays, the authors find that elevated pyruvate import into cells with forced expression of MPC increases the cellular NADH/NAD+ ratio, which drives the production of oxaloacetate via pyruvate carboxylase. Genetic, pharmacological, and metabolic approaches suggest that oxaloacetate is used to support gluconeogenesis rather than amino acid synthesis in cells over-expressing MPC. The reduction in cellular amino acids impairs protein synthesis, leading to impaired cell growth.

      Strengths:

      This study shows that the metabolic program of a cell, and especially its NADH/NAD+ ratio, can play a dominant role in regulating cell growth.

      The combination of complementary approaches, ranging from Drosophila genetics to metabolic flux measurements in mammalian cells, strengthens the findings of the paper and shows a conservation of MPC effects across evolution.

      Weaknesses:

      In general, the strengths of this paper outweigh its weaknesses. However, some areas of inconsistency and rigor deserve further attention.

      Thank you for reviewing our manuscript and offering constructive feedback. We appreciate your recognition of the significance of our work and your acknowledgment of the compelling evidence we have presented. We will carefully revise the manuscript in line with the reviewers' recommendations.

      The authors comment that MPC overrides hormonal controls on gluconeogenesis and cell size (Discussion, paragraph 3). Such a claim cannot be made for mammalian experiments that are conducted with immortalized cell lines or primary hepatocytes.

      We appreciate the reviewer’s insightful comment. Pyruvate is a primary substrate for gluconeogenesis, and our findings suggest that increased pyruvate transport into mitochondria increases the NADH-to-NAD+ ratio, and thereby elevates gluconeogenesis. Notably, we did not observe any changes in the expression of key glucagon targets, such as PC, PEPCK2, and G6PC, suggesting that the glucagon response is not activated upon MPC expression. By the statement referenced by the reviewer, we intended to highlight that excess pyruvate import into mitochondria drives gluconeogenesis independently of hormonal and physiological regulation.

      It seems the reviewer might also have been expressing the sentiment that our in vitro models may not fully reflect the in vivo situation, and we completely agree.  Moving forward, we plan to perform similar analyses in mammalian models to test the in vivo relevance of this mechanism. For now, we will refine the language in the manuscript to clarify this point.

      Nuclear size looks to be decreased in fat body cells with elevated MPC levels, consistent with reduced endoreplication, a process that drives growth in these cells. However, acute, ex vivo EdU labeling and measures of tissue DNA content are equivalent in wild-type and MPC+ fat body cells. This is surprising - how do the authors interpret these apparently contradictory phenotypes?

      We thank the reviewer for raising this important issue. The size of the nucleus is regulated by DNA content and various factors, including the physical properties of DNA, chromatin condensation, the nuclear lamina, and other structural components (PMID 32997613). Additionally, cytoplasmic and cellular volume also impacts nuclear size, as extensively documented during development (PMID 17998401, PMID 32473090).

      In MPC-expressing cells, it is plausible that the reduced cellular volume impacts chromatin condensation or the nuclear lamina in a way that slightly decreases nuclear size without altering DNA content. Specifically, in our whole fat body experiments using CG-Gal4 (as shown in Supplementary Figure 2a-c), we noted that after 12 hours of MPC expression, cell size was significantly reduced (Supplementary Figure 2c and Author response image 1A). However, the reduction in nuclear size became significant only after 36 hours of MPC expression (Author response image 1B), suggesting that the reduction in cell size is a more acute response to MPC expression, followed only later by effects on nuclear size.

      In clonal analyses, this relationship was further clarified. MPC-expressing cells with a size greater than 1000 µm² displayed nuclear sizes comparable to control cells, whereas those with a drastic reduction in cell size (less than 1000 µm²) exhibited smaller nuclei (Author response image 1C and D). These observations collectively suggest that changes in nuclear size are more likely to be downstream rather than upstream of cell size reduction. Given that DNA content remains unaffected, we focused on investigating the rate of protein synthesis. Our findings suggest that protein synthesis might play a causal role in regulating cell size, thereby reinforcing the connection between cellular and nuclear size in this context.

      Author response image 1.

      Cell Size vs. Nuclear Size in MPC-Expressing Fat Body Cells. A. Cell size comparison between control (blue, ay-GFP) and MPC+ (red, ay-MPC) fat body cells over time, measured in hours after MPC expression induction. B. Nuclear area measurements from the same fat body cells in ay-GFP and ay-MPC groups. C. Scatter plot of nuclear area vs. cell area for control (ay-GFP) cells, including the corresponding R<sup>²</sup> value. D. Scatter plot of nuclear area vs. cell area for MPC-expressing (ay-MPC) cells, with the respective R<sup>²</sup> value.

      This image highlights the relationship between nuclear and cell size in MPC-expressing fat body cells, emphasizing the distinct cellular responses observed following MPC induction.

      In Figure 4d, oxygen consumption rates are measured in control cells and those over-expressing MPC. Values are normalized to protein levels, but protein is reduced in MPC+ cells. Is oxygen consumption changed by MPC expression on a per-cell basis?

      As described in the manuscript, MPC-expressing cells are smaller in size. In this context, we felt that it was most appropriate to normalize oxygen consumption rates (OCR) to cellular mass to enable an accurate interpretation of metabolic activity. Therefore, we normalized OCR with protein content to account for variations in cellular size and (probably) mitochondrial mass.

      Trehalose is the main circulating sugar in Drosophila and should be measured in addition to hemolymph glucose. Additionally, the units in Figure 4h should be related to hemolymph volume - it is not clear that they are.

      We appreciate this valuable suggestion. In the revised manuscript, we will quantify trehalose abundance in circulation and within fat bodies. As described in the Methods section, following the approach outlined in Ugrankar-Banerjee et al., 2023, we bled 10 larvae (either control or MPC-expressing) using forceps onto parafilm. From this, 2 microliters of hemolymph were collected for glucose measurement. We will apply this methodology to include the trehalose measurements as part of our updated analysis.

      Measurements of NADH/NAD ratios in conditions where these are manipulated genetically and pharmacologically (Figure 5) would strengthen the findings of the paper. Along the same lines, expression of manipulated genes - whether by RT-qPCR or Western blotting - would be helpful to assess the degree of knockdown/knockout in a cell population (for example, Got2 manipulations in Figures 6 and S8).

      We appreciate this suggestion, which will provide additional rigor to our study. We have already quantified NADH/NAD+ ratios in HepG2 cells under UK5099, NMN, and Asp supplementation, as presented in Figure 6k. As suggested, we will quantify the expression of Got2 manipulations mentioned in Figure 6j using RT-qPCR and validate the corresponding data in Supplementary Figure 8f through western blot analysis.

      Additionally, we will assess the efficiency of pcb, pdha, dlat, pepck2, and Got2 manipulations used to modulate the expression of these genes. These validations will ensure the robustness of our findings and strengthen the conclusions of our study.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This work makes several contributions: (1) a method for the self-supervised segmentation of cells in 3D microscopy images, (2) an cell-segmented dataset comprising six volumes from a mesoSPIM sample of a mouse brain, and (3) a napari plugin to apply and train the proposed method.

      First, thanks for acknowledging our contributions of a new tool, new dataset, and new software.

      (1) Method

      This work presents itself as a generalizable method contribution with a wide scope: self-supervised 3D cell segmentation in microscopy images. My main critique is that there is almost no evidence for the proposed method to have that wide of a scope. Instead, the paper is more akin to a case report that shows that a particular self-supervised method is good enough to segment cells in two datasets with specific properties.

      First, thanks for acknowledging our contributions of a new tool, new dataset, and new software. We agree we focus on lightsheet microscopy data, therefore to narrow the scope we have changed the title to “CellSeg3D: self-supervised 3D cell segmentation for light-sheet microscopy”.

      To support the claim that their method "address[es] the inherent complexity of quantifying cells in 3D volumes", the method should be evaluated in a comprehensive study including different kinds of light and electron microscopy images, different markers, and resolutions to cover the diversity of microscopy images that both title and abstract are alluding to.

      You have selectively dropped the last part of that sentence that is key: “.... 3D volumes, often in cleared neural tissue” – which is what we tackle. The next sentence goes on to say: “We offer a new 3D mesoSPIM dataset and show that CellSeg3D can match state-of-the-art supervised methods.” Thus, we literally make it clear our claims are on MesoSPIM and cleared data.

      The main dataset used here (a mesoSPIM dataset of a whole mouse brain) features well-isolated cells that are easily distinguishable from the background. Otsu thresholding followed by a connected component analysis already segments most of those cells correctly.

      This is not the case, as all the other leading methods we fairly benchmark cannot solve the task without deep learning (i.e., no method is at an F1-Score of 1).

      The proposed method relies on an intensity-based segmentation method (a soft version of a normalized cut) and has at least five free parameters (radius, intensity, and spatial sigma for SoftNCut, as well as a morphological closing radius, and a merge threshold for touching cells in the post-processing). Given the benefit of tweaking parameters (like thresholds, morphological operation radii, and expected object sizes), it would be illuminating to know how other non-learning-based methods will compare on this dataset, especially if given the same treatment of segmentation post-processing that the proposed method receives. After inspecting the WNet3D predictions (using the napari plugin) on the used datasets I find them almost identical to the raw intensity values, casting doubt as to whether the high segmentation accuracy is really due to the self-supervised learning or instead a function of the post-processing pipeline after thresholding.

      First, thanks for testing our tool, and glad it works for you. The deep learning methods we use cannot “solve” this dataset, and we also have a F1-Score (dice) of ~0.8 with our self-supervised method. We don’t see the value in applying non-learning methods; this is unnecessary and beyond the scope of this work.

      I suggest the following baselines be included to better understand how much of the segmentation accuracy is due to parameter tweaking on the considered datasets versus a novel method contribution:

      *  comparison to thresholding (with the same post-processing as the proposed method) * comparison to a normalized cut segmentation (with the same post-processing as the proposed method)

      *  comparison to references 8 and 9.

      Ref 8 and 9 don’t have readily usable (https://github.com/LiangHann/USAR) or even shared code (https://github.com/Kaiseem/AD-GAN), so re-implementing this work is well beyond the bounds of this paper. We benchmarked Cellpose, StartDist, SegResNets, and a transformer – SwinURNet. Moreover, models in the MONAI package can be used. Note, to our knowledge the transformer results also are a new contribution that the Reviewer does not acknowledge.

      I further strongly encourage the authors to discuss the limitations of their method. From what I understand, the proposed method works only on well-separated objects (due to the semantic segmentation bottleneck), is based on contrastive FG/BG intensity values (due to the SoftNCut loss), and requires tuning of a few parameters (which might be challenging if no ground-truth is available).

      We added text on limitations. Thanks for this suggestion.

      (2) Dataset

      I commend the authors for providing ground-truth labels for more than 2500 cells. I would appreciate it if the Methods section could mention how exactly the cells were labelled. I found a good overlap between the ground truth and Otsu thresholding of the intensity images. Was the ground truth generated by proofreading an initial automatic segmentation, or entirely done by hand? If the former, which method was used to generate the initial segmentation, and are there any concerns that the ground truth might be biased towards a given segmentation method?

      In the already submitted version, we have a 5-page DataSet card that fully answers your questions. They are ALL labeled by hand, without any semi-automatic process.

      In our main text we even stated “Using whole-brain data from mice we cropped small regions and human annotated in 3D 2,632 neurons that were endogenously labeled by TPH2-tdTomato” - clearly mentioning it is human-annotated.

      (3) Napari plugin

      The plugin is well-documented and works by following the installation instructions.

      Great, thanks for the positive feedback.

      However, I was not able to recreate the segmentations reported in the paper with the default settings for the pre-trained WNet3D: segments are generally too large and there are a lot of false positives. Both the prediction and the final instance segmentation also show substantial border artifacts, possibly due to a block-wise processing scheme.

      Your review here does not match your comments above; above you said it was working well, such that you doubt the GT is real and the data is too easy as it was perfectly easy to threshold with non-learning methods.

      You would need to share more details on what you tried. We suggest following our code; namely, we provide the full experimental code and processing for every figure, as was noted in our original submission: https://github.com/C-Achard/cellseg3d-figures.

      Reviewer #2 (Public Review):

      Summary:

      The authors propose a new method for self-supervised learning of 3d semantic segmentation for fluorescence microscopy. It is based on a WNet architecture (Encoder / Decoder using a UNet for each of these components) that reconstructs the image data after binarization in the bottleneck with a soft n-cuts clustering. They annotate a new dataset for nucleus segmentation in mesoSPIM imaging and train their model on this dataset. They create a napari plugin that provides access to this model and provides additional functionality for training of own models (both supervised and self-supervised), data labeling, and instance segmentation via post-processing of the semantic model predictions. This plugin also provides access to models trained on the contributed dataset in a supervised fashion.

      Strengths:

      (1) The idea behind the self-supervised learning loss is interesting.

      (2) The paper addresses an important challenge. Data annotation is very time-consuming for 3d microscopy data, so a self-supervised method that yields similar results to supervised segmentation would provide massive benefits.

      Thank you for highlighting the strengths of our work and new contributions.

      Weaknesses:

      The experiments presented by the authors do not adequately support the claims made in the paper. There are several shortcomings in the design of the experiment, presentation of the results, and reproducibility.

      We address your concerns and misunderstandings below.

      Major weaknesses:

      (1) The main experiments are conducted on the new mesoSPIM dataset, which contains quite small nuclei, much smaller than the pretraining datasets of CellPose and StarDist. I assume that this is one of the main reasons why these well-established methods don't work for this dataset.

      StarDist is not pretrained, we trained it from scratch as we did for WNet3D. We retrained Cellpose and reported the results both with their pretrained model and our best-retrained model. This is documented in Figure 1 and Suppl. Figure 1. We also want to push back and say that they both work very well on this data. In fact, our main claim is not that we beat them, it is that we can match them with a self-supervised method.

      Limiting method comparison to only this dataset may create a misleading impression that CellSeg3D is superior for all kinds of 3D nucleus segmentation tasks, whereas this might only hold for small nuclei.

      The GT dataset we labeled has nuclei that are normal brain-cell sized. Moreover in Figure 2 we show very different samples with both dense and noisy (c-FOS) labeling.

      We also clearly do not claim this is superior for all tasks, from our text: “First, we benchmark our methods against Cellpose and StarDist, two leading supervised cell segmentation packages with user-friendly workflows, and show our methods match or outperform them in 3D instance segmentation on mesoSPIM-acquired volumes" – we explicitly do NOT claim beyond the scope of the benchmark. Moreover we state: "We found that WNet3D could be as good or better than the fully supervised models, especially in the low data regime, on this dataset at semantic and instance segmentation" – again noting on this dataset. Again, we only claimed we can be as good as these methods with an unsupervised approach, and in the low-GT data regime we can excel.

      Further, additional preprocessing of the mesoSPIM images may improve results for StarDist and CellPose (see the first point in minor weaknesses). Note: having a method that works better for small nuclei would be an important contribution. But I doubt that the claims hold for larger and or more crowded nuclei as the current version of the paper implies.

      Figure 2 benchmarks our method on larger and denser nuclei, but we do not intend to claim this is a universal tool. It was specifically designed for light-sheet (brain) data, and we have adjusted the title to be more clear. But we also show in Figure 2 it works well on more dense and noisy samples, hinting that it could be a promising approach. But we agree, as-is, it’s unlikely to be good for extremely dense samples like in electron microscopy, which we never claim it would be.

      With regards to preprocessing, we respectfully disagree. We trained StarDist (and asked the main developer of StarDist, Martin Weigert, to check our work and he is acknowledged in the paper) and it does very well. Cellpose we also retrained and optimized and we show it works as-well-as leading transformer and CNN-based approaches. Again, we only claimed we can be as good as these methods with an unsupervised approach.

      The contribution of the paper would be much stronger if a **fair** comparison with StarDist / CellPose was also done on the additional datasets from Figure 2.

      We appreciate that more datasets would be ideal, but we always feel it’s best for the authors of tools to benchmark their own tools on data. We only compared others in Figure 1 to the new dataset we provide so people get a sense of the quality of the data too; there we did extensive searches for best parameters for those tools. So while we think it would be nice, we will leave it to those authors to be most fair. We also narrowed the scope of our claims to mesoSPIM data (added light-sheet to the title), which none of the other examples in Figure 2 are.

      (2) The experimental setup for the additional datasets seems to be unrealistic. In general, the description of these experiments is quite short and so the exact strategy is unclear from the text. However, you write the following: "The channel containing the foreground was then thresholded and the Voronoi-Otsu algorithm used to generate instance labels (for Platynereis data), with hyperparameters based on the Dice metric with the ground truth." I.e., the hyperparameters for the post-processing are found based on the ground truth. From the description it is unclear whether this is done a) on the part of the data that is then also used to compute metrics or b) on a separate validation split that is not used to compute metrics. If a) this is not a valid experimental setup and amounts to training on your test set. If b) this is ok from an experimental point of view, but likely still significantly overestimates the quality of predictions that can be achieved by manual tuning of these hyperparameters by a user that is not themselves a developer of this plugin or an absolute expert in classical image analysis, see also 3.

      We apologize for this confusion; we have now expanded the methods to clarify the setup is now b; you can see what we exactly did as well in the figure notebook: https://c-achard.github.io/cellseg3d-figures/fig2-b-c-extra-datasets/self-supervised-ext ra.html#threshold-predictions.

      For clarity, we additionally link each individual notebook now in the Methods.

      (3) I cannot reproduce any of the results using the plugin. I tried to reproduce some of the results from the paper qualitatively: First I downloaded one of the volumes from the mesoSPIM dataset (c5image) and applied the WNet3D to it. The prediction looks ok, however the value range is quite close (Average BG intensity ~0.4, FG intensity 0.6-0.7). I try to apply the instance segmentation using "Convert to instance labels" from "Utilities". Using "Voronoi-Otsu" does not work due to an error in pyClesperanto ("clGetPlatformIDs failed: PLATFORM_NOT_FOUND_KHR"). Segmentation via "Connected Components" and "Watershed" requires extensive manual tuning to get a somewhat decent result, which is still far from perfect.

      We are sorry to hear of the installation issue; pyClesperanto is a dependency that would be required to reproduce the images (sounds like you had this issue; https://forum.image.sc/t/pyclesperanto-prototype-doesnt-work/45724 ) We added to our docs now explicitly the fix:https://github.com/AdaptiveMotorControlLab/CellSeg3D/pull/90. We recommend checking the reproduction notebooks (which were linked in initial submission): https://c-achard.github.io/cellseg3d-figures/intro.html.

      Then I tried to reproduce the results for the Mouse Skull Nuclei Dataset from EmbedSeg. The results look like a denoised version of the input image, not a semantic segmentation. I was skeptical from the beginning that the method would transfer without retraining, due to the very different morphology of nuclei (much larger and elongated). None of the available segmentation methods yield a good result, the best I can achieve is a strong over-segmentation with watersheds.

      We are surprised to hear this; did you follow the following notebook which directly produces the steps to create this figure? (This was linked in preprint): https://c-achard.github.io/cellseg3d-figures/fig2-c-extra-datasets/self-supervised-extra .html

      We also expanded the methods to include the exact values from the notebook into the text.

      Minor weaknesses:

      (1) CellPose can work better if images are resized so that the median object size in new images matches the training data. For CellPose the cyto2 model should do this automatically. It would be important to report if this was done, and if not would be advisable to check if this can improve results.

      We reported this value in Figure 1 and found it to work poorly, that is why we retrained Cellpose and found good performance results (also reported in Figure 1). Resizing GB to TB volumes for mesoSPIM data is otherwise not practical, so simply retraining seems the preferable option, which is what we did.

      (2) It is a bit confusing that F1-Score and Dice Score are used interchangeably to evaluate results. The dice score only evaluates semantic predictions, whereas F1-Score evaluates the actual instance segmentation results. I would advise to only use F1-Score, which is the more appropriate metric. For Figure 1f either the mean F1 score over thresholds or F1 @ 0.5 could be reported. Furthermore, I would advise adopting the recommendations on metric reporting from https://www.nature.com/articles/s41592-023-01942-8.

      We are using the common metrics in the field for instance and semantic segmentation, and report them in the methods. In Figure 2f we actually report the “Dice” as defined in StarDist (as we stated in the Methods). Note, their implementation is functionally equivalent to F1-Score of an IoU >= 0, so we simply changed this label in the figure now for clarity. We agree this clarifies for the expert readers what was done, and we expanded the methods to be more clear about metrics.

      We added a link to the paper you mention as well.

      (3) A more conceptual limitation is that the (self-supervised) method is limited to intensity-based segmentation, and so will not be able to work for cases where structures cannot be distinguished based on intensity only. It is further unclear how well it can separate crowded nuclei. While some object separation can be achieved by morphological operations this is generally limited for crowded segmentation tasks and the main motivation behind the segmentation objective used in StarDist, CellPose, and other instance segmentation methods. This limitation is only superficially acknowledged in "Note that WNet3D uses brightness to detect objects [...]" but should be discussed in more depth. Note: this limitation does not mean at all that the underlying contribution is not significant, but I think it is important to address this in more detail so that potential users know where the method is applicable and where it isn't.

      We agree, and we added a new section specifically on limitations. Thanks for raising this good point. Thus, while self-supervision comes at the saving of hundreds of manual labor, it comes at the cost of more limited regimes it can work on. Hence why we don’t claim this should replace excellent methods like Cellpose or Stardist, but rather complement them and can be used on mesoSPIM samples, as we show here.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) One of the listed contributions is "adding the SoftNCuts loss". This is not true, reference 10 already introduced that loss.

      “Our changes include a conversion to a fully 3D architecture and adding the SoftNCuts loss” - we dropped the common and added the word “AND” to note that we added the 3D version of the SoftNCuts loss TO the 3D architecture, which 10 did not do.

      (2) "Typically, these methods use a multi-step approach" to segment 3D from 2D: this is only true for CellPose, StarDist does real 3D.

      That is why we preface with “typically” which implies not always.

      (3) "see Methods, Figure 1c, c)" is missing an opening in parentheses.

      (4) K is not introduced in equation (1) (presumably the number of classes, which seems to be 2 for all experiments considered).

      k actually was introduced just below equation 1 as the number of classes. We added the note that k was set to 2.

      (5) X is not introduced in equation (2) (presumably the spatial position of a voxel).

      Sorry for this oversight. We add that $X$ is the spatial position of the voxel.

      Reviewer #2 (Recommendations For The Authors):

      To improve the paper the weaknesses mentioned above should be addressed:

      (1) Compare to StarDist and/or CellPose on further datasets, esp. using pre-trained CellPose, to see if the claims of competitive performance with state-of-the-art approaches hold up for the case of different nucleus morphologies. The EmbedSeg datasets from Figure 2 c are well suited for this. In the current form, the claims are too broad and not supported if thorough experiments are performed on a single dataset with a very specific morphology. Note: even if the method is not fully competitive with CellPose / StarDist on these Datasets it holds merit since a segmentation method that works for small nuclei as in the mesoSPIM dataset and works self-supervised is very valuable.

      (2) Clarify how the best instance segmentation hyperparameters are found. If you indeed optimize these on the same part of the dataset used for evaluating metrics then the current experimental set-up is invalid. If this is not the case I would still rethink if this is a good way to report the results since it does not seem to reflect user experience. I found it not possible to find good hyperparameters for either of the two segmentation approaches I tried (see also next point) so I think these numbers are too optimistic.

      (3) Improve the instance segmentation part of the plugin: either provide troubleshooting for how to install pyClesperanto correctly to use the voronoi-based instance segmentation or implement it based on more standard functionality like skimage / scipy. Provide more guidance for finding good hyperparameters for the segmentation task.

      (4) Make sure image resizing is done correctly when using pre-trained CellPose models and report on this.

      (5) Report F1 Scores only (unless there is a compelling reason to also report Dice).

      (6) Address the limitations of the method in more detail.

      On a positive note: all data and code are available and easy to download/install. A minor comment: it would be very helpful to have line numbers for reviewing a revised version.

      All comments are also addressed in the public reviews.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study provides in vivo evidence for the synchronization of projection neurons in the olfactory bulb at gamma frequency in an activity-dependent manner. This study uses optogenetics in combination with single-cell recordings to selectively activate sensory input channels within the olfactory bulb. The data are thoughtfully analyzed and presented; the evidence is solid, although some of the conclusions are only partially supported.

      We deeply thank all the reviewers for their time, effort, and insightful comments. Their revision led to a significant improvement of the paper.

      The reviewers suggested toning down our claim that we found a mechanism that synchronizes all odor-evoked MTC activities, as we do not directly show that. We concur and address this in our revised version to ensure a precise interpretation of our findings. In short, we state that we revealed a synchronization mechanism between two groups of active mitral and tufted cells (MTCs) and show that this synchronization is activity-dependent and distance-independent. This mechanism can enable the synchronization of all odor-activated MTCs.

      Another issue raised is the interpretation of the results obtained under Ketamine anesthesia. Ketamine is an NMDA receptor antagonist that plays a crucial role in the  MTC-GC reciprocal synapse. To address this, we include new analyses demonstrating that optogenetic activation of granule cells (GCs) can inhibit the recorded MTCs during baseline activity but does not substantially affect odor-evoked MTC firing rates. We show that this is correct in both Ketamine-induced anesthesia and awake mice (Dalal & Haddad, 2022). This indicates that GC-MTC connections are functional even under Ketamine anesthesia, however, they do not exert substantial suppression on odor-evoked MTC responses. We added a paragraph to the discussion section on the potential influence of Ketamine anesthesia on GC-MTC synapses and its implications on our findings.

      Finally, we discuss several recent studies that are particularly relevant to our research and expand the discussion on our hypothesis that parvalbumin-positive cells in the olfactory bulb may serve as key mediators of the activity- and distance-dependent lateral inhibition observed in our findings.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Dalal and Haddad investigated how neurons in the olfactory bulb are synchronized in oscillatory rhythms at gamma frequency. Temporal coordination of action potentials fired by projection neurons can facilitate information transmission to downstream areas. In a previous paper (Dalal and Haddad 2022, https://doi.org/10.1016/j.celrep.2022.110693), the authors showed that gamma frequency synchronization of mitral/tufted cells (MTCs) in the olfactory bulb enhances the response in the piriform cortex. The present study builds on these findings and takes a closer look at how gamma synchronization is restricted to a specific subset of MTCs in the olfactory bulb. They combined odor and optogenetic stimulations in anesthetized mice with extracellular recordings.<br /> The main findings are that lateral synchronization of MTCs at gamma frequency is mediated by granule cells (GCs), independent of the spatial distance, and strongest for MTCs with firing rates close to 40 Hz. The authors conclude that this reveals a simple mechanism by which spatially distributed neurons can form a synchronized ensemble. In contrast to lateral synchronization, they found no evidence for the involvement of GCs in lateral inhibition of nearby MTCs.

      Strengths:

      Investigating the mechanisms of rhythmic synchronization in vivo is difficult because of experimental limitations for the readout and manipulation of neuronal populations at fast timescales. Using spatially patterned light stimulation of opsin-expressing neurons in combination with extracellular recordings is a nice approach. The paper provides evidence for an activity-dependent synchronization of MTCs in gamma frequency that is mediated by GCs.

      Weaknesses:

      An important weakness of the study is the lack of direct evidence for the main conclusion - the synchronization of MTCs in gamma frequency. The data shows that paired optogenetic stimulation of MTCs in different parts of the olfactory bulb increases the rhythmicity of individual MTCs (Figure 1) and that combined odor stimulation and GC stimulation increases rhythmicity and gamma phase locking of individual MTCs (Figure 4). However, a direct comparison of the firing of different MTCs is missing. This could be addressed with extracellular recordings at two different locations in the olfactory bulb. The minimum requirement to support this conclusion would be to show that the MTCs lock to the same phase of the gamma cycle. Also, showing the evoked gamma oscillations would help to interpret the data.

      We agree with the reviewer that direct evidence of mutual synchronization between multiple recorded MTCs has not been shown in our study. Our study only shows a mechanism that can enable this synchronization. We now state this clearly in the manuscript. We based this on previous studies that tested MTC spike synchronization. Specifically, Schoppa 2006, reported that electrical OSN stimulation evokes MTC spikes synchronization in the gamma range, in-vitro. Kashiwadni et al., 1999 and Doucette et al., 2011 showed that odor-evoked MTC spike times are synchronized, in-vivo. Given these studies, we asked what is the underlying mechanism that can support such a synchronization. Our study demonstrates that activating a group of MTCs can entrain another MTC in an activity-dependent and distance-independent manner. We claim this could be the underlying mechanism for the odor-evoked synchronization as demonstrated by these previous studies.

      To make sure this is clearly stated in the manuscript we changed the title to “Activity-dependent lateral inhibition enables the synchronization of active olfactory bulb projection neurons”, and rephrased a sentence in the abstract to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm”. To further clarify this point, we made several other changes throughout the results and the discussion section.

      Another weakness is that all experiments are performed under anesthesia with ketamine/medetomidine. Ketamine is an antagonist of NMDA receptors and NMDA receptors are critically involved in the interactions of MTCs and GCs at the reciprocal synapses (see for example Lage-Rupprecht et al. 2020, https://doi.org/10.7554/eLife.63737; Egger and Kuner 2021, https://doi.org/10.1007/s00441-020-03402-7). This should be considered for the interpretation of the presented data.

      This issue has been raised by reviewers #1 and #2. We think, as also reviewer #2 acknowledged, that this issue does not compromise our results. However, to address this important point we added the below section to the Discussion:

      “Our experiments were performed under Ketamine anesthesia, an NMDA receptor antagonist that affects the reciprocal dendro-dendritic synapses between MTCs and GCs (Egger and Kuner, 2021; Lage-Rupprecht et al., 2020). Consistent with that, recent studies reported lower excitability of GC activity under anesthesia (Cazakoff et al., 2014; Kato et al., 2012).  This raises the concern that our result might not be valid in the awake state. We argue that this is unlikely. First, (Fukunaga et al., 2014) reported that GCs baseline activity in anesthetized and awake mice is similar, suggesting that MTC-GC synapses are functioning. Second, we show that light activation of GCL neurons strongly inhibits the MTC baseline activity (Figure 5) and increases MTC odor-evoked spike-LFP coupling in the gamma range (Figure 4). These experiments validate that GCL neurons can exert inhibition over MTCs in our experimental setup. Third, we have shown that light-activating all accessible GCL neurons has a minor effect on the MTC odor-evoked firing rates in an awake state (Dalal and Haddad, 2022), corroborating the finding that GCL neurons are unlikely to provide strong suppression to MTCs. Fourth, and most importantly, we showed that optogenetic stimulation of MTCs entrains other MTC spike times, which is achieved via the GCL neurons. This suggests that the lack of lateral suppression following MTC or GCL neuron opto-activation is not due to MTC-GC synapse blockage. That said, we cannot exclude the unlikely possibility that NMDA receptor blockage under anesthesia impairs MTC-to-MTC suppressive interactions but not the MTC-to-MTC mediated spike entrainment.”

      Figure 1A and D from Dalal & Haddad 2022 show the effect of GCL neurons opto-activation during odor stimulation on MTC firing rates in awake and anesthetized mice.

      Furthermore, the direct effect of optogenetic stimulation on GCs activity is not shown. This is particularly important because they use Gad2-cre mice with virus injection in the olfactory bulb and expression might not be restricted to granule cells and might not target all subtypes of granule cells (Wachowiak et al., 2013, https://doi.org/10.1523/JNEUROSCI.4824-12.2013). This should be considered for the interpretation of the data, particularly for the absence of an effect of GC stimulation on lateral inhibition.

      In this study we used Gad2-cre mice, and the protocol for viral transfection of GCL neurons reported in Fukunaga et al., 2014. They reported that: ‘more than 90% of Cre-expressing neurons in the GCL also expressed fluorescently tagged ArchT’. Consistently, when Fukunaga et al. expressed ChR2 in the GCL using the same viral infection as we used, they reported that: ”Light presentation in vivo resulted in rapid and strong depolarization of, and action potential (AP) discharges in, GCs (Fig. 3b), which in

      turn consistently and strongly hyperpolarized M/TCs (9 of 9 cells showed 100% AP suppression; Fig. 3c,d)”. This study shows clearly that this infection protocol is robust. Moreover, in new panels we added to the manuscript (Figure 5a-b), we show that optogenetic activation of GCL neurons strongly suppressed MTC activity during baseline conditions but not odor-evoked responses MTCs. This is consistent with the reports by Fukunaga et al, and indicates that GCL neurons are functional as they can suppress MTC baseline activity.

      Finally, since virus injection to the granule cell layer can target other GCL neuron types, we changed the reference in the text to GCL neurons (as was done in Gschwend et al., 2015) instead of ‘GCs’ when referring to GC. We replaced the image in Figure 4A, to show the expression of ChR2 is restricted to GCL neurons. That said, it is still possible that our protocol did not infect all GC subtypes. To address this, we added this line to the Discussion: “We also note that our viral transfection protocol in Gad2-Cre mice might not transfect all subtypes of GCs”

      Several conclusions are only supported by data from example neurons. The paper would benefit from a more detailed description of the analysis and the display of some additional analysis at the population level:

      - What were the criteria based on which the spots for light-activation were chosen from the receptive field map?

      In order to make this point clearer, we extended the explanation in the Methods on the selection criteria: “Spots were selected either randomly or manually. In the manual selection case, we selected spots that caused either significant or mild but insignificant inhibitory effect on the recorded MTC (e.g., local cold spots in the receptive-field map; see example in Figure 2a of example spots that were selected manually)”. We also add a reference in the text to the Methods: “see Methods for spots selection criteria”.

      - The absence of an effect on firing rate for paired stimulations is only shown for one example (Figure 1c). A quantification of the population level would be interesting.

      - Only one example neuron is shown to support the conclusion that "two different neural circuits mediate suppression and entrainment" in Figure 3. A population analysis would provide more evidence.

      Thank you very much for these comments. We added a population analysis in Figure 3. This analysis shows a dissociation between firing rate suppression and the entrainment groups (Figure 3c-d). This suggests that two different circuits mediate suppression and entrainment.

      - Only one example neuron is shown to illustrate the effect of GC stimulation on gamma rhythmicity of MTCs in Figures 4 f,g.

      In this figure, we show that the activation of subsets of GCL neurons elevated odor-evoked spike synchronization to the gamma rhythm. We thought it would be beneficial to demonstrate the change in spike entrainment following GCL neurons optogenetic activation regardless of the ongoing OB gamma oscillations, using the method presented by Fukunaga et al., 2014. However, this analysis requires that the neuron has a relatively high firing rate. As we describe in the figure legend of this panel, this neuron is probably a tufted cell based on the findings shown in Fukunaga et al., 2014 and Burton & Urban, 2021. Most of our recorded cells had a lower firing rate, which coincides with our typical recording depth, targeting mitral cells rather than tufted cells (~400µm deep). Since this analysis is shown only over a single neuron, we moved it to Supplementary Figure 4.

      - In Figure 5 and the corresponding text, "proximal" and "distal" GC activation are not clearly defined.

      We agree. Initially, we used these terms to refer to GC columns that include the recorded MTC (proximal) and columns that are away from it (distal). We decided that instead of using a coarse division, we would show the whole range of distances. We updated the analysis in Figure 5d to show the effect of GC optogenetic activation on MTC odor-evoked responses as a function of the distance from the recorded MTC.

      Reviewer #2 (Public Review):

      Summary

      This study provides a detailed analysis and dissociation between two effects of activation of lateral inhibitory circuits in the olfactory bulb on ongoing single mitral/tufted cell (MTC) spiking activity, namely enhanced synchronization in the gamma frequency range or lateral inhibition of firing rate.

      The authors use a clever combination of single-cell recordings, optogenetics with variable spatial stimulation of MTCs and sensory stimulation in vivo, and established mathematical methods to describe changes in autocorrelation/synchronization of a single MTC's spiking activity upon activation of lateral glomerular MTC ensembles. This assay is rounded off by a gain-of-function experiment in which the authors enhance granule cell (GC) excitation to establish a causal relation between GC activation and enhanced synchronization to gamma (they had used this manipulation in their previous paper Dalal & Haddad 2022, but use a smaller illumination spot here for spatially restricted activation).

      Strengths

      This study is of high interest for olfactory processing - since it shows directly that interactions between only two selected active receptor channels are sufficient to enhance the synchronization of single neurons to gamma in one channel (and thus by inference most likely in both). These interactions are distance-independent over many 100s of µms and thus can allow for non-topographical inhibitory action across the bulb, in contrast to the center-surround lateral inhibition known from other sensory modalities.

      In my view, parallels between vision and olfaction might have been overemphasized so far, since the combinatorial encoding of olfactory stimuli across the glomerular map might require different mechanisms of lateral interaction versus vision. This result is indicative of such a major difference.

      Such enhanced local synchronization was observed in a subset of activated channel pairs; in addition, the authors report another type of lateral interaction that does involve the reduction of firing rates, drops off with distance and most likely is caused by a different circuit-mediated by PV+ neurons (PVN; the evidence for which is circumstantial).

      Weaknesses/Room for improvement

      Thus this study is an impressive proof of concept that however does not yet allow for broad generalization. Therefore the framing of results should be slightly more careful in my opinion.

      We agree with the reviewer. We copy here our response to reviewer #1, who raised the same issue.

      We agree that direct evidence of mutual synchronization between multiple recorded MTCs has not been shown in our study. Our study only shows a mechanism that can enable this synchronization. We now state this clearly in the manuscript. We relayed previous studies that tested MTC spike synchronization. Specifically, Schoppa 2006, reported that electrical OSN stimulation evokes MTC spikes synchronization in the gamma range, in-vitro. Kashiwadni et al., 1999 and Doucette et al., showed that odor-evoked MTC spike times are synchronized, in-vivo. Given these studies, we asked what is the underlying mechanism that can support such a synchronization. Our study demonstrates that activating a group of MTCs can entrain another MTC in an activity-dependent and distance-independent manner. We claim this could be the underlying mechanism for the odor-evoked synchronization as demonstrated by these previous studies.

      To make sure this is clearly stated in the manuscript we changed the title to “Activity-dependent lateral inhibition enables the synchronization of active olfactory bulb projection neurons”, and rephrased a sentence in the abstract to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm”. To further clarify this point, we made several other changes throughout the results and the discussion section.

      Along this line, the conclusions regarding two different circuits underlying lateral inhibition vs enhanced synchronization are not quite justified by the data, e.g.

      (1) The authors mention that their granule cell stimulation results in a local cold spot (l. 527 ff) - how can they then said to be not involved in the inhibition of firing rate (bullet point in Highlights)? Please elaborate further. In l.406 they also state that GCs can inhibit MTCs under certain conditions. The argument, that this stimulation is not physiological, makes sense, but still does not rule out anything. You might want to cite Aghvami et al 2022 on the very small amplitude of GC-mediated IPSPs, also McIntyre and Cleland 2015.

      We apologize for the lack of clarity. We reported that we found a local cold spot in the context of an additional experiment not presented in the manuscript and only described in the Methods section. Following the revision, we decided to add the analysis of this experiment to Figure 5. This experiment validated that optogenetic activation of GCs is potent and can affect the recorded MTC firing rates. This is particularly important as we performed all experiments under Ketamine anesthesia, which is a NMDA receptor antagonist. In this experiment, we recorded the activity of MTCs at baseline conditions (without odor presentation) under optogenetic activation of GCs. We divided the OB surface into a grid and optogenetically activated GC columns at a random order, one light spot in each trial, using light patches of size of size 330um2. We used the same light intensity as in the optogenetic GC activation during odor stimulation (reported in Figures 4-5). We show that the recorded MTC was strongly inhibited by GC light activation, mostly when activating GCs in its vicinity (within its column, i.e., local cold spot). This experiment validates that in our experimental setup, GCs can exert inhibition over MTCs at baseline conditions.

      (2) Even from the shown data, it appears that laterally increased synchronization might co-occur with lateral suppression (See also comment on Figures 1d,e and Figure S1c)

      We kindly note that the panels you referred to do not quantify the firing rate but the rhythmicity of MTC light-evoked responses. We should have explained these graphs better in the main text and not only in the Methods section. We added a panel to Supplementary Figure 1, which describes our analysis: In each of these examples, we performed a time-frequency Wavelet analysis over the average response of the neurons across trials (computed using a sliding Gaussian with a std of 2ms). The results of the Wavelet analysis allowed us to visually capture the enhanced spike alignment across trials under paired activation as a function of the stimulus duration (as, for example, in Figure 1c, middle panel). The response amplitude to light stimulation did not change in this example (shown in Figure 1c lower panel), and the spikes entrainment increased following paired activation of MTCs.

      To address the relations between lateral suppression and synchronization at the population level, we added additional analyses to Figure 3c-d.

      (3) There are no manipulations of PVN activity in this study, thus there is no direct evidence for the substrate of the second circuit.

      We completely agree with the reviewer. Using the current data, we can only claim that optogenetic activation of GCL neurons did not affect the MTC odor-evoked response. This finding is consistent with the loss-of-function experiment reported by Fukunaga et al., 2014, where GC suppression did not change odor-evoke responses in both anesthetized and awake mice. Therefore, we speculated that PVN might be a candidate OB interneuron to mediate lateral inhibition between MTCs. This hypothesis is based on their higher likelihood of interconnecting two MTCs compared with GCs (Burton, 2017). We elaborated on this in the discussion and made sure it is clearly stated as a hypothesis.

      (4) The manipulation of GC activity was performed in a transgenic line with viral transfection, which might result in a lower permeation of the population compared to the line used for optogenetic stimulation of MTCs.

      We used a previously validated protocol for optogenetic manipulation of GCs from Fukunaga et al., 2014 in order to minimize this caveat. As we cited previously from their paper, following the expression of ChR2 in the GCL, ‘Light presentation in vivo resulted in rapid and strong depolarization of, and action potential (AP) discharges in, GCs (Fig. 3b), which in turn consistently and strongly hyperpolarized M/TCs (9 of 9 cells showed 100% AP suppression; Fig. 3c,d)’. These results are consistent with the additional experiment we added to the manuscript, where optogenetic activation of GCL neurons strongly suppressed MTC activity during baseline conditions (without odor presentation). The high similarity between these two reports, in which, in the case of Fukunaga et al., GC activation was directly measured, suggests that lack of opsin expression or insufficient light intensity is unlikely to explain the lack of GCL neuron activation effect on lateral inhibition. Moreover, GCL neurons' optogenetic activation during odor stimulation increased MTC spike-LFP coupling in the gamma range. Therefore, the dissociation between the effects of GCL neurons on spike entrainment and lateral inhibition suggests that the lack of lateral inhibition following GC activation is unlikely due to low expression rates.

      In some instances, the authors tend to cite older literature - which was not yet aware of the prominent contribution of EPL neurons including PVN to recurrent and lateral inhibition of MT cells - as if roles that then were ascribed to granule cells for lack of better knowledge can still be unequivocally linked to granule cells now. For example, they should discuss Arevian et al (2006), Galan et al 2006, Giridhar et al., Yokoi et al. 1995, etc in the light of PVN action.

      Therefore it is also not quite justified to state that their result regarding the role of GCs specifically for synchronization, not suppression, is "in contrast to the field" (e.g. l.70 f.,, l.365, l. 400 ff).

      We changed several sentences in the discussion and introduction to explain that previous studies attributed lateral suppression to GC because they were not aware of the prominent contribution of EPL neurons as has been demonstrated by more recent studies (Burton 2024, Huang et al., 2016,  Kato et al., 2013, and more).

      We also toned down the statement that these findings are in contrast to the field. Instead, we state that our findings support the claim that GCs are not involved in affecting MTC odor-evoked firing rate.

      Why did the authors choose to use the term "lateral suppression", often interchangeably with lateral inhibition? If this term is intended to specifically reflect reductions of firing rates, it might be useful to clearly define it at first use (and cite earlier literature on it) and then use it consistently throughout.

      We agree and have changed the manuscript accordingly. We added the following in the introduction: “We use this phrase here to refer to a process that suppresses the firing rate of the post-synaptic neuron.”

      A discussion of anesthesia effects is missing - e.g. GC activity is known to be reportedly stronger in awake mice (Kato et al). This is not a contentious point at all since the authors themselves show that additional excitation of GCs enhances synchrony, but it should be mentioned.

      We completely agree and added a paragraph to the Discussion in this regard. Please see also the response to reviewer #1, who made a similar suggestion.

      Some citations should be added, in particular relevant recent preprints - e.g. Peace et al. BioRxiv 2024, Burton et al. BioRxiv 2024 and the direct evidence for a glutamate-dependent release of GABA from GCs (Lage-Rupprecht et al. 2020).

      We thank the reviewer for noting us these relevant recent manuscripts. We have now cited Peace et al., when discussing the spatial range of inhibition and gamma synchronization in the OB, Lage-Rupprecht et al in the context of the involvement of NMDA receptor in MTC-GC reciprocal synapse and Burton et al. when discussing PV neurons potential function.

      The introduction on the role of gamma oscillations in sensory systems (in particular vision) could be more elaborated.

      In our previous paper (Dalal & Haddad 2022) we had an elaborated introduction on the role of gamma oscillations in sensory processing, since we focused in this study in the effect of gamma synchronization on information transmission between brain regions. In the current study we looked at gamma rhythms as a mechanism that can facilitate ensemble synchronization.

      Reviewer #3 (Public Review):

      Summary:

      This study by Dalal and Haddad analyzes two facets of cooperative recruitment of M/TCs as discerned through direct, ChR2-mediated spot stimulations:

      (1) mutual inhibition and

      (2) entrainment of action potential timing within the gamma frequency range.

      This investigation is conducted by contrasting the evoked activity elicited by a "central" stimulus spot, which induces an excitatory response alone, with that elicited when paired with stimulations of surrounding areas. Additionally, the effect of Gad2-expressing granule cells is examined.

      Based on the observed distance dependence and the impact of GC stimulations, the authors infer that mutual inhibition and gamma entrainment are mediated by distinct mechanisms.

      Strengths:

      The results presented in this study offer a nice in vivo validation of the significant in vitro findings previously reported by Arevian, Kapoor, and Urban in 2008. Additionally, the distance-dependent analysis provides some mechanistic insights.

      We thank the reviewer for his comments. Indeed, the current study provides in-vivo replication of the results reported in Arevian et al., 2008 in-vitro, and adds further insights by showing that lateral inhibition is distant-dependent. However, this is not the main focus of the current study. Following the findings reported by Dalal & Haddad 2022, the motivation for this study was to test the mechanism that allows co-activated MTCs to entrain their spike timing. By light-activating pairs of MTCs at varying distances, we detected a subset of pairs in which paired light-activation evoked activity-dependent lateral inhibition, as was reported by Arevian et al., 2008. Moreover, we think it is highly important to know that a previous result in an in-vitro study is fully reproducible in-vivo.

      Weaknesses:

      The results largely reproduce previously reported findings, including those from the authors' own work, such as Dalal and Haddad (2022), where a key highlight was "Modulating GC activities dissociates MTCs odor-evoked gamma synchrony from firing rates." Some interpretations, particularly the claim regarding the distance independence of the entrainment effect, may be considered over-interpretations.

      We kindly disagree with the reviewer. We think the current study extends rather than reproduces the findings reported in Dalal & Haddad 2022. The 2022 study mainly focused on the effect of OB gamma synchronization on odor representation in the Piriform cortex. We bidirectionally modulated the level of MTC gamma synchronization and found that it had bidirectional effects on odor representation in one of their downstream targets, the anterior piriform cortex. The current study, however, focuses on the question of how spatially distributed odor-activated MTCs can synchronize their spiking activity. Our current main finding is that paired activation of MTCs can enhance the spikes entrainment of the recorded MTC in an activity-dependent and spatially independent manner. We suggest that this mechanism is mediated by GCL neurons.

      The reviewer did not explain why he\she thinks that the distance independence of the entrainment effects is an over-interpretation. However, to make our claim more precise we added the following sentence to the corresponding results section:” Furthermore, within the distance range that we were able to measure, the increased phase-locking did not significantly correlate with the distance from the MTC”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Minor comments:

      (1) Line 17f: "This lateral synchronization was particularly effective when both MTCs fired at the gamma rhythm, ..."

      This sentence implies a direct comparison of the simultaneously recorded firing of MTCs but I could not find evidence for this in this manuscript. I would suggest to change this.

      We thank the reviewer. The sentence was changed to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm”.

      (2) Line 43f: A brief description of what glomeruli are could help to avoid confusion for readers less familiar with the OB. The phrasing of "activated glomeruli" and "each glomerulus innervates" are somewhat misleading given that they do not contain the cell bodies of the projection neurons.

      We edited this part of the introduction so it briefly describes what glomeruli are: ‘Olfactory processing starts with the activity of odorant-activated olfactory sensory neurons. The axons of these sensory neurons terminate in one or two anatomical structures called glomeruli located on the surface of the olfactory bulb (OB). Each glomerulus is innervated by several mitral and tufted cells (MTCs), which then project the odor information to several cortical regions. ‘

      (3) Line 78ff: The text sounds as if glomeruli are activated by the light stimulation but ChR2 is expressed in MTCs, the postsynaptic component of the glomeruli. It would be clearer to refer to the stimulation as light activation of MTCs.

      We corrected this sentence to: ‘We first mapped each recorded cell's receptive field, i.e., the set of MTCs on the dorsal OB that affect its firing rates when they are light-stimulated.’

      (4) Line 90: It would be great to mention somewhere in this paragraph that you are analyzing single-unit data sorted from extracellular recordings with tungsten electrodes.

      We added that to the description of the experimental setup: ‘To investigate how MTCs interact, we expressed the light-gated channel rhodopsin (ChR2) exclusively in MTCs by crossing the Tbet-Cre and Ai32 mouse lines (Grobman et al., 2018; Haddad et al., 2013), and extracellularly recorded the spiking activity of MTCs in anesthetized mice during optogenetic stimulation using tungsten electrodes.’

      (5) Line 97: The term "delta entrainment" could be easily confused with the entrainment of MTCs to respiration in the delta frequency band. Maybe better to use a different term or stick to "change in entrainment" also used in the text.

      We completely agree. The term was changed to “change in entrainment” throughout the manuscript and figures.

      (6) Line 121f: "Light stimulation did not affect ..." . Should this be "Paired light stimulation did not affect ..."?

      Corrected, thank you.

      (7) Supplementary Figure 1a: The example is not very convincing. It looks a bit like a rhythmic bursting neuron mildly depending on the stimulation.

      This panel serves to present our light stimulation method. The potency of the light stimulation protocol can be seen in the receptive field maps.

      (8) Supplementary Figure 1c: Why is there no confidence interval for 'Paired'?

      This panel shows the power spectrum density of the average neuron response across trials computed over the entire stimulus window (100ms). We decided to remove this panel, as panel Figure 1d shows the evolution of the entrainment in time and, therefore, provides better insight into the effect.

      (9) Line 166f: "... across any light intensities". Maybe better "... for the four light intensities tested"?

      We agree, we changed the text in accordance.

      (10) Figure 2f: It would be more intuitive to have the x-axis in the same orientation as in 2e.

      Corrected, thank you.

      (11) Figure 4a: The image in this panel is identical to Figure 1a in Dalal and Haddad 2022 in Cell reports just with a different intensity. The reuse of items and data from previous publications should be indicated somewhere but I could not find it.

      We apologize for this replication. We replaced it with a photo showing a larger portion of the OB, demonstrating the restricted viral expression within the GCL.

      (12) Line 408ff: A brief explanation for the hypothesis of EPL parvalbumin interneurons as the ones mediating lateral inhibition would be great.

      We agree. We added the following paragraph to the discussion section: “We speculate that MTC-to-MTC suppression is mediated by EPL neurons, most likely the Parvalbumin neuron (PV). This hypothesis is based on their activity and connectivity properties with MTCs(Burton, 2017; Kato et al., 2013; Miyamichi et al., 2013; Burton, 2024). More studies are required to reveal how PV neurons affect MTC activity.”

      (13) Line 425ff: You show that only activity of high firing rate neurons is suppressed by lateral inhibition, whereas "low and noise MTC responses" are not affected. Wouldn't this rather support the conclusion that lateral inhibition prevents excess activity from the OB?

      We found lateral inhibition was mainly effective when the postsynaptic neurons fired at ~30-80Hz in response to light stimulation. That is, it affects MTC firing in this “intermediate” rate, and to a lesser extent when the MTC have low and very high firing rates. To prevent excess activity, one would expect a mechanism that affects more high firing rates than medium ones. This was demonstrated in Kato 2013 for PV-MTC inhibition

      (14) Line 387: "..., only ~20% of the tested MTC pairs exhibited significant lateral inhibition." This is higher than the 16% of neurons you reported to have lateral entrainment (line 100). Why do you consider the lateral inhibition as 'sparse' but the lateral entrainment as relevant?

      We apologize for this unclear statement. The papers we cited in this regard (Fantana et al., 2008; Lehmann et al., 2016; Pressler and Strowbridge, 2017) have tested lateral inhibition when the recorded MTC was not active, which resulted in a sparse MTC-MTC inhibition. We validated and replicated these findings in our setup, by systematically projecting light spots over the dorsal OB without simultaneous activation of the recorded MTC and found similar rates of largely scarce inhibition (data not shown). In this study, using spike-triggered average light stimulation protocol and paired activation of MTCs, we found higher rates of lateral inhibition, consistent with the reports by Isaacson and Strowbridge, 1998, Urban and Sakmann, 2002. We changed this paragraph to the following:

      “We found that in only ~20% of the tested MTC pairs exhibited significant lateral suppression. This rate is consistent with previous in-vitro studies that found lateral suppression between 10-20% of heterotypic MTC pairs (Isaacson and Strowbridge, 1998; Urban and Sakmann, 2002), and is higher compared to a case where the recorded MTC is not active (Lehmann et al., 2016).”

      Reviewer #2 (Recommendations For The Authors):

      Figure-by-figure comments:

      (1) Figures 1d,e: both these examples seem to show that the firing rate is decreased in the paired condition? From maxima at 110 to 58 Hz in d and 100 to 48 Hz in e. Please explain (see also comment on Figure S1c).

      Please see the response in the Public Review section, reviewer #2, bullet (2). We also added a panel to Supplementary Figure 1 to better explain this.

      (2) Figure 1 f The means and SEMs are hard to see. Why is the SEM bar plotted horizontally? Since this is a major finding of the paper, will there be a table provided that shows the distribution of ∆ shifts across animals?

      We apologize for the mistake. The horizontal bar was the marking of the mean. Since the SEM is small, we corrected the graph for better visualization of the SEM.

      (3) Figure 1g Showing the running average of data where there is almost none or no data points (beyond 50 Hz) seems not ideal. Is the enhanced entrainment around 40Hz significant? Perhaps the moving average should be replaced by binned data with indicated n?

      We prefer to show all data points instead of binning the data so the reader can see it all. We agree that such a wide range on the x-axis is unnecessary. We shorten this graph only to include the firing rate range in which the data points ranged.

      (4) Figure 1h Impressive result!

      Thank you!

      (5) Figure S1a: since the authors show the respiratory pattern here and there obviously was no alignment of light stimulation with inspiration, was there any correlation between the respiratory phase and efficiency of light stimulation with respect to lateral interactions?

      This is an interesting idea. In Haddad et al., 2013, figure 7, the authors performed a similar analysis, and showed that optogenetic activation of MTCs had a more pronounced effect on firing rate in the respiration phases where the neuron was less firing. However, we haven’t quantified the impact of lateral interactions with respect to the respiration phase. That being said, the data will be publicly available to test this question.

      (6) Figure S1c: Here the shift towards a lower firing rate seems to be obvious (see comment in Figures 1 d and e). Please also show the plot for Figure 1e.

      This panel shows the power spectrum density of the average neuron's response across trials computed over the entire stimulus window (100ms). We decided to remove this panel, as panel Figure 1d shows the evolution of the entrainment in time and, therefore, provides better insight into the effect.

      (7) Figure 2b: show the same plot also for pair 2? Why is it stated that there is no lateral suppression for lateral stimulation alone, if the MTC did not spike spontaneously in the first place and thus inhibition cannot be demonstrated?

      We use Figure 2b to demonstrate the effect of lateral inhibition, and in Figure 2c we detail the responses under each light intensity for both pairs. We think that showing the mean and SEM for one example is enough to give a sense of the effect, as in Figure 2c we show the average response across time together with significant assessment for each pair (panels without a p-value have no significant difference between the conditions).

      However, we agree with the comment on this specific example and therefore deleted this sentence. However, at the population level we found no inhibition when activating the lateral spots, regardless of their firing rates (shown in Supplementary Figure 2a).

      (8) Figure 2d: why is there no distance-dependent color coding for the significant data points? Or, alternatively, since the distance plot is shown in 2e, perhaps drop this information altogether? Again, the moving average is problematic.

      Distance-dependent color coding is applied to all data points in this panel. Significant data points are shown in full circles and have distance-dependent color coding, which is mainly restricted to the lower part of the distance scale (cold colors).

      We used a moving average to relate to the similar result reported in Arevian 2008.In Figure 2e, the actual distance for each data point is indicated on the x-axis.

      (9) Figure 2f: the diagonal averaging method seems to neglect a lot of the data in Figure S2b, why not use radial coordinates for averaging?

      Thank you for the great suggestion. We indeed performed radial coordinates for the averaging, and the results are more robust and better summarize the entire data.

      (10) Figure 3: These are interesting observations, but are there cumulative data on such types of pairs? Please describe and show, otherwise this can only be a supplemental observation. Regarding 3b was it always the lower light intensity that resulted in suppression and the higher in sync? Since Burton et al. 2024 have just shown that PVNs require very little input to fire!

      This figure shows several examples of entrainment and inhibition properties. As suggested, we added population analysis (Figure 3c-d). This analysis compares the firing rate changes in pairs that evoked significant suppression or entrainment. First, we found only a few pairs in which paired activation evoked both spikes entrainment and suppression. Second, the mean of firing rate changes of pairs that evoked significant entrainment (N=50, shown in Figure 1f in full circles) is significantly different from the mean of the pairs that evoked significant lateral inhibition (N=51, shown in Figure 2d in full circles).

      (11) Figure 4: This Figure and the corresponding section should be entitled "Additional GC activation... ", otherwise it might be confusing for the reader. A loss of function manipulation (local GC silencing) would be also great to have! You did this in the previous paper, why not here? Raw LFP data are not shown. In Figure 4e the reported odor response firing rate ranges only up to 40Hz, but the example in g shows a much higher frequency. Is the maximum in 4e significant? (same issue as for Figure 1g).

      We changed the phrase to ‘optogenetic GCL neurons activation’. Unfortunately, we haven’t performed experiments where we suppress GC columns. In the previous paper, we suppressed the activity of all accessible GCs, which resulted in reduced spike synchronization to the OB gamma oscillations. Silencing only the GC column is, we think, unlikely to have a substantial effect, especially if the GCs have low activity (but this needs to be tested). Furthermore, we added examples of raw LFP data for odor stimulation and odor combined with GCL column activation (see Supplementary Figure 4a).

      The instantaneous firing rate is high (~80Hz), however the firing rate values we report in Figure 4e is the average within a window of 2 seconds (the odor duration is 1.5 seconds and we extend the window to account for responses with late return to baseline). The average firing rate of this example neuron in this window was 28Hz.

      (12) Fig 5: what does "proximal" mean - does this mean stimulation of the GCs below the recorded MTC, that might actually belong to the same glomerular unit?

      Yes, by “proximal” we mean the activation of the GC in the column of the recorded MTC. However, we decided that instead of coarsely dividing the data into proximal and distal optogenetic activation of GCL neurons, we will show the data continuously to show that GC had no significant effect on MTC odor-evoked firing rates regardless of their location (Figure 5d).

      A comment on the title:

      Please tone it down: "Ensemble synchronization" is a hypothesis at this point, not directly shown in the paper. Also, the paper does not show lateral interactions between odor-activated neurons.

      We agree and have rephrased it to “Activity-dependent lateral inhibition enables the synchronization of active olfactory bulb projection neurons ”

      (1) Figure 1a, 2a scale bar missing.

      Corrected, thank you.

      (2) Figure 1 c is the "rebound" in the lateral stim trace (green) real or not significant?

      The activity during this rebound is not significantly different than the baseline activity before light stimulation.

      (3) Figure 2b legend: "lateral alone" instead of lateral?

      We appreciate the suggestion. For simplicity, we will keep it as “lateral”.

      (4) Figure 2c: some of the data plots seem to be breaking off, e.g. the blue line in the bottom third one.

      This line breaking is due to the lack of spikes in this period. The PSTHs used in all analyses result from the convolution of the spike train with a Gaussian window with a standard deviation of 50ms.

      (5) Figure 2f: Why is the x axis flopped vs 2d,e?

      This panel was mistakenly plotted that way, and was corrected.

      Comments on the text:

      Abstract - we had indicated suggestions by strike-throughs and color which are lost in the online submission system, please compare with your original text:

      Information in the brain is represented by the activity of neuronal ensembles. These ensembles are adaptive and dynamic, formed and truncated based on the animal`s experience. One mechanism by which spatially distributed neurons form an ensemble is via synchronization of their spiking activity in response to a sensory event. In the olfactory bulb, odor stimulation evokes rhythmic gamma activity in spatially distributed mitral and tufted cells (MTCs). This rhythmic activity is thought to enhance the relay of odor information to the downstream olfactory targets. However, how only specifically the odor-activated MTCs are synchronized is unknown. Here, we demonstrate that light optogenetic activation of activating one set of MTCs can gamma-entrain the spiking activity of another set. This lateral synchronization was particularly effective when both MTCs fired at the gamma rhythm, facilitating the synchronization of only the odor-activated MTCs. Furthermore, we show that lateral synchronization did not depend on the distance between the MTCs and is mediated by granule cells. In contrast, lateral inhibition between MTCs that reduced their firing rates was spatially restricted to adjacent MTCs and was not mediated by granule cells. Our findings reveal lead us to propose ? a simple yet robust mechanism by which spatially distributed neurons entrain each other's spiking activity to form an ensemble.

      Thank you. We adopted most of the changes and edited the abstract to reflect the reported results better.

      "both MTCs fired at the gamma rhythm"/this is at this point unwarranted since the mutual entrainment is not shown - tone down or present as hypothesis?

      We completely agree. This sentence was changed to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm, facilitating the synchronization of the active MTC”.

      l. 28: distance-independent instead of "spatially independent"?

      Corrected

      l. 46: are there inhibitory neurons in the ONL? Or which 6 layers are you referring to here?

      Corrected to “spanning all OB layers”.

      l. 49: "is mediated" => "likely to be mediated". Schoppa's work is in vitro and did not account for PVNs, see comment in Public Review.

      Corrected. Indeed Schoppa`s work was performed in-vitro. We cite it here since it showed that the synchronized firing of two MTC pairs depends on granule cells.

      l.52: "method"? rather "mechanism"? "specifically" instread of "only"?

      Corrected.

      l.52: perhaps more precise: a recent hypothesis is that GCs enable synchronization solely between odor-activated MTCs via an activity-dependent mechanism for GABA-release (Lage Rupprecht et al. 2020 - please cite the experimental paper here). Again. Galan has no direct evidence for GCs vs PVNs, see comment in Public Review.

      Thank you, we updated this sentence here and in the discussion and added the relevant citation.

      l. 66: spike timings instead of spike's timing?

      Corrected to spike timings

      l. 67 -71: this part could be dropped.

      We appreciate the suggestion; however, we think that it is convenient to briefly read the main results before the results section.

      l. 76 mouse instead of mice.

      Corrected.

      l. 77: for clarification: " a single MTC"?

      In some cases, we recorded more than one cell simultaneously.

      l. 89: just use "hotspot".

      Corrected

      l. 97 instead of "change", "positive change" or "increase"?

      We left the word change, since we wanted to report that the change between hotspot alone and paired stimulation was significantly higher than zero.

      l. 104: the postsyn MTC's firing rate.

      Corrected to MTC instead of MTCs

      l.108: "distributed on the OB surface" sounds misleading, perhaps "across the glomerular map"?

      Corrected.

      l. 254: "which the MTCs form with each other"- perhaps "which interconnect MTCs".

      Corrected.

      l. 270 Additional GC activation.

      Corrected to ‘optogenetic activation of GCL neurons’

      l. 284 somewhat unclear - please expand.

      Corrected to ‘This measure minimizes the bias of the neuron's firing rate on the spike-LFP synchrony value’.

      l. 371: no odors in Schoppa et al.

      Corrected to ‘It has been shown that two active MTCs can synchronize their stimulus-evoked and odor-evoked spike timings’

      l. 406 ff. good point - but where is the transition? How does this observation rule out that GCs can mediate lateral suppression?

      It is an important question. We tested two setups of GCs optogenetic activation, either column activation (in this paper) or the activation of all accessible GCs of the dorsal OB (Dalal & Haddad, 2022). Although the latter manipulation results in significant firing rate suppression, the effect of MTC suppression was relatively small in anesthetized mice and even smaller in awake mice. Optogenetically activating GCs at baseline conditions resulted in a strong suppression of only the adjacent MTCs. Taken together, we think that GCs are capable of strongly inhibit MTCs, but it is not their main function in natural olfactory sensation.

      l. 422 ff: again, this is a hypothesis, please frame accordingly.

      Corrected to ‘Activity-dependent synchronization can enables the synchronization of odor-activated MTCs that are dispersed across the glomerular map’

      l. 551 typo.

      Corrected.

      l 556 ff: Figure 2 does not show odor responses.

      Corrected.

      l 582: Mix up of above/below and low/high?

      Corrected to ‘The values in the STA map that were above or below these high and low percentile thresholds’

      Reviewer #3 (Recommendations For The Authors):

      Line 76: "Ai39" should be corrected to "Ai32".

      Corrected. Thank you.

      Figure Legends: The legends should describe the results rather than interpret the data. For instance, the legends for Figures 1f, g, and h contain interpretations. The authors should review all legends and revise them accordingly.

      We appreciate the comment. However, we kindly disagree. We don’t see these opening sentences as interpretations but as guidance to the reader. For example, ‘Paired stimulation increases spikes’ temporal precision’ is not an interpretation; instead, it describes the finding presented in this panel. We think that legends that only repeat what can already be deduced from the graph are not helpful and, in many cases, obsolete. Explaining what we think this graph shows is common, and we prefer it as it helps the reader.

      For Figures 1d and e, it may be beneficial to add the spectrograms for the second stimulation alone.

      We show the stimulation of the hotspot alone and when we stimulate both.<br /> The spectrogram of the lateral alone does not show anything of importance.

      Figures 1a and 2a: Please add color bars so that readers can understand the meaning of the colors plotted.

      Color bars were added.

      Figure 3: The purpose of this figure is unclear. Why does the baseline firing rate for the paired activation differ? Is this an isolated observation, or is it observed in other units as well?

      This issue has been raised also by reviewer #2. Attached here is our response to reviewer #2

      This figure shows several examples of entrainment and inhibition properties. As suggested, we added population analysis (Figure 3c-d). This analysis compares the firing rate changes in pairs that evoked significant suppression or entrainment. First, we found only a few pairs in which paired activation evoked both spikes entrainment and suppression. Second, the mean of firing rate changes of pairs that evoked significant entrainment (N=50, shown in Figure 1f in full circles) is significantly different from the mean of the pairs that evoked significant lateral inhibition (N=51, shown in Figure 2d in full circles).

      Figures 4 and 5 data seems to come from the same dataset as in Dalal and Haddad (2022) DOI: https://doi.org/10.1016/j.celrep.2022.110693. For example, the fluorescence image looks identical. If this is the case, the authors may want to state that that the image and and some of the data and analyses are reproduced.

      The recorded data shown in these figures are not reproduced from Dalal & Haddad 2022. We collected this data, using GC-columns activation instead of light activating the entire OB dorsal surface as was done in the 2022 paper.

      However, the histology image is the same and we now replaced it with a new image, which shows that the expression is restricted to the GCL.

      Figure 4d: the authors use the data plotted here to argue that the gamma entrainment is distance-independent. But there is a clear decrease over distance (e.g., delta PPC1 over 0.01 is not seen for distance beyond 1000 m). The claim of distance independence may be an over-interpretation of the data. Peace et al. (2024) also claimed that coupling via gamma oscillations occurs over a large spatial extent.

      From a statistical point of view, we can’t state that there is a dependency on distance as the correlation is insignificant (P = 0.86). PPC1 of value 0.01 can be found at 0, 500, and 700 microns. Lower values are found at far distances, but this can result from a smaller number of points. The reduced level of synchrony observed at distances above one mm could be the result of the reduced density of lateral interactions at these distances. That said, we rephrase the sentence to a more careful statement. Please see the rephrased sentence at the Public review section.

    1. Author response:

      We appreciate Reviewer 1’s observation that our findings (i.e., separable dynamic trajectories are systematically translated in response to whether outcomes are rewarded, and this translation is accumulated across trials) are consistent with a line attractor model. We agree with this assessment and, in the revised manuscript, will reframe our findings about the dynamic trajectories to address its consistency with a line attractor.

      However, we would like to emphasize that a line attractor model does not account for the dynamic nature of reversal probability activity observed in the neural data. Line attractor, regardless of whether it is curved or straight, implies that the activity is fixed when no reward information is presented. The focus of our work is to highlight this dynamic nature of reversal probability activity and its incompatibility with the line attractor model.

      This leads to the question of how we could reconcile the line attractor-like properties and the dynamic nature of reversal probability activity. In the revised manuscript, we will provide evidence for an augmented model that has an attractor state at the beginning of each trial, followed by dynamic activity during the trial. Such a model is an example of superposition of initial attractor states with fast within-trial dynamics, as pointed out by Reviewer 1.

      We also thank Reviewer 2 and Reviewer 3 for their comments on how the manuscript could be improved. In the revised manuscript, we will provide detailed explanations to clarify the choice of network model, data analysis methods and experiment and model setups.

      In addition, we would like to take this opportunity to point out potentially misleading statements in the reviews by Reviewer 2 and Reviewer 3. Reviewer 2 stated that “no action is required to be performed by neurons in the RNN, …, no intervening behavior is thus performed by neurons”. Reviewer 3 stated that “the RNN does not have to do any explicit computation during the non-feedback parts of the trial…”. These statements convey the message that the trained RNN does not perform any computation. In fact, the RNN is trained to make a choice during non-feedback period in response to feedback. This is the (and the only) computation RNN performs. “Intervening behavior” refers to the choice the RNN makes across trials until reversing its initially preferred choice. We think that this confusion might have happened because the meaning of the term “intervening behavior” was unclear. We will clarify this point in the revised manuscript.

      Again, thank you for the insightful comments. We will provide a more detailed response to the reviews and revise the manuscript accordingly.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors use high-throughput gene editing technology in larval zebrafish to address whether microexons play important roles in the development and functional output of larval circuits. They find that individual microexon deletions rarely impact behavior, brain morphology, or activity, and raise the possibility that behavioral dysregulation occurs only with more global loss of microexon splicing regulation. Other possibilities exist: perhaps microexon splicing is more critical for later stages of brain development, perhaps microexon splicing is more critical in mammals, or perhaps the behavioral phenotypes observed when microexon splicing is lost are associated with loss of splicing in only a few genes.

      A few questions remain:

      (1) What is the behavioral consequence for loss of srrm4 and/or loss-of-function mutations in other genes encoding microexon splicing machinery in zebrafish?

      It is established that srrm4 mutants have no overt morphological phenotypes and are not visually impaired (Ciampi et al., 2022).

      We chose not to generate and characterize the behavior and brain activity of srrm4 mutants for two reasons: 1) we were aware of two other labs in the zebrafish community that had generated srrm4 mutants (Ciampi et al., 2022 and Gupta et al., 2024, https://doi.org/10.1101/2024.11.29.626094; Lopez-Blanch et al., 2024, https://doi.org/10.1101/2024.10.23.619860), and 2) we were far more interested in determining the importance of individual microexons to protein function, rather than loss of the entire splicing program. Microexon inclusion can be controlled by different splicing regulators, such as srrm3 (Ciampi et al., 2022) and possibly other unknown factors. Genetic compensation in srrm4 mutants could also result in microexons still being included through actions of other splicing regulators, complicating the analysis of these regulators. We mention srrm4 in the manuscript to point out that some selected microexons are adjacent to regulatory elements expected of this pathway. We did not, however, choose microexons to mutate based on whether they were regulated by srrm4, making the characterization of srrm4 mutants disconnected from our overarching project goal.

      We are coordinating our publication with Lopez-Blanch et al. (https://doi.org/10.1101/2024.10.23.619860), which shows that srrm4 mutants also have minimal behavioral phenotypes.

      (2) What is the consequence of loss-of-function in microexon splicing genes on splicing of the genes studied (especially those for which phenotypes were observed).

      We acknowledge that unexpected changes to the mRNA could occur following microexon removal. In particular, all regulatory elements should be removed from the region surrounding the microexon, as any remaining elements could drive the inclusion of unexpected exons that result in premature stop codons.

      First, we will clarify our generated mutant alleles by adding a figure that details the location of the gRNA cut sites in relation to the microexon, its predicted regulatory elements, and its neighboring exons.

      Second, we will experimentally determine whether the mRNA was modified as expected for a subset of mutants with phenotypes.

      Third, we will further emphasize in the manuscript that these observed phenotypes are extremely mild compared to those observed in over one hundred protein-truncating mutations we have assessed in previous and ongoing work. We currently show one mutant, tcf7l2, which we consider to have strong neural phenotypes, and we will expand this comparison in the revision. In our study of 132 genes linked to schizophrenia (Thyme et al., 2019), we established a signal cut-off for whether a mutant would be designated as having a neural phenotype, and we classify this set of microexon mutants in this context. Far stronger phenotypes are expected of loss-of-function alleles for microexon-containing genes, as we showed in Figure S1 of this manuscript in addition to our published work.

      (3) For the microexons whose loss is associated with substantial behavioral, morphological, or activity changes, are the same changes observed in loss-of-function mutants for these genes?

      We had already included two explicit comparisons of microexon loss with a standard loss-of-function allele, one with a phenotype and one without, in Figure S1 of this manuscript. We will make the conclusions and data in this figure more obvious in the main text.

      Beyond the two pairs we had included, Lopez-Blanch et al. (https://doi.org/10.1101/2024.10.23.619860) describes mild behavioral phenotypes for a microexon removal for kif1b, and we already show developmental abnormalities for the kif1b loss-of-function allele (Figure S1).

      Additionally, we can draw expected conclusions from the literature, as some genes with our microexon mutations have been studied as typical mutants in zebrafish or mice. We will modify our manuscript to include a discussion of these mutants.

      (4) Do "microexon mutations" presented here result in the precise loss of those microexons from the mRNA sequence? E.g. are there other impacts on mRNA sequence or abundance?

      See response to point 2. We will experimentally determine whether the mRNA was modified as expected for a subset of mutants with phenotypes.

      (5) Microexons with a "canonical layout" (containing TGC / UC repeats) were selected based on the likelihood that they are regulated by srrm4. Are there other parallel pathways important for regulating the inclusion of microexons? Is it possible to speculate on whether they might be more important in zebrafish or in the case of early brain development?

      The microexons were not selected based on the likelihood that they were regulated by srrm4. We will clarify the manuscript regarding this point. There are parallel pathways that can control the inclusion of microexons, such as srrm3 (Ciampi et al., 2022). It is well-known that loss of srrm3 has stronger impacts on zebrafish development than srrm4 (Ciampi et al., 2022). The goal of our work was not to investigate these splicing regulators, but instead was to determine the individual importance of these highly conserved protein changes.

      Strengths:

      (1) The authors provide a qualitative analysis of splicing plasticity for microexons during early zebrafish development.

      (2) The authors provide comprehensive phenotyping of microexon mutants, addressing the role of individual microexons in the regulation of brain morphology, activity, and behavior.

      We thank the reviewer for their support. The pErk brain activity mapping method is highly sensitive, significantly minimizing the likelihood that the field has simply not looked hard enough for a neural phenotype in these microexon mutants. In our published work (Thyme et al., 2019), we show that brain activity can be drastically impacted without manifesting in differences in those behaviors assessed in a typical larval screen (e.g., tcf4, cnnm2, and more).

      Weaknesses:

      (1) It is difficult to interpret the largely negative findings reported in this paper without knowing how the loss of srrm4 affects brain activity, morphology, and behavior in zebrafish.

      See response to point 1.

      (2) The authors do not present experiments directly testing the effects of their mutations on RNA splicing/abundance.

      See response to point 3.

      (3) A comparison between loss-of-function phenotypes and loss-of-microexon splicing phenotypes could help interpret the findings from positive hits.

      See response to point 2.

      Reviewer #2 (Public review):

      Summary:

      The manuscript from Calhoun et al. uses a well-established screening protocol to investigate the functions of microexons in zebrafish neurodevelopment. Microexons have gained prominence recently due to their enriched expression in neural tissues and misregulation in autism spectrum disease. However, screening of microexon functionality has thus far been limited in scope. The authors address this lack of knowledge by establishing zebrafish microexon CRISPR deletion lines for 45 microexons chosen in genes likely to play a role in CNS development. Using their high throughput protocol to test larval behaviour, brain activity, and brain structure, a modest group of 9 deletion lines was revealed to have neurodevelopmental functions, including 2 previously known to be functionally important.

      Strengths:

      (1) This work advances the state of knowledge in the microexon field and represents a starting point for future detailed investigations of the function of 7 microexons.

      (2) The phenotypic analysis using high-throughput approaches is sound and provides invaluable data.

      We thank the reviewer for their support.

      Weaknesses:

      (1) There is not enough information on the exact nature of the deletion for each microexon.

      To clarify the nature of our mutant alleles, we will add a figure that details the location of the gRNA cut sites in relation to the microexon, its predicted regulatory elements, and its neighboring exons.

      (2) Only one deletion is phenotypically analysed, leaving space for the phenotype observed to be due to sequence modifications independent of the microexon itself.

      We will experimentally determine whether the mRNA is impacted in unanticipated ways for a subset of mutants with mild phenotypes (see the point 2 response to reviewer 1). We also have already compared the microexon removal to a loss-of-function mutant for two lines (Figure S1), and we will make that outcome more obvious as well as increasing the discussion of the expected phenotypes from typical loss-of-function mutants (see point 3 response to reviewer 1).

      In addition, our findings for three microexon mutants (ap1g1, vav2, and vti1a) are corroborated by Lopez-Blanch et al. (https://doi.org/10.1101/2024.10.23.619860).

      Unlike protein-coding truncations, clean removal of the microexon and its regulatory elements is unlikely to yield different phenotypic outcomes if independent lines are generated (with the exception of genetic background effects). When generating a protein-truncating allele, the premature stop codon can have different locations and a varied impact on genetic compensation. In previous work (Capps et al., 2024), we have observed different amounts of nonsense-mediated decay-induced genetic compensation (El-Brolosy, et al., 2019) depending on the location of the mutation. As they lack variable premature stop codons (the expectation of a clean removal), two mutants for the same microexons should have equivalent impacts on the mRNA.

      Reviewer #3 (Public review):

      Summary:

      This paper sought to understand how microexons influence early brain function. By selectively deleting a large number of conserved microexons and then phenotyping the mutants with behavior and brain activity assays, the authors find that most microexons have minimal effects on the global brain activity and broad behaviors of the larval fish-- although a few do have phenotypes.

      Strengths:

      The work takes full advantage of the scale that is afforded in zebrafish, generating a large mutant collection that is missing microexons and systematically phenotyping them with high throughput behaviour and brain activity assays. The work lays an important foundation for future studies that seek to uncover the likely subtle roles that single microexons will play in shaping development and behavior.

      We thank the reviewer for their support.

      Weaknesses:

      The work does not make it clear enough what deleting the microexon means, i.e. is it a clean removal of the microexon only, or are large pieces of the intron being removed as well-- and if so how much? Similarly, for the microexon deletions that do yield phenotypes, it will be important to demonstrate that the full-length transcript levels are unaffected by the deletion. For example, deleting the microexon might have unexpected effects on splicing or expression levels of the rest of the transcript that are the actual cause of some of these phenotypes.

      To clarify the nature of our mutant alleles, we will add a figure that details the location of the gRNA cut sites in relation to the microexon, its predicted regulatory elements, and its neighboring exons.

      We will experimentally determine whether the mRNA is impacted in unanticipated ways for a subset of mutants with mild phenotypes (see the point 2 response to reviewer 1).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Previous studies have shown that treatment with 17α-estradiol (a stereoisomer of the 17β-estradiol) extends lifespan in male mice but not in females. The current study by Li et al, aimed to identify cell-specific clusters and populations in the hypothalamus of aged male rats treated with 17α-estradiol (treated for 6 months). This study identifies genes and pathways affected by 17α-estradiol in the aged hypothalamus.

      Strengths:

      Using single-nucleus transcriptomic sequencing (snRNA-seq) on the hypothalamus from aged male rats treated with 17α-estradiol they show that 17α-estradiol significantly attenuated age-related increases in cellular metabolism, stress, and decreased synaptic activity in neurons.

      Thanks.

      Moreover, sc-analysis identified GnRH as one of the key mediators of 17α-estradiol's effects on energy homeostasis. Furthermore, they show that CRH neurons exhibited a senescent phenotype, suggesting a potential side effect of the 17α-estradiol. These conclusions are supported by supervised clustering by neuropeptides, hormones, and their receptors.

      Thanks.

      Weaknesses:

      However, the study has several limitations that reduce the strength of the key claims in the manuscript. In particular:

      (1) The study focused only on males and did not include comparisons with females. However, previous studies have shown that 17α-estradiol extends lifespan in a sex-specific manner in mice, affecting males but not females. Without the comparison with the female data, it's difficult to assess its relevance to the lifespan.

      This study was originally designed based on previous findings indicating that lifespan extension is only effective in males, leading to the exclusion of females from the analysis. The primary focus of our research was on the transcriptional changes and serum endocrine alterations induced by 17α-estradiol in aged males compared to untreated aged males. We believe that even in the absence of female subjects, the significant effects of 17α-estradiol on metabolism in the hypothalamus, synapses, and endocrine system remain evident, particularly regarding the expression levels of GnRH and testosterone. Notably, lower overall metabolism, increased synaptic activity, and elevated levels of GnRH and testosterone are strong indicators of health and well-being in males, supporting the validity of our primary conclusions. However, including female controls would enhance the depth of our findings. If female controls were incorporated, we propose redesigning the sample groups to include aged male control, aged female control, aged female treated, aged male treated, as well as young male control, young male treated, young female control, and young female treated. We regret that we cannot provide this data in the short term. Nevertheless, we believe this presents a valuable avenue for future research on this topic. In this study, we emphasize the role of 17α-estradiol in overall metabolism, synaptic function, GnRH, and testosterone in aged males and underscore the importance of supervised clustering of neuropeptide-secreting neurons in the hypothalamus.

      (2) It is not known whether 17α-estradiol leads to lifespan extension in male rats similar to male mice. Therefore, it is not possible to conclude that the observed effects in the hypothalamus, are linked to the lifespan extension.

      Thanks for the reminding. 17α-estradiol was reported to extend lifespan in male rats similar to male mice (PMID: 33289482). We have added the valuable reference to introduction in the new version.  

      (3) The effect of 17α-estradiol on non-neuronal cells such as microglia and astrocytes is not well-described (Figure 1). Previous studies demonstrated that 17α-estradiol reduces microgliosis and astrogliosis in the hypothalamus of aged male mice. Current data suggest that the proportion of oligo, and microglia were increased by the drug treatment, while the proportions of astrocytes were decreased. These data might suggest possible species differences, differences in the treatment regimen, or differences in drug efficiency. This has to be discussed.

      We have reviewed reports describing changes in cell numbers following 17α-estradiol treatment in the brain, using the keywords "17α-estradiol," "17alpha-estradiol," and "microglia" or "astrocyte." Only a limited amount of data was obtained. We found one article indicating that 17α-estradiol treatment in Tg (AβPP(swe)/PS1(ΔE9)) model mice resulted in a decreased microglial cell number compared to the placebo (AβPP(swe)/PS1(ΔE9) mice), but this change was not significant when compared to the non-transgenic control (PMID: 21157032). The transgenic AβPP(swe)/PS1(ΔE9) mouse model may differ from our wild-type aging rat model in this context.

      Moreover, the calculation of cell numbers was based on visual observation under a microscope across several brain tissue slices. This traditional method often yields controversial results. For example, oligodendrocytes in the corpus callosum, fornix, and spinal cord have been reported to be 20-40% more numerous in males than in females based on microscopic observations (PMID: 16452667). In contrast, another study found no significant difference in the number of oligodendrocytes between sexes when using immunohistochemistry staining (PMID: 18709647). Such discrepancies arising from traditional observational methods are inevitable.

      We believe the data presented in this article are reliable because the cell number and cell ratio data were derived from high-throughput cell counting of the entire hypothalamus using single-cell suspension and droplet wrapping (10x Genomics).

      (4) A more detailed analysis of glial cell types within the hypothalamus in response to drugs should be provided.

      We provided more enrichment analysis data of differentially expressed genes between Y, O, and O.T in microglia and astrocytes in Figure 2—figure supplement 3. In this supplemental data, we found unlike that in neurons, Micro displayed lower levels of synapse-related cellular processes in O.T. compared to O.

      (5) The conclusion that CRH neurons are going into senescence is not clearly supported by the data. A more detailed analysis of the hypothalamus such as histological examination to assess cellular senescence markers in CRH neurons, is needed to support this claim.

      We also noticed the inappropriate claim and we have changed "senescent phenotype" to "stressed phenotype" and "abnormal phenotype" in abstract and in results.

      Reviewer #2 (Public Review):

      Summary:

      Li et al. investigated the potential anti-ageing role of 17α-Estradiol on the hypothalamus of aged rats. To achieve this, they employed a very sophisticated method for single-cell genomic analysis that allowed them to analyze effects on various groups of neurons and non-neuronal cells. They were able to sub-categorize neurons according to their capacity to produce specific neurotransmitters, receptors, or hormones. They found that 17α-Estradiol treatment led to an improvement in several factors related to metabolism and synaptic transmission by bringing the expression levels of many of the genes of these pathways closer or to the same levels as those of young rats, reversing the ageing effect. Interestingly, among all neuronal groups, the proportion of Oxytocin-expressing neurons seems to be the one most significantly changing after treatment with 17α-Estradiol, suggesting an important role of these neurons in mediating its anti-ageing effects. This was also supported by an increase in circulating levels of oxytocin. It was also found that gene expression of corticotropin-releasing hormone neurons was significantly impacted by 17α-Estradiol even though it was not different between aged and young rats, suggesting that these neurons could be responsible for side effects related to this treatment. This article revealed some potential targets that should be further investigated in future studies regarding the role of 17α-Estradiol treatment in aged males.

      Strengths:

      (1) Single-nucleus mRNA sequencing is a very powerful method for gene expression analysis and clustering. The supervised clustering of neurons was very helpful in revealing otherwise invisible differences between neuronal groups and helped identify specific neuronal populations as targets.

      Thanks.

      (2) There is a variety of functions used that allow the differential analysis of a very complex type of data. This led to a better comparison between the different groups on many levels.

      Thanks.

      (3) There were some physiological parameters measured such as circulating hormone levels that helped the interpretation of the effects of the changes in hypothalamic gene expression.

      Thanks.

      Weaknesses

      (1) One main control group is missing from the study, the young males treated with 17α-Estradiol.

      Given that the treatment period lasts six months, which extends beyond the young male rats' age range, we aimed to investigate the perturbation of 17α-Estradiol on the normal aging process. Including data from young males could potentially obscure the treatment's effects in aged males due to age effects, though similar effects between young and aged animals may exist. Long-term treatment of hormone may exert more developmental effects on the young than the old. Consequently, we decided to exclude this group from our initial sample design. We apologize for this omission.

      (2) Even though the technical approach is a sophisticated one, analyzing the whole rat hypothalamus instead of specific nuclei or subregions makes the study weaker.

      The precise targets of 17α-Estradiol within the hypothalamus remain unresolved. Selecting a specific nucleus for study is challenging. The supervised clustering method described in this manuscript allows us to identify the more sensitive neuron subtypes influenced by 17α-Estradiol and aging across the entire hypothalamus, without the need to isolate specific nuclei in a disturbed hypothalamic environment.

      (3) Although the authors claim to have several findings, the data fail to support these claims. You may mean the claim as the senescent phenotype in Crh neuron induced by 17a-estradiol.

      Thanks. We have changed the "senescent phenotype" to "stressed phenotype"  or "abnormal phenotype" in the abstract and results to avoid such claim.

      (4) The study is about improving ageing but no physiological data from the study demonstrated such a claim with the exception of the testes histology which was not properly analyzed and was not even significantly different between the groups.

      The primary objective of this study is to elucidate the effects of 17α-Estradiol on the endocrine system in the aging hypothalamus; exploring anti-aging effects is not the main focus. From the characteristics of the aging hypothalamus, we know that down-regulated GnRH and testosterone levels, along with elevated mTOR signaling, are indicators of aging in these organs (PMID: 37886966, PMID: 37048056, PMID: 22884327). The contrasting signaling networks related to metabolism and synaptic processes significantly differentiate young and aging hypothalami, and 17α-Estradiol helps rebalance these networks, suggesting its potential anti-aging effects.

      (5) Overall, the study remains descriptive with no physiological data to demonstrate that any of the effects on hypothalamic gene expression are related to metabolic, synaptic, or other functions.

      The study focuses on investigating cellular responses and endocrine changes in the aging hypothalamus induced by 17α-estradiol, utilizing single-nucleus RNA sequencing (snRNA-seq) and a novel data mining methodology to analyze various neuron subtypes. It is important to note that this study does not mainly aim to explore the anti-aging effects. Consequently, we have revised the claim in the abstract from “the effects of 17α-estradiol in anti-aging in neurons” to “the effects of 17α-estradiol on aging neurons.” We observed that the lower overall metabolism and increased expression levels of cellular processes in the synapses align with findings previously reported regarding 17α-estradiol. To address the lack of physiological data and the challenges in measuring multiple endocrine factors due to their volatile nature, we employed several bidirectional Mendelian analyses of various genome-wide association study (GWAS) data related to these serum endocrine factors to identify their mutual causal effects.

      Reviewing Editor Comment:

      Based on the Public Reviews and Recommendations for Authors, the Reviewers strongly recommend that revisions include an experimental demonstration of the physiological effects of the treatment on ageing in rats as well as the CRH-senescence link. Additional analysis of the glia would greatly strengthen the study, as would inclusion of females and young male controls. The important point was also raised that the work linking 17a-estradiol was performed in mice, and the link with lifespan in rats is not known. Discussion of this point is recommended.

      We acknowledge that 17α-estradiol has been reported to extend lifespan in male rats, similar to findings in male mice (PMID: 33289482), and we have noted this in the Introduction. We apologize for not conducting further experiments to validate this point.

      Additionally, we have revised the description of the phenotype of senescent CRH neurons to “stressed phenotype” without carrying out further experiments to confirm the senescent phenotype. To provide more clarity on the performance of glial cells during treatment, we have included additional enrichment analysis data of differentially expressed genes among young (Y), old (O), and old treated (O.T) microglia and astrocytes in Figure 2—figure supplement 3. Notably, the behavior of microglia contrasts with that of total neurons concerning synapse-related cellular processes. We apologize for being unable to include female and young controls in this study.

      Reviewer #2 (Recommendations For The Authors)

      General comments:

      (1) The manuscript is very hard to read. Proofreading and editing by software or a professional seems necessary. The words "enhanced", "extensive" etc. are not always used in the right way.

      Thanks for the suggestion. We have revised the proofreading and editing. The words "enhanced" and "extensive" were also revised in most sentences.

      (2) The numbers of animals and samples are not well explained. Is it 9 rats overall or per group? If there are 8 testes samples per group, should we assume that there were 4 rats per group? The pooling of the hypothalamic how was it done? Were all the hypothalamic from each group pooled together? A small table with the animals per group and the samples would help.

      We appreciate your reminder regarding the initial mistake in our manuscript preparation. In the preliminary submission, we reported 9 rats based solely on sequencing data and data mining. The revised version (v1) now includes additional experimental data, with an effective total of 12 animals (4 per group). Unfortunately, we overlooked updating this information in the v1 submission. We have since added detailed information in the Materials and Methods sections: Animals, Treatment and Tissues, and snRNA-seq Data Processing, Batch Effect Correction, and Cell Subset Annotation.

      (3) The Clustering is wrong. There are genes in there that do not fall into any of the 3 categories: Neurotransmitters, Receptors, Hormones.

      We have changed the description to “Vast majority of these subtypes were clustered by neuropeptides, hormones, and their receptors within all the neurons”.

      (4) The coloring of groups in the graphs is inconsistent. It must be more homogeneous to make it easier to identify.

      We have changed the colors of groups in Fig. 1D to make the color of cell clusters consistent in Fig. 1A-D.

      (5) The groups c1-c4 are not well explained. How did the authors come up with these?

      We have added more descriptions of c1-c4 in materials and methods in the new version.

      (6) In most cases it's not clear if the authors are talking about cell numbers that express a certain mRNA, the level of expression of a certain mRNA, or both. They need to do a better job using more precise descriptions instead of using general terms such as "signatures", "expression profiles", "affected neurons" etc. It is very hard to understand if the number of neurons is compared between the groups or the gene expression.

      We have changed the "signatures" to "gene signatures" to make it more accurate in meaning. The "affected neurons" were also changed to "sensitive neurons". But sorry that we were not able to find better alternatives to the "expression profiles".

      (7) Sometimes there are claims made without justification or a reference. For example, the claim about the senescence of CRH neurons due to the upregulation of mitochondrial genes and downregulation of adherence junction genes (lines 326-328) should be supported by a reference or own findings.

      The "senescence" here is not appropriate. We have changed it to "stressed phenotype" or "aberrant changes" in abstract and results.

      (8) Young males treated with Estradiol as a control group is necessary and it is missing.

      Your suggestion is appreciated; however, the treatment duration for aged mice (O.T) was set at 6 months, while the young mice were only 4 months old. This disparity makes it challenging to align treatment timelines for the young animals. The primary aim of this study is to investigate the perturbation of 17α-estradiol on the aging process, and any distinct effects due to age effect observed in young males might complicate our understanding of its role in aged males, though similar endocrine effects may exist in the young animals. Long-term treatment of hormone may exert more developmental effects on the young than the old. Therefore, we made the decision to exclude the young samples in our initial study design. We apologize for any confusion this may have caused.

      Specific Comments:

      Line 28: "elevated stresses and decreased synaptic activity": Please make this clearer. Can't claim changes in synaptic activity by gene expression.

      We have changed it to "the expression level of pathways involved in synapse".

      Line 32: "increased Oxytocin": serum Oxytocin.

      We have added the “serum”.

      Line 52 - 54: Any studies from rats?

      Thanks. In rats there is also reported that 17α-estradiol has similar metabolic roles as that in mice (PMID: 33289482) and we have added it to the refences. It’s very useful for this manuscript.

      Line 62 - 65: It wasn't investigated thoroughly in this paper so why was it suggested in the introduction?

      We have deleted this sentence as being suggested.

      Line 70: "synaptic activity" Same as line 28.

      We have changed it to "pathways involved in synaptic activity".

      Line 79: Why were aged rats caged alone and young by two? Could that introduce hypothalamic gene expression effects?

      The young males were bred together in peace. But the aged males will fight and should be kept alone.

      Lines 78, 99, 109-110: It is not clear how many animals per group were used and how many samples per group were used separately and/or grouped. Please be more specific.

      We have added these information to Materials and methods/Animals, treatment and tissues and Materials and methods/snRNA-seq data processing, batch effect correction, and cell subset annotation.

      Line 205: "in O" please add "versus young.".

      We have changed accordingly.

      Line 207: replace "were" with "was" .

      We have alternatively changed the "proportion" to "proportions".

      Line 208: replace "that" with "compared to" and after "in O.T." add "compared to?"

      We have changed accordingly.

      Line 223: "O.T." compared to what? Figure?

      We have changed it accordingly.

      Line 227: Figure?

      We have added (Figure 1E) accordingly.

      Line 229: "synaptic activity" Same as line 28.

      We have revised it.

      Line 235: "synaptic activity" and "neuropeptide secretion" Same as line 28.

      We have revised it.

      Line 256:" interfered" please revise.

      We changed to "exerted".

      Line 263: "on the contrary" please revise.

      We have changed "on the contrary" to "opposite".

      Line 270: "conversed" did you mean "conserved"?

      We have changed "conversed" to "inversed".

      Line 296-298: Please explain. Why would these be side effects?

      It’s hard to explain, therefore, we deleted the words "side effects".

      Line 308: "synaptic activity" Same as line 28.

      We have changed it to "expression levels of synapse-related cellular processes".

      Line 314: "and sex hormone secretion and signaling"Isn't this expected?

      Yes, it is expected. We have added it to the sentence "and, as expected, sex hormone secretion and signaling".

      Line 325-328: Why is this senescence? Reference?

      We have added “potent” to it.

      Line 360-361: This doesn't show elevated synaptic activity.

      "elevated synaptic activity" was changed to "The elevated expression of synapse-related pathways"

      Line 363-364: "Unfortunately" is not a scientific expression and show bias.

      We have changed it to "Notably".

      Line 376: Similar as above.

      Yes, we have change it to "in contrast".

      Lines 382-385: This is speculation. Please move to discussion.

      Sorry for that. We think the causal effects derived from MR result is evidence. As such, we have not changed it.

      Line 389: Please revise "hormone expressing".

      We have changed it accordingly.

      Line 401: Isn't this effect expected due to feedback inhibition of the biochemical pathway? Please comment.

      The binding capability of 17alpha-estradiol to estrogen receptors and its role in transcriptional activation remain core questions surrounded by controversy. Earlier studies suggest that 17alpha-estradiol exhibits at least 200 times less activity than 17beta-estradiol (PMID: 2249627, PMID: 16024755). However, recent data indicate that 17alpha-estradiol shows comparable genomic binding and transcriptional activation through estrogen receptor α (Esr1) to that of 17beta-estradiol (PMID: 33289482). Additionally, there is evidence that 17alpha-estradiol has anti-estrogenic effects in rats (PMID: 16042770). These findings imply possible feedback inhibition via estrogen receptors. Furthermore, 17alpha-estradiol likely differs from 17beta-estradiol due to its unique metabolic consequences and its potential to slow aging in males, an effect not attributed to 17beta-estradiol. For instance, neurons are also targets of 17alpha-estradiol, with Esr1 not being the sole target (PMID: 38776045). Nevertheless, the precise effective targets of 17alpha-estradiol are still unresolved.

      Line 409: This conclusion cannot be made because the effect is not statistically significant. Can say "trend" etc.

      Thanks for the recommendation. We have added "potential" in front of the conclusion.

      Line 426: "suggesting" please revise.

      sorry, it’s a verb.

      Lines 426-428: This is speculation. Please move to discussion.

      The elevated GnRH levels in O.T., observed through EIA analysis, suggest a deduction regarding the direct causal effects of 17alpha-estradiol on various endocrine factors related to feeding, energy homeostasis, reproduction, osmotic regulation, stress response, and neuronal plasticity through MR analysis. Thus, we have not amended our position. We apologize for any confusion.

      Lines 431-432: improved compared to what?

      The statement have been revised as " The most striking role of 17α-estradiol treatment revealed in this study showed that HPG axis was substantially improved in the levels of serum Gnrh and testosterone".

      Line 435: " Estrogen Receptor Antagonists". Please revise.

      Thanks for the recommendation. We have changed it to "estrogen receptor antagonists".

      Line 438" "Secrete". Please revise.

      Sorry, it is "secret".

      Lines 439-449: None of this has been demonstrated. Please remove these conclusions.

      These are not conclusions but rather intriguing topics for discussion. Given the role of 17alpha-estradiol in promoting testosterone and reducing estradiol levels in males, we believe it is worthwhile to explore the potential application of 17alpha-estradiol in increasing testosterone levels in aged males, particularly those with hypogonadism.

      Lines 450-457: No females were included in this study. Why? Also, why is this discussed? It is relevant but doesn't belong in this manuscript since it was not studied here.

      Testosterone levels are crucial for male health, while estradiol levels are essential for the health and fertility of females. Previous studies have demonstrated that 17α-estradiol does not contribute to lifespan extension in females. Given the effects of 17α-estradiol on males—specifically, its role in promoting testosterone and reducing estradiol levels—we believe it is important to discuss the potential sex-biased effects of 17α-estradiol, as this could inform future investigations. Therefore, we have chosen not to make changes to this section.

      Lines 458-459: This was not demonstrated in this article. Please remove.

      We have restricted the claim to "expression level of energy metabolism in hypothalamic neurons".

      Line 464: "Promoted lifespan extension" Not demonstrated. Please remove.

      At the end of the sentence it was revised as "which may be a contributing factor in promoting lifespan extension".

      Line 466: "Showed" No.

      The whole sentence was deleted in the new version.

      Line 483: "the sex-based effects". Not studied here.

      Since the changes in testosterone levels are significant in this dataset and this hormone has a sex-biased nature, we find it worthwhile to suggest this as a topic for future investigation. We have added "which needs further verification in the future" at the end of this sentence.

    1. Author response:

      eLife Assessment<br /> This valuable study suggests that Naa10, an N-α-acetyltransferase with known mutations that disrupt neurodevelopment, acetylates Btbd3, which has been implicated in neurite outgrowth and obsessive-compulsive disorder, in a manner that regulates F-actin dynamics to facilitate neurite outgrowth. While the study provides promising insights and biochemical, co-immunoprecipitation, and proteomic data that enhance our understanding of protein N-acetylation in neuronal development, the evidence supporting larger claims is incomplete. Nonetheless, the implications of these findings are noteworthy, particularly regarding neurodevelopmental and psychiatric conditions tied to altered expression of Naa10 or Btbd3.

      Thank you very much for recognizing our study, carefully reviewing our work, and providing insightful comments and constructive criticism!

      Public Reviews:

      Reviewer #1 (Public review):

      The manuscript examines the role of Naa10 in cKO animals, in immortalized neurons, and in primary neurons. Given that Naa10 mutations in humans produce defects in nervous system function, the authors used various strategies to try to find a relevant neuronal phenotype and its potential molecular mechanism.

      This work contains valuable findings that suggest that the depletion of Naa10 from CA1 neurons in mice exacerbates anxiety-like behaviors. Using neuronal-derived cell lines authors establish a link between N-acetylase activity, Btbd3 binding to CapZb, and F-actin, ultimately impinging on neurite extension. The evidence demonstrating this is in most cases incomplete, since some key controls are missing and clearly described or simply because claims are not supported by the data. The manuscript also contains biochemical, co-immunoprecipitation, and proteomic data that will certainly be of value to our knowledge of the effects of protein N--acetylation in neuronal development and function.

      Thanks! It would be appreciated if the Reviewer could point out in the public review which experiment lacks a control group.

      Reviewer #2 (Public review):

      In this study, the authors sought to elucidate the neural mechanisms underlying the role of Naa10 in neurodevelopmental disruptions with a focus on its role in the hippocampus. The authors use an impressive array of techniques to identify a chain of events that occurs in the signaling pathway starting from Naa10 acetylating Btbd3 to regulation of F-actin dynamics that are fundamental to neurite outgrowth. They provide convincing evidence that Naa10 acetylates Btbd3, that Btbd3 facilitates CapZb binding to F-actin in a Naa10 acetylation-dependent manner, and that this CapZb binding to F-actin is key to neurite outgrowth. Besides establishing this signaling pathway, the authors contribute novel lists of Naa10 and Btbd3 interacting partners, which will be useful for future investigations into other mechanisms of action of Naa10 or Btbd3 through alternative cell signaling pathways.

      Thank you very much for recognizing our study!

      The evidence presented for an anxiety-like behavioral phenotype as a result of Naa10 dysfunction is mixed and tenuous, and assays for the primary behaviors known to be altered by Naa10 mutations in humans were not tested. As such, behavioral findings and their translational implications should be interpreted with caution.

      (1) For the anxiety-like behavioral phenotype, we provided a paragraph titled “Naa10 and stress-induced anxiety” in the Discussion section of the text: “Our investigations revealed that hippocampal CA1-KO of Naa10 did not exhibit significant differences in the open field test (Figure S1K) but led to anxiety-like behavior in mice in the elevated plus maze (EPM) test (Figure 1A). This disparity might be attributed to the specific design of the EPM test, which is tailored to elicit a conflict between an animal's inclination to explore and its fear of open spaces and elevated areas. This distinction implies that Naa10 might play a role in stress responses within the emotional regulation circuitry, particularly in navigating potentially threatening and anxiety-provoking environments.” The open field test offers a less challenging, open environment that primarily promotes exploratory behavior. We agree that additional assays, such as the light-dark box test, would be helpful in clarifying the issue.

      (2) We agree that the behavioral findings and their translational implications should be interpreted with caution. The primary neurological behaviors known to be altered by Naa10 mutations in humans include intellectual disability and autism-like syndrome with defective emotional control. These behaviors are influenced by many factors, including defects in the hippocampal CA1. Thus, we tested hippocampal CA1 Naa10-KO mice using the Y-maze, tail suspension test, open field test, and elevated plus maze (EPM). However, only the EPM results were affected, while the other tests showed no significant changes. It should be noted that our study employed a postnatal, CA1-specific Naa10 conditional knockout (cKO) model driven by Camk2a-Cre, which selectively depletes Naa10 from hippocampal CA1 neurons after birth. In contrast, Naa10 mutations in human patients involve global effects and impact multiple brain regions from the embryonic stage, leading to a broader spectrum of phenotypes. The limited disruption in our model likely explains the absence of learning and memory deficits and the incomplete recapitulation of the full range of patient phenotypes. Furthermore, Naa10 knockout may not produce the same effects as Naa10 mutations. Our current study is primarily intended to explore the physiological function of Naa10 in hippocampal function.

      (3) We will replace all instances of “anxiety behavior” with “anxiety-like behavior.”

      Finally, while not central to the main cell signaling pathway delineated, the characterization of brain region-specific and cell maturity of Naa10 expression patterns was presented in few to single animals and not quantified, and as such should also be interpreted with caution.

      We agree that we should provide additional Naa10 immunostaining data from more than three WT and hippocampal CA1 Naa10-KO mouse brains, as well as quantify data such as the silver staining and Light Sheet Fluorescence Microscopy results presented in Figures 1C and 1D, respectively. Nevertheless, the current report presents consistent results across different mice used for various assays. For example, Figures 1B-D, with three different assays, each demonstrate that Naa10-cKO reduces neurite complexity in vivo.

      On a broader level, these findings have implications for neurodevelopment and potentially, although not tested here, synaptic plasticity in adulthood, which means this novel pathway may be fundamental for brain health.

      Thank you very much again for recognizing our study!

      Summarized list of minor concerns

      (1) The early claims of the manuscript are supported by very small sample sizes (often 1-3) and/or lack of quantification, particularly in Figures S1 and 1.

      We agree that we should provide additional Naa10 immunostaining data from more than three WT and hippocampal CA1 Naa10-KO mouse brains, as well as quantify data such as the silver staining and Light Sheet Fluorescence Microscopy results presented in Figures 1C and 1D, respectively. Nevertheless, the current report presents consistent results across different mice used for various assays. For example, Figures 1B-D, with three different assays, each demonstrate that Naa10-cKO reduces neurite complexity in vivo.

      (2) Evidence is insufficient for CA1-specific knockdown of Naa10.

      The Camk2a-Cre mice used in this study were derived from Dr. Susumu Tonegawa’s laboratory. According to the referenced paper, this strain restricts Cre/loxP recombination to the forebrain, with particularly high efficiency in the hippocampal CA1. Consistently, our data show that Naa10 was almost completely absent in the CA1 but partially depleted in the DG of the Naa10-cKO mice (Figure S1F in the text). Similar results were observed in a different pair of

      (3) The relationship between the behaviors measured, which centered around mood, and Ogden syndrome, was not clear, and likely other behavioral measures would be more translationally relevant for this study. Furthermore, the evidence for an anxiety-like phenotype was mixed.

      (1) For the anxiety-like behavioral phenotype, we provided a paragraph titled “Naa10 and stress-induced anxiety” in the Discussion section of the text: “Our investigations revealed that hippocampal CA1-KO of Naa10 did not exhibit significant differences in the open field test (Figure S1K) but led to anxiety-like behavior in mice in the elevated plus maze (EPM) test (Figure 1A). This disparity might be attributed to the specific design of the EPM test, which is tailored to elicit a conflict between an animal's inclination to explore and its fear of open spaces and elevated areas. This distinction implies that Naa10 might play a role in stress responses within the emotional regulation circuitry, particularly in navigating potentially threatening and anxiety-provoking environments.” The open field test offers a less challenging, open environment that primarily promotes exploratory behavior. We agree that additional assays, such as the light-dark box test, would be helpful in clarifying the issue.

      (2) We agree that the behavioral findings and their translational implications should be interpreted with caution. The primary neurological behaviors known to be altered by Naa10 mutations in humans include intellectual disability and autism-like syndrome with defective emotional control. These behaviors are influenced by many factors, including defects in the hippocampal CA1. Thus, we tested hippocampal CA1 Naa10-KO mice using the Y-maze, tail suspension test, open field test, and elevated plus maze (EPM). However, only the EPM results were affected, while the other tests showed no significant changes. It should be noted that our study employed a postnatal, CA1-specific Naa10 conditional knockout (cKO) model driven by Camk2a-Cre, which selectively depletes Naa10 from hippocampal CA1 neurons after birth. In contrast, Naa10 mutations in human patients involve global effects and impact multiple brain regions from the embryonic stage, leading to a broader spectrum of phenotypes. The limited disruption in our model likely explains the absence of learning and memory deficits and the incomplete recapitulation of the full range of patient phenotypes. Furthermore, Naa10 knockout may not produce the same effects as Naa10 mutations. Our current study is primarily intended to explore the physiological function of Naa10 in hippocampal function.

      (3) We will replace all instances of “anxiety behavior” with “anxiety-like behavior.”

      (4) Btbd3 is characterized by the authors as an OCD risk gene, but its status as such is not well supported by the most recent, better-powered genome-wide association studies than the one that originally implicated Btbd3. However, there is evidence that Btbd3 expression, including selectively in the hippocampus, is implicated in OCD-relevant behaviors in mice.

      Thanks for clarifying the issue!

      (5) The reporting of the statistics lacks sufficient detail for the reader to deduce how experimental replicates were defined.

      We believe we have provided sufficient detail for readers to deduce how experimental replicates were defined in each corresponding figure legend. It would be appreciated if the Reviewer could point out which specific figures lack sufficient details.

    1. Author response:

      Reviewer #1:

      Summary:<br /> In this manuscript, Bisht et al address the hypothesis that protein folding chaperones may be implicated in aggregopathies and in particular Tau aggregation, as a means to identify novel therapeutic routes for these largely neurodegenerative conditions.

      The authors conducted a genetic screen in the Drosophila eye, which facilitates the identification of mutations that either enhance or suppress a visible disturbance in the nearly crystalline organization of the compound eye. They screened by RNA interference all 64 known Drosophila chaperones and revealed that mutations in 20 of them exaggerate the Tau-dependent phenotype, while 15 ameliorated it. The enhancer of the degeneration group included 2 subunits of the typically heterohexameric prefoldin complex and other co-translational chaperones.

      In a previous paper, we identified 95 Drosophila chaperones (Raut et al., 2017). We request that “all 64 known Drosophila chaperones” be replaced with “64 out of 95 known Drosophila chaperones” to make it factually correct.

      Strengths:

      Regarding this memory defect upon V377M tau expression. Kosmidis et al (2010) pmid: 20071510, demonstrated that pan-neuronal expression of TauV377M disrupts the organization of the mushroom bodies, the seat of long-term memory in odor/shock and odor/reward conditioning. If the novel memory assay the authors use depends on the adult brain structures, then the memory deficit can be explained in this manner.

      If the mushroom bodies are defective upon TauV377M expression does overexpression of Pfdn5 or 6 reverse this deficit? This would argue strongly in favor of the microtubule stabilization explanation.

      We agree that the disruptive organization of the mushroom body may cause memory deficits upon hTauV337M expression and that expression of Pfdn5 or Pfdn6 could reverse the deficits. One possible mechanism by which overexpression of Pfdn5/6 could rescue the Tau-induced memory deficits may be due to the stabilization of microtubules in the mushroom bodies.

      Proposed revision: We will assess if Tau-induced mushroom body disruption can be rescued with the overexpression of Pfdn5 or Pfdn6.

      Weakness:

      What is unclear however is how Pfdn5 loss or even overexpression affects the pathological Tau phenotypes. Does Pfdn5 (or 6) interact directly with TauV377M? Colocalization within tissues is a start, but immunoprecipitations would provide additional independent evidence that this is so.

      Our data suggests that Pfdn5 stabilizes neuronal microtubules by directly associating with it, and loss of Pfdn5 exacerbates Tau-phenotypes by destabilizing microtubules. However, as the reviewer notes, analysis of direct interaction between Pfdn5 and hTau<sup>V337M</sup> might provide further insights into the mechanism of Pfdn5 and Tau-aggregation.

      Proposed revision: We will perform colocalization analysis and coimmunoprecipitation to ask if Pfdn5 colocalizes and directly interacts with Tau.

      Does Pfdn5 loss exacerbate TauV377M phenotypes because it destabilizes microtubules, which are already at least partially destabilized by Tau expression? Rescue of the phenotypes by overexpression of Pfdn5 agrees with this notion.

      However, Cowan et al (2010) pmid: 20617325 demonstrated that wild-type Tau accumulation in larval motor neurons indeed destabilizes microtubules in a Tau phosphorylation-dependent manner. So, is TauV377M hyperphosphorylated in the larvae?? What happens to TauV377M phosphorylation when Pfdn5 is missing and presumably more Tau is soluble and subject to hyperphosphorylation as predicted by the above?

      Proposed revisions: We will overexpress Pfdn5 or Pfdn6 with hTau<sup>V337M</sup> and ask if microtubule disruption caused by hTau<sup>V337M</sup> is rescued. Further, we will analyze the phospho-Tau levels in controls and Pfdn5 mutant background.

      Expression of WT human Tau (which is associated with most common Tauopathies other than FTDP-17) as Cowan et al suggest has significant effects on microtubule stability, but such Tau-expressing larvae are largely viable. Will one mutant copy of the Pfdn5 knockout enhance the phenotype of these larvae?? Will it result in lethality? Such data will serve to generalize the effects of Pfdn5 beyond the two FDTP-17 mutations utilized.

      Proposed revision: We will incorporate data about the effect of heterozygous mutation of Pfdn5 on the lethality and synaptic phenotypes associated with the hTau<sup>WT</sup> and hTau<sup>V337M</sup> in the revised manuscript.

      Does the loss of Pfdn5 affect TauV377M (and WTTau) levels?? Could the loss of Pfdn5 simply result in increased Tau levels? And conversely, does overexpression of Pfdn5 or 6 reduce Tau levels?? This would explain the enhancement and suppression of TauV377M (and possibly WT Tau) phenotypes. It is an easily addressed, trivial explanation at the observational level, which if true begs for a distinct mechanistic approach.

      We thank the reviewer for suggesting an alternate model for the Pfdn5 function. We will perform the Western blot analysis to assess Tau<sup>WT</sup> and Tau<sup>V337M</sup> levels in the absence of Pfdn5 or animals coexpressing Tau and Pfdn5. We will incorporate these data and conclusions in the revised manuscript.

      Finally, the authors argue that TauV377M forms aggregates in the larval brain based on large puncta observed especially upon loss of Pfdn5. This may be so, but protocols are available to validate this molecularly the presence of insoluble Tau aggregates (for example, pmid: 36868851) or soluble Tau oligomers as these apparently differentially affect Tau toxicity. Does Pfdn5 loss exaggerate the toxic oligomers and overexpression promotes the more benign large aggregates??

      We will perform the Tau solubility assay in control, in the absence of Pfdn5 or animals coexpressing Tau and Pfdn5. Moreover, we will also ask if the large Tau puncta formed in the absence of Pfdn5 are soluble oligomers or stable aggregates. We have found that the coexpression of Tau and Pfdn5 does not result in the formation of  Tau aggregates. We will incorporate these and other relevant data in the revised manuscript.

      Reviewer #2 (Public review):

      Bisht et al detail a novel interaction between the chaperone, Prefoldin 5, microtubules, and tau-mediated neurodegeneration, with potential relevance for Alzheimer's disease and other tauopathies. Using Drosophila, the study shows that Pfdn5 is a microtubule-associated protein, which regulates tubulin monomer levels and can stabilize microtubule filaments in the axons of peripheral nerves. The work further suggests that Pfdn5/6 may antagonize Tau aggregation and neurotoxicity. While the overall findings may be of interest to those investigating the axonal and synaptic cytoskeleton, the detailed mechanisms for the observed phenotypes remain unresolved and the translational relevance for tauopathy pathogenesis is yet to be established. Further, a number of key controls and important experiments are missing that are needed to fully interpret the findings.The major weakness relates to the experiments and claims of interactions with Tau-mediated neurodegeneration. In particular, it is unclear whether knockdown of Pfdn5 may cause eye phenotypes independent of Tau. Further, the GMR>tau phenotype appears to have been incorrectly utilized to examine age-dependent, neurodegeneration.

      We have consistently found the progression of eye degeneration in the population of animals expressing Tau<sup>V337M</sup>, measured as the number of fused ommatidia/total number of ommatidia, with age. A few other studies have also shown age-dependent progressive degeneration in Drosophila retinal axons or lamina (Iijima-Ando et al., 2012; Sakakibara et al., 2018). We appreciate other studies that have proposed hTau-induced eye degeneration as a developmental defect (Malmanche et al., 2017; Sakakibara et al., 2023).

      Proposed revision: a) We will analyze the age-dependent neurodegeneration in the adult brain to further support our main conclusion that Pfdn5 ameliorates hTauV337M-induced progressive neurodegeneration.

      b) We have used three independent Pfdn5 RNAi lines (the RNAi's target different regions of Pfdn5) – all of which enhance the Tau phenotypes. The knockdown of any of these RNAi lines with GMR-Gal4 does not give detectable eye phenotypes. We will include these data in the revised manuscript.

      This manuscript argues that its findings may be relevant to thinking about mechanisms and therapies applicable to tauopathies; however, this is premature given that many questions remain about the interactions from Drosophila, the detailed mechanisms remain unresolved, and absent evidence that tau and Pfdn may similarly interact in the mammalian neuronal context. Therefore, this work would be strongly enhanced by experiments in human or murine neuronal culture or supportive evidence from analyses of human data.

      Proteome analysis of Alzheimer's brain tissue shows that the Pfdn5 level is reduced in patients (Askenazi et al., 2023; Tao et al., 2020). Moreover, the Pfdn5 expression level was found to be reduced in the blood samples from AD patients (Ji et al., 2022). Another study further validates the age-dependent reduction of Pfdn5 in the tauopathy transgenic murine model (Kadoyama et al., 2019). Together, these reports highlight a potential link between Pfdn5 levels and tauopathies. We will revise the manuscript to reflect these findings in more detail.

      References

      Askenazi, M., Kavanagh, T., Pires, G., Ueberheide, B., Wisniewski, T., and Drummond, E. (2023). Compilation of reported protein changes in the brain in Alzheimer's disease. Nat Commun 14, 4466. 10.1038/s41467-023-40208-x.

      Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., and Iijima, K.M. (2012). Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1. PLoS Genet 8, e1002918. 10.1371/journal.pgen.1002918.

      Ji, W., An, K., Wang, C., and Wang, S. (2022). Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm. Hereditas 159, 38. 10.1186/s41065-022-00252-x.

      Kadoyama, K., Matsuura, K., Takano, M., Maekura, K., Inoue, Y., and Matsuyama, S. (2019). Changes in the expression of prefoldin subunit 5 depending on synaptic plasticity in the mouse hippocampus. Neurosci Lett 712, 134484. 10.1016/j.neulet.2019.134484.

      Malmanche, N., Dourlen, P., Gistelinck, M., Demiautte, F., Link, N., Dupont, C., Vanden Broeck, L., Werkmeister, E., Amouyel, P., Bongiovanni, A., et al. (2017). Developmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models. Sci Rep 7, 40764. 10.1038/srep40764.

      Raut, S., Mallik, B., Parichha, A., Amrutha, V., Sahi, C., and Kumar, V. (2017). RNAi-Mediated Reverse Genetic Screen Identified Drosophila Chaperones Regulating Eye and Neuromuscular Junction Morphology. G3 (Bethesda) 7, 2023-2038. 10.1534/g3.117.041632.

      Sakakibara, Y., Sekiya, M., Fujisaki, N., Quan, X., and Iijima, K.M. (2018). Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila. PLoS Genet 14, e1007196. 10.1371/journal.pgen.1007196.

      Sakakibara, Y., Yamashiro, R., Chikamatsu, S., Hirota, Y., Tsubokawa, Y., Nishijima, R., Takei, K., Sekiya, M., and Iijima, K.M. (2023). Drosophila Toll-9 is induced by aging and neurodegeneration to modulate stress signaling and its deficiency exacerbates tau-mediated neurodegeneration. iScience 26, 105968. 10.1016/j.isci.2023.105968.

      Tao, Y., Han, Y., Yu, L., Wang, Q., Leng, S.X., and Zhang, H. (2020). The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Front Neurol 11, 233. 10.3389/fneur.2020.00233.

    1. Author response:

      We appreciate the constructive feedback from the reviewers and will work to address many of these concerns in a revised version.  Here, we provide initial responses to a few key points that the reviewers raised:

      (1) The reviewers rightly pointed out that it is very important to clearly define and explain what qualifies as metastatic potential to particular organs in our system.  We acknowledge the valuable contributions of animal models in metastatic cancer studies, but here we intentionally limited our scope to metastasis that had occurred within the human system only.  For example, we use data from cancer cells that model human organotropism from the breast to the lung, since the cells originated from infiltrative ductal carcinoma (human breast) but were collected from pleural effusions (human lung). We propose that in this case a comparison with a human lung cancer-derived cell line that was itself purified from a pleural effusion could reveal factors essential for lung metastasis, without adding the confounder of an animal microenvironment.  The MetMap Explorer contains valuable information, but the “metastatic potential of each cell line” is measured in a mouse environment.  Knowing that a particular cell line, which originated from a human lung metastasis, can further metastasize to other organs in a mouse does not necessarily mean that those cells could do so in humans.  The microenvironment responses to metastatic colonization can differ among species.  Further, the changes a cell needs to make to adapt to a new organ system in a mouse could be confounded by the changes needed to adapt to mouse conditions in general.  Finally, migration from a site of ectopic injection may not mimic migration from an initial tumor site.  We agree that the very best data would come from matched primary and metastatic tumors in the same human patient, but those data do not currently exist and generating them would require future work beyond the scope of this study.   In our revision, we will ensure that  we more clearly explain how and why we chose the cell lines we did and what the advantages and limitations of this choice are.

      (2) The reviewers are correct that our unsupervised Principal component analysis (PCA) does not precisely stratify cells according to epithelial-mesenchymal status.  In a high dimensional, complex system, it is expected than an unsupervised analysis such as this will not capture just one biological feature in the first principal component. Therefore, when we performed PCA on the compartmental organization profiles of different healthy and cancerous cell lines, instead of finding the largest variation (PC1) following exactly EMT state, it captured an ordering that includes influences from epithelial-mesenchymal state, disease condition, nuclear geometry, and other cellular properties.  However, it was striking that this completely unsupervised analysis did match previous annotations of EMT state so well (as seen in supp fig 1b).  Therefore, we conclude that the most prominent variations in A/B compartment signature strongly relate to EMT state.   In the revision, we will more clearly present the caveats of this interpretation.

      (3) Our decision to focus on A/B compartmentalization rather than TAD or loop structure in this analysis was intentional and biologically motivated, rather than solely being a reflection of data resolution.  Both compartments and topologically associated domains (TADs) are key parts of genome organization and disruption of these structures has the potential to alter downstream gene regulation, as shown by numerous studies. But, compartments have been found, more so than TADs, to be strongly associated with cell type and cell fate.  Therefore,  in this manuscript, we decided to focus only on the compartment organization changes between different healthy and cancerous cells as they are more likely to represent the stable alterations of the genome organization malignant transformations.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The authors performed experimental evolution of MreB mutants that have a slow-growing round phenotype and studied the subsequent evolutionary trajectory using analysis tools from molecular biology. It was remarkable and interesting that they found that the original phenotype was not restored (most common in these studies) but that the round phenotype was maintained. 

      Strengths: 

      The finding that the round phenotype was maintained during evolution rather than that the original phenotype, rod-shaped cells, was recovered is interesting. The paper extensively investigates what happens during adaptation with various different techniques. Also, the extensive discussion of the findings at the end of the paper is well thought through and insighXul. 

      Weaknesses: 

      I find there are three general weaknesses: 

      (1) Although the paper states in the abstract that it emphasizes "new knowledge to be gained" it remains unclear what this concretely is. On page 4 they state 3 three research questions, these could be more extensively discussed in the abstract. Also, these questions read more like genetics questions while the paper is a lot about cell biological findings. 

      Thank you for drawing attention to the unnecessary and gratuitous nature of the last sentence of the Abstract. We are in agreement. It has been modified, and we have taken  advantage of additional word space to draw attention to the importance of the two competing (testable) hypotheses laid out in the Discussion. 

      As to new knowledge, please see the Results and particularly the Discussion. But beyond this, and as recognised by others, there is real value for cell biology in seeing how (and whether) selection can compensate for effects that are deleterious to fitness. The results will very o_en depart from those delivered from, for example, suppressor analyses, or bottom up engineering. 

      In the work recounted in our paper, we chose to focus – by way of proof-of principle – on the most commonly observed mutations, namely, those within pbp1A.  But beyond this gene, we detected mutations  in other components of the cell shape / division machinery whose connections are not yet understood and which are the focus of on-going investigation.  

      As to the three questions posed at the end of the Introduction, the first concerns whether selection can compensate for deleterious effects of deleting mreB (a question that pertains to evolutionary aspects); the second seeks understanding of genetic factors; the third aims to shed light on the genotype-to-phenotype map (which is where the cell biology comes into play).  Given space restrictions, we cannot see how we could usefully expand, let alone discuss, the three questions raised at the end of the Introduction in restrictive space available in the Abstract.   

      (2) It is not clear to me from the text what we already know about the restoration of MreB loss from suppressors studies (in the literature). Are there suppressor screens in the literature and which part of the findings is consistent with suppressor screens and which parts are new knowledge?  

      As stated in the Introduction, a previous study with B. subtilis (which harbours three MreB isoforms and where the isoform named “MreB” is essential for growth under normal conditions), suppressors of MreB lethality were found to occur in ponA, a class A penicillin binding protein (Kawai et al., 2009). This led to recognition that MreB plays a role in recruiting Pbp1A to the lateral cell wall. On the other hand, Patel et al. (2020) have shown that deletion of classA PBPs leads to an up-regulation of rod complex activity. Although there is a connection between rod complex and class A PBPs, a further study has shown that the two systems work semi-autonomously (Cho et al., 2016). 

      Our work confirms a connection between MreB and Pbp1A, and has shed new light on how this interaction is established by means of natural selection, which targets the integrity of cell wall. Indeed, the Rod complex and class A PBPs have complementary activities in the building of the cell wall with each of the two systems able to compensate for the other in order to maintain cell wall integrity. Please see the major part of the Discussion. In terms of specifics, the connection between mreB and pbp1A (shown by Kawai et al (2009)) is indirect because it is based on extragenic transposon insertions. In our study, the genetic connection is mechanistically demonstrated.  In addition, we capture that the evolutionary dynamics is rapid and we finally enriched understanding of the genotype-to-phenotype map.

      (3) The clarity of the figures, captions, and data quantification need to be improved.  

      Modifications have been implemented. Please see responses to specific queries listed below.

      Reviewer #2 (Public Review): 

      Yulo et al. show that deletion of MreB causes reduced fitness in P. fluorescens SBW25 and that this reduction in fitness may be primarily caused by alterations in cell volume. To understand the effect of cell volume on proliferation, they performed an evolution experiment through which they predominantly obtained mutations in pbp1A that decreased cell volume and increased viability. Furthermore, they provide evidence to propose that the pbp1A mutants may have decreased PG cross-linking which might have helped in restoring the fitness by rectifying the disorganised PG synthesis caused by the absence of MreB. Overall this is an interesting study. 

      Queries: 

      Do the small cells of mreB null background indeed have have no DNA? It is not apparent from the DAPI images presented in Supplementary Figure 17. A more detailed analysis will help to support this claim. 

      It is entirely possible that small cells have no DNA, because if cell division is aberrant then division can occur prior to DNA segregation resulting in cells with no DNA. It is clear from microscopic observation that both small and large cells do not divide. It is, however, true, that we are unable to state – given our measures of DNA content – that small cells have no DNA. We have made this clear on page 13, paragraph 2.

      What happens to viability and cell morphology when pbp1A is removed in the mreB null background? If it is actually a decrease in pbp1A activity that leads to the rescue, then pbp1A- mreB- cells should have better viability, reduced cell volume and organised PG synthesis. Especially as the PG cross-linking is almost at the same level as the T362 or D484 mutant.  

      Please see fitness data in Supp. Fig. 13. Fitness of ∆mreBpbp1A is no different to that caused by a point mutation. Cells remain round.  

      What is the status of PG cross-linking in ΔmreB Δpflu4921-4925 (Line 7)? 

      This was not analysed as the focus of this experiment was PBPs. A priori, there is no obvious reason to suspect that ∆4921-25 (which lacks oprD) would be affected in PBP activity.

      What is the morphology of the cells in Line 2 and Line 5? It may be interesting to see if PG cross-linking and cell wall synthesis is also altered in the cells from these lines. 

      The focus of investigation was restricted to L1, L4 and L7. Indeed, it would be interesting to look at the mutants harbouring mutations in :sZ, but this is beyond scope of the present investigation (but is on-going). The morphology of L2 and L5 are shown in Supp. Fig. 9.

      The data presented in 4B should be quantified with appropriate input controls. 

      Band intensity has now been quantified (see new Supp. Fig .20). The controls are SBW25, SBW25∆pbp1A, SBW25 ∆mreB and SBW25 ∆mreBpbp1A as explained in the paper.

      What are the statistical analyses used in 4A and what is the significance value? 

      Our oversight. These were reported in Supp. Fig. 19, but should also have been presented in Fig. 4A. Data are means of three biological replicates. The statistical tests are comparisons between each mutant and SBW25, and assessed by paired t-tests.  

      A more rigorous statistical analysis indicating the number of replicates should be done throughout. 

      We have checked and made additions where necessary and where previously lacking. In particular, details are provided in Fig. 1E, Fig. 4A and Fig. 4B. For Fig. 4C we have produced quantitative measures of heterogeneity in new cell wall insertion. These are reported in Supp. Fig. 21 (and referred to in the text and figure caption) and show that patterns of cell wall insertion in ∆mreB are highly heterogeneous.

      Reviewer #3 (Public Review): 

      This paper addresses an understudied problem in microbiology: the evolution of bacterial cell shape. Bacterial cells can take a range of forms, among the most common being rods and spheres. The consensus view is that rods are the ancestral form and spheres the derived form. The molecular machinery governing these different shapes is fairly well understood but the evolutionary drivers responsible for the transition between rods and spheres are not. Enter Yulo et al.'s work. The authors start by noting that deletion of a highly conserved gene called MreB in the Gram-negative bacterium Pseudomonas fluorescens reduces fitness but does not kill the cell (as happens in other species like E. coli and B. subtilis) and causes cells to become spherical rather than their normal rod shape. They then ask whether evolution for 1000 generations restores the rod shape of these cells when propagated in a rich, benign medium. 

      The answer is no. The evolved lineages recovered fitness by the end of the experiment, growing just as well as the unevolved rod-shaped ancestor, but remained spherical. The authors provide an impressively detailed investigation of the genetic and molecular changes that evolved. Their leading results are: 

      (1) The loss of fitness associated with MreB deletion causes high variation in cell volume among sibling cells a_er cell division. 

      (2) Fitness recovery is largely driven by a single, loss-of-function point mutation that evolves within the first ~250 generations that reduces the variability in cell volume among siblings. 

      (3) The main route to restoring fitness and reducing variability involves loss of function mutations causing a reduction of TPase and peptidoglycan cross-linking, leading to a disorganized cell wall architecture characteristic of spherical cells. 

      The inferences made in this paper are on the whole well supported by the data. The authors provide a uniquely comprehensive account of how a key genetic change leads to gains in fitness and the spectrum of phenotypes that are impacted and provide insight into the molecular mechanisms underlying models of cell shape. 

      Suggested improvements and clarifications include: 

      (1) A schematic of the molecular interactions governing cell wall formation could be useful in the introduction to help orient readers less familiar with the current state of knowledge and key molecular players. 

      We understand that this would be desirable, but there are numerous recent reviews with detailed schematics that we think the interested reader would be better consulting. These are referenced in the text.

      (2) More detail on the bioinformatics approaches to assembling genomes and identifying the key compensatory mutations are needed, particularly in the methods section. This whole subject remains something of an art, with many different tools used. Specifying these tools, and the parameter sesngs used, will improve transparency and reproducibility, should it be needed. 

      We overlooked providing this detail, which has now been corrected by provision of more information in the Materials and Methods. In short we used Breseq, the clonal option, with default parameters. Additional analyses were conducted using Genieous. The BreSeq output files are provided https://doi.org/10.17617/3.CU5SX1 (which include all read data).

      (3) Corrections for multiple comparisons should be used and reported whenever more than one construct or strain is compared to the common ancestor, as in Supplementary Figure 19A (relative PG density of different constructs versus the SBW25 ancestor). 

      The data presented in Supp Fig 19A (and Fig 4A) do not involve multiple comparisons. In each instance the comparison is between SBW25 and each of the different mutants. A paired t-test is thus appropriate.

      (4) The authors refrain from making strong claims about the nature of selection on cell shape, perhaps because their main interest is the molecular mechanisms responsible. However, I think more can be said on the evolutionary side, along two lines. First, they have good evidence that cell volume is a trait under strong stabilizing selection, with cells of intermediate volume having the highest fitness. This is notable because there are rather few examples of stabilizing selection where the underlying mechanisms responsible are so well characterized. Second, this paper succeeds in providing an explanation for how spherical cells can readily evolve from a rod-shaped ancestor but leaves open how rods evolved in the first place. Can the authors speculate as to how the complex, coordinated system leading to rods first evolved? Or why not all cells have lost rod shape and become spherical, if it is so easy to achieve? These are important evolutionary questions that remain unaddressed. The manuscript could be improved by at least flagging these as unanswered questions deserving of further attention. 

      These are interesting points, but our capacity to comment is entirely speculative. Nonetheless, we have added an additional paragraph to the Discussion that expresses an opinion that has yet to receive attention:

      “Given the complexity of the cell wall synthesis machinery that defines rod-shape in bacteria, it is hard to imagine how rods could have evolved prior to cocci. However, the cylindrical shape offers a number of advantages. For a given biomass (or cell volume), shape determines surface area of the cell envelope, which is the smallest surface area associated with the spherical shape. As shape sets the surface/volume ratio, it also determines the ratio between supply (proportional to the surface) and demand (proportional to cell volume). From this point of view, it is more efficient to be cylindrical (Young 2006). This also holds for surface attachment and biofilm formation (Young 2006). But above all, for growing cells, the ratio between supply and demand is constant in rod shaped bacteria, whereas it decreases for cocci. This requires that spherical cells evolve complex regulatory networks capable of maintaining the correct concentration of cellular proteins despite changes in surface/volume ratio. From this point of view, rod-shaped bacteria offer opportunities to develop unsophisticated regulatory networks.”

      why not all cells have lost rod shape and become spherical.

      Please see Kevin Young’s 2006 review on the adaptive significance of cell shape

      The value of this paper stems both from the insight it provides on the underlying molecular model for cell shape and from what it reveals about some key features of the evolutionary process. The paper, as it currently stands, provides more on which to chew for the molecular side than the evolutionary side. It provides valuable insights into the molecular architecture of how cells grow and what governs their shape. The evolutionary phenomena emphasized by the authors - the importance of loss-of-function mutations in driving rapid compensatory fitness gains and that multiple genetic and molecular routes to high fitness are o_en available, even in the relatively short time frame of a few hundred generations - are wellunderstood phenomena and so arguably of less broad interest. The more compelling evolutionary questions concern the nature and cause of stabilizing selection (in this case cell volume) and the evolution of complexity. The paper misses an opportunity to highlight the former and, while claiming to shed light on the latter, provides rather little useful insight. 

      Thank you for these thoughts and comments. However, we disagree that the experimental results are an overlooked opportunity to discuss stabilising selection. Stabilising selection occurs when selection favours a particular phenotype causing a reduction in underpinning population-level genetic diversity. This is not happening when selection acts on SBW25 ∆mreB leading to a restoration of fitness. Driving the response are biophysical factors, primarily the critical need to balance elongation rate with rate of septation. This occurs without any change in underlying genetic diversity.  

      Recommendations for the authors:  

      Reviewer 1 (Recommendations for the Authors): 

      Hereby my suggestion for improvement of the quantification of the data, the figures, and the text. 

      -  p 14, what is the unit of elongation rate?  

      At first mention we have made clear that the unit is given in minutes^-1

      -  p 14, please give an error bar for both p=0.85 and f=0.77, to be able to conclude they are different 

      Error on the probability p is estimated at the 95% confidence interval by the formula:1.96 , where N is the total number of cells. This has been added in the paragraph p »probability » of the Image Analysis section in the Material and Methods. 

      We also added errors on p measurement in the main text.

      -  p 14, all the % differences need an errorbar 

      The error bars and means are given in Fig 3C and 3D.

      -  Figure 1B adds units to compactness, and what does it represent? Is the cell size the estimated volume (that is mentioned in the caption)? Shouldn't the datapoints have error bars? 

      Compactness is defined in the “Image Analysis” section of the Material and Methods. It is a dimensionless parameter. The distribution of individual cell shapes / sizes are depicted in Fig 1B. Error does arise from segmentation, but the degree of variance (few pixels) is much smaller than the representations of individual cells shown.

      -  Figure 1C caption, are the 50.000 cells? 

      Correct. Figure caption has been altered.

      -  Figure 1D, first the elongation rate is described as a volume per minute, but now, looking at the units it is a rate, how is it normalized? 

      Elongation rate is explained in the Materials and Methods (see the image analysis section) and is not volume per minute. It is dV/dt = r*V (the unit of r is min^-1). Page 9 includes specific mention of the unit of r.

      -  Figure 1E, how many cells (n) per replicate? 

      Our apologies. We have corrected the figure caption that now reads:

      “Proportion of live cells in ancestral SBW25 (black bar) and ΔmreB (grey bar) based on LIVE/DEAD BacLight Bacterial Viability Kit protocol. Cells were pelleted at 2,000 x g for 2 minutes to preserve ΔmreB cell integrity. Error bars are means and standard deviation of three biological replicates (n>100).”

      -  Figure 1G, how does this compare to the wildtype 

      The volume for wild type SBW25 is 3.27µm^3 (within the “white zone”). This is mentioned in the text.

      -  Figure 2B, is this really volume, not size? And can you add microscopy images? 

      The x-axis is volume (see Materials and Methods, subsection image analysis). Images are available in Supp. Fig. 9.

      -  Figure 3A what does L1, L4 and L7 refer too? Is it correct that these same lines are picked for WT and delta_mreB 

      Thank you for pointing this out. This was an earlier nomenclature. It was shorthand for the mutants that are specified everywhere else by genotype and has now been corrected. 

      -  Figure 3c: either way write out p, so which probability, or you need a simple cartoon that is plotted. 

      The value p is the probability to proceed to the next generation and is explained in Materials and Methods  subsection image analysis.  We feel this is intuitive and does not require a cartoon. We nonetheless added a sentence to the Materials and Methods to aid clarity.

      -  Figure 4B can you add a ladder to the gel? 

      No ladder was included, but the controls provide all the necessary information. The band corresponding to PBP1A is defined by presence in SBW25, but absence in SBW25 ∆pbp1A.

      -  Figure 4c, can you improve the quantification of these images? How were these selected and how well do they represent the community? 

      We apologise for the lack of quantitative description for data presented in Fig 4C. This has now been corrected. In brief, we measured the intensity of fluorescent signal from between 10 and 14 cells and computed the mean and standard deviation of pixel intensity for each cell. To rule out possible artifacts associated with variation of the mean intensity, we calculated the ratio of the standard deviation divided by the square root of the mean. These data reveal heterogeneity in cell wall synthesis and provide strong statistical support for the claim that cell wall synthesis in ∆mreB is significantly more heterogeneous than the control. The data are provided in new Supp. Fig. 21. 

      Minor comments: 

      -  It would be interesting if the findings of this experimental evolution study could be related to comparative studies (if these have ever been executed).  

      Little is possible, but Hendrickson and Yulo published a portion of the originally posted preprint separately. We include a citation to that paper. 

      -  p 13, halfway through the page, the second paragraph lacks a conclusion, why do we care about DNA content? 

      It is a minor observation that was included by way of providing a complete description of cell phenotype.  

      -  p 17, "suggesting that ... loss-of-function", I do no not understand what this is based upon. 

      We show that the fitness of a pbp1A deletion is indistinguishable from the fitness of one of the pbp1A point mutants. This fact establishes that the point mutation had the same effects as a gene deletion thus supporting the claim that the point mutations identified during the course of the selection experiment decrease (or destroy) PBP1A function.

      -  p 25, at the top of the page: do you have a reference for the statement that a disorganized cell wall architecture is suited to the topology of spherical cells? 

      The statement is a conclusion that comes from our reasoning. It stems from the fact that it is impossible to entirely map the surface of a sphere with parallel strands.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews

      Reviewer #1: 

      Summary:

      In this study, Avila et al. tested the hypothesis that chronic pain states are associated with changes in the excitability of the medial prefrontal cortex (mPFC). The authors used the slope of the aperiodic component of the EEG power spectrum (= the aperiodic exponent) as a novel, non-invasive proxy for the cortical excitation-inhibition ratio. They performed source localization to estimate the EEG signals generated specifically by the mPFC. By pooling resting-state EEG recordings from three existing datasets, the authors were able to compare the aperiodic exponent in the mPFC and across the whole brain (at all modeled cortical sources) between 149 chronic pain patients and 115 healthy controls. Additionally, they assessed the relationship between the aperiodic exponent and pain intensity reported by the patients. To account for heterogeneity in pain etiology, the analysis was also performed separately for two patient subgroups with different chronic pain conditions (chronic back pain and chronic widespread pain). The study found robust evidence against differences in the aperiodic exponent in the mPFC between people with chronic pain and healthy participants, and no correlation was observed between the aperiodic exponent and pain intensity. These findings were consistent across different patient subgroups and were corroborated by the whole-brain analysis.

      Strengths:

      The study is based on sound scientific reasoning and rigorously employs suitable methods to test the hypothesis. It follows a pre-registered protocol, which greatly increases the transparency and, consequently, the credibility of the reported results. In addition to the planned steps, the authors used a multiverse analysis to ensure the robustness of the results across different methodological choices. I find this particularly interesting, as the EEG aperiodic exponent has only recently been linked to network excitability, and the most appropriate methods for its extraction and analysis are still being determined. The methods are clearly and comprehensively described, making this paper very useful for researchers planning similar studies. The results are convincing, and supported by informative figures, and the lack of the expected difference in mPFC excitability between the tested groups is thoroughly and constructively discussed.

      We are grateful for the appreciation of the strengths of our study.  

      Weaknesses:

      Firstly, although I appreciate the relatively large sample size, pooling data recorded by different researchers using different experimental protocols inevitably increases sample variability and may limit the availability of certain measures, as was the case here with the reports of pain intensity in the patient group. Secondly, the analysis heavily relies on the estimation of cortical sources, an approach that offers many advantages but may yield imprecise results, especially when default conduction models, source models, and electrode coordinates are used. In my opinion, this point should be discussed as well.

      We agree that the heterogeneous sample of people with chronic pain increases variability and limits the availability of clinical measures. We further agree on the limitations of source space analysis. Therefore, we have added these limitations to the discussion section.

      Reviewer #2: 

      Summary:

      This study evaluated the aperiodic component in the medial prefrontal cortex (mPFC) using restingstate EEG recordings from 149 individuals with chronic pain and 115 healthy participants. The findings showed no significant differences in the aperiodic component of the mPFC between the two groups, nor was there any correlation between the aperiodic component and pain intensity. These results were consistent across various chronic pain subtypes and were corroborated by whole-brain analyses. The study's robustness was further reinforced by preregistration and multiverse analyses, which accounted for a wide range of methodological choices.

      Strengths:

      This study was rigorously conducted, yielding clear and conclusive results. Furthermore, it adhered to stringent open and reproducible science practices, including preregistration, blinded data analysis, and Bayesian hypothesis testing. All data and code have been made openly available, underscoring the study's commitment to transparency and reproducibility.

      We appreciate the appraisal of the strengths of our study, highlighting our efforts in open and reproducible science practices.

      Weaknesses:

      The aperiodic exponent of the EEG power spectrum is often regarded as an indicator of the excitatory/inhibitory (E/I) balance. However, this measure may not be the most accurate or optimal for quantifying E/I balance, a limitation that the authors might consider addressing in the future.

      We are grateful for this suggestion and fully agree that the aperiodic component of the power spectrum is not necessarily the most optimal and accurate measure for quantifying E/I balance. We have now included this limitation in the discussion section.

      Recommendations for the authors

      Reviewer #1: 

      (1) In the Results section, it might be helpful to provide the mean values of the aperiodic exponent (before age correction) for all tested groups and subgroups. As this measure is still not widely used, providing these values would allow readers to better understand the normal range of the aperiodic exponent.

      We have added the mean values of the aperiodic exponent and their standard deviation (before age correction) to the manuscript's results section (page 6 and 11).

      (2) When reporting the aperiodic exponent across all cortical sources (Q3), I think it would be useful to include the raw values in Figure 6 in the main text rather than in the Supplementary Materials. At a glance, these plots seem to suggest that the aperiodic exponent differs between groups in the occipital and parietal regions, even though no tests were significant after correcting for multiple comparisons. Maybe this observation also deserves a mention in the text and possibly in the Discussion..?

      We have moved the report on the aperiodic exponent across all cortical sources from the Supplementary Material to the main text. It is now Fig. 7 of the main manuscript. Moreover, we agree that the plots suggest group differences in certain brain regions. However, according to our rigorous open and reproducible science practices and pre-registration, we prefer not to speculate on these non-significant findings. 

      (3) In the Methods section, when describing the participants, the authors state that "Gender was balanced across both groups...". It might be better to avoid referring to the datasets as "balanced," considering that the sample includes almost twice as many females as males.

      We have replaced the misleading statement with the more precise statement that ”the gender ratio of both groups was similar.”

      (4) In the Methods section, when describing the source localization, I find it slightly confusing that the authors first mention the anterior cingulate cortex as a possible label included in the mPFC cortical parcels but then state that the version of the cortical atlas used did not contain such a label. It might be simpler not to mention the cingulate cortex at all.

      We have deleted the misleading sentence from the manuscript.  

      Reviewer #2: 

      (1) The aperiodic exponent of the EEG power spectrum is often considered an indicator of the excitatory/inhibitory (E/I) balance, but this measure can be susceptible to artifacts. It is important to acknowledge this limitation and consider exploring alternative measures to quantify the E/I ratio in future studies.

      We are grateful for this suggestion and fully agree that the aperiodic component of the power spectrum is not necessarily the most optimal and accurate measure for quantifying E/I balance. We have now included this limitation in the discussion section.

      (2) The study assumed a linear relationship between the E/I ratio (represented by the aperiodic exponent of the EEG power spectrum) and chronic pain. However, this assumption may not hold true in all cases, and this point could be discussed in the study.

      We fully agree that the relationship between the E/I ratio and chronic pain might not be a linear one and have added this point to the discussion section.

      (3) The aperiodic component was characterized in eyes-closed resting-state EEG recordings, although EEG data were collected in both eyes-closed and eyes-open conditions. The authors could also consider assessing the aperiodic component from EEG data with eyes open.

      We thank the reviewer for this suggestion. We have focused our analysis on eyes-closed recordings since these recordings are usually less contaminated by artifacts than eyes-open recordings. Moreover, in our current datasets, some participants were missing eyes-open recordings. We agree that performing similar analyses for the eyes-open recordings would also be interesting. However, adding these analyses would double the amount of data included in the manuscript, which would likely overload it. We have, therefore, now included a statement to the discussion that future studies should also analyze eyes-open EEG recordings.  

      (4) The EEG power spectrum was calculated from signals after source reconstruction, a crucial step for targeting specific brain regions. However, this process can introduce potential signal distortions, such as variations in source waveforms depending on different regularization parameters. To ensure the robustness of the results, the authors could perform the same analysis at the sensor level, for example, using signals recorded at Fz.

      We agree on the potential shortcomings and limitations of source space analysis and have added this limitation to the discussion section.

      (5) It would be beneficial to present the raw EEG power spectrum averaged across subjects for each condition, along with the scalp distribution of the aperiodic exponent. This would enhance readers' understanding of the study and help demonstrate the quality of the data.

      We are grateful for this suggestion and added the power spectrum for each condition and the scalp distribution of the aperiodic exponent to the Supplementary Material.

      (6) Linear regression models were used to control for the influence of age on aperiodic exponents and pain intensity ratings. However, it is unclear why other relevant variables, such as gender and medication use, were not considered.

      We agree that the aperiodic exponent might be influenced by gender and medication. As these analyses had not been included in our pre-registered analysis plan, we have not performed them. Moreover, although we agree that gender might have an impact, we have not found any evidence for this so far. Regarding medication, we fully agree that medication can influence the measure. However, medication was very heterogeneous, including drugs with fundamentally different mechanisms of action. Thus, we do not see a robust way to appropriately analyze these effects with sufficient statistical power. We have now added this important point to the discussion section.

      (7) The authors may consider addressing or discussing the impact of inter-individual variability on the negative results, particularly given that the data were derived from multiple experiments.

      We agree that the heterogeneous sample of people with chronic pain increases variability and limits the availability of clinical measures. We have added this limitation to the discussion.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable work advances our understanding of the foraging behaviour of aerial insectivorous birds. Its major strength is the large volume of tracking data and the accuracy of those data. However, the evidence supporting the main claim of optimal foraging is incomplete.

      We deeply appreciate the thoughtful review provided by the reviewers, including their valuable insights and meticulous attention to detail. Each comment has been thoroughly evaluated, leading to substantial improvements in the manuscript. Your constructive critique has been instrumental in refining our research and rectifying any oversights. We are confident that the revised article will make a substantial contribution to ecological research, particularly in advancing our understanding of foraging theories and the behaviors of aerial insectivores.

      Public Reviews:

      Reviewer #1 (Public Review):

      This study tests whether Little Swifts exhibit optimal foraging, which the data seem to indicate is the case. This is unsurprising as most animals would be expected to optimize the energy income: expenditure ratio; however, it hasn't been explicitly quantified before the way it was in this manuscript.

      The major strength of this work is the sheer volume of tracking data and the accuracy of those data. The ATLAS tracking system really enhanced this study and allowed for pinpoint monitoring of the tracked birds. These data could be used to ask and answer many questions beyond just the one tested here.

      The major weakness of this work lies in the sampling of insect prey abundance at a single point on the landscape, 6.5 km from the colony. This sampling then requires the authors to work under the assumption that prey abundance is simultaneously even across the study region - an assumption that is certainly untrue. The authors recognize this problem and say that sampling in a spatially explicit way was beyond their scope, which I understand, but then at other times try to present this assumption as not being a problem, which it very much is.

      Further, it is uncertain whether other aspects of the prey data are problematic. For example, the radar only samples insects at 50 m or higher from the ground - how often do Little Swifts forage under 50 m high?

      Another example might be that the phrases "high abundance" and "low abundance" are often used in the manuscript, but never defined.

      It may be fair to say that prey populations might be correlated over space but are not equal. It is this unknown degree of spatial correlation that lends confidence to the findings in the Results. As such, the finding that Little Swifts forage optimally is indeed supported by the data, notwithstanding some of the shortcomings in the prey abundance data. The authors achieved their aims and the results support their conclusions.

      Thanks for this comment.

      The basic assumption of this paper is that the abundance of insects bioflow in the airspace is correlated in space and varies over time. This has been demonstrated by different studies, see for example Bell et al. (Bell, J. R., Aralimarad, P., Lim, K. S., & Chapman, J. W. (2013). Predicting insect migration density and speed in the daytime convective boundary layer. PloS one, 8(1), e54202) in which positive correlation in insect bioflow is demonstrated between different sites that are more than 100 km away in Southern England. Given the much closer proximity of the colony and the radar site, as well as the large foraging distance of the swifts that often forage in the vicinity of the radar and beyond it, it is reasonable to assume that the radar was able to successfully capture between-day variation in the abundance of flying insects in the airspace, which is highly relevant for the foraging swifts. This is likely because meteorological variables such as temperature and wind, which tend to vary over a synoptic-system scale of several hundred kilometers, significantly influence the abundance of aerial insects. Furthermore, the direction of insect flight that has been recorded by the radar points to an overall south-north directionality of the insects during the period of the study (Werber et al. Under Review: Werber, Y., Chapman, J. W., Reynolds, D. R. and Sapir, N. Active navigation and meteorological selectivity drive patterns of mass intercontinental insect migration through the Levant). Hence, it is reasonable to assume that since the colony is positioned approximately 6.5 km south of the radar site, the radar is able to reliable estimate the between-day variation in aerial insect abundance experienced by the foraging swifts. Importantly, this between-day variation is very high, and detailed information regarding this variation is provided in the paper.  We thank the reviewer for the comments on the wording and have corrected it accordingly so that it is explicitly stated that the spatial distribution of the flying insects is indeed not uniform, but is expected to be simultaneously affected by environmental variables creating spatially correlated bioflow of aerial insects.

      The term "high abundance" or "low abundance" is relative to the variable being examined but throughout the manuscript we did not use these terms to describe an absolute amount or a certain threshold but rather to describe the ecological circumstances experienced by the birds on different days that substantially varied in abundance of insect recorded by the radar. However, we have improved the wording of the text so that it is now clear that we refer to relative  and not to absolute values.

      At its centre, this work adds to our understanding of Little Swift foraging and extends to a greater understanding of aerial insectivores in general. While unsurprising that Little Swifts act as optimal foragers, it is good to have quantified this and show that the population declines observed in so many aerial insectivores are not necessarily a function of inflexible foraging habits. Further, the methods used in this research have great potential for other work. For example, the ATLAS system poses some real advantages and an exciting challenge to existing systems, like MOTUS. The radar that was used to quantify prey abundance also presents exciting possibilities if multiple units could be deployed to get a more spatially-explicit view.

      To improve the context of this work, it is worth noting that the authors suggest that this work is important because it has never been done before for an aerial insectivore; however, that justification is untrue as it has been assessed in several flycatcher and swallow species. A further justification is that this research is needed due to dramatic insect population declines, but the magnitude and extent of such declines are fiercely debated in the literature. Perhaps these justifications are unnecessary, and the work can more simply be couched as just a test of optimality theory.

      We appreciate the reviewer's helpful comment. A flycatcher is indeed an aerial insect eater, but its foraging strategy is very different from that of swifts. A comparison with the foraging strategy of the swallow is much more relevant. However, the methods used to quantify bird movement in the airspace in previous articles limited the ability to examine the optimal foraging theory in detail. Following the comment, we revised the text to better describe the uniqueness of our research. Further, since we studied insectivores, it is important to provide a broad context to potentially significant threats to the birds, albeit being debatable

      Reviewer #2 (Public Review):

      Summary:

      Bloch et al. investigate the relationships between aerial foragers (little swifts) tracked with an automated radio-telemetry system (Atlas) and their prey (flying insects) monitored with a small-scale vertical-looking radar device (BirdScan MR1). The aim of the study was to test whether little swifts optimise their foraging with the abundance of their prey. However, the results provided little evidence of optimal foraging behaviour.

      Strengths:

      This study addresses fundamental knowledge gaps on the prey-predator dynamics in the airspace. It describes the coincidence between the abundance of flying insects and features derived from tracking individual swifts.

      Weaknesses:

      The article uses hypotheses broadly derived from optimal foraging theory, but mixes the form of natural selection: parental energetics, parental survival (predation risks), nestling foraging, and breeding success.

      While this study explores additional behavioral theories alongside optimal foraging theory, its findings unequivocally support the latter. The highly statistically significant observed reduction in flight distance from the breeding colony in elation to increasing insect abundance (supporting predictions 1 and 2) coupled with an increased rate of colony visits (supporting prediction 5) demonstrate the Little Swifts' adeptness at optimizing their aerial foraging behavior. This behavior manifests in an enhanced frequency of visits to the breeding colony, underscoring their food provisioning maximization.

      Results are partly incoherent (e.g., "Thus, even when the birds foraged close to the colony under optimal conditions, the shorter traveling distance is not thought to not confer lower flight-related energetic expenditure because more return trips were made.", L285-287),

      Thanks for the comment. We have corrected this sentence.

      and confounding factors (e.g., brooding vs. nestling phase) are ignored.

      The breeding stage may indeed affect food provisioning properties but this factor is not confounded since insect abundance, and the consequent changes in bird foraging properties, fluctuated between sequential days while brooding and nestling phases take place over a period of several weeks, each. Further, despite the possible influence of breeding stages on bird behavior, variability in reproductive stages is expected among pairs in a breeding colony occupying dozens of pairs, despite some coordination in nesting initiation. Practically, the narrow and concealed nest openings hindered direct observation of the nests, posing challenges in determining the precise reproductive stage of each pair. Anyway, we added a short description of the dense colony structure to the Methods section.

      Some limits are clearly recognised by the authors (L329 and ff).

      See above the response about the distribution of insects in space.

      To illustrate potential confounding effects, the daily flight duration (Prediction 4) should decrease with prey abundance, but how far does the daily flight duration coincide with departure and arrival at sunrise and sunset (note that day length increases between March and May), respectively, and how much do parents vary in the duration of nest attendance during the day across chick ages?

      We added the following explanation to the Methods section:

      To standardize the effect of day length on daily foraging duration, we calculated and subtracted the day length from the total daily foraging time (Day duration - Daily foraging duration = Net foraging duration). The resulting data represent the daily foraging duration in relation to sunrise and sunset, independent of day length.

      To conclude, insufficient analyses are performed to rigorously assess whether little swifts optimize their foraging.

      We disagree. See our responses above.

      Filters applied on tracking data are necessary but may strongly influence derived features based on maximum or mean values. Providing sensitivity tests or using features less dependent on extreme values may provide more robust results.

      Thank you for highlighting the importance of considering the impact of data filtering on derived features. In our analysis, we employed rigorous filtering methods to emphasize central data tendencies while mitigating the influence of extreme values. These methods, validated through consultation with experts in tracking data analysis, follow established practices in the literature. Detailed descriptions of our filtering procedures can be found in the Methods section, with citations to relevant published studies.

      Radar insect monitoring is incomplete and strongly size-dependent. What is the favourite prey size of swifts? How does it match with BirdScan MR1 monitoring capability?

      We added an explanation to the Methods section to address this comment:

      The Radar Cross Section (RCS) quantifies the reflectivity of a target, serving as a proxy for size by representing the cross-sectional area of a sphere with identical reflectivity to water, whose diameter equals the target's body length. Recent findings indicate that the BirdScan MR1 radar can detect insects with an RCS as low as 3 mm², enabling the detection of insects with body lengths as small as 2 mm. These capabilities make the radar suitable for locating the primary prey of swifts, which typically range in size from 1 to 16 mm.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Lines 53-59 - major run-on sentence

      Thanks for the comment. Done.

      Line 133 - describe better. Attached where? Were feathers clipped or removed?

      Thanks for the comment. Done.

      Line 153 - shouldn't be a new paragraph

      Done.

      Line 157 - justify choosing four 

      To ensure a robust analysis of swifts' behavior relative to food abundance across multiple individuals simultaneously, we opted to exclude data from instances where only 3 tags were active. This decision was motivated by the fact that these instances accounted for only 2.9% of the data, and their exclusion minimally impacted overall data volume while enhancing data quality. In contrast, instances with 4 tags, comprising 16.2% of the data, provided substantial insights. Omitting these instances would have resulted in significant data loss. Thus, setting a threshold of 4 simultaneous tags represents a balance between maintaining adequate data quantity and ensuring high data quality for meaningful analysis.

      It took me a long time to determine whether the average and maximum flight distance was actual or Euclidean. It was only in the Results that I grasped it was actual. Define up front in the Methods.

      Thanks for the comment. Done.

      In my public review, I mention that optimal foraging has been assessed in other aerial insectivores. Here are some of the papers I was referring to:

      • Davies (1977) Prey selection and the search strategy of the spotted flycatcher (Muscicapa striata): A field study on optimal foraging. Animal Behaviour 25: 1016-1022.

      • Lifjeld & Slagsvold (1988) Effects of energy costs on the optimal diet: an experiment with pied flycatchers Ficedula hypoleuca feeding nestlings. Ornis Scandinavica 19: 111-118.

      • Quinney & Ankney (1985) Prey size selection by tree swallows. Auk 102: 245-250.

      • Turner (1982) Optimal foraging by the swallow (Hirundo rustica, L): Prey size selection. Animal Behaviour 30:862-872.

      Lastly, in terms of the work not being spatially-explicit, I do note that in lines 323-324 you acknowledge that prey populations can be patchy, then ten lines later, you provide citations to say that patchiness is not a problem because of spatial correlations. This is a bit overly dismissive, in my view, and to suggest (lines 336-337) that "patches of high insect concentration...might not exist at all" is certainly incorrect (and misleading). I do note the valiant attempt to address the spatial shortcoming in the remainder of the paragraph - although addressing it does not make the problem go away.

      Thanks for the comment.

      We revised the text to make it more coherent.

      Reviewer #2 (Recommendations For The Authors):

      L161: typo > missing space in 'meanof'

      Corrected.

      L192-193: Did the authors use the timing of sunrise and sunset to determine daytime?

      Yes. The daytime was calculated in relation to sunrise and sunset.

      Did the authors calculate the MTR from sunrise to sunset, or averaging the hourly MTR?

      If using hourly MTR, specify the criteria to assign an hourly MTR to daytime when sunset/sunrise is happening during that hour.

      A simplified terminology for "Average daily insect MTR" might be useful, in particular for the result section (insect MTR).

      Average daily insect MTR is calculated for a fixed period from 5 am to 8 pm local time. An explanation has been added to the Methods section, and the terminology in the text has been simplified as suggested

      Note that the 'M' of MTR stands for migration, which may not be appropriate in this context, and simply using "insect traffic rate" may be a better terminology.

      Thanks for the comment. The 'M' of MTR can also stand for movement, as the insects detected by the radar move in the airspace. This is how this term has been defined in the paper (e.g. in line 23 of the Summary section). Therefore, we did not change the terminology to “insect traffic rate”, which is a term not used in other studies.

      Considering the large number of predictions (10!), it would be appropriate to list them in the results (e.g., "on the daily average flight distance from the breeding colony (Prediction 3)").

      We added prediction numbers to the Results and the Discussion.

      Note that the terminology varies; e.g., in the introduction "overall daily flight distance" (L75), in the results "average length of the daily flight route" (L236), and further confusion with "daily average flight distance from the breeding colony" (L232).

      Thanks for the comment. fixed.

      The terminology - average daily 'air/flight' distance (L74-76) - needs clarification.

      Done.

      Results: Use only a relevant and consistent number of decimals to report on the effect size and p-values.

      Done.

      The authors are citing non-peer-reviewed publications:

      21. Bloch I, Troupin D, Sapir N. Movement and parental care characteristics during the nesting season of 468 the Little Swift (Apus affinis) [Poster presentation]. 12th European Ornithologists' Union Congress. Cluj Napoca, Romania. 2019.

      62. Zaugg S, Schmid B, Liechti F. Ensemble approach for automated classification of radar echoes into functional bird sub-types. In: Radar Aeroecology. 2017. p. 1. doi:10.13140/RG.2.2.23354.80326

      It is acceptable to cite non-peer-reviewed sources if they have a significant contribution to the background of the article without a critical impact on the core of the research.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In the first half of this study, Pham et al. investigate the regulation of TEAD via ubiquitination and PARylation, identifying an E3 ubiquitin ligase, RNF146, as a negative regulator of TEAD activity through an siRNA screen of ubiquitin-related genes in MCF7 cells. The study also finds that depletion of PARP1 reduced TEAD4 ubiquitination levels, suggesting a certain relationship between TEAD4 PARylation and ubiquitination which was also explored through an interesting D70A mutation. Pham et al. subsequently tested this regulation in D. melanogaster by introducing Hpo loss-of-function mutations and rescuing the overgrowth phenotype through RNF146 overexpression.

      In the second half of this study, Pham et al. designed and assayed several potential TEAD degraders with a heterobifunctional design, which they term TEAD-CIDE. Compounds D and E were found to effectively degrade pan-TEAD, an effect which could be disrupted by treatment with TEAD lipid pocket binders, proteasome inhibitors, or E1 inhibitors, demonstrating that the TEAD-CIDEs operate in a proteasome-dependent manner. These TEAD-CIDEs could reduce cell proliferation in OVCAR-8, a YAP-deficient cell line, but not SK-N-FI, a Hippo pathway independent cell line. Finally, this study also utilizes ATAC-seq on Compound D to identify reductions in chromatin accessibility at the regions enriched for TEAD DNA binding motifs.

      Strengths:

      The study provides compelling evidence that the E3 ubiquitin ligase RNF146 is a novel negative regulator of TEAD activity. The authors convincingly delineate the mechanism through multiple techniques and approaches. The authors also describe the development of heterobifunctional pan-degraders of TEAD, which could serve as valuable reagents to more deeply study TEAD biology.

      Weaknesses:

      The scope of this study is extremely broad. The first half of the paper highlights the mechanisms underlying TEAD degradation; however, the connection to the second half of the paper on small molecule degraders of TEAD is jarring, and it seems as though two separate stories were combined into this single massive study. In my opinion, the study would be stronger if it chose to focus on only one of these topics and instead went deeper.

      We thank the reviewer for the thoughtful feedback. In our mind, the two parts of the paper are inherently related as they both focus on proteasome-mediated degradation of TEADs. We first demonstrated that TEAD can be turned over by the ubiquitin proteasome system under endogenous conditions and identified a PARylation-dependent E3 ligase RNF146 as a major regulator of TEAD stability. Intriguingly, we observed that the four TEAD paralogs show different levels of polyubiquitination with some of them being highly stable in cells. These observations raised the question of whether the activity of the ubiquitin-proteasome system could be further enhanced pharmacologically to effectively target TEADs. We then tackled this question by providing a proof-of-concept demonstration of engineered heterobifunctional protein degraders can effectively degrade TEADs in cells and can be exploited as a therapeutic strategy for treating Hippo-dependent cancers.

      Additionally, the figure clarity needs to be substantially improved, as readability and interpretation were difficult in many panels. Lastly, there are numerous typos and poor grammar throughout the text that need to be addressed.

      We appreciate the suggestions from the reviewer and have updated the figures with high resolution images. We also corrected typos and grammatical errors in the text.

      Reviewer #2 (Public Review):

      The paper is made of two parts. One deals with RNF146, the other with the development of compounds that may cause TEAD degradation. The two parts are rather unrelated to each other.

      The main limit of this work is the lack of evidence that TEAD factors are in fact regulated by the proteasome and ubiquitylation under endogenous conditions. Also lacking is the demonstration that TEADs are labile proteins to the extent that such quantitative regulation at the level of stability can impact on YAP-TAZ biology. Without these two elements, the relevance and physiological significance of all these data is lacking.

      As for the development of new inhibitors of TEAD, this is potentially very interesting but underdeveloped in this manuscript. Irrespectively, if TEAD is stable, these molecules are likely lead compounds of interest. If TEAD is unstable, as entertained in the first part of the paper, then these molecules are likely marginal.

      We thank the reviewer for evaluating our manuscript. As the reviewer pointed out, the paper aimed to address 1) whether TEAD is being regulated by the proteasome and ubiquitination under endogenous conditions, and 2) whether TEAD can be inhibited through pharmacologically-induced degradation. First, we demonstrated that TEAD is ubiquitinated in cells and mapped the lysine residues that are poly-ubiquitinated (Fig. 1). Next, we identified RNF146 as a major E3 ligase that ubiquitinates TEADs and reduces their stability. Third, we show that RNF146-mediated TEAD ubiquitination is functionally important: RNF146 suppresses TEAD activity, and RNF146 genetically interacts with Hippo pathway components in fruit flies. Furthermore, as we showed in Fig. S2H, RNF-146 does not affect TEAD1 and TEAD4 to the same extent. Across all four cell lines evaluated, TEAD1 is more stable than TEAD4, raising the question of whether more consistent degradation of different TEAD paralogues could be achieved. To this end, we demonstrated that while the TEAD family of proteins is labile under endogenous conditions, more complete degradation of the TEAD proteins could be achieved using a heterobifunctional CRBN degrader. We further characterized these TEAD degraders in a series of cellular and genomic assays to demonstrate their cellular activity, selectivity, and inhibitory effects against YAP/TAZ target genes. We believe these degrader compounds would be of great interest to the Hippo community. We have revised the main text to clarify these points.

      Here are a few other specific observations:

      (1) The effect of MG is shown in a convoluted way, by MS. What about endogenous TEAD protein stability?

      We thank the reviewer for the question. The MS experiment shown in Figure 1 is a standard KGG experiment, where we used MS to map ubiquitination sites on TEADs. The graphical representation of the process is included in Fig. 1C, and the details of the procedure are included in the Methods section. Fig. 1D shows the different KGG peptides detected with or without MG-132 treatment. Fig. 1E shows the quantified abundance of each of the peptides across the four conditions indicated at the bottom of the plot. Regarding endogenous TEAD stability, ​​we conducted cycloheximide chase experiments to assess the stability of endogenously expressed TEAD isoforms upon RNF146 knockdown (Fig. S2G and S2H). Using isoform-specific antibodies, we demonstrated that siRNF146 significantly stabilized TEAD4 in multiple cell lines, including H226, PATU-8902, Detroit-562, and OVCAR-8 (Fig. S2G, S2H, and S2I), supporting the notion that RNF146 is a negative regulator of TEAD stability. Notably, the effect of siRNF146 on TEAD1 stability was less pronounced, and TEAD1 is more stable than TEAD4 across all four cell lines. These results are consistent with the lower level of ubiquitination of TEAD1 (Fig. 1A) and are corroborated by various biochemical, molecular, and genetic characterizations (Fig. 3A-C and S3E).

      (2) The relevance of siRNF on YAP target genes of Fig.2D is not statistically significant.

      We thank the reviewer for this comment. We have now removed the statistically significant claim.

      (3) All assays are with protein overexpression and Ub-laddering

      We thank the reviewer for the comment. To examine the ubiquitination level of TEAD proteins, we adopted an in vivo ubiquitination assay as described in our Materials and Methods section. To our knowledge, this assay is very standard in the ubiquitination field. Furthermore, as mentioned above, we have included in our revised manuscript cycloheximide chase experiments to assess the stability of endogenously expressed TEAD isoforms upon RNF146 knockdown (Fig. S2G and S2H). In addition to the overexpression system, we also assessed endogenously expressed TEAD using isoform-specific antibodies. We demonstrated that siRNF146 firmly stabilized TEAD4 in multiple cell lines, including H226, PATU-8902, Detroit-562, and OVCAR-8 (Fig. S2G with quantification and t-test), supporting the notion that RNF146 is a negative regulator of TEAD stability.

      (4) An inconsistency exists on the only biological validation (only by overexpression) on the fly eye size. RNF gain in Fig4C is doing the opposite of what is expected from what is portrayed here as a YAP/TEAD inhibitor: RNF gain is shown to INCREASE eye size, phenocopying a Hippo loss of function phenotype. According to the model proposed, RNF addition should reduce eye size. The authors stated that " This is in contrast to the anti-growth effect of RNF-146 in the Hpo loss-of-function background and indicates RNF146 may regulate other genes/pathways controlling eye sizes besides its role as a negative regulator of Sd/yki activity". This raises questions on what the authors are really studying: why, according to the authors, these caveats should occur on the controls, and not when they study Hpo mutants?

      We thank the reviewer for the comment. We acknowledge the complexity of the fly phenotype compared to tumor growth. TEAD (Sd) isn’t the only substrate of RNF146 in the fly. For instance, RNF146 is known to positively regulate Wnt signaling by degrading Axin. Previous studies have shown that activation of the Wnt signaling pathway by removal of the negative regulator Axin from clones of cells results in an overgrowth phenotype (Legent and Treisman, 2008). The overgrowth phenotype that we observed with overexpressing RNF146 only, therefore, likely is due to the role of RNF146 in regulating other signaling pathways. Importantly, we showed that upon Hippo loss of function, overexpression of RNF146 can rescue the Hippo overgrowth phenotype (Fig 4B). This differential outcome of RNF146 expression in wildtype versus Hippo-deficient flies indicates that the genetic interactions between RNF146 and Hippo pathway components altered the phenotypic outcome, and the phenotype we get with RNF146 overexpression in a Hippo loss of function background is not simply due to additive effects of functional loss of either component alone.

      Complementary to these overexpression data, we showed that knockdown of RNF146 increased the eye size further (Fig. S4A, B) in Hippo loss of function background, further supporting the role of RNF146 as a negative regulator of the overall pro-growth signals induced by yki upon Hippo loss of function.

      (5) The role of TEAD inactivation on YAP function is already well known. Disappointingly, no prior literature is cited. In any case, this is a mere control.

      We thank the reviewer for the suggestion. We have cited several published reviews that touch upon this aspect of the TEAD-YAP function, including Calses et al., 2019; Dey et al., 2020; Halder and Johnson, 2011; Wang et al., 2018. We are open to your suggestions on additional citations.

      (6) The second part of the paper on the Development and Screening of pan-TEAD lipid pocket degraders is interesting but unconnected to the above. The degradation pathway it involves has nothing to do with the enzyme described in the first figures.

      We thank the reviewer for the comment. We acknowledge that our paper broadly covers two aspects. We believe that they are inherently connected as they both address ubiquitin/proteasome-mediated TEAD degradation and the functional consequences of TEAD degradation. Given the increasing interest in targeting TEAD/YAP/TAZ in cancers, we think the pharmacological approaches to enhance TEAD degradation using orthogonal E3 ligases provide an important toolbox to understand how this pathway can be regulated under both physiological and pathological conditions. While RNF146 appears to be a major E3 ligase responsible for TEAD turnover under physiological conditions, we showed that the four TEAD paralogs have different poly-ubiquitination levels (Fig. 1A), and are differentially labile in cells (Fig. S2G-I). These observations raised the question of whether the activity of the ubiquitination-proteasome system could be further enhanced to allow more complete removal of TEADs. To this end, we demonstrated that E3 ligases that do not regulate TEAD under endogenous conditions can be leveraged pharmacologically to achieve deep TEAD degradation, thus providing a proof of concept that TEADs can be targeted simultaneously using such approaches. Finally, in addition to establishing the basic biological concept linking RNF146 to TEAD degradation, the compounds we engineered will serve as valuable chemical tools for future studies of TEAD biology and the Hippo pathway in cancers and beyond.

      (7) The role of CIDE on YAP accessibility to Chromatin is superficially executed. Key controls are missing along with the connection with mechanisms and prior knowledge of TEAD, YAP, chromatin, and other TEAD inhibitors, just to mention a few.

      We used ATAC-seq to assess chromatin accessibility comparing cells treated with DMSO and two different concentrations of compound D. We acknowledge there are small molecule inhibitors of TEADs that can modulate accessibility of YAP binding sites. Potential mechanistic differences between TEAD degraders versus TEAD small molecule inhibitions will be a future area of investigation.

      (8) The physiological relevance and the mechanistic interpretation of what should be in the ATAC seq in ovcar cells is missing.

      We showed in Fig. 7A-D the dose response of OVCAR cells to the TEAD degraders. As evident from those experiments, TEAD degraders inhibit the proliferation of OVCAR cells as expected from their dependencies on the TEAD/YAP/TAZ transcription complex. In the ATAC-seq experiment, we showed that the canonical TEAD/YAP/TAZ target genes ANKRD1 and CCN1 have reduced chromatin accessibility at their promoter/enhancer regions (Fig. 8C). By unbiased motif and pathway analyses, we show that TEAD binding sites and YAP signatures are most significantly downregulated in OVCAR-8 cells (Fig. 8D-E). These results are incorporated into the results section of the manuscript.

      Reviewer #3 (Public Review):

      Summary

      Pham, Pahuja, Hagenbeek, et al. have conducted a comprehensive range of assays to biochemically and genetically determine TEAD degradation through RNF146 ubiquitination. Additionally, they designed a PROTAC protein degrader system to regulate the Hippo pathway through TEAD degradation. Overall, the data appears robust. However, the manuscript lacks detailed methodological descriptions, which should be addressed and improved before publication. For instance, the methods used to analyze the K48 ubiquitination site on TEAD and the gene expression analysis of Hippo Signaling are unclear. Furthermore, the multiple proteomics, RNA-seq, and ATAC-seq data must be made publicly available upon publication to ensure reproducibility. Most of the main figures are of low resolution, which needs addressing.

      We thank the reviewer for evaluating our manuscript. All of the data will be uploaded to public databases. We apologize for the low figure resolution and have updated the figures in the revised manuscript. We also expanded the methods section with more details.

      Strengths:

      - A broad range of assays was used to robustly determine the role of RNF146 in TEAD degradation.

      - Development of novel PROTAC for degrading TEAD.

      Weaknesses:

      - An orthogonal approach is needed (e.g., PARP1 inhibitor) to demonstrate PARP1's dependency in TEAD ubiquitination.

      We thank the reviewer for the suggestion. We had attempted to assess the effect of PARP inhibitors (including veliparib and olaparib) on TEAD ubiquitination, but the data is relatively complex to interpret. Besides inhibiting PARP1/2 catalytic activities, these PARP inhibitors also trap PARP on chromatin. Hence, these inhibitors could induce other cellular changes in addition to inhibiting the catalytic activities of PARP1/2. Given these potential pitfalls, we decided not to include these inconclusive data. Even though the experiments with PARP inhibitors were inconclusive, our study supports that TEAD2 and TEAD4 are PARylated in cells using an anti-PAR antibody (Fig. 3B). Furthermore, we show that mutation of the D70 PARsylation site to alanine greatly abolished TEAD4 ubiquitination in cells, suggesting PARylation is important for TEAD4 ubiquitination. In addition, PARP1 depletion by siRNA and CRISPR guide RNA reduced TEAD2 and TEAD4 ubiquitination levels, indicating PARP1 is one of the PARPs responsible for TEAD PARylation in cells.

      - The data from Table 2 is unclear in illustrating the association of identified K48 ubiquitination with TEAD4, especially since the experiments were presumably to be conducted on whole cell lysates with KGG enrichment. This raises the possibility that the K48 ubiquitination could originate from other proteins. Alternatively, if the authors performed immunoprecipitation on TEAD followed by mass spectrometry, this should be explicitly described in the text and materials and methods section.

      We thank the reviewer for this question. The experiment was an IP-mass spectrometry study in a TEAD4 amplified cell line model (PATU-8902) after IP with a pan-TEAD antibody. Here, we observed K48 ubiquitin and other ubiquitin linkages as shown in the Supplementary Table S2 of the original submission. Although it is possible that the IP wash steps could be more stringent, we did enrich for TEAD protein prior to mass spectrometry. While the ubiquitin linkage signals may come mainly from TEAD protein (mainly TEAD4), we recognized that some signals may come from other proteins. Given the caveat, we have now removed the table from our paper and updated the text accordingly.

      - Figure 2D: The methodology for measuring the Hippo signature is unclear, as is the case for Figures 7E and F regarding the analysis of Hippo target genes.

      We apologize for the lack of clarification. In short, we previously developed the Hippo signature using machine learning and chemogenomics as described previously (Pham et al. Cancer Discovery 2021). In the revised version of the manuscript, we added the methodology for measuring the Hippo signature and cited our previous publication where we developed the Hippo signature.

      - Figure S3F requires quantification with additional replicates for validation.

      We thank the reviewer for the suggestion. We added the quantification for the blot and indicated the replication in the figure legend. Note that Figure S3F is now S3G.

      - There is a misleading claim in the discussion stating "TEAD PARylation by PAR-family members (Figure 3)"; however, the demonstration is only for PARP1, which should be corrected.

      We apologize for the statement. We observed both PARP1 and PARP9 in our TEAD IP-mass spec (now Figure S3E), which suggest both PARP-family members could be invovled. Nonetheless, we primarily focus on PARP1, which is widely expressed aross cell line models and present in higher abundance. Thus, our study only experimentally validated PARP1's role in regulating TEAD.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      General comments:

      (1) Please provide a smoother transition and well-defined connection between the first and second parts of the manuscript. The manuscript reads as two papers that were combined into one, without much attempt to disguise the fact.

      We thank the reviewer for the suggestion. We have added a transition paragraph to smoothen the transition. We acknowledge that our paper broadly covers two aspects. However, they both touch upon TEAD ubiquitination and degradation. In the first part of the manuscript, we described TEAD biology and showed that TEADs are post-translationally modified and subsequently regulated through PARylation-dependent RNF146-mediated ubiquitination. In the second part, we highlighted our abilities to leverage the PROTAC system for degrading such labile oncogenic proteins like TEADs. In addition to the biological concept, the compounds we engineered will serve as valuable chemical tools for future studies of TEAD biology and the Hippo pathway in cancers and beyond.

      (2) To confirm the proteasome mechanism of action, viability assays should be conducted with a CRBN KO.

      We thank the reviewer for the comment. In Figure 6E, we measured TEAD protein levels under CRBN knockdown and observed an expected change in TEAD stability. This observation and the other data presented in Figure 6 suggest that TEAD proteins are targeted for proteasomal degradation under compound D treatment.

      (3) As a control, sgPARP1 or PARP1 inhibitors should be used to confirm TEAD PARylation reduction.

      We thank the reviewer for the suggestion. We had attempted to assess the effect of PARP inhibitors (including veliparib and olaparib) on TEAD ubiquitination, but the data is relatively complex to interpret. Besides inhibiting PARP1/2 catalytic activities, PARP inhibitors also trap PARP on chromatin. Hence, these inhibitors could induce other cellular changes in addition to inhibit the catalytic activities of PARP1/2. Given these pitfalls, we decided not to include these inconclusive data. Even though the experiments with PARP inhibitors were inconclusive, our study supports that TEAD2 and TEAD4 are PARylated in cells using an anti-PAR antibody (Fig. 3B). Furthermore, we show that mutation of the D70 PARsylation site to alanine greatly abolished TEAD4 ubiquitination in cells, suggesting PARylation is important for TEAD4 ubiquitination. In addition, PARP1 depletion by siRNA and CRISPR guide RNA reduced TEAD2 and TEAD4 ubiquitination levels, indicating PARP1 is one of the PARPs responsible for TEAD PARylation in cells.

      (4) MS data looks convincing but an FDR of 1% should be applied - this is the accepted standard in the proteomics field. Please research the data with the more stringent filter.

      We thank the reviewer for the suggestion. Our IP-MS experiment comparing siNTC versus siYAP1/WWTR1 in Patu-8902 cells did not have replicates and FDR could not be derived. Therefore, we listed the raw data in Supplemental Table 3 without showing statistics. To validate the putative interactions identified by IP-MS, we performed IP-Western experiments to confirm that TEAD4 interacts with PARP1 (Figure 3A). It is important to note that in addition to our report, the interaction between PARP1 and TEADs has been observed in other publications (Calses et al., 2023; Yang et al., 2017). We have included more details of the IP-MS experiment reported in Supplemental Table 3 in the revised manuscript and cited previous work reporting TEAD-PARP1 interaction.

      (5) Proofread the manuscript more thoroughly for typos and grammatical errors.

      We thank the reviewer for raising this issue and have addressed it in the revision.

      (6) Improve figure clarity (e.g., clearly labeling graph axes).

      We apologize for the oversight. The revised manuscript contains high resolution figures.

      Specific points:

      Generally, the manuscript could use additional proofreading for grammar and clarity. It would not be practical to list all, but some representative examples are listed below:

      Run-on: "They act through an event-driven mechanism instead of conventional occupancy-driven pharmacology, in addition, target protein degradation removes all functions of the target protein and may also lead to destabilization of entire multidomain protein complexes."

      Typo: "Compound D exhibits significant inhibition of cell proliferation and downstream signaling compared to compound A, a reversible TEAD lipid pocket binder that lack the ubiquitin ligase binding moiety."

      Typo: "Thus, we sought to deplete TEAD proteins by directly target them for ubiquitination and proteasomal degradation via pharmacologically inducing interactions between TEAD and other abundantly expressed and PARylation-independent E3 ligases."

      Typo: "Compound A is a close in analog of Compound B as described previously (Holden et al., 2020)."

      We have revised the manuscript and corrected the typos and grammatical errors listed above and beyond.

      Specific comments on the figures are listed below:

      Figure 2:

      • Figures 2B and 2C should be separated into separate panels for clarity.

      We have updated the Figures 2B and 2C as suggested.

      • Figure 2C - "To further assess the function of RNF146, we depleted RNF146 by either sgRNA or siRNA." This should say either CRISPR-Cas9 KO or siRNA-mediated knockdown.

      We thank the reviewer for the suggestion. We revised the text to address this issue.

      • Figure 2D - y-axis is not labeled well/clearly. Additionally, there are different resolutions for the p-values on the graph (the top p-value is slightly clearer than the other two, suggesting either a different font was used or the value was pasted on top of a picture of the graph at a different resolution).

      We updated the figures according to the suggestions.

      • Figure S2A - "We identified three ubiquitin ligases - RNF146, TRAF3, and PH5A - as potential negative regulators for the Hippos pathway from the primary screen using the luciferase reporter." However, the siPHF5A data appears to decrease luciferase levels whereas siRNF146 and siTRAF3 increase it.

      We thank the reviewer for catching this error. We removed PH5A from this list.

      Figure 3:

      • Figure 3A - label more clearly. Is this an endogenous TEAD4 co-IP?

      We thank the reviewer for the suggestion. The experiment was an IP-mass spectrometry study in a TEAD4 amplified cell line model (PATU-8902) with pan-TEAD antibody. We have included the details to in the figure legends. Figure 3A is now Figure S3E in the revised manuscript.

      • Figure 3C - why are the dark and light exposures not matching/corresponding? In the dark exposure, there are two particularly dark bands, the darkest of which is at the top of the gel. However, this darkest band disappears in the light exposure gel. Additionally, the last lane is marked as +TEAD2 and +TEAD4. Not sure if this is a typo, and meant to be only +TEAD4? Seems a bit strange to have a double TEAD lane.

      We thank the reviewer for this comment and apologize for the oversight. There was a typo in the label. The light exposure image was from a replicate run instead of the same run, therefore the lanes didn’t all match up. We have removed the light exposure panel to resolve the confusion. (Figure 3B).

      Figure 5:

      • Figure 5B - why is shTEAD1-4/Sucrose a much higher tumor volume than shNTC/Sucrose negative control? Additionally, should the legend say "sNTC/Sucrose" as it does or "shNTC/Sucrose"?

      The labels for shTEAD1-4/Sucrose and shNTC/Sucrose are correct. We do not understand why there is a slight increase in tumor volume for shTEAD1-4/Sucrose and suspect that is due to the considerable variation in the experiment. This slight change, however, doesn’t influence our observation of tumor regression in shTEAD1-4 under the Doxycycline treatment.

      "sNTC/Sucrose" is a typo. We apologize for the oversight and have revised the figure.

      • Figure 5E - cited in text after Figures 6 and 7.

      We have updated the text accordingly.

      Figure 6:

      • Figure 6B - it is very interesting how this clearly shows the Hook effect for Compound D, but it's a bit harder to see for compound E that the compound degrades pan-TEAD. Would it be possible to quantify the blots to reinforce claims about protein degradation here?

      We thank the reviewer for the question. There may seem to be some hook effect across the three concentrations of compound D treatment in Fig. 6B.  However, in Fig. 6C-E, we observed pretty consistent TEAD degradation levels across a variety of concentrations. In addition, these experiments have been repeated in multiple cell lines with consistent results. We respectfully argue that more detailed investigation of the hook effect is beyond the scope of our study.

      Figure 7:

      • Figure 7F - this heat map is extremely difficult to interpret. Are there any interesting clusters? What are the darker/lighter bands for Compound D compared to DMSO control?

      We thank the reviewer for the comment and apologize for the lack of information on the figure. These are genes from a Hippo signature derived from our earlier work (Pham et al. Cancer Discovery). As a result of degrading TEAD when treating the cells with Compound D, we observed an expected downregulation of most of these genes compared to compound A.

      Figure 8:

      • Figure 8B - these two pie charts are also difficult to interpret. Perhaps try to present the data in a form other than encircling pie charts?

      We thank the reviewer for the suggestion. However, this is a very descriptive pie chart, we used this format to save space.

      • Figure 8C - what is GNE-6915? Is this Compound D?

      Yes, this is compound D. The text is updated accordingly.

      Reviewer #3 (Recommendations For The Authors):

      Figure 3A would benefit from explicitly stating the conditions within the figure, rather than referring to the legend. This clarity is also needed for Figure 8C, indicating whether the treatment was with compound D or GNE-6915.

      We thank the reviewer for the suggestion. We have added the details to the figures and made the suggested edits.

      Standardize the terms "ubiquitination" and "ubiquitylation" throughout the paper for consistency.

      We now use the term “ubiquitination” throughout the manuscript.

      The statement "In this study, we show that the activity of TEAD transcription factors can be post-transcriptionally regulated via the ubiquitin/proteasome system" should be corrected to "post-translationally regulated."

      We have update the manuscript accordingly.

      There is an additional exclamation mark above Figure 5E that should be removed.

      We have revised Figure 5E.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This study presents a useful modification of a standard model of genetic drift by incorporating variance in offspring numbers, claiming to address several paradoxes in molecular evolution. It is unfortunate that the study fails to engage prior literature that has extensively examined the impact of variance in offspring number, implying that some of the paradoxes presented might be resolved within existing frameworks.

      The prior literature the reviewers referred to are all "modified WF models". In the original submission, we lumped the standard and modified WF models together as the "generalized WF models". As the lumping causes confusions, their distinctions are now made clear.  That said, the Haldane model in our proposal is not a modification of the standard WF model because, conceptually, the two models are very different. WF is based on sampling whereas the Haldane model is based on gene transmission.

      While the "modified WF models" often incorporate V(K) [variance in progeny number], the modification is still based on the WF model of population sampling. The modification is mathematically feasible but biologically untenable, as explained explicitly in the revised text. Most important, all four paradoxes are as incompatible with the modified WF models as with the standard model. Note that the Haldane model does not have the sampling step, which is absorbed into the V(K) term. In the integrated WF-Haldane model, these paradoxes are resolved (see the new sections of Discussion, quoted below).

      If readers do not have time to ponder on all four paradoxes, they may simply read the first one, as follows. When the population size (N) is growing exponentially, such as in a bacteria culture, drift is nearly absent when N is small and becomes stronger as N increases, especially when approaching the carrying capacity.  Such common observations are exactly opposite of the WF model's central prediction. Any model based on sampling cannot escape the constraint of "greater drift, smaller N".

      Revision - The following text is a reproduction of the last 7 paragraphs of Discussion.

      “The standard WF model has been extended in several directions (overlapping generations, multiple alleles, ploidy, etc.). The modification most relevant to our studies here is the introduction of V(K) into the model, thus permitting V(K) ≠ E(K). While the modifications are mathematically valid, they are often biologically untenable. Kimura and Crow (1963) may be the first to offer a biological mechanism for V(K) ≠ E(K), effectively imposing the Haldane model on the WF model. Other models (Kimura and Crow 1963; Lynch, et al. 1995; Sjodin, et al. 2005; Der, et al. 2011; Cannings 2016) indeed model mathematically the imposition of the branching process on the population, followed by the WF sampling. The constructions of such models are biologically dubious but, more importantly, still unable to resolve the paradoxes. It would seem more logical to use the Haldane model in the first place by having two parameters, E(K) and V(K). 

      Even if we permit V(K) ≠ E(K) under the WF sampling, the models would face other difficulties. For example, a field biologist needs to delineate a Mendelian population and determine its size, N or Ne. In all WF models, one cannot know what the actual population being studied is. Is it the fly population in an orchard being sampled, in the geographical region, or in the entire species range? It is unsatisfactory when a population biologist cannot identify the population being studied. The Haldane model is an individual-output model (Chen, et al. 2017), which does not require the delineation of a Mendelian population.

      We shall now review the paradoxes specifically in relation to the modified WF models, starting with the multi-copy gene systems such as viruses and rRNA genes covered in the companion study (Wang, et al. 2024). These systems evolve both within and between hosts. Given the small number of virions transmitted between hosts, drift is strong in both stages as shown by the Haldane model (Ruan, Luo, et al. 2021; Ruan, Wen, et al. 2021; Hou, et al. 2023). Therefore, it does not seem possible to have a single effective population size in the WF models to account for the genetic drift in two stages. The inability to deal with multi-copy gene systems may explain the difficulties in accounting for the SARS-CoV-2 evolution (Deng, et al. 2022; Pan, Liu, et al. 2022; Ruan, Wen, et al. 2022; Hou, et al. 2023; Ruan, et al. 2023).

      We now discuss the first paradox of this study, which is about the regulation of N. In the general WF models, N is imposed from outside of the model, rather than self-generating within the model. When N is increasing exponentially as in bacterial or yeast cultures, there is almost no drift when N is very low and drift becomes intense as N grows to near the carrying capacity. As far as we know, no modifications of the WF model can account for this phenomenon that is opposite of its central tenet. In the general WF models, N is really the carrying capacity, not population size. 

      The second paradox of sex chromosomes is rooted in V(K) ≠ E(K). As E(K) is the same between sexes but V(K) is different, clearly V(K) = E(K) would not be feasible. The mathematical solution of defining separate Ne's for males and females (Kimura and Crow 1963; Lynch, et al. 1995; Sjodin, et al. 2005; Der, et al. 2011; Cannings 2016) unfortunately obscures the interesting biology. As shown in Wang et al. (2024; MBE), the kurtosis of the distribution of K indicates the presence of super-breeder males. While the Haldane model can incorporate the kurtosis, the modified WF models are able to absorb only up to the variance term, i.e., the second moment of the distribution. The third paradox of genetic drift is manifested in the fixation probability of an advantageous mutation, 2_s_/V(K). As explained above, the fixation probability is determined by the probability of reaching a low threshold that is independent of N itself. Hence, the key parameter of drift in the WF model, N (or Ne), is missing. This paradox supports the assertion that genetic drift is fundamentally about V(K) with N being a scaling factor. 

      As the domain of evolutionary biology expands, many new systems do not fit into the WF models, resulting in the lack of a genetic drift component in their evolutionary trajectories. Multi-copy gene systems are obvious examples. Others include domestications of animals and plants that are processes of rapid evolution  (Diamond 2002; Larson and Fuller 2014; Purugganan 2019; Chen, Yang, et al. 2022; Pan, Zhang, et al. 2022; Wang, et al. 2022). Due to the very large V(K) in domestication, drift must have played a large role. Somatic cell evolution is another example with “undefinable” genetic drift (Wu, et al. 2016; Chen, et al. 2017; Chen, et al. 2019; Ruan, et al. 2020; Chen, Wu, et al. 2022). The Haldane (or WFH) model, as an "individual output" model, can handle these general cases of genetic drift.

      The Haldane model and the WF model are fundamentally different approaches to random forces of evolution. While the WF models encounter many biological contradictions, they have provided approximate mathematical solutions to more realistic scenarios. In systems such as in viral evolution (Ruan, Hou, et al. 2022; Hou, et al. 2023) or somatic cell evolution (Chen, Wu, et al. 2022; Zhai, et al. 2022) whereby the WF solution is absent, further development of the WFH model will be necessary.”

      In addition, while the modified model yields intriguing theoretical predictions, the simulations and empirical analyses are incomplete to support the authors' claims.

      This point is addressed in the responses to reviewers' comments. Since they are quite technical, they do not fit in the overview here.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors present a theoretical treatment of what they term the "Wright-Fisher-Haldane" model, a claimed modification of the standard model of genetic drift that accounts for variability in offspring number, and argue that it resolves a number of paradoxes in molecular evolution. Ultimately, I found this manuscript quite strange.

      The notion of effective population size as inversely related to the variance in offspring number is well known in the literature, and not exclusive to Haldane's branching process treatment. However, I found the authors' point about variance in offspring changing over the course of, e.g. exponential growth fairly interesting, and I'm not sure I'd seen that pointed out before.

      Weaknesses:

      I have several outstanding issues. First of all, the authors really do not engage with the literature regarding different notions of an effective population. Most strikingly, the authors don't talk about Cannings models at all, which are a broad class of models with non-Poisson offspring distributions that nonetheless converge to the standard Wright-Fisher diffusion under many circumstances, and to "jumpy" diffusions/coalescents otherwise (see e.g. Mohle 1998, Sagitov (2003), Der et al (2011), etc.). Moreover, there is extensive literature on effective population sizes in populations whose sizes vary with time, such as Sano et al (2004) and Sjodin et al (2005).

      Of course in many cases here the discussion is under neutrality, but it seems like the authors really need to engage with this literature more.

      The reviewer's summary and weakness statement reflects the general criticism summarized by the editors. The reply and revision to these criticisms have been presented in the long reply to elife assessment above.

      We hence re-emphasize only the key points here.

      (1) The literature that the reviewers fault us for not citing is about the modifications of the standard WF model. We now cite them as well as a few others in that vein. However, the WF-Haldane model we propose is conceptually very different from the modified WF models. This WFH model is in essence the Haldane model which may use the results of the WF models as the starting point to find the exact solutions.

      (2) The check of the power of the modified WF models is whether they can resolve the paradoxes. None of them can. The arguments apply to neutral cases as well as selection effects. Hence, our central point is that the modifications of the standard WF model [e.g., by incorporating V(K)] do not help the WF model in resolving the paradoxes.  Besides, the incorporation of V(K) is mathematically feasible but biologically untenable as presented in the new sections of Discussion.

      Nonetheless, I don't think the authors' modeling, simulations, or empirical data analysis are sufficient to justify their claims.

      The most interesting part of the manuscript, I think, is the discussion of the Density Dependent Haldane model (DDH). However, I feel like I did not fully understand some of the derivation presented in this section, …… - this is the whole notion of exchangeability, also neglected in this manuscript). As such, I don't believe that their analysis of the empirical data supports their claim. [Since the comments above are highly technical and fairly long, they are not copied verbatim.]

      We thank this reviewer for the detailed comments with respect to the potential confusion in the discussion of the Density Dependent Haldane (DDH) model.

      First, the reviewer appears to ask how Eqs (5-6) are derived. We should clarify that both Eq (5) and (6) are assumptions rather than derived results. Both equations are assumptions based on population ecology. Eq (7) is then derived by substituting the assumptions in Eq (5) and (6) into Eq (3).

      The definition in Equation (5) allows the growth rate of the population size to be dependent on N itself, such that growth rate E(K) (average offspring number per generation) is greater than 1 when N < Ck and less than 1 when N > Ck. The parameter z is introduced to adjust the sensitivity of E(K) to changes in population size (as shown in Fig. 3a).

      Second, we appreciate the comments regarding the use of individual-based simulations and the apparent lack of interaction between individuals. In our simulations, there is indeed an interaction among individuals, which is represented by Eq (5). This equation reflects how the competition between two alleles affects the expected growth rate 𝐸(𝐾), which decreases as the population size increases. Furthermore, once 𝐸(𝐾) for the entire population is determined, the offspring numbers of the alleles are independent.

      We believe that the primary purpose of our simulations was not clearly stated. This lack of clarity may be the root of the criticisms. We now note that the simulations are aimed at testing the accuracy of Equation (10).

      Note that Eq. (10) is a textbook result and quite important in our study. This equation shows that the strength of genetic drift, as given by Pf (the fixation probability of an advantageous mutation), is not a function of N at all. This approximate solution has been obtained using the WF model by Kimura.  The Haldane model solution that can explain Paradox 1 is based on Equation (7) as shown below

      Since the fixation probability of Equation (10) cannot be easily obtained using Eq. (7), we conducted simulations to confirm the accuracy of Eq. (10) when applied to the Haldane model.

      We have revised the relevant sections of the manuscript to clarify these points and to better distinguish between assumptions and results. 

      Revision - Details of the DDH model are given in the Supplementary Information. A synopsis is given here: We consider a non-overlapping haploid population with two neutral alleles. The population size at time t is Nt. We assume that expected growth rate E(K) is greater than 1 when N < Ck and less than 1 when N > Ck, as defined by Eq. (5) below:

      The slope of E(K) vs. N (i.e., the sensitive of growth rate to changes in population size), as shown in Fig 3a, depends on z. To determine the variance V(K), we assume that K follows the negative binomial distribution whereby parents would suffer reproduction-arresting injury with a probability of pt at each birthing (Supplementary Information). Accordingly, V(K) can then be expressed as

      By Eq. (6), the ratio of V(K)/E(K) could be constant, decrease or increase with the increase of population size. With E(K) and V(K) defined, we could obtain the effective population size by substituting Eq. (5) and Eq. (6) into Eq. (3).

      Eq. (7) presents the relationship between effective population size (Ne) and the population size (N) as shown in Fig. 3. The density-dependent E(K) could regulate N with different strength (Fig. 3a). The steeper the slope in Fig. 3a, the stronger the regulation.

      Simulation of genetic drift in the Haldane model and the Wright-Fisher (WF) model. In both models, interactions between individuals are implicitly included through the dependency of the average number of offspring on population size, as defined by Eq. (5). This dependency leads to the logistic population growth, reflecting the density-dependent interactions.

      Thus, while I think there are some interesting ideas in this manuscript, I believe it has some fundamental issues:

      first, it fails to engage thoroughly with the literature on a very important topic that has been studied extensively. Second, I do not believe their simulations are appropriate to show what they want to show. And finally, I don't think their empirical analysis shows what they want to show.

      References omitted

      The comments are the summary of previous ones, which have been addressed in detail in the preceding sections.

      Reviewer #2 (Public Review):

      Summary:

      This theoretical paper examines genetic drift in scenarios deviating from the standard Wright-Fisher model. The authors discuss Haldane's branching process model, highlighting that the variance in reproductive success equates to genetic drift. By integrating the Wright-Fisher model with the Haldane model, the authors derive theoretical results that resolve paradoxes related to effective population size [Ne]

      Thanks.  The issue of Ne will be addressed below where the reviewer returns to this issue. The strength of the integrated WFH model is that N (or Ne) is generated by the model itself, rather than externally imposed as in WF models.

      Strengths:

      The most significant and compelling result from this paper is perhaps that the probability of fixing a new beneficial mutation is 2s/V(K). This is an intriguing and potentially generalizable discovery that could be applied to many different study systems.

      The authors also made a lot of effort to connect theory with various real-world examples, such as genetic diversity in sex chromosomes and reproductive variance across different species.

      Thanks. 

      Weaknesses:

      One way to define effective population size is by the inverse of the coalescent rate. This is where the geometric mean of Ne comes from. If Ne is defined this way, many of the paradoxes mentioned seem to resolve naturally. If we take this approach, one could easily show that a large N population can still have a low coalescent rate depending on the reproduction model. However, the authors did not discuss Ne in light of the coalescent theory. This is surprising given that Eldon and Wakeley's 2006 paper is cited in the introduction, and the multiple mergers coalescent was introduced to explain the discrepancy between census size and effective population size, superspreaders, and reproduction variance - that said, there is no explicit discussion or introduction of the multiple mergers coalescent.

      The Haldane model treats N’s very differently from the WF models.  In the WF models, N’s are imposed externally (say, constant N, exponentially growing N, temporally fluctuating N’s and so on; all provided from outside of the model). Ne and coalescence are all derived from these given N’s.  In order to account for the first paradox (see the next paragraph), N needs to be regulated but the WF models cannot regulate N’s. The density-dependent Haldane model that Reviewer 1 inquired above is a model that regulates N internally. It can thus account for the paradox.

      Paradox 1 -  When the population size (N) is growing exponentially, such as in a bacteria culture, drift is nearly absent when N is small and is much stronger as N increases, especially when approaching the carrying capacity.  Such a pattern is a common observation and is exactly opposite of the WF model's central prediction. In short, a model that does not regulate N cannot explain the paradox

      Ne is a fix of the WF model in order to account for the missing components of genetic drift. The paradoxes presented in this one and the companion study show that the fix is rather inadequate.  In contrast, by the WFH model, N is regulated within the model itself as E(K) and V(K) are both functions of N.

      The Wright-Fisher model is often treated as a special case of the Cannings 1974 model, which incorporates the variance in reproductive success. This model should be discussed. It is unclear to me whether the results here have to be explained by the newly introduced WFH model, or could have been explained by the existing Cannings model. The abstract makes it difficult to discern the main focus of the paper. It spends most of the space introducing "paradoxes".

      We appreciate greatly the illuminating advice.  Nevertheless, we should explain, or should have explained, more clearly that these four paradoxes presented are central to this pair of eLife papers. The WF and Haldane models are very different conceptual ideas altogether. The choice should not be based on mathematical grounds but on how they help us understand biological evolution. We are using four paradoxes to highlight the differences.  We have said in the papers that the origin and evolution of COVID-19 caused a lot of confusions partly because the WF models cannot handle multi-copy gene systems, including viruses that evolve both within- and between- hosts.

      The standard Wright-Fisher model makes several assumptions, including hermaphroditism, non-overlapping generations, random mating, and no selection. It will be more helpful to clarify which assumptions are being violated in each tested scenario, as V(K) is often not the only assumption being violated. For example, the logistic growth model assumes no cell death at the exponential growth phase, so it also violates the assumption about non-overlapping generations.

      We appreciate the question which has two aspects.  First, why do we think the WF models are insufficient? After all, for each assumption of the WF model (as given in the reviewer’s examples), there is often a solution by modifying Ne which relaxes the assumption. In this sense, there is only one grand assumption made by the WF models. That is, however complex the biology is, it is possible to find Ne that can make the WF model work. Our argument is that Ne is a cumbersome fix of the WF model and it does not work in many situations. That is how we replied about the importance of the paradoxes above.  We shall again use the first paradox as an example whereby drift is stronger as N becomes larger, the fix has to make Ne negatively correlated with N. In reality, it does not appear possible to resolve this paradox. Another paradox is the evolution of multi-copy gene systems. In short, it seems clear that Ne is not a useful or usable fix.

      The second aspect is that “why, among the many modifications the WF models make, do we only emphasize the inclusion of V(K)?” This is the essence of the two papers of ours.  Although V(K) is a modification of the WF models, it does not enable the WF models to resolve the paradoxes. In contrast, the Haldane model has incorporate E(K) and V(K) in the model. In presenting paradox 3, it was stated that

      This equation shows that the strength of genetic drift, as given by Pf (the fixation probability of an advantageous mutation), is not a function of N at all. It supports the view that the essence of genetic drift is V(K) with N as a scaling factor. Note that, if V(K) = 0, there is no genetic drift regardless of N. As V(K) is not an add-on to the Haldane model (unlike in WF models), the Haldane model can resolve the paradoxes.

      The theory and data regarding sex chromosomes do not align. The fact that \hat{alpha'} can be negative does not make sense. The authors claim that a negative \hat{alpha'} is equivalent to infinity, but why is that? It is also unclear how theta is defined. It seems to me that one should take the first principle approach e.g., define theta as pairwise genetic diversity, and start with deriving the expected pair-wise coalescence time under the MMC model, rather than starting with assuming theta = 4Neu. Overall, the theory in this section is not well supported by the data, and the explanation is insufficient.

      a' can be negative for the same reason that a (the male/female ratio in mutation rate) can be negative (Miyata, et al. 1987; Li, et al. 2002; Makova and Li 2002). Clearly, this has not been a problem in the large literature on a becoming negative.  In fact, in many reports, a is negative, which is read as a approaching infinity.  Imagine that our equation is a'^2 = 0.25, then a' can be 0.5 or -0.5, although the latter solution is not biologically meaningful.

      As for theta, the reviewer asked why we do not use the pairwise genetic diversity (or theta[pi]) as the first-principle approach to estimating theta. While theta(pi) is the first estimator of theta used, the general principle is that every bin of the frequency spectrum can be used for estimating theta since the expected value is theta/i where i is the occurrence of the mutation in the sample.  (If the sample size is 100, then i is between 1 and 99.)  Hence, the issue is which part of the spectrum has the best statistical properties for the questions at hand.  The pairwise measure is theta(pi) [which the reviewer recommends]. While theta(pi) and theta(w) are most commonly used, there are in fact numerous ways to estimate theta.  ((Fu 2022) presents an excellent review.) For our purpose, we need a theta estimate least affected by selection and we choose the lowest frequency bin of the spectrum, which is theta(1) based on the singletons. Theta(1), least affected by selection, is the basis of the Fu and Li test. 

      Reviewer #3 (Public Review):

      Summary:

      Ruan and colleagues consider a branching process model (in their terminology the "Haldane model") and the most basic Wright-Fisher model. They convincingly show that offspring distributions are usually non-Poissonian (as opposed to what's assumed in the Wright-Fisher model), and can depend on short-term ecological dynamics (e.g., variance in offspring number may be smaller during exponential growth). The authors discuss branching processes and the Wright-Fisher model in the context of 3 "paradoxes": (1) how Ne depends on N might depend on population dynamics; (2) how Ne is different on the X chromosome, the Y chromosome, and the autosomes, and these differences do match the expectations base on simple counts of the number of chromosomes in the populations; (3) how genetic drift interacts with selection. The authors provide some theoretical explanations for the role of variance in the offspring distribution in each of these three paradoxes. They also perform some experiments to directly measure the variance in offspring number, as well as perform some analyses of published data.

      Strengths:

      (1) The theoretical results are well-described and easy to follow.

      (2) The analyses of different variances in offspring number (both experimentally and analyzing public data) are convincing that non-Poissonian offspring distributions are the norm.

      (3) The point that this variance can change as the population size (or population dynamics) change is also very interesting and important to keep in mind.

      (4) I enjoyed the Density-Dependent Haldane model. It was a nice example of the decoupling of census size and effective size.

      Thanks.

      Weaknesses:

      (1) I am not convinced that these types of effects cannot just be absorbed into some time-varying Ne and still be well-modeled by the Wright-Fisher process.

      Please allow us to refer to, again, two of the four paradoxes.  We believe that that no modification of the WF model can resolve the paradoxes.

      (1) When the population size (N) is growing exponentially, such as in a bacteria culture, drift is nearly absent when N is small and is much stronger as N increases, especially when approaching the carrying capacity.  Such common observations are exactly opposite of the WF model's key prediction. It is not possible for a model that does not regulate N to explain the paradox.

      (2) There is no way the WF models can formulate Ne for, say viruses or ribosomal RNA genes that have two levels of populations – the within-host populations as well as the host population itself.

      The fact that there are numerous Ne's suggests that Ne is a collection of cumbersome fixes of the WF model. By the WF-Haldane model, all factors are absorbed into V(K) resulting in a simpler model in the end. V(K) is often a measurable quantity. Note that, even if V(K) is incorporated into the WF model, the paradoxes remain unresolvable.

      (2) Along these lines, there is well-established literature showing that a broad class of processes (a large subset of Cannings' Exchangeable Models) converge to the Wright-Fisher diffusion, even those with non-Poissonian offspring distributions (e.g., Mohle and Sagitov 2001). E.g., equation (4) in Mohle and Sagitov 2001 shows that in such cases the "coalescent Ne" should be (N-1) / Var(K), essentially matching equation (3) in the present paper.

      The criticism of lack of engagement with well-established literature has been responded extensively above.  Briefly, the literature is about modifications of the WF model which share the same feature of population sampling. With that feature, the paradoxes are unresolvable.  For example, however Ne is defined, the fixation probability of an advantageous mutation does not depend on N or Ne. This is the third paradox of the WF models.

      (3) Beyond this, I would imagine that branching processes with heavy-tailed offspring distributions could result in deviations that are not well captured by the authors' WFH model. In this case, the processes are known to converge (backward-in-time) to Lambda or Xi coalescents (e.g., Eldon and Wakely 2006 or again in Mohle and Sagitov 2001 and subsequent papers), which have well-defined forward-in-time processes.

      We admire the learned understanding of the literature expressed by the review, which raise two points.  First, our model may not be able to handle the heavy-tailed progeny distribution (i.e., the kurtosis of the distribution of k). Second, the Xi coalescence models (cited above) can do that.  Below are our clarifications.

      First, the WFH model is based on the general distribution of K, which includes flexible and realistic representations of offspring number distributions. In fact, we have used various forms of K distribution in our publications on the evolution of SARS-CoV-2 (see the Ruan et al publications in the bibliography). Power-law distribution is particularly useful as the K-distribution in viral transmission is highly kurtotic. This is reflected in the super-spreader hypothesis. In short, the branching process on which the WFH model is based in is mainly about the distribution of K. Nevertheless, the variance V(K) can often yield good approximations when the kurtosis is modest.

      Second, we would like to comment on the models of Eldon and Wakely 2006. or Mohle and Sagitov 2001 and subsequent papers. These papers are based on the Moran model by considering a highly skewed distribution of offspring numbers. Fundamentally, the Moran models generally behave like WF models (standard or modified) and hence have the same problems with the paradoxes that are central to our studies. In fact, the reservations about introducing V(K) into the WF models apply as well to the Moran models.  The introduction of V(K) is mathematically valid but biologically untenable. Essentially, the WF models incorporate the Haldane model as a first step in the generation transition. The introduction of V(K) into the Moran model is even less biologically sensible. Furthermore, the model allows K to take only three discrete values: 0, 2, and Nψ (see Eq. (7) in Eldon and Wakely). Their model also assumes a constant population size, which contrasts with our model's flexibility in handling varying population sizes and more complex distributions for K.

      In short, the modifications of the WF (and Moran) models are unnecessarily complicated, biologically untenable but still fail to account for the paradoxes. The WFH model can rectify these problems. 

      (4) These results that Ne in the Wright-Fisher process might not be related to N in any straightforward (or even one-to-one) way are well-known (e.g., Neher and Hallatschek 2012; Spence, Kamm, and Song 2016; Matuszewski, Hildebrandt, Achaz, and Jensen 2018; Rice, Novembre, and Desai 2018; the work of Lounès Chikhi on how Ne can be affected by population structure; etc...)

      The reviewer is correct in pointing out the inexact correlation between N and Ne. Nevertheless, it should still be true that the WF models predict qualitatively weaker drift as N increases. The first paradox is as stated:

      When the population size (N) is growing exponentially, such as in a bacteria culture, drift is nearly absent when N is small and is much stronger as N increases, especially when approaching the carrying capacity.  Such common observations are exactly opposite of the WF model's key prediction.

      (5) I was also missing some discussion of the relationship between the branching process and the Wright-Fisher model (or more generally Cannings' Exchangeable Models) when conditioning on the total population size. In particular, if the offspring distribution is Poisson, then conditioned on the total population size, the branching process is identical to the Wright-Fisher model.

      We thank the reviewer for this important comment. The main difference is that N is imposed from outside the WF models but can be generated from within the Haldane model (see the density-dependent Haldane model). In nature, N of the next generation is the sum of K’s among members of the population. It is how the Haldane model determines N(t+1) from N(t). In the WF models, N is imposed from outside the model and, hence the given N determines the distribution of K.  For this reason, N regulation is not possible in the WF models, thus resulting in the paradoxes.

      (6) In the discussion, it is claimed that the last glacial maximum could have caused the bottleneck observed in human populations currently residing outside of Africa. Compelling evidence has been amassed that this bottleneck is due to serial founder events associated with the out-of-Africa migration (see e.g., Henn, Cavalli-Sforza, and Feldman 2012 for an older review - subsequent work has only strengthened this view). For me, a more compelling example of changes in carrying capacity would be the advent of agriculture ~11kya and other more recent technological advances.

      We thank the reviewer and have used this more convincing case as suggested by the reviewer.

      Recommendations for the authors:

      General replies - We thank the editors and reviewers again.  The points below are re-iterations of the comments received above and have since been replied in detail. Specific instructions about wording and notations have also been rectified. Again, we are grateful for the inputs from which we learned a great deal.

      Reviewing Editor Comments:

      The reviewers recognize the value of this model and some of the findings, particularly results from the density-dependent Haldane model. However, they expressed considerable concerns with the model and overall framing of this manuscript.

      First, all reviewers pointed out that the manuscript does not sufficiently engage with the extensive literature on various models of effective population size and genetic drift, notably lacking discussion on Cannings models and related works.

      We have addressed this issue in the beginning of Introduction and Discussion, pointing to the long section in the new second half of Discussion. The essence is that the literature is all about the modified WF models.  The WF-Haldane model is conceptually and operationally distinct from the WF models, either standard or modified ones,

      Second, there is a disproportionate discussion on the paradoxes, yet some of the paradoxes might already be resolved within current theoretical frameworks. All three reviewers found the modeling and simulation of the yeast growth experiment hard to follow or lacking justification for certain choices. The analysis approach of sex chromosomes is also questioned.

      This criticism is addressed together with the next one as they make the same point.

      The reviewers recommend a more thorough review of relevant prior literature to better contextualize their findings. The authors need to clarify and/or modify their derivations and simulations of the yeast growth experiment to address the identified caveats and ensure robustness. Additionally, the empirical analysis of the sex chromosome should be revisited, considering alternative scenarios rather than relying solely on the MSE, which only provides a superficial solution. Furthermore, the manuscript's overall framing should be adjusted to emphasize the conclusions drawn from the WFH model, rather than focusing on the "unresolved paradoxes", as some of these may be more readily explained by existing frameworks. Please see the reviewers' overall assessment and specific comments.

      Many thanks.  We have carefully reframed and presented the WF-Haldane model to make it clear and logically consistent. Whether a new model (i.e., the WF-Haldane model) deserves to be introduced depends on whether it makes any contribution for understanding nature. That is why we emphasize the four paradoxes. 

      A most important disagreement between the reviewers and the authors is about the nature of the paradoxes. While the reviewers suggest that they "may" be resolvable by the conventional WF model (standard or modified), they did not offer the possible resolutions.  To use the analogy in our provisional response: the WF vs. Haldane models are compared to gas cars vs electric vehicles.  We can say confidently that the internal combustion engine cannot resolve the conflicting demands of transportation and zero emission. Its design has limited its capability. 

      Reviewer #2 (Recommendations For The Authors):

      Many thanks.  We have incorporated all these suggestions.  When the incorporation is not straightforward, we have carefully revised the text to minimize mis-communications.

      In the introduction -- "Genetic drift is simply V(K)" -- this is a very strong statement. You can say it is inversely proportional to V(K), but drift is often defined based on changes in allele frequency.

      We change the word “simply” to “essentially”. This wording is supported by the fixation probability of advantageous mutations, 2s/(V(k). We have shown in the text that N does not matter here because the fixation is nearly deterministic when the copy number reaches, say, 100, regardless of whether N is 10^4 or 10^8,

      Page 3 line 86. "sexes is a sufficient explanation."--> "sex could be a sufficient explanation"

      The strongest line of new results is about 2s/V(K). Perhaps, the paper could put more emphasis on this part and demonstrate the generality of this result with a different example.

      The math notations in the supplement are not intuitive. e.g., using i_k and j_k as probabilities. I also recommend using E[X] and V[X]for expectation and variance rather than \italic{E(X)} to improve the readability of many equations.

      Thank you for your careful reading. Regarding the use of i_k and j_k  as probabilities, we initially considered using 𝑝 or 𝑞 to represent probabilities. However, since 𝑝 and 𝑞 are already used in the main text, we opted for 𝑖 and 𝑗 to avoid potential confusion potential confusion. As for your recommendation to use

      E[X] and V[X] for expectation and variance, we would like to clarify that we follow the standard practice of italicizing these symbols to represent variables.

      Eq A6, A7, While I manage to follow, P_{10}(t) and P_{10} are not defined anywhere in the text.<br /> Supplement page 7, the term "probability of fixation" is confusing in a branching model.

      Thank you for your observation. We have carefully revised the supplement to provide clarity on these points.<br /> Revision - In population genetics, the fixation of M allele means that the population consist entirely of the M allele, with no W alleles remaining. We define the fixation probability of M allele by generation t as follows:

      Given that M and W allele reproduce independently, this can be factored as:

      As t approaches infinity, the ultimate fixation probability of M allele can be derived as follows:

      E.q. A 28. It is unclear eq. A.1 could be used here directly. Some justification would be nice.

      We appreciate your careful review, and we will ensure this connection between the two equations is made clearer in the supplement. 

      Revision - Note we would like to clarify that Eq. (A1) and Eq. (A28) are essentially the same, with the only difference being the subscript 𝑡, which indicates the time dependence in the dynamic process.

      Supplement page 17. "the biological meaning of negative..". There is no clear justification for this claim. As a reader, I don't have any intuition as to why that is the case.

      Thank you for raising this concern. We have addressed this issue earlier.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public Review):

      Comments on revisions:

      This revision addressed all my previous comments.

      Reviewer #3 (Public Review):

      Comments on revisions:

      The authors addressed my comments and it is ready for publication.

      We are grateful for the reviewers’ effort and are encouraged by their generally positive assessment of our manuscript.

      Reviewer #1 (Recommendations For The Authors):

      This revision addressed all my previous comments. The only new issue concerns the authors’ response to the following comment of reviewer 3:

      (2) Authors note ”monovalent positive salt ions such as Na+ can be attracted, somewhat counterintuitively, into biomolecular condensates scaffolded by positively-charged polyelectrolytic IDRs in the presence of divalent counterions”. This may be due to the fact that the divalent negative counterions present in the dense phase (as seen in the ternary phase diagrams) also recruit a small amount of Na+.

      Author reply: The reviewer’s comment is valid, as a physical explanation for this prediction is called for. Accordingly, the following sentence is added to p. 10, lines 27-29: ...

      Here are my comments on this issue. Most IDPs with a net positive charge still have negatively charged residues, which in theory can bind cations. In fact, Caprin1 has 3 negatively charged residues (same as A1-LCD). All-atom simulations of MacAinsh et al (ref 72) have shown that these negatively charged residues bind Na+; I assume this effect can be captured by the coarsegrained models in the present study. Moreover, all-atom simulations showed that Na+ has a strong tendency to be coordinated by backbone carbonyls, which of course are present on all residues. Suggestions:

      (a) The authors may want to analyze the binding partners of Na+. Are they predominantly the3 negatively charged residues, or divalent counterions, or both?

      (b) The authors may want to discuss the potential underestimation of Na+ inside Caprin1 condensates due to the lack of explicit backbone carbonyls that can coordinate Na+ in their models. A similar problem applies to backbone amides that can coordinate anions, but to a lesser extent (see Fig. 3A of ref 72).

      The reviewer’s comments are well taken. Regarding the statement in the revised manuscript “This phenomenon arises because the positively charge monovalent salt ions are attracted to the negatively charged divalent counterions in the protein-condensed phase.”, it should be first noted that the statement was inferred from the model observation that Na+ is depleted in condensed Caprin1 (Fig. 2a) when the counterion is monovalent (an observation that was stated almost immediately preceding the quoted statement). To make this logical connection clearer as well as to address the reviewer’s point about the presence of negatively charged residues in Caprin1, we have modified this statement in the Version of Record (VOR) as follows:

      “This phenomenon most likely arises from the attraction of the positively charge monovalent salt ions to the negatively charged divalent counterions in the proteincondensed phase because although the three negatively charged D residues in Caprin1 can attract Na+, it is notable that Na+ is depleted in condensed Caprin1 when the counterion is monovalent (Fig. 2a).”

      The reviewer’s suggestion (a) of collecting statistics of Na+ interactions in the Caprin1 condensate is valuable and should be attempted in future studies since it is beyond the scope of the present work. Thus far, our coarse-grained molecular dynamics has considered only monovalent Cl− counterions. We do not have simulation data for divalent counterions.

      Following the reviewer’s suggestion (b), we have now added the following sentence in Discussion under the subheading “Effects of salt on biomolecular LLPS”:

      “In this regard, it should be noted that positively and negatively charged salt ions can also coordinate with backbone carbonyls and amides, respectively, in addition to coordinating with charged amino acid sidechains (MacAinsh et al., eLife 2024). The impact of such effects, which are not considered in the present coarse-grained models, should be ascertained by further investigations using atomic simulations (MacAinsh et al., eLife 2024; Rauscher & Pom`es, eLife 2017; Zheng et al., J Phys Chem B 2020).”

      Here we have added a reference to Rauscher & Pom`es, eLife 2017 to more accurately reflect progress made in atomic simulations of biomolecular condensates.

      More generally, regarding the reviewer’s comments on the merits of coarse-grained versus atomic approaches, we re-emphasize, as stated in our paper, that these approaches are complementary. Atomic approaches undoubtedly afford structurally and energetically high-resolution information. However, as it stands, simulations of the assembly-disassembly process of biomolecular condensate are nonideal because of difficulties in achieving equilibration even for a small model system with < 10 protein chains (MacAinsh et al., eLife 2024) although well-equilibrated simulations are possible for a reasonably-sized system with ∼ 30 chains when the main focus is on the condensed phase (Rauscher & Pom`es, eLife 2017). In this context, coarse-grained models are valuable for assessing the energetic role of salt ions in the thermodynamic stability of biomolecular condensates of physically reasonable sizes under equilibrium conditions.

      In addition to the above minor additions, we have also added citations in the VOR to two highly relevant recent papers: Posey et al., J Am Chem Soc 2024 for salt-dependent biomolecular condensation (mentioned in Dicussion under subheadings “Tielines in protein-salt phase diagrams” and “Counterion valency” together with added references to Hribar et al., J Am Chem Soc 2002 and Nostro & Ninham, Chem Rev 2012 for the Hofmeister phenomena discussed by Posey et al.) and Zhu et al., J Mol Cell Biol 2024 for ATP-modulated reentrant behavior (mentioned in Introduction). We have also added back a reference to our previous work Lin et al., J Mol Liq 2017 to provide more background information for our formulation.

      Reviewer #2 (Recommendations For The Authors):

      The authors have done a great job addressing previous comments.

      We thank this reviewer for his/her effort and are encouraged by the positive assessment of our revised manuscript.

      ---

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      The authors used multiple approaches to study salt effects in liquid-liquid phase separation (LLPS). Results on both wild-type Caprin1 and mutants and on different types of salts contribute to a comprehensive understanding.

      Strengths:

      The main strength of this work is the thoroughness of investigation. This aspect is highlighted by the multiple approaches used in the study, and reinforced by the multiple protein variants and different salts studied.

      We are encouraged by this positive overall assessment.

      Weaknesses: (1) The multiple computational approaches are a strength, but they’re cruder than explicit-solvent all-atom molecular dynamics (MD) simulations and may miss subtle effects of salts. In particular, all-atom MD simulations demonstrate that high salt strengthens pi-types of interactions (ref. 42 and MacAinsh et al, https://www.biorxiv.org/content/10.1101/2024.05.26.596000v3).

      The relative strengths and limitations of coarse-grained vs all-atom simulation are now more prominently discussed beginning at the bottom of p. 5 through the first 8 lines of p. 6 of the revised manuscript (page numbers throughout this letter refer to those in the submitted pdf file of the revised manuscript), with MacAinsh et al. included in this added discussion (cited as ref. 72 in the revised manuscript). The fact that coarse-grained simulation may not provide insights into more subtle structural and energetic effects afforded by all-atom simulations with regard to π-related interaction is now further emphasized on p. 11 (lines 23–30), with reference to MacAinsh et al. as well as original ref. 42 (Krainer et al., now ref. 50 in the revised manuscript).

      (2) The paper can be improved by distilling the various results into a simple set of conclusions. By example, based on salt effects revealed by all-atom MD simulations, MacAinsh et al. presented a sequence-based predictor for classes of salt dependence. Wild-type Caprin1 fits right into the “high net charg”e class, with a high net charge and a high aromatic content, showing no LLPS at 0 NaCl and an increasing tendency of LLPS with increasing NaCl. In contrast, pY-Caprin1 belongs to the “screening” class, with a high level of charged residues and showing a decreasing tendency of LLPS.

      This is a helpful suggestion. We have now added a subsection with heading “Overview of key observations from complementary approaches” at the beginning of the “Results” section on p. 6 (lines 18–37) and the first line of p. 7. In the same vein, a few concise sentences to summarize our key results are added to the first paragraph of “Discussion” (p. 18, lines 23– 26). In particular, the relationship of Caprin1 and pY-Caprin1 with the recent classification by MacAinsh et al. (ref. 72) in terms of “high net charge” and “screening” classes is now also stated, as suggested by this reviewer, on p. 18 under “Discussion” (lines 26–30).

      (3) Mechanistic interpretations can be further simplified or clarified. (i) Reentrant salt effects (e.g., Fig. 4a) are reported but no simple explanation seems to have been provided. Fig. 4a,b look very similar to what has been reported as strong-attraction promotor and weak-attraction suppressor, respectively (ref. 50; see also PMC5928213 Fig. 2d,b). According to the latter two studies, the “reentrant” behavior of a strong-attraction promotor, CL- in the present case, is due to Cl-mediated attraction at low to medium [NaCl] and repulsion between Cl- ions at high salt. Do the authors agree with this explanation? If not, could they provide another simple physical explanation? (ii) The authors attributed the promotional effect of Cl- to counterionbridged interchain contacts, based on a single instance. There is another simple explanation, i.e., neutralization of the net charge on Caprin1. The authors should analyze their simulation results to distinguish net charge neutralization and interchain bridging; see MacAinsh et al.

      The relationship of Cl− in bridging and neutralizing configurations, respectively, with the classification of “strong-attraction promoter” and “weak-attraction suppressor” by Zhou and coworkers is now stated on p. 13 (lines 29–31), with reference to original ref. 50 by Ghosh, Mazarakos & Zhou (now ref. 59 in the revised manuscript) as well as the earlier patchy particle model study PMC5928213 by Nguemaha & Zhou, now cited as ref. 58 in the revised manuscript. After receiving this referee report, we have conducted an extensive survey of our coarse-grained MD data to provide a quantitative description of the prevalence of counterion (Cl−) bridging interactions linking positively charged arginines (Arg+s) on different Caprin1 chains in the condensed phase (using the [Na+] = 0 case as an example). The newly compiled data is reported under a new subsection heading “Explicit-ion MD offers insights into counterion-mediated interchain bridging interactions among condensed Caprin1 molecules” on p. 12 (last five lines)–p. 14 (first 10 lines) [∼ 1_._5 additional page] as well as a new Fig. 6 to depict the statistics of various Arg+–Cl−–Arg+ configurations, with the conclusion that a vast majority (at least 87%) of Cl− counterions in the Caprin1-condensed phase engage in favorable condensation-driving interchain bridging interactions.

      (4) The authors presented ATP-Mg both as a single ion and as two separate ions; there is no explanation of which of the two versions reflects reality. When presenting ATP-Mg as a single ion, it’s as though it forms a salt with Na+. I assume NaCl, ATP, and MgCl2 were used in the experiment. Why is Cl- not considered? Related to this point, it looks like ATP is just another salt ion studied and much of the Results section is on NaCl, so the emphasis of ATP (“Diverse Roles of ATP” in the title is somewhat misleading.

      We model ATP and ATP-Mg both as single-bead ions (in rG-RPA) and also as structurally more realistic short multiple-bead polymers (in field-theoretic simulation, FTS). We have now added discussions to clarify our modeling rationale in using and comparing different models for ATP and ATP-Mg, as follows:

      p. 8 (lines 19–36):

      “The complementary nature of our multiple methodologies allows us to focus sharply on the electrostatic aspects of hydrolysis-independent role of ATP in biomolecular condensation by comparing ATP’s effects with those of simple salt. Here, Caprin1 and pY-Caprin1 are modeled minimally as heteropolymers of charged and neutral beads in rG-RPA and FTS. ATP and ATP-Mg are modeled as simple salts (singlebead ions) in rG-RPA whereas they are modeled with more structural complexity as short charged polymers (multiple-bead chains) in FTS, though the latter models are still highly coarse-grained. Despite this modeling difference, rG-RPA and FTS both rationalize experimentally observed ATP- and NaCl-modulated reentrant LLPS of Caprin1 and a lack of a similar reentrance for pY-Caprin1 as well as a prominent colocalization of ATP with the Caprin1 condensate. Consistently, the same contrasting trends in the effect of NaCl on Caprin1 and pY-Caprin1 are also seen in our coarse-grained MD simulations, though polymer field theories tend to overestimate LLPS propensity [99]. The robustness of the theoretical trends across different modeling platforms underscores electrostatics as a significant component in the diverse roles of ATP in the context of its well-documented ability to modulate biomolecular LLPS via hydrophobic and π-related effects [63, 65, 67].”

      Here, the last sentence quoted above addresses this reviewer’s question about our intended meaning in referring to “diverse roles of ATP” in the title of our paper. To make this point even clearer, we have also added the following sentence to the Abstract (p. 2, lines 12–13):

      “... The electrostatic nature of these features complements ATP’s involvement in π-related interactions and as an amphiphilic hydrotrope, ...”

      Moreover, to enhance readability, we have now added pointers in the rG-RPA part of our paper to anticipate the structurally more complex ATP and ATP-Mg models to be introduced subsequently in the FTS part, as follows:

      p. 9 (lines 13–15):

      “As mentioned above, in the present rG-RPA formulation, (ATP-Mg)<sup>2−</sup> and ATP<sup>4−</sup> are modeled minimally as a single-bead ion. They are represented by charged polymer models with more structural complexity in the FTS models below.”

      p. 11 (lines 8–11):

      These observations from analytical theory will be corroborated by FTS below with the introduction of structurally more realistic models of (ATP-Mg) <sup>2−</sup>, ATP<sup>4−</sup> together with the possibility of simultaneous inclusion of Na<sup>+</sup>, Cl−, and Mg<sup>2+</sup> in the FTS models of Caprin1/pY-Caprin1 LLPS systems.

      Reviewer #2 (Public Review):

      Summary:

      In this paper, Lin and colleagues aim to understand the role of different salts on the phase behavior of a model protein of significant biological interest, Caprin1, and its phosphorylated variant, pY-Caprin1. To achieve this, the authors employed a variety of methods to complement experimental studies and obtain a molecular-level understanding of ion partitioning inside biomolecular condensates. A simple theory based on rG-RPA is shown to capture the different salt dependencies of Caprin1 and pY-Caprin1 phase separation, demonstrating excellent agreement with experimental results. The application of this theory to multivalent ions reveals many interesting features with the help of multicomponent phase diagrams. Additionally, the use of CG model-based MD simulations and FTS provides further clarity on how counterions can stabilize condensed phases.

      Strengths:

      The greatest strength of this study lies in the integration of various methods to obtain complementary information on thermodynamic phase diagrams and the molecular details of the phase separation process. The authors have also extended their previously proposed theoretical approaches, which should be of significant interest to other researchers. Some of the findings reported in this paper, such as bridging interactions, are likely to inspire new studies using higher-resolution atomistic MD simulations.

      Weaknesses:

      The paper does not have any major issues.

      We are very encouraged by this reviewer’s positive assessment of our work.

      Reviewer #3 (Public Review):

      Authors first use rG-RPA to reproduce two observed trends. Caprin1 does not phase separate at very low salt but then undergoes LLPS with added salt while further addition of salt reduces its propensity to LLPS. On the other hand pY-Caprin1 exhibits a monotonic trend where the propensity to phase separate decreases with the addition of salt. This distinction is captured by a two component model and also when salt ions are explicitly modeled as a separate species with a ternary phase diagram. The predicted ternary diagrams (when co and counter ions are explicitly accounted for) also predict the tendency of ions to co-condense or exclude proteins in the dense phase. Predicted trends are generally in line with the measurement for Cparin1 [sic]. Next, the authors seek to explain the observed difference in phase separation when Arginines are replaced by Lysines creating different variants. In the current rG-RPA type models both Arginine (R) and Lysine (K) are treated equally since non-electrostatic effects are only modeled in a meanfield manner that can be fitted but not predicted. For this reason, coarse grain MD simulation is suitable. Moreover, MD simulation affords structural features of the condensates. They used a force field that is capable of discriminating R and K. The MD predicted degrees of LLPS of these variants again is consistent with the measurement. One additional insight emerges from MD simulations that a negative ion can form a bridge between two positively charged residues on the chain. These insights are not possible to derive from rG-RPA. Both rG-RPA and MD simulation become cumbersome when considering multiple types of ions such as Na, Cl, [ATP] and [ATP-Mg] all present at the same time. FTS is well suited to handle this complexity. FTS also provides insights into the co-localization of ions and proteins that is consistent with NMR. By using different combinations of ions they confirm the robustness of the prediction that Caprin1 shows salt-dependent reentrant behavior, adding further support that the differential behavior of Caprin1, and pY-Caprin1 is likely to be mediated by charge-charge interactions.

      We are encouraged by this reviewer’s positive assessment of our manuscript.

      Reviewer #1 (Recommendations For The Authors):

      Analysis:

      Analyze the simulation results to distinguish net charge neutralization and interchain bridging; see MacAinsh et al.

      Please see response above to points (3) and (4) under “Weaknesses” in this reviewer’s public review. We have now added a 1.5-page subsection starting from the bottom of p. 12 to the top of p. 14 to discuss a new extensive analysis of Arg<sup>+</sup>–Cl<sup>−</sup>–Arg<sup>+</sup> configurations to identify bridging interactions, with key results reported in a new Fig. 6 (p. 42). Recent results from MacAinsh, Dey & Zhou (cited now as ref. 72) are included in the added discussion. Relevant advances made in MacAinsh et al., including clarification and classification of salt-mediated interactions in the phase separation of A1-LCD are now mentioned multiple times in the revised manuscript (p. 5, lines 19–20; p. 6, lines 2–5; p. 11, line 30; p. 14, line 10; p. 18, lines 28–29; and p. 20, line 4).

      Writing and presentation

      (1) Cite subtle effects that may be missed by the coarser approaches in this study

      Please see response above to point (1) under “Weaknesses” in this reviewer’s public review.

      (2) Try to distill the findings into a simple set of conclusions

      Please see response above to point (2) under “Weaknesses” in this reviewer’s public review.

      (3) Clarify and simplify physical interpretations

      Please see response above to point (2) under “Weaknesses” in this reviewer’s public review.

      (4) Explain the treatment of ATP-Mg as either a single ion or two separate ions; reconsider modifying the reference to ATP in the title

      Please see response above to point (4) under “Weaknesses” in this reviewer’s public review.

      (5) Minor points:

      p. 4, citation of ref 56: this work shows ATP is a driver of LLPS, not merely a regulator (promotor or suppressor)

      This citation to original ref. 56 (now ref. 63) on p. 4 is now corrected (bottom line of p. 4).

      p. 7 and throughout: “using bulk [Caprin1]” – I assume this is the initial overall Caprin1 concentration. It would avoid confusion to state such concentrations as “initial” or “initial overall”

      We have now added “initial overall concentration” in parentheses on p. 8 (line 4) to clarify the meaning of “bulk concentration”.

      p. 7 and throughout: both mM (also uM) and mg/ml have been used as units of protein concentration and that can cause confusion. Indeed, the authors seem to have confused themselves on p. 9, where 400 (750) mM is probably 400 (750) mg/ml. The same with the use of mM and M for salt concentrations (400 mM Mg2+ but 0.1 and 1.0 M Na+)

      Concentrations are now given in both molarity and mass density in Fig. 1 (p. 37), Fig. 2 (p. 38), Fig. 4 (p. 40), and Fig. 7 (p. 43), as noted in the text on p. 8 (lines 4–5). Inconsistencies and errors in quoting concentrations are now corrected (p. 10, line 18, and p. 11, line 2).

      p. 7, “LCST-like”: isn’t this more like a case of a closed coexistence curve that contains both UCST and LCST?

      The discussion on p. 8 around this observation from Fig. 1d is now expanded, including alluding to the theoretical possibility of a closed co-existence curve mentioned by this reviewer, as follows:

      “Interestingly, the decrease in some of the condensed-phase [pY-Caprin1]s with decreasing T (orange and green symbols for ≲ 20◦C in Fig. 1d trending toward slightly lower [pY-Caprin1]) may suggest a hydrophobicity-driven lower critical solution temperature (LCST)-like reduction of LLPS propensity as temperature approaches ∼ 0◦C as in cold denaturation of globular proteins [7,23] though the hypothetical LCST is below 0◦C and therefore not experimentally accessible. If that is the case, the LLPS region would resemble those with both an UCST and a LCST [4]. As far as simple modeling is concerned, such a feature may be captured by a FH model wherein interchain contacts are favored by entropy at intermediate to low temperatures and by enthalpy at high temperatures, thus entailing a heat capacity contribution in χ(T), with [7,109,110] beyond the temperature-independent ϵ<sub>h</sub> and ϵ<sub>s</sub> used in Fig. 1c,d and Fig. 2. Alternatively, a reduction in overall condensed-phase concentration can also be caused by formation of heterogeneous locally organized structures with large voids at low temperatures even when interchain interactions are purely enthalpic (Fig. 4 of ref. [111]).”

      p. 8 “Caprin1 can undergo LLPS without the monovalent salt (Na+) ions (LLPS regions extend to [Na+] = 0 in Fig. 2e,f”: I don’t quite understand what’s going on here. Is the effect caused by a small amount of counterion (ATP-Mg) that’s calculated according to eq 1 (with z s set to 0)?

      The discussion of this result in Fig. 2e,f is now clarified as follows (p. 10, lines 8–14 in the revised manuscript):

      “The corresponding rG-RPA results (Fig. 2e–h) indicate that, in the present of divalent counterions (needed for overall electric neutrality of the Caprin1 solution), Caprin1 can undergo LLPS without the monvalent salt (Na+) ions (LLPS regions extend to [Na+] = 0 in Fig. 2e,f; i.e., ρs \= 0, ρc > 0 in Eq. (1)), because the configurational entropic cost of concentrating counterions in the Caprin1 condensed phase is lesser for divalent (zc \= 2) than for monovalent (zc \= 1) counterions as only half of the former are needed for approximate electric neutrality in the condensed phase.”

      p. 9 “Despite the tendency for polymer field theories to overestimate LLPS propensity and condensed-phase concentrations”: these limitations should be mentioned earlier, along with the very high concentrations (e.g., 1200 mg/ml) in Fig. 2

      This sentence (now on p. 11, lines 11–18) is now modified to clarify the intended meaning as suggested by this reviewer:

      “Despite the tendency for polymer field theories to overestimate LLPS propensity and condensed-phase concentrations quantitatively because they do not account for ion condensation [99]—which can be severe for small ions with more than ±1 charge valencies as in the case of condensed [Caprin1] ≳ 120 mM in Fig. 2i–l, our present rG-RPA-predicted semi-quantitative trends are consistent with experiments indicating “

      In addition, this limitation of polymer field theories is also mentioned earlier in the text on p. 6, lines 30–31.

      Reviewer #2 (Recommendations For The Authors):

      (1) he current version of the paper goes through many different methodologies, but how these methods complement or overlap in terms of their applicability to the problem at hand may not be so clear. This can be especially difficult for readers not well-versed in these methods. I suggest the authors summarize this somewhere in the paper.

      As mentioned above in response to Reviewer #1, we have now added a subsection with heading “Overview of key observations from complementary approaches” at the beginning of the “Results” section on p. 6 (lines 18–37) and the first line of p. 7 to make our paper more accessible to readers who might not be well-versed in the various theoretical and computational techniques. A few sentences to summarize our key results are added as well to the first paragraph of “Discussion” (p. 18, lines 23–26).

      (2) It wasn’t clear if the authors obtained LCST-type behavior in Figure 1d or if another phenomenon is responsible for the non-monotonic change in dense phase concentrations. At the very least, the authors should comment on the possibility of observing LCST behavior using the rG-RPA model and if modifications are needed to make the theory more appropriate for capturing LCST.

      As mentioned above in response to Reviewer #1, the discussion regarding possible LCSTtype behanvior in Fig. 1d is now expanded to include two possible physical origins: (i) hydrophobicity-like temperature-dependent effective interactions, and (ii) formation of heterogeneous, more open structures in the condensed phase at low temperatures. Three additional references [109, 110, 111] (from the Dill, Chan, and Panagiotopoulos group respectively) are now included to support the expanded discussion. Again, the modified discussion is as follows:

      “Interestingly, the decrease in some of the condensed-phase [pY-Caprin1]s with decreasing T (orange and green symbols for ≲ 20◦C in Fig. 1d trending toward slightly lower [pY-Caprin1]) may suggest a hydrophobicity-driven lower critical solution temperature (LCST)-like reduction of LLPS propensity as temperature approaches ∼ 0◦C as in cold denaturation of globular proteins [7,23] though the hypothetical LCST is below 0◦C and therefore not experimentally accessible. If that is the case, the LLPS region would resemble those with both an UCST and a LCST [4]. As far as simple modeling is concerned, such a feature may be captured by a FH model wherein interchain contacts are favored by entropy at intermediate to low temperatures and by enthalpy at high temperatures, thus entailing a heat capacity contribution in χ(T), with [7,109,110] beyond the temperature-independent ϵ<sub>h</sub> and ϵ<sub>s</sub> used in Fig. 1c,d and Fig. 2. Alternatively, a reduction in overall condensed-phase concentration can also be caused by formation of heterogeneous locally organized structures with large voids at low temperatures even when interchain interactions are purely enthalpic (Fig. 4 of ref. [111]).”

      (3) In Figures 4c and 4d, ionic density profiles could be shown as a separate zoomed-in version to make it easier to see the results.

      This is an excellent suggestion. Two such panels are now added to Fig. 4 (p. 40) as parts (g) and (h).

      Reviewer #3 (Recommendations For The Authors):

      I would suggest authors make some minor edits as noted here.

      (1) Please note down the chi values that were used when fitting experimental phase diagrams with rG-RPA theory in Figure 2a,b. At present there aren’t too many such values available in the literature and reporting these would help to get an estimate of effective chi values when electrostatics is appropriately modeled using rG-RPA.

      The χ(T) values and their enthalpic and entropic components ϵh and ϵs used to fit the experimental data in Fig. 1c,d are now stated in the caption for Fig. 1 (p. 37). Same fitted χ(T) values are used in Fig. 2 (p. 38) as it is now stated in the revised caption for Fig. 2. Please note that for clarity we have now changed the notation from ∆h and ∆s in our originally submitted manuscript to ϵh and ϵs in the revised text (p. 7, last line) as well as in the revised figure captions to conform to the notation in our previous works [18, 71].

      (2) Authors note “monovalent positive salt ions such as Na+ can be attracted, somewhat counterintuitively, into biomolecular condensates scaffolded by positively-charged polyelectrolytic IDRs in the presence of divalent counterions”. This may be due to the fact that the divalent negative counterions present in the dense phase (as seen in the ternary phase diagrams) also recruit a small amount of Na+.

      The reviewer’s comment is valid, as a physical explanation for this prediction is called for. Accordingly, the following sentence is added to p. 10, lines 27–29:

      “This phenomenon arises because the positively charge monovalent salt ions are attracted to the negatively charged divalent counterions in the protein-condensed phase.”

      (3) In the discussion where authors contrast the LLPS propensity of Caprin1 against FUS, TDP43, Brd4, etc, they correctly note majority of these other proteins have low net charge and possibly higher non-electrostatic interaction that can promote LLPS at room temperature even in the absence of salt. It is also worth noting if some of these proteins were forced to undergo LLPS with crowding which is sometimes typical. A quick literature search will make this clear.

      A careful reading of the work in question (Krainer et al., ref. 50) does not suggest that crowders were used to promote LLPS for the proteins the authors studied. Nonetheless, the reviewer’s point regarding the potential importance of crowder effects is well taken. Accordingly, crowder effects are now mentioned briefly in the Introduction (p. 4, line 13), with three additional references on the impact of crowding on LLPS added [30–32] (from the Spruijt, Mukherjee, and Rakshit groups respectively). In this connection, to provide a broader historical context to the introductory discussion of electrostatics effects in biomolecular processes in general, two additional influential reviews (from the Honig and Zhou groups respectively) are now cited as well [15, 16].

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      This manuscript explores the multiple cell types present in the wall of murine-collecting lymphatic vessels with the goal of identifying cells that initiate the autonomous action potentials and contractions needed to drive lymphatic pumping. Through the use of genetic models to delete individual genes or detect cytosolic calcium in specific cell types, the authors convincingly determine that lymphatic muscle cells are the origin of the action potential that triggers lymphatic contraction. 

      Strengths: 

      The experiments are rigorously performed, the data justify the conclusions, and the limitations of the study are appropriately discussed. 

      There is a need to identify therapeutic targets to improve lymphatic contraction and this work helps identify lymphatic muscle cells as potential cellular targets for intervention. 

      Weaknesses: 

      My only major comment would be that the manuscript provides a lot of rich information describing the cellular components of the muscular lymphatic vessel wall and that these data are not well represented by the title. The title (while currently accurate) could be tweaked to better represent all that is in this manuscript. Maybe something like

      "Characterization/Interrogation of the cellular components of murine collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells regulating lymphatic contractions" or "Discovery/Confirmation of lymphatic muscle cells as innate pacemaker cells of lymphatic contraction through characterization of the cellular components of murine collecting lymphatic vessels". Potentially a cartoon summary figure of the components that make up the collecting lymphatic vessel wall could also be included. In my opinion, these changes will make this manuscript of more interest to a broader group of scientists. I have a few additional comments for consideration to improve the clarity and enhance the discussion of this work. 

      We agree with the reviewer that our original manuscript, and our resubmission even more so with the addition of the scRNAseq data, provides a significant amount of information regarding the composition of the lymphatic collecting vessel wall. We have changed our title to match one suggestion of the reviewer: “Characterization of the cellular components of murine collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells regulating lymphatic contractions".

      Reviewer #2 (Public Review): 

      Summary: 

      This is a well-written manuscript describing studies directed at identifying the cell type responsible for pacemaking in murine-collecting lymphatics. Using state-of-the-art approaches, the authors identified a number of different cell types in the wall of these lymphatics and then using targeted expression of Channel Rhodopsin and GCaMP, the authors convincingly demonstrate that only activation of lymphatic muscle cells produces coordinated lymphatic contraction and that only lymphatic muscle cells display pressure-dependent Ca2+ transients as would be expected of a pacemaker in these lymphatics. 

      Strengths: 

      The use of a targeted expression of channel rhodopsin and GCaMP to test the hypothesis that lymphatic muscle cells serve as the pacemakers in musing lymphatic collecting vessels. 

      Weaknesses: 

      The only significant weakness was the lack of quantitative analysis of most of the imaging data shown in Figures 1-11. In particular, the colonization analysis should be extended to show cells not expected to demonstrate colocalization as a negative control for the colocalization analysis that the authors present. 

      We understand the reviewer’s concern regarding the lack of a control for the colocalization analysis and that the colocalization analysis was limited to just one set of cell markers. We have now provided a colocalization analysis of Myh11 and PDGFRα, to serve as a co-localization negative control based on our RT-PCR and scRNASeq findings, which is incorporated into the current Supplemental figure 1. In regard to the staining pattern of other various marker combinations, the results were often quite clear with the representative images that two separate cell populations were being stained such as the case with labeling endothelial cells with CD31, macrophage labeling with the MacGreen mice, or hematopoietic cells with CD45. 

      During our lengthy rebuttal process we completed a single cell RNA sequence analysis using our isolated and cleaned mouse inguinal axillary lymphatic collecting vessels to aid in our characterization of the vessel wall and to more thoroughly answer these questions regarding colocalization in arguably a robust manner. The generation of our scRNAseq dataset, derived from isolated and cleaned mouse inguinal axillary collecting vessels from 10 mice, 5 male and 5 females, allowed us to profile over 2200 of the adventitial fibroblast like cells (AdvCs) we had identified in our original submission. Using this dataset, we were able to confirm co-expression of Cd34 and Pdgfrα in AdvCs and assess the co-expression of other genes of interest from our RT-PCR experiments and immunofluorescence experiments. This approach will also allow other lymphatic investigators to assess their genes of interest as our dataset is uploaded to the NIH Gene Omnibus and will be uploaded to the Broad Institute Single Cell Portal upon publication.

      Here we show that the vast majority of non-muscle fibroblast like cells referred to as AdvCs were double positive for both CD34 and PDGFRα. We also show that the AdvCs that express commonly used pericyte markers Pdgfrb and Cspg4 also co-expressed Pdgfrα. Critically, this data also shows that the AdvCs that express genes linked with lymphatic contractile dysfunction (Ano1, Gjc1 or connexin 45, and Cacna1c “Cav1.2”) co-express Pdgfrα and would render these genes susceptible to Cre-mediated recombination using our Pdgfrα-CreER<sup>TM</sup> model.  

      Reviewer #3 (Public Review): 

      Summary: 

      Zawieja et al. aimed to identify the pacemaker cells in the lymphatic collecting vessels. Authors have used various Cre-based expression systems and optogenetic tools to identify these cells. Their findings suggest these cells are lymphatic muscle cells that drive the pacemaker activity in the lymphatic collecting vessels. 

      Strengths: 

      The authors have used multiple approaches to test their hypothesis. Some findings are presented as qualitative images, while some quantitative measurements are provided.   

      Weaknesses: 

      -  More quantitative measurements. 

      -  Possible mechanisms associated with the pacemaker activity. 

      -  Membrane potential measurements. 

      We thank the reviewers for their concerns and have addressed them in the following manner. 

      - We added novel single cell RNA sequencing of isolated and cleaned inguinal axillary vessels from 10 mice (5 males and 5 females). This allowed us to quantify the number of AdvCs that coexpress CD34 and Pdgfrα as well as the number of cells co-expressing Pdgfrα and other markers.

      - We have added a negative control with quantification for the co-localization analysis assessing Myh11 and Pdgfrα. We have added a negative control with quantification for the ChR2-photo stimulated contraction experiments using Myh11CreERT2-ChR2 mice that were not injected with tamoxifen. 

      - We also used Biocytin-AF488 in our intracellular Vm electrodes to map the specific cells in which we recorded action potentials and in neighboring cells since Biocytin-AF488 is under 1KDa and can pass through gap junctions. This approach independently labeled lymphatic muscle cells and their direct neighbors for 3 IALVs from 3 separate mice. 

      - We performed membrane potential recordings in isolated, pressurized (under isobaric conditions), and spontaneously contracting inguinal axillary lymphatic collecting vessels at different pressures. 

      - We also show that the pressure-frequency relationship is dependent on the slope of the diastolic depolarization as no other parameter was significantly altered in our study and the diastolic depolarization slope was highly correlated with contraction frequency. 

      We believe the addition of these novel data, controls, experiments, and quantifications have improved the manuscript in line with the reviewers’ suggestions.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Lines 149-162: The authors rule out the methylene blue staining cells in the cLV wall as pacemakers because they don't form continuous longitudinal connections to drive propagation. Is it possible for a pacemaker cell to only initiate the contraction and then have the LMCs make the axial electrical connections to propagate the electrical wave? I am not trying to suggest the methylene blue cells are pacemakers, but I am not sure the lack of longitudinal (or radial) connectivity is sufficient evidence to rule out the possibility. This comment also is relevant to the 3 criteria for a pacemaker cell listed in the Discussion (Lines 413-417). 

      We agree with the reviewer’s broader point that a pacemaker cell may not require direct contact with other ‘pacemaker’ cells within the tissue as long as they are still within the same electrical syncytium. However, we do expect a continuous presence of a pacemaker cell type throughout the vessel wall length to account for the persistence of spontaneous contractile behavior despite vessel length, and the ability for contraction initiation to shift (Akl et al 2011, Castorena et al 2018 and Castorena et al 2022) and the occurrence of spontaneous action potentials. In Dirk van Helden’s seminal work in 1993 on lymphatic pacemaking, a major finding was that “SM of small lymphangions or that of short segments, cut from lymphangions of any length, behaved similarly”. We have adjusted our phrase regarding the requirement of a contiguous network and instead suggest a continuous presence along the vessel network and integrated into the electrical syncytium. 

      Methylene blue is an alkaline stain that will stain acidic structures and historically methylene blue is noted to stain Interstitial cells of Cajal in the gastrointestinal tract which typically exist as network of cells(Huizinga et al 1993 and Berezin 1988). No such network was readily apparent in our methylene blue staining nor did the stained cells have a similar morphology to the ICCs of the gastrointestinal tract. Further, methylene blue is staining is not limited to ICCs or pacemaker cells at large as it has been used to kill cancer cells. Within the small intestine methylene blue was noted to also stain macrophage like cells (Mikkelsen et al 1988), and we too draw parallels between the macrophage morphology observed with Macgreen mice and methylene-blue stained cells. The specific structure for the ICC affinity for methylene blue is not well described and while the innate cytotoxicity of methylene blue and light has been used to kill ICCs and impair slow wave generation, the lack of specificity of this method leaves much to be desired. What is clear is that the ICC network highlighted by methylene blue in the gut is absent in lymphatic collecting vessels.

      In Figure 15/Video12, is it possible that the cells that are showing intracellular Ca2+ in diastole are the cells that reach a threshold membrane potential that then trigger the rest of the LMCs? As the authors have shown heterogeneity in the LMCs surface markers, is it possible that the cells with Ca2+ activity during diastole are identifiable by a distinct molecular phenotype? Or is the thought that these cells are randomly active in diastole? Some discussion/speculation about this seems appropriate. 

      We are in agreement with the reviewer’s conclusion that there is heterogeneity in the LMCs as it pertains to the calcium oscillations in diastole, either under normal buffer conditions or when L-type channels are inhibited with nifedipine. We also note significant heterogeneity in the gene expression noted within the four LMC subclusters (0-3), though we did not see significant differences in either in Ip3R1 or Ano1 expression. However, subcluster “0” had increased expression of Itprid2, also known as KRas-induced actin-interacting protein (KRAP) which is thought to tether, and thus immobilize, IP3 receptors to the actin cortex beneath the cell membrane. KRAP has been recently proposed to be a critical player in IP3 receptor “licensing” which allows IP3 receptors to release calcium (Vorontsova et al., 2022).  However, whether similar requirement of IP3R licensing is necessitated in all cells or specifically in LMCs is unknown it is quite clear there are specific release sites within the cell and this topic is currently under further investigation for a separate manuscript. We would like to note that there is yet to be a clear consensus on whether IP3R licensing is required as much of these studies are performed in cultured cells and this mechanism has only recently been described. 

      Healthy lymphatic collecting vessels typically have a single pacemaker driving a coordinated propagated contraction in ex vivo isobaric myograph studies (Castorena-Gonzalez et al., 2018), which is typically at either end of the cannulated vessel. We believe that this is due to the lack of a bordering cell in one direction and allows charge to accumulate and voltage to reach threshold at these sites preferentially. We have tried to image calcium at the pacemaking pole of the vessel to observe the specific Ca<sup>2+</sup> transients at these sites though invariably the act of imaging GCaMP6f results in the pacemaker activity initiating from the other pole of the vessel. It is our opinion that the fact that LMCs are heterogenous in their Ca<sup>2+</sup> transients is a feature to the system as it permits a wider range of depolarization signals, and thus allows finer control of the pacing as different physical/pressure or signaling stimuli is encountered. Likely, the cells with the higher propensity of Ca<sup>2+</sup> transients act as the contraction initiation site in vivo, though it must also be noted that the LMC density decreases around lymphatic valve sites. In fact, in guinea pig collecting vessels there are very few LMCs at the valves which can render them electrically uncoupled or poorly coupled (Van Helden, 1993). Thus, valve sites in which there is greater electrical resistance due to lower LMC-LMC coupling may allow for charge accumulation in the LMCs at the valve site, similar to the artificial condition achieved in our myograph preparations with two cut ends, and allow them to reach threshold first and drive coordination at the valve sties.

      An additional description of what the PTCL analysis is meant to represent physiologically would be helpful for readers. 

      We have better described the conversion of the calcium signals into “particles” for analysis at first mention in the methods and results section and have included the requisite reference to this specific methodology in Line 429-30. 

      A description of how DMAX is experimentally determined is needed. 

      We have adjusted our methods section to describe DMAX in line 774-775.

      “with Ca<sup>2+</sup>-free Krebs buffer (3mM EGTA) and diameter at each pressure recorded under passive conditions (DMAX).”

      I think the vessels referred to as popliteal lymphatic vessels are actually saphenous lymphatic vessels (afferent to the popliteal lymph node). Please clarify. 

      Indeed, some of the vessels used in this study are the afferents to the single popliteal node. They travel with the caudal branch of the saphenous vein, but have routinely been described as popliteal vessels, as opposed to saphenous lymphatic vessels, by the lymphatic field at large (Tilney 1971 PMCID: PMC1270981, Liao 2015 PMID: 25512945). To move away from this nomenclature would likely add to confusion although we agree that the lymphatic field may need to improve or correct the vessel naming paradigm to match the vascular pairs they follow.

      Reviewer #2 (Recommendations For The Authors): 

      Lines 214-215 - can you cite a reference for the observation that rhythmic contractions don't require the presence of valves? 

      We have added the reference. In Dr. Van Helden’s seminal work on the topic in 1993, “Vessel segments were then cut from selected small lymphangions (length 300-500 um) by cutting at the valves.” Additionally, work by Dr Anatoliy Gashev utilized sections of lymphatic vessels that lacked valves to study orthograde and retrograde shear sensitivity (Gashev et al., 2002).

      Lines 224-230 - It would have been nice to see colocalization analysis for all cell types so that "negative" results could be compared with the "positives" that you report. This would help bolster evidence of your ability to separate cell types. 

      We understand the reviewer’s sentiment and agree. We have now added a “negative control” colocalization staining and analysis for PDGFR and Myh11 which has been added to the current SuppFigure 1. We stained 3 IALVs from 3 separate mice with PDGFRα and Myh11 and performed confocal microscopy. We ran the FIJI BIOP-JACOP colocalization plugin as before and observed very little colocalization of the two signals. Additionally, we have also added a coexpression assessment for CD34 and PDGFRα and other genes using our scRNAseq dataset.  

      line 293 - Should read "Cx45 in..." 

      This has been corrected. 

      “The expression of the genes critically involved in cLV function—Cav1.2, Ano1, and Cx45—in the PdgfrαCreER<sup>TM</sup>-ROSA26mTmG purified cells and scRNAseq data prompted us to generate PdgfrαCreER<sup>TM</sup>-Ano1<sup>fl/fl</sup>, PdgfrαCreER<sup>TM</sup>-Cx45<sup>fl/fl</sup>, and PdgfrαCreER<sup>TM</sup>-Cav1.2<sup>fl/fl</sup> mice for contractile tests.”

      lines 470-473 - A reference for this statement should be cited. 

      We have added the reference. In Dr. Van Helden’s seminal work on the topic in 1993, “Vessel segments were then cut from selected small lymphangions (length 300-500 um) by cutting at the valves.” Additionally, work by Dr Anatoliy Gashev utilized sections of lymphatic vessels that lacked valves to study orthograde and retrograde shear sensitivity (Gashev et al., 2002).

      Lines 483-487 - References should be cited for these statements. 

      We have narrowed and clarified this statement and supported it with the necessary citations. 

      “Of course, mesenchymal stromal cells (Andrzejewska et al., 2019) and fibroblasts (Muhl et al., 2020; Buechler et al., 2021; Forte et al., 2022) are present, and it remains controversial to what extent telocytes are distinct from or are components/subtypes of either cell type (Clayton et al., 2022). Telocytes are not monolithic in their expression patterns, displaying both organ directed transcriptional patterns as well as intra-organ heterogeneity (Lendahl et al., 2022) as readily demonstrated by recent single cell RNA sequencing studies that provided immense detail about the subtypes and activation spectrum within these cells and their plasticity (Luo et al., 2022).”

      Lines 584-585 - Missing a reference citation. 

      Thank you for catching this error, the correct citation was for Boedtkjer et al 2013 and is now properly cited. 

      Line 638 - "these this" should read "this" 

      Thank you for catching this error. This particular sentence was removed in light of the addition of the scRNAseq data.

      Reviewer #3 (Recommendations For The Authors): 

      This manuscript from Zawieja et al. explored an interesting hypothesis about the pacemaker cells in lymphatic collecting vessels. Many aspects of lymphatic collecting vessels are still under investigation; hence this work provides timely knowledge about the lymphatic muscle cells as a pacemaker. Although it is an important topic of the investigation, the data provided do not support the overall goal of the manuscript. Many figures (Figure 1-5) provide quantitative estimation and the description provided in the results section might only be useful for a restricted audience, but not to the broader audience. Some of the figures are very condensed with multiple imaging panels and it is hard to follow the differences in qualitative analysis. Overall, this manuscript can be improved by more streamlined description/writing and figure arrangements (some of the figures/panels can be moved to the supplementary figures). 

      We disagree with the notion that the original data provided did not support the goal of the manuscript- to identify and test putative pacemaker cell types. Nonetheless we believe we have also added ample novel data to the manuscript, including membrane potential recordings and scRNAseq to highlight and to add further support to our conclusion that the pacemaker cell is an LMC. We believe the scRNAseq data will also greatly enhance the appeal of the manuscript to a broader audience and have renamed the manuscript in line with the wealth of data we have collected on the components of the vessel wall as we tested for putative pacemaker cells.

      As requested, we have moved many figures to the supplement to allow readers to focus more on the more critical experiments.

      A few other points that need to be addressed: 

      (1) Authors used immunofluorescence-based differences in various cell types in the collecting vessels. Initially, they chose ICLC, pericytes, and lymphatic muscle cells. But then they started following adventitial cells and endothelial cells. It is not clear from the description, why these other cells could be possibly involved in the pacemaker activity. It will be easier to follow if authors provide a graphical abstract or summary figure about their hypothesis and what is known from their and others' work. 

      We would like to clarify that we used the endothelial cells as controls to ensure what we observed via immunofluorescence and FACs RT-PCR were a separate cell type from either lymphatic muscle or lymphatic endothelial cells on the vessel wall. Staining for the endothelium also allowed us to assess where these PDGFRα+CD34+ cells reside in the vessel wall.  We started with a wide range of markers that are conventionally used for targeting specific cell types, but as expected those markers are not always 100% specific. Specifically, we focused on CD34, Kit, and Vimentin as those were the markers for the non-muscle cells observed in the lymphatic collecting vessel wall previously. What we found was that CD34 and PDGFRα labeled the same cell type. As there was not a CD34Cre mouse available at the time we instead utilized the inducible PDGFRαCreERTM. We are unsure how well an abstract figure will condense the conclusions from the experiments listed here but if absolutely required for publication we can attempt to highlight the representative cell populations identified on the vessel wall.

      (2) Authors used many acronyms in the manuscript without defining them (when they appeared for the first time). Please follow the convention. 

      We have checked the manuscript and made several corrections regarding the use of abbreviations.

      (3) How specific PDGFR-alpha as a marker of the pericytes? It can also label the mesenchymal cells. Why did the author choose PDGFR-alpha over beta for their Cre-based expression approach? 

      We tried to assess if there were a pericyte like cell present in or along the wall using PDGFRbeta (Pdgfrβ). Pdgfrβ is commonly used to identify pericytes (Winkler et al., 2010), while in contrast Pdgfrα is a known fibroblast marker (Lendahl et al., 2022). Pdgfrβ CreERT2 resulted in recombination in both LMCs and AdvCs, preventing it from being a discriminating marker for our study where as Myh11CreER<sup>T2</sup> and PDGFRαCreER<sup>TM</sup> were specific at least to cell type based on our FACSs-RT-PCR and staining. As you can tell from the scRNAseq data in Figure 5, there was no cell cluster that Pdgfrβ was specific for in contrast to PDGFRα and Myh11.  In Figure 6 we show the expression of another commonly used pericyte marker NG2 (Cspg4) in our scRNAseq dataset which was observed in both LMCs and AdvCs as well. Lastly, MCAM (Figure 6) can also be a marker for pericytes though we see only expression in the LMCs and LECs for this marker. Notably, almost all of the AdvCs express PDGFRα rendering the PDGFRαCreER<sup>TM</sup> a powerful tool to study this population of cells on the vessel wall including those that were PDGFRα+Cspg4+ or PDGFRα+ Pdgfrβ+.

      We were reliant on PDGFRαCreER<sup>TM</sup> as that was the only available PDGFRα Cre model at the time. Note we used PdgfrβCreER<sup>T2</sup> and Ng2Cre in our study but found that both Cre models recombined both LMCs and AdvCs.

      (4) Please include appropriate references for all the labeling markers (PDGFR-alpha, beta, and myc11 etc.) that are used in this manuscript. 

      We have added multiple references to the manuscript to support the use of these common cell “specific” markers as of course each marker is limited in some capacity to fully or specifically label a single population of cells (Muhl et al., 2020).

      (5) One of the criteria for the pacemaker cells is depolarization-induced propagated contractions. Authors have used optogenetics-induced depolarization to test this phenomenon. Please include negative controls for these experiments. 

      We have now added negative controls to this experiment which were non-induced (no tamoxifen) Myh11CreER<sup>T2</sup>-Chr2 popliteal vessels. This data has been added to the Figure 8.  

      (6) What are the resting membrane potentials of Lymphatic muscle cells? The authors should provide some details about this in the manuscript. 

      We agree with the reviewer and have added membrane potential recordings (Figure 13) at different pressures and filled our recording electrode with the cell labeling molecule BiocytinAF488 to highlight the action potential exhibiting cells, which were the LMCs. Lymphatic resting membrane potential is dynamic in pressurized vessels, which appears to be a critical difference in this approach as compared to pinned out vessels or those on wire myographs likely due to improper stretch or damage to the vessel wall. In mesenteric lymphatic vessels isolated from rats the minimum membrane potential achieved during repolarization ranges from -45 to 50mV typically while IALVs from mice are typically around -40mV, though IALVs have a notably higher contraction frequency. Critically, we have also added novel membrane potential recordings to this manuscript in IALVs at different pressures and show that the diastolic depolarization rate is the critical factor driving the pressure-dependent frequency.

      (7) In the discussion, the authors discussed SR Ca2+ cycling in Pacemaking, but the relevant data are not included in this manuscript, but a manuscript from JGP (in revision) is cross-referenced. 

      As discussed above, we have recently published our work where studied IALVs from Myh11CreERT2-Ip3R1fl/fl (Ip3r1ismKO) and Myh1CreERT2-Ip3r1fl/fl-Ip3r2fl/fl-Ip3r3fl/fl mice (Zawieja et al., 2023). Deletion of Ip3r1 from LMCs recapitulated the dramatic reduction in frequency we previously published in Myh11CreERT2-Ano1fl/fl mice and the loss of pressure dependent chronotropy. Furthermore, in this manuscript we also showed that the diastolic calcium transients are nearly completely lost in ILAVs from Myh11CreERT2-Ip3R1fl/fl knockout mice. There was no difference in the contractile function between IALVs from single Ip3r1 knockout and the triple Ip3r1-3 knockout mice suggesting that it is Ip3r1 that is required for the diastolic calcium oscillations. Further, in the presence of 1uM nifedipine there were still no calcium oscillations in the Myh11CreERT2-Ip3r1fl/fl LMCs. These findings provide further support for our interpretation that the pacemaking is of myogenic origin.

      Andrzejewska, A., B. Lukomska, and M. Janowski. 2019. Concise Review: Mesenchymal Stem Cells: From Roots to Boost. Stem Cells. 37:855-864.

      Buechler, M.B., R.N. Pradhan, A.T. Krishnamurty, C. Cox, A.K. Calviello, A.W. Wang, Y.A. Yang, L.

      Tam, R. Caothien, M. Roose-Girma, Z. Modrusan, J.R. Arron, R. Bourgon, S. Muller, and S.J. Turley. 2021. Cross-tissue organization of the fibroblast lineage. Nature. 593:575579.

      Castorena-Gonzalez, J.A., S.D. Zawieja, M. Li, R.S. Srinivasan, A.M. Simon, C. de Wit, R. de la Torre, L.A. Martinez-Lemus, G.W. Hennig, and M.J. Davis. 2018. Mechanisms of Connexin-Related Lymphedema. Circ Res. 123:964-985.

      Clayton, D.R., W.G. Ruiz, M.G. Dalghi, N. Montalbetti, M.D. Carattino, and G. Apodaca. 2022. Studies of ultrastructure, gene expression, and marker analysis reveal that mouse bladder PDGFRA(+) interstitial cells are fibroblasts. Am J Physiol Renal Physiol. 323:F299F321.

      Forte, E., M. Ramialison, H.T. Nim, M. Mara, J.Y. Li, R. Cohn, S.L. Daigle, S. Boyd, E.G. Stanley, A.G. Elefanty, J.T. Hinson, M.W. Costa, N.A. Rosenthal, and M.B. Furtado. 2022. Adult mouse fibroblasts retain organ-specific transcriptomic identity. Elife. 11.

      Gashev, A.A., M.J. Davis, and D.C. Zawieja. 2002. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol. 540:1023-1037.

      Lendahl, U., L. Muhl, and C. Betsholtz. 2022. Identification, discrimination and heterogeneity of fibroblasts. Nat Commun. 13:3409.

      Luo, H., X. Xia, L.B. Huang, H. An, M. Cao, G.D. Kim, H.N. Chen, W.H. Zhang, Y. Shu, X. Kong, Z.

      Ren, P.H. Li, Y. Liu, H. Tang, R. Sun, C. Li, B. Bai, W. Jia, Y. Liu, W. Zhang, L. Yang, Y. Peng, L. Dai, H. Hu, Y. Jiang, Y. Hu, J. Zhu, H. Jiang, Z. Li, C. Caulin, J. Park, and H. Xu. 2022. Pancancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 13:6619.

      Muhl, L., G. Genove, S. Leptidis, J. Liu, L. He, G. Mocci, Y. Sun, S. Gustafsson, B. Buyandelger, I.V.

      Chivukula, A. Segerstolpe, E. Raschperger, E.M. Hansson, J.L.M. Bjorkegren, X.R. Peng, M. Vanlandewijck, U. Lendahl, and C. Betsholtz. 2020. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat Commun. 11:3953.

      Van Helden, D.F. 1993. Pacemaker potentials in lymphatic smooth muscle of the guinea-pig mesentery. J Physiol. 471:465-479.

      Vorontsova, I., J.T. Lock, and I. Parker. 2022. KRAP is required for diffuse and punctate IP(3)mediated Ca(2+) liberation and determines the number of functional IP(3)R channels within clusters. Cell Calcium. 107:102638.

      Winkler, E.A., R.D. Bell, and B.V. Zlokovic. 2010. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener. 5:32.

      Zawieja, S.D., G.A. Pea, S.E. Broyhill, A. Patro, K.H. Bromert, M. Li, C.E. Norton, J.A. CastorenaGonzalez, E.J. Hancock, C.D. Bertram, and M.J. Davis. 2023. IP3R1 underlies diastolic ANO1 activation and pressure-dependent chronotropy in lymphatic collecting vessels. J Gen Physiol. 155.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      This study presents valuable observations of white matter organisation from diffusion MRI and two types of synchrotron imaging in both monkeys and mice. Cross-modality comparisons are interesting as the different methods are able to probe anatomical structures at different length scales, from single axons in high-resolution synchrotron (ESRF) imaging, to clusters of axons in lower-resolution synchrotron (DEXY) data, to axon populations at the mm-scale in diffusion MRI. By acquiring all modalities in monkey and mouse ex vivo samples, the authors can observe principles of fibre organisation, and characterise how fibre characteristics, such as tortuosity and micro-dispersion, vary across select brain regions and in healthy tissue versus a demyelination model. The results are solid, though some statements (in the abstract/discussion) do not appear to be fully supported, and statistical tests would help confirm whether tissue characteristics are similar/different between different conditions.

      R1.1: Thank you for the kind feedback. We have included statistical tests in the paper for tissue characteristics where appropriate.

      Due to the very high number of sample points (one per voxel) within the 3D synchrotron volumes, testing for statistical significance is challenging for the structure tensor-based tissue fractional anisotropy (FA) metric. This causes any standard statistical test to have sufficient power to evaluate even minute differences between the volumes as statistically significant with high confidence. In other words, the null hypothesis (H0) will always be rejected with p = 0, regardless of the practical significance of the difference. Therefore, we have not added statistical analysis for FA results.

      For the tractography based metrics, the number of sample points (one per streamline) is not as high as that for the structure tensor FA, thus making it more reasonable to test for statistical significance. The statistical analyses performed included tests for equality of distributions (Two-sample Kolmogorov-Smirnov tests), equality of medians (Two-sided Wilcoxon rank sum tests), and equality of variance (Brown-Forsythe tests). The results are described in relation to Figure 5(B, D), Figure 8(CF), and detailed in the Methods section.

      One very interesting result is the observation of apparent laminar organisation of fibres in ex vivo monkey white matter samples. DESY data from the corpus callosum shows fibres with two dominant orientations (one L-R, one slightly inclined), clustered in laminar structures within this major fibre bundle. Thanks to the authors providing open data, I was able to look through the raw DESY volume and observe regions with different "textures" (different orientations) in the described laminar arrangement. That this organisation can be observed by eye, as well as by structure tensor, is fairly convincing. As not all readers will download the data themselves, the manuscript could benefit from additional figures/videos to demonstrate (1) the quality of the DESY data and (2) a more 3D visualisation of the laminar structures (where the coronal plane shows convincing columnar structure or stripes). Similarly in Figure 5A, though this nicely depicts two populations with different orientations, it is somewhat difficult to see the laminar structure in the current image.

      ESRF data of the centrum semiovale (CS) contributes evidence for similar laminar structures in a crossing fibre region, where primarily AP fibres are shown to cluster in 3 laminar structures. As above, further visualisations of the ESRF volume in the CS (as shown in Figure 4E) would be of value (e.g. showing consistency across the 4 volumes, 2D images showing stripey/columnar patterns along different axes, etc).

      R1.2: Conveying complex 3D geometry through 2D still images is indeed challenging, and we greatly appreciate the reviewer’s comments and suggestions. To better communicate the understanding of the 3D anatomical environments, we have taken the following actions:

      (1) To enhance insights into the tractography results in Figures 5A and 5D, we have rendered and added animations of the tractography scenes as supplemental material.

      (2) To visually support 3D insights concerning the consistency of the laminar organisation of the callosal fibres, we have replaced the 2D slice views in Figures 3A and 3B with 3D renderings similar to the one in Figure 4E.

      (3) An animation of Figure 4E was created to display the colour-coded structure tensor directions of all four stacked scans. This animation visually supports the complexity of the fibre orientation and the layered structural laminar organisation of the CS sample.

      A key limitation of this result is that, though the DESY data from the CC seems convincing, the same structures were not observed in high-resolution synchrotron (ESRF) data of the same tissue sample in the corpus callosum. This seems surprising and the manuscript does not provide a convincing explanation for this inconsistency. The authors argue that this is due to the limited FOV of the ESRF data (~200x200x800 microns). However, the observed laminar structures in DESY are ~40 microns thick, and ERSF data from the CST suggests laminar thicknesses in the range of 5-40 microns with a similar FOV. This suggests the ERSF FOV would be sufficient to capture at least a partial description of the laminar organisation. Further, the DESY data from the CC shows columnar variations along the LR axis, which we might expect to be observed along the long axis of the ESFR volume of the same sample. Additional analyses or explanations to reconcile these apparently conflicting observations would be of value. For example, the authors could consider down-sampling the ESRF data in an appropriate manner to make it more similar to the DESY data, and running the same analysis, to see if the observed differences are related to resolution (i.e. the thinner laminar structures cluster in ways that they look like a thicker laminar structure at lower resolution), or crop the DESY data to the size of the ESRF volume, to test whether the observed differences can be explained by differences in FOV. Laminar structures were not observed in mouse data, though it is unclear if this is due to anatomical differences or somewhat related to differences in data quality across species.

      R1.3: We have clarified and expanded upon the results regarding the laminar organisation observed in the monkey CC DESY data. As noted in R1.2, we replaced the 2D images in Figures 3A (DESY) and 3B (ESRF) with 3D renderings to better display the spatial outline of the laminar organisation in the volumes. The reviewer is correct that, although the smaller field of view (FOV) of the ESRF data should allow us to at least partially capture parts of the laminar organisation observed in the larger FOV of the DESY data, this is not guaranteed. It depends on how the smaller FOV is positioned relative to the structural organisation, and since we lack co-registration, we do not know this. It should now be visually evident that the ESRF FOV can be placed such that it does not cover the observed laminae, a point which is now also emphasised in the Discussion. 

      Secondly, it is important to emphasise that the voxel colouring using the primary structure tensor direction is just a visualisation technique, which has limitations when it comes to assessing laminar organisation. Mapping 3D directions to RGB colours is inherently difficult and will always have ambiguities. If we had used the standard R-G-B to LR-AP-IS colouring in Figure 3, the laminar organisation would not be evident. Additionally, the laminae will only be visible when there are clear angular differences. There can still be a layered organisation even if we don’t observe it, which is the case for the mouse. The primary direction differences of these layers could be very low (i.e., parallel layers), and consequently not visually evident. This point has been clarified in both the Results and Discussion sections.

      Finally, in response to R1.6, we have added analyses regarding the shape of the FOD, specifically estimating the Orientation Dispersion Index (ODI) and Dispersion Anisotropy (DA). This provides further context to the reviewer’s comments about the discrepancies in laminar organisation. We have reflected on the relationship between DA and the visually observed laminar organisation, and this has been integrated into the relevant parts of the Results and Discussion sections.

      The changes to manuscript reflecting the statements above are listed here: 

      The Discussion section (page 21): “In the monkey CC DESY data, which has a field of view (FOV) comparable to a dMRI voxel, a columnar laminar organisation at a macroscopic level was visually revealed from the structure tensor (ST) direction colouring. However, this laminar organisation was not visible in the higher-resolution ESRF data for the same tissue sample. Although the two samples were not co-registered, the size of a single ESRF FOV within the DESY sample is illustrated in Fig. 3A. This demonstrates the possibility of placing the ESRF sample where the observed laminar structure is absent. Consequently, knowledge of the tissue structural organisation and its orientation is important to fully benefit from the stacked FOV of the ESRF sample and when choosing appropriate minimal FOV sizes in future experiments.

      Interestingly, when characterising FODs with measures like ODI and DA as indicators of fibre organisation, rather than relying on visualisation, results from large- and small-FOV data show no discrepancies. This statistical approach discards the spatial context (visually perceived as laminae), highlighting the need to combine both methods.” 

      The Results section (page 8): “The mid-level DA values suggest some anisotropic spread of the directions, reflecting the angled laminar organisation observed in the DESY sample. Interestingly, the DA value for the ESRF sample is almost identical, despite the laminar bands being less visually apparent.”

      The Results section (page 17): “Nevertheless, visualisation of orientations did not reveal any axonal organisation in the mouse CC due to the lack of local angular contrast, unlike the clear laminar structures seen in the monkey sample (Fig. 3A). Any parallel organisation in tissue remains undetectable because our visual contrast relies on angular differences.”

      The Discussion section (page 22): “In the monkey CC (mid-body), we observed laminar organisation indicated by clear spatial angular differences in the ST directions in the sample (Fig. 3A). Quantifications of the FOD shape showed DA indices of 0.55 and 0.59 for the DESY and ESRF samples, respectively. In contrast, the mouse CC (splenium) did not visually reveal a similar angled laminar organisation (Fig. 7C), and the DA indices were lower, at 0.49 and 0.32, respectively. Two possible explanations exist. First, the within-pathway laminar organisation may not be identical across the entire CC. Consequently, more scans from other CC regions would be required to confirm. Second, the different species might account for the differences. Larger brains like the monkey might foster a different level of within-pathway axon organisation compared to the smaller mouse. Although we could not visually detect laminar organisation from the colour coding of the ST direction in the mouse, the non-zero DA values suggest some level of organisation. This is supported by our streamline tractography, which indicates a vertical layered organisation (Fig. 8A, B). It further aligns with studies using histological tracer mapping that shows a stacked parallel organisation of callosal projections in mice, between cortex regions M1 and S1 (Zhou et al. 2013). Nevertheless, we cannot rely solely on voxel-wise ST directions to fully describe axonal organisation, as this method does not contrast almost parallel fasciculi (inclination angles approaching 0 degrees). Analysing patterns in tractography streamlines would be an interesting future direction for this purpose.”

      The authors further quantify various other characteristics of the white matter, such as micro-dispersion, tortuosity, and maximum displacement. Notably, the microscopic FA calculated via structure tensor is fairly consistent across regions, though not modalities. When fibre orientations are combined across the sample, they are shown to produce similar FODs to dMRI acquired in the same tissue, which is reassuring. As noted in the text, the estimates of tortuosity and max displacement are dependent on the FOV over which they are calculated. Calculating these metrics over the same FOV, or making them otherwise invariant to FOV, could facilitate more meaningful comparisons across samples and/or modalities.

      R1.4: This raises an interesting point about the necessity of normalising the FOV to obtain invariant, tractography-based metrics of tortuosity and maximum deviation across different samples and modalities. In general, achieving this is challenging, and in this study, it is practically not possible. Between species, we encounter significant differences in brain volume ratios, which complicates the establishment of a common reference FOV due to the distinct anatomical organisation of monkey and mouse brains (see our response to R1.8). Within species, we would encounter challenges due to missing contrast—such as issues with staining—and the lack of perfect co-registration.

      The Discussion section (page 28) has been extended to reflect this: ”Within the same species, assuming perfect co-registration of samples, it would be possible to perform correlative imaging and analysis. This would allow validation of whether tractography streamlines could be reproduced at different image resolutions within the same normalised FOV. Although this was not possible with the current data and experimental setup, it would be an interesting point to pursue in future work.”

      Though the results seem solid, some statements, particularly in the abstract and discussion, do not seem to be fully supported by the data. For example, the abstract states "Our findings revealed common principles of fibre organisation in the two species; small axonal fasciculi and major bundles formed laminar structures with varying angles, according to the characteristics of major pathways.", though the results show "no strong indication within the mouse CC of the axonal laminar organisation observed in the monkey". Similarly, the introduction states: "By these means, we demonstrated a new organisational principle of white matter that persists across anatomical length scales and species, which governs the arrangement of axons and axonal fasciculi into sheet-like laminar structures." Further comments on the text are provided below.

      R1.5: We understand that it can be misunderstood that the laminar organisation is identical in monkeys and mice, which is not the case. For example, we show that in the corpus callosum, pathways are parallel in the mouse but not in the monkey. We have clarified that while the principle of layered laminar organisation of pathways is shared between monkeys and mice, species-specific differences do exist.

      We have made the following clarifying changes to the manuscript:

      The Abstract (page 2): “Our findings revealed common principles of fibre organisation that apply despite the varying patterns observed across species” 

      The Introduction (page 4-5): “Through these methods, we demonstrated organisational principles of white matter that persists across anatomical length scales and species. These principles govern the organisation of axonal fasciculi into sheet-like laminar shapes (structures with a predominant planar arrangement). Interestingly, while these principles remain consistent, they result in varied structural organisations in different species.” 

      The Discussion (page 21): “despite species differences”.

      One observation not notably discussed in the paper is that the spherical histograms of Figure 3E/H appear to have an anisotropic spread of the white points about 0,0. It would be interesting if the authors could comment on whether this could be interpreted as the FOD having asymmetric dispersion and if so, whether the axis of dispersion relates to the fibre orientations of the laminar structures.

      R1.6: That is a good point, and to address it, we have fitted spherical Bingham distributions to the FODs, allowing us to quantify their shapes. From each Bingham distribution, we derived two wellknown indices from the diffusion MRI community: the Orientation Dispersion Index (ODI) and Dispersion Anisotropy (DA) index. The ODI explains the dispersion of fibres for a single bundle FOD, whereas DA expresses the shape of the FOD on the unit sphere surface, i.e., the degree of anisotropy. We have integrated the Bingham-based analysis into the Methods, Discussion, and Results sections concerning Figures 3 and 7, but not Figure 4, which contains multiple fibre bundles that we cannot separate on a voxel level. The analysis does not impact the overall message and conclusion but adds interesting context to the discussion around laminar organisation.

      A limitation of the study is that it considers only small ex vivo tissue samples from two locations in a single postmortem monkey brain and slightly larger regions of mouse brain tissue. Consequently, further evidence from additional brain regions and subjects would be required to support more generalised statements about white matter organisation across the brain.

      R1.7: Collecting more samples from various locations in the brain would provide valuable insights into the consistency of white matter organisation across anatomical length scales, as well as the structuretensor based anisotropy and tortuosity metrics. However, being awarded beamtime at two different synchrotron facilities to scan the same sample with different imaging setups is practically challenging. At the ESRF, we have gathered additional image volumes from other white matter regions of the monkey brain that support all our findings, which will be published separately. X-ray synchrotron imaging technology is advancing rapidly, with faster acquisition times enabling more image volumes to be stitched together. This extends the FOV and allows for a more robust statistical description of the anatomy. Consequently, future studies with an extended FOV and varying image resolutions could utilise a single synchrotron facility to collect additional samples, further supporting our findings.

      The Discussion section (page 27) has been extended to reflect this: “Increasing the number of samples across both species and examining laminar organisation at various length scales in more regions would strengthen our findings. However, securing beamtime at two different synchrotron facilities to scan the same sample with varying image resolutions is a limiting factor. Beamline development for multiresolution experimental setups, along with faster acquisition methods, is a rapidly advancing field. For instance, the Hierarchical Phase-Contrast Tomography (HiP-CT) imaging beamline at ID-18 at the ESRF, enables multi-resolution imaging within a single session to address this challenge, though it is currently limited to a resolution of 2.5 μm (Walsh et al. 2021).”

      Given the monkey results, the mouse study (section 2.5 onwards) lacks some motivation. In particular, it is unclear why a demyelination model was studied and if/how this would link to the laminar structure observed in the monkey data. Further, it is unclear how comparable tortuosity/max deviation values are across species, considering the differences in data quality and relative resolution, given that the presented results show these values are very modality-dependent.

      R1.8: We have clarified the motivation for including the mouse part of the study in both the Introduction and the Results sections.

      The Introduction section (page 5): “Furthermore, using a mouse model of focal demyelination induced by cuprizone (CPZ) treatment, we investigate the inflammation-related influence on axonal organisation. This is achieved through the same structure tensor-derived micro-anisotropy and tractography streamline metrics.”

      The Results section (page 15): “Finally, we investigated the organisation of fasciculi in both healthy mouse brains and a murine model of focal demyelination induced by five weeks of cuprizone (CPZ) treatment. This allowed for the exploration of the disease-related influence on axonal organisation, particularly under inflammation-like conditions with high glial cell density at the demyelination site (He et al. 2021). The experimental setup for DESY and ESRF is similar to that described for the monkey, with the exception that we did not perform dMRI and synchrotron imaging on the same brains, and only collected MRI data for healthy mouse brains. This approach allowed us to apply the same structure tensor and tractography streamline analysis used previously, but in a healthy versus disease comparison, demonstrating the methodology’s ability to provide insights into pathological conditions.”

      Across species, the comparison of tortuosity and maximum deviation must be approached with caution. On one hand, we observe a comparable influence of the extra-axonal environment in both the monkey and mice, as discussed in the section “Sources to the non-straight trajectories of axon fasciculi.” On the other hand, the anatomical scale and relative image resolution are significant factors, as correctly pointed out. In the mouse, for instance, the measures are influenced by white matter pathway macroscopic effects, making cross-species comparison challenging to perform in a normalised way.

      The limitations section of the Discussion (page 28) has been updated to reflect this: ”A limiting consequence of having samples imaged at differing anatomical scales is that certain measures become inherently hard to compare in a normalised way. The tractography-based metrics—tortuosity and maximum deviation—serve as good examples of this resolution and FOV dependence. In the ESRF samples, the anatomical scale was at the level of individual axons, and the streamline metrics primarily reflect micro-scale effects from the extra-axonal environment, such as the influence of cells and blood vessels. In comparison, the larger anatomical scale in the DESY samples represents the level of fasciculi and above, with metrics influenced by macroscopic effects, such as the bending of the CC pathway. Both scales are interesting and can provide valuable insights in their own right, but caution is required when comparing the numbers, especially for cross-species studies where there is a significant difference in brain volume ratios.”

      The paper introduces a new method of "scale-space" parameters for structure tensors. Since, to my understanding, this is the first description of the method, some simple validation of the method would be welcomed. Further, the same scale parameters are not used across monkeys and mice, with a larger kernel used in mice (Table 2) which is surprising given their smaller brain size. Some explanation would be helpful.

      R1.9: We have expanded the description of the scale-space structure tensor approach in the Methods section. Specifically, we have elaborated on the empirical process used to select the scale-space parameters shown in Table 2 and explained why multiple scales were applied only to the monkey samples scanned at ESRF (see Table 2, sample IDs 2 and 3) but not to the other datasets. Additionally, we have added a supplementary figure to assist in illustrating the concept.

      Reviewer #2 (Public Review):

      Summary:

      In this work, the authors combine diffusion MRI and high-resolution x-ray synchrotron phase-contrast imaging in monkey and mouse brains to investigate the 3D organization of brain white matter across different scales and species. The work is at the forefront of the anatomical investigation of the human connectome and aligns with several current efforts to bridge the resolution gap between what we can see in vivo at the millimeter scale and the complexity of the human brain at the sub-micron scale. The authors compare the 3D white matter organization across modalities within 2 small regions in one monkey brain (body of the corpus callosum, centrum semiovale) and within one region (splenium of the corpus callosum) in healthy mice and in one murine model of focal demyelination. The study compares measures of tissue anisotropy and fiber orientations across modalities, performs a qualitative comparison of fasciculi trajectories across brain regions and tissue conditions using streamlined tractography based on the structure tensor, and attempts to quantify the shape of fasciculi trajectories by measuring the tortuosity index and the maximum deviation for each reconstructed streamline. Results show measures of anisotropy and fiber orientations largely agree across modalities, especially for larger FOV data. The high-resolution data allows us to explore the fiber trajectories in relation to tissue complexity and pathology. The authors claim the study reveals new common organization principles of white matter fibers across species and scales, for which axonal fasciculi arrange into sheet-like laminar structures.

      Strengths:

      The aim of the study is of central importance within present efforts to bridge the gap between macroscopic structures observable in vivo in humans using conventional diffusion MRI and the microscopic organization of white matter tissue. Results obtained from this type of study are important to interpret data obtained in vivo, inform the development of novel methodologies, and expand our knowledge of the structural and thus functional organization of brain circuits.

      Multi-scale data acquired across modalities within the same sample constitute extremely valuable data that is often hard to acquire and represent a precious resource for validation of both diffusion MRI tractography and microstructure methods.

      The inclusion of multi-species data adds value to the study, allowing the exploration of common organization principles across species.

      The addition of data from a murine cuprizone model of focal demyelination adds interesting opportunities to study the underlying biological changes that follow demyelination and how these impact tissue anisotropy and fiber trajectories. These data can inform the interpretation and development of diffusion MRI microstructure models.

      Weaknesses:

      The main claim of a newly discovered laminar organization principle that is consistent across scales and species is not supported strongly enough by the data. The main evidence in support of the claim comes from the larger FOV data obtained from the body of the corpus callosum in the monkey brain. A laminar organization principle is partially shown in the centrum semiovale in the monkey brain and it is not shown in mice data. Additionally, the methods lack details to help the correct interpretation of these findings (e.g., how were these fasciculi defined?; how well do they represent different axonal populations?; what is the effect of blood vessels on the structure tensor reconstruction?; how was laminar separation quantified?) and the discussion does not provide a biological background for this organization. The corpus callosum sample suggests axons within a bundle of fibers are organized in a sheet-like fashion, while data from the centrum semiovale suggest fibers belonging to different fiber bundles are organized in a sheet-like arrangement. While I acknowledge the challenges in acquiring such high-resolution data, additional samples from different regions in the same animals and from different animals would help strengthen this claim.

      R2.1 

      -  how were these fasciculi defined?

      In the introduction (page 3), we have clarified our definition of an axon fasciculus: “A fasciculus is a bundle of axons that travel together over short or long distances. Its size and shape can vary depending on its internal organisation and its relationship to neighbouring fasciculi.”

      Additionally, we emphasise in the Results section (page 12) that the centroid streamlines are not guaranteed to be actual fasciculi, but rather representations of them. The paragraph now states: “To ease visualisation and quantification, we used QuickBundle clustering(Garyfallidis et al. 2012) to group neighbouring streamlines with similar trajectories into a centroid streamline. This centroid streamline serves as an approximation of the actual trajectory of a fasciculus.”

      - what is the effect of blood vessels on the structure tensor reconstruction?

      Fair point, that was not clear from our description. The clarification contains two parts. First, the estimation of the structure tensor occurs in all voxels, and in that sense, the blood vessels respond very similarly to axons. Second, when it comes to sample statistics derived from the structure tensor analysis (FA histograms and the FODs), they will have an influence, albeit a small one, given the low volume percentage of the blood vessels within the FOVs. In the monkey samples, segmenting the blood vessels was achievable with little effort, allowing us to exclude their contribution from FA statistics and FODs. To make this clear, we have added a paragraph to the Methods section (page 34) titled “Structure tensor-based quantifications,” reflecting this clarification. Additionally, we have restructured the entire structure tensor methods description (starting on page 32) as part of the reviewer comments in R1.6 and R1.9.

      - how was laminar separation quantified?

      We have added a clarification in Results section (page 7): “The laminar thickness was determined by manual measurements on laminae visually identified in the 3D volume”.

      - discussion does not provide a biological background for this organization.

      A good point. Including the biological background is relevant as it supports the laminar organisation of white matter pathways observed in our findings and those of others.

      We have added a section on this background in the Discussion (page 24): “We believe our observed topological rule of white matter laminar organisation can be explained by a biological principle known from studies of nervous tissue development. The first axons to reach their destination, guided by their growth cones, are known as “pioneering” axons. “Follower” axons use the shaft of the pioneering axon for guidance to efficiently reach the target region (Breau and Trembleau 2023). Axons can form a fasciculus by fasciculating or defasciculating along their trajectory through a zippering or unzipping mechanism, controlled by chemical, mechanical, and geometrical parameters. Zippering “glues” the axons together, while unzipping allows them to defasciculate at a low angle (Šmít et al. 2017). Although speculative, the zippering mechanism may be responsible for forming the laminar topology observed across length scales. The defasciculation effect can explain our results in the corpus callosum (CC) of monkeys, with laminar structures at low angles (~35 degrees) also observed by (Innocenti et al. 2019; Caminiti et al. 2009), as well as in other major pathways (Sarubbo et al. 2019). In contrast, a fasciculation mechanism may be observed in the mouse CC (0 degrees). If the geometrical angle between two axons is high, i.e., toward 90 degrees, the zippering mechanism will not occur, and the two axons (fasciculi) will cross (Šmít et al. 2017). This supports our and other findings that crossing fasciculi or pathways occur at high angles toward 90 degrees in the fully matured brain (Wedeen et al. 2012). Once myelination begins, the zippering mechanism is lost (Šmít et al. 2017), suggesting that laminar topology is established at the earliest stages of brain maturation.”

      - additional samples from different regions in the same animals and from different animals would help strengthen this claim

      Reviewer #1 also pointed to the inclusion of additional samples, and this is now discussed as part of the study limitations on page 27 (see also R1.7).

      The main goal of the study is to bridge the organization of white matter across anatomical length scales and species. However, given the substantial difference in FOVs between the two imaging modalities used, and the absence of intermediate-resolution data, it remains difficult to effectively understand how these results can be used to inform conventional diffusion MRI. In this sense, the introduction does not do a good enough job of building a strong motivation for the scientific questions the authors are trying to answer with these experiments and for the specific methodology used.

      R2.2: Indeed, this is an essential point now emphasised in the introduction, page 3, which now states: ”Despite the limited resolution of dMRI, the water diffusion process can reveal microstructural geometrical features, such as axons and cell bodies, though these features are compounded at the voxel level. Consequently, estimating microstructural characteristics depends on biophysical modelling assumptions, which can often be simplistic due to limited knowledge of the 3D morphology of cells and axons and their intermediate-level topological organisation within a voxel. Thus, complementary highresolution imaging techniques that directly capture axon morphology and fasciculi organisation in 3D across different length scales within an MRI voxel are essential for understanding anatomy and improving the accuracy of dMRI-based models(Alexander et al. 2019).”

      Additionally, in the introduction, page 4, we have made the following changes to strengthen the link across modalities, such that it now states: “In the x-ray synchrotron data, we applied a scale-space structure tensor analysis, which allowed for the quantification of structure tensor-derived tissue anisotropy and FOD in the same anatomical regime indirectly detected by dMRI.”

      The cuprizone data represent a unique opportunity to explore the effect of demyelination on white matter tissue. However, this specific part of the study is not well motivated in the introduction and seems to represent a missed opportunity for further exploration of the qualitative and quantitative relationship between diffusion MRI and sub-micron tissue information (although unfortunately not within the same brain sample). This is especially true considering the diffusion MRI protocol for mice would allow extrapolation of advanced measures from different tissue compartments.

      R2.3: A similar point was raised by Reviewer 1 (R1.8), and we have clarified the motivation for including the healthy mice and the demyelination samples.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Many thanks to the authors for providing open data. This was very helpful when reviewing the manuscript and is a valuable resource for the community.

      R1.10: We are happy to share our data with the community. Understanding anatomy in 3D is hard to achieve through still images and animations, so the ability to explore it on your own is quite important. The link to the data repository has been added in the Methods section in the following paragraph: “Due to the size of the data selected, processed image volumes, masks and results are available at https://zenodo.org/records/10458911. Other datasets can be shared on request.“

      One confusing element of the paper is that orientations (or axes) do not seem to be consistent across samples/modalities. For example, the green tensors in Figures 3 C and D are tilted up/down in opposite directions and the streamlines in Figure 5A seem opposite (SL) from what we would expect from Figure 2A (SR). Having consistent orientations across modalities and images would help the reader. When colouring tensors (e.g. in Figure 3), the authors could consider a 3D colour scheme (similar to that used by diffusion MRI) rather than colouring by only inclination, as this would provide useful information on whether different laminae have similar orientations, as implied by the tractography in Figure 4.

      R1.11: Thank you for spotting the suboptimal consistency between Figures 2, 3, and 5. Figure 2 has been corrected and updated. The left-right direction in the coronal views was not correctly displayed. Additionally, the glyph directions have been updated in Figures 2 and 3.

      By default, we use the “standard” RGB colour scheme used in dMRI. However, for the monkey CC— essentially Figure 3—this did not effectively illustrate our findings. We decided to use a different directional colour encoding scheme, which captures the angular deviation from the L-R axis. This was to assist in the visualisation of the inclination angle between the laminars. We have used the same colour scheme for the tensors in Figure 3 to avoid confusion.

      On a general note, the standard colour scheme has uniform “colour contrast” in all directions, but when there is only a single dominant direction in the sample, it can make sense to concentrate the colour contrast in that axis.

      Results: "even higher FA anisotropy in the micro-tensor domain of 0.997, i.e., the micro (μ)FA (20, 21)." I understand these references lead to a definition of μFA that is based on multiple diffusion tensor encodings which is quite different from that suggested by Kaden. It may be preferable to reference Kaden directly (since I understand this is the method used) to avoid confusion.

      R1.12: Correctly spotted, and we now reference the method from Kaden et al. and use the other references elsewhere when relevant.

      "and scanned the mouse brain in a whole." - typo?

      R1.13: Thank you for spotting the typo. The mouse brain was kept in the skull during MRI scanning, which has been clarified in the Methods section.

      The crossing fibre region appears to be sometimes referred to as the centrum semiovale, and other times as the CST. CS seems the better description and keeping this naming consistent would avoid confusion to the reader.

      R1.14: Well spotted, thank you. We have replaced the usage of Corticospinal Tract (CST) with centrum semiovale (CS) where relevant.

      Direct comments on the text:

      Abstract: "Individual axon fasciculi exhibited tortuous paths .... in a manner independent of fibre complexity and demyelination"

      Do statistical comparisons of the various distributions support this? The data shows somewhat increased tortuosity in the CST compared to the CC, and somewhat lower tortuosity in CPZ tissue.

      R1.15: The intention of the text was not to point to the comparison of tortuosity, but rather to highlight the maximum deviation. We observe a high probability density of maximum deviations at approximately 5-10 microns in all samples, which corresponds to the size of structures in the extraaxonal environment, such as blood vessels and cells.

      Additionally, we understand that the original statement might imply an expectation of a statistical analysis demonstrating independence, which is not the case. To clarify, we have reformulated the sentence in the Abstract (page 2) to address these points: “Fasciculi exhibited non-straight paths around obstacles like blood vessels, comparable across the samples of varying fibre complexity and demyelination.”

      Abstract: "A quantitative analysis of tissue anisotropies and fibre orientation distributions gave consistent results for different anatomical length scales and modalities, while being dependent on the field-of-view."

      To my understanding, the FODs here from different modalities are calculated over different FOVs (in monkeys at least), and FODs are only presented for a single FOV for each modality, meaning it is difficult to separate the effects of modality from FOV. The microscopic anisotropy is also noticeably different across modalities (DESY < ESRF < dMRI).

      R1.16: That is a fair point. Our statement was trying to capture too much condensed content to be correctly interpretable. We have reformulated the sentence to state: “Quantifications of fibre orientation distributions were consistent across anatomical length scales and modalities, whereas tissue anisotropy had a more complex relationship, both dependent on the field-of-view”.

      While it is true that we only present the ST-derived quantifications – FOD and FA statistics – for a single FOV per modality and sample, the results shown for the ESRF monkey samples (Figures 3 and 4) are a merge of four individually processed volumes. The quantifications of each individual subFOV have now been added as a supplementary figure (Figure S3) to highlight the consistency of the methodology and the effect of shifting the FOV position. In the case of the mouse, we have two volumes from different mice, which also display similar FOD and FA statistics.

      Abstract: "Our study emphasises the need to balance field-of-view and voxel size when characterising white matter features across anatomical length scales."

      This point does not seem very well explored in the paper, rather it is an observation of the limitations of the different imaging modalities. For example, there aren't analyses to compare metrics from highresolution data at different FOVs (i.e. by taking neighbourhoods of different sizes), nor are metrics compared from data at different resolutions and the same FOV.

      R1.17: The question is related to R1.16, R1.4, and R1.8, and we have addressed this point in our responses to those comments.

      Figure 7 - Taking into account the eigenvalues can be helpful when interpreting the secondary and tertiary eigenvectors of tensors (V2 and V3). It would be interesting to know whether the eigenvalues L2 ~= L3 are approximately equal (suggesting isotropic diffusion about V1, where the definition of V2 versus V3 isn't very meaningful), or if L2 is noticeably larger than L3 (suggesting anisotropic diffusion about V1, potentially similar to the anisotropic dispersion discussed above).

      R1.18: It would be interesting to explore the eigenvalues of the structure tensor in more detail, as has been done for the diffusion tensor. However, we believe this belongs to future work, as such additional detailed methodological analysis would complicate the already complex story. As mentioned in response to R1.10, most processed data has been made publicly available, and the rest can be requested (due to the storage size of the data sets) to perform such additional analysis.

      Discussion: "Importantly, our findings revealed common principles of fibre organisation in both monkeys and mice; small axonal fasciculi and major bundles formed sheet-like laminar structures," See above regarding the lack of evidence for laminar structures in mouse data.

      R1.19: We have reformulated the text for clarification as part of R1.3. Additionally, we added FOD quantifications to support why we do not observe an apparent laminar organisation in the mouse CC— please see our response to R1.6.

      Discussion: "Interestingly, the dispersion magnitude is indicative of fasciculi that skirt around obstacles in the white matter such as cells and blood vessels, and the results are largely independent of both white matter complexity (straight vs crossing fibre region) and pathology." Again, do statistical tests of the various distributions support this?

      R1.20: As part of R1.1, we have added statistical tests of significance for the quantifications of how max deviation changes when bending around objects. Indeed, the distributions are not statistically the same, and we do not wish to convey that sentiment, but they are comparable in the object sizes that they detect. As done in the abstract, we have reformulated the sentence to avoid misunderstanding and have replaced “largely independent” with “observed across.”

      Discussion: "Tax et al. have demonstrated the calculation of a sheet probability index from diffusion MRI data, which suggested the presence of sheet-like features in the CC"

      My understanding was that this was observed in crossing fibre regions, such as where fibres projecting with the CC cross the CST, but not the main body of the CC itself. Tax defines sheet structure as "composed of two tracts that cross each other on the same surface in certain regions along their trajectories." Is this a different phenomenon to the laminar structures observed here (where we observe fibres within a single tract being locally organised into laminar structures)?

      R1.21: Thank you for pointing our attention to this. We have corrected the section in the Discussion (page 23), so it now states: “Additionally, Tax et al. have demonstrated the calculation of a gridcrossing sheet probability index from diffusion MRI data, which suggested the presence of sheet-like features in a crossing fibre region (Tax et al. 2016), which is in line with our findings in the synchrotron data. Note that the method by Tax et al. only detects sheet-like structures crossing on a grid and does not reveal laminar structures with lower inclination angles, as we observed in the monkey CC.”

      Discussion: "We found that FODs were consistent across image resolutions and modalities, but only given that the FOV is the same." See above.

      R1.22: As part of our response to R1.6, we quantified the FODs using the ODI and DA indices, which should help support our statement. Nevertheless, we have toned down the statement and reformulated the text as follows: “We found that FODs were comparable across image resolutions and modalities. The observed discrepancies can be attributed to the fact that the FOVs are not exactly matched.”

      Discussion: "microscopic FA were highly correlated across modalities."

      The data shows FA is considerably lower in DESY to ESRF; within modality FA is quite consistent irrespective of tissue region; and differences between the CC and CG shown in ESRF data in mice are not repeated in DESY. It is unclear from the current data if this would lead to a high correlation across modalities. Some evidence would be helpful.

      R1.23: This is a fair point; we have not performed a correlation analysis. However, the pattern we observe for the synchrotron samples is as follows: When the anatomical length scale increases (becomes more macroscopic), the FA distribution shifts to lower values. This reflects the scale of information captured with the ST analysis (see also R1.9). Therefore, the most interesting comparison of FA statistics occurs when the resolution and anatomical length scale are approximately the same.  The sentence in question has been reformulated to the following: ”Estimates of structure tensor derived microscopic FA show a clear pattern across modalities.”

      Discussion: "If so, the (inclination angle) information might serve to form rules for low-resolution diffusion MRI based tractography about how best to project through bottleneck regions, which is currently a source of false-positives trajectories (6)."

      This is an interesting idea but it is unclear to me how this inclination information would help track through bottlenecks where, by definition, fibres are passing through with the same orientation. Some further explanation would be helpful.

      R1.24: We have elaborated on the section in the Discussion (page 23), explaining how this can be used to improve tractography tracing through complex regions: “The reason is that standard tractography methods do not "remember" or follow anatomical organisation rules as they trace through complex regions. Our findings on pathway lamination and inclination angles—low for parallel-like trajectories and high for crossing-like trajectories—can help incorporate trajectory memory into these methods, reducing the risk of false trajectories”.

      Reviewer #2 (Recommendations For The Authors):

      Below I report comments that if addressed I believe would improve the clarity and readability of the manuscript.

      -  Figures 1 and 2 would be more meaningful if combined into one figure. This would allow for a direct visual comparison of the two modalities. If space is needed, I believe the second row of Figure 1 (coronal views of CC) does not add much information. It is often hard to navigate the different orientations of the tissue in the images; thus any effort in trying to help the reader visually clarify would improve readability.

      R2.4: We considered the reviewer’s suggestion to merge Figures 2 and 3. However, this made both the figures and the main text additionally complex, so we chose to retain the original figure layout. Secondly, Figure 3 utilises a non-standard directional colormap. Keeping the colormap consistent within each figure is a feature we wish to preserve. In response to R1.11, the figures have been updated to have more consistent orientations for the monkey samples.

      In Figure 2, the second row, showing a coronal view of the CC, is essential for comparison with human data in Figure S1. It highlights where we observed the columnar laminar organisation and their inclination angle, as also detected by DTI.

      -  Figure 4 shows synchrotron data revealing an anterior-posterior component within the centrum semiovale that is not necessarily seen in the dMRI data. Could the authors comment on this?

      R2.5: Thank you for pointing this out. We have now addressed this in the Results section (page 10), where we describe the observation in detail: “Interestingly, visual inspection of the colour-coded structure tensor directions in Fig. 4E shows the existence of voxels whose primary direction is along the A-P axis. However, this represents a small enough portion of the volume that it does not appear as a distinct peak on the FOD.“

      -  The authors claim they observed several purple axons crossing orthogonally in Figure 5c. However, that is not necessarily clear in the figure.

      R2.6: We appreciate the feedback. We have now coloured the streamlines of the crossing fasciculi in Figure 5C in red.

      -  Figure 5 would benefit from adding the color encoding scheme for Figure 5d, as sometimes this is not necessarily consistent.

      R2.7: We appreciate the feedback. We have added an indication of the standard directional colour coding to Figure 5D.

      -  Figure 5d shows interesting data from the complex region. However, it is hard to visualize and it looks like there are not many streamlines traveling entirely I-S? Maybe a different orientation of the sample would help visualization.

      R2.8: A similar point was raised by Reviewer 1 (see R1.2). We have added an animation of the scene to assist in the interpretation of the 3D organisation within this complex sample.

      -  The concept of axon fasciculi is not necessarily immediately clear. Adding an explanation for what the authors refer to when using this term would improve clarity.

      R2.9: In the introduction, we now state our conceptual definition of an axon fasciculus as a number of axons that follow each other (see also R2.1).

      -  The methods do not provide details on how structure tensor FA is measured.

      R2.10: Thank you for pointing this out. We have restructured and expanded the structure tensor description in the Methods section (see also R1.9 and R2.1), which now includes the definition of FA.

      -  Why didn't the authors select the same cc region for both mice and monkeys? It seems this would have increased the strength of the comparison.

      R2.11: We agree. The reason lies in the chronology of experiments and the fact that we cannot control where demyelination takes place. We have added a clarifying description in the Methods section (page 31): “Note that several separate beamline experiments were conducted to collect the volumes listed in Table 1. In the first two experiments, samples from the monkey brain were scanned at ESRF and DESY, respectively. The samples from the mouse brain were imaged in two subsequent experiments. Consequently, the location of the identified demyelinating lesion in the cuprizone mice, which cannot be precisely controlled, did not match the location of the CC biopsies in the monkey.”

      -  While it is mentioned in the results, the methods do not explain how vessel segmentations or cell segmentation in mice was performed and for which datasets it was performed.

      R2.12: For the small ROI shown in Figure 6, the labelling was a manual process using the software ITK-SNAP, which has now been clarified in the corresponding figure caption. The generation of ROI masks and blood vessel segmentations involved a combination of intensity thresholding, morphological operations, and manual labelling in ITK-SNAP. This has been clarified in the restructured and expanded description of structure tensor analysis in the Methods section (starting on page 32).

      -  From the methods it is hard to understand (1) how many mice were used; (2) why dMRI was done on a different sample; (3) whether the same selenium region was selected for both healthy and CPZ animals; (4) how the registration across samples was performed.

      R2.13: We appreciate the feedback and have inserted clarifying statements in the relevant parts of the Methods section. (1) The total number of mice included was three: one normal, one cuprizone, and one normal for MRI scanning. (2) The quality of the collected dMRI on the mouse was too poor to use, and it could not be redone as the brain had already been sliced and prepared for synchrotron experiments. (3) The same splenium section was selected for both healthy and cuprizone mice. (4) A paragraph on image registration has been added.

      -  Diffusion MRI method sections would benefit from additional details on the protocols used.

      R2.14: Thank you for pointing this out. We have added more details about the diffusion MRI protocols, including the b-value, gradient strength, and other relevant parameters.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This study extends the previous interesting work of this group to address the potentially differential control of movement and posture. Their earlier work explored a broad range of data to make the case for a downstream neural integrator hypothesized to convert descending velocity movement commands into postural holding commands. Included in that data were observations from people with hemiparesis due to stroke. The current study uses similar data but pushes into a different, but closely related direction, suggesting that these data may address the independence of these two fundamental components of motor control. I find the logic laid out in the second sentence of the abstract ("The paretic arm after stroke is notable for abnormalities both at rest and during movement, thus it provides an opportunity to address the relationships between control of reaching, stopping, and stabilizing") less than compelling, but the study does make some interesting observations. Foremost among them, is the relation between the resting force postural bias and the effect of force perturbations during the target hold periods, but not during movement. While this interesting observation is consistent with the central mechanism the authors suggest, it seems hard to me to rule out other mechanisms, including peripheral ones. 

      Response 1.1. Thank you for your comments, which we address in detail below and in our response to Recommendations to the authors (see pp. 15-19 of this letter). We would first like to clarify the motivation behind our use of a stroke population to understand the interactions between the control of reaching in and holding. We agree that this idea can be laid out in a more compelling way.

      The fact that stroke patients usually display issues with their control of both reaching and holding, allows for within-individual comparisons of those two modes of control. Further, the magnitude of abnormalities is relatively large, making it easier to measure, compare and investigate effects. And, importantly, these two modes of control can be differentially affected after stroke (also pointed out by Reviewer 2, point 4 in Comments to the Authors). Finally, this kind of work – examining interactions between positive signs of stroke (such as abnormal posture or synergy) vs. negative signs (such as loss of motor control) – needs to be done in humans, as positive signs are relatively absent even in primates (Tower, 1940).

      We have changed our abstract (changes shown below in red), and our intro (expanding the second paragraph, lines 75-76), to lay out our motivation more clearly.

      From the abstract:

      “The paretic arm after stroke exhibits different abnormalities during rest vs. movement, providing an opportunity to ask whether control of these behaviors is independently affected in stroke. “

      On the other hand, the relation between force bias and the well-recognized flexor synergy seems rather self-evident, and I don't see that these results add much to that story.

      Response 1.2. While it seems natural that these biases would be the resting expression of abnormal flexor synergies (given their directionality towards the body, as shown in Figures 2-3, and the other similarities we demonstrate in Figure 8), we do not believe it is self-evident. These biases are measured at rest, with the patient passively moved and held still, whereas abnormal synergies emerge when the patient actively tries to move. The lack of relationship we find between these resting force biases and active movement underlines that the relation between force bias and flexor synergy should not be taken as self-evident, making it worthwhile to examine it (as we motivate in lines 589-596 and show in Figure 8).

      The paradox here is that, in spite of a relationship between force bias and flexor synergy (itself manifesting during attempted movement), there seems to be no relationship between force bias and direct measures of active movement (Figures 5,6). This is the paradox that inspired our conceptual model (Figure 9) and inspires to further investigate the factors under which these two systems are intermingled or kept separate. We thus find it to be a helpful element in the story.

      I am also struck by what seems to be a contradiction between the conclusions of the current and former studies: "These findings in stroke suggest that moving and holding still are functionally separable modes of control" and "the commands that hold the arm and finger at a target location depend on the mathematical integration of the commands that moved the limb to that location." The former study is mentioned here only in passing, in a single phrase in the discussion, with no consideration of the relation between the two studies. This is odd and should be addressed. 

      Response 1.3. While these two sets of findings are not contradictory, we understand how they can appear as such without providing context. We now discuss the relationship between our present study and the previous one more directly (lines 66-70 and 663-669 of the revised manuscript).

      The previous study examined how the control of movement informs the control of holding after the movement was over; the current study examines whether abnormalities in holding measured at rest with the movement leading to the rest position being passive. There are thus two important distinctions:

      First, directionality of potential effects: here we examine the effect of (abnormalities in) holding control upon movement, but the 2020 study (Albert et al., 2020) examines the effects of movement upon holding control. Stroke patient data in the 2020 study showed that, under CST damage, while the reach controller is disrupted, the hold controller can continue to integrate the malformed reach commands faithfully. In line with this, we proposed a model where the postural controller system sits downstream of the moving controller (Figure 7G in the 2020 paper). We thus did not claim, in 2020, that integration of movement commands is the only way to do determine posture control, as we stated explicitly back then, e.g. (emphasis ours):

      “Equations (1) and (2) describe how the integration of move activity may relate to changes in hold commands, but does not specify the hold command at the target.”

      In short, finding no effect of holding abnormalities upon movement (present finding) does not mean there is no potential effect of movement upon holding (2020 finding). This is something we had alluded to in the Discussion but not clarified, which we do now (see edits at the end of our response to this point).

      Second, active vs. passive movement: here, we measure holding control at rest (Experiment 1). The 2020 study shows that endpoint forces reflect the integration of learned dynamics exerted during active movement that led to the endpoint position. However, in Experiment 1, there is no active reaching to integrate, as the robot passively moves the arm to the held position. Thus, resting postural forces measured in Experiment 1 could not reflect the integration of reach commands that led to each rest position.  

      Thus, the two sets of findings are not contradictory. Taking our current and 2020 findings together suggests that active holding control would comprise would reflect both the integration of movement control that led to assuming the held position, plus the force biases measured at rest.

      Hence our decision to describe these two systems as functionally separable: while these systems can interact, the effects of post-stroke malfunctions in each can be independent depending on the function and conditions at hand. This does not make this a limited finding: being able to dissociate post-stroke impairment based on each of these two modes of control may inform rehabilitation, and also importantly, understanding the conditions in which these two modes of control become separable can substantially advance our understanding of both how different stroke signs interact with each other and how motor control is assembled in the healthy motor system. Figure 9 illustrates our conceptual model behind this and may serve as a blueprint to further dissect these circuits in the future.

      We discuss these issues briefly in lines 663-669 in our Discussion section, reproduced below for convenience:

      “It should be noted, however, that having distinct neural circuits for reaching and holding does not rule out interactions between them. For example, we recently demonstrated how arm holding control reflects the integration of motor commands driving the preceding active movement that led to the hold position, in both healthy participants and patients with hemiparesis (Albert et al., 2020). However, in that paper, we did not claim that this integration is the only source of holding control. Indeed, in Experiment 1 of the current study, we used passive movement to bring the arm to each probed position, which means that the postural biases could not be the result of integration of motor commands.” 

      And, we have adjusted our Introduction to provide pertinent context regarding our 2020 work (first paragraph, lines 66-70 of the updated manuscript).

      A minor wording concern I had is that the term "holding still" is frequently hard to parse. A couple of examples: "These findings in stroke suggest that moving and holding still are functionally separable modes of control." This example is easily read, "moving and holding [continue to be] functionally separable". Another: "...active reaching and holding still in the same workspace, " could be "...active reaching and holding [are] still in the same workspace." Simply "holding", "posture" or "posture maintenance" would all be better options.

      Response 1.4. Thank you for your suggestion. Following your comment, we have abbreviated this term to simply “holding”, both on the title and throughout the text.

      Reviewer #2 (Public Review):

      Summary: 

      Here the authors address the idea that postural and movement control are differentially impacted with stroke. Specifically, they examined whether resting postural forces influenced several metrics of sensorimotor control (e.g., initial reach angle, maximum lateral hand deviation following a perturbation, etc.) during movement or posture. The authors found that resting postural forces influenced control only following the posture perturbation for the paretic arm of stroke patients, but not during movement. They also found that resting postural forces were greater when the arm was unsupported, which correlated with abnormal synergies (as assessed by the Fugl-Meyer). The authors suggest that these findings can be explained by the idea that the neural circuitry associated with posture is relatively more impacted by stroke than the neural circuitry associated with movement. They also propose a conceptual model that differentially weights the reticulospinal tract (RST) and corticospinal tract (CST) to explain greater relative impairments with posture control relative to movement control, due to abnormal synergies, in those with stroke.

      Strengths: 

      The strength of the paper is that they clearly demonstrate with the posture task (i.e., active holding against a load) that the resting postural forces influence subsequent control (i.e., the path to stabilize, time to stabilize, max. deviation) following a sudden perturbation (i.e., suddenly removal of the load). Further, they can explain their findings with a conceptual model, which is depicted in Figure 9. 

      Weaknesses: 

      Current weaknesses and potential concerns relate to i) not displaying or reporting the results of healthy controls and non-paretic arm in Experiment 2 and ii) large differences in force perturbation waveforms between movement (sudden onset) and posture (sudden release), which could potentially influence the results and or interpretation. 

      Response 2.0. Thank you for your assessment, and for pointing out ways to improve our paper. We address the weakness and potential concerns in detail below.

      Larger concerns

      (1) Additional analyses to further support the interpretation. In Experiment 1 the authors present the results for the paretic arm, non-paretic arm, and controls. However, in Experiment 2 for several key analyses, they only report summary statistics for the paretic arm (Figure 5D-I; Figure 6D-E; Figure 7F). It is understood that the controls have much smaller resting postural force biases, but they are still present (Figure 3B). It would strengthen the position of the paper to show that controls and the non-paretic arm are not influenced by resting postural force biases during movement and particularly during posture, while acknowledging the caveat that the resting positional forces are smaller in these groups. It is recommended that the authors report and display the results shown in Figure 5D-I; Figure 6D-E; Figure 7F for the controls and non-paretic arm. If these results are all null, the authors could alternatively place these results in an additional supplementary. 

      Response 2.1a. Thank you for your recommendations. We agree both on the value of these analyses and the caveat associated with them: these resting postural force biases are substantially smaller for the non-paretic and control data (for example, the magnitude of resting biases in the supported condition is 2.8±0.4N for the paretic data, but only 1.8±0.4N and 1.3±0.2N for the non-paretic and control data, respectively; the difference is even greater in the unsupported condition, though this is not the one being compared to Experiment 2).

      We now conduct a comprehensive series of supplementary analyses, including the examination of non-paretic and control data for all three components of Experiment 2 (unperturbed reaches; pulse perturbations; and active holding control). These are mentioned in the Results (lines 422-424, 512513, and 574-574 of the revised manuscript) and illustrated in the supplementary materials: Supplementary Figures S5-1, S6-1, and S7-1 contain the main analyses (comparisons of instances with the most extreme resting biases for each individual) for the unperturbed reach analysis, pulse perturbation analysis, and active holding control analysis, respectively.

      We find that non-paretic and control data do not display effects of resting biases upon unperturbed reaching control (Figure S5-1) or control against a pulse perturbation early during movement (Figure S6-1) – as is the case with the paretic data. Non-paretic and control data do not display evidence of influence of their resting force biases upon active holding control either (Figure S7-1), unlike the paretic data. For the non-paretic data, however, these influences are nominally towards the same direction as in the paretic data. Given that resting biases are substantially weaker for the non-paretic case, it is possible a similar relationship exists but requires increased statistical power to discern. Moreover, it is possible that the effect of resting biases is non-linear, with small biases effectively kept under check so that their impact upon active holding control is even less than a linearly scaled version of the impact of the stronger, paretic-side biases. This can be the subject of future work.

      Please also note that, following your recommendation (Recommendations to the Authors, point 2.1), we have conducted secondary analyses which estimate sensitivity to resting bias using all datapoints, validating our main analyses; these analyses were also performed for control and non-paretic data, with similar results (Response 2.A.1).

      Further, the results could be further boosted by reporting/displaying additional analyses. In Figure 6D the authors performed a correlation analysis. Can they also display the same analysis for initial deviation and endpoint deviation for the data shown in Figure 5D-F & 5G-I, as well for 7F for the path to stabilization, time to stabilization, and max deviation? This will also create consistency in the analyses performed for each dependent variable across the paper.

      Response 2.1b. Here, we set to test whether resting biases affect movement. It is best to do this using a within-individual comparison design, rather than using across-individual correlations: while correlation analyses can in general be informative, they obscure within-individual effects which are the main comparisons of interest in our study. Consider a participant with strong resting bias towards one direction, tested on opposing perturbations; averaging these responses for each individual would mostly cancel out any effects of resting biases. Even if we were to align responses to the direction of the perturbation before averaging, the power of correlation analyses may be diluted by inter-individual differences in other factors, such as overall stiffness.

      Thus, our analysis design was instead focused on examining the differential effects of resting posture biases within each individual’s data. We compared the most extreme opposing/aligned or clockwise/counter-clockwise instances within each individual, specifically to assess these differential effects. In our revised version, we have further reinforced these analyses to include all data rather than the most extreme instances (see response 2.A.1.a to the Reviewer’s recommendation to the authors) where we performed correlations of within-individual resting posture vs. the corresponding dependent variables and compared the resulting slopes. 

      The across-individual correlation analyses add little to that for the reasons we outlined above. At the same time, it is possible they can be helpful in e.g. illustrating across-individual variability. We thus now include across-individual correlation analyses for all dependent variables, but, given their limited value, only in the supplementary material. This also means that, for consistency, we moved the correlation analysis in Figure 6 to the corresponding supplementary figure as well (Figure S6-3).

      In addition, following the Reviewer’s comment about consistency in the analyses performed for each dependent variable across the paper, we added within-individual comparisons for settling time following the pulse perturbations (Figure 6D, right).

      (2) Inconsistency in perturbations that would differentially impact muscle and limb states during movement and posture. It is well known that differences in muscle state (activation / preloaded, muscle fiber length and velocity) and limb state (position and velocity) impact sensorimotor control (Pruszynski, J. A., & Scott, S. H. (2012). Experimental brain research, 218, 341-359.). Of course, it is appreciated that it is not possible to completely control all states when comparing movement and posture (i.e., muscle and limb velocity). However, using different perturbations differentially impacts muscle and limb states. Within this paper, the authors used very different force waveforms for movement perturbations (i.e., 12 N peak, bell-shaped, 0.7ms duration -> sudden force onset to push the limb; Figure 6A) and posture perturbations (i.e., 6N, 2s ramp up -> 3s hold -> sudden force release that resulted in limb movement; Figure 4) that would differentially impact muscle (and limb) states. Preloaded muscle (as in the posture perturbation) has a very different response compared to muscle that has little preload (as in the movement perturbations, where muscles that would resist a sudden lateral perturbation would likely be less activated since they are not contributing to the forward movement). Would the results hold if the same perturbation had been used for both posture and movement (e.g., 12 N pulse for both experiments)? It is recommended that the authors comment and discuss in the paper why they chose different perturbations and how that might impact the results. 

      Response 2.2a. We agree that it can be impossible to completely control all states when comparing movement and posture. We would also like to stress that these perturbations were not designed so that responses are directly compared to each other (though of course there is an indirect comparison in the sense that we show influence of biases in one type of perturbation but not the other). Instead, Experiment 2 tried to implement a probe optimized for each motor control modality (moving vs. holding). However, the Reviewer has a point that the potential impact of differences between the perturbations is important to discuss in the paper.

      The Reviewer points out two potentially interesting differences between the two perturbations. First, the magnitude (6N for the posture perturbation vs. 12N for the pulse perturbation); second, the presence of background load in the posture perturbation, in contrast to the pulse perturbation.

      For the movement perturbation, we used a 12-N, 70ms pulse. This perturbation and scaled versions have been tested before in both control and patient populations (Smith et al., 2000; Fine and Thoroughman, 2006). For the holding perturbation, we used a background load to ensure that active holding control is engaged, and the duration of the probe (holding for about 5s) made using a stronger perturbation impractical –maintaining a background load at, say, 12N for that long could lead to increased fatigue.

      The question raised by the Reviewer, whether the findings would be the same if the same, 12-N pulse were used to probe both moving and holding control, is interesting to investigate. We would expect the same qualitative findings (i.e. there would still be a connection between resting posture and active holding control when the latter were probed with a 12N pulse). Recent work provides more specific insight into what to expect. Our posture perturbation task is similar to the Unload Task in (Lowrey et al., 2019), whereby a background torque is released, whereas our pulse perturbation is more similar to their Load Task, whereby a torque is imposed against no background load (though it is a step perturbation rather than a pulse). Lowrey et al., 2019 find that their Unload task is harder than the Load task, with 2x the fraction of patient trials classified as failed (with failure defined as task performance being outside of the 95% confidence interval for controls), though there are still clear effects for the Load task. 

      This suggests that the potential effects of using a pulse-like perturbation to probe posture control would likely be weaker in magnitude, all other things being equal. At the same time, however, the Load and Unload tasks in Lowrey et al., 2019 were perturbations of the same magnitude; it is thus also likely that the reduction in effect would be mitigated, or reversed, by the fact that we would be using a 12N instead of a 6N perturbation.

      A relevant consequence of the Lowrey et al., 2019 findings is that the Unload paradigm is superior in its ability to detect impairment in static, posture perturbations, and thus provides a better signal to detect potential relationships with resting posture biases. This is not surprising, as a background load further engages the control of active holding, which what we were trying to probe in the first place.

      But then why not use the same paradigm (preloading and release) for movement? There are two main reasons. First, requiring a background load throughout the experiment is unfeasible due to fatigue. Second, for the holding perturbation, we wanted to ensure that the postural control system is meaningfully engaged when the perturbation hits, hence we picked the background load. Were we to impose the same during moving – i.e. impose a lateral background load on the movement - we could be engaging posture control on top of movement control. This preloading would reduce the degree to which the pulse probe isolates movement control, and lead to intrusion of the posture control system in the movement task by design. This relates to what the Reviewer proposes in the comment below: preloading may result in postural biases i.e. engage posture control; see below where we argue this interpretation is within the scope of our conceptual model rather a counter to it.

      We now explain the rationale behind our perturbation design in the Methods section (lines 211-220).

      Relatedly, an alternative interpretation of the results is that preloading muscle for stroke patients, whether by supporting the weight of one's arm (experiment 1) or statically resisting a load prior to force release (experiment 2), leads to a greater postural force bias that can subsequently influence control. It is recommended that the authors comment on this. 

      Response 2.2b. We find this interpretation valid, but we do not see how it meaningfully differs from the framework we propose. We already state that the RST may be tailored for both posture/holding control and the production of large forces (which would include muscle preloading):

      “Thus, the accumulated evidence suggests that the RST could control posture and large force production in the upper limb.“ (lines 698-699 in the current version)

      “the RST, in contrast, is weighted more towards slower postural control and generation of large isometric forces” (lines 724-726 in the current version)

      And, we discuss other conditions where the RST is involved in large force production, such as power grip, and how these interact with the role of the RST in posture/holding control (lines 758-768 in the current version).

      To better explain our model, we now provide the two examples mentioned by the reviewer along with our description of the proposed role for the RST (lines 726-727):

      “…the RST, in contrast, is weighted more towards slower postural control and generation of large isometric forces (such as vertical forces for arm support, or horizontal forces for holding the arm still against a background load like in our posture/release perturbation trials).”

      We note, however, that we find resting posture abnormalities even in the presence of arm support, suggesting the involvement of the RST in holding control even when the forces involved (and the need to preload the muscle) are small.

      Reviewer #3 (Public Review): 

      The authors attempt to dissociate differences in resting vs active vs perturbed movement biases in people with motor deficits resulting from stroke. The analysis of movement utilizes techniques that are similar to previous motor control in both humans and non-human primates, to assess impairments related to sensorimotor injuries. In this regard, the authors provide additional support to the extensive literature describing movement abnormalities in patients with hemiparesis both at rest and during active movement. The authors describe their intention to separate out the contribution of holding still at a position vs active movement as a demonstration that these two aspects of motor control are controlled by two separate control regimes.

      Strengths: 

      (1) The authors utilize a device that is the same or similar to devices previously used to investigate motor control of movement in normal and impaired conditions in humans and non-human primates. This allows comparisons to existing motor control studies. 

      (2) Experiment 1 demonstrates resting flexion biases both in supported and unsupported forelimb conditions. These biases show a correlated relationship with FM-UE scores, suggesting that the degree of motor impairment and the degree of resting bias are related.

      (3) The stroke patient participant population had a wide range of both levels of impairment and time since stroke, including both sub-acute and chronic cases allowing the results to be compared across impairment levels.

      The authors describe several results from their study: 1. Postural biases were systematically toward the body (flexion) and increased with distance from the body (when the arm was more extended) and were stronger when the arm was unsupported. 2. These postural biases were correlated with FM-UE score. 3. They found no evidence of postural biases impacting movement, even when that movement was perturbed. 4. When holding a position at the end of a movement, if the position was perturbed opposite of the direction of bias, movement back to the target was improved compared to the perturbation in the direction of bias. Taken together, the authors suggest that there are at least two separate motor controls for tasks at rest versus with motion. Further, the authors propose that these results indicate that there is an imbalance between cortical control of movement (through the corticospinal tracts) and postural control (through the reticulospinal tract).

      Response 3.1. Thank you for pointing out some of the strengths of our work and summarizing our findings. A minor clarification we would like to make, related to (3), is that, while our study did enroll two patients towards the end of the subacute stage (2-3 months), the rest of the population were at the chronic stage, at one year and beyond. We thus find it very unlikely that time after stroke was the primary driver of differences in impairment in the population we studied.

      There are several weaknesses related to the interpretation of the results:

      In Experiment 1, the participants are instructed to keep their limbs in a passive position after being moved. The authors show that, in the impaired limb, these resting biases are significantly higher when the limb is unsupported and increase when the arm is moved to a more extended position.

      When supported by the air sled, the arm is in a purely passive position, not requiring the same antigravity response so will have less RST but also less CST involvement. While the unsupported task invokes more involvement of the reticulospinal tract (RST), it likely also has significantly higher CST involvement due to the increased difficulty and novelty of the task.

      If there were an imbalance in CST regulating RST as proposed by the authors, the bias should be higher in the supported condition as there should be relatively less CST activation/involvement/ modulation leading to less moderating input onto the RST and introducing postural biases. In the unsupported condition, there is likely more CST involvement, potentially leading to an increased modulatory effect on RST. If the proportion of CST involvement significantly outweighs the RST activation in the unsupported task, then it isn't obvious that there is a clear differentiation of motor control. As the degree of resting force bias and FM-UE score are correlated, an argument could be made that they are both measuring the impairment of the CST unrelated to any RST output. If it is purely the balance of CST integrity compared to RST, then the degree of bias should have been the same in both conditions. In this idea of controller vs modulator, it is unclear when this switch occurs or how to weigh individual contributions of CST vs. extrapyramidal tracts. Further, it isn't clear why less modulation on the RST would lead only to abnormal flexion.

      Response 3.2. Our model posits two mechanisms by which CST impairment would lead to increased RST involvement. The first – which is the one discussed by the Reviewer here - is a direct one, whereby weaker modulation of the RST by the CST leads to increased RST involvement. The second is an indirect one, whereby the incapacity of CST to drive sufficient motor output to deal with tasks eventually leads to increased RST drive.

      The reviewer suggests it is likely that the unsupported task demands increased activation through both the CST and the RST. If that were the case, however, it would exaggerate the effects of CST/RST imbalance after stroke compared to healthy motor control: if task conditions (lack of support) required higher CST involvement, then CST damage would have an even larger effect. In turn, this would lead to even higher RST involvement and further diminishing the ability of CST to moderate RST. Thus, RST-driven biases would be higher in the unsupported condition.

      And, given that the CST itself is damaged and has to deal with an even-increased RST activation, we would not expect that the proportion of CST involvement would outweigh RST activation, but the opposite. In fact, a series of relatively recent findings suggest just this. For example,

      • Zaaimi et al., 2012  showed that unilateral CST lesions in monkeys lead to significant increases in the excitability of the contralesional RST (Zaaimi et al., 2012). Interestingly, this effect was present in flexors but not extensors, potentially explaining why less modulation and/or overactivation of the RST would primarily lead to abnormal flexion. 

      • McPherson et al. (further discussed in point 2.A.23, by Reviewer 2 – Recommendations to the Authors) showed that, after stroke, contralesional activity (which would include the ipsilateral RST) increases relative to ipsilesional activity (which would include the contralateral CST)

      (McPherson et al., 2018). The same study also provides evidence that FM-UE may primarily reflect RST-driven impairment. The ipsilateral(RST)/contralateral(CST) balance, expressed as a laterality index, correlated with FM-UE, with lower FM-UE for indices indicating higher RST involvement. (Interestingly, the slope of this relationship was steeper when the laterality of brain activation patterns was examined under tasks with less arm support, mirroring the steeper FM-UE vs resting bias slope when arm support is absent, as shown in our Figure 8).

      • Wilkins et al., 2020 (Wilkins et al., 2020) found that providing less support (i.e. requiring increased shoulder abduction) increases ipsilateral activation (representing RST) relative to contralateral activation (representing CST).

      This resting bias could be explained by an imbalance in the activation of flexors vs extensors which follows the results that this bias is larger as the arm is extended further, and/or in a disconnect in sensory integration that is overcome during active movement. Neither would necessitate separate motor control for holding vs active movement. 

      Response 3.3. We do not think that either of these points necessarily argue against our model. First, the resting biases we observe are clearly pointed towards increased flexion, and can thus be seen as the outcome of an imbalance in the activation of flexors vs. extensors at rest. This imbalance between flexors/extensors can also be explained by the CST/RST imbalance posited by our conceptual model: in their study of CST lesions in the monkey, Zaaimi et al., 2012 found increased RST activation for flexors but not extensors, suggesting that RST over-involvement may specifically lead to flexor abnormalities (Zaaimi et al., 2012). Second, overcoming a disconnect in sensory integration may be one way the motor system switches between separate controllers; how this switch happens is not examined by our conceptual model.

      In Experiment 2, the participants are actively moving to and holding at targets for all trials while being supported by the air sled. Even with the support, the paretic participants all showed start- and endpoint force biases around the movement despite not showing systematic deviations in force direction during active movement start or stop. There could be several factors that limit systematic deviations in force direction. The most obvious is that the measured biases are significantly higher when the limb is unsupported and by testing with a supported limb the authors are artificially limiting any effect of the bias.

      Response 3.4. We do expect, in line with what the reviewer suggests, that any potential effects would be stronger in the unsupported condition. The decision to test active motor control with arm support was done as running the same Experiment 2 would pose challenges, particularly with our most impaired patients, given the duration of Experiment 2 (~2 hours, about 1 hour with each arm) and the expected fatigue that would ensue.

      However, a key characteristic of our comparisons is that we are comparing Experiment 2 active control data under arm support, against Experiment 1 resting bias data also under arm support. While Experiment 1 measured biases without arm support as well, these are not used for this comparison. And, while resting biases are weaker with arm support, they are still clear and significant; yet they do not lead to detectable changes in active movement.

      At the same time, we do not rule out that, if we were to repeat Experiment 2 without arm support, we could find some systematic deviation in the direction of resting bias in movement control. Our conceptual model, in fact, suggests that this may be the case, as we described in lines 618-620 of our original manuscript. The idea here is that, when arm support is not provided, the increased strength requirements lead to increased drive through the RST, to the point that posture control (and its abnormalities) spills into movement control (Figure 9). We now better clarify this position in our Discussion (lines 744-750):

      “The interesting implication of this conceptual model is that synergies are in fact postural abnormalities that spill over into active movement when the CST can no longer modulate the increased RST activation that occurs when weight support is removed (i.e. resting biases may influence active reaching in absence of weight support). Supporting this idea, a study found increased ipsilateral activity (which primarily represents activation via the descending ipsilateral RST (Zaaimi et al., 2012)) when the paretic arm had reduced support compared to full support (McPherson et al., 2018).”

      It is also possible that significant adaptation or plasticity with the CST or rubrospinal tracts could give rise to motor output that already accounts for any intrinsic resting bias.  

      Response 3.5. This kind of adaptation – regardless of the tracts potentially involved – is an issue we examined in our experiment. As we talk about in our Results (lines 458-460 in the updated manuscript), with most of our patient population in the chronic stage, it could be likely that their motor system adapted to those biases to the point that movement planning took them into account, thereby limiting their effect. This motivated us to examine responses to unpredictable perturbations during movement (Figure 6) where we still find lack of an obvious effect of resting biases upon reaching control. We thus believe that our findings are not explained by this kind of adaptation, though we agree it would be of great interest for future work to compare resting biases and reaching control in acute vs. chronic stroke populations to examine the degree to which stroke patients adapt to these biases as they recover.

      In any case, the results from the reaching phase of Experiment 2 do not definitively show that directional biases are not present during active reaching, just that the authors were unable to detect them with their design. The authors do acknowledge the limitations in this design (a 2D constrained task) in explaining motor impairment in 3D unconstrained tasks. 

      Response 3.6. It is, of course, an inherent limitation of a negative finding is that it cannot be proven. What we show here is that, there is no hint of intrusion of resting posture abnormalities upon active movement in spite of these resting posture abnormalities being substantial and clearly demonstrated even under arm support. To allow for the maximum bandwidth to detect any such effects, we specifically chose to compare the most extreme instances (resting bias-wise) for each individual, and yet we did not find any relationship between biases and active reaching.

      This suggests that, even if these biases could be in some form present during active movement, their effect would be minimal and thus limited in meaningfully explaining post-stroke impairment in active movement under arm support.

      Note that, as we already discuss, our conceptual model (Figure 9) suggests that the degree to which directional biases would be present in active reaching may be influenced by arm support (or the specific movements examined – hence our limitation in not examining 3D movement). Thus we do not claim that this independence is absolute. Examples include the last line of the passage quoted right above, and the summary statement of our Discussion quoted below (lines 639-641):

      “…which raises the possibility that the observed dissociation of movement and posture control for planar weight-supported movements may break down for unsupported 3D arm movements.”

      Finally, we now more explicitly acknowledge that abnormal resting biases may influence active movement in the absence of arm support (see Response 3.4).

      It would have been useful, in Experiment 2, to use FM-UE scores (and time from injury) as a factor to determine the relationship between movement and rest biases. Using a GLMM would have allowed a similar comparison to Experiment 1 of how impairment level is related to static perturbation responses. While not a surrogate for imaging tractography data showing a degree of CST involvement in stroke, FM-UE may serve as an appropriate proxy so that this perturbation at hold responses may be put into context relative to impairment.

      Response 3.7. Here the Reviewer suggests we use FM-UE scores as a proxy for CST integrity. We do not think this analysis would be particularly helpful in our case for a number of reasons:

      First, while FM-UE is a general measure of post-stroke impairment, it was designed to track - among other things - the emergence and resolution of abnormal synergies, a sign assumed to result from abnormally high RST outflow (McPherson et al., 2018; McPherson and Dewald, 2022). In line with this, the FM-UE scales with EMG-based measures of synergy abnormality (Bourbonnais et al., 1989). Impairments in dexterity, a sign associated with damage to the CST (Lawrence and Kuypers, 1968; Porter and Lemon, 1995; Duque et al., 2003), dissociate with synergy abnormalities when compared under arm support as we do here (Levin, 1996; Hadjiosif et al., 2022). This means that FM-UE would be a stronger proxy for RST activity and thus not a direct proxy for CST integrity particularly when one wants to dissociate RST-specific vs. CST-specific abnormalities. In fact, as we discuss in Response 3.2 above, there is a number of studies supporting this idea: for example, Zaaimi et al., 2012 show that relative RST activation – the balance between ipsilateral excitability, primarily reflecting RST, and contralateral excitability, primarily reflecting the CST, scales with FM-UE (Zaaimi et al., 2012).

      Second, this kind of analysis would obscure within-individual effects, since FM-UE scores are, of course, assigned to each individual. This is the same issue as doing across-individual correlation analyses in general (see response 2.1b).Strong resting force bias would have opposite effects on opposing perturbations, averaging across subjects would occlude these effects.

      Third, while FM-UE is a good measure of synergy abnormality, weakness alone could also give an abnormal FM-UE (Avni et al., 2024).

      The Reviewer also suggests we use time from injury for this analysis. Time from injury can indeed potentially be an important factor. However, this analysis would not be appropriate for our dataset, since the effective variation in recovery stage within our population is limited: our sample is essentially chronic (only two patients were examined within the subacute stage – at 2 and 3 months after stroke - with everybody else examined more than a year after stroke) with the “positive” elements of their phenotype (and FM-UE itself) essentially plateaued (Twitchell, 1951; Cortes et al., 2017). We thus would not expect to see any meaningful effects of time from injury within our population. It would be an excellent question for future work to investigate both resting biases and their relationship to reaching in acute/subacute patients, and examine whether the trajectory of resting biases (both emergence and abatement due to recovery) follows the one for abnormal synergies.

      It is not clear that even in the static perturbation trials that the hold (and subsequent move from perturbation) is being driven by reticulospinal projections. Given a task where ~20% of the trials are going to be perturbed, there is likely a significant amount of anticipatory or preparatory signaling from the CST. How does this balance with any proposed contribution that the RST may have with increased grip?

      Response 3.8. We included our response to this as part of Response 3.2. In brief, while we cannot rule out that these tasks may recruit increased CST signaling, this would tend to increase, rather than reduce, the effects of post-stroke impairment: the requirement for increased signaling from a CST that is damaged would magnify the effects of this damage, in turn leading to increased recruitment of other tracts, such as the RST.

      In general, the weakness of the interpretation of the results with respect to the CST/RST framework is that it is necessary to ascribe relative contributions of different tracts to different phases of movement and hold using limited or indirect measures. Barring any quantification of this data during these tasks, different investigators are likely to assess these contributions in different ways and proportions limiting the framework's utility.

      Response 3.9. We believe that our Reponses 3.2-3.6 put our findings in fair perspective, and the edits undertaken based on the Reviewer’s comments have clarified our position as to how the dissociation between holding and moving control may break down. We do agree, however, that our framework would be strengthened by the use of direct measures of CST/RST connectivity in future research. We present our conceptual model as a comprehensive explanation of our findings and how they blend with current hypotheses regarding the role of these two tracts in motor control after stroke.  As such, it provides a blueprint towards future research that more directly measures or modulates CST and RST involvement, using tools such as tractography or non-invasive brain stimulation.

      Recommendations for the authors:   

      Reviewer #1 (Recommendations For The Authors):

      L226 “…of this issue, we repeated the analysis of Figure 7F (a) by excluding these four patients…”.  Should this be three, based on the previous sentence? 

      Response 1.A.1. Thank you for pointing this typo, which is now corrected. The analysis in question (Figure S1 in the original submission, now re-numbered as Figure S7-4), excluded the three patients mentioned in the previous sentence.

      L254 “…the hand was held in a more distal position. The postural force biases were strongest when…”  Could this be "extended" rather than distal? See my later comment about the inadequate description of targets.

      Response 1.A.2. The reviewer is correct that, the arm will tend to be more extended in the distal targets. However, since these positions were defined in extrinsic coordinates, we think the terms distal/proximal are also appropriate. In either case, we now clarify these definitions in the text (see Response 1.A.3 below).

      L263 “…contained both distal and proximal targets, and, importantly, they were also the movement…”.  Distal/proximal targets were never described as part of the task. 

      Response 1.A.3. We improved our description by (i) changing the wording above to “represented positions both distal and proximal to the body,”, (ii) doing the same in our Methods (line 175) and (iii) indicating distal/proximal targets in Figure 3A (bottom right of panel A).

      L378 “…the pulse perturbation. We hypothesized that, should resting postural forces play a role, they…”  L379 “…would tend to reduce the effect of the pulse if they were in the opposite direction, and…”  Not really obvious why. A reduction in the displacement caused by a force pulse might be caused by different stiffness or viscosity, but not by a linear, time-invariant force bias. This situation is different from that of "moving the arm through a high-postural bias area vs. a low-postural bias area" where it would encounter time- (actually spatially) varying forces and varying amounts of displacement. Clarify the logic if this is a critical point.

      Response 1.A.4. We thank the Reviewer for highlighting this point of potential confusion. We now clarify that these postural bias forces are neuromuscular in origin (Kanade-Mehta et al., 2023), and likely result from an expression of abnormal synergy, at least under static conditions. In this case, we hypothesized that force pulses acting against the gradient of the postural bias field would act to stretch the already active muscles, which would lead to a further increase in postural resistance due to inherent length-tension properties of active muscle. By contrast, force pulses acting along the gradient of the postural bias field would act to shorten the same active muscles, which would lead to a reduction in postural resistance. The data did not support this in the case of force pulses imposed during movement. We note, however, that similar effects would affect responses to static perturbations as well, wherein we do find an effect of resting biases. We now better explain this reasoning (lines 479482).

      L466 “resting postural force). In short, our perturbations revealed that resting flexor biases switched  467 on after movement was over, providing evidence for separate control between moving” and 

      L468 “holding still.”

      I do not think the authors have presented clear evidence that forces, "switch on", implying the switch to a different controller which they posit. This could as easily be a nonlinear or time-varying property of a single controller (admittedly, the latter possibility overlaps broadly with their idea of distinct, interacting controllers). An example that the authors are certainly aware of is that of muscle "thixotropy" a purely peripheral mechanism due to the dynamics of crossbridge cycling that causes resting muscle to be stiffer than moving muscle, changing with a time constant of ~1-2 seconds. Neither this particular example nor changing levels of contraction (more likely during the unpredictable force perturbations) would be in the direction to explain the main observation here -- a point perhaps worth making, together with the stretch reflex comments. 

      Response 1.A.5. Thank you for this perspective. Indeed, it might be that “switching on” represents a shift along a nonlinear property of the same controller: in the extreme, if this nonlinearity is a step (on/off) function, this single controller would be functionally identical to two separate controllers. We thus cannot tell if these controllers are distinct in the strict sense. What we argue here is that, no matter the underlying controller architecture - two distinct controllers or two distinct modes of the same controller - is that the control of reaching vs. holding can be functionally separable even after stroke. In line with this idea, we used a more nuanced phrasing (e.g. “separable functional modes for moving vs. holding”) throughout our manuscript, and we have now edited out a mention of “separate controllers” to be consistent with this.

      Moreover, thank you for pointing out the example of thixotropy, showing how peripheral mechanisms could interact with central control. As you point out, this effect would not explain the main observation here: in fact, if stiffness were substantially higher during rest or holding (instead of moving) that would reduce the impact of the static perturbation, making it harder to detect any effects of resting biases compared to the moving perturbation case.

      L480 “…during movement (Sukal et al., 2007). Yet, Experiment 2 found no relationship between resting…” L481”… postural force biases and active movement control. To further investigate this apparent…”  The methods of the two studies seem fairly similar, but this question warrants a more careful comparison. How did the size of the two workspaces compare? What about the magnitude of the exerted forces? The movement condition in this study was done with the limb entirely supported. Under that condition, the Sukal study also found fairly small effects of the range of motion.

      Response 1.A.6. Sukal et al., 2007 did not directly measure exerted forces, but instead compared the active range of motion under different loading conditions. They used the extent of reach area to quantify the effect of abnormal synergies, with a more extended active range of motion signifying reduced effect of abnormal synergies. As the Reviewer points out, Sukal et al. found fairly small effects of synergies upon the range of motion when arm support was provided (the reach area for the paretic side was found to be about 85% of the nonparetic side under full arm support, though they were statistically significantly different, Figure 5 of their paper). They found increasing effect of synergies as arm support was reduced: on average, the reach area when participants had to fully support the arm was less than 50% the reach area when full arm support was given (comparing the 0% vs. 100% active support conditions [i.e. 100% vs. 0% external support] in their Figure 5). As we discuss in our paper, this effect of arm support upon synergy mirrors the one we found for resting postures.

      To compare our workspace with the one in Sukal et al., we overlaid our workspace (the array of positions for which the posture biases were measured, for a typical participant from Experiment 1) on the one they used as shown in their Figure 4. Note that their figure only shows an example participant, and thus our ability to compare is limited by the fact that each participant can vary widely in terms of their impairment, and assumptions had to be made to prepare this overlay (e.g. that (0,0) represents the position of the right acromion point). 

      For this example, and our assumptions, our workspace was smaller, with the main points of interest (red dots, the movement start/end points used for Experiment 2) within the Sukal et al. workspace. That our workspace is smaller is not surprising, given that the area in Sukal et al. represents the limit of what can be reached, and thus motor control *has* to be examined in a subset of that area.

      Author response image 1.

      Comparing the two study methodologies, however, suggests an advantage of measuring resting biases in terms of sensitivity and granularity: first, resting biases can be clearly detected even under arm support (something we point out in our Discussion, lines 715-717); second, they can measure abnormalities at any point in the workspace, rather than a binary within/without the reach area. The resting bias approach may thus be a more potent tool to probe the shared bias/synergy mechanisms we propose here.

      Figure 2 

      Needs color code. 

      The red dots could be bigger.

      Response 1.A.7. We have increased the size of the red dots and added a color code to explain the levels illustrated by the contours. We also expanded our caption to better explain this illustration.

      Figure 3

      Labeling is confusing. Drop the colored words (from both A and B), and stick to the color legend. Consider using open and filled symbols (and bars) to represent arm support or lack thereof. The different colored ovals are very hard to distinguish.

      Response 1.A.8. We find these recommendations improve the readability of Figure 3 and we have thus adopted them - see updated Figure 3.

      Figure 4

      Not terribly necessary.  

      Response 1.A.9. While this figure is indeed redundant based our descriptions in the text, we kept it as we believe it can be useful in clarifying the different stages of movement we examine.

      Figure 5 

      Tiny blue and green arrows are impossible to distinguish. 

      Although the general idea is clear, E and H are not terribly intuitive.  Add distance scale bars for D-I. 

      Response 1.A.10. For improved contrast, we now use red and blue (also in line with comment below regarding Figure 7), and switched to brighter colors in general. To make E and H more intuitive and easier to follow, we expanded the on-panel legend. Thank you for pointing out that distance scale bars are missing; we have now added them (panels EFHI).

      Figure 6 

      Panel E inset is too small. 

      Response 1.A.11. We have now moved the inset to the right and enlarged it.

      Figure 7 

      Green and blue colors are not good. 

      Response 1.A.12. For improved contrast, we now use red and blue.

      Figure 8 

      Delete or move to supplement? 

      Response 1.A.13. We respectfully disagree. While the relationships on these data are also captured by the ANOVA, we believe these scatter plots offer a better overview of the relationships between force biases and FM-UE across different conditions.

      Really minor

      L113 “…participants' lower arm was supported using a custom-made air-sled (Figure 1C). Above the  participant's…” 

      Response 1.A.14. We put the apostrophe after the s so to refer to participants in general (plural).

      L117 ”…subject-produced forces on the handle were recorder using a 6-axis force transducer.”  recorded 

      Response 1.A.14. Thank you for pointing out this error which we have now corrected.

      L136 “…2013), Experiment 1 assessed resting postural forces by passively moving participants to>…”  The experiment did not move the participant. 

      Response 1.A.15. We now fix this issue: “by having the robot passively move…”

      L248 “…experiment blocks: two with each arm, with or without arm weight support (provided by an air experimental…”

      Response 1.A.16. We have now corrected this.

      L364 “…responses to mid-movement perturbations. In 1/3 of randomly selected reaching movements…”  Obviously, you mean 1/3 of all movements: "One-third of the reaching movements were chosen randomly"  

      Response 1.A.17. We now clarify: “In 1/3 of reaching movements in Experiment 2, chosen randomly”. Also please note our response to Reviewer 2, point 10: we now report the exact number of trials for which each kind of perturbation was present.

      L609 “Damage to the CST after stroke reduces its moderating influence upon the RST (Figure 9,…”  "its" refers to the subject, "Damage", not "CST".

      Response 1.A.18. We have changed this to “Post-stroke damage to the CST reduces the moderating influence the CST has upon the RST”.

      Reviewer #2 (Recommendations For The Authors):

      (1) Throughout, the authors cleverly selected the most opposed and most aligned resting postural force biases to perform a within-subject analysis. However, this approach excludes a lot of data. The authors could perform an additional within-subject analysis. For each participant they could correlate lateral resting posture force bias to each dependent variable, utilizing all the trials of a participant. 

      Response 2.A.1a. Thank you for your appreciating our analysis design, and suggesting additional analyses. We focused our within-subject analysis design on the most extreme instances, as we believe that this approach would offer the best opportunity to detect any potential effects of resting biases. We reasoned that, since resting biases tend to be relatively small for most locations in the workspace, taking all biases into account would inject a disproportionate amount of noise in our analysis, which would in turn diminish our ability to detect any potential relationships. This could be because small biases lead to small effects but also small biases may themselves be more likely to reflect measurement noise in the first place. Note that our study talks about separability of active reaching from resting abnormalities based on lack of relationships between the two. While one cannot definitely prove a negative, it is also important to take the approach that maximizes the ability to detect any such relationship if there were one. We believe taking the most extreme instances fulfills that role.

      However, as the Reviewer points out, this approach also excludes a substantial amount of data. We agree that our findings could be further strengthened by exploring additional within-subject analyses that utilize all trials. Thus, following the reviewer’s suggestion, we estimated the sensitivity of each dependent variable to lateral resting posture force bias. Specifically, we estimated the slope of this relationship for each individual (separately for paretic and non-paretic data) using linear regression, and assessed whether the average slope is significant for each group (paretic data, non-paretic data, and control data).

      This secondary analysis replicated our main findings: lack of relationship between posture biases and active reaching control (both for unperturbed and perturbed movement), and a significant relationship between posture biases and active holding control. In addition, in line with main point 2.1 by the reviewer, we performed the same analyses for non-paretic and control data. While there are no definitive conclusions to be made for these cases (as was likely, given that the resting force biases are smaller, as also pointed out by the Reviewer in 2.1) these data are worthy of discussion, with potentially interesting insights (for example, there are hints that the connection between resting biases and active holding control is present in the non-paretic arm as well, and may be explored in future research).

      We have included these analyses in the supplementary materials, and we point to them in the main text. Specifically:

      First, in line with our main analyses in Figure 5, we find no effect (the average slope is insignificant) for start and endpoint biases upon the corresponding reaching angles. This is now mentioned in lines 425-434 of the Results, and illustrated in Figure S5-2. There was a lack of effect for the non-paretic and control data as well.

      Second, in line with our main analyses in Figure 6, we find no effect of start biases upon responses to the pulse (Figure S6-2, mentioned in lines 513-517 of the Results). As above, there was no effect of non-paretic or control data either.

      And, finally, in line with our main analysis in Figure 7, we find an effect of resting biases upon performance for the static perturbation (Figure S7-2, mentioned in lines 578-586 of the Results). Interestingly, there is a suggestion that resting biases may affect static perturbation responses in the non-paretic data as well based on the relationship between posture bias and maximum deviation, but not the other two metrics. Given the lack of consistency of resting bias effects for all three different dependent variables examined, however, our current data are thus unable to give a definite answer as to whether there is the connection between resting biases and active holding control is also present in the non-paretic side. Our hypothesis is that, since resting abnormalities and their effects are the pathological over-manifestations of mechanisms inherent in the motor system in general, then such a relationship would exist. Answering this question, however, would require an experiment design better tailored to detect relationships in the non-paretic arm, where resting biases are weaker.

      We thank the Reviewer for their suggestions and believe that these additional analyses provide a more complete picture of the data, and their consistency with our main results reinforces the message of the paper.

      Then, they can report the percentage of participants that display significant correlations separately for the paretic, nonparetic, and control arms. 

      Response 2.A.1b. We note that, even in cases where the average slope (across individuals) is significant, the individual slopes themselves are usually not significant, likely due to the large amount of noise for datapoints corresponding to weak resting biases. To further examine this, we performed additional analyses whereby we examined slopes by (a) pooling all participant data together (centered separately for each individual), and then (b) took a further step to normalize each participant’s data not only by centering but by also adjusting by each individual’s variability along each axis (i.e. assess the slope between z-scores of resting bias vs. z-scores of each dependent variable). These two analyses confirmed our finding that resting biases interacted with active motor control, with significant slopes between resting biases and outcome variables. (a) Pooling all data together: path to stabilization: p = 0.032; time to stabilization: p = 1.4x10-5; maximum deviation: p = 0.021. (b) Pooling and normalizing: path to stabilization: p = 0.0013; time to stabilization: p = 8.6x10-6; maximum deviation: p = 0.00056. The latter analysis showed even stronger connection between resting bias and active holding control, probably due to better accounting for differences in the range of resting biases across participants). For simplicity, however, we only provide the across-individual slope comparisons in the paper.

      (2) An important aspect of all the analyses is that they rely heavily on estimates of the resting postural force bias. How stable are these resting postural force biases at the individual level? The authors could assess this by reporting within-subject variance for both the magnitude and direction of the resting postural force bias.

      Response 2.A.2. Thank you for your suggestion. We now assess the individual-level variance in error across measurements for patients’ paretic data using an ANOVA: the variance that remains after all other factors (same probe location; same arm support condition; same participant) are taken into account. We found that individual level measurement variance explained a mere 9.0% of total variance for resting bias magnitude. (We note that the same figure was 20.2% for the non-paretic data, in line with the weaker average biases which would be more susceptible to noise). We now note this in the Methods, as part of the new subsection “Stability of resting posture bias measurements in Experiment 1” (lines 266-273).

      (3) Does resting postural force bias influence hand movement immediately following force release from the postural perturbation? This could be assessed before any volitional responses by examining the velocity of the hand during the first 50 ms following the postural perturbation.

      Response 2.A.3. The influence seems fairly rapid, within the first 100ms as shown to the right. Here we plot hand deviation in the direction of the perturbation for the most-opposed (red) vs. most-aligned (blue) instances to examine when these curves become different. The bottom plots show the difference between these two, whereas shading indicates SEM (note that these curves are referenced to the average deviation in the last 0.5 s before force release). The rightmost plots zoom in to make it easier to see how responses to the most opposed vs. most aligned instances diverge.

      To detect the earliest post-perturbation timepoint for which this effect was significant, we performed paired t-tests at each timestep, and found that the two responses were systematically statistically different 95ms after perturbation onset onwards. For reference, the same method detected a response at 25ms for the most aligned instances and 40ms for the most opposed instances.

      We have now added Supplementary Figure S7-4 with short commentary in the Supplementary Materials.

      (4) Abstract. lines 7-9. At a glance (and when reading the manuscript linearly) this sentence is unclear. If the paretic arm is compromised across rest and movement, how does that afford the opportunity to address the relationship between reaching, stopping, and stabilizing when all could be impacted? It might be useful to specify that these factors may impacted differently relative to one another with stroke, providing an opportunity to better understand the differences between movement and postural control. 

      Response 2.A.4. Thank you for pointing out this issue (also related to Reviewer 1’s point – Response 1.1). We have changed this to more clearly reflect our reasoning and highlight that the issue is that stroke can differentially impact reaching vs. holding, copied below:

      “The paretic arm after stroke exhibits different abnormalities during rest vs. movement, providing an opportunity to ask whether control of these behaviors is independently affected in stroke.”

      (5) Line 27. It is perhaps more appropriate to say conceptual model than simply 'model'.  

      Response 2.A.5. Thank you for your suggestion, which we have adopted throughout the manuscript.

      (6) Line 122-125. Figure 1A caption. The authors should specify that resting posture force biases occur when the limb or hand is physically constrained in a specific position. 

      Response 2.A.6. Thank you for pointing this out – we have clarified the caption:

      “If one were to physically constrain the hand in a position away from the resting posture, the torques involved in each component of the abnormal resting posture translate to a force on the hand (blue arrow);”

      (7) Line 147. Why was the order not randomized or counterbalanced? 

      Response 2.A.7. We prioritized paretic data, as the primary analyses and comparisons in our paper involved resting posture biases and active movement with the paretic arm. We note that our primary analyses, which rely on paretic-paretic comparisons, would not be affected by paretic vs. non-paretic ordering effects. However, ordering effects could potentially affect comparisons between paretic and non-paretic data. We now note the reasoning behind the absence of counterbalancing, and mention the potential limitation in interpreting paretic to non-paretic comparisons in lines 124-129 of the Methods.

      (8) Line 172. 12N is the peak force of the pulse?

      Response 2.A.8. The reviewer is correct; we have clarified our description (line 463 in the updated manuscript):

      “a 70 ms bell-shaped force pulse which was 12N at its peak”

      (9) Line 175. What is a clockwise pulse? Was the force vector rotating in direction over time so that it was always acting orthogonally to the movement, or did it always act leftwards or rightwards?

      Response 2.A.9. The force vector was not rotating in direction over time. Here, we used clockwise/counterclockwise to indicate rightwards/leftwards with respect to the ideal movement direction – the line from start position to target (which is what we understand the Reviewer means by “always act rightwards or leftwards”). We have clarified the text to indicate this (lines 193-195):

      …was applied by the robot lateral to the ideal movement direction (i.e. the direction formed between the center of the start position and the center of the target) after participants reached 2cm away from the starting position (Smith and Shadmehr, 2005; Fine and Thoroughman, 2006).

      (10) Lines 177-182. It might be useful to explicitly mention the frequency of each of the perturbations, just for ease of the reader. 

      Response 2.A.10. We have added this information to our Methods (lines 206-210):

      Thus, in summary, each 96-movement block consisted of 64 unperturbed movements and 32 movements perturbed with a force pulse (16 clockwise, and 16 counter-clockwise). For 20 out of the 96 movements in each block, the hold period was extended to test the hold perturbation (4 trials for each of the 5 target locations, each one of the 4 trials testing one perturbation direction as shown in Figure 7C).

      (11) Line 191. Lines 188-190. It would be useful to see a sample of several of these force traces over time (0-5s) that were used to make the average for a position. That would give insight into the stability of the forces of a participant for one of the postures. These traces could be shown in Figure 2.

      Response 2.A.11. Thank you for your suggestion. We have added these panels to Figure 1, (as Figure 2 was already large). Each panel illustrates the three measurements taken at similar positions (closest to midline, distal from the body) and the same condition (paretic arm, with arm support given) for one participant (same participants as in Figure 2). Solid lines indicate the force on the x-axis (positive values indicate forces towards the left), whereas dashed lines indicate the force on the y-axis (positive values indicate forces towards the body). The shaded area indicates the part averaged in order to estimate the resting bias, illustrating how resting biases were relatively stable by the 2s mark. Note that these examples include one trial (blue traces in the third panel) which was rejected following visual inspection as described in Materials and Methods – Data Exclusion Criteria (“trials where forces appeared unstable and/or there was movement during the robot hold period”). We find this helpful as this illustrates (and motivates) one component of our methodology. 

      (12) Line 196. Figure 1D (not 1E).  

      Response 2.A.12. Thank you for catching this error, which we have now corrected.

      (13) Line 215: The authors mentioned similar results. Were there any different results that impacted interpretation? Some evidence of this, similar to and in addition to Supplementary 1, would be helpful. 

      Response 2.A.13. We repeated our analyses without these exclusion criteria, with no impact to the interpretation. We now include versions of the main outcome panels from Figures 5, 6, and 7 in the supplementary materials calculated without this outlier exclusion (Figures S5-E, S6-E, and S7-E, respectively). 

      (14) Line 231: Perhaps better to explicitly state the furthest three positions are being across as the distal targets for the ANOVA. 

      Response 2.A.14. Thank you for your suggestion. We now explicitly clarify this in line 276:

      “distal targets [furthest three positions] vs. proximal targets [closest two positions]”

      (15) Figure 3B, lines 265. Clearly, these are different, but the authors should report statistics. 

      Response 2.A.15. We now report these numbers (lines 339-346 of the revised manuscript, which also include statistics related to bias direction as described in 2.A.17 below).

      (16) Figure 2 should have a heat map scale.  

      Response 2.A.16. We have now added this (also Response 1.A.7), including an explanation of what the heat map represents in the caption.

      (17) Figure 3C: It would be useful to quantify and plot the direction of the resting force bias vector. 

      Response 2.A.17. Thank you for your suggestion. We have expanded Figure 3 to include the average direction of the resting force bias vector (note the readjustment of colors following Reviewer 1’s comment: striped bars indicate No Support data, and full bars indicate Support data, with the colors being the same). The direction of the force bias vector, however, may not be very informative in cases where the magnitude is small (and the signal-to-noise ratio is small), whereas averaging the direction of the force bias vector across different positions for one participant may average out systematic variations in this direction across different locations. Nevertheless, the average direction appears generally towards the body (around -90°, or 6 o’clock) even in the non-paretic and control data (though the noise – as suggested by the size of the errorbars – is much higher in the latter cases, especially when the arm is supported). This is a (weak) suggestion that these resting biases may be present, though much subdued, in the nonparetic limb and healthy individuals; further work will be needed to elucidate this.

      (18) Line 428. It is not significantly longer compared to controls. Can the authors slightly revise this sentence?

      Response 2.A.18. We have revised this sentence (lines 529-532):

      Patients showed impaired capacity to resist and recover from this perturbation (the abrupt release of the imposed force). The time to stabilization for the paretic side (0.94±0.05s) was longer compared to the non-paretic side (0.79±0.03s, p = 0.024) and controls (0.78±0.06s, though this was statistically marginal, p = 0.061) as shown in Figure 7E, left.

      (19) Line 541. It is unclear how these data support the idea of three distinct controllers. Can the authors please clarify? 

      Response 2.A.19. Here, we compared our findings to previous ideas about distinct controllers, and discuss a potential fusion of these ideas with ours. Specifically, we find that holding is distinct from both initial reaching and coming to a stop. Previous work argues that initial reaching and coming to a stop are themselves distinct (Ghez et al., 2007; Jayasinghe et al., 2022). Combining these two sets of arguments, we arrive at the possibility of three distinct controllers. 

      (20) It would be useful if the authors provided a definition of synergy, as well as distinguishing between muscle and movement synergies. 

      Response 2.A.20. We now provide this in lines 591-594:

      Here, “synergies” refer to abnormal co-activation patterns across joints that manifest as the patient tries to move – for example, the elbow involuntarily flexing as the patient tries to abduct their shoulder (Twitchell, 1951; Brunnstrom, 1966). 

      (21) Line 592-593. The wording of this sentence could be improved. 

      Response 2.A.21. We have switched this sentence to active voice for more clarity:

      Thus, while full weight support reduces both resting flexor biases and movement-related flexor synergies, this reduction seems more complete for synergies rather than resting biases.

      (22) Figure 9. In the left column, it should read normal synergies and normal resting posture.  

      Response 2.A.22. We intentionally used the same terminology, as the idea behind our conceptual model is that these patterns, which manifest as well-recognized abnormal synergies and abnormal resting postures in stroke, may be present in the healthy motor system as well, but kept in check by CST moderating the RST. At the same time, we recognize that, by definition, synergies and posture in controls are the “normal” reference point against which “abnormal” synergies and posture are defined after stroke. To clarify this issue, we thus decided to forgo the use of the terms “abnormal” in the figure, and instead refer to “synergistic movement ” and “synergistic resting posture”.

      (23) Figure 9. With stroke, is RST upregulated, a decreased influence of CST, or both? All seem plausible.

      Response 2.A.23a. We believe both can be happening. From previous work (e.g. McPherson et al., 2018) it seems safe to say that RST upregulation is the case, whereas one would also expect a decreased CST influence due to its damage due to the stroke. The relative weight of these influences would be interesting to elucidate in future work.

      I have not read the paper, but did McPherson et al., 2018 test these different hypotheses?  

      Response 2.A.23b. The main point of McPherson et al., 2018 is that increased synergy expression is due to increased RST involvement, rather than reduced CST influence. However, McPherson et al. do not show separate increases/reductions in RST/CST activity; they show that contralesional activity relative to ipsilesional activity is increased (using a laterality index). While it does seem that RST is upregulated in this case, this does not exclude the possibility that CST influence is reduced as well.

      We also noticed that the citation itself, while mentioned in the text, was missing from the bibliography. This is now fixed.

      For Figure 9, McPherson is cited as they provide evidence for the idea that RST involvement increases when arm support is decreased. This evidence is both direct (e.g. in their Figure 3 where they show that “Stroke participants exhibited increased activity in the contralesional (R) hemisphere as SABD loading increased” [i.e. arm support was reduced]) and indirect: they connect synergies to RST involvement, and also show increased synergies with reduced arm support (also shown multiple times previously). Both these arguments suggest that arm support reduces RST involvement. We have clarified the relevant sentence:

      The interesting implication of this conceptual model is that synergies are in fact postural abnormalities that spill over into active movement when the CST can no longer modulate the increased RST activation that occurs when weight support is removed. Supporting this idea, McPherson et al. found increased ipsilateral activity (which primarily represents activation via the descending RST (Zaaimi et al., 2012)) when the paretic arm had reduced support compared to full support (McPherson et al., 2018).

      Reviewer #3 (Recommendations For The Authors):

      For Experiment 2, it is not immediately clear how the within-subject values are being pooled and compared across the different conditions. For instance, in the static perturbation trials, there are four blocks with 20 perturbation trials per block per arm (80 total per arm) with each location and direction once per block. For each participant, the comparison is between the location/direction that was most opposed (although this doesn't look accurately represented in Fig 7F). Therefore, the within-subject comparison is 4 trials per participant? Were these values averaged or pooled? It is a little odd that the SD for all the within-subjects trials are identical or nearly identical across conditions especially when looking at the example patient data in 7B and 7F.  

      Response 3.A.1. For static perturbation trials, the within-subject comparison involves 8 trials per participant: 4 trials corresponding to the perturbation direction/position combination with resting bias most opposed to the perturbation, and 4 trials corresponding to the perturbation direction/position combination with resting bias most aligned with the perturbation. These values were averaged for each individual. We have expanded our methods to make this part of our data analysis clear (lines 284-296) for all types of comparisons (unperturbed movement, pulse perturbation, static perturbations – now referred to as “release perturbation”).

      The across-subject SDs for the average resting forces for each one of these two conditions, shown in Figure 7F are indeed identical. This is due to how these two instances (most aligned vs. most resistive) were selected: because the perturbation directions come in pairs that exactly oppose each other (Figure 7B), if one were to select the position with the most opposing resting bias, that would mean that the combination with same position and the oppositely-directed perturbation would be the one with the most assistive resting bias. Hence the resting biases selected for the most opposing/assistive instances would be equal in magnitude and opposite to each other for each participant, as illustrated in Figure 7F, whereby the most-opposed bias for each individual is exactly opposite to the corresponding most-aligned bias for the same individual. We have added a brief commentary about this on the caption (lines 551-554), reproduced below:

      Note how the most-opposed resting bias for each patient is equal and opposite to the their mostaligned resting bias. This is because the same resting bias, when projected along the direction of two oppositely-directed perturbations (illustrated in C), it would oppose one with the same magnitude it would align with the other.

      Importantly, following suggestions by Reviewer 2 (see point 2.A.1), we now provide supplementary analyses that use the entirety of the relevant data, rather than the most extreme instances, which provide evidence supporting our main findings (Figures S5-2, S6-2, and S7-2).

      The printed colors in Figure 3 are very muddled and hard to read/interpret, especially in panel A. 

      Response 3.A.2. Thank you for pointing out this issue, also raised by Reviewer 1. We have adjusted the colors to be more distinct from each other and look clear both in print and on-screen, making use of dashed lines and stripes rather than different shades.

      I think it would improve readability and interpretation if Figure 8 and the results related to FM-UE were contained within the description of results for Experiment 1.

      Response 3.A.3. Thank you for this suggestion. This is actually a debate we had among ourselves earlier, and we can see merits to either ordering. It is very arguable that moving Figure 8 and the FMUE results within the rest of Experiment 1 may improve readability somewhat. However, we believe that presenting these results at the end better serves to illustrate the apparent paradox between the lack of direct connection between resting biases and active movement on one hand, and the relationship between resting biases and abnormal synergies on the other. We believe that this better sets the stage to present our conceptual model, which explains this paradox based on the role arm support plays in modulating the expression of both resting biases and abnormal synergies.

      Additional changes/corrections not outlined above

      Figure 1D displayed a right arm, but showed a target array (red dots) for a left arm paradigm. We now flip the target array shown for consistency.

      We corrected Figure 6C, which accidentally used an earlier definition of settling time which was based on lateral stabilization throughout the entire movement, rather focus on the period immediately following the pulse. The intended definition of settling time (as we had described in the Methods, lines 204-206 of original submission) focuses on lateral corrections specific to the pulse (rather than corrections when the participant approaches the endpoint) and better matches the one for settling time for the release (static) perturbation trials. Note that this change did not affect the (lack of) relationship between settling time and resting force bias, both across individuals (correlation plots now in Figure S6-1) and within individuals (now shown in the right part of panel 6D). Also in panel C, an error in the scaling for the maximum lateral deviation in the pulse direction (right side of the panel) is also now corrected.

      In addition, we made minor edits throughout the text to improve readability.

      References

      Albert ST, Hadjiosif AM, Jang J, Zimnik AJ, Soteropoulos DS, Baker SN, Churchland MM, Krakauer JW, Shadmehr R (2020) Postural control of arm and fingers through integration of movement commands. Elife 9:e52507.

      Avni I, Arac A, Binyamin-Netser R, Kramer S, Krakauer JW, Shmuelof L (2024) The Kinematics of 3D Arm Movements in Sub-Acute Stroke: Impaired Inter-Joint Coordination is Attributable to Both Weakness and Flexor Synergy Intrusion. Neurorehabil Neural Repair 38:646–658.

      Bourbonnais D, VANDEN NOVEN S, Carey KM, Rymer WZ (1989) Abnormal spatial patterns of elbow muscle activation in hemiparetic human subjects. Brain 112:85–102.

      Brunnstrom S (1966) Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther 46:357–375.

      Cortes JC, Goldsmith J, Harran MD, Xu J, Kim N, Schambra HM, Luft AR, Celnik P, Krakauer JW,

      Kitago T (2017) A Short and Distinct Time Window for Recovery of Arm Motor Control Early After Stroke Revealed With a Global Measure of Trajectory Kinematics. Neurorehabil Neural Repair 31:552–560.

      Duque J, Thonnard J, Vandermeeren Y, Sébire G, Cosnard G, Olivier E (2003) Correlation between impaired dexterity and corticospinal tract dysgenesis in congenital hemiplegia. Brain 126:732–747.

      Fine MS, Thoroughman KA (2006) Motor Adaptation to Single Force Pulses: Sensitive to Direction but Insensitive to Within-Movement Pulse Placement and Magnitude. J Neurophysiol 96:710–720.

      Ghez C, Scheidt R, Heijink H (2007) Different Learned Coordinate Frames for Planning Trajectories and Final Positions in Reaching. J Neurophysiol 98:3614–3626.

      Hadjiosif AM, Branscheidt M, Anaya MA, Runnalls KD, Keller J, Bastian AJ, Celnik PA, Krakauer JW (2022) Dissociation between abnormal motor synergies and impaired reaching dexterity after stroke. J Neurophysiol 127:856–868.

      Jayasinghe SA, Scheidt RA, Sainburg RL (2022) Neural Control of Stopping and Stabilizing the Arm. Front Integr Neurosci 16.

      Kanade-Mehta P, Bengtson M, Stoeckmann T, McGuire J, Ghez C, Scheidt RA (2023) Spatial mapping of posture-dependent resistance to passive displacement of the hypertonic arm post-stroke. J NeuroEngineering Rehabil 20:163.

      Lawrence DG, Kuypers HG (1968) The functional organization of the motor system in the monkey: II. The effects of lesions of the descending brain-stem pathways. Brain 91:15–36.

      Levin MF (1996) Interjoint coordination during pointing movements is disrupted in spastic hemiparesis. Brain 119:281–293.

      Lowrey CR, Bourke TC, Bagg SD, Dukelow SP, Scott SH (2019) A postural unloading task to assess fast corrective responses in the upper limb following stroke. J NeuroEngineering Rehabil 16:1–17.

      McPherson JG, Chen A, Ellis MD, Yao J, Heckman C, Dewald JP (2018) Progressive recruitment of contralesional cortico-reticulospinal pathways drives motor impairment post stroke. J Physiol 596:1211–1225.

      McPherson LM, Dewald JP (2022) Abnormal synergies and associated reactions post-hemiparetic stroke reflect muscle activation patterns of brainstem motor pathways. Front Neurol 13:934670.

      Porter R, Lemon R (1995) Corticospinal function and voluntary movement. Oxford University Press.

      Smith MA, Brandt J, Shadmehr R (2000) Motor disorder in Huntington’s disease begins as a dysfunction in error feedback control. Nature 403:544.

      Smith MA, Shadmehr R (2005) Intact ability to learn internal models of arm dynamics in Huntington’s disease but not cerebellar degeneration. J Neurophysiol 93:2809–2821.

      Tower SS (1940) Pyramidal lesion in the monkey. Brain 63:36–90.

      Twitchell TE (1951) The restoration of motor function following hemiplegia in man. Brain 74:443–480.

      Wilkins KB, Yao J, Owen M, Karbasforoushan H, Carmona C, Dewald JP (2020) Limited capacity for ipsilateral secondary motor areas to support hand function post-stroke. J Physiol 598:2153– 2167.

      Zaaimi B, Edgley SA, Soteropoulos DS, Baker SN (2012) Changes in descending motor pathway connectivity after corticospinal tract lesion in macaque monkey. Brain 135:2277–2289.

    1. Author response:

      eLife Assessment

      This study provides useful findings about the effects of heterozygosity for Trio variants linked to neurodevelopmental and psychiatric disorders in mice. However, the strength of the evidence is limited and incomplete mainly because the experimental flow is difficult to follow, raising concerns about the conclusions' robustness. Clearer connections between variables, such as sex, age, behavior, brain regions, and synaptic measures, and more methodological detail on breeding strategies, test timelines, electrophysiology, and analysis, are needed to support their claims.

      We appreciate the opportunity to address the constructive feedback provided by eLife and the reviewers. Below, we respond to the overall assessment and individual reviewers' comments, clarifying our experimental approach, addressing concerns, and providing additional details where necessary.

      We thank the editors for highlighting the significance of our findings regarding the effects of Trio variant heterozygosity in mice. We acknowledge the feedback concerning the experimental flow and agree that clarity is paramount. To address these concerns:

      (1) Connections between variables: We will revise the manuscript to explicitly outline and extend explanations and the relationships between sex, age, behavior, brain regions, and synaptic measures, ensuring that the rationale for each experiment and its relevance to the overall conclusions are improved.

      (2) Methodological details: Our paper Methods section was formatted to be short with additional details provided in the Supplemental Methods section.  We will merge all into an extended section to improve clarity. We will also expand on our breeding strategies, test timelines, electrophysiological protocols, and data analysis methods in the revised Methods section. These additions aim to enhance the transparency and reproducibility of our study and to ensure full support of our conclusions.

      (3) Experimental flow: We will revise and extend our results, methods, and discussion sections to clarify the rationale and experimental design to guide readers through the experimental sequence and rationale.

      We are confident these revisions address the concerns raised and enhance the robustness and coherence of our findings.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study explores how heterozygosity for specific neurodevelopmental disorder-associated Trio variants affects mouse behavior, brain structure, and synaptic function, revealing distinct impacts on motor, social, and cognitive behaviors linked to clinical phenotypes. Findings demonstrate that Trio variants yield unique changes in synaptic plasticity and glutamate release, highlighting Trio's critical role in presynaptic function and the importance of examining variant heterozygosity in vivo.

      Strengths:

      This study generated multiple mouse lines to model each Trio variant, reflecting point mutations observed in human patients with developmental disorders. The authors employed various approaches to evaluate the resulting behavioral, neuronal morphology, synaptic function, and proteomic phenotypes.

      Weaknesses:

      While the authors present extensive results, the flow of experiments is challenging to follow, raising concerns about the strength of the experimental conclusions. Additionally, the connection between sex, age, behavioral data, brain regions, synaptic transmission, and plasticity lacks clarity, making it difficult to understand the rationale behind each experiment. Clearer explanations of the purpose and connections between experiments are recommended. Furthermore, the methodology requires more detail, particularly regarding mouse breeding strategies, timelines for behavioral tests, electrophysiology conditions, and data analysis procedures.

      We appreciate the reviewer’s recognition of the novelty and comprehensiveness of our approach, particularly the generation of multiple mouse lines and our efforts to model Trio variant effects in vivo.

      Weaknesses

      (1) Experimental flow and rationale and connection between variables: We will expand on the connections between behavioral data, neuronal morphology, synaptic function, and proteomics in the Results and Discussion sections to clarify how each experiment informs the reasoning and the conclusions and to highlight the relationships between sex, age, behavior, and synaptic measures.

      (2) Methodological details: Our paper Methods section was formatted to be short to fulfill word limits on the submitted version, with additional details provided in the Supplemental Methods section. We will merge our Methods and Supplemental Methods sections and expand on our breeding strategies, test timelines, electrophysiological protocols, and data analysis methods in the revised Methods section.  These additions aim to enhance the transparency and reproducibility of our study and to ensure full support of our conclusions.

      Reviewer #2 (Public review):

      Summary:

      The authors generated three mouse lines harboring ASD, Schizophrenia, and Bipolar-associated variants in the TRIO gene. Anatomical, behavioral, physiological, and biochemical assays were deployed to compare and contrast the impact of these mutations in these animals. In this undertaking, the authors sought to identify and characterize the cellular and molecular mechanisms responsible for ASD, Schizophrenia, and Bipolar disorder development.

      Strengths:

      The establishment of TRIO dysfunction in the development of ASD, Schizophrenia, and Bipolar disorder is very recent and of great interest. Disorder-specific variants have been identified in the TRIO gene, and this study is the first to compare and contrast the impact of these variants in vivo in preclinical models. The impact of these mutations was carefully examined using an impressive host of methods. The authors achieved their goal of identifying behavioral, physiological, and molecular alterations that are disorder/variant specific. The impact of this work is extremely high given the growing appreciation of TRIO dysfunction in a large number of brain-related disorders. This work is very interesting in that it begins to identify the unique and subtle ways brain function is altered in ASD, Schizophrenia, and Bipolar disorder.

      Weaknesses:

      (1) Most assays were performed in older animals and perhaps only capture alterations that result from homeostatic changes resulting from prodromal pathology that may look very different.

      (2) Identification of upregulated (potentially compensating) genes in response to these disorder-specific Trio variants is extremely interesting. However, a functional demonstration of compensation is not provided.

      (3) There are instances where data is not shown in the manuscript. See "data not shown". All data collected should be provided even if significant differences are not observed.

      I consider weaknesses 1 and 2 minor. While they would very interesting to explore, these experiments might be more appropriate for a follow-up study. I would recommend that the missing data in 3 should be provided in the supplemental material.

      We are grateful for the reviewer’s recognition of our study’s significance and methodological rigor. The acknowledgment of Trio dysfunction as a novel and impactful area of research is deeply appreciated.

      Weaknesses: 

      We agree that focusing on older animals may limit insights into early-stage pathophysiology. However, given the goal of this study was to examine the functional impacts of Trio heterozygosity at an adolescent stage and to reveal the ultimate impact of these alleles on synaptic function, we believe the choice of animal age aligns with our objectives. We agree that future studies of earlier developmental stages will be beneficial and complement these findings.

      Functional compensation: In this study, we tested functional compensation through rescue experiments in +/K1431M brain slices using a Rac1-specific inhibitor, NSC, which prevents its activation by Trio or Tiam1. Our findings strongly suggest that increased Rac1 activity, attributed to the proposed compensation, drives the deficiency in neurotransmitter release. Furthermore, this deficiency can be normalized by direct Rac1 inhibition.

      Data not shown: We will incorporate all previously shown data into the Supplemental Materials, even when results are nonsignificant. We agree that this ensures full transparency and facilitates a more comprehensive evaluation of our findings.

    1. Author response:

      We thank the editors at eLife and the reviewers for the care with which our mansucript has been reviewed and the constructive feedback that we have received. Both reviewers viewed the manuscript positively and in particular praised the merits of the forward genetic screen that led to the discovery of a new link between the HIF-1 pathway and fatty acid desaturation.

      We agree with all points by Reviewer #1. We will modify our manuscript to clarify that two types of C18:1 fatty acids are present in our lipidomics, and that the majority is likely vaccenic acid that is not a FAT-2 substrate. The title will be modified and Fig. 1A corrected.

      All points raised by Reviewer #2 are also valid and we will try to address most of them experimentally, though not always as suggested. In particular, we plan to use FRAP to verify that membrane-fluidizing treatments are effective in the fat-2 mutant. We also plan to use qPCR to test whether the novel egl-9(lof) and hif-1(gof) alleles lead to the expected downregulation of ftn-2. We note that the pathway connecting EGL-9, HIF-1 and FTN-2 is well supported by published work and that the alleles isolated in our screen are consistent with it, with the addition that FAT-2 is likely a regulated outcome of FTN-2 inhibition/mutation. We also plan to monitor FAT-2 protein levels using Western blots and thus provide more clarity about the mechanism of action of the novel fat-2(wa17) suppressors. The manuscript will be modified to tone down interpretations not directly supported by experiments.

    1. Author response:

      We would like to thank the editors and reviewers for reviewing our work, for finding it valuable supported by convincing data, which we greatly appreciate, but also for identifying the weaknesses of the manuscript. We plan to address these weaknesses in the revised version, briefly as follows:

      (1) In the Discussion, we will elaborate more on a possible generalization of our results, while being aware of the limited space in this experimental paper and therefore intend to address this in more detail and comprehensively in a subsequent perspective article.

      (2) In the Discussion, we will more clearly address the limitations of our work, in particular the difference between the measurement of extracellular adenosine production ex vivo and the actual production in vivo, where the measurement is indeed very challenging, and also the limitations of manipulating the SAM pathway only at the Ahcy level.

      (3) We will describe in detail and complement the supplementary RNAseq data. The RNAseq data have already been described in detail in our previous paper (doi.org/10.1371/journal.pbio.3002299), but we agree with the reviewers that we should describe the necessary details again here.

      (4) We will fill in the missing data on encapsulation efficiency; we agree that it was unfortunate to omit them.

      (5) We will supplement the data with methyltransferase expressions and better describe the changes in expression of some SAM pathway genes, which, especially with methyltransferase expressions, also support stimulation of this pathway by changes in expression. Although the goal of this work was to test by 13C-labeling whether SAM pathway activity is upregulated, not to analyze how the activity is regulated, we certainly agree that an explanation of possible regulation, especially in the context of the enzyme expressions we show, should be included in our work.

    1. Author response:

      We thank the editors and reviewers for their comments on our manuscript. We found the comments of the reviewers helpful and plan to add new text, analyses, and figures to answer some of the outstanding questions.

      In response to the reviewers’ comments, we will clarify the goal of the paper in the introduction: to test the hypothesis that causal knowledge (i.e., an intuitive theory of biology) is embedded in domain-preferring semantic networks (i.e., semantic animacy network). This work links developmental psychology work on intuitive theories and cognitive neuroscience.

      As we will emphasize in the revised manuscript, the primary goal of the current paper is to test the claim that semantic networks encode causal knowledge, rather than to rule out the contribution of domain-general reasoning mechanisms to causal inference.

      In response to the reviewers’ suggestions, we will add multivariate and univariate whole-cortex analyses that provide further tests for domain-general causality responses. In particular, we will include new figures showing univariate responses to the mechanical inference condition over the non-causal control conditions as well as decoding between these conditions. The reviewers have also asked us to provide individual subject dispersion data. We appreciate this suggestion, and new figures will be added to display this information.

      We will also perform additional analysis in the precuneus (PC) to look for shared responses to illness and mechanical inferences. In accordance with our hypotheses, we have shown that the PC responds preferentially to illness inferences. To address the reviewers’ concerns about the selectivity of the PC to illness inferences, we will compare responses to i) illness inferences compared to the noncausal conditions and ii) mechanical inferences compared to the noncausal conditions in the PC to investigate the extent to which a shared response to causal inference across domains emerges in this region.

      Critically, we find that the cortical areas that distinguish between causal and non-causal conditions in a ‘domain general manner’ (i.e., for both illness and mechanical inferences) are driven by higher responses to the non-causal condition. Moreover, these responses in prefrontal cortex and elsewhere overlap an RT predictor of neural activity, suggesting that they may reflect difficulty effects.

      These results suggest that in the current task, signatures of causal inference are primarily found in domain-preferring semantic networks, rather than in domain-general fronto-parietal reasoning systems. We will provide additional discussion of the argument that the current results do not speak against the role of domain general systems across all types of causal reasoning. Instead, they suggest that the types of implicit causal inferences measured in the current study depend primarily on domain-preferring semantic networks.

      The reviewers have asked us to analyze responses to causal inferences about illness in the fusiform face area (FFA). We will perform this analysis. However, we note that univariate and multivariate whole-cortex analyses that are already included in the paper did not identify lateral ventral occipito-temporal cortex as a key region involved in causal inferences about illness. Further, we do not have FFA localizer data in the current participants; therefore, the results cannot be interpreted to reflect activity in functionally defined FFA.

      Two reviewers asked us to justify our choice of an implicit magic-detection task, which we will now do more clearly in the manuscript. This task was selected to ensure that participants were attending to the meaning of the vignettes. The goal of the current study was to investigate implicit causal inferences that routinely occur in language comprehension, e.g., when someone is reading a book. Past work has shown that explicitly judging the causality of causal and non-causal stimuli results in differences in response times across conditions (e.g., Kuperberg et al., 2006). In the current study, such judgments would also have introduced a confound between the behavioral decision and the condition of interest: the use of an explicit causal judgment task makes it impossible to know whether any observed neural differences between causal and non-causal conditions are simply due to differences in the selection of task responses. The selection of an orthogonal magic-detection task limits these confounds from complicating our interpretation of the neural data.

      One of the reviewers asked us to justify the number of catch trials that we decided to include in our paradigm. Approximately 20% of the vignettes were “magical” vignettes (the same proportion as each of the 4 experimental conditions) to encourage participants to remain attentive throughout the task. Since these catch trials are excluded from analysis, their proportion is unlikely to influence the results of the study. We will clarify this in the manuscript.

      A question was raised about the balance of trial numbers across conditions and across runs. To address this, we will include individual comparisons of each causal condition (n=36) with each non-causal condition (n=36; i.e., equal trial counts) where they are not already shown. With regard to runs, each condition is shown either 6 or 7 times per run (maximum difference of 1 trial between conditions), and the number of trials per condition is equal across the whole experiment: each condition is shown 7 times in two of the runs and 6 times four of the runs. This minor design imbalance is typical of fMRI experiments and is unlikely to impact the results. We will clarify this in the manuscript.

      We believe that our planned revisions will strengthen the paper and highlight its contributions to our understanding of the neural basis of implicit causal inference.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Horizontal gene transfer is the transmission of genetic material between organisms through ways other than reproduction. Frequent in prokaryotes, this mode of genetic exchange is scarcer in eukaryotes, especially in multicellular eukaryotes. Furthermore, the mechanisms involved in eukaryotic HGT are unknown. This article by Banerjee et al. claims that HGT occurs massively between cells of multicellular organisms. According to this study, the cell free chromatin particles (cfChPs) that are massively released by dying cells are incorporated in the nucleus of neighboring cells. These cfChPs are frequently rearranged and amplified to form concatemers, they are made of open chromatin, expressed, and capable of producing proteins. Furthermore, the study also suggests that cfChPs transmit transposable elements (TEs) between cells on a regular basis, and that these TEs can transpose, multiply, and invade receiving cells. These conclusions are based on a series of experiments consisting in releasing cfChPs isolated from various human sera into the culture medium of mouse cells, and using FISH and immunofluorescence to monitor the state and fate of cfChPs after several passages of the mouse cell line.

      Strengths:

      The results presented in this study are interesting because they may reveal unsuspected properties of some cell types that may be able to internalize free-circulating chromatin, leading to its chromosomal incorporation, expression, and unleashing of TEs. The authors propose that this phenomenon may have profound impacts in terms of diseases and genome evolution. They even suggest that this could occur in germ cells, leading to within-organism HGT with long-term consequences.

      Weaknesses:

      The claims of massive HGT between cells through internalization of cfChPs are not well supported because they are only based on evidence from one type of methodological approach: immunofluorescence and fluorescent in situ hybridization (FISH) using protein antibodies and DNA probes. Yet, such strong claims require validation by at least one, but preferably multiple, additional orthogonal approaches. This includes, for example, whole genome sequencing (to validate concatemerization, integration in receiving cells, transposition in receiving cells), RNA-seq (to validate expression), ChiP-seq (to validate chromatin state).

      We agree with the reviewer’s suggestions. We propose to use RNA-seq using an orthogonal platform as a solution. This will allow us to answer multiple questions viz. validation of expression of human DNA in mouse cells, obtaining a detailed insight into genes and pathways driven by human cfChPs and enable us to identify chimeric human and mouse transcripts.

      Another weakness of this study is that it is performed only in one receiving cell type (NIH3T3 mouse cells). Thus, rather than a general phenomenon occurring on a massive scale in every multicellular organism, it could merely reflect aberrant properties of a cell line that for some reason became permeable to exogenous cfChPs. This begs the question of the relevance of this study for living organisms.

      We agree with the reviewer’s suggestion. We propose to show horizontal transfer of cfChPs using four different cell-lines representing four different species.

      Should HGT through internalization of circulating chromatin occur on a massive scale, as claimed in this study, and as illustrated by the many FISH foci observed in Fig 3 for example, one would expect that the level of somatic mosaicism may be so high that it would prevent assembling a contiguous genome for a given organism. Yet, telomere-to-telomere genomes have been produced for many eukaryote species, calling into question the conclusions of this study.

      The reviewer is right in expecting that the level of somatic mosaicism may be so high that it would prevent assembling a contiguous genome. This is indeed the case, and we find that beyond ~ 250 passages the genomes of the cfChPs treated NIH3T3 cells begin to die out apparently become their genomes have become too unstable for survival. This point will be highlighted in the revised version. It is likely that cell death resulting from large scale HGT creates a vicious cycle of more cell death induced by cfChPs thereby helping to explain the massive daily turnover of cells in the body (10<sup>9</sup> – 10<sup>12</sup> cells per day).  

      Reviewer #2 (Public review):

      I must note that my comments pertain to the evolutionary interpretations rather than the study's technical results. The techniques appear to be appropriately applied and interpreted, but I do not feel sufficiently qualified to assess this aspect of the work in detail.

      I was repeatedly puzzled by the use of the term "function." Part of the issue may stem from slightly different interpretations of this word in different fields. In my understanding, "function" should denote not just what a structure does, but what it has been selected for. In this context, where it is unclear if cfChPs have been selected for in any way, the use of this term seems questionable.

      We think this is a matter of semantics. We have used the term “function” since cfChPs that enter the cell are biologically active; they transcribe, translate, synthesize, proteins and proliferate. We, therefore feel that the term function is not inappropriate.

      Similarly, the term "predatory genome," used in the title and throughout the paper, appears ambiguous and unjustified. At this stage, I am unconvinced that cfChPs provide any evolutionary advantage to the genome. It is entirely possible that these structures have no function whatsoever and could simply be byproducts of other processes. The findings presented in this study do not rule out this neutral hypothesis. Alternatively, some particular components of the genome could be driving the process and may have been selected to do so. This brings us to the hypothesis that cfChPs could serve as vehicles for transposable elements. While speculative, this idea seems to be compatible with the study's findings and merits further exploration.

      We take the reviewer’s point. We will replace the term “predatory genome” with a more neutral and factual term “supernumerary genome” in the title and throughout the manuscript in the revised version.

      I also found some elements of the discussion unclear and speculative, particularly the final section on the evolution of mammals. If the intention is simply to highlight the evolutionary impact of horizontal transfer of transposable elements (e.g., as a source of new mutations), this should be explicitly stated. In any case, this part of the discussion requires further clarification and justification.

      We propose to revise the “discussion” section taking into account the issues raised by the reviewer and highlight the potential role of cfChPs in evolution by acting as vehicles of transposable elements.  

      In summary, this study presents important new findings on the behavior of cfChPs when introduced into a foreign cellular context. However, it overextends its evolutionary interpretations, often in an unclear and speculative manner. The concept of the "predatory genome" should be better defined and justified or removed altogether. Conversely, the suggestion that cfChPs may function at the level of transposable elements (rather than the entire genome or organism) could be given more emphasis.

      Our responses to this paragraph are given in the two above sections.

    1. Author response:

      We thank the reviewers for their careful readings of our paper and their very positive assessment. Here we address the two major concerns they raised, referring to the revised version of the manuscript that will be submitted:

      (1) Important points were raised regarding the brief elongation events we reported. The time resolution and noise in our system reduce the accuracy of the burst velocity measurements. To address this, we have reached out to a colleague who is set up to repeat these measurements with microfluidics-assisted TIRF. The noise should be greatly reduced and the system is also optimal for directly visualizing labeled FHOD3, as suggested. We hope this experimental approach will provide new insights.

      In the meantime, we analyzed our data more closely. We were asked about the pauses we observe before bursts of elongation and how we know they are functionally relevant. The short answer is that we do not know. We reported them because they were so common:  in three independent experiments with wild type FHOD3L-CT we analyzed a total of 20 filaments. We detected 112 dim regions and 97 of these were pause/burst events (~87%). Among the cases lacking a pause we include instances of apparent "double bursts" with no time for capping in between (which may be a time resolution issue) and some cases where the burst was in progress when data collection started. In the latter case, we cannot determine whether or not a pause was missed. We cannot rule out that this pause reflects an interaction with the surface but might expect the frequency to be lower if it were. In fact, we did detect pauses in the profilin-actin negative control but only 4 pauses were detected across 21 filaments analyzed compared to 97 pauses observed in the presence of wild type FHOD3L across 20 filaments analyzed. We will revise the text to make our conclusions about pauses more circumspect.

      For comparison to our current data, we further analyzed the filaments in TIRF assays with no formin present. As the reviewers point out, inhomogeneities in filament intensity are normal. Thus, we examined any dim spots for pauses and/or bursts. We will report (future Figure 2G) that the velocity of growth of these dim spots was the same as the velocity of the rest of the filament. While our numbers may not be perfectly accurate due to the noise in our system, the difference of 3-4 fold increase versus no detectable change in rate is substantial and statistically different. In addition, we determined the number of dim spots per length of filament. We found a higher frequency of dim spots when FHOD3L-CT or FHOD3S-CT was present vs no formin, as will be shown in Figure 2 – figure supplement 1G and 2D.

      We are convinced that the brief dim events we observed in the presence of FHOD3L-CT do, in fact, reflect formin-mediated elongation and hope that the reviewers concur. This does not preclude our interest in the microfluidics and two-color assays, which we will pursue in the future.

      (2) The reviewers were concerned about the low protein levels in the GS-FH1 rescue experiments as reflected in the HA fluorescence intensity distributions shown in Fig. 5 – figure supplement 2A. While the scenario proposed could explain our observations with the GSFH1 rescues, it is quite complex and does not preclude the conclusion that the FH1 domain is critical. One limit of this scenario would be that the protein levels in the GS-FH1 cells reflect completely inactive protein, as opposed to FHOD3L that cannot elongate (by design). Given that the C-terminal half of the protein folds and functions and that the changes are made within an intrinsically disordered region, we do not favor this model. The reviewers suggest that the mutant protein detected in the few cells with (probably residual) sarcomeres could be stabilized, in part or entirely, by heterodimerization with residual endogenous wild type protein. We agree that heterodimerization is possible. The question becomes, how active is a heterodimer? If heterodimers have any activity, it seems far from sufficient to rescue sarcomere formation, suggesting that two functional FH1 domains are critical. To confirm this possibility, we would have to be able to determine whether the few sarcomeres present in these cases are residual and/or the new sarcomeres the low level of heterodimers could make. That said, we do not see evidence of correlation between protein levels and rescue at the level present in these cells (addressed below). Unfortunately, the proposed IP to test whether FHOD3L binds actin in vivo would only potentially report on filament side binding (both direct and indirect). It would not address whether the GS-FH1 mutant functions as a nucleator, elongator, bundler and/or capping protein in vivo.

      If we assume that the protein present is active, the critical question that we can address is whether the phenotype is due to low protein levels or if the phenotype is due to loss of elongation activity by FHOD3L. To address this question, we revisited our data.

      First, we plotted the distributions of the intensities of the cells we analyzed further, in addition to the automated readout of all the cells in the dish we originally presented (e.g. Fig. 4 – figure supplement 2A,B). These cells were selected randomly and, as should be the case, the distributions of their intensities agree well with the original distributions for the three different rescue constructs: FHOD3L, K1193L, and GS-FH1 (Fig. 6 – figure supplement 1A,B). We then asked whether there was any correlation between HA intensities with the sarcomere metrics. Consistent with in our pilot data, no correlation is evident in any of the three cases across the range of intensities we collected (400 – 2700 a.u.) (Fig. 6 – figure supplement 1C,D,E). We were originally satisfied with the GS-FH1 data, despite the low average intensity levels, because the intensities were well within the range that we established in pilot studies. These data reconfirm that the intensity levels are reasonable in a larger study.

      To more specifically address the question of whether low HA fluorescence intensity is likely to reflect sufficient protein levels to build sarcomeres, we re-examined two data sets from the FHOD3L WT rescue data. We found that, by chance, the first replicate of data from the wild type rescue has a comparable intensity distribution to that of the GSFH1 rescues (580 +/- 261 / cell vs. 548 +/- 105 / cell). In addition, we collected all of the data from cells with intensity levels <720, selected to mimic the distribution of the GS-FH1 cells (Fig. 6 – figure supplement 3A). We then compared the sarcomere metrics (sarcomere number, sarcomere length, sarcomere width) between the full data set and the two low intensity subsets using statistical tests as reported for the rest of the cell biology data set:

      · Sarcomere number is the only non-normal metric. We therefore used the Mann Whitney U test for each pairwise comparison, which shows no difference between all 3 WT distributions.

      · We compared Z-line lengths by Student’s two-sample, unpaired t-test for each pairwise comparison, again finding no significant difference for all distributions.

      · Sarcomere length shows a weakly significant difference (p=0.017 (compared to 0.033 for 3 treatment groups based on Bonferroni correction)) between the whole WT data set and bio rep 1, but no difference between the whole WT data set and the HA<720 group via Student’s two-sample, unpaired t-test.

      An alternate statistical analysis approach, one-way ANOVA and Tukey post hoc tests, gave similar results. Thus, cells expressing wild type FHOD3L at levels comparable to levels detected in GS-FH1 mutant rescues, are fully rescued. Based on these findings we conclude that the expression levels in the GS-FH1 are high enough to rescue the FHOD3 knock down, supporting our conclusion that the defect is due to loss of elongation activity. We will add this analysis and discussion to the revised manuscript.

      In future studies we will design less severe mutations to the FH1 domain. We hope to identify one with a strong effect on elongation and another with an intermediate effect. Once the best candidates are characterized in vitro, we will test them in our rescue experiments. If the strong mutant mimics the GS-FH1 rescue and the intermediate mutant is less severe, we will have strengthened our conclusion that elongation is a critical FHOD3L activity in sarcomere formation.

      Additional improvements will be made to the manuscript based on recommendations we received from the reviewers.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review):

      Summary:

      In the manuscript "Intergenerational transport of double-stranded RNA limits heritable epigenetic changes," Shugarts and colleagues investigate intergenerational dsRNA transport in the nematode C. elegans. By inducing oxidative damage, they block dsRNA import into cells, which affects heritable gene regulation in the adult germline (Fig. 2). They identify a novel gene, sid-1-dependent gene-1 (sdg-1), upregulated upon SID-1 inhibition (Fig. 3). Both transient and genetic depletion of SID-1 lead to the upregulation of sdg-1 and a second gene, sdg-2 (Fig. 5). Interestingly, while sdg-1 expression suggests a potential role in dsRNA transport, neither its overexpression nor loss-of-function impacts dsRNA-mediated silencing in the germline (Fig. 7).

      Strengths:

      • The authors employ a robust neuronal stress model to systematically explore SID-1 dependent intergenerational dsRNA transport in C. elegans.

      • They discover two novel SID-1-dependent genes, sdg-1 and sdg-2.

      • The manuscript is well-written and addresses the compelling topic of dsRNA signaling in C. elegans.

      Weaknesses:

      • The molecular mechanism downstream of SDG-1 remains unclear. Testing whether sdg-2 functions redundantly with sdg-1could provide further insights.

      • SDG-1 dependent genes in other nematodes remain unknown.

      We thank the reviewer for highlighting the strengths of the work along with a couple of the interesting future directions inspired by the reported discoveries. The restricted presence of genes encoding SDG-1 and its paralogs within retrotransposons suggests intriguing evolutionary roles for these proteins. Future work could examine whether such fast-evolving or newly evolved proteins with potential roles in RNA regulation are more broadly associated with retrotransposons. Multiple SID-1-dependent proteins (including SDG-1 and SDG-2) could act together to mediate downstream effects. This possibility can be tested using combinatorial knockouts and overexpression strains. Both future directions have the potential to illuminate the evolutionarily selected roles of dsRNA-mediated signaling through SID-1, which remain a mystery.

      Reviewer #2 (Public review):

      Summary:

      RNAs can function across cell borders and animal generations as sources of epigenetic information for development and immunity. The specific mechanistic pathways how RNA travels between cells and progeny remains an open question. Here, Shugarts, et al. use molecular genetics, imaging, and genomics methods to dissect specific RNA transport and regulatory pathways in the C. elegans model system. Larvae ingesting double-stranded RNA is noted to not cause continuous gene silencing throughout adulthood. Damage of neuronal cells expressing double-stranded target RNA is observed to repress target gene expression in the germline. Exogenous short or long double-stranded RNA required different genes for entry into progeny. It was observed that the SID-1 double-stranded RNA transporter showed different expression over animal development. Removal of the sid-1 gene caused upregulation of two genes, the newly described sid-1-dependent gene sdg-1 and sdg-2. Both genes were observed to be negatively regulated by other small RNA regulatory pathways. Strikingly, loss then gain of sid-1 through breeding still caused variability of sdg-1 expression for many, many generations. SDG-2 protein co-localizes with germ granules, intracellular sites for heritable RNA silencing machinery. Collectively, sdg-1 presents a model to study how extracellular RNAs can buffer gene expression in germ cells and other tissues.

      Strengths:

      (1) Very cleaver molecular genetic methods and genomic analyses, paired with thorough genetics, were employed to discover insights into RNA transport, sdg-1 and sdg-2 as sid-1-dependent genes, and sdg-1's molecular phenotype.

      (2) The manuscript is well cited, and figures reasonably designed.

      (3) The discovery of the sdg genes being responsive to the extracellular RNA cell import machinery provides a model to study how exogenous somatic RNA is used to regulate gene expression in progeny. The discovery of genes within retrotransposons stimulates tantalizing models how regulatory loops may actually permit the genetic survival of harmful elements.

      Weaknesses:

      (1) The manuscript is broad, making it challenging to read and consider the data presented. Of note, since the original submission, the authors have improved the clarity of the writing and presentation.

      Comments on revised version:

      This reviewer thanks the authors for their efforts in revising the manuscript. In their rebuttal, the authors acknowledged the broad scope of their manuscript. I concur. While I still think the manuscript is a challenge to read due to its expansive nature, the current draft is substantially improved when compared to the previous one. This work will contribute to our general knowledge of RNA biology, small RNA regulatory pathways, and RNA inheritance.

      We thank the reviewer for highlighting the strengths of the manuscript and for helping us improve the presentation of our results and discussion.


      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In the manuscript "Intergenerational transport of double-stranded RNA limits heritable epigenetic changes" Shugarts and colleagues investigate intergenerational dsRNA transport in the nematode C. elegans. They induce oxidative damage in worms, blocking dsRNA import into cells (and potentially affecting the worms in other ways). Oxidative stress inhibits dsRNA import and the associated heritable regulation of gene expression in the adult germline (Fig. 2). The authors identify a novel gene, sid-1-dependent gene-1 (sdg-1), which is induced upon inhibition of SID-1 (Fig. 3). Both transient inhibition and genetic depletion of SID-1 lead to the upregulation of sdg-1 and a second gene, sdg-2 (Fig. 5). The expression of SDG-1 is variable, potentially indicating buffering regulation. While the expression of Sdg-1 could be consistent with a role in intergenerational transport of dsRNA, neither its overexpression nor loss-of-function impacts dsRNA-mediated silencing (Fig. 7) in the germline. It would be interesting to test if sdg-2 functions redundantly.

      In summary, the authors have identified a novel worm-specific protein (sdg-1) that is induced upon loss of dsRNA import via SID-1, but is not required to mediate SID-1 RNA regulatory effects.

      We thank the reviewer for highlighting our findings on SDG-1. We found that oxidative damage in neurons enhanced dsRNA transport into the germline and/or subsequent silencing.

      Remaining Questions:

      • The authors use an experimental system that induces oxidative damage specifically in neurons to release dsRNAs into the circulation. Would the same effect be observed if oxidative damage were induced in other cell types?

      It is possible that oxidative damage of other tissues using miniSOG (as demonstrated in Xu and Chisholm, 2016) could also enhance the release of dsRNA into the circulation from those tissues. However, future experiments would be needed to test this empirically because it is also possible that the release of dsRNA depends on physiological properties (e.g., the molecular machinery promoting specific secretion) that are particularly active in neurons. We chose to use neurons as the source of dsRNA because by expressing dsRNA in a variety of tissues, neurons appeared to be the most efficient at the export of dsRNA as measured using SID-1-dependent silencing in other tissues (Jose et al., PNAS, 2009).

      • Besides dsRNA, which other RNAs and cellular products (macromolecules and small signalling molecules) are released into the circulation that could affect the observed changes in germ cells?

      We do not yet know all the factors that could be released either in naive animals or upon oxidative damage of neurons that influence the uptake of dsRNA into other tissues. The dependence on SID-1 for the observed enhancement of silencing (Fig. 2) shows that dsRNA is necessary for silencing within the germline. Whether this import of dsRNA occurs in conjunction with other factors (e.g., the uptake of short dsRNA along with yolk into oocytes (Marré et al., PNAS, 2016)) before silencing within the germline will require further study. A possible approach could be the isolation of extracellular fluid (Banse and Hunter, J Vis Exp., 2012) followed by characterization of its contents. However, the limited material available using this approach and the difficulty in avoiding contamination from cellular damage by the needle used for isolating the material make it challenging.

      • SID-1 modifies RNA regulation within the germline (Fig. 7) and upregulates sdg-1 and sdg-2 (Fig. 5). However, SID-1's effects do not appear to be mediated via sdg-1. Testing the role of sdg-2 would be intriguing.

      We observe the accumulation of sdg-1 and sdg-2 RNA in two different mutants lacking SID-1, which led us to conservatively focus on the analysis of one of these proteins for this initial paper. We expect that more sensitive analyses of the RNA-seq data will likely reveal additional genes regulated by SID-1. With the ability to perform multiplexed genome-editing, we hope in future work to generate strains that have mutations in many SID-1-dependent genes to recapitulate the defects observed in sid-1(-) animals. Indeed, as surmised by the reviewer, we are focusing on sdg-2 as the first such SID-1-dependent gene to analyze using mutant combinations.

      • Are sdg-1 or sdg-2 conserved in other nematodes or potentially in other species?  appears to be encoded or captured by a retro-element in the C. elegans genome and exhibits stochastic expression in different isolates. Is this a recent adaptation in the C. elegans genome, or is it present in other nematodes? Does loss-of-function of sdg-1 or sdg-2 have any observable effect?

      Clear homologs of SDG-1 and SDG-2 are not detectable outside of C. elegans. Consistent with the location of the sdg-1 gene within a Cer9 retrotransposon that appears to have integrated only within the C. elegans genome, sequence conservation between the genomes of related species is only observed outside the region of the retrotransposon (see Author response image 1, screenshot from UCSC browser). There were no obvious defects detected in animals lacking sdg-1 (Fig. 7) or in animals lacking sdg-2 (data not shown). It is possible that further exploration of both mutants and mutant combinations lacking additional SID-1-dependent genes would reveal defects. We also plan to examine these mutants in sensitized genetic backgrounds where one or more members of the RNA silencing pathway have been compromised.

      Author response image 1.

      Clarification for Readability:

      To enhance readability and avoid misunderstandings, it is crucial to specify the model organism and its specific dsRNA pathways that are not conserved in vertebrates:

      We agree with the reviewer and thank the reviewer for the specific suggestions provided below. To take the spirit of the suggestion to heart we have instead changed the title of our paper to clearly signal that the entire study only uses C. elegans. We have titled the study ‘Intergenerational transport of double-stranded RNA in C. elegans can limit heritable epigenetic changes’

      • In the first sentence of the paragraph "Here, we dissect the intergenerational transport of extracellular dsRNA ...", the authors should specify "in the nematode C. elegans". Unlike vertebrates, which recognise dsRNA as a foreign threat, worms and other invertebrates pervasively use dsRNA for signalling. Additionally, worms, unlike vertebrates and insects, encode RNA-dependent RNA polymerases that generate dsRNA from ssRNA substrates, enabling amplification of small RNA production. Especially in dsRNA biology, specifying the model organism is essential to avoid confusion about potential effects in humans.

      We agree with most statements made by the reviewer, although whether dsRNA is exclusively recognized as a foreign threat by all vertebrates of all stages remains controversial. Our changed title now eliminates all ambiguity regarding the organism used in the study.

      • Similarly, the authors should specify "in C. elegans" in the sentence "Therefore, we propose that the import of extracellular dsRNA into the germline tunes intracellular pathways that cause heritable RNA silencing." This is important because C. elegans small RNA pathways differ significantly from those in other organisms, particularly in the PIWI-interacting RNA (piRNA) pathways, which depend on dsRNA in C. elegans but uses ssRNA in vertebrates. Specification is crucial to prevent misinterpretation by the reader. It is well understood that mechanisms of transgenerational inheritance that operate in nematodes or plants are not conserved in mammals.

      The piRNAs of C. elegans are single-stranded but are encoded by numerous independent genes throughout the genome. The molecules used for transgenerational inheritance of epigenetic changes that have been identified thus far are indeed different in different organisms. However, the regulatory principles required for transgenerational inheritance are general (Jose, eLife, 2024). Nevertheless, we have modified the title to clearly state that the entire study is using C. elegans.  

      • The first sentence of the discussion, "Our analyses suggest a model for ...", would also benefit from specifying "in C. elegans". The same applies to the figure captions. Clarification of the model organism should be added to the first sentence, especially in Figure 1.

      With the clarification of the organism used in the title, we expect that all readers will be able to unambiguously interpret our results and the contexts where they apply. 

      Reviewer #2 (Public review):

      Summary:

      RNAs can function across cell borders and animal generations as sources of epigenetic information for development and immunity. The specific mechanistic pathways how RNA travels between cells and progeny remains an open question. Here, Shugarts, et al. use molecular genetics, imaging, and genomics methods to dissect specific RNA transport and regulatory pathways in the C. elegans model system. Larvae ingesting double stranded RNA is noted to not cause continuous gene silencing throughout adulthood. Damage of neuronal cells expressing double stranded target RNA is observed to repress target gene expression in the germline. Exogenous supply of short or long double stranded RNA required different genes for entry into progeny. It was observed that the SID-1 double-stranded RNA transporter showed different expression over animal development. Removal of the sid-1 gene caused upregulation of two genes, the newly described sid-1-dependent gene sdg-1 and sdg-2. Both genes were observed to also be negatively regulated by other small RNA regulatory pathways. Strikingly, loss then gain of sid-1 through breeding still caused variability of sdg-1 expression for many, many generations. SDG-2 protein co-localizes with a Z-granule marker, an intracellular site for heritable RNA silencing machinery. Collectively, sdg-1 presents a model to study how extracellular RNAs can buffer gene expression in germ cells and other tissues.

      We thank the reviewer for highlighting our findings and underscoring the striking nature of the discovery that mutating sid-1 using genome-editing resulted in a transgenerational change that could not be reversed by changing the sid-1 sequence back to wild-type.

      Strengths:

      (1) Very clever molecular genetic methods and genomic analyses, paired with thorough genetics, were employed to discover insights into RNA transport, sdg-1 and sdg-2 as sid-1-dependent genes, and sdg-1's molecular phenotype.

      (2) The manuscript is well cited, and figures reasonably designed.

      (3) The discovery of the sdg genes being responsive to the extracellular RNA cell import machinery provides a model to study how exogenous somatic RNA is used to regulate gene expression in progeny. The discovery of genes within retrotransposons stimulates tantalizing models how regulatory loops may actually permit the genetic survival of harmful elements.

      We thank the reviewer for the positive comments.

      Weaknesses:

      (1) As presented, the manuscript is incredibly broad, making it challenging to read and consider the data presented. This concern is exemplified in the model figure, that requires two diagrams to summarize the claims made by the manuscript.

      RNA interference (RNAi) by dsRNA is an organismal response where the delivery of dsRNA into the cytosol of some cell precedes the processing and ultimate silencing of the target gene within that cell. These two major steps are often not separately considered when explaining observations. Yet, the interpretation of every RNAi experiment is affected by both steps. To make the details that we have revealed in this work for both steps clearer, we presented the two models separated by scale - organismal vs. intracellular. We agree that this integrative manuscript appears very broad when the many different findings are each considered separately. The overall model revealed here forms the necessary foundation for the deep analysis of individual aspects in the future.

      (2) The large scope of the manuscript denies space to further probe some of the ideas proposed. The first part of the manuscript, particularly Figures 1 and 2, presents data that can be caused by multiple mechanisms, some of which the authors describe in the results but do not test further. Thus, portions of the results text come across as claims that are not supported by the data presented.

      We agree that one of the consequences of addressing the joint roles of transport and subsequent silencing during RNAi is that the scope of the manuscript appears large. We had suggested multiple interpretations for specific observations in keeping with the need for further work. To avoid any misunderstandings that our listing of possible interpretations be taken as claims by the reader, we have followed the instructions of the reviewer (see below) and moved some of the potential explanations we raised to the discussion section.

      (3) The manuscript focuses on the genetics of SDGs but not the proteins themselves. Few descriptions of the SDGs functions are provided nor is it clarified why only SDG-1 was pursued in imaging and genetic experiments. Additionally, the SDG-1 imaging experiments could use additional localization controls.

      We agree that more work on the SDG proteins will likely be informative, but are beyond the scope of this already expansive paper.  We began with the analysis of SDG-1 because it had the most support as a regulator of RNA silencing (Fig. 5f). Indeed, in other work (Lalit and Jose, bioRxiv, 2024), we find that AlphaFold 2 predicts the SDG-1 protein to be a regulator of RNA silencing that directly interacts with the dsRNA-editing enzyme ADR-2 and the endonuclease RDE-8. Furthermore, we expect that more sensitive analyses of the RNA-seq data are likely to reveal additional genes regulated by SID-1. Using multiplexed genome editing, we hope to generate mutant combinations lacking multiple sdg genes to reveal their function(s).

      We agree that given the recent discovery of many components of germ granules, our imaging data does not have sufficient resolution to discriminate between them. We have modified our statements and our model regarding the colocalization of SDG-1 with Z-granules to indicate that the overlapping enrichment of SDG-1 and ZNFX-1 in the perinuclear region is consistent with interactions with other nearby granule components.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      Major

      (1) As presented, the manuscript is almost two manuscripts combined into one. This point is highlighted in Figure 7h, which basically presents two separate models. The key questions addressed in the manuscript starts at Figure 3. Figures 1 and 2 are interesting observations but require more experiments to define further. For example, as the Results text describes for Figure 1, "These differences in the entry of ingested dsRNA into cells and/or subsequent silencing could be driven by a variety of changes during development. These include changes in the uptake of dsRNA into the intestine, distribution of dsRNA to other tissues from the intestine, import of dsRNA into the germline, and availability of RNA silencing factors within the germline." Presenting these (reasonable) mechanistic ideas detracted from the heritable RNA epigenetic mechanism explored in the later portion of the manuscript. There are many ways to address this issue, one being moving Figures 1 and 2 to the Supplement to focus on SID-1 related pathways.

      Since this manuscript addresses the interaction between intercellular transport of dsRNA and heritable epigenetic changes, it was necessary to establish the possible route(s) that dsRNA could take to the germline before any inference could be made regarding heritable epigenetic changes. As suggested below (pt. 2), we have now moved the alternatives we enumerated as possible explanations for some experimental results (e.g., for the differences quoted here) to the discussion section.

      (2) The manuscript includes detailed potential interpretations in the Results, making them seem like claims. Here is an example:

      "Thus, one possibility suggested by these observations is that reduction of sdg-1 RNA via SID-1 alters the amount of SDG-1 protein, which could interact with components of germ granules to mediate RNA regulation within the germline of wild-type animals."

      This mechanism is a possibility, but placing these ideas in the citable results makes it seem like an overinterpretation of imaging data. This text and others should be in the Discussion, where speculation is encouraged. Results sections like this example and others should be moved to the discussion.

      We have rephrased motivating connections between experiments like the one quoted above and also moved such text to the discussion section wherever possible.

      (3) A paragraph describing the SDG proteins will be helpful. Homologs? Conserved protein domains? mRNA and/or protein expression pattern across worm, not just the germline? Conservation across Caenorhabditis sp? These descriptions may help establish context why SDG-1 localizes to Z-granules.

      We have now added information about the conservation of the sdg-1 gene in the manuscript. AlphaFold predicts domains with low confidence for the SDG-1 protein, consistent with the lack of conservation of this protein (AlphaFold requires multiple sequence alignments to predict confidently). In the adult animal, the SDG-1 protein was only detectable in the germline. Future work focused on SDG-1, SDG-2 and other SDG proteins will further examine possible expression in other tissues and functional domains if any. Unfortunately, in multiple attempts of single-molecule FISH experiments using probes against the sdg-1 open reading frame, we were unable to detect a specific signal above background (data not shown). Additional experiments are needed for the sensitive detection of sdg-1 expression outside the germline, if any.  

      (4) Based on the images shown, SDG-1 could be in other nearby granules, such as P granules or mutator foci. Additional imaging controls to rule out these granules/condensates will greatly strengthen the argument that SDG-1 protein localizes to Z-granules specifically.

      We have modified the final model to indicate that the perinuclear colocalization is with germ granules broadly and we agree that we do not have the resolution to claim that the observed overlap of SDG-1::mCherry with GFP::ZNFX-1 that we detect using Airyscan microscopy is specifically with Z granules. Our initial emphasis of Z-granule was based on the prior report of SDG-1 being co-immunoprecipitated with the Z-granule surface protein PID-2/ZSP-1. However, through other work predicting possible direct interactions using AlphaFold (Lalit and Jose, bioRxiv, 2024), we were unable to detect any direct interactions between PID-2 and SDG-1. Indeed, many additional granules have been recently reported (Chen et al., Nat. Commun., 2024; Huang et al., bioRxiv 2024), making it possible that SDG-1 has specific interactions with a component of one of the other granules (P, Z, M, S, E, or D) or adjacent P bodies.

      Minor

      (1) "This entry into the cytosol is distinct from and can follow the uptake of dsRNA into cells, which can rely on other receptors." Awkard sentence. Please revise.

      We have now revised this sentence to read “This entry into the cytosol is distinct from the uptake of dsRNA into cells, which can rely on other receptors”

      (2) Presumably, the dsRNA percent of the in vitro transcribed RNA is different than the 50 bp oligos that can be reliably annealed by heating and cooling. Other RNA secondary structure possibilities warrant further discussion.

      We agree that in vitro transcribed RNA could include a variety of undefined secondary structures in addition to dsRNAs of mixed length. Such structures could recruit or titrate away RNA-binding proteins in addition to the dsRNA structures engaging the canonical RNAi pathway, resulting in mixed mechanisms of silencing. Future work identifying such structures and exploring their impact on the efficacy of RNAi could be informative. We have now added these considerations to the discussion and thank the reviewer for highlighting these possibilities.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This is a potentially interesting study regarding the role of gasdesmin D in experimental psoriasis. The study contains useful data from murine models of skin inflammation, however the main claims (on neutrophil pyroptosis) are incompletely supported in its current form and require additional experimental support to justify the conclusions made.

      We sincerely appreciate the positive assessment regarding the significance of our study, as well as the valuable suggestions provided by the reviewers. We have included new data, further discussions and clarifications in the revised manuscript to adequately address all the concerns raised by the reviewers and better support our conclusions.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this study, Liu, Jiang, Diao et.al. investigated the role of GSDMD in psoriasis-like skin inflammation in mice. The authors have used full-body GSDMD knock-out mice and Gsdm floxed mice crossed with the S100A8- Cre. In both mice, the deficiency of GSDMD ameliorated the skin phenotype induced by the imiquimod. The authors also analyzed RNA sequencing data from the psoriatic patients to show an elevated expression of GSDMD in the psoriatic skin.

      Overall, this is a potentially interesting study, however, the manuscript in its current format is not completely a novel study.

      Strengths:

      It has the potential to unravel the new role of neutrophils.

      Weaknesses:

      The main claims are only partially supported and have scope to improve

      We thank the reviewer for the positive evaluation of the interest and potential of our work. In response to reviewers’ suggestions, we have added new content, including additional data and discussions, to further demonstrate the important role of GSDMD-mediated neutrophil pyroptosis in the pathogenesis of psoriasis, thereby enhancing the completeness of our research.

      Reviewer #2 (Public review):

      Summary:

      The authors describe elevated GSDMD expression in psoriatic skin, and knock-out of GSDMD abrogates psoriasis-like inflammation.

      Strengths:

      The study is well conducted with transgenic mouse models. Using mouse-models with GSDMD knock-out showing abrogating inflammation, as well as GSDMD fl/fl mice without neutrophils having a reduced phenotype.

      I fear that some of the conclusions cannot be drawn by the suggested experiments. My major concern would be the involvement of other inflammasome and GSDMD bearing cell types, esp. Keratinocytes (KC), which could be an explanation why the experiments in Fig 4 still show inflammation.

      Weaknesses:

      The experiments do not entirely support the conclusions towards neutrophils.

      We appreciate the reviewers’ positive evaluation regarding the application of our mouse models. We also thank the reviewers for insightful comments and suggestions that can improve the quality of our work. Addressing these issues has significantly strengthened our conclusions. Our responses to the above questions are as follows.

      Specific questions/comments:

      Fig 1b: mainly in KC and Neutrophils?

      In Figure 1b, we observed that GSDMD expression is higher in the psoriasis patient tissues compared to control samples. As the role of GSDMD in keratinocytes during the pathogenesis of psoriasis has already been explored[1], we focused our study on GSDMD in neutrophils. In response to the comments, we have added co-staining results of the neutrophil marker CD66b and GSDMD in the revised manuscript (see new Figure 3b in the revised manuscript). This addition further substantiates the expression of GSDMD in neutrophils within psoriasis tissue.

      Fig 2a: PASI includes erythema, scaling, thickness and area. Guess area could be trick, esp. in an artificial induced IMQ model (WT) vs. the knock-out mice.

      In our model, to accurately assess the disease condition in mice, we standardized the drug treatment area on the dorsal side (2*3 cm). Therefore, the area was not factored into the scoring process, and we have included a detailed description of this in the revised manuscript.

      Fig 2d: interesting finding. I thought that CASP-1 is cleaving GSDMD. Why would it be downregulated?

      Regarding the downregulation of CASP in GSDMD KO mouse skin tissue, existing studies indicate that GSDMD generates a feed-forward amplification cascade via the mitochondria-STING-Caspase axis [2]. We hypothesize that the absence of GSDMD attenuates STING signaling’s activation of Caspase.

      Line 313: as mentioned before (see Fig 1b). KC also show a stron GSDMD staining positivity and are known producers of IL-1b and inflammasome activation. Guess here the relevance of KC in the whole model needs to be evaluated.

      Our research primarily focuses on the role of neutrophil pyroptosis in psoriasis, this does not conflict with existing reports indicating that KC cell pyroptosis also contributes to disease progression[1]. Both studies underscore the significant role of GSDMD-mediated pyroptotic signaling in psoriasis, and the consistent involvement of KC cells and neutrophils further emphasizes the potential therapeutic value of targeting GSDMD signaling in psoriasis treatment. We have expanded upon this discussion in the revised manuscript.

      Fig 4i - guess here the conclusion would be that neutrophils are important for the pathogenesis in the IMQ model, which is true. This experiment does not support that this is done by pyroptosis.

      To address the question, we analyzed the publicly available single-cell transcriptomic data (GSE165021) and found that, compared to the control group, neutrophils infiltrating in IMQ-induced psoriasis-like tissue display a higher expression of pyroptosis-related genes (see new Figure 3e in the revised manuscript). These results strengthen our conclusions about the role of neutrophil pyroptosis in the progression of psoriasis.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Specific Comments:

      • Figure 1: Micro abscesses would already be dead, which would likely reflect as non-specific staining. Authors should consider double staining (e.g., GSDMD+Ly6G).

      We thank the reviewer for the useful suggestion. We have added co-staining results of the neutrophil marker CD66b and GSDMD in the revised manuscript (see new Figure 3b in the revised manuscript). This addition further substantiates the expression of GSDMD in neutrophils within psoriasis tissue.

      • Figures 1 b, c, and d do not have the n number for representative experiments and images.

      We apologize for our oversight. We have added the relevant information in the revised manuscript and have reviewed and corrected the entire text.

      • What is the difference between psoriasis patients in Figure 1 versus Figure 3 as the staining patterns are different? It is difficult to interpret from Figure 1 that expression is limited to neutrophils. Authors should consider double staining (e.g., GSDMD+Ly6G). How many samples were stained to draw this conclusion?

      We thank the reviewer for the suggestion. In Figure 1b, we observed that GSDMD expression is higher in the psoriasis patient tissues compared to control samples. We have added co-staining results of the neutrophil marker CD66b and GSDMD in the revised manuscript (see new Figure 3b in the revised manuscript). For each staining group, we examined samples from 3-5 patients to draw the conclusion.

      • Figure 2: GSDMD deficiency mitigates psoriasis-like inflammation in mice has been shown before (PMID#37673869). The paper showed that the GSDMD was mainly expressed in keratinocytes. What is the view of the authors on it and how does this data correlate with the data presented in this manuscript by the authors?

      Consistent with previous studies[1], we observed increased expression of pyroptosis-related proteins in psoriatic lesions. However, our research focused specifically on the role of neutrophil pyroptosis in psoriasis, this does not conflict with existing reports indicating that KC cell pyroptosis also contributes to disease progression. Both studies underscore the significant role of GSDMD-mediated pyroptotic signaling in psoriasis, and the consistent involvement of KC cells and neutrophils further emphasizes the potential therapeutic value of targeting GSDMD signaling in psoriasis treatment. We have expanded upon this discussion in the revised manuscript.

      • Figure 3d: It is unclear if the IF shows an epidermal or dermal area. As shown by authors in other figures (human psoriatic skin), do authors observe more GSDMD in the micro abscess, which is localized in the epidermis? The authors should also show the staining of GSDM/Ly6G in the whole skin sample.

      The region we presented for immunofluorescence staining corresponds to the dermis of the mice, as we did not observe typical neutrophil micro abscesses similar to those in human psoriasis in the epidermis of IMQ-induced classical psoriasis vulgaris (PV) model. Therefore, we have only shown the staining in the dermal area.

      • Figure 3e: PI staining also represents necrotic cells and TUNEL staining would not represent just apoptotic cells. It is unclear how the authors conclude an ongoing pyroptosis in neutrophils. A robust dataset is needed to provide evidence supporting neutrophil pyroptosis in the IMQ-challenged mice.

      We thank the reviewer for the valuable suggestion. GSDMD is the effector protein of pyroptosis. To further confirm that cells are undergoing pyroptosis, it is necessary to morphologically stain the GSDMD N-terminal protein. Although there is currently no GSDMD N-terminal fluorescent antibody available, we detected the cleaved N-terminus of GSDMD by WB in mouse psoriasis-like skin tissue, and its increased expression suggested increased cell pyroptosis (see new Figure 1d in the revised manuscript). Moreover, we analyzed the publicly available single-cell transcriptomic data (GSE165021) and found that, compared to the control group, neutrophils infiltrating in IMQ-induced psoriasis-like tissue display a higher expression of pyroptosis-related genes (see new Figure 3e in the revised manuscript). These results strengthen our conclusions about the role of neutrophil pyroptosis in the progression of psoriasis.

      • Figure 4: The authors did not clarify the reason for choosing D4 over the usual D7 for the imiquimod experiment. S100A8-Cre is also reported in monocytes and granulocytes/monocyte progenitors. And, the authors also show the expression in macrophages and neutrophils, but in the text, only neutrophils are mentioned. The authors should state the results in the text as well to avoid misrepresentation of the data.

      We thank the reviewer for the useful suggestion. We have repeated many times of experiments in our previous studies and observed that the IMQ-induced mouse psoriasis model showed the obvious signs of self-resolution after Day 4 even with continuing topical IMQ application, thus we chose 4 days over 7 days for the imiquimod experiment, which are consistent with many other studies[3, 4].

      Many studies use S100A8-Cre mice for neutrophil-specific gene knockout[5, 6]. Moreover, we used Ly6G antibody to eliminate neutrophils in GSDMD-cKO mice and control mice. It was found that the difference in lesions between the two groups was abolished after neutrophil depletion, indicating that neutrophil pyroptosis plays an important role in the pathogenesis of imiquimod-induced psoriasis-like lesions in mice. As the database analysis results showed that macrophages have slight expression of S100a8, according to the suggestion of the reviewer, we have added a more precise description in the revised manuscript.

      • Figure S2a: Ly6G antibody reduced the ly6G positive, but also negative cells compared to PBS. If this is correct, what is the explanation, and how this observation has been considered for concluding results?

      Neutrophils play an important role in regulating inflammatory responses, and their deletion can reduce the overall inflammatory level in the body, which also results in a decrease in other non-neutrophil cells. However, this change does not affect our conclusions. Our results show that after the deletion of neutrophils, there is no difference in the pathological manifestations between the cKO group and the control group. This further that GSDMD in neutrophil plays an important role in the pathogenesis of miquimod-induced psoriasis-like lesions in mice.

      • The conclusion in Figure 4i is incorrect as Ly6G administration had an effect on the wt, so it shows neutrophils play a role, but not neutrophil pyroptosis.

      - 321 "It was found that the difference in lesions between the

      - 321 two groups was abolished after neutrophil depletion (Fig4i, S2a), indicating that

      - 322 neutrophil pyroptosis plays an important role in the pathogenesis of

      - 323 imiquimod-induced psoriasis-like lesions in mice"

      Our results show that after the deletion of neutrophils, there is no difference in the pathological manifestations between the cKO group and the control group. This further indicates that the lower disease scores observed in cKO mice, in the absence of neutrophil deletion, depend on the presence of neutrophils. In the revised manuscript, we have changed the statement to “It was found that the difference in lesions between the two groups was abolished after neutrophil depletion (Fig4i, S2a), indicating that GSDMD in neutrophil plays an important role in the pathogenesis of miquimod-induced psoriasis-like lesions in mice”

      • The effect of LyG Ab: reduced PASI in the wt, but the effect on the ko remains the same. What are the other molecular changes observed? What was the level of neutrophils in the wt and the S1A008Cre GsdmDfl/fl mice under steady state and how are they change upon imiquimod challenge? A complete profiling of the immune cells is needed for all the experiments.

      As demonstrated by the results, the deletion of neutrophils did not significantly alter the pathological phenotype of cKO mice. We believe that this outcome precisely highlights the crucial role of GSDMD in regulating neutrophil inflammatory responses.

      • Figure S2b: The authors conclude that Il-1b in the imiquimod skin is mainly expressed by neutrophils, but the analysis presented in the figure does not support this conclusion. Both neutrophils and macrophages are majorly positive for I1-b, with some expression on Langerhans and fibroblasts. No n numbers are provided for the experiment

      As we discussed in the manuscript, we speculate that neutrophil pyroptosis may release cytokines, which in turn activate other cells to secrete cytokines, forming a complex inflammatory network in psoriasis. This may suggest that neutrophil pyroptosis may be involved in the pathogenesis of psoriasis by affecting the secretion of cytokines such as IL-1B and IL-6 by neutrophils, thereby affecting the function of other immune cells such as T cells and macrophages.

      We have added the n number in the revised manuscript.

      • For clarity and transparency, a list of antibodies with the associate clone and catalogue number should be provided or integrated into the method text.

      We thank the reviewer for the useful suggestion. We have added the associate clone and catalogue number of antibodies used in the method text of revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      Fig 3b: psoriasis and pustular psoriasis have a different pathophysiology (autoimmune vs. autoinflammatory). Neutrophils are centrally important for GPP for the cleavage of IL-36. Guess as not further referred to pustular psoriasis in the paper, that comparison is rather deviating from the story.

      In Figure 3b, we stained for GSDMD and CD66b in both plaque psoriasis (PV) and generalized pustular psoriasis (GPP), not to compare the expression differences between the two types of psoriasis, but rather to demonstrate that significant GSDMD expression is present in neutrophils in different types of psoriasis. Unfortunately, due to the lack of a well-established animal model for GPP, we were only able to conduct studies using the established PV animal model. We acknowledge this limitation in our research. In our revised manuscript, we have added the following explanation in the discussion section: “Although we observed significantly increased GSDMD in neutrophils in pustular psoriasis, we were constrained to studying the established PV animal model due to the current absence of a mature GPP animal model. This represents a limitation of our study.”

      In summary, we appreciate the Reviewer’s comments and suggestions. We feel that the inclusion of new data addresses the concerns in a comprehensive manner and adds further support to our original conclusions. We hope you will now consider the revised manuscript worthy of publication in eLife.

      References:

      (1) Lian, N., et al., Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis. Cell Death & Disease, 2023. 14(9): p. 595.

      (2) Han, J., et al., GSDMD (gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification cascade via mitochondria-STING (stimulator of interferon genes) axis. Hypertension, 2022. 79(11): p. 2505-2518.

      (3) Lin, H., et al., Forsythoside A alleviates imiquimod-induced psoriasis-like dermatitis in mice by regulating Th17 cells and IL-17a expression. Journal of Personalized Medicine, 2022. 12(1): p. 62.

      (4) Emami, Z., et al., Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod‐Induced Psoriasis Model. Mediators of Inflammation, 2024. 2024(1): p. 5821996.

      (5) Stackowicz, J., et al., Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome. Journal of Experimental Medicine, 2021. 218(10): p. e20201466.

      (6) Abram, C.L., et al., Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity, 2013. 38(3): p. 489-501.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Fuchs describes a novel method of enzymatic protein-protein conjugation using the enzyme Connectase. The author is able to make this process irreversible by screening different Connectase recognition sites to find an alternative sequence that is also accepted by the enzyme. They are then able to selectively render the byproduct of the reaction inactive, preventing the reverse reaction, and add the desired conjugate with the alternative recognition sequence to achieve near-complete conversion. I agree with the authors that this novel enzymatic protein fusion method has several applications in the field of bioconjugation, ranging from biophysical assay conduction to therapeutic development. Previously the author has published on the discovery of the Connectase enzymes and has shown its utility in tagging proteins and detecting them by in-gel fluorescence. They now extend their work to include the application of Connectase in creating protein-protein fusions, antibody-protein conjugates, and cyclic/polymerized proteins. As mentioned by the author, enzymatic protein conjugation methods can provide several benefits over other non-specific and click chemistry labeling methods. Connectase specifically can provide some benefits over the more widely used Sortase, depending on the nature of the species that is desired to be conjugated. However, due to a similar lengthy sequence between conjugation partners, the method described in this paper does not provide clear benefits over the existing SpyTag-SpyCatcher conjugation system.  Additionally, specific disadvantages of the method described are not thoroughly investigated, such as difficulty in purifying and separating the desired product from the multiple proteins used. Overall, this method provides a novel, reproducible way to enzymatically create protein-protein conjugates.

      The manuscript is well-written and will be of interest to those who are specifically working on chemical protein modifications and bioconjugation.

      Reviewer #2 (Public review):

      Summary:

      Unlike previous traditional protein fusion protocols, the author claims their proposed new method is fast, simple, specific, reversible, and results in a complete 1:1 fusion. A multi-disciplinary approach from cloning and purification, biochemical analyses, and proteomic mass spec confirmation revealed fusion products were achieved.

      Strengths:

      The author provides convincing evidence that an alternative to traditional protein fusion synthesis is more efficient with 100% yields using connectase. The author optimized the protocol's efficiency with assays replacing a single amino acid and identification of a proline aminopeptidase, Bacilius coagulans (BcPAP), as a usable enzyme to use in the fusion reaction. Multiple examples including Ubiquitin, GST, and antibody fusion/conjugations reveal how this method can be applied to a diverse range of biological processes.

      Weaknesses:

      Though the ~100% ligation efficiency is an advancement, the long recognition linker may be the biggest drawback. For large native proteins that are challenging/cannot be synthesized and require multiple connectase ligation reactions to yield a complete continuous product, the multiple interruptions with long linkers will likely interfere with protein folding, resulting in non-native protein structures. This method will be a good alternative to traditional approaches as the author mentioned but limited to generating epitope/peptide/protein tagged proteins, and not for synthetic protein biology aimed at examining native/endogenous protein function in vitro.

      I would like to sincerely thank both reviewers for their insightful and constructive feedback on the manuscript. I have addressed reviewer #1’s comments below:

      (1) The benefits over the SpyTag-SpyCatcher system. Here, the conjugation partners are fused via the 12.3 kDa SpyCatcher protein, which is considerably larger than the Connectase fusion sequence (20 aa). This is briefly mentioned in the introduction (p. 1 ln 24-25). In a related technology, the SpyTag-SpyCatcher system was split into three components, SpyLigase, SpyTag and KTag  (Fierer et al., PNAS 2014). The resulting method introduces a sequence between the fusion partners (SpyTag (13aa) + KTag (10aa)), which is similar in length to the Connectase fusion sequence. I mention this method in the discussion (p. 8, ln 296 - 297), but preferred not to comment on its efficiency. It appears to require more enzyme and longer incubation times, while yielding less fusion product (Fierer et al., Figure 2).

      (2) Purification of the fusion product. The method is actually advantageous in this respect, as described in the discussion (p. 8, ln 257-263). I plan to add a figure showing an example in the revised article.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      This study presents useful insights into the in vivo dynamics of insulin-producing cells (IPCs), key cells regulating energy homeostasis across the animal kingdom. The authors provide compelling evidence using adult Drosophila melanogaster that IPCs, unlike neighboring DH44 cells, do not respond to glucose directly, but that glucose can indirectly regulate IPC activity after ingestion supporting an incretin-like mechanism in flies, similar to mammals. The authors link the decreased activity of IPCs to hyperactivity observed in starved flies, a locomotive behavior aimed at increasing food search. 

      Furthermore, there is supporting evidence in the paper that IPCs receive inhibitory inputs from Dh44 neurons, which are linked to increased locomotor activity. However, although the electrophysiological data underlying the dynamics of IPCs in vivo is compelling, the link between IPCs and other potential elements of the circuitry (e.g. octopaminergic neurons) regulating locomotive behaviors is not clear and would benefit from more rigorous approaches. 

      This paper is of interest to cell biologists and electrophysiologists, and in particular to scientists aiming to understand circuit dynamics pertaining to internal state-linked behaviors competing with the feeding state, shown here to be primarily controlled by the IPCs. 

      Strengths: 

      (1) By using whole-cell patch clamp recording, the authors convincingly showed the activity pattern of IPCs and neighboring DH44 neurons under different feeding states. 

      (2) The paper provides compelling evidence that IPCs are not directly and acutely activated by glucose, but rather through a post-ingestive incretin-like mechanism. In addition, the authors show that Dh44 neurons located adjacent to the IPCs respond to bath application of glucose contrary to the IPCs. 

      (3) The paper provides useful data on the firing pattern of 2 key cell populations regulating foodrelated brain function and behavior, IPCs and Dh44 neurons, results which are useful to understand their in vivo function. 

      Weaknesses: 

      (1) The term nutritional state generally refers to the nutrients which are beneficial to the animal. In Figure 1, the authors showed that IPCs respond to glucose but not proteins. To validate the term nutritional state the authors could test the effect of a non-nutritive sugar (e.g. D-arabinose or L-Glucose) on the post-ingestive physiological responses of the IPCs.

      We thank the referee for this insightful comment. Following their suggestion, we included two new experimental data sets, which we added to Figure 1: We show that IPCs do not respond to the non-nutritive sugar D-arabinose (Figure 1H). In order to further expand this data set and our conclusions, we additionally show that IPCs do respond to fructose – a second nutritive sugar in addition to glucose (Figure 1H). Together, these data sets permit the conclusion that IPCs are sensitive to the ingestion of nutritive sugars, and do not respond to ingestion of nonnutritive sugars or high protein diets. Thus, we validate the term nutritional state.

      (2) It is difficult to grasp the main message from the figures in the result section as some figures have several results subsections referring to different points the authors want to make. The key results of a figure will be easier to understand if they are summarized in one section of the results. Alternatively, a figure can be split into 2 figures if there are several key messages in those figures, e.g. Figures 2 and 3.  

      We appreciate this suggestion and have made several changes to our manuscript to add more clarity. Among other things, we have changed the order of data presentation in Figure 2, as suggested by the referee below, where we now start with the IPC activation data rather than the OAN activation. We also swapped the order of data presentation and split Figure S1 into Figures S1 & S2. Moreover, we re-arranged the panel order in supplementary figure S4. This significantly improved the flow of the results section. Since the figures the referee refers to contain comparative data, for example between diets (Figure 1) or neuron types (Figure 2), we prefer to keep these data sets together. However, we have carefully revised the results section to more clearly relate our statements to individual figure panels.

      (3) The prime investigation of the paper is about the physiological response and locomotive behavioral readout linked to IPCs. The authors do not show a link between OANs and IPCs in terms of functional or behavioral readouts. In Figure 2 the authors first start with stating a link between OAN neurons and locomotion changes resulting from internal feeding states. The flow of the paper would be better if the authors focused on the effect of optogenetic activation of IPCs under different feeding states and their impact on fly locomotion. If the experiments done on optogenetic activation of OANs were to validate the experimental approach the data on OAN neurons is better suited for the supplement without the need of a subsection in the result section on the OANs.  

      We agree with the reviewer’s suggestion and switched the order of the figure panels and text to aid the flow of the manuscript. We now show and discuss the IPC activation data first (Figure 2C-H) and OAN activation afterwards (Figure 2I-K). We did keep the OAN data in the main document, though, since that facilitates comparisons between the small effects of IPC activation and the large, well-established effects of OAN activation.

      (4) Figure 2F shows that optogenetic activation of IPCs in fed flies does not influence their locomotor output. In the text, the conclusion linked to Figure 2F-H states that IPC activation reduces starvation-induced hyperactivity which is a statement more suited to Figure 2I-K. 

      We edited the text accordingly.

      (5) The authors show activation of Dh44 neurons leads to hyperpolarisation of the IPCs. What is the functional link between non-PI Dh44 neurons and the IPCs? Do IPCs express DH44R or is DH44 required for this effect on IPCs? Investigating a potential synaptic or peptidergic link between DH44 neurons and IPCs and its effect on behavior would benefit the paper, as it is so far not well connected. 

      Although we have not performed any experiments dedicated to investigating the functional link between DH44Ns outside the PI and the IPCs in this study, there are two lines of evidence supporting that this connection is relatively direct. First, IPCs do express DH44R1 & R2, as we show in a parallel study in eLife (Held M, et al. ‘Aminergic and peptidergic modulation of Insulin-Producing Cells in Drosophila’. eLife. 2024;13. doi:10.7554/ELIFE.99548.1). Second, we performed functional connectivity experiments using a Leucokinin (LK) driver line in that paper. This driver line labels two pairs of non-PI DH44Ns in the VNC, which are DH44 and LK positive (Zandawala et al 2018). Activating that line leads to inhibition of IPCs, similar to the effect we observed here for DH44N activation. These two lines of evidence suggest that there could be a direct peptidergic connection between DH44+ neurons and IPCs. We have added a paragraph mentioning these experiments to our discussion:

      ‘Notably, the DH44<sup>PI</sup>Ns express the DH44 peptide, as confirmed by anti-DH44 stainings(100). This also applies to a large fraction of neurons labelled in the broad DH44 driver line(100). However, a subset of neurons labelled in the broad line did not exhibit DH44 immunoreactivity(100), and might therefore not actually express the DH44 peptide. Hence, the inhibition of IPCs could be driven by neurons in the DH44 driver line that do not express DH44. A strong candidate for the inhibition are LK and DH44-positive neurons, which are labelled by the broad line(76). In a parallel study, we showed that LK-expressing neurons strongly inhibit IPCs(30), similar to the broad DH44 line used here. Furthermore, evidence from single-nucleus transcriptomic analysis shows that IPCs express DH44-R1 and DH44-R2 receptors(30). Therefore, it is possible that DH44Ns communicate with IPCs through a direct peptidergic connection. Notably, the inhibitory effect of non-PI DH44Ns on IPCs was very strong and fast, suggesting that a connection via classical synapses is more likely. Regardless, our results show that the glucose sensing DH44<sup>PI</sup>Ns and IPCs act independently of each other.’

      Reviewer #2 (Public Review): 

      Summary: 

      In this study, Bisen et al. characterized the state-dependency of insulin-producing cells in the brain of *Drosophila melanogaster*. They successfully established that IPC activity is modulated by the nutritional state and age of the animal. Interestingly, they demonstrate that IPCs respond to the ingestion of glucose, rather than to perfusion with it, an observation reminiscent of the incretin effect in mammals. The study is well conducted and presented and the experimental data convincingly support the claims made. 

      Strengths: 

      The study makes great use of the tools available in *Drosophila* research, demonstrating the effect that starvation and subsequent refeeding have on the physiological activity of IPCs as well as on the behavior of flies to then establish causal links by making use of optogenetic tools. 

      It is particularly nice to see how the authors put their findings in context to published research and use for example TDC2 neuron activation or DH44 activity to establish baselines to relate their data to. 

      Weaknesses: 

      I find the inability of SD to rescue the IPC starvation effect in Figure 1G&H surprising, given that the fully fed flies were raised and kept on that exact diet. Did the authors try to refeed flies with SD for longer than 24 hours? I understand that at some point the age effect would also kick in and counteract potential IPC activity rescue. I think the manuscript would benefit if the authors could indicate the exact age of the SD refed flies and expand a bit on the discussion of that point.  

      We have expanded the first paragraph of our discussion to tackle these questions, in particular the potential effect of aging, as suggested by the referee. We now also indicate the exact age of the flies. Moreover, we have conducted additional experiments in which we added either glucose or arabinose to our standard diet (Figure 1H). As we would have expected based on our hypothesis that the glucose concentration in our standard diet was too low to cause an increase in IPC activity after starvation, we find that feeding standard diet plus glucose increases IPC activity to the same level as glucose only, and that adding arabinose to the standard diet does not lead to increased IPC activity after starvation (Figure 1H).

      The incretin-like effect is exciting and it will be interesting in the future to find out what might be the signal mediating this effect. It is interesting that IPCs in explants seem to be responsive to glucose. I think it would help if the authors could briefly discuss possible sources for the different findings between these in fact very different preparations. Could the the absence of the inhibitory DH44 feedback in the *ex-vivo* recordings for example play a role? 

      We thank the referee for this interesting point and expanded our discussion accordingly. We included that, in particular in brain explants without a VNC, the inhibitory connection we describe might be absent, as the referee suggested: ‘Previous ex vivo studies suggested that IPCs, like pancreatic beta cells, sense glucose cell-autonomously(23,24). Consistent with this, we observed an increase in IPC activity after the ingestion of glucose (Figure 2B). However, IPC activity did not increase during the perfusion of glucose directly over the brain. Importantly, the fly preparations were kept alive for several hours allowing the glucose-rich saline to enter circulation and reach all body parts. Several factors may explain the difference between ex vivo and in vivo preparations. First, in ex vivo studies, certain regulatory feedback mechanisms present in vivo could be absent. For example, the strong inhibitory input IPCs receive from DH44Ns we found would likely be absent in brain explants without a VNC. A lack of inhibitory feedback might allow for more direct glucose sensing by IPCs ex vivo, whereas in vivo, the IPC response could be suppressed by more complex systemic feedback. Second, we attempted to use the intracellular saline formulation employed in a previous ex vivo study44. However, we observed that IPCs depolarized quickly using this saline, leading to unstable recordings that did not meet our quality standards for in vivo experiments. Another possible explanation for the lack of an effect of glucose might have been that the dominant circulating sugar in flies is trehalose(70,71) which is derived from glucose. When we extended our experiments, we found that trehalose perfusion did not affect IPC activity either, strengthening the idea that IPCs do not directly sense changes in hemolymph sugar levels. Therefore, our findings suggest that, similar to mammals, IPC activity and hence, insulin release, is not simply modulated by hemolymph sugar concentration in Drosophila.’ 

      The incretin-like effect the authors observed seems to start only after 5h which seems longer than in mammals where, as far as I know, insulin peaks around 1h. Do the authors have ideas on how this timescale relates to ingestion and glucose dynamics in flies? 

      We have now included the following section in the discussion to explicitly address the question of different activity dynamics in flies and mammals, but also the limitations of our electrophysiological approach in this regard: ‘We observed that IPC activity increased over a timescale of hours, which is longer compared to the fast insulin response in mammals, where insulin typically peaks within an hour of feeding(97). In flies, insulin levels rise within minutes of refeeding, followed by a drop after 30 min(20). Our experimental techniques limit our ability to capture these fast initial dynamics, since the preparation for intracellular recordings requires tens of minutes, so that we typically recorded IPC activity at least 20 min after the last food ingestion. Notably, studies in fasted mammals have shown that insulin peaks within minutes of refeeding, followed by a rapid decline, with levels stabilizing as feeding continues(98,99). We speculate a similar dynamic could be present in flies, but with our approach, we capture the steady-state reached tens of minutes after food ingestion rather than a potential initial peak.’ 

      The authors mention "a decrease in the FV of IPC-activated starved flies even before the first optogenetic stimulation (Figure 2I),". Could this be addressed by running an experiment in darkness, only using the IR illumination of their behavioral assay? 

      We thank the referee for pointing out this unexpected result. We discuss this in more detail in the new version of our manuscript and expand on the reasons for not performing these optogenetic activation experiments in the dark: First, the red LED required to activate CsChrimson triggers strong startle responses in dark-adapted flies, which mask other behavioral effects, in particular subtle ones such as those observed for IPCs. The startle response is much reduced when performing experiments under low background light conditions. Second, flies, at least in our hands, do not exhibit robust foraging behavior or starvation-induced hyperactivity in the dark, which is critical for our behavioral experiments. However, we also explain in our discussion that we believe the effect of background illumination is relatively small, since flies expressing CsChrimson in OANs or DH44Ns show comparable activity levels to controls. Hence, a part of this effect is likely attributable to leak currents induced by CsChrimson expression. We would like to point out though that we are careful in our description of the IPC effect on behavior, and focus on the fact that it is considerably smaller than the effects of other modulatory neurons (DH44Ns and OANs).

      The authors show an inhibitory effect of DH44 neuron activation on IPC activity. They further demonstrate that DH44PI neurons are not the ones driving this and thus conclude that "...IPCs are inhibited by DH44Ns outside the PI.". As the authors mentioned the broad expression of the DH44-Gal4 line, can they be sure that the cells labeled outside the PI are actually DH44+? If so they should state this more clearly, if not they should adapt the discussion accordingly.   

      We have substantially added to our discussion of this point, according to the referee’s great suggestion. In short, the broad line includes neurons that are DH44 positive and neurons that are not: ‘Notably, the DH44<sup>PI</sup>Ns express the DH44 peptide, as confirmed by anti-DH44 stainings(100). This also applies to a large fraction of neurons labelled in the broad DH44 driver line(100). However, a subset of neurons labelled in the broad line did not exhibit DH44 immunoreactivity(100), and might therefore not actually express the DH44 peptide. Hence, the inhibition of IPCs could be driven by neurons in the DH44 driver line that do not express DH44.’

      Reviewer #3 (Public Review): 

      Although insulin release is essential in the control of metabolism, adjusted to nutritional state, and plays major roles in normal brain function as well as in aging and disease, our knowledge about the activity of insulin-producing (and releasing) cells (IPCs) in vivo is limited. 

      In this technically demanding study, IPC activity is studied in the Drosophila model system by fine in vivo patch clamp recordings with parallel behavioral analyses and optogenetic manipulation. 

      The data indicate that IPC activity is increased with a slow time course after feeding a high-glucose diet. By contrast, IPC activity is not directly affected by increasing blood glucose levels. This is reminiscent of the incretin effect known from vertebrates and points to a conserved mechanism in insulin production and release upon sugar feeding. 

      Moreover, the data confirm earlier studies that nutritional state strongly affects locomotion. Surprisingly, IPC activity makes only a negligible contribution to this. Instead, other modulatory neurons that are directly sensitive to blood glucose levels strongly affect modulation. Together, these data indicate a network of multiple parallel and interacting neuronal layers to orchestrate the physiological, metabolic, and behavioral responses to nutritional state. Together with the data from a previous study, this work sets the stage to dissect the architecture and function of this network. 

      Strengths: 

      State-of-the-art current clamp in situ patch clamp recordings in behaving animals are a demanding but powerful method to provide novel insight into the interplay of nutritional state, IPC activity, and locomotion. The patch clamp recordings and the parallel behavioral analyses are of high quality, as are the optogenetic manipulations. The data showing that starvation silences IPC activity in young flies (younger than 1 week) are compelling. The evidence for the claim that locomotor activity is not increased upon IPC activity but upon the activity of other blood glucose-sensitive modulatory neurons (Dh44) is strong. The study provides a great system to experimentally dissect the interplay of insulin production and release with metabolism, physiology, and behavior. 

      Weaknesses: 

      Neither the mechanisms underlying the incretin effect, nor the network to orchestrate physiological, metabolic, and behavioral responses to nutritional state have been fully uncovered. Without additional controls, some of the conclusions would require significant downtoning. Controls are required to exclude the possibility that IPCs sense other blood sugars than glucose. The claim that IPC activity is controlled by the nutritional state would require that starvation-induced IPC silencing in young animals can be recovered by feeding a normal diet. At current firing in starvation, silenced IPCs can only be induced by feeding a high-glucose diet that lacks other important ingredients and reduces vitality. Therefore, feasible controls are needed to exclude that diet-induced increases in IPC firing rate are caused by stress rather than nutritional changes in normal ranges. The finding that refeeding starved flies with a standard diet had no effect on IPC activity but a strong effect on the locomotor activity of starved flies contradicts the statement that locomotor activity is affected by the same dietary manipulations that affect IPC activity. The compelling finding that starvation induces IPC firing would benefit from determining the time course of the effect. The finding that IPCs are not active in fed animals older than 1 week is surprising and should be further validated. 

      We thank the referee for the thoughtful and constructive criticism of our experiments and conclusions. Below, we lay out how we tackled the individual points raised by the referee.

      (1) ‘Controls are required to exclude the possibility that IPCs sense other blood sugars than glucose.’  

      To address this point, we conducted experiments in which we perfused trehalose (Figure 3B), the main circulating hemolymph sugar in Drosophila and other insects. Our results clearly show that trehalose does not affect IPC activity upon perfusion, confirming our statements that IPCs do not sense key blood sugars directly.

      (2) ‘Feasible controls are needed to exclude that diet-induced increases in IPC firing rate are caused by stress rather than nutritional changes in normal ranges’. 

      We agree with the referee that this point was not completely fleshed out in our first submission. We have now performed additional experiments in which we added glucose (and fructose) to our standard diet (Figure 1H). Flies feeding on this diet received all necessary nutrients but still experienced high concentrations of sugars. The effects of high glucose in a standard diet background were indistinguishable from those of high glucose in agarose, confirming that the IPCs respond to sugar rather than stress. Another important observation in this context is that IPCs in flies kept on a high protein diet exhibited much lower spike rates than flies exhibiting the high glucose diet, even though they had a much shorter lifespan and therefore, presumably, experienced much higher stress levels (Figure 1H, Figure S1). These observations underline that stress is certainly not the primary factor here.

      (3) ‘The finding that refeeding starved flies with a standard diet had no effect on IPC activity but a strong effect on the locomotor activity of starved flies contradicts the statement that locomotor activity is affected by the same dietary manipulations that affect IPC activity.’

      We have revised the respective section of the results and discussion accordingly and are more careful and clearer in our interpretation of this behavioral dataset: ‘These results show that the locomotor activity was affected by the same dietary manipulations that had strong effects on IPC activity. However, IPC activity changes alone cannot explain the modulation of starvation-induced hyperactivity. On the one hand, high-glucose diets which drove the highest activity in IPCs were not sufficient to reduce locomotor activity back to baseline levels. On the other hand, refeeding flies with SD did not revert the effects of starvation on IPC activity (Figure 1H), but it was sufficient to reduce the locomotor activity below baseline levels (Figure 2B). This suggests that the modulation of starvation-induced hyperactivity is achieved by multiple modulatory systems acting in parallel.’

      (4) ‘The compelling finding that starvation induces IPC firing would benefit from determining the time course of the effect.’

      We followed the referee’s excellent suggestion and determined the time course of the starvation effect in three timesteps, similar to the experiments we did for refeeding (Figure 1G). In addition, we now also quantify the number of active IPCs (i.e., IPCs that fired at least one action potential during our five-minute analysis window), which further illustrates the dynamics of the starvation and refeeding effects. We find that the starvation effect is graded, and that IPC activity decreases with increasing starvation duration.

      (5) ‘The finding that IPCs are not active in fed animals older than 1 week is surprising and should be further validated.’

      To address the referee’s comment, we have added 14 new IPC recordings from flies in the 6–26-day range, such that we now have recordings from 9-14 IPCs for each age range (Figure S2B). They confirmed our previous analysis and strengthened the finding that IPC activity dramatically decreases after 8 days (on our standard diet). The total number of IPCs in this supplementary dataset was thus increased from 34 to 48.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      (1) Do IPCs respond to glucose specifically after ingestion or generally to any other nutritive sugars? To tackle this question the IPC responses in starved flies can be recorded after refeeding flies with other nutritive sugars (fructose, sucrose). 

      To address this important question, we have performed additional experiments in which we refed starved flies with fructose, as a nutritive sugar, and arabinose, as a non-nutritive sugar. As expected, IPCs responded to fructose but not arabinose and hence nutritive sugars in general. We describe and discuss these key results in the new version of our manuscript.

      (2) In Figure 2, the x and y axes are not annotated on all subfigures, which might help improve clarity. 

      We have annotated the subfigures as requested.

      (3) In the discussion on page 9 ("...we observed an increase in IPC activity after the ingestion of glucose (Figure 2B)."), the authors refer to Figure 2B instead of 3C.

      We have fixed this oversight.

      Reviewer #2 (Recommendations For The Authors): 

      Introduction 

      I think it could be helpful for the reader if you would briefly state the number of IPCs and whether you are targeting all of them with Dilp2-Gal4. 

      We included the numbers according to the suggestion. 14 IPCs are labeled in the driver line, and this is the number of IPCs commonly assumed to be present in the PI.

      Figures 

      In some Figures (for example 1D & E) the authors state the number of IPCs recorded (N) but not the number of animals used (n). This should be stated as the data from within an animal are dependent and might give insights about IPC heterogeneity. 

      We have compiled tables for the supplementary material (Tables S5 & S6) in which we state the number of IPCs and DH44<sup>PI</sup>Ns recorded and the number of different flies for each figure panel. We have recorded an average of 1.4 IPCs per fly (217 IPCs from 160 flies). We therefore expect the bias introduced by individual flies to be rather small. However, in our parallel study, we specifically investigate the heterogeneity of IPCs by maximizing the number of IPCs recorded per fly (Held M, et al. ‘Aminergic and peptidergic modulation of Insulin-Producing Cells in Drosophila’. eLife. 2024;13. doi:10.7554/ELIFE.99548.1). In the case of DH44PINs, we recorded 24 neurons in 21 flies – 1.1 neurons per fly.

      - Figure 3D: There is some white visible among the cell bodies in the overlay. I assume this comes from projecting across layers rather than indicating DH44 - IPC overlap? It would help to explicitly state that. 

      We have added a statement to the results section, in which we explain that most of the white is due to overlap in the z-projection rather than overlap in the driver lines. However, there are few cases (typically one to two cells per brain), in which neurons labeled by the DH44 line also stain positive for Dilp2, indicating they express both neuropeptides. We have added this information to the manuscript:  

      Results: ‘DH44<sup>PI</sup>Ns are anatomically similar to IPCs, and their cell bodies are located directly adjacent to those of IPCs in the PI, making them an ideal positive control for our experiments (Figure 3D). A small subset of DH44<sup>PI</sup>Ns also expresses Dilp2(75), and our immunostainings confirmed colocalization of Dilp2 and DH44 in a single neuron (Figure 3D, white arrow).’

      In figure caption: ‘UAS-myr-GFP was expressed under a DH44-GAL4 driver to label DH44 neurons. GFP was enhanced with anti-GFP (green), brain neuropils were stained with anti-nc82 (cyan), and IPCs were labelled using a Dilp2 antibody (magenta). White arrow indicates Dilp2 and DH44-GAL4 positive neuron. The other white regions in the image result from an overlap in z-projections between the two channels, rather than from antibody colocalization.’

      - Figure 4I: One might get the impression that the fast onset peak of activity precedes the stimulation onset, using a thinner line width might help avoid that. 

      This effect is due to a combination of using relatively heavy lines for clear visibility of the data and a gentle smoothing step (a 2s median filter, which corresponds to less than 1% of the 300s stimulation window) in our analysis of the behavioral data. However, inspection of the raw data clearly shows increases in velocity after the onset of the optogenetic activation. We clarified this in the figure caption: ‘Average FV across all DH44N activation trials based on two independent replications of the experiment in I. Note that the peak in average FV lies within the first frame of the stimulation window.’

      - S3 panel letters do not match references in the text.

      We fixed this oversight.

      Formatting 

      - Page 10: The paragraphs on the bottom of the page got switched around.

      This has been fixed.

      - Page 14: The first paragraph after the header "Free-walking assay" seems to be coming from elsewhere. 

      We apologize for this slightly embarrassing mistake. We used our related bioRxiv preprint (Held et al.) as a template for formatting this paper, and accidentally left this part of the methods section in the manuscript. We have fixed this error in our resubmission.

      Reviewer #3 (Recommendations For The Authors): 

      Major suggestions: 

      (1) The data show convincingly that IPC activity is decreased by starvation during the first week of adult life (Figures 1C and D). However, the conclusion that IPC activity is controlled by the nutritional state requires additional care. First, refeeding starved adult animals with a normal diet does not bring back normal IPC firing rates (Figure 1H). Therefore, IPC activity does not strictly follow changes in nutritional state, but IPCs are silenced by starvation. Second, from the second week of adult life on, IPCs are silent anyway, and thus unlikely responsive to changes in the nutritional state anymore (which might be different on a different standard diet?) The only effect of feeding on IPC activity is observed upon feeding starved, young animals with high glucose for 12-24 hrs (Figure 1G). However, it is not clear whether increased IPC firing is caused by the effects of high glucose on the nutritional state in a normal range, or because of diet-induced stress (the diet also severely shortens lifespan, Figure 1S). Does high glucose also increase IPC firing rate in young, fed animals? These would have strongly increased glucose concentrations but not suffer the stress of not getting any other nutrients. Such experiments would be required to make the statement that glucose feeding increases IPC firing rate. 

      We have performed several experiments to address this criticism. First, we performed a time course analysis of the starvation effect. We show that the IPC activity reduction is graded, and that IPC activity declines already after two hours of starvation, a timepoint at which stress levels should still be relatively small (Figure 1G). Second, we refed flies with high glucose concentrations added to the standard diet (Figure 1H). This minimized any potential stress responses due to a lack in nutrients. Third, we now show that IPCs specifically respond to nutritive (glucose and fructose), but not to non-nutritive sugars (arabinose, Figure 1H). We believe that these data sets, in addition to the graded refeeding effect, make a strong case for the nutritional state dependent modulation of IPCs. 

      (2) The testing of locomotor activity is well done, nicely recapitulates starvation-induced increases in locomotion, and adds interesting novel findings on refeeding with high glucose versus high protein diet. However, the statement that locomotor activity was affected by the same dietary manipulations that had strong effects on IPC activity does not reflect the data presented. Refeeding starved flies with a standard diet had no effect on IPC activity (Figure 1H) but a strong effect on locomotor activity of starved flies (a strong reduction, even stronger than high glucose diet, Figure 2B). 

      We have revised the respective section of the results and discussion accordingly and are more careful and clearer in our interpretation of this behavioral dataset: ‘These results show that the locomotor activity was affected by the same dietary manipulations that had strong effects on IPC activity. However, IPC activity changes alone cannot explain the modulation of starvationinduced hyperactivity. On the one hand, high-glucose diets which drove the highest activity in IPCs were not sufficient to reduce locomotor activity back to baseline levels. On the other hand, refeeding flies with SD did not revert the effects of starvation on IPC activity (Figure 1H), but it was sufficient to reduce the locomotor activity below baseline levels (Figure 2B). This suggests that the modulation of starvation-induced hyperactivity is achieved by multiple modulatory systems acting in parallel.’

      Related to points 1 and 2, a key statement that the results establish that IPC activity is controlled by the nutritional state requires care. What the data convincingly show is that IPC activity is near zero upon starvation. 

      As described above, we have added several extensive data sets (fructose feeding, arabinose feeding, trehalose perfusion, starvation time course) to show that we indeed observe a nutritional state dependent modulation of IPCs and describe these new results in the results and discussion.

      (3) The time course of nutritional state-dependent changes of IPC activity is claimed to be slow, several hours to days. Unless I have missed a figure, the underlying data are not presented (only for high glucose diet). It would be great if this could also be shown for a standard diet with higher glucose concentrations than the one used so that it rescues starvation-induced IPC silencing without shortening lifespan (if this is feasible?). The data showing starvation-induced IPC silencing are convincing, but, unless I have missed it, the time course has not been determined. It would be very nice to actually show this. Have different starvation times been tested in relation to IPC firing rate, and if yes, with what time resolution? Does IPC activity change already after 0.5 or 1 or a few hours of starvation? If starvation can silence IPCs faster than assumed, the nearzero IPC activity in animals older than a week could very well be caused by longer time intervals between meals. 

      We have performed experiments to address both important points raised by the referee here. 1) We have added high glucose concentrations to our standard diet, and show that it has the same effect – a significant increase in IPC activity – as the high glucose diet (Figure 1H). 2) We have analyzed the time course of IPC activity reduction in response to starvation (Figure 1G). Indeed, we find that a few hours of starvation start reducing IPC activity. We discuss the possibility that reduced IPC activity in older flies could be due to reduced food intake: ‘One of our experiments demonstrated that IPC activity was heavily diminished in flies older than 10 days (Figure S2B). A possible explanation could be that flies feed less as they age. However, this only holds true for flies older than 14 days86. Therefore, reduced IPC activity in 10-11 day old flies is unlikely to result from reduced food intake and likely involves inhibition of insulin signaling.’

      (4) The data on the proposed incretin effect are of high importance in potentially highlighting a highly conserved link between glucose ingestion and insulin release. An important control would be to test different sugars, such as trehalose, an important blood sugar of flies. If glucose is converted into trehalose and this is what IPCs sense, then perfusion of glucose has no effect. The fact fantastic experiments show that the DH44 neurons are sensitive to glucose perfusion does rule out that IPCs sense a different sugar. This would be very different from the incretin effect that requires additional hormones. In addition, as mentioned above, controls are required to show that high glucose affects IPCs as a nutrient and not as a stressor (see point 1), for example refeeding with a standard diet that contains a higher glucose concentration but does not reduce lifespan. Another great control to solidify the exciting claim on the incretin effect would be to knock out candidate Drosophila incretin hormones and test whether a high glucose diet stops increasing the IPC firing rate (although simpler controls might also do the job). 

      We have performed the two key experiments suggested by the referee. 1) We perfused trehalose as the primary blood sugar of flies and showed that IPCs do not respond to trehalose perfusion (Figure 3B & C). This further strengthens the finding that IPC activity in flies shows an incretin-like effect. 2) We have added high concentrations of glucose to our standard diet to provide flies with a full diet that contains high glucose concentrations. IPC activity in these flies was indistinguishable from the activity in flies which consumed pure glucose diets. In contrast, IPC activity in flies kept on a high protein diet, which dramatically reduced lifespan, was very low. These results clearly show that higher IPC activity is not due to increased stress levels, but a function of nutritive sugar ingestion. We further validated this hypothesis by refeeding flies with fructose as a nutritive sugar, which increased IPC activity, and arabinose as a non-nutritive sugar, which did not affect IPC activity (Figure 1H).

      Another point that might be relevant to this discussion is that IPC activity is almost entirely shut down during flight in Drosophila (which we showed in Liessem et al. 2023, Current Biology 33 (3), 449-463. e5). Several ‘stress hormones’ are released during flight, including octopamine. The fact that IPC activity is low in flying flies, starved flies, and flies kept on a pure protein diet (which all experience high stress levels), to us, very clearly suggests that stress is not the predominant factor here. We would also like to point out that, while the lifespan was reduced in flies kept on pure glucose diets, survival rates were at 100% until day 14, and we carried out our experiments on day 2 after starvation. Hence, these flies might not (yet) experience particularly high stress levels.

      (5) The discussion relates the absence of IPC firing in animals older than 1 week to aging. However, given that the flies fed on a normal diet show the typical lifespan for Drosophila, a 10-dayold fly is still in its youth. Maybe flies at 10 days eat simply less and thus IPC spiking goes down as in starved flies, especially because the standard diet used contains low glucose. Do IPCs also become silent after a week if the animals are fed with a standard diet that contains a higher glucose concentration? Without additional controls, this part of the discussion is pretty speculative and should be revised. 

      We agree with the reviewer, that it is not clear whether reduced IPC activity is a direct result of physiological changes that occur with aging, or an indirect effect of reduced food intake, which occur during aging. In both cases, in our view, it would be an age-related effect. Since this is a minor point of our manuscript, we decided not to perform additional experiments, other than significantly increasing the sample size for the aging data set already presented to shore up our findings (Figure S2B). We have, however, revisited the discussion of this point according to the referee’s suggestion: ‘One of our experiments demonstrated that IPC activity was heavily diminished in flies older than 10 days (Figure S2B). A possible explanation could be that flies feed less as they age. However, this only holds true for flies older than 14 days(85). Therefore, reduced IPC activity in 10-11 day old flies is unlikely to result from reduced food intake and likely involves inhibition of insulin signaling.’

      Other suggestions: 

      (6) For the mixed effects of octopamine and tyramine on larval locomotion that are referred to, it might be interesting to also look at Schützler et al 2019, PNAS because it shows that starvation activates TBH so that the octopamine to tyramine ratio is increased. 

      We refer to Schützler et al. in the following paragraph of our discussion: ‘This intermittent locomotor arrest has been previously described in adult flies and is thought to be mediated by ventral unpaired median OANs, which have been suggested to suppress long-distance foraging behavior(69). Since these are not the only neurons we activate in the TDC2 line, we speculate that the stopping phenotype could also result from concerted effects of octopamine and tyramine modulating muscle contractions(65-67) and motor neuron excitability(68), as previously described in Drosophila larvae, or from OANs interfering with pattern generating networks in the ventral nerve cord (VNC) during longer activation(69).’  

      (7) The reference list requires care. For example, reference 43 is identical to 67, reference 66 gives no information on incretin-like hormones in Drosophila as stated in the text 

      We carefully double-checked our reference list and corrected the mistakes mentioned.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      I have reviewed, with interest, the manuscript "Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast". The described findings are relevant and useful for daily practice in periodontology. The paper is concise, professionally written, and easy to read. In this study, Jiayao et al. revealed the role of miR-335-3p in psychological stress-induced osteoporosis. CUMS mice were constructed to observe the femur phenotype, osteoclasts were identified as the primary research object, and miRNA-seq was used to find the key miRNAs linking the brain and peripheral tissues. This study showed that the expression of miR-335-3p was simultaneously reduced in mice's NAC, serum, and bone under psychological stress. The miR-335-3p/Fos/NFATC1 signaling pathway was validated in osteoclasts to reveal the potential mechanism of enhanced osteoclast activity under psychological stress. From a new perspective of miRNAs, this study indicates a possible cause of disturbed bone metabolism due to psychological stress and may suggest a new approach to treating osteoporosis.

      We thank this reviewer for the instructive suggestions and encouragement.

      Reviewer #2 (Public Review):

      Zhang et al. established chronic unpredictable mild stress (CUMS) mouse model, which displayed osteoporosis phenotype, suggesting a potential correlation between psychological stress and bone metabolism. They found that miRNA candidate miR-335-3p is downregulated in the long bone of CUMS mice through microRNA sequencing and qRT-PCR experiments. They further demonstrated that miR-335-3p attenuates osteoclast activity via inhibiting Fos signaling, which can induce NFATC1 expression and regulate osteoclast activity.

      Strengths:

      The authors established CUMS mouse model and confirmed the osteoporosis phenotype through careful characterization of bone and analysis of osteoclast activity. They performed microRNA sequencing to identify the miRNA candidate regulating the bone loss in the CUMS mouse model. They also validated the expression of miR-335-3p and interfered with the function of miR-335-3p through an in vitro assay. Overall, the findings from this study provide important hints for the correlation between psychological stress and bone metabolism.

      We thank this reviewer for the comprehensive summary and positive comment on our work.

      Weakness:

      The data provided by the authors are preliminary, especially the mechanistic insight, which needs to be enhanced. The authors have shown that miR-335-3p expression was altered in the CUMS mouse model and the change of its expression regulated osteoclast activity. The validation should be conducted in vivo, and the mechanism behind this should be investigated further.

      We thank the reviewer’s important insight on the need for further in vivo validation of the role of miR-335-3p. Therefore, we designed and produced Antagomir-335-3p (antagonist) and Agomir-335-3p (agonist). Then, we injected them into the body through the tail vein for about 2 months and observed the bone phenotype in each group of mice. The results suggested that the decrease of miR-335-3p in vivo could lead to bone loss, which was consistent with our in vitro validation results (Figure 5H-I).

      Reviewing Editor:

      Method

      (1) Bone histomorphometric analysis following ASBMR's guidelines Bone histomorphometric analysis of bone formation and bone resorption: The authors should follow ASBMR's guidelines for bone histomorphometry (PMCID: PMC3672237 and PMID: 3455637) to perform standard analyses of histomorphometry, rather than selected areas. They should also clearly describe a software used and define the areas analyzed.

      We carefully re-analyzed bone histomorphometry according to ASBMR guidelines and combine this with our own understanding. At the same time, we improved the description of micro-CT and histological analysis in the method. If there is still any lack of standardization, we would be grateful for any constructive suggestions to improve this.

      (2) Osteoclast cultures require nuclear staining to demonstrate multinucleated Trap positive cells.

      We used the RAW264.7, a mouse macrophage-like cell line, for in vitro culture and induced its differentiation towards osteoclasts. Successfully induced osteoclasts showed enlarged cytoplasm and multinucleated fusion. Tartrate-resistant acid phosphatase (Trap) is the signature enzyme of osteoclasts. It can bind to the chromogen to exhibit a mauve color, based on the principle of azo-coupled immunohistochemistry. At the same time, small and rounded nuclei fused show a lighter color (author response image 1, yellow arrows). We attempted to stain the nuclei with hematoxylin based on this. However, it was unable to further distinguish the contours of the nuclei clearly due to the similar color to the Trap positive signals. Besides, many other scholars have assessed osteoclast activity in vitro experiments based solely on the results of Trap staining (area and number) (Cheng et al., 2022; Li et al., 2019; Ma et al., 2021; Zhong et al., 2023). Nevertheless, in the immunofluorescence staining of osteoclasts, the nuclei were labeled using a Hochest antibody to reflect the multinucleated fusion of osteoclasts (Figure 5G).  

      (3) Osteoclast pit assays should be carried out to necessarily demonstrate the change of osteoclast resorption ability caused by miR-335-3p.

      We added osteoclast pit assays to validate the role of miR-335-3p on osteoclast resorptive capacity (Figure 5D-E).

      (4) Serum ELISA assay should be done to examine the global change of bone remodeling in the CUMS mice to assess bone formation and bone resorption that will support their claim.

      We performed additional tests on serum concentrations of R-hydroxy glutamic acid protein (BGP), TRAP, Cathepsin K (CTSK), parathyroid hormone (PTH), calcium (CA), phosphate (P) in control and CUMS mice, which could better reflect the global change of bone remodeling in the CUMS mice (Figure 3— figure supplement 1).

      (5) miR-RNA-seq: A labeled volcano plot should be used to replace the present one to show significant changes in differential gene expression.

      We appreciate this great suggestion. We replaced the volcano plot that showed significant changes in differential gene expression (Figure 4B). We also uploaded the raw data to the GEO database (GSE253504), making the results clearer and more accessible.

      Discussion

      The authors should discuss previous works on the influences of hormones from the brain on chronic stress-induced bone loss and an association of these influences with their findings.

      The discussion on the relationship between the bone metabolism regulation of both hormones and miR-335-3p in psychological stress was added in the second and fifth paragraphs of the discussion. To conclude, on the one hand, brain-derived and blood-transported miR-335-3p regulate bone metabolism synergistically. On the other hand, it exerted a more direct influence on bone under psychological stress.

      Language

      The language of the MS should be improved.

      The manuscript has been carefully edited by a professional proofreader.

      Reviewer #1 (Recommendations For The Authors):

      (1) Figure 1F: The exact meaning of the Waveform Graph shown at left needs to be clarified for the not-so-experienced reader.

      We added the more detailed meaning of the Waveform Graph in figure legends (Figure legend 1F).

      (2) Is the concomitant increase in osteogenic and osteoblastic activity in this study consistent with that seen in similar disease studies? This could be added to the discussion.

      In the fifth paragraph of the discussion section, we present the alterations of osteogenic and osteoblastic activity observed in other studies that are similar to ours. We also had a detailed discussion based on these observations.

      (3) Figure 6A: Please highlight the key information to visualize the potential linkage among miR-335-3p, Fos, and osteoclast.

      We highlighted the crucial linkage among miR-335-3p, Fos, and osteoclast with red arrows (Figure 6A)

      4) Figure 6E: The specific area of the selected comparison needs to be clarified. Please add white dotted lines and lettering T (trabecular bone) and GP (growth plate) for the not-so-experienced reader. This will provide some orientation.

      We used white dotted lines as well as letters to label the tissue in immunofluorescence staining images (Figure 6E).

      (5) Line 350: "NAC derived and blood-trans, Ported miR-335-3p". There is a grammatical error. Please conduct general proofreading of the text and writing style.

      Thank you for pointing this out. We have corrected this grammatical error, and we also checked the full text to correct similar errors.

      Reviewer #2 (Recommendations For The Authors):

      (1) miR-335-3p was downregulated in the femur in the CUMS mice. The possible mechanism for this outcome should be further discussed. In Figure 4B, the Volcano plot showed that only a few miRNA were differentially expressed between the control and CUMS mice. How do the authors explain this?

      The chronic unpredictable mild stress (CUMS) model was constructed using normal mice. As the name of the model suggests, the stimulus is mild and does not cause developmental damage or teratogenic effects in mice. Conversely, CUMS has the potential to result in the chronic pathological conditions. Besides, in miRNA sequencing results from other tissues with similar models to ours, the number of differential miRNAs is also around a few dozen (Ma et al., 2019).

      (2) The authors have demonstrated that miR-335-3p inhibits osteoclast differentiation based on an in vitro assay in Figure 5; however, an in vivo experiment is required to provide more solid evidence.

      We strongly agree that in vivo experimental validation would bring more convincing results to this study. Therefore, we designed and produced Antagomir-335-3p (antagonist) and Agomir-335-3p (agonist), which were injected into mice via the tail vein every five days. Samples were collected at one and two months following the injection. We found that sustained two-month injections of antagomir could significantly lead to bone loss in mice (Figure 5H-I), which is consistent with our in vitro validation results.

      However, the Agomir-miR-335-3p group did not exhibit a notable enhancement of bone mass. This may be attributed to the fact that the 11-week-old normal mice selected for this study were in their prime and did not have strong osteoclastic activity in vivo. Therefore, the osteoclastic inhibition of Agomir-335-3p could not be demonstrated.

      In addition, no significant difference was seen one month after the injection. The main reason may be that the time is too short. On the one hand, the drug we injected was RNA preparation. They lacked stability resulting in poor delivery efficiency, which took some time to take effect. On the other hand, bone remodeling is also a time-consuming process.

      (3) FOS and NFATC1 should be expressed in the nuclei of the cells, therefore, the quality of the images needs to be improved.

      NFATC1 is a T-cell-activating nuclear factor that is activated in the nucleus to regulate the transcription of a variety of osteoclast-related genes, including ACP5, MMP9, etc. FOS could bind and interact with NFATC1, resulting in nuclear translocation and transcription activated. This could promote the differentiation and maturation of osteoclasts. They are both synthesized and processed in the cytoplasm and eventually enter the nucleus to perform their functions. Therefore, they are expressed in both the nucleus and the cytoplasm (Deng et al., 2022; Hounoki et al., 2008; Li et al., 2022).

      In Figure 5G, we labeled cell nuclei with HOCHEST antibody with blue fluorescence, and more co-localized signals of nuclei (blue), FOS (red), and NFATC1 (green) were seen in the Inhibitor-miR-335-3p group, whereas the opposite result was observed in the Mimic-miR-335-3p group. These results indicated that inhibited miR-335-3p could promote osteoclast differentiation in vitro.

      (4) The expression of FOS was elevated in CUMS group in Figure 6E; however, its mRNA level was unchanged, as shown in Figure 6 supplement; what is the explanation for this? How do the authors claim FOS is the downstream target if its mRNA expression is not impacted by CUMS?

      The results demonstrated that miR-335-3p targeted binding to the mRNA of Fos did not result in mRNA degradation. Instead, this binding interferes with the protein translation process, which ultimately leads to the reduction of FOS protein.

      (5) What would be the bone phenotype if a FOS inhibitor was injected into the control and CUMS mice? It is important to examine FOS function through an in vivo context.

      The regulatory role of FOS for osteoclasts has been validated in numerous articles, both in vivo and in vitro(Aikawa et al., 2008; Cao et al., 2023; Cheng et al., 2022). For example, Aikawa et al. designed a small-molecule inhibitor of c-Fos/activator protein-1 (AP-1) using three-dimensional (3D) pharmacophore modeling, which helped verify the effect of FOS on osteoclasts in vivo(Aikawa et al., 2008).

      We also strongly agree that in vivo injection of inhibitors of FOS, especially in CUMS mice, could further substantiate the role of miR-335-3p in osteoclasts under psychological stress. However, the study was constrained by the unavailability of commercially viable, efficacious small molecule inhibitors of FOS. In the future, we plan to design more precise therapeutic targets for psychological stress induced osteoporosis based on existing research ideas.

      Reference

      Aikawa, Y., Morimoto, K., Yamamoto, T., Chaki, H., Hashiramoto, A., Narita, H., Hirono, S., & Shiozawa, S. (2008). Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nature Biotechnology, 26(7), 817-823. https://doi.org/10.1038/nbt1412

      Cao, Z., Niu, X. B., Wang, M. H., Yu, S. W., Wang, M. K., Mu, S. L., Liu, C., & Wang, Y. X. (2023, Nov). Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone loss [Article]. Biomedicine & Pharmacotherapy, 167, 12, Article 115454. https://doi.org/10.1016/j.biopha.2023.115454

      Cheng, X., Yin, C., Deng, Y., & Li, Z. (2022). Exogenous adenosine activates A2A adenosine receptor to inhibit RANKL-induced osteoclastogenesis via AP-1 pathway to facilitate bone repair. Molecular Biology Reports, 49(3), 2003-2014. https://doi.org/10.1007/s11033-021-07017-1

      Deng, W., Ding, Z., Wang, Y., Zou, B., Zheng, J., Tan, Y., Yang, Q., Ke, M., Chen, Y., Wang, S., & Li, X. (2022). Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 96, 153838. https://doi.org/10.1016/j.phymed.2021.153838

      Hounoki, H., Sugiyama, E., Mohamed, S. G.-K., Shinoda, K., Taki, H., Abdel-Aziz, H. O., Maruyama, M., Kobayashi, M., & Miyahara, T. (2008). Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone, 42(4), 765-774. https://doi.org/10.1016/j.bone.2007.11.016

      Li, Y., Yang, C., Jia, K., Wang, J., Wang, J., Ming, R., Xu, T., Su, X., Jing, Y., Miao, Y., Liu, C., & Lin, N. (2022). Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis. Journal of Ethnopharmacology, 282, 114602. https://doi.org/10.1016/j.jep.2021.114602

      Li, Z., Huang, J., Wang, F., Li, W., Wu, X., Zhao, C., Zhao, J., Wei, H., Wu, Z., Qian, M., Sun, P., He, L., Jin, Y., Tang, J., Qiu, W., Siwko, S., Liu, M., Luo, J., & Xiao, J. (2019). Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research, 34(4), 765-776. https://doi.org/10.1002/jbmr.3652

      Ma, K., Zhang, H., Wei, G., Dong, Z., Zhao, H., Han, X., Song, X., Zhang, H., Zong, X., Baloch, Z., & Wang, S. (2019). Identification of key genes, pathways, and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis. Neuropsychiatric Disease and Treatment, 15, 685-700. https://doi.org/10.2147/NDT.S200264

      Ma, Q., Liang, M., Wu, Y., Luo, F., Ma, Z., Dong, S., Xu, J., & Dou, C. (2021). Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling. Bone Research, 9(1), 5. https://doi.org/10.1038/s41413-020-00121-1

      Zhong, L., Lu, J., Fang, J., Yao, L., Yu, W., Gui, T., Duffy, M., Holdreith, N., Bautista, C. A., Huang, X., Bandyopadhyay, S., Tan, K., Chen, C., Choi, Y., Jiang, J. X., Yang, S., Tong, W., Dyment, N., & Qin, L. (2023). Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone. eLife, 12. https://doi.org/10.7554/eLife.82112

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Batra, Cabrera, Spence et al. present a model which integrates histone posttranslational modification (PTM) data across cell models to predict gene expression with the goal of using this model to better understand epigenetic editing. This gene expression prediction model approach is useful if a) it predicts gene expression in specific cell lines b) it predicts expression values rather than a rank or bin, c) it helps us to better understand the biology of gene expression, or d) it helps us to understand epigenome editing activity. Problematically for points a) and b) it is easier to directly measure gene expression than to measure multiple PTMs and so the real usefulness of this approach mostly relates to c) and d).

      We thank the reviewer for their comment and we agree that directly measuring gene expression (e.g., by performing RNA-seq) is easier than performing multiple PTMs in a new cell line. We designed our approach keeping in mind that the primary use case is to understand how epigenome editing would affect gene expression.

      Other approaches have been published that use histone PTM to predict expression (e.g. 27587684, 36588793). Is this model better in some way? No comparisons are made. The paper does not seem to have substantial novel insights into understanding the biology of gene expression. The approach of using this model to predict epigenetic editor activity on transcription is interesting and to my knowledge novel but I doubt given the variability of the predictions (Figures 6 and S7&8) that many people will be interested in using this in a practical sense. As the authors point out, the interpretation of the epigenetic editing data is convoluted by things like sgRNA activity scoring and to fully understand the results likely would require histone PTM profiling and maybe dCas9 ChIP-seq for each sgRNA which would be a substantial amount of work.

      We thank the reviewer for this insightful comment. We have included citations for a series of papers (PMIDs: 27587684, 30147283, 36588793) that performed gene expression prediction using histone PTM data. However, each of these methods perform classification of gene expression as opposed to predicting the actual gene expression value via regression. Additionally, the referenced studies all work with Roadmap Epigenomics read depth data as opposed to p-values obtained from the ENCODE pipelines, making it difficult to make direct comparisons.

      We outline in the Discussion section that by creating a comprehensive dataset of epigenome editing outcomes, which include quantification of histone PTMs before and after in situ perturbations, will improve our understanding of the effects of dCas9-p300 on gene expression and assist in the design of gRNAs for achieving fine-tuned control over gene expression levels. 

      Furthermore from the model evaluation of H3K9me3 it seems the model is not performing well for epigenetic or transcriptional editing- e.g. we know for the best studied transcriptional editor which is CRISPRi (dCas9-KRAB) that recruitment to a locus is associated with robust gene repression across the genome and is associated with H3K9me3 deposition by recruitment of KAP1/HP1/SETDB1 (PMID: 35688146, 31980609, 27980086, 26501517). However, it seems from Figures 2&4 that the model wouldn't be able to evaluate or predict this.

      We thank the reviewer for their comment. We have included a supplementary figure, Figure 4 – figure supplement 1, that quantifies how sensitive the trained gene expression model is to perturbations in H3K9me3. Indeed our data suggests that the model predictions are sensitive to perturbations in H3K9me3. For instance, there is a clear decrease and a gradual increase as the position where the perturbation is performed moves from upstream to downstream of the TSS. Additionally, the magnitude of the predicted fold-change is a function of how much the H3K9me3 is perturbed and hence the magnitude of change would be even higher if the perturbation magnitude is increased. However, this precise magnitude is hard to estimate In the absence of experimental perturbation data for H3K9me3.

      The model seems to predict gene expression for endogenous genes quite well although the authors sometimes use expression and sometimes use rank (e.g. Figure 6) - being clearer with how the model predicts expression rather than using rank or fold change would be very useful.

      We thank the reviewer for this important suggestion. We have added text in the revised manuscript to clarify that the model predicts gene expression values, which can be interpreted as rank or fold change, depending on the use case.

      One concern overall with this approach is that dCas9-p300 has been observed to induce sgRNA-independent off-target H3K27Ac (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349887/ see Figure S5D) which could convolute interpretation of this type of experiment for the model.

      This is an excellent point and indeed, we and others have observed that dCas9-p300 can result in off-target H3K27ac levels (both increased and suppressed) across the genome. However, p300 is one of the few known proteins that can catalyze H3K27ac in the human genome, and H3K27ac remains a proxy for active genomic regulatory elements. Nevertheless, dCas9-p300 off target activity could certainly convolute our approach. We have included language to address this caveat in our discussion. Interestingly, even though dCas9-p300 (and other epigenome editing enzymes) can lead to off-target chromatin modifications, these effects often occur without coincident disruptions to the transcriptome. This suggests that many chromatin modifications, while “supportive” or “instructive” of/for transcription, may be insufficient (either alone or in the context of dCas9-based fusions) for transcriptional effects.

      Figure 2

      It seems this figure presents known rather than novel findings from the authors' description. Please comment on whether there are any new findings in this figure. Please comment on differences in patterns of repressive and activating histone PTMs between cell lines (e.g. H1-Esc H3K27me3 green 25-50% is more enriched than red 0-25%).

      Thank you for pointing out this issue. We have revised the text in both the Results and Discussion sections to better articulate that the goal of this figure is to validate the hypothesis that there are consistent patterns of histone PTMs with respect to gene expression across different human cell types.

      In Figure 2, which illustrates the raw histone marks data, the non-monotonic behavior of H3K27me3 in H1-hESC cells is indicative of a real biological phenomenon. This interpretation is supported by the relatively low Pearson correlation for the H3K27me3 mark observed in these cells, as documented in Figure 1b of another study: https://www.biorxiv.org/content/10.1101/2024.03.29.587323v1.

      Figure 3&4

      There are a number of approaches including DeepChrome and TransferChrome that predict endogenous gene expression from histone PTMs. I appreciate that the authors have not used the histone PTM data to predict gene expression levels of an "average cell" but rather that they are predicting expression within specific cell types or for unseen cell types. But from what is presented it isn't clear that the author's model is better or enabling beyond other approaches. The authors should show their model is better than other approaches or make clear why this is a significant advance that will be enabling for the field. For example is it that in this approach they are actually predicting expression levels whereas previous approaches have only predicted expressed or not expressed or a rank order or bin-based ranking?

      We thank the reviewer for this comment. We have added text to clarify the difference between our approach and existing approaches. There are two key differences between our model and other approaches. First, the gene expression model that we have trained here predicts gene expression values instead of gene expression levels as either high or low. Second, we have trained our models on ENCODE p-value data instead of read depths obtained from the Roadmap Epigenomics Consortium.

      Figure 5

      From the methods, it seems gene activation is measured by qpcr in hek293 transfected with individual sgRNAs and dCas9-p300. The cells aren't selected or sorted before qPCR so how are we sure that some of the variability isn't due to transfection efficiency associated with variable DNA quality or with variable transfection efficiency?

      This is a good question. All DNA preps were generated using high-quality reagents and consistent protocols. In addition, the only variable that changed with respect to transfection efficiency was the gRNA-encoding vector used in qPCR assays. We have added new data which demonstrates that transfection efficiency is shared across experiments (Figure 5 – figure supplement 1). We have also added additional experimental data as well as computational analysis analyzing a new dCas9-p300 based Perturb-seq dataset to the manuscript (Figure 6 – figure supplement 1), which use lentiviral transduction and RNA-seq as readouts and thus, are buffered against the variances mentioned by the Reviewer.

      Figure 6

      The use of rank in 6D and 6E is confusing. In 6D a higher rank is associated with higher expression while in 6E a higher rank seems to mean a lower fold change e.g. CYP17A1 has a low predicted fold-change rank and qPCR fold-change rank but in Figure 5 a very high qPCR fold change. Labeling this more clearly or explaining it in the text further would be useful.

      We thank the reviewer for their suggestion. We have made relevant changes to the caption of Figure 6 to clarify this.

      Reviewer #2 (Public Review):

      Summary:

      The authors build a gene expression model based on histone post-translational modifications and find that H3K27ac is correlated with gene expression. They proceed to perturb H3K27ac at 8 gene promoters, and measure gene expression changes to test their model.

      Strengths:

      The combination of multiple methods to model expression, along with utilizing 6 histone datasets in 13 cell types allowed the authors to build a model that correlates between 0.7-0.79 with gene expression. This group also utilized a tool they are experts in, dCas9-p300 fusions to perturb H3K27ac and monitor gene expression to test their model. Ranked correlations showed some support for the predictions after the perturbation of H3K27ac.

      Weaknesses:

      The perturbation of only 8 genes, and the only readout being qPCR-based gene expression, as opposed to including H3K27ac, weakened their validation of the computational model. Likewise, the use of six genes that were not expressed being most activated by dCas9-p300 might weaken the correlations vs. looking at a broad range of different gene expressions as the original model was trained on.

      We thank the reviewer for their comments. We have added additional experimental data as well as computational analysis analyzing a new dCas9-p300 based Perturb-seq dataset to the manuscript. We observe that the models we have developed are able to predict the fold-change rank across genes reasonably well (Figure 6 – figure supplement 1), similar to what we observe in Figure 6E.

      Reviewer #1 (Recommendations For The Authors):

      The authors should comment on how their model is different from or better than other models that use histone PTM data to predict gene expression.

      We thank the reviewer for this insightful suggestion. We have included citations for a series of papers (PMIDs: 27587684, 30147283, 36588793) that performed gene expression prediction using histone PTM data. However, each of these methods perform classification of gene expression as opposed to predicting the actual gene expression value via regression. Additionally, the referenced studies all work with Roadmap Epigenomics read depth data as opposed to p-values obtained from the ENCODE pipelines, making it difficult to make direct comparisons.

      The authors need to make clear whether their model will apply to other common epigenetic or transcriptional editors such as CRISPRi/H3K9me3 which is widely used.

      In this study, we focus on the histone changes induced by p300. However, future studies may use the framework described in our manuscript and apply it to other transcriptional editors as well.

      The authors need to be clearer about where they are predicting expression and where they are using rank. Ideally, show both.

      We thank the reviewer for this important suggestion. We have added text in the revised manuscript to clarify that the model predicts gene expression values, which can be interpreted as rank or fold change, depending on the use case.

      The authors should ideally show a case where they use the model to make a prediction of genes that can and can not be activated by dCas9-p300 or other epigenetic editors and then prove this with experiments.

      Thank you for the excellent suggestion. While it is indeed relevant, exploring this would extend beyond the scope of our current study. We consider it a valuable topic for future research.

      Reviewer #2 (Recommendations For The Authors):

      The y-axis in 5C needs to be labeled. The authors state it is "relative mRNA" but these numbers correlated with fold changes shown in Table S2.

      We have clarified the definition of the Y-axis in the caption for Figure 5C.

    1. Author response:

      Reviewer #1 (Public review):

      I did not follow the logic behind including spindle amplitude in the meta-analysis. This is not a measure of SO-spindle coupling (which is the focus of the review), unless the authors were restricting their analysis of the amplitude of coupled spindles only. It doesn't sound like this is the case though. The effect of spindle amplitude on memory consolidation has been reviewed in another recent meta-analysis (Kumral et al, 2023, Neuropsychologia). As standardization this isn't a measure of coupling, it wasn't clear why this measure was included in the present meta-analysis. You could easily make the argument that other spindle measures (e.g., density, oscillatory frequency) could also have been included, but that seems to take away from the overall goal of the paper which was to assess coupling.

      Indeed, spindle amplitude refers to all spindle events rather than only coupled spindles. This choice was made because we recognized the challenge of obtaining relevant data from each study—only 4 out of the 23 included studies performed their analyses after separating coupled and uncoupled spindles. This inconsistency strengthens the urgency and importance of this meta-analysis to standardize the methods and measures used for future analysis on SO-SP coupling and beyond. We agree that focusing on the amplitude of coupled spindles would better reveal their relations with coupling, and we will discuss this limitation in the manuscript.

      Nevertheless, we believe including spindle amplitude in our study remains valuable, as it served several purposes. First, SO-SP coupling involves the modulation between spindle amplitude and slow oscillation phase. Different studies have reported conflicting conclusions regarding how spindle amplitude was related to coupling– some found significant correlations (e.g., Baena et al., 2023), while others did not (e.g., Roebber et al., 2022). This discrepancy highlights an indirect but potentially crucial insight into the role of spindle amplitude in coupling dynamics. Second, in studies related to SO-SP coupling, spindle amplitude is one of the most frequently reported measures along with other coupling measures that significantly correlated with oversleep memory improvements (e.g. Kurz et al., 2023; Ladenbauer et al., 2021; Niknazar et al., 2015), so we believe that including this measure can more comprehensively review of the existing literature on SO-SP coupling. Third, incorporating spindle amplitude allows for a direct comparison between the measurement of coupling and individual events alone in their contribution to memory consolidation– a question that has been extensively explored in recent research. (e.g., Hahn et al., 2020; Helfrich et al., 2019; Niethard et al., 2018; Weiner et al., 2023). Finally, spindle amplitude was identified as a key moderator for memory consolidation in Kumral et al.'s (2023) meta-analysis. By including it in our analysis, we sought to replicate their findings within a broader framework and introduce conceptual overlaps with existing reviews. Therefore, although we were not able to selectively include coupled spindles, there is still a unique relation between spindle amplitude and SO-SP coupling that other spindle measures do not have. 

      Originally, we also intended to include coupling density or counts in the analysis, which seems more relevant to the coupling metrics. However, the lack of uniformity in methods used to measure coupling density posed a significant limitation. We hope that our study will encourage consistent reporting of all relevant parameters in future research, enabling future meta-analyses to incorporate these measures comprehensively. We will add this discussion to the manuscript in the revised version to further clarify these points.

      References:

      Roebber, J. K., Lewis, P. A., Crunelli, V., Navarrete, M. & Hamandi, K. Effects of anti-seizure medication on sleep spindles and slow waves in drug-resistant epilepsy. Brain Sci. 12, 1288 (2022). https://doi.org/10.3390/brainsci12101288

      All other citations were referenced in the manuscript.

      At the end of the first paragraph of section 3.1 (page 13), the authors suggest their results "... further emphasise the role of coupling compared to isolated oscillation events in memory consolidation". This had me wondering how many studies actually test this. For example, in a hierarchical regression model, would coupled spindles explain significantly more variance than uncoupled spindles? We already know that spindle activity, independent of whether they are coupled or not, predicts memory consolidation (e.g., Kumral meta-analysis). Is the variance in overnight memory consolidation fully explained by just the coupled events? If both overall spindle density and coupling measures show an equal association with consolidation, then we couldn't conclude that coupling compared to isolated events is more important.

      While primary coupling measurements, including coupling phase and strength, showed strong evidence for their associations with memory consolidation, measures of spindles, including spindle amplitude, only exhibited limited evidence (or “non-significant” effect) for their association with consolidation. These results are consistent with multiple empirical studies using different techniques (e.g., Hahn et al., 2020; Helfrich et al., 2019; Niethard et al., 2018; Weiner et al., 2023), which reported that coupling metrics are more robust predictors of consolidation and synaptic plasticity than spindle or slow oscillation metrics alone. However, we agree with the reviewer that we did not directly separate the effect between coupled and uncoupled spindles, and a more precise comparison would involve contrasting the “coupling of oscillation events” with ”individual oscillation events” rather than coupling versus isolated events.

      We recognized that Kumral and colleagues’ meta-analysis reported a moderate association between spindle measures and memory consolidation (e.g., for spindle amplitude-memory association they reported an effect size of approximately r = 0.30). However, one of the advantages of our study is that we actively cooperated with the authors to obtain a large number of unreported and insignificant data relevant to our analysis, as well as separated data that were originally reported under mixed conditions. This approach decreases the risk of false positives and selective reporting of results, making the effect size more likely to approach the true value. In contrast, we found only a weak effect size of r = 0.07 with minimal evidence for spindle amplitude-memory relation. However, we agree with the reviewer that using a more conservative term in this context would be a better choice since we did not measure all relevant spindle metrics including the density.

      To improve clarity in our manuscript, we will revise the statement to: “Together with other studies included in the review, our results suggest a crucial role of coupling but did not support the role of spindle events alone in memory consolidation,” and provide relevant references. We believe this can more accurately reflect our findings and the existing literature to address the reviewer’s concern.

      It was very interesting to see that the relationship between the fast spindle coupling phase and overnight consolidation was strongest in the frontal electrodes. Given this, I wonder why memory promoting fast spindles shows a centro-parietal topography? Surely it would be more adaptive for fast spindles to be maximally expressed in frontal sites. Would a participant who shows a more frontal topography of fast spindles have better overnight consolidation than someone with a more canonical centro-parietal topography? Similarly, slow spindles would then be perfectly suited for memory consolidation given their frontal distribution, yet they seem less important for memory.

      Regarding the topography of fast spindles and their relationship to memory consolidation, we agree this is an intriguing issue, and we have already developed significant progress in this topic in our ongoing work. We share a few relevant observations: First, there are significant discrepancies in the definition of “slow spindle” in the field. Some studies defined slow spindle from 9-12 Hz (e.g. Mölle et al., 2011; Kurz et al., 2021), while others performed the event detection within a range of 11-13/14 Hz (e.g. Barakat et al., 2011; D'Atri et al., 2018). Compounding this issue, individual differences in spindle frequency are often overlooked, leading to challenges in reliably distinguishing between slow and fast spindles. Some studies have reported difficulty in clearly separating the two types of spindles altogether (e.g., Hahn et al., 2020). Moreover, a critical factor often ignored in past research is the traveling nature of both slow oscillations and spindles across the cortex, where spindles are coupled with significantly different phases of slow oscillations (see Figure 5). We believe a better understanding of coupling in the context of the movement of these waves will help us better understand the observed frontal relationship with consolidation. We will address this in our revised manuscript.

      The authors rightly note the issues with multiple comparisons in sleep physiology and memory studies. Multiple comparison issues arise in two ways in this literature. First are comparisons across multiple electrodes (many studies now use high-density systems with 64+ channels). Second are multiple comparisons across different outcome variables (at least 3 ways to quantify coupling (phase, consistency, occurrence) x 2 spindle types (fast, slow). Can the authors make some recommendations here in terms of how to move the field forward, as this issue has been raised numerous times before (e.g., Mantua 2018, Sleep; Cox & Fell 2020, Sleep Medicine Reviews for just a couple of examples). Should researchers just be focusing on the coupling phase? Or should researchers always report all three metrics of coupling, and correct for multiple comparisons? I think the use of pre-registration would be beneficial here, and perhaps could be noted by the authors in the final paragraph of section 3.5, where they discuss open research practices.

      There are indeed multiple methods that we can discuss, including cluster-based and non-parametric methods, etc., to correct for multiple comparisons in EEG data with spatiotemporal structures. In addition, encouraging the reporting of all tested but insignificant results, at least in supplementary materials, is an important practice that helps readers understand the findings with reduced bias. We agree with the reviewer’s suggestions and will add more information in section 3.5 to advocate for a standardized “template” used to analyze and report effect size in future research.

      We advocate for the standardization of reporting all three coupling metrics– phase, consistency, and occurrence. Each coupling metric captures distinct properties of the coupling process and may interact with one another (Weiner et al., 2023). Therefore, we believe it is essential to report all three metrics to comprehensively explore their different roles in the “how, what, and where” of long-distance communication and consolidation of memory. As we advance toward a deeper understanding of the relationship between memory and sleep, we hope this work establishes a standard for the standardization, transparency, and replication of relevant studies.

      Reviewer #2 (Public review):

      Regarding the Moderator of Age: Although the authors discuss the limited studies on the analysis of children and elders regarding age as a moderator, the figure shows a significant gap between the ages of 40 and 60. Furthermore, there are only a few studies involving participants over the age of 60. Given the wide distribution of effect sizes from studies with participants younger than 40, did the authors test whether removing studies involving participants over 60 would still reveal a moderator effect?

      We agree that there is an age gap between younger and older adults, as current studies often focus on contrasting newly matured and fully aged populations to amplify the effect, while neglecting the gradual changes in memory consolidation mechanisms across the aging spectrum. We suggest that a non-linear analysis of age effects would be highly valuable, particularly when additional child and older adult data become available.

      In response to the reviewer’s suggestion, we re-tested the moderation effect of age after excluding effect sizes from older adults. The results revealed a decrease in the strength of evidence for phase-memory association due to increased variability, but were consistent for all other coupling parameters. The mean estimations also remained consistent (coupling phase-memory relation: -0.005 [-0.013, 0.004], BF10 = 5.51, the strength of evidence reduced from strong to moderate; coupling strength-memory relation: -0.005 [-0.015, 0.008], BF10 = 4.05, the strength of evidence remained moderate). These findings align with prior research, which typically observed a weak coupling-memory relationship in older adults during aging (Ladenbauer et al, 2021; Weiner et al., 2023) but not during development (Hahn et al., 2020; Kurz et al., 2021; Kurz et al., 2023). Therefore, this result is not surprising to us, and there are still observable moderate patterns in the data. We will report these additional results in the revised manuscript, and interpret “the moderator effect of age becomes less pronounced during development after excluding the older adult data”. We believe the original findings including the older adult group remain meaningful after cautious interpretation, given that the older adult data were derived from multiple studies and different groups.

      Reviewer #3 (Public review):

      First, the authors conclude that "SO-SP coupling should be considered as a general physiological mechanism for memory consolidation". However, the reported effect sizes are smaller than what is typically considered a "small effect" (0.10)

      While we acknowledge the concern about the small effect sizes reported in our study, it is important to contextualize these findings within the field of neuroscience, particularly memory research. Even in individual studies, small effect sizes are not uncommon due to the inherent complexity of the mechanisms involved and the multitude of confounding variables. This is an important factor to be considered in meta-analyses where we synthesize data from diverse populations and experimental conditions. For example, the relationship between SO-slow SP coupling and memory consolidation in older adults is expected to be insignificant.

      As Funder and Ozer (2019) concluded in their highly cited paper, an effect size of r = 0.3 in psychological and related fields should be considered large, with r = 0.4 or greater likely representing an overestimation and rarely found in a large sample or in a replication. Therefore, we believe r = 0.1 should not be considered as a lower bound of the small effect. Bakker et al. (2019) also advocate for a contextual interpretation of the effect size. This is particularly important in meta-analyses, where the results are less prone to overestimation compared to individual studies, and we cooperated with all authors to include a large number of unreported and insignificant results. In this context, small correlations may contain substantial meaningful information to interpret. Although we agree that effect sizes reported in our study are indeed small at the overall level, they reflect a rigorous analysis that incorporates robust evidence across different levels of moderators. Our moderator analyses underscore the dynamic nature of coupling-memory relationships, with certain subgroups demonstrating much stronger and more meaningful effects, especially after excluding slow spindles and older adults. For example, both the coupling phase and strength of frontal fast spindles with slow oscillations exhibited "moderate-to-large" correlations with the consolidation of different types of memory, especially in young adults, with r values ranging from 0.18 to 0.32. (see Table S9.1-9.4). We will add more discussion about the influence of moderators on the dynamics of coupling-memory associations. In addition, we will update the conclusion to be “SO-fast SP coupling should be considered as a general physiological mechanism for memory consolidation”.

      Reference:

      Funder, D. C. & Ozer, D. J. Evaluating effect size in psychological research: sense and nonsense. Adv. Methods Pract. Psychol. Sci. 2, 156–168 (2019). https://doi.org/10.1177/2515245919847202.

      Bakker, A. et al. Beyond small, medium, or large: Points of consideration when interpreting effect sizes. Educ. Stud. Math. 102, 1–8 (2019). https://doi.org/10.1007/s10649-019-09908-4

      Second, the study implements state-of-the-art Bayesian statistics. While some might see this as a strength, I would argue that it is the greatest weakness of the manuscript. A classical meta-analysis is relatively easy to understand, even for readers with only a limited background in statistics. A Bayesian analysis, on the other hand, introduces a number of subjective choices that render it much less transparent.

      This kind of analysis seems not to be made to be intelligible to the average reader. It follows a recent trend of using more and more opaque methods. Where we had to trust published results a decade ago because the data were not openly available, today we must trust the results because the methods can no longer be understood with reasonable effort.

      This becomes obvious in the forest plots. It is not immediately apparent to the reader how the distributions for each study represent the reported effect sizes (gray dots). Presumably, they depend on the Bayesian priors used for the analysis. The use of these priors makes the analyses unnecessarily opaque, eventually leading the reader to question how much of the findings depend on subjective analysis choices (which might be answered by an additional analysis in the supplementary information).

      We appreciate the reviewer for sharing this viewpoint and we value the opportunity to clarify some key points. To address the concern about clarity, we will include a sub-section in the methods section explaining how to interpret Bayesian statistics including priors, posteriors, and Bayes factors, making our results more accessible to those less familiar with this approach.

      On the use of Bayesian models, we believe there may have been a misunderstanding. Bayesian methods, far from being "opaque" or overly complex, are increasingly valued for their ability to provide nuanced, accurate, and transparent inferences (Sutton & Abrams, 2001; Hackenberger, 2020; van de Schoot et al., 2021; Smith et al., 1995; Kruschke & Liddell, 2018). It has been applied in more than 1,200 meta-analyses as of 2020 (Hackenberger, 2020). In our study, we used priors that assume no effect (mean set to 0, which aligns with the null) while allowing for a wide range of variation to account for large uncertainties. This approach reduces the risk of overestimation or false positives and demonstrates much-improved performance over traditional methods in handling variability (Williams et al., 2018; Kruschke & Liddell, 2018). Sensitivity analyses reported in the supplemental material (Table S9.1-9.4) confirmed the robustness of our choices of priors– our results did not vary by setting different priors.

      As Kruschke and Liddell (2018) described, “shrinkage (pulling extreme estimates closer to group averages) helps prevent false alarms caused by random conspiracies of rogue outlying data,” a well-known advantage of Bayesian over traditional approaches. This explains the observed differences between the distributions and grey dots in the forest plots. Unlike p-values, which can be overestimated with a large sample size and underestimated with a small sample size, Bayesian methods make assumptions explicit, enabling others to challenge or refine them– an approach aligned with open science principles (van de Schoot et al., 2021). For example, a credible interval in Bayesian model can be interpreted as “there is a 95% probability that the parameter lies within the interval.”, while a confidence interval in frequentist model means “In repeated experiments, 95% of the confidence intervals will contain the true value.” We believe the former is much more straightforward and convincing for readers to interpret. We will ensure our justification for using Bayesian models is more clearly presented in the manuscript.

      We acknowledge that even with these justifications, different researchers may still have discrepancies in their preferences for Bayesian and frequentist models. To increase the effort of transparent reporting, we have also reported the traditional frequentist meta-analysis results in Supplemental Material 10 to justify the robustness of our analysis, which suggested non-significant differences between Bayesian and frequentist models. We will include clearer references in the next version of the manuscript to direct readers to the figures that report the statistics provided by traditional models.

      References:

      Hackenberger, B.K. Bayesian meta-analysis now—let's do it. Croat. Med. J. 61, 564–568 (2020). https://doi.org/10.3325/cmj.2020.61.564

      Sutton, A.J. & Abrams, K.R. Bayesian methods in meta-analysis and evidence synthesis. Stat. Methods Med. Res. 10, 277–303 (2001). https://doi.org/10.1177/096228020101000404

      Williams, D.R., Rast, P. & Bürkner, P.C. Bayesian meta-analysis with weakly informative prior distributions. PsyArXiv (2018). https://doi.org/10.31234/osf.io/9n4zp

      van de Schoot, R., Depaoli, S., King, R. et al. Bayesian statistics and modelling. Nat Rev Methods Primers 1, 1 (2021). https://doi.org/10.1038/s43586-020-00001-2

      Smith, T.C., Spiegelhalter, D.J. & Thomas, A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat. Med. 14, 2685–2699 (1995). https://doi.org/10.1002/sim.4780142408

      Kruschke, J.K. & Liddell, T.M. The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective. Psychon. Bull. Rev. 25, 178–206 (2018). https://doi.org/10.3758/s13423-016-1221-4

      However, most of the methods are not described in sufficient detail for the reader to understand the proceedings. It might be evident for an expert in Bayesian statistics what a "prior sensitivity test" and a "posterior predictive check" are, but I suppose most readers would wish for a more detailed description. However, using a "Markov chain Monte Carlo (MCMC) method with the no-U-turn Hamiltonian Monte Carlo (HMC) sampler" and checking its convergence "through graphical posterior predictive checks, trace plots, and the Gelman and Rubin Diagnostic", which should then result in something resembling "a uniformly undulating wave with high overlap between chains" is surely something only rocket scientists understand. Whether this was done correctly in the present study cannot be ascertained because it is only mentioned in the methods and no corresponding results are provided. 

      We appreciate the reviewer’s concerns about accessibility and potential complexity in our descriptions of Bayesian methods. Our decision to provide a detailed account serves to enhance transparency and guide readers interested in replicating our study. We acknowledge that some terms may initially seem overwhelming. These steps, such as checking the MCMC chain convergence and robustness checks, are standard practices in Bayesian research and are analogous to “linearity”, “normality” and “equal variance” checks in frequentist analysis. We have provided exemplary plots in the supplemental material and will add more details to explain the interpretation of these convergence checks. We hope this will help address any concerns about methodological rigor.

      In one point the method might not be sufficiently justified. The method used to transform circular-linear r (actually, all references cited by the authors for circular statistics use r² because there can be no negative values) into "Z_r", seems partially plausible and might be correct under the H0. However, Figure 12.3 seems to show that under the alternative Hypothesis H1, the assumptions are not accurate (peak Z_r=~0.70 for r=0.65). I am therefore, based on the presented evidence, unsure whether this transformation is valid. Also, saying that Z_r=-1 represents the null hypothesis and Z_r=1 the alternative hypothesis can be misinterpreted, since Z_r=0 also represents the null hypothesis and is not half way between H0 and H1.

      First, we realized that in the title of Figures 12.2 and 12.3. “true r = 0.35” and “true r = 0.65” should be corrected as “true Z_r”. The method we used here is to first generate an underlying population that has null (0), moderate (0.35), or large (0.65) Z_r correlations, then test whether the sampling distribution drawn from these populations followed a normal distribution across varying sample sizes. Nevertheless, the reviewer correctly noticed discrepancies between the reported true Z_r and its sampling distribution peak. This discrepancy arises because, when generating large population data, achieving exact values close to a strong correlation like Z_r = 0.65 is unlikely. We loop through simulations to generate population data and ensure their Z_r values fall within a threshold. For moderate effect sizes (e.g., Z_r = 0.35), this is straightforward using a narrow range (0.345 < Z_r < 0.355). However, for larger effect sizes like Z_r = 0.65, a wider range (0.6 < Z_r < 0.7) is required. therefore sometimes the population we used to draw the sample has a Z_r slightly deviated from 0.65. This remains reasonable since the main point of this analysis is to ensure that large Z_r still has a normal sampling distribution, but not focus specifically on achieving Z_r = 0.65.

      We acknowledge that this variability of the range used was not clearly explained and it is not accurate to report “true Z_r = 0.65”. In the revised version, we will address this issue by adding vertical lines to each subplot to indicate the Z_r of the population we used to draw samples, making it easier to check if it aligns with the sampling peak. In addition, we will revise the title to “Sampling distributions of Z_r drawn from strong correlations (Z_r = 0.6-0.7)”. We confirmed that population Z_r and the peak of their sampling distribution remain consistent under both H0 and H1 in all sample sizes with n > 25, and we hope this explanation can fully resolve your concern.

      We agree with the reviewer that claiming Z_r = -1 represents the null hypothesis is not accurate. The circlin Z_r = 0 is better analogous to Pearson’s r = 0 since both represent the mean drawn from the population with the null hypothesis. In contrast, the mean effect size under null will be positive in the raw circlin r, which is one of the important reasons for the transformation. To provide a more accurate interpretation, we will update Table 6 to describe the following strength levels of evidence: no effect (r < 0), null (r = 0), small (r = 0.1), moderate (r = 0.3), and large (r = 0.5).

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the Editors and reviewers for their candid evaluation of our work. While it was suggested that we should demonstrate the validity of our approach with maybe 10 different datasets but we felt that this would place an undue burden on our resources. Generally, it takes about 4 to 6 months for us to build a dataset and this does not include the time taken to train and test our AI models. This would mean that it would take us another 3 to 5 years to complete this research project if we chose to provide 10 different datasets. Publishing a research on one dataset is definitely not unheard of: for example, Subramanian et al. (2016) published their widely-cited benchmark dataset for just BACE1 inhibitors. However, we hoped that the additional work where we showed that we were able to improve the benchmark dataset for BACE1 inhibitors and achieve the same high level of predictive performance for this dataset would convince the readers (and reviewers) of the reproducibility of our approach. Furthermore, we also showed that our approach is robust and does not rely on a large volume of data to achieve this near-perfect accuracy. As can be seen in the Supplemental section, even our AI models trained on ONLY 250 BRAF actives and 250 inactives could achieve 96.3% accuracy! Logically, if the model is robust then we would expect the model to be reproducible. As such, we do not feel it is necessary for us to test our approach on 10 different datasets. 

      It was also suggested that we expand this study to other types of molecular representations to give a better idea of generalizability. We would like to point out that we tested, in total, 55 single fingerprints and paired combinations. Our goal was to create an approach that could give superior performance for virtual screening and we believe that we have achieved this. Based on the results of our study, we are of the opinion that molecular representations do not, in general, have an oversized effect on AI virtual screening. Although it is important to be aware that certain molecular representations may give SLIGHTLY better performance but we can see that with the exception of the 79-bit E-State fingerprint (which could still achieve an impressive 85% accuracy for the SVM model), nearly all molecular fingerprints and paired combinations that we used were able to achieve an accuracy of above 97%. Therefore, we do not share the reviewers' concern that our approach may not be useful when applied with other types of molecular representations.

      It is true that our work involved manual curation of the datasets but the goal of this paper is to lay down some  ground rules for the future development of a data-centric AI approach. Although manual curation is a routine practice in AI/ML, but it should be recognised that there is good manual curation and bad manual curation, and rules need to be established to ensure we have good manual curation. Without these rules, we would also not be able to establish and train a data-centric AI. All manual curation involves a level of subjectiveness but that subjectiveness comes from one's experience and domain knowledge of the field in which the AI is being applied. For example, in the case of this study, we relied on our knowledge and understanding of pharmacology to determine whether a compound is pharmacologically inactive or active. This may seem somewhat arbitrary to the uninitiated but it is anything but arbitrary. It is through careful thought and assessment of the chemical compounds that we choose these compounds for training the AI. Unfortunately, this sort of subjective assessment cannot be easily or completely explained but we do show where current practices have failed when building a dataset for training an AI for virtual screening.

    1. Author response:

      (1) Controls for the genetic background are incomplete, leaving open the possibility that the observed oviposition timing defects may be due to targeted knockdown of the period (per) gene but from the GAL4, Gal80, and UAS transgenes themselves. To resolve this issue the authors should determine the egg-laying rhythms of the relevant controls (GAL4/+, UAS-RNAi/+, etc); this only needs to be done for those genotypes that produced an arrhythmic egg-laying rhythm.

      We agree with this objection, and in the corrected version we plan to provide the assessment of the egg laying rhythms for the missing GAL4 controls as recommended only for Figure 3.

      (2) Reliance on a single genetic tool to generate targeted disruption of clock function leaves the study vulnerable to associated false positive and false negative effects: a) The per RNAi transgene used may only cause partial knockdown of gene function, as suggested by the persistent rhythmicity observed when per RNAi was targeted to all clock neurons. This could indicate that the results in Fig 2C-H underestimate the phenotypes of targeted disruption of clock function. b) Use of a single per RNAi transgene makes it difficult to rule out that off-target effects contributed significantly to the observed phenotypes. We suggest that the authors repeat the critical experiments using a separate UAS-RNAi line (for period or for a different clock gene), or, better yet, use the dominant negative UAS-cycle transgene produced by the Hardin lab (https://doi.org/10.1038/22566).

      We have recently acquired mutant flies with a dominant negative-cycle transgene (UAS-cycDN, Tanoue et al. 2004), and we plan to repeat our experiments with these mutants, in order to confirm our results.

      (3) The egg-laying profiles obtained show clear damping/decaying trends which necessitates careful trend removal from the data to make any sense of the rhythm. Further, the detrending approach used by the authors is not tested for artefacts introduced by the 24h moving average used.

      In the revised version we will show that the detrending approach used does not introduce any artefacts. The analysis of numerical simulations with an aperiodic stochastic signal superposed to a decaying signal shows that the detrending method used does not result in a spurious periodic signal. Furthermore, we can show that when the underlying signal is rhythmic, the correct period is obtained even when the moving average is a few hours larger or smaller than 24 h.

      (4) According to the authors the oviposition device cannot sample at a resolution finer than 4 hours, which will compel any experimenter to record egg laying for longer durations to have a suitably long time series which could be useful for circadian analyses.

      We apologize for not being clear enough. The device can in principle sample at any desired resolution. Notice, however, that the variable we are analyzing (number of eggs laid by a single female) has only a few possible values, which is one of the features that render the assessment of rhythmicity a particularly difficult task. If egg laying is sampled more often (say, at 2 h intervals) more time points will be available, but the values available for each time point will be much less. We will show an example where we compare both rates (2h and 4h). Even though the 2h sampling reveals the rhythmicity of the time series, the significance of the peaks obtained is less than when sampling at 4h intervals. We have found that a 4h sampling seems to provide the best compromise between frequency of the sampling and discreteness of the variable.

      On the other hand, it is important to stress that sampling frequency and longer durations are not very correlated (see e.g. Cohen et al. Journal of Theoretical Biology 314, pp 182 [2012]). It has been shown that the best way to make accurate predictions of the period of a rhythmic signal is to have a series spanning many cycles, irrespective of the sampling frequency. In other words, it is not true that with a 2h sampling it would be possible to analyze shorter series than with 4h sampling. Unfortunately, egg laying records are usually less than 5 cycles long, which is one of the reasons for the difficulties in the assessment of their rhythmicity.

      (5) Despite reducing the interference caused by manually measuring egg-laying, the rhythm does not improve the signal quality such that enough individual rhythmic flies could be included in the analysis methods used. The authors devise a workaround by combining both strongly and weakly rhythmic (LSpower > 0.2 but less than LSpower at p < 0.05) data series into an averaged time series, which is then tested for the presence of a 16-32h "circadian" rhythm. This approach loses valuable information about the phase and period present in the individual mated females, and instead assumes that all flies have a similar period and phase in their "signal" component while the distribution of the "noise" component varies amongst them. This assumption has not yet been tested rigorously and the evidence suggests a lot more variability in the inter-fly period for the egg-laying rhythm.

      The assumption is difficult to test rigorously, since for individual flies the records seem to be so noisy that no information can be extracted. As shown in the paper, it is even very difficult to assess the presence of rhythmicity at the individual level. We consider that the appearance of a rhythm after averaging several records shows the presence of this rhythm at the individual level. But it could be argued that the presence of rhythmicity in the average record could be due to only a few (or even a single) rhythmic individuals. In order to show that this is probably not the case, in the revised version we will show that, when the individuals that are rhythmic are left out, the average of the remaining flies still shows a rhythm (albeit a weaker one, as was to be expected).

      Regarding our assumption that all flies have the “same” period, the results on Fig. 1 F cannot really rule out this possibility, because with so few cycles, the determination of the period is not very accurate (see e.g. Cohen et al. Journal of Theoretical Biology 314, pp 182 [2012]). In our case, the error for the period is related to the width of the corresponding peak in the periodogram, which is typically 4 hs. In any case, in the revised version we will try to show, by using numerical simulations, that when the individual periods are not the same, but are distributed approximately as in Fig 1F, the average series is still rhythmic with the correct period.

      (6) This variability could also depend on the genotype being tested, as the authors themselves observe between their Canton-S and YW wild-type controls for which their egg-laying profiles show clearly different dynamics. Interestingly, the averaged records for these genotypes are not distinguishable but are reflected in the different proportions of rhythmic flies observed. Unfortunately, the authors also do not provide further data on these averaged profiles, as they did for the wild-type controls in Figure 1, when they discuss their clock circuit manipulations using perRNAi. These profiles could have been included in Supplementary figures, where they would have helped the reader decide for themselves what might have been the reason for the loss of power in the LS periodogram for some of these experimental lines.

      Even though we think that the individual records are in general too noisy to be really informative, we will provide all the individual egg profiles in the Supplementary Material of the revised version, in order to let the reader, check this for herself/himself.

      (7) By selecting 'the best egg layers' for inclusion in the oviposition analyses an inadvertent bias may be introduced and the results of the assays may not be representative of the whole population.

      We agree that this may introduce some bias in the results. But in our opinion this bias is very difficult to avoid, since for females that lay very few eggs, rhythmicity can even be difficult to define (some females can spend a whole day without laying a single egg). On the other hand, even when the results may not be representative of the whole population, they would be representative of the flies that lay most of the eggs in a population, which seems to be very relevant in ecological terms.

      (8) An approach that measures rhythmicity for groups of individual records rather than separate individual records is vulnerable to outliers in the data, such as the inclusion of a single anomalous individual record. Additionally, the number of individual records that are included in a group may become a somewhat arbitrary determinant for the observed level of rhythmicity. Therefore, the experimental data used to map the clock neurons responsible for oviposition rhythms would be more convincing if presented alongside individual fly statistics, in the same format as used for Figure 1.

      The question of possible rhythmic outliers has been addressed above, in question 5, where we discuss why we think that such outliers are not “determinant for the observed level of rhythmicity”. As also mentioned above, even though we think that they are too noisy to be informative, we plan to include all individual profiles in the Supplementary Material.

      (9) The features in the experimental periodogram data in Figures 3B and D are consistent with weakened complex rhythmicity rather than arrhythmicity. The inclusion of more individual records in the groups might have provided the added statistical power to demonstrate this. Graphs similar to those in 1G and 1I, might have better illustrated qualitative and quantitative aspects of the oviposition rhythms upon per knockdown via MB122B and Mai179; Pdf-Gal80.

      We assume that the features mentioned refer to the appearance in the periodograms of two small peaks under the significance lines. We are aware that in the studies of the rhythmicity of locomotor activity such features are usually interpreted as “complex rhythms”, i.e. as evidence of the existence of two different mechanisms producing two different rhythms in the same individual. In our case, however, at least two other possibilities should be taken into account. Since the periodograms we show assess the rhythmicity of the average time series of several individuals, the two small peaks could correspond to the periods of two different subpopulations. Another possibility could be that such peaks are simply an artifact of the method in the analysis of time series that consist of very few cycles (as explained above) and also few points per cycle. A cursory examination of the individual profiles, that will be provided in the new version, do not seem to support any of the first two possibilities mentioned. On the other hand, we will show evidence that the analysis of series that are perfectly random sometimes result in periodograms with some small peaks.

    1. Author response:

      We would like to thank the editors and reviewers for taking the time to help improve our manuscript. We appreciate the feedback and will definitely increase the level of methodological detail in a revised submission.

      Here is a brief summary of our plan to address the points raised by the reviewers. We will respond to the comments in a point-by-point manner when we resubmit a revised manuscript.

      Reviewer 1

      This reviewer raised a question about the 60 Hz frame rate for recording. We agree that increasing the number of cameras and frame rate would improve the tracking quality, but this would come at the cost of scalability. In the current study (and other concurrent studies in the lab), we recorded from 10-20 families simultaneously to try to sample the distribution of behavioral responses to stimuli observed in animals in our colony. This was only possible logistically because of the lightweight equipment design allowing us to record data from animals without large disruptions to their home-cage environment.

      One strategy for acquiring higher-resolution data is to build a small number of enclosures that are fully surrounded by cameras, and to cycle animals through these enclosures (1). However, this strategy limits throughput by reducing the number of animals per day that can be studied. If the size and cost of cameras and computers decreases in the future, then this recording strategy will be scalable to the whole-colony level. For our current study and analysis, we are limited by the resolution of our dataset. We do believe that our data (although not a perfect 3d reconstruction or an extremely high frame rate) is sufficient to label behavioral states with high accuracy. We will add a figure to more clearly show that behavioral state data can be accurately inferred from this imperfect data, which has also been recently highlighted by other groups (2).

      Additionally, with recent progress in the application of deep learning to animal pose tracking, new models can infer 3d pose dynamics from 2d data (3) and leverage spatiotemporal structure to clean up noisy data (4). We believe that other groups will be able to use these types of approaches to extract much more value from this dataset. So, in summary, we do understand the concern related to reconstruction quality and will 1) more clearly define the usefulness of our current models, 2) release our data and code so that others can build upon it or repurpose it, and 3) plan future experiments with higher camera count and frame rate as permitted by logistical constraints. 

      Reviewer 2

      This reviewer asked for an increased level of methodological detail. We will try to address this in a few ways:

      (1) Code and data sharing. We believe that many of the questions related to the methodology will be best answered by sharing the data and code directly. Because there is a large amount of code associated with this manuscript, it is impractical to list every step and every parameter in the paper. Along with our revised manuscript, we will make our data and code publicly available. That said, we will improve our description of key parameters in the paper as the reviewer suggested.

      (2) More detailed Methods section. The reviewer asked us to provide more methodological detail. We understand that this is currently a weakness of our manuscript, and we will focus on addressing it. For instance, the reviewer rightly points out that we did not describe the motion watches used to generate the data in Figure S7. We will address this.

      (3) Simplify the manuscript. The paper currently has 22 figures, and further analysis could be done based on the results shown in any of them. For instance, this reviewer asked us to add a comparison across females and males (similar to our comparison of juveniles and adults). While we plan to add that analysis, we recognize that there are several figures/panels that are not closely related to our intended goal of describing the patterns we found in our large dataset. We will simplify the manuscript by removing some excess figures/panels and focus on describing the parts of the analysis that are crucial to our conclusions in greater detail.

      (4) More careful language. This reviewer pointed out that there were some inaccuracies with our descriptive language. For instance, we used the term "natural" behavior to describe the behavior of animals in captivity, which may more accurately be described as their home-cage behavior. We will be more careful to align our language to the standard for the field. For instance, several studies refer to unrestrained behavior in a laboratory setting as "spontaneous" behavior rather than "natural" behavior (5). In our case, the data consists of both spontaneously occurring behavior and responses to a set of stimuli. We will make sure that the descriptions are more precise in the revised manuscript.

      (1) Bala, P. C. et al. Automated markerless pose estimation in freely moving macaques with OpenMonkeyStudio. Nat Commun 11, (2020).

      (2) Weinreb, C. et al. Keypoint-MoSeq: parsing behavior by linking point tracking to pose dynamics. bioRxiv (2023) doi:10.1101/2023.03.16.532307.

      (3) Gosztolai, A. et al. LiftPose3D, a deep learning-based approach for transforming two-dimensional to three-dimensional poses in laboratory animals. Nat Methods 18, 975–981 (2021).

      (4) Wu, A. et al. Deep Graph Pose: a semi-supervised deep graphical model for improved animal pose tracking. Adv Neural Inf Process Syst 33, 6040–6052 (2020).

      (5) Levy, D. R. et al. Mouse spontaneous behavior reflects individual variation rather than estrous state. Curr Biol 33, 1358-1364.e4 (2023).

    1. Author response:

      Reviewer #1 (Public review):

      This study is focused on a population of neurons in the mouse parasubthalamic nucleus (pSTN) that express Tackhykinin1 (Tac1). This gene has been used before to target pSTN for functional circuit studies because it is fairly selective for pSTN in this region, though it targets only a subset of pSTN neurons. Prior work has shown that activity in these neurons can impact motivated behaviors, including feeding and drinking behaviors, and that their activity is associated with aversion or avoidance behaviors. While not breaking much new ground, this study adds to that work by making use of a 2-way active avoidance assay, where a CS predicts a US (footshock), that the mice can escape. Using fiber photometry, the authors show convincing evidence that Tac1 neurons in pSTN increase their activity in response to a US footshock, and that after some pairings the neurons will start responding to the CS too, though to a lesser extent than the US. Their most important data shows that either ablation or optogenetic inhibition of these cells can hugely block the active avoidance (escape) behavior, suggesting these neurons are key for the performance of this task, which they interpret as key for learning the task (but see more below). They show that optogenetic stimulation is aversive in a real-time place assay, and when paired with footshock can enhance active avoidance behavior. Finally, they show that Tac1 pSTN axons in PVT recapitulate these effects while showing that axons in CEA or PBN may only recapitulate some of these effects (more below). Overall I think the data is solid and shows that the activity of Tac1 pSTN neurons in the 2 way active avoidance task is causally related to avoidance behavior in the direction that would be predicted by recent literature. However, I think the authors overstate the conclusions in the title, abstract, and text. I do not think the data make a strong case for a role for these cells in learning, at least in any classical sense, as used in the title and abstract and elsewhere. Also, the statement in the abstract that the pSTN mediates its effects 'differentially' through its downstream targets is not convincingly supported by data.

      We are very pleased that Reviewer 1 thought our data is solid.

      Major concerns:

      (1) The authors infer that the activity in the Tac1 pSTN neurons is necessary for aversive or avoidance 'learning'. But this is not well defined, what exactly does that mean and what types of evidence would support or falsify such a hypothesis? Moreover, the authors show convincingly, and in line with prior reports, that these cells are activated by aversive stimuli (here footshock), and that activation of these cells is sufficient to induce avoidance behavior. Because manipulation of these cells can serve as a primary negative reinforcer, it becomes even more challenging and important to explain how experiments that manipulate these cells while measuring behavior/performance can discriminate between changes in: (1) primary aversion, (2) motivation to avoid, (3) associative learning, or (4) memory/retrieval. The authors seem to favor #3, but they don't make a clear case for this point of view or else what they mean by 'avoidance learning'. In my opinion, the data do not well discriminate between possibilities 1 through 3. The authors should clarify their logic and temper their conclusions throughout.

      Thank you Reviewer 1 for providing us insightful suggestions. Based on our fiber photometry data that the activities of PSTN Tac1+ neurons show a significant increase in CS-evoked calcium fluorescent signals in late trials relative to those in early trials (Figure 1H-K) and our optogenetic inhibition experiments during CS (Figure 2N-Q), these results illustrate that the activities of PSTN Tac1+ neurons are modulated by learning and are required for active avoidance learning. Moreover, PSTN Tac1+ neurons are activated by footshock and activation of these cells is sufficient to induce avoidance behavior. These findings demonstrate that PSTN Tac1+ neurons encode aversive information. Together, our current data support that PSTN Tac1+ neurons encode both aversive event and its predicting cue. We will clarify our conclusions in the revised manuscript.

      (2) Abstract line 37 is not well supported. The authors focus mostly on pSTN projections to PVT and show that the measurements or manipulation of these axons recapitulates the effects seen with pSTN cell bodies. The authors do fewer studies of axons in CeA and PBN, but do find that they can recapitulate the effects with opsin inhibition, but detect no effects with opsin stimulation. However, the lack of effect with opsin stimulation in Figure S7a-e proves very little on its own. It could be technical, due to inadequate expression or functional efficacy. It is not supported by histological and functional evidence that the manipulation was effective. Overall, I can only conclude that the projections to these regions might be very similar (based on the inhibition data), or might be a little different. The data are thus inadequate to support the authors' claim that the pSTN mediates learning differentially through its downstream targets.

      In the revised version of manuscript, we will provide more histological and functional evidence for the PSTN-to-CeA and PSTN-to-PBN circuits to support our conclusion on the functional roles of these downstream targets. Similar with our anterograde experiment that the PSTN densely projects to CeA and PBN (Figure S6), optogenetic activation and inhibition experiments showed dense axonal terminals in the CeA and PBN from the PSTN and this line of data will be included in the revised manuscript. In addition, we will further examine these circuits by investigating the functional roles of CeA-projecting or PBN-Projecting PSTN neurons during 2-way active avoidance task.

      Other concerns:

      (3) Line 93 is not adequately supported by data in Figure 1b. Additional data is needed that shows expression across cases, including any spread that may be visible when zooming out from pSTN. Additional methods are needed to indicate what exclusion criteria were applied and how many mice were excluded. These data could help support the statement on line 93 that expression was largely restricted within pSTN.

      In the revised version of manuscript, we will provide larger example images containing pSTN and its adjacent areas to demonstrate that the viral expression is well restricted into this brain area. Moreover, we will provide detailed information on the exclusion criteria and the number of mice excluded in the Method section.   

      (4) From the results and methods it is not clear where the GFP signal would come from in the mice expressing Casp3 for the ablation studies. It is therefore not clear if the absence of GFP should be taken as evidence of cell loss. For example, it is not clear if multiple vectors were used, if volumes and titers were carefully matched between control groups, or if competition/occlusion between AAVs could be ruled out. It is also not clear how this was quantified, that is how many sections/subjects and how counting was done. It is not clear how long was waited between the AAV infusion, behavior, and euthanasia, perhaps especially important for the ablation done after avoidance learning occurred.

      I totally agree with Reviewer 1’s concerns. We will perform immunohistochemistry or in situ hybridization for Tachykinin-1 itself and then measure colocalization of GFP with Tachykinin-1 inside and outside of the PTSN, and the degree of absence of Tachykinin-1 in Casp mice. In addition, we will provide more detailed experimental information in the revised manuscript.

      (5) The authors should consider showing individual measurements and not just mean/sem wherever feasible, for example, to support the statement on line 141 that 'all ablated mice showed...'.

      Thank you Reviewer 1 for this suggestion. We will re-plot the data as individual measurements in the revised manuscript.

      (6) S3 is an important control for interpreting data in Figure 2d-i. Something similar is needed to support the inferences made in 2j-u. The very strong effect showing a lack of active avoidance in response to CS or the US when pSTN Tac1 neurons are inhibited during CS or during US suggests that something gross may be going on, such as a gross motor or sensory response that supersedes the effect of footshock. The authors do not comment on whether there are any gross behavioral responses to the inhibition, but an experiment as in S3 is needed, for example, to show that behavior is intact during pSTN inhibition if delivered after the mice already learned to associate CS with US.

      Thank you Reviewer 1 for this insightful suggestion. During the review process, we have performed this line of experiment as in Figure S3. We measured the behavioral responses during pSTN optogenetic inhibition after the mice already learned to associate CS with US and found most GtACR-expressing mice showed unaffected avoidance learning. This data will be included in the revised manuscript.

      (7) The authors use 100 shocks of 0.8 mA for 7 days. I think this is quite strong and in the pSTN inhibition experiments it seems to be functionally 'inescapable' and could thus produce behaviors similar to 'learned helplessness'. Can the authors consider whether this might contribute to the striking findings they observed in their opsin inhibition assays?

      I agree with the Reviewer 1’s comment on the string findings in the optogenetic inhibition results. Indeed, based on the results on days 1 and 2, optogenetic inhibition of PSTN tac1+ neurons has significantly blocked GtACR-expressing animals’ behavioral performance during 2-way active avoidance task. To examine whether the effect by optogenetic inhibition of these neurons could possibly decline with prolonged training, we conducted additional 5-day training. We will discuss and add this comment in the revised manuscript.

      (8) The description of the experiment in S5 is inadequate. What are the adjacent areas? Where do the authors see spread? The use of the word 'case' in figure S5 implies an individual case, but the legend says 5 mice were used for 'case 1' and 3 mice were used for 'case 2'. The use of the word 'off-target in the figure implies that the expression was of the intended target. But the text of results and methods implies it was intentional targeting of unnamed and unshown adjacent regions. This should be clarified.

      We will add histological images and clarify these comments in the revised manuscript. The purpose of this experiment is to illustrate that even slightly spreading ChR2 viruses into Tac1+ neurons of the adjacent areas of the PSTN did not result in behavioral changes and this will indirectly support the main behavioral function caused by the PSTN tac1+ neurons rather than its neighboring areas. Because Tac1+ neurons outside the PSTN are sparsely expressed, it is quite difficult to completely restrict the viral expression in the PSTN from the anterior to the posterior. Thus, we will provide detailed information on the exclusion criteria and the number of mice excluded in the Method section.   

      (9) The authors suggest the CPA study is divergent from Serra et al 2023. Though I think this could be due to how the conditioning was done, it would be helpful for the authors to include less processed data. This would aid in possible interpretations for any divergences across studies. Can the authors include raw data (in seconds of time spent) in each compartment for each group across baseline and test days?

      We will follow Reviewer 1’s suggestion to include raw data (in seconds of time spent) in each compartment for each group across baseline and test days in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Hu et. al presents a clearly-designed examination of the role of tachykinin1-expressing neurons in the parasubthalamic nucleus of the lateral posterior hypothalamus (PTSN) in active avoidance learning. These glutamatergic neurons have previously been implicated in responding to negative stimuli. This manuscript expands the current understanding of PTSNTac1 neurons in learned responses to threats by showing their role in encoding and mediating the active avoidance response. The authors first use bulk fiber photometry imaging to show the encoding of the active avoidance procedure, followed by cell-type specific manipulations of PTSNTac1 neurons during active avoidance. Finally, they show that encoding and mediation of active avoidance in a downstream target of PTSNTac1 neurons, the PVT/intermediodorsal nuclei of the dorsal thalamus (IMD), has the same effect as what was discovered in the cell body. This contrasts other output regions of the PTSN, such as the PBN and CeA, which were not found to promote active avoidance learning. The experiments presented were well-designed to support the conclusions of the authors, however, the manuscript is missing several key control experiments and supplemental information to support their main findings.

      Strengths:

      The manuscript provides information on a brain region and downstream target that mediates active avoidance learning. The manuscript provides valuable information via necessity and sufficiency experiments to show the role of the population of interest (PTSNTac1 neurons) in active avoidance learning. The authors also performed most behavior experiments in male and female mice, with adequate power to address potential sex differences in the control of active avoidance by PTSNTac1 neurons. Finally, the manuscript provides valuable information about the specificity of the PTSNTac1 downstream target in regulating active avoidance learning, identifying the PVT/intermediodorsal nuclei of the dorsal thalamus as the key target and ruling out the PBN and CeA.

      We highly appreciate that Reviewer 2 thought that our experiments presented were well-designed to support the conclusions and provided valuable information in several aspects.

      Weaknesses:

      However, several main conclusions of the paper must be interpreted carefully due to missing or inadequate control experiments and histological verification.

      (1) Inadequate presentation of viral localization. The authors state that expression was "largely restricted within PSTN" however there is no quantification of the amount of viral expression beyond the target region. Given that Tac1 is expressed in neighboring regions, it is critical to show the viral expression and fiber implant location data for all animals included in the figures. Furthermore, criteria for inclusion and exclusion based on mistargeting should be delineated. This should also be clearly outlined for the experiments in Figure S5, where "behavioral effects of activation of sparsely Tac1-expressing neurons in two adjacent areas of PSTN" was tested but the location of viral expression in those cases is unclear.

      Similar with questions 3 and 8 of Reviewer 1. We will provide the viral expression and fiber implant location data for all animals included in the figures and histological images in Figure S5 in the revised manuscript. Moreover, we will provide detailed information on the exclusion criteria and the number of mice excluded in the Method section.  

      2) Lack of motion artifact correction with isosbestic signal for GCamp recordings. It is appreciated that the authors included a separate EGFP-expressing group to compare to the GCamp-expressing group, however, additional explanation is required for the methods used to analyze the raw fluorescent signal. Namely, were fluorescent signals isosbestic-corrected prior to calculating ΔF/F? If no isosbestic signal was used to correct motion artifacts within a recording session, additional explanation is needed to explain how this was addressed. The lack of motion artifacts in the EGFP signal in a separate cohort is inadequate to answer this caveat as motion artifacts are within-animal.

      We will follow Reviewer 2’s suggestion and perform isosbestic-correction for fluorescent signals prior to calculating ΔF/F. We will re-plot related figures and add this information in the revised manuscript.

      (3) Missing control experiment demonstrating intact locomotor performance in caspase ablation experiments. The authors use caspase ablation of PTSNTac1 neurons prior to active avoidance learning to appraise the necessity of this cell population. However, a control experiment showing intact locomotor ability in ablated mice was not performed.

      We will follow Reviewer 2’s suggestion to perform a control experiment showing intact locomotor ability in caspase 3-ablated mice and will include this data in the revised manuscript.

      (4) Missing control experiment demonstrating [lack of] valence with PTSN silencing manipulations. The authors performed a real-time and conditioned place preference experiments for ChR2-expressing mice (Fig 3M) and found stimulation to be negatively-valenced and generate an aversive memory, respectively. Absent this control experiment with silencing, an alternative conclusion remains possible that optogenetic silencing via GtACR2 created nonspecific location preferences in the active avoidance apparatus, confounding the interpretation of those results.

      Thank you Reviewer 2 for this useful suggestion. We will examine the valence with PTSN silencing manipulations by using a RTPP test and add this data in the revised manuscript.

      (5) Incomplete analysis of sex differences. Data in female mice is conspicuously missing from inhibition experiments. The rationale for exclusion from this dataset would be useful for the interpretation of the other noted sex differences.

      Thank you Reviewer 2 for this useful suggestion. During the review process, we have performed ablation and inhibition experiments in females, demonstrating similar behavioral effects as those in males. We will add these data in the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      This study by Hu et al. examined the role of tachykinin1 (Tac1)-expressing neurons in the para subthalamic nucleus (PSTH) in active avoidance of electric shocks. Bulk recording of PSTH Tac1 neurons or axons of these neurons in PVT showed activation of a shock-predicting tone and shock itself. Ablation of these neurons or optogenetic manipulation of these neurons or their projection to PVT suggests the causality of this pathway with the learning of active avoidance.

      Strengths:

      This work found an understudied pathway potentially important for active avoidance of electric shocks. Experiments were thoroughly done and the presentation is clear. The amount of discussion and references are appropriate.

      We are very pleased to have Reviewer 3’s positive comments on the manuscript.

      Weaknesses:

      Critical control experiments are missing for most experiments, and statistical tests are not clear or not appropriate in most parts. Details are shown below.

      (1) There are some control experiments missing. Notably, optogenetic manipulation is not verified in any experiments. It is important to verify whether neural activation with optogenetic activation is at the physiological level or supra-physiological level, and whether optogenetic inhibition does not cause unwanted activity patterns such as rebound activation at the critical time window.

      Thank you Reviewer 3 for this useful suggestion. We will perform in vitro slice recording experiments to verify optogenetic manipulations and add this line of evidence in the revised manuscript.

      (2) Neural ablation with caspase was confirmed by GFP expression. However, from the present description, a different virus to express EITHER caspase or GFP was injected, and then the numbers of GFP-expressing neurons were compared. It is not clear how this can detect ablation.

      Similar with question 4 of Reviewer 1. We will perform immunohistochemistry or in situ hybridization for Tachykinin-1 itself and then measure colocalization of GFP with Tachykinin-1 inside and outside of the PTSN, and the degree of absence of Tachykinin-1 in Casp-ablated mice. In addition, we will provide more detailed experimental information in the revised manuscript.

      (3) In many places, statistical approaches are not clear from the present figures, figure legends, and Methods. It seems that most statistics were performed by pooling trials, but it is not described, or multiple "n" are described. For example, it is explicitly mentioned in Figure 4H, "n = 3 mice, n = 213 avoidance trials and n = 87 failure trials". The authors should not pool trials, but should perform across-animal tests in this and other figures, and "n" for should be clearly described in each plot.

      We have provided all statistical information in the Supplementary Table 1. In the revised manuscript, we will perform across-animal tests, re-plot new figures and provide clear statistical information.

      (4) It is also unclear how the test types were selected. For example, in Figure 1K and O with similar datasets, one is examined by a paired test and the other is by an unpaired test. Since each animal has both early vs late trials, and avoidance vs failure trials, paired tests across animals should be performed for both.

      Following Reviewer 3’s suggestion, we will perform across-animal tests. In the first version of our manuscript, for fiber photometry experiments, we pooled trial data of each animal and performed statistics tests across trials. Because avoidance and failure trials were different, we thus selected an unpaired test for this kind of dataset.

      (5) It is also strange to show violin plots for only 6 animals. They should instead show each dot for each animal, connected with a line to show consistent increases of activity in late vs early trials and avoidance vs failure trials.

      Similar with question 4 of Reviewer 3, we pooled trial data of each animal and performed statistics tests across trials. We will perform across-animal tests and re-plot figures by connecting with a line to show consistent increases of activity in late vs early trials and avoidance vs failure trials for each animal.

      (6) To tell specificity in avoidance learning, it is better to show escape in the current trials with optogenetic manipulation.

      Thank you Reviewer 3 for this useful suggestion. We will follow this suggestion and add this analysis in the revised manuscript.

      (7) For place aversion, % time decrease across days was tested. It is better to show the original number before normalization, as well.

      Similar with question 9 of Reviewer 1, we will show the original number before normalization in the revised manuscript.

      (8) For anatomical results in Figure S6, it is important to show images with lower magnification, too.

      We will follow this suggestion and provide histological images with lower magnification in the revised manuscript.

      (9) Inactivation of either pathway from PSTH to PBN or to CeA also inhibits active avoidance, but the authors conclude that these effects are "partial" compared to the inactivation of PSTH to PVT. It is not clear how the effects were compared since the effects of PSTH-CeA inactivation are quite strong, comparable to PSTH-PVT inactivation by eye. They should quantify the effects to conclude the difference.

      We will quantify the effects of different downstream targets of the PSTN to make a precise conclusion.

      (10) Supplementary table 1: as mentioned above, n for statistical tests should be clearer.

      As mentioned above, we will perform across-animal tests and provide clear statistical information in the figure legends and supplementary table 1.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public review): 

      Summary: 

      The investigators in this study analyzed the dataset assembly from 540 Salmonella isolates, and those from 45 recent isolates from Zhejiang University of China. The analysis and comparison of the resistome and mobilome of these isolates identified a significantly higher rate of cross-region dissemination compared to localized propagation. This study highlights the key role of the resistome in driving the transition and evolutionary 

      Thank you for summarizing our work. According to your comments, we carefully considered and responded to them and made corresponding revisions to the text. Additionally, to fully contextualize the background knowledge and clarify the major points in this study, we add some references.

      Upon further review of our initial manuscript, we realized that the original submission did not strictly follow the lineage order proposed by Zhou et al. (Natl Sci Rev. 2023 Sep 2;10(10):nwad228). To avoid confusion and keep the uniform knowledge in the typing system, we have adjusted the lineage nomenclature along the revised manuscript to reflect the corrected order as follows:

      Author response table 1.

      To ensure consistency with previous studies, we have revised the nomenclature for the different lineages of bvSP.

      Strengths: 

      The isolates included in this study were from 16 countries in the past century (1920 to 2023). While the study uses S. Gallinarun as the prototype, the conclusion from this work will likely apply to other Salmonella serotypes and other pathogens. 

      Thanks for the constructive comments and the positive reception of the manuscript.

      Weaknesses: 

      While the isolates came from 16 countries, most strains in this study were originally from China. 

      We appreciate the reviewer's observation regarding the sampling distribution of isolates in this study. We acknowledge that while the isolates were collected from 15 different countries, with a significant proportion originated from China (Author response image 1). This focus is due to several reasons:

      Author response image 1.

      Geographic distribution of 580 S. Gallinarum. Different colors indicate the countries of origin for the 580 S. Gallinarum strains in the dataset. Darker shades represent higher numbers of strains.

      (1) As once a globally prevalent pathogen across the 20th century, S. Gallinarum was listed by the World Organization for Animal Health (WOAH) due to its economic importance. After 30 years of implementation of the National Poultry Improvement Plan in the US, it was almost eradicated in high-income countries, and interestingly, it became an endemic pathogen with sporadic outbreaks in most low- or middle-income countries like China and Brazil. Given the vast expanse of China's land area and the country's economic factors, implementing the same measures remains challenging.  

      (2) S. Gallinarum is an avian-specific pathogen, particularly affecting chickens, and its distribution is closely linked to chicken meat production in different countries. There are more frequent reports of fowl typhoid in some high chicken-producing developing countries. Data from the United States Department of Agriculture (USDA) on annual chicken meat production for 2023/2024 show that the global distribution of S. Gallinarum aligns closely with the overall chicken meat production of these countries (https://fas.usda.gov/data/production/commodity/0115000).

      Author response image 2.

      The United States Department of Agriculture (USDA) data on annual chicken meat production for 2023/2024 across different countries globally.

      (3) Our primary objective was to investigate the localized resistome adaptation of S. Gallinarum in regions. Being a region with significant disease burden, China has reported numerous outbreaks (Sci Data. 2022 Aug 13;9(1):495; Sci Data. 2024 Feb 27;11(1):244) and a high AMR prevalence of this serovar (Natl Sci Rev. 2023 Sep 2;10(10):nwad228; mSystems. 2023 Dec 21;8(6):e0088323), making it an excellent example for understanding localized resistance mechanisms.

      (4) As China is the primary country of origin for the strains in this study, it is necessary to ensure that the strains from China are consistent with the local geographic characteristics of the country. Therefore, we conducted a correlation analysis between the number of strains from different provinces in China and the total GDP/population size of those provinces (Author response image 3). The results show that most points fall within the 95% confidence interval of the regression line. Although some points exhibit relative unbalance in the number of S. Gallinarum strains, most data points for these regions have a small sample size (n < 15). Overall, we found that the prevalence of S. Gallinarum in different regions of China is consistent with the overall nationwide trend.

      Author response image 3.

      Correlation analysis between the number of S. Gallinarum collected from different provinces in China and the total GDP/population size. The figure depicts a series of points representing individual provinces. The x-axis indicates the number of S. Gallinarum included in the dataset, while the y-axis displays the values for total GDP and total population size, respectively.

      Nevertheless, a search of nearly a decade of literature on PubMed and a summary of the S. Gallinarum genome available on public databases indicate that the dataset used is the most complete. Furthermore, focusing on a specific region within China allowed us to conduct a detailed and thorough analysis. However, we highly agree that expanding the study to include more isolates from other countries would enhance the generalizability of our findings, and we are actively collecting additional S. Gallinarum genome data. In the revised manuscript, we have further emphasized the limitations as follow:

      Lines 427-429: “However, the current study has some limitations. Firstly, despite assembling the most comprehensive WGS database for S. Gallinarum from public and laboratory sources, there are still biases in the examined collection. The majority (438/580) of S. Gallinarum samples were collected from China, possibly since the WGS is a technology that only became widely available in the 21st century. This makes it impractical to sequence it on a large scale in the 20th century, when S. Gallinarum caused a global pandemic. So, we suspect that human intervention in the development of this epidemic is the main driving force behind the fact that most of the strains in the data set originated in China. In our future work, we aim to actively gather more data to minimize potential biases within our dataset, thereby improving the robustness and generalizability of our findings.”

      Reviewer #2 (Public review): 

      Summary: 

      The authors sequence 45 new samples of S. Gallinarum, a commensal Salmonella found in chickens, which can sometimes cause disease. They combine these sequences with around 500 from public databases, determine the population structure of the pathogen, and coarse relationships of lineages with geography. The authors further investigate known anti-microbial genes found in these genomes, how they associate with each other, whether they have been horizontally transferred, and date the emergence of clades. 

      Thank you for your constructive suggestions, which are valuable and highly beneficial for improving our paper. According to your comments, we carefully considered and responded to them and made corresponding revisions to the text. Furthermore, to fully contextualize the background knowledge and clarify the major points in this study, we add some references to support our findings and policy implications.

      Upon further review of our initial manuscript, we realized that the original submission did not strictly follow the lineage order proposed by Zhou et al. (Natl Sci Rev. 2023 Sep 2;10(10):nwad228). To avoid confusion in the typing system, we have adjusted the lineage nomenclature in the revised manuscript to reflect the corrected order (see Author response table 1).

      Strengths: 

      (1) It doesn't seem that much is known about this serovar, so publicly available new sequences from a high-burden region are a valuable addition to the literature. 

      (2) Combining these sequences with publicly available sequences is a good way to better contextualise any findings. 

      Thank you so much for your thorough review and constructive comments on the manuscript.

      Weaknesses: 

      There are many issues with the genomic analysis that undermine the conclusions, the major ones I identified being: 

      (1) Recombination removal using gubbins was not presented fully anywhere. In this diversity of species, it is usually impossible to remove recombination in this way. A phylogeny with genetic scale and the gubbins results is needed. Critically, results on timing the emergence (fig2) depend on this, and cannot be trusted given the data presented. 

      We sincerely thank you for pointing out this issue. In the original manuscript, we aimed to present different lineages of S. Gallinarum within a single phylogenetic tree constructed using BEAST. However, in the revised manuscript, we have addressed this issue by applying the approach recommended by Gubbins to remove recombination events for each lineage defined by FastBAPs. Additionally, to better illustrate the removal of recombination regions in the genome, we have included a figure generated by Gubbins (New Supplementary Figure 12). 

      Our results indicate that recombination events are relatively infrequent in Lineage 1, followed by Lineage 3, but occur more frequently in Lineage 2. In the revised manuscript, we have included additional descriptions in the Methods section to clarify this analysis. We hope these modifications adequately address the reviewer’s concerns and enhance the trustworthiness of our findings.

      (2) The use of BEAST was also only briefly presented, but is the basis of a major conclusion of the paper. Plot S3 (root-to-tip regression) is unconvincing as a basis of this data fitting a molecular clock model. We would need more information on this analysis, including convergence and credible intervals. 

      Thank you very much for raising this issue. We decided to reconduct separate BEAST analyses for each lineage, accurately presenting the evolutionary scale based on the abovementioned improvements. The implementation of individual lineage for BEAST analysis was conducted based on the following steps:

      (1) Using R51 as the reference, a reference-mapped multiple core-genome SNP sequence alignment was created, and recombination regions were detected and removed as described above.

      (2) TreeTime was used to assess the temporal structure by performing a regression analysis of the root-to-tip branch distances within the maximum likelihood tree, considering the sampling date as a variable (New Supplementary Figures 6). However, the root-to-tip regression analysis presented in New Supplementary Figures 6 was not intended as a basis for selecting the best molecular clock model; its purpose was to clean the dataset with appropriate measurements.

      (3) To determine the optimal model for running BEAST, we tested a total of six combinations in the initial phase of our study. These combinations included the strict clock, relaxed lognormal clock, and three population models (Bayesian SkyGrid, Bayesian Skyline, and Constant Size). Before conducting the complete BEAST analysis, we evaluated each combination using a Markov Chain Monte Carlo (MCMC) analysis with a total chain length of 100 million and sampling every 10,000 iterations. We then summarized the results using NSLogAnalyser and determined the optimal model based on the marginal likelihood value for each combination. The results indicated that the model incorporating the Bayesian Skyline and the relaxed lognormal clock yielded the highest marginal likelihood value in our sample. Then, we proceeded to perform a timecalibrated Bayesian phylogenetic inference analysis for each lineage. The following settings were configured: the "GTR" substitution model, “4 gamma categories”, the "Relaxed Clock Log Normal" model, the "Coalescent Bayesian Skyline" tree prior, and an MCMC chain length of 100 million, with sampling every 10,000 iterations.

      (4) Convergence was assessed using Tracer, with all parameter effective sampling sizes (ESS) exceeding 200. Maximum clade credibility trees were generated using TreeAnnotator. Finally, key divergence time points (with 95% credible intervals) were estimated, and the tree was visualized using FigTree. 

      For the key lineages, L2b and L3b (carrying the resistome, posing antimicrobial resistance (AMR) risks, and exhibiting intercontinental transmission events), we have redrawn Figure 2 based on the updated BEAST analysis results (New Figure 2). For L1, L2a, and L3c, we have added supplementary figures to provide a more detailed visualization of their respective BEAST analysis outcomes (New Supplementary Figures 3-5). The revised BEAST analysis indicates that the origin of L3b in China can be traced back to as early as 1683 (95% CI: 1608 to 1839). In contrast, the earliest possible origin of L2b in China dates back to 1880 (95% CI: 1838 to 1902). This indicates that the previous manuscript's assumption that L2b is an older lineage compared to L3b may be inaccurate. 

      Furthermore, In the revised manuscript, we specifically estimated the time points for the first intercontinental transmission events for the two major lineages, L2b and L3b. Our results indicate that L2b, likely underwent two major intercontinental transmission events. The first occurred around 1893 (95% CI: 1870 to 1918), with transmission from China to South America. The second major transmission event occurred in 1923 (95% CI: 1907 to 1940), involving the spread from South America to Europe. In contrast, the transmission pattern of L3b appears relatively more straightforward. Our findings show that L3b, an S. Gallinarum lineage originating in China, only underwent one intercontinental transmission event from China to Europe, likely occurring around 1790 (95% CI: 1661 to 1890) (New Supplementary Figure 7). Based on the more critical BEAST analysis for each lineage, we have revised the corresponding conclusions in the manuscript. We believe that the updated BEAST analysis, performed using a more accurate recombination removal approach, significantly enhances the rigor and credibility of our findings.

      (3) Using a distance of 100 SNPs for a transmission is completely arbitrary. This would at least need to be justified in terms of the evolutionary rate and serial interval. 

      Using single nucleotide polymorphism (SNP) distance to trace pathogen transmission is a common approach (J Infect Dis. 2015 Apr 1;211(7):1154-63) and in our previous studies (hLife 2024; 2(5):246-256. mLife 2024; 3(1):156-160.). When the SNP distance within a cluster falls below a set threshold, the strains in that cluster are considered to have a potential direct transmission link. It is generally accepted that the lower the threshold, the more stringent the screening process becomes. However, there is little agreement in the literature regarding what such a threshold should be, and the appropriate SNP cut-off for inferring transmission likely depends critically on the context (Mol Biol Evol. 2019 Mar 1;36(3):587-603).

      In this study, we compared various thresholds (SNPs = 5, 10, 20, 25, 30, 35, 40, 50, 100) to ensure clustering in an appropriate manner. First, we summarized the tracing results under each threshold (Author response image 4), which demonstrated that, regardless of the threshold used, all strains associated with transmission events originated from the same location (New Figure 3a).

      Author response image 4.

      Clustering results of 45 newly isolated S. Gallinarum strains using different SNP thresholds of 5, 10, 15, 20, 25, 28, 30, 50, and 100 SNPs. The nine subplots represent the clustering results under each threshold. Each point corresponds to an individual strain, and lines connect strains with potential transmission relationships.

      In response to your comments regarding the evolutionary rate, we estimated the overall evolutionary rate of the S. Gallinarum using BEAST. We applied the methodology described by Arthur W. Pightling et al. (Front Microbiol. 2022 Jun 16; 13:797997). The numbers of SNPs per year were determined by multiplying the evolutionary rates estimated with BEAST by the number of core SNP sites identified in the alignments. We hypothesize that a slower evolutionary rate in bacteria typically requires a lower SNP threshold when tracing transmission events using SNP distance analysis. Pightling et al.'s previous research found an average evolutionary rate of 1.97 SNPs per year (95% HPD, 0.48 to 4.61) across 22 different Salmonella serotypes. Our updated BEAST estimation for the evolutionary rate of S. Gallinarum suggests it is approximately 0.74 SNPs per year (95% HPD, 0.42 to 1.06). Based on these findings, and our previous experience with similar studies (mBio. 2023 Oct 31;14(5):e0133323.), we set a threshold of 5 SNPs in the revised manuscript.

      Then, we adopted the newly established SNP distance threshold (n=5) to update Figure 3a and New Supplementary Figure 8. The heatmap on the far right of New Figure 3a illustrates the SNP distances among 45 newly isolated S. Gallinarum strains from two locations in Zhejiang Province (Taishun and Yueqing). New Supplementary Figure 8 simulates potential transmission events between the bvSP strains isolated from Zhejiang Province (n=95) and those from China with available provincial information (n=435). These analyses collectively demonstrate the localized transmission pattern of bvSP within China. Our analysis using the newly established SNP threshold indicates that the 45 strains isolated from Taishun and Yueqing exhibit a highly localized transmission pattern, with pairs of strains exhibiting potential transmission events below the set threshold occurring exclusively within a single location. Subsequently, we conducted the SNP distance-based tracing analysis for the 95 strains from Zhejiang Province and those from China with available provincial information (n=435) (New Supplementary Figure 8, New Supplementary Table S8). Under the SNP distance threshold (n=5), we identified a total of 91 potential transmission events, all of which occurred exclusively within Zhejiang Province. No inter-provincial transmission events were detected. Based on these findings, we revised the methods and conclusions in the manuscript accordingly. We believe that the updated version well addresses your concerns.

      Nevertheless, the final revised and updated results do not change the conclusions presented in our original manuscript. Instead, applying a more stringent SNP distance threshold allows us to provide solid evidence supporting the localized transmission pattern of S. Gallinarum in China. 

      (4) The HGT definition is non-standard, and phylogeny (vertical inheritance) is not controlled for.  

      The cited method: 

      'In this study, potentially recently transferred ARGs were defined as those with perfect identity (more than 99% nucleotide identity and 100% coverage) in distinct plasmids in distinct host bacteria using BLASTn (E-value {less than or equal to}10−5)' 

      This clearly does not apply here, as the application of distinct hosts and plasmids cannot be used. Subsequent analysis using this method is likely invalid, and some of it (e.g. Figure 6c) is statistically very poor. 

      Thank you for raising this important question. In our study, Horizontal Gene Transfer (HGT) is defined as the transfer of genetic information between different organisms, a process that facilitates the spread of antibiotic resistance genes (ARGs) among bacteria. This definition of HGT is consistent with that used in previous studies (Evol Med Public Health. 2015; 2015(1):193–194; ISME J. 2024 Jan 8;18(1):wrad032). In Salmonella, the transfer of antimicrobial resistance genes via HGT is not solely dependent on plasmids; other mobile genetic elements (MGEs), such as transposons, integrons, and prophages, also play significant roles. This has also  been documented in our previous work (mSystems. 2023 Dec 21;8(6):e0088323). Given the involvement of various MGEs in the horizontal transfer of ARGs, we propose that the criteria for evaluating horizontal transfer via plasmids can also be applied to ARGs mediated by other MGEs.

      In this study, we adopted stricter criteria than those used by Xiaolong Wang et al. Specifically, we defined two ARGs as identical only if they exhibited 100% nucleotide identity and 100% coverage. To address concerns regarding the potential influence of vertical inheritance in our analysis, we have made the following improvements. In the revised manuscript, we provide a more detailed table that includes the co-localization analysis of each ARG with mobile genetic elements (New Supplementary Table 9). For prophages and plasmids, we required that ARGs be located directly within these elements. In contrast, for transposons and integrons, we considered ARGs to be associated if they were located within a 5 kb region upstream or downstream of these elements (Nucleic Acids Res. 2022 Jul 5;50(W1):W768-W773). 

      In the revised manuscript, we first categorized a total of 621 ARGs carried by 436 bvSP isolates collected in China according to the aforementioned criteria and found that 415 ARGs were located on MGEs. After excluding the ARGs not associated with MGEs, we recalculated the overall HGT frequency of 10 types of ARGs in China, the horizontal ARGs transfer frequency in three key regions, and the horizontal ARGs transfer frequency within a single region (New Supplementary Table 7). Based on the results, we updated relevant sections of the manuscript and remade Figure 6. The updated manuscript describes the results of this section as follows:

      “Horizontal transfer of resistome occurs widely in localized bvSP

      Horizontal transfer of the resistome facilitates the acquisition of AMR among bacteria, which may record the distinct acquisition event in the bacterial genome. To compare these events in a geographic manner, we further investigated the HGT frequency of each ARG carried by bvSP isolated from China and explored the HGT frequency of resistome between three defined regions. Potentially horizontally transferred ARGs were defined as those with perfect identity (100% identity and 100% coverage) and were located on MGEs across different strains (Fig. 6a). We first categorized a total of 621 ARGs carried by 436 bvSP isolates collected in China and found that 415 ARGs were located on MGEs. After excluding the ARGs not associated with MGEs, our findings reveal that horizontal gene transfer of ARGs is widespread among Chinese bvSP isolates, with an overall transfer rate of 92%. Specifically, 50% of the ARGs exhibited an HGT frequency of 100%, indicating that these ARGs might underwent extensive frequent horizontal transfer events (Fig. 6b). It is noteworthy that certain resistance genes, such as tet(A), aph(3'')-Ib, and aph(6)-Id, appear to be less susceptible to horizontal transfer.

      However, different regions generally exhibited a considerable difference in resistome HGT frequency. Overall, bvSP from the southern areas in China showed the highest HGT frequency (HGT frequency=95%). The HGT frequencies for bvSP within the eastern and northern regions of China are lower, at 92% and 91%, respectively (Fig. 6c). For specifical ARG type, we found tet(A) is more prone to horizontal transfer in the southern region, and this proportion was considerably lower in the eastern region. Interestingly, certain ARGs such as aph(6)-Id, undergo horizontal transfer only within the eastern and northern regions of China (Fig. 6d). Notably, as a localized transmission pathogen, resistome carried by bvSP exhibited a dynamic potential among inter-regional and local demographic transmission, especially from northern region to southern region (HGT frequency=93%) (Fig. 6e, Supplementary Table 7).”

      We also modified the current version of the pipeline used to calculat the HGT frequency of resistance genes. In the revised pipeline, users are required to provide a file specifying the locations of mobilome on the genome before formally calculating the HGT frequency of the target ARGs. The specific code and data used in the calculation have been uploaded to https://github.com/tjiaa/Cal_HGT_Frequency.

      However, we also acknowledge that the current in silico method has some limitations. This approach heavily relies heavily on prior information in existing resistome/mobilome databases. Additionally, the characteristics of second-generation sequencing data make it challenging to locate gene positions precisely. Using complete genome assemblies might be a crucial approach to address this issue effectively. In the revised manuscript, we have also provided a more detailed explanation of the implications of the current pipeline.

      Regarding your second concern, "some of it (e.g., Figure 6c) is statistically very poor," the horizontal ARG transfer frequency calculation for each region was based on the proportion of horizontal transfer events of ARGs in that region to the total possible transfer events. As a result, we are unable to calculate the statistical significance between the two regions. Our aim with this approach is to provide a rough estimate of the extent of horizontal ARG transfer within the S. Gallinarum population in each region. In future studies, we will refine our conclusions by developing a broader range of evaluation methods to ensure more comprehensive assessment and validation.

      (5) Associations between lineages, resistome, mobilome, etc do not control for the effect of genetic background/phylogeny. So e.g. the claim 'the resistome also demonstrated a lineage-preferential distribution' is not well-supported. 

      Thank you for your comments. We acknowledge that the associations between lineages and the mobilome/resistome may be influenced by the genetic background or phylogeny of the strains. For instance, our conclusion regarding the lineage-preferential distribution of the resistome was primarily based on New Figure 4a, where L3 is clearly shown to carry the most ARGs. Furthermore, we observed that L3b tends to harbor bla<sub>_TEM-1B</sub>, _sul2, and tet(A) more frequently than other lineages. However, we recognize that this evidence is insufficient to support a definitive conclusion of “demonstrated a lineage-preferential distribution”. Therefore, we have re-examined the current manuscript and described these findings as a potential association between the mobilome/resistome and lineages.

      (6) The invasiveness index is not well described, and the difference in means is not biologically convincing as although it appears significant, it is very small. 

      Thank you for pointing this out. For the invasiveness index mentioned in the manuscript, we used the method described in previous studies. (PLoS Genet. 2018 May 8;14(5), Nat Microbiol. 2021 Mar;6(3):327-338). Specifically, Salmonella’s ability to cause intestinal or extraintestinal infections in hosts is related to the degree of genome degradation. We evaluated the potential for extraintestinal infection by 45 newly isolated S. Gallinarum strains (L2b and L3b) using a model that quantitatively assesses genome degradation. We analyzed samples using the 196 top predictor genes, employing a machine-learning approach that utilizes a random forest classifier and delta-bitscore functional variant-calling. This method evaluated the invasiveness of S. Gallinarum towards the host, and the distribution of invasiveness index values for each region was statistically tested using unpaired t-test. The code used for calculating the invasiveness index is available at https://github.com/Gardner-BinfLab/invasive_salmonella. In the revised manuscript, we added a more detailed description of the invasiveness index calculation in the Methods section as follows:

      Lines 592-603: “Specifically, Salmonella’s ability to cause intestinal or extraintestinal infections in hosts is related to the degree of genome degradation. We evaluated the potential for extraintestinal infection by 45 newly isolated S. Gallinarum strains (L2b and L3b) using a model that quantitatively assesses genome degradation. We analyzed each sample using the 196 top predictor genes for measuring the invasiveness of S. Gallinarum, employing a machine-learning approach that utilizes a random forest classifier and deltabitscore functional variant-calling. This method evaluated the invasiveness of S. Gallinarum towards the host, and the distribution of invasiveness index values for each region was statistically tested using unpaired t-test. The code used for calculating the invasiveness index is available at: https://github.com/Gardner-BinfLab/invasive_salmonella.”

      Regarding the second question, 'the difference in means is not biologically convincing as although it appears significant, it is very small,' we believe that this difference is biologically meaningful. In our previous work, we infected chicken embryos with different lineages of S. Gallinarum (Natl Sci Rev. 2023 Sep 2;10(10):nwad228). The virulence of thirteen strains of Salmonella Gallinarum, comprising five from lineage L2b and eight from lineage L3b, was evaluated in 16-day-old SPF chicken embryos through inoculation into the allantoic cavity. Controls included embryos that inoculated with phosphate-buffered saline (PBS). The embryos were incubated in a thermostatic incubator maintained at 37.5°C with a relative humidity ranging from 50% to 60%. Prior to inoculation, the viability of the embryos was assessed by examining the integrity of their venous system and their movements; any dead embryos were excluded from the study. Overnight cultures resuspended in PBS at a concentration of 1000 CFU per 100 μL were administered to the embryos. Mortality was recorded daily for a period of five days, concluding upon the hatching of the chicks. 

      It is generally accepted that strains with higher invasive capabilities are more likely to cause chicken embryo mortality. Our experimental results showed that the L2b, which exhibits higher invasiveness, with a slightly higher to cause chicken embryo death (Author response image 5). 

      Author response image 5.

      The survival curves of chicken embryos infected with bvSP isolates from S. Gallinarum L2b and S. Gallinarum L3b. Inoculation with Phosphate Buffer Saline (PBS) were considered controls. 

      (7) 'In more detail, both the resistome and mobilome exhibited a steady decline until the 1980s, followed by a consistent increase from the 1980s to the 2010s. However, after the 2010s, a subsequent decrease was identified.' 

      Where is the data/plot to support this? Is it a significant change? Is this due to sampling or phylogenetics? 

      Thank you for highlighting these critical points. The description in this statement is based on New Supplementary Figure 11. On the right side of New Supplementary Figure 11, we presented the average number of Antimicrobial Resistance Genes (ARGs) and Mobile Genetic Elements (MGEs) carried by S. Gallinarum isolates from different years, and we described the overall trend across these years. However, we realized that this statement might overinterpret the data. Given that this sentence does not impact our emphasis on the overall increasing trends observed in the resistome and mobilome, as well as their potential association, we decided to remove it in the revised manuscript.

      The revised paragraph would read as follows:

      Lines 261-268: “Variations in regional antimicrobial use may result in uneven pressure for selecting AMR. The mobilome is considered the primary reservoir for spreading resistome, and a consistent trend between the resistome and the mobilome has been observed across different lineages, from L1-L3c. We observed an overall gradual rise in the resistome quantity carried by bvSP across various lineages, correlating with the total mobilome content (S11 Fig). Furthermore, we investigated the interplay between particular mobile elements and resistome types in bvSP.”

      (8) It is not clear what the burden of disease this pathogen causes in the population, or how significant it is to agricultural policy. The article claims to 'provide valuable insights for targeted policy interventions.', but no such interventions are described. 

      Thank you for your constructive suggestions. Salmonella Gallinarum is an avian-specific pathogen that induces fowl typhoid, a severe systemic disease characterized by high mortality rates in chickens, thereby posing a significant threat to the poultry industry, particularly in developing countries (Rev Sci Tech. 2000 Aug;19(2):40524). In our previous research, we conducted a comprehensive meta-analysis of 201 publications encompassing over 900 million samples to investigate the global impact of S. Gallinarum (Sci Data. 2022 Aug 13;9(1):495). Our findings estimated that the global prevalence of S. Gallinarum is 8.54% (with a 95% confidence interval of 8.43% to 8.65%), with notable regional variations in incidence rates.

      Our previously analysis focused on the prevalence of S. Gallinarum (including biovars SP and SG) across six continents. The results revealed that all continents, except Oceania, exhibited positive prevalences of S. Gallinarum. Asia had the highest prevalence at 17.31%, closely followed by Europe at 16.03%. In Asia, the prevalence of biovar SP was higher than that of biovar SG, whereas in Europe, biovar SG was observed to be approximately two hundred times more prevalent than biovar SP. In South America, the prevalence of S. Gallinarum was higher than that of biovar SP, at 10.06% and 13.20% respectively. Conversely, the prevalence of S. Gallinarum was relatively lower in North America (4.45%) compared to Africa (1.10%) (Author response image 6).

      Given the significant economic losses caused by S. Gallinarum to the poultry industry and the potential risk of escalating antimicrobial resistance, more targeted policy interventions are urgently needed. Further elaboration on this implication is provided in the revised “Discussion” section as follows:

      Lines 401-416: “In summary, the findings of this study highlight that S. Gallinarum remains a significant concern in developing countries, particularly in China. Compared to other regions, S. Gallinarum in China poses a notably higher risk of AMR, necessitating the development of additional therapies, i.e. vaccine, probiotics, bacteriophage therapy in response to the government's policy aimed at reducing antimicrobial use ( J Infect Dev Ctries. 2014 Feb 13;8(2):129-36). Furthermore, given the dynamic nature of S. Gallinarum risks across different regions, it is crucial to prioritize continuous monitoring in key areas, particularly in China's southern regions where the extensive poultry farming is located. Lastly, from a One-Health perspective, controlling AMR in S. Gallinarum should not solely focus on local farming environments, with improved overall welfare on poultry and farming style. The breeding pyramid of industrialized poultry production should be targeted on the top, with enhanced and accurate detection techniques (mSphere. 2024 Jul 30;9(7):e0036224). More importantly, comprehensive efforts should be made to reduce antimicrobial usage overall and mitigate potential AMR transmission from environmental sources or other hosts (Vaccines (Basel). 2024 Sep 18;12(9):1067; Vaccines (Basel). 2023 Apr 18;11(4):865; Front Immunol. 2022 Aug 11:13:973224).”

      Author response image 6.

      A comparison of the global prevalence of S. gallinarum across continents.

      (9) The abstract mentions stepwise evolution as a main aim, but no results refer to this. 

      Thank you for raising this issue. In the revised manuscript, we have changed “stepwise evolution” to simply “evolution” to ensure a more accurate and precise description.

      (10) The authors attribute changes in population dynamics to normalisation in China-EU relations and hen fever. However, even if the date is correct, this is not a strongly supported causal claim, as many other reasons are also possible (for example other industrial processes which may have changed during this period). 

      Thank you for raising this critical issue. In the revised manuscript, we conducted a more stringent BEAST analysis for each lineage, as described earlier. This led to some changes in the inferred evolutionary timelines. Consequently, we have removed the corresponding statement from the “Results” section. Instead, we now only provide a discussion of historical events, supported by literature, that could have facilitated the intercontinental spread of L2b and L3b in the “Discussion” section. We believe these revisions have made the manuscript more rigorous and precise.

      Lines 332-342: “_The biovar types of _S. Gallinarum have been well-defined as bvSP, bvSG, and bvSD historically ( J Vet Med B Infect Dis Vet Public Health. 2005 Jun;52(5):2148). Among these, bvSP can be further subdivided into five lineages (L1, L2a, L2b, L3b, and L3c) using hierarchical Bayesian analysis. Different sublineages exhibited preferential geographic distribution, with L2b and L3b of bvSP being predominant global lineage types with a high risk of AMR. The historical geographical transmission was verified using a spatiotemporal Bayesian framework. The result shows that L3b was initially spread from China to Europe in the 18<sup>th</sup>-19<sup>th</sup> century, which may be associated with the European hen fever event in the mid-19th century (Burnham GP. 1855. The history of the hen fever: a humorous record). L2b, on the other hand, appears to have spread to Europe via South America, potentially contributing to the prevalence of bvSP in the United States.”  

      (11) No acknowledgment of potential undersampling outside of China is made, for example, 'Notably, all bvSP isolates from Asia were exclusively found in China, which can be manually divided into three distinct regions (southern, eastern, and northern).'.

      Perhaps we just haven't looked in other places?

      We appreciate the reviewer's observation regarding the sampling distribution of isolates in this study. We acknowledge that while the isolates were collected from 15 different countries with, a significant proportion originated from China (Author response image 1). This focus is due to several reasons:

      (1) As once a globally prevalent pathogen across the 20th century, S. Gallinarum was listed by the World Organization for Animal Health (WOAH) due to its economic importance. After 30 years of implementation the National Poultry Improvement Plan in the US, it was almost eradicated in high-income countries, and interestingly, it became an endemic pathogen with sporadic outbreaks in most low- or middle-income countries like China and Brazil. Given the vast expanse of China's land area and the country's economic factors, implementing the same measures remains a challenging endeavour. 

      (2) S. Gallinarum is an avian-specific pathogen, particularly affecting chickens, and its distribution is closely linked to chicken meat production in different countries. In some high chicken-producing developing countries, such as China and Brazil, there are more frequent reports of fowl typhoid. Data from the United States Department of Agriculture (USDA) on annual chicken meat production for 2023/2024 show that the global distribution of S. Gallinarum aligns closely with the overall chicken meat production of these countries (https://fas.usda.gov/data/production/commodity/0115000).  

      (3) Our primary objective was to investigate the localized resistome adaptation of S. Gallinarum in regions. Being a region with significant disease burden, China has reported numerous outbreaks (Sci Data. 2022 Aug 13;9(1):495; Sci Data. 2024 Feb 27;11(1):244) and a high AMR prevalence of this serovar (Natl Sci Rev. 2023 Sep 2;10(10):nwad228; mSystems. 2023 Dec 21;8(6):e0088323), making it an excellent example for understanding localized resistance mechanisms. 

      Nevertheless, a search of nearly a decade of literature on PubMed and a summary of the S. Gallinarum genome available on public databases indicate that the dataset used is the most complete. Furthermore, focusing on a specific region within China allowed us to conduct a detailed and thorough analysis. However, we highly agree that expanding the study to include more isolates from other countries would enhance the generalizability of our findings, and we are actively collecting additional S. Gallinarum genome data. In the revised manuscript, we modified this sentence to indicate that this phenomenon is only observed in the current dataset, thereby avoiding an overly absolute statement:

      Lines 131-135: “For the bvSP strains from Asia included in our dataset, we found that all originated from China. To further investigate the distribution of bvSP across different regions in China, we categorized them into three distinct regions: southern, eastern, and northern (Supplementary Table 3)”.

      (12) Many of the conclusions are highly speculative and not supported by the data. 

      Thank you for your comment. We have carefully revised the manuscript to address your concerns. We hope that the changes made in the revised version meet your expectations and provide a clearer and more accurate interpretation of our findings.

      (13) The figures are not always the best presentation of the data: 

      a. Stacked bar plots in Figure 1 are hard to interpret, the total numbers need to be shown.

      Panel C conveys little information. 

      b. Figure 4B: stacked bars are hard to read and do not show totals. 

      c. Figure 5 has no obvious interpretation or significance. 

      Thank you for your comments. We have revised the figures to improve the clarity and presentation of the data.

      In summary, the quality of analysis is poor and likely flawed (although there is not always enough information on methods present to confidently assess this or provide recommendations for how it might be improved). So, the stated conclusions are not supported. 

      Thank you for your valuable feedback. We have carefully revised the manuscript to address your concerns. We hope that the updated figures and tables, and new data in the revised version meet your expectations and provide more appropriate interpretation of our findings.

      Recommendations for the authors:  

      Reviewer #1 (Recommendations for the authors): 

      This reviewer enjoyed reading this well-written manuscript. The authors are encouraged to address the following comments and revise the manuscript accordingly. 

      (1) Title: The authors use avian-restrict Salmonella to refer to Salmonella Gallinarum. Please consider using Salmonella Gallinarum in the title. Also, your analysis relates to resistome and mobilome. Would it make sense to add mobilome in the manuscript? 

      Thank you for your guidance. In the revised manuscript, we have changed the title to “Avian-specific Salmonella enterica Serovar Gallinarum transition to endemicity is accompanied by localized resistome and mobilome interaction”. We believe that this revised title more accurately reflects the content of our study.

      (2) Abstract: This study uses 45 isolates from your labs. However, you failed to include these 45 isolates in the Abstract. Also, please clarify the sources of these isolates (from dead chickens, or dead chicken embryos? You wrote in two different ways in this manuscript). Also, I am not entirely convinced how the results from these 45 isolates will support the overall conclusion of this work. 

      Thank you for your thorough review and constructive comments on the manuscript. In the revised version, we have added a description of 45 newly isolated S. Gallinarum strains in the Abstract to provide readers with a clearer understanding of the dataset used in this study.

      Lines 36-41: “Using the most comprehensive whole-genome sequencing dataset of Salmonella enterica serovar Gallinarum (S. Gallinarum) collected from 16 countries, including 45 newly recovered samples from two related local regions, we established the relationship among avian-specific pathogen genetic profiles and localization patterns.”

      Furthermore, the newly isolated S. Gallinarum strains were obtained from dead chicken embryos. We think your second concern may arise from the following description in the manuscript: “All 734 samples of dead chicken embryos were collected from Taishun and Yueqing in Zhejiang Province, China. After the thorough autopsy, the liver, intestines, and spleen were extracted and added separately into 2 mL centrifuge tubes containing 1 mL PBS. The organs were then homogenized by grinding.” In fact, all the collected dead chicken embryos were aged 19 to 20 days. At this developmental stage, collecting the liver, intestines, and spleen for isolation and cultivation of S. Gallinarum is possible. To avoid any confusion, we have included a more detailed description of the dead chicken embryos in the revised manuscript as follows:

      Lines 447-451: “All 734 samples of dead chicken embryos aged 19 to 20 days were collected from Taishun and Yueqing in Zhejiang Province, China. After a thorough autopsy, the liver, intestines, and spleen were extracted and added separately into 2 mL centrifuge tubes containing 1 mL PBS. The organs were then homogenized by grinding.”

      Regarding your concern about the statement, “I am not entirely convinced how the results from these 45 isolates will support the overall conclusion of this work,” we would like to clarify the significance of these new isolates. Our research first identified distinct characteristics in the 45 newly isolated S. Gallinarum strains from Taishun and Yueqing, Zhejiang Province. Specifically, we found that most of the strains from Yueqing belonged to sequence type ST92, whereas the majority from Taishun were ST3717. Additionally, there were significant differences between these geographically close strains in terms of SNP distance and predicted invasion capabilities. These findings suggest that S. Gallinarum may exhibit localized transmission patterns, which forms the basis of the scientific question and hypothesis we originally aimed to address. Furthermore, in our previous work, we collected 325 S. Gallinarum strains. By incorporating the newly isolated 45 strains, we aim to provide a more comprehensive view of the population diversity, transmission pattern and potential risk of S. Gallinarum. We will continue to endeavour to understand the global genomic and population diversity in this field.

      Finally, we revised the sentences that could potentially raise concerns for readers: 

      Lines 175-177: “To investigate the dissemination pattern of bvSP in China, we obtained forty-five newly isolated bvSP from 734 samples (6.1% overall isolation rate) collected from diseased chickens at two farms in Yueqing and Taishun, Zhejiang Province.”  >  “To investigate the dissemination pattern of bvSP, we obtained forty-five newly isolated bvSP from 734 samples (6.1% overall isolation rate) collected from diseased chickens at two farms in Yueqing and Taishun, Zhejiang Province.”

      (3) The manuscript uses nomenclature and classification into different sublineages. Did the authors establish the approaches for defining these sublineages in this group or did you follow the accepted standards? 

      Thank you very much for raising this important issue. The biovar types of Salmonella Gallinarum have historically been well-defined as S. Gallinarum biovar

      Pullorum (bvSP), S. Gallinarum biovar Gallinarum (bvSG), and S. Gallinarum biovar Duisburg (bvSD) (J Vet Med B Infect Dis Vet Public Health. 2005 Jun;52(5):214-8). However, there seems to be no widespread consensus on the population nomenclature for the key biovar bvSP. In a previous study, Zhou et al. classified bvSP into six lineages:

      L1, L2a, L2b, L3a, L3b, and L3c (Natl Sci Rev. 2023 Sep 2;10(10):nwad228). However, our more comprehensive analysis of S. Gallinarum using a larger dataset and hierarchical Bayesian clustering revealed that L3a, previously considered a distinct lineage, is actually a sublineage of L3c. Upon further review of our initial manuscript, we realized that the original submission did not strictly follow the lineage order proposed by Zhou et al. To avoid confusion in the typing system, we have adjusted the lineage nomenclature in the revised manuscript to reflect the corrected order (see Author response table 1).

      (4) This reviewer is convinced with the analysis approaches and conclusion of this work.

      In the meantime, the authors are encouraged to discuss the application of the conclusion of this study: a) can the data be somehow used in the prediction model? b) would the conclusion from S. Gallinarum have generalized application values for other pathogens. 

      Thank you for your constructive comments on the manuscript. 

      a) can the data be somehow used in the prediction model?

      We believe that genomic data can be effectively used for constructing prediction models; however, the success of such models largely depends on the specific traits being predicted. In this study, we utilized a random forest prediction model based on 196 top genes (PLoS Genet. 2018 May 8;14(5)) to predict the invasiveness of 45 newly isolated strains. In relation to the antimicrobial resistance (AMR) issue discussed in this paper, we also conducted relevant analyses. For instance, we explored the use of image-based models to predict whether a genome is resistant to specific antibiotics (Comput Struct Biotechnol J. 2023 Dec 29:23:559-565). We are confident that the incorporation of newly generated data will facilitate the development of future predictive models, and we plan to pursue further research in this area.

      b) would the conclusion from S. Gallinarum have generalized application values for other pathogens.

      This might be explained from two perspectives. First, the key role of the mobilome in facilitating the spread of the resistome, as emphasized in this study, has also been confirmed in research on other pathogens (mBio. 2024 Oct 16;15(10):e0242824). Thus, we believe that the pipeline we developed to assess the horizontal transfer frequency of different resistance genes across regions applies to various pathogens. On the other hand, due to distinct evolutionary histories, different pathogens exhibit varying levels of adaptation to their environments. In this study, we found that S. Gallinarum tends to spread highly localized; however, this conclusion may not necessarily hold for other pathogens.

      Reviewer #2 (Recommendations for the authors): 

      The authors would need to: 

      (1) Address my concerns about genomic analyses listed in the public review. 

      Thank you for your valuable feedback. We have carefully reviewed your concerns and made the necessary revisions to address the points raised about genomic analyses in the public review. We sincerely hope that these modifications meet your expectations and provide more robust analysis. We appreciate your thoughtful input and remain open to further suggestions to improve the manuscript.

      (2) Add more detail on the genomic methods and their outputs, as suggested above. 

      We have added further details to clarify the methodologies and outputs as mentioned above. Specifically, we expanded the description of the data processing, and the bioinformatic tools used for analysis. To ensure clarity, we also included an expanded discussion of the key outputs, highlighting their implications. We hope these revisions meet your expectations.

      (3) Critically rewrite their introduction to make it clear what problem they are trying to address. 

      Thank you for your guidance. In the revised manuscript, we have made the necessary modifications to the Introduction section to more clearly articulate the problem we aim to address.

      (4) Critically rewrite their conclusions so they are supported by the data they present, and make it clear when claims are more speculative. 

      Thank you for your guidance. In the revised manuscript, we have made the recommended modifications to the relevant sections of the conclusion as outlined above.

      More minor issues I identified: 

      (1) Typo in the title 'avian-restrict'. 

      Done.

      Line 1: “Avian-specific Salmonella enterica Serovar Gallinarum transition to endemicity is accompanied by localized resistome and mobilome interaction.”

      (2) 'By utilizing the pipeline we developed' -- a pipeline has not been introduced at this point. 

      In the revised manuscript, we have removed this section from the 'Abstract'.

      Lines 46-48: “Notably, the mobilome-resistome combination among distinct lineages exhibits a geographical-specific manner, further supporting a localized endemic mobilome-driven process.”

      (3) 'has more than 90% serovars' -- doesn't make sense. 

      Revised.

      Lines 82-83: “Salmonella, a pathogen with distinct geographical characteristics, has more than 90% of its serovars frequently categorized as geo-serotypes.”

      (4) 'horrific mortality rates that remain a disproportionate burden'. 

      Revised.

      Lines 83-87: “Among the thousands of geo-serotypes, Salmonella enterica Serovar Gallinarum (S. Gallinarum) is an avian-specific pathogen that causes severe mortality, with particularly detrimental effects on the poultry industry in low- and middle-income countries.”

      (5) What is the rate, what is a comparison, how is it disproportionate? 

      Thank you for your valuable feedback. It is challenging to accurately estimate the specific prevalence of S. Gallinarum, particularly due to the lack of comprehensive data in many countries. Numerous cases likely go unreported. However, S. Gallinarum is more commonly detected in low- and middle-income countries. Here, we provide three evidence supporting this observation. First, in our previous research, we conducted a comprehensive meta-analysis of 201 studies, involving over 900 million samples, to evaluate the global impact of S. Gallinarum (Sci Data. 2022 Aug 13;9(1):495). The estimated prevalence in 17 countries showed that Bangladesh had the highest rate (25.75%) of S. Gallinarum infections. However, for biovar Pullorum (bvSP), Argentina (20.69%) and China (18.18%) reported the highest prevalence rates. Second, previous studies have also reported that S. Gallinarum predominantly occurs in low- and middleincome countries (Vet Microbiol. 2019 Jan:228:165-172; BMC Microbiol. 2024 Oct 18;24(1):414). Finally, S. Gallinarum was once a globally prevalent pathogen in the 20th century. Following the implementation of eradication programs in most high-income countries, it was listed by the World Organization for Animal Health and subsequently became an endemic pathogen with sporadic outbreaks. However, similar eradication efforts are challenging to implement in low- and middle-income countries, leading to a disproportionately higher incidence of S. Gallinarum in these regions.

      In the revised manuscript, we have rephrased this sentence to enhance its accuracy:

      Lines 83-87: “Among the thousands of geo-serotypes, Salmonella enterica serovar Gallinarum (S. Gallinarum) is an avian-specific pathogen that causes severe mortality, with particularly detrimental effects on the poultry industry in low- and middle-income countries.”

      (6) 'we collected the most comprehensive set of 580 S. Gallinarum isolates', -> 'we collected the most comprehensive set S. Gallinarum isolates, consisting of 580 genomes'. 

      Revised.

      Lines 97-100: “To fill the gaps in understanding the evolution of S. Gallinarum under regional-associated AMR pressures and its adaptation to endemicity, we collected the most comprehensive set S. Gallinarum isolates, consisting of 580 genomes, spanning the period from 1920 to 2023.” 

      (7) Sequence reads are not available, and use a non-standard database. The eLife policy states: 'Sequence reads and assembly must be included for reference genomes, while novel short sequences, including epitopes, functional domains, genetic markers and haplotypes should be deposited, together with surrounding sequences, into Genbank, DNA Data Bank of Japan (DDBJ), or EMBL Nucleotide Sequence Database (ENA). DNA and RNA sequencing data should be deposited in NCBI Trace Archive or NCBI Sequence Read Archive (SRA).' So the sequences assemblies and reads should ideally be mirrored appropriately. 

      Thank you for your valuable suggestion regarding submitting the genome data for the newly isolated 45 S. Gallinarum strains. The genome data have been deposited in the NCBI Sequence Read Archive (SRA) under two BioProjects. The “SRA Accession number” for each strain have been added to New Supplementary Table 1. We believe this will ensure that the data are more readily accessible to a broader audience of researchers for download and analysis. We have revised the corresponding paragraph in the manuscript as follows:

      Lines 606-608: “For the newly isolated 45 strains of Salmonella Gallinarum, genome data have been deposited in NCBI Sequence Read Archive (SRA) database. The “SRA Accession” for each strain are listed in Supplementary Table 1.”

      (8) You should state at the start of the results which data is public, and how much is newly sequenced. 

      Revised.

      Lines 109-112: “To understand the global geographic distribution and genetic relationships of S. Gallinarum, we assembled the most comprehensive S. Gallinarum WGS dataset (n=580), comprising 535 publicly available genomes and 45 newly sequenced genomes.”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      Cell metabolism exhibits a well-known behavior in fast-growing cells, which employ seemingly wasteful fermentation to generate energy even in the presence of sufficient environmental oxygen. This phenomenon is known as Overflow Metabolism or the Warburg effect in cancer. It is present in a wide range of organisms, from bacteria and fungi to mammalian cells.

      In this work, starting with a metabolic network for Escherichia coli based on sets of carbon sources, and using a corresponding coarse-grained model, the author applies some well-based approximations from the literature and algebraic manipulations. These are used to successfully explain the origins of Overflow Metabolism, both qualitatively and quantitatively, by comparing the results with E. coli experimental data.

      By modeling the proteome energy efficiencies for respiration and fermentation, the study shows that these parameters are dependent on the carbon source quality constants K_i (p.115 and 116). It is demonstrated that as the environment becomes richer, the optimal solution for proteome energy efficiency shifts from respiration to fermentation. This shift occurs at a critical parameter value K_A(C).

      This counterintuitive result qualitatively explains Overflow Metabolism.

      Quantitative agreement is achieved through the analysis of the heterogeneity of the metabolic status within a cell population. By introducing heterogeneity, the critical growth rate is assumed to follow a Gaussian distribution over the cell population, resulting in accordance with experimental data for E. coli. Overflow metabolism is explained by considering optimal protein allocation and cell heterogeneity.

      The obtained model is extensively tested through perturbations: 1) Introduction of overexpression of useless proteins; 2) Studying energy dissipation; 3) Analysis of the impact of translation inhibition with different sub-lethal doses of chloramphenicol on Escherichia coli; 4) Alteration of nutrient categories of carbon sources using pyruvate. All model perturbation results are corroborated by E. coli experimental results.

      We appreciate the reviewer's highly positive comments and the accurate summary of our manuscript.

      Strengths:

      In this work, the author employs modeling methods typical of Physics to address a problem in Biology, standing at the interface between these two scientific fields. This interdisciplinary approach proves to be highly fruitful and should be further explored in the literature. The use of Escherichia coli as an example ensures that all hypotheses and approximations in this study are well-founded in the literature. Examples include the approximation for the Michaelis-Menten equation (line 82), Eq. S1, proteome partition in Appendix 1.1 (lines 68-69), and a stable nutrient environment in Appendix 1.1 (lines 83-84). The section "Testing the model through perturbation" heavily relies on bacterial data. The construction of the model and its agreement with experimental data are convincingly presented.

      We appreciate the reviewer's highly positive comments. We have incorporated many of the reviewer's insightful suggestions and added citations in the appropriate contexts, which have significantly improved our manuscript.

      Weaknesses:

      In Section Appendix 6.4, the author explores the generalization of results from bacteria to cancer cells, adapting the metabolic network and coarse-grained model accordingly. It is argued that as a consequence, all subsequent steps become immediately valid. However, I remain unconvinced, considering the numerous approximations used to derive the equations, which the literature demonstrates to be valid primarily for bacteria. A more detailed discussion about this generalization is recommended. Additionally, it is crucial to note that the experimental validation of model perturbations heavily relies on E. coli data.

      We appreciate the reviewer's insightful suggestions. We apologize for not clearly illustrating the generalization of results from bacteria to cancer cells in the previous version of our manuscript. Indeed, in our earlier version, there was no experimental validation of model results related to cancer cells.

      Following the reviewer’s suggestions, we have now added Fig. 5 and Appendix-fig. 5, fully expanded the previous Appendix 6.4 into Appendix 9 in our current version, and added a new section entitled “Explanation of the Crabtree effect in yeast and the Warburg effect in cancer cells” in our main text to provide a detailed discussion of the generalization from bacteria to yeast and cancer cells. Through the derivations shown in Appendix 9 (Eqs. S180-S189), we arrived at Eq. 6 (or Eq. S190 in Appendix 9) to facilitate the comparison of our model results with experimental data in yeast and cancer cells. This comparison is presented in Fig. 5, where we demonstrate that our model can quantitatively explain the data for the Crabtree effect in yeast and the Warburg effect in cancer cells (related experimental data references: Shen et al., Nature Chemical Biology 20, 1123–1132 (2024); Bartman et al., Nature 614, 349-357 (2023)). These additions have significantly strengthened our manuscript.

      Reviewer #2 (Public Review):

      Summary

      This paper has three parts. The first part applied a coarse-grained model with proteome partition to calculate cell growth under respiration and fermentation modes. The second part considered single-cell variability and performed population average to acquire an ensemble metabolic profile for acetate fermentation. The third part used model and simulation to compare experimental data in literature and obtained substantial consistency.

      We thank the reviewer for the accurate summary and positive comments on our manuscript.

      Strengths and major contributions

      (i) The coarse-grained model considered specific metabolite groups and their interrelations and acquired an analytical solution for this scenario. The "resolution" of this model is in between the Flux Balanced Analysis/whole-cell simulation and proteome partition analysis.

      (ii) The author considered single-cell level metabolic heterogeneity and calculated the ensemble average with explicit calculation. The results are consistent with known fermentation and growth phenomena qualitatively and can be quantitatively compared to experimental results.

      We appreciate the reviewer’s highly positive comments.

      Weaknesses

      (i) If I am reading this paper correctly, the author's model predicts binary (or "digital") outcomes of single-cell metabolism, that is, after growth rate optimization, each cell will adopt either "respiration mode" or "fermentation mode" (as illustrated in Figure Appendix - Figure 1 C, D). Due to variability enzyme activity k_i^{cat} and critical growth rate λ_C, each cell under the same nutrient condition could have either respiration or fermentation, but the choice is binary.

      The binary choice at the single-cell level is inconsistent with our current understanding of metabolism. If a cell only uses fermentation mode (as shown in Appendix - Figure 1C), it could generate enough energy but not be able to have enough metabolic fluxes to feed into the TCA cycle. That is, under pure fermentation mode, the cell cannot expand the pool of TCA cycle metabolites and hence cannot grow.

      This caveat also appears in the model in Appendix (S25) that assumes J_E = r_E*J_{BM} where r_E is a constant. From my understanding, r_E can be different between respiration and fermentation modes (at least for real cells) and hence it is inappropriate to conclude that cells using fermentation, which generates enough energy, can also generate a balanced biomass.

      We thank the reviewer for raising this question. Indeed, regarding energy biogenesis between respiration and fermentation, our model predicts binary outcomes at the single-cell level. However, this outcome does not hinder cell growth, as there are three independent possible fates for the carbon source (e.g., glucose) in metabolism: fermentation, respiration for energy biogenesis, and biomass generation. Each fate is associated with a distinct fraction of the proteome, with no overlap between them (see Appendix-figs. 1 and 5). Consequently, in a purely fermentative mode, a cell can still use the proteome dedicated to the biomass generation pathway to produce biomass precursors via the TCA cycle.

      The classification of the carbon source’s fates into three independent pathways was initially introduced by Chen and Nielsen (Chen and Nielsen, PNAS 116, 17592-17597 (2019)). We apologize for the oversight in not citing their paper in this context in the previous version of our manuscript (although it was cited elsewhere). We have now included the citation in all appropriate places.

      To illustrate this issue more clearly, we explicitly present the proteome allocation results for optimal growth in a fermentation mode below, where the proteome efficiency (i.e., the proteome energy efficiency in our previous version) in fermentation is higher than in respiration (i.e., ). We use the model shown in Fig. 1B as an example, with the relevant equations being Eqs. S26 and S28 in Appendix 2.1. By substituting Eq. S28 into Eq. S26, we arrive at Eq. 3 (or Eq. S29 in Appendix 2.1), which we restate here as Eq. R1:

      For a given nutrient condition, i.e., for a specific value of κ<sub>A</sub> at the single-cell level, the values of are determined (see Eqs. S20, S27, S31 and S32), while  ϕ and φ<sub>max</sub> are constants (see Eq. S33 and Appendix 1.1). Therefore, if , then , since all coefficients are positive (i.e., ) and takes non-negative values. Hence, the solution for optimal growth is (see Eqs. S35-S36 in Appendix 2.2):

      Here, the result signifies a pure fermentation mode with no respiration flux for energy biogenesis. Then, by combining Eq. R2 with Eqs. S28 and S30 from Appendix 2.1, we obtain the optimal proteome allocation results for this case:

      where , while κ<sub>A</sub> and take given values (see Eqs. S20 and S27). In Eq. R3, φ<sub>3</sub> corresponds to the fraction of the proteome devoted to carrying the carbon flux from Acetyl-CoA (the entry point of Pool b, see Fig. 1B and Appendix 1.2) to α-Ketoglutarate (the entry point of Pool c), with all of these being enzymes within the TCA cycle. The optimal growth solution is , which demonstrates that in a pure fermentation mode, the optimal growth condition includes the presence of enzymes within the TCA cycle capable of carrying the flux required for biomass generation.

      Regarding Eq. S25, J<sub>E</sub> represents the energy demand for cell proliferation, expressed as the stoichiometric energy flux in ATP. Although the influx of carbon sources (e.g., glucose) varies significantly between fermentation and respiration modes, J<sub>BM</sub> and J<sub>E</sub>  are the biomass and energy fluxes used to build cells, respectively. In bacteria, whether in fermentation or respiration mode, the proportion of maintenance energy used for protein degradation is roughly negligible (see Locasale and Cantley, BMC Biol 8, 88 (2010)). Consequently, the energy demand represented by J_E scales approximately linearly with the biomass production rate _J<sub>BM</sub> (related experimental data reference: Ebenhöh et al., Life 14, 247 (2024)), regardless of the energy biogenesis mode. Therefore, _r_E can be regarded as roughly constant for bacteria. However, in eukaryotic cells such as yeast and mammalian cells, the proportion of maintenance energy is much more significant (see Locasale and Cantley, BMC Biol 8, 88 (2010)). Therefore, we have explicitly considered the contribution of maintenance energy in these cases and have extended the previous Appendix 6.4 into Appendix 9 in the current version.

      (ii) The minor weakness of this model is that it assumes a priori that each cell chooses its metabolic strategy based on energy efficiency. This is an interesting assumption but there is no known biochemical pathway that directly executes this mechanism. In evolution, growth rate is more frequently considered for metabolic optimization. In Flux Balanced Analysis, one could have multiple objective functions including biomass synthesis, energy generation, entropy production, etc. Therefore, the author would need to justify this assumption and propose a reasonable biochemical mechanism for cells to sense and regulate their energy efficiency.

      We thank the reviewer for raising this question and apologize for not explaining this point clearly enough in the previous version of our manuscript. Just as the reviewer mentioned, growth rate should be considered for metabolic optimization under the selection pressure of the evolutionary process. In fact, in our model, the sole optimization objective is exactly the cell growth rate. The determination of whether to use fermentation or respiration based on proteome efficiency (i.e., the proteome energy efficiency in our previous version) is not an a priori assumption in our model; rather, it is a natural consequence of growth rate optimization, as we detail below. 

      For a given nutrient condition with a determined value of κ<sub>A</sub> , as we have explained in the aforementioned responses, the constraint on the fluxes is summarized in Eq. 3 and is restated as Eq. R1. Mathematically, we can obtain the solution for the optimal growth strategy by combining Eq. R1 (i.e., Eq. 3) with the optimization on cell growth rate λ, and the solution can be obtained as follows: If the proteome efficiency in fermentation is larger than that in respiration, i.e., , then from Eq. R1, we obtain , since the values of ε<sub>r</sub> , ε<sub>f </sub>, Ψ, ϕ and φ<sub>max</sub> are all fixed for a given κ_A_ , with ε<sub>r</sub> , ε<sub>f </sub>, Ψ, ϕ, φ<sub>max</sub> > 0 . Hence, (since ), and note that . Therefore is the solution for optimal growth, where the growth rate can take the maximum value of . Similarly, for the case where the proteome efficiency in respiration is larger than that in fermentation (i.e ), is the solution for optimal growth. With this analysis, we have demonstrated that the choice between fermentation and respiration based on proteome efficiency is a natural consequence of growth rate optimization.

      We have now revised the related content in our manuscript to clarify this point.

      My feeling is that the mathematical structure of this model could be correct, but the single-cell interpretation for the ensemble averaging has issues. Each cell could potentially adopt partial respiration and partial fermentation at the same time and have temporal variability in its metabolic mode as well. With the modification of the optimization scheme, the author could have a revised model that avoids the caveat mentioned above.

      We thank the reviewer for raising this question. In fact, in the above two responses, we have addressed the issues raised here, clarifying that the binary mode between respiration and fermentation does not hinder cell growth and that the sole optimization objective is the cell growth rate, as the reviewer suggested. Regarding temporal variability, due to factors such as cell cycle stages and the intrinsic noise arising from stochastic processes, temporal variability in the fermentation or respiration mode is indeed likely. However, at any given moment at the single-cell level, a binary choice between fermentation and respiration is what our model predicts for the optimal growth strategy. 

      Discussion and impact for the field

      Proteome partition models and Flux Balanced Analysis are both commonly used mathematical models that emphasize different parts of cellular physiology. This paper has ingredients for both, and I expect after revision it will bridge our understanding of the whole cell.

      We appreciate the reviewer’s very positive comments. We have followed many of the good suggestions raised by the reviewer, and our revised manuscript is much improved as a result.

      Reviewer #3 (Public Review):

      Summary:

      In the manuscript "Overflow metabolism originates from growth optimization and cell heterogeneity" the author Xin Wang investigates the hypothesis that the transition into overflow metabolism at large growth rates actually results from an inhomogeneous cell population, in which every individual cell either performs respiration or fermentation.

      We thank the reviewer for carefully reading our manuscript and the accurate summary.

      Weaknesses:

      The paper has several major flaws. First, and most importantly, it repeatedly and wrongly claims that the origins of overflow metabolism are not known. The paper is written as if it is the first to study overflow metabolism and provide a sound explanation for the experimental observations. This is obviously not true and the author actually cites many papers in which explanations of overflow metabolism are suggested (see e.g. Basan et al. 2015, which even has the title "Overflow metabolism in E. coli results from efficient proteome allocation"). The paper should be rewritten in a more modest and scientific style, not attempting to make claims of novelty that are not supported. In fact, all hypotheses in this paper are old. Also the possiblility that cell heterogeneity explains the observed 'smooth' transition into overflow metabolism has been extensively investigated previously (see de Groot et al. 2023, PNAS, "Effective bet-hedging through growth rate dependent stability") and the random drawing of kcat-values is an established technique (Beg et al., 2007, PNAS, "Intracellular crowding defines the mode and sequence of substrate uptake by Escherichia coli and constrains its metabolic activity"). Thus, in terms of novelty, this paper is very limited. It reinvents the wheel and it is written as if decades of literature debating overflow metabolism did not exist.

      We thank the reviewer for both the critical and constructive comments. Following the reviewer’s suggestion, we have revised our manuscript to adopt a more modest style. However, we respectfully disagree with the criticism regarding the novelty of our study, as detailed below.

      First, while many explanations for overflow metabolism have been proposed, we have cited these in both the previous and current versions of our manuscript. We apologize for not emphasizing the distinctions between these previous explanations and our study in the main text of our earlier version, though we did provide details in Appendix 6.3. In fact, most of these explanations (e.g., Basan et al., Nature 528, 99-104 (2015); Chen and Nielsen, PNAS 116, 17592-17597 (2019); Majewski and Domach, Biotechnol. Bioeng. 35, 732-738 (1990); Niebel et al., Nat. Metab. 1, 125-132 (2019); Shlomi et al., PLoS Comput. Biol. 7, e1002018 (2011); Varma and Palsson, Appl. Environ. Microbiol. 60, 3724-3731 (1994); Vazquez et al., BMC Syst. Biol. 4, 58 (2010); Vazquez and Oltvai, Sci. Rep. 6, 31007 (2016); Zhuang et al., Mol. Syst. Biol. 7, 500 (2011)) heavily rely on the assumption that cells optimize their growth rate for a given rate of carbon influx under each nutrient condition (or certain equivalents) to explain the growth rate dependence of fermentation flux. However, this assumption—that cell growth rate is optimized for a given rate of carbon influx—is questionable, as the given factors in a nutrient condition are the identity and concentration of the carbon source, rather than the carbon influx itself.

      Consequently, in our model, we purely optimize cell growth rate without imposing a special constraint on carbon influx. Our assumption that the given factors in a nutrient condition are the identity and concentration of the carbon source aligns with the studies by Molenaar et al. (Molenaar et al., Mol. Syst. Biol. 5, 323 (2009)), where they specified an identical assumption on page 5 of their Supplementary Information (SI); Scott et al. (Scott et al., Science 330, 1099-1102 (2010)), where the growth rate formula was derived for a culturing condition with a given nutrient quality; and Wang et al. (Wang et al., Nat. Comm. 10, 1279 (2019)), our previous study on microbial growth. Among these three studies, only Molenaar et al. addresses overflow metabolism. However, Molenaar et al. did not consider cell heterogeneity, resulting in their model predictions on the growth rate dependence of fermentation flux being a digital response, which is inconsistent with experimental data.

      Furthermore, prevalent explanations such as those by Basan et al. (Basan et al., Nature 528, 99-104 (2015)) and Chen and Nielsen (Chen and Nielsen, PNAS 116, 17592-17597 (2019)) suggest that overflow metabolism originates from the proteome efficiency in fermentation always being higher than in respiration. However, Shen et al. (Shen et al., Nature Chemical Biology 20, 1123–1132 (2024)) recently discovered that the proteome efficiency measured at the cell population level in respiration is higher than in fermentation for many yeast and cancer cells, despite the presence of fermentation fluxes through aerobic glycolysis. This finding clearly contradicts the studies by Basan et al. (2015) and Chen and Nielsen (2019). 

      Nevertheless, our model may resolve this puzzle by incorporating two important features. First, in our model, the proteome efficiency (i.e., the proteome energy efficiency in our previous version) in respiration is larger than that in fermentation when nutrient quality is low (Eqs. S174-S175 in Appendix 9). Second, and crucially, due to the incorporation of cell heterogeneity in our model, there could be a proportion of cells with higher proteome efficiency in fermentation than in respiration, even when the overall proteome efficiency at the cell population level is higher in respiration than in fermentation. As shown in the newly added Fig. 5A-B, our model results can quantitatively illustrate the experimental data from Shen et al., Nature Chemical Biology 20, 1123–1132 (2024).

      Finally, regarding the criticism of the novelty of our hypothesis: As specified in our main text, cell heterogeneity has been widely reported experimentally in both microbes (e.g., Ackermann, Nat. Rev. Microbiol. 13, 497-508 (2015); Bagamery et al., Curr. Biol. 30, 4563-4578 (2020); Balaban et al., Science 305, 1622-1625 (2004); Nikolic et al., BMC Microbiol. 13, 1-13 (2013); Solopova et al., PNAS 111, 7427-7432 (2014); Wallden et al., Cell 166, 729-739 (2016)) and tumor cells (e.g., Duraj et al., Cells 10, 202 (2021); Hanahan and Weinberg, Cell 164, 681-694 (2011); Hensley et al., Cell 164, 681-694 (2016)). However, to the best of our knowledge, cell heterogeneity has not yet been incorporated into theoretical models for explaining overflow metabolism or the Warburg effect. The reviewer mentioned the study by de Groot et al. (de Groot et al., PNAS 120, e2211091120 (2023)) as studying overflow metabolism similarly to our work. We have carefully read this paper, including the main text and SI, and found that it is not directly relevant to either overflow metabolism or the Warburg effect. Instead, their model extends the work of Kussell and Leibler (Kussell and Leibler, Science 309, 2075-2078 (2005)), focusing on bet-hedging strategies of microbes in changing environments.

      Regarding the criticism that random drawing of kcat-values is an established technique (Beg et al., PNAS 104, 12663-12668 (2007)), we need to stress that the distribution noise on kcat-values considered in our model is fundamentally different from that in Beg et al. In Beg et al., their model involved 876 reactions (see Dataset 1 in Beg et al.), of which only 109 had associated biochemical experimental data. Thus, their distribution of kcat-values pertains to different enzymes within the same cell. In contrast, we have the mean of the kcat-values from experimental data for each relevant enzymes, with the distribution of kcat-values representing the same enzyme in different cells.           

      Moreover, the manuscript is not clearly written and is hard to understand. Variables are not properly introduced (the M-pools need to be discussed, fluxes (J_E), "energy coefficients" (eta_E), etc. need to be more explicitly explained. What is "flux balance at each intermediate node"? How is the "proteome efficiency" of a pathway defined? The paper continues to speak of energy production. This should be avoided. Energy is conserved (1st law of thermodynamics) and can never be produced. A scientific paper should strive for scientific correctness, including precise choice of words.

      We thank the reviewer for the constructive comments. Following these, we have provided more explicit information and revised our manuscript to enhance readability. In our initially submitted version, the phrase "energy production" was borrowed from Nelson et al. (Nelson et al., Lehninger principles of biochemistry, 2008) and Basan et al. (Basan et al., Nature 528, 99-104 (2015)), and we chose to follow this terminology. We appreciate the reviewer’s suggestion and have now revised the wording to use more appropriate expressions.

      The statement that the "energy production rate ... is proportional to the growth rate" is, apart from being incorrect - it should be 'ATP consumption rate' or similar (see above), a non-trivial claim. Why should this be the case? Such statements must be supported by references. The observation that the catabolic power indeed appears to increase linearly with growth rate was made, based on chemostat data for E.coli and yeast, in a recent preprint (Ebenhöh et al, 2023, bioRxiv, "Microbial pathway thermodynamics: structural models unveil anabolic and catabolic processes").

      We thank the reviewer for the insightful suggestions. Following these, we have revised our manuscript and cited the suggested reference (i.e., Ebenhöh et al., Life 14, 247 (2024)).

      All this criticism does not preclude the possibility that cell heterogeneity plays a role in overflow metabolism. However, according to Occam's razor, first the simpler explanations should be explored and refuted before coming up with a more complex solution. Here, it means that the authors first should argue why simpler explanations (e.g. the 'Membrane Real Estate Hypothesis', Szenk et al., 2017, Cell Systems; maximal Gibbs free energy dissipation, Niebel et al., 2019, Nature Metabolism; Saadat et al., 2020, Entropy) are not considered, resp. in what way they are in disagreement with observations, and then provide some evidence of the proposed cell heterogeneity (are there single-cell transcriptomic data supporting the claim?).

      We thank the reviewer for raising these questions and providing valuable insights. Regarding the shortcomings of simpler explanations, as explained above, most proposed explanations (including the references mentioned by the reviewer: Szenk et al., Cell Syst. 5, 95-104 (2017); Niebel et al., Nat. Metab. 1, 125-132 (2019); Saadat et al., Entropy 22, 277 (2020)) rely heavily on the assumption that cells optimize their growth rate for a given rate of carbon influx under each nutrient condition (or its equivalents). However, this assumption is questionable, as the given factors in a nutrient condition are the identities and concentrations of the carbon sources, rather than the carbon influx itself.

      Specifically, Szenk et al. is a perspective paper, and the original “membrane real estate hypothesis” was proposed by Zhuang et al. (Zhuang et al., Mol. Syst. Biol. 7, 500 (2011)). Zhuang et al. specified in Section 7 of their SI that their model’s explanation of the experimental results shown in Fig. 2C of their manuscript relies on the assumption of restrictions on carbon influx. In Niebel et al. (Niebel et al., Nat. Metab. 1, 125-132 (2019)), the Methods section specifies that the glucose uptake rate was considered a given factor for a growth condition. In Saadat et al. (Saadat et al., Entropy 22, 277 (2020)), Appendix A notes that their model results depend on minimizing carbon influx for a given growth rate, which is equivalent to the assumption mentioned above (see Appendix 6.3 in our manuscript for details). 

      Regarding the experimental evidence for our proposed cell heterogeneity, Bagamery et al. (Bagamery et al., Curr. Biol. 30, 4563-4578 (2020)) reported non-genetic heterogeneity in two subpopulations of Saccharomyces cerevisiae cells upon the withdrawal of glucose from exponentially growing cells. This strongly indicates the coexistence of fermentative and respiratory modes of heterogeneity in S. cerevisiae cultured in a glucose medium (refer to Fig. 1E in Bagamery et al.). Nikolic et al. (Nikolic et al., BMC Microbiol. 13, 1-13 (2013)) reported a bimodal distribution in the expression of the acs gene (the transporter for acetate) in an E. coli cell population growing on glucose as the sole carbon source within the region of overflow metabolism (see Fig. 5 in Nikolic et al.), indicating the cell heterogeneity we propose. For cancer cells, Duraj et al. (Duraj et al., Cells 10, 202 (2021)) reported a high level of intra-tumor heterogeneity in glioblastoma using optical microscopy images, where 48%~75% of the cells use fermentation and the remainder use respiration (see Fig. 1C in Duraj et al.), which aligns with the cell heterogeneity picture of aerobic glycolysis predicted by our model.   

      We have now added related content to the discussion section to strengthen our manuscript.

      Reviewer #1 (Recommendations For The Authors): 

      Some minor corrections:

      (1) Adjusted the reference: (García-Contreras et al., 2012)

      (2) Corrected line 255: Removed the duplicate "the genes"

      We thank the reviewer for the suggestions and have implemented each of them to revise our manuscript. The reference in the form of García-Contreras et al., 2012, although somewhat unusual, is actually correct, so we have kept it unchanged.

      General comment to the author:

      Considering that this work exists at the interface between Physics and Biology, where a significant portion of the audience may not be familiar with the mathematical manipulations performed, it would enhance the paper's readability to provide more explicit indications in the text. For example, in line 91, explicitly define phi_A as phi_R; or in line 115, explain the K_i parameter in the text for better readability.

      We thank the reviewer for the suggestion. Following this, we have now provided more explicit information for the definition of mathematical symbols to enhance readability.

      Reviewer #2 (Recommendations For The Authors):

      The current form of this manuscript is difficult to read for general readers. In addition, the model description in the Appendix can be improved for biophysics readers to keep track of the variables. Here are my suggestions:

      a) In the main text, the author should give the definition of "proteome energy efficiency" explicitly both in English and mathematical formula - since this is the central concept of the paper. The biological interpretation of formula (4) should also be stated.

      We thank the reviewer for the suggestion. Following this, we have now added definitions and biological interpretations to fix these issues.

      b) I feel the basic model of the reaction network in the Appendix could be stated in a more concise way, by emphasizing whether a variable is extensive (exponential growing) or intensive (scale-invariant under exponential growth).

      From my understanding, this work assumes balanced exponential growth and hence there is a balanced biomass vector Y* (a constant unit vector with all components sum to 1) for each cell. The steady-state fluxes {J} are extensive and all have growth rate λ. The proteome partition and relative metabolite fractions are ratios of different components of Y* and hence are intensive.

      The normalized fluxes {J^(n)} (with respect to biomass) are a function of Y* and are all kept as constant ratios with each other. They are also intensive.

      The biomass and energy production are linear combinations of {J} and hence are extensive and follow exponential growth. The biomass and energy efficiency are ratios between flux and proteome biomass, and hence are intensive.

      We thank the reviewer for the insightful suggestion. Following this, we have now added the intensive and extensive information for all relevant variables in the newly added Appendix-table 3.

      c) In the Appendix, the author should have a table or list of important variables, with their definition, units, and physiological values under respiration and fermentation.

      We thank the reviewer for the very useful suggestion. Following this, we have now added Appendix-table 3 (pages 54-57 in the appendices) to illustrate the symbols used throughout our manuscript, as well as the model variables and parameter settings.   

      d) Regarding the single-cell variability, the author ignored recent experimental measurements on single-cell metabolism. This includes variability on ATP, NAD(P)H in E. coli, which will be useful background for the readers, see below.

      https://pubmed.ncbi.nlm.nih.gov/25283467/

      https://pubmed.ncbi.nlm.nih.gov/29391569/

      We thank the reviewer for the very useful suggestion. We have now cited these relevant studies in our manuscript.  

      e) The choice between 100% respiration and 100% fermentation is based on the optimization of proteome energy efficiency, while the intermediate strategies are not favored in this model. This is similar to a concept in control theory called the bang-bang principle. This can be added to the Discussion.

      We thank the reviewer for this suggestion. We have reviewed the concept and articles on the bang-bang principle. While the bang-bang principle is indeed relevant to binary choices, it is somewhat distant from the topic of metabolic strategies related to optimal growth. The elementary flux mode (see Müller et al., J. Theor. Biol. 347, 182190 (2014); Wortel et al., FEBS J. 281, 1547-1555 (2014)) is more pertinent to this topic, as it may lead to diauxic microbial growth (another binary metabolic strategy) in microbes grown on a mixture of two carbon sources from Group A (see Wang et al., Nat. Comm. 10, 1279 (2019)). Therefore, we have cited and mentioned only the elementary flux mode (Müller et al., J. Theor. Biol. 347, 182-190 (2014); Wortel et al., FEBS J. 281, 1547-1555 (2014)) in the introduction and discussion sections of our manuscript.

    1. Author response:

      (1) General Statements

      We thank all three reviewers for their constructive comments and suggestions. We also thank reviewers #2 and #3 for considering our work to be timely and of interest to the field, not only for basic researchers, but also for translational scientists and industry. We are now providing additional results to further support our hypothesis and hope that all reviewers will find that our manuscript is now ready for publication. 

      (2) Point-by-point description of the revisions

      Reviewer #1 (Evidence, reproducibility and clarity (Required)): 

      The manuscript by Coquel et al. investigates the effects of BKC and IBC, two compounds found in Psoralea corylifolia in DNA replication and the response to DNA damage, and explores their potential use in cancer treatment. These compounds have been previously shown to affect different cellular pathways and the authors use transformed cancer cells of different origins and a non-transformed cell line to question if their combination is toxic in cancer versus non-cancer cells. They propose that BKC inhibits DNA polymerases while IBC targets CHK2. Their results show that both compounds do affect DNA replication, inducing replication stress and affecting double strand break repair. They also show that their combined use increases their toxicity in a synergistic manner. 

      However, there are some major conclusions that are still not very well supported by the data: first, the differential effect on cancer and non-transformed cells; second, the direct link of BKC to the inhibition of DNA polymerases; and third, it is unclear if CHK2 is the relevant target for IBC in this context. 

      Regarding these points the authors should address the following issues: 

      (1) Most of the experiments use BJ fibroblasts as a control cell line. In order to evaluate if these compounds are preferentially toxic for cancer cells, the use of more than one non-transformed cell line is necessary. In addition, BJ cells are fibroblasts while most of the cancer cell lines employed are of epithelial origin. The authors could use MCF10 and RPE cells (both of epithelial origin) as control cell lines to complement the results and better support this claim. 

      We have now monitored the effect of IBC and BKC on the proliferation of MCF-7, MCF-10A and RPE-1 cells using the WST-1 assay and obtained similar results as for BJ and MCF-7 cells. These results are now included in the revised manuscript as Fig. S1A and S1B.

      (2) In order to explore what are the targets of BKC and IBC Cellular Thermal Shift Assays (CETSA) could be used. Either by doing an unbiased mass spectrometry analysis of proteins stabilized by these compounds or by a direct analysis of candidate proteins by western blot (a similar approach has been used for IBC to show that it inhibits SIRT2 in Ren et al., 2024 Phytotherapy Res).

      We thank this Reviewer for suggesting the use of the CETSA assay. We have now performed  CETSA on MCF-7 cells and found that IBC stabilizes CHK2 but not CHK1, to the same extent as the commercial CHK2 inhibitor BML-277 used here as a positive control. These results are now shown in new Fig. 4G and 4H.

      (3) For BKC in vitro polymerase assays could be carried out to show the direct inhibition of the DNA polymerase delta, for instance. 

      We have used high-speed Xenopus egg extracts to replicate ssDNA in vitro (Fig. S2C). This assay differs from the in vitro replication assay using low-speed Xenopus egg extracts (Fig. 2H) in that it only monitors elongation by replicative DNA polymerases (Pol δ and ε) and not earlier steps such as origin licensing and activation. The combined use of both low-speed and highspeed extracts strongly supports the view that BKC inhibits replicative DNA polymerases. 

      To confirm this result, we have also used CETSA to monitor BKC binding to different subunits of DNA Polδ and Polε in MCF-7 cells and in Xenopus egg extracts (Fig. 3C-D Fig. S3). We found that BKC binds POLD1 and POLE, the catalytic subunits of Pol δ and ε respectively, but not the accessory subunit POLD3 nor PCNA. Together with our docking results and DNA fiber experiments, these data strongly support the view that BKC is a potent inhibitor of DNA Pol and Pol. 

      (4) In addition, the authors could analyze the integrity of replication forks by PCNA immunofluorescence analysis. The colocalization of PCNA and POLD or POLE subunits could also support the role of DNA polymerases as targets of BKC. 

      Our molecular docking results also show that BKC occupies the catalytic sites of DNA Pol δ and ε, which may not affect their subcellular localization and/or PCNA binding. Since our DNA replication assays, CETSA and DNA fiber analyses strongly support the view that BKC inhibits replicative DNA polymerases, we have not performed this additional experiment.

      (5) In the case of IBC and the inhibition of CHK2, the authors should check the effect of IBC on the phosphorylation of BRCA1 on S988. The changes in CHK2 phosphorylation in Figure 3B are not convincing. The experiment should be repeated and the average of at least three experiments needs to be quantified. 

      We now provide evidence that IBC inhibits BRCA1 phosphorylation on S988. Western blots and quantification for three biological replicates are shown in Fig. 4C and Fig. S4H. Densitometric quantification of CHK2 phosphorylation on S516 from 3 biological replicates, along with statistical analysis, is now shown in Fig. S4G.

      (6) To prove that CHK2 is the relevant target for IBC the authors could test if ATM and CHK2 knockout cells are more resistant to this compound, since it would prevent the phosphorylation of CHK2. 

      We have performed siRNA transfection targeting CHK2. The transfected cells died after 72 hours in culture, so we have been unable to determine whether CHK2-KD cells have increased resistance to IBC.  

      In addition to these experiments, I would suggest some other major improvements in the manuscript: 

      (1) The concentration of both compounds should be provided in molar units throughout the paper.

      Thanks for pointing this out, we now use molar units throughout the paper.

      (2) The authors do not clearly indicate the concentration that is employed in the different experiments, making it difficult to assess the results. For instance, Figure 2 does not include the concentration in the legend or in the text. Time and concentration need to be clearly shown for each experiment. 

      The experimental conditions and inhibitor concentrations are now clearly indicated for each experiment.

      (3) Some experiments are only repeated once (fiber assays) or twice (cell cycle analysis by flow cytometry). These experiments need to be repeated 3 times and the proper statistical analysis performed (comparison of the medians). 

      Superplots with biological replicates for all DNA fiber assays are now displayed. The number of biological replicates is now indicated in the legends and appropriate statistical analyses are used.

      Other minor points or suggestions: 

      (1) Analyzing fork asymmetry would further support the direct effect of BKC on DNA polymerases. 

      The effect of BKC on fork asymmetry is now shown in Fig. 2F. 

      (2) A dose dependent analysis of BKC on the speed of DNA replication would also support this point. 

      Superplots of DNA fiber assays showing the effect of different concentrations of BKC on fork speed from three biological replicates are now included in Fig. 2E.

      (3) Page 7: BKC reduces fork speed ...two-fold. This sentence is not very clear, it would be better to say that speed is half of the control. 

      This sentence was changed to “BKC reduced fork speed by a factor of two relative to untreated cells”.

      (4) Figure 4G and S4D show contradictory results regarding the induction of Rad51 foci by IBC treatment. This needs to be clarified. 

      Figure 4G and S4D (now Fig. 5G and S5D) do not show contradictory results. In both cases, IBC treatment impaired the induction of RAD51 foci by IR or bleomycin.  

      (5) Page 12, Figure S5C is called for but it does not exist (probably meaning Figure S5B). 

      We apologize for this error, which has now been corrected.  

      Reviewer #1 (Significance): 

      The work by Coquel et al. aims at elucidating the use of BKC and IBC as a combined therapy to induce cell death in cancer cells by targeting DNA replication and CHK2. Both BKC and IBC have been previously shown to affect the proliferation of cancer cells. BKC has been shown to induce S phase arrest in an ATR dependent manner in MCF7 cells (Li et al., 2016 Front Pharm), while IBC induces cell death in MDA-MB-231 cells (Wu et al., 2022 Molecules). In this regard, the more interesting contribution of the manuscript is the potential identification of the targets of these compounds in cancer cells. The inhibition of CHK2 by IBC is quite compelling although it needs to be further proven. In contrast, the hypothesis that BKC inhibits DNA polymerases remains highly speculative. The results offer a limited advance in the knowledge of the mechanism of action of these two compounds. Focusing on the action of IBC on CHK2 would increase the impact of the results. In this sense a very recent report has been published showing that IBC inhibits SIRT2 (Ren et al., 2024 Phyto Res), showing that IBC can affect multiple enzymes and processes. This should be taken into account for a further analysis of its mechanism of action. 

      In addition to the identification of the targets of BKC and IBC, the authors also focus on their combination for cancer treatment. This is based on the idea that blocking the DSB repair and inducing replication stress at the same time is an efficient approach to induce cancer cell death. This is not a new concept, since the loss of ATM sensitizes cancer cells to the inhibition of the replication stress response and several combination therapies have been put forward with the idea of generating replication stress and preventing the subsequent repair of the double strand breaks induced in these cells. Thus, the novelty here is limited, especially considering that the effect of BKC on DNA replication has already been described. Further, since its mechanism of action is unclear, it is difficult to ascribe the observed synergy to the speculated hypothesis. A deeper analysis of IBC as a CHK2 inhibitor would be more interesting, and the potential combination with other chemotherapy agents such as replication stress inhibitors, HU or DNA damaging agents. Also, the lack of a good control of non-transformed cells also reduces the relevance of the work. 

      In its current state, the interest of the manuscript is limited. The mechanistical advance is not strong enough and is not completely supported by the data, and the use of these compounds as a combination therapy does not provide new insights in cancer treatment. In my opinion, focusing on the inhibition of CHK2 by IBC and its potential use would broaden the impact of the results beyond the mere analysis of the action of these compounds. 

      We thank this reviewer for his/her constructive and insightful comments. We have followed his/her advice and focused our analysis on the action of IBC on CHK2. Using CETSA, we confirmed that IBC binds CHK2 to the same extent as BML-277 inhibitor, but does not bind CHK1. We also show that IBC inhibits BRCA1 phosphorylation on S988 and CHK2 phosphorylation on S516. Together with the results presented in the initial version of the manuscript, these data support the view that CHK2 is a key IBC target. We have also applied CETSA to DNA polymerases and confirmed that BKC directly targets DNA Polδ and ε. Although it is unlikely that IBC and BKC will ever be used in combination therapies, the synergistic effect that we measured on cancer cells in vivo and in vitro indicates that IBC sensitizes cancer cells to endogenous replication stress and to exogenous sources of DNA damage, which could be used to replace BKC in combination therapies. For instance, our data indicate that IBC can be used in combination with drugs such as etoposide, doxorubicin or cyclophosphamide to potentiate their effect on drug-resistant lymphoma cell lines (DLBCL). As requested by this Reviewer, we have modified the discussion section to put more emphasis on IBC and CHK2 inhibitors and we hope that he/she will now find this revised version suitable for publication.

      Reviewer #2 (Evidence, reproducibility and clarity): 

      In the manuscript by Coquel et al., the authors report their findings on the effect of 2 natural compounds from Psoralea corylofolia plant extracts on cancer cells. They show that these compounds, bakuchiol (BKC) and isobavachalcone (IBC), inhibit proliferation of cancer cells and tumor development in xenografted mice, particularly when used in combination. They further show that BKC inhibited DNA polymerases and induced replication stress, and show evidence that IBC inhibits Chk2 kinase activity and downstream double-strand break repair. Based on their findings, the authors conclude that Chk2 inhibition and DNA replication inhibition represent a potential synergistic strategy to selecting target cancer cells. 

      Major: 

      (1) The data showing IBC is a Chk2 inhibitor is weak and more rigorous investigation is needed to establish this compound as a Chk2 inhibitor. 

      As indicate in our response to Reviewer #1, we have now analyzed the binding of IBC to CHK2 using the Cellular Thermal Shift Assay (CETSA) in MCF-7 cells. Our data clearly show that IBC binds to CHK2 but not CHK1. These results are now shown in Fig. 4G and 4H.

      For one, the authors mention they screened 43 cell cycle-related kinases in vitro, but only show data for 8 kinases in their kinase activity screens. Of these 8 kinases, Chk2 is the most strongly inhibited, but there are no data shown for the other 35 kinases. 

      Data for all the protein kinases tested in the in vitro assay are now presented in Fig. S4D and S4E.  

      Additionally, the purpose of the CHK2 mutants should be discussed in the text. 

      The CHK2(I157T) mutation is linked to an increased risk of breast and colorectal cancers. CHK2(R145W) is associated with Li-Fraumeni Syndrome. Both mutations do not affect the basal kinase activity of CHK2. This information is now indicated in the legend of Fig. S4D. 

      Secondly, the western blot in Fig 3B, appears to show a very modest effect of IBC on Chk2 autophosphorylation and not that different from the effect of IBC on Akt phosphorylation in Fig S3a. Yet, the authors claim that IBC inhibits Chk2 but not Akt. To strengthen these blots, a known Chk2 inhibitor, such as the one shown in Fig 4 (BML-277) should be included as a positive control for pChk2 similarly to what was shown for Akt with MK-2206. 

      We have now replaced the western blot in Fig. 3B (now Fig. 4B) with another biological replicate. Quantifications and statistical analyses of biological replicates are shown in Fig. S4G. Overall, we observed a 50% reduction of CHK2 auto-phosphorylation in MCF7 cells treated with IBC, and a 20% reduction in AKT phosphorylation (Fig. S4A). There was no additional reduction in AKT phosphorylation when cells were treated with IBC in combination with MK-2206, compared to cells treated with MK-2206 alone. We now include the CHK2 inhibitor BML-277 as a positive control alongside with IBC to monitor CHK2 and CHK1 auto-phosphorylation in Fig. 4B, S4G, 4D and S4I, respectively.

      Western blots showing a loss of phosphorylation of additional Chk2 targets is also needed. The manuscript mentions Brca1 S988 as a Chk2 substrate important for DSB repair. Showing the effect of IBC on this phosphorylation site would strengthen the conclusions. 

      We now provide evidence that IBC inhibits BRCA1 phosphorylation at S988. Western blots and quantification for three biological replicates are shown in Fig. 4C and S4H. 

      (2) The authors claim that the combination of IBC and BKC inhibit cell growth in a synergistic manner and that the "effect is more pronounce on cancer cells than on non-cancer cells." However, only 1 non-malignant cell line was used, and it was a fibroblast line. To make this claim, the authors need to show the effect in additional non-malignant cells, preferably with epithelial cell types. 

      We have now monitored cell proliferation using the WST-1 assay in two additional non-malignant cell lines, namely MCF-10A and RPE-1 cells. Cells were treated with IBC/BKC and their growth was compared to that of MCF-7 cells. These experiments yielded similar results to those obtained with BJ fibroblasts. These new data are now included in the revised version as Fig. S1A and S1B. 

      Minor: 

      (1) Densitometry data for all western blots should be shown with mean+/- stdev of independent western blots. 

      Densitometry data for all western blots with biological replicates are now shown in supplementary figures.

      (2) In Figure 1B the statistical test used to analyze cell number was not stated. 

      The statistical test is now indicated in Fig. 1B.

      (3) In Figure 2A, the DAPI image for BKC is the merged image and should be replaced with just DAPI. 

      This error has now been corrected.

      (4) In Figure 2B, the y-axis label says "yH2AX foci (MFI)". MFI and foci are not the same thing, and for yH2AX, the signal is often not focal. MFI of yH2AX is an appropriate measurement for replication stress, it's just not appropriate to equate MFI to foci. 

      We apologize for this labeling error, which has now been corrected.

      (5) For the 53BP1 MFI and Rad51 MFI shown in Fig 4 and Fig S4, it is more appropriate to show the number of foci/cell as these are better indicators of breaks and repair sites. MFI is influenced by expression levels of the proteins and not necessarily the break/repair. 

      The numbers of 53BP1 and RAD51 foci are now shown.

      (6) The data in Figures 5B and 5C are very difficult to read. Perhaps color-coat the lines/symbols. 

      We have now colored the graph to increase its readability. 

      Reviewer #2 (Significance): 

      The findings reported in this manuscript are timely, of interest to the field, and are mostly wellsupported by the experimental data. However, there are a few concerns that need to be addressed. 

      We are grateful to Reviewer #2 for his positive assessment of our manuscript. We hope that we have adequately addressed all of his/her specific concerns and that he/she will agree with the need to put more emphasis on IBC and CHK2 inhibition as requested by Reviewer #1.

      Reviewer #3 (Evidence, reproducibility and clarity): 

      The manuscript: "Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth" successfully demonstrates that the compounds BKC and IBC found in Psoralea corylifolia act synergistically to inhibit cancer cell proliferation, using a wide range of well-chosen methodologies. Moreover, the authors characterized the mechanisms of action of both drugs, which result in inhibition of cell proliferation. The use of multiple cell lines and the mice models makes the study robust and complete. The manuscript presents a well written study that offers new insights and contributions to the field. 

      A few suggestions to improve the study: 

      (1) Given that both compounds BKC and IBC have already been previously described in the literature, it would be helpful for the reader to have them described better at the beginning of the study. 

      Thanks for pointing this out. We have now better described BKC and IBC at the beginning of the results section, as well as in the discussion. We agree that this could be helpful to readers.

      (2) Addition of western blot quantifications over the number of experimental repeats is important specifically for Fig. 2C and Fig. 3C where partial effect of treatment on a signal level is reported. 

      The densitometry analysis of data shown in Fig. 2C and biological replicates are now shown in Fig. S2B. Quantification for Fig. 3C (now Fig. 4D) is shown in Fig. S4I.

      (3) The quantification of mean intensity for 53BP1 and RAD51 foci should be exchanged with the quantification of number of foci per cell. While the quantification of gH2AX signal intensity is a correct representation of induction of this signal upon damage, foci formed by protein recruitment to DNA damage sites should be quantified by counting the number of foci, rather than signal in the whole cell/nucleus. These proteins exist before damage and are re-located in response to the damage. 

      Quantification of 53BP1 and RAD51 foci is now expressed as the number of foci per cell. 

      (4) Materials & Methods section is missing the methods for the experiment described in Fig. 1B. In summary, after addressing our few concerns, we believe the manuscript should be accepted for publication. 

      The WST-1 assay used for cell number quantification is included in “Reagents” in Material & Methods section.

      Reviewer #3 (Significance):

      The manuscript presents a well written study that offers new insights and contributions to the field. Although the inhibitors described have been known in science, the authors present convincingly their mode of action, which is either better characterized (for BKC) or inhibiting a different than previously suggested enzyme (for IBC). Authors also nicely pinpoint and explain the narrow window of concentrations when these two compounds act synergistically rather than additively. The analyses in multiple cell lines, mouse models and in combination with other cancer treatments, makes this study of interest not only for fundamental researchers but also for translational scientists and industry.

      My field of expertise: DNA replication and replication stress across model systems. 

      We are grateful to Reviewer #3 for his/her very positive assessment of our work and we hope that he/she will find this revised version suitable for publication.

    1. Author response:

      Reviewer #1: 

      Summary:

      Ngo et. al use several computational methods to determine and characterize structures defining the three major states sampled by the human voltage-gated potassium channel hERG: the open, closed, and inactivated state. Specifically, they use AlphaFold and Rosetta to generate conformations that likely represent key features of the open, closed, and inactivated states of this channel. Molecular dynamics simulations confirm that ion conduction for structure models of the open but not the inactivated state. Moreover, drug docking in silico experiments show differential binding of drugs to the conformation of the three states; the inactivated one being preferentially bound by many of them. Docking results are then combined with a Markov model to get state-weighted binding free energies that are compared with experimentally measured ones.

      Strengths:

      The study uses state-of-the art modeling methods to provide detailed insights into the structure-function relationship of an important human potassium channel. AlphaFold modeling, MD simulations, and Markov modeling are nicely combined to investigate the impact of structural changes in the hERG channel on potassium conduction and drug binding.

      We appreciate the reviewer’s recognition of our integration of state-of-the-art computational methods, including AlphaFold2, Rosetta, MD simulations, and Markov modeling. We are pleased that the reviewer found our approach to investigating the structure-function relationship of the hERG channel insightful.

      Weaknesses:

      (1) The selection of inactivated conformations based on AlphaFold modeling seems a bit biased. The authors base their selection of the "most likely" inactivated conformation on the expected flipping of V625 and the constriction at G626 carbonyls. This follows a bit of the "Streetlight effect". It would be better to have selection criteria that are independent of what they expect to find for the inactivated state conformations. Using cues that favour sampling/modeling of the inactivated conformation, such as the deactivated conformation of the VSD used in the modeling of the closed state, would be more convincing. There may be other conformations that are more accurately representing the inactivated state. I see no objective criteria that justify the non-consideration of conformations from cluster 3 of the inactivated state modeling. I am not sure whether pLDDT is a good selection criterion. It reports on structural confidence, but that may not relate to functional relevance.

      We acknowledge the concern regarding the selection criteria for the inactivated state models. In the revised manuscript version, we plan to broaden our selection approach and explicitly include conformations from different clusters beyond those highlighted in the initial submission (e.g., from cluster 3). We will also incorporate structural metrics that do not solely depend on the known channel inactivation hallmarks or reply on the pLDDT scores to further justify our chosen representative inactivated state models.

      (2) The comparison of predicted and experimentally measured binding affinities lacks an appropriate control. Using binding data from open-state conformations only is not the best control. A much better control is the use of alternative structures predicted by AlphaFold for each state (e.g. from the outlier clusters or not considered clusters) in the docking and energy calculations. Using these docking results in the calculations would reveal whether the initially selected conformations (e.g. from cluster 2 for the inactivated state) are truly doing a better job in predicting binding affinities. Such a control would strengthen the overall findings significantly.

      We agree that a more rigorous control for our drug-binding predictions is desirable. To address this, we will include molecular docking simulations and associated drug binding affinity estimations for more hERG channel models, including alternate conformations from the initial clustering that were not chosen as the final models. This will allow us to test whether our inactivated state structure from cluster 2 indeed outperforms or differs significantly from other possible inactivated hERG channel conformations in reproducing experimental drug potencies.

      (3) Figures where multiple datapoints are compared across states generally lack assessment of the statistical significance of observed trends (e,g. Figure 3d).

      (4) Figure 3 and Figures S1-S4 compare structural differences between states. However, these differences are inferred from the initial models. The collection of conformations generated via the MD runs allow for much more robust comparisons of structural differences.

      We will incorporate statistical analyses and measures of uncertainty for key comparisons. In Figures 3 and S1-S4 the consensus structural hERG channel models for open, inactivated and closed states are being compared, i.e. one representative model for each state. We believe this is a valid comparison, and the statistical analysis of the observed trends based on those models (e.g., in the bar plot of Figure 3d) alone might not be possible. However, we agree with the reviewer that instead of relying solely on those initial static models, we will also draw on the ensemble of states sampled during the MD simulations to quantify structural differences between different putative hERG channel states. Specifically, we will present ensemble-averaged measurements and highlight how these distributions differ significantly between states.

      Reviewer #2:

      Summary:

      Ngo et al. use AlphaFold2 and Rosetta to model closed, open, and inactive states of the human ion channel hERG. Subsequent MD simulations and comparisons with experiments support the plausibility of their models.

      Strengths:

      This is thorough work studied from many different angles. It provides a self-consistent picture of how conformational changes in hERG may affect its function and binding to different targets.

      We are grateful for the reviewer’s recognition of the thoroughness and multi-faceted nature of our study.

      Weaknesses:

      Though this work claims the methodologies can be generalized to other systems, it is not obvious how. Many modeling choices seem arbitrary and also seem to have required extensive expert knowledge of the system. This limits the applicability of the modeling strategy.

      We appreciate the reviewer’s comment on the generalizability of our approach. In the revision, we will more explicitly discuss the rationale behind the modeling choices and the extent to which they reflect system-specific knowledge. We will clarify how the strategies we developed (e.g., iterative refinement with AlphaFold2 and Rosetta, followed by MD simulation validation) can be adapted to other ion channels or related proteins. We will also outline a more generalizable workflow, specifying which steps require system-specific information and which steps are broadly applicable.

      Reviewer #3:

      Summary:

      The authors use Alphafold2, Rosetta, and Molecular Dynamics to model structures of the hERG K channel in open, inactive, and closed states. Experimental CryoEM data for open hERG (Wang and Mackinnon 2017), and closed EAG (Mandala and Mackinnon, 2002) were used as the main templates for channel models presented here. Given the importance of hERG as a safety pharmacology target, the identification of a robust simulation method to assess drug block is an important addition to the field.

      Strengths

      The key findings here are new inactivated and closed hERG channel conformations and hERG channel conformations with drugs docked in the inner vestibule below the selectivity filter. Amino acid pathways and interaction networks for different states are also presented.

      The inactive state and drug block models are carefully correlated with experimental data for the inactivated state of hERG (Lau et al, 2024) and with experimental free energy data for drug binding and have overall good agreement.

      It is remarkable that using cytoplasmic domain structures of hERG as a starting point revealed inactivation state structures in the hERG selectivity filter in Figures 2,3.

      We thank the reviewer for highlighting the novelty and importance of our work, particularly regarding the identification of new inactivated and closed hERG channel conformations and the modeling of drug block. We are also pleased that the reviewer found the correlation with experimental data to be strong and the structural insights to be valuable.

      Weaknesses

      Figure 6, if each data point is for a different drug, then perhaps identify each point.

      Thank you so much for this suggestion. Please note that Table 3 contains drug-specific data plotted in Figure 6 including drug names. We will provide a reference to Table 3 in the revised Figure 6 caption. We will also revise Figure 6 (and any similar figures) to clearly identify each data point with the corresponding drug and/or include a corresponding key in the Figure legend. This will make it easier to correlate each data point’s binding prediction with the experimental datasets.

      The PAS domain was not included in the models as stated in Methods page 14 but the PAS does appear in some of the templates used as starting points for models in Figure 1 a,b,c. Perhaps mentioning that the PAS was not included in some (all?) of the final models should be moved into the main text and discussed.

      The drug block of 1b channels (which do not contain PAS) has been reported to be slightly different than that for 1a channels (which contain PAS) and for 1a/1b channels (see London et al., 1997; https://doi.org/10.1161/01.RES.81.5.870 and Abi-Gerges et. al., 2011; DOI: 10.1111/j.1476-5381.2011.01378.x) and this should be discussed since the models presented here appear to be performed in the absence of the PAS.

      It also appears that the N-linker region (between PAS and the S1) and distal C region of hERG (post CNBHD-COOH) are not included in models, please state this if correct, and discuss.

      We appreciate the reviewer’s insightful comment regarding the PAS domain and the potential influence of other regions, such as the N-linker and distal C-region, on hERG channel drug binding and state transitions.

      The PAS domain did appear in the starting templates used for initial structural modeling (as shown in Figure 1a, b, c), but it was not included in the final models used for subsequent analyses. Similarly, the N-linker and the distal C-region were also omitted from the final models. These omissions were primarily due to hardware constraints used for AlphaFold structural modeling, as including these additional protein regions would exceed the memory capacity of graphical processing unit (GPU) cards on our available intramural, external and cloud high-performance computing resources, leading to failures during the protein structure prediction step.

      The PAS domain of hERG 1a isoform, even if not serving as a direct drug-binding site, can influence the gating kinetics of hERG channels as the reviewer pointed out. By altering the probability and duration with which those ion channels occupy specific conformational states, it can indirectly affect how well drugs bind. For example, if the presence of the PAS domain shifts channel gating so that more channels enter (and remain in) the inactivated state, drugs with a higher affinity for that state would appear to bind more potently, as observed in electrophysiological experiments. It is also plausible that the PAS domain could exert allosteric effects that alter the conformational landscape of the ion channel during gating transitions, potentially impacting drug accessibility or binding stability. This is an intriguing hypothesis and an important avenue for future research.

      With access to more powerful computational resources, it would be valuable to explore the full-length hERG 1a channel, including the PAS domain and associated regions, to assess their potential contributions to drug binding and gating dynamics. We will incorporate a discussion of these points into the main text, acknowledging the limitations of our current models, citing the references provided by the reviewer, and highlighting the need for future studies to explore these protein regions in greater detail.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary: 

      The study by Fang et al. reports a 3D MERFISH method that enables spatial transcriptomics for tissues up to 200um in thickness. MERFISH, as well as other spatial transcriptomics technologies, have been mainly used for thin (e.g, 10um) tissue slices, which limits the dimension of spatial transcriptomics technique. Therefore, expanding the capacity of MERFISH to thick tissues represents a major technical advance to enable 3D spatial transcriptomics. Here the authors provide detailed technical descriptions of the new method, troubleshooting, optimization, and application examples to demonstrate its technical capacity, accuracy, sensitivity, and utility. The method will likely have a major impact on future spatial transcriptomics studies to benefit diverse biomedical fields. 

      Strengths: 

      The study was well-designed, executed, and presented. Extensive protocol optimization and quality assessments were carried out and conclusions are well supported by the data. The methods were sufficiently detailed, and the results are solid and compelling. 

      Response: We thank the reviewer for the positive comments on our manuscript.  

      Weaknesses: 

      The biological application examples were limited to cell type/subtype classification in two brain regions. Additional examples of how the data could be used to address important biological questions will enhance the impact of the study. 

      We appreciate the reviewer's suggestion that demonstrating the broader applications of our thick-tissue 3D MERFISH method to address important biological questions would enhance the impact of our study. In line with the reviewer's feedback, we have included discussions on how this method could be applied to address various biological questions in the summary (last) paragraph of our manuscript. These discussions highlight the versatility and utility of our approach in studying diverse biological processes beyond cell type classification. 

      However, the goal of this work is to develop a method and establish its validity. While we are interested in applying it to addressing important biological questions in the future, we consider these applications beyond the scope of this work. 

      Reviewer #2 (Public Review): 

      Summary: 

      In their preprint, Fang et al present data on extending a spatial transcriptomics method, MERFISH, to 3D using a spinning disc confocal. MERFISH is a well-established method, first published by Zhuang's lab in 2015 with multiple follow-up papers. In the last few years, MERFISH has been used by multiple groups working on spatial transcriptomics, including approximately 12 million cell maps measured in the mouse brain atlas project. Variants of MERFISH were used to map epigenetic information complementary to gene expression and RNA abundance. However, MERFISH was always limited to thin ~10um sections to this date.

      The key contribution of this work by Fang et al. was to perform the optimization required to get MERFISH working in thick (100-200um) tissue sections. 

      Major strengths and weaknesses: 

      Overall the paper presents a technical milestone, the ability to perform highly multiplexed RNA measurements in 3D using MERFISH protocol. This is not the first spatial transcriptomics done in thick sections. Wang et al. 2018 - StarMAP used thick sections (150 um), and recently, Wang 2021 (EASI-FISH, not cited) performed serial HCR FISH on 300um sections. Data so far suggest that MERFISH has better sensitivity than in situ sequencing approaches (StarMAP) and has built-in multiplexing that EASI-FISH lacks. Therefore, while there is an innovation in the current work, i.e., it is a technically challenging task, the novelty, and overall contribution are modest compared to recently published work.  

      The authors could improve the writing and the manuscript text that places their work in the right context of other spatial transcriptomics work. Out of the 25 citations, 12 are for previous MERFISH work by Zhuang's lab, and only one manuscript used a spatial transcriptomics approach that is not MERFISH. Furthermore, even this paper (Wang et al, 2018) is only discussed in the context of neuroanatomy findings. The fact that Wang et al. were the first to measure thick sections is not mentioned in the manuscript. The work by Wang et al. 2021 (EASI-FISH) is not cited at all, as well as the many other multiplexed FISH papers published in recent years that are very relevant. For example, a key difference between seqFISH+ and MERFISH was the fact that only seqFISH+ used a confocal microscope, and MERFISH has always been relying on epi. As this is the first MERFISH publication to use confocal, I expect citations to previous work in seqFISH and better discussions about differences. 

      We thank the reviewer for recognizing our work as a technical milestone. Since the aim of this work is to build upon the strengths of MERFISH and address some of its limitations, we primarily cited previous MERFISH papers to clarify the specific improvements made in this work. Given the rapid growth of the spatial omics field, it has become impractical to comprehensively cite all method development papers. Instead, we cited a 2021 review article in the first sentence of the originally submitted manuscript and limited all discussions afterwards to MERFISH. In light of this reviewer’s suggestion to more broadly cite spatial transcriptomics work, we added two additional review articles on spatial omics. Spatial omics methods primarily include two categories: 1) imaging-based methods and 2) next-generation-sequencing based methods. The 2021 review article [Zhuang, Nat Methods 18,18–22 (2021)) included in the originally submitted manuscript is focused on imaging-based methods. The additional 2021 review article [Larsson et al., Nat Methods 18, 15–18 (2021)] that we now included in the revised manuscript is focused on next-generation-sequencing based methods. We also added a more recent review article published in 2023 [Bressan et al., Science 381:eabq4964 (2023)], which covers both categories of methods and include more recent technology developments. All three review articles are now cited in parallel in the first introductory paragraph of the manuscript.

      Although we presented our work as an advance in MERFISH specifically, we do consider the reviewer’s suggestion of citing the 2018 STARmap paper [Wang et al., Science 361, eaat5961 (2018)] in the introduction part of our manuscript reasonable. This STARmap paper was already cited in the results part of our originally submitted manuscript, and we have now described this work in the introduction part of our revised manuscript (third paragraph), as this paper was the first to demonstrate 3D in situ sequencing in thick tissues. In addition, we thank the reviewer for bringing to our attention the EASI-FISH paper [Wang et al, Cell 184, 6361-6377 (2021)], which reported a method for thick-tissue FISH imaging and demonstrated imaging of 24 genes using multiple rounds of multi-color FISH imaging. We also recently became aware of a paper reporting 3D imaging of thick samples using PHYTOMap [Nobori et al, Nature Plants 9, 10261033 (2023)]. This paper, published a few days after we submitted our manuscript to eLife, demonstrated imaging of 28 genes in thick plant samples using multiple rounds of multicolor FISH and the probe targeting and amplification methods previously developed for in situ sequencing. We also included these two papers in the introduction section of our revised manuscript (third paragraph). In addition, we also expanded the discussion paragraph (last paragraph) of the manuscript to discuss these thick tissue imaging methods in more details, and in the same paragraph, we also included discussions on two recent bioRxiv preprints in thicktissue transcriptomic imaging [Gandin et al., bioRxiv, doi:10.1101/2024.05.17.594641 (2024); Sui et al., bioRxiv, doi:10.1101/2024.08.05.606553 (2024)]

      However, we do not consider our use of confocal imaging in this work an advance in MERFISH because confocal microscopy, like epi-fluorescence imaging, is a commonly used approach that could be applied to MERFISH of thin tissues directly without any alteration of the protocol. Confocal imaging has been broadly used for both DNA and RNA FISH before any genomescale imaging was reported. Confocal and epi-imaging geometries have their distinct advantages, and which of these imaging geometries to use is the researcher’s choice depending on instrument availability and experimental needs. Thus, we do not find it necessary to cite specific papers just for using confocal imaging in spatial transcriptomic profiling. Our real advance related to confocal imaging is the use of machine-learning to increase the imaging speed. Without this improvement, 3D imaging of thick tissue using confocal would take a long time and likely degrade image quality due to photobleaching of out-of-focus fluorophores before they are imaged. We thus cited several papers that used deep learning to improve imaging quality and/or speed [(Laine et al., International Journal of Biochemistry & Cell Biology 140:106077 (2021); Ouyang et al., Nat Biotechnol 36:460–468 (2018); Weigert et al., Nat Methods 15:1090–1097 (2018)] in our original submission. Our unique contribution is the combination of machine learning with confocal imaging for 3D multiplexed FISH imaging of thick tissue samples, which had not been demonstrated previously.

      To get MERFISH working in 3D, the authors solved a few technical problems. To address reduced signal-to-noise due to thick samples, Fang et al. used non-linear filtering (i.e., deep learning) to enhance the spots before detection. To improve registrations, the authors identified an issue specific to their Z-Piezo that could be improved and replaced with a better model. Finally, the author used water immersion objectives to mitigate optical aberrations. All these optimization steps are reasonable and make sense. In some cases, I can see the general appeal (another demonstration of deep learning to reduce exposure time). Still, in other cases, the issue is not necessarily general enough (i.e., a different model of Piezo Z stage) to be of interest to a broad readership. There were a few additional optimization steps, i.e., testing four concentrations of readout and encoder probes. So while the preprint describes a technical milestone, achieving this milestone was done with overall modest innovation. 

      We appreciate the reviewer's recognition of the technical challenges we have overcome in developing this 3D thick-tissue MERFISH method. To achieve high-quality thick- tissue MERFISH imaging, we had to overcome multiple different challenges. We agree with the reviewer that the solutions to some of the above challenges are intellectually more impressive than the remaining ones that required relatively more mundane efforts. However, all of these are needed to achieve the overall goal, a goal that is considered a milestone by the reviewer.  We believe that the impact of a method should be evaluated based on its capabilities, potential applications, and its adaptability for broader adoption. In this regard, we anticipate that our reported method will be valuable and impactful contribution to the field of spatial biology.

      Data and code sharing - the only link in the preprint related to data sharing sends readers to a deleted Dropbox folder. Similarly, the GitHub link is a 404 error. Both are unacceptable. The author should do a better job sharing their raw and processed data. Furthermore, the software shared should not be just the MERlin package used to analyze but the specific code used in that package.  

      We shared the data through Dropbox as a temporary data-sharing approach for the review process, because of the potential needs to revise and/or add data during the paper revision process. We have now made all data publicly available at Dryad (https://doi.org/10.5061/dryad.w0vt4b922).

      The GitHub link that we provided for the MERlin package was valid and when we clicked on it, it took us to the correct GitHub site. However, to make the code a permanent record, we also deposited the code to Zenodo (https://zenodo.org/records/13356944). Moreover, following the suggestion by the reviewer, in addition to the MERlin v2.2.7 package itself, we have also shared the specific code to utilize this package for analyzing the data taken in this work at Dryad (https://doi.org/10.5061/dryad.w0vt4b922). 

      Recommendations For The Authors:

      Reviewer #1 (Recommendations For The Authors): 

      (1) It will be good to expand the application section to demonstrate the utility of 3D MERFISH to address diverse types of biological questions for the two brain regions examined. At present, it only examined the localization of various cell clusters in the tissues. Can it be used to examine both short and long-range interactions, for example? 

      We appreciate the reviewer's feedback and agree that demonstrating the broader applications of our 3D thick-tissue MERFISH imaging method in addressing diverse biological questions would enhance the impact of our study.  

      In line with the reviewer’s comments, one of the analyses we performed in the manuscript was examining short-range interactions based on soma contact between adjacent neurons in the two brain regions studied (see third-to-last and second-to-last paragraphs of the Main text). This analysis provided insights into the spatial organization of inhibitory neurons and potential interactions between the same type of interneurons in these brain regions. 

      Although long-range interactions, for example synaptic interactions between neurons, would be of great interest, our current 3D MERFISH measurements does not allow such interactions to be determined. Future research to enable measurements of synaptic interactions between molecularly defined neuronal subtypes would be interesting, but we consider this to be out of the scope of the current study.

      (2) For the nearest neighbor distance analysis in Figure 3, the method seems to be missing. Please add details about this analysis to allow better understanding. It is counterintuitive that the cell subtypes showed tight local distribution (Figure 3 - supplement 3), but the nearest neighbor distances with subtypes are not different from those between subtypes. Please explain. 

      We apologize for the missing the nearest neighbor distance analysis in the Materials and Methods section.  We have added the detailed description of this analysis to the Materials and Methods section of the revised manuscript (last subsection of Materials and Methods).

      Regarding the comment “It is counterintuitive that the cell subtypes showed tight local distribution (Figure 3 - supplement 3), but the nearest neighbor distances with subtypes are not different from those between subtypes”, this is not necessarily counter-intuitive given how we defined nearest-neighbor distances between the same subtype of neurons and nearestneighbor distances between different subtypes of neurons. Here is how we performed this analysis for interneurons. First, we determined the nearest-neighbor neurons for each interneuron and classified it as either having another interneuron of the same type as the nearest neighbor or having a different type of interneuron or an excitatory neuron as the nearest neighbor. We then determine the distributions for the distances between these two types of nearest neighbors and compared these distributions. When a neuronal subtype for a tight spatial cluster, such as the type-A cluster shown in the schematic below, the nearest-neighbor distances between nearest neighbor A-A pairs are indeed small. However, the distance between a type-A neuron and a different type of neurons (for example, type-B) is not necessarily bigger than those between two type-A neurons, if the nearest neighbor cell for this type-A neuron is a type-B neuron. These nearest-neighbor A-B pairs are likely formed between type-A neurons at the edge of the cluster with type-B neurons near the edge of the type-A cluster. If the distance of an A-B pair is not comparable to those of nearest-neighbor A-A pairs, it is unlikely a nearestneighbor pair by our definition as described above.

      Author response image 1.

      Reviewer #2 (Recommendations For The Authors): 

      (1) The scholarship in this work is lacking. All of the non-MERFISH parts of the field of spatial transcriptomics are ignored. The work needs to be discussed in the context of the literature. 

      We thank the reviewer for this suggestion and have included discussions of other spatial omics work, and other thick-tissue multiplexed imaging work in the Introduction and discussion section of the manuscript. Please see details in our response to the Public Review  portion of this reviewer’s comments.  

      (2) The data/code sharing links are broken and need to be fixed. 

      Response: We shared the data through Dropbox as a temporary data-sharing approach for the review process, because of the potential needs to revise and/or add data during the paper revision process We have now placed all data publicly available at Dryad (https://doi.org/10.5061/dryad.w0vt4b922). 

      The GitHub link that we provided for the MERlin package was valid and when we clicked on it, it took us to the correct GitHub site. However, to make the code a permanent record, we also deposited the code to Zenodo (https://zenodo.org/records/13356944). Moreover, following the suggestion by the reviewer, in addition to the MERlin (MERFISH decoding package itself), we have also shared the specific code to utilize this package for analyzing the data taken in this work at Dryad (https://doi.org/10.5061/dryad.w0vt4b922) to ensure that the readers can fully reproduce the results presented in our manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, Kume et al examined the role of the protein Semaphorin 4a in steady-state skin homeostasis and how this relates to skin changes seen in human psoriasis and imiquimod-induced psoriasis-like disease in mice. The authors found that human psoriatic skin has reduced expression of Sema4a in the epidermis. While Sema4a has been shown to drive inflammatory activation in different immune populations, this finding suggested Sema4a might be important for negatively regulating Th17 inflammation in the skin. The authors go on to show that Sema4a knockout mice have skin changes in key keratinocyte genes, increased gdT cells, and increased IL-17 similar to differences seen in non-lesional psoriatic skin, and that bone marrow chimera mice with WT immune cells and Sema4a KO stromal cells develop worse IMQ-induced psoriasis-like disease, further linking expression of Sema4a in the skin to maintaining skin homeostasis. The authors next studied downstream pathways that might mediate the homeostatic effects of Sema4a, focusing on mTOR given its known role in keratinocyte function. As with the immune phenotypes, Sema4a KO mice had increased mTOR activation in the epidermis in a similar pattern to mTOR activation noted in non-lesional psoriatic skin. The authors next targeted the mTOR pathway and showed rapamycin could reverse some of the psoriasis-like skin changes in Sema4a KO mice, confirming the role of increased mTOR in contributing to the observed skin phenotype.

      Strengths:

      The most interesting finding is the tissue-specific role for Sema4a, where it has previously been considered to play a mostly pro-inflammatory role in immune cells, this study shows that when expressed by keratinocytes, Sema4a plays a homeostatic role that when missing leads to the development of psoriasis-like skin changes. This has important implications in terms of targeting Sema4a pharmacologically. It also may yield a novel mouse model to study mechanisms of psoriasis development in mice separate from the commonly used IMQ model. The included experiments are well-controlled and executed rigorously.

      Weaknesses:

      A weakness of the study is the lack of tissue-specific Sema4a knockout mice (e.g. in keratinocytes only). The authors did use bone marrow chimeras, but only in one experiment. This work implies that psoriasis may represent a Sema4a-deficient state in the epidermal cells, while the same might not be true for immune cells. Indeed, in their analysis of non-lesional psoriasis skin, Sema4a was not significantly decreased compared to control skin, possibly due to compensatory increased Sema4a from other cell types. Unbiased RNA-seq of Sema4a KO mouse skin for comparison to non-lesional skin might identify other similarities besides mTOR signaling. Indeed, targeting mTOR with rapamycin reveres some of the skin changes in Sema4a KO mice, but not skin thickness, so other pathways impacted by Sema4a may be better targets if they could be identified. Utilizing WT→KO chimeras in addition to global KO mice in the experiments in Figures 6-8 would more strongly implicate the separate role of Sema4a in skin vs immune cell populations and might more closely mimic non-lesional psoriasis skin.

      We sincerely appreciate your summary and for pointing out the strengths and weaknesses of our study. Although we were unfortunately unable to perform all these experiments due to limitations in our resources, we fully agree with the importance of studying tissue-specific Sema4A KO mice. As an alternative, we compared the IL-17A-producing potential of skin T cells between WT→KO mice and KO→KO mice following 4 consecutive days of IMQ treatment using flow cytometry. The results were comparable between the two groups. Additionally, we performed RNA-seq on the epidermis of WT and Sema4A KO mice. While we did not find similarities between Sema4A KO skin and non-lesional psoriasis except for S100a8 expression, we will further try to seek for the mechanisms how Sema4A KO skin mimics non-lesional psoriasis skin as a future project.

      Although targeting mTOR with rapamycin did not reverse the epidermal thickness in Sema4A KO mice, rapamycin was effective in reducing epidermal thickness in a murine psoriasis model induced by IMQ in Sema4A KO mice. These results suggest potential clinical relevance for treating active, lesional psoriatic skin changes, which would be of interest to clinicians. Thank you once again for your valuable insights.

      Reviewer #2 (Public Review):

      Summary:

      Kume et al. found for the first time that Semaphorin 4A (Sema4A) was downregulated in both mRNA and protein levels in L and NL keratinocytes of psoriasis patients compared to control keratinocytes. In peripheral blood, they found that Sema4A is not only expressed in keratinocytes but is also upregulated in hematopoietic cells such as lymphocytes and monocytes in the blood of psoriasis patients. They investigated how the down-regulation of Sema4A expression in psoriatic epidermal cells affects the immunological inflammation of psoriasis by using a psoriasis mice model in which Sema4A KO mice were treated with IMQ. Kume et al. hypothesized that down-regulation of Sema4A expression in keratinocytes might be responsible for the augmentation of psoriasis inflammation. Using bone marrow chimeric mice, Kume et al. showed that KO of Sema4A in non-hematopoietic cells was responsible for the enhanced inflammation in psoriasis. The expression of CCL20, TNF, IL-17, and mTOR was upregulated in the Sema4AKO epidermis compared to the WT epidermis, and the infiltration of IL-17-producing T cells was also enhanced.

      Strengths:

      Decreased Sema4A expression may be involved in psoriasis exacerbation through epidermal proliferation and enhanced infiltration of Th17 cells, which helps understand psoriasis immunopathogenesis.

      Weaknesses:

      The mechanism by which decreased Sema4A expression may exacerbate psoriasis is unclear as yet.

      We greatly appreciate your summary and thoughtful feedback on the strengths and weaknesses of our study. In response, we have included the results of additional experiments on IL-23-mediated psoriasis-like dermatitis, which showed that epidermal thickness was significantly greater in KO mice compared to WT mice. When we analyzed the T cells infiltrating the ears using flow cytometry, the proportion of IL-17A producing Vγ2 and DNγδ T cells within the CD3 fraction of the epidermis was significantly higher in Sema4A KO mice, consistent with the results from IMQ-induced psoriasis-like dermatitis. Furthermore, we examined STAT3 expression in the epidermis of WT and Sema4A KO mice using Western blot analysis, and the results were comparable between the two groups. However, the mechanism by which decreased Sema4A expression may exacerbate psoriasis remains unclear. We have added some explanations and presumptions to the limitations section. Thank you once again for your valuable insights.

      Recommendations For The Authors:

      Reviewer #1 (Recommendations For The Authors):

      Figure 1C

      What statistics were used? The supplemental notes adjusted the P value, what correction for multiple comparisons was utilized? Could the authors instead show logFC for the DEGs between Ctl and L in each cluster? This might be best demonstrated with a volcano plot, highlighting SEMA4A, and other genes known to be DE in psoriasis.

      We apologize for not including the detailed analysis methods in the original manuscript submission. We analyzed the scRNA-seq data using Cellxgene VIP with Welch’s t-test. Multiple comparisons were performed using the Benjamini-Hochberg procedure, setting the false discovery rate (FDR) at 0.05. These details are now explained in the MATERIALS AND METHODS section of the resubmitted manuscript. We also added a log2FC-log10 p-value graph for the DEGs in keratinocytes between Ctl and L to Figure 1-figure supplement 1D. The log2FC values in keratinocytes, dendritic cells, and macrophages were -0.07, 0.00, and -0.05, respectively. Although the log2FC is low in keratinocytes, the adjusted p-value (padj) for Sema4A is 2.83×10-39, indicating a statistically significant difference.

      Page 8 Line 111 in the resubmitted manuscript:

      “The adjusted p-value (padj) for SEMA4A in keratinocytes between Ctl and L was 2.83×10-39, indicating a statistically significant difference despite not being visually prominent in the volcano plot, which shows comprehensive differential gene expression in keratinocytes (Figure 1C; Figure 1-figure supplement 1D).”

      Page 54: In the Figure legend of Figure 1-figure supplement 1D in the resubmitted manuscript:

      “(D) The volcano plot displays changes in gene expression in psoriatic L compared to Ctl.”

      Page 30 Line 481 in the resubmitted manuscript: In the “Data processing of single-cell RNA-sequencing and bulk RNA-sequencing” section.

      “The data was integrated into an h5ad file, which can be visualized in Cellxgene VIP (K. Li et al., 2022). We then performed differential analysis between two groups of cells to identify differential expressed genes using Welch’s t-test. Multiple comparisons were controlled using the Benjamini-Hochberg procedure, with the false discovery rate set at 0.05 and significance defined as padj < 0.05.”

      Figure 2B

      The results narrative notes WT->WT is comparable to KO->WT. No statistics are given for this comparison. It appears the difference is less than the other comparisons, but still may be significant. Also, in the supplemental for Figure 2B, there appear to be missing columns for the 4 BM chimera groups (columns for WT and KO, but not 4 columns for each donor: recipient pair).

      We sincerely apologize for any confusion. We presented the results of the chimeric mice in Figure 3, and Figure 3-source data 1 shows the 4 BM chimera groups. In Figure 3B, the p-value for the comparison between WT->WT mice and KO->WT mice was 0.7988, as indicated in Figure 3-source data 1.

      Figure 3B

      While ear skin is not easily obtainable at day 0 for comparison, why not also include back skin at Wk 8? If the back skin epidermis is thicker like the ear skin, it supports the ear skin conclusion and adds a more consistent comparison. If the back skin epidermis is not thicker, what would be the author's explanation as to the why only ear skin epidermis is thicker in KO mice at 8 weeks?

      We appreciate and completely agree with the reviewer’s insightful comment. We have added images and dot plots of the back skin at Week 8 in Figure 4B. Since the back skin epidermis is thicker, similar to the ear skin, these results support the conclusion drawn from the ear skin data. Regarding Figure 4C, which shows the expression of Sema4a in the epidermis and dermis of 8-week-old WT mouse ear, we have modified the sentence in the manuscript to ‘the epidermis of WT ear at Week 8’ for clarification.

      Page 12 Line 180 in the resubmitted manuscript:

      “While epidermal thickness of back skin was comparable at birth (Figure 4B), on week 8, epidermis of Sema4AKO back and ear skin was notably thicker than that of WT mice (Figure 4B), suggesting that acanthosis in Sema4AKO mice is accentuated post-birth.”

      Page 47: In the Figure legend of Figure 4B in the resubmitted manuscript:

      “(B) Left: representative Hematoxylin and eosin staining of Day 0 back and Wk 8 back and ear. Scale bar = 50 μm. Right: Epi and Derm thickness in Day 0 back (n = 5) and Wk 8 back (n = 5) and ear (n = 8).”

      Figures 3C&D, Figures 4 D-F

      The figures might be easier to read if some of the data is moved to supplemental, especially in Figure 4, which has 36 panels just in D-F. Conversely, the dLN data is important in establishing the skin microenvironment as important in the accumulation of γδ cells and IL-17 production in the setting of Sema4a KO, so this might be more impactful if moved to the main figure.

      We appreciate and agree with your comments. As recommended, we have moved data from Figure 3C and 4D-F to the supplemental section. The dLN data have been moved to the main figure as Figure 4E. This has improved the readability of the figures.

      Figure 5 and Figure 6 might work better if combined. The differences in keratinocytes in psoriasis are well-known, so the novelty is how Sema4a KO skin appears to share similar differences. This would be easier to see if compared side-by-side in the same figure. Also, there is an opportunity to show this more rigorously by performing RNA-seq on WT vs Sema4a KO skin. Showing a larger set of DEGs that trend similarly between Ctl/NL psoriasis and WT/Sema4a KO skin in a heatmap would bolster the conclusion that Sema4a deficiency contributes to a psoriasis-like skin defect.

      We appreciate your valuable suggestion. Following your recommendation, we have combined Figures 5 and 6 to facilitate a side-by-side comparison. This highlights the similarities between Sema4AKO skin and psoriasis, making it easier to observe differences in keratinocytes. Additionally, we performed RNA-seq on WT and Sema4a KO epidermis (n = 3 per group). We analyzed the raw count data using iDEP 2.0 (Ge S.X., BMC Bioinformatics, 2018), setting the minimal counts per million to 0.5 in at least one library. Differential gene expression analysis was conducted using DEseq2, with an FDR cutoff of 0.1 and a minimum fold change of 2. As a result, we identified 46 upregulated and 70 downregulated genes in Sema4AKO mice compared to WT mice (see the volcano plot and heat map). However, except for S100a8, we did not observe significant expression changes in non-lesional psoriasis-related genes between WT and Sema4AKO mice. In the future, we aim to identify subtle stimuli that could cause gene expression changes between these groups and we would like to perform additional RNA-seq experiments.

      Author response image 1.

      Author response image 2.

      Page 48: The Figure title of Figure 5 in the resubmitted manuscript:

      “Figure 5: Sema4AKO skin shares the features of human psoriatic NL.”

      SEMA4A is not significantly DE between Ctl and NL in the psoriasis RNA-seq data. If a lower expression of SEMA4A in psoriasis skin is a driving part of the phenotype, why is this not observed in the RNA-seq data? Presumably, this could be explained by infiltration of immune cells with increased SEMA4A expression, like in the scRNA-seq data in Figure 1. If so, might it be useful to analyze WT->KO chimera mice similarly to global KO mice in Figures 6-8? This might more accurately reflect what is happening in psoriasis, if epidermal SEMA4A expression is low, but immune expression is not. The KO data on their own nicely show a skin phenotype, but these additional experiments might more closely mimic psoriatic disease and increase the rigor and impact of the study.

      We really appreciate your insightful comments. Due to the limitations of the animal experimentation facility, we regret that we are unable to create additional chimeric mice. Although our analysis is limited, we compared IL-17A production from T cells of WT→KO mice and KO→KO mice following 4 consecutive days of IMQ treatment using flow cytometry (see Author response image 3 below; n = 6 for WT→KO, n = 4 for KO→KO). This comparison revealed that IL-17A production from T cells was comparable, regardless of whether they were derived from WT or Sema4AKO mice, when the skin constituent cells were derived from Sema4AKO. We appreciate the value of your advice, and agree that investigating keratinocyte differentiation and mTOR signaling in the epidermis, using either WT→KO chimeric mice or keratinocyte-specific Sema4A-deficient mice, is a crucial next step in our research.

      Author response image 3.

      Figure 8

      Rapamycin was able to partially reverse the psoriasis-like skin phenotype in Sema4a KO mice. Would rapamycin also be effective in the more severe disease induced by IMQ in Sema4a KO mice? While partially reducing the effect of Sema4a KO on steady-state skin with rapamycin strengthens the link to mTOR dysregulation, it did not change skin thickness. It's unclear if this would be useful clinically for patients with well-controlled psoriasis (NL skin). Would it be useful to reverse active, lesional psoriatic skin changes? Testing this might yield results more relevant to clinicians and patients.

      We are grateful for your valuable feedback. Rapamycin showed effectiveness in reducing epidermal thickness in a murine psoriasis model induced by IMQ in Sema4AKO mice. Rapamycin treatment downregulated the expression of Krt10, Krt14, and Krt16. We included these results to Figure 7-figure supplement 2. These results suggest potential clinical relevance for treating active, lesional psoriatic skin changes and may be of interest to clinicians and patients.

      Page 17 Line 269 in the resubmitted manuscript:

      “Next, we investigated whether intraperitoneal rapamycin treatment effectively downregulates inflammation in the IMQ-induced murine model of psoriasis in Sema4AKO mice (Figure 7-figure supplement 2A). Rapamycin significantly reduced epidermal thickness compared to vehicle treatment (Figure 7-figure supplement 2B). Additionally, rapamycin treatment downregulated the expression of Krt10, Krt14, and Krt16 (Figure 7-figure supplement 2C). While the upregulation of Il17a in the Sema4AKO epidermis in IMQ model was not clearly modified by rapamycin (Figure 7-figure supplement 2C), immunofluorescence revealed a decrease in the number of CD3 T cells in Sema4AKO epidermis by rapamycin (Figure 7-figure supplement 2D). In the naive states, mTORC1 primarily regulates keratinocyte proliferation, whereas mTORC2 mainly involved in the keratinocyte differentiation through Sema4A-related signaling pathways. Conversely, in the psoriatic dermatitis state, rapamycin downregulated both keratinocyte differentiation and proliferation markers. The observed similarities in Il17a expression following treatment with rapamycin and JR-AB2-011, regardless of additional IMQ treatment, suggest that Il17a production is not significantly dependent on Sema4A-related mTOR signaling.”

      Page 29 Line 461 in the resubmitted manuscript: In the “Inhibition of mTOR” section.

      “To analyze the preventive effectiveness of rapamycin in an IMQ-induced murine model of psoriatic dermatitis, Sema4AKO mice were administered either vehicle or rapamycin intraperitoneally from Day 0 to Day 17, and IMQ was topically applied to both ears for 4 days starting on Day 14. Then, on Day 18, ears were collected for further analysis.”

      Page 71: Figure 7-figure supplement 2 in the resubmitted manuscript:

      “Figure 7-figure supplement 2: Rapamycin treatment reduced the epidermal swelling observed in IMQ-treated Sema4AKO mice.

      (A) Experimental scheme. (B) The Epi thickness on Day 18. (n = 10 for Ctl, n = 12 for Rapamycin). (C) Relative expression of keratinocyte differentiation markers and Il17a in Sema4AKO Epi (n = 10 for Ctl, n = 12 for Rapamycin). (D) The number of T cells in the Epi (left) and Derm (right), under Ctl or rapamycin and IMQ treatments (n = 10 for Ctl, n = 12 for Rapamycin). Each dot represents the sum of numbers from 10 unit areas across 3 specimens. A-C: *p < 0.05, **p < 0.01. NS, not significant.”

      Reviewer #2 (Recommendations For The Authors):

      (1) To know whether the decrease of Sema4A in the epidermis of psoriasis patients is a result or a cause of psoriasis, it is necessary to show how the expression of Sema4A in epidermal cells is regulated. Shouldn't the degree of change in the expression of essential molecules (which is the cause of psoriasis) be more pronounced in L than in NL?

      We surveyed transcription factors of human Sema4A using GeneCards and found that NF-κB is the transcription factor most frequently associated with psoriasis. Wang et al. (Arthritis Res Ther. 2015) indicated NF-κB-dependent modulation of Sema4A expression in synovial fibroblasts of rheumatoid arthritis. However, since NF-κB expression is reportedly upregulated in psoriasis lesions, other transcription factors may function as key modulators of Sema4A expression in the epidermis.

      Although the molecules causing psoriasis remain to be elucidated, we investigated the correlation between the expression of psoriasis-related essential molecules in keratinocytes—such as S100A7A, S100A7, S100A8, S100A9, and S100A12—and SEMA4A expression in L and NL samples using qRT-PCR. We could not identify a correlation between these molecules and SEMA4A expression. We added a note to the limitations section to acknowledge that we were not able to reveal how Sema4A expression is regulated and that we could not determine the relationships between Sema4A expression and the essential molecules upregulated in psoriatic keratinocytes.

      Page 21 Line 328 in the resubmitted manuscript:

      “We were not able to reveal how Sema4A expression is regulated. Although we showed that downregulation of Sema4A is related to the abnormal cytokeratin expression observed in psoriasis, we could not determine the relationships between Sema4A expression and the essential molecules upregulated in psoriatic keratinocytes.”

      (2) Using bone marrow chimeric mice, it has already been reported that hematopoietic cells contain keratinocyte stem cells. Therefore, their interpretation is not supported by the results of their bone marrow chimeric mice experiment, and it is essential to generate keratinocyte-specific Sema4A knockout mice and perform similar experiments to support their interpretation.

      We value the reviewer’s insightful comment. We have assessed the expression of Sema4a in the epidermis of WT→KO chimeric mice using qRT-PCR. Our findings indicate that Sema4a expression levels in the epidermis of these mice are minimal (cycle threshold values of Sema4a ranged from 31.9 to not detected in WT→KO chimeric mice, whereas they ranged from 24.5 to 26.2 in WT→ WT mice). Consequently, we believe that the impact of keratinocyte stem cells derived from WT-hematopoietic cells is limited in this model. We appreciate this opportunity to clarify our results and will consider the generation of keratinocyte-specific Sema4A knockout mice for future experiments to further substantiate our interpretation.

      Page 11 Line 159 in the resubmitted manuscript:

      “Since it has already been reported that bone marrow cells contain keratinocyte stem cells (Harris et al., 2004; Wu, Zhao, & Tredget, 2010), we confirmed that epidermis of mice deficient in non-hematopoietic Sema4A (WT→KO) showed no obvious detection of Sema4a, thereby ruling out the impact of donor-derived keratinocyte stem cells infiltrating the host epidermis (Figure 3-figure supplement 1A).”

      Page 60: In the Figure legend of Figure 3-figure supplement 1A in the resubmitted manuscript:

      “(A) Sema4a expression in the Epi of WT→ WT mice and WT→ KO mice (n = 8 for WT→ WT, n = 7 for WT→ KO).”

      (3) Since Sema4A KO mice already have immunological and epidermal cell characteristics similar to psoriasis, albeit weak, it is possible that the nonspecific stimulus of simply topical IMQ may have appeared to exacerbate psoriasis. It is advisable to confirm whether a more psoriasis-specific stimulus, IL-23 administration, would produce similar results.

      Thank you for your suggestion. Following your advice, we have analyzed IL-23-mediated psoriasis-like dermatitis. To induce the model, 20 μl of phosphate-buffered saline containing 500 ng of recombinant mouse IL-23 was injected intradermally into both ears for 4 consecutive days. Unlike with the application of IMQ, there was no significant difference in ear thickness. However, H&E staining revealed that the epidermal thickness was significantly greater in KO mice compared to WT mice. Although a longer period of IL-23 induction might result in more pronounced ear swelling, we conducted this experiment over the same duration as the IMQ application experiment to maintain consistency. When we analyzed the T cells infiltrating the ears using flow cytometry, the proportion of IL-17A producing Vγ2 and DNγδ T cells in CD3 fraction in the epidermis was significantly higher in Sema4A KO mice, consistent with the results from IMQ-induced psoriasis-like dermatitis.

      The lack of significant difference in ear thickness changes with IL-23 administration might be due to IL-23 administration not reflecting upstream events of IL-23 production.

      We consider that in psoriasis, the expression of Sema4A in keratinocytes is likely more important than in T cells. Therefore, it makes sense that the phenotype difference was more pronounced with IMQ, which likely has a greater effect on keratinocytes compared to IL-23.

      Page 9 Line 137 in the resubmitted manuscript:

      “Though the imiquimod model is well-established and valuable murine psoriatic model (van der Fits et al., 2009), the vehicle of imiquimod cream can activate skin inflammation that is independent of toll-like receptor 7, such as inflammasome activation, keratinocyte death and interleukin-1 production (Walter et al., 2013). This suggests that the imiquimod model involves complex pathway. Therefore, we subsequently induced IL-23-mediated psoriasis-like dermatitis (Figure2-figure supplement 2A), a much simpler murine psoriatic model, because IL-23 is thought to play a central role in psoriasis pathogenesis (Krueger et al., 2007; Lee et al., 2004). Although ear swelling on day 4 was comparable between WT mice and Sema4AKO mice (Figure2-figure supplement 2B), the epidermis, but not the dermis, was significantly thicker in Sema4AKO mice compared to WT mice (Figure2-figure supplement 2C). We found that the proportion of CD4 T cells among T cells was significantly higher in Sema4A KO mice compared to WT mice, while the proportion of Vγ2 and DNγδ T cells among T cells was comparable between them (Figure 2-figure supplement 2D). On the other hand, focusing on IL-17A-producing cells, the proportion of IL-17A-producing Vγ2 and DNγδ T cells in CD3 fraction in the epidermis was significantly higher in Sema4A KO mice, consistent with the results from imiquimod-induced psoriasis-like dermatitis. (Figure 2-figure supplement 2E).”

      Page 24 Line 363 in the resubmitted manuscript: In the “Mice” section.

      “To induce IL-23-mediated psoriasis-like dermatitis, 20 μl of phosphate-buffered saline containing 500 ng of recombinant mouse IL-23 (BioLegend, San Diego, CA) was injected intradermally into both ears of anesthetized mice using a 29-gauge needle for 4 consecutive days.”

      Page 58: In the Figure legend of Figure 2-figure supplement 2 in the resubmitted manuscript:

      “IL-23-mediated psoriasis-like dermatitis is augmented in Sema4AKO mice.

      (A) An experimental scheme involved intradermally injecting 20 μl of phosphate-buffered saline containing 500 ng of recombinant mouse IL-23 into both ears of WT mice and KO mice for 4 consecutive days. Samples for following analysis were collected on Day 4. (B and C) Ear thickness (B) and Epi and Derm thickness (C) of WT mice and KO mice on Day 4 (n = 12 per group). (D and E) The percentages of Vγ3, Vγ2, DNγδ, CD4, and CD8 T cells (D) and those with IL-17A production (E) in CD3 fraction in the Epi (top) and Derm (bottom) of WT and KO ears (n = 5 per group). Each dot represents the average of 4 ear specimens. B-E: *p < 0.05, **p < 0.01. NS, not significant.”

      (4) How is STAT3 expression in the epidermis crucial in the pathogenesis of psoriasis in Sem4AKO mice?

      We appreciate your insightful comment. In our study, given the established role of activated STAT3 in psoriasis, we investigated both total STAT3 and phosphorylated STAT3 (p-STAT3) levels in the naive epidermis of WT and Sema4AKO mice (See the figure below). Our findings indicate that STAT3 activation does not occur in the epidermis of Sema4AKO mice. Therefore, we speculated that the hyperkeratosis observed in Sema4AKO mice is due to aberrant mTOR signaling rather than STAT3 activation. STAT3 may be relevant to other pathways independent of Sema4A signaling, or it may function as a complex with other molecules in the Sema4A signaling.

      Author response image 4.

    1. Author response:

      Response to Reviewer 1

      We will investigate the intracellular localization of ABCA1 in both EpH4 and EpH4-Snail cells. We will also examine the changes in ACAT expression levels within these cell lines.

      Response to Reviewer 2

      We will first investigate whether the chemoresistance exhibited by EpH4-Snail cells can be abolished not only through pharmacological inhibition of ABCA1 but also by knocking out the ABCA1 gene. Regarding causality, as demonstrated in Figure 2, we have already shown that reducing cholesterol levels in EpH4-Snail cells decreases ABCA1 expression. To further explore this relationship, we will assess whether increasing sphingomyelin levels by adding ceramide to the culture medium, thereby correcting the sphingomyelin-to-cholesterol ratio, would reduce ABCA1 expression. Furthermore, we will evaluate whether lowering cholesterol levels in EpH4-Snail cells via simvastatin treatment, along with normalization of the sphingomyelin-to-cholesterol ratio, attenuates their resistance to the anticancer drug nitidine chloride. Additionally, we will incorporate quantitative analyses for several experiments, as suggested in the reviewers’ comments, to enhance the robustness of our findings.

    1. Author response:

      We thank the reviewers for their support of this work and insightful recommendations for how to improve it. We have provided specific responses to each reviewer comment below. To summarize how we intend to address the requested revisions:

      Many of the reviewers’ comments requested additional technical or quality details about the DMS libraries or assays (e.g., number of cells tested, number of sequencing reads, assay replication, assay sensitivity, library balance), and we provide additional information and analyses that we can incorporate into the relevant portions of the text, supplementary tables, and supplementary figures to address these questions.

      Some comments asked to clarify nomenclature/wording or provide additional labels to images, and we will make these changes as requested.

      A few questions would require additional experimental data to address. Where experiments have already been performed, we will incorporate those results or cite relevant work previously reported in the literature.

      Reviewer 1:

      Summary

      Howard et al. performed deep mutational scanning on the MC4R gene, using a reporter assay to investigate two distinct downstream pathways across multiple experimental conditions. They validated their findings with ClinVar data and previous studies. Additionally, they provided insights into the application of DMS results for personalized drug therapy and differential ligand responses across variant types.

      Strengths

      They captured over 99% of variants with robust signals and investigated subtle functionalities, such as pathway-specific activities and interactions with different ligands, by refining both the experimental design and analytical methods.

      Weaknesses

      While the study generated informative results, it lacks a detailed explanation regarding the input library, replicate correlation, and sequencing depth for a given number of cells.

      Additionally, there are several questions that it would be helpful for authors to clarify.

      (1) It would be helpful to clarify the information regarding the quality of the input library and experimental replicates. Are variants evenly represented in the library? Additionally, have the authors considered using long-read sequencing to confirm the presence of a single intended variant per construct? Finally, could the authors provide details on the correlation between experimental replicates under each condition?

      Are variants evenly represented in the library?

      We strive to achieve as evenly balanced library as possible at every stage of the DMS process (e.g., initial cloning in E. coli through integration into human cells). Below is a representative plot showing the number of barcodes per amino acid variant at each position in a given ~60 amino acid subregion of MC4R, which highlights how evenly variants are represented at the E. coli cloning stage.

      Author response image 1.

      We also make similar measurements after the library is integrated into HEK293T cell lines, and see similarly even coverage across all variants, as shown in the plot below.

      Author response image 2.

      Additionally, have the authors considered using long-read sequencing to confirm the presence of a single intended variant per construct?

      We agree long-read sequencing would be an excellent way to confirm that our constructs contain a single intended variant. However, we elected for an alternate method (outlined in more detail in Jones et al. 2020) that leverages multiple layers of validation. First, the oligo chip-synthesized portions of the protein containing the variants are cloned into a sequence-verified plasmid backbone, which greatly decreases the chances of spuriously generating a mutation in a different portion of the protein. We then sequence both the oligo portion and random barcode using overlapping paired end reads during barcode mapping to avoid sequencing errors and to help detect DNA synthesis errors. At this stage, we computationally reject any constructs that have more than one variant. Given this, the vast majority of remaining unintended variants would come from somatic mutations introduced by the E. coli cloning or replication process, which should be low frequency. We have used our in-house full plasmid sequencing method, OCTOPUS, to sample and spot check this for several other DMS libraries we have generated using the same cloning methods. We have found variants in the plasmid backbone in only ~1% of plasmids in these libraries. Our statistical model also helps correct for this by accounting for barcode-specific variation. Finally we believe this provides further motivation for having multiple barcodes per variant, which dilutes the effect of any unintended additional variants.

      Finally, could the authors provide details on the correlation between experimental replicates under each condition?

      Certainly! In general, the Gs reporter had higher correlation between replicates than the Gq system (r ~ 0.5 vs r ~ 0.4). The plots below show two representative correlations at the RNA-seq stage of read counts for barcodes between the low a-MSH conditions. One important advantage of our statistical model is that it’s able to leverage information from barcodes regardless of the number of replicates they appear in.

      Author response image 3.

      Since the functional readout of variants is conducted through RNA sequencing, it seems crucial to sequence a sufficient number of cells with adequate sequencing saturation. Could the authors clarify the coverage depth used for each RNA-seq experiment and how this depth was determined? Additionally, how many cells were sequenced in each experiment?

      This will be addressed by incorporating the following details into the manuscript:

      We seeded 17 million cells per replicate at the start of each assay and, with a doubling of ~1.5x over the course of the assay, harvested ~25.5 million cells per replicate for RNA extraction and sequencing. We found this sufficient to get at least ~30-60x cellular coverage per amino acid variant.

      Total mapped reads per replicate at RNA-seq stage

      - Gs/CRE: 9.1-18.2 million mapped reads, median=12.3

      - Gq/UAS: 8.6-24.1 million mapped reads, median=14.5

      - Gs/CRE+Chaperone: 6.4-9.5 million mapped reads, median=7.5

      Reads per barcode distribution

      - Median read counts of 8, 10, and 6 reads per sample per barcode for Gs/CRE, Gq/UAS, and Gs/CRE+Chaperone assays, respectively.

      Barcodes per variant distribution

      - As reported, the median number of barcodes per variant across samples (the “median of medians”) is 56 for Gs/CRE and 28 for Gq/UAS

      - Additionally, it is 44 for Gs/CRE+Chaperone

      It appears that the frequencies of individual RNA-seq barcode variants were used as a proxy for MR4C activity. Would it be important to also normalize for heterogeneity in RNA-seq coverage across different cells in the experiment? Variability in cell representation (i.e., the distribution of variants across cells) could lead to misinterpretation of variant effects. For example, suppose barcode_a1 represents variant A and barcode_b1 represents variant B. If the RNA-seq results show 6 reads for barcode_a1 and 7 reads for barcode_b1, it might initially appear that both variants have similar effect sizes. However, if these reads correspond to 6 separate cells each containing 1 copy of barcode_a1, and only 1 cell containing 7 copies of barcode_b1, the interpretation changes significantly. Additionally, if certain variants occupy a larger proportion of the cell population, they are more likely to be overrepresented in RNA sequencing.

      We account for this heterogeneity in several ways. First, as shown above (Response to Reviewer 1, Question 1), we aim to have even representation of variants within our libraries. Second, we utilize compositional control conditions like forskolin or unstimulated conditions to obtain treatment-independent measurements of barcode abundance and, consequently, of mutant-vs-WT effects that are due to compositional rather than biological variability. We expect that variability observed under these controls is due to subtle effects of molecular cloning, gene expression, and stochasticity. Using these controls, we observe that mutant-vs-WT effects are generally close to zero in these normalization conditions (e.g., in untreated Gq, see Supplementary Figure 3) as compared to drug-treated conditions. For example, pre-mature stops behave similar to WT in normalization conditions. This indicates that mutant abundance is relatively homogenous. Where there are barcode-dependent effects on abundance, we can use information from these conditions to normalize that effect. Finally, our mixed-effect model accounts for barcode-specific deviations from the expected mutant effect (e.g. a “high count” barcode consistently being high relative to the mean).

      Although the assay system appears to effectively represent MC4R functionality at the molecular level, we are curious about the potential disparity between the DMS score system and physiological relevance. How do variants reported in gnomAD distribute within the DMS scoring system?

      Figure 2D shows DMS scores (variant effect on Gs signaling) relative to human population frequency for all MC4R variants reported in gnomAD as of January 8, 2024.

      To measure Gq signaling, the authors used the GAL4-VPR relay system. Is there additional experimental data to support that this relay system accurately represents Gq signaling?

      The full Gq reporter uses an NFAT response element from the IL-2 promoter to regulate the expression of the GAL4-VPR relay. In this system, the activation of Gq signaling results in the activation of the NFAT response element, and this signal is then amplified by the GAL4-VPR relay. The NFAT response element has been previously well-validated to respond to the activation of Gq signaling (e.g., PMID: 8631834). We will add this reference to the text to further support the use of the Gq assay.

      Identifying the variants responsive to the corrector was impressive. However, we are curious about how the authors confirmed that the restoration of MC4R activity was due to the correction of the MC4R protein itself. Is there a possibility that the observed effect could be influenced by other factors affected by the corrector? When the corrector was applied to the cells, were any expected or unexpected differential gene expression changes observed?

      While we do not directly measure whether Ipsen-17 has effects on other signaling processes, previous work has shown that Ipsen-17 treatment does not indirectly alter signaling kinetics such as receptor internalization (Wang et al., 2014). Furthermore, our analysis methods inherently account for this by normalizing variant effects to WT signaling levels. Any observed rescue of a given variant inherently means that the variant is specifically more responsive to Ipsen-17 than WT, and the fact that different variants exhibit different levels of rescue is reassuring that the mechanism is on target to MC4R. Lastly, Ipsen-17 is known to be an antagonist of alpha-MSH activity and is thought to bind directly to the same site on MC4R (Wang et al., 2014).

      As mentioned in the introduction, gain-of-function (GoF) variants are known to be protective against obesity. It would be interesting to see further studies on the observed GoF variants. Do the authors have any plans for additional research on these variants?

      We agree this would be an excellent line of inquiry, but due to changes in company priorities we unfortunately do not have any plans for additional research on these variants.

      Reviewer 2:

      Overview

      In this manuscript, the authors use deep mutational scanning to assess the effect of ~6,600 protein-coding variants in MC4R, a G protein-coupled receptor associated with obesity. Reasoning that current deep mutational scanning approaches are insufficiently precise for some drug development applications, they focus on articulating new, more precise approaches. These approaches, which include a new statistical model and innovative reporter assay, enable them to probe molecular phenotypes directly relevant to the development of drugs that target this receptor with high precision and statistical rigor.

      They use the resulting data for a variety of purposes, including probing the relationship between MC4R's sequence and structure, analyzing the effect of clinically important variants, identifying variants that disrupt downstream MC4R signaling via one but not both pathways, identifying loss of function variants are amenable to a corrector drug and exploring how deep mutational scanning data could guide small molecule drug optimization.

      Strengths

      The analysis and statistical framework developed by the authors represent a significant advance. In particular, the study makes use of barcode-level internally replicated measurements to more accurately estimate measurement noise.

      The framework allows variant effects to be compared across experimental conditions, a task that is currently hard to do with rigor. Thus, this framework will be applicable to a large number of existing and future deep mutational scanning experiments.

      The authors refine their existing barcode transcription-based assay for GPCR signaling, and develop a clever "relay" new reporter system to boost signaling in a particular pathway. They show that these reporters can be used to measure both gain of function and loss of function effects, which many deep mutational scanning approaches cannot do.

      The use of systematic approaches to integrate and then interrogate high-dimensional deep mutational scanning data is a big strength. For example, the authors applied PCA to the variant effect results from reporters for two different MC4R signaling pathways and were able to discover variants that biased signaling through one or the other pathway. This approach paves the way for analyses of higher dimensional deep mutational scans.

      The authors use the deep mutational scanning data they collect to map how different variants impact small molecule agonists activate MC4R signaling. This is an exciting idea, because developing small-molecule protein-targeting therapeutics is difficult, and this manuscript suggests a new way to map small-molecule-protein interactions.

      Weaknesses

      The authors derive insights into the relationship between MC4R signaling through different pathways and its structure. While these make sense based on what is already known, the manuscript would be stronger if some of these insights were validated using methods other than deep mutational scanning.

      Likewise, the authors use their data to identify positions where variants disrupt MC4R activation by one small molecule agonist but not another. They hypothesize these effects point to positions that are more or less important for the binding of different small molecule agonists. The manuscript would be stronger if some of these insights were explored further.

      Impact

      In this manuscript, the authors present new methods, including a statistical framework for analyzing deep mutational scanning data that will have a broad impact. They also generate MC4R variant effect data that is of interest to the GPCR community.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public Review:

      Previously, this group showed that Tgfbr1 regulates the reorganization of the epiblast and primitive streak into the chordo-neural hinge and tailbud during the trunk-to-tail transition. Gdf11 signaling plays a crucial role in orchestrating the transition from trunk to tail tissues in vertebrate embryos, including the reallocation of axial progenitors into the tailbud and Tgfbr1 plays a key role in mediating its signaling activity. Progenitors that contribute to the extension of the neural tube and paraxial mesoderm into the tail are located in this region. In this work, the authors show that Tgfbr1 also regulates the reorganization of the posterior primitive streak/base of allantois and the endoderm as well. 

      By analyzing the morphological phenotypes and marker gene expression in Tgfbr1 mutant mouse embryos, they show that it regulates the merger of somatic and splanchnic layers of the lateral plate mesoderm, the posterior streak derivative. They also present evidence suggesting that Tgfbr1 acts upstream of Isl1 (key effector of Gdf11 signaling for controlling differentiation of lateral mesoderm progenitors) and regulates the remodelling of the major blood vessels, the lateral plate mesoderm and endoderm associated with the trunk-to-tail transition. Through a detailed phenotypic analysis, the authors observed that, similarly to Isl1 mutants, the lack of Tgfbr1 in mouse embryos hinders the activation of hindlimb and external genitalia maker genes and results in a failure of lateral plate mesoderm layers to converge during tail development. As a result, they interpret that ventral lateral mesoderm, which generates the peri cloacal mesenchyme and genital tuberculum, fails to specify. 

      They also show defects in the morphogenesis of the dorsal aorta at the trunk/tail juncture, resulting in an aberrant embryonic/extraembryonic vascular connection. Endoderm reorganization defects following abnormal morphogenesis of the gut tube in the Tgfbr1 mutants cause failure of tailgut formation and cloacal enlargement. Thus, Tgfbr1 activity regulates the morphogenesis of the trunk/tail junction and the morphogenetic switch in all germ layers required for continuing post-anal tail development. Taken together with the previous studies, this work places Gdf11/8 - Tgfbr1 signaling at the pivot of trunk-to-tail transition and the authors speculate that critical signaling through Tgfbr1 occurs in the posterior-most part of the caudal epiblast, close to the allantois. 

      Strengths: 

      The data shown is solid with excellent embryology/developmental biology. This work demonstrates meticulous execution and is presented in a comprehensive and coherent manner. Although not completely novel, the results/conclusions add to the known function of Gdf11 signaling during the trunk-to-tail transition. 

      Weaknesses: 

      The authors rely on the expression of a small number of key regulatory genes to interpret the developmental defects. The alternative possibilities remain to be ruled out thoroughly. The manuscript is also quite descriptive and would benefit from more focused highlighting of the novelty regarding the absence of Tgfbr1 in the mouse embryo. They should also strengthen some of their conclusions with more details in the results.

      Although we used a limited number of key regulatory genes to interpret the phenotype, these genes were carefully chosen to focus on specific processes involving the lateral mesoderm, its derivatives, and the endoderm. In addition to these markers, we included references to other relevant markers that were previously analyzed and initially led us to examine the lateral plate mesoderm and tail gut in Tgfbr1 mutants. To strengthen our analysis, we have now incorporated additional data to clarify specific phenotypes. For instance, in situ hybridization (ISH) for Shh further confirms abnormalities at the caudal end of the endoderm in mutant embryos, while no endodermal defects are observed in the trunk region. We also included an analysis of the intermediate mesoderm, which shows abnormalities at the same level as those found in the lateral plate mesoderm and endoderm of Tgfbr1 mutants.

      It’s important to note that using additional markers to assess the epiblast/primitive streak of Tgfbr1 mutants at E7.5–E8.5, as suggested by a reviewer, is unlikely to yield new insights. At these early stages, Tgfbr1 mutant embryos do not display observable phenotypes in the main body axis. Data in this manuscript already demonstrate the absence of abnormalities at this stage, as shown in Figure 3 and Supplementary Figure 6. Additionally, the expression of certain genes showing abnormalities when the embryo would enter tail development, in the trunk their expression remains unaffected, indicating that trunk extension is not significantly impacted by Tgfbr1 deficiency. While transcriptomic analysis of these Tgfbr1 mutants could provide interesting insights, it would be more appropriate to focus on later developmental stages, which would be beyond the scope of the current study.

      The second major critique was that the manuscript is primarily descriptive. We disagree with this assessment. Several hypotheses were rigorously tested using genetic approaches, including Isl1 knockout experiments, cell tracing from the primitive streak with a newly generated Cre driver to activate a reporter from the ROSA26 locus, and assessment of extraembryonic endoderm fate in Tgfbr1 mutants by introducing the Afp-GFP transgene into the Tgfbr1 mutant background. Additionally, we conducted tracing analyses of tail bud cell contributions to the tail gut via DiI injection and embryo incubation. To address potential concerns regarding this experiment, we have included data showing the DiI position immediately after injection to confirm that it does not contact the tail gut. We also considered and accounted for potential DiI leakage into neuromesodermal progenitors to clarify the endodermal results.

      Our genetic and DiI experiments were specifically designed to differentiate between alternative hypotheses and to confirm hypotheses generated from other analyses. Additionally, improvements in some of the imaging data have helped address remaining concerns.

      Reviewer #1 (Recommendations For The Authors): 

      I have listed my suggestions as queries. The authors may perform experiments or clarify by editing the text to address them. 

      The authors state on Page 11 and elsewhere that the ventral lateral mesoderm is absent in the Tgfbr1 mutant. What is the basis for this conclusion? Are there specific markers for PCM or GT primordium? 

      The specific marker of PCM and GT primordium is Isl1. The absence of this marker in the Tgfbr1 mutants is shown in (Dias et al, 2020). The reference is introduced in the manuscript.

      A schematic illustrating the VLM and the expression patterns of Tgfbr1, Gdf11, etc., would be helpful. 

      Characterization of Gdf11 expression has been previously reported (e.g. McPherron et al 1999, cited in our manuscript). It is expressed in the region containing of axial progenitors before the trunk to tail transition and not expressed in the VLM. As for Tgfbr1 expression is hard to detect, likely because it is ubiquitously expressed at low level. We include in this document some pictures of an ISH, including a control using the Tgfbr1 mutants to illustrate that the staining resembling background actually represents Tgfbr1 expression. If the reviewers find it important, we can also incorporate these data into the manuscript. Under these circumstances, we feel that a schematic might not be very informative.

      Author response image 1.

      Image showing an example of an ISH procedure with a probe against Tgfbr1, showing widespread and low expression. The lower picture shows a ventral view of a stained wild type E10.5 embryo.

      Foxf1+ cells in the 'extended LPM' of Tgfbr1 mutants suggest fate transformation, or does it indicate the misexpression of marker gene otherwise suppressed by Tgfbr1 activity? The authors suggest that Foxf1+ cells are VLM progenitors from posterior PS trapped in the extended LPM. Do they continue to express PS markers? 

      The observation that both in wild type and Tgfbr1 mutant embryos Foxf1 expression in the trunk is restricted to the splanchnic LPM indicates that the absence of this marker in the somatic LPM is not the result of a suppression of its expression by Tgfbr1. In wild type embryos Foxf1 is also expressed in the posterior PS, regulated independently of its expression in the LPM (i.e. Shh-independent) and later in the pericloacal mesoderm (our supplementary figure 2). As Foxf1 expression in the posterior PS was not suppressed in the Tgfbr1 mutants, together with the absence of pericloacal mesoderm, we interpret that the Foxf1-positive cells in the two layers around the extended celomic cavity in the posterior end of the mutant embryos derived from the posterior PS, resulting from the absence of its normal progression through the embryonic tissues.

      We did not find expression of PS markers giving rise to paraxial mesoderm, like Tbxt, further suggesting that those cells could derive from the restricted set of cells within the posterior PS that contribute to the pericloacal mesoderm

      For example, the misexpression of Apela is interpreted as mis-localized endoderm cells. They show scattered Keratin 8 misexpression to support the interpretation. It would be more convincing if the authors tested the expression of other endoderm markers. 

      As indicated in the manuscript, we suggest that these cells are endoderm progenitors (p. 13), like those present at the posterior end of the gut tube at E9.5 and E10.5, that are unable to incorporate into the gut tube. Apela is not a general endodermal marker: it is expressed in the foregut pocket and the nascent cells of the hindgut/tail gut, becoming down regulated as cells take typical endodermal signatures. The presence of ectopic Apela expression in the extended LPM of the mutant embryos might indeed indicate the presence of progenitors that failed to downregulate Apela resulting from the lack differentiation-associated downregulation. This would also implicate the absence of definitive endodermal markers.

      The Nodal signaling pathway in the anterior PS drives endoderm development. It acts through Alk7. Does Tgfbr1 (Alk5) mutation impact endoderm development, in general? It isn't easy to assess this from the Foxa2 in situ RNA hybridization shown in Figures 6A and B. It would be helpful for the readers if the authors clarified this point. 

      In the pictures shown in Figure 7D-D’ it is already shown that the endoderm is mostly preserved until the region of the trunk to tail transition. The presence of a rather normal endoderm in the embryonic trunk can also be seen with Shh, a figure added as Supplementary Fig.5.

      Reviewer #2 (Recommendations For The Authors): 

      The authors mention two interesting novel points which they should develop in the discussion, and probably also in the results. 

      (1) The authors speculate about the possible involvement of the posterior PS as a mediator of Gdf11/Tgfbr1 signaling activity. However, as mentioned in the manuscript, their experiments do not allow regional sublocalization within the PS... Here it would be important to assess/discuss in more detail which progenitors respond to this signaling activity and when they do it. At the very least, the authors should provide high-resolution spatiotemporal data of the expression of Tgfbr1 in the PS. 

      Tgfbr1 expression at this embryonic stage does not give clear differential patterns. The data reported for this expression in Andersson et al 2006 is very low quality and we have not been able to reproduce the reported pattern. On the contrary, all our efforts over the years provided a very general staining that could even be interpreted as background. When we now included Tgfbr1 mutants as controls, it became clear that the ubiquitous and low level signal observed in wild type embryos indeed represent Tgfbr1 expression pattern: low level and ubiquitous. We are attaching a figure to this document illustrating these observations. If required, this can also be included in the manuscript as a supplementary figure. 

      Also, the work of Wymeersch et al., 2019 regarding the lateral plate mesoderm progenitors (LPMPs) should be referred to and discussed here. 

      This was now added in the results (page 11) and in discussion (page 16). 

      For instance, are the LPMP transcriptomic differences detected between E7.5 and E8.5 caused by Tgfbr1 signaling activity? This question could be easily answered through a comparative bulk RNAseq analysis of the posterior-most region of the PS of mutant and WT embryos. The possible colocalization of Tgfb1 (Wymeersch et al., 2019) and Tgfbr1 in the LPMPs should also be addressed. 

      We agree with the suggestion that RNA-seq in the posterior PS of WT and mutant embryos might be informative. However, it is very likely that within the proposed timeframe (E7.5 to E8.5) that there are no significant differences between the wild type and the Tgfbr1 mutant embryos because there is no apparent axial phenotype in Tgfbr1 mutant embryos before the trunk to tail transition. Therefore, at this stage, we think that this experiment is out of the scope of the present manuscript. 

      (2) The activity of Tgfbr1 during the trunk-to-tail transition is critical for the development of tail endodermal tissues. Here the authors suggest again the involvement of the posterior PS/allantois region, but a similar phenotype can also be observed for instance in the absence of Snai1 in the caudal epiblast (Dias et al., 2020)... It would be important to assess/discuss the origin of those morphogenetic problems in the gut. Is it due to the reallocation of NMC cells into the CNH? The tailbud-EMT process? LPMPs specification?... Regional mutations or gain of functions of Snai1 or Tgfbr1 in the caudal epiblast would help answer the question.  

      The endodermal phenotype in the Snai1 mutants is different to that observed in the Tgfbr1 mutants. As can be observed in Figures 3, 4 and 5 of Dias et al. the absence of tailbud is replaced by a structure that extends the epiblast. As a consequence, the endoderm finishes at the base of that structure, even expanding to make a structure resembling the cloaca, which is different to what is seen in the Tgfbr1 mutants. In this case, the lack of tail gut is likely to result either from the lack of formation of the progenitors of the gut endoderm or from the dissociation of what would be the tail bud from the LPM. Actually, hindlimb/pericloacal mesoderm markers, like Tbx4, are preserved in the Snai1 mutant. As for the gain of function of Snai1 experiment, already reported also in Dias et al 2020, the destiny of these cells is not clear. The ISH for Foxa2 showed extra signals but as it is not an exclusive marker for endoderm it is not possible to know whether any of these signals correspond to endodermal tissues.

      Regarding the development of tail endodermal tissues, the authors suggest that it occurs from a structure derived from the PS that is located posteriorly, in the tailbud, after the tip of the growing gut. This is an important and novel point as it suggests that the primordia of the endoderm is not wholly specified during gastrulation. So the observation should be well supported. How can Anastasiia et al. distinguish such "structure" from the actual developing gut? Does it have a distinct molecular signature or any morphological landmark that enables its separation from the actual gut? The data suggests that the region highlighted in Supplementary Figure 4Ab contains part of the actual gut tube (the same is suggested in Figure 5B). If the authors think otherwise, they must characterize that region of the tailbud by doing a thorough morphological and gene/protein expression analysis and assess its potency, via transplantation experiments. Also, the authors' claim mostly relies on the DiI experiments and those have three problems: #1 Anastasiia et al. assess "tail" endodermal growth at E9.5 when the correct stage to do it is after E10.5 (after tailbud formation). 2# Incongruencies, low number (only three embryos), and diversity in the results shown in Figure 8 and Supplementary Figure 4. For instance, despite similar staining at 0h, the extension and amount of DiI present in the gut tube after 20h varies significantly amongst the differently labeled embryos. A possible explanation lies in the abnormal leakiness of the DiI labelings and that is confirmed by the observations shown in Supplementary Figure 4M-O; the same for Supplementary Figure 4G, which shows a substantial amount of DiI in the neural tube. 3# The authors must provide high-quality data showing which tissues/regions were labelled at time 0h, including transversal and sagittal sections as they did for the 20h time-point. Additionally, it is important to re-orient the sagittal optical sections to a position that also shows the neural tube (like a mid-sagittal section) and include information concerning the AP/DV axis, as well as the location of the transversal optical sections in the sagittal image. 

      As described in the reply to reviewer 1, Apela is expressed in the nascent tail gut endoderm but not in more anterior areas except for a foregut pocket, and becomes downregulated as the tube acquires endodermal signatures. Therefore, the structure to which the reviewer refers to might indeed represent a group of progenitors that extend the tail gut. And the observation that this property is observed only in the tail gut as it grows, already separates this region of the gut, which in the end do not contribute to mature organs, from more anterior areas of the endoderm (essentially anterior to the cloaca) that will become a relevant tissue of the intestinal organs. Our DiI labelling experiment was aimed to test whether this pool of cells contributes to the gut but does not allow to determine the nature of those cells, a question that will require further research (discussed on p. 17) and we think is beyond the scope of the present manuscript.

      Regarding the labelling at E10.5, we agree that the tail bud in terms of NMCs is not completely formed, for example, at E9.5 the neuropore is not yet closed. However, we are more interested in regression of the epiblast, which is complete by E9.5. Injecting at E9.5 also has technical advantages for us, first, because in our hands earlier embryos grow better in culture, and second, because it is easier to inject in the tailbud at E9.5 because it is a little bit bigger than at E10.5. Therefore, injecting at E9.5 is less prone to technical artifacts due to injection inaccuracy and compromised growth in culture.

      We agree that the injected DiI could also leak into NMPs, which might be located in the same area. However, while this could result in labeling of the neural tube, it would not affect the interpretation of the finding of labeled cells in the tail gut. Indeed, the presence of this label in the gut epithelium indicates the presence of progenitors in the injected region of the tail gut. We added some considerations of this the possible leakage into the results section of the manuscript (p. 15). We thank the reviewer for drawing our attention to this issue. 

      We also now provide high quality data showing labelled tissue at 0h in Supplementary figure 8A-c’, higher magnification images in Fig. 8, and reoriented optical sections in Fig.6 and in Supplementary Fig. 7, including axis and location of the sections as suggested by the reviewer.

      Minor concerns/comments: 

      (1) The abstract is quite long, though this might be fine for this journal. 

      (2) In relation to the comment on the abstract, the manuscript needs an initial Figure descrbing the events that are described in the introduction. Otherwise, the manuscript will only be accessible to mouse embryologists.

      We have a figure summarizing the results at the end of the manuscript, we think that including similar figure in the beginning might be redundant. What we could do, if required, is to include this type of schematic as a graphical abstract.

      (3) The authors need to clarify what they mean when they use the following expressions "PS fate" and "fate of the posterior PS".

      I do not think that we have used such expressions. Indeed, they did not come out when we run a “find” in the word document. However, they would mean the tissue that would come out from them at later developmental stages.

      (4) The assessment of Isl1 expression in Tgfbr1 mutant and transgenic mouse embryos would be better indicative of their molecular relationship than a comparative phenotypic analysis. 

      These data have been reported in Dias et al 2020 and Jurberg et al 2013, both cited in the manuscript.  

      (5) The authors should explain or discuss what the upregulation of Foxa2 in the posterior end of Tgfbr1 mutants means.

      While an upregulation is apparent in the figure, looking at other pictures we cannot be sure of this being a significantly quantifiable up-regulation. We therefore removed the statement from the text.

      (6) What happens to the intermediate mesoderm during the trunk-to-tail transition? Is Tgfbr1 involved in the regulation of its development?

      We have tested this using Pax2 and added the relevant data in Supplementary Fig. 1 and described in the results.

      (7) The term "potential" should not be used during the description of DiI labeling experiments as this technique only assesses cell fate.

      Corrected

      (8) Some figures lack AP/DV axis information (e.g. Figures 6, C, and D).

      Corrected

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors investigate ligand and protein-binding processes in GPCRs (including dimerization) by the multiple walker supervised molecular dynamics method. The paper is interesting and it is very well written.

      Strengths:

      The authors' method is a powerful tool to gain insight into the structural basis for the pharmacology of G protein-coupled receptors.

      Weaknesses:

      Cholesterol may play a fundamental role in GPCR dimerization (as cited by the authors, Prasanna et al, "Cholesterol-Dependent Conformational Plasticity in GPCR Dimers"). Yet they do not use cholesterol in their simulations of the dimerization.

      We thank Reviewer #1 for the positive comment on mwSuMD.

      In the revised version of the manuscript, the section about the A<sub>2A</sub>/D2 receptors dimerization has been removed because largely speculative. We agree that the lack of cholesterol in those simulations added uncertainty to the presented results.

      Reviewer #2 (Public Review):

      The study by Deganutti and co-workers is a methodological report on an adaptive sampling approach, multiple walker supervised molecular dynamics (mwSuMD), which represents an improved version of the previous SuMD.

      Case-studies concern complex conformational transitions in a number of G protein Coupled Receptors (GPCRs) involving long time-scale motions such as binding-unbinding and collective motions of domains or portions. GPCRs are specialized GEFs (guanine nucleotide exchange factors) of heterotrimeric Gα proteins of the Ras GTPase superfamily. They constitute the largest superfamily of membrane proteins and are of central biomedical relevance as privileged targets of currently marketed drugs.

      MwSuMD was exploited to address:

      (1) Binding and unbinding of the arginine-vasopressin (AVP) cyclic peptide agonist to the V2 vasopressin receptor (V2R);

      (2) Molecular recognition of the β2-adrenergic receptor (β2-AR) and heterotrimeric GDPbound Gs protein;

      (3) Molecular recognition of the A1-adenosine receptor (A1R) and palmitoylated and geranylgeranylated membrane-anchored heterotrimeric GDP-bound Gi protein;

      (4) The whole process of GDP release from membrane-anchored heterotrimeric Gs following interaction with the glucagon-like peptide 1 receptor (GLP1R), converted to the active state following interaction with the orthosteric non-peptide agonist danuglipron;

      (5) The heterodimerization of D2 dopamine and A2A adenosine receptors (D2R and A2AR, respectively) and binding to a bi-valent ligand.

      The mwSuMD method is solid and valuable, has wide applicability, and is compatible with the most world-widely used MD engines. It may be of interest to the computational structural biology community.

      The huge amount of high-resolution data on GPCRs makes those systems suitable, although challenging, for method validation and development.

      While the approach is less energy-biased than other enhanced sampling methods, knowledge, at the atomic detail, of binding sites/interfaces and conformational states is needed to define the supervised metrics, the higher the resolution of such metrics is the more accurate the outcome is expected to be. The definition of the metrics is a user- and system-dependent process.

      The too many and ambitious case-studies undermine the accuracy of the output and reduce the important details needed for a methodological report. In some cases, the available CryoEM structures could have been exploited better.

      The most consistent example concerns AVP binding/unbinding to V2R. The consistency with CryoEM data decreases with an increase in the complexity of the simulated process and involved molecular systems (e.g. receptor recognition by membrane-anchored G protein and the process of nucleotide exchange starting from agonist recognition by an inactive-state receptor). The last example, GPCR hetero-dimerization, and binding to a bi-valent ligand, is the most speculative one as it does not rely on high-resolution structural data for metrics supervision.

      We praise Reviewer #2 for the detailed comment on the manuscript. In this revised version, the hetero-dimerization between A<sub>2A</sub>R and D<sub>2</sub>R has been removed. Also, results about GPCR case studies other than GLP-1R have been reduced and downgraded in importance to focus on the fundamental key points of the adaptive sampling method.  We agree that the consistency with cryoEM data tends to decrease with an increase in the complexity of the simulated process and involved molecular systems. While it is possible to approximate cryoEM results  our unbiased adaptive sampling technique finds its most interesting application in mechanistically unknown out-of-equilibrium processes rather than reproducing known experimental data perfectly. The simulated case studies we present showcase the versatility, speed and consistency of our adaptive method to explore energetically unbiased transitions.

      Reviewer #3 (Public Review):

      Summary:

      In the present work, Deganutti et al. report a structural study on GPCR functional dynamics using a computational approach called supervised molecular dynamics.

      Strengths:

      The study has the potential to provide novel insight into GPCR functionality. An example is the interaction between loops of GPCR and G proteins, which are not resolved experimentally, or the interaction between D344 and R385 identified during the Gs coupling by GLP-1R. However, validation of the findings, even computationally through for instance in silico mutagenesis study, is advisable.

      Weaknesses:

      In its current form, the manuscript seems immature and in particular, the described results grasp only the surface of the complex molecular mechanisms underlying GPCR activation. No significant advance of the existing structural data on GPCR and GPCR/G protein coupling is provided. Most of the results are a reproduction of the previously reported structures.

      We thank Reviewer #3 for the positive comment on the work. The revised manuscript focuses more on the GLP-1R and Gs case studies. We believe it addresses the weaknesses raised by showing the behaviour of key structural motifs and providing new hypotheses about GDP release.  

      Reviewer #2 (Recommendations For The Authors):

      In this methodological report, Deganutti and co-workers propose an improved version of supervised molecular dynamics (SuMD), named multiple walker SuMD (mwSuMD). Such an adaptive sampling method was challenged in simulations of complex transitions involving GPCRs, which are out of reach by classical MD.

      Although less energy-biased than other enhanced sampling methods, mwSuMD requires knowledge of the atomic detail of the ligand-protein or protein-protein binding site/interfaces and the structural hallmarks of the states whose conversion the method is going to address. Such knowledge is, indeed, necessary to define the supervised metrics (e.g. distances, RMSD, etc), which is a user- and system-dependent process.

      We classify mwSuMD as an adaptive, rather than enhanced, sampling method as it does not use any energy bias. We agree with the Reviewer that some knowledge of the system is required to productively set up the simulations, but this is the case for almost any MD advanced methods.  

      The text requires improvement in the essential methodological details and cleaning of those parts is not properly instrumental in method validation.

      While attempting to prove the widest possible applicability of the method, the authors exaggerated the number of examples, which, in spite of the increasing complexity were only summarily described. Please, limit the case studies to AVP binding/unbinding to V2R and the whole process of GDP release from membrane-anchored Gs following activation of GLP1R by danuglipron. The latter case, indeed, involves small ligand binding (danuglipron), small ligand dissociation (GDP), receptor activation, and activated receptor binding to membraneanchored G protein and G protein conformational transition instrumental to nucleotide depletion, which is already too much. In this framework, the cases of Gs-β2AR and Gi-A2R recognition are redundant. Most importantly, the case of D2R-A2AR heterodimerization and binding to a bi-valent ligand must be eliminated. The reason is that the case is not entirely based on the mwSuMD and the biased protein-protein interface does not rely on highresolution data (i.e. no structural model of D2R-A2AR dimer has been determined so far). Last but not least, the high intrinsic flexibility of the bi-valent ligand adds further indetermination to the computational experiment. Being too speculative, the case-study does not serve to model validation.

      We thank the Reviewer for the suggestion. In the current revised form, the manuscript focuses on AVP binding/unbinding to V2R and the GLP-1R activation, Gs recognition and GDP release.

      While eliminating the three case studies mentioned above, the remaining ones should be described more extensively and clearly, highlighting the most productive setup for each system. Incidentally, listing the performance parameters (e.g. distribution mode and minimum RMSD) of each simulation setting in Table S1 is worth doing.

      More accuracy in the methodological description is needed.

      As for the supervised metrics, the rationale behind the choice of a particular index and whether it is the outcome of a number of trials must be declared and the selected indices must be better defined. Here there are a few examples.

      AVP-V2R case. It is not clear why the AVP centroids were computed on residues C1-Q4 (I suppose the Cα-atoms) and not on the Cα-atoms of the whole cyclic part (C1-C6). Along the same line, the choice of the Cα-atoms of four amino acid residues to compute the receptor binding-site centroids requires justification.

      We have amended the text to clarify that all the heavy atoms of AVP residues C1-Q4, which are anticipated to bind deep into V<sub>2</sub>R, were considered alongside V<sub>2</sub>R residues part of the peptide binding site (Cα atoms only). From our experience, the choice of including side chains or not for the definition of centroids usually does not affect the supervision output. It should only affect the output of mwSuMD simulations based on the RMSD which considers the specific relative distance from the reference. However, a benchmark of the differences produced by divergent selections is beyond the scope of the present work.

      GLP1R case. The statement: "Since the opening of TM1-ECL1 was observed in two replicas out of four, we placed the ligand in a favorable position for crossing that region of GLP-1R" is rather weak as a strategy to manually (?) define the input position of the ligand.

      As stated in the manuscript, placing the agonist in that position was driven by preliminary 8 μs of classic MD simulations that pointed out the possible path for binding.  We agree with the Reviewer that there is still some degree of arbitrarity in it and for this reason, we have not presented structural details of the F06882961 binding path.

      As for the supervised metrics, what does it mean "the distance between the ligand and GLP-1R TM7 residues L3797.34-F3817.36"? Was the distance computed between ligand and L379-F381 centroids? Also: "In the supervised stages, the distance between residues M386-L394 Gas of helix 5 (α5) and the GLP-1R intracellular residues R1762.46, R3486.37, S3526.41, and N4057.60 was monitored" was it an inter-centroid distance? Furthermore, "supervising the distance between AHD residues G70-R199 Gas and K300-L394Gas" was it the distance between the centroid of the AHD and the centroid of the C-terminal half of the Ras-like domain? In general, when more than two atoms are involved in distance calculation, please, specify if the distance is inter-centroid.

      Also: "During the third phase, the RMSD of PF06882961, as well as the RMSD of ECL3 (residues A3686.57-T3787.33, Ca atoms), were supervised" was the RMSD computed without superimposing the ligand to estimate its roto-translations?

      We have added details about the selections used for computing centroids throughout the methods section. For example, all the heavy atoms of F06882961 and the Ca atoms of L379-F381 were considered. RMSD values during GLP-1R activation were computed after superimposition on TM2, ECL1, and TM3 residues 170-240 (Ca atoms). This now has been specified in the text.

      The authors considered the 7LCJ GLP1R-danuglipron complex as a fully active reference state instead of considering the receptor from a ternary complex with Gs. The ternary complex (7LCI) was indeed considered as a reference only in simulations of receptor-G protein recognition. 

      7LCJ and 7LCI are both fully active states. The main difference is that in 7LCJ, Gs coordinates were not deposited. Indeed, their RMSD computed on the TMD Ca atoms and F06882961 is 0.63 Å and 0.54 Å, respectively.

      Most importantly, the ternary complex chosen by the authors is not adequate as a reference for simulating the "opening" of the AHD because it bears a miniGs, hence, missing the AHD. In that framework, such an opening is rather vague and was not properly supervised by mwSuMD. The authors must repeat metrics supervisions by using, as a reference, the 6X1A ternary complex, which bears a displaced AHD. This would likely lead to a different path of GDP release.

      To the best of our knowledge, there is no evidence that a specific open conformation of the AHD is linked to GDP release. In support, we note that in GPCR ternary complexes, the AHD is usually not modelled because of its high flexibility. The only body of evidence we are aware of is that AHD must open up to allow GDP release. For this reason,  we decided to supervise the distance between AHD and the Ras domain without using a reference.

      In the statement: "The AHD opening was simulated starting from the best GLP-1R:Gs binding mwSuMD replica" the definition "best binding" requires clarification.

      This has been amended, specifying that Replica 2 was considered the “best replica” due to the closed deviation to the cryoEM structure.

      As for the case study on β2-AR-Gs recognition, I strongly suggest to eliminate it. However, I'd like to make some comments. The sentence: "the adrenergic β2 receptor (b2 AR) in an intermediate active state was downloaded from GPCRdb (https://gpcrdb.org/)" is vague as it does not indicate what intermediate active state structure was used. Since the goal of the case study was to probe the method in simulating receptor-G protein binding, it would have been better to start with a fully active state of the receptor like the 4LDO structure, employed by the authors only to extract epinephrine.

      mwSuMD is designed to provide insights into structural transitions. We started from an intermediate active state of β2-AR in complex with adrenaline because resembling the most populated state stabilised by a full agonist according to NMR studies (DOI:10.1016/j.cell.2015.08.045); the fully-active β2-AR conformation is stabilized only after Gs binding. However, following the Reviewer’s suggestion, we have reduced the presented results for the β2-AR-Gs recognition.

      Also in this case, it is not clear if the supervised receptor-G protein distance is between the centroid of the whole 7-helix bundle and the centroid of Gs α5. It is not clear why the TM6 RMSD concerned only the cytosolic end of the helix and did not include the kink region. With that selection, to estimate the outward displacement, RMSD should have been computed without superimposing the considered portion (once all remaining Cα-atoms of the receptors are superimposed).

      As the Reviewer pointed out above, some knowledge of the system is required to set up mwSuMD. Using more generic metrics as we did in this case, like the distance between the whole TMD and Gs α5 represents a general approach applicable to other GPCRs, that should allow orthogonal metrics to evolve independently from the supervision.

      As now specified in the text, the superimposition for RMSD calculation was performed on residues 40 to 140 Ca atoms, hence not considering TM6.

      As for the A1R-Gi recognition, as already stated, I strongly suggest eliminating it. However, I'd like to add some comments. I would discourage the employment of an AlphaFold model for simulations deputed to model validation in general and, in particular, when highresolution structures are available. In this case, the authors would have used the 1GP2 structure of heterotrimeric Gi no matter if from the rat species.

      Following the Reviewer’s suggestion, we have dramatically reduced the results presented for the A1R-Gi recognition. We considered 1GP2 for the simulations but H5 lacks the Cterminal six residues and therefore some extent of modelling was still necessary. However, we take the Reviewer’s comment on board and consider it for future work.

      Also, the palmitoylation and geranylgeranylation process is quite tortuous and it is not clear why the NVT ensemble was employed in the second stage of equilibration. This is reflected also on the GLP1R case study.

      We have amended the text to clarify this passage. The second NVT stage is required for stabilizing the G protein and its orientation in the simulation box. The figure below shows that a plateau of the Ca RMSD during the NVT step was reached after 700 ns for both Gi (black) and Gs (orange).

      Author response image 1.

      Here, it is not clear if the RMSD of α5 of Gi was computed with or without superposition.

      The RMSD of α5  was computed after superimposing on A<sub>1</sub>R residues 40-140 Ca atoms (the less flexible region of the receptor). We have now amended the text to report this information. 

      Reviewer #3 (Recommendations For The Authors):  

      Points to address:

      (1) Root Mean Square Deviation (RMSD) data are often reported as minimum values. It would be useful to provide the average value along the stable part of the trajectories. From the plots in Figure 2ab, it seems that the minimum values reported in the paper are very far from the average ones and thus represent special cases that are seldom reached during simulation. The authors should clarify this point;

      For the revised manuscript, we moved Figure 2 to the supplementary material and added average RMSD values for the most notable replicas in Figures 4e and S8a,b. As a reference, in the text, we now report RMSDs from our previous classic MD simulations (https://doi.org/10.1038/s41467-021-27760-0) of Gs:GLP-1R cryoEM structure (G<sub>α</sub> = 6.18 ± 2.40 Å; G<sub>β</sub> \= 7.22 ± 3.12 Å; G<sub>γ</sub> = 9.30 ± 3.65 Å) which show how flexible G proteins bound to GPCRs are and give better context to the RMSD values we measured during mwSuMD simulations.

      (2) The RMSD values reported in the paper always refer to single molecules or proteins. It would be useful to also report the RMSD computed over the whole complexes (ligand/GPCR or GPCR/G protein). It would provide a better metric for understanding the general distance between the results and the reference experimental structures;

      We have now removed the results sections for A<sub>1</sub>R and β<sub>2</sub> AR to focus on GLP-1R, whose RMSD is analyzed in detail in Figures 2, 3 and 4.

      (3) A number of computational works investigated the GPCR/G protein interaction and these studies should be cited and discussed. Examples are the works from Mafi et al. 2023 (doi: 10.1038/s41557-023-01238-6), Fleetwood et al. 2020 (doi: 10.1021/acs.biochem.9b00842), Calderon et al. 2023 and 2024 (doi: 10.1021/acs.jcim.3c00805 and doi: 10.1021/acs.jcim.3c01574), Maria-Solano and Choi 2023 (doi: 10.7554/eLife.90773.1), Mitrovic et al. 2023 (doi: 10.1021/acs.jpcb.3c04897), and D'Amore et al. 2023 (doi: 10.1101/2023.09.14.557711). Many of these works focused on the activation of B2AR and the interaction with its G protein. In addition, Maria-Solano and Choi 2023 and D'Amore et al. 2023 also characterized the rotation of TM6 during the A1R and A2AR activation. Therefore, the claim "To the best of our knowledge, this is the first time an MD simulation captures the TM6 rotation upon receptor activation as results reported so far are largely limited to the TM6 opening and kinking55." is untimely;

      We thank the Reviewer for the suggested references. We have added them to the introduction as examples of energy-biased (Calderon et al. 2023 and 2024, Maria-Solano and Choi, Mitrovic et al., D'Amore et al) or adaptive sampling (Fleetwood et al) approaches to GPCR. Since the above articles focus on β<sub>2</sub>  AR and A<sub>1</sub>R, we do not discuss them in detail because the results sections for A<sub>1</sub>R and b<sub>2</sub> AR have been drastically reduced in the manuscript.

      We note that among the suggested references, only Mafi et al report about a simulated G protein (in a pre-formed complex) and none of the work sampled TM6 rotation without input of energy. However, we have removed the claim from the text.   

      (4) In the discussion section, the authors claim that a distance-based approach can be employed when the structural data of the endpoints is limited. However, the results obtained from the distance-based protocol during the validation of the approach, which was done using V2R as a reference, are unsatisfying, as acknowledged by the authors themselves. For instance, the RMSD mode value reported for the AVP C alpha atoms with respect to 7DW9 is high, 0.7 nm, whereas the minimum value is 0.38 nm. In addition, some side chains are not oriented in the experimental conformation and might have a different interaction pattern with the receptor if compared with the experimental structure. Considering that in this case the endpoint is known, it is plausible that the performance of the method would degrade even further when data about the target structure is limited. In a real case scenario, the ligand binding mode is unknown and in such a case no RMSD matrix can be used. This represents the major concern of this study that is no prediction is provided, but only - rather inaccurate - reproduction of the known structural data;

      The goal of the first part of the work was to compare mwSuMD to SuMD to justify its application on ligand binding using a challenging case study like vasopressin. The general validation of the parent method SuMD as a predictive tool for ligand binding mode has been extensively reported over the years (a few examples: https://doi.org/10.1021/ci400766b ; https://doi.org/10.1021/acs.jcim.5b00702 ; https://doi.org/10.1038/s41598-020-77700-z) and fell beyond the scope of this work. 

      (5) In the discussion, the authors write "A complete characterization of the possible interfaces between GPCR monomers, which falls beyond the goal of the present work, should be achieved by preparing different initial unbound states characterized by divergent relative orientations between monomers to dynamically dock." It would be useful for the reader to refer to and cite here advanced computational approaches that allow a comprehensive sampling of GPCR dimerization independently from the starting conformation of the receptors. One example is coarse-grained metadynamics as shown in doi: 10.1038/s41467-023-42082-z;

      The A<sub>2A</sub/D<sub>2</sub receptors dimerization has been removed from the manuscript. 

      (6) In many cases, it is not reported how residues missing from the experimental structures used to model the proteins were reconstructed. This information is important, considering that the authors comment on the results of their calculations on addressing these regions, such as in the case of B2AR. Furthermore, the authors did not report how their initial models were validated. The authors should also explain why they did not model the IC loops of A2AR and D2R;

      In the current version of the manuscript, for V2R ECL2 and GLP-1R, we specify that we produced 10 solutions with Modeller and considered the best one in terms of the DOPE score. 

      The only receptor model used,  β<sub>2</sub> AR, is now presented as preliminary data focusing on Gs and avoiding any structural detail of the Gs recognition. 

      As reported above the A2A-D2 dimerization has been removed from the manuscript.

      (7) In several cases, the authors state that residues never investigated before play an important role in the interaction between different proteins. An example is provided on page 6 for the B2AR/G protein association. Since this claim is quite significant, it would benefit from validation, at least for further calculations such as in silico mutagenesis studies. Another example is at the end of page 10 where the authors report a hidden interaction between D344 and R385 that is pivotal for Gs coupling by GLP-1R. Is there other evidence supporting this result (previously reported literature data, conservation rate of these residues, etc.)?;

      We have removed the supplementary table reporting B2AR/G protein interactions to reduce speculations and added a reference that reports GLP-1 EC50 reduction upon mutation of position 344 to Ala (https://doi.org/10.1021/acscentsci.3c00063).

      (8) The authors should provide a deeper discussion about the conformational rearrangement of GPCR and G protein during the coupling. In detail, the conformational changes of microswitich amino acids of GPCR (e.g., PIF, NPxxY, inactivating ionic lock) and alpha helix 5 of G proteins should be discussed in relation to the literature data and experimental structures;

      We have removed the A1R and b2 AR results to focus on GLP-1R. Key structural motifs in the polar central network and TM6 kink are analyzed more in detail in Figure 3.

      (9) The chronology of the conformational changes of GLP-1R is arbitrarily chosen. During the simulation, the RMSD values reported in Fig. 3 are high and do not demonstrate the full accomplishment of the simulation of the activation process of the receptor;

      We agree with the Reviewer that the GLP-1R inactive to active transition was not fully accomplished, compared to other work on class A GPCRs.  Unlike class A, class B GPCRs represent a challenging system to work with in silico because inactive starting conformations (e.g 6LN2) are extremely distant from the active one (e.g 7LCJ, 7LCI or 6X18), as demonstrated in Figure S6 for GLP-1R. Here we report the first attempt to model a class B GPCR activation mechanism starting from the inactive state, and even if not fully achieved, we believe it represents state-of-the-art simulations for this class of receptors.

      (10) It would be helpful for the reader not familiar with the employed technique that the authors explain in one sentence in the main text the pros and cons of using multiple walkers instead of single walker SuMD;

      We thank the Reviewer for the excellent suggestion. In the Discussion, we have now commented that: “more extensive sampling obtainable by seeding multiple parallel short simulations instead of a single simulation for batch”, while in the Methods we explain that “mwSuMD is designed to increase the sampling from a specific configuration by seeding user-decided parallel replicas (walkers) rather than one short simulation as per SuMD. Since one replica for each batch of walkers is always considered productive, mwSuMD gives more control than SuMD on the total wall-clock time used for a simulation. On the flip side, mwSuMD requires multiple GPUs to be the most effective, although any multi-threaded GPU can run more walkers on the same hardware keeping the sampling variety.”.

      Minor points to address:

      (11) Page 3: the following sentence is duplicated (also found on page 2) "GPCRs preferentially couple to very few G proteins out of 23 possible counterparts";

      (12) Page 20: Figure S13 refers to the QM validation of PF06882961 torsional angle, not to the image of the receptor conformational changes, which is instead Figure S14 (please correct figure caption).

      We thank the Reviewer for the accurate reading of the manuscript. These typos have been corrected.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Overall authors’ response

      We would like to thank the 3 reviewers for a thorough critique of our manuscript, and acknowledging the novelty and importance of our studies, in particular the relevance to collagenrelated pathologies such as idiopathic pulmonary fibrosis and chronic skin wound. We appreciate that there are shortcomings in these studies, as highlighted by reviewers; we have rewritten parts of our manuscript to clarify any misunderstandings, and conducted additional experiments to address concerns raised by reviewers (please see below red text within each response), which have been incorporated into our revised manuscript (modified text highlighted in yellow in revised manuscript). We believe that the revision had made our manuscript stronger in support of our original conclusions. 

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The authors describe that the endocytic pathway is crucial for ColI fibrillogenesis. ColI is endocytosed by fibroblasts, prior to exocytosis and formation of fibrils, which can include a mixture of endogenous/nascent ColI chains and exogenous ColI. ColI uptake and fibrillogenesis are regulated by circadian rhythm as described by the authors in 2020, thanks to the dependence of this pathway on circadian-clock-regulated protein VPS33B. Cells are capable of forming fibrils with recently endocytosed ColI when nascent chains are not available. Previously identified VPS33B is demonstrated not to have a role in endocytosis of ColI, but to play a role in fibril formation, which the authors demonstrate by showing the loss of fibril formation in VPS33B KO, and an excess of insoluble fibrils - along-side a decrease in soluble ColI secretion - in VPS33B overexpression conditions. A VPS33B binding protein VIPAS39 is also shown to be required for fibrillogenesis and to colocalise with ColI. The authors thus conclude that ColI is internalised into endosomal structures within the cell, and that ColI, VPS33B, and VIPA39 are co-trafficked to the site of fibrillogenesis, where along with ITGA11, which by mass spectrometric analysis is shown to be regulated by VPS33B levels, ColI fibrils are formed. Interestingly, in involved human skin sections from idiopathic pulmonary fibrosis (IPF) patients, ITGA11 and VPS33B expression is increased compared to healthy tissue, while in patient-derived fibroblasts, uptake of fluorescently-labelled ColI is also increased. This suggests that there may be a significant contribution of endocytosis-dependent fibrillogenesis in the formation of fibrotic and chronic wound-healing diseases in humans. 

      Strengths: 

      This is an interesting paper that contributes an exciting novel understanding of the formation of fibrotic disease, which despite its high occurrence, still has no robust therapeutic options. The precise mechanisms of fibrillogenesis are also not well understood, so a study devoted to this complex and key mechanism is well appreciated. The dependence of fibrillogenesis on VPS33B and VIPA39 is convincing and robust, while the distinction between soluble ColI secretion and insoluble fibrillar ColI is interesting and informative. 

      Weaknesses: 

      There are a number of limitations to this study in its current state. Inhibition of ColI uptake is performed using Dyngo4a, which although proposed as an inhibitor of Clathrin-dependent endocytosis is known to be quite un-specific. This may not be a problem however, as the endocytic mechanism for ColI also does not seem to be well defined in the literature, in fact, the principle mechanism described in the papers referred to by the authors is that of phagocytosis.

      We thank the reviewer for pointing this out. Macropinocytosis or phagocytosis could be modelled using high molecular weight dextran, and we have used fluorescently-labelled dextran to investigate potential co-localisation with exogenous collagen to investigate the involvement of these mechanisms in addition to endocytosis, and showed very little co-localisation (revised Figure S2B, lines 123-126). Further, we have performed a competition experiment where unlabelled collagen was added in excess at the same time as labelled collagen and showed that excess unlabelled collagen led to a retention of labelled collagen at the cell periphery (revised Figure S2C, lines 126-129). This is suggestive of collagen-I uptake utilises a different pathway to dextran (i.e. fluid-phase endocytosis) and is a receptor-mediated process.  

      It would be interesting to explore this important part of the mechanism further, especially in relation to the intracellular destination of ColI.

      We agree with the reviewer that the intracellular destination of ColI is very interesting, which is what the current Chang lab is investigating, although we believe the research findings fall out of scope for the revised manuscript here. However, we have included additional immunofluorescence data to support that collagen is indeed taken up into endosomal compartments using GFP-tagged Rab5 constructs (revised Figure 1D, Figure S6A).

      The circadian regulation does not appear as robust as the authors' last paper, however, there could be a larger lag between endocytosis of ColI and realisation of fibrils.

      The authors state that the endocytic pathway is the mechanism of trafficking and that they show ColI, VPS33B, and VIPA39 are co-trafficked. However, the only link that is put forward to the endosomes is rather tenuously through VPS33B/VIPA39.

      We would like to clarify that we meant the post-Golgi compartment. We did not mean VPS33b/VIPAS39 as an endosome marker; however as we see collagen entering the cell in intracellular compartments, which is then recycled, we take that as convention, the endosome would be involved. This is further supported that we see some colocalisation with the classic Rab5 endosome marker.

      There is no direct demonstration of ColI localisation to endosomes (ie. immunofluorescence), and this is overstated throughout the text.

      We appreciate the comment and have modified overstatements in the revised manuscript as appropriate. As stated above, we have included additional immunofluorescence data to support that collagen is indeed taken up into endosomal compartments.

      Demonstrating the intracellular trafficking and localisation of ColI, and its actual relationship to VPS33B and VIPA39, followed by ITGA11, would broaden the relevance of this paper significantly to incorporate the field of protein trafficking. Finally, the "self-formation" of ColI fibrils is discussed in relation to the literature and the concentration of fluorescently-tagged ColI, however as the key message of the paper is the fibrillogenesis from exocytosed colI, I do not feel like it is demonstrated to leave no doubt. Specific inhibition of intracellular trafficking steps, or following the progressive formation of ColI fibrils over time by immunofluorescence would demonstrate without any further doubt that ColI must be endocytosed first, to form fibrils as a secondary step, rather than externally-added ColI being incorporated directly to fibrils, independent of cellular uptake.

      We appreciate the concern raised here. This is precisely why we trypsinised and replated cells as part of the workflow, so we can make sure that there is no residual exogenous collagen which is not endocytosed being incorporated onto pre-existing fibrils. We have new data using flow imaging, which showed that cells that don’t endocytose exogenous collagen has accumulation of said collagen at the periphery of the cells, which is greatly reduced after trypsinisation. This new data is in a more detailed methodology-based study which is under preparation, which will allow future studies to further dissect the collagen intracellular trafficking process, and thus is not included in the revised manuscript. 

      Reviewer #2 (Public Review): 

      Summary: 

      In this manuscript, the authors describe a mechanism, by which fluorescently-labelled Collagen type

      I is taken up by cells via endocytosis and then incorporated into newly synthesized fibers via an ITGA11 and VPS33B-dependent mechanism. The authors claim the existence of this collagen recycling mechanism and link it to fibrotic diseases such as IPF and chronic wounds. 

      Strengths: 

      he manuscript is well-written, and experimentally contains a broad variation of assays to support their conclusions. Also, the authors added data of IPF patient-derived fibroblasts, patient-derived lung samples, and patient-derived samples of chronic wounds that highlight a potential in vivo disease correlation of their findings. 

      The authors were also analyzing the membrane topology of VPS33B and could unravel a likely 'hairpin' like conformation in the ER membrane. 

      Weaknesses: 

      Experimental evidence is missing that supports the non-degradative endocytosis of the labeled collagen.

      We thank the reviewer for raising this. We would like to clarify that we do not think that all endocytosed collagen-I is recycled, but rather sorted in the endosome which determines the fate of endocytosed collagen. Interestingly, results from Kadler’s group has shown that blocking lysosome function (through chloroqine and bafilomycin) significantly reduced endogenous collagen fibril formation (https://www.biorxiv.org/content/10.1101/2024.05.09.593302v1), suggesting a nondegradative role for lysosome in fibrillogenesis.   

      The authors show and mention in the text that the endocytosis inhibitor Dyngo®4a shows an effect on collagen secretion. It is not clear to me how specific this readout is if the inhibitor affects more than endocytosis. This issue was unfortunately not further discussed.

      We thank the reviewer for this comment and have included in discussion the specificity of Dyngo4a (revised manuscript lines 383392). The ponceau stain suggests that Dyngo4a treatment did not affect global secretion and thus the effects are specific to collagen-I (Fig 2B).

      The authors use commercial rat tail collagen, it is unclear to me which state the collagen is in when it's endocytosed. Is it fully assembled as collagen fiber or are those single heterotrimers or homotrimers?

      We apologise for the confusion and will clarify in our revision. These would be single helical trimers from acid-extracted rat tail collagen. We have performed additional light scattering and CD spectra to confirm the molecular weight and helicity, and confirm that adding fluorescent tags did not alter the readout. We have included this in the revised manuscript (revised Figure S1A-C, manuscript lines 82-86).    

      The Cy-labeled collagen is clearly incorporated into new fibers, but I'm not sure whether the collagen is needed to be endocytosed to be incorporated into the fibers or if that is happening in the extracellular space mediated by the cells.

      We appreciate the concern raised here, which is also raised by reviewer 1. As answered above, this is why we trypsinised and replated cells as part of the workflow, so we can make sure that there is no residual exogenous collagen being incorporated onto pre-existing fibrils. We also have new data using flow imaging, which shows that cells that don’t endocytose exogenous collagen has accumulation of said collagen at the periphery of the cells, which is greatly reduced after trypsinisation. This new data is in a methodology-based manuscript which is under preparation, thus will not be included in the revised manuscript.  

      In general for the collagen blots, due to the lack of molecular weight markers, what chain/form of collagen type I are you showing here?

      Apologies for the lack of molecular weight markers, it was an oversight by the authors and have been included in the revised figures.  

      Besides the VPS33B siRNA transfected cells the authors also use CRISPR/Cas9-generated KO. The KO cells do not seem to be a clean system, as there is still a lot of mRNA produced. Were the clones sequenced to verify the KO on a genomic level?

      Yes, the clones were verified and used in our previous paper on circadian control of collagen homeostasis. There are instances where despite knockout at the protein level, mRNA is still persistent; however these transcripts are likely then directed to degradation through nonsense-mediated mRNA decay. To fully understand this mechanism is beyond the scope of this paper. 

      For the siRNA transfection, a control blot for efficiency would be great to estimate the effect size. To me it is not clear where the endocytosed collagen and VPS33B eventually meet in the cells and whether they interact. Or is ITGA11 required to mediate this process, in case VPS33B is not reaching the lumen?

      This is an interesting question. We have conducted experiments with Col1-GFP11 containing conditioned media incubated with VPS33b-barrell in the revised paper, which showed that they interact within the cell and not at the cell periphery (revised Figure 6G, lines 293-296), again highlighting that VPS33b is not involved in the endocytosis step but interacts with endocytosed collagen-I intracellularly. We have attempted colocliasation studies using the split GFP approach with VPS33B and ITGA11 to investigate where they interact, but as the ITGA11 construct we used did not localise to the cell surface as expected, we are not confident that this system is appropriate for investigating how/if VPS33B interacts with ITGA11, and there are simply no good antibody for VPS33B for staining. 

      The authors show an upregulation of ITGA11 and VPS33B in IPF patients-derived fibroblasts, which can be correlated to an increased level of ColI uptake, however, it is not clear whether this increased uptake in those cells is due to the elevated levels of VPS33B and/or ITGA11.

      We would like to clarify here that we do not think collagen-I uptake is due to VPS33B and/or ITGA11, as siITGA11 and VPS33B in fibroblasts showed no consistent changes in uptake as determined by flow cytometry, which was included in the original manuscript (now revised Figure 6H, 7I). VPS33B and ITGA11 are involved in the ‘outward’ arm of recycled collagen-I, i.e. directing to fibrillogenesis route. We agree that the inclusion of additional functional studies using IPF patient-derived patient fibroblasts would add to the manuscript, and have performed siRNA against VPS33B and ITGA11 on IPF fibroblasts, and demonstrated a late of endocytic recycling events (revised Figure 8D, S6B, lines 351-353).  

      Reviewer #3 (Public Review): 

      Summary: 

      Chang et al. investigated the mechanisms governing collagen fibrillogenesis, firstly demonstrating that cells within tail tendons are able to uptake exogenous collagen and use this to synthesize new collagen-1 fibrils. Using an endocytic inhibitor, the authors next showed that endocytosis was required for collagen fibrillogenesis and that this process occurs in a circadian rhythmic manner. Using knockdown and overexpression assays, it was then demonstrated that collagen fibril formation is controlled by vacuolar protein sorting 33b (VPS33b), and this VPS33b-dependent fibrillogenesis is mediated via Integrin alpha-11 (ITGA11). Finally, the authors demonstrated increased expression of VPS33b and ITGA11 at the gene level in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF), and greater expression of these proteins in both lung samples from IPF patients and in chronic skin wounds, indicating that endocytic recycling is disrupted in fibrotic diseases. 

      Strengths: 

      The authors have performed a comprehensive functional analysis of the regulators of endocytic recycling of collagen, providing compelling evidence that VPS33b and ITGA11 are crucial regulators of this process. 

      Weaknesses: 

      Throughout the study, several different cell types have been used (immortalised tail tendon fibroblasts, NIHT3T cells, and HEK293T cells). In general, it is not clear which cells have been used for a particular experiment, and the rationale for using these different cell types is not explained. In addition, some experimental details are missing from the methods.

      We thank the reviewer for pointing out the lack of clarity, and have filled in missing information in the methods. HEK293T cells were used for virus production for the VPSoe system, and we have clarified the cell types used in figure legends (predominantly iTTF). We have also provided justification when NIH3T3 cells were used (revised lines 290-291).    

      There is also a lack of functional studies in patient-derived IPF fibroblasts which means the link between endocytic recycling of collagen and the role of VPS33b and ITGA11 cannot be fully established.

      We thank the reviewer for this comment, which was also raised by reviewer 2 above. We agree that the inclusion of additional functional studies using IPF patient-derived patient fibroblasts would add to the manuscript and have performed siRNA against VPS33B and ITGA11 on IPF fibroblasts, and demonstrated a late of endocytic recycling events (revised Figure 8D, S6B, lines 351-353).  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      The authors inhibit Clathrin-dependent endocytosis with dyngo4a. It is well known that this inhibitor is not highly specific for this pathway. It is also not explained why the authors only inhibit the Clathrin uptake pathway, and not pinocytosis or Clathrin-independent endocytosis too. The authors refer to papers that describe pinocytosis for collagen endocytosis.

      We thank the reviewer for raising this question. Based on the fact that inhibition of clathrin-dependent pathway does not completely abrogate endocytosis of collagen-I, we anticipate that other pathways are involved in mediating collagen-I uptake, although additional data suggested this is unlikely through fluid-phase endocytosis, and is receptor mediated (revised Figure S2B, C).  

      Where does the ColI go in the cell? Depending on the uptake pathway, it is likely to pass through endocytic carriers to endosomes, where it may be recycled to the PM or degraded. From the start, the authors describe the ColI as being in vesicular structures, however, the imaging data that this is based on is not co-labelled with anything to determine the potential structure/localisation. This is not done at any point in the paper, until IF is shown of ColI with VIPA39, however without the relevant controls, this IF is unconvincing, as the general pattern of ColI and VIPA39 as an endosomal marker are not classically recognisable. Additionally, VPS33B is described as a late endosome/lysosome marker, which would have different connotations on ColI trafficking or destination than other types of endosomes.

      We thank the reviewer for pointing out the weaknesses in our original IF. We have included new confocal images showing labelled collagen co-localisation with GFP-tagged Rab5 through transient transfection, which is a more traditional endosome marker (revised Figure 1D, Figure S6A).  

      We are currently characterising the compartments to where ColI is trafficked to, which is being prepared as part of a methodology-based manuscript. We believe that this characterisation would be too detailed to be included in a revised version of this manuscript. The Kadler lab also have data suggesting that the lysosome is involved in collagen fibrillogenesis instead of its canonical degradation function, which is in another submitted manuscript (https://www.researchsquare.com/article/rs-1336021/v1). It was not included in this manuscript due to our focus (i.e. endocytic-recycling).   

      In Figure 5H, the pattern of Cy5-ColI staining looks like it could even be ER/Golgi in the VPSKO zoom panel, but in the absence of co-labelling, we cannot conclude anything. In order for the authors to conclude that ColI is within the endosomes, co-labelled If should be performed to demonstrate ColIendosomal colocalization. Likewise for the role of VPS33B in ColI fibrillogenesis: dependence of the process is demonstrated, but the relationship is not defined. This could be clarified using IF. This would also support the authors' statements of co-trafficking between ColI, VPS33B, and VIPA39, which as the paper stands, is not demonstrated.

      We would like to clarify that our hypothesis is that the endosome controls how collagen is being deposited outside the cell, i.e. whether it’s protomeric secretion or fibrillogenesis, and that the decision of whether an endocytosed collagen is recycled or degraded lies in this compartment. The reviewer is correct that it may not be just the endosome that endocytosed collagen-I ends up in, as we have new data suggesting involvement of other intracellular compartment, although the detailed mechanism is beyond the scope of this manuscript. Nonetheless, we have included new data showing co-localisation of endocytosed collagen with Rab5 in this revised manuscript (revised Figure 1D, Figure S6A).  

      The basis of this paper is that endocytosis of ColI must occur before re-exocytosis as fibrillar ColI. The authors show this through pulse-chase experiments, with a trypsinisation step to remove any externally bound ColI. The authors also show nice time progression by flow cytometry, but it would truly demonstrate this point if they showed 0 timepoint, or low timepoint of IF to show progressive lengthening of ColI fibrils. This is used early on in Figure 1D, although the presentation here is not very clear. This is especially important as the authors address the self-seeding capabilities of Collagen in cell-free conditions in Figure 1F.

      We would like to thank the reviewer for this suggestion.  From previous endogenously tagged collagen data, we know that the appearance of collagen fibrils is rather rapid, thus it may not be a gradual lengthening as expected, but rather a depletion of endocytosed collagen in the initial seeding/growth step (please see https://www.researchsquare.com/article/rs-1336021/v1). We have included an image of replated fibroblasts after 18 hours showing no appearance of extracellular collagen, endogenous or otherwise (revised Figures S2A, line 110).  

      Finally, although the involvement of ITGA11 is interesting, it is not well described, and its role is not well demonstrated. This could likely be clarified by an additional introduction to ITGA11 and its role in collagen exocytosis/fibrillogenesis.

      We would like to thank the reviewer for pointing this out and have included additional sentences to specifically introduce ITGA11 and its role in fibrillogenesis (see lines 320, 321; 446-450).  

      Specific points: 

      Line 73: You haven't compared reuse vs production, so you can't say that reuse is central rather than production. They may be both as important or production still may be the most crucial, maybe it depends on cell/collagen type. Using the ColI KD or CHX to block nascent synthesis, you could directly compare the impact of both.

      We would like to clarify that we are not referring to reuse/recycling here. We meant that production of collagen (i.e. single hetero/homotrimer molecules within the cell) is not as crucial as the utilisation (i.e. are these being secreted as protomers, or assembled into fibrils) of these building blocks by the cells, which was supported by our finding that production (as suggested by mRNA levels) of IPF fibroblasts are similar to that in control fibroblasts (now revised Figure 8A). We have conducted ColI siRNA to block nascent synthesis in the original manuscript and showed that fibroblasts can efficiently make new fibrils by recycling exogenous collagen (Figure 3B, C), although we appreciate that siRNA may not completely inhibit endogenous production. Thus, we have also included new data using collagen-I knockout cells to support our hypothesis that without endogenous production, fibroblasts can still effectively make collagen fibrils if they can reuse what is available in the extracellular space (revised Figure 4, Figure S3C, D; lines 178-199).  

      Lines 83-87: The rationale for this experiment is not clear. Cy3-ColI is added, taken up into cells, and incorporated into fibrils coming from cells. 5FAM-ColI is added at a later stage, then at 2 days (when incorporation is demonstrated in Fig 1B), it is also incorporated into cells as expected. Why does this comment on ColI not being degraded any more than Cy3-ColI alone?

      We believe that the pulse chase experiment using the differently tagged collagen demonstrated a dimension of dynamics that is not demonstrated with Cy3-ColI alone. In this case, Cy3-ColI was initially added, and removed after 3 days; 5FAM-ColI is then added and incubated for 2 more days. Thus after 5 days since the initial pulse, the Cy3-ColI persisted and was not degraded. We would like to apologise for causing this confusion, and have clarified in the revised manuscript (lines 542-549; Figure S1D figure legend).  

      Figure 1A: I would like to see a negative control: either dark colI or no Cy3-Col, or timescale. Is B quantified from these images?

      We thank the reviewer for this comment. We have added the nocollagen control image in our revision (revised Figure S1D). 1B is not quantified from the ex vivo tendon experiments, but rather the in vitro cell culture experiments (i.e. those from 1D-1F, although they are all from independent experiments).  

      Figure 1B: in iTTF cells (immortalised tendon cells) Corrected to max: What does that mean?

      As there are variations between individual experiments (e.g. changes in the amount of collagen added due to pipetting) we have normalised to the maximum value obtained in each individual experiments so that we can display all biological repeats within the same graph.  

      Figure 1C: You can't say ColI is in vesicular structures from this, they are spots, yes, but that could also be in Golgi/ER (unlikely to be cytosolic but not impossible).

      We appreciate this comment and have change the wording accordingly and call them intracellular/punctate structures.

      Figure 1D: Not the best presentation: The cell mask has structures: what are these? It's not clear if this is a single cell, would be better with a defined marker (endocytic marker, lysosome etc). Instead of a low-resolution 3D view, it would be clearer with normal confocal XY and zooms of "vesicular structures" using appropriate markers as 3D reconstructions I think it could be removed.

      This is a single cell and the cell mask is staining plasma membrane. We didn’t use defined marker as we wanted to visualise the whole intracellular cell compartment. We appreciate that further proof is needed to verify the location of the endocytosed collagen, and have included additional confocal imaging data to support the localisation of collagen into Rab5 positive intracellular compartments (revised Figure 1D, Figure S6B).  

      Figure 1 E/F: Cy3 is only visible in extracellular structure, not also intracellular. Why? Would be useful to see the time points of incorporation at the end of the pulse, then at an early point into the chase, to demonstrate 1) Cy3-ColI uptake into cells and progressive incorporation rather than potential direct binding of ColI-Cy3 to ECM, or other non-specific factors. Showing the image at 0t would demonstrate an absence of external labelled colI and therefore its appearance later could be presumed that it had been internalised before.

      As the cells were trypsinized and replated after one hour labelled collagen feeding to ensure we are only tracking endocytosed collagen, t=0 in this case would be cells that are unattached. We have included t=18hr images post replate instead to show baseline level of collagen (revised Figures S2A, line 110).

      Figure S1A: yellow box: doesn't show only Cy3-ColI, there is red and yellow in the central cell, and large yellow blobs in the cell above. These images do not support this claim, including the Fiber Zoom box. They should also be shown in single channels to demonstrate the authors' points better.

      Apologies for the confusion – this is to show that newly added FAM5 Collagen is also co-localising with previously endocytosed Cy3-ColI, i.e. the Cy3-ColI is persisting rather than being degraded.  

      Line 92: endocytosed into distinct structures: These images are very vague, but I don't think you can call them distinct structures, all you can say from this is that they are spots.

      We have changed the wording to ‘distinct puncta’.  

      It is not clear why the authors use Cy3, Cy5, and 5FAM labelled colI. A brief explanation would be useful.

      Apologies for the confusion, we initially included our justification (to show that the fluorescence labels do not change the way collagen is internalised) but removed it in the final manuscript due to length. We have added the justification (revised line 101-102).   

      Figure 1F: It would be useful to see a quantification of the Cy3 channel here: I agree with the conclusions, and find the 0.5 ug/ml condition more convincing than 0.1 actually, although there is some feint Cy3 in cell-free samples there seems to be quite a big increase in the presence of cells, and this would look more convincing if quantified.

      We thank the reviewer for this suggestion and have included quantification in the revised manuscript (revised Figure 1G-I).  

      Figure 2B: Dyng is not an abbreviation of Dyng. Standardise Dyng/Dyngo/Dyngo4a. WB is soluble colI and represents little (if any) insoluble col. IF is more or less the other way round. How do they compare this?

      Thank you for pointing out the inconsistencies, we have corrected this in the revised manuscript. We took the conditioned media from the same experiment where cells are fixed for IF and carried out Western blot analyses. The IF showed some collagen still present, albeit significantly reduced. This is in agreement with the western blot results (i.e. Dyng4a inhibits both soluble and insoluble forms of collagen deposition).  

      Figure 2C: not an image series. Quant: no cells/independent exps and STATS?

      Apologies for the missing experimental details in figure legends, it should say ‘representative of N=3 experiments’. We are not sure what the reviewer meant by Figure 2C not being an image series, as we meant it to be an image series of the individual fluorescence channels. We have changed this terminology to avoid confusion, and have included statistical analyses in the methods section. The statistical analyses of the fibril quantification is next to the fluorescence images.  

      Figures 2D/E: The authors show that internalised ColI peaks at 20h and decreases to 60h, Fibers peak at 40h. How is this measured? ECM removed? Why would there be less in the cells, degradation? Whats the synchronisation?

      We apologise for omitting the synchronisation method in methods section, and have included in our revised manuscript (revised lines 542-544). This is through dexamethasone addition (and removal after 1hr incubation) as standard. The internalised Col-I is measured using Cy3ColI so the cells would have both nascent and external collagen. Total intracellular collagen at the different time points would likely be higher than represented as a result, but here we are demonstrating that internalisation is a rhythmic event using the external labelled collagen. Fibers are measured using standard IF and then fibril counting.  

      Please note that we are only overlaying the two graphs to form our hypothesis that endocytosis may be used for accumulation of collagen protomers that then allows for efficient fibrillogenesis. They are not directly comparable as the quantification are of different things (internalised Cy3-ColI, total collagen fibrils). We have clarified this in our discussion (revised lines 399-401).  

      Discussion: Where does the ColI go? Solubilised? Degraded? Taken up by other cells? 

      The inverse correlation is not very tight. In fact, at 38h where fiber count peaks, Cy3-ColI also peaks (esp in normalised data, Figure S2D).

      We thank the reviewer for this comment and have reworded our main text to reflect this, and included additional discussion in our revised manuscript (revised lines 401-404).  

      Line 123: What is the turnover rate of Fibrils? Don't know for how long the transcription has been done, or when this would affect the fibril number. You have the quant for Fn1, where is the quant for ColI?

      We have included the quantification of collagen-I in original Figure 2A. We appreciate that it might cause confusion in Figure 2C (as we co-stained ColI and Fn1 in the same experiment) we have removed the collagen-I panel from the revised Figure 2C. We know from previous results that the number of fibrils fluctuate over 24hour period, although the turnover of one specific fibril is unlikely going to be 24 hours (https://www.biorxiv.org/content/10.1101/331496v2)

      Line 124: no accumulation of col in extracellular space, but you don't know how much endogenous colI (or other endogenous ECM proteins) they're taking up as it isn't measured here. If the author wants to comment on this, should use either exogenous col to monitor take up and resection or block transcription/translation to show fibril formation endo/exocytosis independent of endogenous synthesis.

      This experiment has been done in the original manuscript – siCol1a1 experiment was done with two rounds of siRNA, first round is normal transfection followed by reverse transfection onto fresh coverslips (this will ensure no prior ECM is being deposited, see Figure 3). However we appreciate that there may still be low levels of endogenous collagen-I, and thus have included new data using collagen-I knock-out fibroblasts to strengthen our findings (revised Figure 4).  

      Line 142: Why is fibronectin synthesis also decreased in Col KD? This is clear in the image but no explanation/reference is given.

      Due to the dynamic and complex nature of ECM, it is unsurprising if there is a knockon effect when knocking down one matrix protein. However, we have quantified the amount of fibronectin fibril deposited by scr and siCol1a1 fibroblasts, and showed that there was in fact no significant change between the two treatments (revised Figure 3A).

      Figure 3A: Need labels for which colour/protein is shown. Needs quantifying, especially as the Fn1 decrease is not so obvious here, it is consistent between Figure 3A and 2C?

      We have provided quantification in the revision (revised Figure 3A). Figure 3A and 2C are two separate experiments (one is Dyngo treatment and one is siCol1a1), and neither showed significant changes in fibronectin fibril areas.   

      Figure 3B: Line 151: the text states that "The observation of fibrillar Cy3 signals in siCol1a1 cells showed that the cells can repurpose collagen into fibrils without the requirement for intrinsic collagen-I production (red arrow Figure 3B), however, there is clearly endogenous colI here too (along the fiber and also strongly at each end). Does the ColI antibody recognise the exogenous ColI?

      In our hands the ColI antibody does not recognise exogenous ColI, as the cell-free Cy3-ColI images were also stained with ColI antibody to ensure the two experimental conditions were treated exactly the same.

      This conclusion could only be made in the true absence of collagen: either in knock-out cells, or where collagen production/trafficking has been blocked (ie knockout of ColI chaperone or ERES block), or in a cell type that produces collagens but not ColI. Alternatively, if there are any fibrils seen that are completely negative, they should be shown in the figure and quantified (number of Cy3-ColI+-ColI+ vs Cy3-ColI+-ColI-).

      We thank the reviewer for this suggestion. We have included new data from collagen knock-out fibroblasts in this revision (revised Figure 4).  

      Figure S4A: the quality of this blot isn't very high, the result is not very clear and the high intensity (unspecific?) band below confounds the interpretation. In the author's previous paper (NCB 2020) the blots for VPS33B were much clearer, as is Fig S4D. It would be nice to include a clearer blot, maybe from the other repeats.

      This is the only blot that we used to select which knockout clones to use for our previous paper, which is why the quality is not as high. Knockout clones were all verified with additional western blots, and we do not think that endogenous VPS33b is expressed at high levels (also verified by MS analyses).  Fig S4D is overexpression of VPS33b, which is much easier to detect.  

      Figure S4D: This blot is much clearer, it would be useful to include a high gain to show the VPS33B band in CT to be able to understand the true increase.

      From the qPCR data one can see that the increase at mRNA is 20+ fold increase; we’ve always had problems trying to detect endogenous VPS33b using western blot or mass spectrometry analysis.  

      Figure 4A: The fibrils here in the CT are not obvious, and the difference between CT and KOs is not appreciable. Would this be clearer shown at a lower magnification, with zooms where needed? Or immunogold labelling/CLEM to label the ColI?

      It is not trivial to carry out immunogold labelling/CLEM. These are cell-derived matrices in culture and thus lower magnification may not show as many collagen fibrils as one would expect. We are not confident that lower magnification will provide more information as the characteristic D-banded collagen pattern will be lost.  

      Line 167/Figure 4B: It looks like there is more internal ColI in KO, but the images are not good enough to tell. This could be better shown by flow cytometry.

      We have previously seen that VPSKO leads to accumulation of collagen-I in intracellular punctas (NCB2020) which is also seen here. Flow cytometry data for internalisation of external collagen is already included in original Figure 5G (revised Figure 6H).  

      Again you mention intercellular vesicles, but based on these images, it is not possible to conclude this. These large spots could be aggregation elsewhere in the cell. Specific localisation should be shown by co-labelled IF/confocal, or it could be nicely shown by EM + fluorescent element (CLEM / Immunogold), or these statements removed from the text.

      We appreciate that the term ‘vesicles’ is very defined in the trafficking field, and have changed it to ‘intracellular compartments’.  

      Line 173-174 / Figure 4E: Why do you think the matrix mass is not increased in VPSoe by the approach shown in E when there is seemingly a huge increase by IF? E must also measure other ECM matrix proteins, which do you expect to be secreted by these cells? Could this confound the data if they too are affected by VPSoe?

      IF is showing specifically collagen-I. Hydroxyproline detects multiple collagens, and shows a trend of increase (although not significant due to one outlier). Matrix mass is a very generic measurement of total ECM deposited based on decellularized ECM weight. The reviewer is correct that VPSoe may also affect other ECM deposition, however here we are focussing specifically with its effect on collagen-I. How VPSoe changes other types of ECM deposition would be something that could be addressed in future studies and is not within scope of this manuscript.   

      Are the results in E paired?

      Individual values between control and VPSoe in each separate experiments are paired.  

      Figure 4F: Is quantification from IF shown in D? Specify which kind of microscopy it is based on.

      Quantification is based on fibril counting using standard fluorescence microscopy, as used in our previous paper. D is independent of F, as F is specifically looking at synchronised circadian effects, and D (and elsewhere) we are looking at global collagen deposition effects, irrespective of what time of day the cells are in.  

      Figure S5F: What do the yellow/red spots in the blots represent?

      We apologise for the initial unclear description of what the yellow/magenta circles depict in relation to the phosphoimages of the radiolabelled cell free translation products displayed in Supplementary Figure 5, panels F, G and I. These circles indicate non-glycosylated (yellow) and N-glycosylated (magenta) species respectively, as is now clearly descried in the revised manuscript.

      Figure 5 title: You can't conclude this from these images, need confocal and PM or cytosolic marker.

      We have changed the title to ‘VPS33B co-trafficks with collagen-I”. There is no good commercial VPS33b antibody for immunofluorescence staining, which is why we used the split GFP approach in this paper, and the images were acquired using confocal imaging (Olympus SpinSR system).  

      Figure 5E: The authors describe that ColI is in endosomes throughout most of the paper, and this is based on the involvement of VPS33B in the colI pathway. VPS33B is thought to be at the late endosome/lysosome. However, these images do not look like classic endosomes or lysosomes, or other normal organelle IF phenotypes. The fluorescent intensity looks saturated, and it is difficult to conclude anything from these images. It is unclear where in the cell the largest blob in the zoom would be localised and in which cell. I would suggest that this image is replaced and proper controls included (IgG controls and single channels) as well as using different markers for other potential intracellular structures.

      We appreciate the reviewers comment with regards to the classification of VPS33b localisation in the endosome compartment. We did not mean to use VPS33b as an endosome marker, as the focus of our studies are the function of VPS33b in directing endogenous or exogenous collagen to fibrillogenesis. With live imaging we could see endocytosed collagen moving in intracellular compartments, and have conducted additional staining to show co-localisation with Rab5 (revised Figure 1), which we take to indicate, through convention, that it is occupying an endosome compartment. We have included single channel images in the revised manuscript (revised Figure 6E).

      Line 255/ Figure 5G: no consistent change in uptake. Why are the results so varied in the KO and oe, here and in Fig 4C/E? N=4, what does that mean? 4 cells? 4 independent exps?

      In all cases, “N” represents independent biological experiments in this manuscript. Thus “N=4” in this case is 4 independent biological experiments, with at least 10,000 cells analysed per experiment. 

      We don’t know why there is a variation in response, however that is also why we concluded that it is unlikely that VPS33B is directly involved with collagen uptake. We have changed 5G (now revised Figure 5H) to a paired line graph for better representation.  

      Figure 5H shows the uptake of Cy5ColI. At this resolution, VP2ko looks like the col is ER, in one of the cells in the zoom, it looks like it is at Golgi. I think that the uptake route of ColI needs to be better defined, as there is no way to tell here where the colI goes. ColI being recycled/degraded would be most likely. But this figure looks like that might not be the case. It is also not clear where the zooms come from, they should be indicated with dashed boxes in the lower mag image

      We thank the reviewer for this comment, and agree that we need to define the uptake route of ColI. This is currently being assembled as a methodology manuscript, and how ColI is being recycled/degraded is one major research area of the Chang lab. 

      We have added dashed boxes in the lower mag images to indicate where the zooms derived from, and we would also like to thank the reviewer for pointing this out as we realised we have accidentally cropped the image to a slightly different area for the VPSko image, and have now corrected this.  

      Line 257: Based on this data, it could be trafficking through the cell as well as into the extracellular space.

      We think that VPS33B is involved in trafficking collagen through the cell to plasma membrane but not secreted, as based on our split-GFP experiment we never observed extracellular GFP signal, which suggests VPS33b is not deposited extracellularly.

      Line 259: "highlighting the role in recycling col to fibril formation sites" is an overstatement based on the data shown here, there is no data on colI trafficking or its regulation

      We respectfully disagree that we have not shown data on col-I trafficking or regulation by VPS33b – split GFP highlighted cotrafficking to the plasma membrane, and we have shown a clear relationship between VPS33b and collagen-I fibril formation, with minimal changes to collagen-I mRNA levels. We acknowledge that we have not shown specifically the location of VPS33b at fibrillogenic sites and have modified this statement in revised manuscript (revised line 302).  

      Line 262: "Having identified VPS33B as specifically driving collagen-I fibril formation" is also an overstatement.

      We refer here the data that VPS33b is not controlling collagen-I secretion (as demonstrated by the CM westerns) and specifically fibrillogenesis. We have clarified this in the revised text (revised line 304).  

      Line 286: It would be useful to have a brief intro to PLOD3.

      We have included a brief intro to PLOD3 in the introduction, as well as the results highlighted by the reviewer, in our revised manuscript (revised line 54-58).  

      Line 289/290: There could be other explanations for disruption to exo-endocytosis when disrupting col trafficking. Is VPS33B controlling exocytosis in general? Why should it be specific to col? Likewise with siITGA11 KD? Hypothesis for ITGA11 and fibrillogenesis?

      The relationship between ITGA11 and collagen fibrillogenesis is currently in a manuscript by Donald Gullberg and Cedric Zeltz, under revision at Matrix Biology (see reference 63 in revised manuscript). We do not think that VPS33b is controlling exocytosis in general, which is supported by the minimal change in ponceau stain of the western blots in the manuscript. Previously it has been shown that VPS33B co-trafficks with PLOD3, a collagen-I modifier.  

      Figure 6I: Why only quant Scr + siITGA11, not in VPSoe? It looks like there is still an increase in intracellular or fibril formation in VPSoe + siITGA11, which would be a key result to discuss.

      We would like to clarify that 6I (now revised Figure 7I) is on the endocytosis of exogenous collagen-I, not quantification of Figure 6H.  

      Line 307: Discuss fibrillogenic sites, what are they?

      As we have not shown direct evidence of VPS33B delivering endocytosed collagen at the site of fibrillogenesis, we have decided to alter the text to avoid overstatement, as suggested from previous reviewers’ comments.  

      Figure 8: What does pentachrome label?

      Pentachrome staining allows for simultaneous staining of multiple species: collagen in red, sulphated mucopolysaccharides in violet, red blood cells in yellow, muscle in orange, nuclei in green.

      Line 326: "In this study we have identified the endosome as a major protagonist in..." This is an overstatement and cant be drawn from this data.

      We have modified this statement to “In this study we have identified an endocytic recycling mechanism for type I collagen fibrillogenesis that is under circadian regulation”

      Line 330/331: "Collagen-I co-traffics with VPS33B in a VIPAS-containing endosomal compartment that directs collagen-I to sites of fibril assembly," This is also an overstatement that cannot be drawn from this data.

      We have modified this statement to “Collagen-I co-traffics with VPS33B to the plasma membrane for fibrillogenesis”.  

      Line 340: again, the demonstration of the involvement of the endocytic pathway is very limited.

      We have provided new evidence in the revised manuscript that support the involvement of classical endosomal compartments.  

      Line 366: You cant conclude this, you have not manipulated these proteins to show a functional effect or modulation of fibrillogenesis, it could still be a secondary effect.

      We have provided new evidence in the revised manuscript that supports this conclusion. 

      Line 569: "Unless otherwise stated, incubation and washes were done at room temperature." Which incubations? Specify if this is just post-fixation during the EM prep or during cell culture.

      This is specific to the EM preparation and we have clarified in the revised manuscript (revised line 663).  

      Small text alterations:

      Overall we would like to thank the reviewer for highlighting these errors and mistakes in our manuscript, and have corrected them in our revised manuscript.  

      Figure 1E: Fluoro image series? This is only one image.

      We wrote this to mean single channel images, we have corrected the terminology.  

      Line 111: Ref for Dyngo4a?

      We have included this in the revised manuscript  

      Line 121: introduction/abbreviation definition for Fn1? Instead it is on Line 140.

      Thank you for highlighting this, we have corrected this in revised manuscript.  

      Figure S2C: Alignment of labels cleaves x-axis.

      We thank the reviewer for catching this and have corrected this with our revised manuscript.  

      Figure S4F and G should be inverted to mention sequentially in the text.

      We thank the reviewer for catching this and have corrected this in our revised manuscript.  

      Line 182: Figure 4J should be G.

      We thank the reviewer for catching this and have corrected this in our revised manuscript.

      Line 209: typo: N-glycosylated.

      We have corrected this typo in our revised manuscript.

      Fig 6E: Very big as a figure element compared to others.

      We have made this smaller in the revised manuscript to fit better with rest of the figure.  

      Line 313: Figure 7E not F.

      Thank you for spotting this, we have corrected it.  

      Line 555: Typo: Scraped.

      We have corrected this typo in our revised manuscript.

      Line 562: missing )

      We have corrected this typo in our revised manuscript.

      Standardise

      We thank the reviewer for spotting the mistakes below and have corrected in our revised manuscript.  

      Legends: Include numbers of repeats and STATs throughout. 

      Terminology: Dyng etc. 

      Scale bars: some included as editable lines, some with size on top, small/large etc.

      In certain cases we have positioned the scale bars in different regions of the figures to ensure no obscuring of the images.

      VPS33b v B. 

      Reviewer #2 (Recommendations For The Authors):  

      The authors can improve the experimental part of the manuscript the following: 

      -  For all the western blots please include molecular weight markers.

      We thank the reviewer for noticing this omission and have included molecular weight markers in the revised manuscript.  

      - Performing immunofluorescence and western blot analysis of endocytosed collagen -/+ inhibitors for lysosomal degradation (BafA1 or E64d+PepstatinA) in order to exclude endocytosis for degradation.

      We thank the reviewer for this comment, another paper from the lab has identified lysosome to be involved in collagen fibrillogenesis (https://www.biorxiv.org/content/10.1101/2024.05.09.593302v1), thus  

      - Figure out how Dyngo4a is affecting Col1 secretion in the first place? Does it interfere with the secretory pathway. Alternatively, use a different model to block endocytosis (e.g. siRNA Dynamin).

      We thank the reviewer for raising this. The Dyngo CM blot for total ponceau stain (revised Figure 2B) showed minimal changes, which suggest that global secretion is not affected.  

      - Further characterization of the VPS33B / collagen vesicles by immunofluorescence containing markers for early, late, and recycling endosomes. Block endocytic recycling by depletion of either Rabs or e.g. EHD1.

      There are no good VPS33b antibody for staining. We have included images of GFP-tagged Rab5 co-localisation with labelled collagen-I (revised Figure 1D, Figure S6B).  

      - Further clarify the status of the VPS33B knockouts e.g. by sequencing. also provide a readout of the siRNA KD, besides the mRNA levels, since there the difference is not striking.

      The knockout cell lines were characterised previously in our 2020 paper, which is referred to in our revised manuscript. We have always had issues detecting endogenous VPS33b due to reagents limitations, which is why we resorted to mRNA as the key readout.  

      - Doing siRNA knockdowns and endocytosis inhibition in the IPF fibroblasts to further strengthen the link between elevated expression of VPS33B/ ITGA11 and increased collagen uptake.

      We thank the reviewer for suggesting these experiments. Due to limitations of the patient-derived fibroblasts (cell numbers and passage numbers) we had to prioritise experiments, and thus have performed siRNA against VPS33B and ITGA11 in the IPF fibroblasts. We showed that in both cases the amount of recycled labelled-collagen in collagen fibrils is significantly reduced (revised Figure 8D).  

      Reviewer #3 (Recommendations For The Authors): 

      Major points 

      (1) Choice of cells: Please provide a rationale for why each cell line was used, and make sure that it is clear throughout the manuscript which cell line was used for each particular experiment. The HEK293T cell line is also missing from the reagent table.

      We thank the reviewer for pointing out this omission, and have clarified in our revised manuscript which cell lines were used in each experiment. We used HEK293T to generate lentiviruses as described in the methods section.  

      (2) Missing information from methods. Experimental details are missing from the methods in several places, making it difficult for someone to replicate an experiment. For example, no details are given in the methods describing the explant culture of murine tail tendons (described in results lines 78100), and there are no details on how the skin samples were obtained or stained. Further, no ethical approval details are provided for the use of human skin tissue.

      We apologise for leaving the ethical approval details and skin sample collection out, this was an oversight and will be included in the revised manuscript. We have also included the method to how murine tail tendons were cultured ex vivo (revised lines 527-531, 546-553).  

      (3) Functional studies in patient-derived cells. To fully establish the role of VPS33b and ITGA11 in fibrotic diseases, functional studies including the knockdown/overexpression of these genes could be performed to establish if the same response is seen as in non-diseased cells.

      We agree that this will add much to the paper, and have performed siRNA against VPS33B and ITGA11 in the IPF fibroblasts. We showed that in both cases the amount of recycled labelled-collagen in collagen fibrils is significantly reduced (revised Figure 8D).

      Minor Points

      We thank the reviewer for pointing out these mistakes, and have corrected and included additional details in the revised manuscript.  

      (1) Lines 51-52. Wording of this sentence is unclear, please rephrase. 

      (2) Line 182. Should this be Fig 4G rather than J? 

      (3) Line 209. Correct spelling of glycosylated. 

      (4) Line 463. Incomplete brackets and details missing? 

      (5) Line 590. Correct tense - was rather than are. 

      (6) Line 593. Specify centrifugation speed. 

      (7) Line 619. Nuclei rather than nucleus. 

      (8) Ln 650. Statistical analysis - was normality tested? 

      (9) Figure 1e - Difficult to read labels for coll/DAPI.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public review:

      Summary:

      This work provides a new general tool for predicting post-ERCP pancreatitis before the procedure depending on pancreatic calcification, female sex, intraductal papillary mucinous neoplasm, a native papilla of Vater, or the use of pancreatic duct procedures. Even though it is difficult for the endoscopist to predict before the procedure which case might have post-ERCP pancreatitis, this new model score can help with the maneuver and when the patient is at high risk of pancreatitis, sometimes can be deadly), so experienced endoscopists can do the procedure from the start. This paper provides a model for stratifying patients before the ERCP procedure into low, moderate, and high risk for pancreatitis. To be validated, this score should be done in many countries and on large numbers of patients. Risk factors can also be identified and added to the score to increase rank.

      Thank you for reviewing our manuscript. We hope that this score will be validated in other countries from now on.

      Strengths

      (1) One of the severe complications of endoscopic retrograde cholangiopancreatography procedure is pancreatitis, so investigators try all the time to find a score that can predict which patients will probably have pancreatitis after the procedure. Most scores depend on the intraprocedural maneuver. Some studies discuss the preprocedural score that can predict pancreatitis before the procure. This study discusses a new preprocedural score for post-ERCP pancreatitis.

      Thank you for evaluating our manuscript and raising a strength of this manuscript.

      (2) Depending on this score that identifies low, moderate, and high-risk patients for post-pancreatitis, so from the start, experienced and well-trained endoscopists can do the procedure or can refer patients to tertiary hospitals or use interventional radiology or endoscopic retrograde cholangiopancreatography.

      Thank you for evaluating our manuscript and raising a strength of this manuscript.

      (3) The number of patients in this study is sufficient to analyze data correctly.

      Thank you for evaluating our manuscript and raising a strength of this manuscript.

      Weaknesses:

      (1) It is a single-country, retrospective study.

      Thank you for this comment. It’s exactly as you said. This is a limitation (Lines 326-327).

      (2) Many cases were excluded, so the score cannot be applied to those patients.

      Thank you for this valuable comment. The predictive PEP score is not necessary for the excluded patients. The reasons were as follows. Biliary duct cannulation was not attempted in patients for whom it was difficult to identify the Vater papilla. The biliary tract was separated from the pancreas in patients with a past history of choledochojejunostomy, pancreatojejunostomy, or pancreatogastrostomy. PEP risk was thought to be low in these patients and patients who underwent bile duct cannulation via the choledochoduodenal fistula. PEP diagnosis is difficult in patients with acute pancreatitis, whose diagnosis is currently in progress. We added these explanations (Lines 98-106).

      (3) Many other studies, e.g., https://link.springer.com/article/10.1007/s00464-021-08491-1, https://pubmed.ncbi.nlm.nih.gov/36344369/, that have been published before discussing the same issue, so what is the new with this score?

      Thank you for raising the new reference written by Archibugi et al. in 2023. The novelty of our score is that it is calculated using the factors that are investigated before ERCP procedures. The study written by Archibugi et al. involved procedure time and cannulation attempts for PEP prediction. These two factors are unknown before ERCP procedures. Therefore, a preprocedural predictive risk model for PEP was not created before our study was performed. We added the content of the past study written by Archibugi and included the report as a reference (Lines 65-67, 73-74).

      (4) The discussion section needs reformulation to express the study's aim and results.

      Thank you for this valuable comment. I have rewritten the first paragraph of the discussion. In the paragraph, we showed that the study achieved the aim on the basis of the results (Lines 245-255).

      (5) Why did the authors select these items in their scoring system and did not add more variables?

      Thank you for this valuable comment. We selected the items listed in the Japanese guidelines for acute pancreatitis and post-ERCP pancreatitis. We added this description (Lines 123-126). The original references of the guidelines were cited in the first draft version.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Comment1. Please revise these documents: copyright, disclaimer, ethics approval, consent to participate, consent for publication, data and material availability, competing interests, funding, authors' contributions, and acknowledgments.

      First, thank you for reviewing our manuscript. We have already described the required information in the “author information” section. The sentences containing this information were proofread in English.

      Reviewer #2 (Recommendations for the authors):

      Comment 1. It would be best if you did this study in a Prospective way for more validation.

      First, thank you for reviewing our manuscript. We have revised our manuscript according to your comments. It’s exactly as you said. These points are limitations (Lines 312-318, lines 326-327). We hope that future validation studies over wider geographic regions will prove our opinions.

      Comment 2. The model name should be Acronyum (the first letter of the five items in the risk model).

      Thank you for this valuable comment. Sorry, we could not create a memorable model name using the first letter of the five items.

      Comment 3. You say that you include the pre-procedure criteria that predict PEP. You state one of the items, pancreatic duct procedure. Do you mean it is a history?

      Thank you for this valuable comment. This means that the main purpose is the pancreatic duct. Therefore, the pancreatic duct procedure is listed as “planned pancreatic duct procedures” in Figure 2 (Lines 40-41, 231-234). When an unintended pancreatic duct procedure is performed, we can calculate the risk score by adding two points for “planned pancreatic duct procedures” (Lines 48-49, 247-250).

      Comment 4. Regarding calcification, do you mean chronic pancreatitis? It needs more clarification regarding its degree.

      Thank you for this valuable comment. We regard pancreatic calcification as a finding of chronic pancreatitis. Pancreatic calcification was defined as the degree that was confirmed by imaging, such as CT, MRI, and EUS. These definitions have been written in the first draft version (Lines 134-137).

      Comment 5. Why don't you include young age in the model? Your result found that age less than 50 is significantly associated with PEP.

      Thank you for this valuable comment. We selected the PEP risk factors listed in the Japanese guidelines for acute pancreatitis and post-ERCP pancreatitis. Age less than 50 years was listed as a PEP risk factor in the Japanese guidelines for acute pancreatitis. We added this description (Lines 123-126).

      Comment 6. There is an ancient reference, some of them in 1994,1996.

      Sorry for the old references. These references were written by Cotton et al. 1991, Freeman et al. 1996, and Loperfido et al. 1998. These are still important today. The diagnostic criteria for PEP were determined in the report written by Cotton et al., which is Cotton’s criteria. The other two references are representative reports that described risk factors for PEP, and these two reports were cited in the Japanese guidelines for pancreatitis written by Takada et al. 2022 (Lines 123-126).

      Comment 7. In the introduction, you say that the first score includes one of the items for PEP pain during the procedure. It is a little bit strange.

      Thank you for this comment. The first PEP risk score did not involve PEP pain but involved pain during the procedure (Line 68).

      Comment 8. We know that once ERCP is indicated, you justify the importance of the risk model, stating that if one or more risks are found, we can do EUS or PTD. It is not reasonable to abort the procedure in case of frequent pancreatic duct cannulation or cancel ERCP if pt has one or more risk factors.

      Thank you for this valuable comment. If ERCP is performed for high-risk patients, prophylaxes for PEP, such as procedures by experts, pancreatic stent placement, and NSAID suppository insertion, should be performed as much as possible (Lines 281-287, 308-311).

      Comment 9. Regarding ERCP pancreatitis criteria, does it include amylase 3t or lipase?

      Thank you for this comment. We used Cotton’s criteria for diagnosing PEP. Cotton’s criteria include hyperamylasemia (more than three times the normal upper limit) at least 24 hours after ERCP (114-116).

      Comment 10. It is well known that pr with functional biliary disorder has a high incidence of PEP; it doesn't need a manometer for diagnosis. It needs to be included.

      Thank you for this comment. Moreover, functional biliary disorders are difficult to diagnose before ERCP procedures (Lines 259-262). The factor that is not apparent before ERCP could not be included in the predictive PEP scoring system.

      Comment 11: What is gabexare and nafamost.

      Thank you for this comment, and sorry for our insufficient explanation. These compounds include gabexate masilate and nafamostat masilate, which are protease inhibitors. In some institutions, protease inhibitors are used as prophylaxis for PEP. We added “protease inhibitors” (Lines 138-139, Tables 1 and 2).

      Reviewer #3 (Recommendations for the authors):

      Comment 1. The sample size needs clarification.

      First, thank you for reviewing our manuscript. The sample size has been included in the “Methods” section (Lines 157-165).

      Comment 2. They need to be mentioned cause they depend on old references in discussion and background.

      Thank you for this comment. The previous references were written by Cotton et al. 1991, Freeman et al. 1996, and Loperfido et al. 1998. These are still important today. The diagnostic criteria for PEP were determined in the report written by Cotton et al., which is Cotton’s criteria. The other two references are representative reports that described risk factors for PEP, and these two reports were cited in the Japanese guidelines for pancreatitis written by Takada et al. 2022 (Lines 122-126). In the background and discussion, we added new recent references and information related to the references (Lines 65-67, 285-287, 291-295, 308-311).

      Comment 3. Case definition should be added to the methodology.

      Thank you for this comment. We added patient information. Please refer to the response against the eLife assessment, weakness, (2).

      Comment 4. Do you include all who met the inclusion criteria, or was there any random sampling technique?

      No, we did not use random sampling techniques.

      Comment 5. What is the value of comparing the development and validation groups? I do not think it adds anything new as if you want to exclude confounders. Has the comparison revealed that a confounder does exist? What was your point of view concerning that?

      Thank you for this valuable comment, and sorry for the insufficient explanation. The differences between the development cohort and the validation cohort are important because the goodness of fit for the score could be confirmed in significantly different groups. We added this explanation (Lines 197-199, 251-253).

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary

      The authors determine the phylogenetic relation of the roughly two dozen wtf elements of 21 S. pombe isolates and show that none of them in the original S. pombe are essential for robust mitotic growth. It would be interesting to test their meiotic function by simply crossing each deletion mutant with the parent and analyzing spores for non-Mendelian inheritance. If this has been reported already, that information should be added to the manuscript. If not, I suggest the authors do these simple experiments and add this information.

      Thanks for the great summary! Most of the wtf genes have been tested for meiotic drive phenotypes previously by Bravo Nunez et al. (2020; http://doi.org/10.1371/journal.pgen.1008350). The reference was cited in our original manuscript, and we added the details in the revised manuscript.

      Strengths:

      The most interesting data (Figure 4) show that one recombinant (wtfC4) between wtf18 and wtf23 produces in mitotic growth a poison counteracted by its own antidote but not by the parental antidotes. Again, it would be interesting to test this recombinant in a more natural setting - meiosis between it and each of the parents.

      We will test the meiotic driver phenotype of the wtfC4 we constructed in S. pombe as suggested.

      Weaknesses:

      In the opinion of this reviewer, some minor rewriting is needed.

      We did the rewriting as this reviewer suggested in the comments to authors.

      Reviewer #2 (Public review):

      Summary:

      This important study provides a mechanism that can explain the rapid diversification of poison-antidote pairs (wtf genes) in fission yeast: recombination between existing genes.

      Thanks!

      Strengths:

      The authors analyzed the diversity of wtf in S. pombe strains, and found pervasive copy number variations. They further detected signals of recurrent recombination in wtf genes. To address whether recombination can generate novel wtf genes, the authors performed artificial recombination between existing wft genes, and showed that indeed a new wtf can be generated: the poison cannot be detoxified by the antidotes encoded by parental wtf genes but can be detoxified by own antidote.

      Thanks for the great summary!

      Weaknesses:

      The study can benefit from demonstrating that the novel poison-antidote constructed by the authors can serve as a meiotic driver.

      We will test the meiotic driver phenotype of the wtfC4 we constructed in S. pombe as suggested.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, Wang and colleagues explore factors contributing to the diversification of wtf meiotic drivers. wtf genes are autonomous, single-gene poison-antidote meiotic drivers that encode both a spore-killing poison (short isoform) and an antidote to the poison (long isoform) through alternative transcriptional initiation. There are dozens of wtf drivers present in the genomes of various yeast species, yet the evolutionary forces driving their diversification remain largely unknown. This manuscript is written in a straightforward and effective manner, and the analyses and experiments are easy to follow and interpret. While I find the research question interesting and the experiments persuasive, they do not provide any deeper mechanistic understanding of this gene family.

      Thanks! Please see the following for our point-to-point response.

      Strengths:

      (1) The authors present a comprehensive compendium and analysis of the evolutionary relationships among wtf genes across 21 strains of S. pombe.

      (2) The authors found that a synthetic chimeric wtf gene, combining exons 1-5 of wtf23 and exon 6 of wtf18, behaves like a meiotic driver that could only be rescued by the chimeric antidote but neither of the parental antidotes. This is a very interesting observation that could account for their inception and diversification.

      Thanks for the great summary!

      Weaknesses:

      (1) Deletion strains

      The authors separately deleted all 25 Wtf genes in the S. pombe ference strain. Next, the authors performed a spot assay to evaluate the effect of wtf gene knockout on the yeast growth. They report no difference to the WT and conclude that the wtf genes might be largely neutral to the fitness of their carriers in the asexual life cycle at least in normal growth conditions.

      The authors could have conducted additional quantitative growth assays in yeast, such as growth curves or competition assays, which would have allowed them to detect subtle fitness effects that cannot be quantified with a spot assay. Furthermore, the authors do not rule out simpler explanations, such as genetic redundancy. This could have been addressed by crossing mutants of closely related paralogs or editing multiple wtf genes in the same genetic background.

      Another concern is the lack of detailed information about the 25 knockout strains used in the study. There is no information provided on how these strains were generated or, more importantly, validated. Many of these wtf genes have close paralogs and are flanked by repetitive regions, which could complicate the generation of such deletion strains. As currently presented, these results would be difficult to replicate in other labs due to insufficient methodological details

      We will generate growth curves for all the 25 wtf deletion strains. We will also provide detailed for wtf gene knockout. However, for 25 wtf genes, there are too many combinations for editing two genes, and it is technically challenging to knock out multiple wtf together. Nevertheless, our results suggest single wtf gene has little effect on the host fitness under normal condition.  

      (2) Lack of controls

      The authors found that a synthetic chimeric wtf gene, constructed by combining exons 1-5 of wtf23 and exon 6 of wtf18, behaves as a meiotic driver that can be rescued only by its corresponding chimeric antidote, but not by either of the parental antidotes (Figure 4F). In contrast, three other chimeric wtf genes did not display this property (Figure 4C-E). No additional experiments were conducted to explain these differences, and basic control experiments, such as verifying the expression of the chimeric constructs, were not performed to rule out trivial explanations. This should be at the very least discussed. Also, it would have been better to test additional chimeras.

      We will verify the expression of the chimeric genes, and test the phenotype of meiotic diver for wtfC4 in S. pombe.

      (3) Statistical analyses

      In line 130 the authors state that: "Given complex phylogenetic mixing observed among wtf genes (Figure 1E), we tested whether recombination occurred. We detected signals of recombination in the 25 wtf genes of the S. pombe reference genome (p = 0) and in the wtf genes of the 21 S. pombe strains (p = 0) using pairwise homoplasy index (HPI) test. ". Reporting a p-value of 0 is not appropriate. Exact P-values should be reported.

      We will report the exact p values in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reply to reviewer comments:

      (1) Given the interpretations of this study hinge on the specificity of the antibodies used in immune fluorescence, the authors should provide full western-blot images of all their antibodies in supplementary information. 

      The commercial antibodies have been validated by the provider. 

      Additionally, we did our own tests. Of note is that proper validation of any antibody is only possible by using a knockout mouse for each protein analyzed (i.e. for pPKA wt vs. pka ko mice). This is not possible, because we do not have all these knock-out strains. However, specific proteins like pPKA, pCAMKII, and pCAMKIV are known to be increased by a light pulse. We show by western blot that pPKA (Fig. 2a, b) and pCamKII (Fig. S2a, b) are increased in wt animals mirroring what we observed in the immunofluorescence. These results suggest that the signal is specific to these antibodies. We provide a full panel of western blots, including the other proteins studied by immunofluorescence such as pCamKIV, pCREB, CaV 3.1, and pDARP32 and show that they detect a protein of the expected size. Full Western-blots mentioned in the manuscript are shown in Supplementary Figure 7. Below are additional validations of antibodies used in the immunofluorescence experiments.

      Author response image 1.

      Author response image 2.

      (2) The explanation in the results section surrounding Fig. 4 seems to be specific for the representative trace rather than the group. Specifically, does the following statement apply to all the replicates?  " A Ca2+ transient was observed right before the light was given at ZT14 (Fig. 4b), which showed the same magnitude as those observed during and after the light stimulus". 

      If not this should be corrected.  

      We have replaced now Fig. 4b with an average trace of all experiments. The individual traces can be seen in supplementary figure 4d.

      (3) Are lines 236 -244 and figure 5A/B demonstrating shCDK5 being similar to no-calcium or EGTA conditions at the level of CREB not contradicting Figure 3 which argues that the reason behind the increase in CAMK-phosphorylation and pCREB following shCDK5 is increased basal calcium? If this is the case then why does removing the external calcium phenocopy shCDK5 in these cells? The authors need to clarify this and give an explanation. 

      (4) The authors should explain why they see an equivalent level (or more) of CREB activation, 5 minutes following forskolin activation in Ca2+-free condition (apparent in the case of shCDK5 and EGTA) in the FRET assay. Does this not imply PKA is the most likely candidate mediating this reaction at this stage? Given this interaction has been demonstrated in multiple (other) experiments including in vitro isolated enzyme experiments involving CREB and PKA (E.G. fig 6A in PMID: 2900470) an absence of p-PKA pulldown is not sufficient to justify the non-involvement of PKA (PMID: 22583753). This statement needs support in the form of positive data or acknowledging the limitations in the text (conditions, single technique, etc). 

      (5) The authors should better explain the fret pairs used in the experiments involving ICAP for the reader's benefit - a reduction in fluorescence as a function of CREB activation is non-intuitive.

      We answer all three questions (3-5) together since they belong to the same concept.

      (1) How FRET works.

      The Forster resonance energy transfer (FRET) technique is widely used to investigate molecular interactions between proteins such as CREB: CBP in living cells. We used a sensor called ICAP (an Indicator of CREB Activation due to Phosphorylation) published by Friedrich and colleagues in 2010

      (https://doi.org/10.1074/jbc.M110.124545). The sensor is composed of three different elements: 1) the KID domain of CREB containing the Ser-133, which is phosphorylated upon forskolin induction in our experimental setup, 2) the KIX domain of CBP, which is responsible for the dimerization with phospho-CREB and 3) a short linker that separates the KID with the KIX domain. KID is flanked by a cyan fluorescent protein (CFP), while KIX is flanked by a yellow fluorescent protein (YFP). When KID is not phosphorylated, the ICAP conformation allows CFP - stimulated by blue UV light - to transfer energy to YFP, producing FRET resulting in yellow light emission. Therefore, the ratiometric analysis FRET/CFP shows FRET > CFP. After a stimulus (forskolin), the serine-133 in KID is phosphorylated and KID can bind to KIX. The dimerization separates CFP from YFP, resulting in decreased FRET and increased CFP-dependent blue light emission (see Author response image 3 below). Therefore, the ratiometric analysis FRET/CFP shows FRET<CFP over time (usually within 20’ after the forskolin stimulus).

      Author response image 3.

      FRET model. On the left is a schematic representation of how ICAP works. On the right, an example of the quantified FRET decrease associated with increased KID: KIX interaction.

      (2) The ‘apparent’ contradiction between Figure 5A and Fig 3.

      As mentioned before, the chosen FRET method is ratiometric, meaning that a relative FRET signal in fluorescence is measured compared to the baseline (absence of forskolin, assay buffer). The FRET experiment can only tell whether there is a change in the phosphorylation state of KID during the live imaging comparing the baseline to the period after the forskolin treatment. The result produces a delta [ (time after forskolin)(baseline)]. The higher the delta, the more KID is phosphorylated after forskolin treatment. If KID phosphorylation is not increased compared to the baseline, the FRET signal tends to return to the baseline with a reduced delta [ (time after forskolin)-(baseline)]. Therefore, the experiment does not tell at the quantitative level the amount of KID (CREB domain) phosphorylation before the stimulus. It only tells whether after the stimulus the phosphorylation is increased producing or not a delta. This means that the lack of delta can be caused by: A) high KID phosphorylation in the baseline which does not further increase after the forskolin stimulus; B) very low KID phosphorylation in the baseline which does not increase after the forskolin stimulus. In Fig. 5A, wt cells (orange trace, lines, and double arrow) show a higher delta compared to the ko cells (blue trace, lines, and double arrow). The result indicated that the phosphorylation of CREB (KID domain) is increased after the forskolin stimulus only in the wt. To that extent, the results are in line with the experiment that we show in Figure 3. Indeed, the increased delta in CREB phosphorylation is observed only in the scramble animals, where it is lost in the ko (the blue double arrow indicates the delta in the scramble). 

      Author response image 4.

      (3) The FRET signal within 3 minutes after forskolin stimulation

      The signal mentioned by the reviewers at 5’ is an artifact given by the light diffraction promoted by the addition of Forskolin in DMSO which propagates through the plate. The same effect is observed in the only DMSO treatment (Fig.S5). Therefore, it needs not to be taken into account. The amplitude of this signal in this window of time is due to many independent variables (buffer composition, cell shape, room temperature, pipetting), therefore it is not possible to speculate any consideration about it. We never consider this time window for describing our results.

      Author response image 5.

      (4) Role of PKA and considerations about experiments performed in Fig. 5a and b

      To answer the question about the role of PKA, we believe it is a pivotal player. Our results indicate that PKA might promote CaV3.1, the entrance of calcium, and therefore, CAM Kinase pathway activation leading to CREB phosphorylation (Fig. 5). However, if the calcium is depleted, even a channel activation mediated by PKA cannot propagate the signal. For that reason, when we deplete calcium in wt cells as we do in the experiment performed in Figure 5B the activation of PKA alone cannot promote the CREB phosphorylation associated with a reduction of the FRET signal. As mentioned before, the FRET method gives a binary answer. It means either a higher or lower delta comparing time after forskolin to baseline. It cannot give stoichiometric info about the level of calcium and/or phosphorylation in the baseline. To that extent, the FRET experiment in Figure 5A cannot be connected to the experiment in Figure 5B. The method is the same, but the scientific questions are different. In Figure 5A we demonstrate that CDK5 plays a role in the PKA activation pathway. In Figure 5B we demonstrate that the general pathway needs calcium.

      We modified the text accordingly.

      (6) The presentation of the data in Figure 6 seems to be divergent from the rest of the data presentations. Please make it more consistent and also provide more explanations. Specifically, the authors suggest increased P-CREB nuclear localization (and an increase in phosphorylated PKA/CAMK) following shCDK5. Won't this lead to an increase in Per1, Dec1, cFos, and Sik1 basally (pre-light pulse)?

      We followed the reviewer's suggestion and present data in Figure 6 as done before in the manuscript. The reviewers should also consider our papers published before (Brenna et al., 2019; Brenna et al., 2021). In these papers, we demonstrate two important concepts that are in line with this manuscript. First, the lack of CDK5 promotes PER2 degradation and lack of nuclear translocation (Brenna et al., 2019). Second, PER2 plays a scaffold role in promoting the formation of the CREB transcriptional complex involved in the regulation of the expression of light-dependent genes (Brenna et al., 2021). Therefore, the take-home message here is that even if a lack of Cdk5 promotes a higher basal level of CREB phosphorylation, it also promotes PER2 degradation. Therefore, without PER2, the CREB-dependent gene expression is reduced. For this reason, we say that CDK5 gates phase shift (via PKA-CAM Kinases-CREB axis) of the circadian clock (via PER2).

      (7) The authors should discuss why calcium-sensitive phosphatases such as PP2A (PMID: 23752926) or calcineurin (PMID: 10217279) are not considered candidates for dephosphorylation of DARPP32 as these are described previously (CDK5) and conditions of increased calcium as seen here would favour these enzymes. The phospho-T75 data are supportive, but such additional discussion could be important given the past demonstrations.

      We thank the reviewers for the great insight. The pathway that promotes the T75 phosphorylation/dephosphorylation indeed includes many players as calcineurin and PPA2A. We mention this in the discussion now as follows:

      However, phosphatases such as PP2A and calcineurin, which de-phosphorylate DARPP32 including the Cdk5 phosphorylation site, may be involved in this process as well (Girault and Nairn, 2021). Upon light treatment and increase of Ca2+ these phosphatases would dephosphorylate DARPP32 and thereby inactivate it, leading to PKA activation. This process may occur in parallel to the Cdk5 regulation of DARPP32 contributing to a sustained activation of the light signaling pathway via PKA activation.

      (8) additional details on the knock-downs would be helpful: 

      - the relative amount of reduction in gene expression upon shRNA treatment should be provided  - How was the exact viral delivery and reduction in shRNA-induced knock-down confirmed for the individual animals?  

      The validation of Cdk5 knockdown was widely performed in the previous paper (Brenna et al., 2019, Fig2-Fig supp1, and Fig3-Fig suppl2). We used the same mice. We confirmed the goodness of the silencing also in the supp figure 1A of the current paper.

      (9) The authors only focus on male mice. This is rather incomplete, as it leaves away an important half of biological reality. Testing relevant aspects of the work in female mice would close this significant gap and also increase the number of biological replicates, which can still be considered relatively low. 

      We thank the reviewers for the suggestion. We injected female mice and performed the Ashoff type-II light pulse experiment at ZT14 and observe the same phenotype as for male mice. This is stated now in the paper and the data are shown in supplemental figure 1 e-f.

      (10) Given the roles of CdK5 in circadian clock period length regulation, but also light-induced phase delays, it would be interesting for a broader audience to discuss possible expectations of CdK5's roles, e.g. 

      (a) How will other circadian parameters, eg. activity bouts (numbers, length, activity onset/ offset) be affected? 

      (b) How does that relate to sleep, sleep phases? 

      (c) What is the expected impact on other physiological rhythms, eg food intake, cortisol levels? 

      (d) What are the expected effects on circadian oscillation of gene expression in other brain regions, organs? 

      We thank the reviewers for the observations. 

      a) The activity was discussed in the previous paper (Brenna et al. 2019). ShCdk5 mice show a reduced activity in both DD and LD 12:12 compared to wt, mirroring the Per2 brdm phenotype (Figure- Suppl3, with the difference mostly observed at night time (Figure 2-suppl4).

      We also demonstrate in Suppl Fig1 b, c of the current paper that light pulse does not affect the period length either in scramble mice or in sh Cdk5.

      b) We performed preliminary experiments with SCN shCdk5 knock-down animals and compared them to scr control mice using the Piezo sleep system. Total sleep was not different, however during the dark phase shCdk5 animals tended to sleep a bit more, similar to the neuronal Per2 KO animals (Wendrich et al., 2023 https://doi.org/10.3390/clockssleep5020017 ). After sleep-deprivation no differences were observed between shCdk5 and scr animals. This was comparable to the neuronal Per2 KO animals that also showed no phenotype after sleep deprivation.

      c) and d) We did not investigate food intake, cortisol, or other parameters involving peripheral clocks. We did not investigate the gene expression in other brain regions because the SCN is the main brain region involved in the regulation of the circadian clock phase shift. However future studies will address these questions.

    1. Author response:

      We appreciate the reviewers' thoughtful and constructive comments. In this provisional response, we aim to address what we see as the key critiques, with a detailed, point-by-point reply to be provided alongside the revised manuscript. Below, we outline how we intend to address these critiques in the revised manuscript.

      (1) We will revise sections of the manuscript to ensure that all results, particularly those concerning the effects of lesions, are described more clearly and with sufficient context. This includes providing additional visualizations and rewording any ambiguous statements.

      (2) In this study, we examined a subset of 7,396 blocks where animals quickly adapted after block switches (achieving LCriterion in 20 or fewer trials), thereby focusing on expert-level performance and avoiding periods that might be affected by low motivation. It is valid to question whether the same observations would hold if the full dataset were analyzed. To address this, we expanded our analysis to include a supplementary figure Supplementary Figure 1.1 that illustrate the same relationships based on block length (BL) instead of LRandom, both with and without the restriction on LCriterion (n = 9,156 blocks in which the block length is under 100 trials, without any LCriterion restrictions), and based on LRandom without any LCriterion restrictions and with a less stringent LCriterion restriction (with ≤ 50 Trials for the criterion). This method allowed us to include all trials in our dataset. We observed similar effects of block length on choice behavior around switches (Figure 3), confirming the consistency of our findings across different analytical conditions.

      (3) We agree that robust validation of model selection is crucial. To address this, we will generate a confusion matrix to assess whether our model selection process accurately identifies the correct model class across a range of generative parameters. Include additional model selection metrics, such as cross-validation, to complement the BIC analysis and provide a more robust comparison of models.

      (4) We acknowledge the concern regarding our comparison of the "best" and the "4th best" models. The "4th best" model was chosen because it is the most widely recognized in the literature. Our intention was to demonstrate the performance of the most commonly used model, but we understand how this may have been misleading. To address this, we will revise our comparison to focus on the "best" and the "2nd best" models, ensuring greater clarity in the manuscript. Additionally, we will include supplementary simulation results and figures to provide a more comprehensive analysis on models.

    1. Author response:

      We appreciate the expression of enthusiasm for our paper by the editors and the three reviewers and the suggestions on how to improve the study. Here we outline how we will address the reviewers’ concerns and suggestions in a planned revision of our manuscript.

      Reviewer #1 listed two primary weaknesses:

      (1) the need for discussion of the extent to which the cell line we used resembles CRH neurons and

      (2) that we did not test for the effect of blockade of the glucocorticoid receptor.

      (1) As the reviewer acknowledges, our experiments called for the use of a cell line to dissect intracellular trafficking of the α1 adrenoreceptor. We selected the N42 cell line for this purpose because it is an immortalized hypothalamic cell line (developed by Belsham and colleagues, Belsham et al., 2004) that expresses CRH. We have used this cell line successfully in the past to study transcriptional and rapid non-genomic actions of glucocorticoids, which indicated that, in addition to expressing CRH, these cells also express both the nuclear glucocorticoid receptor and a membrane-associated receptor that binds glucocorticoids (Rainville et al., 2019; Weiss et al., 2019). We believe that this hypothalamic cell line is the most closely related to native PVN CRH neurons of any cell line available. As requested, we will add to the Discussion of the manuscript to further justify our choice of cells.

      (2) We agree that this experiment should be performed. We will test the classical GR (and progesterone) antagonist RU486 (mifepristone) for its effect on the cort regulation of α1 adrenoreceptor trafficking. Our ex vivo electrophysiology studies have indicated that the rapid glucocorticoid effect in native hypothalamic CRH neurons is not blocked by RU486 and is not, therefore, dependent on activation of the classical nuclear GR (Di et al., 2003; Di et al., 2016).

      Reviewer #2 also listed two main weaknesses of the study:

      (1) that we did not test whether the adrenoreceptor desensitization by restraint stress generalizes to other stress modalities and might be more robust with a pure somatic stressor, and

      (2) the lack of identification of a target protein as a mechanism for the role of nitrosylation.

      (1) We used restraint stress as a means to elicit corticosterone release, which desensitized the HPA response to a NE-dependent somatic stressor (lipopolysaccharide injection) but not to a NEindependent psychological stressor (predator odor) (Jiang et al., 2021). We got a near-complete loss of the sensitivity of CRH neurons to NE with restraint (i.e., near ceiling effect), such that a different stressor, including a more purely somatic stressor, should not increase the Cort-induced desensitization further. For that reason, we would argue that testing other stressors would not add value to the current study. That said, we plan and have received new funding to test in the future whether the Cort desensitization of the HPA response to LPS stress generalizes to other somatic stressors. We also have future plans to test for the Cort desensitization of other Gq-coupled receptors.

      (2) We agree that finding the molecular target of nitrosylation as the mechanism for Cort desensitization of α1 adrenoreceptors would significant improve the study, but this is a potentially enormous undertaking as it will require the screening and validation of multiple proteins involved in protein trafficking to find the one(s) targeted for nitrosylation by Cort. We tested β-arrestin as a possible target in the paper, but did not find Cort to regulate β-arrestin nitrosylation. We plan to undertake a general nitrosylation screen of proteins to identify multiple possible targets, but prefer to defer this and the validation of possible targets to a future, more thorough analysis.

      Reviewer #3 also pointed out two main weaknesses of our study:

      (1) that the glucocorticoidnitrosylation link was confusing, and

      (2) that it was unclear how blocking α1 adrenoreceptors reversed the Cort-induced cytosolic accumulation of the receptor.

      We appreciate the reviewer pointing out these deficiencies in our interpretation and explanation of our findings. We plan to address them directly in the revised version of the paper. 

      References

      Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AMF, Shkreta L (2004) Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 145:393–400.

      Weiss GL, Rainville JR, Zhao Q, Tasker JG (2019) Purity and stability of the membrane-limited glucocorticoid receptor agonist dexamethasone-BSA. Steroids 142:2-5. 

      Rainville JR, Weiss GL, Evanson N, Herman JP, Vasudevan N, Tasker JG (2019) Membrane-initiated nuclear trafficking of the glucocorticoid receptor in hypothalamic neurons. Steroids 142:55-64.

      Di S, Malcher-Lopes R, Halmos KCs, Tasker JG (2003) Non-genomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. Journal of Neuroscience 23:4850-4857.

      Di S, Itoga CA, Fisher MO, Solomonow J, Roltsch EA, Gilpin NW, Tasker JG (2016) Acute stress suppresses inhibition and increases anxiety via endocannabinoid release in the basolateral amygdala. Journal of Neuroscience 36:8461-8470.

      Jiang Z, Chen C, Weiss GL, Fu X, Stelly CE, Sweeten BLW, Tirrell PS, Pursell I, Stevens CR, Fisher MO, Begley JC, Harrison LM, Tasker JG (2022) Stress-induced glucocorticoid desensitizes adrenoreceptors to gate the neuroendocrine response to somatic stress in male mice. Cell Reports 41(3):111509.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      "Neural noise", here operationalized as an imbalance between excitatory and inhibitory neural activity, has been posited as a core cause of developmental dyslexia, a prevalent learning disability that impacts reading accuracy and fluency. This study is the first to systematically evaluate the neural noise hypothesis of dyslexia. Neural noise was measured using neurophysiological (electroencephalography [EEG]) and neurochemical (magnetic resonance spectroscopy [MRS]) in adolescents and young adults with and without dyslexia. The authors did not find evidence of elevated neural noise in the dyslexia group from EEG or MRS measures, and Bayes factors generally informed against including the grouping factor in the models. Although the comparisons between groups with and without dyslexia did not support the neural noise hypothesis, a mediation model that quantified phonological processing and reading abilities continuously revealed that EEG beta power in the left superior temporal sulcus was positively associated with reading ability via phonological awareness. This finding lends support for analysis of associations between neural excitatory/inhibitory factors and reading ability along a continuum, rather than as with a case/control approach, and indicates the relevance of phonological awareness as an intermediate trait that may provide a more proximal link between neurobiology and reading ability. Further research is needed across developmental stages and over a broader set of brain regions to more comprehensively assess the neural noise hypothesis of dyslexia, and alternative neurobiological mechanisms of this disorder should be explored.

      Strengths:

      The inclusion of multiple methods of assessing neural noise (neurophysiological and neurochemical) is a major advantage of this paper. MRS at 7T confers an advantage of more accurately distinguishing and quantifying glutamate, which is a primary target of this study. In addition, the subject-specific functional localization of the MRS acquisition is an innovative approach. MRS acquisition and processing details are noted in the supplementary materials according to the experts' consensus-recommended checklist (https://doi.org/10.1002/nbm.4484). Commenting on the rigor, the EEG methods is beyond my expertise as a reviewer.

      Participants recruited for this study included those with a clinical diagnosis of dyslexia, which strengthens confidence in the accuracy of the diagnosis. The assessment of reading and language abilities during the study further confirms the persistently poorer performance of the dyslexia group compared to the control group.

      The correlational analysis and mediation analysis provide complementary information to the main case-control analyses, and the examination of associations between EEG and MRS measures of neural noise is novel and interesting.

      The authors follow good practice for open science, including data and code sharing. They also apply statistical rigor, using Bayes Factors to support conclusions of null evidence rather than relying only on non-significant findings. In the discussion, they acknowledge the limitations and generalizability of the evidence and provide directions for future research on this topic.

      Weaknesses:

      Though the methods employed in the paper are generally strong, there are certain aspects that are not clearly described in the Materials & Methods section, such as a description of the statistical analyses used for hypothesis testing.

      Thank you for pointing this out. A description of the statistical models used in the analyses of EEG biomarkers has been added to the Materials and Methods:

      “First, exponent and offset values were averaged across all electrodes and analyzed using a 2x2 repeated measures ANOVA with group (dyslexic, control) as a between-subjects factor and condition (resting state, language task) as a within-subjects factor. Age was included in the analyses as a covariate due to the correlation between variables. Next, exponent and offset values were averaged across electrodes corresponding to the left (F7, FT7, FC5) and right inferior frontal gyrus (F8, FT8, FC6), and to the left (T7, TP7, TP9) and right superior temporal sulcus (T8, TP8, TP10). The electrodes were selected based on the analyses outlined by Giacometti and colleagues (2014) and Scrivener and Reader (2022). For these analyses, a 2x2x2x2 repeated measures ANOVA with age as a covariate was conducted with group (dyslexic, control) as a between-subjects factor and condition (resting state, language task), hemisphere (left, right), and region (frontal, temporal) as within-subjects factors. Results for the alpha and beta bands were calculated for the same clusters of frontal and temporal electrodes and analyzed with a similar 2x2x2x2 repeated measures ANOVA; however, for these analyses, age was not included as a covariate due to a lack of significant correlations.”

      We also expanded the description of the statistical models used in the analyses of MRS biomarkers:

      “To analyze the metabolite results, separate univariate ANCOVAs were conducted for Glu, GABA+, Glu/GABA+ ratio and Glu/GABA+ imbalance measures with group (control, dyslexic) as a between-subjects factor and voxel gray matter volume (GMV) as a covariate. Additionally, for the Glu analysis, age was included as a covariate due to a correlation between variables. Both frequentist and Bayesian statistics were calculated. Glu/GABA+ imbalance measure was calculated as the square root of the absolute residual value of a linear relationship between Glu and GABA+ (McKeon et al., 2024).”

      With regard to metabolite quantification, it is unclear why the authors chose to analyze and report metabolite values in terms of creatine ratios rather than quantification based on a water reference given that the MRS acquisition appears to support using a water reference.

      We have decided to use the ratio of Glu and GABA to total creatine (tCr), as this is still a common practice in MRS studies at 7T (e.g., Nandi et al., 2022; Smith et al., 2021). This approach normalizes the signal, reducing the impact of intensity variations across different regions and tissue compositions. Additionally, total creatine concentration is considered relatively stable across different brain regions, which is particularly important in our study, where a functional localizer was used to establish the left STS region individually. Our decision was further influenced by previous studies on dyslexia (Del Tufo et al., 2018; Pugh et al., 2014) which have reported creatine ratios and included GM volume as a covariate in their models, thus providing comparability. It is now indicated in the Results:

      “For comparability with previous studies in dyslexia (Del Tufo et al., 2018; Pugh et al., 2014) we report Glu and GABA as a ratio to total creatine (tCr).”

      and in the Method sections:

      “Glu and GABA+ concentrations were expressed as a ratio to total-creatine (tCr; Creatine + Phosphocreatine) following previous MRS studies in dyslexia (Del Tufo et al., 2018; Pugh et al., 2014).

      We did not estimate absolute concentrations using water signals as a reference, as this would require accounting for water relaxation times, which may vary across our age range. Nevertheless, our dataset has been made publicly available for future researchers to calculate and compare absolute values.

      Del Tufo, S. N., Frost, S. J., Hoeft, F., Cutting, L. E., Molfese, P. J., Mason, G. F., Rothman, D. L., Fulbright, R. K., & Pugh, K. R. (2018). Neurochemistry Predicts Convergence of Written and Spoken Language: A Proton Magnetic Resonance Spectroscopy Study of Cross-Modal Language Integration. Frontiers in Psychology, 9, 1507. https://doi.org/10.3389/fpsyg.2018.01507

      Nandi, T., Puonti, O., Clarke, W. T., Nettekoven, C., Barron, H. C., Kolasinski, J., Hanayik, T., Hinson, E. L., Berrington, A., Bachtiar, V., Johnstone, A., Winkler, A. M., Thielscher, A., Johansen-Berg, H., & Stagg, C. J. (2022). tDCS induced GABA change is associated with the simulated electric field in M1, an effect mediated by grey matter volume in the MRS voxel. Brain Stimulation, 15(5), 1153–1162. https://doi.org/10.1016/j.brs.2022.07.049

      Pugh, K. R., Frost, S. J., Rothman, D. L., Hoeft, F., Del Tufo, S. N., Mason, G. F., Molfese, P. J., Mencl, W. E., Grigorenko, E. L., Landi, N., Preston, J. L., Jacobsen, L., Seidenberg, M. S., & Fulbright, R. K. (2014). Glutamate and choline levels predict individual differences in reading ability in emergent readers. Journal of Neuroscience, 34(11), 4082–4089. https://doi.org/10.1523/JNEUROSCI.3907-13.2014

      Smith, G. S., Oeltzschner, G., Gould, N. F., Leoutsakos, J. S., Nassery, N., Joo, J. H., Kraut, M. A., Edden, R. A. E., Barker, P. B., Wijtenburg, S. A., Rowland, L. M., & Workman, C. I. (2021). Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T. Journal of Affective Disorders, 279, 417–425. https://doi.org/10.1016/j.jad.2020.10.011

      GABA is typically quantified using J-editing sequences as lower field strengths (~3T), and there is some evidence that the GABA signal can be reliably measured at 7T without editing, however, the authors should discuss potential limitations, such as reliability of Glu and GABA measurements with short-TE semi-laser at 7T.

      In addition, MRS measurements of GABA are known to be influenced by macromolecules, and GABA is often denoted as GABA+ to indicate that other compounds contribute to the measured signal, especially at a short TE and in the absence of symmetric spectral editing.

      A general discussion of the strengths and limitations of unedited Glu and GABA quantification at 7T is warranted given the interest of this work to researchers who may not be experts in MRS.

      While we agree with the Reviewer that at 3T, it is recommended to use J-edited MRS to measure GABA (Mullins et al., 2014), the better spectral resolution at 7T allows for more reliable results for both metabolites using moderate echo-time, non-edited MRS (Finkelman et al., 2022). In this study, we used a short echo time (TE), which is optimal for Glu but not ideal for GABA, as it interferes with other signals. We are grateful to the Reviewer for suggesting the addition of a short paragraph to the Discussion, describing the practicalities of 3T and 7T MRS and changing the abbreviation to GABA+ to inform readers of possible macromolecule contamination:

      “We chose ultra-high-field MRS to improve data quality (Özütemiz et al., 2023), as the increased sensitivity and spectral resolution at 7T allows for better separation of overlapping metabolites compared to lower field strengths. Additionally, 7T provides a higher signal-to-noise ratio (SNR), improving the reliability of metabolite measurements and enabling the detection of small changes in Glu and GABA concentrations. Despite these theoretical advantages, several practical obstacles should be considered, such as susceptibility artifacts and inhomogeneities at higher field strengths that can impact data quality. Interestingly, actual methodological comparisons (Pradhan et al., 2015; Terpstra et al., 2016) show only a slight practical advantage of 7T single-voxel MRS compared to optimized 3T acquisition. For example, fitting quality yielded reduced estimates of variance in concentration of Glu in 7T (CRLB) and slightly improved reproducibility levels for Glu and GABA (at both fields below 5%). Choosing the appropriate MRS sequence involves a trade-off between the accuracy of Glu and GABA measurements, as different sequences are recommended for each metabolite. J-edited MRS is recommended for measuring GABA, particularly with 3T scanners (Mullins et al., 2014). However, at 7T, more reliable results can be obtained using moderate echo-time, non-edited MRS (Finkelman et al., 2022). We have opted for a short-echo-time sequence, which is optimal for measuring Glu. However, this approach results in macromolecule contamination of the GABA signal (referred to as GABA+).”

      Finkelman, T., Furman-Haran, E., Paz, R., & Tal, A. (2022). Quantifying the excitatory-inhibitory balance: A comparison of SemiLASER and MEGA-SemiLASER for simultaneously measuring GABA and glutamate at 7T. NeuroImage, 247, 118810. https://doi.org/10.1016/j.neuroimage.2021.118810

      Mullins, P. G., McGonigle, D. J., O'Gorman, R. L., Puts, N. A., Vidyasagar, R., Evans, C. J., Cardiff Symposium on MRS of GABA, & Edden, R. A. (2014). Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. NeuroImage, 86, 43–52. https://doi.org/10.1016/j.neuroimage.2012.12.004

      Özütemiz, C., White, M., Elvendahl, W., Eryaman, Y., Marjańska, M., Metzger, G. J., Patriat, R., Kulesa, J., Harel, N., Watanabe, Y., Grant, A., Genovese, G., & Cayci, Z. (2023). Use of a Commercial 7-T MRI Scanner for Clinical Brain Imaging: Indications, Protocols, Challenges, and Solutions-A Single-Center Experience. AJR. American Journal of Roentgenology, 221(6), 788–804. https://doi.org/10.2214/AJR.23.29342

      Pradhan, S., Bonekamp, S., Gillen, J. S., Rowland, L. M., Wijtenburg, S. A., Edden, R. A., & Barker, P. B. (2015). Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. Magnetic Resonance Imaging, 33(8), 1013–1018. https://doi.org/10.1016/j.mri.2015.06.003

      Terpstra, M., Cheong, I., Lyu, T., Deelchand, D. K., Emir, U. E., Bednařík, P., Eberly, L. E., & Öz, G. (2016). Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T. Magnetic Resonance in Medicine, 76(4), 1083–1091. https://doi.org/10.1002/mrm.26022

      Further, the single MRS voxel location is a limitation of the study as neurochemistry can vary regionally within individuals, and the putative excitatory/inhibitory imbalance in dyslexia may appear in regions outside the left temporal cortex (e.g., network-wide or in frontal regions involved in top-down executive processes). While the functional localization of the MRS voxel is a novelty and a potential advantage, it is unclear whether voxel placement based on left-lateralized reading-related neural activity may bias the experiment to be more sensitive to small, activity-related fluctuations in neurotransmitters in the CON group vs. the DYS group who may have developed an altered, compensatory reading strategy.

      We agree that including only one region of interest for the MRS measurements is a potential limitation of our study, and we have now added this information to the Discussion:

      “Moreover, since the MRS data was collected only from the left STS, it is plausible that other areas might be associated with differences in Glu or GABA concentrations in dyslexia.”

      However, differences in Glu and GABA concentrations in this region were directly predicted by the neural noise hypothesis of dyslexia. We acknowledge that this information was missing in the previous version of the manuscript. It is now included in the Results:

      “Moreover, the neural noise hypothesis of dyslexia identifies perisylvian areas as being affected by increased glutamatergic signaling, and directly predicts associations between Glu and GABA levels in the superior temporal regions and phonological skills (Hancock et al., 2017).”

      as well as in the Discussion:

      “Nevertheless, the neural noise hypothesis predicted increased glutamatergic signaling in perisylvian regions, specifically in the left superior temporal cortex (Hancock et al., 2017).”

      Figure 1 contains a lot of information, and it may be helpful to split it into 2 figures (EEG vs. MRS) so that the plots could be made larger and the reader could more easily digest the information.

      (a) I would also recommend displaying separate metabolite fit plots for each group, since the current presentation in panel F makes it appear that the MRS data is examined by testing differences between groups across the full spectrum (where the lines diverge), which really isn't the case.

      (b) The GABA peak is not visible in the spectrum, and Glutamate and GABA both have multiple peaks that should be shown on the spectrum. This may be best achieved by displaying the individual metabolite sub-spectra below the full spectrum

      Thank you for these suggestions. We have split the information into two Figures following the Reviewer’s recommendations.

      It is not clear why the 3T structural images were used for segmentation and calculation of tissue fraction if 7T structural images were also acquired (which would presumably have higher resolution).

      Generally, T1-weighted images from the 7T scanner exhibit more artifacts than those from the 3T scanner due to higher magnetic field inhomogeneity. These artifacts are especially pronounced in regions near air-tissue interfaces, such as the temporal lobes. Therefore, we chose the 3T structural images for segmentation and tissue fraction calculations and clarified this in the Method section:

      “Voxel segmentation was performed on structural images from a 3T scanner, coregistered to 7T structural images in SPM12, as the latter exhibited excessive artifacts and intensity bias in the temporal regions”.

      The basis set includes a large number of metabolites (27), including many low-concentration metabolites/compounds (e.g., bHG, bHB, Citrate, Threonine, ethanol) that are typically only included in studies targeting specific metabolites in disease/pathology. Please justify the inclusion of this maximal set of metabolites in the basis set, given that the inclusion of overlapping low-concentration metabolites may influence metabolite measurements of interest (https://doi.org/10.1002/mrm.10246).

      There is still no consensus in the MR community on which metabolites should be included in the model of human cerebral 1H-MR spectra. Typically, only major contributors such as NAA, Cr, Cho, Lac, mI, and possibly Glx are evaluated. Some studies also include additional metabolites like Ace, Ala, Asp, GABA, Glc, Gly, sI, NAAG, and Tau. In this study, as in a few others, further metabolites such as PCh, GPC, PCr, GSH, PE, and Thr were introduced and this approach seems suitable for high-field spectra (Hofmann et al., 2002).

      Hofmann, L., Slotboom, J., Jung, B., Maloca, P., Boesch, C., & Kreis, R. (2002). Quantitative 1H-magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model-fitting. Magnetic Resonance in Medicine, 48(3), 440–453. https://doi.org/10.1002/mrm.10246

      Please provide a figure indicating the localization of the MRS voxel for a sample subject.

      A figure indicating the localization of the MRS voxel for a sample subject was added to the MRS checklist.

      It would be helpful to include Table S1 in the main article.

      Table S1 from the Supplementary Material has now been added to the main manuscript as Table 1 in the Results section.

      Please report descriptive statistics for EEG and MRS measures in Table S1.

      We have added a new Table S1 in the Supplementary Material, providing descriptive statistics for EEG and MRS E/I balance measures, presented separately for the dyslexic and control groups.

      I recommend avoiding using the terms "direct" and "indirect" to contrast MRS and EEG measures of E/I balance. Both of these measures are imperfect and it is misleading to say that MRS is a "direct" measure of neurotransmitters. There is also ambiguity in what is meant by "direct": in contrast to EEG, MRS does not measure neural activity and does not provide high-resolution temporal information, so in a sense, it is less direct.

      Thank you for this suggestion. We have replaced the terms 'direct' and 'indirect' biomarkers with 'MRS' and 'EEG' biomarkers throughout the text.

      There are many cases throughout the results in which Bayes and frequentist stats seem to contradict each other in terms of significance and what should be included in the models, especially with regard to the interaction effects (the Bayes factors appear to favor non-significant interactions). I think this is worth considering and describing to offer more clarity for the readers.

      We agree that a discussion of the divergent results between Bayesian and frequentist models was missing in the previous version of the manuscript. To provide greater clarity for the readers, we have conducted follow-up Bayesian t-tests in every case where the results indicated the inclusion of non-significant interactions with the effect of group in the model. These additional analyses have been performed for the exponent, offset, as well as for beta bandwidth in the Supplementary Material. We have also added a paragraph addressing these discrepancies in the Discussion:

      “Remarkably, in some models, results from Bayesian and frequentist statistics yielded divergent conclusions regarding the inclusion of non-significant effects. This was observed in more complex ANOVA models, whereas no such discrepancies appeared in t-tests or correlations. Given reports of high variability in Bayesian ANOVA estimates across repeated runs of the same analysis (Pfister, 2021), these results should be interpreted with caution. Therefore, following the recommendation to simplify complex models into Bayesian t-tests for more reliable estimates (Pfister, 2021), we conducted follow-up Bayesian t-tests in every case that favored the inclusion of non-significant interactions with the group factor. These analyses provided further evidence for the lack of differences between the dyslexic and control groups. Another source of discrepancy between the two methods may stem from the inclusion of interactions between covariates and within-subject effects in frequentist ANOVA, which were not included in Bayesian ANOVA to adhere to the recommendation for simpler Bayesian models (Pfister, 2021).”

      Pfister, R. (2021). Variability of Bayes factor estimates in Bayesian analysis of variance. The Quantitative Methods for Psychology, 17(1), 40-45. doi:10.20982/tqmp.17.1.p040

      It would be helpful to indicate whether participants in the DYS group had a history of reading intervention/remediation. In addition to showing that the DYS group performed lower than the CON group on reading assessments as a whole and given their age, was the performance on the reading assessments at an individual level considered for inclusion in the study? (i.e., were participants' persistent poor reading abilities confirmed with the research assessments?)

      We were unable to assess individual reading skills due to the lack of standardized diagnostic norms for adult dyslexia in Poland. Therefore, participants in the dyslexic group were recruited based on a previous clinical diagnosis of dyslexia, and reading and reading-related tasks were used for group-level comparisons only. This information has been added to the Methods section:

      “Since there are no standardized diagnostic norms for dyslexia in adults in Poland, individuals were assigned to the dyslexic group based on a past diagnosis of dyslexia.”

      Unfortunately, we did not collect information about participants' history of reading intervention or remediation. In this context, we acknowledge that including a sample of adult participants is a potential limitation of our study, however, this was already mentioned in the Discussion.

      Regarding the fMRI task, please indicate whether the participants whose threshold and/or contrast was changed for localization were from the DYS or CON group.

      This information is now added to the Method section:

      “For 6 participants (DYS n = 2, CON n = 4), the threshold was lowered to p < .05 uncorrected, while for another 6 participants (DYS n = 3, CON n = 3) the contrast from the auditory run was changed to auditory words versus fixation cross due to a lack of activation for other contrasts.”

      Reviewer #2 (Public Review):

      Summary:

      This study utilized two complementary techniques (EEG and 7T MRI/MRS) to directly test a theory of dyslexia: the neural noise hypothesis. The authors report finding no evidence to support an excitatory/inhibitory balance, as quantified by beta in EEG and Glutamate/GABA ratio in MRS. This is important work and speaks to one potential mechanism by which increased neural noise may occur in dyslexia.

      Strengths:

      This is a well-conceived study with in-depth analyses and publicly available data for independent review. The authors provide transparency with their statistics and display the raw data points along with the averages in figures for review and interpretation. The data suggest that an E/I balance issue may not underlie deficits in dyslexia and is a meaningful and needed test of a possible mechanism for increased neural noise.

      Weaknesses:

      The researchers did not include a visual print task in the EEG task, which limits analysis of reading-specific regions such as the visual word form area, which is a commonly hypoactivated region in dyslexia. This region is a common one of interest in dyslexia, yet the researchers measured the I/E balance in only one region of interest, specific to the language network.

      We agree with the Reviewer that including different tasks for the EEG biomarkers assessment would be valuable. However, this limitation was already addressed in the Discussion:

      “Importantly, our study focused on adolescents and young adults, and the EEG recordings were conducted during rest and a spoken language task. These factors may limit the generalizability of our results. Future research should include younger populations and incorporate a broader array of tasks, such as reading and phonological processing, to provide a more comprehensive evaluation of the E/I balance hypothesis.”

      Further, this work does not consider prior studies reporting neural inconsistency; a potential consequence of increased neural noise, which has been reported in several studies and linked with candidate-dyslexia gene variants (e.g., Centanni et al., 2018, 2022; Hornickel & Kraus, 2013; Neef et al., 2017). While E/I imbalance may not be a cause of increased neural noise, other potential mechanisms remain and should be discussed.

      Thank you for referring us to other works reporting neural variability in dyslexia. We agree that a broader context regarding sources of reduced neural synchronization, beyond E/I imbalance, was missing in the previous version of the manuscript. We have now included these references in the Discussion:

      “Furthermore, although our results do not support the idea of E/I balance alterations as a source of neural noise in dyslexia, they do not preclude other mechanisms leading to less synchronous neural firing posited by the hypothesis. In this context, there is evidence showing increased trial-to-trial inconsistency of neural responses in individuals with dyslexia (Centanni et al., 2022) or poor readers (Hornickel and Kraus, 2013) and its associations with specific dyslexia risk genes (Centanni et al., 2018; Neef et al., 2017). At the same time, the observed trial-to-trial inconsistency was either present only in a subset of participants (Centanni et al., 2018), limited to some experimental conditions (Centanni et al., 2022), or specific brain regions – e.g., brainstem in Hornickel and Kraus (2013), left auditory cortex in Centanni et al. (2018), or left supramarginal gyrus in Centanni et al. (2022).”

      A better description of the exponent and offset components is needed at the beginning of the results, given that the methods are presented in detail at the end. I also do not see a clear description of these components in the methods.

      A description of the aperiodic components is now included in the Results:

      “In the initial step of the analysis, we analyzed the aperiodic (exponent and offset) components of the EEG spectrum. The exponent reflects the steepness of the EEG power spectrum, with a higher exponent indicating a steeper signal; while the offset represents a uniform shift in power across frequencies, with a higher offset indicating greater power across the entire EEG spectrum (Donoghue et al., 2020).”

      as well as in the Materials and Methods:

      “Two broadband aperiodic parameters were extracted: the exponent, which quantifies the steepness of the EEG power spectrum, and the offset, which indicates signal’s power across the entire frequency spectrum.”

      Reviewer #3 (Public Review):

      Summary:

      This study by Glica and colleagues utilized EEG (i.e., Beta power, Gamma power, and aperiodic activity) and 7T MRS (i.e., MRS IE ratio, IE balance) to reevaluate the neural noise hypothesis in Dyslexia. Supported by Bayesian statistics, their results show solid 'no evidence' of EI balance differences between groups, challenging the neural noise hypothesis. The work will be of broad interest to neuroscientists, and educational and clinical psychologists.

      Strengths:

      Combining EEG and 7T MRS, this study utilized both the indirect (i.e., Beta power, Gamma power, and aperiodic activity) and direct (i.e., MRS IE ratio, IE balance) measures to reevaluate the neural noise hypothesis in Dyslexia.

      Weaknesses:

      The authors may need to provide more data to assess the quality of the MRS data.

      We have addressed the following specific recommendations of the Reviewer providing more data about the quality of the MRS data.

      The authors may need to explain how the number of subjects is determined in the MRS section.

      We have clarified the MRS sample description in the Results section:

      “Due to financial and logistical constraints, 59 out of the 120 recruited subjects, selected progressively as the study unfolded, were examined with MRS. Subjects were matched by age and sex between the dyslexic and control groups. Due to technical issues and to prevent delays and discomfort for the participants, we collected 54 complete sessions. Additionally, four datasets were excluded based on our quality control criteria, and three GABA+ estimates exceeded the selected CRLB threshold. Ultimately, we report 50 estimates for Glu (21 participants with dyslexia) and 47 for GABA+ and Glu/GABA+ ratios (20 participants with dyslexia).”

      Is there a reason why theta and gamma peaks were not observed in the majority of participants? What are the possible reasons that likely caused the discrepancy between this study and previously reported relevant studies?

      We have now added a discussion about the absence of oscillatory peaks in the theta and gamma bands to the Discussion section:

      “We could not perform analyses for the gamma oscillations since in the majority of participants the gamma peak was not detected above the aperiodic component. Due to the 1/f properties of the EEG spectrum, both aperiodic and periodic components should be disentangled to analyze ‘true’ gamma oscillations; however, this approach is not typically recognized in electrophysiology research (Hudson and Jones, 2022). Indeed, previous studies that analyzed gamma activity in dyslexia (Babiloni et al., 2012; Lasnick et al., 2023; Rufener and Zaehle, 2021) did not separate the background aperiodic activity. For the same reason, we could not analyze results for the theta band, which often does not meet the criteria for an oscillatory component manifested as a peak in the power spectrum (Klimesch, 1999). Moreover, results from a study investigating developmental changes in both periodic and aperiodic components suggest that theta oscillations in older participants are mostly observed in frontal midline electrodes (Cellier et al., 2021), which were not analyzed in the current study.”

      Hudson, M. R., & Jones, N. C. (2022). Deciphering the code: Identifying true gamma neural oscillations. Experimental Neurology357, 114205. https://doi.org/10.1016/j.expneurol.2022.114205

      Klimesch, W. (1999). EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Research Reviews29(2-3), 169-195. https://doi.org/10.1016/S0165-0173(98)00056-3

      Based on Figure 1F, the quality of the MRS data may be contaminated by the lipid signal, especially for the DYS group. To better evaluate the MRS data, especially the GABA measurements, the authors need to show:

      (a) the placement of the MRS voxel on the anatomical images;

      Averaged MRS voxel placement was already presented in Figure 1 (now Figure 2) in the manuscript. Now, we have also added exemplary single-subject images to the MRS checklist in the Supplement.

      (b) Glu and GABA model functions

      We have now provided more meaningful Glu and GABA indications in Figure 2.

      (c) CRLB for GABA

      We have added respective estimates to the Supplement:

      %CRLB of Glu: mean 2.96, SD = 0.79

      %CRLB of GABA: mean 10.59, SD = 2.76

      %CRLB of NAA: 1.76 SD = 0.46

      Further, the authors added voxel's gray matter volume as a covariate when performing separate ANCOVAs. The authors may need to use alpha correction or 1-fCSF correction to corroborate these results.

      We chose to use the ratio of Glu and GABA to total creatine (tCr), as this remains a common practice in MRS studies at 7T (e.g., Nandi et al., 2022; Smith et al., 2021). This decision was also influenced by previous dyslexia studies (Del Tufo et al., 2018; Pugh et al., 2014) and is now clarified in the Results and Methods sections.

      Regarding alpha correction, a recent paper (García-Pérez et al., 2023) recommends: 'In general, avoid corrections for multiple testing if statistical claims are to be made for each individual test, in the absence of an omnibus null hypothesis.' Since we report null findings, further alpha correction would not significantly impact the results.

      García-Pérez, M. A. (2023). Use and misuse of corrections for multiple testing. Methods in Psychology8, 100120. https://doi.org/10.1016/j.metip.2023.100120

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public Review):

      This publication applies 3D super-resolution STORM imaging to understanding the role of developmental neural activity in the clustering of retinal inputs to the mouse dorsal lateral geniculate nucleus (dLGN). The authors argue that retinal ganglion cell (RGC) synaptic boutons start forming clusters early in postnatal development (P2). They then argue that these clusters contribute to eye-specific segregation of retinal inputs by activity-dependent stabilization of nearby boutons from the same eye. The data provided is N=3 animals for each condition of P2, P4, and P8 animals in wild-type mice and in mice where early patterns of structured retinal activity are blocked.

      Strengths:

      The 3D storm imaging of pre and postsynaptic elements provides convincing high-resolution localization of synapses.

      The experimental design of comparing ipsilateral and contralateral RGC axon boutons in a region of the dLGN that is known to become contralateral is elegant. The design makes it possible to relate fixed time point structural data to a known outcome of activity-dependent remodeling.

      Weaknesses:

      Based on previous literature, it is known that synapse density, synapse clustering, and synaptic specificity increase during postnatal development. Previous work has also shown that both the changes in synaptic clustering and synaptic specificity are affected by retinal activity. The data and analysis provided by the authors add little unambiguous evidence that advances this understanding.

      We agree with the reviewer that previous literature shows that synapse density, synapse clustering, and synaptic specificity increase during postnatal development and that these processes are affected by retinal activity. The majority of studies on synaptic refinement have been performed after eye-opening, when eye-specific segregation is already complete. In contrast, most studies of eye-specific segregation focus on axonal refinement phenotypes. To our knowledge, only a small number of experiments have examined retinogeniculate synaptic properties at the nanoscale during eye-specific segregation (1-4). Our broad goal is to understand the mechanisms of synaptogenesis and competition at the earliest stages of eye-specific refinement, when spontaneous retinal activity is a major driver of activity-dependent remodeling. We hope that readers will appreciate that there is still much to discover in this fascinating model system of synaptic competition.

      General problem 1: Most of the statistical analysis is limited to ANOVA comparison of axons from the contralateral and ipsilateral retina in the contralateral dLGN. The hypothesis that ipsilateral and contralateral axons would be statistically identical in the contralateral dLGN is not a plausible hypothesis so rejecting the hypothesis with P < X does not advance the authors' arguments beyond what was already known.

      General problem 2: Most of the interpretation of data is qualitative. While error bars are provided, these error bars are not used to draw conclusions. Given the small sample size (N=3), there is a large degree of uncertainty regarding the magnitude of changes (synapse size, number, specificity). The authors base their conclusions on the averages of these values when the likely degree of uncertainty could allow for the opposite interpretation.

      We appreciate the reviewer’s concerns regarding the use of ANOVA for statistical testing in the original submission. We have generated new figures that show confidence intervals for each analysis in the manuscript and these are included in the response to reviewers document below. To address the underlying concern that our N=3 sample size limits the interpretation of our results, we have revised the manuscript to be cautious in our interpretations and to discuss additional possibilities that are consistent with the anatomical data.

      General problem 3: Two of the four results sections depend on using the frequency of single active zone vGlut2 clusters near multiple active zone vGlut2 as a proxy for synaptic stabilization of the single active zone vGlut2 clusters by the multiple active zone vGlut2 clusters. The authors argue that the increased frequency of same-eye single active zone clusters relative to opposite-eye single active zone clusters means that multiple active zone vGlut2 clusters are selectively stabilizing single active zone clusters. There are other plausible explanations for this observation that are not eliminated. An increased frequency of nearby single active zone clusters would also occur if RGC axons form more than one synapse in the dLGN. Eye-specific segregation is, by definition, a relative increase in the frequency of nearby boutons from the same eye. The authors were, therefore, guaranteed to observe a non-random relationship between boutons from the same eye. The authors do compare their measures to a random model, but I could not find a description of the model. I would expect that the model would need to account for RGC arbor size, arbor structure, bouton number, and segregation independent of multi-active-zone vGlut2 clusters. The most common randomization for the type of analysis described here, a shift in the positions of single-active zone boutons, would not be adequate.<br /> In discussing the claimed cluster-induced stabilization of nearby boutons, the authors state that the specificity increases with age due to activity-dependent refinement. Their quantification does not support an increase in specificity with age. In fact, the high degree of clustering "specificity" they observe at P2 argues for the trivial same axon explanation.

      We agree with the reviewer that individual RGC axons form multiple synapses and that, over time, eye-specific segregation must increase the frequency of like-eye synapses relative to opposite-eye synapses. Indeed, our previous study of eye-specific refinement showed that at P8, the density of eye-specific inputs had increased for the dominant-eye and decreased for the non-dominant-eye (1). However, at postnatal day 4, contralateral and ipsilateral input densities were the same in the future contralateral-eye territory. One of our goals in this study was to determine if the process of synaptic clustering begins at these earliest stages of synaptic competition and, if so, whether it is influenced by retinal wave activity. It is plausible that the RGC axons from the same eye could initially form synapses randomly and, at some later stage, synapses may be selectively added to produce mature glomeruli. Consistent with this possibility, previous analysis of JAM-B RGC axon refinement showed the progressive clustering of axonal boutons at later stages of development after eye-specific segregation (5).

      Regarding the randomization that we employed, we performed a repositioning of synapse centroids within the volume of the neuropil after accounting for neuronal soma volumes and edge effects. We agree that this type of randomization cannot account for the fine scale structure of axons and dendrites, which we did not have access to in this four-color volumetric super-resolution data set. To address this, we have performed additional clustering analyses surrounding both single-active zone and multi-active zone synapses. This new analysis showed that there is a modest clustering effect around single-active zone synapses compared to complete randomization described above. We now present this information using a normalized clustering index for direct comparison of clustering between multi-active zone and single-active zone synapses. We have measured effect sizes and confidence intervals, which we present in point-by-point responses below. We have restructured the manuscript figures and discussion to provide a balanced interpretation of our results and the limitations of our study.

      Analysis of specific claims:

      Result Section 1

      Most of the figures show mean, error bars, and asterisks, but not the three data points from which these statistics are derived. Large changes in variance from condition to condition suggest that displaying the data points would provide more useful information.

      We thank the reviewer for their suggestion. We have updated all figures to display the means of all biological replicates as individual data points.

      Claim 1: Contralateral density increases more than ipsilateral in the contralateral region over the course of development. This claim is supported by the qualitative comparison of means and error bars in Figure 2D. The argument could be made quantitative by providing a confidence interval for synapse density increase for dominant and non-dominant synapse density. A confidence interval could then be generated for the difference in this change between the two groups. Currently, the most striking effect is a big difference in variance between P4 and P8 for dominant eye complex synapses. Given that N=3, I assume there is one extreme outlier here.

      We appreciate the comment and believe the reviewer was referring to the data presented in the original Figure 1D, rather than Figure 2D.

      We agree with the reviewer that our comment on the change in synapse density across ages was not quantitatively supported by the figure as we did not perform a proper age-wise statistical comparison. We have removed this claim in the revised manuscript.

      We also appreciate the suggestions to clarify the presentation of our statistical analyses and to utilize confidence interval measurements wherever possible. We present Author response image 1 below, showing the density of multi-AZ synapses in the contralateral-eye territory over time (P2-P8), for both CTB(+) contralateral (black) and CTB(-) ipsilateral inputs (red) featuring 5/95% confidence intervals:

      Author response image 1.

      More broadly, the reviewer has raised the concern that the low number of biological replicates (N=3) presents challenges in the use of ANOVA for statistical testing. We agree with the concern and have revised the manuscript to be cautious in our statistical tests and resulting claims. We have chosen to use paired T-tests to compare measurements of eye-specific synapse properties because these measurements were always made within each individual biological replicate (paired measurements). Below, we discuss our logic for this change and the effects on the results we present in the revised manuscript.

      Considering the above image:

      (1) ANOVA: In our initial submission, we used an ANOVA test which showed P<0.05 for the CTB(+) P4 vs. P8 comparison above, leading to our statement about an age-dependent increase in multi-AZ density. However, the figure above shows that P8 data has higher variance. Thus, the homogeneity of variance assumption of ANOVA may lead to false positives in this comparison.

      (2) Confidence interval for N=3: We calculated confidence intervals for P4 and P8 data (5/95% CI shown above). Overlap between the two groups indicates the true mean values of the two groups could be identical. However, the P8 confidence intervals (as well as other confidence intervals across other comparisons in the manuscript) also include the value of 0. This indicates there actually might be no multi-active zone synapses in the mouse dLGN. The failure arises because the low number of biological replicates (N=3 data points) precludes a reliable confidence interval measurement. CI measurements require sufficient sample sizes to determine the true population variance.

      (3) Difficulty in achieving sufficient sample sizes for CI analysis in ultrastructural studies of the brain: volumetric STORM experiments are technically complex and make use of sample preparation and analysis methods that are similar to volumetric electron microscopy (physical ultrathin sectioning and computational 3D stack alignment). For these technical reasons, it is difficult to collect imaging data from >10 mice for each group of data (e.g. age and tissue location) in one single project. Because of the technical challenges, most ultrastructural studies published to date present results from single biological replicates. In our STORM dataset, we collected imaging data of N=3 biological replicates for each age and genotype. We agree that in the future the collection of additional replicates will be important for improving the reliability of statistical comparisons in super-resolution and electron-microscopy studies. Continued advances in the throughput of imaging/analysis should help to make this easier over time. 

      (4) The use of paired T-tests: In this study, we have eye-specific CTB(+) and CTB(-) synapse imaging data from the same STORM fields within single biological replicates. When there is only one measurement from each replicate (e.g. synapse density, ratio of total synapses), using paired tests to compare these groups increases statistical power and does not assume similar variance. However, this limits our analysis to comparisons within each age, and not between ages. Accordingly, we have revised our discussion of the results and interpretations throughout the manuscript. When there are thousands of measurements of synapses from each replicate (e.g. Figure 2A-B on synapse volumes), we use a mixed linear model to analyze the variance. In the revised figures we present the results using standard error of the mean and link measurements from within the same individual replicates to show the paired data structure. In cases where specific comparisons are made across ages, we present 5/95% confidence interval measurements.

      Claim 2: The fraction of multiple-active zone vGlut2 clusters increases with age. This claim is weakly supported by a qualitative reading of panel 1E. The error bars overlap so it is difficult to know what the range of possible increases could be. In the text, the authors report mean differences without confidence intervals (or any other statistics). The reported results should, therefore, be interpreted as a description of their three mice and not as evidence about mice in general.

      We appreciate the reviewer’s concern that statistical accuracy of our synapse density comparisons over age is limited by the small sample size as discussed above. We have removed all strong claims about age-dependent changes in the density of multi-active zone and single-active zone synapses. Instead, we focus our analyses on comparisons between CTB(+) and CTB(-) synapse measurements, which are paired within each biological replicate. To specifically address the reviewer’s concern about figure panel 1E, we present Author response image 2 with confidence intervals below.

      Author response image 2.

      Figure S1. Panel A makes the point that the study could not be done without STORM by comparing the STORM images to "Conventional" images. The images are over-saturated low-resolution images. A reasonable comparison would be to a high-quality quality confocal image acquired with a high NA objective (~1.4) and low laser power (PSF ~ 0.2 x 0.2 x 0.6 um) that was acquired over the same amount of time it takes to acquire a STORM volume.

      We agree with the reviewer that the presentation of low-resolution conventional images is not necessary. We have deleted the panel and modified the text accordingly.

      Result section 2.

      Claim 1: The ipsi/contra (in contra LGN) difference in VGluT2 cluster volume increases with development. While there are many p-values listed, the main point is not directly quantified. A reasonable way to quantify the relative increase in volume could be in the form: the non-dominant volumes were 75%-95%(?) of the dominant volume at P2 and 60%-80% (?) at P8. The difference in change was -5 to 15%(?).

      We thank the reviewer for their helpful suggestion to improve the clarity of the results presented in this analysis of eye-specific synapse volumes. In our original report, we found differences in eye-specific VGluT2 volume at each time point (P2/P4/P8) in control mice (1). The original measurements used the entire synapse population. Here, we aimed to determine whether eye-specific differences in VGluT2 volumes were present for both multi-AZ synapses and single-AZ synapses, and whether one population may have a greater contribution to the previous population measurement that we reported. We found that at P4 (a time when the overall eye-specific synapse density is equivalent for both eyes in the dLGN), WT multi-AZ synapses showed a greater difference (372%) in eye-specific VGluT2 volume compared with single-AZ synapses (135%). In β2KO mice multi-AZ synapses showed a greater difference (110%) in eye-specific VGluT2 volume compared with single-AZ synapses (41%). In our initial manuscript submission, we included statistical comparisons of eye-specific volume differences across ages, but we did not highlight these differences in our discussion of the results. For clarity, we have removed all statistical comparisons across ages in the revised manuscript. We have modified the text to focus on eye-specific VGluT2 volume differences at P4 described above. To specifically address the reviewer’s question, we provide the percentage differences between multi- and single-AZ eye-specific synapses for each age/genotype below:

      Author response table 1.

      Claim 2: Complex synapses (vGlut2 clusters with multiple active zones) represent clusters of simple synapses and not single large boutons with multiple active zones. The authors argue that because vGlut2 cluster volume scales roughly linearly with active zone number, the vGlut2 clusters are composed of multiple boutons each containing a single active zone. Their analysis does not rule out the (known to be true) possibility that RGC bouton sizes are much larger in boutons with multiple active zones. The correlation of volume and active zone number, by itself, does not resolve the issue. A good argument for multiple boutons might be that the variance is smallest in clusters with 4 active zones (looks like it in the plot) since they would be the average of four active zones to vesicle pool ratios. It is very likely that the multi-active zone vGlut2 clusters represent some clustering and some multi-synaptic boutons. The reference cited by the authors as evidence for the presence of single active zone boutons in young tissue does not rule out the existence of multiple active zone boutons.

      We agree with the reviewer’s comments on the challenges of classifying multi-active zone synapses in STORM images as single terminals versus aggregates of terminals. To help address this, we have performed electron microscopy imaging of genetically labeled RGC axons and identified the existence of single retinogeniculate terminals with multiple active zones. Our EM imaging was limited to 2D sections and does not rule out the clustering of small, single- active zone synapses within 3D volumes. Future volumetric EM reconstructions will be informative for this question. We have significantly updated the figures and text to discuss the new results and provide a careful interpretation of the nature of multi-AZ synapses in STORM imaging data. 

      Several arguments are made that depend on the interpretation of "not statistically significant" (n.s.) meaning that "two groups are the same" instead of "we don't know if they are different". This interpretation is incorrect and materially impacts the conclusions.

      Several arguments are made that interpret statistical significance for one group and a lack of statistical significance for another group meaning that the effect was bigger in the first group. This interpretation is incorrect and materially impacts the conclusions.

      We thank the reviewer for raising these concerns. We have extensively revised the manuscript text to report the data in a more precise way without overinterpreting the results. All references to “N.S.” and associated conclusions have been either removed or substantiated with 5/95% confidence interval testing.

      Result Section 3.

      Claim 1: Complex synapses stabilize simple synapses. There are alternative explanations (mentioned above) for the observed clustering that negate the conclusions. 1) Boutons from the same axon tend to be found near one another. 2) Any form of eye-specific segregation would produce non-random associations in the analysis as performed. The authors compare each observation to a random model, but I cannot determine from the text if the model adequately accounts for alternative explanations.

      We thank the reviewer for their suggestion to consider alternative explanations for our results. We agree that our study does not provide direct molecular mechanistic data demonstrating synaptic stabilization effects. We have significantly revised the manuscript to be more cautious in our interpretations and specifically address alternative biological mechanisms that are consistent with the non-random arrangement of retinogeniculate synapses in our data.

      We agree with the reviewer that individual RGC axons form multiple synapses, however, nascent synapses might not always form close together. If synapses are initially added randomly within RGC axons, eye-specific segregation may conclude with a still-random pattern of dominant-eye inputs. At some later stage, synapses may be selectively refined to produce mature glomeruli. Consistent with this, individual RGCs undergo progressive clustering of axonal boutons at later stages of development after eye-specific segregation (5). One of our goals in this work was to determine if the process of synaptic clustering begins at the earliest stages of synapse formation and, if so, whether it is influenced by retinal wave activity.

      To measure synaptic clustering in our STORM data, we used a randomization of single-AZ synapse centroids within the volume of the neuropil after accounting for neuronal soma volumes and edge effects. Multi-AZ centroid positions were held fixed. Comparing the randomized result to the original distribution, we found a higher fraction of single-AZ synapse associated with multi-AZ synapses, arguing for a non-random clustering effect. However, we agree with the reviewer’s concern that this type of randomization cannot account for the fine scale structure of axons, which we did not have access to in this four-color volumetric super-resolution data set. Thus, there could still be errors in a purely volumetric randomization (e.g. the assignment of synapses to regions in the volume that would not be synaptic locations in the original neuropil), which would effectively decrease the measured degree of clustering after the randomization. To address this, we have revised our analysis to measure the degree of synapse clustering nearby both multi-AZ and single-AZ synapses after an equivalent randomization of single-AZ synapse positions in the volume. 

      We now present the revised results as a “clustering index” for both multi-AZ and single-AZ synapses. This measurement was performed in several steps: 1) randomization of single-AZ position with the imaging volume while holding multi-AZ centroid positions fixed, 2) independent measurements of the fraction of single-AZ synapses within the local shell (1.5 μm search radius) around multi-AZ and single-AZ synapses within the random distribution, 3) comparison of the result from (2) with the actual fractional measurements in the raw STORM data to compute a “clustering index” value. 4) Because the randomization is equivalent for both multi-AZ and single-AZ synapse measurements, any measured differences in the degree of clustering reflect the synapse type.

      We have updated Figure 3 in the revised manuscript to present the relative clustering index described above. We have updated the results, discussion, and methods sections accordingly.

      The authors claim that specificity increases over time. Figure 3b (middle) shows that the number of synapses near complex synapses might increase with time (needs confidence interval for effect size), but does not show that specificity (original relative to randomized) increases with time. The fact that nearby simple synapse density is always (P2) very different from random suggests a primarily non-activity-dependent explanation. The simplest explanation is that same-side boutons could be from the same axon whereas different-side axons could not be.

      We have significantly revised the analysis and presentation of results in Figure 3 to include a comparative measurement of synaptic clustering between multi-AZ and single-AZ synapses (discussed above). The data presented in the original Figure 3B have been moved to Supplemental Figure 4. Statistical comparisons in Figure S4 between the original and randomized synapse distributions are limited to within-age measurements. Cross-age comparisons were not performed or presented. To address the reviewer’s question concerning CI analysis in the original Figure 3B, we provide Author response image 3 below showing 5/95% confidence intervals for WT mice:

      Author response image 3.

      Claim 2: vGlut2 clusters more than 1.5 um away from multi-active zone vGlut2 clusters are not statistically significantly different in size than vGlut2 clusters within 1.5 um of multi-active zone vGlut2 clusters. Therefore "activity-dependent synapse stabilization mechanisms do not impact simple synapse vesicle pool size". The specific measure of 1.5 um from multi-active zone vGlut2 clusters does not represent all possible synapse stabilization mechanisms.

      We agree with the reviewer that this specific measure does not capture all possible synapse stabilization mechanisms. We have modified the text in the revised manuscript throughout to be more cautious in our data interpretation and have included additional discussion of alternative mechanisms consistent with our results.

      Result Section 4.

      Claim: The proximity of complex synapses with nearby simple synapses to other complex synapses with nearby simple synapses from the same eye is used to argue that activity is responsible for all this clustering.

      It is difficult to derive anything from the quantification besides 'not-random'. That is a problem because we already know that axons from the left and right eye segregate during the period being studied. All the measures in Section 4 are influenced by eye-specific segregation. Given this known bias, demonstrating a non-random relationship (P<X) doesn't mean anything. The test will reveal any non-random spatial relationship between same-eye and opposite-eye synapses.

      The results can be stated as: If you are a contralateral complex synapse, contralateral complex synapses that are also close to contralateral simple synapses will, on average, be slightly closer to you than contralateral complex synapses that are not close to contralateral ipsilateral synapses. That would be true if there is any eye-specific segregation (which there is).

      We appreciate the reviewer’s comments that our anatomical data are consistent with several possible mechanisms, suggesting the need for alternative interpretations of the results. In the original writing, we interpreted our results in the context of activity-dependent mechanisms of like-eye stabilization and opposite-eye competition. However, our results are also consistent with other mechanisms, including non-random molecular specification of eye-specific inputs onto subregions of postsynaptic target cells (e.g. distinct relay neuron dendrites). We have rewritten the manuscript to be more cautious in our interpretations and to provide a balanced discussion of alternative possibilities.

      Regarding the concern that the data in section four are influenced by eye-specific segregation, we previously found synapse density from both eyes is equivalent in the contralateral region at the P4 time point presented (1), which is consistent with binocular axonal overlap at this age. Within our imaging volumes, ipsilateral and contralateral inputs were broadly intermingled throughout the volume, and we did not find evidence for regional segregation with the imaging fields. By these metrics, retraction of ipsilateral inputs from the contralateral territory has not yet occurred.

      It is an overinterpretation of the data to claim that the lack of a clear correlation between vGlut2 cluster volume and distance to vGlut2 clusters with multiple active zones provides support for the claim that "presynaptic protein organization is not influenced by mechanisms governing synaptic clustering".

      We agree with the reviewer that our original language was imprecise in referring to presynaptic protein organization broadly. We have revised this text to present a more accurate description of the results.

      Reviewer #2 (Public Review):

      In this manuscript, Zhang and Speer examine changes in the spatial organization of synaptic proteins during eye-specific segregation, a developmental period when axons from the two eyes initially mingle and gradually segregate into eye-specific regions of the dorsal lateral geniculate. The authors use STORM microscopy and immunostain presynaptic (VGluT2, Bassoon) and postsynaptic (Homer) proteins to identify synaptic release sites. Activity-dependent changes in this spatial organization are identified by comparing the β2KO mice to WT mice. They describe two types of presynaptic organization based on Bassoon clustering, the complex and the simple synapse. By analyzing the relative densities and distances between these proteins over age, the authors conclude that the complex synapses promote the clustering of simple synapses nearby to form the future mature glomerular synaptic structure.

      Strengths:

      The data presented is of good quality and provides an unprecedented view at high resolution of the presynaptic components of the retinogeniculate synapse during active developmental remodeling. This approach offers an advance to the previous mouse EM studies of this synapse because of the CTB label allows identification of the eye from which the presynaptic terminal arises. Using this approach, the authors find that simple synapses cluster close to complex synapses over age, that complex synapse density increases with age.

      Weaknesses:

      From these data, the authors conclude that the complex synapse serves to "promote clustering of like-eye synapses and prohibit synapse clustering from the opposite eye". However, the authors show no causal data to support these ideas. There are a number of issues that the authors should consider:

      (1) Clustering of retinal synapses is in part due to the fact that retinal inputs synapse on the proximal dendrites. With increased synaptogenesis, there will be increased density of retinal terminals that are closely localized. And with development, perhaps simple synapses mature into complex synapses. Simple synapses may also represent ones that are in the process of being eliminated as previously described by Campbell and Shatz, JNeurosci 1992 (consider citing). Can the authors distinguish these scenarios from the ones that they conclude?

      We thank the reviewer for their thoughtful commentary and suggestions to improve our manuscript. We agree with the reviewer that our original interpretation of synaptic clustering by activity-dependent stabilization and punishment mechanisms is not directly supported by causal data. We have extensively revised the manuscript to take a more cautious view of the results and to discuss alternative mechanisms that are consistent with our data.

      During eye-specific circuit development, there is indeed increased synaptogenesis and, ultimately, RGC terminals are closely clustered within synaptic glomeruli. This process involves the selective addition and elimination of synapses. Bouton clustering has been shown to occur within individual RGC axons after eye-opening in the mouse (5). The convergence of other RGC types into clustered boutons has been shown at eye-opening by light and electron microscopy (3). There is also qualitative evidence that synaptic clusters may form earlier during eye-specific segregation in the cat (4). Our data provide additional evidence that synaptic clustering begins prior to eye-opening in the mouse (P2-P8). Although synapse numbers also increase during this period, the distribution of synapse addition is non-random. 

      Single-active zone synapses (we previously called these “simple”) may indeed mature into multi-active zone synapses (we previously called these “complex”). At the same time, single-active zone synapses may be eliminated. We believe that each of these events occurs as part of the synaptic refinement process. Our STORM images are static snapshots of eye-specific refinement, and we cannot infer the dynamic developmental trajectory of an individual synapse in our data. Future live imaging experiments in vivo/in situ will be needed to track the maturation and pruning of individual connections. We have expanded our discussion of these limitations and future directions in the manuscript.

      (2) The argument that "complex" synapses are the aggregate of "simple" synapses (Fig 2, S2) is not convincing.

      We agree with the reviewer’s concern about the ambiguous identity of complex synapses. To clarify the nature of multi-active zone synapses, we have performed RGC-specific dAPEX2 labeling to visualize retinogeniculate terminals by electron microscopy (EM). These experiments revealed the presence of synaptic terminals with multiple active zones. We have added images and text to the results section describing these findings. Our 2D EM images do not rule out the possibility that some multi-active zone synapses observed in STORM images are in fact clusters of individual RGC terminals. We have revised the text to provide a more accurate discussion of the nature of multi-active zone synapses.  

      (3) The authors use of the β2KO mice to assess changes in the organization of synaptic proteins in retinal terminals that have disrupted retinal waves. However, β2-nAChRs are also expressed in the dLGN and other areas of the brain and glutamatergic synapse development has been reported in the CNS independent of the disruption in retinal waves. This issue should be considered when interpreting the total reduced retinal synapse density in the dLGN of the mutant.

      We thank the reviewer for their suggestion to consider non-retinal effects of the germline deletion of the beta 2 subunit of the nicotinic acetylcholine receptor. Previously, Xu and colleagues reported the development of a conditional transgenic mouse model lacking β2-nAChR expression specifically in the retina (6). These retina-specific β2-nAChR mutant mice (Rx-β2cKO) have disrupted retinal wave properties and defects in eye-specific axonal segregation in binocular anterograde tracing experiments. This work suggests that the defects seen in germline β2-nAChR KO mice arise from defects in retinal wave activity rather than the loss of nicotinic receptors elsewhere in the brain. Additionally, the development of brainstem cholinergic inputs to the dLGN is delayed until the closure of the eye-specific segregation period (7), further suggesting a limited role for cholinergic transmission in the retinogeniculate refinement process.

      (4) Outside of a total synapse density difference between WT and β2KO mice, the changes in the spatial organization of synaptic proteins over development do not seem that different. In fact % simple synapses near complex synapses from the non-dominant eye in the mutant is not that different from WT at P8 (Fig 3C), an age when eye-specific segregation is very different between the genotypes. Can the authors explain this discrepancy?

      We thank the reviewer for their question concerning differences between synapse organization in WT versus β2KO mice. In the original presentation of Figure 3C at P4, the percentage of non-dominant eye single-AZ synapses near multi-AZ synapses increased at P4 in WT mice, but this did not occur in β2KO mice. This is consistent with our previous results showing that there is an increase in non-dominant eye synaptic density at this age, which does not occur in β2KO mice (1). At P8, this clustering effect is lost in WT as eye-specific segregation has taken place and non-dominant eye inputs have been eliminated. However, in β2KO mice, the overall synapse density is still low at this age. We interpret this result as a failure of synaptogenesis in the β2KO line, which leads to increased growth of individual RGC axons (8) and eye-specific overlap at P8 (9, 10). Evidence in support of this interpretation comes from live dynamic imaging studies of RGC axon branching in Xenopus and Zebrafish, showing that synapse formation stabilizes local axon branching and that disruptions of synapse formation or neurotransmission lead to enlarged axons (11-13).

      Our anatomical results do not provide a specific biological mechanism for the remaining clustering observed in the β2KO mice. We have revised our discussion of the fact that individual RGC axons may form multiple synaptic connections leading to clustering, which may be independent of changes in retinal wave properties in the β2KO mouse. We have also extensively revised the analysis and presentation of results in Figure 3 to directly compare synaptic clustering around both multi-AZ synapses and single-AZ synapses within the same imaging volumes.

      (5) The authors use nomenclature that has been previously used and associated with other aspects of retinogeniculate properties. For example, the phrases "simple" and "complex" synapses have been used to describe single boutons or aggregates of boutons from numerous retinal axons, whereas in this manuscript the phrases are used to describe vesicle clusters/release sites with no knowledge of whether they are from single or multiple boutons. Likewise, the use of the word "glomerulus" has been used in the context of the retinogeniculate synapse to refer to a specific pattern of bouton aggregates that involves inhibitory and neuromodulatory inputs. It is not clear how the release sites described by the authors fit in this picture. Finally the use of the word "punishment" is associated with a body of literature regarding the immune system and retinogeniculate refinement-which is not addressed in this study. This double use of the phrases can lead to confusion in the field and should be clarified by clear definitions of how they are used in the current study.

      We appreciate the reviewer’s concern that the terminology we used in the initial submission may cause confusion. We have revised the text throughout for clarity. “Simple” synapses are now referred to as “single-active zone synapses”. “Complex” synapses are now referred to as “multi-active zone synapses”. We have removed all text that previously referred to synaptic clusters in STORM images as glomeruli. We agree that we have not provided causal evidence for synaptic stabilization and punishment mechanisms, which would require additional molecular genetic studies. We have restructured the manuscript to remove these references and discuss our anatomical results impartially.  

      Reviewer #3 (Public Review):

      This manuscript is a follow-up to a recent study of synaptic development based on a powerful data set that combines anterograde labeling, immunofluorescence labeling of synaptic proteins, and STORM imaging (Cell Reports 2023). Specifically, they use anti-Vglut2 label to determine the size of the presynaptic structure (which they describe as the vesicle pool size), anti-Bassoon to label a number of active zones, and anti-Homer to identify postsynaptic densities. In their previous study, they compared the detailed synaptic structure across the development of synapses made with contra-projecting vs ipsi-projecting RGCs and compared this developmental profile with a mouse model with reduced retinal waves. In this study, they produce a new analysis on the same data set in which they classify synapses into "complex" vs. "simple" and assess the number and spacing of these synapses. From these measurements, they make conclusions regarding the processes that lead to synapse competition/stabilization.

      Strengths:

      This is a fantastic data set for describing the structural details of synapse development in a part of the brain undergoing activity-dependent synaptic rearrangements. The fact that they can differentiate eye of origin is also a plus.

      Weaknesses:

      The lack of details provided for the classification scheme as well as the interpretation of small effect sizes limit the interpretations that can be made based on these findings.

      We thank the reviewer for their reading of the manuscript and helpful comments to improve the work. We provide details on how single-active zone and multi-active zone synapses are classified in the methods section. We agree with the suggestion to be more careful in interpreting the results. We have extensively revised the manuscript to 1) include additional electron microscopy data demonstrating the presence of multi-active zone retinogeniculate synapses, 2) extend the synaptic clustering analysis to both single-active zone and multi-active zone synapses for comparison, and 3) improve the clarity and accuracy of the discussion throughout the manuscript.

      (1) The criteria to classify synapses as simple vs. complex is critical for all of the analysis in this study. Therefore this criteria for classification should be much more explicit and tested for robustness. As stated in the methods, it is based on the number of active zones which are designated by the number of Bassoon clusters associated with a Vglut2 cluster (line 697). A second part of the criteria is the size of the presynaptic terminal as assayed by "greater Vglut2 signal" (line 116). So how are these thresholds determined? For Bassoon clusters, is one voxel sufficient? Two? If it's one, how often do they see a Bassoon positive voxel with no Vglut2 cluster and therefore may represent "noise"? There is no distribution of Bassoon volumes that is provided that might be the basis for selecting this number of sites. Unfortunately, the images are not helpful. For example, does P8 WT in Figure 1B have 7 or 2? According to Figure 2C, it appears the numbers are closer to 2-4.

      The Vglut volume measurements also do not seem to provide a clear criterion. Figure 2 shows that the distributions of Vglut2 cluster volumes for complex and for simple synapses are significantly overlapping.

      The authors need to clarify the quantitative approach used for this classification strategy and test how sensitive the results of the study are to how robust this strategy is

      We thank the reviewer for their question concerning the STORM data analysis. Here we provide a brief overview of the complete analysis details, which are provided in the methods section.

      Our raw STORM data sets consisted of spectrally separate volumetric imaging channels of VGluT2, Bassoon, and Homer1 signals. For each of these channels, raw STORM data were processed by 1) application of the corresponding low-resolution conventional image of each physical section to the STORM data to filter artifacts in the STORM image which do not appear in the conventional image, 2) STORM images are then thresholded using a 2-factor Otsu threshold that removes low-intensity background noise while preserving all single-molecule localizations that correspond to genuine antibody labeling as well as non-specific antibody labeling in the tissue, 3) application of the MATLAB function “conncomp” to identify connected component voxel in 3D across the image stack. Clusters are only kept for further analysis steps if they are connected across at least 2 continuous physical sections (140 nm Z depth). 4) for every connected component (clusters corresponding to genuine antibody labeling and background labeling), we measure the volume and signal density (intensity/volume) for every cluster in the dataset, 5) a threshold is applied to retain clusters that have a higher volume and lower signal density. We exclude signals that have low-volume and high-density, which correspond to single antibody labels. This analysis retains larger clusters that correspond to synaptic objects and excludes non-specific antibody background. 

      The average size of WT synaptic Bassoon clusters ranges from 55 - 3532 voxels (0.00092~0.059 μm<sup>3</sup>), with a median size of 460 voxels (0.0077 μm<sup>3</sup>).

      The average size of WT synaptic VGluT2 clusters ranges from 50 -73752 voxels (0.00084~1.2 μm<sup>3</sup>), with a median size of 980 voxels (0.016 μm<sup>3</sup>).

      The average size of WT synaptic Homer1 clusters ranges from 63-7118 (0.0010~0.12 μm3), with a median size of 654 voxels (0.011 μm<sup>3</sup>).

      In practice, any Bassoon/VGluT2/Homer1 clusters with <10 voxels are immediately filtered at the Otsu thresholding step (2) above.

      The reviewer is correct that we often see Bassoon(+) clusters that are not associated with VGluT2, and these may reflect synapses of non-retinal origin or retinogeniculate synapses that lack VGluT2 expression. To identify retinogeniculate synapses containing VGluT2, we performed a synapse pairing analysis that measured the association between VGluT2 and Bassoon clusters after the synapse cluster filtering described above. We first measured the centroid-centroid distance from each VGluT2 cluster to the closest cluster in the Bassoon channel. We next quantified the signal intensity of the Bassoon channel within a 140 nm shell surrounding each VGluT2 cluster. A 2D histogram was plotted based on the measured centroid-centroid distances and opposing channel signal densities of each cluster. Paired clusters with closely positioned centroids and high intensities of apposed channel signal were identified using the OPTICS algorithm (14).

      In the original Figure 1B, the multi-active zone synapse in WT at P8 had two Bassoon clusters. To clarify this, we have revised the images in Figure 1 to include arrowheads that point to individual active zones. We have also revised Supplemental Figure 1 to show volumetric renderings of individual example synapses that help illustrate the 3D structure of these multi-active zone inputs. All details about synapse analysis and synapse pairing are provided in the methods section.

      (2) Effect sizes are quite small and all comparisons are made on medians of distributions. This leads to an n=3 biological replicates for all comparisons. Hence this small n may lead to significant results based on ANOVAS/t-tests, but the statistical power of these effects is quite weak. To accurately represent the variance in their data, the authors should show all three data points for each category (with a SD error bar when possible). They should also include the number of synapses in each category (e.g. the numerators in Figure 1D and the denominators for Figure 1E). For other figures, there are additional statistical questions described below.

      We thank the reviewer for their suggestion to improve the presentation of our results. We have added all three data points (individual biological replicates) to each figure plot when applicable. We have also included a supplemental table (Table S1) listing total eye-specific synapse numbers of each type (mAZ and sAZ) and AZ number for each biological replicate in both genotypes.

      (3) The authors need to add a caveat regarding their classification of synapses as "complex" vs. "simple" since this is a terminology that already exists in the field and it is not clear that these STORM images are measuring the same thing. For example, in EM studies, "complex" refers to multiple RGCs converging on the same single postsynaptic site. The authors here acknowledge that they cannot assign different AZs to different RGCs so this comparison is an assumption. In Figure 2 they argue this is a good assumption based on the finding that the Vglut column/active zone is constant and therefore each represents a single RGC. However, the authors should acknowledge that they are actually seeing quite different percentages than those in EM studies. For example, in Monavarfeshani et al, eLife 2018, there were no complex synapses found at P8. (Note this study also found many more complex vs. simple synapses in the adult - 70% vs. the 20% found in the current study - but this difference could be a developmental effect). In the future, the authors may want to take another data set in the adult dLGN to make a direct comparison based on numbers and see if their classification method for complex/simple maps onto the one that currently exists in the literature.

      We appreciate the reviewer’s comment that the use of the terms “complex” and “simple” may cause confusion. We have significantly revised the manuscript for clarity: 1) we now refer to “complex” synapses as “multi-active zone synapses” and “simple” synapses as “single-active zone synapses. 2) We have performed electron microscopy analysis of dAPEX2-labeled retinogeniculate projections to confirm the existence of large synaptic terminals with multiple active zones. 3) We have expanded our discussion of previous electron microscopy results describing a lack of axonal convergence at P8 (3). 4) We have added a discussion on how individual RGCs may form multiple synapses in close proximity within their axonal arbor, which would create a clustering effect.

      We agree that it will be informative to collect a STORM data set in the adult mouse dLGN and we look forward to working on this project to compare with EM results in the future.  

      (4) Figure 3 assays the relative distribution of simple vs. complex synapses. They found that a larger percentage of simple synapses were within 1.5 microns of complex synapses than you would expect by chance for both ipsi and contra projecting RGCs, and hence conclude that complex synapses are sites of synaptic clustering. In contrast, there was no clustering of ipsi-simple to contra-complex synapses and vice versa. The authors also argue that this clustering decreases between P4 and P8 for ipsi projecting RGCs.

      This analysis needs much more rigor before any conclusions can be drawn. First, the authors need to justify the 1.5-micron criteria for clustering and how robust their results are to variations in this distance. Second, these age effects need to be tested for statistical significance with an ANOVA (all the stats presented are pairwise comparisons to means expected by random distributions at each age). Finally, the authors should consider what n's to use here - is it still grouped by biological replicate? Why not use individual synapses across mice? If they do biological replicates, then they should again show error bars for each data point in their biological replicates. And they should include the number of synapses that went into these measurements in the caption.

      We appreciate the suggestion to improve the rigor of our analysis of synaptic clustering presented in Figure 3. We have revised our analysis to measure the degree of synapse clustering nearby both multi-AZ and single-AZ synapses after an equivalent randomization of single-AZ synapse positions in the volume. 

      We now present the revised results as a “clustering index” for both multi-AZ synapses and single-AZ synapses. This measurement was performed in several steps: 1) randomization of single-AZ positions within the imaging volume while holding multi-AZ centroid positions fixed, 2) independent measurements of the fraction of single-AZ synapses within the local shell (1.5 μm search radius) around multi-AZ and single-AZ synapses within the random distribution, 3) comparison of the result from (2) with the actual fractional measurements in the raw STORM data to compute a “clustering index” value. 4) Because the randomization is equivalent for both multi-AZ and single-AZ synapse measurements, the measured differences in the degree of clustering reflect a synapse type-specific effect.

      We have also updated Supplemental Figure 3 showing the results of varying the search radius from 1-4 μm for both contralateral- and ipsilateral-eye synapses. The results showed that a search radius of 1.5 μm resulted in the largest difference between the original synapse distribution and a randomized synapse distribution (shuffling of single-active zone synapse position while holding multi-active zone synapse position fixed).

      Finally, we have removed all statistical comparisons of single measurements (means or ratios) across ages from the manuscript. We focus our statistical analysis on paired data comparisons within individual biological replicates.

      For the analysis of synapse clustering, we grouped the data by biological replicates (N=3) to look for a global effect on synapse clustering. In the revised manuscript, we added data points for each replicate in the figure and included the number of synapses in Supplementary Table 1.

      (5) Line 211-212 - the authors conclude that the absence of clustered ipsi-simple synapses indicates a failure to stabilize (Figure 3). Yet, the link between this measurement and synapse stabilization is not clear. In particular, the conclusion that "isolated" synapses are the ones that will be eliminated seems to be countered by their finding in Figure 3D/E which shows that there is no difference in vesicle pool volume between near and far synapses. If isolated synapses are indeed the ones that fail to stabilize by P8, wouldn't you expect them to be weaker/have fewer vesicles? Also, it's hard to tell if there is an age-dependent effect since the data presented in Figures 3D/E are merged across ages.

      We thank the reviewer for their suggestion to clarify the results in Figure 3. Based on the measured eye-specific differences in vesicle pool size and organization, we also expected that synapses outside of clusters would show a reduced vesicle population. However, across all ages, we found no differences in the vesicle pool size of single-active zone synapses based on their proximity to multi-active zone synapses. Below, we show cumulative distributions of these results across all ages (P2/P4/P8) for WT mice CTB(+) data. Statistical tests (Kolmogorov-Smirnov tests) show no significant differences. P = 0.880, 0.767, 0.494 respectively. Separate 5/95% confidence interval calculations showed overlap between far and near populations at each age.

      Author response image 4.

      To clarify the presentation of the results, we have changed the text to state that the “vesicle pool size of sAZ synapses is independent of their distance to mAZ synapses”. We have removed references to stabilization and punishment from the results section of the manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Because none of the phenomena being measured can be expected to behave randomly (given what is already known about the system) and the sample size is small, I believe quantification of the data requires confidence intervals for effect sizes. Resolving the multi-bouton vs multi-active zone bouton with EM would also help.

      We thank the reviewer for their thorough reading of the manuscript and many helpful suggestions. We provide analysis with confidence intervals in a point-by-point response below. In the manuscript we revised our results and focused our statistical analyses on comparisons within the same biological replicate (paired effects). In addition, we have performed electron microscopy of RGC inputs to the dLGN at postnatal day 8 to demonstrate the presence of retinogeniculate synapses with multiple active zones.

      Figure 1:

      Please show data points in scatter bar plots and not just error bars.

      We have updated all plots to show data points for independent biological replicates.

      Please describe the image processing in more detail and provide an image in which the degree of off-target labeling can be evaluated.

      We have updated the description of the image processing in the methods sections. We have made all the code used in this analysis freely available on GitHub (https://github.com/SpeerLab). We have uploaded the raw STORM images of the full data set to the open-access Brain Imaging Library (16). These images can be accessed here: https://api.brainimagelibrary.org/web/view?bildid=ace-dud-lid (WTP2A data for example). All 18 datasets are currently searchable on the BIL by keyword “dLGN” or PI last name “Speer” and a DOI for the grouped dataset is pending.

      How does panel 1D get very small error bars with N = 3? Please provide scatter plots.

      We have updated panel 1D to show the means for each independent biological replicate.

      Line 129: over what volume is density measured? What are the n's? What is the magnitude (with confidence intervals) of increase?

      The volume we collected from each replicate was ~80μm*80μm*7μm (total volume ~44,800 μm3). N=3 biological replicates for each age, genotype, and tissue location. Because of concerns with the use of ANOVA for low sample numbers, we have removed a majority of the age-wise comparisons from the manuscript and instead focus on within-replicate paired data comparisons. Author response image 5 showa 5/95% confidence intervals for WT data (left panel) and β2KO data (right panel) is shown below:

      Author response image 5.

      The 5/95% CI range for the increase in synapse density from P2 to P8 for CTB(+) synapses is ~ -0.001 ~ 0.037 synapses / μm<sup>3</sup>.

      Line 131: You say that non-dominant increases and then decreases. It appears that the error bars argue that you do not have enough information to reliably determine how much or little density changes.

      Line 140: No confidence intervals. It appears the error bars allow both for the claimed effect of increased fraction and the opposite effect of decreased density.

      Because of concerns with the use of ANOVA for low sample numbers, we have removed age-wise comparisons of single-measurements (means and ratios) from the manuscript and instead focus on within-replicate paired data comparisons.

      Line 144: Confidence intervals would be a reasonable way to argue that fraction is not changed in KO: normal fraction XX%-XX%. KO fraction XX%-XX%.

      Author response image 6 shows panels for WT (left) and β2KO mice (right) with 5/95% CIs.

      Author response image 6.

      In the revised manuscript, we have updated the text to report the measurements, but we do not draw conclusions about changes over development.

      I find it hard to estimate magnitudes on a log scale.

      We appreciate the reviewer’s concern with the presentation of results on a log scale. Because the measured synapse properties are distributed logarithmically, we have elected to present the data on a log scale so that the distribution(s) can be seen clearly. Lognormal distributions enable us to use a mixed linear model for statistical analysis.

      Line 156: Needs confidence interval for difference.

      Line 158: Needs confidence interval for difference of differences.

      Line 160: Needs confidence interval for difference of differences.

      Why only compare at P4 where there is the biggest difference? The activity hypothesis would predict an even bigger effect at P8.

      Below is a table listing the mean volume (log10μm3) and [5/95%] confidence intervals for comparisons of VGluT2 signal between CTB(+) and CTB(-) synapses from Figure 2A and 2B:

      Author response table 2.

      Based on the values given above, the mean difference of differences and [5/95%] confidence intervals are listed below:

      Author response table 3.

      We added these values to the manuscript. We have also reported the difference in median values on a linear scale (as below) so that the readers can have a straightforward understanding of the magnitude.

      Author response table 4.

      We elected to highlight the results at P4 based on our previous finding that the synapse density from each eye-of-origin is similar at this time point (1).

      At P8, there is a decrease in the magnitude of the difference between CTB(+)/CTB(-) synapses compared to P4. This may be due to an increase in VGluT2 volume within non-dominant eye synapses that survive competition between P4-P8.

      At P8 in the mutant, there is an increase in the magnitude of the difference between CTB(+)/CTB(-) synapses compared to P4. This may be due to delayed synaptic maturation in β2KO mice.

      Line 171: The correct statistical comparison was not performed for the claim. Lack of * at P2 does not mean they are the same. Why do you get the same result for KO?

      We have revised the statistical analysis, figure presentation, and text to remove discussion of changes in the number of active zones per synapse over development based on ANOVA. We now report eye-specific differences at each time point using paired T-test analysis, which is mathematically equivalent to comparing the 5/95% confidence interval in the difference.

      Line 175: Qualitative claim. Correlation coefficients and magnitudes of correlation coefficients are not reported.

      Linear fitting slop and R square values are attached:

      Author response table 5.

      The values are added to the manuscript to support the conclusions.

      Line 177: n.s. does not mean that you have demonstrated the values are the same. An argument for similarity could be made by calculating a confidence interval a for potential range of differences. Example: Complex were 60%-170% of Simple.

      Author response image 7 with 5/95% CI is shown below (WT and B2KO):

      Author response image 7.

      Comparing the difference between multi-AZ synapse and single-AZ synapse revealed that the difference in average VGluT2 cluster volume per AZ is:

      Author response table 6.

      The values are added to the manuscript for discussion.

      Line 178: There is no reason to think that the vesical pool for a single bouton does not scale with active zone number within the range of uncertainty presented here.

      We have collected EM images of multi-AZ zone synapses and modified our discussion and conclusions in the revised text.

      Line 196: "non-random clustering increased progressively" is misleading. The density of the boutons increases for both the Original and Randomized. Given the increase in variance at P8, it is unlikely that the data supports the claim that the non-randomness increased. Would be easy to quantify with confidence intervals for a measure of specificity (O/R).

      We have revised the manuscript to remove analysis and discussion of changes in clustering over development. We have modified this section of the manuscript and figures to present a normalized clustering index that describes the non-random clustering effect present at each time point.

      Line 209: Evidence is for correlation, not causation and there is a trivial potential explanation for correlation.

      We appreciate the reviewer’s concern with over interpretation of the results. We have changed the text to more accurately reflect the data.

      Line 238:239: Authors failed to show effect is activity-dependent. Near/Far distinction is not necessarily a criterion for the effect of activity. The claim is likely false in other systems.

      We agree with the reviewer that the original text overinterpreted the results. We have changed the text to more accurately reflect the data. 

      Line 265-266: Assumes previous result is correct and measure of vGlut2 provides information about all presynaptic protein organization.

      We thank the reviewer for pointing out the incorrect reference to all presynaptic protein organization. We have corrected the text to reference only the VGluT2 and Bassoon signals that were measured.

      Line 276: There are many other interpretations that include trivial causes. It is unclear what the measure indicates about the biology and there is no interpretable magnitude of effect.

      We agree with the reviewer that the original text overinterpreted the results. We have changed the text to remove references to mechanisms of synaptic stabilization.

      Line 289: Differences cannot be demonstrated by comparing P-values. Try comparing confidence intervals for effect size or generate a confidence interval for the difference between the two groups.

      5/95% confidence intervals are given below for Figure 4C/D:

      Author response table 7.

      We have added these values to the manuscript to support our conclusion.

      Line 305: "This suggests that complex synapses from the non-dominant-eye do not exert a punishment effect on synapses from the dominant-eye" Even if all the other assumptions in this claim were true, "n.s." just means you don't know something. It cannot be compared with an asterisk to claim a lack of effect.

      We thank the reviewer for raising this concern. We have modified the text to remove references to synaptic punishment mechanisms in the results section.

      Below are the 5/95% confidence intervals for the results in Figure 4F:

      Author response table 8.

      We have added these values to the manuscript to support our conclusion.

      Line 308: "mechanisms that act locally". 6 microns is introduced based on differences in curves above(?). I don't see any analysis that would argue that longer-distance effects were not present.

      The original reference referred to the differences in the cumulative distribution measurements between multi-active zone synapses versus single-active zone synapses in their distance to the nearest neighboring multi-active zone synapse. For clarity, we have deleted the reference to the 6 micron distance in the revised text.

      Reviewer #2 (Recommendations For The Authors):

      (1) This data set would be valuable to the community. However, unless the authors can show experiments that manipulate the presence of complex synapses to test their concluding claims, the manuscript should be rewritten with a reassessment of the conclusions that is more grounded in the data.

      We thank the reviewer for their careful reading of the manuscript and we agree the original interpretations were not causally supported by the experimental results. We have made substantial changes to the text throughout the introduction, results, and discussion sections so that the conclusions accurately reflect the data.

      (2) To convincingly address the claim that "complex synapse" are aggregates of simple synapses, the authors should perform experiments at the EM level showing what the bouton correlates are to these synapses.

      We thank the reviewer for their suggestion to perform EM to gain a better understanding of retinogeniculate terminal structure. We generated an RGC-specific transgenic line expressing the EM reporter dAPEX2 localized to mitochondria. We have collected EM images of retinogeniculate terminals that demonstrate the presence of multiple active zones within individual synapses. These results are now presented in Figure 1. The text has been updated to reflect the new results.

      (3) Experiments using the conditional β2KO mice would help address questions of the contribution of β2-nAChRs in dLGN to the synaptic phenotype.

      We appreciate the reviewer’s concern that the germline β2KO model may show effects that are not retina-specific. To address this, Xu and colleagues generated a retina-specific conditional β2KO transgenic and characterized wave properties and defective eye-specific segregation at the level of bulk axonal tracing (6). The results from the conditional mutant study suggest that the main effects on eye-specific axon refinement in the germline β2KO model are likely of retinal origin through impacts on retinal wave activity. Additionally, anatomical data shows that brainstem cholinergic axons innervate the dLGN toward the second half of eye-specific segregation and are not fully mature at P8 when eye-specific refinement is largely complete (7). We agree with the reviewer that future synaptic studies of previously published wave mutants, including the conditional reporter line, would be needed to conclusively assess a contribution of non-retinal nAChRs. These experiments will take significant time and resources and we respectfully suggest this is beyond the scope of the current manuscript.

      Reviewer #3 (Recommendations For The Authors):

      (1) The authors need to be more transparent that they are using the same data set from the previous publication (right now it does not appear until line 471) and clarify what was found in that study vs what is being tested here.

      We thank the reviewer for their thoughtful reading of the manuscript and helpful recommendations to improve the clarity of the work. We have edited the text to make it clear that this study is a reanalysis of an existing data set. We have revised the text to discuss the results from our previous study and more clearly define how the current analysis builds upon that initial work. 

      (2) The authors restricted their competition argument in Figure 4 to complex synapses, but why not include the simple ones? This seems like a straightforward analysis to do.

      We appreciate the reviewer’s suggestion to measure spatial relationships between “clustered” and “isolated” single-AZ synapses as we have done for multi-AZ synapses in Figure 4. However, we are not able to perform a direct and interpretable comparison with the results shown for multi-AZ synapses. First, we would need to classify “clustered” and “isolated” single-AZ synapses. This classification convolves two effects: 1) a distance threshold to define clustering and 2) subsequent distance measurements between clustered synapses.

      If we apply an equivalent 1.5 μm distance threshold (or any other threshold) to define clustered synapses, the distance from each “clustered” single-AZ synapse to the nearest other single-AZ synapse will always be smaller than the defined threshold (1.5 μm). Alternatively, if all of the single-AZ synapses within each local 1.5 μm shell are excluded from the subsequent intersynaptic distance measurements, this will set a hard lower boundary on the distance between synaptic clusters (1.5 μm minimum). The two effects discussed above were separated in our original analysis of multi-AZ synapses defined as “clustered” and “isolated” based on their relationship to single-AZ synapses, but these effects cannot be separated when analyzing single-AZ distributions alone.

      (3) The Discussion seems much too long and speculative from the current data that is represented - particularly without verification of complex synapses actually being inputs from different RGCs. Along the same lines, figure captions are misleading. For example, for Figure 4 - the title indicates that the complex synapses are driving the rearrangements. But of course, these are static images. The authors should use titles that are more reflective of their findings rather than this interpretation.

      We thank the reviewer for these helpful suggestions. We have changed each of the figure captions to more accurately reflect the results. We have deleted all of the speculative discussion and revised the remaining text to improve the accuracy of the presentation.

      (4) In the future, the authors may want to consider an analysis as to whether ipsi and contra projection contribute to the same synapses

      We agree with the reviewer that it is of interest to investigate the contribution of binocular inputs to retinogeniculate synaptic clusters during development. At maturity, some weak binocular input remains in the dominant-eye territory (15). To look for evidence of binocular synaptic interactions, we measured the percentage of the total small single-active zone synapses that were within 1.5 micrometers of larger multi-active zone synapses of the opposite eye. On average, ~10% or less of the single-active zone synapses were near multi-active zone synapses of the opposite eye. This analysis is presented in Supplemental Figure S3C/D.

      It is possible that some large mAZ synapses might reflect the convergence of two or more smaller inputs from the two eyes. Our current analyses do not rule this out. However, previous EM studies have found limited evidence for convergence of multiple RGCs (3) at P8 and our own EM images show that larger terminals with multiple active zones are formed by a single RGC bouton. Future volumetric EM reconstructions with eye-specific labels will be informative to address this question.

      References

      (1) Zhang C, Yadav S, Speer CM. The synaptic basis of activity-dependent eye-specific competition. Cell Rep. 2023;42(2):112085.

      (2) Bickford ME, Slusarczyk A, Dilger EK, Krahe TE, Kucuk C, Guido W. Synaptic development of the mouse dorsal lateral geniculate nucleus. J Comp Neurol. 2010;518(5):622-35.

      (3)Monavarfeshani A, Stanton G, Van Name J, Su K, Mills WA, 3rd, Swilling K, et al. LRRTM1 underlies synaptic convergence in visual thalamus. Elife. 2018;7.

      (4) Campbell G, Shatz CJ. Synapses formed by identified retinogeniculate axons during the segregation of eye input. J Neurosci. 1992;12(5):1847-58.

      (5) Hong YK, Park S, Litvina EY, Morales J, Sanes JR, Chen C. Refinement of the retinogeniculate synapse by bouton clustering. Neuron. 2014;84(2):332-9.

      (6) Xu HP, Burbridge TJ, Chen MG, Ge X, Zhang Y, Zhou ZJ, et al. Spatial pattern of spontaneous retinal waves instructs retinotopic map refinement more than activity frequency. Dev Neurobiol. 2015;75(6):621-40.

      (7) Sokhadze G, Seabrook TA, Guido W. The absence of retinal input disrupts the development of cholinergic brainstem projections in the mouse dorsal lateral geniculate nucleus. Neural Dev. 2018;13(1):27.

      (8) Dhande OS, Hua EW, Guh E, Yeh J, Bhatt S, Zhang Y, et al. Development of single retinofugal axon arbors in normal and beta2 knock-out mice. J Neurosci. 2011;31(9):3384-99.

      (9) Rossi FM, Pizzorusso T, Porciatti V, Marubio LM, Maffei L, Changeux JP. Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system. Proc Natl Acad Sci U S A. 2001;98(11):6453-8.

      (10) Muir-Robinson G, Hwang BJ, Feller MB. Retinogeniculate axons undergo eye-specific segregation in the absence of eye-specific layers. J Neurosci. 2002;22(13):5259-64.

      (11) Fredj NB, Hammond S, Otsuna H, Chien C-B, Burrone J, Meyer MP. Synaptic Activity and Activity-Dependent Competition Regulates Axon Arbor Maturation, Growth Arrest, and Territory in the Retinotectal Projection. J Neurosci. 2010;30(32):10939.

      (12) Hua JY, Smear MC, Baier H, Smith SJ. Regulation of axon growth in vivo by activity-based competition. Nature. 2005;434(7036):1022-6.

      (13) Rahman TN, Munz M, Kutsarova E, Bilash OM, Ruthazer ES. Stentian structural plasticity in the developing visual system. Proc Natl Acad Sci U S A. 2020;117(20):10636-8.

      (14) Ankerst M, Breunig MM, Kriegel H-P, Sander J. OPTICS: ordering points to identify the clustering structure. SIGMOD Rec. 1999;28(2):49–60.

      (15) Bauer J, Weiler S, Fernholz MHP, Laubender D, Scheuss V, Hübener M, et al. Limited functional convergence of eye-specific inputs in the retinogeniculate pathway of the mouse. Neuron. 2021;109(15):2457-68.e12.

      (16) Benninger K, Hood G, Simmel D, Tuite L, Wetzel A, Ropelewski A, et al. Cyberinfrastructure of a Multi-Petabyte Microscopy Resource for Neuroscience Research.  Practice and Experience in Advanced Research Computing; Portland, OR, USA: Association for Computing Machinery; 2020. p. 1–7.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      Though the Norrin protein is structurally unrelated to the Wnt ligands, it can activate the Wnt/βcatenin pathway by binding to the canonical Wnt receptors Fzd4 and Lrp5/6, as well as the tetraspanin Tspan12 co-receptor. Understanding the biochemical mechanisms by which Norrin engages Tspan12 to initiate signaling is important, as this pathway plays an important role in regulating retinal angiogenesis and maintaining the blood-retina-barrier. Numerous mutations in this signaling pathway have also been found in human patients with ocular diseases. The overarching goal of the study is to define the biochemical mechanisms by which Tspan12 mediates Norrin signaling. Using purified Tspan12 reconstituted in lipid nanodiscs, the authors conducted detailed binding experiments to document the direct, high-affinity interactions between purified Tspan12 and Norrin. To further model this binding event, they used AlphaFold to dock Norrin and Tspan12 and identified four putative binding sites. They went on to validate these sites through mutagenesis experiments. Using the information obtained from the AlphaFold modeling and through additional binding competition experiments, it was further demonstrated that Tspan12 and Fzd4 can bind Norrin simultaneously, but Tspan12 binding to Norrin is competitive with other known co-receptors, such as HSPGs and Lrp5/6. Collectively, the authors proposed that the main function of Tspan12 is to capture low concentrations of Norrin at the early stage of signaling, and then "hand over" Norrin to Fzd4 and Lrp5/6 for further signal propagation. Overall, the study is comprehensive and compelling, and the conclusions are well supported by the experimental and modeling data. 

      Strengths: 

      • Biochemical reconstitution of Tspan12 and Fzd4 in lipid nanodiscs is an elegant approach for testing the direct binding interaction between Norrin and its co-receptors. The proteins used for the study seem to be of high purity and quality. 

      • The various binding experiments presented throughout the study were carried out rigorously. In particular, BLI allows accurate measurement of equilibrium binding constants as well as on and off rates. 

      • It is nice to see that the authors followed up on their AlphaFold modeling with an extensive series of mutagenesis studies to experimentally validate the potential binding sites. This adds credence to the AlphaFold models. 

      • Table S1 is a further testament to the rigor of the study. 

      • Overall, the study is comprehensive and compelling, and the conclusions are well supported by the experimental and modeling data. 

      Suggestions for improvement: 

      • It would be helpful to show Coomassie-stained gels of the key mutant Norrin and Tspan12 proteins presented in Figures 2E and 2F. 

      We have included Stain-Free SDS-PAGE gels from the purification of the Norrin and Tspan12 mutants in a new Figure S4.

      • Many Norrin and Tspan12 mutations have been identified in human patients with FEVR. It would be interesting to comment on whether any of the mutations might affect the NorrinTspan12 binding sites described in this study. 

      Thank you for this suggestion. We have inspected human mutation databases gnomAD, ClinVar, and HGMD for known mutations in the predicted Tspan12-Norrin binding interface and their occurrence in human patients with FEVR or Norrie disease.

      While a number of Tspan12 residues that we predict to interact with Norrin are impacted by rare mutations in humans (e.g., L169M, E170V, E173K, D175N, E196G, S199C, as found in the gnomAD database), these alleles are of unknown clinical significance (as found in ClinVar or HGMD databases). It is possible that mutations that slightly weaken the Norrin-Tspan12 interface may not produce a strong phenotype, especially given the avidity we expect from this system. By our examination, the missense variants of clinical significance that have been found in the Tspan12 LEL would be expected to destabilize the protein (i.e., mutations to or from cysteine or proline, or mutations to residues involved in packing interactions within the LEL fold), and therefore these mutations may produce a disease phenotype by impacting Tspan12 protein expression levels.  

      Several Norrin mutations that are associated with Norrie disease, FEVR, or other diseases of the retinal vasculature have been found in the predicted Tspan12 binding site. For example, Norrin mutations at positions L103 (L103Q, L103V), K104 (K104N, K104Q), and A105 (A105T, A105P, A105E, A105S, A105T, A105V) have been found in patients, all of which may disrupt binding to Tspan12. However, the deleterious effect of K104 mutations on Norrin-stimulated signaling could also be explained by a weakened Norrin-Fzd4 binding interface. Norrin mutations at R115 (R115L and R115Q), as well as R121 (R121L, R121G, R121Q, and R121W) have also been found in patients with various diseases of the retinal vasculature. Additionally, the Norrin mutation T119P has been found in patients with Norrie disease, but we would expect this mutation to destabilize Norrin in addition to disrupting the Tspan12 binding site. 

      While we commented briefly on mutations R115L and R121W in the original draft (page 5, paragraphs 4 and 1, respectively), we have updated the manuscript with more comments on disease-associated mutations to the predicted Tspan12 binding site on Norrin (page 5, first partial paragraph; page 9, first partial paragraph). 

      • Some of the negative conclusions (e.g. the lack of involvement of Tspan12 in the formation of the Norrin-Lrp5/6-Fzd4-Dvl signaling complex) can be difficult to interpret. There are many possible reasons as to why certain biological effects are not recapitulated in a reconstitution experiment. For instance, the recombinant proteins used in the experiment may not be presented in the correct configurations, and certain biochemical modifications, such as phosphorylation, may also be missing. 

      We agree that different Tspan12 and Fzd4 stoichiometries, lipid compositions, and posttranslational modifications could impact the results of our study, and that it is important to mention these possibilities. We have added these caveats to the discussion section (page 10, last paragraph).  

      Reviewer #2 (Public Review): 

      This is an interesting study of high quality with important and novel findings. Bruguera et al. report a biochemical and structural analysis of the Tspan12 co-receptor for norrin. Major findings are that Norrin directly binds Tspan12 with high affinity (this is consistent with a report on BioRxiv: Antibody Display of cell surface receptor Tetraspanin12 and SARS-CoV-2 spike protein) and a predicted structure of Tspan12 alone or in complex with Norrin. The

      Norrin/Tspan12 binding interface is largely verified by mutational analysis. An interaction of the Tspan12 large extracellular loop (LEL) with Fzd4 cannot be detected and interactions of fulllength Tspan12 and Fzd4 cannot be tested using nano-disc based BLI, however, Fzd4/Tspan12 heterodimers can be purified and inserted into nanodiscs when aided by split GFP tags. An analysis of a potential composite binding site of a Fzd4/Tspan12 complex is somewhat inconclusive, as no major increase in affinity is detected for the complex compared to the individual components. A caveat to this data is that affinity measurements were performed for complexes with approximately 1 molecule Tspan12 and FZD4 per nanodisc, while the composite binding site could potentially be formed only in higher order complexes, e.g., 2:2 Fzd4/Tspan12 complexes. Interestingly, the authors find that the Norrin/Tspan12 binding site and the Norrin/Lrp6 binding site partially overlap and that the Lrp6 ectodomain competes with Tspan12 for Norrin binding. This result leads the authors to propose a model according to which Tspan12 captures Norrin and then has to "hand it off" to allow for Fzd4/Lrp6 formation. By increasing the local concentration of Norrin, Tspan12 would enhance the formation of the Fzd4/Lrp5 or Fzd4/Lrp6 complex. 

      Thank you for pointing out the BioRxiv report showing Norrin-Tspan12 LEL binding. We have cited this in the introduction of our revised manuscript (page 2, paragraph 3).

      The experiments based on membrane proteins inserted into nano-discs and the structure prediction using AlphaFold yield important new insights into a protein complex that has critical roles in normal CNS vascular biology, retinal vascular disease, and is a target for therapeutic intervention. However, it remains unclear how Norrin would be "handed off" from Tspan12 or Tspan12/Fzd4 complexes to Fzd4/Lrp6 complexes, as the relatively high affinity of Norrin to Fzd4/Tspan12 dimers likely does not favor the "handing off" to Fzd4/Lrp6 complexes. 

      While the Fzd4-Tspan12 interaction is strong, our data suggest that Fzd4 and Tspan12 bind Norrin with negative cooperativity, suggesting that Fzd4 binding may enhance Norrin-Tspan12 dissociation to facilitate handoff. This model is based on 1) the dissociation of Norrin from beadbound Tspan12 in the presence of saturating Fzd4 CRD (Figure 3D), and 2) a weaker measured affinity of Norrin-Tspan12LEL in the presence of saturating Fzd4 CRD (Figure 3F). We have now added wording to emphasize this in the discussion section (page 9, end of first full paragraph).

      However, as you note, the Norrin-Tspan12 affinity that we measured in the presence of Fzd CRD (tens of nM) is still much stronger than the known Norrin-LRP6 affinity (0.5-1µM), which predicts that the efficiency of this handoff may be low. We have now commented on this in the discussion section and mentioned an alternative model in which Tspan12 presents the second Norrin protomer to LRP5/6 for signaling, instead of dissociating (page 9, paragraph 2). However, the handoff efficiency could also be impacted by other factors such as the relative abundance and surface distribution of Tspan12, Fzd4, LRP6 and HSPGs.  

      Areas that would benefit from further experiments, or a discussion, include: 

      -  The authors test a potential composite binding site of Fzd4/Tspan12 heterodimers for norrin using nanodiscs that contain on average about 1 molecule Fzd4 and 1 molecule Tspan12. The Fzd4/Tspan12 heterodimer is co-inserted into the nanodiscs supported by split-GFP tags on Fzd4 and Tspan12. The authors find no major increase in affinity, although they find changes to the Hill slope, reflecting better binding of norrin at low norrin concentrations. In 293F cells overexpressing Fzd4 and Tspan12 (which may result in a different stoichiometry) they find more pronounced effects of norrin binding to Fzd4/Tspan12. This raises the possibility that the formation of a composite binding requires Fzd4/Tspan12 complexes of higher order, for example, 2:2 Fzd4/Tspan12 complexes, where the composite binding site may involve residues of each Fzd4 and Tspan12 molecule in the complex. This could be tested in nanodiscs in which Fzd4 and Tspan12 are inserted at higher concentrations or using Fzd4 and Tspan12 that contain additional tags for oligomerization. 

      It is quite possible that Tspan12 and Fzd4 cluster into complexes with a stoichiometry greater than 1:1 in cells (this is supported by e.g., BRET experiments in (Ke et al., 2013)), and we mention in the discussion that that receptor clustering may be an additional mechanism by which Tspan12 exerts its function (page 10, paragraph 4). We would be quite interested to know the stoichiometry of Fzd4 and Tspan12 complexes in cells at endogenous expression levels, both in the presence and absence of Norrin, and to biochemically characterize these putative larger complexes in the future. We have amended the discussion to mention the caveat that our reconstitution experiments do not test higher-stoichiometry Fzd4/Tspan12 complexes (page 10, last paragraph).

      - While Tspan12 LEL does not bind to Fzd4, the successful reconstitution of GFP from Tspan12 and Fzd4 tagged with split GFP components provides evidence for Fzd4/Tspan12 complex formation. As a negative control, e.g., Fzd5, or Tspan11 with split GFP tags (Fzd5/Tspan12 or Fzd4/Tspan11) would clarify if FZD4/Tspan12 heterodimers are an artefact of the split GFP system. 

      The split-GFP system allows us to co-purify receptors that do not normally co-localize (for example, as we have shown with Fzd4 and LRP6 in the absence of ligand (Bruguera et al., 2022)) so we do not mean to claim that it provides evidence for Fzd4/Tspan12 complex formation. In fact, we were unable to co-purify co-expressed Fzd4 and Tspan12 unless they were tethered with the split GFP system, and separately-purified Fzd4 and Tspan12 did not incorporate into nanodiscs together unless they were tethered by split GFP. Based on these experiments, we expect that the purported Fzd4-Tspan12 interaction that others have found by co-IP or co-localization is easily disrupted by detergent, may require a specific lipid, and/or may not be direct.

      To clarify this point, we have noted in the results section that without the split GFP tags, Tspan12 and Fzd4 did not co-purify or co-reconstitute into nanodiscs, and that co-reconstitution was enabled by the split GFP system (page 6, first full paragraph).   

      - Fzd4/Tspan12 heterodimers stabilized by split GFP may be locked into an unfavorable orientation that does not allow for the formation of a composite binding site of FZD4 and Tspan12, this is another caveat for the interpretation that Fzd4/Tspan12 do not form a composite binding site. This is not discussed. 

      While the split GFP does enforce a Fzd4/Tspan12 dimer, the split GFP is removed by protease cleavage during the final step of the purification process, after the dimer is contained in a nanodisc. This should allow Fzd4 and Tspan12 to freely adopt any pose and to diffuse within the confines of the nanodisc lipid bilayer. However, it has been shown that the phospholipid bilayer in small nanodiscs is not as fluid as the physiological plasma membrane, and although we used the slightly larger belt protein (MSP1E3D1, 13 nm diameter nanodiscs), perhaps the receptors are indeed locked in some unfavorable state for this reason. Additionally, the nanodiscs are planar, so if the formation of a composite binding site requires membrane curvature, this would not be recapitulated in our system. We have cited these caveats in the discussion section (page 10, last paragraph).  

      - Mutations that affect the affinity of norrin/fzd4 are not used to further test if Fzd4 and Tspan12 form a composite binding site. Norrin R41E or Fzd4 M105V were previously reported to reduce norrin/frizzled4 interactions and signaling, and both interaction and signaling were restored by Tspan12 (Lai et al. 2017). Whether a Fzd4/Tspan12 heterodimer has increased affinity for Norrin R41E was not tested. Similarly, affinity of FZD4 M105V vs a Fzd4 M105V/Tspan12 heterodimer were not tested. 

      Since the high affinity of Norrin for both Fzd4 and Tspan12 may have obscured any enhancement of Norrin affinity for Fzd4/Tspan12 compared to either receptor alone, we did consider weakening Fzd-Norrin affinity to sensitize this experiment, inspired by the experiments you mention in (Lai et al., 2017). However, we suspected that the slight increase in Norrin affinity for the Fzd4/Tspan12 dimer compared to Fzd4 alone was driven mainly by increased avidity that enhanced binding of low Norrin concentrations, and this avidity effect would likely confound the interpretation of any experiment monitoring 2:2 complex formation. Additionally, on the basis that soluble Fzd4 extracellular domain and Tspan12 bind Norrin with negative cooperativity (Figures 3D and 3F), we concluded that this composite binding site was unlikely.

      - An important conclusion of the study is that Tspan12 or Lrp6 binding to Norrin is mutually exclusive. This could be corroborated by an experiment in which LRP5/6 is inserted into nanodiscs for BLI binding tests with Norrin, or Tspan12 LEL, or a combination of both. Soluble LRP6 may remove norrin from equilibrium binding/unbinding to Tspan12, therefore presenting LRP6 in a non-soluble form may yield different results. 

      We agree that testing this conclusion in an orthogonal experiment would be a valuable addition to this study. We have now performed a similar experiment to the one you described, but with Norrin immobilized on biosensors, and with LRP6 in detergent competing with Tspan12 LEL for Norrin binding (Figure S12, discussed on page 8, first full paragraph). The results of this experiment show that biosensor-immobilized Norrin will bind LRP6, and that soluble Tspan12 inhibits LRP6 binding in a concentration-dependent manner. The LRP6 construct we use (residues 20-1439) includes the transmembrane domain but has a truncated C terminus, since LRP6 constructs containing the full C terminus tend to aggregate during purification. We chose to immobilize Norrin to make the experiment as interpretable as possible, since immobilizing LRP6 and competing Norrin off with the LEL could result in an increase in signal (from the LEL binding the second available Norrin protomer) as well as a decrease (from Norrin being competed off of the immobilized LRP6). We conducted the experiment in detergent (DDM) instead of nanodiscs to be able to test higher concentrations of LRP6.

      - The authors use LRP6 instead of LRP5 for their experiments. Tspan12 is less effective in increasing the Norrin/Fzd4/Lrp6 signaling amplitude compared to Norrin/Fzd4/Lrp5 signaling, and human genetic evidence (FEVR) implicates LRP5, not LRP6, in Norrin/Frizzled4 signaling. The authors find that Norrin binding to LRP6 and Tspan12 is mutually exclusive, however this may not be the case for Lrp5. 

      This is an important point which we have now addressed in the text (page 8, end of first full paragraph). LRP5 is indeed the receptor implicated in FEVR and expressed in the relevant tissues for Tspan12/Norrin signaling. Unfortunately, LRP5 expresses poorly and we are unable to purify sufficient quantities to perform these experiments. However, LRP5 and LRP6 both transduce Tspan12-enhanced Norrin signaling in TOPFLASH assays (as you mention and as shown by (Zhou and Nathans, 2014)), bind Norrin, and are highly similar (they share 71% sequence identity overall and 73% sequence identity in the extracellular domain), so we expect their Norrin-binding sites to be conserved.

      - The biochemical data are largely not correlated with functional data. The authors suggest that the Norrin R115L FEVR mutation could be due to reduced norrin binding to tspan12, but do not test if Tspan12-mediated enhancement of the norrin signaling amplitude is reduced by the R115L mutation. Similarly, the impressive restoration of binding by charge reversal mutations in site 3 is not corroborated in signaling assays. 

      We agree that testing the impact of Norrin mutations in cell-based signaling assays would be an informative way to further test our model. However, the Norrin mutants we tested generated poor TopFlash signals in all conditions tested. This may be due to general protein instability, weakened affinity for LRP, or weaker interactions with HSPGs. Whatever the cause, the low signal made it challenging to conclusively say whether the Norrin mutations affected Tspan12mediated signaling enhancement.

      When expressed for purification, Tspan12 mutants generally expressed poorly compared to WT Tspan12, so we were concerned that differences in protein stability or trafficking would lead to lower cell-surface levels of mutant Tspan12 relative to WT in TopFlash signaling assays, which would confound interpretation of mutant Tspan’s ability to enhance Norrin signaling.

      Because of these challenges, follow-up experiments to investigate the signaling capabilities of Norrin and Tspan12 mutants were not informative and we have not included them in the revised manuscript.

      Reviewer #3 (Public Review): 

      Brugeuera et al present an impressive series of biochemical experiments that address the question of how Tspan12 acts to promote signaling by Norrin, a highly divergent TGF-beta family member that serves as a ligand for Fzd4 and Lrp5/6 to promote canonical Wnt signaling during CNS (and especially retinal) vascular development. The present study is distinguished from those of the past 15 years by its quantitative precision and its high-quality analyses of concentration dependencies, its use of well-characterized nano-disc-incorporated membrane proteins and various soluble binding partners, and its use of structure prediction (by AlphaFold) to guide experiments. The authors start by measuring the binding affinity of Norrin to Tspan12 in nanodiscs (~10 nM), and they then model this interaction with AlphaFold and test the predicted interface with various charge and size swap mutations. The test suggests that the prediction is approximately correct, but in one region (site 1) the experimental data do not support the model. [As noted by the authors, a failure of swap mutations to support a docking model is open to various interpretations. As AlphFold docking predictions come increasingly into common use, the compendium of mutational tests and their interpretations will become an important object of study.] Next, the authors show that Tspan12 and Fzd4 can simultaneously bind Norrin, with modest negative cooperativity, and that together they enhance Norrin capture by cells expressing both Tspan12 and Fzd4 compared to Fzd4 alone, an effect that is most pronounced at low Norrin concentration. Similarly, at low Norrin concentration (~1 nM), signaling is substantially enhanced by Tspan12. By contrast, the authors show that LRP6 competes with Tspan12 for Norrin binding, implying a hand-off of Norrin from a Tspan12+Fzd4+Norrin complex to a LRP5/6+Fzd4+Norrin complex. Thanks to the authors' careful dose-response analyses, they observed that Norrin-induced signaling and Tspan12 enhancement of signaling both have bell-shaped dose-response curves, with strong inhibition at higher levels of Norrin or Tspan12. The implication is that the signaling system has been built for optimal detection of low concentrations of Norrin (most likely the situation in vivo), and that excess Tspan12 can titrate Norrin at the expense of LRP5/6 binding (i.e., reduction in the formation of the LRP5/6+Fzd4+Norrin signaling complex). In the view of this reviewer, the present work represents a foundational advance in understanding Norrin signaling and the role of Tspan12. It will also serve as an important point of comparison for thinking about signaling complexes in other ligand-receptor systems. 

      Recommendations for the authors: 

      Reviewer #2 (Recommendations For The Authors):   

      - In Figure 5F high concentrations of transfected Tspan12 plasmid inhibit signaling, which the authors interpret to support the model that Tspan12/Norrin binding prevents Norrin/LRP6/FZD4 complex formation. Alternatively, the cells do not tolerate the expression of the tetraspanin at high levels, for example, due to misfolding and aggregate formation. To distinguish these possibilities: Do high levels of Tspan12 overexpression also inhibit signaling induced by Wnt3a and appropriate Frizzled receptors, even though Tspan12 has no influence on Wnt/LRP6 binding? 

      We thank the reviewer for suggesting this important control experiment. We have added the Wnt-simulated TOPFLASH values to the figure in 5F for all conditions. In repeating this experiment, we noticed that high levels of transfected Tspan12 may decrease cell viability and therefore have adjusted the range of transfected Tspan12 in the new Figure 5F (discussed on page 8, second full paragraph). Under this new protocol, both Norrin- and Wnt-stimulated signaling were inhibited by the highest amount of transfected Tspan12. However, Norrinstimulated signaling is inhibited by lower amounts of transfected Tspan12 than Wnt-stimulated signaling, and to a greater extent, supporting our proposed model that Tspan12 competes with LRP for Norrin binding.

      - Is Tspan12 with c-terminal rho-tag (the form incorporated into nanodiscs) also used for functional luciferase assays, or was untagged Tspan12 used for the luciferase assays in Fig 4D and 5F? Does the c-terminal tag interfere with Tspan12-mediated enhancement of Norrin signaling? 

      For the luciferase assays included in this manuscript, wildtype, full-length, untagged Tspan12 is used. We have clarified this in our methods section. When we tested the wildtype vs Cterminally rho1D4-tagged version of Tspan12 in TOPFLASH assays, we saw that the enhancement of Norrin signaling by Tspan12-1D4 was weaker than enhancement by untagged Tspan12. This is consistent with the finding reported in Cell Reports (Lai et al., 2017) that a chimeric Tspan12 receptor with its C-terminus replaced with that of Tspan11 was still capable of enhancing Norrin signaling, though to a lesser extent than WT Tspan12. The deficiency of signaling by our rho1D4-tagged Tspan12 could be due to a difference in receptor expression level or trafficking, but in the absence of a reliable antibody against Tspan12, we were unable to assess the expression levels or localization of the untagged Tspan12 to compare it to the rho1D4-tagged version. (For binding experiments, we reasoned that the C-terminal tag should not affect Tspan12’s ability to bind Norrin extracellularly, especially as we found that purified fulllength Tspan12 and Tspan12∆C (residues 1-252) bound Norrin equally well; we have added this comparison to table S1.)  

      Reviewer #3 (Recommendations For The Authors): 

      Minor comments. 

      Based on the Fzd4-Dvl binding experiment, the authors might state explicitly the possibility that Tspan12's relevance is entirely accounted for by extracellular ligand capture. 

      We have stated this possibility explicitly in the discussion section (page 9, last paragraph). 

      Page 4, 3rd paragraph. I suggest "To experimentally test this structural prediction..." rather than "validate". 

      Thank you for this suggestion; we have replaced this wording. 

      This next item is optional, but I hope that the authors will consider it. This manuscript provides an opportunity for the authors to be more expansive in their thinking, and to put their work into the larger context of ligand+receptor+accessory protein interactions. The authors describe the Wnt7a/7b-Gpr124-RECK system and the role of HSPs in Norrin and Wnt signaling, but perhaps they can also comment on non-Wnt ligand-receptor systems where accessory proteins are found. They might add a figure (or supplemental figure) with a schematic showing the roles of HSP and Gpr124-RECK, and some non-Wnt ligand-receptor systems. This would help to make the present work more widely influential.

      Thank you for this suggestion. We have added a figure (Figure 6, discussed on page 10, paragraphs 2 and 3) and expanded our discussion to include other co-receptor systems. We have specifically focused on co-receptors that both capture ligands and interact with their primary receptor(s), thus delivering ligands to their receptors, as we have proposed for Tspan12. Within Wnt signaling, other co-receptor systems with this mechanism are RECK/Gpr124 (for Wnt7a/b) and Glypican-3. We found it interesting that this mechanism is also shared by several growth factor pathways with cystine knot ligands (like Norrin), so we have illustrated and mentioned three of these examples.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, Zhang et al., presented an electrophysiology method to identify the layers of macaque visual cortex with high density Neuropixels 1.0 electrode. They found several electrophysiology signal profiles for high-resolution laminar discrimination and described a set of signal metrics for fine cortical layer identification.

      Strengths:

      There are two major strengths. One is the use of high density electrodes. The Neuropixels 1.0 probe has 20 um spacing electrodes, which can provide high resolution for cortical laminar identification. The second strength is the analysis. They found multiple electrophysiology signal profiles which can be used for laminar discrimination. Using this new method, they could identify the most thin layer in macaque V1. The data support their conclusion.

      Weaknesses:

      While this electrophysiology strategy is much easier to perform even in awake animals compared to histological staining methods, it provides an indirect estimation of cortical layers. A parallel histological study can provide a direct matching between the electrode signal features and cortical laminar locations. However, there are technical challenges, for example the distortions in both electrode penetration and tissue preparation may prevent a precise matching between electrode locations and cortical layers. In this case, additional micro wires electrodes binding with Neuropixels probe can be used to inject current and mark the locations of different depths in cortical tissue after recording.

      While we agree that it would be helpful to adopt a more direct method for linking laminar changes observed with electrophysiology to anatomical layers observed in postmortem histology, we do not believe that the approach suggested by the reviewer would be particularly helpful. The approach suggested involves making lesions, which are known to be quite variable in size, asymmetric in shape, and do not have a predictable geometry relative to the location of the electrode tip. In contrast, our electrophysiology measures have identified clear boundaries which precisely match the known widths and relative positions of all the layers of V1, including layer 4A, which is only 50 microns thick, much smaller than the resolution of lesion methods.

      Reviewer #2 (Public Review):

      Summary:

      This paper documents an attempt to accurately determine the locations and boundaries of the anatomically and functionally defined layers in macaque primary visual cortex using voltage signals recorded from a high-density electrode array that spans the full depth of cortex with contacts at 20 um spacing. First, the authors attempt to use current source density (CSD) analysis to determine layer locations, but they report a striking failure because the results vary greatly from one electrode penetration to the next and because the spatial resolution of the underlying local field potential (LFP) signal is coarse compared to the electrical contact spacing. The authors thus turn to examining higher frequency signals related to action potentials and provide evidence that these signals reflect changes in neuronal size and packing density, response latency and visual selectivity.

      Strengths:

      There is a lot of nice data to look at in this paper that shows interesting quantities as a function of depth in V1. Bringing all of these together offers the reader a rich data set: CSD, action potential shape, response power and coherence spectrum, and post-stimulus time response traces. Furthermore, data are displayed as a function of eye (dominant or non-dominant) and for achromatic and cone-isolating stimuli.

      This paper takes a strong stand in pointing out weaknesses in the ability of CSD analysis to make consistent determinations about cortical layering in V1. Many researchers have found CSD to be problematic, and the observations here may be important to motivate other researchers to carry out rigorous comparisons and publish their results, even if they reflect negatively on the value of CSD analysis.

      The paper provides a thoughtful, practical and comprehensive recipe for assigning traditional cortical layers based on easily-computed metrics from electrophysiological recordings in V1, and this is likely to be useful for electrophysiologists who are now more frequently using high-density electrode arrays.

      Weaknesses:

      Much effort is spent pointing out features that are well known, for example, the latency difference associated with different retinogeniculate pathways, the activity level differences associated with input layers, and the action potential shape differences associated with white vs. gray matter. These have been used for decades as indicators of depth and location of recordings in visual cortex as electrodes were carefully advanced. High density electrodes allow this type of data to now be collected in parallel, but at discrete, regular sampling points. Rather than showing examples of what is already accepted, the emphasis should be placed on developing a rigorous analysis of how variable vs. reproducible are quantitative metrics of these features across penetrations, as a function of distance or functional domain, and from animal to animal. Ultimately, a more quantitative approach to the question of consistency is needed to assess the value of the methods proposed here.

      We thank the reviewer for suggesting the addition of quantitative metrics to allow more substantive comparisons between various measures within and between penetrations. We have added quantification and describe this in the context of more specific comments made by this reviewer. We have retained descriptions of metrics that are well established because they provide an important validation of our approaches and laminar assignments.

      Another important piece of information for assessing the ability to determine layers from spiking activity is to carry out post-mortem histological processing so that the layer determination made in this paper could be compared to anatomical layering.

      We are not aware of any approach that would provide such information at sufficient resolution. For example, it is well known that electrolytic lesions often do not match to the locations expected from electrophysiological changes observed with single electrodes. As noted above, our observation that the laminar changes in electrophysiology precisely match the known widths and relative positions of all the layers of V1, including layer 4A, provides confidence in our laminar assignments.

      On line 162, the text states that there is a clear lack of consistency across penetrations, but why should there be consistency: how far apart in the cortex were the penetrations? How long were the electrodes allowed to settle before recording, how much damage was done to tissue during insertion? Do you have data taken over time - how consistent is the pattern across several hours, and how long was the time between the collection of the penetrations shown here?

      Answers to most of these questions can be found within the manuscript text. We have added text describing distance between electrode penetrations (at least 1mm, typically far more) and added a figure which shows a map of the penetration locations. The Methods section describes electrode penetration methods to minimize damage and settling times of penetrations. Data are provided regarding changes in recordings over time (see Methods, Drift Correction). The stimuli used to generate the data described are presented within a total of 30 minutes or less, minimizing any changes that might occur due to electrode drift. There is a minimum of 3 hours between different penetrations from the same animal.

      The impact of the paper is lessened because it emphasizes consistency but not in a consistent manner. Some demonstrations of consistency are shown for CSDs, but not quantified. Figure 4A is used to make a point about consistency in cell density, but across animals, whereas the previous text was pointing out inconsistency across penetrations. What if you took a 40 or 60 um column of tissue and computed cell density, then you would be comparing consistency across potentially similar scales. Overall, it is not clear how all of these different metrics compare quantitatively to each other in terms of consistency.

      As noted above, we have now added quantitative comparisons of consistency between different metrics. It is unclear why the reviewer felt that we use Figure 4A to describe consistency. That figure was a photograph from a previous publication simply showing the known differences in neuron density that are used to define layers in anatomical studies. This was intended to introduce the reader to known laminar differences. At any rate, we have been unable to contact the previous publishers of that work to obtain permission to use the figure. So we have removed that figure as it is unnecessary to illustrate the known differences in cell density that are used to define layers. We have kept the citation so that interested readers can refer to the publication.

      In many places, the text makes assertions that A is a consistent indicator of B, but then there appear to be clear counterexamples in the data shown in the figures. There is some sense that the reasoning is relying too much on examples, and not enough on statistical quantities.

      Without reference to specific examples we are not able to address this point.

      Overall

      Overall, this paper makes a solid argument in favor of using action potentials and stimulus driven responses, instead of CSD measurements, to assign cortical layers to electrode contacts in V1. It is nice to look at the data in this paper and to read the authors' highly educated interpretation and speculation about how useful such measurements will be in general to make layer assignments. It is easy to agree with much of what they say, and to hope that in the future there will be reliable, quantitative methods to make meaningful segmentations of neurons in terms of their differentiated roles in cortical computation. How much this will end up corresponding to the canonical layer numbering that has been used for many decades now remains unclear.

      Reviewer #3 (Public Review):

      Summary:

      Zhang et al. explored strategies for aligning electrophysiological recordings from high-density laminar electrode arrays (Neuropixels) with the pattern of lamination across cortical depth in macaque primary visual cortex (V1), with the goal of improving the spatial resolution of layer identification based on electrophysiological signals alone. The authors compare the current commonly used standard in the field - current source density (CSD) analysis - with a new set of measures largely derived from action potential (AP) frequency band signals. Individual AP band measures provide distinct cues about different landmarks or potential laminar boundaries, and together they are used to subdivide the spatial extent of array recordings into discrete layers, including the very thin layer 4A, a level of resolution unavailable when relying on CSD analysis alone for laminar identification. The authors compare the widths of the resulting subdivisions with previously reported anatomical measurements as evidence that layers have been accurately identified. This is a bit circular, given that they also use these anatomical measurements as guidelines limiting the boundary assignments; however, the strategy is overall sensible and the electrophysiological signatures used to identify layers are generally convincing. Furthermore, by varying the pattern of visual stimulation to target chromatically sensitive inputs known to be partially segregated by layer in V1, they show localized response patterns that lend confidence to their identification of particular sublayers.

      The authors compellingly demonstrate the insufficiency of CSD analysis for precisely identifying fine laminar structure, and in some cases its limited accuracy at identifying coarse structure. CSD analysis produced inconsistent results across array penetrations and across visual stimulus conditions and was not improved in spatial resolution by sampling at high density with Neuropixels probes. Instead, in order to generate a typical, informative pattern of current sources and sinks across layers, the LFP signals from the Neuropixels arrays required spatial smoothing or subsampling to approximately match the coarser (50-100 µm) spacing of other laminar arrays. Even with smoothing, the resulting CSDs in some cases predicted laminar boundaries that were inconsistent with boundaries estimated using other measures and/or unlikely given the typical sizes of individual layers in macaque V1. This point alone provides an important insight for others seeking to link their own laminar array recordings to cortical layers.

      They next offer a set of measures based on analysis of AP band signals. These measures include analyses of the density, average signal spread, and spike waveforms of single- and multi-units identified through spike sorting, as well as analyses of AP band power spectra and local coherence profiles across recording depth. The power spectrum measures in particular yield compact peaks at particular depths, albeit with some variation across penetrations, whereas the waveform measures most convincingly identified the layer 6-white matter transition. In general, some of the new measures yield inconsistent patterns across penetrations, and some of the authors' explanations of these analyses draw intriguing but rather speculative connections to properties of anatomy and/or responsivity. However, taken as a group, the set of AP band analyses appear sufficient to determine the layer 6-white matter transition with precision and to delineate intermediate transition points likely to correspond to actual layer boundaries.

      Strengths:

      The authors convincingly demonstrate the potential to resolve putative laminar boundaries using only electrophysiological recordings from Neuropixels arrays. This is particularly useful given that histological information is often unavailable for chronic recordings. They make a clear case that CSD analysis is insufficient to resolve the lamination pattern with the desired precision and offer a thoughtful set of alternative analyses, along with an order in which to consider multiple cues in order to facilitate others' adoption of the strategy. The widths of the resulting layers bear a sensible resemblance to the expected widths identified by prior anatomical measurements, and at least in some cases there are satisfying signatures of chromatic visual sensitivity and latency differences across layers that are predicted by the known connectivity of the corresponding layers. Thus, the proposed analytical toolkit appears to work well for macaque V1 and has strong potential to generalize to use in other cortical regions, though area-targeted selection of stimuli may be required.

      Weaknesses:

      The waveform measures, and in particular the unit density distribution, are likely to be sensitive to the criteria used for spike sorting, which differ widely among experimenters/groups, and this may limit the usefulness of this particular measure for others in the community. The analysis of detected unit density yields fluctuations across cortical depth which the authors attribute to variations in neural density across layers; however, these patterns seemed particularly variable across penetrations and did not consistently yield peaks at depths that should have high neuronal density, such as layer 2. Therefore, this measure has limited interpretability.

      While we agree that our electrophysiological measure of unit density does not strictly reflect anatomical neuronal density, we would like to remind the reader that we use this measure only to roughly estimate the correspondence between changes in density and likely layer assignments. We rely on other measures (e.g. AP power, AP power changes in response to visual stimuli) that have sharp borders and more clear transitions to assign laminar boundaries. Further, as noted in the reviewer’s list of strengths, the laminar assignments made with these measures are cross validated by differences in response latencies and sensitivity to different types of stimuli that are observed at different electrode depths.

      More generally, although the sizes of identified layers comport with typical sizes identified anatomically, a more powerful confirmation would be a direct per-penetration comparison with histologically identified boundaries. Ultimately, the absence of this type of independent confirmation limits the strength of their claim that veridical laminar boundaries can be identified from electrophysiological signals alone.

      As we have noted in response to similar comments from other reviewers, we are not aware of a method that would make this possible with sufficient resolution.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      The reviewers have indicated that their assessment would potentially be stronger if their advice for quantitative, statistically validated comparisons was followed, for example, to demonstrate variability or consistency of certain measures that are currently only asserted. Also, if available, some histological confirmation would be beneficial. It was requested that the use and modification of the layering from Balaram & Kaas is addressed, as well as dealing with inconsistencies in the scale bars on those figures. There are two figure permission issues that need to be resolved prior to publication: Balaram & Kaas 2014 in Fig 1A, Kelly & Hawken 2017 in Fig. 4A.

      Please see detailed responses to reviewer comments below. We have added new supplemental figures to quantitatively compare variability among metrics. As noted above, the suggested addition of data linking the electrophysiology directly to anatomical observations of laminar borders from the same electrode penetration is not feasible. The figure reused in Figure 1A is from open-access (CC BY) publication (Balaram & Kaas 2014). After reexamining the figure in the original study, we found that the inferred scale bar would give an obviously inaccurate result. So, we decided to remove the scale bar in Figure 1A. We haven’t received any reply from Springer Nature for Figure 4A permission, so we decided to remove the reused figure from our article (Kelly & Hawken 2017).

      Reviewer #1 (Recommendations For The Authors):<br /> Figure 4A has a different scale to Figure 4B-4F. It is better to add dashed lines to indicate the relationship between the cortical layers or overall range from Figure 4A to the corresponding layers in 4B to 4F.

      The reused figure in Figure 4A is removed due to permission issue. See also comments above.

      Reviewer #2 (Recommendations For The Authors):

      General comments

      This paper demonstrates that voltage signals in frequency bands higher than those used for LFP/CSD analysis can be used from high-density electrical contact recording to generate a map of cortical layering in macaque V1 at a higher spatial resolution than previously attained.

      My main concern is that much of this paper seems to show that properties of voltage signals recorded by electrodes change with depth in V1. This of course is well known and has been mapped by many who have advanced a single electrode micron-by-micron through the cortex, listening and recording as they go. Figure 4 shows that spike shapes can give a clear indication of GM to WM borders, and this is certainly true and well known. Figures 5 and 6 show that activity level on electrodes can indicate layers related to LGN input, and this is known. Figure 7 shows that latencies vary with layer, and this is certainly true as we know. A main point seems to be that CSD is highly inconsistent. This is important to know if CSD is simply never going to be a good measure for layering in V1, but it would require quantification and statistics to make a fair comparison.

      We are glad to see that the reviewer understands that changes in electrical signals across layers are well known and are expected to have particular traits that change across layers. We do not claim that have discovered anything that is unexpected or unknown. Instead, we introduce quantitative measures that are sensitive to these known differences (historically, often just heard with an audio monitor e.g. “LGN axon hash”). While the primary aim of this paper is not to show that Neuropixels probes can record some voltage signal properties that cannot be recorded with a single electrode before, we would like to point out that multi-electrode arrays have a very different sampling bias and also allow comparisons of simultaneous recordings across contacts with known fixed distances between them. For example our measure of “unit spread” could not be estimated with a single electrode.

      We’ve added Figure S3 to show quantitative comparison of variation between CSD and AP metrics. These figures add support to our prior, more anecdotal descriptions showing that CSDs are inconsistent and lack the resolution needed to identify thin layers.

      Some things are not explained very clearly. Like achromatic regions, and eye dominance - these are not quantified, and we don't know if they are mutually consistent - are achromatic/chromatic the same when tested through separate eyes? How consistent are these basic definitions? How definitive are they?

      The quantitative definitions of achromatic region/COFD and eye dominance column can be found in our previous paper (Li et al., 2022) cited in this article. The main theme of this study is to develop a strategy for accurately identifying layers, the more detailed functional analysis will be described in future publications.

      Specific comments

      The abstract refers to CSD analysis and CSD signals. Can you be more precise - do you aim to say that LFP signals in certain frequency bands are already known to lack spatial localization, or are you claiming to be showing that LFP signals lack spatial resolution? A major point of the results appears to be lack of consistency of CSD, but I do not see that in the Abstract. The first sentence in the abstract appears to be questionable based on the results shown here for V1.

      We have updated the Abstract to minimize confusion and misunderstanding.

      Scale bar on Fig 1A implies that layers 2-5 are nearly 3 mm thick. Can you explain this thickness? Other figures here suggest layers 1-6 is less than 2 mm thick. Note, in a paper by the same authors (Balaram et al) the scale bar (100 um, Figure 4) on similar macaque tissue suggests that the cortex is much thinner than this. Perhaps neither is correct, but you should attempt to determine an approximately accurate scale. The text defines granular as Layer 4, but the scale bar in A implies layer 4 is 1 mm thick, but this does not match the ~0.5 mm thickness consistent with Figure 1E, F. The text states that L4A is less then 100 um thick, but the markings and scale bar in Figure 1A suggests that it could be more than 100 um thick.

      We thank the reviewer for pointing out that there are clearly errors in the scale bars used in these previously published figures from another group. In the original figure 1(Balaram & Kaas 2014), histological slices were all scaled to one of the samples (Chimpanzee) without scale bar. After reexamining the scale bar we derived based on figure 2 of the original study, we found the same problem. Since relative widths of layers are more important than absolute widths in our study, we decided to remove the scale bar that we had derived and added to the Figure 1A.

      Line 157. Fix "The most commonly visual stimulus"

      Text has been changed

      Line 161. Fix "through dominate eye"

      Text has been changed

      Line 166. Please specify if the methods established and validated below are histological, or tell something about their nature here.

      The Abstract and Introduction already described the nature of our methods

      Line 184. Text is mixing 'dominant' and 'dominate', the former is better.

      Text has been changed accordingly

      Line 188. Can you clarify "beyond the time before a new stimulus transition". Are you generally referring to the fact that neuronal responses outlast the time between changes in the stimulus?

      That is correct. We are referring to the fact that neuronal responses outlast the time between changes in the stimulus. We have edited the text for clarity.

      Line 196. Fix "dominate eye" in two places.

      Text has been changed

      Line 196. The text seems to imply it is striking to find different response patterns for the two eyes, but given the OD columns, why should this be surprising?

      Since we didn’t find systematic comparison for CSD depth profiles of dominant/non-dominant eyes, or black/white in the past studies, we just describe what we saw in our data. The rational for testing each eye is that it is known that LGN projections from two eyes remain separated in direct input layer of V1, so comparing CSDs from two eyes could potentially help identifying input layers, such as L4C. Here we provide evidence showing that CSD profiles from two eyes deviate from naive expectations. For example, CSDs from black stimulus show less variation between two eyes, whereas CSDs from white stimulus could range from similar profile to drastically different ones across eyes.

      Line 198. Text like, "The most consistent..." is stating overall conclusions drawn by the authors before pointing the reader specifically to the evidence or the quantification that supports the statement.

      We’ve adjusted the text pointing to Figure S2, where depth profiles of all penetrations are visualized, and a newly added Figure S3, where the coefficients of variation for several metric profiles were shown.

      Line 200. "white stimulus is more variable" - the text does not tell us where/how this is supported with quantitative analysis/statistics.

      We’ve adjusted the text pointing to Figure S2, S3

      The metric in 4B is not explained, the text mentions the plot but the reader is unable to make any judgement without knowledge of the method, nor any estimate of error bars.

      The figure is first mentioned in section: Unit Density, and text in this section already described the definition of neuron density and unit density.  We’ve also modified the text pointing to the method section for details.

      Line 236. The text states the peak corresponds to L4C, but does not explain how the layer lines were determined.

      As described early in the CSD section, all layer boundaries are determined following the guide which layouts the strategy for how to draw borders by combining all metrics.

      At Line 296 the spike metrics section ends without providing a clear quantification of how useful the metrics will be. It is clear that the GM to WM boundary can be identified, but that can be found with single electrodes as well, as neurophysiologists get to see/hear the change in waveform as the electrode is advanced in even finer spatial increments than the 20 um spacing of the contacts here.

      The aim of this study is to develop an approach for accurately delineating layers simultaneously. The metrics we explored are considered estimation of well-known properties, so they can provide support for the correctness we hope to achieve. Here we first demonstrate the usefulness and later show the average across penetrations (Figure 9C-F). We are less concerned in quantification of how different factors affect precision and consistency of these metrics or how useful a single metric is, but rather, as described in the guide section, whether we can delineate all layers given all metrics.

      Line 302-306. Why this statement is made here is unclear, it interrupts the flow for a reason that perhaps will be explained later.

      This statement notes the insensitivity of this measure to temporal differences, introducing the value of incorporating a measure of how AP powers changes over time in the next section of the manuscript.

      Line 311. What is the reason to speculate about no canceling because of temporal overlap? Are you assuming a very sparse multi unit firing rate such that collisions do not happen?

      Here we describe a simple theoretical model in which spike waveforms only add without cancelling, then the power would be proportional to the number of spikes. In reality, spike waveform sometimes cancels causing the theoretical relationship to deteriorate to some degree.

      Lines 327-346. There is a considerable amount of speculation and arguing based on particular examples and there is a lack of quantification. Neuron density is mentioned, but not firing rate. would responses from fewer neurons with higher firing rate not be similar to more neurons with lower firing rates?

      According to the theoretical model we described, power is proportional to numbers of spikes which then depend on both neuron density and firing rate. So fewer neurons with higher firing rate would generate similar power to more neurons with lower firing rate. We’ve expanded the explanation of the model and added Figure S4 about the depth profile of firing rate. Text has also been adjusted pointing to the Figure S2, S3 about quantitively comparisons of variability.

      Line 348 states there is a precise link between properties and cortical layers, but the manuscript has not, up to this point, shown how that link was determined or quantified it.

      Through our generative model of power and the similarity between depth profile of firing rate and depth profile of neuron density (Figure S4), depth profile of power can be used to approximate depth profile of neuron density which is known to be closely correlated to cortical layering.

      Line 350. What is meant by "stochastic variability"?

      The text essentially says distances from electrode contact to nearby cell bodies were random, so closer cells have higher spike amplitudes and in turn result in higher power on a channel.

      The figures showing the two metrics, Pf and Cf, should be shown for the same data sets. The markings indicate that Fig 5 and Fig 6 show results from non-overlapping data sets. This does not build confidence about the results in the paper.

      Here we use typical profiles to demonstrate the characteristics of the power spectrum/coherence spectrum because of the variation across penetrations. We show later, in the guide section, all metrics for one penetration (another two cases in supplemental figures) and how to combine all metrics to derive layer delineations.

      Line 375 the statement is somewhat vague, "there are nevertheless sometimes cases where they can resolve uncertainties," can you please provide some quantitative support?

      We provided 3 examples in Figure 6, and more examples are shown in Figure 8, Figure S5, S6.

      Line 379. I believe the change you want to describe here is a change associated with a transition in the visual stimulus. It would be good to clarify this in the first several sentences here. Baseline can mean different things. I got the impression that your stimuli flip between states at a rate fast enough that signals do not really have time to return to a baseline.

      We rephrased the sentence to describe the metric more precisely. A pair of uniform colors flipping in 1.5 second intervals is usually long enough for spiking activities to decay to a saturated level.

      This section (379 - 398) continues a qualitative show-and-tell feel. There appears to be a lot of variability across the examples in Figure 7. How could you try to quantify this variability versus the variability in LFP? And, in this section overall, the text and figure legend don't really describe what the baseline is.

      Text adjustments are made to briefly describe the baseline window and point to the Method section where definitions are described in detail. We’ve added Figure S3 together with Figure S2 to address the variability across penetrations, stimuli, and metrics.

      Line 405 - 415. The discussion here does not consider that layers may not have well defined boundaries, the text gives the impression that there is some ultimate ground truth to which the metrics are being compared, but that may not be accurate.

      Except for a few layers/sublayers, such as L2, L3A, L3B, most layer boundaries of neocortex are well defined (Figure 1A) and histological staining of neurons/density and correlated changes in chemical content show very sharp transitions. The best of these staining methods is cytochrome oxidase, which shows sharp borders at the top and bottom of layer 4A, top and bottom of layer 4C, and the layer 5/6 border. There is also a sharp transition in neuronal cell body size and density at the top and bottom of layer 4Cb. The definition and delineation of all possible layers are constantly being refined, especially by accumulated knowledge of genetic markers of different cell types and connection patterns. In our study, we develop metrics to estimate well known anatomical and functional properties of different layers. We have also discussed layer boundaries that have been ambiguous to date and explained the reason and criteria to resolve them.

      Line 423. The text references Figure 1A in stating that relative thickness and position is crucial, but FIgure 1A does not provide that information and does not explain how it might be determined, or how much of a consensus there is. Also, the text does not consider that the electrode may go through the cortex at oblique angles, and not the same angle in each layer, and the relative thickness may not be a dependable reference.

      There are numerous studies that describe criteria to delineate cortical layers, the referenced article (Balaram & Kaas 2014) is used here as an example. We are not aware of any publication that has systematically compared the relative thickness of layers across the V1 surface of a given animal or across animals. Nevertheless, it is clear from the literature that there is considerable similarity across animals. Accordingly, we cannot know what the source of variability in overall cortical thickness in our samples is, but we do see considerable consistency in the relative thickness of the layers we infer from our measures. We illustrate the differences that we see across penetrations and consider likely causes, such as the extent to which the coverslip pressing down on the cortex might differentially compress the cortex at different locations within the chamber.

      The angle deviation of probe from surface will not change the relative thickness of layers, and the rigid linear probe is unlikely to bend in the cortex.

      Line 433. The term "Coherence" is used, clarify is this is you Cf from Figure 6. The text states, "marked decrease at the bottom of layer 6". Please clarify this, I do not see that in Figure 6.

      Text has been adjusted.

      In Figure 6, the locations of the lines between L1 and 2 do not seem to be consistent with respect to the subtle changes in light blue shading, across all three examples, yet the text on line 436 states that there is a clear transition.

      We feel that the language used accurately reflects what is shown in the figure. While the transition is not sharp, it is clear that there is a transition. This transition is not used to define this laminar border. We have edited the text to clarify that the L1/2 border is better defined based on the change in AP power which shows a sharp transition (Figure 7). 

      The text states that the boundary is also "always clear" from metrics... and sites Figure 5, but I do not see that this boundary is clear for all three examples in Figure 5.

      Text has been adjusted.

      Line 438. The text states that "it is not unusual for unit density to fall to zero below the L1/2 border (Figure 8E)", but surprisingly, the line in Figure 8 E does not even cover the indicated boundary between L1 and L2.

      At this point, the number of statements in the text that do not clearly and precisely correlate to the data in the figures is worrisome, and I think you could lose the confidence of readers at this point.

      We do not see any inconstancy between what is stated in our text and what is noted by the reviewer. The termination of the blue line corresponds to the location where no units are detected. This is the location where “unit density falls to zero”.  In this example, no units resolved through spike sorting until ~100mm beneath the L1/L2 boundary, which is exactly zero unity density (Figure 8E). That there are electrical signals in this region is clear from the AP power change (Figure 8C) which also shows the location of the L1/L2 border.

      Line 448. Text states that the 6A/B border is defined by a sharp boundary in AP power, but Figure 8A "AP power spectrum" does not show a sharp change at the A/B line. There is a peak in this metric in the middle to upper middle of 6A, but nothing so sharp to define a boundary between distinct layers, at least for penetration A2.

      Text has been adjusted.

      In Figure 8, the layer labels are not clear, whereas they are reasonably clear in the other figures.

      This is a technical problem regarding vector graphics that were not properly converted in PDF generation. We will upload each high-quality vector graphics when we finalize the version of record.

      The text emphasizes differences in L4B and L4C with respect to average power and coherence, but the transition seems a bit gradual from layer 3B to 4C in some examples in Figure 6. And in Figure 5, A3, there doesn't appear to be any particular transition along the line between 4B and 4C.

      In this guide section, we pointed out early that some metrics are good for some boundaries and variation exists between penetrations. We’ve expanded text emphasizing the importance of timing differences in DP/P for differentiating sublayers in L4. Lastly, in case of several unresolvable boundaries given all the metrics, the prior knowledge of relative thickness should be used.

      Line 466 provides prescriptions in absolute linear distances, but this is unwise given that cortex may be crossed at oblique angles by electrodes, particularly for parts of V1 that are not on the surface of the brain. Other parts of the text have emphasized relative measurements.

      Text has been changed using relative measurements.

      Line 507. The text says 9C and 4A are a good match, but the match does not look that good (4A has substantial dips at 0.5 and 0.75, and substantial peaks), and there is no quantification of fit. The error bars on 9C do not help show the variability across penetrations, they appear to be SEM, which shows that error bars get smaller as you average more data. It would seem more important to understand what is the variance in the density from one penetration to the next compared to the variance in density across layers.

      We have replaced “good match” with “roughly corresponds”. We note that we do not use unit density as a metric for identification of laminar borders and instead show that the expected locations of layers with higher neuronal density correspond to the locations where there are similar changes in unit density. It should be noted that Figure 9C is an average across many penetrations so should not be expected to show transitions that are as sharp in individual penetrations. Because of the figure permission issue, we have removed Figure 4A, and changed the text accordingly.

      Figure 9C-F show a lot of variability in the individual curves (dim gray lines) compared to the overall average. Does this show that these metrics are not reliable indicators at the level of single penetration, but show some trends across larger averages?

      In the beginning of the guide, we emphasized that all metrics should be combined for individual penetration, because some metrics are only reliable for delineating certain layer boundaries and the quality of data for the various measures varies between penetrations. The penetration average serves the same purpose explained in the previous question as an indicator that our layer delineation was not far off.

      The discussion mentions improvements in layer identification made here. Did this work check the assignments for these penetration against assignments made based on some form of ground truth? Previous methods would advance electrodes steadily, and make lesions, and carry out histology. Is there any way to tell how this method would compare to that?

      Even electrolytic lesions do not necessarily reveal ground truth and can be quite misleading. And their resolution is limited by lesion size. Lesions are typically variable in size, asymmetric and have variable shape and position relative to the location of the electrode tip, likely affected by the quality and location of electrical grounding and variations in current flow due to locations of blood vessels. A review of the published literature with electrode lesions shows that electrophysiological transitions are likely a far more accurate indicator of recording locations than post-mortem histology from electrolytic lesions. It is extremely rare for the locations of lesions to be precisely aligned to expected laminar transitions. See for example Chatterjee et al (Nature 2004). Also see several manuscripts from the Shapley lab. The lone rare exception of which we are aware is Blasdel and Fitzpatrick1984 in which consistently small and round lesions were produced and even these would be too large (~100 microns) to accurately identify layers if it were not for the fact that the electrode penetrations were very long and tangential to the cortical layers. 

      Reviewer #3 (Recommendations For The Authors):

      - The authors say (lines 360-362) that "Assuming spikes of a neuron spread to at least two adjacent recording channels, then the coherence between the two channels would be directly proportional to number of spikes, independent of spike amplitude." Has this been demonstrated? Very large amplitude spikes should show up on more channels than small amplitude spikes. Do waveform amplitudes and unit densities from the spike waveform analyses show consistent relationships to the power and/or coherence distributions over depth across penetrations?

      This part of the manuscript is providing a theoretical rational for what might be expected to affect the measures that we have derived. That is why we begin by stating that we are making an assumption. The answers to the reviewer’s questions are not known and have not been demonstrated. By beginning with this theoretical preface, we can point to cases where the data match these expectations as well as other cases where the data differ from the theoretical expectations.

      Coherence, by definition, is a normalized metric that is insensitive to amplitude. Spike amplitude mainly depends on how close the signal source is to electrode, and spike spread mainly depends on cell body size and shape given the same distance to electrode. Therefore, a very large spike amplitude could stem from a very close small cell to electrode, but would result in a small spike spread, especially axonal spikes (Figure 4B, red spike). Spike amplitudes on average are higher in L4C which matches the expectation that higher cell density would result, on average, closer cell body to electrode (Figure S4A). Nonetheless, the high-density small cell bodies in L4C result in a small spike spread (Figure 9D).

      - I suggest clarifying what is defined as the baseline window for the ΔP/P measure - is it the entire 10-150 ms response window used for the power spectrum analysis?

      Text adjustments are made in the Methods where the time windows are defined at the beginning of the CSD section. Only temporal change metrics (ΔCSD and ΔP/P) use the baseline window ([-40, 10]ms). The other two spectrum metrics (Power and Coherence) use the response window ([10, 150]ms).

      - Firing rate differs by cell type and, on average, differs by layer in V1. Many layer 2/3 neurons, for example, have low maximum firing rates when driven with optimized achromatic grating stimuli. To the extent that the generative models explaining the sources of power and coherence signals rely on the assumption that firing rates are matched across cortical depth, these models may be inaccurate. This assumption is declared only subtly, and late in the paper, but it is relevant to earlier claims.

      Text adjustments are made to explicitly describe the possibility that uneven depth profile of firing rate could counteract the depth profile of neuron density, resulting distorted or even a flat depth profile of power/coherence that deviates far from the depth profile of neuron density. In a newly added Figure S4, we first show the average firing rate profile during a set of stimuli (uniform color, static/drifting, achromatic/chromatic gratings), then specifically the PSTHs of the same stimuli shown in this study. It can be seen that layers receiving direct LGN inputs tend to fire at a higher rate (L4C, L6A). Firing rates in the PSTHs either roughly match across layers or are much higher in the densely packed layers. Therefore, the depth profile of firing rate contributes to rather than counteracting that of neuron density, enhancing the utility of the power/coherence profile for identification of correct layer boundaries.

      - Given the acute preparation used for recordings, I wonder whether tissue is available for histological evaluation. Although the layers identified are generally appropriate in relative size, it would be particularly compelling if the authors could demonstrate that the fraction of the cortical thickness occupied by each layer corresponded to the proportion occupied by that layer along the probe trajectory in histological sections. This would lend strength to the claim that these analyses can be used to identify layers in the absence of histology. Furthermore, variations in apparent cortical thickness could arise from different degrees of deviation from surface normal approach angles, which might be apparent by evaluation of histological material. I would add that variation in thickness on the scale shown in Fig. S4 is more likely to have an explanation of this kind.

      To serve other purposes unrelated to this study (identification of CO blobs), we cut the postmortem tissue in horizontal slices, so the histological comparison suggested cannot be made. The cortical thickness measured in this study had been affected not only by the angle deviation from the surface normal but also the swelling and compression of cortex. Nevertheless, evaluating the absolute thickness of cortex is not the main purpose of this study.

      Text and figure suggestions:

      - Fig 1A has been modified from Balaram & Kaas (2014) to revert to the Brodmann nomenclature scheme they argue against using in that paper; I wonder if they would object to this modification without explanation. Related, in the main text the authors initially refer to layers using Brodmann's labels with a secondary scheme (Hassler's) in parentheses and later drop the parenthetical labels; these conventions are not described or explained. Readers less familiar with the multiple nomenclature schemes for monkey V1 layers might be confused by the multiple labels without context, and could benefit from a brief description of the convention the authors have adopted.

      Throughout our article, we only used Brodmann’s naming convention because it has historically been adopted for old world monkey which we use in our study, whereas Hassler’s naming convention is more commonly used for new world monkey. Different naming conventions do not change our result, and it is out of scope for our study to discuss which nomenclature is more appropriate.

      - References to "dominate eye" throughout the text and figure legends should be replaced with "dominant eye."

      It has been changed throughout the article.

      - It is a bit odd to duplicate the same example in Fig. 2C and 2E. Perhaps a unique example would be a better use of the space.

      Here we first demonstrate the filtering effect, then compare profiles across different penetrations. The same example bridges the transition allowing side-by-side comparison.

      - The legend for Fig. 3 might be clearer if it simply listed the stimulus transitions for each column left to right, i.e. "black to white (non-dominant eye), white to black (non-dominant eye), black to white (dominant eye), ..."

      We feel that the icons are helpful. Here we want to show the stimulus colors directly to readers.

      - The misalignment between Fig. 4A vs. 4B-F, combined with the very small font size of the layer labels in Fig. 4B-F, make the visual comparison difficult. In Figs. 7 and 8, layer labels (and most labels in general) are much too small and/or low resolution to read easily. Overall, I would recommend increasing font size of labels in figures throughout the paper.

      The reused figure in Figure 4A is removed due to permission issue. Font sizes are adjusted.

      - Line 591 "using of high-density probes" should be "using high-density probes"

      Text has been changed accordingly

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment:

      “…However, the findings are reliant on high concentrations of inhibitor drugs, and mechanistic details about the molecular interaction and respective functions of ABHD2 and mPRb are incomplete.”

      As discussed below in the response to Reviewers the drug concentrations used span the full dose response of the active range of each drug. In cases where the drug concentrations required to block oocyte maturation where significantly higher than those reported in the literature, we considered those drugs ineffective. In terms of the molecular details of the mechanistic interaction between mPRb and ABHD2, we now provide additional data confirming their molecular interaction to produce PLA2 activity where each protein alone is insufficient. Although these new studies provide more mechanistic insights, there remains details of the ABHD2-mPR interactions that would need to be addressed in future studies which are beyond the scope of the current already extensive study.   

      Public Reviews:

      Reviewer 1

      (1) The mechanism governing the molecular assembly of mPRbeta and ABHD2 remains unclear. Are they constitutively associated or is their association ligand-dependent? Does P4 bind not only to mPRbeta but also to ABHD2, as indicated in Figure 6J? In the latter case, the reviewer suggests that the authors conduct a binding experiment using labeled P4 with ABHD2 to confirm this interaction and assess any potential positive or negative cooperativity with a partner receptor.

      The co-IP experiments presented in Figure 5E argue that the two receptors are constitutively associated at rest before exposure to P4; but at low levels since addition of P4 increases the association between mPRβ and ABHD2 by ~2 folds. Importantly, we know from previous work (Nader et al., 2020) and from imaging experiments in this study that mPR recycles in immature oocytes between the PM and the endosomal compartment. It is not clear at this point within which subcellular compartment the basal association of mPR and ABHD2 occurs. We have tried to elucidate this point but have not been able to generate a functional tagged ABHD2. We generated GFP-tagged ABHD2 at both the N- and C-terminus but these constructs where not functional in terms of their ability to rescue ABHD2 knockdown. This prevented us from testing the association dynamics between ABHD2 and mPR.   

      Regarding whether ABHD2 in the oocyte directly binds P4 or not, we had in the initial submission no data directly supporting this rather we based the cartoon in Fig. 6J on the findings from Miller et al. (Science 2016) who showed that ABHD2 in sperm binds biotinylated P4. With the use of a new expression system to produce ABHD2 in vitro (please see below) we were able to try the experiment suggested by the Reviewer. In vitro expressed ABHD2 was incubated with biotinylated P4, and binding tested on a streptavidin column. Under these conditions we could not detect any specific binding of P4 to ABHD2, however, these experiments remain somewhat preliminary and would require validation using additional approaches to conclusively test whether Xenopus ABHD2 binds P4 or not. The discrepancy with the Miller et al. findings could be species specific as they tested mammalian ABHD2.  

      (2) The authors have diligently determined the metabolite profile using numerous egg cells. However, the interpretation of the results appears incomplete, and inconsistencies were noted between Figure 2B and Supplementary Figure 2C. Furthermore, PGE2 and D2 serve distinct roles and have different elution patterns by LC-MS/MS, thus requiring separate measurements. In addition, the extremely short half-life of PGI2 necessitates the measurement of its stable metabolite, 6-keto-PGF1a, instead. The authors also need to clarify why they measured PGF1a but not PGF2a.

      We believe the Reviewer meant to indicate discrepancies between Fig. 2E (not 2B) and Supp. Fig. 2C. Indeed, the Reviewer is correct, and this is because Fig. 2E shows pooled normalized data on a per PG species and frog, whereas Supp. Fig. 2E shows and example of absolute raw levels from a single frog to illustrate the relative basal abundance of the different PG species. We had failed to clarify this in the Supp. Fig. 2E figure legend, which we have now added in the revised manuscript. So, the discrepancies are due to variation between different donor animals which is highlighted in Supp. Fig. 2A. Furthermore, to minimize confusion, in the revised manuscript we revised Supp. Fig. 2C to show only PG levels at rest, to illustrate basal levels of the different PG species relative to each other, which is the goal of this supplemental figure. 

      (3) Although they propose PGs, LPA, and S1P are important downstream mediators, the exact roles of the identified lipid mediators have not been clearly demonstrated, as receptor expression and activation were not demonstrated. While the authors showed S1PR3 expression and its importance by genetic manipulation, there was no observed change in S1P levels following P4 treatment (Supplementary Figure 2D). It is essential to identify which receptors (subtypes) are expressed and how downstream signaling pathways (PKA, Ca, MAPK, etc.) relate to oocyte phenotypes.

      We agree conceptually with the Reviewer that identifying the details of the signaling of the different GPCRs involved in oocyte maturation would be interesting. However, our lipidomic data argue that the activation of a PLA2 early in the maturation process in response to P4 leads to the production of multiple lipid messengers that would activate GPCRs and branch out the signaling pathway to activate various pathways required for the proper and timely progression of oocyte maturation. Preparing the egg for fertilization is complex; so, it is not surprising that a variety of pathways are activated simultaneously to properly initiate both cytoplasmic and nuclear maturation to transition the egg from its meiotic arrest state to be ready to support the rapid growth during early embryogenesis. We focus on the S1P signaling pathway specifically because, as pointed out by the Reviewer, we could not detect an increase in S1P even though our metabolomic data collectively argued for an increase. Our results on the S1P pathway -as well as a plethora of other studies historically in the literature that we allude to in the manuscript- argue that these different GPCRs support and regulate oocyte maturation, but they are not essential for the early maturation signaling pathway. For example, for S1P, as shown in Figure 4, the delay/inhibition of oocyte maturation due to S1PR3 knockdown can be reversed at high levels of P4, which presumably leads to higher levels of other lipid mediators that would bypass the need for signaling through S1PR3. This is reminiscent of the kinase cascade driving oocyte maturation where there is significant redundancy and feedback regulation. Therefore, analyzing each receptor subtype that may regulate the different PG species, LPA, and S1P would be a tedious and time-consuming undertaking that goes beyond the scope of the current manuscript. More importantly based on the above arguments, we suggest that findings from such an analysis, similar to the conclusions from the S1PR3 studies (Fig. 4), would show a modulatory role on oocyte maturation rather than a core requirement for the maturation process as observed with mPR and ABHD2. Thus they would provide relatively little insights into the core signaling pathway driving P4-mediated oocyte maturation.

      Reviewer 2:

      (1) The ABHD2 knockdown and rescue, presented in Fig 1, is one of the most important findings. It can and should be presented in more detail to allow the reader to understand the experiments better. E.g.: the antisense oligos hybridize to both ABHD2.S and ABHD2.L, and they knock down both (ectopically expressed) proteins. Do they hybridize to either or both of the rescue constructs? If so, wouldn't you expect that both rescue constructs would rescue the phenotype since they both should sequester the AS oligo? Maybe I'm missing something here.

      For the ABHD2 rescue experiment, the ABHD2 constructs (S or L) were expressed 48 hrs before the antisense was injected. The experiment was conducted in this way to avoid the potential confounding issue of both constructs sequestering the antisense. The assumption is that the injected RNA after protein expression would be degraded thus allowing the injected antisense to target endogenous ABHD2. The idea is to confirm that ABHD2.S expression alone is sufficient to rescue the antisense knockdown as confirmed experimentally.

      However, to further confirm the rescue, we performed the experiment in a different chronological order, where we started with injecting the antisense to knock down endogenous ABHD2 and this was followed 24 hrs later by expressing wild type ABHD2.S. As shown in Author response image 1 this also rescues the knockdown.

      Author response image 1.

      ABHD2 knockdown and rescue. Oocytes were injected with control antisense (Ctrl AS) or specific ABHD2 antisense (AS) oligonucleotides and incubated at 18 oC for 24 hours. Oocytes were then injected with mRNA to overexpress ABHD.S for 48 hours and then treated with P4 overnight. The histogram shows % GVBD in naïve, oocytes injected with control or ABHD2 antisense with or without mRNA to overexpress ABHD2.S.

      In addition, it is critical to know whether the partial rescue (Fig 1E, I, and K) is accomplished by expressing reasonable levels of the ABHD2 protein, or only by greatly overexpressing the protein. The author's antibodies do not appear to be sensitive enough to detect the endogenous levels of ABHD2.S or .L, but they do detect the overexpressed proteins (Fig 1D). The authors could thus start by microinjecting enough of the rescue mRNAs to get detectable protein levels, and then titer down, assessing how low one can go and still get rescue. And/or compare the mRNA levels achieved with the rescue construct to the endogenous mRNAs.

      The dose response of ABHD2 protein expression in correlation with rescue of the ABHD2 knockdown is shown indirectly in Figure 1I and 1J. In experiments ABHD2 knockdown was rescued using either the WT protein or two mutants (H120A and N125A). All three constructs rescued ABHD2 KD with equal efficiency (Fig. 1I), eventhough their expression levels varied (Fig. 1J). The WT protein was expressed at significantly higher levels than both mutants, and N125A was expressed at higher levels than H120A (Fig. 1J), note the similar tubulin loading control. Crude estimation of the WBs argues for the WT protein expression being ~3x that of H120A and ~2x that of N125A, yet all three have similar rescue of the ABHD2 knockdown (Fig. 1I). This argues that low levels of ABHD2 expression is sufficient to rescue the knockdown, consistent with the catalytic enzymatic nature of the ABHD2 PLA2 activity.

      Finally, please make it clear what is meant by n = 7 or n = 3 for these experiments. Does n = 7 mean 7 independently lysed oocytes from the same frog? Or 7 groups of, say, 10 oocytes from the same frog? Or different frogs on different days? I could not tell from the figure legends, the methods, or the supplementary methods. Ideally one wants to be sure that the knockdown and rescue can be demonstrated in different batches of oocytes, and that the experimental variability is substantially smaller than the effect size.

      The n reflects the number of independent female frogs. We have added this information to the figure legends. For each donor frog at each time point 10-30 oocytes were used.

      (2) The lipidomics results should be presented more clearly. First, please drop the heat map presentations (Fig 2A-C) and instead show individual time course results, like those shown in Fig 2E, which make it easy to see the magnitude of the change and the experiment-to-experiment variability. As it stands, the lipidomics data really cannot be critically assessed.

      [Even as heat map data go, panels A-C are hard to understand. The labels are too small, especially on the heat map on the right side of panel B. The 25 rows in panel C are not defined (the legend makes me think the panel is data from 10 individual oocytes, so are the 25 rows 25 metabolites? If so, are the individual oocyte data being collapsed into an average? Doesn't that defeat the purpose of assessing individual oocytes?) And those readers with red-green colorblindness (8% of men) will not be able to tell an increase from a decrease. But please don't bother improving the heat maps; they should just be replaced with more informative bar graphs or scatter plots.]

      We have revised the lipidomics data as requested by the Reviewer. The Reviewer asked that we show the data as a time course with each individual frog as in Fig. 2E. This turns out to be confusing and not a good way to present the data (please see Author response image 2).

      Author response image 2.

      Metabolite levels from 5 replicates of 10 oocytes each at each time point were measured and averaged per frog and per time point. Fold change was measured as the ratio at the 5- and 30-min time points relative to untreated oocytes (T0). FCs that are not statistically significant are shown as faded. Oocytes with mPR knockdown (KD) are boxed in green and ABHD2-KD in purple.

      We therefore revised the metabolomics data as follow to improve clarity. The changes in the glycerophospholipids and sphingolipids determined on the Metabolon CLP platform (specific for lipids) are now shown as single metabolites clustered at the levels of species and pathways and arranged for the 5- and 30-min time points sequentially on the same heatmap as requested (Fig. 2B). This allows for a quick visual overview of the data that clearly shows the decrease in the lipid species following P4 treatment in the control oocytes and not in the mPR-KD or ABHD2-KD cells (Fig. 2B). The individual species are listed in Supplemental Tables 1 and 2. We also revised the Supplemental Tables to include the values for the non-significant changes, which were omitted from the previous submission.

      We revised the metabolomics data from the HD4 platform in a similar fashion but because the lipid data were complimentary and less extensive than those from the CLP platform, we moved that heatmap to Supplemental Fig. 2B.

      For the single oocyte metabolomics, we now show the data as the correlation between FC and p value, which clearly shows the upregulated (including LPA) and downregulated metabolites at T30 relative to T0 (Fig. 2C). The raw data is now shown in a new Supplemental Table 7.  

      (3) The reticulocyte lysate co-expression data are quite important and are both intriguing and puzzling. My impression had been that to express functional membrane proteins, one needed to add some membrane source, like microsomes, to the standard kits. Yet it seems like co-expression of mPR and ABHD2 proteins in a standard kit is sufficient to yield progesterone-regulated PLA2 activity. I could be wrong here - I'm not a protein expression expert - but I was surprised by this result, and I think it is critical that the authors make absolutely certain that it is correct. Do you get much greater activities if microsomes are added? Are the specific activities of the putative mPR-ABHD2 complexes reasonable?

      We thank the Reviewer for this insightful comment. We agree that this is a critical result that would benefit from cross validation, especially given the low level of PLA2 activity detected in the reticulocyte lysate expression system. We have therefore expanded these studies using another in vitro expression system with microsomal membranes based on tobacco extracts (ALiCE®Cell-Free Protein Synthesis System, Sigma Aldrich) to enhance production and stability of the expressed receptors as suggested by the Reviewer. We further prepared virus-like particles (VLPs) from cells expressing each receptor individually or both receptors together. We however could not detect any PLA2 activity from the VLPs. We thus focused on the coupled in vitro transcription/translation tobacco extracts that allow the expression of difficult-to-produce membrane proteins in microsomes. This kit targets membrane protein directly to microsomes using a microsome targeting melittin signal peptide. This system took significant time and effort to troubleshoot and adapt to mPR and ABHD2 expression. We were however ultimately able to produce significantly higher amounts of both ABHD2 and mPRb, which were readily detected by WBs (Supplemental Fig. 4I). In contrast, we could not reliably detect mPR or ABHD2 using WBs from reticulocyte lysates given the limited amounts produced.

      Similarly to our previous findings with proteins produced in reticulocytes, expression of ABHD2 or mPRβ alone was not associated with an increase in PLA2 activity over a two-hour incubation period (Fig. 5C). It is worth noting here that the tobacco lysates had high endogenous PLA2 activity. However, co-expression of both mPRb and ABHD2 produced robust PLA2 activity that was significantly higher than that detected in reticulocyte lysate system (Fig. 5C). Surprisingly, however this PLA2 activity was P4 independent as it was observed when both receptors are co-expressed in the absence of P4.

      These results validate our earlier conclusion that PLA2 activity requires both mPR and ABHD2, so their interaction in needed for enzymatic activity. It is interesting however that in the tobacco expression system this mPR-ABHD2 PLA2 activity becomes for the most part P4 independent. As the tobacco expression system forces both ABHD2 and mPR into microsomes using a signal sequence, the two receptors are enriched in the same vesicular compartment. As they can interact independently of P4 as shown in the co-IP experiments in immature oocytes (Fig. 5D), their forced co-expression in the same microsomal compartment could lead to their association and thus PLA2 activity. This is an attractive possibility that fits the current data, but would need independent validation.

      Reviewer 3:

      There were concerns with the pharmacological studies presented. Many of these inhibitors are used at high (double-digit micromolar) concentrations that could result in non-specific pharmacological effects and the authors have provided very little data in support of target engagement and selectivity under the multiple experimental paradigms. In addition, the use of an available ABHD2 small molecule inhibitor was lacking in these studies.

      For the inhibitors used we performed a full dose response to define the active concentrations. So, inhibitors were not used at one high dose. We then compared the EC50 for each active inhibitor to the reported EC50 in the literature (Table 1). The inhibitors were deemed effective only if they inhibited oocyte maturation within the range reported in the literature. This despite the fact that frog oocytes are notorious in requiring higher concentrations of drug given their high lipophilic yolk content, which acts as a sponge for drugs. So our criteria for an effective inhibitor are rather stringent.  

      Based on these criteria, only 3 inhibitors were ‘effective’ in inhibiting oocyte maturation: Ibuprofen, ACA and MP-A08 with relative IC50s to those reported in the literature of 0.7, 1.1, and 1.6 respectively. Ibuprofen targets Cox enzymes, which produce prostaglandins. We independently confirmed an increase in PGs in response to P4 in oocytes thus validating the drug inhibitory effect. ACA blocks PLA2 and inhibits maturation, a role supported by the metabolomics analyses that shows decrease in the PE/PE/LPE/LPC species; and by the ABHD2-mPR PLA2 activity following in vitro expression. Finally, MP-A08 blocks sphingosine kinase activity, which role is supported by the metabolomics showing a decrease in sphingosine levels in response to P4; and our functional studies validating a role for the S1P receptor 3 in oocyte maturation.     

      As pointed out by the Reviewer, other inhibitors did block maturation at very high concentration, but we do not consider these as effective and have not implicated the blocked enzymes in the early steps of oocyte maturation. To clarify this point, we edited the summary panel (now Fig. 2D) to simplify it and highlight the inhibitors with an effect in the reported range in red and those that don’t inhibit based on the above criteria in grey. Those with intermediate effects are shown in pink. We hope these edits clarify the inhibitors studies.

      Recommendations For the Authors

      Reviewer 2:

      (1) Introduction, para 1. Please change "mPRs mediated" to "mPR-mediated".

      Done

      (2) Introduction, para 2. Please change "cyclin b" to "cyclin B".

      Done

      (3) Introduction, para 2. Please change "that serves" to "which serves".

      Done

      (4) Introduction, para 4. I know that the authors have published evidence that "a global decrease in cAMP levels is not detectable" (2016), but old work from Maller and Krebs (JBC 1979) did see an early, transient decrease after P4 treatment, and subsequent work from Maller said that there was both a decrease in adenylyl cyclase activity and an increase in cAMP activity. Perhaps it would be better to say something like "early work showed a transitory drop in cAMP activity within 1 min of P4 treatment (Maller), although later studies failed to detect this drop and showed that P4-dependent maturation proceeds even when cAMP is high (25)".

      We agree and thank the Reviewer for this recommendation. The text was revised accordingly.

      (5) Results, para 1. Based on the results in Fig 1B, one should probably not assert that ABHD2 is expressed "at levels similar to those of mPRβ in the oocyte"-with different mRNAs and different PCR primers, it's hard to say whether they are similar or not. The RNAseq data from Xenbase in Supp Fig 1 supports the idea that the ABHD2 and mPRβ mRNAs are expressed at similar levels at the message level, although of course mRNA levels and protein levels do not correlate well when different gene products are compared (Wuhr's 2014 Curr Biol paper reported correlation coefficients of about 0.3).

      We agree and have changed the text as follow to specifically point out to RNA: “we confirmed that ABHD2 RNA is expressed in the oocyte at levels similar to those of mPRβ RNA (Fig. 1B).”

      (6) Results, para 2. It would be worth pointing out that since an 18 h incubation with microinjected antisense oligos was sufficient to substantially knock down both the ABHD2 mRNAs (Fig 1C) and the ectopically-expressed proteins (Fig 1D), the mRNA and protein half-lives must be fairly short, on the order of a few hours or less.

      Done

      (7) Figure 1. Please make the western blots (especially Fig 1D) and their labeling larger. These are key results and as it stands the labeling is virtually unreadable on printed copies of the figures. I'm not sure about eLife's policy, but many journals want the text in figures to be no smaller than 5-7 points at 100% size.

      Likewise for many of the western blots in subsequent figures.

      As requested by the Reviewer we have increased the font and size of all Western blots in the Figures.

      (8) Figure 1E, G. I am not sure one should compare the effectiveness of the ABHD2 rescue (Fig 1E) and the mPRβ rescue (Fig 1G). Even if these were oocytes from the same frog, we do not know how the levels of the overexpressed ABHD2 and mPRβ proteins compare. E.g. maybe ABHD2 was highly overexpressed and mPRβ was overexpressed by a tiny amount.

      Although this is a possibility, the expression levels of the proteins here is not of much concern because we previously showed that mPRβ expression effectively rescues mPRβ antisense knockdown which inhibits maturation (please see (Nader et al., 2020)). This argues that at the levels of mRNA injected mPR is functional to support maturation, yet it does not rescue ABHD2 knockdown to the same levels (Fig. 1G). With that it is fair to argue that mPRβ is not as effective at rescuing ABHD2 KD maturation.

      (9) Inhibitor studies: There are two likely problems in comparing the observed potencies with legacy data - in vitro vs in vivo data and frog vs. mammalian data. Please make it clear what is being compared to what when you are comparing legacy data.

      The legacy data are from the literature based on the early studies that defined the IC50 for inhibition primarily using in vivo models (cell line mostly) but not oocytes. Typically, frog oocytes require significantly higher concentrations of inhibitors to mediate their effect because of the high lipophilic yolk content which acts as a sponge for some drugs. So, the fact that the drugs that are effective in inhibiting oocyte maturation (ACA, MP-A08, and Ibuprofen) work in a similar or lower concentration range to the published IC<sub50</sub> gives us confidence as to the specificity of their effect. We have revised Table 1 to include the reference for each IC<sub50</sub> value from the literature to allow the reader to judge the exact model and context used.

      (10) Isn't it surprising that Gas seems to promote maturation, given the Maller data (and data from others) that cAMP and PKA oppose maturation (see also the authors' own Fig 1A) and the authors' previous data sees no positive effect (minor point 7 above)?

      We show that a specific Gas inhibitor NF-449 inhibits maturation (although at relatively high concentrations), which is consistent with a positive role for Gas in oocyte maturation. We argue based on the lipidomics data and the inhibitors data that GPCRs play a modulatory role and not a central early signaling role in terms of releasing oocyte meiotic arrest. They are likely to have effects on the full maturation of the egg in preparation for embryonic development. The actions of the multiple lipid messengers generated downstream of mPRβ activation are likely to act through GPCRs and could signal through Gas or other Ga or even through Gβγ. Minor point 7 refers to the size of Western blots.

      (11) Page 9, bottom: "...one would predict activation of sphingosine kinases...." Couldn't it just be the activity of some constitutively active sphingosine kinase? Maybe replace "activation" with "activity".

      A constitutively sphingosine kinase activity would not make sense as it needs to be activated by P4.

      (12) Sometimes the authors refer to concentrations in molar units plus a power of 10 (e.g. 10-5 M) and sometime in µM or nM, sometimes even within the same paragraph. This makes it unnecessarily difficult to compare. Please keep consistent.

      We replaced all the concentrations through the text to M with scientific notation for consistency as requested by the Reviewer.

      (13) Fig 3I: "Sphingosine kinase" is misspelled.

      This has been corrected. We thank the Reviewer for catching it.

      (14) Legend to Fig. 5: Please change "after P4 treatment in reticulocytes" to "after P4 treatment in reticulocyte lysates".

      Done

      (15) Fig 6J. Doesn't the MAPK cascade inhibit MYT1? I.e. shouldn't the arrow be -| rather than ->?

      Yes the Reviewer is correct. This has been changed. We thank the Reviewer for noticing this error.

      (16) Materials and Methods, second paragraph. Please change "inhibitor's studies" to "inhibitor studies".

      Corrected thanks.

      (17) Table 1: Please be consistent in how you write Cox-2.

      Done.

      Reviewer #3:

      The findings are of potential broad interest, but I have some concerns with the pharmacological studies presented. Many of these inhibitors are used at high (double-digit micromolar) concentrations that could result in non-specific pharmacological effects and the authors have provided very little data in support of target engagement and selectivity under the multiple experimental paradigms. Importantly, several claims regarding lipid metabolism signaling in the context of oocyte maturation are made without critical validation that the intended target is inactivated with reasonable selectivity across the proteome. Several of the inhibitors used for pharmacology and metabolomics are known covalent inhibitors (JZL184 and MJN110) that can readily bind additional lipases depending on the treatment time and concentration.

      I did not find any data using the reported ABHD2 inhibitor (compound 183; PMID: 31525885). Is there a reason not to include this compound to complement the knockdown studies? I believe this is an important control given that not all lipid effects were reversed with ABHD2 knockdown. The proper target engagement and selectivity studies should be performed with this ABHD2 inhibitor.

      We obtained aliquots the reported ABHD2 inhibitor compound 183 from Dr. Van Der Stelt and tested its effect on oocyte maturation at 10<sup>-4</sup>M using both low (10<sup>-7</sup>M) or high (10<sup>-5</sup>M) P4 concentration. Compound 183 partially inhibited P4-mediated oocyte maturation. The new data was added to the manuscript as Supplemental Figure 3D.

      Additional comments:

      (1) Pristimerin was tested at low P4 concentration for effects on oocyte maturation. Authors should also test JZL184 and MJN110 under this experimental paradigm.

      We have tested the effect of high concentration (2.10-<sup>-5</sup>M) of JZL184 or MJN110 on oocyte maturation at low P4 concentration (Author response image 3).  MJN 110 did not have a prominent effect on oocyte maturation at low P4, whereas JZL184 inhibited maturation by 50%. However, this inhibition of maturation required concentrations of JZL 184 that are 10 times higher than those reported in rat and human cells (Cui et al., 2016; Smith et al., 2015), arguing against an important role for a monoacylglycerol enzymatic activity in inducing oocyte maturation.

      Author response image 3.

      The effect of MJN110 and JZL184 compounds on oocyte maturation at low P4 concentration. Oocytes were pre-treated for 2 hours with the vehicle or with the highest concentration of 2.10-<sup>-5</sup> M for both JZL184 or MJN110, followed by overnight treatment with P4 at 10-<sup>7</sup>M. Oocyte maturation was measured as % GVBD normalized to control oocytes (treated with vehicle) (mean + SEM; n = 2 independent female frogs for each compound).

      2) Figure 4A showed different ct values of ODC between Oocytes and spleen, please explain them in the text. There is not any description regarding spleen information in Figure 4A, please make it clear in the text.

      We thank the Reviewer for this recommendation. The text was revised accordingly.

      (3) For Figures 3A, E, and I, there are different concentration settings for comparing the activity, is it possible to get the curves based on the same set of concentrations? The concentration gradient didn't include higher concentration points in these figures, thus the related values are incorrect. Please set more concentration points to improve the figures. And for the error bar, there are different display formats like Figure 4c and 4d, etc. Please uniform the format for all the figures. Additionally, for the ctrl. or veh., please add an error bar for all figures.

      Some of the drugs tested were toxic to oocytes at high concentrations so the dose response was adjusted accordingly. The graphs were plotted to encompass the entire tested dose response. We could have plotted the data on the same x-axis range but that would make the figures uneven and awkward.

      We are not clear what the Reviewer means by “The concentration gradient didn't include higher concentration points in these figures, thus the related values are incorrect.”

      The error bars for all dose responses are consistent throughout all the Figures. They are different from those on bar graphs to improve clarity. If the Reviewer wishes to have the error bars on the bar graphs and dose response the same, we are happy to do so. 

      For the inhibitor studies the data were normalized on a per frog basis to control for variability in the maturation rate in response to P4, which varies from frog to frog. It is thus not possible to add error bars for the controls.

      (4) Please check the sentence "However, the concentration of HA130...... higher that......'; Change "IC50" to "IC50" in the text and tables. Table 1 lists IC50 values in the literature, but the references are not cited. Please include the references properly. For the IC50 value obtained in the research, please include the standard deviation in the table. For reference parts, Ref 1, 27, 32, 46, doublecheck the title format.

      We edited the sentence as follows to be more clear: “However, this inhibition of maturation required high concentrations of HA130  -at least 3 orders of magnitude higher that the reported HA130 IC<sub>50</sub>-…”

      We changed IC50 to subscript in Table 1.

      We added the relevant references in Table 1 to provide context for the cited IC50 values for the different inhibitors used.

      We added SEM to the IC<sub>50</sub> for inhibition of oocyte maturation values in Table 1.

      We checked the titles on the mentioned references and cannot identify any problems.

      References

      Cui, Y., Prokin, I., Xu, H., Delord, B., Genet, S., Venance, L., and Berry, H. (2016). Endocannabinoid dynamics gate spike-timing dependent depression and potentiation. eLife 5, e13185.

      Nader, N., Dib, M., Hodeify, R., Courjaret, R., Elmi, A., Hammad, A.S., Dey, R., Huang, X.Y., and Machaca, K. (2020). Membrane progesterone receptor induces meiosis in Xenopus oocytes through endocytosis into signaling endosomes and interaction with APPL1 and Akt2. PLoS Biol 18, e3000901.

      Smith, M., Wilson, R., O'Brien, S., Tufarelli, C., Anderson, S.I., and O'Sullivan, S.E. (2015). The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation. PloS one 10, e0136546.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Response to Editor and Reviewer Comments:

      Many thanks to the editor and reviewers for the thoughtful assessment of our manuscript “Commissureless acts as a substrate adapter in a conserved Nedd4 E3 ubiquitin ligase pathway to promote axon growth across the midline.” Thank you also for the positive comments about the quality of our writing, and for deeming our study rigorous and thorough. We are very pleased that, overall, you believe our combination of genetic and biochemical approaches offers useful insight into the mechanism of Robo regulation at the Drosophila embryonic midline and effectively reconciles the contradictory findings of previous studies done in this field.

      Response to the previous Public Reviews:

      We appreciate the concerns expressed by the reviewers and the suggestions of areas in which the study and manuscript could be improved. The reviewer suggestions were very helpful as we revised our manuscript in order to strengthen our mechanistic understanding of Robo downregulation and better characterize the role Nedd4 plays in this process. We strongly agree with Reviewer 1 that our insight into the mechanism of Robo downregulation via Comm would be much stronger had we not solely relied on overexpression experiments to investigate the effects of PY motif mutations on Comm function. While it is outside the scope of this particular paper, we appreciate your suggestion to use gene editing to investigate the role of PY motif mutation on endogenous comm function and believe this would be a useful question to address in future papers. In addition to this concern, both reviewers identified additional opportunities to strengthen the paper. We have done our best to incorporate reviewer suggestions and will outline how we addressed the following four areas that were identified by both reviewers as areas where additional data could strengthen our conclusions:

      (1) Additional experiments to examine Comm and Robo1 localization in vivo: Characterizing Robo localization in vivo when co-expressed with PY-mutant Comm variants.

      (2) Testing biochemical interactions in embryonic protein extracts: Examining the biochemical interaction between Robo, Comm, and Nedd4 in a more biologically relevant context than cell culture.

      (3) Additional genetic interaction experiments: A) Investigating whether Nedd4 overexpression enhances the Comm G.O.F phenotype of enhanced ectopic crossing. B) Testing for additional genetic interactions with comm.

      (4) Editing the text of the manuscript for clarity.

      (1) Characterizing Robo localization in vivo when co-expressed with Comm variants.

      In the first version of our manuscript, we characterized the localization of wild-type and PY mutant Comm variants expressed in apterous neurons (Figure 5C), but did not examine how these variants of Comm affected localization of their cargo Robo1. To address this gap, we co-expressed 10X UAS Comm-myc (WT, 1PY, 2PY) with 10X UAS Robo-HA under the ap gal4 driver, visualized Comm and Robo by immunostaining for Myc and HA, and measured colocalization between Comm and Robo. We found that Robo colocalizes equally with all comm variants and that its expression pattern mimics that of the Comm variant with which it is expressed. We observe that Robo is restricted to cell bodies when overexpressed with WT Comm but “leaks out” into axons when co-expressed with Comm 1PY or 2PY. This finding suggests that PY motifs are not only required for effective Comm localization to the appropriate cellular areas, but also for proper routing of its cargo, Robo1. These new data are presented in a new supplemental figure: Figure S3.

      (2) Examining the biochemical interaction between Robo, Comm, and Nedd4 in vivo.

      To examine biochemical interaction between Comm, Robo, and Nedd4 in a more biologically relevant context, we performed immunoprecipitations in fly embryonic lysate prepared from the following categories: WT, elav gal4: 5X UAS Comm-myc WT, and elav gal4: 5X UAS Comm-myc WT + 10X UAS Nedd4-HA. We performed immunoprecipitation for myc (Comm), and blotted for endogenous Robo, Myc (Comm), and HA (Nedd4). Corroborating our results in cell culture (Figure 7 A-C), we were able to pull down a three-protein complex consisting of Comm, Nedd4 and Robo in embryonic fly tissue. These new data are presented in a new supplemental figure: Figure S8.

      (3) Investigating additional genetic interactions between Comm and Nedd4.

      A) In our submitted manuscript, we demonstrated that overexpression of Nedd4 enhances Comm-induced downregulation of Robo levels (Figure 7 D-G). To determine whether Nedd4 also increases ectopic crossing, which is a morphological output of Comm activity/Robo downregulation, we analyzed nerve cord phenotypes in embryos from the following categories: WT, embryos expressing WT Comm under the elav gal4, and embryos co-expressing WT Comm and Nedd4 under the elav gal4 driver. We measured nerve cord widths and sorted them into three different “bins” of phenotypic severity, with more severe phenotypes being characterized by thinner nerve cords. We find that the distribution of phenotypes in embryos expressing Comm alone differs significantly from embryos expressing Comm + Nedd4, with the latter shifted toward more severe/thinner phenotypic classes. In addition to examining nerve cord width, we investigated whether Nedd4 can enhance collapse of the nerve cord segments (defined by loss of negative space within the segment) induced by Comm overexpression. We determined percentage of collapsed nerve cord segments and divided these values into three phenotypic classes: no collapse, partial collapse, and total collapse. The distribution of phenotypes in embryos co-expressing Nedd4 and Comm differs significantly from those expressing Comm alone. In the Comm expressing population, we only observe nerve cords with no or partial collapse, but in flies co-expressing Comm and Nedd4 we observe the more severe complete collapse phenotype. These findings suggest that addition of Nedd4 enhances the Comm gain of function phenotype both by further reducing nerve cord width and increasing the occurrence of defects related to ectopic crossing. These new data are presented in a new supplemental figure: Figure S9.

      B) The reviewers also suggested additional genetic interaction experiments between Nedd4 and Comm. It was suggested that we included experiments to look at Nedd4 manipulations in Comm null mutant backgrounds. However, given the complete penetrance and expressivity of the Comm null mutation in which no axons cross the midline, these experiments would not be informative. As an alternative, we attempted to use the described hypomorphic Comm allele, but here too, the baseline commissural axon guidance defects are too strong to allow meaningful detection of enhanced phenotypes. Finally, we tested whether removing one copy of comm could reveal phenotypes in the nedd4 zygotic mutants, but we did not detect defects. This is perhaps unsurprising given that comm heterozygotes have no detectable midline crossing defects.

      (4) Text edits.

      We have made a variety of changes to decrease ambiguity in the text and create a more user-friendly experience for the reader. In the text, as opposed to just the figures, we now explicitly state whether we use 5X or 10X UAS constructs for each of our overexpression constructs. We also edited all mentions of the truncated frazzled construct (FraDc) so that they are uniform. We have also edited all mentions of MiMIC so that they are uniform. In addition, we answer a few questions the reviewers posed. First, we clarify that S2R+ cells express endogenous Comm at very low levels. In addition, we clarify about how we know expression levels are similar across the three Comm variants by explaining that transgenes incorporated into the fly genome by targeted insertion into the same location on the third chromosome.

      We hope that these changes adequately address reviewer concerns, strengthen our study, and enhance readability of the paper. We appreciate the time you took to evaluate our manuscript and the thoughtful commentary and suggestions that you provided.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      This work addresses an important question in the field of Drosophila aggression and mating- prior social isolation is known to increase aggression in males by increased lunging, which is suppressed by group housing (GH). However, it is also known that single-housed (SH) males, despite their higher attempts to court females, are less successful. Here, Gao et al., developed a modified aggression assay, to address this issue by recording aggression in Drosophila males for 2 hours, over a virgin female which is immobilized by burying its head in the food. They found that while SH males frequently lunge in this assay, GH males switch to higher intensity but very low-frequency tussling. Constitutive neuronal silencing and activation experiments implicate cVA sensing Or67d neurons promoting high-frequency lunging, similar to earlier studies, whereas Or47b neurons promote low-frequency but higher intensity tussling. Using optogenetic activation they found that three pairs of pC1 neurons- pC1SS2 increase tussling. While P1a neurons, previously implicated in promoting aggression and courtship, did not increase tussling in optogenetic activation (in the dark), they could promote aggressive tussling in thermogenetic activation carried out in the presence of visible light. It was further suggested, using a further modified aggression assay that GH males use increased tussling and are able to maintain territorial control, providing them mating advantage over SI males and this may partially overcome the effect of aging in GH males.

      Strengths:

      Using a series of clever neurogenetic and behavioral approaches, subsets of ORNs and pC1 neurons were implicated in promoting tussling behaviors. The authors devised a new paradigm to assay for territory control which appears better than earlier paradigms that used a food cup (Chen et al, 2002), as this new assay is relatively clutter-free, and can be eventually automated using computer vision approaches. The manuscript is generally well-written, and the claims made are largely supported by the data.

      Thank you for your precise summary of our study and being very positive on the novelty and significance of the study.

      Weaknesses:

      I have a few concerns regarding some of the evidence presented and claims made as well as a description of the methodology, which needs to be clarified and extended further.

      (1) Typical paradigms for assaying aggression in Drosophila males last for 20-30 minutes in the presence of nutritious food/yeast paste/females or all of these (Chen et al. 2002, Nilsen et al., 2004, Dierick et al. 2007, Dankert et al., 2009, Certel & Kravitz 2012). The paradigm described in Figure 1 A, while important and more amenable for video recording and computational analysis, seems a modification of the assay from Kravitz lab (Chen et al., 2002), which involved using a female over which males fight on a food cup. The modifications include a flat surface with a central food patch and a female with its head buried in the food, (fixed female) and much longer adaptation and recording times respectively (30 minutes, 2 hours), so in that sense, this is not a 'new' paradigm but a modification of an existing paradigm and its description as new should be appropriately toned down. It would also be important to cite these earlier studies appropriately while describing the assay.

      We will tone down the description and cite related references.

      (2) Lunging is described as a 'low intensity' aggression (line 111 and associated text), however, it is considered a mid to high-intensity aggressive behavior, as compared to other lower-intensity behaviors such as wing flicks, chase, and fencing. Lunging therefore is lower in intensity 'relative' to higher intensity tussling but not in absolute terms and it should be mentioned clearly.

      Ww will textually address this issue.

      (3) It is often difficult to distinguish faithfully between boxing and tussling and therefore, these behaviors are often clubbed together as box, tussle by Nielsen et al., 2004 in their Markov chain analysis as well as a more detailed recent study of male aggression (Simon & Heberlein, 2020). Therefore, authors can either reconsider the description of behavior as 'box, tussle' or consider providing a video representation/computational classifier to distinguish between box and tussle behaviors.

      We will textually address this issue.

      (4) Simon & Heberlein, 2020 showed that increased boxing & tussling precede the formation of a dominance hierarchy in males, and lunges are used subsequently to maintain this dominant status. This study should be cited and discussed appropriately while introducing the paradigm.

      We will cite this paper and discuss on this issue.

      (5) It would be helpful to provide more methodological details about the assay, for instance, a video can be helpful showing how the males are introduced in the assay chamber, are they simply dropped to the floor when the film is removed after 30 minutes (Figures 1-2)?

      We will provide more methodological details.

      (6) The strain of Canton-S (CS) flies used should be mentioned as different strains of CS can have varying levels of aggression, for instance, CS from Martin Heisenberg lab shows very high levels of aggressive lunges. Are the CS lines used in this study isogenized? Are various genetic lines outcrossed into this CS background? In the methods, it is not clear how the white gene levels were controlled for various aggression experiments as it is known to affect aggression (Hoyer et al. 2008).

      We will textually address this issue.

      (7) How important it is to use a fixed female for the assay to induce tussling? Do these females remain active throughout the assay period of 2.5 hours? Is it possible to use decapitated virgin females for the assay? How will that affect male behaviors?

      We will textually address this issue and provide additional videos.

      (8) Raster plots in Figure 2 suggest a complete lack of tussling in SH males in the first 60 minutes of the encounter, which is surprising given the longer duration of the assay as compared to earlier studies (Nielsen et al. 2004, Simon & Heberlein, 2020 and others), which are able to pick up tussling in a shorter duration of recording time. Also, the duration for tussling is much longer in this study as compared to shorter tussles shown by earlier studies. Is this due to differences in the paradigm used, strain of flies, or some other factor? While the bar plots in Figure 2D show some tussling in SH males, maybe an analysis of raster plots of various videos can be provided in the main text and included as a supplementary figure to address this.

      We will textually address the first question and provide more detailed analysis for the second question.

      (9) Neuronal activation experiments suggesting the involvement of pC1SS2 neurons are quite interesting. Further, the role of P1a neurons was demonstrated to be involved in increasing tussling in thermogenetic activation in the presence of light (Figure 4, Supplement 1), which is quite important as the role of vision in optogenetic activation experiments, which required to be carried out in dark, is often not mentioned. However, in the discussion (lines 309-310) it is mentioned that PC1SS2 neurons are 'necessary and sufficient' for inducing tussling. Given that P1a neurons were shown to be involved in promoting tussling, this statement should be toned down.

      We will tone down this statement.

      (10) Are Or47b neurons connected to pC1SS2 or P1a neurons?

      We conducted pathway analysis in the FlyWire electron microscopy database to investigate the connection between Or47b neurons and pC1 neurons. The results indicate that at least three intermediate neurons are required to establish a connection from Or47b neurons to pC1 neurons. Although the FlyWire database currently only contains neuronal data from female brains, they provide a reference for circuit connect in males. Using the currently available upstream and downstream tracing tools (e.g., retro-/trans-Tango), it is not possible to establish a direct connection between the two. Identifying the intermediate neurons involved in this connection is beyond this study. We will discuss on this concern in our revised manuscript.

      (11) The paradigm for territory control is quite interesting and subsequent mating advantage experiments are an important addition to the eventual outcome of the aggressive strategy deployed by the males as per their prior housing conditions. It would be important to comment on the 'fitness outcome' of these encounters. For instance, is there any fitness advantage of using tussling by GH males as compared to lunging by SH males? The authors may consider analyzing the number of eggs laid and eclosed progenies from these encounters to address this.

      We will discuss on this concern.

      Reviewer #2 (Public review):

      Summary:

      Gao et al. investigated the change of aggression strategies by the social experience and its biological significance by using Drosophila. Two modes of inter-male aggression in Drosophila are known: lunging, high-frequency but weak mode, and tussling, low-frequency but more vigorous mode. Previous studies have mainly focused on the lunging. In this paper, the authors developed a new behavioral experiment system for observing tussling behavior and found that tussling is enhanced by group rearing while lunging is suppressed. They then searched for neurons involved in the generation of tussling. Although olfactory receptors named Or67d and Or65a have previously been reported to function in the control of lunging, the authors found that these neurons do not function in the execution of tussling, and another olfactory receptor, Or47b, is required for tussling, as shown by the inhibition of neuronal activity and the gene knockdown experiments. Further optogenetic experiments identified a small number of central neurons pC1[SS2] that induce the tussling specifically. In order to further explore the ecological significance of the aggression mode change in group rearing, a new behavioral experiment was performed to examine territorial control and mating competition. Finally, the authors found that differences in the social experience (group vs. solitary rearing) are important in these biologically significant competitions. These results add a new perspective to the study of aggressive behavior in Drosophila. Furthermore, this study proposes an interesting general model in which the social experience-modified behavioral changes play a role in reproductive success.

      Strengths:

      A behavioral experiment system that allows stable observation of tussling, which could not be easily analyzed due to its low frequency, would be very useful. The experimental setup itself is relatively simple, just the addition of a female to the platform, so it should be applicable to future research. The finding about the relationship between the social experience and the aggression mode change is quite novel. Although the intensity of aggression changes with the social experience was already reported in several papers (Liu et al., 2011, etc.), the fact that the behavioral mode itself changes significantly has rarely been addressed and is extremely interesting. The identification of sensory and central neurons required for the tussling makes appropriate use of the genetic tools and the results are clear. A major strength of the neurobiology in this study is the finding that another group of neurons (Or47b-expressing olfactory neurons and pC1[SS2] neurons), distinct from the group of neurons previously thought to be involved in low-intensity aggression (i.e. lunging), function in the tussling behavior. Further investigation of the detailed circuit analysis is expected to elucidate the neural substrate of the conflict between the two aggression modes.

      Thank you for the acknowledgment of the novelty and significance of the study, and your suggestions for improving the manuscript.

      Weaknesses:

      The experimental systems examining the territory control and the reproductive competition in Figure 5 are novel and have advantages in exploring their biological significance. However, at this stage, the authors' claim is weak since they only show the effects of age and social experience on territorial and mating behaviors, but do not experimentally demonstrate the influence of aggression mode change itself. In the Abstract, the authors state that these findings reveal how social experience shapes fighting strategies to optimize reproductive success. This is the most important perspective of the present study, and it would be necessary to show directly that the change of aggression mode by social experience contributes to reproductive success.

      We will either tone down this statement or provide additional analysis.

      In addition, a detailed description of the tussling is lacking. For example, the authors state that the tussling is less frequent but more vigorous than lunging, but while experimental data are presented on the frequency, the intensity seems to be subjective. The intensity is certainly clear from the supplementary video, but it would be necessary to evaluate the intensity itself using some index. Another problem is that there is no clear explanation of how to determine the tussling. A detailed method is required for the reproducibility of the experiment.

      We will provide more detailed methods and data analysis regarding tussling behavior.

      Reviewer #3 (Public review):

      In this manuscript, Gao et al. presented a series of intriguing data that collectively suggest that tussling, a form of high-intensity fighting among male fruit flies (Drosophila melanogaster) has a unique function and is controlled by a dedicated neural circuit. Based on the results of behavioral assays, they argue that increased tussling among socially experienced males promotes access to resources. They also concluded that tussling is controlled by a class of olfactory sensory neurons and sexually dimorphic central neurons that are distinct from pathways known to control lunges, a common male-type attack behavior.

      A major strength of this work is that it is the first attempt to characterize the behavioral function and neural circuit associated with Drosophila tussling. Many animal species use both low-intensity and high-intensity tactics to resolve conflicts. High-intensity tactics are mostly reserved for escalated fights, which are relatively rare. Because of this, tussling in the flies, like high-intensity fights in other animal species, has not been systematically investigated. Previous studies on fly aggressive behavior have often used socially isolated, relatively young flies within a short observation duration. Their discovery that 1) older (14-days-old) flies tend to tussle more often than younger (2-days-old) flies, 2) group-reared flies tend to tussle more often than socially isolated flies, and 3) flies tend to tussle at a later stage (mostly ~15 minutes after the onset of fighting), are the result of their creativity to look outside of conventional experimental settings. These new findings are key for quantitatively characterizing this interesting yet under-studied behavior.

      Precisely because their initial approach was creative, it is regrettable that the authors missed the opportunity to effectively integrate preceding studies in their rationale or conclusions, which sometimes led to premature claims. Also, while each experiment contains an intriguing finding, these are poorly related to each other. This obscures the central conclusion of this work. The perceived weaknesses are discussed in detail below.

      Thank you for the precise summary of the key findings and novelty of the study, and your insightful suggestions.

      Most importantly, the authors' definition of "tussling" is unclear because they did not explain how they quantified lunges and tussling, even though the central focus of the manuscript is behavior. Supplemental movies S1 and S2 appear to include "tussling" bouts in which 2 flies lunge at each other in rapid succession, and supplemental movie S3 appears to include bouts of "holding", in which one fly holds the opponent's wings and shakes vigorously. These cases raise a concern that their behavior classification is arbitrary. Specifically, lunges and tussling should be objectively distinguished because one of their conclusions is that these two actions are controlled by separate neural circuits. It is impossible to evaluate the credibility of their behavioral data without clearly describing a criterion of each behavior.

      We will add more details in methods.

      It is also confusing that the authors completely skipped the characterization of the tussling-controlling neurons they claimed to have identified. These neurons (a subset of so-called pC1 neurons labeled by previously described split-GAL4 line pC1SS2) are central to this manuscript, but the only information the authors have provided is its gross morphology in a low-resolution image (Figure 4D, E) and a statement that "only 3 pairs of pC1SS2 neurons whose function is both necessary and sufficient for inducing tussling in males" (lines 310-311). The evidence that supports this claim isn't provided. The expression pattern of pC1SS2 neurons in males has been only briefly described in reference 46. It is possible that these neurons overlap with previously characterized dsx+ and/or fru+ neurons that are important for male aggressions (measured by lunges), such as in Koganezawa et al., Curr. Biol. 2016 and Chiu et al., Cell 2020. This adds to the concern that lunge and tussling are not as clearly separated as the authors claim.

      Reply: we will perform additional morphological and functional experiments on pC1<sup>SS2</sup> neurons, e.g., whether they are fru or dsx positive and comparing them with P1a neurons.

      While their characterizations of tussling behaviors in wild-type males (Figures 1 and 2) are intriguing, the remaining data have little link with each other, making it difficult to understand what their main conclusion is. Figure 3 suggests that one class of olfactory sensory neurons (OSN) that express Or47b is necessary for tussling behavior. While the authors acknowledged that Or47b-expressing OSNs promote male courtship toward females presumably by detecting cuticular compounds, they provided little discussion on how a class of OSN can promote two different types of innate behavior. No evidence of a functional or circuitry relationship between the Or47b pathway and the pC1SS2 neurons was provided. It is unclear how these two components are relevant to each other. Lastly, the rationale of the experiment in Figure 5 and the interpretation of the results is confusing. The authors attributed a higher mating success rate of older, socially experienced males over younger, socially isolated males to their tendency to tussle, but tussling cannot happen when one of the two flies is not engaged. If, for instance, a socially isolated 14-day-old male does not engage in tussling as indicated in Figure 2, how can they tussle with a group-housed 14-day-old male? Because aggressive interactions in Figure 5 were not quantified, it is impossible to conclude that tussling plays a role in copulation advantage among pairs as authors argue (lines 282-288).

      Regarding why Or47b-expressing OSNs regulate two types of innate behaviors, we will add a discussion in the revised manuscript to explore the possible mechanisms underlying this phenomenon.

      Regarding the relationship between Or47b-expressing OSNs and pC1<sup>SS2</sup> neurons, we conducted pathway connection analyses using the FlyWire database. Although the FlyWire database currently only contains neuronal data from female brains, these findings provide a certain degree of reference. The results indicate that at least three intermediate neurons are required to establish the connection between these two neuronal types. We hope the editor and reviewers would agree with us that identifying these intermediate neurons involved in this connection is beyond this study.

      Regarding the rationale and conclusions from the experiments in Figure 5, we acknowledge the difficulty in quantifying tussling and lunging behaviors in these experiments. In the revised manuscript, we will tone down the statements about the relationship between fighting strategies and reproductive success. Additionally, we will provide further behavioral experiments to support the association between these two factors.

      Despite these weaknesses, it is important to acknowledge the authors' courage to initiate an investigation into a less characterized, high-intensity fighting behavior. Tussling requires the simultaneous engagement of two flies. Even if there is confusion over the distinction between lunges and tussling, the authors' conclusion that socially experienced flies and socially isolated flies employ distinct fighting strategies is convincing. Questions that require more rigorous studies are 1) whether such differences are encoded by separate circuits, and 2) whether the different fighting strategies are causally responsible for gaining ethologically relevant resources among socially experienced flies. Enhanced transparency of behavioral data will help readers understand the impact of this study. Lastly, the manuscript often mentions previous works and results without citing relevant references. For readers to grasp the context of this work, it is important to provide information about methods, reagents, and other key resources.

      We will add more details in methods and cite additional references, we will also perform additional experiment on pC1<sup>SS2</sup> function.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study investigates the role of macrophage lipid metabolism in the intracellular growth of Mycobacterium tuberculosis. By using a CRISPR-Cas9 gene-editing approach, the authors knocked out key genes involved in fatty acid import, lipid droplet formation, and fatty acid oxidation in macrophages. Their results show that disrupting various stages of fatty acid metabolism significantly impairs the ability of Mtb to replicate inside macrophages. The mechanisms of growth restriction included increased glycolysis, oxidative stress, pro-inflammatory cytokine production, enhanced autophagy, and nutrient limitation. The study demonstrates that targeting fatty acid homeostasis at different stages of the lipid metabolic process could offer new strategies for host-directed therapies against tuberculosis.

      The work is convincing and methodologically strong, combining genetic, metabolic, and transcriptomic analyses to provide deep insights into how host lipid metabolism affects bacterial survival.

      Strengths:

      The study uses a multifaceted approach, including CRISPR-Cas9 gene knockouts, metabolic assays, and dual RNA sequencing, to assess how various stages of macrophage lipid metabolism affect Mtb growth. The use of CRISPR-Cas9 to selectively knock out key genes involved in fatty acid metabolism enables precise investigation of how each step-lipid import, lipid droplet formation, and fatty acid oxidation affect Mtb survival. The study offers mechanistic insights into how different impairments in lipid metabolism lead to diverse antimicrobial responses, including glycolysis, oxidative stress, and autophagy. This deepens the understanding of macrophage function in immune defense.

      The use of functional assays to validate findings (e.g., metabolic flux analyses, lipid droplet formation assays, and rescue experiments with fatty acid supplementation) strengthens the reliability and applicability of the results.

      By highlighting potential targets for HDT that exploit macrophage lipid metabolism to restrict Mtb growth, the work has significant implications for developing new tuberculosis treatments.

      Weaknesses:

      The experiments were primarily conducted in vitro using CRISPR-modified macrophages. While these provide valuable insights, they may not fully replicate the complexity of the in vivo environment where multiple cell types and factors influence Mtb infection and immune responses.

      We thank the reviewer for pointing this out. We acknowledge that our in vitro system may indeed not fully replicate the complex in vivo environment in light of the heterogenous responses of macrophages to Mtb infection in whole animal models. We do believe, however, that the Hoxb8 in vitro model provides a powerful genetic tool to interrogate host-Mtb interactions using primary macrophages that represent the bone marrow-derived macrophage lineage. Reviewer #1 also made several helpful suggestions in their recommendations to authors relating to the reorganization of the data in our Figures in both the manuscript and the supplemental data.  We will incorporate these suggestions into the revised version of the manuscript upon resubmission.

      Reviewer #2 (Public review):

      Summary:

      Host-derived lipids are an important factor during Mtb infection. In this study, using CRISPR knockouts of genes involved in fatty acid uptake and metabolism, the authors claim that a compromised uptake, storage, or metabolism of fatty acid restricts Mtb growth upon infection. Further, the authors claim that the mechanism involves increased glycolysis, autophagy, oxidative stress, pro-inflammatory cytokines, and nutrient limitation. The authors also claim that impaired lipid droplet formation restricts Mtb growth. However, promoting lipid droplet biogenesis does not reverse/promote Mtb growth.

      Strengths:

      The strength of the study is the use of clean HOXB8-derived primary mouse macrophage lines for generating CRISPR knockouts.

      Weaknesses:

      There are many weaknesses of this study, they are clubbed into four categories below

      (1) Evidence and interpretations: The results shown in this study at several places do not support the interpretations made or are internally contradictory or inconsistent. There are several important observations, but none were taken forward for in-depth analysis. A

      a) The phenotypes of PLIN2-/-, FATP1-/-, and CPT-/- are comparable in terms of bacterial growth restriction; however, their phenotype in terms of lipid body formation, IL1B expression, etc., are not consistent. These are interesting observations and suggest additional mechanisms specific to specific target genes; however, clubbing them all as altered fatty acid uptake or catabolism-dependent phenotypes takes away this important point.

      We thank the reviewer for highlighting this. Our main focus was on assessing the impact of manipulating lipid homeostasis in macrophages and the consequences this has on the intracellular growth of Mtb.  It was never our intention to imply these mutants generated equivalent phenotypes, and we will modify the revised manuscript to reflect this point.  We will stress that interfering with lipid processing at different stages in macrophages results in both shared and divergent anti-microbial conditions against Mtb.

      b) Finding the FATP1 transcript in the HOXB8-derived FATP1-/- CRISPR KO line is a bit confusing. There is less than a two-fold decrease in relative transcript abundance in the KO line compared to the WT line, leaving concerns regarding the robustness of other experiments as well using FATP1<sup>-/-</sup> cells.

      CRISPR-Cas9 targeting of genes with single sgRNAs as is the case with our mutants generates insertions and deletions (INDELs) at the CRISPR cut site. These INDELs do not block mRNA transcription totally, and this is widely reported and accepted in the field.  In these cases, RT-PCR or RNA-seq methods are not used to verify CRISPR knockouts as they are not sensitive enough to identify INDELs. We provide knockout efficiencies by ICE analysis in supplemental information file 1 for all the mutants used in the study. We also demonstrate protein depletion by western blot and flow cytometry for all the mutants (Figure 1 - figure supplement 1). Only mutants with greater than >90% protein depletion were used for subsequent characterization.

      c) No gene showing differential regulation in FATP1<sup>-/-</sup> macrophages, which is very surprising.

      We assume the reviewer is referring to the Mtb transcriptome response in FATP1<sup>-/-</sup> macrophages, which we agree was unexpected.  However, we saw a significant compensatory response in the host cell (at transcriptional level) in FATP1-/- macrophages as evidenced by an upregulation of other fatty acid transporters (Figure 5 - figure supplement 1). We postulate that these compensatory responses could, in part, alleviate the stresses the bacteria experience within the cell, and these were discussed in the manuscript.

      d) ROS measurements should be done using flow cytometry and not by microscopy to nail the actual pattern.

      We thank the reviewer for the suggestion. However, confocal imaging is also widely used to measure ROS with similar quantitative power and individual cell resolution (PMID: 32636249, 35737799).

      (2) Experimental design: For a few assays, the experimental design is inappropriate

      a) For autophagy flux assay, immunoblot of LC3II alone is not sufficient to make any interpretation regarding the state of autophagy. This assay must be done with BafA1 or CQ controls to assess the true state of autophagy.

      We would like to point out that monitoring LC3I to LC3II conversion by western blot, confocal imaging of LC3 puncta and qPCR analysis of autophagy related genes are all validated assays for monitoring autophagic flux in a wide variety of cells. We refer the reviewer to the latest extensive guidelines on the subject (PMID: 33634751). Furthermore, Bafilomycin A and chloroquine are not specific inhibitors of autophagy and therefore are of limited value as controls. BafA is an inhibitor of the proton-ATPase apparatus as well impacting autophagy through activity on the Ca-P60A/SERCA pathway. Chloroquine impacts vacuole acidification, autophagosome/lysosome fusion and slows phagosome maturation. So, while BafA and chloroquine will reduce autophagy their effects are pleotropic and their impact on Mtb is unknown.

      b) Similarly, qPCR analyses of autophagy-related gene expression do not reflect anything on the state of autophagy flux.

      See our response above.

      (3) Using correlative observations as evidence:

      a) Observations based on RNAseq analyses are presented as functional readouts, which is incorrect.

      We are not entirely sure where we used our RNA-seq data sets as functional readouts. We used our transcriptome data to provide a preliminary identification of anti-microbial responses in the mutant macrophages infected with Mtb. Where applicable, we followed up and confirmed the more compelling RNA-seq data either by metabolic flux analyzes, qPCR, ROS measurements, and quantitative imaging.

      b) Claiming that the inability to generate lipid droplets in PLIN2-/- cells led to the upregulation of several pathways in the cells is purely correlative, and the causal relationship does not exist in the data presented.

      Again, it was not our intention to infer causality. Throughout the manuscript, we endeavor to present our data with a specific focus on describing the consequences of interfering with either fatty acid import, lipid droplet biogenesis and fatty acid oxidation on macrophage responses to Mtb.  We will revisit the revised manuscript to remove any sections that imply causality.

      (4) Novelty: A few main observations described in this study were previously reported. That includes Mtb growth restriction in PLIN2 and FATP1 deficient cells. Similarly, the impact of Metformin and TMZ on intracellular Mtb growth is well-reported. While that validates these observations in this study, it takes away any novelty from the study.

      To the best of our knowledge, Mtb growth restrictions in PLIN2 and FATP1 deficient macrophages have not been reported elsewhere. To the contrary, PLIN2 knockout macrophages obtained from PLIN2 deficient mice have been reported to robustly support Mtb replication (PMID: 29370315), quite the opposite to our data. We extensively discuss these discrepancies in the manuscript. We also discuss and cite appropriate references where Mtb growth restriction for similar macrophage mutants have been reported (CD36<sup>-/-</sup> and CPT2<sup>-/-</sup>). Our aim was to carry out a systematic myeloid specific genetic interference of fatty acid import, storage and catabolism to assess the effect on Mtb growth at all stages of lipid handling instead of focusing on one target. In the chemical approach, we used TMZ and Metformin deliberately because they had already been reported as being active against intracellular Mtb and we wished to place our data in the context of existing literature.  These studies were referenced extensively in the text.

      (5) Manuscript organisation: It will be very helpful to rearrange figures and supplementary figures.

      We will re-organize the figures in the manuscript revision as per the reviewer’s recommendation, and the recommendations of reviewer #1.

      We will address the other concerns raised by reviewer #2 in the recommendations to authors during revision of the manuscript. 

      Reviewer #3 (Public review):

      Summary:

      This study provides significant insights into how host metabolism, specifically lipids, influences the pathogenesis of Mycobacterium tuberculosis (Mtb). It builds on existing knowledge about Mtb's reliance on host lipids and emphasizes the potential of targeting fatty acid metabolism for therapeutic intervention.

      Strengths:

      To generate the data, the authors use CRISPR technology to precisely disrupt the genes involved in lipid import (CD36, FATP1), lipid droplet formation (PLIN2), and fatty acid oxidation (CPT1A, CPT2) in mouse primary macrophages. The Mtb Erdman strain is used to infect the macrophage mutants. The study, reveals specific roles of different lipid-related genes. Importantly, results challenge previous assumptions about lipid droplet formation and show that macrophage responses to lipid metabolism impairments are complex and multifaceted. The experiments are well-controlled and the data is convincing.

      Overall, this well-written paper makes a meaningful contribution to the field of tuberculosis research, particularly in the context of host-directed therapies (HDTs). It suggests that manipulating macrophage metabolism could be an effective strategy to limit Mtb growth.

      Weaknesses:

      None noted. The manuscript provides important new knowledge that will lead mpvel to host-directed therapies to control Mtb infections.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      This study investigates what happens to the stimulus-driven responses of V4 neurons when an item is held in working memory. Monkeys are trained to perform memory-guided saccades: they must remember the location of a visual cue and then, after a delay, make an eye movement to the remembered location. In addition, a background stimulus (a grating) is presented that varies in contrast and orientation across trials. This stimulus serves to probe the V4 responses, is present throughout the trial, and is task-irrelevant. Using this design, the authors report memory-driven changes in the LFP power spectrum, changes in synchronization between the V4 spikes and the ongoing LFP, and no significant changes in firing rate.

      Strengths:

      (1) The logic of the experiment is nicely laid out.

      (2) The presentation is clear and concise.

      (3) The analyses are thorough, careful, and yield unambiguous results.

      (4) Together, the recording and inactivation data demonstrate quite convincingly that the signal stored in FEF is communicated to V4 and that, under the current experimental conditions, the impact from FEF manifests as variations in the timing of the stimulus-evoked V4 spikes and not in the intensity of the evoked activity (i.e., firing rate).

      Weaknesses:

      I think there are two limitations of the study that are important for evaluating the potential functional implications of the data. If these were acknowledged and discussed, it would be easier to situate these results in the broader context of the topic, and their importance would be conveyed more fairly and transparently.

      (1) While it may be true that no firing rate modulations were observed in this case, this may have been because the probe stimuli in the task were behaviorally irrelevant; if anything, they might have served as distracters to the monkey's actual task (the MGS). From this perspective, the lack of rate modulation could simply mean that the monkeys were successful in attending the relevant cue and shielding their performance from the potentially distracting effect of the background gratings. Had the visual probes been in some way behaviorally relevant and/or spatially localized (instead of full field), the data might have looked very different.

      Any task design involves tradeoffs; if the visual stimulus was behaviorally relevant, then any observed neurophysiological changes would be more confounded by possible attentional effects. We cannot exclude the possibility that a different task or different stimuli would produce different results; we ourselves have reported firing rate enhancements for other types of visual probes during an MGS task (Merrikhi et al. 2017). We have added an acknowledgement of these limitations in the discussion section (lines 311-319). At minimum, our results show a dissociation between the top-down modulation of phase coding, which is enhanced during WM even for these task-irrelevant stimuli, and rate coding. Establishing whether and how this phase coding is related to perception and behavior will be an important direction for future work.

      With this in mind, it would be prudent to dial down the tone of the conclusions, which stretch well beyond the current experimental conditions (see recommendations).

      We have edited the title (removing the word ‘primarily’) and key sentences throughout to tone down the conclusions, generally to state that the importance of a phase code in WM modulations is *possible* given the observed results, rather than certain (see abstract line 27, introduction lines 58-60, results line 215, conclusion lines 294-295).

      (2) Another point worth discussing is that although the FEF delay-period activity corresponds to a remembered location, it can also be interpreted as an attended location, or as a motor plan for the upcoming eye movement. These are overlapping constructs that are difficult to disentangle, but it would be important to mention them given prior studies of attentional or saccade-related modulation in V4. The firing rate modulations reported in some of those cases provide a stark contrast with the findings here, and I again suspect that the differences may be due at least in part to the differing experimental conditions, rather than a drastically different encoding mode or functional linkage between FEF and V4.

      We have added a paragraph to the discussion section addressing links to attention and motor planning (lines 301-322), and specifically acknowledging the inherent difficulties of fully dissociating these effects when interpreting our results (lines 311-319).

      Reviewer #2 (Public review):

      Summary:

      It is generally believed that higher-order areas in the prefrontal cortex guide selection during working memory and attention through signals that selectively recruit neuronal populations in sensory areas that encode the relevant feature. In this work, Parto-Dezfouli and colleagues tested how these prefrontal signals influence activity in visual area V4 using a spatial working memory task. They recorded neuronal activity from visual area V4 and found that information about visual features at the behaviorally relevant part of space during the memory period is carried in a spatially selective manner in the timing of spikes relative to a beta oscillation (phase coding) rather than in the average firing rate (rate code). The authors further tested whether there is a causal link between prefrontal input and the phase encoding of visual information during the memory period. They found that indeed inactivation of the frontal eye fields, a prefrontal area known to send spatial signals to V4, decreased beta oscillatory activity in V4 and information about the visual features. The authors went one step further to develop a neural model that replicated the experimental findings and suggested that changes in the average firing rate of individual neurons might be a result of small changes in the exact beta oscillation frequency within V4. These data provide important new insights into the possible mechanisms through which top-down signals can influence activity in hierarchically lower sensory areas and can therefore have a significant impact on the Systems, Cognitive, and Computational Neuroscience fields.

      Strengths:

      This is a well-written paper with a well-thought-out experimental design. The authors used a smart variation of the memory-guided saccade task to assess how information about the visual features of stimuli is encoded during the memory period. By using a grating of various contrasts and orientations as the background the authors ensured that bottom-up visual input would drive responses in visual area V4 in the delay period, something that is not commonly done in experimental settings in the same task. Moreover, one of the major strengths of the study is the use of different approaches including analysis of electrophysiological data using advanced computational methods of analysis, manipulation of activity through inactivation of the prefrontal cortex to establish causality of top-down signals on local activity signatures (beta oscillations, spike locking and information carried) as well as computational neuronal modeling. This has helped extend an observation into a possible mechanism well supported by the results.

      Weaknesses:

      Although the authors provide support for their conclusions from different approaches, I found that the selection of some of the analyses and statistical assessments made it harder for the reader to follow the comparison between a rate code and a phase code. Specifically, the authors wish to assess whether stimulus information is carried selectively for the relevant position through a firing rate or a phase code. Results for the rate code are shown in Figures 1B-G and for the phase code are shown in Figure 2. Whereas an F-statistic is shown over time in Figure 1F (and Figure S1) no such analysis is shown for LFP power. Similarly, following FEF inactivation there is no data on how that influences V4 firing rates and information carried by firing rates in the two conditions (for positions inside and outside the V4 RF). In the same vein, no data are shown on how the inactivation affects beta phase coding in the OUT condition.

      We plan to incorporate statistical analysis of this point in the revised version.

      Moreover, some of the statistical assessments could be carried out differently including all conditions to provide more insight into mechanisms. For example, a two-way ANOVA followed by post hoc tests could be employed to include comparisons across both spatial (IN, OUT) and visual feature conditions (see results in Figures 2D, S4, etc.). Figure 2D suggests that the absence of selectivity in the OUT condition (no significant difference between high and low contrast stimuli) is mainly due to an increase in slope in the OUT condition for the low contrast stimulus compared to that for the same stimulus in the IN condition. If this turns out to be true it would provide important information that the authors should address.

      We plan to incorporate statistical analysis of this point in the revised version.

      There are also a few conceptual gaps that leave the reader wondering whether the results and conclusion are general enough. Specifically,

      (1) the authors used microstimulation in the FEF to determine RFs. It is thus possible that the FEF sites that were inactivated were largely more motor-related. Given that beta oscillations and motor preparatory activity have been found to be correlated and motor sites show increased beta oscillatory activity in the delay period, it is possible that the effect of FEF inactivation on V4 beta oscillations is due to inactivation of the main source of beta activity. Had the authors inactivated sites with a preponderance of visual neurons in the FEF would the results be different?

      We do not believe this to be likely based on what is known anatomically and functionally about this circuitry. Anatomically, the projections from FEF to V4 arise primarily from the supragranular layers, not layers which contain the highest proportion of motor activity (Barone et al. 2000, Pouget et al. 2009, Markov et al. 2013). Functionally, based on electrical identification of V4-projecting FEF neurons, we know that FEF to V4 projections are predominantly characterized by delay rather than motor activity (Merrikhi et al. 2017). We have now tried to emphasize these points when we introduce the inactivation experiments (lines 180-182).

      Experimentally, the spread of the pharmacological effect with our infusion system is quite large relative to any clustering of visual vs. motor neurons within the FEF, with behavioral consequences of inactivation spreading to cover a substantial portion of the visual hemifield (e.g., Noudoost et al. 2014, Clark et al. 2014), and so our manipulation lacks the spatial resolution to selectively target motor vs. other FEF neurons.

      (2) Somewhat related to this point and given the prominence of low-frequency activity in deeper layers of the visual cortex according to some previous studies, it is not clear where the authors' V4 recordings were located. The authors report that they do have data from linear arrays, so it should be possible to address this.

      Unfortunately our chamber placement for V4 has produced linear array penetration angles which do not reliably allow identification of cortical layers. We are aware of previous results showing layer-specific effects of attention in V4 (e.g., Pettine et al. 2019, Buffalo et al. 2011), and it would indeed be interesting to determine whether our observed WM-driven changes follow similar patterns. We may be able to analyze a subset of the data with current source density analysis to look for layer-specific effects in the future, but are not able to provide any information at this time.

      (3) The authors suggest that a change in the exact frequency of oscillation underlies the increase in firing rate for different stimulus features. However, the shift in frequency is prominent for contrast but not for orientation, something that raises questions about the general applicability of this observation for different visual features.

      We plan to incorporate statistical analysis of this point in the revised version.

      (4) One of the major points of the study is the primacy of the phase code over the rate code during the delay period. Specifically, here it is shown that information about the visual features of a stimulus carried by the rate code is similar for relevant and irrelevant locations during the delay period. This contrasts with what several studies have shown for attention in which case information carried in firing rates about stimuli in the attended location is enhanced relative to that for stimuli in the unattended location. If we are to understand how top-down signals work in cognitive functions it is inevitable to compare working memory with attention. The possible source of this difference is not clear and is not discussed. The reader is left wondering whether perhaps a different measure or analysis (e.g. a percent explained variance analysis) might reveal differences during the delay period for different visual features across the two spatial conditions.

      We have added discussion regarding the relationship of these results to previous findings during attention in the discussion section (lines 301-322).

      The use of the memory-guided saccade task has certain disadvantages in the context of this study. Although delay activity is interpreted as memory activity by the authors, it is in principle possible that it reflects preparation for the upcoming saccade, spatial attention (particularly since there is a stimulus in the RF), etc. This could potentially change the conclusion and perspective.

      We have added a new discussion paragraph addressing the relationship to attention and motor planning (lines 301-322). We have also moderated the language used to describe our conclusions throughout the manuscript in light of this ambiguity.

      For the position outside the V4 RF, there is a decrease in both beta oscillations and the clustering of spikes at a specific phase. It is therefore possible that the decrease in information about the stimuli features is a byproduct of the decrease in beta power and phase locking. Decreased oscillatory activity and phase locking can result in less reliable estimates of phase, which could decrease the mutual information estimates.

      We plan to incorporate statistical analysis of this point in the revised version.

      The authors propose that coherent oscillations could be the mechanism through which the prefrontal cortex influences beta activity in V4. I assume they mean coherent oscillations between the prefrontal cortex and V4. Given that they do have simultaneous recordings from the two areas they could test this hypothesis on their own data, however, they do not provide any results on that.

      This paper only includes inactivation data. We are working on analyzing the simultaneous recording data for a future publication.

      The authors make a strong point about the relevance of changes in the oscillation frequency and how this may result in an increase in firing rate although it could also be the reverse - an increase in firing rate leading to an increase in the frequency peak. It is not clear at all how these changes in frequency could come about. A more nuanced discussion based on both experimental and modeling data is necessary to appreciate the source and role (if any) of this observation.

      As the reviewer notes, it is difficult to determine whether the frequency changes drive the rate changes, vice versa, or whether both are generated in parallel by a common source. We have adjusted our language to reflect this (lines 277-278). Future modeling work may be able to shed more light on the causal relationships between various neural signatures.

      Reviewer #3 (Public review):

      Summary:

      In this report, the authors test the necessity of prefrontal cortex (specifically, FEF) activity in driving changes in oscillatory power, spike rate, and spike timing of extrastriate visual cortex neurons during a visual-spatial working memory (WM) task. The authors recorded LFP and spikes in V4 while macaques remembered a single spatial location over a delay period during which task-irrelevant background gratings were displayed on the screen with varying orientation and contrast. V4 oscillations (in the beta range) scaled with WM maintenance, and the information encoded by spike timing relative to beta band LFP about the task-irrelevant background orientation depended on remembered location. They also compared recorded signals in V4 with and without muscimol inactivation of FEF, demonstrating the importance of FEF input for WM-induced changes in oscillatory amplitude, phase coding, and information encoded about background orientations. Finally, they built a network model that can account for some of these results. Together, these results show that FEF provides meaningful input to the visual cortex that is used to alter neural activity and that these signals can impact information coding of task-irrelevant information during a WM delay.

      Strengths:

      (1) Elegant and robust experiment that allows for clear tests for the necessity of FEF activity in WM-induced changes in V4 activity.

      (2) Comprehensive and broad analyses of interactions between LFP and spike timing provide compelling evidence for FEF-modulated phase coding of task-irrelevant stimuli at remembered location.

      (3) Convincing modeling efforts.

      Weaknesses:

      (1) 0% contrast background data (standard memory-guided saccade task) are not reported in the manuscript. While these data cannot be used to consider information content of spike rate/time about task-irrelevant background stimuli, this condition is still informative as a 'baseline' (and a more typical example of a WM task).

      We plan to incorporate statistical analysis of this point in the revised version.

      (2) Throughout the manuscript, the primary measurements of neural coding pertain to task-irrelevant stimuli (the orientation/contrast of the background, which is unrelated to the animal's task to remember a spatial location). The remembered location impacts the coding of these stimulus variables, but it's unclear how this relates to WM representations themselves.

      Indeed, here we have focused on how maintaining spatial WM impacts visual processing of incoming sensory information, rather than on how the spatial WM signal itself is represented and maintained. Behaviorally, this impact on visual signals could be related to the effects of the content of WM on perception and reaction times (e.g., Soto et al. 2008, Awh et al. 1998, Teng et al. 2019), but no such link to behavior is shown in our data.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews

      Reviewer #1 (Public Review): 

      Summary: 

      In this study, Masroor Ahmad Paddar and his/her colleagues explore the noncanonical roles of ATG5 and membrane atg8ylation in regulating retromer assembly and function. They begin by examining the interactomes of ATG5 and expand the scope of these effects to include homeostatic responses to membrane stress and damage. 

      Strengths: 

      This study provides novel insights into the noncanonical function of ATG8ylation in endosomal cargo sorting process. 

      Weaknesses: 

      The direct mechanism by which ATG8ylation regulates the retromer remains unsolved. 

      We agree with the reviewer.  We do however show how at least one aspect of atg8ylation contributes to the proper retromer function, which occurs via lysosomal membrane maintenance and repair. Understanding the more direct effects on retromer will require a separate study. We now emphasize this in the revised manuscript (p. 18) and point out the limitations of the present work (p. 18): “One of the limitations of our study is that beyond effects of membrane atg8ylation on quality of lysosomal membrane and its homeostasis there could be more direct effects of membrane modification with mATG8s that still need to be understood”.

      Reviewer #2 (Public Review): 

      Summary:

      Padder et al. demonstrate that ATG5 mediates lysosomal repair via the recruitment of the retromer components during LLOMe-induced lysosomal damage and that mAtg8-ylation contributes to retromer-dependent cargo sorting of GLUT1. Although previous studies have suggested that during glucose withdrawal, classical autophagy contributes to retromer-dependent GLUT1 surface trafficking via interactions between LC3A and TBC1D5, the experiments here demonstrate that during basal conditions or lysosomal damage, ATGs that are not involved in mATG8ylation, such as FIP200, are not functionally required for retromer-dependent sorting of GLUT1. Overall, these studies suggest a unique role for ATG5 in the control of retromer function, and that conjugation of ATG8 to single membranes (CASM) is a partial contributor to these phenotypes. 

      Strengths: 

      (1) Overall, these studies suggest a unique non-autophagic role for ATG5 in the control of retromer function. They also demonstrate that conjugation of ATG8 to single membranes (CASM) is a partial contributor to these phenotypes. Overall, these data point to a new role for ATG5 and CASM-dependent mATG8ylation in lysosomal membrane repair and trafficking. 

      (2) Although the studies are overall supportive of the proposed model that the retromer is controlled by CASM-dependent mATG8-ylaytion, it is noteworthy that previous studies of GLUT1 trafficking during glucose withdrawal (Roy et al. Mol Cell, PMID: 28602638) were predominantly conducted in cells lacking ATG5 or ATG7, which would not be able to discriminate between a CASM-dependent vs. canonical autophagy-dependent pathway in the control of GLUT1 sorting. Is the lack of GLUT1 mis-sorting to lysosomes observed in FIP200 and ATG13KO cells also observed during glucose withdrawal? Notably, deficiencies in glycolysis and glucose-dependent growth have been reported in FIP200 deficient fibroblasts (Wei et al. G&D, PMID: 21764854) so there may be differences in regulation dependent on the stress imposed on a cell. 

      We thank the reviewer for the overall assessment of the strengths of the study.  We have discussed in the manuscript the elegant study by Roy et al., PMID 28602683. To accommodate reviewer’s comment, we have additionally emphasized in the text that our study is focused on basal conditions and conditions that perturb endolysosomal compartments. We agree with the reviewer that under metabolic stress conditions (such as glucose limitation) more complex pathways may be engaged and have acknowledged that in the discussion. We have now included this in the limitations of the study (p. 18): “Another limitation of our study is that we have focused on basal conditions or conditions causing lysosomal damage, whereas metabolic stress including glucose excess or limitation with its multitude of metabolic effects have not been addressed”.

      Weaknesses: 

      (1) Additional controls are needed to clarify the role of CASM in the control of retromer function. Because the manuscript proposes both CASM-dependent and independent pathways in the ATG5 mediated regulation of the retromer, it is important to provide robust evidence that CASM is required for retromer-dependent GLUT1 sorting to the plasma membrane vs. lysosome. The experiments with monensin in Fig. 7C-E are consistent with but not unequivocally corroborative of a role for CASM. 

      We fully agree with the reviewer. In fact, our data with bafilomycin A1 treatment causing GLUT1 miss-sorting show that it is the perturbance of lysosomes  and not CASM per se that leads to mis-sorting of GLUT1 (Fig. 7D,E). Note that it has been shown (PMIDs: 28296541, 25484071 and 37796195) that although bafilomycin A1 deacidifies lysosomes it does not induce but instead inhibits CASM. This is because bafilomycin A1 causes dissociation of V1 and V0 sectors of V-ATPase, unlike other CASM-inducing agents which promote V1 V0 association. Complementing this, our data with ATG2AB DKO and ESCRT VPS37A KO (Fig. 8A-F) indicate that the repair of lysosomes is important to keep the retromer machinery functional (as illustrated in Fig. 8G). This may be one of the effector mechanisms downstream of membrane atg8ylation in general and hence also downstream of CASM. We have revised Fig. 7 title to read “Lysosomal perturbations cause GLUT1 mis-sorting” and have explained these relationships in the text (p. 12-13): “Since bafilomycin A1 does not induce CASM but disturbs luminal pH, we conclude that it is the less acidic luminal pH of the endolysosomal organelles, and not CASM, that is sufficient to interfere with the proper sorting of GLUT1.”

      Based on the results shown with ATG16KO in Fig 4A-D, rescue experiments of these 16KO cells with WT vs. C-terminal WD40 mutant versions of ATG16 will specifically assess the requirement for CASM and potentially provide more rigorous support for the conclusions drawn. 

      We have carried out complementation with ATG16L1 WT and its E230 mutant (devoid of WD40 repeats but still capable of canonical autophagy) and placed these data in Fig. 7 (panels I and J) as recommended by the reviewer. This is now described on p. 13 (To additionally test this notion, we compared ATG16L1 full length (ATG16L1FL) and ATG16L1E230 (Rai et al., PMID 30403914) for complementation of the GLUT1 sorting defect in ATG16L1 KO cells (Fig. 7I,J). ATG16L1E230 [Rai, 2019, 30403914] lacks the key domain to carry out CASM via binding to VATPase 29,30 31-33 but retains capacity to carry out atg8ylation.  Both ATG16L1FL and ATG16L1E230 complemented mis-sorting of GLUT1 (Fig. 7I,J). Collectively, these data indicate that it is not absence of CASM/VAIL but absence of membrane atg8ylation in general that promotes GLUT1 mis-sorting.).

      (2) Also, the role of TBC1D5 should be further clarified. In Fig S7, are there any changes in the interactions between TBC1D5 and VPS35 in response to LLOMe or other agents utilized to induce CASM? 

      We thank the reviewer for pointing this out. We do have data with VPS35 in co-IPs shown in Fig. S7.  There is no change in the amounts of VPS35 or TBC1D5 in GFP-LC3A co-IPs. We now include in Fig. S7 (new panel D) a graph with quantification in the revised manuscript and emphasize this point (p. 12): “However, under CASM-inducing conditions, no changes were detected (Fig. S7B-D) in interactions between TBC1D5 and LC3A or in levels of VPS35 in LC3A co-IP, a proxy for LC3A-TBC1D5-VPS29/retromer association. This suggests that CASM-inducing treatments and additionally bafilomycin A1 do not affect the status of the TBC1D5-Rab7 system”.        

      Does TBC1D5 loss-of-function modulate the numbers of GLUT1 and Gal3 puncta observed in ATG5 deficient cells in response to LLOMe? 

      We agree that TBC1D5 is an interesting aspect. However, because TBC1D5 does not change its interactions in the experiments in our study, we consider this topic (i.e. whether TBC1D5 phenocopies VPS35 and ATG5 KOs in its effects on Gal3) to be beyond the scope of the present work. We underscore that LLOMe (lysosomal damage) mis-sorts GLUT1 even without any genetic intervention (e.g., in WT cells in the absence of ATG5 KO; Fig. 7). Thus, in our opinion the effects of TBC1D5 inactivation may be a moot point.  

      (3) Finally, the studies here are motivated by experiments in Fig. S1 (as well as other studies from the Deretic and Stallings labs) suggesting unique autophagy-independent functions for ATG5 in myeloid cells and neutrophils in susceptibility to Mycobacterium tuberculosis infection. However, it is curious that no attempt is made to relate the mechanistic data regarding the retromer or GLUT1 receptor mis-sorting back to the infectious models. Do myeloid cells or neutrophils lacking ATG5 have deficiencies in glucose uptake or GLUT1 cell surface levels? 

      Reviewer’s point is well taken. Glucose uptake, its metabolism, and diabetes underly resurgence in TB in certain populations and are important factors in a range of other diseases. This was alluded to in our discussion (lines 461-469). However, these are complex topics for future studies. We have now expanded this section of the discussion (p. 18): “In the context of tuberculosis, diabetes, which includes glucose dysregulation, is associated with increased incidence of active disease and adverse outcomes” (Dheda et al., ,PMID: 26377143; Dooley, et al., PMID:19926034).

      Reviewer #3 (Public Review): 

      In this manuscript, Padder et al. used APEX2 proximity labeling to find an interaction between ATG5 and the core components of the Retromer complex, VPS26, VPS29, and VPS35. Further studies revealed that ATG5 KO inhibited the trafficking of GLUT1 to the plasma membrane. They also found that other autophagy genes involved in membrane atg8ylation affected GLUT1 sorting. However, knocking out other essential autophagy genes such as ATG13 and FIP200 did not affect GLUT1 sorting. These findings suggest that ATG5 participates in the function of the Retromer in a noncanonical autophagy manner. Overall, the methods and techniques employed by the authors largely support their conclusions. These findings are intriguing and significant, enriching our understanding of the non-autophagic functions of autophagy proteins and the sorting of GLUT1.

      Nevertheless, there are several issues that the authors need to address to further clarify their conclusions. 

      (1) The authors confirmed the interaction between Atg5 and the Retromer complex through Co-IP experiments. Is the interaction between Atg5 and the Retromer direct? If it is direct, which Retromer complex protein regulates the interaction with Atg5? Additionally, does ATG5 K130R mutant enhance its interaction with the Retromer? 

      AlphaFold modeling in the initial submission of our study to eLife (absent from the current version) suggested the possibility of a direct interaction between ATG5 and VPS35 with ATG12—ATG5 complex facing outwards, in which case K130R would not matter. However, mutational experiments in putative contact residues did not alter association in co-IPs. So either ATG5 interacts with other retromer subunits or more likely is in a larger protein complex containing retromer. It will take a separate study to dissect associations and find direct interaction partners. 

      (2) To more directly elucidate how ATG5 regulates Retromer function by interacting with the Retromer and participates in the trafficking of GLUT1 to the plasma membrane, the authors should identify which region or crucial amino acid residues of ATG5 regulate its interaction with the Retromer. Additionally, they should test whether mutations in ATG5 that disrupt its interaction with the Retromer affect Retromer function (such as participating in the trafficking of GLUT1 to the plasma membrane) and whether they affect Atg8ylation. They also need to assess whether these mutations influence canonical autophagy and lysosomal sensitivity to damage. 

      Please see the response to point 1.

      Recommendations for the authors.

      Reviewer #1 (Recommendations For The Authors): 

      While most data are solid and convincing, the following questions need to be addressed before publication: 

      Major Concerns: 

      (1) Examining only one cargo (GLUT1) is insufficient to reflect the retromer's function comprehensively. At least two additional cargoes should be analyzed to observe the phenotypes more accurately. 

      We agree that having another retromer cargo (in addition to GLUT1) would be of interest. We point out that our data also show mis-sorting of SNX27 to lysosomes (Fig. 3H, quantifications in Fig. 3I).  SNX27 in turn sorts nearly 80 ion channels, signaling receptors, and other nutrient transporters. Which of the 80 cargos to prioritize and check (the expectation is that all 80 might be missorted given that they need SNX27)?  We have instead tested MPR, a SNX27-independent cargo. We now include data on effects of ATG5 knockout on CI-MPR (Fig. S9A-F). This is described in the text (p. 14; “Effect of ATG5 knockout on MPR sorting

      We tested whether ATG5 affects cation-independent mannose 6-phosphate receptor (CI-MPR). For this, we employed the previously developed methods (Fig. S9A) of monitoring retrograde trafficking of CI-MPR from the plasma membrane to the TGN 70,118-121. In the majority of such studies, CI-MPR antibody is allowed to bind to the extracellular domain of CI-MPR at the plasma membrane and its localization dynamics following endocytosis serves as a proxy for trafficking of CI-MPR. We used ATG5 KOs in HeLa and Huh7 cells and quantified by HCM retrograde trafficking to TGN of antibody-labeled CI-MPR at the cell surface, after being taken up by endocytosis and allowed to undergo intracellular sorting, followed by fixation and staining with TGN46 antibody. There was a minor but statistically significant reduction in CIMPR overlap with TGN46 in HeLaATG5-KO that was comparable to the reduction in HeLa cells when

      VPS35 was depleted by CRISPR (HeLaVPS35-KO) (Fig. S9B,C). Morphologically, endocytosed Ab-CI-

      MPR appeared dispersed in both HeLaATG5-KO and HeLaVPS35-KO cells relative to HeLaWT cells (Fig. S9D). Similar HCM results were obtained with Huh7 cells (WT vs. ATG5KO; Fig. S9E,F). We interpret these data as evidence of indirect action of ATG5 KO on CI-MPR sorting via membrane homeostasis, although we cannot exclude a direct sorting role via retromer. We favor the former interpretation based on the strength of the effect and the controversial nature of retromer engagement in sorting of CI-MPR (57,70,75,98,120).”)

      (2) The evidence from Alphafold predictions is weak. The direct interaction of ATG5 with retromer subunits should be tested. 

      Please see the above response to Reviewer 3.

      In addition, does retromer also interact with ATG16L1 similarly to the phenomenon in VAIL? 

      We fully agree with the reviewer that finding the direct interacting partners between retromer and membrane atg8ylation machinery is an important direction as in our opinion it would expand the repertoire of E3 ligases and its adaptors. However, given the complexity and variety of possibilities, we believe that this is a topic for a future study.  

      (3) In Line 166, Figures 2C and 2D, the Gal3 phenotype does not seem to be well complemented by VPS35. 

      We have adjusted the text to acknowledge incomplete complementation (p.7). 

      (4) In Figures 3 and 4, the authors show that KO of membrane atg8ylation machineries and ATG8-Hexa KO affects the localization of retromer cargo GLUT1 and SNX27. However, the mechanism by which membrane ATG8ylation affects retromer remains unresolved.

      Additionally, are other retromer subunits' locations are also affected, if so, how are they impacted? At least a speculative explanation should be provided. 

      Following reviewers request, we now state on p. 19 that “one of the limitations of our study is that beyond effects of membrane atg8ylation on quality of lysosomal membrane and its homeostasis there could be more direct effects of membrane modification with mATG8s on retromer that still need to be understood”.

      (5) In Figure 3, endogenous IP results are required to examine the interaction of ATG5 with retromer if suitable retromer antibodies for IP are available. 

      Endogenous IPs are given in Fig. 1. We have modified text on p. 8 to clarify this.

      (6) In Figure 4, ATG8 Hexa KO, and triple KO of LC3s or GABARAPs all increase the localization of GLUT1 on lysosomes. It seems redundant for ATG8 family proteins here.

      Can any individual member of the ATG8 family rescue this phenotype? 

      If the intent of such complementation analysis is to identify a specific mATG8 responsible for the observed effects, this is already pre-empted by the fact that TKOs also have a similar effect as HEXA mutants (i.e. loss of at least two of mATG8s is enough to cause the phenotype). We now discuss this in the text (p. 10): “Thus, at least two mATG8s, each one from two different mATG8 subclasses (LC3s and GABARAPs) or the entire membrane atg8ylation machinery was engaged in and required for proper GLUT-1 sorting”.  

      (7) In Figure 5, knockdown of ATG5 in FIP200 KO cells inhibited GLUT1 sorting from endosomes, leading to its trafficking to lysosomes. However, it is known that very little remnant ATG5 in ATG5 KD cells is enough to support ATG8 lipidation. Therefore, it is essential to repeat this experiment using ATG5/FIP200 double KO or ATG5 KO combined with an autophagy inhibitor. 

      We point out to this limitation in the text (p. 11): “….we knocked down ATG5 in FIP200 KO cells (Fig. S5D) and found that GLUT1 puncta and GLUT1+LAMP2+ profiles increased even in the FIP200 KO background with the effects nearing those of VPS35 knockout (Figs. 5D-F and S5C), with the difference between VPS35 KO and ATG5 KD attributable to any residual ATG5 levels in cells subjected to siRNA knockdowns”.

      (8) In Figure 7, the authors show that the induction of CASM inhibited GLUT1 sorting from endosomes. However, ATG5 KO, which abolishes membrane ATG8ylation, also inhibits GLUT1 sorting. This seems paradoxical and requires a reasonable explanation or discussion. 

      We understand reviewer’s comment. The answer to this paradox is that it is actually the lysosomal damage that causes GLUT1 mis-sorting and not CASM. Membrane atg8ylation, such as CASM and probably other processes given that involvement of both ATG2 and ESCRTs (Fig. 8) counteracts the damage and works in the direction of restoring/maintaining proper retromer-dependent sorting. This is now explained better in the text, and have revised the title of Fig. 7 to read “Lysosomal damage causes GLUT1 mis-sorting”. Our data with bafilomycin A1 show that it is the perturbance of lysosomes (not CASM per se) that leads to mis-sorting of GLUT1 (Fig. 7D,E), and our data with ATG2AB DKO and ESCRT (VPS37A) KO (Fig. 8A-F) indicate that repair of lysosomes is important to keep the retromer working machinery functional (as illustrated in Fig. 8G), which may be one of the effector mechanisms downstream of membrane atg8ylation  in general (and hence also of CASM).  

      (9) The immuno-staining results for Figures 7F and 7G are lacking. 

      We now provide the requested images.

      (10) In Figure 8D, the quality of the image for VPS37 KO cells treated with LLOME is not sufficient to show increased colocalization between GLUT1 and LAMP2. 

      We now provide a different example image. We note that these are epiflorescent HCM images  

      Minor Concerns: 

      (1) It would be better to distinguish the function of the membrane ATG8ylation machinery (i.e., ATG5) from the function of membrane ATG8ylation in the description. No ATG8ylation-deficient mutants were used in this study. 

      We have used atg8ylation mutants (e.g. KOs in ATG3, ATG5, ATG7, and ATG16L1). We now emphasize this better in the text (p. 10). 

      (2) In Figure 2D, a green box appears there by incident. 

      This has been fixed.

      (3) In Figure 3A, the conjugate for ATG5-ATG12 is absent in the gel for IB: ATG5.

      The ATG5 antibody used in Fig. 3A recognizes primarily the conjugated form of ATG5. This is now clarified in the figure legend. 

      (4) Figure 5G is missing in the manuscript. 

      Fig 5G is now mentioned in the text. Thank you.

      (5) The gRNA sequence information for FIP200 KO is missing in the Methods section. 

      Reference(s) to the already published gRNA sequence are in the manuscript. 

      (6) Suggest moving the last paragraph in Result section to Discussion section. 

      We kept this single-paragraph section in Results as it contains actual data.

      Reviewer #2 (Recommendations For The Authors): 

      (1) It is unclear why the rescue of VPS35KO cells in Fig 1C-D is so modest. 

      Complementation data depend on transfection efficiency and some variability is to be expected.

      Reviewer #3 (Recommendations For The Authors): 

      (1) Figures 2A, 2C, 2E, and 2G lack scale bars. Figure 2D has a small square above the y axis. 

      Relative scale bars are now included. 

      (2) Figures S3B, S3D, and S3F lack scale bars. 

      Relative scale bars are now included.

    1. Author response:

      We thank the Editor and Reviewers for their work on our manuscript, and are happy to receive their positive comments, as well as their questions and suggestions. We are currently revising the manuscript and are planning to de-emphasize Brownian recovery as a simple yet biologically irrelevant benchmark and include comparisons with other biologically inspired strategies suggested by the reviewers. As for sharing the code and data: we completely agree: dataset 1 is already public and we will share the other dataset as well as the code. In a nutshell, we will be addressing the referee’s suggestions as follows:

      (1)   As Referee 1 points out, even if the algorithm does not require a map of space, the agent is still required to tell apart North, East, South and West relative to the wind direction which is implicitly assumed known. We will better clarify the spatial encoding required to implement these strategies.

      (2)   Referee 1 remarks that the learned recovery strategy works best and suggests to give it a more prominent role and better characterize it. We agree that what is done in the void state is definitely key and more work is needed to understand it. In the revised manuscript, we are planning to further substantiate the statistics of the learned recovery by repeating training several times and comparing several trajectories. Note that this strategy is much more flexible than the others and could potentially mix aspects of recovery to aspects of exploitation: we defer a more in-depth analysis that disentangles these two aspects elsewhere.

      (3)   Referee 1 asks whether an optimal, minimal representation of the olfactory states exists. Q learning defines the olfactory states prior to training and does not allow to systematically optimize odor representation for the task. Given the odor features, we can however discretize them in more or less olfactory states. We expect that decreasing the number of olfactory states provides less positional information and potentially degrades performance, although loss in performance may be overshadowed by noise or by efficient recovery. We are planning to re-train our model with a smaller numer of non-void states and will provide the comparison. The number of void states does not need further testing: we chose 50 void states because it matches the time agents typically remain in the void and indeed achieves very high performance (less than 50 void states results in no convergence and more than 50 introduces states that are rarely visited)

      (4)   Both reviewers correctly remark that Brownian motion is not biologically relevant. We will make sure to further clarify that this is a rather simple --but biologically irrelevant-- benchmark. We are planning to include results with both circling and zigzaging as biologically inspired recovery strategies.

      (5)   We agree with reviewer 2 that animal locomotion does not look like a series of discrete displacements on a checkerboard. However, to overcome this limitation, one has to first focus on a specific system to define actions in a way that best adheres to a species’ motor controls. Second, these actions are likely continuous, which makes reinforcement learning notoriously more complex. While we agree that more realistic models are definitely needed for a comparison with real systems, this remains outside the scope of the current work.

      (6)   We agree with the referees and editor that it is important to publish the code and data alongside with the manuscript. It was already planned and we will make sure to share the links within the revised version of the manuscript.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review):

      Summary:

      The study by Nelson et al. is focused on formation of the Drosophila Posterior Signaling Center (PSC) which ultimately acts as a niche to support hematopoietic stem cells of the lymph gland (LG). Using a combination of genetics and live imaging, the authors show that PSC cells migrate as a tight collective and associate with multiple tissues during a trajectory that positions them at the posterior of the LG.

      This is an important study that identifies Slit-Robo signaling as a regulator of PSC morphogenesis, and highlights the complex relationship of interacting cell types - PSC, visceral mesoderm (VM) and cardioblasts (CBs) - in coordinated development of these three tissues during organ development. However, one point requiring clarification is the idea that PSC cells exhibit a collective cell migration; it is not clear that the cells are migrating rather than being pushed to a more dorsal position through dorsal closure and/or other similar large scale embryo movement. This does not detract from the very interesting analysis of PSC morphogenesis as presented.

      This Public Review by Reviewer #1 is identical to their original Public Review, thus we are unsure whether Reviewer #1 assessed the revised version of our manuscript, and whether they read our responses to their original Public Review. Below we summarize our original responses to the weaknesses listed for the first version of our manuscript.

      Strengths:

      • Using expression of Hid or Grim to ablate associated tissues, they find evidence that the VM and CB of the dorsal vessel affect PSC migration/morphology whereas the alary muscles do not. Slit is expressed by both VM and CBs, and therefore Slit-Robo signaling was investigated as PSCs express Robo.

      • Using a combination of approaches, the authors convincingly demonstrate that Slit expression in the CBs and VM acts to support PSC positioning. A strength is the ability to knockdown slit levels in particular tissue types using the Gal4 system and RNAi.

      • Although in the analysis of robo mutants, the PSC positioning phenotype is weaker in the individual mutants (robo1 and robo2) with only the double mutant (robo1,robo2) exhibiting a phenotype comparable to the slit RNAi. The authors make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs, because PSCs show a phenotype even when CBs do not (Fig 4G).

      • New insight into dorsal vessel formation by VM is presented in Fig 4A,B, as loss of the VM can affect dorsal vessel morphogenesis. This result additionally points to the VM as important.

      Weaknesses:

      • The authors are cautioned to temper the result that Slit-Robo signaling is intrinsic to PSC since loss of robo may affect other cell types (besides CBs and PSCs) to indirectly affect PSC migration/morphogenesis. In fact, in the robo2, robo1 mutant, the VM appears to be incorrectly positioned (Fig. 4G).

      We maintain our conclusion, and, we point out that the Reviewer stated, “The authors make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs”. We already added a statement to the Discussion reminding the reader of the possibility of secondary defects (“Finally, it is possible that PSC cells do not intrinsically require Robo activation, but rather CB-independent PSC mis-positioning in sli or robo mutants could be a secondary defect caused by compromised Slit-Robo signaling in some other tissue.”).

      • If possible, the authors should use RNAi to knockdown Robo1 and Robo2 levels specifically in the PSCs if a Gal4 is available; might Antp.Gal4 (Fig 1K) be useful? Even if knockdown is achieved in PSCs+CBs, this would be a better/complementary experiment to support the approach outlined in Fig 4D.

      As described in our first response, use of Antp-GAL4 with RNAi would be no better than a whole animal double Robo mutant.

      • Movies are hard to interpret, as it seems unclear that the PSCs actively migrate rather than being pushed/moved indirectly due to association with VM and CBs/dorsal vessel.

      Vm does not directly contact the PSC, so the Vm cannot be physically pushing the PSC. In their original review, Reviewer #3 expressed similar concerns (Weaknesses #1 and #2), and upon their review of our revised manuscript they determined we addressed these concerns.

      Reviewer #2 (Public review):

      The paper by Nelson KA, et al. explored the collective migration, coalescence and positioning of the posterior signaling center (PSC) cells in Drosophila embryo. With live imaging, the authors observed the dynamic progress of PSC migration. Throughout this process, visceral mesoderm (VM), alary muscles (Ams) and cardioblasts (CBs) are in proximity of PSC. Genetic ablation of these tissues reveals the requirement for VM and CBs, but not AMs in this process. Genetic manipulations further demonstrated that Slit-Robo signaling was critical during PSC migration and positioning. While the genetic mechanisms of positioning the PSC were explored in much detail, including using live imaging, the functional consequence of mispositioning or (partial) absence of PSC cells has not been addressed, but would much increase the relevance of their findings. A few additional issues need to be addressed as well in this otherwise well-done study.

      Previous major points:

      (1) The only readout in their experiments is the relative correctness of PSC positioning. Importantly, what is the functional consequence if PSC is not properly positioned? This would be particularly important with robo-sli manipulations, where the PSC is present but some cells are misplaced. What is the consequence? Are the LGs affected, like specification of their cell types, structure and function? To address this for at least the robo-slit requirement in the PSC, it may be important to manipulate them directly in the PSC with a split Gal4 system, using Antp and Odd promoters.

      We state in our original response that exploring the functional consequences of PSC mis-positioning was outside the scope of this study. Given that the necessary cis-regulatory modules have not been identified at Antp or Odd, creating a split-GAL4 with ‘Antp and Odd promoters’ cannot be accomplished in a reasonable time frame, as we previously detailed in our original response.

      (2) The densely, parallel aligned fibers in the lower part of Figure 1J seemed to be visceral mesoderm, but further up (dorsally) that may be epidermis. It is possible that the PSC migrate together with the epidermis? This should be addressed.

      This was directly addressed by the additional data included in our revision. When epidermal closure is stalled, the PSC is able to migrate past the stalled leading edge, closer to the midline.

      (3) Although the authors described the standards of assessing PSC positioning as "normal" or "abnormal", it is rather subtle at times and variable in the mutant or KD/OE examples. The criteria should be more clearly delineated and analyzed double-blind, also since this is the only readout. Further examples of abnormal positioning in supplementary figures would also help.

      We addressed this comment in detail in our original response. Briefly, double-blinding was oftentimes not possible due to the obviousness of the genotype in the image. The criteria we outline for normal PSC positioning is as comprehensive as possible given the subtlety variability of mis-positioning phenotypes. Two of the authors independently analyzed the relatively large sets of samples and arrived at the same conclusions.

      (4) Discussion is very lengthy and should shortened.

      We shortened the Discussion in the revised version.

      Comments on revised version:

      Although the authors have responded to my concerns as they deemed suitable, these concerns still stand for the revised version.

      Given our responses above and the lack of detail in this comment, we are unsure why the Reviewer is still concerned.

      Reviewer #3 (Public review):

      Summary:

      This work is a detailed and thorough analysis of the morphogenesis of the posterior signaling center (PSC), a hematopoietic niche in the Drosophila larva. Live imaging is performed from the stage of PSC determination until the appearance of a compact lymph gland and PSC in the stage 16 embryo. This analysis is combined with genetic studies that clarify the involvement of adjacent tissue, including the visceral mesoderm, alary muscle, and cardioblasts/dorsal vessel. Lastly, the Slit/Robo signaling system is clearly implicated in the normal formation of the PSC.

      Strengths:

      The data are clearly presented and well documented, and fully support the conclusions drawn from the different experiments.

      The authors have addressed all of my previous comments, in particular concerning the role of epidermal cell rearrangements during dorsal closure as a possible force acting on the movement of PSC cells. The authors have clarified their definition of "collective migration" as it applies to the movement of PSC. The revised paper will make an important contribution to our understanding of the mechanisms driving morphogenesis.

      We are appreciative of the time spent by the Reviewer reading our responses and assessing the revision.

      ---------

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The study by Nelson et al. is focused on the formation of the Drosophila Posterior Signaling Center (PSC) which ultimately acts as a niche to support hematopoietic stem cells of the lymph gland (LG). Using a combination of genetics and live imaging, the authors show that PSC cells migrate as a tight collective and associate with multiple tissues during a trajectory that positions them at the posterior of the LG.

      This is an important study that identifies Slit-Robo signaling as a regulator of PSC morphogenesis, and highlights the complex relationship of interacting cell types - PSC, visceral mesoderm (VM), and cardioblasts (CBs) - in the coordinated development of these three tissues during organ development. However, one point requiring clarification is the idea that PSC cells exhibit a collective cell migration; it is not clear that the cells are migrating rather than being pushed to a more dorsal position through dorsal closure and/or other similar large-scale embryo movement. This does not detract from the very interesting analysis of PSC morphogenesis as presented.

      Since each referee asked for clarification concerning collective cell migration, we present a combined response further below, placed after the comments from Reviewer #3.

      Strengths:

      (1) Using the expression of Hid or Grim to ablate associated tissues, they find evidence that the VM and CB of the dorsal vessel affect PSC migration/morphology whereas the alary muscles do not. Slit is expressed by both VM and CBs, and therefore Slit-Robo signaling was investigated as PSCs express Robo.

      (2) Using a combination of approaches, the authors convincingly demonstrate that Slit expression in the CBs and VM acts to support PSC positioning. A strength is the ability to knockdown slit levels in particular tissue types using the Gal4 system and RNAi.

      (3) Although in the analysis of robo mutants, the PSC positioning phenotype is weaker in the individual mutants (robo1 and robo2) with only the double mutant (robo1,robo2) exhibiting a phenotype comparable to the slit RNAi. The authors make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs because PSCs show a phenotype even when CBs do not (Figure 4G).

      (4) New insight into dorsal vessel formation by VM is presented in Figure 4A, B, as loss of the VM can affect dorsal vessel morphogenesis. This result additionally points to the VM as important.

      Weaknesses:

      (1) The authors are cautioned to temper the result that Slit-Robo signaling is intrinsic to PSC since the loss of robo may affect other cell types (besides CBs and PSCs) to indirectly affect PSC migration/morphogenesis. In fact, in the robo2, robo1 mutant, the VM appears to be incorrectly positioned (Figure 4G).

      We have reexamined our wording in the relevant Results section and, given that this referee agrees that we, “make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs because PSCs show a phenotype even when CBs do not (Figure 4G)”, it was not clear how we might temper our conclusions more. Given that PSC cells express Robo1 and Robo2, and that the Vm does not contact the PSC, our ‘reasonable argument’ appears fair and parsimonious. Since we agree with the referee that a reader should be made as aware as possible of alternatives, we will add a comment to the Discussion, reminding the reader of the possibility of a secondary defect.

      (2) If possible, the authors should use RNAi to knockdown Robo1 and Robo2 levels specifically in the PSCs if a Gal4 is available; might Antp.Gal4 (Fig 1K) be useful? Even if knockdown is achieved in PSCs+CBs, this would be a better/complementary experiment to support the approach outlined in Figure 4D.

      While we agree that PSC-specific knockdown of Robo1 and Robo2 simultaneously would be ideal, this is not possible. First, the most-effective UAS-RNAi transgenes (that is, those in a Valium 20 backbone) are both integrated at the same chromosomal position; these cannot be simultaneously crossed with a GAL4 transgenic line to attempt double knock down. Additionally, as with all RNAi approaches that must rely on efficient knockdown over the rapid embryonic period, even having facile access to the above does not ensure the RNAi approach will cause as effective depletion as the genetic null condition that we use. Second, as the referee concedes, there is no embryonic PSC-specific GAL4. The proposed use of Antp-GAL4 would cause knockdown in many tissues (PSC, CB, Vm, epidermis and amnioserosa). This would lead to a reservation similar to that caused by our use of the straight genetic double mutant, as regards potential indirect requirement for Robo function.

      (3) Movies are hard to interpret, as it seems unclear that the PSCs actively migrate rather than being pushed/moved indirectly due to association with VM and CBs/dorsal vessel.

      First, the Vm does not directly contact the PSC, so it cannot be pushing the PSC dorsally. We will re-examine our text to be certain to make this clear. Second, in our analysis of bin mutants, which lack Vm, LGs and PSCs are able to reach the dorsal midline region in the absence of Vm. Finally, please see our response to Reviewer #3, point 2, for why we maintain that PSC cells are “migrating” even though some PSC cells are attached to CBs.

      Reviewer #2 (Public Review):

      The paper by Nelson KA, et al. explored the collective migration, coalescence, and positioning of the posterior signaling center (PSC) cells in Drosophila embryo. With live imaging, the authors observed the dynamic progress of PSC migration. Throughout this process, visceral mesoderm (VM), alary muscles (Ams), and cardioblasts (CBs) are in proximity to PSC. Genetic ablation of these tissues reveals the requirement for VM and CBs, but not AMs in this process. Genetic manipulations further demonstrated that Slit-Robo signaling was critical during PSC migration and positioning. While the genetic mechanisms of positioning the PSC were explored in much detail, including using live imaging, the functional consequence of mispositioning or (partial) absence of PSC cells has not been addressed, but would much increase the relevance of their findings. A few additional issues need to be addressed as well in this otherwise well-done study.

      Major points:

      (1) The only readout in their experiments is the relative correctness of PSC positioning. Importantly, what is the functional consequence if PSC is not properly positioned? This would be particularly important with robo-sli manipulations, where the PSC is present but some cells are misplaced. What is the consequence? Are the LGs affected, like the specification of their cell types, structure, and function? To address this for at least the robo-slit requirement in the PSC, it may be important to manipulate them directly in the PSC with a split Gal4 system, using Antp and Odd promoters.

      We agree that the functional consequence of PSC mis-positioning is important and a relevant question to eventually address. However, virtually all markers and reagents used to assess the effect of the PSC on progenitor cells and their differentiated descendants are restricted to analyses carried out on the third larval instar - some three days after the experiments reported here. Most of the manipulated conditions in our work are no longer viable at this phase and, thus, addressing the functional consequences of a malformed PSC will require the field to develop new tools. 

      As we noted in the Introduction, the consistency with which the wildtype PSC forms as a coalesced collective at the posterior of the LG strongly suggests importance of its specific positioning and shape, as has now been found for other niches (citations in manuscript). Additionally, in the Discussion we mention the existence of a gap junction-dependent calcium signaling network in the PSC that is important for progenitor maintenance. Without continuity of this network amongst all PSC cells (under conditions of PSC mis-positioning), we strongly anticipate that the balance of progenitors to differentiated hemocytes will be mis-managed, either constitutively, and / or under immune challenge conditions. 

      Finally, to our knowledge, the tools do not exist to build a “split Gal4 system using Antp and Odd promoters”. The expression pattern observed using the genomic Antp-GAL4 line must be driven by endogenous enhancers–none of which have been defined by the field, and thus cannot be used in constructing second order drivers. Similarly, for odd skipped, in the embryo the extant Odd-GAL4 driver expresses only in the epidermis, with no expression in the embryonic LG. Thus, the cis regulatory element controlling Odd expression in the embryonic LG is unknown. In the future, the discovery of an embryonic PSC-specific driver will aid in addressing the specific functional consequences of PSC mis-positioning.

      (2) The densely, parallel aligned fibers in the part of Figure 1J seemed to be visceral mesoderm, but further up (dorsally) that may be epidermis. It is possible that the PSC migrate together with the epidermis? This should be addressed.

      See response to Reviewer #3.

      (3) Although the authors described the standards of assessing PSC positioning as "normal" or "abnormal", it is rather subtle at times and variable in the mutant or KD/OE examples. The criteria should be more clearly delineated and analyzed double-blind, also since this is the only readout. Further examples of abnormal positioning in supplementary figures would also help.

      We appreciate the Reviewer’s concern and acknowledge that the phenotypes we observed were indeed variable, and, at times subtle. As we show and discuss in the paper, our results revealed that the signaling requirements for proper PSC positioning are complex; this was favorably commented upon by Reviewer #1 (“...highlights the complex relationship of interacting cell types - PSC, visceral mesoderm (VM), and cardioblasts (CBs) - in the coordinated development of these three tissues during organ development.…”). We suspect the phenotypic variability is attributable to any number of biological differences such as heterogeneity of PSC cells and an accompanying difference in the timing of their competence to receive and respond to Slit-Robo signaling, the timing of release of Slit from CBs and Vm, number of cells in a given PSC, which PSC cells in the cluster respond to too little or too much signaling, and/or typical variability between organisms. Furthermore, PSC positioning analyses were conducted by two of the authors, who independently came to the same conclusions. For many of the manipulations double blinding was not possible since the genotype of the embryo was discernible due to the obvious phenotype of the manipulated tissue.

      (4) The Discussion is very lengthy and should shortened.

      We will re-examine the prose and emphasize more conciseness, while maintaining clarity for the reader.

      Reviewer #3 (Public Review):

      Summary:

      This work is a detailed and thorough analysis of the morphogenesis of the posterior signaling center (PSC), a hematopoietic niche in the Drosophila larva. Live imaging is performed from the stage of PSC determination until the appearance of a compact lymph gland and PSC in the stage 16 embryo. This analysis is combined with genetic studies that clarify the involvement of adjacent tissue, including the visceral mesoderm, alary muscle, and cardioblasts/dorsal vessels. Lastly, the Slit/Robo signaling system is clearly implicated in the normal formation of the PSC.

      Strengths:

      The data are clearly presented, well documented, and fully support the conclusions drawn from the different experiments. The manuscript differs in character from the mainstay of "big data" papers (for example, no sets of single-cell RNAseq data of, for instance, PSC cells with more or less Slit input, are offered), but what it lacks in this regard, it makes up in carefully planned and executed visualizations and genetic manipulations.

      Weaknesses:

      A few suggestions concerning improvement of the way the story is told and contextualized.

      (1) The minute cluster of PSC progenitors (5 or so cells per side) is embedded (as known before and shown nicely in this study) in other "migrating" cell pools, like the cardioblasts, pericardial cells, lymph gland progenitors, alary muscle progenitors. These all appear to move more or less synchronously. What should also be mentioned is another tissue, the dorsal epidermis, which also "moves" (better: stretches?) towards the dorsal midline during dorsal closure. Would it be reasonable to speculate (based on previously published data) that without the force of dorsal closure, operating in the epidermis, at least the lateral>medial component of the "migration" of the PSC (and neighboring tissues) would be missing? If dorsal closure is blocked, do essential components of PSC and lymph gland morphogenesis (except for the coming-together of the left and right halves) still occur? Are there any published data on this?

      Each of the Reviewers is interested in our response to this very relevant question, and, thus, we will address the issue en bloc here. First, we will add a Supplementary Figure showing that LG and CBs are still able to progress medially towards the dorsal midline when dorsal closure stalls.  This rules out any major effect for the most prominent “large-scale embryo cell sheet movement” in positioning the PSC. Second, published work by Haack et. al. and Balaghi et. al. shows that CBs and leading edge epidermal cells are independently migratory, and we will add this context to the manuscript for the reader.

      (2) Along similar lines: the process of PSC formation is characterized as "migration". To be fair: the authors bring up the possibility that some of the phenotypes they observe could be "passive"/secondary: "Thus, it became important to test whether all PSC phenotypes might be 'passive', explained by PSC attachment to a malforming dorsal vessel. Alternatively, the PSC defects could reflect a requirement for Robo activation directly in PSC cells." And the issue is resolved satisfactorily. But more generally, "cell migration" implies active displacement (by cytoskeletal forces) of cells relative to a substrate or to their neighbors (like for example migration of hemocytes). This to me doesn't seem really clearly to happen here for the dorsal mesodermal structures. Couldn't one rather characterize the assembly of PSC, lymph gland, pericardial cells, and dorsal vessel in terms of differential adhesion, on top of a more general adhesion of cells to each other and the epidermis, and then dorsal closure as a driving force for cell displacement? The authors should bring in the published literature to provide a background that does (or does not) justify the term "migration".

      Before addressing this specifically, we remind readers of our response above that states the rationale ruling out large, embryo-scale movements, such as epidermal dorsal closure, in driving PSC positioning. So, how are PSC cells arriving at their reproducible position? This manuscript reports the first live-imaging of the PSC as it comes to be positioned in the embryo. We interpret these movies to suggest strongly that these cells are a ‘collective’ that migrates. Neither the data, nor we, are asserting that each PSC cell is ‘individually’ migrating to its final position. Rather, our data suggest that the PSC migrates as a collective. The most paradigmatic example of directed, collective cell migration, is of Drosophila ovarian border cells. That cell cluster is surrounded at all times by other cells (nurse cells, in that case), and for the collective to traverse through the tissue, the process requires constant remodeling of associations amongst the migrating cells in the collective (the border cells), as well as between cells in the collective and those outside of it (the nurse cells). In fact, the nurse cells are considered the substrate upon which border cells migrate. Note also that in collective border cell migration cells within the collective can switch neighbors, suggesting dynamic changes to cell associations and adhesions. 

      In our analysis, the PSC cells exhibit qualities reminiscent of the border cells, and thus we infer that the PSC constitutes a migratory cell collective.  We also show in Figure 1H that PSC cells exhibit cellular extensions, and thus have a very active, intrinsic actin-based cytoskeleton. In fact, in Figure 1I, we point out that PSC cells shift position within the collective, which is not only a direct feature of migration, but also occurs within the border cell collective as that collective migrates. Additionally, the fact that the lateral-most PSC cells shift position in the collective while remaining a part of the collective–and they do this while executing net directional movement–makes a strong argument that the PSC is migratory, as no cell types other than PSCs are contacting the surfaces of those shifting PSC cells. Lastly, the Reviewer’s supposition that, rather than migration, dorsal mesoderm structures form via “differential adhesion, on top of a more general adhesion of cells to each other” is, actually, precisely an inherent aspect of collective cell migration as summarized above for the ovarian border collective.

      In our resubmission we will adjust text citing the existing literature to better put into context the reasoning for why PSC formation based on our data is an example of collective cell migration.

      (3) That brings up the mechanistic centerpiece of this story, the Slit/Robo system. First: I suggest adding more detailed data from the study by Morin-Poulard et al 2016, in the Introduction, since these authors had already implicated Slit-Robo in PSC function and offered a concrete molecular mechanism: "vascular cells produce Slit that activates Robo receptors in the PSC. Robo activation controls proliferation and clustering of PSC cells by regulating Myc, and small GTPase and DE-cadherin activity, respectively". As stated in the Discussion: the mechanism of Slit/Robo action on the PSC in the embryo is likely different, since DE-cadherin is not expressed in the embryonic PSC; however, it maybe not be THAT different: it could also act on adhesion between PSC cells themselves and their neighbors. What are other adhesion proteins that appear in the late lateral mesodermal structures?

      Could DN-cadherin or Fasciclins be involved?

      We agree with the Reviewer that Slit-Robo signaling likely acts in part on the PSC by affecting PSC cell adhesion to each other and/or to CBs (lines 428-435). As stated in the Discussion, we do not observe Fasciclin III expression in the PSC until late stages when the PSC has already been positioned, suggesting that Fasciclin III is not an active player in PSC formation. Assessing whether the PSC expresses any other of the suite of potential cell adhesion molecules such as DN-Cadherin or other Fasciclins, and then study their potential involvement in the Slit-Robo pathway in PSC cells, would be part of a follow-up study.  

      Recommendations for the authors:

      Reviewing Editor Comments:

      The authors are encouraged to address several key issues and provide more explicit clarification when interpreting the behavior of the PSC cells as "migration." It is recommended that the authors engage with all reviewers' comments and refine the text based on the feedback they find valuable.

      Reviewer #1 (Recommendations For The Authors):

      Major concerns:

      (1) Is it possible to assay robo1 and/or robo1 RNAi in a tissue-specific manner to further explore an intrinsic role in the PSC? Might the VM indirectly affect PSCs in a CB-independent manner? How does this affect the interpretation of results in Figure 4.

      See also our response to Reviewer #1, Public review weaknesses #2.

      Though we agree with the Reviewer that this is the better experiment to test for an intrinsic role for Robo in the PSC, this experiment is not possible at this time. As we noted in the manuscript, we do not yet have an embryonic PSC-specific GAL4, though we have been putting efforts towards identifying/developing such a tool. The Antp-GAL4 driver we used in this study will drive not only in both PSCs and CBs, but also in Vm, epidermis, and amnioserosa, as well as other tissues. The other available embryonic PSC drivers are not specific to the PSC and will drive expression in CBs and Vm, at minimum. This, combined with the reality that RNAi can be ineffective in embryonic tissues, resulted in our use of whole organism mutants to best address this question. 

      We acknowledge that it is possible the Vm indirectly effects the PSC in a CB-independent manner in the double Robo mutant, and we added a statement to the Discussion reiterating this point. However, because the PSC expresses Robo1 and Robo2, we maintain that the simplest interpretation of the results in Figure 4 is that PSC cells require intrinsic Robo signaling. And, as we state in the manuscript, it is possible that Slit signals directly from Vm to Robo on the PSC.

      (2) As this is the first study to be presenting PSC formation as involving collective cell migration, can the authors provide experimental evidence and rationale for this categorization?

      We have added our rationale to the Results section in the revision.

      See also our response to Reviewer #3, Public review weakness #2.

      (3) The Slit staining presented in Fig 3 W', Z' should be quantified. Furthermore, what is the VM phenotype when Robo1 is overexpressed? Is there a VM-specific phenotype and could this indirect effect cause the PSC to misform/mismigrate?

      We didn’t quantify Slit levels in the Vm-specific Robo overexpression condition because there was a visually striking difference compared to controls (increased intensity and specific localization to Vm membranes), and the manipulation resulted in a PSC phenotype. Thus, the evidence we show appears sufficient to strongly suggest that our genetic manipulation resulted in successful trapping of Slit on the Vm.

      As to a Vm phenotype when Robo1 is overexpressed Vm-specifically: we know Vm is present, but we haven’t performed an in-depth phenotypic analysis. In the manuscript we show that this manipulation at least affects organization of PSC-adjacent CBs, which we go on to show is correlated with mis-positioned PSCs. Thus, the PSC phenotype in this condition is not solely due to a Vm-specific phenotype.

      Minor concerns/suggestions:

      (1) I might have missed it but where are the Movies referenced in the text? Are legends provided for the videos? It is important that this is included in the final version (or more clearly presented if I missed it).

      We thank you the Reviewer for pointing this out; we now direct the reader to the movies at appropriate places within the text.

      (2) In Figure 5, it might be helpful to add a third column to A in which the PSCs are pseudo-colored and thus highlighted because it is difficult to discern the white (not pink) PSCs...

      We appreciate the suggestion and now include these panels as Figure 5A’’ in the revision.

      (3) If I am following correctly, the lost PSC cells in Figure 5 don't move. Doesn't this suggest that what is critical is that the PSCs attach to the VM and/or CBs, and not necessarily that they are an actively migrating cell type? They "move" but might be passively carried.

      See also the response to Reviewer #3, Public reviews weaknesses #2.

      The Reviewer is correct that the PSC cells in Fig. 5 don’t move very much, but we interpret this differently from the Reviewer. After detachment of the cells in question they undergo dramatic shape changes, indicating active cytoskeletal remodeling, so the molecular machinery needed for migration appears to remain intact. Thus, we suggest that this observation actually emphasizes our finding that collectivity is needed for the migration. Given the consistency of PSC coalescence/collectivity and the intricate regulation that controls it, we believe it to be an integral part of PSC identity. When PSC cells become detached, they likely lose an aspect of their identity. In various manipulations we’ve noted instances of severely dispersed PSC cells expressing very low levels of identity markers Antp or Odd. Cells in such cases are likely compromised for their function, and this can include, for example, whether they can properly sense cues for migration.

      Reviewer #2 (Recommendations For The Authors):

      Minor points:

      (1) The expression pattern of Antp-Gal4 > myrGFP in the whole embryo should be shown to better demonstrate the overlap with Odd. How does it compare with Antp-Gal4 > CD8::GFP?

      We do not understand the question posed. We are not suggesting that Antp and Odd overlap in all cells, nor even many cells. It has been demonstrated by the field that co-expression among mesodermal cells, in the position where LG cells are specified, is a marker for the PSC. We have not thoroughly investigated all reporter lines for the GAL4 drivers used by the field.

      (2) Does Tincdelta4-Gal4 not at all express in the PSC? This should be verified.

      This question appears to refer to depletion of Slit by RNAi or cell killing driven by tinCΔ4-GAL4. TinCΔ4-GAL4 is expressed in CBs and in precisely 1 embryonic PSC cell. First, Slit isn’t expressed by any PSC cells to our eye, so any PSC mis-positioning observed upon tinCΔ4>Sli RNAi implicates CB involvement in PSC positioning. In designing tests for CB involvement, we were unable to identify any mutant known to lack CBs (or have fewer CBs) that didn’t also affect specification of the LG/PSC. The cell killing approach seemed best.  It is possible that, in this scenario, perhaps ablation of a single, key PSC cell could affect final positioning of the other PSCs, but we think that less likely than a role for CBs. We also retain our original conclusion due to the fact that we often find mis-positioned PSC cells adjacent to mis-positioned CBs, including in the panel representing the CB ablation experiment, Figure 2S.  

      (3) Line 212: The data provide evidence that Vm is necessary, but clearly not sufficient, as CBs are also necessary.

      We see how this wording was misleading and have adjusted the text accordingly.

      (4) The CBs are not visible in Figure 3B.

      We are unsure what the Reviewer is referring to, as we are certain that the signal between the blue outlines is indeed Slit expression in CBs.

      Reviewer #3 (Recommendations For The Authors):

      One minor mistake (I believe): in line 229 it should say "3C and 3D"

      We have corrected this error.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public Review:

      Summary

      This manuscript explores the transcriptomic identities of olfactory ensheathing cells (OECs), glial cells that support life-long axonal growth in olfactory neurons, as they relate to spinal cord injury repair. The authors show that transplantation of cultured, immunopurified rodent OECs at a spinal cord injury site can promote injury-bridging axonal regrowth. They then characterize these OECs using single-cell RNA sequencing, identifying five subtypes and proposing functional roles that include regeneration, wound healing, and cell-cell communication. They identify one progenitor OEC subpopulation and also report several other functionally relevant findings, notably, that OEC marker genes contain mixtures of other glial cell type markers (such as for Schwann cells and astrocytes), and that these cultured OECs produce and secrete Reelin, a regrowth-promoting protein that has been disputed as a gene product of OECs.

      This manuscript offers an extensive, cell-level characterization of OECs, supporting their potential therapeutic value for spinal cord injury and suggesting potential underlying repair mechanisms. The authors use various approaches to validate their findings, providing interesting images that show the overlap between sprouting axons and transplanted OECs, and showing that OEC marker genes identified using single-cell RNA sequencing are present in vivo, in both olfactory bulb tissue and spinal cord after OEC transplantation.

      Despite the breadth of information presented, however, further quantification of results and explanation of experimental approaches would be needed to support some of the authors' claims. Additionally, a more thorough discussion is needed to contextualize their findings relative to previous work.

      (1) a. Important quantification is lacking for the data presented. For example, multiple figures include immunohistochemistry or immunocytochemistry data (Figures 1, 5, 6), but they are presented without accompanying measures like fractions of cells labeled or comparisons against controls.

      We would like to clarify that the immunohistochemistry or immunocytochemistry data presented are meant to be qualitative rather than quantitative. The main purpose of the images is to show the presence or absence of markers of OEC subtypes rather than how much is present. That being said, in the revision we now add quantitative estimates of cell fractions for OECs along with other major cell types in Supplemental Table 1 and each OEC subtype marker in Supplemental Table 2. 

      b. As a result, for axons projecting via OEC bridges in Figure 1, it is unclear how common these bridges are in the presence or absence of OECs.

      We note that the number of spinal cord transected rats with bridges of axons crossing the lesion core are extremely rare following a severe spinal cord injury in adult mammals. Our first example of axon bridging following a complete spinal cord transection followed by OEC transplants was reported in Thornton et al., (2018) and compared to an incomplete transection in a fibroblast-transplanted control in his Figure 4. That figure also appeared the cover of Experimental Neurology when the paper was published. Figure 1 in the current paper was from an independent experiment which replicated the previously observed rare bridge formation. We noted this in the revised manuscript.

      Page 6: “We note, however, that such bridge formation is rare following a severe spinal cord injury in adult mammals.”

      c. For Figure 6., it is unclear whether cells having an alternative OEC morphology coincide with progenitor OEC subtype marker genes to a statistically significant degree. (see top paragraph on page 11)

      Franceschini & Barnett (1996) suggested that there were 2 distinct types of OECs that could be distinguished by their different morphology: one type resembling a Schwann cell and the other, an astrocyte. The purpose of Figure 6 is to determine if there is a link between our OEC subtypes based on scRNAseq with those previously described based on morphology alone (Franceschini and Barnett, 1996). There could be agreement between large, flat or small fusiform OECs morphological and their progenitor status, but it is not required that the two classification types would significantly overlap. Here we report the percentage of morphology-based cell subtypes that show expression of our OEC subtype markers to estimate the overlap between the two. Our results indicate the two types of OEC morphologies share a certain degree of overlap, a finding that indicates similarities as well as differences between the two classification methods.

      In our results section we show that ~3/4ths of the Ki67-expressing OEC progenitor cells sampled were astrocyte-like, i.e., flat in shape and weakly Ngfr<sup>p75</sup>-labeled. The remaining ~1/4th of the Ki67-labeled  OECs were fusiform in shape and expressed Ngfr<sup>p75</sup> strongly. We feel that this is important to include as it is the only previous report of OB-OEC subtypes. The statistics of these results were in our original manuscript on page 11 and we further revise the text as follows:

      Page 12: “To determine if the proliferative OECs differ in appearance from adult OECs, and whether there is concordance between our OEC subtypes based on gene expression markers and previously described morphology-based OEC subtyping (Franceschini & Barnett, 1996), we analyzed OECs identified with the anti-Ki67 nuclear marker and anti-Ngfr<sup>p75</sup>  (Figure 6g-h). Of the Ki67-positive OECs in our cultures, 24% ± 8% were strongly Ngfr<sup>p75</sup>-positive and spindle-shaped, whereas 76% ± 8% were flat and weakly Ngfr<sup>p75</sup>-labeled (n=4 cultures, p\= 0.023). Here we show that a large percentage (~3/4ths) of proliferative OECs are characterized by large, flat morphology and weak Ngfr<sup>p75</sup> expression resembling the previously described morphology-based astrocyte-like subtype. Our results indicate the two types of OEC classifications share a certain degree of overlap, indicating similarities but also differences between the two classification methods.”

      d. Similar quantification is missing in other types of data such as Western blot images (Fig. 9) and OEC marker gene data (for which p-values are not reported; Table S2). 

      Response on Western blots: The Western blot signals shown in Figure 9 are from experiments that were designed to be qualitative rather than quantitative, by addressing the question, “Can we detect Reelin signals or not? in the different samples.” Both Western blots show that Reln<sup>+/+</sup> mouse olfactory bulbs (d) or cortices (e) contain Reelin whereas Reln<sup>-/-</sup>  samples do not and therefore provide positive and negative controls, respectively. The rat olfactory nerve layer (ONL, laminae I-II of olfactory bulb, d lane 1; e lane 3) contains mainly OECs wrapped around the axons of the olfactory sensory neurons that transmit olfactory signals into the olfactory bulb. To address your request for quantification, Dr. Khankan measured the density of the three isoforms of Reelin, 400 kD, 300 kD and 180 kD in Fig. 9e and normalized them against the GADPH control (37 kD). The graph below shows the normalized band density in arbitrary units on the Y-axis relative to the first 3 conditions, i.e., Reln<sup>+/+</sup> and Reln<sup>-/-</sup> mouse cerebral cortices and rat  Reln<sup>+/+</sup> ONL. Because the conditioned medium was collected from tissue culture medium rather than cells or tissue, the GAPDH control was not present and therefore these data cannot be normalized in a similar analysis.  

      Author response image 1.

      Response for OEC marker gene data: We now add new full supplementary Table S1 (for major cell types) and Table S2 (for OEC subtypes) to report statistical p values and adjusted p values, as well as additional statistics information including percent cell expressing a subtype marker in a given subtype versus in other subtypes. 

      e. The addition of quantitative measures and, where appropriate, statistical comparisons with p-values or other significance measures, would be important for supporting the authors' claims and more rigorously conveying the results.

      As detailed in the above responses, we now add quantifications and statistics to support the claims and enhance the rigor of our analysis.

      (2) a. Some aspects of the experimental design that are relevant to the interpretation of the results are not explained. For example, OECs appear to be collected from only female rats, but the potential implications of this factor are not discussed.

      We added a short explanation in the Discussion and Methods section regarding why spinal cord injury studies are carried out on female rats.

      Page 24, Discussion: “Due to the extensive urinary tract dysfunction in spinal cord transected rats, most studies prefer females as their short urethra facilitates daily manual bladder expression. Our study, therefore, was carried out only on adult female rats, so sex differences and the generalizability of our findings to adult male rats would require further investigation.”

      Page 26, Methods: “Only females were used in order to match the sex of previous SCI studies conducted exclusively on female rats (Dixie, 2019; Khankan et al., 2016; Takeoka et al., 2011; Thornton et al., 2018). Following complete thoracic spinal cord transection, an adult rat is unable to urinate voluntarily and therefore urine must be manually “expressed” twice a day throughout the experiment. Females have a shorter urethra than males, and thus their bladders are easier to empty completely.”

      b. Additionally, it is unclear from the manuscript to what degree immunopurified cells are OECs as opposed to other cell types. The antibody used to retain OECs, nerve growth factor receptor p75 (Ngfr-p75), can also be expressed by non-OEC olfactory bulb cell types including astrocytes [1-3]. The possible inclusion of Ngfr-p75-positive but non-OEC cell types in the OEC culture is not sufficiently addressed.

      (a) Cragnolini, A.B. et al., Glia, (2009), doi: 10.1002/glia.20857.

      (b) Vickland H. et al., Brain Res., (1991), doi: 10.1016/0006-8993(91)91659-O.

      (c) Ung K. et al., Nat Commun., (2021), doi: 10.1038/s41467-021-25444-3.

      Our OECs are dissected primarily from the olfactory nerve layer that is concentrated medially and ventrally around the olfactory bulb together with a small part of the glomerular layer (layer II). OECs are the only glia present in olfactory nerve layer. Thus, although it is possible that other cell types also express Ngfr-p75 as pointed out by the reviewer and in the references provided, our OEC dissection method severely limits the number of astrocytes that might be included in our cultures. We further provide additional evidence (see updated Figure 2d and the detailed responses to the next question) that our immunopanned OECs using our dissection method consistently express all classic OEC markers but do not consistently express the majority of classic markers for other glial cell types such as astrocytes or oligodendrocytes.

      Such non-OEC cell types are also not distinguished in the analysis of single-cell RNA sequencing data (only microglia, fibroblasts, and OECs are identified; Figure 2). Thus, it is currently unclear whether results related to the OEC subtype may have been impacted by these experimental factors.

      We need to clarify that when determining potential cell types in Figure 2, we compared our cell cluster marker genes against a broad array of cell types including astrocytes, oligodendrocytes and Schwann cells, but the gene overlap was only significant for microglia, fibroblasts, and OECs, which we labeled in new Figure 2d. We added more details in methods and results to clarify how we determined the cell types in Figure 2 (text added below). We did consider all the potential cell types that could have been present in our OEC cultures, including astrocytes. However, astrocyte or oligodendrocyte markers were not significantly enriched in the clusters, but markers for microglia, fibroblasts, and OECs were prominent in the cell clusters.

      In the revised Figure 2d, we now illustrate that the OEC clusters not only express typical OEC markers, but also express a few but not all marker genes from other glial cells. We show the comparative data on markers for astrocytes, oligodendrocytes, and Schwann cells in Figure 2d in parallel with the marker genes for OECs, microglia, and fibroblasts. For each of the other glial cell types, there are some genes which overlap with OECs, and that is the reason why we identified OECs as hybrid glia.

      Page 6, Results: “Based on previously reported cell type marker genes for fibroblasts and major glial cell types including OECs, astrocytes, oligodendrocytes, and microglia, we found elevated expression of OEC marker genes in clusters 2, 3 and 7, microglia marker genes in clusters 4, 6, and 7, and fibroblast marker genes in clusters 0, 1, and 5 (Figure 2d).”

      Page 33, Methods: “Additional marker genes for fibroblasts and multiple glial cell types including astrocytes, oligodendrocytes, and microglia were also used to compare with those of the cell clusters.”

      (3) The introduction, while well written, does not discuss studies showing no significant effect of OEC implantation after spinal cord injury. The discussion also fails to sufficiently acknowledge this variability in the efficacy of OEC implantation. This omission amplifies bias in the text, suggesting that OECs have significant effects that are not fully reflected in the literature. The introduction would need to be expanded to properly address the nuance suggested by the literature regarding the benefits of OECs after spinal cord injury. Additionally, in the discussion, relating the current study to previous work would help clarify how varying observations may relate to experimental or biological factors.

      We appreciate the insightful comment and have now included information about the variability in OEC transplantation in previous studies in both the introduction and discussion sections. We discuss technical differences that lead to variability in the Introduction and how our findings could help interpret the variability in the Discussion.

      Page 4-5: Text added to the Introduction: “The outcomes of OEC transplantation studies after spinal cord injury vary substantially in the literature due to many technical differences between their experimental designs. The source of OECs has a great impact on the outcome, with OB-OECs showing more promise than peripheral lamina propria-derived OECs, and purified, freshly-prepared OECs being required for optimal OEC survival. Other important variables include the severity of the injury (hemisection to complete spinal cord transection), the age of the spinal cord injured host (early postnatal versus adult), and OEC transplant strategies (delayed or acute transplantation, cell transplants with or without a matrix; Franssen et al., 2007). Franssen et al. (2007) evaluated studies that used only OECs as a transplant, and reported that 41 out of 56 studies showed positive effects, such as OEC stimulation of regeneration, positive interactions with the glial scar and remyelination of axons. More recent systematic reviews and meta-analyses on the effects of OEC transplantation following different spinal cord injury models reported that OECs significantly improved locomotor function (Watzlawick et al.2016; Nakjavan-Shahraki et al., 2018), but did not improve neuropathic pain (Nakjavan-Shahraki et al., 2018.)”

      Pages 24-25: Discussion on OEC source variability  “Extensive differences between OEC preparations contribute to the large variation in results from OEC treatments following spinal cord injury. This scRNA-seq study focused entirely on OB-OECs, and the next step would be to carry out similar studies on the peripheral, lamina-propria-derived OECs to discern the differences between these OEC populations. Such comparative studies using scRNA-seq will help define the underlying mechanisms and help resolve the variability in results from OEC-based therapy. Detailed studies of the composition of different OEC transplant types will contribute to identifying the most reparative cell transplantation treatments.”

      Reviewer #1 (Recommendations For The Authors):

      This is an extremely well-written and impactful series of experiments from a renowned leader in the field. The experimental questions are timely, with similar therapeutic approaches being prepared for clinical trial. The results address a gap that has persisted in the field for several decades and one that has been considered by many scientists long before technology existed to find answers. This highlights the importance of these experiments and the results reported here. With these things in mind, there are only a few minor factors that I have, that should be addressed to strengthen the paper.

      We truly appreciate the positive evaluations from the reviewer!

      Primary concerns

      (1) Quantification of results: The authors report on the data with broad brush strokes, missing the opportunity to quantify results and strengthen the interpretations. For instance, when describing gene expression, what proportion of cells analyzed were expressing these genes? How did this compare with detectable levels of protein? Can the author draw correlations between data sets collected that could offer even more insight into the identities of the cells studied? There is also a missed opportunity to evaluate how transplantation into injured neural tissue might alter gene expression of the phenotypes identified prior to transplantation.

      We appreciate these insightful comments and have added quantitative information and other relevant discussions in the revision. We now add Suppl Tables 1 (for major cell types including OECs, fibroblast, and microglia) and 2 (for OEC subtypes) to indicate the proportion of cells expressing each marker gene in each given cell cluster/subtype in the column. “Percentage of cells expressing the gene in the subtype/cell type” versus the proportion of cells expression the given marker genes in other cell types in the column “Percentage of cells expressing the gene in the other subtypes/cell types.” In the new supplementary tables, we report statistical p values and adjusted p values after multiple testing correction to indicate statistical significance.

      Regarding the comparison with protein levels, we carried out immunohistochemistry experiments to confirm the proteins corresponding to OEC subtype markers. Our findings show that proteins for the gene markers can be detected, and thereby supports our sc-seq findings. However, the immunofluorescence only provides a qualitative measure of protein levels in situ, so we cannot perform a correlation analysis. This is something we plan to  pursue in a follow-up study with measurable protein levels. We also discuss future directions to examine the genes and proteins in in vivo transplantation studies in the Discussion.

      (2) Discussion and interpretation: Greater depth to interpretation and discussion of data and its impact on future work is needed. For example, on pages 20-21, the authors reflect briefly on why Reelin might be of interest (it could lead to Dab-1 expression), but why is that important? There are several instances like this where it would be useful for the authors to provide a little more insight into the potential impact of these data and interpretations.

      We appreciate these valuable suggestions. We have revised our Results and Discussion sections to offer deeper insight and interpretation of the importance of the data, especially that for Reelin.

      Page 17: Results: “In the canonical Reelin-signaling pathway, Reelin binds to the very-low-density lipoprotein receptor (Vldlr) and apolipoprotein E receptor 2 (ApoER2) and induces Src-mediated tyrosine phosphorylation of the intracellular adaptor protein Disabled-1 (Dab1). Both Reelin and Dab1 are highly expressed in embryos and contribute to correct neuronal positioning.”

      Page 22-23, Discussion: “Reelin is a developmentally expressed protein detected in specific neurons, in addition to OECs and Schwann cells. The canonical Reelin-signaling pathway involves neuronal-secreted Reelin binding to Vldlr and ApoER2 receptors expressed on Dab1-labeled neurons. Following Reelin binding, Dab1 is phosphorylated by Src family kinases which initiates multiple downstream pathways. Very little is known, however, about Reelin secreted by glia. Panteri et al. (2006) reported that Schwann cells express low levels of Reelin in adults, and that it is upregulated following a peripheral nerve crush, as is reported above for many neurotrophic factors. Reelin loss in Schwann cells reduced the diameter of small myelinated axons but did not affect unmyelinated axons (Panteri et al., 2005). In the olfactory system, OECs ensheath the Dab1-labeled, unmyelinated axons of olfactory sensory neurons which are continuously generated and die throughout life. OEC transplantation following spinal cord injury would provide an exogenous source of Reelin that could phosphorylate Dab1-containing neurons or their axons. Dab1 is expressed at high levels in the axons of some projection neurons, such as the corticospinal pathway (Abadesco et al., 2014). Future experiments are needed to explore the function that glial-secreted Reelin may have on axonal regeneration.”

      Minor concerns

      (3) The authors reflect on the spontaneous glial bridge that develops in the repairing spinal cord of Zebrafish, but perhaps even more relevant is that this same phenomenon occurs in mammals as well if the spinal cord is injured during early development (opossum; Lane et al, EJN 2007). This should be considered and the statement that there is little regeneration in the mammalian spinal cord should be clarified.

      We appreciate this insightful comment. We now add discussions of the axonal regeneration and bridging observed following severe spinal cord injury in young developing mouse and opossum spinal cords.

      Page 23: “Adult mammals show little evidence of spontaneous axonal regeneration after a severe spinal cord injury in contrast to transected neonatal rats (Bregman, 1987; Bregman et al., 1993) and young postnatal opossums (Lane et al., 2007). In immature mammals, axons continue to project across or bridge the spinal cord transection site during development. Lower organisms such as fish, show even more evidence of regeneration following severe SCI. Mokalled et al. (2016) reported that glial secretion of Ctgfa/Ccn2 was both necessary and sufficient to stimulate a glial bridge for axon regeneration across the zebrafish transection site. Cells in the injury site that express Ctgf include ependymal cells, endothelial cells, and reactive astrocytes (Conrad et al., 2005; Mokalled et al., 2016; Schwab et al., 2001). Here we show that, although rare, Ctgf-positive OECs can contribute to glial bridge formation in adult rats. The most consistent finding among our severe SCI studies combined with OEC transplantation is the extent of remodeling of the injury site and axons growing into the inhibitory lesion site, together with OECs and astrocytes. The formation of a glial bridge across the injury was critical to the spontaneous axon generation seen in zebrafish (Mokalled et al., 2016) and likely contributed to the axon regeneration detected in our OEC transplanted, transected rats (Dixie, 2019; Khankan et al., 2016; Takeoka et al., 2011; Thornton et al., 2018).

      Reviewer #2 (Recommendations For The Authors):

      (1) The manuscript title and abstract must include the species and sex studied.

      The title and abstract have been modified as suggested.

      Page 1: “Olfactory ensheathing cells from adult female rats are hybrid glia that promote neural repair”

      (2) OECs submitted for sequencing were like those about to be transplanted; however, the phenotype of the cells would likely change immediately and shift over time post-implantation. Please briefly address or discuss this point in the Discussion (or Results).

      We have added this important discussion point.

      Pages 23-24: Discussion: “We recognize that this study is a single snapshot of OEC gene expression derived from adult female rats before they are transplanted above and below the spinal cord transection site. We would expect the gene expression of transplanted OECs to change in each new environment, i.e. as they migrate into the injury site, integrate into the glial scar, and wrap around axons. Based on our past studies, OECs survived in an outbred Sprague-Dawley rat model for ~ 4 weeks (Khankan et al., 2016) and in an inbred Fischer 344 model for 5 months (Dixie, 2019). As spinal cord injury transplant procedures are further enhanced and OEC survival improves, these hybrid glial cells should be examined at multiple time points to better evaluate their proregenerative characteristics.”

      (3) Page 12: Use of "monocytes" - the word "monocyte" implies a circulating, undifferentiated innate immune cell. This should not be used interchangeably with macrophage or microglia.

      We agree and now refer to microglia or macrophages depending on the context. We did leave the term monocyte in Table 3 if these cells were found in a top 20 gene reported in the references.

      (4) Page 12: "We now show that these unique monocytes reported between the bundles of olfactory axons surrounded by OECs (Smithson & Kawaja, 2010), are in fact, a distinct subtype of OECs."

      Is it possible to conclude that these cells are a "distinct subtype of OECs?" Perhaps these cells are a hybrid between microglia/macrophages and OECs? This is speculative, so should be worded more carefully - especially in the Results section. Please clarify, dampen conclusions, and/or better justify the wording here.

      We agree and have modified the entire paragraph to dampen and more carefully explain our conclusions. We also added an additional observation that strengthens the relationship between OECs and microglial/macrophages.  

      Page 12, Results: Additional observation: “In fact, all top 20 genes in cluster 3 are expressed in microglia, macrophages, and/or monocytes (Suppl. Table 3).”

      Page 13, Results: The statement referenced in your review was deleted and we wrote the following: “Smithson and Kawaja (2010) identified unique microglial/macrophages that immunolabeled with Iba-1 (Aif1) and Annexin A3 (Anxa3) in the olfactory nerve and outer nerve layer of the olfactory bulb. These authors proposed that Iba1-Anxa3 double-labeled cells were a distinct population of microglia/macrophages that protected the olfactory system against viral invasion into the cranial cavity. Based on our scRNA-seq data we offer an alternative interpretation that at least some of these Iba-1-Anxa3 cells may be a hybrid OEC-microglial cell type. Supporting this interpretation, there are a number of reports that suggest OECs frequently function as phagocytes (e.g., Khankan et al., 2016; Nazareth et al., 2020; Su et al. 2013).”

      (5) Page 13: "Pseudotime trajectory analysis, a widely used approach to predict cell plasticity and lineages based on scRNA-seq data, suggests that there are potential transitions between specific OEC subclusters." This is interesting but is somewhat unclear. Please add one more sentence to aid the reader's understanding regarding how this analysis is performed.

      Thank you for your valuable feedback. We have revised the text for clarity as follows:

      Page 14, Results: “We performed pseudotime trajectory analysis using the Slingshot algorithm to infer lineage trajectories, cell plasticity and lineages by ordering cells in pseudotime based on their transcriptional progression reflected in scRNA-seq data. Transcriptional progression refers to the changes in gene expression profiles of cells as they undergo differentiation or transition through different states. The trajectory analysis results suggest that there are potential transitions between specific OEC subclusters.”

      (6) The authors could discuss potential reasons for variability in OEC treatment results after spinal cord injury between studies and labs. How might sequencing results here inform the debate about whether OECs are helpful or not?

      In response to the Public Review, we added discussions about the variability in OEC treatments between studies in both the Introduction and Discussion, and these comments are copied on pages 6-7 of this document. In the Discussion we included a statement about how the current findings may inform the debate on OECs.

      (7) Discussion: please add a discussion of limitations and future directions that addresses the following points:

      a) Please add one sentence on the lack of studying sex differences - only females were studied here.

      b) There is no correlation or modulation of any target genes, so all results here are correlative.

      c) Please add a brief paragraph with future directions for the field, including acknowledgment that the role of OECs in repair after SCI is not fully resolved and that future studies might consider targeting some of the specific pathways described herein.

      d) Which pathways and OEC subpopulations likely best support repair, and how might these be reinforced or better maintained in the SCI environment? If not known, what are the next steps for identifying the most reparative OEC subtype?

      Thank you for the valuable suggestions. We have added these to the discussion as detailed below.

      Pages 23-25, Discussion:

      “Limitations of these OEC scRNA-Seq studies”

      “We recognize that this study is a single snapshot of OEC gene expression derived from adult female rats before they are transplanted above and below the spinal cord transection site. We would expect the gene expression of transplanted OECs to change in each new environment, i.e. as they migrate into the injury site, integrate into the glial scar, and wrap around axons. Based on our past studies, OECs survived in an outbred Sprague-Dawley rat model for ~ 4 weeks (Khankan et al., 2016) and in an inbred Fischer 344 model for 5 months (Dixie, 2019). As spinal cord injury transplant procedures are further enhanced and OEC survival improves, these hybrid glial cells should be examined at multiple time points to better evaluate their proregenerative characteristics.”

      “Due to the extensive urinary tract dysfunction in spinal cord transected rats, most studies are conducted on females as their short urethra facilitates daily manual bladder expression. Our study was carried out only on adult female rats, so sex differences and the generalizability of our findings to adult male rats would require further investigation. We also did not modulate any of the genes or proteins in the identified OEC subtypes to test their causal and functional roles, thus our findings remain correlative in the current study. Future gene/protein modulation studies are necessary to understand the functional roles of the individual OEC subtypes in the context of their reparative functions to determine which pathways and subtypes are more critical and can be enhanced for neural repair. Our current findings build the foundation for these future studies to help resolve the role of OECs in spinal cord injury repair.” 

      “Extensive differences between OEC preparations contribute to the large variation in results from OEC treatments following spinal cord injury. This scRNA-seq study focused entirely on OB-OECs, and the next step would be to carry out similar studies on the peripheral, lamina-propria-derived OECs to discern the differences between the two OEC populations. Such comparative studies using scRNA-seq will help define the underlying mechanisms and resolve the variability in results from OEC-based therapy. Detailed studies of the composition of different OEC transplant types will contribute to identifying the most reparative cell transplantation treatments.”

      (8) Figure 6: What is the major point of this figure and its related immunocytochemistry? Please clarify.

      Franceschini & Barnett (1996) suggested that there were 2 distinct types of OECs that could be distinguished by their different morphology: One type resembling a Schwann cell and the other, an astrocyte. The purpose of Figure 6 is to determine if there is a link between our scRNA-seq-based OEC subtypes with those previously described based on morphology alone (Franceschini and Barnett, 1996). In our results section we show that ~3/4ths of the OECs sampled that were Ki67+ progenitor cells and were astrocyte-like, i.e., flat in shape and weakly Ngfr<sup>p75</sup>-labeled. The remainder were Schwann cell-like, fusiform in shape and strongly Ngfr<sup>p75</sup>-labeled. Our results indicate the two types of OEC classifications share certain degrees of overlap, indicating similarities but also differences between the different classification methods.

      (9) Figure 9, caption: "OEC whole cell lysates (WCL; lanes: 4, 6, and 8), and OEC conditioned medium (CM; lanes: 5 and 7)."  This statement is unclear - please clarify the result here.

      We added clarification to the legend for Figure 9d. 

      Page 50: (d) “Western blot confirms the expression of Reelin in rat olfactory nerve layer I and layer II (ONL; lane 1 of western blot). Reln<sup>+/+</sup> and Reln<sup>-/-</sup> mouse olfactory bulbs were used as positive and negative controls, respectively (lanes: 2 and 3). Reelin that was synthesized by cultured OECs was found in whole cell lysates (WCL; lanes: 4, 6, and 8), whereas Reelin that was secreted by cultured OECs into tissue culture medium was measured in the OEC “conditioned medium” (CM; lanes: 5 and 7). GAPDH was the loading control for tissue homogenates (lanes 1-4, 6, 8).”

      (10) Methods: A Cat. No. for all antibodies and key supplies should be included.

      Response: All of the antibody information in the revised version is in Suppl. Table 4. Information for other key supplies is included in the extensive methods section.

      (11) Methods: How was primary antibody specificity validated for less-used antibodies? Background staining can be a major issue after SCI; e.g., with the CTGF antibody used in Figure 5.

      The spinal cord section shown in Figure 5 was compared to sections from the same SCI cohort that had been injected with control cells, i.e. skin fibroblasts. We have used the first two antibodies (anti-Glial fibrillary acidic protein and anti-Green fluorescent protein) for many years so only the CTGF was a “less-used antibody.” Our strategy for working with “less-used” or “newly-purchased” antibodies was as follows.

      First, we studied the literature to find the best antibodies for neuronal tissue. Many of the images in Figure 7 were generated with antibodies purchased just for this study. Our goal was to characterize them on normal adult lamina propria and olfactory bulb tissues rather than in the injured spinal cord where background can be an issue. In the olfactory bulb we examined the olfactory nerve layer where OECs are concentrated and then examined the olfactory epithelium, lamina propria, and the deep layers of the olfactory bulb to find regions without immunolabel. As described above, we tested anti-CTGF antibodies in SCI sections implanted with skin fibroblasts controls when conducting experiments for CTGF in sections with OECs. New antibodies were tested at multiple concentrations and we tried different immunocytochemical techniques. Anti-CTFG is expressed by several different cell types, but expression is low in most of the areas above and below the injury site. Despite our success with many “newly-purchased” antibodies there were at least 4 of them that we were never able obtain specific labeling. 

      (12) Will the data (especially the sequencing data) be shared publicly?

      The data has been uploaded to and shared via the public data repository GEO. Data availability is stated on the title page of this manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews

      Reviewer #1 (Public Review): 

      (1) Although the theory is based on memory, it also is based on spatially-selective cells.

      Not all cells in the hippocampus fulfill the criteria of place/HD/border/grid cells, and place a role in memory. E.g., Tonegawa, Buszaki labs' work does not focus on only those cells, and there are certainly a lot of non-pure spatial cells in monkeys (Martinez-Trujillo) and humans (iEEG). Does the author mainly focus on saying that "spatial cells" are memory, but do not account for non-spatial memory cells? This seems to be an incomplete account of memory - which is fine, but the way the model is set up suggests that *all* memory is, place (what/where), and non-spatial attributes ("grid") - but cells that don't fulfil these criteria in MTL (Diehl et al., 2017, Neuron; non-grid cells; Schaeffer et al., 2022, ICML; Luo et al., 2024, bioRxiv) certainly contribute to memory, and even navigation. This is also related to the question of whether these cell definitions matter at all (Luo et al., 2024). The authors note "However, this memory conjunction view of the MTL must be reconciled with the rodent electrophysiology finding that most cells in MTL appear to have receptive fields related to some aspect of spatial navigation (Boccara et al., 2010; Grieves & Jeffery, 2017). The paucity of non-spatial cells in MTL could be explained if grid cells have been mischaracterized as spatial." Is the author mainly talking about rodent work?

      There is a new section in the introduction that deals with these issues, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ That section reads:

      “Spatial navigation is inherently a memory problem – learning the spatial arrangement of a new enclosure requires memory for the conjunction of what and where. This has long been realized and in the introduction to ‘Hippocampus as a Cognitive Map’, O’Keefe and Nadel (1978) wrote “We shall argue that the hippocampus is the core of a neural memory system providing an objective spatial framework within which the items and events of an organism's experience are located and interrelated” (emphasis added). Furthermore, in the last chapter of their book, they extended cognitive map theory to human memory for non-spatial characteristics. However, in the decades since the development of cognitive map theory, the rodent spatial navigation and human memory literatures have progressed somewhat independently.

      The ideas proposed in this model are an attempt to reunify these literatures by returning to the original claim that spatial navigation is inherently a memory problem. The goal of the current study is to explain the rodent spatial navigation literature using a memory model that has the potential to also explain the human memory literature. In contrast, most grid cell models (Bellmund et al., 2016; Bush et al., 2015; Castro & Aguiar, 2014; Hasselmo, 2009; Mhatre et al., 2012; Solstad et al., 2006; Sorscher et al., 2023; Stepanyuk, 2015; Widloski & Fiete, 2014) are domain specific models of spatial navigation and as such, they do not lend themselves to explanations of human memory. Thus, the reason to prefer this model is parsimony. Rather than needing to develop a theory of memory that is separate from a theory of spatial navigation, it might be possible to address both literatures with a unified account.

      This study does not attempt to falsify other theories of grid cells. Instead, this model reaches a radically different interpretation regarding the function of grid cells; an interpretation that emerges from viewing spatial navigation as a memory problem. All other grid cell models assume that an entorhinal grid cell displaying a spatially arranged grid of firing fields serves the function of spatial coding (i.e., spatial grid cells exist to support a spatial metric). In contrast, the proposed memory model of grid cells assumes that the hexagonal tiling reflects the need to keep memories separate from each other to minimize confusion and confabulation – the grid pattern is the byproduct of pattern separation between memories rather than the basis of a spatial code. 

      It is now understood that grid-like firing fields can occur for non-spatial twodimensional spaces. For instance, human entorhinal cortex exhibits grid-like responses to video morph trajectories in a two-dimensional bird neck-length versus bird leg-length space (Constantinescu et al., 2016). As a general theory of learning and memory, the proposed memory model of grid cells is easily extended to explain these results (e.g., relabeling the border cell inputs in the model as neck-length and leg-length inputs). However, there are other grid cell models that can explain both spatial grid cells as well as non-spatial grid-like responses (Mok & Love, 2019; Rodríguez-Domínguez & Caplan, 2019; Stachenfeld et al., 2017; Wei et al., 2015). Similar to this memory model of grid cells, these models are also positioned to explain both the rodent spatial navigation and human memory literatures. Nevertheless, there is a key difference between this model and other grid cell models that generalize to non-spatial representations. Specifically, these other models assume that grid cells exhibiting spatial receptive fields serve the function of identifying positions in the environment (i.e., their function is spatial). As such, these models do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). This memory model of grid cells provides an answer to the apparent paucity of nonspatial cell types in rodent MTL by proposing that grid cells with spatial receptive fields have been misclassified as spatial (they are what cells rather than where cells) and that place cells are fundamentally memory cells that conjoin what and where.”

      (2) Related to the last point, how about non-grid multi-field mEC cells? In theory, these also should be the same; but the author only presents perfect-look grid cells. In empirical work, clearly, this is not the case, and many mEC cells are multi-field non-grid cells (Diehl et al., 2017). Does the model find these cells? Do they play a different role? As noted by the author "Because the non-spatial attributes are constant throughout the two-dimensional surface, this results in an array of discrete memory locations that are approximately hexagonal (as explained in the Model Methods, an "online" memory consolidation process employing pattern separation rapidly turns an approximately hexagonal array into one that is precisely hexagonal). " If they are indeed all precisely hexagonal, does that mean the model doesn't have non-grid spatial cells? 

      Grid cells with irregular firing fields are now considered in the discussion with the following paragraphs

      “According to this model, hexagonally arranged grid cells should be the exception rather than the rule when considering more naturalistic environments. In a more ecologically valid situation, such as with landmarks, varied sounds, food sources, threats, and interactions with conspecifics, there may still be remembered locations were events occurred or remembered properties can be found, but because the non-spatial properties are non-uniform in the environment, the arrangement of memory feedback will be irregular, reflecting the varied nature of the environment. This may explain the finding that even in a situation where there are regular hexagonal grid cells, there are often irregular non-grid cells that have a reliable multi-location firing field, but the arrangement of the firing fields is irregular (Diehl et al., 2017). For instance, even when navigating in an enclosure that has uniform properties as dictated by experimental procedures, they may be other properties that were not well-controlled (e.g., a view of exterior lighting in some locations but not others), and these uncontrolled properties may produce an irregular grid (i.e., because the uncontrolled properties are reliably associated with some locations but not others, hippocampal memory feedback triggers retrieval of those properties in the associations locations).

      In this memory model, there are other situations in which an irregular but reliable multilocation grid may occur, even when everything is well controlled. In the reported simulations, when the hippocampal place cells were based on variation in X/Y (as defined by Border cells), nothing else changed as a function of location, and the model rapidly produced a precise hexagonal arrangement of hippocampal place cell memories. When head direction was included (i.e., real-world variation in X, Y, and head direction), the model still produced a hexagonal arrangement as per face-centered cubic packing of memories, but this precise arrangement was slower to emerge, with place cells continuing to shift their positions until the borders of the enclosure were sufficiently well learned from multiple viewpoints. If there is real-world variation in four or more dimensions, as is likely the case in a more ecologically valid situation, it will be even harder for place cell memories to settle on a precise regular lattice. Furthermore, in the case of four dimensions, mathematicians studying the “sphere packing problem” recently concluded that densest packing is irregular (Campos et al., 2023). This may explain why the multifield grid cells for freely flying bats have a systematic minimum distance between firing fields, but their arrangement is globally irregular (Ginosar et al., 2021). Assuming that the memories encoded by a bat include not just the three real-world dimensions of variation, but also head direction, the grid will likely be irregular even under optimal conditions of laboratory control.”

      (3) Theoretical reasons for why the model is put together this way, and why grid cells must be coding a non-spatial attribute: Is this account more data-driven (fits the data so formulated this way), or is it theoretical - there is a reason why place, border, grid cells are formulated to be like this. For example, is it an efficient way to code these variables? It can be both, like how the BVC model makes theoretical sense that you can use boundaries to determine a specific location (and so place cell), but also works (creates realistic place cells). 

      The motivation for this model is now articulated in the new section, quoted above, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ Regarding the assumption that border cells provide a spatial metric, this assumption is made for the same reasons as in the BVC model. Regarding this, the text said: “These assumptions regarding border cells are based on the boundary vector cell (BVC) model of Barry et al. (2006). As in the BVC model, combinations of border cells encode where each memory occurred in the realworld X/Y plane.”. A new sentence is added to model methods, stating: “This assumption is made because border cells provide an efficient representation of Euclidean space (e.g., if the animal knows how far it is from different walls of the enclosure, this already available information can be used to calculate location).”

      But in this case, the purpose of grid cell coding a non-spatial attribute, and having some kind of system where it doesn't fire at all locations seems a little arbitrary. If it's not encoding a spatial attribute, it doesn't have to have a spatial field. For example, it could fire in the whole arena - which some cells do (and don't pass the criteria of spatial cells as they are not spatially "selective" to another location, related to above).  

      Some cells have a constant high firing rate, but they are the exception rather than the rule. More typically, cells habituate in the presence of ongoing excitatory drive and by doing so become sensitive to fluctuations in excitatory drive. Habituation is advantageous both in terms of metabolic cost and in terms of function (i.e., sensitivity to change). This is now explained in the following paragraph:

      “In theory, a cell representing a non-spatial attribute found at all locations of an enclosure (aka, a grid cell in the context of this model), could fire constantly within the enclosure. However, in practice, cells habituate and rapidly reduce their firing rate by an order of magnitude when their preferred stimulus is presented without cessation (Abbott et al., 1997; Tsodyks & Markram, 1997). After habituation, the firing rate of the cell fluctuates with minor variation in the strength of the excitatory drive. In other words, habituation allows the cell to become sensitive to changes in the excitatory drive (Huber & O’Reilly, 2003). Thus, if there is stronger top-down memory feedback in some locations as compared to others, the cell will fire at a higher rate in those remembered locations rather than in all locations even though the attribute is found at all locations. In brief when faced with constant excitatory drive, the cell accommodates, and becomes sensitive to change in the magnitude of the excitatory drive. In the model simulation, this dynamic adaptation is captured by supposing that cells fire 5% of the time on-average across the simulation, regardless of their excitatory inputs.”

      (4) Why are grid cells given such a large role for encoding non-spatial attributes? If anything, shouldn't it be lateral EC or perirhinal cortex? Of course, they both could, but there is less reason to think this, at least for rodent mEC.  

      This is a good point and the following paragraph has been added to the introduction to explain that lateral EC is likely part of the explanation. But even when including lateral EC, it still appears that most of the input to hippocampus is spatial.

      “One possible answer to the apparent lack of non-spatial cells in MTL is to highlight the role of the lateral entorhinal cortex (LEC) as the source of non-spatial what information for memory encoding (Deshmukh & Knierim, 2011). LEC can be contrasted with mEC, which appears to only provide where information (Boccara et al., 2010a; Diehl et al., 2017). Although it is generally true that LEC is involved in non-spatial processing, there is evidence that LEC provides some forms of spatial information (Knierim et al., 2014). The kind of non-spatial information provided by LEC appears to be in relation to objects (Connor & Knierim, 2017; Wilson et al., 2013). However, in a typical rodent spatial navigation study there are no objects within the enclosure. Thus, although the distinction between mEC and LEC is likely part of the explanation, it is still the case that rodent entorhinal input to hippocampus appears to heavily favor spatial information.”

      (5) Clarification: why do place cells and grid cells differ in terms of stability in the model? Place cells are not stable initially but grid cells come out immediately. They seem directly connected so a bit unclear why; especially if place cell feedback leads to grid cell fields. There is an explanation in the text - based on grid cells coding the on-average memories, but these should be based on place cell inputs as well. So how is it that place fields are unstable then grid fields do not move at all? I wonder if a set of images or videos (gifs) showing the differences in spatial learning would be nice and clarify this point.  

      In this revision, I provide a new video focused on learning of place cell memories that include head direction. This second video is in relation to the results reported in Figure 9. The short answer is that the grid fields for the non-spatial cell are based on the average across several view-dependent memories (i.e., across several place cells that have head direction sensitivity) and the average is reliable even if the place cells are unstable. The text of this explanation now reads:

      “Why was the grid immediately apparent for the non-spatial attribute cell whereas the grid took considerable prior experience for the head direction cells? The answer relates to memory consolidation and the shifting nature of the hippocampal place cells. Head direction cells only produced a reliable grid once the hippocampal place cells (aka, memory cells) assumed stable locations. During the first few sessions, the hippocampal place cells were shifting their positions owing to pattern separation and consolidation. But once the place cells stabilized, they provided reliable top-down memory feedback to the head direction cells in some places but not others, thus producing a reliable grid arrangement to the firing maps of the head direction cells. In other words, for the head direction cells, the grid only appeared once the place cells stabilized. This slow stabilization of place fields is a known property (Bostock et al., 1991; Frank et al., 2004).

      In the simulation, the place cells did not stabilize until a sufficient number of place cells were created (Figure 9C). Specifically, these additional memories were located immediately outside the enclosure, around all borders (Figure 9D). These “outside the box” memories served to constrain the interior place cells, locking them in position despite ongoing consolidation. This dynamic can be seen in a movie showing a representative simulation. The movie shows the positions of the head direction sensitive place cells during initial learning, and then during additional sessions of prior experience as the movie speeds up (see link in Figure 9 capture).

      Why did the non-spatial grid cell (k) produce a grid immediately, before the place cells stabilized? As discussed in relation to Figure 8, the non-spatial grid cell is the projection through the 3D volume of real-world coordinates that includes X, Y, and head direction. Each grid field of a non-spatial grid cell reflects feedback from several place cells that each have a different head direction sensitivity (see for instance the allocentric pairs of memories illustrated in Figure 8C and 8D). Thus, each grid field is the average across several memories that entail different viewpoints and this averaging across memories provides stability even if the individual memories are not yet stable. This average of unstable memories produces a blurry sort of grid pattern without any prior experience.

      A final piece of the puzzle relies on the same mechanism that caused the grid pattern to align with the borders as reported in the results of Figures 6 and 7. Specifically, there are some “sticky” locations with ongoing consolidation because the connection weights are bounded. Because weights cannot go below their minimum or above their maximum, it is slightly more difficult for consolidation to push or pull connection weights over the peak value or under the minimum value of the tuning curve. Thus, the place cells tend to linger in locations that correspond to the peak or trough of a border cell. There are multiple peak and trough locations but for the parameter values in this simulation, the grid pattern seen in Figure 9C shows the set of peak/trough locations that satisfy the desired spacing between memories. Thus, the average across memories shows a reliable grid field at these locations even though the memories are unstable.”

      (6) Other predictions. Clearly, the model makes many interesting (and quite specific!) predictions. But does it make some known simple predictions? 

      • More place cells at rewarded (or more visited) locations. Some empirical researchers seem to think this is not as obvious as it seems (e.g., Duvellle et al., 2019; JoN; Nyberg et al., 2021, Neuron Review).  

      • Grid cell field moves toward reward (Butler et al., 2019; Boccera et al., 2019).  

      • Grid cells deform in trapezoid (Krupic et al., 2015) and change in environments like mazes (Derikman et al., 2014).  

      Thank you for these suggestions and I have added the following paragraph to the discussion:

      “In terms of the animal’s internal state, all locations in the enclosure may be viewed as equally aversive and unrewarding, which is a memorable characteristic of the enclosure. Reward, or lack thereof, is arguably one of the most important nonspatial characteristics and application of this model to reward might explain the existence of goal-related activity in place cells (Hok et al., 2007; although see Duvelle et al., 2019), reflecting the need to remember rewarding locations for goal directed behavior. Furthermore, if place cell memories for a rewarding location activate entorhinal grid cells, this may explain the finding that grid cells remap in an enclosure with a rewarded location such that firing fields are attracted to that location (Boccara et al., 2019; Butler et al., 2019). Studies that introduce reward into the enclosure are an important first step in terms of examining what happens to grid cells when the animal is placed in a more varied environment.”

      Regarding the changes in shape of the environment, this was discussed in the section of the paper that reads “As seen in Figure 12, because all but one of the place cells was exterior when the simulated animal was constrained to a narrow passage, the hippocampal place cell memories were no longer arranged in a hexagonal grid. This disruption of the grid array for narrow passages might explain the finding that the grid pattern (of grid cells) is disrupted in the thin corner of a trapezoid (Krupic et al., 2015) and disrupted when a previously open enclosure is converted to a hairpin maze by insertion of additional walls within the enclosure (Derdikman et al., 2009).” This particular section of the paper now appears in the Appendix and Figure 12 is now Appendix Figure 2.

      Reviewer #2 (Public Review): 

      The manuscript describes a new framework for thinking about the place and grid cell system in the hippocampus and entorhinal cortex in which these cells are fundamentally involved in supporting non-spatial information coding. If this framework were shown to be correct, it could have high impact because it would suggest a completely new way of thinking about the mammalian memory system in which this system is non-spatial. Although this idea is intriguing and thought-provoking, a very significant caveat is that the paper does not provide evidence that specifically supports its framework and rules out the alternate interpretations. Thus, although the work provides interesting new ideas, it leaves the reader with more questions than answers because it does not rule out any earlier ideas. 

      Basically, the strongest claim in the paper, that grid cells are inherently non-spatial, cannot be specifically evaluated versus existing frameworks on the basis of the evidence that is shown here. If, for example, the author had provided behavioral experiments showing that human memory encoding/retrieval performance shifts in relation to the predictions of the model following changes in the environment, it would have been potentially exciting because it could potentially support the author's reconceptualization of this system. But in its current form, the paper merely shows that a new type of model is capable of explaining the existing findings. There is not adequate data or results to show that the new model is a significantly better fit to the data compared to earlier models, which limits the impact of the work. In fact, there are some key data points in which the earlier models seem to better fit the data.  

      Overall, I would be more convinced that the findings from the paper are impactful if the author showed specific animal memory behavioral results that were only supported by their memory model but not by a purely spatial model. Perhaps the author could run new experiments to show that there are specific patterns of human or animal behavior that are only explained by their memory model and not by earlier models. But in its current form, I cannot rule out the existing frameworks and I believe some of the claims in this regard are overstated. 

      As previously detailed in Box 1 and as explained in the text in several places, the model provides an explanation of several findings that remain unexplained by other theories (see “Results Uniquely Explained by the Memory Model”). But more generally this is a good point, and the initial draft failed to fully articulate why a researcher might choose this model to guide future empirical investigations. A new section in the introduction that deals with these issues, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ That section reads:

      “Spatial navigation is inherently a memory problem – learning the spatial arrangement of a new enclosure requires memory for the conjunction of what and where. This has long been realized and in the introduction to ‘Hippocampus as a Cognitive Map’, O’Keefe and Nadel (1978) wrote “We shall argue that the hippocampus is the core of a neural memory system providing an objective spatial framework within which the items and events of an organism's experience are located and interrelated” (emphasis added). Furthermore, in the last chapter of their book, they extended cognitive map theory to human memory for non-spatial characteristics. However, in the decades since the development of cognitive map theory, the rodent spatial navigation and human memory literatures have progressed somewhat independently.

      The ideas proposed in this model are an attempt to reunify these literatures by returning to the original claim that spatial navigation is inherently a memory problem. The goal of the current study is to explain the rodent spatial navigation literature using a memory model that has the potential to also explain the human memory literature. In contrast, most grid cell models (Bellmund et al., 2016; Bush et al., 2015; Castro & Aguiar, 2014; Hasselmo, 2009; Mhatre et al., 2012; Solstad et al., 2006; Sorscher et al., 2023; Stepanyuk, 2015; Widloski & Fiete, 2014) are domain specific models of spatial navigation and as such, they do not lend themselves to explanations of human memory. Thus, the reason to prefer this model is parsimony. Rather than needing to develop a theory of memory that is separate from a theory of spatial navigation, it might be possible to address both literatures with a unified account.

      This study does not attempt to falsify other theories of grid cells. Instead, this model reaches a radically different interpretation regarding the function of grid cells; an interpretation that emerges from viewing spatial navigation as a memory problem. All other grid cell models assume that an entorhinal grid cell displaying a spatially arranged grid of firing fields serves the function of spatial coding (i.e., spatial grid cells exist to support a spatial metric). In contrast, the proposed memory model of grid cells assumes that the hexagonal tiling reflects the need to keep memories separate from each other to minimize confusion and confabulation – the grid pattern is the byproduct of pattern separation between memories rather than the basis of a spatial code. 

      It is now understood that grid-like firing fields can occur for non-spatial twodimensional spaces. For instance, human entorhinal cortex exhibits grid-like responses to video morph trajectories in a two-dimensional bird neck-length versus bird leg-length space (Constantinescu et al., 2016). As a general theory of learning and memory, the proposed memory model of grid cells is easily extended to explain these results (e.g., relabeling the border cell inputs in the model as neck-length and leg-length inputs). However, there are other grid cell models that can explain both spatial grid cells as well as non-spatial grid-like responses (Mok & Love, 2019; Rodríguez-Domínguez & Caplan, 2019; Stachenfeld et al., 2017; Wei et al., 2015). Similar to this memory model of grid cells, these models are also positioned to explain both the rodent spatial navigation and human memory literatures. Nevertheless, there is a key difference between this model and other grid cell models that generalize to non-spatial representations. Specifically, these other models assume that grid cells exhibiting spatial receptive fields serve the function of identifying positions in the environment (i.e., their function is spatial). As such, these models do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). This memory model of grid cells provides an answer to the apparent paucity of nonspatial cell types in rodent MTL by proposing that grid cells with spatial receptive fields have been misclassified as spatial (they are what cells rather than where cells) and that place cells are fundamentally memory cells that conjoin what and where.”

      - The paper does not fully take into account all the findings regarding grid cells, some of which very clearly show spatial processing in this system. For example, findings on grid-bydirection cells (e.g., Sargolini et al. 2006) would seem to suggest that the entorhinal grid system is very specifically spatial and related to path integration. Why would grid-bydirection cells be present and intertwined with grid cells in the author's memory-related reconceptualization? It seems to me that the existence of grid-by-direction cells is strong evidence that at least part of this network is specifically spatial.

      Head by direction grid cells were a key part of the reported results. These grid cells naturally arise in the model as the animal forms memories (aka, hippocampal place cells) that conjoin location (as defined by border cells), head direction at the time of memory formation, and one or more non-spatial properties found at that location. In this revision, I have attempted to better explain how including head direction in hippocampal memories naturally gives rise to these cell types. The introduction to the head direction module simulations now reads:

      “According to this memory model of spatial navigation, place cells are the conjunction of location, as defined by border cells, and one or more properties that are remembered to exist at that location. Such memories could, for instance, allow an animal to remember the location of a food cache (Payne et al., 2021). The next set of simulations investigates behavior of the model when one of the to-be-remembered properties is head direction at the time when the memory was formed (e.g., the direction of a pathway leading to a food cache). Indicating that head direction is an important part of place cell representations, early work on place cells in mazes found strong sensitivity to head direction, such that the place field is found in one direction of travel but not the other (McNaughton et al., 1983; Muller et al., 1994). Place cells can exhibit a less extreme version of head direction sensitivity in open field recordings (Rubin et al., 2014), but the nature of the sensitivity is more complicated, depending on location of the animal relative to the place field center (Jercog et al., 2019).

      It is possible that some place cell memories do not receive head direction input, as was the case for the simulations reported in Figures 6/7 – in those simulations, place cells were entirely insensitive to head direction, owing to a lack of input from head direction cells. However, removal of head direction input to hippocampus affects place cell responses (Calton et al., 2003) and grid cell responses (Winter et al., 2015), suggesting that head direction is a key component of the circuit. Furthermore, if place cells represent episodic memories, it seems natural that they should include head direction (i.e., viewpoint at the time of memory formation).

      In the simulations reported next, head direction is simply another property that is conjoined in a hippocampal place cell memory. In this case, a head direction cell should become a head direction conjunctive grid cell (i.e., a grid cell, but only when the animal is heading in a particular direction), owing to memory feedback from the hexagonal array of hippocampal place cell memories. When including head direction, the real-world dimensions of variation are across three dimensions (X, Y, and head direction) rather than two, and consolidation will cause the place cells to arrange in a three-dimensional volume. The simulation reported below demonstrates that this situation provides a “grid module”.”

      - I am also concerned that the paper does not do enough to address findings regarding how the elliptical shape of grid fields shifts when boundaries of an environment compress in one direction or change shape/angles (Lever et al., & Krupic et al). Those studies show compression in grid fields based on boundary position, and I don't see how the authors' model would explain these findings.  

      This finding was covered in the original submission: “For instance, perhaps one egocentric/allocentric pair of mEC grid modules is based on head direction (viewpoint) in remembered positions relative to the enclosure borders whereas a different egocentric/allocentric pair is based on head direction in remembered positions relative to landmarks exterior to the enclosure. This might explain why a deformation of the enclosure (moving in one of the walls to form a rectangle rather than a square) caused some of the grid modules but not others to undergo a deformation of the grid pattern in response to the deformation of the enclosure wall (see also Barry et al., 2007). More specifically, if there is one set of non-orthogonal dimensions for enclosure borders and the movement of one wall is too modest as to cause avoid global remapping, this would deform the grid modules based the enclosure border cells. At the same time, if other grid modules are based on exterior properties (e.g., perhaps border cells in relation to the experimental room rather than the enclosure), then those grid modules would be unperturbed by moving the enclosure wall.”

      I apologize for being unclear in describing how the model might explain this result. The paragraph has been rewritten and now reads:

      “Consider the possibility that one mEC grid modules is based on head direction (viewpoint) in remembered positions relative to the enclosure borders (e.g., learning the properties of the enclosure, such as the metal surface) while a different grid module is based on head direction in remembered positions relative to landmarks exterior to the enclosure (e.g., learning the properties of the experimental room, such as the sound of electronics that the animal is subject to at all locations). This might explain why a deformation of the enclosure (moving one of the walls to form a rectangle rather than a square) caused some of the grid modules but not others to undergo a deformation of the grid pattern in response to the deformation of the enclosure wall (see also Barry et al., 2007). More specifically, suppose that the movement of one wall is modest and after moving the wall, the animal views the enclosure as being the same enclosure, albeit slightly modified (e.g., when a home is partially renovated, it is still considered the same home). In this case, the set of non-orthogonal dimensions associated with enclosure borders would still be associated with the now-changed borders and any memories in reference to this border-determined space would adjust their positions accordingly in real-world coordinates (i.e., the place cells would subtly shift their positions owing to this deformation of the borders, producing a corresponding deformation of the grid). At the same time, there may be other sets of memories that are in relation to dimensions exterior to the enclosure. Because these exterior properties are unchanged, any place cells and grid cells associated with the exterior-oriented memories would be unchanged by moving the enclosure wall.”

      - Are findings regarding speed modulation of grid cells problematic for the paper's memory results? 

      - A further issue is that the paper does not seem to adequately address developmental findings related to the timecourses of the emergence of different cell types. In their simulation, researchers demonstrate the immediate emergence of grid fields in a novel environment, while noting that the stabilization of place cell positions takes time. However, these simulation findings contradict previous empirical developmental studies (Langston et al., 2010). Those studies showed that head direction cells show the earliest development of spatial response, followed by the appearance of place cells at a similar developmental stage. In contrast, grid cells emerge later in this developmental sequence. The gradual improvement in spatial stability in firing patterns likely plays a crucial role in the developmental trajectory of grid cells. Contrary to the model simulation, grid cells emerge later than place cells and head direction cells, yet they also hold significance in spatial mapping. 

      - The model simulations suggest that certain grid patterns are acquired more gradually than others. For instance, egocentric grid cells require the stabilization of place cell memories amidst ongoing consolidation, while allocentric grid cells tend to reflect average place field positions. However, these findings seemingly conflict with empirical studies, particularly those on the conjunctive representation of distance and direction in the earliest grid cells. Previous studies show no significant differences were found in grid cells and grid cells with directional correlates across these age groups, relative to adults (Wills et al., 2012). This indicates that the combined representation of distance and direction in single mEC cells is present from the earliest ages at which grid cells emerge. 

      These are good points and they have been addressed in a new section of the introduction titled ‘The Scope of the Proposed Model’. That section reads:

      “The reported simulations explain why most mEC cell types in the rodent literature appear to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). Assuming that rodents can form non-spatial memories, rodent hippocampus must receive non-spatial input from entorhinal cortex. These simulations suggest that characterization of the rodent mEC cortex as primarily spatial might be incorrect if most grid cells (except perhaps head direction conjunctive grid cells) have been mischaracterized as spatial. Other literatures with other species find non-spatial representations in MTL (Gulli et al., 2020; Quiroga et al., 2005; Wixted et al., 2014) and non-spatial hippocampal memory encoding has been found in rodents (Liu et al., 2012; McEchron & Disterhoft, 1999). The proposed memory model is compatible with these results – the ideas contained in this model could be applied to nonspatial memory representations. However, surveys of cell types in rodent entorhinal cortex seem to indicate that most cells are spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). How can the rodent hippocampus encode nonspatial memories if most of its input is spatial? The goal of the reported simulations is to explain the apparent paucity of non-spatial cells in rodent entorhinal cortex by proposing that grid cells have been misclassified as spatial (see also Luo et al., 2024).

      Given the simplicity of the proposed model, there are important findings that the model cannot address -- it is not that the model makes the wrong predictions but rather that it makes no predictions. The role of running speed (Kraus et al., 2015) is one such variable for which the model makes no predictions. Similarly, because the model is a rate-coded model rather than a model of oscillating spiking neurons, it makes no predictions regarding theta oscillations (Buzsáki & Moser, 2013). The model is an account of learning and memory for an adult animal, and it makes no predictions regarding the developmental (Langston et al., 2010; Muessig et al., 2015; Wills et al., 2012) or evolutionary (Rodrıguez et al., 2002) time course of different cell types. This model contains several purely spatial representations such as border cells, head direction cells, and head direction conjunctive grid cells and it may be that these purely spatial cell types emerged first, followed by the evolution and/or development of non-spatial cell types. However, this does not invalidate the model. Instead, this is a model for an adult animal that has both episodic memory capabilities and spatial navigation capabilities, irrespective of the order in which these capabilities emerged.

      This model has the potential to explain context effects in memory (Godden & Baddeley, 1975; Gulli et al., 2020; Howard et al., 2005). According to this model, different grid cells represent different non-spatial characteristics and place cells represent the combination of these “context” factors and location. In the simulation, just one grid cell is simulated but the same results would emerge when simulating hundreds of different non-spatial inputs provided that all of the simulated non-spatial inputs exist throughout the recording session. However, there is evidence that hippocampus can explicitly represent the passage of time (Eichenbaum, 2014), and time is assuredly an important factor in defining episodic memory (Bright et al., 2020). Thus, although the current model addresses unique combinations of what and where, it is left to future work to incorporate representations of when in the memory model.”

      Reviewer #3 (Public Review): 

      A crucial assumption of the model is that the content of experience must be constant in space. It's difficult to imagine a real-world example that satisfies this assumption. Odors and sounds are used as examples. While they are often more spatially diffuse than an objects on the ground, odors and sounds have sources that are readily detectable. Animals can easily navigate to a food source or to a vocalizing conspecific. This assumption is especially problematic because it predicts that all grid cells should become silent when their preferred non-spatial attribute (e.g. a specific odor) is missing. I'm not aware of any experimental data showing that grid cells become silent. On the contrary, grid cells are known to remain active across all contexts that have been tested, including across sleep/wake states. Unlike place cells, grid cells do not seem to turn off. Since grid cells are active in all contexts, their preferred attribute must also be present in all contexts, and therefore they would not convey any information about the specific content of an experience.  

      These are good points and in this revision I have attempted to explain that there is a great deal of contextual similarity across all recording sessions. One paragraph in the discussion now reads

      “In a typical rodent spatial navigation study, the non-spatial attributes are wellcontrolled, existing at all locations regardless of the enclosure used during testing (hence, a grid cell in one enclosure will be a grid cell in a different enclosure). Because labs adopt standard procedures, the surfaces, odors (e.g., from cleaning), external lighting, time of day, human handler, electronic apparatus, hunger/thirst state, etc. might be the same for all recording sessions. Additionally, the animal is not allowed to interact with other animals during recording and this isolation may be an unusual and highly salient property of all recording sessions. Notably, the animal is always attached to wires during recording. The internal state of the animal (fear, aloneness, the noise of electronics, etc.) is likely similar across all recording situations and attributes of this internal state are likely represented in the hippocampus and entorhinal input to hippocampus. According to this model, hippocampal place cells are “marking” all locations in the enclosure as places where these things tend to happen.”

      The proposed novelty of this theory is that other models all assume that grid cells encode space. This isn't quite true of models based on continuous attractor networks, the discussion of which is notably absent. More specifically, these models focus on the importance of intrinsic dynamics within the entorhinal cortex in generating the grid pattern. While this firing pattern is aligned to space during navigation and therefore can be used as a representation of that space, the neural dynamics are preserved even during sleep. Similarly, it is because the grid pattern does not strictly encode physical space that gridlike signals are also observed in relation to other two-dimensional continuous variables. 

      These models were briefly discussed in the general discussion section and in this revision they are further discussed in the introduction in a new section, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ That section reads:

      “Spatial navigation is inherently a memory problem – learning the spatial arrangement of a new enclosure requires memory for the conjunction of what and where. This has long been realized and in the introduction to ‘Hippocampus as a Cognitive Map’, O’Keefe and Nadel (1978) wrote “We shall argue that the hippocampus is the core of a neural memory system providing an objective spatial framework within which the items and events of an organism's experience are located and interrelated” (emphasis added). Furthermore, in the last chapter of their book, they extended cognitive map theory to human memory for non-spatial characteristics. However, in the decades since the development of cognitive map theory, the rodent spatial navigation and human memory literatures have progressed somewhat independently.

      The ideas proposed in this model are an attempt to reunify these literatures by returning to the original claim that spatial navigation is inherently a memory problem. The goal of the current study is to explain the rodent spatial navigation literature using a memory model that has the potential to also explain the human memory literature. In contrast, most grid cell models (Bellmund et al., 2016; Bush et al., 2015; Castro & Aguiar, 2014; Hasselmo, 2009; Mhatre et al., 2012; Solstad et al., 2006; Sorscher et al., 2023; Stepanyuk, 2015; Widloski & Fiete, 2014) are domain specific models of spatial navigation and as such, they do not lend themselves to explanations of human memory. Thus, the reason to prefer this model is parsimony. Rather than needing to develop a theory of memory that is separate from a theory of spatial navigation, it might be possible to address both literatures with a unified account.

      This study does not attempt to falsify other theories of grid cells. Instead, this model reaches a radically different interpretation regarding the function of grid cells; an interpretation that emerges from viewing spatial navigation as a memory problem. All other grid cell models assume that an entorhinal grid cell displaying a spatially arranged grid of firing fields serves the function of spatial coding (i.e., spatial grid cells exist to support a spatial metric). In contrast, the proposed memory model of grid cells assumes that the hexagonal tiling reflects the need to keep memories separate from each other to minimize confusion and confabulation – the grid pattern is the byproduct of pattern separation between memories rather than the basis of a spatial code. 

      It is now understood that grid-like firing fields can occur for non-spatial two dimensional spaces. For instance, human entorhinal cortex exhibits grid-like responses to video morph trajectories in a two-dimensional bird neck-length versus bird leg-length space (Constantinescu et al., 2016). As a general theory of learning and memory, the proposed memory model of grid cells is easily extended to explain these results (e.g., relabeling the border cell inputs in the model as neck-length and leg-length inputs). However, there are other grid cell models that can explain both spatial grid cells as well as non-spatial grid-like responses (Mok & Love, 2019; Rodríguez-Domínguez & Caplan, 2019; Stachenfeld et al., 2017; Wei et al., 2015). Similar to this memory model of grid cells, these models are also positioned to explain both the rodent spatial navigation and human memory literatures. Nevertheless, there is a key difference between this model and other grid cell models that generalize to non-spatial representations. Specifically, these other models assume that grid cells exhibiting spatial receptive fields serve the function of identifying positions in the environment (i.e., their function is spatial). As such, these models do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). This memory model of grid cells provides an answer to the apparent paucity of nonspatial cell types in rodent MTL by proposing that grid cells with spatial receptive fields have been misclassified as spatial (they are what cells rather than where cells) and that place cells are fundamentally memory cells that conjoin what and where.”

      The use of border cells or boundary vector cells as the main (or only) source of spatial information in the hippocampus is not well supported by experimental data. Border cells in the entorhinal cortex are not active in the center of an environment. Boundary-vector cells can fire farther away from the walls but are not found in the entorhinal cortex. They are located in the subiculum, a major output of the hippocampus. While the entorhinalhippocampal circuit is a loop, the route from boundary-vector cells to place cells is much less clear than from grid cells. Moreover, both border cells and boundary-vector cells (which are conflated in this paper) comprise a small population of neurons compared to grid cells.

      AUTHOR RESPONSE: The model can be built without assuming between-border cells (early simulations with the model did not make this assumption). Regarding this issue, the text reads “Unlike the BVC model, the boundary cell representation is sparsely populated using a basis set of three cells for each of the three dimensions (i.e., 9 cells in total), such that for each of the three non-orthogonal orientations, one cell captures one border, another the opposite border, and the third cell captures positions between the opposing borders (Solstad et al., 2008). However, this is not a core assumption, and it is possible to configure the model with border cell configurations that contain two opponent border cells per dimension, without needing to assume that any cells prefer positions between the borders (with the current parameters, the model predicts there will be two border cells for each between-border cell). Similarly, it is possible to configure the model with more than 3 cells for each dimension (i.e., multiple cells representing positions between the borders).” The Solstad paper found a few cells that responded in positions between borders, but perhaps not as many as 1 out of 3 cells, such as this particular model simulation predicts. If the paucity of between-border cells is a crucial data point, the model can be reconfigured with opponent-border cells without any between border cells. The reason that 3 border cells were used rather than 2 opponent border cells was for simplicity. Because 3 head direction cells were used to capture the face-centered cubic packing of memories, the simulation also used 3 border cells per dimensions to allow a common linear sum metric when conjoining dimensions to form memories. If the border dimensions used 2 cells while head direction used 3 cells, a dimensional weighting scheme would be needed to allow this mixing of “apples and oranges” in terms of distances in the 3D space that includes head direction.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Specific questions/clarifications:  

      (1) Assumption of population-based vs single unit link to biological cells: At the start, the author assumes that each unit here can be associated with a population: "the simulated activation values can be thought of as proportional to the average firing rate of an ensemble of neurons with similar inputs and outputs (O'Reilly & Munakata, 2000)." But is a 'grid cell' found here a single cell or an average of many cells? Does this mean the model assumes many cells that have different fields that are averaged, which become a grid-like unit in the model? But in biology, these are single cells? Or does it mean a grid response is an average of the place cell inputs? 

      I apologize for being unclear about this. The grid cells in the model are equivalent to real single cells except that the simulation uses a ratecoded cell rather than a spiking cell. The averaging that was mentioned in the paper is across identically behaving spiking cells rather than across cells with different grid field arrangements. To better explain this, I have added the following text:

      “For instance, consider a set of several thousand spiking grid cells that are identical in terms of their firing fields. At any moment, some of these identically-behaving cells will produce an action potential while others do not (i.e., the cells are not perfectly synchronized), but a snapshot of their behavior can be extracted by calculating average firing rate across the ensemble. The simulated cells in the model represent this average firing rate of identically-behaving ensembles of spiking neurons.” 

      This is a mathematical short-cut to avoid simulating many spiking neurons. Because this model was compared to real spike rate maps, this real-valued average firing rate is down-sampled to produce spikes by finding the locations that produced the top 5% of real-valued activation values across the simulation.

      (2) It is not clear to me why they are circular border cells/basis sets.  

      In the initial submission, there was a brief paragraph describing this assumption. In this revision, that paragraph has been expanded and modified for greater clarity. It now reads:

      “Because head direction is necessarily a circular dimension, it was assumed that all dimensions are circular (a circular dimension is approximately linear for nearby locations). This assumption of circular dimensions was made to keep the model relatively simple, making it easier to combine dimensions and allowing application of the same processes for all dimensions. For instance, the model requires a weight normalization process to ensure that the pattern of weights for each dimension corresponds to a possible input value along that dimension. However, the normalization for a linear dimension is necessarily different than for a circular dimension. Because the neural tuning functions were assumed to be sine waves, normalization requires that the sum of squared weights add up to a constant value. For a linear dimension, this sum of squares rule only applies to the subset of cells that are relevant to a particular value along the dimension whereas for a circular dimension, this sum of squares rule is over the entire set of cells that represent the dimension (i.e., weight normalization is easier to implement with circular dimensions). Although all dimensions were assumed to be circular for reasons of mathematical convenience and parsimony, circular dimensions may relate to the finding that human observers have difficultly re-orienting themselves in a room depending on the degree of rotational symmetry of the room (Kelly et al., 2008). In addition, this simplifying assumption allows the model to capture the finding that the population of grid cells lies on a torus (Gardner et al., 2022), although I note that the model was developed before this result was known.”

      (3) Why is it 3 components? I realise that the number doesn't matter too much, but I believe more is better, so is it just for simplicity? 

      In this revision, additional text has been added to explain this assumption: “To keep the model simple, the same number of cells was assumed for all dimensions and all dimensions were assumed to be circular (head direction is necessarily circular and because one dimension needed to be circular, all dimensions were assumed to be circular). Three cells per dimensions was chosen because this provides a sparse population code of each dimension, with few border cells responding between borders, with few border cells responding between borders, while allowing three separate phases of grid cells within a grid cell module (in the model, a grid cell module arises from combination of a third dimension, such as head direction, with the real-world X/Y dimensions defined by border cells).”

      As a reminder, the text explaining the sparse coding of border cells reads: “However, this is not a core assumption, and it is possible to configure the model with border cell configurations that contain two opponent border cells per dimension, without needing to assume that any cells prefer positions between the borders (with the current parameters, the model predicts there will be two border cells for each between-border cell). Similarly, it is possible to configure the model with more than 3 cells for each dimension (i.e., multiple cells representing positions between the borders).”

      The model can work with just two opponent cells or with more than three cells per basis set. In different simulations, I have explored these possibilities. Three was chosen because it is a convenient way to highlight the face-centered cubic packing of memories that tends to occur (FCP produces 3 alternating layers of hexagonally arranged firing fields). Thus, each of the three head direction cells captures a different layer of the FCP arrangement. A more realistic simulation might combine 6 different head direction cells tiling the head direction dimension with opponent border cells (just 2 cells for each border dimensions). Such a combination would produce responses at borders, but no responses between borders and, at the same time, the head direction cells would still reveal the FCP arrangement. However, it is not easy to find the right parameters for such a mix-and-match simulation in which different dimensions have different numbers of tuning functions (e.g., some dimensions having 2 cells while others have 3 or 6 and some dimensions being linear while others are circular). When all of the dimensions are of the same type, the simple sum that arises from multiplying the input by the weight values gives rise to Euclidean distance (see Figure 3B). With a mix-and-match model of different dimension-types, it should be possible to adjust the sum to nevertheless produce a monotonic function with Euclidean distance although I leave this to future work. To keep things simple, I assumed that all dimensions are of the same type (circular, with 3 cells per dimension).  

      (4) Confusion due to the border cells/box was unclear to me. "If the period of the circular border cells was the same as the width of the box, then a memory pushed outside the box on one side would appear on the opposite side of the box, in which case the partial grid field on one side should match up with its remainder on the other side. This would entail complete confusion between opposite sides of the box, and the representation of the box would be a torus (donut-shaped) rather than a flat two-dimensional surface. To reduce confusion ..." Is this confusion of the model? Of the animal?  

      This would be confusion of the animal (e.g., a memory field overlapping with one border would also appear at the opposite border in the corresponding location). At one point in model development, I made the assumption that one side of the box wraps to the other side, and I asked Trygve Solstad to run some analyses of real data to see if cells actually wrap around in this manner. He did not find any evidence of this, and so I decided to include outsidethe-box representational area which, as it turned out, allowed the model to capture other behaviors as detailed in the paper.

      This section of the paper now reads:

      “The cosine tuning curves of the simulated border cells represent distance from the border on both sides of the border (i.e., firing rate increases as the animal approaches the border from either the inside or the outside of the enclosure). Experimental procedures do not allow the animal to experience locations immediately outside the enclosure, but these locations remain an important part of the hypothetic representation, particularly when considering the modification of memories through consolidation (i.e., a memory created inside the enclosure might be moved to a location outside the enclosure). This symmetry about the border cell’s preferred location is needed to maintain an unbiased representation, with a constant sum of squares for the border cell inputs (see methods section). Rather than using linear dimensions, all dimensions were assumed to be circular to keep the model relatively simple. This assumption was made because head direction is necessarily a circular dimension and by having all dimensions be circular, it is easy to combine dimensions in a consistent manner to produce multidimensional hippocampal place cell memories. Thus, the border cells define a torus (or more accurately a three-torus) of possible locations. This provides a hypothetical space of locations that could be represented.

      In light of the assumption to represent border cells with a circular dimension, when a memory is pushed outside the East wall of the enclosure, it would necessarily be moved to the West wall of the enclosure if the period of the circular dimension was equal to the width of the enclosure. If this were true, then the partial grid field on one side of the enclosure would match up with its remainder on the other side. Such a situation would cause the animal to become completely confused regarding opposite sides of the enclosure (a location on the West wall would be indistinguishable from the corresponding location on the East wall). To reduce confusion between opposite sides of the enclosure, the width of the enclosure in which the animal navigated (Figure 5) was assumed to be half as wide as the full period of the border cells. In other words, although the space of possible representations was a three-torus, it was assumed that the real-world twodimensional enclosure encompassed a section of the torus (e.g., a square piece of tape stuck onto the surface of a donut). The torus is better thought of as “playing field” in which different sizes and shapes of enclosure can be represented (i.e., different sizes and shapes of tape placed on the donut). Furthermore, this assumption provides representational space that is outside the box without such locations wrapping around to the opposite side of the box.”

      (5) Figure 3 - This result seems to be related to whether you use Euclidean or city-block distance. If you use Euclidean distances in two dimensions wouldn't this work out fine?  

      Euclidean distance was the metric used in the analysis of the two-dimensional simulation, but this did not work out. To make this clear, I have changed the label on the x-axes to read “Euclidean distance” for both the two- and three-dimensional simulations. The two-dimensional simulation produced city block behavior rather than Euclidean behavior because memory retrieval is the sum of the two dimensions, as is standard in neural networks, rather than the Euclidian distance formula, which would require that memory retrieval be the square root of the sum of squares of the two dimensions. One way to address this problem with the two-dimensional simulation would be to use a specific Euclidean-mimicking activation function rather than a simple sum of dimensions. The very first model I developed used such an activation function as applied to opponent border cells with just two dimensions (so 4 cells in total – left/right and top/down). This produced Euclidean behavior, but the activation function was implausible and did not generalize to simulations that also included head direction. In contrast, with three non-orthogonal dimensions, the simple sum of dimensions is approximately Euclidean.

      (6) Final sentence of the Discussion: "However, unlike the present model, these models still assume that entorhinal grid cells represent space rather than a non-spatial attribute." I am not sure if the authors of the cited papers will agree with this. They consider the spatial cases, but most argue they can treat non-spatial features as well. What the author might mean is that they assume non-spatial features are in some metric space that, in a way, is spatial. However, I am not sure if the author would argue that non-spatial features cannot be encoded metrically (e.g., Euclidean distance based on the similarity of odours). 

      In this section, when referring to “entorhinal grid cells” I was specifically referring to traditional grid cells in a rodent spatial navigation experiment. I did not mean to imply that these other theories cannot explain nonspatial grid fields, such as in the two-dimensional bird space grid cells found with humans. The way in which the proposed memory model and these other models differ is in terms of what they assume regarding the function of grid cells that exhibit spatial grid fields. In this revision, I have changed this text to read:

      “These models can capture some of the grid cell results presented in the current simulations, including extension to non-spatial grid-like responses (e.g., grid field that cover a two-dimensional neck/leg length bird space). Furthermore, these models may be able to explain memory phenomena similar to the model proposed in this study. However, unlike the proposed model, these models assume that the function of entorhinal grid cells that exhibit spatial X/Y grid fields during navigation is to represent space. In contrast, the memory model proposed in this study assume that the function of spatial X/Y grid cells is to represent a non-spatial attribute; the only reason they exhibit a spatial X/Y grid is because memories of that non-spatial attribute are arranged in a hexagonal grid owing to the uncluttered/unvarying nature of the enclosure. Thus, these model do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010b; Diehl et al., 2017; Grieves & Jeffery, 2017) whereas the proposed model can explain this situation as reflecting the miss-classification of grid cells with a spatial arrangement as providing spatial input to hippocampus.”

      (7) It would be interesting to see videos/gifs of the model learning, and an idea of how many steps of trials it takes (is it capturing real-time rodent cell firing whilst foraging, or is it more abstracted, taking more trials). 

      The short answer is “yes”, the model is capturing real-time rodent cell firing while foraging. This is particularly true when simulating place cell memories in the absence of head direction information, as was shown in a video provided in the initial submission in relation to Figure 4. In this revision, I have provided a second video of learning when simulating place cell memories that include head direction. This second video is in relation to the results reported in Figure 9. This shows that even when learning a three-dimensional real-world space (X, Y, and head direction), the model rapidly produces an on-average hexagonal arrangement of place cells memories owing to the slight tendency of the place cell memories to linger in some locations as compared to others during consolidation. More specifically, they are more likely to linger in the locations that are the intersections of the peaks and/or troughs of the border cells and it is this tendency that supports the immediate appearance of grid cells. However, because the place cell memories are still shifting, head direction conjunctive grid cells are slower to emerge (the head direction conjunctive grid cells require stabilization of the place cells). The video then speeds up the learning process to so how place cells eventually stabilize after sufficient learning of the borders of the enclosure from different head/view directions.

      (8) One question is whether all the results have to be presented in the main text. It was difficult to see which key predictions fit the data and do so better than a spatial/navigation account. 

      Thank you for this suggestion. To make the paper more readable and easier for different readers with different interests to choose different aspects of the results to read, the second half of the results have been put in an appendix. More specifically, the second half of the results concerned place cells rather than grid cells. Thus, in this revision, the main text concerns grid cell results and the appendix concerns place cell results.

      Reviewer #3 (Recommendations For The Authors):  

      The title could usefully be shortened to focus on the main argument that observed firing patterns could be consistent with mapping memories instead of space. It's a stretch to argue that memory is the primary role when no such data is presented (i.e., there is no comparison of competing models). 

      This is a good point (I do not present evidence that conclusively indicates the function of MTL). This original title was chosen to make clear how this account is a radical departure from other accounts of grid cells. The revised title highlights that: 1) a memory model can also explain rodent single cell recording data during navigation; and 2) grid cell may not be non-spatial. The revised title is: “A Memory Model of Rodent Spatial Navigation: Place Cells are Memories Arranged in a Grid and Grid Cells are Non-spatial”

      When arguing that the main role of the hippocampus is memory, I strongly suggest engaging with the work of people like Howard Eichenbaum who spent the better part of their career arguing the same (e.g. DOI:10.1152/jn.00005.2017.)  

      Thank you for pointing out this important oversight. Early in introduction, I now write: “The proposal that hippocampus represents the multimodal conjunctions that define an episode is not new (Marr et al., 1991; Sutherland & Rudy, 1989) and neither is the proposal that hippocampal memory supports spatial/navigation ability (Eichenbaum, 2017). This view of the hippocampus is consistent with “feature in place” results (O’Keefe & Krupic, 2021) in which hippocampal cells respond to the conjunction of a non-spatial attribute affixed to a specific location, rather than responding more generically to any instance of a non-spatial attribute. In other words, the what/where conjunction is unique. Furthermore, the uniqueness of the what/where conjunction may be the fundamental building block of spatial memory and navigation. In reviewing the hippocampal literature, Howard Eichenbaum (2017) concludes that ‘the hippocampal system is not dedicated to spatial cognition and navigation, but organizes experiences in memory, for which spatial mapping and navigation are both a metaphor for and a prominent application of relational memory organization.’”

      With a focus on episodic memory, there should be a mention of the temporal component of memory. While it may rightfully be beyond the scope of this model, it's confusing to omit time completely from the discussion. 

      This issue and several others are now addressed in a new section in the introduction titled ‘The Scope of the Proposed Model’. That section reads:

      “The reported simulations explain why most mEC cell types in the rodent literature appear to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). Assuming that rodents can form non-spatial memories, rodent hippocampus must receive non-spatial input from entorhinal cortex. These simulations suggest that characterization of the rodent mEC cortex as primarily spatial might be incorrect if most grid cells (except perhaps head direction conjunctive grid cells) have been mischaracterized as spatial. Other literatures with other species find non-spatial representations in MTL (Gulli et al., 2020; Quiroga et al., 2005; Wixted et al., 2014) and non-spatial hippocampal memory encoding has been found in rodents (Liu et al., 2012; McEchron & Disterhoft, 1999). The proposed memory model is compatible with these results – the ideas contained in this model could be applied to nonspatial memory representations. However, surveys of cell types in rodent entorhinal cortex seem to indicate that most cells are spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). How can the rodent hippocampus encode nonspatial memories if most of its input is spatial? The goal of the reported simulations is to explain the apparent paucity of non-spatial cells in rodent entorhinal cortex by proposing that grid cells have been misclassified as spatial (see also Luo et al., 2024).

      Given the simplicity of the proposed model, there are important findings that the model cannot address -- it is not that the model makes the wrong predictions but rather that it makes no predictions. The role of running speed (Kraus et al., 2015) is one such variable for which the model makes no predictions. Similarly, because the model is a rate-coded model rather than a model of oscillating spiking neurons, it makes no predictions regarding theta oscillations (Buzsáki & Moser, 2013). The model is an account of learning and memory for an adult animal, and it makes no predictions regarding the developmental (Langston et al., 2010; Muessig et al., 2015; Wills et al., 2012) or evolutionary (Rodrıguez et al., 2002) time course of different cell types. This model contains several purely spatial representations such as border cells, head direction cells, and head direction conjunctive grid cells and it may be that these purely spatial cell types emerged first, followed by the evolution and/or development of non-spatial cell types. However, this does not invalidate the model. Instead, this is a model for an adult animal that has both episodic memory capabilities and spatial navigation capabilities, irrespective of the order in which these capabilities emerged.

      This model has the potential to explain context effects in memory (Godden & Baddeley, 1975; Gulli et al., 2020; Howard et al., 2005). According to this model, different grid cells represent different non-spatial characteristics and place cells represent the combination of these “context” factors and location. In the simulation, just one grid cell is simulated but the same results would emerge when simulating hundreds of different non-spatial inputs provided that all of the simulated non-spatial inputs exist throughout the recording session. However, there is evidence that hippocampus can explicitly represent the passage of time (Eichenbaum, 2014), and time is assuredly an important factor in defining episodic memory (Bright et al., 2020). Thus, although the current model addresses unique combinations of what and where, it is left to future work to incorporate representations of when in the memory model.”

      I recommend explaining the motivation of the theory in more detail in the introduction. It reads as "what if it's like this?" It would be helpful to instead highlight the limitations of current theories and argue why this theory is either a better fit for the data or is logically simpler. 

      This issue and several others are now addressed in the new section in the introduction titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’, which I quoted above in response to the public reviews.

      It's worth considering shortening the results section to include only those that most convincingly support the main claim. The manuscript is quite long and appears to lack focus at times. 

      Thank you for this suggestion. To make the paper more readable and easier for different readers with different interests to choose different aspects of the results to read, the second half of the results have been put in an appendix. More specifically, the second half of the results concerned place cells rather than grid cells. Thus, in this revision, the main text concerns grid cell results and the appendix concerns place cell results.

      The discussion of path dependence on the formation of the grid pattern is important but only briefly discussed. It may be useful to add simulations testing whether different paths (not random walks) produce distorted grid patterns. 

      The short answer is that the path doesn’t affect things in general. The consolidation rule ensures equally spaced memories even if, for instance, one side of the enclosure is explored much more than the other side. As just one example, I have run simulations with a radial arm maze and even though the animal is constrained to only run on the maze arms. The memories still arrange hexagonally as memories become pushed outside the arms. Rather than adding additional simulations to study, I now briefly describe this in the model methods:

      “Of note, the ability of the model to produce grid cell responses does not depend on this decision to simulate an animal taking a random walk – the same results emerge if the animal is more systematic in its path. All that matters for producing grid cell responses is that the animal visits all locations and that the animal takes on different head directions for the same location in the case of simulations that also include head direction as an input to hippocampal place cells.”

      I struggle to understand in Figure 3 why retrieval strength ought to scale monotonically with Euclidean distance, and why that justifies a more complex model (three non-orthogonal dimensions). 

      The introduction to this section now reads: “Animals can plan novel straight line paths to reach a known position and evidence suggests they do so by learning Euclidean representations of space (Cheng & Gallistel, 2014; Normand & Boesch, 2009; Wilkie, 1989). Thus, it was assumed that hippocampal place cells represent positions in Euclidean space (as opposed to non-Euclidean space, such a occurs with a city-block metric).”

      p.17 "although the representational space is a torus (or more specifically a three-torus), it is assumed that the real-world two-dimensional surface is only a section of the torus (e.g., a square piece of tape stuck onto the surface of a donut)." I fail to understand how the realworld surface is only a part of the torus. In the existing theoretical and experimental work on toroidal topology of grid cell activity, the torus represents a very small fraction of the real world, and repeating activity on the toroidal manifold is a crucial feature of how it maps 2D space in a regular manner. Why then here do you want the torus to be larger than the realworld? 

      This section has been rewritten to better explain these assumptions. The relevant paragraphs now read:

      “The cosine tuning curves of the simulated border cells represent distance from the border on both sides of the border (i.e., firing rate increases as the animal approaches the border from either the inside or the outside of the enclosure). Experimental procedures do not allow the animal to experience locations immediately outside the enclosure, but these locations remain an important part of the hypothetic representation, particularly when considering the modification of memories through consolidation (i.e., a memory created inside the enclosure might be moved to a location outside the enclosure). This symmetry about the border cell’s preferred location is needed to maintain an unbiased representation, with a constant sum of squares for the border cell inputs (see methods section). Rather than using linear dimensions, all dimensions were assumed to be circular to keep the model relatively simple. This assumption was made because head direction is necessarily a circular dimension and by having all dimensions be circular, it is easy to combine dimensions in a consistent manner to produce multidimensional hippocampal place cell memories. Thus, the border cells define a torus (or more accurately a three-torus) of possible locations. This provides a hypothetical space of locations that could be represented.

      In light of the assumption to represent border cells with a circular dimension, when a memory is pushed outside the East wall of the enclosure, it would necessarily be moved to the West wall of the enclosure if the period of the circular dimension was equal to the width of the enclosure. If this were true, then the partial grid field on one side of the enclosure would match up with its remainder on the other side. Such a situation would cause the animal to become completely confused regarding opposite sides of the enclosure (a location on the West wall would be indistinguishable from the corresponding location on the East wall). To reduce confusion between opposite sides of the enclosure, the width of the enclosure in which the animal navigated (Figure 5) was assumed to be half as wide as the full period of the border cells. In other words, although the space of possible representations was a three-torus, it was assumed that the real-world twodimensional enclosure encompassed a section of the torus (e.g., a square piece of tape stuck onto the surface of a donut). The torus is better thought of as “playing field” in which different sizes and shapes of enclosure can be represented (i.e., different sizes and shapes of tape placed on the donut). Furthermore, this assumption provides representational space that is outside the box without such locations wrapping around to the opposite side of the box.”

      p.28 "More specifically, egocentric grid cells (e.g., head direction conjunctive grid cells) require stabilization of the place cell memories in the face of ongoing consolidation whereas allocentric grid cells reflect on-average place field positions." and p.32 "if place cells represent episodic memories, it seems natural that they should include head direction (an egocentric viewpoint)." But the head direction signal is not egocentric, it is allocentric. I'm unsure whether this is a typo or a potentially more serious conceptual misunderstanding. 

      Any reference to egocentric has been removed in this revision. In the initial submission, when I used egocentric, I was referring to memories that depended on the head direction of the animal at the time of memory formation. I was using “egocentric” in relation to whether the memory was related to the animal’s personal bodily experience at the time of memory formation. But I concede that this is confusing since the ego/allo distinction is typically used to differentiate angular directions that are relative to the person (left/right) versus earth (East/West). Instead, throughout the manuscript I now refer to these as view-dependent memories since head direction would entail having a different view of the environment at the time of memory formation. I still refer to the stacking of multiple view-dependent memories on the same X/Y location as being the development of an allocentric representation however, since this can be thought of as one way to learn a cognitive map of the enclosure that is view independent.

      p.37 "But if the border cells had changed their alignment with the new enclosure (e.g., if the E border dimension aligned with the North-South borders), then the place cells would have appeared to undergo global remapping as their positions rotated by 90 degrees and the grid pattern would have also rotated." But this would not be interpreted as global remapping by standard analyses of place and grid cell responses. A coherent rotation of firing patterns is not interpreted as remapping. 

      This sentence now reads: “But if the border cells had changed their alignment with the new enclosure (e.g., if the E border dimension aligned with the North-South borders), then the place cells would remain in their same positions relative to the now-rotated borders (i.e., no remapping relative to the enclosure) and the corresponding grid cells would also retain their same alignment relative to the enclosure.”

      p.37 "this is more accurately described as partial remapping (nearly all place fields were unaffected)." If nearly all place fields were unaffected, this should be interpreted as a stable map. Partial remapping is a mix of stability, rate remapping, and global remapping within a population of place cells. 

      This sentence has been removed.

      p.40 "The dependence of grid cell responses on memory may help explain why grid cells have been found for bats crawling on a two-dimensional surface (Yartsev et al., 2011), but three-dimensional grid cells have never been observed for flying bats." This is not true. Ginosar et al. (2021) observed 3D grid cells in flying bats.  

      Thank you for highlighting this issue. In the initial submission I was using “grid cell” to mean a cell that produced a precise hexagonal grid, which is not the case for the 3D grid cells in bats. In this revision, I now discuss grid cell that produce irregular grid fields, writing:

      “According to this model, hexagonally arranged grid cells should be the exception rather than the rule when considering more naturalistic environments. In a more ecologically valid situation, such as with landmarks, varied sounds, food sources, threats, and interactions with conspecifics, there may still be remembered locations were events occurred or remembered properties can be found, but because the non-spatial properties are non-uniform in the environment, the arrangement of memory feedback will be irregular, reflecting the varied nature of the environment. This may explain the finding that even in a situation where there are regular hexagonal grid cells, there are often irregular non-grid cells that have a reliable multi-location firing field, but the arrangement of the firing fields is irregular (Diehl et al., 2017). For instance, even when navigating in an enclosure that has uniform properties as dictated by experimental procedures, they may be other properties that were not well-controlled (e.g., a view of exterior lighting in some locations but not others), and these uncontrolled properties may produce an irregular grid (i.e., because the uncontrolled properties are reliably associated with some locations but not others, hippocampal memory feedback triggers retrieval of those properties in the associations locations).

      In this memory model, there are other situations in which an irregular but reliable multi-location grid may occur, even when everything is well controlled. In the reported simulations, when the hippocampal place cells were based on variation in X/Y (as defined by Border cells), nothing else changed as a function of location, and the model rapidly produced a precise hexagonal arrangement of hippocampal place cell memories. When head direction was included (i.e., real-world variation in X, Y, and head direction), the model still produced a hexagonal arrangement as per face centered cubic packing of memories, but this precise arrangement was slower to emerge, with place cells continuing to shift their positions until the borders of the enclosure were sufficiently well learned from multiple viewpoints. If there is realworld variation in four or more dimensions, as is likely the case in a more ecologically valid situation, it will be even harder for place cell memories to settle on a precise regular lattice. Furthermore, in the case of four dimensions, mathematicians studying the “sphere packing problem” recently concluded that densest packing is irregular (Campos et al., 2023). This may explain why the multifield grid cells for freely flying bats have a systematic minimum distance between firing fields, but their arrangement is globally irregular (Ginosar et al., 2021). Assuming that the memories encoded by a bat include not just the three realworld dimensions of variation, but also head direction, the grid will likely be irregular even under optimal conditions of laboratory control.”

      Multiple typos are found on page 25, end of paragraph 3: "More specifically, if there is one set of non-orthogonal dimensions for enclosure borders and the movement of one wall is too modest as to cause avoid global remapping, this would deform the grid modules based the enclosure border cells."

      As detailed above in the response the public reviews, this paragraph has been rewritten.

    1. Author Response:

      Reviewer #1 (Public Review):

      Summary:

      The study by Gupta et al. investigates the role of mast cells (MCs) in tuberculosis (TB) by examining their accumulation in the lungs of M. tuberculosis-infected individuals, non-human primates, and mice. The authors suggest that MCs expressing chymase and tryptase contribute to the pathology of TB and influence bacterial burden, with MC-deficient mice showing reduced lung bacterial load and pathology.

      Strengths:

      (1) The study addresses an important and novel topic, exploring the potential role of mast cells in TB pathology.

      (2) It incorporates data from multiple models, including human, non-human primates, and mice, providing a broad perspective on MC involvement in TB.

      (3) The finding that MC-deficient mice exhibit reduced lung bacterial burden is an interesting and potentially significant observation.

      Weaknesses:

      (1) The evidence is inconsistent across models, leading to divergent conclusions that weaken the overall impact of the study.

      The strength of the study is the use of multiple models including mouse, non-human primate as well as human samples. The conclusions have now been refined to reflect the complexity of the disease and the use of multiple models.

      (2) Key claims, such as MC-mediated cytokine responses and conversion of MC subtypes in granulomas, are not well-supported by the data presented.

      To address the reviewer’s comments, we will carry out further experimentation to strengthen the link between MC subtypes and cytokine responses.

      (3) Several figures are either contradictory or lack clarity, and important discrepancies, such as the differences between mouse and human data, are not adequately discussed.

      We will further clarify the figures and streamline the discussions between the different models used in the study.

      (4) Certain data and conclusions require further clarification or supporting evidence to be fully convincing.

      We will either provide clarification or supporting evidence for some of the key conclusions in the paper.

      Reviewer #2 (Public review):

      Summary:

      The submitted manuscript aims to characterize the role of mast cells in TB granuloma. The manuscript reports heterogeneity in mast cell populations present within the granulomas of tuberculosis patients. With the help of previously published scRNAseq data, the authors identify transcriptional signatures associated with distinct subpopulations.

      Strengths:

      (1) The authors have carried out a sufficient literature review to establish the background and significance of their study.

      (2) The manuscript utilizes a mast cell-deficient mouse model, which demonstrates improved lung pathology during Mtb infection, suggesting mast cells as a potential novel target for developing host-directed therapies (HDT) against tuberculosis.

      Weaknesses:

      (1) The manuscript requires significant improvement, particularly in the clarity of the experimental design, as well as in the interpretation and discussion of the results. Enhanced focus on these areas will provide better coherence and understanding for the readers.

      The strength of the study is the use of multiple models including mouse, non-human primate as well as human samples. The conclusions have now been refined to reflect the complexity of the disease and the use of multiple models.

      (2) Throughout the manuscript, the authors have mislabelled the legends for WT B6 mice and mast cell-deficient mice. As a result, the discussion and claims made in relation to the data do not align with the corresponding graphs (Figure 1B, 3, 4, and S2). This discrepancy undermines the accuracy of the conclusions drawn from the results.

      We apologize for the discrepancy which will be corrected in the revised manuscript

      (3) The results discussed in the paper do not add a significant novel aspect to the field of tuberculosis, as the majority of the results discussed in Figure 1-2 are already known and are a re-validation of previous literature.

      This is the first study which has used mouse, NHP and human TB samples from Mtb infection to characterize and validate the role of MC in TB. We believe the current study provides significant novel insights into the role of MC in TB.

      (4) The claims made in the manuscript are only partially supported by the presented data. Additional extensive experiments are necessary to strengthen the findings and enhance the overall scientific contribution of the work.

      We will either provide clarification or supporting evidence for some of the key conclusions in the paper.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, BOUTRY et al examined a cnidarian Hydra model system where spontaneous tumors manifest in laboratory settings, and lineages featuring vertically transmitted neoplastic cells (via host budding) have been sustained for over 15 years. They observed that hydras harboring long-term transmissible tumors exhibit an unexpected augmentation in tentacle count. In addition, the presence of extra tentacles, enhancing the host's foraging efficiency, correlated with an elevated budding rate, thereby promoting tumor transmission vertically. This study provided evidence that tumors, akin to parasitic entities, can also exert control over their hosts.<br /> Strengths:

      The manuscript is well-written, and the phenotype is intriguing.

      Weaknesses:

      The quality of this manuscript could be improved if more evidence were to be provided regarding the beneficial versus detrimental effects of the tumors.

      We thank the reviewer for taking the time to examine our work carefully and for their highly relevant comments and precise suggestions. We have incorporated these suggestions, which greatly improved the clarity of our manuscript concerning the beneficial and detrimental effects of tumors. Specifically, we have added a new analysis and rephrased the results section, as well as the corresponding sentences in the discussion, to enhance clarity.

      Additionally, regarding the impact of tumor size on the development of supernumerary tentacles, we have included as suggested a new analysis that was previously only available in the supplementary materials of the earlier version. This addresses the reviewer's question and significantly enhances the quality of our paper.

      We have thanked the two referees in the Acknowledgements section of our article.

      Reviewer #2 (Public Review):

      Background and Summary:

      This study addresses the intriguing question of whether and how tumors can develop in the freshwater polyp hydra and how they influence the fitness of the animals. Hydra is notable for its significant morphogenetic plasticity and nearly unlimited capacity for regeneration. While its growth through asexual reproduction (budding) and the associated processes of pattern formation have been extensively studied at the cellular level, the occurrence of tumors was only recently described in two strains of Hydra oligactis (Domazet-Lošo et al, 2014). In that research, an arrest in the differentiation of female germ cells led to an accumulation of germline cells that failed to develop into eggs. In hydra, fertile egg cells typically incorporate nurse cells, which originate from large interstitial stem cells (ISCs) restricted to the germline, through apoptosis. However, this increase in apoptosis activity is absent in "germline tumors," and germline ISCs instead form slowly growing patches that do not compromise tissue integrity. Despite the upregulation of certain genes associated with mammalian neoplasms (such as tpt1 and p23) in this tissue, determining whether this differentiation arrest and the resulting egg patches truly constitute neoplasms remains a challenge.

      The authors have recently published two papers on the ecological and evolutionary aspects of hydra tumor formation (Boutry et al 2022, 2023), which is also the focus of this manuscript. They transplanted tissues derived from animals with germline tumors to wildtype animals and analyzed their growth patterns, specifically the number of tentacles in the host tissue. They observed that such tissues induced the growth of additional tentacles compared to tissues without germline tumors. The authors conclude that this growth pattern (increased number of tentacles) is correlated with "reducing the burden on the host by (over-)compensating for the reproductive costs of tumors" and claim that "transmissible tumors in hydra have evolved strategies to manipulate the phenotype of their host". While it might be stimulating to add a fresh view from other disciplines (here, ecological and evolutionary aspects), the authors completely ignore the current knowledge of the underlying cell biology of the processes they analyze.

      Strengths:

      The study focuses on intriguing questions. Whether and how tumors can develop in the freshwater polyp hydra, and how they influence the fitness of the animals?

      Weaknesses:

      Concept of germline tumors.

      The conceptual foundation of their experiments on germline tumors was the study of Domazet-Lošo et al (2014) introducing the concept of germline tumors in hydra (see above). While this is an intriguing hypothesis, there has been little advancement in comprehending the molecular mechanisms underlying tumor formation in hydra beyond this initial investigation. Germline tumors in hydra do not fully meet the typical criteria for neoplasms observed in mammalian tissues. More importantly, a similar phenotype was already reported by the work of Paul Brien and described as "crise gametique" (Brien, 1966, Biologie de la reproduction animale - Blastogenèse, Gamétogenèse, Sexualisation, ed. Masson & Cie, Paris). This phenomenon of gametic crisis is unique to Hydra oligactis, a stenotherm, cold-adapted cosmopolitan species. In this species, gametogenesis severely impacts the vitality of the polyps, often leading to complete exhaustion and death (Tardent, 1974). Animals can only be rescued during the initial phase of the cold-induced sexual period (see also the research of Littlefield (1984, 1985, 1986, 1991). The observed arrest in differentiation arrest in germline tumors might represent an epigenetically established consequence of surviving gametogenesis. Regrettably, this important work was not mentioned by the authors or by Domazet-Lošo et al. (2014), highlighting a notable gap in the recognition of basic research in this area that might challenge the hydra tumor hypothesis.

      "Super-nummary" tentacles in graft experiments.

      The authors describe that after grafting tissue from animals with germline tumors to wild-type animals, the number of tentacles in the host tissue increased when the donor tissue had germline tumors. A maximum effect of four additional tentacles was found with donor strain H. oligactis robusta and three additional tentacles with donor strain H.oligactis St Petersburg. In general, H.oligactis wild-type host strains had fewer tentacles than H.oligactis St Petersburg strains. This is consistent with the results of Domazet-Lošo et al (2014) who showed that the number of tentacles increased in the strains with germline tumors. What conclusions can be drawn from these experiments? 

      The authors might want to conclude that transmissible tumors in Hydra have developed strategies to manipulate the phenotype of their host. But there is no evidence for this, as essential controls are missing. It is known that the size of hydra polyps is proportion-regulated, i.e. the number of tentacles varies with the size and number of (epithelial) cells. Such controls are missing in the experiments. There is also a lack of controls from wild-type animals in gametogenesis: it is very likely that grafts with wild-type animals with egg spots of comparable size as the germline tumors (see above) will result in similar numbers of tentacles in host tissue.

      We thank the reviewer for their thoughtful comments. While we appreciate the concerns raised, we maintain that the evidence provided by Domazet-Lošo et al. (2014, Nature Communications) supports the relevance of this model, including the suggested comparisons with the expression profiles of individuals undergoing induced sexual reproduction. Our study focuses primarily on the impact of these tumors on the host phenotype rather than their origin. Tumors are defined as accumulations of abnormally proliferating cells. This includes the definition provided by the referee, which describes “apoptosis activity as absent in 'germline tumors,' with germline ISCs forming slowly growing patches.” Compromise of tissue integrity is not a criterion for defining neoplasms, and many benign neoplasms do not meet this criterion. We are interested in continuing this discussion with the referee to better understand the expected evidence and agree that histological nomenclature could be improved. While further investigation into the cell biology of these tumors would be valuable, this is currently beyond the scope of our article but is being pursued in separate research.

      We also appreciate the points raised regarding the definition of germline tumors and the reference to the pioneering work of Paul Brien. However, in that publication, the concept of gametic crisis in H. oligactis describes reproductive exhaustion leading to death, rather than abnormal cell proliferation indicative of a tumor-like phenotype. This distinction likely explains why this specific paper was not cited previously.

      Our study builds on prior research using the same model (e.g., Domazet-Lošo et al. 2014; Boutry et al. 2023) and describes observations across different hydra strains from various locations worldwide (not just two), all conducted under stable warm temperatures that are not conducive to sexual development. These investigations reveal a phenomenon distinct from the senescence observed post-reproduction in H. oligactis. The phenotype we describe, characterized by an accumulation of cells in the ectoderm, aligns with studies referenced by the reviewer from leading groups in hydra research, known for their expertise in hydra cellular biology. We have relied on these studies after carefully reviewing their results and receiving training from these experts. Furthermore, our team is focused on eco-evolutionary topics and does not aim to specialize in cellular biology, as other teams are already dedicated to that field.

      We also thank the reviewer for their comments on the relevance of our findings and the missing controls. However, we have noted that the reviewer may have misunderstood our experimental design and results.

      Firstly, it appears that the reviewer based their critique mainly on the initial sentences of our Results section (illustrated in Figure 2), which outline the donor groups used in our study rather than presenting the results of the grafting experiments. This description alone is insufficient for drawing conclusions, which is why we conducted further analyses using these donor groups grafted onto different recipients. The maximum effects mentioned by the reviewer (+10 tentacles with St. Petersburg tumoral tissue and +8 tentacles with Robusta tumoral tissue, Results Section 2) represent only a part of our study. We encourage the reviewer to focus on the model analyses presented in Results Section 2, which directly relate to the grafting experiments and provide a more comprehensive evaluation of our results and conclusions. These analyses include comparisons between transmissible tumors and spontaneous tumors, offering deeper insights into their effects on tentacle development.

      In our methods (as depicted in Figure 3), we explicitly compared different types of tumorous tissue from various donors, distinguishing between spontaneous and transmissible tumors. Although we avoid labeling spontaneous tumors as "controls" to prevent confusion with healthy tissue controls, they serve as controls to the “treatment” that involves transmissible tumors, and thus are appropriate comparisons for assessing the size effect suggested by the reviewer. Spontaneous and transmissible tumors share similar size and cellular characteristics but differ significantly in the number of tentacles their hosts possess. Furthermore, we refer the reviewer to a relevant study (Ngo et al. 2021) that found no increase in tentacle numbers with larger polyps of healthy tissue. This reference has been included in the revised discussion (line 309 to 312), which now also addresses the potential effect of body size with additional explanations.

      Regarding the suggestion to include controls from animals undergoing gametogenesis, we did not find evidence in the literature indicating an increase in tentacle numbers during this process in hydra. If such studies exist, we kindly request the complete references so we can include them in our discussion. Additionally, as noted in Brien's work, Hydra oligactis undergoing gametogenesis are known to either die or experience significant degeneration afterward. Transplanting tissue from dead or dying (and reproducing) hydras poses technical challenges and raises questions about whether any observed effects result from incomplete gametogenesis, the onset of senescence, or both. While these questions are intriguing, they fall outside the scope of our article.

      In conclusion, we appreciate the opportunity to address these points and reaffirm that our study offers valuable insights into the evolutionary dynamics of interactions between transmissible tumor tissues and host phenotypes in hydra. We remain open to further discussion and welcome any additional feedback to enhance the clarity and robustness of our manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) If the fitness of hydra is altered in those with spontaneous tumors is the increased number of tentacles associated with those with transmitted tumors able to rescue this phenotype?

      We thank the reviewer for reformulating our results. Indeed, fitness can be restored and even improved in tumorous polyps harboring supernumerary tentacles. This phenomenon, which we referred to as compensation and over-compensation in Section 3 and Figure 4, was initially discussed only in the discussion section. To improve the clarity of our manuscript, we have now specified this in the Conclusion (lines 345 to 347 and some minor rewording in the same paragraph) in the Results section (lines 284 to 286).

      (2) Does the size of the tumor predict the number of tentacles formed?

      We agree that this would be a valuable complementary analysis. We have conducted an analysis considering the qualitative size of the tumors (based on visual categories) and the number of tentacles, which is now included in our paper (lines 160-161; lines 193 to 198; lines 253 to 259; lines 314 - 322).

      (3) Considering the mentioned association of body size with tentacle numbers for hydra, is a change in size a phenotype associated with transmitted tumors, and is such a phenotype transmittable. 

      All tumorous individuals, regardless of their tumor type, exhibit a swollen body. We have added a sentence in the introduction to clarify this point (line 62).

      (4) Is there anything unique about the Rob population that would explain their mass mortality following transplantation? For instance, their resistance to spontaneous tumor formation? Similarly, is there a difference in transplantation success based on the type of tissue transplanted? The authors could address this point in the discussion.

      It is a very old lineage described nearly 80 years ago. It is unknown whether natural populations of Robusta exist, and no reports of any male individuals have been documented. We have added a sentence in the Materials and Methods section to clarify this information (lines 98 to 102).

      (5) What downsides are known about the transmittable tumors in hydra and how present are they in the grafted individuals? Are other physiological aspects such as mobility, regeneration, or sexual reproduction hindered?

      Transmissible tumors have been associated with increased vulnerability to predation and alterations in life history traits, including a higher budding rate and decreased sexual reproduction. While we were unable to measure behavioral traits in this study of our grafted individuals, this is an intriguing avenue for further research. We have included this perspective in the discussion section as a concluding remark (lines 375 to 382). Thanks a lot for the suggestion of this conclusion.

      (6) It is important to explore the mechanisms behind the phenotypic variation conferred by the types of tumors, whether of different lineage or transmissibility. For this purpose, RNA-Seq on the recipients seems like a good starting point.

      Thanks for this suggestion, we've reworded the sentence about this perspective in our discussion to be more precise (line 320).

      Boutry, Justine, Marie Buysse, Sophie Tissot, Chantal Cazevielle, Rodrigo Hamede, Antoine M. Dujon, Beata Ujvari, et al. 2023. « Spontaneously Occurring Tumors in Different Wild-Derived Strains of Hydra ». Scientific Reports 13 (1): 7449. https://doi.org/10.1038/s41598-023-34656-0.

      Domazet-Lošo, Tomislav, Alexander Klimovich, Boris Anokhin, Friederike Anton-Erxleben, Mailin J. Hamm, Christina Lange, et Thomas C. G. Bosch. 2014. « Naturally occurring tumours in the basal metazoan {Hydra} ». Nat Commun 5 (1): 4222. https://doi.org/10.1038/ncomms5222.

      Ngo, Kha Sach, Berta R-Almási, Zoltán Barta, et Jácint Tökölyi. 2021. « Experimental Manipulation of Body Size Alters Life History in Hydra ». Ecology Letters 24 (4): 728‑38. https://doi.org/10.1111/ele.13698.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      This important study provides proof of principle that C. elegans models can be used to accelerate the discovery of candidate treatments for human Mendelian diseases by detailed high-throughput phenotyping of strains harboring mutations in orthologs of human disease genes. The data are compelling and support an approach that enables the potential rapid repurposing of FDA-approved drugs to treat rare diseases for which there are currently no effective treatments. The authors should provide a clearer explanation of how the statistical analyses were performed, as well as a link to a GitHub repository to clarify how figures and tables in the manuscript were generated from the phenotypic data.

      We have amended our description of the statistical analysis in the materials and methods section of the manuscript. We have also updated the GitHub repository link to a dedicated repository for this study, this contains all of the code needed to generated all the figures made from the phenotypic data provided. Additionally, we have updated the Zenodo repository to contain both the code and datasets within the same file.

      We have also updated the GitHub repository link to a dedicated repository for this manuscript, that contains all of the code needed to generate all figures from the phenotypic data provided. Additionally, we have updated the Zenodo repository link to contain both the code and datasets within the same folder structure. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors have responded to previous review to improve the presentation of the work. The paper more than meets publication standards.

      No response required.

      Reviewer #2 (Recommendations for the authors):

      The authors have addressed all of my questions and concerns. I'm happy to see this updated paper of record.

      No response required.

      Reviewer #3 (Recommendations for the authors):

      Regarding the interactive heatmap

      The html version and the panel in Figure 2C appear not to coincide visually. Maybe the features are ordered in a different way?

      The html version of Figure 2C is for the entire feature set extract per strain and not the condensed Tierpsy256 set shown in the panel figure. We have now remade this figure to show this reduced feature set (aligning with what is shown in Figure 2C) and included both versions of the interactive heatmaps as static html files within the same repository.

      Regarding data accessibility overall

      More generally, the html file does not address my initial concern about the accessibility of the data to non-experts. Making the full dataset available was a necessary first step, but the hermetic nature of its format and the lack of a simple way to query the data remains an issue for me that limits the usefulness of this data to the broadest audience.

      We agree, but unfortunately do not currently have the resources to build a public-facing database to facilitate this.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      This paper examines the role of MLCK (myosin light chain kinase) and MLCP (myosin light chain phosphatase) in axon regeneration. Using loss-of-function approaches based on small molecule inhibitors and siRNA knockdown, the authors explore axon regeneration in cell culture and in animal models. Their evidence shows that MLCK activity facilitates axon extension/regeneration, while MLCP prevents it.

      Major concern:

      A global inconsistency in the conclusions of the authors is evident when trying to understand the role of NMII in axon growth and to understand the present results in light of previous reports by the authors and many others on the role of NMII in axon extension. The discussion of the matter fails to acknowledge a vast literature on how NMII activity is regulated. The authors study enzymes responsible for the phosphorylation and dephosphorylation of NMII, referring to something that is strongly proven elsewhere, that phosphorylation activates NMII and dephosphorylation deactivates it. The authors mention their own previous evidence using inhibitors of NMII ATPase activity (blebbistatin, Bleb for short) and inhibitors of a kinase that phosphorylates NMII (ROCK), highlighting that Bleb increases axon growth. Since Bleb inhibits the ATPase activity of NMII, it follows that NMII is in itself an inhibitor of axon growth, and hence when NMII is inhibited, the inhibition on axon growth is relieved, and axonal growth takes place (REF1). It is known that NMII exists in an inactive folded state, and ser19 phosphorylation (by MLCK or ROCK) extends the protein, allowing NMII filament formation, ATPase activity, and force generation on actin filaments (REF2). From this, it is derived that if MLCK is inhibited, then there is no NMII phosphorylation, and hence no NMII activity, and, according to their previous work, this should promote axon growth. On the contrary, the authors show the opposite effect: in the lack of phospho-MLC, authors show axon growth inhibition.

      We thank the Reviewer for taking time to review our manuscript, and we really appreciated the comments from the reviewer. We have tried our best to revise the manuscript to address all the comments raised by the Reviewer.

      Reporting evidence challenging previous conclusions is common business in scientific endeavors, but the problem with the current manuscript is that it fails to point to and appropriately discuss this contradiction. Instead, the authors refer to the fact that MLCK and Bleb inhibit NMII in different steps of the activation process. While this is true, this explanation does not solve the contradiction. There are many options to accommodate the information, but it is not the purpose of this revision to provide them. Since the manuscript is focused solely on phosphorylation states of MLC and axon extension, the claims are simply at odds with the current literature, and this important finding, if true, is not properly discussed.

      Thank you for reviewer's very good comments. As suggested by Reviewer, we discuss more detail it in our revised manuscripts (line 357-368; line 373-374).

      What follows is a discussion of the merits and limitations of different claims of the manuscript in light of the evidence presented.

      (1) Using western blot and immunohistochemical analyses, authors first show that MLCK expression is increased in DRG sensory neurons following peripheral axotomy, concomitant to an increase in MLC phosphorylation, suggesting a causal effect (Figure 1). The authors claim that it is common that axon growth-promoting genes are upregulated. It would have been interesting at this point to study in this scenario the regulation of MLCP, which is a main subject in this work, and expect its downregulation.

      We thank the Reviewer for taking time to review our manuscript, and we really appreciated the positive comments from the Reviewer.

      (2) Using DRG cultures and sciatic nerve crush in the context of MLCK inhibition and down-regulation, authors conclude that MLCK activity is required for mammalian peripheral axon regeneration both in vitro and in vivo (Figure 2).

      The in vitro evidence is of standard methods and convincing. However, here, as well as in all other experiments using siRNAs, it is not clear what the control is about (the identity of the plasmids and sequences, if any).

      We used the pCMV–EGFP–N3 as control, and the pCMV–EGFP–N3 plasmid was from Clontech, Inc. (line 114-115).   

      Related to this, it is not helpful to show the same exact picture as a control example in Figures 2 and 3 (panels J and E, respectively). Either because they should not have received the same control treatment, or simply because it raises concern that there are no other control examples worth showing. In these images, it is not also clear where and how the crush site is determined in the GFP channel. This is of major importance since the axonal length is measured from the presumed crush site. Apart from providing further details in the text, the authors should include convincing images.

      Thank you so much for your comments. We changed the control example in Figure 3J. For sciatic nerve regeneration experiments, the sciatic nerve was exposed at the sciatic notch by a small incision 2 days after the in vivo electroporation. The nerve was then crushed, and the crush site was marked with a 11-0 nylon epineural suture. After surgeries, the wound was closed, and the mice were allowed to recover. Three days after the sciatic nerve crush, the whole sciatic nerves from the perfused animals were dissected out and postfixed overnight in 4% PFA at 4°C. Before whole-mount flattening, it was confirmed that the place of epineural suture matched the injury site, and experiments were included in the analysis only when the crush site was clearly identifiable. Using whole mounted tissue, all identifiable EGFP-labeled axons in the sciatic nerve were manually traced from the crush site to the distal growth cone to measure the length of axon regeneration. (line 159-164).

      (3) The authors then examined the role of the phosphatase MLCP in axon growth during regeneration. The authors first use a known MLCP blocker, phorbol 12,13-dibutyrate (PDBu), to show that is able to increase the levels of p-MLC, with a concomitant increase in the extent of axon regrowth of DRG neurons, both in permissive as well as non-permissive. The authors repeat the experiments using the knockdown of MYPT1, a key component of the MLC-phosphatase, and again can observe a growth-promoting effect (Figure 3).

      The authors further show evidence for the growth-enhancing effect in vivo, in nerve crush experiments. The evidence in vivo deserves more evidence and experimental details (see comment 2). Some key weaknesses of the data were mentioned previously (unclear RNAi controls and duplication of shown images), but in this case, it is also not clear if there is a change only in the extent of growth, or also in the number of axons that are able to regenerate.

      Thank you so much for your comments. We used same control as in vitro experiments (the pCMV– EGFP–N3 plasmid was from Clontech, Inc), and we also changed the control image in Figure 3J. For in vivo axon regeneration experiments, we measured the lengths of all identifiable EGFP-labelled axons in the sciatic nerve from the crush site to the distal axonal ends. The number of EGFP labeled regenerating axons were actually determined by the electroporation rate of EGFP, which is similar, but not identical, in different mice. Thus, our data only can show the differences in axon lengths among different experimental conditions. Such approach has been used in many of our previously published papers (e.g. Saijilafu et al. Nature Communications, 2011, Saijilafu et al. Nature Communications, 2013). (line 152-153).

      (4) In the next set of experiments (presented in Figure 4) authors extend the previous observations in primary cultures from the CNS. For that, they use cortical and hippocampal cultures, and pharmacological and genetic loss-of-function using the above-mentioned strategies. The expected results were obtained in both CNS neurons: inhibition or knockdown of the kinase decreases axon growth, whereas inhibition or knockdown of the phosphatase increases growth. A main weakness in this set is that it is not indicated when (at what day in vitro, DIV) the treatments are performed. This is important to correctly interpret the results, since in the first days in vitro these neurons follow well-characterized stages of development, with characteristic cellular events with relevance to what is being evaluated. Importantly, this would be of value to understand whether the treatments affect axonal specification and/or axonal extension. Although these events are correlated, they imply a different set of molecular events.

      The treatments were started from the initial of cell culture period, and this procedure may affect axon specification as the Reviewer point out. However, we mainly focused on axon length in our experiments, thus, for quantification of axon length, neurons with processes longer than twice the diameter of cell bodies were photographed, and the longest axon of each neuron was measured. We revised the manuscript as suggested by the reviewer (line 143-145).

      The title of this section is misleading: line 241 "MLCK/MLCP activity regulated axon growth in the embryonic CNS"... the title (and the conclusion) implies that the experiments were performed in situ, looking at axons in the developing brain. The most accurate title and conclusion should mention that the evidence was collected in CNS primary cultures derived from embryos.

      We have revised the manuscript as suggested by the reviewer (line 251).

      (5) Performing nerve crush injury in CNS nerves (optic nerve and spinal cord), and the local application of PBDu, the author shows contrasting results (Figure 5). In the ON nerve, they can see axons extending beyond the lesion site due to PBDu. On the contrary, the authors fail to observe so in the corticospinal tract present in the spinal cord. The authors fail to discuss this matter in detail. Also, they accommodate the interpretation of the evidence in light of a process known as axon retraction, and its prevention by MLCP inhibition. Since the whole paper is on axon extension, and it is known that mechanistically axon retraction is not merely the opposite of axon extension, the claim needs far more evidence.

      Thank you so much for your comments. Compared to optic nerve axons, corticospinal tract axons exhibit a reduced intrinsic axon growth capability. Consequently, we observed that PBDu stimulates optic nerve axon regeneration. However, unfortunately, we did not detect any enhancement in corticospinal tract axons beyond the injury site in SCI following the inhibition of myosin light chain phosphatase (MLCP) with PBDu.

      In panel 5F and the supplementary data, the authors mention the occurrence of retraction bulbs, but the images are too small to support the claim, and it is not clear how these numbers were normalized to the number of axons labeled in each condition.

      Thank you so much for your comments. In this study, we used a similar method from Ertürk et al. (2007) to quantify the retraction bulb. Both maximum width of the enlarged distal tip of the axon and the width of its immediately adjacent axon shaft was measured. Then, the ratio of these two widths was then calculated. An axonal tip was considered as a retraction bulb if its tip/shaft ratio exceeded 4. Averages number of retraction bulb were calculated from 3 sections in every mice for each group (n=5). (line 187-191).

      [Ref] Ertürk A, Hellal F, Enes J, and Bradke F (2007). Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration. J. Neurosci 27, 9169–9180. [PubMed:17715353].

      (6) The author combines MLCK and MLCP inhibitors with Bleb, trying to verify if both pairs of inhibitors act on the same target/pathway (Figure 6). The rationale is wrong for at least two reasons.<br /> a- Because both lines of evidence point to contrasting actions of NMII on axon growth, one approach could never "rescue" the other.

      If MLCK regulates axon growth through the activation of Myosin, the inhibitory effect of ML-7 (an MLCK inhibitor) on axon growth might be influenced by Bleb, a NMII inhibitor. However, our findings reveal that the combination of Bleb and ML-7 does not alter the rate of axon outgrowth compared to ML-7 alone. This suggests that the roles of ML-7 and Bleb in axon growth are independent. It means MLCK may regulates axon growth independent of NMII activity.

      b. Because the approaches target different steps on NMII activation, one could never "prevent" or rescue the other. For example, for Bleb to provide a phenotype, it should find any p-MLC, because it is only that form of MLC that is capable of inhibiting its ATPase site. In light of this, it is not surprising that Bleb is unable to exert any action in a situation where there is no p-MLC (ML-7, which by inhibiting the kinase drives the levels of p-MLC to zero, Figure 4A). Hence, the results are not possible to validate in the current general interpretation of the authors. (See 'major concern').

      The reported mechanism of blebbistatin is not through competition with the ATP binding site of myosin. Instead, it selectively binds to the ATPase intermediate state associated with ADP and inorganic phosphate, which decelerates the phosphate release. Importantly, blebbistatin does not impede myosin's interaction with actin or the ATP-triggered disassociation of actomyosin. It rather inhibits the myosin head when it forms a product complex with a reduced affinity for actin. This indicates that blebbistatin functions by stabilizing a particular myosin intermediate state that is independent of the phosphorylation status of myosin light chain (MLC).

      [Ref] Kovács M, Tóth J et al. Mechanism of blebbistatin inhibition of myosin II. J Biol Chem. 2004 Aug 20;279(34):35557-63. doi: 10.1074/jbc.M405319200.

      (7) In Figure 7, the authors argue that the scheme of replating and using ML7 before or after replating is evidence for a local cytoskeletal action of the drug. However, an alternative simpler explanation is that the drug acts acutely on its target, and that, as such, does not "survive" the replating procedure. Hence, the conclusion raised by the evidence shown is not supported.

      In our study, we meticulously assessed the neuronal survival rates across various experimental groups. The findings indicate no significant variation in survival rates among the groups. This suggests that the drug treatment exerts no discernible influence on cell viability but primarily modulates axonal elongation."

      Author response image 1.

      (8) In Figure 8, the authors show that the inhibitory treatments on MLCK and MLCP (ML7 and PRBu) alter the morphology of growth cones. However, it is not clear how this is correlated with axon growth. The authors also mention in various parts of the text that a local change in the growth cone is evidence for a local action/activity of the drug or enzyme. However, the local change<->local action is not a logical truth. It can well be that MLCK and MLCP activity trigger molecular events that ultimately have an effect elsewhere, and by looking at "elsewhere" one observes of course a local effect but is not because the direct action of MLCK or MLCP are localized. To prove true localized effects there are numerous efforts that can be made, starting from live imaging, fluorescent sensors, and compartmentalized cultures, just to mention a few.

      About the relationship between growth cone size and its growth rate, the previous published literatures found that a fast-growing axon tended to have small growth cones (Mason C. et al. 1997). A recent study on Aplysia further supports this by noting that growth cones enlarge significantly when axonal elongation halts (Miller and Suter, 2018). Consistent with these findings, our data indicate that inhibiting MLCP with PDBu treatment leads to a reduction in growth cone size, which in turn promotes axon regeneration.

      [Ref] Mason CA, Wang LC. Growth cone form is behavior-specific and, consequently, position-specific along the retinal axon pathway. J Neurosci. 1997; 13:1086–1100. [PubMed: 8994063]

      [Ref] Miller KE, Suter DM. An Integrated Cytoskeletal Model of Neurite Outgrowth. Front Cell Neurosci. 2018 Nov 26;12:447. doi: 10.3389/fncel.2018.00447. eCollection 2018.

      References:

      (1) Eun-Mi Hur 1, In Hong Yang, Deok-Ho Kim, Justin Byun, Saijilafu, Wen-Lin Xu, Philip R Nicovich, Raymond Cheong, Andre Levchenko, Nitish Thakor, Feng-Quan Zhou. 2011. Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules. Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5057-62. doi: 10.1073/pnas.1011258108.

      (2) Garrido-Casado M, Asensio-Juárez G, Talayero VC, Vicente-Manzanares M. 2024. Engines of change: Nonmuscle myosin II in mechanobiology. Curr Opin Cell Biol. 2024 Apr;87:102344. doi: 10.1016/j.ceb.2024.102344.

      (3) Karen A Newell-Litwa 1, Rick Horwitz 2, Marcelo L Lamers. 2015. Non-muscle myosin II in disease: mechanisms and therapeutic opportunities. Dis Model Mech. 2015 Dec;8(12):1495-515. doi: 10.1242/dmm.022103.

      Reviewer #2 (Public review):

      Summary:

      Saijilafu et al. demonstrate that MLCK/MLCP proteins promote axonal regeneration in both the central nervous system (CNS) and peripheral nervous system (PNS) using primary cultures of adult DRG neurons, hippocampal and cortical neurons, as well as in vivo experiments involving sciatic nerve injury, spinal cord injury, and optic nerve crush. The authors show that axon regrowth is possible across different contexts through genetic and pharmacological manipulation of these proteins. Additionally, they propose that MLCK/MLCP may regulate F-actin reorganization in the growth cone, which is significant as it suggests a novel strategy for promoting axonal regeneration.

      Strengths:

      This manuscript presents a comprehensive array of experimental models, addressing the biological question in a broad manner. Particularly noteworthy is the use of multiple in vivo models, which significantly strengthens the overall validity of the study.

      We thank the Reviewer for taking time to review our manuscript, and we really appreciated the positive comments from the Reviewer.

      Weaknesses:

      The following aspects apply:

      (1) The manuscript initially references prior research by the authors suggesting that NMII inhibition enhances axonal growth and that MLCK activates NMII. However, the study introduces a contradiction by demonstrating that MLCK inhibition (via ML-7 or siMLCK) inhibits axonal growth. This inconsistency is not adequately addressed or discussed in the manuscript.

      Thank you for reviewer's very good comments. As suggested by Reviewer, we discuss more detail it in our revised manuscripts (line 357-368; line373-374).

      (2) While the study proposes that MLCK/MLCP regulates F-actin redistribution in the growth cone, the mechanism is not explored in depth. The only figure showing how pharmacological manipulation affects the growth cone suggests that not only F-actin but also the microtubule cytoskeleton might be affected, indicating that the mechanism may not be specific. A deeper exploration of this relationship in DRG neurons, in addition to cortical neurons, as shown in the study, would be beneficial.

      Thank you for your insightful suggestion. However, our study primarily focuses on actin and myosin dynamics in the context of axonal elongation, as indicated by our direct observations in growing dorsal root ganglia (DRGs). Athamneh et al. (2017) elegantly demonstrated that the bulk movement of microtubules (MTs), rather than their assembly, predominantly drives MT advance during axonal elongation. Consequently, our manuscript concentrates on the actomyosin system, which is central to our findings. While the role of MTs in axonal growth is indeed significant and fascinating, the data we present is predominantly concerned with the actomyosin mechanism.

      [Ref] Athamneh, A. I. M. et al. Neurite elongation is highly correlated with bulk forward translocation of microtubules. Scientific Reports 7, (2017).

      (3) In the sciatic nerve injury experiments, it would be crucial to include additional controls that clearly demonstrate that siMYPT1 treatment increases MLCP in the L4-L5 ganglia. Additionally, although the manuscript mentions quantifying axons expressing EGFP, the Materials and Methods section only discusses siMYPT1 electroporation, which could lead to confusion.

      Thank you for your suggestion. However, due to the unavailability of a suitable commercial MLCP antibody, we were unable to directly detect MLCP expression. Instead, we assessed the phosphorylation level of myosin light chain (MLC) as a proxy to indicate that siMYPT1 transfection effectively downregulates MLCP activity in L4/5 dorsal root ganglia (DRG). This approach was taken to ensure the integrity of our findings despite the limitations in antibody availability.

      About the electroporation method section, we have now included detailed information about the control plasmid used in our experiments to ensure a clear understanding of our experimental setup and to validate our results. A 1 μl solution containing indicated siRNAs together with the plasmid encoding EGFP (pCMV–EGFP–N3) was then microinjected into the L4–L5 DRG….. (line 152-153).

      (4) In some panels, it is difficult to differentiate the somas from the background (Figures 3, 4, 7). In conditions where images with shorter axonal lengths are represented, it is unclear whether this is due to fewer cells or reduced axonal growth (Figures 2, 4, 6).

      In the original submission, there was some loss of image quality while converting the TIFF to PDF. We improved the quality of images in our revised manuscripts.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      There are a number of typos and language errors that should be thoroughly revised. For example, line 219: "It is well known that the opposite role of MLCK and MLCP to regulate the MLC phosphorylation status". The term "opposite role" is vague. Using "opposite roles" and specifying that they are in regulating MLC phosphorylation status clarifies the relationship between MLCK and MLCP. Also, the original phrase "to regulate" was not correctly integrated into the sentence. Rephrasing it to "in regulating" makes the role of MLCK and MLCP clearer.

      We have revised the manuscript as suggested by the reviewer (line 229).

      In the same line, there is a high number of panels that are not referred to in the text or references for panels that have another letter. Just to mention a few:

      - line 199: "(Figure 1F, G)", → BUT figure 1 contains no G panel.

      We have revised the manuscript as suggested by the reviewer (line 209).

      - line 203: "The results showed that ML-7 administration led to a significant reduction in MLC phosphorylation levels (Figure 2A, B) and impaired axonal growth in sensory neurons (Figure 2C, D). → BUT panel C is related to A and B, and only D and E show impaired axonal growth.

      We have revised the manuscript as suggested by the reviewer (line 214; line 215; line 217; line 219 ).

      Reviewer #2 (Recommendations for the authors):

      (1) Improving the quality of the images would significantly strengthen the results presented.

      In the original submission, there was some loss of image quality while converting the TIFF to PDF. We improved the quality of images in our revised manuscripts.

      (2) The representative images of controls do not always show the same number of cells or axonal growth (e.g., Figure 4).

      We have changed some images as suggested by the reviewer.

      (3) The text has citation errors when referring to the figure labels.

      Upon thorough review, we have carefully examined our manuscript and have made the necessary corrections to address the identified errors. We appreciate the opportunity to enhance the quality of our work and believe that these revisions have significantly improved the clarity of our manuscript.

      (4) What happens to MLCK levels when MLCP activity is inhibited in the optic nerve?

      Upon analyzing our experimental data, we observed no significant alterations in the protein levels of MLCK when the activity of MLCP was inhibited. This finding suggests that the regulatory mechanisms governing MLCK expression may not be directly influenced by short-term MLCP inhibition. It is plausible that the duration of the inhibition period was insufficient to elicit a detectable change in MLCK expression levels.

      (5) The text in line 266: "In contrast, local PBS administration at the injury site or intravitreal PDBu injection induced little axon regeneration beyond the injury site (Figure 5 A-C)." However, this is not reflected in the figure.

      In our revised manuscript, we have provided a more precise description of our findings: In contrast, local PBS administration at the injury site or intravitreal PDBu injection did not significantly enhance axon regeneration beyond the injury site (Figure 5 A-C). This observation suggests that the only treatment employed in the injury site (the inhibition of MLCP activity within the growth cone) effective promote axonal growth. (line 276-279).

      (6) Line 287: The phrase "Consistent with our previous study" requires a citation to support it.

      We added the reference paper; Consistent with our previous study 1, the inhibition of myosin II activity with 25 μM blebbistatin markedly promoted axonal growth (Figure 6A, B). (line 298)

      (7) Line 333: The paper cited by Yu P et al. (2012) does not mention MLCK or p-MLC, so it appears to be misquoted.

      Thank you for comments. We rechecked this cited paper and confirmed that the author provided the western data C in the supplementary figure 1, it showed that Bleb did not alter the phosphorylation status of MLC.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The work by Chuong et al. provides important new insights into the contribution of different molecular mechanisms in the dynamics of CNV formation. It will be of interest to anyone curious about genome architecture and evolution from yeast biologists to cancer researchers studying genome rearrangements.

      Thank you for recognizing the broad significance of our study.

      Strengths:

      Their results are especially striking in that the "simplest" mechanism of GAP1 amplification-non-allelic homologous recombination between the flanking Ty-LTR elements is not the most common route taken by the cells, emphasizing the importance of experimentally testing what might seem on the surface to be obvious answers. One of the important developments of their work is the use of their neural network simulation-based inference (nnSBI) model to derive rates of amplicon formation and their fitness effects.

      We agree with this assessment as the results of our study challenge our intuition that the simplest path to structural variation is the most likely and reveals the great diversity in mechanisms that can lead to large scale changes in the genome.

      Weaknesses:

      The manuscript reads as though two different people wrote two different sections of the manuscript - an experimental evolutionist and a computational scientist. If the goal is to reach both groups of readers, there needs to be more explanation of both types of work. I found the computational sections to be particularly dense but even the experimental sections need clearer explanations and more specific examples of the rearrangements found. I will point out these areas in the detailed remarks to the authors. While I have no reason to question their conclusions, I couldn't independently verify the results that ODIRA was the majority mechanism since the sequence of amplified clones was not made available during the review. I've encouraged the authors to include specific, detailed sequence information for both ODIRA events as well as the specific clones where GAP1 was amplified but the flanking gene GFP was not.

      We have revised the manuscript to expand explanations of both the experimental and computational aspects of our study and to provide additional information for the reader. In doing so, we have edited the text to improve readability. We have made all raw data publicly available through the NCBI short read archive (SRA) and are hosting all sequence data for easy visualization in JBrowse using a public server.

      Reviewer #2 (Public Review):

      Summary:

      This study examines how local DNA features around the amino acid permease gene GAP1 influence adaptation to glutamine-limited conditions through changes in GAP1 Copy Number Variation (CNV). The study is well motivated by the observation of numerous CNVs documented in many organisms, but difficulty in distinguishing the mechanisms by which they are formed, and whether or how local genomic elements influence their formation. The main finding is convincing and is that a nearby Autonomous Replicating Sequence (ARS) influences the formation of GAP1 CNVs and this is consistent with a predominate mechanism of Origin Dependent Inverted Repeat Amplification (ODIRA). These results along with finding and characterizing other mechanisms of GAP1 CNV formation will be of general interest to those studying CNVs in natural systems, experimental evolution, and in tumor evolution. While the results are limited to a single CNV of interest (GAP1), the carefully controlled experimental design and quantification of CNV formation will provide a useful guide to studying other CNVs and CNVs in other organisms.

      Thank you for this positive assessment of our study.

      Strengths:

      The study was designed to examine the effects of two flanking genomic features next to GAP1 on CNV formation and adaptation during experimental evolution. This was accomplished by removing two Long Terminal Repeats (LTRs), removing a downstream ARS, and removing both LTRs and the ARS. Although there was some heterogeneity among replicates, later shown to include the size and breakpoints of the CNV and the presence of an unmarked CNV, both marker-assisted tracking of CNV formation and modeling of CNV rate and fitness effects showed that deletion of the ARS caused a clear difference compared to the control and the LTR deletion.

      The consequence of deletion of local features (LTR and ARS) was quantified by genome sequencing of adaptive clones to identify the CNV size, copy number and infer the mechanism of CNV formation. This greatly added value to the study as it showed that i) ODIRA was the most common mechanism but ODIRA is enhanced by a local ARS, ii) non-allelic homologous recombination (NAHR) is also used but depends on LTRs, and iii) de novo insertion of transposable elements mediate NAHR in strains with both ARS and LTR deletions. Together, these results show how local features influence the mechanism of CNV formation, but also how alternative mechanisms can substitute when primary ones are unavailable.

      We agree with this assessment.

      Weaknesses:

      The CNV mutation rate and its effect on fitness are hard to disentangle. The frequency of the amplified GFP provides information about mutation rate differences as well as fitness differences. The data and analysis show that each evolved population has multiple GAP1 CNV lineages within it, with some being unmarked by GFP. Thus, estimates of CNV fitness are more of a composite view of all CNV amplifications increasing in frequency during adaptation. Another unknown but potential complication is whether the local (ARS, LTR) deletions influence GAP1 expression and thus the fitness gain of GAP1 CNVs. The neural network simulation-based inference does a good job at estimating both mutation rates and fitness effects, while also accounting for unmarked CNVs. However, the model does not account for the population heterogeneity of CNVs and their fitness effects. Despite these limitations of distinguishing mutation rate and fitness differences, the authors' conclusions are well supported in that the LTR and ARS deletions have a clear impact on the CNV-mediated evolutionary outcome and the mechanism of CNV formation.

      While it is true that the inferred mutation rate and fitness effect are negatively correlated, as in other studies (Gitschlag et al., 2023; Caspi et al., 2023; Avecilla et al., 2022), our modeling approach does generate an estimate of each parameter that is best explained by the data. By reporting the confidence intervals (i.e. the 95% HDI) we define the set of parameter values that are consistent with the data. It is true that our model doesn't explicitly account for population heterogeneity; rather, following Hegreness et al. (2006), we employ a single effective fitness effect and mutation rate for all GAP1 CNVs. It is interesting to consider whether the ARS and LTR affect GAP1 expression; however, we have no evidence that this is the case.

      Reviewer #3 (Public Review):

      Summary:

      The authors represent an elegant and detailed investigation into the role of cis-elements, and therefore the underlying mechanisms, in gene dosage increase. Their most significant finding is that in their system copy number increase frequently occurs by what they call replication errors that result from the origin of replication firing.

      The authors somewhat quantitatively determine the effect of the presence of a proximal origin of replication or LTR on the different CNV scenarios.

      Strengths:

      (1) A clever and elegant experimental design.

      (2) A quantitative determination of the effect of a proximal origin of replication or LTR on the different CNV scenarios. Measuring directly the contribution of two competing elements.

      (3) ODIRA can occur by firing of a distal ARS element.

      (4) Re-insertion of Ty elements is interesting.

      We agree that these are interesting and novel findings from our study.

      Weaknesses:

      (1) Overall, the research does not considerably advance the current knowledge. The research does not investigate what the maximum distance between ARS for ODIRA is to occur. This is an important point since ODIRA was previously described. A considerable contribution to the field would be to understand under what conditions ODIRA wins NAHR.

      We agree that these are important questions and they are ones that we are pursuing in future studies.

      (2) The title and some sentences in the abstract give a wrong impression of the generality and the novelty of the observations presented. Below are some examples of much earlier work that dealt with mechanisms of CNV and got different conclusions. The Lobachev lab (Cell 2006) published a different scenario years ago, with a very different mechanism (hair-pin capped breaks). The Argueso lab found something different (NAHR) (Genetics 2013).

      In fact, the CUP1 system presents a good example of this point. The Houseley group showed a complex replication transcription-based mechanism (NAR 2022, cited), the Argueso group showed Ty-based amplification and the Resnick group showed aneuploidy-based amplification. While aneuploidy is a minor factor here the numerous works in Candida albicans, Cryptococcus neoformans, and Yeast suggest otherwise (Selmecki et al Science 2006, Yona et al PNAS 2013, Yang et al Microbiology Spectrum 2021).

      As the reviewer points out there have been several important published studies investigating mechanisms by which structural variation is generated. It is important to note that we are explicitly looking at CNVs in the context of adaptive evolution and the role of genomic features that enable different mechanisms of CNV formation. To emphasize this point, we have changed the title of our manuscript to “Template switching during DNA replication is a prevalent source of adaptive gene amplification”. Aneuploidy is indeed a mechanism of adaptive gene amplification in our current and previously reported studies. We have expanded our discussion to place our study in the context of previous studies reporting mechanisms of gene amplification.

      (3) The authors added a mathematical model to their experimental data. For me, it was very difficult to understand the contribution of the model to the research. I anticipated, for example, that the model would make predictions that would be tested experimentally. For example, " ARSΔ and ALLΔ are predicted to be almost eliminated by generation 116, as the average predicted WT proportion is 0.998 and 0.999" But to my understanding without testing the model.

      In our previous publication (Avecilla et al. 2022, PLoS Biology) we experimentally validated the use of nnSBI to infer evolutionary parameters. In this study, we have extended our modeling framework to quantify differences between genotypes, which was not previously possible. Our results reveal that the local ARS has a key role in the overall supply rate of CNVs at this locus.

      Recommendations for the authors:

      We have addressed all public reviews and recommendations.

      Reviewer #1 (Recommendations For The Authors):

      Specific comments about the work are covered in the order of appearance in the text or Figures. I apologize in advance for the number of comments. They are made out of curiosity, enthusiasm for the research, and a desire to help highlight the most interesting aspects of this work.

      We are grateful for the thoughtful comments that have helped us to significantly improve our manuscript.

      (1) I would appreciate the inclusion of several references to the work on the ODIRA model.

      a) Page 3 last paragraph: "(2) DNA replication-based mechanisms (Harel et al., 2015; Hastings, Lupski, et al., 2009; Malhotra & Sebat, 2012; Pös et al., 2021; Zhang, Gu, et al., 2009; Brewer et al., 2011)" (Addition of Brewer et al., 2011).

      We have added all suggested references.

      b) Page 4 top: (Brewer et al., 2011; Brewer et al., 2015; Martin et al., 2024). (Addition of Brewer et al., 2011).

      We have added all suggested references.

      c) Page 14 top: "Recent work has proposed that ODIRA CNVs are a major mechanism of CNVs in human genomes (Brewer et al., 2015; Martin et al., 2024; Brewer et al., 2024)." Brewer et al., 2024 focuses specifically on ODIRA and human CNVs. (Addition of Brewer et al., 2024).

      We have added all suggested references.

      (2) Page 6, third paragraph: I was surprised that a single inoculating strain was used to establish the replicate chemostats because of the possibility of non-independence of the resulting GAP1 CNVs. A nnSBI model was used to correct for this possibility later in the paper. It seems like it could have been avoided by a simple change in protocol to inoculate each chemostat with an independent inoculum. Was there a reason that the replicate chemostats were not conducted as independent events? Establishing the presence of 'founder' GAP1 CNVs without GFP seems rather secondary to the point of the paper (examining the CNVs that arise during evolution) and I would recommend it being moved to the supplement.

      As is typical in microbial experimental evolution studies, we aimed to start with genetically identical homogenous populations and observe the emergence and selection of de novo variation. Therefore, we founded independent populations from a single inoculum. However, this study, and our prior work using lineage tracking barcodes, has clearly demonstrated that during the initial growth of the culture used for the inoculum CNVs are generated that contribute to the adaptation dynamics on all derived populations. This unanticipated result now suggests that the reviewer’s suggestion is a valid one - independent populations should be derived from independent inocula and this will be our standard practice in future studies.

      We believe that our results, presented in Figure 2, establishing the presence of pre-existing GAP1 CNVs without the GFP are important as it highlights a limitation of the use of CNV reporters of gene copy number that was not previously known. However, we subsequently show that this class of variant - CNVs that are not detected by the reporter system - can be incorporated into our modeling framework enabling estimation of evolutionary parameters, which we believe is an important finding warranting inclusion in the main text.

      (3) Page 7 first full paragraph: "Finally, we also observe a significant delay (ANOVA, p = 0.00833) in the generation at which the CNV frequency reaches equilibrium in ARS∆ (~generation 112) compared to WT (pairwise t-test, adjusted p = 0.05) . . .". Is the delay in reaching a plateau in Figure 1E just a consequence of the later appearance of CNVs or do the authors believe there are two separate events responsible for this delay? E.g. if the authors think that the delay in reaching a plateau is related to lower selection coefficients of the CNVs that do arise compared to the CNVs of other strains, then this should be explicitly discussed.

      We believe that the delay in reaching equilibrium is a consequence of both a lower CNV formation and reduced selection coefficients. Lower values for the fitness coefficient and formation rate in ARS∆ explain both the delay in CNV appearance and CNV equilibrium as shown by the predicted dynamics (Figure S3B). We have added an explicit discussion of the effect of the ARS on CNV dynamics in paragraph 2 of the Discussion section paragraph 2 starting at line 456.

      (4) Page 7: Incorporating pre-existing CNVs into an evolutionary model: The rationale for how you are able to discount the formation rate of GFP-free CNVs (C-) in your model isn't clear to me. How are you able to assume that these C- events don't form after timepoint 0? Why do you assume a starting population of C- events but not a starting population of C+ events?

      We explored the possibility of modeling C- (amplifications of GAP1 without amplification of the reporter) during the evolution experiment. However, because the rate at which C- events occurs is slower than the rate at which C+ events occur (GAP1 amplifications with amplification of the reporter) we found that the effect was negligible. Importantly, the simple model is sufficient to describe the observed dynamics and thus we do not include these possible rare events.

      (5) Figure 1:

      (a) Panel B: Please put the tRNAs on the line diagrams of the four strains. I first interpreted ALLΔ as missing the tRNAs, too.

      Thank you for this suggestion. We added tRNAs to all diagrams to provide additional detail about the structure of the GAP1 locus.

      (b) Panels C, D, and E: the dark shade of the colored boxplots obscures the individual points. I recommend reducing the opacity of the box or choosing a lighter shade so that the individual points are visible on top of the box. Is the percent increase in CNVs per generation (Panel D) based on the slopes of the curves in panel B? By eye the slopes of ARS∆ and ALL∆ appear at least as steep as those of wild type and LTR∆.

      Thank you for this suggestion. We have now made the individual points visible on top of the boxplots in Figures 1C, 1D, and 1E. The lines in Figure 1B show the median value across populations per time point whereas each point in Figure 1D is the slope from linear regression using values from individual populations (data from individual populations are shown in Figure 3C).

      (6) Figure 2:

      (a) Panel A: Please remind the readers what FSC-A is measuring and label the different groups of cells in each sample. Are we supposed to assume the upper scatter in generation 8 is the pre-existing CNV variants? Are the three species at generation 50 due to 1, 2, and 3 copies of GFP? Is the new species in generation 137 further amplification of the locus? And if so, how many copies does it represent? I find it fascinating that what I assume is the 2-copy CNV (presumably a direct oriented amplicon produced by NAHR) at 50 generations is lost (out-competed by a potential inverted triplication) at later times, but I didn't find any mention of this phenomenon in the text. What do the different mutant strains look like over the same time course? Please supply supplemental figures with the flow cytometry gating and vertically aligned histograms of the GFP signal so that the peaks are more easily compared. And provide this information for each of the altered strains in supplementary materials.

      Thank you for these useful suggestions. We have added a gating legend to the figure to clearly indicate the copy-number for each subpopulation. We have edited the caption and main text to explain forward scatter (FSC-A). Raw flow cytometry plots are now provided as Supplementary figure 2 and distributions of cell-size normalized GFP signal are provided in Supplementary figure 3. Although our primary objective with Figure 2A was to show the persistence of the 1-copy GFP population the reviewer is correct that we did not highlight interesting aspects of the CNV dynamics. We have added additional text starting at line 251 to point out these features of the data.

      (b) Panel B: It would help to label the different colored boxes inside cells in Figure 2B - it took me a while to identify the white box as an unrelated adaptive mutation elsewhere in the genome. The linear arrangement of these small colored blocks seems to indicate their structural arrangement. Is that the case? And are they inverted or direct amplicons? Perhaps the authors are being agnostic at this point but it would be better if each of the blocks were separate. If there are other mutations that can explain these GFP-non-amplified survivors, were they identified in your whole genome sequencing?

      We have now included a complete legend for Figure 2B indicating that the white box reflects other beneficial mutations. We have separated this class of beneficial mutation from the GAP1 and reporter elements to reflect that they are not linked. We did not identify additional beneficial mutations but plan to pursue this question in a future project.

      (c) Panel C: Are the two sets of lines mislabeled? One would expect the "reported" CNV proportions to be lower than the total CNV proportions, not the other way around. Maybe the labels "total CNVs" and "reported CNVs" are unclear to me and I am misunderstanding what "reported" refers to. Please clarify.

      Thank you for identifying this mistake. The lines were mislabeled and have now been corrected in the revised version.

      (7) Figure 3:

      (a) A fuller discussion of panels A and B is needed. The results of panel A in particular seem like an excellent opportunity for connecting the computation to the biology. Can the authors speculate on why the ALL∆ strain has a higher CNV formation rate (𝛿c) than the ARS∆ strain? I would think that taking away one means of amplification would decrease CNV formation. Likewise, could the authors discuss why the selection coefficient (sc) for the LTR∆ strain would be the same as for the wild type? Overall, I would like to see more discussion about what these differences in formation rates and selection coefficients could mean for the types of amplicons arising in the chemostats. (In panel B I don't see the shaded area referred to in the figure legend.) A side-by-side comparison of the data in Panel A with the data shown in Supplemental Figure S3A would be instructive..

      Thank you for raising these points. We have added substantial text to the manuscript to address these findings. Starting at line 456 we state:

      “The lower CNV formation rate in the LTR∆ could be a closer approximation of ODIRA formation rates at this locus as ODIRA CNVs are the predominant CNV mechanism in the LTR∆ strain (Figure 4F). Furthermore, the low formation rates in the LTR∆ relative to WT might suggest that the presence of the flanking long terminal repeats may increase the rate of ODIRA formation through an otherwise unknown combinatorial effect of DNA replication across these flanking LTRs and template switching at the GAP1 locus. ARS∆ has the lowest CNV formation rate and it could be an approximation of the rates of NAHR between flanking LTRs and ODIRA at distal origins. We find that the ALL∆ has a higher CNV formation rate than the ARS∆, even though three elements are deleted instead of one. One explanation for this is that the deletion of the flanking LTRs in ALL∆ gives opportunity for novel transposon insertions and subsequent LTR NAHR. Indeed we find an enrichment of novel transposon-insertions in the ALL∆ (Figure 4F) and subsequent CNV formation through recombination of the Ty1-associated repeats (Figure 4H, ALL∆). Both events, transposon insertion followed by LTR NAHR, would have to occur quickly at a rate that explains our estimated CNV rate in ALL∆. While remarkable, increased transposon activity has been associated with nutrient stress (Curcio & Garfinkel, 1999; Lesage & Todeschini, 2005; Todeschini et al., 2005) and therefore feasible explanation for the CNV rate estimated in the ALL∆. Additionally, ARS∆ clones rely more on LTR NAHR to form CNVs (Figure 4F). The prevalence of ODIRA in ARS∆ and ALL∆ are similar. LTR NAHR usually occurs after double strand breaks at the long terminal repeats to give rise to CNVs (Argueso et al., 2008). Because we use haploid cells, such double strand break and homology-mediated repair would have to occur during S-phase after DNA replication with a sister chromatid repair template to form tandem duplications. Therefore the dependency on LTR NAHR to form CNVs and the spatial (breaks at LTR sequences) and temporal (S-phase) constraints could explain the lower formation rate in ARS∆.”

      In addition, we added a discussion of the different selection coefficients estimated and how the simulated competitions help us understand the decreased selection coefficients in the architecture mutants. In newly added text starting at line 479 we state:

      “The genomic elements have clear effects on the evolutionary dynamics in simulated competitive fitness experiments. The similar selection coefficients in WT and LTR∆ suggest that CNV clones formed in these background strains are similar. Indeed, the predominant CNV mechanism in both is ODIRA followed by LTR NAHR (Figure 4F). While LTR NAHR is abolished in the LTR∆, it seems that CNVs formed by ODIRA allow adaptation to glutamine-limitation similar to WT. The lower selection coefficients in ARS∆ and ALL∆ suggest that GAP1 CNVs formed in these strains have some cost. In a competition, they would get outcompeted by CNV alleles in the WT and LTR∆ background.”

      (b) The data shown in panel C seems redundant to what is shown more clearly in Supplemental Figure S3B. It seems to me the more important comparison to make in panel C would be the overlay of the predicted data to the median proportion of cells obtained from the experimental data (Figure 1B). Also, overlays of the cultures from each strain could be added to S3A. It is difficult to see the variation within each strain when the data from all four strains are superimposed as they are in Figure 3C.

      We agree and have edited Figure 3C to incorporate these suggestions and more clearly convey the intra- and interstrain variation.

      (8) Figure 4:

      (a) Panels A, B, and C are nice summaries and certainly helpful for understanding panel E, but it would be instructive to see some actual rearrangements of the ODIRA events, the NAHR, and the transposon-mediated rearrangements. It isn't clear to me what these last events look like. A figure that shows the specific architecture of example clones for each category would be helpful. I am also having a hard time reconciling ODIRA events with a copy number of 2. Are these rearrangements free isochromosomes with amplification to the telomere or are they secondary rearrangements like those described in Brewer et al., 2024? And what about the non-aneuploid rearrangement that includes the centromere? Is it a dicentric?

      We have now added more detailed depictions of CNVs in Figure 4A and provide links to visualize the alignment files. We have added additional discussion starting at line 397 of the non-canonical ODIRA events and putative neochromosome amplicons with reference to Brewer et al 2024. Starting at line 397 we state:

      “Surprisingly, we found CNVs with breakpoints consistent with ODIRA that contained only 2 copies of the amplified region, whereas ODIRA typically generates a triplication. In the absence of additional data, we cannot rule out inaccuracy in our read-depth estimates of copy numbers for these clones (ie. they have 3 copies). An alternate explanation is a secondary rearrangement of an original inverted triplication resulting in a duplication (Brewer et al., 2024); however, we did not detect evidence for secondary rearrangements in the sequencing data. A third alternate explanation is that a duplication was formed by hairpin capped double-strand break repair (Narayanan et al., 2006). Notably, we found 3 additional ODIRA clones that end in native telomeres, each of which had amplified 3 copies. In these clones the other breakpoint contains the centromere, indicating the entire right arm of chromosome XI was amplified 3 times via ODIRA, each generating supernumerary chromosomes. Thus,ODIRA can result in amplifications of large genomics regions from segmental amplifications to supernumerary chromosomes.”

      (b) In Panel B the violin plots appear to indicate that there are two size categories for amplicons in the ARS∆ strain. Do clones from these different sub-populations share a common CNV architecture?

      Thank you for making this point. (Please note that the violin plots are now Figure 4E) We added a short discussion and Supplementary Figure 14. In line 432, we state:

      “In ARS∆, we find two CNV length groups (Figure 4E) that correspond with two different CNV mechanisms (Supplementary Figure 14). 100% of smaller CNVs (6-8kb) (Supplementary Figure 14) correspond with a mechanism of NAHR between LTRs flanking the GAP1 gene (Figure 4H, ARS∆, bottom left green points). Larger CNVs (8kb-200kb) (Supplementary Figure 14) correspond with other mechanisms that tend to produce larger CNVs, including ODIRA and NAHR between one local and one distal LTR element (Figure 4H).”

      (c) Panels D and E: There is great information in these two panels but I find the color keys confusing. There doesn't seem to be any reason for the strain color key in panel E. I am assuming that the key should go with Panel D. Is there some way to indicate in Panel D which events are in which CNV category? It is cumbersome to find that information from Panel E. Perhaps the color-coding from Panel E could be applied to the row labels in Panel D. Being able to link amplicon to the mechanism of CNV formation is especially important for seeing which ODIRA events contain an origin.

      Thank you for this suggestions. We now indicate the mechanism of CNV formation using a consistent color coding in panels G and H (previously panels D and E).

      (d) Panel E: I don't understand the two axes in Panel E. If both axes are log scales, why is the origin 0 for the X-axis and 1 for the Y-axis? And why are the focal amplicons (most of which are recombination events between the two LTRs) scattered in both X and Y coordinates? Shouldn't they form a single point? The same for the recombinants with distal LTRs. Also, orange and red (ODIRA and complex CNVs, respectively) are very hard to distinguish. All of these data need to be presented in a spreadsheet identifying each clone's strain ID, chemostat number, GAP1 and GFP copy numbers, sequence across the junction, and their coordinates. The SRA project (PRJNA1016460) for the sequence data was not found in SRA. Will this data be available to easily look at read depth across chromosome XI for all of the sequenced strains - perhaps as .bam files?

      Thank you for calling these issues with data visualization to our attention. Indeed, the focal amplifications do form around a single point. We originally had jittered the data to show each individual focal amplification but agree that this is confusing. We now overlay the individual points and have altered opacity to enable visualization of individual values. The suggested table of clone data is provided in Supplementary File 2 and the SRA project is now publicly available. Moreover, we are providing all alignment (.bam) files, split, and discordant read depth profiles for each CNV strain and their corresponding ancestor aligned to our custom reference genomes in a public jbrowse server at:

      https://jbrowse.bio.nyu.edu/gresham/?data=data/ee_gap1_arch_muts for WT strains, https://jbrowse.bio.nyu.edu/gresham/LTRKO_clones for LTR∆ strains, https://jbrowse.bio.nyu.edu/gresham/ARSKO_clones for ARS∆ strains, https://jbrowse.bio.nyu.edu/gresham/ALLKO_clones for ALL∆ strains.

      (e) Supplementary Table 1 and Supplementary Figure S2: Please indicate which rearrangements (of the 8 reported in Figure S2A) were identified in each of the clones described in the table. If each of the 8 amplicons is identified by a letter, then this information could be added as a column in the table. I am assuming that each of the eight rearrangements was found in more than one chemostat. Showing these data is crucial for establishing the possibility that they were preexisting at the time of chemostat inoculation. The other possibility is that the clones with amplified GAP1 but a single copy of GFP could have been created by a secondary rearrangement in the outgrowth of the clones that originally had amplified both genes to the same extent. What is the structure of these amplicons? Is there a common junction between GAP1 and GFP? I couldn't find these data in the paper. A suggestion for Supplemental Figure S2A - include a zoomed-in inset for the GAP1 GFP region for each of the 8 read-depth plots. It is hard to see the exact location of GFP and GAP1 across all 8 tracks without getting out a ruler. Were these sequences aligned to your custom reference genome or the reference genome without GFP? If they were aligned to the custom reference that includes the GFP reporter, the reader could visually confirm the absence of GFP amplification.

      Thank you for these suggestions. We edited Supplementary Table 1 and Supplementary Figure 1A as requested. We now provide the precise CNV breakpoints in the GFP-GAP1 region (supplemental figure 1B) displaying both genome read depth and split read depth tracks. These sequences were aligned to the custom reference containing the GFP reporter, which is now clearer in the figure and caption text in line 1226.

      The clones in this figure were sampled from the five different chemostats and we have clarified this in the edited table and text at line 210. We did not detect the same CNV allele in different chemostats and therefore we do not have evidence to support GAP1 amplification without the GFP reporter pre-existing at time of inoculation. We are not able to definitively distinguish whether the amplicons were pre-existing at the time of inoculation or occurred after as we do not have barcoded lineages. We isolated clones carrying this class of amplification from the 1-GFP-copy subfraction late in the experimental evolution (generation 165-182). Given that the alleles appear to differ between populations we think the most parsimonious explanation is that these amplifications occurred after chemostat inoculation but early in the evolution experiment. We explicitly state this in the text starting in line 219.

      (9) Page 8-9: I am sorry to say that I can't evaluate the "HDI of posterior distributions". It is out of my competency range. So I am not sure what this analysis is adding to the paper. The same goes for the rest of the supplementary figures.

      HDI is a measure of certainty in an estimate, similar to confidence interval. We state this in the text in line 276. With the editing of the text we hope the modeling and its supplementary figures are more clear now.

      (10) Page 9 top: Deletion of the ARS appears to lower the fitness of the amplified GAP1 variants. Can the authors speculate on why the ARS deletion would reduce fitness? Did they consult published replication profiles to determine the size of the origin-free gap that could result from the deletion of this mid-S phase origin? Could it explain the delay in the appearance of GAP1 amplicons in the ARS-deletion strains and be responsible for their reduced selection coefficients? Did you examine the growth properties of the starting strain or any of the amplified GAP1 derivatives? Perhaps this consideration could contribute to the discussion. Could there be a bit fuller discussion on the interaction between CNV length differences as shown in Figure 4A and differences in selection coefficient as determined by the nnSBI?

      Thank you for raising this point. We have now added text to our discussion of the reduced fitness in ARS∆ in relation to DNA replication starting on line 359:

      “ARS1116 is a major origin (McGuffee et al., 2013) and ODIRA CNVs found around this origin corroborate its activity. GAP1 is highly transcribed in glutamine-limited chemostats (Airoldi et al., 2016). Head-on transcription-replication collisions at this locus may be contributing to the higher CNV formation rate in wild type and LTR∆. Elimination of the local ARS could result in less transcription-replication collisions and the slower CNV formation rates estimated. Once formed they get outcompeted by faster-forming CNVs and thus in theory are less fit than CNVs in other strain backgrounds. These simulated competitions further suggest that the ARS is a more important contributor to adaptive evolution mediated by GAP1 CNVs.”

      We examined replication profiles in McGuffee et al. Mol Cell. 2013 but could not determine the size of the origin-free gap. ARS1116 and its neighboring ARSs, ARS1118 downstream and ARS1115 upstream are efficient firing origins (Supplement 1 of McGuffee et al. 2013) and therefore the gap is likely to be minimal. The dynamics of the distal firing ARS elements involved in creating ODIRA CNVs might explain the reduced fitness, but further experiments would be required to address this. Regarding growth properties, the growth rate at steady-state in the chemostat is the same as the dilution rate regardless of strain background. Because we had the same dilution rate for each chemostat, the ARS∆ populations would have the same replication rate as the other three strains even if there may be replication rate differences in bulk culture growth. Finally, we found no significant interaction between CNV length and selection coefficients and we state this in line 359.

      (11) Page 10: WT competition simulations: It may help to explicitly state that the competition modeling approach was experimentally validated in Avecilla 2022 as opposed to just citing the paper. I found the results much more convincing after reading Avecilla 2022, but I imagine many readers may skip that.

      We added a sentence to state that the nnSBI method was experimentally validated in Avecilla et 2022 at line 249.

      Reviewer #2 (Recommendations For The Authors):

      (1) Figure 2: says reported CNV proportions (dashed). This may be a typo since I think the GFP reported should be solid, not dashed. Also, (C) isn't bold.

      Thank you for identifying these mistakes. We have corrected the figure’s caption in line 1157.

      (2) "compared to 898/345 clones" Does this refer to transposition/clone? Seems more natural to compare clones with transpositions to a total number of clones. This could be clarified.

      We rephrased the sentence (lines 519-520) to clarify that in their study Hays et al. 2023 found 898 novel Ty insertions across 345 nitrogen-evolved clones. As a result of this high rate of transposition, some clones are expected to have multiple Ty insertions.

      (3) The methods state that Kan replaces the Nat cassette that was used to make the deletions. It should be made more clear whether Kan is present and where Kan is with respect to GFP and GAP1.

      Thank you for pointing this out. To clarify we added the following sentence to the methods starting in line 567:

      “The CNV reporter is 3.1 kb and located 1117 nucleotides upstream of the GAP1 coding sequence. It consists of, in the following order, an ACT1 promoter, mCitrine (GFP) coding sequence, ADH1 terminator, and kanamycin cassette under control of a TEF promoter and terminator.”

      Additionally in line 571 we clarify the drug resistance of the genomic architecture ∆ strains that are kanamycin(+) and nourseothricin(-).

      Reviewer #3 (Recommendations For The Authors):

      (1) The major advancement of the manuscript is stated in the title "DNA replication errors are a major source of adaptive gene amplification" First, in my humble opinion the term replication errors is not quite right; the term template switching is more accurate. In that regard, recently a paper was published just on this topic (Martin et al Plos Genetics, 2024).

      We have changed the title to “Template-switching during DNA replication is a prevalent source of adaptive gene amplification”. We cite Martin et al Plos Genetics 2024 throughout the main text in lines 93, 126, 159, 502, 555.

      (2) I find the statement "We find that 49% of all GAP1 CNVs are mediated by the DNA replication-based mechanism Origin Dependent Inverted Repeat Amplification (ODIRA) regardless of background strain." Somewhat misleading, there were considerable differences between the strains. If I am not mistaken the range was 20-80%.

      Thank you for pointing this out. Indeed, the range was 26-80% across the four strains. We updated this sentence in the abstract at line 40, and in the main text at line 141 to clearly state the range.

      (3) In their attempt to fill the gap of knowledge regarding the fitness effect of the adaptive CNV the authors use a mathematical model. As an experimental biologist, I found the description lacking. It is hard for me to evaluate the contribution of the model to understanding the results and I think the authors could improve this part.

      We have edited the text regarding the modeling and associated results and hope that it is now more clear. The mathematical model describes the experiment in a simplified manner. We use it to predict the outcomes of additional experiments without additional experimental work. For example, we used it to simulate a competition between two strains, predict the total proportion of GAP1 CNVs, and predict the relative genetic diversity.

      (4) Experiments the authors may want to consider to increase the novelty of their work:

      a) Place the GAP1 gene right in the middle of the two most distant ARS elements and test the mechanism of CNV.

      Thank you for this proposed experiment. It is beyond the scope of this paper and will be pursued in future studies.

      b) The finding of de-novo Ty element insertion is interesting. What happens if the overdose strain of Jef Boeke is used (Retrotransposon overdose and genome integrity, PNAS 2009) or in contrast, a reverse transcriptase deficient strain?

      We agree. Our study has revealed a critical role for novel Ty insertion in mediating CNVs. The suggested experiments as well as using strains that lack Ty sequences will be very interesting to explore in followup studies.

      c) The genomic analyses were based on single colony isolates. To my understanding, the CNV events are identified at least partly by split reads. Therefore, each event may have a "signature" that is unique and can be concluded from single reads and not necessarily from the assembled genome. If true, a distinction between the scenarios could be achieved if bulk cultures are sequenced with enough depth. Thus, a truly dynamic and quantitative determination of the different events, rate of appearance, and disappearance can be made.

      Thank you for this suggestion, which is a good idea but not currently feasible for several reasons. First, although split reads are a powerful way to detect CNV breakpoints, we have found that even at high coverage (21-153X, median 78.5X), in clonal samples that are rare with only 3-30 split reads (median 14) detected. These observations are from a total of 23 breakpoints across 16 sequenced clones. Thus, when sequencing heterogeneous cultures, in which different CNVs only comprise a fraction of the population, our ability to detect single CNV alleles by split reads and quantify their frequency is limited. Given our observations, with a median of 14 split reads when sequencing to 78.5X genome-wide read coverage it is possible we may be able to detect an individual CNV allele once it makes up (14/78.5) 17% of the population. However, our previous study has shown that there are tens to hundreds of unique CNV alleles initially and thus this would only be feasible at very late timepoints. Second, recurrent CNVs may occur independently at the same exact location, such as LTR NAHR. Thus, unique signatures may not be obtained even if they are independent events. Third, it would be not appropriate to pursue this analysis with our current dataset, as we lack lineage tracking barcodes to validate the results.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      The authors sometimes seem to equivocate on to what extent they view their model as a neural (as opposed to merely behavioral) description. For example, they introduce their paper by citing work that views heterogeneity in strategy as the result of "relatively independent, separable circuits that are conceptualized as supporting distinct strategies, each potentially competing for control." The HMM, of course, also relates to internal states of the animal. Therefore, the reader might come away with the impression that the MoA-HMM is literally trying to model dynamic, competing controllers in the brain (e.g. basal ganglia vs. frontal cortex), as opposed to giving a descriptive account of their emergent behavior. If the former is really the intended interpretation, the authors should say more about how they think the weighting/arbitration mechanism between alternative strategies is implemented, and how it can be modulated over time. If not, they should make this clearer.

      The MoA-HMM is meant to be descriptive in identifying behaviorally distinct strategies. Our intention in connecting it with a “mixture-of-strategies” view of the brain is that the results of the MoA-HMM could be indicative of an underlying arbitration process, but not modeling that process per se, that can be used to test neural hypotheses driven by this idea. We’ve added additional clarification in the discussion to highlight this point.

      Explicitly, we added the following sentence in the discussion: “For example, while the MoA-HMM itself is a descriptive model of behavior and is not explicitly modeling an underlying arbitration of controllers in the brain, the resulting behavioral states may be indicative of underlying neural processes and help identify times when different neural controllers are prevailing”

      Second, while the authors demonstrate that model recovery recapitulates the weight dynamics and action values (Fig. 3), the actual parameters that are recovered are less precise (Fig. 3 Supplement 1). The authors should comment on how this might affect their later inferences from behavioral data. Furthermore, it would be better to quantify using the R^2 score between simulated and recovered, rather than the Pearson correlation (r), which doesn't enforce unity slope and zero intercept (i.e. the line that is plotted), and so will tend to exaggerate the strength of parameter recovery.

      In the methods section, we noted that the interaction between parameters can cause the recovery of randomly drawn parameter sets to fail, as seen in Figure 3 Supplement 1. This is because there are parameter regimes (specifically when a softmax temperature is near zero) which causes choices to be random, and therefore other parameters no longer matter. To address this, we included a second supplemental figure, Figure 3 Supplement 2, where we recovered model parameters from data simulated solely from models inferred from the behavioral data. Recovery of these models is much more precise, which credits our later inferences from the behavioral data.

      To make this point clearer, we changed the reference to Figure 3 Supplements 1 & 2 to: “(Figure 3 – figure supplement 1 for recovery of randomized parameters with noted limitations, and figure supplement 2 for recovery of models fit to real data)” We additionally added the following to the Figure 3 Supplement 1 caption: “Due to the interaction between different model parameters (e.g. a small 𝛽 weight will affect the recoverability of the agent’s learning rate 𝛼), a number of “failures” can be seen.”

      Furthermore, we added an R^2 score that enforces unity slope and zero intercept alongside the Pearson correlation coefficient for more comprehensive metrics of recovery. The R^2 scores are plotted on both Figure 3 Supplements 1 & 2 as “R2”, and the following text was added in both captions: “"r" is the Pearson's correlation coefficient between the simulated and recovered parameters, and "R2" is the coefficient of determination, R2, calculating how well the simulated parameters predict the recovered parameters.”

      Finally, the authors are very aware of the difficulties associated with long-timescale (minutes) correlations with neural activity, including both satiety and electrode drift, so they do attempt to control for this using a third-order polynomial as a time regressor as well as interaction terms (Fig. 7 Supplement 1). However, on net there does not appear to be any significant difference between the permutation-corrected CPDs computed for states 2 and 3 across all neurons (Fig. 7D). This stands in contrast to the claim that "the modulation of the reward effect can also be seen between states 2 and 3 - state 2, on average, sees a higher modulation to reward that lasts significantly longer than modulation in state 3," which might be true for the neuron in Fig. 7C, but is never quantified. Thus, while I am convinced state modulation exists for model-based (MBr) outcome value (Fig. 7A-B), I'm not convinced that these more gradual shifts can be isolated by the MoA-HMM model, which is important to keep in mind for anyone looking to apply this model to their own data.

      We agree with the reviewers that our initial test of CPD significance was not sufficient to support the claims we made about state differences, especially for Figure 7D. To address this, we updated the significance test and indicators in Figure 7B,D to instead signify when there is a significant difference between state CPDs. This updated test supports a small, but significant difference in early post-outcome reward modulation between states 2 and 3.

      We clarified and updated the significance test in the methods with the following text:

      “A CPD (for a particular predictor in a particular state in a particular time bin) was considered significant if that CPD computed using the true dataset was greater than 95% of corresponding CPDs (same predictor, same state, same time bin) computed using these permuted sessions. For display, we subtract the average permuted session CPD from the true CPD in order to allow meaningful comparison to 0.

      To test whether neural coding of a particular predictor in a particular time bin significantly differed according to HMM state, we used a similar test. For each CPD that was significant according to the above test, we computed the difference between that CPD and the CPD for the same predictor and time bin in the other HMM states. We compare this difference to the corresponding differences in the circularly permuted sessions (same predictor, time bin, and pair of HMM states). We consider this difference to be significant if the difference in the true dataset is greater than 95% of the CPD differences computed from the permuted sessions.”

      We updated the significance indicators above the panels in Figure 7B,D (colored points) to refer to significant differences between states, with additional text to the left of each row of points to specify the tested state and which states it is significantly greater than. We updated the figure caption for both B and D to reflect these changes.

      We also changed text in the results to focus on significant differences between states. Specifically, we replaced the sentence “Looking at the CPD of expected outcome value split by state (Figure 7B) reveals that the trend from the example neuron is consistent across the population of OFC units, where state 2 shows the greatest CPD.” with the sentence “Looking at the CPD of expected outcome value split by state (Figure 7B) reveals that the trend from the example neuron is consistent across the population of OFC units, where state 2 has a significantly greater CPD than states 1 and 3.”

      We also replaced the sentence “Suggestively, the modulation of the reward effect can also be seen between states 2 and 3 – state 2, on average, sees a higher modulation to reward that lasts significantly longer than modulation in state 3.” with the sentence “Additionally, the modulation of the reward effect can also be seen between states 2 and 3 — immediately after outcome, we see a small but significantly higher modulation to reward during state 2 than during state 3.”

      Reviewer #2 (Public Review):

      There were a lot of typos and some figures were mis-referenced in the text and figure legends.

      We apologize for the numerous typos and errors in the text and are grateful for the assistance in identifying many of them. We have taken another thorough pass through the manuscript to address those identified by the reviewer as well as fix additional errors. To reduce redundancy, we’ll address all typoand error-related suggestions from both reviewers here.

      ● We fixed all Figure 1 references. We additionally reversed the introduction order of the agents in Figure 1 and in the results section “Reinforcement learning in the rat two-step task”, where we introduce both model-free agents before both model-based agents. This is to make the model-based choice agent description (which references the model-free choice agent in the statement “That is, like MFc, this agent tends to repeat or switch choices regardless of reward”) come after introducing the model-free choice agent.

      ● We fixed all Figure 4 references.

      ● We fixed all Figure 6 references and fixed the panel references in the figure caption to match the figure labeling: Starting with panel B, the reference to (i) was removed, and the reference to (ii) was updated to C. The previous reference to C was updated to D.

      ● All line-numbered suggestions were addressed.

      ● The text “(move to supplement?)” was removed from the methods heading, and the mistaken reference to Q_MBr was fixed.

      ● We removed all “SR” acronyms from the statistics as it was an artifact from an earlier draft.

      ● We homogenized notation in Figure 2, replacing all “c” variable references with “y”, as well as homogenized notation of β

      ● We replaced many uses of the word “action” with the word “choice” for consistency throughout the manuscript.

      ● We addressed many additional minor errors

      Reviewer #1 (Recommendations For The Authors):

      (1) Could the authors comment on why the cross-validated accuracy continues to increase, albeit non-significantly, after four states, as opposed to decreasing (as I would naively expect would be the result due to overfitting)?

      Due to the large amounts of trials and sessions obtained from each rat (often >100 sessions with >200 trials per session) and the limited number of training iterations (capped at 300 iterations), it is not guaranteed that the cross-validated accuracy would decrease over the range of states we included in Figure 4, especially given that the number of total parameters in the largest model shown (7-states, 95 parameters) is greatly less than the number of observations. Since we’re mainly interested in using this tool to identify interpretable, consistent structure across animals, we did not focus on interpreting the regime of larger models.

      (2) It seems like the model was refit multiple times with different priors ("Estimation of Population Prior"), each derived from the previous step of fitting. I'm not very familiar with fitting these kinds of models. Is this standard practice? It gives off the feeling of double-dipping. It would be helpful if the authors could cite some relevant literature here or further justify their choices.

      We adopted a “one-step” hierarchical approach, where we estimate the population prior a single time on (nearly) unconstrained model fits, and use it for a second, final round of model fits which were used for analysis. Since the prior is only estimated once, in practice there isn’t risk of converging on an overly constrained prior. This is a somewhat simplified approach motivated by analogy to the first step of EM fit in a hierarchical model, in which population- and subject-level parameters are iteratively re-estimated in terms of one another until convergence (Huys et al., 2012; Daw 2010). We have clarified this approach in the methods with citations by adding the following paragraph:

      “Hierarchical modeling gives a better estimate of how model parameters can vary within a population by additionally inferring the population distribution over which individuals are likely drawn (Daw, 2011). This type of modeling, however, is notoriously difficult in HMMs; therefore, as a compromise, we adopt a “one-step” hierarchical model, where we estimate population parameters from “unconstrained” fits on the data, which are then used as a prior to regularize the final model fits. This approach is motivated by analogy to the first step of EM fit in a hierarchical model, in which population- and subject-level parameters are iteratively re-estimated in terms of one another until convergence (Daw, 2011; Huys et al., 2012). It is important to emphasize, since we aren’t inferring the population distributions directly, that we only estimate the population prior a single time on the “unconstrained” fits as follows.”

      Reviewer #2 (Recommendations For The Authors):

      Figure 3a.iii: Did the model capture the transition probabilities correctly as well?

      We have updated Figure 3E to include additional panels (iii) and (iv) to show the recovered initial state probabilities and transition matrix.

      For Figure 6, panel B makes it look like there is a larger influence of state on ITI rate after omission, in both the top and bottom plots. However, the violin plots in panel C show a different pattern, where state has a greater effect on ITIs following rewarded trials. Is it that the example in panel B is not representative of the population, or am I misinterpreting?

      We thank the reviewer for catching this issue, as the colors were erroneously flipped in panel C. We have fixed this figure by ensuring that the colors appropriately matched the trial type (reward or omission). Additionally, we updated the colors in B and C that correspond to reward (previously gray, now blue) and omission (previously gold, now red) trials to match the color scheme used in Figure 1. We also inverted the corresponding line styles (reward changed to solid, omission changed to dashed) to match the convention used in Figure 7. To differentiate from the reward/omission color changed, we additionally changed the colors in Figure 6D and Figure 7 Supplement 1, where the color for “time” was changed from blue to gray, and the color for “state” was changed from red to gold.

      For figure 4B right, I am confused. The legend says that this is the change in model performance relative to a model with one fewer state. But the y-axis says it's the change from the single-state model. Please clarify.

      The plot is showing the increase in performance from the single-state model, while the significance tests were done between consecutive numbered states. We updated the significance indicators on the plot to more clearly identify that adjacent models are being compared (with the exception of the 2-state model, which is being compared to 0). We updated the Figure 4B caption text for the left panel to state: “Change in normalized, cross-validated likelihood when adding additional hidden states into the MoA-HMM, relative to the single-state model. Significant changes are computed with respect to models with one fewer states (e.g. 2-state vs 1-state, 3-state vs 2-state)”

    1. Author response:

      Thank you for reviewing our manuscript and providing constructive feedback. We are grateful that you recognize the importance of our work and find the evidences presented compelling. We will revise our manuscripts in accordance with reviewers’ recommendations. Below is our plan.

      (1) As recommended by Reviewer 1, we will improve the image resolution and presentation in the figures, by adjusting dark colors into brighter ones, including single-channel images, and incorporating schematic illustrations to dipict morphological changes.

      (2) Following the suggestions of reviewer 2, we will provide explanations and speculative insights into potential non-tissue autonomous effects.

      (3) As suggested by reviewer 2, we will perform principal component analyses on our RNA-seq and Cut&Tag data. 

      (2) Once we have addressed all the major and minor points raised by the reviewers, we will provide a detailed point-to-point response and submit the revised version of the manuscript.

    1. Author response:

      Responses to Editors:

      We appreciate Reviewer 1’s first concern regarding the difficulty of disentangling the contributions of tightly-coupled brain regions to the speech-gesture integration process—particularly due to the close temporal and spatial proximity of the stimulation windows and the potential for prolonged disruption. We would like to provide clarification and evidence supporting the validity of our methodology.

      Our previous study (Zhao et al., 2021, J. Neurosci) employed the same experimental protocol—using inhibitory double-pulse transcranial magnetic stimulation (TMS) over the inferior frontal gyrus (IFG) and posterior middle temporal gyrus (pMTG) in one of eight 40-ms time windows. The findings from that study demonstrated a time-window-selective disruption of the semantic congruency effect (i.e., reaction time costs driven by semantic conflict), with no significant modulation of the gender congruency effect (i.e., reaction time costs due to gender conflict). This result establishes that double-pulse TMS provides sufficient temporal precision to independently target the left IFG and pMTG within these 40-ms windows during gesture-speech integration. Importantly, by comparing the distinctively inhibited time windows for IFG and pMTG, we offered clear evidence of distinct engagement and temporal dynamics between these regions during different stages of gesture-speech semantic processing.

      Furthermore, we reviewed prior studies utilizing double-pulse TMS on structurally and functionally connected brain regions to explore neural contributions across timescales as brief as 3–60 ms. These studies, which encompass areas from the tongue and lip areas of the primary motor cortex (M1) to high-level semantic regions such as the pMTG and ATL (Author response table 1), consistently demonstrate the methodological rigor and precision of double-pulse TMS in disentangling the neural dynamics of different regions within these short temporal windows.

      Author response table 1.

      Double-pulse TMS studies on brain regions over 3-60 ms time interval

      Response to Reviewer #1:

      (1) For concern on the difficulty of disentangling the contributions of tightly-coupled brain regions to the speech-gesture integration process:

      We trust that the explanation provided above has clarified this issue.

      (2) For concern on the rationale for delivering HD-tDCS/TMS in set time windows for each region, as well as how these time windows were determined and how the current results compare to our previous studies from 2018 and 2023:

      The current study builds on a series of investigations that systematically examined the temporal and spatial dynamics of gesture-speech integration. In our earlier work (Zhao et al., 2018, J. Neurosci), we demonstrated that interrupting neural activity in the IFG or pMTG using TMS selectively disrupted the semantic congruency effect (reaction time costs due to semantic incongruence), without affecting the gender congruency effect (reaction time costs due to gender incongruence). These findings identified the IFG and pMTG as critical hubs for gesture-speech integration. This informed the brain regions selected for subsequent studies.

      In Zhao et al. (2021, J. Neurosci), we employed a double-pulse TMS protocol, delivering stimulation within one of eight 40-ms time windows, to further examine the temporal involvement of the IFG and pMTG. The results revealed time-window-selective disruptions of the semantic congruency effect, confirming the dynamic and temporally staged roles of these regions during gesture-speech integration.

      In Zhao et al. (2023, Frontiers in Psychology), we investigated the semantic predictive role of gestures relative to speech by comparing two experimental conditions: (1) gestures preceding speech by a fixed interval of 200 ms, and (2) gestures preceding speech at its semantic identification point. We observed time-window-selective disruptions of the semantic congruency effect in the IFG and pMTG only in the second condition, leading to the conclusion that gestures exert a semantic priming effect on co-occurring speech. These findings underscored the semantic advantage of gesture in facilitating speech integration, further refining our understanding of the temporal and functional interplay between these modalities.

      The design of the current study—including the choice of brain regions and time windows—was directly informed by these prior findings. Experiment 1 (HD-tDCS) targeted the entire gesture-speech integration process in the IFG and pMTG to assess whether neural activity in these regions, previously identified as integration hubs, is modulated by changes in informativeness from both modalities (i.e., entropy) and their interactions (mutual information, MI). The results revealed a gradual inhibition of neural activity in both areas as MI increased, evidenced by a negative correlation between MI and the tDCS inhibition effect in both regions. Building on this, Experiments 2 and 3 employed double-pulse TMS and event-related potentials (ERPs) to further assess whether the engaged neural activity was both time-sensitive and staged. These experiments also evaluated the contributions of various sources of information, revealing correlations between information-theoretic metrics and time-locked brain activity, providing insights into the ‘gradual’ nature of gesture-speech integration.

      We acknowledge that the rationale for the design of the current study was not fully articulated in the original manuscript. In the revised version, we will provide a more comprehensive and coherent explanation of the logic behind the three experiments, ensuring clear alignment with our previous findings.

      (3) For concern about the use of Pearson correlation and the normality of EEG data.

      We appreciate the reviewer’s thoughtful consideration. In Figure 5 of the manuscript, we have already included normal distribution curves that illustrate the relationships between the average ERP amplitudes within each ROI or elicited clusters and the three information models. Additionally, multiple comparisons were addressed using FDR correction, as outlined in the manuscript.

      To further clarify the data, we will calculate the Shapiro-Wilk test, a widely accepted method for assessing bivariate normality, for both the MI/entropy and averaged ERP data. The corresponding p-values will be provided in the following-up point-to-point responses.

      (4) For concern about the ROI selection, and the suggestion of using whole-brain electrodes to build models of different variables (MI/entropy) to predict neural responses:

      For the EEG data, we conducted both a traditional region-of-interest (ROI) analysis, with ROIs defined based on a well-established work (Habets et al., 2011), and a cluster-based permutation approach, which utilizes data-driven permutations to enhance robustness and address multiple comparisons. The latter method complements the hypothesis-driven ROI analysis by offering an exploratory, unbiased perspective. Notably, the results from both approaches were consistent, reinforcing the reliability of our findings.

      To make the methods more accessible to a broader audience, we will provide a clear description of the methods used and how they relate to each other in the revised manuscript.

      Reference:

      Habets, B., Kita, S., Shao, Z.S., Ozyurek, A., and Hagoort, P. (2011). The Role of Synchrony and Ambiguity in Speech-Gesture Integration during Comprehension. J Cognitive Neurosci 23, 1845-1854. 10.1162/jocn.2010.21462

      (5) For concern about the median split of the data:

      To identify ERP components or spatiotemporal clusters that demonstrated significant semantic differences, we split each model into higher and lower halves, focusing on indexing information changes reflected by entropy or mutual information (MI). To illustrate the gradual activation process, the identified components and clusters were further analyzed for correlations with each information matrix. Remarkably, consistent results were observed between the ERP components and clusters, providing robust evidence that semantic information conveyed through gestures and speech significantly influenced the amplitude of these components or clusters. Moreover, the semantic information was shown to be highly sensitive, varying in tandem with these amplitude changes.

      We acknowledge that the rationale behind this approach may not have been sufficiently clear in the initial manuscript. In our revision, we will ensure a more detailed and precise explanation to enhance the clarity and coherence of this logical framework.

      Response to Reviewer #2:

      We greatly appreciate Reviewer2 ’s concern regarding whether "mutual information" adequately captures the interplay between the meanings of speech and gesture. We would like to clarify that the materials used in the present study involved gestures performed without actual objects, paired with verbs that precisely describe the corresponding actions. For example, a hammering gesture was paired with the verb “hammer”, and a cutting gesture was paired with the verb “cut”. In this design, all gestures conveyed redundant meaning relative to the co-occurring speech, creating significant overlap between the information derived from speech alone and that from gesture alone.

      We understand the reviewer’s concern about cases where gestures and speech may provide complementary rather than redundant information. To address this, we have developed an alternative metric for quantifying information gains contributed by supplementary multisensory cues, which will be explored in a subsequent study. However, for the present study, we believe that the observed overlap in information serves as an indicator of the degree of multisensory convergence, a central focus of our investigation.

      Regarding the reviewer’s concern about how the neural processes of speech-gesture integration may change with variations in the relative timing between speech and gesture stimuli, we would like to highlight findings from our previous study (Zhao, 2023, Frontiers in Psychology). In that study, we explored the semantic predictive role of gestures relative to speech under two conditions: (1) gestures preceding speech by a fixed interval of 200 ms, and (2) gestures preceding speech of its semantic identification point. Interestingly, only in the second condition did we observe time-window-selective disruptions of the semantic congruency effect in the IFG and pMTG. This led us to conclude that gestures play a semantic priming role for co-occurring speech. Building on this, we designed the present study with gestures preceding speech of its semantic identification point to reflect this semantic priming relationship. Additionally, ongoing research is exploring gesture and speech interactions in natural conversational settings to investigate whether the neural processes identified here are consistent across varying contexts.

      To prevent any similar concerns from causing doubt among the audience and to ensure clarity regarding the follow-up study, we will provide a detailed discussion of the two issues in the revised manuscript.

      Response to Reviewer #3:

      The primary aim of this study is to investigate whether the degree of activity in the established integration hubs, IFG and pMTG, is influenced by the information provided by gesture-speech modalities and/or their interactions. While we provided evidence for the differential involvement of the IFG and pMTG by delineating their dynamic engagement across distinct time windows of gesture-speech integration and associating these patterns with unisensory information and their interaction, we acknowledge that the mechanisms underlying these dynamics remain open to interpretation. Specifically, whether the observed effects stem from difficulties in semantic control processes, as suggested by Reviewer 3, or from resolving information uncertainty, as quantified by entropy, falls outside the scope of the current study. Importantly, we view these two interpretations as complementary rather than mutually exclusive, as both may be contributing factors. Nonetheless, we agree that addressing this question is a compelling avenue for future research. In the revised manuscript, we will include an exploratory analysis to investigate whether the confounding difficulty, stemming from the number of lexical or semantic representations, is limited to high-entropy items. Additionally, we will address and discuss alternative interpretations.

      Regarding the concern of conceptual equivocation, we would like to emphasize that this study represents the first attempt to focus on the relationship between information quantity and neural engagement. In our initial presentation, we inadvertently conflated the commonly used term "graded hub," which refers to anatomical distribution, with its usage in the present context. We sincerely apologize for this oversight and are grateful for the reviewer’s careful critique. In the revised manuscript, we will clearly articulate the study’s objectives, clarify the representations of entropy and mutual information, and accurately describe their association with neural engagement.

      Reference

      Teige, C., Mollo, G., Millman, R., Savill, N., Smallwood, J., Cornelissen, P. L., & Jefferies, E. (2018). Dynamic semantic cognition: Characterising coherent and controlled conceptual retrieval through time using magnetoencephalography and chronometric transcranial magnetic stimulation. Cortex, 103, 329-349.

      Amemiya, T., Beck, B., Walsh, V., Gomi, H., & Haggard, P. (2017). Visual area V5/hMT+ contributes to perception of tactile motion direction: a TMS study. Scientific reports, 7(1), 40937.

      Muessgens, D., Thirugnanasambandam, N., Shitara, H., Popa, T., & Hallett, M. (2016). Dissociable roles of preSMA in motor sequence chunking and hand switching—a TMS study. Journal of Neurophysiology, 116(6), 2637-2646.

      Vernet, M., Brem, A. K., Farzan, F., & Pascual-Leone, A. (2015). Synchronous and opposite roles of the parietal and prefrontal cortices in bistable perception: a double-coil TMS–EEG study. Cortex, 64, 78-88.

      Pitcher, D. (2014). Facial expression recognition takes longer in the posterior superior temporal sulcus than in the occipital face area. Journal of Neuroscience, 34(27), 9173-9177.

      Bardi, L., Kanai, R., Mapelli, D., & Walsh, V. (2012). TMS of the FEF interferes with spatial conflict. Journal of cognitive neuroscience, 24(6), 1305-1313.

      D’Ausilio, A., Bufalari, I., Salmas, P., & Fadiga, L. (2012). The role of the motor system in discriminating normal and degraded speech sounds. Cortex, 48(7), 882-887.

      Pitcher, D., Duchaine, B., Walsh, V., & Kanwisher, N. (2010). TMS evidence for feedforward and feedback mechanisms of face and body perception. Journal of Vision, 10(7), 671-671.

      Gagnon, G., Blanchet, S., Grondin, S., & Schneider, C. (2010). Paired-pulse transcranial magnetic stimulation over the dorsolateral prefrontal cortex interferes with episodic encoding and retrieval for both verbal and non-verbal materials. Brain Research, 1344, 148-158.

      Kalla, R., Muggleton, N. G., Juan, C. H., Cowey, A., & Walsh, V. (2008). The timing of the involvement of the frontal eye fields and posterior parietal cortex in visual search. Neuroreport, 19(10), 1067-1071.

      Pitcher, D., Garrido, L., Walsh, V., & Duchaine, B. C. (2008). Transcranial magnetic stimulation disrupts the perception and embodiment of facial expressions. Journal of Neuroscience, 28(36), 8929-8933.

    1. Author response:

      We would like to express our sincere gratitude to both of you, and the reviewers, for the time and effort you have invested in reviewing our manuscript. We greatly appreciate the constructive feedback provided and are committed to addressing the suggested revisions.

      In response to the public reviews, we would like to outline the following plan of action:

      (1) Addressing Weaknesses in the Manuscript: We have carefully considered the comments regarding the weaknesses identified in the manuscript. Specifically, we will:

      - Provide further clarification on the mechanism of IVM resistance in our study.

      - Expand our discussion of the limitations and future directions of the research, addressing the concerns related to the potential translation of our findings to parasitic nematodes.

      (2) Additional Experiments: We are currently conducting additional experiments to address the reviewers' suggestions, which include:

      - Testing whether the overexpression of a relevant GluCl, such as AVR-15, can restore Ivermectin sensitivity in ubr-1 mutants.

      - Examining the impact of Ceftriaxone treatment on the Ivermectin resistance in worms lacking key GluCls, such as avr-15, avr-14, and glc-1.

      - Incorporating an analysis of major human parasitic nematodes in the phylogeny and discussing the conservation of relevant mechanisms across species.

      - Double-checking the Dye filling (Dyf) phenotype in ubr-1 mutants, as suggested.

      (3) Point-by-Point response: We will respond to both sets of comments (public reviews and editorial recommendations) in a comprehensive point-by-point manner in the revised manuscript.

      (4) Timely Revisions: We aim to complete all revisions within a single round, ensuring that we address all comments thoroughly while maintaining the integrity of the data.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      IPF is a disease lacking regressive therapies which has a poor prognosis, and so new therapies are needed. This ambitious phase 1 study builds on the authors' 2024 experience in Sci Tran Med with positive results with autologous transplantation of P63 progenitor cells in patients with COPD. The current study suggests that P63+ progenitor cell therapy is safe in patients with ILD. The authors attribute this to the acquisition of cells from a healthy upper lobe site, removed from the lung fibrosis. There are currently no cell-based therapies for ILD and in this regard the study is novel with important potential for clinical impact if validated in Phase 2 and 3 clinical trials.

      Strengths:

      This study addresses the need for an effective therapy for interstitial lung disease. It offers good evidence that the cells used for therapy are safe. In so doing it addresses a concern that some P63+ progenitor cells may be proinflammatory and harmful, as has been raised in the literature (articles which suggested some P63+ cells can promote honeycombing fibrosis; references 26 &35). The authors attribute the safety they observed (without proof) to the high HOPX expression of administered cells (a marker found in normal Type 1 AECs. The totality of the RNASeq suggests the cloned cells are not fibrogenic. They also offer exploratory data suggesting a relationship between clone roundness and PFT parameters (and a negative association between patient age and clone roundness).

      We thank the reviewer for the important comments.

      Weaknesses:

      The authors can conclude they can isolate, clone, expand, and administer P63+ progenitor cells safely; but with the small sample size and lack of a placebo group, no efficacy should be implied.

      We thank the reviewer for the suggestion and agree that we should be more cautious to discuss the efficacy of current study.

      Specific points:

      (1) The authors acknowledge most study weaknesses including the lack of a placebo group and the concurrent COVID-19 in half the subjects (the high-dose subjects). They indicate a phase 2 trial is underway to address these issues.

      N/A

      (2) The authors suggest an efficacy signal on pages 18 (improvement in 2 subjects' CT scans) and 21 (improvement in DLCO) but with such a small phase 1 study and such small increases in DLCO (+5.4%) the authors should refrain from this temptation (understandable as it is).

      We believe that exploring potential efficacy signal is also one important aim of this study in addition to safety evaluation. All these efficacy endpoint analyses had been planned in prior to the start of clinical trials (as registered in ClinicalTrial.gov) and the results anyhow need be analyzed and reported in the manuscript. And we will cautiously discuss the significance of the efficacy signal and avoid over-interpretation.

      (3) Likewise most CT scans were unchanged and those that improved were in the mid-dose group (albeit DLCO improved in the 2 patients whose CT scans improved).

      Yes, it is.

      (4) The authors note an impressive 58m increase in 6MWTD in the high-dose group but again there is no placebo group, and the low-dose group has no net change in 6MWTD at 24 weeks.

      Yes.

      (5) I also raise the question of the enrollment criteria in which 5 patients had essentially normal DLCO/VA values. In addition there is no discussion as to whether the transplanted stem cells are retained or exert benefit by a paracrine mechanism (which is the norm for cell-based therapies).

      Thank you for your detailed feedback.  The enrollment criteria are based on DLCO instead of DLCO/VA. And we would like to further discuss the possible benefit by paracrine mechanism in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      This manuscript describes a first-in-human clinical trial of autologous stem cells to address IPF. The significance of this study is underscored by the limited efficacy of standard-of-care anti-fibrotic therapies and increasing knowledge of the role p63+ stem cells in lung regeneration in ARDS. While models of acute lung injury and p63+ stem cells have benefited from widespread and dynamic DAD and immune cell remodeling of damaged tissue, a key question in chronic lung disease is whether such cells could contribute to the remodeling of lung tissue that may be devoid of acute and dynamic injury. A second question is whether normal regions of the lung in an otherwise diseased organ can be identified as a source of "normal" p63+ stem cells, and how to assess these stem cells given recently identified p63+ stem cell variants emerging in chronic lung diseases including IPF. Lastly, questions of feasibility, safety, and efficacy need to be explored to set the foundation for autologous transplants to meet the huge need in chronic lung disease. The authors have addressed each of these questions to different extents in this initial study, which has yielded important if incomplete information for many of them.

      Strengths:

      As with a previous study from this group regarding autologous stem cell transplants for COPD (Ref. 24), they have shown that the stem cells they propagate do not form colonies in soft agar or cancers in these patients. While a full assessment of adverse events was confounded by a wave of Covid19 infections in the study participants, aside from brief fevers it appears these transplants are tolerated by these patients.

      We thank the reviewer for the important comments.

      Weaknesses:

      The source of stem cells for these autologous transplants is generally bronchoscopic biopsies/brushings from 5th-generation bronchi. Although stem cells have been cloned and characterized from nasal, tracheal, and distal airway biopsies, the systematic cloning and analysis of p63+ stem cells across the bronchial generations is less clear. For instance, p63+ stem cells from the nasal and tracheal mucosa appear committed to upper airway epithelia marked by 90% ciliated cells and 10% goblet cells (Kumar et al., 2011. Ref. 14). In contrast, p63+ stem cells from distal lung differentiate to epithelia replete with Club, AT2, and AT1 markers. The spectrum of p63+ stem cells in the normal bronchi of any generation is less studied. In the present study, cells are obtained by bronchoscopy from 3-5 generation bronchi and expanded by in vitro propagation. Single-cell RNAseq identifies three clusters they refer to as C1, C2, and C3, with the major C1 cluster said to have characteristics of airway basal cells and C2 possibly the same cells in states of proliferation. Perhaps the most immediate question raised by these data is the nature of the C1/C2 cells. Whereas they are clearly p63/Krt5+ cells as are other stem cells of the airways, do they display differentiation character of "upper airway" marked by ciliated/goblet cell differentiation or those of the lung marked by AT2 and AT1 fates? This could be readily determined by 3-D differentiation in so-called air-liquid interface cultures pioneered by cystic fibrosis investigators and should be done as it would directly address the validity of the sourcing protocol for autologous cells for these transplants. This would more clearly link the present study with a previous study from the same investigators (Shi et al., 2019, Ref. 9) whereby distal airway stem cells mitigated fibrosis in the murine bleomycin model. The authors should also provide methods by which the autologous cells are propagated in vitro as these could impact the quality and fate of the progenitor cells prior to transplantation.

      We totally agree that the sub-population of the progenitor cells should be further analyzed. We would try this in the revised manuscript. And the methods to expand P63+ lung progenitor cells have been described in full details by Frank McKeon/Wa Xian group (Rao, et.al., STAR Protocols, 2020), which is adapted to pharmaceutical-grade technology patented by Regend Therapeutics, Ltd.

      The authors should also make a more concerted effort to compare Clusters 1, 2, and 3 with the variant stem cell identified in IPF (Wang et al., 2023, Ref. 27). While some of the markers are consistent with this variant stem cell population, others are not. A more detailed informatics analysis of normal stem cells of the airways and any variants reported could clarify whether the bronchial source of autologous stem cells is the best route to these transplants. 

      We thank for reviewer for the good suggestion and would like to make more detailed comparison in the revised manuscript.

      Other than these issues the authors should be commended for these first-in-human trials for this important condition.

      Thank you so much for the kind compliment.

    1. Author response:

      Public Review:

      In this work, the authors develop a new computational tool, DeepTX, for studying transcriptional bursting through the analysis of single-cell RNA sequencing (scRNA-seq) data using deep learning techniques. This tool aims to describe and predict the transcriptional bursting mechanism, including key model parameters and the steady-state distribution associated with the predicted parameters. By leveraging scRNA-seq data, DeepTX provides high-resolution transcriptional information at the single-cell level, despite the presence of noise that can cause gene expression variation. The authors apply DeepTX to DNA damage experiments, revealing distinct cellular responses based on transcriptional burst kinetics. Specifically, IdU treatment in mouse stem cells increases burst size, promoting differentiation, while 5FU affects burst frequency in human cancer cells, leading to apoptosis or, depending on the dose, to survival and potential drug resistance. These findings underscore the fundamental role of transcriptional burst regulation in cellular responses to DNA damage, including cell differentiation, apoptosis, and survival. Although the insights provided by this tool are mostly well supported by the authors' methods, certain aspects would benefit from further clarification.

      The strengths of this paper lie in its methodological advancements and potential broad applicability. By employing the DeepTXSolver neural network, the authors efficiently approximate stationary distributions of mRNA count through a mixture of negative binomial distributions, establishing a simple yet accurate mapping between the kinetic parameters of the mechanistic model and the resulting steady-state distributions. This innovative use of neural networks allows for efficient inference of kinetic parameters with DeepTXInferrer, reducing computational costs significantly for complex, multi-gene models. The approach advances parameter estimation for high-dimensional datasets, leveraging the power of deep learning to overcome the computational expense typically associated with stochastic mechanistic models. Beyond its current application to DNA damage responses, the tool can be adapted to explore transcriptional changes due to various biological factors, making it valuable to the systems biology, bioinformatics, and mechanistic modelling communities. Additionally, this work contributes to the integration of mechanistic modelling and -omics data, a vital area in achieving deeper insights into biological systems at the cellular and molecular levels.

      We thank the reviewers for their positive opinion on our manuscript. As reflected in our detailed responses to the reviewers’ comments, we will make significant changes to address their concerns comprehensively.

      This work also presents some weaknesses, particularly concerning specific technical aspects. The tool was validated using synthetic data, and while it can predict parameters and steady-state distributions that explain gene expression behaviour across many genes, it requires substantial data for training. The authors account for measurement noise in the parameter inference process, which is commendable, yet they do not specify the exact number of samples required to achieve reliable predictions. Moreover, the tool has limitations arising from assumptions made in its design, such as assuming that gene expression counts for the same cell type follow a consistent distribution. This assumption may not hold in cases where RNA measurement timing introduces variability in expression profiles.

      Thank you for your detailed and constructive feedback on our work. We will address the key concerns raised from the following points:

      (1) Clarification on the required sample size: We tested the robustness of our inference method on simulated datasets by varying the number of single-cell samples. Our results indicated that the predictions of burst kinetics parameters become accurate when the number of cells reaches 500 (Supplementary Figure S3d, e). This sample size is smaller than the data typically obtained with current single-cell RNA sequencing (scRNA-seq) technologies, such as 10x Genomics and Smart-seq3 (Zheng GX et al., 2017; Hagemann-Jensen M et al., 2020). Therefore, we believed that our algorithm is well-suited for inferring burst kinetics from existing scRNA-seq datasets, where the sample size is sufficient for reliable predictions. We will clarify this point in the main text to make it easier for readers to use the tool.

      (2) Assumption-related limitations: One of the fundamental assumptions in our study is that the expression counts of each gene are independently and identically distributed (i.i.d.) among cells, which is a commonly adopted assumption in many related works (Larsson AJM et al., 2019; Ochiai H et al., 2020; Luo S et al., 2023). However, we acknowledged the limitations of this assumption. The expression counts of the same gene in each cell may follow distinct distributions even from the same cell type, and dependencies between genes could exist in realistic biological processes. We recognized this and will deeply discuss these limitations from assumptions and prospect as an important direction for future research.

      The authors present a deep learning pipeline to predict the steady-state distribution, model parameters, and statistical measures solely from scRNA-seq data. Results across three datasets appear robust, indicating that the tool successfully identifies genes associated with expression variability and generates consistent distributions based on its parameters. However, it remains unclear whether these results are sufficient to fully characterize the transcriptional bursting parameter space. The parameters identified by the tool pertain only to the steady-state distribution of the observed data, without ensuring that this distribution specifically originates from transcriptional bursting dynamics.

      We appreciate your insightful comments and the opportunity to clarify our study’s contributions and limitations. Although we agree that assessing whether the results from these three realistic datasets can represent the characterize transcriptional burst parameter space is challenging, as it depends on data property and conditions in biology, we firmly believe that DeepTX has the capacity to characterize the full parameter space. This believes stems from the extensive parameters and samples we input during model training and inference across a sufficiently large parameter range (Method 1.3). Furthermore, the training of the model is both flexible and scalable, allowing for the expansion of the transcriptional burst parameter space as needed. We will clarify this in the text to enable readers to use DeepTX more flexibly.

      On the other hand, we agree that parameter identification is based on the steady-state distribution of the observed data (static data), which loses information about the fine dynamic process of the burst kinetics. In principle, tracking the gene expression of living cells can provide the most complete information about real-time transcriptional dynamics across various timescales (Rodriguez J et al., 2019). However, it is typically limited to only a small number of genes and cells, which could not investigate general principles of transcriptional burst kinetics on a genome-wide scale. Therefore, leveraging the both steady-state distribution of scRNA-seq data and mathematical dynamic modelling to infer genome-wide transcriptional bursting dynamics represents a critical and emerging frontier in this field. For example, the statistical inference framework based on the Markovian telegraph model, as demonstrated in (Larsson AJM et al., 2019), offers a valuable paradigm for understanding underlying transcriptional bursting mechanisms. Building on this, our study considered a more generalized non-Mordovian model that better captures transcriptional kinetics by employing deep learning method under conditions such as DNA damage. This provided a powerful framework for comparative analyses of how DNA damage induces alterations in transcriptional bursting kinetics across the genome. We will highlight the limitations of current inference using steady-state distributions in the text and look ahead to future research directions for inference using time series data across the genome.

      A primary concern with the TXmodel is its reliance on four independent parameters to describe gene state-switching dynamics. Although this general model can capture specific cases, such as the refractory and telegraph models, accurately estimating the parameters of the refractory model using only steady-state distributions and typical cell counts proves challenging in the absence of time-dependent data.

      We thank you for highlighting this critical concern regarding the TXmodel's reliance on four independent parameters to describe gene state-switching dynamics. We acknowledge that estimating the parameters of the TXmodel using only steady-state distributions and typical single-cell RNA sequencing (scRNA-seq) data poses significant challenges, particularly in the absence of time-resolved measurements.

      As described in the response of last point, while time-resolved data can provide richer information than static scRNA-seq data, it is currently limited to a small number of genes and cells, whereas static scRNA-seq data typically capture genome-wide expression. Our framework leverages deep learning methods to link mechanistic models with static scRNA-seq data, enabling the inference of genome-wide dynamic behaviors of genes. This provides a potential pathway for comparative analyses of transcriptional bursting kinetics across the entire genome.

      Nonetheless, the refractory model and telegraphic model are important models for studying transcription bursts. We will discuss and compare them in terms of the accuracy of inferred parameters. Certainly, we agree that inferring the molecular mechanisms underlying transcriptional burst kinetics using time-resolved data remains a critical future direction. We will include a brief discussion on the role and importance of time-resolved data in addressing these challenges in the discussion section of the revised manuscript.

      The claim that the GO analysis pertains specifically to DNA damage response signal transduction and cell cycle G2/M phase transition is not fully accurate. In reality, the GO analysis yielded stronger p-values for pathways related to the mitotic cell cycle checkpoint signalling. As presented, the GO analysis serves more as a preliminary starting point for further bioinformatics investigation that could substantiate these conclusions. Additionally, while GSEA analysis was performed following the GO analysis, the involvement of the cardiac muscle cell differentiation pathway remains unclear, as it was not among the GO terms identified in the initial GO analysis.

      We thank the reviewer for this valuable feedback and for pointing out the need for clarification regarding the GO and GSEA analyses. We agree that the connection between the cardiac muscle cell differentiation pathway identified in the GSEA analysis and the GO terms from the initial analysis requires further clarification. This discrepancy arises because GSEA examines broader sets of pathways and may capture biological processes not highlighted by GO analysis due to differences in the statistical methods and pathway definitions used. We will revise the manuscript to address this point, explicitly discussing the distinct yet complementary nature of GO and GSEA analyses and providing a clearer interpretation of the results.

      As the advancement is primarily methodological, it lacks a comprehensive comparison with traditional methods that serve similar functions. Consequently, the overall evaluation of the method, including aspects such as inference accuracy, computational efficiency, and memory cost, remains unclear. The paper would benefit from being contextualised alongside other computational tools aimed at integrating mechanistic modelling with single-cell RNA sequencing data. Additional context regarding the advantages of deep learning methods, the challenges of analysing large, high-dimensional datasets, and the complexities of parameter estimation for intricate models would strengthen the work.

      We greatly appreciate your insightful feedback, which highlights important considerations for evaluating and contextualizing our methodological advancements. Below, we emphasize our advantages from both the modeling perspective and the inference perspective compared with previous model. As our work is rooted in a model-based approach to describe the transcriptional bursting process underlying gene expression, the classic telegraph model (Markovian) and non-Markovian models which are commonly employed are suitable for this purpose:

      Classic telegraph model: The classic telegraph model allows for the derivation of approximate analytical solutions through numerical integration, enabling efficient parameter point estimation via maximum likelihood methods, e.g., as explored in (Larsson AJM et al., 2019). Although exact analytical solutions for the telegraph model are not available, certain moments of its distribution can be explicitly derived. This allows for an alternative approach to parameter inference using moment-based estimation methods, e.g., as explored in (Ochiai H et al., 2020). However, it is important to note that higher-order sample moments can be unstable, potentially leading to significant estimation bias.

      Non-Markovian Models: For non-Markovian models, analytical or approximate analytical solutions remain elusive. Previous work has employed pseudo-likelihood approaches, leveraging statistical properties of the model’s solutions to estimate parameters, e.g., as explored in (Luo S et al., 2023). However, the method may suffer from low inference efficiency.

      In our current work, we leverage deep learning to estimate parameters of TXmodel, which is non-Markovian model. First, we represent the model's solution as a mixture of negative binomial distributions, which is obtained by the deep learning method. Second, through integration with the deep learning architecture, the model parameters can be optimized using automatic differentiation, significantly improving inference efficiency. Furthermore, by employing a Bayesian framework, our method provides posterior distributions for the estimated dynamic parameters, offering a comprehensive characterization of uncertainty. Compared to traditional methods such as moment-based estimation or pseudo-likelihood approaches, we believe our approach not only achieves higher inference efficiency but also delivers posterior distributions for kinetics parameters, enhancing the interpretability and robustness of the results. We will present and emphasize the computational efficiency and memory cost of our methods the revised version.

      Reference

      Zheng, G.X., Terry, J.M., Belgrader, P., Ryvkin, P., Bent, Z.W., Wilson, R., Ziraldo, S.B., Wheeler, T.D., McDermott, G.P., Zhu, J., Gregory, M.T., Shuga, J., Montesclaros, L., Underwood, J.G., Masquelier, D.A., Nishimura, S.Y., Schnall-Levin, M., Wyatt, P.W., Hindson, C.M., Bharadwaj, R., Wong, A., Ness, K.D., Beppu, L.W., Deeg, H.J., McFarland, C., Loeb, K.R., Valente, W.J., Ericson, N.G., Stevens, E.A., Radich, J.P., Mikkelsen, T.S., Hindson, B.J., Bielas, J.H. 2017. Massively parallel digital transcriptional profiling of single cells. Nature Communications 8: 14049. DOI: https://dx.doi.org/10.1038/ncomms14049, PMID: 28091601

      Hagemann-Jensen, M., Ziegenhain, C., Chen, P., Ramsköld, D., Hendriks, G.J., Larsson, A.J.M., Faridani, O.R., Sandberg, R. 2020. Single-cell RNA counting at allele and isoform resolution using Smart-seq3. Nat Biotechnol 38: 708-714. DOI: https://dx.doi.org/10.1038/s41587-020-0497-0, PMID: 32518404

      Larsson, A.J.M., Johnsson, P., Hagemann-Jensen, M., Hartmanis, L., Faridani, O.R., Reinius, B., Segerstolpe, A., Rivera, C.M., Ren, B., Sandberg, R. 2019. Genomic encoding of transcriptional burst kinetics. Nature 565: 251-254. DOI: https://dx.doi.org/10.1038/s41586-018-0836-1, PMID: 30602787

      Ochiai, H., Hayashi, T., Umeda, M., Yoshimura, M., Harada, A., Shimizu, Y., Nakano, K., Saitoh, N., Liu, Z., Yamamoto, T., Okamura, T., Ohkawa, Y., Kimura, H., Nikaido, I. 2020. Genome-wide kinetic properties of transcriptional bursting in mouse embryonic stem cells. Science Adavances 6: eaaz6699. DOI: https://dx.doi.org/10.1126/sciadv.aaz6699, PMID: 32596448

      Luo, S., Wang, Z., Zhang, Z., Zhou, T., Zhang, J. 2023. Genome-wide inference reveals that feedback regulations constrain promoter-dependent transcriptional burst kinetics. Nucleic Acids Research 51: 68-83. DOI: https://dx.doi.org/10.1093/nar/gkac1204, PMID: 36583343

      Rodriguez, J., Ren, G., Day, C.R., Zhao, K., Chow, C.C., Larson, D.R. 2019. Intrinsic dynamics of a human gene reveal the basis of expression heterogeneity. Cell 176: 213-226.e218. DOI: https://dx.doi.org/10.1016/j.cell.2018.11.026, PMID: 30554876

      Luo, S., Zhang, Z., Wang, Z., Yang, X., Chen, X., Zhou, T., Zhang, J. 2023. Inferring transcriptional bursting kinetics from single-cell snapshot data using a generalized telegraph model. Royal Society Open Science 10: 221057. DOI: https://dx.doi.org/10.1098/rsos.221057, PMID: 37035293

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      (1) Gap of knowledge:

      From the introduction, I got the impression that the manuscript tries to answer the question of whether homeostatic structural plasticity is functionally redundant to synaptic scaling. However, the importance of this question needs to be worked out better. Also, I think it is hard to tackle this question with the shown experiments as one would have to block all other redundant mechanisms and see whether HSP functionally replaces them.

      We appreciate the reviewer’s valuable feedback regarding the relationship between homeostatic structural plasticity (HSP) and synaptic scaling. The main objective of our study is indeed to investigate whether structural plasticity is homeostatically regulated, and if so, whether it acts as a redundant or heterogeneous mechanism in relation to synaptic scaling, which is widely recognized as a primary homeostatic process.

      In our revised introduction, we have clarified this central question and its significance. Specifically, we explored why experimentally observed changes in spine density, a measure of structural plasticity, do not exhibit the same homeostatic characteristics as changes in spine head size, which reflects synaptic scaling, particularly under conditions of activity blockade.

      We hypothesized two key points:

      (1) Structural plasticity may not follow a monotonically activity-dependent rule as strictly as synaptic scaling.

      (2) The observed changes in spine density may be influenced by the simultaneous modulation of spine size, suggesting that structural plasticity and synaptic scaling interact within the same biological system.

      Both hypotheses were tested through a combination of experimental observations and systematic computer simulations. Our conclusions demonstrate that spine-number-based structural plasticity follows a biphasic activity-dependent rule. While it largely overlaps with synaptic scaling under typical conditions, it exhibits heterogeneity under extreme conditions, such as activity silencing. Furthermore, our simulations revealed that both mechanisms can compete and complement each other within neural networks.

      We believe that these results offer a nuanced understanding of the interaction between structural plasticity and synaptic scaling, highlighting their redundancy under most conditions but also their heterogeneity under specific circumstances. Blocking all other redundant mechanisms, as suggested, would provide a more reductionist view, which may not capture the complexity and interplay of these processes in a physiological setting. Our approach reflects this complexity, providing insight into how these mechanisms operate together in a naturalistic context.

      We have revised the introduction to better convey these points and emphasize the significance of this question for understanding the dynamics of homeostatic regulation in neural networks.

      Similarly, the simulations do not really tackle redundancy as, e.g. network growth cannot be achieved by scaling alone.

      We appreciate the reviewer’s comment regarding synaptic scaling's limitations in achieving network growth. We would like to clarify that we did not intend to suggest that structural plasticity and synaptic scaling are fully redundant. In fact, it is well established in the literature that structural plasticity plays a dominant role during development, particularly in network growth, which synaptic scaling alone cannot achieve.

      The primary objective of our study was to investigate the interaction between structural plasticity and synaptic scaling under conditions of activity perturbation, rather than during network growth or development. To avoid any confusion regarding developmental processes, we chose to grow the network using only structural plasticity in our simulations. Synaptic scaling was then introduced (or not) during the phase of activity deprivation to specifically examine its role in regulating homeostasis under these conditions.

      We have revised the corresponding sections of the manuscript to clarify this distinction, and we have ensured that the simulations reflect our focus on activity perturbation rather than network development. This distinction should help readers avoid conflating developmental processes with the specific goals of our study.

      Instead, the section on "Integral feedback mechanisms" (L112-129) contains a much better description of the actual goals of the paper than is given in the introduction. Moreover, this section does not seem to include any new results (at least the Ca-dependent structural plasticity and synaptic scaling rules seem to be very common for me). I, therefore, suggest fusing this paragraph in the introduction to obtain a clearer and better understandable gap of knowledge, which is addressed by the paper.

      We agree that the "Integral feedback control" section provides key information relevant to both the Introduction and Methodology. It outlines the theoretical framework and serves as a basis for the experimental design.

      To better reflect this, we have revised the Introduction to include the gap in knowledge. However, we opted to retain the section in the Results, slightly modified, to set the context for the first experiment.

      Along this line, as it seems a central point of the manuscript to distinguish the controller dependencies on Calcium, the different dependencies (working models) should be described in more detail. Also, the description of the inconsistencies of the previous results on HSP can be moved from the discussion (l419-l441) to the introduction.

      We have revised the manuscript to place less emphasis on the controller models while retaining the core principles of control theory. The description of the HSP model has been moved to the Introduction, as suggested, while the detailed history remains in the Discussion to maintain the manuscript's consistency.

      Systematic text revision: Regarding comment (1), we thank the reviewer for suggesting the text reorganization. We have adjusted several parts in the introduction, M&M section, and results section to increase clarity.

      (2) Pharmacological Choice:

      It should be discussed why NBQX is used to induce the homeostatic effect instead of TTX. As there are studies showing that it might block homeostatic rewiring (doi.org/10.1073/pnas.0501881102) as well as synaptic scaling (10.1523/JNEUROSCI.3753-08.2009), it seems unclear whether the observed effects are actually corresponding to those in other publications.

      The rationale for using NBQX in our experiments, rather than TTX, is detailed in the public response. We selected NBQX based on specific experimental motivations relevant to our study’s objectives, while acknowledging the potential differences in effects compared to other studies.

      Local text revision: We added one paragraph in the discussion section to explain the idea better.

      (3) Model-Experiment Connection:

      The paper combines simulations with experimental work, which is very good. However, in my opinion, the only connection between the two parts is that the experiments suggest a non-monotonic dependency between firing rate and synapse density (i.e. the biphasic dependency). The rest of the experimental results seem to be neglected in the modeling part. It is not even shown that the model reproduces the experiments. Instead, the model is tested in different situations and paradigms (blocking AMPARs in the whole culture vs network growth or silencing a sub-population). I think it would make the paper stronger and more consequential when a reproduction of the experiment by the model is demonstrated (with analogue analyses).

      The experimental results serve three main purposes. First, as the reviewer noted, the spine analysis was conducted to inform the biphasic rule. Second, spine size analysis was performed to replicate published findings and confirm our modeling results, showing that activity deprivation leads to fewer synapses with larger sizes or higher weights. Third, the correlation analysis of spine density and size across dendritic segments suggested a hybrid combination of two types of plasticity across different neurons.

      While we addressed these aspects in the Results and Discussion sections, the collective presentation in Fig. 2 may have caused some confusion. To improve clarity, we have now split the experimental results, presenting them alongside the relevant modeling data in Fig. 2, Fig. 8, and Fig. 9.

      Also, there are a few more mismatches between the experiment and the model that you will want to discuss:

      • The size-dependent homeostatic effect (l154ff, Fig2F) is not reflected by the used scaling model.

      We revised Fig 8 and the corresponding text to explain how the scaling model reflects such an effect.

      • The model assumes reduced Ca levels. Yet, the experimental protocol blocks AMPARs, which are to my knowledge not the primary source of Ca influx, but rather the NMDARs.

      The model is based on neural activity, with calcium concentration serving as an internal integral signal of the firing rate, allowing for integral control. While calcium plays a critical role in homeostasis, we caution against drawing a strict correspondence between the model's calcium dynamics and the experimental protocol, as calcium can be sourced from multiple pathways in neurons beyond AMPARs, such as NMDARs, voltage gated calcium channels, and intracellular stores. Also, our recent work demonstrated that under baseline conditions, the majority of AMPARs are not Ca2+ permeable, i.e., GluA2-lacking (Kleidonas et al., 2023)

      Improving the calcium dynamics, including secondary calcium release and calcium stores, is part of our future plan to refine the HSP model and address experimental findings that are not fully explained by the current model.

      • The model further assumes silencing by input removal, whereas the recurrent connections stay intact. Wouldn't this rather correspond to a deafferentation experiment, where connections to another brain area are cut?

      Thank you for pointing at this. The modeling section was not intended to directly replicate the tissue culture experiments but rather to provide insights into a broader range of scenarios, including pharmacological treatments, deafferentation, lesions, and even monocular deprivation.

      Systematic text revision: Regarding comment (3), the goal of our modeling work was more than reproducing. To better serve the purposes of experimental results used in the present study, to inform, confirm, and inspire, we have systematically adjusted the layout of experimental and modeling results to link them better.

      (4) Is the recurrent component too weak?

      Your results show that HSP does not restore activity after silencing (deafferentation), whereas you discuss that earlier models did achieve this by active neighbors in a spatially organized network. However, the silenced neurons in your simulations also receive inputs through the "recurrent" connections from their neighbors (at least shortly after silencing). Therefore, given the recurrent input is strong enough, they should be able to recover in a similar way as the spatially organized ones. As a consequence, I obtained the impression that, in your model networks, activity is strongly driven by external stimulation and less by recurrent connections. I understand that this is important to achieve silencing through removing the Poisson stimulation. Yet, this fact may be responsible for the failure to restore activity such that presented effects are only applicable for networks that are strongly driven by external inputs, but not for strongly recurrent networks, which would severely limit the generality of the results. As a consequence, the paper would benefit from a systematic analysis of the trade-off between recurrent strength and input strength. Maybe, different constant negative currents could be injected in all neurons, such that HSP creates more recurrent synapses in the network.

      We appreciate this insight. However, increasing recurrent input strength is beyond the scope of the current study, as it would fundamentally alter the predefined network dynamics of the Brunel network used. As noted in the manuscript, complete isolation or cell death is not always the outcome after input deprivation, lesion, or stroke, which cannot be fully explained by the Gaussian HSP rule alone. Butz and colleagues offered a solution using growth rules that maximized recurrent input, and we recognize the importance of their work.

      That said, we approached the issue from a different angle, emphasizing the role of synaptic scaling in recurrence rather than relying solely on recurrent input strength. In biological networks, external inputs may vary, recurrency can be weak or strong, and synaptic scaling can dominate. Our model offers a complementary hypothesis, suggesting that these factors, in combination, contribute to the diverse and sometimes contradictory results found in the literature, rather than posing a strict constraint on network topology.

      Local text revision: We emphasized these points in the Discussion section again.

      (5) Missing conclusions / experimental predictions

      As already described, the modelling work is not reproducing the presented or previous experimental data. Hence, the goal of modelling should be to derive a more general understanding and make experimental predictions. Yet, the conclusions in the discussion stay superficial and vague and there are no specific experimental predictions derived from the model results.

      For example, the authors report that the recovery of activity in silenced cultures is observed in a previously spatially structured model but not in theirs -- at least with slow or no scaling. Yet it is left to the reader to think about whether the current model is an improvement to the previous one, how they could be experimentally distinguished, or to which experimental findings they relate or compare, which I would expect at this point. I would advise reworking the discussion and thoroughly working out which new insights the modelling part of the study has generated (not to be confused with the assumptions of the model aka the biphasic plasticity rule) and relating them to experimental pre- and postdiction.

      We recognize the reviewer’s concern, which is closely related to comment (4). We have addressed these points by reorganizing the text to better clarify the purpose of our experimental work and its connection to the modeling results.

      Specifically, we have reworked the discussion to highlight the new insights gained from the modeling, and how these can inform experimental predictions and interpretations. This includes distinguishing our model from previous ones and providing clearer connections to experimental findings.

      Systematic text revision: Most of the comments on combining experiments and modeling results and on developing the story based on our expectations raised here are sincere and may also reflect the expectations and concerns of a broader readership, so we have accordingly adjusted the text in the Results and Discussion sections to make our points clear.

      Suggestions for minor changes:

      Fig 1I: Please check the graph and make it more self-explaining. For example, mark the "setpoint" activity (in my opinion, both curves should be at baseline there. In that case, however, I do not see the biphasic behavior anymore). Maybe the table and the graph can be aligned along the activity axis? Also: synaptic inhibition should be increased and not decreased, right?

      Local text and figure revision: I guess the reviewer meant for Fig. 2I? We have improved the visualization to avoid confusion.

      L74-81: I would reverse the order of associative and homeostatic plasticity in this paragraph.

      Local text and figure revision: We have fine-tuned the order in the first and second paragraphs to match the readers' expectations.

      L74-75: Provide references for such theories.

      Local text and figure revision: fixed.

      L84-86: Please provide a reference for the claim that negative feedback, redundancy, and heterogeneity contribute to robustness.

      Local text and figure revision: fixed.

      L 95-97: I think the heterogeneity aspect needs to be worked out a bit better. Do you mean that the described mechanisms contribute to firing rate homeostasis in a different mixture for each neuron (as shown assumed in the last figure)?

      Local text and figure revision: The term heterogeneity is used in the manuscript for two major different settings: (1) heterogeneity in terms of control theory and (2) different combinations of HSP and SS rules. We have named the second condition as diversity to avoid confusion.

      L 132: The question of linearity has not been posed so far. Also, I think "monotonous" would be a much better term than linear (as a test for linearity would require more than 2 datapoints).

      Local text and figure revision: We agreed linear is not a good term. We replaced it with ‘monotonic’ throughout the manuscript.

      Fig2 Bii: The data for 50um is clearly not Gaussian.

      We did not imply that the 50 µM condition is Gaussian. Instead, we noted that the non-linearity observed in both the 200 nM and 50 µM data suggests a non-monotonic growth rule rather than a linear one. We applied the Gaussian rule because it has been extensively studied in previous simulations, allowing us to benchmark our findings against those results.

      Fig2 D, E inset: The point at time 0 does not convey any information and could be left out.

      The time zero data is included to demonstrate that the three groups have a similar baseline, ensuring that any observed differences are due to the treatment and not pre-existing biases in the grouping.

      L 178: As the Gaussian rule drops below zero above the upper set-point again, it is rather tri-phasic than bi-phasic.

      We intended to convey that inhibition results in either spine growth or deletion, reflecting a bi-phasic response rather than a true tri-phasic one.

      Fig 6A: You may want to mark the eta variables in the curves.

      Local text and figure revision: fixed.

      Fig 6E: The curve of the S population extending to the next panel looks a bit messy.

      We retained the curve extension to visually convey the impression of excessive network activity.

      L272: It needs to be better described/motivated how protocol 1 and 2 are supposed to study the role of recurrent connection as well as what kind of biological situation this may be.

      Local text and figure revision: The corresponding text has been adjusted to avoid confusion.

      L 272: It is not clear how faster simulation leads to less recurrent connectivity, when the stimulation protocol and the rates stay the same and the algorithm compensates for the timestep properly. Maybe you rather want to say that you silence 10x longer and stimulate 10x longer?

      Local text revision: The corresponding text has been adjusted to avoid confusion.

      L. 302: "reactivate"?

      Local text revision: fixed.

      L 322f: I would suggest showing the connectivity matrix for a time-point with restored activity as well.

      Local text and figure revision: fixed.

      Fig 8A: The use of the morphological reconstructions is a bit misleading as the model uses point neuron.

      Local text revision: Now after reorganization, it is in Fig.9. We kept the reconstruction figure for motivational purposes, suggesting how to understand the meaning of the combinations in more biologically realistic scenarios. The corresponding text has been adjusted to avoid confusion.

      Fig 8E-F: the y axis should be in the same orientation as in panel D.

      Local text and figure revision: Good idea and fixed in the new Fig. 9.

      Fig. 8F: The results here look a little bit random. Maybe more runs with the same parameters would smooth out the contours or reveal a phase transition.

      Local text and figure revision: Thank you for the suggestion. We conducted an additional ten random trials to average the traces and heatmaps, improving the clarity of the results now presented in Fig. 9.

      L411: Note that there are earlier HSP models by Damasch and van Ooyen & van Pelt, that might be worth discussing here.

      Local text revision: fixed.

      L416 "beyond synaptic scaling" reference needed.

      Local text revision: fixed.

      L419: The biphasic rule was suggested by Butz already.

      Local text revision: We adjusted the text to emphasize our contribution in suggesting/confirming the biphasic rule based on direct experimental observations.

      L 419-44: Most of this is actually state-of-the art and may be better placed in the introduction to justify the use of NBQX as a competititve blocker.

      Local text revision: We adjusted the text in the introduction and Discussion sections to cover the raised points.

      L487: In my opinion, although scaling adapts the weights quickly, the information about deviating firing rate is still stored in the calcium signal such that it will also give rise to structural changes (although they may be small when the rate is low). Thus, I think that fast scaling does not abolish structural changes.

      Local text revision: We adjusted the text to account for other factors that could lead to the same or opposite conclusions.

      L502f: Sentence unclear. Do you mean Ca is an integrated (low-pass filtered) version of the firing rate?

      Yes.

      L504: What is the cumulative temporal effect of error in estimating firing rates?

      We were referring to the potential instability in numeric simulations if the firing rate is not tracked by an integral signal (calcium concentration) but is instead estimated through average spike counts over time. In our model, calcium serves as a proxy for the firing rate to guide homeostatic structural plasticity. The intake and decay constants are set to minimize the accumulation of errors over time, making long-term error accumulation unlikely. In any case, this is not intended to be a precise measure of the firing rate but rather a smooth guide for homeostatic control.

      Local text revision: We rewrote the section so as not to cause extra concerns.

      L505: Which two rules are meant here? Ca- and firing rate based or HSP and scaling?

      Local text revision: The two rules are the HSP rule and the HSS rule. We have adjusted the text to improve clarity.

      L505ff: I did not really understand the control theoretic view here and Supp Fig 5 is not self-explaining enough to help. In my view, scaling is a proportional controller for the calcium level (the setpoint is defined for calcium and not firing rate). Also, all of the HSP rules do neither contain an integral nor a differential of the error and are thus nonlinear but proportional controllers in first approximation. If this part is supposed to stay in the manuscript, the supporting information should contain a more detailed mathematical explanation. Relevant previous work on homeostatic control by synaptic scaling and homeostatic rewiring, e.g. doi: 10.23919/ECC54610.2021.9655157 should be discussed

      Local text revision: We have updated the last paragraph to increase clarity. The HSP and HSS rules are proportional and integral for neural activity, as neural firing rate homeostasis is the meaningful goal. However, it is also correct that the integral component is gone if we view calcium concentration as the goal or setpoint. This paper is discussed and cited in a paragraph above this one.

      Reviewer #2 (Recommendations For The Authors):

      I have some additional suggestions and questions for the authors, which I am presenting following the order of the figures.

      Fig 1A: I'm a little bit puzzled by the timescales between Hebbian and homeostatic plasticity; a wealth of data suggests that Hebbian plasticity acts on a faster timescale than homeostatic plasticity, while Aii-Aiii implies the opposite. In lesion-induced degeneration, for instance, which is mentioned later by the authors, spine loss has been suggested to be Hebbian (LTD) while the subsequent recovery is homeostatic. Additionally, it will not be clear to the reader if the same stimulus could induce Hebbian and homeostatic plasticity, or why; the rest of the manuscript seems to imply that any stimulus could and would trigger homeostatic plasticity, which is not the case. Finally, there should be a mention somewhere that Hebbian structural plasticity also exists.

      Local text and figure revision: We thank the reviewer for pointing out the time scale issue, which was not explicitly considered here and is now updated.

      Fig. 2Bii: There is no significant difference at 200nm NBQX for sEPSC amplitude, contrary to what is stated in the text (line 136). Which one is it?

      Local text revision: We thank the reviewer for pointing out the mistake. We have inspected the original statistical file and corrected the text.

      Fig. 2F: The description of Fig. 2F in the text confused me for the longest time. I am still unsure why 200nm NBQX is described as leading to a general size increase when it follows the control line so closely, crosses 0 at the same point, and is even below the control line for the largest spine sizes. Similarly, 50um NBQX neatly overlaps with the control condition except for the smallest and largest spines, so the "shrinkage of middle-sized spines" doesn't seem different from the control condition. I also couldn't find any data supporting the statement that 50um NBQX increased only the size of "a small subset of large spines". Maybe the authors could clarify this section? I would also suggest adding statistics between the treatments at each spine size bin to support the claims, as they are central to the rest of the paper.

      Importantly, there is no description of the normalization nor the quantification of the difference between days in the methods; I am assuming post-pre for the difference and (post-pre)/pre for the normalization, but this should be much more detailed in the methodology. I was happy to see the baseline raw spine sizes in Supplementary Fig. 1, and would also suggest adding the raw spine sizes after treatment for comparison.

      Local text and figure revision: We have adjusted the text and figure to improve clarity.

      Fig. 2G/S2A: a scale for the label sizes would be helpful. I would also like to have the same correlation for 50um NBQX treatment and the control condition (at least in the supplementary figures).

      Local text and figure revision: We have adjusted the text and figure to improve clarity.

      Fig. 2I: I might be missing something, but why is the activity line flat when there are changes in spine density and size?

      Local text and figure revision: We have adjusted the text and figure to improve clarity.

      Fig. 3C-D: they are referenced in the text as Fig. 1C-D (lines 188-194).

      Local text revision: fixed.

      Fig. 5: it is interesting that the biphasic model captures both spine loss and recovery, fitting well with lesion-induced degeneration and recovery. Does this mean that the model captures other types of plasticity, or does it suggest to the authors that both steps are homeostatic?

      Indeed, the biphasic HSP rule captures two types of activity dependence. The pioneering work by Gallinaro and Rotter (2018) also demonstrated that the HSP rule, even in its monotonic/linear form, exhibits associative properties, which are typically associated with Hebbian plasticity.

      Fig. 6A: This figure requires a more detailed legend - what are the various insets? Does the top right graph only have one curve because they are overlapping and the growth rules are the same for axons and dendrites?

      Local text revision: fixed.

      Fig. 6E: There is usually an overshoot when a stimulus is removed, in this case at the end of the silencing period (as shown in Fig. 1Aiii). Is there a reason why this is not recapitulated here? It shouldn't be as extreme as in the right panel so there should be no degeneration.

      We agree that removing the stimulus would typically trigger an opposite homeostatic process. However, in this protocol, we aimed to emphasize the role of recurrency by presenting extreme cases to illustrate potential scenarios for the readers.

      Local text revision: We revised this paragraph to walk the readers through the rationale better.

      Fig. 6: the authors mention distance-dependent connectivity (line 268), but I couldn't find any data related to that statement. I was particularly curious about that aspect, so I would like to know what this statement is based on, especially as they touch again on the role of morphology in Fig. 8, and distance-dependent connectivity is more prominent in the discussion. On a similar note, would the authors have data from other layers of CA1 that would show similar or other rules? Please note that I am not asking to include these data in the present paper - I am just curious if these data exist (or if the experiments are considered).

      Such an extensive dataset is included and thoroughly investigated in another study that has just been published in Lenz et al., 2023. We updated the reference in the revised text.

      Fig. 7E top: the scalebar is missing.

      Local text revision: fixed.

      Fig. 8A: do the colors have meaning? If yes, please state them. Also indicate that the left two neurons are pyramidal cells from CA1 and the right neurons are granule cells from the dentate gyrus.

      Local text revision: fixed.

      Line 302: "reactive" should be "reactivate".

      Local text revision: fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this work, the authors investigate the functional difference between the most commonly expressed form of PTH, and a novel point mutation in PTH identified in a patient with chronic hypocalcemia and hyperphosphatemia. The value of this mutant form of PTH as a potential anabolic agent for bone is investigated alongside PTH(1-84), which is a previously used anabolic therapy. The authors have achieved the aims of the study. Their conclusion, however, that this suggests a "new path of therapeutic PTH analog development" seems unfounded; the benefit of this PTH variant is not clear, but the work is still interesting.

      The work does not identify why the patient with this mutation has hypocalcemia and hyperphosphatemia; this was not the goal of the study, but the data are useful for helping to understand that.

      Strengths:

      The work is novel, as it describes the function of a novel, naturally occurring, variant of PTH in terms of its ability to dimerise, to lead to cAMP activation, to increase serum calcium, and its pharmacological action compared to normal PTH.

      Weaknesses:

      (1) The use of very young, 8-10 week old, mice as a model of postmenopausal osteoporosis is a major limitation of this study. At 8 weeks, the effect of ovariectomy leads to lack of new trabecular bone formation, rather than trabecular bone loss due to a defect in bone remodelling. Although the findings here provide a comparison between two forms of PTH, it is unlikely to be of direct relevance to the patient population. For example, the authors find an inhibitory effect of PTH on osteoclast surface, which is very unusual. Adding to this concern is that the authors have not described the regions used for histomorphometry, and from their figures (particularly the TRAP stain), it seems that the primary spongiosa (which is a region of growth) has been used for histomorphometry, rather than the secondary spongiosa (which more accurately reflects bone remodelling). Much further detail is needed to justify the use of this very young model, and a section on the limitations of this model is needed. Please provide that section in the revised manuscript.

      Thank you for your crucial comment. We obtained 8-week-old female mice and stabilized them in our facility for 2 weeks. Then, we performed OVX using 10-week-old mice and determined the effects of dimeric <sup>R25C</sup>PTH(1-34) on bone after 8 weeks because of 4 weeks for recovery and 4 weeks for PTH or <sup>R25C</sup>PTH(1-34). Therefore, we sacrificed the mice at 18-week-old mice. We revised the method section on page 18, line 436-441 and page 18, line 442-448 as follows.

      - ‘Eight-week-old C57BL/6N female mice were purchased from KOATECH (Gyeonggi-do, Republic of Korea), and stabilized mice for 2 weeks. All animal care and experimental procedures were conducted under the guidelines set by the Institutional Animal Care and Use Committees of Kyungpook National University (KNU-2021-0101). The mice were housed in a specific pathogen-free environment, with 4-5 mice per cage, under a 12-h light cycle at 22 ± 2°C. They were provided with standard rodent chow and water ad libitum.’

      - ‘An ovariectomized (OVX) mouse model was established using 10-week-old C57BL/6N female mice. Following surgery, mice were divided into the following four groups (n = 6 mice/group) as follows: sham, OVX control group, OVX + PTH (1–34) treated group (40 µg/kg/day), and OVX + dimeric <sup>R25C</sup>PTH treated group (40-80 µg/kg/day). OVX mice were allowed to recover for 4 weeks after surgery. Afterward, PTH (1–34) or <sup>R25C</sup>PTH was injected subcutaneously 5 times a week for 4 weeks. Micro-computed tomography (μ-CT) and histological analyses were performed on 4 groups at 18 weeks of age.’

      We also appreciate the reviewer's helpful comment on histology analysis. We agree with the reviewer’s comment that the primary spongiosa does not fully reflect bone remodeling. For histomorphometry analysis in young or male mice, we commonly use the secondary spongiosa, which more accurately reflects bone remodeling. However, in aged or OVX-induced osteoporosis mouse models, we use the primary and secondary spongiosa for histomorphometry analysis because of the barely detectable bone in the secondary spongiosa. In the TRAP staining, we observed an inhibitory effect of PTH on the osteoclast surface/bone surface, which was due to an increased bone surface in the PTH treatment group and less bone in the OVX-vehicle group. Serum CTX1 levels showed no significant difference between the OVX+vehicle and OVX+PTH(1-34) groups. We revised the Materials and Methods (page 21, line 502) and Discussion (page 14, line 330) sections as follows.

      - ‘In the histomorphometry analysis for TRAP staining, we used the secondary and primary spongiosa for the trabecular ROI because of the barely detectable in the secondary spongiosa of OVX model.’

      - ‘This study has several limitations. First, it is urgently necessary to determine whether dimeric <sup>R25C</sup>PTH is present in human patient serum. Second, TRAP staining showed an inhibitory effect of PTH treatment on the primary spongiosa area. However, the secondary spongiosa, which more accurately reflects bone remodeling (55), was not examined due to the barely detectable bone in this area in OVX-induced osteoporosis mouse models. Third, it is unclear whether similar bone phenotypes exist between human <sup>R25C</sup>PTH patients and dimeric <sup>R25C</sup>PTH-treated mice, particularly regarding low bone strength. Although the dimeric <sup>R25C</sup>PTH-treated group showed higher cortical BMD compared to WT-Sham or PTH groups, there was no difference in bone strength compared to the osteoporotic mouse model. Fourth, our study showed that PTH or <sup>R25C</sup>PTH treatment decreased circumferential length; it is uncertain if this phenotype is also present in PTH-treated or <sup>R25C</sup>PTH patients. Finally, we did not analyze the <sup>R25C</sup>PTH mutant mouse model, which would allow us to compare phenotypes that most closely resemble those of human patients.’

      (2) It is also somewhat concerning that the age range is from 8-10 weeks, increasing the variability within the model. Did the age of mice differ between the groups analysed?

      We utilized mice of the same age (10 weeks) across all experiments involving the surgically induced ovariectomy (OVX) model described as above.

      (3) Methods are not sufficiently detailed. For example, the regions used for histomorphometry are not described, there is no information on micro-CT thresholds, no detail on the force used for mechanical testing. Please address this request.

      Thank you for your comment. Let me address your points step by step.

      (1) Thresholds for analysis were determined manually based on grayscale values for each experimental group as follows: trabecular bone: 3000; cortical bone: 5000 for all samples. We utilized an HA (calcium hydroxyapatite) phantom with HA content ranging from 0 to 1200 mg CaHA/cm³ to measure the grayscale values via µ-CT. These measurements were then used to generate a standard curve.

      Author response image 1.

      (2) Bone parameters and density were analyzed in the region between 0.3–1.755 mm (Voxel size: 9.7um, 150 slices) from the bottom of the growth plate. Analysis of bone structure was performed using adaptive thresholding in a CT Analyser.

      Author response image 2.

      (3) Three‐point bending test, the left femur of the mouse was immersed in 0.9 % NaCl solution, wrapped in gauze, and stored at −20°C until ready for a three-point bending test. In this test, we placed the mouse femurs positioned horizontally with the anterior surface facing upwards, centered on the supports, and the compressive force was applied vertically to the mid-shaft. The pressure sensor was positioned at a distance that allowed for the maximum allowable pressure (200N) without interfering with the test (20.0 mm for the femur). A miniature material testing machine (Instron, MA, USA) was used for this test. The crosshead speed was decreased to 1 mm/min until failure. During the test, force-displacement data were collected to determine the maximum load and slope of the bones.

      (4)  As the reviewer’s suggestion, we revised the methods on page 20, line 477 and line 482-486 as follows.

      - ‘Bone parameters and density were analyzed in the region between 0.3–1.755 mm (150 slices) from the bottom of the growth plate. Analysis of bone structure was performed using adaptive thresholding in a µ-CT Analyser. Thresholds for analysis were determined manually based on grayscale values for each experimental group: trabecular bone: 3000; cortical bone: 5000 for all samples.’

      -  ‘The left femur of the mouse was immersed in 0.9 % NaCl solution, wrapped in gauze, and stored at −20°C until ready for a three-point bending test. In this test, we placed the mouse femurs horizontally with the anterior surface facing upwards, centered on the supports, and the compressive force was applied vertically to the mid-shaft. The pressure sensor was positioned at a distance that allowed maximum allowable pressure (1000N) without interfering with the test (20.0 mm for the femur). A miniature material testing machine (Instron, MA, U.S.A.) was used for this test. The crosshead speed was decreased to 1 mm/min until failure. During the test, force-displacement data were collected to determine the maximum load and slope of the bones.’

      (4) There are three things unclear about the calvarial injection mouse model. Firstly, were the mice injected over the calvariae or with a standard subcutaneous injection (e.g. at the back of the neck)? If they were injected over the calvaria, why were both surfaces measured? Secondly, why was the dose of the R25C-PTH double that of PTH(1-34)? Thirdly, there is no justification for the use of "more intense coloration" as a marker of new bone; this requires calcein labelling to prove it new bone. It would be more reliable to measure and report the thickness of the calvaria. Please address these technical questions.

      Thank you for your valuable feedback on the calvarial injection mouse model. Below are our responses to the specific points mentioned:

      (1) Injection method and measurement sites: The injections were administered subcutaneously above the calvaria, rather than at the standard subcutaneous site such as the back of the neck. This approach was chosen to ensure direct delivery of the peptide to the target area, enhancing the localized effects on bone formation. Measurements were taken at two different parts of the calvaria to account for any variation in the spread and absorption of the administered substance following injection. By analyzing both surfaces, we aimed to provide a comprehensive assessment of the impact on calvarial bone thickness.

      (2) Dose of <sup>R25C</sup>PTH compared to PTH(1-34): The dose of <sup>R25C</sup>PTH used in our study was determined based on molecular weight calculations. The molecular weight of the dimeric <sup>R25C</sup>PTH(1-34) is approximately twice that of the monomeric PTH(1-34). Therefore, to maintain a consistent molar concentration and ensure comparable biological effects, the dose of <sup>R25C</sup>PTH was adjusted accordingly.

      (3) Use of "more intense coloration" as a marker of new bone: We acknowledge that calcein labeling would provide a more reliable and quantifiable way to identify new bone formation. The use of “more intense coloration” was intended as a qualitative indicator in this study, and we recognize the technical limitations of this approach.

      (5) The presentation of mechanical testing data is not sufficient. Example curves should be shown, and data corrected for bone size needs to be shown. The difference in mechanical behaviour is interesting, but does it stem from a difference in the amount of bone, or two a difference in the quality of the bone? Please explain this matter better in the manuscript.

      Thank you for your comment.

      As a reviewer's comment, we provided example curves for the rat femur three-point bending test as shown below.

      Author response image 3.

      (1) The cortical bone area was decreased in the OVX-Vehicle and OVX-<sup>R25C</sup>PTH(1-34) groups but not in the OVX-PTH(1-34) group compared to the Sham group. However, the total bone area was decreased in the PTH(1-34) and <sup>R25C</sup>PTH(1-34) treated groups, with no significant difference in the OVX-Vehicle group compared to the Sham group. Collectively, there was an increase in cortical thickness which resulted in a narrowing of the bone marrow space in OVX-<sup>R25C</sup>PTH(1-34) groups. Accordingly, we revised Fig 5B with the addition of Tt.Ar and Ct.Ar.

      (2) As the reviewer’s suggestion, we revised the results on page 10, line 220-228 s follows.

      - ‘Quantitative micro-computed tomography (μ-CT) analysis of the femurs obtained from each group revealed that, as compared to OVX + vehicle controls, treatment with PTH(1–34) increased femoral trabecular bone volume fraction (Tb.BV/TV) by 121%, cortical bone volume fraction (Ct.BV/TV) by 128%, cortical thickness (Ct.Th) by 115%, cortical area (Ct.Ar) by 110%, and cortical area fraction (Ct.Ar/Tt.Ar) by 118% while decreased total tissue area (Tt.Ar) by 93% (Figure 5A and 5B). Treatment with dimeric <sup>R25C</sup>PTH(1-34) had similar effects on the femoral cortical bone parameters, as it increased Ct.BMD by 104%, Ct.BV/TV by 125%, Ct.Th by 107%, and Ct.Ar/Tt.Ar by 116%, while decreased Tt.Ar 86% (Figure 5). Considering the reduction of Tt.Ar and no change of Ct.Ar compared to the OVX+vehicle controls, the increase of Ct.Ar/Tt.Ar indicates a decrease in bone marrow space. The increase in cortical bone BMD was significant with dimeric <sup>R25C</sup>PTH(1-34) but not with PTH(1-34), whereas an increase in femoral trabecular bone was only observed with PTH(1-34).’

      (6) The micro-CT analysis of the cortical bone in the OVX model is insufficient. Please indicate whether cross-sectional area has increased. Is there an increase in the size of the bones, or is the increase in cortical thickness due to a narrowing of the marrow space? This may help resolve the apparent contradiction between the cortical thickness data (where there is no difference between the two PTH formulations) and the mechanical testing data (where there is a difference). Please explain this matter better in the manuscript.

      Thank you for your comment.

      (1) The cortical bone area was decreased in the OVX-Vehicle and OVX-<sup>R25C</sup>PTH(1-34) groups but not in the OVX-PTH(1-34) group compared to the Sham group. However, the total bone area was decreased in the PTH(1-34) and <sup>R25C</sup>PTH(1-34) treated groups, with no significant difference in the OVX-vehicle group compared to the Sham group. Taken together, there was an increase in cortical thickness due to a narrowing of the bone marrow space in OVX-<sup>R25C</sup>PTH(1-34) groups. Therefore, we revised as above.

      (2) As the reviewer’s suggestion, we revised the results on page 10, line 220-228 as follows.

      - ‘Quantitative micro-computed tomography (μ-CT) analysis of the femurs obtained from each group revealed that, as compared to OVX + vehicle controls, treatment with PTH(1–34) increased femoral trabecular bone volume fraction (Tb.BV/TV) by 121%, cortical bone volume fraction (Ct.BV/TV) by 128%, cortical thickness (Ct.Th) by 115%, cortical area (Ct.Ar) by 110%, and cortical area fraction (Ct.Ar/Tt.Ar) by 118% while decreased total tissue area (Tt.Ar) by 93% (Figure 5A and 5B). Treatment with dimeric <sup>R25C</sup>PTH(1-34) had similar effects on the femoral cortical bone parameters, as it increased Ct.BMD by 104%, Ct.BV/TV by 125%, Ct.Th by 107%, and Ct.Ar/Tt.Ar by 116%, while decreased Tt.Ar 86% (Figure 5B). Considering the reduction of Tt.Ar and no change of Ct.Ar compared to the OVX+vehicle controls, the increase of Ct.Ar/Tt.Ar indicates a decrease in bone marrow space. The increase in cortical bone BMD was significant with dimeric <sup>R25C</sup>PTH(1-34) but not with PTH(1-34), whereas an increase in femoral trabecular bone was only observed with PTH(1-34).’

      (7) The evidence that dimeric PTH has a different effect to monomeric PTH is very slim; I am not sure this is a real effect. Such differences take a long time to sort out (e.g. the field is still trying to determine whether teriparatide and abaloparatide are different). I think the authors need to look more carefully at their data - almost all effects are the same. Ultimately, the statement that dimeric PTH may be a more effective anabolic therapy than monomeric PTH are not supported by the data, and this should be removed. There is little to no difference found between normal PTH and the variant in their effects on calcium and phosphate homeostasis or on bone mass. However, the analysis has been somewhat cursory, with insufficient mechanical testing or cortical data presented. Many of the effects seem to be the same (e.g. cortical thickness, P1NP, ALP, vertebral BV/TV and MAR), but the way it is written it sounds like there is a difference. Please remove some of the unfounded claims that you have made in this manuscript.

      Thank you for your insightful comments. We strongly agree with your conclusion that PTH and dimeric <sup>R25C</sup>PTH indeed exhibit similar activities. We have toned-down our statement, however, there are still some elements showing statistical significance that need to be clearly stated. Specifically, when we changed the statistical method from t-test to one-way ANOVA, the significance of bone formation markers were only observed in dimeric PTH treated samples, and we have revised the manuscript of Results section on page 9, line 206-212 as follows to reflect the change.

      - ‘These analyses revealed that both PTH(1-34) and dimeric <sup>R25C</sup>PTH(1-34) significantly increased the width of the new bone area by approximately four-fold, as compared to the vehicle group (Figure 4B). These findings thus support a capacity of dimeric <sup>R25C</sup>PTH(1-34) to induce new bone formation in vivo, similar to PTH, despite molecular and structural changes.’

      Although it is unclear whether <sup>R25C</sup>PTH circulate as dimeric form or mutant monomeric form, the absence of bone resorption associated with long-term PTH exposure in the patients suggests the potential for a bone anabolic drug without side effects. Also, continued observation of the recently reported young patient in Denmark is expected to clarify this effect further. However, we acknowledge that our current data alone are insufficient to claim that <sup>R25C</sup>PTH may be a more effective anabolic therapy than wild type PTH, and we have adjusted our tone accordingly.

      (8) Statistical analysis used multiple t-tests. ANOVA would be more appropriate.

      We agree with your suggestion. To compare the means among three or more groups, ANOVA is more appropriate than the t-test. Accordingly, we performed new statistical analyses using one-way and two-way ANOVA. One-way ANOVA was applied to figure 4, 5, and 6 (In previous, figure 5, 6, and 7), and two-way ANOVA was applied to Figure 3, considering both time and treatment variables. We revised some of the figures and descriptions to reflect the changes in significance.

      Thank you for Reviewer #1’s thorough and thoughtful review. We greatly appreciate the suggestions and will incorporate them to enhance the quality of our paper.

      Reviewer #2 (Public Review):

      Summary:

      The study conducted by Noh et al. investigated the effects of parathyroid hormone (PTH) and a dimeric PTH peptide on bone formation and serum biochemistry in ovariectomized mice as a model for postmenopausal osteoporosis. The authors claimed that the dimeric PTH peptide has pharmacological benefits over PTH in promoting bone formation, despite both molecules having similar effects on bone formation and serum Ca2+. However, after careful evaluation, I am not convinced that this manuscript adds a significant contribution to the literature on bone and mineral research.

      Strengths:

      Experiments are well performed, but strengths are limited to the methodology used to evaluate bone formation and serum biochemical analysis.

      Weaknesses:

      (1) Limited significance of this study:

      • This study follows a previous study (not cited) reporting the effect of the dimeric R25CPTH(1-34) on bone regeneration in an osteoporotic dog (Beagle) model (Jeong-Oh Shin et al., eLife 13:RP93830, 2024). It's unclear why the authors tested the dimeric R25C-PTH peptide on a rodent animal model, which has limitations because the healing mechanism of human bone is more similar in dogs than in mice.

      Thank you for your interest in our research. To address the paper by Shin et al. (2024, DOI:10.7554/eLife.93830.1), we would like to clarify that our research on dimeric <sup>R25C</sup>PTH(1-34) was conducted first. Initially, we confirmed dimerization under in vitro conditions and observed its effects in a mouse model. Recognizing the need for additional animal models, we collaborated with Shin et al.'s team. Due to delays during the submission process, our paper was submitted later, which seems to have led to this misunderstanding. However, Shin et al. (2024) cited our pre-print article on bioRxiv (Noh, M., Che, X., Jin, X., Lee, D. K., Kim, H. J., Park, D. R., ... & Lee, S. (2024). Dimeric R25CPTH (1-34) Activates the Parathyroid Hormone-1 Receptor in vitro and Stimulates Bone Formation in Osteoporotic Female Mice. bioRxiv, 2024-03.DOI: 10.1101/2024.03.13.584815). Both Shin et al., and our mouse work supports the action of dimeric R25CPTH(1-34) on regulating bone metabolism.

      • The authors should clarify why they tested the effects of dimeric <sup>R25C</sup>PTH(1-34) and not dimeric <sup>R25C</sup>PTH(1-84)?

      Thank you for your valid comments. Here are several reasons why we used the 1-34 fragment peptide in our experiment. Currently, PTH analog peptides for medical purposes include human parathyroid hormone fragment 1-34 (PTH(1-34)) and full-length recombinant human parathyroid hormone (rhPTH(1-84)). PTH(1-34) is used as a bone anabolic agent, while rhPTH(1-84) is used for PTH replacement therapy in hypoparathyroid patients with hypocalcemia. We aimed to compare the bone formation effects of R25CPTH with wild-type PTH, for which PTH(1-34) was deemed more appropriate. Additionally, previous studies have shown that both PTH(1-34) and PTH(1-84) possess equal ligand binding affinity for the PTH1 receptor. Key sites within the first 34 N-terminal amino acids of PTH are critical for high-affinity interactions and receptor activation. Alterations in the N-terminal sequence of PTH(1-84) significantly reduce receptor binding, while truncations at the C-terminal end do not affect receptor affinity. The peptide used in our experiment was synthetic, and if the length does not affect affinity to its receptor affinity, the shorter length of PTH(1-34) made its synthesis more reasonable. Consequently, we tested the effects of PTH(1-34) and dimeric R25CPTH(1-34) due to its known efficacy on bone anabolic effect and relevance in receptor interactions. However, we aim to conduct functional analysis of the dimeric R25CPTH(1-84) in further study.

      • The study is descriptive with no mechanism.

      We recognize that your concern is legitimate. While our study includes descriptive elements, it extends beyond mere observation. The R25CPTH research, which began with a case report, has evolved to utilize molecular techniques to better understand the unique physiological phenomena observed in patients. We have validated the peptide’s dimerization caused by mutations in vitro and assessed their effects in both in vitro cell line models and in vivo mouse models. Although we have not yet confirmed whether <sup>R25C</sup>PTH exists as a dimer or monomer in patient blood, we anticipate it may exist in dimeric form at least some fractions and are currently conducting mass spectrometry on patient blood samples to determine this. Therefore, this paper serves as the first report on this PTH mutant suggesting that it may form a homodimer. Importantly, we are actively investigating the molecular mechanisms and downstream signaling pathways that differentiate normal PTH from dimeric <sup>R25C</sup>PTH. This includes analyzing differences in proteome and transcriptome induced by PTH and dimeric <sup>R25C</sup>PTH and examining the direct molecular characteristics and structural changes responsible for these mutations. Through this comprehensive approach, we aim to provide a detailed mechanistic understanding of <sup>R25C</sup>PTH in the subsequent publication.

      (2) Statistics are inadequately described or performed for the experimental design:

      • The statistical analysis in Figure 5 needs to be written in a way that makes it clearer how statistics were done; t-test or one-way ANOVA?

      Sorry for the inconvenience and thank you for your thorough review. Initially, we conducted the statistical analysis using a t-test. However, during the revision process, we performed a new statistical analysis using one-way ANOVA, as it is more appropriate for comparing the means among three or more groups. Despite this change, there were no differences in statistical significance, so the descriptions remained unchanged.

      • Statistics in Figures 6 and 7 should be performed by one-way ANOVA to compare the mean values of one variable among three or more groups, and not t-test.

      Thank you for your thorough review, and I apologize for any inconvenience. I agree with your suggestion that ANOVA is more appropriate than the t-test for comparing means among three or more groups. Accordingly, we performed new statistical analyses using one-way ANOVA. When we changed the statistical method from t-test to one-way ANOVA, the significance of bone formation markers, P1NP and ALP, appeared only in dimeric R25CPTH and not in wild-type PTH. We have reflected these findings in the text.

      (3) Misleading and confused discussion:

      • The first paragraph lacks clarity in the PTH nomenclature and the authors should provide a clear statement that the PTH mutant found in patients is likely a monomeric R25CPTH(1-84), considering that there has been no proof of a dimeric form.

      Thank you for your insightful comments. I agree that there was some ambiguity in the nomenclature used in the first paragraph of the Discussion section. However, we do not believe that no proof of a dimeric form of the <sup>R25C</sup>PTH(1-84) mutant necessarily indicates that the PTH mutant in the blood is solely monomeric. Identifying the in vivo structure of <sup>R25C</sup>PTH(1-84) is one of the goals of our ongoing project. While the exact form of <sup>R25C</sup>PTH(1-84) in patients is still elusive, we are investigating the possibility that some fraction may exist as a dimer. On page 12, line 274-276, we have revised the content to address this issue and improve clarity as follows.

      - ‘In this study, we show the introduction of a cysteine mutation at the 25th amino acid position of mature parathyroid hormone (<sup>R25C</sup>PTH) facilitates the formation of homodimers comprised of the resulting dimeric R25CPTH peptide in vitro.’

      • Moreover, the authors should discuss the study by White et al. (PNAS 2019), which shows that there are defective PTH1R signaling responses to monomeric R25CPTH(1-34). This results in faster ligand dissociation, rapid receptor recycling, a short cAMP time course, and a loss of calcium ion allosteric effect.

      Sorry for the inconvenience and thank you for your thorough review. The authors were aware of the referenced paper and deeply apologize for its omission during the writing and editing process. Citing this paper will enhance the credibility of our findings. We have now included this citation and made the necessary adjustments to the manuscript of Discussion section on page 12, line 295-296 as follows.

      - ‘We also observed that the potency of cAMP production in cells was lower for dimeric <sup>R25C</sup>PTH as compared to the monomeric <sup>R25C</sup>PTH, in accordance with a lower PTH1R-binding affinity. Previous reports indicated that a mutation at the 25th position of PTH results in the loss of calcium ion allosteric effects on monomeric <sup>R25C</sup>PTH, leading to faster ligand dissociation, rapid receptor recycling, and a shorter cAMP time course (50). Correspondingly, the weaker receptor affinity and reduced cAMP production observed in dimeric <sup>R25C</sup>PTH suggest a possibility that the formation of a disulfide bond at the 25th position significantly alters the function of PTH as a PTH1R ligand. These structural effects are not yet fully understood and need to be investigated further.’

      • The authors should also clarify what they mean by "the dimeric form of R25CPTH can serve as a new peptide ...(lines 328-329)" The dimeric R25CPTH(1-34) induces similar bone anabolic effects and calcemic responses to PTH(1-34), so it is unclear what the new benefit of the dimeric PTH is.

      We apologize for any confusion in our previous description. We concur that, as you mentioned, PTH and dimeric <sup>R25C</sup>PTH indeed exhibit similar activities. We have toned-down our statement, however, there are still some elements showing statistical significance that need to be clearly stated. Specifically, when we changed the statistical method from t-test to one-way ANOVA, the significance of bone formation markers was only observed in dimeric PTH treated samples, and we have revised the manuscript of Results section on page 9, line 206-212 as follows to reflect the change.

      - ‘These analyses revealed that both PTH(1-34) and dimeric <sup>R25C</sup>PTH(1-34) significantly increased the width of the new bone area by approximately four-fold, as compared to the vehicle group (Figure 4B). These findings thus support a capacity of dimeric <sup>R25C</sup>PTH(1-34) to induce new bone formation in vivo, similar to PTH, despite molecular and structural changes.’

      Although it is unclear whether <sup>R25C</sup>PTH circulate as dimeric form or mutant monomeric form, the absence of bone resorption associated with long-term PTH exposure in the patients suggests the potential for a bone anabolic drug without side effects. Also, continued observation of the recently reported young patient in Denmark is expected to clarify this effect further. However, we acknowledge that our current data alone are insufficient to claim that <sup>R25C</sup>PTH may be a more effective anabolic therapy than wild type PTH, and we have adjusted our tone accordingly.

      Thank you for Reviewer #2’s comprehensive and considerate review. We are grateful for the ideas, and we have revised our manuscript accordingly them to improve our paper.

      Reviewer #1 (Recommendations For The Authors):

      (1) Figure 1D lacks molecular weight markers.

      Thank you for your thorough review. We added protein molecular weight markers in the figure.

      (2) The lack of change in plasma cAMP is very surprising, particularly given that there is no difference in the effect of the two forms of PTH on serum calcium or phosphate, or urinary phosphate. This data is somewhat of a distraction since no effort has been made to assess the difference in the effects of these PTH forms on kidney function. I suggest removing this data and spending time working on the origin of this difference.

      Thank you for your insightful comments and valuable suggestions on our manuscript. We also could not precisely explain the discrepancy between the cell line and animal model experiments. However, since the results were consistently observed, we included them in the paper as they may be significant. We acknowledge that in the context of our current research, these data lack sufficient correlation with other findings. Therefore, we have removed the data about the lack of change in plasma cAMP by PTH injection (Figure 4. Effect of cAMP production by PTH injection in CD1 female mice) and revised the manuscript accordingly (Page 8, line 188-194; page 12, line 301-306; page 19, line 454-456). We are currently conducting further research with multiomics data analysis to elucidate potential differences in the sub-signaling pathways between PTH and dimeric R25CPTH, to identify the specific functions affected by these variations, and to understand the underlying mechanisms. The lack of changes in plasma cAMP levels in vivo will be addressed in a subsequent publication detailing our findings.

      (3) Introduction, line 61. The authors state that "most" anti-resorptive therapies cannot stimulate new bone formation. I don't believe that ANY anti-resorptive therapies stimulate new bone formation! If there is one, this should be referenced.

      Thank you for pointing out important aspects. Romosozumab, a humanized monoclonal anti-sclerostin antibody, has a dual effect by enhancing bone formation and inhibiting bone resorption. Sclerostin, a protein produced by osteocytes, plays a role in the regulation of bone metabolism. It promotes osteoclast differentiation, which is associated with bone resorption, and suppresses osteoblast activity, which is crucial for bone formation. By binding to sclerostin, Romosozumab prevents it from blocking the signaling pathways necessary for osteogenesis. Consequently, Romosozumab therapy not only regulates bone resorption but also affects new bone formation. We added the references to that information.

      (4) The authors tend to include a lot of methods in the results section (e.g. describing the number of replicates, and details of histological analysis). This should be minimized.

      Thank you for your thorough review, and sorry for the inconvenience. We have minimized the methodological details in the results section, ensuring that only essential information for understanding the findings and the procedures remain.

      (5) Lines 302-305: If retaining the blood cAMP data, please provide references for the assertion that renal PTH receptors mediate this response.

      PTH exerts its effects primarily through the PTH1 receptor (PTH1R), a G protein-coupled receptor present in various tissues, including bone and kidney (Chase et al., 1968, Chase et al., 1970). When activated by PTH, this receptor stimulates the production of cyclic AMP (cAMP), with the kidneys playing a significant role in this process (Maeda et al., 2013). In the initial manuscript, the importance of renal PTH receptors in mediating the blood cAMP response may have been overemphasized. We appreciate your feedback on this point, and we have provided references to support this assertion. However, by process following the former ‘Recommendations for the Authors’, we removed the data about the lack of change in plasma cAMP by PTH injection, the description of the renal PTH receptors mediate this response of blood cAMP also removed.

      - Chase, Lewis R., and G. D. Aurbach. "Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin." Science 159.3814 (1968): 545-547.DOI:10.1126/science.159.3814.545

      - Chase, Lewis R., and G. D. Aurbach. "The effect of parathyroid hormone on the concentration of adenosine 3', 5'-monophosphate in skeletal tissue in vitro." Journal of Biological Chemistry 245.7 (1970): 1520-1526.DOI:10.1016/S0021-9258(19)77126-9

      - Maeda, Akira, et al. "Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH." Proceedings of the National Academy of Sciences 110.15 (2013): 5864-5869.DOI: 10.1073/pnas.1301674110

      (6) Eosin stains bone pink and haematoxylin stains cells purple. This has been incorrectly described in the manuscript.

      Thank you for your thorough review, and I apologize for any confusion caused by the poor description. It appears that the terms were used interchangeably during the editing process. We have corrected the description in the manuscript and will ensure such mistakes do not occur again in the future.

      (7) Sodium thiosulphate is a fixative for Von Kossa staining, not an agent that removes nonspecific binding.

      Thank you for your careful review. However, there seems to be a misunderstanding of sodium formaldehyde as sodium thiosulfate. A 5% sodium thiosulfate solution is a critical in vitro diagnostic agent used in various staining kits. As a reducing agent, it effectively removes excess silver ions in staining kits based on silver impregnation techniques. In our experiment, sodium thiosulfate was specifically used to remove residual silver ions in Von Kossa staining. For more details, please refer to the following link: https://www.morphisto.de/en/shop/detail/d/Natriumthiosulfat_5//12825/.

      Reviewer #2 (Recommendations For The Authors):

      Moderate-to-Minor points:

      • Line 73: it's either class B GPCR or secretin receptor family but not class B GPCR family.

      Thank you for your thorough review, and I apologize for any confusion in our previous description. We corrected the description in the manuscript as class B GPCR.

      • Line 79: correct "adenylate cyclase" to "transmembrane adenylate cyclases"

      Thank you for your thorough review, and I apologize for any confusion in our previous description. We corrected the description in the manuscript as transmembrane adenylate cyclases.

      • Line 89: should "hypothyroidism" be "hypoparathyroidism"?

      Thank you for your thorough review, and I apologize for any confusion in our previous description. We corrected the description in the manuscript as hypoparathyroidism.

      • Line 159: all agonists display higher binding affinities when their receptors are coupled to G proteins, so it's unclear why the higher affinity of the dimeric <sup>R25C</sup>PTH(1-34) for the RG state seems to be important for the authors.

      Thank you for your insightful comments. First of all, comparing the binding affinities of the R0 (G protein-uncoupled) and RG (G protein-coupled) conformations of the receptor is inappropriate. This is because the form and size of the radio-label ligand bound to each conformation differ, which consequently affects their binding affinities and, in turn, influences the binding strength of target ligands such as PTH, monomeric <sup>R25C</sup>PTH, and dimeric <sup>R25C</sup>PTH. Therefore, it is preferable to compare how the binding strengths of test ligands differ for each conformation. Additionally, the fact that significant binding affinity is lost for R<sup>0</sup> while remaining high for the RG conformation of PTH1R is important because typical PTH exhibits high binding affinity for R0, whereas PTHrP shows higher affinity for the RG conformation. This suggests that dimeric <sup>R25C</sup>PTH may possess distinct molecular characteristics and potentially induce different downstream signaling pathways compared to typical PTH.

      • Line 169-170 and Fig. 2: According to the theory of receptor pharmacology established in the 60s' for native receptors (Arch. Int. Pharmacodyn. 127:459-478 (1960); Arch. Int. Pharmacodyn. 136:385-413 (1962)) and verified later in the 80-90's for recombinant GPCRs, the activity constant (Kact or EC50) value of hormone actions in various tissues or cells is equal to the dissociation constant (Kd) of the hormone when receptors are not overexpressed (EC50 = Kd). When receptors are overexpressed (presence of spare receptors), then EC50 < Kd. Assuming that after Cheng-Prussof correction for data in Fig. 2, IC50 < Ki = Kd, how do the authors explain that IC50 values for RG are about 1-Log lower than EC50s (i.e., EC50 > Kd)?

      We appreciate your insightful comment and fully acknowledge the established theory of receptor pharmacology, which states that Kd equals EC50, and when the receptor is overexpressed, EC50 is less than Kd. After having read your comments, we have revisited this paper Okazaki et al, PNAS, 2008 to better understand the PTH interaction with PTH1R. While our data might appear to contradict this theory, we believe that a direct comparison between the IC50 of RG and the EC50 in Figure 2 may not be entirely appropriate for the following reasons. First, the IC50 was determined from membrane preparations of a receptor-overexpressing cell line (GP-2.3), whereas the EC50 was calculated based on the cAMP response in SaOS-2 cells. These different experimental conditions contribute to the observed discrepancies. Second, the peptides used in the competition assays differ. R<sup>0</sup> utilized radiolabeled PTH(1-34), while RG employed M-PTH(1-15) with several amino acid substitutions and a shorter length. This further complicates a direct comparison between the EC50 and IC50 values in our study.

      Thank you for all the reviewers’ thorough and thoughtful reviews. We greatly appreciate your suggestions and have addressed all the issues to enhance the quality of our paper.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Aging reduces tissue regeneration capacity, posing challenges for an aging population. In this study, the authors investigate impaired bone healing in aging, focusing on calvarial bones, and introduce a two-part rejuvenation strategy. Aging depletes osteoprogenitor cells and reduces their function, which hinders bone repair. Simply increasing the number of these cells does not restore their regenerative capacity in aged mice, highlighting intrinsic cellular deficits. The authors' strategy combines Wnt-mediated osteoprogenitor expansion with intermittent fasting, which remarkably restores bone healing. Intermittent fasting enhances osteoprogenitor function by targeting NAD+ pathways and gut microbiota, addressing mitochondrial dysfunction - an essential factor in aging. This approach shows promise for rejuvenating tissue repair, not only in bones but potentially across other tissues.

      Strengths:

      This study is exciting, impressive, and novel. The data presented is robust and supports the findings well.

      Weaknesses:

      As mentioned above the data is robust and supports the findings well. I have minor comments only.

      We thank the reviewer for their enthusiastic and positive assessment of our study. We appreciate the recognition of the novelty and robustness of our data and findings. We have carefully considered the reviewer's comments and have revised the manuscript accordingly. We believe these revisions further strengthen the clarity and impact of our work.

      Reviewer #2 (Public review):

      Summary:

      Reeves et al explore a model of bone healing in the context of aging. They show that intermittent fasting can improve bone healing, even in aged animals. Their study combines a 'bone bandage' which delivers a canonical Wnt signal with intermittent fasting and shows impacts on the CD90 progenitor cell population and the healing of a critical-sized defect in the calvarium. They also explore potential regulators of this process and identify mitochondrial dysfunction in the age-related decline of stem cells. In this context, by modulating NAD+ pathways or the gut microbiota, they can also enhance healing, hinting at an effect mediated by complex impacts on multiple pathways associated with cellular metabolism.

      Strengths:

      The study shows a remarkable finding: that age-related decreases in bone healing can be restored by intermittent fasting. There is ample evidence that intermittent fasting can delay aging, but here the authors provide evidence that in an already-aged animal, intermittent fasting can restore healing to levels seen in younger animals. This is an important finding as it may hint at the potential benefits of intermittent fasting in tissue repair.

      Weaknesses:

      The authors explore potential mechanisms by which the intermittent fasting protocol might impact bone healing. However, they do not identify a magic bullet here that controls this effect. Indeed, the fact that their results with intermittent fasting can be replicated by changing the gut microbiota or modulating fundamental pathways associated with NAD, suggests that there is no single mechanism that drives this effect, but rather an overall complex impact on metabolic processes, which may be very difficult to untangle.

      We thank the reviewer for their positive assessment of our study and for highlighting the significant finding that intermittent fasting can restore age-related declines in bone healing. We appreciate the observation that our results suggest a complex interplay of metabolic processes rather than a single "magic bullet" mechanism. Indeed, the ability of gut microbiota modulation or NAD+ pathway targeting to replicate intermittent fasting's benefits underscores this complexity. While we recognize the challenges of disentangling these interconnected pathways, we believe our findings offer valuable insights into the multifaceted nature of intermittent fasting's impact on aged tissue repair. We hope this study serves as a foundation for future research aimed at identifying the individual contributions of these pathways and developing targeted therapeutic strategies.

      Reviewer #3 (Public review):

      Summary:

      This study aims to address the significant challenge of age-related decline in bone healing by developing a dual therapeutic strategy that rejuvenates osteogenic function in aged calvarial bone tissue. Specifically, the authors investigate the efficacy of combining local Wnt3a-mediated osteoprogenitor stimulation with systemic intermittent fasting (IF) to restore bone repair capacity in aged mice. The highlights are:

      (1) Novel Approach with Aged Models:

      This pioneering study is among the first to demonstrate the rejuvenation of osteoblasts in significantly aged animals through intermitted fasting, showcasing a new avenue for regenerative therapies.

      (2) Rejuvenation Potential in Aged Tissues:

      The findings reveal that even aged tissues retain the capacity for rejuvenation, highlighting the potential for targeted interventions to restore youthful cellular function.

      (3) Enhanced Vascular Health:

      The study also shows that vascular structure and function can be significantly improved in aged tissues, further supporting tissue regeneration and overall health.<br /> Through this innovative approach, the authors seek to overcome intrinsic cellular deficits and environmental changes within aged osteogenic compartments, ultimately achieving bone healing levels comparable to those seen in young mice.

      Strengths:

      The study is a strong example of translational research, employing robust methodologies across molecular, cellular, and tissue-level analyses. The authors leverage a clinically relevant, immunocompetent mouse model and apply advanced histological, transcriptomic, and functional assays to characterise age-related changes in bone structure and function. Major strengths include the use of single-cell RNA sequencing (scRNA-seq) to profile osteoprogenitor populations within the calvarial periosteum and suture mesenchyme, as well as quantitative assessments of mitochondrial health, vascular density, and osteogenic function. Another important point is the use of very old animals (up to 88 weeks, almost 2 years) modelling the human bone aging that usually starts >65 yo. This comprehensive approach enables the authors to identify critical age-related deficits in osteoprogenitor number, function, and microenvironment, thereby justifying the combined Wnt3a and IF intervention.

      Weaknesses:

      One limitation is the use of female subjects only and the limited exploration of immune cell involvement in bone healing. Given the known role of the immune system in tissue repair, future studies including a deeper examination of immune cell dynamics within aged osteogenic compartments could provide further insights into the mechanisms of action of IF.

      We thank the reviewer for their thorough summary and positive assessment of our study, particularly highlighting its translational nature, the robust methodologies employed, and the relevance of our aged animal model. We appreciate the insightful suggestion to include male subjects and to explore immune cell dynamics in future investigations.

      We acknowledge the limitation of using only female mice in the current study and agree that future studies incorporating both sexes and investigating immune cell contributions within aged osteogenic compartments would offer valuable insights into the mechanisms underlying intermittent fasting and its impact on bone healing.

      Our focus on female mice was informed by their distinct characteristics, including delayed healing and higher fracture risk (PMID: 37508423, PMID: 34434120). Importantly, female mice present a more challenging case for bone repair, making them a stringent test for evaluating the effectiveness of our rejuvenation approaches. Moreover, our research protocol, approved under animal license, adhered to ethical principles and the 3Rs, allowing us to reduce the number of animals required by focusing on a single sex.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The authors should provide a justification for the use of female mice in this study. Additionally, the section on animal methods should be expanded to align with ARRIVE guidelines.

      We thank the reviewer for their valuable feedback. In response to the comment regarding the use of female mice, we have included a justification in the updated manuscript. As noted, female mice were selected for this study due to their distinct characteristics, such as delayed healing and higher fracture risk (PMID: 37508423, PMID: 34434120), which provide a more challenging model for evaluating bone repair strategies. We believe this made our study a stringent test of the efficacy of the rejuvenation approaches being investigated.

      Additionally, we have revised the animal methods section to ensure it aligns with the ARRIVE guidelines.

      (2) Intermittent fasting can influence circadian rhythms in various ways. In the RNA-seq data, do the authors observe any changes related to circadian rhythm pathways?

      The reviewer raises an important point regarding the influence of intermittent fasting (IF) on circadian rhythms. Our RNA-seq data revealed significant alterations in circadian rhythm pathways, particularly within the aged periosteal CD90+ cell population during IF. Specifically, the PAR bZip family transcription factors Dbp, Hlf, and Tef (q < 0.05) were significantly upregulated, consistent with their established roles as circadian rhythm regulators (PMID: 16814730, PMID: 31428688).

      In suture CD90+ cells from the Aged + IF group, Dbp expression was significantly elevated compared to the Aged AL control group. Moreover, several other circadian-controlled genes, including Sirt1, Kat2b, Csnk1e, Ezh2, Fbxw11, and Ucp2 (p < 0.05), were also upregulated (Fig. 4b), suggesting enrichment of Clock/Per2/Arntl transcriptional targets, essential components of the circadian clock.

      The observed upregulation of circadian rhythm effectors like Dbp, Hlf, and Tef further suggests a potential role for circadian transcription in CD90+ cell rejuvenation and bone repair in aged mice. While previous studies have primarily focused on the role of circadian rhythms in osteoblasts in vitro (PMID: 34579752, PMID: 30290183), our findings provide compelling evidence for their involvement in bone regeneration in vivo, providing compelling evidence for future investigation into this mechanism.

      Chip-SEQ studies have shown D-box sites near promoters in Wnt/β-catenin components (e.g. Lrp6, Lrp5, Wnt8a, Fzd4) in pro-osteogenic transcription factor Zbtb16 (and see Fig 5), and in 11 of the 44 mouse collagen genes (PMID: 31428688). These components are known to regulate osteogenesis, and their proximity to circadian-controlled transcription factors suggests a possible overlap between circadian regulation and Wnt signaling in promoting bone repair.  Additionally, circadian rhythmicity, stem cell function, and Wnt signaling are interlinked (PMID: 29277155, PMID: 25414671). Food intake is a powerful regulator of the circadian rhythm in several organs (PMID: 11114885, PMID: 32363197), but little is known about the diet-circadian interaction in bone repair. The possibility that circadian transcription can be harnessed to target Aged stem cell function towards bone repair is a promising prospect.

      We have incorporated this information in Figure 2 - figure supplement 3G-H, the results section as well as in the discussion.

      Reviewer #2 (Recommendations for the authors):

      (1) The authors refer to 'altered cellular mechanobiology', 'age-related changes in mechanobiology', etc. Here, they are using this terminology to refer to changes in F-actin intensity and nuclear shape. While I agree that these measures are indicators of a cellular response to mechanical cues, calling this 'changes in mechanobiology' doesn't sound quite correct to me. 'Mechanobiology' to me, is a field of study. Perhaps the authors should consider changing their terminology.

      We appreciate the reviewer’s insightful comment on the terminology used in our manuscript. We agree that the term "mechanobiology" is a broad field of study and using it in the context of changes in F-actin intensity and nuclear shape may be misleading. We have revised the text to better reflect the specific cellular responses to mechanical cues, such as changes in the cytoskeleton and nuclear morphology, rather than referring to them as "altered mechanobiology." The updated terminology more accurately conveys the observed cellular alterations in response to mechanical forces. We have made these adjustments throughout the manuscript for clarity and precision.

      (2) Three of the measures the authors use to highlight age-related changes (and rejuvenation) in their animal model are F-actin intensity, nuclear shape, and vascularisation. However, they never really explain what they believe these readouts mean practically/functionally. Indeed, it makes sense that less vascularisation would be associated with an aged phenotype and preclude healing, but this is only mentioned somewhat cursorily in the discussion. While vascularisation is discussed in the context of aging in the discussion, it is not discussed in the context of healing (which would seem relevant in the context of vascularisation being used as a readout in the healing models in response to Akk and IF treatment). Similarly, the changes in F-actin intensity and nuclear shape might suggest changes in the stiffness of the periosteum (as mentioned in the discussion), which could indeed be an indicator of an aged phenotype; however, their role in healing (in response to Akk and IF) are not clearly articulated.

      We appreciate the reviewer’s insightful comments and have made revisions to clarify the implications of age-related changes in vascularization, F-actin intensity, and nuclear shape, as well as the functional significance of these observations in the context of healing and rejuvenation.

      Vascularization:

      Vascularization and modulation of blood flow are critical for calvarial bone repair, as supported by multiple studies (e.g., PMID: 38032405, PMID: 21156316, PMID: 25640220). Early in the calvarial repair process, blood vessels grow independently of osteoprogenitor cells, establishing a supportive environment that promotes osteoprogenitor migration and subsequent ossification (PMID: 38834586). Furthermore, angiogenic vessels from the periosteum at defect edges contribute to creating a specialized microenvironment essential for bone healing (PMID: 38834586, PMID: 38032405). Compromised vascularization significantly impairs the healing of critical-sized calvarial defects (PMID: 29702250).

      Our data reveal a decline in periosteal vascularization with age, potentially compromising this microenvironment and impairing repair in aged animals. Importantly, our findings indicate that intermittent fasting (IF) reverses this phenotype by restoring periosteal vascularization. This rejuvenation of the vascular microenvironment aligns with improved bone repair outcomes in aged mice subjected to IF. We have revised the manuscript to emphasize the importance of vascularization in healing and to highlight the role of IF in restoring this critical aspect of the bone healing microenvironment.

      F-actin intensity and nuclear shape:

      Age-related changes in F-actin intensity and nuclear shape are associated with increased tissue stiffness, a hallmark of aging. Tissue stiffness has been shown to impair progenitor cell function and hinder repair in various systems, including neuroprogenitors (PMID: 31413369). Softening the extra cellular matrix in aged tissues has been demonstrated to partially restore progenitor function and improve repair outcomes, as seen in the case of neuroprogenitors (PMID: 31413369). In our study, IF reversed age-associated changes in F-actin expression and nuclear shape, restoring these parameters to a phenotype resembling that of younger animals. This suggests that IF mitigates the mechanical changes associated with aging, reducing tissue stiffness and rejuvenating the periosteum to facilitate improved bone healing, similar to the outcomes observed in younger models.

      Following the reviewer’s advice, we have revised the text to clearly articulate the correlations and interpretations of our data regarding tissue mechanics and bone repair. Thank you for highlighting these critical aspects.

      (3) In relation to my point 2) on nuclear shape, there are reports that aging is linked to changes in Lamin B1. Have the authors considered this? It might provide a clearer link between their data and the tissue-level phenotypes they observe.

      Thank you for your comment regarding the potential link between aging and changes in Lamin B1. Following your suggestion, we performed Lamin B1 immunostaining on samples from Young, Adult, Aged, and Aged + IF groups. However, no significant differences in Lamin B1 levels were observed across these groups. These findings indicate that changes in Lamin B1 in osteoprogenitors are not apparent during aging, suggesting that Lamin B1 alterations in the context of aging may be tissue- and cell-type-specific.

      The new data was added in Figure 1 - figure supplement 2i-j.

      (4) In the data associated with Figure 2, the authors find that in the aged mice, MMP9 expression is increased, but MMP2 expression is decreased. They associate the decrease in MMP2 expression with decreased migration, but the canonical function of MMP9 should be similar to that of MMP2. Are there tissue-specific differences in the activity of MMP2/9 that could account for this?

      Thank you for the thoughtful comment. While both MMP-2 and MMP-9 are involved in ECM remodeling and share some overlapping canonical functions, their roles are context-dependent and exhibit tissue-specific differences that could explain the observed changes in aged mice. MMP-2 has been shown to play a critical role in maintaining the structural and functional integrity of flat bones, such as those in the craniofacial skeleton, by supporting bone remodeling (PMID: 17400654, PMID: 17440987, PMID: 16959767). The decreased expression of MMP-2 in aged mice may impair these local processes, leading to reduced migratory capacity of osteoprogenitors and contributing to aging-related changes in flat bone structure and function.

      In contrast, MMP-9 is more prominently involved in long bone remodeling, particularly at the growth plate where it regulates hypertrophic chondrocyte turnover, vascularization, and ossification during endochondral bone formation (PMID: 21611966, PMID: 9590175, PMID: 23782745, PMID: 16169742 ). Additionally, MMP-2 and MMP-9 differ in their regulation of specific ECM substrates and their interactions with bone-resident cells, which may further drive divergent outcomes in distinct bone types. For example, MMP-9’s role in osteoclastogenesis and its regulation of ECM proteins like type I collagen could be more critical in long bones, while MMP-2’s involvement in fine-tuning ECM microarchitecture may hold greater importance in flat bones.

      The increased expression of MMP-9 in aged calvarial osteoprogenitors may reflect a compensatory mechanism in response to the reduced MMP-2 activity, possibly in response to increased ECM turnover demands. Further studies examining the precise molecular pathways driving these changes in osteoprogenitors will help clarify the underlying mechanisms and their contributions to age-related alterations in flat bone structure and function.

      (5) In lines 391-2, the authors conclude that the data from Figure 4 shows that "during IF, CD90 cells, despite being aged, are more capable of ECM modulation and migration". The authors certainly present evidence that this is true, but the RNAseq showed that the enriched GO terms were predominantly associated with immune responses ('response to cytokine') and the proliferation phenotype seems very strong. Therefore, I would suggest that this overarching statement regarding the findings be less focussed on this one aspect of the finding, which doesn't look to be the dominant phenotype of the cellular response. And indeed, the authors move on from here to explore a mechanism associated with metabolism, not specifically with ECM remodelling.

      We greatly appreciate the reviewer insight regarding the interpretation of our findings, particularly the conclusion drawn from Figure 4.

      In response, we have revised the conclusion to more accurately reflect these findings.

      The revised text in the conclusion now reads: " Together, these findings suggest that IF rejuvenates aged CD90+ cells, in part, by enhancing proliferation, immune response, ECM remodeling, Wnt/β-catenin pathway, and metabolism, including increased ATP levels and decreased AMPK levels.”

      We hope that this adjustment better aligns with your suggestion and provides a more accurate summary of the key findings.

      (6) Fasting blood glucose levels are often cited as an indicator of metabolic health. Did the authors look at this in their animals who underwent the IF protocol? Could this have had an impact on the healing response?

      We thank the reviewer for this insightful comment. Throughout our study, we have withdrawn blood from the animals for various analyses that were not included in this manuscript in order to maintain focus on the osteoprogenitors.

      Our analysis included the assessment of the metabolic health of the animals using fasting blood glucose levels and the area under the curve (AUC) of the intraperitoneal glucose tolerance test (IPGTT).

      Fasting blood glucose levels reflect the animals' ability to maintain stable glucose levels after fasting, while the AUC from the IPGTT measures how efficiently glucose is cleared from the bloodstream following a glucose challenge. Typically, lower fasting blood glucose levels and reduced AUC indicate improved insulin sensitivity, better glucose metabolism, and enhanced metabolic control (PMID: 18812462, PMID: 19638507).

      Our findings show that intermittent fasting (IF) significantly reduced both the fasting blood glucose levels and the AUC in the IPGTT. This indicates that IF enhances metabolic flexibility, likely through improved insulin sensitivity and better glucose homeostasis. By lowering fasting blood glucose, IF reduces the reliance on excessive gluconeogenesis during fasting, while a reduced AUC indicates more efficient postprandial glucose clearance, consistent with enhanced insulin action and reduced fluctuations in blood glucose levels. The new data has been incorporated in Figure 3 - figure supplement 1d-g.

      Methods:

      “Blood glucose level measurement

      Fasting blood glucose levels were measured (Accu-Check tests strips) from 6h fasting mice by blood sampling the tail vein. For intraperitoneal glucose tolerance test (IPGTT), glucose was injected intraperitoneally (2 g/kg), and the blood glucose levels were measured after 15, 30, 60 and 120 minutes.”

      Improved metabolic health through lower fasting glucose and reduced AUC can have profound implications for tissue repair (PMID: 32809434). Stable glucose levels ensure a consistent energy supply for key cellular processes, such as cell proliferation, migration, and differentiation, which are essential for regeneration. Enhanced insulin sensitivity supports nutrient delivery to cells and reduces inflammation, creating an environment conducive to tissue healing. Additionally, intermittent fasting's ability to optimize glucose metabolism and regulate insulin secretion may enhance the function of stem and progenitor cells, further improving the tissue repair process (PMID: 28843700). Together, these findings suggest a mechanistic link between improved metabolic health and the enhanced healing observed in animals subjected to intermittent fasting.

      (7) In Supplementary Figure 10, the authors look at bone remodelling by assessing TRAP staining, as an indicator of osteoclast activity. I'm not sure if these data add all that much to the study. The authors have looked at bone formation at a tissue level using microCT. Here, they look at bone resorption at a cellular level with the TRAP assay. Overall, this probably suggests more bone remodelling, but the TRAP assay on its own at the cellular level could also be interpreted as an osteoporosis-like phenotype. This is clearly not the case because the authors show robust bone healing by microCT. In short, as an isolated measure of osteoclast activity at the cellular level without cellular-level assays of osteoblast activity, the interpretation of these data is not that clear. The microCT speaks far more of the phenotype and is, in my opinion, sufficient to make this point.

      We thank the reviewer for their comments regarding the interpretation of the TRAP staining data and its context within the study. We appreciate the concern that, without direct assays of osteoblast activity, the TRAP assay could lead to ambiguity.

      We have shown that intermittent fasting significantly increases the number and function of osteoprogenitor cells, the precursors to osteoblasts. While we acknowledge that these data do not directly measure osteoblast numbers or activity, they strongly suggest an increased capacity for osteoblast differentiation and bone formation. This aligns with the microCT findings of robust bone structure and healing.

      After careful consideration and given that the microCT and histology findings  already provide robust and comprehensive evidence for bone structure and healing, we have decided to remove the TRAP staining data from the manuscript. We believe this change simplifies the manuscript and strengthens its focus on the most impactful data.

      (8) In the discussion, the authors make a number of links between aging and IF. However, one of the exciting conclusions of this manuscript is that IF aids in healing in aged animals. In this context, IF has not impacted the aging process itself because the animals have not experienced an IF protocol across their lifespan, but rather only after injury. In this context, perhaps the authors should also be focussing their discussion on evidence of the short-term response to IF rather than its effects on aging, which are longer-term.

      We appreciate the reviewer's comment and agree that emphasizing the short-term effects of intermittent fasting is crucial. Our study is the first to examine this protocol in Aged animals.

      To address this, we have revised the discussion and highlighted how short-term IF enhances metabolic health, promotes osteoprogenitor functionality, and supports bone remodeling, as observed in our study.

      Reviewer #3 (Recommendations for the authors):

      (1) The authors should clarify details on intermittent fasting protocols, especially regarding caloric intake differences between fasting and non-fasting days, to aid reproducibility.

      We appreciate the reviewer's suggestions and have incorporated them by clarifying the relevant details. The new data are presented in Figure 3 - figure supplement 1a-c.

      Methods:

      “Caloric intake calculation

      To assess the caloric intake of mice, the food was weighted when made available to the mice (Win), and when removed (Wout). The daily consumed food was calculated based on the weight difference (Win - Wout), then converted to kcal (1 g = 3.02 kcal, LabDiet, 5053), and expressed as kcal/mouse/day for each cage (n cage ³ 3 with 1 to 5 mice/cage).”

      (2) Did the authors evaluate the effect of their intermittent fasting protocol on fasting blood glucose levels?

      Following the reviewer comment we included two measurements: 1) Fasting blood glucose, which reflects the ability to maintain glucose homeostasis during fasting, and 2) fasting blood glucose levels and the area under the curve (AUC) of the intraperitoneal glucose tolerance test (IPGTT), which measures glucose clearance efficiency after a glucose challenge. Lower values for both typically indicate improved insulin sensitivity, glucose metabolism, and metabolic control.

      Our findings demonstrate that intermittent fasting significantly reduced both fasting blood glucose and IPGTT AUC, suggesting enhanced metabolic flexibility, likely through improved insulin sensitivity and glucose homeostasis. Lower fasting blood glucose with IF indicates reduced reliance on gluconeogenesis during fasting, while a reduced AUC suggests more efficient postprandial glucose clearance, consistent with enhanced insulin action and reduced blood glucose fluctuations. This new data is included in Figure 3 - figure supplement 1.

      Generally, the improved metabolic environment supports tissue repair by ensuring adequate energy for cell proliferation and migration, reducing inflammation, and promoting the function of stem cells involved in tissue regeneration. Thus, this outcome of intermittent fasting may create a more favorable environment for tissue repair, potentially accelerating the healing of damaged tissues and improving overall regenerative capacity.

      (3) In Figure 1E-F, the nuclei have an interesting shape and the authors quantified F-actin. Given the role of lamin B in nuclear integrity, an analysis of lamin B expression and its structural integrity in aged osteoprogenitors could provide valuable insights into cellular aging mechanisms and their potential reversal with intermittent fasting.

      In response to the reviewer's comment, we performed Lamin B1 immunostaining on samples from Young, Adult, Aged, and Aged + IF groups. We observed no significant differences in Lamin B1 levels across these groups. This suggests that age-related changes in Lamin B1 are not evident in osteoprogenitors and may be tissue- or cell-type specific. The new data was added in Figure 1 - figure supplement 2i-j.

      (4) The authors should explain, in the main text or the methods section, why are they only using females in this study.

      We appreciate the reviewer's comment regarding the use of female mice. Female mice were chosen for this study due to their delayed healing and higher fracture risk (PMID: 37508423, PMID: 34434120), presenting a more challenging model for evaluating bone repair strategies and providing a stringent test of our rejuvenation approaches. This justification has been added to the revised manuscript. The animal methods section has also been updated to comply with ARRIVE guidelines.

      (5) This story stands alone and has an incredible amount of data. However, for a follow-up study, I would like to suggest consideration of including a broader analysis of immune cell involvement within the osteogenic compartments to strengthen the mechanistic understanding of IF's impact.

      We thank the reviewer for this insightful suggestion. We agree that investigating the role of immune cells within the osteogenic compartments could provide valuable mechanistic insights into how intermittent fasting influences tissue regeneration. Immune cells are key mediators of inflammation and repair, and their interactions with osteoprogenitors and other cells in the bone healing environment likely contribute to IF's effects.

      While our study focuses on IF's impact on osteoprogenitor function and tissue repair, we acknowledge the importance of future research exploring immune cell involvement. Techniques like single-cell RNA sequencing or flow cytometry could characterize immune cell populations and their functional states within osteogenic niches, allowing for a deeper understanding of immune-skeletal interactions during IF-mediated bone healing. We appreciate the reviewer highlighting this promising avenue for future research.

      Minor corrections to the text and figures:

      (1) References formatting should be revised (eg. line 41).

      The reference formatting was corrected.

      (2) Line 144 - what do the authors mean by p2 in the references?

      Thank you for your comment, we corrected the error and removed p2 from the reference.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review): 

      Summary: 

      Nitric oxide (NO) has been implicated as a neuromodulator in the retina. Specific types of amacrine cells (ACs) produce and release NO in a light-dependent manner. NO diffuses freely through the retina and can modulate intracellular levels of cGMP, or directly modify and modulate proteins via S-nitrosylation, leading to changes in gap-junction coupling, synaptic gain, and adaptation. Although these system-wide effects have been documented, it is not well understood how the physiological function of specific neuronal types is affected by NO. This study aims to address this gap in our knowledge. 

      There are two major findings. 1) About a third of the retinal ganglion cells display cell-type specific adaptation to prolonged stimulus protocols. 2) Application of NO specifically affected Off-suppressed ganglion cells designated as G32 cells. The G32 cluster likely contains 3 ganglion cell types that are differentially affected. 

      This is the first comprehensive analysis of the functional effects of NO on ganglion cells in the retina. The cell-type specificity of the effects is surprising and provides the field with valuable new information. 

      Strengths: 

      NO was expected to produce small effects, and considerable effort was expended in validating the system to ensure that changes in the state of the preparation would not confound any effects of NO. The authors used a sequential stimulus protocol to control for changes in the sensitivity of the retina during the extended recording periods. The approach potentially increases the sensitivity of the measurements and allows more subtle effects to be observed. 

      Neural activity was measured by Ca-imaging. Responsive ganglion cells were grouped into 32 types using a clustering analysis. Initial control experiments demonstrated that the celltypes revealed by the analysis largely recapitulate those from their earlier landmark study using a similar approach. 

      Application of NO to the retina modulated responses of a single cluster of cells, labeled G32, while having little effect on the remaining 31 clusters. In separate experiments, ganglion cell spiking activity was recorded on a multi-electrode array (MEA). Together the Ca-imaging and MEA recordings provide complementary approaches and demonstrate that NO modulates the temporal but not spatial properties of affected cell-types.

      Weaknesses: 

      The concentration of NO used in these experiments was ~0.25µM, which is 5- to 10-fold lower than the endogenous concentration previously measured in rodent retina. It is perhaps surprising that this relatively low NO concentration produced significant effects. However, the endogenous measurements were done in an eye-cup preparation, while the current experiments were performed in a bare (no choroid) preparation. Perhaps the resting NO level is lower in this preparation. It is also possible that the low concentration of NO promoted more selective effects.

      Reviewer #2 (Public review): 

      Neuromodulators are important for circuit function, but their roles in the retinal circuitry are poorly understood. This study by Gonschorek and colleagues aims to determine the modulatory effect of nitric oxide on the response properties of retinal ganglion cells. The authors used two photon calcium imaging and multi-electrode arrays to classify and compare cell responses before and after applying a NO donor DETA-NO. The authors found that DETA-NO selectively increases activity in a subset of contrast-suppressed RGC types. In addition, the authors found cell-type specific changes in light response in the absence of pharmacological manipulation in their calcium imaging paradigm. This study focuses on an important question and the results are interesting. The limitations of the method and data interpretation are adequately discussed in the revised manuscript. 

      The authors have addressed my previous comments, included additional discussions on the limitations of the method, and provided a more careful interpretation of their data. 

      Recommendations for the authors: 

      Please correct the citation that reviewer #1 mentioned. In addition, a little more discussion of the NO concentration issue would be helpful. The low NO concentration is not a weakness in the data; it simply raises questions regarding the interpretation.

      Thank you for these recommendations.

      Regarding the citation error, we are not sure if Reviewer #1 refers to a citation   formatting error or incorrect placement. In any case, we modified the text: We  specified the extracted information regarding the NO concentrations and put the  applied concentration into that context (Lines 621-635). In addition, we made clear  that the citation of Guthrie (2014) refers to the dissertation, which can be easily  retrieved via Google Scholar. We also cited the mentioned ARVO abstract by   Guthrie and Mieler (2014). 

      We hope that these modifications solve the above-mentioned issues. 


      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):  

      Summary: 

      Nitric oxide (NO) has been implicated as a neuromodulator in the retina. Specific types of amacrine cells (ACs) produce and release NO in a light-dependent manner. NO diffuses freely through the retina and can modulate intracellular levels of cGMP, or directly modify and modulate proteins via S-nitrosylation, leading to changes in gap-junction coupling, synaptic gain, and adaptation. Although these system-wide effects have been documented, it is not well understood how the physiological function of specific neuronal types is affected by NO. This study aims to address this gap in our knowledge. 

      Strengths: 

      NO was expected to produce small effects, and considerable effort was expended in validating the system to ensure that any effects of NO would not be confounded by changes in the state of the preparation. The authors used a paired stimulus protocol to control for changes in the sensitivity of the retina during the extended recording periods. The approach potentially increases the sensitivity of the measurements and allows more subtle effects to be observed. 

      Neural activity was initially measured by Ca-imaging. Responsive ganglion cells were grouped into 32 types using a clustering analysis. Initial control experiments demonstrated that the cell-types revealed here largely recapitulate those from their earlier landmark study using the same approach (Fig. 2). 

      Application of NO to the retina strongly modulated responses of a single cluster of cells, labeled G32, while having little effect on the remaining 31 clusters. This result is evident in Fig. 3e. 

      Separate experiments measured ganglion cell spiking activity on a multi-electrode array (MEA). Clustering analysis of the peri-stimulus spike-time histograms (PSTHs) obtained from the MEA data also revealed 32 clusters. The PSTHs for each cluster were aligned to the Ca-imaging data using a convolution approach. The higher temporal resolution of the MEA recordings indicated that NO increased the speed of sub-cluster 2 responses but had no effect on receptive field size. The physiological significance of the small change in kinetics remains unclear. 

      We thank the reviewer for their detailed and constructive comments.

      Weaknesses: 

      The G32 cluster was further divided into three sub-types using Bayesian Information Criterion (BIC) based on the temporal properties of the Ca-responses. This sub-clustering result seems questionable due to the small difference in the BIC parameter between 2 and 3 clusters. Three sub-clusters of the G32 cluster were also revealed for the PSTH data, however, the BIC analysis was not applied to further validate this result. 

      (1.1) We agree with the reviewer that this is an important point to be clarified. To this end, we repeated the analysis with n=2 clusters (see Author response image 1 below). In brief, we found that the overall interpretation did not change: Both clusters in the Ctrl1-dataset showed barely any type-specific adaptational effects, whereas under NO application, temporal contrast responses decreased (see Author response image 1 below). If requested, we would be happy to add this image to the supplementary material. 

      Author response image 1.

      In an additional analysis, we evaluated if n=2 or n=3 was the “better” choice for the number of clusters. In the new Supplementary Fig. S4, we compared the clusters with n=2 (top) and n=3 (bottom). For n=2, the two clusters are relatively strongly correlated for both visual stimuli, whereas for n=3, the clusters become more distinct, especially with respect to differences in the correlations for the two stimuli (Fig. S4b). For n=2, the low intra-cluster correlation (ICC) strongly suggests that cluster 2 contains multiple response types (ICC(C2) = 0.5 ± 0.48, mean ± s.d.; Fig. S4c). For n=3, the mean ICC values are high for all three clusters (ICC(C1) = 0.81 ± 0.16; ICC(C2) = 0.86 ± 0.07; ICC(C3) = 0.83 ± 0.1; mean ± s.d.). Together, this suggests that n=3 clusters captures the response diversity in G32 better than n=2 clusters. 

      Finally, we performed a BIC analysis for the MEA dataset and found the optimal number of clusters to be also n=3 (see new Suppl. Fig. S5).

      The alignment of sub-clusters 1, 2, and 3 identified in the Ca-imaging and the MEA recordings seemed questionable, because the temporal properties of clusters did not align well, nor did the effects of NO. 

      (1.2) To address this important point, we analyzed the correlations between the control responses of the three clusters from the Ca<sup>2+</sup>-dataset with the ones from the MEA-dataset (see new Suppl. Fig. S7). To avoid confusion, we named the clusters in the MEA-dataset i,ii,iii (see Fig. 8). We found two of the three clusters to be highly correlated (Ca<sup>2+</sup> clusters 2,3 and MEA clusters iii, ii), whereas one cluster was much less so (cluster 1 vs. cluster i), likely due to differences in response kinetics. In clusters i and ii NO application led to a release of suppression for temporal contrasts – similar to what we observed in the Ca<sup>2+</sup> data (see also our new analysis of the MEA data in Suppl. Fig. S6, as discussed further below).

      We agree that the cell types underlying the Ca<sup>2+</sup> and MEA G32 clusters may not be the same – aligning functional types between those two methods is challenging due to several factors, mainly because while Ca<sup>2+</sup> is a proxy for spiking activity, other Ca<sup>2+</sup> sources as well as sub-threshold membrane potential changes affect the intracellular Ca<sup>2+</sup>, potentially in a cell type-specific way. We explain this now better in the text.

      In any case, our main point was not to unambiguously align the cell types but to show that in both datasets, we find three subclusters of G<sub>32</sub>, which are affected by NO in a differential manner, particularly their suppression to temporal contrasts.

      The title of the paper indicates that nitric oxide modulates contrast suppression in a subset of mouse retinal ganglion cells, however, this result appears to be inferred from previous results showing that G32 is identified as a "suppressed-by-contrast" cell. The present study does not explicitly evaluate the amount of contrast-suppression in G32 cells. 

      (1.3) The reviewer is correct in that we did not quantify contrast-suppression in G<sub>32</sub> in detail but focused on the responses to temporal contrast (chirp and moving bar) and its modulation by NO (Fig. 5). In this context, please note that G<sub>32</sub>’s responses to the moving bar stimulus suggests that the cells are also suppressed by spatial contrast (i.e., an edge appearing in their RF). The functional RGC type G<sub>32</sub> (“Off suppressed 2”) was defined in an earlier study (Baden et al. 2016); it was assigned to the “Suppressed-by-Contrast” (SbC) category mainly because temporal contrast suppresses its responses. Already then, coverage analysis indicated that G<sub>32</sub> may indeed contain several RGC types – in line with our clustering analysis. It is still unclear if G<sub>32</sub> contains one (or more) of the SbC cells described by Jacoby & Schwartz (2018); in their recent study, Wienbar and Schwarz (2022) introduced the novel bursty-SbC RGC, which Goetz et al. (2022) speculated to potentially align with G<sub>32</sub>.<br /> We now discuss the relationship between G<sub>32</sub> and the SbC RGCs defined in other studies in the revised manuscript.

      In its current form, the work is likely to have limited impact, since the morphological and functional properties of the affected sub-cluster remain unknown. The finding that there can be cell-specific adaptation effects during experiments on in vitro retina is important new information for the field.

      (1.4) Again, we thank the reviewer for the detailed and helpful feedback. We hope that the reviewer finds our revised manuscript improved.

      Reviewer #1 (Recommendations For The Authors):  

      Most of the calcium activity traces (dF/F) throughout the paper have neither vertical nor horizontal calibration bars. Presumably, most values are positive, but this is unclear as a zero level is not indicated anywhere. Without knowing where zero dF/F is, it is not possible to determine whether the NO increased the Ca-signal or blocked a decrease in the Ca-signal. 

      Both ∆F/F and z-scoring, as we used here, are ways to normalize Ca<sup>2+</sup> traces. We decided against using ∆F/F<sub>0</sub> because this typically assumes that F represents the cell’s Ca<sup>2+</sup> resting level (F<sub>0</sub>; without activity). However, in our measurements, the “resting” Ca<sup>2+</sup> levels (i.e. before presenting a stimulus) may indeed reflect no spiking activity (e.g., in an ON RGC) but may also reflect baseline spiking activity (e.g., in an G<sub>32</sub>, which has a baseline firing rate of ~10 Hz; see Fig. S6). Hence, we used z-scoring, which carries no assumption of resting Ca<sup>2+</sup> level equal to no activity. In practice, we normalized all traces to the Ca<sup>2+</sup> level prior to the light stimulus and defined this as zero (as described in the Methods).

      We considered the reviewer’s suggestion of adding zero lines to every trace but felt that this would hamper the overall readability of the figures.

      Regarding calibration bars: We made sure that horizontal bars (indicating time) are present in all figures. We decided to leave out vertical bars in Ca<sup>2+</sup> responses, because as explained above, the traces are normalized (and unit-free), and within a figure all traces are scaled the same.

      Points of clarification for the Methods: 

      (1) The stimulus field was 800 x 600 µm. Presumably, both scan fields were contained within this region when scanning either Field 1 or Field 2 so that the adaptation level of the preparation at both locations was maintained? 

      Yes, the stimulation field is always kept centered on the respective recording (scan) field and the adaptation level for each recording field was maintained.

      (2) There appeared to be an indeterminate amount of time between the initial 10-minute adaptation period and Ctrl1, whereas there were no such gaps between subsequent scans. Is this likely to produce differences in adaptation state and thus represent a systematic error? 

      At this time point, recording (scan) fields were selected to make sure that the cells in the field were uniformly labelled with the Ca<sup>2+</sup> indicator and responsive to light stimuli. This typically happened already at the end of the light adaptation phase and/or right after. When selecting the fields, light stimuli were presented (to test responsiveness) and thereby the adaptation level was maintained independent of the duration of this procedure, minimizing systematic errors.

      (3) Was the dense white noise stimulus applied during the wash-in period to maintain the adaptation state of the preparation prior to the subsequent scan? 

      The dense noise was not applied throughout the wash-in period but at least 5-10min before the field was recorded with a drug (e.g., NO). 

      Fig. 1d illustrates very nicely how the stimuli align with the responses. It would have been helpful to have this format continue throughout the paper but unfortunately, the vertical lines are dropped in Fig. 2a and then the stimulus waveform is omitted in Fig. 2e onwards. 

      Thanks, good idea. We added the vertical lines and the stimulus waveform to the figures where they were missing to improve the readability. 

      What was the rationale for selecting the concentration of the NO donor used? Is it likely to mimic natural levels? 

      A DETA/NO concentration of 100 µM is commonly used in studies investigating NOinduced effects. DETA/NO has a half-life time (t<sub>0.5</sub>) of 20 hours, which makes it more suitable for application in tissues (like our whole-mount preparation), because the donor can penetrate into the issue before releasing NO. In turn, this long t0.5 means that only a fraction of the bound NO is released per time unit.

      Based on t<sub>0.5</sub> for DETA/NO and NO, one can roughly estimate the NO range as follows: t<sub>0.5</sub> of NO strongly depends on the tissue and is estimated in the second to minute range (Beckman & Koppenol, 1996). Assuming a t<sub>0.5</sub> for NO of 2 minutes, a freshly prepared 100 µM DETA/NO solution is expected to result within the first hour a NO concentration of approx. 0.25 µM (taking into account that 1 mole of DETA/NO releases 1.5 moles of NO molecules; see Ramamurthi & Lewis 1997).

      In general, it is difficult to determine the physiological concentration of NO in the retina. Different measurements point at peaks of a few 100 nM (e.g., frog retina, ganglion cells: 0.25 µM, Kalamkarov et al. 2016; rodent inner retina, 0.1 to 0.4 µM, Micah et al. 2014). Hence, the NO concentrations we apply should be within the measured physiological range.

      Fig. 3e: what are the diamond symbols? If these are the individual cells, it might be better to plot them on top of the box plots so all are visible. 

      Indeed, the diamond symbols represent individual cells, yet outliers only. We decided not to plot all cells as a dot plot on top of the box plots since the readability will suffer as there are too many individual dots to show, e.g., n=251 for G<sub>32</sub> Ctrl and n=135 for G<sub>32</sub> DETA/NO.

      Fig. 3: please explain more clearly the x-axis units in a-d and the y-axis units in e. 

      To estimate potential response differences between the first and the second scan (i.e. either Ctrl 2 or NO), the traces were subtracted cell-pairwise (∆ Ctrl: Ctrl 2 – Ctrl 1; ∆ DETA/NO: NO – Ctrl 1). As all Ca<sup>2+</sup> traces were normalized, they are unit-free. Therefore, the x-axes in Fig. 3a-d represent the mean differences of each cell per cell type, e.g., a value of zero would mean that the traces of Ctrl 1 and Ctrl 2 for a cell are identical. The y-axis in Fig. 3e is also unit-free, because technically, it is the same measure as Fig. 3a-d. But since it summarizes the control- and NO-data, we refer to this as “delta mean trace.” We tried to make this clearer in the revised manuscript and a detailed description can be found in the Methods.

      Fig. 3: "...a substantial number of RGC types (34%) changed their responses to chirp and/or moving bar stimuli in the absence of any pharmacological perturbation in a highly reproducible manner...". How many of the cell types showed a significant difference? Two cell-types with p<0.001are highlighted with 3 asterisks. It would be helpful to indicate on this plot which of the other cells showed significant differences. 

      Yes, this is a good idea. Thank you. We tried to add this information to the figure, but it became rather crowded. Therefore, we added a new Suppl. Fig. S3 (same style as Fig. 3) where we exclusively summarized the control-dataset. 

      Fig. 7: To illustrate the transform from PSTH to Ca-imaging, why not use G32 data as an example?

      Fair point. We modified the figure and added G<sub>32</sub> as an example.

      It would be clearer if the cells were labeled consistently throughout the paper using their Baden cluster numbers rather than switching to the older nomenclature (JAM-B, local edge, alpha, etc), e.g. Fig. 7a,b. 

      In the revised manuscript, we now changed the nomenclature to the Ca2+ Baden et al. (2016) terminology. We used the alternative cell type names here because where Fig. 7a is discussed in the manuscript, the cell type matching did not happen yet. But we agree that a consistent nomenclature is helpful.

      The evidence supporting the sub-clustering of the G32 cells for the two recording methods could have been stronger. In Fig. 5, the BIC difference between 2 and 3 clusters is rather small. Is this result robust enough to justify 3 rather than 2 clusters? The BIC analysis should also be performed on the PSTH data-set to support the notion that the MEA G32 cluster also contains 3 rather than 2 sub-clusters. 

      Regarding the sub-clustering of G<sub>32</sub> into n=2 or n=3 clusters for both datasets, please see our detailed reply #1.1 in our response to the public comments above.

      The alignment of the three sub-clusters across the Ca-imaging and MEA data looked questionable. For example, the cluster 2 and cluster 3 traces in Fig. 5e,f look similar, with cluster 1 being more different. In Fig. 8c on the other hand, cluster 1 and 3 look similar with cluster 2 being more different. The pharmacological results also did not align well. For the Ca-imaging, NO appeared to have a large effect on cluster 1, a more modest effect on cluster 2 and less effect on cluster 3 (Fig. 5f). In comparison, the MEA results diverged, with NO producing the largest effect on cluster 2 and very modest if any effects on clusters 1 and 3 (Fig. 8c). Moreover, the temporal properties of cluster 1 and cluster 3 look very different between the Ca-imaging and MEA data. Without further comment, these differences raise concerns about the reliability of the clustering and the validity of comparisons made across the two sets of experiments. 

      We agree that this is a critical point. Please see our reply #1.2 in our response to the public comments above.

      Fig. 8: Transforming the PSTHs into Ca-traces is important to align the MEA recordings with the Ca-imaging data. It would also be very informative to see a more detailed overall presentation of the PSTH data since it provides a much higher temporal resolution of the responses. For example, illustrating the average PSTHs for the G32 cells under all the experimental conditions could be quite illuminating. 

      To address this point, we added a new Supplementary Fig. S6, which shows the pseudo-Ca<sup>2+</sup> traces for each cluster and condition next to the PSTHs. In addition, we quantified the cumulative firing rate for response features (time windows) where temporal suppression was observed in the Ca<sup>2+</sup> data. This new analysis shows that during NO-application, we can see an increase in firing rate in all clusters. Nevertheless, the effect of NO on the PSTHs is admittedly small and it is better visible in the pseudo-Ca<sup>2+</sup> transformed traces. One possible explanation for this difference may be that the overall firing rates are quite dynamic in G<sub>32</sub> such that a significant increase in “suppression” phases relative to the peak firing appears small.

      Reviewer #2 (Public Review):  

      Neuromodulators are important for circuit function, but their roles in the retinal circuitry are poorly understood. This study by Gonschorek and colleagues aims to determine the modulatory effect of nitric oxide on the response properties of retinal ganglion cells. The authors used two photon calcium imaging and multi-electrode arrays to classify and compare cell responses before and after applying a NO donor DETA-NO. The authors found that DETA-NO selectively increases activity in a subset of contrast-suppressed RGC types.

      In addition, the authors found cell-type specific changes in light response in the absence of pharmacological manipulation in their calcium imaging paradigm. While this study focuses on an important question and the results are interesting, the following issues need further clarification for better interpretation of the data. 

      We thank the reviewer for her/his detailed and constructive comments.

      (1) Design of the calcium imaging experiments: the control-control pair has a different time course from the control-drug pair (Fig 1e). First, the control-control pair has a 10 minute interval while the control-drug pair has a 25 minute interval. Second, Control 1 Field 2 was imaged 10 min later than Control 1 Field 1 since the start of the calcium imaging paradigm. 

      Given that the control dataset is used to control for time-dependent adaptational changes throughout the experiment, I wonder why the authors did not use the same absolute starting time of imaging and the same interval between the first and second round of imaging for both the control-control and the control-drug pairs. This can be readily done in one of the two ways: 1. In a set of experiment, add DETA/NO between "Control 1 Field 1 and "Control 2 Field 1" in Fig. 1e as the drug group; or 2. Omit DETA/NO in the Fig. 1e protocol as the control group to monitor the time course of adaptational changes. 

      Thank you for raising this point. We hope that in the following we can clarify the reasoning behind our protocol and the analysis approach.

      (2.1) Initially, we performed these experiments in different ways (also in the sequence suggested by the reviewer), before homing in on the paradigm illustrated in Fig. 1. We chose this paradigm for two reasons: First, we wanted to have for each retina both Ctrl1/Ctrl2 and Ctr1/NO data sets, to be sure that the time-dependent (adaptational) effects were not related to the general condition of an individual retina preparation. Second, we did not see obvious differences in time-dependent or NO-induced effects between paradigms. Therefore, while we cannot exclude that the absolute time between recordings can affect the observed changes, we do not think that such effects are substantial enough to change our conclusions.

      In the revised manuscript, we now explicitly point at the different intervals. 

      Related to the concern above, to determine NO-specific effect, the authors used the criterion that "the response changes observed for control (ΔR(Ctrl2−Ctrl1)) and NO (ΔR(NO−Ctrl1)) were significantly different". This criterion assumes that without DETA-NO, imaging data obtained at the time points of "Control 1 Field 2" and "DETA/NO Field 2" would give the same value of ΔR as ΔR(Ctrl2−Ctrl1) for all RGC types. It is not obvious to me why this should be the case, because of the unknown time-dependent trajectory of the adaptational change for each RGC type. For example, a RGC type could show stable response in the first 30 min and then change significantly in the following 30 min. DETA/NO may counteract this adaptational change, leading to the same ΔR as the control condition (false negative). Alternatively, DETA/NO may have no effect, but the nonlinear timedependent response drift can give false positive results. 

      (2.2) Initially, we assumed that after adapting the retina to a certain light level, RGCs exhibit stable responses over time, such that when adding a pharmacological agent, we can identify drug-induced response changes (e.g., by calculating the response difference). To our surprise, we found that for some RGC types the responses changed between the first and the second recording (referred to as cell type-specific adaptational effects), which is why we devised the Ctrl1/Ctrl2 vs. Ctr2/NO analysis. 

      The reviewer is correct in that we assume in our analysis that the adaptational- and NO-induced effects are independent and sum linearly. Further, we agree with the reviewer that there may be other possibilities, two of which are highlighted by the reviewer:

      (a) Interaction: for instance, if NO compensates for the adaptational effect, we would not be able to measure this; or, if this compensation was partial, underestimate both effects. 

      (b) More complex time-dependency: for example, if an RGC shows a pronounced adaptational effect with a longer delay (i.e. only after the second scan), or that a very transient NO effect has already disappeared when we perform the second scan. On the one hand, as we only can take snapshots of the RGC responses, we cannot exclude these possibilities. On the other hand, both effects (adaptational- and NO-dependent) were type-specific and reproducible between experiments (also with varying timing, see reply #2.1), which makes complex time dependencies less likely.

      The revised manuscript now reflects these limitations of our recording paradigm and points out which effects can be detected, and which likely not.

      I also wonder why washing-out, a standard protocol for pharmacological experiments, was not done for the calcium protocol since it was done in the MEA experiments. A reversible effect by washing in and out DETA/NO in the calcium protocol would provide a much stronger support that the observed NO modulation is due to NO and not to other adaptive changes. 

      (2.3) We agree that a clear wash-out would strengthen our findings. Indeed, in the beginning of our experiments, we tried to wash-out the agent in the Ca<sup>2+</sup> recordings, as we did in the MEA recordings. We soon stopped doing this in the Ca<sup>2+</sup> experiments, because response quality decreased for the third scan of the same field, likely due to bleaching of fluorescent indicator and photopigment. This is why we typically restrict the total recording time of the same field of RGCs to about 30 min (~ two scans with all light stimuli). Moreover, our MEA data showed that DETA/NO can largely be washed-out, which supports that we observed NO-specific effects. Therefore, we decided against further attempts to establish the wash-out also in the Ca<sup>2+</sup> experiments (e.g., shortening the recording time by presenting fewer light stimuli).

      (2) Effects of Strychnine: In lines 215-219, " In the light-adapted retina, On-cone BCs boost light-Off responses in Off-cone BCs through cross-over inhibition (83, 84) and hence, strychnine affects Off-response components in RGCs - in line with our observations (Fig. S2)" However, Fig. S2 doesn't seem to show a difference in the Off-response components. Rather, the On response is enhanced with strychnine. In addition, suppressed-by-contrast cells are known to receive glycinergic inhibition from VGluT3 amacrine cells (Tien et al., 2016). However, the G32 cluster in Fig. S2 doesn't seem to show a change with strychnine. More explanation on these discrepancies will be helpful.

      (2.4) We thank the reviewer for this comment. Regarding the first part, we agree that the figure does not support differences in the Off-response components. We therefore rephrased the corresponding text accordingly. Additionally, we now show all RGC types with n>3 cells per recording condition in the revised Suppl. Fig. S2 and added statistics.

      Regarding the second part, there are several possible explanations for these discrepancies:

      (a) The SbC (transient Off SbC) studied in Tien et al. (2016) likely corresponds to the RGC type G<sub>28</sub> (see Höfling et al. 2024). As mentioned above (see reply #1.2), it is unclear if G<sub>32</sub> corresponds to a previously described SbC, and if so, to which. Goetz et al. (2022) proposed that G<sub>32</sub> may align with the bursty-SbC (bSbC) type (their Supplemental Table 3), as described also by Wienbar and Schwartz (2022). An important feature of the bSbC type is that its contrast response function is mainly driven by intrinsic properties rather than synaptic input. If G<sub>32</sub> indeed included the bSbC, this may explain why strychnine does not interfere with the suppression of temporal contrast.

      (b) In Tien et al. (2016), the authors genetically removed the VG3-ACs (see their Fig. 3) and show that this ablation reduces the inhibition of tSbC cells in a stimulus size-dependent manner. Specifically, larger light stimuli (600 µm) only show marginal effects on the IPSCs and inhibitory synaptic conductance (see their Figs. 3c,d and 3e,f, respectively). In our study, the full-field chirp had a size of 800 x 600 µm. Therefore – and assuming that G<sub>32</sub> indeed included tSbCs – our observation that strychnine did not affect temporal suppression in the full-field chirp responses would be in line with Tien et al. (2016).   

      (3) This study uses DETA-NO as an NO donor for enhancing NO release. However, a previous study by Thompson et al., Br J Pharmacol. 2009 reported that DETA-NO can rapidly and reversible induce a cation current independent of NO release at the 100 uM used in the current study, which could potentially cause the observed effect in G32 cluster such as reduced contrast suppression and increased activity. This potential caveat should at least be discussed, and ideally excluded by showing the absence of DETA-NO effects in nNOS knockout mice, and/or by using another pharmacological reagent such as the NO donor SNAP or the nNOS inhibitor l-NAME. 

      Thank you for pointing out this potential caveat. We certainly cannot exclude such side effects. However, we think that this explanation of our observations is unlikely, because Thompson et al. barely see effects at 100 µM DETA/NO; in fact, their data suggests that clear NO-independent effects on the cation-selective channel occur at much higher DETA/NO concentrations, such as 3 mM. 

      In any case, in the revised manuscript, we refer to this paper in the Discussion

      (4) Clarification of methods: In the Methods, lines 1119-1127, the authors describe the detrending, baseline subtraction, and averaging. Then, line 1129, " the mean activity r(t) was computed and then traces were normalized such that: max t(|r(t)|) = 1. How is the normalization done? Is it over the entire recording (control and wash in) for each ROI? Or is it normalized based on the mean trace under each imaging session (i.e. twice for each imaging field)? 

      The normalization (z-scoring) was done for each ROI individually per stimulus and condition (Ctrl 1, Ctrl 2, DETA/NO). We normalized the traces, because the absolute Ca<sup>2+</sup> signal depends on factors, such as “resting” state of the cell (e.g., silent vs. baseline spiking activity in the absence of a light stimulus) and its fluorescent dye concentration. This also means that absolute response amplitudes are difficult to interpret. Hence, we focused on analyzing relative changes per ROI and condition, which still allowed us to investigate adaptational and drug-induced effects. In the revised manuscript, we changed the corresponding paragraph for clarification.

      As for the clustering of RGC types, I assume that each ROI's cluster identity remains unchanged through the comparison. If so, it may be helpful to emphasize this in the text.

      Yes, this is correct. We identified G<sub>32</sub> RGCs based on their Ctrl1 responses and then compares these responses with those for Ctrl2 or NO. We now clarified this in the revised manuscript.

      Reviewer #2 (Recommendations For The Authors):  

      The manuscript would benefit from a discussion of how the findings in this study relate to known mechanisms of NO modulation and previously reported effects of NO manipulations on RGC activity. 

      Thank you for the recommendation. We already refer to known mechanisms of NO within the retina in the Introduction. In the revised manuscript, we now added information to the Discussion.

      In the abstract, "a paired-recording paradigm" could be misleading because paired recording generally refers to the simultaneous recording of two neurons. However, the paradigm in this study is essentially imaging experiments done at two time points. 

      We agree with the reviewer. To avoid any confusion with paired electrophysiological recordings, we changed the term “paired-recording paradigm” to “sequential recording paradigm” and replaced the term “pair-/ed” with “sequentially recorded”.

    1. Author response:

      Reviewer 1:

      Summary:

      This paper describes molecular dynamics simulations (MDS) of the dynamics of two T-cell receptors (TCRs) bound to the same major histocompatibility complex molecule loaded with the same peptide (pMHC). The two TCRs (A6 and B7) bind to the pMHC with similar affinity and kinetics, but employ different residue contacts. The main purpose of the study is to quantify via MDS the differences in the inter- and intra-molecular motions of these complexes, with a specific focus on what the authors describe as catch-bond behavior between the TCRs and pMHC, which could explain how T-cells can discriminate between different peptides in the presence of weak separating force.

      Strengths:

      The authors present extensive simulation data that indicates that, in both complexes, the number of high-occupancy interdomain contacts initially increases with applied load, which is generally consistent with the authors’ conclusion that both complexes exhibit catch-bond behavior, although to different extents. In this way, the paper somewhat expands our understanding of peptide discrimination by T-cells.

      The reviewer makes thoughtful assessments of our manuscript. While our manuscript is meant to be a “short” contribution, our significant new finding is that even for TCRs targeting the same pMHC, having similar structures, and leading to similar functional outcomes in conventional assays, their response to applied load can be different. This supports out recent experimental work where TCRs targeting the same pMHC differed in their catch bond characteristics, and importantly, in their response to limiting copy numbers of pMHCs on the antigen-presenting cell (Akitsu et al., Sci. Adv., 2024; cited in our manuscript). Our present manuscript provides the physical basis where two similar TCRs respond to applied load differently. In the revised manuscript, we will make this point clearer.

      Weaknesses:

      While generally well supported by data, the conclusions would nevertheless benefit from a more concise presentation of information in the figures, as well as from suggesting experimentally testable predictions.

      Following the reviewers’ suggestions, we will update figures and use Figure Supplements to make the main figures more concise and to simplify the overall presentation.

      Regarding testable predictions, one prediction would be that B7 TCR will exhibit weaker catch bond behavior than A6. This is an important prediction because the two TCRs targeting the same pMHC have similar structures and are functionally similar in conventional assays. This prediction can be tested by single-molecule optical tweezers experiments. We also predict the A6 TCR may perform better when the number of pMHC molecules presented are limited, analogous to our recent experiments on different TCRs, Akitsu et al., Sci. Adv. (2024).

      Another testable prediction for the conservation of the basic allostery mechanism is to test the Cβ FG-loop deletion mutant located at the hinge region of the β chain, yet its deletion severely impairs the catch bond formation. These predictions will be mentioned and discussed in the updated manuscript.

      Reviewer 2:

      In this work, Chang-Gonzalez and coworkers follow up on an earlier study on the force-dependence of peptide recognition by a T-cell receptor using all-atom molecular dynamics simulations. In this study, they compare the results of pulling on a TCR-pMHC complex between two different TCRs with the same peptide. A goal of the paper is to determine whether the newly studied B7 TCR has the same load-dependent behavior mechanism shown in the earlier study for A6 TCR. The primary result is that while the unloaded interaction strength is similar, A6 exhibits more force stabilization.

      This is a detailed study, and establishing the difference between these two systems with and without applied force may establish them as a good reference setup for others who want to study mechanobiological processes if the data were made available, and could give additional molecular details for T-Cell-specialists. As written, the paper contains an overwhelming amount of details and it is difficult (for me) to ascertain which parts to focus on and which results point to the overall take-away messages they wish to convey.

      As mentioned above and as the reviewer correctly pointed out, the condensed appearance of this manuscript arose largely because we intended it to be a Research Advances article as a short follow up study of our previous paper on A6 TCR published in eLife. Most of the analysis scripts for the A6 TCR study are already available on Github. We will additionally deposit sample structures and simulation scripts for the B7 TCR. Trajectory will be provided upon request given their large size.

      Regarding the focus issue, it is in part due to the complex nature of the problem, which required simulations under different conditions and multi-faceted analyses. Concisely presenting the complex analyses also has been a challenge in our previous papers on TCR simulations (Hwang et al., PNAS 2020; Chang-Gonzalez et al., eLife, 2024 – both are cited in our manuscript). With updated figures and texts, we expect that the presentation will be a lot clearer. But even in the present form, the reviewer points out the main take-away message well: “The primary result is that while the unloaded interaction strength is similar, A6 exhibits more force stabilization.

      Detailed comments:

      (1) In Table 1 - are the values of the extension column the deviation from the average length at zero force (that is what I would term extension) or is it the distance between anchor points (which is what I would assume based on the large values. If the latter, I suggest changing the heading, and then also reporting the average extension with an asterisk indicating no extensional restraints were applied for B7-0, or just listing 0 load in the load column. Standard deviation in this value can also be reported. If it is an extension as I would define it, then I think B7-0 should indicate extension = 0+/- something.

      The distance between anchor points could also be labeled in Figure 1A.

      “Extension” is the distance between anchor points (blue spheres at the ends of the added strands in Fig. 1A). While its meaning should be clear in the section “Laddered extensions” in MD simulation protocol, at first glance it may lead to confusion. In a strict sense, use of “extension” for the distance is a misnomer, but we have used it in our previous two papers (Hwang et al., PNAS 2020; Chang-Gonzalez et al., eLife, 2024), so we prefer to keep it for consistency. Instead, in the caption of Table 1, we will explain its meaning, and also explicitly label it in Fig. 1A, as the reviewer suggested.

      Please also note that the no-load case B7<sup>0</sup> does not have a particular extension that yields zero load on average. It would in fact be very difficult to find such an extension (distance between two anchor points). To simulate the system without load, we separately built a TCR-pMHC complex without added linkers, and held the distal part of pMHC with weak harmonic restraints (explained in sections “Structure preparation” and “Systems without load”). In this way, no external force is applied to TCR as it moves relative to pMHC. We will clarify this when introducing B7<sup>0</sup> in the Results section.

      (2) As in the previous paper, the authors apply ”constant force” by scanning to find a particular bond distance at which a desired force is selected, rather than simply applying a constant force. I find this approach less desirable unless there is experimental evidence suggesting the pMHC and TCR were forced to be a particular distance apart when forces are applied. It is relatively trivial to apply constant forces, so in general, I would suggest this would have been a reasonable comparison. Line 243-245 speculates that there is a difference in catch bonding behavior that could be inferred because lower force occurs at larger extensions, but I do not believe this hypothesis can be fully justified and could be due to other differences in the complex.

      There is indeed experimental evidence that the TCR-pMHC complex operates under constant separation. The spacing between a T-cell and an antigen-presenting cell is maintained by adhesion molecules such as the CD2CD58 pair, as explained in our paper on the A6 TCR, (Chang-Gonzalez et al., eLife, 2024; please see the bottom paragraph on page 4 of the paper). In in vitro single-molecule experiments, pulling to a fixed separation and holding is also commonly done. Detailed comparison between constant extension vs. constant force simulations is definitely a subject of our future study. We will clarify these points when explaining about the constant extension (or separation).

      Regarding line 243–245, we agree with the reviewer that without further tests, lower forces at larger extensions per se cannot be an indicator that B7 forms a weaker catch bond. But with additional insight, it does have an indirect relevance. In addition to fewer TCR-pMHC contacts (Fig. 1C of our manuscript), the intra-TCR contacts are also reduced compared to those of A6 (Fig. 1D vs. Chang-Gonzalez et al., eLife, 2024, Fig. 8A,B, first column; reproduced in the figure in our response to reviewer 3 below). This shows that the B7 TCR forms a looser complex with pMHC compared to A6. With its higher compliance, the B7 TCR-pMHC complex needs to be under a greater extension than A6 to apply comparable levels of force, and it would be more difficult to achieve load-induced stabilization of the TCR-pMHC interface, hence a weaker catch bond. We will add this point when explaining the weaker catch bond behavior of B7.

      (3) On a related note, the authors do not refer to or consider other works using MD to study force-stabilized interactions (e.g. for catch bonding systems), e.g. these cases where constant force is applied and enhanced sampling techniques are used to assess the impact of that applied force: https://www.cell.com/biophysj/fulltext/S0006-3495(23)00341-7, https://www.biorxiv.org/content/10.1101/2024.10.10.617580v1. I was also surprised not to see this paper on catch bonding in pMHC-TCR referred to, which also includes some MD simulations: https://www.nature.com/articles/s41467-023-38267-1

      We thank the reviewer for bringing the three papers to our attention, which are:

      (1) Languin-Cattoën, Sterpone, and Stirnemann, Biophys. J. 122:2744 (2023): About bacterial adhesion protein FimH.

      (2) Peña Ccoa, et al., bioRxiv (2024): About actin binding protein vinculin.

      (3) Choi et al., Nat. Comm. 14:2616 (2023): About a mathematical model of the TCR catch bond.

      Catch bond mechanisms of FimH and vinculin are different from that of TCR in that FimH and vinculin have relatively well-defined weak- and strong-binding states where there are corresponding crystal structures. Availability of the end-state structures enable using simulation approaches such as enhanced sampling of individual states and studying the transition between the two states. In contrast, TCR does not have any structurally well-defined weakor strong-binding states, which requires a different approach. As demonstrated in our current manuscript as well as in our previous two papers (Hwang et al., PNAS 2020; Chang-Gonzalez et al., eLife, 2024), our microsecond-long simulations of the complex under realistic pN-level loads and a combination of analysis methods are effective for elucidating the catch bond mechanism of TCR. In the revised manuscript, we will cite the two papers, to compare the TCR catch bond mechanism with those of FimH and vinculin, which will offer a broader perspective.

      The third paper (Choi, 2023) proposes a mathematical model to analyze extensive sets of data, and also perform new experiments and additional simulations. Of note, their model assumptions are based mainly on the steered MD (SMD) simulation in their previous paper (Wu, et al., Mol. Cell. 73:1015, 2019). In their model, formation of a catch bond (called catch-slip bond in Choi’s paper) requires partial unfolding of MHC and tilting of the TCR-pMHC interface. While further studies are needed to find whether those changes are indeed required, even so, the question remains regarding how the complex in the fully folded state can bear load and enter such a state in the first place. Our current and previous simulation studies suggest a mechanism by which ligand- and load-dependent responses occur as the first obligatory step of catch bond formation, after which partial unfolding and/or extensive conformational transitions may occur, as described in our recent paper (Akitsu et al., Sci. Adv., 2024). In the revised manuscript, we will cite Wu’s paper and briefly explain the above.

      (4) The authors should make at least the input files for their system available in a public place (github, zenodo) so that the systems are a more useful reference system as mentioned above. The authors do not have a data availability statement, which I believe is required.

      As mentioned above, we will make sample input files and coordinates available on Github. Data availability statement will be added.

      Reviewer 3:

      Summary:

      The paper by Chang-Gonzalez et al. is a molecular dynamics (MD) simulation study of the dynamic recognition (load-induced catch bond) by the T cell receptor (TCR) of the complex of peptide antigen (p) and the major histocompatibility complex (pMHC) protein. The methods and simulation protocols are essentially identical to those employed in a previous study by the same group (Chang-Gonzalez et al., eLife 2024). In the current manuscript, the authors compare the binding of the same pMHC to two different TCRs, B7 and A6 which was investigated in the previous paper. While the binding is more stable for both TCRs under load (of about 10-15 pN) than in the absence of load, the main difference is that, with the current MD sampling, B7 shows a smaller amount of stable contacts with the pMHC than A6.

      Strengths:

      The topic is interesting because of the (potential) relevance of mechanosensing in biological processes including cellular immunology.

      Weaknesses:

      The study is incomplete because the claims are based on a single 1000-ns simulation at each value of the load and thus some of the results might be marred by insufficient sampling, i.e., statistical error. After the first 600 ns, the higher load of B7high than B7low is due mainly to the simulation segment from about 900 ns to 1000 ns (Figure 1D). Thus, the difference in the average value of the load is within their standard deviation (9 +/- 4 pN for B7low and 14.5 +/- 7.2 for B7high, Table 1). Even more strikingly, Figure 3E shows a lack of convergence in the time series of the distance between the V-module and pMHC, particularly for B70 (left panel, yellow) and B7low (right panel, orange). More and longer simulations are required to obtain a statistically relevant sampling of the relative position and orientation of the V-module and pMHC.

      The reviewer uses data points during the last 100 ns to raise an issue with sampling. But since we are using realistic pN range forces, force fluctuates more slowly. In fact, in our simulation of B7<sup>high</sup>, while the force peaks near 35 pN at 500 ns (Fig. 1D of our manuscript; reproduced as panels C and D below), the contact heat map shows no noticeable changes around 500 ns (Fig. 2C of our manuscript). Thus, a wider time window must be considered rather than focusing on instantaneous force.

      We believe the reviewer’s concern about sampling arose also due to a lack of clear explanation. Author response image 1 below contains panels from our earlier eLife paper on the A6 TCR. Panels A and B are from Fig. 8 of the A6 paper, and panels C and D are from Fig. 1D of our present manuscript. The high-load simulations in both cases (outlined circles) fluctuate widely in force so that one might argue that sampling was insufficient. However, unless one is interested in finding the precise value of force for a given extension, sampling in our simulations was reasonable enough to distinguish between high- and low-force behaviors. To support this, we show panel E below, which is from Appendix 3–Fig. 1 of our A6 paper. Added to this panel are the average forces and standard deviations of B7<sup>low</sup> and B7<sup>high</sup> from Table 1 of our manuscript (red squares). Please note that all of the data were measured after 500 ns. Except for Y8A<sup>low</sup> and dFG<sup>low</sup> of A6 (explained below), all of the data points lie on nearly a straight line.

      Author response image 1.

      Thermodynamically, the force and position of the restraint (blue spheres in Fig. 1A of our manuscript) form a pair of generalized force and the corresponding spatial variable in equilibrium at temperature 300 K, which is akin to the pressure P and volume V of an ideal gas. If V is fixed, P fluctuates. Denoting the average and std of pressure as ⟨P⟩ and ∆P, respectively, Burgess showed that ∆P/P⟩ is a constant (Eq. 5 of Burgess, Phys. Lett. A, 44:37; 1973). In the case of the TCRαβ-pMHC system, although individual atoms are not ideal gases, since their motion leads to the fluctuation in force on the restraints, the situation is analogous to the case where pressure arises from individual ideal gas molecules hitting the confining wall as the restraint. Thus, the near-linear behavior in panel E above is a consequence of the system being many-bodied and at constant temperature. The linearity is also an indirect indicator that sampling of force was reasonable. The fact that A6 and B7 data show a common linear profile further demonstrates the consistency in our force measurement. That said, the B7 data points (red in panel E) are elevated slightly above nearby A6 data points. This is consistent with B7 forming an overall weaker complex, both at the TCR-pMHC interface (panels A vs. C) and within intra-TCR interfaces (panels B vs. D), which can be seen by the wider ranges of color bars in panels A and B for A6 compared to panels C and D for B7.

      About the two outliers of A6, Y8A<sup>low</sup> is for an antagonist peptide and dFG<sup>low</sup> is the Cβ FG-loop deletion mutant. Interestingly, both cases had reduced numbers of contacts with pMHC, which likely caused a wider conformational motion, hence greater fluctuation in force.

      A similar argument applies to Fig. 3E of our manuscript. If precise values of the V-module to pMHC distance were needed, longer or duplicate simulations would be necessary, however, Fig. 3E as it currently stands clearly shows that B7<sup>high</sup> maintains more stable interface compared to B7<sup>low</sup>, which is consistent with all other measures we used, such as Fig. 3B (Hamming distance), Fig. 3C (buried surface area), and Fig. 4A–E (Vα-Vβ motion and CDR3 distance). They are also consistent with our simulations of A6.

      Thus, rather than relying on peculiarities of individual trajectories, we analyze data in multiple ways and draw conclusions based on features that are consistent across different simulations. Please also note that reviewer 1 mentioned that our conclusions are “generally well supported by data.”

      We will update our manuscript to concisely explain the above and also will add Panel E above as a supplement of Fig. 1.

      It is not clear why ”a 10 A distance restraint between alphaT218 and betaA259 was applied” (section MD simulation protocol, page 9).

      αT218 and βA259 are the residues attached to a leucine-zipper handle in in vitro optical trap experiments (Das, et al., PNAS 2015). In T cells, those residues also connect to transmembrane helices. Author response image 2 is a model of N15 TCR used in experiments in Das’ paper, constructed based on PDB 1NFD. Blue spheres represent Cα atoms corresponding to αT218 and βA259 of B7 TCR. Their distance is 6.7 ˚A. The 10-˚A distance restraint in simulation was applied to mimic the presence of the leucine zipper that prevents excessive separation of the added strands. The distance restraint is a flat-bottom harmonic potential which is activated only when the distance between the two atoms exceeds 10 ˚A, which we did not clarify in our original manuscript. The same restraint was used in our previous studies on JM22 and A6 TCRs.

      We will add the figure as a supplement of Fig. 1, cite Das’ paper, and also update description of the distance restraint in the MD simulation protocol section.

      Author response image 2.

    1. Author response:

      Reviewer #1 (Public review):

      The significance of the target molecule and mechanisms may help in understanding the molecular mechanisms of metformin.

      We greatly appreciate the reviewer’s insightful comment regarding the significance of the target molecule and its mechanisms in understanding the molecular actions of metformin. ATP5I is responsible for the dimerization of the F<sub>1</sub>F<sub>0</sub>-ATPase(1-3). Hence, we propose conducting BN-PAGE followed by a western blot using the β-subunit of the F1 domain of F1F0-ATP synthase to investigate whether metformin affects its dimerization. This will provide a more direct evidence of the on target action of metformin on ATP5I. Due to the high abundance of F<sub>1</sub>F<sub>0</sub>-ATP synthase in cells and the slow ability of metformin to enter mitochondria, we plan to perform long-term treatments (3 and 6 days) with high concentrations of metformin (10 mM) to enhance the likelihood of detecting subtle yet biologically relevant shifts in the monomer and dimer populations. Prolonged exposure is expected to reveal the cumulative effects of metformin on F<sub>1</sub>F<sub>0</sub>-ATP synthase dimers/monomers ratio. We do not expect that metformin will totally mimic the cumulative effect of the dimerization as in ATP5I KO cells but we think it will be important to report to what extent this ratio is affected.

      Reviewer #2 (Public review):

      (1) The interpretation of the cellular co-localization of the biotin-biguanide conjugate with TOMM20 (Figure 1-D) as mitochondrial "accumulation" of the conjugate is overstated because it cannot exclude binding of the conjugate to the mitochondrial membrane. It would have been more convincing if additional incubations with the biotin-biguanide conjugate in combination with metformin had shown that metformin is competitive with the biotin-conjugate.

      We appreciate the reviewer’s insightful comment and agree that the resolution provided by fluorescence microscopy makes it challenging to pinpoint the specific mitochondrial compartment where the biotin-biguanide conjugate localizes, even with additional markers such as TOMM20 antibodies for the inner mitochondrial membrane. While it remains a possibility that the conjugate binds to the mitochondrial surface, another plausible explanation is that the biotin moiety may facilitate entry into mitochondria through a biotin-specific transporter, adding further mechanistic intricacies. Furthermore, while a competition assay with metformin might help investigate interactions with mitochondrial targets and transporters (OCT family), it would not compete for biotin-mediated transport. Thus, while we acknowledge the reviewer’s suggestion, we believe such an experiment may not provide conclusive evidence regarding the conjugate’s mitochondrial localization or mechanism of entry. Instead, we will revise the manuscript to more accurately describe the findings as "mitochondrial association" rather than "mitochondrial accumulation," ensuring that our interpretation remains consistent with the resolution and limitations of the data presented.

      (2) The manuscript reports the identification of 69 proteins by mass spectrometry of the pull-down assay of which 31 proteins were eluted by metformin. However, no Mass Spectrometry data is presented of the peptides identified. The methodology does not state the minimum number of peptides (1, 2?) that were used for the identification of the 31/69 proteins.

      Concerning the mass spectrometry results, our intention was to provide a comprehensive table summarizing these findings in a separate data sheet, as part of the data availability section. To address the reviewer’s comment and ensure full transparency, we will include this table as supplementary material in the revised manuscript. Additionally, we will update the methodology section to explicitly state these criteria and ensure clarity regarding the identification process.

      (3) The validation of ATP5I was based on the use of recombinant protein (which was 90% pure) for the SPR and the use of a single antibody to ATP5I. The validity of the immunoblotting rests on the assumption that there is no "non-specific" immunoactivity in the relevant mol wt range. Information on the validation of the antibody would be helpful.

      Regarding the recombinant protein used for SPR, its purity was evaluated using a Coomassie-stained gel. For the antibody used in immunoblotting, its specificity was validated through knockout cell lines, ensuring minimal concerns about non-specific immunoactivity within the relevant molecular weight range. Unfortunately, the KO data comes in the paper after the first immunoblots are presented. In the revised manuscript, we will clearly outline these validation steps in the methods section and additional manufacturer documentation for the antibody we used.

      (4) Knock-out of ATP5I markedly compromised the NAD/NADH ratio (Fig.3A) and cell proliferation (Figure 3D). These effects may be associated with decreased mitochondrial membrane potential which could explain the low efficacy of metformin (and most of the data in Figures 3-5). This possibility should be discussed. Effects of [metformin] on the NAD/NADH ratio in control cells and ATP5I-KO would have been helpful because the metformin data on cell growth is normalized as fold change relative to control, whereas the NAD/NADH ratio would represent a direct absolute measurement enabling comparison of the absolute effect in control cells with ATP5I KO.

      The mitochondrial membrane potential depends on a functional electron transport chain which drives proton pumping from the matrix to the intermembrane space. Metformin can decrease the mitochondrial membrane potential and this usually explained as a consequence of complex I inhibition(4). It has been published the metformin requires this membrane potential to accumulate in mitochondria so the actions of metformin are self-limiting due to this requirement. The reviewer is right that ATP5I KO cells could be resistant to metformin because they may have a lower membrane potential. We do not believe this to be the case because the response to phenformin, another biguanide that can enter mitochondria through the membrane without the need of the OCT transporters(5), is also affected in ATP5IKO cells. Of note, compensatory mechanisms such as enhanced glycolysis, as observed in ATP5I-KO cells (elevated ECAR and increased sensitivity to 2-D-deoxyglucose), and the ATPase activity of F<sub>1</sub>F<sub>0</sub>-ATP synthase could potentially help maintain membrane potential suggesting that this might not be an issue in the ATP5I KO cells. We will discuss these possibilities in the revised manuscript.

      Nevertheless, to experimentally address this point, we propose measuring mitochondrial membrane potential using tetramethylrhodamine methyl ester (TMRE) and ATP levels using luciferase-based assays (CellTiter-Glo) in ATP5I-KO cells.

      Regarding the NAD+/NADH in both control and KO cells may not be very helpful because this ratio can be corrected by LDH which is induced as part of the glycolytic adaptation that occurs after inhibition of respiration. Since our KO cells have been propagated already for several passages, the extent of this adaptation is likely different from metformin-treated cells. As we mentioned in answering Reviewer 1, we will provide a more direct measurement of metformin acting on ATP5I: the levels of F1F0-ATPase dimers and monomers.

      (5) Figure-6 CRISPR/Cas9 KO at 16mM metformin in comparison with 70nM rotenone and 2 micromolar oligomycin (in serum-containing medium). The rationale for the use of such a high concentration of metformin has not been explained. In liver cells metformin concentrations above 1mM cause severe ATP depletion, whereas therapeutic (micromolar) concentrations have minimal effects on cellular ATP status. The 16mM concentration is ~2 orders of magnitude higher than therapeutic concentrations and likely linked to compromised energy status. The stronger inhibition of cell proliferation by 16mM metformin compared with rotenone or oligomycin raises the issue of whether the changes in gene expression may be linked to the greater inhibition of mitochondrial metabolism. Validation of the cellular ATP status and NAD/NADH with metformin as compared with the two inhibitors could help the interpretation of this data.

      To address the reviewer’s final comment, we would like to clarify the rationale behind our experimental approach. NALM-6 cells are very glycolytic, have low respiration rates, and weak dependence on ATP5I (DepMap score: -0.47)(6). The concentration of 16 mM metformin was chosen based on the IC50 for this cell line. This approach aligns with our focus on the anticancer mechanism of action rather than the antidiabetic effects of metformin. Both ATP status and NAD+/NADH ratios will depend on the extent of the compensatory glycolysis. On the other hand, our genetic screening evaluates cell proliferation as an integration of all metabolic activities required for the process. This unbiased screening revealed a common pathway affected by metformin and oligomycin different that the pathway affected by rotenone, which is consistent with the finding that metformin acts of the F<sub>1</sub>F<sub>0</sub>ATPase.

      Reviewer #3 (Public review):

      (1) Most of the data are based on measurements of the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measured by the Seahorse analyser in control and ATP5l KO cells. However, these measurements are conducted by a single injection of a biguanide, followed over time and presented as fold change. By doing so, the individual information on the effect of metformin and derivate on control and KO cells are lost. In addition, the usual measurement of OCR is coupled with certain inhibitors and uncouplers, such as oligomycin, FCCP, and Antimycin A/rotenone, to understand the contribution of individual complexes to respiration. Since biguanides and ATP5l KO affect protein levels of components of complex I and IV, it would be informative to measure their individual contributions/effects in the Seahorse. To further strengthen the data, it would be helpful to obtain measurements of actual ATP levels in these cells, as this would explain the activation of AMPK.

      We appreciate the reviewer’s observations regarding the Seahorse measurements and acknowledge the potential limitations of presenting the data as fold change. Due to experimental challenges in maintaining KP-4 and ATP5I-KO cells with sufficient nutrients, caused by their rapid glucose uptake and subsequent lactate production, it was more practical to present the Seahorse results in this format. Using inhibitors at each time point during the Seahorse experiment was not feasible, as the delay between inhibitor injections and the corresponding changes in oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) would introduce variability and complicate the interpretation of dynamic responses. Nevertheless, we recognize the importance of understanding the contributions of specific respiratory complexes to OCR and ECAR. To address this, we will include a representative figure showcasing a typical Seahorse analysis, highlighting ATP turnover and proton leak after oligomycin addition, maximal respiration with FCCP, and disruption with rotenone and antimycin A. While these experiments are inherently complex due to the metabolic demands of ATP5I-KO cells, this approach will provide a clearer breakdown of mitochondrial activity. Furthermore, as mentioned in our response to Reviewer 2, we will measure ATP levels using a luciferase-based assay (CellTiter-Glo) in both control and ATP5I-KO cells to better explain AMPK activation. This will provide additional context to strengthen the interpretation of mitochondrial function and metabolic compensation mechanisms in these cells.

      (2) The authors report on alterations in mitochondrial morphology upon ATP5l KO, which is measured by subjective quantifications of filamentous versus puncta structures. Fiji offers great tools to quantify the mitochondrial network unbiasedly and with more accuracy using deconvolution and skeletonization of the mitochondria, providing the opportunity to measure length, shape, and number quantitatively. This will help to understand better, whether mitochondria are really fragmented upon ATP5l KO and rescued by its re-introduction.

      Concerning the analysis of mitochondrial morphology, we acknowledge the potential benefits of using Fiji and additional plugins such as MiNA for more accurate and unbiased quantification. Indeed, this approach could provide stronger evidence for mitochondrial fragmentation upon ATP5I-KO and its potential rescue by ATP5I reintroduction. We will consider integrating this methodology into our analysis to enhance the precision and robustness of our findings.

      (3) Finally, the authors report in the last part of the paper a genetic CRISPR/Cas9 KO screen in NALM-6 cells cultured with high amounts of metformin to identify potential new mediators of metformin action. It is difficult to connect that to the rest of the paper because a) different concentrations of metformin are used and b) the metabolic effects on energy consumption are not defined. They argue about the molecular function of the obtained hits based on literature and on a comparison of the pattern of genetic alterations based on treatments with known inhibitors such as oligomycin and rotenone. However, a direct connection is not provided, thus the interpretation at the end of the results that "the OMA1-DEL1-HRI pathway mediates the antiproliferative activity of both biguanides and the F1ATPase inhibitor oligomycin" while increasing glycolysis, needs to be toned down. This is an interesting observation, but no causality is provided. In general, this part stands alone and needs to be better connected to the rest of the paper.

      NALM-6 are very glycolytic, have low respiration rates, and weak dependence on ATP5I(6), forcing us to use higher concentrations of metformin to inhibit their growth. Recent results show that metformin targets PEN2 in the cytosol to increase AMPK activity, controlling both the glucose lowering and the life span extension abilities of metformin 7. This work raises the question whether the antiproliferative and anticancer effects of metformin are due to a mitochondrial activity or are controlled by this new pathway of AMPK activation. Hence, the genetic screening was performed to unbiasedly find how metformin works. The results provide compelling evidence for mitochondria and in particular the ATP synthase as potential targets of metformin and a foundation for future studies. We will revise the text and abstract to better reflect the exploratory nature of this finding and ensure clarity.

      (1) Paumard, P. et al. Two ATP synthases can be linked through subunits i in the inner mitochondrial membrane of Saccharomyces cerevisiae. Biochemistry 41, 10390-10396 (2002). https://doi.org/10.1021/bi025923g

      (2) Paumard, P. et al. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J 21, 221-230 (2002). https://doi.org/10.1093/emboj/21.3.221

      (3) Habersetzer, J. et al. ATP synthase oligomerization: from the enzyme models to the mitochondrial morphology. Int J Biochem Cell Biol 45, 99-105 (2013). https://doi.org/10.1016/j.biocel.2012.05.017

      (4) Xian, H. et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54, 1463-1477 e1411 (2021). https://doi.org/10.1016/j.immuni.2021.05.004

      (5) Hawley, S. A. et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell metabolism 11, 554-565 (2010). https://doi.org/10.1016/j.cmet.2010.04.001

      (6) Hlozkova, K. et al. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase. BMC Cancer 20, 526 (2020). https://doi.org/10.1186/s12885-020-07020-y

      (7) Ma, T. et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603, 159-165 (2022). https://doi.org/10.1038/s41586-022-04431-8

    1. Author response:

      We thank the reviewers for taking the time to read and critically assess our manuscript.

      We agree with the main points and they will be addressed in both writing and in additional experiments in a revised version of the paper.

      The shared and major point of criticism are non-conclusive metabolomic data that indicate the bc1-complex in T. gondii as a MMV1028806 target tachyzoites and bradyzoites. Regarding the former, our conclusion was mainly based on both metabolite abundance changes that are observed after treatment with one bona-fide bc1-complex inhibitor atovaquone and also steady-state stable isotope incorporation patterns. While it is true that secondary effects of metabolic inhibition occur and are often dominant, isotope labelling equilibria take more time to establish and may reflect more accurately blocked metabolic reactions i.e. the primary target.

      Regardless, we will follow the excellent suggestions to functionally assay particular mitochondrial electron transfer reactions to corroborate or revise our conclusions regarding the primary MMV1028806 target.

      For more details please refer the full author responses that will accompany the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      The reviewers suggest a number of experiments and re-analyses to strengthen their claims and enhance the impact of the study. While a number of these are longer term, below is a summary of experiments and analyses recommended by the reviewers that can be accomplished in the shorter term:

      (1) Clarification of statistical approaches, quantification, data presentation and description of cerebellar anatomical nomenclature (e.gs. detailed statistical methods for the GEO dataset analysis, FDR correction, quantification in Figs 2-4)

      The revised manuscript will provide detailed statistical methods including FDR  correction for GEO dataset analyses and quantification. Please see specific responses to GEO dataset analyses below.

      (2) Improved quality of images for select immunostains and in situ hybridization

      The revised manuscript will address the quality of the images as indicated by the reviewers.

      (3) Include a control group of hGFAP-Cre mice with loxP sites but without Sufu deletion to assess the effects of Cre-induced double-strand breaks on phosphorylated H2AX-DSB signaling.

      The breeding scheme we used to generate homozygous SUFU conditional mutants will not generate pups carrying only hGFAP-Cre. Thus, we are unable to compare expression of gH2AX expression in littermates that do not carry loxP sites. The reviewer is correct in pointing out the possibility of Cre recombinase activity inducing double-strand breaks on its own. However, it is likely that any hGFAP-Cre induced double-strand breaks does not sufficiently cause the phenotypes we observed in homozygous mutants (Sufu-cKO) mice because the cerebellum of mice carry heterozygous SUFU mutations (hGFAP-Cre;Sufu-fl/+) do not display the profound cerebellar phenotypes observed in Sufu-cKO mice. We cannot rule out, however, any undetectable abnormalities that could be present which may require further analyses.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      SUFU modulates Sonic hedgehog (SHH) signaling and is frequently mutated in the B-subtype of SHH-driven medulloblastoma. The B-subtype occurs mostly in infants, is often metastatic, and lacks specific treatment. Yabut et al. found that Fgf5 was highly expressed in the B-subtype of SHH-driven medulloblastoma by examining a published microarray expression dataset. They then investigated how Fgf5 functions in the cerebellum of mice that have embryonic Sufu loss of function. This loss was induced using the hGFAP-cre transgene, which is expressed in multiple cell types in the developing cerebellum, including granule neuron precursors (GNPs) derived from the rhombic lip. By measuring the area of Pax6+ cells in the external granule cell layer (EGL) of Sufu-cKO mice at postnatal day 0, they find Pax6+ cells occupy a larger area in the posterior lobe adjacent to the secondary fissure, which is poorly defined. They show that Fgf5 RNA and phosphoErk1/2 immunostaining are also higher in the same disrupted region. Some of the phosphoErk1/2+ cells are proliferative in the Sufu-cKO. Western blot analysis of Gli proteins that modulate SHH signaling found reduced expression and absence of Gli1 activity in the region of cerebellar dysgenesis in Sufu-cKO mice. This suggests the GNP expansion in this region is independent of SHH signaling. Amazingly, intraventricular injection of the FGFR1-2 antagonist AZD4547 from P0-4 and examined histologically at P7 found the treatment restored cytoarchitecture in the cerebella of Sufu-cKO mice. This is further supported by NeuN immunostaining in the internal granule cell layer, which labels mature, non-diving neurons, and KI67 immunostaining, indicating dividing cells, and primarily found in the EGL. The mice were treated beginning at a timepoint when cerebellar cytoarchitecture was shown to be disrupted and it is indistinguishable from control following treatment. Figure 3 presents the most convincing and exciting data in this manuscript.

      Sufu-cKO do not readily develop cerebellar tumors. The authors detected phosphorylated H2AX immunostaining, which labels double-strand breaks, in some cells in the EGL in regions of cerebellar dysgenesis in the Sufu-cKO, as was cleaved Caspase 3, a marker of apoptosis. P53, downstream of the double-strand break pathway, the protein was reduced in Sufu-cKO cerebellum. Genetically removing p53 from the Sufu-cKO cerebellum resulted in cerebellar tumors in 2-month old mice. The Sufu;p53-dKO cerebella at P0 lacked clear foliation, and the secondary fissure, even more so than the Sufu-cKO. Fgf5 RNA and signaling (pERK1/2) were also expressed ectopically.

      The conclusions of the paper are largely supported by the data, but some data analysis need to be clarified and extended.

      (1) The rationale for examining Fgf5 in medulloblastoma is not sufficiently convincing. The authors previously reported that Fgf15 was upregulated in neocortical progenitors of mice with conditional loss of Sufu (PMID: 32737167). In Figure 1, the authors report FGF5 expression is higher in SHH-type medulloblastoma, especially the beta and gamma subtypes mostly found in infants. These data were derived from a genome-wide dataset and are shown without correction for multiple testing, including other Fgfs. Showing the expression of other Fgfs with FDR correction would better substantiate their choice or moving this figure to later in the manuscript as support for their mouse investigations would be more convincing.

      To assess FGF5 (ENSG00000138675) expression in MB tissues, we used Geo2R (Barrett et al., 2013) to analyze published human MB subtype expression arrays from accession no. GSE85217 (Cavalli et al., 2017). GEO2R is an interactive web tool that compares expression levels of genes of interest (GOI) between sample groups in the GEO series using original submitter-supplied processed data tables. We entered the GOI Ensembl ID and organized data sets according to age and MB subgroup or MB<sup>SHH</sup> subtype classifications. GEO2R results presented gene expression levels as a table ordered by FDR-adjusted (Benjamini & Hochberg) p-values, with significance level cut-off at 0.05, processed by GEO2R’s built-in limma statistical test. Resulting data were subsequently exported into Prism (GraphPad). We generated scatter plots presenting FGF5 expression levels across all MB subgroups (Figure 1A) and MB<sup>SHH</sup> subtypes (Figure 1D). We performed additional statistical analyses to compare FGF5 expression levels between MB subgroups and MB<sup>SHH</sup> subtypes and graphed these data as violin plots (Figure 1B, 1C, and 1E). For these analyses, we used one-way ANOVA with Holm-Sidak’s multiple comparisons test, single pooled variance. P value ≤0.05 was considered statistically significant. Graphs display the mean ± standard error of the mean (SEM).

      Author response image 1.

      Comparative expression of FGF ligands, FGF5, FGF10, FGF12, and FGF19, across all MB subgroups. FGF12 expression is not significantly different, while FGF5, FGF10, and FGF19, show distinct upregulation in MB<sup>SHH subgroup (MB<sup>WNT</sup> n=70, MB<sup>SHH</sup> n=224, MB<sup>GR3</sup> n=143, MB<sup>GR4</sup> n=326).

      Expression of the 21 known FGF ligands were also analyzed. Many FGFs did not exhibit differential expression levels in MB<sup>SHH</sup> compared to other MB subgroups, such as with FGF12 in Figure 1. FGF5, FGF10, and FGF19 (the human orthologue of mouse FGF15) all showed specific upregulation in MB<sup>SHH</sup> compared to other MB subgroups (Author response image 1), supporting our previous observations that FGF15 is a downstream target of SHH signaling (Yabut et al., 2020), as the reviewer pointed out. However, further stratification of MB<sup>SHH</sup> patient data revealed that only FGF5 specifically showed upregulation in infants with MBSHH (MB<sup>SHHβ</sup> and MB<sup>SHHγ</sup> Author response image 2) indicating a more prominent role for FGF5 in the developing cerebellum and driver of MB<sup>SHH</sup> tumorigenesis in this dynamic environment.

      Author response image 2.

      Comparative expression of FGF5, FGF10, and FGF19 in different MB<sup>SHH</sup> subtypes. FGF5 specifically show mRNA relative levels above 6 in 81% of MB<sup>SHH</sup> infant patient tumors (n=80 MB<sup>SHHα</sup> and MB<sup>SHHγ</sup> tumors) unlike 35% of MB<sup>SHHα</sup> (n=65) or 0% of MB<sup>SHHδ</sup>  (n=75) tumors.

      (2) The Sufu-cKO cerebellum lacks a clear anchor point at the secondary fissure and foliation is disrupted in the central and posterior lobes. It would be helpful for the authors to review Sudarov & Joyner (PMID: 18053187) for nomenclature specific to the developing cerebellum.

      The reviewers are correct that the cerebellar foliation is severely disrupted in central and posterior lobes, as per Sudarov and Joyner (Neural Development 2007). This nomenclature may be referred to describe the regions referred in this manuscript.

      (3) The metrics used to quantify cerebellar perimeter and immunostaining are not sufficiently described. It is unclear whether the individual points in the bar graph represent a single section from independent mice, or multiple sections from the same mice. For example, in Figures 2B-D. This also applies to Figure 3C-D.

      All quantification were performed from 2-3 20 um cerebellar sections of 3-6 independent mice per genotype analyzed. Individual points in the bar graphs represent the average cell number (quantified from 2-3 sections) from each mice. Figure 2B show data points from n=4 mice per genotype. Figure 2C show data from n=3 mice per genotype. Figure 2D show data from n=6 mice per genotype.  Figure 3C-D show data from n=3 mice per genotype.

      (4) The data on Fgf5 RNA expression presented in Figure 2E are not sufficiently convincing. The perimeter and cytoarchitecture of the cerebellum are difficult to see and the higher magnification shown in 2F should be indicated in 2E.

      The lack of foliation in Sufu-cKO cerebellum is clear particularly when visualizing the perimeter via DAPI labeling (Figure 2E). The expression area of FGF5 is also visibly larger, given that all images in Figure 2E are presented in the same scale (scale bars = 500 um). 

      (5) The data presented in Figure 3 are not sufficiently convincing. The number of cells double positive for pErk and KI67 (Figure 3B) are difficult to see and appear to be few, suggesting the quantification may be unreliable.

      We used KI67+ expression to provide a molecular marker of regions to be quantified in both WT and Sufu-cKO sections. Quantification of labeled cells were performed in images obtained by confocal microscopy, enabling imaging of 1-2 um optical slices since Ki67 or pERK expression might not localize within the same cellular compartments. We relied on continuous DAPI nuclear staining to distinguish individual cells in each optical slice and the colocalization of of Ki67 and pERK. All quantification were performed from 2-3 20 um cerebellar sections of 3-6 independent mice per genotype analyzed. Individual points in the bar graphs represent the average cell number (quantified from 2-3 sections) from each mice.

      (6) The data presented in Figure 4F-J would be more convincing with quantification. The Sufu;p53-dKO appears to have a thickened EGL across the entire vermis perimeter, and very little foliation, relative to control and single cKO cerebella. This is a more widespread effect than the more localized foliation disruption in the Sufu-cKO. 

      We agree with the reviewers that quantification of these phenotypes provide a solid measure of the defects. The phenotypes of Sufu:p53-dKO cerebellum are so profound requiring  in-depth characterization that will be the focus of future studies.

      (7) Figure 5 does not convincingly summarize the results. Blue and purple cells in sagittal cartoon are not defined. Which cells express Fgf5 (or other Fgfs) has not been determined. The yellow cells are not defined in relation to the initial cartoon on the left.

      The revised manuscript will address this confusion by clearly labeling the cells and their roles in the schematic diagram.

      Reviewer #2 (Public Review):

      Summary:

      Mutations in SUFU are implicated in SHH medulloblastoma (MB). SUFU modulates Shh signaling in a context-dependent manner, making its role in MB pathology complex and not fully understood. This study reports that elevated FGF5 levels are associated with a specific subtype of SHH MB, particularly in pediatric cases. The authors demonstrate that Sufu deletion in a mouse model leads to abnormal proliferation of granule cell precursors (GCPs) at the secondary fissure (region B), correlating with increased Fgf5 expression. Notably, pharmacological inhibition of FGFR restores normal cerebellar development in Sufu mutant mice.

      Strengths:

      The identification of increased FGF5 in subsets of MB is novel and a key strength of the paper.

      Weaknesses:

      The study appears incomplete despite the potential significance of these findings. The current paper does not fully establish the causal relationship between Fgf5 and abnormal cerebellar development, nor does it clarify its connection to SUFU-related MB. Some conclusions seem overstated, and the central question of whether FGFR inhibition can prevent tumor formation remains untested.

      Reviewer #3 (Public Review):

      Summary:

      The interaction between FGF signaling and SHH-mediated GNP expansion in MB, particularly in the context of Sufu LoF, has just begun to be understood. The manuscript by Yabut et al. establishes a connection between ectopic FGF5 expression and GNP over-expansion in a late-stage embryonic Sufu LoF model. The data provided links region-specific interaction between aberrant FGF5 signaling with the SHH subtype of medulloblastoma. New data from Yabut et al. suggest that ectopic FGF5 expression correlates with GNP expansion near the secondary fissure in Sufu LoF cerebella. Furthermore, pharmacological blockade of FGF signaling inhibits GNP proliferation. Interestingly, the data indicate that the timing of conditional Sufu deletion (E13.5 using the hGFAP-Cre line) results in different outcomes compared to later deletion (using Math1-cre line, Jiwani et al., 2020). This study provides significant insights into the molecular mechanisms driving GNP expansion in SHH subgroup MB, particularly in the context of Sufu LoF. It highlights the potential of targeting FGF5 signaling as a therapeutic strategy. Additionally, the research offers a model for better understanding MB subtypes and developing targeted treatments.

      Strengths:

      One notable strength of this study is the extraction and analysis of ectopic FGF5 expression from a subset of MB patient tumor samples. This translational aspect of the study enhances its relevance to human disease. By correlating findings from mouse models with patient data, the authors strengthen the validity of their conclusions and highlight the potential clinical implications of targeting FGF5 in MB therapy.

      The data convincingly show that FGFR signaling activation drives GNP proliferation in Sufu, conditional knockout models. This finding is supported by robust experimental evidence, including pharmacological blockade of FGF signaling, which effectively inhibits GNP proliferation. The clear demonstration of a functional link between FGFR signaling and GNP expansion underscores the potential of FGFR as a therapeutic target in SHH subgroup medulloblastoma.

      Previous studies have demonstrated the inhibitory effect of FGF2 on tumor cell proliferation in certain MB types, such as the ptc mutant (Fogarty et al., 2006)(Yaguchi et al., 2009). Findings in this manuscript provide additional support suggesting multiple roles for FGF signaling in cerebellar patterning and development.

      Weaknesses:

      In the GEO dataset analysis, where FGF5 expression is extracted, the reporting of the P-value lacks detail on the statistical methods used, such as whether an ANOVA or t-test was employed. Providing comprehensive statistical methodologies is crucial for assessing the rigor and reproducibility of the results. The absence of this information raises concerns about the robustness of the statistical analysis.

      The revised manuscript will include the following detailed explanation of the statistical analyses of the GEO dataset:

      For the analysis of expression values of FGF5 (ENSG00000138675), we obtained these values using Geo2R (Barrett et al., 2013), which directly analyze published human MB subtype expression arrays from accession no. GSE85217 (Cavalli et al., 2017). GEO2R is an interactive web tool that compares expression levels of genes of interest (GOI) between sample groups in the GEO series using original submitter-supplied processed data tables. We simply entered the GOI Ensembl ID and organized data sets according to age and MB subgroup or MBSHH subtype classifications. GEO2R results presented gene expression levels as a table ordered by FDR-adjusted (Benjamini & Hochberg) p-values, with significance level cut-off at 0.05, processed by GEO2R’s built-in limma statistical test. Resulting data were subsequently exported into Prism (GraphPad). We generated scatter plots presenting FGF5 expression levels across all MB subgroups (Figure 1A) and MBSHH subtypes (Figure 1D). We performed additional statistical analyses to compare FGF5 expression levels between MB subgroups and MBSHH subtypes and graphed these data as violin plots (Figure 1B, 1C, and 1E). For these analyses, we used one-way ANOVA with Holm-Sidak’s multiple comparisons test, single pooled variance. P value ≤0.05 was considered statistically significant. Graphs display the mean ± standard error of the mean (SEM). Sample sizes were:

      Author response table 1.

      Another concern is related to the controls used in the study. Cre recombinase induces double-strand DNA breaks within the loxP sites, and the control mice did not carry the Cre transgene (as stated in the Method section), while Sufu-cKO mice did. This discrepancy necessitates an additional control group to evaluate the effects of Cre-induced double-strand breaks on phosphorylated H2AX-DSB signaling. Including this control would strengthen the validity of the findings by ensuring that observed effects are not artifacts of Cre recombinase activity.

      The breeding scheme we used to generate homozygous SUFU conditional mutants will not generate pups carrying only hGFAP-Cre. Thus, we are unable to compare expression of gH2AX expression in littermates that do not carry loxP sites. The reviewer is correct in pointing out the possibility of Cre recombinase activity inducing double-strand breaks on its own. However, it is likely that any hGFAP-Cre induced double-strand breaks does not sufficiently cause the phenotypes we observed in homozygous mutants (Sufu-cKO) mice because the cerebellum of mice carry heterozygous SUFU mutations (hGFAP-Cre;Sufu-fl/+) do not display the profound cerebellar phenotypes observed in Sufu-cKO mice. We cannot rule out, however, any undetectable abnormalities that could be present which may require further analyses.

      Although the use of the hGFAP-Cre line allows genetic access to the late embryonic stage, this also targets multiple celltypes, including both GNPs and cerebellar glial cells. However, the authors focus primarily on GNPs without fully addressing the potential contributions of neuron-glial interaction. This oversight could limit the understanding of the broader cellular context in which FGF signaling influences tumor development. 

      The reviewer is correct in that hGFAP-Cre also targets other cell types, such as cerebellar glial cells, which are generated when Cre-expression has begun. It is possible that cerebellar glial cell development is also compromised in Sufu-cKO mice and may disrupt neuron-glial interaction, due to or independently of FGF signaling. In-depth studies are required to interrogate how loss of SUFU specifically affect development of cerebellar glial cells and influence their cellular interactions in the developing cerebellum.

      Recommendations for the authors:

      Editorial Comments:

      The reviewers suggest a number of steps to improve the manuscript that include additional experiments and a deeper analyses and re-evaluation of existing data. Short of significant new experiments, there appears to be number of straightforward analyses that can improve the study:

      (1) Reanalyses of statistical and quantitative approaches used (e.gs FDR correction, cerebellar deficits, GEO analyses.

      The revised manuscript will include detailed information on the statistical and quantitative approaches as addressed in our response to the reviewer’s comments.

      (2) More clear presentation of qualitative labeling approaches (immunohistochemistry and in situ hybridization).

      A detailed description of the protocols used will be included in  the methods section for labeling methods in the revised manuscript.

      Reviewer #1 (Recommendations For The Authors):

      AZD4547 treatment of the dKO mice would provide more convincing evidence that FGF-targeted treatments could curtail tumor growth in these mice or refute the suggestion that FGF-targeted treatment could prevent tumor growth.

      We agree that performing AZD4547 treatment on Sufu-dKO mice will strengthen these studies. However, we are unable to address since these mice are now unavailable. We hope that future studies will address these.

      Atoh1 is referred to as Math1 (older nomenclature) and should be corrected.

      The revised manuscript will include this change in nomenclature.

      Check verb tense throughout the manuscript.

      We will edit the manuscript further to check verb tenses prior to submission of the revised manuscript.

      Reviewer #2 (Recommendations For The Authors):

      Specific Comments:

      (1) The identification of increased FGF5 in subsets of MB is novel and a key strength of the paper. However, the causal relationship between FGF5 and MB remains unestablished. Based on the current data, FGF5 can only be considered a biomarker for stratifying MB.

      We agree with the reviewer that our studies do not provide direct evidence that FGF5 cause MB. Future investigation focusing on determining if FGF5 inhibition leads to phenotypic rescue will strongly establish the relationship between FGF5 and MB. The reviewer is also correct that our studies reveal that FGF5 acts as a potential biomarker, as we mentioned in the Discussion section.

      (2) The upregulation of Fgf5 in Sufu-deficient cerebella is crucial to this study, yet the presented data are unconvincing to support this conclusion. In comparing Fgf5 expression between WT and Sufu mutants (Figures 2E, F and 4I), the cerebellar sections differ significantly, with mutant sections seemingly from a more lateral position. The authors should provide images of mutant sections from more comparable positions to accurately assess the effect of Sufu deficiency on Fgf5 expression. Additionally, the signals in Figure 2F resemble non-specific backgrounds rather than specific RNAscope signals.

      The WT and mutant sections analyzed were carefully selected from comparable levels. The abnormal foliation in Sufu-cKO make the mutant sections look like they are from the lateral cerebellum.

      Figure 2F (enlarged regions) point to punctate RNAScope signals which is characteristic of this labeling method (see RBFOX3 or GFAP labeling in DAPI-labeled cells in the mouse brain at https://acdbio.com/science/applications/research-areas/neuroscience). The higher number of punctate signals in some, but not all, DAPI-labeled cells in Figure 2F indicate that the FGF5 RNAScope signal is specific.

      (3) Jiwani et al. (2020) reported that Fgf8 also expressed in region B of the EGL, is upregulated in Sufu-deficient cerebella and is necessary and sufficient for Sufu mutant GCP proliferation. The current study does not distinguish whether the FGFR inhibitor AZD4547 blocks Fgf5 and Fgf8 function in restoring cerebellar histology in Sufu mutants.

      AZD4547 potently inhibits FGFR1, FGFR2, and FGFR3 autophosphorylation (Gavine et al., Cancer Research, 2012). FGF8 is reported to bind to these receptors (Ornitz and Itoh, 2015). Thus, the reviewer is correct that the studies will not distinguish between FGF5 or FGF8 activity. Further investigation on FGF8 expression and the effects of its inhibition in the Sufu-cKO neonatal cerebellum will determine whether tumorigenic processes are driven by either FGF5 or FGF8. Nevertheless, we postulate that FGF5 is exerting a greater effect in activating FGF signaling in the developing cerebellum given that it is highly expressed along the external granule layers of the developing cerebellum (Author response image 3).

      Author response image 3.

      Expression of FGF5 and FGF8 in the P4 mouse cerebellum (Allen Brain Atlas, https://developingmouse.brain-map.org )

      (4) The authors should show whether AZD4547 treatment restores normal Fgf5 expression. Importantly, they need to test whether AZD4547 rescues the proliferation defect observed in Sufu;p53 double mutants.

      We agree that performing AZD4547 treatment on Sufu-dKO mice will strengthen these studies. However, we are unable to address since these mice are now unavailable. We hope that future studies will address these.

      (5) Jiwani et al. (2020) showed that deleting Sufu with Atoh1-Cre promotes Gli3R and suppresses Gli2 levels, leading to increased cell proliferation and delayed cell cycle exit in the central lobe. The findings of the current study (Supplementary Figure 1) seem to differ from this previous report, yet both studies conclude that Sufu-KO disrupts differentiation. The authors should provide an explanation for this discrepancy.

      Our results align completely with the findings by Jiwani et al. (2020). Both studies showed reduced levels of Gli3R, showing nearly 50% reduction, when Sufu is deleted (see Figure 4A-4D in Jiwani et al., 2020).

      (6) The hGFAP-Cre mouse line is used to delete Sufu from the cerebellum, but it is not commonly used for GCP-specific deletion. The authors need to provide a reference or more details on the temporal and spatial activity of the Cre line, as the cited paper describes its generation but offers little information on its activity in the developing cerebellum.

      We appreciate the reviewer’s reminder to include the reference for the Schuller et al. 2008 paper. This study characterized the hGFAP-Cre temporal and spatial expression in the developing cerebellum, including granule cell precursors. We will include this reference in the revised manuscript.

      (7) Based on the provided data, it is difficult to determine which cell types express Fgf5. Given that hGFAP-cre may delete Sufu in other cerebellar cell types, the authors should demonstrate that Fgf5 is expressed in granule cells or granule cell precursors.

      Future studies will focus on further characterization of the role of FGF5 in cerebellar development, including the identity cells expressing FGF5. The reviewer is correct in that hGFAP-Cre also targets other cell types and that Sufu deletion in these cells induced ectopic FGF5 expression.

      (8) The provided data show an increase in pERK+ cells in GCPs at the secondary fissure. This increase may simply reflect an accumulation of GCPs. It is unconvincing that there is an increase in pERK due to the loss of Sufu.

      The reviewer is correct that the increase in GCPs will also result increase the number of pERK+ cells. To control for this, our quantification reflects the number of cells per unit area where Ki67+ cells. With these parameters, we found that there is an increased density of pERK+ cells in a given Ki67+ region. All quantification were performed from 2-3 20 um cerebellar sections of 3-6 independent mice per genotype analyzed. Individual points in the bar graphs represent the average cell number (quantified from 2-3 sections) from each mice.

      (9) No data are provided on MB formation in Sufu-cKO; p53- mutants, and it is unknown whether FGFR inhibitors block tumor formation.

      We agree that performing AZD4547 treatment on Sufu-dKO mice will strengthen these studies. However, we are unable to address since these mice are now unavailable. We hope that future studies will address these.

      (10) The authors frequently mention "preneoplastic lesions" of GCPs in Sufu mutant mice. What evidence supports this claim?

      Preneoplastic lesions are defined as cells carrying genetic and phenotypic alterations that show higher risk of malignancy (such as MB) but lack the capacity to grow autonomously in the absence of a secondary factor (Feo et al., 2011). In Sufu-cKO mice, we see abnormally proliferating and behaving granule precursor cells that do not grow autonomously, in the absence of a p53 LOF. The combined deletion of Sufu and p53 transforms these cells to become neoplastic.

      (11) Fgf5 is normally expressed in region B. What is its potential function? Does AZD4547 affect normal development? 

      Future studies will focus on further characterization of the role of FGF5 in cerebellar development, including the identity cells expressing FGF5. Regarding AZD4547, we did not observe any obvious difference between AZD4547-treated and vehicle-treated cerebelli. These indicate that AZD4547 inhibition of FGFRs under physiologic conditions does not significantly disrupt normal cerebellar development.

      (12) Figure 3G: It is unclear which specimens were treated with AZD4547. The authors mention treatment in line 281 but contradict themselves in the figure legend.

      We thank the reviewer for pointing out this typo. Cerebellar tissues shown in Figure 3G were all treated with AZD4547. The figure legend will be corrected in the revised manuscript.

      (13) Figure 4J: The higher magnification images of the pERK/Ki67 staining appear identical in the control and Sufu;p53-dKO. The authors need to correct the mistake.

      We thank the reviewer for pointing this out. We will correct this figure in the revised manuscript.

      Minor Comments:

      (1) Whenever possible, images comparing WT and mutants should be presented at the same scale within a figure. For example, readers might easily conclude that mutant brains are smaller than controls in Figure 4G.

      Unfortunately, because the cerebellum of Sufu;p53-dKO mice are significantly bigger, we are unable to show the whole cerebellum in the same scale in Figure 4G. We wanted to emphasize the significant and abnormal cerebellar growth in this figure.

      (2) The figure legend for Supplementary Figure 2 is missing.

      Thank you for pointing this out. We will add a figure legend in this Supplementary data in the revised manuscript.

      (3) The authors state that the expansion of Pax6+ GNPs in the newborn Sufu-cKO cerebellum (Figure 2) occurs in similar anatomical subregions where infantile MB tumors typically arise (Tan et al., 2018). The cited paper describes more abundant SHH MB in the cerebellar hemisphere. The authors need to elaborate on their statement to clarify this point.

      The reviewer is correct in that Tan et al., 2018 observed tumors arising from the cerebellar hemisphere. More specifically, these tumors arise in the posterior/ventral regions of the cerebellar hemispheres (Figure 2 in Tan et al., 2018). Similarly, Sufu-cKO mice have more severe defects in the posterior/ventral regions of the cerebellar hemisphere (Figures 2A and 3F) and therefore corroborate the findings by Tan et al., that abnormal SHH signaling in these regions results in increased sensitivity to MB formation.

      Reviewer #3 (Recommendations For The Authors):

      Figure1 [Upregulated FGF5 expression in MBS-HH tumors]

      - Statistical analysis from the Geo expression dataset does not provide enough detail. At least, the authors should mention whether they have made any adjustments from the default settings and how they extracted/plotted the FGF5 expression (Figure 1BCE).

      For the analysis of expression values of FGF5 (ENSG00000138675), we obtained these values using Geo2R (Barrett et al., 2013), which directly analyze published human MB subtype expression arrays from accession no. GSE85217 (Cavalli et al., 2017). GEO2R is an interactive web tool that compares expression levels of genes of interest (GOI) between sample groups in the GEO series using original submitter-supplied processed data tables. We simply entered the GOI Ensembl ID and organized data sets according to age and MB subgroup or MBSHH subtype classifications. GEO2R results presented gene expression levels as a table ordered by FDR-adjusted (Benjamini & Hochberg) p-values, with significance level cut-off at 0.05, processed by GEO2R’s built-in limma statistical test. Resulting data were subsequently exported into Prism (GraphPad). We generated scatter plots presenting FGF5 expression levels across all MB subgroups (Figure 1A) and MB<sup>SHH</sup> subtypes (Figure 1D). We performed additional statistical analyses to compare FGF5 expression levels between MB subgroups and MB<sup>SHH</sup> subtypes and graphed these data as violin plots (Figure 1B, 1C, and 1E). For these analyses, we used one-way ANOVA with Holm-Sidak’s multiple comparisons test, single pooled variance. P value ≤0.05 was considered statistically significant. Graphs display the mean ± standard error of the mean (SEM). See Author response table 1 for sample sizes.

      Figure 3 [Ectopic activation of FGF signaling in the EGL of P0 Sufu-cKO cerebellum]

      - Gil1-lz mice reference wrong. Correct Bai CB, et al. 2002

      - Generation of Sufu-cKO;Gli1-LacZ triple transgenic mice not described 

      - Veh vs. treated not labelled (Figure 3F)

      We will address these minor text changes in the revised manuscript. A more detailed description of the generation of Sufu-cKO;Gli1-LacZ triple transgenic will also be included in the Methods section.

      Figure 5 [Proposed model]

      - In the text, Figure 5 is mistaken for Figure 8. 

      We will address these minor text changes in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      Sun et al. are interested in how experience can shape the brain and specifically investigate the plasticity of the Toll-6 receptor-expressing dopaminergic neurons (DANs). To learn more about the role of Toll-6 in the DANs, the authors examine the expression of the Toll-6 receptor ligand, DNT-2. They show that DNT-2 expressing cells connect with DANs and that loss of function of DNT-2 in these cells reduces the number of PAM DANs, while overexpression causes alterations in dendrite complexity. Finally, the authors show that alterations in the levels of DNT-2 and Toll-6 can impact DAN-driven behaviors such as climbing, arena locomotion, and learning and long-term memory.

      Strengths:

      The authors methodically test which neurotransmitters are expressed by the 4 prominent DNT-2 expressing neurons and show that they are glutamatergic. They also use Trans-Tango and Bac-TRACE to examine the connectivity of the DNT-2 neurons to the dopaminergic circuit and show that DNT-2 neurons receive dopaminergic inputs and output to a variety of neurons including MB Kenyon cells, DAL neurons, and possibly DANS.

      We are very pleased that Reviewer 1 found our connectivity analysis a strength.

      Weaknesses:

      (1) To identify the DNT-2 neurons, the authors use CRISPR to generate a new DN2-GAL4.

      They note that they identified at least 12 DNT-2 plus neurons. In Supplementary Figure 1A, the DNT-2-GAL4 driver was used to express a UAS-histoneYFP nuclear marker. From these figures, it looks like DNT-2-GAL4 is labeling more than 12 neurons. Is there glial expression?

      Indeed, we claimed that DNT-2 is expressed in at least 12 neurons (see line 141, page 6 of original manuscript), which means more than 12 could be found. The membrane tethered reporters we used – UAS-FlyBow1.1, UASmcD8-RFP, UAS-MCFO, as well as UAS-DenMark:UASsyd-1GFP – gave a consistent and reproducible pattern. However, with DNT-2GAL4>UAS-Histone-YFP more nuclei were detected that were not revealed by the other reporters. We have found also with other GAL4 lines that the patterns produced by different reporters can vary. This could be due to the signal strength (eg His-YFP is very strong) and perdurance of the reporter (e.g. the turnover of His-YFP may be slower than that of the other fusion proteins).

      We did not test for glial expression, as it was not directly related to the question addressed in this work.

      (2) In Figure 2C the authors show that DNT-2 upregulation leads to an increase in TH levels using q-RT-PCR from whole heads. However, in Figure 3H they also show that DNT-2 overexpression also causes an increase in the number of TH neurons. It is unclear whether TH RNA increases due to expression/cell or the number of TH neurons in the head.

      Figure 3H shows that over-expression of DNT-2 FL increased the number of Dcp1+ apoptotic cells in the brain, but not significantly (p=0.0939). The ability of full-length neurotrophins to induce apoptosis and cleaved neurotrophins promote cell survival is well documented in mammals. We had previously shown that DNT-2 is naturally cleaved, and that over-expression of DNT-2 does not induce apoptosis in the various contexts tested before (McIlroy et al 2013 Nature Neuroscience; Foldi et al 2017 J Cell Biol; Ulian-Benitez et al 2017 PLoS Genetics). Similarly, throughout this work we did not find DNT-2FL to induce apoptosis.

      Instead, in Figure 3G we show that over-expression of DNT-2FL causes a statistically significant increase in the number of TH+ cells. This is an important finding that supports the plastic regulation of PAM cell number. We thank the Reviewer for highlighting this point, as we had forgotten to add the significance star in the graph. In this context, we cannot rule out the possibility that the increase in TH mRNA observed when we over-express DNT-2FL could not be due to an increase in cell number instead. Unfortunately, it is not possible for us to separate these two processes at this time. Either way, the result would still be the same: an increase in dopamine production when DNT-2 levels rise.

      We have now edited the abstract lines 38-39 adding that “By contrast, over-expressed DNT-2 increased DAN cell number,…”, within the main text in Results page 10 lines 259-265 and in the Discussion section page 15 lines 391, 393-396.

      (3) DNT-2 is also known as Spz5 and has been shown to activate Toll-6 receptors in glia (McLaughlin et al., 2019), resulting in the phagocytosis of apoptotic neurons. In addition, the knockdown of DNT-2/Spz5 throughout development causes an increase in apoptotic debris in the brain, which can lead to neurodegeneration. Indeed Figure 3H shows that an adult specific knockdown of DNT-2 using DNT2-GAL4 causes an increase in Dcp1 signal in many neurons and not just TH neurons.

      Indeed, we did find Dcp1+ TH-negative cells too (although not widely throughout the brain), although this is not shown in the images of Figure 3H where we showed only TH+ Dcp+ cells.

      That is not surprising, as DNT-2 neurons have large arborisations that can reach a wide range of targets; DNT-2 is secreted, and could reach beyond its immediate targets; Toll-6 is expressed in a vast number of cells in the brain; DNT-2 can bind promiscuously at least also Toll-7 and other Keks, which are also expressed in the adult brain (Foldi et al 2017 J Cell Biology; Ulian-Benitez et al 2017 PLoS Genetics; Li et al 2020 eLife). Together with the findings by McLaughlin et al 2019, our findings further support the notion that DNT-2 is a neuroprotective factor in the adult brain. It will be interesting to find out what other neuron types DNT-2 maintains.

      We have made some edits on these points in page 10 lines 259-265.

      We would like to thank Reviewer 1 for their positive comments on our work and their interesting and valuable feedback.

      Reviewer #2 (Public review):

      This paper examines how structural plasticity in neural circuits, particularly in dopaminergic systems, is regulated by Drosophila neurotrophin-2 (DNT-2) and its receptors, Toll-6 and Kek-6. The authors show that these molecules are critical for modulating circuit structure and dopaminergic neuron survival, synaptogenesis, and connectivity. They show that loss of DNT-2 or Toll-6 function leads to loss of dopaminergic neurons, dendritic arborization, and synaptic impairment, whereas overexpression of DNT-2 increases dendritic complexity and synaptogenesis. In addition, DNT-2 and Toll-6 modulate dopamine-dependent behaviors, including locomotion and long-term memory, suggesting a link between DNT-2 signaling, structural plasticity, and behavior.

      A major strength of this study is the impressive cellular resolution achieved. By focusing on specific dopaminergic neurons, such as the PAM and PPL1 clusters, and using a range of molecular markers, the authors were able to clearly visualize intricate details of synapse formation, dendritic complexity, and axonal targeting within defined circuits. Given the critical role of dopaminergic pathways in learning and memory, this approach provides a good opportunity to explore the role of DNT-2, Toll-6, and Kek-6 in experience-dependent structural plasticity. However, despite the promise in the abstract and introduction of the paper, the study falls short of establishing a direct causal link between neurotrophin signaling and experience-induced plasticity.

      Simply put, this study does not provide strong evidence that experience-induced structural plasticity requires DNT-2 signaling. To support this idea, it would be necessary to observe experience-induced structural changes and demonstrate that downregulation of DNT-2 signaling prevents these changes. The closest attempt to address this in this study was the artificial activation of DNT-2 neurons using TrpA1, which resulted in overgrowth of axonal arbors and an increase in synaptic sites in both DNT-2 and PAM neurons. However, this activation method is quite artificial, and the authors did not test whether the observed structural changes were dependent on DNT-2 signaling. Although they also showed that overexpression of DNT-2FL in DNT-2 neurons promotes synaptogenesis, this phenotype was not fully consistent with the TrpA1 activation results (Figures 5C and D).

      In conclusion, this study demonstrates that DNT-2 and its receptors play a role in regulating the structure of dopaminergic circuits in the adult fly brain. However, it does not provide convincing evidence for a causal link between DNT-2 signaling and experience-dependent structural plasticity within these circuits.

      We would like to thank Reviewer 2 for their very positive assessment of our approach to investigate structural circuit plasticity. We are delighted that this Reviewer found our cellular resolution impressive. We are also very pleased that Reviewer 2 found that our work demonstrates that DNT-2 and its receptors regulate the structure of dopaminergic circuits in the adult fly brain. This is already a very important finding that contributes to demonstrating that, rather than being hardwired, the adult fly brain is plastic, like the mammalian brain. Furthermore, it is remarkable that this involves a neurotrophin functioning via Toll and kinase-less Trks, opening an opportunity to explore whether such a mechanism could also operate in the human brain.

      We are very pleased that this Reviewer acknowledges that this work provides a good opportunity to explore the role of DNT-2, Toll-6, and Kek-6 in experience-dependent structural plasticity. We provide a molecular mechanism and proof of principle, and we demonstrate a direct link between the function of DNT-2 and its receptors in circuit plasticity. We also showed a link of DNT-2 to neuronal activity, as neuronal activity increased the production of DNT-2GFP, induced the cleavage of DNT-2 and a feedback loop between DNT-2 and dopamine, and both neuronal activity and increased DNT-2 levels promoted synaptogenesis.

      As the Reviewer acknowledges this approach provides a good opportunity to explore the role of DNT-2, Toll-6, and Kek-6 in experience-dependent structural plasticity. Finding out the direct link in response to lived experience is a big task, beyond the scope of this manuscript, and we will be testing this with future projects. Nevertheless, it is important to place our findings within this context together with the link to mammalian neurotrophins (as explained in the discussion), as it is here where the findings have deep and impactful implications.

      To accommodate the criticism of this Reviewer, we have now toned down our narrative. This does not diminish the importance of the findings, it makes the argument more stringent. Please see edits in: Abstract page 2 lines 42-44; and Discussion page 22 line 586 – which were the only points were a direct claim had been made.

      We would like to thank Reviewer 2 for the positive and thoughtful evaluation of our work, and for their feedback.

      Reviewer #3 (Public review):

      Summary:

      The authors used the model organism Drosophila melanogaster to show that the neurotrophin Toll-6 and its ligands, DNT-2 and kek-6, play a role in maintaining the number of dopaminergic neurons and modulating their synaptic connectivity. This supports previous findings on the structural plasticity of dopaminergic neurons and suggests a molecular mechanism underlying this plasticity.

      Strengths:

      The experiments are overall very well designed and conclusive. Methods are in general state-of-the-art, the sample sizes are sufficient, the statistical analyses are sound, and all necessary controls are in place. The data interpretation is straightforward, and the relevant literature is taken into consideration. Overall, the manuscript is solid and presents novel, interesting, and important findings.

      We are delighted that Reviewer 3 found our work solid, novel, interesting and with important findings. We are also very pleased that this Reviewer found that all necessary controls have been carried out.

      Weaknesses:

      There are three technical weaknesses that could perhaps be improved.

      First, the model of reciprocal, inhibitory feedback loops (Figure 2F) is speculative. On the one hand, glutamate can act in flies as an excitatory or inhibitory transmitter (line 157), and either situation can be the case here. On the other hand, it is not clear how an increase or decrease in cAMP level translates into transmitter release. One can only conclude that two types of neurons potentially influence each other.

      Thank you for pointing out that glutamate can be inhibitory. In response, we have removed the word ‘excitatory’ from the only point it had been used in the text: page 7 line 167.

      In mammals, the neurotrophin BDNF has an important function in glutamatergic synapses, thus we were intrigued by a potential evolutionary conservation. Our evidence that DNT-2A neurons could be excitatory is indirect, yet supportive: exciting DNT-2 neurons with optogenetics resulted in an increase in GCaMP in PAMs (data not shown); over-expression of DNT-2 in DNT-2 neurons increased TH mRNA levels; optogenetic activation of DNT-2 neurons results in the Dop2R-dependent downregulation of cAMP levels in DNT-2 neurons. Dop2R signals in response to dopamine, which would be released only if dopaminergic neurons had been excited. Accordingly, glutamate released from DNT-2 neurons would have been rather unlikely to inhibit DANs.

      cAMP is a second messenger that enables the activation of PKA. PKA phosphorylates many target proteins, amongst which are various channels. This includes the voltage gated calcium channels located at the synapse, whose phosphorylation increases their opening probability. Other targets regulate synaptic vesicle release. Thus, a rise in cAMP could facilitate neurotransmitter release, and a downregulation would have the opposite effect. Other targets of PKA include CREB, leading to changes in gene expression. Conceivably, a decrease in PKA activity could result in the downregulation of DNT-2 expression in DNT-2 neurons. This negative feedback loop would restore the homeostatic relationship between DNT-2 and dopamine levels.

      We agree with this Reviewer that whereas our qRT-PCR data show that over-expression of DNT-2 increases TH mRNA levels, this does not demonstrate that originates from PAM neurons. Similarly, although our EPAC data imply that dopamine must be released from DANs and received by DNT-2 neurons to explain those data, the evidence did not include direct visualisation of dopamine release in response to DNT-2 neuron activation. To accommodate these criticisms, we have edited the summary Figure 2E adding question marks to indicate inference points and page 9 line 221.

      Our data indeed demonstrate that DNT-2 and PAM neurons influence each other, not potentially, but really. We have provided data that: DNT-2 and PAMs are connected through circuitry; that the DNT-2 receptors Toll-6 and kek-6 are expressed in DANs, including in PAMs; that alterations in the levels of DNT-2 (both loss and gain of function) and loss of function for the DNT-2 receptors Toll-6 and Kek-6 alter PAM cell number, alter PAM dendritic complexity and alter synaptogenesis in PAMs; alterations in the levels of DNT-2, Toll-6 and kek-6 in adult flies alters dopamine dependent behaviours of climbing, locomotion in an arena and learning and long-term memory. These data firmly demonstrate that the two neuron types DNT-2 and PAMs influence each other.

      We have also shown that over-expression of DNT-2 in DNT-2 neurons increases TH mRNA levels, whereas activation of DNT-2 neurons decreases cAMP levels in DNT-2 neurons in a dopamine/Dop2R-dependent manner. These data show a functional interaction between DNT-2 and PAM neurons.

      Second, the quantification of bouton volumes (no y-axis label in Figure 5 C and D!) and dendrite complexity are not convincingly laid out. Here, the reader expects fine-grained anatomical characterizations of the structures under investigation, and a method to precisely quantify the lengths and branching patterns of individual dendritic arborizations as well as the volume of individual axonal boutons.

      Figure 5C, D do contain Y-axis labels, all our graphs in main manuscript and in supplementary files contain Y-axis labels.

      In fact, we did use a method to precisely quantify the lengths and branching patterns of individual dendritic arborisations, volume of individual boutons and bouton counting. These analyses were carried out using Imaris software. For dendritic branching patterns, the “Filament Autodetect” function was used. Here, dendrites were analysed by tracing semi-automatically each dendrite branch (ie manual correction of segmentation errors) to reconstruct the segmented dendrite in volume. From this segmented dendrite, Imaris provides measurements of total dendrite volume, number and length of dendrite branches, terminal points, etc. For bouton size and number, we used the Imaris “Spot” function. Here, a threshold is set to exclude small dots (eg of background) that do not correspond to synapses/boutons. All samples and genotypes are treated with the same threshold, thus the analysis is objective and large sample sizes can be analysed effectively. We had already provided a description of the use of Imaris in the methods section.

      We have now exapanded the protocol on how we use Imaris to analyse dendrites and synapses, in: Materials and Methods section, page 28 lines 756-768 and page 29 lines 778-799.

      Third, Figure 1C shows two neurons with the goal of demonstrating between-neuron variability. It is not convincingly demonstrated that the two neurons are actually of the very same type of neuron in different flies or two completely different neurons.

      We thank Reviewer 3 for raising this interesting point. It is not possible to prove which of the four DNT-2A neurons per hemibrain, which we visualised with DNT-2>MCFO, were the same neurons in every individual brain we looked at. This is because in every brain we have looked at, the soma of the neurons were not located in exactly the same location. Furthermore, the arborisation patterns are also different and unique, for each individual brain. Thus, there is natural variability in the position of the soma and in the arborisation patterns. Such variability presumably results from the combination of developmental and activity-dependent plasticity. Importantly, for every staining we carried out using DNT-2GAL4 and various membrane reporters and MCFO clones, we never found two identical DNT-2 neuron profiles.

      To increase the evidence in support of this point, we have now expanded Figure 1, adding one more image of DNT-2>FlyBow (Figure 1A) and two more images of DNT-2>MCFO (Figure 1D). In total, seven images in Figure 1 and two further images in Figure 5A demonstrate the variability of DNT-2 neurons.

      We would like to thank Reviewer 3 for the very positive evaluation of our work and the interesting and valuable feedback.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      In the fly list, several fly lines are missing references and sources. 

      Apologies for this over-sight, this has now been corrected.

      We thank Reviewer 1 for their effort and time to scrutinise our work, and for their very positive and helpful feedback.

      Reviewer #2 (Recommendations for the authors):

      (1) Here I provide some more specific comments that I hope will help the authors further improve the study.

      (2) L148: "single neuron clones revealed variability in the DNT-2A". How do the authors know that they are labeling the same subtype of DNT-2A neurons? 

      There are four anterior DNT-2A cells per hemibrain, that project from the SOG area to the SMP. It is not possible to verify that every time we look at exactly the same neuron, because the exact position of the somas and the arborisation patterns vary from brain to brain. We know this from two sources of data: (1) when using DNT-2GAL4 to visualise the expression of membrane reporters (e.g. UAS-FlyBow, UAS-mCD8-GFP, UAS-CD8-RFP) no brain ever showed a pattern identical to that of another brain, neither in the exact position of the somas nor in the exact arborisation patterns. (2) When we generated DNT-2>MCFO clones to visualise 1-2 cells at a time, no single neuron or 2-neuron clones ever showed an identical pattern. The most parsimonious interpretation is that the exact location of the somas and the exact arborisation patterns vary across individual flies. Developmental variability in neuronal patterns has also been reporter by Linneweber et al (2020) Science.

      To make our evidence more compelling, and in response to this Reviewer’s query, we have now added further images. Please find in revised Figure 1 A,B three examples of three different brains expressing DNT-2>FlyBow1.1. In Figure 1D, two more examples (altogether 4) of DNT-2>MCFO clones. Here it is clear to see that no neuron shape is identical to that of others, demonstrating variability in individual fly brains. We now show four images in Figure 1 and two more in Figure 5A that demonstrate the variability of DNT-2A neurons.

      (3) Figure 1E: Are all DNT-2A neurons positive for vGlut and Dop2R? This figure shows only two DNT-2A neurons. 

      Yes, all four DNT-2A neurons per hemibrain are vGlut positive and we have now added more images to Supplementary Figure S1A (right), also showing that presynaptic DNT-2A endings at SMP also coincide with a vGlut+ domain (Figure S1A left).

      Yes, all all four DNT-2A neurons per hemibrain are Dop2R positive and we have now added more images to Supplementary Figure S1B.

      (4) L156: Glutamate is generally considered to be inhibitory in the adult fly brain. More evidence is needed before the authors can claim that "DNT-2A neurons are excitatory glutamatergic neurons". 

      Thank you for pointing this out. Although our data do not conclusively demonstrate it, they are consistent with DNT-2A neurons being excitatory. BDNF is most commonly released from glutamatergic neurons in mammals, its release is activity-dependent and leads to formation and stabilisation of synapses.  The phenotypes we have observed are consistent with this and reveal functional evolutionarily conservation: (1) exciting DNT-2 neurons with TrpA1 results in increased production and cleavage of DNT-2GFP and de novo synaptogenesis; (2) over-expression of DNT-2 in the adult induces de novo synaptogenesis; (3) down-regulation or loss of DNT-2 and its receptors Toll-6 and Kek-6 impair synaptogenesis. Furthermore, we show that DNT-2 dependent synaptogenesis is between DNT-2 and dopaminergic neurons, which are involved in the control of locomotion, reward learning and long-term memory, and dopamine itself is required for such behaviour. Consistently with this we found that: (1) over-expression of DNT-2 increases TH mRNA levels, which would lead to the up-regulation of dopamine production; (2) exciting DNT-2 neurons increases locomotion speed in an arena; (3) knock-down of DNT-2 and its receptors decreases locomotion, whereas over-expression of DNT-2 increases locomotion; (4) over-expression of DNT-2 increases learning and long-term memory. Finally, in a previous version in bioRxiv, we also showed using optogenetics and calcium imaging that exciting DNT-2 neurons induced GCaMP signalling in their output PAM neurons, and in this version we show that exciting DNT-2 neurons regulates cAMP in DNT-2 neurons via dopamine-release dependent feedback. Altogether, the most parsimonious interpretation of these data is that vGlut+ DNT-2 neurons are excitatory.

      In any case, to address this reviewer’s point, we have now removed the word ‘excitatory’ from page 7 line 167.

      (5) Figure 1H, I: A more detailed description of the Toll-6 and Kek-6 expressing neurons will be helpful. Are they expressed in specific types of PAM and PPL1 DANs? The legend in Figure S2 mentions labeling in γ2α′1 zones, but it seems to be more than that.

      This information had been already provided, presumable this Reviewer overlooked this. This was already described in great detail by comparing our microscopy data with the single cell RNA-seq data available through Fly Cell Atlas (https://flycellatlas.org) and Scope (https://scope.aertslab.org/#/b77838f4-af3c-4c37-8dd9-cf7a41e4b034/*/welcome).

      Please see our previously submitted Table S1 “Expression of Tolls, keks and Toll downstream adaptors in cells related to DNT-2A neurons”.

      (6) Figure S3 should be controls for Figure 2A. It is incorrectly labeled as controls for Figure 3A. 

      Thank you for pointing out this typo, this has now been corrected.

      (7) L197: The authors state, "This showed that DNT-2 could stimulate dopamine production in neighboring DANs". However, the results do not fully support this conclusion because the experiments measure overall TH levels in the brain, not specifically in neighboring DANs. The observed effect could be indirect via other neurons. 

      Indeed, we have now edited the text to: “This showed that DNT-2 could stimulate dopamine production”: page 8 line 208.

      (8) Figure 3: If Toll-6 is expressed in specific subtypes of PAM DANs, are they the dying cells when Toll-6 was knocked down? I think the paper will be significantly improved if the authors provide a more in-depth analysis of the phenotype. Also, permissive temperature controls are missing for the experiments in (E)-(H). Permissive controls are essential to confirm that the observed effects are due to adult-specific RNAi knockdown.

      Current tools do not enable us to visualise Toll-6+ neurons at the same time as manipulating DNT-2 neurons and at the same time as monitoring Dcp1. Stainings with Dcp1 in the adult brain are not trivial. Thus, we cannot guarantee this. However, Toll-6 is the preferential receptor for DNT-2, and given that apoptosis increases when we knock-down DNT-2, the most parsimonious interpretation is that the dying cells bear the DNT-2 receptor Toll-6. Even if DNT-2 can promiscuously bind other Toll receptors, the simplest way to interpret these data remains that DNT-2 promotes cell survival by signalling via its receptors, as no other possible route is known to date. This would be consistent with all other data in this figure.

      We thank this Reviewer for the feedback on the controls. Unfortunately, these are not trivial experiments, they require considerable time, effort, dedication and skill. This manuscript has already taken 5 years of daily hard work. We no longer have the staff (ie the first author left the lab) nor resources to dedicate to address this point.

      (9) Figure 4B: This phenotype in DNT-2 mutants is very striking. Did the neurons still survive and did their axonal innervation in the lobes remain intact?

      Homozygous DNT-2 mutants are viable and have impair climbing, as we had already shown in Figure 7C.

      (10) L261: The authors mention that "PAM-β2β′2 neurons express Toll-6 (Table S1)". However, I cannot find this information in Table S1. 

      Unfortunately, I cannot identify the source of that statement at present and the first authors has left the lab. In any case, although the fact that knocking down Toll-6 in these neurons causes a phenotype means they must, it does not directly prove it. We have now corrected this to: “PAM-b2b'2 neuron dendrites overlap axonal DNT2 projections”, page 11 line 280.

      (11) Figure 4C, D: What about their synaptogenesis? Do they agree with the result in Figure 4B? 

      This was not tested at the time. Unfortunately, these are not trivial experiments and require considerable time, effort, dedication and skill. Addressing this point experimentally is not possible for us at this point. In any case, given the evidence we already provide, it is highly unlikely they would alter the interpretation of our findings and the value of the discoveries already provided.

      (12) L270: The authors state: "To ask whether DNT-2 might affect axonal terminals, we tested PPL1 axons." However, it is unclear why the focus was shifted to PPL1 neurons when similar analyses could have been performed on PAM DANs for consistency. In addition, it would be beneficial to assess dendritic arbor complexity and synaptogenesis in PPL1-γ1-pedc neurons to provide a more comprehensive comparison between PPL1 and PAM DANs. Performing parallel analyses on both neuron types would strengthen the study by providing insight into the generality and specificity of DNT-2 in different dopaminergic circuits. 

      The question we addressed with Figure 4 was whether the DNT-2 and its receptors could modify axons, dendrites and synapses, ie all features of neuronal plasticity. The reason we used PPL1-g1-pedc to analyse axonal terminals was because of their morphology, which offered a clearer opportunity to visualise axonal endings than PAMs did. An exhaustive analysis of PPL1-g1-pedc is beyond the scope of this work and not the central focus.

      (13) Figure 4G lacks a permissive temperature control, which is essential to confirm that the observed effects are due to adult-specific RNAi knockdown. 

      We thank this Reviewer for this feedback, which we will bear in mind for future projects.

      (14) Figure 5A requires quantification and statistical comparison.

      We thank this Reviewer for this feedback. We did consider this, but the data are too variable to quantify and we decided it was best to present it simply as an observation, interesting nonetheless. This is consistent as well with the data in Figure 1, which we have now expanded with this revision, which show the natural variability in DNT-2 neurons.

      (15) Figure 5B: Many green signals in the control image are not labeled as PSDs, raising concerns about the accuracy of the image analysis methods used for synapse identification. While I trust that the authors have validated their analysis approach, it would strengthen the study if they provided a clearer description or evidence of the validation process. 

      This was done using the Imaris “Spot function”, in volume. A threshold is set to exclude spots due to GFP background and select only synaptic spots. The selection of spots and quantification are done automatically by Imaris. All spots below the threshold are excluded, regardless of genotype and experimental conditions, rendering the analysis objective. We have now provided a detailed description of the protocol in the Materials and Methods section: page 29 lines 778-799.

      (16) Figure 5C lacks genotype controls (i.e., DNT2-GAL4-only and UAS-TrpA1-only). These controls are essential because elevated temperatures alone, without activation of DNT2 neurons, could potentially increase Syt-GCaMP production, leading to an increase in the number of Syt+ synapses. Including these controls would help ensure that the observed effects are truly due to the activation of DNT2 neurons and not temperature-related artifacts. 

      We thank this Reviewer for this feedback, which we will bear in mind for future projects.

      (17) L314-316: The authors state, "Here, the coincidence of... revealed that newly formed synapses were stable." I think this statement needs to be toned down because there is no evidence that these pre- and post-synaptic sites are functionally connected. 

      The Reviewer is correct that our data did not visualise together, in the same preparation and specimen, both pre- and post-synaptic sites. Still, given that PAMs have already been proved by others to be required for locomotion, learning and long-term memory, our data strongly suggest that synapses between them at the SMP are functionally connected.

      Nevertheless, as we do not provide direct cellular evidence, we have now edited the text to tone down this claim: “Here, the coincidence of increased pre-synaptic Syt-GFP from PAMs and post-synaptic Homer-GFP from DNT-2 neurons at SMP suggests that newly formed synapses could be stable”, page 13 line 351.

      (18) Figure 5D lacks permissive temperature controls. Also, the DNT-2FL overexpression phenotypes are different from the TpA1 activation phenotypes. The authors may want to discuss this discrepancy. 

      Regarding the controls, these are not appropriate for this data set. These data were all taken at a constant temperature of 25°C, there were no shifts, and therefore do not require a permissive temperature control. We thank this Reviewer for drawing our attention to the fact that we made a mistake drawing the diagram, which we have now corrected in Figure 5D.

      Regarding the discrepancy, this had already been discussed in the Discussion section of the previously submitted version, page 19 Line 509-526. Presumably this Reviewer missed this before.

      (19) Figure 6A, B lack permissive temperature controls. These controls are important if the authors want to claim that the behavioral defects are due to adult-specific manipulations. In addition, there is no statistical difference between the PAM-GAL4 control and the RNAi knockdown group. The authors should be careful when stating that climbing was reduced in the RNAi knockdown flies (L341-342). 

      We thank this Reviewer for this feedback, which we will bear in mind for future projects.

      Point taken, but climbing of the tubGAL80ts, PAM>Toll-6RNAi flies was significantly different from that of the UAS-Toll-6RNAi/+ control.

      (20) Figure 6C: It seems that the DAN-GAL4 only control (the second group) also rescued the climbing defect. The authors may want to clarify this point. 

      The phenotype for this genotype was very variable, but certainly very distinct from that of flies over-expressing Toll-6[CY].

      We thank Reviewer 2 for their very thorough analysis of our paper that has helped improve the work.

      Reviewer #3 (Recommendations for the authors): 

      Overall, the manuscript reports highly interesting and mostly very convincing experiments. 

      We are very grateful to this Reviewer for their very positive evaluation of our work.

      Based on my comments under the heading "public review", I would like to suggest three possible improvements. 

      First, the quantification of structural plasticity at the sub-cellular level should be explained in more detail and potentially improved. For example, 3D reconstructions of individual neurons and quantification of the structure of boutons and dendrites could be undertaken. At present, it is not clear how bouton volumes are actually recorded accurately. 

      Thank you for the feedback. The analyses of dendrites and synapses were carried out in 3D-volumes using Imaris “Filament” module and “Spot function”, respectively. Dendrites are analysed semi-automatically, ie correcting potential branching errors of Imaris, and synapses are counted automatically, after setting appropriate thresholds. Details have now been expanded in the Materials and Sections section: page 28 lines 756-768 and page 29 lines 780-799.

      We would also like to thank Imaris for enabling and facilitating our remote working using their software during the Covid-19 pandemic, post-pandemic lockdowns and lab restrictions that spanned for over a year.

      Second, the variability between DNT-2A-positive neurons with increasing sample size compared to a control (DNT-2A-negative neurons) should be demonstrated. Figure 2C does currently not present convincing evidence of increased structural variability. 

      It is unclear what data the Reviewer refers to. Figure 2C shows qRT-PCR data, and it does not show structural variability, which instead is shown with microscopy. If it is the BacTrace data in Figure 2B, the controls had been provided and the data were unambiguous. If Reviewer means Figure 1C, it is unclear why DNT-2GAL4-negative flies are needed when the aim was to visualise normal (not genetically manipulated) DNT-2 neurons. Thus, unfortunately we do not understand what the point is here.

      The observation that DNT-2 neurons are very variable, naturally, is highly interesting, and presumably this is what drew the attention of Reviewer 3. We agree that showing further data in support of this is interesting and valuable. Thus, in response to this Reviewer’s comment we have now increased the number of images that demonstrate variability of DNT-2 neurons:

      (1) We have added an extra image, altogether providing three images in new Figure 1A showing three different individual brains stained with DNT-2GAL4>UAS-FlyBow1.1. These show common morphology and features, but different location of the somas and distinct detailed arborisation patterns. Two more images using DNT-2GAL4 are provided in Figure 5A.

      (2) We have now added two further MCFO images, altogether showing four examples where the somas are not always in the same location and the axons arborise consistently at the SMP, but the detailed projections are not identical: new Figure 1D.

      These data compellingly show natural variability in DNT-2 neuron morphology.

      Third, I propose to simplify the feedback model (Figure 2F) to be less speculative. 

      Indeed, some details in Figure 2F are speculative as we did not measure real dopamine levels. Accordingly, we have now edited this diagram, adding question marks to indicate speculative inference, to distinguish from the arrows that are grounded on the data we provide.

      Accordingly, we have also edited the text in:

      - page 9, lines 221: “Altogether, this shows that DNT-2 up-regulated TH levels (Figure 2E), and presumably via dopamine release, this inhibited cAMP in DNT-2A neurons (Figure 2F)”.

      - page 20, lines 515: “Importantly, we showed that activating DNT-2 neurons increased the levels and cleavage of DNT-2, up-regulated DNT-2 increased TH expression, and this initial amplification resulted in the inhibition of cAMP signalling via the dopamine receptor Dop2R in DNT-2 neurons.”

      As minor points: 

      (1) Appetitive olfactory learning is based on Tempel et al., (1983); Proc Natl Acad Sci U S A. 1983 Mar;80(5):1482-6. doi: 10.1073/pnas.80.5.1482. This paper should perhaps be cited. 

      Thank you for bringing this to our attention, we have now added this reference to page 14 line 394.

      (2) Line 34: I would add ..."ligand for Toll-6 AND KEK-6,". 

      Indeed, thank you, now corrected.

      (3) Line 39: DNT-2-POSITIVE NEURONS. 

      Now corrected, thank you.

      (4) The levels of TH mRNA were quantified. Why not TH or dopamine directly using antibodies, ELISA, or HPLC? After all, later it is explicitly written that DNT modulates dopamine levels (line 481)! 

      We thank this Reviewer for this suggestion. We did try with HPLC once, but the results were inconclusive and optimising this would have required unaffordable effort by us and our collaborators. Part of this work spanned over the pandemic and subsequent lockdowns and lab restrictions to 30% then 50% lab capacity that continued for one year, making experimental work extremely challenging. Although we were unable to carry out all the ideal experiments, the DNT-2-dependent increase in TH mRNA coupled with the EPAC-Dop2R data provided solid evidence of a DNT-2-dopamine link.

      (5) Line 271: The PPL1-g1-pedc neuron has mainly (but not excusively) a function in short-term memory! 

      They do, but others have also shown that PPL1-g1-pedc neurons have a gating function in long-term memory (Placais et al 2012; Placais et al 2017; Huang et al 2024) and are required for long-term memory (Adel and Griffith 2020; Boto et al 2020).

      (6) Line 401: Reward learning requires PAM neurons. PPL1 neurons are required for aversive learning. 

      Indeed, PPL1 neurons are required for aversive learning, but they also have a gating function in long-term memory common for both reward and aversive learning (Adel and Griffith, 2020 Neurosci Bull; Placais et al, 2012 Nature Neuroscience; Placais et al 2017 Nature Communications; Huang et al 2024 Nature).

      Overall, the manuscript presents extremely interesting, novel results, and I congratulate the authors on their findings. 

      We would like to thank this Reviewer for taking the time to scrutinise our work, their helpful feedback that has helped us improve the work and for their interest and positive and kind works.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      The work is important and of potential value to areas other than the bone field because it supports a role and mechanism for beta-catenin that is novel and unusual. The findings are significant in that they support the presence of another anabolic pathway in bone that can be productively targeted for therapeutic goals. The data for the most part are convincing. The work could be strengthened by better characterizing the osteoclast KO of Malat1 related to the Lys cre model and by including biochemical markers of bone turnover from the mice.

      We thank the editors and reviewers for their time and their positive and insightful comments. We are pleased that the editors and reviewers were very enthusiastic, as stated in their Strength comments. We have performed experiments and addressed all of the points raised by the reviewers. We have revised the manuscript accordingly and the reviewers’ points are specifically addressed below. 

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary

      The authors were trying to discover a novel bone remodeling network system. They found that an IncRNA Malat1 plays a central role in the remodeling by binding to β-catenin and functioning through the β-catenin-OPG/Jagged1 pathway in osteoblasts and chondrocytes. In addition, Malat1 significantly promotes bone regeneration in fracture healing in vivo. Their findings suggest a new concept of Malat1 function in the skeletal system. One significantly different finding between this manuscript and the competing paper pertains to the role of Malat1 in osteoclast lineage, specifically, whether Malat1 functions intrinsically in osteoclast lineage or not.

      Strengths:

      This study provides strong genetic evidence demonstrating that Malat1 acts intrinsically in osteoblasts while suppressing osteoclastogenesis in a non-autonomous manner, whereas the other group did not utilize relevant conditional knockout mice. As shown in the results, Malat1 knockout mouse exhibited abnormal bone remodeling and turnover. Furthermore, they elucidated molecular function of Malat1, which is sufficient to understand the phenotype in vivo.

      We are grateful to the reviewer for highlighting the novelty, strengths and significance of our work.

      Weaknesses:

      Discussing differences between previous paper and their status would be highly informative and beneficial for the field, as it would elucidate the solid underlying mechanisms.

      These points have been fully addressed in the point-to-point response below.

      Reviewer #2 (Public Review):

      Summary:

      The authors investigated the roles of IncRNA Malat1 in bone homeostasis which was initially believed to be non-functional for physiology. They found that both Malat1 KO and conditional KO in osteoblast lineage exhibit significant osteoporosis due to decreased osteoblast bone formation and increased osteoclast resorption. More interestingly they found that deletion of Malat1 in osteoclast lineage cells does not affect osteoclast differentiation and function. Mechanistically, they found that Malat1 acts as a co-activator of b-Catenin directly regulating osteoblast activity and indirectly regulating osteoclast activity via mediating OPG, but not RANKL expression in osteoblast and chondrocyte. Their discoveries establish a previously unrecognized paradigm model of Malat1 function in the skeletal system, providing novel mechanistic insights into how a lncRNA integrates cellular crosstalk and molecular networks to fine-tune tissue homeostasis, and remodeling.

      Strengths:

      The authors generated global and conditional KO mice in osteoblast and osteoclast lineage cells and carefully analyzed the role of Matat1 with both in vivo and in vitro systems. The conclusion of this paper is mostly well supported by data.

      We are grateful to the reviewer for highlighting the novelty, strengths and significance of our work.

      Weaknesses:

      More objective biological and biochemical analyses are required.

      These points have been fully addressed in the point-to-point response below.

      Reviewer #3 (Public Review):

      Summary:

      In this manuscript, Qin and colleagues study the role of Malat1 in bone biology. This topic is interesting given the role of lncRNAs in multiple physiologic processes. A previous study (PMID 38493144) suggested a role for Malat1 in osteoclast maturation. However, the role of this lncRNA in osteoblast biology was previously not explored. Here, the authors note osteopenia with increased bone resorption in mice lacking Malat1 globally and in osteoblast lineage cells. At the mechanistic level, the authors suggest that Malat1 controls beta-catenin activity. These results advance the field regarding the role of this lncRNA in bone biology.

      Strengths:

      The manuscript is well-written and data are presented in a clear and easily understandable manner. The bone phenotype of osteoblast-specific Malat1 knockout mice is of high interest. The role of Malat1 in controlling beta-catenin activity and OPG expression is interesting and novel.

      We are grateful to the reviewer for highlighting the novelty, strengths and significance of our work.

      Weaknesses:

      The lack of a bone phenotype when Malat1 is deleted with LysM-Cre is of interest given the previous report suggesting a role for this lncRNA in osteoclasts. However, to interpret the findings here, the authors should investigate the deletion efficiency of Malat1 in osteoclast lineage cells in their model. The data in the fracture model in Figure 8 seems incomplete in the absence of a more complete characterization of callus histology and a thorough time course. The role of Malat1 and OPG in chondrocytes is unclear since the osteocalcin-Cre mice (which should retain normal Malat1 levels in chondrocytes) have similar bone loss as the global mutants.

      These points have been fully addressed in the point-to-point response below.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      There are several suggestions for improving the manuscript, and we hope that you will review the recommendations carefully and make changes to the paper to address the concerns raised. Suggestions have been made to better characterize the osteoclast KO of Malat1 related to the Lys cre model as well as suggestions to include biochemical markers of bone turnover from your mice.

      These points have been fully addressed in the point-to-point response below.

      Reviewer #1 (Recommendations For The Authors):

      (1) Replicate numbers in Figure 3 should be noted.

      We thank the reviewer for this point. The experiments in Fig. 3 have been replicated three times, which is now noted in the figure legend.

      (2) It is novel to identify OPG expression in chondrocytes. More discussion is expected.

      Yes, a paragraph regarding this point has been added to the Discussion section.  

      Reviewer #2 (Recommendations For The Authors):

      (1) It is better to show serum osteoblast bone formation marker and osteoclast resorption marker, such as P1NP and CTx, in both Malat1 KO and osteoblast conditional KO mice.

      We thank the reviewer for this important point. Since CTx values are often influenced by food intake, we measured serum TRAP levels, which also reflect changes in osteoclastic bone resorption. We have observed that the serum osteoblastic bone formation marker P1NP was decreased, while osteoclastic bone resorption marker TRAP was increased, in both Malat1<sup>-/-</sup> and Malat1<sup>ΔOcn</sup> mice. These changes in serum biochemical markers of bone turnover are consistent with the bone phenotype caused by Malat1 deficiency. The new data are shown in Fig.1i, Fig. 2e, and Fig.5b.    

      (2) in vitro osteoblast differentiation assay is required to further confirm Malat1 regulates osteoblast differentiation.

      We thank the reviewer for this suggestion. As recommended, we have performed in vitro osteoblast differentiation multiple times using calvarial cells, a commonly used system in the field. However, we observed big variability in the culture results across different experimental batches, whether conducted by different scientists or the same individual. This variability is likely due to differences in the purity of the cultured cells, as literature shows that the current culture system in the field contains a mixture of tissue cells, including not only osteoblasts but also other cells, such as stromal and hematopoietic lineage cells (DOI: 10.1002/jbmr.4052). We hope to test osteoblast differentiation using a purer culture system once it becomes available in the field. In contrast, our in vivo data, indicated by multiple parameters, show consistent osteoblast and bone formation phenotypes across a large number of mice. Therefore, the in vivo results in our study strongly support our conclusion regarding Malat1's role in osteoblastic bone formation.

      (3) The authors found that Matat1 regulates osteoclast activity through OPG expression not only in osteoblasts, but also in chondrocytes and concluded that chondrocyte is involved in the crosstalk with osteoclast lineage cells in marrow. This is a very novel finding. Do the authors have any in vivo data to support this point, such as deleting Malat1 in chondrocyte lineage cells with chondrocyte-specific Cre?

      We appreciate the reviewer for highlighting our novel findings and providing valuable suggestions. Given the considerable time required to generate chondrocyte-specific conditional KO mice, we plan to thoroughly investigate the crosstalk between chondrocytes and osteoclasts via Malat1 in vivo in our next project.

      Reviewer #3 (Recommendations For The Authors):

      (1) Ideally would show male and female data side by side in the main text figures

      We thank the reviewer for this suggestion. The male and female data are now displayed side by side in Fig. 1b. 

      (2) The sample size for the in vivo datasets is quite large. A power calculation should be provided to better understand how the authors decided to analyze so many mice.

      Due to staff turnover during the pandemic, the first authors and several co-authors were involved in breeding the mice and collecting and analyzing bone samples. To avoid bias in sample selection, we pooled all the samples, resulting in a highly consistent phenotype across mice. This robust approach further strengthens our conclusion. 

      (3) The candidate gene approach to look at beta-catenin is a bit random, it would be ideal to assess Malat1 binding proteins in osteoblasts in an unbiased way. Also, does Malat1 bind bcatenin in other cell types? The importance of this point is further underscored by ref 47 which indicates that Malat binds TEAD3.

      As β-catenin is a key regulator in osteoblasts, we believe that studying the interaction between β-catenin and Malat1 is not random. Instead, this approach is well-founded and based on established knowledge in the field (as discussed below). In parallel, we are investigating genome-wide Malat1-bound targets beyond β-catenin, which will be reported in future studies. 

      More detailed points have been discussed in the manuscript: 

      Given that we identified Malat1 as a critical regulator in osteoblasts, we sought to investigate the mechanisms underlying the regulation of osteoblastic bone formation by Malat1. β-catenin is a central transcriptional factor in canonical Wnt signaling pathway, and plays an important role in positively regulating osteoblast differentiation and function (28-33). Upon stimulation, most notably from canonical Wnt ligands, β-catenin is stabilized and translocates into the nucleus, where it interacts with coactivators to activate target gene transcription. Previous reports observed a link between Malat1 and β-catenin signaling pathway in cancers (34,35), but the underlying molecular mechanisms in terms of how Malat1 interacts with β-catenin and regulates its nuclear retention and transcriptional activity are unclear. 

      Ref47 tested Malat1 binding to Tead3 in osteoclasts. However, a key difference between our findings and those of Ref47 is that both our in vitro and in vivo data, using myeloid osteoclastspecific conditional Malat1 KO mice, do not support an intrinsically significant role for Malat1 in osteoclasts. 

      (4) The statement on page 6 concluding that Malat acts as a scaffold to tether β-catenin in the nucleus is not supported by data in Fig 3d demonstrating that b-catenin nucleus translocation in response to Wnt3a is similar in control and Malat-deficient cells.

      The experiment in Fig. 3d is not designed to demonstrate Malat1 and β-catenin binding, but it is essential as the result rules out the possibility that Malat1 may affect β-catenin nuclear translocation. Moreover, we have utilized two robust approaches, CHIRP and RIP, to demonstrate that Malat1 acts as a scaffold to tether β-catenin in the nucleus (Fig. 3a, b, c, Supplementary Fig. 3). 

      (5) Figure 4e: can the authors show Malat deletion efficiency in the LysM-Cre model? This is important in light of the negative data in this figure and ref 47 which claims an osteoclast intrinsic role for Malat

      We thank the reviewer for this suggestion. The deletion efficiency of Malat1 in the LysM-Cre mice is very high (>90%). This data is now presented in Fig. 4e. 

      (6) Figure 5: since the magnitude of the effects on osteoclasts at the histology level are mild, it would be nice to also look at serum markers of bone resorption (CTX)

      The magnitude of osteoclast changes at the histological level in Fig. 5 is not mild in our view, as we observe 25-30% changes with statistical significance in the osteoclast parameters of Malat1ΔOcn mice. Since CTx values are often influenced by food intake, we measured serum TRAP levels, which reflect changes in osteoclastic bone resorption. As shown in Fig.5b, serum TRAP levels are significantly elevated in Malat1<sup>ΔOcn</sup> mice compared to control mice.

      (7) Data showing chondrocytic expression of OPG is not as novel as the authors claim. Should think about growth plate versus articular sources of OPG. Growth plate chondrocytes express OPG to regulate osteoclasts in the primary spongiosa which resorb mineralized cartilage.

      In the present study, we do not focus on comparing the sources of OPG from the chondrocytes in the growth plate versus articular cartilage. The novelty of our work lies in the discovery that Malat1 links chondrocyte and osteoclast activities through the β-catenin-OPG/Jagged1 axis. This Malat1-β-catenin-OPG/Jagged1 axis represents a novel mechanism regulating the crosstalk between chondrocytes and osteoclasts. 

      (8) The relevance of the chondrocyte role of Malat is unclear since the bone phenotype in global and osteocalcin-Cre mice is similar.

      Bone mass was decreased by 20% in Malat1<sup>ΔOcn</sup> mice, while a 30% reduction was observed in global KO (Malat1<sup>-/-</sup>) mice. This difference indicates potential contributions from other cell types, such as chondrocytes, and our results in Fig. 6 further support the impact of chondrocytes in Malat1's regulation of bone mass. We plan to thoroughly investigate the crosstalk between chondrocytes and osteoclasts via Malat1 in vivo in our next project.

      (9) Fracture data in Figure 8 seems incomplete, it would be ideal to support micro CT with histology and look at multiple time points.

      We thank the reviewer for this suggestion. We have performed histological analysis of our samples, and found that Malat1 promotes bone healing in the fracture model (Fig. 8f), which is consistent with our μCT data.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public Review):

      In this revision, the authors significantly improved the manuscript. They now address some of my concerns. Specifically, they show the contribution of end-effects on spreading the inputs between dendrites. This analysis reveals greater applicability of their findings to cortical cells, with long, unbranching dendrites than other neuronal types, such as Purkinje cells in the cerebellum.

      They now explain better the interactions between calcium and voltage signals, which I believe improve the take-away message of their manuscript. They modified and added new figures that helped to provide more information about their simulations.

      However, some of my points remain valid. Figure 6 shows depolarization of ~5mV from -75. This weak depolarization would not effectively recruit nonlinear activation of NMDARs. In their paper, Branco and Hausser (2010) showed depolarizations of ~10-15mV.

      More importantly, the signature of NMDAR activation is the prolonged plateau potential and activation at more depolarized resting membrane potentials (their Figure 4). Thus, despite including NMDARs in the simulation, the authors do not model functional recruitment of these channels. Their simulation is thus equivalent to AMPA only drive, which can indeed summate somewhat nonlinearly.

      In the current study, we used short sequences of 5 inputs, since the convergence of longer sequences is extremely unlikely in the network configurations we have examined. This resulted in smaller EPSP amplitudes of ~5mV (Figure 6 - Supplement 2A, B). Longer sequences containing 9 inputs resulted in larger somatic depolarizations of ~10mV (Figure 6 - Supplement 2E, F). Although we had modified the (Branco, Clark, and Häusser 2010) model to remove the jitter in the timing of arrival of inputs and made slight modifications to the location of stimulus delivery on the dendrite, we saw similar amplitudes when we tested a 9-length sequence using (Branco, Clark, and Häusser 2010)’s published code (Figure 6 - Supplement 2I, J). In all the cases we tested (5 input sequence, 9 input sequence, 9 input sequence with (Branco, Clark, and Häusser 2010) code repository), removal of NMDA synapses lowered both the somatic EPSPs (Figure 6 - Supplement 2C,D,G,H,K,L) as well as the selectivity (measured as the difference between the EPSPs generated for inward and outward stimulus delivery) (Figure 6 Supplement 2M,N,O). Further, monitoring the voltage along the dendrite for a sequence of 5 inputs showed dendritic EPSPs in the range of 20-45 mV (Figure 6 - Supplement 2P, Q), which came down notably (10-25mV) when NMDA synapses were abolished (Figure 6 - Supplement 2R, S). Thus, even sequences containing as few as 5 inputs were capable of engaging the NMDA-mediated nonlinearity to show sequence selectivity, although the selectivity was not as strong as in the case of 9 inputs.

      Reviewer #1 (Recommendations for the authors):

      Minor points:

      Figure 8, what does the scale in A represent? I assume it is voltage, but there are no units. Figure 8, C, E, G, these are unconventional units for synaptic weights, usually, these are given in nS / per input.

      We have corrected these. The scalebar in 8A represents membrane potential in mV. The units of 8C,E,G are now in nS.

      Reviewer #2 (Public Review):

      Summary:

      If synaptic input is functionally clustered on dendrites, nonlinear integration could increase the computational power of neural networks. But this requires the right synapses to be located in the right places. This paper aims to address the question of whether such synaptic arrangements could arise by chance (i.e. without special rules for axon guidance or structural plasticity), and could therefore be exploited even in randomly connected networks. This is important, particularly for the dendrites and biological computation communities, where there is a pressing need to integrate decades of work at the single-neuron level with contemporary ideas about network function.

      Using an abstract model where ensembles of neurons project randomly to a postsynaptic population, back-of-envelope calculations are presented that predict the probability of finding clustered synapses and spatiotemporal sequences. Using data-constrained parameters, the authors conclude that clustering and sequences are indeed likely to occur by chance (for large enough ensembles), but require strong dendritic nonlinearities and low background noise to be useful.

      Strengths:

      (1) The back-of-envelope reasoning presented can provide fast and valuable intuition. The authors have also made the effort to connect the model parameters with measured values. Even an approximate understanding of cluster probability can direct theory and experiments towards promising directions, or away from lost causes.

      (2) I found the general approach to be refreshingly transparent and objective. Assumptions are stated clearly about the model and statistics of different circuits. Along with some positive results, many of the computed cluster probabilities are vanishingly small, and noise is found to be quite detrimental in several cases. This is important to know, and I was happy to see the authors take a balanced look at conditions that help/hinder clustering, rather than to just focus on a particular regime that works.

      (3) This paper is also a timely reminder that synaptic clusters and sequences can exist on multiple spatial and temporal scales. The authors present results pertaining to the standard `electrical' regime (~50-100 µm, <50 ms), as well as two modes of chemical signaling (~10 µm, 100-1000 ms). The senior author is indeed an authority on the latter, and the simulations in Figure 5, extending those from Bhalla (2017), are unique in this area. In my view, the role of chemical signaling in neural computation is understudied theoretically, but research will be increasingly important as experimental technologies continue to develop.

      Weaknesses:

      (1) The paper is mostly let down by the presentation. In the current form, some patience is needed to grasp the main questions and results, and it is hard to keep track of the many abbreviations and definitions. A paper like this can be impactful, but the writing needs to be crisp, and the logic of the derivation accessible to non-experts. See, for instance, Stepanyants, Hof & Chklovskii (2002) for a relevant example.

      It would be good to see a restructure that communicates the main points clearly and concisely, perhaps leaving other observations to an optional appendix. For the interested but time-pressed reader, I recommend starting with the last paragraph of the introduction, working through the main derivation on page 7, and writing out the full expression with key parameters exposed. Next, look at Table 1 and Figure 2J to see where different circuits and mechanisms fit in this scheme. Beyond this, the sequence derivation on page 15 and biophysical simulations in Figures 5 and 6 are also highlights.

      We appreciate the reviewers' suggestions. We have tightened the flow of the introduction. We understand that the abbreviations and definitions are challenging and have therefore provided intuitions and summaries of the equations discussed in the main text.

      Clusters calculations

      Our approach is to ask how likely it is that a given set of inputs lands on a short segment of dendrite, and then scale it up to all segments on the entire dendritic length of the cell.

      Thus, the probability of occurrence of groups that receive connections from each of the M ensembles (PcFMG) is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative zone-length with respect to the total dendritic arbor (Z/L) and the number of ensembles (M).

      Sequence calculations

      Here we estimate the likelihood of the first ensemble input arriving anywhere on the dendrite, and ask how likely it is that succeeding inputs of the sequence would arrive within a set spacing.

      Thus, the probability of occurrence of sequences that receive sequential connections (PcPOSS) from each of the M ensembles is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative window size with respect to the total dendritic arbor (Δ/L) and the number of ensembles (M).

      (2) I wonder if the authors are being overly conservative at times. The result highlighted in the abstract is that 10/100000 postsynaptic neurons are expected to exhibit synaptic clustering. This seems like a very small number, especially if circuits are to rely on such a mechanism. However, this figure assumes the convergence of 3-5 distinct ensembles. Convergence of inputs from just 2 ense mbles would be much more prevalent, but still advantageous computationally. There has been excitement in the field about experiments showing the clustering of synapses encoding even a single feature.

      We agree that short clusters of two inputs would be far more likely. We focused our analysis on clusters with three of more ensembles because of the following reasons:

      (1) The signal to noise in these clusters was very poor as the likelihood of noise clusters is high.

      (2) It is difficult to trigger nonlinearities with very few synaptic inputs.

      (3) At the ensemble sizes we considered (100 for clusters, 1000 for sequences), clusters arising from just two ensembles would result in high probability of occurrence on all neurons in a network (~50% in cortex, see p_CMFG in figures below.). These dense neural representations make it difficult for downstream networks to decode (Foldiak 2003).

      However, in the presence of ensembles containing fewer neurons or when the connection probability between the layers is low, short clusters can result in sparse representations (Figure 2 - Supplement 2). Arguments 1 and 2 hold for short sequences as well.

      (3) The analysis supporting the claim that strong nonlinearities are needed for cluster/sequence detection is unconvincing. In the analysis, different synapse distributions on a single long dendrite are convolved with a sigmoid function and then the sum is taken to reflect the somatic response. In reality, dendritic nonlinearities influence the soma in a complex and dynamic manner. It may be that the abstract approach the authors use captures some of this, but it needs to be validated with simulations to be trusted (in line with previous work, e.g. Poirazi, Brannon & Mel, (2003)).

      We agree that multiple factors might affect the influence of nonlinearities on the soma. The key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. Since simulating a wide range of connectivity and activity patterns in a detailed biophysical model was computationally expensive, we analyzed the exemplar detailed models for nonlinearity separately (Figures 5, 6, and new figure 8), and then used our abstract models as a proxy for understanding population dynamics. A complete analysis of the role played by morphology, channel kinetics and the effect of branching requires an in-depth study of its own, and some of these questions have already been tackled by (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017). However, in the revision, we have implemented a single model which incorporates the range of ion-channel, synaptic and biochemical signaling nonlinearities which we discuss in the paper (Figure 8, and Figure 8 Supplement 1, 2,3). We use this to demonstrate all three forms of sequence and grouped computation we use in the study, where the only difference is in the stimulus pattern and the separation of time-scales inherent in the stimuli.

      (4) It is unclear whether some of the conclusions would hold in the presence of learning. In the signal-to-noise analysis, all synaptic strengths are assumed equal. But if synapses involved in salient clusters or sequences were potentiated, presumably detection would become easier? Similarly, if presynaptic tuning and/or timing were reorganized through learning, the conditions for synaptic arrangements to be useful could be relaxed. Answering these questions is beyond the scope of the study, but there is a caveat there nonetheless.

      We agree with the reviewer. If synapses receiving connectivity from ensembles had stronger weights, this would make detection easier. Dendritic spikes arising from clustered inputs have been implicated in local cooperative plasticity (Golding, Staff, and Spruston 2002; Losonczy, Makara, and Magee 2008). Further, plasticity related proteins synthesized at a synapse undergoing L-LTP can diffuse to neighboring weakly co-active synapses, and thereby mediate cooperative plasticity (Harvey et al. 2008; Govindarajan, Kelleher, and Tonegawa 2006; Govindarajan et al. 2011). Thus if clusters of synapses were likely to be co-active, they could further engage these local plasticity mechanisms which could potentiate them while not potentiating synapses that are activated by background activity. This would depend on the activity correlation between synapses receiving ensemble inputs within a cluster vs those activated by background activity. We have mentioned some of these ideas in a published opinion paper (Pulikkottil, Somashekar, and Bhalla 2021). In the current study, we wanted to understand whether even in the absence of specialized connection rules, interesting computations could still emerge. Thus, we focused on asking whether clustered or sequential convergence could arise even in a purely randomly connected network, with the most basic set of assumptions. We agree that an analysis of how selectivity evolves with learning would be an interesting topic for further work.

      References

      • Bhalla, Upinder S. 2017. “Synaptic Input Sequence Discrimination on Behavioral Timescales Mediated by Reaction-Diffusion Chemistry in Dendrites.” Edited by Frances K Skinner. eLife 6 (April):e25827. https://doi.org/10.7554/eLife.25827.

      • Branco, Tiago, Beverley A. Clark, and Michael Häusser. 2010. “Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons.” Science (New York, N.Y.) 329 (5999): 1671–75. https://doi.org/10.1126/science.1189664.

      • Foldiak, Peter. 2003. “Sparse Coding in the Primate Cortex.” The Handbook of Brain Theory and Neural Networks. https://research-repository.st-andrews.ac.uk/bitstream/handle/10023/2994/FoldiakSparse HBTNN2e02.pdf?sequence=1.

      • Golding, Nace L., Nathan P. Staff, and Nelson Spruston. 2002. “Dendritic Spikes as a Mechanism for Cooperative Long-Term Potentiation.” Nature 418 (6895): 326–31. https://doi.org/10.1038/nature00854.

      • Govindarajan, Arvind, Inbal Israely, Shu-Ying Huang, and Susumu Tonegawa. 2011. “The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-Dependent LTP.” Neuron 69 (1): 132–46. https://doi.org/10.1016/j.neuron.2010.12.008.

      • Govindarajan, Arvind, Raymond J. Kelleher, and Susumu Tonegawa. 2006. “A Clustered Plasticity Model of Long-Term Memory Engrams.” Nature Reviews Neuroscience 7 (7): 575–83. https://doi.org/10.1038/nrn1937.

      • Harvey, Christopher D., Ryohei Yasuda, Haining Zhong, and Karel Svoboda. 2008. “The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine.” Science (New York, N.Y.) 321 (5885): 136–40. https://doi.org/10.1126/science.1159675.

      • Losonczy, Attila, Judit K. Makara, and Jeffrey C. Magee. 2008. “Compartmentalized Dendritic Plasticity and Input Feature Storage in Neurons.” Nature 452 (7186): 436–41. https://doi.org/10.1038/nature06725.

      • Poirazi, Panayiota, Terrence Brannon, and Bartlett W. Mel. 2003. “Pyramidal Neuron as Two-Layer Neural Network.” Neuron 37 (6): 989–99. https://doi.org/10.1016/S0896-6273(03)00149-1.

      • Pulikkottil, Vinu Varghese, Bhanu Priya Somashekar, and Upinder S. Bhalla. 2021. “Computation, Wiring, and Plasticity in Synaptic Clusters.” Current Opinion in Neurobiology, Computational Neuroscience, 70 (October):101–12. https://doi.org/10.1016/j.conb.2021.08.001.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      In the current manuscript, the authors use theoretical and analytical tools to examine the possibility of neural projections to engage ensembles of synaptic clusters in active dendrites. The analysis is divided into multiple models that differ in the connectivity parameters, speed of interactions, and identity of the signal (electric vs. second messenger). They first show that random connectivity almost ensures the representation of presynaptic ensembles. As expected, this convergence is much more likely for small group sizes and slow processes, such as calcium dynamics. Conversely, fast signals (spikes and postsynaptic potentials) and large groups are much less likely to recruit spatially clustered inputs. Dendritic nonlinearity in the postsynaptic cells was found to play a highly important role in distinguishing these clustered activation patterns, both when activated simultaneously and in sequence. The authors tackled the difficult issue of noise, showing a beneficiary effect when noise 'happens' to fill in gaps in a sequential pattern but degraded performance at higher background activity levels. Last, the authors simulated selectivity to chemical and electrical signals. While they find that longer sequences are less perturbed by noise, in more realistic activation conditions, the signals are not well resolved in the soma.

      While I think the premise of the manuscript is worth exploring, I have a number of reservations regarding the results.

      (1) In the analysis, the authors made a simplifying assumption that the chemical and electrical processes are independent. However, this is not the case; excitatory inputs to spines often trigger depolarization combined with pronounced calcium influx; this mixed signaling could have dramatic implications on the analysis, particularly if the dendrites are nonlinear (see below)

      We thank the reviewer for pointing out that we were not entirely clear about the strong basis upon which we had built our analyses of nonlinearity. In the previous version we had relied on published work, notably (Bhalla 2017), which does include these nonlinearities. However, we agree it is preferable to unambiguously demonstrate all the reported selectivity properties in a single model with all the nonlinearities discussed. We have now done so. This is now reported in the paper:

      “A single model exhibits multiple forms of nonlinear dendritic selectivity

      We implemented all three forms of selectivity described above, in a single model which included six voltage and calcium-gated ion channels, NMDA, AMPA and GABA receptors, and chemical signaling processes in spines and dendrites. The goal of this was three fold: To show how these nonlinear operations emerge in a mechanistically detailed model, to show that they can coexist, and to show that they are separated in time-scales. We implemented a Y-branched neuron model with additional electrical compartments for the dendritic spines (Methods). This model was closely based on a published detailed chemical-electrical model (Bhalla 2017). We stimulated this model with synaptic input corresponding to the three kinds of spatiotemporal patterns described in figures Figure 8 - Supplement 1 (sequential synaptic activity triggering electrical sequence selectivity), Figure 8 - Supplement 2 (spatially grouped synaptic stimuli leading to local Ca4_CaM activation), and Figure 8 - Supplement 3 (sequential bursts of synaptic activity triggering chemical sequence selectivity). We found that each of these mechanisms show nonlinear selectivity with respect to both synaptic spacing and synaptic weights. Further, these forms of selectivity coexist in the composite model (Figure 8 Supplements 1, 2, 3), separated by the time-scales of the stimulus patterns (~ 100 ms, ~ 1s and ~10s respectively). Thus mixed signaling in active nonlinear dendrites yields selectivity of the same form as we explored in simpler individual models. A more complete analysis of the effect of morphology, branching and channel distributions deserves a separate in-depth analysis, and is outside the scope of the current study.”

      (2) Sequence detection in active dendrites is often simplified to investigating activation in a part of or the entirety of individual branches. However, the authors did not do that for most of their analysis. Instead, they treat the entire dendritic tree as one long branch and count how many inputs form clusters. I fail to see why simplification is required and suspect it can lead to wrong results. For example, two inputs that are mapped to different dendrites in the 'original' morphology but then happen to fall next to each other when the branches are staggered to form the long dendrites would be counted as neighbors.

      We have added the below section within the main text in the section titled “Grouped Convergence of Inputs” to address the effect of branching.

      “End-effects limit convergence zones for highly branched neurons

      Neurons exhibit considerable diversity with respect to their morphologies. How synapses extending across dendritic branch points interact in the context of a synaptic cluster/group, is a topic that needs detailed examination via experimental and modeling approaches. However for the sake of analysis, we present calculations under the assumption that selectivity for grouped inputs might be degraded across branch points.

      Zones beginning close to a branch point might get interrupted. Consider a neuron with B branches. The length of the typical branch would be L/B. As a conservative estimate if we exclude a region of length Z for every branch, the expected number of zones that begin too close to a branch point is

                                                                          [Equation 3]

      For typical pyramidal neurons B~50, so Eend ~ 0.05 for values of Z of ~10 µm. Thus pyramidal neurons will not be much affected by branching effects, Profusely branching neurons like Purkinje cells have B~900 for a total L of ~7800 µm, (McConnell and Berry, 1978), hence Eend ~1 for values of Z of ~10 µm. Thus almost all groups in Purkinje neurons would run into a branch point or terminal. For the case of electrical groups, this estimate would be scaled by a factor of 5 if we consider a zone length of 50 µm. However, it is important to note that these are very conservative estimates, as for clusters of 4-5 inputs, the number of synapses available within a zone are far greater (~100 synapses within 50 µm).”

      (3) The simulations were poorly executed. Figures 5 and 6 show examples but no summary statistics.

      We have included the summary statistics in Figure 5F and Figure 6E. The statistics for both these panels were generated by simulating multiple spatiotemporal combinations of ectopic input in the presence of different stimulus patterns for each sequence length.

      The authors emphasize the importance of nonlinear dendritic interactions, but they do not include them in their analysis of the ectopic signals! I find it to be wholly expected that the effects of dendritic ensembles are not pronounced when the dendrites are linear.

      We would like to clarify that both Figures 5 and 6 already included nonlinearities. In Figure 5, the chemical mechanism involving the bistable switch motif is strongly selective for ordered inputs in a nonlinear manner. A separate panel highlighting this (Panel C) has now been included in Figure 5. This result had been previously shown in Figure 3I of (Bhalla 2017). We have reproduced it in Figure 5C.

      The published electrical model used in Figure 6 also has a nonlinearity which predominantly stems from the interaction of the impedance gradient along the dendrite with the voltage dependence of NMDARs. Check Figure 4C,D of (Branco, Clark, and Häusser 2010).

      To provide a comprehensive analysis of dendritic integration, the authors could simulate more realistic synaptic conductances and voltage-gated channels. They would find much more complicated interactions between inputs on a single site, a sliding temporal and spatial window of nonlinear integration that depends on dendritic morphology, active and passive parameters, and synaptic properties. At different activation levels, the rules of synaptic integration shift to cooperativity between different dendrites and cellular compartments, further complicated by nonlinear interactions between somatic spikes and dendritic events.

      We would like to clarify two points. First, the key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. In this revision we provide simulations to show the mechanistic basis for the nonlinearities, and then abstracted these out in order to scale the analysis to networks. These nonlinearities were taken as a given, though we elaborated previous work slightly in order to address the question of ectopic inputs. Second, in our original submission we relied on published work for the estimates of dendritic nonlinearities. Previous work from (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017) have already carried out highly detailed realistic simulations, and in some cases including chemical and electrical nonlinearities as the reviewer mentions (Bhalla 2017). Hence we did not feel that this needed to be redone.

      In this resubmission we have addressed the above and two additional concerns, namely whether the different forms of selectivity can coexist in a single model including all these nonlinearities, and whether there is separation of time-scales. The answer is yes to both. The outcome of this is presented in Figure 8 and the associated supplementary figures, and all simulation details are provided on the github repository associated with this paper. A more complete analysis of interaction of multiple nonlinearities in a detailed model is material for further study.

      While it is tempting to extend back-of-the-napkin calculations of how many inputs can recruit nonlinear integration in active dendrites, the biological implementation is very different from this hypothetical. It is important to consider these questions, but I am not convinced that this manuscript adequately addressed the questions it set out to probe, nor does it provide information that was unknown beforehand.

      We developed our analysis systematically, and perhaps the reviewer refers to the first few calculations as back-of-the-napkin. However, the derivation rapidly becomes more complex when we factor in combinatorics and the effect of noise. This derivation is in the supplementary material. Furthermore, the exact form of the combinatorial and noise equations was non-trivial to derive and we worked closely with the connectivity simulations (Figures 2 and 4) to obtain equations which scale across a large parameter space by sampling connectivity for over 100000 neurons and activity over 100 trials for each of these neurons for each network configuration we have tested.

      the biological implementation is very different from this hypothetical.

      We do not quite understand in what respect the reviewer feels that this calculation is very different from the biological implementation. The calculation is about projection patterns. In the discussion we consider at length how our findings of selectivity from random projections may be an effective starting point for more elaborate biological connection rules. We have added the following sentence:

      “We present a first-order analysis of the simplest kind of connectivity rule (random), upon which more elaborate rules such as spatial gradients and activity-dependent wiring may be developed.”

      In case the reviewer was referring to the biological implementation of nonlinear integration, we treat the nonlinear integration in the dendrites as a separate set of simulations, most of which are closely based on published work (Bhalla 2017). We use these in the later sections of the paper to estimate selectivity terms, which inform our final analysis.

      In the revision we have worked to clarify this progression of the analysis. As indicated above, we have also made a composite model of all of the nonlinear dendritic mechanisms, chemical and electrical, which underlie our analysis.

      nor does it provide information that was unknown beforehand.

      We conducted a broad literature survey and to the best of our knowledge these calculations and findings have not been obtained previously. If the reviewer has some specific examples in mind we would be pleased to refer to it.

      Reviewer #2 (Public Review):

      Summary:

      If synaptic input is functionally clustered on dendrites, nonlinear integration could increase the computational power of neural networks. But this requires the right synapses to be located in the right places. This paper aims to address the question of whether such synaptic arrangements could arise by chance (i.e. without special rules for axon guidance or structural plasticity), and could therefore be exploited even in randomly connected networks. This is important, particularly for the dendrites and biological computation communities, where there is a pressing need to integrate decades of work at the single-neuron level with contemporary ideas about network function.

      Using an abstract model where ensembles of neurons project randomly to a postsynaptic population, back-of-envelope calculations are presented that predict the probability of finding clustered synapses and spatiotemporal sequences. Using data-constrained parameters, the authors conclude that clustering and sequences are indeed likely to occur by chance (for large enough ensembles), but require strong dendritic nonlinearities and low background noise to be useful.

      Strengths:

      (1) The back-of-envelope reasoning presented can provide fast and valuable intuition. The authors have also made the effort to connect the model parameters with measured values. Even an approximate understanding of cluster probability can direct theory and experiments towards promising directions, or away from lost causes.

      (2) I found the general approach to be refreshingly transparent and objective. Assumptions are stated clearly about the model and statistics of different circuits. Along with some positive results, many of the computed cluster probabilities are vanishingly small, and noise is found to be quite detrimental in several cases. This is important to know, and I was happy to see the authors take a balanced look at conditions that help/hinder clustering, rather than to just focus on a particular regime that works.

      (3) This paper is also a timely reminder that synaptic clusters and sequences can exist on multiple spatial and temporal scales. The authors present results pertaining to the standard `electrical' regime (~50-100 µm, <50 ms), as well as two modes of chemical signaling (~10 µm, 100-1000 ms). The senior author is indeed an authority on the latter, and the simulations in Figure 5, extending those from Bhalla (2017), are unique in this area. In my view, the role of chemical signaling in neural computation is understudied theoretically, but research will be increasingly important as experimental technologies continue to develop.

      Weaknesses:

      (1) The paper is mostly let down by the presentation. In the current form, some patience is needed to grasp the main questions and results, and it is hard to keep track of the many abbreviations and definitions. A paper like this can be impactful, but the writing needs to be crisp, and the logic of the derivation accessible to non-experts. See, for instance, Stepanyants, Hof & Chklovskii (2002) for a relevant example.

      It would be good to see a restructure that communicates the main points clearly and concisely, perhaps leaving other observations to an optional appendix. For the interested but time-pressed reader, I recommend starting with the last paragraph of the introduction, working through the main derivation on page 7, and writing out the full expression with key parameters exposed. Next, look at Table 1 and Figure 2J to see where different circuits and mechanisms fit in this scheme. Beyond this, the sequence derivation on page 15 and biophysical simulations in Figures 5 and 6 are also highlights.

      We appreciate the reviewers' suggestions. We have tightened the flow of the introduction. We understand that the abbreviations and definitions are challenging and have therefore provided intuitions and summaries of the equations discussed in the main text.

      Clusters calculations

      “Our approach is to ask how likely it is that a given set of inputs lands on a short segment of dendrite, and then scale it up to all segments on the entire dendritic length of the cell.

      Thus, the probability of occurrence of groups that receive connections from each of the M ensembles (PcFMG) is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative zone-length with respect to the total dendritic arbor (Z/L) and the number of ensembles (M).”

      Sequence calculations

      “Here we estimate the likelihood of the first ensemble input arriving anywhere on the dendrite, and ask how likely it is that succeeding inputs of the sequence would arrive within a set spacing.

      Thus, the probability of occurrence of sequences that receive sequential connections (PcPOSS) from each of the M ensembles is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative window size with respect to the total dendritic arbor (Δ/L) and the number of ensembles (M).”

      (2) I wonder if the authors are being overly conservative at times. The result highlighted in the abstract is that 10/100000 postsynaptic neurons are expected to exhibit synaptic clustering. This seems like a very small number, especially if circuits are to rely on such a mechanism. However, this figure assumes the convergence of 3-5 distinct ensembles. Convergence of inputs from just 2 ense mbles would be much more prevalent, but still advantageous computationally. There has been excitement in the field about experiments showing the clustering of synapses encoding even a single feature.

      We agree that short clusters of two inputs would be far more likely. We focused our analysis on clusters with three of more ensembles because of the following reasons:

      (1) The signal to noise in these clusters was very poor as the likelihood of noise clusters is high.

      (2) It is difficult to trigger nonlinearities with very few synaptic inputs.

      (3) At the ensemble sizes we considered (100 for clusters, 1000 for sequences), clusters arising from just two ensembles would result in high probability of occurrence on all neurons in a network (~50% in cortex, see p_CMFG in figures below.). These dense neural representations make it difficult for downstream networks to decode (Foldiak 2003).

      However, in the presence of ensembles containing fewer neurons or when the connection probability between the layers is low, short clusters can result in sparse representations (Figure 2 - Supplement 2). Arguments 1 and 2 hold for short sequences as well.

      (3) The analysis supporting the claim that strong nonlinearities are needed for cluster/sequence detection is unconvincing. In the analysis, different synapse distributions on a single long dendrite are convolved with a sigmoid function and then the sum is taken to reflect the somatic response. In reality, dendritic nonlinearities influence the soma in a complex and dynamic manner. It may be that the abstract approach the authors use captures some of this, but it needs to be validated with simulations to be trusted (in line with previous work, e.g. Poirazi, Brannon & Mel, (2003)).

      We agree that multiple factors might affect the influence of nonlinearities on the soma. The key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. Since simulating a wide range of connectivity and activity patterns in a detailed biophysical model was computationally expensive, we analyzed the exemplar detailed models for nonlinearity separately (Figures 5, 6, and new figure 8), and then used our abstract models as a proxy for understanding population dynamics. A complete analysis of the role played by morphology, channel kinetics and the effect of branching requires an in-depth study of its own, and some of these questions have already been tackled by (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017). However, in the revision, we have implemented a single model which incorporates the range of ion-channel, synaptic and biochemical signaling nonlinearities which we discuss in the paper (Figure 8, and Figure 8 Supplement 1, 2,3). We use this to demonstrate all three forms of sequence and grouped computation we use in the study, where the only difference is in the stimulus pattern and the separation of time-scales inherent in the stimuli.

      (4) It is unclear whether some of the conclusions would hold in the presence of learning. In the signal-to-noise analysis, all synaptic strengths are assumed equal. But if synapses involved in salient clusters or sequences were potentiated, presumably detection would become easier? Similarly, if presynaptic tuning and/or timing were reorganized through learning, the conditions for synaptic arrangements to be useful could be relaxed. Answering these questions is beyond the scope of the study, but there is a caveat there nonetheless.

      We agree with the reviewer. If synapses receiving connectivity from ensembles had stronger weights, this would make detection easier. Dendritic spikes arising from clustered inputs have been implicated in local cooperative plasticity (Golding, Staff, and Spruston 2002; Losonczy, Makara, and Magee 2008). Further, plasticity related proteins synthesized at a synapse undergoing L-LTP can diffuse to neighboring weakly co-active synapses, and thereby mediate cooperative plasticity (Harvey et al. 2008; Govindarajan, Kelleher, and Tonegawa 2006; Govindarajan et al. 2011). Thus if clusters of synapses were likely to be co-active, they could further engage these local plasticity mechanisms which could potentiate them while not potentiating synapses that are activated by background activity. This would depend on the activity correlation between synapses receiving ensemble inputs within a cluster vs those activated by background activity. We have mentioned some of these ideas in a published opinion paper (Pulikkottil, Somashekar, and Bhalla 2021). In the current study, we wanted to understand whether even in the absence of specialized connection rules, interesting computations could still emerge. Thus, we focused on asking whether clustered or sequential convergence could arise even in a purely randomly connected network, with the most basic set of assumptions. We agree that an analysis of how selectivity evolves with learning would be an interesting topic for further work.

      References

      Bhalla, Upinder S. 2017. “Synaptic Input Sequence Discrimination on Behavioral Timescales Mediated by Reaction-Diffusion Chemistry in Dendrites.” Edited by Frances K Skinner. eLife 6 (April):e25827. https://doi.org/10.7554/eLife.25827.

      Branco, Tiago, Beverley A. Clark, and Michael Häusser. 2010. “Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons.” Science (New York, N.Y.) 329 (5999): 1671–75. https://doi.org/10.1126/science.1189664.

      Foldiak, Peter. 2003. “Sparse Coding in the Primate Cortex.” The Handbook of Brain Theory and Neural Networks. https://research-repository.st-andrews.ac.uk/bitstream/handle/10023/2994/FoldiakSparse HBTNN2e02.pdf?sequence=1.

      Golding, Nace L., Nathan P. Staff, and Nelson Spruston. 2002. “Dendritic Spikes as a Mechanism for Cooperative Long-Term Potentiation.” Nature 418 (6895): 326–31. https://doi.org/10.1038/nature00854.

      Govindarajan, Arvind, Inbal Israely, Shu-Ying Huang, and Susumu Tonegawa. 2011. “The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-Dependent LTP.” Neuron 69 (1): 132–46. https://doi.org/10.1016/j.neuron.2010.12.008.

      Govindarajan, Arvind, Raymond J. Kelleher, and Susumu Tonegawa. 2006. “A Clustered Plasticity Model of Long-Term Memory Engrams.” Nature Reviews Neuroscience 7 (7): 575–83. https://doi.org/10.1038/nrn1937.

      Harvey, Christopher D., Ryohei Yasuda, Haining Zhong, and Karel Svoboda. 2008. “The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine.” Science (New York, N.Y.) 321 (5885): 136–40. https://doi.org/10.1126/science.1159675.

      Losonczy, Attila, Judit K. Makara, and Jeffrey C. Magee. 2008. “Compartmentalized Dendritic Plasticity and Input Feature Storage in Neurons.” Nature 452 (7186): 436–41. https://doi.org/10.1038/nature06725.

      Poirazi, Panayiota, Terrence Brannon, and Bartlett W. Mel. 2003. “Pyramidal Neuron as Two-Layer Neural Network.” Neuron 37 (6): 989–99. https://doi.org/10.1016/S0896-6273(03)00149-1.

      Pulikkottil, Vinu Varghese, Bhanu Priya Somashekar, and Upinder S. Bhalla.     2021.

      “Computation, Wiring, and Plasticity in Synaptic Clusters.” Current Opinion in Neurobiology, Computational Neuroscience, 70 (October):101–12. https://doi.org/10.1016/j.conb.2021.08.001.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Review:

      Reviewer #2 (Public Review): 

      Regarding reviewer #2 public review, we update here our answers to this public review with new analysis and modification done in the manuscript. 

      This manuscript is missing a direct phenotypic comparison of control cells to complement that of cells expressing RhoGEF2-DHPH at "low levels" (the cells that would respond to optogenetic stimulation by retracting); and cells expressing RhoGEF2-DHPH at "high levels" (the cells that would respond to optogenetic stimulation by protruding). In other words, the authors should examine cell area, the distribution of actin and myosin, etc in all three groups of cells (akin to the time zero data from figures 3 and 5, with a negative control). For example, does the basal expression meaningfully affect the PRG low-expressing cells before activation e.g. ectopic stress fibers? This need not be an optogenetic experiment, the authors could express RhoGEF2DHPH without SspB (as in Fig 4G). 

      Updated answer: We thank reviewer #2 for this suggestion. PRG-DHPH overexpression is known to affect the phenotype of the cell as shown in Valon et al., 2017. In our experiments, we could not identify any evidence of a particular phenotype before optogenetic activation apart from the area and spontaneous membrane speed that were already reported in our manuscript (Fig 2E and SuppFig 2). Regarding the distribution of actin and myosin, we did not observe an obvious pattern that will be predictive of the protruding/retracting phenotype. Trying to be more quantitative, we have classified (by eye, without knowing the expression level of PRG nor the future phenotype) the presence of stress fibers, the amount of cortical actin, the strength of focal adhesions, and the circularity of cells. As shown below, when these classes are binned by levels of expression of PRG (two levels below the threshold and two above) there is no clear determinant. Thus, we concluded that the main driver of the phenotype was the PRG basal expression rather than any particularity of the actin cytoskeleton/cell shape.

      Author response image 1.

      Author response image 2.

      Relatedly, the authors seem to assume ("recruitment of the same DH-PH domain of PRG at the membrane, in the same cell line, which means in the same biochemical environment." supplement) that the only difference between the high and low expressors are the level of expression. Given the chronic overexpression and the fact that the capacity for this phenotypic shift is not recruitmentdependent, this is not necessarily a safe assumption. The expression of this GEF could well induce e.g. gene expression changes. 

      Updated answer: We agree with reviewer #2 that there could be changes in gene expression. In the next point of this supplementary note, we had specified it, by saying « that overexpression has an influence on cell state, defined as protein basal activity or concentration before activation. »  We are sorry if it was not clear, and we changed this sentence in the revised manuscript (in red in the supp note). 

      One of the interests of the model is that it does not require any change in absolute concentrations, beside the GEF. The model is thought to be minimal and fits well and explains the data with very few parameters. We do not show that there is no change in concentration, but we show that it is not required to invoke it. We revised a sentence in the new version of the manuscript to include this point.

      Additional answer: During the revision process, we have been looking for an experimental demonstration of the independence of the phenotypic switch to any change in global gene expression pattern due to the chronic overexpression of PRG. Our idea was to be in a condition of high PRG overexpression such that cells protrude upon optogenetic activation, and then acutely deplete PRG to see if cells where then retracting. To deplete PRG in a timescale that prevent any change of gene expression, we considered the recently developed CATCHFIRE (PMID: 37640938) chemical dimerizer. We designed an experiment in which the PRG DH-PH domain was expressed in fusion with a FIRE-tag and co-expressing the FIRE-mate fused to TOM20 together with the optoPRG tool. Upon incubation with the MATCH small molecule, we should be able to recruit the overexpressed PRG to the mitochondria within minutes, hereby preventing it to form a complex with active RhoA in the vicinity of the plasma membrane. Unfortunately, despite of numerous trials we never achieved the required conditions: we could not have cells with high enough expression of PRGFIRE-tag (for protrusive response) and low enough expression of optoPRG (for retraction upon PRGFIRE-tag depletion). We still think this would be a nice experiment to perform, but it will require the establishment of a stable cell line with finely tuned expression levels of the CATCHFIRE system that goes beyond the timeline of our present work.      

      Concerning the overall model summarizing the authors' observations, they "hypothesized that the activity of RhoA was in competition with the activity of Cdc42"; "At low concentration of the GEF, both RhoA and Cdc42 are activated by optogenetic recruitment of optoPRG, but RhoA takes over. At high GEF concentration, recruitment of optoPRG lead to both activation of Cdc42 and inhibition of already present activated RhoA, which pushes the balance towards Cdc42."

      These descriptions are not precise. What is the nature of the competition between RhoA and Cdc42? Is this competition for activation by the GEFs? Is it a competition between the phenotypic output resulting from the effectors of the GEFs? Is it competition from the optogenetic probe and Rho effectors and the Rho biosensors? In all likelihood, all of these effects are involved, but the authors should more precisely explain the underlying nature of this phenotypic switch. Some of these points are clarified in the supplement, but should also be explicit in the main text. 

      Updated answer: We consider the competition between RhoA and Cdc42 as a competition between retraction due to the protein network triggered by RhoA (through ROCK-Myosin and mDia-bundled actin) and the protrusion triggered by Cdc42 (through PAK-Rac-ARP2/3-branched Actin). We made this point explicit in the main text.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):  

      Major 

      - why this is only possible for such few cells. Can the authors comment on this in the discussion? Does the model provide any hints? 

      As said in our answer to the public comment or reviewer #1, we think that the low number of cells being able to switch can be explained by two different reasons: 

      (1) First, we were looking for clear inversions of the phenotype, where we could see clear ruffles in the case of the protrusion, and clear retractions in the other case. Thus, we discarded cells that would show in-between phenotypes, because we had no quantitative parameter to compare how protrusive or retractile they were. This reduced the number of switching cells 

      (2) Second, we had a limitation due to the dynamic of the optogenetic dimer used here. Indeed, the control of the frequency was limited by the dynamic of unbinding of the optogenetic dimer. This dynamic of recruitment (~20s) is comparable to the dynamics of the deactivation of RhoA and Cdc42. Thus, the differences in frequency are smoothed and we could not vary enough the frequency to increase the number of switches. Thanks to the model, we can predict that increasing the unbinding rate of the optogenetic tool (shorter dimer lifetime) should allow us to increase the number of switching cells. 

      We have added a sentence in the discussion to make this second point explicit.

      - I would encourage the authors to discuss this molecular signaling switch in the context of general design principles of switches. How generalizable is this network/mechanism? Is it exclusive to activating signaling proteins or would it work with inhibiting mechanisms? Is the competition for the same binding site between activators and effectors a common mechanism in other switches? 

      The most common design principle for molecular switches is the bistable switch that relies on a nonlinear activation (for example through cooperativity) with a linear deactivation. Such a design allows the switch between low and high levels. In our case, there is no need for a non-linearity since the core mechanism is a competition for the same binding site on active RhoA of the activator and the effectors. Thus, the design principle would be closer to the notion of a minimal “paradoxical component” (PMID: 23352242) that both activate and limit signal propagation, which in our case can be thought as a self-limiting mechanism to prevent uncontrolled RhoA activation by the positive feedback. Yet, as we show in our work, this core mechanism is not enough for the phenotypic switch to happen since the dual activation of RhoA and Cdc42 is ultimately required for the protrusion phenotype to take over the retracting one. Given the particularity of the switch we observed here, we do not feel comfortable to speculate on any general design principles in the main text, but we thank reviewer #1 for his/her suggestion.

      - Supplementary figures - there is a discrepancy between the figures called in the text and the supplementary files, which only include SF1-4. 

      We apologize for this error and we made the correction. 

      - In the text, the authors use Supp Figure 7 to show that the phenotype could not be switched by varying the fold increase of recruitment through changing the intensity/duration of the light pulse. Aside from providing the figure, could you give an explanation or speculation of why? Does the model give any prediction as to why this could be difficult to achieve experimentally (is the range of experimentally feasible fold change of 1.1-3 too small? Also, could you clarify why the range is different than the 3 to 10-fold mentioned at the beginning of the results section? 

      We thank the reviewer for this question, and this difference between frequency and intensity can be indeed understood in a simple manner through the model. 

      All the reactions in our model were modeled as linear reactions. Thus, at any timepoint, changing the intensity of the pulse will only change proportionally the amount of the different components (amount of active RhoA, amount of sequestered RhoA, and amount of active Cdc42). This explains why we cannot change the balance between RhoA activity and Cdc42 activity only through the pulse strength. We observed the same experimentally: when we changed the intensity of the pulses, the phenotype would be smaller/stronger, but would never switch, supporting our hypothesis on the linearity of all biochemical reactions. 

      On the contrary, changing the frequency has an effect, for a simple reason: the dynamics of RhoA and Cdc42 activation are not the same as the dynamics of inhibition of RhoA by the PH domain (see

      Figure 4). The inhibition of RhoA by the PH is almost instantaneous while the activation of RhoGTPases has a delay (sets by the deactivation parameter k_2). Intuitively, increasing the frequency will lead to sustained inhibition of RhoA, promoting the protrusion phenotype. Decreasing the frequency – with a stronger pulse to keep the same amount of recruited PRG – restricts this inhibition of RhoA to the first seconds following the activation. The delayed activation of RhoA will then take over. 

      We added two sentences in the manuscript to explain in greater details the difference between intensity and frequency.  

      Regarding the difference between the 1.3-3 fold and the 3 to 10 fold, the explanation is the following: the 3 to 10 fold referred to the cumulative amount of proteins being recruited after multiple activations (steady state amount reached after 5 minutes with one activation every 30s); while the 1.3-3 fold is what can be obtained after only one single pulse of activation.  

      - The transient expression achieves a large range of concentration levels which is a strength in this case. To solve the experimental difficulties associated with this, i.e. finding transfected cells at low cell density, the authors developed a software solution (Cell finder). Since this approach will be of interest for a wide range of applications, I think it would deserve a mention in the discussion part. 

      We thank the reviewer for his/her interest in this small software solution.

      We developed the description of the tool in the Method section. The Cell finder is also available with comments on github (https://github.com/jdeseze/cellfinder) and usable for anyone using Metamorph or Micromanager imaging software. 

      Minor 

      - Can the authors describe what they mean with "cell state"? It is used multiple times in the manuscript and can be interpreted as various things. 

      We now explain what we mean by ‘cell state’ in the main text :

      “protein basal activities and/or concentrations - which we called the cell state”

      - “(from 0% to 45%, Figure 2D)", maybe add here: "compare also with Fig. 2A". 

      We completed the sentence as suggested, which clarifies the data for the readers.

      - The sentence "Given that the phenotype switch appeared to be controlled by the amount of overexpressed optoPRG, we hypothesized that the corresponding leakiness of activity could influence the cell state prior to any activation." might be hard to understand for readers unfamiliar with optogenetic systems. I suggest adding a short sentence explaining dark-state activity/leakiness before putting the hypothesis forward. 

      We changed this whole beginning of the paragraph to clarify.

      - Figure 2E and SF2A. I would suggest swapping these two panels as the quantification of the membrane displacement before activation seems more relevant in this context. 

      We thank reviewer #1 for this suggestion and we agree with it (we swapped the two panels)

      - Fig. 2B is missing the white frames in the mixed panels. 

      We are sorry for this mistake, we changed it in the new version.  

      - In the text describing the experiment of Fig. 4G, it would again be helpful to define what the authors mean by cell state, or to state the expected outcome for both hypotheses before revealing the result.

      We added precisions above on what we meant by cell state, which is the basal protein activities and/or concentrations prior to optogenetic activation. We added the expectation as follow: 

      To discriminate between these two hypotheses, we overexpressed the DH-PH domain alone in another fluorescent channel (iRFP) and recruited the mutated PH at the membrane. “If the binding to RhoA-GTP was only required to change the cell state, we would expect the same statistics than in Figure 2D, with a majority of protruding cells due to DH-PH overexpression. On the contrary, we observed a large majority of retracting phenotype even in highly expressing cells (Figure 4G), showing that the PH binding to RhoA-GTP during recruitment is a key component of the protruding phenotype.”

      - Figure 4H,I: "of cells that overexpress PRG, where we only recruit the PH domain" doesn't match with the figure caption. Are these two constructs in the same cell? If not please clarify the main text. 

      We agree that it was not clear. Both constructs are in the same cell, and we changed the figure caption accordingly.  

      - "since RhoA dominates Cdc42" is this concluded from experiments (if yes, please refer to the figure) or is this known from the literature (if yes, please cite). 

      The assumption that RhoA dominates Cdc42 comes from the fact that we see retraction at low PRG concentration. We assumed that RhoA is responsible for the retraction phenotype. Our assumption is based on the literature (Burridge 2004 as an example of a review, confirmed by many experiments, such as the direct recruitment of RhoA to the membrane, see Berlew 2021) and is supported by our observations of immediate increase of RhoA activity at low PRG. We modified the text to clarify it is an assumption.

      - Fig. 6G  o left: is not intuitive, why are the number of molecules different to start with? 

      The number of molecules is different because they represent the active molecules: increasing the amount of PRG increases the amount of active RhoA and active Cdc42. We updated the figure to clarify this point.

      o right: the y-axis label says "phenotype", maybe change it to "activity" or add a second y-axis on the right with "phenotype"? 

      We updated the figure following reviewer #1 suggestion.

      - Discussion: "or a retraction in the same region" sounds like in the same cell. Perhaps rephrase to state retraction in a similar region? 

      Sorry for the confusion, we change it to be really clear: “a protrusion in the activation region when highly expressed, or a retraction in the activation region when expressed at low concentrations.”

      Typos: 

      - "between 3 and 10 fold" without s. 

      - Fig. 1H, y-axis label. 

      - "whose spectrum overlaps" with s. 

      - "it first decays, and then rises" with s. 

      - Fig 4B and Fig 6B. Is the time in sec or min? (Maybe double-check all figures). 

      - "This result suggests that one could switch the phenotype in a single cell by selecting it for an intermediate expression level of the optoPRG.". 

      - "GEF-H1 PH domain has almost the same inhibition ability as PRG PH domain". 

      We corrected all these mistakes and thank the reviewer for his careful reading of the manuscript.

      Reviewer #2 (Recommendations For The Authors): 

      Likewise, the model assumes that at high PRG GEF expression, the "reaction is happening far from saturation ..." and that "GTPases activated with strong stimuli -giving rise to strong phenotypic changes- lead to only 5% of the proteins in a GTP-state, both for RhoA and Cdc42". Given the high levels of expression (the absolute value of which is not known) this assumption is not necessarily safe to assume. The shift to Cdc42 could indeed result from the quantitative conversion of RhoA into its active state. 

      We agree with the reviewer that the hypothesis that RhoA is fully converted into its active state cannot be completely ruled out. However, we think that the two following points can justify our choice.

      - First, we see that even in the protruding phenotype, RhoA activity is increasing upon optoPRG recruitment (Figure 3). This means that RhoA is not completely turned into its active GTP-loaded state. The biosensor intensity is rising by a factor 1.5 after 5 minutes (and continue to increase, even if not shown here). For sure, it could be explained by the relocation of RhoA to the place of activation, but it still shows that cells with high PRG expression are not completely saturated in RhoA-GTP. 

      - We agree that linearity (no saturation) is still an hypothesis and very difficult to rule out, because it is not only a question of absolute concentrations of GEFs and RhoA, but also a question of their reaction kinetics, which are unknow parameters in vivo. Yet, adding a saturation parameter would mean adding 3 unknown parameters (absolute concentrations of RhoA, as well as two reaction constants). The fact that there are not needed to fit the complex curves of RhoA as we do with only one parameter tends to show that the minimal ingredients representing the interaction are captured here.  

      The observed "inhibition of RhoA by the PH domain of the GEF at high concentrations" could result from the ability of the probe to, upon membrane recruitment, bind to active RhoA (via its PH domain) thereby outcompeting the RhoA biosensor (Figure 4A-C). This reaction is explicitly stated in the supplemental materials ("PH domain binding to RhoA-GTP is required for protruding phenotype but not sufficient, and it is acting as an inhibitor of RhoA activity."), but should be more explicit in the main text. Indeed, even when PRG DHPH is expressed at high concentrations, it does activate RhoA upon recruitment (figure 3GH). Not only might overexpression of this active RhoA-binding probe inhibit the cortical recruitment of the RhoA biosensor, but it may also inhibit the ability of active RhoA to activate its downstream effectors, such as ROCK, which could explain the decrease in myosin accumulation (figure 3D-F). It is not clear that there is a way to clearly rule this out, but it may impact the interpretation. 

      This hypothesis is actually what we claim in the manuscript. We think that the inhibition of RhoA by the PH domain is explained by its direct binding. We may have missed what Reviewer #2 wanted to say, but we think that we state it explicitly in the main text :

      “Knowing that the PH domain of PRG triggers a positive feedback loop thanks to its binding to active RhoA 18, we hypothesized that this binding could sequester active RhoA at high optoPRG levels, thus being responsible for its inhibition.”

      And also in the Discussion:

      “However, this feedback loop can turn into a negative one for high levels of GEF: the direct interaction between the PH domain and RhoA-GTP prevents RhoA-GTP binding to effectors through a competition for the same binding site.”

      We may have not been clear, but we think that this is what is happening: the PH domain prevents the binding to effectors and decreases RhoA activity (as was shown in Chen et al. 2010).  

      The X-axis in Figure 4C time is in seconds not minutes. The Y-axis in Figure 4H is unlabeled. 

      We are sorry for the mistake of Figure 4C. We changed the Y-axis in the Figure 4h.  

      Although this publication cites some of the relevant prior literature, it fails to cite some particularly relevant works. For example, the authors state, "The LARG DH domain was already used with the iLid system" and refers to a 2018 paper (ref 19), whereas that domain was first used in 2016 (PMID 27298323). Indeed, the authors used the plasmid from this 2016 paper to build their construct. 

      We thank the reviewer for pointing out this error, we have corrected the citation and put the seminal one in the revised version.

      An analogous situation pertains to previous work that showed that an optogenetic probe containing the DH and PH domains in RhoGEF2 is somewhat toxic in vivo (table 6; PMID 33200987). Furthermore, it has previously been shown that mutation of the equivalent of F1044A and I1046E eliminates this toxicity (table 6; PMID 33200987) in vivo. This is particularly important because the Rho probe expressing RhoGEF2-DHPH is in widespread usage (76 citations in PubMed). The ability of this probe to activate Cdc42 may explain some of the phenotypic differences described resulting from the recruitment of RhoGEF2-DHPH and LARG-DH in a developmental context (PMID 29915285, 33200987). 

      We thank reviewer #2 for these comments, and added a small section in the discussion, for optogenetic users: 

      This underlines the attention that needs to be paid to the choice of specific GEF domains when using optogenetic tools. Tools using DH-PH domains of PRG have been widely used, both in mammalian cells and in Drosophila (with the orthologous gene RhoGEF2), and have been shown to be toxic in some contexts in vivo 28. Our study confirms the complex behavior of this domain which cannot be reduced to a simple RhoA activator.   

      Concerning the experiment shown in 4D, it would be informative to repeat this experiment in which a non-recruitable DH-PH domain of PRG is overexpressed at high levels and the DH domain of LARG is recruited. This would enable the authors to distinguish whether the protrusion response is entirely dependent on the cell state prior to activation or the combination of the cell state prior to activation and the ability of PRG DHPH to also activate Cdc42. 

      We thank the reviewer for his suggestion. Yet, we think that we have enough direct evidence that the protruding phenotype is due to both the cell state prior to activation and the ability of PRG DHPH to also activate Cdc42. First, we see a direct increase in Cdc42 activity following optoPRG recruitment (see Figure 6). This increase is sustained in the protruding phenotype and precedes Rac1 and RhoA activity, which shows that it is the first of these three GTPases to be activated. Moreover, we showed that inhibition of PAK by the very specific drug IPA3 is completely abolishing only the protruding phenotype, which shows that PAK, a direct effector of Cdc42 and Rac1, is required for the protruding phenotype to happen. We know also that the cell state prior to activation is defining the phenotype, thanks to the data presented in Figure 2. 

      We further showed in Figure 1 that LARG DH-PH domain was not able to promote protrusion. The proposed experiment would be interesting to confirm that LARG does not have the ability to activate another GTPase, even in a different cell state with overexpressed PRG. However, we are not sure it would bring any substantial findings to understand the mechanism we describe here, given the facts provided above.  

      Similarly, as PRG activates both Cdc42 and Rho at high levels, it would be important to determine the extent to which the acute Rho activation contributes to the observed phenotype (e.g. with Rho kinase inhibitor). 

      We agree with the reviewer that it would be interesting to know whether RhoA activation contributes to the observed phenotype, and we have tried such experiments. 

      For Rho kinase inhibitor, we tried with Y-27632 and we could never prevent the protruding phenotype to happen. However, we could not completely abolish the retracting phenotype either (even when the effect on the cells was quite strong and visible), which could be due to other effectors compensating for this inhibition. As RhoA has many other effectors, it does not tell us that RhoA is not required for protrusion. 

      We also tried with C3, which is a direct inhibitor of RhoA. However, it had too much impact on the basal state of the cells, making it impossible to recruit (cells were becoming round and clearly dying. As both the basal state and optogenetic activation require the activation of RhoA, it is hard to conclude out of experiments where no cell is responding. 

      The ability of PRG to activate Cdc42 in vivo is striking given the strong preference for RhoA over Cdc42 in vitro (2400X) (PMID 23255595). Is it possible that at these high expression levels, much of the RhoA in the cell is already activated, so that the sole effect that recruited PRG can induce is activation of Cdc42? This is related to the previous point pertaining to absolute expression levels.  

      As discussed before, we think that it is not only a question of absolute expression levels, but also of the affinities between the different partners. But Reviewer #2 is right, there is a competition between the activation of RhoA and Cdc42 by optoPRG, and activation of Cdc42 probably happens at higher concentration because of smaller effective affinity.

      Still, we know that activation of the Cdc42 by PRG DH-PH domain is possible in vivo, as it was very clearly shown in Castillo-Kauil et al., 2020 (PMID 33023908). They show that this activation requires the linker between DH and PH domain of PRG, as well as Gαs activation, which requires a change in PRG DH-PH conformation. This conformational switch does not happen in vitro, which might explain why the affinity against Cdc42 was found to be very low. 

      Minor points 

      In both the abstract and the introduction the authors state, "we show that a single protein can trigger either protrusion or retraction when recruited to the plasma membrane, polarizing the cell in two opposite directions." However, the cells do not polarize in opposite directions, ie the cells that retract do not protrude in the direction opposite the retraction (or at least that is not shown). Rather a single protein can trigger either protrusion or retraction when recruited to the plasma membrane, depending upon expression levels. 

      We thank the reviewer for this remark, and we agree that we had not shown any data supporting a change in polarization. We solved this issue, by showing now in Supplementary Figure 1 the change in areas in both the activated and in the not activated region. The data clearly show that when a protrusion is happening, the cell retracts in the non-activated region. On the other hand, when the cell retracts, a protrusion happens in the other part of the cell, while the total area is staying approximately constant. 

      We added the following sentence to describe our new figure:

      Quantification of the changes in membrane area in both the activated and non-activated part of the cell (Supp Figure 1B-C) reveals that the whole cell is moving, polarizing in one direction or the other upon optogenetic activation.

      While the authors provide extensive quantitative data in this manuscript and quantify the relative differences in expression levels that result in the different phenotypes, it would be helpful to quantify the absolute levels of expression of these GEFs relative to e.g. an endogenously expressed GEF. 

      We agree with the reviewer comment, and we also wanted to have an idea of the absolute level of expression of GEFs present in these cells to be able to relate fluorescent intensities with absolute concentrations. We tried different methods, especially with the purified fluorescent protein, but having exact numbers is a hard task.

      We ended up quantifying the amount of fluorescent protein within a stable cell line thanks to ELISA and comparing it with the mean fluorescence seen under the microscope. 

      We estimated that the switch concentration was around 200nM, which is 8 times more than the mean endogenous concentration according to https://opencell.czbiohub.org/, but should be reachable locally in wild type cell, or globally in mutated cancer cells. 

      Given the numerical data (mostly) in hand, it would be interesting to determine whether RhoGEF2 levels, cell area, the pattern of actin assembly, or some other property is most predictive of the response to PRG DHPH recruitment. 

      We think that the manuscript made it clear that the concentration of PRG DHPH is almost 100% predictive of the response to PRG DHPH. We believe that other phenotypes such as the cell area or the pattern of actin assembly would only be consequences of this. Interestingly, as experimentators we were absolutely not able to predict the behavior by only seeing the shape of the cell, event after hundreds of activation experiments, and we tried to find characteristics that would distinguish both populations with the data in our hands and could not find any.

      There is some room for general improvement/editing of the text. 

      We tried our best to improve the text, following reviewers suggestions.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We are thankful to the reviewers and the editor for their detailed feedback, insightful suggestions, and thoughtful assessment of our work. The revised manuscript has taken into account all the comments of the three reviewers. We have also undertaken additional analyses and added materials in response to reviewer suggestions. In brief:

      (1) We have conducted a more in-depth analysis of frequency domain HRV metrics to better depict the change of autonomic tone.

      (2) We have revised the manuscript to provide justifications for the chosen taVNS protocol and to clearly articulate the objectives of the current study.

      (3) In response to comments from reviewer #2, we have included two new tables that present the absolute changes in cardiovascular metrics, clinical characteristics for the two trial arms, and effects of taVNS adjusted for age.

      Other significant amendments include:

      (1) An expanded discussion linking our findings to the existing literature on the effects of taVNS on cardiovascular function, biomarkers for taVNS response, the safety of taVNS, and the dose-response relationship of taVNS.

      (2) Revision to the Method section to provide details of QT interval calculation.

      Reviewer #1 (Public Review):

      The authors report the results of a randomized clinical trial of taVNS as a neuromodulation technique in SAH patients. They found that taVNS appears to be safe without inducing bradycardia or QT prolongation. taVNS also increased parasympathetic activity, as assessed by heart rate variability measures. Acute elevation in heart rate might be a biomarker to identify SAH patients who are likely to respond favorably to taVNS treatment. The latter is very important in light of the need for acute biomarkers of response to neuromodulation treatments.

      Comments:

      (1) Frequency domain heart rate variability measures should be analyzed and reported. Given the short duration of the ECG recording, the frequency domain may more accurately reflect autonomic tone.

      We sincerely appreciate this encouraging summary of our paper. We have analyzed and reported frequency-domain heart rate variability measures, including the relative power of the high-frequency band (0.15–0.4 Hz) and the relative power of the low-frequency band (0.04 – 0.15). We showed the distribution of the two frequency-domain HRV measures in supplementary Figure 2C-D. For 24-hour ECG recording, we found that the change in the relative high-frequency power from Day 1 was not significantly different between the treatment groups. As both high-frequency band and low-frequency band power are relative to the total power, the comparison of the relative power of the low-frequency band between groups would be the opposite of the relative power of the high-frequency band. As both time-domain and frequency-domain HRV measures can reflect the autonomic tone, we performed factor analysis to identify the parasympathetic activity component (Figure 2D). Comparing the change in parasympathetic activity component and relative high-frequency power, we observed similarities and discrepancies. Specifically, both the change in parasympathetic activity component and the change in relative high-frequency power were higher in the taVNS group at the early phase (Day 2 - 4).

      We also observed higher high-frequency power in the Sham group at the later phase. If the factor analysis successfully isolates the parasympathetic activity, there should be other factors than the parasympathetic activity affecting the relative power of the high-frequency band. One such factor is the respiration rate. The high-frequency range is between 0.15 to 0.4 Hz, corresponding to respiration's frequency range of approximately 9 to 24 breaths per minute. If the respiration rate increases and exceeds 24 breaths per minute, the respiratory-driven HRV might occur at a frequency higher than the typical high-frequency band. Given that the respiration rate was higher in the taVNS treatment group, a compensatory mechanism to ensure oxygen delivery (Figure 4E), we hypothesized that observed lower high-frequency power in the taVNS treatment group compared to sham at later phases is a result of increased respiration rate in the taVNS treatment group. Indeed, we found the normalized high-frequency power is higher when RR is less than 25 bpm compared to when RR > 25 bpm (Cohen’s d = 0.85, Supplementary Figure 3A). Moreover, an increase in RR in the taVNS treatment group is associated with a decrease in high-frequency power (Supplementary Figure 3B). These control analyses underscored the necessity of performing factor analysis to robustly measure parasympathetic activities and confirm that taVNS treatment mitigated the sympathetic overactivation during the early phase.

      We have now discussed the results of frequency-domain HRV measures in the Discussion section: taVNS and autonomic system (p23): “A key metric that reflects this restored sympathovagal balance is the increase in heart rate variability (Figure 3F). Specifically, the factor analysis showed that the parasympathetic activity was significantly higher in the taVNS treatment group. This difference was most pronounced during the early phase, particularly between Days 2 and 4 following SAH. In addition to analyzing the correlation between the parasympathetic activity factor and established HRV measures that reflect parasympathetic activity such as RMSSD and pNNI_50 (Figure 3C), we also examined changes in a frequency-domain HRV measure—the relative power of the high-frequency band (0.15–0.4 Hz)—to validate the accuracy of the factor analysis. the relative power of the high-frequency band is widely used to indicate respiratory sinus arrhythmia, a process primarily driven by the parasympathetic nervous system (Supplementary Figure 2). We found that both the change in parasympathetic activity factor and relative high-frequency power were higher in the taVNS group at the early phase (Day 2 - 4). Conversely, we observed higher high-frequency power in the Sham group during the later phase. If the factor analysis successfully isolates the parasympathetic activity, there should be other factors than the parasympathetic activity affecting the relative power of the high-frequency band. One such factor is the respiration rate. The high-frequency range is between 0.15 to 0.4 Hz, corresponding to respiration's frequency range of approximately 9 to 24 breaths per minute. If the respiration rate increases and exceeds 24 breaths per minute, the respiratory-driven HRV might occur at a frequency higher than the typical high-frequency band. Given that the respiration rate was higher in the taVNS treatment group, a compensatory mechanism to ensure oxygen delivery (Figure 4E), we hypothesized that observed lower high-frequency power in the taVNS treatment group compared to sham at later phases is a result of increased respiration rate in the taVNS treatment group. Indeed, we found the normalized high-frequency power is higher when RR is less than 25 bpm compared to when RR > 25 bpm (Cohen’s d = 0.85, Supplementary Figure 3A). Moreover, an increase in RR in the taVNS treatment group is associated with a decrease in high-frequency power (Supplementary Figure 3B). These control analyses underscored the necessity of performing factor analysis to robustly measure parasympathetic activities and confirm that taVNS treatment mitigated the sympathetic overactivation during the early phase.”

      We have also reported the changes in the relative power of the high-frequency band between the two treatment groups in Supplementary Figure 6. We did not find a significant change in relative high-frequency band power between the treatment groups (Treatment – pre-treatment difference: p = 0.74, Cohen’s d = -0.08, N(Sham) = 199, N(taVNS) = 188, Mann-Whitney U test). We reported these results in the Results section: Acute effects of taVNS on cardiovascular function (p18): “There were no significant differences in changes in corrected QT interval or heart rate variability, as measured by RMSSD, SDNN, and relative power of high-frequency band between treatment groups (Figure 5D and E and Supplementary Figure 6).”

      How was the "dose" chosen (20 minutes twice daily)?

      The choice of a 20-minute taVNS session twice daily was informed by findings from Addorisio et al. (2019), where the authors administered 5-minute taVNS twice daily to patients with rheumatoid arthritis for two days. They found that the circulating c-reactive protein (CRP) levels significantly reduced after two days of treatment but returned to baseline at the second clinical assessment by day 7. Given the high inflammatory state associated with subarachnoid hemorrhage (SAH) and our intention to maintain a steady reduction in inflammation, we extended the duration of taVNS to 20 minutes per session. We have clarified this stimulation schedule's rationale in the Results section (p5-6): “This treatment schedule was informed by findings from Addorisio et al., where a 5-minute taVNS protocol was administered twice daily to patients with rheumatoid arthritis for two days.29 Their study found that circulating c-reactive protein (CRP) levels significantly reduced after 2 days of treatment but returned to baseline at the second clinical assessment by day 7. Given the high inflammatory state associated with SAH and our intention to maintain a steady reduction in inflammation, we decided to extend the treatment duration to 20 minutes per session.”

      Addorisio, Meghan E., et al. "Investigational treatment of rheumatoid arthritis with a vibrotactile device applied to the external ear." Bioelectronic Medicine 5 (2019): 1-11.

      The use of an acute biomarker of response is very important. A bimodal response to taVNS has been previously shown in patients with atrial fibrillation (Kulkarni et al. JAHA 2021).

      Thank you for this valuable insight and for bringing the study by Kulkarni et al. to our attention. Their study showed that the response to Low-Level Tragus Stimulation (LLTS) varied among patients with atrial fibrillation, which can be predicted by acute P-wave alternans (PWA) to some degree. We have discussed the implication of the bimodal response to taVNS in the Discussion section (p26-27): “Kulkarni et al. showed that the response to low-level tragus stimulation (LLTS) varied among patients with atrial fibrillation.49 Similarly, in our study, not all patients in the taVNS treatment group showed a reduction in mRS scores (improved degree of disability or dependence). This differential response may be inherent to taVNS and potentially influenced by factors such as anatomical variations in the distribution of the vagus nerve at the outer ear. These findings underscore the importance of using acute biomarkers to guide patient selection and optimize stimulation parameters. Furthermore, we found that increased heart rate was a potential acute biomarker for identifying SAH patients who are most likely to respond favorably to taVNS treatment. Translating this finding into clinical practice will require further research to elucidate the mechanisms by which an acute increase in heart rate may predict the outcomes of patients receiving taVNS, including its relationship with neurological evaluations, vasospasm, echocardiography, and inflammatory markers.”

      Reviewer #2 (Public Review):

      Summary:

      This study investigated the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on cardiovascular dynamics in subarachnoid hemorrhage (SAH) patients. The researchers conducted a randomized clinical trial with 24 SAH patients, comparing taVNS treatment to a Sham treatment group (20 minutes per day twice a day during the ICU stay). They monitored electrocardiogram (ECG) readings and vital signs to assess acute as well as middle-term changes in heart rate, heart rate variability, QT interval, and blood pressure between the two groups. The results showed that repetitive taVNS did not significantly alter heart rate, corrected QT interval, blood pressure, or intracranial pressure. However, it increased overall heart rate variability and parasympathetic activity after 5-10 days of treatment compared to the sham treatment. Acute taVNS led to an increase in heart rate, blood pressure, and peripheral perfusion index without affecting corrected QT interval, intracranial pressure, or heart rate variability. The acute post-treatment elevation in heart rate was more pronounced in patients who showed clinical improvement. In conclusion, the study found that taVNS treatment did not cause adverse cardiovascular effects, suggesting it is a safe immunomodulatory treatment for SAH patients. The mild acute increase in heart rate post-treatment could potentially serve as a biomarker for identifying SAH patients who may benefit more from taVNS therapy.

      Strengths:

      The paper is overall well written, and the topic is of great interest. The methods are solid and the presented data are convincing.

      Weaknesses:

      (1) It should be clearly pointed out that the current paper is part of the NAVSaH trial (NCT04557618) and presents one of the secondary outcomes of that study while the declared first outcomes (change in the inflammatory cytokine TNF-α in plasma and cerebrospinal fluid between day 1 and day 13, rate of radiographic vasospasm, and rate of requirement for long-term CSF diversion via a ventricular shunt) are available as a pre-print and currently under review (doi: 10.1101/2024.04.29.24306598.). The authors should better stress this point as well as the potential association of the primary with the secondary outcomes.

      Thank you for this valuable suggestion. The current study indeed focuses on the trial’s secondary outcomes. The main objective is to evaluate the cardiovascular safety of the taVNS protocol and to provide insights that will inform the application of taVNS in SAH patients. Following your comments, we have clarified this in the Introduction section (p6): “The current study is part of the NAVSaH trial (NCT04557618) and focuses on the trial’s secondary outcomes, including heart rate, QT interval, HRV, and blood pressure.32 This interim analysis aims to evaluate the cardiovascular safety of the taVNS protocol and to provide insights that will inform the application of taVNS in SAH patients. The primary outcomes of this trial, including change in the inflammatory cytokine TNF-α and rate of radiographic vasospasm, are available as a pre-print and currently under review.26”

      The negative association between HRV and inflammatory cytokines has been reported in numerous studies such as (Williams et al., Brain, Behavior, and Immunity, 2019; Haensel et al., Psychoneuroendocrinology. 2008). There are some studies suggesting that increased sympathetic tone following SAH is associated with vasospasm (Bjerkne Wenneberg, S. et al., Acta Anaesthesiologica Scandinavica. 2020; Megjhani et al., Neurocrit Care. 2020). Based on the literature, we compared the effects of taVNS on primary and secondary outcomes. The findings from the two parallel analyses are consistent: taVNS treatment reduced pro-inflammatory cytokines and increased HRV. Furthermore, the analyses of the primary outcomes revealed a reduction in the presence of any radiographic vasospasm in the taVNS treatment group compared to the sham. We have now integrated these findings and discussed them in the Discussion section (p25-26): “Given the negative association between pro-inflammatory markers and HRV, our finding that HRV was higher in the taVNS treatment group aligns with the findings of primary outcomes of this clinical trial, which showed that taVNS treatment reduced pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) and interleukin-6.26,52 The consistency between these findings strengthens the evidence supporting the anti-inflammatory effects of taVNS. In addition, the sympathetic predominance following SAH is implicated in an increased risk of delayed cerebral vasospasm, which is most commonly detected 5-7 days after SAH.12 Given that taVNS treatment mitigated the sympathetic overactivation before the typical onset of cerebral vasospasm, it could potentially reduce the severity of this complication.”

      (2) The references should be implemented particularly concerning other relevant papers (including reviews and meta-analysis) of taVNS safety, particularly from a cardiovascular standpoint, such as doi: 10.1038/s41598-022-25864-1 and doi: 10.3389/fnins.2023.1227858).

      Thank you for providing the relevant papers. We have provided these references in the Introduction section to provide a more comprehensive background of our study (p6): “While some animal studies have reported a potential risk of bradycardia and decreased blood pressure associated with vagus nerve stimulation, two reviews of human studies have considered the cardiovascular effects of taVNS generally safe, with adverse effects reported only in patients with pre-existing heart diseases. 21,22,23

      (3) The dose-response issue that affects both VNS and taVNS applications in different settings should be mentioned (doi: 10.1093/eurheartjsupp/suac036.) as well as the need for more dose-finding preclinical as well as clinical studies in different settings (the best stimulation protocol is likely to be disease-specific).

      Overall, the present work has the important potential to further promote the usage of taVNS even on critically ill patients and might set the basis for future randomized studies in this setting

      Thank you for this valuable insight. Scientific understanding of the dose-response relationship and determining optimal parameters tailored to specific disease contexts has been recognized as an important part of taVNS research and, more generally, in the electrical neuromodulation field. Studies in this direction are often complex and time-intensive due to the multitude of possible parameter combinations. As such, most taVNS studies opted to use parameters that have been established in previous studies. For example, 20 Hz taVNS is extensively used as a therapeutic intervention in stroke (Matyas Jelinek ,2024, https://www.sciencedirect.com/science/article/pii/S0014488623003138). As we pioneer the application of taVNS as an immunomodulation technique in SAH patients, we also adopt parameters reported in similar studies, aiming to provide a basis for future preclinical and clinical studies of taVNS in this patient population. As you noted, the effects of taVNS are dose-dependent, necessitating systematic exploration of the parameter space, including frequency, intensity, and duration. Our findings of the acute biomarker (heart rate) hold the promise of close-loop taVNS. We have now emphasized the importance of investigating how parameters/dose affect taVNS’s effects on immune function and cardiovascular function in SAH patients (p28): “As we pioneer the application of taVNS as an immunomodulation technique in SAH patients, we adopt parameters (20 Hz, 0.4 mA) reported in similar studies.55 The current study provides a basis for future preclinical and clinical studies of taVNS in this patient population. To build on our findings, a systematic evaluation of the relationship between parameters such as frequency, intensity, and duration and taVNS’s effects on the immune system and cardiovascular function is necessary to establish taVNS as an effective therapeutic option for SAH patients.56”

      Reviewer #2 (Recommendations For The Authors):

      The paper is overall well written, and the topic is of great interest. The reviewer has some major comments:

      (1) It should be clearly pointed out that the current paper is part of the NAVSaH trial and presents one of the secondary outcomes of that study while the declared first outcomes (change in the inflammatory cytokine TNF-α in plasma and cerebrospinal fluid between day 1 and day 13, rate of radiographic vasospasm, and rate of the requirement for long-term CSF diversion via a ventricular shunt) are available as a pre-print and currently under review (doi: 10.1101/2024.04.29.24306598.).

      We have revised the manuscript following your comment. Please see comment Reviewer 2 Public Review and our response.

      The authors should assess the relationship between the impact of taVNS on inflammatory markers in plasma and in cerebrospinal fluid and the autonomic responses. The association between inflammatory markers and noninvasive autonomic markers as well as sympathovagal balance should also be assessed. Specifically, the authors should try to assess whether the acute post-treatment elevation in heart rate was more pronounced in patients who experienced a more pronounced reduction in inflammatory biomarkers. Indeed, since all patients in the current study received the same dose of taVNS (20 Hz frequency, 250 μs pulse width, and 0.4 mA intensity), while in several cardiovascular studies (doi: 10.1016/j.jacep.2019.11.008, doi: 10.1007/s10286-023-00997-z) the intensity (amplitude) of taVNS was differentially set based on the subjective pain/sensory threshold, that might be a marker of acute afferent neuronal engagement.

      We agree that analyzing the change in cardiovascular metrics and changes in inflammatory markers is an important next step. In particular, testing whether the acute elevation in heart rate correlates with changes in inflammatory markers could further establish heart rate as a biomarker to guide patient selection and optimize stimulation parameters. (Please refer to comment 1.3 and our responses). However, in this paper, the primary objective is the cardiovascular safety of the current taVNS protocol in SAH patients. This association between inflammatory markers and autonomic responses extends beyond the scope of the current manuscript and would be more appropriately addressed in a separate publication.

      Previous literature has shown a negative association between HRV and inflammatory markers in SAH patients (for example, Adam, J., 2023). It is reasonable to postulate that taVNS modulates the immune system and the autonomic system synergistically. We found that parasympathetic tone was higher in the taVNS treatment group, with the most notable differences observed between Days 2 and 4 following SAH (Figure 3F). In a separate study of the primary outcomes of this trial (Huguenard et al., 2024), serum levels of IL-6 (pro-inflammation cytokine) were also significantly lower in the taVNS treatment group on Day 4 (Figure 3A, in our preprint, https://doi.org/10.1101/2024.04.29.24306598).

      We appreciate your input regarding the potential mechanism behind acute heart rate changes. In this trial, all patients who were able to engage in verbal communication were asked if they felt any prickling or pain during all sessions. We confirmed that the current stimulation setting was sub-perception in all trialed patients, making it unlikely that the observed heart rate increase was due to pain or sensory perception. Our current hypothesis is that successful activation of the afferent vagal pathway by taVNS increased arousal, resulting in increased heart rate. We have revised the Discussion section based on your insight (p29): “All patients who were capable of verbal communication were asked if they felt any prickling or pain during all sessions. We confirmed that the current taVNS protocol is below the perception threshold for all trialed patients. Altogether, successful activation of the afferent vagal pathway by taVNS increased arousal, resulting in increased heart rate.50,51”

      Huguenard, A. L. et al. Auricular Vagus Nerve Stimulation Mitigates Inflammation and Vasospasm in Subarachnoid Hemorrhage: A Randomized Trial. (2024) doi:10.1101/2024.04.29.24306598.

      Adam, J., Rupprecht, S., Künstler, E. C. S. & Hoyer, D. Heart rate variability as a marker and predictor of inflammation, nosocomial infection, and sepsis – A systematic review. Autonomic Neuroscience vol. 249 103116 (2023).

      A new table should be provided with the mean (or median) values of the two arms of the population (taVNS and sham) including baseline clinical characteristics, comorbidities (mean age, % of female, % with known hypertension, diabetes, etc), ongoing medications (% on beta-betablockers, etc), and pre, during and post-treatment absolute values (expressed as mean or median depending on the distribution) of the studied parameters (QT and QTc absolute values, heart rate, SDNN, etc) in order for the reader to have a better understanding of how SAH affects these parameters. Absolute changes in the abovementioned parameters should also be presented in the table. For instance, the reported absolute increase in heart rate, based on Figure 5, panel C, seems very modest, below 2 bpm. This is very important to underlying for several reasons, including the fact that the evaluation of the impact of treatment on heart rate variability as assessed in the time domain might be influenced by concomitant changes in heart rate due to the nonlinearity of neural modulation of sinus node cycle length. Indeed, time-domain indexes of HRV intrinsically increase when heart rate decreases in a nonlinear way, while frequency domain indexes (e.g. the low frequency/high frequency (LF/HF) ratio), appear to be devoid of intrinsic rate-dependency (doi: 10.1016/s0008-6363(01)00240-1).

      Thank you for your suggestion. We have added the new table to the manuscript. In this table, we include clinical characteristics, the median of absolute values of cardiovascular metrics from 24-hour ECG recording, and the median absolute changes in these metrics for both arms. We believe that absolute values of cardiovascular metrics from 24-hour ECG recording are more informative about how SAH affects these parameters than metrics for the pre-, during-, and post-treatment periods.

      In Result (p7), we have added: “Supplementary Table 3 shows the clinical characteristics of the two treatment groups.” In Result, Acute effect of taVNS on cardiovascular function (p20), we have added: “Supplementary Table 3 summarizes the absolute changes in cardiovascular metrics for the treatment groups.”

      Thank you for raising the concern about HRV and providing the reference. We have now reported frequency domain indexes in our results: relative power of high-frequency power, which is negatively correlated with the LF/HF ratio. The high-frequency power is used to capture sinus arrhythmia, reflecting the parasympathetic modulation of the heart. Although the frequency domain metrics might be less susceptible to the rate-dependency (doi: 10.1016/s0008-6363(01)00240-1), there are circumstances when the frequency domain metrics might not accurately reflect the autonomic tone (Please see Reviewer 1 Publice Review and our responses).

      An attempt to correct the effect of taVNS on the evaluated autonomic parameters according to age should be provided, considering that there were no age limits and parasympathetic indexes, particularly at the sinus node level, are known to decrease with age, particularly for those older than 65 years.

      Thank you for the suggestion. We were aware of the influence of age on cardiac heart rate and heart rate variability. In our initial analysis, we compared the change in autonomic parameters from day 1 within each subject across the two treatment groups. This approach controls for individual differences, including those due to age. In addition to your comment, age is a risk factor for subarachnoid hemorrhage. Older individuals often face an increased risk of poor outcomes. To further verify if age influences autonomic changes following SAH, we performed ANCOVA on autonomic function parameters with age included as a covariate. This analysis showed that age was negatively correlated with changes in heart rate, SDNN, and RMSSD from Day 1, but not with changes in QT intervals. After adjusting for age, we found that RMSSD changes and SDNN changes were significantly higher in the taVNS treatment group, while QTc changes were significantly lower in this group. These results align with the main findings (Figures 2 and 3). In addition, autonomic changes following SAH may be influenced by age. Specifically, lower RMSSD and SDNN in older individuals suggest a greater shift toward sympathetic predominance following SAH. We have now reported these results in Supplementary Table 4 and discussed their implication in the Discussion section (p28): “To control for individual differences, including those due to age, our study compared the change in cardiovascular parameters from Day 1 within each subject across treatment groups. To further verify if age influences autonomic changes following SAH, we performed ANCOVA on autonomic function parameters with age included as a covariate. This analysis showed that age was negatively correlated with changes in heart rate, SDNN, and RMSSD from Day 1 but not with changes in QT intervals. After adjusting for age, we found that RMSSD changes and SDNN changes were significantly higher, while QTc changes were significantly lower in the taVNS treatment group (Supplementary Table 4). These results align with the conclusion that repetitive taVNS treatment increased HRV and was unlikely to cause bradycardia or QT prolongation. In addition, autonomic changes following SAH may be influenced by age. Specifically, lower RMSSD and SDNN in older individuals suggest a greater shift toward sympathetic predominance following SAH (Supplementary Table 4).”

      The results of the current study should be discussed considering what was previously demonstrated concerning the cardiovascular effects of taVNS (doi: 10.3389/fnins.2023.1227858).

      We appreciate the suggestion to consider previous findings on the cardiovascular effects of taVNS. However, it is important to note that most studies investigating the cardiovascular effects of taVNS involve healthy individuals, whereas our study focuses on SAH patients who are critically ill. Given the influence of SAH on cardiovascular parameters, we should be cautious when generalizing our findings to the broader population. Previous studies involving stroke populations have reported cardiovascular parameters descriptively as part of their safety assessments (doi: 10.1155/2020/8841752). Our study is currently the only one systematically investigating the cardiovascular safety of taVNS in SAH patients. Furthermore, the review paper (doi: 10.3389/fnins.2023.1227858) includes a highly heterogeneous mix of studies, such as auricular acupressure, auricular acupuncture, and electrical stimulation applied to different parts of the ear. For the subset of studies involving electrical stimulation, there is considerable variation in the parameters used, with frequencies ranging from 0.5 Hz to 100 Hz, currents from 0.1 mA to 45 mA, and durations spanning from 20 minutes to 168 days. These variations make direct comparisons with our findings challenging.

      It looks like QT measurements were performed automatically. It should be specified which method was used for the measurements (threshold, tangent, or superimposed method?).

      In our study, QT intervals were measured based on thresholding after wavelet transforming the ECG signals (Martínez, J. P., IEEE Transactions on Biomedical Engineering, 2004, doi: 10.1109/TBME.2003.821031). The local maxima of the wavelet transform correspond to significant changes in the ECG signal, such as the rapid upward or downward deflections associated with the QRS complex. The algorithm searches modulus maxima, that is, peaks of wavelet transform coefficients that exceed specific thresholds, to identify the QRS complex. R peaks are found as the zeros crossing between the positive-negative modulus maxima pair. After localizing the R peak, the Q onset is detected as the beginning of the first modulus maximum before the modulus maximum pair created by the R wave. To identify the T wave, the algorithm searches for local maxima in the absolute wavelet transform in a search window defined relative to the QRS complex. Thresholding is used to identify the offset of the T wave. Please refer to comments 3.4 and 3.5 and our responses for details. We have clarified the method for measuring QT in the Method section (p35): “This algorithm identifies the QRS complex by searching for modulus maxima, which are peaks in the wavelet transform coefficients that exceed specific thresholds. The onset of the QRS complex is determined as the beginning of the first modulus maximum before the modulus maximum pair created by the R wave. To identify the T wave, the algorithm searches for local maxima in the absolute wavelet transform in a search window defined relative to the QRS complex. Thresholding is used to identify the offset of the T wave.”

      QTc dispersion was not evaluated, and this should be listed as a limitation of the current study.

      We have added this limitation in the Discussion section: Limitations and outlook (p31): “The current study did not explore the effects of taVNS on less commonly used cardiovascular metrics, such as QTc dispersion.”

      It has been recently suggested (doi: 10.1016/j.brs.2018.12.510) that QTc, as a potential indirect marker of HRV, might be used as a biomarker for VNS response in the treatment of resistant depression. The author should try to assess whether in the current study baseline QTc before taVNS is associated with outcome and with taVNS response.

      Thank you for the suggestion. The conference abstract in the provided doi stated that QTc as an indirect marker of HRV before implantation was correlated with changes in the depression rating scale. The mechanism seems to be that QTc has information about the pathophysiology of the depression (10.1097/YCT.0000000000000684). The current study focused on the comparison between taVNS treatment and sham treatment. Our future study will further test if SAH patients’ response to taVNS can be predicted by baseline QTc.

      The dose-response issue that affects both VNS and taVNS in different settings should be mentioned (doi: 10.1093/eurheartjsupp/suac036.) as well as the need for more dose-finding preclinical as well as clinical studies in different settings (the best stimulation protocol is likely to be disease-specific).

      Please refer to our responses to comment 3.

      Minor Comments

      Some typos or commas instead of affirmative points and vice versa.

      Thank you for pointing this out. We have carefully proofread the manuscript and made the necessary corrections to ensure proper punctuation and grammar throughout.

      Table 1: why age is expressed as a range for each person?

      MedRxiv asks authors to remove all identifying information. Precise ages are direct identifiers, as opposed to age ranges. We have now revised the age column to ‘decade of life’ in the updated table. We believe this modification reduces confusion while adhering to MedRxiv’s guidelines.

      Although already reported in the study protocol (doi: 10.1101/2024.03.18.24304239), the heart rate limits for inclusion should be reported (sustained bradycardia on arrival with a heart rate < 50 beats per minute for > 5 minutes, implanted pacemaker or another electrical device).

      We have now added the specific inclusion and exclusion criteria in the Method details section (p33): “Inclusion criteria were: (1) Patients with SAH confirmed by CT scan; (2) Age > 18; (3) Patients or their legally authorized representative are able to give consent. Exclusion criteria were: (1) Age < 18; (2) Use of immunosuppressive medications; (3) Receiving ongoing cancer therapy; (4) Implanted electrical device; (5) Sustained bradycardia on admission with a heart rate < 50 beats per minute for > 5 minutes; (6) Considered moribund/at risk of imminent death.”

      Why did the authors choose a taVNS schedule of two times per day of 30 minutes each as compared for instance to one hour per day? Please comment on that also referring to other taVNS studies in the acute setting such as the one by Dasari T et al (doi: 10.1007/s10286-023-00997-z.) where taVNS was applied for 4 hours twice daily. For instance, Yum Kim et al (doi: 10.1038/s41598-022-25864-1) recently reported in a systematic review and meta-analysis of taVNS, safety, that repeated sessions and sessions lasting 60 min or more were shown to be more likely to lead to adverse events.

      The International Consensus-Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation should be referred to and contextualized (doi: 10.3389/fnhum.2020.568051).

      Thank you for raising this question and providing relevant references. We have reviewed the proposed checklist for minimum reporting items in taVNS research (10.3389/fnhum.2020.568051) and have ensured that our manuscript complies with the recommended reporting items.

      The current taVNS schedule was based on findings from Addorisio et al. (2019). We have revised the manuscript to clarify the rationale behind the current taVNS protocol. Please refer to our response to comment 1.2. The two studies mentioned in the comments were published after our trial was designed and initiated (https://clinicaltrials.gov/study/NCT04557618). Based on the meta-analysis by Yum Kim et al., the short duration of treatment sessions might explain the cardiovascular safety of the current taVNS protocol. We are also currently assessing the effects of our taVNS protocol on inflammatory markers.

      Reviewer #3 (Public Review):

      Summary:

      The authors aimed to characterize the cardiovascular effects of acute and repetitive taVNS as an index of safety. The authors concluded that taVNS treatment did not induce adverse cardiovascular effects, such as bradycardia or QT prolongation.

      Strengths:

      This study has the potential to contribute important information about the clinical utility of taVNS as a safe immunomodulatory treatment approach for SAH patients.

      Weaknesses:

      A number of limitations were identified:

      (1) A primary hypothesis should be clearly stated. Even though the authors state the design is a randomized clinical trial, several aspects of the study appear to be exploratory. The method of randomization was not stated. I am assuming it is a forced randomization given the small sample size and approximately equal numbers in each arm.

      Thank you for the suggestion. The current study is part of the NAVSaH trial (NCT04557618), aiming to define the effects of taVNS on inflammatory markers, vasospasm, hydrocephalus, and continuous physiology data. This study focuses on the effects of repetitive and acute taVNS on continuous physiology data to evaluate the cardiovascular safety of the current taVNS protocol. The primary hypothesis tested in our study is that repetitive taVNS increased HRV but did not cause bradycardia and QT prolongation. Following your comments, we have clarified this in the Introduction section (p6): “This interim analysis aims to evaluate the cardiovascular safety of the taVNS protocol and to provide insights that will inform the application of taVNS in SAH patients. The primary outcomes of this trial, including change in the inflammatory cytokine TNF-α and rate of radiographic vasospasm, are available as a pre-print and currently under review.26 Based on a meta-analysis, repeated sessions lasting 60 min or more are likely to lead to aversive effects; therefore, we hypothesized that repetitive taVNS increased HRV but did not cause bradycardia and QT prolongation.23”

      (2) The authors "first investigated whether taVNS treatment induced bradycardia or QT prolongation, both potential adverse effects of vagus nerve stimulation. This analysis showed no significant differences in heart rate calculated from 24-hour ECG recording between groups." A justification should be provided for why a difference is expected from 20 minutes of taVNS over a period of 24 hours. Acute ECG changes are a concern for increasing arrhythmic risk, for example, due to cardiac electrical restitution properties.

      A human study (Clancy, L. A. et al., Brain Stimulation, 2017, https://doi.org/10.1016/j.brs.2014.07.031) has found that 15-min taVNS led to reduced sympathetic activity measured by low-frequency/high-frequency (LF/HF) ratio. The sympathetic activity remained lower than baseline levels during the recovery period, suggesting potential long-term effects of taVNS on cardiovascular function. In addition, the repetitive taVNS treatment in this clinical trial was intended to maintain a steady low-inflammatory state. Given the potential life-threatening implications of bradycardia and QT prolongation in these critically ill patients, we deemed it crucial to evaluate heart rate and QT interval both acutely and from 24-hour ECG monitoring. We have now provided the justification in the Result section (p11): “A study has shown that 15 minutes of taVNS reduced sympathetic activity in healthy individuals, with effects that persist during the recovery period.33 This finding suggests that taVNS may exert long-term effects on cardiovascular function. Therefore, we investigated whether repetitive taVNS treatment affects heart rate and QT interval, key indicators of bradycardia or QT prolongation, using 24-hour ECG recording.”

      An additional value of analyzing 24-hour ECG recording is that we can detect bradycardia or QT prolongation that happen outside the period of the stimulation, which could caused by repetitive taVNS. To this end, we reanalyzed the data and calculated the percentage of prolonged QT intervals using 500ms criterion (Giudicessi, J. R., Noseworthy, P. A. & Ackerman, M. J. The QT Interval. Circulation, 2019). When comparing the percentage of prolonged QT intervals between the treatment groups, we found that changes in prolonged QT intervals percentage from Day 1 were higher in the Sham group (Figure 3F, Mann–Whitney U test, N(taVNS) = 94, N(Sham)=95, p-value < 0.001, Cohen’s d = -0.72). We have now reported the results in the Result section (p11): “To ensure that repetitive taVNS did not lead to QT prolongation happening outside the period of stimulation, we calculated the percentage of prolonged QT intervals. Prolonged QT intervals were defined as corrected QT interval >= 500 ms. We found that changes in prolonged QT intervals percentage from Day 1 were higher in the Sham group (Figure 3F, Mann–Whitney U test, N(taVNS) = 94, N(Sham)=95, p-value < 0.001, Cohen’s d = -0.72).

      The concern regarding acute ECG changes related to increased arrhythmic risk is valid. We have improved the reasoning behind analyzing acute ECG change, which now reads (p20): “Assessing the acute effect of taVNS on cardiovascular is crucial for its safe translation into clinical practice. We compared the acute change of heart rate, corrected QT interval, and heart rate variability between treatment groups, as abrupt changes in the pacing cycle may increase the risk of arrhythmias.”

      (3) More rigorous evaluation is necessary to support the conclusion that taVNS did not change heart rate, HRV, QTc, etc. For example, shifts in peak frequencies of the high-frequency vs. low-frequency power may be effective at distinguishing the effects of taVNS. Further, compensatory sympathetic responses due to taVNS should be explored by quantifying the changes in the trajectory of these metrics during and following taVNS.

      We appreciate your concerns regarding the potential effects on the autonomic system associated with taVNS treatment. We would like to clarify that the primary objective of our study was to evaluate the cardiovascular safety of the taVNS protocol in SAH, with a specific focus on detecting any acute changes in heart rate and QT interval. As you highlighted, such acute ECG changes are a concern for increasing arrhythmic risk. By directly studying the trend of heart rate, HRV, and QT over the acute treatment periods, we found no significant change in these metrics between treatment groups. In addition, these metrics remained within 0.5 standard deviations of their daily fluctuations during and following taVNS treatment (Figure 5 and Supplementary Figure 6). These findings support the conclusion that the current protocol is unlikely to cause cardiac complications.

      In response to your suggestion to conduct a more rigorous analysis, particularly concerning peak frequencies within the high-frequency (HF) and low-frequency (LF) bands, we pursued this analysis to explore more nuanced effects of taVNS on the autonomic system. We compared the shifts in peak frequencies within these bands between the treatment groups and found no significant changes that would suggest a sympathetic or parasympathetic shift following acute taVNS.

      In detail, we have made the following revisions following your comments:

      (1) We have clarified the motivation behind studying the acute change of cardiac metrics following taVNS treatment – monitoring the cardiovascular safety of current taVNS protocol in SAH patients (p18): please refer to response to comment 3.2.

      (2) We compared the peak frequencies of the high-frequency and low-frequency bands following taVNS. added the results in the supplementary materials:

      We note that neurophysiology underlying peak frequencies has not been thoroughly studied in the literature compared to the LF-band power or HF-band power. Therefore, we report this result as an exploratory analysis.

      (3) We have added the changes of QTc during and following taVNS in Figure 5 and showed that they were within 0.5 standard deviations of their daily fluctuations during and following taVNS treatment. We have now shown the changes of HRV during and following taVNS in Supplementary Figure 6 A-D. We added the change of high-frequency power following Reviewer #1’s comment 1.1. Overall, our results suggest that repetitive taVNS increased parasympathetic activities, while there is no evidence that acute taVNS significantly affected heart rate or QT.

      (4) The authors do not state how the QT was corrected and at what range of heart rates. Because all forms of corrections are approximations, the actual QT data should be reported along with the corrected QT.

      The corrected QT interval (QTc) estimates the QT interval at a standard heart rate of 60 bpm. In practice, we removed RR intervals outside of the 300 – 2000 ms range. Further, we removed ectopic beats, defined as RR intervals differing by more than 20% from the one proceeding. We used the Bazett formula to correct the QT intervals: . We have now clarified how QT was corrected in the Method section – Data processing (p35-36): “R-peaks were detected as local maxima in the QRS complexes. P-waves, T-waves, and QRS waves were delineated based on the wavelet transform (Figure 2A-C).34  RR intervals were preprocessed to exclude outliers, defined as RR intervals greater than 2 s or less than 300 ms. RR intervals with > 20% relative difference to the previous interval were considered ectopic beats and excluded from analyses. After preprocessing, RR intervals were used to calculate heart rate, heart rate variability, and corrected QT (QTc) based on Bazett's formula: .44 The corrected QT interval (QTc) estimates the QT interval at a standard heart rate of 60 bpm.”

      We have reported the actual QT data in the Result section (p10 and p 19):” Moreover, changes in corrected QT interval from Day 1 were significantly higher in the Sham group compared to the taVNS group (Figure 3B, Mann–Whitney U test, N(taVNS) = 94, N(Sham)=95, p-value < 0.001, Cohen’s d = -0.57). Similarly, uncorrected QT intervals from Day 1 were higher in the Sham group (Supplementary Figure 10A, Cohen’s d = -0.42).”

      “Supplementary Figure 10B-C shows the acute changes in uncorrected QT interval.”

      (5) The QT extraction method needs to be more robust. For example, in Figure 2C, the baseline voltage of the ECG is shifting while the threshold appears to be fixed. If indeed the threshold is not dynamic and does not account for baseline fluctuations (e.g., due to impedance changes from respiration), then the measures of the QT intervals were likely inaccurate.

      A robust method to estimate the QT interval is essential in our study. To this end, we used the state-of-the-art method to calculate QT intervals. We first applied a 0.5 Hz fifth-order high-pass Butterworth filter and a 60 Hz powerline filter on the ECG recording. The high-pass filtering is used to correct potential baseline fluctuations. Subsequently, a wavelet-based algorithm was used to delineate the QRS complex and T wave (Martínez, J. P., IEEE Transactions on Biomedical Engineering, 2004). In short, this algorithm identifies QRS based on modulus maxima of the wavelet transform of ECG signals. After localizing the R peak, the Q onset is detected as the beginning of the first modulus maximum before the modulus maximum pair created by the R wave. The detection is performed on wavelet transform at a small scale rather than on the original signal, minimizing the effect of baseline shift (see III Detection methods, (5), Cuiwei Li et al., IEEE TBME, 1995, Detection of ECG Characteristic Points Using Wavelet Transforms). T wave is detected similarly based on wavelet transform. Please refer to our response to comment 2.9.

      Martínez, J. P., Almeida, R., Olmos, S., Rocha, A. P., & Laguna, P. (2004). A wavelet-based ECG delineator: evaluation on standard databases. IEEE Transactions on Biomedical Engineering, 51(4), 570-581.

      In Figure 2C, the purple and green lines take the value of 1 at the QRS onset or the T wave offset; otherwise, 0, which might appear to be a threshold. We have now used verticle lines to denote the detected QRS onsets and T wave offsets. Please see below for a comparison of the annotation:

      We have clarified the details of extracting QT intervals from ECG recordings in the Method section (p31): “To calculate cardiac metrics, we first applied a 0.5 Hz fifth-order high-pass Butterworth filter and a 60 Hz powerline filter on ECG data to reduce artifacts. 35 We detected QRS complexes based on the steepness of the absolute gradient of the ECG signal using the Neurokit2 software package.35 R-peaks were detected as local maxima in the QRS complexes. P waves, T waves, and QRS complexes were delineated based on the wavelet transform of the ECG signals proposed by Martinez J. P. et al. (Figure 2A-C).36 This algorithm identifies the QRS complex by searching for modulus maxima, which are peaks in the wavelet transform coefficients that exceed specific thresholds. The onset of the QRS complex is determined as the beginning of the first modulus maximum before the modulus maximum pair created by the R wave. To identify the T wave, the algorithm searches for local maxima in the absolute wavelet transform in a search window defined relative to the QRS complex. Thresholding is used to identify the offset of the T wave.”

      We have modified Figure 2C for better clarity:

      More statistical rigor is needed. For example, in Figure 2D, the change in heart rate for days 5-7, 8-10, and 11-13 is clearly a bimodal distribution and as such, should not be analyzed as a single distribution. Similarly, Figure 2E also shows a bimodal distribution. Without the QT data, it is unclear whether this is due to the application of the heart rate correction method.

      Thank you for raising this concern. Several factors could contribute to the observed distribution of changes in heart rate for days 5-7, 8-10, and 11-13, as shown in Figure 2D. One such factor is the smaller sample size in the later days. The mean duration of hospitalization for the 24 subjects included in this study was 11.29 days, with a standard deviation of 6.43, respectively. Other factors include variations in medical history, SAH pathology, and clinical outcomes during hospitalization. Further analysis revealed that heart rate was lower in patients with improved mRS scores (Supplementary Figure 4B), suggesting that clinical outcomes might impact changes in heart rate. Understanding the association between cardiovascular metrics and clinical assessments, such as vasospasm and inflammation, could help decide whether future taVNS trials should control for these factors when evaluating the effects of taVNS on cardiovascular function. We are currently continuing to recruit SAH patients in this clinical trial, and we plan to perform such analyses in future studies.

      In the manuscript, we reported the effect size between the treatment groups for days 5-7, 8-10, and 11-13. This should be interpreted in conjunction with the characteristics of the distribution. To provide a rigorous interpretation of our results, we have now discussed these considerations in the discussion section (p28): “We noticed a high variance of change in heart rate for days 5 – 7, 8 – 10, and 11 – 13 for both treatment groups (Figure 2D). This may be due to the small sample size in the later days, given that the mean duration of hospitalization for the 24 subjects included in this study was 11.3 days with a standard deviation of 6.4. Differences in medical history and clinical outcomes during hospitalization may also explain the variance of change in heart rate for the later days. For example. heart rate was lower in patients with improved mRS scores (Supplementary Figure 4B). Understanding the association between cardiovascular metrics and clinical assessments, such as vasospasm and inflammation, could help decide whether future taVNS trials should control for these factors when evaluating the effects of taVNS on cardiovascular function.”

      To test our hypothesis that repetitive taVNS does not induce significant heart rate change, we performed a two-tailed equivalence test of heart rate change between the two treatment groups, including data from days 2-13 (Figure 2D, left panel). To verify the validity of this approach, we calculated the Bimodality Coefficient (BC) and performed the Dip Test for unimodality for the distribution of heart rate change for the two treatment groups. The Bimodality Coefficient (BC) is a measure that combines skewness and kurtosis to assess whether a distribution is bimodal or unimodal. A BC value greater than 0.555 typically indicates a bimodal distribution, whereas a BC value less than or equal to 0.555 suggests an unimodal distribution. The Dip Test is a statistical test that assesses the unimodality of a distribution. A non-significant p-value (p-value ≥ 0.05) indicates that the distribution is likely unimodal. This analysis suggests that the distributions of heart rate changes in both treatment groups (days 2 - 13) are unimodal (BC = 0.457 and p = 0.374 for the taVNS treatment group; BC = 0.421 and p = 0.656 for the sham treatment group). This finding provides justification for our statistical approaches.

      Figure 3A shows a number of outliers. A SDNN range of 200 msec should raise concern for a non-sinus rhythm such as arrhythmia or artifact, instead of sinus arrhythmia. Moreover, Figure 3B shows that the Sham RMSSD data distribution is substantially skewed by the presence of at least 3 outliers, resulting in lower RMSSD values compared to taVNS. What types of artifact or arrhythmia discrimination did the authors employ to ensure the reported analysis is on sinus rhythm? The overall results seem to be driven by outliers.

      Mild cardiac abnormalities are common in SAH patients. Therefore, change in cardiovascular metrics was expected to differ from healthy individuals, which makes studying the cardiovascular effect on taVNS extremely important in this context. Following your comment, we investigated whether the large SDNN change was due to arrhythmia or artifacts. Except for a single instance where one subject exhibited an SDNN change of 200 ms on a particular day, all other SDNN changes were less than 150 msec. We identified the subject and day associated with the largest SDNN change, which is Day 7. As shown in Author response image 1A and B, SDNN of this subject increased on day 7 while the heart rate (HR) of this subject decreased. Changes in HRV were inversely related to HR changes, suggesting shifts in sympathetic and parasympathetic tone. We checked the ECG recording and the extracted NN intervals (processed RR intervals) on that day. The NN intervals are more variate on day 7 compared to day 1 (Author response image 1C and D). To determine whether the significant variance observed between 5:01 am and 5:02 am was due to arrhythmia or artifacts, we closely examined the corresponding ECG signals (Author response image 1E and F). Based on our analysis, the elevated SDNN is unlikely to be attributed to artifacts.

      Author response image 1.

      Similarly, we identified the subjects and days corresponding to the most prominent RMSSD decrease in the sham treatment group. We verified the ECG quality for this subject and the accuracy of RR interval identification, and that there was no significant cardiovascular event during the subject’s stay in the ICU. Based on the inclusion and exclusion criteria defined in our protocol (Huguenard A et al.m PLOS ONE, 2024), we did not exclude these data from our analysis.

      Huguenard A, Tan G, Johnson G, Adamek M, Coxon A, et al. (2024) Non-invasive Auricular Vagus nerve stimulation for Subarachnoid Hemorrhage (NAVSaH): Protocol for a prospective, triple-blinded, randomized controlled trial. PLOS ONE 19(8): e0301154. https://doi.org/10.1371/journal.pone.0301154

      To ensure accurate inferences about sympathetic and parasympathetic tone from these cardiovascular metrics, we have rigorously refined our methodologies, including correcting RR intervals outliers, correcting ectopic peaks, using state-of-art algorithms to identify QRS complex, P wave, and T wave (please refer to response to comment 3.5), and performing factor analysis. In addition, no significant cardiac complications have been reported by the attending physicians for the subjects included in this study. Nonetheless, it is important to note that ECG patterns in patients with SAH differ from those in healthy individuals, potentially impacting the accuracy of R peak identification. For example, one identified R peak (out of 73) was Q peak (F in the above figure). The pathology associated with SAH complicates the precise calculation of cardiovascular metrics and the interpretation of the results. We are committed to continually improving our methodologies for assessing autonomic function in SAH patients. We have now discussed these limitations in the Discussion section (p31-32): “Mild cardiac abnormalities are common in SAH patients5, complicating the precise calculation of cardiovascular metrics from ECG signals and the interpretation of the results. Systematic verification of methods for calculating cardiovascular metrics to ensure their applicability in SAH patients is crucial.”

      The above concern will also affect the power analysis, which was reported by authors to have been performed based on the t-test assuming the medium effect size, but the details of sample size calculations were not reported, e.g., X% power, t-test assumed Bonferroni correction in the power analysis, etc.

      Thank you for raising this concern. The current study is part of the NAVSaH trial (NCT04557618), focusing on the trial’s secondary outcomes (Please refer to comment 2.1 and our responses). The main objective of this interim analysis is to evaluate the cardiovascular safety of the current taVNS protocol. Goal enrollment for the pilot NAVSaH trial is 50 patients, based on power calculations to detect significant differences in inflammatory cytokines, radiographic vasospasm, and chronic hydrocephalus. The detailed power analysis is described in the protocol (Huguenard A et al.m PLOS ONE, 2024):

      “Under a 2-by-2 repeated measures design consisting of two groups of patients, each measured at two time points, our goal is to compare the change across time in the taVNS group to the change across time in the Sham group. Based upon previous work from Koopman et al. [67], we assume our study will observe 1.1 standardized inflammatory cytokines mean change difference between the two groups. Using a two-sided, two-sample t-test, assuming both time points have equal variance and there is a weak correlation (i.e., 0.15) between measurement pairs, a sample size of 25 in each group achieves at least 80% power to detect a standardized difference of 1.1 in mean changes, with a significance level (alpha) of 0.05 [68].

      Based on our preliminary data, we assume this study will observe 25% and 55% severe vasospasm in the taVNS and Sham groups, respectively. Under a design with 2 repeated measurements (i.e., 2 raters), assuming a compound symmetry covariance structure with a Rho of 0.2, at a significance level (alpha) of 0.05, a sample size of 25 in each group achieves at least 80% power when the null proportion is 0.55, and the alternative proportion is 0.25 [69–71].

      As previously described, LV et al. [8] studied the relationship between cytokine levels and clinical endpoints in SAH, including hydrocephalus. From their outcomes, we predict a needed enrollment of approximately 50 to detect these endpoints. From our own preliminary data, with an incidence of chronic hydrocephalus 0% in treated patients and 28.6% in control (despite grade of hemorrhage), alpha = 0.05 and power = 0.80, the projected sample size to capture that change is approximately 44 patients.”

      In this study, we used power analysis to report the achieved power of insignificant findings. For example, a Mann-Whitney U test on heart rate change between the treatment groups revealed no significant differences. We then used power analysis to calculate the achieved power. We have added the details of power analysis in the Method section (p34): “We calculated the achieved power of tests on heart rate change between the treatment groups assuming a medium effect size (Cohen’s d of 0.5) and a Type I error probability (a) of 0.05. Given that the Mann-Whitney U test is a non-parametric counterpart to the t-test and that the asymptotic relative efficiency of the U test relative to the t-test is 0.95 with normal distributions, we estimated the achieved power based on the power of a two-sample t-test, which is 0.93. We have clarified this in the introduction section and in the method section (p6 and p38):

      “The current study is part of the NAVSaH trial (NCT04557618) and focuses on the trial’s secondary outcomes, including heart rate, QT interval, HRV, and blood pressure.30 This interim analysis aims to evaluate the cardiovascular safety of the taVNS protocol and to provide insights that will inform the application of taVNS in SAH patients. The primary outcomes of this trial, including change in the inflammatory cytokine TNF-α and rate of radiographic vasospasm, are available as a pre-print and currently under review.24”

      “In this study, we reported the statistical power achieved for tests that yielded non-significant results. The achieved power is calculated based on a two-sample t-test assuming a medium effect size (Cohen’s d of 0.5) and a Type I error probability (a) of 0.05.”

      If the study was designed to show a cardiovascular effect, I am surprised that N=10 per group was considered to be sufficiently powered given the extensive reports in the literature on how HRV measures (except when pathologically low) vary within individuals. Moreover, HRV measures are especially susceptible to noise, artifacts, and outliers.

      If the study was designed to show a lack of cardiovascular effect (as the conclusions and introduction seem to suggest), then a several-fold larger sample size is warranted.

      The primary goal of this study is to assess the cardiovascular safety of the current taVNS protocol in SAH patients (please refer to comments 2.1 and 3.8 and our responses). More specifically, we want to assess whether the current taVNS protocol is associated with bradycardia or QT prolongation. The data in this study included ECG signals and vital signals from 24 subjects recruited between 2021 and 2024. The total number of days in the ICU is 271 days, which corresponds to 542 taVNS/sham treatment sessions. These data allow us to detect significant cardiovascular effects of acute taVNS with high power. For example, the comparison of heart rate from pre- to post-treatment sessions between treatment groups had power > 99% (N1 = 188, N2 = 199, assuming 0.05 type I error probability, medium effect size two sample t-test).

      To safely conclude that there is no significant cardiovascular effect of repetitive taVNS on any given day following SAH, we would need to perform statistical tests between treatment groups on Day 1, Day 2, and Day N. In this context, 64 subjects per treatment group are required to achieve 80% power assuming medium effect size and 0.05 type I error probability (two-sample t-test). We have acknowledged this limitation in the Discussion section. Thank you for raising this concern!

      The results reported in this study treat each day as an independent sample for several reasons. First, heart rate and HRV metrics exhibited great daily variations (Figure in comment 3.7, for example). Their value on one day was not predictive of the metrics on another day, which could be due to medications, interventions, or individualized SAH recovery process during the patient’s stay in the ICU. Second, SAH patients in the ICU often experience rapid/daily changes in clinical status, including fluctuations in intracranial pressure, blood pressure, neurological status, and other vital signs. Also, the recovery process from SAH is highly individualized, with different patients exhibiting distinct trajectories of recovery or complications. Day-to-day cardiovascular function changes varied as the patient recovered or encountered setbacks. Moreover, we verified ECG signal quality, corrected outliers and artifacts in ECG processing, and employed a state-of-the-art QRS delineation method (Please refer to comment 3.5). All these ensure the accuracy of our reported results.

      The revised Discussion section now reads (31): ” Our study considers each day as an independent sample for the following considerations: 1. heart rate and HRV metrics exhibited great daily variations. Their value on one day was not predictive of the metrics on another day, which could be due to medications, interventions, or individualized SAH recovery process during the patient’s stay in the ICU. 2. SAH patients in the ICU often experience daily changes in clinical status, including fluctuations in intracranial pressure, blood pressure, neurological status, and other vital signs. 3. Day-to-day cardiovascular function changes varied as the patient recovered or encountered setbacks. To conclusively establish that there is no significant cardiovascular effect of repetitive taVNS on any given day following SAH, we would need to perform statistical tests between treatment groups for each day. In this context, 64 subjects per treatment group are required to achieve 80% power assuming medium effect size and 0.05 type I error probability (two-sample t-test).”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Reviewer #1 was very appreciative of our results and commented “This is a novel result in ferredoxin and a significant contribution to the field”. We are very honored and pleased.

      Reviewer #2:

      (1) Changing the nomenclature of the models investigated to include the oxidation state being discussed. As they are now (CM, CMNA, etc), multiple re-reads were required to ascertain which redox state was being discussed for a particular model in a given section of the text. Appending "Ox" or "Red" for oxidized or reduced would be sufficient. 

      As you indicated there are several nomenclatures to distinguish the model systems in the text. On the other hand, the main issue discussed in the text is the ionization potential (IP), which is calculated by the difference in energies between oxidized and reduced states for each model. In other words, a discussion of the IP value on each model includes both the “Ox” and “Red” energies. In order to clarify the relationship between the nomenclature of models and redox states, we added sentences below.

      “Note that the IP value is obtained for each model by calculating both the Ox and Red state energies of the model.” (lines 195-196).

      On the other hand, we must specify the charge state when the geometry optimization is performed for CM and CMH models. Therefore, we revised the sentence as follows.

      “The decrease in |IP| value indicates that the relative stability of the Red state is suppressed compared with the CMH but is significantly larger than the CM, suggesting the importance of the protonation of Asp64 (Fig. S2B). 

      To consider the effect of the structural change caused by the redox on the IP, geometrical optimization of the 4Fe-4S core was performed for the CM (Red) and CMH (Red) models using the same level of theory to the single-point calculations. The optimized Cartesian coordinates are summarized in Table S3. As illustrated in Fig. S2A, the IP values of CM and CMH change from –3.27 to –2.38 eV (|DIP| = 0.89 eV), and from –1.06 to –0.19 eV (|DIP| = 0.87 eV), respectively, before and after the geometrical optimization.” (lines 224-232)

      (2) In addition to the very thorough DFT investigation of the different spin and charge combinations, did the authors try a broken-symmetry calculation to obtain the ground state description of the FeS cluster? Given the ubiquity of this approach in other FeS cluster studies, it was surprising that this approach was not taken here. Granted, the DFT investigation of each possible combination is sufficiently thorough and need not be redone. 

      Thank you for your comments. A term “spin-unrestricted method”, which is used in the manuscript in the text is synonym of “broken-symmetry method”. In order to emphasize this, we revised the manuscript as follows. 

      “All calculations were performed by using the spin-unrestricted (broken-symmetry) hybrid DFT method with the B3LYP functional set. As the basis set, 6-31G* and 6-31+G* were used for [Fe, C, N, O, H] and [S] atoms, respectively, for the IP calculations.” (Line 451)

      (3) Line 161 "an" to "a" 

      We corrected the mistake. Thank you so much. (Line 161)

      (4) Figure 4A seems a bit odd. Why do the traces eclipse the y-axis? And the traces between 330 and 370 nm are much noisier and appear thicker than the rest of the plot. Is this an issue with the monochromator grating used in wavelength selection? Reducing the thickness of the individual traces may help the data presentation in this figure. Also, the arrows on the plot have an opaque white background. Can this be removed so that the arrows do not eclipse the traces in the plot? 

      The spectrum in the Fig.4A seemed to be odd. The spectral figure has been revised to improve its appearance. (We have also corrected E53A in Figure 5B.) This reviewer also pointed out that “the traces between 330 and 370 nm are much noisier”. We are struggling with the noise caused by the grating (or the motor malfunction) of the monochromator as you pointed out. Once the monochromator is repaired and a smooth spectrum is obtained, we will upload further revisions.

      (5) Figure S9 is a very nice schematic illustrating the general findings of the study. Can this be moved to the main text?

      Thank you for your helpful comment. Accordingly, the Fig.9S and its legend are moved to the main text. (Lines 675-680)